{"text_format":"2","workbook":"xlsx","n_sheets":10,"sheets":["UQD register","Salesforce Report Data","UQD register NEW","2017-19 UQD","GOS UQD Report 04022020","User Information","UQD register NEW (2)","PAAR_UQD report","Country Comp missing end date","AUP dates 2017-2019"],"not_rendered":{"charts":0,"images":2,"macros":0,"external_links":0,"defined_names":24,"comments":2,"pivot_tables":4},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":2,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"UQD register","index":0,"n_rows":2853,"n_cols":11,"rows_kept":1125,"cut":true,"hidden":true,"merged":[[4,0,4,11],[5,0,5,11]],"bounds":{"rows_first":500,"rows_last":125,"rows_between":500,"halvings":2}}
[]
[null,null,"Register of Unfunded Quality Demand, Updated: 30/10/2019"]
[null,null,"Please refer to the 'User Information' for essential information on interpreting the Register of UQD"]
[]
["UQD Register Analysis"]
{"$rows_empty":11}
[{"$nulls":4},"Applicant","Disease Component","Module","Intervention","UQD Description","UQD expiry date"," UQD amount US$"]
[{"$nulls":4},"Country or Multicountry","FR Component","Module","Intervention","Brief Rationale","End Date","Sum of UQD amount"]
[{"$nulls":4},"Afghanistan","HIV/AIDS","Program management","Grant management","This refers to the PR 7% Grant Management Services (GMS) cost and Sub-recipient 5% overhead cost.","12/31/2020",214501]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","Currently there were 6 provincial coordinators, 5 CDC focal points, 6 drivers and their PPHO running costs. The running cost included maintenance & fuel of vehicles and mobile phone top ups.  This module helped coordinate program activities at sub national level, therefore, it is proposed under above allocation but with some changes. The change aims to increase the number of CDC focal points from 5 to 11 and drop the provincial coordinators and PPHO related costs.","12/31/2020",377846]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","In order to increase adherence of patients to treatment certain social support pckages are proposed.","12/31/2020",768060]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","7-10% total grant budget can be allocated to M&E & surveillance related activities. Hence, the NACP encounters numerous issues in terms of data quality, verification, collection, capacity building in terms of trainings for the M&E and Surveillance staff. Need to recruit three national epidemiologists short-term basis to train staff. Assessment on FIDUs is a critical component of the programs as previously recommended by the TRP to be further strengthened to ensure that the country needs are met.","12/31/2020",483280]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Condoms and lubricant programming for PWID","The activity for female injecting drug users will be started in four provinces i.e. Kabul, Nangarhar, Balkh and Herat provinces. The initiation of this activity will be subject to the assessment results by the end of the year 2017. Currently, there is no intervention for FIDU in the 3 country by any partners.","12/31/2020",423465]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Condoms and lubricant programming for PWID","There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.","12/31/2020",172108]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Sub-recipient NGOs  could mobilize food items for PWID in Drop In Centers (DICs) from other sources.  Considering the status of 5 mentioned clients, it was necessary to provide cooked food; therefore, it was needed to hire six cooks in six provinces. The provinces include: Badakhshan, Kunduz, Ghazni, Kandahar, Nimroz, and Farah.","12/31/2020",28770]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},2468030]
[{"$nulls":5},"Malaria","Case management","Active case detection and investigation (elimination phase)","To  prevent  the  spread  of  malaria  in  Category  2&3   provinces,  early  detection  ,  prompt  treatment  and  case  based  surveillance  are  considered  as  the  top  priority  by  the  program.  These measures are not costed in allocated  funding  request.  In the revised National Malaria Strategy, for the areas in Category 2 & 3 (low or malaria elimination areas), it is recommended to strengthen  malaria  surveillance  through case-based investigation.","12/31/2020",96000]
[{"$nulls":6},"Case management","Facility-based treatment","Studies show variation of G6PD deficiency in areas with high malaria endemicity. 95%   of   cases   are   due   to   Plasmodium   Vivax   whose recurrence results in PV malaria case increase. The cure is a full dose of Primaquine save for G6PD deficiency cases which require supply of G6PD care tests to health facilities. To deploy the testing, a training will be conducted on administration of tests in malaria endemic areas. Estimated test cost $: 2*370,347 = 740,694. Workshop (# of people 1351*51= 68901.Total= 740,694+68901=809,595.","12/31/2020",809595]
[{"$nulls":6},"Case management","Facility-based treatment","To focus on enhancing case confirmation and reduction of  clinical  malaria  cases  specifically  in  high  burden  province  bordering Pakistan,  it  is  needed  to  distribute RDT and have a regular coordination meeting with   health   facilities   staff   and   Community   Health   Supervisors to  share  the  surveillance  gaps, guidance on improvement of on the spot data quality, and review the implementation of malaria case management    by    conducting    Biannual meetings with staff from   7   high-risk   malaria   provinces   bordering  Pakistan.","12/31/2020",100044]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Based on the Malaria  Program  Review recommendation, National Strategy was revised  in  March  2017, it stratified the country into 3 categories with category 1 consisting of high malaria endemicity provinces. LLINs is the only vector control measure used.  Funding was requested to procure LLINs  to  cover  category  1  districts  but  not  all  districts were covered.  Therefore, funds are needed to procure more LLINs. Distribution will   be   done   as   per   WHO   recommendation. No. of LLINs required = 1,615,363.","12/31/2020",0]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Pregnant women living in malaria endemic areas (category 1) require protection and will receive LLIN.  It is recommended  to provide a LLIN to all pregnant women visiting ANC  in  areas of Category 1 which are not covered in the malaria funding  request.  Due to inaccurate data the LLIN numbers are insufficient. No. of LLINs estimated to be distributed among  pregnant women visiting ANCs  (calculated  based  on  the ANC visits in those areas) = 364,307.","12/31/2020",1092920]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","Category  2&3  provinces  prone  for  malaria  epidemics lack vector  control measure (LLINs) Population here is mostly  not immune, so single  malaria  case  carries high transmission risk (especially considering  migration and movement of internally   displaced population).   It is proposed to procure the stock of insecticide for IRS and larvaciding, cosnidering   geographic and  logistical challenges of re-supply.    This will facilitate immediate response to   outbreak   investigation   and   response   in   the   elimination areas.","12/31/2020",300000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Under   the   2015-2017 grant,   Malaria   &   Leishmaniosis Information Systems (MLIS) have been piloted in 4 provinces, evidence based scale up of MLIS is planned for the next grant period.  Required activities are;  training session for HMIS  officers  from  PHDs  &  BPHS  implementers, Malaria  Control  officers  and heads of health facilities.  Lower  health  facilities level,  which   are   considered   for   RDTs   distribution  under  allocation  request,  planned  to  be  oriented on MLIS reporting system in RDT use training sessions.","12/31/2020",36520]
[{"$nulls":5},"Malaria Total",{"$nulls":4},2435079]
[{"$nulls":5},"Tuberculosis, RSSH","TB care and prevention","Case detection and diagnosis","5 GeneXpert machines are already deployed. Ten machines will be deployed by CTB and 10 are included GF TB grant for Provincial Hospitals. This UQD includes additional 10 GeneXpert machines for Provincial and District Hospital TB diagnostic centers. This requires installation costs ($25,000 per machine X 10 = $250,000) and testing kits ($24,000 per unit X 10 units x 3 years = $720,000).","(blank)",970000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","The TB grant incudes active contact management through household visits for smear-positive cases. To maximize impact, active contact management of all cases is required. This expansion should identify an additional 1,000 cases per year. This UQD includes the costs of household visits for an additional 20,000 smear-negative and extra-pulmonary cases per year ($20 per visit X 20,000 cases = $400,000 per year or $1,200,000 for 3 years).","(blank)",1200000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","To enhance diagnostic capacities and provide high quality laboratory services, the preferred LPA DST equipment is being proposed for 3 RRLs. The cost of each LPA with PCR is US$ 50,000 or US$ 150,000 for 3 RRLs. US$ 10,000 per laboratory per year is necessary for the diagnostic kits (US$ 10,000 X 3 X 3 = US$ 90,000) for a total of US$ 240,000.","(blank)",240000]
[{"$nulls":6},"TB care and prevention","Collaborative activities with other programs and sectors (TB care and prevention)","Expanding PPM DOTS will further increase case notifications while engaging the private sector. The NTP proposes to scale-up 10 additional cities with significant numbers of private practitioners. This expansion should identify an additional 600 cases per year. This PAAR includes costs for site preparation in 10 provinces (US$ 1,500 X 10 = US$ 15,000) and costs for private practitioner orientation (US$ 1,800 X 10 = US$ 18,000).","(blank)",33000]
[{"$nulls":6},"TB care and prevention","Community TB care delivery","Based on effective results, scale up CB-DOTS in additional 15 provinces to expand case notifications and broaden efforts to reduce stigma. This expansion should identify another 1,000 cases per year. This UQD includes training  ($5,000 per training X 15 provinces = $75,000) and incentives for case-finding and treatment support ($3 each to two persons per case X 1,000 cases x 3 years = $18,000).","(blank)",93000]
[{"$nulls":6},"TB care and prevention","Community TB care delivery","TB Patient Associations in 12 provinces have been supported by GF and are included in the allocation to reduce stigma, address gender-related issues and support community empowerment. This UQD includes expansion to all remaining provinces ($400 per Association X 22 X 3 years = $26,400) and incentives for case-finding and treatment support.","(blank)",31800]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The nations only Quality Control Laboratory for pharmaceuticals and medical products has limited capacity, staff and resources although there is a huge private sector importing pharmaceuticals. A second Regional Laboratory is requested in TB-RSSH Funding Request including training and the development of a National Strategy, SOPs and Quality Assurance Guidelines. This UQD includes functionalization of another Regional Pharmaceutical Quality Control Laboratory.","(blank)",756132]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","To promote engagement of the large private sector, 10 Private Public Partnerships (PPPs) are being requested through the TB-RSSH Funding Request within the allocation. An additional 40 PPPs are being proposed for UQD funding to expand pilot testing and enrich the data in diverse geographical and cultural settings in 4 remaining Regions. This UQD includes renovation of selected facilities, supplies and equipment, monitoring visits and operational costs.","(blank)",400752]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Service organization and facility management","To address high Maternal Mortality, the Citizen Charter proposes a few thousand FHHs. All partners indicated support for the expansion of FHHs. The TB-RSSH grant includes 35 FHHs and this UQD includes additional 15 FHHs. This UQD includes medical kits ($39,525), socialization and awareness in communities for site mapping ($78,026), basic supplies, equipment, medicines, staff support, training expenses, operational/maintenance costs ($493,525) and transportation of renovation materials ($2,239).","(blank)",613315]
[{"$nulls":5},"Tuberculosis, RSSH Total",{"$nulls":4},4337999]
[{"$nulls":4},"Albania","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Assess sex worker conditions and legislation and implications for their security and health","12/31/2022",9750]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Prepare Sex worker monitoring health guidelines","12/31/2022",7000]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","Establish outreach programmes of VCT services in most-at-risk communities","12/31/2022",40344]
[{"$nulls":6},"TB care and prevention","Community TB care delivery","Implement ACSM activities during the World TB Days. Various ACSM activities, including the organization of a nation-wide conference for TB professionals, will be conducted on and around the World TB Day 24 March, following the topics will be  proposed for each years campaign","12/31/2022",6000]
[{"$nulls":6},"TB care and prevention","Community TB care delivery","Training of Social workers on support for TB patients (is NOT a No 1 priority: 1-day training of 25 social workers in Tirana","12/31/2022",1713]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Counselling Services: Counselling support fordiscordant couples","12/31/2022",6724]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Provide counselling for children and adolescents LHIV services on HIV status disclosure, ART adherence, healthy nutrition, coping with emotions etc.Strengthening the quality of Counselling will contribute to higher utilisation of HIV testing services.","12/31/2022",15000]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Support for documenting human rights violations and train community-based groups on their rights, to facilitate access to justice for key populations and to enforce their rights.","12/31/2022",3000]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Support the ageing PLHIV; Drive support and education for older people with HIV, emotional, psychological and social support for people aging with HIV/AIDS and offering support in order to have access on HIV services to ensure a good quality of life","12/31/2022",15000]
[{"$nulls":6},"Treatment, care and support","HIV care","Provide support services to increase and improve women knowledge and skills for the information and education on issue related to women LHIV; and develop I&E materials on strengthening and the building capacities of HIV women group on their gender, SRH and treatment issues","12/31/2022",15000]
[{"$nulls":6},"Treatment, care and support","Prevention, diagnosis and treatment of opportunistic infections","Improve diagnostic capacities for OI (according to guidelines) by Training of microbiologist and ID for diagnosis of OI","12/31/2022",7850]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Assess current Viral Hepatitis treatment capacities and capabilities (drugs, guidelines, services etc)  for Albanian population and especially risk groups","12/31/2022",20000]
[{"$nulls":6},"Treatment, care and support","Differentiated ART service delivery","Provide TA to further strengthen Patient monitoring system for adherence. A partient-monitoring system is in place, but additional TA can further strengthen it.","12/31/2022",7350]
[{"$nulls":6},"Treatment, care and support","Differentiated ART service delivery","Review and update the PEP and PrEP guidelines pilot PrEP for MSM","12/31/2022",3925]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Evaluate pilot of a new technology in TB and HIV care, such as Video Dots","12/31/2022",9350]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Evaluate pilot of PREP for MSM to assess its impact","12/31/2022",10100]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Establish a quality assurance monitoring system of HIV prevention, treatment care and support services","12/31/2022",12350]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Establish service performance indicators and their measurement","12/31/2022",7500]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Improve the database system for HIV by web linking of laboratory and epidemiological data. This would further strengthen the HIV database that is already being developed.","12/31/2022",11600]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Update HIV / AIDS / TB reporting forms to ensure consistency with proposed joint HIV / TB database","12/31/2022",3750]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Update surveillance guideline system","12/31/2022",10200]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Conduct next round of IBBSin KPs; IBBS will be done in late 2019. Given the high cost, the Transition grant cannot finance it, but if available, PAAR could finance the next round in 2022.","12/31/2022",137335]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Establish a sustainable sentinel surveillance system for HIV/STI/Viral Hepatitis in KPs (MSM, sex workers, prisoners) by a partnership of government structures with civil society and other partners","12/31/2022",9750]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","TB knowledge, attitude and practice (KAP) study","12/31/2022",19350]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Prepare a training program for HIV for district epidemiologists. The training of district-level epidemiologists will support the overal decentralisation of health services, and HIV services in particular.","12/31/2022",7250]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Administrative and finance data sources","Implement OneHealth tool to harmonize and strengthen health system analysis, costing and financing scenarios at the country level","12/31/2022",33500]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish auditing programmes for MMT services","12/31/2022",750]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish auditing programs for KP (sex workers, LGBTQ, PWID) health and social services offered by all stakeholders","12/31/2022",2250]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish guidelines and provide KP-specific friendly health services (PWID, sex workers,  Roma)","12/31/2022",1500]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Offer IEM for KPs health for communities and offer continuous community education programs (LGBTI, sex workers)","12/31/2022",24850]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Assess behaviour change and influence of stigma, discrimination and social exclusion in certain KPs (LGBTQ / sex workers) in Albania through a national study","12/31/2022",32000]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish online resource centre with materials and training courses (in Albanian) for professionals and NGOs on KP (sex worker, LGBTI) health and social services","12/31/2022",9500]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish standards for Key population social and health services (sex workers, LGBTI)","12/31/2022",15250]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},516791]
[{"$nulls":4},"Algeria","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","The prevalence among female sex workers is 72 times higher than the national average. Several factors contribute to this situation, including limited access to prevention, care and treatment services and the lack of coverage of certain areas by Community Systems Organisation (CSOs). This additional investment will provide services to 6248 Commercial Sex Workers (CSWs) in areas currently not covered by CSOs based on the results of the mapping of key populations that will be available before the start of the transition grant.","12/31/2022",234098.55]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Migrants are classified as a priority population. However, to date they have not benefited from structured prevention activities and the 2019 IBBS results confirmed a HIV prevalence rate of 2.2% among migrants, similar to the rate among Men having sex with Men (MSMs). Migrants' access to care is difficult due to their lack of awareness about available prevention programs and HIV treatment centers. This access is also made difficult due to their fear to consult public health structures, given their illegal status and rumors that public structures poison people with AIDS. Thus, this request will provide at least the 1,500 migrants who participated in the IBBS with prevention, screening and treatment activities in collaboration with the International Organisation for Migration (IOM) and other technical partners.","12/31/2022",720342]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Stigma and discrimination in care settings for PLHIV and key populations is a reality in Algeria, as evidenced by the results of the \"Index stigma\" study. These behaviors are an obstacle to key populations accessing services, especially treatment. Thus, it is planned to train the staff of 60 testing centers and 15 reference centers on medical ethics to raise their awareness about challenges faced by KPs, reduce social rejection and discrimination within care structures as well as improve the quality of care on the one hand and on the other hand organize meetings periodically to handle complaints in accordance with Article 28 of the new law on health.","12/31/2022",252540.1]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","The adoption of the community-based testing strategy will allow the community-based organizations and structures to test key populations with the objective of extending access to testing services. In light of the modest resources for the transition funding request (2.3 million), it is planned to organize a training for a reduced number of staff (15 persons, 3 per Community Service Organisation/CSO). This will allow to train a critical number of staff, with a planned government contribution to increase the number of staff trained to the 123 outreach CSO workers (Peer educators, Supervisors and Social health workers) who will contribute to implementing activities included in the transition grant.","12/31/2022",114469.88]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},1321450.5300000003]
[{"$nulls":4},"Angola","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Addressing stigma, discrimination and violence against sex workers","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate sex workers to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of sex workers reached with services.","(blank)",30000]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","Presently, sex workers have weak organizations and networks to organize and mobilize their members. The PAAR  application  will  strengthen KP organizations to organize and mobilize members for KP service delivery including advocacy.  Activities will include community mobilization, training on sexuality, strengthening and supporting organizing of sex workers , providing safe spaces/drop in centres. Expected outcome will be increase in sex worker  reached with programs through sex workers networks and organizations.","(blank)",600000]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","This is a program still in its infancy in the current grant with only 1,764  youth and adolescent -out of school  who had been reached by program implemented by UNFPA (SSR)  that started in July 2016 in three provinces of Luanda, Benguela, Cunene and  Huila.The allocation amount in this application plus domestic contribution will only scale up this up to 31% (400,559) of country need. The PAAR will aim to expand  coverage to six  more provinces (Cuando-Cubango, Moxico,Lunda Sul, Lunda Norte, Cuanza Norte and Bie) and scale up targets  to 15% in 2018; 20% in 2019, 30% in 2019 and 40% in 2021 respectively ( 172,289 in 2018; 239,596 in 2019; 375,070 in 2020; and 587,341 in 2021). Expected outcome will be increase in percentage of adolescent and young girls out of school reached with a package of prevention services and linked to care and treatment.","(blank)",1000000]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Socioeconomic approaches","The PAAR application will support social grants and cash transfers to support out- of -school young girls and women with  income generating activities (IGAs) grants. This activity will provide training in vocational skills and grants  through SR/SSR targeting young and women working in markets and vocational jobs like knitting, saloons, tailoring, poultry farming, piggery projects, etc to reduce their  economic vulnerability.","(blank)",400000]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Implementation of activities will commence in this application as the current grant is only planned to conduct  an IBBS study among truck drivers. The allocation amount in this application plus domestic contribution will only scale up targets in this module up to 40% (8,219) of country need. The PAAR will aim to scale up  coverage to 30% in 2018; 35% in 2019, 40% in 2019 and 50% in 2021 respectively (5,414 in 2018; 6,676 in 2019; 7,918 in 2020; and 10,278 in 2021). Expected outcome will be increase in percentage of truck drivers  reached with a package of prevention services and linked to care and treatment.","(blank)",580000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","PAAR to support procurement of additional laboratory  materials and consumable in  2019, 2020 and 2021 to reach targets. The items will include sputum containers and protection masks(3M N95) and reagents. Expected outcome will be increase in CNR.","(blank)",499050]
[{"$nulls":6},"TB care and prevention","Community TB care delivery","The PAAR will support development of IEC Materials and  training  for community workers and Social mobilization on Community TB Care  in 18 provinces (210 agents for 84 municipalities)PAAR investment  will support Treatment Adherence  interventions (TAIs) catalytic to achieving the ambitious CNR and TSR targets, focusing on strengthening community  and peer support (ex-TB patients etc), food vouchers and transport refunds , home visits and others initiatives to mitigate the castrophic  costs from TB and improve treatment outcomes. Expected outcome will be increase in CNR and TSR.","(blank)",260000]
[{"$nulls":6},"TB care and prevention","Prevention","PAAR application will support procurement  INH for IPT among eligible  PLHIV and children of contacts with TB patients who test negative for TB screening in years 2019, 2020 and 2021. (see TB/HIV collaboration). Expected outcome will reduction in TB incidence.","(blank)",536058]
[{"$nulls":6},"TB care and prevention","Treatment","PAAR to support quarterly supervision to health facilities (84 DOT sites in 18 provinces and communities)  in 2019, 2020 and, 2021. Expected outcome will be increase in TSR of TB cases.","(blank)",238560]
[{"$nulls":6},"TB care and prevention","Treatment","PAAR to support the printing  of  handbooks on (i) TB cases management (ii) TB in children; (iii) MDR-TB management and control; (iv) TB/HIV coinfection control; (iv) tasks of DOTS-C agents  in 2019. Expected outcome will be increase in quality of TB services in line with international standard for TB care (ISTC).","(blank)",150000]
[{"$nulls":6},"TB/HIV","Engaging all care providers (TB/HIV)","PAAR investment will support activities of engaging public and private/CSO providers (PPP/PPM)  in TB/HIV control activities (screening, diagnosis, treatment and follow-up of patients), CBOs will be supported to connect people at risk of HIV and/or TB with information and services.  Activities will include training of service providers, certification and accreditation, quality assurance, supervision and monitoring, advocacy and communication. PAAR investment will support training in cases management of TB  and directly observed short treatment among TB cases detected and followed up by  prisons health teams, mines and oil companies, and  NGOs who work with TB high risk groups. Expected outcome will be increase in TB CNR and TSR.Expected outcome will be increase in coverage targets and quality of TB/HIV services.","(blank)",750000]
[{"$nulls":6},"TB/HIV","TB/HIV collaborative interventions","PAAR investment will support activities for TB/ HIV increased integration at both national and district level by  supporting  TWG quarterly meeting at  provincial and municipality levels, joint TB/ HIV planning and supervision of integrated delivery of TB and HIV services.","(blank)",360000]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","Additional PAAR investment for activities to contribute to the 90-90-90 targets will include intensifying peer adherence counseling and provision of psychosocial support to PLHIV at ART sites and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities. Expected out will be number of PLHIV retained in care and virally suppressed.","(blank)",600000]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","This study to be conducted in 2019 and 2021  provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the DHIS2. This cohort analysis will include adults, children and women initiated on ART during pregnancy for the first time. The impact will be increased availability of strategic information to inform programming and implementation","(blank)",300000]
[{"$nulls":6},"Treatment, care and support","Differentiated ART service delivery","Current ART coverage for Angola according to the revised program  data (2016) from a recent program data assessment standards at  21.4% (adults and children). The allocation amount in this application plus domestic contribution will only scale up this up to 45% which is still far below the global 90-90-90 targets. The PAAR will aim to scale up ART coverage to 33% in 2018; 39% in 2019, 46% in 2019 and 50% in 2021 respectively ( 100,404 in 2018; 121,281 in 2019; 146,008 in 2020; and 161,871 in 2021). Expected outcome will be increase in percentage of adults and children receiving antiretroviral therapy.","(blank)",3000000]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","The investment in the allocation amount is able to support one Viral load platform in Luanda and is inadequate to achieve viral load testing targets. PAAR in this module is request to support the three additional viral load testing  platforms to be able to meet all targets ( see Annex 17 on projections of viral load testing). The expected outcome will be number of PLHIV on ART test for viral load and improved monitoring of the 90-90-90 care and treatment cascade.","(blank)",1000000]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Addressing stigma, discrimination and violence against MSM","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate MSM to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of MSM reached with services.","(blank)",30000]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis: MDR-TB","PAAR will support refresher training of Laboratory staff  in  diagnosis of MDRTB in 2019  and reagents for solid and liquid culture, three (3) LPA (Line Probe Assay) equipments and their respective reagents. Expected outcome will be increase in MDR TB cases detected and notified.","(blank)",177750]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.","(blank)",355500]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","The investment in the allocation amount is able to support one Early Infant diagnosis (EID) platform in Luanda and is inadequate to achieve all PMTCT targets in this application. PAAR in this module is requested to support IEC, Rapid test , M& E tools and the two additional viral load/IED testing  platforms to be able to meet PMTCT targets ( see Annex 17 on projections of viral load testing). The expected outcome will increase in number of children diagnosed of HIV and initiated on antiretroviral therapy.","(blank)",0]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},10866918]
[{"$nulls":5},"Malaria","Case management","Other case management intervention(s)","Increasing access to primary health care services(iCCM) through ADECOs is seen as a priority by the GoA. In this above allocation, iCCM will be expanded to a further six (6) municipalities, distributed as follows: Moxico (1), Malange (3) and Uige Province(2). These Provinces were chosen for increased coverage due to their malaria burden, access to health care and population   The total ADECOS expected to be trained under this above allocation will be 240. Children less than 5 years of age that have access to health care will  increase from 11% to 20% by the end of the Grant. The total cost is 500.000 USD, to cover, five days training for ADECOS ( ToT and ADECOS training) visibility materials( t-shirts, cups, boots, cup rain, smartphones, mobile data service.","6/30/2021",500000]
[{"$nulls":6},"Case management","Other case management intervention(s)","This above allocation is to support the procurement of injectable artesunate and injectable artemether for treatment of severe malaria over the 3 years of this grant. In 2018, 2019 and 2020 respectively 442,275; 482,813 and 490,296 estimated cases of severe malaria will occur. In Angola severe malaria is treated in the following proportion: 50% receive injectable Artesunate, 33% injectable Artemether and 17% quinine. The GOA has prioritized increasing access to diagnosis and treatment in the most vulnerable groups shown by their increased domestic allocation for both RDTs and ACTs. Increasing access to early and correct diagnosis and treatment in the community through ADECOS will in turn reduce the number of severe malaria cases and therefore mortality from severe malaria in hospitals. Injectable artesunate requested is intended for the treatment of the vulnerable population of children <5 years of age, that represent 17% of severe malaria cases per year is requested under this concept note. The MoH will procure the rest of injectable artesunate for patients> 5 years. The purchase cost of 1 ampoule of 70mg / ml is estimated at 2.52 USD (price) + PSM (35%). For injectable Artemether, Angola is requesting sufficient to treat 33% of all severe malaria  cases  from  all age groups with severe malaria. The cost of purchasing an ampoule of 80 mg / ml is estimated at $ 0.46 (price) + PSM (35%). The TOTAL of these purchases is USD 4,895,388 requested in this above allocation.","6/30/2021",0]
[{"$nulls":6},"Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Improving ANC attendance and increasing IPTp coverage is a priority for the NMCP, to improve health outcomes for the pregnant women and her unborn child. The IIMS (2015/2016) showed that only 19% of pregnant women had received 3 or more doses of IPTp during ANC visits. Stock-out have been a major reason for this low coverage. The gap analysis shows a gap in the aquisition of Sulfadoxine + Pyrimethamine (SP) for intermittent Preventative treatment for pregnant woman, one of the MoH target groups.. The MoH and PMI will acquire a total of 31,146 bottles of 1000 tablets during the 3 years. The gap is 7166 bottles of 1000 SP tablets which is requested from the FG in this above allocation. The expected impact is the reduction of maternal morbidity and mortality from malaria and improved outcomes for newborn child. The cost is estimated at 27 USD per bottle of 1000 tablets + PSM (35%). The total is 261,267.00 USD","6/30/2021",261267]
[{"$nulls":6},"Other module","Other module","In order to ensure epidemiological surveillance, monitoring and evaluation of malaria activities are implemented at the operational level (provincial, municipal, health and community units), particularly in the regions of the country where the Multiple Indicators and Health Survey IIMS 2015/16 showed a high prevalence of malaria, , an amount for the payment of salaries of 6 OPPMs for the last year of the 2018-2021 grant is requested in the above allocation. It should be noted that the number of OPPMs was 18 in the current GF 2016-2017 grant, and will be reduced to 6 in be financed under the first 2 years of the FG 2018-2021 grant. The annual salary of each OPPM is USD 47,994.48 and the annual cost of the 6 OPPMs for the last year of the grant is USD 287,966.88. The provincial focal points are to maintain active epidemiological surveillance in these high prevalence provinces to mitigate the emergence of possible malaria epidemics and thereby have quality data and evidence to allow for better quantification and programming of resources.","6/30/2021",287967]
[{"$nulls":6},"Other module","Other module","The survey to determine the epidemiological stratification of the country was conducted in the early 1980s, sampling at Provincial rather than municipality level. Recent surveys have shown a shift in prevalence patterns and malaria burden  that requires that the country epidemiological profile is updated to facilitate the planning and geographical targeting of types of interventions and decision-making.To this end, an amount of US $ 355,378.12 is requested to carry out a. study in 2019.","6/30/2021",355378]
[{"$nulls":5},"Malaria Total",{"$nulls":4},1404612]
[{"$nulls":5},"RSSH","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","For effective public health decision-making, morbidity and logistics data have to be available, analysed and interpreted jointly. Interoperability and integration of the two DHIS2 and OpenLMIS platforms is therefore essential.This allocation will allow the installation of OpenLMIS on the HIS platform and of DHIS2 on Amazon Web Services (AWS, a cloud-based infrastructure). Most importantly, the human resources involved in entering and using data in the two systems will require adequate training.","12/31/2021",86062]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Geographic and historic expansion of DHIS2: Training on the health information system and on how to use DHIS2 has been provided to health technicians in all of the countrys 164 Municipalities. However, only selected municipalities in 7 provinces currently report through DHIS. Funding is required to ensure national coverage (11 remaining provinces) to fund equipment provision, data quality assurance and supervision of reporting through DHIS 2 from all 164 Municipalities. DHIS 2 deployment will be gradual in accordance with the Road map agreed between MoH and its development partners. While current and future data is being entered into DHIS 2, there is a need to capture and archive historic data before data collection instruments are destroyed or disappear. Migration of historic, Excel based data available at municipal level into DHIS 2 (2016-2017 data) is therefore urgent.","12/31/2021",274440]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","RSSH: DHIS 2: The issue of maintenance of the IT equipment, and IT capacity to use DHIS 2 risks limiting the sustainability of DHIS 2 if it is not adequately addressed. There is an urgent need to assess to what extent Municipalities have access to IT expertise. Once identified, IT Focal Points should be hired in each of the 164 Municipalities, and motivated, to provide maintenance and data insertion services. The Focal Points will also ensure access to Internet and address some difficulties inherent to IT in all provinces.RSSH: LMIS: OpenLMIS requires a functioning national PSM system to be sustainable. Therefore, systemic issues identified through this Funding Request need to be addressed for OpenLMIS to function as intended. At provincial level, a comprehensive support to warehouses should be given which includes 1) support to rehabilitation; 2) facilitation of access to alternative sources of energy, such as solar energy; 3) development of Procedures Manual; acquisition of standard warehousing equipment including temperature and humidity monitors, air conditioners, pallets, forklifts, shelves. At central level, CECOMA should also be supported with a similar package involving infrastructure rehabilitation, development of a Procedures Manual, acquisition of air conditioners. Opportunities for review and validation of the stock data from OpenLMIS, involving central and provincial level warehouse managers should also be created and funded. Still at central level, advocacy and technical assistance to DNME is required for the validation of the national List of Essential Medicines, the creation of an effective drug registration system and a national pharmaco vigilance system.","12/31/2021",2383489]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","HIS Governance Strengthening: Support Expanded Terms of Reference by the National Technical Team for inclusion in OpenLMIS; Support creation of municipal technical teams.","12/31/2021",34224]
[{"$nulls":5},"RSSH Total",{"$nulls":4},2778215]
[{"$nulls":4},"Armenia","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Diagnosis and treatment of STIs and other sexual and reproductive health services for sex workers","STI testing and treatment for Sex Workers (SW) (medical staff salaries, procurement of medical supplies for STI and STI drugs): 30% of reached clients will receive referral for STI testing and 18% of reached clients are expected to require STI treatment.Screening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","9/30/2021",0]
[{"$nulls":6},"Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","The total number of urban migrants in Armenia can be as high as 60,000. Therefore, although coverage of 5000 migrants and their sexual partners has been included in the main allocation request, covering additional 5000 is needed in particular if the Russian aid program fails to continue. So additional amount of funds is planned to be spent on this program component if available.","9/30/2021",0]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","HCV treatment procurement for HIV positive and HCV treatment monitoring for 600 persons during the 2,5 years periodSocial support program (cash-incentives for adherence to treatment) for patients with DS (regular) TB.HCV represents a growing concern with the prevalence among seasonal urban migrants found to be 3.3% in 2018 IBBS study. MoH and NCAP have piloted DAA HCV treatment with medicines donated by the Georgian government and MSF. MoH and NCAP are currently negotiating continued HCV treatment programmes with producers and suppliers of DAA medications. While these negotiations are under was modest number of treatment courses required to treat HIV/HCV coinfected patients is included in the above allocation request.","9/30/2021",495000]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Social support program to incentivise treatment adherence among patient with drug-susceptible tuberculosis in addition to the social support of patients with drug-resistant TB covered under the TB grant program.","9/30/2021",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Improvement of client registration, unification of coding system and integration of programme monitoring data into common database. Training regarding stigma and discrimination - in total 5 trainings were budgeted. Trainings for outreach workers - in total 5 trainings were budgeted.In order to strengthen programme monitoring and reporting accuracy and avoid potential duplication of efforts (e.g. of Men who have Sex with Men (MSM), SW and PWID activities funded by the Global Fund and EJAF) Principal Recipient will introduce uniform Unique Identification Code across projects and organisations and pursue integration of monitoring systems and introduction of a shared database. Accurate programme reporting is essential for adequate target setting and precise measurements of achievements in the response to the epidemic. Introduction of these innovations will require training for field workers.","9/30/2021",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","IBBS (Integrated Biology and Behavioural Survey) among PWID, MSM, TG, SW, Migrants in Y2 in order to assess the situation and measure progress in HIV prevention and treatment.The previous IBBS studies have been funded by the Global Fund grants. The government has not yet assumed this function, hence funding for IBBS studies is included in the above allocation request.","9/30/2021",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","USD 200,000 to support the roll out of ECHO project (tele-medecine platform) in Armenia in cooperation with the ADB. Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services.","9/30/2021",0]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Procurement of HCV rapid tests (for 1390 tests in Y1, 1748 tests in Y2 and 1600 tests in Y3 based on the assumptions that 50% of PWIDs tested for HIV will be tested for HCV).","9/30/2021",0]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Diagnosis and treatment of STIs and other sexual health services for MSM","STI testing and treatment for MSM (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment. Screening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","9/30/2021",0]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Diagnosis and treatment of STIs and sexual health services for TGs","STI testing and treatment for Transgender (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment. Screening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","9/30/2021",0]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},495000]
[{"$nulls":4},"Azerbaijan","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services (currently HIV services are only provided in Yerevan). The vision is to further expand Echo in other areas of health in collaboration with the recent Asian Development Bank (ADB) program focused on health sector policy reforms to strengthen efficient utilization of resources and to improve quality of services.","6/30/2021",70148]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Build awareness of key decision makers on evidence-based HIV prevention interventions in penitentiary sector. Activities include information and advocacy meetings (round tables/workshops) to increase awareness about evidence-based HIV prevention intervention in prisons.","6/30/2021",13595]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Behavioral interventions for people in prisons and other closed settings","Proposed funding will cover the Echo start-up activities: (a) Establishing Echo network hub in Yerevan; (b) Training of medical staff in using the web-based software; (c) Tele-echo clinics in AIDS and TB curated by ECHO team from University of New Mexico; (d) Case-based learning and guided practice in TB and AIDS; e) Access to specialist knowledge in AIDS, TB, infectious diseases, pharmacology.","6/30/2021",99000]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","1. Strengthen stigma related capacity for medical personnel of ART centres.2. Organization of 2 communication campaigns organized per year in the eve of notable days (WAD, Candlelight) to build public awareness and reduce stigma and discrimination.","6/30/2021",48927]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","Procurement of HIV Viral Load tests and CD4 tests for regular laboratory and clinical examination of PLHIV in civil sector. Treatment monittoring is critical considering increasing treatment coverage and low VL suppression in the country.","6/30/2021",1272512]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Procurement of AIDS software as part of National HIS support.","6/30/2021",20991]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Operational research: Surveys among detainees in 23 penitentiary facilities to evaluate the efficiency of the implemented HIV prevention interventions in penitentiary sector.","6/30/2021",20812]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Echo is a tele-medicine platform developed at the University of New Mexico to serve rural populations, and which has been used by US CDC as a method for introducing new approaches in clinical practice in elimination of HIV and Hep C, and then has been also extended for TB. It was successfully introduced in Georgia for these three diseases. It links expert specialist teams at an academic hub with primary care clinicians in local communities. It allows primary care clinicians/TB or HIV doctors from multiple sites present patient cases to the specialist teams and to each other, discuss new developments relating to their patients, and determine treatment.","6/30/2021",328814]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Training for service providers from OST sites.","6/30/2021",6798]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","PDI, Optimized HIV case finding and HIV case management interventions with focus on men who have sex with men","6/30/2021",30441]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","1. Training for community health workers on ARV treatment.2. Participation in trainings, international conferences for Republican AIDS Centre, MoJ staff and NGOs in priority issues of HIV/AIDS.","6/30/2021",97684]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},2009722]
[{"$nulls":5},"Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Joint TB Program Review led by the WHO Country Offices and conducted jointly with international experts.","12/31/2020",50000]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Participation in training courses and conferences in various aspects of TB control including of TB control in prisons, for knowledge update and experience exchange","12/31/2020",42000]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","1. Procurement of additional 1000 Xpert cartridges/year;2. Operational research on prevalence of the latent TB infection among prison population and revising the algorithm for active case finding for penitentiary sector","12/31/2020",59269]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","12/31/2020",0]
[{"$nulls":6},"MDR-TB","Community MDR-TB care delivery","Procurement and operation of mobile mini-lab unit for TB case finding and treatment monitoring. About 1000 new TB cases to be detected annuallyGeographical coverage: southern regions of Azerbaijan that are the most affected by TB and HIV, migration and drug use and distantly located from the rayon center (Djilalibad, Massaly, Lenkoran, Astara, Lerik)","12/31/2020",195518]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},346787]
[{"$nulls":4},"Bangladesh","HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Technical assistance will be requested from WHO to assist in developing different protocols, guidelines, conducting quality research and training to complement updating/developing various guidelines.","11/30/2020",110000]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","Piloting different ART service delivery models for key and general populations will allow improved linkages to treatment, care and support for people living with HIV.","11/30/2020",332408]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).","11/30/2020",940181]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Bi-annual monitoring survey among People Who Inject Drugs (PWID): Recent rise of HIV prevalence in Dhaka requires in-depth, routine and systematic monitoring of injecting and sexual behaviour of PWID, drug context, drug taking frequency etc. Routine monitoring survey will be conducted to strengthen the reach, quality of services, and to revalidate spot-wise size estimates so that program can be more responsive to the community needs.","11/30/2020",431006]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","HIV surveillance is important for key population monitoring at regular intervals.","11/30/2020",1163391]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Scale-up ICT based data collection system in the HIV/AIDS program to integrate with the national Health Management Information System (HMIS). A pilot initiative will introduce a ICT based data collection system using tablets with mobile apps. The ICT based data collection system will be scaled-up for the entire program and to be integrated into MIS system of HIV/AIDS program, contributing to the national HMIS.","11/30/2020",142272]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Further scale-up Opioid Substitution Therapy (OST) in 3 priority districts: Considering the HIV and HCV epidemic, another 1,000 PWID will be targeted for OST in selected districts by 2020, which will increase the national coverage to 11%. This harm reduction intervention is critical in the fight against the transmission of HIV/HCV.","11/30/2020",580302]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Prevention and management of coinfections and co-morbidities for PWID","Prevention, screening, diagnosis and management for Hepatitis C virus (HCV): Information Education Communication/Behaviour Change Communication activities for the prevention of HCV will be conducted among targeted People Who Inject Drugs (PWID). PWID will be routinely screened for HCV and around 200 HCV positive PWID will be provided medicine support. Trained physicians will be responsible for screening, diagnosis and management of HCV from Drop-In-Centres. The impact will be to reduce morbidity and mortality for PWID who may be co-infected with HIV.","11/30/2020",431028]
[{"$nulls":6},"Other module","Routine reporting","Under the Government funded Health Sector Program, there is provision for establishing 150 service delivery points  throughout the country. Above allocation funding will allow the National AIDS/STI Program (NASP) to set up a digital data collection and management system. NASP will receive regular data from service delivery points which will help monitor the progress of program implementation and further decision-making.","11/30/2020",450000]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},4580588]
[{"$nulls":5},"Malaria","Case management","Active case detection and investigation (elimination phase)","There are considerable additional demands associated with the elimination effort. A substantial increase in manpower will allow the programme to accelerate progress towards its targets, taking full advantage of this critical window of opportunity to eliminate malaria from Bangladesh.","12/31/2020",1284504]
[{"$nulls":6},"Case management","Facility-based treatment","Quality Assurnce (QA) of diagnosis needs improvement and will be strengthened through expansion and upgrading of the Central Medical Reference Laboratory and collaborating laboratories. A QA database and support for external competency testing will be conducted every 3 years. Sensitivity and specificity of diagnosis will increase as a result, improving rationality of treatment.","12/31/2020",25795]
[{"$nulls":6},"Case management","Other case management intervention(s)","Target-group-specific, locally appropriate, Behaviour Change Communication (BCC) materials and methodologies will be developed and produced for all high-risk groups, as well as for communities approaching elimination. Border-specific packages will also be produced. A mobile phone-based BCC programme  will be developed. Where appropriate work will be carried out in partnership with a commercial advertising agency. This should result in significant improvements in LLIIN utilization in forest goers and treatment seeking in elimination areas, leading to impact in terms of burden reduction and elimination.","12/31/2020",1524883]
[{"$nulls":6},"Program management","Grant management","The general management of the programme requires support that goes beyond that covered by the within allocation request. WHO will provide Technical Assistance. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programmes elimination goal.","12/31/2020",190443]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","Quarterly meetings will be held at district level to support planning, coordination and management. The HR development plan will be updated, key staff will be recruited for the Program Managment Unit to support the reorientation of the programme, and needs-based training will be provided as necessary. Equipment will be maintained. Furniture (medium priority) and office equipment will be replaced where necessary. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programmes elimination goal.","12/31/2020",1692852]
[{"$nulls":6},"Vector control","Entomological monitoring","Entomological monitoring. In-line with the recommendations of the last two programme reviews,extensive support to revitalize entomological services will be conducted including: set-up, running and maintenance costs for an insectary; Technical Assistance; purchasing a training microscope. Vector incrimination surveys will be conducted in 3 sentinel sites. This work should serve to better guide and more effectively target the vector control and a personal protection approach.","12/31/2020",207367]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN  Mass campaign. The within allocation request covers the absolute, high and medium priority areas. There are a significant number of people at risk in low priority areas that will be left uncovered. Free LLINs will be expanded to cover the entire population residing in targeted established settlements. This will complement the within allocation LLIN approach and result in reduced transmission.","12/31/2020",2198599]
[{"$nulls":6},"Vector control","Other vector control measure(s)","The protection provided by LLINs is limited to some extent by the early outdoor biting habit of local vectors. Personal protection measures could improve impact, especially for populations at increased occupational risk. Investigations into the effectiveness of personal repellents for reducing residual malaria transmission (RMT) in Bangladesh will be carried out. If repellents prove effective, a roll-out of this intervention will be effected to complement the LLIN approach and result in reduced vectorial capacity and reduced transmission.","12/31/2020",57600]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","A comprehensive package of needs-based operational research will be conducted in collaboration with WHO and national and international experts and institutes. Equipment will be procured as required. LLIN utilization surveys will be carried out in different risk populations and resulting data will be used to fine-tune strategies and thereby improve impact.","12/31/2020",72698]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Mapping can significantly strengthen the management of malaria elimination efforts. Health Information Systems in elimination districts will be upgraded to include a GIS component with mapping down to household level. Selected healthcare providers will be equipped with a smartphone so that they can report the geographical position of all confirmed malaria cases. The Government will strengthen the pharmacovigilance system.","12/31/2020",438173]
[{"$nulls":5},"Malaria Total",{"$nulls":4},7692914]
[{"$nulls":5},"Tuberculosis","TB care and prevention","Case detection and diagnosis","Additional community case finding activities in hard-to reach areas not covered by the allocation and/or matching fund request, introduction of the new diagnostic algorithm in additional upazilas in remote areas, establishment of additional diagnostic facilities (X-ray, FNAC, X-pert) to improve the diagnosis of smear-negative, Child-TB and Extra Pulmoniary cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","12/31/2020",24407218]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Further expansion of case finding activities targeting specific risk groups (urban poor, factory workers, garment workers, brick field workers, miners, elderly people, pregnant women) in areas not covered by the allocation and/or matching fund request, additional IEC activities targeting high-risk groups in urban- and sub-district areas. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","12/31/2020",408949]
[{"$nulls":6},"TB/HIV","TB/HIV collaborative interventions","Establishment and running costs of additional VCT centers in hard-to reach areas, social support for additional detected TB/HIV patients Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","12/31/2020",195225]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Provision of second-line drugs, case based-incentives for community providers and patient social support to manage additional detected MDR-TB cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","12/31/2020",4296821]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},29308213]
[{"$nulls":4},"Belarus","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. From 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the clients desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant Sustainability of Services for Key Populations in the EECA Region, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.","12/31/2021",331819.28000000003]
[{"$nulls":6},"Treatment, care and support","Differentiated ART service delivery","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. As a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. In line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD). MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.","12/31/2021",986668]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Interventions for young people who inject drugs","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.In Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".","12/31/2021",98759.99]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.","12/31/2021",556161.96]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Needle and Syringe programs for PWID and their partners","When planning the BLR-C-RSPCMT grant for 2019-2021, it was assumed that, starting in 2020, Belarus will purchase supplies (syringes, condoms, etc.) for HIV prevention cabinets for PWID at the expense of the state budget. An analysis of the existing legislative framework showed that legislative amendments are required to conduct such purchases. Changes can be made to the rulemaking plan only for 2021, adopted - not earlier than 2022. Thus, we consider it necessary to include the provision of supplies for HIV prevention cabinets for PWID at the expense of the grant BLR-C-RSPCMT.","12/31/2021",185040.65]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},2158449.88]
[{"$nulls":5},"Tuberculosis","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","12/31/2021",3400000.08]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},3400000.08]
[{"$nulls":4},"Belize","HIV/AIDS, Tuberculosis","Program management","Other program management intervention(s)","The role of the Civil Society Organizations Hub (CSO Hub) as coordinator is an important component of this grant.  This intervention will enable regular Monitoring and Evaluation visits by the CSO hub, and includes the development of M&E Tools, the preparation of reports, the development of and implementation of a mechanism for project coordination including in terms of operational planning.","12/31/2021",100000]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","The operationalization of the non-discrimination law is key.  Once the non-discrimination law is introduced by Cabinet there will be need for mass education on this new legislation to make it effective. This is a key activity of the funding request based on the Transition Readiness Assessment findings to improve the legislative environment.","12/31/2021",50000]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","This intervention proposes to conduct an assessment of the implementation of the HIV/AIDS Policy of the Public Service of Belize and revise the policy based on the recommendations of the assessment. This is important to strengthen the capacity of the Employee Assistance Program to enforce the implementation of the HIV policy which addresses issues like non-discrimination among public officers.","12/31/2021",20000]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Develop an electronic information system to track demand and supply of medicines and commodities at the facility level. This is a key component of the roadmap for Treat All to ensure that challenges presently experienced with stock outs are minimized.","12/31/2021",30000]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Mini grants of USD 10,000 each for Civil Society Organisations (CSO) to build their institutional capacity necessary to carry out the work of the CSO Hub in the 4 different areas beyond the Global Fund grant. The need will vary among the CSOs, but will evolve around needs for equipment, furnitures or/and to pay stipends.","12/31/2021",50000]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Mini grants of USD 5,000 each for Civil Society Organisations (CSO) to build their capacity to be sustainable beyond the Global Fund. This could include strategic sustainability planning, social networking advocacy and negotiation, non-traditional income generation, developing proposals for external funding and any other activity or progamme that would contribute to their sustainability beyond 2021.","12/31/2021",50000]
[{"$nulls":6},"RSSH: Community responses and systems","Community led advocacy","The capacity of Civil Society Hubs members in human rights, legal and anti-stigma discrimination is key as communities must play an integral role in advocating for policy change and legal reform at all levels of the public system (including the Attorney Generals Office, Ministries of Finance and Economic Development) on issues like the non-discrimination law, social contracting and other key populations human rights issues.","12/31/2021",50000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","A major recommendation of the Transition Readiness Assessment is to collect and report updated HIV/TB sero-prevalence data on transgender persons, sex workers (SWs), prisoners, uniformed personnel and undocumented persons to be complemented by a Knowledge, Attitude and Practices (KAP) study with the same key populations. This will provide evidence for future programming especially within the context of sustainability.","12/31/2021",200000]
[{"$nulls":6},"Comprehensive prevention programs for MSM","HIV testing services for MSM","HIV testing will be provided by a Civil Society Organisation (CSO) through the CSO Hub.  This activity will fund stipends of peer educators to reach more hard-to-reach Men who have sex with Men (MSM) and transgender people (TG) for testing. The activity will also include support for staff members conducting testing.","12/31/2021",40000]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},590000]
[{"$nulls":4},"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Organize a six-monthly community-based screening campaign among sex workers, under the supervision of adapted services and NGOs to de-medicalize screening and provides better access to the service for sex workers.","12/31/2020",52692.18]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Sessions for the above.","12/31/2020",514120.75]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Supplies for screening sex workers: to address those sex workers and clients who do not attend adapted services, screening at this level will be carried out by sex worker peer educators (de-medicalized approach).","12/31/2020",486623.27]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Condoms and lubricant programming for sex workers","Procure male condoms for sex workers: planned for year 3.","12/31/2020",90107.73]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Cover the monthly travel costs of facilitators from NGOs working with sex workers: planned for year 3. Travel by actors on the ground working with key populations.","12/31/2020",47546.85]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Exchange and working visit with the sex workers network of Cte dIvoire","12/31/2020",16821.91]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Implement a network for sex workers associations in Benin:iInterventions that aim to provide more space and more capacity for the sex workers network to improve their involvement in the national response.","12/31/2020",17894.740000000002]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Organize a consultation meeting between the various actors from NGOs working with sex workers(based on 25,758 actors each year for the three years): This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","12/31/2020",86716.42]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Organize training/refresher training sessions for peer educators working with sex workers: planned for year 3. This intervention will build the capacities of peer educators for holding awareness-raising sessions addressing the target populations.","12/31/2020",30837.17]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Provide monthly remuneration for facilitators and peer educators from NGOs working with sex workers: planned for year 3. Remuneration for actors on the ground working with key populations.","12/31/2020",197597.35]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Six-monthly supervision of prevention activities implemented by the sex workers network in areas frequented by sex workers","12/31/2020",17963.189999999999]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","This intervention aims to reduce HIV prevalence within this target group. This intervention was not budgeted for within the allocation amount. This intervention entailsprocuring male condoms to raise awareness among female bar workers.","12/31/2020",17947.48]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Train medical and paramedical staff in treatment for sexually transmitted infections (STIs) and disseminate the algorithm.","12/31/2020",282796.53999999998]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Organize an annual two-day information meeting of 40 actors from the Ministry of Health and the Ministry of Justice on interventions in the prison system: This activity is planned to raise awareness among actors from the Ministries of Justice and Health so as to increase the impact of HIV interventions on prisoners.","12/31/2020",18758.84]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Organize a quarterly consultation meeting between the various actors from NGOs working with prisoners:Planned for year 3. This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","12/31/2020",4585.34]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Pay allowances for facilitators from NGOs working with prisoners: planned for year 3. Remuneration for actors on the ground working with prisoners.","12/31/2020",27715.18]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Pay the travel costs of facilitators from NGOs working with prisoners: planned for year 3. Travel by actors on the ground working with prisoners.","12/31/2020",5542.59]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Although prevalence remains low among adolescents and young people aged 1524, levels of knowledge of prevention measures (61 percent) and access to testing (23.4 percent) remain critical and must be improved. This intervention was not budgeted for within the above allocation amount.It relates to capacity building for young leaders and adolescents to provide quality interventions for other young people and adolescents. This intervention involvesproviding training to 60 young leaders and adolescents and eight facilitators during three two-day sessions on peer education, the package of interventions that are based on a human rights and gender perspective (intervention strategies and SC/BCC) and data reporting tools.","12/31/2020",23782.959999999999]
[{"$nulls":6},"Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","This screening intervention will intensify prevention activities for truck drivers to provide better coverage of screening and protection among the target group, with a view to improving the framework for achieving the 909090 targets. This activity was not budgeted for within the allocation amount. This intervention entails a quarterly ten-day screening mission undertaken by four people, including a driver, aimed at truck drivers.","12/31/2020",24388.959999999999]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Male and female condoms for other vulnerable populations","This intervention aims to reduce HIV prevalence within this target group. Condoms were not budgeted for within the allocation amount. This intervention entailsprocuring male and female condoms for truck drivers.","12/31/2020",86223.77]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","The interventions involve the updating of modules, refresher training for actors, the editing of tools and consultation sessions. They will intensify prevention activities for truck drivers to ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention was not budgeted for within the allocation amount.This intervention comprises the following activities:-Updating the training modules for truck driver peer educators using a human rights and gender-transformative perspective. These include modules on health education, new forms of masculinity and the prevention of gender-based violence (2,939.22)-Refresher training for 75 truck driver peer educators and 20 facilitators during four two-day sessions with 30 participants on the package of interventions (intervention strategies, Social Change and Behavior Change Communication (SC/BCC), pre- and post-test counseling) and data reporting tools (15,726.64)-Producing 100 registers of people who have undergone awareness training and of the distribution of condoms and lubricants for truck drivers, and 3,500 fact sheets (922.32)-Producing 90 visual aids based on a human rights and gender perspective for truck driver peer educators, including on health education, new forms of masculinity and the prevention of gender-based violence (1,372.04)-Providing truck driver peer educators with one meal per day of the intervention, two days a month (outreach, communication and follow-up activities, distribution of condoms) (38,417.15)-Recruiting consultants for the SGSS for truck drivers (27,451)-An SGSS for truck drivers (4,610)-A one-day consultation session with haulage trade unions (room hire, coffee break, administration and travel for 30 participants, supplies and photocopying) every six months, totaling six sessions over the three years by the sub-recipient (8,378.60)-Producing 30 copies of the report on the SGSS for truck drivers (228.67)-Covering the costs of the supply, storage, quality control and distribution of condoms for truck drivers (6,146.74)-Producing 100 training manuals based on a human rights and gender perspective for truck driver peer educators (381.12)","12/31/2020",119598.25]
[{"$nulls":6},"Program management","Grant management","Organize a six-monthly, ten-day mission to validate the financial documents and accounts of NGOs and the six CIPEC from the previous six-month period (two teams of four people: one manager, one accountant, one fiduciary management agency and drivers):This activity aims to improve the quality of accounts and prevent ineligible amounts.","12/31/2020",27971.05]
[{"$nulls":6},"Program management","Grant management","Organize a six-monthly, ten-day mission to validate the use of rapid diagnostic tests in the activities in the following six-month period (two teams of four people: one manager, one accountant, one monitoring and evaluation specialist and one driver):This activity facilitates the implementation of activities, particularly at the CIPEC level.","12/31/2020",27971.05]
[{"$nulls":6},"Program management","Grant management","Organize quarterly five-day missions to validate the accounts of private clinics for the payment of services, undertaken by two teams of three people:This activity aims to improve the quality of accounts and prevent ineligible amounts.","12/31/2020",24225.119999999999]
[{"$nulls":6},"Program management","Grant management","Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):This will motivate actors at the peripheral level.","12/31/2020",92382.45]
[{"$nulls":6},"Program management","Other program management intervention(s)","Ensure the participation of ten actors from the system each year in discussions and seminars:This activity aims to provide actors from the program and from facilities with information on progress relating to HIV and also to allow them to share their experiences with actors from other countries.","12/31/2020",51324.21]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","Draw up an annual list of suppliers: This activity allows for the preselection of providers and facilitates the implementation of activities.","12/31/2020",8418.81]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","Other external services. This intervention comprises two activities that were not budgeted for in the last three quarters of the final year (2020):-The provision of a driver to the Executive Secretariat of the National AIDS Committee so that it may implement and monitor activities on the ground (management of the National AIDS, Tuberculosis, Malaria, STIs and Epidemics Committee driver) (2,744)-Support for the costs of a monitoring and evaluation intern (60,000 CFA francs per month for three years) to promote learning among adolescents and young people (823)","12/31/2020",4002.92]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","The study to evaluate the legal setting for key populations aims to provide data to better target interventions for them.","12/31/2020",12532.82]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","With regard to women and girls in Benin, according to the national gender promotion policy that has been developed, socioeconomic factors in the country tend to confer inferior status to women compared with men, particularly in the areas of education, employment, health and access to land and finance. Stereotypes and gender roles increase the vulnerability of women and girls to HIV and AIDS and restrict their access to existing information and services. The submission of women and girls demanded by tradition makes them subject to certain types of violence: levirate, early or forced marriage, sexual violence, sexual relations with older partners, etc. In addition, the imbalance of power makes women less able to negotiate the use of condoms or to choose their sexual partner.Education sessions on gender-based violence and training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence are aimed at reducing HIV prevalence within this group. The sessions will address gender discrimination, harmful gender norms and all types of violence against women and girls in relation to HIV.In detail, this intervention comprises the following activities:-Training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence (six sessions with 25 participants each, lasting two days) (20,754)-Educational sessions on HIV, health education, sexual and reproductive health and rights, new forms of masculinity and the prevention of gender-based violence for Plan International Benin staff members (session with one coffee break for 30 people per month and for five teams) (1,372)-Recruitment of a consultant to undertake an evaluation study of the legal setting for key populations (13,500)","12/31/2020",39980.92]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Organize workshops on establishing ARV treatment adherence clubs in each care facility with the support of the Benin Action Network for People living with HIV (ReBAP+) and care facilities (to reduce the number of appointments at care facilities for stable patients receiving treatment).","12/31/2020",53582.09]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Quarterly supervision of adherence clubs by ReBAP+ and the NACP:The establishment of adherence clubs requires regular monitoring by ReBAP+ and the program during the first few years.","12/31/2020",35926.379999999997]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV.","12/31/2020",121722.59]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities:-Refresher training for 400 people (health workers, social workers, health mediators, therapeutic educators, MSM and transgender associations and other social organizations) during 20 sessions with 30 participants each. This training will address the specific needs of key and vulnerable populations (psychological support for improved referral and care for key and vulnerable populations), human rights and medical ethics linked to combating HIV and tuberculosis (49,430.07)-Procuring nutritional kits to support the most vulnerable PLHIV on ART (men, women, boys and girls) to help improve their nutrition and their adherence to ART (356,730) -Repackaging nutritional kits and distributing them to beneficiary PLHIV (men, women, boys and girls) on a quarterly basis. These kits are gender-specific, non-discriminatory and inclusive (9,146.94)-Paying the salaries of ReBAP+ staff (program lead, administrative assistant, accountant and monitoring and evaluation specialist) (16,670)-Paying health insurance for ReBAP+ staff (4,390.53)-Contributing to the running costs of ReBAP+ (office rent, water, electricity, communications and supplies) (3,978)","12/31/2020",417326.9]
[{"$nulls":6},"Treatment, care and support","HIV care","Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.","12/31/2020",3329341.26]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.","12/31/2020",441113.23]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Coaching and mentoring on ART in civilian prisons by neighboring care facilities(10 days: one experienced prescriber, one CIPEC, one SPECS and a driver).HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. Given the lack of experience of these nurses and the noted organizational difficulties, coaching and mentorship should be organized to improve care quality. This will be undertaken by an experienced prescriber, along with a departmental and national supervisor.","12/31/2020",12325.22]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Give each care facility a means of communicating so that they may offer differentiated services (to communicate results, make appointments and undertake follow-up) (One smartphone per facility costing 100,000 CFA francs each, for 150 facilities) In December 2016, Benin adopted the test and treat approach and anticipates a substantial increase to the active file, placing increased pressure on the health system. To prepare for this, the country changed the schedule for dispensing ARVs to every three months, and every six months for medical consultations. To ensure the quality of care while empowering patients, the country plans to establish a system for communication between health workers and patients to deliver results, make appointments and undertake remote follow-up.","12/31/2020",25650.32]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Hold 18 five-day training sessions for 450 doctors and paramedics in care facilities on pediatric care (25 participants, three trainers and one supervisor per session), following the new World Health Organization recommendations:This activity aims to improve pediatric care.","12/31/2020",59423.18]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Monitor the care provided at each facility on a quarterly basis: One medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.","12/31/2020",243274.6]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Organize an advocacy meeting on the community care strategy: With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system. It is important to involve all actors in defining the basis for community involvement.","12/31/2020",11883.07]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):Improvement of the biological monitoring of people living with HIV (PLHIV).","12/31/2020",19066.32]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Procure 100 extra cupboards for care facilities that have not yet been equipped:(610 per cupboard)During the first part of the grant, 43 cupboards with shelves were procured for care facilities to improve storage conditions for ARVs. The intention is to procure more for the remaining facilities and for the new facilities that will be set up.","12/31/2020",68431.149999999994]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Six-monthly supervision and monitoring of care in prisons(one NACP representative plus driver, one CIPEC, one prescriber from a neighboring facility, registered prison nurse)HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. The intention is now to scale this up and involve all ten prisons. Regular supervision and monitoring is therefore vital in the initial years to ensure that the care is given properly.","12/31/2020",8725.17]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: -Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (2,103.80) -Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (4,315.07)-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (4,573.47) -Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (7,546.23) -Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (1,632.73) -Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (6,585.80) -The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (4,102.40) -Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (5,460.72) -Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (3,430.10)-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for OVC and PLHIV in all departments (plan) (343.01) -Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (4,573.47) -Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (332,582.78) -Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (10,425.99) -Covering the costs of the ReBAP+ helpline (1,646.45) -Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (4,573.47) -Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (42,807.68) -Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (8,479.21) -Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (9,878.70) -Producing badges for the peer educators/health mediators involved in the projects (1,524.49)","12/31/2020",467496.35]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Train 250 paramedics and medics in care for patients receiving antiretroviral therapy (ART) (184 providers from the 92 former sites, 24 from the new sites and 42 participants from the central level and the Information and Support Centers for STIs, HIV and AIDS (CIPEC)). The training will take place over ten sessions with 25 participants, two facilitators, one supervisor, one manager and two drivers: This activity is important for the delegation of tasks to paramedics and ensuring the quality of care despite the limited number of doctors in care facilities.","12/31/2020",51518.35]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Train providers on the use of tools to assist treatment adherence during six three-day sessions:This activity aims to improve care, given the risk of patients abandoning treatment linked to early diagnosis and the improved survival rate of PLHIV.","12/31/2020",30821.46]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","Transport viral load samples from care facilities to molecular biology platforms on a monthly basis: Provide access to viral load testing for facilities located far from the molecular biology platform.","12/31/2020",83144.429999999993]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Organize two six-monthly consultation meetings per year for each region (north and south), a total of four two-day meetings of 40 people, including actors from treatment and prevention of mother-to-child transmission (PMTCT) facilities:This activity should allow for the sharing of experiences and good practice, as well as any difficulties encountered so that they may be resolved.","12/31/2020",75035.350000000006]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Mobilize therapeutic assistants via two DAT consultants to draw up the community care strategy. With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.","12/31/2020",19052.86]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Organize a meeting to validate the community care strategy:(45 participants)With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.","12/31/2020",11883.07]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Contribute to the annual three-day regional consultation workshop held by the National AIDS Control Program (NACP) with actors from the departments (CIPEC, Departmental Health Directorate, District Health Management Team), involving 45 participants and 17 drivers:This supports the monitoring of activities by actors on the ground and allows for actors at the intermediary and operational levels to better take ownership of HIV interventions.","12/31/2020",40887.67]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","The following activities relate to data quality (quality control, supervision and the review of progress update and disbursement requests), as well as planning and other activities linked to information systems and management, with the aim of improving the quality of the program: -Ensuring the participation of grant actors in discussions and short training sessions each year (44,820) -Six-monthly quality control of the data collected by each team working on the ground, including the data disaggregated by sex and by age produced within their intervention areas (6,105) -Six-day supervision, carried out by the Principal Recipient every six months, of actors on the ground at the departmental level (sub-sub-recipients and others) and at the commune level (NGOs and others), in terms of monitoring and evaluation (two three-person teams, including a driver) based on human rights and gender standards (2,309) -The drafting of a six-monthly gender-sensitive report on the results obtained and the progress made in implementing the grant (6,469) -Six-monthly quality control exercises carried out by the Principal Recipient to monitor data from teams working on the ground and NGOs, peer educators (MSM, people who inject drugs, young people who no longer attend, or have never attended, school and truck drivers, disaggregated by sex and by age) via two three-person teams. These exercises will last six days and take place in the 12 departments (5,282) -Six-monthly monitoring and traceability of condoms, from wholesaler to the final distributers, carried out by two three-person teams over six days (5,241)-An annual on-site data verification exercise at the sub-recipient level carried out by three three-person teams over six days (7,923) -A six-monthly review of the progress update and disbursement requests of the two sub-recipients and the teams on the ground by the Principal Recipient -A six-monthly planning and review workshop with teams on the ground lasting four days (administration of 31 participants, including seven drivers, over four days) (5,230)-The six-monthly maintenance of the integrated system of community data (SIDOC) by the developer (six days consultancy every six months) (2,552)","12/31/2020",104237.46]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Update the PLHIV biometric database periodically","12/31/2020",17963.189999999999]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Procure tablets to record the biometric data of PLHIV (to avoid duplication and ensure the procurement of biological services is well documented) and contract Internet services for facilities","12/31/2020",360415.22]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","These activities combine community data collected by NGOs and peer educators and allow for experiences to be shared between sub-sub-recipients and teams on the ground. They aim to produce quality data and strengthen interventions on the ground:-Six-monthly, two-day consultation meetings between sub-sub-recipients working with adolescents and young people who no longer attend, or who have never attended, school and adolescent and youth leaders to combine community data (room hire, coffee break, administration and travel of participants, supplies and photocopies) (1,474)-Twelve two-day, gender-sensitive and inclusive consultation meetings with 30 implementation actors to improve the coordination of interventions for key and vulnerable populations (MSM, people who inject drugs, PLHIV, sex workers, adolescents, young people, transgender people, truck drivers and those close to them, and community-based organizations that include women and girls) (10,281)-Six-monthly, two-day consultation meetings between sub-sub-recipients and peer educators working with people who inject drugs to combine community data disaggregated by sex and age (room hire, coffee break, administration and travel of participants, supplies and photocopies) (7,299.19)-Monthly outreach supervision sessions for peer educators working with people who inject drugs and MSM, led by NGO facilitators (3,366)-A six-monthly, two-day meeting for teams working on the ground to combine data and share the results of interventions for young people, MSM, people who inject drugs, and support for OVC and PLHIV with CPS, decentralized financial systems (SFD), ART facility managers, NGO facilitators, psychological support workers and legal experts (20,361)","12/31/2020",56022.89]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","HIV surveillance survey among pregnant women: this is an important activity for epidemiological surveillance and also for SPECTRUM projections. This activity has been undertaken for more than 20 years.","12/31/2020",63712.27]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Study to evaluate the prevalence of hepatitis B among PLHIV:After tuberculosis, hepatitis B is the biggest threat to the care of PLHIV. This study will identify those with co-infections (so as to provide better care for them) and evaluate prevalence.","12/31/2020",68431.149999999994]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Procure 125 desktop computers and printers for care facilities:The availability of IT equipment will improve the follow-up of the active file and medical files  monitoring software (ESOPE) and dispensing software (Mdistock).","12/31/2020",171079.56]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Administrative and finance data sources","The financial monitoring of sub-sub-recipients will ensure that the resources allocated to them are managed correctly. This intervention entails the on-site monitoring of financial management at the sub-sub-recipient level, at a cost of 2,881.29.","12/31/2020",3233.08]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","This intervention aims to facilitate access to prevention, care and treatment services for people who inject drugs. In addition to the quarterly meeting with the Interministerial Committee for Combating Narcotic Drugs and Psychotropic Substances Abuse (CILAS) budgeted as part of the catalytic funds, this intervention will take place twice a year during the first two years and in three quarters during the final year. These studies were not budgeted for as part of the allocation amount or the catalytic funds. This intervention comprises the following activities:-Quarterly advocacy meetings with CILAS to promote a favorable, non-discriminatory, inclusive environment that takes the gender perspective into account (10,561)-Recruiting a consultant for a gender-sensitive update study that will estimate the number of people who inject drugs and map them (23,212)-A gender-sensitive update study that will estimate the number of people who inject drugs and map them (13,348)-Producing 50 copies of the report on the gender-sensitive update study that will estimate the number of people who inject drugs and map them (381)-Recruiting a consultant to conduct a satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (30,623)-A satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (10,556)-Producing 50 copies of the report on the satisfaction survey completed by the beneficiaries of the programs interventions throughout the country and in the service delivery areas (228)-Recruiting a consultant to conduct a Second-Generation Surveillance Survey (SGSS) for people who inject drugs (23,159)-An SGSS for people who inject drugs (11,771)-Producing 30 copies of the report on the SGSS for people who inject drugs (228)-A workshop to draw up and validate training modules to train 75 staff members on treatment for opioid users (8,590)-Training for 75 health workers on treatment for opioid users (28,298)-Recruiting a consultant to carry out a baseline (feasibility) study into treatment for opioid users (14,403)-Elaborating and validating a document setting out the regulations and procedures for the treatment of opioid users (9,101)-The procurement of methadone and other substitutes, amounting to one box (seven 1-mg capsules per box) per month per person who injects drugs over two years (20,428)-Treatment costs for people who inject drugs for the treatment of opioid addiction (69,516)-A baseline (feasibility) study into treatment for opioid users (11,396)","12/31/2020",320735.05]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","This is a demonstration study into the scaling-up of pre-exposure prophylaxis (PrEP) to prevent HIV infection among MSM in Benin (PrEP/MSM). We will continue to provide PrEP to maximize the reduction in HIV transmission within the MSM population.This is a HIV prevention method that involves people who do not have the infection, but who are at a high risk of it. They receive ART with Truvada to protect against potential exposure to HIV in order to reduce the risk of infection. The effectiveness of this strategy has been widely documented through several randomized trials. It reduces HIV transmission among MSM by more than 86 percent. It is a very promising preventive biomedical intervention that has a high impact on combating the HIV pandemic. This demonstration study will involve around 250 MSM.The main cost categories are: -Consultant costs (national and international) -Laboratory studies (including HIV, creatinemia, gonorrhea/chlamydia, hepatitis B serology and hepatitis C serology) -Transporting of study samples from laboratories (the Johns Hopkins University Laboratory with ARV dosage of Truvada, including the transport of samples) -Management of the monitoring and research teams -Management of the participants travel at project launch and during the four monitoring phases -Workshops to draft and validate protocols and provisional and definitive reports","12/31/2020",647037.37]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Run three-day training/refresher training sessions for 180 health workers, including those working with men who have sex with men (MSM), on the revised algorithms for STI treatment. One session per former department will take place in 2019:Planned for 2019, this intervention will support treatment for STIs in adapted services, a reference point for the targets addressed by NGOs.","12/31/2020",39863.089999999997]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)The residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.","12/31/2020",126598.59]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.","12/31/2020",146149.70000000001]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Train 20 auxiliary nurses in each health district on PMTCT/IMPC and early diagnosis through dried blood spots in the health districts not covered by UNICEF (25) during 15 three-day sessions with 20 participants (plus two facilitators, one supervisor, one driver and one accountant) in 2018 and 2020:This is an important activity for the program that will help achieve universal coverage of PMTCT and contribute to the ETME.","12/31/2020",27184.38]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Undertake mentoring on PMTCT/IMPC and early diagnosis through dried blood spots.","12/31/2020",26971.16]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Behavioral interventions for TGs","The management of transgender peer educators and support groups aims to intensify prevention activities for transgender people and ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention comprises the activities listed below. The management of transgender peer educators was planned for two years and nine months only, using the allocation amount and catalytic funds. It is planned for the final quarter as part of the prioritized above allocation request. The various activities are detailed below:-Five support groups per quarter that take a human rights-based and gender-transformative approach for 20 transgender people (educational session followed by condom distribution) (1,295)-Management of ten transgender peer educators as part of SC/BCC activities (1,097)","12/31/2020",2685.44]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Other intervention(s) for TGs","Studies were not budgeted for within the allocation amount. The studies (size estimation and SGSS) will provide data to better monitor the impact of the interventions: -A gender-sensitive study that includes adolescents and young people to estimate the size of the transgender population in Benin and map it (11,771)-Production of 30 copies of the study to estimate the size of the transgender population in Benin and map it (228)-Recruitment of a consultant to conduct a gender-sensitive SGSS for the transgender population (19,683)- An SGSS for transgender people (11,771)-Production of 30 copies of the report on the SGSS for the transgender population (228)","12/31/2020",49022.559999999998]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},10318044]
[{"$nulls":5},"Malaria","Case management","Private sector case management","Given the contribution of the private sector (20.7%) in the attendance of health services (SNIGS 2015), it is proposed to continue activities started in the 2016-2017 grant and the partnership between the PNLP and the Private Sector Platform (PSB). This will improve the quality of malaria management through training / supervision of stakeholders, dissemination of care / prevention protocols, reporting of data, provision of subsidized inputs.","12/31/2020",801942.54]
[{"$nulls":6},"Case management","Removing human rights and gender related barriers to case management","Specific new actions will enable approximately 7,000 persons deprived of liberty to access quality treatment services and thus guarantee their right to health.These actions are: i) Training / supervision of prison medical staff; ii) Provision of treatment; iii) Provision of prison health centers in Inputs Malaria control for the free care; and iiii) Consultative meetings with the concerned ministries for a good coordination of activities","12/31/2020",48261.7]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","In order to achieve the objectives assigned to it, to improve its performance in terms of financial management, administrative and to be up to standard, the NMCP plans to upgrade its staff.The different training courses proposed in this funding match the needs according to the profile of the agents available for the implementation of the program's activities.","12/31/2020",196762.43]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The gap of 315 000 LLIN has been filled","12/31/2020",1739000.11]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","The NMCP proposes to implement the extension of the IRS to other communes eligible for a pre-elimination of malaria in the medium and long term. The area of Dassa Glazou in the hills department is chosen for funding beyond.This choice is mainly based on scientific evidence in terms of short transmission period and the abundance of vectors and their infectivity in this area.","12/31/2020",5023248.79]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","The last program's performance review in 2016 noted that indicators related to the annual incidence of malaria and lethality have evolved positively. However, it was noted the weak involvement of the private sector in the fight against malaria, the failure to comply with the guidelines for the management of malaria cases despite the availability ILPs and weaknesses related to the use of DHIS2 software. The next review is scheduled for 2019.","12/31/2020",68946.25]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Mandatory test that follows mass distribution campaigns and provides information on the effectiveness of distributed LLINs, it also guides the choice of LLINs for subsequent campaigns, and the next one is for 2020. It is therefore necessary that this monitoring be carried out as recommended by the international scientific committee. The NMCP must therefore carry out these studies in 2019 and 2020.","12/31/2020",68432.27]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","To be effective in vector control, it is necessary to carry out vector susceptibility tests to determine the status of the vector against insecticides available on the international market. This study is conducted as a prelude to IDP campaigns to select the appropriate insecticide. The latest study conducted in 2017 noted that pyrimiphos methyl remains the sensitive insecticide from which it was chosen during the 2017 IRS campaign","12/31/2020",110260.35]
[{"$nulls":5},"Malaria Total",{"$nulls":4},8056854.4399999995]
[{"$nulls":5},"RSSH","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","10 percent of health care facilities are renovated and fitted out, based on the assessment outcomes, in order to improve drug quality at the local level.","6/30/2022",1112017.73]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Strategy for community health workers can be expanded, through the use of community data applications. Procurement of 3,312 smartphones and accessories, and training of 3,312 community health workers already active in partner programs.","6/30/2022",2180230.0499999998]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","The additional investment will make it possible to cover 65 percent of needs (from 47% with only allocation and matching funds): recruitment, training, incentivization, equipment, provision of tools, and monitoring of 4,147 community health workers implementing the complete package of interventions.","6/30/2022",2569275.0499999998]
[{"$nulls":5},"RSSH Total",{"$nulls":4},5861522.8300000001]
[{"$nulls":5},"Tuberculosis","TB care and prevention","Case detection and diagnosis","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.","12/31/2020",3534458.53]
[{"$nulls":6},"TB care and prevention","Treatment","Objective : To reduce the fatality rate of TB patients who have any other associated comorbidities (HIV, Diabetes, Anaemia, Viral hepatitis B and C). The mortality rate is 14% among TB/HIV co-infected patients vs 6% for all patients. A well-equipped technical block will be established at the main hospital in Cotonou, treatment protocols will be created and disseminated in all treatment centers. As part of the quality assurance policy, a portable spectroscope and a highperformance liquid chromatograph will be procured to ensure more regular monitoring of the quality of anti-tuberculosis medication.","12/31/2020",342159.13]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Objective: to conduct research work on the mathematic modelling of the transmission of tuberculosis in Benin, to obtain a better estimate of the number of cases of tuberculosis in the population, in partnership with the University of Liverpool and the National University Hospital Centre for Pneumo-Phthisiology in Cotonou.","12/31/2020",67332.509999999995]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Objective: to conduct an evaluation of the catastrophic costs borne by the patients and their households, for the introduction of appropriate measures (WHO protocol: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/ meetings/tf6_background_5a_patient_cost_surveys_protocol.pdf).","12/31/2020",61537.43]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},4005487.5999999996]
[{"$nulls":4},"Bhutan","HIV/AIDS","Program management","Other program management intervention(s)","This funding will be used to build the capacity of the National HIV/AIDS Commission in order to create an enabling policy environment and improve long-term impact.","6/30/2021",35000]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Given the critical future role of community organizations in service delivery, competency and organizational development of relevant CSOs will have a benefit on the national program.","6/30/2021",76173]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This funding will be used to establish a national surveillance system and address gaps in program knowledge related to data analysis for strategic decision-making.","6/30/2021",0]
[{"$nulls":6},"HSS - Policy and governance","Other policy and governance intervention(s)","This funding will be used to purchase a vehicle to suport program monitoring and evaluation and to transport pharmaceutical and health products between the centers.","6/30/2021",55000]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},166173]
[{"$nulls":5},"Malaria","Case management","Other case management intervention(s)","Introduction of new diagnostic tools, improving quality of diagnostics.","6/30/2021",121018]
[{"$nulls":6},"Vector control","Other vector control measure(s)","Strengthening community action groups, establishing cross-border information sharing on vector species, improving program capacity for prevention of re-establishment","6/30/2021",51181]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Further development/strengthening community action groups at the block level.","6/30/2021",42225]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Establishment of web-based reporting system and improving cross-border data sharing.","6/30/2021",0]
[{"$nulls":5},"Malaria Total",{"$nulls":4},214424]
[{"$nulls":5},"Tuberculosis","TB care and prevention","Case detection and diagnosis","Procurement of biosafety cabinets, training interdisciplinary team on tb screening, contact tracing and follow-up for MDR-TB patients.","6/30/2021",155236]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Funds for conducting operational research, establishing internet connectivity for web-based reporting and funding for an external review of the TB program","6/30/2021",0]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis: MDR-TB","Procurement of additional laboratory equipment for MDR-TB diagnosis and drugs for XDR-TB treatment.","6/30/2021",0]
[{"$nulls":6},"Other module","Case detection and diagnosis","Training of medical doctors on management of TB/HIV co-infection, training of TB and VCT focal persons on TB/HIV collaborative guidelines.","6/30/2021",41670]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},196906]
[{"$nulls":4},"Bolivia (Plurinational State)","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Conducting of a study of primary resistance to ARV in new patients is planned as a critical element of strategic information in order to strengthen management, decision-making in terms of antiretroviral drug policies, sustainability and progress towards the goal of suppressing viral loads. A total cost of USD 100,000 is estimated.","12/31/2021",100000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.","12/31/2021",50000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.","12/31/2021",5808]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},155808]
[{"$nulls":5},"Malaria","Case management","Active case detection and investigation (elimination phase)","Activity 59: Amazon Region Meeting to consolidate the AOP for each municipality. (Participants: organized civil population, municipality, regional authorities) prior to preparation of the AOP (July each year) in Cobija.Activity mentioned in the diagnosis for transition as part of the negotiation with municipalities.","12/31/2021",52155]
[{"$nulls":6},"Case management","Other case management intervention(s)","Activity 31: Training plan for microscopists in low parasitaemia and strengthening of quality control (Guayaramern)","12/31/2021",47377.5]
[{"$nulls":6},"Case management","Other case management intervention(s)","Activity 45: Training of medical personnel in clinical handling of malaria cases (2 events per year, from different health services in the endemic area) Riberalta","12/31/2021",55788]
[{"$nulls":6},"Case management","Other case management intervention(s)","Activity 46: Training for nurses from the Bolivian Amazon Region (Riberalta)","12/31/2021",30533.15]
[{"$nulls":6},"Vector control","Other vector control measure(s)","Activity 137: Strategy for elimination and recycling of waste, with communication actions","12/31/2021",64315.13]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the regions needs.","12/31/2021",62117.18]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Activity 299: Review of the purchasing process, delivery documents, official receipts from end users in the different regions. Support is required from a person to conclude the processes within time limits appropriate to the intervention.","12/31/2021",30172.41]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Activity 269.1: Quarterly supervision of municipalities or lower levels  for healthcare establishments that carry out diagnosis and treatment (laboratory, hospital, pharmacy); IRS activities and distribution of LLINs in priority locations. Due to reduce allocation, it is essential for the regional authorities to have these resources, especially since the municipalities that intervene in the Amazon region are the poorest in the country and do not receive in equal proportion to the other municipalities the amounts that would contribute to the monitoring of malaria in the Amazon region.","12/31/2021",367286]
[{"$nulls":5},"Malaria Total",{"$nulls":4},709744.37]
[{"$nulls":4},"Burkina Faso","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Equip infirmaries in 7 detention centers. 14 have been already equipped with Rd 10 and NFM.","12/31/2020",51503.76]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Renovating the infirmaries and social services in 20 detention centers. 3 have been already renovated. It addresses concerns raised by the TRP issue 2.","12/31/2020",149753.10999999999]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","Organize trainings for counsellors (RSSH) regarding community screening.","12/31/2020",88955.22]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","Organize yearly workshop for pediatricians on early infant diagnosis (EID) and pediatric HIV care.","12/31/2020",107062.06]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","Performing quality control mission every six months on the HIV testing carried out by community personnel during testing campaigns among the key populations and the general population. New Activity.","12/31/2020",86121.65]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","Scaling-up EWI in health regions through maternity facilities for them to measure early warning indicators (EWI) each year.","12/31/2020",149023.67999999999]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","Training care providers in each of the 3 health regions for them to measure early warning indicators (EWI) each year.","12/31/2020",19434.41]
[{"$nulls":6},"Treatment, care and support","HIV care","Training and retraining of service providers to provide health services to key populations in 13 regions.","12/31/2020",53325.1]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","Procure part of the reagents for biological follow up to provide free access to ARV patients in need (50%b of people in treatment).","12/31/2020",1529674.56]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","Workshop to review the training modules for the counsellors (RSSH) regarding community screening.","12/31/2020",17198.97]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Equip 11 community organizations that offer HIV treatment and care with basic medical equipment.","12/31/2020",152466.60999999999]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Equipment 36 non-governmental testing sites (including the 13 rehabilitated) with client oriented equipment.","12/31/2020",218639.88]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Holding a workshop to approve the training modules for community RSSH counsellors.","12/31/2020",4950.0600000000004]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","TProviding operational support for the national coordination of the Network for Greater Involvement of People Infected with HIV (NEGIPIH).","12/31/2020",121637.3]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Study on the stigmatization index in Burkina Faso.","12/31/2020",61094.15]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.","12/31/2020",80404]
[{"$nulls":6},"PMTCT","Prong 3: Preventing vertical HIV transmission","Holding an annual national forum on the elimination of mother-to-child transmission of HIV in Burkina Faso (each year).","12/31/2020",24006.28]
[{"$nulls":6},"PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Monitoring/support for pregnant women who have recently tested positive, provided by pairs of peer educators.100 couples who are PLHIV will be trained and will provide peer support. Based on a UNICEF pilot activity.","12/31/2020",1026431.38]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},3941682.1799999992]
[{"$nulls":5},"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The current funding (World Fund, USAID and State) covers needs from 2018 to 2020 except for routine LLIN for pregnant women in 2019. This Gap is included in the above allocation to acquire 886,517 MILDA. The mass distribution campaign is planned for the first half of 2019.","12/31/2020",2530411.85]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","BAcquire reagents and consumables for the production of labile blood products (PSL). The request is to support the procurement of kits consisting of serological reagents, blood bags, tubes, etc.","12/31/2020",4603524.41]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","For the period 2018-2020, the CNTS needs 617,009 kits.","12/31/2020",188647.62]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Implement a pilot project to improve the quality of the integrated management of childhood illnesses by the CHWs and data flow using the MEDSINC tool.","12/31/2020",157109.19]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Expand IMCI-REC in 12 new health districts. As of 31 December 2017, 16 health districts will have the capacity to implement integrated child care through the use of the electronic tool (IMCI-REC).","12/31/2020",0]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Training for providers of districts in clinical IMCI. Previous training have not met all the needs. The planning involves the training of an average of 25 staff per health district in the 8 regions not covered by the IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center-Sud, Center-East, Central): 25 sessions of 25 agents on average for 11 days in 2018 and 2020.","12/31/2020",568340.06000000006]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Training / refresher training CHWs s on the community-based response package (including the use of RDTs). This will involve training / refresher training for all the CHWs of the remaining 42 remaining districts on integrated ICCM package in 2018 in 6 days with 2 trainers per CSPS.","12/31/2020",928007.52]
[{"$nulls":6},"Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Acquire SPAQ doses for the implementation of SMC in 49 districts in 2020 and carry out the campaign in the same year.","12/31/2020",1034984.3]
[{"$nulls":6},"Other module","Other module","Acquiring artesunate injectables for the management of severe malaria in patients aged 5 and above (except pregnant women) in 2019 and 2020.","12/31/2020",5300153.74]
[{"$nulls":6},"Other module","Other module","Training/refresher of public and private sector health workers on case management of malaria. IMC/USAID-PMI will fund training for 2/3 of the 8,554 agents to (5,782 agents) and the remaining shall be funded by the above allocation (2,891 agents).","12/31/2020",358872.18]
[{"$nulls":5},"Malaria Total",{"$nulls":4},15670050.870000001]
[{"$nulls":5},"Tuberculosis","TB care and prevention","Prevention","Broadcasting each of the adverts 3 times per week and per language (French, Mossi, Dyula and Fula) on the 3 television channels. In fact, the radio adverts will be broadcast from 2018 until the first quarter of 2019, so that the KAP survey planned for the second quarter of 2019 will be used to measure their impact, among other things.","12/31/2020",400326.23]
[{"$nulls":6},"TB care and prevention","Prevention","Broadcasting each year, 6 times per week, the radio adverts in French, Mossi, Dyula and Fula concerning the fight against tuberculosis on the stations of the 25 radio partners. The 3 broadcasts per week are due to the need to take advantage of the 2 weekend days during which the audience is larger .","12/31/2020",427014.64]
[{"$nulls":6},"TB care and prevention","Prevention","Produce 3 TV adverts on the fight against tuberculosis in the following languages: French, Dyula, Mossi and Fula in order to reach a large number of people among the urban population (27.53% of the total population in 2015)","12/31/2020",8211.82]
[{"$nulls":6},"TB care and prevention","Treatment","Provision of nutritional support to 20% of drug sensitive TB patients, with expected outcome to increase the tuberculosis treatment success rate (currently at 78%). Since 2010 When nutritional support stopped), the rate of patients lost to follow-up has been on the rise (6.4% in 2010 to 7.4% in 2015). The target for this support: 1165 in 2018, 1202 in 2019 and 1250 in 2020 for a monthly ration cost: 35,000 CFA francs, or 53.36 euros. Composition of a ration: protein-rich foods, cereals, vegetables, oil and sugar.","12/31/2020",1652182.26]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Refurbishing 9 Centre for the Diagnosis and Treatment of TB in 2019. The selection of the 9 sites was based on findings from the supervision with major refurbishment needs as: cramped, lack of ventilation, watertightness, dilapidated roof, etc. These CDT are the following: D, Dori, Orodara, Pama, Dedougou, Mangodara, Manni, Sapouy and Bokin","12/31/2020",391767.47]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Acquiring complete office computers for electronic registration of TB patients in 20 CDT. this will include complete office computers: monitor, central unit, uninterruptable power supply and printer. and will be allocated to the 20 TTCs with the highest numbers of patients that will take part in this electronic registration pilot phase.","12/31/2020",33360.519999999997]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Conduct a training of the NTBCP workers by WHO and a training of TTC staff. This will be done during support mission  at the start of the period and a second follow-up mission six months later.","12/31/2020",9922.61]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.","12/31/2020",25470.81]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Training CDT patients in electronic TB registration. The training will target the  24 structures (20 TTCs and 4 reference centres) involved in the pilot phase of TB electronic registration. The estimated duration of this training is 3 days. The content of the training will be the following: One and a half days on general aspects of the IT and the second half of the training will concern the use of the software itself.","12/31/2020",7031.55]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Organize a 3-day training session in 2020 to train 100 (centres dinformation et des statistiques sanitaires, CISSE) and (services de planification de linformation hospitalire SPIH) workers regarding the new directives and the analysis of data concerning the fight against tuberculosis  the target will be: 100 CISSE and SPIH workers : 1 x 70 HD + 1 x 13 RHD + 1 x 8 CHR + 1 x 5 CHU + 4 central workers (DSS = 3 and DLM = 1).","12/31/2020",28937.09]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Carry out a new survey in order to assess the impact of the communication strategy of the 2013-2017 of national tuberculosis control program (NTBCP) that is being implemented, in terms of knowledge, attitudes and practices among the population in relation to tuberculosis. This second KAP survey, planned for the second quarter of 2019.","12/31/2020",55600.86]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Conduct a feasibility study of the integration of active screening for TB among children aged 3 to 59 months seen during the SMC campaigns. This innovative, integrated approach is expected to boost active TB screening and to improve the performance of the 4 NTBCP in relation to tuberculosis among children. Location: 2 of the 12 health regions covered by the SMC. Study period: 2018 Partners: NMCP, Paediatricians, WHO/RDT.","12/31/2020",85539.79]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Equipping 2 medical units specialized in MDR-TB treatment: The 2 pneumology centres of CHUYO and CHUSS (16 beds in Ouagadougou and 9 beds in Bobo) are under construction in the 2 hospitals, planned for completion in late 2017. The equipment include: Medical bed, orthopaedic mattress, 2-section viewbox, separate lighting, office desk, air conditioning unit, fan, office chair, visitor chair, side table, wardrobe, examination table...","12/31/2020",56199.64]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},3181565.2899999996]
[{"$nulls":4},"Burundi","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.This activity aims to reduce new infections by facilitating PS to access prevention and care services.","12/31/2020",4350]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","Activity: Acquire reagents for HIV testingThe 2018-2020 grant and other partners (FM, UNICEF, PEPFAR) are planning to acquire HIV testing reagents to cover the various screening tests for $ 165,979.77, with a total requirement of 4,066 730,3USD is a Gaps of 2 443853USDThis funding beyond this will enable the country to reach screening coverage for the different types of Country Target Testing.","12/31/2020",2443853]
[{"$nulls":6},"Prevention programs for general population","Other intervention(s) for general population","Activity: Security stock of prevention inputs (condom and lubricating gel)The 2018-2020 grant does not provide security stocks for prevention inputs.This funding will allow the country to have a 4-month security stock representing 25% of annual needs. This will prevent any stockouts. For the 2018-2020 grant, the expected input quantities (male condoms, female condoms and lubricant gels) are 26,931,063; 870,979 and 29,938,622 with an aggregate amount of US $ 2,027,089.37.","12/31/2020",225232]
[{"$nulls":6},"Program management","Grant management","Activity: Pay the performance bonuses of the PNLS:This is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.","12/31/2020",238919]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Activity: Organize training sessions on the psychosocial care of children and adolescents living with HIV for providers at ARV sites.This activity, begun during the past grant, will be continued because the low antiretroviral treatment coverage of children and adolescents living with HIV requires special monitoring for this population. The psychosocial care of children and adolescents living with HIV will facilitate the announcement of seropositivity to patients which will increase adherence to treatment and retention rate. Providers will also be able to help strengthen family caring as a strategy to reach more children and adolescents.","12/31/2020",45109]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)Nutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyondActivity is related to indicator #: TCS-1 (M)","12/31/2020",173582]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)This activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target","12/31/2020",202134]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond","12/31/2020",25343]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)Given the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond","12/31/2020",560962]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Activity: Acquire ARVs to fill the GAPTo cover the country's ARV targets for the year 2019 and 2020 on the different categories of PLHIV (Adults, children, PMTCT children and adults, post-exposure prophylaxis).","12/31/2020",7575400]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Activity: Organization of PLHIV in community solidarity network (supervision, monitoring, legal capacity building).This activity contributes to reducing the socio-economic impact of HIV infectionPromoting / empowering PLHIV through capacity building on cluster management, business learning, micro-project initiation and management will contribute to reducing the socio-economic impact of HIV . It is an activity that will be done through the organization of PLHIV network community solidarity (supervision, monitoring, strengthening legal capacity). It will increase ARV coverage and retention rate.","12/31/2020",3822]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","Activity: Acquire the complement of reagents for the viral load.The 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. This funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.","12/31/2020",1432738]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structuresCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.","12/31/2020",250000]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Assure the subscription to the WHO Pharmacovigilance Center (Uppsalla Monitoring Center) to access the VIGIFLOW softwareThe Vigiflow makes it possible to transmit the cases of undesirable events in the international database (VigiBase). The VigiFlow software and the Base are managed by the WHO International Center (Uppsala Monitoring Center). To have access to this software and to be able to transmit the cases, you need a subscription. The subscription fee is 1500 USD per year","12/31/2020",3139]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Buy three trucks for active distribution of health inputsThese trucks will be used to transport drugs from CAMEBU to district pharmacies.","12/31/2020",438366]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance planQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.","12/31/2020",130925]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Provide formative supervision of 20 pharmacovigilance-trained hospitals and the adverse event reporting systemFormative supervision will involve 10 regional and national hospitals and 10 other district hospitals. The aim will be to evaluate the challenges that arise in the reporting of adverse events while retraining staff on the system of pharmacovigilance in general and the use of reporting tools in particular. This will improve the quality of notifications and promote patient safety.","12/31/2020",7335]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Provide pharmacovigilance training for providers in 40 district hospitals at 5 per hospitalThis training will enable hospital providers to gain knowledge of the basics of pharmacovigilance and the system for reporting adverse events, which events will be transmitted to the International Vaccine Monitoring Database (VigiBase) for surveillance. The training will be organized at peripheral level for 200 participants at a rate of 25 participants per session for 4 days.","12/31/2020",48001]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: To train 3 users of DPML on the WHO Pharmacovigilance Software (VIGIFLOW) for two weeksThe training will allow users of VigiFlow software to have basic knowledge of pharmacovigilance and especially the use of VigiFlow to ensure the transmission of adverse event cases to the WHO international base. \"","12/31/2020",26999]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Activity: Maintain viral load and PCR equipmentIn order to ensure the achievement of CVs and PCRs among PLHIV and children born to HIV-positive mothers, machine functionality is a prerequisite.This subsidy is currently being implemented and includes the maintenance of 2 viral load devices for 2019. As in 2020, the OPP-ERA project will be closed, maintenance will be extended on the other 4 Opp-era machines. (Muyinga, ANSS, CHUK, Gitega). For the two Abboth machines, we have a Gap of $ 10,000 a year and for the machines provided by OPP-ERA we have a gap of $ 32,000. This makes a total gap of $ 52,000 for the period from 2019 to 2020.","12/31/2020",52000]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Activity: shelf purchase and warehouse upgrades where Global Fund products are stored: District 10 stores upgraded and part of Main Compound","12/31/2020",641923]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Establishment of a quality control unit for medical devicesThe LNCQM does not perform quality control of medical devices (gloves, condoms, needles and others) .Technical staff does not have experience in quality control of medical devices","12/31/2020",62000]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Need technical assistance to accompany the quality control laboratory of the drug towards the pre-qualificationThe laboratory is implementing the ISO 17025 standard and is in the process of applying for prequalification by WHO. - The laboratory wants to be prequalified by WHO or accredited. A technical assistant is required to accompany the laboratory to apply the related requirements. He would provide technical coaching to better prepare for evaluations","12/31/2020",40500]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthen the biological diagnosis of viral hepatitisThe National Laboratory does not have an external maintenance contract for certain equipment. Some lab equipment needs to be serviced by external experts \"","12/31/2020",114000]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthen the technical platform of the NPHI National Reference LaboratoryThe National Laboratory needs to expand the range of analysis as a national laboratory to meet the national need. For this, he needs modern and diversified equipment to ensure his missions.","12/31/2020",358767]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthening Quality Assurance at the National Reference Laboratory of INSPThis involves acquiring equipment maintenance contracts (HPLC, Spectrophotometer), equipment calibration with BBN, and participating in the rendering of inter-laboratory test results. This will allow the reliability of the results and ensure the reliability of the results and the performance of the laboratory compared to WHO / Accredited Prequalified Loboratory. This will serve to know if the prescribed drugs are of good quality and have positive effects for the patients.","12/31/2020",60800]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Supply of equipment and materials for microbiological controlThe National Laboratory does not have equipment, consumables and equipment for the microbiological control of drugs. Some molecules require microbiological procedures and can not be controlled in the laboratory.","12/31/2020",81828]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training in quality control of associated molecules (ARV, anti-TB).Training in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.","12/31/2020",12000]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on Good Laboratory Practice (GLP)Since LNCQM's inception, staff have not had this opportunity. To be comfortable when performing tasks all staff must be trained / recycled on this standard","12/31/2020",10069]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on Microbiological Control of DrugsThe training would complete the physico-chemical analyzes of drugs by microbiological analyzes","12/31/2020",12000]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on preventive maintenance and qualification of the HPLC chainLack of expertise on the qualification of the HPLC chain. No local expertise in this area. It would be good to train 2 units","12/31/2020",12000]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Activity: Provide training to 3 members of the Quantification Committee on the management of the GAS PlanThis training will allow these people to know the tools of quantification and input management.","12/31/2020",30300]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Activity: Buying Reagents and Consumables for the Automaton for the Screening of Blood Transfusion Transmitted Disease (GAS) MarkersIn the previous grant, the Global Fund delivered the AUTOMATE with the reagents for only 3 months considered as starting. As these three months have elapsed, for the moment the reagents are broken and the appariel is not operational. These reagents will allow the use of the device for a period of 2 years and this will improve the benefits of the CNTS.","12/31/2020",1592613]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Activity: Ensuring the maintenance of the AUTOMATE (GAS)The CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.","12/31/2020",35069]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Activity: Establish a panel of sera for reagent validation (especially for HIV), HBV and HCV)This activity is done in four (4) steps: sensitization of sites involved in sample collection, sample collection, sample analysis, aliquoting and sample conservation. The sensitization will inform providers about the importance of making this panel and how to do it to obtain good quality samples for the constitution of this panel. This panel will evaluate testing and quality control.","12/31/2020",17535]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Activity: Training 210 people in biomedical equipment maintenanceThis training is intended for laboratory technicians. It involves training 210 laboratory technicians for 4 days for the 7 training sessions. This will enable these laboratory technicians to do the preventive and curative maintenance of laboratory equipment. This improves the quality of the analyzes for the follow-up of PLHIV.","12/31/2020",40826]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Activity: Implementation of the LMIS system and its maintenance for 3 years.","12/31/2020",433080]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Activity: Conduct a study on estimating mother-to-child transmission rate of HIVThe estimate of the mother-to-child transmission rate is an indicator of the NHP, the current grant performance framework, but also an indicator of the progress of PMTCT. Until then the indicator was estimated by the Spectrum. In order to obtain an indicator that is as close as possible to the reality of the scope of the interventions we propose to carry out this study which in addition to the transmission rate makes it possible to evaluate the quality, availability and accessibility of PMTCT services.This is a study that will be conducted in 2019 and will cover the entire country according to a methodology that will be proposed by the consultant / firm and validated by the steering committee.","12/31/2020",36348]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Activity: Make a study on the prevalence of HIV-viral hepatitis coinfection.In Burundi, the seroprevalence of HIV-viral hepatitis co-infection is not known because no study has been conducted for the determined. Or, currently, it is well known that viral hepatitis is the main cause of complications in PLHIV where they can have very serious consequences in accelerating the progression of HIV to AIDS disease and vice versa. It is in this context that a seroprevalence survey of HIV-hepatitis co-infection is essential in order to make a global care planning for co-infected PLHIV based on evidence in order to improve the care that is offered to them.","12/31/2020",32221]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Ensuring a link between AIDS-INFO and central, intermediate and peripheral DHIS 2 levelsThe Server for networking has already been acquired and installed at the level of the PNLS / IST. This link can not be done without all patient records being entered in AIDS-INFO. This amount will enable data entry in AIDS-INFO to update all patient records for an activity queue of 65,000 PLHIV.","12/31/2020",37992]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Ensuring DHIS2-GIS interconnection for georeferenced data analysis:DSNIS has developed a health map that is interconnected to DHIS2. However, the interconnection stopped at the level of the BDS and BPS coordinates for lack of skills to integrate the geographic coordinates of health facilities. This interconnection requires international consultancy","12/31/2020",10667]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session","12/31/2020",65947]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:The DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days","12/31/2020",27237]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Providing sites with support for adequate computer equipment for data managementFor the moment, the CDS make the data entry themselves in DHI2. Field visits show that most CDS have a single laptop. This computer is used for the administrative activities of the CDS. It is necessary that the SIS service of the FOSA who take care of the data regularly has its own computer. In total, we have 750 support structures. In the past grant, the computer support concerned only about 170 structures.","12/31/2020",762756]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:Following the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.","12/31/2020",24888]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Support DHIS2 hosting for 2 yearsThe DHIS2 is hosted by a house that provides maintenance and regular back up of the base. A contract is signed between the MSPLS and the said house for a monthly amount of US $ 650","12/31/2020",15600]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Train 210 users on the AIDS-INFO database at all levelsThe training will be organized for the 210 sites of care of the PVIH by favoring those who have a large active girl. In the current grant we had the budget to train only 100 people. The training will be 30 participants per session for 4 days so a total of 7 training sessions. This activity will improve the monitoring of PLHIV and the quality of the data.","12/31/2020",31197]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Train 3 people by BPS, by BDS and by hospitals / CDT on the tracker integrated in the DHIS2 for the follow-up of the tuberculous patient.The DSNIS, in collaboration with the TB program, intends to strengthen the capacities of the BPS, the BDS and the hospitals / CDT (Director, DACS and chief of the nursing) in the follow-up of the CDTs to the use of the integrated tracker in the DHIS2 in 1 mission per quarter for 2 years. Each mission lasts 6 days","12/31/2020",78499]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Acquire the equipment for archiving patient records at the sites of care (mettallic cabinets and files to hang).Patient records must be kept secure and confidential. To do this, each of the 750 care sites needs at least one metallicall cabinet for the preservation of patient records. In addition to the wardrobes, there will be a need for suspends for every patient file estimated at 65,000 PLHIV across the country.","12/31/2020",371150]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Multiply standardized tools for collecting health dataThe unit price of the black and white photocopies of the different houses is 60 Fbu the copy and the binding is 2000 Fbu per document. The standard tools are integrated and are multiplied throughout the grant to reason to have data for different indicators. These are patient records, CPN registers, CPoN, Childbirth, PEC, STA, Lab, CDV, TB / HIV Coinfection. These registries will be multiplied once a year for the 750 sites of care for PLHIV that patients will be multiplied once a year for the PLHIV expected.","12/31/2020",605529]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Review the tools for collecting HIV dataThe set of HIV tools will be revised by integrating all the indicators of the new strategic plan 2018-2022 and the adequacy of the new guidelines for the care of PLHIV. This will provide data for monitoring the strategic plan. Two workshops of 25 people for 4 days will be carried out inside the country.","12/31/2020",8287]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Activity: Training / retraining Peer Educators of IDUs at the national level on the HIV prevention and harm reduction package related to drug use.This activity helps to improve the prevention of HIV / AIDS and STIs among IDUs and to increase their knowledge of the concepts of HIV prevention and harm reduction.","12/31/2020",31542]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Community empowerment for PWID","Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDUThis activity aims to improve the living conditions of key populations.","12/31/2020",43274]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Activity: Organizing at the national level, an advocacy workshop with different actors for LGBT mainstreaming in program design and LGBT interaction with the general population.This activity helps to improve the prevention of HIV / AIDS and STIs among LGBT people and create an enabling environment to facilitate access of this population to prevention and care services.","12/31/2020",4776]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Activity: Train 45 pharmacy managers from 45 districts on HIV / TB drug management in two sessionsThe training will target 46 district pharmacy managers to strengthen them on the rational management of medicines and the supply chain. The training will be done in two training sessions. \"","12/31/2020",9770]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Activity: Strengthen the capacity of men champions (PLHIV) to raise men's awareness of the support and support of pregnant and lactating women for PMTCTThis activity aims to reduce new infections by reducing the transmission of HIV from mother to child.","12/31/2020",17146]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},19658345]
[{"$nulls":5},"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","This amount includes bonuses for 12 iNMCP staff involved in implementing the grant, and maintenance, fuel and insurance for 11 extra vehicles not covered by the allocation amount and are required for supervision and training activities on the ground as well as implementing the 2019 LLIN distribution campaign support for the National Health Information System Directorate, information, education and communication and the transport of central level staff during the different stages of campaign implementation, including the census, micro-planning, pre-positioning of LLINs and supervision of distribution).","12/31/2020",111628]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","This budget is required to cover for technical assistance  to support the implementation of the next LLIN campaign in 2020. It comprises international and domestic technical assistance to support the entire process of the 2020 mass campaign, up to the final report. Given the complexity of the organization on the ground, ongoing technical assistance is required throughout the campaign.","12/31/2020",206160]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This budget is required to: (i) Bridge a gap of 466,000 LLINs to meet all of the needs of the 2019 mass campaign. Of the total 6,997,954 LLINs required, taking into account an increase of 15 percent linked to counts and to logistical security, 6,531,828 have been provided using the allocation amount; (ii) The amount requested includes procurement costs and procurement and supply management/pooled procurement mechanism costs; (iii) The gap in the implementation costs that have not been included in the allocation amount (US$ 1,600,000); (iv) Expected outcomes: this funding will provide universal coverage of LLINs during the 2019 campaign.","12/31/2020",2658053]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This LLIN campaign is aimed at key populations (special groups, including boarding schools, military camps, prisons and orphanages that were not included in the mass campaign). The requested amount will cover (i) procurements costs for 182,000 LLINs and (ii) implementation costs for the special groups. This amount includes procurement costs and implementation costs. This activity is planned for 2020.","12/31/2020",520475]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","In order to comply with the TRPs decisions, the Integrated National Malaria Program (iNMCP) asked the Global Fund to finance for the 20182020 period the 11 health districts already validated by the TRP in 20162017 (not included in the grant due to budget constraints).  This budget is required to cover: (i) Supply costs, (ii) Implementation costs,(iii) Technical assistance, for IRS activities in 11 health districts.  The total requested budget for IRS is US$ 17,037,235, of which US$ 6,787,954 is for the four health districts covered by the Global Fund under the NFM, and US$ 10,249,281 is for the other seven health districts requiring resistance management.CT update (Aug. 2018): The country has been awared 4.9m USD to implement IRS in the 4 districts previously supported by the GF.","12/31/2020",12166628]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","General training in all sectors (malariology, monitoring and evaluation, finances and community health workers). This is a range of vital training to strengthen the program which has not been funded under the allocation amount. In particular, it involves (i) an international malariology course for two people each year, which is vital for strengthening the malaria response; (ii) training at the international level in the monitoring and evaluation of malaria response programs, given in Ouagadougou or Senegal; (iii) training at the international level in financial management; (iv) refresher training for community health workers providing iCCM in the health districts funded by the Global Fund, planned for 2019.","12/31/2020",296091]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Partner coordination/policy drafting and dissemination The budget is intended for (i) partner coordination meetings, particularly transnational meetings, and strengthening the coordination of the private sector not addressed by other partners; (ii) a fund mobilization meeting; (iii) meetings to draw up plans of action and annual and six-monthly reports. The needs for 2018 are covered.","12/31/2020",49614]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Implementing the following innovative strategies to combat malaria:(i) A communication strategy in primary schools; (ii) Outreach communication for the Batwa community; (iii) The production of communication media and contracts with the media: Expected outcomes: This budget is requested as part of efforts to strengthen communication in order to provide regular guidance for the population on the correct use of LLINs and the early use of health care services. The activities relate to procuring communication media and contracts with the media, such as mobile telephone companies.","12/31/2020",328510]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Activity:  Provide quarterly supervision missions for quality control of slides and rapid diagnostic tests in health care facilities in the 46 health districts.(i) The allocation amount covers 12 health districts per quarter. Supervision is undertaken in three facilities per mission per health district, covering a maximum of 72 facilities over the year, equivalent to 10 percent of the total. (ii) Additional funding is therefore requested to be able to cover 12 health districts per quarter so as to sample 20 percent of health care facility laboratories each year.","12/31/2020",32834]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Activity: Support for health districts and health provinces in the supervision of malaria-related activities. The costs include per diems, fuel for supervision vehicles and motorcycles used by health districts and provincial health offices, as well as communication costs.","12/31/2020",1003636]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","This budget is required to cover a survey on the current malaria epidemic in Burundi. A survey on the underlying causes of the epidemiological setting to understand the causes of the epidemic and thus evaluate what type of response would be appropriate and effective, and what measures should be adopted after the epidemic. This epidemic survey will assist the program in guiding the response appropriately.","12/31/2020",172237]
[{"$nulls":5},"Malaria Total",{"$nulls":4},17545866]
[{"$nulls":5},"Tuberculosis","Program management","Grant management","Performance bonuses.The motivation of the staff is essential to maintain the achievements and safeguard the performance of the ProgramThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.","12/31/2020",30183]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Equipment maintenance (package: 10% of the cost). As the devices come with a one year warranty, it would be worthwhile to purchase a 3 year warranty extension as we did for GeneXpert devices.","12/31/2020",62500]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Extend the technical platform by purchasing radiology equipment and ultrasound scanners. To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, tuberculosis in children, tuberculosis in PLWHA and multidrug-resistant tuberculosis, the PNILT intends to expand the technical platform by purchasing radiology equipment and ultrasound. It should be noted that the main reasons for the poor performance in the reporting of tuberculosis cases are mainly: the insufficiency of a technical platform for the para- clinical diagnosis of TPB- and PET cases (RX, Ultrasound); the difficulty of early diagnosis of TB in PLWHIV by lack of effective diagnostic means (GeneXpert); the absence of policies / strategic approach directed at vulnerable and vulnerable groups: prisoners, refugees, Batwa, children, PHAs (screening), the weak investigation of cases contacts TPB +.","12/31/2020",330600]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Installation and handling (operator training) for all equipment.","12/31/2020",25900]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Meeting of TB coordinators. It aims to anticipate possible blockages in order to improve the performance of the implementation of the TB grant. It is planned once a quarter.","12/31/2020",28224]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.","12/31/2020",160535]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Purchase of 2 power generators 5KVA energy source for 2 mobile radiology devices for use on sites without power source (cost includes transport if imported).","12/31/2020",5000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Purchase of 2 vehicles to transport digital radiology devices to screening sites.","12/31/2020",100000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Purchase of 6 Horizon G2 laser reprograms codonics: These are devices for printing X-ray images produced by the 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile X-ray devices).","12/31/2020",33995]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Purchase of 6 kits of 500 codicon films in 3 sizes: These are films for printing radiology radiographs produced by 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile radiology devices).","12/31/2020",12996]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Purchase of 9 ultrasound machines with accessories. The mapping of ultrasound machines performed in 2016 showed a need for 9 devices instead of 11. The purchase of these devices completes the technical platform so to strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA, the diagnosis of multidrug-resistant tuberculosis.","12/31/2020",90000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Training of laboratory technicians / microscopists.The PNILT intends to form one unit per CDT (170 CDT) with 60 units in 2018, 60 units in 2019 and 50 units in 2020:","12/31/2020",34166]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Former activity n  63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validatedBurundi has a total of 11 prisons with infirmary.With the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.","12/31/2020",10463]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","National product selection, registration and quality monitoring","Drug Registration Support (Cross-Cutting RSS): Drug registration is one of the pillars of drug quality assurance. In the past 3 years, just over 700 drug application files have been filed with the Department of Pharmacy, Medicines and Laboratories (DPML), which acts as the Burundian Agency for Drug Regulation. These files concern both products financed by the Global Fund and essential drugs imported into Burundi. To date, only 200 files have been processed. The requested support will mobilize the probate commission to process the 500 files registered to date at the DPML. Subsequently, the commission will be able to process new files as they arrive.","12/31/2020",46922]
[{"$nulls":6},"RSSH: National health strategies","Other policy and governance intervention(s)","A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.","12/31/2020",73811]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Data validation and dissemination activity.Verification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.","12/31/2020",161830]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Supervision by TB / HIV coordinators. The budget covers vehicle and fuel insurance costs.The budget for the 2018-2020 grant is 661,500 BIF, per quarter and per BPS, to cover fuel costs only.The said budget omits the costs of insurance, vehicle repair and technical control, which, for most of them, are already obsolete and amortized.","12/31/2020",102239]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Purchase of 17 vehicles and their insurance.Supervision is a priority activity in the fight against tuberculosis. The available supervision vehicles are old and most of them were acquired more than ten years ago. With depreciation and rugged terrain, repair costs become more and more huge.","12/31/2020",520200]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Purchase of computer equipment.","12/31/2020",68600]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Prevalence and anti-tuberculosis drug resistance study: The PNILT is preparing for the start of the TB drug resistance survey. On the basis of this review, a detailed budget was agreed between the PNILT, the Global Fund and Damien Action, which provides technical support and project management. The preparatory activities have already started as, among other things, the validation of the study protocol by the National Technical Committee.  The requested budget will complete the existing budget and bring the overall budget of the study to USD 251,838 (the existing USD 171,838 and a gap of USD 80,000).","12/31/2020",80000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Installation and implementation of GxAlert (or similar system) / networking of GeneXpert devices: The PNILT has acquired 18 GeneXpert devices from the Global Fund, which it has installed on strategic sites throughout the country. These devices were added to 6 acquired with funding from the World Bank, a fleet of 24 devices in total. To achieve the full value of the investments made in Xpert, the results must be transmitted from the machine to the service provider in a timely manner. However, xpert results are currently reported on paper. This reporting system is time consuming and limits the potential for optimizing patient care and management.","12/31/2020",150000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Purchase a teleconference device.","12/31/2020",4069]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis: MDR-TB","Acquire a PSM class II microbiological safety cabinet hood: The National Reference Laboratory (LNR) is equipped with an old safety hood that has just been out of service for a few months. The consultant sent for his repair recommends the purchase of a new hood. The cost includes transportation and installation.","12/31/2020",25000]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis: MDR-TB","Acquisition, installation and formation of sites for the utilization of LPA technology for National Reference Laboratory (LNR). This cost includes the layout of the laboratory, the purchase of equipment, reagents and consumables, the training of personnel.","12/31/2020",200000]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis: MDR-TB","Operational research on the use of oral forms in the treatment of MDR-TB. Development of an operational research protocol and conduct over a period of 3 years operational research on \"the tolerance and effectiveness of a short treatment 9 months without injectable for patients with MDR-TB. \"The overall goal of the project will be to evaluate the treatment outcomes and adverse effects of a new 9-month, non-injectable, short-course regimen for MDR-TB.","12/31/2020",150000]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis: MDR-TB","Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.","12/31/2020",501858]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","Gap to be filled in relation to the activity on the provincial coordination TB / HIV:The frequency of holding TB / HIV coordination meetings is quarterly.","12/31/2020",30355]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.","12/31/2020",170205]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},3209651]
[{"$nulls":4},"Cabo Verde","HIV/AIDS, Tuberculosis, Malaria, RSSH","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","These activities are aimed at strengthening training sessions among  SWs, field sessions and interpersonal communication on HIV and other STIs by SWs peer educators  included in the budget of the allocation amount. They will complement activities that have already been taken into account in the allocation amount.","(blank)",24781.73]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","These are consumables and laboratory reagents to complement the diagnostic and follow-up services. They refer, in particular, to the strengthening of blood safety during the 3rd year of the grant.","(blank)",81308.5]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","These interventions are  directed  towards: 1)  150 vulnerable children and adolescents who are received at day centres by facilitators from ICCA; 2) 80 vulnerable youths and adolescents in Praia with training and psychological support; 3) 620 peer educators within 21 secondary schools and, additionally, the coordination and follow-up of the activities performed by peer educators. These will supplement activities considered in the allocation amount.","(blank)",141119.96]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","These interventions are intended to improve the psychological support provided to vulnerable children and orphans within the ICCA drop-in centre in Praia.","(blank)",14654.92]
[{"$nulls":6},"Prevention programs for general population","Condoms as part of programs for general population","HIV is transmitted during unprotected sex. In this regards, this investment is to acquire 9,000,000 condoms (total for 3 years) to prevent the transmission of HIV and other STIs within the populations.","(blank)",295043.21000000002]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","These interventions aim at sensitizing 10 TB patients to ensure adherence and good compliance to treatment and adoption of preventive standards.","(blank)",5373.13]
[{"$nulls":6},"TB/HIV","TB/HIV collaborative interventions","These interventions are aimed at strengthening the capacity of NGO members working for TB / HIV prevention at the community level.","(blank)",16689.48]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","Good adherence to antiretroviral treatment is key condition for the suppression of a patients viral load. Therefore, it is intended to appoint 12 mediators in 10 health facilities with the largest volume of patients.  The role of these mediators will include provision of counseling to people living with HIV newly tested positive, providing them with information on treatment and provide adherence support.","(blank)",136296.71]
[{"$nulls":6},"Vector control","Entomological monitoring","With support from WHO, the Global Fund and partners, the INSP has recently established a medical entomology laboratory, which enables monitoring the distribution and density of vector mosquitoes within the country. It is expected to acquire equipment to improve entomological monitoring to ensure that the response is as efficient as possible. These acquisitions are intended to supplement those taken into account in the allocation amount.","(blank)",177571.54]
[{"$nulls":6},"Vector control","Other vector control measure(s)","The aim of these interventions is to support door-to-door awareness campaigns regarding the fight against malaria, the transmission routes, symptoms and other preventive measures in partnership with NGOs and community associations, health delegations and the INSP.","(blank)",30531.93]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","To have a better understanding of modes of transmission of new HIV infections and to better use these data, a study on the modes of HIV transmission is planned, to orient strategic decisions for HIV prevention. Also, an audit of patient data will be performed and ART cascade will be determined to provide baseline data that will enable to measure progress toward achieving the three 90s by 2020.","(blank)",86358.43]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","The exchange visit to a country that is in the process of obtaining certification of malaria elimination will strengthen the skills of the technicians working on the malaria program in Cape Verde, particularly when it comes to monitoring and documenting the elimination process.","(blank)",29051.73]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","The program so far reports data in Excel and/or Word documents, which are sometimes incomplete and submitted late. For this, with the introduction of the DHIS2 application, promptness and completeness of reports will be improved, which will ensure better disease surveillance. This is for an upgrade of the existing system.","(blank)",14817.64]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","For the TB/HIV component, a study is expected to be carried out in 2020 to update the bio-behavioral data for key HIV populations (sex workers, drug users and men who have sex with men).","(blank)",58289.75]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","A study is expected to be conducted on the impact of HIV within individuals, families and Cape Verdean society in general.","(blank)",27610.82]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","A study was conducted within the general population in 2017 on knowledge of attitudes towards and practices in connection with methods for preventing malaria and its transmission. Nevertheless, it is essential that an initial study is conducted within migrant population in 2018. It is expected that the KAP study will be carried out again within the general population in 2020 to update these data.","(blank)",44737.96]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Men who have sex with men represent a key population in the fight against HIV. The proposed activities are linked to interventions that will be conducted in the community and to training. These will complement activities that have already been taken into account in the allocation amount.","(blank)",42331.95]
[{"$nulls":5},"HIV/AIDS, Tuberculosis, Malaria, RSSH Total",{"$nulls":4},1226569.3899999999]
[{"$nulls":4},"Cambodia","HIV/AIDS","HIV Testing Services","Other module","Introduction of Alere DETERMINE Ab/Ag Combo 4th generation RDT. TRP  recommends 10% of the requested amount.","12/31/2020",106321]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","In order to reach 90% coverage of all KP with a defined package of prevention services, above allocation funding is requested to expand prevention outreach to those provinces not included in the withinallocation target provinces.","12/31/2020",0]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","To expand requested activities to provide legal services and case documentation of rights violations in KP. TRP recommends 50% of request of $ 300,000 and recommends more details on the content of interventions to be provided before this module can be funded.","12/31/2020",0]
[{"$nulls":6},"TB/HIV","Other TB/HIV intervention(s)","Contribution to HEF to cover HIV service packages: HIV and STI Testing and Counselling at Health Centres, HIV Testing and Counselling at VCCT Centres,Adult and Paediatric Pre-ART and ART Service, and transportation fees to ART patients in need.","12/31/2020",1824459]
[{"$nulls":6},"Treatment, care and support","Payment for results","A bonus payment based on results to all PHDs to help improve B-IACM.TRP recommends only 10% of the request.","12/31/2020",157862]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Co-infection with HCV is a significant contributor to morbidity and mortality among PLHIV. Request for HCV testing and treatment for 262 cases is included within the allocation request. Above allocation funding is requested for drugs, commodities and PSM to provide treatment to a further 261 in 2019 and 262 in 2020 PLHIV with chronic HCV co-infection (F3-F4) to cover all estimated need and to reduce mortality and morbidity among PLHIV in Cambodia. The TRP ranked this activity as low priority but also considers that this activity cannot be funded using Global Fund funding as the conditions of the Global Fund policy on this subject are not met. See link https://www.theglobalfund.org/media/41 67/bm33_11-co-infectionsandcomorbidities_report_en.pdf","12/31/2020",329505]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of Sihanouk Hospital Centre of Hope,  funding is requested to provide additional year for staffing and lab costs after 2018.","12/31/2020",400000]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of the AHF clinic which provides HIV services at 12 sites,  funding is requested to provide an additional year after 2018 for staffing (estimated total cost USD 400,000 for 2019).","12/31/2020",400000]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of the KP-friendly clinic, Chuuk Sor, previously funded through PEPFAR, one year of support (2018) is requested within allocation.","12/31/2020",0]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","QC/QA will be implemented in collaboration with DDF and CMS and sampling will be undertaken using current SOP employing a risk based approach in product selection. TRP recommends 10% of the request.","12/31/2020",40000]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","A substantial cohort of children with HIV have already or are about to transition out of paediatric care and into adult HIV services. To support this transition and to ensure retention in ART and other HIV services, above allocation funding is requested for Adolescent Case Officers (peer PLHIV) to be located at each ART site. TRP only recommends 75% of original request of $ 397,656 from the CCM.","12/31/2020",0]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested for a Case Management Assistant (CMA) within each of 67 Funding Request: Full review 23 May 2017 | 42 Provincial AIDS and STI Programs (PASP). TRP only recommends 30% of original reqeust of $849,070.","12/31/2020",254721]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested to Increase the number of CSO (peer PLHIV) located at ART sites to help support differentiated ART delivery and to provide support for PLHIV in greatest need.","12/31/2020",295732]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Replace or update 67 ART sites & 68 VCCT and NCHADS with laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information. TRP recomends only 15% of the request.","12/31/2020",60000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Replace or update NGO/CSO laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information.TRP recommends only 15% of the request.","12/31/2020",60000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To deploy the B-IACM dashboards (national, provincial, OD and daily CMA) nationally in order to improve data management, link HIV related databases and to improve overall tracking of patients throughout the cascade. In addition NCHADS will scale-up systems for patient identification, sample tracking and remote services. Primarily this request is for training in the use of new technologies and for hardware to support the deployment is requested.","12/31/2020",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To improve understanding of epidemic status and collection of pathology information in Cambodia. TRP recommends 20% of the request.","12/31/2020",60000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To support NASA 2020.","12/31/2020",60000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","TRP recommended funding 25% of requested amount of $300,000 to conduct the survey proposed to feed into development of policies and targeted interventions.","12/31/2020",75000]
[{"$nulls":6},"Other module","Other module","Above allocation funding is requested for technical assistance from WHO, as well as for a Procurement Agent and forecasting. TRP only approves 10% of the request.","12/31/2020",226500]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},4350100]
[{"$nulls":5},"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Entertainment Workers (EW) and their clients.  Prolonging the working hours of outreach workers until mid-night will allow for greater reach and will offer HIV & syphilis testing to young freelance EWs.Expected outcomes: Additional 2,146 EWs reached with defined package of services","12/31/2020",0]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)Reproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) Expected outcome: at least 2,160 hidden KPs reached","12/31/2020",500]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Currently, the country implements TB prevention using Isoniazid Preventive Therapy (IPT). The National TB Program has now committed to adopting and implementing the new WHO recommendations for latent TB infection management. This request will facilitate building of capacity for screening, treatment, including the use of new drugs combinations for high risk groups targeting contacts of TB patients and PLHIV.","12/31/2020",0]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","This is aimed to expand the implementation of TB active case finding (ACF) activities including implementation of C-DOTS, ACF in prisons and hospital linkages to cover 30 operational districts (30 ODs). Currently, TB active case finding activities are limited to 46 ODs. Expansion to the 30 ODs will contribute to detection of 5,240 by the end of 2020.","12/31/2020",114963]
[{"$nulls":6},"TB care and prevention","Community TB care delivery","Community TB care delivery through Community mobilization activities","12/31/2020",0]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","ACF in prisons","12/31/2020",96330]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Advocacy, strategic communicaton and Mass Media","12/31/2020",414000]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Logistics and Commodities: Mobile TB Vans with GeneXpert and digital X ray","12/31/2020",1854180]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Improve HIV/STI referral and counselling via SwipeRx Mobile AppSwipeRx is a free mobile application for pharmacy professionals. Its online network of over 1,600 pharmacists. SwipeRx will give NCHADS the ability to communicate with pharmacies to improve awareness, education, prevention & treatment of STIs, including HIV, which may be improved by increasing provider-level awareness on referral pathways to testing facilities.Expected outcome: 5,000 STI patients refer to HIV testing and 5% diagnose HIV positive","12/31/2020",0]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Increased access to STI services Improve the access to STI services by KPs in Family Health Clinics (FHC) and public clinics across the country through facility upgrade where necessary, development of SOPs, training and mentoring and monitoring of practitioners.  NCHADS Behavioral Change Communication (BCC) unit will promote services via Information & Communication Technology (ICT)/social media to KPs.  Expected:- Increased number of staff trained- Increased access by KPs to STI services- Reduced transmission of HIV and other STI","12/31/2020",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Design and Conduct Morbidity & Mortality StudyMorbidity & Mortality study is essential at this stage of the response to better understand the number of AIDS deaths, considering the high treatment coverage, improved access to testing and counselling over the past decade.Expected: Improved data on PLHIV morbidity and mortality will facilitate evidence informed HIV policy and program development","12/31/2020",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Improve Data Quality The recent Assessment of the Cambodian HIV information systems, conducted in 2018, made a recommendation for a development of SOP on Data quality. NCHADS has developed the SOP (to be approved by MoH). This activity will ensure that M&E staff in ART/VCCT sites will receive technical support and assistance in applying the SOP in everyday work.Expected: - Improved Data quality- Consolidated/comprehensive progress reports and dashboards to be used across levels sub-national and national will inform and improve HIV service delivery","12/31/2020",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Strengthening and linking HIV health information systems in CambodiaTo collate data from contributing databases in a national repository, the existing Master Patient Index (MPI) will be operationalized and the Universal Unique ID Code (U-UIC) will be used as an identifier across databases (B-IACM, ART and VL). At the same time efforts will be made to develop interoperability between the all date bases so clients are followed longitudinally from diagnosis until viral suppression. It is complementary to CDC support through the new PEPFAR ROP19.Expected: An integrated HIV information system for patients tracking across the HIV cascade to support sustained HIV epidemic control in Cambodia","12/31/2020",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Operational Research","12/31/2020",100000]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Men who have Sex with Men (MSM).Prolonging the working hours of outreach workers will allow for a greater reach and will offer HIV and syphilis testing to MSM. Expected outcome:  additional 438 MSM reached with defined package of services","12/31/2020",0]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","KPs self-testing & access to Pre-exposure Prophylaxis (PreP) Building on HIV self-testing in PrEP pilot initiated in Phnom Penh in 2018, this intervention will expand access to self-testing and PrEP in Phnom Phnom Penh,  Battambang, Siem ReapExpected outcomes:- At least 1,500 MSM enrolled in PrEP- Approx. 7% HIV+ at initial screen or 105 HIV+ enrolled in care - Reduced transmission of HIV among MSM- Increased referrals to VCCT- Increased repeated testing","12/31/2020",0]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Behavioral interventions for TGs","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)Reproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) Expected outcome: at least 2,160 hidden KPs reached","12/31/2020",500]
[{"$nulls":5},"Tuberculosis","Program management","Grant management","Support NGO SSI to implement C-DOTS activities to cover additional 18 ODs to enhance case notification. TRP recommends 30% of the reqeust of $ 544,630.","12/31/2020",163389]
[{"$nulls":6},"TB care and prevention","Prevention","This will facilitate scale up of CI and IPT for children the high burden 18 ODs.","12/31/2020",125460]
[{"$nulls":4},"Cameroon","HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Keeping girls in school","This  would  be  used  towards supporting activities  for  1,500 adolescent  girls  and  young  women  in  highly  vulnerable situations. Conditionned to evidence that the activities budgeted under the alloacation are  effective.","(blank)",787564.81]
[{"$nulls":6},"Treatment, care and support","HIV care","This funding would enable the country's cohort to be increased from  320,000  to  358,000 patients by 2020.  It  would  support 38,000 patients to be enrolled on ART using EUR 9.3 million of Spanish funding via the Debt2Health initiative.","(blank)",420.83]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","This  funding  would  be  used for the  construction  of  a  new central medical  store or renovation of Regional Store, with  other  technical  and  financial partners (IDB, USAID, etc.): purchase of land and construction (EUR  9,000,000). Investment in the supply chain is conditional to recommendation of the supply chain report. In  addition,  it  will  provide  funding  for technical assistance (EUR 649,440) for national coordination (a team of one international and one national expert)  for the three programs, to improve quantification and procurement of supplies, and to reduce instances of stock-outs.","(blank)",10828683.65]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","This  would  fund  activities  to  extend  drug  dispensing  and monitoring  software  to  40 additional  health  care  facilities between 2018 and 2020.It would also cover the validation of community data, and the harmonization  and  production  of  community  data  collection tools for MSM, SWs, people who inject drugs and transgender people.","(blank)",281062.73]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},27282675.350000001]
[{"$nulls":6},"Program management","Other program management intervention(s)","Malaria control strategies are evolving at the global level, given the innovations in this area. To this end, the Program will undergo several phases  of  change  in  program  and  financial management  policies  and  procedures.  For example, NMCP is  considering assessments of current  strategies,  revision  of  the  national strategic  plan,  capacity  building  of  staff  in different areas of specialization and updating of  normative  documents.  To  this  end,  all normative  documents will be up to date and at least  80%  of  the  qualified staff in the specialties  required  for  the  performance of their duties.","12/31/2020",56110.43]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to train the  new  4'500  CHWs  through  periodic recycling. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to extend  the  response  to  80 additional  health districts.Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","12/31/2020",1288703.8500000001]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to train the  remaining  492  CHWs  through  periodic recycling not funded under the new grant due to budget constraint.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","12/31/2020",164309.28]
[{"$nulls":6},"Program management","Grant management","Increase treatment coverage and expand prevention services beyond the stated priority districts the allocation will support additional program management costs.","12/31/2020",2514661.65]
[{"$nulls":6},"TB/HIV","Other TB/HIV intervention(s)","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","12/31/2020",37637.75]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Community empowerment for MSM","Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.","12/31/2020",0]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Ensure availability of human resources for the provision of services.","12/31/2020",77875.66]
[{"$nulls":5},"Malaria","Case management","Facility-based treatment","To ensure sound management of commodities procured with Global Fund grant funds and their availability in CAR, the World Food Program (WFP) was selected as SCM partner, given their known expertise and logistical capacity. WFPs budget and costs cover transportation of inputs in country, insurance, warehousing, handling, security and support costs. The original budget that was estimated to cover their services during three years of implementation reached EUR 2,100,000 and did not include management fees paid to WFP. Given WFPs budget rate consumption so far and projected level of expenses at the end of 2019, EUR 2,326,922, it results in a EUR 226,922 over expenditure (10% above original budget planned for this purpose). This budget only covers logistics of health products excluding mosquito nets. Note that for the year 2019 the Global Fund had recommended that these costs should not exceed EUR 1,260,000.During year 2020, there will be an increase of number of functional health facilities (going from 736 to 838) in the country that will result in an increase demand of commodities (ACTs and RDTs, partly covered with grant savings), transportation costs (especially considering that their estimation is based on volume), warehousing and insurance. Adding this, the projected budget needs for WFP in 2020 (which are estimated on current budget absorption) raise up to EUR 1,653,302. If we consider the above mentioned 10% over expense, the funding gap is EUR 1,880,224. However, some efficiencies in country (identified in other budget lines) will contribute to cover part of the gap. Which results in a final gap of EUR 1,673,649.68.","12/31/2020",1878183]
[{"$nulls":6},"Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","Voluntary counseling and testing (VCT) for HIV: - Differentiated screening: with the aid of the task delegation standards, the peer educators will be trained to screen their peers during advocacy sessions on the islands and islets. The first screening sessions will be carried out under the supervision of a health worker. If a person tests positive for HIV, the peer educator will refer him/her to a health-care center for confirmation and treatment using a referral sheet. He/she will then be made aware of family screening. Having tested positive, he/she will be given repeat supplies by the association or health center on which he/she depends. Actions to be carried out: i) advocacy, ii) HIV screening, iii) training, iv) availability of screening kits, v) waste management (peer educators will be given safety boxes to collect waste and transport it to the reporting health center for destruction) and vi) reporting of cases to the health-care center.- Advanced strategy screening: Advocacy and screening teams will be composed as follows: 1 peer educator, 1 nurse, 1 midwife and 1 community leader. Advocacy activities and TB and HIV screening for the island populations will be carried out by the teams, which will each complete a day-long visit to cover 1,000 people per quarter. ii) Percentage of the island population who have had a HIV test and know the results during the reporting period.Country targets: 14% (32,200/230,000) in 2019; 17% (39,387/238,084) in 2020; 19% (47,397/246,494) in 2021. All of these targets are assigned to the Global Fund.","(blank)",348461.12]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Program Review HIV, Epidemiology and Impact AnalysisThis review will assess the performance, impact, quality and effectiveness of HIV programs and link program funding, scaling up interventions and disease trends through systematic plausibility analysisThe costs provided here are historical costs related to past grants","(blank)",51324.21]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Using State funding, the NTBCP has acquired a MDR-plus/sl machine for the completion of Hain tests for all patients screened for RR-TB.To supplement the consumables and reagents included in the allocation amount, this request will make it possible to obtain all of the reagents and consumables required for performing first and second-line sensitivity tests","(blank)",817904.3]
[{"$nulls":5},"Malaria","Case management","Integrated community case management (ICCM)","The country has successfully implemented iCCM in 2 regions and intends to expand this intervention in 2 other regions with high malaria burden. This intervention will increase malaria diagnostic and treatment services among vulnerable groups and, hence, improve coverage of malaria treatment seeking among children under five. This will have an impact on the reduction of malaria mortality which continues to be considerable.","6/30/2021",2534322.41]
[{"$nulls":5},"Malaria Total",{"$nulls":4},18965237.149999999]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","HIV testing services for adolescents and youth, in and out of school","Outreach strategies for HIV awareness-raising and screening among people who use drugs: The 2018 biobehavioral survey of people who use drugs confirmed the presence of people who use drugs, as well as their high vulnerability. The DNLS therefore intends to use this grant to carry out the 2019 biobehavioral survey included within the allocation amount to further investigate this phenomenon and identify risk factors for HIV transmission among this population.The amount requested in the PAAR will facilitate the implementation of outreach strategies for HIV awareness-raising and screening among people who use drugs and who are known to NGOs such as APSM (Mohli), Sida Espoir (Anjouan) and RNJ (Ngazijia), which all collected data on this population for the survey. Five strategies will begin in the second half of the first year (two on Moroni, two on Anjouan and one on Mohli). Twenty strategies are planned for the second year (eight on Moroni, eight on Anjouan and four on Mohli) and 30 for the third year (12 on Grande Comore, 12 on Anjouan and 6 on Mohli). Each outreach strategy will target an average of ten people who use drugs.  This activity will reach a total of 550 people who use drugs through awareness-raising and screening activities. The results of the 2019 biobehavioral survey, as well as the results of the various activities planned in this funding request, will help adapt the outreach strategy plans (such as risk reduction) to this target group in a future grant.","6/30/2022",1436.43]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","HIV testing services for adolescents and youth, in and out of school","Supporting nutritional care for PLHIV in the active file: Nutritional support has been recognized as a very important factor in adherence to ART among PLHIV. The intention is to use the allocation amount to provide nutritional support to 60 PLHIV on a quarterly basis in the first year. This above allocation funding request facilitates providing for 60 percent of PLHIV in the second year (95 PLHIV) and 115 PLHIV in the third year. The nutritional kit, which includes eggs, fruit and vegetables, also needs to be improved, as recommended during the country dialog with PLHIV associations. This above allocation request also covers providing a nutritional kit for children in affected families.  It is estimated that these kits will be provided to an average of three children aged between 0 and 5 years per family from the second year onwards. This equates to 285 children in the second year and 345 children in the third year. The kit will cost EUR 25 and contain milk and fortified foods.","6/30/2022",43601.17]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","Organizing a multisectoral coordination and follow-up meeting with all stakeholders (education, justice, law enforcement, etc.):In order to take into account the multisectoral dimension of AIDS control, the DNLS plans to hold twice-yearly meetings involving all stakeholders (education, justice, law enforcement, etc.). These meetings provide an opportunity to share the status of both grant implementation and planning.","6/30/2022",7321.29]
[{"$nulls":6},"PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Organizing awareness-raising sessions and screening in schools and communities:Among young people aged 1524, the rate of regular condom use is low, at only 12 percent and the rate of HIV screening among the same group was less than 7 percent in 2014. Of 11 new HIV-positive cases reported in the Union of the Comoros in 2013, almost half were aged between 15 and 24 years.The allocation amount provides for contracting five youth NGOs (FCAS, RNFD, CAP, Stop AIDS, CRCO) to carry out 400 awareness-raising and screening sessions for young people aged 1024 in schools and communities in the first year, 500 sessions in the second year and 600 sessions in the third year. To contribute to the goal of halving new infections, particularly among young people, this above allocation grant will be used to provide an additional 300 sessions  in the second year and an additional 600 sessions in the third year.","6/30/2022",11989.68]
[{"$nulls":6},"PMTCT","Prong 3: Preventing vertical HIV transmission","Supporting the operation of the Network for People Infected with or Affected by HIV: TAS TAS is a community-based organization engaged in HIV prevention and caring for PLHIV. Given the weak performance in the area of treatment and the ambitious targets of this funding request for ART (from 35 percent in 2019 to 65 percent in 2022), the DNLS recommended making TAS a sub-recipient to take part in family screening strategies (partner and child), the search for people lost to follow-up, the referral of HIV-positive people (test and treat), the distribution of nutritional kits and mediation for treatment of TB/HIV co-infection. Given the importance of this organization in the HIV response, the government has provided a building for TAS to use as its premises.This activity supports TASs equipment needs (refurbishment of premises, chairs, tables, photocopiers, computers, office supplies, maintenance of equipment, Internet connection, etc.) in order to improve its results efficiency.","6/30/2022",43796.43]
[{"$nulls":6},"Case management","Ensuring drug and other health product quality","\"Slide exchanges with internal and external laboratories for quality assurance: According to World Health Organization recommendations, slide quality control is essential in a country that is moving toward elimination, as is the case for the Union of the Comoros. A correct reading of the slides is of paramount importance to avoid any misdiagnosis that may lead to the spread of the disease. Indeed, a positive slide read as negative may lead to an epidemic and undermine all efforts made so far toward eliminating the disease. As a result, the training supervision of quality control officials has been included in the budget to enable continuous training on the theoretical and practical aspects of quality diagnosis. The NMCP requests funding under the PAAR for the following: the exchange of slides internally (from the islands to the NMCP reference laboratory) and from the NMCP laboratory to an external accredited laboratory. This would ensure that these slides are read correctly to avoid this kind of situation and would also be a means of assessing other laboratories in the country from which the NMCP collects data, in order to ensure reliable results and avoid any step that might hinder the elimination process.\"","12/31/2021",12126.59]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","\"Routine LLIN distribution for pregnant women in the third year (30,582 LLINs):LLINs are a key intervention for reducingexposure to mosquito bites and vector survival, which considerably reducesvector capacity and transmission. Stopping LLIN distribution prematurely may lead to renewed malaria transmission at previous levels.High LLIN coverage can be rapidly achieved and maintained bymerging free mass distribution campaigns with routine distribution channels. Routine distribution channels includeprenatal care and vaccinations. There is a sufficient stock of LLINs to cover routine distribution for the first two years of the grant. Within the PAAR, funds are requested to cover procurement of LLINs for pregnant women for the third year of the grant. \"","12/31/2021",64914.15]
[{"$nulls":6},"Specific prevention interventions (SPI)","Other specific prevention intervention(s)","\"Organization of awareness-raising meetings on the malaria elimination process with community, political and religious leaders and NGOs: In recent years, the country has made concerted efforts to combat malaria. The number of malaria cases has fallen significantly, from an incidence of more than 120 per 1,000 population in 2010 to 5 per 1,000 population in 2017. To maintain this progress, effective involvement of the entire community is required. It is important that the political, communal and village authorities and the general population are invested in beating malaria. To this end, awareness-raising and advocacy sessions will be held every month in the countrys 19 health districts. This activity will be led by the chief physician in the area. It has already been planned and the unit cost has been approved by the Global Fund. The total of 350 includes both village chiefs and prefects: 26 village chiefs and 3 prefects on Mohli (Mwali); 91 village chiefs and 5 prefects on Anjouan (Ndzuwani); and 204 village chiefs, 14 district chiefs from Moroni and 7 prefects on Grand Comore (Ngazidja). The activity will be carried out in each health district through the health centers, which are the administrative centers for each district. The district is directly responsible for the activity, under the supervision of the Regional Health Directorate.  Travel costs of KMF 3,000 are budgeted for to facilitate the travel of village chiefs and other individuals (approved by the Global Fund in the current grant). The aim is to get leaders to adhere to the process so that they may influence peoples behavior.\"","12/31/2021",15897.21]
[{"$nulls":5},"Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Activity 2: Replace the four program cars (1/coordination, 3/islands). Rationale: At the end of the new grant period, the cars purchased in 2015 will be six years old and will have depreciated and be in poor condition (with a mileage of up to 50,000 km/year on degraded roads). Result: The NTCP will have four new cars available for its supervision, monitoring and evaluation activities, outreach strategies, contact investigation and coordination, unhindered by major logistical obstacles for a prolonged period of time. Impact: One of the essential prerequisites for effective TB control in the Union of the Comoros is guaranteed.","9/30/2021",150549.88]
[{"$nulls":4},"Congo","HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","The issue of sexual and reproductive health including HIV among female adolescents is not being covered adequately by health projects and programs. The current grant makes it a priority. This is why a bio-behavioral study for young people and adolescents is being conducted to mitigate these weaknesses.","12/31/2020",336662.55]
[{"$nulls":6},"TB/HIV","Other TB/HIV intervention(s)","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS in prisons.","12/31/2020",6570.38]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","The three months of buffer stock constitute a supplement to the adult ARV drugs which will be procured from the allocated funds in order to have 6 months as a standard quantity.","12/31/2020",1180280.55]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","Procure 190 cartridge kits for GeneXpert MTB/RIFGDF diagnosis CGXMTB-RIF-50 in years 1, 2 and 3.","12/31/2020",2348.75]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},4203188.3599999994]
[{"$nulls":6},"Case management","Other case management intervention(s)","(blank)","4/30/2021",2305016.27]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.","4/30/2021",32544.05]
[{"$nulls":5},"Malaria Total",{"$nulls":4},5628997.879999999]
[{"$nulls":5},"Tuberculosis","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","12/31/2020",391999.78]
[{"$nulls":6},"TB/HIV","Collaborative activities with other programs and sectors (TB/HIV)","Involvement of private facilities and traditional medicine practitioners Scale up efforts to identify missing cases by training private care providers and traditional medicine practitioners (three providers trained in each of the 243 high-priority HZs).","12/31/2020",374564]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Treatment for people living with HIV (purchase of antiretrovirals - ARVs) This amount represents 24,399 patients to enroll on antiretroviral therapy (ART), including 1,078 children. It includes the cost of the test, ARVs, biological monitoring and procurement and supply management (PSM).","12/31/2020",19919968]
[{"$nulls":6},"MDR-TB","Prevention for MDR-TB","Pharmacovigilance and laboratory strengthening This additional investment is intended to address rising drug resistance in the country and respond to the introduction of new drugs, initially to treat XDR-TB cases. It will be used to help establish a pharmacovigilance system to monitor and manage DR-TB drug side effects, with a view to future extension of the new drugs to treat DR-TB (non-XDR-TB).","12/31/2020",2083840]
[{"$nulls":6},"Case management","Severe malaria","The WHO recommends the preferential use of injectable artesunate in cases of severe malaria. A total of 33,997 deaths linked to malaria were recorded in 2016 out of 96.166 deaths recorded in health facilities, i.e. a proportional mortality rate of 35%. Given that the funds for purchasing injectable artesunate for children under five years of age have already been secured, we are requesting a budget of an extra $13,800,000, which will be used to complete the purchase, transportation and storage of injectable artesunate for treating adolescents and adults suffering from severe malaria.Only the needs of children under five years of age are covered in the allocation.","12/31/2020",13800000]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Mass distribution campaigns involving 20,934,506 LLINs in eight (8) DPSs (Kongo Central, Kasa, Kinshasa, Maniema, Tshopo, Ituri, Haut-Uele and Bas-Uele) with a total estimated population of 34,234,164, representing 30% of the country.  The average cost is USD 4.15 per LLIN distributed. The total estimated cost is USD 86,878,200. This will make it possible to maintain adequate universal coverage among these populations, in line with WHO recommendations, and to ensure that the gains made are not lost because of the decrease in mosquito net ownership.","12/31/2020",36193670.549999997]
[{"$nulls":4},"Costa Rica","HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","This intervention includes:- a cost-benefit analysis of incorporating PrEP into the offer of Social Security services for key  populations (especially important given the countrys constrained fiscal situation); and  - based  on  the results of that analysis, a Pilot Study on Availability of the PrEP in two HIV clinics, during which the  required  flow  of  services  will  be  analyzed. Both the  analysis  and  the  pilot  study  will  generate evidence to   analyze   the possibility  of  incorporating  PrEP  into  the  Social Security Institutes national offer of services for key populations.","6/30/2021",803034]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Insufficient degrees of adherence to ART to have a sustainable impact on the rate of new infections and mortality caused by AIDS. Specialized counseling in ART adherence is not systematic, and follow-up by the health care team and other Polyclinic services to take on adherence and serodiscordance is weak.","12/31/2020",84450]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","Insufficient outreach to PLHIV for VC tests, affected by the interruptions of regional laboratory services, especially due to equipment breakdown and maladjustment caused by years of continuous operation. Likewise, the centralization of blood tests for VL studies hinders follow-up on PLHIV follow-up and limits the capacity of the PCS, especially as regards the Polyclinic to mobilize the PLHIV under their care. The additional resources will be dedicated to increasing the number of PLHIV with undetectable VL by gradual replacement of obsolete equipment and increasing access to blood testing points.","12/31/2020",0]
[{"$nulls":6},"Other module","Other module","Reinforcement of primary and secondary health care will contribute to maintaining the achievements in mother-to-child transmission and the control of opportunistic diseases.","12/31/2020",475000]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},2226100]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","The service providers and community workers will be trained on the quality of services and RTTR(Reach, test, treat, and retain)-HIV-TB-Human Rights. They will contribute to identifing and referring suspect HIV and TB cases (index and contacts).","12/31/2020",8475]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","See line 44 (data validation).","12/31/2020",14237]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","The implementation of the national strategy of condom distribution for young people will allow prevention of STIs (sexually-transmitted infections) and HIV and prevention of unintended pregnancies.","12/31/2020",3763]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Staff training in the use of digital radiology equipment (See line 21).","12/31/2020",3763]
[{"$nulls":6},"TB care and prevention","Prevention","The study on TB/diabetes co-infection will allow better identification of new cases of TB and of diabetes.","12/31/2020",8475]
[{"$nulls":6},"TB/HIV","TB/HIV collaborative interventions","The aim is to strengthen the capacities of the DOTS and APS agents on the dispensing of INH, cotri and TB screening among PLWHA, RTTR, algorthyme and human rights (cost includes allowances). The expected result is a better understanding of RTTR,  TB prevention and improved diagnosis of new TB cases in PLWHA.","12/31/2020",24585]
[{"$nulls":6},"TB/HIV","Key populations (TB/HIV) - Prisoners","Through peer education, inform and educate inmates and prison staff on HIV, sexually transmitted infections, viral hepatitis and tuberculosis. The expected result is the identification and treatment/care of new HIV and TB cases among prisoners.","12/31/2020",8475]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Recruit the national technical assistant for capacity assessment for the transfer (Fees related to technical assistance - Consultants).","12/31/2020",85831]
[{"$nulls":6},"PMTCT","Analysis, review and transparency","The peer educators- traning is meant to contribute to  the action plan in the context of the RTTR (Reach, test, treat, and retain) TB-HIV-Human Rights strategy, the enrollment and retaining of patients and data collection.","12/31/2020",24585]
[{"$nulls":5},"Malaria","Case management","Facility-based treatment","This is an important activity to ensure effective management of malaria that is based on a good quality diagnosis.","12/31/2020",11948]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","The allocated amount, does not allow to implement the Indoor Residual Spraying as third which is why this amount is included in the above allocation. However, as long as this intervention would be effective, it would be unfortunate not to be able to mobilize funds for  implementation in the third as the risk of an epidemic would be inevitable.","12/31/2020",455122]
[{"$nulls":6},"Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","Community testing for Socially Vulnerable Women resident in Bateyes does not always take place in areas where prevalence is supposed to be higher (Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.","12/31/2021",0]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The national storageand distribution management  network need to maintain appropriate standards to guarantee conservation and quality of the medicines and reagents, which requires covering the demand in terms of infrastructure for warehouses and transport resources, as well as strengthening the infrastructure. In addition, improvement of logistics and improvement of the conditions of the importing entity will determine the flow of the supply management chain.","12/31/2021",500000]
[{"$nulls":6},"RSSH: Community responses and systems","Community-based monitoring","Studies of HIV prevention indicators are costly and would not be able to rely on sufficient resources to be conducted regularly.","12/31/2021",350000]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Behavioral interventions for TGs","The practices of self-care, prevention of HIV and other STIs in transgender people and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources would be allocated to increasing the targets that can be reached to improve self-care and prevention practices.","12/31/2021",0]
[{"$nulls":4},"Egypt","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","(1) One drop-in center model program in Cairo; (2) One peer education outreach model programme in Alexandria","3/31/2022",195000.18]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Strengthen national HIV surveillance system starting with an assessment and building its capacity to address bottlenecks","3/31/2022",15288.52]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Intervention for females who inject drugs is being proposed for implementation in Cairo through the Al-Shebab Foundation. The overlap between sex work and injecting drug use among females is reported to be high. Al Shehab already runs programmes to address womens vulnerability and have been reaching out to FSWs, women living with HIV and survivors of GBV.","3/31/2022",129282.05]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","PMTCT. A pilot was implemented and was nationally owned and received wide acceptance and helped in addressing stigma among healthcare providers and spreading awareness to women in child bearing age. This model will be evaluated and refined for scale up near hot spots of KPs where testing is expected to have greater yield.","3/31/2022",150000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","With this component several interventions will be carried out:1- Development of the SUIS (Sistema nico de Informacin de Salud = Unique Health Information System): the SUIS laboratory modules will be updated to standardise the information platform of the laboratories at the local level, regional laboratories and NRL that will allow there to be consolidated information for local and national reports.2- Implementation process: to use the SUIS, it is necessary for the Information and Communication Technologies Directorate of the Ministry to provide the laboratories with computer equipment and establish the virtual communication network, as well as maintain the network. This requires the training of laboratory staff in the use of tools, the changing of equipment that is on loan for analysis or testing and the deployment of laboratory modules.3-Management tool: when updated, the platform will allow the transmission of tests and results, which will increase the resolution capacity of the establishments and the timely delivery of results for decision-making.4- With the generation of information, specific reports or national reports will be developed whose data quality will be verified at the NRL.","12/31/2021",0]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Diagnosis and treatment of STIs and other sexual and reproductive health services for sex workers","The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.","12/31/2020",12700]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Socioeconomic approaches","The allocation will support the scale up of life skills education for out of school adolescents to acquire life skills. In order to address GBV in addition to creating awareness among the population and law enforcements more women headed households in 6 zoba will be assisted through income generating activities/ microcredit loan.","12/31/2020",517800]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x-rays, ECGs, etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas.","12/31/2020",824700]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","12/31/2020",270000]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},10275018.66]
[{"$nulls":5},"Malaria","Case management","Facility-based treatment","Monitoring activities at field level/facility level on stock of supplies, adherence of health workers to various guidelines as well as supervision of implementation of QA/QC of malaria diagnosis are all important activities that should complement production of guidelines and provision of medicines/laboratory supplies. Moreover, training health professionals on safety monitoring of anti-malarial medicines augments delivery of quality assured malaria services. Hence, additional investments of USD 610,950.00 are estimated to cover costs of executing the above activities.","12/31/2020",211872]
[{"$nulls":6},"Vector control","Other vector control measure(s)","In line with the above request, operational cost of larviciding has been included within Allocation Amount partially. However, for the intervention to function optimally and bring about the desired impact, an additional funding of USD 430,000 will be required. This will ensure full coverage of the intervention wherever suitable or relevant. In addition, select health workforce need to be trained on IVM regularly. For this purpose, USD 65,424 will be required to organize the training every other year.","12/31/2020",396979]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.","12/31/2020",90406]
[{"$nulls":6},"TB/HIV","Engaging all care providers (TB/HIV)","In this section heath care workers working in TB clinics will be trained on comprehensive HIV care and treatment and on HIV counselling and testing skills in order to provide a one-stop service.","12/31/2020",33840]
[{"$nulls":4},"Eswatini","HIV/AIDS, Tuberculosis","HIV Testing Services","Differentiated HIV testing services","Additional working tools for HTS providers (lab coats) and further learning and experience sharing(conferences, exchanges) to share results from innovative testing modalities.","9/30/2021",30893]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Recruit and retain four regional sexual and reproductive health coordinators/mentors to enhance regional-level coordination of AGYW investments across Global Fund, PEPFAR, UN family, government and others. It is expected that this investment will help address some of the HRH-related implementation bottlenecks, especially for programmatic interventions requiring an integrated approach.","9/30/2021",296471]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Additional support for targeting the ACFs approach towards key populations, including mapping and screening of Key affected populations by ACFs, including comprehensive training of ACFs and training of peer educators and caregivers to support TB key populations (factories, prisoners, orphanages, day care centers).","9/30/2021",166667]
[{"$nulls":6},"TB/HIV","TB/HIV collaborative interventions","Additional demand creation and treatment literacy activities, including conducting  campaigns targeting miners, ex-miners and their families; conducting campaigns targeting public transport operators; IEC materials, TV campaigns; radio campaigns and activities to create awareness on World TB day (24 March 2017).","9/30/2021",111061]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Additional treatment literacy support, including social and transitional media campaigns, recruitment of Community Outreach Workers (5 men per region and 5 AGYW). These groups are prioritized as outreach workers based on data that shows limited ART uptake among men (Table 3) and limited viral load suppression among young people. Lastly, funding will support the procurement of two vehicles to support the national PLHIV network SWANNEPHA. Funding is requested to recruit community outreach workers, with five men and five AGYW per region.","9/30/2021",417688]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Additional LIS support and Laboratory Personnel to support and strengthen the Quality Assurance Unit and to support the supply chain system.","9/30/2021",696078]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Development of a national community health strategy.","9/30/2021",50000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Train at least 200 health workers, mentors and champions at all levels on data analysis, interpretation and use for decision making, update national and sub-national HIV and TB (EPP/Spectrum) estimates and Develop and update TB&HIV Treatment Cascades by age, sex and location.","9/30/2021",185000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Administrative and finance data sources","Update and maintain MIS information databank on all social welfare grants and in the future also social work case management. It will allow DPMO to have real-time statistics on social welfare grants, for better evidence-based management and better advocacy for sustained social budgeting. It will also support the matching funds activity to support 1000 AGYW (by year 3) with educational subsidies and other cash plus care models, as prioritized in Swazilands investment case.","9/30/2021",2800000]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Train the remaining 4,400 Rural Health Motivators (RHMs) (above the 600 that are prioritized in the allocation) using revised curriculum.","9/30/2021",100000]
[{"$nulls":6},"MDR-TB","Community MDR-TB care delivery","Training of community treatment supporters in basic facts on TB, ethical considerations (privacy, patient confidentiality), infection control,treatment adherence and psychosocial support.This training helps them to execute their patient support duties with greater knowledge and broader understanding of their clients needs.","9/30/2021",135000]
[{"$nulls":5},"Malaria","Case management","Active case detection and investigation (elimination phase)","This investment which includes salaries of (155,674.09) Survey gear (USD 3,104.09) and (USD 6,593.15) communication, will facilitate scale up of the case investigation rate to 48 hours and implement weekend shift patterns. Six more surveillance agents who will be covered by this investment will be absorbed by the government beyond 2020.","12/31/2020",165371]
[{"$nulls":5},"Malaria Total",{"$nulls":4},165371]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Through engagement of all stakeholders and extensive consultative process, Ethiopia has prepared the second edition of a National Plan for TB Research, 2017 -2022. A second round TB prevalence survey is among the priority TB researches planned for 2020. Through this above allocation request, CCM/E plans to partially support the national TB prevalence survey as well as other priority researches. The grant will also partially support the annual national TB Research conference.","(blank)",799008]
[{"$nulls":5},"RSSH","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Relates to warehouse infrastructure, imporving operational work flow design, packing and wrapping materials, and trolley jacks.","6/30/2021",436108]
[{"$nulls":5},"RSSH Total",{"$nulls":4},5081934]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","i) To create 12 new CDTs to increase TB notification rates and decrease rate of loss to follow up in 4 regions (Woleu Ntem, Ogooue Ivindo, Haut Ogooue, Ngouni and Nyanga)  ii) To secure the supply of first-line drugs for at least the first two (2) years.","12/31/2021",164726.74]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","Indoor Residual Spraying is used as a complementary vector control strategy to mitigate the effects of vector resistance to insecticides. Over the past years, IRS implementation was limited to 2 regions of central river region and upper river region due to funding gap. The 2017 HMIS data have shown regional changes in incidences of malaria where LRR (27/1000 cases) and WR2 (36/1000 cases) have recorded higher incidences compared to other regions. The preliminary results of 2017 MIS have also shown similar trends of parasite prevalence by regions. It has been prioritized for inclusion in the prioritised above allocation request to mitigate effect of insecticide resistance on LLINs in these regions. Therefore, IRS will be scaled up to cover LRR and rural settlements of WR2 using the above allocation request. The request will cover the cost of insecticides, logistics, operational cost and implementation and it amounts to U$1,215,424.  As the Gambia continues to implement IRS in the targeted regions (URR/CRR), and as part of the the two country collaboration clustering of border communities will be conducted to line list villages in the Senegalese side (2 km from the Gambian Border) for posible coverage by the Gambia IRS teams.Insecticide resistance monitoring in the IRS program and LLINs are covered in the program continuation request recently approved.","6/30/2021",1215424]
[{"$nulls":4},"Ghana","HIV/AIDS, Tuberculosis","HIV Testing Services","Other module","Nationally representative sample of men and adolescents to assess the acceptability of the testing model in an effort to improve uptake of HIV testing in these two groups. Phase two will assess its feasibility in selected regions. Phase three will utilize findings from phases 1 and 2, and will be scaled up to other regions.","12/31/2020",1200000]
[{"$nulls":6},"Other module","Other module","Differentiated models of care (DMOC) are an important intervention for achieving 90 90 90.  DMOC, introduced in 2017, will be continued during the 2018-2020 funding cycle with support from EQUIP at 20 existing ART sites. USAID will support 10 facilities in 2017 and 2018 while the Global Fund will support 10 sites in 2018 and all 20 sites in 2019-2020.","12/31/2020",0]
[{"$nulls":6},"Other module","Other module","Scale up of intensified case finding (ICF) and TB GeneXpert tests are key interventions to identify the missed cases in Ghana. Currently those interventions are limited to 113 districts (of 216 total). This budget will be used to procure 20 additional GeneXpert machines with three years running cost to be deployed in 20 district hospitals. This will increase the geographical coverage of grant intervention sites by 10%. As NTP is applying decentralized ambulatory MDR TB treatment, GeneXpert MTB/RIF test will have vital role in diagnosing drug resistant TB.","12/31/2020",4400000]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The funds are required to ensure continued VC coverage by procuring LLIN for the 2021 Q1 mass distribution campaign. The funds for the 2021 campaign were not included in the current grant. The bed nets used for the 2018 mass distribution campaign where procured in 2017 with NFM1 grant budget.","12/31/2020",23000000]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","This request is for the development of a transition plan that addresses Service Level Agreements, maintenance procedures, and training for supply chain managers on the Logistics Management Information System (LMIS). This will ensure sustained and optimal functioning of the LMIS, thus contributing to increased data visibility and reduced expiries.","12/31/2020",0]
[{"$nulls":5},"Tuberculosis","MDR-TB","Treatment: MDR-TB","Current death rates among the MDR cohort will reduce from 25%-15% as MDR treatment adherence and end-of-life care with reduced transmission of MDR/XDR TB will improve by the $1.1million refurbishment of a health facility with 20-bed isolation rooms, pediatric wards, and negative pressure airflow facilities treating 180 patients/year. MoH will provide of beds, equipment, staffing, maintenance costs and running costs.","12/31/2020",1100000]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},1100000]
[{"$nulls":6},"Program management","Grant management","Operational support of personnel for the MSPAS and INCAP consisting of:1- A facilitator for the ETMI hired for the PNS.2- Officer dedicated to the Monitoring and Evaluation of the ETMI component in the PNS3- Responsible for ETMI4- Secretarial supportTo this is added the percentage of operational expenses of INCAP (1% for the acquisition of tests and 5% for the rest of the items)Transversal contribution to the indicators related to prevention and treatment. This item was updated in October 2019 to increment the original approaved amount of 211260","12/31/2020",0]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Asuncin Mita Health Center, Jutiapa. Renovation of a 16 m clinic, including: preliminary work; foundations; structural elements; erecting a block wall; laying reinforced concrete floor; finishing for walls and floor; laying ceramic flooring; installing one door, five windows, one washbasin; installing water and electricity; concrete bench; pavement; outer metal structure; paintwork.","12/31/2020",10000]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Escuintla health area department (planning pending).","12/31/2020",9677.42]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Escuintla National Hospital (planning pending).","12/31/2020",10755]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Pedro de Bethancourt Hospital, Antigua Guatemala. Renovation of a 70.20 m facility, including: preliminary work; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; erecting a plasterboard wall; supplying ceramic flooring; metal structure; suspended ceiling; installing water and electricity; two metal doors, three MDF doors, six windows; pavement and outside steps; paintwork.","12/31/2020",10775]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Retalhuleu health area department. Renovation of a 51.53 m facility, including: removing and supplying sliding aluminum door; nine windows; three lights; six power sockets; four fixed furniture units; paintwork; installing an 18,000 BTU air conditioning unit.","12/31/2020",9677.42]
[{"$nulls":6},"Comprehensive prevention programs for MSM","HIV testing services for MSM","70,108 HIV tests to cover 100 percent of the programmatic gap in 2020.","12/31/2020",110771]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Condoms and lubricant programming for MSM","5,802,056 condoms to cover 82 percent of the programmatic gap in 2020.","12/31/2020",174062]
[{"$nulls":6},"PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Interinstitutional Articulation National Program of STIs, HIV and AIDS - Comprehensive Health System - National Reproductive Health Plan - Health Areas Directorate - National Health Laboratory - Hospitals; IGSS, APROFAM, Military Health, Association of private hospitals among others and non-governmental organizations that work on the subject, to support the sustainability of interventions.Covers the cost of consultancy to facilitate thisIndicators:Reduce the gap of 2016 on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 2000","12/31/2020",0]
[{"$nulls":6},"PMTCT","Prong 3: Preventing vertical HIV transmission","Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women, adapted to needs. This plan must be specific for clearly identified target groups and with translation into the local language, including people's rights approaches .The same TA will be used to conduct end user surveys to evaluate the impact of messages devliered by the campaignIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 119290","12/31/2020",0]
[{"$nulls":6},"PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","onsultancy fees to develop a strategy to strengthen the system for monitoring compliance and achieving results through a non-economic recognition system.Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","12/31/2020",5000]
[{"$nulls":6},"PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Strategy for tracking positive cases lost and improving the link (mobilization vouchers, health promoters, mobile phones) (will investigate possible synergies with existing strategies such as multisectoral networks. (consultancy fees)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017). This item was updated in October 2019 to increment the original approaved amount of 20000","12/31/2020",0]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Condoms and lubricant programming for TGs","2,767,550 condoms to cover 82 percent of the programmatic gap in 2019.","12/31/2020",83027]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Conducting a second KAP survey to respond to the indicators in the performance framework (on LLIN use).","6/30/2021",0]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","First aid kits.","6/30/2022",0]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Regional and local training for health personnel (including medical staff) to raise awareness and disseminate information on identifying respiratory symptoms and taking samples.","6/30/2022",43601.95]
[{"$nulls":6},"MDR-TB","Collaborative activities with other programs and sectors (MDR-TB)","Local and regional meetings on the implementation of differentiated models for treatment adherence and support at community, family and personal levels (peer strategies, mentoring, patient support groups etc.).","6/30/2022",106695.05]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","4. Request for additional resources for printing and distribution of the SNIS data collection tools validated by the Ministry in April 2017. The requested funding is to cover at least 50% of the costs, whilst awaiting the mobilization of pledged funds from other partners (CRS, Jpeg, GIZ, World Bank and Measure Evaluation).The new tools ensure better data collection and reporting for the MoH different programs.","12/31/2020",582858.23999999999]
[{"$nulls":5},"Tuberculosis","Program management","Other program management intervention(s)","Advocacy platform bringing together the TB and HIV programs, the government, elected members, TFPs and representatives from the various sectors; advocacy before the government and the partners in order to mobilise resources and to achieve the adoption of legislation beneficial to the effort to combat tuberculosis.","12/31/2020",6069]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Four GeneXpert machines will be purchased. Three of these will be placed in the heavily used CDTs in the municipalities of Matoto and Ratoma, which are the most populated and cover the largest area; the 4th machine will be sited in the CDT in Macir (municipality of Dixin), near to the CHU which is home to a large paediatrics department. Impact: increase in the detection of cases of TB, TB-HIV, MDR-TB, childhood TB. The cost includes the purchase of the four machines, their calibration in years 2 and 3 and the provision of 1200 cartridges per machine per year.","12/31/2020",220983]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The DPSs will supervise activities relating to the combating of TB in the CDTs and Health Centres within their catchment zones.","12/31/2020",195636]
[{"$nulls":6},"Program management","Grant management","Equipment (laptop) for the National Secretariat to fight against HIV/AIDS.","12/31/2020",940.41]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Thanks to the NFM TB grant, a new TB reference laboratory has been built. In order to render it functional, a negative-pressure system must be installed (to respect the bio-safety norms) and a few other corrections must be made (Mechanical and Civil Budgets costs of NTRL Guinea Bissau, WHO Expert Mission - Appendix B). For this reason, the WHO hired an international expert to perform an evaluation and implementation of his recommendations will require the requested amounts.Once this laboratory is functional, it will be used to perform the necessary exams to fight tuberculosis including the multi-resistant version. The agents will work there under optimum bio-safety conditions.","12/31/2020",743538.91]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Organize 3 data collection missions to inform the indicator on the 12-month survival rate for 2018, 2019 and 2020. The information for this indicator is taken from the GARP report.","12/31/2020",567.84]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Ensure communication costs of PMTCT sites for follow-up of deadlines. Credit for communication is provided to communicate with women as part of PMTCT.","12/31/2020",40956.120000000003]
[{"$nulls":6},"Other module","Other module","Conduct a Resistance Surveillance Survey (Studying the drug resistance of HIV to ARVs - Estimate the level of primary resistance, classify resistance levels of HIV-1 to ARVs and describe the types of mutations encountered). This study is essential for evaluating the resistance levels of HIV to ARVs, together with the types of mutations. The results of this study will enable better use of ARVs, thereby improving the survival rate for patients.","12/31/2020",23846.93]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","PSM: We are requesting 433,481 EUR for the new warehouse, in addition to the 628,002 EUR already approved by the TRP in Nov 2017, bringing the total PAAR UQD for PSM storage and distribution to 1,061,483 EUR.Almost 50% of Global Fund NFC grants in Guinea Bissau consist of medical supplies and commodities. The GF Risk Matrix Action Plan identified numerous PSM distribution and storage issues during a review in 2016-2017.  The TRP approved 628,002 EUR for additional supply chain monitors (to trace GF funded medical supplies to end user level) and international technical assistance for the national medical stores-CECOME.As part of the reprogramming of the NFM M grant, GF authorized UNDP to purchase a Warehouse In a Box (WIB) from WFP, to replace the existing warehouse which had several fires in the last 3 years due to improper construction (frail walls, insufficient ventilation, electrical wires for air conditioners of 1.5 mm instead of 3 mms, etc). To assemble and construct a fully operational WIB would require 1.4 m EUR - breakdown provided.The existing NFC M grant has 0.4 m EUR in funding for the new warehouse, sufficient to cover the design, construction of the base and assembly of the WIB. We anticipate having savings from PSM purchases in the amount of 0.5 m EUR (which will cover the walls, insulation, multifold doors, air conditioners, and machine equipment). This leaves a gap of 433,481 EUR (for the racking, solar pannels, Warehouse Information System hardware, UNDP GMS, etc.), which is being requested now.","12/31/2020",486456.07]
[{"$nulls":6},"Other module","Other module","Bridge the funding gap for capacity building activities of MOH. Most of the personnel involved in the NMCP have been newly recruited (since 2016) and are responsible for the various positions within the NMCP, however they have not received any training.","12/31/2020",244858.04]
[{"$nulls":6},"Other module","Other module","Strengthening of the supply chain management system. It is essential that a strict monitoring system and dedicated technical assistance are put in place to guarantee the rational use of the drugs and health products provided under the three grants. The direct collection of information regarding consumption in real time as well as on-the-job training provide additional safeguards for the national PSM system.","12/31/2020",704749.19]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","The BSL3 certification process of the LNSP is under way and must finish on schedule in April 2018. Its operating budget has not yet been met by any funder. The maintenance cost requested includes certification of hoods, maintenance of negative pressure and maintenance of equipment.","12/31/2020",373577]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Drug resistance surveillance","HIV resistance to ARV treatment is a threat to achieving 90-90-90 objectives and eradicating HIV by 2030. In Haiti, there have not been any national surveys of the prevalence of resistance (RDP-RDA) of HIV-1 to ARV treatment. Recommendation: Develop a National Plan for Surveillance and Response to HIVDR   Develop guidelines for surveillance of HIVDR  Train healthcare managers on surveillance and prevention of HIVDR, including systematic monitoring of EWIs.","12/31/2020",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Programme data is always available late (long laps of time between production and approval). The PNLT will implement the module based on DHIS2 cases for drug-susceptible TB and MR-TB in a single system with cases of MDR marked MDR. After pilot phase and assessment, its extension will enable the operation of a single TB data management system which generates optimum quality information on the MSPP's open-access website.","12/31/2020",250000]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","Screening for the side effects of MDR-TB treatments at vestibular/cochlear and cardiac level will be conducted systematically while the treatment of MDR patients is being monitored. MDR treatment extension sites will be fitted out with the appropriate equipment, an Audiogram System, Software, computer and ECG with automatic interpretation.","12/31/2020",45000]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Purchase of LLINs for victims of natural disasters (cyclones, hurricanes, flooding, landslides, etc.). Every year, about 20,000 people experience these disasters and are left homeless, exposed to mosquito bites, the vectors of malaria. Needs over three years are estimated at 60,000 LLINs.expected result: all this population affected is protected from malaria by means of a LLIN;impact: morbidity due to malaria amongst people homeless, who have suffered natural disasters, has dropped considerably (by 90%).","12/31/2020",202200]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Reproduction of data collection tools for agents on the groundexpected result: all agents on the ground, including ones at community level, have tools for collection, on paper, in a sufficient quantityimpact: no shortage of stock of tools for collecting data over 3 years","12/31/2020",30000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Organise 4 quarterly meetings on monitoring and co-ordination between the PNCM and departmental directorsexpected results: co-ordination of activities to combat malaria with departmental authorities is ensured; .impact: players at operational level will correctly implement Global Fund projects and correctly apply directives and policies to combat malaria dictated by the PNCM.","12/31/2020",149685.6]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Contracting a coordinator and workers for organizations that intervene in FSW population","7/31/2022",140898]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Contracting a coordinator and workers for organizations that intervene in prisoners population","7/31/2022",120292.8]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Montly salaries of staff included in the budget of the future grant (the number of monthly salaries were reduced at the beginning and end of the grant due to the reduction of funding)","7/31/2022",0]
[{"$nulls":6},"Treatment, care and support","HIV care"," Training new human resources to provide assistance in the HIV Clinics, VICITS and \"friendly services clinics\" HIV clinics advocacy strategies","7/31/2022",-0.19]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Montly salaries of staff included in the budget of the future grant (the number of monthly salaries were reduced at the beginning and end of the grant due to the reduction of funding)","7/31/2022",0]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis"," Strengthen the coordination mechanism between agencies, civil society and community-based organizations in the field of Tuberculosis. Introduction of portable X-rays to reinforce diagnosis in patients with sputum-negative results, patients with presumptive Extra Pulmonary TB, and HIV patients with presumptive TB. Refresher training to laboratory staff in the bacilloscopy technique to gradually replace the practice of smears by the sending of sputum samples.  Strengthen the advocacy, prevention, detection and tracking of cases in Maternal-Childrens Clinics.","7/31/2022",274620.49]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Activities to improve prevention, advocacy, detection, diagnosis and timely treatment in TB key populations, such as people with diabetes, mental patients, kidney patients and tobacco users. Similarly, activities to improve the control of TB at the different levels of care and, subsequently, decrease the number of deaths due to TB in association with these pathologies.","7/31/2022",429826.35]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},967097.99000000011]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","As a part of alternate strategies to improve adherence to ARVs, adherence clubs at all Link ART Centers (LACs) are being proposed.","3/31/2021",4700000]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","This conference aims at re-enforcing the commitment towards accomplishing the national strategy of 90:90:90 and sustaining the gains as part of the national health policy. Its al the more pertinent in the wake of HIV bill which has been recently passed by Parliament. It is now to ensure its operationalization towards improving quality of lives of PLHIV.","3/31/2021",16276]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","This budget is towards addressing the gap for additional ICTCs proposed in the NSP. As a part of integration of MIS systems, moving from manual record maintenance to electronic mode is important. Funds proposed under the above allocation will help further strengthen and fill the need for the balance of ICTC centers that need tablets.","3/31/2021",500000]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","State based PR staff will be sent to other States to learn and implement EPTCT in their respective regions.","3/31/2021",11327]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","The project is planning to conduct 2 operational research studies as part of EMTCT towards elimination. This will be conducted in coordination with the National Health System.","3/31/2021",45455]
[{"$nulls":5},"Malaria","Vector control","Other vector control measure(s)","This includes procurement and distribution cost of LLINs for Odisha which need to be replaced in 2020 to sustain the impact of LLINs distributed in 2017. Odisha accounts for more than 40% of malaria in India. Maintaining LLINs coverage in Odisha would reduce malaria morbidity & mortality by 70% in 2020 compared to 2015, similar to NE states. 90% of LLNs are assumed to be used by population in coverage areas.","3/31/2021",25800725]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","ICT support for NIKSHAY: National Case Based web-based surveillance system (Nikshay) has been developed and deployed across the country with more than 7 million TB patients registered including 0.7Million cases notified by private sector since 2012. The scope of NIKSHAY is being enhanced through a mobile-based solution to enable real time TB notification at source, provide adherence support, programme management, DBT support for providers, etc. This requires a national level ICT support unit for database architecture, system security, and development work, help desk, website and server management.","3/31/2021",430000]
[{"$nulls":6},"TB care and prevention","Engaging all care providers (TB care and prevention)","Under Joint Effort for Elimination of TB (JEET) project Provider/Patient Support Agencies (PPSA) to be set up across in 58 cities/towns in India with population >1 million; 33 of these cities are covered by allocation budget. Additional PAAR request of $6M will cover PPSAs in additional 25 cities/urban agglomerates realizing additional 100,000 notifications with limited HR involvement as compared to the PPSAs in 33 prioritized cities under allocation funding request.","3/31/2021",6000000]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Management of DRTB patients - SLD: An above allocation grant with funding amounting to USD 29.85 million is requested to initiate additional 20,000 MDR-TB patients on treatment.","3/31/2021",29850000]
[{"$nulls":4},"Indonesia","HIV/AIDS, Tuberculosis, RSSH","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","(blank)",238921]
[{"$nulls":6},"Program management","Grant management","Support for human resource for MSM and TG comprehensive program at (32 districts for MSM, and 50 districts for TG).","(blank)",372827]
[{"$nulls":6},"Program management","Other program management intervention(s)","This intervention covers Tanah Papua area, targeting general population, on top of interventions in the within allocation targeting pregnant women, TB patients and KAPs. This would target a number of 75,000 general population tested with a projected 1,725 additional persons starting treatment. The activities include trainings, mentoring session, home-based care of PLHIV, tracing of pre and in treatment list of patients by health cadres, as well as monthly coordination meetings.","(blank)",0]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Mobile clinic to screen for TB in urban poor population in 10, 12, 15 high burdened cities in 2018, 2019, 2020. Additional 1000 patients from urban poor is expected per year. Technical mentoring of TB ICF in 34 provinces, printing of TB ICF materials. Printing IEC material for vulnerable population at workplace.","(blank)",947184]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Additional 75,000 PLHIV receiving psychosocial support.","(blank)",151884]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","The additional 8,682 patients above will also receive prevention, diagnosis and treatment of opportunistic infections. Activities include OI and STI drugs procurement, trainings, mentoring session, home-based care of PLHIV.","(blank)",775733]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Scaling-up ARV Decentralization: sub-national level training, and mentoring & Monitoring ARV Decentralization.","(blank)",101957]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Community empowerment for MSM","Expansion of Comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts).","(blank)",57652]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Community empowerment for TGs","Expansion of Comprehensive program to reach additional 5,250 TG for testing and 756 for treatment.","(blank)",88604]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Determine to what extent oxidase-based resistance mechanisms are prevalent in insecticide resistance via bottle bioassay synergist assays. The research will be done in 10 district sites in Eastern Indonesia. Will cost US$ 50,000 per each site (Total US$ 500,000).","12/31/2020",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Evaluation of the 1-2-5 protocol to assess its effectiveness. It will take 30 sites of districts with API<1 per 1000 from 20 provinces. Cost will be US$ 10,000 per district (Total US$ 300,000).","12/31/2020",0]
[{"$nulls":4},"Jamaica","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Condoms and lubricant programming for sex workers","Develop and roll out campaigns to glamorize condom use to target KPs to improve condom uptake and reduce risk  especially among sex workers (SW) and clients to improve  improve condom use and reduce risk for HIV.","12/31/2021",100000]
[{"$nulls":6},"RSSH: National health strategies","Other policy and governance intervention(s)","Develop a change management communication and advocacy strategy to support implementation of the National Information System for Health (IS4H) Strategy.","12/31/2021",30000]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Community empowerment for MSM","Skills development programmes to improve employability /educational attainment and thereby reducing sexual risk taking and improving protective behaviours among KP.","12/31/2021",300000]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","Based on the Pilot of PrEP being supported under the allocation, scale-up to provide for at least 1500 additional MSM on PrEP by project end.","12/31/2021",172296]
[{"$nulls":6},"Prevention programs for general population","Behavioral interventions as part of programs for general population","This above allocation funding (UQD) will increase coverage of men and women reached with comprehensive HIV prevention package (including education, HTS, condom use, GBV and treatment) through campaigns in informal private sector and mass media building on similar interventions under allocation funding.This funding is to enable the country address the low coverage in prevention among men and adolescents which will also contribute to scale up of PLHIV on ART.Interventions to be funded under this module (UQD) are: Behavioral interventions: US$ 1,441,473 (increase coverage of men and women reached with comprehensive HIV prevention package); Procurement of 40 million male Condoms, promotion and distribution: US$ 2,610,973; Male circumcision US$ 42,820 (funding will support the planning process for the roll out of Early Infant Male Circumcision (EIMC)); Gender based violence prevention and treatment program: US$ 101,962 (funding will support the development and dissemination of SGBV screening tool targeting 4 urban areas); Other interventions for general population: US$ 2,160,096 (scale up of PrEP for an additional total of 35,000 people and sustain the supply of blood safety reagents in year 3 of the program at the same funded under allocation funding for year 1 and 2).","(blank)",6357324]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","This above allocation funding (UQD) aims to cover the critical gap in laboratory systems by operationalising the 15 laboratories that were renovated by providing essential basic amenities such as laboratory equipment seats, safety and an access control systems.","(blank)",1148795]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","This above allocation funding (UQD) aims to expand the Field Epidemiology and Laboratory Training Programme (FELTP) that has been instrumental in building high level capacity for epidemiology and laboratory science whose graduates largely support the HIV, TB and Malaria programmes. The scope has been limited by the available resources from the Centres for Disease Control yet there is a greater need. In order to expand access to this program to county HIV and TB coordinators, this above allocation funding is proposed to meet this gap.","(blank)",640796]
[{"$nulls":6},"RSSH: Financial management systems","Routine financial management improvement (non-PFM)","This above allocation funding (UQD) will support an Analysis on Health Return on Investment and Resource gap analysis for health financing in Kenya. This is critical to support the domestic resource mobilization agenda given Kenya has transitioned to LMIC status.","(blank)",574698]
[{"$nulls":6},"Other module","Other module","The above allocation funding (UQD) aims to maintain high levels of treatmnet with quality assured ACTs in private sector and for improvemnet of malaria diagnosis, treatmnet and surveilance. Activities wil include: update of the curriculum and the guidelines to be undertaken in the next one-year. This will be followed up with training to strengthen surveillance and reporting. A total of 282 ToTs, 7960 health workers at county, sub-county and facility levels are targeted for training. Within the allocation 282 ToTs and 3050 have been budgeted for, the balance of 4910 health workers is requested in the above allocation (UQD - $1,020,164). The other request is to facilitate one Private Sector QoC survey (US$ 152,670).","6/30/2021",0]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","Additional financial support is required to provide overarching programmatic management and to maximise national capacity in policy planning, coordination and management as the country transitions to elimination. While not directly linked to program impact / outcome it will provide an enabling environment for the program to implement more effectively and efficiently. Above allocation funding will be utilised for 1) training on programme management in the elimination phase, and 2) International Conferences on the elimination of malaria (4 persons 2018-2020).","2/28/2021",252755]
[{"$nulls":6},"Other module","Other module","In addition to provision of X-ray the diagnostic capacity for pediatric TB will be further increased through the procurement of ultrasound machines under the above allocation amount.","6/30/2021",3420000]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Additional funds for sex workers programmes will be used for increasing HIV counselling and testing in medical facilities includes, by providing incentives for sex workers to get tested.","12/31/2020",11429.69]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","Additional funds will be used for training of police and other stakeholders regarding Human Rights-related issues that affect access to HIV prevention, care and treatment services for KPs and PLHIV.","12/31/2020",3433.96]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Additional funds will be used to further develop and support networking of community groups, particularly of key populations, to ensure social mobilisation, representation and advocacy at national level.","12/31/2020",20704.75]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Additional funds will be used to raise awareness amongst KAPs and PLHIV community members about their legal and other entitlements, and for development of community sector services including gender-sensitive services that are critical but under-supported within the grant's allocation.","12/31/2020",46459.43]
[{"$nulls":6},"Comprehensive prevention programs for MSM","HIV testing services for MSM","Given limited amount allocated to HIV prevention services among MSM in the grant, additional funds will be used to expand VCT delivered by NGOs. It will help to attain targets set.","12/31/2020",24522.5]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","This funding is to build capacity of Sub-Recipients to manage grants, reportand provide HIV counselling andtesting","(blank)",111600]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","To promote early HIV testing in Chui obast by providing supporting testing in NGOs andhealth organizations","(blank)",127000]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Service organization and facility management","This funding is to develop a mechanism for the state funding of OST and NEP points, elaboration and implementation of the electronic monitoring tool for this ($20,244). Additionally, funding request includes incentives for service providers at the PHC level for viral load suppression and quality provision of medical services for PLHIV (US$ 48,004)","(blank)",68248]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","This funding is for expansion of electronic TB database including software update, user trainings, monitoring, and supportive supervision activities.","(blank)",550435]
[{"$nulls":6},"MDR-TB","Prevention for MDR-TB","Funding is requested to support the procurement of masks and respirators, as well as UV lamps for TB facilities.","(blank)",482640]
[{"$nulls":6},"MDR-TB","Community MDR-TB care delivery","Motivation support for patients with both susceptible (2018-2020) and resistant TB forms (2020)","(blank)",647677]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},3020000]
[{"$nulls":6},"Program management","Other program management intervention(s)","The fundiing will support the strengthening of lower level management needed to enable ownership and sustainability at the lower levels.  Management structures are the District Committee for the Control of AIDS,and Provincial Committee for the Control of AIDS through capacity building, staffing.","12/31/2020",344882]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This is a key capacity building event to increase the skills and capacity in IT configurations, data use and analysis. The academy would be run for two weeks for 60 people. Attendance would be open for HIS from national and subnational level and would provide intensive capacity building relevant to their roles. The expected outcomes would be to build capacity in targeted HIS skills to improve the efficiency, accuracy and sustainability of the Lao HIS.The remaining budget required for this event has been included in the GF TB budget application and co financing budget for government.","12/31/2020",200]
[{"$nulls":4},"Lesotho","HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","The Ministry of Health conducted quantifications for health products in order to inform the government 2019/2020 finacial year budget for health products. From the quantification, it was determined that the national need for ARVs would need LSL 444,172,844.54 (approximately US$ 32 million). It was already known that the Global Fund contribution for ARVs for the 2019/2020 financial year is LSL 68,536,085.87. Due to fiscus challenges, the Ministry of Health was only allocated LSL 236,775,819 for the ARVs and this led to a funding gap of LSL 138,860,939.67. Efforts were made by both the Ministry of Health and Ministry of Finance to mobilise the funds but the resource mobilisation did not yield positive results. It is against this background that the country is requesting support from the Global Fund towards procurement of ARVs in order to close the eminent funding gap. The funds that are being sought will go a long way in ensuring that there is availability of commodities (ARVs) so tht there is continuity of treatment for People Living with HIV. The ARVs to be procured with the funds being sought will take ARV stock holding to December 2020 and this will give the Government of Lesotho ample time to mobilise adequate resources to ensure there will not be any shortages going forward.","6/30/2021",9212649]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","The HIV prevalence for Adolescents and young people is 13% among young women and 6% among young men (Avert 2016). One of the key drivers for the high prevalence among adolescents and young people is limited knowledge of HIV prevention and available services. This is evidence by the LDHS (2013) that indicated for persons aged 15 -24 years, comprehensive knowledge was as low at 30.9% and the LePHIA (2017) report indicated that awareness of HIV and status among the same age group is at 56.2% for males and 61.4 % for the females.  Social marketing has been established as an effective behavioural change model for several public health issues. To increase the comprehensive knowledge, several interventions are funded including the development of the SBCC strategy by UNICEF and the  social marketing strategy under NFM 2. The main gap identified is the operationalisation of these strategies, in particular is the social marketing strategy. The intervention bridges the skills gap in delivering comprehensive prevention services for adolescents and young people through understanding the barriers and the factors accounting for the low knowledge on HIV and uptake of health care services among AGY. The focus will be on: Training of PR and SRs on delivering SBCC interventions for AGY. This will include market insights and analysis for target segments based on behavioural insights (for differentiated messaging) obtained from phase one (informative assessment). Defining the communication strategy and develop specific massages, compelling visuals and custom channels for AGY. This exercise will produce the campaign assets for communicating to young people. Deliver and test the SBCC marketing campaign in pre-determined pilot area and presentation of evaluation for full scale implementation.","6/30/2021",860000]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Gender-based violence prevention and treatment programs for adolescents and youth","The funding will be used for multimedia platforms, including social media, to enhance service uptake by adolescents and young people. The activities will include establishing a hotline for survivors of gender based violence and design of webpages and databases. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.","6/30/2021",0]
[{"$nulls":6},"Prevention programs for general population","Behavioral interventions as part of programs for general population","The activity will support educational resources for peer educators and general population as Lesotho rolls out self-testing and pre-exposure prophylaxis (PrEP).  The activity will be funded through the reinvestment of the efficiencies identified during the grant making.","6/30/2021",0]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","The Government of Lesotho has adopted differentiated care models to enhance adherence to ART. Different models have been piloted and implemented in Lesotho and the evidence demonstrates their effectiveness in ensuring that People Living with HIV, in particular young people can adhere to treatment when supported. The network/teen-clubs model that supports treatment adherence for adolescents and young people have been implemented by both Baylor and Sentebale with positive results on the level of adherence and the improved viral load suppression. An assessment of this model implemented in Maseru, Mafeteng and Mohale's Hoek showed an increase in the number of adolescents and young people with good (95 to 105%) adherence to ART. The same study presented an increase in viral load suppression among the AGY enrolled in the adherence support program.Currently USAID supports implementation of AGY adherence support in three (Maseru, Mafeteng and Mohale's Hoek) of the 10 districts. Although NFM2, provides adherence support in districts not supported by PEPFAR however, this support does not cover the comprehensive implementation of the intervention/model. A key intervention to increase ART adherence and viral load suppression AGY across the remaining districts is operationalising the network/teen-clubs. The requirement in this regard includes: (i) provision of a stipend for the club facilitators, (ii) transport for the facilitators and children on ART to attend club session; (iii) meals and refreshments for the club sessions and (iv) procurement of art equipment and stationary for children participating in the adherence clubs. The key outcomes for this intervention will be increased adherence to treatment and viral load suppression among adolescents and young people","6/30/2021",624379]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},8799530]
[{"$nulls":6},"Prevention programs for general population","Other intervention(s) for general population","The non-clinical prevention of HIV is prioritized in the NSP 2015  2020. Liberia has generalized HIV epidemic with a prevalence rate of 2.1% (LDHS 2013), an increase from 1.6% (LDHS 2007). Correct and consistent use of condoms has been proven to prevent sexually transmitted infections including HIV, in addition to preventing unintended pregnancies in young women and HIV positive women. About 339,094,404 condoms (335,431,024 male condoms and 3,663,380 female condoms) including socially marketed condoms distributed by 2020. Condoms and lubricants readily available to reduce the risk of transmission. Know Your Status Campaign  To jump start the number of people who know their HIV status, currently a Know Your Status (KYS) is being implemented in 2017. It is proposed to continue the campaign in 2018 through mid-2019. It is proposed to target 602,262 contacts in the counties of Montserrado, Margibi and Grand Bassa. The campaign will end by not later than June 2019. Each contact is provided with basic HIV and AIDS messages and an option to collect a voucher so as to get tested for HIV at the nearest public health facility. No geographical area is repeated with messages as far as possible. The campaign targets young males and females in the age of 16 years to 35 years. Messages on the radio are also broadcast in these counties motivating people to approach the nearest public health facility for HIV testing. Social marketing of branded condoms  Liberia over the years has built a very strong social marketed brand of condoms. Community outreach, radio jingles, star party hours and other promotional events have been used to popularize the brand. In 2016 the branded condoms sold a total of 1,009,920 pieces, that translates into 3,862 DALY and 2,157 CYP. Currently the branded condom recovers 108% of cost of goods sold and returns it back to Global Fund. The branded condom is targeted at young population who can afford to pay for the condom. The focus for sales though national is more targeted towards Montserrado, Margibi and Grand Bassa. This program is likely to become sustainable over period of time. Approximately 4,032,989 pieces of branded condoms are expected to be sold between 2018 and 2020. This intervention is a national priority but this amount is placed in PAAR due to limited funding within Allocation.","12/31/2020",1331889]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Nutritional support for adherence to treatment. Empirical evidence and program implementation experience have shown that good nutrition improves treatment outcomes for TB and HIV and AIDS, including increase in treatment uptake and retention in care. Considering most of these affected population fall below the poverty line, nutrition support is a necessary and imperative complementary TB-HIV intervention. Providing ART to patients is not only a good treatment strategy but is also an important strategy for preventing HIV infections, preventing opportunistic infections, and reducing AIDSrelated deaths (Treatment as Prevention strategy). It is expected that additional 2,499 in Yr1, 7,461 for Yr2 and 9,647 Yr3 will be placed on treatment. Once funded these additional persons will add to the numbers of people who positive and receiving ART to help in meeting the second 90% of the global target. Private sector is a significant service provider in some counties of Liberia. Private sector comprises NGO, faith based (not for profit), faith based (for profit), private sector (corporate social responsibility) and private sector (for profit). It is proposed to engage the private sector in Montserrado (around 20 facilities) in a more comprehensive way that cuts across many diseases and areas for health intervention including TB and HIV.1. Reviewing current partnerships: Undertake a comprehensive review of current partnerships with private providers in the health sector, which may include but not be limited to (a) outputs specifications, (b) pricing; (c) partner selection mechanisms, (d) contracting mechanisms, (e) management information system and monitoring mechanisms, (f) payment administration mechanisms, (g) fraud control measures; and (h) contract management capacity. The review shall be aimed at documenting the as-is process,identifying systemic gaps and challenges, assessing user and provider perceptions and perceptions of the government.2. Reviewing Service Package: Undertake an assessment of the services for which the private providers are currently being engaged.Some of the key questions that will be answered at this stage are: a. Are the current sets of services being offered through the private partners adequate? Is there a need to expand the service package through additionalproducts and services? b. Is there a willingness among the private sector to offer the entire service package through one-stop health kiosks; and if no, what are the services / products that can be clustered?3. Assessing Private Sector Readiness: Assess the readiness of the private sector to partner with the government including the scope and extent of partnership.4. Structuring Partnership Options: Based on the above assessment, identify options for engagement with the private sector in a social franchising model. The options may be generated based on role of the government, demand strategies, financing models and extent of risk sharing. Each option shall be assessed for its relevance with pros and cons allowing the government to make an informed choice.5. Drafting an Integrated Social FranchisingStrategy: Based on the options assessment outlined above, develop a draft integrated. Social Franchising Strategy which will include among other details institutional structures, systems and capacities required at different  levels to implement the strategy. The draft strategy will be discussed at the national level to seek inputs, align it with the health policy objectives of the Ministry and arrive at a consensus on other operational aspects including, but not limited to, who would be the holding agency within the Ministry.6. Set up a Centralized Facilitating Agency (CFA): The institutional structure could include a centralized facilitating agency for procurement, supply chain management, franchisee partner selection, standardization of processes, capacity building and monitoring. The CFA shall be recruited / appointed by the Ministry. For the pilot phase PSI may assume that role for quick implementation.7. Develop Standard Operating Procedures(SOP) for Operationalizing the Strategy: Develop a detailed SOP for operationalizing the strategy. The SOP shall among a range of other areas include guidelines on: a. interface between the National Drug Service, the CFA and other stakeholders b. inventory management c. supply chain management d. record management, MIS and reporting The SOP shall be approved by the Ministry.8. Partner identification and management: The CFA shall, as per the detailed SOP, identify a set of interested and eligible partners; enter into contracting arrangements with private partners as per the SOP of the SF Strategy.The CFA shall develop the capacity of the identified partners and will ensure that the partners start delivering the services as per the contracting arrangement. The CFA shall build capacity and assist in projecting quarterly inventory requirements for each facility and ensuring availability of supplies through the NDS. It shall also establish the MIS system that can be integrated with the DHIS2.9. The establishment of additional 50 ART sites to scale up care, treatment and support services.","12/31/2020",7545187]
[{"$nulls":5},"Malaria","Case management","Facility-based treatment","The request amount is intended to improve targeted health facilities for better provision of malaria, HIV and TB services aimed at improving maternal and child health services for increased mother and child survival. Adopting a facility shall include the provision of relevant equipment as per targeted health facility type, upgrading some existing health facility for improved capacity, strengthen emergency, preparedness and response.","6/30/2021",1482080]
[{"$nulls":6},"Program management","Grant management","This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria during the 2021 Mass Distribution Campaign. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.","6/30/2021",91440]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Amount represents 253,037 LLINs as 15% buffer of 2021 LLINs quantification that is within allocation.  Experience from the 2018 campaign show that more than 10% buffer is required. Hence the 15% target for 2021. Cost is inclusive of PSM cost, freight and insurance, quality assurance and quality control as well as custom clearance.","6/30/2021",1057001]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","The matching funds requested to support integrated service delivery, seek to focus on investments in the platform for serviced delivery and strengthening clinical systems for integrated screening, diagnosis, and care, in-service skills building of clinicians to be able to deliver both TB and HIV services including management of late-stage HIV infection, and capacitating the community platform for support of TB treatment adherence and HIV supportive care.  The proposed site for initial intervention through matching fund investments is Liberias national referral facility for TB  The TB Annex, based in Monrovia. As the countrys national referral center for TB services, all forms of TB including management of TB and co-morbidities like diabetes, DR-TB, and TB/HIV co-infection are managed at the facility, where integrated service delivery can serve as a model to further scale this approach at all levels from primary care through hospital-based treatment, at the county and regional levels.","6/30/2021",742905]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Supportive policy and programmatic environment","The request amount in this cost category and intervention aimes to ensur community health workforce retention. It includes: 3 years of monthly compensation/salary for 252 CHAs and  26 CHSS for 4 additional districts in Grand Bassa (a priority national ICCM gap) 3 years of monthly compensation/salary for 355 CHAs and 36 CHSS for 4 additional districts in Bong (a priority national ICCM gap)","6/30/2021",5253702]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The cost is to cover the training of the District Health Officers in the 14 counties except Montserrado in Monitoring and Evaluation.","6/30/2021",157890]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The vehicles and motorbikes, being requested, will support quarterly field visits, Joint Support Supervisions, Last Mile Delivery of commodities, Surveys, etc... The benefits of the planned procurement are: i. To increase the number of vehicles, thus assisting the PR to improve its programmatic performance; ii. Supporting the PR in reducing the cost of vehicle rental, thus allowing unspent funds to be reprogrammed for service delivery activities. iii. Improved operational efficiency, through the replacement of vehicles which have already be retained longer than the five years period.   Currently, there are limited number of vehicles to conduct program activities and the PR has to rent additional vehicles to support program activities. An analysis was done which demonstrates that procuring the vehicles represents better value for money than rental in the current vehicle market. The rationale to buy vs renting is entirely to ensure value for money and long term sustainability.","6/30/2021",704110]
[{"$nulls":4},"Madagascar","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","This refers to consultancy costs for supervising activities carried out by peer educators for the HIV program.","12/31/2020",5943]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","HIV testing services for adolescents and youth, in and out of school","This refers to costs for piloting the new prevention strategy on community rapid diagnostic tests (TROD) to accelerate the response.The request includes:- running workshops on advocacy and for updating the screening protocol;- running training and capacity building for outreach workers (peer educators or their supervisors);- implementation at pilot sites;- supervision and quality control of service provision;- midterm evaluation and final evaluation of the pilot scheme;- study trip on TROD. The country will pilot the new strategy under this additional funding.","12/31/2020",465029]
[{"$nulls":6},"Program management","Grant management","ES/NAC and SR staff will be provided with information technology (IT) equipment. These needs have been listed under the above allocation amount, despite their importance for delivering the activities.","12/31/2020",14633]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","Logistics management is very important, as is quantification of supplies. Training is allocated for the central level. Under NFM 2, training will be extended to the regional level.","12/31/2020",9275]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","This component comprises the supervision of activities on the ground in the 42 intervention towns by the district managers of the psychosocial care SR, MAD'AIDS. Supervision is carried out twice a year, the first time covered by the allocation amount and the second by the above allocation amount. Costs related to supervision cover transport/fuel and allowances.","12/31/2020",19520]
[{"$nulls":6},"Treatment, care and support","HIV care","This refers to the procurement of laboratory supplies (biochemistry and hematology). This purchasing was originally planned under health systems strengthening (HSS), but had to be omitted following the prioritization of activities and also due to lack of funding.","12/31/2020",869057]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","This covers attendance by the two technicians in the monitoring and evaluation technical group (GTSE) at the regional training workshop run by UNAIDS, on updating Spectrum software. This is to ensure national capacity to prepare, assess and revise national HIV/AIDS estimates.The activity costs cover airline tickets, registration fees and allowances for attending the regional training workshop in Dakar in 2019.","12/31/2020",27140]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Given the poor quality and inconsistency of data, and the stock-outs of supplies, it is essential that managers receive training in monitoring and evaluation. This training should also improve the completeness of reports.","12/31/2020",7345]
[{"$nulls":6},"Case management","Other case management intervention(s)","To provide appropriate treatment for at least 95 percent of diagnosed malaria cases, continuous availability of treatment supplies  including artemisinin-based combination therapy (ACT) and rapid diagnostic tests (RDTs)  in the various health care facilities is essential. This sum from the above allocation amount will cover these requirements for 2021. This intervention will also contribute to achieving the target of zero malaria-related deaths by 2022.","6/30/2021",946863]
[{"$nulls":5},"Malaria Total",{"$nulls":4},30482503]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","HIV self-testing program and commodities ($3.50M) Malawi pilot results indicate HIVST is a promising intervention for expanding testing to hard to reach populations, especially men, youth and KPs. These funds will support commodity and program costs for 879,430 self-tests.","12/31/2020",0]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Expand YFHS weekend clinics to cover the entire country ($0.71M) Catalytic funding will provide funding for the initial 110 weekend clinics in currently targeted AGYW districts. Above allocation funding to support an additional 490 weekend clinics necessary for nationwide coverage (600 total).","12/31/2020",710000]
[{"$nulls":6},"Prevention programs for general population","Other intervention(s) for general population","Continuation of general population community activities ($2.45M) Support will continue activities within current grant for general population prevention, including raising community demand for HIV testing and referral to care especially among high prevalence populations and communities. Other activities include mapping of condom distribution outlets and orientation of condom distributors, training of marriage counselors, and community progress review meetings.","12/31/2020",2450000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","TB Case Detection Diagnosis and Treatment (USD 620,280): Building on TB treatment targets within allocation, this line item would support case detection and treatment of an additional 9,784 TB patients. This additional coverage will increase the case detection rate from 60%, 63% and 65% in Y1, Y2, and Y3, to 70%, 70% and 75%, respectively, over three years, leading to the full achievement of the NSP target. These additional 9,784 cases will be detected and diagnosed through a combination of the scale-up strategies outlined in line items 2, and 3, whereby: a) additional private for-profit facilities will be engaged, contributing a projected 7% of TB cases notified; and b) additional CSCPs will be established in rural areas contributing an additional 4% of TB cases notified. Additional funds will be applied to screening all HCWs and testing approximately 900 annually, assuming 6% of all HCWs screen positive.","12/31/2020",403140]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","Malawi has recently adopted the WHO guidelines on treatment monitoring (annual viral load tests), until now viral load tests had been conducted every two years. This has resulted in a gap in commodities (especially reagents). Based on existing and targeted patients to be reached between 2019 and 2020 and taking into consideration existing resources (reagents for 1.36 million tests), the potential reagents gap is for 518,000 tests. The scale-up plan for treatment monitoring and optimized laboratory network was completed and the annual testing policy is now in effect. The required amount to cover the gap is US$ 8 million. This is in addition to existing resources from PEPFAR committed to investments in laboratory capacity strengthening under COP 18. The gap is therefore in 2020 and orders will have to be placed in January 2020 to full coverage of all patients.","12/31/2020",8054327]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","National costed supply chain master plan, and implementation","These activities will also build on HSSP strategies to expand both the scope of the drug theft investigations unit, and continue to support capacity development of pharmacy assistants. Expected outcomes includes improved rational used of essential medicine, and reduced leakages through theft and medicines management. Specific activities included in this intervention: ? DTIU implementation of transparency and accountability mechanisms on commodities ? Integrated supervision and mentorship on medicines management in health facilities ? Tuition support for pre-service training of pharmacy assistants.","12/31/2020",1089187]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","These funds will be used to cover M&E printing costs and CMED activities that build on activities found both within allocation and in the catalytic investment funding.","12/31/2020",873425]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Expanding MSM programming to additional districts ($1.11M) Expansion of MSM programming to 4 additional priority districts, including enhanced linkage to care and drop-in centers.","12/31/2020",1110000]
[{"$nulls":6},"PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Continuation of current community PMTCT activities ($2.72M) Support will continue activities to raise community demand for PMTCT services and promote adherence to care and treatment for HIV positive mothers and children in all 290 TAs within all 28 districts. Current grant target is to increase percentage of HIV positive adults and children receiving ART from 50.4 % to 70% by December 2017.","12/31/2020",2720000]
[{"$nulls":6},"Other module","Other module","These funds will be used towards salaries and benefits for two additional data clerks per facility for 600 facilities and builds on M&E capacity development plans within allocation.","12/31/2020",3414959.12]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","National product selection, registration and quality monitoring","Malawi requests continued funding for the PSM malaria activities in 2020. Malaria commodities will be procured and distributed using within allocated funding by GF in 2020. It is essential therefore that during this period QC and QA for these commodities is supported to ensure quality assurance is maintained.","12/31/2020",399636]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Malawi requests for funding in 2020 to continue to support monitoring and evaluation so as to build upon global fund and partners investments and sustain the gains achieved in the first two years. This support will maintain the routine disease surveillance systems and enable Malawi to collect robust, timely, and accurate data for improved program management. Thus enabling the National Malaria Control program and development partners to assess implementation progress and reprogram as maybe required in addition to providing evidence for allocation of resources so as to support achievement of maximum impact.","12/31/2020",42437]
[{"$nulls":5},"Malaria Total",{"$nulls":4},61094371]
[{"$nulls":6},"Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Since 2016 SMC  is carried out in the whole country.  It should continue to be scaled up for greater impact on the target population (children under 5) because evaluation shows  its protective effectiveness in reducing the number of malaria cases. UQD not needed anymore as funds were found in efficiency gains during malaria grant making.","12/31/2021",0]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Covering the school costs of 280 infected and affected children with the aim of improving patient retention (39%) and decreasing patients abandoning treatment (50.8%). This strategy has shown its merit in the past and has made it possible to achieve a good level of treatment adherence among PLHIV. The recipients of this coverage are selected through a committee, which includes PLHIV, the NACP, the NESAC and representatives of the OTC and the CUs.","12/31/2021",247200]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","IGA feasibility study for PLHIV: Ensuring the independence of PLHIV requires the creation of conditions that enable them to provide for their health needs and to cover a certain cost linked to ARV treatment. Experiments have been carried out through IGAs, but they have not been documented. This request in the above allocation amount will make it possible to conduct a feasibility study and provide the country with clarity regarding the effectiveness of this strategy.","12/31/2021",7540]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Drug resistance surveillance","Providing training for 2 biologists and 3 laboratory technicians in using the genotyping machine in a laboratory in a different country.","12/31/2021",42500]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},1130302]
[{"$nulls":6},"TB care and prevention","Engaging all care providers (TB care and prevention)","Due to a lack of data on the contribution of the private sector to detecting cases and for the need of prioritization, activities aimed at involving the private sector in the referral of suspected cases of TB and in patient follow-up (inventory of private facilities, development of a PPM guide with technical assistance and of memoranda of understanding with the private facilities, discussion meetings and training for private sector personnel) have been selected.","12/31/2021",283384]
[{"$nulls":4},"Mauritius","HIV/AIDS","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","This Key population has a concentrated epidemic and are usually well hidden in the general population because of bisexuality amongst them. They pose a silent bridge to the general population. The request is to increase coverage of prevention activities and increased condom and lubricant distribution.","12/31/2020",705585]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","This intervention is very important to recruit additional new SW, by providing peer-to-peer educational session and referring them to access services.Estimated 500 additional clients to be reached each year. Taking into consideration the new estimations and the established targets, this intervention will contribute to cover more SW with prevention services","12/31/2020",40399.51]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","In order to strengthen capacity and expertise of members of the civil society it is important to be involved in trainings and attendance of international meetings/conferences regarding issues of HIV/AIDS control.","12/31/2020",8416.56]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Taking  into  consideration  the  need  to  cover  more PWID  with  prevention  programs  (according  to  new estimations)  and  the  flow  of  employed  persons,  it  is crucial   to   have   an   opportunity   to   train   the   new employed  persons  (most  of  them  outreach)onbasic harm   reduction issuesto   ensure   quality   service provision and minimal standards of services.","12/31/2020",20981.93]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","The sessions will be organized for MSM beneficiaries, III generation and young MSM from Chisinau and from Balti in order to provide information about MSM practices, services providers, education, stigma and discrimination, etc.","12/31/2020",4174.62]
[{"$nulls":6},"Program management","Other program management intervention(s)","Regular central and regional (in Transnistria) supervision visits will be conducted by the NTP teams to TB service and PHC facilities at the district level.  These visits will cover case detection, laboratory diagnosis, treatment and patient support, TB/HIV collaboration, etc. The supervision will focus on service interactions in ambulatory management of TB cases and local partnerships for provision of adherence support and community involvement.","12/31/2020",22348.5]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","In April 2017 the Ministry of Health has adopted a roadmap to modernize the TB service through people-centered model of TB care. In this context there is a need to increase communities support and to decrease stigma toward people with TB in the communities. This above allocation budget will support broadcasting audio and video materials on the local and national TV and radio spots.","12/31/2020",67332.509999999995]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},537382.78141735005]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","MDR-TB regimen change","12/31/2020",350000]
[{"$nulls":6},"Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","Piloting self-testing or other innovative approach to testing for Key affected population (KAPs): MSM, PWUID and SW. As a result it is expected to achieve a sustainable increase of testing rates among KAPs.","12/31/2021",11222.09]
[{"$nulls":6},"Treatment, care and support","HIV care","Purchase bronchoscopy machine for the Infectious Disease Clinic (IDC). Currently available machine is at the Clinical Center which is highly overused. PLHIV are forced to wait treatment for months. The expected outcome is reaching the set targets with a greater reach of the PLHIV, better service and decreasing stigma and discrimination. This would enable PLHIV to access complete diagnostics at one place.","12/31/2021",3366.63]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Needle and Syringe programs for PWID and their partners","Introduction of focused programs for prevention of Hepatitis C, care and treatment programs and self-supporting groups. As a result it is expected to achieve better coverage and reaching the targets (impact, outcome and coverage indicators) both related to preventive services and testing.","12/31/2021",44888.34]
[{"$nulls":4},"Morocco","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of SRH provision and services meeting the specific needs of SWs, including STIs; acquire a stock of additional lubricants for SWs; awareness-raising day on GBV; SMS platform for prevention.","12/31/2020",392825.72]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of sexual and reproductive health (SRH) provision and services meeting the specific needs of MSM, including STIs; acquire a stock of additional lubricants for MSM; establish a CBD network for distributing condoms (extended to a further 17 towns in 2019 and 2020).","12/31/2020",140250.25]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Implement the eMTCT certification process.","12/31/2020",42601.279999999999]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","EPT accounts for more than 45 percent of all TB cases in Morocco, with this percentage having risen steadily since 1980 (see Evaluation of the epidemiological situation of TB in Morocco, 1980-2013  Report). Together, pleural and ganglion TB represent around 70 percent of EPT cases. Only a handful of these EPT cases are bacteriologically confirmed. Just over 50 percent of cases are diagnosed by histopathology. There are no widely accepted international recommendations on EPT diagnosis, and the NTCP has not yet issued guidelines on this matter. The NTCP therefore needs to produce a set of EPT diagnosis standards, for use by all doctors within its network, as a matter of urgency. A national workshop, led by a national consultant, will be held for this purpose (activity 1.5.2). Based on the workshop outcomes, the consultant will produce a framework document on EPT diagnosis (activity 1.5.3). The document will then be printed and widely distributed (activity 1.5.4).","12/31/2020",98.76]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},135323122]
[{"$nulls":6},"Program management","Other program management intervention(s)","All 11 Provincial Directorates of Health have a gap of vehicles to ensure implementation of supervision activities. The vehicles included in this UQD are to be used exclusively by National Malaria Control Program staff at provincial and district level, to ensure implementation of routine activities such as supervision visits to health facilities and community health workers.","12/31/2020",602931.37]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","Insecticide cost (including procurement costs) to expand the spraying campaign of 2019 and 2020 from focalized to full coverage of 8 districts of Maputo province, 10 districts of Zambezia province and 8 districts of Nampula province.","12/31/2020",0]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Funds to strengthen joint visits to project countries to all 22 countries to determine progress and provide support. Ideally, new entrants to the project will be visited twice including a first visit to conduct a baseline assessment.","6/30/2022",65792]
[{"$nulls":4},"Multicountry Americas EMMIE","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This includes a mid-term and final in-house evaluation of the Facility.","12/31/2023",850000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Capacity building for health workers, including those at community level","Expand telecommunication capacity in all countries to reduce the cost of conducting country level and regional trainings, improve communication between and among country teams, save costs on travel and accommodation and improve overall coordination. This can facilitate access to more training for community teams who would be able to participate in their local settings.The Governments will cover the cost of internet access and space with designated space being made available to civil society. -","3/31/2022",90000]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Interventions for young men who have sex with men","Extend Sexual and reproductive health services to dedicated safe spaces run by or for key populations of Men who have Sex with Men (MSM) with a focus on adolescent MSM to include Sexually Transmitted Infections (STI) screenings, HIV and Syphillis testing, referrals tocare (through linking clients to peer navigators), contraception education, and providing access to behavioral experts. Such an intervention would seek to reduce HIV/STI infection among MSM youth in \" friendly spaces\" that incorporates other professionals including education, social work and mental health experts encompasing a comprehensive approach to health care for adolescents who are  at risk for HIV infection.","3/31/2022",90000]
[{"$nulls":6},"Case management","Other case management intervention(s)","Conduct therapeutic efficacy studies of new drugs and drug combinations, and conduct a drug resistance mapping supplement DRS information- strengthening capacity of the NMCP and ODPC.","12/31/2020",0]
[{"$nulls":6},"Program management","Other program management intervention(s)","1. The semi-annual meetings are to review 6 months activities and adjust annual workplan based on results 2. WHO TA fees in 2018 and 2019 are included in within allocation budget. In 2020, even though it is expected that the program's capacity has been strengthened, TA from WHO will still be necessary to develop elimination strategies for 2021 - 2025 period.","12/31/2020",309000]
[{"$nulls":6},"Other module","Other module","To enhance supervision in Zone 3 areas.","12/31/2020",0]
[{"$nulls":5},"Malaria Total",{"$nulls":4},686572]
[{"$nulls":6},"Case management","Other case management intervention(s)","IEC/BCC also covered under iCCM. However, the mass media campaign is not fully optimized.","(blank)",1729813]
[{"$nulls":6},"Program management","Other program management intervention(s)","Essential to continue trajectory of malaria reduction and avert outbreaks.","(blank)",1416404]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Secondary importance to intensified routine M&E.","(blank)",0]
[{"$nulls":4},"Multicountry EECA PAS","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Annual workplan meetings for effective multi-partner coordination of the project implementation.","12/31/2021",0]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","Introduce improved pathways to be adopted by clinical practice. The activity will allow organizing 2 additional regional consultations to support and facilitate introduction of the improved pathways by clinical practice at the country level.","12/31/2021",65000]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","Revise and update TB and PHC providers service packages and HR functions to deliver relevant TB services. Developing and introducing latest WHO-compatible policy guidance for active case finding approaches, including the effective identification of presumptive TB cases, contact investigation, treatment support will improve quality of diagnosis and referral case management for patients.","12/31/2021",0]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},1004800]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Development of IEC materials to support KP friendly service delivery and adaptation of toolkit for HCW and Law Enforcment to support GBV screening. Continue training in HR and KP sensitization for law enforcement officers and other social protection service providers","9/30/2022",8000]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Improve knowledge, generation and use of strategic information on key populations for decision-making through Advocacy and inclusion of these sites as part of the regional HIV/STI testing network to ensure sustainability and recognition of CSO testing sites as key players in the regional HIV response. This will include regional quality oversight and negotiated pricing arrangements for HIV and STI testing reagents, supplies and equipment in order to improve CSO testing quality and access to cost-effective supplies. A regional repository will also be estbalished to identify, document, share and promote best practices for effective regional HIV and STI testing sites through the establishment of a repository which will include materials innovatively developed and customised to share best practices and models related to 1) Assessments conducted of selected HIV/STI testing sites (technical, quality and operational) to identify critical success factors for these Caribbean sites that serve key populations 2) HIV and STI algorithms, validated under the OECS GF grant and in collaboration with PAHO/WHO 3) A regional HIV testing policy that addresses HIV self-testing, validated through conduct of a self-testing pilot with triage 4) Regional standardised tools for quality monitoring, customised for key population sites (both technical as well as stigma and discrimination monitoring).","9/30/2022",200000]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","(To be read in conjunction with the SW intervention) Developing more effective models to reach DL MSM and 2.3 Developing more effective models to reach female partners of MSM. Throughout this module CVC would institute 4 axis to ensure more effective sub-population HIV prevention programs: (i) strengthened programmatic and contextual understanding, especially of the heterogeneity of sex work and complexity of closeted MSM behaviour; (ii) intensified program implementation and delivery of comprehensive, proven interventions; (iii) improved program monitoring and evaluation, including greater use of real-time monitoring for continuous program improvement and constant strategic and tactical adaptations and rigorous program evaluation, to refine understanding of what works, under what circumstances and how; and (iv) predictable, sustained financing for key population HIV prevention programmes for specific sub-groups, including increased domestic financing where feasible. Furthermore, this module will pay special attention to strengthening community-based monitoring and evaluation systems as they pertain to MSM, transgender women, and Female Sex Workers sub-groups and their respective HIV related issues in the Caribbean; document model interventions with technical briefs that have practical, how-to examples for strengthening critical enablers and service delivery for key populations subgroups; and to strengthen commitment to a sustainable CBO response in relation to Key Populations post transition.","9/30/2022",200000]
[{"$nulls":4},"Multicountry HIV EECA APH","HIV/AIDS","Program management","Grant management","In order to organize and coordinate activities implemenation in 5 new countries, provide reports to GF","12/31/2021",0]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Venezuela would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in addressing stigma and discrimination within health services, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the changes they consider necessary, in line with the regional activities emerging from this module.Establishment of strategic partnerships with other sectors representing the intersectionality of HIV to address social determinants and the development and implementation of regional, subregional and national programs to tackle stigma and discrimination of PLHIV, from a gender, multiethnic and rights-based approach, based on findings from the stigma indices.","9/30/2022",17923]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Nicaragua would contribute to reinforcing the desired regional impact. Civil society is facing many difficulties in continuing its community work, due to severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the social mobilization they consider necessary in addressing the aforementioned activities, in line with the regional activities emerging from this module.Design and implementation of a strategy to share resource mobilization initiatives for key populations, with an emphasis on PLHIV, and advocacy to strengthen the social contracting processes for the HIV response. The aim is to establish or strengthen links with state programs that will enable support for the creation of entrepreneurial ventures for PLHIV.To contribute to developing and monitoring community-based adherence models and to monitor integrated care models for PLHIV (taking into account key populations and including women and migrants living with HIV).","9/30/2022",0]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Expand piloting of an electronic reporting system for violations of KP rights and occurrence of stigma and discrimination.","12/31/2021",0]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Capacity Development Fund: Additional support for building the institutional capacity of sub recipients for sustainability.","12/31/2021",150000]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Conduct workshops for health providers and other sectors on gender tranformative approaches and GBV; Outcomes of these workshops will be presented in the regional dialogues","12/31/2021",0]
[{"$nulls":6},"RSSH: Community responses and systems","Community led advocacy","Advocacy planning workshops at regional and country level (utilizing findings of the participatory mapping and analysis exercise)","12/31/2021",0]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},903390]
[{"$nulls":6},"Program management","Other program management intervention(s)","To organize, at regional level, a workshop for the staff of the NRLs of the five countries; the workshop will be facilitated by an international consultant and will cover the key aspects inherent to the management of a national TB laboratory network.","12/31/2021",50000]
[{"$nulls":6},"Program management","Other program management intervention(s)","To rehabilitate the TB centers/hospitals damaged in the conflicts in Iraq and Syria (including Ibn Zohr Hospital in Baghdad, Iraq and Al-Hareth Hospital in Homs, Syria), so as to support the provision of admission facilities for patients admitted with TB.","12/31/2021",100000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","In order to strengthen TB services for affected women, food supplementation is needed for women with TB who are treated in IDP and refugee settings","12/31/2021",1335000]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","To cover the cost of the regular evaluation of TB dugs management process in the five countries","12/31/2021",145800]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To provide support to all the five countries to implement the DHIS2 (TB Tracker) in the settings where it should be implemented","12/31/2021",20000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To purchase laptops\\desktops for the governorate TB coordination units with no computers or with dilapidated computers in the five countries","12/31/2021",150000]
[{"$nulls":5},"HIV/AIDS, Tuberculosis, Malaria Total",{"$nulls":4},32695572]
[{"$nulls":6},"Program management","Other program management intervention(s)","Coordination meetings with representatives of different health sectors from the governorates and private to explore means of cooperation to fight tuberculosis, introduce TB and LTBI management guidelines into educational and training curriculum, develop a draft national plan for education and adoption of the plan","(blank)",25811]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Develop/update SOPs for the continuation of TB treatment among refugees and migrants outside Jordan","(blank)",5611]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Install and pilot the Computer-Aided Detection for Tuberculosis (CAD4TB) software at the NTP center/s. More than 6000 Xrays/month are conducted in Amman only. CAD4TB works with a pay-per-screening model and is supplied in bundles, where customers pay for bundles of CXR analyses up front. The software has been proven to help readers detect TB more accurately and quickly and it is recommended to pilot the software in the NTP.","(blank)",107732]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Re-evaluate and revise the TB screening algorithm and assessment of migrant workers to ensure it is in line with the national TB treatment guidelines and the other new TB guidelines","(blank)",4489]
[{"$nulls":6},"TB care and prevention","Prevention","PPD and IGRA for contact investigation, latent TB infection","(blank)",25811]
[{"$nulls":6},"TB care and prevention","Treatment","Workshop for representatives of civil society organizations and tuberculosis patients to improve the quality of provided treatment services. Training course for private doctors, hospitals and doctors of the chest diseases centers on TB diagnosis, treatment and Training of staff of non-governmental organizations concerned with TB management.workshop for representatives of civil society organizations and TB patients to improve the quality of treatment services. Training pharmacists on TB treatments first and second line.","(blank)",31422]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Capacity building for health staff in NAP and identified staff in primary and secondary care services and VCTs to ensure sustainable support for PLHIV in the context of Jordan to address the stigma and discrimination","(blank)",28055]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Develop checklist and conduct systematic supervision visits to the chest diseases centers to supervise, monitor and evaluate the provided services for TB and MDR and to the peripheral laboratories in these centers for QC .","(blank)",29177]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Conduct an assessment of the health status of labour migrants and develop a plan of supervision, coordination and adress the tuberculosis and other health issues related to migration among migrants in industrial zones","(blank)",22444]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Other health and community workforce intervention(s)","Contracting with health and support staff in the north, central and south of the Kingdom and Strengthening central NTP unit with surveillance, laboratory and monitoring expertise through consultant expertise","(blank)",235664]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Other health and community workforce intervention(s)","Contracting with health support staff in the north, central and south of the Kingdom and activate the VCT centers in the governorates","(blank)",89777]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Procurement of Second Line Drugs SLD","(blank)",31422]
[{"$nulls":6},"RSSH: National health strategies","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 184 for Laos for year 2 second round grants","12/31/2021",119652.38]
[{"$nulls":6},"RSSH: National health strategies","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 187 for Philippines for year 2 second round grants","12/31/2021",119652.38]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},957220.04]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Activity: Evaluation of E8 Malaria Border Health Posts Description: This funding request includes support for Phase 2 (end-line survey) of the E8 impact evaluation of the border health posts to be completed in 2020/2021. Phase 1 will be completed in early 2019 with funding from other E8 sources.Rationale: The aim of the impact evaluation is to assess the effect of two years of border health post implementation on 1) access to malaria testing and treatment in border areas of the E8 and 2) malaria transmission among residents and MMPs, and malaria importation rates and patterns in frontline countries. While border posts are used as a malaria elimination strategy in other regions of the world, little evidence exists on their impact as compared to other interventions. While the establishment of the E8 border health posts was funded under the E8's previous Global Fund grant, funding for a comprehensive evaluation of this intervention was not. Funds to establish a baseline for the evaluation were mobilised through the University of California San Francisco with sponsorship from the Bill & Melinda Gates Foundation to fill this gap. However, the end-line survey remains unfunded and therefore included in this above allocation request. In addition to providing valuable data to inform future programming of the border health posts in the E8 region, this impact evaluation (if completed) would also be filling a critical gap in the global evidence base surrounding border posts as a malaria elimination approach. Border posts have been used in other regions of the world without conducting a systematic assessment on their impact. Given that Phase 1 of the impact evaluation will have already been completed in early 2019, it will be a missed opportunity to allow for the impact evaluation to remain incomplete due to lack of funding for Phased 2.Expected Outcomes/Impact: The results of this impact evluation (if completed) will show the effect of two years of border health post implementation on 1) access to malaria testing and treatment in border areas of the E8 and 2) malaria transmission among residents and MMPs, and malaria importation rates and patterns in frontline countries.Budget: Costs associated with this activity include maintaining a Research Manager (50% effort) to provide stufy oversight and full time study coordinator. Additional costs include implementation subcontracts to the seven E8 country research institutions to carry out the data collection activities (KAP questionnaires, Health facility survey, Qualitative interviews and MMP prevalance survey). The total cost of this activity is therefore estimated to US$ 781,864 for between the period 2019-2020.","9/30/2021",390932]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","This request will cover the cost of IRS and IEC/BCC in Gaza and Inhambane provinces in southern Mozambique, specifically in the following districts: Limpopo (2020), Xai-Xai (2020-2022), Zavala (2020), Panda (2020-2022), and Inharrime (2020-2022). These districts have a strong epidemiological and entomological indication that IRS would be impactful (due to high burden of disease, proliferation of A. funestus vector, and pyrethroid resistance). Due to budgetary constraints, key districts in Gaza and Inhambane provinces have been excluded from the within allocation budget.  Without funding these districts, the potentially historical impact of this grant will be compromised.","12/31/2022",3936699]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","The PAAR request entails expansion of IRS operations into 4 new districts in Gaza and Inhambane Provinces in Southern Mozambique. Regional epidemiological analyses clearly demonstrate the urgency by which activities must be expanded to Gaza and Inhambane provinces if the MOSASWA sub-region hopes to accelerate its pathway to elimination.","(blank)",0]
[{"$nulls":6},"TB care and prevention","Removing human rights and gender related barriers to TB care and prevention","Within allocation funding focuses on human rights and gender barriers among ASM. PAAR focuses on three aspects:(i)Human rights and gender awareness raising among LSMs and communities:This intervention will improve LSM mining companies, as well as labour unions, miners and ex-miners, peri-mining and labour-sending communities awareness about  worker rights and access to occupational and public health services. This will include mine health legal provision adoption and mineworkers entitlements through training of trainers (ToT) by regional CSOs.","12/31/2020",468228]
[{"$nulls":6},"TB care and prevention","Engaging all care providers (TB care and prevention)","Training of service providers on human rights based approach, updated guidelines and referral services (development of e-learning module and integration within the training curriculum of health providers).","12/31/2021",100000]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Proposed approaches supporting sputumtransportation, results feedback andfinancial support to referred patients; andACF targeting migrants are required tomaximize impact of proposedinterventions","12/31/2021",1670950]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Adaptation of the gender in TB module. Based on the module produced by the Stop TB Partnership and UNAIDS, we will validate and adapt this module to the LAC context.","6/30/2022",0]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Regional workshop on Social Protection in TB. This event will bring together representatives of government, cooperating and multilateral organizations and civil society from the 8 LAC countries to exchange experiences and new agreements.","6/30/2022",0]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Study to identify social protection programs associated with TB. Activity seeking to describe the existing state and private social protection programs in each country, and their relationship and the gaps in access for people affected by TB to these programs.","6/30/2022",0]
[{"$nulls":6},"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Technical assistance on the analysis of the legal environment that limits the rights of people with TB. With the support of technical members of the National Social TB Observatories, a standardized protocol will be developed and the survey will be carried out in each of the 8 countries participating in the grant.","6/30/2022",0]
[{"$nulls":6},"Program management","Supporting procurement and supply management","This intervention will ensure availability of essential drugs, now purchased and distributed largely independently.","(blank)",0]
[{"$nulls":6},"TB care and prevention","Engaging all care providers (TB care and prevention)","The funds are requested for diagnosis and treatment for Tuberculosis and interruption of transmission of TB.","(blank)",198314]
[{"$nulls":6},"Treatment, care and support","Differentiated ART service delivery","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.","(blank)",0]
[{"$nulls":6},"Removing legal barriers to access","Legal and policy environment assessment and law reform","This intervention will tackle structural issues that hinder key populations' access to prevention and treatment.","(blank)",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","This intervention will provide data to support Program activities.","(blank)",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","(blank)",0]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Addressing limited capacity of health and community workforce will help remove bottlenecks for program implementation.","(blank)",9068313]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},33358079]
[{"$nulls":6},"Prevention programs for general population","Diagnosis and treatment of STIs and other sexual health services for general population","The development of an STI strategy and encouraging treatment seeking behavior should result in less HIV infections.","12/31/2020",17689]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","100 additional field promoters to be retained over 3 years. These are critical to accelerated and expanded TB case finding as well as treatment support, including for patients with drug-resistant TB. Earlier case detection and commencement of treatment through community health education and TB screening is one of the key interventions to be implemented by these field promoters. This also includes field promoters to conduct TB screening in correctional settings and other high risk areas.","12/31/2020",0]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","This activity includes training so that care workers are trained in PrEP and are able to offer care and support to MSM.","12/31/2020",63237]
[{"$nulls":6},"Case management","Facility-based treatment","Case management trainings over the past 5 years have contributed to tremendous gains in malaria case management practice. The aim of the trainings is to ensure that all health workers in the country are competent in the case management of malaria.  The amount covers refresher trainings in Years 1 and 3 of the grant. This amount includes per diem, venue, and stationary for the trainings.","12/31/2020",48887]
[{"$nulls":6},"Vector control","Entomological monitoring","Entomological capacity has been identified as a key gap in Namibias vector control landscape.  In order, to improve this, the National Vector and Disease Control Programme (NVDCP) proposes training on basic entomology for Environmental Health Practitioners.This amount includes course fees, travel, and per diem.","12/31/2020",14717]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","In order to coordinate the MOHSS strategies on malaria elimination with the community response, the NVDCP proposes the recruitment of a Community-based Interventions Coordinator to ensure increased acceptance of indoor residual spraying and use of long lasting insecticide treated nets. This amount includes the salary of this individual for Years 1 & 2 of the grant.","12/31/2020",48692]
[{"$nulls":4},"Nepal","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","To date, FSW have been covered USAID-FHI360 (80% coverage). USAID-FHI360 has not committed any funding for the continuation of the program beyond 2018-19.  Support through PAAR would therefore enable the country to meet the NHIP targets of 87% and 90% coverage of FSW in 2019-20 and 2020-21, with prevention programming and HIV testing.","3/15/2021",3850000]
[{"$nulls":6},"Other module","Other module","Migration to India, particularly to states where HIV prevalence among FSW is high, is recognised as source of infection. The main source of information for targeting HIV interventions among migrants is a 2007 study by UNFPA. However, it is likely that changes in health seeking behaviour and migration patterns (e.g. the shift to Gulf countries as the preferred destination) over the last decade have implications for HIV transmission and access to HIV services, which will be explored in the assessment. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.","3/15/2021",0]
[{"$nulls":6},"Case management","Private sector case management","HR cost at SR for engaging the private sector provider; Orientation cost for SR for engaging the private sector provider; Field visit for engaging the private sector provider; and, Operational costs for the SR.","3/15/2021",557208]
[{"$nulls":6},"Case management","Ensuring drug and other health product quality","Support facility visits by enforcement teams in cases where inappropriate drugs are identified.","3/15/2021",11742]
[{"$nulls":6},"Case management","Other case management intervention(s)","Support broadcasting of IEC messages over radio/FM. Hold regular orientation meetings to maximize community involvement in malaria elimination.","3/15/2021",70339]
[{"$nulls":6},"Program management","Supporting procurement and supply management","Support QA/QC of Health Product/Pharmaceuticals (as per GFATM rules); Provide LMIS training workshops for RHDs, DHOs, DPHO, storekeepers, accountants and other officers for GFATM activities to strengthen capacity in-line with the additional workload associated with elimination.","3/15/2021",54640]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Procurement of mobile phones/tablets for electronic based malaria reporting. Mapping of all villages in endemic areas based on GIS.  Training workshops to strengthen PSM, M&E, finance and programme management.","3/15/2021",283538]
[{"$nulls":5},"Malaria Total",{"$nulls":4},1664512]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","For improving access, enabling early diagnosis with introduction of the pay for performance for the diagnosis, DOT provision and further expansion to the remaining districts. This can further improve the notification of additional 5,000 cases over 3 years.","3/15/2021",100000]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},2662760]
[{"$nulls":6},"Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","SMC will be scaled up to cover all children aged 3-59 months across all eligible districts in Niger from 2018 onwards. Several partners (Global Fund, World Bank, UNICEF and Presidents Malaria Initiative (PMI)) support this intervention, covering both supplies and implementation costs. The funding requested here is aiming to cover the gaps currently not funded in 2019 and 2020.","12/31/2020",0]
[{"$nulls":5},"Malaria Total",{"$nulls":4},5897872.2599999998]
[{"$nulls":6},"Treatment, care and support","Other program management intervention(s)","System Strengthening for Pharmacovigilance (PV) & HIV Drug Resistance (HIV-DR) Monitoring Reduce ARVs adverse effects and drug resistance related deaths/morbidity by:- Strengthening capacity of NAFDAC in managing PV monitoring, based on UNAIDS/WHO assessment- Pharmacovigilance active monitoring cohorts for ARVs- Conducting combined PDR/ADR survey - Assessing pediatric ADR - Strengthening stakeholders coordination on HIV-DR","12/31/2020",6497265]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},40831337]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","6 States in 2020 will be due for LLINs mass replacement campaigns requiring 16,619,549 LLINs. This is highly prioritized to ensure continued coverage of the population in these States in line with the WHO universal coverage for LLIN, and to ensure that gains made are not lost due to decline in net ownership.","12/31/2020",0]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Conduct survey to determine TB catastrophic costs:Baseline survey was conducted in 2017 and findings revealed 71% of TB patients and their households experienced catastrophic cost. With the scale up of innovative interventions, most patient related cost might be mitigated and monitoring this is necessary to alleviate burden on TB patients. The follow up catastrophic cost survey is proposed in 2020 using above allocation.","12/31/2020",305982]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Case detection and diagnosis","Support site level joint lab-clinic patient education program for increased lab services uptake-develop IEC materials, health talk, and awareness creation for uptake of laboratory services.","12/31/2020",209626]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Support the training of lab professionals within the National Lab network on the standard biosafety and biosecurity procedures and processes:All the GF supported PCR and TB Reference laboratories will be supported to achieve local and international accreditation through this activity.  The Global fund will support the implementation of standard biosafety and biosecurity requirements in all supported laboratories within the network of 111 laboratories.","12/31/2020",254384]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis","Connect GX Alert to 280 machines:The request is for the cost of connection to GX Alert and procurement/ installation 280 routers (including data) of the proposed 280, 4-modular Xpert MTB/Rif sites.","12/31/2020",231197]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis","Inverters and Solar Panels for 280 Xpert MTB/Rif Sites and 237 existing Xpert MTB/Rif Sites: The plan is to procure inverters and Solar panels for additional 280, 4-modular Xpert MTB/Rif sites and 237 existing Xpert MTB/Rif Sites to ensure availability of electricity to run the machines.","12/31/2020",4728000]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis","Training of 560 healthcare workers at 280 Xpert MTB/Rif Machines (including Gxalert):If 280 additional Xpert machines are procured, operationalization of the sites would require capacity building of the HCWs. The above allocation will be used to train 2 staff per GeneXpert site (560 HCWs) for additional 280 GeneXpert sites. This will ensure that staff have requisite skills to operate these machines and optimize utilization.","12/31/2020",346920]
[{"$nulls":4},"Pakistan","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Cost of reaching additional 33,200 FSW with prevention package. It is prioritized because prevalence rate for this population is growing at the fastest rate amongst KP for whom the primary means of transmission is sexual. Unit costs ($71) have been fixed with reference to those used for the AEM modelling. Proposed coverage would amount to 42% of the annual gap for this population through this grant.","12/31/2020",1975300]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","PR Nai Zindagi has now been allowed to work in the major agglomerations of Punjab. Based on the Punjab IBBS 2014, the number of PWID mapped in 8 cities of Lahore, Faisalabad, Sargodha, Sialkot, Gujranwala, Sheikhupura, Mandi Bahaudin and DG Khan is 25,929. As per the IBBS, 9,715 (37.46%) based on city wise prevalence were HIV positive in 2014. In the absence of services since 2016, this number is now likely to reach 60% if not more. Outcomes of the proposed intervention: By end of 2020 appr. 20,743 (80%) of mapped PWID will be enrolled in CoPc+ services (complete package) in those cities By end of 2020 appr. 7772 (80%) of HIV+ PWID will be channeled through AAU and put on ART Similarly, spouses and all partners will receive prevention, treatment and life support No additional costs on management (like PR staffing  costs)  By end of 2020, NZT will cover 23% of PWID in Pakistan","12/31/2020",5012397]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Cost of reaching additional 100,000 MSM with prevention package. Proposed additional coverage would amount to 13% of the annual gap for MSM through the grant period.  Since this expansion of prevention program coverage for MSM would imply an increase in the numbers of MSM being identified as positive we consider it to be joint first priority with the Treatment, Care and Support item in the following row.","12/31/2020",5647558]
[{"$nulls":6},"Program management","Other program management intervention(s)","Current National Malaria Strategic Plan was developed in 2014 for 2015-2020, guided by the MPR led by WHO. National and provincial strategic plans need to be updated to align with GTS 2016  2030. Findings from malaria programmatic review in 2018 and malaria prevalence survey would guide for strategizing interventions (quality case management, prompt and effective treatment, selective vector control, scaling up of treated LLINs use and epidemic preparedness, detection and response) according to disease endemicity.","12/31/2020",100000]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.","12/31/2020",4807799]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Action: To scale up a mobile based TB case notification system to initial 50, then to 90 districts. Rational: This will facilitate TB cases notification in private sector. The majority of the population is seeking care in the private sector. Legislation for mandatory case notification will facilitate that. 35,000 additional cases are expected to be identified anually for year 2 and 3.The pilot intervention is proposed through catalytic funding. After evaluation, the intervention will be scaled up throughout the country based on phased approach, selecting additional 50 districts in year 2019 & rest 90 in year 2020.","12/31/2020",1500000]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","Action: Scale-up of Xpert testing of B positive cases Rationale:The expansion of Xpert network across the country has a throughput  to test additional B-positive TB cases to reach up to 90% of B positives cases. This will give a yield of additional 16% of RR-TB cases. The major reason for putting it into  PAAR being requirement of additional resources for Xpert cartridges  and  second line Drugs and social support to reach 55% of all pulmonary MDR cases ( which is  70%.(2019)  90%  (2020) of B positive cases, 1000 + 2150 =3150 additional Cases over three years.Cost implications: SLDs for 3150 MDR cases (4300/case)  US 13,545,000100,000 cartridges:  (US 1 million (diagnostics)Social support  (528 US per patient)  US 1,663,200.","12/31/2020",16208000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Goal 3 of the End TB strategy is to reach 0 catastrophic costs in terms of tuberculosis. Panama has no information to measure progress; therefore, this survey would need to be performed in the first two years in which the 2018-2022 PENTB is implemented.","12/31/2021",70000]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},376500]
[{"$nulls":6},"TB/HIV","TB/HIV collaborative interventions","An above allocation investment would be used to i) strengthen private health sector capacity to scale up TB care, treatment and prevention services; ii) strengthen regulation to increase quality assurance of private health facilities and private sector TB service delivery.","12/31/2020",181519]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","The investment aims to exceed national targets (93% coverage for case detection vs. 90% target) by reducing misdiagnosis, delays in diagnosis and under reporting. The investment would be used to i) empower communities to refer patients suspected of having presumptive TB; ii) provide monthly incentives to CHWs for active tracing of LTFU patients and treatment completion monitoring; iii) conduct social mobilization for TB interventions using social mobilization approaches of proven effectiveness and iv) conduct advocacy for increased TB financial resources.","12/31/2020",809694]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","a) Strategic information: support for 9 positions in Y3 for TB/HIV/STI surveillance and logistics team (shared positions for KP database support; national HIV/STI/TB testing policy and practice support, logistics support and data entry). b) HIV Patient database training: This will provide for an annual HIV patient database training for 10 participants. The HIV patient database will eventually be integrated into the national e-NHIS. c) KPMIS training: Key staff will also be trained in the use of the KPMIS system, collecting data on KP outreach and KP attendance at STI, HIV and TB services.","12/31/2020",196097]
[{"$nulls":6},"Vector control","Other vector control measure(s)","This program delivers antenatal nets to about 50% of pregnant women each year. This protects both  pregnant women and newly born children from malaria. Delivery to pregnant women is done through health centers. Nets are also distributed every three years to prisons and boarding pupils in boarding schools.","12/31/2020",1723192]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This allows Polymerase Chain Reaction (PCR) analysis of all samples taken from the Malaria Information System. At present this is not possible but PCR gives a much better idea of prevalence of malaria than either microscopy or Rapid Diagnostic Tests can supply.","12/31/2020",146851]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This is considered a good alternative to prevalence surveys and may give good information at a very low cost.","12/31/2020",65000]
[{"$nulls":5},"Malaria Total",{"$nulls":4},7778230]
[{"$nulls":6},"Treatment, care and support","HIV care","Awareness visits and the planning of a joint and articulated work agenda between representatives of the Health Regions (RS), PRONASIDA and civil society (CS), at the local level. These visits have the objective of empowering local actors to carry out activities related to the national response to HIV, in addition to promoting an articulated work with the CS and the local level. It is suggested that with these visits, regional work plans would be developed and then followed up.","2/28/2021",16090]
[{"$nulls":6},"Treatment, care and support","HIV care","Modular update course (120hs) for continuous training for health professionals, in health, dignity and positive HIV prevention. This activity seeks to respond to the need to improve the quality of care of health personnel towards people of target populations, since stigma and discrimination towards them remain an important barrier for access to care and adherence. The training will cover the following contents: promotion and access to health, human rights, HIV and STI prevention, sexual and reproductive health, gender equality, among others. As a result, it is expected that health personnel will have the knowledge and skills that will enable them to implement actions of promotion and prevention appropriate to the reality of each person in the target population, without stigma or discrimination.","2/28/2021",60225]
[{"$nulls":6},"RSSH: Community responses and systems","Community led advocacy","Recruitment of consultancy to study the adequacy of the legal framework, including the tax area for contracting by the state, services and products made by CS. Include the drafting of adjustment proposals. Consulting contract to update the Political Advocacy Plan. Monitoring of the advocacy plan designed in 2017 and its updating, which includes monitoring progress of Law 4313 (Budgetary Assurance of Sexual and Reproductive Health), Law 3940, TB Act, Access to Justice Act, Sexual and Reproductive Health, Law against all forms of discrimination, among others. Recruitment of Consultancy in Political incidence. Recruitment of Consultancy to design and establish a Plan of Institutional Communication of the CSOs and the agreed goals and objectives. Implement the Institutional Communication Plan to inform and sensitize the general population and leaders of different sectors, in particular, about the social work of organizations, especially CSOs of key populations.Develop a training plan on public financing models of civil society and determine their applicability in the national context. Design and implement a fundraising plan for CS. These activities are the gaps identified in the framework of the TA funded by the GF through the CRAT, which sought to identify the key activities required to advance the sustainability of civil society organizations linked to the national response to HIV, and of the interventions implemented by them.","2/28/2021",141920]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","To carry out a cost / effectiveness study of the PREp in Paraguay using a mathematical model, by an international expert. To carry out a clinical and therapeutic guide for the PREp by an international expert. Consultancy with the international expert for the elaboration of the protocol and manuals of implementation of the Study of feasibility (acceptability, adherence, behaviors and risk behavior, side effects) of a combined HIV prevention intervention with PREp in MSM in Paraguay, Training and sensitization of HR in PREp. 3 days of training for 30 people. Implementation of the feasibility study (acceptability, adherence, behavior and risk behavior, side effects) of an HIV prevention intervention combined with PREp in the MSM population in Paraguay. The PREp is part of the combined prevention package promoted by PAHO / WHO. It is proposed to carry out the aforementioned activities in order to have information for decision-making regarding its full implementation in the short term. The objective of the effectiveness and feasibility study is to demonstrate, numerically, that PREP implementation is cost / effective as a public health strategy. In addition, the study implementation will allow us to have information on the PREP response in the Paraguayan cultural context, on the conditions necessary for its implementation, the situations that may arise and that will require action by the MPyBS, among others. We hope that with the implementation of these activities, the country will have enough information and experience to complete the implementation of all the strategies that form part of Combined Prevention in the short term.","2/28/2021",255371]
[{"$nulls":6},"Program management","Other program management intervention(s)","Lab Dept (LCSP) managementImplementation of new diagnostic algorithms including cultures and PSD for all cases of Pulmonary TB and universal rapid molecular diagnosis.This requires hiring of HR who can carry out cultures and rapid molecular diagnosis on all samples arriving at LCSP.","12/31/2021",50386]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Expansion of laboratory network with rapid molecular diagnostic devices and consumables.Acquisition of 3 rapid molecular diagnosis devices and consumables is deemed necessary, by means of this grant, for districts with a high load of TB cases. It should be noted that for universal diagnosis approximately 35 devices will be required across the country, and in order for this to be effective, the State must acquire them gradually.In accordance with the indications of the Global Laboratory Initiative (GLI), this test must be used in place of conventional microscopy and cultures for initial diagnostic testing in all adults and children with suspected pulmonary tuberculosis. Chiefly, for initial diagnosis for adults and children with suspected MDR tuberculosis or HIV / TB (GLI Practical Guide to TB Laboratory Strengthening - March 2017)This is aimed at universal diagnosis of TB in districts with this technology.","12/31/2021",93832.7]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Analysis, review and disclosure.The considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required the monitor the grant, which is why these financial resources are required to comply with this duty with the required technical accuracy.","12/31/2021",4429]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},0]
[{"$nulls":6},"Treatment, care and support","Differentiated ART service delivery","This additional investment will help transitioning 13,000 patients to TLD regimen","12/31/2020",2500000]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},3586038.7]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Target reflects the remaining programmatic gap to achieve 100% coverage of all estimated cases for the 3 years.","12/31/2020",1336280]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","This amount is needed in order to allow the roll-out of the new MDR-TB treatment regimen from Q2 2019 for a target of 10,000 patients (42% of new enrollment taking long oral regimen, 45% taking on the modified shorter regimen (replacing KM with AM), and the remaining 13% of patients to be enrolled in an OR with a modified shorter regimen with BDQ, which is already registered in country). The transition has been carefully planned in consultation with national stakeholders and with the support from partners.Regimen Change: introduction of new treatment regimen approved by WHO","12/31/2020",0]
[{"$nulls":6},"TB care and prevention","Engaging all care providers (TB care and prevention)","This investment is intended to support stakeholder engagement in implementing ambulatory care reform developed through the grant.","3/31/2021",361329.82]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.","(blank)",10958103]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","This request is for alignment of grant.","(blank)",1003118]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Broaden utilization of GeneXpert is planned in the funding request. Above allocation will support the purchase of 50 ventilated workstations to improve biosafety of GeneXpert laboratories as recommended in the MTR.","(blank)",0]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","National product selection, registration and quality monitoring","Above allocation funding will support NRL quality improvement towards accreditation as well as a research (TB-NSP page 65).","(blank)",56207]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Other health and community workforce intervention(s)","Since 2012, the HRH Program has trained specialists in different medical fields. USD 2,356,241 is earmarked for the programs continuation to ensure that the current cohort of trainees can complete the training program within 3 years thereby ensuring sustainability and the quality of care in HIV and co-morbidities (Malaria, TB, Hepatitis). Efficiencies have been generated in the program through the use of local faculty trainers","(blank)",2709372]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.","6/30/2021",2727600]
[{"$nulls":5},"Malaria Total",{"$nulls":4},5491922]
[{"$nulls":6},"Other module","Other module","The process has been launched with support from WHO; this represents a contribution by the Global Fund to the development process.","(blank)",0]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Male and female condoms for other vulnerable populations","Owing to the prevalence rate (2 percent) among prisoners, the interventions cited under the allocation amount need to be strengthened. The aim is to strengthen prisoner access to prevention and treatment services by establishing a community-based system for screening for and treating HIV and introducing methadone substitution therapy to ensure continuity of care.","12/31/2020",169710.47]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for people in prisons and other closed settings","The low overall HIV prevalence of 0.5 percent conceals differences between certain vulnerable groups, where prevalence can be up to three or four times the national average. This is the case for people living with disabilities (1.9 percent). Strategies funded with the allocated funds do not adequately address these targets. Plans have therefore been made to strengthen strategies to reduce risky behaviors by offering a capacity-building program for 975 health care providers and people living with disabilities, and to improve access to information, education, and prevention, care and treatment services for people living with disabilities by making tools to support health care providers and communities available.","12/31/2020",118776.79]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","In the three target districts for this project (Touba, Diourbel and Passy), disease incidence is high.Within each district, criteria for selecting areas are defined based on the intensity of transmission (more than 10 cases per 1,000 population) and the feasibility of the intervention (predominant type of housing and population behavior). The area is demarcated at the health-post level, according to the degree of incidence reported by each health post.One treatment cycle per district (hot spots) is planned per year, to be carried out just before the main malaria transmission period (rainy season). The insecticide used will be chosen based on the susceptibility of the vectors in the intervention areas. IRS activities will be carried out based on the World Health Organization (WHO) IRS operational manual and adapted to the local context, but also based on the countrys ten years of experience with IRS.","12/31/2020",11917841.99]
[{"$nulls":6},"Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","With regard to boosting malaria control in the country, the NMCP plans to strengthen control strategies in the central part of the country, where the Diourbel and Kaolack medical regions accounted for about 20 percent of the countrys cases in 2016. This morbidity is mainly concentrated in the Touba, Diourbel and Kaolack health districts, where cases among children aged under 10 years account for more than 10 percent of all cases recorded.The implementation of SMC in these health districts and for children aged 3120 months will reduce the malaria morbidity and mortality burden and thus enable substantial gains to be made in achieving the pre-elimination target by 2020. The expected benefits of SMC are:- a reduction of at least 50 percent in all malaria cases- a reduction of at least 50 percent in severe malaria cases- a reduction in mortality of at least 40 percent- a reduction in the incidence of anemia. The sum requested covers procurement of SMC drugs for the 359 month target age group, for 2018 and 2019; for 2019, the amount is 315,497 and for 2020, it is 324,016.","12/31/2020",717666.93]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","To reduce the gap in missing cases in high-burden regions, this amount would enable implementation strategies to be scaled up through the purchase of five mobile digital X-ray machines and a fixed X-ray machine for a second prison in the country to conduct screening upon entry.","(blank)",536957.68999999994]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Service organization and facility management","IImplementation of the Integrated Package of Services (IPS) is budgeted within the allocation for 2018 and 2019, however due to limited funding 2020 is not budgeted.  The IPS ensures a better quality of service for the three diseases and for reproductive, maternal and neonatal health. It also supports the integration of TB, HIV, malaria and reproductive health/MNCH materials to be produced and a workshop organized to quantify the need for drugs and other health supplies in the 14 regions and at the national level.","(blank)",182654.02]
[{"$nulls":5},"Tuberculosis, RSSH Total",{"$nulls":4},9081729.3099999987]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","PLWH Training of outreach workers","6/30/2022",6425.77]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.","6/30/2022",5510.04]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.","6/30/2022",5510.04]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},289454.61]
[{"$nulls":6},"PMTCT","Prong 3: Preventing vertical HIV transmission","Sierra Leone has adopted a dual HIV-Syphilis testing protocol for pregnant women during ANC. Within the allocation amount, the country will scale up the dual testing to cover 181,766 pregnant women per year (545,300 total across 3 years) in 691 health facilities (60% of the estimated number of pregnant women).The PAAR will be utilized to procure DUO HIV/syphilis test kits to cover all pregnant women in the country.","12/31/2020",1055356]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Funding is needed for nutritional support to be provided for all TB cases, about 20,000 TB cases per year, during the intensive phase of treatment. MDR-TB cases, 300 cases per year, will receive the nutritional support throughout the course of treatment. The estimated cost will cover the nutritional support for TB patients for two years and this intervention will support the program to improve adherence to treatment.","6/30/2021",1200000]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","In order to have a successful  implementation for the Universal coverage of the  Population the following activities are very important  for LLINs to reach the beneficiaries:    (1) Distribution to PHUs/Distribution Points.  (2).Transportation and Warehousing at district/chiefdom levels (3) Trainings (4) Microplanning (5) Social Mobilization                   (6) Monitoring and Evaluation.                                                                                                                                                                                                                                                              The final budget for 2020 LLINs mass campaign non-net costs will be available after the finalization of the plan of action, logistics plan and the communication plan with support and guidance from AMP  tentatively in April 2019.The total budget for the 2017 mass campaign non-net cost was $4.4m.  $2,541,578.56 has already been secured on the current GF grant towards non-net costs. The current estimated gap of ($1,858,421) + 20% buffer to cover the increase in fuel costs and other contingencies is required to fully fund these activities.","6/30/2021",0]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","The treatment of MDR-TB is highly centralized in Lakka government hospital. The program is planning to decentralize the programmatic management of drug resistant and needs funding for capacity building training on PMDT, technical monitoring missions, development of tools for PMDT, allowances and transport for PMDT nurses, adaptation and printing of PMDT tools, quarterly and annual monitoring meetings, advocacy and sensitization activities. In the phase of scale-up of Gene Xpert testing, more MDR-TB cases are expected to be notified and the request additional funding will enable the programme to meet the target of enrolling all detected RR/MDR-TB.","6/30/2021",600000]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Anonymous free confidential hotlines that are currently supported by the GF funding. Hotlines provide factual information, counselling and referral information and support. This will support the current 3 hotlines which cover all Somalia.","12/31/2020",193222]
[{"$nulls":6},"Program management","Other program management intervention(s)","Support technical assistance to develop strategies to better mainstream HIV into broader development areas. Improving the roles of focal points for areas such as gender, education, rule of law etc.","12/31/2020",136192]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","To address community based stigma and complement the allocation funding in RSSH addressing health worker related stigma. To help improve PLHIV rights knowledge.","12/31/2020",284811]
[{"$nulls":6},"Treatment, care and support","Socioeconomic approaches","Funding to support the other 70% of PLHIV (see above for $0.99 M). Continue to support cash payments for food and hygiene products which have been a key part of improved treatment adherence and continuing to support PLHIV engage in the PLHIV networks and support groups.","12/31/2020",2162884]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Support the expansion to ART delivery to three new sites where key service gaps have been identified based on situational and response mapping. This would also support the expansion of the number of HCT and people on treatment.","12/31/2020",384889]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Expand the training of new Female Health Workers to regions and districts without trained personnel. Particularly to regions in south and central where malaria and TB is more prevalent.","12/31/2020",1281928.8]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","WHO technical assistance P3 level  currently funded through the grant. Proposal is 50% from Malaria and 50% from RSSH to support essential medicines oversight for all health areas.","12/31/2020",375432]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Recent improvements in strategic information are improving the reliability and confidence in spectrum results. Annual spectrum is required to be maintained as an essential component.","12/31/2020",75000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To address gaps in regional and local capacity to ensure effective monitoring evaluation training will be provided to key regional personnel in MoHs and program partners.","12/31/2020",110580]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},13121960.150000002]
[{"$nulls":6},"Case management","Other case management intervention(s)","World Malaria Day commemoration by implementing partners. Each SR in South and Central Somalia will receive funding for one event. There are five SRs in South Central Somalia.","12/31/2020",13500]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Supervisory visit by NMCPs. Supervisory visits will include visits to private sector facilities, visits to IEC/BCC and to supervise LLIN distribution, amongst others.This is one visit per MOHper quarter (total 3 visits per quarter as there are three MOHs). Total costs = 850 USD per supervision x 3 MOH x 12 quarters = 30,600 USD. The NMCPs will use their own vehicles and only require fuel costs.","12/31/2020",30600]
[{"$nulls":5},"Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Intensified training and monitoring activities for central level staff to improve managerial capacity.","12/31/2020",37870]
[{"$nulls":4},"South Africa","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Pre-exposure prophylaxis (PrEP) for sex workers","According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for sex workers is 95%. For the Global Fund program, this equates to 19,192 sex workers. 3,439 sex workers will be given PrEP through the allocation funding. PAAR funding will fill the gap between the allocation and optimal coverage, providing an additional 15,753 sex workers with PrEP. This will be paired with an intensive and targeted knowledge campaign to increase demand for PrEP among sex workers. PAAR will increase PrEP coverage in the target districts from 17% to 95%, and decrease the national programmatic gap for AGYW PrEP by 32% (from 49,420 to 33,667).","3/31/2022",4013576]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Funding will support in providing child care for children of sex workers, by supporting 26 entry-level child and youth care workers (R3,500/month), 2 per sex worker district. Children of sex workers have been identified as an area of need. FSW in South Africa are responsible for four child or adult dependents (on average), while MSW and TGSW are responsible for two.  A research study on the basic demographics, living arrangements, risk factors and supervision is underway in the current grant, with findings anticipated in February 2019. Allocation funding will support defining and providing parenting programs suitable for sex workers who have children living with them. The PAAR request to provide direct childcare services for children who live at home with sex workers will be a value add to the parenting programs prioritized in the allocation request.","3/31/2022",1210436]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","PAAR funding will support development of information systems/data analytics for the AGYW program, in order to:1) enable grant-wide analytics by allowing data from all PRs to be merged and analyzed together;2) enable PRs to perform rich analysis on their data, including being able to disaggregate data easily, quickly generate new indicators, easily collect new data elements when needed, and take a case-based approach to tracking beneficiaries so that an individuals history in relationship to interventions can be easily viewed;3) reduce potential for data entry errors by leveraging user-friendly digital data entry forms, having multiple pathways to capture data, and multiple identification methods for uniquely identifying beneficiaries in the program.","3/31/2022",3360000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","PAAR funding will support provision of an additional 825,000 Xpert tests in the six priority TB districts. Several cross-sectional studies have reported a high yield of a universal TB testing strategy; one which tests everyone irrespective of the presence of TB symptoms. Examples of populations in whom targeted universal testing has been implemented are: adults admitted to hospital, HIV-infected pregnant women, household contacts of a TB patient. A cluster randomized study is about to commence to test this strategy in South African. If results of this study support this intervention; funding is requested for targeted universal testing for TB (TUTT) for PLHIV, pregnant women and TB household contacts.","3/31/2022",13290140]
[{"$nulls":6},"TB care and prevention","Community TB care delivery","Funding will support expansion of the TB screening and testing services in facilities and community hot spots by supporting fee-for-service agreements for 264,000 digital chest x-rays and 66,000 Xpert tests. This will catalyze the impact of both the allocation (in facilities) and the matching funds request (in community hot spots), to find an estimated additional 5,280 missing TB patients.","3/31/2022",5834695]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Funding will support in placing an additional 500 drug users on OST. With the allocation amount, 300 people will be placed on OST by year three of the grant. If PAAR is granted, OST coverage will increase from 4% of PWID reached, to 10%. Note: This PAAR request is only for the OST procurement, since human resources for OST and site costs are provided for in the allocation request.","3/31/2022",2602628]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},189031883]
[{"$nulls":6},"Treatment, care and support","Differentiated ART service delivery","The allocation makes provision for ARVs for 35,000 people while this above allocation would cover additional demand. This funding includes procurement of drugs for opportunistic infections, training facility staff and those from Internally Displaced Persons (IDPs) and refugee camps and Protection of Civilian sites (PoCs) in HIV and TB treatment and care, establishing of 4 mobile lab services and operational support.","12/31/2020",0]
[{"$nulls":5},"Malaria Total",{"$nulls":4},9624969]
[{"$nulls":6},"Program management","Other program management intervention(s)","This funding is for training of health workers to improve TB case detection. As training and capacity building have been substantially covered within the allocation, additional training/capacity building will have to be clearly justified.","12/31/2020",830619]
[{"$nulls":6},"TB care and prevention","Treatment","The updated forecasting and quantification of First Line Anti-TB drugs (FLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnerships Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the budget required the FLD is USD1,049,562 to cover the treatment needs up to the end of 2020.  By the end of 2018, a total of 14,362 cases were notified against a set target of 12,678. Similarly, an increasing trend was reported as at June 2019 - 8,566 cases notified which is above the set target of 6,973 by 23%. It is projected that by the end of 2020, the number of notified cases will increase to 20,832.","12/31/2020",1049562]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Cordaid shall support the Ministry of Health to improve MDR-TB and TB data management (eTBr, customize and install GenEX software)","12/31/2020",20000]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},6495494]
[{"$nulls":6},"Comprehensive prevention programs for MSM","HIV testing services for MSM","Others tests and consumables to the Mobile HIV testing vehicles- Unable to predict at this stage, detailed cost breakdown will be informed during grant making.","12/31/2021",0]
[{"$nulls":6},"Comprehensive prevention programs for MSM","HIV testing services for MSM","To promote early detection of HIV, community-based HIV testing will be carried out through mobile   testing service. As KP intervention activity is going to be piloted by NSACP in 2018, and the same is proposed under the Funding Request HIV testing using a vehicle is planned for the first time. This vehicle will be equipped with clinical facilities to conduct testing of rapid HIV and syphilis and others testing facilities according to the need.- 2 such vehicles are requested to cover Western Province. These 2 will be managed by the project office with the NSACP staff and KPs.","12/31/2021",171392]
[{"$nulls":5},"Tuberculosis","TB care and prevention","Case detection and diagnosis","4 nos of mobile x ray units to be mounted to vehicles","12/31/2021",52000]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Procurement of 13 nos of Light microscopes for new centers and for replacing  the unserviciable microscopes","12/31/2021",26000]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},160500]
[{"$nulls":6},"Program management","Grant management","This amount represents 4% handling fee for UNICEF as procurement agent for bed net, ACTs and RDTs. It may be noted that a small proportion of the 4% is considered as cost recovery for UNICEF Country office.","12/31/2020",1114747]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Target population: Refugees and other vulnerable populations including miners and nomads. The total number of bed net procured for refugees in 2017 was 573,672 LLINs (526,572 for South Sudan Refugees and 47,100 for East Sudan Refugees). FMOH, UNDP and UNHCR jointly distributed LLIN.","12/31/2020",123501]
[{"$nulls":6},"Vector control","Other vector control measure(s)","Vector mapping aims at creating evidence based vector control interventions for all vector born disease. Focusing on risk mapping, updating distribution map of vectors, distribution map of insecticides resistance, assessing the role of malaria vector control interventions for control of other disease such as leishmaniasis  and lymphatic filariasis. These will update distribution maps of malaria vectors that were developed in 1950s.","12/31/2020",758352]
[{"$nulls":4},"Suriname","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Outreach activities in the Gold-Mining Areas of the Interior of Suriname. Each of the gold-mining sites receive 2 outreach sessions per year with the  minimum package of services (BCC, condom distribution and lubricants, and HIV, STI, TB, SRH). In addition, on each of the outreach sessions, a tester is there to make testing available to people reached via the outreach.","12/31/2021",11000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","Create a repository of reports, including strategic plans, annual reports, evaluations and assessments.","12/31/2021",10500]
[{"$nulls":5},"Malaria Total",{"$nulls":4},613156]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","With PAAR, the project will improve the quality and expand the NSEP and OST services for PWID by the end of the project cycle. The expected outcome is to contain the spread of the HIV infection among the key population and eventually general population. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.","12/31/2020",1845632]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Other intervention(s) for TGs","As there is currently a lack of information on the TG population, this request will develop IBBS and GIS to create mappings to guide interventions for TG persons.","12/31/2020",0]
[{"$nulls":4},"Tanzania (United Republic)","HIV/AIDS, Tuberculosis","Prevention programs for general population","Other intervention(s) for general population","During 2018-2020 Global fund grant application only 7201996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44% of the blood recipients to be at risk of infections through blood transfusion.","12/31/2020",5769918]
[{"$nulls":6},"TB care and prevention","Community TB care delivery","High level priority: it is in line with FR one of the main objective  to intensify TB case notification  and module 1 TB care and prevention: To support coordination mechanisms at the community level.","12/31/2020",43499]
[{"$nulls":6},"TB/HIV","Other TB/HIV intervention(s)","It is hypothesized that Low TB case notification among PLHIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among PLHIV disaggregated by age, gender and pregnancy status.","12/31/2020",356600]
[{"$nulls":6},"TB/HIV","Other TB/HIV intervention(s)","Testing of TB patients partners for HIV is also an important component of HIV prevention services for TB patients. Partner/ Couple testing and partner notification remain low in our settings. Few TB clinics have systems in place to adequately document partner testing. This requested funding is to provide minimal additional training in line with the Couple Counselling refresher training package and HTC tools for documentation. It is expected that through this, existing cadres of skilled medical staff will be able to extend HIV testing Tanzania Funding Request: Full review 22 May 2017 | 43 and counselling to the partners of their TB patients.","12/31/2020",350000]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","Tanzania is planning to scale up establishment of centers of excellence for management of advanced cases of pediatric and adults living with HIV.","12/31/2020",1800000]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Installation of Blood Established Computer System (BECS) in 10 regional blood collection and coordination centres to scale up collection of blood transfusion information. Collected Data will be used for decision making and safe blood service strengthening.","12/31/2020",207500]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},26594612]
[{"$nulls":6},"Case management","Integrated community case management (ICCM)","This funds critical activities to accelerate access to care for high burdened, hard to reach populations, through community-based workers. The program will address service gaps through expanding health services beyond formal health services.","(blank)",900000]
[{"$nulls":6},"Vector control","Other vector control measure(s)","This funds will cover active disease surveillance activities, screening of populations irrespective of the presence of fever or any other signs or symptoms of malaria to detect infections and residual parasite carriers in the low transmission regions nearing malaria elimination.","(blank)",0]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Other health and community workforce intervention(s)","The intervention is aimed at supporting the provision of additional essential health workers for the delivery of CEmONC serives and services for AIDS, Tuberculosis and Malaria in a setting of severe human resource shortages.","12/31/2020",3402374]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","RTF BL 15-161. Community empowerment for migrants: Population group building (e.g. saving group, women group)2. Community empowerment for migrants: Population network strengthening","12/31/2020",16342]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","HIV and HIV/TB-related legal services","RTF BL 17Meeting on legal services related HIV-TB. Meeting police, MOI, CSO Units/Participants: 37 person per day.","12/31/2020",30235]
[{"$nulls":6},"TB care and prevention","Community TB care delivery","RTF BL 42:Support TB patient group activitiesTo establish a group to share past experiences, communicate and inform on counter effects of medicines and on the different forms of care and support present in the community for the benefit and of both KPs and care takers.","12/31/2020",16342]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","DDC BL 289:Support of 3 small mobile x-ray vans, including read and digital CXR scanner set to render regular mobile services for prisoners and prisoner guards in 20 high TB burden prisons (2 prisons for one van) with prompt referral of symptomatic patients or patients with abnormal CXR to facilities with GeneXpert for TB confirmation and TB treatment. This demonstrationproject is hoped to generate evidence of TB disease burden in prisons and feasibility for prevention and care in order to support policy decision.Small mobile x-ray van, including read and digital CXR scanner set to provide services for the prisons that have the narrow entry/entrance.","12/31/2020",0]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","DDC BL 275, 329-337, 338-3431. Co-invest with PIF for national capacity building forum and scaling up to more sites in Bangkok2. Capacity Building and TA for community Led services in 3 Provinces , BangkokChiang Rai and Naratiwas3.  Capacity Building and TA for Reach and Recruit for Key population, MSM TG and PWID.","12/31/2020",581432]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","RTF BL 23-281.Monitoring progress of institutional development capacity and training in the area of 1) Organizational strategic plan, 2) Program management, 3) Resource management, 4) Financial management, 5) Risk management, and 6) Data and Information management 2.Promote digital platform of CSO accreditation3. Kick off for digital platform to multiply impacts for CSO accreditation at national and regional level 4. Community led training -Training Outreach worker and Field staff  by TRC5. Visualise advocacy documentation and training manual6. Kick off for Visualise documentation.","12/31/2020",0]
[{"$nulls":6},"RSSH: National health strategies","Other policy and governance intervention(s)","DDC BL 360-364Preparing Thailand for effective and sustainable transition from GFATM using domestic funding and efficient implementation system through a partnership between communities, private and public sectors, 1. Setting up management unit of the Thai Fund, a public-private resource mobilization.","12/31/2020",725656]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Prevention and management of coinfections and co-morbidities for PWID","RTF BL 12-14,411. Hep C advisory board2. Hep C advisory board meeting3. HCV test kit procurement for 17 provinces -in addition to Community led4. Direct acting anti-viral treatment (DAA) dialogue for HEP C-group for HEP C following up during the intensive.","12/31/2020",124245]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","DDC BL 302-308Purchase  HIV testing ,Kidney function test , HepatitisB test, Urine pregnancy test, Syphilis test, ARV drug: TDF/FTC, (302-307)Activity : Set up PrEP service and included referral system (308).","12/31/2020",367506]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","The request is based on the current number of modules (600 modules) in country (125 machines) @ 3 tests per module (assuming 3 runs per day per site)/ day X 600 modules X 255 days a year (excluding weekends and public holidays) = 459,000 tests.","12/31/2020",2168952]
[{"$nulls":5},"Tuberculosis","MDR-TB","Treatment: MDR-TB","MDR-TB regimen change","12/31/2020",500000]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","This request includes for TA support for TB/HIV and ART treatment in 2019 and 2020.","12/31/2020",0]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","This request includes for TA support for a mid-term review of the program/NSP in 2019/2020.","12/31/2020",0]
[{"$nulls":5},"Malaria","Case management","Active case detection and investigation (elimination phase)","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Lestes transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector","12/31/2020",0]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Provision of LLIN procurement and mass-distribution (2019/2020) to maximise coverage in and utilization by vulnerable populations in an expanded geographic area which reported =2 malaria cases in the last 3 years (2014-2016). Whilst within allocation aims to prioritise investment to ensure maximum impact is extended to the most vulnerable population, this request focuses on maintaining core preventative measures in highly receptive areas which could confer a high risk of malaria resurgence once the operational effectiveness of current LLINs has diminished. Ensuring extended coverage would provide the outcome of Universal Access to Coverage (90%) amongst a wider population denominator and would ensure targets are achieved across all 4 Impact Indicators.","12/31/2020",0]
[{"$nulls":5},"Malaria Total",{"$nulls":4},1029243]
[{"$nulls":6},"Treatment, care and support","HIV care","Pre-treatment assessments and biological monitoring.2Biological assessments make it possible to determine the suitable treatment  scheme,  monitor  the  effectiveness  and  safety  of  the treatments and, consequently, to improve the quality of life of the patients.","(blank)",2211534.06]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Analysis  of  the  range  of  services  in  the  HIV  treatment cascade:Carry out a study to analyze the range of services in the  HIV  treatment  cascade. The results  of  this  analysis  will  make  it  possible  to  analyze  the progress  made  in  relation  to  the  90-90-90  targets  by  2020, through the identification of the shortcomings of each stage of the HIV   treatment   cascade   concerning   the   different   population groups and sub-national units (health regions and districts).","(blank)",121499.27]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Range of services for IDUs:  (i)  minimum  prevention  package  and, (ii) establishment of a needle exchange program (a new syringe in exchange for a used syringe) , so that IDUs adopt less risky sexual behavior and safer behavior regarding injection.","(blank)",62517.11]
[{"$nulls":6},"PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Elimination of Mother to Child Transmission of HIV:In 2016, with the aim of achieving the objectives of eliminating the mother to child transmission of HIV, the NACP introduced the use of HIV/Syphilis DUO test at the sites for the prevention of mother to  child  transmission  of  HIV  (PMTCT).  This  intervention will contribute to achieving coverage of screening for syphilis, one of the certification criteria for Togo for the elimination of mother to child transmission of HIV.","(blank)",699585.91]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Strengthening human resources for health (HRH) management capacity initiated during the NFM1:- Institutionalization of HRH: 1) updating the HRH management database (12,000 health staff and 11,000 CHWs); 2) linking the iHRIS 4.2 software with District Health Information System (DHIS2); 3) preparing and periodically updating the country profile on HRH; 4) producing statistical yearbooks on HRH; 5) decentralizing the use of iHRIS to enable decision-making at the regional and health district levels.- Improvement of quality and promptness of malaria data reporting through trainings and supervisions.","12/31/2020",327527.77]
[{"$nulls":5},"Malaria Total",{"$nulls":4},6021897.6399999987]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Better treatment for PLHIV and key populations is supported by accurate assessment and proper planning with respect to the quantification, supply and distribution of health products.","12/31/2021",77390]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Conducting assessment surveys on resistance to antiretrovirals (ARVs) at the four treatment sites, conducting a study on adherence to treatment, conducting a community bio-behavioral study (MSM, people who inject drugs, SWs) to measure the impact of prevention interventions, and updating the estimated sizes of key population (mapping/studies estimating the population size of MSM/SW/people who inject drugs) will all help to better guide the planning of HIV control activities, thereby guaranteeing an improved impact of disease control activities in Tunisia.","12/31/2021",86600]
[{"$nulls":4},"Turkmenistan","Tuberculosis","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Community involvement to TB care is weak due to the  lack  of  social  contracting  mechanisms.  Civil society formally   participates in  the Country Coordinating  Mechanism.  Proper  involvement  of CSOs is stipulated in the National Programme for TB Prevention and Control, 2016-2020. However, the only CSO with meaningful engagement to TB care is the National Red Crescent Society through the  Global  Fund  grant,  and its  role is  limited to service provision. The transitional grant includes  technical  support  with  establishing  legal and  financial  mechanisms  for  direct  contracting and building  capacities  of  CSOs  as  to  enhance  their contribution to the national TB response. In order to  increase the number of CSO involved in  providing   TB  prevention  and  treatment adherence support interventions, under Prioritized Above Allocation Budget CCM is asking to fund  a Small grants program for CSOs. The project will support the first grants aiming at involvement of the CSOs in TB control activities, including  work  on  reducing stigma, dissemination of information, advocacy for ambulatory  model,  or support to patients  during ambulatory treatment (focus on women patients or other vulnerable groups).","6/30/2021",100000]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Turkmenistan plans to make the transition to the new WHO guidelines from July 2019 and would require additional funding for 2019 and 2020. Over 1000 RR/MDR TB patients are expected to transition to the new RR/MDR TB treatment regimens in next 1.5 years, leading to an estimated gap to be funded through portfolio optimization.","6/30/2021",0]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","This is to support procurement of cartridges for operationalizing Xpert MTB/Rif machines to enhance the finding of missed cases including in key populations such as prisons and PLHIV. Secondly, approximately $1.7m is for procuring digital X-rays.","(blank)",15152070]
[{"$nulls":6},"Other module","Other module","Additional Condoms, Condom dispensers and alternative condom distribution mechanisms will support the delivery of condoms to those who need them.","(blank)",41133256]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Prioritization on the printing and distribution of the HMIS reporting tools to reach out to all 116 districts and all health facilities in the country with these updated HMIS reporting tools. Due to limited funding, this was placed under PAAR for any savings in the first year (2018) to contribute to at least 30% of the country required HMIS tools.","12/31/2020",1042566]
[{"$nulls":5},"Tuberculosis","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","12/31/2020",0]
[{"$nulls":6},"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","The suuplementary services for current MPSS patienst (10,000) under OST progranmme.","12/31/2020",328568]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","The intervention is oriented to create shelters for displaced persons and representatives of LGBT community in difficult situations in controlled area. The PAAR request also includes costs for 50% of MSM outreach package in 2019 and 80% in 2020 to pilot Social Impact Bond as described under Module 2.3. above. The intervention will improve MSM perception of health care and prevention programs as well.","12/31/2020",0]
[{"$nulls":6},"MDR-TB","Case detection and diagnosis: MDR-TB","TB case detection and diagnosis among general population in Non-Government Controlled Areas (NGCA) Donetsk and Luhansk. It is planned to cover about 3,800 additional MDR-TB cases implementing rapid testing. In addition, a total of 3,100 Xpert cartridges will be procured (1,800 for Donetsk and 1,300 for Luhansk).","12/31/2020",0]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},0]
[{"$nulls":6},"Treatment, care and support","Other intervention(s) for treatment","CD4 tests for treatment monitoring in patients receiving therapy  under the grant.","6/30/2021",0]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Laboratory tests for the full implementation of the program for the prevention of vertical transmission of HIV from mother to child for determining the viral load  for 600 HIV-positive pregnant women and proviral DNA of 650 children born from HIV-infected mothers.","6/30/2021",0]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},2958638]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Transgender women are 50 times more likely living with HIV than general population (Global Fund Strategy 2017-2022). In Vietnam, the TG network was established in 2015. It manages 25 CBOs in 8 provinces/cities. It is a new network that is not yet equipped with knowledge on HIV/AIDS prevention, governance and OD. To provide capacity building as well as encourage this network in engaging in HIV response, VUSTA will provide initiative packages focusing on prioritized, specific topics: addressing stigma, discrimination and violence against TG; Preexposure prophylaxis (PrEP), harm reduction and interventions for ATS use. With above allocation funding, VUSTA will reach With above allocation funding VUSTA will reach the following number of TGW in Hanoi, HCMC and Nghe An: 2018: 2,025 2019: 2,625 2020: 2,725 Of those reached with prevention services, 75% will also be referred for HTS by 2020.","12/31/2020",66793]
[{"$nulls":6},"Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Information and sensitization programs for legal aid providers on critical health and human rights aspects of HIV response, with emphasis on those that pertain to key populations.","12/31/2020",12488]
[{"$nulls":6},"RSSH: Community responses and systems","Community-based monitoring","In previous years, considerable support has been given to the development of a robust community system for HIV response, resulting in the establishment and growth of national networks for PWID, of SW, and of MSM and TG. Funding from this allocation will continue to build on this foundation, strengthening the institutional and service delivery capacity of new and existing CBO and KP networks to support HIV prevention services, advocate effectively and to provide community-based monitoring and feedback. Community-based monitoring will be implemented between 2017-2020 using the set of tools and procedures developed during the last allocation period.","12/31/2020",60965]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Targets for sub-national coverage of HIV services are currently set at the central level. Sometime, the provincial agencies feel that these targets are not realistic. There is a need for province and district level agencies to be involved in the development of ambitious but realistic targets for HIV service delivery. These targets will then be shared with district-level authorities for their consensus. Once consensus has been reached, the province and district level agencies can develop a plan to achieve their targets, which will then be submitted to the CPMU for approval. In above allocation, support is requested in each of the 32 Global Fund-focus provinces for the following: i. Technical assistance for PPAC to develop relevant and realistic target; ii. 1 x workshop between province and district level agencies to finalise the targets; and iii. Technical assistance to develop a plan to reach the targets.","12/31/2020",610976]
[{"$nulls":6},"Comprehensive prevention programs for MSM","HIV testing services for MSM","Viet Nam envisions to move towards 90% of PLHIV (People Living with HIV) know their status by 2020. The number of MSM received HIV test and know their results in 2018 is 61,172, which is only 36% estimated MSM. It is critical to implement innovative approaches to improve access to HTS and increase coverage of HIV testing for MSM. Community-based testing, lay provider and self-testing are being supported by the Global Fund within the funding allocation for approximately 34,000 MSM in 2019. Additional funding is requested to implement new approach of index testing to facilitate earlier diagnosis and linkage to care. In addition, VAAC also proposes to support HIV recent incidence assay among MSM to help incidence estimation, analyse HIV transmission tendency and evaluate effectiveness and impact of prevention program in response to HIV. Additional funding is requested to implement new approaches: 1) index testing to facilitate earlier diagnosis and linkage to care; 2) HIV recent incidence assay for 70,000 newly identified HIV+ MSM to monitor estimated incidence and HIV transmission trends, and evaluate effectiveness and impact of the prevention activities in for prompt action. - Procurement of oral test for index testing, 4th generation HIV test Ag/Ab, Asante, Viral Load, PCR- Labor fee for testing, transportation- Support Peer Educators to refer MSM to confirmatory testing and ARV treatment- Training for provincial health staff, Community Based Organizations, Peer Educators on index testing and recency testing","12/31/2020",1200000]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","HIV prevention training for CBO: knowledge and skills fundamental to prevention of HIV transmission, ARV treatment, medical insurance, synthetic drugs, HIV testing in community Prep, PEP, ATS, HBV, methadone, HBC, gender equality.","12/31/2020",31296]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","Integration of TB prevention and control education into school extra-curricular activities in 2018 - E-learning to screen potential candidates for MECOR course and maintenance for the e-learning system for MECOR Supervision of GX including EQA and on-site technical support for GX implementation - Updates to the NTP guidelines and training in updated guidelines/ techniques (testing, GX, etc.) - Development of remote coordination and connectivity for clinical discussions and program support (i.e. ECHO system).","12/31/2020",204866]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","The elderly in Vietnam have a high prevalence of TB. According to the TIME model, about 10,000 elderly cases can be detected with large scale ACF. The PAAR will provide screening for 6000 elderly in community, 2000 in mental health institutions, and 2000 in in some social protection centers in 0seven provinces per year using CXR and Xpert . PAAR will also support workshops to improve awareness of TB among the elderly.","12/31/2020",316820]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","To support expansion of childhood TB activities, the PAAR will support revision of the diagnosis, treatment, and prevention training materials. NTP will also develop, print, and distribute IEC materials (poster, leaflets, etc.) for community awareness and support health workers on IPT and childhood TB management, with the ambition to detect and treat about 3,000 more cases per year.","12/31/2020",75243]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","National costed supply chain master plan, and implementation","Upgrades to VITIMES and E-TB Manager to meet the supply chain management needs and link to health insurance, training, connect GeneXpert to eTB manager, and using GxAlert TA to support key provinces. - Development of \"Guidelines of supervision and technical support of management of supplying system at the facilities\", training on supply operation procedure (SOP) and supply statistic report, building a costing toolkit for quarterly needs and tentative needs for first line drugs, compile TB handbook \"what you need to know\" for drug resistant TB patients, and training on using TB drugs rationally and safely - Enhancing the application of information technology in medical stores by procuring computers, printer and uninterrupted power supply (UPS), and management of central and regional store software - Needs assessment and development of SOPs for supplying free drugs to MDR-TB patients in the private sector.","12/31/2020",296644]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","TA and supervision of data collection, data quality assessments, and one staff to participate in a regional TB/HIV conference.","12/31/2020",14299]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","12/31/2020",0]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},23989343]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Fully oral shorter regimen implemented under operational research conditions.","12/31/2020",100000]
[{"$nulls":6},"Treatment, care and support","Differentiated ART service delivery","National ART guidelines for 2018 have changed towards the new regimens.  This has altered the gap analysis for ARVs, leading to the need for increased Global Fund resources. Global Fund had initially committed $47,078,326 towards ARVs to cover 3 years 2018-2020. However, Global Fund exhausted all its obligation before 2020.","12/31/2020",14289750]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Due to the changes that have been made to the Drug Resistant-TB guidelines, the gap has increased as the drugs being introduced are more expensive. Most of the patients will be on Bedaquiline which will no longer be a donation and a few on Delamanide which is more costly. Note that the Bedaquiline gap is in 2020.","12/31/2020",1033887.39]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},24963342.390000001]
[{"$nulls":5},"HIV/AIDS, Tuberculosis, RSSH","HIV Testing Services","Differentiated HIV testing services","To scale up self-testing (200,000 test/year). Aligns with accelerated prevention interventions for AGYW.","(blank)",1365570]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Socioeconomic approaches","The funding will contribute to empower communities to help prevent HIV among adolescents and young women. It will cover cash transfers for 7000 girls and school fees for 3000 boys.","(blank)",0]
[{"$nulls":6},"Prevention programs for general population","Male circumcision","Voluntary medical male circumcision reusable and consumables kits, early infant male circumcision training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly.","(blank)",10743359]
[{"$nulls":6},"Prevention programs for general population","Condoms as part of programs for general population","For male and female condoms. There is an anticipated funding shortfall due to reduced funding from other partners over the implementation period.","(blank)",5028497]
[{"$nulls":6},"Program management","Grant management","Funding will provide additional risk mitigation for the management of the expanded scope of the program, particularly the additional civil society and community sub-recipients.","(blank)",974242]
[{"$nulls":6},"TB care and prevention","Treatment","First line drugs for additional patients in view of scaled up diagnostics in addition to external quality assessment activities for smear microscopies. This will support expanded diagnostic capacity.","(blank)",3286392]
[{"$nulls":6},"TB care and prevention","Treatment","Second line drugs for additional MDR-TB patients and improvement of Treatment Success Rate.","(blank)",2487307]
[{"$nulls":6},"TB/HIV","Community TB/HIV care delivery","To strengthen community TB/HIV activities by training 5000 community TB/HIV supporters in 104 districts in TB and HIV prevention, care and support, including contact tracing.","(blank)",0]
[{"$nulls":6},"TB/HIV","TB/HIV collaborative interventions","Additional 100 Xpert machines, with related cartridges, printers and UPS, and 4 digital X-Ray machines. The TRP considers this low priority as there are 200 machines within allocation funding that need to be phased in while ensuring optimum utilisation.","(blank)",8137710]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","Radio programs on treatment literacy, incentives for 2000 Adherence Support Workers (ASW) per year. The TRP recommends that these resources be leveraged to also support TB/HIV collaborative activities  i.e. MDR-TB.","(blank)",79996]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","These are RSSH PSM strengthening activities although labelled as viral load and monitoring. The request will further strengthen PSM quality of health products, and improve rational use of medicines.","(blank)",7859920]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","These funds will support health care waste management systems. The funds will be used for 5 incinerators, 10 air samplers, a laptop for integrated inventory management, supervision, M&E, and quality control.","(blank)",2349640]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Recruitment and placement of additonal 1400 nurses in rural areas and disease hotspots. Only 600 nurses could be covered by the allocation, whereas 2000 new nurses are required to achieve treatment targets for the implementation period.","(blank)",41076000]
[{"$nulls":5},"HIV/AIDS, Tuberculosis, RSSH Total",{"$nulls":4},83388633]
[{"$nulls":5},"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The number of LLINs to be distributed to at risk population through mass campaign in 2020 is 7,512,678.","12/31/2020",19215531.5]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The number of LLINs to be distributed through routine channel to targeted  at risk populations is 2,158,203  and 1,948,203 in 2019 and 2020 respectively.","12/31/2020",5778982.7999999998]
[{"$nulls":6},"Vector control","Indoor residual spraying (IRS)","The target number of structures in 2019 is 3,376,196 translating in estimated 14,585,167 people protected at an average of 4.32 persons per structure. For 2020 the target is 3,474,106 structures translating in 15,008,138 people protected.","12/31/2020",0]
[{"$nulls":5},"Malaria Total",{"$nulls":4},24994514.300000001]
[{"$nulls":5},"Malaria, RSSH","Vector control","Other vector control measure(s)","This is a relevant component of the countrys elimination strategy that is critical as the burden progressively declines. This strategy will support the development of case-based surveillance in areas with low malaria transmission.","(blank)",10686696]
[{"$nulls":6},"Vector control","Other vector control measure(s)","This will complement the support for entomological surveillance to ensure quality and effectiveness of the vector control operations, particularly IRS.","(blank)",900000]
[{"$nulls":5},"Malaria, RSSH Total",{"$nulls":4},11586696]
[{"$nulls":4},"Zanzibar","HIV/AIDS, Tuberculosis","Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","The intervention will fund Hepatitis B screening as an adjunct to the HIV testing programs among key populations.","12/31/2020",44445]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","Procurement and supply chain management (PSM) capacity was identified as a potential bottleneck to program scale-up. These funds will cover capacity building for PSM, including necessary technical assistance, in line with the needs of the program expansion.","12/31/2020",121042]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","Enhancing TB prevention activities and case detection is in line with program needs.  However with the purchase and institution of GeneXpert from within the allocation budget, it is rated as medium priority.","12/31/2020",52308]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","The intervention will fund treatment of opportunistic infections, toxicity monitoring and home-based care interventions in view of maintaining safety and efficacy of ART and improve survival and overall impact of ART scale up.","12/31/2020",1029107]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","This activity will complement program scale-up by availing and enabling data use for implementation.","12/31/2020",82716]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","This intervention will improve routine data collection and data quality in light of the planned scale-up of Zanzibars treatment programs.","12/31/2020",217227]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","These funds would enable an implementation research study on the bottlenecks to access opioid substitution therapy for people who inject drugs, which is a key programmatic gap. These funds would also fund a study on adherence to ART. Both studies are likely to inform program strategy.","12/31/2020",43915]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention is meant improve the overall quality and monitoring of health data in the expanded program. It will serve to extend the institution of the electronic medical records through the increase in the number of health facilities and capacity building for the health workforce.","12/31/2020",186665]
[{"$nulls":6},"PMTCT","Prong 3: Preventing vertical HIV transmission","This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women.","12/31/2020",544241]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},2321666]
[{"$nulls":5},"Malaria","Case management","Active case detection and investigation (elimination phase)","This intervention is meant to ensure that every malaria case is reached in order to achieve elimination.","12/31/2020",22624]
[{"$nulls":6},"Case management","Therapeutic efficacy surveillance","This intervention aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.","12/31/2020",104768]
[{"$nulls":6},"Program management","Grant management","This item covers program management activities to ensure effective and smooth undertaking of the program's operational plan, monitoring of program budget and implementation of the planned activities.","12/31/2020",13100]
[{"$nulls":6},"Program management","Policy, planning, coordination and management of national disease control programs","This activity will cover the cost for trainings and meeting attendances.","12/31/2020",28775]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The installation of network infrastructure will support and strengthen procurement and supply chain activities.","12/31/2020",1548]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Analysis, review and transparency","This activity will strengthen the monitoring and evaluation component for the entire program.","12/31/2020",100233]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","This item will cover interventions to support improving the accuracy of data collection and analysis to inform decision making.","12/31/2020",17308]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","This activity will cover the cost to monitor and support regular and timely reporting of all activities conducted at various levels of implementation.","12/31/2020",58909]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Surveys","Data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","12/31/2020",51510]
[{"$nulls":5},"Malaria Total",{"$nulls":4},398775]
[{"$nulls":4},"Zimbabwe","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Addressing stigma, discrimination and violence against sex workers","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",81125]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",2463120]
[{"$nulls":6},"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",1938840]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","(blank)",76500]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Behavioral interventions for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","(blank)",11700]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Community empowerment for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","(blank)",184701]
[{"$nulls":6},"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","(blank)",251100]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","Above allocation funding is requested for the procurement of self-test kits. Self-testing is prioritized in this funding request based on lessons learned about its effectiveness in reaching young people and men, as well as evidence from pilot programs which show this is a high yield method at more than 20% positivity","(blank)",9014947]
[{"$nulls":6},"HIV Testing Services","Differentiated HIV testing services","Filling gaps in standard test kit procurement for year 3 is the top priority request in the PAAR.","(blank)",2092061]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Community adolescent treatment supporters in 6 additional districts.","(blank)",1300000]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Scale up the modified DREAMS package to an additional 4 districts.","(blank)",3174288]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","Brother2brother pilot: 10 Districts.","(blank)",900000]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","In school and tertiary programme.","(blank)",3000000]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","Youth Centers (Multi-sectoral approach model).","(blank)",1300000]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Gender-based violence prevention and treatment programs for adolescents and youth","Funding is requested for community infrastructure, technology and transport systems to establish six additional one-stop centres (in addition to the four requested in the matching funds application) for HIV/SRHR/GBV, building on successes of existing centres in Rusape General Hospital (Makoni), Harare and Gweru. As more than 1 in 3 Zimbabwean women experience physical violence, the 17,000 GBV survivors served by the current centres is an enormous service gap. The need to decentralize access to GBV services and strengthen linkages to communities is vital.","(blank)",1617630]
[{"$nulls":6},"Prevention programs for adolescents and youth, in and out of school","Keeping girls in school","Doubling the education subsidies in the existing 4 DREAMS districts to reach at least 30% of the vulnerable AGYW in those districts.","(blank)",2160000]
[{"$nulls":6},"Prevention programs for general population","Gender-based violence prevention and treatment programs for general population","Primary gender-based violence prevention programs to protect vulnerable women and girls. Specifically, funding is requested to roll out the MenEngage Padere model in 25 districts (Note: Piloting of the SASA! model is prioritized in the matching funds request for AGYW).","(blank)",355668]
[{"$nulls":6},"Prevention programs for general population","Male circumcision","Building on the targeted and tailored prevention packages for AGYW and key populations which have been prioritized for within allocation request, high impact prevention interventions for the general population also have the potential for significant impact. Prevention is a strong focus of this funding request. In line with Zimbabwes new Roadmap to Revitalise HIV Prevention in Zimbabwe (2016). Above allocation funding is requested to scale up of VMMC, prioritizing the 7 underserved districts not covered by PEPFAR (Inyanga, Chimanimani, Bikita, Rushinga, Uzumba-MarambaPfungwe, Kariba and Binga) prioritized first, scaling up to other underserved areas from there. Funding is requested both for VMMC commodities ($4,496,750.00) and programming ($1,202,027.72).Robust impact modelling in the countrys Accelerated Strategic and Operational Plan on VMMC shows that scaling up this activity will avert 212,000 HIV infections by 2025 and reduce prevalence by 3%. Achieving the target of circumcising 1.3 million men will result in more than $1 billion in financial savings.","(blank)",5698778]
[{"$nulls":6},"Prevention programs for general population","Other intervention(s) for general population","Other prevention activities including program coordination, learning and support.","(blank)",939252]
[{"$nulls":6},"Prevention programs for general population","Other intervention(s) for general population","Positive health dignity and prevention (PHDP) activities.","(blank)",10185]
[{"$nulls":6},"Prevention programs for general population","Other intervention(s) for general population","Procure and provide targeted PrEP for populations at elevated risk, prioritizing PrEP for serodiscordant couples ($3,413,954.14) and scaling up through a phased approach.","(blank)",1495731]
[{"$nulls":6},"Prevention programs for general population","Condoms as part of programs for general population","Close gaps in male and female condom programming when delivering the comprehensive prevention package of services at community levels. The expected impact is based on continuing trends which show that an estimated 2 million HIV infections were averted by the increase in actual condom use between 1990 and 2016, compared to a scenario in which condom use levels stagnated in 1990. This investment will also complement PEPFARs investment in condom procurement by prioritizing filling the gaps in social marketing, including TV, radio and community sensitization. $299,700 is requested for demonstration models and dispensers while $1,064,316 is requested for programming. The US government continues to invest significant amounts in the procurement of male and female condoms, with Global Fund resources intended to complement these investments.","(blank)",1364016]
[{"$nulls":6},"Prevention programs for general population","Diagnosis and treatment of STIs and other sexual health services for general population","HIV prevention-related STI services, including for the provision of dual HIV and syphilis testing, STI screening and treatment, referrals for HPV vaccines and cervical cancer services.","(blank)",3568111]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","(blank)",142164]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","(blank)",276588]
[{"$nulls":6},"Prevention programs for other vulnerable populations","Behavioral interventions as part of programs for general population","Supporting existing behavior change facilitators in 46 districts and extend their work to workplaces (including informal sector) to reach men with out of facility prevention, testing and linkage to care.","(blank)",858090]
[{"$nulls":6},"Program management","Grant management","PR (7%) and SR (3%) costs for implementation of the total PAAR request.","(blank)",27688]
[{"$nulls":6},"TB care and prevention","Case detection and diagnosis","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","(blank)",374255]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","(blank)",2438660]
[{"$nulls":6},"TB/HIV","Collaborative activities with other programs and sectors (TB/HIV)","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.","(blank)",975000]
[{"$nulls":6},"TB/HIV","Other TB/HIV intervention(s)","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.","(blank)",1475266]
[{"$nulls":6},"TB/HIV","TB/HIV collaborative interventions","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.","(blank)",106700]
[{"$nulls":6},"TB/HIV","TB/HIV collaborative interventions","Third, above allocation funding is requested to fill gaps in opportunistic infections medicines and related commodities including cotimoxisole, IPT, Ampotericin, kaposi sarcoma and gastric lavage.","(blank)",4897537]
[{"$nulls":6},"Treatment, care and support","Treatment monitoring - Viral load","Following test kits, filling gaps in viral load scale-up and other patient monitoring and quality of care gaps (CD4, EID, Haematology, etc.) is the second priority for the PAAR. Increasingly phasing out CD4 testing and scaling up viral load testing (to move to the maintenance phase of the VL scale up plan) is prioritized to ensure 90% of PLHIV who are on sustained ART are virally supressed by 2020.","(blank)",66987154]
[{"$nulls":6},"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Additional PSM strengthening to scale up viral load monitoring, optimize the use of GeneXpert, strengthen LMIS and links it to patient monitoring, and ensure quality medicines and diagnostics.","(blank)",7312508]
[{"$nulls":6},"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Funding is requested for the delivery of quality integrated services across the continuum of care for HIV/TB/Malaria/SRH. Activities will include revision of the SRH/HIV Linkages Guidelines to include TB and malaria. Second, the requested investment will strengthen outreach as part of decentralized service delivery models. Activities will include establishing new cervical cancer screening and management centers and revise EPI service provision package to include HIV testing at 18 months. Closely linked with the above activities, funding is requested to boost differentiated care across the continuum of care, based on profiling by age and retention in care. This will include the development and implementation of service guidelines for linkages and referrals between health facilities, schools and community service delivery points to provide integrated HIV/TB/malaria/SRH (including family planning) services to adolescents. Lastly, funding is requested for activities to buttress the school health program (and catalyze impact from the proposed investments in HIV prevention among AGYW).","(blank)",1063192]
[{"$nulls":6},"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations and womens networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","(blank)",850295]
[{"$nulls":6},"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations and womens networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","(blank)",8410509]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Program and data quality","Funding is requested to support an additional 267 data entry clerks for the ePMS and DHIS2 systems.","(blank)",1922400]
[{"$nulls":6},"RSSH: Health management information systems and M&E","Routine reporting","Support and maintenance for the ePMS, DHIS2 and plans for greater integration with HIV, TB and RMNCAH indicators, including improving patient-level tracking","(blank)",1328850]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",402785]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Addressing stigma, discrimination and violence against MSM","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",72600]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Community empowerment for MSM","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",534032]
[{"$nulls":6},"Comprehensive prevention programs for MSM","Condoms and lubricant programming for MSM","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",800]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Additional support for the performance-based retention scheme for facility-based staff in 1600 facilities.","(blank)",0]
[{"$nulls":6},"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).","(blank)",3132000]
[{"$nulls":6},"MDR-TB","Other MDR-TB intervention(s)","The final proposed investment will support prevention for MDR-TB and will include activities to strengthen and support TB infection control (IC) at community levels. Specifically the investment will support IC assessments for homes of diagnosed DR-TB patients and provide education on transmission risk reduction to family members, as well as initiate investigation of contacts. Engaging community leaders will place DR-TB on the agenda and facilitate a cascade of information within communities as part of the broader community TB care intervention. Decentralization of DR-TB treatment has meant that the majority of diagnosed patients are managed from their homes, justifying the rationale for these interventions, aimed at empowering community members to protect themselves and other vulnerable groups such as children, the elderly and PLHIV from acquiring TB.","(blank)",493087]
[{"$nulls":6},"PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","(blank)",230400]
[{"$nulls":6},"PMTCT","Prong 3: Preventing vertical HIV transmission","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","(blank)",568000]
[{"$nulls":6},"PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","(blank)",375900]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","(blank)",2403200]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Other intervention(s) for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","(blank)",394920]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Condoms and lubricant programming for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","(blank)",1200]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Community empowerment for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","(blank)",224561]
[{"$nulls":6},"Comprehensive prevention programs for TGs","Addressing stigma, discrimination and violence against TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","(blank)",5240]
[{"$nulls":6},"RSSH: Financial management systems","Other financial management intervention(s)","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",3446640]
[{"$nulls":6},"RSSH: Financial management systems","Routine financial management improvement (non-PFM)","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",929559]
[{"$nulls":6},"RSSH: Financial management systems","Public financial management (PFM) strengthening","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",254910]
[{"$nulls":5},"HIV/AIDS, Tuberculosis Total",{"$nulls":4},155914443]
[{"$nulls":5},"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLINs will be distributed to at risk population where IRS is not implemented, targeting every sleeping space in prioritized wards with API <5/1000 population. The MSP requires mass campaign every three years to replace obsolete LLINs. The 2020 mass campaign aimed at replacing the LLINs distributed in 2017 projected to protect a population of 516053 persons living in highly endemic areas. This gap would leave a total of 7.2% of total population at risk without any intervention if not supported. This will lead to poor coverage and increase in areas with high local transmission.","12/31/2020",0]
[{"$nulls":6},"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The costs are for distribution of LLINs in 2020. This cost will include the orientation of distribution teams, management of the processes and administration of the activities including the related SBCC and M&E components. The LLINs cannot be distributed without this cost and hence a population of 860,464 persons (12% of total population at risk) living in highly endemic areas will remain without adequate protection from any vector control intervention.","12/31/2020",0]
[{"$nulls":5},"Malaria Total",{"$nulls":4},0]
[{"$nulls":5},"(blank)","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Phase II: Construction of Harare NatPharm Central warehouse and purchase of equipment. Previously TRP cleared in 2013, transferred from NFM grant (2014-2017) due to transition policy.","(blank)",22737584]
[{"$nulls":5},"(blank) Total",{"$nulls":4},22737584]
[{"$nulls":4},"CÃ´te d'Ivoire","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Establish savings and credit groups in order to empower those living with HIV/AIDS. This will include the training of community health workers to implement activities to strengthen the economic and sustainable development of households with people living with HIV/AIDS. This is expected to be done through regular monitoring and supervision of 56 savings and credit groups. Kits will be made available to these 56 groups to implement this approach. This activity will ensure the increase to access and adherence to treatment for a more robust impact of the interventions described in the within-allocation demand.","12/31/2020",0]
[{"$nulls":6},"Treatment, care and support","Counseling and psycho-social support","Strengthen nutritional monitoring among people living with HIV/AIDS and orphans and vulnerable children This intervention will provide nutritional support to 671 households of orphans and vulnerable children experiencing food insecurity. Moreover, 2 additional post-distribution evaluations will be done during 2019-2020 in order to quantify the impact of this nutritional assistance. Tools to raise awareness will be produced in order to increase the impact of nutritional interventions included in the within-allocation demand, with a view to more patient adherence to the program.","12/31/2020",0]
[{"$nulls":6},"Treatment, care and support","Treatment adherence","Organize biannual exchange meeting by district between health care workers in health facilities, traditional healers, and religious leaders in 28 health districts in order to increase referrals of PLWHA to health centers in order to have better program adherence and to reduce stigma.","12/31/2020",0]
[{"$nulls":6},"PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Train CHWs to focus on the socio-cultural barriers to access to maternal and child health services This activity will consist of organizing one orientation session by health district in order to increase the number of pregnant women seeking PMTCT services and the retention rate of seropositive pregnant women to these services. This activity will strengthen the family-based approach to be implemented by CHWs in 28 districts as part of the within-allocation funding request.","12/31/2020",0]
[{"$nulls":6},"PMTCT","Other intervention(s) for PMTCT","Develop the Husband School approach Implement the husband school approach in the Sud-Como region. This innovative approach has a double benefitit increases the Funding request: Full review 15 February 2017 | 57 involvement of men in reducing barriers to access of PMTCT services as well improving the retention of seropositive pregnant women in care. Also, it fill the gaps on the vulnerable population of men over 35 by ensuring their access to screening through the front door of the PMTCT service. This intervention will involve the training of community actors in this approach so that they can implement the activities in 3 health districts in the Sud-Como region. It also involves the supplying of kits and guidance documents concerning this approach as well as workshops, missions, and supervisory visits.","12/31/2020",0]
[{"$nulls":5},"HIV/AIDS Total",{"$nulls":4},0]
[{"$nulls":5},"Tuberculosis","TB care and prevention","Collaborative activities with other programs and sectors (TB care and prevention)","Involvement of practitioners of traditional medicine in the treatment of tuberculosis: The funding for 2016-17 is intended to be used for capacity building for the technical and operational capabilities of 50 leading practitioners of traditional medicine and 400 practitioners from 20 health districts in relation to tuberculosis. The 2018-2020 funding above allocation amount aims to ensure their mentoring and the collection and management of data. The funding above allocation amount provides for the extension of this strategy to 50 new traditional leaders and 400 new practitioners of traditional medicine per year.","12/31/2020",95015.08]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Acquire nine digital radiography devices and digitize the 17 old radiography tables Radiography remains an indispensable diagnostic tool for smear-negative pulmonary tuberculosis, and even extrapulmonary TB. Therefore, strengthening the diagnosis of TB in children requires the use of this technology. The NTCP has 17 standard radiography devices available, in 16 existing regional coordination centers and at Abidjan central prison (MACA). Of these devices, five date from 2004, three from 2009 and nine from 2016. The older devices require extensive maintenance with spare parts that are increasingly hard to find. This type of radiography is being gradually replaced by digital radiography. As part of this concept note, the NTCP also anticipates the purchase of nine digital radiography tables for the nine new regional coordination centers including Sgula, and the acquisition of 17 digitization devices to adapt older equipment. The funding also provides for the training of trainers and training sessions for users of digital radiography equipment.","12/31/2020",0]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Active search for TB among drug users With regard to drug users, the activities proposed in collaboration with Mdecins du Monde are the following: - Awareness-raising sessions by community outreach agents in  fumoirs7  (smoking rooms) to reduce the stigma and discrimination that are associated with them; - Screening by active search for tuberculosis in the community of approximately 1,800 drug users over the three years of screening; - Community support for the 135 drug users with TB treated in eight prisons (1 per 6 drug users with TB).","12/31/2020",158231.4]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Ensure the transportation of sputum samples from regional to central laboratories. All the regional laboratories will send GeneXpert positive sputum samples to the central laboratories for confirmation and to carry out 1st and 2nd line sensitivity tests. The rapid diagnosis of multi-resistant and ultra-resistant TB patients followed by appropriate treatment will slow transmission and reduce the number of cases in the long term.","12/31/2020",0]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Pilot project for the use of new technologies in the active search for TB and among contact cases With regard to contact cases, a pilot project is planned for Abidjan with the use of awarenessraising/educational videos on tablets during surveys of patient contacts, and registration of all contact cases on an electronic database.","12/31/2020",90501.1]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Purchase eight automated slide stainers and eight incinerators for eight new regional coordination and maintenance centers All 17 existing regional coordination centers have incinerators and automated slide stainers. These devices are requested for the eight new regional coordination centers. The automated slide stainers not only make it easier to read the slides, but also allow standardization of procedures for better quality control.","12/31/2020",312628.09000000003]
[{"$nulls":6},"TB care and prevention","Other TB care and prevention intervention(s)","Purchase of 16 GeneXpert devices This request focuses on the acquisition of 16 additional GeneXpert devices in order to meet the needs of all regional laboratories. There are currently 13 GeneXpert devices, of which nine are located in nine regional laboratories (TB TCs) and four in the central laboratories (two at the Institut Pasteur de Cte dIvoire (IPCI) and two at the Research and Diagnosis Center for AIDS (CeDReS)). The NTCP plans to acquire 16 additional GeneXpert devices during this program continuation. Of these, eight will be purchased in 2018 to meet the needs of the eight existing regional laboratories and eight in 2019 for the eight new regional coordination centers opened in 2017. These GeneXpert devices will require maintenance and calibration each year. In addition, all machines require cartridges to operate. An average of 1,500 cartridges per machine per year is expected. These machines will strengthen the diagnosis of tuberculosis in general, and detection of the resistance profile in particular.","12/31/2020",0]
[{"$nulls":6},"MDR-TB","Treatment: MDR-TB","Psycho-social follow-up and nutritional support for 400 MDR-TB patients per year: MDR-TB patients do not benefit from community support in the current grant. The aim is to train at least two TB Community Counselors (CCs) per TB TC (for a total of 50 CCs) on MDR-TB and nutritional care, ensure home visits to MDR-TB patients to educate them and their families (follow-up to treatment, transmission control measures, nutrition), carry out patient contact surveys and provide psychosocial and nutritional support. The CCs will form the link between patients and health personnel who provide the daily DOT and will ensure absentees are returned to treatment where required.","12/31/2020",694343.6]
[{"$nulls":5},"Tuberculosis Total",{"$nulls":4},1350719.27]
[{"$nulls":4},"Grand Total",{"$nulls":5},3187316174.4695425]

{"sheet":"Salesforce Report Data","index":1,"n_rows":2657,"n_cols":22,"rows_kept":1125,"cut":true,"hidden":true,"merged":[],"bounds":{"rows_first":500,"rows_last":125,"rows_between":500,"halvings":2}}
["Country or Multicountry","End Date","FR Component","FR Name","Intervention","Last Modified","Module","Region Name","Status","TRP Comment","TRP Priority Rating","Uqd Id","URL","Recommended PAAR (USD)","Remaining UQD (USD)","Brief Rationale","Requested PAAR (USD)","UQD Funded by D2H or PSC (USD)","UQD Funded by Other Sources (USD)","UQD Funded by Portfolio Optimization (USD)","UQD Funded by Savings (USD)","UQD amount"]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other case management intervention(s)","10/30/2019","Case management","Central Africa","Active",null,"High","PAI-4024","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2M/view","268,207.83","268,207.83",null,0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":268207.83}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other case management intervention(s)","10/30/2019","Case management","Central Africa","Active",null,"Low","PAI-4018","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2G/view","1,711,367.97","1,711,367.97",null,0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1711367.97}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other case management intervention(s)","10/30/2019","Case management","Central Africa","Active",null,"High","PAI-4025","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2N/view","325,440.47","325,440.47",null,0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":325440.46999999997}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other module","10/30/2019","Other module","Central Africa","Active",null,"Medium","PAI-4030","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2S/view","39,277.3","39,277.3",null,0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":39277.300000000003}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-4028","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2Q/view","3,366.63","3,366.63",null,0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3366.63}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-4027","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2P/view","506,116.04","506,116.04",null,0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":506116.04}]
["Benin","6/30/2022","RSSH","FR352-BEN-S-01","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"High","PAI-3823","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz7/view","1,112,017.73","1,112,017.73","10 percent of health care facilities are renovated and fitted out, based on the assessment outcomes, in order to improve drug quality at the local level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1112017.73}]
["Chad","6/30/2021","Malaria","FR550-TCD-M","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"Low","PAI-5726","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTo/view","593,576.11","593,576.11","93% of the population in Chad religious (composed of Muslims, Catholics and Protestants). These three religions are well-structured with national coordinating bodies: the Higher Council of Islamic Affairs for Muslims, the Episcopal Conference of Chad for Catholics and the Agreement of Evangelical Churches and Missions for Protestants. In addition, there is a peaceful coexistence between these three religious congregations with regular consultations at all levels between the various officials.This structuring of religious congregations is a powerful means to spread health messages. The country plans to use their support to sensitize community members on the fight against malaria, HIV/AIDS and tuberculosis. The requested funding has the following objectives: Ensure the training of 438 trainers / leaders from 146 health districts in the country Train 9,000 women and 9,000 young people as malaria awareness agents Organize broadcasts on 10 community radio stations Support the monitoring of the activities implemented by the religious congregations",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":593576.11}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Treatment: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-5712","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTa/view","437,625.41","437,625.41","401 patients (106 in 2019, 132 in 2020 and 163 in 2021) must be screened and administered treatment between 2019 and 2021. Each patient must provide 5 culture samples (2 culture tubes per patient, equating to 4,010 culture tubes). Allowing a contamination margin of 5% would result in 4,211 culture tubes to be tested over the 3 years.Each patient must complete a sensitivity test at the start of treatment, equating to 401 sensitivity tests. Looking at the data for 2017, 2 of 60 MDR-TB cases remained positive in the 4th month, equating to 3.3%. This provides an estimate of 414 (401 x 3.3%+401).All of the targets for the culture and sensitivity tests will be covered in full by the Global Fund.The NTBCP in Chad is in the process of implementing a 2016-2018 extension plan for health care for RR-TB/MDR-TB cases. This plan aims to improve health care for these cases.At present, the tuberculosis drug sensitivity profile of the screened RR-TB/MDR-TB patients who are receiving treatment is unknown. In addition, the monitoring of these patients, which requires periodic culture tests and antibiogram tests, is still not carried out. Consequently, this monitoring is carried out only by the clinic, using microscopy. Culture confirmation tests for recovery are still not carried out. In addition, as yet, no RR-TB/MDR-TB patient who has completed a course of treatment has been reported as cured.The configuration of the premises of the NRL does not allow for the establishment of a functional culture laboratory that meets the minimum standards for the number of rooms required. The request is based on the recommendations resulting from the technical assistance mission report of the WHO Regional Green Light Committee (rGLC), which took place between November 4 and November 9, 2015.This funding request for a pre-fabricated culture laboratory will enable the NTBCP to:- perform culture tests and determine the sensitivity profile of patients screened for RR-TB/MDR-TB;- perform follow-up culture tests for RR-TB/MDR-TB patients receiving treatment.This funding will make it possible to acquire a prefabricated container for the culture of mycobacteria (ref: Specification LabMobile MCL WHO) including:- laminar flow hoods;- an autoclave;- a refrigeration unit at -4C;- a refrigeration unit at -20C;- two incubators;- a decontamination system;- the installation cost (preparatory work and earthworks);- a WHO evaluation mission;- annual maintenance for 2019-2020-2021;- power supply using a solar kit;- the administrative cost (shipping, training and assistance).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":437625.41}]
["Sao Tome and Principe",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR100-STP-Z","Other module","10/30/2019","Other module","Central Africa","Inactive",null,"High","PAI-5640","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSQ/view","617,214.68",0,"A consultant will be recruited as part of the current grant, and will be responsible for reviewing the current status of the health information system (HIS), establishing a road map to implement the software in all districts and a comprehensive budget for the entire process through to rollout of the software. This sum represents the resources required to continue the process.",0,0,0,0,"617,214.68",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"Medium","PAI-5719","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTh/view","1,507,474.16","1,507,474.16","A National Public Health Laboratory (NPHL) was established by Law No. 13/PR/2008 of June 10, 2008, on the creation of a National Public Health Laboratory. The government has provided premises for this laboratory. It is currently in the process of being made operational. Via the German government, G5 Sahel has made a mobile device available to the NPHL. The World Bank is currently purchasing a portion of the equipment.  In order to support the health system strengthening included in the allocation amount, this above-allocation funding request aims to upgrade the NPHL from level 1 to level 2. It is necessary to renovate the premises supplied, to provide capacity building for the NPHL personnel and to supplement the equipment to improve its performance. This intervention is linked to focus point 4 of the DGPL Strategic Plan.The establishment of this laboratory will make it possible to improve quality control for pharmaceutical products and biological analysis at national level.   This intervention will be implemented by the DGPL.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1507474.16}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-4095","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3V/view","27,610.82","27,610.82","A study is expected to be conducted on the impact of HIV within individuals, families and Cape Verdean society in general.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":27610.82}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","Central Africa","Active",null,"High","PAI-3721","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxT/view","73,811","73,811","A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":73811}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-4098","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3Y/view","44,737.96","44,737.96","A study was conducted within the general population in 2017 on knowledge of attitudes towards and practices in connection with methods for preventing malaria and its transmission. Nevertheless, it is essential that an initial study is conducted within migrant population in 2018. It is expected that the KAP study will be carried out again within the general population in 2020 to update these data.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":44737.96}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3735","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxh/view","25,000","25,000","Acquire a PSM class II microbiological safety cabinet hood: The National Reference Laboratory (LNR) is equipped with an old safety hood that has just been out of service for a few months. The consultant sent for his repair recommends the purchase of a new hood. The cost includes transportation and installation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25000}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","HIV care","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3743","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxp/view","4,729,341.26","3,329,341.26","Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.",0,0,0,"1,400,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3329341.26}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","10/30/2019","PMTCT","Central Africa","Inactive",null,"High","PAI-3942","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ12/view","121,466.73",-0.27,"Acquisition of ARVs for 4,909 pregnant women who are HIV positive, reagents and consumables for screening pregnant women and advocacy campaigns directed towards women of childbearing age. This high priority given the low coverage of PMTCT services.",0,0,0,"121,467",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":-0.27}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3730","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxc/view","200,000","200,000","Acquisition, installation and formation of sites for the utilization of LPA technology for National Reference Laboratory (LNR). This cost includes the layout of the laboratory, the purchase of equipment, reagents and consumables, the training of personnel.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":200000}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3681","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwp/view","7,575,400","7,575,400","Activity: Acquire ARVs to fill the GAPTo cover the country's ARV targets for the year 2019 and 2020 on the different categories of PLHIV (Adults, children, PMTCT children and adults, post-exposure prophylaxis).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7575400}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Central Africa","Active",null,"High","PAI-3659","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwT/view","2,443,853","2,443,853","Activity: Acquire reagents for HIV testingThe 2018-2020 grant and other partners (FM, UNICEF, PEPFAR) are planning to acquire HIV testing reagents to cover the various screening tests for $ 165,979.77, with a total requirement of 4,066 730,3USD is a Gaps of 2 443853USDThis funding beyond this will enable the country to reach screening coverage for the different types of Country Target Testing.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2443853}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3648","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwI/view","1,432,738","1,432,738","Activity: Acquire the complement of reagents for the viral load.The 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. This funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1432738}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Administrative and finance data sources","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3664","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwY/view","371,150","371,150","Activity: Acquire the equipment for archiving patient records at the sites of care (mettallic cabinets and files to hang).Patient records must be kept secure and confidential. To do this, each of the 750 care sites needs at least one metallicall cabinet for the preservation of patient records. In addition to the wardrobes, there will be a need for suspends for every patient file estimated at 65,000 PLHIV across the country.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":371150}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"High","PAI-3668","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwc/view","3,139","3,139","Activity: Assure the subscription to the WHO Pharmacovigilance Center (Uppsalla Monitoring Center) to access the VIGIFLOW softwareThe Vigiflow makes it possible to transmit the cases of undesirable events in the international database (VigiBase). The VigiFlow software and the Base are managed by the WHO International Center (Uppsala Monitoring Center). To have access to this software and to be able to transmit the cases, you need a subscription. The subscription fee is 1500 USD per year",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3139}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"Low","PAI-3689","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwx/view","438,366","438,366","Activity: Buy three trucks for active distribution of health inputsThese trucks will be used to transport drugs from CAMEBU to district pharmacies.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":438366}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3665","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwZ/view","1,592,613","1,592,613","Activity: Buying Reagents and Consumables for the Automaton for the Screening of Blood Transfusion Transmitted Disease (GAS) MarkersIn the previous grant, the Global Fund delivered the AUTOMATE with the reagents for only 3 months considered as starting. As these three months have elapsed, for the moment the reagents are broken and the appariel is not operational. These reagents will allow the use of the device for a period of 2 years and this will improve the benefits of the CNTS.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1592613}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3700","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx8/view","36,348","36,348","Activity: Conduct a study on estimating mother-to-child transmission rate of HIVThe estimate of the mother-to-child transmission rate is an indicator of the NHP, the current grant performance framework, but also an indicator of the progress of PMTCT. Until then the indicator was estimated by the Spectrum. In order to obtain an indicator that is as close as possible to the reality of the scope of the interventions we propose to carry out this study which in addition to the transmission rate makes it possible to evaluate the quality, availability and accessibility of PMTCT services.This is a study that will be conducted in 2019 and will cover the entire country according to a methodology that will be proposed by the consultant / firm and validated by the steering committee.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":36348}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3656","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwQ/view","37,992","37,992","Activity: Ensuring a link between AIDS-INFO and central, intermediate and peripheral DHIS 2 levelsThe Server for networking has already been acquired and installed at the level of the PNLS / IST. This link can not be done without all patient records being entered in AIDS-INFO. This amount will enable data entry in AIDS-INFO to update all patient records for an activity queue of 65,000 PLHIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":37992}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3660","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwU/view","10,667","10,667","Activity: Ensuring DHIS2-GIS interconnection for georeferenced data analysis:DSNIS has developed a health map that is interconnected to DHIS2. However, the interconnection stopped at the level of the BDS and BPS coordinates for lack of skills to integrate the geographic coordinates of health facilities. This interconnection requires international consultancy",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10667}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-3687","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwv/view","35,069","35,069","Activity: Ensuring the maintenance of the AUTOMATE (GAS)The CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":35069}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3667","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwb/view","17,535","17,535","Activity: Establish a panel of sera for reagent validation (especially for HIV), HBV and HCV)This activity is done in four (4) steps: sensitization of sites involved in sample collection, sample collection, sample analysis, aliquoting and sample conservation. The sensitization will inform providers about the importance of making this panel and how to do it to obtain good quality samples for the constitution of this panel. This panel will evaluate testing and quality control.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":17535}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Low","PAI-3691","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwz/view","62,000","62,000","Activity: Establishment of a quality control unit for medical devicesThe LNCQM does not perform quality control of medical devices (gloves, condoms, needles and others) .Technical staff does not have experience in quality control of medical devices",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":62000}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3677","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwl/view","433,080","433,080","Activity: Implementation of the LMIS system and its maintenance for 3 years.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":433080}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Improving service delivery infrastructure","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"High","PAI-3675","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwj/view","52,000","52,000","Activity: Maintain viral load and PCR equipmentIn order to ensure the achievement of CVs and PCRs among PLHIV and children born to HIV-positive mothers, machine functionality is a prerequisite.This subsidy is currently being implemented and includes the maintenance of 2 viral load devices for 2019. As in 2020, the OPP-ERA project will be closed, maintenance will be extended on the other 4 Opp-era machines. (Muyinga, ANSS, CHUK, Gitega). For the two Abboth machines, we have a Gap of $ 10,000 a year and for the machines provided by OPP-ERA we have a gap of $ 32,000. This makes a total gap of $ 52,000 for the period from 2019 to 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":52000}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3678","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwm/view","32,221","32,221","Activity: Make a study on the prevalence of HIV-viral hepatitis coinfection.In Burundi, the seroprevalence of HIV-viral hepatitis co-infection is not known because no study has been conducted for the determined. Or, currently, it is well known that viral hepatitis is the main cause of complications in PLHIV where they can have very serious consequences in accelerating the progression of HIV to AIDS disease and vice versa. It is in this context that a seroprevalence survey of HIV-hepatitis co-infection is essential in order to make a global care planning for co-infected PLHIV based on evidence in order to improve the care that is offered to them.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":32221}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Administrative and finance data sources","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3663","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwX/view","605,529","605,529","Activity: Multiply standardized tools for collecting health dataThe unit price of the black and white photocopies of the different houses is 60 Fbu the copy and the binding is 2000 Fbu per document. The standard tools are integrated and are multiplied throughout the grant to reason to have data for different indicators. These are patient records, CPN registers, CPoN, Childbirth, PEC, STA, Lab, CDV, TB / HIV Coinfection. These registries will be multiplied once a year for the 750 sites of care for PLHIV that patients will be multiplied once a year for the PLHIV expected.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":605529}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Low","PAI-3694","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx2/view","40,500","40,500","Activity: Need technical assistance to accompany the quality control laboratory of the drug towards the pre-qualificationThe laboratory is implementing the ISO 17025 standard and is in the process of applying for prequalification by WHO. - The laboratory wants to be prequalified by WHO or accredited. A technical assistant is required to accompany the laboratory to apply the related requirements. He would provide technical coaching to better prepare for evaluations",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":40500}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Medium","PAI-3682","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwq/view","3,822","3,822","Activity: Organization of PLHIV in community solidarity network (supervision, monitoring, legal capacity building).This activity contributes to reducing the socio-economic impact of HIV infectionPromoting / empowering PLHIV through capacity building on cluster management, business learning, micro-project initiation and management will contribute to reducing the socio-economic impact of HIV . It is an activity that will be done through the organization of PLHIV network community solidarity (supervision, monitoring, strengthening legal capacity). It will increase ARV coverage and retention rate.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3822}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3683","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwr/view","65,947","65,947","Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":65947}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3684","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIws/view","27,237","27,237","Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:The DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":27237}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3650","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwK/view","4,350","4,350","Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.This activity aims to reduce new infections by facilitating PS to access prevention and care services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4350}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"Low","PAI-3688","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIww/view","130,925","130,925","Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance planQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":130925}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3701","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx9/view","45,109","45,109","Activity: Organize training sessions on the psychosocial care of children and adolescents living with HIV for providers at ARV sites.This activity, begun during the past grant, will be continued because the low antiretroviral treatment coverage of children and adolescents living with HIV requires special monitoring for this population. The psychosocial care of children and adolescents living with HIV will facilitate the announcement of seropositivity to patients which will increase adherence to treatment and retention rate. Providers will also be able to help strengthen family caring as a strategy to reach more children and adolescents.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":45109}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Central Africa","Active",null,"High","PAI-3702","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxA/view","4,776","4,776","Activity: Organizing at the national level, an advocacy workshop with different actors for LGBT mainstreaming in program design and LGBT interaction with the general population.This activity helps to improve the prevention of HIV / AIDS and STIs among LGBT people and create an enabling environment to facilitate access of this population to prevention and care services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4776}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3692","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx0/view","250,000","250,000","Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structuresCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":250000}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Grant management","10/30/2019","Program management","Central Africa","Active",null,"Medium","PAI-3679","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwn/view","238,919","238,919","Activity: Pay the performance bonuses of the PNLS:This is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":238919}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"High","PAI-3672","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwg/view","7,335","7,335","Activity: Provide formative supervision of 20 pharmacovigilance-trained hospitals and the adverse event reporting systemFormative supervision will involve 10 regional and national hospitals and 10 other district hospitals. The aim will be to evaluate the challenges that arise in the reporting of adverse events while retraining staff on the system of pharmacovigilance in general and the use of reporting tools in particular. This will improve the quality of notifications and promote patient safety.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7335}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3654","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwO/view","173,582","173,582","Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)Nutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyondActivity is related to indicator #: TCS-1 (M)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":173582}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3651","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwL/view","202,134","202,134","Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)This activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":202134}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3652","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwM/view","25,343","25,343","Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25343}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"High","PAI-3671","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwf/view","48,001","48,001","Activity: Provide pharmacovigilance training for providers in 40 district hospitals at 5 per hospitalThis training will enable hospital providers to gain knowledge of the basics of pharmacovigilance and the system for reporting adverse events, which events will be transmitted to the International Vaccine Monitoring Database (VigiBase) for surveillance. The training will be organized at peripheral level for 200 participants at a rate of 25 participants per session for 4 days.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":48001}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3711","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxJ/view","32,834","32,834","Activity:  Provide quarterly supervision missions for quality control of slides and rapid diagnostic tests in health care facilities in the 46 health districts.(i) The allocation amount covers 12 health districts per quarter. Supervision is undertaken in three facilities per mission per health district, covering a maximum of 72 facilities over the year, equivalent to 10 percent of the total. (ii) Additional funding is therefore requested to be able to cover 12 health districts per quarter so as to sample 20 percent of health care facility laboratories each year.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":32834}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Service organization and facility management","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Low","PAI-3699","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx7/view","30,300","30,300","Activity: Provide training to 3 members of the Quantification Committee on the management of the GAS PlanThis training will allow these people to know the tools of quantification and input management.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30300}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3657","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwR/view","762,756","762,756","Activity: Providing sites with support for adequate computer equipment for data managementFor the moment, the CDS make the data entry themselves in DHI2. Field visits show that most CDS have a single laptop. This computer is used for the administrative activities of the CDS. It is necessary that the SIS service of the FOSA who take care of the data regularly has its own computer. In total, we have 750 support structures. In the past grant, the computer support concerned only about 170 structures.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":762756}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Administrative and finance data sources","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3658","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwS/view","8,287","8,287","Activity: Review the tools for collecting HIV dataThe set of HIV tools will be revised by integrating all the indicators of the new strategic plan 2018-2022 and the adequacy of the new guidelines for the care of PLHIV. This will provide data for monitoring the strategic plan. Two workshops of 25 people for 4 days will be carried out inside the country.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8287}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other intervention(s) for general population","10/30/2019","Prevention programs for general population","Central Africa","Active",null,"High","PAI-3670","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwe/view","225,232","225,232","Activity: Security stock of prevention inputs (condom and lubricating gel)The 2018-2020 grant does not provide security stocks for prevention inputs.This funding will allow the country to have a 4-month security stock representing 25% of annual needs. This will prevent any stockouts. For the 2018-2020 grant, the expected input quantities (male condoms, female condoms and lubricant gels) are 26,931,063; 870,979 and 29,938,622 with an aggregate amount of US $ 2,027,089.37.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":225232}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Improving service delivery infrastructure","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"High","PAI-3676","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwk/view","641,923","641,923","Activity: shelf purchase and warehouse upgrades where Global Fund products are stored: District 10 stores upgraded and part of Main Compound",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":641923}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Low","PAI-3698","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx6/view","114,000","114,000","Activity: Strengthen the biological diagnosis of viral hepatitisThe National Laboratory does not have an external maintenance contract for certain equipment. Some lab equipment needs to be serviced by external experts \"",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":114000}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","Central Africa","Active",null,"High","PAI-3703","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxB/view","17,146","17,146","Activity: Strengthen the capacity of men champions (PLHIV) to raise men's awareness of the support and support of pregnant and lactating women for PMTCTThis activity aims to reduce new infections by reducing the transmission of HIV from mother to child.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":17146}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Low","PAI-3696","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx4/view","358,767","358,767","Activity: Strengthen the technical platform of the NPHI National Reference LaboratoryThe National Laboratory needs to expand the range of analysis as a national laboratory to meet the national need. For this, he needs modern and diversified equipment to ensure his missions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":358767}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Low","PAI-3697","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx5/view","60,800","60,800","Activity: Strengthening Quality Assurance at the National Reference Laboratory of INSPThis involves acquiring equipment maintenance contracts (HPLC, Spectrophotometer), equipment calibration with BBN, and participating in the rendering of inter-laboratory test results. This will allow the reliability of the results and ensure the reliability of the results and the performance of the laboratory compared to WHO / Accredited Prequalified Loboratory. This will serve to know if the prescribed drugs are of good quality and have positive effects for the patients.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60800}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Low","PAI-3695","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx3/view","81,828","81,828","Activity: Supply of equipment and materials for microbiological controlThe National Laboratory does not have equipment, consumables and equipment for the microbiological control of drugs. Some molecules require microbiological procedures and can not be controlled in the laboratory.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":81828}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-3686","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwu/view","24,888","24,888","Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:Following the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":24888}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3661","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwV/view","15,600","15,600","Activity: Support DHIS2 hosting for 2 yearsThe DHIS2 is hosted by a house that provides maintenance and regular back up of the base. A contract is signed between the MSPLS and the said house for a monthly amount of US $ 650",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":15600}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3706","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxE/view","1,003,636","1,003,636","Activity: Support for health districts and health provinces in the supervision of malaria-related activities. The costs include per diems, fuel for supervision vehicles and motorcycles used by health districts and provincial health offices, as well as communication costs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1003636}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3653","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwN/view","560,962","560,962","Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)Given the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":560962}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"High","PAI-3669","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwd/view","26,999","26,999","Activity: To train 3 users of DPML on the WHO Pharmacovigilance Software (VIGIFLOW) for two weeksThe training will allow users of VigiFlow software to have basic knowledge of pharmacovigilance and especially the use of VigiFlow to ensure the transmission of adverse event cases to the WHO international base. \"",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":26999}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3662","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwW/view","78,499","78,499","Activity: Train 3 people by BPS, by BDS and by hospitals / CDT on the tracker integrated in the DHIS2 for the follow-up of the tuberculous patient.The DSNIS, in collaboration with the TB program, intends to strengthen the capacities of the BPS, the BDS and the hospitals / CDT (Director, DACS and chief of the nursing) in the follow-up of the CDTs to the use of the integrated tracker in the DHIS2 in 1 mission per quarter for 2 years. Each mission lasts 6 days",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":78499}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Capacity building for health workers, including those at community level","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Central Africa","Active",null,"High","PAI-3673","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwh/view","9,770","9,770","Activity: Train 45 pharmacy managers from 45 districts on HIV / TB drug management in two sessionsThe training will target 46 district pharmacy managers to strengthen them on the rational management of medicines and the supply chain. The training will be done in two training sessions. \"",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9770}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3655","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwP/view","31,197","31,197","Activity: Train 210 users on the AIDS-INFO database at all levelsThe training will be organized for the 210 sites of care of the PVIH by favoring those who have a large active girl. In the current grant we had the budget to train only 100 people. The training will be 30 participants per session for 4 days so a total of 7 training sessions. This activity will improve the monitoring of PLHIV and the quality of the data.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":31197}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Community empowerment for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Central Africa","Active",null,"High","PAI-3649","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwJ/view","43,274","43,274","Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDUThis activity aims to improve the living conditions of key populations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":43274}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3666","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwa/view","40,826","40,826","Activity: Training 210 people in biomedical equipment maintenanceThis training is intended for laboratory technicians. It involves training 210 laboratory technicians for 4 days for the 7 training sessions. This will enable these laboratory technicians to do the preventive and curative maintenance of laboratory equipment. This improves the quality of the analyzes for the follow-up of PLHIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":40826}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Behavioral interventions for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Central Africa","Active",null,"Medium","PAI-3680","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwo/view","31,542","31,542","Activity: Training / retraining Peer Educators of IDUs at the national level on the HIV prevention and harm reduction package related to drug use.This activity helps to improve the prevention of HIV / AIDS and STIs among IDUs and to increase their knowledge of the concepts of HIV prevention and harm reduction.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":31542}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Medium","PAI-3685","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwt/view","12,000","12,000","Activity: Training in quality control of associated molecules (ARV, anti-TB).Training in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12000}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"High","PAI-3674","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwi/view","10,069","10,069","Activity: Training on Good Laboratory Practice (GLP)Since LNCQM's inception, staff have not had this opportunity. To be comfortable when performing tasks all staff must be trained / recycled on this standard",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10069}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Low","PAI-3690","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwy/view","12,000","12,000","Activity: Training on Microbiological Control of DrugsThe training would complete the physico-chemical analyzes of drugs by microbiological analyzes",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12000}]
["Burundi","12/31/2020","HIV/AIDS","FR577-BDI-H","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Low","PAI-3693","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx1/view","12,000","12,000","Activity: Training on preventive maintenance and qualification of the HPLC chainLack of expertise on the qualification of the HPLC chain. No local expertise in this area. It would be good to train 2 units",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12000}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3933","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0t/view",940.41,940.41,"Addressing key populations important.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":940.41}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Behavioral change as part of programs for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Central Africa","Active",null,"Medium","PAI-3788","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyY/view","23,782.96","23,782.96","Although prevalence remains low among adolescents and young people aged 1524, levels of knowledge of prevention measures (61 percent) and access to testing (23.4 percent) remain critical and must be improved. This intervention was not budgeted for within the above allocation amount.It relates to capacity building for young leaders and adolescents to provide quality interventions for other young people and adolescents. This intervention involvesproviding training to 60 young leaders and adolescents and eight facilitators during three two-day sessions on peer education, the package of interventions that are based on a human rights and gender perspective (intervention strategies and SC/BCC) and data reporting tools.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":23782.959999999999}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-5740","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU2/view","121,499.27","121,499.27","Analysis  of  the  range  of  services  in  the  HIV  treatment cascade:Carry out a study to analyze the range of services in the  HIV  treatment  cascade. The results  of  this  analysis  will  make  it  possible  to  analyze  the progress  made  in  relation  to  the  90-90-90  targets  by  2020, through the identification of the shortcomings of each stage of the HIV   treatment   cascade   concerning   the   different   population groups and sub-national units (health regions and districts).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":121499.27}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-5739","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU1/view","168,703.85","168,703.85","Bio-behavioral monitoring surveys:  Conduct a  bio-behavioral study in 2019 to provide information for the impact indicators (percentage of   key   populations   living   with   HIV)   and   effect   indicators (percentage of key populations whoclaim to have used a condom with their latest client/sexual partner) to better assess the impact of the interventions carried out concerning these key populations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":168703.85}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"Medium","PAI-5743","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU5/view","100,512.85","100,512.85","Broadcast adverts on 17 local radio stations within the high-prevalence areas in order to improve the programs performance in terms of TB screening and treatment results in Togo.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100512.85}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other case management intervention(s)","10/30/2019","Case management","Central Africa","Active",null,"Medium","PAI-4031","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2T/view","534,171.25","534,171.25","Care providers will be trained to support the supply of ACT and artesunate as well as supervision at different levels of the health system. The above allocation funding request will enable the gap in drugs to be met and the support activities to be implemented",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":534171.25}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Low","PAI-3802","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIym/view","12,325.22","12,325.22","Coaching and mentoring on ART in civilian prisons by neighboring care facilities(10 days: one experienced prescriber, one CIPEC, one SPECS and a driver).HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. Given the lack of experience of these nurses and the noted organizational difficulties, coaching and mentorship should be organized to improve care quality. This will be undertaken by an experienced prescriber, along with a departmental and national supervisor.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12325.22}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-5737","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTz/view","56,495.34","56,495.34","Community-based activities for sex workers:This  intervention  will  consist  of  capacity  building  for  all  of  the public  and  voluntary  adapted  service  (AS)  providers,  so  as  to create a more favorable environment and thereby encourage the key populations to visit the ASs and other health care facilities, so as to receive better psycho-social and medical care.The  additional  resources  will  make  it  possible  to  organize sessions on topics relating to the MARPs (issues affecting the key populations: stigmatization and discrimination) (EUR 20,868) and leadership of SWs (EUR 29,474).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":56495.34}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-5736","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTy/view","1,960,614.97","1,960,614.97","Condoms and lubricants for key populations: The budget for this intervention will make it possible to prevent HIV infection among sex workers and MSM.-According  to  the  results  of  the  recent  bio-behavioral  study among sex workers (SWs) in 2015, seroprevalence is 11.7%, which   is   significantly   higher   than   among   the   general population  (2.5%,  TDHS  2013-2014).  As  regards  sexual practices, according to the results of the bio-behavioral study, 90%  of  SWs  reported  having  used  condoms  systematically during    their    most    recent    working    week.    Given    this epidemiological situation, SWs have been chosen as priority targets for systematic inclusion in the treatment cascade of the various  HIV  prevention  services.  Thus,  under  the  next  grant for 2018-2020, there are plans for 90% of SWs to receive the minimum  prevention  package  in  2020.    The  sum  allocated permitsonly the acquisition of 7,961,468 units of condoms for SWs, out  of   a  requirement  of  19,903,667.  The  above allocation   resources   to   be   mobilized   will   allow   for   the acquisition of 11,942,000 units of condoms (EUR 1,056,417) and 10,856,546 units of gel (EUR 528,566) for distribution to SWs,  as  part  of  the  range  of  servicesof  the  prevention package.-According  to  the  results  of  the  recent  bio-behavioral  study among   MSM   in   2015,   seroprevalence   is   13%   (Second Generation   Monitoring   Survey   [SGMS],   2015),   which   is significantly higher than among the general population (2.5%, TDHS 2013-2014). According to the same results of the bio-behavioral  study,  74.5%  of  MSM  consider  condoms  as  a means  of  protection  against  HIV  and  68.5%  regularly  used condoms  during  active  anal  sex.  The  statistic  is  71.9%  for passive  anal  sex.  Given  this  epidemiological  situation,  the National Strategic Plan for HIV (2016-2020 NSP) aims for 90% of  the  key  populations  (SWs,  MSM,  IDUs  and  Prisoners)  to adopt less risky behaviors in relation to HIV by 2020. The sum allocated  permitonlythe  acquisition  of  1,422,878  units  of condoms for MSM, out of a requirement of 3,557,196.  Thus, the  above  allocation  resources  to  be  mobilized  will  make  it possible to acquire 2,134,318 units of condoms (EUR 58,209) and  2,134,318  units  of  gel  (EUR  103.912)  for  distribution  to MSM as part of the range of servicesduring the activities for peer education, social involvement and fixed and advanced-mobile strategy.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1960614.97}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-4053","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2p/view","7,992.37","7,992.37","Conduct 6 training/refresher training sessions lasting 3 days at the 4 centers on co-infection management (25 participants: 2 sessions in year 1, 2 sessions in year 2 and 2 sessions in year 3).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7992.37}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-4034","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2W/view","95,756.93","95,756.93","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS for refugees.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":95756.93}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-4033","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2V/view","1,211.99","1,211.99","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS in prisons.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1211.99}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-4035","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2X/view","5,358.39","5,358.39","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS in prisons.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5358.39}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3775","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyL/view","40,887.67","40,887.67","Contribute to the annual three-day regional consultation workshop held by the National AIDS Control Program (NACP) with actors from the departments (CIPEC, Departmental Health Directorate, District Health Management Team), involving 45 participants and 17 drivers:This supports the monitoring of activities by actors on the ground and allows for actors at the intermediary and operational levels to better take ownership of HIV interventions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":40887.67}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3744","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxq/view","47,546.85","47,546.85","Cover the monthly travel costs of facilitators from NGOs working with sex workers: planned for year 3. Travel by actors on the ground working with key populations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":47546.85}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3719","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxR/view","161,830","161,830","Data validation and dissemination activity.Verification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":161830}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Central Africa","Active",null,"Low","PAI-3795","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyf/view","8,418.81","8,418.81","Draw up an annual list of suppliers: This activity allows for the preselection of providers and facilitates the implementation of activities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8418.81}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","National product selection, registration and quality monitoring","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"High","PAI-3727","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxZ/view","46,922","46,922","Drug Registration Support (Cross-Cutting RSS): Drug registration is one of the pillars of drug quality assurance. In the past 3 years, just over 700 drug application files have been filed with the Department of Pharmacy, Medicines and Laboratories (DPML), which acts as the Burundian Agency for Drug Regulation. These files concern both products financed by the Global Fund and essential drugs imported into Burundi. To date, only 200 files have been processed. The requested support will mobilize the probate commission to process the 500 files registered to date at the DPML. Subsequently, the commission will be able to process new files as they arrive.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":46922}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","10/30/2019","PMTCT","Central Africa","Active",null,"High","PAI-5748","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUA/view","118,021.55","118,021.55","Early  HIV  screening  for  newborns  and  community  health care for newborns:-  Increase  the  coverage  of  PCR  testing among children exposed to HIV from 53% to 70% (2020);-Community activities, such as group discussion     sessions,     referral/counter-referral,     capacity building  for  56  HIVpositive  women  from  NGOs  to  lead  the discussion  groups  and  provide  personalized  monitoring  for their    peers ;-Improve adhesion to the PMTCT program among  HIV  positive  mothers  and  their  children.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":118021.55}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Prong 1: Primary prevention of HIV infection among women of childbearing age","10/30/2019","PMTCT","Central Africa","Active",null,"High","PAI-5734","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTw/view","699,585.91","699,585.91","Elimination of Mother to Child Transmission of HIV:In 2016, with the aim of achieving the objectives of eliminating the mother to child transmission of HIV, the NACP introduced the use of HIV/Syphilis DUO test at the sites for the prevention of mother to  child  transmission  of  HIV  (PMTCT).  This  intervention will contribute to achieving coverage of screening for syphilis, one of the certification criteria for Togo for the elimination of mother to child transmission of HIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":699585.91}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Retention and scale-up of health workers, including for community health workers","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Central Africa","Active",null,"High","PAI-3938","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0y/view","77,875.66","77,875.66","Ensure availability of human resources for the provision of services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":77875.66}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other program management intervention(s)","10/30/2019","Program management","Central Africa","Active",null,"Medium","PAI-3777","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyN/view","51,324.21","51,324.21","Ensure the participation of ten actors from the system each year in discussions and seminars:This activity aims to provide actors from the program and from facilities with information on progress relating to HIV and also to allow them to share their experiences with actors from other countries.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":51324.21}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Treatment: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-5733","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTv/view","138,748.74","138,748.74","Equipment for new  MDR-TB  care center  will  improve  iMDR-TB diagnostic    capacity    by    making    it    possible    to    perform bronchoalveolar lavage, induced sputum testing and gastric tubing.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":138748.74}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3741","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxn/view","62,500","62,500","Equipment maintenance (package: 10% of the cost). As the devices come with a one year warranty, it would be worthwhile to purchase a 3 year warranty extension as we did for GeneXpert devices.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":62500}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"Low","PAI-3796","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyg/view","16,821.91","16,821.91","Exchange and working visit with the sex workers network of Cte dIvoire",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":16821.91}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3932","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0s/view","25,709.8","25,709.8","Expansion of diagnostic activities important in as large a part of the country as possible.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25709.8}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3715","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxN/view","330,600","330,600","Extend the technical platform by purchasing radiology equipment and ultrasound scanners. To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, tuberculosis in children, tuberculosis in PLWHA and multidrug-resistant tuberculosis, the PNILT intends to expand the technical platform by purchasing radiology equipment and ultrasound. It should be noted that the main reasons for the poor performance in the reporting of tuberculosis cases are mainly: the insufficiency of a technical platform for the para- clinical diagnosis of TPB- and PET cases (RX, Ultrasound); the difficulty of early diagnosis of TB in PLWHIV by lack of effective diagnostic means (GeneXpert); the absence of policies / strategic approach directed at vulnerable and vulnerable groups: prisoners, refugees, Batwa, children, PHAs (screening), the weak investigation of cases contacts TPB +.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":330600}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other case management intervention(s)","10/30/2019","Case management","Central Africa","Active",null,"Medium","PAI-3968","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1S/view","665,209.29","665,209.29","Failure to follow guidelines on case management of malaria by health providers is a major challenge to achieving program objectives. This situation is linked to the lack of mastery of certain providers of good practices  in  terms  of  taking charge  and  also to  the  low  capacity of pharmacy clerks  to ensure a permanent  availability of quality rapid diagnostic tests (RDTs) and  anti-malarials.  In addition, there is a poor quality of microscopic examinations and interpretation of TDR results. Planned activities will improve the  management of malaria  through quality control and quality assurance activities for diagnosis,  training of health personnel  for proper management of malaria inputs and adverse effects. Thus, diagnostic coverage in the general population will be improved from 78% to at least 95% and free treatment from 52% to at least 95% by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":665209.29}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other case management intervention(s)","10/30/2019","Case management","Central Africa","Active",null,"Low","PAI-3961","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1L/view","2,677,508.7","2,677,508.7","Failure to follow guidelines on case management of malaria by health providers is a major challenge to achieving program objectives. This situation is linked to the lack of mastery of certain providers of good practices  in  terms  of  taking charge  and  also to  the  low  capacity of pharmacy clerks  to ensure a permanent  availability of qualityrapid diagnostic tests (RDTs) and  anti-malarials.  In addition, we found poor quality of microscopic examinations and interpretation of TDR results. Planned activities will improve the  management of malaria  through quality control and quality assurance activities for diagnosis,  training of health personnel  for proper management of malaria inputs and adverse effects. Thus, diagnostic coverage in the general population will be improved from 78% to at least 95% and free treatment from 52% to at least 95% by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2677508.7000000002}]
["Sao Tome and Principe",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR100-STP-Z","Indoor residual spraying (IRS)","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-5642","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSS/view","831,143.53","634,782.85","Focalized spraying planned for 2020, but due to lack of funds, we are requesting this important support in the PAAR. The amount requested in the PAAR for effective implementation of IRS in 2020 will cover procurement of insecticide, transport, storage, payment of sprayers and operating costs.",0,0,0,0,"196,360.68",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":634782.85}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-4023","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2L/view","39,277.3","39,277.3","For good adherence to treatment, pharmacovigilance should monitor the occurrence of adverse reactions in order to report these for more in-depth research. Since the process initiated in 2012 with R8 funding was not continued, the above allocation funding request will support this pharmacovigilance through the General Directorate of Pharmacies, Laboratories and Drugs. The expected impact of this module will be a reduction in the malaria mortality rate.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":39277.300000000003}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-4104","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3e/view","58,289.75","58,289.75","For the TB/HIV component, a study is expected to be carried out in 2020 to update the bio-behavioral data for key HIV populations (sex workers, drug users and men who have sex with men).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":58289.75}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3716","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxO/view","10,463","10,463","Former activity n  63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validatedBurundi has a total of 11 prisons with infirmary.With the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10463}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3732","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxe/view","30,355","30,355","Gap to be filled in relation to the activity on the provincial coordination TB / HIV:The frequency of holding TB / HIV coordination meetings is quarterly.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30355}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Institutional capacity building, planning and leadership development","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"High","PAI-3713","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxL/view","296,091","296,091","General training in all sectors (malariology, monitoring and evaluation, finances and community health workers). This is a range of vital training to strengthen the program which has not been funded under the allocation amount. In particular, it involves (i) an international malariology course for two people each year, which is vital for strengthening the malaria response; (ii) training at the international level in the monitoring and evaluation of malaria response programs, given in Ouagadougou or Senegal; (iii) training at the international level in financial management; (iv) refresher training for community health workers providing iCCM in the health districts funded by the Global Fund, planned for 2019.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":296091}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Low","PAI-3801","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyl/view","25,650.32","25,650.32","Give each care facility a means of communicating so that they may offer differentiated services (to communicate results, make appointments and undertake follow-up) (One smartphone per facility costing 100,000 CFA francs each, for 150 facilities) In December 2016, Benin adopted the test and treat approach and anticipates a substantial increase to the active file, placing increased pressure on the health system. To prepare for this, the country changed the schedule for dispensing ARVs to every three months, and every six months for medical consultations. To ensure the quality of care while empowering patients, the country plans to establish a system for communication between health workers and patients to deliver results, make appointments and undertake remote follow-up.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25650.32}]
["Benin","12/31/2020","Malaria","FR410-BEN-M","Private sector case management","10/30/2019","Case management","Central Africa","Active",null,"High","PAI-3814","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyy/view","801,942.54","801,942.54","Given the contribution of the private sector (20.7%) in the attendance of health services (SNIGS 2015), it is proposed to continue activities started in the 2016-2017 grant and the partnership between the PNLP and the Private Sector Platform (PSB). This will improve the quality of malaria management through training / supervision of stakeholders, dissemination of care / prevention protocols, reporting of data, provision of subsidized inputs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":801942.54}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Treatment adherence","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-4091","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3R/view","136,296.71","136,296.71","Good adherence to antiretroviral treatment is key condition for the suppression of a patients viral load. Therefore, it is intended to appoint 12 mediators in 10 health facilities with the largest volume of patients.  The role of these mediators will include provision of counseling to people living with HIV newly tested positive, providing them with information on treatment and provide adherence support.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":136296.71}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Condoms as part of programs for general population","10/30/2019","Prevention programs for general population","Central Africa","Active",null,"Low","PAI-4099","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3Z/view","295,043.21","295,043.21","HIV is transmitted during unprotected sex. In this regards, this investment is to acquire 9,000,000 condoms (total for 3 years) to prevent the transmission of HIV and other STIs within the populations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":295043.21000000002}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3798","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyi/view","63,712.27","63,712.27","HIV surveillance survey among pregnant women: this is an important activity for epidemiological surveillance and also for SPECTRUM projections. This activity has been undertaken for more than 20 years.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":63712.27}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR558-COG-C","Prong 3: Preventing vertical HIV transmission","10/30/2019","PMTCT","Central Africa","Inactive",null,"High","PAI-4045","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2h/view","1,178,681.41",-1.164153218E-10,"HIV testing for pregnant women in Antenatal clinics and treatment of additional 4,807 HIV positive pregnant women by 2020 (48% of estimated PMTCT needs at national level);",0,0,0,"335,000","843,681.41",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":-1.164153218E-10}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-5708","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTW/view","51,324.21","51,324.21","HIV treatment cascade service analysis surveyThe aim is to determine the extent to which the 90-90-90 targets have been achieved, together with the explanatory factors and bottlenecks relating to performance. This will require the following, specifically:- establishing the performance development profile for medical health care and the PMTCT;- determining the current treatment cascade and suggesting its development trend;- determining the current PMTCT cascade and suggesting its development trend;- identifying and analyzing success factors and bottlenecks of the cascade;- proposing modeling scenarios for development trends up to 2022.The costs stated here are historic costs linked to previous grants.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":51324.21}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Medium","PAI-3771","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyH/view","59,423.18","59,423.18","Hold 18 five-day training sessions for 450 doctors and paramedics in care facilities on pediatric care (25 participants, three trainers and one supervisor per session), following the new World Health Organization recommendations:This activity aims to improve pediatric care.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":59423.18}]
["Gabon","12/31/2021","Tuberculosis","FR42-GAB-T-01","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-4260","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6A/view","164,726.74","164,726.74","i) To create 12 new CDTs to increase TB notification rates and decrease rate of loss to follow up in 4 regions (Woleu Ntem, Ogooue Ivindo, Haut Ogooue, Ngouni and Nyanga)  ii) To secure the supply of first-line drugs for at least the first two (2) years.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":164726.74}]
["Gabon","12/31/2021","Tuberculosis","FR42-GAB-T-01","Grant management","10/30/2019","Program management","Central Africa","Active",null,"High","PAI-4263","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6D/view","409,460.22","409,460.22","i) To support five (5) community relays in the four regions to refer suspected cases in the community to the 12 CDTs for testing, ensure adherence treatment and prevent loss to follow up.ii) To strengthen the capacities of the national coordination of the TB program, such as the staffing of the monitoring and evaluation service in computer equipment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":409460.22}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3746","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxs/view","17,894.74","17,894.74","Implement a network for sex workers associations in Benin:iInterventions that aim to provide more space and more capacity for the sex workers network to improve their involvement in the national response.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":17894.740000000002}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"High","PAI-3714","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxM/view","328,510","328,510","Implementing the following innovative strategies to combat malaria:(i) A communication strategy in primary schools; (ii) Outreach communication for the Batwa community; (iii) The production of communication media and contracts with the media: Expected outcomes: This budget is requested as part of efforts to strengthen communication in order to provide regular guidance for the population on the correct use of LLINs and the early use of health care services. The activities relate to procuring communication media and contracts with the media, such as mobile telephone companies.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":328510}]
["Togo","12/31/2020","Malaria","FR111-TGO-M","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-5729","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTr/view","1,402,760.63","1,402,760.63","In 2016, the MoH started a national rollout of DHIS 2 in all its 40 health districts. A roadmap for this was drawn up and is currently being implemented with funding from the World Bank and technical assistance from AEDES. In accordance with the national health development plan (2017-2022) the scale-up of DHIS2 will be completed in 2018 and expanded at community level during the NFM2 in partnership with the GF. The funding request will support the reproduction of standardized tools for data collection including at community level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1402760.63}]
["Benin","12/31/2020","Malaria","FR410-BEN-M","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Central Africa","Active",null,"Low","PAI-3820","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz4/view","196,762.43","196,762.43","In order to achieve the objectives assigned to it, to improve its performance in terms of financial management, administrative and to be up to standard, the NMCP plans to upgrade its staff.The different training courses proposed in this funding match the needs according to the profile of the agents available for the implementation of the program's activities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":196762.43}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-3708","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxG/view","17,037,235","12,166,628","In order to comply with the TRPs decisions, the Integrated National Malaria Program (iNMCP) asked the Global Fund to finance for the 20182020 period the 11 health districts already validated by the TRP in 20162017 (not included in the grant due to budget constraints).  This budget is required to cover: (i) Supply costs, (ii) Implementation costs,(iii) Technical assistance, for IRS activities in 11 health districts.  The total requested budget for IRS is US$ 17,037,235, of which US$ 6,787,954 is for the four health districts covered by the Global Fund under the NFM, and US$ 10,249,281 is for the other seven health districts requiring resistance management.CT update (Aug. 2018): The country has been awared 4.9m USD to implement IRS in the 4 districts previously supported by the GF.",0,0,0,"4,870,607",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12166628}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Low","PAI-4050","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2m/view","1,009,987.66","1,009,987.66","In the absence of recent data at the national level and in the face of the heavy burden of HIV/TB co-infection in Congo Brazzaville, this survey should reveal the hospital mortality level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1009987.66}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-5707","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTV/view","1,292,844.25","1,292,844.25","In view of the under-reporting, this request includes a plan to carry out active screening for cases of tuberculosis among prisoners, refugees/displaced persons, nomads and children in the malnutrition treatment centers (TNUs) using 2 trucks equipped with screening and diagnostic resources (x-ray and GeneXpert). This active screening will be organized biannually, in accordance with specific focus points (see the supervision focus points). During the screening campaigns, all suspected cases of TB or MDR-TB will initially receive a chest x-ray and those exhibiting symptoms of TB will be given a GeneXpert examination to confirm the diagnosis. In addition, HIV screening will be carried out among these populations. Advocacy sessions will be carried out prior to and during these campaigns. The campaign team will be composed of: 1 x-ray operator, 1 laboratory technician, 1 health-care worker and 1 driver.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1292844.25}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Grant management","10/30/2019","Program management","Central Africa","Active",null,"High","PAI-3934","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0u/view","2,958,424.42","2,514,661.65","Increase treatment coverage and expand prevention services beyond the stated priority districts the allocation will support additional program management costs.",0,0,0,0,"443,762.77",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2514661.65}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3740","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxm/view","25,900","25,900","Installation and handling (operator training) for all equipment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25900}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3728","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxa/view","150,000","150,000","Installation and implementation of GxAlert (or similar system) / networking of GeneXpert devices: The PNILT has acquired 18 GeneXpert devices from the Global Fund, which it has installed on strategic sites throughout the country. These devices were added to 6 acquired with funding from the World Bank, a fleet of 24 devices in total. To achieve the full value of the investments made in Xpert, the results must be transmitted from the machine to the service provider in a timely manner. However, xpert results are currently reported on paper. This reporting system is time consuming and limits the potential for optimizing patient care and management.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":150000}]
["Chad","6/30/2021","Malaria","FR550-TCD-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-5722","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTk/view","13,715,315.31","3,578,444.03","LLIN mass distribution campaigns represent the most important vector control strategy. With the exception of the desert region in the far north, all other regions are eligible for this strategy, i.e. 19 out of the 23 regions. The Global Funds continuous financial support resulted in carrying out 3 campaigns in the country at a regular interval of 3 years (2011, 2014 and 2017). These, respectively, allowed covering 44%, 73% and 69.1% of the total population of the country. The support provided by the government and other partners was very limited, and resulted in covering only one region in 2011 (Logone Occidental: 6.2% of the population) and 3 regions in 2014 (Batha, Ouaddai and Barh El Gazel: 12.7%). The 2017 campaign was possible only thanks to the support of the Global Fund. The next mass distribution campaign is planned in 2020. Due to reduced resources allocated to the country by the Global Fund for the Malaria Grant, only 6 regions (Tandjil, Logone Oriental, Mandoul, Moyen Chari, Salamat and Lac) will benefit from the next campaign. This represents 31.3% of the total population living in endemic regions. Conscious of the importance of the mass campaign for malaria prevention, and in order to avoid a resurgence of cases in the 13 regions that have already benefited from mass campaigns in 2017, the country wishes to sustain the gains. The requested amount will provide 3,931,586 LLINs, cover for logistics and other operational costs to carry out the campaign in 7 regions with 6,433,505 inhabitants (37.8% of the population of the malaria endemic regions). This will ensure that all 13 regions that were covered by the 2017 mass distribution campaign supported by the Global Fund will benefit from the 2020 mass distribution campaign.",0,0,0,"10,136,871.28",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3578444.03}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Grant management","10/30/2019","Program management","Central Africa","Active",null,"Medium","PAI-5738","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU0/view","247,901.47","247,901.47","Maintenance of the automobile fleet:The  implementation  of  the  various  activities  requires  greater logistical  availability.  Maintenance  of  the  rolling  stock  and  the cohesion   among   stakeholders   are   becoming   imperative   for achieving the objectives. This resource will make it possible to keep the automobile fleet in good condition and to support the program and the other services in the coordination of the grant activities concerning the response to HIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":247901.47}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other program management intervention(s)","10/30/2019","Program management","Central Africa","Active",null,"High","PAI-3967","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1R/view","56,110.43","56,110.43","Malaria control strategies are evolving at the global level, given the innovations in this area. To this end, the Program will undergo several phases  of  change  in  program  and  financial management  policies  and  procedures.  For example, NMCP is  considering assessments of current  strategies,  revision  of  the  national strategic  plan,  capacity  building  of  staff  in different areas of specialization and updating of  normative  documents.  To  this  end,  all normative  documents will be up to date and at least  80%  of  the  qualified staff in the specialties  required  for  the  performance of their duties.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":56110.43}]
["Benin","12/31/2020","Malaria","FR410-BEN-M","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3817","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz1/view","68,432.27","68,432.27","Mandatory test that follows mass distribution campaigns and provides information on the effectiveness of distributed LLINs, it also guides the choice of LLINs for subsequent campaigns, and the next one is for 2020. It is therefore necessary that this monitoring be carried out as recommended by the international scientific committee. The NMCP must therefore carry out these studies in 2019 and 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":68432.27}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3717","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxP/view","28,224","28,224","Meeting of TB coordinators. It aims to anticipate possible blockages in order to improve the performance of the implementation of the TB grant. It is planned once a quarter.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":28224}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","Central Africa","Active",null,"High","PAI-4100","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3a/view","42,331.95","42,331.95","Men who have sex with men represent a key population in the fight against HIV. The proposed activities are linked to interventions that will be conducted in the community and to training. These will complement activities that have already been taken into account in the allocation amount.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":42331.95}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"Low","PAI-3805","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyp/view","19,052.86","19,052.86","Mobilize therapeutic assistants via two DAT consultants to draw up the community care strategy. With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":19052.86}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Low","PAI-3797","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyh/view","243,274.6","243,274.6","Monitor the care provided at each facility on a quarterly basis: One medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":243274.6}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Treatment: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3724","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxW/view","170,205","170,205","Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":170205}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Treatment: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-5741","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU3/view","476,537.99","476,537.99","Nutritional support and transport fees for MDR-TB patients.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":476537.99}]
["Benin","12/31/2020","Tuberculosis","FR300-BEN-T","Treatment","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3824","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz8/view","342,159.13","342,159.13","Objective : To reduce the fatality rate of TB patients who have any other associated comorbidities (HIV, Diabetes, Anaemia, Viral hepatitis B and C). The mortality rate is 14% among TB/HIV co-infected patients vs 6% for all patients. A well-equipped technical block will be established at the main hospital in Cotonou, treatment protocols will be created and disseminated in all treatment centers. As part of the quality assurance policy, a portable spectroscope and a highperformance liquid chromatograph will be procured to ensure more regular monitoring of the quality of anti-tuberculosis medication.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":342159.13}]
["Benin","12/31/2020","Tuberculosis","FR300-BEN-T","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3830","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzE/view","61,537.43","61,537.43","Objective: to conduct an evaluation of the catastrophic costs borne by the patients and their households, for the introduction of appropriate measures (WHO protocol: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/ meetings/tf6_background_5a_patient_cost_surveys_protocol.pdf).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":61537.43}]
["Benin","12/31/2020","Tuberculosis","FR300-BEN-T","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-3831","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzF/view","67,332.51","67,332.51","Objective: to conduct research work on the mathematic modelling of the transmission of tuberculosis in Benin, to obtain a better estimate of the number of cases of tuberculosis in the population, in partnership with the University of Liverpool and the National University Hospital Centre for Pneumo-Phthisiology in Cotonou.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":67332.509999999995}]
["Benin","12/31/2020","Tuberculosis","FR300-BEN-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3825","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz9/view","1,223,560.77","1,223,560.77","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1223560.77}]
["Benin","12/31/2020","Tuberculosis","FR300-BEN-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3826","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzA/view","1,831,875.21","1,831,875.21","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1831875.21}]
["Benin","12/31/2020","Tuberculosis","FR300-BEN-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3827","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzB/view","290,834.92","290,834.92","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":290834.92}]
["Benin","12/31/2020","Tuberculosis","FR300-BEN-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3828","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzC/view","85,540.34","85,540.34","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":85540.34}]
["Benin","12/31/2020","Tuberculosis","FR300-BEN-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3829","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzD/view","102,647.29","102,647.29","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":102647.29}]
["Central African Republic","12/31/2020","Malaria","FR630-CAF-M","Integrated community case management (ICCM)","2019-04-12","Case management","Central Africa","Active",null,"High","PAI-6197","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnJ/view","514,827","514,827","One of the strategies that will strengthen real-time malaria case management is the creation of Malaria Points (palu points) with MSF's technical support within their areas of intervention. This strategy will increase the demand for services at the community level and consequently the demand of commodities. The number of palu points managed by MSF is 78 with an average monthly consumption of 420 doses of ACTs. The total estimated dose is therefore 589,680 (including a 6-month buffer stock). The procurement of these inputs (EUR 272,974.67) also requires the estimation of transport and insurance costs from the supplier / manufacturer to Bangui, which were estimated to raise EUR 185,788.This gives an overall budget of EUR 458,762.67 for this intervention.","458,762.67",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":514827}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3731","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxd/view","150,000","150,000","Operational research on the use of oral forms in the treatment of MDR-TB. Development of an operational research protocol and conduct over a period of 3 years operational research on \"the tolerance and effectiveness of a short treatment 9 months without injectable for patients with MDR-TB. \"The overall goal of the project will be to evaluate the treatment outcomes and adverse effects of a new 9-month, non-injectable, short-course regimen for MDR-TB.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":150000}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Central Africa","Active",null,"Medium","PAI-4042","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2e/view","117,831.89","117,831.89","Organize 2 training/refresher training sessions lasting 5 days for 80 heads of TTC (2 nurses per TTC) on TB treatment for adults and children (including drug management), with 4 training centers in years 1 and 2.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":117831.89}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"Medium","PAI-3778","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyO/view","86,716.42","86,716.42","Organize a consultation meeting between the various actors from NGOs working with sex workers(based on 25,758 actors each year for the three years): This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":86716.42}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"Low","PAI-3806","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyq/view","11,883.07","11,883.07","Organize a meeting to validate the community care strategy:(45 participants)With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11883.07}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","Central Africa","Active",null,"Medium","PAI-3781","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyR/view","4,585.34","4,585.34","Organize a quarterly consultation meeting between the various actors from NGOs working with prisoners:Planned for year 3. This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4585.34}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-4040","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2c/view","7,309.2","7,309.2","Organize a six-day training workshop in Brazzaville for 12 participants from the four GeneXpert centers on the use of GeneXpert, culture and sensitivity tests in year 1.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7309.2}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","HIV testing services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3747","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxt/view","52,692.18","52,692.18","Organize a six-monthly community-based screening campaign among sex workers, under the supervision of adapted services and NGOs to de-medicalize screening and provides better access to the service for sex workers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":52692.18}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Grant management","10/30/2019","Program management","Central Africa","Active",null,"Low","PAI-3792","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyc/view","27,971.05","27,971.05","Organize a six-monthly, ten-day mission to validate the financial documents and accounts of NGOs and the six CIPEC from the previous six-month period (two teams of four people: one manager, one accountant, one fiduciary management agency and drivers):This activity aims to improve the quality of accounts and prevent ineligible amounts.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":27971.05}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Grant management","10/30/2019","Program management","Central Africa","Active",null,"Medium","PAI-3774","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyK/view","27,971.05","27,971.05","Organize a six-monthly, ten-day mission to validate the use of rapid diagnostic tests in the activities in the following six-month period (two teams of four people: one manager, one accountant, one monitoring and evaluation specialist and one driver):This activity facilitates the implementation of activities, particularly at the CIPEC level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":27971.05}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Low","PAI-3804","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyo/view","11,883.07","11,883.07","Organize an advocacy meeting on the community care strategy: With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system. It is important to involve all actors in defining the basis for community involvement.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11883.07}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Addressing stigma, discrimination and violence against people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","Central Africa","Active",null,"Medium","PAI-3767","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyD/view","18,758.84","18,758.84","Organize an annual two-day information meeting of 40 actors from the Ministry of Health and the Ministry of Justice on interventions in the prison system: This activity is planned to raise awareness among actors from the Ministries of Justice and Health so as to increase the impact of HIV interventions on prisoners.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":18758.84}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","Central Africa","Active",null,"High","PAI-3762","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy8/view","126,598.59","126,598.59","Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)The residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":126598.59}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-4041","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2d/view","7,283.54","7,283.54","Organize one training session (doctors, nurses and laboratory technicians) on MDR-TB treatment in Brazzaville for 20 people.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7283.54}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Grant management","10/30/2019","Program management","Central Africa","Active",null,"Medium","PAI-3772","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyI/view","24,225.12","24,225.12","Organize quarterly five-day missions to validate the accounts of private clinics for the payment of services, undertaken by two teams of three people:This activity aims to improve the quality of accounts and prevent ineligible amounts.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":24225.119999999999}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-5742","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU4/view","42,677.59","42,677.59","Organize the final evaluationof the NSP 2015-2020 in 2019 with the support of two consultants (one national and one international) for a sum of EUR 12,191-Developthe NSP 2021-2026 in 2019 with the support of two consultants (one national and one international) for a sum of EUR 25,839.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":42677.59}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Medium","PAI-3770","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyG/view","19,066.32","19,066.32","Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):Improvement of the biological monitoring of people living with HIV (PLHIV).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":19066.32}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3745","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxr/view","30,837.17","30,837.17","Organize training/refresher training sessions for peer educators working with sex workers: planned for year 3. This intervention will build the capacities of peer educators for holding awareness-raising sessions addressing the target populations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30837.17}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Service organization and facility management","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"Medium","PAI-3766","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyC/view","75,035.35","75,035.35","Organize two six-monthly consultation meetings per year for each region (north and south), a total of four two-day meetings of 40 people, including actors from treatment and prevention of mother-to-child transmission (PMTCT) facilities:This activity should allow for the sharing of experiences and good practice, as well as any difficulties encountered so that they may be resolved.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":75035.350000000006}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3751","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxx/view","53,582.09","53,582.09","Organize workshops on establishing ARV treatment adherence clubs in each care facility with the support of the Benin Action Network for People living with HIV (ReBAP+) and care facilities (to reduce the number of appointments at care facilities for stable patients receiving treatment).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":53582.09}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Central Africa","Active",null,"Low","PAI-3794","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIye/view","4,002.92","4,002.92","Other external services. This intervention comprises two activities that were not budgeted for in the last three quarters of the final year (2020):-The provision of a driver to the Executive Secretariat of the National AIDS Committee so that it may implement and monitor activities on the ground (management of the National AIDS, Tuberculosis, Malaria, STIs and Epidemics Committee driver) (2,744)-Support for the costs of a monitoring and evaluation intern (60,000 CFA francs per month for three years) to promote learning among adolescents and young people (823)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4002.92}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Institutional capacity building, planning and leadership development","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"High","PAI-3712","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxK/view","49,614","49,614","Partner coordination/policy drafting and dissemination The budget is intended for (i) partner coordination meetings, particularly transnational meetings, and strengthening the coordination of the private sector not addressed by other partners; (ii) a fund mobilization meeting; (iii) meetings to draw up plans of action and annual and six-monthly reports. The needs for 2018 are covered.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":49614}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Grant management","10/30/2019","Program management","Central Africa","Active",null,"Low","PAI-3793","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyd/view","92,382.45","92,382.45","Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):This will motivate actors at the peripheral level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":92382.45}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","Central Africa","Active",null,"High","PAI-3748","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxu/view","27,715.18","27,715.18","Pay allowances for facilitators from NGOs working with prisoners: planned for year 3. Remuneration for actors on the ground working with prisoners.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":27715.18}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","Central Africa","Active",null,"High","PAI-3749","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxv/view","5,542.59","5,542.59","Pay the travel costs of facilitators from NGOs working with prisoners: planned for year 3. Travel by actors on the ground working with prisoners.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5542.59}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3966","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1Q/view","841,692.29","841,692.29","Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":841692.29}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3971","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1V/view","163,372.24","163,372.24","Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":163372.24}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Grant management","10/30/2019","Program management","Central Africa","Active",null,"High","PAI-3720","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxS/view","30,183","30,183","Performance bonuses.The motivation of the staff is essential to maintain the achievements and safeguard the performance of the ProgramThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30183}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","HIV care","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-5746","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU8/view","2,211,534.06","2,211,534.06","Pre-treatment assessments and biological monitoring.2Biological assessments make it possible to determine the suitable treatment  scheme,  monitor  the  effectiveness  and  safety  of  the treatments and, consequently, to improve the quality of life of the patients.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2211534.06}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3729","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxb/view","80,000","80,000","Prevalence and anti-tuberculosis drug resistance study: The PNILT is preparing for the start of the TB drug resistance survey. On the basis of this review, a detailed budget was agreed between the PNILT, the Global Fund and Damien Action, which provides technical support and project management. The preparatory activities have already started as, among other things, the validation of the study protocol by the National Technical Committee.  The requested budget will complete the existing budget and bring the overall budget of the study to USD 251,838 (the existing USD 171,838 and a gap of USD 80,000).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":80000}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Behavioral interventions for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Central Africa","Inactive",null,"High","PAI-3944","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ14/view","39,758.73",0,"Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.",0,0,0,0,"39,758.73",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Community empowerment for MSM","10/30/2019","Comprehensive prevention programs for MSM","Central Africa","Inactive",null,"High","PAI-3943","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ13/view","60,562.23",0,"Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.",0,0,0,0,"60,562.23",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Prong 1: Primary prevention of HIV infection among women of childbearing age","10/30/2019","PMTCT","Central Africa","Active",null,"High","PAI-5718","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTg/view","953,877.23","953,877.23","Prevention and health care for HIV/early marriage/GBV among adolescents aged 10-19 and young women aged 20-24. This intervention will make it possible to carry out structural activities relating to early marriage and GBV, community screening and counseling, psycho-social health care for cases and the participation of adolescents and young women through the Ureport and Upartner platform. Strengthening the young peoples network, in particular the monitoring of adolescents living with HIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":953877.23}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Prevention for MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3931","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0r/view","126,116.04","126,116.04","Prevention of MDR-TB highly relevant to prevent escalation of the MDR-TB situation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":126116.04}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-4036","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2Y/view",519.32000000000005,519.32000000000005,"Procure 6 GeneXpert machines: 6.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":519.32000000000005}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-4037","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2Z/view","24,474.65","24,474.65","Procure 6 UPS 3000 VA - 210V for GeneXpert (Gdf diagnosis no. 106081).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":24474.65}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-4038","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2a/view","12,237.32","12,237.32","Procure 06 GeneXpert printers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12237.32}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Low","PAI-3800","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyk/view","68,431.15","68,431.15","Procure 100 extra cupboards for care facilities that have not yet been equipped:(610 per cupboard)During the first part of the grant, 43 cupboards with shelves were procured for care facilities to improve storage conditions for ARVs. The intention is to procure more for the remaining facilities and for the new facilities that will be set up.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":68431.149999999994}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-3799","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyj/view","171,079.56","171,079.56","Procure 125 desktop computers and printers for care facilities:The availability of IT equipment will improve the follow-up of the active file and medical files  monitoring software (ESOPE) and dispensing software (Mdistock).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":171079.56}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-4039","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2b/view","2,348.75","2,348.75","Procure 190 cartridge kits for GeneXpert MTB/RIFGDF diagnosis CGXMTB-RIF-50 in years 1, 2 and 3.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2348.75}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Condoms and lubricant programming for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3750","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxw/view","90,107.73","90,107.73","Procure male condoms for sex workers: planned for year 3.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":90107.73}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-3807","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyr/view","360,415.22","360,415.22","Procure tablets to record the biometric data of PLHIV (to avoid duplication and ensure the procurement of biological services is well documented) and contract Internet services for facilities",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":360415.22}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-5710","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTY/view","51,324.21","51,324.21","Program Review HIV, Epidemiology and Impact AnalysisThis review will assess the performance, impact, quality and effectiveness of HIV programs and link program funding, scaling up interventions and disease trends through systematic plausibility analysisThe costs provided here are historical costs related to past grants",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":51324.21}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-4051","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2n/view","25,699.92","25,699.92","Provide 2 training/refresher training sessions to 50 community liaison workers and community leaders in Brazzaville.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25699.919999999998}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-4052","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2o/view","19,163.65","19,163.65","Provide 3-day training/refresher training sessions to 25 members of associations of cured TB patients and NGOs/liaison workers on community DOTS.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":19163.650000000001}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","Central Africa","Active",null,"High","PAI-3765","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyB/view","146,149.7","146,149.7","Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":146149.70000000001}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3812","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyw/view","197,597.35","197,597.35","Provide monthly remuneration for facilitators and peer educators from NGOs working with sex workers: planned for year 3. Remuneration for actors on the ground working with key populations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":197597.35}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3723","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxV/view","4,069","4,069","Purchase a teleconference device.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4069}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3725","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxX/view","501,858","501,858","Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":501858}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3726","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxY/view","160,535","160,535","Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":160535}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3737","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxj/view","5,000","5,000","Purchase of 2 power generators 5KVA energy source for 2 mobile radiology devices for use on sites without power source (cost includes transport if imported).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5000}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3736","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxi/view","100,000","100,000","Purchase of 2 vehicles to transport digital radiology devices to screening sites.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3738","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxk/view","33,995","33,995","Purchase of 6 Horizon G2 laser reprograms codonics: These are devices for printing X-ray images produced by the 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile X-ray devices).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":33995}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3739","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxl/view","12,996","12,996","Purchase of 6 kits of 500 codicon films in 3 sizes: These are films for printing radiology radiographs produced by 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile radiology devices).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12996}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3742","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxo/view","90,000","90,000","Purchase of 9 ultrasound machines with accessories. The mapping of ultrasound machines performed in 2016 showed a need for 9 devices instead of 11. The purchase of these devices completes the technical platform so to strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA, the diagnosis of multidrug-resistant tuberculosis.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":90000}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3733","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxf/view","520,200","520,200","Purchase of 17 vehicles and their insurance.Supervision is a priority activity in the fight against tuberculosis. The available supervision vehicles are old and most of them were acquired more than ten years ago. With depreciation and rugged terrain, repair costs become more and more huge.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":520200}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","HIV care","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-5744","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU6/view","5,591,384.81","1,005,744.38","Purchase of ARVs for People Living with HIV (PLHIV). In  order  to maintain the upscaling dynamic implemented under the NFM, and in  accordance  with  the  objectives  of  the  NSP/acceleration  plan, this  intervention  will  make  it  possible  to  place  67,031  patients (67%)  on  treatment  in  2018,  73,112  (73%)  in  2019  and  78,691 (79%) in 2020.",0,0,0,"734,200.43","3,851,440",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1005744.38}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3722","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxU/view","68,600","68,600","Purchase of computer equipment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":68600}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Medium","PAI-3782","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyS/view","35,926.38","35,926.38","Quarterly supervision of adherence clubs by ReBAP+ and the NACP:The establishment of adherence clubs requires regular monitoring by ReBAP+ and the program during the first few years.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":35926.379999999997}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Behavioral interventions for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Central Africa","Active",null,"High","PAI-5735","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTx/view","62,517.11","62,517.11","Range of services for IDUs:  (i)  minimum  prevention  package  and, (ii) establishment of a needle exchange program (a new syringe in exchange for a used syringe) , so that IDUs adopt less risky sexual behavior and safer behavior regarding injection.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":62517.11}]
["Congo","12/31/2020","Tuberculosis","FR606-COG-T","Treatment: MDR-TB","2019-06-11","MDR-TB","Central Africa","Active",null,"High","PAI-6123","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcA/view","391,999.78","391,999.78","Regimen Change: introduction of new treatment regimen approved by WHO","349,311",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":391999.78}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-5709","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTX/view","51,324.21","51,324.21","Review of the TB program, epidemiology and impact analysisThis review will make it possible to evaluate the performance, impact, quality and effectiveness of the TB programs and to establish a link between the program funding, the upscaling of the intervention and the disease trends by means of a systematic plausibility analysis.The costs stated here are historic costs linked to previous grants.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":51324.21}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Central Africa","Active",null,"Medium","PAI-3779","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyP/view","39,863.09","39,863.09","Run three-day training/refresher training sessions for 180 health workers, including those working with men who have sex with men (MSM), on the revised algorithms for STI treatment. One session per former department will take place in 2019:Planned for 2019, this intervention will support treatment for STIs in adapted services, a reference point for the targets addressed by NGOs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":39863.089999999997}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","HIV testing services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3787","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyX/view","514,120.75","514,120.75","Sessions for the above.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":514120.75}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Low","PAI-3803","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyn/view","8,725.17","8,725.17","Six-monthly supervision and monitoring of care in prisons(one NACP representative plus driver, one CIPEC, one prescriber from a neighboring facility, registered prison nurse)HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. The intention is now to scale this up and involve all ten prisons. Regular supervision and monitoring is therefore vital in the initial years to ensure that the care is given properly.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8725.17}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"Medium","PAI-3780","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyQ/view","17,963.19","17,963.19","Six-monthly supervision of prevention activities implemented by the sex workers network in areas frequented by sex workers",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":17963.189999999999}]
["Benin","12/31/2020","Malaria","FR410-BEN-M","Removing human rights and gender related barriers to case management","10/30/2019","Case management","Central Africa","Active",null,"High","PAI-3815","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyz/view","48,261.7","48,261.7","Specific new actions will enable approximately 7,000 persons deprived of liberty to access quality treatment services and thus guarantee their right to health.These actions are: i) Training / supervision of prison medical staff; ii) Provision of treatment; iii) Provision of prison health centers in Inputs Malaria control for the free care; and iiii) Consultative meetings with the concerned ministries for a good coordination of activities",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":48261.7}]
["Benin","6/30/2022","RSSH","FR352-BEN-S-01","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3821","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz5/view","2,180,230.05","2,180,230.05","Strategy for community health workers can be expanded, through the use of community data applications. Procurement of 3,312 smartphones and accessories, and training of 3,312 community health workers already active in partner programs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2180230.0499999998}]
["Togo","12/31/2020","Malaria","FR111-TGO-M","Capacity building for health workers, including those at community level","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Central Africa","Active",null,"Medium","PAI-5732","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTu/view","327,527.77","327,527.77","Strengthening human resources for health (HRH) management capacity initiated during the NFM1:- Institutionalization of HRH: 1) updating the HRH management database (12,000 health staff and 11,000 CHWs); 2) linking the iHRIS 4.2 software with District Health Information System (DHIS2); 3) preparing and periodically updating the country profile on HRH; 4) producing statistical yearbooks on HRH; 5) decentralizing the use of iHRIS to enable decision-making at the regional and health district levels.- Improvement of quality and promptness of malaria data reporting through trainings and supervisions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":327527.77}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for TGs","10/30/2019","Comprehensive prevention programs for TGs","Central Africa","Active",null,"High","PAI-3761","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy7/view","49,022.56","49,022.56","Studies were not budgeted for within the allocation amount. The studies (size estimation and SGSS) will provide data to better monitor the impact of the interventions: -A gender-sensitive study that includes adolescents and young people to estimate the size of the transgender population in Benin and map it (11,771)-Production of 30 copies of the study to estimate the size of the transgender population in Benin and map it (228)-Recruitment of a consultant to conduct a gender-sensitive SGSS for the transgender population (19,683)- An SGSS for transgender people (11,771)-Production of 30 copies of the report on the SGSS for the transgender population (228)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":49022.559999999998}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3783","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyT/view","68,431.15","68,431.15","Study to evaluate the prevalence of hepatitis B among PLHIV:After tuberculosis, hepatitis B is the biggest threat to the care of PLHIV. This study will identify those with co-infections (so as to provide better care for them) and evaluate prevalence.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":68431.149999999994}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3734","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxg/view","102,239","102,239","Supervision by TB / HIV coordinators. The budget covers vehicle and fuel insurance costs.The budget for the 2018-2020 grant is 661,500 BIF, per quarter and per BPS, to cover fuel costs only.The said budget omits the costs of insurance, vehicle repair and technical control, which, for most of them, are already obsolete and amortized.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":102239}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","HIV testing services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3776","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyM/view","486,623.27","486,623.27","Supplies for screening sex workers: to address those sex workers and clients who do not attend adapted services, screening at this level will be carried out by sex worker peer educators (de-medicalized approach).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":486623.27}]
["Benin","6/30/2022","RSSH","FR352-BEN-S-01","Retention and scale-up of health workers, including for community health workers","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Central Africa","Active",null,"High","PAI-3822","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz6/view","2,569,275.05","2,569,275.05","The additional investment will make it possible to cover 65 percent of needs (from 47% with only allocation and matching funds): recruitment, training, incentivization, equipment, provision of tools, and monitoring of 4,147 community health workers implementing the complete package of interventions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2569275.0499999998}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","HIV care","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-5747","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU9/view","254,351.92","254,351.92","The additional resources will make it possible to offer CD4 counting to the new inclusions (11,849 per year) and to monitor patients on ARVs within the 6 months after the start of treatment, meaning it will  be  possible  to  offer  CD4  counting  to  17,562,  19,079  and 20,288 PLHIV in 2018, 2019 and 2020, respectively.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":254351.92}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Other vector control measure(s)","10/30/2019","Vector control","Central Africa","Active",null,"Low","PAI-4096","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3W/view","30,531.93","30,531.93","The aim of these interventions is to support door-to-door awareness campaigns regarding the fight against malaria, the transmission routes, symptoms and other preventive measures in partnership with NGOs and community associations, health delegations and the INSP.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30531.93}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","HIV care","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3928","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0o/view","10,560,118.95","1,988,897.99","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.",0,0,0,"8,264,649.31","306,571.65",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1988897.99}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Prevention, diagnosis and treatment of opportunistic infections","10/30/2019","Treatment, care and support","Central Africa","Inactive",null,"High","PAI-3941","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ11/view","216,656.94",0,"The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.",0,0,0,0,"216,656.94",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Central Africa","Inactive",null,"High","PAI-3939","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0z/view","1,443,950.17",0,"The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.",0,0,0,"1,443,950.17",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Prong 3: Preventing vertical HIV transmission","10/30/2019","PMTCT","Central Africa","Inactive",null,"High","PAI-3940","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ10/view","669,933.79",-0.21,"The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.",0,0,0,"669,934",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":-0.21}]
["Chad","6/30/2021","Malaria","FR31-TCD-M","Integrated community case management (ICCM)","10/30/2019","Case management","Central Africa","Active",null,"High","PAI-5720","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTi/view","3,520,086.41","2,534,322.41","The country has successfully implemented iCCM in 2 regions and intends to expand this intervention in 2 other regions with high malaria burden. This intervention will increase malaria diagnostic and treatment services among vulnerable groups and, hence, improve coverage of malaria treatment seeking among children under five. This will have an impact on the reduction of malaria mortality which continues to be considerable.",0,0,0,0,"985,764",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2534322.41}]
["Chad","6/30/2021","Malaria","FR31-TCD-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-5721","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTj/view","2,220,048.25","2,220,048.25","The country successfully implemented (IRS) in the Moissala locality and intends to expand it in 3 districts with the highest malaria mortality.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2220048.25}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other module","10/30/2019","Other module","Central Africa","Active",null,"Medium","PAI-4029","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2R/view","90,898.89","90,898.89","The current coverage of third dose intermittent preventive treatment (IPT 3) among pregnant woman is low, standing at 12 percent in 2016. The needs met by the country in terms of SP doses are 629,170 in 2018, 645,530 in 2019 and 662,314 in 2020, giving a total of 1,937,013 for the three years, or 100 percent. Only the support activities for this intervention, namely the development and validation of refocused antenatal clinic standards and directives, and training care providers in prenatal care, will be taken into account by the above allocation funding from the Global Fund. The availability of SP and the implementation of these support activities will increase IPT 3 to 80 percent in 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":90898.89}]
["Central African Republic","12/31/2020","Malaria","FR630-CAF-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","2019-04-12","Vector control","Central Africa","Active",null,"High","PAI-6195","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnH/view","6,410,432","6,410,432","The distribution of LLINs in Regions 1, 2 and 3 in 2019 was planned to protect populations against malaria, as the last campaign in these 3 regions was in 2014.The report of micro planning in these areas reveals that the population has increased by 49% compared to macro planning figures. Given that the LLINs available in country for the campaign are only 1,800,700, while the need resulting from population increase requires 2,552,998 LLINs to cover these areas, there is a resulting gap of 752,300 LLINs that will cost EUR 1,847,798.The initial budget for the campaign was only EUR 3,325,097(operational cost). The increase of the population has generated not only a gap in nets but also an exorbitant financial gap related to operational costs amounting to EUR 3,864,538. In order to keep covering the three regions within the mass campaing, the new budget would reach EUR 7,189,635 (including costs related to implementing NGOs). With the current level of funding, this results in a gap of EUR 5,712,336 including additional nets and respective distribution and operational costs.If this gap is not filled, the country will not be able to implement the campaign in the 3 regions and will not be able to achieve coverage targets of mass distribution for the year 2019-2020.","5,712,336",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6410432}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other intervention(s) to reduce human rights-related barriers to HIV services","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Central Africa","Active",null,"Medium","PAI-4043","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2f/view","561,104.25","561,104.25","The embryonic structure that was put in place by the current concept note needs to be strengthened by the future project, to count, document and reduce the number of cases of violence towards the key populations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":561104.25}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-4097","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3X/view","29,051.73","29,051.73","The exchange visit to a country that is in the process of obtaining certification of malaria elimination will strengthen the skills of the technicians working on the malaria program in Cape Verde, particularly when it comes to monitoring and documenting the elimination process.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":29051.73}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Administrative and finance data sources","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-3810","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyu/view","3,233.08","3,233.08","The financial monitoring of sub-sub-recipients will ensure that the resources allocated to them are managed correctly. This intervention entails the on-site monitoring of financial management at the sub-sub-recipient level, at a cost of 2,881.29.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3233.08}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3758","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy4/view","104,237.46","104,237.46","The following activities relate to data quality (quality control, supervision and the review of progress update and disbursement requests), as well as planning and other activities linked to information systems and management, with the aim of improving the quality of the program: -Ensuring the participation of grant actors in discussions and short training sessions each year (44,820) -Six-monthly quality control of the data collected by each team working on the ground, including the data disaggregated by sex and by age produced within their intervention areas (6,105) -Six-day supervision, carried out by the Principal Recipient every six months, of actors on the ground at the departmental level (sub-sub-recipients and others) and at the commune level (NGOs and others), in terms of monitoring and evaluation (two three-person teams, including a driver) based on human rights and gender standards (2,309) -The drafting of a six-monthly gender-sensitive report on the results obtained and the progress made in implementing the grant (6,469) -Six-monthly quality control exercises carried out by the Principal Recipient to monitor data from teams working on the ground and NGOs, peer educators (MSM, people who inject drugs, young people who no longer attend, or have never attended, school and truck drivers, disaggregated by sex and by age) via two three-person teams. These exercises will last six days and take place in the 12 departments (5,282) -Six-monthly monitoring and traceability of condoms, from wholesaler to the final distributers, carried out by two three-person teams over six days (5,241)-An annual on-site data verification exercise at the sub-recipient level carried out by three three-person teams over six days (7,923) -A six-monthly review of the progress update and disbursement requests of the two sub-recipients and the teams on the ground by the Principal Recipient -A six-monthly planning and review workshop with teams on the ground lasting four days (administration of 31 participants, including seven drivers, over four days) (5,230)-The six-monthly maintenance of the integrated system of community data (SIDOC) by the developer (six days consultancy every six months) (2,552)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":104237.46}]
["Togo","12/31/2020","Malaria","FR111-TGO-M","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-5728","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTq/view","2,214,569.63","2,214,569.63","The funding request will allow the Ministry of Health to conduct the following surveys:- Malaria Indicators Survey in 2020 with technical support from MEASURE Evaluation- Prevalence study of molecular markers of Plasmodium falciparum resistance to sulfadoxine- pyrimethamine (SP) and amodiaquine (AQ) in 2018- Evaluation of the therapeutic effectiveness of artemisinin-based combination therapies (ACTs) to treat uncomplicated malaria - Review of data quality and quality of care in public facilities",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2214569.63}]
["Togo","12/31/2020","Malaria","FR111-TGO-M","Entomological monitoring","10/30/2019","Vector control","Central Africa","Active",null,"Medium","PAI-5731","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTt/view","154,796.32","154,796.32","The funding request will assess the continuous effectiveness of insecticides and drugs (LLINs, ACTs, SP, SP+AQ and injectable artesunate) used to measure the sensitivity and effectiveness tests for long-lasting insecticidal nets (LLINs) as part of an overall resistance monitoring and surveillance strategy in accordance with WHO recommendations. The budget will cover the characterization of specific Plasmodium species and their resistance mechanisms to antimalarial drugs, a test for vector sensitivity to insecticides and community monitoring of the effectiveness of LLINs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":154796.32}]
["Benin","12/31/2020","Malaria","FR410-BEN-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-3813","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyx/view","1,739,000.11","1,739,000.11","The gap of 315 000 LLIN has been filled",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1739000.11}]
["Chad","6/30/2021","Malaria","FR550-TCD-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-5723","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTl/view","6,883,375.54","6,883,375.54","The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.In order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6883375.54}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other vector control measure(s)","10/30/2019","Vector control","Central Africa","Active",null,"Medium","PAI-4026","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2O/view","1,931,320.84","1,931,320.84","The intervention of this module will focus on the routine distribution of 589,164 LLINs to pregnant women and children under one year of age during antenatal clinics, seasonal malaria chemoprevention (SMC), and/or linked to vaccination. In effect, these population groups are the most vulnerable to malaria but do not currently benefit from LLINs. The Chinese Government has signed a donation agreement with Congo to provide 200,000 LLINs per year for five years. However, programmatic gap analysis shows that there will be a 48 percent shortage of LLINs in 2018, 6 percent in 2019 and 51 percent in 2020 for the routine provision of nets, equivalent to a shortage of 589,164 LLINs. The household coverage rate of LLINs in 2015 is 36.7 percent. The rates of use are respectively 60.5 percent among children under one year of age and 60.3 percent among pregnant women, also for 2015. The above allocation funding by the Global Fund will cover the gap in LLINs and improve the rate of coverage (99 percent among pregnant women and 90 percent among children under one year of age), and the rate of use of LLINs to at least 80 percent in these two vulnerable groups. The expected impact will be a reduction of the burden of malaria morbidity among these vulnerable groups.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1931320.84}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Central Africa","Active",null,"Medium","PAI-3786","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyW/view","119,598.25","119,598.25","The interventions involve the updating of modules, refresher training for actors, the editing of tools and consultation sessions. They will intensify prevention activities for truck drivers to ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention was not budgeted for within the allocation amount.This intervention comprises the following activities:-Updating the training modules for truck driver peer educators using a human rights and gender-transformative perspective. These include modules on health education, new forms of masculinity and the prevention of gender-based violence (2,939.22)-Refresher training for 75 truck driver peer educators and 20 facilitators during four two-day sessions with 30 participants on the package of interventions (intervention strategies, Social Change and Behavior Change Communication (SC/BCC), pre- and post-test counseling) and data reporting tools (15,726.64)-Producing 100 registers of people who have undergone awareness training and of the distribution of condoms and lubricants for truck drivers, and 3,500 fact sheets (922.32)-Producing 90 visual aids based on a human rights and gender perspective for truck driver peer educators, including on health education, new forms of masculinity and the prevention of gender-based violence (1,372.04)-Providing truck driver peer educators with one meal per day of the intervention, two days a month (outreach, communication and follow-up activities, distribution of condoms) (38,417.15)-Recruiting consultants for the SGSS for truck drivers (27,451)-An SGSS for truck drivers (4,610)-A one-day consultation session with haulage trade unions (room hire, coffee break, administration and travel for 30 participants, supplies and photocopying) every six months, totaling six sessions over the three years by the sub-recipient (8,378.60)-Producing 30 copies of the report on the SGSS for truck drivers (228.67)-Covering the costs of the supply, storage, quality control and distribution of condoms for truck drivers (6,146.74)-Producing 100 training manuals based on a human rights and gender perspective for truck driver peer educators (381.12)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":119598.25}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other intervention(s) for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Central Africa","Active",null,"Low","PAI-4049","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2l/view","336,662.55","336,662.55","The issue of sexual and reproductive health including HIV among female adolescents is not being covered adequately by health projects and programs. The current grant makes it a priority. This is why a bio-behavioral study for young people and adolescents is being conducted to mitigate these weaknesses.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":336662.55}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Male and female condoms for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Central Africa","Active",null,"High","PAI-5716","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTe/view","851,056.41","851,056.41","The justification for the selection of this intervention is the same as that described above. The plan is to provide a box of 144 condoms per person receiving advocacy.Country targets: 14% (33,120/230,000) in 2019; 16% (36,925/238,084) in 2020; 16% (40,024/246,494) in 2021. All of these targets are assigned to the Global Fund.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":851056.41}]
["Benin","12/31/2020","Malaria","FR410-BEN-M","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-3819","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz3/view","68,946.25","68,946.25","The last program's performance review in 2016 noted that indicators related to the annual incidence of malaria and lethality have evolved positively. However, it was noted the weak involvement of the private sector in the fight against malaria, the failure to comply with the guidelines for the management of malaria cases despite the availability ILPs and weaknesses related to the use of DHIS2 software. The next review is scheduled for 2019.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":68946.25}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Behavioral interventions for TGs","10/30/2019","Comprehensive prevention programs for TGs","Central Africa","Active",null,"High","PAI-3760","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy6/view","2,685.44","2,685.44","The management of transgender peer educators and support groups aims to intensify prevention activities for transgender people and ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention comprises the activities listed below. The management of transgender peer educators was planned for two years and nine months only, using the allocation amount and catalytic funds. It is planned for the final quarter as part of the prioritized above allocation request. The various activities are detailed below:-Five support groups per quarter that take a human rights-based and gender-transformative approach for 20 transgender people (educational session followed by condom distribution) (1,295)-Management of ten transgender peer educators as part of SC/BCC activities (1,097)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2685.44}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other intervention(s) for IDUs and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Central Africa","Active",null,"Low","PAI-4048","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2k/view","448,883.4","448,883.4","The mapping that is currently being validated revealed a population of 450 people who inject drugs. To offer complete prevention to people who inject drugs, some of the existing resources will be used to start providing basic services to this community, and the above allocation resources will be used to implement a pilot project for this target population.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":448883.4}]
["Chad","6/30/2021","Malaria","FR550-TCD-M","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-5724","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTm/view","2,860,414.02","2,860,414.02","The Ministry of Public Health has developed their 2018-2022 National Strategic Plan for the development of the Health Information System which was integrated in the 2019-2021 Triennial Operational Plan, to make information available with the purpose of ensuring the effective management of the interventions by health system actors. The Operational Plan for Strengthening the Health Information System will allow Chad to have a well-functioning health information system, producing quality health information in real time at all levels, accessible and used by all stakeholders for evidence-based decision-making on health issues in order to improve the health of populations. The achievement of such an ambition requires the implementation of interventions that revolve around two axes namely:1. Improving the quality of the routine health information system to make readily available information tailored to the needs of the health system's implementing partners;2. Improved coordination of all elements of the health information system. The total cost of the National Strategic Plan for the development of the Health Information System (2018-2022) is 10,580,535 euros (6,940,375,997 FCFA). Of this amount, 8,031,620 euros are being mobilized through other funding sources. The remainder of 2,548,915 euros are requested through the UQD.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2860414.02}]
["Togo","12/31/2020","Malaria","FR111-TGO-M","National costed supply chain master plan, and implementation","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"High","PAI-5730","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTs/view","68,196.61","68,196.61","The MoH is planning to develop a national strategy aimed at strengthening the national supply chain around five thematic areas: (i) availability and accessibility of drugs and health products; (ii) structure of the supply system for drugs and health products; (iii) regulation of the health product supply chain and quality of health products; (iv) human, financial and material resources; and (v) governance of the system. The new strategy will address the weaknesses of the distribution system as well as guide a domestic finance mobilization initiative planned by the MoH.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":68196.61}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Inactive",null,"High","PAI-3935","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0v/view","521,475.7",0,"The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.",0,0,0,0,"521,475.7",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Inactive",null,"High","PAI-3936","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0w/view","463,685.33",0,"The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.",0,0,0,0,"463,685.33",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3937","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0x/view","80,065.09","80,065.09","The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":80065.09}]
["Benin","12/31/2020","Malaria","FR410-BEN-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","Central Africa","Active",null,"Low","PAI-3818","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz2/view","5,023,248.79","5,023,248.79","The NMCP proposes to implement the extension of the IRS to other communes eligible for a pre-elimination of malaria in the medium and long term. The area of Dassa Glazou in the hills department is chosen for funding beyond.This choice is mainly based on scientific evidence in terms of short transmission period and the abundance of vectors and their infectivity in this area.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5023248.79}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Behavioral interventions for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Central Africa","Active",null,"High","PAI-5715","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTd/view","1,024,440.86","1,024,440.86","The other vulnerable populations taken into consideration by this PAAR are the Lake Chad island populations, as they still do not receive any interventions to fight HIV and TB. Access to the island population requires a differentiated strategy. Given the limits of the available budget and in view of the specific nature of the Lake Chad region (prevalence of 5.5% in the island area, according to the 2012 LCBI survey), we have concluded that it is necessary to request additional funding to cover this target population. The 2018-2022 NSP contains plans to provide coverage for at least 70% of the island population living on the islands and islets in the Chadian part of Lake Chad, in terms of access to combined preventive services, by 2021. In view of the difficult security context for obtaining access to this population, the humanitarian stakeholders present (MSF, the IRC, UNICEF, etc.) on the ground will be asked to implement this module. The justifications of this request concern all of the interventions included for the island populations.According to the seroprevalence survey carried out by the Lake Chad Basin Initiative (LCBI) among individuals of the priority vulnerable groups in this conventional basin, HIV seroprevalence is 5.5% on the islands and islets, which is 4 times higher than the prevalence among the general population.The interventions by humanitarian stakeholders currently do not provide sufficient coverage for the fight against HIV/AIDS and TB for these populations and their host populations.The current island populations, which numbered 230,000 people in 2017, move between the islands and the mainland in accordance with the security situation. They come from the following 18 islands: Banagori, (10,332 inhabitants), Blangui (8,955 inhabitants), Finikim (7,055 inhabitants), Kargulim (8,250 inhabitants), Tchongol (9,900 inhabitants), Kinasserom (7,194 inhabitants), Ttchoua (10,137 inhabitants), Choara (7,692 inhabitants), Tchoukoultaya (18,321 inhabitants), Bol Urbain (34,023 inhabitants), Milea 18,848 (inhabitants), Gougoua (18,445 inhabitants), Ameroun (10,070 inhabitants), Iserom (17,704 inhabitants), Kakigou (4,123 inhabitants), Yourtou (9,114 inhabitants), Makarati (11,011 inhabitants) and Kirkira (9,262 inhabitants).In order to rectify this inequality in access to health-care services, the government has recently established a National Health Program for Nomadic and Island Populations and Populations in Hard-to-Reach Areas (NHPN). Therefore, the interventions to fight HIV and TB in the Lake Chad region are of sub-regional interest, as the foreign populations that frequent this area are there for economic reasons, primarily in relation to fishing. Their toing and froing between their countries of origin and Lake Chad is a factor in the propagation of the HIV epidemic in this sub-region.This above-allocation funding request for Chad will make it possible to provide services to fight HIV and TB to these populations (native and island populations).Indicators: i) Percentage of the vulnerable populations who have benefited from the HIV prevention program - defined package of services (islands populations, refugees and nomads)Country targets: 20% (46,000/230,000) in 2019; 40% (95,233/238,084) in 2020; 60% (147,897/246,494) in 2021. All of these targets are assigned to the Global Fund.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1024440.86}]
["Sao Tome and Principe",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR100-STP-Z","Other module","10/30/2019","Other module","Central Africa","Inactive",null,"Medium","PAI-5643","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJST/view","22,444.17",0,"The process has been launched with support from WHO; this represents a contribution by the Global Fund to the development process.",0,0,0,0,"22,444.17",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-4103","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3d/view","14,817.64","14,817.64","The program so far reports data in Excel and/or Word documents, which are sometimes incomplete and submitted late. For this, with the introduction of the DHIS2 application, promptness and completeness of reports will be improved, which will ensure better disease surveillance. This is for an upgrade of the existing system.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":14817.64}]
["Chad","6/30/2021","Malaria","FR550-TCD-M","Removing human rights and gender related barriers to case management","10/30/2019","Case management","Central Africa","Active",null,"Low","PAI-5725","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTn/view","295,056.79","295,056.79","The security context in Chad and in the countries of the subregion results in a population movement with its corollaries of internally displaced persons, refugees, returnees and even asylum seekers. This situation affects nearly 450,000 people whose health situation is increasingly precarious. One of the major challenges facing organizations supporting refugees is the difficulty of ensuring access for these populations to malaria prevention and case management services. Currently, only 35% of needs are regularly covered by UNHCR. The NFM II budget also plans to cover 15% of refugees' needs. This additional demand will cover 50% of the remaining needs, to ensure full coverage.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":295056.78999999998}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Stigma and discrimination reduction","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Central Africa","Active",null,"Medium","PAI-3790","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIya/view","12,532.82","12,532.82","The study to evaluate the legal setting for key populations aims to provide data to better target interventions for them.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12532.82}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-4032","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2U/view","1,180,280.55","1,180,280.55","The three months of buffer stock constitute a supplement to the adult ARV drugs which will be procured from the allocated funds in order to have 6 months as a standard quantity.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1180280.55}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-4101","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3b/view","24,781.73","24,781.73","These activities are aimed at strengthening training sessions among  SWs, field sessions and interpersonal communication on HIV and other STIs by SWs peer educators  included in the budget of the allocation amount. They will complement activities that have already been taken into account in the allocation amount.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":24781.73}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-3945","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ15/view","37,637.75","37,637.75","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":37637.75}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Community empowerment for MSM","10/30/2019","Comprehensive prevention programs for MSM","Central Africa","Inactive",null,"High","PAI-3930","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0q/view","2,394.79",0,"These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.",0,0,0,0,"2,394.79",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Inactive",null,"High","PAI-3929","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0p/view","8,553.47",0,"These activities are under-financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.",0,0,0,0,"8,553.47",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Central African Republic","12/31/2020","HIV/AIDS, Tuberculosis","FR100-CAF-C","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","Central Africa","Inactive",null,"High","PAI-3946","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ16/view","33,227.47",0,"These activities are under-financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.",0,0,0,0,"33,227.47",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3789","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyZ/view","56,022.89","56,022.89","These activities combine community data collected by NGOs and peer educators and allow for experiences to be shared between sub-sub-recipients and teams on the ground. They aim to produce quality data and strengthen interventions on the ground:-Six-monthly, two-day consultation meetings between sub-sub-recipients working with adolescents and young people who no longer attend, or who have never attended, school and adolescent and youth leaders to combine community data (room hire, coffee break, administration and travel of participants, supplies and photocopies) (1,474)-Twelve two-day, gender-sensitive and inclusive consultation meetings with 30 implementation actors to improve the coordination of interventions for key and vulnerable populations (MSM, people who inject drugs, PLHIV, sex workers, adolescents, young people, transgender people, truck drivers and those close to them, and community-based organizations that include women and girls) (10,281)-Six-monthly, two-day consultation meetings between sub-sub-recipients and peer educators working with people who inject drugs to combine community data disaggregated by sex and age (room hire, coffee break, administration and travel of participants, supplies and photocopies) (7,299.19)-Monthly outreach supervision sessions for peer educators working with people who inject drugs and MSM, led by NGO facilitators (3,366)-A six-monthly, two-day meeting for teams working on the ground to combine data and share the results of interventions for young people, MSM, people who inject drugs, and support for OVC and PLHIV with CPS, decentralized financial systems (SFD), ART facility managers, NGO facilitators, psychological support workers and legal experts (20,361)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":56022.89}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"Low","PAI-3963","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1N/view","265,816.41","265,816.41","These activities will allow for work to advocacy at city/distric/region level to put in place transition plan for the current 4'400 CHW to be funded in the future by local authorities.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":265816.40999999997}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other vector control measure(s)","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-3964","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1O/view","270,101","270,101","These activities will allow for work to ensure communication around the use of LLINs and  IPT activities for  the prevention of malaria in pregnant women a,  infant  and neonatal health through the routine distribution LLINs, the implementation of  the refocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":270101}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other vector control measure(s)","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-3960","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1K/view","4,233,348.67","4,233,348.67","These activities will allow for work to ensure  the prevention of malaria in pregnant women and improve access to promotional and preventive services for maternal,  infant  and neonatal health through the routine distribution LLINs, the implementation of  therefocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4233348.67}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"High","PAI-3965","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1P/view","959,726.18","959,726.18","These activities will allow for work to maintain the  remaining  492  CHWs not funded under the new grant due to budget constraint only  4400 Community Health Workers (CHW) out of  the 4892 operational  will  be supported. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country.  In  addition,  due  to  budget constraints .  To  achieve universal coverage, it is important to maintain the  remaining  492  CHWs.  In  addition,  a  performance-based funding mechanism for Community Health Workers accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":959726.18}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"Low","PAI-3962","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1M/view","8,784,908.54","8,784,908.54","These activities will allow for work to support the new   4'500  CHWs. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to recruit 4500  CHWs additonal through  and  to  extend  the  response  to  80 additional  health districts by ensuring adequate  equipment  for the smooth  running of  the  activity.  In  addition,  a  performance-based funding mechanism for CHW accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8784908.5399999991}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"Medium","PAI-3970","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1U/view","1,288,703.85","1,288,703.85","These activities will allow for work to train the  new  4'500  CHWs  through  periodic recycling. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to extend  the  response  to  80 additional  health districts.Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1288703.8500000001}]
["Cameroon","12/31/2020","Malaria","FR446-CMR-M","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Central Africa","Active",null,"Medium","PAI-3969","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1T/view","164,309.28","164,309.28","These activities will allow for work to train the  remaining  492  CHWs  through  periodic recycling not funded under the new grant due to budget constraint.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":164309.28}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Central Africa","Active",null,"High","PAI-4106","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3g/view","81,308.5","81,308.5","These are consumables and laboratory reagents to complement the diagnostic and follow-up services. They refer, in particular, to the strengthening of blood safety during the 3rd year of the grant.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":81308.5}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Central Africa","Active",null,"Medium","PAI-4107","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3h/view","5,373.13","5,373.13","These interventions aim at sensitizing 10 TB patients to ensure adherence and good compliance to treatment and adoption of preventive standards.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5373.13}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","TB/HIV collaborative interventions","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-4102","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3c/view","16,689.48","16,689.48","These interventions are aimed at strengthening the capacity of NGO members working for TB / HIV prevention at the community level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":16689.48}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Behavioral change as part of programs for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Central Africa","Active",null,"High","PAI-4105","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3f/view","141,119.96","141,119.96","These interventions are  directed  towards: 1)  150 vulnerable children and adolescents who are received at day centres by facilitators from ICCA; 2) 80 vulnerable youths and adolescents in Praia with training and psychological support; 3) 620 peer educators within 21 secondary schools and, additionally, the coordination and follow-up of the activities performed by peer educators. These will supplement activities considered in the allocation amount.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":141119.96}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Other intervention(s) for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Central Africa","Active",null,"Low","PAI-4094","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3U/view","14,654.92","14,654.92","These interventions are intended to improve the psychological support provided to vulnerable children and orphans within the ICCA drop-in centre in Praia.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":14654.92}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3756","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy2/view","121,722.59","121,722.59","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":121722.59}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Treatment adherence","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3755","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy1/view","441,113.23","441,113.23","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":441113.23}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3757","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy3/view","396,203.57","396,203.57","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: -Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (2,103.80) -Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (4,315.07)-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (4,573.47) -Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (7,546.23) -Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (1,632.73) -Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (6,585.80) -The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (4,102.40) -Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (5,460.72) -Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (3,430.10)-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for OVC and PLHIV in all departments (plan) (343.01) -Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (4,573.47) -Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (332,582.78) -Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (10,425.99) -Covering the costs of the ReBAP+ helpline (1,646.45) -Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (4,573.47) -Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (42,807.68) -Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (8,479.21) -Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (9,878.70) -Producing badges for the peer educators/health mediators involved in the projects (1,524.49)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":396203.57}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Medium","PAI-3764","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyA/view","71,292.78","71,292.78","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: -Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (2,103.80) -Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (4,315.07)-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (4,573.47) -Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (7,546.23) -Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (1,632.73) -Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (6,585.80) -The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (4,102.40) -Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (5,460.72) -Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (3,430.10)-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for OVC and PLHIV in all departments (plan) (343.01) -Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (4,573.47) -Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (332,582.78) -Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (10,425.99) -Covering the costs of the ReBAP+ helpline (1,646.45) -Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (4,573.47) -Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (42,807.68) -Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (8,479.21) -Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (9,878.70) -Producing badges for the peer educators/health mediators involved in the projects (1,524.49)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":71292.78}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Medium","PAI-3763","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy9/view","417,326.9","417,326.9","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities:-Refresher training for 400 people (health workers, social workers, health mediators, therapeutic educators, MSM and transgender associations and other social organizations) during 20 sessions with 30 participants each. This training will address the specific needs of key and vulnerable populations (psychological support for improved referral and care for key and vulnerable populations), human rights and medical ethics linked to combating HIV and tuberculosis (49,430.07)-Procuring nutritional kits to support the most vulnerable PLHIV on ART (men, women, boys and girls) to help improve their nutrition and their adherence to ART (356,730) -Repackaging nutritional kits and distributing them to beneficiary PLHIV (men, women, boys and girls) on a quarterly basis. These kits are gender-specific, non-discriminatory and inclusive (9,146.94)-Paying the salaries of ReBAP+ staff (program lead, administrative assistant, accountant and monitoring and evaluation specialist) (16,670)-Paying health insurance for ReBAP+ staff (4,390.53)-Contributing to the running costs of ReBAP+ (office rent, water, electricity, communications and supplies) (3,978)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":417326.9}]
["Sao Tome and Principe",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR100-STP-Z","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Inactive",null,"High","PAI-5641","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSR/view","22,444.17",0,"This amount covers recruitment of international consultants and validation workshops.",0,0,0,0,"22,444.17",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Central Africa","Active",null,"High","PAI-3705","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxD/view","111,628","111,628","This amount includes bonuses for 12 iNMCP staff involved in implementing the grant, and maintenance, fuel and insurance for 11 extra vehicles not covered by the allocation amount and are required for supervision and training activities on the ground as well as implementing the 2019 LLIN distribution campaign support for the National Health Information System Directorate, information, education and communication and the transport of central level staff during the different stages of campaign implementation, including the census, micro-planning, pre-positioning of LLINs and supervision of distribution).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":111628}]
["Gabon","12/31/2021","Tuberculosis","FR42-GAB-T-01","Treatment","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-4261","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6B/view","175,648.08","175,648.08","This amount represents the costs to ensure the availability of a safety stock for the first year and the availability of all first-line drugs for the second year. The immediate result is the absence of drug stockouts in the first two years. This will allow the program to make some adjustments to the resources of the state that do not always arrive at the desired time",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":175648.08}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3710","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxI/view","172,237","172,237","This budget is required to cover a survey on the current malaria epidemic in Burundi. A survey on the underlying causes of the epidemiological setting to understand the causes of the epidemic and thus evaluate what type of response would be appropriate and effective, and what measures should be adopted after the epidemic. This epidemic survey will assist the program in guiding the response appropriately.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":172237}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Central Africa","Active",null,"High","PAI-3709","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxH/view","206,160","206,160","This budget is required to cover for technical assistance  to support the implementation of the next LLIN campaign in 2020. It comprises international and domestic technical assistance to support the entire process of the 2020 mass campaign, up to the final report. Given the complexity of the organization on the ground, ongoing technical assistance is required throughout the campaign.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":206160}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-3704","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxC/view","2,658,053","2,658,053","This budget is required to: (i) Bridge a gap of 466,000 LLINs to meet all of the needs of the 2019 mass campaign. Of the total 6,997,954 LLINs required, taking into account an increase of 15 percent linked to counts and to logistical security, 6,531,828 have been provided using the allocation amount; (ii) The amount requested includes procurement costs and procurement and supply management/pooled procurement mechanism costs; (iii) The gap in the implementation costs that have not been included in the allocation amount (US$ 1,600,000); (iv) Expected outcomes: this funding will provide universal coverage of LLINs during the 2019 campaign.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2658053}]
["Togo",null,"HIV/AIDS, Tuberculosis","FR466-TGO-C","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-5745","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU7/view","2,872,542.92","1,306,162.17","This funding will make  it  possible  to  provide  viral  load  testing  for  the  PLHIV  on ARVs, so as to increase coverage from 20% under the allocation funding  to  50%  by  the  end  of  2020.  The  number  of  PLHIV on ARVs who will receive viral load testing will be 23,126, 30,890 and 39,346 in 2018, 2019 and 2020, respectively.",0,0,0,"796,884.75","769,496",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1306162.17}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Central Africa","Inactive",null,"High","PAI-3989","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1n/view","687,928.4",0,"This  funding  would  be  used  for  additional  VL  tests  to  those covered  by  the  allocation  amount:  50,000  VL  tests in  2018, 60,000  in  2019  and  80,000  in  2020.  In  addition,  it  would  be used for annual corrective and preventive maintenance for ten  additional  Abbott  enclosed  platforms,  at  ten  reference laboratories",0,0,0,"687,928.4",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Other procurement supply chain management intervention(s)","10/30/2019","RSSH: Procurement and supply chain management systems","Central Africa","Active",null,"High","PAI-3974","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1Y/view","10,828,683.65","10,828,683.65","This  funding  would  be  used for the  construction  of  a  new central medical  store or renovation of Regional Store, with  other  technical  and  financial partners (IDB, USAID, etc.): purchase of land and construction (EUR  9,000,000). Investment in the supply chain is conditional to recommendation of the supply chain report. In  addition,  it  will  provide  funding  for technical assistance (EUR 649,440) for national coordination (a team of one international and one national expert)  for the three programs, to improve quantification and procurement of supplies, and to reduce instances of stock-outs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10828683.65}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Treatment monitoring - Drug resistance surveillance","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3973","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1X/view","427,698.35","427,698.35","This funding would be used to carry out a study into initial and acquired resistance to ARVs among infectedadult and child patients, in Year 1.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":427698.35}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Treatment adherence","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Low","PAI-3981","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1f/view","34,216.14","34,216.14","This funding would be used to improve treatment adherence for children and adolescents during the grant period, through the production of additional treatment education manuals and tools,  to  improve  treatment  education  at  the  CBOs  and PMTCTsites wherethe manuals and toolsalready exist.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":34216.14}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3985","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1j/view","49,771.07","49,771.07","This funding would be used to purchase tests for initial check-up and follow-up of 100 additional MDR-TB patients between Year  1  and  Year 3.  It  would  also  cover  screening  for  MDR-TB/RR-TB among new TB cases. This would be after having tested 100 percent of the primary group at higher risk, which is patients with a history of previous treatment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":49771.07}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Central Africa","Inactive",null,"High","PAI-3983","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1h/view","248,008.08",0,"This funding would be used to purchase two mobile digital X-ray  machines  for  PLHIV  who  cannot  pay  for  X-rays,  in  the Douala   and   Yaound   regions.   This   would   significantly improve the rate of return for TB screening in these patients. TRP recommends swaping between X-Ray equipment for hospital currently budgeted in the allocation.",0,0,0,0,"248,008.08",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Differentiated ART service delivery","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3991","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1p/view","10,637,439.12","10,637,439.12","This  funding  would  be  used  to  put an additional 38,600 HIV-positive patients on treatment by 2020. This budget line also include maintenance.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10637439.119999999}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Prevention for MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3987","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1l/view","25,148.69","25,148.69","This  funding  would  be  used  to  renovate  hospital  wards  for MDR-TB/RR-TB   patients   in five hospital   (Limb,   Maroua, Bafoussam,  Bertoua  and  Garoua)  in  Year  2.  The  funding wouldalso provide community care for 100 additional MDR-TB/RR-TB patients between Year 1 and Year 3.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25148.69}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Addressing stigma, discrimination and violence against PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Central Africa","Active",null,"Low","PAI-3984","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1i/view","15,746.83","15,746.83","This   funding   would   be   used   to   run   additional   training workshops for magistrates on the subject of access to health services for MSM, people who inject drugs and sex workers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":15746.83}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","HIV care","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3990","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1o/view","10,457,343.73",420.83,"This funding would enable the country's cohort to be increased from  320,000  to  358,000 patients by 2020.  It  would  support 38,000 patients to be enrolled on ART using EUR 9.3 million of Spanish funding via the Debt2Health initiative.",0,"10,456,922.9",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":420.83}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-4019","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2H/view","32,544.05","32,544.05","This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":32544.05}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for IDUs and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Central Africa","Active",null,"High","PAI-3752","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxy/view","320,735.05","320,735.05","This intervention aims to facilitate access to prevention, care and treatment services for people who inject drugs. In addition to the quarterly meeting with the Interministerial Committee for Combating Narcotic Drugs and Psychotropic Substances Abuse (CILAS) budgeted as part of the catalytic funds, this intervention will take place twice a year during the first two years and in three quarters during the final year. These studies were not budgeted for as part of the allocation amount or the catalytic funds. This intervention comprises the following activities:-Quarterly advocacy meetings with CILAS to promote a favorable, non-discriminatory, inclusive environment that takes the gender perspective into account (10,561)-Recruiting a consultant for a gender-sensitive update study that will estimate the number of people who inject drugs and map them (23,212)-A gender-sensitive update study that will estimate the number of people who inject drugs and map them (13,348)-Producing 50 copies of the report on the gender-sensitive update study that will estimate the number of people who inject drugs and map them (381)-Recruiting a consultant to conduct a satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (30,623)-A satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (10,556)-Producing 50 copies of the report on the satisfaction survey completed by the beneficiaries of the programs interventions throughout the country and in the service delivery areas (228)-Recruiting a consultant to conduct a Second-Generation Surveillance Survey (SGSS) for people who inject drugs (23,159)-An SGSS for people who inject drugs (11,771)-Producing 30 copies of the report on the SGSS for people who inject drugs (228)-A workshop to draw up and validate training modules to train 75 staff members on treatment for opioid users (8,590)-Training for 75 health workers on treatment for opioid users (28,298)-Recruiting a consultant to carry out a baseline (feasibility) study into treatment for opioid users (14,403)-Elaborating and validating a document setting out the regulations and procedures for the treatment of opioid users (9,101)-The procurement of methadone and other substitutes, amounting to one box (seven 1-mg capsules per box) per month per person who injects drugs over two years (20,428)-Treatment costs for people who inject drugs for the treatment of opioid addiction (69,516)-A baseline (feasibility) study into treatment for opioid users (11,396)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":320735.05}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Male and female condoms for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Central Africa","Active",null,"Medium","PAI-3784","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyU/view","86,223.77","86,223.77","This intervention aims to reduce HIV prevalence within this target group. Condoms were not budgeted for within the allocation amount. This intervention entailsprocuring male and female condoms for truck drivers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":86223.77}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3753","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxz/view","17,947.48","17,947.48","This intervention aims to reduce HIV prevalence within this target group. This intervention was not budgeted for within the allocation amount. This intervention entailsprocuring male condoms to raise awareness among female bar workers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":17947.48}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Inactive",null,"Low","PAI-4021","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2J/view","80,799.01",0,"This intervention will enable insecticide sensitivity tests for vectors to be carried out with the updating of the sentinel surveillance system. The financing of this intervention will support the current WHO funding for the NMCP which has proved to be insufficient because it does not cover testing in all sites. For this reason, an above allocation funding request is being made.",0,0,0,0,"80,799.01",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-4020","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2I/view","74,065.76","74,065.76","This intervention will focus on the organization of a mid-term review of the NSP 2018-2022. This will assess the NSP mid-term, with the potential to adjust the interventions. This intervention will be funded by the above allocation funding from the Global Fund. The expected impact of this module will be better planning and better coordination of malaria control interventions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":74065.759999999995}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-4022","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2K/view","72,943.55","72,943.55","This intervention will focus on the organization of World Malaria Day on 25 April each year for three years, which constitutes an opportunity to raise awareness and mobilize, targeting decision makers and key players in the fight against malaria. The expected impact of this module will be a reduction in malaria morbidity among pregnant women, as well as increased awareness and mobilization of populations and decision-makers with regard to malaria control.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":72943.55}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","Central Africa","Active",null,"High","PAI-3759","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy5/view","647,037.37","647,037.37","This is a demonstration study into the scaling-up of pre-exposure prophylaxis (PrEP) to prevent HIV infection among MSM in Benin (PrEP/MSM). We will continue to provide PrEP to maximize the reduction in HIV transmission within the MSM population.This is a HIV prevention method that involves people who do not have the infection, but who are at a high risk of it. They receive ART with Truvada to protect against potential exposure to HIV in order to reduce the risk of infection. The effectiveness of this strategy has been widely documented through several randomized trials. It reduces HIV transmission among MSM by more than 86 percent. It is a very promising preventive biomedical intervention that has a high impact on combating the HIV pandemic. This demonstration study will involve around 250 MSM.The main cost categories are: -Consultant costs (national and international) -Laboratory studies (including HIV, creatinemia, gonorrhea/chlamydia, hepatitis B serology and hepatitis C serology) -Transporting of study samples from laboratories (the Johns Hopkins University Laboratory with ARV dosage of Truvada, including the transport of samples) -Management of the monitoring and research teams -Management of the participants travel at project launch and during the four monitoring phases -Workshops to draft and validate protocols and provisional and definitive reports",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":647037.37}]
["Sao Tome and Principe",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR100-STP-Z","Other financial management intervention(s)","10/30/2019","RSSH: Financial management systems","Central Africa","Inactive",null,"Low","PAI-5644","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSU/view","16,833.13",0,"This is the assessment of the TB/HIV/malaria grant.",0,0,0,0,"16,833.13",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Burundi","12/31/2020","Malaria","FR525-BDI-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Central Africa","Active",null,"High","PAI-3707","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxF/view","520,475","520,475","This LLIN campaign is aimed at key populations (special groups, including boarding schools, military camps, prisons and orphanages that were not included in the mass campaign). The requested amount will cover (i) procurements costs for 182,000 LLINs and (ii) implementation costs for the special groups. This amount includes procurement costs and implementation costs. This activity is planned for 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":520475}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Treatment: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-5713","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTb/view","335,434.87","335,434.87","This request will make it possible to obtain all of the reagents and consumables necessary for carrying out the MDR-TB culture and sensitivity tests.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":335434.87}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","HIV testing services for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Central Africa","Active",null,"Medium","PAI-3785","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyV/view","24,388.96","24,388.96","This screening intervention will intensify prevention activities for truck drivers to provide better coverage of screening and protection among the target group, with a view to improving the framework for achieving the 909090 targets. This activity was not budgeted for within the allocation amount. This intervention entails a quarterly ten-day screening mission undertaken by four people, including a driver, aimed at truck drivers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":24388.959999999999}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Other intervention(s) for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Central Africa","Active",null,"Low","PAI-5711","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTZ/view","155,677.08","155,677.08","This sum will be needed by the stakeholders involved in implementation for the administrative management of the interventions for the island populations, equating to 7% of the total amount for the interventions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":155677.07999999999}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3972","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1W/view","2,260,063.97","2,260,063.97","This would be used for the following activities:  -Procurement   and   distribution   of   culture   laboratory products, consumables and  reagents  for LPA/Hain and TB LAM,andfor additional cases (solid and liquid).  -Improvement/refurbishment  of  culture  laboratories  (old and new).-Additional   maintenance   and   equipment   for   culture laboratories in order to retain certification.In  addition,  it  would  enable  the  purchase  of  four  new GeneXpert machines, calibration kits and waste filters for all the machines, seven  TB  LAM  machines  and  accessories in 2020,   and   25,000   additional   cartridges   for   GeneXpert MTB/RIF tests. This  activity  will  focus  on  the  second  population  at  risk  of MDR-TB -new cases with positive microscopy -whowill have a sensitivity test(GeneXpert).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2260063.9700000002}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Treatment: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-3986","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1k/view","534,321.62","363,595.55","This would be used for the following activities: -Support for community DOTS (home-based treatment by a  qualified  nurse)  for  daily  administration  of  MDR-TB drugs     to     240  additional  MDR-TB  outpatients; hospitalization costs.-Purchase of ten audiometer machines for MDR-TB in the year.",0,0,0,0,"170,726.07",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":363595.55}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3980","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1e/view","78,756.59","78,756.59","This would be used to fund regional evaluation TB/HIV meetings, and partially to fund regional data verification visits by central supervisors.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":78756.59}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Engaging all care providers (TB care and prevention)","10/30/2019","TB care and prevention","Central Africa","Active",null,"Medium","PAI-3976","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1a/view","340,419.71","340,419.71","This would be used to fund the following activities: -Activities to actively search for TB in additional (existing) health  care  facilities,  identified  as  having  high  potential for  suspected  TB  cases  and  receiving  high  numbers of adults   and  children   (primary   target   for  active case finding)-Performance incentives (different to top-ups for program managers;  this  is  an  incentive  for  service  providers  at health  care facilities with  high  potential  for  suspected cases)  for health care providers involved in the routine screening  activities  at health care facilities identified  as having high potential for suspected TB cases.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":340419.71}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Behavioral interventions for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Central Africa","Active",null,"Medium","PAI-3978","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1c/view","95,945.46","95,945.46","This  would  be  used  to  fund  training  for  some  of  the  peer educators   for  people   who inject drugs,  and  to   develop additional  BCC  activities  (educational  talks,  conferences, etc.).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":95945.46}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","HIV testing services for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Central Africa","Active",null,"Medium","PAI-3977","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1b/view","38,799.24","38,799.24","This would be used to fund training for some of the self-help groups  for  people  who  use  drugs,  and  to  develop  additional testing activities for people who inject drugs.It would also be used to supplement performance-based incentivesfor cases tested positive by peer educators among the group of people who inject drugs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":38799.24}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-3979","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1d/view","556,386.49","556,386.49","This would be used to fund various studies and evaluations, including updated mapping of key and vulnerable populations, and the midterm review of the NSP. It would also be used to fund the development of a monitoring and evaluation plan for the HIV NSP.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":556386.49}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-3988","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1m/view","708,964.2","460,956.12","This would be used to support the following activities: -Additional six-monthly mass   TB/HIV   campaigns   in prisons with more than 1,000 inmates and on a quarterlybasisin   institutions   with   less   than   1,000   inmates. Purchase   of   additional   supplies   for   TB   and   HIV prevention (infection control, safe shaving) for prisoners and support for the coordination of these activities, which will  help  to  ensure  TB  is  diagnosed  earlier  and  avoid  it being spread. In  addition,  it  would  facilitate  the  purchase  of  two  mobile digital X-ray machines exclusively for prisoners, which would significantly improve the rate of return for screening.",0,0,0,0,"248,008.08",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":460956.12}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Keeping girls in school","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Central Africa","Active",null,"Low","PAI-3982","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1g/view","787,564.81","787,564.81","This  would  be  used  towards supporting activities  for  1,500 adolescent  girls  and  young  women  in  highly  vulnerable situations. Conditionned to evidence that the activities budgeted under the alloacation are  effective.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":787564.81}]
["Cameroon",null,"HIV/AIDS, Tuberculosis","FR215-CMR-C","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3975","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1Z/view","281,062.73","281,062.73","This  would  fund  activities  to  extend  drug  dispensing  and monitoring  software  to  40 additional  health  care  facilities between 2018 and 2020.It would also cover the validation of community data, and the harmonization  and  production  of  community  data  collection tools for MSM, SWs, people who inject drugs and transgender people.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":281062.73}]
["Congo","4/30/2021","Malaria","FR214-COG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Inactive",null,"High","PAI-4017","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2F/view","62,843.68",0,"To assess the level of knowledge of the population on the modes of transmission and means of prevention of malaria, a KAP survey is planned as part of the above allocation funding request.",0,0,0,0,"62,843.68",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Benin","12/31/2020","Malaria","FR410-BEN-M","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"High","PAI-3816","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz0/view","110,260.35","110,260.35","To be effective in vector control, it is necessary to carry out vector susceptibility tests to determine the status of the vector against insecticides available on the international market. This study is conducted as a prelude to IDP campaigns to select the appropriate insecticide. The latest study conducted in 2017 noted that pyrimiphos methyl remains the sensitive insecticide from which it was chosen during the 2017 IRS campaign",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":110260.35}]
["Central African Republic","12/31/2020","Malaria","FR630-CAF-M","Facility-based treatment","2019-04-12","Case management","Central Africa","Active",null,"High","PAI-6196","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnI/view","1,878,183","1,878,183","To ensure sound management of commodities procured with Global Fund grant funds and their availability in CAR, the World Food Program (WFP) was selected as SCM partner, given their known expertise and logistical capacity. WFPs budget and costs cover transportation of inputs in country, insurance, warehousing, handling, security and support costs. The original budget that was estimated to cover their services during three years of implementation reached EUR 2,100,000 and did not include management fees paid to WFP. Given WFPs budget rate consumption so far and projected level of expenses at the end of 2019, EUR 2,326,922, it results in a EUR 226,922 over expenditure (10% above original budget planned for this purpose). This budget only covers logistics of health products excluding mosquito nets. Note that for the year 2019 the Global Fund had recommended that these costs should not exceed EUR 1,260,000.During year 2020, there will be an increase of number of functional health facilities (going from 736 to 838) in the country that will result in an increase demand of commodities (ACTs and RDTs, partly covered with grant savings), transportation costs (especially considering that their estimation is based on volume), warehousing and insurance. Adding this, the projected budget needs for WFP in 2020 (which are estimated on current budget absorption) raise up to EUR 1,653,302. If we consider the above mentioned 10% over expense, the funding gap is EUR 1,880,224. However, some efficiencies in country (identified in other budget lines) will contribute to cover part of the gap. Which results in a final gap of EUR 1,673,649.68.","1,673,649.68",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1878183}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Medium","PAI-4093","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3T/view","86,358.43","86,358.43","To have a better understanding of modes of transmission of new HIV infections and to better use these data, a study on the modes of HIV transmission is planned, to orient strategic decisions for HIV prevention. Also, an audit of patient data will be performed and ART cascade will be determined to provide baseline data that will enable to measure progress toward achieving the three 90s by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":86358.43}]
["Gabon","12/31/2021","Tuberculosis","FR42-GAB-T-01","Collaborative activities with other programs and sectors (TB/HIV)","10/30/2019","TB/HIV","Central Africa","Active",null,"High","PAI-4262","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6C/view","6,569.41","6,569.41","To strengthen the collaboration between the TB and HIV programs and decrease TB / HIV co-infection mortality through TB / HIV coordination meetings at both national and regional levels and the creation of six new single wards for joint management of both TB and HIV pathologies among the 12 new CDTs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6569.41}]
["Togo","12/31/2020","Malaria","FR111-TGO-M","Service organization and facility management","10/30/2019","RSSH: Integrated service delivery and quality improvement","Central Africa","Active",null,"High","PAI-5727","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTp/view","3,354,046.68","1,854,046.68","Togo launched a project in 2017 to improve the quality of integrated HIV, tuberculosis (TB) and malaria care in antenatal and postnatal services, with technical assistance from the Liverpool School of Tropical Medicine. This project aims to introduce quality standards in public health care facilities that will in time be established as centers of excellence. The funding requested will enable follow-up with the initial critical phase, to inform new health policies and steer national rollout.",0,0,0,"1,500,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1854046.68}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","Central Africa","Active",null,"Medium","PAI-3768","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyE/view","27,184.38","27,184.38","Train 20 auxiliary nurses in each health district on PMTCT/IMPC and early diagnosis through dried blood spots in the health districts not covered by UNICEF (25) during 15 three-day sessions with 20 participants (plus two facilitators, one supervisor, one driver and one accountant) in 2018 and 2020:This is an important activity for the program that will help achieve universal coverage of PMTCT and contribute to the ETME.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":27184.38}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Central Africa","Active",null,"Low","PAI-4044","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2g/view","226,861.18","226,861.18","Train 43 laboratory technicians in acid-alcohol fast bacillus microscopy and rapid HIV tests. One training session will be organized per Center, with 4 training centers in year 1 (Brazzaville Center, 12; Pointe-Noire Center, 11; Owando Center, 10; Impfondo Center, 10).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":226861.18}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Medium","PAI-3769","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyF/view","51,518.35","51,518.35","Train 250 paramedics and medics in care for patients receiving antiretroviral therapy (ART) (184 providers from the 92 former sites, 24 from the new sites and 42 participants from the central level and the Information and Support Centers for STIs, HIV and AIDS (CIPEC)). The training will take place over ten sessions with 25 participants, two facilitators, one supervisor, one manager and two drivers: This activity is important for the delegation of tasks to paramedics and ensuring the quality of care despite the limited number of doctors in care facilities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":51518.35}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Central Africa","Active",null,"High","PAI-3811","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyv/view","282,796.54","282,796.54","Train medical and paramedical staff in treatment for sexually transmitted infections (STIs) and disseminate the algorithm.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":282796.53999999998}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Central Africa","Active",null,"Medium","PAI-3773","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyJ/view","30,821.46","30,821.46","Train providers on the use of tools to assist treatment adherence during six three-day sessions:This activity aims to improve care, given the risk of patients abandoning treatment linked to early diagnosis and the improved survival rate of PLHIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30821.46}]
["Burundi","12/31/2020","Tuberculosis","FR578-BDI-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Central Africa","Active",null,"High","PAI-3718","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxQ/view","34,166","34,166","Training of laboratory technicians / microscopists.The PNILT intends to form one unit per CDT (170 CDT) with 60 units in 2018, 60 units in 2019 and 50 units in 2020:",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":34166}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Central Africa","Active",null,"High","PAI-3754","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy0/view","83,144.43","83,144.43","Transport viral load samples from care facilities to molecular biology platforms on a monthly basis: Provide access to viral load testing for facilities located far from the molecular biology platform.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":83144.429999999993}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR289-COG-C","Other intervention(s) for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Central Africa","Active",null,"Low","PAI-4047","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2j/view","112,220.85","112,220.85","Under the current concept note, mapping of meeting sites combined with a bio-behavioral study of SWs, MSM and people who inject drugs is being conducted in the dpartements of Brazzaville, Pointe-Noire, Niari and Sangha. This mapping will therefore need to be extended to the dpartements of Bouenza and Kouilou, where the key populations are growing due to the recent arrival of oil and mining companies.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":112220.85}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","Central Africa","Active",null,"High","PAI-3809","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyt/view","26,971.16","26,971.16","Undertake mentoring on PMTCT/IMPC and early diagnosis through dried blood spots.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":26971.16}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Central Africa","Active",null,"Low","PAI-3808","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIys/view","17,963.19","17,963.19","Update the PLHIV biometric database periodically",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":17963.189999999999}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","Treatment: MDR-TB","10/30/2019","MDR-TB","Central Africa","Active",null,"High","PAI-5714","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTc/view","817,904.3","817,904.3","Using State funding, the NTBCP has acquired a MDR-plus/sl machine for the completion of Hain tests for all patients screened for RR-TB.To supplement the consumables and reagents included in the allocation amount, this request will make it possible to obtain all of the reagents and consumables required for performing first and second-line sensitivity tests",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":817904.3}]
["Congo","12/31/2020","HIV/AIDS, Tuberculosis","FR558-COG-C","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","10/30/2019","PMTCT","Central Africa","Inactive",null,"High","PAI-4046","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2i/view","790,791.16",5.8207660910000002E-11,"Viral load testing for 50% of the new enrollments under PMTCT. Increase in Early Infant Diagnosis (EID) coverage from 6% to 30% by 2020; and increase pediatric ART coverage from 37% to 49% (with additional 269 cases).",0,0,0,"335,000","455,791.16",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5.8207660910000002E-11}]
["Chad",null,"HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z","HIV testing services for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Central Africa","Active",null,"High","PAI-5717","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTf/view","348,461.12","348,461.12","Voluntary counseling and testing (VCT) for HIV: - Differentiated screening: with the aid of the task delegation standards, the peer educators will be trained to screen their peers during advocacy sessions on the islands and islets. The first screening sessions will be carried out under the supervision of a health worker. If a person tests positive for HIV, the peer educator will refer him/her to a health-care center for confirmation and treatment using a referral sheet. He/she will then be made aware of family screening. Having tested positive, he/she will be given repeat supplies by the association or health center on which he/she depends. Actions to be carried out: i) advocacy, ii) HIV screening, iii) training, iv) availability of screening kits, v) waste management (peer educators will be given safety boxes to collect waste and transport it to the reporting health center for destruction) and vi) reporting of cases to the health-care center.- Advanced strategy screening: Advocacy and screening teams will be composed as follows: 1 peer educator, 1 nurse, 1 midwife and 1 community leader. Advocacy activities and TB and HIV screening for the island populations will be carried out by the teams, which will each complete a day-long visit to cover 1,000 people per quarter. ii) Percentage of the island population who have had a HIV test and know the results during the reporting period.Country targets: 14% (32,200/230,000) in 2019; 17% (39,387/238,084) in 2020; 19% (47,397/246,494) in 2021. All of these targets are assigned to the Global Fund.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":348461.12}]
["Benin","12/31/2020","HIV/AIDS","FR520-BEN-H","Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Central Africa","Active",null,"Medium","PAI-3791","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyb/view","39,980.92","39,980.92","With regard to women and girls in Benin, according to the national gender promotion policy that has been developed, socioeconomic factors in the country tend to confer inferior status to women compared with men, particularly in the areas of education, employment, health and access to land and finance. Stereotypes and gender roles increase the vulnerability of women and girls to HIV and AIDS and restrict their access to existing information and services. The submission of women and girls demanded by tradition makes them subject to certain types of violence: levirate, early or forced marriage, sexual violence, sexual relations with older partners, etc. In addition, the imbalance of power makes women less able to negotiate the use of condoms or to choose their sexual partner.Education sessions on gender-based violence and training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence are aimed at reducing HIV prevalence within this group. The sessions will address gender discrimination, harmful gender norms and all types of violence against women and girls in relation to HIV.In detail, this intervention comprises the following activities:-Training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence (six sessions with 25 participants each, lasting two days) (20,754)-Educational sessions on HIV, health education, sexual and reproductive health and rights, new forms of masculinity and the prevention of gender-based violence for Plan International Benin staff members (session with one coffee break for 30 people per month and for five teams) (1,372)-Recruitment of a consultant to undertake an evaluation study of the legal setting for key populations (13,500)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":39980.92}]
["Cabo Verde",null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z","Entomological monitoring","10/30/2019","Vector control","Central Africa","Active",null,"Medium","PAI-4092","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3S/view","177,571.54","177,571.54","With support from WHO, the Global Fund and partners, the INSP has recently established a medical entomology laboratory, which enables monitoring the distribution and density of vector mosquitoes within the country. It is expected to acquire equipment to improve entomological monitoring to ensure that the response is as efficient as possible. These acquisitions are intended to supplement those taken into account in the allocation amount.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":177571.54}]
["Ukraine","12/31/2020","HIV/AIDS, Tuberculosis","FR100-UKR-C","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Eastern Europe and Central Asia","Active",null,"High","PAI-5898","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWa/view","11,317,522","11,317,522","1. Improving technical capacity of the laboratories2. Developing  technical compliance and biological safety and security.3. Building of 4 regional reference centers (This was considered as low priority by TRP).4. Capacity building and support to the national surveillance system.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11317522}]
["Azerbaijan","12/31/2020","Tuberculosis","FR317-AZE-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-3644","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwE/view","59,269","59,269","1. Procurement of additional 1000 Xpert cartridges/year;2. Operational research on prevalence of the latent TB infection among prison population and revising the algorithm for active case finding for penitentiary sector",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":59269}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Stigma and discrimination reduction","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Eastern Europe and Central Asia","Active",null,"Low","PAI-3634","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw4/view","48,927","48,927","1. Strengthen stigma related capacity for medical personnel of ART centres.2. Organization of 2 communication campaigns organized per year in the eve of notable days (WAD, Candlelight) to build public awareness and reduce stigma and discrimination.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":48927}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Capacity building for health workers, including those at community level","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Eastern Europe and Central Asia","Active",null,"High","PAI-3642","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwC/view","97,684","97,684","1. Training for community health workers on ARV treatment.2. Participation in trainings, international conferences for Republican AIDS Centre, MoJ staff and NGOs in priority issues of HIV/AIDS.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":97684}]
["Multicountry HIV EECA APH","12/31/2021","HIV/AIDS","FR545-MCEECAAPH-H-01","Improving laws,regulations and polices relating to HIV and HIV/TB","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Eastern Europe and Central Asia","Active",null,"High","PAI-4806","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEy/view","982,000","165,119","Activities:- Assessments of legal and regulatory barriers for access to services for KPs in SEE;- Advocacy plan on national level related to key legal and policy barriers regarding challenges for implementing social contracting mechanism within Ministry of Health in SEE;- Implementation of advocacy plan and social contracting mechanism put in place for financing CSOs preventive services for key population in SEE;- ENPUD, SWAN, ECOM oversee documentation of human rights and access to service barriers (developed by EHRA) in  Balkans countries for their respective KPs;- SEE countries regional training on documentation and reporting on human right violation by community and situation analysis by EHRA;- Workshop for Country Coordination Mechanism  in SEE on strengthening the role and imfluence of key populations representatives, by ECOM;- EECA platform for PWID partners with EURONPUD and conducts annual regional forums;- Community mobilization and empowerment of SW in SEE by SWANExpected results:- Social contracting mechanism within MoH is regulated with appropriate by-laws and procedures in all 5 SEE countries, pertaining to minimum criteria for implementing organizations, selection procedures, contracting and payments and reporting, monitoring and evaluation;- CSOs are formally recognized as service providers for HIV prevention and support in the legislation of 5 SEE countries;- Developed manuals and protocols for implementation of new standards in 5 SEE countries;- PWID, SW and MSM communities are strengthened in SEE to play a meaningful role in national dialogues on programming, transition, and to receive national resources to support their ongoing activities.",0,0,0,0,"816,881",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":165119}]
["Multicountry HIV EECA APH","12/31/2021","HIV/AIDS","FR545-MCEECAAPH-H-01","Public financial management (PFM) strengthening","10/30/2019","RSSH: Financial management systems","Eastern Europe and Central Asia","Active",null,"High","PAI-4807","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEz/view","1,695,500","380,884","Activities:- Sharing good practices on transition in Macedonia and Montenegro across EECA ;- Documenting good SEE country practices on financial and political sustainability within the countries of EECA region ;- Organizing annual coordination regional meeting of SEE RCM;- Technical assistance on Budget advocacy, Public Finance and Budget Policy, formation and implementation of Social Policy  in 5 SEE countries;- Training for budget advocacy in 5 SEE countries and common regional advocacy;- Technical assistance to the SEE national decision-makers and civil society representatives in the revision, development and institutionalization of unified unit-costs for standard HIV-prevention and HIV-care services packages for PLHIV and KPs; - Development of budget advocacy plan at national level in 5 SEE countries;- Implementation of budget advocacy plan at national level in 5 SEE countries;- Investigate, develop and promote innovative models and sources of funding, to complement social contracting in 5 SEE countries;- Online tool for monitoring transition plans in EECA region developed by ECOM; - Analyse allocations, produce report and disseminate it in regional consultation on best prectices on implementation of transition plans in EECA by EHRA, using data from ECOM developed online tool;- Hold 4th regional forum for MSM and TG by ECOM.Expected results:- Strengthened governance of the SEE regional level through national response to HIV through formalized good practices of operation and decision-making of the National governance bodies;   - Best practices identified and shared within EECA region in terms of CCM role and evolution and Macedonian and Montenegro case in transition;- Optimized budgets for HIV prevention programs for different KAPs are developed and used in budgeting of national HIV programs in 5 SEE countries;- Generated strategic information, including on the treatment cascade, cascade of HIV services, prevalence and behavioral data to feed into planning of the national HIV programs and strategic plans and into civil society and community-based advocacy for adequate funding and scale-up of services in 5 SEE countries;- Civil society and community representatives are meaningfully engaged in annual program and budget planning of national HIV programs in 5 SEE coutries;- CSOs in all 5 SEE countries receive national funding to implement HIV programs for key populations;- At least 1 M USD is released additionally for key populations programs in 5 SEE countries in total in the lifetime of the grant;- Community monitoring tools are developed and implemented in 5 SEE countries; - Developed national guidance for continuous and reliable provision of ARVs for Ministry of Health in 5 SEE countries;- Transition plans are effectively and systematically monitored across EECA.",0,0,0,0,"1,314,616",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":380884}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","HIV testing services for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"High","PAI-5984","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXy/view","148,362.7","148,362.7","Additional funds for PWID programmes will be used for increasing counselling and testing for HIV, HBV and HCV in NGO centres in Pristina, Prizren and Gjilan.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":148362.70000000001}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","HIV testing services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"High","PAI-5986","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJY0/view","11,429.69","11,429.69","Additional funds for sex workers programmes will be used for increasing HIV counselling and testing in medical facilities includes, by providing incentives for sex workers to get tested.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11429.69}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","HIV testing services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"High","PAI-5987","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJY1/view","5,942.09","5,942.09","Additional funds for sex workers programmes will be used for increasing HIV counselling and testing in NGO-supported VCT centres, by supplying test kits and other commodities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5942.09}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Improving laws,regulations and polices relating to HIV and HIV/TB","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Eastern Europe and Central Asia","Active",null,"High","PAI-5990","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJY4/view","3,433.96","3,433.96","Additional funds will be used for training of police and other stakeholders regarding Human Rights-related issues that affect access to HIV prevention, care and treatment services for KPs and PLHIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3433.96}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Improving laws,regulations and polices relating to HIV and HIV/TB","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Eastern Europe and Central Asia","Active",null,"High","PAI-5989","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJY3/view","12,680.96","12,680.96","Additional funds will be used to amend the legislation for social sub-contracting of NGOs and advocate for HIV prevention service delivery by NGOs using domestic financing.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12680.96}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Eastern Europe and Central Asia","Active",null,"High","PAI-5975","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXp/view","33,666.26","33,666.26","Additional funds will be used to conduct additional advocacy activities at local level in support of enabling environments for service delivery among KAPs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":33666.26}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-5974","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXo/view","89,776.68","89,776.68","Additional funds will be used to conduct IBBS and population size estimates among KAPs in 2020, and to use findings of these studies for decision-making.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":89776.68}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Eastern Europe and Central Asia","Active",null,"High","PAI-5978","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXs/view","20,704.75","20,704.75","Additional funds will be used to further develop and support networking of community groups, particularly of key populations, to ensure social mobilisation, representation and advocacy at national level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20704.75}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Eastern Europe and Central Asia","Active",null,"High","PAI-5977","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXr/view","1,009.99","1,009.99","Additional funds will be used to further support the participation of community actors (including key populations) in local and national decision-making/consultative bodies.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1009.99}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Improving laws,regulations and polices relating to HIV and HIV/TB","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Eastern Europe and Central Asia","Active",null,"High","PAI-5988","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJY2/view","8,248.23","8,248.23","Additional funds will be used to intensify efforts of policy dialogue aiming at removing existing legal barriers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8248.23}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Eastern Europe and Central Asia","Active",null,"High","PAI-5981","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXv/view","46,459.43","46,459.43","Additional funds will be used to raise awareness amongst KAPs and PLHIV community members about their legal and other entitlements, and for development of community sector services including gender-sensitive services that are critical but under-supported within the grant's allocation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":46459.43}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Capacity building for health workers, including those at community level","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Eastern Europe and Central Asia","Active",null,"High","PAI-5980","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXu/view","20,603.75","20,603.75","Additional funds will be used to support HIV related trainings for outreach and medical workers who work with PWIDs, MSM, SW: this will strengthen the continuum of care and collaboration between civil society and government healthcare providers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20603.75}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Eastern Europe and Central Asia","Active",null,"High","PAI-5976","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXq/view","3,029.96","3,029.96","Additional funds will be used to support planning for community sector-led service delivery including monitoring, supervision, quality assurance, and integration with other services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3029.96}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Capacity building for health workers, including those at community level","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Eastern Europe and Central Asia","Active",null,"High","PAI-5979","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXt/view","5,049.94","5,049.94","Additional funds will be used to support professional development for community workers for professional ethics, human rights, stigma reduction and development and dissemination of good practice standards.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5049.9399999999996}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Institutional capacity building, planning and leadership development","10/30/2019","RSSH: Community responses and systems","Eastern Europe and Central Asia","Active",null,"High","PAI-5982","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXw/view","3,366.63","3,366.63","Additional funds will be used to support the development of transition plan to absorb HIV human resources-related costs (i.e. staff currently supported by the grant).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3366.63}]
["Tajikistan","12/31/2020","HIV/AIDS","FR100-TJK-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"High","PAI-5795","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUv/view","2,800,000","2,800,000","Aiming to scale up to reach 73.9% (10,800 individuals) of PLWH who aware their status, on ART. The cost also includes VL and CD4 testing. The expected outcome is to achieve viral suppression as per treatment as prevention initiative.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2800000}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Inactive",null,"High","PAI-4948","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHG/view","45,000",0,"Annual workplan meetings for effective multi-partner coordination of the project implementation.",0,0,0,0,"45,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Tajikistan","12/31/2020","HIV/AIDS","FR100-TJK-H","Other intervention(s) for TGs","10/30/2019","Comprehensive prevention programs for TGs","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5797","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUx/view","50,000",0,"As there is currently a lack of information on the TG population, this request will develop IBBS and GIS to create mappings to guide interventions for TG persons.",0,0,0,0,"50,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"Low","PAI-3598","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvU/view","32,000","32,000","Assess behaviour change and influence of stigma, discrimination and social exclusion in certain KPs (LGBTQ / sex workers) in Albania through a national study",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":32000}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"Low","PAI-3599","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvV/view","20,000","20,000","Assess current Viral Hepatitis treatment capacities and capabilities (drugs, guidelines, services etc)  for Albanian population and especially risk groups",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20000}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3594","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvQ/view","9,750","9,750","Assess sex worker conditions and legislation and implications for their security and health",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9750}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-5622","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJS8/view","71,190.66","71,190.66","Bio-BBS tracking the trends in behaviour and HIV-prevalence should be conducted every 2-3 years. The last Bio-BBS was conducted in 2013 and Serbia is missing data on outcome and impact indicators, which helps to evaluate the efforts in controlling the HIV/AIDS epidemic. IBBS to be conducted in 2019 to evaluate the services provided and make improvements in 2020. Second round is planned in 2021.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":71190.66}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Addressing stigma, discrimination and violence against people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","Eastern Europe and Central Asia","Active",null,"High","PAI-3640","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwA/view","13,595","13,595","Build awareness of key decision makers on evidence-based HIV prevention interventions in penitentiary sector. Activities include information and advocacy meetings (round tables/workshops) to increase awareness about evidence-based HIV prevention intervention in prisons.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":13595}]
["Romania","3/31/2021","Tuberculosis","FR320-ROU-T","Capacity building for health workers, including those at community level","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5462","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPY/view","448,883.4","448,883.4","Capacity building for implementers of the National TB Strategy (Marius Nasta Institute staff, county coordinators, central and local authority representatives) in programmatic, financial management, and procurement, participation at international capacity building events (trainings, conferences), regional and national management meetings for TB stakeholders for improving the capacity of strategic planning based on collected data.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":448883.4}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","Prevention, diagnosis and treatment of opportunistic infections","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5912","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWo/view","45,012",0,"Cartridge for GeneXpert  for TB  diagnostics.",0,0,0,0,"45,012",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Community MDR-TB care delivery","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-4616","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBu/view","316,980","316,980","Case management services utilizing people centered approach will be provided by local NGOs building on successful models implemented by GF and other donors. Case management activities include evaluating patients risks to interrupt or default from treatment, raising patients awareness on TB diagnostics and treatment and infection control. Follow up activities include screening patient family members and close contacts as part of active case finding interventions. These interventions will reach up to 250 patients with high risk of treatment default annually nationwide.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":316980}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5911","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWn/view","306,180",0,"CD4 tests for treatment monitoring in patients receiving therapy  under the grant.",0,0,0,0,"306,180",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-4946","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHE/view","80,000","69,750","Collect evidence on access barriers through patient pathway analysis (additional countries). Better data on who is missed (geographically and by key populations) and analysis of pathway barriers and bottlenecks with development of subnational differentiated responses.",0,0,0,0,"10,250",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":69750}]
["Turkmenistan","6/30/2021","Tuberculosis","FR198-TKM-T","Institutional capacity building, planning and leadership development","10/30/2019","RSSH: Community responses and systems","Eastern Europe and Central Asia","Active",null,"High","PAI-5805","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJV5/view","100,000","100,000","Community involvement to TB care is weak due to the  lack  of  social  contracting  mechanisms.  Civil society formally   participates in  the Country Coordinating  Mechanism.  Proper  involvement  of CSOs is stipulated in the National Programme for TB Prevention and Control, 2016-2020. However, the only CSO with meaningful engagement to TB care is the National Red Crescent Society through the  Global  Fund  grant,  and its  role is  limited to service provision. The transitional grant includes  technical  support  with  establishing  legal and  financial  mechanisms  for  direct  contracting and building  capacities  of  CSOs  as  to  enhance  their contribution to the national TB response. In order to  increase the number of CSO involved in  providing   TB  prevention  and  treatment adherence support interventions, under Prioritized Above Allocation Budget CCM is asking to fund  a Small grants program for CSOs. The project will support the first grants aiming at involvement of the CSOs in TB control activities, including  work  on  reducing stigma, dissemination of information, advocacy for ambulatory  model,  or support to patients  during ambulatory treatment (focus on women patients or other vulnerable groups).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"High","PAI-5611","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRx/view","3,212.88","3,212.88","Comprehensive prevention programs for sex workers and their clients",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3212.88}]
["Tajikistan","12/31/2020","HIV/AIDS","FR100-TJK-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5798","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUy/view","900,000","817,459","Condom and counselling will be expanded to SW to improve the accessibility of services. Violation against women, SW, girls will be reported. Client will receive psycho-social support. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.",0,0,0,0,"82,541",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":817459}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Inactive",null,"Medium","PAI-5915","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWr/view","82,869",0,"Condoms for HIV prevention among discordant couples and food packages for social support for socially unprotected PLHIV.",0,0,0,0,"82,869",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3620","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvq/view","137,335","137,335","Conduct next round of IBBSin KPs; IBBS will be done in late 2019. Given the high cost, the Transition grant cannot finance it, but if available, PAAR could finance the next round in 2022.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":137335}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4939","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJH7/view","60,000","60,000","Conduct regulatory framework assessment encapsulating the elements, including health financing (HF), Human Resources in Health (HRH) and Health System Delivery (HSD), self- assessment of the regulatory documents, to enable implementation of people-centered model of TB care.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60000}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Pre-exposure prophylaxis (PrEP) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"High","PAI-5623","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJS9/view","114,459.66","114,459.66","Conducting PrEP pilot project among MSM at high risk in Belgrade which would be the first one in Balkan region. PrEP is the first biomedical intervention which reduces HIV acquisition among MSM at highest risk. Implementing PrEP strategy on a large scale requires understanding the parameters of implementation in Serbian environment (sexual practices, level of interest, acceptability) and  collaboration between CSOs and health care providers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":114459.66}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5914","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWq/view","188,864",0,"Conduction of IBSS will allow in the dynamics to monitor the HIV epidemic process trends and their relationship to risky behavior among key populations, and will provide necessary information to take informed decisions when formulating strategies for combating HIV infection.",0,0,0,0,"188,864",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"Low","PAI-3607","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvd/view","6,724","6,724","Counselling Services: Counselling support fordiscordant couples",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6724}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"High","PAI-5626","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSC/view","6,425.77","6,425.77","CSW Training of outreach workers",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6425.77}]
["Belarus","12/31/2021","HIV/AIDS","FR650-BLR-H","Behavioral interventions for PWID","11/25/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"High","PAI-6170","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJit/view","556,161.96","556,161.96","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.","556,161.96",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":556161.96}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-4944","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHC/view","115,000","115,000","Developing and introducing a context-adapted capacity increasing module targeting facility levels of provision of people-centered care. Increase provider capacity and standardize quality of services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":115000}]
["Tajikistan","3/31/2021","Tuberculosis","FR580-TJK-T","Procurement strategy","10/30/2019","RSSH: Procurement and supply chain management systems","Eastern Europe and Central Asia","Inactive",0,"High","PAI-5804","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJV4/view","350,000",0,"Development and operationalization of the medicines QA/QC system",0,0,0,0,"350,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4599","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBd/view","35,176","35,176","Development of GX Alert system nationwide to expedite the availability of GeneXpert results for clinicians",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":35176}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","OST and other drug dependence treatment for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5916","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWs/view","249,690","124,824","Drugs and Opiate tests to expand the OST program for 50 PLHIV / IDUs receiving ART.",0,0,0,0,"124,866",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":124824}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"High","PAI-3637","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw7/view","70,148","70,148","Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services (currently HIV services are only provided in Yerevan). The vision is to further expand Echo in other areas of health in collaboration with the recent Asian Development Bank (ADB) program focused on health sector policy reforms to strengthen efficient utilization of resources and to improve quality of services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":70148}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Behavioral interventions for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"High","PAI-3633","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw3/view","328,814","328,814","Echo is a tele-medicine platform developed at the University of New Mexico to serve rural populations, and which has been used by US CDC as a method for introducing new approaches in clinical practice in elimination of HIV and Hep C, and then has been also extended for TB. It was successfully introduced in Georgia for these three diseases. It links expert specialist teams at an academic hub with primary care clinicians in local communities. It allows primary care clinicians/TB or HIV doctors from multiple sites present patient cases to the specialist teams and to each other, discuss new developments relating to their patients, and determine treatment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":328814}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Treatment adherence","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"High","PAI-4611","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBp/view","865,080","865,080","Eight multidisciplinary teams will be supported at base of AIDS Centeres and PHC to implement the activities for PLHIV: motivational trainings and self-support groups, SRH services, viral hepatitis B &C prevention and treatment, dental services. Three additional NGOs from PLHIV community will be supported. These interventions will contribute to achieving targets of the main grant (coverage of 80% of PLHIV by 2020, the achievement of viral suppression in 70% of them).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":865080}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","HIV testing services for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Inactive",null,"Medium","PAI-5917","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWt/view","403,200",0,"Encouraging packages for attracting representatives of vulnerable groups to HIV testing (for testing 19,200  PWID).",0,0,0,0,"403,200",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","HIV testing services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Inactive",null,"Medium","PAI-5908","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWk/view","220,500",0,"Encouraging packages to attract representatives of vulnerable groups to HIV testing (for testing 10500 SW).",0,0,0,0,"220,500",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Inactive",null,"Medium","PAI-5909","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWl/view","16,800",0,"Encouraging packages to attract vulnerable groups to HIV testing (for testing 800 MSM).",0,0,0,0,"16,800",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"Low","PAI-3602","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvY/view","12,350","12,350","Establish a quality assurance monitoring system of HIV prevention, treatment care and support services",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12350}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-3601","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvX/view","9,750","9,750","Establish a sustainable sentinel surveillance system for HIV/STI/Viral Hepatitis in KPs (MSM, sex workers, prisoners) by a partnership of government structures with civil society and other partners",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9750}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other intervention(s) for IDUs and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3592","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvO/view",750,750,"Establish auditing programmes for MMT services",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":750}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other intervention(s) for IDUs and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"Low","PAI-3604","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIva/view","2,250","2,250","Establish auditing programs for KP (sex workers, LGBTQ, PWID) health and social services offered by all stakeholders",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2250}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other intervention(s) for IDUs and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"Low","PAI-3603","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvZ/view","1,500","1,500","Establish guidelines and provide KP-specific friendly health services (PWID, sex workers,  Roma)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1500}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"Low","PAI-3605","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvb/view","9,500","9,500","Establish online resource centre with materials and training courses (in Albanian) for professionals and NGOs on KP (sex worker, LGBTI) health and social services",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9500}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Eastern Europe and Central Asia","Active",null,"High","PAI-3617","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvn/view","40,344","40,344","Establish outreach programmes of VCT services in most-at-risk communities",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":40344}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"Low","PAI-3616","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvm/view","7,500","7,500","Establish service performance indicators and their measurement",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7500}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3595","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvR/view","15,250","15,250","Establish standards for Key population social and health services (sex workers, LGBTI)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":15250}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"Low","PAI-3615","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvl/view","9,350","9,350","Evaluate pilot of a new technology in TB and HIV care, such as Video Dots",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9350}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"Low","PAI-3597","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvT/view","10,100","10,100","Evaluate pilot of PREP for MSM to assess its impact",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10100}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Prevention for MDR-TB","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-4590","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBU/view","482,640","482,640","Funding is requested to support the procurement of masks and respirators, as well as UV lamps for TB facilities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":482640}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Eastern Europe and Central Asia","Active",null,"Low","PAI-4605","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBj/view","148,305","148,305","Funding to support the operation and maintenance (recurrent cost) of a new Osh lab expected to be installed in Osh in 2019, with support from USAID Challenge TB project",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":148305}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","HIV testing services for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"High","PAI-5973","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXn/view","24,522.5","24,522.5","Given limited amount allocated to HIV prevention services among MSM in the grant, additional funds will be used to expand VCT delivered by NGOs. It will help to attain targets set.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":24522.5}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Behavioral interventions for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"High","PAI-5983","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXx/view","31,757.38","31,757.38","Given limited amount allocated to HIV prevention services among PWID in the grant, these additional resources will be used for additional outreach workers and peer educators. It will help to attain targets set.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":31757.38}]
["Kosovo","12/31/2020","HIV/AIDS","FR265-QNA-H","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"High","PAI-5985","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXz/view","10,099.88","10,099.88","Given limited amount allocated to HIV prevention services among sex workers in the grant, these additional resources will be used for additional outreach workers and peer educators. It will help to attain targets set.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10099.879999999999}]
["Armenia","9/30/2021","HIV/AIDS, Tuberculosis","FR538-ARM-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"High","PAI-3629","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvz/view","540,000","495,000","HCV treatment procurement for HIV positive and HCV treatment monitoring for 600 persons during the 2,5 years periodSocial support program (cash-incentives for adherence to treatment) for patients with DS (regular) TB.HCV represents a growing concern with the prevalence among seasonal urban migrants found to be 3.3% in 2018 IBBS study. MoH and NCAP have piloted DAA HCV treatment with medicines donated by the Georgian government and MSF. MoH and NCAP are currently negotiating continued HCV treatment programmes with producers and suppliers of DAA medications. While these negotiations are under was modest number of treatment courses required to treat HIV/HCV coinfected patients is included in the above allocation request.",0,0,0,0,"45,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":495000}]
["Armenia","9/30/2021","HIV/AIDS, Tuberculosis","FR538-ARM-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Inactive",null,"High","PAI-3628","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvy/view","120,000",0,"IBBS (Integrated Biology and Behavioural Survey) among PWID, MSM, TG, SW, Migrants in Y2 in order to assess the situation and measure progress in HIV prevention and treatment.The previous IBBS studies have been funded by the Global Fund grants. The government has not yet assumed this function, hence funding for IBBS studies is included in the above allocation request.",0,0,0,"120,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Community TB care delivery","10/30/2019","TB care and prevention","Eastern Europe and Central Asia","Active",null,"Low","PAI-3611","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvh/view","6,000","6,000","Implement ACSM activities during the World TB Days. Various ACSM activities, including the organization of a nation-wide conference for TB professionals, will be conducted on and around the World TB Day 24 March, following the topics will be  proposed for each years campaign",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6000}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Administrative and finance data sources","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-3619","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvp/view","33,500","33,500","Implement OneHealth tool to harmonize and strengthen health system analysis, costing and financing scenarios at the country level",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":33500}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Prevention, diagnosis and treatment of opportunistic infections","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"Low","PAI-3600","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvW/view","7,850","7,850","Improve diagnostic capacities for OI (according to guidelines) by Training of microbiologist and ID for diagnosis of OI",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7850}]
["Tajikistan","12/31/2020","HIV/AIDS","FR100-TJK-H","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","Eastern Europe and Central Asia","Active",null,"High","PAI-5794","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUu/view","350,000","255,936","Improve overall health outcomes, reduce costs and gain efficiencies. Offering service in different modalities to increase clients and reduce workload. Scale up access in nationwide in any location.",0,0,0,0,"94,064",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":255936}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-3590","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvM/view","11,600","11,600","Improve the database system for HIV by web linking of laboratory and epidemiological data. This would further strengthen the HIV database that is already being developed.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11600}]
["Armenia","9/30/2021","HIV/AIDS, Tuberculosis","FR538-ARM-C","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Inactive",null,"Medium","PAI-3627","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvx/view","58,000",0,"Improvement of client registration, unification of coding system and integration of programme monitoring data into common database. Training regarding stigma and discrimination - in total 5 trainings were budgeted. Trainings for outreach workers - in total 5 trainings were budgeted.In order to strengthen programme monitoring and reporting accuracy and avoid potential duplication of efforts (e.g. of Men who have Sex with Men (MSM), SW and PWID activities funded by the Global Fund and EJAF) Principal Recipient will introduce uniform Unique Identification Code across projects and organisations and pursue integration of monitoring systems and introduction of a shared database. Accurate programme reporting is essential for adequate target setting and precise measurements of achievements in the response to the epidemic. Introduction of these innovations will require training for field workers.",0,0,0,"44,210","13,790",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Treatment: MDR-TB","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-4613","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBr/view","746,393","746,393","In 2020, 66% of the SLD annual need has been funded by the approved GF grant. Additional 15% will be covered by state funds. The missing 19% (projected to cover 259 MDR TB patients) of the SLD need is therefore requested through PAAR.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":746393}]
["Moldova","12/31/2020","Tuberculosis","FR438-MDA-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5031","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIb/view","67,332.51","67,332.51","In April 2017 the Ministry of Health has adopted a roadmap to modernize the TB service through people-centered model of TB care. In this context there is a need to increase communities support and to decrease stigma toward people with TB in the communities. This above allocation budget will support broadcasting audio and video materials on the local and national TV and radio spots.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":67332.509999999995}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-5128","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKA/view","22,444.17",107.17,"In case of secured funding, the second bio-behavioural survey (BBS) will be implemented in 2020 in prisons. The first and the only BBS was implemented by the Institute of Public Health in March 2012. Results of the new survey will be compared with the one from 2012.",0,0,0,"22,337",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":107.17}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-5127","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJK9/view","61,721.47",0.47,"In case of secured funding, this will be the fifth study on HIV prevalence and risky behavior among commercial sex workers. Earlier attempts to provide data by Respondent Driven Sample did not give results due to insufficient sex workers network. Surveys were implemented successfully by using snowball sample method, however they did not provide the information on the population size. This research will therefore help to estimate the SW population size.",0,0,0,"61,721",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0.47}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-5123","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJK5/view","56,110.43",0.43,"In case of secured funding, this will be the third bio-behavioural survey (BBS) implemented among MSM in Montenegro. The research, planned for 2020, will aim to estimate the population size, based on a representative sample. Previous surveys were aimed at providing basic data related to population size, HIV status, prevalence of STIs, condom use etc. However, Montenegro is a highly homophobic country where LGBT community is hard to reach, which has affected success of the previous surveys.",0,0,0,"56,110",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0.43}]
["Moldova","12/31/2020","HIV/AIDS","FR437-MDA-H","Other program management intervention(s)","10/30/2019","Program management","Eastern Europe and Central Asia","Active",null,"Low","PAI-5017","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIN/view","56,110.43","56,110.43","In order to assess the existing NAP, the achieved targets and the existinginterventions and formulate proposals for improvement it is important to have aninternational technical assistance.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":56110.43}]
["Moldova","12/31/2020","HIV/AIDS","FR437-MDA-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"High","PAI-5013","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIJ/view","12,565.37","12,565.37","In order to ensure good adherence to ARV treatment and taking into consideration the ambitious targets for enrollment in ARV treatment, it be necessary to involve more specialist in case management provision and update the information and abilities for the involved staff. The training course on HIV case management willensure quality service provisionand in the end will support ARV treatment adherence.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12565.37}]
["Multicountry HIV EECA APH","12/31/2021","HIV/AIDS","FR545-MCEECAAPH-H-01","Grant management","10/30/2019","Program management","Eastern Europe and Central Asia","Inactive",null,"High","PAI-4808","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJF0/view","318,700",0,"In order to organize and coordinate activities implemenation in 5 new countries, provide reports to GF",0,0,0,0,"318,700",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Moldova","12/31/2020","HIV/AIDS","FR437-MDA-H","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Eastern Europe and Central Asia","Active",null,"Low","PAI-5016","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIM/view","8,416.56","8,416.56","In order to strengthen capacity and expertise of members of the civil society it is important to be involved in trainings and attendance of international meetings/conferences regarding issues of HIV/AIDS control.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8416.56}]
["Turkmenistan","6/30/2021","Tuberculosis","FR632-TKM-T","Treatment: MDR-TB","2019-10-12","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-6203","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJpr/view","1,460,500","1,460,500","Increase of funding needs for XDR-TB due to WHO recommendation to increase treatment with Bedaquilin/Delamanit to 12-18m instead of 6m, this amount is expected to cover 2020-2021 needs. This comes in addition to previously approved Portfolio Optimization Amount. Module: MDR-TB; Intervention: Treatment","1,460,500",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1460500}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"Low","PAI-5615","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJS1/view","5,510.04","5,510.04","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5510.04}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5613","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRz/view","5,510.04","5,510.04","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5510.04}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Other intervention(s) for IDUs and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5614","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJS0/view","5,510.04","5,510.04","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5510.04}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4940","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJH8/view","65,000","65,000","Introduce improved pathways to be adopted by clinical practice. The activity will allow organizing 2 additional regional consultations to support and facilitate introduction of the improved pathways by clinical practice at the country level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":65000}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","Needle and Syringe programs for PWID and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5133","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKF/view","44,888.34","44,888.34","Introduction of focused programs for prevention of Hepatitis C, care and treatment programs and self-supporting groups. As a result it is expected to achieve better coverage and reaching the targets (impact, outcome and coverage indicators) both related to preventive services and testing.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":44888.34}]
["Tajikistan","12/31/2020","HIV/AIDS","FR100-TJK-H","Other intervention(s) to reduce human rights-related barriers to HIV services","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5799","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUz/view","250,000","250,000","Involving government and civil society organizations to support key populations and understand their rights. Reducing vilifications against women, girls and gender violation. Improving acceptable service for key population and PLWH. Degreasing social, cultural, legal, and self-stigma and discrimination against key populations and PLWH.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":250000}]
["Azerbaijan","12/31/2020","Tuberculosis","FR317-AZE-T","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Eastern Europe and Central Asia","Active",null,"High","PAI-3646","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwG/view","50,000","50,000","Joint TB Program Review led by the WHO Country Offices and conducted jointly with international experts.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":50000}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5913","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWp/view","176,236",0,"Laboratory tests for the full implementation of the program for the prevention of vertical transmission of HIV from mother to child for determining the viral load  for 600 HIV-positive pregnant women and proviral DNA of 650 children born from HIV-infected mothers.",0,0,0,0,"176,236",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","Differentiated ART service delivery","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5907","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWj/view","1,248,523",0,"Laboratory tests, antiretroviral drugs, etc. to provide high-grade treatment and psycho-social support for PLHIV.",0,0,0,0,"1,248,523",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4941","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJH9/view","50,000","50,000","Mid-term project assessment to assess the progress of the project, define the interim project results and implementation performance.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":50000}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4601","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBf/view","71,195","71,195","Mid-term review of the State HIV programs to be conducted in 2020",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":71195}]
["Belarus","12/31/2021","HIV/AIDS","FR650-BLR-H","Differentiated ART service delivery","11/25/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"High","PAI-6171","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJiu/view","986,668","986,668","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. As a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. In line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD). MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.","986,668",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":986668}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","HIV testing services for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Eastern Europe and Central Asia","Active",null,"High","PAI-5129","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKB/view","56,110.43","56,110.43","Montenegro needs two field-testing vehicles to conduct outreach work, in order to reach a higher number of KAPs and enable greater service delivery.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":56110.43}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Community MDR-TB care delivery","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4596","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBa/view","647,677","647,677","Motivation support for patients with both susceptible (2018-2020) and resistant TB forms (2020)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":647677}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"High","PAI-5620","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJS6/view","9,638.65","9,638.65","MSM Training for outreach workers",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9638.65}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3593","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvP/view","24,850","24,850","Offer IEM for KPs health for communities and offer continuous community education programs (LGBTI, sex workers)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":24850}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Inactive",null,"Medium","PAI-5132","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKE/view","44,888.34",0,"Opening of the new or improved social spaces for MSM community in order to improve well-being and increase the network with the community. As a result it is expected to achieve higher coverage and reaching the targets (impact, outcome and coverage indicators) both related to preventive services and testing.",0,0,0,0,"44,888.34",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"Low","PAI-3635","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw5/view","20,812","20,812","Operational research: Surveys among detainees in 23 penitentiary facilities to evaluate the efficiency of the implemented HIV prevention interventions in penitentiary sector.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20812}]
["Romania","3/31/2021","Tuberculosis","FR320-ROU-T","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","Eastern Europe and Central Asia","Active",null,"High","PAI-5460","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPW/view","65,443.83","65,443.83","Optima HIV analysis to inform Government's strategic decision making in resource allocation for HIV/AIDS, thus finding a sustainable way of financing HIV prevention among key affected populations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":65443.83}]
["Romania","3/31/2021","Tuberculosis","FR320-ROU-T","Capacity building for health workers, including those at community level","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5461","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPX/view","336,662.55","336,662.55","Organisation of trainings, workshops and conferences by National TB Program (Marius Nasta Institute) to improve TB healthcare providers' communication skills with TB patients and sensitize them about patients rights, establish a feedback loop between patients and care providers, and contribute to internal evaluation and re-design of programmatic approaches for the National TB Strategy.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":336662.55}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4942","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHA/view","45,000","45,000","Oversight committee meetings to ensure effective project implementation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":45000}]
["Azerbaijan","12/31/2020","Tuberculosis","FR317-AZE-T","Capacity building for health workers, including those at community level","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3647","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwH/view","42,000","42,000","Participation in training courses and conferences in various aspects of TB control including of TB control in prisons, for knowledge update and experience exchange",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":42000}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"High","PAI-3638","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw8/view","30,441","30,441","PDI, Optimized HIV case finding and HIV case management interventions with focus on men who have sex with men",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30441}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","HIV testing services for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5125","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJK7/view","56,110.43","11,222.09","Piloting self-testing or other innovative approach to testing for Key affected population (KAPs): MSM, PWUID and SW. As a result it is expected to achieve a sustainable increase of testing rates among KAPs.",0,0,0,0,"44,888.34",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11222.09}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Treatment adherence","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"High","PAI-5612","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRy/view","6,425.77","6,425.77","PLWH Training of outreach workers",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6425.77}]
["Belarus","12/31/2021","HIV/AIDS","FR650-BLR-H","Interventions for young people who inject drugs","11/25/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"High","PAI-6169","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJis/view","98,759.99","98,759.99","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.In Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".","98,759.99",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":98759.99}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-3612","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvi/view","7,250","7,250","Prepare a training program for HIV for district epidemiologists. The training of district-level epidemiologists will support the overal decentralisation of health services, and HIV services in particular.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7250}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"Low","PAI-3606","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvc/view","7,000","7,000","Prepare Sex worker monitoring health guidelines",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7000}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","Pre-exposure prophylaxis (PrEP) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5131","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKD/view","44,888.34","44,888.34","Preparing the methodology and piloting PrEP and PeP programs among MSM. As a result, the growth of HIV epidemics among MSM is expected to decrease.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":44888.34}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4943","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHB/view","35,000","35,000","Presence and active participation in international conferences. TB Europe Coalition in partnership with Global TB Caucus will help to press for policy change, National Caucuses to host parliamentary dialogues and events.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":35000}]
["Azerbaijan","12/31/2020","Tuberculosis","FR317-AZE-T","Community MDR-TB care delivery","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-3645","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwF/view","195,518","195,518","Procurement and operation of mobile mini-lab unit for TB case finding and treatment monitoring. About 1000 new TB cases to be detected annuallyGeographical coverage: southern regions of Azerbaijan that are the most affected by TB and HIV, migration and drug use and distantly located from the rayon center (Djilalibad, Massaly, Lenkoran, Astara, Lerik)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":195518}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4598","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBc/view","50,000","50,000","Procurement of 2'000 quantiferon tests to support the community testing of contacts of TB cases nationwide in addition to 1'000 tests to be covered annually by USAID funded Stop Transmission of Drug Resistant TB in Central Asian TB Hospitals project.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":50000}]
["Romania","3/31/2021","Tuberculosis","FR320-ROU-T","Case detection and diagnosis: MDR-TB","10/30/2019","TB care and prevention","Eastern Europe and Central Asia","Active",null,"High","PAI-5458","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPU/view","802,693.3","802,693.3","Procurement of 10 GeneXpert + 1 GeneXpert Infinity-48s + 12,000 Genexpert Ultra tests to enhance rapid testing (currently, only 40% of patients receive a GeneXpert test). This investment will complement the EU/Norway grant which foresees the procurement of 16 additional GeneXpert equipments.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":802693.3}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3643","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwD/view","20,991","20,991","Procurement of AIDS software as part of National HIS support.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20991}]
["Ukraine","12/31/2020","HIV/AIDS, Tuberculosis","FR100-UKR-C","Treatment: MDR-TB","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-5899","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWb/view","15,113,304","13,775,864","Procurement of equipment: stationary and mobile X-rays for uniformed services and Isoniazid Preventive Therapy IDP.TB services quality for oblast medical institutions and infrastructure improvement.",0,0,0,0,"1,337,440",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":13775864}]
["Armenia","9/30/2021","HIV/AIDS, Tuberculosis","FR538-ARM-C","Behavioral interventions for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Inactive",null,"High","PAI-3623","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvt/view","4,864",0,"Procurement of HCV rapid tests (for 1390 tests in Y1, 1748 tests in Y2 and 1600 tests in Y3 based on the assumptions that 50% of PWIDs tested for HIV will be tested for HCV).",0,0,0,0,"4,864",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"High","PAI-3641","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwB/view","1,272,512","1,272,512","Procurement of HIV Viral Load tests and CD4 tests for regular laboratory and clinical examination of PLHIV in civil sector. Treatment monittoring is critical considering increasing treatment coverage and low VL suppression in the country.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1272512}]
["Azerbaijan","6/30/2021","HIV/AIDS","FR316-AZE-H","Behavioral interventions for people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","Eastern Europe and Central Asia","Active",null,"High","PAI-3639","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw9/view","99,000","99,000","Proposed funding will cover the Echo start-up activities: (a) Establishing Echo network hub in Yerevan; (b) Training of medical staff in using the web-based software; (c) Tele-echo clinics in AIDS and TB curated by ECHO team from University of New Mexico; (d) Case-based learning and guided practice in TB and AIDS; e) Access to specialist knowledge in AIDS, TB, infectious diseases, pharmacology.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":99000}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3591","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvN/view","15,000","15,000","Provide counselling for children and adolescents LHIV services on HIV status disclosure, ART adherence, healthy nutrition, coping with emotions etc.Strengthening the quality of Counselling will contribute to higher utilisation of HIV testing services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":15000}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","HIV care","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"Low","PAI-3609","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvf/view","15,000","15,000","Provide support services to increase and improve women knowledge and skills for the information and education on issue related to women LHIV; and develop I&E materials on strengthening and the building capacities of HIV women group on their gender, SRH and treatment issues",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":15000}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Differentiated ART service delivery","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3621","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvr/view","7,350","7,350","Provide TA to further strengthen Patient monitoring system for adherence. A partient-monitoring system is in place, but additional TA can further strengthen it.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7350}]
["Moldova","12/31/2020","HIV/AIDS","FR437-MDA-H","Other intervention(s) for IDUs and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"High","PAI-5019","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIP/view","273,304.9","273,304.9","Providing   harm   reduction   services   through   mobile services has been launchedin 2017 and this modality of   preventive   services   provision   for   PWID   is   an important  opportunity  to  cover  the  PWID  in  territories with   luck   of   outreaches   and   due   to   diversity   of provided services: testing, medical counseling, etc.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":273304.90000000002}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","HIV care","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"High","PAI-5130","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKC/view","3,366.63","3,366.63","Purchase bronchoscopy machine for the Infectious Disease Clinic (IDC). Currently available machine is at the Clinical Center which is highly overused. PLHIV are forced to wait treatment for months. The expected outcome is reaching the set targets with a greater reach of the PLHIV, better service and decreasing stigma and discrimination. This would enable PLHIV to access complete diagnostics at one place.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3366.63}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5124","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJK6/view","3,366.63","3,366.63","Purchase of one CD4 counter for the Infectious Disease Clinic (IDC) which is a front line to help PLHIV. The expected outcome is contributing to reaching the set targets and indicators. The expected impact is greater reach of the PLHIV and greater service delivery, and decreased level of stigma and discrimination towards this population.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3366.63}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Other intervention(s) for IDUs and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"High","PAI-5624","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSA/view","6,425.77","6,425.77","PWID Training for outreach workers",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6425.77}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Other intervention(s) for TGs","10/30/2019","Comprehensive prevention programs for TGs","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5608","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRu/view","16,907.15",0,"Recognizing trans*people as one of  populations at risk  and lacking key information on them  needs assessment survey and size estimation for this population  is necessary for planning preventive  intervention",0,0,0,0,"16,907.15",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Kyrgyzstan","12/31/2020","Tuberculosis","FR615-KGZ-T","Treatment: MDR-TB","2019-10-12","MDR-TB","Eastern Europe and Central Asia","Inactive",null,"High","PAI-6132","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJct/view","1,197,668",0,"Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","1,197,668",0,0,"1,197,668",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Kyrgyzstan","12/31/2020","Tuberculosis","FR629-KGZ-T","Treatment: MDR-TB","2019-10-12","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-6200","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJpc/view","3,020,000","3,020,000","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","3,020,000",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3020000}]
["Romania","3/31/2021","Tuberculosis","FR617-ROU-T","Treatment: MDR-TB","2019-06-11","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-6134","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJd3/view","862,153.518123669","862,153.518123669","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","768,265",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":862153.51812366897}]
["Uzbekistan","6/30/2021","Tuberculosis","FR619-UZB-T","Treatment: MDR-TB","11/28/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-6136","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJdD/view","2,958,638","2,958,638","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","2,958,638",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2958638}]
["Azerbaijan","12/31/2020","Tuberculosis","FR612-AZE-T","Treatment: MDR-TB","11/27/2019","MDR-TB","Eastern Europe and Central Asia","Inactive",null,"High","PAI-6129","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJce/view","2,227,664",0,"Regimen Change: introduction of new treatment regimen approved by WHO","2,227,664",0,0,"2,227,664",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Belarus","12/31/2021","Tuberculosis","FR605-BLR-T","Treatment: MDR-TB","11/27/2019","MDR-TB","Eastern Europe and Central Asia","Inactive",null,"High","PAI-6122","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJc5/view","1,150,000",0.08,"Regimen Change: introduction of new treatment regimen approved by WHO","1,150,000",0,0,"1,149,999.92",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0.08}]
["Belarus","12/31/2021","Tuberculosis","FR675-BLR-T","Treatment: MDR-TB","2019-10-12","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-6199","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJpX/view","3,400,000","3,400,000","Regimen Change: introduction of new treatment regimen approved by WHO","3,400,000",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3400000}]
["Moldova","12/31/2020","Tuberculosis","FR607-MDA-T","Treatment: MDR-TB","11/28/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-6124","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcF/view","1,074,153.67141735","116,975.71141735","Regimen Change: introduction of new treatment regimen approved by WHO","957,178.3366",0,0,"957,177.96",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":116975.71141735}]
["Tajikistan","3/31/2021","Tuberculosis","FR609-TJK-T","Treatment: MDR-TB","11/27/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-6126","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcP/view","1,419,703",1.07,"Regimen Change: introduction of new treatment regimen approved by WHO","1,419,703",0,0,"1,419,701.93",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1.07}]
["Ukraine","12/31/2020","Tuberculosis","FR611-UKR-T","Treatment: MDR-TB","11/27/2019","MDR-TB","Eastern Europe and Central Asia","Inactive",null,"High","PAI-6128","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcZ/view","1,600,000",0,"Regimen Change: introduction of new treatment regimen approved by WHO","1,600,000",0,0,"1,600,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-4951","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHJ/view","75,000","51,900","Regional and country work to improve clinical practice and review and update clinical/patient pathways to be adopted as part of TB practice.",0,0,0,0,"23,100",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":51900}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-4937","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJH5/view","75,000","36,540","Regional work to improve quality of TB care and clinical practice. The activity will focus on supporting countries in developing a planning approach to rapid and modern diagnostics at subregional level.",0,0,0,0,"38,460",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":36540}]
["Moldova","12/31/2020","Tuberculosis","FR438-MDA-T","Other program management intervention(s)","10/30/2019","Program management","Eastern Europe and Central Asia","Active",null,"High","PAI-5029","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIZ/view","22,348.5","22,348.5","Regular central and regional (in Transnistria) supervision visits will be conducted by the NTP teams to TB service and PHC facilities at the district level.  These visits will cover case detection, laboratory diagnosis, treatment and patient support, TB/HIV collaboration, etc. The supervision will focus on service interactions in ambulatory management of TB cases and local partnerships for provision of adherence support and community involvement.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":22348.5}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Differentiated ART service delivery","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3622","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvs/view","3,925","3,925","Review and update the PEP and PrEP guidelines pilot PrEP for MSM",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3925}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Inactive",null,"High","PAI-4950","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHI/view","30,000",0,"Revise and update TB and PHC providers service packages and HR functions to deliver relevant TB services. Developing and introducing latest WHO-compatible policy guidance for active case finding approaches, including the effective identification of presumptive TB cases, contact investigation, treatment support will improve quality of diagnosis and referral case management for patients.",0,0,0,0,"30,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Multicountry EECA PAS","12/31/2021","Tuberculosis","FR524-MCPAS-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-4949","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHH/view","370,000","328,250","Roll-out community-based monitoring application (additional countries) to enhance community empowerment, engagement and support.",0,0,0,0,"41,750",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":328250}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"High","PAI-4610","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBo/view","463,052","463,052","Similarly, to interventions for PWID and SW, the number of outreach workers for the MSM group in the framework of additional funding covers the deficit from 27% in 2018 to 58% of the demand in 2020.As a result, together with the main grant, 65% of MSM will be covered by quality prevention, treatment, care and support services, and 80% of them will be tested for HIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":463052}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"High","PAI-4600","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBe/view","123,075","123,075","Similarly, to interventions for PWID, this amount  is to recruit additional outreach workers to cover gaps for human resources for health (reduce the HRH gap for outreach workers by 10 percent) to enable theapplicant to reach a coverage target of 80 percent of sex workers by 2020. This cadre of workers will provide various services including HIV testing and counselling and adherence support.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":123075}]
["Belarus","12/31/2021","HIV/AIDS","FR650-BLR-H","Differentiated HIV testing services","2019-03-12","HIV Testing Services","Eastern Europe and Central Asia","Active",null,"High","PAI-6167","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJiq/view","331,819.28","331,819.28","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. From 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the clients desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant Sustainability of Services for Key Populations in the EECA Region, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.","331,819.28",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":331819.28000000003}]
["Armenia","9/30/2021","HIV/AIDS, Tuberculosis","FR538-ARM-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Inactive",null,"High","PAI-3631","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw1/view","300,000",0,"Social support program to incentivise treatment adherence among patient with drug-susceptible tuberculosis in addition to the social support of patients with drug-resistant TB covered under the TB grant program.",0,0,0,"300,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Diagnosis and treatment of STIs and other sexual health services for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"Low","PAI-5616","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJS2/view","3,839.08","3,839.08","STI test kit -syphilis",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3839.08}]
["Albania","12/31/2022","HIV/AIDS, Tuberculosis","FR452-ALB-C","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Active",null,"Medium","PAI-3596","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvS/view","3,000","3,000","Support for documenting human rights violations and train community-based groups on their rights, to facilitate access to justice for key populations and to enforce their rights.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3000}]
["Moldova","12/31/2020","HIV/AIDS","FR437-MDA-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Eastern Europe and Central Asia","Active",null,"High","PAI-5022","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIS/view","12,565.37","12,565.37","Taking into consideration the need to cover more SW with prevention programs (according to new estimations) and the flow of employed persons, it is crucial to have an opportunity to train the new employed persons (most of them outreach)  on basic prevention services provision for SW  to ensure quality service provision and minimal standards of services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12565.37}]
["Ukraine","12/31/2020","HIV/AIDS, Tuberculosis","FR100-UKR-C","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5893","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWV/view","220,643",0,"TB case detection and diagnosis among general population in Non-Government Controlled Areas (NGCA) Donetsk and Luhansk. It is planned to cover about 3,800 additional MDR-TB cases implementing rapid testing. In addition, a total of 3,100 Xpert cartridges will be procured (1,800 for Donetsk and 1,300 for Luhansk).",0,0,0,0,"220,643",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Ukraine","12/31/2020","HIV/AIDS, Tuberculosis","FR100-UKR-C","Needle and Syringe programs for PWID and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"High","PAI-5900","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWc/view","4,592,807","3,209,369","The extended package of services for PWID along with the HBV testing, vaccination and HCV treatment. TGF is requested to support additional communication materials.  The proposed activities also include further the expansion of tailored harm reduction activities for adolescents who use drugs. This intervention will further increase the uptake of essential HIV prevention and detection services and engage the underserved segments of PWID community.",0,0,0,0,"1,383,438",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3209369}]
["Ukraine","12/31/2020","HIV/AIDS, Tuberculosis","FR100-UKR-C","Behavioral interventions for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5897","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWZ/view","861,640","861,640","The intervention includes support for basic package on prevention for sex partners of PLHIV, HIV and HBV rapid test kits.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":861640}]
["Montenegro","12/31/2021","HIV/AIDS","FR392-MNE-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-5126","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJK8/view","61,721.47",0.47,"The previous three bio-behavioural surveys (BBS) conducted among PWID in 2009, 2011 and 2013 complied with the Respondent Driven Sampling (RDS) principles. In case funding is obtained for the fourth BBS, planned for 2019, PWID population size would be estimated for the first time in Montenegro.",0,0,0,"61,721",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0.47}]
["Moldova","12/31/2020","HIV/AIDS","FR437-MDA-H","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"High","PAI-5011","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIH/view","1,332.06","1,332.06","The purpose of these sessions is to raise awareness about HIV/STIsin LGBT groups. Such activities are quite effective and useful for members of the LGBT community because, through such activities, beneficiaries have the opportunity to communicate more easily and directly with different HIV / AIDS and other STI prevention specialists, and also to have a correct attitude towards healthy lifestyle.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1332.06}]
["Armenia","9/30/2021","HIV/AIDS, Tuberculosis","FR538-ARM-C","HIV testing services for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Eastern Europe and Central Asia","Inactive",null,"High","PAI-3630","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw0/view","200,000",0,"The total number of urban migrants in Armenia can be as high as 60,000. Therefore, although coverage of 5000 migrants and their sexual partners has been included in the main allocation request, covering additional 5000 is needed in particular if the Russian aid program fails to continue. So additional amount of funds is planned to be spent on this program component if available.",0,0,0,"200,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Ukraine","12/31/2020","HIV/AIDS, Tuberculosis","FR100-UKR-C","HIV testing services for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"High","PAI-5906","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWi/view","1,402","1,402","This activity includes HIV rapid test kits and condoms and lubricant procurement for NGCA Donetsk and Luhansk.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1402}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Behavioral interventions for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Eastern Europe and Central Asia","Active",null,"High","PAI-4589","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBT/view","936,168","936,168","This amount is to recruit additional outreach and social workers to cover gaps for human resources for health gaps to enable the applicant to reach acoverage target of 75 percent of people who inject drugs by 2020. This cadre of workers will providevarious services including HIV testing and counselling and adherence support.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":936168}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Eastern Europe and Central Asia","Active",null,"High","PAI-4592","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBW/view","550,435","550,435","This funding is for expansion of electronic TB database including software update, user trainings, monitoring, and supportive supervision activities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":550435}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","HIV testing services for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Eastern Europe and Central Asia","Active",null,"Medium","PAI-4595","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBZ/view","180,000","180,000","This funds is for the coordinating group (doctor, nurse and community worker) to conduct information campaign for motivation for HIV testing in cooperation with local communities, health committees and self-government bodies in Chu oblast. Additionally, this amount includes purchasing additional 10,000 express-tests of 3-4th generation for capillary blood to test for HIV along with traditionally used ELISA to expand testing in small settlements of Chui oblast with the highest rates of epidemic growth.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":180000}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Other program management intervention(s)","10/30/2019","Program management","Eastern Europe and Central Asia","Active",null,"High","PAI-4593","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBX/view","608,133","608,133","This is a fixed 7 percent cost. Amount was calculated based on the revised budget. Final amount will be revised based on actual budget allocated.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":608133}]
["Moldova","12/31/2020","HIV/AIDS","FR437-MDA-H","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Eastern Europe and Central Asia","Active",null,"High","PAI-5015","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIL/view","12,565.37","12,565.37","To continue the development of the roles and capacity of key affected populations and communities and to ensure the good quality of services provision and in organizing the advocacy activitites, communications, social mobilization, etc it is important to have at list two training per year for civil society representatives and KAP organizations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12565.37}]
["Moldova","12/31/2020","Tuberculosis","FR438-MDA-T","Other program management intervention(s)","10/30/2019","Program management","Eastern Europe and Central Asia","Active",null,"Medium","PAI-5030","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIa/view","89,451.24","89,451.24","To support realization of the three operation researches realized by PI Institute of Phthysio-pneumology Chiril Draganiuc in 2019-2020. It will look into the issues of TB control activities in country and aim to: \"Evaluate resistance to new anti-TB drugs in Moldova\", \"MDR-TB at children in Moldova\" and \"Minimal inhibitory concentration of the anti-TB drugs\". The results should help to update treatment guidelines and national protocols using evidence-based data.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":89451.24}]
["Serbia","6/30/2022","HIV/AIDS","FR390-SRB-H","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Eastern Europe and Central Asia","Active",null,"High","PAI-5610","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRw/view","3,212.88","3,212.88","Training for service providers on community based VCT for PWID",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3212.88}]
["Turkmenistan","6/30/2021","Tuberculosis","FR198-TKM-T","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5806","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJV6/view","340,383",0,"Two among five regions of Turkmenistan, Balkan and  Akhal,  do  not  have  laboratory  capacity  to perform   liquid   culture   and   drug   susceptibility testing. In 2012-2017 the Government invested into large renovation works of the Akhal regional TB hospital and   its   laboratory,   including   modernization   of infrastructure   (water,   sewage,   electricity).   The Government also procured general lab equipment (autoclaves,  etc).    However,  procurement  of Bactec  MGIT  and  LPA  equipment  is  still  being delayed.  At  present,  due  to  proximity  of  Akhal regional  TB  lab  to  the  capital  Ashgabat,  DST  is done  by  the  NRL.  However,  this  is  an  interim solution as it adds workload on the NRL staff. Procurement  of  lab  equipment  for  Balkan  and Akhal  regional  TB  labs  was  planned  within  the cost-sharing   agreements   between   UNDP   and MoH  for  2018,  but  due  to  large  investment  into procurement   of   TB   reagents   and   drugs   the Government   decided   to   postpone   funding   the procurement of equipment. The  current Prioritized  Above  Allocation  Requestincludes procurement of some equipment required for  two regional TB labs  in case the Government funding will not be available in 2018.",0,0,0,"340,207",176,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Uzbekistan","6/30/2021","HIV/AIDS","FR490-UZB-H","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Eastern Europe and Central Asia","Inactive",null,"High","PAI-5910","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWm/view","1,039,534",0,"Viral load to determine the effectiveness of treatment in patients receiving therapy under the grant.",0,0,0,0,"1,039,534",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Kyrgyzstan",null,"HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z","Treatment: MDR-TB","10/30/2019","MDR-TB","Eastern Europe and Central Asia","Active",null,"High","PAI-4615","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBt/view","44,009","44,009","Vitamin B6 is part of the MDR TB regimen but it  cannot be procured with domestic funding as it is not available in local market in mono doses (not combined with other vitamins). The MoH and NTP have initiated a process to establish mechanisms of drugs procurement through international suppliers. However, the process may need long time for agreement and approval.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":44009}]
["CÃ´te d'Ivoire","12/31/2020","Tuberculosis","FR37-CIV-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Africa 1","Inactive",null,"High","PAI-3952","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1C/view","1,937,815.06",0,"Acquire nine digital radiography devices and digitize the 17 old radiography tables Radiography remains an indispensable diagnostic tool for smear-negative pulmonary tuberculosis, and even extrapulmonary TB. Therefore, strengthening the diagnosis of TB in children requires the use of this technology. The NTCP has 17 standard radiography devices available, in 16 existing regional coordination centers and at Abidjan central prison (MACA). Of these devices, five date from 2004, three from 2009 and nine from 2016. The older devices require extensive maintenance with spare parts that are increasingly hard to find. This type of radiography is being gradually replaced by digital radiography. As part of this concept note, the NTCP also anticipates the purchase of nine digital radiography tables for the nine new regional coordination centers including Sgula, and the acquisition of 17 digitization devices to adapt older equipment. The funding also provides for the training of trainers and training sessions for users of digital radiography equipment.",0,0,0,"1,937,815.06",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["CÃ´te d'Ivoire","12/31/2020","Tuberculosis","FR37-CIV-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Africa 1","Active",null,"High","PAI-3958","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1I/view","158,231.4","158,231.4","Active search for TB among drug users With regard to drug users, the activities proposed in collaboration with Mdecins du Monde are the following: - Awareness-raising sessions by community outreach agents in  fumoirs7  (smoking rooms) to reduce the stigma and discrimination that are associated with them; - Screening by active search for tuberculosis in the community of approximately 1,800 drug users over the three years of screening; - Community support for the 135 drug users with TB treated in eight prisons (1 per 6 drug users with TB).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":158231.4}]
["Burkina Faso","12/31/2020","Tuberculosis","FR362-BFA-T","Prevention","10/30/2019","TB care and prevention","High Impact Africa 1","Active",null,"Medium","PAI-3870","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzs/view","427,014.64","427,014.64","Broadcasting each year, 6 times per week, the radio adverts in French, Mossi, Dyula and Fula concerning the fight against tuberculosis on the stations of the 25 radio partners. The 3 broadcasts per week are due to the need to take advantage of the 2 weekend days during which the audience is larger .",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":427014.64}]
["Nigeria","12/31/2020","Tuberculosis","FR491-NGA-T","Case detection and diagnosis","10/30/2019","MDR-TB","High Impact Africa 1","Active",null,"High","PAI-5283","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMf/view","561,781","561,781","Capacity building of health workers on TB management for 7 additional DR TB Treatment centres:This request is to support the community expansion in the hospitalized management of critically ill and comorbid DR TB patients, or patients with severe adverse reactions. There are 31 DR TB treatment centres existing in 30 states leaving a gap of 7 States yet to have treatment centres.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":561781}]
["Burkina Faso","12/31/2020","Tuberculosis","FR362-BFA-T","Surveys","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 1","Active",null,"High","PAI-3865","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzn/view","85,539.79","85,539.79","Conduct a feasibility study of the integration of active screening for TB among children aged 3 to 59 months seen during the SMC campaigns. This innovative, integrated approach is expected to boost active TB screening and to improve the performance of the 4 NTBCP in relation to tuberculosis among children. Location: 2 of the 12 health regions covered by the SMC. Study period: 2018 Partners: NMCP, Paediatricians, WHO/RDT.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":85539.79}]
["Nigeria","12/31/2020","HIV/AIDS","FR604-NGA-H","Other program management intervention(s)","10/30/2019","Treatment, care and support","High Impact Africa 1","Active",null,"High","PAI-5269","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMR/view","1,050,000","1,050,000","Contextual analysis of NAIIS for improved understanding of epidemic and improved programming Support further analysis of NAIIS data to generate qualitative information on the observed trends and patterns to better plan for improvements to programme planning especially for areas including AGYP and: - qualitative explanation to observed epidemiologic and service delivery trends/pattern- geo-spatial sub-national analyses- underserved populations analyses",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1050000}]
["Congo (Democratic Republic)","12/31/2020","Malaria","FR477-COD-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 1","Active",null,"Medium","PAI-3998","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1w/view","2,470,235","2,470,235","DHS: National study to determine the health-related and demographic indicators, including those involved in the fight against malaria. This study will be carried out in order to evaluate the evolution of the impact indicators and the result indicators and will be able to inform the various performance frameworks.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2470235}]
["Congo (Democratic Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR100-COD-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Africa 1","Active",null,"High","PAI-4001","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1z/view","8,806,628","8,806,628","Diagnosis and treatment of additional cases The requested funding (allocation amount), including the catalyst funding to identify missing cases, will make it possible to treat 439,784 patients with all forms of TB (TBAF). Using the strategies outlined in this funding request, the country believes it would be able to achieve more ambitious targets. However, the targets have been kept at a level commensurate with currently available funds from the government, the Global Fund and other partners. The additional investment would allow the country to cover an extra 65,297 TBAF patients. The activities involve purchasing supplies and drugs, as well as the corresponding procurement and supply management (PSM) and distribution costs (detailed breakdowns available).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8806628}]
["Burkina Faso","12/31/2020","Tuberculosis","FR362-BFA-T","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 1","Active",null,"Medium","PAI-3862","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzk/view","25,470.81","25,470.81","Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25470.81}]
["Burkina Faso","12/31/2020","HIV/AIDS","FR430-BFA-H","Institutional capacity building, planning and leadership development","10/30/2019","RSSH: Community responses and systems","High Impact Africa 1","Active",null,"High","PAI-3834","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzI/view","218,639.88","218,639.88","Equipment 36 non-governmental testing sites (including the 13 rehabilitated) with client oriented equipment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":218639.88}]
["Burkina Faso","12/31/2020","Malaria","FR433-BFA-M","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","High Impact Africa 1","Inactive",null,"Low","PAI-3851","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzZ/view","3,091,978.07",0,"Expand IMCI-REC in 12 new health districts. As of 31 December 2017, 16 health districts will have the capacity to implement integrated child care through the use of the electronic tool (IMCI-REC).",0,0,0,"3,091,978.07",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Ghana","12/31/2020","HIV/AIDS, Tuberculosis","FR222-GHA-C","Other module","10/30/2019","Other module","High Impact Africa 1","Active",null,"Medium","PAI-4274","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6O/view","150,000","150,000","HIV vulnerabilities and barriers to access to HIV services among the physically challenged are unknown. This study aims to identify these and articulate options to address them as part of addressing human rights issues.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":150000}]
["Burkina Faso","12/31/2020","Malaria","FR433-BFA-M","Improving service delivery infrastructure","10/30/2019","RSSH: Integrated service delivery and quality improvement","High Impact Africa 1","Active",null,"Medium","PAI-3857","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzf/view","157,109.19","157,109.19","Implement a pilot project to improve the quality of the integrated management of childhood illnesses by the CHWs and data flow using the MEDSINC tool.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":157109.19}]
["Nigeria","12/31/2020","Tuberculosis","FR491-NGA-T","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","High Impact Africa 1","Active",null,"High","PAI-5287","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMj/view","1,803,279","1,803,279","Infrastructural upgrade of selected labs in targets states for lab services integration:Based on the findings and recommendations of the baseline assessment of infrastructural amenities at the labs, the prioritised labs and recommendations of the report will be supported with infrastructural upgrade to raise their standard for effective service provision.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1803279}]
["Congo (Democratic Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR100-COD-C","Collaborative activities with other programs and sectors (TB/HIV)","10/30/2019","TB/HIV","High Impact Africa 1","Active",null,"High","PAI-4016","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2E/view","374,564","374,564","Involvement of private facilities and traditional medicine practitioners Scale up efforts to identify missing cases by training private care providers and traditional medicine practitioners (three providers trained in each of the 243 high-priority HZs).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":374564}]
["Nigeria","12/31/2020","HIV/AIDS","FR604-NGA-H","Other intervention(s) for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","High Impact Africa 1","Active",null,"High","PAI-5268","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMQ/view","2,500,000","2,500,000","Know Your Rights Programme for PLHIV and Key Populations Recommendations of Stigma Index will be used to develop a nation wide but targeted \"Know Your Rights Programme\" aimed at empowering PLHIV and KPs. This project will be coordinated by the KP secretariat and PLHIV Network (NEPWHAN). This is also be used to sensitize PLHIV on usefulness of knowing viral suppression status and supporting them to demand for VL tests",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2500000}]
["Burkina Faso","12/31/2020","Tuberculosis","FR362-BFA-T","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 1","Active",null,"Medium","PAI-3871","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzt/view","28,937.09","28,937.09","Organize a 3-day training session in 2020 to train 100 (centres dinformation et des statistiques sanitaires, CISSE) and (services de planification de linformation hospitalire SPIH) workers regarding the new directives and the analysis of data concerning the fight against tuberculosis  the target will be: 100 CISSE and SPIH workers : 1 x 70 HD + 1 x 13 RHD + 1 x 8 CHR + 1 x 5 CHU + 4 central workers (DSS = 3 and DLM = 1).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":28937.09}]
["Congo (Democratic Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR100-COD-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Africa 1","Active",null,"High","PAI-4015","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2D/view","224,064","224,064","Pediatric TB training for maternal, neonatal and child health (MNCH) and diabetes providers The investment will be used to better incorporate pediatric TB screening and case management into the following activities: - Delivering pediatric TB training to two service providers per MNCH and malnutrition treatment center (TT)/TTC (2,068 x 2); - Delivering training to 516 diabetes and malnutrition treatment service providers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":224064}]
["Ghana","12/31/2020","HIV/AIDS, Tuberculosis","FR222-GHA-C","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","High Impact Africa 1","Inactive",null,"High","PAI-4281","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6V/view","245,000",0,"Power fluctuations and interruption often lead to no results which means waste of cartridge, and sometimes, damage to the GeneXpert equipment. The purchase of 35 Back-Up power equipment for GenXpert machines will forestall this.",0,0,0,0,"245,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Congo (Democratic Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR100-COD-C","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 1","Active",null,"Low","PAI-4007","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ25/view","3,120,000","3,120,000","Prevalence survey, DRS, external review and training This additional investment covers essential activities to improve program outcomes and performance. However, these activities have been excluded from the allocation amount because of limited funding availability. The activities are as follows: - Organize mini Drug Resistance Survey (DRS) in the six provinces with high TB drug-resistance prevalence rates not included under the allocation amount; - Organize the general population TB prevalence survey in 2019.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3120000}]
["Nigeria","12/31/2020","Tuberculosis","FR665-NGA-T","Case detection and diagnosis: MDR-TB","2019-04-12","MDR-TB","High Impact Africa 1","Active",null,"High","PAI-6183","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJmx/view","9,515,528","9,515,528","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.","9,515,528",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9515528}]
["Ghana","12/31/2020","Malaria","FR218-GHA-M","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 1","Active",null,"High","PAI-4267","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6H/view","400,000","400,000","Programmes carry out periodic trainings on DHIMS2  usually centralised at the regional level with officers from district and facilities levels travelling long distances for such training. The aim is to digitise all DHIMS2 training modules making them accessible to all staff of Ghana Health Services. Implementation will involve curriculum and manual development and regular updates to reflect current needs, recording of all modules on DHIMS2, eTracker data capture and reporting, and capacity building of technical team, focal persons, and regional administrators.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":400000}]
["CÃ´te d'Ivoire","12/31/2020","Tuberculosis","FR37-CIV-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Africa 1","Inactive",null,"High","PAI-3954","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1E/view","1,621,217.39",0,"Purchase of 16 GeneXpert devices This request focuses on the acquisition of 16 additional GeneXpert devices in order to meet the needs of all regional laboratories. There are currently 13 GeneXpert devices, of which nine are located in nine regional laboratories (TB TCs) and four in the central laboratories (two at the Institut Pasteur de Cte dIvoire (IPCI) and two at the Research and Diagnosis Center for AIDS (CeDReS)). The NTCP plans to acquire 16 additional GeneXpert devices during this program continuation. Of these, eight will be purchased in 2018 to meet the needs of the eight existing regional laboratories and eight in 2019 for the eight new regional coordination centers opened in 2017. These GeneXpert devices will require maintenance and calibration each year. In addition, all machines require cartridges to operate. An average of 1,500 cartridges per machine per year is expected. These machines will strengthen the diagnosis of tuberculosis in general, and detection of the resistance profile in particular.",0,0,0,0,"1,621,217.39",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Burkina Faso","12/31/2020","HIV/AIDS","FR430-BFA-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 1","Active",null,"High","PAI-3844","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzS/view","80,404","80,404","Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":80404}]
["Congo (Democratic Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR100-COD-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Africa 1","Inactive",null,"High","PAI-4005","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ23/view","350,000",0,"Renovation of the national reference laboratory (NRL) for AIDS.",0,0,0,0,"350,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Mali",null,"RSSH","FR600-MLI-S","Improving service delivery infrastructure","10/30/2019","RSSH: Integrated service delivery and quality improvement","High Impact Africa 1","Inactive",null,"High","PAI-5079","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJN/view","213,848",0,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.Significant direct impact on 3 diseases:Malaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.Malaria: Increased SP3 coverage among pregnant women from 40% to 60%.HIV: Increased PMTCT testing coverage from 50% to 70%.HIV: Increased PMTCT treatment coverage from 85% to 95%.TB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",0,0,0,"213,848",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Mali",null,"RSSH","FR600-MLI-S","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","High Impact Africa 1","Inactive",null,"Low","PAI-5081","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJP/view","2,000,000",0,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.Significant direct impact on 3 diseases:Malaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.Malaria: Increased SP3 coverage among pregnant women from 40% to 60%.HIV: Increased PMTCT testing coverage from 50% to 70%.HIV: Increased PMTCT treatment coverage from 85% to 95%.TB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",0,0,0,"2,000,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Mali",null,"RSSH","FR600-MLI-S","Retention and scale-up of health workers, including for community health workers","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","High Impact Africa 1","Inactive",null,"High","PAI-5076","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJK/view","773,862",0,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.Significant direct impact on 3 diseases:Malaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.Malaria: Increased SP3 coverage among pregnant women from 40% to 60%.HIV: Increased PMTCT testing coverage from 50% to 70%.HIV: Increased PMTCT treatment coverage from 85% to 95%.TB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",0,0,0,"773,862",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Congo (Democratic Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR100-COD-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Africa 1","Inactive",null,"High","PAI-4012","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2A/view","2,421,488",0,"Supply chain and quality assurance strengthening This investment will significantly improve the TB drugs supply chain, through the following activities: - Have the Programme National dApprovisionnement en Mdicaments essentiels [National Program for the Procurement of Essential Medicines  PNAM] and the National Tuberculosis Control Program (NTCP) take part in PSM monitoring and supervision missions at the Centrale de Distribution Rgionale des Mdicaments [Regional Drug Distribution Center  CDR]; - Organize drug sample collection missions at all levels of the supply chain for quality control, in conjunction with the Direction de la Pharmacie et du Mdicament [Directorate of Pharmacy and Drugs  DPM]; - Cover the costs of having the samples analyzed by a foreign laboratory prequalified by the World Health Organization (WHO) to analyze first-line drugs. (10 percent of the drugs value  see Quality Assurance Plan); - Create and configure databases, produce reports and deliver training on Apisoft to the central and provincial levels; - Cover handling costs for drugs and other supplies; - Deliver TB drug management training to service providers.",0,0,0,0,"2,421,488",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Nigeria","12/31/2020","HIV/AIDS","FR604-NGA-H","Other program management intervention(s)","10/30/2019","Treatment, care and support","High Impact Africa 1","Active",null,"High","PAI-5265","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMN/view","6,497,265","6,497,265","System Strengthening for Pharmacovigilance (PV) & HIV Drug Resistance (HIV-DR) Monitoring Reduce ARVs adverse effects and drug resistance related deaths/morbidity by:- Strengthening capacity of NAFDAC in managing PV monitoring, based on UNAIDS/WHO assessment- Pharmacovigilance active monitoring cohorts for ARVs- Conducting combined PDR/ADR survey - Assessing pediatric ADR - Strengthening stakeholders coordination on HIV-DR",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6497265}]
["Congo (Democratic Republic)","12/31/2020","Malaria","FR477-COD-M","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","High Impact Africa 1","Active",null,"Medium","PAI-3997","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1v/view","147,170","147,170","The cost of implementing the NSP for 2016-2020 has been estimated as US$ 1,520,554,318. Analysis of the financial shortfalls after taking into account support from PMI, DFID, the Government and the allocation from The Global Fund in 2015-2017 and 2018-2020 shows an estimated shortfall of US$ 707,374,658. In order to bridge this gap, a process of internal resource mobilization within the Government and among private sector actors, both national and international. After the round table meeting which will take place on October 10, 2017, round table meetings are planned in the provinces (US$ 95,368) and externally (US$ 51,802).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":147170}]
["Burkina Faso","12/31/2020","Malaria","FR433-BFA-M","Long-lasting insecticidal nets (LLIN) - Continuous distribution","10/30/2019","Vector control","High Impact Africa 1","Active",null,"High","PAI-3854","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzc/view","2,530,411.85","2,530,411.85","The current funding (World Fund, USAID and State) covers needs from 2018 to 2020 except for routine LLIN for pregnant women in 2019. This Gap is included in the above allocation to acquire 886,517 MILDA. The mass distribution campaign is planned for the first half of 2019.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2530411.85}]
["Congo (Democratic Republic)","12/31/2020","Malaria","FR477-COD-M","Severe malaria","10/30/2019","Case management","High Impact Africa 1","Active",null,"High","PAI-3994","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1s/view","13,800,000","13,800,000","The WHO recommends the preferential use of injectable artesunate in cases of severe malaria. A total of 33,997 deaths linked to malaria were recorded in 2016 out of 96.166 deaths recorded in health facilities, i.e. a proportional mortality rate of 35%. Given that the funds for purchasing injectable artesunate for children under five years of age have already been secured, we are requesting a budget of an extra $13,800,000, which will be used to complete the purchase, transportation and storage of injectable artesunate for treating adolescents and adults suffering from severe malaria.Only the needs of children under five years of age are covered in the allocation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":13800000}]
["Ghana","12/31/2020","HIV/AIDS, Tuberculosis","FR222-GHA-C","Other module","10/30/2019","Other module","High Impact Africa 1","Active",null,"High","PAI-4283","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6X/view","300,000","300,000","This study to be conducted in 2019 provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the e-tracker. This cohort analysis will include women initiated on ART during pregnancy for the first time.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":300000}]
["Burkina Faso","12/31/2020","HIV/AIDS","FR430-BFA-H","Institutional capacity building, planning and leadership development","10/30/2019","RSSH: Community responses and systems","High Impact Africa 1","Active",null,"Medium","PAI-3840","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzO/view","121,637.3","121,637.3","TProviding operational support for the national coordination of the Network for Greater Involvement of People Infected with HIV (NEGIPIH).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":121637.3}]
["CÃ´te d'Ivoire","12/31/2020","HIV/AIDS","FR184-CIV-H","Prong 1: Primary prevention of HIV infection among women of childbearing age","10/30/2019","PMTCT","High Impact Africa 1","Inactive",null,"Low","PAI-3951","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1B/view","314,578.54",0,"Train CHWs to focus on the socio-cultural barriers to access to maternal and child health services This activity will consist of organizing one orientation session by health district in order to increase the number of pregnant women seeking PMTCT services and the retention rate of seropositive pregnant women to these services. This activity will strengthen the family-based approach to be implemented by CHWs in 28 districts as part of the within-allocation funding request.",0,0,0,0,"314,578.54",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Burkina Faso","12/31/2020","Malaria","FR433-BFA-M","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","High Impact Africa 1","Active",null,"Medium","PAI-3858","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzg/view","568,340.06","568,340.06","Training for providers of districts in clinical IMCI. Previous training have not met all the needs. The planning involves the training of an average of 25 staff per health district in the 8 regions not covered by the IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center-Sud, Center-East, Central): 25 sessions of 25 agents on average for 11 days in 2018 and 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":568340.06000000006}]
["Ghana","12/31/2020","Malaria","FR218-GHA-M","Community-based monitoring","10/30/2019","RSSH: Community responses and systems","High Impact Africa 1","Active",null,"High","PAI-4268","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6I/view","658,000","658,000","With CHPs roll out, effective monitoring of delivery and impact on these populations with limited access to services is essential.  Funds will provide training resource for NSAs,  assessment of their contribution to interventions in Ghana, and feedback/lesson learned for future interventions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":658000}]
["Mozambique","12/31/2020","Malaria","FR408-MOZ-M","Other program management intervention(s)","10/30/2019","Program management","High Impact Africa 2","Active",null,"Medium","PAI-5147","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKT/view","739,580","739,580","A prioritized operational research agenda will be updated and implemented, including bio-effectiveness, access and usage of Long-Lasting Insecticide-trerated Nets and a Therapeutic Efficacy Study, both expected to provide needed data to better target and increase efficiency of vector control interventions, as well as understanding the efficacy of the antimalarial drug, recommended in national guidelines.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":739580}]
["Tanzania (United Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR219-TZA-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Africa 2","Active",null,"Medium","PAI-5876","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWE/view","1,612,000","1,612,000","A scale up plan for HVL testing is being implemented in Tanzania. The funding request has set ambitious target to enrol 95% of PLHIV on ART by 2020. To achieve the third ninety of the 90-90-90 strategy, scale up of HVL testing to district level will be crucial. The PAAR will be used to procure HVL reagents and build capacity of health care workers including laboratory personnel to conduct Viral Load tests and EID testing. This will also involve strengthening lab systems and providing technical assistance for accreditation of new sites. The aim is to increase coverage and reduce the turnaround time.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1612000}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","TB/HIV collaborative interventions","10/30/2019","TB/HIV","High Impact Africa 2","Active",null,"High","PAI-6095","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZl/view","106,700","106,700","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":106700}]
["Multicountry Southern Africa E8","9/30/2021","Malaria","FR500-MCE8-M","Other vector control measure(s)","10/30/2019","Vector control","High Impact Africa 2","Inactive",null,"High","PAI-4792","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEk/view","100,000",0,"Activity: IEC/BCC in five districts of Southern Angola in 2020 Description: This funding request includes support for additional IEC/BCC activities to support the LLIN replenishment campaign in 2020 in five districts of southern Angola, including Rivungo, Mavinga, southern Menongue, Nankova, and Cuanhama.Rationale: The impact of LLINs is dependent on net usage. Therefore, this activity is proposed as a compliment to the LLIN replenishment activity noted above with the goal of increasing uptake and usage of the LLINs. By coupling the net distribution with community mobilization and IEC/BCC efforts, the utilization of LLINs is expected to increase. Expected Outcomes/Impact: Studies among communities in nearby Botswana found that assisted hanging of nets, distribution of IEC/BCC materials, and follow-up health-education visits all positively influenced LLIN usage. It is expected that this activity, coupled with the LLIN replenishment activity mentioned above, will have high impact in reducing malaria within these high risk communities. There is a high likelihood of resurgence in both malaria prevalence and incidence if the population is left without any potent vector control intevervention after existing nets lose efficacy. With the goal being to achieve pre-elimination in Angola's southern provinces, sufficient vector control coverage will remain a high priority. Budget: Costs associated with this activity include funding for IEC/BCC materials as well as transportation for health educators to visit communities in five districts during one year only. The total cost of this activity is therefore estimated at US$ 100,000 for one year (2020). *Note - the intervention category does not provide all intervention options in the dropdown menu. The correct intervention for this activity is \"IEC/BCC (Vector Control).\" However, this is not an option in the dropdown menu of this template.",0,0,0,0,"100,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Uganda",null,"HIV/AIDS, Tuberculosis","FR188-UGA-C","Other module","10/30/2019","Other module","High Impact Africa 2","Active",null,"High","PAI-5886","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWO/view","51,533,256","41,133,256","Additional Condoms, Condom dispensers and alternative condom distribution mechanisms will support the delivery of condoms to those who need them.",0,0,0,"10,400,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":41133256}]
["Uganda",null,"HIV/AIDS, Tuberculosis","FR188-UGA-C","Other intervention(s) for PMTCT","10/30/2019","PMTCT","High Impact Africa 2","Active",null,"Medium","PAI-5887","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWP/view","913,488","913,488","Additional funding will support capacity enhancement for PLHIV community groups to deliver interventions that are intended to further increase uptake of PMTCT services, increase male partner testing, reduce loss to follow up for mother-baby pairs, and improve treatment adherence.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":913488}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Addressing stigma, discrimination and violence against MSM","10/30/2019","Comprehensive prevention programs for MSM","High Impact Africa 2","Active",null,"High","PAI-6088","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZe/view","72,600","72,600","Additional scale up through extended outreach from fixed and mobile sites.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":72600}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Public financial management (PFM) strengthening","10/30/2019","RSSH: Financial management systems","High Impact Africa 2","Active",null,"High","PAI-6111","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa1/view","254,910","254,910","Additional scale up through extended outreach from fixed and mobile sites.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":254910}]
["Mozambique","12/31/2020","Malaria","FR408-MOZ-M","Other program management intervention(s)","10/30/2019","Program management","High Impact Africa 2","Active",null,"Low","PAI-5149","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKV/view","602,931.37","602,931.37","All 11 Provincial Directorates of Health have a gap of vehicles to ensure implementation of supervision activities. The vehicles included in this UQD are to be used exclusively by National Malaria Control Program staff at provincial and district level, to ensure implementation of routine activities such as supervision visits to health facilities and community health workers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":602931.37}]
["Ethiopia",null,"HIV/AIDS, Tuberculosis","FR313-ETH-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","High Impact Africa 2","Active",null,"High","PAI-4257","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ67/view","7,933,464","7,933,464","An early nine months implementation lessons from pilot project in four urban areas of the country (Addis Ababa, Dire Dawa, Harar and Adama57) shows, 12% MTB and 2% RR-TB cases from the total GeneXpert tests performed. In addition, the proportion of bacteriologically confirmed TB cases has doubled, which supports scaling up the project to additional 20 urban sites. This initiative aims at improving DR-TB case finding among new presumptive TB cases in urban areas, as part of the national plan towards universal access to FL DST for all TB patients. Through this initiative, the country will detect and treat additional 552 RR-TB cases over the grant period. Furthermore, through this phased expansion, Ethiopia can truly progress in achieving universal DST at the time of TB diagnosis. The interventions include: Procurement of 120 Gene X-pert Machines, cartridge, and Falcon tubes, maintenance costs, capacity building and program management.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7933464}]
["Ethiopia",null,"HIV/AIDS, Tuberculosis","FR313-ETH-C","Community TB care delivery","10/30/2019","TB care and prevention","High Impact Africa 2","Active",null,"High","PAI-4256","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ66/view","7,615,756","7,615,756","Community based care has been main strategy to access health services in Ethiopia. 53 NTP has implemented intensified community based interventions in 257 woredas/districts in 15 Zones with low TB case notification, through NFM GF grant incentive funding. Based on 18 months of data, the proportion of health posts implementing full package CBTB care has raised from 30% to 60%, with increased proportion of notified TB cases, in these woredas, by 7-10% of the national average. This above allocation request will expand this initiative to additional low performing and high burden 543 woredas, enabling the program to detect and treat additional 16,709 TB cases over the three years grant period. The packages of CBTB interventions include community based TB symptom screening and referral linkage, contact screening, community based DOT and patient support, tracing LTFU, and strengthening program monitoring and human resource capacity.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7615756}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Keeping girls in school","10/30/2019","Prevention programs for adolescents and youth, in and out of school","High Impact Africa 2","Active",null,"Low","PAI-6076","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZS/view","2,160,000","2,160,000","Doubling the education subsidies in the existing 4 DREAMS districts to reach at least 30% of the vulnerable AGYW in those districts.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2160000}]
["Tanzania (United Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR219-TZA-C","Other intervention(s) for PMTCT","10/30/2019","PMTCT","High Impact Africa 2","Active",null,"High","PAI-5875","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWD/view","1,501,658","1,501,658","Evidence from Pilot of Partnership for HIV Free Survival (PHFS) project in Tanzania where QI-approaches were used in enhancing postnatal follow up of maternal-infant pairs through available community structures, showed greatly improved retention of motherinfant pairs in PMTCT Care. Nutritional Assessment, Counselling and Support integrated in the model resulted into improved maternal and child survival through early identification of malnourished individuals and intervening timely. Scaling up the interventions in other regions is expected to improve both maternal and child survival by reducing mortality attributable to malnutrition and retention of clients into PMTCT Care.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1501658}]
["Uganda","12/31/2020","Malaria","FR100-UGA-M","Other procurement supply chain management intervention(s)","10/30/2019","RSSH: Procurement and supply chain management systems","High Impact Africa 2","Active",null,"Medium","PAI-5884","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWM/view","10,648,768","10,648,768","Expansion of appropriate storage capacity at the Joint Medical Stores (JMS). Roll out Vendor Managed Inventory (VMI)  (Enterprise Resource Planning) System to NMS and JMS and link them to each other and high volume health facilities. Strengthen Uganda Blood Transfusion Services (UBTS) through accreditation to ISO 9001 & ISO15189 & acquisition of 7 blood component preparative centrifuges, 20 refrigerators and 10 automated plasma extractors. Strengthen NDA capacity for post market surveillance and market assurance reviews for HIV, TB and malaria commodities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10648768}]
["Zambia","12/31/2020","HIV/AIDS","FR595-ZMB-H","Condoms as part of programs for general population","10/30/2019","Prevention programs for general population","High Impact Africa 2","Active",null,"High","PAI-6044","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYw/view","2,782,587","2,782,587","Focus is on reducing the gap in 2020 for male condoms by increasing the allocation to the procurement of male condoms",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2782587}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Retention and scale-up of health workers, including for community health workers","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","High Impact Africa 2","Active",null,"High","PAI-6110","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa0/view","3,132,000","3,132,000","Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3132000}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Gender-based violence prevention and treatment programs for adolescents and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","High Impact Africa 2","Active",null,"High","PAI-6062","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZE/view","1,617,630","1,617,630","Funding is requested for community infrastructure, technology and transport systems to establish six additional one-stop centres (in addition to the four requested in the matching funds application) for HIV/SRHR/GBV, building on successes of existing centres in Rusape General Hospital (Makoni), Harare and Gweru. As more than 1 in 3 Zimbabwean women experience physical violence, the 17,000 GBV survivors served by the current centres is an enormous service gap. The need to decentralize access to GBV services and strengthen linkages to communities is vital.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1617630}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Institutional capacity building, planning and leadership development","10/30/2019","RSSH: Community responses and systems","High Impact Africa 2","Active",null,"High","PAI-6107","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZx/view","850,295","850,295","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations and womens networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":850295}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 2","Active",null,"High","PAI-6106","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZw/view","2,883,600","1,922,400","Funding is requested to support an additional 267 data entry clerks for the ePMS and DHIS2 systems.",0,0,0,0,"961,200",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1922400}]
["South Africa","3/31/2022","HIV/AIDS, Tuberculosis","FR427-ZAF-C","Community TB care delivery","10/30/2019","TB care and prevention","High Impact Africa 2","Active",null,"High","PAI-6012","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYQ/view","5,834,695","5,834,695","Funding will support expansion of the TB screening and testing services in facilities and community hot spots by supporting fee-for-service agreements for 264,000 digital chest x-rays and 66,000 Xpert tests. This will catalyze the impact of both the allocation (in facilities) and the matching funds request (in community hot spots), to find an estimated additional 5,280 missing TB patients.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5834695}]
["South Africa","3/31/2022","HIV/AIDS, Tuberculosis","FR427-ZAF-C","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","High Impact Africa 2","Active",null,"Medium","PAI-5997","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYB/view","1,210,436","1,210,436","Funding will support in providing child care for children of sex workers, by supporting 26 entry-level child and youth care workers (R3,500/month), 2 per sex worker district. Children of sex workers have been identified as an area of need. FSW in South Africa are responsible for four child or adult dependents (on average), while MSW and TGSW are responsible for two.  A research study on the basic demographics, living arrangements, risk factors and supervision is underway in the current grant, with findings anticipated in February 2019. Allocation funding will support defining and providing parenting programs suitable for sex workers who have children living with them. The PAAR request to provide direct childcare services for children who live at home with sex workers will be a value add to the parenting programs prioritized in the allocation request.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1210436}]
["Multicountry Africa ECSA-HC","6/30/2022","Tuberculosis","FR497-MCECSA-HC-T","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 2","Active",null,"Medium","PAI-4801","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEt/view","34,708","34,708","Funds for eLIMS adaptation for NRLs in line with the WHO End TB strategy. The SRL-Uganda has developed and deployed the eLIMS suitable for NRLs in two countries and can expand to other countries if additional funds become available.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":34708}]
["Multicountry Africa ECSA-HC","6/30/2022","Tuberculosis","FR497-MCECSA-HC-T","Grant management","10/30/2019","Program management","High Impact Africa 2","Active",null,"Medium","PAI-4805","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEx/view","149,954","149,954","Funds to strengthen learning and program management, e.g. project initiation and closure meetings, workshops to review project performance and adpatation, and capacity building of ECSA-HC.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":149954}]
["Tanzania (United Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR219-TZA-C","Prevention for MDR-TB","10/30/2019","MDR-TB","High Impact Africa 2","Active",null,"High","PAI-5870","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJW8/view","1,071,389","1,071,389","High level priority: it is in line with FR one of the main objective  to increase MDR-TB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1071389}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Diagnosis and treatment of STIs and other sexual health services for general population","10/30/2019","Prevention programs for general population","High Impact Africa 2","Active",null,"Medium","PAI-6071","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZN/view","3,568,111","3,568,111","HIV prevention-related STI services, including for the provision of dual HIV and syphilis testing, STI screening and treatment, referrals for HPV vaccines and cervical cancer services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3568111}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Community mobilization and norms change","10/30/2019","Prevention programs for adolescents and youth, in and out of school","High Impact Africa 2","Active",null,"Low","PAI-6077","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZT/view","3,000,000","3,000,000","In school and tertiary programme.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3000000}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Other intervention(s) for people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","High Impact Africa 2","Active",null,"High","PAI-6118","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa8/view","251,100","251,100","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":251100}]
["Tanzania (United Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR219-TZA-C","Case detection and diagnosis","10/30/2019","TB care and prevention","High Impact Africa 2","Inactive",null,"Low","PAI-5873","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWB/view","10,874,531",0,"Low level priority. The scale up of GeneXpert should be done according to the WHO recommendations. The country plan to include outreach mobile screening units in the 25 targeted regions and extra 552 iLED microscopes and associated reagents will be procured to improve quality of the TB diagnostic network in the lower health facilities.",0,0,0,"10,692,426","182,105",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Other intervention(s) for general population","10/30/2019","Prevention programs for general population","High Impact Africa 2","Active",null,"Low","PAI-6074","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZQ/view","939,252","939,252","Other prevention activities including program coordination, learning and support.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":939252}]
["Ethiopia","6/30/2021","RSSH","FR268-ETH-S","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","High Impact Africa 2","Inactive",null,"High","PAI-4250","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ60/view","2,500,000",0,"Out of the country's PAAR request for lab equipment to equip 4 labs in emreging regions (US 5,000,000), the TRP approved 50% (USD 2,500,000). As an outcome of the review of the proposed lab equipment and the reinvestment of savings, the Secretariat and PR were able to equip a total of 6 labs i.e. an addition of 3 to the 3 that were approved under the allocation funding request.",0,"2,500,000",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["South Africa","3/31/2022","HIV/AIDS, Tuberculosis","FR427-ZAF-C","Prevention and management of coinfections and co-morbidities for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","High Impact Africa 2","Active",null,"Low","PAI-6001","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYF/view","3,934,721","3,934,721","PAAR investment will support in reaching 3,385 sex workers with in-patient alcohol and drug treatment programs (3% of sex workers reached through the allocation amount) in districts and sub-districts where referrals to these services are not possible since they are not available. A 2009 study among sex workers in Pretoria found that 3% of SW tried but were unable to enter alcohol and drug treatment programs in the past year (Wechsberg et al., 2009).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3934721}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Africa 2","Active",null,"High","PAI-6099","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZp/view","9,450","9,450","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9450}]
["Uganda","12/31/2020","Malaria","FR100-UGA-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 2","Active",null,"Medium","PAI-5883","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWL/view","2,499,317","1,042,566","Prioritization on the printing and distribution of the HMIS reporting tools to reach out to all 116 districts and all health facilities in the country with these updated HMIS reporting tools. Due to limited funding, this was placed under PAAR for any savings in the first year (2018) to contribute to at least 30% of the country required HMIS tools.",0,0,0,0,"1,456,751",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1042566}]
["Uganda","12/31/2020","Malaria","FR100-UGA-M","Other case management intervention(s)","10/30/2019","Case management","High Impact Africa 2","Active",null,"High","PAI-5882","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWK/view","12,668,499","12,668,499","Private sector ACT subsidy covered under current grant will be maintained under this Application to maintain high levels of treatment with quality assured ACTs and crowd out counterfeits. The need for the first two years is requested within Allocation while the need for 2020 is requested under PAAR.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12668499}]
["Ethiopia","6/30/2021","Tuberculosis","FR613-ETH-T","Treatment: MDR-TB","2019-06-11","MDR-TB","High Impact Africa 2","Active",null,"High","PAI-6130","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcj/view","3,000,000","3,000,000","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","3,000,000",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3000000}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Behavioral change as part of programs for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","High Impact Africa 2","Active",null,"Low","PAI-6075","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZR/view","3,174,288","3,174,288","Scale up the modified DREAMS package to an additional 4 districts.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3174288}]
["Tanzania (United Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR219-TZA-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Africa 2","Active",null,"Medium","PAI-5857","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVv/view","1,800,000","1,800,000","Tanzania is planning to scale up establishment of centers of excellence for management of advanced cases of pediatric and adults living with HIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1800000}]
["Tanzania (United Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR219-TZA-C","Other intervention(s) for PMTCT","10/30/2019","PMTCT","High Impact Africa 2","Active",null,"Medium","PAI-5877","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWF/view","1,304,000","1,304,000","Tanzania plans to achieve elimination of MTCT by 2020. The funding request ensures pregnant and lactating women are enrolled and retained on ART. If the request above allocation is available, the country will scale up of Point of Care (POC) services to expand early HIV diagnosis in regions with high volume of HIV + pregnant women will be prioritized. To improve MTCT surveillance and early diagnosis targeted Nucleic Acid Test (NAT) will be established in at least 20 pregnant women in a year. This is expected to capture more children who need ART much earlier and put them on care.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1304000}]
["Uganda",null,"HIV/AIDS, Tuberculosis","FR188-UGA-C","Other program management intervention(s)","10/30/2019","Program management","High Impact Africa 2","Active",null,"Low","PAI-5892","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWU/view","3,782,991","3,782,991","The above allocation request for strengthening program management includes funding to support coordination and leadership roles of the program; for reviewing, developing, printing and disseminating guidelines including on new and more sensitive algorithms for screening for TB. It also includes capacity building TB management, mentorship and community mobilization and involvement in TB prevention and care.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3782991}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","High Impact Africa 2","Active",null,"High","PAI-6101","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZr/view","493,087","493,087","The final proposed investment will support prevention for MDR-TB and will include activities to strengthen and support TB infection control (IC) at community levels. Specifically the investment will support IC assessments for homes of diagnosed DR-TB patients and provide education on transmission risk reduction to family members, as well as initiate investigation of contacts. Engaging community leaders will place DR-TB on the agenda and facilitate a cascade of information within communities as part of the broader community TB care intervention. Decentralization of DR-TB treatment has meant that the majority of diagnosed patients are managed from their homes, justifying the rationale for these interventions, aimed at empowering community members to protect themselves and other vulnerable groups such as children, the elderly and PLHIV from acquiring TB.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":493087}]
["Tanzania (United Republic)","12/31/2020","RSSH","FR341-TZA-S-01","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","High Impact Africa 2","Active",null,"High","PAI-5851","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVp/view","12,886,522","6,466,702","The intervention includes essential inputs to improve the functionality of the local health system.",0,0,0,0,"6,419,820",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6466702}]
["Tanzania (United Republic)","12/31/2020","RSSH","FR341-TZA-S-01","Other health and community workforce intervention(s)","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","High Impact Africa 2","Active",null,"High","PAI-5852","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVq/view","3,402,374","3,402,374","The intervention is aimed at supporting the provision of additional essential health workers for the delivery of CEmONC serives and services for AIDS, Tuberculosis and Malaria in a setting of severe human resource shortages.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3402374}]
["Zambia","12/31/2020","Malaria","FR575-ZMB-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","High Impact Africa 2","Active",null,"High","PAI-6036","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYo/view","19,215,531.5","19,215,531.5","The number of LLINs to be distributed to at risk population through mass campaign in 2020 is 7,512,678.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":19215531.5}]
["Zambia","12/31/2020","Malaria","FR575-ZMB-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","High Impact Africa 2","Inactive",null,"High","PAI-6035","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYn/view","12,437,067",0,"The target number of structures in 2019 is 3,376,196 translating in estimated 14,585,167 people protected at an average of 4.32 persons per structure. For 2020 the target is 3,474,106 structures translating in 15,008,138 people protected.",0,0,0,"12,437,067",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Zanzibar","12/31/2020","HIV/AIDS, Tuberculosis","FR378-QNB-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 2","Active",null,"Medium","PAI-6031","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYj/view","43,915","43,915","These funds would enable an implementation research study on the bottlenecks to access opioid substitution therapy for people who inject drugs, which is a key programmatic gap. These funds would also fund a study on adherence to ART. Both studies are likely to inform program strategy.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":43915}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","TB/HIV collaborative interventions","10/30/2019","TB/HIV","High Impact Africa 2","Active",null,"High","PAI-6081","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZX/view","4,897,537.32","4,897,537","Third, above allocation funding is requested to fill gaps in opportunistic infections medicines and related commodities including cotimoxisole, IPT, Ampotericin, kaposi sarcoma and gastric lavage.",0,0,0,0,0.32,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4897537}]
["Kenya","6/30/2021","Malaria","FR206-KEN-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","High Impact Africa 2","Active",null,"High","PAI-4570","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBA/view","13,220,483","13,220,483","This above allocation funding (UQD) aims to support Kenya meet its IRS funding gap. Kenya conducts IRS insecticide resistance management (IRM) using a non-pyrethroid insecticide in counties of the lake endemic zone, where LLINs are distributed and pyrethroid resistance in malaria vectors has been documented. Total requirement for targeted areas is $ 34.2 million and PMI will support $ 21 million (61% of need). The gap of $ 13.2 million (38.6%) is requested through this above allocation request (UQD).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":13220483}]
["Kenya",null,"HIV/AIDS, Tuberculosis","FR333-KEN-C","TB/HIV collaborative interventions","10/30/2019","TB/HIV","High Impact Africa 2","Active",null,"Medium","PAI-4575","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBF/view","1,875,000","1,875,000","This above allocation funding (UQD) will support procurement of cartridges for Early Infant Diagnostics and viral load testing in HIV in order to cover pediatric co-infections.The within allocation funding will support TB/HIV collaborative interventions targeting adults with a focus on strengthening coordination at county level, improving screening and treatment of both diseases including providing required diagnostic equipment and drugs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1875000}]
["Zanzibar","12/31/2020","Malaria","FR377-QNB-M","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 2","Active",null,"Medium","PAI-6021","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYZ/view","58,909","58,909","This activity will cover the cost to monitor and support regular and timely reporting of all activities conducted at various levels of implementation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":58909}]
["Zanzibar","12/31/2020","HIV/AIDS, Tuberculosis","FR378-QNB-C","Prong 3: Preventing vertical HIV transmission","10/30/2019","PMTCT","High Impact Africa 2","Active",null,"High","PAI-6029","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYh/view","544,241","544,241","This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":544241}]
["Kenya",null,"HIV/AIDS, Tuberculosis","FR333-KEN-C","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","High Impact Africa 2","Active",null,"High","PAI-4572","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBC/view","9,250,390","9,250,390","This funding (above allocation UQD) aims to improve Lab networking and access to universal DST through procuring larger capacity gene xpert machines for facilities with highest workload/ more than 80% utilization instead of the 4 modular machines; and mobile gene xpert/ omni xpert to increase physical access to xpert. Funding also aims to facilitate trainings to the facilities receiving the new equipment and to procure additional cartridges to ensure availability of cartridges to support utilization of equipment procured. Aditional power inverters to ensure there is no service interruption caused by power outages will also be procured; this is key to improving access to DST.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9250390}]
["Zanzibar","12/31/2020","Malaria","FR377-QNB-M","Therapeutic efficacy surveillance","10/30/2019","Case management","High Impact Africa 2","Active",null,"High","PAI-6016","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYU/view","104,768","104,768","This intervention aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":104768}]
["Zambia",null,"Malaria, RSSH","FR254-ZMB-Z","Other vector control measure(s)","10/30/2019","Vector control","High Impact Africa 2","Active",null,"High","PAI-6033","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYl/view","10,686,696","10,686,696","This is a relevant component of the countrys elimination strategy that is critical as the burden progressively declines. This strategy will support the development of case-based surveillance in areas with low malaria transmission.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10686696}]
["Uganda",null,"HIV/AIDS, Tuberculosis","FR188-UGA-C","Case detection and diagnosis","10/30/2019","TB care and prevention","High Impact Africa 2","Active",null,"Medium","PAI-5889","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWR/view","18,652,070","15,152,070","This is to support procurement of cartridges for operationalizing Xpert MTB/Rif machines to enhance the finding of missed cases including in key populations such as prisons and PLHIV. Secondly, approximately $1.7m is for procuring digital X-rays.",0,0,0,"3,500,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":15152070}]
["South Africa","3/31/2022","HIV/AIDS, Tuberculosis","FR427-ZAF-C","Addressing stigma, discrimination and violence against TGs","10/30/2019","Comprehensive prevention programs for TGs","High Impact Africa 2","Active",null,"Low","PAI-6004","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYI/view","1,628,308","1,628,308","This PAAR request is for hormone replacement therapy for 840 transgender people (50% of those reached through the program). It is expected that this intervention will help address gender-related barriers for transgender people. It is also linked with improved attainment of the 90-90-90 targets, since global data suggests that ART initiation and treatment adherence improves among transwomen in a gender affirming context.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1628308}]
["Multicountry Southern Africa MOSASWA","12/31/2022","Malaria","FR515-MCMOSASWA-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","High Impact Africa 2","Inactive",null,"High","PAI-4931","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGz/view","4,624,817",0,"This request will cover the cost of insecticide for focal IRS in Maputo province, southern Mozambique. The Mozambique NMCP has committed to providing insecticide for focal IRS in Maputo province for 2020-2022 through its country GF grant and government resources.  However, providing such support necessarily removes it from higher burden provinces in Gaza/Inhambane and central/northern Mozambique.  There is strong epidemiological and entomological evidence that IRS would have a rapid impact on onward transmission in the identified districts (due to high burden of disease, proliferation of A. funestus vector, and pyrethroid resistance).  Without coverage of insecticide, country funding constraints could compromise the ability to maintain gains in Maputo province.",0,0,0,0,"4,624,817",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Ethiopia",null,"HIV/AIDS, Tuberculosis","FR313-ETH-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Africa 2","Active",null,"High","PAI-4251","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ61/view","3,139,446","3,139,446","Through this request, CCM/E aims to strengthen program monitoring and evaluation at sub-national and community levels through quarterly joint program supervisions, reviews and performancetracking.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3139446}]
["Tanzania (United Republic)","12/31/2020","HIV/AIDS, Tuberculosis","FR219-TZA-C","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","High Impact Africa 2","Active",null,"Medium","PAI-5856","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVu/view","157,600","157,600","Timely, reliable and comprehensive information for the management of the national response enables the country to estimate resource flows and expenditures in support of the Multisectoral response to HIV and AIDS. Tanzania therefore plans to conduct the National AIDS Spending Assessment (NASA) study to track expenditure among, Public sources, External sources, Providers of HIV and AIDS services (Public and Private), Out of pocket (Individual spending). The NASA report is expected to form a basis for leveraging both technical and financial support for national HIV response based on available resources.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":157600}]
["Zambia",null,"HIV/AIDS, Tuberculosis, RSSH","FR257-ZMB-Z","Community TB/HIV care delivery","10/30/2019","TB/HIV","High Impact Africa 2","Inactive",null,"High","PAI-6053","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZ5/view","491,304",0,"To strengthen community TB/HIV activities by training 5000 community TB/HIV supporters in 104 districts in TB and HIV prevention, care and support, including contact tracing.",0,0,0,0,"491,304",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Zimbabwe",null,"HIV/AIDS, Tuberculosis","FR100-ZWE-C","Condoms and lubricant programming for TGs","10/30/2019","Comprehensive prevention programs for TGs","High Impact Africa 2","Active",null,"High","PAI-6065","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZH/view","1,200","1,200","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1200}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Other program management intervention(s)","10/30/2019","Program management","High Impact Asia","Active",null,"High","PAI-4480","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9i/view","301,800","301,800",null,0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":301800}]
["Multicountry East Asia and Pacific RAI","12/31/2020","Malaria","FR196-MCRAI-M","Other program management intervention(s)","10/30/2019","Program management","High Impact Asia","Active",null,"Low","PAI-4969","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHb/view","464,727","309,000","1. The semi-annual meetings are to review 6 months activities and adjust annual workplan based on results 2. WHO TA fees in 2018 and 2019 are included in within allocation budget. In 2020, even though it is expected that the program's capacity has been strengthened, TA from WHO will still be necessary to develop elimination strategies for 2021 - 2025 period.",0,0,0,0,"155,727",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":309000}]
["Cambodia","12/31/2020","Tuberculosis","FR100-KHM-T","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","High Impact Asia","Active",null,"Low","PAI-4666","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCi/view","180,862","180,862","A local lab consultant and lab technician will be recruited to ensure the quality of TB, maintenance lab equipment and support GeneXpert troubleshooting. Recruitment of one full time effort WHO Medical Office and short term TA will assist the program to ensure quality services. TRP only recommends 20% of the request.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":180862}]
["Pakistan","12/31/2020","Tuberculosis","FR202-PAK-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"Medium","PAI-5365","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNz/view","2,300,000","2,300,000","Action: LHWs are to be engaged in contact tracing, promote screening of the elderly and screening of children for TB. 30% of LHWs will be engaged mainly in rural districts by 2020.  37,500 cases (0.75 case per LHW/annually) will be detected through this engagement.Rational:  Pakistan has 150,000 LHWs based in the community, paid for by Provincial programs & they play a major role in MNCH, including immunization. This workforce will be utilized for early case detection and treatment adherence.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2300000}]
["Pakistan","12/31/2020","Tuberculosis","FR202-PAK-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","High Impact Asia","Active",null,"High","PAI-5356","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNq/view","3,200,000","3,200,000","Action: To establish 11 more PMDT sites in Public and private sector in an equitable manner.Rationale: These PMDT sites will facilitate the enrollment of DR-TB patients near their residences for better treatment adherence.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3200000}]
["Pakistan","12/31/2020","Tuberculosis","FR202-PAK-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","High Impact Asia","Active",null,"High","PAI-5363","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNx/view","1,630,000","1,630,000","Action: To introduce a comprehensive TB detection, care & prevention package in District Hafizabad (Punjab) and Mirpurkhas (Sindh). The package includes scaling up of PPM interventions, involving GPs in CHTB case detection & management, active case finding through organizing mobile screening chest camps using chest x-rays algorithm, implementing FAST (Finding TB cases Actively, Separating Safely, and Treating effectively) intervention at the District Headquarter Hospitals (DHQ) in 2 districts. Rational: The selected districts have high yield of patients in the current NFM grant and the high influx of patients to these districts from nearby areas. The  proposed  interventions  will  help  to provide  a  rationale  to  scale  up  this  package  of activities in other districts to achieve END TB strategy goals to detect over 90% of cases. Additional 3,000 DS-TB cases and around 385 MDR-TB cases will be detected in three years.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1630000}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","High Impact Asia","Active",null,"Low","PAI-4507","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJA9/view","1,669","1,669","Additional 5 SSR at new districts.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1669}]
["Multicountry South-Eastern Asia AFAO","12/31/2021","HIV/AIDS","FR543-MCSEAAFAO-H","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","High Impact Asia","Active",null,"High","PAI-5000","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJI6/view","119,652.38","119,652.38","Additional amount to add to Within Allocation Budget Line 184 for Laos for year 2 second round grants",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":119652.38}]
["Multicountry South-Eastern Asia AFAO","12/31/2021","HIV/AIDS","FR543-MCSEAAFAO-H","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","High Impact Asia","Active",null,"High","PAI-5005","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIB/view","119,652.38","119,652.38","Additional amount to add to Within Allocation Budget Line 189 for Timor Leste for year 2 second round grants",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":119652.38}]
["Multicountry South-Eastern Asia AFAO","12/31/2021","HIV/AIDS","FR543-MCSEAAFAO-H","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","High Impact Asia","Active",null,"High","PAI-5006","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIC/view","119,653.38","119,653.38","Additional amount to add to Within Allocation Budget Line 190 for Sri Lanka for year 2 second round grants",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":119653.38}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","High Impact Asia","Inactive",null,"High","PAI-4476","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9e/view","1,413,935",0,"Additional people receiving viral load testing.",0,0,0,0,"1,413,935",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Viet Nam","12/31/2020","HIV/AIDS","FR100-VNM-H","Community led advocacy","10/30/2019","RSSH: Community responses and systems","High Impact Asia","Active",null,"Medium","PAI-5927","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJX3/view","33,380","33,380","Advocacy for preferential tax policy for CSO.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":33380}]
["Indonesia","12/31/2020","Malaria","FR396-IDN-M","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","High Impact Asia","Active",null,"Medium","PAI-4467","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9V/view","100,000","100,000","Annual workshop to bring together leading researchers with both PRs and the NMCP.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["India","3/31/2021","HIV/AIDS","FR185-IND-H","Treatment adherence","10/30/2019","Treatment, care and support","High Impact Asia","Active",null,"Medium","PAI-4536","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAc/view","4,700,000","4,700,000","As a part of alternate strategies to improve adherence to ARVs, adherence clubs at all Link ART Centers (LACs) are being proposed.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4700000}]
["India","3/31/2021","HIV/AIDS","FR185-IND-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","High Impact Asia","Active",null,"Low","PAI-4529","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAV/view","27,097","27,097","At end of the project, the project team will develop an end term documentation and disseminate it as part of the Elimination of Paediatric HIV in India.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":27097}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Community led advocacy","10/30/2019","RSSH: Community responses and systems","High Impact Asia","Active",null,"Medium","PAI-4471","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9Z/view","1,284,292","1,284,292","Community led advocacy and lobby to district parliament is expected to facilitate the development of district level regulation and realization of existing regulation on TB control. Organizational capacity of ex-TB patients will be strengthened to improve the quality of advocacy. Award to well-performing district, cadres, and community group aims to stimulate multi sector engagement to TB control. The plan includes also TB caledoscope and guideline printing for advocacy purposes.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1284292}]
["Philippines","12/31/2020","HIV/AIDS","FR192-PHL-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Asia","Inactive",null,"High","PAI-5378","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOC/view","554,152.41",0,"Constitutes prevention, testing and treatment costs for 14 sites out of the 39 high disease burden sites identified as FR sites.",0,0,0,0,"554,152.41",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Multicountry East Asia and Pacific RAI","12/31/2020","Malaria","FR196-MCRAI-M","Other case management intervention(s)","10/30/2019","Case management","High Impact Asia","Inactive",null,"Low","PAI-4971","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHd/view","64,000",0,"Contingency measure for new foci in anticipation of occurrence in drug resistant villages.",0,0,0,0,"64,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Pakistan","12/31/2020","HIV/AIDS","FR203-PAK-H","Other intervention(s) for TGs","11/29/2019","Comprehensive prevention programs for TGs","High Impact Asia","Active",null,"Medium","PAI-5347","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNh/view","511,200","226,540","Cost of reaching additional 7,200 TG with prevention package. It is prioritized because prevalence rate for this population is the highest (7.1%) amongst KP for whom the primary mode of transmission is sexual. Unit costs ($71) were fixed with reference to those used for the AEM modelling. Proposed additional coverage would amount to 100% of the annual gap.",0,0,0,"184,660","100,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":226540}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Grant management","10/30/2019","Program management","High Impact Asia","Active",null,"Medium","PAI-4510","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAC/view","1,886,633","1,886,633","Cover 72 and 81 priority districts in 2019 and 2020 as addition to the 271 districts covered by allocation. The additional data officer and financial assistant will strengthen the monitoring of the districts.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1886633}]
["Viet Nam","12/31/2020","HIV/AIDS","FR100-VNM-H","Other intervention(s) for people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","High Impact Asia","Active",null,"High","PAI-5919","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWv/view","363,080","83,927","Currently, there are more than 100,000 prisoners detained in more than 100 prisons managed by the Ministry of Public Security. Female offenders account for about 11% of the total number of detainees. Approximately 30% of prisoners have a history of drug abuse and other infectious diseases such as hepatitis, tuberculosis and HIV and services for HIV infected people in closed settings remain limited. Delivering HIV services including prevention, counselling, and care and treatment in closed settings face challenges including limited funding and a lack of facilities. Health staffs are few in number, with low capacity to deliver HIV services and little chance to exchange or update new knowledge. The Ministry of Public Security currently manages HIV prevention, care and treatment activities at 54 prisons in 63 provinces and cities, of which 32 are supported by the Global Fund. In the near future, prisons will implement MMT. The police force plays an important role in supporting HIV prevention interventions in the community. In the 2018-2020 allocation period, VAAC requests Global Fund support for the following activities: i. Training for medical staff working in detention centres, prisons, medical facilities in the police force on HIV prevention and harm reduction, counselling, testing, and treatment and care (2018). ii. Training for police officers belonging to the criminal police, drug and crime prevention police, social order police in HIV harm reduction interventions (2019- 2020) These interventions will provide capacity building for health workers in custody and health facilities in HIV prevention, counselling, and care and treatment activities; as well as assist the medical staff in the implementation of HIV prevention interventions in prisons and in the community.",0,0,0,0,"279,153",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":83927}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Asia","Inactive",null,"High","PAI-5772","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUY/view","397,208",0,"DDC BL 273:Support renovation of isolation TB room and DOT corner for prisoners including UV light in order to prevent TB/MDR transmission in prison in 70 prisons.The prisons are the closed setting areas and crowded, provision of molecular test by GeneXpert will detect more TB patients. Good management for infectious TB control will prevent and cut off transmission in prisons.Emphasizing on infection control and environment management control that is important both for prisoners and prison guards.",0,0,0,"397,208",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Asia","Inactive",null,"Medium","PAI-5774","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUa/view","723,486",0,"DDC BL 289:Support of 3 small mobile x-ray vans, including read and digital CXR scanner set to render regular mobile services for prisoners and prisoner guards in 20 high TB burden prisons (2 prisons for one van) with prompt referral of symptomatic patients or patients with abnormal CXR to facilities with GeneXpert for TB confirmation and TB treatment. This demonstrationproject is hoped to generate evidence of TB disease burden in prisons and feasibility for prevention and care in order to support policy decision.Small mobile x-ray van, including read and digital CXR scanner set to provide services for the prisons that have the narrow entry/entrance.",0,0,0,"723,486",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","Treatment: MDR-TB","10/30/2019","MDR-TB","High Impact Asia","Active",null,"High","PAI-5754","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUG/view","769,377","769,377","DDC BL 292, 293, 294, 295, 296, 297, 298, 299, 300, 301:Support intensive case finding and comprehensive treatment and care of migrant refugees at border area, includingCase detection (passive and Targeted Active Case detection), diagnostic capacity, case holding and case managementAccess to care and TB treatment for all TB cases including MDR-TB and TB/HIV co-infected patientsCare and support for TB patient with transportation, and psychosocial care or patients and care takers in residential TB center located on Thai sideContinue and strengthen partnership with Mae Tao Clinic for TB control activities among Migrants who attend MTC.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":769377}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","Community empowerment for people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","High Impact Asia","Active",null,"High","PAI-5761","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUN/view","63,270","63,270","DDC BL 358TB-HIV in PrisonsTelemedicine to improve and follow up patient' s clinical from hospital to prison in order to improve TB, HIV, IPT and OST service in 5 prisons in each year.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":63270}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","HIV testing services for people in prisons and other closed settings","10/30/2019","Comprehensive programs for people in prisons and other closed settings","High Impact Asia","Inactive",null,"High","PAI-5762","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUO/view","355,100",0,"DDC BL 359HIV testing services for Prisoner by using oral fluidHIV testing  for Prisoner is set 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.",0,0,0,0,"355,100",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","Treatment: MDR-TB","10/30/2019","MDR-TB","High Impact Asia","Inactive",null,"High","PAI-5760","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUM/view","174,960",0,"DDC BL 374:XDR-TB drug procuring for XDR-TB patients;Y1,2018 = 10 casesY2,2019 = 15 casesY3,2020 = 20 cases.This request will be support for the expansion of XDR-TB treatment by the national TB program. NTP will be expanding diagnosis capacity in 12 ODPCs that will increase number of XDR detection. BTB will put more investment on treatment of those increasing but it may not reach the same diagnosis XDR-TB cases which expected to be 58, 70  and 82 cases in 2018, 2019, 2020 respectively.",0,0,0,0,"174,960",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Viet Nam","12/31/2020","HIV/AIDS","FR589-VNM-H","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","High Impact Asia","Active",null,"Medium","PAI-5942","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXI/view","100,000","100,000","Due to the preference for anonymity when it comes to accessing healthcare, communication through social media and technology is essential to provide HIV prevention information to MSM. The Global Fund is requested to support communication on HIV prevention for MSM, HIV/HCV (Hep-C Virus) co-infection and Sexually Transmitted Infection (STI).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["Multicountry East Asia and Pacific RAI",null,null,null,"Other vector control measure(s)","10/30/2019","Vector control","High Impact Asia","Inactive",null,"High","PAI-4984","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHq/view","1,617,680",0,"Essential to continue trajectory of malaria reduction and avert outbreaks.",0,0,0,0,"1,617,680",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Multicountry East Asia and Pacific RAI",null,null,null,"Other case management intervention(s)","10/30/2019","Case management","High Impact Asia","Inactive",null,"High","PAI-4988","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHu/view","4,505,000",0,"Essential to continue trajectory of malaria reduction and avert outbreaks.",0,0,0,0,"4,505,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Multicountry East Asia and Pacific RAI",null,null,null,"Other case management intervention(s)","10/30/2019","Case management","High Impact Asia","Active",null,"High","PAI-4983","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHp/view","720,000","720,000","Essential to monitor known delayed parasite clearance times.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":720000}]
["India","3/31/2021","HIV/AIDS","FR185-IND-H","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","High Impact Asia","Active",null,"Low","PAI-4515","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAH/view","3,000,000","3,000,000","Evidence generation for policy change.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3000000}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Community empowerment for TGs","10/30/2019","Comprehensive prevention programs for TGs","High Impact Asia","Active",null,"High","PAI-4489","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9r/view","44,302","44,302","Expansion of Comprehensive program to reach additional 5,250 TG for testing and 756 for treatment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":44302}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Community empowerment for TGs","10/30/2019","Comprehensive prevention programs for TGs","High Impact Asia","Active",null,"Medium","PAI-4496","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9y/view","44,302","44,302","Expansion of Comprehensive program to reach additional 5,250 TG for testing and 756 for treatment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":44302}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Behavioral interventions for TGs","10/30/2019","Comprehensive prevention programs for sex workers and their clients","High Impact Asia","Active",null,"High","PAI-4490","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9s/view","238,921","238,921","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":238921}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Community empowerment for MSM","10/30/2019","Comprehensive prevention programs for MSM","High Impact Asia","Active",null,"High","PAI-4486","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9o/view","57,652","57,652","Expansion of Comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":57652}]
["Cambodia","12/31/2020","HIV/AIDS, Tuberculosis","FR582-KHM-C","Behavioral interventions for TGs","10/30/2019","Comprehensive prevention programs for TGs","High Impact Asia","Inactive",null,"High","PAI-4632","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCA/view","45,000",0,"Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Transgender (TG).  Prolonging the working hours of outreach workers until midnight will allow for greater reach and will offer HIV and syphilis testing to TGs. Expected outcome:  177 TGs reached with defined package of services",0,0,0,"45,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Viet Nam","12/31/2020","HIV/AIDS","FR100-VNM-H","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","High Impact Asia","Active",null,"Low","PAI-5937","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXD/view","44,131","44,131","Facilitate meetings among key CBOs, VNGOs and local stakeholders to review progress of CBO's outreach activities, and discuss about challenges/barriers, needs for further support and improvement. Organize community events through small grants to CBOs to mobilize and encourage active lifestyles for KP.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":44131}]
["Multicountry East Asia and Pacific RAI","12/31/2020","Malaria","FR196-MCRAI-M","Other case management intervention(s)","10/30/2019","Case management","High Impact Asia","Active",null,"High","PAI-4964","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHW/view","500,000","114,156","For patients with confirmed P. falciparum or mixed infection, a slide is collected at D28 to ascertain efficacy of treatment with full parasitological clearance. If positive, the patient will receive second line treatment according to NTG. Investigation of all positives cases found during reactive case detection to prevent ongoing local transmission.",0,"385,844",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":114156}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Engaging all care providers (TB/HIV)","10/30/2019","TB/HIV","High Impact Asia","Active",null,"High","PAI-4482","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9k/view","147,756","147,756","Health Provider Training on HIV Testing, Care, Support and Treatment for 243 basic districts.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":147756}]
["Myanmar",null,"HIV/AIDS, Tuberculosis","FR301-MMR-C","Differentiated ART service delivery","10/30/2019","Treatment, care and support","High Impact Asia","Inactive",null,"High","PAI-5109","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJr/view","26,355,783",0,"HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.",0,0,0,0,"26,355,783",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Myanmar",null,"HIV/AIDS, Tuberculosis","FR301-MMR-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Asia","Inactive",null,"High","PAI-5114","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJw/view","2,049,801",0,"HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.",0,0,0,0,"2,049,801",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["India","3/31/2021","Malaria","FR186-IND-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","High Impact Asia","Active",null,"High","PAI-4542","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAi/view","17,700,000","16,876,385","HMIS will be used for real-time collection and compilation of data to strengthen monitoring, supervision and data quality. It would encompass epidemiological, logistics, and human resource management. Moving towards malaria elimination, it would enhance the real-time monitoring at different levels. Moreover, the proper implementation of HMIS tool on PAN India basis would enhance disease control leading to reduction in morbidity and mortality, and ensure proper use of logistics. Dashboard would have provision for other implementing partners too.",0,0,0,0,"823,615",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":16876385}]
["Cambodia","12/31/2020","HIV/AIDS, Tuberculosis","FR582-KHM-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Asia","Inactive",null,"High","PAI-4642","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCK/view","80,000",0,"Improve HIV/STI referral and counselling via SwipeRx Mobile AppSwipeRx is a free mobile application for pharmacy professionals. Its online network of over 1,600 pharmacists. SwipeRx will give NCHADS the ability to communicate with pharmacies to improve awareness, education, prevention & treatment of STIs, including HIV, which may be improved by increasing provider-level awareness on referral pathways to testing facilities.Expected outcome: 5,000 STI patients refer to HIV testing and 5% diagnose HIV positive",0,0,0,"80,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Viet Nam","12/31/2020","Tuberculosis","FR100-VNM-T","Case detection and diagnosis","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"High","PAI-5971","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXl/view","9,710,510","9,710,510","In order to use Xpert for all TB suspects by 2020, the procurement and adaptation of GeneXpert machines is essential. The allocation amount covers procurement of 30 GX machines to scale up Xpert capacity. PAAR will cover a) 20 additional 4-module GX machines and 40 Xpert Omni per year, b) 100k cartridges in 2018, 150k in 2019, and 237k in 2020 (+ consumables and testing fee), and c) training for TB units receiving new machines, and for transition to Ultra cartridges. This will cover Xpert testing among 12,000 people per year with an abnormal CXR. - Additional costs will include:  Two ILEDs per year, ILED maintenance & repair, and EQA for microscope's smear  Three digital X-ray cars per year (total 9 cars) to contribute to I/ACF  Implementation of the FAST strategy.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9710510}]
["Viet Nam","12/31/2020","HIV/AIDS","FR100-VNM-H","Community-based monitoring","10/30/2019","RSSH: Community responses and systems","High Impact Asia","Active",null,"High","PAI-5944","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXK/view","60,965","60,965","In previous years, considerable support has been given to the development of a robust community system for HIV response, resulting in the establishment and growth of national networks for PWID, of SW, and of MSM and TG. Funding from this allocation will continue to build on this foundation, strengthening the institutional and service delivery capacity of new and existing CBO and KP networks to support HIV prevention services, advocate effectively and to provide community-based monitoring and feedback. Community-based monitoring will be implemented between 2017-2020 using the set of tools and procedures developed during the last allocation period.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60965}]
["Indonesia","12/31/2020","Malaria","FR396-IDN-M","Other vector control measure(s)","10/30/2019","Vector control","High Impact Asia","Inactive",null,"High","PAI-4462","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9Q/view","2,300,000",0,"IVM (IRS and environment management) and community engagement in additional 12 high endemic districts with API > 50 and < 100 (Yapen, Waropen, Asmat, Arfak) and API > 20 and < 50 (Supiori, Mappi, Nabire, Deiyai, Lembata, Tambraw, Teluk Wondama, Kota Jayapura). Activities will include insecticide procurement and IRS at 120 villages in 12 districts. The target population will be approximately 120,000 people (200 households per village @5 person per house)IVM will cover following activities:- Feasibility assessment of IVM application (USD 50,000/district = USD 600,000 for 12 districts)- Environment Management  larval habitat reduction via drainage works where feasible (USD 50,000 per district = USD 600,000 for 12 districts). - Larvaciding (@ US$ 50,000 per district = US$ 600,000 for 12 districts)- Insecticide for 24,000 houses: US$ 250,000- IRS for 120 villages: US$ 250,000 (@US$ 2,000 per village)Total amount for this activity is USD 2,300,000",0,0,0,0,"2,300,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["India","3/31/2021","Tuberculosis","FR187-IND-T","Treatment: MDR-TB","10/30/2019","MDR-TB","High Impact Asia","Active",null,"High","PAI-4546","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAm/view","29,850,000","29,850,000","Management of DRTB patients - SLD: An above allocation grant with funding amounting to USD 29.85 million is requested to initiate additional 20,000 MDR-TB patients on treatment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":29850000}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"High","PAI-4492","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9u/view","947,184","947,184","Mobile clinic to screen for TB in urban poor population in 10, 12, 15 high burdened cities in 2018, 2019, 2020. Additional 1000 patients from urban poor is expected per year. Technical mentoring of TB ICF in 34 provinces, printing of TB ICF materials. Printing IEC material for vulnerable population at workplace.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":947184}]
["Pakistan","12/31/2020","Malaria","FR412-PAK-M","Other program management intervention(s)","10/30/2019","Program management","High Impact Asia","Active",null,"Medium","PAI-5352","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNm/view","100,000","100,000","MPR objectives are to review in 2018 the malaria program structure and capacity in each province and at national level, identify challenges and have the epidemiological outlook of malaria per province. Furthermore, this will assess current program performance and help redefine strategic direction, including revision of policies and strategic plans at provincial levels.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["Cambodia","12/31/2020","HIV/AIDS, Tuberculosis","FR582-KHM-C","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","High Impact Asia","Active",0,"Low","PAI-4659","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCb/view","100,000","100,000","Operational Research",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["Pakistan","12/31/2020","HIV/AIDS","FR623-PAK-H","Differentiated HIV testing services","11/29/2019","HIV Testing Services","High Impact Asia","Inactive",null,"High","PAI-6120","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJaZ/view","200,000",0,"Outreach and Community Based testing in Sindh Province. Outreach workers, Counsellors and Test kits and consummables.","200,000",0,0,"200,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"Medium","PAI-4511","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAD/view","395,356","395,356","Piloting Rifapentin (3HP) for LTBI in 2 hospitals in 5 provinces for 200 children in 2018, then gradually increase 5 provinces per year. The distribution of healthy life style education materials will facilitate TB prevention in community based.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":395356}]
["Bangladesh","11/30/2020","HIV/AIDS","FR100-BGD-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Asia","Active",null,"Low","PAI-3880","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ02/view","940,181","940,181","Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":940181}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"High","PAI-4470","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9Y/view","10,897,856","7,497,856","Procurement of 200 Xpert MTB/RIF (800 modules)and 650 Xpert MTB/RIF omni with the cartridge to do 266,363 test. This machine will support additional effort to find more cases planned in this activities (mobile clinic, mass screening) and increase the diagnostic capacity for regular health service. It is expected to detect additional 1500 MDR TB patients.",0,0,0,0,"3,400,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7497856}]
["Multicountry TB Asia UNOPS","12/31/2021","Tuberculosis","FR530-MCASIAUNOPS-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"High","PAI-4783","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEb/view","1,670,950","1,670,950","Proposed approaches supporting sputumtransportation, results feedback andfinancial support to referred patients; andACF targeting migrants are required tomaximize impact of proposedinterventions",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1670950}]
["Cambodia","12/31/2020","HIV/AIDS","FR100-KHM-H","Other procurement supply chain management intervention(s)","10/30/2019","RSSH: Procurement and supply chain management systems","High Impact Asia","Active",null,"Low","PAI-4623","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJC1/view","40,000","40,000","QC/QA will be implemented in collaboration with DDF and CMS and sampling will be undertaken using current SOP employing a risk based approach in product selection. TRP recommends 10% of the request.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":40000}]
["Bangladesh","12/31/2020","Malaria","FR100-BGD-M","Facility-based treatment","10/30/2019","Case management","High Impact Asia","Active",null,"High","PAI-3882","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ04/view","25,795","25,795","Quality Assurnce (QA) of diagnosis needs improvement and will be strengthened through expansion and upgrading of the Central Medical Reference Laboratory and collaborating laboratories. A QA database and support for external competency testing will be conducted every 3 years. Sensitivity and specificity of diagnosis will increase as a result, improving rationality of treatment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25795}]
["Philippines","12/31/2020","HIV/AIDS","FR192-PHL-H","Other intervention(s) for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","High Impact Asia","Inactive",null,"High","PAI-5380","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOE/view","124,944.56",0,"Requirement for parental consent makes it difficult for YKP to address. Through capacity building of YKP and service providers and the issuance of policies, more YKP will be able to access services.",0,0,0,0,"124,944.56",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","Prevention and management of coinfections and co-morbidities for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","High Impact Asia","Active",null,"High","PAI-5768","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUU/view","124,245","124,245","RTF BL 12-14,411. Hep C advisory board2. Hep C advisory board meeting3. HCV test kit procurement for 17 provinces -in addition to Community led4. Direct acting anti-viral treatment (DAA) dialogue for HEP C-group for HEP C following up during the intensive.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":124245}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","Community led advocacy","10/30/2019","RSSH: Community responses and systems","High Impact Asia","Active",null,"Low","PAI-5785","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUl/view","68,842","68,842","RTF BL 22Training on Information and Data system  and specific topic for all KPs e.g. RTCM, Application, other digital platforms, and specific issue (organized by TA): Train project staff Units/Participants: 15 persons per day, 2 days  Locations: 36 provinces in year 1, year 2.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":68842}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","Institutional capacity building, planning and leadership development","10/30/2019","RSSH: Community responses and systems","High Impact Asia","Inactive",null,"High","PAI-5753","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUF/view","343,911",0,"RTF BL 23-281.Monitoring progress of institutional development capacity and training in the area of 1) Organizational strategic plan, 2) Program management, 3) Resource management, 4) Financial management, 5) Risk management, and 6) Data and Information management 2.Promote digital platform of CSO accreditation3. Kick off for digital platform to multiply impacts for CSO accreditation at national and regional level 4. Community led training -Training Outreach worker and Field staff  by TRC5. Visualise advocacy documentation and training manual6. Kick off for Visualise documentation.",0,0,0,0,"343,911",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Thailand","12/31/2020","HIV/AIDS, Tuberculosis","FR200-THA-C-01","Community TB care delivery","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"High","PAI-5770","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUW/view","16,342","16,342","RTF BL 42:Support TB patient group activitiesTo establish a group to share past experiences, communicate and inform on counter effects of medicines and on the different forms of care and support present in the community for the benefit and of both KPs and care takers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":16342}]
["Viet Nam","12/31/2020","Tuberculosis","FR100-VNM-T","Treatment","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"Low","PAI-5963","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXd/view","424,820","424,820","Scaling up mHEalthin four provinces and piloting mHealth for MDR-TB - Renovating to improve TBIC for five TB/HIV patient care facilities per year and training in TBIC for general hospital and prison staff.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":424820}]
["Cambodia","12/31/2020","HIV/AIDS, Tuberculosis","FR582-KHM-C","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","High Impact Asia","Active",null,"High","PAI-4636","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCE/view","15,500",500,"Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)Reproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) Expected outcome: at least 2,160 hidden KPs reached",0,0,0,"15,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":500}]
["Cambodia","12/31/2020","HIV/AIDS, Tuberculosis","FR582-KHM-C","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","High Impact Asia","Active",null,"High","PAI-4635","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCD/view","15,500",500,"Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)Reproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) Expected outcome: at least 2,160 hidden KPs reached",0,0,0,"15,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":500}]
["Viet Nam","12/31/2020","Tuberculosis","FR100-VNM-T","Surveys","10/30/2019","RSSH: Health management information systems and M&E","High Impact Asia","Active",null,"Low","PAI-5964","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXe/view","25,000","25,000","Study of the LTBI prevalence among child contacts and their characteristics (contact, index patient and environmental) associated with infection.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25000}]
["Pakistan","12/31/2020","HIV/AIDS","FR623-PAK-H","Routine reporting","11/29/2019","RSSH: Health management information systems and M&E","High Impact Asia","Inactive",null,"High","PAI-6119","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJaY/view","100,000",0,"Surveillance system through sentinel sites in Sindh Province after the HIV outbreak (as recommended by WHO led investigation): a. HIV screening in all TB centresb. Screening in all registered blood banks (public and private)c. Screening of all Ante Natal clinics attendee in all BHUs in Sindh (Done by PPHI).d. Screening in all PPTCT centres in Larkana and Ratodero, e.HIV screening in sentinel sites in Larkana (Urban setting) and Ratodero (Rural settings)f. support for routine reporting, improving reporting.","100,000",0,0,"100,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Bangladesh","11/30/2020","HIV/AIDS","FR100-BGD-H","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","High Impact Asia","Active",null,"Low","PAI-3878","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ00/view","170,000","110,000","Technical assistance will be requested from WHO to assist in developing different protocols, guidelines, conducting quality research and training to complement updating/developing various guidelines.",0,0,0,0,"60,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":110000}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Asia","Active",null,"High","PAI-4475","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9d/view","775,733","775,733","The additional 8,682 patients above will also receive prevention, diagnosis and treatment of opportunistic infections. Activities include OI and STI drugs procurement, trainings, mentoring session, home-based care of PLHIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":775733}]
["Myanmar",null,"HIV/AIDS, Tuberculosis","FR301-MMR-C","Other interventions for MSM and TGs","10/30/2019","Prevention programs for MSM and TGs","High Impact Asia","Active",null,"High","PAI-5088","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJW/view","136,363","136,363","The additional investment will support the program to reach more target population.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":136363}]
["Myanmar",null,"HIV/AIDS, Tuberculosis","FR301-MMR-C","Diagnosis and treatment of STIs and other sexual and reproductive health services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","High Impact Asia","Active",null,"High","PAI-5100","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJi/view","674,264","66,104","The additional investment will support the program to reach more target population.",0,0,0,0,"608,160",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":66104}]
["Myanmar",null,"HIV/AIDS, Tuberculosis","FR301-MMR-C","Behavioral change as part of programs for MSM and TGs","10/30/2019","Prevention programs for MSM and TGs","High Impact Asia","Active",null,"High","PAI-5086","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJU/view","9,468,402","2,672,089","The additional investment will support the program to reach more target population.",0,0,0,0,"6,796,313",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2672089}]
["Myanmar",null,"HIV/AIDS, Tuberculosis","FR301-MMR-C","Condoms as part of programs for MSM and TGs","10/30/2019","Prevention programs for MSM and TGs","High Impact Asia","Active",null,"High","PAI-5087","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJV/view","1,076,812","227,115","The additional investment will support the program to reach more target population.",0,0,0,0,"849,697",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":227115}]
["Philippines","12/31/2020","HIV/AIDS","FR192-PHL-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","High Impact Asia","Active",null,"Low","PAI-5383","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOH/view","263,918.29","263,918","The funding will further enhance and sustain mapping of KP venues, as well as generate strategic information needed for program planning and implementation.",0,0,0,0,0.28999999999999998,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":263918}]
["Myanmar",null,"HIV/AIDS, Tuberculosis","FR301-MMR-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"High","PAI-5108","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJq/view","4,118,491","1,933,633","The funds are requested for diagnosis and treatment for Tuberculosis and interruption of transmission of TB.",0,0,0,0,"2,184,858",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1933633}]
["Pakistan","12/31/2020","Malaria","FR412-PAK-M","Other case management intervention(s)","10/30/2019","Case management","High Impact Asia","Active",null,"Low","PAI-5355","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNp/view","300,000","300,000","The Malaria Indicator survey (MIS) showed only 35% utilization of LLIN by the community during high transmission season. Mass media campaign will be conducted for all 66 districts and aired in the malaria transmission season to encourage LLINs utilization and achieve maximum impact. In addition, the campaign will raise awareness amongst the population for utilization of most famous intervention of LLINs and early care seeking by malaria suspects to reduce morbidity and mortality.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":300000}]
["Multicountry East Asia and Pacific RAI","12/31/2020","Malaria","FR196-MCRAI-M","Other case management intervention(s)","10/30/2019","Case management","High Impact Asia","Active",null,"Low","PAI-4970","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHc/view","67,000","67,000","The program would like to support the overall health system strengthening by enhancing adverse drug reaction control and monitoring.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":67000}]
["India","3/31/2021","HIV/AIDS","FR185-IND-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","High Impact Asia","Active",null,"Low","PAI-4527","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAT/view","60,000","60,000","The project printed and disseminated 4 types of IEC materials which is facilitating the increase om demand for PPTCT within the community and health system. There has been a huge demand for these IEC materials in the field. The project is proposing to print and disseminate the same materials in local languages in 7 new project states.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60000}]
["Bangladesh","12/31/2020","Malaria","FR100-BGD-M","Active case detection and investigation (elimination phase)","10/30/2019","Case management","High Impact Asia","Active",null,"High","PAI-3884","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ06/view","3,384,120","1,284,504","There are considerable additional demands associated with the elimination effort. A substantial increase in manpower will allow the programme to accelerate progress towards its targets, taking full advantage of this critical window of opportunity to eliminate malaria from Bangladesh.",0,0,0,0,"2,099,616",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1284504}]
["India","3/31/2021","HIV/AIDS","FR185-IND-H","Differentiated ART service delivery","10/30/2019","Treatment, care and support","High Impact Asia","Active",null,"Medium","PAI-4537","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAd/view","8,600,000","8,600,000","This budget is towards differentiated ART care in 246 centers. This will help saturate the service requirement.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8600000}]
["India","3/31/2021","HIV/AIDS","FR185-IND-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Asia","Active",null,"Low","PAI-4532","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAY/view","16,276","16,276","This conference aims at re-enforcing the commitment towards accomplishing the national strategy of 90:90:90 and sustaining the gains as part of the national health policy. Its al the more pertinent in the wake of HIV bill which has been recently passed by Parliament. It is now to ensure its operationalization towards improving quality of lives of PLHIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":16276}]
["Myanmar",null,"HIV/AIDS, Tuberculosis","FR301-MMR-C","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","High Impact Asia","Inactive",null,"High","PAI-5118","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJK0/view","341,440",0,"This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.",0,0,0,0,"341,440",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Myanmar",null,"HIV/AIDS, Tuberculosis","FR301-MMR-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","High Impact Asia","Inactive",null,"High","PAI-5116","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJy/view","835,427",0,"This intervention will provide data to support Program activities.",0,0,0,0,"835,427",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Differentiated ART service delivery","10/30/2019","Treatment, care and support","High Impact Asia","Active",null,"High","PAI-4474","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9c/view","808,527","808,527","This module covers pre-ART testing for an additional 8, 682 PLHIV from districts to be targeted above allocation. CST training at abive additional districts.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":808527}]
["Philippines","12/31/2020","HIV/AIDS","FR192-PHL-H","Other module","10/30/2019","Other module","High Impact Asia","Active",null,"Medium","PAI-5382","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOG/view","126,146.7","126,146.7","This will ensure that higher risk TGW are reached with prevention programs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":126146.7}]
["Indonesia",null,"HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z","Other health information systems and M&E intervention(s)","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"High","PAI-4509","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAB/view","1,713,484","1,713,484","Though smear microscopy will gradually decrease if more and more rapid molecular test use, support is still needed to ensure diagnostic access in the place which are not covered by Xpert MTB/RIF. Moreover, treatment outcome will be still tested by smear microscopy. The cost will also cover existing activities during transition of satellite centers to microscopy centers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1713484}]
["Viet Nam","12/31/2020","HIV/AIDS","FR100-VNM-H","Other module","10/30/2019","HIV Testing Services","High Impact Asia","Active",null,"Low","PAI-5933","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJX9/view","416,071","416,071","To contribute to the national goal to reduce mortality among PLHIV, VAAC requests support for annual HCV testing among PWID in the 32 Global Fund-Focus profit, prioritizing newly identified PLHIV. PLHIV who are identified as coinfected with HCV will either receive treatment under SHI or will self-fund their treatment. With above allocation funding, Vietnam will test 74,814 PWID in four provinces with high PWID population and high burden of HIV and HCV infection.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":416071}]
["Cambodia","12/31/2020","HIV/AIDS","FR100-KHM-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Asia","Active",null,"Low","PAI-4627","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJC5/view","400,000","400,000","To facilitate the transition of Sihanouk Hospital Centre of Hope,  funding is requested to provide additional year for staffing and lab costs after 2018.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":400000}]
["Cambodia","12/31/2020","HIV/AIDS","FR100-KHM-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","High Impact Asia","Active",null,"Low","PAI-4626","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJC4/view","400,000","400,000","To facilitate the transition of the AHF clinic which provides HIV services at 12 sites,  funding is requested to provide an additional year after 2018 for staffing (estimated total cost USD 400,000 for 2019).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":400000}]
["India","3/31/2021","HIV/AIDS","FR185-IND-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","High Impact Asia","Active",null,"Low","PAI-4519","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAL/view","75,000","75,000","To review and strengthen the EPTCT activities in a systematic and periodical manner, review meetings will be organized at District level. The District Health Chief will chair the meeting and review the performance of uptake of EPTCT with Block Medical Officers and Block Programme Managers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":75000}]
["Indonesia","12/31/2020","Malaria","FR396-IDN-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","High Impact Asia","Active",null,"High","PAI-4463","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9R/view","7,400,000","3,250,000","Total of 1,474,793 bed nets will be distributed to selected areas in Sumatera, Kalimantan, and Sulawesi. The costs include bed net procurement, custom and distribution costs, and field distribution cost.",0,0,0,0,"4,150,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3250000}]
["Pakistan","12/31/2020","HIV/AIDS","FR623-PAK-H","HIV care","11/29/2019","Treatment, care and support","High Impact Asia","Inactive",null,"High","PAI-6121","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJaa/view","600,000",0,"Treatment services for general population in Sindh: Funding for ARVs, Management of Opportunistic infections, Provision of psychosocial  and nutritional support. Improving retention on ART through outreach support. Training of counsellors and health workers and case managers.","600,000",0,0,"600,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Cambodia","12/31/2020","HIV/AIDS","FR100-KHM-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","High Impact Asia","Active",null,"Medium","PAI-4652","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCU/view","75,000","75,000","TRP recommended funding 25% of requested amount of $300,000 to conduct the survey proposed to feed into development of policies and targeted interventions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":75000}]
["Viet Nam","12/31/2020","Tuberculosis","FR100-VNM-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","High Impact Asia","Active",null,"High","PAI-5951","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXR/view","2,034,765","2,034,765","Under-served populations have a higher prevalence which requires ACF on a large scale. The allocation does not cover these activities. PAAR will reach the estimated additional cases based on the TIME model for these populations: about 33,000 patients per year. - PAAR will further support:  Scaling up ACF in four districts per year with large populations and high TB prevalence  TB screening and preventive treatment for 4000 immigrants per year  Routine screening for 6000 patients per year at the Methadone centers and at voluntary drug detoxication centers.  Screening for 7000 miners per year in Quang Ninh.  Screening for 7000 health workers with high risk of TB.  Establishment of a comprehensive model for TB detection and control in social protection centers in 3 provinces by MOLISA.  Procurement of 2 digital mobile X-ray machines to scale ACF in 3 border provinces.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2034765}]
["Viet Nam","12/31/2020","HIV/AIDS","FR100-VNM-H","Other intervention(s) for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","High Impact Asia","Active",null,"High","PAI-5921","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWx/view","80,323","80,323","With above allocation funding, VUSTA intends to extend the coverage of MSM reached with the defined package of prevention services in Thai Nguyen by 2020. With above allocation funding VUSTA will reach the following number of additional MSM: 2018: 660 2019: 720 2020: 720 Of these, 75% will also be referred to HIV testing services by 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":80323}]
["Viet Nam","12/31/2020","Tuberculosis","FR100-VNM-T","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","High Impact Asia","Active",null,"Medium","PAI-5957","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXX/view","277,956","277,956","With the expansion of PMDT sites, strengthening laboratory and MDR-TB treatment facility infrastructure is will be crucial to support PMDT implementation. PAAR will support this activity in 5 provinces/year and support development of IEC materials for home-based TB-IC.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":277956}]
["Viet Nam","12/31/2020","HIV/AIDS","FR100-VNM-H","Other intervention(s) for PMTCT","10/30/2019","PMTCT","High Impact Asia","Active",null,"Medium","PAI-5923","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWz/view","700,159","700,159","Within the allocation VAAC has requested Global Fund support for training for MCH staff in 160 districts with high HIV burden to intensively identify pregnant women with HIV; link HIV positive pregnant women to immediate ART; and to provide early diagnose to new-borns to initiate ART. To contribute towards the national goal to reduce the vertical transmission rate of HIV to less than 5% by 2015 and to",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":700159}]
["Honduras","7/31/2022","Tuberculosis","FR62-HND-T","Collaborative activities with other programs and sectors (TB care and prevention)","10/30/2019","TB care and prevention","Latin America and Caribbean","Active",null,"High","PAI-4421","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8l/view","25,004.36","25,004.36"," Activities to raise awareness of legislators, judges, law enforcement agents since they play an important role in protecting and enforcing the rights of tuberculosis patients and their families.  Activities relating to referring prisoner patients to health facilities when obtaining their release letter or when transferred to another penitentiary center. Social audits: involve civil society in the monitoring and tracking of TB control activities in the prioritized Health Regions with the highest TB load.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25004.36}]
["Honduras","7/31/2022","HIV/AIDS","FR61-HND-H","Other intervention(s) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Latin America and Caribbean","Inactive",null,"High","PAI-4403","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8T/view","107,742.95",-0.05," Training staff from HIV clinics and friendly services clinics, in the assisted notification strategy for couples.  Stipend for voluntary navigators in VICITS (Surveillance and Control of HIV and STI clinics) to strengthen adherence of MSM and Trans populations",0,0,0,0,"107,743",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":-0.05}]
["Guatemala","12/31/2020","HIV/AIDS","FR100-GTM-H-01","Condoms and lubricant programming for TGs","10/30/2019","Comprehensive prevention programs for TGs","Latin America and Caribbean","Active",null,"High","PAI-4385","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8B/view","89,271","89,271","2,975,714 condoms to cover 82 percent of the programmatic gap in 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":89271}]
["Guatemala","12/31/2020","HIV/AIDS","FR100-GTM-H-01","Condoms and lubricant programming for TGs","10/30/2019","Comprehensive prevention programs for TGs","Latin America and Caribbean","Active",null,"High","PAI-4347","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7Z/view","119,029","119,029","2,975,714 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":119029}]
["Guatemala","12/31/2020","HIV/AIDS","FR100-GTM-H-01","Condoms and lubricant programming for MSM","10/30/2019","Comprehensive prevention programs for MSM","Latin America and Caribbean","Active",null,"High","PAI-4345","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7X/view","232,082.24","232,082.24","5,802,056 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":232082.24}]
["Guatemala","12/31/2020","HIV/AIDS","FR100-GTM-H-01","HIV testing services for MSM","10/30/2019","Comprehensive prevention programs for MSM","Latin America and Caribbean","Active",null,"High","PAI-4363","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7p/view","110,771","110,771","70,108 HIV tests to cover 100 percent of the programmatic gap in 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":110771}]
["Cuba","12/31/2020","HIV/AIDS","FR100-CUB-H","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Latin America and Caribbean","Active",null,"Medium","PAI-4111","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3l/view","65,000","20,000","A need to reinforce legal counseling and judicial literacy (training in legal rights for PLHIV, Trans, MSM, PPTS, Youth; as well as community-based legal counseling programs - Observatories). Covering this demand will result in empowerment of key populations and being able to provide them with the means to process any violations of their rights.",0,0,0,0,"45,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20000}]
["Paraguay","2/28/2021","HIV/AIDS","FR432-PRY-H","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Latin America and Caribbean","Inactive",null,"High","PAI-5440","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPC/view","18,598",0,"Acquisition of Lubricants for prevention activities in trans. Acquiring lubricants helps reduce the risk of transmission of HIV and other STIs because of potential condom breaks, and minimizes the possibility of lesions that contribute to transmission. The country does not currently have a regulatory framework that enables the procurement of lubricants for HIV prevention. For this reason, as part of the advocacy actions, we seek to reverse this situation, but it is a medium-term process. Therefore, within the framework of the project, we need to have the financial resources so that this input is part of the prevention package delivered in the different strategies of promotion by pairs, which are directly linked to the goals of the project.",0,0,0,0,"18,598",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Paraguay","12/31/2021","Tuberculosis","FR451-PRY-T","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","Latin America and Caribbean","Active",null,"Low","PAI-5457","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPT/view","35,149.95","35,149.95","Acquisition of portable rapid molecular diagnosis devices.Purchase of two portable rapid molecular diagnosis devices and consumables is deemed necessary, mainly for visits to several remote indigenous communities or settlement, such as the regions of Pte. Hayes and Boquern.This will allow active detection of cases in key geographically hard-to-reach communities, bringing diagnosis to them and immediate start of treatment, whether simple or RR.This has no budget yet, but it is expected that soon, in the second quarter of 2018, these will launched for sale to the public.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":35149.949999999997}]
["Bolivia (Plurinational State)","12/31/2021","Malaria","FR17-BOL-M","Other case management intervention(s)","10/30/2019","Case management","Latin America and Caribbean","Active",null,"Low","PAI-3915","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0b/view","47,377.5","47,377.5","Activity 31: Training plan for microscopists in low parasitaemia and strengthening of quality control (Guayaramern)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":47377.5}]
["Bolivia (Plurinational State)","12/31/2021","Malaria","FR17-BOL-M","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"Medium","PAI-3911","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0X/view","367,286","367,286","Activity 269.1: Quarterly supervision of municipalities or lower levels  for healthcare establishments that carry out diagnosis and treatment (laboratory, hospital, pharmacy); IRS activities and distribution of LLINs in priority locations. Due to reduce allocation, it is essential for the regional authorities to have these resources, especially since the municipalities that intervene in the Amazon region are the poorest in the country and do not receive in equal proportion to the other municipalities the amounts that would contribute to the monitoring of malaria in the Amazon region.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":367286}]
["Bolivia (Plurinational State)","12/31/2021","Malaria","FR17-BOL-M","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"High","PAI-3909","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0V/view","62,117.18","62,117.18","Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the regions needs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":62117.18}]
["Multicountry Americas EMMIE","12/31/2023","Malaria","FR358-MCEMMIE-M","Other module","10/30/2019","Other module","Latin America and Caribbean","Active",null,"Medium","PAI-4810","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJF2/view","1,500,000","1,500,000","Additional technical assiatnce to support countries.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1500000}]
["Guatemala","12/31/2020","HIV/AIDS","FR640-GTM-H","Prong 3: Preventing vertical HIV transmission","11/28/2019","PMTCT","Latin America and Caribbean","Inactive",null,"High","PAI-6145","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe8/view","913,060",0,"Assurance of availability and access to screening tests for HIV, syphilis and hepatitis B for women in pregnancy, delivery and puerperiumIncludes HIV and Syphilis tests to cover the gap of pregnant women not receiving an HIV or syphilis test (PSM costs included)Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 808989","913,060","913,060",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Guatemala","12/31/2020","HIV/AIDS","FR640-GTM-H","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","11/28/2019","PMTCT","Latin America and Caribbean","Inactive",null,"High","PAI-6149","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeC/view","20,000",0,"Based on official guidelines, design a training protocol to ensure readiness of health services to attend pregnant women arriving to health facilities at the moment of delivery without having attended previously ANC. (consultancy fees)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","20,000","20,000",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Jamaica","12/31/2021","HIV/AIDS","FR66-JAM-H","Pre-exposure prophylaxis (PrEP) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Latin America and Caribbean","Active",null,"Medium","PAI-4565","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJB5/view","350,000","172,296","Based on the Pilot of PrEP being supported under the allocation, scale-up to provide for at least 1500 additional MSM on PrEP by project end.",0,0,0,0,"177,704",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":172296}]
["Multicountry TB LAC PIH","6/30/2022","Tuberculosis","FR560-MCPIH-T","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Latin America and Caribbean","Inactive",null,"Medium","PAI-4954","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHM/view","72,000",0,"Civil society participation in regional and global TB events. Considering the advocacy and surveillance role of social TB observatories, it is necessary to promote the participation of civil society representatives in important events, such as the UNION Conference, the PAHO Regional TB Meeting, and/or the follow-up meetings to be scheduled at the UN General Assembly High-Level Meeting on Ending TB.",0,0,0,0,"72,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Paraguay","2/28/2021","HIV/AIDS","FR432-PRY-H","Behavioral interventions for MSM","10/30/2019","Comprehensive prevention programs for MSM","Latin America and Caribbean","Active",null,"Low","PAI-5438","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPA/view","33,333","33,333","Communication activities to improve the quality of the intervention of the promoters / peers with the MSM population and to approach and identify new people in the population who will be future contacts. Currently the promoters / agents have a great challenge in the work that they have to carry out within the project, because the goals are very ambitious, and despite the great effort that the promoters / agents perform is still a constant challenge the achievement of them. Within the scope of the goals we must approach the occult population in a special way, which implies a great effort for the promoters / agents. In this context, we have implemented new working models such as the so-called \"PROCONS\" (Promoters / Counselors), which implies reaching hidden contacts with information, prevention inputs + Voluntary Counceling and Testing Center, since it is very difficult to obtain access to these populations by high degree of stigma and discrimination that exists in society, which relegates them to anonymity and sometimes even to self-homophobia as a mechanism of survival. Taking all this into account, and based on our field experience, we have identified that the hidden population is attracted to participating in activities that are of interest to them, these being entertainment / communication activities based on education.In addition, these spaces facilitate the identification and access to new MSM of sub hidden groups that in another context of approach would not be reached by the project. CSOs have made a great effort and have worked on our approach strategies, through a constant reengineering of the models of approaches so that they adapt and can respond to the new challenges faced by the promoters / agents. We believe that we must work with attractive strategies for the MSM population and adapt them to the demands of the MSM population.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":33333}]
["Dominican Republic","12/31/2021","HIV/AIDS","FR39-DOM-H","HIV testing services for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Latin America and Caribbean","Active",null,"High","PAI-4186","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4y/view","332,500","332,500","Community testing for Haitian migrants does not always take place in areas where prevalence is supposed to be higher (Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":332500}]
["Jamaica","12/31/2021","HIV/AIDS","FR66-JAM-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"Medium","PAI-4556","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAw/view","75,000","75,000","Conduct adherence and time use study to inform program planning and improve retention in care among PLHIV .",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":75000}]
["Honduras","7/31/2022","HIV/AIDS","FR61-HND-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Latin America and Caribbean","Active",null,"High","PAI-4415","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8f/view","140,898","140,898","Contracting a coordinator and workers for organizations that intervene in FSW population",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":140898}]
["Honduras","7/31/2022","HIV/AIDS","FR61-HND-H","Other intervention(s) for TGs","10/30/2019","Comprehensive prevention programs for TGs","Latin America and Caribbean","Active",null,"Low","PAI-4414","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8e/view","21,326.28","21,326.28","Contracting a coordinator and workers for organizations that intervene in the Trans population",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":21326.28}]
["Guatemala","6/30/2022","Tuberculosis","FR417-GTM-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Latin America and Caribbean","Active",null,"Medium","PAI-4395","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8L/view","3,408","3,408","Desktop computers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3408}]
["Suriname","12/31/2021","HIV/AIDS, Tuberculosis","FR415-SUR-C","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","Latin America and Caribbean","Active",null,"High","PAI-5651","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSb/view","5,250","5,250","Develop / standardize a mechanism for cost recovery of public sector to recover costs for services provided by them, to patients with private health insurance.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5250}]
["Multicountry HIV Caribbean PCC Consortium","9/30/2022","HIV/AIDS","FR562-MCLACPCC-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Latin America and Caribbean","Active",null,"Low","PAI-4814","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJF6/view","200,000","200,000","Developing more effective models to reach informal sex workers, male and transgender sex workers, and mobile and internet-based sex workers;  As with the MSM intervention, throughout this module CVC would institute 4 axis to ensure more effective sub-population HIV prevention programs: (i) strengthened programmatic and contextual understanding, especially of the heterogeneity of sex work and complexity of closeted MSM behaviour; (ii) intensified program implementation and delivery of comprehensive, proven interventions; (iii) improved program monitoring and evaluation, including greater use of real-time monitoring for continuous program improvement and constant strategic and tactical adaptations and rigorous program evaluation, to refine understanding of what works, under what circumstances and how; and (iv) predictable, sustained financing for key population HIV prevention programmes for specific sub-groups, including increased domestic financing where feasible. Furthermore, this module will pay special attention to strengthening community-based monitoring and evaluation systems as they pertain to MSM, transgender women, and Female Sex Workers sub-groups and their respective HIV related issues in the Caribbean; document model interventions with technical briefs that have practical, how-to examples for strengthening critical enablers and service delivery for key populations subgroups; and to strengthen commitment to a sustainable CBO response in relation to Key Populations post transition.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":200000}]
["Guatemala","12/31/2020","HIV/AIDS","FR100-GTM-H-01","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Inactive",null,"High","PAI-4351","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7d/view","200,000",0,"Drug-resistance prevalence study for 2020: Develop a HIV drug-resistance plan Develop an ARV drug-resistance protocol  Analyze acquired resistance profiles in second-line regimen (ART).",0,0,0,0,"200,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Jamaica","12/31/2021","HIV/AIDS","FR66-JAM-H","Differentiated ART service delivery","10/30/2019","Treatment, care and support","Latin America and Caribbean","Active",null,"High","PAI-4553","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAt/view","300,000","300,000","Establish KP friendly clinics with special focus on men and boys to address late diagnosis snd support retention in care as well as improve coverage of MSM and TG.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":300000}]
["Guatemala","12/31/2020","HIV/AIDS","FR640-GTM-H","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","11/28/2019","PMTCT","Latin America and Caribbean","Active",null,"Low","PAI-6147","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeA/view","25,000","15,000","Establishment of a routine system for measuring the quality of care in NC services through measurement of user satisfaction and provision of services (mystery clients) (consultancy fees)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","25,000","10,000",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":15000}]
["Guatemala","12/31/2020","HIV/AIDS","FR640-GTM-H",null,"11/28/2019","PMTCT","Latin America and Caribbean","Active",null,"High","PAI-6143","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe6/view","1,129,912","643,270","Expand the resolution capacity of the health service network of the second and third level of care, for the diagnosis of HIV, syphilis and hepatitis B in pregnant women, as well as ensuring the link of newborns exposed to HIV to the UAI that corresponds to them .Includes: TA to conduct the needs assessment and 2 other sums to cover; (i) design of a costed strengthening plan based on the assessment and (ii) fund to implement actions of the stenghtening planIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","1,129,912","486,642",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":643270}]
["El Salvador","12/31/2021","HIV/AIDS","FR325-SLV-H","Other program management intervention(s)","10/30/2019","Program management","Latin America and Caribbean","Inactive",null,"High","PAI-5546","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQu/view","246,930.51",0,"For the execution of the Debt 2 Health grant it is necessary to contract human resources for the implementation of the Debt 2 Health grant as detailed: 1 financial technician who keeps the register, control and monitoring of funds in the Financial Unit of External Funds, 1 administrative technician in the NRL, 1 infrastructure technician for follow-up and verification of the adaptation of areas and a technician for monitoring laboratory equipment; these resources will strengthen the Global Fund Support Unit. Salaries are defined in compliance with the current institutional Salary Law in force and there is no commitment to absorb them at the end of the project.A contribution of $25,000.00 per year is required for office supplies and materials for the NRL, which will be the office that implements the Debt 2 Health project.The contracting of external audit services during the implementation of the Debt 2 Health is included in this module. The assurance mechanism includes an annual audit conducted by an independent auditor, the Debt 2 Health is subject to constant monitoring, verification and reporting throughout the implementation period.It includes the fees of the procurement agent related to health equipment management and/or furniture expenses.",0,"246,930.51",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Paraguay","12/31/2021","Tuberculosis","FR451-PRY-T","Grant management","10/30/2019","Program management","Latin America and Caribbean","Active",null,"Low","PAI-5448","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPK/view","147,392.84","147,392.84","Grant management. The considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required at the main receiver, which is why these financial resources are required to retain most of the staff currently comprising the working team.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":147392.84}]
["Paraguay","12/31/2021","Tuberculosis","FR451-PRY-T","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","Latin America and Caribbean","Active",null,"Medium","PAI-5453","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPP/view","60,590.66","60,590.66","Health Regions - Program ManagementExecution and coordination of activities, funding applications and financial reporting/funds return. Application of preventive and corrective controls on recording forms and reports in the expert system.The intention with this intervention is to effectively execute the proposed activities and ensure proper data management.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60590.66}]
["Guatemala","12/31/2020","HIV/AIDS","FR100-GTM-H-01","Improving service delivery infrastructure","10/30/2019","RSSH: Integrated service delivery and quality improvement","Latin America and Caribbean","Active",null,"Medium","PAI-4367","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7t/view","10,775","10,775","Huehuetenango National Hospital (planning pending).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10775}]
["Peru","6/30/2022","Tuberculosis","FR91-PER-T","Prevention","10/30/2019","TB care and prevention","Latin America and Caribbean","Inactive",null,"High","PAI-5376","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOA/view","54,800",0,"Implementation of updated national guidelines for management of pediatric TB at the primary health care level",0,0,0,0,"54,800",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Cuba","12/31/2020","HIV/AIDS","FR100-CUB-H","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Latin America and Caribbean","Inactive",null,"High","PAI-4124","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3y/view","450,000",0,"Insufficient outreach to PLHIV for VC tests, affected by the interruptions of regional laboratory services, especially due to equipment breakdown and maladjustment caused by years of continuous operation. Likewise, the centralization of blood tests for VL studies hinders follow-up on PLHIV follow-up and limits the capacity of the PCS, especially as regards the Polyclinic to mobilize the PLHIV under their care. The additional resources will be dedicated to increasing the number of PLHIV with undetectable VL by gradual replacement of obsolete equipment and increasing access to blood testing points.",0,0,0,"450,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Guatemala","12/31/2020","HIV/AIDS","FR640-GTM-H","Prong 1: Primary prevention of HIV infection among women of childbearing age","11/28/2019","PMTCT","Latin America and Caribbean","Inactive",null,"High","PAI-6152","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeF/view","2,069",0,"Interinstitutional Articulation National Program of STIs, HIV and AIDS - Comprehensive Health System - National Reproductive Health Plan - Health Areas Directorate - National Health Laboratory - Hospitals; IGSS, APROFAM, Military Health, Association of private hospitals among others and non-governmental organizations that work on the subject, to support the sustainability of interventions.Covers the cost of consultancy to facilitate thisIndicators:Reduce the gap of 2016 on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 2000","2,069","2,069",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Paraguay","12/31/2021","Tuberculosis","FR451-PRY-T","Other program management intervention(s)","10/30/2019","Program management","Latin America and Caribbean","Active",null,"Medium","PAI-5454","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPQ/view","50,386","50,386","Lab Dept (LCSP) managementImplementation of new diagnostic algorithms including cultures and PSD for all cases of Pulmonary TB and universal rapid molecular diagnosis.This requires hiring of HR who can carry out cultures and rapid molecular diagnosis on all samples arriving at LCSP.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":50386}]
["Multicountry HIV Latin America ALEP","9/30/2022","HIV/AIDS","FR567-MCALEP-H","Stigma and discrimination reduction","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Latin America and Caribbean","Active",null,"Low","PAI-4774","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJES/view","17,923","17,923","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Venezuela would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in addressing stigma and discrimination within health services, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the changes they consider necessary, in line with the regional activities emerging from this module.Establishment of strategic partnerships with other sectors representing the intersectionality of HIV to address social determinants and the development and implementation of regional, subregional and national programs to tackle stigma and discrimination of PLHIV, from a gender, multiethnic and rights-based approach, based on findings from the stigma indices.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":17923}]
["Suriname","3/31/2021","Malaria","FR568-SUR-M","Other case management intervention(s)","10/30/2019","Case management","Latin America and Caribbean","Active",null,"Medium","PAI-5645","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSV/view","139,867","139,867","MALAKIT (6 month extension of the study - partial costs): Despite a decrease in the number of cases reported to CIRE Cellule de l'Institut de Veille Sanitaire, an interregionalepidemiological surveillance center, malaria affects many gold miners working illegally in French Guiana. The ORPALstudy carried out by CIC Centre dInvestigation Clinique (clinical investigation center) in 2015, showed that theprevalence of Plasmodium in illegal gold miners was 22.3%, of which 84% were asymptomatic. Self-medicationpractices are very common (52.4%) using artemisinin derivatives.Key issues identified:? The mobile population of workers in illegal gold mining sites is particularly affected by malaria due to theirliving and working conditions and as such represents a reservoir of transmission.? Their undocumented irregular status and difficult access to health centers makes care from healthprofessionals rare or belated.? The use of inadequate drugs, without prior diagnosis and with improper compliance, mainly due to the highcost of treatment on the black market, is common. These non-recommended practices contribute to the riskof emergence of ACT resistance.? Knowledge of the disease by illegal gold miners (causes, symptoms, preventive measures and treatment)remains insufficient.Considering the problems, the identified need is to ensure sufficient intervention coverage of appropriate and rapidcare, amongst the malaria \"reservoir\" population, in order to reduce:? Malaria transmission and ACT non-compliance;? The ensuing risk of P. falciparum resistance to ACT;? The morbidity and mortality of illegal workers in gold-mining sites;The working hypothesis is:The free distribution of self-diagnosis and self-treatment kits, together with appropriate training / information, atresting sites, Brazil and Suriname, would be a strategy relevant to the specific context of French Guiana, and wouldrespond to the identified need.ObjectivesThis study aims to assess a new malaria control strategy targeting gold miners working illegally in French Guiana,based on the distribution of self-diagnosis kits and self-treatment against P. falciparum in cross-border areas.? Main objectiveIncrease the part of illegal gold miners in French Guiana who take ACT entirely after a positive rapid diagnostic test.? Secondary objectiveso Improve the use of anti-malarial treatments against P. falciparum appropriately and in compliance withWHO recommendations.o Reduce the prevalence of malaria among illegal gold miners in French Guiana.o Increase the part of illegal gold miners in French Guiana who:6? Know malaria, its causes, the symptoms and protection measures.? Have a positive attitude towards recommended prevention measures, the use of adequate antimalarialtreatment, and adherence to treatment.? Report applying good preventive practices.Project implementation:This project will be carried out in cooperation with Brazil, Suriname and France. It is divided into 2 sections:? Part 1: Implementation and monitoring of the interventionDistribution of self-diagnosis and self-treatment kits to people working illegally at gold-mining sites in French Guiana,along with the provision of training. This distribution will take place at resting sites by trained facilitators. Proactivedigital collection of data will be conducted by these facilitators and via gold miners themselves through a mobileapplication.? Part 2: Evaluation of the interventionThe final evaluation of the project will be carried out in a cross-sectional study \"Orpal bis\", with a questionnaire onknowledge, attitudes and practices and blood sampling to measure the prevalence of Plasmodium carriers before /after the intervention. The same study (Orpal) was carried out in 2015 along the Surinamese border, and will becarried out before implementation along the Brazilian border. Therefore, it will be a pre-post evaluation.Depending on the results, the sustainability of the action will be determined by the Health Authorities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":139867}]
["Guatemala","6/30/2022","Tuberculosis","FR417-GTM-T","TB/HIV collaborative interventions","10/30/2019","TB/HIV","Latin America and Caribbean","Active",null,"Medium","PAI-4390","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8G/view","25,554.44","6,814.37","Meetings on the development, approval and dissemination of plans regarding TB/HIV co-infection, to establish implementation approaches at the regional and local levels.",0,0,0,0,"18,740.07",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6814.37}]
["Paraguay","2/28/2021","HIV/AIDS","FR432-PRY-H","HIV care","10/30/2019","Treatment, care and support","Latin America and Caribbean","Active",null,"Medium","PAI-5432","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJP4/view","60,225","60,225","Modular update course (120hs) for continuous training for health professionals, in health, dignity and positive HIV prevention. This activity seeks to respond to the need to improve the quality of care of health personnel towards people of target populations, since stigma and discrimination towards them remain an important barrier for access to care and adherence. The training will cover the following contents: promotion and access to health, human rights, HIV and STI prevention, sexual and reproductive health, gender equality, among others. As a result, it is expected that health personnel will have the knowledge and skills that will enable them to implement actions of promotion and prevention appropriate to the reality of each person in the target population, without stigma or discrimination.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60225}]
["Guatemala","6/30/2022","Tuberculosis","FR417-GTM-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Latin America and Caribbean","Inactive",null,"Medium","PAI-4396","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8M/view",688,0,"Multifunctional desktop printer.",0,0,0,0,688,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Guatemala","12/31/2020","HIV/AIDS","FR640-GTM-H","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","11/28/2019","PMTCT","Latin America and Caribbean","Active",null,"High","PAI-6146","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe9/view","15,000","5,000","onsultancy fees to develop a strategy to strengthen the system for monitoring compliance and achieving results through a non-economic recognition system.Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","15,000","10,000",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5000}]
["Guatemala","12/31/2020","HIV/AIDS","FR640-GTM-H","Grant management","11/28/2019","Program management","Latin America and Caribbean","Inactive",null,"High","PAI-6153","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeG/view","261,834",0,"Operational support of personnel for the MSPAS and INCAP consisting of:1- A facilitator for the ETMI hired for the PNS.2- Officer dedicated to the Monitoring and Evaluation of the ETMI component in the PNS3- Responsible for ETMI4- Secretarial supportTo this is added the percentage of operational expenses of INCAP (1% for the acquisition of tests and 5% for the rest of the items)Transversal contribution to the indicators related to prevention and treatment. This item was updated in October 2019 to increment the original approaved amount of 211260","261,834","261,834",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Suriname","12/31/2021","HIV/AIDS, Tuberculosis","FR415-SUR-C","HIV testing services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Latin America and Caribbean","Active",null,"Medium","PAI-5654","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSe/view","11,000","11,000","Outreach activities in the Gold-Mining Areas of the Interior of Suriname. Each of the gold-mining sites receive 2 outreach sessions per year with the  minimum package of services (BCC, condom distribution and lubricants, and HIV, STI, TB, SRH). In addition, on each of the outreach sessions, a tester is there to make testing available to people reached via the outreach.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11000}]
["Paraguay","2/28/2021","HIV/AIDS","FR432-PRY-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Latin America and Caribbean","Active",null,"Medium","PAI-5435","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJP7/view","7,669","7,669","PLWH bi-annual meeting 2019 for PLWH empowerment, joint work CS/ State / cooperation agencies and quality of life. There is a need to carry out, on a bi-annual basis, an in-depth study on the various thematic axes associated with comprehensive care for PLWH, access to justice and human rights, stigma and discrimination, promoting the greater involvement of people living with HIV in terms of their health, dignity and prevention needs in all aspects of the policies and programs that affect them. This meeting will be national since it will involve PLWH from all over the country, in addition to local actors linked to the National Response to HIV, such as representatives of international organizations, cooperation agencies, public institutions, CS, among others.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7669}]
["Haiti","12/31/2020","HIV/AIDS, Tuberculosis","FR476-HTI-C","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"High","PAI-4445","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ99/view","250,000","250,000","Programme data is always available late (long laps of time between production and approval). The PNLT will implement the module based on DHIS2 cases for drug-susceptible TB and MR-TB in a single system with cases of MDR marked MDR. After pilot phase and assessment, its extension will enable the operation of a single TB data management system which generates optimum quality information on the MSPP's open-access website.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":250000}]
["Multicountry HIV Caribbean PCC Consortium","9/30/2022","HIV/AIDS","FR562-MCLACPCC-H","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Latin America and Caribbean","Active",null,"Medium","PAI-4821","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFD/view","100,000","100,000","Provide microgrants to support resource mobilization strategies. Development of best practice guidelines on social contracting.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["Guatemala","12/31/2020","HIV/AIDS","FR100-GTM-H-01","Improving service delivery infrastructure","10/30/2019","RSSH: Integrated service delivery and quality improvement","Latin America and Caribbean","Active",null,"Medium","PAI-4377","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ83/view","9,677.42","9,677.42","Quetzaltenango health area department (planning pending).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9677.42}]
["Paraguay","2/28/2021","HIV/AIDS","FR432-PRY-H","Community led advocacy","10/30/2019","RSSH: Community responses and systems","Latin America and Caribbean","Active",null,"High","PAI-5428","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJP0/view","41,920","41,920","Recruitment of consultancy to study the adequacy of the legal framework, including the tax area for contracting by the state, services and products made by CS. Include the drafting of adjustment proposals. Consulting contract to update the Political Advocacy Plan. Monitoring of the advocacy plan designed in 2017 and its updating, which includes monitoring progress of Law 4313 (Budgetary Assurance of Sexual and Reproductive Health), Law 3940, TB Act, Access to Justice Act, Sexual and Reproductive Health, Law against all forms of discrimination, among others. Recruitment of Consultancy in Political incidence. Recruitment of Consultancy to design and establish a Plan of Institutional Communication of the CSOs and the agreed goals and objectives. Implement the Institutional Communication Plan to inform and sensitize the general population and leaders of different sectors, in particular, about the social work of organizations, especially CSOs of key populations.Develop a training plan on public financing models of civil society and determine their applicability in the national context. Design and implement a fundraising plan for CS. These activities are the gaps identified in the framework of the TA funded by the GF through the CRAT, which sought to identify the key activities required to advance the sustainability of civil society organizations linked to the national response to HIV, and of the interventions implemented by them.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":41920}]
["Guatemala","6/30/2022","Tuberculosis","FR417-GTM-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Latin America and Caribbean","Active",null,"High","PAI-4389","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8F/view","43,601.95","43,601.95","Regional and local training for health personnel (including medical staff) to raise awareness and disseminate information on identifying respiratory symptoms and taking samples.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":43601.95}]
["Guatemala","6/30/2022","Tuberculosis","FR417-GTM-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Latin America and Caribbean","Active",null,"High","PAI-4392","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8I/view","1,025.76","1,025.76","Regional training in line probe assays (LPAs) at the Rodolfo Robles Hospital.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1025.76}]
["Cuba","12/31/2020","HIV/AIDS","FR100-CUB-H","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Latin America and Caribbean","Active",null,"Medium","PAI-4113","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3n/view","55,000","55,000","Renewal of health care staff in primary healthcare requires systematic training of new human resources dedicated to the management of HIV/AIDS infection to improve healthcare quality.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":55000}]
["Guatemala","12/31/2020","HIV/AIDS","FR100-GTM-H-01","Improving service delivery infrastructure","10/30/2019","RSSH: Integrated service delivery and quality improvement","Latin America and Caribbean","Active",null,"Medium","PAI-4359","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7l/view","6,000","6,000","San Marcos health area department.  Renovation of XX  m laboratory, including: preliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":6000}]
["Bolivia (Plurinational State)","12/31/2021","HIV/AIDS","FR15-BOL-H","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"High","PAI-3906","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0S/view","50,000","50,000","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":50000}]
["Bolivia (Plurinational State)","12/31/2021","HIV/AIDS","FR15-BOL-H","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"High","PAI-3905","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0R/view","5,808","5,808","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5808}]
["Haiti","12/31/2020","Malaria","FR472-HTI-M","Other specific prevention intervention(s)","10/30/2019","Specific prevention interventions (SPI)","Latin America and Caribbean","Active",null,"Low","PAI-4443","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ97/view","26,520","11,363","Sign contracts with 17 television stations to broadcast messages to towns bordering areas in stratum 3expected results:  to broadcast messages to towns bordering areas in stratum 3; 2/ populations in towns bordering areas in stratum 3 are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localitiesimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.",0,"15,157",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11363}]
["Multicountry HIV Caribbean PCC Consortium","9/30/2022","HIV/AIDS","FR562-MCLACPCC-H","Community led advocacy","10/30/2019","RSSH: Community responses and systems","Latin America and Caribbean","Active",null,"High","PAI-4817","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJF9/view","60,000","60,000","Social mobilization campaigns at regional and national level for increase in domestic resources to address the needs of KP will be undertaken using advocacy videos and other IEC tools developed to target Ministries of Health and Finance and used in training sessions with CSOs. Support will also be provided for partcipation of KPs to high level national and regional meetings to undertake community-based advocacy and moniytoring a=for policy and law reform related to HIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60000}]
["Haiti","12/31/2020","Malaria","FR569-HTI-M","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"High","PAI-4434","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8y/view","61,695","61,695","Strengthen microstratification.Expected outcome:  Quarterly review of community-based epidemiological surveillance (SEBAC) data in the North, Centre and South departments is carried out. Increase in current budget to enable 1 day of microstratification.Impact: Data analyzed and used in more detail.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":61695}]
["Haiti","12/31/2020","Malaria","FR569-HTI-M","Capacity building for health workers, including those at community level","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Latin America and Caribbean","Active",null,"High","PAI-4432","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8w/view","1,344,216","1,344,216","Strengthen the capacities of polyvalent community health workers (PCHWs) and Epidemiological Surveillance Officers (OSE) for community-based treatment and monitoring.Expected outcome: Treatment is strengthened at the community level. 100 percent of detected cases are investigated and treated.Impact: Breaking the chain of transmission.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1344216}]
["Paraguay","12/31/2021","Tuberculosis","FR451-PRY-T","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"Medium","PAI-5452","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPO/view","129,138.5","129,138.5","Strengthening of TB Expert System input with provision of computer equipmentNot all districts have computer equipment to input symptomatic respirotary cases data and other cases into the system. It is important to note that from this year, PNCT will implement reporting in the Expert System as a source for official information. This implies that if the local service has no equipment and/or Internet access, the district must manage the data input.Acquisition of equipment will ensure timely and correct data input, analysis of the same at every care level and official reporting of indicators at the national level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":129138.5}]
["Haiti","12/31/2020","HIV/AIDS, Tuberculosis","FR476-HTI-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Latin America and Caribbean","Active",null,"Medium","PAI-4451","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9F/view","60,000","60,000","TB patients will be screened for diabetes: 35 people from the most frequented DCTs and conversely, screening for tuberculosis in diabetic patients will be systematically conducted by the FHADIMAC (Haitian Foundation for Diabetes and Cardiovascular Diseases) and the 10 departmental hospitals. It will reduce risk factors of diabetes through screening for diabetes amongst TB patients and integrated treatment of patients suffering from this comorbidity.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60000}]
["Belize","12/31/2021","HIV/AIDS, Tuberculosis","FR375-BLZ-C","Community led advocacy","10/30/2019","RSSH: Community responses and systems","Latin America and Caribbean","Active",null,"High","PAI-3896","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0I/view","50,000","50,000","The capacity of Civil Society Hubs members in human rights, legal and anti-stigma discrimination is key as communities must play an integral role in advocating for policy change and legal reform at all levels of the public system (including the Attorney Generals Office, Ministries of Finance and Economic Development) on issues like the non-discrimination law, social contracting and other key populations human rights issues.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":50000}]
["Panama","12/31/2021","HIV/AIDS, Tuberculosis","FR376-PAN-C","Other health and community workforce intervention(s)","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Latin America and Caribbean","Active",null,"Medium","PAI-5368","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJO2/view","60,000","60,000","The community education program will supplement individual TB prevention actions that are implemented by tuberculosis health promoters in indigenous areas, enhancing the capacity of health regions with indigenous populations to continue with health promotion programs with an intercultural approach, including the prevention of TB.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60000}]
["Haiti","12/31/2020","HIV/AIDS, Tuberculosis","FR476-HTI-C","Other intervention(s) for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Latin America and Caribbean","Active",null,"High","PAI-4447","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9B/view","1,089,000","198,500","The intervention proposed the chance to pursue learning and social integration for OVC and fight structural factors. The 2018-2020 grant will fund 3,400 OVC in 2018, 2,000 in 2019 and 900 in 2020. At $150 per OVC per year, the amount requested will take the level of educational support to OVC to the level of the 2015-2017 grant, guaranteeing the educational costs of 4,520 OVC for the term of the grant.",0,"890,500",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":198500}]
["Panama","12/31/2021","HIV/AIDS, Tuberculosis","FR376-PAN-C","Other intervention(s) for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Latin America and Caribbean","Active",null,"High","PAI-5366","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJO0/view","70,000","70,000","The pilot project will contribute to guaranteeing the ability of national institutions to offer one of the most innovative interventions of combined prevention in the future.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":70000}]
["Dominican Republic","12/31/2021","HIV/AIDS","FR39-DOM-H","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Latin America and Caribbean","Active",null,"High","PAI-4183","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4v/view","592,400","357,334.02","The practices of self-care, prevention of HIV and other STIs in sex workers and their clients, and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources will be allocated to increasing the targets that can be reached to improve self-care and prevention practices.",0,0,0,0,"235,065.98",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":357334.02}]
["Dominican Republic","12/31/2021","HIV/AIDS","FR39-DOM-H","Behavioral interventions for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Latin America and Caribbean","Inactive",null,"High","PAI-4187","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4z/view","592,400",0,"The practices of self-care, prevention of HIV and other STIs in Socially-Vulnerable Women Resident in Bateyes and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources would be allocated to increasing the targets that can be reached to improve self-care and prevention practices.",0,0,0,0,"592,400",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Cuba","12/31/2020","HIV/AIDS","FR100-CUB-H","HIV testing services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Latin America and Caribbean","Active",null,"High","PAI-4119","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3t/view","80,500","63,500","The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.",0,0,0,0,"17,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":63500}]
["Multicountry Americas EMMIE","12/31/2023","Malaria","FR358-MCEMMIE-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"High","PAI-4809","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJF1/view","850,000","850,000","This includes a mid-term and final in-house evaluation of the Facility.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":850000}]
["Panama","12/31/2021","HIV/AIDS, Tuberculosis","FR376-PAN-C","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"Medium","PAI-5371","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJO5/view","48,000","48,000","This request includes the integration of the Ministry of Public Helath (SIS) and Social Security Fund (SEIS) care and epidemiological surveillance systems. Integration of both systems would make all national information on HIV and tuberculosis available in a single database to facilitate corresponding analysis.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":48000}]
["Paraguay","2/28/2021","HIV/AIDS","FR432-PRY-H","Pre-exposure prophylaxis (PrEP) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Latin America and Caribbean","Active",null,"Low","PAI-5439","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPB/view","255,371","255,371","To carry out a cost / effectiveness study of the PREp in Paraguay using a mathematical model, by an international expert. To carry out a clinical and therapeutic guide for the PREp by an international expert. Consultancy with the international expert for the elaboration of the protocol and manuals of implementation of the Study of feasibility (acceptability, adherence, behaviors and risk behavior, side effects) of a combined HIV prevention intervention with PREp in MSM in Paraguay, Training and sensitization of HR in PREp. 3 days of training for 30 people. Implementation of the feasibility study (acceptability, adherence, behavior and risk behavior, side effects) of an HIV prevention intervention combined with PREp in the MSM population in Paraguay. The PREp is part of the combined prevention package promoted by PAHO / WHO. It is proposed to carry out the aforementioned activities in order to have information for decision-making regarding its full implementation in the short term. The objective of the effectiveness and feasibility study is to demonstrate, numerically, that PREP implementation is cost / effective as a public health strategy. In addition, the study implementation will allow us to have information on the PREP response in the Paraguayan cultural context, on the conditions necessary for its implementation, the situations that may arise and that will require action by the MPyBS, among others. We hope that with the implementation of these activities, the country will have enough information and experience to complete the implementation of all the strategies that form part of Combined Prevention in the short term.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":255371}]
["Honduras","7/31/2022","HIV/AIDS","FR61-HND-H","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Latin America and Caribbean","Active",null,"Medium","PAI-4408","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8Y/view","9,247.42","9,247.42","Training for HIV counselors to guarantee access to testing with counseling, in compliance with national standards",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9247.42}]
["Multicountry HIV Caribbean PCC Consortium","9/30/2022","HIV/AIDS","FR562-MCLACPCC-H","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Latin America and Caribbean","Active",null,"Low","PAI-4822","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFE/view","70,000","70,000","Undertake research on best practice models of service delivery as well as user-friendly management planning toolkits for KP CSOs on Participatory Action Research (PAR) including the use of global implementation tools i.e. MSMIT, SWIT, TRANSIT etc for national and community use including interventions aimed at resource mobilization. TA to support training and data use analysis and reporting.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":70000}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4879","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJG9/view","673,325","673,325","2 Mobile X-ray equipped units to cover the NTP needs and enable the program to conduct outreach TB screening activities in the south, north and center, especially among the hard-to-reach populations and high-risk groups in Jordan.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":673325}]
["Egypt","3/31/2022","HIV/AIDS, Tuberculosis","FR534-EGY-C","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Active",null,"High","PAI-4197","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ59/view","250,000","250,000","90-90-90 HIV services cascade analysis + ART cohort analysis for each of the focus key populations (PWID, MSM and FSW)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":250000}]
["Somalia","12/31/2020","Malaria","FR405-SOM-M","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Middle East and North Africa","Active",null,"Medium","PAI-5600","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRm/view","96,141","96,141","A consultant for NMCP Somaliland to develop and implement an exit strategy, as well as a fund-raising strategy for Somaliland.The consultant will work for 3 months (21 days per month) per year = 63 days per year x 3 years = 189 days.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":96141}]
["Somalia","12/31/2020","Tuberculosis","FR100-SOM-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-5603","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRp/view","8,066,920","5,291,816","Additional community case finding activities, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. Additional active case finding activities for high-risk groups and cross-border activities.",0,0,0,"1,312,920","1,462,184",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5291816}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Other intervention(s) for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Middle East and North Africa","Active",null,"High","PAI-5549","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQx/view","278,822","193,222","Anonymous free confidential hotlines that are currently supported by the GF funding. Hotlines provide factual information, counselling and referral information and support. This will support the current 3 hotlines which cover all Somalia.",0,0,0,0,"85,600",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":193222}]
["South Sudan","12/31/2020","Malaria","FR382-SSD-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","Middle East and North Africa","Active",null,"High","PAI-5634","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSK/view","4,354,769","4,354,769","As malaria is endemic throughout South Sudan, indoor residual spraying (IRS) is too costly to roll-out everywhere. Targeted IRS to address specific problem areas (e.g. population displacement) could be considered.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4354769}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Case detection and diagnosis","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4151","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4P/view","3,899","3,899","Associated to the procurement of 20 microscopes for selected health facilities under the RTTR strategy framework.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3899}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Other procurement supply chain management intervention(s)","10/30/2019","RSSH: Procurement and supply chain management systems","Middle East and North Africa","Active",null,"High","PAI-5572","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRK/view","250,744","250,744","Building on the national and sub national efforts to strengthen supply chain capacity, this would further strengthen regional supply chain capacity.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":250744}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Prong 3: Preventing vertical HIV transmission","10/30/2019","PMTCT","Middle East and North Africa","Active",null,"High","PAI-4144","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4I/view","7,322","7,322","Capacity-building of service-providers on pregnant women enriollment, including treating STIs, notably syphillis, will contribute to reduce vulerability to HIV and mother-to-child-transmission of HIV.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7322}]
["Egypt","3/31/2022","HIV/AIDS, Tuberculosis","FR534-EGY-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Middle East and North Africa","Active",null,"High","PAI-4208","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5K/view","607,500","607,500","Case detection and diagnosis: (1) Procurement of additional 6 XpertMTB/Rif modules (four-cartridge module) and 850 cartridges per module per year; (2) Lab supplies for solid and liquid cultures",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":607500}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Inactive",null,"High","PAI-5588","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRa/view","72,000",0,"Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. This will build on the 2016/2017 Stigma Survey and provide a means of measuring outcomes of community and health worker stigma reduction efforts.",0,0,0,0,"72,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Active",null,"High","PAI-4896","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGQ/view","22,444","22,444","Conduct an assessment of the health status of labour migrants and develop a plan of supervision, coordination and adress the tuberculosis and other health issues related to migration among migrants in industrial zones",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":22444}]
["Eritrea","12/31/2020","Malaria","FR384-ERI-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","Middle East and North Africa","Active",null,"High","PAI-4234","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5k/view","38,019","38,019","Conduct of review meetings is of paramount importance to make assessment of IRS activities at the end each round of spraying. Moreover, provision of milk to spraymen will help them carry out the operation efficiently and with less hazards. A total of USD 38,019 estimated to cover the above two IRS related activities which have been well funded in the previous funding cycle.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":38019}]
["South Sudan","12/31/2020","HIV/AIDS","FR383-SSD-H","Treatment adherence","10/30/2019","Treatment, care and support","Middle East and North Africa","Active",null,"High","PAI-5631","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSH/view","1,059,733","1,059,733","Conduct training of community based organisations, peer counsellors, and civil society coordinators and do outreach to key populations and the general population to ensure treatment adherence. Treatment adherence usually decreases at 24 and 36 months resulting in an increase in AIDS related deaths. With the on-going insecurity and displacement of people, treatment adherence is vitally important.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1059733}]
["Mauritania","12/31/2021","HIV/AIDS","FR346-MRT-H","Interventions for young people who sell sex","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Middle East and North Africa","Active",null,"High","PAI-5153","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKZ/view","35,657","35,657","Contracting 1 NGO for managing and monitoring the activities carried out by CSOs and SW outreach workers. The PAAR amount will allow for the extension to 3 other regions from year 2, for greater geographical coverage of the interventions and requiring the recruitment of an additional NGO to guarantee the quality of the interventions by the community outreach workers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":35657}]
["South Sudan","12/31/2020","Tuberculosis","FR625-SSD-T","Routine reporting","11/18/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Active",null,"High","PAI-6166","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgy/view","20,000","20,000","Cordaid shall support the Ministry of Health to improve MDR-TB and TB data management (eTBr, customize and install GenEX software)","20,000",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20000}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Active",null,"High","PAI-4897","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGR/view","29,177","29,177","Develop checklist and conduct systematic supervision visits to the chest diseases centers to supervise, monitor and evaluate the provided services for TB and MDR and to the peripheral laboratories in these centers for QC .",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":29177}]
["Somalia","12/31/2020","Tuberculosis","FR100-SOM-T","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Active",null,"High","PAI-5606","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRs/view","874,360","874,360","Develop legislation for TB services in the private sector, expand and strengthen on-going in-service training for all health workers involved in the implementation of TB Control.  ? Drug Resistance Survey, country-wide implementation of eTB-Manager, research fund for operational research activities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":874360}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Prevention","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4870","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJG0/view","19,639","19,639","Development of IEC materials in different languages of the migrants countries and coordination with relevant embassies to address the language barrier and deliver educational messages on TB among migrant workers in the industrial zones in Jordan",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":19639}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4876","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJG6/view","782,545","782,545","Digital Xrays 12 that will be placed as follows: 2 in Amman center (~6000 screening per month), 1 in Karak center, 1 Ma'an center, 1 Madabah, 1 Jarash, 1 Ajloun, 1 in Delail and 1 in Sahab.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":782545}]
["Mauritania","12/31/2021","HIV/AIDS","FR346-MRT-H","Prong 3: Preventing vertical HIV transmission","10/30/2019","PMTCT","Middle East and North Africa","Active",null,"High","PAI-5157","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKd/view","140,940","140,940","Ensuring the payment of the performance bonuses for 87 midwives for monitoring the active cohort of mother-and-child pairs, from childbirth until the final determination of the childs condition at the age of 18 months",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":140940}]
["Sudan","12/31/2020","Malaria","FR467-SDN-M","Entomological monitoring","10/30/2019","Vector control","Middle East and North Africa","Active",null,"Medium","PAI-5497","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQ7/view","545,532","545,532","Entomological monitoring is crucial to guide and feed the national strategies for Integrated Vector Management and Insecticide Resistance Management. UQD will equip the entomological labs in both IRS and LLINs targeted states with the necessary supplies and equipment to enable states to carry out the susceptibility, bioassay and bio efficacy tests.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":545532}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","Middle East and North Africa","Active",null,"High","PAI-4170","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4i/view","16,949","16,949","Establishment of an efficient transport system in the Testing and Treatment Centers in Djibouti (includes daily allowances related to awareness (transport / meeting / and other costs)).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":16949}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Middle East and North Africa","Active",null,"High","PAI-4908","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGc/view","336,663","336,663","Extend the provided services to the KPs to include the drop in center, STD investigations, lab tests for beneficiaries, VCT services, collaboration with primary and secondary healthcare providers. Follow up of PLHIV (estimated 250 to 300) with comprehensive treatment monitoring and treatment support over two years.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":336663}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Other program management intervention(s)","10/30/2019","Program management","Middle East and North Africa","Active",null,"High","PAI-4919","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGn/view","11,222","11,222","Form a National HIV Committee that will include members representing various entities , develop on annual basis a work agenda and will meet at least every 6 months and on ad hoc basis",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11222}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Other program management intervention(s)","10/30/2019","Program management","Middle East and North Africa","Active",null,"High","PAI-4902","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGW/view","11,222","11,222","Form a National TB Committee that will include members representing various entities, develop on an annual basis a work agenda and meet at least every 6 months and on ad hoc basis",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11222}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Other program management intervention(s)","10/30/2019","Program management","Middle East and North Africa","Active",null,"Medium","PAI-5569","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRH/view","401,580","280,885.8","Funding to support important coordination meetings between program partners at the national, sub national and priority regional levels. This will support improved program planning and review.",0,0,0,0,"120,694.2",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":280885.8}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Engaging all care providers (TB/HIV)","10/30/2019","TB/HIV","Middle East and North Africa","Active",null,"High","PAI-4171","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4j/view","39,000","39,000","Handling costs of Genexpert machines to measure the Viral Load (VL) (Cost of the service agent). This will allow the permanent use of the machines and thus increase the percentage of PLHIV having access to the VL.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":39000}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Other procurement supply chain management intervention(s)","10/30/2019","RSSH: Procurement and supply chain management systems","Middle East and North Africa","Active",null,"High","PAI-5564","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRC/view","109,806","109,806","If no MRA funding is secured through GF or other sources, the continuation of the Medicines Steering Committees will be needed to fill the gap of coordination and oversight of medicines management.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":109806}]
["Mauritania","12/31/2021","HIV/AIDS","FR346-MRT-H","Treatment adherence","10/30/2019","Treatment, care and support","Middle East and North Africa","Active",null,"Medium","PAI-5161","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKh/view","7,540","7,540","IGA feasibility study for PLHIV: Ensuring the independence of PLHIV requires the creation of conditions that enable them to provide for their health needs and to cover a certain cost linked to ARV treatment. Experiments have been carried out through IGAs, but they have not been documented. This request in the above allocation amount will make it possible to conduct a feasibility study and provide the country with clarity regarding the effectiveness of this strategy.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7540}]
["Tunisia","12/31/2021","HIV/AIDS","FR391-TUN-H","Addressing stigma, discrimination and violence against MSM","10/30/2019","Comprehensive prevention programs for MSM","Middle East and North Africa","Active",null,"High","PAI-5829","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVT/view","151,089","151,089","In accordance with the outcomes of previous analyses, MSM often encounter a lack of understanding and intolerance from law enforcement and security forces and those operating in the health care system responsible for treating key populations. The activities included in the modules and interventions opposite will contribute to building the capacity and knowledge of these different categories (law enforcement officers and health workers) with respect to the human rights of populations in the context of HIV control.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":151089}]
["Mauritania","12/31/2021","Malaria","FR349-MRT-M","Seasonal malaria chemoprevention","10/30/2019","Specific prevention interventions (SPI)","Middle East and North Africa","Active",null,"High","PAI-5164","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKk/view","2,463,468","2,463,468","In order to implement this intervention, guidelines and handbooks will be drawn up, training will take place and agents will be provided with medicines. Annual assessment of operations will be carried out.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2463468}]
["Multicountry Middle East MER","12/31/2021","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"Medium","PAI-4853","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFj/view","20,000","20,000","In order to strengthen culture and DST activities, 6 Bactec MGIT960 kits with immunochromatographic assays need to be acquired:  4 for Iraq and 2 for Yemen",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20000}]
["Multicountry Middle East MER","12/31/2021","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4849","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFf/view","1,335,000","1,335,000","In order to strengthen TB services for affected women, food supplementation is needed for women with TB who are treated in IDP and refugee settings",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1335000}]
["Eritrea","12/31/2020","HIV/AIDS","FR285-ERI-H","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Middle East and North Africa","Active",null,"High","PAI-4218","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5U/view","314,134","314,134","In this above allocation request, the newly upgraded LMIS system is expected to be rolled out to all the outpatient and inpatient departments of the hospitals and will reach the lower health facilities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":314134}]
["Egypt","3/31/2022","HIV/AIDS, Tuberculosis","FR534-EGY-C","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","Middle East and North Africa","Active",null,"High","PAI-4199","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5B/view","36,728.74","26,896.74","Integration of TB/HIV services into existing structures (e.g. the existing Hepatitis C program): Quarterly coordination meetings for HIV and TB managers and focal points on governorates level",0,0,0,0,"9,832",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":26896.74}]
["Somalia","12/31/2020","Malaria","FR405-SOM-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","Middle East and North Africa","Active",null,"Low","PAI-5593","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRf/view","110,295","110,295","IRS campaigns are proposed for three new areas that are outbreak prone. Each campaign costs 24,510 USD. The funds will cover IRS campaigns in response to epidemic.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":110295}]
["Eritrea","12/31/2020","Malaria","FR384-ERI-M","Indoor residual spraying (IRS)","2019-09-12","Vector control","Middle East and North Africa","Active",null,"High","PAI-4233","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5j/view","1,923,048","725,368","IRS is conducted in three out of six regions of the country to control malaria. Bendiocarb 80% WP is one of the insecticides used. A total of 22,104kgs of the insecticide are estimated to cover spraying operation for the year 2018. The product costs USD 1,923,048 (CIF cost) at USD 87.0 per kg. Since this is an expensive chemical and that the Global Fund allocation made for the next funding cycle is less-than-expected, the Global Fund was requested for no-objection for the country to use existing savings to cover the above cost. As the request was not approved, this request is being included under PAAR and funding this activity will contribute in preventing malaria as part of IVM strategy.",0,0,0,"1,000,000","197,680",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":725368}]
["Egypt","3/31/2022","HIV/AIDS, Tuberculosis","FR534-EGY-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4207","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5J/view","29,414.12","29,414.12","Key affected population: School children and old age widows and pensioners covered through HIO for social support",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":29414.12}]
["Sudan","12/31/2020","Malaria","FR573-SDN-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Middle East and North Africa","Active",null,"High","PAI-5487","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPx/view","2,916,646","2,916,646","LLIN to replace LLIN distributed in 2017 to maintain universal coverage in the 12 targeted states (5 Darfur states, 3 Kordofan states, White Nile, Blue Nile, Kassala and Gadarif states). Advocacy and awareness campaigns are ongoing to sensitize targeted communities to increase the bed net utilization.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2916646}]
["Algeria","12/31/2022","HIV/AIDS","FR393-DZA-H","Behavioral interventions for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Middle East and North Africa","Active",null,"High","PAI-4192","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ54/view","720,342","720,342","Migrants are classified as a priority population. However, to date they have not benefited from structured prevention activities and the 2019 IBBS results confirmed a HIV prevalence rate of 2.2% among migrants, similar to the rate among Men having sex with Men (MSMs). Migrants' access to care is difficult due to their lack of awareness about available prevention programs and HIV treatment centers. This access is also made difficult due to their fear to consult public health structures, given their illegal status and rumors that public structures poison people with AIDS. Thus, this request will provide at least the 1,500 migrants who participated in the IBBS with prevention, screening and treatment activities in collaboration with the International Organisation for Migration (IOM) and other technical partners.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":720342}]
["Eritrea","12/31/2020","Malaria","FR384-ERI-M","Facility-based treatment","10/30/2019","Case management","Middle East and North Africa","Active",null,"High","PAI-4237","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5n/view","610,950","211,872","Monitoring activities at field level/facility level on stock of supplies, adherence of health workers to various guidelines as well as supervision of implementation of QA/QC of malaria diagnosis are all important activities that should complement production of guidelines and provision of medicines/laboratory supplies. Moreover, training health professionals on safety monitoring of anti-malarial medicines augments delivery of quality assured malaria services. Hence, additional investments of USD 610,950.00 are estimated to cover costs of executing the above activities.",0,0,0,"399,078",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":211872}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Other program management intervention(s)","10/30/2019","Program management","Middle East and North Africa","Active",null,"High","PAI-4900","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGU/view","39,277","39,277","NTP offices supplies (12 centers)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":39277}]
["Mauritania","12/31/2021","HIV/AIDS","FR346-MRT-H","Prong 1: Primary prevention of HIV infection among women of childbearing age","10/30/2019","PMTCT","Middle East and North Africa","Active",null,"Low","PAI-5163","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKj/view","223,714","223,714","Organizing a quarterly advocacy session around the 87 PMTCT sites each year. The country is committed to eliminating the mother-to-child transmission of HIV in 2021. A large portion of pregnant women do not attend the ANCs. These sessions will be performed by the midwife, the outreach worker and the manager from the NGO. The funding requested as part of the above allocation amount will make it possible to complete these sessions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":223714}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Prevention","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4869","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFz/view","25,811","25,811","PPD and IGRA for contact investigation, latent TB infection",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25811}]
["Multicountry HIV MENA IHAA","12/31/2021","HIV/AIDS","FR528-MCMENAIHAA-H","Grant management","10/30/2019","Program management","Middle East and North Africa","Active",null,"Medium","PAI-4842","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFY/view","90,000","90,000","PR Management Dashboard",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":90000}]
["South Sudan","12/31/2020","Malaria","FR382-SSD-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Middle East and North Africa","Active",null,"High","PAI-5633","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSJ/view","13,887,989","5,041,994","Procurement and distribution of LLINs are crucial to sustain and build on the gains in malaria prevention. In comparison to other interventions, this is the only one that can ensure universal coverage.",0,0,0,"6,116,526","2,729,469",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5041994}]
["Egypt","3/31/2022","HIV/AIDS, Tuberculosis","FR534-EGY-C","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Active",null,"Medium","PAI-4200","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5C/view","250,000","250,000","Program and Data quality assessment",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":250000}]
["Morocco","12/31/2020","HIV/AIDS","FR235-MAR-H","Community empowerment for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Middle East and North Africa","Active",null,"Medium","PAI-4760","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEE/view","77,881.27","62,336.44","Provide socio-professional training grants to vulnerable people who inject drugs (8 priority sites).",0,0,0,0,"15,544.83",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":62336.44}]
["Mauritania","12/31/2021","HIV/AIDS","FR346-MRT-H","Treatment monitoring - Drug resistance surveillance","10/30/2019","Treatment, care and support","Middle East and North Africa","Active",null,"Low","PAI-5155","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKb/view","42,500","42,500","Providing training for 2 biologists and 3 laboratory technicians in using the genotyping machine in a laboratory in a different country.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":42500}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4880","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGA/view","4,489","4,489","Re-evaluate and revise the TB screening algorithm and assessment of migrant workers to ensure it is in line with the national TB treatment guidelines and the other new TB guidelines",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4489}]
["Morocco","12/31/2020","HIV/AIDS","FR235-MAR-H","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Active",null,"High","PAI-4762","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEG/view","128,743.13","128,743.13","Regional NSP workshop; NSP review; production of national reports; situational study on disabled peoples vulnerability to HIV and STIs; socioeconomic study on PLHIV, SWs, MSM and people who inject drugs; annual program and financial audits of NSP implementation; supervision of above allocation activities; qualitative situational study on the vulnerability of street children; procurement of equipment and IT services for health centers and community centers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":128743.13}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Inactive",null,"High","PAI-5560","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJR8/view","75,000",0,"Required to allow the continuation of essential strategic information collection to guide programming and measure outcomes. Current MoT data only recognised sexual transmission and PMTCT. No details available on types of sexual transmission or IDU.",0,0,0,0,"75,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Morocco","12/31/2020","HIV/AIDS","FR235-MAR-H","Other intervention(s) for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Middle East and North Africa","Active",null,"High","PAI-4755","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJE9/view","717,921.67","696,604.2","Review of migrant prevention programs; establishment of six community centers for migrant sexual and reproductive health; training of actors and representatives to carry out prevention work targeting truckers; constant presence at trucking sites; identification of sites of vulnerability linked to working environments; improve combined prevention coverage along corridors; womens SRH; advocacy with managers of large companies; AIDS prevention awareness-raising tools adapted to different working environments; PE for manual workers, miners, sailors, fishermen and artisans; training and remuneration of actors involved and PEs; information, education and communication (IEC) sessions for female manual workers and other vulnerable women; prevention tools for the working environment; actors and PE manual workers, miners, sailors, fishermen and artisans; : Evaluation of youth prevention; review of kit for ongoing training on HIV, GBV and addictions in the school environment; coaching of young PEs in high schools and university, including through ICT; mapping of youth NGOs and networking and capacity development actions for youths so that they can be involved in HIV prevention; training guide on young people not in school for facilitators; awareness-raising and training of youth organizers; prevention materials for youths / ICT (tel. application, social networks).",0,0,0,0,"21,317.47",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":696604.2}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Behavioral change as part of programs for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Middle East and North Africa","Active",null,"High","PAI-4150","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4O/view","14,237","14,237","See line 44 (data validation).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":14237}]
["Multicountry HIV MENA IHAA","12/31/2021","HIV/AIDS","FR528-MCMENAIHAA-H","Stigma and discrimination reduction","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Middle East and North Africa","Inactive",null,"Medium","PAI-4828","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFK/view","78,000",0,"Sensitization of media practitioners, social media bloggers, religious leaders and other key influencers to the challenges, needs and issues of stigma and discrimination towards KPs and PLHIV.",0,0,0,0,"78,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Case detection and diagnosis","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4168","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4g/view","3,763","3,763","Staff training in the use of digital radiology equipment (See line 21).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3763}]
["Algeria","12/31/2022","HIV/AIDS","FR393-DZA-H","Stigma and discrimination reduction","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Middle East and North Africa","Active",null,"High","PAI-4190","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ52/view","252,540.1","252,540.1","Stigma and discrimination in care settings for PLHIV and key populations is a reality in Algeria, as evidenced by the results of the \"Index stigma\" study. These behaviors are an obstacle to key populations accessing services, especially treatment. Thus, it is planned to train the staff of 60 testing centers and 15 reference centers on medical ethics to raise their awareness about challenges faced by KPs, reduce social rejection and discrimination within care structures as well as improve the quality of care on the one hand and on the other hand organize meetings periodically to handle complaints in accordance with Article 28 of the new law on health.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":252540.1}]
["Tunisia","12/31/2021","HIV/AIDS","FR391-TUN-H","Addressing stigma, discrimination and violence against sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Middle East and North Africa","Active",null,"High","PAI-5837","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVb/view","233,722","117,165","Strengthening the conditions for addressing stigma, discrimination and violence against SWs through the establishment of an accreditation mechanism for HIV screening by community actors and by raising awareness of the rights of key populations will, in the long term, have a positive and sustainable impact on HIV control.",0,0,0,0,"116,557",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":117165}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Active",null,"High","PAI-5575","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRN/view","116,730","8,214","Support HIV program partners quarterly M&E review meetings and reporting. To ensure strategic information and lessons learnt are feeding into program planning.",0,0,0,0,"108,516",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8214}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","Middle East and North Africa","Active",null,"Medium","PAI-5585","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRX/view","142,240","142,240","Support the mid term review of the 2017 to 2021 HSSPs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":142240}]
["Sudan","12/31/2020","Malaria","FR467-SDN-M","Other program management intervention(s)","10/30/2019","Program management","Middle East and North Africa","Active",null,"Medium","PAI-5486","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPw/view","497,889","497,889","Supportive supervision to service delivery points providing treatment and prevention services to the refugees from South Sudan, in camps that currently are not getting sufficient services. This activity also includes a component of capacity building for staff involved in entomological monitoring to guide the national strategies for Integrated Vector Management and Insecticide Resistance Management.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":497889}]
["Egypt","3/31/2022","HIV/AIDS, Tuberculosis","FR534-EGY-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4206","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5I/view","30,841.96","30,841.96","TB case detection and diagnosis: (1) Increasing case detection through revising access to diagnosis pathway and implementing access to new and more sensitive diagnostic technology; revision of program guidelines; revision of diagnostic algorithm; (2) Increasing notification from university hospitals; (3) Increasing notification from the private sector",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30841.96}]
["Eritrea","12/31/2020","Tuberculosis","FR400-ERI-T","Treatment","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4243","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5t/view","165,600","165,600","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":165600}]
["Eritrea","12/31/2020","HIV/AIDS","FR285-ERI-H","Pre-exposure prophylaxis (PrEP) for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Middle East and North Africa","Active",null,"Medium","PAI-4220","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5W/view","56,880","56,880","The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":56880}]
["Eritrea","12/31/2020","HIV/AIDS","FR285-ERI-H","Diagnosis and treatment of STIs and other sexual and reproductive health services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Middle East and North Africa","Active",null,"High","PAI-4213","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5P/view","12,700","12,700","The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12700}]
["South Sudan","12/31/2020","HIV/AIDS","FR383-SSD-H","Differentiated ART service delivery","10/30/2019","Treatment, care and support","Middle East and North Africa","Inactive",null,"Medium","PAI-5632","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSI/view","4,230,795",0,"The allocation makes provision for ARVs for 35,000 people while this above allocation would cover additional demand. This funding includes procurement of drugs for opportunistic infections, training facility staff and those from Internally Displaced Persons (IDPs) and refugee camps and Protection of Civilian sites (PoCs) in HIV and TB treatment and care, establishing of 4 mobile lab services and operational support.",0,0,0,"4,230,795",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Multicountry Middle East MER","12/31/2021","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z","Integrated community case management (ICCM)","10/30/2019","Case management","Middle East and North Africa","Active",null,"High","PAI-4888","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGI/view","472,430","472,430","The iCCM contribute to ensure an equitable access of women and girls, malnourished children and IPDs in remote and rural areas to malaria services. The involvement of women in providing iCCM services in rural areas will address the financial and social/cultural barriers that restrict women movement.   The PAAR amount will cover the cost of expansion to new districts who will receive support for iCCM.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":472430}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Behavioral change as part of programs for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Middle East and North Africa","Active",null,"High","PAI-4145","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4J/view","16,627","11,085","The mapping of key and vulnerable populations, namely young people, at national level (consultant) will allow a better focus of interventions for identifying new HIV and TB cases.",0,0,0,0,"5,542",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11085}]
["Morocco","12/31/2020","Tuberculosis","FR256-MAR-T","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","Middle East and North Africa","Active",null,"High","PAI-4765","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEJ/view","52,915.5","28,193.25","The NSP adopts a human-rights based approach to TBrelated stigma and discrimination and to equitable access to TB control services. A workshop will be held to determine the corresponding intervention pathways and to develop a strategy document (activity 4.8.1), and 500 copies of this document will be printed (activity 4.8.2). This document will be used to produce TB and human rights information and awareness-raising documents for health workers (sub-sub-activity 4.8.4.1.2), directors and managers of industrial, commercial and other companies (sub-sub-activity 4.8.4.2.2), and primary school, secondary school and college teaching staff (sub-subactivity 4.8.4.3.2).",0,0,0,0,"24,722.25",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":28193.25}]
["Eritrea","12/31/2020","HIV/AIDS","FR285-ERI-H","Counseling and psycho-social support","10/30/2019","Prevention programs for general population","Middle East and North Africa","Active",null,"Low","PAI-4224","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5a/view","2,748,000","2,748,000","The OVCs that need critical financial support is estimated at 4,200. Only 820 (20%) are catered in the under allocation. With is above allocation more OVCs will be provided with monthly monetary, school uniforms and books support, community outreaches in all villages and catchment areas to sensitize communities and caregivers on the rights of the OVC will be supported. Community based group homes & Orphanage centers will be supported to reduce vulnerability to HIV infection.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2748000}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Middle East and North Africa","Active",null,"High","PAI-4158","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4W/view","8,475","8,475","The service providers and community workers will be trained on the quality of services and RTTR(Reach, test, treat, and retain)-HIV-TB-Human Rights. They will contribute to identifing and referring suspect HIV and TB cases (index and contacts).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8475}]
["South Sudan","12/31/2020","Tuberculosis","FR625-SSD-T","Treatment","11/18/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-6154","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgm/view","1,049,562","1,049,562","The updated forecasting and quantification of First Line Anti-TB drugs (FLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnerships Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the budget required the FLD is USD1,049,562 to cover the treatment needs up to the end of 2020.  By the end of 2018, a total of 14,362 cases were notified against a set target of 12,678. Similarly, an increasing trend was reported as at June 2019 - 8,566 cases notified which is above the set target of 6,973 by 23%. It is projected that by the end of 2020, the number of notified cases will increase to 20,832.","1,049,562",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1049562}]
["South Sudan","12/31/2020","Tuberculosis","FR625-SSD-T","Treatment: MDR-TB","11/18/2019","MDR-TB","Middle East and North Africa","Active",null,"High","PAI-6155","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgn/view","122,794","122,794","The updated forecasting and quantification of Second Line Anti-TB drugs (SLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments of 220 for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnerships Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the requires resources for SLD up to the end of the grant with 6 months buffer is USD122,794.  The National TB Program at central level now has on board the Inspector for Management of Multi-Drug Resistant TB who is mandated to provide oversight, monitoring and support to the implementation of the PMDT program. With this newly created position, it is expected that the proposed critical intensive case detection and treatment activities being proposed for support under this application will improve case notification and linkage to treatment.","122,794",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":122794}]
["Sudan","12/31/2020","Malaria","FR467-SDN-M","Grant management","10/30/2019","Program management","Middle East and North Africa","Active",null,"High","PAI-5499","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQ9/view","1,114,747","1,114,747","This amount represents 4% handling fee for UNICEF as procurement agent for bed net, ACTs and RDTs. It may be noted that a small proportion of the 4% is considered as cost recovery for UNICEF Country office.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1114747}]
["Multicountry Middle East MER","12/31/2021","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z","Entomological monitoring","10/30/2019","Vector control","Middle East and North Africa","Active",null,"Medium","PAI-4899","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGT/view","220,800","220,800","This includes the cost for entomological survey and BCC/Tracking system in 2019, 20 and 21.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":220800}]
["South Sudan","12/31/2020","Tuberculosis","FR625-SSD-T","Grant management","11/18/2019","Program management","Middle East and North Africa","Active",null,"High","PAI-6164","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgw/view","109,822","109,822","This is to cover the costs of key technical project personnel under Cordaid who are required to continue providing technical backup to the project in 2020.  The two key staff will continue to provide supervision, oversight and mentoring to the local staff and to ensure smooth handing over to local authorities at project termination. These staff also undertake grant management functions related to the Sub-Recipient Agreement.","109,822",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":109822}]
["Multicountry Middle East MER","12/31/2021","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z","HIV testing services for MSM","10/30/2019","Comprehensive prevention programs for MSM","Middle East and North Africa","Active",null,"High","PAI-4844","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFa/view","3,000,000","3,000,000","This is to include parts of Yemen in this intervention and also expand the services for the other three countries (Syria, Lebanon, Jordan). As the coverage of HIV testing among MSM is expected to reach 31% by funds within the allocation, it is expected that it will approach 60% with PAAR fund.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3000000}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Other intervention(s) to reduce human rights-related barriers to HIV services","10/30/2019","Programs to reduce human rights-related barriers to HIV services","Middle East and North Africa","Active",null,"High","PAI-5559","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJR7/view","284,811","284,811","To address community based stigma and complement the allocation funding in RSSH addressing health worker related stigma. To help improve PLHIV rights knowledge.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":284811}]
["Somalia","12/31/2020","HIV/AIDS","FR100-SOM-H","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Middle East and North Africa","Active",null,"Medium","PAI-5583","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRV/view","463,600","463,600","To implement hospital Data Assistants to improve hospital based data collection and reporting. One per region.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":463600}]
["Multicountry Middle East MER","12/31/2021","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z","Other program management intervention(s)","10/30/2019","Program management","Middle East and North Africa","Active",null,"High","PAI-4848","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFe/view","50,000","50,000","To organize, at regional level, a workshop for the staff of the NRLs of the five countries; the workshop will be facilitated by an international consultant and will cover the key aspects inherent to the management of a national TB laboratory network.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":50000}]
["Multicountry Middle East MER","12/31/2021","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4845","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFb/view","980,000","980,000","To procure 7 digital X-ray machines for TB facilities: 4 for Iraq and 3 for Jordan; these machines will cover the needs in TB screening, evaluation and diagnosis for IDPs, refugees and hard-to-reach populations scattered in Iraq and for refugees in Jordan",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":980000}]
["Multicountry Middle East MER","12/31/2021","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z","Other program management intervention(s)","10/30/2019","Program management","Middle East and North Africa","Active",null,"High","PAI-4850","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFg/view","100,000","100,000","To rehabilitate the TB centers/hospitals damaged in the conflicts in Iraq and Syria (including Ibn Zohr Hospital in Baghdad, Iraq and Al-Hareth Hospital in Homs, Syria), so as to support the provision of admission facilities for patients admitted with TB.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["Multicountry Middle East MER","12/31/2021","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z","Treatment: MDR-TB","10/30/2019","MDR-TB","Middle East and North Africa","Active",null,"Low","PAI-4864","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFu/view","25,000","25,000","To undertake a national TB drug resistance survey in Syria",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25000}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Behavioral change as part of programs for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Middle East and North Africa","Active",null,"High","PAI-4153","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4R/view","9,127","9,127","Training of peer educators at CDC (Community development center) level on prevention, HIV testing, TB testing (Reach, test, treat, and retain) and sexual and reproductive health will allow identifying new cases of HIV and TB and prevention of STIs (sexually-transmitted infections) and HIV among young people.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":9127}]
["Djibouti","12/31/2020","HIV/AIDS, Tuberculosis","FR264-DJI-C-01","Case detection and diagnosis","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4131","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ45/view",678,678,"Training supervision of technicians on the radiology machine (per diem related to awareness / transport / meeting / and other costs). (See line 21).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":678}]
["Egypt","3/31/2022","HIV/AIDS, Tuberculosis","FR534-EGY-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Middle East and North Africa","Active",null,"Medium","PAI-4209","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5L/view","70,000","70,000","Treatment (MDR-TB): Microscops",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":70000}]
["Sudan","12/31/2020","Malaria","FR573-SDN-M","Other vector control measure(s)","10/30/2019","Vector control","Middle East and North Africa","Active",null,"Medium","PAI-5491","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQ1/view","758,352","758,352","Vector mapping aims at creating evidence based vector control interventions for all vector born disease. Focusing on risk mapping, updating distribution map of vectors, distribution map of insecticides resistance, assessing the role of malaria vector control interventions for control of other disease such as leishmaniasis  and lymphatic filariasis. These will update distribution maps of malaria vectors that were developed in 1950s.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":758352}]
["Multicountry Middle East MER",null,"HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z","Treatment","10/30/2019","TB care and prevention","Middle East and North Africa","Active",null,"High","PAI-4886","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGG/view","31,422","31,422","Workshop for representatives of civil society organizations and tuberculosis patients to improve the quality of provided treatment services. Training course for private doctors, hospitals and doctors of the chest diseases centers on TB diagnosis, treatment and Training of staff of non-governmental organizations concerned with TB management.workshop for representatives of civil society organizations and TB patients to improve the quality of treatment services. Training pharmacists on TB treatments first and second line.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":31422}]
["Somalia","12/31/2020","Malaria","FR405-SOM-M","Other case management intervention(s)","10/30/2019","Case management","Middle East and North Africa","Active",null,"Low","PAI-5594","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRg/view","13,500","13,500","World Malaria Day commemoration by implementing partners. Each SR in South and Central Somalia will receive funding for one event. There are five SRs in South Central Somalia.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":13500}]
["Afghanistan","12/31/2020","HIV/AIDS","FR443-AFG-H","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","South East Asia","Active",null,"High","PAI-3538","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuW/view","483,280","483,280","7-10% total grant budget can be allocated to M&E & surveillance related activities. Hence, the NACP encounters numerous issues in terms of data quality, verification, collection, capacity building in terms of trainings for the M&E and Surveillance staff. Need to recruit three national epidemiologists short-term basis to train staff. Assessment on FIDUs is a critical component of the programs as previously recommended by the TRP to be further strengthened to ensure that the country needs are met.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":483280}]
["Korea (Democratic Peoples Republic)","2/28/2021","Malaria","FR266-PRK-M","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","South East Asia","Active",null,"Low","PAI-5421","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOt/view","252,755","252,755","Additional financial support is required to provide overarching programmatic management and to maximise national capacity in policy planning, coordination and management as the country transitions to elimination. While not directly linked to program impact / outcome it will provide an enabling environment for the program to implement more effectively and efficiently. Above allocation funding will be utilised for 1) training on programme management in the elimination phase, and 2) International Conferences on the elimination of malaria (4 persons 2018-2020).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":252755}]
["Lao (Peoples Democratic Republic)","12/31/2020","HIV/AIDS","FR100-LAO-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","South East Asia","Active",null,"High","PAI-4672","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCo/view","832,386","832,386","Allocation funding provides for antiretroviral therapy (ART) services at 11 sites in eight provinces.  Additional funding would provide for expansion of ART sites to all remaining 10 provinces, and associated capacity building of staff.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":832386}]
["Lao (Peoples Democratic Republic)","12/31/2020","HIV/AIDS","FR100-LAO-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","South East Asia","Active",null,"High","PAI-4670","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCm/view","549,986","549,986","Allocation funding will reach female sex workers with prevention packages in 5 priority provinces only, leaving a 27% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address a 39% gap in condom supply.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":549986}]
["Nepal","3/15/2021","Malaria","FR335-NPL-M","Other case management intervention(s)","10/30/2019","Case management","South East Asia","Active",null,"High","PAI-5321","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNH/view","20,259","20,259","Assessment of BCC methodology and approaches to guide policy revision in light of requirements for elimination.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20259}]
["Papua New Guinea","12/31/2020","Malaria","FR389-PNG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","South East Asia","Active",null,"High","PAI-5397","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOV/view","150,000","150,000","Carry out priority entomological and operational work which feeds into malaria program decisions, particularly factor which can reduce man vector contact.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":150000}]
["Lao (Peoples Democratic Republic)","12/31/2020","Tuberculosis","FR100-LAO-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","South East Asia","Active",null,"High","PAI-4674","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCq/view","818,472","149,310","Current limitation in access and offer of services by the primary health care network requires reaching more vulnerable and isolated populations by mobile active case finding teams equipped with portables digital X-ray and GeneXpert for using efficient diagnosis algorithm. Provinces and districts health staffs who participated in outreach camps, are aware of local TB epidemics, and learned how to conduct TB screening themselves if provided with portable digital X-ray and technical support at start. 2 additional provincial teams will be established in high TB burden provinces with demonstrated management capacity. Including equipment per team (1 portable digital X-ray system, 1 GeneXpert 4 modules machine, 1 pickup car, 20% PSM). In average, one team in one site (6 days including travel and installation) can screen 600 persons, test 150 presumptive TB patients by Xpert and start on treatment 30 new TB patients (15 bacteriologically confirmed and 15 clinical TB) x 12 sites x 2 teams. Total 720 additional new TB patients each year can be diagnosed and started on treatment, over 10% additional notification of new TB cases above the allocation targets each year in 2018-20.",0,0,0,"659,259","9,903",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":149310}]
["Korea (Democratic Peoples Republic)","6/30/2021","Tuberculosis","FR297-PRK-T","Other module","10/30/2019","Other module","South East Asia","Active",null,"High","PAI-5423","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOv/view","2,040,304","2,040,304","Current NRL infrastructure is inadequate to ensure the quality of LPA diagnosis while current C&DST capacity (NRL and 1 RRL (Hamhung RRL)) is too limited to cater for country needs. Under the above allocation the expansion of NRL and establishment of 2 RRLs will be done to strengthen the C&DST capacity and LPA tests.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2040304}]
["Sri Lanka","12/31/2021","HIV/AIDS","FR419-LKA-H","Treatment monitoring - Drug resistance surveillance","10/30/2019","Treatment, care and support","South East Asia","Inactive",null,"Low","PAI-4721","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDb/view","12,000",0,"Drug resistance surveillance  / Conduct a drug resistance surveillance to see the prevalence of HIV drug resistance in the country. A baseline surveillance for the pre-treatment drug resistance is required to understand whether circulating HIV strains are already resistant before starting an ARV regimen. An international TA is requested since Sri Lanka lacks hand on experience. TA will provide necessary training. As per WHO rates 600USD/day 20 days.",0,0,0,0,"12,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Nepal","3/15/2021","Malaria","FR335-NPL-M","Surveys","10/30/2019","RSSH: Health management information systems and M&E","South East Asia","Active",null,"Medium","PAI-5315","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNB/view","33,428","33,428","External program evaluation to review progress and inform programme direction (Y3).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":33428}]
["Timor-Leste","12/31/2020","HIV/AIDS","FR100-TLS-H","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","South East Asia","Active",null,"Low","PAI-5815","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVF/view","142,735","142,735","Funding is requested in this category to support program management technical advice and policy, planning and advocacy technical assistance.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":142735}]
["Korea (Democratic Peoples Republic)","2/28/2021","Malaria","FR266-PRK-M","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","South East Asia","Active",null,"High","PAI-5418","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOq/view","67,000","67,000","Funding will increase the capabilities of the National Malaria Program  to conduct enhanced parasitological surveillance. This will provide a more nuanced evidence base for decision making from a molecular level analysis. Genotyping of P. vivax strains will help highlight parasite strain diversity and parasite flows between local and imported cases (from other provinces within the country). It will also prove confirm suspicions of asymptomatic parasite carriage or below detection parasite infections in which foci investigation followed by RCD / Reactive focal IRS has not interrupted transmission. Funding will also cover procurement/supply management cost of consumables/equipment to conduct polmerase chain reaaction (PCR) testing, training and external TA. Operational research will also be conducted.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":67000}]
["Nepal","3/15/2021","HIV/AIDS","FR336-NPL-H","Other intervention(s) for IDUs and their partners","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","South East Asia","Active",null,"Low","PAI-5308","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJN4/view","2,000,000","2,000,000","Harm reduction interventions, including the OST scale up, have often been challenged by issues related to quality of service, coordination, institutionalisation and monitoring. Technical assistance is sought to expedite solutions to the challenges. This will build on the GF investment in OST by informing efforts to increase uptake, retention and quality.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2000000}]
["Lao (Peoples Democratic Republic)","12/31/2020","Tuberculosis","FR100-LAO-T","Community TB care delivery","10/30/2019","TB care and prevention","South East Asia","Active",null,"High","PAI-4675","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCr/view","425,970","265,959","Increasing coverage and output of CBOs in 22 high TB burden districts. Expected to increase the number of additional TB cases referred from community as well as improve TB patient support at local level.",0,0,0,"52,100","107,911",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":265959}]
["Mongolia","12/31/2020","Tuberculosis","FR557-MNG-T","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","South East Asia","Active",null,"High","PAI-5142","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKO/view","1,000,000","1,000,000","Investment to incentivise the integration of TB and HIV services with other services at the primary and secondary health care level leveraging on Asian Development Bank funding to the Government of Mongolia on improving the integration of the primary and secondary health care and improving primary health care services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1000000}]
["Nepal","3/15/2021","Malaria","FR335-NPL-M","Facility-based treatment","10/30/2019","Case management","South East Asia","Active",null,"Medium","PAI-5311","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJN7/view","32,286","32,286","Kits for community-based healthcare providers to improve the quality of service provision.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":32286}]
["Nepal","3/15/2021","HIV/AIDS","FR336-NPL-H","Other module","10/30/2019","Other module","South East Asia","Inactive",null,"High","PAI-5303","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMz/view","50,000",0,"Migration to India, particularly to states where HIV prevalence among FSW is high, is recognised as source of infection. The main source of information for targeting HIV interventions among migrants is a 2007 study by UNFPA. However, it is likely that changes in health seeking behaviour and migration patterns (e.g. the shift to Gulf countries as the preferred destination) over the last decade have implications for HIV transmission and access to HIV services, which will be explored in the assessment. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.",0,0,0,0,"50,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Nepal","3/15/2021","Malaria","FR335-NPL-M","Entomological monitoring","10/30/2019","Vector control","South East Asia","Active",null,"Medium","PAI-5316","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNC/view","44,472","44,472","On-going longitudinal surveys of vector distribution, abundance and bionomics in Y2&3.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":44472}]
["Papua New Guinea","12/31/2020","HIV/AIDS, Tuberculosis","FR100-PNG-C","Behavioral interventions for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","South East Asia","Inactive",null,"High","PAI-5410","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOi/view","452,241",0,"Outreach: This allocation will add 65 sex worker peer outreach workers to the program  31 in NCD, 8 in Jiwaka, 8 in Madang, 8 in Western Highland and 10 in Morobe. Peer outreach in Jiwaka and Madang ceased in 2016 and 2017 respectively, so this will re-start these important programs (additional coverage of individuals with a package of prevention programs: Y1-4,342; Y2-5,969; Y3-7,639. Additional HIV testing access targets: Y1-1,303; Y2-2,388 and Y3-3,846).",0,0,0,"452,241",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Lao (Peoples Democratic Republic)","12/31/2020","HIV/AIDS","FR100-LAO-H","Other module","10/30/2019","Other module","South East Asia","Active",null,"High","PAI-4669","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCl/view","536,494","536,494","Population Mapping, Integrated Bio Behavorial Surveillance (IBBS), research and program design on key populatinos for which data is currently not available or out of date eg - People who Inject Drugs, prisoners and other vulnerable populations. Additional investments are need to improve the ability of the Program to analysis data and strengthen M and E in order to enable timely program decision making.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":536494}]
["Sri Lanka","12/31/2021","Tuberculosis","FR548-LKA-T","Case detection and diagnosis","10/30/2019","TB care and prevention","South East Asia","Active",null,"Medium","PAI-4732","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDm/view","69,000","69,000","Procurement &  Installation of  3 nos of Digital X-ray machines for National Hospital of Sri Lanka, Colombo North teaching hospital, Kandy teaching hospital.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":69000}]
["Nepal","3/15/2021","Malaria","FR335-NPL-M","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","South East Asia","Active",null,"High","PAI-5330","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNQ/view","283,538","283,538","Procurement of mobile phones/tablets for electronic based malaria reporting. Mapping of all villages in endemic areas based on GIS.  Training workshops to strengthen PSM, M&E, finance and programme management.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":283538}]
["Timor-Leste","12/31/2020","Malaria","FR108-TLS-M","Active case detection and investigation (elimination phase)","10/30/2019","Case management","South East Asia","Active",null,"Low","PAI-5820","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVK/view","39,881","39,881","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Lestes transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":39881}]
["Timor-Leste","12/31/2020","Malaria","FR108-TLS-M","Facility-based treatment","10/30/2019","Case management","South East Asia","Active",null,"Low","PAI-5818","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVI/view","35,644","10,564","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Lestes transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector.",0,0,0,0,"25,080",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":10564}]
["Timor-Leste","12/31/2020","Malaria","FR108-TLS-M","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","South East Asia","Inactive",null,"High","PAI-5821","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVL/view","309,536",0,"Provision of LLIN procurement and routine ANC distribution to maximise coverage in and utilization by pregnant women to prevent the acquisition of malaria with complications. It would complement the above (Priority 1 request) in ensuring complementary coverage would provide the outcome of Universal Access to Coverage (90%) amongst a wider population denominator and would ensure targets are achieved across all 4 Impact Indicators.",0,0,0,0,"309,536",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Papua New Guinea","12/31/2020","Malaria","FR389-PNG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","South East Asia","Active",null,"High","PAI-5394","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOS/view","200,100","200,100","Review progress of the malaria program to establish recommendations for the new Malaria Strategic Plan for 2021-2025.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":200100}]
["Nepal","3/15/2021","HIV/AIDS","FR336-NPL-H","Other intervention(s) for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","South East Asia","Active",null,"High","PAI-5305","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJN1/view","100,000","100,000","Studies have indicated that a number of young people (under the age of 20) engage in sex or sell sex, begin using illicit drugs and ultimately progress to injecting. Youth groups and youth-led organisations anticipate that engaging young people in prevention and behaviour change can have positive and lasting impacts. This work would complement the in-reach interventions for young key populations in the main allocation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["Nepal","3/15/2021","Malaria","FR335-NPL-M","Ensuring drug and other health product quality","10/30/2019","Case management","South East Asia","Active",null,"Medium","PAI-5318","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNE/view","11,742","11,742","Support facility visits by enforcement teams in cases where inappropriate drugs are identified.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11742}]
["Mongolia","12/31/2020","Tuberculosis","FR183-MNG-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","South East Asia","Active",null,"Medium","PAI-5138","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKK/view","50,000","50,000","Technical assistance is required to improve the NTP clinical management when shortened MDR-TB regimen will be introduced in 2018 in UB, to assist drug management, laboratory assistance and infection control. TA will be required at least once a year for the clinical management and laboratory assistance.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":50000}]
["Papua New Guinea","12/31/2020","Malaria","FR389-PNG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","South East Asia","Active",null,"Medium","PAI-5391","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOP/view","200,000","200,000","The Institute of Medical Research has funding for its malaria sentinel sites until 2018. These funds are included here to extend the sentinel sites until 2020 if necessary.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":200000}]
["Afghanistan",null,"Tuberculosis, RSSH","FR100-AFG-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","South East Asia","Active",null,"Medium","PAI-3559","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIur/view","1,200,000","1,200,000","The TB grant incudes active contact management through household visits for smear-positive cases. To maximize impact, active contact management of all cases is required. This expansion should identify an additional 1,000 cases per year. This UQD includes the costs of household visits for an additional 20,000 smear-negative and extra-pulmonary cases per year ($20 per visit X 20,000 cases = $400,000 per year or $1,200,000 for 3 years).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1200000}]
["Afghanistan","12/31/2020","HIV/AIDS","FR443-AFG-H","Condoms and lubricant programming for PWID","10/30/2019","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","South East Asia","Active",null,"High","PAI-3542","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIua/view","172,108","172,108","There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":172108}]
["Papua New Guinea","12/31/2020","HIV/AIDS, Tuberculosis","FR100-PNG-C","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","South East Asia","Active",null,"Medium","PAI-5402","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOa/view","388,013","388,013","This allocation provides TB/HIV/STI M&E Officers at provincial level in Western Highlands, Enga, Jiwaka, Morobe and Madang. These officers will assist the TB/HIV Coordinators to improve data collecting and reporting, assist in providing up to date information to the TB-HIV Provincial Coordinating Committee and assist in disseminating data and information to services to assist them in service review and planning.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":388013}]
["Bhutan","6/30/2021","HIV/AIDS","FR397-BTN-H","Other policy and governance intervention(s)","10/30/2019","HSS - Policy and governance","South East Asia","Active",null,"Low","PAI-3919","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0f/view","55,000","55,000","This funding will be used to purchase a vehicle to suport program monitoring and evaluation and to transport pharmaceutical and health products between the centers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":55000}]
["Papua New Guinea","12/31/2020","Malaria","FR389-PNG-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","South East Asia","Active",null,"Medium","PAI-5400","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOY/view","65,000","65,000","This is considered a good alternative to prevalence surveys and may give good information at a very low cost.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":65000}]
["Papua New Guinea","12/31/2020","Malaria","FR389-PNG-M","Other module","10/30/2019","Other module","South East Asia","Inactive",null,"Medium","PAI-5399","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOX/view","2,800,000",0,"This is for the procurement of 800,000 Rapid Diagnostic Tests and 400,000 Artemisinin-based combination therapy per year. This is an emergency amount in the case that the National Department of Health fails to procure drugs.",0,0,0,"2,800,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Timor-Leste","12/31/2020","HIV/AIDS","FR100-TLS-H","Treatment adherence","10/30/2019","Treatment, care and support","South East Asia","Inactive",null,"High","PAI-5811","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVB/view","13,674",0,"This request includes for TA support for TB/HIV and ART treatment in 2019 and 2020.",0,0,0,0,"13,674",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Afghanistan",null,"Tuberculosis, RSSH","FR100-AFG-Z","Service organization and facility management","10/30/2019","RSSH: Integrated service delivery and quality improvement","South East Asia","Active",null,"High","PAI-3553","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIul/view","613,315","613,315","To address high Maternal Mortality, the Citizen Charter proposes a few thousand FHHs. All partners indicated support for the expansion of FHHs. The TB-RSSH grant includes 35 FHHs and this UQD includes additional 15 FHHs. This UQD includes medical kits ($39,525), socialization and awareness in communities for site mapping ($78,026), basic supplies, equipment, medicines, staff support, training expenses, operational/maintenance costs ($493,525) and transportation of renovation materials ($2,239).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":613315}]
["Nepal","3/15/2021","Tuberculosis","FR334-NPL-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","South East Asia","Active",null,"Medium","PAI-5339","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNZ/view","781,111","781,111","To improve accessibility to TB services and make treatment adherence user-friendly in the remaining districts; districts with sparse population would require more investments then the existing districts, but important from patient perspective.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":781111}]
["Afghanistan","12/31/2020","Malaria","FR439-AFG-M","Active case detection and investigation (elimination phase)","10/30/2019","Case management","South East Asia","Active",null,"Medium","PAI-3550","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIui/view","96,000","96,000","To  prevent  the  spread  of  malaria  in  Category  2&3   provinces,  early  detection  ,  prompt  treatment  and  case  based  surveillance  are  considered  as  the  top  priority  by  the  program.  These measures are not costed in allocated  funding  request.  In the revised National Malaria Strategy, for the areas in Category 2 & 3 (low or malaria elimination areas), it is recommended to strengthen  malaria  surveillance  through case-based investigation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":96000}]
["Bhutan","6/30/2021","Tuberculosis","FR399-BTN-T","Case detection and diagnosis","10/30/2019","Other module","South East Asia","Active",null,"High","PAI-3927","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0n/view","41,670","41,670","Training of medical doctors on management of TB/HIV co-infection, training of TB and VCT focal persons on TB/HIV collaborative guidelines.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":41670}]
["Nepal","3/15/2021","Tuberculosis","FR334-NPL-T","Other community responses and systems intervention(s)","10/30/2019","RSSH: Community responses and systems","South East Asia","Active",null,"Low","PAI-5342","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNc/view","60,000","60,000","Under community-based monitoring by HFOMC to assess stigma, discrimination and staff attitude toward patients at selected health facilities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":60000}]
["Mongolia","12/31/2020","Tuberculosis","FR183-MNG-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","South East Asia","Active",null,"Low","PAI-5139","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKL/view","123,029","123,029","With introduction of new diagnostic technologies, lab staff require capacity building to work and provide update to other lab network units through on-the-job- training.  Diagnostic and treatment equipment at the National Centre of Infectious Disease has not been fully updated since 90s. TB hospital provides care for 2000 patients each year. Of these, 34.5% are surgical and 15% are pediatric cases. Increasiing trend of EPTB cases (41%) require modern equipment (3D ultrasound and CRAM) for accurate diagnosis and treatment of these cases.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":123029}]
["Namibia","12/31/2020","HIV/AIDS, Tuberculosis","FR229-NAM-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Southern and Eastern Africa","Inactive",null,"High","PAI-5251","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJM9/view","1,599,000",0,"100 additional field promoters to be retained over 3 years. These are critical to accelerated and expanded TB case finding as well as treatment support, including for patients with drug-resistant TB. Earlier case detection and commencement of treatment through community health education and TB screening is one of the key interventions to be implemented by these field promoters. This also includes field promoters to conduct TB screening in correctional settings and other high risk areas.",0,0,0,"1,599,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Comoros","12/31/2021","Malaria","FR553-COM-M","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Southern and Eastern Africa","Active",null,"High","PAI-4082","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3I/view","89,987.66","89,987.66","\"Organization of a six-monthly, disease surveillance forum bringing together managers from the central, regional and district level who are involved in surveillance: the country does not have the same epidemiological stratum. All those responsible for program monitoring, from the district level on the three islands to the central level, need to be brought together so that the epidemiological situation in each area can be better understood and the relevant measures taken for each case.This meeting will bring together 34 people over the course of three days: 19 district surveillance officers, 3 island focal points, 3 island entomologists, 3 island laboratory focal points and 6 NMCP staff  the focal point, 3 monitoring and evaluation staff, 1 vector control manager and 1 treatment manager). It will be organized every six months to better analyze previous activities and plan future activities.The unit costs for this activity are shown in the initial budget.\"",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":89987.66}]
["Comoros","12/31/2021","Malaria","FR553-COM-M","Facility-based treatment","10/30/2019","Case management","Southern and Eastern Africa","Active",null,"High","PAI-4085","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3L/view","48,544.5","48,544.5","\"Organization of training for 300 health care providers on policy and the treatment guide: Malaria can only be eliminated if treatment is effective. However, it has been noted that in some cases, particularly in the private sector, patients did not receive adequate treatment, either because the person responsible for providing care did not know how to do so or because the treatment they provided was unsuitable. The most recent training took place in 2016 and those trained on this treatment policy are no longer in their posts. This training will thus enable new health care providers to familiarize themselves with the new policy so that they can correctly treat patients and will enable existing providers to benefit from retraining. The training will take place over 15 two-day sessions, every two years.\"",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":48544.5}]
["Rwanda",null,"HIV/AIDS, Tuberculosis","FR290-RWA-C","Other intervention(s) for general population","10/30/2019","Prevention programs for general population","Southern and Eastern Africa","Active",null,"Medium","PAI-5472","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPi/view","4,614,826","4,614,826","Above allocation (USD 3,218,722) will provide educational support to Most Vulnerable Children (particularly vocational training). Economic empowerment and life skills building will reduce the risk of HIV infection for these vulnerable children. The other support covered by above allocation amount in this programmatic area is salary for service providers at decentralized level , which will improve quality of prevention services. (USD 1,396,104)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4614826}]
["Rwanda",null,"HIV/AIDS, Tuberculosis","FR290-RWA-C","National product selection, registration and quality monitoring","10/30/2019","RSSH: Procurement and supply chain management systems","Southern and Eastern Africa","Active",null,"Medium","PAI-5482","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPs/view","56,207","56,207","Above allocation funding will support NRL quality improvement towards accreditation as well as a research (TB-NSP page 65).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":56207}]
["Rwanda",null,"HIV/AIDS, Tuberculosis","FR290-RWA-C","Engaging all care providers (TB care and prevention)","10/30/2019","TB care and prevention","Southern and Eastern Africa","Active",null,"High","PAI-5480","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPq/view","265,622","265,622","Above allocation will support additional capacity building activities including strengthening knowledge of health care workers in management of TB, infection control and community DOTS.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":265622}]
["Comoros","9/30/2021","Tuberculosis","FR551-COM-T","Case detection and diagnosis","10/30/2019","TB care and prevention","Southern and Eastern Africa","Active",null,"High","PAI-4089","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3P/view","30,109.98","30,109.98","Activity 1: Replacement of TB focal points motorbikes. Rationale: The available motorbikes  facilitating home visits and program outreach strategies  have depreciated and are in poor condition. Result: Home visits for the systematic investigation of case contacts will not be hampered by logistical constraints. Impact: Increase in the number of identified and expected TB cases, with reduced TB transmission and also reduced morbidity and mortality.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30109.98}]
["Eswatini","9/30/2021","HIV/AIDS, Tuberculosis","FR230-SWZ-C","Other intervention(s) for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Southern and Eastern Africa","Inactive",null,"High","PAI-5656","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSg/view","2,274,777",0,"Additional funding for demand creation, clinical activities and overhead costs to perform an additional 7040 medical male circumcisions. This above allocation request will enable the country to deliver 11,720 procedures over the three years.",0,0,0,"725,938","1,548,839",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Malawi","12/31/2020","Malaria","FR100-MWI-M-01","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Southern and Eastern Africa","Active",null,"Low","PAI-5179","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKz/view","1,580,592","1,580,592","Additional funding is being requested for 2020 to ensure that the key SBCC activities are maintained in order to ensure maintained uptake and utilization of the malaria interventions implemented during this period. Specifically, this will include the following activities: Support National Malaria Commemorative Days(SADC Week and World Malaria Day); Identify and orient media team on emerging issues, successes and challenges in malaria programming; Document malaria success stories through Media visits to different communities; Conduct School Based Malaria Awareness Campaign; Conduct training of Primary Teachers as Malaria School Patrons/Matrons; Conduct Community Meetings with Malaria Champions; Conduct malaria information dissemination sessions (malaria open days and community dialogues). Train Community Structures (CLANS) in Care Group Model for dissemination of Malaria messages.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1580592}]
["Angola",null,"HIV/AIDS, Tuberculosis","FR258-AGO-C","Treatment adherence","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",null,"High","PAI-3578","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvA/view","600,000","600,000","Additional PAAR investment for activities to contribute to the 90-90-90 targets will include intensifying peer adherence counseling and provision of psychosocial support to PLHIV at ART sites and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities. Expected out will be number of PLHIV retained in care and virally suppressed.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":600000}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","Southern and Eastern Africa","Active",null,"High","PAI-5212","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLW/view","30,000","30,000","Aligned with the HSSPII objective to reduce environmental and social risk factors that have a direct impact on health, the PAAR activity within this intervention aims to engage key departments (Fisheries, Tourism, Local Government, and Agriculture) to foster multi-sectoral collaboration on improved utilization of malaria interventions. Engaging with these departments in a coordinated manner can support overall delivery of the Basic Healthcare Package. This activity is aimed at reducing the incidence and prevalence of malaria and other Funding Request: Tailored to Material Change 15 December 2016 38 key diseases of public health importance through improved collaboration and better use of resources.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":30000}]
["Comoros","6/30/2022","HIV/AIDS","FR552-COM-H","HIV testing services for MSM","10/30/2019","Comprehensive prevention programs for MSM","Southern and Eastern Africa","Active",null,"High","PAI-4064","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ30/view","48,385.14","48,385.14","Awareness-raising and HIV screening for clients of SWs on the three islands: It is estimated that partners of SWs account for 9 percent of new HIV infections. As part of this grant, the DNLS therefore intends to carry out innovative interventions for SWs partners, in addition to actions for SWs.  In the first year, the plan is to use the allocation amount to implement twice-yearly awareness-raising sessions and targeted screening sessions in order to cover 100 partners of SWs per half-year. This above allocation funding request will allow this strategy to be scaled up in the second year through awareness-raising and screening strategies across the three islands, in order to reach an additional 200 clients per half-year in the second year and an additional 400 clients per half-year in the third year. This strategy will cover 2,000 clients of SWs over the three years.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":48385.14}]
["Lesotho","6/30/2021","HIV/AIDS, Tuberculosis","FR579-LSO-C","Retention and scale-up of health workers, including for community health workers","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Southern and Eastern Africa","Active",null,"High","PAI-4743","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDx/view","560,840","560,840","Based on the observation study currently rolled out, increased monitoring and management of patients with adverse side effects is required. Furthermore, an opportunity for the decentralisation of MDR-TB services is presented with the use of all oral medications. To increase monitoring and management of patients with adverse side effects, and decentralise the MDR-TB services, the following gaps need to be addressed: Two additional physicians to facilitate accurate diagnosis and follow up at district level as well training, mentorship and supervision of district teams.  Four registered nurses are needed for the intensive clinical care for those admitted and ambulatory patients.  To closely monitor, document and report as well as provide expert interventions to address the adverse effects. two pharmacy technicians and one pharmacist are needed The key outcome of increasing the human resource capacity will be:  Increased community implementation and providing support and case management to remote districts.  Increased number of treatment initiation sites and strengthening treatment literacy.  Sustainability as the doctors (especially Basotho doctors for sustainability) at district level will be trained to build a team of experts who can continue the management or even the PMDT in a sustainable manner.The use of all oral medications is an opportunity to further decentralize MDR services having removed the complicated aspect of treatment of administering the injectable. The very clinicians and nurses will serve as resource persons for the envisaged consillium aimed at providing remote support to districts as they manage the cases. It means that it will be feasible to increase initiation sites and treatment literacy strengthened through additional pharmacist and Pharmacy Technicians",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":560840}]
["Namibia","12/31/2020","Malaria","FR224-NAM-M-01","Facility-based treatment","10/30/2019","Case management","Southern and Eastern Africa","Active",null,"Medium","PAI-5237","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLv/view","48,887","48,887","Case management trainings over the past 5 years have contributed to tremendous gains in malaria case management practice. The aim of the trainings is to ensure that all health workers in the country are competent in the case management of malaria.  The amount covers refresher trainings in Years 1 and 3 of the grant. This amount includes per diem, venue, and stationary for the trainings.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":48887}]
["Eswatini","9/30/2021","HIV/AIDS, Tuberculosis","FR230-SWZ-C","Community mobilization and norms change","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Southern and Eastern Africa","Active",null,"Medium","PAI-5680","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJT4/view","32,500","32,500","Conduct a half day orientation for 1300 head teachers and deputies on the LSE curriculum in primary schools.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":32500}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Other intervention(s) for general population","10/30/2019","Prevention programs for general population","Southern and Eastern Africa","Active",null,"High","PAI-5195","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLF/view","2,450,000","2,450,000","Continuation of general population community activities ($2.45M) Support will continue activities within current grant for general population prevention, including raising community demand for HIV testing and referral to care especially among high prevalence populations and communities. Other activities include mapping of condom distribution outlets and orientation of condom distributors, training of marriage counselors, and community progress review meetings.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2450000}]
["Angola",null,"HIV/AIDS, Tuberculosis","FR258-AGO-C","Differentiated ART service delivery","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",null,"High","PAI-3584","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvG/view","3,000,000","3,000,000","Current ART coverage for Angola according to the revised program  data (2016) from a recent program data assessment standards at  21.4% (adults and children). The allocation amount in this application plus domestic contribution will only scale up this up to 45% which is still far below the global 90-90-90 targets. The PAAR will aim to scale up ART coverage to 33% in 2018; 39% in 2019, 46% in 2019 and 50% in 2021 respectively ( 100,404 in 2018; 121,281 in 2019; 146,008 in 2020; and 161,871 in 2021). Expected outcome will be increase in percentage of adults and children receiving antiretroviral therapy.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3000000}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Other intervention(s) for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Southern and Eastern Africa","Active",null,"High","PAI-5194","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLE/view","330,000","330,000","Double investment for school-based RFHS referral agents ($0.33M) Catalytic funding will allow initial roll out of 400 referral agents. Above allocation funding will provide sufficient funding for an additional 400 (800 total).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":330000}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Engaging all care providers (TB/HIV)","10/30/2019","TB care and prevention","Southern and Eastern Africa","Active",null,"High","PAI-5196","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLG/view","1,005,475","685,552.96","Engage All Care Providers (USD 1,005,475): Malawis PPM National Action Plan (2016-2020), endorsed by Global Fund and WHO, and elaborates a series of strategies for engagement and linkage between public and private practitioners. MoHs support to CHAM facilities led to these sites generating 18% of all TB notifications in 2015, indicating that engagement of private facilities is a promising strategy to increase TB notifications. Building on continued support to CHAM facilities in the within allocation request, this above allocation request will engage additional for-profit private facilities in 13 districts over 3 years (3 districts in Y1 and 5 districts in both Y2 and Y3). Activities within this area will include: 1) orientation for private practitioners, 2) provision of a package of TB recording and reporting tools, 3) training private healthcare workers on comprehensive TB/HIV integration and TB microscopic techniques, 4) providing TB diagnostic equipment and supplies, microscopes, and lab reagent, 5) providing job aides and national guidelines; 6) supportive supervision, EQA and review meetings, and 7) engagement of traditional healers. Implementation of this new strategy for private sector engagement will contribute 7% of TB notifications.",0,0,0,0,"319,922.04",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":685552.96}]
["Madagascar","12/31/2020","HIV/AIDS","FR547-MDG-H","Grant management","10/30/2019","Program management","Southern and Eastern Africa","Active",null,"Medium","PAI-5043","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIn/view","14,633","14,633","ES/NAC and SR staff will be provided with information technology (IT) equipment. These needs have been listed under the above allocation amount, despite their importance for delivering the activities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":14633}]
["Eswatini","9/30/2021","HIV/AIDS, Tuberculosis","FR230-SWZ-C","Behavioral interventions as part of programs for general population","10/30/2019","Prevention programs for general population","Southern and Eastern Africa","Active",null,"High","PAI-5704","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTS/view","35,750","35,750","evelop a directory of sector HIV, SRH, TB and social services interventions available in the different target population areas for different target population groups: This shall be an overall directory of sectors interventionsto guide implementers and target populations on what is available in different sectors for different targetpopulations that they can refer clients to. This will assist service providers in platforms such as the U-report to know what is available and guide target populationstowards those services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":35750}]
["Angola","12/31/2021","RSSH","FR597-AGO-S","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Southern and Eastern Africa","Active",null,"High","PAI-3569","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv1/view","86,062","86,062","For effective public health decision-making, morbidity and logistics data have to be available, analysed and interpreted jointly. Interoperability and integration of the two DHIS2 and OpenLMIS platforms is therefore essential.This allocation will allow the installation of OpenLMIS on the HIS platform and of DHIS2 on Amazon Web Services (AWS, a cloud-based infrastructure). Most importantly, the human resources involved in entering and using data in the two systems will require adequate training.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":86062}]
["Lesotho","6/30/2021","HIV/AIDS, Tuberculosis","FR509-LSO-C","Gender-based violence prevention and treatment programs for general population","10/30/2019","Prevention programs for general population","Southern and Eastern Africa","Inactive",null,"High","PAI-4749","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJE3/view","351,805",0,"Funding will be used to support integration of human rights and prevention of sexual and gender-based violence among adolescents as part of HIV and TB prevention intervention to address structural issues and expand geographical coverage to eight districts. The activity will be funded through the reinvestment of the efficiencies identified during the grant making.",0,0,0,0,"351,805",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Madagascar","12/31/2020","HIV/AIDS","FR547-MDG-H","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Southern and Eastern Africa","Active",null,"High","PAI-5035","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIf/view","7,345","7,345","Given the poor quality and inconsistency of data, and the stock-outs of supplies, it is essential that managers receive training in monitoring and evaluation. This training should also improve the completeness of reports.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7345}]
["Namibia","12/31/2020","Malaria","FR224-NAM-M-01","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Southern and Eastern Africa","Active",null,"High","PAI-5234","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLs/view","62,479","62,479","Given the remoteness and mobile nature of the San people and the cattle herders, having community health workers (CHWs) that are embedded with the community will improve community level access and targeting for hard to reach areas, as well as ensure timely reporting of data. This amount includes CHW salaries, CHW supervisor salaries, regional coordinator salaries, and the necessary SMS/transport reimbursements for these staff in Omusati region.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":62479}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Southern and Eastern Africa","Active",null,"High","PAI-5200","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLK/view","6,200,000","3,812,724.61","HTS trainings ($6.20M) Covers half of the need for skills intensive training. Also covers in full: 1) trainings to allow expansion of HDAs to non-PEPFAR-supported facilities. HDAs have proven instrumental in expansion of HTS for reaching 1st 90; 2) orientation in Bioline rapid test kit. This has been endorsed as the first test in the national HIV testing algorithm; 3) district quarterly reviews; and 4) district mentorship.",0,0,0,0,"2,387,275.39",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3812724.61}]
["Rwanda",null,"HIV/AIDS, Tuberculosis","FR290-RWA-C","Other procurement supply chain management intervention(s)","10/30/2019","RSSH: Procurement and supply chain management systems","Southern and Eastern Africa","Inactive",null,"High","PAI-5484","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPu/view","5,445,022",0,"In order to acquire WHO accreditation the following are included in the above allocation: a) 3% out of 9% of MPPD management fees (USD 4,072,691); b) functional costs of the Rwanda Standards Bureaus drug quality control laboratory (USD 1,372,331); c) air conditioning for 25 district pharmacies; d) 2 trucks for supply chain activities; and e) an Enterprise Resource Planning system (ERP) at the central warehouse.",0,0,0,0,"5,445,022",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Angola","6/30/2021","Malaria","FR211-AGO-M","Other case management intervention(s)","10/30/2019","Case management","Southern and Eastern Africa","Active",null,"High","PAI-3563","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuv/view","500,000","500,000","Increasing access to primary health care services(iCCM) through ADECOs is seen as a priority by the GoA. In this above allocation, iCCM will be expanded to a further six (6) municipalities, distributed as follows: Moxico (1), Malange (3) and Uige Province(2). These Provinces were chosen for increased coverage due to their malaria burden, access to health care and population   The total ADECOS expected to be trained under this above allocation will be 240. Children less than 5 years of age that have access to health care will  increase from 11% to 20% by the end of the Grant. The total cost is 500.000 USD, to cover, five days training for ADECOS ( ToT and ADECOS training) visibility materials( t-shirts, cups, boots, cup rain, smartphones, mobile data service.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":500000}]
["Namibia","12/31/2020","HIV/AIDS, Tuberculosis","FR229-NAM-C","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Southern and Eastern Africa","Active",null,"High","PAI-5252","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMA/view","525,429","525,429","Increasing accessibility of HIV testing is expected to increase the number of people who are tested in the general and key populations who are able to access high quality testing.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":525429}]
["Comoros","12/31/2021","Malaria","FR663-COM-M","Indoor residual spraying (IRS)","2019-04-12","Vector control","Southern and Eastern Africa","Active",null,"High","PAI-6181","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJmn/view","419,652","419,652","IRS for indigenous cases in elimination areas (5 km radius): In the elimination areas, malaria cases should undergo both epidemiological and entomological investigations to determine the origin of the case. Once the case is declared indigenous, case management (treatment) and interruption of parasite transmission by the vector (IRS) are the two main response interventions used to prevent epidemics. This activity will take place following the results of the prior entomological investigations. A total of nine IRS interventions are planned based on an expected 5 percent of imported cases over the three years in elimination areas. Thus, nine cases are expected in total  two cases in 2019, four cases in 2020 and three cases in 2021. Expected outcome: interruption of transmission. Expected impact: prevention of re-introduction of the disease.","373,951.8972",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":419652}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Southern and Eastern Africa","Active",null,"High","PAI-5204","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLO/view","300,000","250,000","Key Affected Populations (USD 300,000): The usefulness of digital chest X-rays for screening and diagnosis of TB is considerably limited by lack of trained healthcare workers. Computer-aided detection (CAD) programs constitute a viable alternative, and initial studies have indicated that CAD programs have potential high sensitivity.31,32 CAD is particularly useful in high volume screening settings, such as OPD in high burden hospitals. While digital X-rays have been procured through the NFM grant, complementing them with CAD will enhance their effectiveness. This line item will cover the cost of procurement and utilization of CAD software for TB diagnosis, in particular concentrating on screening urban poor populations in high volume sites, complementing the within allocation strategy for reaching this high risk group by improving standardization, sensitivity and speed of diagnosis. Utilization of CAD will also contribute to the generating evidence on this innovative technology, to inform policy on usage in resource constrained settings with high TB burden. Finally, imaging generated by CAD can be repurposed for teaching in health colleges.",0,0,0,0,"50,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":250000}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR584-MWI-C","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",0,"High","PAI-5226","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLk/view","8,054,327","8,054,327","Malawi has recently adopted the WHO guidelines on treatment monitoring (annual viral load tests), until now viral load tests had been conducted every two years. This has resulted in a gap in commodities (especially reagents). Based on existing and targeted patients to be reached between 2019 and 2020 and taking into consideration existing resources (reagents for 1.36 million tests), the potential reagents gap is for 518,000 tests. The scale-up plan for treatment monitoring and optimized laboratory network was completed and the annual testing policy is now in effect. The required amount to cover the gap is US$ 8 million. This is in addition to existing resources from PEPFAR committed to investments in laboratory capacity strengthening under COP 18. The gap is therefore in 2020 and orders will have to be placed in January 2020 to full coverage of all patients.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":8054327}]
["Malawi","12/31/2020","Malaria","FR100-MWI-M-01","National product selection, registration and quality monitoring","10/30/2019","RSSH: Procurement and supply chain management systems","Southern and Eastern Africa","Active",null,"Low","PAI-5176","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKw/view","399,636","399,636","Malawi requests continued funding for the PSM malaria activities in 2020. Malaria commodities will be procured and distributed using within allocated funding by GF in 2020. It is essential therefore that during this period QC and QA for these commodities is supported to ensure quality assurance is maintained.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":399636}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Case detection and diagnosis: MDR-TB","10/30/2019","MDR-TB","Southern and Eastern Africa","Active",null,"High","PAI-5201","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLL/view","740,365","524,471","MDR-TB Case Detection (USD 740,365): The national policy is to test re-treatment patients, contacts of MDR-TB patients and seriously ill patients for MDR-TB. Within allocation, 67,131 cases will be notified in 2018-20, of which approximately 10% (or 6,700) are expected to be re-treatment cases. Of these, 6.4% (or 430) are expected to be MDR-TB cases. From within allocation, 381 MDR-TB patients are targeted for treatment, representing 88.6% of expected retreatment cases. The remaining 49 of 430 cases, along with the new MDR-TB cases that will be identified from the additional 9,784 TB cases found through the above allocation request above, will be covered through these above allocation funds (See Target Assumption Table attached). To support increased case detection rates, an additional 2,060 Xpert cartridges will be procured, alongside orientation for HCWs on Xpert diagnostic algorithms, as well as supervision and mentorship for HCWs in high burden MDR-TB facilities to encourage screening of patients using Xpert.",0,0,0,0,"215,894",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":524471}]
["Comoros","12/31/2021","Malaria","FR553-COM-M","Other specific prevention intervention(s)","10/30/2019","Specific prevention interventions (SPI)","Southern and Eastern Africa","Active",null,"Medium","PAI-4076","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3C/view","12,497.48","12,497.48","Organization of events for World Malaria Day: This is an opportunity to draw attention to the malaria response at the national level by raising awareness among all stakeholders on: (i) adopting behavior conducive to malaria control, (ii) the importance of local and private financial contributions for NMCP activities, (iii) compliance with recommended actions for case monitoring  health care facility visits, use of LLINs, presentation of the current epidemiological situation (pre-elimination of malaria), etc.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":12497.48}]
["Comoros","6/30/2022","HIV/AIDS","FR552-COM-H","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Southern and Eastern Africa","Active",null,"High","PAI-4058","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2u/view","20,406.24","20,406.24","Organizing seven training courses for untrained teachers and teaching supervisors per year on the three islands The current grant has introduced STIs and HIV into the curriculum. It has also provided training for 200 teachers and pedagogical supervisors on the three islands. However, this training has covered only 45 percent of needs. The allocation amount provides for three training courses for 60 teachers in the first year. Funding is therefore requested to cover 35 percent of the gap and to cover the needs of seven additional first-year training courses for teachers and teaching supervisors, to build their capacities to teach participants about STI and HIV prevention messages.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20406.240000000002}]
["Comoros","6/30/2022","HIV/AIDS","FR552-COM-H","HIV care","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",null,"Medium","PAI-4060","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2w/view","64,668.39","64,668.39","Organizing TV and radio broadcasts:The country aims to eliminate mother-to-child transmission of HIV. Two TV channels and seven radio stations will be contracted within the allocation amount. This PAAR application will enable contracts to be signed with one more TV channel and three more radio stations to cover the three islands.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":64668.39}]
["Angola",null,"HIV/AIDS, Tuberculosis","FR258-AGO-C","Case detection and diagnosis","10/30/2019","TB care and prevention","Southern and Eastern Africa","Active",null,"High","PAI-3588","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvK/view","499,050","499,050","PAAR to support procurement of additional laboratory  materials and consumable in  2019, 2020 and 2021 to reach targets. The items will include sputum containers and protection masks(3M N95) and reagents. Expected outcome will be increase in CNR.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":499050}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",null,"Medium","PAI-5217","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLb/view","7,620,000","3,945,502.01","Point of care for VL/EID ($7.62M) Point of Care is critical for patient monitoring and early provision of lifesaving interventions The Ministry of Health with support from CHAI conducted a POC mapping and identified 99 Health facilities that would benefit from Point of Care for VL/EID. High volume sites will be considered for deployment of POC, because of availability of infrastructure and linkage to care for higher throughput. This will enable providers make timely clinical decisions to switch failing patients to second/third line ART. This request will enable the Ministry of Health to procure an additional 15 platforms and procure 50,000 viral load tests and 15,000 EID tests. This will complement existing POC investments available in country including funding from UNITAID for 2017 to 2019.",0,0,0,0,"3,674,497.99",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3945502.01}]
["Eswatini","9/30/2021","HIV/AIDS, Tuberculosis","FR230-SWZ-C","Prong 1: Primary prevention of HIV infection among women of childbearing age","10/30/2019","PMTCT","Southern and Eastern Africa","Inactive",null,"High","PAI-5689","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTD/view","81,800",0,"Procure syphilis test kits to cover 50% of the country need. This builds on the 50% which is contained in the allocation amount.",0,0,0,0,"81,800",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Eswatini","9/30/2021","HIV/AIDS, Tuberculosis","FR230-SWZ-C","Case detection and diagnosis","10/30/2019","TB care and prevention","Southern and Eastern Africa","Active",null,"High","PAI-5658","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSi/view","1,310,137","616,130","Procurement of additional buffer stock of GeneXpert cartridges (to support government absorbing this in year 2 and 3 of the grant).",0,0,0,0,"694,007",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":616130}]
["Comoros","6/30/2022","HIV/AIDS","FR552-COM-H","HIV testing services for sex workers","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Southern and Eastern Africa","Active",null,"High","PAI-4055","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2r/view","29,727.3","29,727.3","Providing training on PMTCT to 60 providers at public and private health posts to scale up the elimination of mother-to-child transmission (eMTCT):  The country has set itself the challenge of eliminating mother-to child transmission by 2021. The current grant provided for PMTCT scale-up at 30 sites. This increase is coupled with a need for capacity building among untrained staff at antenatal clinics. This activity involves 60 providers at public and private health posts in the first year. This above allocation funding request will cover the additional training of 60 other PMTCT providers in the second year and 60 in the third year. These health workers at antenatal sites, including midwives, will be responsible for Pillar 1 of PMTCT and for monitoring HIV-positive pregnant women until early childhood diagnosis.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":29727.3}]
["Eswatini","9/30/2021","HIV/AIDS, Tuberculosis","FR230-SWZ-C","Treatment","10/30/2019","TB care and prevention","Southern and Eastern Africa","Active",null,"Medium","PAI-5683","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJT7/view","366,148","366,148","Refurbishment and implementing IPC measures at non-BMU sites. This will support the further expansion of accredited BMUs from the existing 118, towards ensuring that all ART sites (170) also offer TB treatment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":366148}]
["Eswatini","9/30/2021","HIV/AIDS, Tuberculosis","FR230-SWZ-C","Routine reporting","2019-05-12","RSSH: Health management information systems and M&E","Southern and Eastern Africa","Inactive",null,"High","PAI-5666","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSq/view","3,424,843",0,"Scale up CMIS to 142 additional small volume facilities. This will enable CMIS to be operational in all facilities in the country. The more facilities where CMIS is operational, the better the functionality of the system as a whole. In other words, this PAAR activity is acatalytic one to the allocation CMIS scale-up. This means clients can move from one facility to another, and continue to be captured on the live system.",0,0,0,"2,267,806","1,157,037",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Rwanda",null,"HIV/AIDS, Tuberculosis","FR290-RWA-C","Other health and community workforce intervention(s)","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Southern and Eastern Africa","Active",null,"Medium","PAI-5471","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPh/view","4,059,303","2,709,372","Since 2012, the HRH Program has trained specialists in different medical fields. USD 2,356,241 is earmarked for the programs continuation to ensure that the current cohort of trainees can complete the training program within 3 years thereby ensuring sustainability and the quality of care in HIV and co-morbidities (Malaria, TB, Hepatitis). Efficiencies have been generated in the program through the use of local faculty trainers",0,0,0,0,"1,349,931",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2709372}]
["Comoros","6/30/2022","HIV/AIDS","FR552-COM-H","Prong 3: Preventing vertical HIV transmission","10/30/2019","PMTCT","Southern and Eastern Africa","Active",null,"Medium","PAI-4059","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2v/view","43,796.43","43,796.43","Supporting the operation of the Network for People Infected with or Affected by HIV: TAS TAS is a community-based organization engaged in HIV prevention and caring for PLHIV. Given the weak performance in the area of treatment and the ambitious targets of this funding request for ART (from 35 percent in 2019 to 65 percent in 2022), the DNLS recommended making TAS a sub-recipient to take part in family screening strategies (partner and child), the search for people lost to follow-up, the referral of HIV-positive people (test and treat), the distribution of nutritional kits and mediation for treatment of TB/HIV co-infection. Given the importance of this organization in the HIV response, the government has provided a building for TAS to use as its premises.This activity supports TASs equipment needs (refurbishment of premises, chairs, tables, photocopiers, computers, office supplies, maintenance of equipment, Internet connection, etc.) in order to improve its results efficiency.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":43796.43}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Case detection and diagnosis","10/30/2019","TB care and prevention","Southern and Eastern Africa","Active",null,"High","PAI-5198","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLI/view","620,280","403,140","TB Case Detection Diagnosis and Treatment (USD 620,280): Building on TB treatment targets within allocation, this line item would support case detection and treatment of an additional 9,784 TB patients. This additional coverage will increase the case detection rate from 60%, 63% and 65% in Y1, Y2, and Y3, to 70%, 70% and 75%, respectively, over three years, leading to the full achievement of the NSP target. These additional 9,784 cases will be detected and diagnosed through a combination of the scale-up strategies outlined in line items 2, and 3, whereby: a) additional private for-profit facilities will be engaged, contributing a projected 7% of TB cases notified; and b) additional CSCPs will be established in rural areas contributing an additional 4% of TB cases notified. Additional funds will be applied to screening all HCWs and testing approximately 900 annually, assuming 6% of all HCWs screen positive.",0,0,0,0,"217,140",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":403140}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Southern and Eastern Africa","Active",null,"High","PAI-5216","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLa/view","502,437","471,949.68","The activities within this module are linked to the HSSPII objective to generate quality information, and increase quality information accessibility to all intended users for evidence-based decision-making, through standardized and harmonized tools that avoids duplication across all programmes. These activities encourage the adoption of ICT systems for routine data management including data collection, data analysis, use and dissemination. These activities include procurement of IT equipment for all levels, and procurement of 10 vehicles to support programme implementation. Funding Request: Tailored to Material Change 15 December 2016 39 An inventory of all vehicles has been created and priority will be given to those government departments who have critical supervision/audit responsibilities A pooled system is in force at Headquarters level.",0,0,0,0,"30,487.32",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":471949.68}]
["Madagascar","12/31/2020","HIV/AIDS","FR547-MDG-H","Counseling and psycho-social support","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",null,"High","PAI-5066","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJA/view","25,274","25,274","The activity consists of organizing discussion groups and an observance club to provide information sessions within associations in order to reduce stigma toward PLHIV. This activity is run twice a year, with one session covered under the allocation amount and one under the above allocation amount.The budget item relates to transport, allowances and refreshments.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25274}]
["Angola",null,"HIV/AIDS, Tuberculosis","FR258-AGO-C","Treatment: MDR-TB","10/30/2019","MDR-TB","Southern and Eastern Africa","Active",null,"High","PAI-3574","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv6/view","355,500","355,500","The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":355500}]
["Namibia","12/31/2020","HIV/AIDS, Tuberculosis","FR229-NAM-C","Diagnosis and treatment of STIs and other sexual health services for general population","10/30/2019","Prevention programs for general population","Southern and Eastern Africa","Active",null,"Low","PAI-5246","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJM4/view","17,689","17,689","The development of an STI strategy and encouraging treatment seeking behavior should result in less HIV infections.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":17689}]
["Lesotho","6/30/2021","HIV/AIDS, Tuberculosis","FR509-LSO-C","Other intervention(s) for general population","10/30/2019","Prevention programs for general population","Southern and Eastern Africa","Active",null,"High","PAI-4747","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJE1/view","436,283","307,323","The funding will support adherence and economic empowerment through support groups to overcome the suboptimal retention level. 31 support groups comprising 620 members are expected to be trained on various livelihood options, such as voluntary savings, loans and access to microfinance, in three high burden districts. The activity will be partially funded through the reinvestment of the efficiencies identified during the grant making.",0,0,0,0,"128,960",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":307323}]
["Lesotho","6/30/2021","HIV/AIDS, Tuberculosis","FR509-LSO-C","Behavioral interventions as part of programs for general population","10/30/2019","Prevention programs for general population","Southern and Eastern Africa","Inactive",null,"High","PAI-4748","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJE2/view","196,037",0,"The funding will support sensitization and prevention of sexual and gender based violence to reduce HIV transmission among vulnerable populations. It will include production and dissemination of education materials and simplified laws for training of law enforcement agencies. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.",0,0,0,0,"196,037",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Angola",null,"HIV/AIDS, Tuberculosis","FR258-AGO-C","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",null,"High","PAI-3577","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv9/view","1,000,000","1,000,000","The investment in the allocation amount is able to support one Viral load platform in Luanda and is inadequate to achieve viral load testing targets. PAAR in this module is request to support the three additional viral load testing  platforms to be able to meet all targets ( see Annex 17 on projections of viral load testing). The expected outcome will be number of PLHIV on ART test for viral load and improved monitoring of the 90-90-90 care and treatment cascade.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1000000}]
["Rwanda",null,"HIV/AIDS, Tuberculosis","FR290-RWA-C","HIV care","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",null,"Medium","PAI-5470","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPg/view","5,194,737","4,015,611","The nutrition support included in the allocation will only cover the needs of the most vulnerable patients. The above allocation will cover nutrition support for PLHIV suffering from malnutrition (USD 3,441,205) (23% for CSB+ and 60% for RUTF). USD 112,232 is earmarked for training and start-up capital for 27 PLHIV cooperatives. Also USD 1,641,299 is included for human resources support to health care providers.",0,0,0,0,"1,179,126",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4015611}]
["Lesotho","6/30/2021","HIV/AIDS, Tuberculosis","FR509-LSO-C","Case detection and diagnosis","10/30/2019","TB care and prevention","Southern and Eastern Africa","Inactive",null,"High","PAI-4733","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDn/view","2,200,000",0,"The prevalence survey will enable the program to improve the quality of data, planning, reporting and forecasting. The survey was initiated in 2017, however, could not be continued due to a number of reasons, including the need to improve the National Reference Lab and procure X-ray machines. Both activities are to be completed with the World Bank support in June 2018. The prevalence survey will be funded through the reinvestment of the efficiencies identified during the grant making.",0,0,0,0,"2,200,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Malawi","12/31/2020","Malaria","FR100-MWI-M-01","Facility-based treatment","10/30/2019","Case management","Southern and Eastern Africa","Active",null,"Medium","PAI-5186","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJL6/view","1,821,952","1,821,952","The program will complete training in malaria case management of all health workers in service with support from GF NFM in 2017. However during, the MPR it was observed that a training gap remains in health workers not yet in service and those in the private sector. Therefore in this grant, an additional 3990 HWs from the private sector and those not currently in service will be trained. These trained health workers will receive subsequent supportive supervision to ensure mastering of skills maintenance of high standards of case management practices. In addition, to complement implementation of OTSS, targeted mentorship will be carried out by specialized national mentors, focusing on high volume poorly performing facilities so as to ensure quality improvement in specifically identified facilities. Ensuring these activities are supported in 2020 will contribute significantly to malaria morbidity and mortality reduction.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1821952}]
["Namibia","12/31/2020","HIV/AIDS, Tuberculosis","FR229-NAM-C","Community TB/HIV care delivery","10/30/2019","TB/HIV","Southern and Eastern Africa","Active",null,"Low","PAI-5255","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMD/view","2,358,757","2,358,757","These activities support TB/ HIV increased integration at both national and district level. Through these integrated services, TB HIV co-infected people are more likely to receive enhanced treatment. This will result in people being more adherent to treatment and better treatment outcomes, including retention of people on ART.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2358757}]
["Malawi","12/31/2020","HIV/AIDS, Tuberculosis","FR100-MWI-C","Other module","10/30/2019","Other module","Southern and Eastern Africa","Active",null,"High","PAI-5210","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLU/view","4,846,588","3,414,959.12","These funds will be used towards salaries and benefits for two additional data clerks per facility for 600 facilities and builds on M&E capacity development plans within allocation.",0,0,0,0,"1,431,628.88",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3414959.12}]
["Madagascar","12/31/2020","HIV/AIDS","FR547-MDG-H","HIV care","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",null,"High","PAI-5064","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJ8/view","807,757","807,757","This activity consists of monitoring the additional PLHIV covered by the above allocation component.It covers the procurement of laboratory supplies for:- HIV viral load (VL) measurement;- quarterly transportation of samples for HIV VL measurement, from the 26 regional test sites to the national reference laboratory (NRL);- early testing for infants aged under 18 months and prompt transportation of pediatric samples from the 26 regional sites to the NRL;- lymphocyte (T4) count (CD4).A proportion of needs is already covered within the allocation amount under NFM 2, at a cost of US$ 656,337.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":807757}]
["Namibia","12/31/2020","HIV/AIDS, Tuberculosis","FR229-NAM-C","Pre-exposure prophylaxis (PrEP) for MSM","10/30/2019","Comprehensive prevention programs for MSM","Southern and Eastern Africa","Active",null,"Medium","PAI-5254","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMC/view","63,237","63,237","This activity includes training so that care workers are trained in PrEP and are able to offer care and support to MSM.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":63237}]
["Madagascar","12/31/2020","HIV/AIDS","FR547-MDG-H","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Southern and Eastern Africa","Active",null,"High","PAI-5033","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJId/view","2,560,923","2,560,923","This amount is for HIV tests to cover the needs for the new testing targets under the above allocation goals.Within the above allocation amount, testing will reach 2,409,783 people, of which 10% will be from key populations (MSM, SWs, people who inject drugs) and 90% from other vulnerable populations.Of the total targets for testing, the above allocation amount covers 53% of the targets for pregnant women, 35% for TB patients, 50% for STI patients, 60% for young people, 20% for prisoners, 75% for other vulnerable populations, 41% for MSM, 46% for SWs and 28% for people who inject drugs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2560923}]
["Eswatini","9/30/2021","HIV/AIDS, Tuberculosis","FR230-SWZ-C","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","Southern and Eastern Africa","Active",null,"High","PAI-5671","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSv/view","189,306","189,306","This funding will be utilised to integrate CMIS with the lab information system (LIS). In addition, funding will go towards training at least 100 health workers on LIS, quality management systems and safety, disease prevention and surveillance. This training will respond to finding from the 2016 Report on Assessment of Quality of Maternal and Neonatal Care in Swaziland. In particular, it will respond to the finding that infection prevention practice of health workers was poor and there was no mechanism to monitor adherence of providers to IP principles in assessed facilities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":189306}]
["Madagascar","12/31/2020","HIV/AIDS","FR547-MDG-H","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Southern and Eastern Africa","Active",null,"Low","PAI-5060","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJ4/view","16,047","16,047","This is already a very popular topic on the global stage, especially in the context of demedicalized screening. The technicians would like to receive training on this topic in countries with prior experience.  This would be an exchange trip on the topic of demedicalized screening, with countries advanced in using a community approach to control HIV/AIDS.The activity costs cover travel and allowances.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":16047}]
["Namibia","12/31/2020","HIV/AIDS, Tuberculosis","FR229-NAM-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Southern and Eastern Africa","Active",null,"Low","PAI-5243","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJM1/view","1,360,888","1,360,888","This is expected to support PLHIV by providing nutritional support to those most in need and unable to meet their daily requirements to access therapeutic food, encouraging them to seek timely treatment and adhere to ART.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1360888}]
["Madagascar","12/31/2020","HIV/AIDS","FR547-MDG-H","HIV testing services for adolescents and youth, in and out of school","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Southern and Eastern Africa","Active",null,"High","PAI-5055","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIz/view","131,082","131,082","This refers to activities to accompany young people who agree to testing. This funding will cover monitoring of targets for testing at health centers, with a view to achieving testing coverage of 36 per cent in 2018 and 45 per cent in 2020. It will also provide for activities to accompany young people who test positive to referral doctors, in order to reduce the number of initial patients lost to follow-up and improve retention from 127 cases in 2018 to 168 cases in 2020, thus helping to achieve the enrolment target of 65 per cent of new cases on ART. There will also be mobile testing targeting young people, ensuring local service provision through mobile clinics. The above allocation amount will cover 27 per cent of the target for accompanying during testing, representing an additional 198,114 young people tested.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":131082}]
["Madagascar","12/31/2020","HIV/AIDS","FR547-MDG-H","Other intervention(s) for sex workers and their clients","10/30/2019","Comprehensive prevention programs for sex workers and their clients","Southern and Eastern Africa","Active",null,"Low","PAI-5061","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJ5/view","74,995","74,995","This refers to packaging production costs for condoms for social marketing (Yes and Protector Plus).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":74995}]
["Rwanda",null,"HIV/AIDS, Malaria","FR668-RWA-Z","Other intervention(s) for PMTCT","2019-04-12","PMTCT","Southern and Eastern Africa","Active",null,"High","PAI-6193","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnF/view","1,003,118","1,003,118","This request is for alignment of grant.","1,003,118",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1003118}]
["Rwanda",null,"HIV/AIDS, Malaria","FR668-RWA-Z","Other intervention(s) for treatment","2019-04-12","Treatment, care and support","Southern and Eastern Africa","Active",null,"High","PAI-6191","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnD/view","11,617,393","11,617,393","This request is for alignment of grant.","11,617,393",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11617393}]
["Malawi","12/31/2020","Malaria","FR100-MWI-M-01","Other specific prevention intervention(s)","10/30/2019","Specific prevention interventions (SPI)","Southern and Eastern Africa","Active",null,"Medium","PAI-5185","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJL5/view","46,395","46,395","To ensure GF and development partner supported efforts in 2018 and 2019 towards increase of ANC uptake of at least three doses of IPTp from 12% in 2014 (MIS) to 60% by 2022 through supportive supervision this request is for continued funding in 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":46395}]
["Eswatini","9/30/2021","HIV/AIDS, Tuberculosis","FR230-SWZ-C","Retention and scale-up of health workers, including for community health workers","10/30/2019","RSSH: Human resources for health (HRH), including community health workers","Southern and Eastern Africa","Active",null,"High","PAI-5670","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSu/view","100,000","100,000","Train the remaining 4,400 Rural Health Motivators (RHMs) (above the 600 that are prioritized in the allocation) using revised curriculum.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100000}]
["Lesotho","6/30/2021","HIV/AIDS, Tuberculosis","FR579-LSO-C","Other intervention(s) for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Southern and Eastern Africa","Active",null,"Medium","PAI-4739","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDt/view","25,916","25,916","UNICEF. MOH, PACT and CHAI and funding received under NFM2 will be used to map the services for adolescents and young people and develop a service directory. The service directory will guide all implementers and mitigate against duplication of services. To enhance implementation and coordination of service delivery amongst implementing partners the following needs to be strengthened: Documentation of a standardised and harmonised referral system to provide guidance for services to adolescents and young people Induction of implementing partners on the utilisation of the harmonised referral system across the 8 districts Facilitate coordination of quarterly meetings (in total 32 meetings annually) at district level to monitor implementation and outcomes of the harmonised referral system",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":25916}]
["Madagascar","6/30/2021","Malaria","FR664-MDG-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","2019-04-12","Vector control","Southern and Eastern Africa","Active",null,"High","PAI-6182","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJms/view","16,758,100","16,758,100","Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.","16,758,100",0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":16758100}]
["Guinea","12/31/2020","Malaria","FR561-GIN-M","Seasonal malaria chemoprevention","10/30/2019","Specific prevention interventions (SPI)","Western Africa","Active",null,"High","PAI-4285","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6Z/view","5,070,552","5,070,552","1. Request for Additional Funding for Seasonal Malaria Chemo Prophylaxis (SMC) to cover 478,354 New Children in Guinea.  SMC is the intermittent administration of full treatment courses of an antimalarial medicine to children aged 3-59 months in areas of highly seasonal transmission during the malaria season. The previous SMC national campaign (2017) was funded by the GF and protected nearly 480,000 children.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5070552}]
["Guinea","12/31/2020","Malaria","FR561-GIN-M","Grant management","10/30/2019","Program management","Western Africa","Active",null,"High","PAI-4288","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6c/view","275,000","275,000","6. Request for additional funding for the rehabilitation of the NMCP offices as per the studies carried out by UNOPS. The geotechnical and technical studies in preparations for the renovation work were financed by CRS (with the subsidy NFM 2015-2017).  The requested funding is to cover the gap in the costs of renovation that were initially budgeted prior to the finalization of the UNOPS studies.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":275000}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Western Africa","Active",null,"High","PAI-4327","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7F/view","13,493.44","13,493.44","Acquire equipment for the Management Unit for TB/HIV collaboration activities and purchase IT tools for the management of the TB/HIV data by  treatment centers.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":13493.44}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4696","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDC/view","90,000","90,000","Although the LMHRA has worked strongly with other agencies and developing partners to develop capacity in medicine quality regulations, quality control, and data generation and post market quality surveillance, these efforts are challenged with limited funding from the Government of Liberia, developing partners and other agencies to support the operation and implementation of medicines regulatory policies. This intervention has been earmarked for the first time in the National Malaria Control monitoring and evaluation plan 2016  2020 as one of the Programs monitoring mechanisms to be implemented by the LHMRA.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":90000}]
["Guinea-Bissau","12/31/2020","Malaria","FR370-GNB-M","Other module","10/30/2019","Other module","Western Africa","Active",null,"Low","PAI-4310","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6y/view","244,858.04","244,858.04","Bridge the funding gap for capacity building activities of MOH. Most of the personnel involved in the NMCP have been newly recruited (since 2016) and are responsible for the various positions within the NMCP, however they have not received any training.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":244858.04}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Integrated community case management (ICCM)","10/30/2019","Case management","Western Africa","Active",null,"High","PAI-4684","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD0/view","525,630","464,935","CHA feedback meeting which is held on quarterly basis is an activity that brings the community health frontline workers together on quarterly basis.   This request covers: Total year 3 cost of the activity within the program continuation because the within allocation cannot accommodate this; Total cost for 3 years cost for the activity in additional 5 counties including 2 additional districts in Margibi with gaps in iCCM implementation as recognized by the LCM, MOH and other iCCM partners as being critical in rollout and implementation of the Revised National Community Health program in Liberia.",0,"60,695",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":464935}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Other module","10/30/2019","Other module","Western Africa","Active",null,"Medium","PAI-4332","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7K/view","36,541.35","36,541.35","Conduct a PMTCT services quality survey and provide qualitative indicators (Calculation of effective coverage indicators); as well as a health care quality survey, and provide indicators on quality of care (calculation of indicators of effective coverage of patients).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":36541.35}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Other module","10/30/2019","Other module","Western Africa","Active",null,"Medium","PAI-4331","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7J/view","23,846.93","23,846.93","Conduct a Resistance Surveillance Survey (Studying the drug resistance of HIV to ARVs - Estimate the level of primary resistance, classify resistance levels of HIV-1 to ARVs and describe the types of mutations encountered). This study is essential for evaluating the resistance levels of HIV to ARVs, together with the types of mutations. The results of this study will enable better use of ARVs, thereby improving the survival rate for patients.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":23846.93}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4323","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7B/view","1,122,208.51","1,122,208.51","Conduct a Tuberculosis Prevalence Survey in Guinea-Bissau. This study will provide the information for this indicator, to be reported as part of the performance framework for this grant.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1122208.51}]
["Senegal",null,"Tuberculosis, RSSH","FR288-SEN-Z-01","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-5521","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQV/view","100,799.01","100,799.01","Conducting a national survey  into the prevalence of drug-resistant TB. The conclusions would enable subsequent interventions in the MDR-TB response to be strategically orientated.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":100799.01}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Supportive policy and programmatic environment","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4690","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD6/view","3,000,000","2,323,861","County level capacity building in all counties, minus the 4 counties in the South Eastern region where UNICEF is already providing capacity building.  The capacity building efforts will be led by specialists in the field for CHTs that require capacity building. Exact details of capacity building will be finalized once capacity assessments are be completed.",0,"676,139",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2323861}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Supportive policy and programmatic environment","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4679","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCv/view","301,400","301,400","County-level capacity assessments, to identify the capacity level of the CHT to implement the NCHA and develop plan tool.  The assessemnt is repeated every 2 years to: a) assess the environmental and operational readiness of the CHT to implement the program b) develop and implement a capacity development plan to improve effective program management c) assess progress of the CHT and capacity building activities",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":301400}]
["Gambia","6/30/2021","Malaria","FR549-GMB-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"Low","PAI-4306","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6u/view","4,489,393","4,489,393","Cross Border Initiative The epidemiology of malaria in the SeneGambia region has changed considerably over recent years, as a result of impressive progress being made by the governments and their implementing partners of both countries. With transmission becoming noticeably lower and much more focal, the question arises as to what it would take to sustain these achievements and to make further progress towards elimination. It was based on this premise that a Cross Border Initiative was conceived and established between Senegal and Gambia. Due to limited funding in the PC request, these activities are requested under PAAR for posible funding. As the countries observe low transmission rates, it is imperative to strengthen the surveillance system to identify foci of transmission in both countries, especially along the border villages/communities for targeted interventions. Hence, this request is made to set the scene for such initiative. The overarching goal of the initiative hinges on the following activities: 1) Establish a surveillance system capable of capturing malaria disease and entomological data for both countries;2) Ensure appropriate sharing and use of data for effective targeting of interventions and ensure monitoring of malaria situation;3) Encourage use of multiple strategies and interventions to reduce transmission with view to reaching malaria elimination for both countries;4) Build technical capacities of both countries to support the acceleration of malaria elimination efforts;Therefore, the inclusion of cross border activities in the above allocation request will support to scaling up of the use of mobile technology for real time reporting, case detection and treatment, entomological surveillance and other innovative strategies in both countries.Some of the key activities relative to cross border are budgeted for under PC for both countries. The Funding Gaps for Senegal to fulfill cross border teagets is US$ 3,448,977 while the funding Gap for The Gambia is US$ 970,416. The request made here with amouting to US$ 4,419,393 is in respect of the total funding gaps for both The Gambia and Senegal.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4489393}]
["Sierra Leone","12/31/2020","HIV/AIDS","FR474-SLE-H","TB/HIV collaborative interventions","10/30/2019","TB/HIV","Western Africa","Active",null,"High","PAI-5529","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQd/view","240,000","240,000","Currently 170 health facilities provide comprehensive TB/HIV services (12-13% of TB/HIV co-infection). The PAAR will be utilized to: Increase the number of health facilities providing TB/HIV services by 150 and train 300 health care providers in these facilities Supportive supervision and monitoring to all the targeted health facilities at least once every quarter Provide one-stop care for co-infected patients",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":240000}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other intervention(s) for general population","10/30/2019","Prevention programs for general population","Western Africa","Active",null,"Medium","PAI-4714","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDU/view","1,685,586","1,685,586","Currently condoms are provided by partners and this contribution may not continue beyond 2017. This cause is placed under PAAR to ensure no stock out of condoms in the country in the event that the current partner supply is discontinued beyond 2017.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1685586}]
["Gambia","6/30/2021","Malaria","FR549-GMB-M","Seasonal malaria chemoprevention","10/30/2019","Specific prevention interventions (SPI)","Western Africa","Active",null,"High","PAI-4303","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6r/view","4,758,135","4,758,135","Currently SMC is being implemented at low scale covering only two regions of the country (URR and CRR) with funding from the current GF New Funding Model (NFM) which has just ended.  Although funding is secured under Program Continuation (PC) to continue with SMC implementation, it is still confined to the two regions due to the limited funding. In line with the malaria strategic plan 2014-2020, SMC should be scaled up to cover 80% of children less than five years of age. The funds being requested will be used to extend SMC implementation to cover; Lower, river region (LRR), North bank region east (NBRE), North Bank Region West (NBRW), Western Region 2 (WR 2) and Western Region (WR 1). These regions have recenlty witnessed an increase in the malaria case incidences. The request will cover the cost of SMC  medicines, review and printing of SMC tools and guidelines, surveillance, pre- and post SMC campaign activities, logistics and impelemntation costs in The Gambia. The Request will further fund the evaluation of the impact of traning and involvement of VHWs/TBAs in improving the uptake of IPTp services as an integral part of Specific Prevention Intervention (SPI).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":4758135}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Social mobilization, building community linkages, collaboration and coordination","10/30/2019","RSSH: Community responses and systems","Western Africa","Active",null,"High","PAI-4324","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7C/view","5,254.18","5,254.18","Develop and reproduce communication materials (leaflets, posters and charter of the patient). This amount is planned to renew the reproduction of the communication materials to be used for advocacy and BCC among the populations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5254.18}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Other module","10/30/2019","Other module","Western Africa","Active",null,"High","PAI-4320","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ78/view","20,614.97","20,614.97","Elaborate a combination prevention plan for vulnerable populations. It is essential to have a national strategy, which is adapted through a plan, to guide the various interventions by stakeholders. The funds will be used to recruit an international consultant to propose and adapt the plan and to have it approved by all stakeholders at national level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":20614.97}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Other intervention(s) for PMTCT","10/30/2019","PMTCT","Western Africa","Active",null,"High","PAI-4340","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7S/view","40,956.12","40,956.12","Ensure communication costs of PMTCT sites for follow-up of deadlines. Credit for communication is provided to communicate with women as part of PMTCT.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":40956.120000000003}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Western Africa","Active",null,"High","PAI-4339","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7R/view","2,629,135.9","2,629,135.9","Ensure viral load testing for all patients on ART. For better management of treatment failures, each patient must have at least one viral load test per year. However, the PSM plan takes into account only 2,000 patients per year, for a target of 12,000, 13,000 and 14,000 patients for the three years of the grant. The acquisition of these additional tests will make it possible to cover 30% in 2018, 40% in 2019 and 50% in 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2629135.9}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other program management intervention(s)","10/30/2019","Program management","Western Africa","Active",null,"High","PAI-4712","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDS/view","1,300,477","1,300,477","Ensuring quality programing in challenging operating environment where skills are limited and chances of frauds and wrongdoing are high, requires a high-quality response and management. It has not been easy to establish a key population friendly program in  Liberia given the environment of phobia, stigma and discrimination and criminalization. There are challenges of finding adequate staff, infrastructure (rental spaces), human resources and security to implement key population program. It is important that the program delivers the intended results in a timely and quality manner. Adequate staff and infrastructure is required for the same. In the current allocationa limited amount is available to manage theprograms specially for the civil society PR. This request is to ensure adequate management support to deliver a high quality program in a scaled up fashion. The key population program was initiated only in second half of 2016. It is requested that adequate program management support is provided scaling and delivering tangible results. The support requested is as follows: a. Grant management and office running costs including but not limited to: Office security, legal counsel, annual external and internal audit, office equipment, communication and internet, fuel for vehicles and generator, maintenance of office equipment and vehicles, office equipment and rent, vehicle insurance. Amount requested is USD 1,448,771 b. Staff training on finance and technical issues: Such  opportunities allow PSI staff to ensure the highest quality of technical and financial/administrative management of the project by allowing them remain on the cutting-edge as regards technical issues, new policies and procedures, as well as attend trainings to enhance their own skills in technical and programmatic areas, including new prevention technologies like self-testing, PrEP, and other such innovations. The amount requested is USD 86,938 Human Resource: The current allocation does not provide enough to over the following positions that are required to deliver the program: Country Representative, Grants and Contracts Manager, Program Director, Internal Auditor (in country), M&E manager, Finance manager, M&E officer, Finance Coordinator, warehouse manager, drivers and similar positions. These positions have proven themselves crucial in the current grant to ensure technical quality and oversight, financial and administrative compliance, and fraud management and prevention; the program would be impossible to implement without them. Some of the common cost positions and other positions will be phased out as the program scales down for general population. The total amount requested is USD 2,365,724.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1300477}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Grant management","10/30/2019","Program management","Western Africa","Active",null,"Low","PAI-4333","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7L/view",940.41,940.41,"Equipment (laptop) for the National Secretariat to fight against HIV/AIDS.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":940.41}]
["Guinea","12/31/2020","Tuberculosis","FR260-GIN-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-4292","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6g/view","922,800","922,800","Extension of the community DOTS into 12 administrative districts, in order to provide coverage in the 33 administrative districts and 2 municipalities of Conakry by 2020, as stated in the NSP.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":922800}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Other policy and governance intervention(s)","10/30/2019","RSSH: National health strategies","Western Africa","Active",null,"High","PAI-4322","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7A/view","16,741.11","16,741.11","Final evaluation of the National Strategic Plan to fight against TB and HIV/AIDS 2015-2020 in 2020. In preparation for the next National Strategic Plan, this evaluation will make it possible to see the progress made, to identify the various challenges and, above all, to set the future national objectives in an informed manner. This will cover the costs of international and national consultants, field missions of teams conducting the final evaluation and workshop to review the results of the final evaluation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":16741.11}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR541-GNB-C","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Western Africa","Inactive",null,"High","PAI-4330","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7I/view","355,318.26",0,"For the purpose of Information, Education and Communication for Behavioral Change (IEC/CCC) under the current grant, the number of people (men in uniform, drivers, young street sellers) who are supposed to be sensitized and referred to the health centers for voluntary testing, is 15,000, 23,760, and 9,000, respectively, for a total number of 47,760. For other projects such as FEVE  (Borders and Vulnerabilities to HIV in West Africa), which is managed by the NGO ENDA, and the INCLUSIPH sub-regional project, managed by the NGO Humanity and Inclusion (formerly Handicap International), 3,600 prisoners and drug-users, and 4,000 people living with disabilities were targeted by the same activities.Nevertheless, tests to cover these vulnerable populations were not specified under the current grant due to budgetary constraints.In addition, and in accordance with the TRP recommendations to meet the 90-90-90 targets in the HIV Services Differentiated Approaches, 26,000 hospitalized patients and 38,000 others (general population) not part of the aforementioned vulnerable groups, have been targeted for testing. In total, the portion of the targeted population that is not covered is 119,360 who are supposed to be tested twice per year and this amounts to 238,720 tests over 2 years (2019-2020).This amount is requested in order to cover the very large testing gap (quantification of additional ARV requirements and HIV tests - Appendix 7). In fact, the PSM plan quantities were approved on the basis of budgetary constraints and were not based on the actual needs of the country. This quantification only specifies pregnant women and key populations (MSM, SW).The catch up plan, developed under 90-90-90 target, seeks to address the general population, to propose systematic testing of hospital patients, both adults and children, children admitted in nutritional rehabilitation centers (CRENI, CRENAS, CRENAM), people living with disabilities, prisoners, drug-users, men in uniform, young street sellers, drivers, and also the volunteers who come to do the tests in the countrys various Voluntary Counseling and Testing centers. In contrast with this, at the community level, the program will conduct testing campaigns for vulnerable groups, especially men in uniform, young saleswomen, and drivers. Self-testing is also planned, at the community level, for key populations.It is also important to specify that the behavioral bio-study, conducted by Humanity and Inclusion (HI), revealed a prevalence of 7.3% in the population of people living with disabilities and, on that basis, HI plans to perform 2,000 tests per year in this group. It is within this context that the program has found the essential necessity of testing these other groups, cited above, in order to improve the performance of the cascade which is currently very low.",0,0,0,"355,318.26",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Guinea","12/31/2020","Tuberculosis","FR260-GIN-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-4296","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6k/view","220,983","220,983","Four GeneXpert machines will be purchased. Three of these will be placed in the heavily used CDTs in the municipalities of Matoto and Ratoma, which are the most populated and cover the largest area; the 4th machine will be sited in the CDT in Macir (municipality of Dixin), near to the CHU which is home to a large paediatrics department. Impact: increase in the detection of cases of TB, TB-HIV, MDR-TB, childhood TB. The cost includes the purchase of the four machines, their calibration in years 2 and 3 and the provision of 1200 cartridges per machine per year.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":220983}]
["Sierra Leone","6/30/2021","Tuberculosis, Malaria, RSSH","FR564-SLE-Z","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-5541","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQp/view","1,200,000","1,200,000","Funding is needed for nutritional support to be provided for all TB cases, about 20,000 TB cases per year, during the intensive phase of treatment. MDR-TB cases, 300 cases per year, will receive the nutritional support throughout the course of treatment. The estimated cost will cover the nutritional support for TB patients for two years and this intervention will support the program to improve adherence to treatment.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1200000}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Integrated community case management (ICCM)","10/30/2019","Case management","Western Africa","Active",null,"High","PAI-4686","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD2/view","901,210","825,561","funding need for equipment and materials to CHAs and CHSS for the scale-up counties and also includes replacement of motorbike tyres for 92 CHS in within allocation in the initial 4 GF supported counties.",0,"75,649",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":825561}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Other case management intervention(s)","10/30/2019","Case management","Western Africa","Active",null,"High","PAI-4680","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCw/view","229,999","229,999","Funding to support the NMCP new strategy and approach for continue training. Continuous education ensures that clinical staff are supplied with all the relevant training modules and given a prescribed period of time to read and self-educate. In addition, regular hands-on, on-site mentoring and coaching will be carried out after which an evaluation test will be administered to determine the trainees level of comprehension.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":229999}]
["Senegal",null,"Tuberculosis, RSSH","FR288-SEN-Z-01","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-5522","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQW/view","2,244,417.01","2,244,417.01","Given the need to prioritize, the applicant plans to  use  the  allocation  amount  to  implement  the new  strategy  of  using  GeneXpert  as  a  first-line test in the six regions of the country that are home to 81% of missing cases. The additional investment enables this strategy to be extended to the whole country to obtain maximum impact.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2244417.0099999998}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Other specific prevention intervention(s)","10/30/2019","Specific prevention interventions (SPI)","Western Africa","Active",null,"High","PAI-4698","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDE/view","2,234,920","2,225,320","High Specific prevention interventions (SPI) IEC/BCC (SPI) 488,160 This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.    Year 3 cost for program continuation (within allocation); 3 years cost for additional 5 counties including 2 additional districts in Margibi (iCCM priority gaps recognized by the LCM, MOH and other iCCM partners in the implementation of the Revised National Community Health program in Liberia.",0,"9,600",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2225320}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4713","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDT/view","240,624","240,624","IBBSS: The rationale for this activity is to monitor the HIV positivity rate among key population and vulnerable groups with the interventions that will be conducted during the funding cycle. This activity is currently being implemented and expected to be conducted in 2020. Although this is a priority intervention, it is placed in PAAR due to limited funding within allocation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":240624}]
["Senegal",null,"Tuberculosis, RSSH","FR288-SEN-Z-01","Service organization and facility management","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"Medium","PAI-5524","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQY/view","182,654.02","182,654.02","IImplementation of the Integrated Package of Services (IPS) is budgeted within the allocation for 2018 and 2019, however due to limited funding 2020 is not budgeted.  The IPS ensures a better quality of service for the three diseases and for reproductive, maternal and neonatal health. It also supports the integration of TB, HIV, malaria and reproductive health/MNCH materials to be produced and a workshop organized to quantify the need for drugs and other health supplies in the 14 regions and at the national level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":182654.02}]
["Guinea","12/31/2020","Tuberculosis","FR260-GIN-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-4301","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6p/view","76,818","76,818","Improving the capacity to monitor and treat patients of MDR-TB (Bactec MGIT 960 device: USD 38,950; other equipment: USD 180; reagents USD 37,688 over the 3-year period).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":76818}]
["Niger","12/31/2020","Malaria","FR504-NER-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Western Africa","Active",null,"High","PAI-5259","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMH/view","2,601,638.42","2,601,638.42","In 2020 Niger intends to run a mass LLIN distribution campaign in the hypoendemic districts of Tahoua and Agadez regions (1,246,595 people) to protect the population against vector-borne diseases such as malaria and Rift Valley fever. These zones have not been covered since 2009.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2601638.42}]
["Senegal","12/31/2020","Malaria","FR559-SEN-M","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Western Africa","Active",null,"High","PAI-5513","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQN/view","1,881,875.21","1,881,875.21","In addition to improving the PNAs storage capacity, the capacities of the medical regions will need to be strengthened by setting up storage facilities for storing antimalarial supplies as well as supplies for other programs, in order to achieve local health objectives (70,000*1,000 m2*14 regions).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1881875.21}]
["Senegal","12/31/2020","Malaria","FR559-SEN-M","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Western Africa","Active",null,"Medium","PAI-5514","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQO/view","1,676,579.51","1,676,579.51","In addition to improving the PNAs storage capacity, the capacities of the medical regions will need to be strengthened by setting up storage facilities for storing antimalarial supplies as well as supplies for other programs, in order to achieve local health objectives (70,000*1,000 m2*14 regions).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1676579.51}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Routine reporting","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4682","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCy/view","400,000","400,000","In Liberia, Malaria is placed under passive surveillance under the Integrated Disease Surveillance and Response strategy.  In 2013, two surveillance sites were opened however, the sites did not function as the result of the outbreak of the Ebola Virus Disease outbreak which plagued the Country in 2014 and 2015.  Post Ebola, the Program decided to expand to three other health facilities in order to geographically balance the surveillance activities.  The requested fund is to set up the five sites (US$100,000) and another one hundred thousand dollars per year to run the sites for three years.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":400000}]
["Senegal","12/31/2020","HIV/AIDS","FR556-SEN-H","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","10/30/2019","PMTCT","Western Africa","Active",null,"High","PAI-5505","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQF/view","111,851.64","111,851.64","In line with the international community, Senegal has developed a business plan to expedite the elimination of mother-to-child transmission of HIV. To this end, a partnership with midwives has been established. This strategy will be strengthened by the coaching system and support will be provided for finding patients lost to follow-up, as will assistance for transport and checkup costs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":111851.64}]
["Sierra Leone","6/30/2021","Tuberculosis, Malaria, RSSH","FR564-SLE-Z","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Western Africa","Inactive",null,"High","PAI-5534","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQi/view","2,230,105",0,"In order to have a successful  implementation for the Universal coverage of the  Population the following activities are very important  for LLINs to reach the beneficiaries:    (1) Distribution to PHUs/Distribution Points.  (2).Transportation and Warehousing at district/chiefdom levels (3) Trainings (4) Microplanning (5) Social Mobilization                   (6) Monitoring and Evaluation.                                                                                                                                                                                                                                                              The final budget for 2020 LLINs mass campaign non-net costs will be available after the finalization of the plan of action, logistics plan and the communication plan with support and guidance from AMP  tentatively in April 2019.The total budget for the 2017 mass campaign non-net cost was $4.4m.  $2,541,578.56 has already been secured on the current GF grant towards non-net costs. The current estimated gap of ($1,858,421) + 20% buffer to cover the increase in fuel costs and other contingencies is required to fully fund these activities.",0,0,"2,230,105",0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR541-GNB-C","Diagnosis and treatment of STIs and other sexual health services for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Western Africa","Active",null,"High","PAI-4337","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7P/view","170,543.15","170,543.15","In order to reinforce HIV prevention based on the UNAIDS five pillars, the country has developed plans such as the plan of Human Rights and Gender Plan which is designed to reduce the cultural, legal, and social barriers which are preventing access to health services for adolescents and young women (10 to 25 years of age), and the coverage plan and the HIV services differentiated approach plan which is designed for key and vulnerable populations as well as the general population.The amount requested here amounts to 151,971 euros and concerns the PrEP feasibility study (21,551 euros) (PrEP Feasibility Study Budget - Appendix 12) as well as the activities without which the coverage plans objectives could not be reached. These fees are associated with: i) implementation of the pilot phase among 500 persons (67,207 euros); ii) the IEC/CCC activities of targeted groups (25,225 euros); iii) the targeted testing of key and vulnerable populations (37,988 euros) (Drafting of the HIV Services Differentiated Approaches Plan - Appendix 6).With regards to the PrEP, after the pilot phase, we plan to perform a study to measure the impact of this intervention in order to help us to make the decision to launch full-scale operations.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":170543.15}]
["Sierra Leone","6/30/2021","Tuberculosis, Malaria, RSSH","FR564-SLE-Z","TB/HIV collaborative interventions","10/30/2019","TB/HIV","Western Africa","Active",null,"High","PAI-5542","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQq/view","500,000","500,000","In the first semester of 2018, Jan  Dec, a total of 34,346 HIV positive people were screened for TB and only 1.6% TB cases were reported among PLHIV. This signifies limited access to TB prevention and care for PLHIV and a premature loss in the TB/HIV care cascade. Under the current grant NLTP funds integrated model involving placement of referral officers in 87 ART sites in 6 high burden district, however 50% of the funding is still missing. NLTP will build the capacity through intensive trainings and re-training.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":500000}]
["Senegal","12/31/2020","Malaria","FR559-SEN-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","Western Africa","Active",null,"Medium","PAI-5510","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQK/view","11,917,841.99","11,917,841.99","In the three target districts for this project (Touba, Diourbel and Passy), disease incidence is high.Within each district, criteria for selecting areas are defined based on the intensity of transmission (more than 10 cases per 1,000 population) and the feasibility of the intervention (predominant type of housing and population behavior). The area is demarcated at the health-post level, according to the degree of incidence reported by each health post.One treatment cycle per district (hot spots) is planned per year, to be carried out just before the main malaria transmission period (rainy season). The insecticide used will be chosen based on the susceptibility of the vectors in the intervention areas. IRS activities will be carried out based on the World Health Organization (WHO) IRS operational manual and adapted to the local context, but also based on the countrys ten years of experience with IRS.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":11917841.99}]
["Gambia","6/30/2021","Malaria","FR549-GMB-M","Indoor residual spraying (IRS)","10/30/2019","Vector control","Western Africa","Active",null,"Low","PAI-4305","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6t/view","1,215,424","1,215,424","Indoor Residual Spraying is used as a complementary vector control strategy to mitigate the effects of vector resistance to insecticides. Over the past years, IRS implementation was limited to 2 regions of central river region and upper river region due to funding gap. The 2017 HMIS data have shown regional changes in incidences of malaria where LRR (27/1000 cases) and WR2 (36/1000 cases) have recorded higher incidences compared to other regions. The preliminary results of 2017 MIS have also shown similar trends of parasite prevalence by regions. It has been prioritized for inclusion in the prioritised above allocation request to mitigate effect of insecticide resistance on LLINs in these regions. Therefore, IRS will be scaled up to cover LRR and rural settlements of WR2 using the above allocation request. The request will cover the cost of insecticides, logistics, operational cost and implementation and it amounts to U$1,215,424.  As the Gambia continues to implement IRS in the targeted regions (URR/CRR), and as part of the the two country collaboration clustering of border communities will be conducted to line list villages in the Senegalese side (2 km from the Gambian Border) for posible coverage by the Gambia IRS teams.Insecticide resistance monitoring in the IRS program and LLINs are covered in the program continuation request recently approved.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1215424}]
["Gambia","6/30/2021","Malaria","FR549-GMB-M","Integrated community case management (ICCM)","10/30/2019","Case management","Western Africa","Active",null,"High","PAI-4304","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6s/view","749,062","749,062","Integrated Community Case Management of childhood diseases is an integral part of village health Services system. Strengthening iCCM will enhance the childhood disease management at village and community levels, and further improve efficiency in malaria diagnosis and treatment.  Although detecting and treating every case of malaria in communities will be the core architect and guiding principles as the country moves towards malaria elimination, currently there is no strategy to transformed malaria case management into Integrated Community Case Management (iCCM).Both Integrated community case management strategy and guidelines will be developed with reference from the existing Malaria Case Management strategy (MCM) to incorporate and enhance community diagnosis and management of malaria and other childhood diseases.  Under this request, Village Health Workers (VHW) will be trained to conduct reactive and active case detection at community level.  The above allocation request of U$ 749,062 is being made for implementation of the planned introduction of iCCM strategy within the context of the national Primary Health Care structure. The request will cover the following:1. In service training of village health workers on iCCM2. Revise and print iCCM reporting tools3. Print iCCM strategy and guidelines4. Logistics support for supervision at regional level5. Monitoring the iCCM activities by central level UNICEF as a key partner has highighted in its annual Plan Of Action (POA) that the institution will provide non anti malaria medicines for village health services. Further to that, it will provide technical assistance to develop iCCM strategy, guidelines and protocols. In order to initaive discussion on this, NMCP has proposed stakeholders consultative meeting for July, 2018 when partners will meet to discuss the modalities and way forward for start of work on iCCM strategy development.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":749062}]
["Guinea-Bissau","12/31/2020","Malaria","FR370-GNB-M","Other module","10/30/2019","Other module","Western Africa","Active",null,"High","PAI-4318","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ76/view","88,039.5","88,039.5","Malaria Indicator Survey (MIS): This survey, which is carried out once every three years, provides the principal household indicators associated with all of the modules for the malaria control interventions. Bridge funding gap for the MIS 2020. The MIS will include the impact indicators relating to the mass distribution of LLINs, the SMC campaign and case management at community level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":88039.5}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Keeping girls in school","10/30/2019","Other module","Western Africa","Active",null,"Medium","PAI-4329","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7H/view","29,562.34","29,562.34","Monitor the activities of activists working in schools. This sum covers the allowances of the regional supervisors for the 3 years of the grant.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":29562.34}]
["Senegal",null,"Tuberculosis, RSSH","FR288-SEN-Z-01","Analysis, review and transparency","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"Medium","PAI-5523","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQX/view","80,326.56","80,326.56","Monitoring is a management tool that uses tracer indicators for each program to ensure regular monitoring of activities. This activity is financed within the allocation until 2020 due to lack of funding.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":80326.559999999998}]
["Guinea-Bissau","12/31/2020","Malaria","FR370-GNB-M","Other module","10/30/2019","Other module","Western Africa","Active",null,"Medium","PAI-4317","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ75/view","101,053.75","101,053.75","National Health Accounts. This process aims to improve the planning, the allocation of resources and the accountability of the Ministry for Public Health. By generating coherent and complete data regarding health expenditure, the NHA will contribute to the establishment of evidence-based policies in Guinea Bissau.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":101053.75}]
["Sierra Leone","6/30/2021","Tuberculosis, Malaria, RSSH","FR564-SLE-Z","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-5538","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQm/view","500,000","500,000","NLPT plans to scale-up the TB services in all prison by supporting the health facilities in the prisons to effectively identify and treat all cases of TB, TB-HIV co-infected and DR-TB cases, establishing TB/HIV screening on entry including capacity building, increase access to diagnostic facilities, improve screening among inmates, create awareness and also build a solid infection control model. The TB care in prisons will be also integrated into the national surveillance framework with proper disaggregation and support printing and updating of tools for correctional sites.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":500000}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Western Africa","Active",null,"High","PAI-4707","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDN/view","7,545,187","7,545,187","Nutritional support for adherence to treatment. Empirical evidence and program implementation experience have shown that good nutrition improves treatment outcomes for TB and HIV and AIDS, including increase in treatment uptake and retention in care. Considering most of these affected population fall below the poverty line, nutrition support is a necessary and imperative complementary TB-HIV intervention. Providing ART to patients is not only a good treatment strategy but is also an important strategy for preventing HIV infections, preventing opportunistic infections, and reducing AIDSrelated deaths (Treatment as Prevention strategy). It is expected that additional 2,499 in Yr1, 7,461 for Yr2 and 9,647 Yr3 will be placed on treatment. Once funded these additional persons will add to the numbers of people who positive and receiving ART to help in meeting the second 90% of the global target. Private sector is a significant service provider in some counties of Liberia. Private sector comprises NGO, faith based (not for profit), faith based (for profit), private sector (corporate social responsibility) and private sector (for profit). It is proposed to engage the private sector in Montserrado (around 20 facilities) in a more comprehensive way that cuts across many diseases and areas for health intervention including TB and HIV.1. Reviewing current partnerships: Undertake a comprehensive review of current partnerships with private providers in the health sector, which may include but not be limited to (a) outputs specifications, (b) pricing; (c) partner selection mechanisms, (d) contracting mechanisms, (e) management information system and monitoring mechanisms, (f) payment administration mechanisms, (g) fraud control measures; and (h) contract management capacity. The review shall be aimed at documenting the as-is process,identifying systemic gaps and challenges, assessing user and provider perceptions and perceptions of the government.2. Reviewing Service Package: Undertake an assessment of the services for which the private providers are currently being engaged.Some of the key questions that will be answered at this stage are: a. Are the current sets of services being offered through the private partners adequate? Is there a need to expand the service package through additionalproducts and services? b. Is there a willingness among the private sector to offer the entire service package through one-stop health kiosks; and if no, what are the services / products that can be clustered?3. Assessing Private Sector Readiness: Assess the readiness of the private sector to partner with the government including the scope and extent of partnership.4. Structuring Partnership Options: Based on the above assessment, identify options for engagement with the private sector in a social franchising model. The options may be generated based on role of the government, demand strategies, financing models and extent of risk sharing. Each option shall be assessed for its relevance with pros and cons allowing the government to make an informed choice.5. Drafting an Integrated Social FranchisingStrategy: Based on the options assessment outlined above, develop a draft integrated. Social Franchising Strategy which will include among other details institutional structures, systems and capacities required at different  levels to implement the strategy. The draft strategy will be discussed at the national level to seek inputs, align it with the health policy objectives of the Ministry and arrive at a consensus on other operational aspects including, but not limited to, who would be the holding agency within the Ministry.6. Set up a Centralized Facilitating Agency (CFA): The institutional structure could include a centralized facilitating agency for procurement, supply chain management, franchisee partner selection, standardization of processes, capacity building and monitoring. The CFA shall be recruited / appointed by the Ministry. For the pilot phase PSI may assume that role for quick implementation.7. Develop Standard Operating Procedures(SOP) for Operationalizing the Strategy: Develop a detailed SOP for operationalizing the strategy. The SOP shall among a range of other areas include guidelines on: a. interface between the National Drug Service, the CFA and other stakeholders b. inventory management c. supply chain management d. record management, MIS and reporting The SOP shall be approved by the Ministry.8. Partner identification and management: The CFA shall, as per the detailed SOP, identify a set of interested and eligible partners; enter into contracting arrangements with private partners as per the SOP of the SF Strategy.The CFA shall develop the capacity of the identified partners and will ensure that the partners start delivering the services as per the contracting arrangement. The CFA shall build capacity and assist in projecting quarterly inventory requirements for each facility and ensuring availability of supplies through the NDS. It shall also establish the MIS system that can be integrated with the DHIS2.9. The establishment of additional 50 ART sites to scale up care, treatment and support services.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":7545187}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","HIV care","10/30/2019","Treatment, care and support","Western Africa","Active",null,"High","PAI-4325","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7D/view","340,003.37","340,003.37","Nutritional support for people living with HIV. According to the vulnerability study carried out in December 2016, 23% of the patients on ART are malnourished. Therefore, this nutritional support forms an integral part of the optimum health care package for these patients. The amount requested will allow health care for 2,730 PLHIV for 180 days per year, in accordance with the specified inclusion criteria.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":340003.37}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Supportive policy and programmatic environment","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4705","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDL/view","1,060,304","1,060,304","Of the countrys total population of 4,148.567, Montserrado County accounts for 1,362,395 approximately 65% of Liberias entire population for FY 2017/2018 with a projected annual growth rate of 2.1%.  The MOH plans to contract-in with the Montserrado County Health Team to implement a differentiated service delivery approach to provide HIV, TB and Malaria prevention, care, and treatment service. With differentiated care, stable patients may receive key services in a community setting rather than in health facilities, enabling them to make less frequent visits to clinics and pharmacies. In addition to streamlining their care and making it more convenient, this approach will allow health workers to spend more time with less stable patients and those with advanced disease, increasing efficiency and improving quality of care. Services will be tailored for other groups with diverse needs, such as adolescents and young people, pregnant and breast-feeding women, mobile and migrant populations, and others. The goal is to place the client at the center of service delivery while maximizing health system efficiency.The expected outcomes will be a marked reduction in overcrowding at health facilities, reduction in wait times for patients, reduction in workload for clinicians, improvement in program quality such as increased retention rates, overall satisfactory patient outcome and public health goal, and improved supply chain performance.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1060304}]
["Senegal","12/31/2020","HIV/AIDS","FR556-SEN-H","Program and data quality","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-5508","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQI/view","118,960.83","118,960.83","One of the key challenges of the strategic plan is to improve data availability and quality. The DHIS 2 platform will therefore be strengthened through training and monitoring of system implementation within facilities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":118960.83}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4321","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ79/view",567.84,567.84,"Organize 3 data collection missions to inform the indicator on the 12-month survival rate for 2018, 2019 and 2020. The information for this indicator is taken from the GARP report.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":567.84}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Other module","10/30/2019","Other module","Western Africa","Active",null,"Medium","PAI-4328","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7G/view","44,344.07","44,344.07","Outreach activities for peer educators interurban drivers (SAB, GABU, BAFATA, CACHEU, OIO, QUINARA) during the 36-month allocation period. This activity will make it possible to ensure the quality of the data sent by the regions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":44344.07}]
["Senegal","12/31/2020","HIV/AIDS","FR556-SEN-H","Male and female condoms for other vulnerable populations","10/30/2019","Prevention programs for other vulnerable populations","Western Africa","Active",null,"High","PAI-5503","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQD/view","169,710.47","169,710.47","Owing to the prevalence rate (2 percent) among prisoners, the interventions cited under the allocation amount need to be strengthened. The aim is to strengthen prisoner access to prevention and treatment services by establishing a community-based system for screening for and treating HIV and introducing methadone substitution therapy to ensure continuity of care.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":169710.47}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other intervention(s) for PMTCT","10/30/2019","PMTCT","Western Africa","Active",null,"High","PAI-4709","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDP/view","108,014.41","108,014.41","Prevention of Mother-To-Child Transmission(PMTCT) has been prioritized in the NSP 2015 -2020 as a high impact intervention for clinical prevention of HIV infection aimed at achieving an HIV-free generation. Additional 75 PLHIV mothers will be trained in adherence support, prevention and tracing of lost to follow up, and psychosocial counselling to increase retention of mother-baby pairs in care. Although this is a priority intervention, it is placed in PAAR due to limited funding within allocation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":108014.41}]
["Guinea-Bissau","12/31/2020","Malaria","FR370-GNB-M","Other module","10/30/2019","Other module","Western Africa","Inactive",null,"High","PAI-4313","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ71/view","1,827,666.93",0,"Provision of integrated community case management.",0,0,"1,827,666.93",0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Guinea-Bissau","12/31/2020","Malaria","FR540-GNB-M","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Western Africa","Active",null,"High","PAI-4311","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6z/view","486,456.07","486,456.07","PSM: We are requesting 433,481 EUR for the new warehouse, in addition to the 628,002 EUR already approved by the TRP in Nov 2017, bringing the total PAAR UQD for PSM storage and distribution to 1,061,483 EUR.Almost 50% of Global Fund NFC grants in Guinea Bissau consist of medical supplies and commodities. The GF Risk Matrix Action Plan identified numerous PSM distribution and storage issues during a review in 2016-2017.  The TRP approved 628,002 EUR for additional supply chain monitors (to trace GF funded medical supplies to end user level) and international technical assistance for the national medical stores-CECOME.As part of the reprogramming of the NFM M grant, GF authorized UNDP to purchase a Warehouse In a Box (WIB) from WFP, to replace the existing warehouse which had several fires in the last 3 years due to improper construction (frail walls, insufficient ventilation, electrical wires for air conditioners of 1.5 mm instead of 3 mms, etc). To assemble and construct a fully operational WIB would require 1.4 m EUR - breakdown provided.The existing NFC M grant has 0.4 m EUR in funding for the new warehouse, sufficient to cover the design, construction of the base and assembly of the WIB. We anticipate having savings from PSM purchases in the amount of 0.5 m EUR (which will cover the walls, insulation, multifold doors, air conditioners, and machine equipment). This leaves a gap of 433,481 EUR (for the racking, solar pannels, Warehouse Information System hardware, UNDP GMS, etc.), which is being requested now.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":486456.07}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Private sector case management","10/30/2019","Case management","Western Africa","Active",null,"High","PAI-4697","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDD/view","40,000","40,000","Quarterly Feedback Meeting PSACT implementation together to provide feedback about the program. The meeting will seek to understand the impression of the proprietors of the program and get feedback on the community reaction to the testing and treatment as well as the overall program. Also the forum will be used to provide feedback to proprietors on their performance and adherence to the program rules as well as recognize best practice pharmaceutical outlets to engender competition among the proprietors. The forum will also be used to identify pharmaceutical outlets that are noncompliant and depending on the degree of noncompliance inform them on the actions that will be taken on the non-compliant proprietor. This will further improve the quality of the PSACT program.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":40000}]
["Guinea-Bissau","12/31/2020","Malaria","FR370-GNB-M","Other module","10/30/2019","Other module","Western Africa","Inactive",null,"High","PAI-4316","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ74/view","393,804.29",0,"Real Time Monitoring (RTM) to improve the collection of HMIS data, the timeliness and completeness of reports and the analysis and performance of actions for improvement at all levels for all of the health programs via the DHIS2. This will involve the use of an interface between the data production site and the DHIS2 at regional level in order to allow the latter to be provided with data concerning malaria and other health programs from 137 sites in real time. An automated feedback system will enable decisions to be made with regard to the quality of data at the site.",0,0,"393,804.29",0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Other module","10/30/2019","Other module","Western Africa","Active",null,"High","PAI-4338","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7Q/view","201,997.53","201,997.53","Recruit an international laboratory specialist to strengthen the capacities of the Directorate for Pharmaceutical, Laboratory and Drug Services/Ministry for Public Health and the National Health Institute [INASA] to draw up regulatory documents for the laboratory system.  In addition, the specialist will contribute to improving the quality of the laboratory services involved in health care for the three diseases.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":201997.53}]
["Sierra Leone","6/30/2021","Tuberculosis, Malaria, RSSH","FR564-SLE-Z","Case detection and diagnosis","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-5540","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQo/view","1,500,000","1,500,000","Resources are needed for the following activities to upgrades CHCs to TB diagnostic sites: training of health care workers, training of microscopists, procurement of consumables and sputum containers , orientation of DHMT & local councils on the implementation of universal access for TB care, support six monthly min-campaign/sensitization  at slum and hard to reach areas, printing  of Xpert tools , support specimen transportation to lakka and SRL, support printing of registers and monitoring tools for district activities, dissemination of Xpert tools, and support international training of staff and study tours.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1500000}]
["Sierra Leone","6/30/2021","Tuberculosis, Malaria, RSSH","FR564-SLE-Z","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Western Africa","Active",null,"High","PAI-5543","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQr/view","400,000","400,000","Resources are needed to strengthen the TB programme management at district level through supporting monthly DHMT meetings, support DHMT supportive supervisions to PHUs and office supplies (stationary and communication).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":400000}]
["Senegal",null,"Tuberculosis, RSSH","FR288-SEN-Z-01","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"Medium","PAI-5526","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQa/view","106,480.75","106,480.75","ScalingScaling up case-finding requires improvements in the   capacity   and   quality   of   the   microscopy network. The  following  activities  are  proposed: Purchase  of microscopes  for  regional laboratories; Training of service providers; Supervision and quality assurance. This additional financing should ensure the improved effectiveness of TB screening. up case-finding requires improvements in the   capacity   and   quality   of   the   microscopy network.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":106480.75}]
["Senegal","12/31/2020","Malaria","FR559-SEN-M","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Western Africa","Active",null,"High","PAI-5511","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQL/view","1,194,317.14","1,194,317.14","Senegal and the Gambia have undertaken cross-border activities to strengthen the malaria response along their shared borders.Identifying gaps has enabled relevant activities in several response areas to be highlighted.Part of the total cost for the identified activities will be funded under the New Funding Model 2 (NFM2); the rest (3,800,678) will be requested under above allocation funding.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1194317.1399999999}]
["Senegal","12/31/2020","Malaria","FR559-SEN-M","Policy, planning, coordination and management of national disease control programs","10/30/2019","Program management","Western Africa","Active",null,"Medium","PAI-5512","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQM/view","3,070,836.05","3,070,836.05","Senegal and the Gambia have undertaken cross-border activities to strengthen the malaria response along their shared borders.Identifying gaps has enabled relevant activities in several response areas to be highlighted.Part of the total cost for the identified activities will be funded under the New Funding Model 2 (NFM2); the rest (3,800,678) will be requested under above allocation funding.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3070836.05}]
["Gambia","6/30/2021","Malaria","FR549-GMB-M","Policy, planning, coordination and management of national disease control programs","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"Low","PAI-4308","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6w/view","68,247","68,247","Sharing and learning best practices from other countries in orher regions that are in elimination phase will help design specific and innovative approaches to malaria elimination. The program intends to  embark on study tour to either any West, East African or middle east country where malaria is eliminated or on the verge of elimination. The amount of US$ 68,247 is requested in PAAR to cover these expenses.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":68247}]
["Sierra Leone","6/30/2021","Tuberculosis, Malaria, RSSH","FR564-SLE-Z","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Western Africa","Active",null,"High","PAI-5537","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQl/view","560,000","560,000","Sierra Leone adopted the following three regimen design options for the management of MDR-TB: (i)Shorter regimen with Amikacin: 4-6 Am-Mfx-Pto-Cfz-Z-high-dose H-E/5 Mfx-Cfz-Z-E; (ii) Modified shorter regimen under operational research, oral regimen: 9 Lfx-Bdq-Lzd-Cfz-Z; and (iii)  Fully oral longer regimen: 18 Lfx-Bdq-Lzd-Cfz-Z. The second regimen - modified shorter regimen, is expected to be implemented under operational research. In this regard, additional funding is needed for clinical training for health care workers; pharmacovigilance training; patient care including monitoring tests and patient support; technical assistance missions to support the development of protocol and its implementation; data management, documentation and dissemination of results.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":560000}]
["Sierra Leone","12/31/2020","HIV/AIDS","FR474-SLE-H","Prong 3: Preventing vertical HIV transmission","10/30/2019","PMTCT","Western Africa","Active",null,"High","PAI-5528","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQc/view","1,055,356","1,055,356","Sierra Leone has adopted a dual HIV-Syphilis testing protocol for pregnant women during ANC. Within the allocation amount, the country will scale up the dual testing to cover 181,766 pregnant women per year (545,300 total across 3 years) in 691 health facilities (60% of the estimated number of pregnant women).The PAAR will be utilized to procure DUO HIV/syphilis test kits to cover all pregnant women in the country.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1055356}]
["Guinea","12/31/2020","Tuberculosis","FR260-GIN-T","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Western Africa","Active",null,"High","PAI-4299","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6n/view","34,182","34,182","Six-monthly meetings of the national and regional TB/HIV committees; joint, half-yearly supervisory visits.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":34182}]
["Guinea-Bissau","12/31/2020","Malaria","FR540-GNB-M","Seasonal malaria chemoprevention","10/30/2019","Specific prevention interventions (SPI)","Western Africa","Active",null,"High","PAI-4309","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6x/view","587,681.52","587,681.52","SMC was initiated in Guinea Bissau in 2016 by the MOH in partnership with MSF, UNDP and AIFO covering 50% of the Bafata Region (7 of 14 ADS = Area de Saud = Health Districts) and 74% of the Gabu region (14 of 19 ADS).  Over 85% (37,379 / 43,715) children aged 3-59 months in the 21 ADS received at least 1 dose of SMC. In 2017, SMC was expanded to geographically cover 100% of the 2 high malaria prevalence regions. Over 99% of 83,667 children received at least 1 dose, 82% received 3 doses and 61% of children received 4 doses, with a high level of acceptability and tolerance by the community. WHO recommends an SMC coverage with 3 to 4 doses for an effective impact. It is essential to maintain SMC in these regions to ensure a sustainable impact of the intervention.The operational costs for SMC have been significantly reduced by changing the strategy from Fixed Point to Door to Door. In 2019 and 2020 the MOH has planned the SMC campaigns to be implemented without International NGOs only by regional health departments, further reducing costs. Despite these efforts the country has a gap of 523,683 EUR for SMC operational costs, including UNDP GMS.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":587681.52}]
["Niger","12/31/2020","Malaria","FR504-NER-M","Seasonal malaria chemoprevention","10/30/2019","Specific prevention interventions (SPI)","Western Africa","Inactive",null,"High","PAI-5256","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJME/view","10,000,000",0,"SMC will be scaled up to cover all children aged 3-59 months across all eligible districts in Niger from 2018 onwards. Several partners (Global Fund, World Bank, UNICEF and Presidents Malaria Initiative (PMI)) support this intervention, covering both supplies and implementation costs. The funding requested here is aiming to cover the gaps currently not funded in 2019 and 2020.",0,"5,000,000",0,"5,000,000",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Senegal",null,"Tuberculosis, RSSH","FR288-SEN-Z-01","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-5518","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQS/view","1,683,312.76","1,683,312.76","Some community management activities are already included in the grant, however  due to limited funding - this additional  investment  proposes  scaling  up community  activities  (increased  home  visits  to find  contacts,  informal  discussions,  systematic sampling  in  hard-to-reach  areas,  increased awareness-raising in crossborder areas, etc.) and expanding  the  network of CBOs involved in TB.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1683312.76}]
["Guinea-Bissau","12/31/2020","Malaria","FR370-GNB-M","Other module","10/30/2019","Other module","Western Africa","Active",null,"High","PAI-4315","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ73/view","704,749.19","704,749.19","Strengthening of the supply chain management system. It is essential that a strict monitoring system and dedicated technical assistance are put in place to guarantee the rational use of the drugs and health products provided under the three grants. The direct collection of information regarding consumption in real time as well as on-the-job training provide additional safeguards for the national PSM system.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":704749.19}]
["Guinea-Bissau","12/31/2020","Malaria","FR370-GNB-M","Other vector control measure(s)","10/30/2019","Vector control","Western Africa","Active",null,"High","PAI-4314","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ72/view","501,290.54","501,290.54","Targeted vector control on the regions of Bijagos and Bolama (islands), which present the highest incidence rates. A project  is currently being developed, which aims to reduce this rate to less than 7.6 per 100,000 inhabitants.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":501290.54}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Western Africa","Active",null,"Medium","PAI-4715","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDV/view","792,000","792,000","TB increases the risk of HIV infection and vice versa, and TB is the leading cause of death among HIV patients. AIDS is a major cause of death among TB patients. About 16% of TB patients are co-infected with HIV. Joint HIV and TB collaborative activities produce better and improved outcomes for both TB and HIV programs and in patients co-infected with HIV and TB. This PAAR investment is intended to strengthen TB HIV integration at the subnational, particularly at health facility and community levels.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":792000}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR541-GNB-C","Laboratory systems for disease prevention, control, treatment and disease surveillance","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4335","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7N/view","743,538.91","743,538.91","Thanks to the NFM TB grant, a new TB reference laboratory has been built. In order to render it functional, a negative-pressure system must be installed (to respect the bio-safety norms) and a few other corrections must be made (Mechanical and Civil Budgets costs of NTRL Guinea Bissau, WHO Expert Mission - Appendix B). For this reason, the WHO hired an international expert to perform an evaluation and implementation of his recommendations will require the requested amounts.Once this laboratory is functional, it will be used to perform the necessary exams to fight tuberculosis including the multi-resistant version. The agents will work there under optimum bio-safety conditions.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":743538.91}]
["Niger","12/31/2020","Malaria","FR504-NER-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Western Africa","Active",null,"High","PAI-5258","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMG/view","15,732,507.01","2,455,543.01","The 2018 LLIN campaign only covers 12 hyperendemic health districts in Maradi, Tahoua and Zinder regions because of a funding shortfall. Niger is planning to run a mass campaign in 2019, covering the 18 mesoendemic districts (7,538,350 people) omitted in 2018, in order to avoid adversely affecting the outcomes and to maintain the campaign cycle.",0,0,0,"13,276,964",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2455543.0099999998}]
["Senegal","12/31/2020","HIV/AIDS","FR556-SEN-H","Other intervention(s) for general population","10/30/2019","Prevention programs for general population","Western Africa","Active",null,"High","PAI-5502","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQC/view","439,236.9","439,236.9","The analysis of the cohort of children and adolescents monitored showed a high failure rate, mainly due to limited access to treatment services (owing, for the most part, to the cost of transport and medical expenses), failure to inform adolescents of their HIV status, inadequacy of the treatment adherence support program and limited access to viral load testing. At the same time, there is a lack of support for health care providers at the decentralized level. The plan is therefore to develop a support program for adolescents who have been informed of their HIV status, strengthen ART adherence among children, establish treatment follow-up committees, strengthen coaching for decentralized facilities, subsidize treatment and transport costs for children attending facilities for follow-up, and help establish a national pediatric cohort.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":439236.9}]
["Guinea","12/31/2020","Tuberculosis","FR260-GIN-T","Other TB/HIV intervention(s)","10/30/2019","TB/HIV","Western Africa","Active",null,"High","PAI-4300","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6o/view","112,552","112,552","The annual training of 30 medical clinicians in the interpreting of pulmonary X-rays. The purchase of a second mobile digital X-ray machine, in order to successfully implement the active testing campaigns at locations characterised by a high prevalence of TB and HIV. Impact: an increase in testing within the risk groups, especially PLHIVs and children.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":112552}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4695","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDB/view","157,890","157,890","The cost is to cover the training of the District Health Officers in the 14 counties except Montserrado in Monitoring and Evaluation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":157890}]
["Senegal","12/31/2020","Malaria","FR559-SEN-M","Seasonal malaria chemoprevention","10/30/2019","Specific prevention interventions (SPI)","Western Africa","Active",null,"High","PAI-5517","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQR/view","1,853,322.86","1,853,322.86","The cost of drugs for the 60120 month target age group for 2019 is 334,251 and operational costs for both target age groups are 1,317,245 euros; for 2020 the cost of drugs for the 60120 month target age group is 343,276 and operational costs for both target age groups are 1,358,520.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1853322.86}]
["Senegal","12/31/2020","Malaria","FR559-SEN-M","Seasonal malaria chemoprevention","10/30/2019","Specific prevention interventions (SPI)","Western Africa","Active",null,"Medium","PAI-5516","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQQ/view","1,909,769.95","1,909,769.95","The cost of drugs for the 60120 month target age group for 2019 is 334,251 and operational costs for both target age groups are 1,317,245 euros; for 2020 the cost of drugs for the 60120 month target age group is 343,276 and operational costs for both target age groups are 1,358,520.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1909769.95}]
["Senegal","12/31/2020","HIV/AIDS","FR556-SEN-H","HIV care","10/30/2019","Treatment, care and support","Western Africa","Active",null,"High","PAI-5504","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQE/view","307,942.99","307,942.99","The costs associated with medical checkups are one of the obstacles to treatment adherence among PLHIV.  In addition to the PLHIV enrolled in the national UMC policy, support will be provided to 7,500 PLHIV to improve patient retention.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":307942.99}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR541-GNB-C","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4336","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7O/view","134,037.71","134,037.71","The country deployed significant efforts to obtain data on the key and vulnerable populations obtained from the various bio-behavioral studies. The country is asking for financial support in the amount of 25,460 euros to perform the in-depth epidemiological analyses using all the data collected over the past 2 years (Budget for an HIV Epidemiological Review - Appendix 9). The results of this analysis will help us to better understand the epidemics decisive factors in these groups and also in the general population and this will help to define better strategies for an effective and efficient national strategy.In addition, in order to understand the source of these new infections, we wish to perform a study of the HIV transmission dynamics within our country and this will cost 72,583 euros (HIV Transmission Dynamics Study Budget - Appendix 10).In order to evaluate the quality of the HIV health care, we also would like to perform a study of the retention of PLHIV, who are undergoing treatment, at 12, 24, and 36 months, for a total cost of 21,398 euros for 2019 and 2020. (PLHIV Under-Going Treatment Retention Study Budget - Appendix 11).",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":134037.71}]
["Senegal",null,"Tuberculosis, RSSH","FR288-SEN-Z-01","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"Medium","PAI-5525","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQZ/view","1,122,208.51","1,122,208.51","The country has never undertaken a national TB prevalence survey. Such a survey would enable better knowledge to be gained of the epidemiological context and help orient the response more toward interventions that will have the maximum impact.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1122208.51}]
["Guinea","12/31/2020","Tuberculosis","FR260-GIN-T","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4302","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6q/view","195,636","195,636","The DPSs will supervise activities relating to the combating of TB in the CDTs and Health Centres within their catchment zones.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":195636}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-4710","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDQ/view","955,307.43","955,307.43","The epidemiology of the disease indicates low case notification, low case detection rate, low treatment success rate, underreporting of childhood TB, and high lost-to-follow-up are challenges of the program that will be addressed by this investment. This intervention will strengthen TB-HIV collaborative activities particularly prevention and reduction of TB morbidity and mortality in PLHIV. This investment will strengthen diagnostic capacity, sample transportation, community engagement, nutritional support for in-patient feeding, data quality training and subnational level capacity for program management. Strengthening lab services in GeneXpert sites will increase uptake and case detection and diagnosis. This intervention is a national priority but this amount is placed in PAAR due to limited funding within Allocation. This intervention also complements the investment within allocation for this module.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":955307.43}]
["Sierra Leone","12/31/2020","HIV/AIDS","FR474-SLE-H","Differentiated ART service delivery","10/30/2019","Treatment, care and support","Western Africa","Active",null,"High","PAI-5527","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQb/view","3,936,056","3,936,056","The grant has ART targets respectively at 46%, 52% and 56% of PLHIVs for  2018, 2019 and 2020, which the current funding landscape cannot meet. With the PAAR funding the country will correspondingly increase the ART to reach these targets.Key activities will include: Procurement of ARVs and drugs for treatment of OIs. Strengthen the quality of services in the existing 156 ART facilities country.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3936056}]
["Senegal","12/31/2020","HIV/AIDS","FR556-SEN-H","Other intervention(s) for people in prisons and other closed settings","10/30/2019","Prevention programs for other vulnerable populations","Western Africa","Active",null,"High","PAI-5501","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQB/view","118,776.79","118,776.79","The low overall HIV prevalence of 0.5 percent conceals differences between certain vulnerable groups, where prevalence can be up to three or four times the national average. This is the case for people living with disabilities (1.9 percent). Strategies funded with the allocated funds do not adequately address these targets. Plans have therefore been made to strengthen strategies to reduce risky behaviors by offering a capacity-building program for 975 health care providers and people living with disabilities, and to improve access to information, education, and prevention, care and treatment services for people living with disabilities by making tools to support health care providers and communities available.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":118776.79}]
["Niger","12/31/2020","Malaria","FR504-NER-M","Long-lasting insecticidal nets (LLIN) - Mass campaign","10/30/2019","Vector control","Western Africa","Active",null,"High","PAI-5257","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMF/view","15,027,252.83","840,690.83","The mass LLIN distribution campaign has been implemented on a cyclical basis in the seven eligible regions of Niger.  In 2017 LLINs were distributed in the hyper/mesoendemic districts in Diffa, Dosso and Tillabri regions. These same districts (7,200,422 people) will need to be included in the 2020 distribution campaign in order to comply with the WHO recommendations on universal access and the three-year distribution cycle.",0,0,0,"14,186,562",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":840690.83}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4691","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD7/view","742,905","742,905","The matching funds requested to support integrated service delivery, seek to focus on investments in the platform for serviced delivery and strengthening clinical systems for integrated screening, diagnosis, and care, in-service skills building of clinicians to be able to deliver both TB and HIV services including management of late-stage HIV infection, and capacitating the community platform for support of TB treatment adherence and HIV supportive care.  The proposed site for initial intervention through matching fund investments is Liberias national referral facility for TB  The TB Annex, based in Monrovia. As the countrys national referral center for TB services, all forms of TB including management of TB and co-morbidities like diabetes, DR-TB, and TB/HIV co-infection are managed at the facility, where integrated service delivery can serve as a model to further scale this approach at all levels from primary care through hospital-based treatment, at the county and regional levels.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":742905}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Supply chain infrastructure and development of tools","10/30/2019","RSSH: Procurement and supply chain management systems","Western Africa","Active",null,"Medium","PAI-4687","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD3/view","635,000","635,000","The MOH is working towards a transition to the new warehouse. Funding request is for building additional office space for the essential CMS staff.  The total estimated cost for the office building is set at $882,500. Out of this amount, the MOH has internally mobilized $200,000.00 and have also secured a $50,000.00 commitment from GAVI against the cost of the building. This leaves a balance of $632,500.00 to be sourced through external partners, including the Global Fund.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":635000}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Entomological monitoring","10/30/2019","Vector control","Western Africa","Active",null,"High","PAI-4685","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD1/view","39,990","39,990","The Mount Coffee Project (MCP) aims to rehabilitate a hydropower plant in order to provide electricity to Monrovia, Montserrado County, Liberia. It is located on the St. Paul River, approximately 27 km (17 miles) northeast of Monrovia. The reservoir of the plant covers a large flooded area where 15 rural communities are located. To assess an eventual impact of the reservoir on mosquitos proliferation, the NMCP intends to conduct preliminary vector monitoring in some sites around the reservoir, and assess the level of malaria transmission in villages located in and around the hydropower reservoir. Pyrethrum Spray Collection (PSC) will be used to determine the indoor resting density of malaria vectors and how this varies per village. CDC Light Traps light traps will be used to determine the nocturnal species composition and abundance of both indoor and outdoor mosquitoes in the 5 villages.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":39990}]
["Sierra Leone","6/30/2021","Tuberculosis, Malaria, RSSH","FR564-SLE-Z","Community TB care delivery","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-5539","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQn/view","120,000","120,000","The NLTP has trained and deployed about 1500 CHWs to strengthen the community-based TB prevention and care activities. Provision of Bicycles for each CHW is part of the package and 750 bicycles were procured under the current grant. The additional funds will serve for the remaining 750 bicycles to support the CHWs activities. In addition biannual CHWs meetings at national level to monitor the implementation integrated TB and HIV CHW program will be conducted.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":120000}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other intervention(s) for general population","10/30/2019","Prevention programs for general population","Western Africa","Active",null,"Low","PAI-4708","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDO/view","1,331,889","1,331,889","The non-clinical prevention of HIV is prioritized in the NSP 2015  2020. Liberia has generalized HIV epidemic with a prevalence rate of 2.1% (LDHS 2013), an increase from 1.6% (LDHS 2007). Correct and consistent use of condoms has been proven to prevent sexually transmitted infections including HIV, in addition to preventing unintended pregnancies in young women and HIV positive women. About 339,094,404 condoms (335,431,024 male condoms and 3,663,380 female condoms) including socially marketed condoms distributed by 2020. Condoms and lubricants readily available to reduce the risk of transmission. Know Your Status Campaign  To jump start the number of people who know their HIV status, currently a Know Your Status (KYS) is being implemented in 2017. It is proposed to continue the campaign in 2018 through mid-2019. It is proposed to target 602,262 contacts in the counties of Montserrado, Margibi and Grand Bassa. The campaign will end by not later than June 2019. Each contact is provided with basic HIV and AIDS messages and an option to collect a voucher so as to get tested for HIV at the nearest public health facility. No geographical area is repeated with messages as far as possible. The campaign targets young males and females in the age of 16 years to 35 years. Messages on the radio are also broadcast in these counties motivating people to approach the nearest public health facility for HIV testing. Social marketing of branded condoms  Liberia over the years has built a very strong social marketed brand of condoms. Community outreach, radio jingles, star party hours and other promotional events have been used to popularize the brand. In 2016 the branded condoms sold a total of 1,009,920 pieces, that translates into 3,862 DALY and 2,157 CYP. Currently the branded condom recovers 108% of cost of goods sold and returns it back to Global Fund. The branded condom is targeted at young population who can afford to pay for the condom. The focus for sales though national is more targeted towards Montserrado, Margibi and Grand Bassa. This program is likely to become sustainable over period of time. Approximately 4,032,989 pieces of branded condoms are expected to be sold between 2018 and 2020. This intervention is a national priority but this amount is placed in PAAR due to limited funding within Allocation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1331889}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other intervention(s) for adolescent and youth","10/30/2019","Prevention programs for adolescents and youth, in and out of school","Western Africa","Active",null,"Low","PAI-4716","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDW/view","295,775","295,775","The NSP 2015  2020 and the National HIV Prevention Strategy 2017  2020 prioritize high impact HIV prevention interventions for adolescents and youths in and out of school. HIV prevalence in young people has increased from 1.1% (young women, 1.6%; and young men, 0.5%) in 2007 to 1.8% (LDHS 2007 & 2013). A total of 823,777 youth and adolescents reached with targeted HIV prevention messages in the six counties in 2018; 841,073 in 2019; and 858,736 in 2020. A total of 120 peer educators trained in HIV prevention for in-and-out-of-school youth and adolescents. The investment for ART will be leveraged to provide treatment and care for positive PLHIV identified among targeted adolescents and youth.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":295775}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Improving service delivery infrastructure","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4688","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD4/view","89,772","89,772","The perfect functioning of the GeneXpert machine will support the case detection of Multi Drug Resistance (MDR/RIF) cases.  All the Genexpert machines warranty will expire in 2019. Therefore. updating the warranty of these machines will ensure perfect mantiance by Chepid for the following reasons: module replacement and fan replacement. If there is a major problem on a machine with the updated warranty, Chepid can be replace the machine at no cost.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":89772}]
["Guinea-Bissau","12/31/2020","Malaria","FR540-GNB-M","Grant management","10/30/2019","Program management","Western Africa","Active",null,"Medium","PAI-4312","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ70/view","112,438.56","112,438.56","The previous PAAR proposal did not contain the 7% UNDP GMS (overhead). The 100k EUR amount includes the 7% for all previous TRP approved activities.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":112438.56}]
["Guinea","12/31/2020","Tuberculosis","FR260-GIN-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-4295","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6j/view","480,000","480,000","The renovation of the LNRM planned for 2017 will not include upgrading it to bring it into compliance with the biosecurity standards. Cost in USD, based on a quotation.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":480000}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Supportive policy and programmatic environment","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4700","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDG/view","3,506,474","3,256,257","The request amount in this cost category and intervention aimes to ensur community health workforce retention. It includes: 3 years of monthly compensation/salary for 110 CHAs and 11 CHSS for 2 additional districts in Margibi (a priority national ICCM gap) 3 years of monthly compensation/salary for 202 CHAs and 23 CHSS for Lofa county (3 districts) with gap in the implementation of the Revised National Community Health Policy in Liberia.  The Revised National Community Health Policy requires payment of the monthly compensation of US$70 per CHA and US$269 per CHSS working in counties included in this activity.",0,"250,217",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":3256257}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Supportive policy and programmatic environment","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4701","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDH/view","5,253,702","5,253,702","The request amount in this cost category and intervention aimes to ensur community health workforce retention. It includes: 3 years of monthly compensation/salary for 252 CHAs and  26 CHSS for 4 additional districts in Grand Bassa (a priority national ICCM gap) 3 years of monthly compensation/salary for 355 CHAs and 36 CHSS for 4 additional districts in Bong (a priority national ICCM gap)",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":5253702}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Facility-based treatment","10/30/2019","Case management","Western Africa","Active",null,"High","PAI-4689","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD5/view","1,482,080","1,482,080","The request amount is intended to improve targeted health facilities for better provision of malaria, HIV and TB services aimed at improving maternal and child health services for increased mother and child survival. Adopting a facility shall include the provision of relevant equipment as per targeted health facility type, upgrading some existing health facility for improved capacity, strengthen emergency, preparedness and response.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1482080}]
["Liberia","12/31/2020","HIV/AIDS, Tuberculosis","FR191-LBR-C","Other MDR-TB intervention(s)","10/30/2019","MDR-TB","Western Africa","Active",null,"High","PAI-4711","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDR/view","706,580.57","350,000.57","The supply of drugs, lab consumables and reagents for culture and DST and AFB microscopy and PSM cost for year 3. A year Technical Assistance for decentralization of services, assessment, and training on Infection Control. Though these interventions are priorities for the program, they are placed in PAAR due to limited funding within allocation. This intervention also complements the investment within allocation for this module.",0,0,0,0,"356,580",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":350000.57}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR541-GNB-C","HIV care","10/30/2019","Treatment, care and support","Western Africa","Inactive",null,"High","PAI-4319","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ77/view","1,082,666.11",0,"The TB/HIV/HSS performance framework foresees that 12,000 patients will be treated with ARVs in 2018, 13,000 in 2019, and 14,000 in 2020. Nevertheless, in the PUDR, as at 31 December 2017, 11,985 ARV-treated patients had been monitored, which represents 99.8% of the 2018 target. This situation presents a risk of premature stock-outs of ARVs with the inclusion of a significant number of patients not being specified in the approved quantification.Also, it is important to consider the fact that the country is under a treat everyone strategy which requires the testing of persons within the general population as well as the priority populations included in the quantification. In fact, the historical data for 2013 to 2017 reveals that, since 2013, the ARV coverage is low as it was less than one-third of what was required due to, among other things, insufficient access to testing and problems with retaining the patients. Nevertheless, over that same period, there was an increase in the proportion of patients on ART from 16% to 28%. Notwithstanding this growth, beginning in 2018, and considering the budgetary constraints, the country has been obliged to adjust its patient cohort targets to match the available funds, i.e., 27.6% in 2018, 29.3% in 2019, and 31.1% in 2020, with respect to the requirements estimated by Spectrum 2018 and in contrast with the NSP targets for the same years, of 66%, 78%, and 90%. Considering the number of ART patients as at 30 June 2018 (13,103), as well as the capacity of the current health structures, the country decided to increase the performance framework targets approved under the current grant to 14,035, 16,063, and 18,080 (PLHIV on ART) for 2018, 2019, and 2020, respectively. In fact, for the purpose of health care decentralization and delegation of tasks, 24 treatment centers and 118 outpatient treatment units (former PMTCT sites) initiated ART. In addition, the Differentiated Approach for Services includes community ART and this will help to reinforce the enrolment capacity and retention of HIV+ patients within the health care circuit. As a result of these new targets, additional purchases of ARV drugs are required in order to treat 2,035, 3,063, and 4,080 patients, respectively, which represents 16.9% in 2018, 23.6% in 2019, and 29.1% in 2020. The purpose of the requested amount is to avoid a stock-out in the ARV treatment of patients and to facilitate the treatment of persons who test positive under the coverage plan with a 90-90-90 strategy.",0,0,0,"1,082,666.11",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Sierra Leone","12/31/2020","HIV/AIDS","FR474-SLE-H","Differentiated HIV testing services","10/30/2019","HIV Testing Services","Western Africa","Active",null,"High","PAI-5530","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQe/view","505,000","505,000","The total targeted testing need is 913,700 in 2018, 1,011,543 in 2019 and 1,115,506 in 2020.The in-allocation budget covers 620,843 in 2018, 682,972 in 2019 and 751,220 in 2020 respectively. Testing interventions are focused on key and vulnerable populations conducted through static clinics and outreaches.The PAAR will support pilot study among key populations and discordant couples on self-testing to cover 5%of PF target for MSMs and PWID and 2% of PF target for FSW for 2018-2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":505000}]
["Sierra Leone","6/30/2021","Tuberculosis, Malaria, RSSH","FR564-SLE-Z","Treatment: MDR-TB","10/30/2019","MDR-TB","Western Africa","Active",null,"High","PAI-5536","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQk/view","600,000","600,000","The treatment of MDR-TB is highly centralized in Lakka government hospital. The program is planning to decentralize the programmatic management of drug resistant and needs funding for capacity building training on PMDT, technical monitoring missions, development of tools for PMDT, allowances and transport for PMDT nurses, adaptation and printing of PMDT tools, quarterly and annual monitoring meetings, advocacy and sensitization activities. In the phase of scale-up of Gene Xpert testing, more MDR-TB cases are expected to be notified and the request additional funding will enable the programme to meet the target of enrolling all detected RR/MDR-TB.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":600000}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR541-GNB-C","Other service delivery intervention(s)","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Inactive",null,"High","PAI-4334","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7M/view","240,542.03",0,"The TRP has encouraged the country to develop a plan to improve the continuity of HIV health care, i.e., the detection of cases not diagnosed with HIV, the enrolment of these persons in a health care program, a monitoring of the annual viral load for PLHIV who receive ART as well as the retention and re-mobilization of those who are no longer monitored, based on the use of differentiated service models.In response to this suggestion, this plan was developed and the amount of 214,347 euros would allow to cover the financial gap, since it is unclear whether the necessary savings can be made in order to implement it based on the resources of the current grant.This budget concerns activities without which the objectives of the plan cannot be attained. It concerns the fees associated with: i) technical assistance to develop the various documents (differentiated health care guide) and assistance with the plans implementation; ii) the 44 outpatient treatment units operations, iii) the sample transportation circuit operations; iv) the training of the various players in the differentiated approach plans various aspects (Drafting of the HIV Services Differentiated Approach Plan - Appendix 6).",0,0,0,"240,542.03",0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":0}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4699","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDF/view","768,000","704,110","The vehicles and motorbikes, being requested, will support quarterly field visits, Joint Support Supervisions, Last Mile Delivery of commodities, Surveys, etc... The benefits of the planned procurement are: i. To increase the number of vehicles, thus assisting the PR to improve its programmatic performance; ii. Supporting the PR in reducing the cost of vehicle rental, thus allowing unspent funds to be reprogrammed for service delivery activities. iii. Improved operational efficiency, through the replacement of vehicles which have already be retained longer than the five years period.   Currently, there are limited number of vehicles to conduct program activities and the PR has to rent additional vehicles to support program activities. An analysis was done which demonstrates that procuring the vehicles represents better value for money than rental in the current vehicle market. The rationale to buy vs renting is entirely to ensure value for money and long term sustainability.",0,"63,890",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":704110}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Supportive policy and programmatic environment","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4704","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDK/view","791,700","791,700","This activity is meant to provide technical assistance at district level in the form of one Quality Assurance Officer (QAO) for each of the 33 districts in River Gee, Sinoe, Maryland, Grand Kru, Gbarpolu counties to support NCHA Program implementation, supervision, monitoring, and documentation",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":791700}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Grant management","10/30/2019","Program management","Western Africa","Active",null,"High","PAI-4692","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD8/view","91,440","91,440","This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria during the 2021 Mass Distribution Campaign. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":91440}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Integrated community case management (ICCM)","10/30/2019","Case management","Western Africa","Active",null,"High","PAI-4683","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCz/view","964,634","916,854","This activity is to increase community involvement and participation in the implementation of the Revised Community Health policy in Liberia and it is part of the policy requirement to work with the Health Facility Development Committees (HFDC) in Community Health program or integrated community case management (iCCM) interventions.  The HFDCs are representatives of the communities in the catchment of the health facilities. These HFDC are the linkage between communities and health facilities and will provide support to the CHAs and TTM by promoting the work of the TTM and CHAs, and the health facilities.",0,"47,780",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":916854}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Supportive policy and programmatic environment","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4702","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDI/view","144,000","144,000","This activity provides dedicated management support to the CHSD (Community health services division) via an international TA which would work together with CHSD on topics such as: NCHA program financing sustainability, resource mapping and coordination, NCHA program management.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":144000}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Supportive policy and programmatic environment","10/30/2019","RSSH: Integrated service delivery and quality improvement","Western Africa","Active",null,"High","PAI-4703","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDJ/view","177,627","177,627","This activity supports CHC (County Health Committees) and Health Facility Development Committees (HFDC) first meeting and orientation across the full country (where the NCHAP is present). Once the orientation will be completed, it is expected that CHC and HFDC meetings will happen regularly, as per NCHAP policy.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":177627}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Grant management","10/30/2019","Program management","Western Africa","Active",null,"High","PAI-4693","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD9/view","56,100","46,560","This activity will add quality to the community health program implementation.  The activity (program review) for which the request is made creates opportunity for quarterly program review and planning where field staff, county health teams and program staff at county and central levels meet to discuss and find solutions to program implementation challenges where they exist or strategize for quality implementation for the period ahead. Performance against achievement is discussed at the meetings and the meetings contribute to the program data review and report writing issues. The also creates opportunity for review of compliance issues related to finance, program technical areas, policies and grant agreement. It also promotes, learning and sharing, coordination and effective collaboration as different stakeholders are brought together to discuss and work in a coordinated manner.",0,"9,540",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":46560}]
["Guinea","12/31/2020","Tuberculosis","FR260-GIN-T","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-4297","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6l/view","106,170","106,170","This connectivity system will enable the remote monitoring in real time of the usage data of the GeneXpert machines, of any faults or breakdowns that occur and will make it possible to put in place the relevant solutions; the transmission of results will also be improved. Cost indicated by the regional adviser from the WHO + internet connection charges.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":106170}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Grant management","10/30/2019","Program management","Western Africa","Active",null,"High","PAI-4694","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDA/view","1,967,591","1,711,101","This covers program HR cost for the PR including salaries & benefits working on or supporting the program management and implementation.  This is for implementing in additional 2 districts in Margibi and gap in Lofa - 3 existing GF supported districts (2 M & E Officers for Margibi  - 1 & Lofa - 1)",0,"256,490",0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1711101}]
["Guinea","12/31/2020","Tuberculosis","FR260-GIN-T","Other program management intervention(s)","10/30/2019","Program management","Western Africa","Active",null,"High","PAI-4298","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6m/view","145,217","145,217","This intervention aims to strengthen the capabilities of the National TB Program in its capacity of PR. This includes training for the staff of the National TB Program, the updating of standards documents, such as the Financial and Administrative Procedures Manual, the strengthening of internal auditing and the operational costs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":145217}]
["Liberia","6/30/2021","Malaria","FR532-LBR-M","Other health information systems and M&E intervention(s)","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"High","PAI-4681","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCx/view","652,410","652,410","This request is targeted at piloting the use of mobile data collection using tablets. Tablets will be customized with applications for data reporting (treatment, diagnosis and communications for the 3 diseases and the name, and location of the person receiving the interventions, among others). The tablets will also contain an application for long distance training/ refresher of CHAs.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":652410}]
["Senegal",null,"Tuberculosis, RSSH","FR288-SEN-Z-01","Other TB care and prevention intervention(s)","10/30/2019","TB care and prevention","Western Africa","Active",null,"High","PAI-5520","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQU/view","536,957.69","536,957.69","To reduce the gap in missing cases in high-burden regions, this amount would enable implementation strategies to be scaled up through the purchase of five mobile digital X-ray machines and a fixed X-ray machine for a second prison in the country to conduct screening upon entry.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":536957.68999999994}]
["Gambia","6/30/2021","Malaria","FR549-GMB-M","Capacity building for health workers, including those at community level","10/30/2019","Case management","Western Africa","Active",null,"Low","PAI-4307","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6v/view","319,298","319,298","Trainings activities will be organised to develop the skills of service providers in (1) case detection and management; (2) active case surveillance and investigation at community level as well as faciity level. We request for more sensitive RDTs (parasite differentiation). In areas or regions of more extremly low malaria transmission, more sensitive RDTs will be procured for the purpose of parasite species differentiation. As private sector reporting is crucial for current decision-making on malaria elimination efforts, this request also highlights orientation meetings with private sector actors, on standardized MCM treatment policies and data reporting and quality.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":319298}]
["Senegal","12/31/2020","HIV/AIDS","FR556-SEN-H","Surveys","10/30/2019","RSSH: Health management information systems and M&E","Western Africa","Active",null,"Medium","PAI-5509","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQJ/view","56,707.44","56,707.44","Two operational research studies will be undertaken on adolescents and key populations to guide the program toward these targets.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":56707.44}]
["Guinea-Bissau","12/31/2020","HIV/AIDS, Tuberculosis","FR369-GNB-C","Other module","10/30/2019","Other module","Western Africa","Active",null,"High","PAI-4326","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7E/view","2,596.79","2,596.79","Update the national list of Generic Essential Medicines. Organize 2 workshops to revise and update the national list of generic essential medicines and the national form of essential medicines in 3 days in 2018 and 2020.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2596.79}]
["Senegal","12/31/2020","HIV/AIDS","FR556-SEN-H","Treatment monitoring - Viral load","10/30/2019","Treatment, care and support","Western Africa","Active",null,"High","PAI-5507","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQH/view","1,028,096.73","1,028,096.73","Viral load testing coverage is one of the obstacles to achieving the 909090 targets. Therefore, in addition to support from CHAI for optimizing GeneXpert testing and POC assays, 20 machines will be procured to be distributed to the most remote areas.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1028096.73}]
["Sierra Leone","12/31/2020","HIV/AIDS","FR474-SLE-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Western Africa","Active",null,"High","PAI-5531","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQf/view","1,043,410","1,043,410","WFP estimates, 6184 adult PLHIVs, positive pregnant women and OVCs in need of nutritional support from 2018-2020. The within allocation budget will provide nutritional support for 1,797 positive pregnant women, adults PLHIVs and OVCs in 2018.The PAAR will be used to procure and distribute food for an additional 4,351 positive pregnant women, adults PLHIVs and OVCs in 2018 plus 6148 additional PLHIVs in 2019 and 6148 in 2020 respectively.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":1043410}]
["Sierra Leone","12/31/2020","HIV/AIDS","FR474-SLE-H","Other intervention(s) for treatment","10/30/2019","Treatment, care and support","Western Africa","Active",null,"High","PAI-5532","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQg/view","3,756,370","2,286,370","WFP estimates, 6184 adult PLHIVs, positive pregnant women and OVCs in need of nutritional support from 2018-2020. The within allocation budget will provide nutritional support for 1,797 positive pregnant women, adults PLHIVs and OVCs in 2018.The PAAR will be used to procure and distribute food for an additional 4,351 positive pregnant women, adults PLHIVs and OVCs in 2018 plus 6148 additional PLHIVs in 2019 and 6148 in 2020 respectively.",0,0,0,"700,000","770,000",{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":2286370}]
["Senegal","12/31/2020","Malaria","FR559-SEN-M","Seasonal malaria chemoprevention","10/30/2019","Specific prevention interventions (SPI)","Western Africa","Active",null,"High","PAI-5515","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQP/view","717,666.93","717,666.93","With regard to boosting malaria control in the country, the NMCP plans to strengthen control strategies in the central part of the country, where the Diourbel and Kaolack medical regions accounted for about 20 percent of the countrys cases in 2016. This morbidity is mainly concentrated in the Touba, Diourbel and Kaolack health districts, where cases among children aged under 10 years account for more than 10 percent of all cases recorded.The implementation of SMC in these health districts and for children aged 3120 months will reduce the malaria morbidity and mortality burden and thus enable substantial gains to be made in achieving the pre-elimination target by 2020. The expected benefits of SMC are:- a reduction of at least 50 percent in all malaria cases- a reduction of at least 50 percent in severe malaria cases- a reduction in mortality of at least 40 percent- a reduction in the incidence of anemia. The sum requested covers procurement of SMC drugs for the 359 month target age group, for 2018 and 2019; for 2019, the amount is 315,497 and for 2020, it is 324,016.",0,0,0,0,0,{"$f":"VALUE(SUBSTITUTE(SUBSTITUTE(Table2[[#This Row],[Remaining UQD (USD)]],\"'\",\"\"),\",\",\"\"))","v":717666.93}]

{"sheet":"UQD register NEW","index":2,"n_rows":2843,"n_cols":8,"rows_kept":1125,"cut":true,"hidden":true,"merged":[[4,0,4,7],[5,0,5,7]],"bounds":{"rows_first":500,"rows_last":125,"rows_between":500,"halvings":2}}
[]
["2017-2019 Register of Unfunded Quality Demand, Updated: 04/02/2020"]
["Please refer to the 'User Information' for essential information on interpreting the Register of UQD"]
[]
["UQD Register Analysis - 2017-2019 Funding Cycle"]
{"$rows_empty":10}
[null,"Applicant","Component","Module","Intervention","UQD description","UQD expiry Date","UQD amount USD"]
[null,"Afghanistan","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Condoms and lubricant programming for PWID","The activity for female injecting drug users will be started in four provinces i.e. Kabul, Nangarhar, Balkh and Herat provinces. The initiation of this activity will be subject to the assessment results by the end of the year 2017. Currently, there is no intervention for FIDU in the 3 country by any partners.","2020-12-31",423465]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Condoms and lubricant programming for PWID","There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.","2020-12-31",172108]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Sub-recipient NGOs  could mobilize food items for PWID in Drop In Centers (DICs) from other sources.  Considering the status of 5 mentioned clients, it was necessary to provide cooked food; therefore, it was needed to hire six cooks in six provinces. The provinces include: Badakhshan, Kunduz, Ghazni, Kandahar, Nimroz, and Farah.","2020-12-31",28770]
[null,null,"HIV/AIDS","Program management","Grant management","This refers to the PR 7% Grant Management Services (GMS) cost and Sub-recipient 5% overhead cost.","2020-12-31",214501]
[null,null,"HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Currently there were 6 provincial coordinators, 5 CDC focal points, 6 drivers and their PPHO running costs. The running cost included maintenance & fuel of vehicles and mobile phone top ups.  This module helped coordinate program activities at sub national level, therefore, it is proposed under above allocation but with some changes. The change aims to increase the number of CDC focal points from 5 to 11 and drop the provincial coordinators and PPHO related costs.","2020-12-31",377846]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","7-10% total grant budget can be allocated to M&E & surveillance related activities. Hence, the NACP encounters numerous issues in terms of data quality, verification, collection, capacity building in terms of trainings for the M&E and Surveillance staff. Need to recruit three national epidemiologists short-term basis to train staff. Assessment on FIDUs is a critical component of the programs as previously recommended by the TRP to be further strengthened to ensure that the country needs are met.","2020-12-31",483280]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment adherence","In order to increase adherence of patients to treatment certain social support pckages are proposed.","2020-12-31",768060]
[null,null,"HIV/AIDS Total",{"$nulls":4},2468030]
[null,null,"Malaria","Case management","Active case detection and investigation (elimination phase)","To  prevent  the  spread  of  malaria  in  Category  2&3   provinces,  early  detection  ,  prompt  treatment  and  case  based  surveillance  are  considered  as  the  top  priority  by  the  program.  \nThese measures are not costed in allocated  funding  request.  In the revised National Malaria Strategy, for the areas in Category 2 & 3 (low or malaria elimination areas), it is recommended to strengthen  malaria  surveillance  through case-based investigation.","2020-12-31",96000]
[null,null,"Malaria","Case management","Facility-based treatment","Studies show variation of G6PD deficiency in areas with high malaria endemicity. 95%   of   cases   are   due   to   Plasmodium   Vivax   whose recurrence results in PV malaria case increase. The cure is a full dose of Primaquine save for G6PD deficiency cases which require supply of G6PD care tests to health facilities. To deploy the testing, a training will be conducted on administration of tests in malaria endemic areas. Estimated test cost $: 2*370,347 = 740,694. Workshop (# of people 1351*51= 68901.Total= 740,694+68901=809,595.","2020-12-31",809595]
[null,null,"Malaria","Case management","Facility-based treatment","To focus on enhancing case confirmation and reduction of  clinical  malaria  cases  specifically  in  high  burden  province  bordering Pakistan,  it  is  needed  to  distribute RDT and have a regular coordination meeting with   health   facilities   staff   and   Community   Health   Supervisors to  share  the  surveillance  gaps, guidance on improvement of ?on the spot data quality?, and review the implementation of malaria case management    by    conducting    Biannual meetings with staff from   7   high-risk   malaria   provinces   bordering  Pakistan.","2020-12-31",100044]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","Under   the   2015-2017 grant,   Malaria   &   Leishmaniosis Information Systems (MLIS) have been piloted in 4 provinces, evidence based scale up of MLIS is planned for the next grant period.  Required activities are;  training session for HMIS  officers  from  PHDs  &  BPHS  implementers, Malaria  Control  officers  and heads of health facilities.  Lower  health  facilities level,  which   are   considered   for   RDTs   distribution  under  allocation  request,  planned  to  be  oriented on MLIS reporting system in RDT use training sessions.","2020-12-31",36520]
[null,null,"Malaria","Vector control","Indoor residual spraying (IRS)","Category  2&3  provinces  prone  for  malaria  epidemics lack vector  control measure (LLINs) Population here is mostly  not immune, so single  malaria  case  carries high transmission risk (especially considering  migration and movement of internally   displaced population).   It is proposed to procure the stock of insecticide for IRS and larvaciding, cosnidering   geographic and  logistical challenges of re-supply.    This will facilitate immediate response to   outbreak   investigation   and   response   in   the   elimination areas.","2020-12-31",300000]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Pregnant women living in malaria endemic areas (category 1) require protection and will receive LLIN.  It is recommended  to provide a LLIN to all pregnant women visiting ANC  in  areas of Category 1 which are not covered in the malaria funding  request.  Due to inaccurate data the LLIN numbers are insufficient. No. of LLINs estimated to be distributed among  pregnant women visiting ANCs  (calculated  based  on  the ANC visits in those areas) = 364,307.","2020-12-31",0]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Based on the Malaria  Program  Review recommendation, National Strategy was revised  in  March  2017, it stratified the country into 3 categories with category 1 consisting of high malaria endemicity provinces. LLINs is the only vector control measure used.  \nFunding was requested to procure LLINs  to  cover  category  1  districts  but  not  all  districts were covered.  Therefore, funds are needed to procure more LLINs. Distribution will   be   done   as   per   WHO   recommendation. No. of LLINs required = 1,615,363.","2020-12-31",0]
[null,null,"Malaria Total",{"$nulls":4},1342159]
[null,null,"Tuberculosis, RSSH","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","To promote engagement of the large private sector, 10 Private Public Partnerships (PPPs) are being requested through the TB-RSSH Funding Request within the allocation. An additional 40 PPPs are being proposed for UQD funding to expand pilot testing and enrich the data in diverse geographical and cultural settings in 4 remaining Regions. This UQD includes renovation of selected facilities, supplies and equipment, monitoring visits and operational costs.","(blank)",400752]
[null,null,"Tuberculosis, RSSH","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","To address high Maternal Mortality, the Citizen Charter proposes a few thousand FHHs. All partners indicated support for the expansion of FHHs. The TB-RSSH grant includes 35 FHHs and this UQD includes additional 15 FHHs. This UQD includes medical kits ($39,525), socialization and awareness in communities for site mapping ($78,026), basic supplies, equipment, medicines, staff support, training expenses, operational/maintenance costs ($493,525) and transportation of renovation materials ($2,239).","(blank)",613315]
[null,null,"Tuberculosis, RSSH","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The nation?s only Quality Control Laboratory for pharmaceuticals and medical products has limited capacity, staff and resources although there is a huge private sector importing pharmaceuticals. A second Regional Laboratory is requested in TB-RSSH Funding Request including training and the development of a National Strategy, SOPs and Quality Assurance Guidelines. This UQD includes functionalization of another Regional Pharmaceutical Quality Control Laboratory.","(blank)",756132]
[null,null,"Tuberculosis, RSSH","TB care and prevention","Case detection and diagnosis","5 GeneXpert machines are already deployed. Ten machines will be deployed by CTB and 10 are included GF TB grant for Provincial Hospitals. This UQD includes additional 10 GeneXpert machines for Provincial and District Hospital TB diagnostic centers. This requires installation costs ($25,000 per machine X 10 = $250,000) and testing kits ($24,000 per unit X 10 units x 3 years = $720,000).","(blank)",970000]
[null,null,"Tuberculosis, RSSH","TB care and prevention","Case detection and diagnosis","The TB grant incudes active contact management through household visits for smear-positive cases. To maximize impact, active contact management of all cases is required. This expansion should identify an additional 1,000 cases per year. This UQD includes the costs of household visits for an additional 20,000 smear-negative and extra-pulmonary cases per year ($20 per visit X 20,000 cases = $400,000 per year or $1,200,000 for 3 years).","(blank)",1200000]
[null,null,"Tuberculosis, RSSH","TB care and prevention","Case detection and diagnosis","To enhance diagnostic capacities and provide high quality laboratory services, the preferred LPA DST equipment is being proposed for 3 RRLs. The cost of each LPA with PCR is US$ 50,000 or US$ 150,000 for 3 RRLs. US$ 10,000 per laboratory per year is necessary for the diagnostic kits (US$ 10,000 X 3 X 3 = US$ 90,000) for a total of US$ 240,000.","(blank)",240000]
[null,null,"Tuberculosis, RSSH","TB care and prevention","Collaborative activities with other programs and sectors (TB care and prevention)","Expanding PPM DOTS will further increase case notifications while engaging the private sector. The NTP proposes to scale-up 10 additional cities with significant numbers of private practitioners. This expansion should identify an additional 600 cases per year. This PAAR includes costs for site preparation in 10 provinces (US$ 1,500 X 10 = US$ 15,000) and costs for private practitioner orientation (US$ 1,800 X 10 = US$ 18,000).","(blank)",33000]
[null,null,"Tuberculosis, RSSH","TB care and prevention","Community TB care delivery","Based on effective results, scale up CB-DOTS in additional 15 provinces to expand case notifications and broaden efforts to reduce stigma. This expansion should identify another 1,000 cases per year. This UQD includes training  ($5,000 per training X 15 provinces = $75,000) and incentives for case-finding and treatment support ($3 each to two persons per case X 1,000 cases x 3 years = $18,000).","(blank)",93000]
[null,null,"Tuberculosis, RSSH","TB care and prevention","Community TB care delivery","TB Patient Associations in 12 provinces have been supported by GF and are included in the allocation to reduce stigma, address gender-related issues and support community empowerment. This UQD includes expansion to all remaining provinces ($400 per Association X 22 X 3 years = $26,400) and incentives for case-finding and treatment support.","(blank)",31800]
[null,null,"Tuberculosis, RSSH Total",{"$nulls":4},4337999]
[null,"Albania","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Offer IEM for KPs health for communities and offer continuous community education programs (LGBTI, sex workers)","2022-12-31",24850]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Assess behaviour change and influence of stigma, discrimination and social exclusion in certain KPs (LGBTQ / sex workers) in Albania through a national study","2022-12-31",32000]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish online resource centre with materials and training courses (in Albanian) for professionals and NGOs on KP (sex worker, LGBTI) health and social services","2022-12-31",9500]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish standards for Key population social and health services (sex workers, LGBTI)","2022-12-31",15250]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish auditing programmes for MMT services","2022-12-31",750]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish auditing programs for KP (sex workers, LGBTQ, PWID) health and social services offered by all stakeholders","2022-12-31",2250]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish guidelines and provide KP-specific friendly health services (PWID, sex workers,  Roma)","2022-12-31",1500]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Assess sex worker conditions and legislation and implications for their security and health","2022-12-31",9750]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Prepare Sex worker monitoring health guidelines","2022-12-31",7000]
[null,null,"HIV/AIDS, Tuberculosis","HIV Testing Services","Differentiated HIV testing services","Establish outreach programmes of VCT services in most-at-risk communities","2022-12-31",40344]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Administrative and finance data sources","Implement OneHealth tool to harmonize and strengthen health system analysis, costing and financing scenarios at the country level","2022-12-31",33500]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","Evaluate pilot of a new technology in TB and HIV care, such as Video Dots","2022-12-31",9350]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","Evaluate pilot of PREP for MSM to assess its impact","2022-12-31",10100]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Prepare a training program for HIV for district epidemiologists. The training of district-level epidemiologists will support the overal decentralisation of health services, and HIV services in particular.","2022-12-31",7250]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Establish a quality assurance monitoring system of HIV prevention, treatment care and support services  ","2022-12-31",12350]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Establish service performance indicators and their measurement","2022-12-31",7500]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Improve the database system for HIV by web linking of laboratory and epidemiological data. This would further strengthen the HIV database that is already being developed.","2022-12-31",11600]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Update HIV / AIDS / TB reporting forms to ensure consistency with proposed joint HIV / TB database  ","2022-12-31",3750]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Update surveillance guideline system","2022-12-31",10200]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Conduct next round of IBBS in KPs; IBBS will be done in late 2019. Given the high cost, the Transition grant cannot finance it, but if available, PAAR could finance the next round in 2022.","2022-12-31",137335]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Establish a sustainable sentinel surveillance system for HIV/STI/Viral Hepatitis in KPs (MSM, sex workers, prisoners) by a partnership of government structures with civil society and other partners","2022-12-31",9750]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Surveys","TB knowledge, attitude and practice (KAP) study","2022-12-31",19350]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Community TB care delivery","Implement ACSM activities during the World TB Days. Various ACSM activities, including the organization of a nation-wide conference for TB professionals, will be conducted on and around the World TB Day 24 March, following the topics will be  proposed for each year?s campaign","2022-12-31",6000]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Community TB care delivery","Training of Social workers on support for TB patients (is NOT a No 1 priority: 1-day training of 25 social workers in Tirana","2022-12-31",1713]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Counseling and psycho-social support","Counselling Services: Counselling support for discordant couples","2022-12-31",6724]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Counseling and psycho-social support","Provide counselling for children and adolescents LHIV services on HIV status disclosure, ART adherence, healthy nutrition, coping with emotions etc.\nStrengthening the quality of Counselling will contribute to higher utilisation of HIV testing services.","2022-12-31",15000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Counseling and psycho-social support","Support for documenting human rights violations and train community-based groups on their rights, to facilitate access to justice for key populations and to enforce their rights.","2022-12-31",3000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Counseling and psycho-social support","Support the ageing PLHIV; Drive support and education for older people with HIV, emotional, psychological and social support for people aging with HIV/AIDS and offering support in order to have access on HIV services to ensure a good quality of life","2022-12-31",15000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Differentiated ART service delivery","Provide TA to further strengthen Patient monitoring system for adherence. A partient-monitoring system is in place, but additional TA can further strengthen it.","2022-12-31",7350]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Differentiated ART service delivery","Review and update the PEP and PrEP guidelines pilot PrEP for MSM","2022-12-31",3925]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","HIV care","Provide support services to increase and improve women knowledge and skills for the information and education on issue related to women LHIV; and develop I&E materials on strengthening and the building capacities of HIV women group on their gender, SRH and treatment issues","2022-12-31",15000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Other intervention(s) for treatment","Assess current Viral Hepatitis treatment capacities and capabilities (drugs, guidelines, services etc)  for Albanian population and especially risk groups","2022-12-31",20000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Prevention, diagnosis and treatment of opportunistic infections","Improve diagnostic capacities for OI (according to guidelines) by Training of microbiologist and ID for diagnosis of OI","2022-12-31",7850]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},516791]
[null,"Algeria","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","The prevalence among female sex workers is 72 times higher than the national average. Several factors contribute to this situation, including limited access to prevention, care and treatment services and the lack of coverage of certain areas by Community Systems Organisation (CSOs). This additional investment will provide services to 6248 Commercial Sex Workers (CSWs) in areas currently not covered by CSOs based on the results of the mapping of key populations that will be available before the start of the transition grant.","2022-12-31",234098.55]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Migrants are classified as a priority population. However, to date they have not benefited from structured prevention activities and the 2019 IBBS results confirmed a HIV prevalence rate of 2.2% among migrants, similar to the rate among Men having sex with Men (MSMs). Migrants' access to care is difficult due to their lack of awareness about available prevention programs and HIV treatment centers. This access is also made difficult due to their fear to consult public health structures, given their illegal status and rumors that public structures poison people with AIDS. Thus, this request will provide at least the 1,500 migrants who participated in the IBBS with prevention, screening and treatment activities in collaboration with the International Organisation for Migration (IOM) and other technical partners.","2022-12-31",720342]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Stigma and discrimination in care settings for PLHIV and key populations is a reality in Algeria, as evidenced by the results of the \"Index stigma\" study. These behaviors are an obstacle to key populations accessing services, especially treatment. Thus, it is planned to train the staff of 60 testing centers and 15 reference centers on medical ethics to raise their awareness about challenges faced by KPs, reduce social rejection and discrimination within care structures as well as improve the quality of care on the one hand and on the other hand organize meetings periodically to handle complaints in accordance with Article 28 of the new law on health.","2022-12-31",252540.1]
[null,null,"HIV/AIDS","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","The adoption of the community-based testing strategy will allow the community-based organizations and structures to test key populations with the objective of extending access to testing services. In light of the modest resources for the transition funding request (2.3 million), it is planned to organize a training for a reduced number of staff (15 persons, 3 per Community Service Organisation/CSO). This will allow to train a critical number of staff, with a planned government contribution to increase the number of staff trained to the 123 outreach CSO workers (Peer educators, Supervisors and Social health workers) who will contribute to implementing activities included in the transition grant.","2022-12-31",114469.88]
[null,null,"HIV/AIDS Total",{"$nulls":4},1321450.5300000003]
[null,"Angola","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Addressing stigma, discrimination and violence against MSM","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate MSM to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of MSM reached with services.","(blank)",30000]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Addressing stigma, discrimination and violence against sex workers","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate sex workers to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of sex workers reached with services.","(blank)",30000]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","Presently, sex workers have weak organizations and networks to organize and mobilize their members. The PAAR  application  will  strengthen KP organizations to organize and mobilize members for KP service delivery including advocacy.  Activities will include community mobilization, training on sexuality, strengthening and supporting organizing of sex workers , providing safe spaces/drop in centres. Expected outcome will be increase in sex worker  reached with programs through sex workers networks and organizations.","(blank)",600000]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","PAAR will support refresher training of Laboratory staff  in  diagnosis of MDRTB in 2019  and reagents for solid and liquid culture, three (3) LPA (Line Probe Assay) equipment?s and their respective reagents. Expected outcome will be increase in MDR TB cases detected and notified.","(blank)",177750]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Treatment: MDR-TB","The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.","(blank)",355500]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Other intervention(s) for PMTCT","The investment in the allocation amount is able to support one Early Infant diagnosis (EID) platform in Luanda and is inadequate to achieve all PMTCT targets in this application. PAAR in this module is requested to support IEC, Rapid test , M& E tools and the two additional viral load/IED testing  platforms to be able to meet PMTCT targets ( see Annex 17 on projections of viral load testing). The expected outcome will increase in number of children diagnosed of HIV and initiated on antiretroviral therapy.","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","This is a program still in its infancy in the current grant with only 1,764  youth and adolescent -out of school  who had been reached by program implemented by UNFPA (SSR)  that started in July 2016 in three provinces of Luanda, Benguela, Cunene and  Huila.The allocation amount in this application plus domestic contribution will only scale up this up to 31% (400,559) of country need. The PAAR will aim to expand  coverage to six  more provinces (Cuando-Cubango, Moxico,Lunda Sul, Lunda Norte, Cuanza Norte and Bie) and scale up targets  to 15% in 2018; 20% in 2019, 30% in 2019 and 40% in 2021 respectively ( 172,289 in 2018; 239,596 in 2019; 375,070 in 2020; and 587,341 in 2021). Expected outcome will be increase in percentage of adolescent and young girls out of school reached with a package of prevention services and linked to care and treatment.","(blank)",1000000]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Socioeconomic approaches","The PAAR application will support social grants and cash transfers to support out- of -school young girls and women with  income generating activities (IGAs) grants. This activity will provide training in vocational skills and grants  through SR/SSR targeting young and women working in markets and vocational jobs like knitting, saloons, tailoring, poultry farming, piggery projects, etc to reduce their  economic vulnerability.","(blank)",400000]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Implementation of activities will commence in this application as the current grant is only planned to conduct  an IBBS study among truck drivers. The allocation amount in this application plus domestic contribution will only scale up targets in this module up to 40% (8,219) of country need. The PAAR will aim to scale up  coverage to 30% in 2018; 35% in 2019, 40% in 2019 and 50% in 2021 respectively (5,414 in 2018; 6,676 in 2019; 7,918 in 2020; and 10,278 in 2021). Expected outcome will be increase in percentage of truck drivers  reached with a package of prevention services and linked to care and treatment.","(blank)",580000]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","PAAR to support procurement of additional laboratory  materials and consumable in  2019, 2020 and 2021 to reach targets. The items will include sputum containers and protection masks(3M N95) and reagents. Expected outcome will be increase in CNR.","(blank)",499050]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Community TB care delivery","The PAAR will support development of IEC Materials and  training  for community workers and Social mobilization on Community TB Care  in 18 provinces (210 agents for 84 municipalities)\nPAAR investment  will support Treatment Adherence  interventions (TAIs) catalytic to achieving the ambitious CNR and TSR targets, focusing on strengthening community  and peer support (ex-TB patients etc), food vouchers and transport refunds , home visits and others initiatives to mitigate the castrophic  costs from TB and improve treatment outcomes. Expected outcome will be increase in CNR and TSR.","(blank)",260000]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Prevention","PAAR application will support procurement  INH for IPT among eligible  PLHIV and children of contacts with TB patients who test negative for TB screening in years 2019, 2020 and 2021. (see TB/HIV collaboration). Expected outcome will reduction in TB incidence.","(blank)",536058]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Treatment","PAAR to support quarterly supervision to health facilities (84 DOT sites in 18 provinces and communities)  in 2019, 2020 and, 2021. Expected outcome will be increase in TSR of TB cases.","(blank)",238560]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Treatment","PAAR to support the printing  of  handbooks on (i) TB cases management (ii) TB in children; (iii) MDR-TB management and control; (iv) TB/HIV coinfection control; (iv) tasks of DOTS-C agents  in 2019. Expected outcome will be increase in quality of TB services in line with international standard for TB care (ISTC).","(blank)",150000]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","Engaging all care providers (TB/HIV)","PAAR investment will support activities of engaging public and private/CSO providers (PPP/PPM)  in TB/HIV control activities (screening, diagnosis, treatment and follow-up of patients), CBOs will be supported to connect people at risk of HIV and/or TB with information and services.  Activities will include training of service providers, certification and accreditation, quality assurance, supervision and monitoring, advocacy and communication. \nPAAR investment will support training in cases management of TB  and directly observed short treatment among TB cases detected and followed up by  prisons health teams, mines and oil companies, and  NGOs who work with TB high risk groups. Expected outcome will be increase in TB CNR and TSR.\nExpected outcome will be increase in coverage targets and quality of TB/HIV services.","(blank)",750000]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","TB/HIV collaborative interventions","PAAR investment will support activities for TB/ HIV increased integration at both national and district level by  supporting  TWG quarterly meeting at  provincial and municipality levels, joint TB/ HIV planning and supervision of integrated delivery of TB and HIV services.","(blank)",360000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Differentiated ART service delivery","Current ART coverage for Angola according to the revised program  data (2016) from a recent program data assessment standards at  21.4% (adults and children). The allocation amount in this application plus domestic contribution will only scale up this up to 45% which is still far below the global 90-90-90 targets. The PAAR will aim to scale up ART coverage to 33% in 2018; 39% in 2019, 46% in 2019 and 50% in 2021 respectively ( 100,404 in 2018; 121,281 in 2019; 146,008 in 2020; and 161,871 in 2021). Expected outcome will be increase in percentage of adults and children receiving antiretroviral therapy.","(blank)",3000000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Other intervention(s) for treatment","This study to be conducted in 2019 and 2021  provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the DHIS2. This cohort analysis will include adults, children and women initiated on ART during pregnancy for the first time. The impact will be increased availability of strategic information to inform programming and implementation","(blank)",300000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Treatment adherence","Additional PAAR investment for activities to contribute to the 90-90-90 targets will include intensifying peer adherence counseling and provision of psychosocial support to PLHIV at ART sites and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities. Expected out will be number of PLHIV retained in care and virally suppressed.","(blank)",600000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Treatment monitoring - Viral load","The investment in the allocation amount is able to support one Viral load platform in Luanda and is inadequate to achieve viral load testing targets. PAAR in this module is request to support the three additional viral load testing  platforms to be able to meet all targets ( see Annex 17 on projections of viral load testing). The expected outcome will be number of PLHIV on ART test for viral load and improved monitoring of the 90-90-90 care and treatment cascade.","(blank)",1000000]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},10866918]
[null,null,"Malaria","Case management","Other case management intervention(s)","Increasing access to primary health care services(iCCM) through ADECOs is seen as a priority by the GoA. In this above allocation, iCCM will be expanded to a further six (6) municipalities, distributed as follows: Moxico (1), Malange (3) and Uige Province(2). These Provinces were chosen for increased coverage due to their malaria burden, access to health care and population   The total ADECOS expected to be trained under this above allocation will be 240. Children less than 5 years of age that have access to health care will  increase from 11% to 20% by the end of the Grant. The total cost is 500.000 USD, to cover, five days training for ADECOS ( ToT and ADECOS training) visibility materials( t-shirts, cups, boots, cup rain, smartphones, mobile data service.","2021-06-30",500000]
[null,null,"Malaria","Case management","Other case management intervention(s)","This above allocation is to support the procurement of injectable artesunate and injectable artemether for treatment of severe malaria over the 3 years of this grant. In 2018, 2019 and 2020 respectively 442,275; 482,813 and 490,296 estimated cases of severe malaria will occur. In Angola severe malaria is treated in the following proportion: 50% receive injectable Artesunate, 33% injectable Artemether and 17% quinine. The GOA has prioritized increasing access to diagnosis and treatment in the most vulnerable groups shown by their increased domestic allocation for both RDTs and ACTs. Increasing access to early and correct diagnosis and treatment in the community through ADECOS will in turn reduce the number of severe malaria cases and therefore mortality from severe malaria in hospitals. Injectable artesunate requested is intended for the treatment of the vulnerable population of children <5 years of age, that represent 17% of severe malaria cases per year is requested under this concept note. The MoH will procure the rest of injectable artesunate for patients> 5 years. The purchase cost of 1 ampoule of 70mg / ml is estimated at 2.52 USD (price) + PSM (35%). For injectable Artemether, Angola is requesting sufficient to treat 33% of all severe malaria  cases  from  all age groups with severe malaria. The cost of purchasing an ampoule of 80 mg / ml is estimated at $ 0.46 (price) + PSM (35%). The TOTAL of these purchases is USD 4,895,388 requested in this above allocation.","2021-06-30",0]
[null,null,"Malaria","Other module","Other module","In order to ensure epidemiological surveillance, monitoring and evaluation of malaria activities are implemented at the operational level (provincial, municipal, health and community units), particularly in the regions of the country where the Multiple Indicators and Health Survey IIMS 2015/16 showed a high prevalence of malaria, , an amount for the payment of salaries of 6 OPPMs for the last year of the 2018-2021 grant is requested in the above allocation. It should be noted that the number of OPPMs was 18 in the current GF 2016-2017 grant, and will be reduced to 6 in be financed under the first 2 years of the FG 2018-2021 grant. The annual salary of each OPPM is USD 47,994.48 and the annual cost of the 6 OPPMs for the last year of the grant is USD 287,966.88. The provincial focal points are to maintain active epidemiological surveillance in these high prevalence provinces to mitigate the emergence of possible malaria epidemics and thereby have quality data and evidence to allow for better quantification and programming of resources.","2021-06-30",287967]
[null,null,"Malaria","Other module","Other module","The survey to determine the epidemiological stratification of the country was conducted in the early 1980?s, sampling at Provincial rather than municipality level. Recent surveys have shown a shift in prevalence patterns and malaria burden  that requires that the country epidemiological profile is updated to facilitate the planning and geographical targeting of types of interventions and decision-making.To this end, an amount of US $ 355,378.12 is requested to carry out a. study in 2019.","2021-06-30",355378]
[null,null,"Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Improving ANC attendance and increasing IPTp coverage is a priority for the NMCP, to improve health outcomes for the pregnant women and her unborn child. The IIMS (2015/2016) showed that only 19% of pregnant women had received 3 or more doses of IPTp during ANC visits. Stock-out have been a major reason for this low coverage.\n The gap analysis shows a gap in the aquisition of Sulfadoxine + Pyrimethamine (SP) for intermittent Preventative treatment for pregnant woman, one of the MoH target groups.. The MoH and PMI will acquire a total of 31,146 bottles of 1000 tablets during the 3 years. The gap is 7166 bottles of 1000 SP tablets which is requested from the FG in this above allocation. The expected impact is the reduction of maternal morbidity and mortality from malaria and improved outcomes for newborn child. The cost is estimated at 27 USD per bottle of 1000 tablets + PSM (35%). The total is 261,267.00 USD","2021-06-30",261267]
[null,null,"Malaria Total",{"$nulls":4},1404612]
[null,null,"RSSH","RSSH: Health management information systems and M&E","Program and data quality","Geographic and historic expansion of DHIS2: \nTraining on the health information system and on how to use DHIS2 has been provided to health technicians in all of the country?s 164 Municipalities. However, only selected municipalities in 7 provinces currently report through DHIS. Funding is required to ensure national coverage (11 remaining provinces) to fund equipment provision, data quality assurance and supervision of reporting through DHIS 2 from all 164 Municipalities. DHIS 2 deployment will be gradual in accordance with the Road map agreed between MoH and its development partners. \nWhile current and future data is being entered into DHIS 2, there is a need to capture and archive historic data before data collection instruments are destroyed or disappear. Migration of historic, Excel based data available at municipal level into DHIS 2 (2016-2017 data) is therefore urgent.","2021-12-31",274440]
[null,null,"RSSH","RSSH: Health management information systems and M&E","Program and data quality","RSSH: DHIS 2: The issue of maintenance of the IT equipment, and IT capacity to use DHIS 2 risks limiting the sustainability of DHIS 2 if it is not adequately addressed. There is an urgent need to assess to what extent Municipalities have access to IT expertise. Once identified, IT Focal Points should be hired in each of the 164 Municipalities, and motivated, to provide maintenance and data insertion services. The Focal Points will also ensure access to Internet and address some difficulties inherent to IT in all provinces.\n\nRSSH: LMIS: OpenLMIS requires a functioning national PSM system to be sustainable. Therefore, systemic issues identified through this Funding Request need to be addressed for OpenLMIS to function as intended. At provincial level, a comprehensive support to warehouses should be given which includes 1) support to rehabilitation; 2) facilitation of access to alternative sources of energy, such as solar energy; 3) development of Procedures Manual; acquisition of standard warehousing equipment including temperature and humidity monitors, air conditioners, pallets, forklifts, shelves. At central level, CECOMA should also be supported with a similar package involving infrastructure rehabilitation, development of a Procedures Manual, acquisition of air conditioners. Opportunities for review and validation of the stock data from OpenLMIS, involving central and provincial level warehouse managers should also be created and funded. Still at central level, advocacy and technical assistance to DNME is required for the validation of the national List of Essential Medicines, the creation of an effective drug registration system and a national pharmaco vigilance system.","2021-12-31",2383489]
[null,null,"RSSH","RSSH: Health management information systems and M&E","Routine reporting","HIS Governance Strengthening: Support Expanded Terms of Reference by the National Technical Team for inclusion in OpenLMIS; Support creation of municipal technical teams.","2021-12-31",34224]
[null,null,"RSSH","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","For effective public health decision-making, morbidity and logistics data have to be available, analysed and interpreted jointly. Interoperability and integration of the two DHIS2 and OpenLMIS platforms is therefore essential.\nThis allocation will allow the installation of OpenLMIS on the HIS platform and of DHIS2 on Amazon Web Services (AWS, a cloud-based infrastructure). Most importantly, the human resources involved in entering and using data in the two systems will require adequate training.","2021-12-31",86062]
[null,null,"RSSH Total",{"$nulls":4},2778215]
[null,"Armenia","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Diagnosis and treatment of STIs and other sexual health services for MSM","STI testing and treatment for MSM (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment.\n \nScreening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Procurement of HCV rapid tests (for 1390 tests in Y1, 1748 tests in Y2 and 1600 tests in Y3 based on the assumptions that 50% of PWIDs tested for HIV will be tested for HCV).","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Diagnosis and treatment of STIs and other sexual and reproductive health services for sex workers","STI testing and treatment for Sex Workers (SW) (medical staff salaries, procurement of medical supplies for STI and STI drugs): 30% of reached clients will receive referral for STI testing and 18% of reached clients are expected to require STI treatment.\n\nScreening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for TGs","Diagnosis and treatment of STIs and sexual health services for TGs","STI testing and treatment for Transgender (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment. \n\nScreening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","The total number of urban migrants in Armenia can be as high as 60,000. Therefore, although coverage of 5000 migrants and their sexual partners has been included in the main allocation request, covering additional 5000 is needed in particular if the Russian aid program fails to continue. So additional amount of funds is planned to be spent on this program component if available.","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","USD 200,000 to support the roll out of ECHO project (tele-medecine platform) in Armenia in cooperation with the ADB. Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services.","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Improvement of client registration, unification of coding system and integration of programme monitoring data into common database. Training regarding stigma and discrimination - in total 5 trainings were budgeted. Trainings for outreach workers - in total 5 trainings were budgeted.\nIn order to strengthen programme monitoring and reporting accuracy and avoid potential duplication of efforts (e.g. of Men who have Sex with Men (MSM), SW and PWID activities funded by the Global Fund and EJAF) Principal Recipient will introduce uniform Unique Identification Code across projects and organisations and pursue integration of monitoring systems and introduction of a shared database. Accurate programme reporting is essential for adequate target setting and precise measurements of achievements in the response to the epidemic. Introduction of these innovations will require training for field workers.","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Surveys","IBBS (Integrated Biology and Behavioural Survey) among PWID, MSM, TG, SW, Migrants in Y2 in order to assess the situation and measure progress in HIV prevention and treatment.\nThe previous IBBS studies have been funded by the Global Fund grants. The government has not yet assumed this function, hence funding for IBBS studies is included in the above allocation request.","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Other intervention(s) for treatment","HCV treatment procurement for HIV positive and HCV treatment monitoring for 600 persons during the 2,5 years period\nSocial support program (cash-incentives for adherence to treatment) for patients with DS (regular) TB.\nHCV represents a growing concern with the prevalence among seasonal urban migrants found to be 3.3% in 2018 IBBS study. MoH and NCAP have piloted DAA HCV treatment with medicines donated by the Georgian government and MSF. MoH and NCAP are currently negotiating continued HCV treatment programmes with producers and suppliers of DAA medications. While these negotiations are under was modest number of treatment courses required to treat HIV/HCV coinfected patients is included in the above allocation request.","2021-09-30",495000]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Other intervention(s) for treatment","Social support program to incentivise treatment adherence among patient with drug-susceptible tuberculosis in addition to the social support of patients with drug-resistant TB covered under the TB grant program.","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},495000]
[null,"Azerbaijan","HIV/AIDS","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","PDI, Optimized HIV case finding and HIV case management interventions with focus on men who have sex with men","2021-06-30",30441]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Echo is a tele-medicine platform developed at the University of New Mexico to serve rural populations, and which has been used by US CDC as a method for introducing new approaches in clinical practice in elimination of HIV and Hep C, and then has been also extended for TB. It was successfully introduced in Georgia for these three diseases. It links expert specialist teams at an academic ?hub? with primary care clinicians in local communities. It allows primary care clinicians/TB or HIV doctors from multiple sites present patient cases to the specialist teams and to each other, discuss new developments relating to their patients, and determine treatment.","2021-06-30",328814]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Training for service providers from OST sites.","2021-06-30",6798]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services (currently HIV services are only provided in Yerevan). The vision is to further expand Echo in other areas of health in collaboration with the recent Asian Development Bank (ADB) program focused on health sector policy reforms to strengthen efficient utilization of resources and to improve quality of services.","2021-06-30",70148]
[null,null,"HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Build awareness of key decision makers on evidence-based HIV prevention interventions in penitentiary sector. Activities include information and advocacy meetings (round tables/workshops) to increase awareness about evidence-based HIV prevention intervention in prisons.","2021-06-30",13595]
[null,null,"HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Behavioral interventions for people in prisons and other closed settings","Proposed funding will cover the Echo start-up activities: (a) Establishing Echo network hub in Yerevan; (b) Training of medical staff in using the web-based software; (c) Tele-echo clinics in AIDS and TB curated by ECHO team from University of New Mexico; (d) Case-based learning and guided practice in TB and AIDS; e) Access to specialist knowledge in AIDS, TB, infectious diseases, pharmacology.","2021-06-30",99000]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","1. Strengthen stigma related capacity for medical personnel of ART centres.\n2. Organization of 2 communication campaigns organized per year in the eve of notable days (WAD, Candlelight) to build public awareness and reduce stigma and discrimination.","2021-06-30",48927]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Procurement of AIDS software as part of National HIS support.","2021-06-30",20991]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Operational research: Surveys among detainees in 23 penitentiary facilities to evaluate the efficiency of the implemented HIV prevention interventions in penitentiary sector.","2021-06-30",20812]
[null,null,"HIV/AIDS","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","1. Training for community health workers on ARV treatment.\n2. Participation in trainings, international conferences for Republican AIDS Centre, MoJ staff and NGOs in priority issues of HIV/AIDS.","2021-06-30",97684]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Procurement of HIV Viral Load tests and CD4 tests for regular laboratory and clinical examination of PLHIV in civil sector. Treatment monittoring is critical considering increasing treatment coverage and low VL suppression in the country.","2021-06-30",1272512]
[null,null,"HIV/AIDS Total",{"$nulls":4},2009722]
[null,null,"Tuberculosis","MDR-TB","Community MDR-TB care delivery","Procurement and operation of mobile mini-lab unit for TB case finding and treatment monitoring. About 1?000 new TB cases to be detected annually\n\nGeographical coverage: southern regions of Azerbaijan that are the most affected by TB and HIV, migration and drug use and distantly located from the rayon center (Djilalibad, Massaly, Lenkoran, Astara, Lerik)","2020-12-31",195518]
[null,null,"Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","1. Procurement of additional 1000 Xpert cartridges/year;\n2. Operational research on prevalence of the latent TB infection among prison population and revising the algorithm for active case finding for penitentiary sector","2020-12-31",59269]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO","2020-12-31",0]
[null,null,"Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Joint TB Program Review led by the WHO Country Offices and conducted jointly with international experts.","2020-12-31",50000]
[null,null,"Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Participation in training courses and conferences in various aspects of TB control including of TB control in prisons, for knowledge update and experience exchange","2020-12-31",42000]
[null,null,"Tuberculosis Total",{"$nulls":4},346787]
[null,"Bangladesh","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Further scale-up Opioid Substitution Therapy (OST) in 3 priority districts: Considering the HIV and HCV epidemic, another 1,000 PWID will be targeted for OST in selected districts by 2020, which will increase the national coverage to 11%. This harm reduction intervention is critical in the fight against the transmission of HIV/HCV.","2020-11-30",0]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Prevention and management of coinfections and co-morbidities for PWID","Prevention, screening, diagnosis and management for Hepatitis C virus (HCV): Information Education Communication/Behaviour Change Communication activities for the prevention of HCV will be conducted among targeted People Who Inject Drugs (PWID). PWID will be routinely screened for HCV and around 200 HCV positive PWID will be provided medicine support. Trained physicians will be responsible for screening, diagnosis and management of HCV from Drop-In-Centres. The impact will be to reduce morbidity and mortality for PWID who may be co-infected with HIV.","2020-11-30",0]
[null,null,"HIV/AIDS","Other module","Routine reporting","Under the Government funded Health Sector Program, there is provision for establishing 150 service delivery points  throughout the country. Above allocation funding will allow the National AIDS/STI Program (NASP) to set up a digital data collection and management system. NASP will receive regular data from service delivery points which will help monitor the progress of program implementation and further decision-making.","2020-11-30",450000]
[null,null,"HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Technical assistance will be requested from WHO to assist in developing different protocols, guidelines, conducting quality research and training to complement updating/developing various guidelines.","2020-11-30",110000]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Analysis, review and transparency","Bi-annual monitoring survey among People Who Inject Drugs (PWID): Recent rise of HIV prevalence in Dhaka requires in-depth, routine and systematic monitoring of injecting and sexual behaviour of PWID, drug context, drug taking frequency etc. Routine monitoring survey will be conducted to strengthen the reach, quality of services, and to revalidate spot-wise size estimates so that program can be more responsive to the community needs.","2020-11-30",431006]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Scale-up ICT based data collection system in the HIV/AIDS program to integrate with the national Health Management Information System (HMIS). A pilot initiative will introduce a ICT based data collection system using tablets with mobile apps. The ICT based data collection system will be scaled-up for the entire program and to be integrated into MIS system of HIV/AIDS program, contributing to the national HMIS.","2020-11-30",142272]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","HIV surveillance is important for key population monitoring at regular intervals.","2020-11-30",1163391]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).","2020-11-30",940181]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment adherence","Piloting different ART service delivery models for key and general populations will allow improved linkages to treatment, care and support for people living with HIV.","2020-11-30",332408]
[null,null,"HIV/AIDS Total",{"$nulls":4},3569258]
[null,null,"Malaria","Case management","Active case detection and investigation (elimination phase)","There are considerable additional demands associated with the elimination effort. A substantial increase in manpower will allow the programme to accelerate progress towards its targets, taking full advantage of this critical window of opportunity to eliminate malaria from Bangladesh.","2020-12-31",1284504]
[null,null,"Malaria","Case management","Facility-based treatment","Quality Assurnce (QA) of diagnosis needs improvement and will be strengthened through expansion and upgrading of the Central Medical Reference Laboratory and collaborating laboratories. A QA database and support for external competency testing will be conducted every 3 years. Sensitivity and specificity of diagnosis will increase as a result, improving rationality of treatment.","2020-12-31",25795]
[null,null,"Malaria","Case management","Other case management intervention(s)","Target-group-specific, locally appropriate, Behaviour Change Communication (BCC) materials and methodologies will be developed and produced for all high-risk groups, as well as for communities approaching elimination. Border-specific packages will also be produced. A mobile phone-based BCC programme  will be developed. Where appropriate work will be carried out in partnership with a commercial advertising agency. This should result in significant improvements in LLIIN utilization in forest goers and treatment seeking in elimination areas, leading to impact in terms of burden reduction and elimination.","2020-12-31",1524883]
[null,null,"Malaria","Program management","Grant management","The general management of the programme requires support that goes beyond that covered by the ?within allocation? request. WHO will provide Technical Assistance. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programme?s elimination goal.","2020-12-31",190443]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","Quarterly meetings will be held at district level to support planning, coordination and management. The HR development plan will be updated, key staff will be recruited for the Program Managment Unit to support the reorientation of the programme, and needs-based training will be provided as necessary. Equipment will be maintained. Furniture (medium priority) and office equipment will be replaced where necessary. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programme?s elimination goal.","2020-12-31",1692852]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","A comprehensive package of needs-based operational research will be conducted in collaboration with WHO and national and international experts and institutes. Equipment will be procured as required. LLIN utilization surveys will be carried out in different risk populations and resulting data will be used to fine-tune strategies and thereby improve impact.","2020-12-31",72698]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","Mapping can significantly strengthen the management of malaria elimination efforts. Health Information Systems in elimination districts will be upgraded to include a GIS component with mapping down to household level. Selected healthcare providers will be equipped with a smartphone so that they can report the geographical position of all confirmed malaria cases. The Government will strengthen the pharmacovigilance system.","2020-12-31",0]
[null,null,"Malaria","Vector control","Entomological monitoring","Entomological monitoring. In-line with the recommendations of the last two programme reviews,extensive support to revitalize entomological services will be conducted including: set-up, running and maintenance costs for an insectary; Technical Assistance; purchasing a training microscope. Vector incrimination surveys will be conducted in 3 sentinel sites. This work should serve to better guide and more effectively target the vector control and a personal protection approach.","2020-12-31",207367]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN ? Mass campaign. The within allocation request covers the absolute, high and medium priority areas. There are a significant number of people at risk in low priority areas that will be left uncovered. Free LLINs will be expanded to cover the entire population residing in targeted established settlements. This will complement the within allocation LLIN approach and result in reduced transmission.","2020-12-31",0]
[null,null,"Malaria","Vector control","Other vector control measure(s)","The protection provided by LLINs is limited to some extent by the early outdoor biting habit of local vectors. Personal protection measures could improve impact, especially for populations at increased occupational risk. Investigations into the effectiveness of personal repellents for reducing residual malaria transmission (RMT) in Bangladesh will be carried out. If repellents prove effective, a roll-out of this intervention will be effected to complement the LLIN approach and result in reduced vectorial capacity and reduced transmission.","2020-12-31",57600]
[null,null,"Malaria Total",{"$nulls":4},5056142]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Provision of second-line drugs, case based-incentives for community providers and patient social support to manage additional detected MDR-TB cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","2020-12-31",4296821]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Additional community case finding activities in hard-to reach areas not covered by the allocation and/or matching fund request, introduction of the new diagnostic algorithm in additional upazilas in remote areas, establishment of additional diagnostic facilities (X-ray, FNAC, X-pert) to improve the diagnosis of smear-negative, Child-TB and Extra Pulmoniary cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","2020-12-31",4414536]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Further expansion of case finding activities targeting specific risk groups (urban poor, factory workers, garment workers, brick field workers, miners, elderly people, pregnant women) in areas not covered by the allocation and/or matching fund request, additional IEC activities targeting high-risk groups in urban- and sub-district areas. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","2020-12-31",408949]
[null,null,"Tuberculosis","TB/HIV","TB/HIV collaborative interventions","Establishment and running costs of additional VCT centers in hard-to reach areas, social support for additional detected TB/HIV patients Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","2020-12-31",195225]
[null,null,"Tuberculosis Total",{"$nulls":4},9315531]
[null,"Belarus","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.","2021-12-31",556161.96]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Interventions for young people who inject drugs","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.\nIn Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".","2021-12-31",98759.99]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Needle and Syringe programs for PWID and their partners","When planning the BLR-C-RSPCMT grant for 2019-2021, it was assumed that, starting in 2020, Belarus will purchase supplies (syringes, condoms, etc.) for HIV prevention cabinets for PWID at the expense of the state budget. An analysis of the existing legislative framework showed that legislative amendments are required to conduct such purchases. Changes can be made to the rulemaking plan only for 2021, adopted - not earlier than 2022. Thus, we consider it necessary to include the provision of supplies for HIV prevention cabinets for PWID at the expense of the grant BLR-C-RSPCMT.","2021-12-31",185040.65]
[null,null,"HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. \nFrom 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the client?s desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant ?Sustainability of Services for Key Populations in the EECA Region?, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.","2021-12-31",331819.28000000003]
[null,null,"HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. \nAs a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. \nIn line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD).\n MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.","2021-12-31",986668]
[null,null,"HIV/AIDS Total",{"$nulls":4},2158449.88]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO","2021-12-31",0.08]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","2021-12-31",0]
[null,null,"Tuberculosis Total",{"$nulls":4},0.08]
[null,"Belize","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","HIV testing services for MSM","HIV testing will be provided by a Civil Society Organisation (CSO) through the CSO Hub.  This activity will fund stipends of peer educators to reach more hard-to-reach Men who have sex with Men (MSM) and transgender people (TG) for testing. The activity will also include support for staff members conducting testing.","2021-12-31",40000]
[null,null,"HIV/AIDS, Tuberculosis","Program management","Other program management intervention(s)","The role of the Civil Society Organizations Hub (CSO Hub) as coordinator is an important component of this grant.  This intervention will enable regular Monitoring and Evaluation visits by the CSO hub, and includes the development of M&E Tools, the preparation of reports, the development of and implementation of a mechanism for project coordination including in terms of operational planning.","2021-12-31",100000]
[null,null,"HIV/AIDS, Tuberculosis","Programs to reduce human rights-related barriers to HIV services","Improving laws, regulations and polices relating to HIV and HIV/TB","The operationalization of the non-discrimination law is key.  Once the non-discrimination law is introduced by Cabinet there will be need for mass education on this new legislation to make it effective. This is a key activity of the funding request based on the Transition Readiness Assessment findings to improve the legislative environment.","2021-12-31",50000]
[null,null,"HIV/AIDS, Tuberculosis","Programs to reduce human rights-related barriers to HIV services","Improving laws, regulations and polices relating to HIV and HIV/TB","This intervention proposes to conduct an assessment of the implementation of the ?HIV/AIDS Policy of the Public Service of Belize? and revise the policy based on the recommendations of the assessment. This is important to strengthen the capacity of the Employee Assistance Program to enforce the implementation of the HIV policy which addresses issues like non-discrimination among public officers.","2021-12-31",20000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Community led advocacy","The capacity of Civil Society Hub?s members in human rights, legal and anti-stigma discrimination is key as communities must play an integral role in advocating for policy change and legal reform at all levels of the public system (including the Attorney General?s Office, Ministries of Finance and Economic Development) on issues like the non-discrimination law, social contracting and other key populations human rights issues.","2021-12-31",50000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Mini grants of USD 10,000 each for Civil Society Organisations (CSO) to build their institutional capacity necessary to carry out the work of the CSO Hub in the 4 different areas beyond the Global Fund grant. The need will vary among the CSOs, but will evolve around needs for equipment, furnitures or/and to pay stipends.","2021-12-31",50000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Mini grants of USD 5,000 each for Civil Society Organisations (CSO) to build their capacity to be sustainable beyond the Global Fund. This could include strategic sustainability planning, social networking advocacy and negotiation, non-traditional income generation, developing proposals for external funding and any other activity or progamme that would contribute to their sustainability beyond 2021.","2021-12-31",50000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","A major recommendation of the Transition Readiness Assessment is to collect and report updated HIV/TB sero-prevalence data on transgender persons, sex workers (SWs), prisoners, uniformed personnel and undocumented persons to be complemented by a Knowledge, Attitude and Practices (KAP) study with the same key populations. This will provide evidence for future programming especially within the context of sustainability.","2021-12-31",200000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Develop an electronic information system to track demand and supply of medicines and commodities at the facility level. This is a key component of the roadmap for Treat All to ensure that challenges presently experienced with stock outs are minimized.","2021-12-31",30000]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},590000]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","This is a demonstration study into the scaling-up of pre-exposure prophylaxis (PrEP) to prevent HIV infection among MSM in Benin (PrEP/MSM). We will continue to provide PrEP to maximize the reduction in HIV transmission within the MSM population.This is a HIV prevention method that involves people who do not have the infection, but who are at a high risk of it. They receive ART with Truvada to protect against potential exposure to HIV in order to reduce the risk of infection. The effectiveness of this strategy has been widely documented through several randomized trials. It reduces HIV transmission among MSM by more than 86 percent. It is a very promising preventive biomedical intervention that has a high impact on combating the HIV pandemic. This demonstration study will involve around 250 MSM.The main cost categories are: \n-Consultant costs (national and international) \n-Laboratory studies (including HIV, creatinemia, gonorrhea/chlamydia, hepatitis B serology and hepatitis C serology) \n-Transporting of study samples from laboratories (the Johns Hopkins University Laboratory with ARV dosage of Truvada, including the transport of samples) \n-Management of the monitoring and research teams \n-Management of the participants? travel at project launch and during the four monitoring phases \n-Workshops to draft and validate protocols and provisional and definitive reports","2020-12-31",647037.37]
[null,null,"HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Run three-day training/refresher training sessions for 180 health workers, including those working with men who have sex with men (MSM), on the revised algorithms for STI treatment. One session per former department will take place in 2019:\nPlanned for 2019, this intervention will support treatment for STIs in adapted services, a reference point for the targets addressed by NGOs.","2020-12-31",39863.089999999997]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","This intervention aims to facilitate access to prevention, care and treatment services for people who inject drugs. In addition to the quarterly meeting with the Interministerial Committee for Combating Narcotic Drugs and Psychotropic Substances Abuse (CILAS) budgeted as part of the catalytic funds, this intervention will take place twice a year during the first two years and in three quarters during the final year. These studies were not budgeted for as part of the allocation amount or the catalytic funds.\n This intervention comprises the following activities:\n\n-Quarterly advocacy meetings with CILAS to promote a favorable, non-discriminatory, inclusive environment that takes the gender perspective into account (?10,561)\n-Recruiting a consultant for a gender-sensitive update study that will estimate the number of people who inject drugs and map them (?23,212)\n-A gender-sensitive update study that will estimate the number of people who inject drugs and map them (?13,348)\n-Producing 50 copies of the report on the gender-sensitive update study that will estimate the number of people who inject drugs and map them (?381)\n-Recruiting a consultant to conduct a satisfaction survey of the beneficiaries of the program?s interventions throughout the country and in the service delivery areas (?30,623)\n-A satisfaction survey of the beneficiaries of the program?s interventions throughout the country and in the service delivery areas (?10,556)\n-Producing 50 copies of the report on the satisfaction survey completed by the beneficiaries of the program?s interventions throughout the country and in the service delivery areas (?228)\n-Recruiting a consultant to conduct a Second-Generation Surveillance Survey (SGSS) for people who inject drugs (?23,159)\n-An SGSS for people who inject drugs (?11,771)\n-Producing 30 copies of the report on the SGSS for people who inject drugs (?228)\n-A workshop to draw up and validate training modules to train 75 staff members on treatment for opioid users (?8,590)\n-Training for 75 health workers on treatment for opioid users (?28,298)\n-Recruiting a consultant to carry out a baseline (feasibility) study into treatment for opioid users (?14,403)\n-Elaborating and validating a document setting out the regulations and procedures for the treatment of opioid users (?9,101)\n-The procurement of methadone and other substitutes, amounting to one box (seven 1-mg capsules per box) per month per person who injects drugs over two years (?20,428)\n-Treatment costs for people who inject drugs for the treatment of opioid addiction (?69,516)\n-A baseline (feasibility) study into treatment for opioid users (?11,396)","2020-12-31",320735.05]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Condoms and lubricant programming for sex workers","Procure male condoms for sex workers: planned for year 3.","2020-12-31",90107.73]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Organize a six-monthly community-based screening campaign among sex workers, under the supervision of adapted services and NGOs to de-medicalize screening and provides better access to the service for sex workers.","2020-12-31",52692.18]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Sessions for the above.","2020-12-31",514120.75]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Supplies for screening sex workers: to address those sex workers and clients who do not attend adapted services, screening at this level will be carried out by sex worker peer educators (de-medicalized approach).","2020-12-31",486623.27]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Cover the monthly travel costs of facilitators from NGOs working with sex workers: planned for year 3. Travel by actors on the ground working with key populations.","2020-12-31",47546.85]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Exchange and working visit with the sex workers? network of Côte d?Ivoire","2020-12-31",16821.91]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Implement a network for sex workers? associations in Benin:iInterventions that aim to provide more space and more capacity for the sex workers? network to improve their involvement in the national response.","2020-12-31",17894.740000000002]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Organize a consultation meeting between the various actors from NGOs working with sex workers\n(based on 25,758 actors each year for the three years): \nThis intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","2020-12-31",86716.42]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Organize training/refresher training sessions for peer educators working with sex workers: planned for year 3. This intervention will build the capacities of peer educators for holding awareness-raising sessions addressing the target populations.","2020-12-31",30837.17]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Provide monthly remuneration for facilitators and peer educators from NGOs working with sex workers: planned for year 3. Remuneration for actors on the ground working with key populations.","2020-12-31",197597.35]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Six-monthly supervision of prevention activities implemented by the sex workers? network in areas frequented by sex workers","2020-12-31",17963.189999999999]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","This intervention aims to reduce HIV prevalence within this target group. This intervention was not budgeted for within the allocation amount. This intervention entails\nprocuring male condoms to raise awareness among female bar workers.","2020-12-31",17947.48]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Train medical and paramedical staff in treatment for sexually transmitted infections (STIs) and disseminate the algorithm.","2020-12-31",282796.53999999998]
[null,null,"HIV/AIDS","Comprehensive prevention programs for TGs","Behavioral interventions for TGs","The management of transgender peer educators and support groups aims to intensify prevention activities for transgender people and ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 90?90?90 targets. This intervention comprises the activities listed below. The management of transgender peer educators was planned for two years and nine months only, using the allocation amount and catalytic funds. It is planned for the final quarter as part of the prioritized above allocation request. The various activities are detailed below:\n-Five support groups per quarter that take a human rights-based and gender-transformative approach for 20 transgender people (educational session followed by condom distribution) (?1,295)\n-Management of ten transgender peer educators as part of SC/BCC activities (?1,097)","2020-12-31",2685.44]
[null,null,"HIV/AIDS","Comprehensive prevention programs for TGs","Other intervention(s) for TGs","Studies were not budgeted for within the allocation amount. The studies (size estimation and SGSS) will provide data to better monitor the impact of the interventions: \n-A gender-sensitive study that includes adolescents and young people to estimate the size of the transgender population in Benin and map it (?11,771)\n-Production of 30 copies of the study to estimate the size of the transgender population in Benin and map it (?228)\n-Recruitment of a consultant to conduct a gender-sensitive SGSS for the transgender population (?19,683)\n- An SGSS for transgender people (?11,771)\n-Production of 30 copies of the report on the SGSS for the transgender population (?228)","2020-12-31",49022.559999999998]
[null,null,"HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Organize an annual two-day information meeting of 40 actors from the Ministry of Health and the Ministry of Justice on interventions in the prison system: \nThis activity is planned to raise awareness among actors from the Ministries of Justice and Health so as to increase the impact of HIV interventions on prisoners.","2020-12-31",18758.84]
[null,null,"HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Organize a quarterly consultation meeting between the various actors from NGOs working with prisoners:\nPlanned for year 3. This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","2020-12-31",4585.34]
[null,null,"HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Pay allowances for facilitators from NGOs working with prisoners: planned for year 3. Remuneration for actors on the ground working with prisoners.","2020-12-31",27715.18]
[null,null,"HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Pay the travel costs of facilitators from NGOs working with prisoners: planned for year 3. Travel by actors on the ground working with prisoners.","2020-12-31",5542.59]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:\n(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)\nThe residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.","2020-12-31",126598.59]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.","2020-12-31",146149.70000000001]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Train 20 auxiliary nurses in each health district on PMTCT/IMPC and early diagnosis through dried blood spots in the health districts not covered by UNICEF (25) during 15 three-day sessions with 20 participants (plus two facilitators, one supervisor, one driver and one accountant) in 2018 and 2020:\nThis is an important activity for the program that will help achieve universal coverage of PMTCT and contribute to the ETME.","2020-12-31",27184.38]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Undertake mentoring on PMTCT/IMPC and early diagnosis through dried blood spots.","2020-12-31",26971.16]
[null,null,"HIV/AIDS","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Although prevalence remains low among adolescents and young people aged 15?24, levels of knowledge of prevention measures (61 percent) and access to testing (23.4 percent) remain critical and must be improved. This intervention was not budgeted for within the above allocation amount.\nIt relates to capacity building for young leaders and adolescents to provide quality interventions for other young people and adolescents. This intervention involves\nproviding training to 60 young leaders and adolescents and eight facilitators during three two-day sessions on peer education, the package of interventions that are based on a human rights and gender perspective (intervention strategies and SC/BCC) and data reporting tools.","2020-12-31",23782.959999999999]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","This screening intervention will intensify prevention activities for truck drivers to provide better coverage of screening and protection among the target group, with a view to improving the framework for achieving the 90?90?90 targets. This activity was not budgeted for within the allocation amount. This intervention entails \na quarterly ten-day screening mission undertaken by four people, including a driver, aimed at truck drivers.","2020-12-31",24388.959999999999]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","Male and female condoms for other vulnerable populations","This intervention aims to reduce HIV prevalence within this target group. Condoms were not budgeted for within the allocation amount. This intervention entailsprocuring male and female condoms for truck drivers.","2020-12-31",86223.77]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","The interventions involve the updating of modules, refresher training for actors, the editing of tools and consultation sessions. They will intensify prevention activities for truck drivers to ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 90?90?90 targets. This intervention was not budgeted for within the allocation amount.\nThis intervention comprises the following activities:\n-Updating the training modules for truck driver peer educators using a human rights and gender-transformative perspective. These include modules on health education, new forms of masculinity and the prevention of gender-based violence (?2,939.22)\n-Refresher training for 75 truck driver peer educators and 20 facilitators during four two-day sessions with 30 participants on the package of interventions (intervention strategies, Social Change and Behavior Change Communication (SC/BCC), pre- and post-test counseling) and data reporting tools (?15,726.64)\n-Producing 100 registers of people who have undergone awareness training and of the distribution of condoms and lubricants for truck drivers, and 3,500 fact sheets (?922.32)\n-Producing 90 visual aids based on a human rights and gender perspective for truck driver peer educators, including on health education, new forms of masculinity and the prevention of gender-based violence (?1,372.04)\n-Providing truck driver peer educators with one meal per day of the intervention, two days a month (outreach, communication and follow-up activities, distribution of condoms) (?38,417.15)\n-Recruiting consultants for the SGSS for truck drivers (?27,451)\n-An SGSS for truck drivers (?4,610)\n-A one-day consultation session with haulage trade unions (room hire, coffee break, administration and travel for 30 participants, supplies and photocopying) every six months, totaling six sessions over the three years by the sub-recipient (?8,378.60)\n-Producing 30 copies of the report on the SGSS for truck drivers (?228.67)\n-Covering the costs of the supply, storage, quality control and distribution of condoms for truck drivers (?6,146.74)\n-Producing 100 training manuals based on a human rights and gender perspective for truck driver peer educators (?381.12)","2020-12-31",119598.25]
[null,null,"HIV/AIDS","Program management","Grant management","Organize a six-monthly, ten-day mission to validate the financial documents and accounts of NGOs and the six CIPEC from the previous six-month period (two teams of four people: one manager, one accountant, one fiduciary management agency and drivers):\nThis activity aims to improve the quality of accounts and prevent ineligible amounts.","2020-12-31",27971.05]
[null,null,"HIV/AIDS","Program management","Grant management","Organize a six-monthly, ten-day mission to validate the use of rapid diagnostic tests in the activities in the following six-month period (two teams of four people: one manager, one accountant, one monitoring and evaluation specialist and one driver):\nThis activity facilitates the implementation of activities, particularly at the CIPEC level.","2020-12-31",27971.05]
[null,null,"HIV/AIDS","Program management","Grant management","Organize quarterly five-day missions to validate the accounts of private clinics for the payment of services, undertaken by two teams of three people:\nThis activity aims to improve the quality of accounts and prevent ineligible amounts.","2020-12-31",24225.119999999999]
[null,null,"HIV/AIDS","Program management","Grant management","Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):\nThis will motivate actors at the peripheral level.","2020-12-31",92382.45]
[null,null,"HIV/AIDS","Program management","Other program management intervention(s)","Ensure the participation of ten actors from the system each year in discussions and seminars:\nThis activity aims to provide actors from the program and from facilities with information on progress relating to HIV and also to allow them to share their experiences with actors from other countries.","2020-12-31",51324.21]
[null,null,"HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Draw up an annual list of suppliers: \nThis activity allows for the preselection of providers and facilitates the implementation of activities.","2020-12-31",8418.81]
[null,null,"HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Other external services. This intervention comprises two activities that were not budgeted for in the last three quarters of the final year (2020):\n-The provision of a driver to the Executive Secretariat of the National AIDS Committee so that it may implement and monitor activities on the ground (management of the National AIDS, Tuberculosis, Malaria, STIs and Epidemics Committee driver) (?2,744)\n-Support for the costs of a monitoring and evaluation intern (60,000 CFA francs per month for three years) to promote learning among adolescents and young people (?823)","2020-12-31",4002.92]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","With regard to women and girls in Benin, according to the national gender promotion policy that has been developed, socioeconomic factors in the country tend to confer inferior status to women compared with men, particularly in the areas of education, employment, health and access to land and finance. \nStereotypes and gender roles increase the vulnerability of women and girls to HIV and AIDS and restrict their access to existing information and services. The submission of women and girls demanded by tradition makes them subject to certain types of violence: levirate, early or forced marriage, sexual violence, sexual relations with older partners, etc. In addition, the imbalance of power makes women less able to negotiate the use of condoms or to choose their sexual partner.\nEducation sessions on gender-based violence and training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence are aimed at reducing HIV prevalence within this group. The sessions will address gender discrimination, harmful gender norms and all types of violence against women and girls in relation to HIV.\nIn detail, this intervention comprises the following activities:\n-Training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence (six sessions with 25 participants each, lasting two days) (?20,754)\n-Educational sessions on HIV, health education, sexual and reproductive health and rights, new forms of masculinity and the prevention of gender-based violence for Plan International Benin staff members (session with one coffee break for 30 people per month and for five teams) (?1,372)\n-Recruitment of a consultant to undertake an evaluation study of the legal setting for key populations (?13,500)","2020-12-31",39980.92]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","The study to evaluate the legal setting for key populations aims to provide data to better target interventions for them.","2020-12-31",12532.82]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Mobilize therapeutic assistants via two DAT consultants to draw up the community care strategy. With the adoption of the ?test and treat? strategy, a significant active file is anticipated, which will place pressure on the health system.","2020-12-31",19052.86]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Organize a meeting to validate the community care strategy:\n(45 participants)\nWith the adoption of the ?test and treat? strategy, a significant active file is anticipated, which will place pressure on the health system.","2020-12-31",11883.07]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Administrative and finance data sources","The financial monitoring of sub-sub-recipients will ensure that the resources allocated to them are managed correctly. This intervention entails the on-site monitoring of financial management at the sub-sub-recipient level, at a cost of ?2,881.29.","2020-12-31",3233.08]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Analysis, review and transparency","Contribute to the annual three-day regional consultation workshop held by the National AIDS Control Program (NACP) with actors from the departments (CIPEC, Departmental Health Directorate, District Health Management Team), involving 45 participants and 17 drivers:\nThis supports the monitoring of activities by actors on the ground and allows for actors at the intermediary and operational levels to better take ownership of HIV interventions.","2020-12-31",40887.67]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Procure 125 desktop computers and printers for care facilities:\nThe availability of IT equipment will improve the follow-up of the active file and medical files ? monitoring software (ESOPE) and dispensing software (Médistock).","2020-12-31",171079.56]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","The following activities relate to data quality (quality control, supervision and the review of progress update and disbursement requests), as well as planning and other activities linked to information systems and management, with the aim of improving the quality of the program: \n-Ensuring the participation of grant actors in discussions and short training sessions each year (?44,820) \n-Six-monthly quality control of the data collected by each team working on the ground, including the data disaggregated by sex and by age produced within their intervention areas (?6,105) \n-Six-day supervision, carried out by the Principal Recipient every six months, of actors on the ground at the departmental level (sub-sub-recipients and others) and at the commune level (NGOs and others), in terms of monitoring and evaluation (two three-person teams, including a driver) based on human rights and gender standards (?2,309) \n-The drafting of a six-monthly gender-sensitive report on the results obtained and the progress made in implementing the grant (?6,469) \n-Six-monthly quality control exercises carried out by the Principal Recipient to monitor data from teams working on the ground and NGOs, peer educators (MSM, people who inject drugs, young people who no longer attend, or have never attended, school and truck drivers, disaggregated by sex and by age) via two three-person teams. These exercises will last six days and take place in the 12 departments (?5,282) \n-Six-monthly monitoring and traceability of condoms, from wholesaler to the final distributers, carried out by two three-person teams over six days (?5,241)\n-An annual on-site data verification exercise at the sub-recipient level carried out by three three-person teams over six days (?7,923) \n-A six-monthly review of the progress update and disbursement requests of the two sub-recipients and the teams on the ground by the Principal Recipient -A six-monthly planning and review workshop with teams on the ground lasting four days (administration of 31 participants, including seven drivers, over four days) (?5,230)\n-The six-monthly maintenance of the integrated system of community data (SIDOC) by the developer (six days? consultancy every six months) (?2,552)","2020-12-31",104237.46]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Update the PLHIV biometric database periodically","2020-12-31",17963.189999999999]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Procure tablets to record the biometric data of PLHIV (to avoid duplication and ensure the procurement of biological services is well documented) and contract Internet services for facilities","2020-12-31",360415.22]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","These activities combine community data collected by NGOs and peer educators and allow for experiences to be shared between sub-sub-recipients and teams on the ground. They aim to produce quality data and strengthen interventions on the ground:\n-Six-monthly, two-day consultation meetings between sub-sub-recipients working with adolescents and young people who no longer attend, or who have never attended, school and adolescent and youth leaders to combine community data (room hire, coffee break, administration and travel of participants, supplies and photocopies) (?1,474)\n-Twelve two-day, gender-sensitive and inclusive consultation meetings with 30 implementation actors to improve the coordination of interventions for key and vulnerable populations (MSM, people who inject drugs, PLHIV, sex workers, adolescents, young people, transgender people, truck drivers and those close to them, and community-based organizations that include women and girls) (?10,281)\n-Six-monthly, two-day consultation meetings between sub-sub-recipients and peer educators working with people who inject drugs to combine community data disaggregated by sex and age (room hire, coffee break, administration and travel of participants, supplies and photocopies) (?7,299.19)\n-Monthly outreach supervision sessions for peer educators working with people who inject drugs and MSM, led by NGO facilitators (?3,366)\n-A six-monthly, two-day meeting for teams working on the ground to combine data and share the results of interventions for young people, MSM, people who inject drugs, and support for OVC and PLHIV with CPS, decentralized financial systems (SFD), ART facility managers, NGO facilitators, psychological support workers and legal experts (?20,361)","2020-12-31",56022.89]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","HIV surveillance survey among pregnant women: this is an important activity for epidemiological surveillance and also for SPECTRUM projections. This activity has been undertaken for more than 20 years.","2020-12-31",63712.27]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Study to evaluate the prevalence of hepatitis B among PLHIV:\nAfter tuberculosis, hepatitis B is the biggest threat to the care of PLHIV. This study will identify those with co-infections (so as to provide better care for them) and evaluate prevalence.","2020-12-31",68431.149999999994]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Organize two six-monthly consultation meetings per year for each region (north and south), a total of four two-day meetings of 40 people, including actors from treatment and prevention of mother-to-child transmission (PMTCT) facilities:\nThis activity should allow for the sharing of experiences and good practice, as well as any difficulties encountered so that they may be resolved.","2020-12-31",75035.350000000006]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Organize workshops on establishing ARV treatment adherence clubs in each care facility with the support of the Benin Action Network for People living with HIV (ReBAP+) and care facilities (to reduce the number of appointments at care facilities for stable patients receiving treatment).","2020-12-31",53582.09]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Quarterly supervision of adherence clubs by ReBAP+ and the NACP:\nThe establishment of adherence clubs requires regular monitoring by ReBAP+ and the program during the first few years.","2020-12-31",35926.379999999997]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV.","2020-12-31",121722.59]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities:\n-Refresher training for 400 people (health workers, social workers, health mediators, therapeutic educators, MSM and transgender associations and other social organizations) during 20 sessions with 30 participants each. This training will address the specific needs of key and vulnerable populations (psychological support for improved referral and care for key and vulnerable populations), human rights and medical ethics linked to combating HIV and tuberculosis (?49,430.07)\n-Procuring nutritional kits to support the most vulnerable PLHIV on ART (men, women, boys and girls) to help improve their nutrition and their adherence to ART (?356,730) \n-Repackaging nutritional kits and distributing them to beneficiary PLHIV (men, women, boys and girls) on a quarterly basis. These kits are gender-specific, non-discriminatory and inclusive (?9,146.94)\n-Paying the salaries of ReBAP+ staff (program lead, administrative assistant, accountant and monitoring and evaluation specialist) (?16,670)\n-Paying health insurance for ReBAP+ staff (?4,390.53)\n-Contributing to the running costs of ReBAP+ (office rent, water, electricity, communications and supplies) (?3,978)","2020-12-31",417326.9]
[null,null,"HIV/AIDS","Treatment, care and support","HIV care","Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.","2020-12-31",1929341.26]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Coaching and mentoring on ART in civilian prisons by neighboring care facilities\n(10 days: one experienced prescriber, one CIPEC, one SPECS and a driver).\nHIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. Given the lack of experience of these nurses and the noted organizational difficulties, coaching and mentorship should be organized to improve care quality. This will be undertaken by an experienced prescriber, along with a departmental and national supervisor.","2020-12-31",12325.22]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Give each care facility a means of communicating so that they may offer differentiated services (to communicate results, make appointments and undertake follow-up) \n(One smartphone per facility costing 100,000 CFA francs each, for 150 facilities) In December 2016, Benin adopted the ?test and treat? approach and anticipates a substantial increase to the active file, placing increased pressure on the health system. To prepare for this, the country changed the schedule for dispensing ARVs to every three months, and every six months for medical consultations. To ensure the quality of care while empowering patients, the country plans to establish a system for communication between health workers and patients to deliver results, make appointments and undertake remote follow-up.","2020-12-31",25650.32]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Hold 18 five-day training sessions for 450 doctors and paramedics in care facilities on pediatric care (25 participants, three trainers and one supervisor per session), following the new World Health Organization recommendations:\nThis activity aims to improve pediatric care.","2020-12-31",59423.18]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Monitor the care provided at each facility on a quarterly basis: \nOne medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.","2020-12-31",243274.6]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Organize an advocacy meeting on the community care strategy: With the adoption of the ?test and treat? strategy, a significant active file is anticipated, which will place pressure on the health system. It is important to involve all actors in defining the basis for community involvement.","2020-12-31",11883.07]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):\nImprovement of the biological monitoring of people living with HIV (PLHIV).","2020-12-31",19066.32]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Procure 100 extra cupboards for care facilities that have not yet been equipped:\n(?610 per cupboard)\nDuring the first part of the grant, 43 cupboards with shelves were procured for care facilities to improve storage conditions for ARVs. The intention is to procure more for the remaining facilities and for the new facilities that will be set up.","2020-12-31",68431.149999999994]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Six-monthly supervision and monitoring of care in prisons\n(one NACP representative plus driver, one CIPEC, one prescriber from a neighboring facility, registered prison nurse)\nHIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. The intention is now to scale this up and involve all ten prisons. Regular supervision and monitoring is therefore vital in the initial years to ensure that the care is given properly.","2020-12-31",8725.17]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: \n-Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (?2,103.80) \n-Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (?4,315.07)\n-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (?4,573.47) \n-Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (?7,546.23) \n-Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (?1,632.73) \n-Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (?6,585.80) \n-The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (?4,102.40) \n-Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (?5,460.72) \n-Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (?3,430.10)\n-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for OVC and PLHIV in all departments (plan) (?343.01) \n-Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (?4,573.47) \n-Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (?332,582.78) \n-Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (?10,425.99) \n-Covering the costs of the ReBAP+ helpline (?1,646.45) \n-Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (?4,573.47) \n-Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (?42,807.68) \n-Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?8,479.21) \n-Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?9,878.70) \n-Producing badges for the peer educators/health mediators involved in the projects (?1,524.49)","2020-12-31",467496.35]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Train 250 paramedics and medics in care for patients receiving antiretroviral therapy (ART) (184 providers from the 92 former sites, 24 from the new sites and 42 participants from the central level and the Information and Support Centers for STIs, HIV and AIDS (CIPEC)). The training will take place over ten sessions with 25 participants, two facilitators, one supervisor, one manager and two drivers: \nThis activity is important for the delegation of tasks to paramedics and ensuring the quality of care despite the limited number of doctors in care facilities.","2020-12-31",51518.35]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Train providers on the use of tools to assist treatment adherence during six three-day sessions:\nThis activity aims to improve care, given the risk of patients abandoning treatment linked to early diagnosis and the improved survival rate of PLHIV.","2020-12-31",30821.46]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment adherence","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.","2020-12-31",220113.23]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Transport viral load samples from care facilities to molecular biology platforms on a monthly basis: Provide access to viral load testing for facilities located far from the molecular biology platform.","2020-12-31",83144.429999999993]
[null,null,"HIV/AIDS Total",{"$nulls":4},8697043.9999999981]
[null,null,"Malaria","Case management","Private sector case management","Given the contribution of the private sector (20.7%) in the attendance of health services (SNIGS 2015), it is proposed to continue activities started in the 2016-2017 grant and the partnership between the PNLP and the Private Sector Platform (PSB). This will improve the quality of malaria management through training / supervision of stakeholders, dissemination of care / prevention protocols, reporting of data, provision of subsidized inputs.","2020-12-31",801942.54]
[null,null,"Malaria","Case management","Removing human rights and gender related barriers to case management","Specific new actions will enable approximately 7,000 persons deprived of liberty to access quality treatment services and thus guarantee their right to health.\nThese actions are: i) Training / supervision of prison medical staff; ii) Provision of treatment; iii) Provision of prison health centers in Inputs Malaria control for the free care; and iiii) Consultative meetings with the concerned ministries for a good coordination of activities","2020-12-31",48261.7]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","In order to achieve the objectives assigned to it, to improve its performance in terms of financial management, administrative and to be up to standard, the NMCP plans to upgrade its staff.\n\nThe different training courses proposed in this funding match the needs according to the profile of the agents available for the implementation of the program's activities.","2020-12-31",196762.43]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","The last program's performance review in 2016 noted that indicators related to the annual incidence of malaria and lethality have evolved positively. However, it was noted the weak involvement of the private sector in the fight against malaria, the failure to comply with the guidelines for the management of malaria cases despite the availability ILPs and weaknesses related to the use of DHIS2 software. The next review is scheduled for 2019.","2020-12-31",68946.25]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Surveys","Mandatory test that follows mass distribution campaigns and provides information on the effectiveness of distributed LLINs, it also guides the choice of LLINs for subsequent campaigns, and the next one is for 2020. It is therefore necessary that this monitoring be carried out as recommended by the international scientific committee. The NMCP must therefore carry out these studies in 2019 and 2020.","2020-12-31",68432.27]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Surveys","To be effective in vector control, it is necessary to carry out vector susceptibility tests to determine the status of the vector against insecticides available on the international market. This study is conducted as a prelude to IDP campaigns to select the appropriate insecticide. The latest study conducted in 2017 noted that pyrimiphos methyl remains the sensitive insecticide from which it was chosen during the 2017 IRS campaign","2020-12-31",110260.35]
[null,null,"Malaria","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","2020-12-31",750000]
[null,null,"Malaria","Vector control","Indoor residual spraying (IRS)","The NMCP proposes to implement the extension of the IRS to other communes eligible for a pre-elimination of malaria in the medium and long term. The area of Dassa Glazoué in the hills department is chosen for funding beyond.\nThis choice is mainly based on scientific evidence in terms of short transmission period and the abundance of vectors and their infectivity in this area.","2020-12-31",5023248.79]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The gap of 315 000 LLIN has been filled","2020-12-31",0]
[null,null,"Malaria Total",{"$nulls":4},7067854.3300000001]
[null,null,"RSSH","RSSH: Health management information systems and M&E","Routine reporting","Strategy for community health workers can be expanded, through the use of community data applications. Procurement of 3,312 smartphones and accessories, and training of 3,312 community health workers already active in partner programs.","2022-06-30",2180230.0499999998]
[null,null,"RSSH","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","The additional investment will make it possible to cover 65 percent of needs (from 47% with only allocation and matching funds): recruitment, training, incentivization, equipment, provision of tools, and monitoring of 4,147 community health workers implementing the complete package of interventions.","2022-06-30",2569275.0499999998]
[null,null,"RSSH","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","10 percent of health care facilities are renovated and fitted out, based on the assessment outcomes, in order to improve drug quality at the local level.","2022-06-30",1112017.73]
[null,null,"RSSH Total",{"$nulls":4},5861522.8300000001]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","Objective: to conduct research work on the mathematic modelling of the transmission of tuberculosis in Benin, to obtain a better estimate of the number of cases of tuberculosis in the population, in partnership with the University of Liverpool and the National University Hospital Centre for Pneumo-Phthisiology in Cotonou.","2020-12-31",67332.509999999995]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Objective: to conduct an evaluation of the catastrophic costs borne by the patients and their households, for the introduction of appropriate measures (WHO protocol: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/ meetings/tf6_background_5a_patient_cost_surveys_protocol.pdf).","2020-12-31",61537.43]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.","2020-12-31",3534458.53]
[null,null,"Tuberculosis","TB care and prevention","Treatment","Objective : To reduce the fatality rate of TB patients who have any other associated comorbidities (HIV, Diabetes, Anaemia, Viral hepatitis B and C). The mortality rate is 14% among TB/HIV co-infected patients vs 6% for all patients. A well-equipped technical block will be established at the main hospital in Cotonou, treatment protocols will be created and disseminated in all treatment centers. As part of the quality assurance policy, a portable spectroscope and a highperformance liquid chromatograph will be procured to ensure more regular monitoring of the quality of anti-tuberculosis medication.","2020-12-31",342159.13]
[null,null,"Tuberculosis Total",{"$nulls":4},4005487.5999999996]
[null,"Bhutan","HIV/AIDS","HSS - Policy and governance","Other policy and governance intervention(s)","This funding will be used to purchase a vehicle to suport program monitoring and evaluation and to transport pharmaceutical and health products between the centers.","2021-06-30",55000]
[null,null,"HIV/AIDS","Program management","Other program management intervention(s)","This funding will be used to build the capacity of the National HIV/AIDS Commission in order to create an enabling policy environment and improve long-term impact.","2021-06-30",35000]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Given the critical future role of community organizations in service delivery, competency and organizational development of relevant CSOs will have a benefit on the national program.","2021-06-30",76173]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This funding will be used to establish a national surveillance system and address gaps in program knowledge related to data analysis for strategic decision-making.","2021-06-30",0]
[null,null,"HIV/AIDS Total",{"$nulls":4},166173]
[null,null,"Malaria","Case management","Other case management intervention(s)","Introduction of new diagnostic tools, improving quality of diagnostics.","2021-06-30",121018]
[null,null,"Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Further development/strengthening community action groups at the block level.","2021-06-30",42225]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Establishment of web-based reporting system and improving cross-border data sharing.","2021-06-30",0]
[null,null,"Malaria","Vector control","Other vector control measure(s)","Strengthening community action groups, establishing cross-border information sharing on vector species, improving program capacity for prevention of re-establishment","2021-06-30",51181]
[null,null,"Malaria Total",{"$nulls":4},214424]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Procurement of additional laboratory equipment for MDR-TB diagnosis and drugs for XDR-TB treatment.","2021-06-30",0]
[null,null,"Tuberculosis","Other module","Case detection and diagnosis","Training of medical doctors on management of TB/HIV co-infection, training of TB and VCT focal persons on TB/HIV collaborative guidelines.","2021-06-30",41670]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","Funds for conducting operational research, establishing internet connectivity for web-based reporting and funding for an external review of the TB program","2021-06-30",0]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Procurement of biosafety cabinets, training interdisciplinary team on tb screening, contact tracing and follow-up for MDR-TB patients.","2021-06-30",155236]
[null,null,"Tuberculosis Total",{"$nulls":4},196906]
[null,"Bolivia (Plurinational State)","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Conducting of a study of primary resistance to ARV in new patients is planned as a critical element of strategic information in order to strengthen management, decision-making in terms of antiretroviral drug policies, sustainability and progress towards the goal of suppressing viral loads. A total cost of USD 100,000 is estimated.","2021-12-31",100000]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.","2021-12-31",50000]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.","2021-12-31",5808]
[null,null,"HIV/AIDS Total",{"$nulls":4},155808]
[null,null,"Malaria","Case management","Active case detection and investigation (elimination phase)","Activity 59: Amazon Region Meeting to consolidate the AOP for each municipality. (Participants: organized civil population, municipality, regional authorities) prior to preparation of the AOP (July each year) in Cobija.\nActivity mentioned in the diagnosis for transition as part of the negotiation with municipalities.","2021-12-31",52155]
[null,null,"Malaria","Case management","Other case management intervention(s)","Activity 31: Training plan for microscopists in low parasitaemia and strengthening of quality control (Guayaramerín)","2021-12-31",47377.5]
[null,null,"Malaria","Case management","Other case management intervention(s)","Activity 45: Training of medical personnel in clinical handling of malaria cases (2 events per year, from different health services in the endemic area) Riberalta","2021-12-31",55788]
[null,null,"Malaria","Case management","Other case management intervention(s)","Activity 46: Training for nurses from the Bolivian Amazon Region (Riberalta)","2021-12-31",30533.15]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the region?s needs.","2021-12-31",62117.18]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","Activity 299: Review of the purchasing process, delivery documents, official receipts from end users in the different regions. Support is required from a person to conclude the processes within time limits appropriate to the intervention.","2021-12-31",30172.41]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","Activity 269.1: Quarterly supervision of municipalities or lower levels  for healthcare establishments that carry out diagnosis and treatment (laboratory, hospital, pharmacy); IRS activities and distribution of LLINs in priority locations. Due to reduce allocation, it is essential for the regional authorities to have these resources, especially since the municipalities that intervene in the Amazon region are the poorest in the country and do not receive in equal proportion to the other municipalities the amounts that would contribute to the monitoring of malaria in the Amazon region.","2021-12-31",367286]
[null,null,"Malaria","Vector control","Other vector control measure(s)","Activity 137: Strategy for elimination and recycling of waste, with communication actions","2021-12-31",64315.13]
[null,null,"Malaria Total",{"$nulls":4},709744.37]
[null,"Burkina Faso","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Equip infirmaries in 7 detention centers. 14 have been already equipped with Rd 10 and NFM.","2020-12-31",51503.76]
[null,null,"HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Renovating the infirmaries and social services in 20 detention centers. 3 have been already renovated. It addresses concerns raised by the TRP issue 2.","2020-12-31",149753.10999999999]
[null,null,"HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Organize trainings for counsellors (RSSH) regarding community screening.","2020-12-31",88955.22]
[null,null,"HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Organize yearly workshop for pediatricians on early infant diagnosis (EID) and pediatric HIV care.","2020-12-31",107062.06]
[null,null,"HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Performing quality control mission every six months on the HIV testing carried out by community personnel during testing campaigns among the key populations and the general population. New Activity.","2020-12-31",86121.65]
[null,null,"HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Scaling-up EWI in health regions through maternity facilities for them to measure early warning indicators (EWI) each year.","2020-12-31",149023.67999999999]
[null,null,"HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Training care providers in each of the 3 health regions for them to measure early warning indicators (EWI) each year.","2020-12-31",19434.41]
[null,null,"HIV/AIDS","PMTCT","Prong 3: Preventing vertical HIV transmission","Holding an annual national forum on the elimination of mother-to-child transmission of HIV in Burkina Faso (each year).","2020-12-31",24006.28]
[null,null,"HIV/AIDS","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Monitoring/support for pregnant women who have recently tested positive, provided by pairs of peer educators.100 couples who are PLHIV will be trained and will provide peer support. Based on a UNICEF pilot activity.","2020-12-31",1026431.38]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Equip 11 community organizations that offer HIV treatment and care with basic medical equipment.","2020-12-31",152466.60999999999]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Equipment 36 non-governmental testing sites (including the 13 rehabilitated) with client oriented equipment.","2020-12-31",218639.88]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Holding a workshop to approve the training modules for community RSSH counsellors.","2020-12-31",4950.0600000000004]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","TProviding operational support for the national coordination of the Network for Greater Involvement of People Infected with HIV (NEGIPIH).","2020-12-31",121637.3]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.","2020-12-31",80404]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Study on the stigmatization index in Burkina Faso.","2020-12-31",61094.15]
[null,null,"HIV/AIDS","Treatment, care and support","HIV care","Training and retraining of service providers to provide health services to key populations in 13 regions.","2020-12-31",53325.1]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Procure part of the reagents for biological follow up to provide free access to ARV patients in need (50%b of people in treatment).","2020-12-31",1529674.56]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Workshop to review the training modules for the counsellors (RSSH) regarding community screening.","2020-12-31",17198.97]
[null,null,"HIV/AIDS Total",{"$nulls":4},3941682.18]
[null,null,"Malaria","Other module","Other module","Acquiring artesunate injectables for the management of severe malaria in patients aged 5 and above (except pregnant women) in 2019 and 2020.","2020-12-31",0]
[null,null,"Malaria","Other module","Other module","Training/refresher of public and private sector health workers on case management of malaria. IMC/USAID-PMI will fund training for 2/3 of the 8,554 agents to (5,782 agents) and the remaining shall be funded by the above allocation (2,891 agents).","2020-12-31",358872.18]
[null,null,"Malaria","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Training / refresher training CHWs s on the community-based response package (including the use of RDTs). This will involve training / refresher training for all the CHWs of the remaining 42 remaining districts on integrated ICCM package in 2018 in 6 days with 2 trainers per CSPS.","2020-12-31",928007.52]
[null,null,"Malaria","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","BAcquire reagents and consumables for the production of labile blood products (PSL). The request is to support the procurement of kits consisting of serological reagents, blood bags, tubes, etc.","2020-12-31",4603524.41]
[null,null,"Malaria","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","For the period 2018-2020, the CNTS needs 617,009 kits.","2020-12-31",188647.62]
[null,null,"Malaria","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Implement a pilot project to improve the quality of the integrated management of childhood illnesses by the CHWs and data flow using the MEDSINC tool.","2020-12-31",157109.19]
[null,null,"Malaria","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Expand IMCI-REC in 12 new health districts. As of 31 December 2017, 16 health districts will have the capacity to implement integrated child care through the use of the electronic tool (IMCI-REC).","2020-12-31",0]
[null,null,"Malaria","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Training for providers of districts in clinical IMCI. Previous training have not met all the needs. The planning involves the training of an average of 25 staff per health district in the 8 regions not covered by the IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center-Sud, Center-East, Central): 25 sessions of 25 agents on average for 11 days in 2018 and 2020.","2020-12-31",568340.06000000006]
[null,null,"Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Acquire SPAQ doses for the implementation of SMC in 49 districts in 2020 and carry out the campaign in the same year.","2020-12-31",1034984.3]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The current funding (World Fund, USAID and State) covers needs from 2018 to 2020 except for routine LLIN for pregnant women in 2019. This Gap is included in the above allocation to acquire 886,517 MILDA. The mass distribution campaign is planned for the first half of 2019.","2020-12-31",2530411.85]
[null,null,"Malaria Total",{"$nulls":4},10369897.130000001]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Equipping 2 medical units specialized in MDR-TB treatment: The 2 pneumology centres of CHUYO and CHUSS (16 beds in Ouagadougou and 9 beds in Bobo) are under construction in the 2 hospitals, planned for completion in late 2017. The equipment include: Medical bed, orthopaedic mattress, 2-section viewbox, separate lighting, office desk, air conditioning unit, fan, office chair, visitor chair, side table, wardrobe, examination table...","2020-12-31",56199.64]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Acquiring complete office computers for electronic registration of TB patients in 20 CDT. this will include complete office computers: monitor, central unit, uninterruptable power supply and printer. and will be allocated to the 20 TTCs with the highest numbers of patients that will take part in this electronic registration pilot phase.","2020-12-31",33360.519999999997]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Conduct a training of the NTBCP workers by WHO and a training of TTC staff. This will be done during support mission  at the start of the period and a second follow-up mission six months later.","2020-12-31",9922.61]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.","2020-12-31",25470.81]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Training CDT patients in electronic TB registration. The training will target the  24 structures (20 TTCs and 4 reference centres) involved in the pilot phase of TB electronic registration. The estimated duration of this training is 3 days. The content of the training will be the following: One and a half days on general aspects of the IT and the second half of the training will concern the use of the software itself.","2020-12-31",7031.55]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Organize a 3-day training session in 2020 to train 100 (centres d?information et des statistiques sanitaires, CISSE) and (services de planification de l?information hospitalière SPIH) workers regarding the new directives and the analysis of data concerning the fight against tuberculosis  the target will be: 100 CISSE and SPIH workers : 1 x 70 HD + 1 x 13 RHD + 1 x 8 CHR + 1 x 5 CHU + 4 central workers (DSS = 3 and DLM = 1).","2020-12-31",28937.09]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Carry out a new survey in order to assess the impact of the communication strategy of the 2013-2017 of national tuberculosis control program (NTBCP) that is being implemented, in terms of knowledge, attitudes and practices among the population in relation to tuberculosis. This second KAP survey, planned for the second quarter of 2019.","2020-12-31",55600.86]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Conduct a feasibility study of the integration of active screening for TB among children aged 3 to 59 months seen during the SMC campaigns. This innovative, integrated approach is expected to boost active TB screening and to improve the performance of the 4 NTBCP in relation to tuberculosis among children. Location: 2 of the 12 health regions covered by the SMC. Study period: 2018 Partners: NMCP, Paediatricians, WHO/RDT.","2020-12-31",85539.79]
[null,null,"Tuberculosis","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Refurbishing 9 Centre for the Diagnosis and Treatment of TB in 2019. The selection of the 9 sites was based on findings from the supervision with major refurbishment needs as: cramped, lack of ventilation, watertightness, dilapidated roof, etc. These CDT are the following: Dô, Dori, Orodara, Pama, Dedougou, Mangodara, Manni, Sapouy and Bokin","2020-12-31",391767.47]
[null,null,"Tuberculosis","TB care and prevention","Prevention","Broadcasting each of the adverts 3 times per week and per language (French, Mossi, Dyula and Fula) on the 3 television channels. In fact, the radio adverts will be broadcast from 2018 until the first quarter of 2019, so that the KAP survey planned for the second quarter of 2019 will be used to measure their impact, among other things.","2020-12-31",400326.23]
[null,null,"Tuberculosis","TB care and prevention","Prevention","Broadcasting each year, 6 times per week, the radio adverts in French, Mossi, Dyula and Fula concerning the fight against tuberculosis on the stations of the 25 radio partners. The 3 broadcasts per week are due to the need to take advantage of the 2 weekend days during which the audience is larger .","2020-12-31",427014.64]
[null,null,"Tuberculosis","TB care and prevention","Prevention","Produce 3 TV adverts on the fight against tuberculosis in the following languages: French, Dyula, Mossi and Fula in order to reach a large number of people among the urban population (27.53% of the total population in 2015)","2020-12-31",8211.82]
[null,null,"Tuberculosis","TB care and prevention","Treatment","Provision of nutritional support to 20% of drug sensitive TB patients, with expected outcome to increase the tuberculosis treatment success rate (currently at 78%). Since 2010 When nutritional support stopped), the rate of patients lost to follow-up has been on the rise (6.4% in 2010 to 7.4% in 2015). The target for this support: 1165 in 2018, 1202 in 2019 and 1250 in 2020 for a monthly ration cost: 35,000 CFA francs, or 53.36 euros. Composition of a ration: protein-rich foods, cereals, vegetables, oil and sugar.","2020-12-31",1652182.26]
[null,null,"Tuberculosis Total",{"$nulls":4},3181565.29]
[null,"Burundi","HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Activity: Organizing at the national level, an advocacy workshop with different actors for LGBT mainstreaming in program design and LGBT interaction with the general population.\nThis activity helps to improve the prevention of HIV / AIDS and STIs among LGBT people and create an enabling environment to facilitate access of this population to prevention and care services.","2020-12-31",4776]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Activity: Training / retraining Peer Educators of IDUs at the national level on the HIV prevention and harm reduction package related to drug use.\nThis activity helps to improve the prevention of HIV / AIDS and STIs among IDUs and to increase their knowledge of the concepts of HIV prevention and harm reduction.","2020-12-31",31542]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Community empowerment for PWID","Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDU\nThis activity aims to improve the living conditions of key populations.","2020-12-31",43274]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.\nThis activity aims to reduce new infections by facilitating PS to access prevention and care services.","2020-12-31",4350]
[null,null,"HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Activity: Acquire reagents for HIV testing\nThe 2018-2020 grant and other partners (FM, UNICEF, PEPFAR) are planning to acquire HIV testing reagents to cover the various screening tests for $ 165,979.77, with a total requirement of 4,066 730,3USD is a Gaps of 2 443853USD\nThis funding beyond this will enable the country to reach screening coverage for the different types of Country Target Testing.","2020-12-31",2443853]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Activity: Strengthen the capacity of men champions (PLHIV) to raise men's awareness of the support and support of pregnant and lactating women for PMTCT\nThis activity aims to reduce new infections by reducing the transmission of HIV from mother to child.","2020-12-31",17146]
[null,null,"HIV/AIDS","Prevention programs for general population","Other intervention(s) for general population","Activity: Security stock of prevention inputs (condom and lubricating gel)\nThe 2018-2020 grant does not provide security stocks for prevention inputs.\nThis funding will allow the country to have a 4-month security stock representing 25% of annual needs. This will prevent any stockouts. For the 2018-2020 grant, the expected input quantities (male condoms, female condoms and lubricant gels) are 26,931,063; 870,979 and 29,938,622 with an aggregate amount of US $ 2,027,089.37.","2020-12-31",225232]
[null,null,"HIV/AIDS","Program management","Grant management","Activity: Pay the performance bonuses of the PNLS:\nThis is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.","2020-12-31",238919]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Acquire the equipment for archiving patient records at the sites of care (mettallic cabinets and files to hang).\nPatient records must be kept secure and confidential. To do this, each of the 750 care sites needs at least one metallicall cabinet for the preservation of patient records. In addition to the wardrobes, there will be a need for suspends for every patient file estimated at 65,000 PLHIV across the country.","2020-12-31",371150]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Multiply standardized tools for collecting health data\nThe unit price of the black and white photocopies of the different houses is 60 Fbu the copy and the binding is 2000 Fbu per document. The standard tools are integrated and are multiplied throughout the grant to reason to have data for different indicators. These are patient records, CPN registers, CPoN, Childbirth, PEC, STA, Lab, CDV, TB / HIV Coinfection. These registries will be multiplied once a year for the 750 sites of care for PLHIV that patients will be multiplied once a year for the PLHIV expected.","2020-12-31",605529]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Review the tools for collecting HIV data\nThe set of HIV tools will be revised by integrating all the indicators of the new strategic plan 2018-2022 and the adequacy of the new guidelines for the care of PLHIV. This will provide data for monitoring the strategic plan. Two workshops of 25 people for 4 days will be carried out inside the country.","2020-12-31",8287]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Ensuring a link between AIDS-INFO and central, intermediate and peripheral DHIS 2 levels\nThe Server for networking has already been acquired and installed at the level of the PNLS / IST. This link can not be done without all patient records being entered in AIDS-INFO. This amount will enable data entry in AIDS-INFO to update all patient records for an activity queue of 65,000 PLHIV.","2020-12-31",37992]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Ensuring DHIS2-GIS interconnection for georeferenced data analysis:\nDSNIS has developed a health map that is interconnected to DHIS2. However, the interconnection stopped at the level of the BDS and BPS coordinates for lack of skills to integrate the geographic coordinates of health facilities. This interconnection requires international consultancy","2020-12-31",10667]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session","2020-12-31",65947]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:\nThe DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days","2020-12-31",27237]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Providing sites with support for adequate computer equipment for data management\nFor the moment, the CDS make the data entry themselves in DHI2. Field visits show that most CDS have a single laptop. This computer is used for the administrative activities of the CDS. It is necessary that the SIS service of the FOSA who take care of the data regularly has its own computer. In total, we have 750 support structures. In the past grant, the computer support concerned only about 170 structures.","2020-12-31",762756]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:\nFollowing the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.","2020-12-31",24888]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Support DHIS2 hosting for 2 years\nThe DHIS2 is hosted by a house that provides maintenance and regular back up of the base. A contract is signed between the MSPLS and the said house for a monthly amount of US $ 650","2020-12-31",15600]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Train 210 users on the AIDS-INFO database at all levels\nThe training will be organized for the 210 sites of care of the PVIH by favoring those who have a large active girl. In the current grant we had the budget to train only 100 people. The training will be 30 participants per session for 4 days so a total of 7 training sessions. This activity will improve the monitoring of PLHIV and the quality of the data.","2020-12-31",31197]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Train 3 people by BPS, by BDS and by hospitals / CDT on the tracker integrated in the DHIS2 for the follow-up of the tuberculous patient.\nThe DSNIS, in collaboration with the TB program, intends to strengthen the capacities of the BPS, the BDS and the hospitals / CDT (Director, DACS and chief of the nursing) in the follow-up of the CDTs to the use of the integrated tracker in the DHIS2 in 1 mission per quarter for 2 years. Each mission lasts 6 days","2020-12-31",78499]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Activity: Buying Reagents and Consumables for the Automaton for the Screening of Blood Transfusion Transmitted Disease (GAS) Markers\nIn the previous grant, the Global Fund delivered the AUTOMATE with the reagents for only 3 months considered as starting. As these three months have elapsed, for the moment the reagents are broken and the appariel is not operational. These reagents will allow the use of the device for a period of 2 years and this will improve the benefits of the CNTS.","2020-12-31",1592613]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Activity: Ensuring the maintenance of the AUTOMATE (GAS)\nThe CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.","2020-12-31",35069]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Activity: Establish a panel of sera for reagent validation (especially for HIV), HBV and HCV)\nThis activity is done in four (4) steps: sensitization of sites involved in sample collection, sample collection, sample analysis, aliquoting and sample conservation. The sensitization will inform providers about the importance of making this panel and how to do it to obtain good quality samples for the constitution of this panel. This panel will evaluate testing and quality control.","2020-12-31",17535]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Activity: Training 210 people in biomedical equipment maintenance\nThis training is intended for laboratory technicians. It involves training 210 laboratory technicians for 4 days for the 7 training sessions. This will enable these laboratory technicians to do the preventive and curative maintenance of laboratory equipment. This improves the quality of the analyzes for the follow-up of PLHIV.","2020-12-31",40826]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Activity: Implementation of the LMIS system and its maintenance for 3 years.","2020-12-31",433080]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Activity: Conduct a study on estimating mother-to-child transmission rate of HIV\nThe estimate of the mother-to-child transmission rate is an indicator of the NHP, the current grant performance framework, but also an indicator of the progress of PMTCT. Until then the indicator was estimated by the Spectrum. In order to obtain an indicator that is as close as possible to the reality of the scope of the interventions we propose to carry out this study which in addition to the transmission rate makes it possible to evaluate the quality, availability and accessibility of PMTCT services.\nThis is a study that will be conducted in 2019 and will cover the entire country according to a methodology that will be proposed by the consultant / firm and validated by the steering committee.","2020-12-31",36348]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Activity: Make a study on the prevalence of HIV-viral hepatitis coinfection.\nIn Burundi, the seroprevalence of HIV-viral hepatitis co-infection is not known because no study has been conducted for the determined. Or, currently, it is well known that viral hepatitis is the main cause of complications in PLHIV where they can have very serious consequences in accelerating the progression of HIV to AIDS disease and vice versa. It is in this context that a seroprevalence survey of HIV-hepatitis co-infection is essential in order to make a global care planning for co-infected PLHIV based on evidence in order to improve the care that is offered to them.","2020-12-31",32221]
[null,null,"HIV/AIDS","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Activity: Train 45 pharmacy managers from 45 districts on HIV / TB drug management in two sessions\nThe training will target 46 district pharmacy managers to strengthen them on the rational management of medicines and the supply chain. The training will be done in two training sessions. \"","2020-12-31",9770]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Activity: Maintain viral load and PCR equipment\nIn order to ensure the achievement of CVs and PCRs among PLHIV and children born to HIV-positive mothers, machine functionality is a prerequisite.\nThis subsidy is currently being implemented and includes the maintenance of 2 viral load devices for 2019. As in 2020, the OPP-ERA project will be closed, maintenance will be extended on the other 4 Opp-era machines. (Muyinga, ANSS, CHUK, Gitega). For the two Abboth machines, we have a Gap of $ 10,000 a year and for the machines provided by OPP-ERA we have a gap of $ 32,000. This makes a total gap of $ 52,000 for the period from 2019 to 2020.","2020-12-31",52000]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Activity: shelf purchase and warehouse upgrades where Global Fund products are stored: District 10 stores upgraded and part of Main Compound","2020-12-31",641923]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Establishment of a quality control unit for medical devices\nThe LNCQM does not perform quality control of medical devices (gloves, condoms, needles and others) .Technical staff does not have experience in quality control of medical devices","2020-12-31",62000]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Need technical assistance to accompany the quality control laboratory of the drug towards the pre-qualification\nThe laboratory is implementing the ISO 17025 standard and is in the process of applying for prequalification by WHO. - The laboratory wants to be prequalified by WHO or accredited. A technical assistant is required to accompany the laboratory to apply the related requirements. He would provide technical coaching to better prepare for evaluations","2020-12-31",40500]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthen the biological diagnosis of viral hepatitis\nThe National Laboratory does not have an external maintenance contract for certain equipment. Some lab equipment needs to be serviced by external experts \"","2020-12-31",114000]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthen the technical platform of the NPHI National Reference Laboratory\nThe National Laboratory needs to expand the range of analysis as a national laboratory to meet the national need. For this, he needs modern and diversified equipment to ensure his missions.","2020-12-31",358767]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthening Quality Assurance at the National Reference Laboratory of INSP\nThis involves acquiring equipment maintenance contracts (HPLC, Spectrophotometer), equipment calibration with BBN, and participating in the rendering of inter-laboratory test results. This will allow the reliability of the results and ensure the reliability of the results and the performance of the laboratory compared to WHO / Accredited Prequalified Loboratory. This will serve to know if the prescribed drugs are of good quality and have positive effects for the patients.","2020-12-31",60800]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Supply of equipment and materials for microbiological control\nThe National Laboratory does not have equipment, consumables and equipment for the microbiological control of drugs. Some molecules require microbiological procedures and can not be controlled in the laboratory.","2020-12-31",81828]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training in quality control of associated molecules (ARV, anti-TB).\nTraining in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.","2020-12-31",12000]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on Good Laboratory Practice (GLP)\nSince LNCQM's inception, staff have not had this opportunity. To be comfortable when performing tasks all staff must be trained / recycled on this standard","2020-12-31",10069]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on Microbiological Control of Drugs\nThe training would complete the physico-chemical analyzes of drugs by microbiological analyzes","2020-12-31",12000]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on preventive maintenance and qualification of the HPLC chain\nLack of expertise on the qualification of the HPLC chain. No local expertise in this area. It would be good to train 2 units","2020-12-31",12000]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Activity: Provide training to 3 members of the Quantification Committee on the management of the GAS Plan\nThis training will allow these people to know the tools of quantification and input management.","2020-12-31",30300]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Assure the subscription to the WHO Pharmacovigilance Center (Uppsalla Monitoring Center) to access the VIGIFLOW software\nThe Vigiflow makes it possible to transmit the cases of undesirable events in the international database (VigiBase). The VigiFlow software and the Base are managed by the WHO International Center (Uppsala Monitoring Center). To have access to this software and to be able to transmit the cases, you need a subscription. The subscription fee is 1500 USD per year","2020-12-31",3139]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Buy three trucks for active distribution of health inputs\nThese trucks will be used to transport drugs from CAMEBU to district pharmacies.","2020-12-31",438366]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance plan\nQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.","2020-12-31",130925]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Provide formative supervision of 20 pharmacovigilance-trained hospitals and the adverse event reporting system\nFormative supervision will involve 10 regional and national hospitals and 10 other district hospitals. The aim will be to evaluate the challenges that arise in the reporting of adverse events while retraining staff on the system of pharmacovigilance in general and the use of reporting tools in particular. This will improve the quality of notifications and promote patient safety.","2020-12-31",7335]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Provide pharmacovigilance training for providers in 40 district hospitals at 5 per hospital\nThis training will enable hospital providers to gain knowledge of the basics of pharmacovigilance and the system for reporting adverse events, which events will be transmitted to the International Vaccine Monitoring Database (VigiBase) for surveillance. The training will be organized at peripheral level for 200 participants at a rate of 25 participants per session for 4 days.","2020-12-31",48001]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: To train 3 users of DPML on the WHO Pharmacovigilance Software (VIGIFLOW) for two weeks\nThe training will allow users of VigiFlow software to have basic knowledge of pharmacovigilance and especially the use of VigiFlow to ensure the transmission of adverse event cases to the WHO international base. \"","2020-12-31",26999]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: Organize training sessions on the psychosocial care of children and adolescents living with HIV for providers at ARV sites.\nThis activity, begun during the past grant, will be continued because the low antiretroviral treatment coverage of children and adolescents living with HIV requires special monitoring for this population. The psychosocial care of children and adolescents living with HIV will facilitate the announcement of seropositivity to patients which will increase adherence to treatment and retention rate. Providers will also be able to help strengthen family caring as a strategy to reach more children and adolescents.","2020-12-31",45109]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)\nNutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. \nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond\nActivity is related to indicator #: TCS-1 (M)","2020-12-31",173582]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)\nThis activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target","2020-12-31",202134]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)\nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond","2020-12-31",25343]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)\nGiven the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond","2020-12-31",560962]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Activity: Acquire ARVs to fill the GAP\nTo cover the country's ARV targets for the year 2019 and 2020 on the different categories of PLHIV (Adults, children, PMTCT children and adults, post-exposure prophylaxis).","2020-12-31",7575400]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Activity: Organization of PLHIV in community solidarity network (supervision, monitoring, legal capacity building).\nThis activity contributes to reducing the socio-economic impact of HIV infection\nPromoting / empowering PLHIV through capacity building on cluster management, business learning, micro-project initiation and management will contribute to reducing the socio-economic impact of HIV . It is an activity that will be done through the organization of PLHIV network community solidarity (supervision, monitoring, strengthening legal capacity). It will increase ARV coverage and retention rate.","2020-12-31",3822]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Activity: Acquire the complement of reagents for the viral load.\nThe 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. \nThis funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.","2020-12-31",1432738]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structures\nCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.","2020-12-31",250000]
[null,null,"HIV/AIDS Total",{"$nulls":4},19658345]
[null,null,"Malaria","Case management","Facility-based treatment","Les bases de quantification nationale des intrants antipaludiques pour la période 2020-2021 au Burundi tiennent compte de l'évolution des cas sur 5 ans (2017-2021). La demande soumise pour le financement au-delà prend en compte la période 2020 et 6 mois de stock de sécurité correspondant à la période de transition entre 2 subventions. En plus, l'Arthemether-Luméfantrine étant une nouvelle molécule, la reconstitution des stocks à tous les niveaux de la pyramide sanitaire est indispensable. Les données épidémiologiques de la période en cours corroborent les besoins exprimés (voir Fichier de quantification sénario moyen). Les engagements déjà reçus des partenaires restent ceux inventoriés : Allocation du FM pour l'année 2020, la contribution de PMI et celle du gouvernement. L'analyse des gaps en intrants nous conduit à la demande de financement au-delà . Une fois que la demandée soumise est approuvée, les intrants de prise en charge seront disponibles dans toutes les formations sanitaires à la satisfaction des malades. Nous anticipons en disant que les épisodes de paludisme seront réduits au sein de la communauté, par conséquent réduction de la morbidité liée au paludisme.","2020-12-31",0]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","This amount includes bonuses for 12 iNMCP staff involved in implementing the grant, and maintenance, fuel and insurance for 11 extra vehicles not covered by the allocation amount and are required for supervision and training activities on the ground as well as implementing the 2019 LLIN distribution campaign support for the National Health Information System Directorate, information, education and communication and the transport of central level staff during the different stages of campaign implementation, including the census, micro-planning, pre-positioning of LLINs and supervision of distribution).","2020-12-31",111628]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","This budget is required to cover for technical assistance  to support the implementation of the next LLIN campaign in 2020. It comprises international and domestic technical assistance to support the entire process of the 2020 mass campaign, up to the final report. Given the complexity of the organization on the ground, ongoing technical assistance is required throughout the campaign.","2020-12-31",206160]
[null,null,"Malaria","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","General training in all sectors (malariology, monitoring and evaluation, finances and community health workers). This is a range of vital training to strengthen the program which has not been funded under the allocation amount. In particular, it involves (i) an international malariology course for two people each year, which is vital for strengthening the malaria response; (ii) training at the international level in the monitoring and evaluation of malaria response programs, given in Ouagadougou or Senegal; (iii) training at the international level in financial management; (iv) refresher training for community health workers providing iCCM in the health districts funded by the Global Fund, planned for 2019.","2020-12-31",296091]
[null,null,"Malaria","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Partner coordination/policy drafting and dissemination \nThe budget is intended for (i) partner coordination meetings, particularly transnational meetings, and strengthening the coordination of the private sector not addressed by other partners; (ii) a fund mobilization meeting; (iii) meetings to draw up plans of action and annual and six-monthly reports. \nThe needs for 2018 are covered.","2020-12-31",49614]
[null,null,"Malaria","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Implementing the following innovative strategies to combat malaria:\n(i) A communication strategy in primary schools; (ii) Outreach communication for the Batwa community; (iii) The production of communication media and contracts with the media: \nExpected outcomes: This budget is requested as part of efforts to strengthen communication in order to provide regular guidance for the population on the correct use of LLINs and the early use of health care services. The activities relate to procuring communication media and contracts with the media, such as mobile telephone companies.","2020-12-31",328510]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Program and data quality","Activity:  Provide quarterly supervision missions for quality control of slides and rapid diagnostic tests in health care facilities in the 46 health districts.\n(i) The allocation amount covers 12 health districts per quarter. Supervision is undertaken in three facilities per mission per health district, covering a maximum of 72 facilities over the year, equivalent to 10 percent of the total. \n(ii) Additional funding is therefore requested to be able to cover 12 health districts per quarter so as to sample 20 percent of health care facility laboratories each year.","2020-12-31",32834]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Program and data quality","Activity: Support for health districts and health provinces in the supervision of malaria-related activities. The costs include per diems, fuel for supervision vehicles and motorcycles used by health districts and provincial health offices, as well as communication costs.","2020-12-31",1003636]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Surveys","This budget is required to cover a survey on the current malaria epidemic in Burundi. A survey on the underlying causes of the epidemiological setting to understand the causes of the epidemic and thus evaluate what type of response would be appropriate and effective, and what measures should be adopted after the epidemic. This epidemic survey will assist the program in guiding the response appropriately.","2020-12-31",172237]
[null,null,"Malaria","Vector control","Indoor residual spraying (IRS)","In order to comply with the TRP?s decisions, the Integrated National Malaria Program (iNMCP) asked the Global Fund to finance for the 2018?2020 period the 11 health districts already validated by the TRP in 2016?2017 (not included in the grant due to budget constraints).  This budget is required to cover: (i) Supply costs, (ii) Implementation costs,\n(iii) Technical assistance, for IRS activities in 11 health districts.  \nThe total requested budget for IRS is US$ 17,037,235, of which US$ 6,787,954 is for the four health districts covered by the Global Fund under the NFM, and US$ 10,249,281 is for the other seven health districts requiring resistance management.\nCT update (Aug. 2018): The country has been awared 4.9m USD to implement IRS in the 4 districts previously supported by the GF.","2020-12-31",12166628]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This budget is required to: \n(i) Bridge a gap of 466,000 LLINs to meet all of the needs of the 2019 mass campaign. Of the total 6,997,954 LLINs required, taking into account an increase of 15 percent linked to counts and to logistical security, 6,531,828 have been provided using the allocation amount; (ii) The amount requested includes procurement costs and procurement and supply management/pooled procurement mechanism costs; (iii) The gap in the implementation costs that have not been included in the allocation amount (US$ 1,600,000); (iv) Expected outcomes: this funding will provide universal coverage of LLINs during the 2019 campaign.","2020-12-31",2658053]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This LLIN campaign is aimed at key populations (special groups, including boarding schools, military camps, prisons and orphanages that were not included in the mass campaign). The requested amount will cover (i) procurements costs for 182,000 LLINs and (ii) implementation costs for the special groups. This amount includes procurement costs and implementation costs. This activity is planned for 2020.","2020-12-31",520475]
[null,null,"Malaria Total",{"$nulls":4},17545866]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Acquire a PSM class II microbiological safety cabinet hood: The National Reference Laboratory (LNR) is equipped with an old safety hood that has just been out of service for a few months. The consultant sent for his repair recommends the purchase of a new hood. The cost includes transportation and installation.","2020-12-31",25000]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Acquisition, installation and formation of sites for the utilization of LPA technology for National Reference Laboratory (LNR). This cost includes the layout of the laboratory, the purchase of equipment, reagents and consumables, the training of personnel.","2020-12-31",200000]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Operational research on the use of oral forms in the treatment of MDR-TB. \nDevelopment of an operational research protocol and conduct over a period of 3 years operational research on \"the tolerance and effectiveness of a short treatment 9 months without injectable for patients with MDR-TB. \"The overall goal of the project will be to evaluate the treatment outcomes and adverse effects of a new 9-month, non-injectable, short-course regimen for MDR-TB.","2020-12-31",150000]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.","2020-12-31",501858]
[null,null,"Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Gap to be filled in relation to the activity on the provincial coordination TB / HIV:\nThe frequency of holding TB / HIV coordination meetings is quarterly.","2020-12-31",30355]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.","2020-12-31",170205]
[null,null,"Tuberculosis","Program management","Grant management","Performance bonuses.\nThe motivation of the staff is essential to maintain the achievements and safeguard the performance of the Program\nThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.","2020-12-31",30183]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Installation and implementation of GxAlert (or similar system) / networking of GeneXpert devices: The PNILT has acquired 18 GeneXpert devices from the Global Fund, which it has installed on strategic sites throughout the country. These devices were added to 6 acquired with funding from the World Bank, a fleet of 24 devices in total. To achieve the full value of the investments made in Xpert, the results must be transmitted from the machine to the service provider in a timely manner. However, xpert results are currently reported on paper. This reporting system is time consuming and limits the potential for optimizing patient care and management.","2020-12-31",150000]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Purchase a teleconference device.","2020-12-31",4069]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Data validation and dissemination activity.\nVerification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.","2020-12-31",161830]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Supervision by TB / HIV coordinators. The budget covers vehicle and fuel insurance costs.\nThe budget for the 2018-2020 grant is 661,500 BIF, per quarter and per BPS, to cover fuel costs only.\nThe said budget omits the costs of insurance, vehicle repair and technical control, which, for most of them, are already obsolete and amortized.","2020-12-31",102239]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Purchase of 17 vehicles and their insurance.\nSupervision is a priority activity in the fight against tuberculosis. The available supervision vehicles are old and most of them were acquired more than ten years ago. With depreciation and rugged terrain, repair costs become more and more huge.","2020-12-31",520200]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Purchase of computer equipment.","2020-12-31",68600]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Prevalence and anti-tuberculosis drug resistance study: The PNILT is preparing for the start of the TB drug resistance survey. On the basis of this review, a detailed budget was agreed between the PNILT, the Global Fund and Damien Action, which provides technical support and project management. The preparatory activities have already started as, among other things, the validation of the study protocol by the National Technical Committee.  The requested budget will complete the existing budget and bring the overall budget of the study to USD 251,838 (the existing USD 171,838 and a gap of USD 80,000).","2020-12-31",80000]
[null,null,"Tuberculosis","RSSH: National health strategies","Other policy and governance intervention(s)","A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.","2020-12-31",73811]
[null,null,"Tuberculosis","RSSH: Procurement and supply chain management systems","National product selection, registration and quality monitoring","Drug Registration Support (Cross-Cutting RSS): Drug registration is one of the pillars of drug quality assurance. In the past 3 years, just over 700 drug application files have been filed with the Department of Pharmacy, Medicines and Laboratories (DPML), which acts as the Burundian Agency for Drug Regulation. These files concern both products financed by the Global Fund and essential drugs imported into Burundi. To date, only 200 files have been processed. The requested support will mobilize the probate commission to process the 500 files registered to date at the DPML. Subsequently, the commission will be able to process new files as they arrive.","2020-12-31",46922]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Equipment maintenance (package: 10% of the cost). As the devices come with a one year warranty, it would be worthwhile to purchase a 3 year warranty extension as we did for GeneXpert devices.","2020-12-31",62500]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Extend the technical platform by purchasing radiology equipment and ultrasound scanners. To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, tuberculosis in children, tuberculosis in PLWHA and multidrug-resistant tuberculosis, the PNILT intends to expand the technical platform by purchasing radiology equipment and ultrasound. It should be noted that the main reasons for the poor performance in the reporting of tuberculosis cases are mainly: the insufficiency of a technical platform for the para- clinical diagnosis of TPB- and PET cases (RX, Ultrasound); the difficulty of early diagnosis of TB in PLWHIV by lack of effective diagnostic means (GeneXpert); the absence of policies / strategic approach directed at vulnerable and vulnerable groups: prisoners, refugees, Batwa, children, PHAs (screening), the weak investigation of cases contacts TPB +.","2020-12-31",330600]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Installation and handling (operator training) for all equipment.","2020-12-31",25900]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Meeting of TB coordinators. It aims to anticipate possible blockages in order to improve the performance of the implementation of the TB grant. It is planned once a quarter.","2020-12-31",28224]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.","2020-12-31",160535]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 2 power generators 5KVA energy source for 2 mobile radiology devices for use on sites without power source (cost includes transport if imported).","2020-12-31",5000]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 2 vehicles to transport digital radiology devices to screening sites.","2020-12-31",100000]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 6 Horizon G2 laser reprograms codonics: These are devices for printing X-ray images produced by the 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile X-ray devices).","2020-12-31",33995]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 6 kits of 500 codicon films in 3 sizes: These are films for printing radiology radiographs produced by 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile radiology devices).","2020-12-31",12996]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 9 ultrasound machines with accessories. The mapping of ultrasound machines performed in 2016 showed a need for 9 devices instead of 11. The purchase of these devices completes the technical platform so to strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA, the diagnosis of multidrug-resistant tuberculosis.","2020-12-31",90000]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Training of laboratory technicians / microscopists.\nThe PNILT intends to form one unit per CDT (170 CDT) with 60 units in 2018, 60 units in 2019 and 50 units in 2020:","2020-12-31",34166]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Former activity n ° 63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validated\nBurundi has a total of 11 prisons with infirmary.\nWith the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.","2020-12-31",10463]
[null,null,"Tuberculosis Total",{"$nulls":4},3209651]
[null,"Cabo Verde","HIV/AIDS, Tuberculosis, Malaria, RSSH","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Men who have sex with men represent a key population in the fight against HIV. The proposed activities are linked to interventions that will be conducted in the community and to training. These will complement activities that have already been taken into account in the allocation amount.","(blank)",42331.95]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","These activities are aimed at strengthening training sessions among  SWs, field sessions and interpersonal communication on HIV and other STIs by SWs peer educators  included in the budget of the allocation amount. They will complement activities that have already been taken into account in the allocation amount.","(blank)",24781.73]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","HIV Testing Services","Differentiated HIV testing services","These are consumables and laboratory reagents to complement the diagnostic and follow-up services. They refer, in particular, to the strengthening of blood safety during the 3rd year of the grant.","(blank)",81308.5]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","These interventions are  directed  towards: 1)  150 vulnerable children and adolescents who are received at day centres by facilitators from ICCA; 2) 80 vulnerable youths and adolescents in Praia with training and psychological support; 3) 620 peer educators within 21 secondary schools and, additionally, the coordination and follow-up of the activities performed by peer educators. These will supplement activities considered in the allocation amount.","(blank)",141119.96]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","These interventions are intended to improve the psychological support provided to vulnerable children and orphans within the ICCA drop-in centre in Praia.","(blank)",14654.92]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","Prevention programs for general population","Condoms as part of programs for general population","HIV is transmitted during unprotected sex. In this regards, this investment is to acquire 9,000,000 condoms (total for 3 years) to prevent the transmission of HIV and other STIs within the populations.","(blank)",295043.21000000002]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","RSSH: Health management information systems and M&E","Analysis, review and transparency","To have a better understanding of modes of transmission of new HIV infections and to better use these data, a study on the modes of HIV transmission is planned, to orient strategic decisions for HIV prevention. Also, an audit of patient data will be performed and ART cascade will be determined to provide baseline data that will enable to measure progress toward achieving the three 90s by 2020.","(blank)",86358.43]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","A study is expected to be conducted on the impact of HIV within individuals, families and Cape Verdean society in general.","(blank)",27610.82]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","A study was conducted within the general population in 2017 on knowledge of attitudes towards and practices in connection with methods for preventing malaria and its transmission. Nevertheless, it is essential that an initial study is conducted within migrant population in 2018. It is expected that the KAP study will be carried out again within the general population in 2020 to update these data.","(blank)",44737.96]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","RSSH: Health management information systems and M&E","Program and data quality","The exchange visit to a country that is in the process of obtaining certification of malaria elimination will strengthen the skills of the technicians working on the malaria program in Cape Verde, particularly when it comes to monitoring and documenting the elimination process.","(blank)",29051.73]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","RSSH: Health management information systems and M&E","Routine reporting","The program so far reports data in Excel and/or Word documents, which are sometimes incomplete and submitted late. For this, with the introduction of the DHIS2 application, promptness and completeness of reports will be improved, which will ensure better disease surveillance. This is for an upgrade of the existing system.","(blank)",14817.64]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","RSSH: Health management information systems and M&E","Surveys","For the TB/HIV component, a study is expected to be carried out in 2020 to update the bio-behavioral data for key HIV populations (sex workers, drug users and men who have sex with men).","(blank)",58289.75]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","TB care and prevention","Other TB care and prevention intervention(s)","These interventions aim at sensitizing 10 TB patients to ensure adherence and good compliance to treatment and adoption of preventive standards.","(blank)",5373.13]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","TB/HIV","TB/HIV collaborative interventions","These interventions are aimed at strengthening the capacity of NGO members working for TB / HIV prevention at the community level.","(blank)",16689.48]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","Treatment, care and support","Treatment adherence","Good adherence to antiretroviral treatment is key condition for the suppression of a patient?s viral load. Therefore, it is intended to appoint 12 mediators in 10 health facilities with the largest volume of patients.  The role of these mediators will include provision of counseling to people living with HIV newly tested positive, providing them with information on treatment and provide adherence support.","(blank)",136296.71]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","Vector control","Entomological monitoring","With support from WHO, the Global Fund and partners, the INSP has recently established a medical entomology laboratory, which enables monitoring the distribution and density of vector mosquitoes within the country. It is expected to acquire equipment to improve entomological monitoring to ensure that the response is as efficient as possible. These acquisitions are intended to supplement those taken into account in the allocation amount.","(blank)",177571.54]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","Vector control","Other vector control measure(s)","The aim of these interventions is to support door-to-door awareness campaigns regarding the fight against malaria, the transmission routes, symptoms and other preventive measures in partnership with NGOs and community associations, health delegations and the INSP.","(blank)",30531.93]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH Total",{"$nulls":4},1226569.3899999997]
[null,"Cambodia","HIV/AIDS","HIV Testing Services","Other module","Introduction of Alere DETERMINE Ab/Ag Combo 4th generation RDT. TRP  recommends 10% of the requested amount.","2020-12-31",106321]
[null,null,"HIV/AIDS","Other module","Other module","Above allocation funding is requested for technical assistance from WHO, as well as for a Procurement Agent and forecasting. TRP only approves 10% of the request.","2020-12-31",226500]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","In order to reach 90% coverage of all KP with a defined package of prevention services, above allocation funding is requested to expand prevention outreach to those provinces not included in the withinallocation target provinces.","2020-12-31",0]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","To expand requested activities to provide legal services and case documentation of rights violations in KP. TRP recommends 50% of request of $ 300,000 and recommends more details on the content of interventions to be provided before this module can be funded.","2020-12-31",0]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","A substantial cohort of children with HIV have already or are about to transition out of paediatric care and into adult HIV services. To support this transition and to ensure retention in ART and other HIV services, above allocation funding is requested for Adolescent Case Officers (peer PLHIV) to be located at each ART site. TRP only recommends 75% of original request of $ 397,656 from the CCM.","2020-12-31",0]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested for a Case Management Assistant (CMA) within each of 67 Funding Request: Full review 23 May 2017 | 42 Provincial AIDS and STI Programs (PASP). TRP only recommends 30% of original reqeust of $849,070.","2020-12-31",254721]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested to Increase the number of CSO (peer PLHIV) located at ART sites to help support differentiated ART delivery and to provide support for PLHIV in greatest need.","2020-12-31",295732]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Replace or update 67 ART sites & 68 VCCT and NCHADS with laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information. TRP recomends only 15% of the request.","2020-12-31",60000]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Replace or update NGO/CSO laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information.TRP recommends only 15% of the request.","2020-12-31",60000]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To deploy the B-IACM dashboards (national, provincial, OD and daily CMA) nationally in order to improve data management, link HIV related databases and to improve overall tracking of patients throughout the cascade. In addition NCHADS will scale-up systems for patient identification, sample tracking and remote services. Primarily this request is for training in the use of new technologies and for hardware to support the deployment is requested.","2020-12-31",0]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To improve understanding of epidemic status and collection of pathology information in Cambodia. TRP recommends 20% of the request.","2020-12-31",60000]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To support NASA 2020.","2020-12-31",60000]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","TRP recommended funding 25% of requested amount of $300,000 to conduct the survey proposed to feed into development of policies and targeted interventions.","2020-12-31",75000]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","QC/QA will be implemented in collaboration with DDF and CMS and sampling will be undertaken using current SOP employing a risk based approach in product selection. TRP recommends 10% of the request.","2020-12-31",40000]
[null,null,"HIV/AIDS","TB/HIV","Other TB/HIV intervention(s)","Contribution to HEF to cover HIV service packages: HIV and STI Testing and Counselling at Health Centres, HIV Testing and Counselling at VCCT Centres,Adult and Paediatric Pre-ART and ART Service, and transportation fees to ART patients in need.","2020-12-31",1824459]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Co-infection with HCV is a significant contributor to morbidity and mortality among PLHIV. Request for HCV testing and treatment for 262 cases is included within the allocation request. Above allocation funding is requested for drugs, commodities and PSM to provide treatment to a further 261 in 2019 and 262 in 2020 PLHIV with chronic HCV co-infection (F3-F4) to cover all estimated need and to reduce mortality and morbidity among PLHIV in Cambodia. The TRP ranked this activity as low priority but also considers that this activity cannot be funded using Global Fund funding as the conditions of the Global Fund policy on this subject are not met. See link https://www.theglobalfund.org/media/41 67/bm33_11-co-infectionsandcomorbidities_report_en.pdf","2020-12-31",329505]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of Sihanouk Hospital Centre of Hope,  funding is requested to provide additional year for staffing and lab costs after 2018.","2020-12-31",400000]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of the AHF clinic which provides HIV services at 12 sites,  funding is requested to provide an additional year after 2018 for staffing (estimated total cost USD 400,000 for 2019).","2020-12-31",400000]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of the KP-friendly clinic, Chuuk Sor, previously funded through PEPFAR, one year of support (2018) is requested within allocation.","2020-12-31",0]
[null,null,"HIV/AIDS","Treatment, care and support","Payment for results","A bonus payment based on results to all PHDs to help improve B-IACM.TRP recommends only 10% of the request.","2020-12-31",157862]
[null,null,"HIV/AIDS Total",{"$nulls":4},4350100]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Addressing stigma, discrimination and violence against MSM","Peer-Led Psycho-Educational HIV Intervention that provides knowledge/skills to address social isolation experienced by young MSM (<30) in Phnom Penh\nThis proposed peer-based intervention focuses on psycho-educational/psycho-social support and will partner with the social media intervention, developed by NCHADS and the Peer Outreach program, currently implemented by KHANA. 15 champions will be trained by a team of KHANA experts, including in-house psychiatric expert on HIV and MSM from Australia, in collaboration with NCHADS. These champions will then conduct peer-led psycho educational support for young MSM.\nExpected outcomes: 1,820 young MSM will gain knowledge/skills to addresses social isolation","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Men who have Sex with Men (MSM).\nProlonging the working hours of outreach workers will allow for a greater reach and will offer HIV and syphilis testing to MSM. \nExpected outcome:  additional 438 MSM reached with defined package of services","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)\nReproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) \nExpected outcome: at least 2,160 hidden KPs reached","2020-12-31",500]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","HIV testing services for MSM","Expand peer-driven intervention plus (PDI+) to optimize case detection among MSM in 7 provinces \nPDI+ is an innovative intervention that can to reach out those, who are in higher risk of HIV and link them to prevention, treatment and care services. The suggested activity will allow for the PDI+ approach to be applied in 7 provinces: Phnom Penh, Kandal, Kg. Speu, Kg. Cham, Thbaung Khmum, Prey Veng and Preah Sihanouk \nExpected outcome: Increased case detection among MSM  in 7 provinces","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","KPs self-testing & access to Pre-exposure Prophylaxis (PreP) \nBuilding on HIV self-testing in PrEP pilot initiated in Phnom Penh in 2018, this intervention will expand access to self-testing and PrEP in Phnom Phnom Penh,  Battambang, Siem Reap\nExpected outcomes:\n- At least 1,500 MSM enrolled in PrEP\n- Approx. 7% HIV+ at initial screen or 105 HIV+ enrolled in care \n- Reduced transmission of HIV among MSM\n- Increased referrals to VCCT\n- Increased repeated testing","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Entertainment Workers (EW) and their clients.  \nProlonging the working hours of outreach workers until mid-night will allow for greater reach and will offer HIV & syphilis testing to young freelance EWs.\nExpected outcomes: Additional 2,146 EWs reached with defined package of services","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)\nReproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) \nExpected outcome: at least 2,160 hidden KPs reached","2020-12-31",500]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for TGs","Behavioral interventions for TGs","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Transgender (TG).  \nProlonging the working hours of outreach workers until midnight will allow for greater reach and will offer HIV and syphilis testing to TGs. \nExpected outcome:  177 TGs reached with defined package of services","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for TGs","Behavioral interventions for TGs","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)\nReproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) \nExpected outcome: at least 2,160 hidden KPs reached","2020-12-31",500]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for TGs","HIV testing services for TGs","Expand peer-driven intervention plus (PDI+) to optimize case detection among TG in 7 provinces \nPDI+ is an innovative intervention that can to reach out those, who are in higher risk of HIV and link them to prevention, treatment and care services. The suggested activity will allow for the PDI+ approach to be applied in 7 provinces: Phnom Penh, Kandal, Kg. Speu, Kg. Cham, Thbaung Khmum, Prey Veng and Preah Sihanouk \nExpected outcome: Increased case detection among TG in 7 provinces","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Other intervention(s) for PMTCT","eMTCT Roadmap implementation\nIn 2018 the MoH launched the national roadmap for elimination of Mother To Child Transmission (MTCT) of HIV & syphilis. The suggested intervention will support enhanced service delivery, including HIV testing and treatment, to reach the global impact indicators.  \nExpected:\n- Coverage of pregnant women who know their status of ? 95%\n- Antiretroviral treatment coverage of HIV-positive pregnant women of ? 95%\n- Antenatal coverage (at least one visit) of ? 95%\n- Infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth of ? 90%\n- Coverage of syphilis testing of pregnant women of ? 95\n- Treatment of syphilis-seropositive pregnant women ? 95%","2020-12-31",285000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","Design and Conduct Morbidity & Mortality Study\nMorbidity & Mortality study is essential at this stage of the response to better understand the number of AIDS deaths, considering the high treatment coverage, improved access to testing and counselling over the past decade.\nExpected: Improved data on PLHIV morbidity and mortality will facilitate evidence informed HIV policy and program development","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Operational Research","2020-12-31",100000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Improve Data Quality \nThe recent Assessment of the Cambodian HIV information systems, conducted in 2018, made a recommendation for a development of SOP on Data quality. NCHADS has developed the SOP (to be approved by MoH). This activity will ensure that M&E staff in ART/VCCT sites will receive technical support and assistance in applying the SOP in everyday work.\nExpected: \n- Improved Data quality\n- Consolidated/comprehensive progress reports and dashboards to be used across levels sub-national and national will inform and improve HIV service delivery","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","Currently, the country implements TB prevention using Isoniazid Preventive Therapy (IPT). The National TB Program has now committed to adopting and implementing the new WHO recommendations for latent TB infection management. This request will facilitate building of capacity for screening, treatment, including the use of new drugs combinations for high risk groups targeting contacts of TB patients and PLHIV.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Logistics and Commodities: Mobile TB Vans with GeneXpert and digital X ray","2020-12-31",1854180]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},2865973]
[null,null,"Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","A local lab consultant and lab technician will be recruited to ensure the quality of TB, maintenance lab equipment and support GeneXpert troubleshooting. Recruitment of one full time effort WHO Medical Office and short term TA will assist the program to ensure quality services. TRP only recommends 20% of the request.","2020-12-31",180862]
[null,null,"Tuberculosis Total",{"$nulls":4},5452569]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Prevention for MDR-TB","This  funding  would  be  used  to  renovate  hospital  wards  for MDR-TB/RR-TB   patients   in five hospital   (Limbé,   Maroua, Bafoussam,  Bertoua  and  Garoua)  in  Year  2.  The  funding wouldalso provide community care for 100 additional MDR-TB/RR-TB patients between Year 1 and Year 3.","(blank)",25148.69]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Surveys","This would be used to fund various studies and evaluations, including updated mapping of key and vulnerable populations, and the midterm review of the NSP. It would also be used to fund the development of a monitoring and evaluation plan for the HIV NSP.","(blank)",556386.49]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","This would be used for the following activities:  -Procurement   and   distribution   of   culture   laboratory products, consumables and  reagents  for LPA/Hain and TB LAM,andfor additional cases (solid and liquid).  -Improvement/refurbishment  of  culture  laboratories  (old and new).-Additional   maintenance   and   equipment   for   culture laboratories in order to retain certification.In  addition,  it  would  enable  the  purchase  of  four  new GeneXpert machines, calibration kits and waste filters for all the machines, seven  TB  LAM  machines  and  accessories in 2020,   and   25,000   additional   cartridges   for   GeneXpert MTB/RIF tests. This  activity  will  focus  on  the  second  population  at  risk  of MDR-TB -new cases with positive microscopy -whowill have a sensitivity test(GeneXpert).","(blank)",2260063.9700000002]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","HIV care","This funding would enable the country's cohort to be increased from  320,000  to  358,000 patients by 2020.  It  would  support 38,000 patients to be enrolled on ART using EUR 9.3 million of Spanish funding via the Debt2Health initiative.","(blank)",420.83]
[null,null,"Malaria","Program management","Other program management intervention(s)","Malaria control strategies are evolving at the global level, given the innovations in this area. To this end, the Program will undergo several phases  of  change  in  program  and  financial management  policies  and  procedures.  For example, NMCP is  considering assessments of current  strategies,  revision  of  the  national strategic  plan,  capacity  building  of  staff  in different areas of specialization and updating of  normative  documents.  To  this  end,  all normative  documents will be up to date and at least  80%  of  the  qualified staff in the specialties  required  for  the  performance of their duties.","2020-12-31",56110.43]
[null,null,"Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to train the  new  4'500  CHWs  through  periodic recycling. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to extend  the  response  to  80 additional  health districts.\nDiagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","2020-12-31",1288703.8500000001]
[null,null,"Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to train the  remaining  492  CHWs  through  periodic recycling not funded under the new grant due to budget constraint.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","2020-12-31",164309.28]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Community empowerment for MSM","Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Prevention for MDR-TB","Prevention of MDR-TB highly relevant to prevent escalation of the MDR-TB situation.","2020-12-31",126116.04]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Ensure availability of human resources for the provision of services.","2020-12-31",77875.66]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Addressing key populations important.","2020-12-31",940.41]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},4851904.3899999997]
[null,"Chad","HIV/AIDS, Tuberculosis, RSSH","MDR-TB","Treatment: MDR-TB","401 patients (106 in 2019, 132 in 2020 and 163 in 2021) must be screened and administered treatment between 2019 and 2021. Each patient must provide 5 culture samples (2 culture tubes per patient, equating to 4,010 culture tubes). Allowing a contamination margin of 5% would result in 4,211 culture tubes to be tested over the 3 years.\n\nEach patient must complete a sensitivity test at the start of treatment, equating to 401 sensitivity tests. Looking at the data for 2017, 2 of 60 MDR-TB cases remained positive in the 4th month, equating to 3.3%. This provides an estimate of 414 (401 x 3.3%+401).\n\nAll of the targets for the culture and sensitivity tests will be covered in full by the Global Fund.\n\nThe NTBCP in Chad is in the process of implementing a 2016-2018 extension plan for health care for RR-TB/MDR-TB cases. This plan aims to improve health care for these cases.\n\nAt present, the tuberculosis drug sensitivity profile of the screened RR-TB/MDR-TB patients who are receiving treatment is unknown. In addition, the monitoring of these patients, which requires periodic culture tests and antibiogram tests, is still not carried out. Consequently, this monitoring is carried out only by the clinic, using microscopy. Culture confirmation tests for recovery are still not carried out. In addition, as yet, no RR-TB/MDR-TB patient who has completed a course of treatment has been reported as cured.\n\nThe configuration of the premises of the NRL does not allow for the establishment of a functional culture laboratory that meets the minimum standards for the number of rooms required. \n\nThe request is based on the recommendations resulting from the technical assistance mission report of the WHO Regional Green Light Committee (rGLC), which took place between November 4 and November 9, 2015.\n\nThis funding request for a pre-fabricated culture laboratory will enable the NTBCP to:\n- perform culture tests and determine the sensitivity profile of patients screened for RR-TB/MDR-TB;\n- perform follow-up culture tests for RR-TB/MDR-TB patients receiving treatment.\n\nThis funding will make it possible to acquire a prefabricated container for the culture of mycobacteria (ref: Specification LabMobile MCL WHO) including:\n- laminar flow hoods;\n- an autoclave;\n- a refrigeration unit at -4°C;\n- a refrigeration unit at -20°C;\n- two incubators;\n- a decontamination system;\n- the installation cost (preparatory work and earthworks);\n- a WHO evaluation mission;\n- annual maintenance for 2019-2020-2021;\n- power supply using a solar kit;\n- the administrative cost (shipping, training and assistance).","(blank)",437625.41]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","The other vulnerable populations taken into consideration by this PAAR are the Lake Chad island populations, as they still do not receive any interventions to fight HIV and TB. \nAccess to the island population requires a differentiated strategy. Given the limits of the available budget and in view of the specific nature of the Lake Chad region (prevalence of 5.5% in the island area, according to the 2012 LCBI survey), we have concluded that it is necessary to request additional funding to cover this target population. \nThe 2018-2022 NSP contains plans to provide coverage for at least 70% of the island population living on the islands and islets in the Chadian part of Lake Chad, in terms of access to combined preventive services, by 2021. In view of the difficult security context for obtaining access to this population, the humanitarian stakeholders present (MSF, the IRC, UNICEF, etc.) on the ground will be asked to implement this module. \nThe justifications of this request concern all of the interventions included for the island populations.\nAccording to the seroprevalence survey carried out by the Lake Chad Basin Initiative (LCBI) among individuals of the priority vulnerable groups in this conventional basin, HIV seroprevalence is 5.5% on the islands and islets, which is 4 times higher than the prevalence among the general population.\nThe interventions by humanitarian stakeholders currently do not provide sufficient coverage for the fight against HIV/AIDS and TB for these populations and their host populations.\nThe current island populations, which numbered 230,000 people in 2017, move between the islands and the mainland in accordance with the security situation. They come from the following 18 islands: Banagori, (10,332 inhabitants), Blangui (8,955 inhabitants), Finikim (7,055 inhabitants), Kargulim (8,250 inhabitants), Tchongolé (9,900 inhabitants), Kinasserom (7,194 inhabitants), Tétchoua (10,137 inhabitants), Choara (7,692 inhabitants), Tchoukoultaya (18,321 inhabitants), Bol Urbain (34,023 inhabitants), Milea 18,848 (inhabitants), Gougoua (18,445 inhabitants), Ameroun (10,070 inhabitants), Iserom (17,704 inhabitants), Kakigou (4,123 inhabitants), Yourtou (9,114 inhabitants), Makarati (11,011 inhabitants) and Kirkira (9,262 inhabitants).\n\nIn order to rectify this inequality in access to health-care services, the government has recently established a National Health Program for Nomadic and Island Populations and Populations in Hard-to-Reach Areas (NHPN). \nTherefore, the interventions to fight HIV and TB in the Lake Chad region are of sub-regional interest, as the foreign populations that frequent this area are there for economic reasons, primarily in relation to fishing. Their toing and froing between their countries of origin and Lake Chad is a factor in the propagation of the HIV epidemic in this sub-region.\nThis above-allocation funding request for Chad will make it possible to provide services to fight HIV and TB to these populations (native and island populations).\nIndicators: i) Percentage of the vulnerable populations who have benefited from the HIV prevention program - defined package of services (islands populations, refugees and nomads)\nCountry targets: 20% (46,000/230,000) in 2019; 40% (95,233/238,084) in 2020; 60% (147,897/246,494) in 2021. All of these targets are assigned to the Global Fund.","(blank)",1024440.86]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","This sum will be needed by the stakeholders involved in implementation for the administrative management of the interventions for the island populations, equating to 7% of the total amount for the interventions.","(blank)",155677.07999999999]
[null,null,"Malaria","Case management","Integrated community case management (ICCM)","The country has successfully implemented iCCM in 2 regions and intends to expand this intervention in 2 other regions with high malaria burden. This intervention will increase malaria diagnostic and treatment services among vulnerable groups and, hence, improve coverage of malaria treatment seeking among children under five. This will have an impact on the reduction of malaria mortality which continues to be considerable.","2021-06-30",2534322.41]
[null,null,"Malaria","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","2021-06-30",1400000]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Harm reduction interventions for sex workers who inject drugs","Providing performance bonuses for midwives undertaking PMTCT activities:\nThe funding request also plans to give midwives more responsibility for PMTCT activities and in monitoring babies born to HIV-positive mothers, prior to Polymerase Chain Reaction (PCR) testing being carried out when the child is 18 months old. This funding request will cover the cost of performance bonuses for midwives who manage 12 HIV-positive pregnant women in 2019 and 13 HIV-positive pregnant women in 2020 and 2021. This funding is being requested in order to implement the performance bonus. Performance criteria will relate to the number of women monitored up until the child?s PCR test is carried out at age 18 months. Once a report certified by a referring physician and validated by the DNLS has been submitted, midwifes will be paid a nominal amount for each HIV-positive pregnant woman they monitor.","2022-06-30",3332.96]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Providing training on PMTCT to 60 providers at public and private health posts to scale up the elimination of mother-to-child transmission (eMTCT):  \nThe country has set itself the challenge of eliminating mother-to child transmission by 2021. The current grant provided for PMTCT scale-up at 30 sites. This increase is coupled with a need for capacity building among untrained staff at antenatal clinics. This activity involves 60 providers at public and private health posts in the first year. This above allocation funding request will cover the additional training of 60 other PMTCT providers in the second year and 60 in the third year. These health workers at antenatal sites, including midwives, will be responsible for Pillar 1 of PMTCT and for monitoring HIV-positive pregnant women until early childhood diagnosis.","2022-06-30",29727.3]
[null,null,"HIV/AIDS","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Arrange a midterm evaluation of the national strategic plan (NSP) in 2022\nThe country will develop a new strategic plan 2020?2024. This plan, which will serve as the basis for planning the entire HIV program, will require a midterm (2022) evaluation to adjust interventions.  \nA budget for arranging this midterm evaluation is included in the PAAR.","2022-06-30",29858.6]
[null,null,"HIV/AIDS","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Implementing community-based condom distribution points in villages and towns: \nAn unreliable supply of condoms at the community level was reported as a major constraint that could hinder prevention interventions. As part of this grant, the DNLS therefore initiated the implementation of community-based condom distribution points in villages and towns run by community workers, as recommended in the national community health strategy. Mapping of villages shows that there are 331 villages to cover: 214 on Grande Comore (Ngazidja), 91 on Anjouan (Ndzuwani) and 26 on Mohéli (Mwali). \nThis above allocation funding request should cover 10 percent of the villages on each island in the first year, 20 percent in the second year and 35 percent in the third year. In each village, one distribution point will be selected in the first year, which will increase to three distribution points in the second and third years.   \nA total of 579 distribution points will be established in 215 villages over the three-year period: 372 on Grande Comore, 159 on Anjouan and 48 on Mohéli.","2022-06-30",12995.17]
[null,null,"HIV/AIDS Total",{"$nulls":4},433675.23]
[null,null,"Malaria","Case management","Ensuring drug and other health product quality","\"Slide exchanges with internal and external laboratories for quality assurance: \nAccording to World Health Organization recommendations, slide quality control is essential in a country that is moving toward elimination, as is the case for the Union of the Comoros.  A correct reading of the slides is of paramount importance to avoid any misdiagnosis that may lead to the spread of the disease. Indeed, a positive slide read as negative may lead to an epidemic and undermine all efforts made so far toward eliminating the disease. \nAs a result, the training supervision of quality control officials has been included in the budget to enable continuous training on the theoretical and practical aspects of quality diagnosis. The NMCP requests funding under the PAAR for the following: the exchange of slides internally (from the islands to the NMCP reference laboratory) and from the NMCP laboratory to an external accredited laboratory. This would ensure that these slides are read correctly to avoid this kind of situation and would also be a means of assessing other laboratories in the country from which the NMCP collects data, in order to ensure reliable results and avoid any step that might hinder the elimination process.\"","2021-12-31",12126.59]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","\"Development of the Program Performance Review and the strategic plan:\nThe Program Performance Review helps identify progress in terms of outcomes and impact, best practices, lessons learned, and bottlenecks and their causes. This information can then be used to propose solutions for improving program implementation and revising the strategic plan. Such an exercise was carried out in 2011 and 2017 and resulted in the formulation of new program directions.\nIn addition, the review brings together national and regional managers from the public health system, implementation partners and technical and financial partners. At the end of each review, specific recommendations will be made. It should be noted that before this review is held at the central level, it is first organized on each island. This ensures mutual accountability among the implementers.\"","2021-12-31",51558.75]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","\"Six-monthly data validation meeting:\nEvery six months, a data validation meeting will be organized for each island by a technical working group responsible for monitoring and evaluation. The aim of these meetings is to acquire reliable and identical data at all levels. To this end, the technical team will analyze the data submitted by the health care facilities and take decisions to improve their quality (promptness, completeness, archiving, etc.).\"","2021-12-31",55033.11]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","\"Routine LLIN distribution for pregnant women in the third year (30,582 LLINs):\nLLINs are a key intervention for reducing\nexposure to mosquito bites and vector survival, which considerably reduces\nvector capacity and transmission. Stopping LLIN distribution prematurely may lead to renewed malaria transmission at previous levels.\nHigh LLIN coverage can be rapidly achieved and maintained by\nmerging free mass distribution campaigns with routine distribution channels. \nRoutine distribution channels include\nprenatal care and vaccinations. \nThere is a sufficient stock of LLINs to cover routine distribution for the first two years of the grant. Within the PAAR, funds are requested to cover procurement of LLINs for pregnant women for the third year of the grant.  \"","2021-12-31",64914.15]
[null,null,"Malaria Total",{"$nulls":4},1616776.3599999999]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Procure 06 GeneXpert printers.","2020-12-31",12237.32]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Prong 3: Preventing vertical HIV transmission","HIV testing for pregnant women in Antenatal clinics and treatment of additional 4,807 HIV positive pregnant women by 2020 (48% of estimated PMTCT needs at national level);","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Organize 2 training/refresher training sessions lasting 5 days for 80 heads of TTC (2 nurses per TTC) on TB treatment for adults and children (including drug management), with 4 training centers in years 1 and 2.","2020-12-31",117831.89]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","Conduct 6 training/refresher training sessions lasting 3 days at the 4 centers on co-infection management (25 participants: 2 sessions in year 1, 2 sessions in year 2 and 2 sessions in year 3).","2020-12-31",7992.37]
[null,null,"Malaria","Case management","Other case management intervention(s)","Care providers will be trained to support the supply of ACT and artesunate as well as supervision at different levels of the health system. The above allocation funding request will enable the gap in drugs to be met and the support activities to be implemented","2020-12-31",534171.25]
[null,null,"Malaria","Other module","Other module","(blank)","2020-12-31",39277.300000000003]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.","2020-12-31",32544.05]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","(blank)","2020-12-31",509482.67]
[null,"Congo (Democratic Republic)","HIV/AIDS, Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Diagnosis and treatment of XDR-TB cases This additional request would allow treatment to begin for 62 patients with extensively drug-resistant TB (XDR-TB) in 2018, 75 in 2019 and 88 in 2020. The activities concerned are the purchase of drugs, the corresponding PSM costs and three technical assistance activities for managing XDR-TB patients.","2020-12-31",2364088]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Prevention for MDR-TB","Pharmacovigilance and laboratory strengthening This additional investment is intended to address rising drug resistance in the country and respond to the introduction of new drugs, initially to treat XDR-TB cases. It will be used to help establish a pharmacovigilance system to monitor and manage DR-TB drug side effects, with a view to future extension of the new drugs to treat DR-TB (non-XDR-TB).","2020-12-31",2083840]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","Collaborative activities with other programs and sectors (TB/HIV)","Involvement of private facilities and traditional medicine practitioners Scale up efforts to identify missing cases by training private care providers and traditional medicine practitioners (three providers trained in each of the 243 high-priority HZs).","2020-12-31",374564]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Other intervention(s) for treatment","Renovation of the national reference laboratory (NRL) for AIDS.","2020-12-31",0]
[null,null,"Malaria","Case management","Other case management intervention(s)","The NSP provides for the following in the SBCC activities: advocating for meaningful engagement from the state, notably in terms of direct matching funding (>5%), a ban of drugs not recommended by the NMCP, tax relief/removal, strengthening the area of communication, which involves resource mobilization, actor and grantee  information so that they change their behavior and take ownership of all elements of the fight against malaria. It is within this framework that $800,000 is requested as part of the PAAR.","2020-12-31",800000]
[null,null,"Malaria","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","This sum will consist of buying in services from the structures/Programs of the Ministry of Health, which can contribute to achieving the objectives linked to the 3 diseases. For example: FOSAs, DPSs, CDRs, PNAM, 3workers DEP,IGs). This involves defining a package of support for services affected in exchange for results, which have a proven impact on the performance of the fight against the threediseases. It will be possible to use these sums in a co-financing arrangement with domestic funds or with other partners such as the World Bank or the European Union.","2020-12-31",22300000]
[null,null,"HIV/AIDS Total",{"$nulls":4},953034]
[null,"Côte d'Ivoire","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Develop the ?Husband School? approach Implement the ?husband school? approach in the Sud-Comoé region. This innovative approach has a double benefit?it increases the Funding request: Full review 15 February 2017 | 57 involvement of men in reducing barriers to access of PMTCT services as well improving the retention of seropositive pregnant women in care. Also, it fill the gaps on the vulnerable population of men over 35 by ensuring their access to screening through the front door of the PMTCT service. This intervention will involve the training of community actors in this approach so that they can implement the activities in 3 health districts in the Sud-Comoé region. It also involves the supplying of kits and guidance documents concerning this approach as well as workshops, missions, and supervisory visits.","2020-12-31",0]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Acquire nine digital radiography devices and digitize the 17 old radiography tables Radiography remains an indispensable diagnostic tool for smear-negative pulmonary tuberculosis, and even extrapulmonary TB. Therefore, strengthening the diagnosis of TB in children requires the use of this technology. The NTCP has 17 standard radiography devices available, in 16 existing regional coordination centers and at Abidjan central prison (MACA). Of these devices, five date from 2004, three from 2009 and nine from 2016. The older devices require extensive maintenance with spare parts that are increasingly hard to find. This type of radiography is being gradually replaced by digital radiography. As part of this concept note, the NTCP also anticipates the purchase of nine digital radiography tables for the nine new regional coordination centers including Séguéla, and the acquisition of 17 digitization devices to adapt older equipment. The funding also provides for the training of trainers and training sessions for users of digital radiography equipment.","2020-12-31",0]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Pilot project for the use of new technologies in the active search for TB and among contact cases With regard to contact cases, a pilot project is planned for Abidjan with the use of awarenessraising/educational videos on tablets during surveys of patient contacts, and registration of all contact cases on an electronic database.","2020-12-31",90501.1]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Purchase of 16 GeneXpert devices This request focuses on the acquisition of 16 additional GeneXpert devices in order to meet the needs of all regional laboratories. There are currently 13 GeneXpert devices, of which nine are located in nine regional laboratories (TB TCs) and four in the central laboratories (two at the Institut Pasteur de Côte d?Ivoire (IPCI) and two at the Research and Diagnosis Center for AIDS (CeDReS)). The NTCP plans to acquire 16 additional GeneXpert devices during this program continuation. Of these, eight will be purchased in 2018 to meet the needs of the eight existing regional laboratories and eight in 2019 for the eight new regional coordination centers opened in 2017. These GeneXpert devices will require maintenance and calibration each year. In addition, all machines require cartridges to operate. An average of 1,500 cartridges per machine per year is expected. These machines will strengthen the diagnosis of tuberculosis in general, and detection of the resistance profile in particular.","2020-12-31",0]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.","2020-12-31",63500]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","A need to reinforce legal counseling and judicial literacy (training in legal rights for PLHIV, Trans, MSM, PPTS, Youth; as well as community-based legal counseling programs - Observatories). Covering this demand will result in empowerment of key populations and being able to provide them with the means to process any violations of their rights.","2020-12-31",20000]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Insufficient outreach to PLHIV for VC tests, affected by the interruptions of regional laboratory services, especially due to equipment breakdown and maladjustment caused by years of continuous operation. Likewise, the centralization of blood tests for VL studies hinders follow-up on PLHIV follow-up and limits the capacity of the PCS, especially as regards the Polyclinic to mobilize the PLHIV under their care. The additional resources will be dedicated to increasing the number of PLHIV with undetectable VL by gradual replacement of obsolete equipment and increasing access to blood testing points.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Treatment: MDR-TB","Coaching and transfer of competence in multi drug resistant TB (Daily allowance related to supervision / investigation / data collection / transport / other costs).\nThis is to ensure the quality of services, including the identification of MDR TB patients to improve the inclusion rate of these patients put on treatment and retention until recovery.","2020-12-31",14237]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Prong 3: Preventing vertical HIV transmission","Capacity-building of service-providers on pregnant women enriollment, including treating STIs, notably syphillis, will contribute to reduce vulerability to HIV and mother-to-child-transmission of HIV.","2020-12-31",7322]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Same as line 49 (sensitization meeting for young people by peer educators).","2020-12-31",68644]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","The implementation of the national strategy of condom distribution for young people will allow prevention of STIs (sexually-transmitted infections) and HIV and prevention of unintended pregnancies.","2020-12-31",3763]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","The analysis of performance of the TB program and, following that, following up with the resulting recommendations will allow reaching the program's objectives.","2020-12-31",678]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 20 microscopes for selected health facilities under the RTTR strategy framework.","2020-12-31",6000]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","Training supervision of technicians on the radiology machine (per diem related to awareness / transport / meeting / and other costs). (See line 21).","2020-12-31",678]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","Key populations (TB/HIV) - Prisoners","Through peer education, inform and educate inmates and prison staff on HIV, sexually transmitted infections, viral hepatitis and tuberculosis. The expected result is the identification and treatment/care of new HIV and TB cases among prisoners.","2020-12-31",8475]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","TB/HIV collaborative interventions","The organization of monthly outpatients visits of the mobile team for TB / HIV screening in Djibouti-city and quarterly in the regions of the interior, will allow the identification and treatment (Test and treat) of new HIV and TB in rural communities and vulnerable urban communities.","2020-12-31",4271]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","HIV care","It involves organizing with the community the search for PLWHA lost to follow-up, including patients initially not eligible for treatment and irregular patients (allowances). This activity will increase the number of PLWHA put on treatment and retention.","2020-12-31",21356]
[null,null,"Malaria","Case management","Facility-based treatment","This is an important activity to ensure effective management of malaria that is based on a good quality diagnosis.","2020-12-31",11948]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","The practices of self-care, prevention of HIV and other STIs in sex workers and their clients, and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources will be allocated to increasing the targets that can be reached to improve self-care and prevention practices.","2021-12-31",357334.02]
[null,null,"HIV/AIDS","Comprehensive prevention programs for TGs","HIV testing services for TGs","Community testing does not always take place in areas where prevalence is supposed to be higher (according to the Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.","2021-12-31",0]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","Community testing for Socially Vulnerable Women resident in Bateyes does not always take place in areas where prevalence is supposed to be higher (Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.","2021-12-31",0]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Primary healthcare staff replacement requires systematic training of newly-hired resources in the handling of HIV/AIDS infection to improve quality of care.","2021-12-31",110000]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","This will complement the activity included in the main funding request which features the establishment of a drop in center for people who inject drugs in Cairo. This intervention will also include the strengthening of referral systems to government-run testing and treatment centers.","2022-03-31",129282.05]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Other intervention(s) for PMTCT","PMTCT. A pilot was implemented and was nationally owned and received wide acceptance and helped in addressing stigma among healthcare providers and spreading awareness to women in child bearing age. This model will be evaluated and refined for scale up near hot spots of KPs where testing is expected to have greater yield.","2022-03-31",150000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Strengthen national HIV surveillance system starting with an assessment and building its capacity to address bottlenecks","2022-03-31",15288.52]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Conduct of a Procurement and Supply Chain Management workshop","2022-03-31",6610.64]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","The National Institute of Health is made up of three areas: 1) Government School, 2) Department of Health Research and 3) Department of Specialised Laboratories. The first two operate in a single building and the National Reference Laboratory (NRL) that is part of the Department of Specialised Laboratories operates in a separate building. The proposal intends to integrate these areas into a single physical place, so that the relationship between them integrates the topics of research, health surveillance and training, achieving optimum performance and better organisation.\n\nThe NRL operates with 4 technical areas: the Health Surveillance Laboratory Area, Toxicology and Food Quality Control Laboratory Area, Health and Environment Laboratory Area and Cytology Laboratory. So it also has an administrative area.\n\nThe analyses carried out by the NRL are accredited according to ISO/IEC 17025: 2005 standards and develop a Quality Management System in accordance with ISO 15189: 2012. Likewise, it has implemented an internal quality control programme and participates in international external quality control programmes. It provides direct and indirect quality control programmes and an external quality assessment programme to the National Network of Clinical Laboratories, National Network of Blood Banks, and the different sectors of the National Health System, including the Salvadoran Social Security Institute. This allows the country to guarantee epidemiological surveillance at a national level in humans, food, water and the environment, quality control of diagnostic tests and to respond to events that may constitute a Public Health emergency of national and international importance in compliance with International Health Regulations.\n\nWith the project there will be the progressive dismantling of the different areas of the NRL, its transfer to, and assembly in the new facilities; the methodology to follow will allow us to maintain the provision of services with the least possible interruption, in some cases new equipment will need to be purchased since, due to biosecurity, it is unusable when dismantled.\n\nThe relocation and equipping of the National Reference Laboratory will allow the country to have safe technological and scientific infrastructure, so that the biosafety processes are compliant with the international guidelines already defined and in response to health problems, especially HIV, tuberculosis and malaria, with a comprehensive vision of public health, integrated into the regional response of the Health Plan of Central America and the Dominican Republic.","2021-12-31",0]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Pre-exposure prophylaxis (PrEP) for sex workers","The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.","2020-12-31",56880]
[null,null,"HIV/AIDS","Prevention programs for adolescents and youth, in and out of school","Socioeconomic approaches","The allocation will support the scale up of life skills education for out of school adolescents to acquire life skills. In order to address GBV in addition to creating awareness among the population and law enforcements more women headed households in 6 zoba will be assisted through income generating activities/ microcredit loan.","2020-12-31",517800]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","This above allocation will be used to strengthen the referral from the community to the health facilities for services, Print and disseminate the referral tools, Advocacy meetings to engage influential people.","2020-12-31",155250]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","2020-12-31",535000]
[null,null,"HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","As part of this module, ARV providing sites will be scaled up to improve access and reduce transport cost and increase retention. More CD4 and viral load point of care machines will be procured. Additional equipment and reagents to strengthen the existing molecular laboratory, will be procured. To enhance the care and support activities positive living training for new Bidho members, support IGA activities to PLHIV and long term economic support will be supported.","2020-12-31",225000]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","As part of this module, ARV providing sites will be scaled up to improve access and reduce transport cost and increase retention. More CD4 and viral load point of care machines will be procured. Additional equipment and reagents to strengthen the existing molecular laboratory, will be procured. To enhance the care and support activities positive living training for new Bidho members, support IGA activities to PLHIV and long term economic support will be supported.","2020-12-31",515000]
[null,null,"Malaria","Vector control","Indoor residual spraying (IRS)","IRS is conducted in three out of six regions of the country to control malaria. Bendiocarb 80% WP is one of the insecticides used. A total of 22,104kgs of the insecticide are estimated to cover spraying operation for the year 2018. The product costs USD 1,923,048 (CIF cost) at USD 87.0 per kg. Since this is an expensive chemical and that the Global Fund allocation made for the next funding cycle is less-than-expected, the Global Fund was requested for no-objection for the country to use existing savings to cover the above cost. As the request was not approved, this request is being included under PAAR and funding this activity will contribute in preventing malaria as part of IVM strategy.","2020-12-31",725368]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","The above allocation will support the procurement and maintenance cost of van for transporting MDR-TB patients from diagnostic centers to MDR hospital in order to reduce transmission. It will also enhance electronic surveillance for the programmatic management of MDR-TB.","2020-12-31",148800]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.","2020-12-31",90406]
[null,null,"Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","In this section heath care workers working in TB clinics will be trained on comprehensive HIV care and treatment and on HIV counselling and testing skills in order to provide a one-stop service.","2020-12-31",156510]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Treatment: MDR-TB","Procurement of ear tips used for the Kuduwave to monitor for ototoxicity and Procurement of 2 additional pediatric audiology equipment, GSI audiometer and audio booth for Manzini and Lubombo region.","2021-09-30",80160]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Procure syphilis test kits to cover 50% of the country need. This builds on the 50% which is contained in the allocation amount.","2021-09-30",0]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Recruit and retain four regional sexual and reproductive health coordinators/mentors to enhance regional-level coordination of AGYW investments across Global Fund, PEPFAR, UN family, government and others. It is expected that this investment will help address some of the HRH-related implementation bottlenecks, especially for programmatic interventions requiring an integrated approach.","2021-09-30",296471]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Support capacity building of systems at community level; these include a mix of short-term and longer-term interventions adapted according to needs of each community.   The intervention may also include professional development for community workers/volunteers not supported elsewhere, e.g. for professional ethics, human rights, gender sensitivity and equality, and stigma reduction.","2021-09-30",50000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Conduct regular coordination and review meetings at community level by all service providers.","2021-09-30",50000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Support for 3 TB program staff and 3 HIV program staff to attend relevant international conferences.This will enable the program to share the lessons learned from Swaziland?s response, as well as learn from other countries an contexts to improve innovation.","2021-09-30",26664]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Procure 2 additional vehicles and drivers for Shiselweni region to support the MSF transitionthere, recalling that this is one of this proposal?s main strategic modifications. Support Laboratory Personnel for the Lab Commodity Quality Assurance to support Supply Chain System (1 Technologist, 7 Warehouse Assistants). Support Laboratory Personnel to support and strengthen the Quality Assurance Unit.","2021-09-30",189306]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","This funding will be utilised to integrate CMIS with the lab information system (LIS). In addition, funding will go towards training at least 100 health workers on LIS, quality management systems and safety, disease prevention and surveillance. This training will respond to finding from the 2016 Report on Assessment of Quality of Maternal and Neonatal Care in Swaziland. In particular, it will respond to the finding that infection prevention practice of health workers was poor and there was no mechanism to monitor adherence of providers to IP principles in assessed facilities.","2021-09-30",189306]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","Procurement of additional buffer stock of GeneXpert cartridges (to support government absorbing this in year 2 and 3 of the grant).","2021-09-30",616130]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","TB/HIV collaborative interventions","Additional demand creation and treatment literacy activities, including conducting  campaigns targeting miners, ex-miners and their families; conducting campaigns targeting public transport operators; IEC materials, TV campaigns; radio campaigns and activities to create awareness on World TB day (24 March 2017).","2021-09-30",111061]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Counseling and psycho-social support","Additional treatment literacy support, including social and transitional media campaigns, recruitment of Community Outreach Workers (5 men per region and 5 AGYW). These groups are prioritized as outreach workers based on data that shows limited ART uptake among men (Table 3) and limited viral load suppression among young people. Lastly, funding will support the procurement of two vehicles to support the national PLHIV network SWANNEPHA. Funding is requested to recruit community outreach workers, with five men and five AGYW per region.","2021-09-30",417688]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},23311088]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Community TB care delivery","Community based care has been main strategy to access health services in Ethiopia. 53 NTP has implemented intensified community based interventions in 257 woredas/districts in 15 Zones with low TB case notification, through NFM GF grant incentive funding. Based on 18 months of data, the proportion of health posts implementing full package CBTB care has raised from 30% to 60%, with increased proportion of notified TB cases, in these woredas, by 7-10% of the national average. This above allocation request will expand this initiative to additional low performing and high burden 543 woredas, enabling the program to detect and treat additional 16,709 TB cases over the three years grant period. The packages of CBTB interventions include community based TB symptom screening and referral linkage, contact screening, community based DOT and patient support, tracing LTFU, and strengthening program monitoring and human resource capacity.","(blank)",7615756]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Treatment monitoring - Viral load","Out of the estimated cost for viral load testing, 25%, 20% and 15% of the costs for 2018, 2019 and 2020 couldn?t be covered within the allocation. Viral load testing is the key intervention of treatment outcome monitoring and to track the progress towards the achievement of the third 90?s of the 90-90-90 global targets.","(blank)",67934253]
[null,null,"RSSH Total",{"$nulls":4},5081934]
[null,null,"Tuberculosis Total",{"$nulls":4},3000000]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Cross Border Initiative \nThe epidemiology of malaria in the SeneGambia region has changed considerably over recent years, as a result of impressive progress being made by the governments and their implementing partners of both countries. With transmission becoming noticeably lower and much more focal, the question arises as to what it would take to sustain these achievements and to make further progress towards elimination. It was based on this premise that a Cross Border Initiative was conceived and established between Senegal and Gambia. Due to limited funding in the PC request, these activities are requested under PAAR for posible funding. As the countries observe low transmission rates, it is imperative to strengthen the surveillance system to identify foci of transmission in both countries, especially along the border villages/communities for targeted interventions. Hence, this request is made to set the scene for such initiative.\n The overarching goal of the initiative hinges on the following activities: \n1) Establish a surveillance system capable of capturing malaria disease and entomological data for both countries;\n2) Ensure appropriate sharing and use of data for effective targeting of interventions and ensure monitoring of malaria situation;\n3) Encourage use of multiple strategies and interventions to reduce transmission with view to reaching malaria elimination for both countries;\n4) Build technical capacities of both countries to support the acceleration of malaria elimination efforts;\nTherefore, the inclusion of cross border activities in the above allocation request will support to scaling up of the use of mobile technology for real time reporting, case detection and treatment, entomological surveillance and other innovative strategies in both countries.Some of the key activities relative to cross border are budgeted for under PC for both countries. The Funding Gaps for Senegal to fulfill cross border teagets is US$ 3,448,977 while the funding Gap for The Gambia is US$ 970,416. The request made here with amouting to US$ 4,419,393 is in respect of the total funding gaps for both The Gambia and Senegal.","2021-06-30",4489393]
[null,null,"Malaria","Vector control","Indoor residual spraying (IRS)","Indoor Residual Spraying is used as a complementary vector control strategy to mitigate the effects of vector resistance to insecticides. Over the past years, IRS implementation was limited to 2 regions of central river region and upper river region due to funding gap. The 2017 HMIS data have shown regional changes in incidences of malaria where LRR (27/1000 cases) and WR2 (36/1000 cases) have recorded higher incidences compared to other regions. The preliminary results of 2017 MIS have also shown similar trends of parasite prevalence by regions. It has been prioritized for inclusion in the prioritised above allocation request to mitigate effect of insecticide resistance on LLINs in these regions. Therefore, IRS will be scaled up to cover LRR and rural settlements of WR2 using the above allocation request. The request will cover the cost of insecticides, logistics, operational cost and implementation and it amounts to U$1,215,424.  As the Gambia continues to implement IRS in the targeted regions (URR/CRR), and as part of the the two country collaboration clustering of border communities will be conducted to line list villages in the Senegalese side (2 km from the Gambian Border) for posible coverage by the Gambia IRS teams.\nInsecticide resistance monitoring in the IRS program and LLINs are covered in the program continuation request recently approved.","2021-06-30",1215424]
[null,null,"HIV/AIDS, Tuberculosis","Other module","Other module","Differentiated models of care (DMOC) are an important intervention for achieving 90 90 90.  DMOC, introduced in 2017, will be continued during the 2018-2020 funding cycle with support from EQUIP at 20 existing ART sites. USAID will support 10 facilities in 2017 and 2018 while the Global Fund will support 10 sites in 2018 and all 20 sites in 2019-2020.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Other module","Other module","HIV vulnerabilities and barriers to access to HIV services among the physically challenged are unknown. This study aims to identify these and articulate options to address them as part of addressing human rights issues.","2020-12-31",150000]
[null,null,"HIV/AIDS, Tuberculosis","Other module","Other module","Viral load is the key outcome measure for the third 90. At present its use is very limited. The amount requested is necessary to support implementation of the viral load scale-up plan (that is being finalized) for three years.","2020-12-31",0]
[null,null,"Malaria","Case management","Private sector case management","This will target rural deprived and remote locations to benefit the vulnerable and under-served by increasing access to quality-assured and affordable ACTs. A process has been initiated to transition from the current copayment program through a phased approach (from urban and rural to rural only, then to complete weaning off). The transition plan will leverage strengthened community case management through CHPS supported by an improved NHIS which covers the vulnerable and rural populations.","2020-12-31",5291765]
[null,null,"Malaria","Vector control","Other vector control measure(s)","This request will cover a population of 1,180,463 (203,528 households) in 13 districts UER (2018-2020) recently moved to LLINs but with high pyrethroid resistance and an upsurge of malaria parasitemia among the poor and vulnerable population. There will be no overlap between IRS and ITNs.","2020-12-31",24253344]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Current death rates among the MDR cohort will reduce from 25%-15% as MDR treatment adherence and end-of-life care with reduced transmission of MDR/XDR TB will improve by the $1.1million refurbishment of a health facility with 20-bed isolation rooms, pediatric wards, and negative pressure airflow facilities treating 180 patients/year. MoH will provide of beds, equipment, staffing, maintenance costs and running costs.","2020-12-31",1100000]
[null,null,"HIV/AIDS","Comprehensive prevention programs for MSM","Condoms and lubricant programming for MSM","5,802,056 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","2020-12-31",232082.24]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","10,900,316 condoms to cover 82 percent of the programmatic gap in 2019.","2020-12-31",327009]
[null,null,"HIV/AIDS","Comprehensive prevention programs for TGs","Condoms and lubricant programming for TGs","2,975,714 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","2020-12-31",119029]
[null,null,"HIV/AIDS","Comprehensive prevention programs for TGs","HIV testing services for TGs","2,669 HIV tests to cover 100 percent of the programmatic gap in 2019.","2020-12-31",4217]
[null,null,"HIV/AIDS","PMTCT","Prong 3: Preventing vertical HIV transmission","Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women, adapted to needs. This plan must be specific for clearly identified target groups and with translation into the local language, including people's rights approaches .\nThe same TA will be used to conduct end user surveys to evaluate the impact of messages devliered by the campaign\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 119290","2020-12-31",0]
[null,null,"HIV/AIDS","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Consultancy to develop a follow-up strategy for new-born babies to HIV-positive mothers and ensure adequate care (resources for mobilization, promoters, linkage to strategies already in progress)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","2020-12-31",20000]
[null,null,"HIV/AIDS","Program management","Grant management","Operational support of personnel for the MSPAS and INCAP consisting of:\n1- A facilitator for the ETMI hired for the PNS.\n2- Officer dedicated to the Monitoring and Evaluation of the ETMI component in the PNS\n3- Responsible for ETMI\n4- Secretarial support\n\nTo this is added the percentage of operational expenses of INCAP (1% for the acquisition of tests and 5% for the rest of the items)\nTransversal contribution to the indicators related to prevention and treatment. This item was updated in October 2019 to increment the original approaved amount of 211260","2020-12-31",0]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Capacity building and mobilization of human rights and key population NGOs (PLHIV, MSM, trans, FSWs) to advocate against stigma, discrimination and other HR violations related to HIV through regional (Central America or broader international scale) meetings focused on:\n? Exchange of knowledge with activists;\n? Planning advocacy initiatives;\n? Implement these initiatives through forums (e.g. Organization of American States (OAS) mechanisms, United Nations organs for HR or other UN forums).","2020-12-31",75000]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Central Guatemala health department. Renovation of a 44.18 m² facility, including: \nRemove existing metal structure and fit  a new structure; remove a suspended ceiling; erect and repair walls; make furniture units; two wooden doors; one aluminum door; installing electricity; paintwork; renovate balconies and 1 metal door; replace mechanisms and adhesive vinyl for 3 aluminum window; fit ducting for electrical wiring; install a 18,000 BTU ACU.","2020-12-31",9677.42]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Escuintla health area department. Renovation of a 23.79 m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; erecting a plasterboard wall; eight windows; three balconies; one metal door; installing water and electricity; making fixed furniture units; one sink; laying ceramic flooring; perimeter pavement; metal structure; suspended ceiling; enclosure for gas cylinders; paintwork.","2020-12-31",6000]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Malacatán Hospital, San Marcos. Renovation of a 416 m² facility, including: \nwaterproof treatment of floor; paintwork for walls; epoxy paint in laboratory; making fixed furniture units; removing and replacing 13 wooden doors; fitting one aluminum door; installing two 2 x 32 lights; three washbasins; installing water; replacing fittings for eight washbasins; replacing one existing door lock; supplying ten fluorescent light tubes.","2020-12-31",10775]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Petén Sur health area department (planning pending).","2020-12-31",9677.42]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","San Marcos health area department.  Renovation of XX  m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.","2020-12-31",6000]
[null,null,"HIV/AIDS Total",{"$nulls":4},4707094.2399999993]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","International consultancy services for technical assistance and GxAlert platform support.","2022-06-30",0]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Modular office furniture with overhead storage cabinets.","2022-06-30",110.55]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Regional training in line probe assays (LPAs) at the Rodolfo Robles Hospital.","2022-06-30",1025.76]
[null,null,"Malaria","Program management","Grant management","6. Request for additional funding for the rehabilitation of the NMCP offices as per the studies carried out by UNOPS. The geotechnical and technical studies in preparations for the renovation work were financed by CRS (with the subsidy NFM 2015-2017).  The requested funding is to cover the gap in the costs of renovation that were initially budgeted prior to the finalization of the UNOPS studies.","2020-12-31",275000]
[null,null,"Malaria Total",{"$nulls":4},17348915.66]
[null,null,"Tuberculosis","Program management","Other program management intervention(s)","Advocacy platform bringing together the TB and HIV programs, the government, elected members, TFPs and representatives from the various sectors; advocacy before the government and the partners in order to mobilise resources and to achieve the adoption of legislation beneficial to the effort to combat tuberculosis.","2020-12-31",6069]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","This connectivity system will enable the remote monitoring in real time of the usage data of the GeneXpert machines, of any faults or breakdowns that occur and will make it possible to put in place the relevant solutions; the transmission of results will also be improved. Cost indicated by the regional adviser from the WHO + internet connection charges.","2020-12-31",106170]
[null,null,"Tuberculosis Total",{"$nulls":4},2315427]
[null,null,"HIV/AIDS, Tuberculosis","Other module","Keeping girls in school","Monitor the activities of activists working in schools. This sum covers the allowances of the regional supervisors for the 3 years of the grant.","2020-12-31",29562.34]
[null,null,"HIV/AIDS, Tuberculosis","Other module","Other module","Recruit an international laboratory specialist to strengthen the capacities of the Directorate for Pharmaceutical, Laboratory and Drug Services/Ministry for Public Health and the National Health Institute [INASA] to draw up regulatory documents for the laboratory system.  In addition, the specialist will contribute to improving the quality of the laboratory services involved in health care for the three diseases.","2020-12-31",201997.53]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Develop and reproduce communication materials (leaflets, posters and charter of the patient). This amount is planned to renew the reproduction of the communication materials to be used for advocacy and BCC among the populations.","2020-12-31",5254.18]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Thanks to the NFM TB grant, a new TB reference laboratory has been built. In order to render it functional, a negative-pressure system must be installed (to respect the bio-safety norms) and a few other corrections must be made (Mechanical and Civil Budgets costs of NTRL Guinea Bissau, WHO Expert Mission - Appendix B). \nFor this reason, the WHO hired an international expert to perform an evaluation and implementation of his recommendations will require the requested amounts.\nOnce this laboratory is functional, it will be used to perform the necessary exams to fight tuberculosis including the multi-resistant version. The agents will work there under optimum bio-safety conditions.","2020-12-31",743538.91]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},5576924.6299999999]
[null,null,"Malaria","Other module","Other module","National Health Accounts. This process aims to improve the planning, the allocation of resources and the accountability of the Ministry for Public Health. By generating coherent and complete data regarding health expenditure, the NHA will contribute to the establishment of evidence-based policies in Guinea Bissau.","2020-12-31",101053.75]
[null,null,"Malaria","Program management","Grant management","The previous PAAR proposal did not contain the 7% UNDP GMS (overhead). The 100k EUR amount includes the 7% for all previous TRP approved activities.","2020-12-31",112438.56]
[null,"Haiti","HIV/AIDS, Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Direct contacts of MDR-TB patients on treatment are at risk of infection. The WHO recommends that they are monitored periodically for at least two years to track any development of resistant germ tuberculosis-type infection or disease. ASCPs must receive appropriate training so that they can conduct this task correctly.","2020-12-31",9216]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Other community responses and systems intervention(s)","This proposal for the PAAR will bring the following added value to the current grant: 3,480 PLHIV per year will benefit from Individual Counselling Services/Psychological Support; 2,800 more PLHIV/per year who will benefit from support groups; 5,084 more Home Visits; 2,300 patients on ARV/per year will receive ARV treatment at community level; 2,584 more Visits searching for people lost to follow up; 920 HIV+ women lost to follow up after childbirth, who will benefit from active detection; starting of community relay points for ARV treatment provisioning of PLHIV; community distribution of ARV treatment through PLHIV Peers-Trainers.","2020-12-31",675354]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","The BSL3 certification process of the LNSP is under way and must finish on schedule in April 2018. Its operating budget has not yet been met by any funder. The maintenance cost requested includes certification of hoods, maintenance of negative pressure and maintenance of equipment.","2020-12-31",373577]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Refurbishment of structures reserved for treating and isolating detainees with tuberculosis in three prisons. The existing isolation structures will be refitted in a sensitive TB space with a room for contagious TB in its intensive treatment phase, a room for non-contagious TB in its treatment maintenance phase and an MDR-TB space where people can be isolated. Works will also be conducted in consultation room to bring it up to infection control standards.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Treatment monitoring - Drug resistance surveillance","HIV resistance to ARV treatment is a threat to achieving 90-90-90 objectives and eradicating HIV by 2030. In Haiti, there have not been any national surveys of the prevalence of resistance (RDP-RDA) of HIV-1 to ARV treatment. \nRecommendation:\n? Develop a National Plan for Surveillance and Response to HIVDR  \n? Develop guidelines for surveillance of HIVDR \n? Train healthcare managers on surveillance and prevention of HIVDR, including systematic monitoring of EWIs.","2020-12-31",0]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Organise 4 quarterly meetings on monitoring and co-ordination between the PNCM and departmental directors\nexpected results: co-ordination of activities to combat malaria with departmental authorities is ensured; .\nimpact: players at operational level will correctly implement Global Fund projects and correctly apply directives and policies to combat malaria dictated by the PNCM.","2020-12-31",149685.6]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Program and data quality","Strengthen central supervision of health institutions.\nExpected outcome: Field activity monitoring is improved.\nImpact: Better implementation monitoring.","2020-12-31",35650]
[null,null,"Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Sign contracts with 23 new radio stations to broadcast messages on eliminating malaria in towns bordering areas in stratum 3\nexpected results: increase efforts againts progression of malaria; 2/ populations in towns bordering red areas are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localities\nimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.","2020-12-31",8280]
[null,"Honduras","HIV/AIDS","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Training leaders and monitoring of interventions for MSM population","2022-07-31",121919.44]
[null,null,"HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Contracting a coordinator and workers for organizations that intervene in the MSM population","2022-07-31",36196.46]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Montly salaries of staff included in the budget of the future grant (the number of monthly salaries were reduced at the beginning and end of the grant due to the reduction of funding)","2022-07-31",0]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Contracting a coordinator and workers for organizations that intervene in the Garifuna population","2022-07-31",225281]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","? Preventive maintenance for the IT equipment following the implementation of the integrated health information system\n? Website maintenance\n? Training health personnel in the processes and information system\n? Study of HIV cases? notifications and compliance with the HIV diagnostic algorithm \n? KAP study with serology in the Miskito population and intravenous drug users\n? Prevalence study in young people between the ages of 15 and 30\n? Study on the HIV vulnerability factors in young girls\n? Study of HIV and TB prevalence in migrants\n? Study on the characterization of Opportunistic Infections in persons with HIV and \n? Study on the main causes of death in persons with HIV in hospitals","2022-07-31",430939.69]
[null,null,"Tuberculosis","Program management","Grant management","Strengthen the PR?s and SR?s (at central and regional level) capacity to improve implementation, through technical, administrative and financial guidelines.","2022-07-31",81701.149999999994]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Activities to improve prevention, advocacy, detection, diagnosis and timely treatment in TB key populations, such as people with diabetes, mental patients, kidney patients and tobacco users. Similarly, activities to improve the control of TB at the different levels of care and, subsequently, decrease the number of deaths due to TB in association with these pathologies.","2022-07-31",429826.35]
[null,"India","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Additional confirmation sites - 3000 Integrated sustainable Model ICTC at CHCs. With this all CHCs will be covered.","2021-03-31",0]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","The project implemented the activity Nukkad Nataks as part of demand generation under the NFM grant. It is proposed to organize Nukkad Nataks in new project districts / states.","2021-03-31",200000]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","The project printed and disseminated 4 types of IEC materials which is facilitating the increase om demand for PPTCT within the community and health system. There has been a huge demand for these IEC materials in the field. The project is proposing to print and disseminate the same materials in local languages in 7 new project states.","2021-03-31",60000]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","The project team organised DRT refresher trainings under the current grant to improve the provision of PPTCT services through periphery health care providers. This facilitated to improve the overall performance of the project. The project is proposing a similar activity under the new grant.","2021-03-31",300000]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Procurement strategy","As an extension to the comprehensive logistic strategy to supply mentioned under allocation, it is proposed to include HIV testing kits supply up to the peripheral centers.","2021-03-31",0]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Proposed for refresher training of all SRs and SSRs to update them on new trends of treatment policies and other related latest information.","2021-03-31",277573]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment adherence","As a part of alternate strategies to improve adherence to ARVs, adherence clubs at all Link ART Centers (LACs) are being proposed.","2021-03-31",4700000]
[null,null,"Malaria","Vector control","Other vector control measure(s)","This includes procurement and distribution cost of LLINs for Odisha which need to be replaced in 2020 to sustain the impact of LLINs distributed in 2017. Odisha accounts for more than 40% of malaria in India. Maintaining LLINs coverage in Odisha would reduce malaria morbidity & mortality by 70% in 2020 compared to 2015, similar to NE states. 90% of LLNs are assumed to be used by population in coverage areas.","2021-03-31",25800725]
[null,null,"Tuberculosis","Program management","Other program management intervention(s)","Programme-provided daily FDC will be available for free to patients in private sector. Establishing effective provider/patient linkages will ensure accessibility to those drugs, and increase uptake of free services offered by program.  Additionally, new aspirational \"brand\" would be introduced, promoted, marketed and owned by RNTCP. Experience from large scale social marketing will be leveraged to generate demand and ensure access to quality anti-TB drugs in private sector in line with program recommended regimen. Incentives will be provided to distributors/pharmacies to cover their costs of stocking, distributing and dispensing, and to ensure drugs are dispensed at affordable cost from qualified private retailers.\nImplementing organizations will use supply chain, retailers and distributors for supplying the socially marketed drugs at the door step of chemists and Private Providers. \nRequest: USD 1.59million for 5 cities.","2021-03-31",1590000]
[null,null,"Tuberculosis","TB care and prevention","Prevention","Diagnostics: Rapid molecular diagnostics scale up requires 1000 CBNAAT (GeneXpert) machines: 25% to be covered from GF allocation, 25% from PAAR, and 50% from domestic resources. This will assist the rollout of universal DST component and diagnosis of TB among the key population including TB/HIV. 250 machines under PAAR will increase the testing capacity by 1.5 million tests & early diagnosis of 0.21 million TB patients (1 out of 7 tests). PAAR will cover additional 533,400 cartridges, with the remaining coming from domestic resources. Total Request: USD 10.86 million.","2021-03-31",0]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Comprehensive prevention programs for MSM","HIV testing services for MSM","Expansion of Comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts).","(blank)",820996]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","(blank)",985773]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Comprehensive prevention programs for TGs","Community empowerment for TGs","Expansion of Comprehensive program to reach additional 5,250 TG for testing and 756 for treatment.","(blank)",88604]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Program management","Other program management intervention(s)","(blank)","(blank)",301800]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Operational Research of new districts providing Counselling, Testing, and Treatment, as well as adding these districts in the IBBS (for NG and Chlamydia).","(blank)",224110]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB care and prevention","Other TB care and prevention intervention(s)","Additional 100 patients per year (the entry and cough surveillance will detect already more cases, about 1,500 cases per year). The mass screening will detect the patients which are missed during routine surveillance). Joint prison TB-HIV planning and ICF workshop at national level for 9 provinces. Joint supervision for TB control implementation in prison by DG of correctional services MoLHR, NTP, and NAP.","(blank)",361848]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB care and prevention","Other TB care and prevention intervention(s)","Mobile clinic to screen for TB in urban poor population in 10, 12, 15 high burdened cities in 2018, 2019, 2020. Additional 1000 patients from urban poor is expected per year. Technical mentoring of TB ICF in 34 provinces, printing of TB ICF materials. Printing IEC material for vulnerable population at workplace.","(blank)",947184]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB/HIV","Other TB/HIV intervention(s)","Training for 80 districts not supported by CSO intervention. MoH will be responsible to provide training in these districts. The above allocation is requested to finance the setting up or revitalize TB HIV working group at district level not supported by HIV program, while the main allocation is requested to support TB HIV working group in provincial level, which is considered more strategic and cost effective. Transport for case manager to assure TB HIV patient access HIV clinics is included.","(blank)",1262018]
[null,null,"HIV/AIDS, Tuberculosis, RSSH Total",{"$nulls":4},37841774]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","Needed for collaboration with Malaysia (Kalimantan), Timor Leste (NTT), and PNG (Papua).\nEstimate requirement for each collaboration meeting would be US$ 20,000 with total 10 times of meeting/workshop.\nKalimantan-Malaysia : 3 times\nNTT-Timor Leste : 4 times\nPapua-PNG  : 4 times\nEach activity will involve Ministry of Health (NMP, Foreign Affair Bureau, Surveillance program, maternal and child health program), Ministry of Finance, Ministry of Foreign Affair, Ministry of Home Affair, PHO, DHO, Private Sector, Local NGOs","2020-12-31",200000]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Surveys","Operational research to update vector status and determine vectorial capacity of mosquitoes in the areas of intense transmission in Papua, to be conducted in conjunction with an evaluation of innovative vector-control interventions suited to the high transmission areas. To be conducted in 25 district sites representing the different condition and situation of vector.  (US$500,000)","2020-12-31",500000]
[null,null,"HIV/AIDS","Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","Based on the Pilot of PrEP being supported under the allocation, scale-up to provide for at least 1500 additional MSM on PrEP by project end.","2021-12-31",172296]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Development and roll out of a communication campaign  (including E-posters) in treatment sites to scale up treatment literacy, educate clients on available services and their rights as well as redress opportunities. This will seek to build capacity among KP service users to know their rights and demand quality services, thereby reducing stigma and discrimination in  health facilities.","2021-12-31",250000]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Conduct adherence and time use study to inform program planning and improve retention in care among PLHIV .","2021-12-31",75000]
[null,null,"HIV/AIDS Total",{"$nulls":4},2414041]
[null,null,"HIV/AIDS, Tuberculosis","HIV Testing Services","Differentiated HIV testing services","This above allocation funding (UQD) aims to support quality assurance and systems strengthening to ensure effective HIV Testing Services ( HTS) program. Overall, above allocation funding will procure testing kits to support 7 million tests. The within allocation funding is supporting innovative HTS strategies such as self-testing, assisted partner services and capacity building for service providers as well as procurement of testing kits.","(blank)",9611854]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","This above allocation funding (UQD) aims to operationalize infrastructure for electronic medical records in 5 counties and on interoperability of the different Electronic Medical Records/Electronic Health Records (EMRs/EHRs) developed for HIV and TB programmes and development of a health ID policy framework. Within allocation, routine data collection is mainly ensured by the availability of printed M&E tools. This remains a short to medium term strategy since the overall goal is to introduce electronic health systems to enhance efficiency and sustainability.","(blank)",4679226]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","This above allocation funding (UQD) aims to expand the Field Epidemiology and Laboratory Training Programme (FELTP) that has been instrumental in building high level capacity for epidemiology and laboratory science whose graduates largely support the HIV, TB and Malaria programmes. The scope has been limited by the available resources from the Centres for Disease Control yet there is a greater need. In order to expand access to this program to county HIV and TB coordinators, this above allocation funding is proposed to meet this gap.","(blank)",640796]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","TB/HIV collaborative interventions","This above allocation funding (UQD) will support procurement of cartridges for Early Infant Diagnostics and viral load testing in HIV in order to cover pediatric co-infections.The within allocation funding will support TB/HIV collaborative interventions targeting adults with a focus on strengthening coordination at county level, improving screening and treatment of both diseases including providing required diagnostic equipment and drugs.","(blank)",1875000]
[null,null,"Malaria","Other module","Other module","The above allocation funding (UQD) aims to maintain high levels of treatmnet with quality assured ACTs in private sector and for improvemnet of malaria diagnosis, treatmnet and surveilance. Activities wil include: update of the curriculum and the guidelines to be undertaken in the next one-year. This will be followed up with training to strengthen surveillance and reporting. A total of 282 ToTs, 7960 health workers at county, sub-county and facility levels are targeted for training. Within the allocation 282 ToTs and 3050 have been budgeted for, the balance of 4910 health workers is requested in the above allocation (UQD - $1,020,164). The other request is to facilitate one Private Sector QoC survey (US$ 152,670).","2021-06-30",0]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","Additional financial support is required to provide overarching programmatic management and to maximise national capacity in policy planning, coordination and management as the country transitions to elimination. While not directly linked to program impact / outcome it will provide an enabling environment for the program to implement more effectively and efficiently. Above allocation funding will be utilised for 1) training on programme management in the elimination phase, and 2) International Conferences on the elimination of malaria (4 persons 2018-2020).","2021-02-28",252755]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","Funding will increase the capabilities of the National Malaria Program  to conduct enhanced parasitological surveillance. This will provide a more nuanced evidence base for decision making from a molecular level analysis. Genotyping of P. vivax strains will help highlight parasite strain diversity and parasite flows between local and imported cases (from other provinces within the country). It will also prove confirm suspicions of asymptomatic parasite carriage or below detection parasite infections in which foci investigation followed by RCD / Reactive focal IRS has not interrupted transmission. Funding will also cover procurement/supply management cost of consumables/equipment to conduct polmerase chain reaaction (PCR) testing, training and external TA. Operational research will also be conducted.","2021-02-28",67000]
[null,null,"Tuberculosis","Other module","Other module","Using the allocation, it will not be possible to treat all MDR-TB cases that are expected to be detected. UQD will enable treatment of all detected MDR-TB cases and includes drug costs, food support, ancillary drugs. (4,000 DR-TB patients including 3280 cases of short-regimen and 220 cases of long-term regimen, 300 cases of XDR treatment and 200 cases of H mono-poly resistant regimen).","2021-06-30",5814623]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","HIV testing services for PWID","Additional funds for PWID programmes will be used for increasing counselling and testing for HIV, HBV and HCV in NGO centres in Pristina, Prizren and Gjilan.","2020-12-31",148362.70000000001]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Additional funds will be used to support the development of transition plan to absorb HIV human resources-related costs (i.e. staff currently supported by the grant).","2020-12-31",3366.63]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Additional funds will be used to conduct additional advocacy activities at local level in support of enabling environments for service delivery among KAPs.","2020-12-31",33666.26]
[null,null,"HIV/AIDS","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Additional funds will be used to support HIV related trainings for outreach and medical workers who work with PWIDs, MSM, SW: this will strengthen the continuum of care and collaboration between civil society and government healthcare providers.","2020-12-31",20603.75]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Similarly, to interventions for PWID, this amount  is to recruit additional outreach workers to cover gaps for human resources for health (reduce the HRH gap for outreach workers by 10 percent) to enable the\napplicant to reach a coverage target of 80 percent of sex workers by 2020. This cadre of workers will provide various services including HIV testing and counselling and adherence support.","(blank)",123075]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","MDR-TB","Prevention for MDR-TB","Funding is requested to support the procurement of masks and respirators, as well as UV lamps for TB facilities.","(blank)",482640]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","MDR-TB","Treatment: MDR-TB","The request for funding to GF for 2018-2020 (allocated amount) includes SLD coverage through the end of 2020. Additional SLD supply for 2021 is requested from PAAR to cover SLDs for patients who have started MDR TB treatment through the end of 2020 and will continue in 2021. Totally, 1040 MDR TB patients will be covered. The additional SLD supply will ensure the continuum of care for MDR TB patients started treatment during 2019-2020 within GF grant for bridging the potential treatment gap for period January- September 2021.","(blank)",1609942]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","RSSH: Health management information systems and M&E","Routine reporting","This funding is for expansion of electronic TB database including software update, user trainings, monitoring, and supportive supervision activities.","(blank)",550435]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Trainings to build capacity of medical workers at all levels of health care on tuberculosis including implementation of individual and short-term treatment regimens for TB using new and reprofiled drugs, active monitoring and management of adverse reactions, TB infection control, etc.","(blank)",50000]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","This funding is to develop a mechanism for the state funding of OST and NEP points, elaboration and implementation of the electronic monitoring tool for this ($20,244). Additionally, funding request includes incentives for service providers at the PHC level for viral load suppression and quality provision of medical services for PLHIV (US$ 48,004)","(blank)",68248]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Treatment, care and support","Treatment adherence","Eight multidisciplinary teams will be supported at base of AIDS Centeres and PHC to implement the activities for PLHIV: motivational trainings and self-support groups, SRH services, viral hepatitis B &C prevention and treatment, dental services. Three additional NGOs from PLHIV community will be supported. These interventions will contribute to achieving targets of the main grant (coverage of 80% of PLHIV by 2020, the achievement of viral suppression in 70% of them).","(blank)",865080]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Allocation funding will reach female sex workers with prevention packages in 5 priority provinces only, leaving a 27% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address a 39% gap in condom supply.","2020-12-31",549986]
[null,null,"HIV/AIDS Total",{"$nulls":4},2515711]
[null,"Lesotho","HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","(blank)","2021-06-30",668016]
[null,null,"HIV/AIDS, Tuberculosis","HIV Testing Services","Differentiated HIV testing services","The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) reported that the country is making good progress towards the UNAIDS 90-90-90 targets with 81% of PLHIV knowing their status, 92% of those who know their status on treatment, and 88% of those on treatment being virally suppressed. Despite tremendous efforts in scaling up HTS in Lesotho still 82, 000 PLHIV do not know their status, among these men, adolescents and young people, key populations and partners of people living with HIV (PLHIV). A key strategy to addressing this gap in the abovementioned target group is the provision of HIV self-testing (HIVST). In support of MOH Lesotho (MOHL), Unitaid funded the introduction and scale up of HIV self-testing in 2017. In 2018 a total of 58, 000 HIVST were distributed, mainly through community-based distribution. During this period majority of the self-testers were high-risk men (58%), adolescents 15-24 (35%) and key populations (7%). Furthermore, the Unitaid supported project reported that the number of HIV positive cases increased. The HTS Strategy has since been developed (Annex 1).\n\nIn 2019 Unitaid will fund 43,342 HIVST kits and 64, 000 will be funded by CDC. The implementation of the differentiated strategy for HTS will require scaling up of HIVST, i.e. to expand HIVST across the entire country a substantial increase in the procurement of HIVST kit is needed. The estimated gap in HIVST kit commodities for the period 2020 is 240,000 and 2021 is 200,000 to cover all geographic areas. In particular the focus will be on:\n? Hot spots, male dominated workplaces, places frequented by adolescents and young people, market places, taxi ranks, door to door distribution and campaign style distribution. \n? Key populations (MSM, Sex workers) - based on current trends, it is estimated that 2000 HIVST kits would be distributed annually to these populations.\n? Antenatal clinics (ANC) - based on current trends for this target group, an estimated 34, 560 test kits will be required to reach male sexual partners of ANC clinic attendees. \n? Distribution through index patients (ART initiations at public sector hospitals): the current trends indicate that uptake by positive index patients and by sexual partner, estimates the requirement of 15, 000 test kits annually.\n? Direct distribution to Outpatients departments: Based on current trends indicates that annually an estimated 72, 000 test kits would be required.","2021-06-30",0]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Gender-based violence prevention and treatment programs for adolescents and youth","The funding will be used for multimedia platforms, including social media, to enhance service uptake by adolescents and young people. The activities will include establishing a hotline for survivors of gender based violence and design of webpages and databases. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.","2021-06-30",0]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Gender-based violence prevention and treatment programs for general population","Funding will be used to support integration of human rights and prevention of sexual and gender-based violence among adolescents as part of HIV and TB prevention intervention to address structural issues and expand geographical coverage to eight districts. The activity will be funded through the reinvestment of the efficiencies identified during the grant making.","2021-06-30",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","The funding will be used to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA) as part of community systems strengthening. This will include development of key users manuals, procurement of key infrastructure, and training of stakeholders to enable full operation of LOMSHA.","2021-06-30",53318]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Based on the observation study currently rolled out, increased monitoring and management of patients with adverse side effects is required. Furthermore, an opportunity for the decentralisation of MDR-TB services is presented with the use of all oral medications. To increase monitoring and management of patients with adverse side effects, and decentralise the MDR-TB services, the following gaps need to be addressed:\n? Two additional physicians to facilitate accurate diagnosis and follow up at district level as well training, mentorship and supervision of district teams. \n? Four registered nurses are needed for the intensive clinical care for those admitted and ambulatory patients. \n? To closely monitor, document and report as well as provide expert interventions to address the adverse effects. two pharmacy technicians and one pharmacist are needed \n\nThe key outcome of increasing the human resource capacity will be: \n? Increased community implementation and providing support and case management to remote districts. \n? Increased number of treatment initiation sites and strengthening treatment literacy. \n? Sustainability as the doctors (especially Basotho doctors for sustainability) at district level will be trained to build a team of experts who can continue the management or even the PMDT in a sustainable manner.\n\nThe use of all oral medications is an opportunity to further decentralize MDR services having removed the complicated aspect of treatment of administering the injectable. The very clinicians and nurses will serve as resource persons for the envisaged consillium aimed at providing remote support to districts as they manage the cases. It means that it will be feasible to increase initiation sites and treatment literacy strengthened through additional pharmacist and Pharmacy Technicians","2021-06-30",560840]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","The NSP 2015 ? 2020 and the National HIV Prevention Strategy 2017 ? 2020 prioritize high impact HIV prevention interventions for adolescents and youths in and out of school. HIV prevalence in young people has increased from 1.1% (young women, 1.6%; and young men, 0.5%) in 2007 to 1.8% (LDHS 2007 & 2013). A total of 823,777 youth and adolescents reached with targeted HIV prevention messages in the six counties in 2018; 841,073 in 2019; and 858,736 in 2020. A total of 120 peer educators trained in HIV prevention for in-and-out-of-school youth and adolescents. The investment for ART will be leveraged to provide treatment and care for positive PLHIV identified among targeted adolescents and youth.","2020-12-31",295775]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","IBBSS: The rationale for this activity is to monitor the HIV positivity rate among key population and vulnerable groups with the interventions that will be conducted during the funding cycle. This activity is currently being implemented and expected to be conducted in 2020. Although this is a priority intervention, it is placed in PAAR due to limited funding within allocation.","2020-12-31",240624]
[null,null,"Malaria","Case management","Integrated community case management (ICCM)","CHA feedback meeting which is held on quarterly basis is an activity that brings the community health frontline workers together on quarterly basis.   This request covers: Total year 3 cost of the activity within the program continuation because the within allocation cannot accommodate this; Total cost for 3 years cost for the activity in additional 5 counties including 2 additional districts in Margibi with gaps in iCCM implementation as recognized by the LCM, MOH and other iCCM partners as being critical in rollout and implementation of the Revised National Community Health program in Liberia.","2021-06-30",464935]
[null,null,"Malaria","Case management","Integrated community case management (ICCM)","funding need for equipment and materials to CHAs and CHSS for the scale-up counties and also includes replacement of motorbike tyres for 92 CHS in within allocation in the initial 4 GF supported counties.","2021-06-30",825561]
[null,null,"Malaria","Program management","Grant management","This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria during the 2021 Mass Distribution Campaign. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.","2021-06-30",91440]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","In Liberia, Malaria is placed under passive surveillance under the Integrated Disease Surveillance and Response strategy.  In 2013, two surveillance sites were opened however, the sites did not function as the result of the outbreak of the Ebola Virus Disease outbreak which plagued the Country in 2014 and 2015.  Post Ebola, the Program decided to expand to three other health facilities in order to geographically balance the surveillance activities.  The requested fund is to set up the five sites (US$100,000) and another one hundred thousand dollars per year to run the sites for three years.","2021-06-30",400000]
[null,null,"Malaria","RSSH: Integrated service delivery and quality improvement","Supportive policy and programmatic environment","Of the country?s total population of 4,148.567, Montserrado County accounts for 1,362,395 approximately 65% of Liberia?s entire population for FY 2017/2018 with a projected annual growth rate of 2.1%.  The MOH plans to contract-in with the Montserrado County Health Team to implement a differentiated service delivery approach to provide HIV, TB and Malaria prevention, care, and treatment service. With differentiated care, stable patients may receive key services in a community setting rather than in health facilities, enabling them to make less frequent visits to clinics and pharmacies. In addition to streamlining their care and making it more convenient, this approach will allow health workers to spend more time with less stable patients and those with advanced disease, increasing efficiency and improving quality of care. Services will be tailored for other groups with diverse needs, such as adolescents and young people, pregnant and breast-feeding women, mobile and migrant populations, and others. The goal is to place the client at the center of service delivery while maximizing health system efficiency.\nThe expected outcomes will be a marked reduction in overcrowding at health facilities, reduction in wait times for patients, reduction in workload for clinicians, improvement in program quality such as increased retention rates, overall satisfactory patient outcome and public health goal, and improved supply chain performance.","2021-06-30",1060304]
[null,null,"Malaria","RSSH: Integrated service delivery and quality improvement","Supportive policy and programmatic environment","The request amount in this cost category and intervention aimes to ensur community health workforce retention. It includes:\n? 3 years of monthly compensation/salary for 252 CHAs and  26 CHSS for 4 additional districts in Grand Bassa (a priority national ICCM gap)\n? 3 years of monthly compensation/salary for 355 CHAs and 36 CHSS for 4 additional districts in Bong (a priority national ICCM gap)","2021-06-30",5253702]
[null,null,"Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","High Specific prevention interventions (SPI) IEC/BCC (SPI) 488,160 This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.   ? Year 3 cost for program continuation (within allocation); 3 years cost for additional 5 counties including 2 additional districts in Margibi (iCCM priority gaps recognized by the LCM, MOH and other iCCM partners in the implementation of the Revised National Community Health program in Liberia.","2021-06-30",2225320]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","This refers to consultancy costs for supervising activities carried out by peer educators for the HIV program.","2020-12-31",5943]
[null,null,"HIV/AIDS","Prevention programs for adolescents and youth, in and out of school","HIV testing services for adolescents and youth, in and out of school","This refers to activities to accompany young people who agree to testing. This funding will cover monitoring of targets for testing at health centers, with a view to achieving testing coverage of 36 per cent in 2018 and 45 per cent in 2020. It will also provide for activities to accompany young people who test positive to referral doctors, in order to reduce the number of initial patients lost to follow-up and improve retention from 127 cases in 2018 to 168 cases in 2020, thus helping to achieve the enrolment target of 65 per cent of new cases on ART. There will also be mobile testing targeting young people, ensuring local service provision through mobile clinics. The above allocation amount will cover 27 per cent of the target for accompanying during testing, representing an additional 198,114 young people tested.","2020-12-31",131082]
[null,null,"HIV/AIDS","Program management","Grant management","ES/NAC and SR staff will be provided with information technology (IT) equipment. These needs have been listed under the above allocation amount, despite their importance for delivering the activities.","2020-12-31",14633]
[null,null,"HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","It is important to empower the local levels, as they are the most directly involved in delivering activities and targets on the ground. Part of this activity is included under the allocation amount; support is requested for the other part under the above allocation amount. The district level closely monitors health care facilities.","2020-12-31",35161]
[null,null,"HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","This component comprises the supervision of activities on the ground in the 42 intervention towns by the district managers of the psychosocial care SR, MAD'AIDS. Supervision is carried out twice a year, the first time covered by the allocation amount and the second by the above allocation amount. Costs related to supervision cover transport/fuel and allowances.","2020-12-31",19520]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","The country is planning to introduce a unique identification system to avoid duplication among beneficiaries. To maintain confidentiality and ensure continuum of care, especially within services, PSI is going to introduce a unique identifier code (UIC) system to monitor beneficiaries. it will be crucial to run an exchange visit to another country with experience in using the system. This request also covers international technical assistance to provide technical support to the team, particularly for the programmatic and monitoring and evaluation components, due to the complexity of the interventions under this continuation and the strategic reorientation of HIV activities. Throughout implementation, it will be vitally important to strengthen coordination through a regular meeting between the PRs, SRs and partners with the objective to closely monitor progress and to address bottlenecks, and to improve collaboration and harmonization in implementation on the ground. The request also includes training to provide capacity building for peer educator supervisors and district managers.The total budget for this activity falls within the above allocation amount, so it will be completely dependent on approval of this request.","2020-12-31",280931]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Given the poor quality and inconsistency of data, and the stock-outs of supplies, it is essential that managers receive training in monitoring and evaluation. This training should also improve the completeness of reports.","2020-12-31",7345]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","The activity consists of providing social and financial support to patients living in extreme poverty. This amount would provide medical care for those testing HIV-positive throughout the country, estimated at 50 patients a year on average, covering both hospitalization and outpatients.\nThe average cost is 1 million Malagasy ariary per PLHIV per year. This covers drugs other than ARVs, paraclinical examinations (including imagery), non-subsidized additional tests, food, transport and medical waste disposal.","2020-12-31",94403]
[null,null,"Malaria","Case management","Therapeutic efficacy surveillance","Long-term surveillance of the therapeutic efficacy of antimalarial drugs is one of the objectives of the NSP and should provide annual data on any potential therapeutic failures that could result in a resurgence of malaria. This amount will help to maintain surveillance during the final two years of the grant. In 2018, it will be implemented with funding from the President?s Malaria Initiative (PMI).","2021-06-30",289892]
[null,null,"Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Improved IPT coverage, will be implemented in all health care facilities.  This above allocation request will therefore allow the continued provision of sulfadoxine-pyrimethamine (SP) in 2021. This intervention will help achieve the NSP target to protect at least 80 percent of women through IPT, and to reduce the risk of low birth weight by approximately 21 percent and neonatal mortality by 61 percent.","2021-06-30",1074953]
[null,"Malawi","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Drop-in centers for MSM ($1.08M) Establish one drop-in center per district to facilitate provision and linkages of non-biomedical and biomedical services.","2020-12-31",1080000]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Enhanced linkages to care ($0.40M) Additional activities to strengthen FSW programming linkage to care and monitoring in current 11 districts.","2020-12-31",400000]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Prevention for MDR-TB","MDR TB Prevention (USD 600,000): With the increase in TB diagnosis and treatment that will occur through the emphasis on case detection and diagnosis in this FR, effective infection control measures must be put in place. This line item will be used for the upgrading of MDR-TB wards in three central hospitals to include negative pressure isolation rooms.","2020-12-31",600000]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Double investment for adolescent girls and boys and young women men to distribute condoms ($0.16M) Catalytic funding is currently funding incentives for the first 250. Above allocation funding will provide sufficient funding for an additional 250 (500 total).","2020-12-31",160000]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Diagnosis and treatment of STIs and other sexual health services for general population","Training of HCWs in STI syndromic management approach ($0.36M) Important for ongoing capacity building and treatment of STIs and prevention of HIV; already partially funded within allocation; allows full training roll out to HCWs. The STI program has no alternative sources of funding.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Financial management systems","Public financial management (PFM) strengthening","The activities prioritized in this intervention are central to financial management strengthening for the Government of Malawi. Linked to the HSSPII, these activities will strengthen the capacity of the finance staff in terms of skills and necessary equipment needed to improve overall management. These activities coupled with the support from other donors and the Government of Malawi itself will improve financial management capacity specifically through improved planning, and budget execution. Specific activities in this intervention include: ? Training on bank reconciliation ? Management training ? Office furniture and equipment.","2020-12-31",4026804]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Integration of cervical cancer screenings in ART clinics for HIVpositive women ($0.56M) Yearly cervical cancer screening will be integrated in ART clinics for HIVpositive women aged 25 and above, important for the prevention and management of cervical cancer which is highly prevalent in Malawi. This investment will support the training of service providers and their supervision and mentoring.","2020-12-31",248415.58]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Community TB care delivery","Community TB Care (USD 1,688,069): Through the within allocation request, funds will be used to maintain and expand community TB care strategies including CSCPs in rural areas and house-to-house screening in urban areas. These activities will contribute a projected 18% of TB case notifications. Through the above allocation request: 1) an additional 700 CSCPs will be established and maintained with supplies and consumables, 2) an additional 7,000 CSCP volunteers will be trained to conduct community mobilization and sensitization, 3) refresher trainings will be conducted with house-to-house screening volunteers and CSCP volunteers. Deployment of these 700 additional CSCPs will increase coverage of CSCPs to 85% of the estimated country need. Establishment of CSCPs are critical to a human rights-based approach that prioritizes investments to reach the most rural and remote. These interventions will contribute approximately 4% of the additional 9,784 TB patients that will be reached through line item 1 above.","2020-12-31",1132696]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Treatment adherence","Business case for investment\na. Transition to new regimens: Based on WHO updated treatment guideline and other evaluated evidence on NNRTI resistance, it is imperative that Malawi transition and shift to the new treatment regimen. The full transition is planned to start in October 2019 for both adult and pediatrics.  The total estimated gap is US$ 7,144,985.\nb. Program scale-up: In February 2019 the quantification was revised to reflect current program realities.  As of 31 December 2018, the country had surpassed the original target (755,967 patients alive and on ART), reaching 805,000 patients. The program expects to put 128,000 more patients on treatment by 31 December 2020 (total of 928,000 patients alive and on ART compared to original target). As a result, the gap is estimated at US$ 12,356,242.  The ARV gap is for 2020, for which, orders must be made in January 2020 at the latest (grant revision in October 2019) to ensure full transition of all patients and avoid any treatment disruption.","2020-12-31",19501227]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Treatment monitoring - Viral load","Malawi has recently adopted the WHO guidelines on treatment monitoring (annual viral load tests), until now viral load tests had been conducted every two years. This has resulted in a gap in commodities (especially reagents). Based on existing and targeted patients to be reached between 2019 and 2020 and taking into consideration existing resources (reagents for 1.36 million tests), the potential reagents? gap is for 518,000 tests. The scale-up plan for treatment monitoring and optimized laboratory network was completed and the annual testing policy is now in effect. The required amount to cover the gap is US$ 8 million. This is in addition to existing resources from PEPFAR committed to investments in laboratory capacity strengthening under COP 18. The gap is therefore in 2020 and orders will have to be placed in January 2020 to full coverage of all patients.","2020-12-31",8054327]
[null,null,"Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Additional funding is being requested for 2020 to ensure that the key SBCC activities are maintained in order to ensure maintained uptake and utilization of the malaria interventions implemented during this period. Specifically, this will include the following activities: Support National Malaria Commemorative Days(SADC Week and World Malaria Day); Identify and orient media team on emerging issues, successes and challenges in malaria programming; Document malaria success stories through Media visits to different communities; Conduct School Based Malaria Awareness Campaign; Conduct training of Primary Teachers as Malaria School Patrons/Matrons; Conduct Community Meetings with Malaria Champions; Conduct malaria information dissemination sessions (malaria open days and community dialogues). Train Community Structures (CLANS) in Care Group Model for dissemination of Malaria messages.","2020-12-31",445803]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","Malawi requests for funding in 2020 to continue to support monitoring and evaluation so as to build upon global fund and partners? investments and sustain the gains achieved in the first two years. This support will maintain the routine disease surveillance systems and enable Malawi to collect robust, timely, and accurate data for improved program management. Thus enabling the National Malaria Control program and development partners to assess implementation progress and reprogram as maybe required in addition to providing evidence for allocation of resources so as to support achievement of maximum impact.","2020-12-31",380318]
[null,null,"Malaria","RSSH: Procurement and supply chain management systems","National product selection, registration and quality monitoring","Malawi requests continued funding for the PSM malaria activities in 2020. Malaria commodities will be procured and distributed using within allocated funding by GF in 2020. It is essential therefore that during this period QC and QA for these commodities is supported to ensure quality assurance is maintained.","2020-12-31",399636]
[null,"Mali","Malaria","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Since 2016 SMC  is carried out in the whole country.  It should continue to be scaled up for greater impact on the target population (children under 5) because evaluation shows  its protective effectiveness in reducing the number of malaria cases. UQD not needed anymore as funds were found in efficiency gains during malaria grant making.","2021-12-31",0]
[null,null,"RSSH","RSSH: National health strategies","Other policy and governance intervention(s)","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","(blank)",0]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Interventions for young people who sell sex","Contracting 1 NGO for managing and monitoring the activities carried out by CSOs and SW outreach workers. The PAAR amount will allow for the extension to 3 other regions from year 2, for greater geographical coverage of the interventions and requiring the recruitment of an additional NGO to guarantee the quality of the interventions by the community outreach workers.","2021-12-31",35657]
[null,null,"HIV/AIDS","Treatment, care and support","HIV care","Contracting 1 NGO to manage and monitor the activities of the CSOs and outreach workers in the 8 new regions for the establishment of CUs. This  extension from year 2 will lead to greater geographical coverage for the interventions and will require the recruitment of an additional NGO and 20 additional community outreach workers.","2021-12-31",35657]
[null,null,"HIV/AIDS Total",{"$nulls":4},1130302]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","Health care for MDR-TB will be decentralized gradually at regional level, with the short 9-month treatment protocol following a MDR-TB extension plan (created with the support of MDR-TB technical assistance from the NTBLCP). Only seriously ill cases will be hospitalized at the beginning of treatment. Other cases will be treated as outpatients.","2021-12-31",67340]
[null,null,"Tuberculosis Total",{"$nulls":4},1043157]
[null,null,"HIV/AIDS Total",{"$nulls":4},2432928]
[null,null,"HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","The sessions will be organized for MSM beneficiaries, III generation and young MSM from Chisinau and from Balti in order to provide information about MSM practices, services providers, education, stigma and discrimination, etc.","2020-12-31",4174.62]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","This intervention is very important to recruit additional new  clients,  by  providing  peer-to-peer  educational session  and  referring  them  to  NSP  sites  to  access services.   Estimated   750   additional   clients   to   be reached each year. Taking into consideration the new estimations    and    the established    targets,    this intervention  will  contribute  to  cover  more  PWID  with prevention services.","2020-12-31",40399.51]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","In order to strengthen capacity and expertise of members of the civil society it is important to be involved in trainings and attendance of international meetings/conferences regarding issues of HIV/AIDS control.","2020-12-31",8416.56]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","The established Harm Reduction Resource Centeris the only one consolidated center for providing technical support and trainings in harmreduction. It is important to maintain the specialist of the center, the website with developed resources in order to continue the  advocacy activities at local and national level (workshops / roundtables at central and local (rayon) level) to increase commitment for Harm Reduction of public authorities, improve coordination between LPAs, health and social services, civil society and other relevantactors.","2020-12-31",61126.7]
[null,null,"Tuberculosis","Other module","Other module","The previous grants supported TB/HIV retrospective audit of records of people with TB/HIV coinfection allowing to develop a plan of action and improve quality of care. This request allows to conduct an Operational Research assessing the quality of clinical management of HIV/TB co-infection, and evaluate if new diagnostic technologies and protocols of care had impact on quality of care and clinical outcomes. The OR will identify the remaining regulatory and process challenges.","2020-12-31",26933]
[null,null,"Tuberculosis","Program management","Other program management intervention(s)","To support the adjustment and maintenance of the National Information System for Monitoring and Evaluation of TB (SYME-TB) in 2020.The national authorities partially cover the costs (staff, introducing and validating data, etc.). Periodically adjustments of program, as per request of NTP  (depending of the new data to be included in soft and/or reports to be performed), and maintenance have not been fully covered by NTP.","2020-12-31",15710.92]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.","2020-12-31",0]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","For joint training and capacity building of all health care workers in Mongolia on TB screening, diagnosis and treatment, as well as increased awareness on TB through joint information, education and communication activities contributing towards increased TB case detection. The Global Fund will leverage on the Asian Development Bank Technical Assistance to Mongolia for improving the screening for viral hepatitis.","2020-12-31",0]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Needle and Syringe programs for PWID and their partners","Introduction of focused programs for prevention of Hepatitis C, care and treatment programs and self-supporting groups. As a result it is expected to achieve better coverage and reaching the targets (impact, outcome and coverage indicators) both related to preventive services and testing.","2021-12-31",44888.34]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","In case of secured funding, this will be the third bio-behavioural survey (BBS) implemented among MSM in Montenegro. The research, planned for 2020, will aim to estimate the population size, based on a representative sample. Previous surveys were aimed at providing basic data related to population size, HIV status, prevalence of STIs, condom use etc. However, Montenegro is a highly homophobic country where LGBT community is hard to reach, which has affected success of the previous surveys.","2021-12-31",0.43]
[null,"Morocco","HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of sexual and reproductive health (SRH) provision and services meeting the specific needs of MSM, including STIs; acquire a stock of additional lubricants for MSM; establish a CBD network for distributing condoms (extended to a further 17 towns in 2019 and 2020).","2020-12-31",140250.25]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of SRH provision and services meeting the specific needs of SWs, including STIs; acquire a stock of additional lubricants for SWs; awareness-raising day on GBV; SMS platform for prevention.","2020-12-31",392825.72]
[null,null,"HIV/AIDS Total",{"$nulls":4},2403090.5699999998]
[null,null,"Tuberculosis","RSSH: National health strategies","Other policy and governance intervention(s)","NTCP managers will attend the annual conference of the International Union against Tuberculosis and Lung Disease, thereby helping strengthen their technical skills and capacities around TB control and forging new ties with potential international partners. Morocco has commemorated World Tuberculosis Day on 24 March for more than 20 years. The event is a unique opportunity to draw the attention of the public, communities, NGOs and political decision-makers to TB and efforts to control the disease in the country. Some authorities in large cities have provided material support to the CDTMRs to mark the occasion. This concept note includes a request for funding for World Tuberculosis Day commemorations in each of the three years covered.","2020-12-31",120253.62]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Other intervention(s) for treatment","PAAR investment is requested to support reaching the following outcomes and impact: Increase in the proportion of PLHIV receiving ART from 54% in 2014 to 80% in 2020, and increased ART retention rates from 70% at 12 months in 2016 to 80% in 2020. This will lead to reduction in AIDS related mortality by 40% by 2020 and reduction in incidence by 40% by 2020.","2020-12-31",29882400]
[null,null,"Malaria","Program management","Other program management intervention(s)","All 11 Procvincial Directorates of Health have a gap of vehicles to ensure implementation of supervision activities. The motorbikes included in this UQD are to be used exclusively by National Malaria Control Program staff at provincial and district level, to ensure implementation of routine activities such as supervision visits to health facilities and community health workers.","2020-12-31",801546.08]
[null,null,"Malaria","Vector control","Entomological monitoring","11 Provincial Insectaries and Entomological Laboratories (PIEL) were established under the  Global Fund 2015-2017 grant. This covers the cost of annual and biennial consumables for one PIEL. WHO and PMI will support the maintenance and supplies of the other PIELs.","2020-12-31",85603.85]
[null,"Multicountry Africa ECSA-HC","Tuberculosis","Program management","Grant management","Funds to strengthen learning and program management, e.g. project initiation and closure meetings, workshops to review project performance and adpatation, and capacity building of ECSA-HC.","2022-06-30",149954]
[null,null,"Tuberculosis Total",{"$nulls":4},1319599]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This includes a mid-term and final in-house evaluation of the Facility.","2023-12-31",850000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Implement a social contracting model in the six OECS countries, involving the conduct of an assessment of the types of services and capacity of Civil Society Organizations (CSO) to provide these services; Government?s willingness/political will to contractually engage civil society; a legal environment assessment to review impediments relating to registration of CSOs, determine government procurement procedures, applicable service standards and licensing among other issues.","2022-03-31",62530]
[null,null,"Malaria","Case management","Other case management intervention(s)","Conduct therapeutic efficacy studies of new drugs and drug combinations, and conduct a drug resistance mapping supplement DRS information- strengthening capacity of the NMCP and ODPC.","2020-12-31",0]
[null,null,"Malaria","Case management","Other case management intervention(s)","The program would like to support the overall health system strengthening by enhancing adverse drug reaction control and monitoring.","2020-12-31",67000]
[null,null,"Malaria","Other module","Other module","Additional VMV training to improve data collection and reporting, electronic equipment to improve capacity for reporting, training at central and province level on DHIS2 usage, and supplementary training to improve outbreak preparedness and response.","2020-12-31",0]
[null,null,"Malaria Total",{"$nulls":4},686572]
[null,null,"Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Developing and introducing a context-adapted capacity increasing module targeting facility levels of provision of people-centered care. Increase provider capacity and standardize quality of services.","2021-12-31",115000]
[null,null,"Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Regional work to improve quality of TB care and clinical practice. The activity will focus on supporting countries in developing a planning approach to rapid and modern diagnostics at subregional level.","2021-12-31",36540]
[null,null,"Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Revise and update TB and PHC providers service packages and HR functions to deliver relevant TB services. Developing and introducing latest WHO-compatible policy guidance for active case finding approaches, including the effective identification of presumptive TB cases, contact investigation, treatment support will improve quality of diagnosis and referral case management for patients.","2021-12-31",0]
[null,null,"HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Under the PANCAP Round 9 grant CVC supported some model prison-based programmes, and CVC is currently conducting work in prisons in the OECS multi-country grant in relation to TB and prison health in general. Through this module CVC seeks to foster partnerships between national health authorities, and civil society organizations to improve health care delivery for prisoners and develop and document model programmes that can be scaled up by national governments to reduce HIV prevalence in the prison settings.  This will be achiveed through Proposed Activities:\n1.1 Offer inmate orientation and training\n? Provide all new inmates with information on HIV, drug use, and other relevant issues to increase their capacity to safely navigate the prison environment \n? Train inmates as peer educators\n1.2 Build the capacity of prison staff\n?Train prison staff on HIV, drug use, and other relevant issues to increase their understanding and appropriate management of issues related to sexuality, HIV transmission, and drug use\n1.3 Institute pre-release programs\n? Develop and implement orientation and information programs for inmates who are about to be released to enable a smooth transition and reintegration into society \n?  Enable NGOs and CBOs to work in prisons to create links between prison health services and community health services, which will facilitate transition and reintegration\n1.3 Ensure continuity of care after discharge\n? Establish protocols and referral systems to ensure that discharged inmates have continued access to antiretroviral therapy and medical care \n? Provide inmates with social service cards for free medical care for a defined period (e.g., 4 to 6 months), with provision for renewal should they remain unemployed","2022-09-30",200000]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Development of IEC materials to support KP friendly service delivery and adaptation of toolkit for HCW and Law Enforcment to support GBV screening. Continue training in HR and KP sensitization for law enforcement officers and other social protection service providers","2022-09-30",8000]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Improve knowledge, generation and use of strategic information on key populations for decision-making through Advocacy and inclusion of these sites as part of the regional HIV/STI testing network to ensure sustainability and recognition of CSO testing sites as key players in the regional HIV response. This will include regional quality oversight and negotiated pricing arrangements for HIV and STI testing reagents, supplies and equipment in order to improve CSO testing quality and access to cost-effective supplies. A regional repository will also be estbalished to identify, document, share and promote best practices for effective regional HIV and STI testing sites through the establishment of a repository which will include materials innovatively developed and customised to share best practices and models related to 1) Assessments conducted of selected HIV/STI testing sites (technical, quality and operational) to identify critical success factors for these Caribbean sites that serve key populations 2) HIV and STI algorithms, validated under the OECS GF grant and in collaboration with PAHO/WHO 3) A regional HIV testing policy that addresses HIV self-testing, validated through conduct of a self-testing pilot with triage 4) Regional standardised tools for quality monitoring, customised for key population sites (both technical as well as stigma and discrimination monitoring).","2022-09-30",200000]
[null,null,"HIV/AIDS Total",{"$nulls":4},1238000]
[null,"Multicountry HIV Latin America ALEP","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Improving laws, regulations and polices relating to HIV and HIV/TB","Given its social and political situation, it is felt that Nicaragua cannot guarantee implementation of the full program planned for the other countries. However, implementation of this selection of some of the same activities as the other countries, and the inclusion of Nicaragua in the regional activities, would ensure that the regional objectives of this multicountry funding request are achieved. For evidence of the situation in Nicaragua, see the report by the Organization of American States (OAS) at: http://www.oas.org/en/iachr/reports/pdfs/Nicaragua2018-en.pdf\nCivil society is facing difficulties in addressing the necessary legislative, regulatory and policy changes, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of people living with HIV (PLHIV) and other key populations achieve the reforms they consider necessary, in line with the regional activities emerging from this module.\nTo provide an effective HIV response, open data strategies are being designed and implemented, along with oversight and social control of public policies, and legal barriers related to intellectual property are being analyzed. Strategies to overcome these are being designed and implemented.","2022-09-30",0]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Nicaragua would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in developing its institutional capacities, in an environment of severe social instability and even faces persecution of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the strengthening they consider necessary in addressing the aforementioned activities, in line with the regional activities emerging from this module.\nLiteracy on antiretroviral therapy (ART) and improved quality of life for PLHIV. Strengthening of the leadership skills and capacities of each network.\nGeneration and analysis of strategic information from and for key populations.\nDesign and implementation of external and internal communication strategies for networks and for national organizations of PLHIV.","2022-09-30",0]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Conduct KP-led sensitivity training for health care service providers, based on findings from 'mystery shopper' surveys to evaluate services to key populations","2021-12-31",24000]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Y3: Expand referral platform  being built by Ministry of Public Health for drugs  to include other KPs.","2021-12-31",10000]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Community led advocacy","Organize national and regional workshops to develop advocacy plans focused on removal of legal barriers to KP access to services.","2021-12-31",0]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Conduct workshops for health providers and other sectors on gender tranformative approaches and GBV; Outcomes of these workshops will be presented in the regional dialogues","2021-12-31",0]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Y3: Conduct participatory workshops on Global and regional guidance to build knowege of (1) MSM, (2) PWID, (3) Sex Workers to improve national level programming.Lebanon\ncan host these workshops for the region-wide learning activity.","2021-12-31",0]
[null,null,"HIV/AIDS Total",{"$nulls":4},903390]
[null,null,"HIV/AIDS, Tuberculosis, Malaria","Program management","Other program management intervention(s)","To ensure a training on programmatic management in an international course for the relevant NTP staff from Central and governorate levels of the five countries.","2021-12-31",35000]
[null,null,"HIV/AIDS, Tuberculosis, Malaria","Program management","Other program management intervention(s)","To procure computers for the NTP central units of Iraq, Yemen and Syria","2021-12-31",75000]
[null,null,"HIV/AIDS, Tuberculosis, Malaria","Program management","Other program management intervention(s)","To renovate the main drug warehouse in Baghdad","2021-12-31",30000]
[null,null,"HIV/AIDS, Tuberculosis, Malaria","RSSH: Health management information systems and M&E","Policy, planning, coordination and management of national disease control programs","This intervention is of great importance to build the capacity of eDEWS sentinel sites to determine the alert and outbreak thresholds and develop a preparedness and prompt response plan to contain malaria outbreak. It fosters the collaboration and coordination with the surveillance department and eDEWS programme and ensure the flow of malaria case management data on weekly basis from 2000 HFs in the country","2021-12-31",462000]
[null,null,"HIV/AIDS, Tuberculosis, Malaria","TB care and prevention","Case detection and diagnosis","In order to strengthen TB services for affected women, food supplementation is needed for women with TB who are treated in IDP and refugee settings","2021-12-31",1335000]
[null,null,"HIV/AIDS, Tuberculosis, Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This includes procurement and supply of LLIN for mass campaign and LLIN for refugees and IDPs to cover target populations at risk in 2019, 20 and 21, in areas of lower risk of transmission","2021-12-31",8299572]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","HSS - Policy and governance","Other policy and governance intervention(s)","Development of national TB elimination strategy","(blank)",16833]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Other module","Other module","\"Contribute to the Jordan Health Fund for Refugees (JHFR); \"\"In exchange for a GoJ commitment to provide quality primary and secondary health care services for Syrian refugees in MOH facilities at the same rate as for uninsured Jordanians, contributions to the JHFR will off-set the following component costs of the MOH's annual budget related to providing subsidized primary and secondary health care services in MOH facilities to Syrian refugees: ( I) primary health care; (2) secondary health care; and (3) medicines, medical solutions, consumables, and supplies. \"","(blank)",5611043]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Program management","Other program management intervention(s)","Form a National HIV Committee that will include members representing various entities , develop on annual basis a work agenda and will meet at least every 6 months and on ad hoc basis","(blank)",11222]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Evaluation of NTP to assist NTP staff monitor progress toward program goals, learn from the lessons resulted during the program implementation, make needed actions to improve quality and evalute the program in achieving its short-term, intermediate, and long-term outcomes.","(blank)",22444]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","RSSH: Health management information systems and M&E","Surveys","Conduct an assessment of the health status of labour migrants and develop a plan of supervision, coordination and adress the tuberculosis and other health issues related to migration among migrants in industrial zones","(blank)",22444]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","RSSH: Human resources for health (HRH), including community health workers","Other health and community workforce intervention(s)","NAP and Key Population participation in international trainings, conferences, workshops etc.","(blank)",22444]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB care and prevention","Case detection and diagnosis","2 Mobile X-ray equipped units to cover the NTP needs and enable the program to conduct outreach TB screening activities in the south, north and center, especially among the hard-to-reach populations and high-risk groups in Jordan.","(blank)",673325]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB care and prevention","Case detection and diagnosis","Laboratory equipments xpertMTB/Rif, refrigerators, personal protection equipment, laboratory furniture etc .","(blank)",157109]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB care and prevention","Prevention","Development of IEC materials in different languages of the migrants countries and coordination with relevant embassies to address the language barrier and deliver educational messages on TB among migrant workers in the industrial zones in Jordan","(blank)",19639]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB care and prevention","Prevention","Development of SOPs on latent TB Infection management, translating into Arabic and printing","(blank)",22444]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB care and prevention","Treatment","FLD for Jordan (Pharmaceutical Products)","(blank)",14589]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Treatment, care and support","Other intervention(s) for treatment","Extend the provided services to the KPs to include the drop in center, STD investigations, lab tests for beneficiaries, VCT services, collaboration with primary and secondary healthcare providers. Follow up of PLHIV (estimated 250 to 300) with comprehensive treatment monitoring and treatment support over two years.","(blank)",336663]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Treatment, care and support","Other intervention(s) for treatment","Purchase of required diagnostic reagents (CD4 & PCR), clinical chemistry and hematology testing, viral load, genotyping kits gentotyping sequencer devices etc.","(blank)",112221]
[null,null,"HIV/AIDS","RSSH: National health strategies","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 184 for Laos for year 2 second round grants","2021-12-31",119652.38]
[null,null,"HIV/AIDS","RSSH: National health strategies","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 189 for Timor Leste for year 2 second round grants","2021-12-31",119652.38]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Support cross-district planning, data sharing, and implementation aimed at reducing cross-border transmission\n\nDescription: This funding request includes support for regular cross-district meetings along E8 priority borders. These meetings will occur every three years of the proposed investment.\n\nRationale: These meetings will be used to improve cross-border planning at the district level which is otherwise not included during the regular E8 forums (Ministerial Committee, Technical Committee, Technical Working Groups, etc.). These district level meetings will provide data sharing opportunities for teams on both sides of the border. In order to maximize impact of national level activities, sub-regional district level collaboration is required to better coordinate and plan activities. This level of coordination will allow for the harmonisation of policies, promote data sharing, strengthen capacity, coordinate IRS spraying, distribution of LLIN, community-based education, etc. \n\nExpected Outcomes/Impact: Expected outcomes of these district-level meetings will include more harmonised strategies for key interventions such as IRS, LLINs, etc. on both sides of national borders. \n\nBudget: Costs associated with this activity include $106,433 per year to support cross-colaboation meetings, including transportation, per diems, and venue rental. Funding also includes some travel for meetings to establish new cross-border initiatives in the region during this funding period for example between Zambia and Mozambique. The total cost of this activity is therefore estimated to US$ 319,299 for the three year period. \n\n*Note - the intervention category does not provide all intervention options in the dropdown menu. The correct intervention for this activity is \"Routine Reporting.\" However, this is not an option in the dropdown menu of this template.","2021-09-30",319299]
[null,"Multicountry Southern Africa MOSASWA","Malaria","Other module","Other module","(blank)","2022-12-31",0]
[null,null,"Malaria Total",{"$nulls":4},9308591]
[null,null,"Tuberculosis Total",{"$nulls":4},1915245]
[null,"Multicountry TB Asia UNOPS","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","One third of funds are to increase ACF and find more cases (2,154).  One third to address human rights and gender-related barriers to TB care, and one third for mix remaining actions (making diagnostic algorithm more sensitive with use of Xpert at DiCs, urban refugee screening, infection control by UVGI in immigration detention centres, engagement with employers, bilateral meetings with Cambodia, Lao, Myanmar and Malaysia).","2021-12-31",3376787]
[null,null,"Tuberculosis Total",{"$nulls":4},6248347]
[null,null,"Tuberculosis","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Civil society participation in regional and global TB events. Considering the advocacy and surveillance role of social TB observatories, it is necessary to promote the participation of civil society representatives in important events, such as the UNION Conference, the PAHO Regional TB Meeting, and/or the follow-up meetings to be scheduled at the UN General Assembly High-Level Meeting on Ending TB.","2022-06-30",0]
[null,null,"Tuberculosis","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Regional workshop on Social Protection in TB. This event will bring together representatives of government, cooperating and multilateral organizations and civil society from the 8 LAC countries to exchange experiences and new agreements.","2022-06-30",0]
[null,null,"Tuberculosis","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Technical assistance on the analysis of the legal environment that limits the rights of people with TB. With the support of technical members of the National Social TB Observatories, a standardized protocol will be developed and the survey will be carried out in each of the 8 countries participating in the grant.","2022-06-30",0]
[null,"Myanmar","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","The additional investment will support the program to reach more target population.","(blank)",3183156]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","The additional investment will support the program to reach more target population.","(blank)",408328]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","The funds are requested for diagnosis and treatment for MDRTB.","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","The additional investment will support the program to reach more target population.","(blank)",122929]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","This intervention will target dispersed rural communities to provide increased case finding and adherence to treatment in both HIV and TB.","(blank)",3181829]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","This intervention will allow improving existing Ministry of Health warehousing infrastructure and storage conditions which are currently inadequate","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Other intervention(s) for treatment","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis","HIV Testing Services","Differentiated HIV testing services","Increasing accessibility of HIV testing is expected to increase the number of people who are tested in the general and key populations who are able to access high quality testing.","2020-12-31",525429]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The M&E systems in Namibia are currently very weak. These activities which support improvements in routine monitoring and evaluation at district, regional and national level are expected to result in more timely and accurate information for reporting and decision making.","2020-12-31",3134809]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","These targeted supply chain activities and controls are expected to improve the supply chain systems and therefore drug management and availability at national, regional and district levels","2020-12-31",351283]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","Community TB/HIV care delivery","These activities support TB/ HIV increased integration at both national and district level. Through these integrated services, TB HIV co-infected people are more likely to receive enhanced treatment. This will result in people being more adherent to treatment and better treatment outcomes, including retention of people on ART.","2020-12-31",2358757]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Given the remoteness and mobile nature of the San people and the cattle herders, having community health workers (CHWs) that are embedded with the community will improve community level access and targeting for hard to reach areas, as well as ensure timely reporting of data. This amount includes CHW salaries, CHW supervisor salaries, regional coordinator salaries, and the necessary SMS/transport reimbursements for these staff in Omusati region.","2020-12-31",62479]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","In order to coordinate the MOHSS strategies on malaria elimination with the community response, the NVDCP proposes the recruitment of a Community-based Interventions Coordinator to ensure increased acceptance of indoor residual spraying and use of long lasting insecticide treated nets. This amount includes the salary of this individual for Years 1 & 2 of the grant.","2020-12-31",48692]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO","2020-12-31",0]
[null,null,"HIV/AIDS","Other module","Other module","Migration to India, particularly to states where HIV prevalence among FSW is high, is recognised as source of infection. The main source of information for targeting HIV interventions among migrants is a 2007 study by UNFPA. However, it is likely that changes in health seeking behaviour and migration patterns (e.g. the shift to Gulf countries as the preferred destination) over the last decade have implications for HIV transmission and access to HIV services, which will be explored in the assessment. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.","2021-03-15",0]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Differentiated service package for migrants with linkages to testing & treatment. \nThis key population is the driver of new HIV infections, however, currently not covered with HIV prevention services. \nAs mentioned above, in order to ensure meaning scale-up of coverage with comprehensive HIV prevention services for this population  and roll-out of the differentiated service package from 2020, additional funding is requested by the country. \nExpected outcome: coverage of 100,000 migrants with HIV prevention services and linkages of HIV+ migrants to treatment and care. \n\nMigrants\nKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 100,000\nKP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 80,000","2021-03-15",0]
[null,null,"HIV/AIDS Total",{"$nulls":4},11300000]
[null,null,"Malaria","Case management","Other case management intervention(s)","Additional Technical assistance as required.","2021-03-15",60000]
[null,null,"Malaria","Case management","Private sector case management","HR cost at SR for engaging the private sector provider; Orientation cost for SR for engaging the private sector provider; Field visit for engaging the private sector provider; and, Operational costs for the SR.","2021-03-15",557208]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","Prepare annual HR development plan.","2021-03-15",10512]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","Procurement of mobile phones/tablets for electronic based malaria reporting. Mapping of all villages in endemic areas based on GIS.  Training workshops to strengthen PSM, M&E, finance and programme management.","2021-03-15",283538]
[null,null,"Malaria","Vector control","Entomological monitoring","On-going longitudinal surveys of vector distribution, abundance and bionomics in Y2&3.","2021-03-15",44472]
[null,null,"Tuberculosis","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Under community-based monitoring by HFOMC to assess stigma, discrimination and staff attitude toward patients at selected health facilities.","2021-03-15",60000]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","For improving access, enabling early diagnosis with introduction of the pay for performance for the diagnosis, DOT provision and further expansion to the remaining districts. This can further improve the notification of additional 5,000 cases over 3 years.","2021-03-15",100000]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","GeneXpert expansion to the remaining inaccessible districts is required though the testing load is less, but access remains a challenge. Additional 15 machines with provision of 3,000 cartridges for grant period can enable access to major parts of remaining districts. This will enable 45,000 presumptive TB patients to get the rapid molecular test with expected 4,000 notifications of TB patients.","2021-03-15",0]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The 2018 LLIN campaign only covers 12 hyperendemic health districts in Maradi, Tahoua and Zinder regions because of a funding shortfall. Niger is planning to run a mass campaign in 2019, covering the 18 mesoendemic districts (7,538,350 people) omitted in 2018, in order to avoid adversely affecting the outcomes and to maintain the campaign cycle.","2020-12-31",2455543.0099999998]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Evaluation of national PMTCT programme \nThere is need to conduct a prospective survey following a cohort of pregnant women to evaluate programme effectiveness that will help to understand the PMTCT services performance towards the 2020 elimination target. This will address the causes of low PMTCT programme performance in terms of service coverage and high vertical HIV transmission rate and lack of local data to validate or understand the modelled high vertical HIV transmission.","2020-12-31",3888244]
[null,null,"HIV/AIDS","Treatment, care and support","Other program management intervention(s)","System Strengthening for Pharmacovigilance (PV) & HIV Drug Resistance (HIV-DR) Monitoring \nReduce ARVs adverse effects and drug resistance related deaths/morbidity by:\n- Strengthening capacity of NAFDAC in managing PV monitoring, based on UNAIDS/WHO assessment\n- Pharmacovigilance active monitoring cohorts for ARVs\n- Conducting combined PDR/ADR survey \n- Assessing pediatric ADR \n- Strengthening stakeholders coordination on HIV-DR","2020-12-31",6497265]
[null,null,"HIV/AIDS","Treatment, care and support","Prevention, diagnosis and treatment of opportunistic infections","Comprehensive HIV/AIDS Services in Humanitarian Settings (North East) \nMainstream and coordinate HIV services into the ongoing humanitarian health response, with at least  1/4 of those reached with humanitarian health interventions tested for HIV and 15,400 newly initiated and retained on ART. This includes: Training, HIV commodities, facilitation of referral of HIV positive clients/lab specimens through existing inter-agency referral system, facilitating PLHIV peer support activities, HIV monitoring/coordination strengthening within the context of humanitarian health response.","2020-12-31",13244777]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","6 States in 2020 will be due for LLINs mass replacement campaigns requiring 16,619,549 LLINs. This is highly prioritized to ensure continued coverage of the population in these States in line with the WHO universal coverage for LLIN, and to ensure that gains made are not lost due to decline in net ownership.","2020-12-31",0]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis","Drug Resistant TB Survey:\nThe increasing case notification of PreXDR and XDR TB has been an issue and the country is yet to conduct an analysis of the reasons for the increase. The survey will assess changes in epidemiological trend of DR TB, prevalence of XDR TB, HIV among DR TB patients, develop evidence based recommendations for the NTBLCP to control and prevent DR TB.","2020-12-31",3643207]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis","Procurement of 280 4-modular Xpert MTB/Rif machines:\nThis request would provide additional 280, 4-modules Xpert MTB/RIF machines to be placed at high volume health facilities. This will increase the testing capacity in the country and potentially notify an additional 58,061 and 2,322 DSTB and DRTB cases respectively annually.","2020-12-31",4900000]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis","Procurement of lab reagents and consumables for first and second line LPA:\nThe request is for procurement of Lab reagents and consumables, PPEs, etc. (including consumables for healthcare workers) for additional 2,592 patients (50% of the remaining gap).This will also improve surveillance and diagnosis of XDR TB. This also includes procurement fee, Insurance, Freight, in country distribution, QA charges and in country QA/QC.","2020-12-31",3437667]
[null,null,"Tuberculosis","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Baseline and follow-on assessment of target GF supported labs enrolled into the Continuous quality improvement program:\nThe consensus to establish a national CQI programme require a detailed baseline assessment to better understand what gaps exist and use it to inform priorities for investment. The report will be used to guide future investments by government and other partners and also used as an advocacy tool.","2020-12-31",2044830]
[null,null,"Tuberculosis","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Support the training of lab professionals within the National Lab network on the standard biosafety and biosecurity procedures and processes:\nAll the GF supported PCR and TB Reference laboratories will be supported to achieve local and international accreditation through this activity.  The Global fund will support the implementation of standard biosafety and biosecurity requirements in all supported laboratories within the network of 111 laboratories.","2020-12-31",254384]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Intensified Case Finding (ICF) among urban slum dweller in 10 additional states (Benue, Plateau, Rivers, Edo, Nassarawa, Niger, Taraba, Akwa Ibom, Zamfara and Ondo). Ten States have been prioritized for intensified case finding in slums within allocation. The scale up of ICF will complement PPM expansion. The ICF will increase awareness, health education and create demand for services and increase TB case notification.","2020-12-31",330762]
[null,null,"Tuberculosis","TB care and prevention","Treatment","First Line Medicines:\nThe budget for First Line medicines under allocation provide for 59% (288,486) of total number of cases targeted in the PF (492,411).  $3,530,072 of the remained 40% will be covered by the GON. The Country is requesting the costs for TB medicine for the remaining amount of $ 8,293,937 under above allocation.","2020-12-31",8293937]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Cost of reaching additional 33,200 FSW with prevention package. It is prioritized because prevalence rate for this population is growing at the fastest rate amongst KP for whom the primary means of transmission is sexual. Unit costs ($71) have been fixed with reference to those used for the AEM modelling. Proposed coverage would amount to 42% of the annual gap for this population through this grant.","2020-12-31",1975300]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Cost of implementing national level HIV communication strategy. The plan targets policy makers, opinion leaders, key populations, PLHA, media, healthcare service providers, men and women of reproductive age, and young people. Main objectives are to: \n? strengthen information and knowledge, thus leading to behaviour change and motivation (awareness) \n? generate an enabling environment (advocacy) \n? reinforce social and community support (social support) \n? enhance access to quality services (ability to act)","2020-12-31",96100]
[null,null,"Malaria","Program management","Other program management intervention(s)","WHO technical assistance is continuously required for supporting the provincial malaria control programs. The NPOs will be based in WHO provincial sub-offices and will provide technical guidance and support to the provincial government in minimizing the public health impact resulting from epidemics of communicable diseases mainly malaria, HIV/AIDS and TB.","2020-12-31",200000]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.","2020-12-31",4807799]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Action: LHWs are to be engaged in contact tracing, promote screening of the elderly and screening of children for TB. 30% of LHWs will be engaged mainly in rural districts by 2020.  37,500 cases (0.75 case per LHW/annually) will be detected through this engagement.\nRational:  Pakistan has 150,000 LHWs based in the community, paid for by Provincial programs & they play a major role in MNCH, including immunization. This workforce will be utilized for early case detection and treatment adherence.","2020-12-31",2300000]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Action: To scale up a mobile based TB case notification system to initial 50, then to 90 districts. \nRational: This will facilitate TB cases notification in private sector. The majority of the population is seeking care in the private sector. Legislation for mandatory case notification will facilitate that. 35,000 additional cases are expected to be identified anually for year 2 and 3.\nThe pilot intervention is proposed through catalytic funding. After evaluation, the intervention will be scaled up throughout the country based on phased approach, selecting additional 50 districts in year 2019 & rest 90 in year 2020.","2020-12-31",1500000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The MoniTARV system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future. system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future.","2021-12-31",94500]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This request includes the integration of the Ministry of Public Helath (SIS) and Social Security Fund (SEIS) care and epidemiological surveillance systems. Integration of both systems would make all national information on HIV and tuberculosis available in a single database to facilitate corresponding analysis.","2021-12-31",48000]
[null,null,"HIV/AIDS, Tuberculosis","Program management","Grant management","This allocation allows for the addition of a highly-experienced SR to carry out sex worker, MSM and transgender people outreach in NCD. This SR has run successful outreach and KP clinical services in NCD for 10 years and will increase reach and quality of services. The additional predicted coverage is included in the MSM and sex worker tables above.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","This allocation provides for six-monthly TB/HIV program review in 5 provinces: Western Highlands, Enga, Jiwaka, Morobe and Madang. This will assist provinces to embed the new TB-HIV coordination mechanisms and review and planning cycles.","2020-12-31",266268]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","TB/HIV collaborative interventions","One position to work with the NDoH, DoNPDD and NDoT to assist in the integration of TB, STI and HIV vertical programs into Provincial Health Authority budgets and one  position to work with provinces to embed the quarterly TB/HIV/STI planning, coordination and review cycle into practice. Living support to client/target populations: This allocation will provide support to CBOs (commencing in Y2) in Morobe, Madang, Jiwaka, Western Highlands and Enga to connect people at risk of HIV and/or TB with information and services.","2020-12-31",452521]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Differentiated ART service delivery","a) Adherence Support: additional 8 Expert Patient PLHIV peer workers and 5 PLHIV peer counsellors will be added to high ART-volume clinics in the NCD, Western Highlands, Enga and Morobe. \nb) Clinic staff support: continuation into Y3 of clinic support in NCD (10 HCWs), Western Highlands (13 HCWs), Morobe and Enga (5 HCWs each) ? who will contribute to clinical care and maintenance of PLHIV on ART. \nc) Continuation into Y3 of training and mentoring for improved quality of ART prescribing, HIV clinical management, TB testing and prophylaxis/treatment.","2020-12-31",0]
[null,null,"Malaria","Other module","Other module","This is for the procurement of 800,000 Rapid Diagnostic Tests and 400,000 Artemisinin-based combination therapy per year. This is an emergency amount in the case that the National Department of Health fails to procure drugs.","2020-12-31",0]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This is considered a good alternative to prevalence surveys and may give good information at a very low cost.","2020-12-31",65000]
[null,null,"Malaria","Vector control","Other vector control measure(s)","This program delivers antenatal nets to about 50% of pregnant women each year. This protects both  pregnant women and newly born children from malaria. Delivery to pregnant women is done through health centers. Nets are also distributed every three years to prisons and boarding pupils in boarding schools.","2020-12-31",3192]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Acquisition of Lubricants for prevention activities in trans. Acquiring lubricants helps reduce the risk of transmission of HIV and other STIs because of potential condom breaks, and minimizes the possibility of lesions that contribute to transmission. The country does not currently have a regulatory framework that enables the procurement of lubricants for HIV prevention. For this reason, as part of the advocacy actions, we seek to reverse this situation, but it is a medium-term process. Therefore, within the framework of the project, we need to have the financial resources so that this input is part of the prevention package delivered in the different strategies of promotion by pairs, which are directly linked to the goals of the project.","2021-02-28",0]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Community led advocacy","Forum on Combating HIV and other STIs and 3rd. Multisectoral meeting to analyze the application of Law 3940, with a human rights approach, Commemoration December 1st. The HIV Forum is a space for updating the new recommendations regarding prevention and treatment as well as a space for analyzing the implementation of the different actions that make the national response to HIV. Representatives from various governmental and non-governmental sectors, as well as cooperation agencies, are participating in this space. The Multisectoral Meeting is a space for analyzing the application, by the different actors of the National Response, of what is established in Law 3940, identifying the gaps and difficulties in applying it, for the elaboration of a plan multisectoral work. The resources presented for the commemoration of December 1 constitute a co-financing between cooperation agencies, PRONASIDA, CSOs and the Project so as to, in addition to commemorating the day, to make visible the actions and contributions of the different actors involved , inform and raise awareness about HIV to reduce stigma and discrimination towards people affected by HIV.","2021-02-28",37255]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","PLWH bi-annual meeting 2019 for PLWH empowerment, joint work CS/ State / cooperation agencies and quality of life. There is a need to carry out, on a bi-annual basis, an in-depth study on the various thematic axes associated with comprehensive care for PLWH, access to justice and human rights, stigma and discrimination, promoting the greater involvement of people living with HIV in terms of their health, dignity and prevention needs in all aspects of the policies and programs that affect them. This meeting will be national since it will involve PLWH from all over the country, in addition to local actors linked to the National Response to HIV, such as representatives of international organizations, cooperation agencies, public institutions, CS, among others.","2021-02-28",7669]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment adherence","Visit to Tacumbu prison for PLWH monitoring. This activity contributes to improving the adherence of PLHIV who are in the Tacumbú penitentiary, the country's main confinement institution in which the largest number of PPLs are living with HIV. These visits contribute to providing medical care, information and follow-up and consolidate the ART of the PPL, achieving an undetectable viral load. It should be noted that this activity is part of the Vencer Foundation's self-help program, in which its counselor interacts with the inmates reinforcing them with information about HIV, nutrition, care, and managing their hospitalization when they are critically ill because of some IO in addition to carrying out follow-ups (and bringing medicines) to the inmates who need it, even outside the visiting days. The visits to the prison are also accompanied by a doctor and 1 IMT (Institute of Tropical Medicine) social worker.","2021-02-28",4133]
[null,null,"Tuberculosis","Program management","Other program management intervention(s)","Consultation for implementation of the Health Region Training Plan.\nHR are required for this since the PNCT has a deficit of physicians available for trips to the interior to carry out this duty.","2021-12-31",3259.85]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Analysis, review and disclosure.\nThe considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required the monitor the grant, which is why these financial resources are required to comply with this duty with the required technical accuracy.","2021-12-31",4429]
[null,null,"Tuberculosis Total",{"$nulls":4},948894.93999999983]
[null,null,"Tuberculosis","TB care and prevention","Prevention","Implementation of updated national guidelines for management of pediatric TB at the primary health care level","2022-06-30",0]
[null,null,"Tuberculosis Total",{"$nulls":4},0]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Constitutes prevention, testing and treatment costs for 14 sites out of the 39 high disease burden sites identified as FR sites.","2020-12-31",0]
[null,null,"Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Critical to the success of the NTP in finding and treating missing cases is adopting GX as primary diagnostic tool and that making it available in all its 2600 primary health care units. To date, there are existing 336 GX machines and 580 are being request through this funding request ( both from within allocation and matching fund). Through PAAR, an additional 1684 GX machines will help achieve 100% coverage.","2020-12-31",6057028]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Establishment of TB-DM service delivery system at the RHU level for TB detection and case management among DM patients nationwide.","2020-12-31",1713543]
[null,"Romania","Tuberculosis","MDR-TB","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","2021-03-31",862153.52]
[null,null,"Tuberculosis","TB care and prevention","Engaging all care providers (TB care and prevention)","This investment is intended to support stakeholder engagement in implementing ambulatory care reform developed through the grant.","2021-03-31",361329.82]
[null,null,"HIV/AIDS, Malaria Total",{"$nulls":4},30844801]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Above allocation will: a) support the transition from aggregated to a case based reporting system (capacity building of M&E officers and data managers on quarterly reporting through e-TB); b) support training on PAL for DHs and HCs to strengthen health workers? capacities to manage respiratory diseases including TB; and c) allow the hiring of a data manager at NRL to assist in data acquisition, aggregation and analysis.","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Above allocation will provide payment of Community-based health insurance (CBHI) for vulnerable groups which are not able to pay for themselves therefore removing financial barriers for access to basic health services in general and HIV services in particular. It is estimated that around 1,926, 292 people/ 3years (CBHI fee=3.43 USD /person/year ) will benefit from the support.","(blank)",6607183]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","Above allocation will contribute to NRL equipment that will reinforce the laboratory network and contribute to acquiring the accreditation.","(blank)",245000]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Rwanda will undertake the next DHS in 2019-2020. This is a national activity implemented under the leadership of the National Institute of Statistic of Rwanda (NISR). The request will support the NMCP to ensure malaria is included in the DHS such as through the reading of blood smears for malaria prevalence. Part of the TA for this activity will be supported by PMI.","2021-06-30",500000]
[null,null,"Malaria Total",{"$nulls":4},5491922]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","Other module","Other module","The process has been launched with support from WHO; this represents a contribution by the Global Fund to the development process.","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis, Malaria, RSSH","Vector control","Indoor residual spraying (IRS)","Focalized spraying planned for 2020, but due to lack of funds, we are requesting this important support in the PAAR. The amount requested in the PAAR for effective implementation of IRS in 2020 will cover procurement of insecticide, transport, storage, payment of sprayers and operating costs.","(blank)",69127.850000000006]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","One of the key challenges of the strategic plan is to improve data availability and quality. The DHIS 2 platform will therefore be strengthened through training and monitoring of system implementation within facilities.","2020-12-31",118960.83]
[null,null,"HIV/AIDS Total",{"$nulls":4},3006176.62]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","Senegal and the Gambia have undertaken cross-border activities to strengthen the malaria response along their shared borders.\nIdentifying gaps has enabled relevant activities in several response areas to be highlighted.\nPart of the total cost for the identified activities will be funded under the New Funding Model 2 (NFM2); the rest (?3,800,678) will be requested under above allocation funding.","2020-12-31",4265153.1899999995]
[null,null,"Malaria","Vector control","Indoor residual spraying (IRS)","In the three target districts for this project (Touba, Diourbel and Passy), disease incidence is high.\nWithin each district, criteria for selecting areas are defined based on the intensity of transmission (more than 10 cases per 1,000 population) and the feasibility of the intervention (predominant type of housing and population behavior). The area is demarcated at the health-post level, according to the degree of incidence reported by each health post.\n\nOne treatment cycle per district (hot spots) is planned per year, to be carried out just before the main malaria transmission period (rainy season). \nThe insecticide used will be chosen based on the susceptibility of the vectors in the intervention areas. \nIRS activities will be carried out based on the World Health Organization (WHO) IRS operational manual and adapted to the local context, but also based on the country?s ten years of experience with IRS.","2020-12-31",11917841.99]
[null,null,"Tuberculosis, RSSH","TB care and prevention","Other TB care and prevention intervention(s)","Given the need to prioritize, the applicant plans to  use  the  allocation  amount  to  implement  the new  strategy  of  using  GeneXpert  as  a  first-line test in the six regions of the country that are home to 81% of missing cases. The additional investment enables this strategy to be extended to the whole country to obtain maximum impact.","(blank)",2244417.0099999998]
[null,null,"Tuberculosis, RSSH","TB care and prevention","Other TB care and prevention intervention(s)","To reduce the gap in missing cases in high-burden regions, this amount would enable implementation strategies to be scaled up through the purchase of five mobile digital X-ray machines and a fixed X-ray machine for a second prison in the country to conduct screening upon entry.","(blank)",536957.68999999994]
[null,null,"HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.","2022-06-30",5510.04]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","PWID Training for outreach workers","2022-06-30",6425.77]
[null,null,"HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.","2022-06-30",5510.04]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment adherence","PLWH Training of outreach workers","2022-06-30",6425.77]
[null,null,"HIV/AIDS","TB/HIV","TB/HIV collaborative interventions","Currently 170 health facilities provide comprehensive TB/HIV services (12-13% of TB/HIV co-infection). The PAAR will be utilized to:\n? Increase the number of health facilities providing TB/HIV services by 150 and train 300 health care providers in these facilities\n? Supportive supervision and monitoring to all the targeted health facilities at least once every quarter\n? Provide one-stop care for co-infected patients","2020-12-31",240000]
[null,null,"HIV/AIDS Total",{"$nulls":4},9066192]
[null,null,"Tuberculosis, Malaria, RSSH","TB care and prevention","Other TB care and prevention intervention(s)","Funding is needed for nutritional support to be provided for all TB cases, about 20,000 TB cases per year, during the intensive phase of treatment. MDR-TB cases, 300 cases per year, will receive the nutritional support throughout the course of treatment. The estimated cost will cover the nutritional support for TB patients for two years and this intervention will support the program to improve adherence to treatment.","2021-06-30",1200000]
[null,null,"Tuberculosis, Malaria, RSSH","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","In order to have a successful  implementation for the Universal coverage of the  Population the following activities are very important  for LLINs to reach the beneficiaries:    (1) Distribution to PHUs/Distribution Points.  (2).Transportation and Warehousing at district/chiefdom levels (3) Trainings (4) Microplanning (5) Social Mobilization                   (6) Monitoring and Evaluation.                                                                                                                                                                                                                                                              The final budget for 2020 LLINs mass campaign non-net costs will be available after the finalization of the plan of action, logistics plan and the communication plan with support and guidance from AMP ? tentatively in April 2019.\n\nThe total budget for the 2017 mass campaign non-net cost was $4.4m.  $2,541,578.56 has already been secured on the current GF grant towards non-net costs. The current estimated gap of ($1,858,421) + 20% buffer to cover the increase in fuel costs and other contingencies is required to fully fund these activities.","2021-06-30",0]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","This funding would support the doubling of the number of female key population peer educators and improve outreach to vulnerable women. Aims to improve knowledge and awareness and support referral.","2020-12-31",0]
[null,null,"HIV/AIDS","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Anonymous free confidential hotlines that are currently supported by the GF funding. Hotlines provide factual information, counselling and referral information and support. This will support the current 3 hotlines which cover all Somalia.","2020-12-31",193222]
[null,null,"HIV/AIDS","Program management","Other program management intervention(s)","Provision of funding to support the development of a new NSP for 2021 to 2025.","2020-12-31",106192]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Support the inclusion of a further 150 trained FHWs in the delivery of outreach services to support HIV, TB, Malaria, MCH and GBV related services as part of the Community Health Strategy. This would allow expansion to a second tier of districts.","2020-12-31",413228.79999999999]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","WHO technical assistance P3 level ? currently funded through the grant. Proposal is 50% from Malaria and 50% from RSSH to support essential medicines oversight for all health areas.","2020-12-31",375432]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Required to allow the continuation of essential strategic information collection to guide programming and measure outcomes. Current MoT data only recognised sexual transmission and PMTCT. No details available on types of sexual transmission or IDU.","2020-12-31",0]
[null,null,"HIV/AIDS","RSSH: Human resources for health (HRH), including community health workers","Other health and community workforce intervention(s)","Health Professional Councils as part of the Health Sector Strategic Plans (HSSPs) are key to addressing the lack of oversight and regulation of different health sectors and will support standards.","2020-12-31",0]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","A key component of the Health Sector Strategic Plans to address the lack of regulation of medicines and health technologies, particularly in the private sector.","2020-12-31",585752]
[null,null,"HIV/AIDS","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.","2020-12-31",119520]
[null,null,"HIV/AIDS","Treatment, care and support","Socioeconomic approaches","Funding to support the other 70% of PLHIV (see above for $0.99 M). Continue to support cash payments for food and hygiene products which have been a key part of improved treatment adherence and continuing to support PLHIV engage in the PLHIV networks and support groups.","2020-12-31",2162884]
[null,null,"Malaria","Case management","Other case management intervention(s)","World Malaria Day commemoration by implementing partners. Each SR in South and Central Somalia will receive funding for one event. There are five SRs in South Central Somalia.","2020-12-31",13500]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Surveys","There are three operational research planned, specifically for Puntland, to be better able to understand the malaria in Puntland and plan for pre-elimination, as well as outbreaks such as that in Bossaso. The research are: Malaria Vector Identification and geographical distribution of main source of breeding sites including vector behaviour study in Bossaso District; Risk mapping and cases distribution malaria cases density by villages and providing appropriate anti-malaria interventions for both vector control and case management as well as surveillance; and Relation of malaria in pregnancy and Obstetric problems (LPW, Apportions, Stillbirths, Anemia including maternity deaths) among pregnancy mother in Bossaso.","2020-12-31",128652]
[null,null,"Malaria Total",{"$nulls":4},12063518]
[null,null,"Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Intensified training and monitoring activities for central level staff to improve managerial capacity.","2020-12-31",37870]
[null,null,"Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","Additional training, co-ordination and case management activities for TB/HIV.","2020-12-31",445170]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Pre-exposure prophylaxis (PrEP) for sex workers","According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for sex workers is 95%. For the Global Fund program, this equates to 19,192 sex workers. 3,439 sex workers will be given PrEP through the allocation funding. PAAR funding will fill the gap between the allocation and optimal coverage, providing an additional 15,753 sex workers with PrEP. This will be paired with an intensive and targeted knowledge campaign to increase demand for PrEP among sex workers. PAAR will increase PrEP coverage in the target districts from 17% to 95%, and decrease the national programmatic gap for AGYW PrEP by 32% (from 49,420 to 33,667).","2022-03-31",4013576]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for TGs","Addressing stigma, discrimination and violence against TGs","This PAAR request is for hormone replacement therapy for 840 transgender people (50% of those reached through the program). It is expected that this intervention will help address gender-related barriers for transgender people. It is also linked with improved attainment of the 90-90-90 targets, since global data suggests that ART initiation and treatment adherence improves among transwomen in a gender affirming context.","2022-03-31",1628308]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Gender-based violence prevention and treatment programs for adolescents and youth","Funding will support the 13 existing Thuthuzela Care Centres (TCCs) that are supported by the current Global Fund grant. The TCCs are a one-stop GBV model. Through this intervention, clients of TCCs will be tested for HIV, and either offered PEP (if eligible) or linked to treatment and care (as appropriate). The requested above allocation investment will reach 40,204 AGYW who are survivors of gender-based violence (including 20,017 survivors reached with HTS). It is estimated that 20?25% of new HIV infections in young women in South Africa are attributable to GBV.  It has also been (conservatively) estimated that gender-based violence costs South Africa between R28.4 billion and R42.4 billion per year ? or between 0.9% and 1.3% of GDP annually.","2022-03-31",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","PAAR request will provide remuneration for an additional 1,000 CHWs (R3,500/month), which when added to the 400 supported through the allocation equates to 10% of the CHW registered workforce in the target 10 districts for the Global Fund program. This additional support will help NDOH to retain more of the existing cadre. There are currently 49 344 CHWs registered in the NDoH CHW database, of which 33,333 are already funded by treasury, 8000 funded by PEPFAR and 400 funded through the Global Fund allocation amount. These are active CHWs who have been validated by the provincial departments. This investment complements the significant commitment from Treasury, which has allocated R4.4 billion for the CHW programme over a three year period with R1.4 billion allocated for the financial year starting in April 2018/19, 1.4 Billion for April 2019/2020 and 1.5 Billion for the April 2020/21 financial year.","2022-03-31",0]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Treatment","This PAAR investment will support innovative TB treatment adherence models, including mHealth app development, adherence supporters, and medication devices. 40% of coverage is requested in the allocation budget for DR-TB adherence support. Another 60% is requested in PAAR for DS-TB adherence to ensure that the missing patients found with Global Fund and increased national efforts are supported to complete TB treatment to limit transmission, TB relapse and the development of resistance. There is an international move away from Directly Observed Treatment (DOT) towards more patient-centred adherence support which is modified to patient's need.","2022-03-31",4999175]
[null,"South Sudan","HIV/AIDS","Comprehensive prevention programs for MSM","HIV testing services for MSM","Training of peer educators and health workers to deliver services to key populations and MSM in particular.This will expand HIV testing services (HTS) and reduce gaps in the first 90 of the HIV care cascade (90% of people knowing their HIV status by 2020).","2020-12-31",238262]
[null,null,"HIV/AIDS Total",{"$nulls":4},2401596]
[null,null,"Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","The number of MDR-TB cases being diagnosed is currently below the set target.  Currently, there are 17 GeneXpert MTB/RIF machines deployed at 16 sites across the country - 10 of these machines were procured using Global Fund resources.  The rollout of this GeneXpert MTB/RIF test highlights the existing need for strong testing site networks, good infrastructure, robust quality assurance systems and uninterrupted supplies. With the projected number of 220 MDR cases to be notified in 2020, there is need to procure adequate cartridges ($252,160), LPA and liquid culture reagents, and other laboratory supplies and consumables valued at ($194,688).  To ensure optimal functionality of these machines, it is necessary that a maintenance and technical support contract with the Cephied is in place to cover the year 2020.  This contract is valued at $38,776. In additional $6,679 will be used to cover the travel, lodging and facilitation feed of the Cepheid certified trainer and in-country training expenses for participants.  An additional 7 super users will be trained to support the roll-out and in-country trouble shooting of the GeneXpert platforms across the country for accurate and timely diagnosis.  This covers the cost of the trainer, A total of 10 super users were trained in May 2019.   A separate maintenance contract for the maintenance of other equipment such as the BD BACTEC MGIT 960 System, LPA machine, medical refrigerators is being also being finalized at a cost of $37,930.","2020-12-31",531171]
[null,null,"Tuberculosis","Program management","Grant management","This is to cover the costs of key technical project personnel under Cordaid who are required to continue providing technical backup to the project in 2020.  The two key staff will continue to provide supervision, oversight and mentoring to the local staff and to ensure smooth handing over to local authorities at project termination. These staff also undertake grant management functions related to the Sub-Recipient Agreement.","2020-12-31",109822]
[null,null,"Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","In order to strengthen the capacity of the National TB Program in PMDT, it is important that central-level staff who are charged with the responsibility of providing oversight, supervision and mentorship are adequately trained.  As the country is currently scaling up the implementation and coverage of MDR TB services, this training is critical. 3 staff will be undergo international training in PMDT at a cost of USD22,820.00.  As this intervention is already approved, the country has updated the intervention highlighting the training in PMDT as a priority.","2020-12-31",22820]
[null,null,"Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","The NFM TB grant already supports the strengthening and sustaining of the technical and managerial capacity of the National TB program at all levels through: training in TB management; financial management; provision of salary support; and training of County Health Department teams. A coordinating body could only be considered once all the positions have been filled.","2020-12-31",785616]
[null,"Sri Lanka","HIV/AIDS","Comprehensive prevention programs for MSM","HIV testing services for MSM","Consultant, 2 Nursing officers , 2 Office assistants & 2 drivers Salary for 3 yrs- KPs incentives are already included under the detail budget.","2021-12-31",0]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Drug resistance surveillance","Drug resistance surveillance - Consultative meetings & preliminary survey / Proposal development meetings, ethical clearence, data collector's training, data collection cost, data collection related travel, data entry, data analysis, preliminary dissamination meetings, final dissamination meeting & (Per diem,Airfaire & Visa Fee). - 3200000LKR.","2021-12-31",0]
[null,null,"HIV/AIDS","Treatment, care and support","Treatment monitoring - Drug resistance surveillance","International tour to learn the methods & implementation methods   / The technique is new to Sri Lanka. To learn an international study tour is arranged. 3ppl  - 2 people from lab, 1 from treatment & care sector, 5000 USD/person*3ppl Y 1 (Additional payment of perdiem(USD 250 per day*5), airfare (USD 520) & Visa Fee (USD 40).","2021-12-31",20430]
[null,null,"Malaria Total",{"$nulls":4},61187]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","Procurement &  Installation of  3 nos of Digital X-ray machines for National Hospital of Sri Lanka, Colombo North teaching hospital, Kandy teaching hospital.","2021-12-31",69000]
[null,null,"Malaria","Other module","Laboratory systems for disease prevention, control, treatment and disease surveillance","The National Malaria Research and Training center- Sennar is delivering training courses for researchers, CHW, parasitologist, entomologist, molecular biologist and public health officers in vector borne diseases both nationally and in EMRO region.The centre includes main three labs beside other units:1- Medical Entomology training laboratory ,2- Molecular biology lab,3- Parasitology and reference parasitology laboratory.the buildings needs rehablitation to support those activities","2020-12-31",1205000]
[null,null,"Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","BCC and ICE to promote uptake of malaria prevention and treatment services. Approx. 50% of this budget will be invested in social mobilization and community awareness to increase the LLINs utilization.","2020-12-31",6901380]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Funding to replace 976,130 LLIN with  Quality issues (DawaPlus 2.0 commercialized byTana Nettings Co Ltd REF: quality notice of 01.02.2019)  that were distributed in south Darfur state ( prevelance  9.2 %MIS 2016). Request to replace these bed nets will ensure the needed protection is provided for south Darfur population where the LLINS is the main vector control intervention.","2020-12-31",2903401]
[null,null,"Malaria Total",{"$nulls":4},35145834.049999997]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: National health strategies","Other policy and governance intervention(s)","Analyze which services related to HIV, TB and malaria can be targeted for cost recovery.","2021-12-31",5250]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Refresher training in procurement and supply management icluding revisiting of SOPs and tools that meet specific needs of labs.","2021-12-31",6000]
[null,null,"HIV/AIDS","Comprehensive prevention programs for TGs","Other intervention(s) for TGs","As there is currently a lack of information on the TG population, this request will develop IBBS and GIS to create mappings to guide interventions for TG persons.","2020-12-31",0]
[null,null,"HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Improve overall health outcomes, reduce costs and gain efficiencies. Offering service in different modalities to increase clients and reduce workload. Scale up access in nationwide in any location.","2020-12-31",0]
[null,null,"Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","The activities under this intervention will be oriented to further development the roles and strengthening capacity of key affected populations and communities, community organizations, NGOs and networks in the design, delivery, monitoring and evaluation of services and activities. Particularly, The Global Fund sources are requested to support the activities oriented to build PR-ship capacity of the National Stop TB partnership coalition to take over activities related to community support and involvement. The coalition includes under his umbrella local NGOs involved in realization of TB control activities under NSP 2015-2020 in country. The National Stop TB Coalition will develop its capacities to coordinate community involvement on local and central level. In this respect, a series of capacity building events should be planned for civil society in service provision, advocacy, communication and social mobilization, organizational development, etc. Estimated costs per years 50,000 USD.","2021-03-31",150000]
[null,null,"Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","The Rasht region is situated in east part of the country, composed from 5 rayons with a total population of 370,000 people. Around 40,000 people are seasonal labor migrants. There are 5 microscopic center that performed sputum microscopy and one Xpert equipment installed in Rasht city that assure investigations of symptomatics from all region. Due its geographical characteristics: situated in mountain area, 400 km distance from Dushanbe, with full isolation from the center during winter time for 4-5 months, there are big challenges related to the bacteriological investigations of the patients, diagnosis on time of the resistant TB cases, early beginning of the MDR/XDR-TB treatments and possibilities to monitor the efficiency of anti-tuberculosis medication. The number of TB cases in region increased during last years, from 201 in 2015 to 255 in 2016, situation characteristic and for MDR-TB cases registered: 20 and 26 cases respectively. Under above allocation budget sources are requested from the Global Fund to organize level 2 laboratory for the region. The local authorities are ready to provide building for the laboratory, sources being necessary or renovation of the building, laboratory equipment and some staff training. The estimated costs includes 150,000 USD for renovation, 240,000 for equipment, and training of staff 20,000 USD. The impact of this activity result in timely diagnosis of the all forms (including resistant) of TB for patients from region, timely administration of the treatment, and it adequate monitoring.","2021-03-31",410000]
[null,null,"Tuberculosis Total",{"$nulls":4},1001001.07]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Other intervention(s) for general population","During 2018-2020 Global fund grant application only 7201996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44% of the blood recipients to be at risk of infections through blood transfusion.","2020-12-31",5769918]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","Low level priority. The scale up of GeneXpert should be done according to the WHO recommendations. The country plan to include outreach mobile screening units in the 25 targeted regions and extra 552 iLED microscopes and associated reagents will be procured to improve quality of the TB diagnostic network in the lower health facilities.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Engaging all care providers (TB care and prevention)","High level priority: it is in line with FR of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.","2020-12-31",45694]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","It is hypothesized that Low TB case notification among PLHIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among PLHIV disaggregated by age, gender and pregnancy status.","2020-12-31",356600]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Other intervention(s) for treatment","Tanzania is planning to improve referrals and linkages from HTC to care and treatment using the Unique Identifier Code biometric technology. This will reduce duplications, and reduce loss to follow up. It will also help to track and return clients back into care. The planned unique identification biometric system (in the RSSH grant) and the related funds are to pilot a small scale in one region-Dar es Salaam. The funding requested in the PAAR for this activity will be used to scale up use of unique identifier (biometric) in all CTCs in the country.","2020-12-31",1500000]
[null,null,"Malaria, RSSH","Case management","Therapeutic efficacy surveillance","These funds are critical for covering therapeutic efficacy studies (TES), and detection of any other evidence of treatment failures or emerging drug resistance.","(blank)",240000]
[null,null,"Malaria, RSSH","Vector control","Other vector control measure(s)","This funds will cover active disease surveillance activities, screening of populations irrespective of the presence of fever or any other signs or symptoms of malaria to detect infections and residual parasite carriers in the low transmission regions nearing malaria elimination.","(blank)",0]
[null,null,"RSSH","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","The intervention includes essential inputs to improve the functionality of the local health system.","2020-12-31",6466702]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","RTF BL 1Referral for PrEP for MSM & TGObjectives: Referral for PREP MSM/TG Units/Participants: 84  per year in year 1, year 2,year 3 Locations: 7 provinces year 1, year 2 , year 3 Costs: Travel cost Measurements:direct indicator record/report, referral form.","2020-12-31",11916]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive programs for people in prisons and other closed settings","Community empowerment for people in prisons and other closed settings","DDC BL 358TB-HIV in PrisonsTelemedicine to improve and follow up patient' s clinical from hospital to prison in order to improve TB, HIV, IPT and OST service in 5 prisons in each year.","2020-12-31",63270]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive programs for people in prisons and other closed settings","HIV testing services for people in prisons and other closed settings","DDC BL 359HIV testing services for Prisoner by using oral fluidHIV testing  for Prisoner is set 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","The intervension of $ 1 million will support the transition to the new MDR/RR-TB regimen recommended by the WHO which the country plans to begin implementing from Q4 2019.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","DDC BL 276,278, 281, 282, 2831. Lesson learned workshop for S&D reduction related to HIV and HIV/TB in health care facilities2. Monitoring and coaching at sites by provincial team3. Meeting of key stakeholders on S&D reduction4. Cost for media production through social mediachannel5. Rolling-out of the E-learning for health care workers.","2020-12-31",1076088]
[null,null,"HIV/AIDS, Tuberculosis","Programs to reduce human rights-related barriers to HIV services","Training of health care providers on human rights and medical ethics related to HIV and HIV/TB","DDC BL 277Monitoring and coaching on S&D reduction related to HIV and HIV/TB in hospitals by central team.","2020-12-31",10404]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","RTF BL 31-32Migrant Health Insurance1. Modellingof Migrant Health Insurance (MHI) TA -Consultants for  MHI in Mae Sot2. Scale up the Migrant Volunteer and Village Health Volunteer-Buddy System throughmeeting with Local Administrative Office for HIV and TB and other health related issues.","2020-12-31",50786]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: National health strategies","Other policy and governance intervention(s)","RTF BL 31-321. Twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii.  Field visit with stakeholders Units/Participants: 27 persons per day, 2 days. Locations: 2 provinces in year 1, year2 2. Fundraising specialist for CRM strategic plan. Contact professional consultant Units/Participants: 4 persons per team  Locations: 1 team in year 1, year 2, year 3.","2020-12-31",43921]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Engaging all care providers (TB care and prevention)","RTF BL 45:Support monitor for Public-Private-Mix collaboration in TB control activitiesTo ensure that the TB control is effectively implemented in the community.","2020-12-31",47495]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","DDC BL 274:IPT service fee for Data recorder 400 Baht per time, 4 times per month for 27 hospitals, 54 hospitals and 108 hospitals in 2018, 2019 and 2020 respectively.","2020-12-31",102956]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},8696748]
[null,null,"HIV/AIDS","Other module","Other module","Funding is requested in this category to share costs across the Global Fund Program for a Program Management Adviser.","2020-12-31",0]
[null,null,"HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","This request includes for TA support for TB/HIV and ART treatment in 2019 and 2020.","2020-12-31",97847]
[null,null,"Malaria","Case management","Active case detection and investigation (elimination phase)","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Leste?s transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector.","2020-12-31",39881]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","Provision of enhancing case/foci investigation and outbreak response capabilities of the Elimination Programme by strengthening national surveillance systems to produce relevant and quality data in a ?real-time? manner. Whilst such efforts are not directly linked to producing impact and outcome, their addition to the programme is vital in that it provides assurance in the quality of the data values that are being reported periodically for all Impact Indicators and for the Annual Blood Examination Rate (ABER) (Outcome Indicator), as well as, ensuring reliable estimates of LLIN coverage through the National MIS. Funding would be utilised to provide, 1) Provision of funds to conduct a malaria module (MIS) as part of a national household survey (Year 2), 2) Routine National Reporting Supervision to municipalities - WHO TA M&E activities ? 7 months in Year 3, 3) Routine Reporting Supervision from National to municipalities: Production of stock control books (anti-malarial stock book (ACT and non-ACT) and RDT stock book ? Year 3.","2020-12-31",9052]
[null,null,"Malaria","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Provision of LLIN procurement and routine ANC distribution to maximise coverage in and utilization by pregnant women to prevent the acquisition of malaria with complications. It would complement the above (Priority 1 request) in ensuring complementary coverage would provide the outcome of Universal Access to Coverage (90%) amongst a wider population denominator and would ensure targets are achieved across all 4 Impact Indicators.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Community-based activities for sex workers:This  intervention  will  consist  of  capacity  building  for  all  of  the public  and  voluntary  adapted  service  (AS)  providers,  so  as  to create a more favorable environment and thereby encourage the key populations to visit the ASs and other health care facilities, so as to receive better psycho-social and medical care.The  additional  resources  will  make  it  possible  to  organize sessions on topics relating to the MARPs (issues affecting the key populations: stigmatization and discrimination) (EUR 20,868) and leadership of SWs (EUR 29,474).","(blank)",56495.34]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Treatment: MDR-TB","Equipment for new  MDR-TB  care center  will  improve  iMDR-TB diagnostic    capacity    by    making    it    possible    to    perform bronchoalveolar lavage, induced sputum testing and gastric tubing.","(blank)",138748.74]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","Organize the final evaluationof the NSP 2015-2020 in 2019 with the support of two consultants (one national and one international) for a sum of EUR 12,191-Developthe NSP 2021-2026 in 2019 with the support of two consultants (one national and one international) for a sum of EUR 25,839.","(blank)",42677.59]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","HIV care","Purchase of ARVs for People Living with HIV (PLHIV). In  order  to maintain the upscaling dynamic implemented under the NFM, and in  accordance  with  the  objectives  of  the  NSP/acceleration  plan, this  intervention  will  make  it  possible  to  place  67,031  patients (67%)  on  treatment  in  2018,  73,112  (73%)  in  2019  and  78,691 (79%) in 2020.","(blank)",1005744.38]
[null,null,"Malaria","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Strengthening human resources for health (HRH) management capacity initiated during the NFM1:\n- Institutionalization of HRH: 1) updating the HRH management database (12,000 health staff and 11,000 CHWs); 2) linking the iHRIS 4.2 software with District Health Information System (DHIS2); 3) preparing and periodically updating the country profile on HRH; 4) producing statistical yearbooks on HRH; 5) decentralizing the use of iHRIS to enable decision-making at the regional and health district levels.\n- Improvement of quality and promptness of malaria data reporting through trainings and supervisions.","2020-12-31",327527.77]
[null,null,"Malaria","Vector control","Entomological monitoring","The funding request will assess the continuous effectiveness of insecticides and drugs (LLINs, ACTs, SP, SP+AQ and injectable artesunate) used to measure the sensitivity and effectiveness tests for long-lasting insecticidal nets (LLINs) as part of an overall resistance monitoring and surveillance strategy in accordance with WHO recommendations. The budget will cover the characterization of specific Plasmodium species and their resistance mechanisms to antimalarial drugs, a test for vector sensitivity to insecticides and community monitoring of the effectiveness of LLINs.","2020-12-31",154796.32]
[null,null,"HIV/AIDS","Comprehensive prevention programs for MSM","Diagnosis and treatment of STIs and other sexual health services for MSM","The setting up of new community centers in accordance with mapping and the installation of a hot line will improve treatment conditions for key MSM populations in the context of HIV control","2021-12-31",183791]
[null,null,"HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Strengthening the conditions for addressing stigma, discrimination and violence against people in prisons and other closed settings through the establishment of an accreditation mechanism for HIV screening by community actors and by raising awareness of the rights of key populations will, in the long term, have a positive and sustainable impact on HIV control.","2021-12-31",7161]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Conducting assessment surveys on resistance to antiretrovirals (ARVs) at the four treatment sites, conducting a study on adherence to treatment, conducting a community bio-behavioral study (MSM, people who inject drugs, SWs) to measure the impact of prevention interventions, and updating the estimated sizes of key population (mapping/studies estimating the population size of MSM/SW/people who inject drugs) will all help to better guide the planning of HIV control activities, thereby guaranteeing an improved impact of disease control activities in Tunisia.","2021-12-31",86600]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Increase of funding needs for XDR-TB due to WHO recommendation to increase treatment with Bedaquilin/Delamanit to 12-18m instead of 6m, this amount is expected to cover 2020-2021 needs. This comes in addition to previously approved Portfolio Optimization Amount. Module: MDR-TB; Intervention: Treatment","2021-06-30",0]
[null,"Uganda","HIV/AIDS, Tuberculosis","HIV Testing Services","Other module","The HTS test kits have a gap of $21.2 million (after the allocation request). Additional funding is sought to support HTS services including review and update of HTS training materials; printing of revised HTS tools to complement PEPFAR support; support for quarterly performance review meetings at national level; finalize the HTS certification framework; Conduct routine QC; Quarterly support supervision visits to HTS points; and HTS outreaches in safe places and hard-to-reach settings such as fishing communities.  This request includes $21.2 million for test kits and 1,991,800 for the support activities.","(blank)",11620344]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Other intervention(s) for PMTCT","Additional funding will support capacity enhancement for PLHIV community groups to deliver interventions that are intended to further increase uptake of PMTCT services, increase male partner testing, reduce loss to follow up for mother-baby pairs, and improve treatment adherence.","(blank)",913488]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Prioritization on the printing and distribution of the HMIS reporting tools to reach out to all 116 districts and all health facilities in the country with these updated HMIS reporting tools. Due to limited funding, this was placed under PAAR for any savings in the first year (2018) to contribute to at least 30% of the country required HMIS tools.","2020-12-31",1042566]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO","2020-12-31",0]
[null,null,"Tuberculosis Total",{"$nulls":4},0]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","The PAAR funds are requested for creation of integrated centers providing services based on community and safe places (centers of social and medical care). Extended package for specific subgroups and needs, including HBV testing, vaccination, STI testing procurement. Also, the Project includes essential package on prevention and case-finding for NGCA Donetsk and Luhansk as well as communication materials. The PAAR request also includes 50% of SW outreach package funding in 2019 and 80% in 2020 for piloting Social Impact Bond as described under Module 2.2. above.","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","TB case detection and diagnosis among general population in Non-Government Controlled Areas (NGCA) Donetsk and Luhansk. It is planned to cover about 3,800 additional MDR-TB cases implementing rapid testing. In addition, a total of 3,100 Xpert cartridges will be procured (1,800 for Donetsk and 1,300 for Luhansk).","2020-12-31",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","1. Improving technical capacity of the laboratories\n2. Developing  technical compliance and biological safety and security.\n3. Building of 4 regional reference centers (This was considered as low priority by TRP).\n4. Capacity building and support to the national surveillance system.","2020-12-31",11317522]
[null,"Uzbekistan","HIV/AIDS","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Encouraging packages to attract vulnerable groups to HIV testing (for testing 800 MSM).","2021-06-30",0]
[null,null,"HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Condoms for HIV prevention among discordant couples and food packages for social support for socially unprotected PLHIV.","2021-06-30",0]
[null,null,"HIV/AIDS Total",{"$nulls":4},124824]
[null,null,"HIV/AIDS","Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","HI does not cover preventative medicines and it is anticipated that many persons at substantial risk for HIV infection are able and willing to pay for PrEP ARVs. Others, however, will require subsidies to access PrEP. For all persons accessing P.rEP, appropriate monitoring is required consistent with WHO guidelines. VAAC requests Global Fund support to procure PrEP medicines for user-pays and subsidized distribution for the following number of patients: 2018 2000 2019 3000 2020 4000.","2020-12-31",0]
[null,null,"HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Needle and Syringe programs for PWID and their partners","In order to remove used needles from the community, Global Fund support for needle collection activities has been included in the allocation request. Should the above allocation request for expanded PWID prevention.","2020-12-31",32300]
[null,null,"HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Following WHO recommendation for triple elimination, VAAC proposes to pilot triple HIVsyphilis-HBV testing among pregnant women in three provinces that indicate high prevalence of at least two of the three diseases. Triple test will be offer free of charge at ANC as early as possible. Women who are identified to be infected with any of the three infection and their infants will receive treatment as indicated, including ARV, penicillin and/or HBV vaccination. Certain health care workers will be trained on service implementation and data collection and reporting. VAAC propose to demonstrate the integration of syphilis and HBV to MNCH care package at all ANC levels reaching 85% of pregnant women in six districts in three provinces in 2018. In 2019 and 2020, 95% of pregnant women in 9 districts (the same six districts form 2018 + three new districts) will be offered the triple test. Results from this pilot will inform the National Triple Elimination Policy with a view to nation-wide rollout.","2020-12-31",711944]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Improving laws, regulations and polices relating to HIV and HIV/TB","Community opinion assessment on management of drug users post rehabilitation - consultant fee. Organize national level workshop to discuss policy relating to KP - Advocate for removal of barriers for KAP's access to HIV/AIDS services and CSO's participation. One national dialogue between CSO and VAAC and government agencies on HIV/AIDS response.","2020-12-31",67063]
[null,null,"HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Events for community initiatives to reduce Stigma & Discrimination in five Global-Fund supported provinces.","2020-12-31",10588]
[null,null,"HIV/AIDS","RSSH: Community responses and systems","Community led advocacy","Advocacy for preferential tax policy for CSO.","2020-12-31",33380]
[null,null,"HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Conduct a behavioural survey and size estimate of transgender women in eight provinces in Vietnam: HIV/STIs risk behaviours, stigma & discrimination, gender base violence and health care needs. Budget includes consultant fee, survey implementation costs.","2020-12-31",64292]
[null,null,"HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","HIV epidemic in Vietnam is driven by people who inject drugs (PWID). Since sharing injecting equipment is a major transmission route for Hepatitis C, prevalence among PWID is very high ranging from 31% to 98% as reported in previous study (Sereno L et all, 2012). Among HIV patients, data from IBBS show prevalence of HCV coinfection at 27% (Nadol P et al 2015). There is remarkable development of direct-acting agents (DAAs) as ?break-through? medicines for hepatitis C treatment in recent years. Up to 95% of people with hepatitis C infection can be cured in 3 to 6 months. These new medicines are more efficacious, having less adverse effects and convenient for patients, compared to older medicines, e.g. interferon or pegylated interferon with ribavirin. Hepatitis C is major cause of cirrhosis, liver cancer in Vietnam. Without treatment, HIV/HCV co-infected patients could die because of advanced hepatitis such as decompensated cirrhosis and liver cancer. However, as new medicines, DAA has not been included for reimbursement by health insurance, thus access to the lifesaving treatment of HCV is not yet available for HIV/HCV co-infected patients. VAAC proposes to provide treatment for 1,000 HIV/HCV co-infected patients with SOF/LDV for 3 months. Estimated at least 900 patients will be cured from hepatitis C. Providing hepatitis C treatment service will be capacitated for 40 doctors and nurses at 10 selected OPCs in 2 provinces.","2020-12-31",1200000]
[null,null,"Tuberculosis","MDR-TB","Treatment: MDR-TB","The allocation amount is currently covering 60% of MDR-TB cases targeted for treatment (1950 cases in 2018, 2190 cases in 2019 and 2130 cases in 2020). The PAAR will support the remaining 40% of estimated MDR-TB cases enrolled for treatment. NTP will use PAAR to procure SLDs for 9-month and 20-month regimens and patient support for MDR-TB patients. : 1300 cases in 2018, 1460 cases in 2019, and 1420 cases in 2020 - PAAR will also support supervision by community staff for supporting MDR-TB patients, essential to ensure treatment adherence and treatment success. - The aDSM model is also crucial to detect, manage and report suspected or confirmed drug toxicities drugs at all MDR-TB sites, manage adverse drug reactions (ADRs), and relieve patient suffering and improve treatment outcomes. Related PAAR-supported activities include: developing materials, training, assessing current situation, and consolidating aDSM data electronically.","2020-12-31",3694973]
[null,null,"Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Integration of TB prevention and control education into school extra-curricular activities in 2018 - E-learning to screen potential candidates for MECOR course and maintenance for the e-learning system for MECOR Supervision of GX including EQA and on-site technical support for GX implementation - Updates to the NTP guidelines and training in updated guidelines/ techniques (testing, GX, etc.) - Development of remote coordination and connectivity for clinical discussions and program support (i.e. ECHO system).","2020-12-31",204866]
[null,null,"Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Study of the LTBI prevalence among child contacts and their characteristics (contact, index patient and environmental) associated with infection.","2020-12-31",25000]
[null,null,"Tuberculosis","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Annual maintenance, calibration, and testing of equipment to meet requirements to maintain the ISO certification - Training for QMS lecturers for NRL, RRLs, PRLs laboratories.","2020-12-31",18935]
[null,null,"Tuberculosis","RSSH: Procurement and supply chain management systems","National costed supply chain master plan, and implementation","Upgrades to VITIMES and E-TB Manager to meet the supply chain management needs and link to health insurance, training, connect GeneXpert to eTB manager, and using GxAlert TA to support key provinces. - Development of \"Guidelines of supervision and technical support of management of supplying system at the facilities\", training on supply operation procedure (SOP) and supply statistic report, building a costing toolkit for quarterly needs and tentative needs for first line drugs, compile TB handbook \"what you need to know\" for drug resistant TB patients, and training on using TB drugs rationally and safely - Enhancing the application of information technology in medical stores by procuring computers, printer and uninterrupted power supply (UPS), and management of central and regional store software - Needs assessment and development of SOPs for supplying free drugs to MDR-TB patients in the private sector.","2020-12-31",296644]
[null,null,"Tuberculosis","TB care and prevention","Case detection and diagnosis","In order to use Xpert for all TB suspects by 2020, the procurement and adaptation of GeneXpert machines is essential. The allocation amount covers procurement of 30 GX machines to scale up Xpert capacity. PAAR will cover a) 20 additional 4-module GX machines and 40 Xpert Omni per year, b) 100k cartridges in 2018, 150k in 2019, and 237k in 2020 (+ consumables and testing fee), and c) training for TB units receiving new machines, and for transition to Ultra cartridges. This will cover Xpert testing among 12,000 people per year with an abnormal CXR. - Additional costs will include: ? Two ILEDs per year, ILED maintenance & repair, and EQA for microscope's smear ? Three digital X-ray cars per year (total 9 cars) to contribute to I/ACF ? Implementation of the FAST strategy.","2020-12-31",9710510]
[null,null,"Tuberculosis","TB care and prevention","Community TB care delivery","Zero TB city in 2 provinces - Scaling up two provinces implementing a model of early TB detection and two additional provinces implementing m-Heallth by the Farmers? Union - Implementing ACSM for stigma reduction through TB literacy and use of social media.","2020-12-31",633069]
[null,null,"Tuberculosis","TB care and prevention","Engaging all care providers (TB care and prevention)","Scaling up two additional PPM-DOTS provinces by NTP and 3 additional PPMDOTS provinces by RCSCH - Development of guidelines for PPM of Childhood TB, for working with pediatric hospitals and pediatric departments of general/infectious diseases hospitals, covering 20 provinces and cities Scaling up PAL to 20 provinces by NTP and 6 provinces by CCHD.","2020-12-31",805783]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","The elderly in Vietnam have a high prevalence of TB. According to the TIME model, about 10,000 elderly cases can be detected with large scale ACF. The PAAR will provide screening for 6000 elderly in community, 2000 in mental health institutions, and 2000 in in some social protection centers in 0seven provinces per year using CXR and Xpert . PAAR will also support workshops to improve awareness of TB among the elderly.","2020-12-31",316820]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","To support expansion of childhood TB activities, the PAAR will support revision of the diagnosis, treatment, and prevention training materials. NTP will also develop, print, and distribute IEC materials (poster, leaflets, etc.) for community awareness and support health workers on IPT and childhood TB management, with the ambition to detect and treat about 3,000 more cases per year.","2020-12-31",75243]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Under-served populations have a higher prevalence which requires ACF on a large scale. The allocation does not cover these activities. PAAR will reach the estimated additional cases based on the TIME model for these populations: about 33,000 patients per year. - PAAR will further support: ? Scaling up ACF in four districts per year with large populations and high TB prevalence ? TB screening and preventive treatment for 4000 immigrants per year ? Routine screening for 6000 patients per year at the Methadone centers and at voluntary drug detoxication centers. ? Screening for 7000 miners per year in Quang Ninh. ? Screening for 7000 health workers with high risk of TB. ? Establishment of a comprehensive model for TB detection and control in social protection centers in 3 provinces by MOLISA. ? Procurement of 2 digital mobile X-ray machines to scale ACF in 3 border provinces.","2020-12-31",2034765]
[null,null,"Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","With regard to this key population, PAAR will support scaling up entry TB screening for more 7000 new prisoners, IC of MDR-TB for MDR treatment areas in 07 prisons, examination and screening for prisoners of two prisons for LTBI treatment, peer education training for temporary detention centers, and support for prisoners with active disease.","2020-12-31",419016]
[null,null,"Tuberculosis","TB care and prevention","Prevention","Preventive treatment for children living with a family that has a TB patient (3500 children per year) - Preventive treatment for household contacts of AFB (+) patients by CXR and GX - Procurement of equipment, consumables, reagents, etc. for expanding IGRA test at one laboratory per year and training - Development and printing of TBIC communication materials/ posters, etc. - Development and assessment of TBIC indicators for health facilities.","2020-12-31",0]
[null,null,"Tuberculosis","TB care and prevention","Treatment","Scaling up mHEalthin four provinces and piloting mHealth for MDR-TB - Renovating to improve TBIC for five TB/HIV patient care facilities per year and training in TBIC for general hospital and prison staff.","2020-12-31",424820]
[null,null,"Tuberculosis","TB/HIV","TB/HIV collaborative interventions","The current allocation amount covers 30,000 Xpert tests in 2018, 35,000 tests in 2019, and 50,000 tests in 2020. The PAAR will provide 20,000 additional tests in 2018, 25,000 tests in 2019, and 40,000 tests in 2020. PAAR scale-up of TB screening 5000 newly detected HIV patients per year. (Current allocation for the 2018-2020 period is 37,000 patients)\\ - Additional PAAR-supported costs are: ? TB/HIV training for TB and HIV staff ? Conference and training on ARV and CPT, including monitoring for HIV positive TB patients ? Reagents, consumables, and test kit supplies to maintain LF-LAM in 2020.","2020-12-31",688328]
[null,null,"Tuberculosis Total",{"$nulls":4},23989343]
[null,"Zambia","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Due to changes in funding landscape, additional funding is required to maintain and scale up HIV testing","2020-12-31",3210727]
[null,null,"HIV/AIDS","MDR-TB","Treatment: MDR-TB","Due to the changes that have been made to the Drug Resistant-TB guidelines, the gap has increased as the drugs being introduced are more expensive. Most of the patients will be on Bedaquiline which will no longer be a donation and a few on Delamanide which is more costly. Note that the Bedaquiline gap is in 2020.","2020-12-31",1033887.39]
[null,null,"HIV/AIDS","Prevention programs for general population","Condoms as part of programs for general population","Focus is on reducing the gap in 2020 for male condoms by increasing the allocation to the procurement of male condoms","2020-12-31",2782587]
[null,null,"HIV/AIDS","TB care and prevention","Case detection and diagnosis","Finding missing cases (People with TB) using campaign based model. This concerns heightened activities for 8 weeks once every quarter using digital x-ray mounted vehicles and GeneXpert machines.","2020-12-31",3546391]
[null,null,"HIV/AIDS","TB care and prevention","Other TB care and prevention intervention(s)","Fully oral shorter regimen implemented under operational research conditions.","2020-12-31",100000]
[null,null,"HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","National ART guidelines for 2018 have changed towards the new regimens.  This has altered the gap analysis for ARVs, leading to the need for increased Global Fund resources. Global Fund had initially committed $47,078,326 towards ARVs to cover 3 years 2018-2020. However, Global Fund exhausted all its obligation before 2020.","2020-12-31",14289750]
[null,null,"HIV/AIDS Total",{"$nulls":4},24963342.390000001]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","HIV Testing Services","Differentiated HIV testing services","To scale up self-testing (200,000 test/year). Aligns with accelerated prevention interventions for AGYW.","(blank)",1365570]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Prevention programs for adolescents and youth, in and out of school","Socioeconomic approaches","The funding will contribute to empower communities to help prevent HIV among adolescents and young women. It will cover cash transfers for 7000 girls and school fees for 3000 boys.","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Prevention programs for general population","Condoms as part of programs for general population","For male and female condoms. There is an anticipated funding shortfall due to reduced funding from other partners over the implementation period.","(blank)",5028497]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Prevention programs for general population","Male circumcision","Voluntary medical male circumcision reusable and consumables kits, early infant male circumcision training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly.","(blank)",10743359]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Program management","Grant management","Funding will provide additional risk mitigation for the management of the expanded scope of the program, particularly the additional civil society and community sub-recipients.","(blank)",974242]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Recruitment and placement of additonal 1400 nurses in rural areas and disease hotspots. Only 600 nurses could be covered by the allocation, whereas 2000 new nurses are required to achieve treatment targets for the implementation period.","(blank)",41076000]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","These funds will support health care waste management systems. The funds will be used for 5 incinerators, 10 air samplers, a laptop for integrated inventory management, supervision, M&E, and quality control.","(blank)",2349640]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB care and prevention","Treatment","First line drugs for additional patients in view of scaled up diagnostics in addition to external quality assessment activities for smear microscopies. This will support expanded diagnostic capacity.","(blank)",3286392]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB care and prevention","Treatment","Second line drugs for additional MDR-TB patients and improvement of Treatment Success Rate.","(blank)",2487307]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB/HIV","Community TB/HIV care delivery","To strengthen community TB/HIV activities by training 5000 community TB/HIV supporters in 104 districts in TB and HIV prevention, care and support, including contact tracing.","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","TB/HIV","TB/HIV collaborative interventions","Additional 100 Xpert machines, with related cartridges, printers and UPS, and 4 digital X-Ray machines. The TRP considers this low priority as there are 200 machines within allocation funding that need to be phased in while ensuring optimum utilisation.","(blank)",8137710]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Treatment, care and support","Treatment adherence","Radio programs on treatment literacy, incentives for 2000 Adherence Support Workers (ASW) per year. The TRP recommends that these resources be leveraged to also support TB/HIV collaborative activities ? i.e. MDR-TB.","(blank)",79996]
[null,null,"HIV/AIDS, Tuberculosis, RSSH","Treatment, care and support","Treatment monitoring - Viral load","These are RSSH PSM strengthening activities although labelled as viral load and monitoring. The request will further strengthen PSM quality of health products, and improve rational use of medicines.","(blank)",7859920]
[null,null,"HIV/AIDS, Tuberculosis, RSSH Total",{"$nulls":4},83388633]
[null,null,"Malaria","Vector control","Indoor residual spraying (IRS)","The target number of structures in 2019 is 3,376,196 translating in estimated 14,585,167 people protected at an average of 4.32 persons per structure. For 2020 the target is 3,474,106 structures translating in 15,008,138 people protected.","2020-12-31",0]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The number of LLINs to be distributed through routine channel to targeted  at risk populations is 2,158,203  and 1,948,203 in 2019 and 2020 respectively.","2020-12-31",5778982.7999999998]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The number of LLINs to be distributed to at risk population through mass campaign in 2020 is 7,512,678.","2020-12-31",6714256.5]
[null,null,"Malaria Total",{"$nulls":4},12493239.300000001]
[null,null,"Malaria, RSSH","Vector control","Other vector control measure(s)","This is a relevant component of the country?s elimination strategy that is critical as the burden progressively declines. This strategy will support the development of case-based surveillance in areas with low malaria transmission.","(blank)",10686696]
[null,null,"Malaria, RSSH","Vector control","Other vector control measure(s)","This will complement the support for entomological surveillance to ensure quality and effectiveness of the vector control operations, particularly IRS.","(blank)",900000]
[null,null,"Malaria, RSSH Total",{"$nulls":4},11586696]
[null,"Zanzibar","HIV/AIDS, Tuberculosis","PMTCT","Prong 3: Preventing vertical HIV transmission","This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women.","2020-12-31",544241]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","The intervention will fund Hepatitis B screening as an adjunct to the HIV testing programs among key populations.","2020-12-31",44445]
[null,null,"HIV/AIDS, Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Procurement and supply chain management (PSM) capacity was identified as a potential bottleneck to program scale-up. These funds will cover capacity building for PSM, including necessary technical assistance, in line with the needs of the program expansion.","2020-12-31",121042]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","This activity will complement program scale-up by availing and enabling data use for implementation.","2020-12-31",82716]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention is meant improve the overall quality and monitoring of health data in the expanded program. It will serve to extend the institution of the electronic medical records through the increase in the number of health facilities and capacity building for the health workforce.","2020-12-31",186665]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","This intervention will improve routine data collection and data quality in light of the planned scale-up of Zanzibar?s treatment programs.","2020-12-31",217227]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Surveys","These funds would enable an implementation research study on the bottlenecks to access opioid substitution therapy for people who inject drugs, which is a key programmatic gap. These funds would also fund a study on adherence to ART. Both studies are likely to inform program strategy.","2020-12-31",43915]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","Enhancing TB prevention activities and case detection is in line with program needs.  However with the purchase and institution of GeneXpert from within the allocation budget, it is rated as medium priority.","2020-12-31",52308]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Treatment adherence","The intervention will fund treatment of opportunistic infections, toxicity monitoring and home-based care interventions in view of maintaining safety and efficacy of ART and improve survival and overall impact of ART scale up.","2020-12-31",1029107]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},2321666]
[null,null,"Malaria","Case management","Active case detection and investigation (elimination phase)","This intervention is meant to ensure that every malaria case is reached in order to achieve elimination.","2020-12-31",22624]
[null,null,"Malaria","Case management","Therapeutic efficacy surveillance","This intervention aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.","2020-12-31",104768]
[null,null,"Malaria","Program management","Grant management","This item covers program management activities to ensure effective and smooth undertaking of the program's operational plan, monitoring of program budget and implementation of the planned activities.","2020-12-31",13100]
[null,null,"Malaria","Program management","Policy, planning, coordination and management of national disease control programs","This activity will cover the cost for trainings and meeting attendances.","2020-12-31",28775]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","This activity will strengthen the monitoring and evaluation component for the entire program.","2020-12-31",100233]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Program and data quality","This item will cover interventions to support improving the accuracy of data collection and analysis to inform decision making.","2020-12-31",17308]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Routine reporting","This activity will cover the cost to monitor and support regular and timely reporting of all activities conducted at various levels of implementation.","2020-12-31",58909]
[null,null,"Malaria","RSSH: Health management information systems and M&E","Surveys","Data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","2020-12-31",51510]
[null,null,"Malaria","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The installation of network infrastructure will support and strengthen procurement and supply chain activities.","2020-12-31",1548]
[null,null,"Malaria Total",{"$nulls":4},398775]
[null,"Zimbabwe","HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Addressing stigma, discrimination and violence against MSM","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",72600]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Community empowerment for MSM","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",534032]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Condoms and lubricant programming for MSM","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",800]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",402785]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Addressing stigma, discrimination and violence against sex workers","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",81125]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",2463120]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",1938840]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for TGs","Addressing stigma, discrimination and violence against TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","(blank)",5240]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for TGs","Community empowerment for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","(blank)",224561]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for TGs","Condoms and lubricant programming for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","(blank)",1200]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive prevention programs for TGs","Other intervention(s) for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","(blank)",394920]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","(blank)",76500]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive programs for people in prisons and other closed settings","Behavioral interventions for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","(blank)",11700]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive programs for people in prisons and other closed settings","Community empowerment for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","(blank)",184701]
[null,null,"HIV/AIDS, Tuberculosis","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","(blank)",251100]
[null,null,"HIV/AIDS, Tuberculosis","HIV Testing Services","Differentiated HIV testing services","Above allocation funding is requested for the procurement of self-test kits. Self-testing is prioritized in this funding request based on lessons learned about its effectiveness in reaching young people and men, as well as evidence from pilot programs which show this is a high yield method at more than 20% positivity","(blank)",9014947]
[null,null,"HIV/AIDS, Tuberculosis","HIV Testing Services","Differentiated HIV testing services","Filling gaps in standard test kit procurement for year 3 is the top priority request in the PAAR.","(blank)",2092061]
[null,null,"HIV/AIDS, Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","The final proposed investment will support prevention for MDR-TB and will include activities to strengthen and support TB infection control (IC) at community levels. Specifically the investment will support IC assessments for homes of diagnosed DR-TB patients and provide education on transmission risk reduction to family members, as well as initiate investigation of contacts. Engaging community leaders will place DR-TB on the agenda and facilitate a cascade of information within communities as part of the broader community TB care intervention. Decentralization of DR-TB treatment has meant that the majority of diagnosed patients are managed from their homes, justifying the rationale for these interventions, aimed at empowering community members to protect themselves and other vulnerable groups such as children, the elderly and PLHIV from acquiring TB.","(blank)",493087]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Other intervention(s) for PMTCT","Funding is requested for additional PMTCT activities, supporting the country?s eMTCT validation.","(blank)",2403200]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Funding is requested for additional PMTCT activities, supporting the country?s eMTCT validation.","(blank)",230400]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Prong 3: Preventing vertical HIV transmission","Funding is requested for additional PMTCT activities, supporting the country?s eMTCT validation.","(blank)",568000]
[null,null,"HIV/AIDS, Tuberculosis","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Funding is requested for additional PMTCT activities, supporting the country?s eMTCT validation.","(blank)",375900]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Community adolescent treatment supporters in 6 additional districts.","(blank)",1300000]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Scale up the modified DREAMS package to an additional 4 districts.","(blank)",3174288]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","Brother2brother pilot: 10 Districts.","(blank)",900000]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","In school and tertiary programme.","(blank)",3000000]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","Youth Centers (Multi-sectoral approach model).","(blank)",1300000]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Gender-based violence prevention and treatment programs for adolescents and youth","Funding is requested for community infrastructure, technology and transport systems to establish six additional one-stop centres (in addition to the four requested in the matching funds application) for HIV/SRHR/GBV, building on successes of existing centres in Rusape General Hospital (Makoni), Harare and Gweru. As more than 1 in 3 Zimbabwean women experience physical violence, the 17,000 GBV survivors served by the current centres is an enormous service gap. The need to decentralize access to GBV services and strengthen linkages to communities is vital.","(blank)",1617630]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for adolescents and youth, in and out of school","Keeping girls in school","Doubling the education subsidies in the existing 4 DREAMS districts to reach at least 30% of the vulnerable AGYW in those districts.","(blank)",2160000]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Condoms as part of programs for general population","Close gaps in male and female condom programming when delivering the comprehensive prevention package of services at community levels. The expected impact is based on continuing trends which show that an estimated 2 million HIV infections were averted by the increase in actual condom use between 1990 and 2016, compared to a scenario in which condom use levels stagnated in 1990. This investment will also complement PEPFAR?s investment in condom procurement by prioritizing filling the gaps in social marketing, including TV, radio and community sensitization. $299,700 is requested for demonstration models and dispensers while $1,064,316 is requested for programming. The US government continues to invest significant amounts in the procurement of male and female condoms, with Global Fund resources intended to complement these investments.","(blank)",1364016]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Diagnosis and treatment of STIs and other sexual health services for general population","HIV prevention-related STI services, including for the provision of dual HIV and syphilis testing, STI screening and treatment, referrals for HPV vaccines and cervical cancer services.","(blank)",3568111]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Gender-based violence prevention and treatment programs for general population","Primary gender-based violence prevention programs to protect vulnerable women and girls. Specifically, funding is requested to roll out the MenEngage Padere model in 25 districts (Note: Piloting of the SASA! model is prioritized in the matching funds request for AGYW).","(blank)",355668]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Male circumcision","Building on the targeted and tailored prevention packages for AGYW and key populations which have been prioritized for within allocation request, high impact prevention interventions for the general population also have the potential for significant impact. Prevention is a strong focus of this funding request. In line with Zimbabwe?s new Roadmap to Revitalise HIV Prevention in Zimbabwe (2016). Above allocation funding is requested to scale up of VMMC, prioritizing the 7 underserved districts not covered by PEPFAR (Inyanga, Chimanimani, Bikita, Rushinga, Uzumba-MarambaPfungwe, Kariba and Binga) prioritized first, scaling up to other underserved areas from there. Funding is requested both for VMMC commodities ($4,496,750.00) and programming ($1,202,027.72).Robust impact modelling in the country?s Accelerated Strategic and Operational Plan on VMMC shows that scaling up this activity will avert 212,000 HIV infections by 2025 and reduce prevalence by 3%. Achieving the target of circumcising 1.3 million men will result in more than $1 billion in financial savings.","(blank)",5698778]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Other intervention(s) for general population","Other prevention activities including program coordination, learning and support.","(blank)",939252]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Other intervention(s) for general population","Positive health dignity and prevention (PHDP) activities.","(blank)",10185]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for general population","Other intervention(s) for general population","Procure and provide targeted PrEP for populations at elevated risk, prioritizing PrEP for serodiscordant couples ($3,413,954.14) and scaling up through a phased approach.","(blank)",1495731]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for other vulnerable populations","Behavioral interventions as part of programs for general population","Supporting existing behavior change facilitators in 46 districts and extend their work to workplaces (including informal sector) to reach men with out of facility prevention, testing and linkage to care.","(blank)",858090]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","(blank)",142164]
[null,null,"HIV/AIDS, Tuberculosis","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","(blank)",276588]
[null,null,"HIV/AIDS, Tuberculosis","Program management","Grant management","PR (7%) and SR (3%) costs for implementation of the total PAAR request.","(blank)",27688]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations? and women?s networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","(blank)",850295]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations? and women?s networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","(blank)",8410509]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Financial management systems","Other financial management intervention(s)","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",3446640]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Financial management systems","Public financial management (PFM) strengthening","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",254910]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Financial management systems","Routine financial management improvement (non-PFM)","Additional scale up through extended outreach from fixed and mobile sites.","(blank)",929559]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Funding is requested to support an additional 267 data entry clerks for the ePMS and DHIS2 systems.","(blank)",1922400]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Support and maintenance for the ePMS, DHIS2 and plans for greater integration with HIV, TB and RMNCAH indicators, including improving patient-level tracking","(blank)",1328850]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Additional support for the performance-based retention scheme for facility-based staff in 1600 facilities.","(blank)",0]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).","(blank)",3132000]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Funding is requested for the delivery of quality integrated services across the continuum of care for HIV/TB/Malaria/SRH. Activities will include revision of the SRH/HIV Linkages Guidelines to include TB and malaria. Second, the requested investment will strengthen outreach as part of decentralized service delivery models. Activities will include establishing new cervical cancer screening and management centers and revise EPI service provision package to include HIV testing at 18 months. Closely linked with the above activities, funding is requested to boost differentiated care across the continuum of care, based on profiling by age and retention in care. This will include the development and implementation of service guidelines for linkages and referrals between health facilities, schools and community service delivery points to provide integrated HIV/TB/malaria/SRH (including family planning) services to adolescents. Lastly, funding is requested for activities to buttress the school health program (and catalyze impact from the proposed investments in HIV prevention among AGYW).","(blank)",1063192]
[null,null,"HIV/AIDS, Tuberculosis","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Additional PSM strengthening to scale up viral load monitoring, optimize the use of GeneXpert, strengthen LMIS and links it to patient monitoring, and ensure quality medicines and diagnostics.","(blank)",7312508]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Case detection and diagnosis","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","(blank)",374255]
[null,null,"HIV/AIDS, Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","(blank)",2438660]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","Collaborative activities with other programs and sectors (TB/HIV)","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.","(blank)",975000]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.","(blank)",1475266]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","TB/HIV collaborative interventions","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.","(blank)",106700]
[null,null,"HIV/AIDS, Tuberculosis","TB/HIV","TB/HIV collaborative interventions","Third, above allocation funding is requested to fill gaps in opportunistic infections medicines and related commodities including cotimoxisole, IPT, Ampotericin, kaposi sarcoma and gastric lavage.","(blank)",4897537]
[null,null,"HIV/AIDS, Tuberculosis","Treatment, care and support","Treatment monitoring - Viral load","Following test kits, filling gaps in viral load scale-up and other patient monitoring and quality of care gaps (CD4, EID, Haematology, etc.) is the second priority for the PAAR. Increasingly phasing out CD4 testing and scaling up viral load testing (to move to the maintenance phase of the VL scale up plan) is prioritized to ensure 90% of PLHIV who are on sustained ART are virally supressed by 2020.","(blank)",66987154]
[null,null,"HIV/AIDS, Tuberculosis Total",{"$nulls":4},155914443]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLINs will be distributed to at risk population where IRS is not implemented, targeting every sleeping space in prioritized wards with API <5/1000 population. The MSP requires mass campaign every three years to replace obsolete LLINs. The 2020 mass campaign aimed at replacing the LLINs distributed in 2017 projected to protect a population of 516053 persons living in highly endemic areas. This gap would leave a total of 7.2% of total population at risk without any intervention if not supported. This will lead to poor coverage and increase in areas with high local transmission.","2020-12-31",0]
[null,null,"Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The costs are for distribution of LLINs in 2020. This cost will include the orientation of distribution teams, management of the processes and administration of the activities including the related SBCC and M&E components. The LLINs cannot be distributed without this cost and hence a population of 860,464 persons (12% of total population at risk) living in highly endemic areas will remain without adequate protection from any vector control intervention.","2020-12-31",0]
[null,null,"Malaria Total",{"$nulls":4},0]
[null,"Grand Total",{"$nulls":5},2961723213.8500009]

{"sheet":"2017-19 UQD","index":3,"n_rows":2648,"n_cols":31,"rows_kept":1125,"cut":true,"hidden":true,"merged":[],"bounds":{"rows_first":500,"rows_last":125,"rows_between":500,"halvings":2}}
["Organization Name","PAAR Name","PAAR Intervention Name","Module Reference Id: Name ID","Module Reference Id: Name","Intervention Reference Id: Name ID","Intervention Reference Id: Name","Brief Rationale","TRP Approved","Requested Amount","Status","PAAR Intervention ID","UQD Funded Savings","UQD Funded PO","UQD Funded D2H PSC","UQD Funded Other","Remaining UQD","No Longer In Demand","Last Submitted Date Time","Applicant Priority Rating","Brief Rationale (Translated)","TRP Priority Rating","TRP Comment","Comment","Last Modified By: Full Name","Last Modified Date","Allocation Cycle Name","Components Name","Region","End_Date_Current","Component type"]
["CT Pakistan","Pakistan","PAI-6121","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Treatment services for general population in Sindh: Funding for ARVs, Management of Opportunistic infections, Provision of psychosocial  and nutritional support. Improving retention on ART through outreach support. Training of counsellors and health workers and case managers.",600000,600000,"Inactive","a6Q1R000000AJaa",null,600000,null,null,0,1,null,"High","Treatment services for general population in Sindh: Funding for ARVs, Management of Opportunistic infections, Provision of psychosocial  and nutritional support. Improving retention on ART through outreach support. Training of counsellors and health workers and case managers.","High",null,null,"Alana Sharp","2019-11-29","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Pakistan","Pakistan","PAI-6120","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Outreach and Community Based testing in Sindh Province. Outreach workers, Counsellors and Test kits and consummables.",200000,200000,"Inactive","a6Q1R000000AJaZ",null,200000,null,null,0,1,null,"High","Outreach and Community Based testing in Sindh Province. Outreach workers, Counsellors and Test kits and consummables.","High",null,null,"Alana Sharp","2019-11-29","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Pakistan","Pakistan","PAI-6119","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Surveillance system through sentinel sites in Sindh Province after the HIV outbreak (as recommended by WHO led investigation): \na. HIV screening in all TB centres\nb. Screening in all registered blood banks (public and private)\nc. Screening of all Ante Natal clinics attendee in all BHUs in Sindh (Done by PPHI).\nd. Screening in all PPTCT centres in Larkana and Ratodero, \ne.HIV screening in sentinel sites in Larkana (Urban setting) and Ratodero (Rural settings)\nf. support for routine reporting, improving reporting.",100000,100000,"Inactive","a6Q1R000000AJaY",null,100000,null,null,0,1,null,"High","Surveillance system through sentinel sites in Sindh Province after the HIV outbreak (as recommended by WHO led investigation): \na. HIV screening in all TB centres\nb. Screening in all registered blood banks (public and private)\nc. Screening of all Ante Natal clinics attendee in all BHUs in Sindh (Done by PPHI).\nd. Screening in all PPTCT centres in Larkana and Ratodero, \ne.HIV screening in sentinel sites in Larkana (Urban setting) and Ratodero (Rural settings)\nf. support for routine reporting, improving reporting.","High",null,null,"Alana Sharp","2019-11-29","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Uzbekistan","Uzbekistan","PAI-6136","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",2958638,2958638,"Active","a6Q1R000000AJdD",null,0,null,null,2958638,0,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2019-11-28","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-06-30","Tuberculosis"]
["CT Belarus","Belarus","PAI-6171","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. \nAs a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. \nIn line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD).\n MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.",986668,986668,"Active","a6Q1R000000AJiu",{"$nulls":4},986668,0,null,"High","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. \nAs a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. \nIn line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD).\n MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.","High","The TRP applauds the recipients efforts to reduce the costs of DTG and the cost-savings that this has resulted in, and urges the country to continue to work with GF and others to achieve the best price. Gaps in the treatment cascade, especially in the second 90 are still marked and the TRP requests that these additional resources be prioritized to closing that gap and enabling more PLWH to access ART.",null,"Alana Sharp","2019-11-25","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT Belarus","Belarus","PAI-6170","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.",556161.96,556161.96,"Active","a6Q1R000000AJit",{"$nulls":4},556161.96,0,null,"High","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.","High","Linkage-to care is a critical gap in the treatment cascade and therefore this activity is especially welcome. The TRP requests that active linkage to care and retention should be included int eh psychosocial support and the impact monitored. The TRP would also encourage the expansion of OST within this framework as this has been shown to assist with linkage and retention.",null,"Alana Sharp","2019-11-25","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT Belarus","Belarus","PAI-6169","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00551","Interventions for young people who inject drugs","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.\nIn Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".",98759.99,98759.99,"Active","a6Q1R000000AJis",{"$nulls":4},98759.99,0,null,"High","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.\nIn Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".","High","This activity is in line with the main allocation and provides additional prevention programming which is technically sound and strategically focussed",null,"Alana Sharp","2019-11-25","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT South Sudan","South Sudan","PAI-6166","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Cordaid shall support the Ministry of Health to improve MDR-TB and TB data management (eTBr, customize and install GenEX software)",20000,20000,"Active","a6Q1R000000AJgy",{"$nulls":4},20000,0,null,"High","Cordaid shall support the Ministry of Health to improve MDR-TB and TB data management (eTBr, customize and install GenEX software)","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6165","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Cordaid shall support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, intergrate TB services at new health facilities.",56993,56993,"Active","a6Q1R000000AJgx",{"$nulls":4},56993,0,null,"High","Cordaid shall support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, intergrate TB services at new health facilities.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6164","MCI-00023","Program management","MCI-00207","Grant management","This is to cover the costs of key technical project personnel under Cordaid who are required to continue providing technical backup to the project in 2020.  The two key staff will continue to provide supervision, oversight and mentoring to the local staff and to ensure smooth handing over to local authorities at project termination. These staff also undertake grant management functions related to the Sub-Recipient Agreement.",109822,109822,"Active","a6Q1R000000AJgw",{"$nulls":4},109822,0,null,"High","This is to cover the costs of key technical project personnel under Cordaid who are required to continue providing technical backup to the project in 2020.  The two key staff will continue to provide supervision, oversight and mentoring to the local staff and to ensure smooth handing over to local authorities at project termination. These staff also undertake grant management functions related to the Sub-Recipient Agreement.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6163","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Given the challenges of limited government support to the health sector, there is a risk of service interruption if additional funding is not provided. There is a need to maintain essential clinical and laboratory staff at selected facilties.  With additional funding, Cordaid will continue to support direct service delivery for key TB diagnostic and treatment services and its presence is critical especially is high volume facilities such as these facilities such Munuki PHCC, Torit State  Hospital, Nyong PHCC, Hiyala PHCC, Hileu PHCC, Lowoi PHCC, Chukudum Hospital,  Nimule Hospital ,  Bentiu state Hospital,  Kapoeta Mission Hospital, Kapoeta State Hospital, Mary Help Hospital, Tharkueng PHCC, Achong Chong PHCC and Marial Bai PHCC.  These facilities are mostly in localities where Cordaid has presence with other health projects ongoing.  This is so because it will help cut down on running costs by cost-sharing with other projects. Under this budget line, Cordaid shall also support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, and intergrate TB services at new health facilities.",209003,209003,"Active","a6Q1R000000AJgv",{"$nulls":4},209003,0,null,"High","Given the challenges of limited government support to the health sector, there is a risk of service interruption if additional funding is not provided. There is a need to maintain essential clinical and laboratory staff at selected facilties.  With additional funding, Cordaid will continue to support direct service delivery for key TB diagnostic and treatment services and its presence is critical especially is high volume facilities such as these facilities such Munuki PHCC, Torit State  Hospital, Nyong PHCC, Hiyala PHCC, Hileu PHCC, Lowoi PHCC, Chukudum Hospital,  Nimule Hospital ,  Bentiu state Hospital,  Kapoeta Mission Hospital, Kapoeta State Hospital, Mary Help Hospital, Tharkueng PHCC, Achong Chong PHCC and Marial Bai PHCC.  These facilities are mostly in localities where Cordaid has presence with other health projects ongoing.  This is so because it will help cut down on running costs by cost-sharing with other projects. Under this budget line, Cordaid shall also support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, and intergrate TB services at new health facilities.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6162","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","Community TB care delivery continues to be an important intervention.  Cordaid works closely with the Home Health Promoters (HHPs) to conduct outreach activities, including contact tracing, treatment support and community sensitisation.  These resources will go towards continuing support for incentives for HHPs. This budget line is increased to support the intergration of TB services to more health facilities.",21812,21812,"Active","a6Q1R000000AJgu",{"$nulls":4},21812,0,null,"High","Community TB care delivery continues to be an important intervention.  Cordaid works closely with the Home Health Promoters (HHPs) to conduct outreach activities, including contact tracing, treatment support and community sensitisation.  These resources will go towards continuing support for incentives for HHPs. This budget line is increased to support the intergration of TB services to more health facilities.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6161","MCI-00023","Program management","MCI-00207","Grant management","General Management Service (GMS) Fee for UNDP",212469,212469,"Active","a6Q1R000000AJgt",{"$nulls":4},212469,0,null,"High","General Management Service (GMS) Fee for UNDP","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6160","MCI-00008","TB care and prevention","MCI-00127","Treatment","This is to cater for the PSM-related costs for the drugs, laboratory reagents and other supplies for FY2020.   These costs include:  \n? Procurement agent and handling fees\n? Freight and insurance costs \n? Warehouse Storage Costs, i.e. insurance for commodities\n? In-country distribution costs\n? Quality assurance and quality control costs (QA/QC)\n? PSM Customs clearance, i.e. clearance agent fees; Drug and Food Control Authority Fees",438674,438674,"Active","a6Q1R000000AJgs",{"$nulls":4},438674,0,null,"High","This is to cater for the PSM-related costs for the drugs, laboratory reagents and other supplies for FY2020.   These costs include:  \n? Procurement agent and handling fees\n? Freight and insurance costs \n? Warehouse Storage Costs, i.e. insurance for commodities\n? In-country distribution costs\n? Quality assurance and quality control costs (QA/QC)\n? PSM Customs clearance, i.e. clearance agent fees; Drug and Food Control Authority Fees","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6159","MCI-00008","TB care and prevention","MCI-00127","Treatment","With the operationalisation of the Wau Warehouse ? starting January 2020, health commodities for the selected states will be prepositioned in this location thereby greatly reducing the delivery timeliness of health commodities to facilities and overall enhancing the supply chain management support to this region.  In addition, procured commodities meant for this region will in due course be delivered directly to the Wau Regional Warehouse thereby reducing the distribution costs currently being incurred from Juba.  Following the integration of the malaria commodities HIV and TB grant health commodities under the Juba Riverside Warehouse, this integration will also be decentralized to the Wau Regional Warehouse.  Going forward, it is expected that there will be a gradual integration of other health commodities by being procured by other partners.",422163,422163,"Active","a6Q1R000000AJgr",{"$nulls":4},422163,0,null,"High","With the operationalisation of the Wau Warehouse ? starting January 2020, health commodities for the selected states will be prepositioned in this location thereby greatly reducing the delivery timeliness of health commodities to facilities and overall enhancing the supply chain management support to this region.  In addition, procured commodities meant for this region will in due course be delivered directly to the Wau Regional Warehouse thereby reducing the distribution costs currently being incurred from Juba.  Following the integration of the malaria commodities HIV and TB grant health commodities under the Juba Riverside Warehouse, this integration will also be decentralized to the Wau Regional Warehouse.  Going forward, it is expected that there will be a gradual integration of other health commodities by being procured by other partners.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6158","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","In order to strengthen the capacity of the National TB Program in PMDT, it is important that central-level staff who are charged with the responsibility of providing oversight, supervision and mentorship are adequately trained.  As the country is currently scaling up the implementation and coverage of MDR TB services, this training is critical. 3 staff will be undergo international training in PMDT at a cost of USD22,820.00.  As this intervention is already approved, the country has updated the intervention highlighting the training in PMDT as a priority.",22820,22820,"Active","a6Q1R000000AJgq",{"$nulls":4},22820,0,null,"High","In order to strengthen the capacity of the National TB Program in PMDT, it is important that central-level staff who are charged with the responsibility of providing oversight, supervision and mentorship are adequately trained.  As the country is currently scaling up the implementation and coverage of MDR TB services, this training is critical. 3 staff will be undergo international training in PMDT at a cost of USD22,820.00.  As this intervention is already approved, the country has updated the intervention highlighting the training in PMDT as a priority.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6157","MCI-00010","MDR-TB","MCI-00143","Engaging all care providers (MDR-TB)","In order to optimize the utilization of GeneXpert platforms, improve diagnostic access for TB and undertake patient monitoring; quarterly focused supervisory and mentorship site level visits will be undertaken by team composed of 1 clinician, 1 laboratory staff and 1 State TB/HIV Coordinator.  These field visits will also include the orientation of staff in the recently developed PMDT guidelines and DR Recording and Reporting tools and strengthening prompt linkage to treatment for all detected cases. PMDT job aids have also been developed.",30464,30464,"Active","a6Q1R000000AJgp",{"$nulls":4},30464,0,null,"High","In order to optimize the utilization of GeneXpert platforms, improve diagnostic access for TB and undertake patient monitoring; quarterly focused supervisory and mentorship site level visits will be undertaken by team composed of 1 clinician, 1 laboratory staff and 1 State TB/HIV Coordinator.  These field visits will also include the orientation of staff in the recently developed PMDT guidelines and DR Recording and Reporting tools and strengthening prompt linkage to treatment for all detected cases. PMDT job aids have also been developed.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6156","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","The number of MDR-TB cases being diagnosed is currently below the set target.  Currently, there are 17 GeneXpert MTB/RIF machines deployed at 16 sites across the country - 10 of these machines were procured using Global Fund resources.  The rollout of this GeneXpert MTB/RIF test highlights the existing need for strong testing site networks, good infrastructure, robust quality assurance systems and uninterrupted supplies. With the projected number of 220 MDR cases to be notified in 2020, there is need to procure adequate cartridges ($252,160), LPA and liquid culture reagents, and other laboratory supplies and consumables valued at ($194,688).  To ensure optimal functionality of these machines, it is necessary that a maintenance and technical support contract with the Cephied is in place to cover the year 2020.  This contract is valued at $38,776. In additional $6,679 will be used to cover the travel, lodging and facilitation feed of the Cepheid certified trainer and in-country training expenses for participants.  An additional 7 super users will be trained to support the roll-out and in-country trouble shooting of the GeneXpert platforms across the country for accurate and timely diagnosis.  This covers the cost of the trainer, A total of 10 super users were trained in May 2019.   A separate maintenance contract for the maintenance of other equipment such as the BD BACTEC MGIT 960 System, LPA machine, medical refrigerators is being also being finalized at a cost of $37,930.",531171,531171,"Active","a6Q1R000000AJgo",{"$nulls":4},531171,0,null,"High","The number of MDR-TB cases being diagnosed is currently below the set target.  Currently, there are 17 GeneXpert MTB/RIF machines deployed at 16 sites across the country - 10 of these machines were procured using Global Fund resources.  The rollout of this GeneXpert MTB/RIF test highlights the existing need for strong testing site networks, good infrastructure, robust quality assurance systems and uninterrupted supplies. With the projected number of 220 MDR cases to be notified in 2020, there is need to procure adequate cartridges ($252,160), LPA and liquid culture reagents, and other laboratory supplies and consumables valued at ($194,688).  To ensure optimal functionality of these machines, it is necessary that a maintenance and technical support contract with the Cephied is in place to cover the year 2020.  This contract is valued at $38,776. In additional $6,679 will be used to cover the travel, lodging and facilitation feed of the Cepheid certified trainer and in-country training expenses for participants.  An additional 7 super users will be trained to support the roll-out and in-country trouble shooting of the GeneXpert platforms across the country for accurate and timely diagnosis.  This covers the cost of the trainer, A total of 10 super users were trained in May 2019.   A separate maintenance contract for the maintenance of other equipment such as the BD BACTEC MGIT 960 System, LPA machine, medical refrigerators is being also being finalized at a cost of $37,930.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6155","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","The updated forecasting and quantification of Second Line Anti-TB drugs (SLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments of 220 for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnership?s Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the requires resources for SLD up to the end of the grant with 6 months buffer is USD122,794.  \nThe National TB Program at central level now has on board the Inspector for Management of Multi-Drug Resistant TB who is mandated to provide oversight, monitoring and support to the implementation of the PMDT program. With this newly created position, it is expected that the proposed critical intensive case detection and treatment activities being proposed for support under this application will improve case notification and linkage to treatment.",122794,122794,"Active","a6Q1R000000AJgn",{"$nulls":4},122794,0,null,"High","The updated forecasting and quantification of Second Line Anti-TB drugs (SLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments of 220 for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnership?s Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the requires resources for SLD up to the end of the grant with 6 months buffer is USD122,794.  \nThe National TB Program at central level now has on board the Inspector for Management of Multi-Drug Resistant TB who is mandated to provide oversight, monitoring and support to the implementation of the PMDT program. With this newly created position, it is expected that the proposed critical intensive case detection and treatment activities being proposed for support under this application will improve case notification and linkage to treatment.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-6154","MCI-00008","TB care and prevention","MCI-00127","Treatment","The updated forecasting and quantification of First Line Anti-TB drugs (FLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnership?s Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the budget required the FLD is USD1,049,562 to cover the treatment needs up to the end of 2020.  By the end of 2018, a total of 14,362 cases were notified against a set target of 12,678. Similarly, an increasing trend was reported as at June 2019 - 8,566 cases notified which is above the set target of 6,973 by 23%. It is projected that by the end of 2020, the number of notified cases will increase to 20,832.",1049562,1049562,"Active","a6Q1R000000AJgm",{"$nulls":4},1049562,0,null,"Low","The updated forecasting and quantification of First Line Anti-TB drugs (FLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnership?s Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the budget required the FLD is USD1,049,562 to cover the treatment needs up to the end of 2020.  By the end of 2018, a total of 14,362 cases were notified against a set target of 12,678. Similarly, an increasing trend was reported as at June 2019 - 8,566 cases notified which is above the set target of 6,973 by 23%. It is projected that by the end of 2020, the number of notified cases will increase to 20,832.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT Mongolia","Mongolia","PAI-6201","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","MDR-TB Regimen change",350000,350000,"Inactive","a6Q1R000000AJph",null,350000,null,null,0,1,null,"High","MDR-TB Regimen change","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis"," South East Asia","2020-12-31","Tuberculosis"]
["CT Turkmenistan","Turkmenistan","PAI-6203","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Increase of funding needs for XDR-TB due to WHO recommendation to increase treatment with Bedaquilin/Delamanit to 12-18m instead of 6m, this amount is expected to cover 2020-2021 needs. This comes in addition to previously approved Portfolio Optimization Amount. Module: MDR-TB; Intervention: Treatment",1460500,1460500,"Inactive","a6Q1R000000AJpr",null,1460500,null,null,0,1,null,"High","Increase of funding needs for XDR-TB due to WHO recommendation to increase treatment with Bedaquilin/Delamanit to 12-18m instead of 6m, this amount is expected to cover 2020-2021 needs. This comes in addition to previously approved Portfolio Optimization Amount. Module: MDR-TB; Intervention: Treatment","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-06-30","Tuberculosis"]
["CT Mongolia","Mongolia","PAI-6198","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.",832198,832198,"Inactive","a6Q1R000000AJpS",null,832198,null,null,0,1,null,"High","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis"," South East Asia","2020-12-31","Tuberculosis"]
["CT Thailand","Thailand","PAI-6202","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","MDR-TB regimen change",500000,500000,"Inactive","a6Q1R000000AJpm",null,500000,null,null,0,1,null,"High","MDR-TB regimen change","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-6200","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",3020000,3020000,"Inactive","a6Q1R000000AJpc",null,3020000,null,null,0,1,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","Tuberculosis"]
["CT Belarus","Belarus","PAI-6199","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO",3400000,3400000,"Inactive","a6Q1R000000AJpX",null,3400000,null,null,0,1,null,"High","Regimen Change: introduction of new treatment regimen approved by WHO","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-12-31","Tuberculosis"]
["CT Nepal","Nepal","PAI-6209","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","As described above, the following prioritized interventions of US$ 2,150,000 are requested to strenghten TB case detection and diagnosis and address existing gaps: \n i) the expansion of GenXperts and sputum transportation to expand access to rapid diagnosis (US$950,000); ii) strengthening two regional laboratories to make them fully operational and efficient to strengthen case detection and expand TB diagnosis also at the regional level (US$800,000); iii) strengthening drug susceptibility testing (DST) at the regional level to scale-up MDR-TB diagnosis (US$200,000), and; iv) supporting the development of a structured quality improvement program based on SLMTA model designed for resource limited settings (US$200,000).  \nSustainability of activities: these activities represent a 12-month investment of predominantly products to be procured to strengthen the existing laboratory system.\nExpected outcomes: increased case notification by 25% as compared to current achievement resulting in 8,000 additional TB cases notified and linked to treatment by the end of the grant; expanded access to early TB diagnosis; improved treatment monitoring and outcomes for DR-TB; strengthened laboratory system at the regional level to deliver timely TB diagnostic services, and; a SLMTA program design and costed implementation plan in place as well as the training of a core quality management team.  \n\nPF Indicator: \nTCP-1 (M): Number of notified cases of all forms of TB-(i.e. bacteriologically confirmed + clinically diagnosed), includes new and relapse cases\nTargets will be revised upwards for 2020. Revised target for 2020: 40,451.",2150000,2150000,"Inactive","a6Q1R000000AJsb",null,2150000,null,null,0,1,null,"High","As described above, the following prioritized interventions of US$ 2,150,000 are requested to strenghten TB case detection and diagnosis and address existing gaps: \n i) the expansion of GenXperts and sputum transportation to expand access to rapid diagnosis (US$950,000); ii) strengthening two regional laboratories to make them fully operational and efficient to strengthen case detection and expand TB diagnosis also at the regional level (US$800,000); iii) strengthening drug susceptibility testing (DST) at the regional level to scale-up MDR-TB diagnosis (US$200,000), and; iv) supporting the development of a structured quality improvement program based on SLMTA model designed for resource limited settings (US$200,000).  \nSustainability of activities: these activities represent a 12-month investment of predominantly products to be procured to strengthen the existing laboratory system.\nExpected outcomes: increased case notification by 25% as compared to current achievement resulting in 8,000 additional TB cases notified and linked to treatment by the end of the grant; expanded access to early TB diagnosis; improved treatment monitoring and outcomes for DR-TB; strengthened laboratory system at the regional level to deliver timely TB diagnostic services, and; a SLMTA program design and costed implementation plan in place as well as the training of a core quality management team.  \n\nPF Indicator: \nTCP-1 (M): Number of notified cases of all forms of TB-(i.e. bacteriologically confirmed + clinically diagnosed), includes new and relapse cases\nTargets will be revised upwards for 2020. Revised target for 2020: 40,451.","High","The PAAR is strategically sound and scientifically based to support increased access to diagnostic testing, based on the recent surveillance survey identifying a larger gap in undiagnosed cases than previously predicted.",null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis"," South East Asia","2021-03-15","Tuberculosis"]
["CT Papua New Guinea","Papua New Guinea","PAI-6210","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","Switch the cohort of 29,420 PHIV on ART to DTG based regiment to respond to very high ART drug resistance and replenish the ART buffer stock back to the required minimum of 12 months to ensure the linkage between the currently supported prevention activities and treatment and care. No change in the targets for the treatment indicator.",2975000,2975000,"Active","a6Q1R000000AJsg",null,2919868,null,null,55132,0,null,"High","Switch the cohort of 29,420 PHIV on ART to DTG based regiment to respond to very high ART drug resistance and replenish the ART buffer stock back to the required minimum of 12 months to ensure the linkage between the currently supported prevention activities and treatment and care. No change in the targets for the treatment indicator.","High","This funding request is critical to procure needed drugs and buffer stocks to prevent ART resistance and to align the PNG to the current ART recommendations. The rationale and description indicate that this is a much needed expenditure within the context of on-going technical and programmatic support provided by the Global Fund, WHO and other partners, and it is therefore approved by the TRP",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis"," South East Asia","2020-12-31","TB/HIV"]
["CT Nepal","Nepal","PAI-6208","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","National Malaria Program needs to strengthen activities to eliminate malaria and address malaria outbreaks in 2018-2019 in areas originally classified ?malaria-free?. Additional funding is therefore needed to support LLINs where due to decentralization, Government funding for LLINs for continuous distribution for 2020 has not been realized.\nOutcome: coverage with LLINs of vulnerable and in-risk populations, approximately 180,000 persons will be covered with LLINs.\n\nNo increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.",320000,320000,"Inactive","a6Q1R000000AJsX",null,320000,null,null,0,1,null,"High","National Malaria Program needs to strengthen activities to eliminate malaria and address malaria outbreaks in 2018-2019 in areas originally classified ?malaria-free?. Additional funding is therefore needed to support LLINs where due to decentralization, Government funding for LLINs for continuous distribution for 2020 has not been realized.\nOutcome: coverage with LLINs of vulnerable and in-risk populations, approximately 180,000 persons will be covered with LLINs.\n\nNo increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.","High","This intervention is appropriate for the endemic situation in country and for control of the epidemic through a dual net distribution scheme. The vulnerable groups are identified and the distribution method are adequate. The TRP approves this intervention and recommends on-going monitoring of factors  which could influence the epidemic such as climate or seasonal migration to ensure that the continuous distribution to target groups is conducted at appropriate times.",null,"Alana Sharp","2020-01-14","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-6207","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","National Malaria Program needs to strengthen activities to eliminate malaria including rolling out a community-based response. Additional funding is therefore needed to support  a critical gap in RDTs for the roll-out of community-based testing of in-risk and vulnerable populations. \nOutcome: strengthened case management at the community level; approximately 88,000 persons will be tested for malaria at the community level.\n\nNo increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.",88000,88000,"Inactive","a6Q1R000000AJsW",null,88000,null,null,0,1,null,"High","National Malaria Program needs to strengthen activities to eliminate malaria including rolling out a community-based response. Additional funding is therefore needed to support  a critical gap in RDTs for the roll-out of community-based testing of in-risk and vulnerable populations. \nOutcome: strengthened case management at the community level; approximately 88,000 persons will be tested for malaria at the community level.\n\nNo increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.","High","A community intervention to control malaria is very important in a country such as Nepal where health centers are remote and difficult to access. Rolling out a community based response is a productive way to control malaria in hard to reach communities where malaria risk is still present; therefore the TRP approves this intervention.",null,"Alana Sharp","2020-01-27","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-6206","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","Prevention services for prisoners with linkages to testing & treatment. \nThis is a high risk group and no prevention services are currently provided to them. \nAs mentioned above, in order to ensure meaningful scale-up of coverage with comprehensive HIV prevention services for this population, additional funding is requested by the country. \nExpected outcome: coverage of 14,000 with HIV prevention services and linkages of HIV+ prisoners to treatment and care.\n\nKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 14,000\nKP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 11,200",100000,100000,"Inactive","a6Q1R000000AJsS",null,100000,null,null,0,1,null,"High","Prevention services for prisoners with linkages to testing & treatment. \nThis is a high risk group and no prevention services are currently provided to them. \nAs mentioned above, in order to ensure meaningful scale-up of coverage with comprehensive HIV prevention services for this population, additional funding is requested by the country. \nExpected outcome: coverage of 14,000 with HIV prevention services and linkages of HIV+ prisoners to treatment and care.\n\nKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 14,000\nKP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 11,200","High","While approving this intervention, the TRP considers that prevention services for prisoners are very high priority. According to the funding request, out of 14,000 prisoners, 11,200 will be tested, indicating one-time testing rather than ongoing access (taking into account prisoner turnover). The TRP suggests that, should any efficiencies be identified in the the migrants' intervention (row above), funds should be re-programmed to expand the prisoners intervention, to increase number of tests and improve ongoing access to testing and services to ensure linkage to treatment.",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Nepal","Nepal","PAI-6205","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","Differentiated service package for migrants with linkages to testing & treatment. \nThis key population is the driver of new HIV infections, however, currently not covered with HIV prevention services. \nAs mentioned above, in order to ensure meaning scale-up of coverage with comprehensive HIV prevention services for this population  and roll-out of the differentiated service package from 2020, additional funding is requested by the country. \nExpected outcome: coverage of 100,000 migrants with HIV prevention services and linkages of HIV+ migrants to treatment and care. \n\nMigrants\nKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 100,000\nKP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 80,000",860000,860000,"Inactive","a6Q1R000000AJsR",null,860000,null,null,0,1,null,"High","Differentiated service package for migrants with linkages to testing & treatment. \nThis key population is the driver of new HIV infections, however, currently not covered with HIV prevention services. \nAs mentioned above, in order to ensure meaning scale-up of coverage with comprehensive HIV prevention services for this population  and roll-out of the differentiated service package from 2020, additional funding is requested by the country. \nExpected outcome: coverage of 100,000 migrants with HIV prevention services and linkages of HIV+ migrants to treatment and care. \n\nMigrants\nKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 100,000\nKP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 80,000","High","The TRP considers prevention services for Migrants as high priority as migration is a key driver of new HIV infections in Nepal. However, few HIV services have been tailored to migrants. Therefore, it's  important to ensure coverage for this population.",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Lesotho","Lesotho","PAI-6204","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery",null,9212649,9212649,"Active","a6Q1R000000AJs2",null,8544633,null,null,668016,0,null,"High","The Ministry of Health conducted quantifications for health products in order to inform the government 2019/2020 finacial year budget for health products. From the quantification, it was determined that the national need for ARVs would need LSL 444,172,844.54 (approximately US$ 32 million). It was already known that the Global Fund contribution for ARVs for the 2019/2020 financial year is LSL 68,536,085.87. Due to fiscus challenges, the Ministry of Health was only allocated LSL 236,775,819 for the ARVs and this led to a funding gap of LSL 138,860,939.67. Efforts were made by both the Ministry of Health and Ministry of Finance to mobilise the funds but the resource mobilisation did not yield positive results. \nIt is against this background that the country is requesting support from the Global Fund towards procurement of ARVs in order to close the eminent funding gap. \nThe funds that are being sought will go a long way in ensuring that there is availability of commodities (ARVs) so tht there is continuity of treatment for People Living with HIV. The ARVs to be procured with the funds being sought will take ARV stock holding to December 2020 and this will give the Government of Lesotho ample time to mobilise adequate resources to ensure there will not be any shortages going forward.","High","The TRP supports the additional request for ARVs, given that the programme?s shift in strategic approaches with an increased focus on test and start towards the targets of 95/95/95 have led to an increased in expected need for ARVs.",null,"Alana Sharp","2020-01-17","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2021-06-30","HIV/AIDS"]
["CT Ghana","Ghana","PAI-6178","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","The funds are required to ensure continued VC coverage by procuring LLIN for the 2021 Q1 mass distribution campaign. The funds for the 2021 campaign were not included in the current grant. The bed nets used for the 2018 mass distribution campaign where procured in 2017 with NFM1 grant budget.",23000000,23000000,"Active","a6Q1R000000AJjU",{"$nulls":4},23000000,0,null,"High","The funds are required to ensure continued VC coverage by procuring LLIN for the 2021 Q1 mass distribution campaign. The funds for the 2021 campaign were not included in the current grant. The bed nets used for the 2018 mass distribution campaign where procured in 2017 with NFM1 grant budget.","High","The TRP recommends that only pre-qualified nets be considered, and that the optimization exercise is informed by entomological information on the type, intensity and geographic spread of pyrethroid resistance, durability as well as unit costs. In addition, the TRP recommends that the Secretariat ensures that, by the time the intervention is incorporated into the grant, data on entomological stratification support the use of PBOs and new nets in appropriate locations.",null,"Alana Sharp","2019-11-26","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Philippines","Philippines","PAI-6177","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","The current allocation is mostly focused on prevention but the GF investment to the treatment is minimal due to limited allocation. The grant has a high absorption as 92% and has limited savings for reprogramming to support treatment related activities. The Philippines is prepared to fast track the  transition to TLD regimen from 2020, under the strong encouragement from the partners and request from the communities. The Government funding covers ARV and VL but faces gaps for 2020 for transition to new TLD regimen. The CCM would like to request the Global Fund to fund this fast-tracked transition. This additional funding will support the transition of 13,000 patients to TLD regimen in Philippines and cover up to 40,000 VL tests. This will bridge the gap in 2020 so the  Government could plan the budget for procurement for TLD from 2021 onwards. This investment will also be supported by the TA provided by PEPFAR project to start from 2020, to assist the national program in developing the new treatment guideline, fast tracking the FDA registration and training of facilities to adopt the new treatment guidelines.",2500000,2500000,"Inactive","a6Q1R000000AJjF",null,2500000,null,null,0,1,null,null,"This additional investment will help transitioning 13,000 patients to TLD regimen","High","The PAAR request is aligned with and complements the within-allocation program, and increases the overall contribution of funding support to maximize impact in the fight against HIV in Philippines. The request is strategically focused and technically sound, aiming to scale up an optimized antiretroviral treatment regimen in accordance with WHO recommendations. The TRP recommends the country continue working on strengthening the HIV cascade specially focusing on linkage to care as recommended in the TRP form dated 2 May 2017.",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Philippines","Philippines","PAI-6125","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","This amount is needed in order to allow the roll-out of the new MDR-TB treatment regimen from Q2 2019 for a target of 10,000 patients (42% of new enrollment taking long oral regimen, 45% taking on the modified shorter regimen (replacing KM with AM), and the remaining 13% of patients to be enrolled in an OR with a modified shorter regimen with BDQ, which is already registered in country). The transition has been carefully planned in consultation with national stakeholders and with the support from partners.Regimen Change: introduction of new treatment \nregimen approved by WHO",20000000,20000000,"Inactive","a6Q1R000000AJcK",null,20000000,null,null,0,1,null,"High","This amount is needed in order to allow the roll-out of the new MDR-TB treatment regimen from Q2 2019 for a target of 10,000 patients (42% of new enrollment taking long oral regimen, 45% taking on the modified shorter regimen (replacing KM with AM), and the remaining 13% of patients to be enrolled in an OR with a modified shorter regimen with BDQ, which is already registered in country). The transition has been carefully planned in consultation with national stakeholders and with the support from partners.Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Tajikistan","Tajikistan","PAI-6219","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Request for additional funding for PreP. Rationale: PEPFAR is in the process of initiating a work with in country stakeholders in understanding programing of innovative prevention strategies, namely Pre Exposure Prophylaxes (PrEP) among MSM and developing an engagement strategy for the design and roll-out of the pilot programme. According to the new estimates, in order to offer the pre-exposure prophylaxis to key population, there is a need of USD 173K as opposed to the originally planned USD 100K.",73561,73561,"Inactive","a6Q1R000000AK0B",null,73561,null,null,0,1,null,"High",null,"High",null,null,"Alana Sharp","2020-01-29","2017-2019","HIV/AIDS, RSSH"," Eastern Europe and Central Asia",null,"Multi-component"]
["CT Burundi","Burundi","PAI-6217","MCI-00012","Case management","MCI-00154","Facility-based treatment","Les bases de quantification nationale des intrants antipaludiques pour la période 2020-2021 au Burundi tiennent compte de l'évolution des cas sur 5 ans (2017-2021). La demande soumise pour le financement au-delà prend en compte la période 2020 et 6 mois de stock de sécurité correspondant à la période de transition entre 2 subventions. En plus, l'Arthemether-Luméfantrine étant une nouvelle molécule, la reconstitution des stocks à tous les niveaux de la pyramide sanitaire est indispensable. Les données épidémiologiques de la période en cours corroborent les besoins exprimés (voir Fichier de quantification sénario moyen). Les engagements déjà reçus des partenaires restent ceux inventoriés : Allocation du FM pour l'année 2020, la contribution de PMI et celle du gouvernement. L'analyse des gaps en intrants nous conduit à la demande de financement au-delà . Une fois que la demandée soumise est approuvée, les intrants de prise en charge seront disponibles dans toutes les formations sanitaires à la satisfaction des malades. Nous anticipons en disant que les épisodes de paludisme seront réduits au sein de la communauté, par conséquent réduction de la morbidité liée au paludisme.",5328486,5328486,"Inactive","a6Q1R000000AK01",28486,5300000,null,null,0,1,null,"High","National quantification of antimalarial drugs for the period 2020-2021 takes into account the evolution of cases over 5 years (2017-2021). The request submitted for this above allocation funds takes into account the 2020 period and 6 months of security stock corresponding to the transition period between two allocations. In addition, since Arthemether-Lumefantrine is a new molecule, stocks rebuilding at all levels of the health pyramid is essential. Epidemiological data for the current period corroborate the expressed needs (see Quantification File - average scenario). The commitments already received from partners remain those inventoried: Global Fund, PMI and government contributions. The gap analysis related to antimalarians drugs leads us to this demand for funds above allocation. Once the submitted application is approved, the treatment inputs will be available in all facilities to the benefit of patients. We anticipate that new cases of malaria will be reduced within the community, thus reducing the morbidity associated with malaria.","High","o The request is justified as a bridge between two allocation periods, to build appropriate stock of the newly introduced drug in all facilities, and (by the CT) as a critical measure to cope with current upsurge of malaria in the country. \no The quantification provided appears technically sound. It takes into account epidemiological data, projected according to the expected evolution, choosing a medium scenario. \no The request for funding takes into account the resources allocated by other funding parties including the government (mostly zero for this need).   \no The absorption rate of external resources ? as communicated by the CT ? is acceptable, at 69%, and for expected to reach 98%.  \no Assets and capacities for drug storage, management, distribution and data are provided through the already approved PAAR, implementation currently ongoing: upgrade of drug stores, LMIS, vehicles for drug transport. The allocation and approved PAAR also cover vector control activities, presumably appropriate to cope with current malaria upsurge.",null,"Alana Sharp","2020-01-14","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Tajikistan","Tajikistan","PAI-6218","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Intervention planned to strengthen control of nosocomial infection, strengthening lab capacity, and human resources, assess and improve infection control measures, assess and improve QA and QC of the center of blood safety, health facilities providing blood transfusions, waste management. Establishing greater integration and improve linkage to HIV services, Integrate and offer HIV tests in all levels of the national health care system. Different modalities including Facility based HIV testing, Community based testing.",1626520,1626520,"Inactive","a6Q1R000000AK06",null,1626520,null,null,0,1,null,"High",null,"Medium","The TRP notes that some elements included in the request are considered as high priority ( trainings for CHW, development of ME tools, evaluation of QA and QC of center for blood safety and health facilities). The TRP rates this request overall as medium priority based on the limited information available with regards to numberous items such as justification on the proposed location of EIA lab facilities and , justification for creation and use of software (ie development of an EMR software vs exploring opportunities to use a commercialised version), overall IT support, etc. Additionally, the TRP considers that some elements (purchase of cars and renovation of warehouse) should be of a low priority and can potentially be funded from domestic sources. In addition, the TRP considers the request for funds to establish and further enhance systems for medical waste disposal & management a priority, ensuring (future) compliance with international environmental health standards.\n\nThe TRP would like to note the following recommendations, should the funding become available:\n1) The TRP recommends that the applicant review the practice of pediatric blood transfusions to ensure practices are conforming to the WHO guidelines and standards as well as revise practices that deviate from the WHO guidelines. 2) The implementation of the proposed system strengthening through expansion of access to testing and enhanced blood safety to the existing district and city health polyclinics would require close monitoring. The TRP recommends build-in regular monitoring with plans for system improvement. 3) The request for funds to improve medical waste disposal & management is a priority.",null,"Alana Sharp","2020-01-21","2017-2019","HIV/AIDS, RSSH"," Eastern Europe and Central Asia",null,"Multi-component"]
["CT Viet Nam","Viet Nam","PAI-6137","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1500000,1500000,"Inactive","a6Q1R000000AJdI",null,1500000,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-28","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Belarus","Belarus","PAI-6122","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1150000,1150000,"Inactive","a6Q1R000000AJc5",0,1149999.92,0,0,0.08,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-12-31","Tuberculosis"]
["CT Thailand","Thailand","PAI-5779","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","DDC BL 291:Purchasing of IGRA supply for LTBI diagnosis in children.Objective:  above allocation-To support LTBI diagnosis in children especially in contact tracing-To prevent tuberculosis in children.How: Purchasing of IGRA supply for LTBI diagnosis in children by NTRLTarget:  to cover 90% of close contact (children)Frequency: 1 time per year.",1089674,null,"Inactive","a6Q1R000000AJUf",0,1089674,0,0,0,1,null,null,"DDC BL 291:Purchasing of IGRA supply for LTBI diagnosis in children.Objective:  above allocation-To support LTBI diagnosis in children especially in contact tracing-To prevent tuberculosis in children.How: Purchasing of IGRA supply for LTBI diagnosis in children by NTRLTarget:  to cover 90% of close contact (children)Frequency: 1 time per year.","Medium","This activity supports purchasing IGRAs to screen 90% of close contacts (children) for LTBI during contact investigations, to prevent active TB among children",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Madagascar","Madagascar","PAI-5074","MCI-00011","Vector control","MCI-00152","Entomological monitoring","It has been noted that between 2013 and 2016, the amount of endophagic vectors became increasingly lower. This could lead to a major change in the use of indoor residual spraying campaigns (IRSCs) in certain areas. Changes of times at which mosquitoes bite have also been observed, with the insects becoming aggressive increasingly earlier. This amount will be used to continue the surveillance program.",180529,null,"Inactive","a6Q1R000000AJJI",180529,0,0,0,0,1,null,null,"It has been noted that between 2013 and 2016, the amount of endophagic vectors became increasingly lower. This could lead to a major change in the use of indoor residual spraying campaigns (IRSCs) in certain areas. Changes of times at which mosquitoes bite have also been observed, with the insects becoming aggressive increasingly earlier. This amount will be used to continue the surveillance program.","Medium",null,null,"Alana Sharp","2020-01-14","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Madagascar","Madagascar","PAI-5073","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conducting national surveys on malaria indicators will be essential for measuring progress toward achieving the objectives and expected outcomes of implementation. A survey on malaria indicators in Madagascar (MIS) will therefore be scheduled every three years, to reorient the program based on the outcomes achieved. Part of the funding for this survey is requested from the above allocation amount, with the remainder funded by PMI.",836000,null,"Inactive","a6Q1R000000AJJH",0,0,0,836000,0,1,null,null,"Conducting national surveys on malaria indicators will be essential for measuring progress toward achieving the objectives and expected outcomes of implementation. A survey on malaria indicators in Madagascar (MIS) will therefore be scheduled every three years, to reorient the program based on the outcomes achieved. Part of the funding for this survey is requested from the above allocation amount, with the remainder funded by PMI.","High","Malaria surveys, particularly Malaria Indicator Survey (MIS) is a very important activity that represents quality demand. Data from MIS are needed every two years, not only for future programming, but are also key for periodic measurement of the performance of the program.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Alana Sharp","2020-01-14","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Madagascar","Madagascar","PAI-5072","MCI-00012","Case management","MCI-00158","Therapeutic efficacy surveillance","Long-term surveillance of the therapeutic efficacy of antimalarial drugs is one of the objectives of the NSP and should provide annual data on any potential therapeutic failures that could result in a resurgence of malaria. This amount will help to maintain surveillance during the final two years of the grant. In 2018, it will be implemented with funding from the President?s Malaria Initiative (PMI).",325607,null,"Active","a6Q1R000000AJJG",35715,0,0,0,289892,0,null,null,"Long-term surveillance of the therapeutic efficacy of antimalarial drugs is one of the objectives of the NSP and should provide annual data on any potential therapeutic failures that could result in a resurgence of malaria. This amount will help to maintain surveillance during the final two years of the grant. In 2018, it will be implemented with funding from the President?s Malaria Initiative (PMI).","High","Therapeutic efficacy of anti-malaria drugs is an important study that generates data to ensure quality of malaria treatment and avoid drugs resistance. Per WHO guidelines, therapeutic efficacy study should be conducted every two years",null,"Alana Sharp","2020-01-14","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Pakistan","Pakistan","PAI-5349","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","PR Nai Zindagi has now been allowed to work in the major agglomerations of Punjab. Based on the Punjab IBBS 2014, the number of PWID mapped in 8 cities of Lahore, Faisalabad, Sargodha, Sialkot, Gujranwala, Sheikhupura, Mandi Bahaudin and DG Khan is 25,929. As per the IBBS, 9,715 (37.46%) based on city wise prevalence were HIV positive in 2014. In the absence of services since 2016, this number is now likely to reach 60% if not more. \n\nOutcomes of the proposed intervention:\n? By end of 2020 appr. 20,743 (80%) of mapped PWID will be enrolled in CoPc+ services (complete package) in those cities\n? By end of 2020 appr. 7772 (80%) of HIV+ PWID will be channeled through AAU and put on ART\n? Similarly, spouses and all partners will receive prevention, treatment and life support\n? No additional costs on management (like PR staffing  costs) \n? By end of 2020, NZT will cover 23% of PWID in Pakistan",5012397,null,"Active","a6Q1R000000AJNj",0,5012000,0,0,397,0,null,null,"PR Nai Zindagi has now been allowed to work in the major agglomerations of Punjab. Based on the Punjab IBBS 2014, the number of PWID mapped in 8 cities of Lahore, Faisalabad, Sargodha, Sialkot, Gujranwala, Sheikhupura, Mandi Bahaudin and DG Khan is 25,929. As per the IBBS, 9,715 (37.46%) based on city wise prevalence were HIV positive in 2014. In the absence of services since 2016, this number is now likely to reach 60% if not more. \n\nOutcomes of the proposed intervention:\n? By end of 2020 appr. 20,743 (80%) of mapped PWID will be enrolled in CoPc+ services (complete package) in those cities\n? By end of 2020 appr. 7772 (80%) of HIV+ PWID will be channeled through AAU and put on ART\n? Similarly, spouses and all partners will receive prevention, treatment and life support\n? No additional costs on management (like PR staffing  costs) \n? By end of 2020, NZT will cover 23% of PWID in Pakistan","High","These activities will provide crucial support for the programming for people who inject drugs, and will enable this vulnerable population and their partners to access quality services, thereby positively impacting the epidemic","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Prevention and Treatment services for IDUs ","Alana Sharp","2020-01-27","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Madagascar","Madagascar","PAI-5071","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.",7711695,null,"Inactive","a6Q1R000000AJJF",122437,7711695,0,0,0,1,null,null,"Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.","High","The applicant requests an amount US$7,711,695 for LLINs for mass campaign in 2021 under the PAAR. While the TRP considers this to be quality demand, the TRP notes that these nets are to be used outside the grant utilization period of the current allocation cycle. As such the TRP requests the Global Fund?s Grants Approval Committee (GAC) to decide whether this component of the request can be placed on the current register of Unfunded Quality Demand.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-14","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Madagascar","Madagascar","PAI-5069","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","To provide appropriate treatment for at least 95 percent of diagnosed malaria cases, continuous availability of treatment supplies ? including artemisinin-based combination therapy (ACT) and rapid diagnostic tests (RDTs) ? in the various health care facilities is essential. This sum from the above allocation amount will cover these requirements for 2021. This intervention will also contribute to achieving the target of zero malaria-related deaths by 2022.",2148828,null,"Inactive","a6Q1R000000AJJD",2148828,0,0,0,0,1,null,null,"To provide appropriate treatment for at least 95 percent of diagnosed malaria cases, continuous availability of treatment supplies ? including artemisinin-based combination therapy (ACT) and rapid diagnostic tests (RDTs) ? in the various health care facilities is essential. This sum from the above allocation amount will cover these requirements for 2021. This intervention will also contribute to achieving the target of zero malaria-related deaths by 2022.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Thailand","Thailand","PAI-5754","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","DDC BL 292, 293, 294, 295, 296, 297, 298, 299, 300, 301:Support intensive case finding and comprehensive treatment and care of migrant refugees at border area, including·Case detection (passive and Targeted Active Case detection), diagnostic capacity, case holding and case management·Access to care and TB treatment for all TB cases including MDR-TB and TB/HIV co-infected patients·Care and support for TB patient with transportation, and psychosocial care or patients and care takers in residential TB center located on Thai side·Continue and strengthen partnership with Mae Tao Clinic for TB control activities among Migrants who attend MTC.",769377,null,"Inactive","a6Q1R000000AJUG",0,769377,0,0,0,1,null,null,"DDC BL 292, 293, 294, 295, 296, 297, 298, 299, 300, 301:Support intensive case finding and comprehensive treatment and care of migrant refugees at border area, including·Case detection (passive and Targeted Active Case detection), diagnostic capacity, case holding and case management·Access to care and TB treatment for all TB cases including MDR-TB and TB/HIV co-infected patients·Care and support for TB patient with transportation, and psychosocial care or patients and care takers in residential TB center located on Thai side·Continue and strengthen partnership with Mae Tao Clinic for TB control activities among Migrants who attend MTC.","High","This intervention integrates various activities needed for improving the access to TB services of migrant refugees at border area. The better TB control in this vulnerable population will also contribute to prevent TB and MDRTB transmission at borders","NA Original Module: Multidrug-resistant TB","Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Pakistan","Pakistan","PAI-5348","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Cost of reaching additional 33,200 FSW with prevention package. It is prioritized because prevalence rate for this population is growing at the fastest rate amongst KP for whom the primary means of transmission is sexual. Unit costs ($71) have been fixed with reference to those used for the AEM modelling. Proposed coverage would amount to 42% of the annual gap for this population through this grant.",2357200,null,"Active","a6Q1R000000AJNi",250000,131900,0,0,1975300,0,null,null,"Cost of reaching additional 33,200 FSW with prevention package. It is prioritized because prevalence rate for this population is growing at the fastest rate amongst KP for whom the primary means of transmission is sexual. Unit costs ($71) have been fixed with reference to those used for the AEM modelling. Proposed coverage would amount to 42% of the annual gap for this population through this grant.","Low","The funding request allocation already provides adequate coverage and resources and priority should go to diagnosis and treatment of sexually transmitted infections and other sexual health services for female sex workers.","NA Original Intervention: Condoms and lubricant programming for female sex workers HIV testing services for female sex workers. Diagnosis and treatment of sexually transmitted infections and other sexual health services for female sex workers","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Pakistan","Pakistan","PAI-5347","MCI-00531","Comprehensive prevention programs for TGs","MCI-00562","Other intervention(s) for TGs","Cost of reaching additional 7,200 TG with prevention package. It is prioritized because prevalence rate for this population is the highest (7.1%) amongst KP for whom the primary mode of transmission is sexual. \nUnit costs ($71) were fixed with reference to those used for the AEM modelling. \nProposed additional coverage would amount to 100% of the annual gap.",511200,null,"Active","a6Q1R000000AJNh",100000,184660,0,0,226540,0,null,null,"Cost of reaching additional 7,200 TG with prevention package. It is prioritized because prevalence rate for this population is the highest (7.1%) amongst KP for whom the primary mode of transmission is sexual. \nUnit costs ($71) were fixed with reference to those used for the AEM modelling. \nProposed additional coverage would amount to 100% of the annual gap.","Medium","Proposed interventions in the funding request adequately addressed needs of transgender people and above allocation funds should focus on quality of the proposed interventions.","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Condoms and lubricant programming for transgender people HIV testing services for transgender people with men. Diagnosis and treatment of sexually transmitted infections and other sexual health services for transgender people","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Pakistan","Pakistan","PAI-5345","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Cost of reaching additional 100,000 MSM with prevention package. \nProposed additional coverage would amount to 13% of the annual gap for MSM through the grant period.  Since this expansion of prevention program coverage for MSM would imply an increase in the numbers of MSM being identified as positive we consider it to be joint first priority with the Treatment, Care and Support item in the following row.",7100000,null,"Active","a6Q1R000000AJNf",450000,1002442,0,0,5647558,0,null,null,"Cost of reaching additional 100,000 MSM with prevention package. \nProposed additional coverage would amount to 13% of the annual gap for MSM through the grant period.  Since this expansion of prevention program coverage for MSM would imply an increase in the numbers of MSM being identified as positive we consider it to be joint first priority with the Treatment, Care and Support item in the following row.","Medium","Proposed modules and interventions in particular a) HIV testing services, and b) diagnosis and treatment of sexually transmitted infections and other sexual health services for men who have sex with men will strengthen and scale up existing interventions proposed for men having sex with men and male sex workers.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Condoms and lubricant programming for men who have sex with men, HIV testing services for men who have sex with men. Diagnosis and treatment of sexually transmitted infections and other sexual health services for men who have sex with men.","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Pakistan","Pakistan","PAI-5344","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Cost of treating additional 20,000 PLHA or 12% of the annual gap. This will help the program to: \n1. Mitigate risk if PC1 budgets don?t materialize timely to supply the projected quantities of ARVs. \n2. Address potential surge in demand for ARTs if numbers of current pre-ART (i.e. CD4 >500) are higher than originally anticipated when treatment-for-all is implemented. \n3. Cover additional treatment demand that would result from increased coverage in MSM programs under PAAR.",4940000,null,"Active","a6Q1R000000AJNe",700000,1140998,0,0,3099002,0,null,null,"Cost of treating additional 20,000 PLHA or 12% of the annual gap. This will help the program to: \n1. Mitigate risk if PC1 budgets don?t materialize timely to supply the projected quantities of ARVs. \n2. Address potential surge in demand for ARTs if numbers of current pre-ART (i.e. CD4 >500) are higher than originally anticipated when treatment-for-all is implemented. \n3. Cover additional treatment demand that would result from increased coverage in MSM programs under PAAR.","High","Existing low level of coverage in the existing proposal should be addressed by expanding the coverage and increase number of HIV positive people to HIV care, Differentiated ARV therapy service delivery, Treatment monitoring ? Viral load and Treatment adherence counselling","NA Original Intervention: HIV care differentiated ARV therapy service delivery treatment monitoring ? Viral load Treatment adherence Counseling and psychosocial support","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Pakistan","Pakistan","PAI-5343","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","Cost of implementing national level HIV communication strategy. The plan targets policy makers, opinion leaders, key populations, PLHA, media, healthcare service providers, men and women of reproductive age, and young people. Main objectives are to: \n? strengthen information and knowledge, thus leading to behaviour change and motivation (awareness) \n? generate an enabling environment (advocacy) \n? reinforce social and community support (social support) \n? enhance access to quality services (ability to act)",96100,null,"Active","a6Q1R000000AJNd",0,0,0,0,96100,0,null,null,"Cost of implementing national level HIV communication strategy. The plan targets policy makers, opinion leaders, key populations, PLHA, media, healthcare service providers, men and women of reproductive age, and young people. Main objectives are to: \n? strengthen information and knowledge, thus leading to behaviour change and motivation (awareness) \n? generate an enabling environment (advocacy) \n? reinforce social and community support (social support) \n? enhance access to quality services (ability to act)","High","Will allow to reduce stigma and discrimination towards people living with HIV and cover existing gap of the funding request. Recommend to move into allocation category.","The funds on this intervention in the UQD form  is higher by 487387 USD because of the cost. PO replied: \"this amount refers to the associated costs to support the interventions, targeting the activities in the UQD description\". As the TRP looked at the full program there is an agreement on this cost. Original Intervention: Stigma and discrimination reduction. Sensitization of lawmakers and law enforcement agents Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Eswatini","Eswatini","PAI-5666","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Scale up CMIS to 142 additional small volume facilities. This will enable CMIS to be operational in all facilities in the country. The more facilities where CMIS is operational, the better the functionality of the system as a whole. In other words, this PAAR activity is acatalytic one to the allocation CMIS scale-up. This means clients can move from one facility to another, and continue to be captured on the live system.",3424843,null,"Inactive","a6Q1R000000AJSq",1157037,2267806,0,0,0,1,null,null,"Scale up CMIS to 142 additional small volume facilities. This will enable CMIS to be operational in all facilities in the country. The more facilities where CMIS is operational, the better the functionality of the system as a whole. In other words, this PAAR activity is acatalytic one to the allocation CMIS scale-up. This means clients can move from one facility to another, and continue to be captured on the live system.","High","This intervention will enable client management information system (CMIS) to be operational in all facilities across the country","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Alana Sharp","2019-12-05","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Mongolia","Mongolia","PAI-5134","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.",367802,null,"Inactive","a6Q1R000000AJKG",0,367802,0,0,0,1,null,null,"ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.","High","TB diagnostic, GeneXpert and TB lamp proposed to support active case finding interventions. Improved diagnosis to TB is a high impact intervention. TB-LAMP investments from the proposed amount needs to be deprioritized.",null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis"," South East Asia","2020-12-31","Tuberculosis"]
["CT Sao Tome and Principe","Sao Tome and Principe","PAI-5642","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","Focalized spraying planned for 2020, but due to lack of funds, we are requesting this important support in the PAAR. The amount requested in the PAAR for effective implementation of IRS in 2020 will cover procurement of insecticide, transport, storage, payment of sprayers and operating costs.",831143.53,null,"Active","a6Q1R000000AJSS",196360.68,565655,0,0,69127.850000000006,0,null,null,"Focalized spraying planned for 2020, but due to lack of funds, we are requesting this important support in the PAAR. The amount requested in the PAAR for effective implementation of IRS in 2020 will cover procurement of insecticide, transport, storage, payment of sprayers and operating costs.","High","This funding is requested to support IRS gaps (procurement of insecticides and implementation costs). This prioritization is also conditional of TRP approval as stated in issue 7","NA Original Intervention: Indoor residual spraying","Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH"," Central Africa",null,"Multi-component"]
["CT Mozambique","Mozambique","PAI-5150","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","PAAR investment is requested to support reaching the following outcomes and impact: Increase in the proportion of PLHIV receiving ART from 54% in 2014 to 80% in 2020, and increased ART retention rates from 70% at 12 months in 2016 to 80% in 2020. This will lead to reduction in AIDS related mortality by 40% by 2020 and reduction in incidence by 40% by 2020.",70795813,null,"Active","a6Q1R000000AJKW",3118755,37794658,0,0,29882400,0,null,null,"PAAR investment is requested to support reaching the following outcomes and impact: Increase in the proportion of PLHIV receiving ART from 54% in 2014 to 80% in 2020, and increased ART retention rates from 70% at 12 months in 2016 to 80% in 2020. This will lead to reduction in AIDS related mortality by 40% by 2020 and reduction in incidence by 40% by 2020.","High","The interventions are considered high priority as they address critical interventions which plan to increase the proportion of people living with HIV/AIDS receiving ART from 54% in 2014 to 80% in 2020, increase ART retention rates from 70% at 12 months in 2016 to 80% in 2020 and reduce AIDS-related mortality by 40% by 2020 and incidence by 40% by 2020.","NA Original Intervention: Differenditated ART for people living with HIV/AIDS","Alana Sharp","2020-01-17","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Turkmenistan","Turkmenistan","PAI-5805","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Community involvement to TB care is weak due to the  lack  of  social  contracting  mechanisms.  Civil society formally   participates in  the Country Coordinating  Mechanism.  Proper  involvement  of CSOs is stipulated in the National Programme for TB Prevention and Control, 2016-2020. However, the only CSO with meaningful engagement to TB care is the National Red Crescent Society through the  Global  Fund  grant,  and its  role is  limited to service provision. The transitional grant includes  technical  support  with  establishing  legal and  financial  mechanisms  for  direct  contracting and building  capacities  of  CSOs  as  to  enhance  their contribution to the national TB response. In order to  increase the number of CSO involved in  providing   TB  prevention  and  treatment adherence support interventions, under Prioritized Above Allocation Budget CCM is asking to fund  a Small grants? program for CSOs. The project will support the first grants aiming at involvement of the CSOs in TB control activities, including  work  on  reducing stigma, dissemination of information, advocacy for ambulatory  model,  or support to patients  during ambulatory treatment (focus on women patients or other vulnerable groups).",100000,null,"Inactive","a6Q1R000000AJV5",0,100000,0,0,0,1,null,null,"Community involvement to TB care is weak due to the  lack  of  social  contracting  mechanisms.  Civil society formally   participates in  the Country Coordinating  Mechanism.  Proper  involvement  of CSOs is stipulated in the National Programme for TB Prevention and Control, 2016-2020. However, the only CSO with meaningful engagement to TB care is the National Red Crescent Society through the  Global  Fund  grant,  and its  role is  limited to service provision. The transitional grant includes  technical  support  with  establishing  legal and  financial  mechanisms  for  direct  contracting and building  capacities  of  CSOs  as  to  enhance  their contribution to the national TB response. In order to  increase the number of CSO involved in  providing   TB  prevention  and  treatment adherence support interventions, under Prioritized Above Allocation Budget CCM is asking to fund  a Small grants? program for CSOs. The project will support the first grants aiming at involvement of the CSOs in TB control activities, including  work  on  reducing stigma, dissemination of information, advocacy for ambulatory  model,  or support to patients  during ambulatory treatment (focus on women patients or other vulnerable groups).","High","The TRP considers this\nintervention quality demand as it\nwill to contribute to improved\nprogram management and\nimplementation after transition.\nBecause of its importance, the\nTRP recommends this module to\nmove into allocation.","NA Original Module: RSSH - Community responses and systems","Alana Sharp","2020-01-14","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-06-30","Tuberculosis"]
["CT Uganda","Uganda","PAI-5889","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","This is to support procurement of cartridges for operationalizing Xpert MTB/Rif machines to enhance the finding of missed cases including in key populations such as prisons and PLHIV. Secondly, approximately $1.7m is for procuring digital X-rays.",18652070,null,"Active","a6Q1R000000AJWR",0,6500000,0,0,12152070,0,null,null,"This is to support procurement of cartridges for operationalizing Xpert MTB/Rif machines to enhance the finding of missed cases including in key populations such as prisons and PLHIV. Secondly, approximately $1.7m is for procuring digital X-rays.","Medium","This is to support expansion of GeneXpert through procurement of cartridges in addition to procurement and deployment of digital X-rays. The applicant is attempting to respond to the findings of the TB disease prevalence survey in which nearly half of the identified TB cases had no symptoms and to take advantage of the better sensitivity of the Xpert test to find missing cases.",null,"Alana Sharp","2020-01-27","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Tajikistan","Tajikistan","PAI-5800","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","With PAAR, the project will improve the quality and expand the NSEP and OST services for PWID by the end of the project cycle. The expected outcome is to contain the spread of the HIV infection among the key population and eventually general population. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.",2000000,null,"Active","a6Q1R000000AJV0",154368,961565,0,0,884067,0,null,null,"With PAAR, the project will improve the quality and expand the NSEP and OST services for PWID by the end of the project cycle. The expected outcome is to contain the spread of the HIV infection among the key population and eventually general population. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.","Medium","This intervention will allow to improve the quality and expand the needle and syringe exchange program and opioid substitution treatment services for people who inject drugs. It will allow as well to conduct an integrated biobehavioral survey (IBBS) among peope who inject drugs.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Provide needle and syringe exchange program, HIV testing and counselling and opioid substitution treatmentto people who inject drugs","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Tajikistan","Tajikistan","PAI-5799","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","Involving government and civil society organizations to support key populations and understand their rights. Reducing vilifications against women, girls and gender violation. Improving acceptable service for key population and PLWH. Degreasing social, cultural, legal, and self-stigma and discrimination against key populations and PLWH.",250000,null,"Inactive","a6Q1R000000AJUz",0,250000,0,0,0,1,null,null,"Involving government and civil society organizations to support key populations and understand their rights. Reducing vilifications against women, girls and gender violation. Improving acceptable service for key population and PLWH. Degreasing social, cultural, legal, and self-stigma and discrimination against key populations and PLWH.","Medium","This intervention will allow to involve government and civil society organizations to support key populations and understand their rights, to reduce vilifications against women, girls and gender violation, tomprove acceptable service for key population and people living with HIV, and to decrease social, cultural, legal, and self-stigma and discrimination against key populations and people living with HIV.","NA Original Intervention: Legal/patients? rights' literacy trainings for women, girls and key populations ? Training of health care providers on nondiscrimination, duty to treat and rights based approach. ? Human Rights roundtable and workshop for parliamentarians, ministries of justice, judges, prosecutors, police, law expert and religious leaders.","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Sudan","Sudan","PAI-5492","MCI-00012","Case management","MCI-00154","Facility-based treatment","During the year 2018 remarkable increase in the consumption of malaria first line (AL) were report (2.9m vs 3.9m reported) The increase is attributed to: Increase in malaria cases trend reported through DHIS2, shifting in the patient seeking behaver toward public sector due to inflation, Shifting in National health Insurance  policy from providing the services to paying for service in the public sector",5937480.6900000004,null,"Inactive","a6Q1R000000AJQ2",1005700,4931779,0,0,1.69,1,null,null,"During the year 2018 remarkable increase in the consumption of malaria first line (AL) were report (2.9m vs 3.9m reported) The increase is attributed to: Increase in malaria cases trend reported through DHIS2, shifting in the patient seeking behaver toward public sector due to inflation, Shifting in National health Insurance  policy from providing the services to paying for service in the public sector","High",null,null,"Alana Sharp","2019-12-05","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Sudan","Sudan","PAI-5488","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","Funding to maintain the scope and scale of The global Fund investment in malaria control in Sudan, IRS  for Y3 should be  continued  in the irrigated scheme namely Gazira and Sinnar state  (in 2018 Population protected  3811881/household covered 727967 considering 10% increase in 2020 ) IVM Is advocating for supporting other localities from the irrigated scheme",11538304.939999999,null,"Active","a6Q1R000000AJPy",2000000,9052453.5800000001,0,0,485851.36,0,null,null,"Funding to maintain the scope and scale of The global Fund investment in malaria control in Sudan, IRS  for Y3 should be  continued  in the irrigated scheme namely Gazira and Sinnar state  (in 2018 Population protected  3811881/household covered 727967 considering 10% increase in 2020 ) IVM Is advocating for supporting other localities from the irrigated scheme","High",null,"NA Original Intervention: Indoor residual spraying","Alana Sharp","2019-12-05","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Papua New Guinea","Papua New Guinea","PAI-5395","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This allows a further year of Insecticide Resistance Monitoring in four site in year two which are presently not possible in the present grant allocation.",101609,null,"Active","a6Q1R000000AJOT",0,0,100000,0,1609,0,null,null,"This allows a further year of Insecticide Resistance Monitoring in four site in year two which are presently not possible in the present grant allocation.","High","The TRP recommended in its review of the Program Continuation Request that the monitoring of insecticide resistance be sustained.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Additional year of Insecticide Resistance Monitoring in 4 sites","Alana Sharp","2020-01-14","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Papua New Guinea","Papua New Guinea","PAI-5394","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Review progress of the malaria program to establish recommendations for the new Malaria Strategic Plan for 2021-2025.",200100,null,"Active","a6Q1R000000AJOS",0,0,200000,0,100,0,null,null,"Review progress of the malaria program to establish recommendations for the new Malaria Strategic Plan for 2021-2025.","High","In its review of the Program Continuation Request, the TRP expressed concern that the epidemiology of malaria in PNG is changing and P. vivax is assuming a more prominent role. The TRP recommended an early review of the national malaria program with a view to establish recommendations for the new Malaria Strategic Plan for 2021-2025 and a possible evidence-based request to the Global Fund for re-programming if the data suggests.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: National Malaria Programme Review","Alana Sharp","2020-01-14","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Papua New Guinea","Papua New Guinea","PAI-5393","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","These are relatively low risk malaria zone where epidemics might occur at 1600 meters altitude and P.vivax predominates at higher altitudes. Long Lasting Insecticide Treated Nets have been distributed in these areas since 2006 but will not continue past 2017 due to lack of funds. These funds are needed to distribute a total of 649,300 Long Lasting Insecticide Treated Nets for household distribution.",3765940,null,"Active","a6Q1R000000AJOR",0,0,300000,0,3465940,0,null,null,"These are relatively low risk malaria zone where epidemics might occur at 1600 meters altitude and P.vivax predominates at higher altitudes. Long Lasting Insecticide Treated Nets have been distributed in these areas since 2006 but will not continue past 2017 due to lack of funds. These funds are needed to distribute a total of 649,300 Long Lasting Insecticide Treated Nets for household distribution.","High","Use of grant savings to increase coverage of LLIN was recommended by the TRP in its review of the Program Continuation Request","NA Original Intervention: Distribution of LLINs to people living in the 1600 to 2000m zone of PNG","Alana Sharp","2020-01-14","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Tajikistan","Tajikistan","PAI-5798","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Condom and counselling will be expanded to SW to improve the accessibility of services. Violation against women, SW, girls will be reported. Client will receive psycho-social support. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.",900000,null,"Active","a6Q1R000000AJUy",82541,352491,0,0,464968,0,null,null,"Condom and counselling will be expanded to SW to improve the accessibility of services. Violation against women, SW, girls will be reported. Client will receive psycho-social support. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.","Medium","This intervention will allow scale up of condoms distributions and counselling to sex workers, reporting of violation against women, sex workers, girls, provision of psychosocial support to sex workers. Within this intervention, an integrated bio-behavioral survey (IBBS) among sex workers will be conducted .","NA Original Module: Comprehensive prevention programs and support for sex workers. Original Intervention: Provide standard package of services to sex workers and their clients (condoms, HIV testing, information, education and communication material and sexually treansmitted infections treatment)","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Tajikistan","Tajikistan","PAI-5796","MCI-00071","Other module","MCI-00071","Other module","This will be pilot based on the result of the study the PR will develop strategy and action plan to offer PrEP.",100000,null,"Inactive","a6Q1R000000AJUw",0,100000,0,0,0,1,null,null,"This will be pilot based on the result of the study the PR will develop strategy and action plan to offer PrEP.","High","This intervention will allow to accelerate prevention among key populations in particular among men who have sex with men.","NA Original Module: Pre-exposure prophylaxis. Original Intervention: Offering counselling and pre-exposure prophylaxis to key populations","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Tajikistan","Tajikistan","PAI-5795","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Aiming to scale up to reach 73.9% (10,800 individuals) of PLWH who aware their status, on ART. The cost also includes VL and CD4 testing. The expected outcome is to achieve viral suppression as per treatment as prevention initiative.",2800000,null,"Active","a6Q1R000000AJUv",69515,1704235,0,0,1026250,0,null,null,"Aiming to scale up to reach 73.9% (10,800 individuals) of PLWH who aware their status, on ART. The cost also includes VL and CD4 testing. The expected outcome is to achieve viral suppression as per treatment as prevention initiative.","High","This intervention will allow the program to reach people who inject drugs who are aware of their status, to scale up antiretroviral therapy, and viral load and CD4 testing, and to achieve viral suppression as per treatment as prevention initiative.","NA Original Module: Treatment, care and support for adults, adolescents, and children. Original Intervention: Enroll 2000 people living with HIV to antiretroviral treatment, counselling and support to increase adherence. Viral loas test and CD4 count test.","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Tajikistan","Tajikistan","PAI-5794","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Improve overall health outcomes, reduce costs and gain efficiencies. Offering service in different modalities to increase clients and reduce workload. Scale up access in nationwide in any location.",350000,null,"Inactive","a6Q1R000000AJUu",94064,255936,0,0,0,1,null,null,"Improve overall health outcomes, reduce costs and gain efficiencies. Offering service in different modalities to increase clients and reduce workload. Scale up access in nationwide in any location.","High","This intervention will allow to support innovative approaches, and integration of services.","NA Original Module: Resilent and Sustainable Systems of Health (RSSH) and Integration of HIV services to primary Health care system and differentiated HIV Testing Services.. Original Intervention: Establishing greater integration and improve linkage to HIV services, Integrate and offer HIV tests in all levels of the national health care system. Different modalities including Facilitybased HIV testing, Communitybased testing (including outreach, mobile, home-based, targeted campaigns, partner testing) ? Provider- and client-initiated testing based on voluntary and informed consent","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Zambia","Zambia","PAI-6036","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","The number of LLINs to be distributed to at risk population through mass campaign in 2020 is 7,512,678.",19215531.5,null,"Active","a6Q1R000000AJYo",1010899,11490376,0,0,6714256.5,0,null,null,"The number of LLINs to be distributed to at risk population through mass campaign in 2020 is 7,512,678.","High","The proposed action is in line with the national strategic plan and vector control interventions for significant reduction in malaria by 2020.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-14","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Papua New Guinea","Papua New Guinea","PAI-5392","MCI-00071","Other module","MCI-00071","Other module","Home Based Management of Malaria (HMM) has been previously supported through three non-governmental organizations in three provinces in the country but will not continue past 2017. Funds are to develop national policies for HMM to be implemented by staff in health centers, supporting National Department of Health to work with provinces (particularly the three provinces) to integrate these programs at the health facility level.",600000,null,"Inactive","a6Q1R000000AJOQ",0,0,600000,0,0,1,null,null,"Home Based Management of Malaria (HMM) has been previously supported through three non-governmental organizations in three provinces in the country but will not continue past 2017. Funds are to develop national policies for HMM to be implemented by staff in health centers, supporting National Department of Health to work with provinces (particularly the three provinces) to integrate these programs at the health facility level.","Low","Home Based Management of Malaria (HMM) extended through national policies for HMM for implementation by health staff in health centers throughout the country where communities live in difficult to reach areas. However, the TRP considers that more work is required before this program can be implemented. In particular, the TRP recommends that the applicant, supported by the Secretariat, considers the implications of the government program of decentralization of health responsibilities and seeks to safeguard arrangements for the extension of HMM accordingly","NA Original Module: Community based treatment. Original Intervention: Integration of home based management of malaria into the national health system","Alana Sharp","2020-01-14","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Papua New Guinea","Papua New Guinea","PAI-5390","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","This program delivers antenatal nets to about 50% of pregnant women each year. This protects both  pregnant women and newly born children from malaria. Delivery to pregnant women is done through health centers. Nets are also distributed every three years to prisons and boarding pupils in boarding schools.",1723192,null,"Active","a6Q1R000000AJOO",0,0,1720000,0,3192,0,null,null,"This program delivers antenatal nets to about 50% of pregnant women each year. This protects both  pregnant women and newly born children from malaria. Delivery to pregnant women is done through health centers. Nets are also distributed every three years to prisons and boarding pupils in boarding schools.","High","Use of grant savings to increase coverage of LLIN was recommended by the TRP in its review of the Program Continuation Request","NA Original Intervention: Distribution of Long Lasting Insecticidal Nets (LLINs) to Vulnerable Groups","Alana Sharp","2020-01-14","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Chad","Chad","PAI-5723","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.\n\nIn order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.",6883375.54,null,"Active","a6Q1R000000AJTl",0,6338971,0,0,544404.54,0,null,null,"The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.\n\nIn order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.","High","The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.\n\nIn order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-23","2017-2019","Malaria"," Central Africa","2021-06-30","Malaria"]
["CT Chad","Chad","PAI-5722","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN mass distribution campaigns represent the most important vector control strategy. With the exception of the desert region in the far north, all other regions are eligible for this strategy, i.e. 19 out of the 23 regions. The Global Fund?s continuous financial support resulted in carrying out 3 campaigns in the country at a regular interval of 3 years (2011, 2014 and 2017). These, respectively, allowed covering 44%, 73% and 69.1% of the total population of the country. The support provided by the government and other partners was very limited, and resulted in covering only one region in 2011 (Logone Occidental: 6.2% of the population) and 3 regions in 2014 (Batha, Ouaddai and Barh El Gazel: 12.7%). The 2017 campaign was possible only thanks to the support of the Global Fund.\n \nThe next mass distribution campaign is planned in 2020. Due to reduced resources allocated to the country by the Global Fund for the Malaria Grant, only 6 regions (Tandjilé, Logone Oriental, Mandoul, Moyen Chari, Salamat and Lac) will benefit from the next campaign. This represents 31.3% of the total population living in endemic regions. Conscious of the importance of the mass campaign for malaria prevention, and in order to avoid a resurgence of cases in the 13 regions that have already benefited from mass campaigns in 2017, the country wishes to sustain the gains. The requested amount will provide 3,931,586 LLINs, cover for logistics and other operational costs to carry out the campaign in 7 regions with 6,433,505 inhabitants (37.8% of the population of the malaria endemic regions). This will ensure that all 13 regions that were covered by the 2017 mass distribution campaign supported by the Global Fund will benefit from the 2020 mass distribution campaign.",13715315.310000001,null,"Active","a6Q1R000000AJTk",0,13432297.279999999,0,0,283018.03000000003,0,null,null,"LLIN mass distribution campaigns represent the most important vector control strategy. With the exception of the desert region in the far north, all other regions are eligible for this strategy, i.e. 19 out of the 23 regions. The Global Fund?s continuous financial support resulted in carrying out 3 campaigns in the country at a regular interval of 3 years (2011, 2014 and 2017). These, respectively, allowed covering 44%, 73% and 69.1% of the total population of the country. The support provided by the government and other partners was very limited, and resulted in covering only one region in 2011 (Logone Occidental: 6.2% of the population) and 3 regions in 2014 (Batha, Ouaddai and Barh El Gazel: 12.7%). The 2017 campaign was possible only thanks to the support of the Global Fund.\n \nThe next mass distribution campaign is planned in 2020. Due to reduced resources allocated to the country by the Global Fund for the Malaria Grant, only 6 regions (Tandjilé, Logone Oriental, Mandoul, Moyen Chari, Salamat and Lac) will benefit from the next campaign. This represents 31.3% of the total population living in endemic regions. Conscious of the importance of the mass campaign for malaria prevention, and in order to avoid a resurgence of cases in the 13 regions that have already benefited from mass campaigns in 2017, the country wishes to sustain the gains. The requested amount will provide 3,931,586 LLINs, cover for logistics and other operational costs to carry out the campaign in 7 regions with 6,433,505 inhabitants (37.8% of the population of the malaria endemic regions). This will ensure that all 13 regions that were covered by the 2017 mass distribution campaign supported by the Global Fund will benefit from the 2020 mass distribution campaign.","High","LLIN mass distribution campaigns represent the most important vector control strategy. With the exception of the desert region in the far north, all other regions are eligible for this strategy, i.e. 19 out of the 23 regions. The Global Fund?s continuous financial support resulted in carrying out 3 campaigns in the country at a regular interval of 3 years (2011, 2014 and 2017). These, respectively, allowed covering 44%, 73% and 69.1% of the total population of the country. The support provided by the government and other partners was very limited, and resulted in covering only one region in 2011 (Logone Occidental: 6.2% of the population) and 3 regions in 2014 (Batha, Ouaddai and Barh El Gazel: 12.7%). The 2017 campaign was possible only thanks to the support of the Global Fund.\n \nThe next mass distribution campaign is planned in 2020. Due to reduced resources allocated to the country by the Global Fund for the Malaria Grant, only 6 regions (Tandjilé, Logone Oriental, Mandoul, Moyen Chari, Salamat and Lac) will benefit from the next campaign. This represents 31.3% of the total population living in endemic regions. Conscious of the importance of the mass campaign for malaria prevention, and in order to avoid a resurgence of cases in the 13 regions that have already benefited from mass campaigns in 2017, the country wishes to sustain the gains. The requested amount will provide 3,931,586 LLINs, cover for logistics and other operational costs to carry out the campaign in 7 regions with 6,433,505 inhabitants (37.8% of the population of the malaria endemic regions). This will ensure that all 13 regions that were covered by the 2017 mass distribution campaign supported by the Global Fund will benefit from the 2020 mass distribution campaign.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-23","2017-2019","Malaria"," Central Africa","2021-06-30","Malaria"]
["CT Thailand","Thailand","PAI-5787","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","The request is based on the current number of modules (600 modules) in country (125 machines) @ 3 tests per module (assuming 3 runs per day per site)/ day X 600 modules X 255 days a year (excluding weekends and public holidays) = 459,000 tests.",5278500,null,"Active","a6Q1R000000AJUn",0,4309548,0,0,968952,0,null,null,"The request is based on the current number of modules (600 modules) in country (125 machines) @ 3 tests per module (assuming 3 runs per day per site)/ day X 600 modules X 255 days a year (excluding weekends and public holidays) = 459,000 tests.","High","The request is based on the current number of modules (600 modules) in country (125 machines) @ 3 tests per module (assuming 3 runs per day per site)/ day X 600 modules X 255 days a year (excluding weekends and public holidays) = 459,000 tests.","Amount validated and description updated by CT Original Module: Multidrug-resistant TB. Original Intervention: Case detection and diagnosis: MDR-TB ","Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Bangladesh","Bangladesh","PAI-3892","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Additional community case finding activities in hard-to reach areas not covered by the allocation and/or matching fund request, introduction of the new diagnostic algorithm in additional upazilas in remote areas, establishment of additional diagnostic facilities (X-ray, FNAC, X-pert) to improve the diagnosis of smear-negative, Child-TB and Extra Pulmoniary cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.",41348864,null,"Active","a6Q1R000000AJ0E",22232521,14701807,0,0,4414536,0,null,null,"Additional community case finding activities in hard-to reach areas not covered by the allocation and/or matching fund request, introduction of the new diagnostic algorithm in additional upazilas in remote areas, establishment of additional diagnostic facilities (X-ray, FNAC, X-pert) to improve the diagnosis of smear-negative, Child-TB and Extra Pulmoniary cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","High","Expands evidence-based and appropriate interventions for increased case finding.",null,"Alana Sharp","2020-01-17","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Benin","Benin","PAI-3755","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.",441113.23,null,"Active","a6Q1R000000AIy1",0,221000,0,0,220113.23,0,null,null,"These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4614","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","The request for funding to GF for 2018-2020 (allocated amount) includes SLD coverage through the end of 2020. Additional SLD supply for 2021 is requested from PAAR to cover SLDs for patients who have started MDR TB treatment through the end of 2020 and will continue in 2021. Totally, 1040 MDR TB patients will be covered. The additional SLD supply will ensure the continuum of care for MDR TB patients started treatment during 2019-2020 within GF grant for bridging the potential treatment gap for period January- September 2021.",1609942,null,"Active","a6Q1R000000AJBs",null,null,0,0,1609942,0,null,null,"The request for funding to GF for 2018-2020 (allocated amount) includes SLD coverage through the end of 2020. Additional SLD supply for 2021 is requested from PAAR to cover SLDs for patients who have started MDR TB treatment through the end of 2020 and will continue in 2021. Totally, 1040 MDR TB patients will be covered. The additional SLD supply will ensure the continuum of care for MDR TB patients started treatment during 2019-2020 within GF grant for bridging the potential treatment gap for period January- September 2021.","High","The TRP was not able to distinguish this from the intervention above. It is\ntherefore not clear to the TRP what the funding shortfall is (is it 1,609, 942 plus 746,393)? This said, the TRP re-iterates the importance of identifying other sources of financing\nto forestall MDR-TB medicines/\nSLDs shortages by 2020.","NA Original Module: Multidrug-resistant TB","Alana Sharp","2019-12-10","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Eastern Europe and Central Asia",null,"Multi-component"]
["CT Bangladesh","Bangladesh","PAI-3887","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN ? Mass campaign. The within allocation request covers the absolute, high and medium priority areas. There are a significant number of people at risk in low priority areas that will be left uncovered. Free LLINs will be expanded to cover the entire population residing in targeted established settlements. This will complement the within allocation LLIN approach and result in reduced transmission.",2198599,null,"Inactive","a6Q1R000000AJ09",876518,1322081,0,0,0,1,null,null,"LLIN ? Mass campaign. The within allocation request covers the absolute, high and medium priority areas. There are a significant number of people at risk in low priority areas that will be left uncovered. Free LLINs will be expanded to cover the entire population residing in targeted established settlements. This will complement the within allocation LLIN approach and result in reduced transmission.","High","There are a significant number of people at risk in low priority areas that will be left uncovered.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-17","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Bangladesh","Bangladesh","PAI-3885","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Mapping can significantly strengthen the management of malaria elimination efforts. Health Information Systems in elimination districts will be upgraded to include a GIS component with mapping down to household level. Selected healthcare providers will be equipped with a smartphone so that they can report the geographical position of all confirmed malaria cases. The Government will strengthen the pharmacovigilance system.",438173,null,"Inactive","a6Q1R000000AJ07",438173,0,0,0,0,1,null,null,"Mapping can significantly strengthen the management of malaria elimination efforts. Health Information Systems in elimination districts will be upgraded to include a GIS component with mapping down to household level. Selected healthcare providers will be equipped with a smartphone so that they can report the geographical position of all confirmed malaria cases. The Government will strengthen the pharmacovigilance system.","High","Mapping can significantly strengthen the management of malaria elimination efforts, especially in malaria elimination districts.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Alana Sharp","2020-01-17","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Benin","Benin","PAI-3813","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","The gap of 315 000 LLIN has been filled",1739000.11,null,"Inactive","a6Q1R000000AIyx",1739000.11,0,0,0,0,1,null,null,"The gap of 315 000 LLIN has been filled","High",null,"NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-14","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Benin","Benin","PAI-3743","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.",4729341.26,null,"Active","a6Q1R000000AIxp",1400000,1400000,0,0,1929341.26,0,null,null,"Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Bangladesh","Bangladesh","PAI-3874","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00098","OST and other drug dependence treatment for PWID","Further scale-up Opioid Substitution Therapy (OST) in 3 priority districts: Considering the HIV and HCV epidemic, another 1,000 PWID will be targeted for OST in selected districts by 2020, which will increase the national coverage to 11%. This harm reduction intervention is critical in the fight against the transmission of HIV/HCV.",935188,null,"Inactive","a6Q1R000000AIzw",665925,269263,0,0,0,1,null,null,"Further scale-up Opioid Substitution Therapy (OST) in 3 priority districts: Considering the HIV and HCV epidemic, another 1,000 PWID will be targeted for OST in selected districts by 2020, which will increase the national coverage to 11%. This harm reduction intervention is critical in the fight against the transmission of HIV/HCV.","High","Increases and impacts transmission of HIV/HCV among people who inject drugs.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","Alana Sharp","2020-01-17","2017-2019","HIV/AIDS"," High Impact Asia","2020-11-30","HIV/AIDS"]
["CT Bangladesh","Bangladesh","PAI-3873","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00099","Prevention and management of coinfections and co-morbidities for PWID","Prevention, screening, diagnosis and management for Hepatitis C virus (HCV): Information Education Communication/Behaviour Change Communication activities for the prevention of HCV will be conducted among targeted People Who Inject Drugs (PWID). PWID will be routinely screened for HCV and around 200 HCV positive PWID will be provided medicine support. Trained physicians will be responsible for screening, diagnosis and management of HCV from Drop-In-Centres. The impact will be to reduce morbidity and mortality for PWID who may be co-infected with HIV.",431028,null,"Inactive","a6Q1R000000AIzv",100723,330305,0,0,0,1,null,null,"Prevention, screening, diagnosis and management for Hepatitis C virus (HCV): Information Education Communication/Behaviour Change Communication activities for the prevention of HCV will be conducted among targeted People Who Inject Drugs (PWID). PWID will be routinely screened for HCV and around 200 HCV positive PWID will be provided medicine support. Trained physicians will be responsible for screening, diagnosis and management of HCV from Drop-In-Centres. The impact will be to reduce morbidity and mortality for PWID who may be co-infected with HIV.","Medium","Increases coverage and impact of hepatitis C virus (HCV) intervention to reduce morbidity and mortality in people who inject drugs.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Prevention and management of co-infections and co-morbidities for people who inject drugs","Alana Sharp","2020-01-17","2017-2019","HIV/AIDS"," High Impact Asia","2020-11-30","HIV/AIDS"]
["CT Afghanistan","Afghanistan","PAI-3548","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Pregnant women living in malaria endemic areas (category 1) require protection and will receive LLIN.  It is recommended  to provide a LLIN to all pregnant women visiting ANC  in  areas of Category 1 which are not covered in the malaria funding  request.  Due to inaccurate data the LLIN numbers are insufficient. No. of LLINs estimated to be distributed among  pregnant women visiting ANCs  (calculated  based  on  the ANC visits in those areas) = 364,307.",1092920,null,"Inactive","a6Q1R000000AIug",0,1092920,0,0,0,1,null,null,"Pregnant women living in malaria endemic areas (category 1) require protection and will receive LLIN.  It is recommended  to provide a LLIN to all pregnant women visiting ANC  in  areas of Category 1 which are not covered in the malaria funding  request.  Due to inaccurate data the LLIN numbers are insufficient. No. of LLINs estimated to be distributed among  pregnant women visiting ANCs  (calculated  based  on  the ANC visits in those areas) = 364,307.","High","In the context of the human rights and gender issues, the disproportionately high malaria burden among women and girls is to be reduced. In particular, pregnant women are the most vulnerable population targeted for protection, thus those visiting ANC in Category 1 areas should receive LLINs. However, the TRP recommends that this procurement and distribution should be coordinated to complement and not overlap with the LLIN distribution already in place in Category 1 areas","NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Alana Sharp","2020-01-14","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Eritrea","Eritrea","PAI-4233","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","IRS is conducted in three out of six regions of the country to control malaria. Bendiocarb 80% WP is one of the insecticides used. A total of 22,104kgs of the insecticide are estimated to cover spraying operation for the year 2018. The product costs USD 1,923,048 (CIF cost) at USD 87.0 per kg. Since this is an expensive chemical and that the Global Fund allocation made for the next funding cycle is less-than-expected, the Global Fund was requested for no-objection for the country to use existing savings to cover the above cost. As the request was not approved, this request is being included under PAAR and funding this activity will contribute in preventing malaria as part of IVM strategy.",1923048,null,"Active","a6Q1R000000AJ5j",197680,1000000,0,0,725368,0,null,null,"IRS is conducted in three out of six regions of the country to control malaria. Bendiocarb 80% WP is one of the insecticides used. A total of 22,104kgs of the insecticide are estimated to cover spraying operation for the year 2018. The product costs USD 1,923,048 (CIF cost) at USD 87.0 per kg. Since this is an expensive chemical and that the Global Fund allocation made for the next funding cycle is less-than-expected, the Global Fund was requested for no-objection for the country to use existing savings to cover the above cost. As the request was not approved, this request is being included under PAAR and funding this activity will contribute in preventing malaria as part of IVM strategy.","High","IRS is planned to complement the distribution of nets, though funds in the initial Program Continuation request were inadequate due to a reduce allocation amount. These funds will cover the budget shortfall for IRS insecticide.","Comment from CT: As mentioned above, priority was given to procure country needs for LLINs within the allocation and accordingly budget for IRS was decreased in allocation but increased under PAAR (3,770,679.50). MS: Update data for GAC section from Grant sign off form Original Intervention: Indoor residual spraying","Alana Sharp","2019-12-09","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Burkina Faso","Burkina Faso","PAI-3850","MCI-00071","Other module","MCI-00071","Other module","Acquiring artesunate injectables for the management of severe malaria in patients aged 5 and above (except pregnant women) in 2019 and 2020.",5300153.74,null,"Inactive","a6Q1R000000AIzY",0,5300153.74,0,0,0,1,null,null,"Acquiring artesunate injectables for the management of severe malaria in patients aged 5 and above (except pregnant women) in 2019 and 2020.","High","For the procurement of medicines for the treatment of severe malaria cases 2019-2020. To ensure availability and increase access to quality medicines, consequently, reducing fatality from severe malaria","NA Original Module: Support. Original Intervention: Medicines for the treatment of severe malaria","Alana Sharp","2020-01-15","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Guatemala","Guatemala","PAI-6151","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","IEC actions (information, education and communication) to develop a strategy to promote safe and responsible sexual practices (consultancy fees)\n\nIndicators:\nReduce the gap of 2016 on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",20000,20000,"Active","a6Q1R000000AJeE",{"$nulls":4},20000,0,null,"High","IEC actions (information, education and communication) to develop a strategy to promote safe and responsible sexual practices (consultancy fees)\n\nIndicators:\nReduce the gap of 2016 on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Alana Sharp","2019-11-08","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6150","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Consultancy to develop a follow-up strategy for new-born babies to HIV-positive mothers and ensure adequate care (resources for mobilization, promoters, linkage to strategies already in progress)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)",20000,20000,"Active","a6Q1R000000AJeD",{"$nulls":4},20000,0,null,"High","Consultancy to develop a follow-up strategy for new-born babies to HIV-positive mothers and ensure adequate care (resources for mobilization, promoters, linkage to strategies already in progress)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","High",null,null,"Alana Sharp","2019-11-08","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6141","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Special TA for the expansion of ETMI interventions progressively to establishments of all levels of care, prioritizing the first and second levels to increase the coverage of prenatal, delivery and puerperium care with qualified personnel within the framework of the primary health care strategy.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",10395,10395,"Active","a6Q1R000000AJe4",{"$nulls":4},10395,0,null,"High","Special TA for the expansion of ETMI interventions progressively to establishments of all levels of care, prioritizing the first and second levels to increase the coverage of prenatal, delivery and puerperium care with qualified personnel within the framework of the primary health care strategy.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Alana Sharp","2019-11-08","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-6132","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",1197668,1197668,"Inactive","a6Q1R000000AJct",null,1197668,null,null,0,1,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2019-12-10","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","Tuberculosis"]
["CT Ukraine","Ukraine","PAI-6128","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1600000,1600000,"Inactive","a6Q1R000000AJcZ",null,1600000,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","Tuberculosis"]
["CT Turkmenistan","Turkmenistan","PAI-6135","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Turkmenistan plans to make the transition to the new WHO guidelines from July 2019 and would require additional funding for 2019 and 2020. Over 1000 RR/MDR TB patients are expected to transition to the new RR/MDR TB treatment regimens in next 1.5 years, leading to an estimated gap to be funded through portfolio optimization.",786793,786793,"Inactive","a6Q1R000000AJd8",null,786793,null,null,0,1,null,"High","Turkmenistan plans to make the transition to the new WHO guidelines from July 2019 and would require additional funding for 2019 and 2020. Over 1000 RR/MDR TB patients are expected to transition to the new RR/MDR TB treatment regimens in next 1.5 years, leading to an estimated gap to be funded through portfolio optimization.","High",null,null,"Alana Sharp","2019-11-28","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-06-30","Tuberculosis"]
["CT Namibia","Namibia","PAI-6133","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1059911,1059911,"Inactive","a6Q1R000000AJcy",null,1059911,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis"," Southern and Eastern Africa","2020-12-31","Tuberculosis"]
["CT Tajikistan","Tajikistan","PAI-6126","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1419703,1419703,"Active","a6Q1R000000AJcP",null,1419701.93,null,null,1.07,0,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-03-31","Tuberculosis"]
["CT Ethiopia","Ethiopia","PAI-6130","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",3000000,3000000,"Active","a6Q1R000000AJcj",{"$nulls":4},3000000,0,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2019-11-06","2017-2019","Tuberculosis"," High Impact Africa 2","2021-06-30","Tuberculosis"]
["CT Kenya","Kenya","PAI-6131","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",1578834,1578834,"Active","a6Q1R000000AJco",{"$nulls":4},1578834,0,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2019-11-06","2017-2019","Tuberculosis"," High Impact Africa 2","2021-06-30","Tuberculosis"]
["CT Azerbaijan","Azerbaijan","PAI-6129","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",2227664,2227664,"Inactive","a6Q1R000000AJce",null,2227664,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","Tuberculosis"]
["CT Uganda","Uganda","PAI-6127","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",2000000,2000000,"Inactive","a6Q1R000000AJcU",null,2000000,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis"," High Impact Africa 2","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-6184","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.",206900,206900,"Active","a6Q1R000000AJn2",{"$nulls":4},206900,0,null,"High","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Rwanda","Rwanda","PAI-6194","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","This request is for alignment of grant.",2100000,2100000,"Active","a6Q1R000000AJnG",{"$nulls":4},2100000,0,null,"High","This request is for alignment of grant.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria"," Southern and Eastern Africa",null,"Multi-component"]
["CT Rwanda","Rwanda","PAI-6193","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","This request is for alignment of grant.",1003118,1003118,"Active","a6Q1R000000AJnF",{"$nulls":4},1003118,0,null,"High","This request is for alignment of grant.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria"," Southern and Eastern Africa",null,"Multi-component"]
["CT Rwanda","Rwanda","PAI-6192","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","This request is for alignment of grant.",5166187,5166187,"Active","a6Q1R000000AJnE",{"$nulls":4},5166187,0,null,"High","This request is for alignment of grant.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria"," Southern and Eastern Africa",null,"Multi-component"]
["CT Rwanda","Rwanda","PAI-6191","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","This request is for alignment of grant.",11617393,11617393,"Active","a6Q1R000000AJnD",{"$nulls":4},11617393,0,null,"High","This request is for alignment of grant.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria"," Southern and Eastern Africa",null,"Multi-component"]
["CT Rwanda","Rwanda","PAI-6190","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.",10958103,10958103,"Active","a6Q1R000000AJnC",{"$nulls":4},10958103,0,null,"High","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria"," Southern and Eastern Africa",null,"Multi-component"]
["CT Madagascar","Madagascar","PAI-6182","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.",16758100,16758100,"Inactive","a6Q1R000000AJms",null,16758100,null,null,0,1,null,"High","Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Nigeria","Nigeria","PAI-6183","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.",9515528,9515528,"Active","a6Q1R000000AJmx",{"$nulls":4},9515528,0,"2020-01-29T12:52:00","High","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Namibia","Namibia","PAI-6180","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Procure essential   350 000 LLIN's to cover cover the gap currently experieneced with populations living in Zinc Structures.   The Zinc structures were earmarked for IRS as well but it was found that IRS is not best suited for Zinc Structures.  The programme is currently testing the residual efficacy of insecticides (Actelic) on Zinc structures, while collecting this data, people residing in these structure should be protected by mosquito nets. The 300,000  Nets constitute the gap since these population were not targeted  for nets before. Price includes PSM costs",1384600,1384600,"Active","a6Q1R000000AJkm",{"$nulls":4},1384600,0,null,"High","Procure essential   350 000 LLIN's to cover cover the gap currently experieneced with populations living in Zinc Structures.   The Zinc structures were earmarked for IRS as well but it was found that IRS is not best suited for Zinc Structures.  The programme is currently testing the residual efficacy of insecticides (Actelic) on Zinc structures, while collecting this data, people residing in these structure should be protected by mosquito nets. The 300,000  Nets constitute the gap since these population were not targeted  for nets before. Price includes PSM costs","High","Population at risk to malaria  should always be protected. As zinc structure is not sprayable and as the change from zink structure to sprayable surfaces is not possible now and as research is going on to find  a solution for this problem; it isjustified to shift to LLINs to protect at risk population",null,"Malgorzata Matysek","2019-11-29","2017-2019","Malaria"," Southern and Eastern Africa","2020-12-31","Malaria"]
["CT Nigeria","Nigeria","PAI-6213","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",10000000,10000000,"Inactive","a6Q1R000000AJtZ",null,10000000,null,null,0,1,"2020-01-29T12:52:00","High","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Anouk Chevalier Plante","2020-01-29","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Nigeria","Nigeria","PAI-5270","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Across the country, 227 LGAs in Nine States are eligible for SMC. With funding from UNITAID, 37 LGAs will be covered up to 2018 and PMI plans to fund SMC in 58 LGAs across 3 states in 2018.according to the state selection document, 122 LGAs (4 states) are eligible for SMC within the 13 GF supported states. To cover the eligible children over the next 3 years, in selected LGAs for SMC implementation under the GF grant, 13,977,294 children need to be reached with SMC. Being able to implement SMC will lead to rapid decline in malaria prevalence, contributing to overall goals of Nigeria?s malaria control programme",15400000,null,"Inactive","a6Q1R000000AJMS",0,15400000,0,0,0,1,"2020-01-29T12:52:00",null,"Across the country, 227 LGAs in Nine States are eligible for SMC. With funding from UNITAID, 37 LGAs will be covered up to 2018 and PMI plans to fund SMC in 58 LGAs across 3 states in 2018.according to the state selection document, 122 LGAs (4 states) are eligible for SMC within the 13 GF supported states. To cover the eligible children over the next 3 years, in selected LGAs for SMC implementation under the GF grant, 13,977,294 children need to be reached with SMC. Being able to implement SMC will lead to rapid decline in malaria prevalence, contributing to overall goals of Nigeria?s malaria control programme","High","High impact intervention for SMC-eligible Global Fund states, complementing PMI and UNITAID investment in 5 states.","From email from Bianca on the 10/07/2019 frpm CT: This UQD amount will cover 3.56m children under 5 in 2020 in Jigawa (with DFID)(100%), Kano (38%), Katsina (100%),  and Yobe (100%). Last week, SPAQ worth of 5,967,166 US$ needed for 2020 SMC were ordered. Grant savings will be used to cover the costs. The remaining UQD amount is needed to cover 2020 SMC operational costs. Original Module: Specific prevention interventions. Original Intervention: Seasonal Malaria Chemoprevention (SMC)","Anouk Chevalier Plante","2020-01-29","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Guatemala","Guatemala","PAI-6152","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","Interinstitutional Articulation National Program of STIs, HIV and AIDS - Comprehensive Health System - National Reproductive Health Plan - Health Areas Directorate - National Health Laboratory - Hospitals; IGSS, APROFAM, Military Health, Association of private hospitals among others and non-governmental organizations that work on the subject, to support the sustainability of interventions.\n\nCovers the cost of consultancy to facilitate this\n\nIndicators:\nReduce the gap of 2016 on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 2000",2069,2069,"Inactive","a6Q1R000000AJeF",null,null,2069,null,0,1,null,"High","Interinstitutional Articulation National Program of STIs, HIV and AIDS - Comprehensive Health System - National Reproductive Health Plan - Health Areas Directorate - National Health Laboratory - Hospitals; IGSS, APROFAM, Military Health, Association of private hospitals among others and non-governmental organizations that work on the subject, to support the sustainability of interventions.\n\nCovers the cost of consultancy to facilitate this\n\nIndicators:\nReduce the gap of 2016 on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 2000","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6153","MCI-00023","Program management","MCI-00207","Grant management","Operational support of personnel for the MSPAS and INCAP consisting of:\n1- A facilitator for the ETMI hired for the PNS.\n2- Officer dedicated to the Monitoring and Evaluation of the ETMI component in the PNS\n3- Responsible for ETMI\n4- Secretarial support\n\nTo this is added the percentage of operational expenses of INCAP (1% for the acquisition of tests and 5% for the rest of the items)\nTransversal contribution to the indicators related to prevention and treatment. This item was updated in October 2019 to increment the original approaved amount of 211260",261834,261834,"Inactive","a6Q1R000000AJeG",null,null,261834,null,0,1,null,"High","Operational support of personnel for the MSPAS and INCAP consisting of:\n1- A facilitator for the ETMI hired for the PNS.\n2- Officer dedicated to the Monitoring and Evaluation of the ETMI component in the PNS\n3- Responsible for ETMI\n4- Secretarial support\n\nTo this is added the percentage of operational expenses of INCAP (1% for the acquisition of tests and 5% for the rest of the items)\nTransversal contribution to the indicators related to prevention and treatment. This item was updated in October 2019 to increment the original approaved amount of 211260","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6148","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Strategy for tracking positive cases lost and improving the link (mobilization vouchers, health promoters, mobile phones) (will investigate possible synergies with existing strategies such as multisectoral networks. (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017). This item was updated in October 2019 to increment the original approaved amount of 20000",30000,30000,"Inactive","a6Q1R000000AJeB",null,null,30000,null,0,1,null,"High","Strategy for tracking positive cases lost and improving the link (mobilization vouchers, health promoters, mobile phones) (will investigate possible synergies with existing strategies such as multisectoral networks. (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017). This item was updated in October 2019 to increment the original approaved amount of 20000","High","The TRP recommends this activity to be included in the ongoing program submitted under the Program Continuation modality, to be funded with the savings / efficiencies found from ?within allocation? funds.",null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6149","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Based on official guidelines, design a training protocol to ensure readiness of health services to attend pregnant women arriving to health facilities at the moment of delivery without having attended previously ANC. (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)",20000,20000,"Inactive","a6Q1R000000AJeC",null,null,20000,null,0,1,null,"High","Based on official guidelines, design a training protocol to ensure readiness of health services to attend pregnant women arriving to health facilities at the moment of delivery without having attended previously ANC. (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","High","The TRP recommends this activity to be included in the proposed activities to \"Strengthening of capacities, improvement of sensitivity and quality care to all health providers in topics related to orientation, screening and the approach of pregnant women with HIV, Syphilis and Hepatitis B? as detailed in the eighth item recommended in this Review Form.",null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6140","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Pilot to articulate and integrate test screening into midwives and other community actors EMTCT activities.\nIncludes; consultancy fees for the design of the pilot program (tools, pedagogic materials, monitoring and evaluation system, includes syphilis, Hep B and HIV tests, as well as costs to evaluate the program and a final consultancy to analyze the sustainability of this strategy and potential absorption by MSPAS.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 70211",119938,119938,"Inactive","a6Q1R000000AJe3",null,null,119938,null,0,1,null,"High","Pilot to articulate and integrate test screening into midwives and other community actors EMTCT activities.\nIncludes; consultancy fees for the design of the pilot program (tools, pedagogic materials, monitoring and evaluation system, includes syphilis, Hep B and HIV tests, as well as costs to evaluate the program and a final consultancy to analyze the sustainability of this strategy and potential absorption by MSPAS.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 70211","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6147","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Establishment of a routine system for measuring the quality of care in NC services through measurement of user satisfaction and provision of services (mystery clients) (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)",25000,25000,"Active","a6Q1R000000AJeA",null,null,10000,null,15000,0,null,"High","Establishment of a routine system for measuring the quality of care in NC services through measurement of user satisfaction and provision of services (mystery clients) (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","Low","The TRP recommends this activity to be embedded in the scope of work for the \"Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women? as detailed in the second item recommended in this Review Form.",null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6146","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","onsultancy fees to develop a strategy to strengthen the system for monitoring compliance and achieving results through a non-economic recognition system.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",15000,15000,"Active","a6Q1R000000AJe9",null,null,10000,null,5000,0,null,"High","onsultancy fees to develop a strategy to strengthen the system for monitoring compliance and achieving results through a non-economic recognition system.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6145","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Assurance of availability and access to screening tests for HIV, syphilis and hepatitis B for women in pregnancy, delivery and puerperium\nIncludes HIV and Syphilis tests to cover the gap of pregnant women not receiving an HIV or syphilis test (PSM costs included)\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 808989",913060,913060,"Inactive","a6Q1R000000AJe8",null,null,913060,null,0,1,null,"High","Assurance of availability and access to screening tests for HIV, syphilis and hepatitis B for women in pregnancy, delivery and puerperium\nIncludes HIV and Syphilis tests to cover the gap of pregnant women not receiving an HIV or syphilis test (PSM costs included)\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 808989","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6144","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Strengthening of capacities, improvement of sensitivity and quality care to all health providers in topics related to orientation, screening and the approach of pregnant women with HIV, Sifilis and Hepatitis B, integrating these topics into the routine work of health services. Health\n\nIncludes: pedagogical material for trainings, training costs (accomodation, food and transportation),  consultancy fees to provide support conducting the trainings that are scheduled and reduce the work volumen for the National HIV program (a total of 87 trainings) and development of an online training module through a consultancy\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)",517363,517363,"Active","a6Q1R000000AJe7",null,null,399798,null,117565,0,null,"High","Strengthening of capacities, improvement of sensitivity and quality care to all health providers in topics related to orientation, screening and the approach of pregnant women with HIV, Sifilis and Hepatitis B, integrating these topics into the routine work of health services. Health\n\nIncludes: pedagogical material for trainings, training costs (accomodation, food and transportation),  consultancy fees to provide support conducting the trainings that are scheduled and reduce the work volumen for the National HIV program (a total of 87 trainings) and development of an online training module through a consultancy\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6143","MCI-00006","PMTCT",null,null,"Expand the resolution capacity of the health service network of the second and third level of care, for the diagnosis of HIV, syphilis and hepatitis B in pregnant women, as well as ensuring the link of newborns exposed to HIV to the UAI that corresponds to them .\n\nIncludes: TA to conduct the needs assessment and 2 other sums to cover; (i) design of a costed strengthening plan based on the assessment and (ii) fund to implement actions of the stenghtening plan\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",1129912,1129912,"Active","a6Q1R000000AJe6",null,null,486642,null,643270,0,null,"High","Expand the resolution capacity of the health service network of the second and third level of care, for the diagnosis of HIV, syphilis and hepatitis B in pregnant women, as well as ensuring the link of newborns exposed to HIV to the UAI that corresponds to them .\n\nIncludes: TA to conduct the needs assessment and 2 other sums to cover; (i) design of a costed strengthening plan based on the assessment and (ii) fund to implement actions of the stenghtening plan\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6142","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Update and implement protocols, care guides and standards for prenatal monitoring and follow-up of pregnant women with HIV, syphilis and hepatitis B and feeding children exposed to HIV with breast milk substitutes, to children exposed to HIV.\nIncludes funds to print all the updated materials for all services accross the EMTCT care continuum\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",75000,75000,"Active","a6Q1R000000AJe5",null,null,62216,null,12784,0,null,"High","Update and implement protocols, care guides and standards for prenatal monitoring and follow-up of pregnant women with HIV, syphilis and hepatitis B and feeding children exposed to HIV with breast milk substitutes, to children exposed to HIV.\nIncludes funds to print all the updated materials for all services accross the EMTCT care continuum\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6139","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Involve key community actors (organized networks of women and departmental networks of responsible paternity and HIV and HIV), leaders, promoters, auxiliary mayors and midwives to search and recruit of pregnant women and in the promotion of screening in pregnant women.\n\nIncludes consultancy fees to do a mapping exercice of actors, and costs for meetings and training sessions for community leaders and midwives, as well as training kits for midwives (to facilitate the implementation of renewed EMTCT scope of work)\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",349001,349001,"Active","a6Q1R000000AJe2",null,null,236745,null,112256,0,null,"High","Involve key community actors (organized networks of women and departmental networks of responsible paternity and HIV and HIV), leaders, promoters, auxiliary mayors and midwives to search and recruit of pregnant women and in the promotion of screening in pregnant women.\n\nIncludes consultancy fees to do a mapping exercice of actors, and costs for meetings and training sessions for community leaders and midwives, as well as training kits for midwives (to facilitate the implementation of renewed EMTCT scope of work)\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-6138","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women, adapted to needs. This plan must be specific for clearly identified target groups and with translation into the local language, including people's rights approaches .\nThe same TA will be used to conduct end user surveys to evaluate the impact of messages devliered by the campaign\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 119290",142697,142697,"Inactive","a6Q1R000000AJe1",null,null,142697,null,0,1,null,"High","Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women, adapted to needs. This plan must be specific for clearly identified target groups and with translation into the local language, including people's rights approaches .\nThe same TA will be used to conduct end user surveys to evaluate the impact of messages devliered by the campaign\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 119290","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Congo","Congo","PAI-6123","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",391999.78,391999.78,"Inactive","a6Q1R000000AJcA",null,391999.78,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Togo","Togo","PAI-6214","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",309000,309000,"Inactive","a6Q1R000000AJte",null,309000,null,null,0,1,null,"High","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Shalini Mitra","2020-01-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Belarus","Belarus","PAI-6168","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00097","Needle and Syringe programs for PWID and their partners","When planning the BLR-C-RSPCMT grant for 2019-2021, it was assumed that, starting in 2020, Belarus will purchase supplies (syringes, condoms, etc.) for HIV prevention cabinets for PWID at the expense of the state budget. An analysis of the existing legislative framework showed that legislative amendments are required to conduct such purchases. Changes can be made to the rulemaking plan only for 2021, adopted - not earlier than 2022. Thus, we consider it necessary to include the provision of supplies for HIV prevention cabinets for PWID at the expense of the grant BLR-C-RSPCMT.",185040.65,185040.65,"Active","a6Q1R000000AJir",{"$nulls":4},185040.65,0,null,"High","When planning the BLR-C-RSPCMT grant for 2019-2021, it was assumed that, starting in 2020, Belarus will purchase supplies (syringes, condoms, etc.) for HIV prevention cabinets for PWID at the expense of the state budget. An analysis of the existing legislative framework showed that legislative amendments are required to conduct such purchases. Changes can be made to the rulemaking plan only for 2021, adopted - not earlier than 2022. Thus, we consider it necessary to include the provision of supplies for HIV prevention cabinets for PWID at the expense of the grant BLR-C-RSPCMT.","High","This activity is in line with the main allocation and provides additional prevention programming which is technically sound and strategically focussed",null,"Shalini Mitra","2019-12-03","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT Belarus","Belarus","PAI-6167","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. \nFrom 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the client?s desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant ?Sustainability of Services for Key Populations in the EECA Region?, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.",331819.28000000003,331819.28000000003,"Active","a6Q1R000000AJiq",{"$nulls":4},331819.28000000003,0,null,"High","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. \nFrom 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the client?s desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant ?Sustainability of Services for Key Populations in the EECA Region?, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.","High","The TRP agrees that some oral fluid based tests may be needed, especially for self-screening or CSO based screening programmes. The TRP notes that it is important to ensure that adequate information is available emphasising the need for  confirmation of any positive oral fluid tests with blood-based rapid tests.",null,"Shalini Mitra","2019-12-03","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT Liberia","Liberia","PAI-4698","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","High Specific prevention interventions (SPI) IEC/BCC (SPI) 488,160 This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.   ? Year 3 cost for program continuation (within allocation); 3 years cost for additional 5 counties including 2 additional districts in Margibi (iCCM priority gaps recognized by the LCM, MOH and other iCCM partners in the implementation of the Revised National Community Health program in Liberia.",2234920,null,"Active","a6Q1R000000AJDE",0,0,9600,0,2225320,0,null,null,"High Specific prevention interventions (SPI) IEC/BCC (SPI) 488,160 This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.   ? Year 3 cost for program continuation (within allocation); 3 years cost for additional 5 counties including 2 additional districts in Margibi (iCCM priority gaps recognized by the LCM, MOH and other iCCM partners in the implementation of the Revised National Community Health program in Liberia.","High",null,"NA Original Module: Specific prevention interventions. Original Intervention: Information, education, communication/Behavior change communications (specific prevention interventions)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-6215","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","SMC was initiated in Guinea Bissau in 2016 by the MOH in partnership with MSF, UNDP and AIFO covering 50% of the Bafata Region (7 of 14 ADS = Area de Saud = Health Districts) and 74% of the Gabu region (14 of 19 ADS). Over 85% (37,379 / 43,715) children aged 3-59 months in the 21 ADS received at least 1 dose of SMC. In 2017, SMC was expanded to geographically cover 100% of the 2 high malaria prevalence regions. Over 99% of 83,667 children received at least 1 dose, 82% received 3 doses and 61% of children received 4 doses, with a high level of acceptability and tolerance by the community. WHO recommends an SMC coverage with 3 to 4 doses for an effective impact. It is essential to maintain SMC in these regions to ensure a sustainable impact of the intervention.The operational costs for SMC have been significantly reduced by changing the strategy from Fixed Point to Door to Door. In 2019 and 2020 the MOH has planned the SMC campaigns to be implemented without International NGOs only by regional health departments, further reducing costs. Despite these efforts the country has a gap of 523,683 EUR for SMC operational costs, including UNDP GMS.",312318,312318,"Active","a6Q1R000000AJtj",{"$nulls":4},312318,0,null,"High","SMC was initiated in Guinea Bissau in 2016 by the MOH in partnership with MSF, UNDP and AIFO covering 50% of the Bafata Region (7 of 14 ADS = Area de Saud = Health Districts) and 74% of the Gabu region (14 of 19 ADS). Over 85% (37,379 / 43,715) children aged 3-59 months in the 21 ADS received at least 1 dose of SMC. In 2017, SMC was expanded to geographically cover 100% of the 2 high malaria prevalence regions. Over 99% of 83,667 children received at least 1 dose, 82% received 3 doses and 61% of children received 4 doses, with a high level of acceptability and tolerance by the community. WHO recommends an SMC coverage with 3 to 4 doses for an effective impact. It is essential to maintain SMC in these regions to ensure a sustainable impact of the intervention.The operational costs for SMC have been significantly reduced by changing the strategy from Fixed Point to Door to Door. In 2019 and 2020 the MOH has planned the SMC campaigns to be implemented without International NGOs only by regional health departments, further reducing costs. Despite these efforts the country has a gap of 523,683 EUR for SMC operational costs, including UNDP GMS.","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Shalini Mitra","2020-01-30","2017-2019","Malaria"," Western Africa","2020-12-31","Malaria"]
["CT Benin","Benin","PAI-6211","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",750000,750000,"Active","a6Q1R000000AJtP",{"$nulls":4},750000,0,null,"High","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Shalini Mitra","2020-01-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Chad","Chad","PAI-6212","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",5400000,5400000,"Active","a6Q1R000000AJtU",null,4000000,null,null,1400000,0,null,"High","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Shalini Mitra","2020-01-30","2017-2019","Malaria"," Central Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4693","MCI-00023","Program management","MCI-00207","Grant management","This activity will add quality to the community health program implementation.  The activity (program review) for which the request is made creates opportunity for quarterly program review and planning where field staff, county health teams and program staff at county and central levels meet to discuss and find solutions to program implementation challenges where they exist or strategize for quality implementation for the period ahead. Performance against achievement is discussed at the meetings and the meetings contribute to the program data review and report writing issues. The also creates opportunity for review of compliance issues related to finance, program technical areas, policies and grant agreement. It also promotes, learning and sharing, coordination and effective collaboration as different stakeholders are brought together to discuss and work in a coordinated manner.",56100,null,"Active","a6Q1R000000AJD9",0,0,9540,0,46560,0,null,null,"This activity will add quality to the community health program implementation.  The activity (program review) for which the request is made creates opportunity for quarterly program review and planning where field staff, county health teams and program staff at county and central levels meet to discuss and find solutions to program implementation challenges where they exist or strategize for quality implementation for the period ahead. Performance against achievement is discussed at the meetings and the meetings contribute to the program data review and report writing issues. The also creates opportunity for review of compliance issues related to finance, program technical areas, policies and grant agreement. It also promotes, learning and sharing, coordination and effective collaboration as different stakeholders are brought together to discuss and work in a coordinated manner.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4687","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","The MOH is working towards a transition to the new warehouse. Funding request is for building additional office space for the essential CMS staff.  The total estimated cost for the office building is set at $882,500. Out of this amount, the MOH has internally mobilized $200,000.00 and have also secured a $50,000.00 commitment from GAVI against the cost of the building. This leaves a balance of $632,500.00 to be sourced through external partners, including the Global Fund.",635000,null,"Active","a6Q1R000000AJD3",0,0,0,0,635000,0,null,null,"The MOH is working towards a transition to the new warehouse. Funding request is for building additional office space for the essential CMS staff.  The total estimated cost for the office building is set at $882,500. Out of this amount, the MOH has internally mobilized $200,000.00 and have also secured a $50,000.00 commitment from GAVI against the cost of the building. This leaves a balance of $632,500.00 to be sourced through external partners, including the Global Fund.","Medium","While the Global Fund has already invested in infrastructure and within a context of major persisting gaps, the TRP considers gaps in service delivery are more pressing.","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4697","MCI-00012","Case management","MCI-00161","Private sector case management","Quarterly Feedback Meeting PSACT implementation together to provide feedback about the program. The meeting will seek to understand the impression of the proprietors of the program and get feedback on the community reaction to the testing and treatment as well as the overall program. Also the forum will be used to provide feedback to proprietors on their performance and adherence to the program rules as well as recognize best practice pharmaceutical outlets to engender competition among the proprietors. The forum will also be used to identify pharmaceutical outlets that are noncompliant and depending on the degree of noncompliance inform them on the actions that will be taken on the non-compliant proprietor. This will further improve the quality of the PSACT program.",40000,null,"Active","a6Q1R000000AJDD",0,0,0,0,40000,0,null,null,"Quarterly Feedback Meeting PSACT implementation together to provide feedback about the program. The meeting will seek to understand the impression of the proprietors of the program and get feedback on the community reaction to the testing and treatment as well as the overall program. Also the forum will be used to provide feedback to proprietors on their performance and adherence to the program rules as well as recognize best practice pharmaceutical outlets to engender competition among the proprietors. The forum will also be used to identify pharmaceutical outlets that are noncompliant and depending on the degree of noncompliance inform them on the actions that will be taken on the non-compliant proprietor. This will further improve the quality of the PSACT program.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4696","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Although the LMHRA has worked strongly with other agencies and developing partners to develop capacity in medicine quality regulations, quality control, and data generation and post market quality surveillance, these efforts are challenged with limited funding from the Government of Liberia, developing partners and other agencies to support the operation and implementation of medicines regulatory policies. This intervention has been earmarked for the first time in the National Malaria Control monitoring and evaluation plan 2016 ? 2020 as one of the Program?s monitoring mechanisms to be implemented by the LHMRA.",90000,null,"Active","a6Q1R000000AJDC",0,0,0,0,90000,0,null,null,"Although the LMHRA has worked strongly with other agencies and developing partners to develop capacity in medicine quality regulations, quality control, and data generation and post market quality surveillance, these efforts are challenged with limited funding from the Government of Liberia, developing partners and other agencies to support the operation and implementation of medicines regulatory policies. This intervention has been earmarked for the first time in the National Malaria Control monitoring and evaluation plan 2016 ? 2020 as one of the Program?s monitoring mechanisms to be implemented by the LHMRA.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4688","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","The perfect functioning of the GeneXpert machine will support the case detection of Multi Drug Resistance (MDR/RIF) cases.  All the Genexpert machines warranty will expire in 2019. Therefore. updating the warranty of these machines will ensure perfect mantiance by Chepid for the following reasons: module replacement and fan replacement. If there is a major problem on a machine with the updated warranty, Chepid can be replace the machine at no cost.",89772,null,"Active","a6Q1R000000AJD4",0,0,0,0,89772,0,null,null,"The perfect functioning of the GeneXpert machine will support the case detection of Multi Drug Resistance (MDR/RIF) cases.  All the Genexpert machines warranty will expire in 2019. Therefore. updating the warranty of these machines will ensure perfect mantiance by Chepid for the following reasons: module replacement and fan replacement. If there is a major problem on a machine with the updated warranty, Chepid can be replace the machine at no cost.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4694","MCI-00023","Program management","MCI-00207","Grant management","This covers program HR cost for the PR including salaries & benefits working on or supporting the program management and implementation.  This is for implementing in additional 2 districts in Margibi and gap in Lofa - 3 existing GF supported districts (2 M & E Officers for Margibi  - 1 & Lofa - 1)",1967591,null,"Active","a6Q1R000000AJDA",0,0,256490,0,1711101,0,null,null,"This covers program HR cost for the PR including salaries & benefits working on or supporting the program management and implementation.  This is for implementing in additional 2 districts in Margibi and gap in Lofa - 3 existing GF supported districts (2 M & E Officers for Margibi  - 1 & Lofa - 1)","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Rwanda","Rwanda","PAI-5474","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Above allocation will support salaries for M&E staff at central level and in health facilities. Data collection, reporting and analysis are essential for informed decision making and efficient program management.",328260,null,"Active","a6Q1R000000AJPk",0,0,0,0,328260,0,null,null,"Above allocation will support salaries for M&E staff at central level and in health facilities. Data collection, reporting and analysis are essential for informed decision making and efficient program management.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Rwanda","Rwanda","PAI-5473","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Above allocation will ensure adequate maintenance of infrastructures and equipment as well as ambulance and other vehicles necessary for supervision and sample transportation. Capacity building of laboratory technologists will also be supported. These expenses are essential to ensure quality of HIV services in the long term.",2764891,null,"Active","a6Q1R000000AJPj",0,0,0,0,2764891,0,null,null,"Above allocation will ensure adequate maintenance of infrastructures and equipment as well as ambulance and other vehicles necessary for supervision and sample transportation. Capacity building of laboratory technologists will also be supported. These expenses are essential to ensure quality of HIV services in the long term.","Medium","Not an essential service for impact","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Rwanda","Rwanda","PAI-5472","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","Above allocation (USD 3,218,722) will provide educational support to Most Vulnerable Children (particularly vocational training). Economic empowerment and life skills building will reduce the risk of HIV infection for these vulnerable children. The other support covered by above allocation amount in this programmatic area is salary for service providers at decentralized level , which will improve quality of prevention services. (USD 1,396,104)",4614826,null,"Active","a6Q1R000000AJPi",0,0,0,0,4614826,0,null,null,"Above allocation (USD 3,218,722) will provide educational support to Most Vulnerable Children (particularly vocational training). Economic empowerment and life skills building will reduce the risk of HIV infection for these vulnerable children. The other support covered by above allocation amount in this programmatic area is salary for service providers at decentralized level , which will improve quality of prevention services. (USD 1,396,104)","Medium","OVCs are not driving the epidemic","NA Original Intervention: Support for orphans and vulnerable children minimum package","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Rwanda","Rwanda","PAI-5471","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00177","Other health and community workforce intervention(s)","Since 2012, the HRH Program has trained specialists in different medical fields. USD 2,356,241 is earmarked for the program?s continuation to ensure that the current cohort of trainees can complete the training program within 3 years thereby ensuring sustainability and the quality of care in HIV and co-morbidities? (Malaria, TB, Hepatitis). Efficiencies have been generated in the program through the use of local faculty trainers",4059303,null,"Active","a6Q1R000000AJPh",1349931,0,0,0,2709372,0,null,null,"Since 2012, the HRH Program has trained specialists in different medical fields. USD 2,356,241 is earmarked for the program?s continuation to ensure that the current cohort of trainees can complete the training program within 3 years thereby ensuring sustainability and the quality of care in HIV and co-morbidities? (Malaria, TB, Hepatitis). Efficiencies have been generated in the program through the use of local faculty trainers","Medium","Sustainability issue","NA Original Module: RSSH - Human resources for health, including community health workers. Original Intervention: Capacity building for health workers and scale up of health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Rwanda","Rwanda","PAI-5470","MCI-00007","Treatment, care and support","MCI-00117","HIV care","The nutrition support included in the allocation will only cover the needs of the most vulnerable patients. The above allocation will cover nutrition support for PLHIV suffering from malnutrition (USD 3,441,205) (23% for CSB+ and 60% for RUTF). USD 112,232 is earmarked for training and start-up capital for 27 PLHIV cooperatives. Also USD 1,641,299 is included for human resources support to health care providers.",5194737,null,"Active","a6Q1R000000AJPg",1179126,0,0,0,4015611,0,null,null,"The nutrition support included in the allocation will only cover the needs of the most vulnerable patients. The above allocation will cover nutrition support for PLHIV suffering from malnutrition (USD 3,441,205) (23% for CSB+ and 60% for RUTF). USD 112,232 is earmarked for training and start-up capital for 27 PLHIV cooperatives. Also USD 1,641,299 is included for human resources support to health care providers.","Medium","No strong scientific evidence that nutrition support the outcome of TB treatment",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Rwanda","Rwanda","PAI-5469","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Above allocation will provide payment of Community-based health insurance (CBHI) for vulnerable groups which are not able to pay for themselves therefore removing financial barriers for access to basic health services in general and HIV services in particular. It is estimated that around 1,926, 292 people/ 3years (CBHI fee=3.43 USD /person/year ) will benefit from the support.",6607183,null,"Active","a6Q1R000000AJPf",0,0,0,0,6607183,0,null,null,"Above allocation will provide payment of Community-based health insurance (CBHI) for vulnerable groups which are not able to pay for themselves therefore removing financial barriers for access to basic health services in general and HIV services in particular. It is estimated that around 1,926, 292 people/ 3years (CBHI fee=3.43 USD /person/year ) will benefit from the support.","Medium","Concerns about issues of sustainability","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Supportive policy and programmatic environment (Community-based health insurance)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Philippines","Philippines","PAI-5378","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Constitutes prevention, testing and treatment costs for 14 sites out of the 39 high disease burden sites identified as FR sites.",554152.41,null,"Inactive","a6Q1R000000AJOC",554152.41,0,0,0,0,1,null,null,"Constitutes prevention, testing and treatment costs for 14 sites out of the 39 high disease burden sites identified as FR sites.","High","The motivational support to help enrol and maintain new people into HIV treatment has the potential to improve the leakages in the treatment cascade.","NA Original Module: Access to treatment, care and support. Original Intervention: Counselling and psycho-social support (treatment hub care agents, transportation and meal for support visits)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Philippines","Philippines","PAI-5377","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","The war on drugs makes it even more difficult for PWID to access services. An expanded options for PWID, coupled with high level advocacy, will contribute to increased access of PWIDs to services.",507799.52,null,"Inactive","a6Q1R000000AJOB",507799.52,0,0,0,0,1,null,null,"The war on drugs makes it even more difficult for PWID to access services. An expanded options for PWID, coupled with high level advocacy, will contribute to increased access of PWIDs to services.","High","The PWID interventions face the largest funding gap in both national and allocation responses, therefore need prioritization as one of the key affected populations with the most challenging access to evidencebased package of services","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioural interventions for PWID condom lubricant and programming HIV testing services","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Peru","Peru","PAI-5376","MCI-00008","TB care and prevention","MCI-00128","Prevention","Implementation of updated national guidelines for management of pediatric TB at the primary health care level",54800,null,"Inactive","a6Q1R000000AJOA",54800,0,0,0,0,1,null,null,"Implementation of updated national guidelines for management of pediatric TB at the primary health care level","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Peru","Peru","PAI-5375","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","Systematization of the experience with the prison population in the 12 prisons targeted by interventions",20000,null,"Inactive","a6Q1R000000AJO9",20000,0,0,0,0,1,null,null,"Systematization of the experience with the prison population in the 12 prisons targeted by interventions","High",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Other other community responses and systems intervention(s)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Peru","Peru","PAI-5374","MCI-00010","MDR-TB","MCI-00144","Community MDR-TB care delivery","Capacity-building workshops to train CHWs on MDR-TB management and treatment adherence",142500,null,"Inactive","a6Q1R000000AJO8",142500,0,0,0,0,1,null,null,"Capacity-building workshops to train CHWs on MDR-TB management and treatment adherence","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Peru","Peru","PAI-5373","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Strengthening of local government capacities to ensure timely delivery of the PANTBC package",25000,null,"Inactive","a6Q1R000000AJO7",25000,0,0,0,0,1,null,null,"Strengthening of local government capacities to ensure timely delivery of the PANTBC package","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Peru","Peru","PAI-5372","MCI-00010","MDR-TB","MCI-00144","Community MDR-TB care delivery","Evaluation of CHW contribution to the TB response in order to justify its absorption with the national budget",10000,null,"Inactive","a6Q1R000000AJO6",10000,0,0,0,0,1,null,null,"Evaluation of CHW contribution to the TB response in order to justify its absorption with the national budget","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Panama","Panama","PAI-5371","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This request includes the integration of the Ministry of Public Helath (SIS) and Social Security Fund (SEIS) care and epidemiological surveillance systems. Integration of both systems would make all national information on HIV and tuberculosis available in a single database to facilitate corresponding analysis.",48000,null,"Active","a6Q1R000000AJO5",0,0,0,0,48000,0,null,null,"This request includes the integration of the Ministry of Public Helath (SIS) and Social Security Fund (SEIS) care and epidemiological surveillance systems. Integration of both systems would make all national information on HIV and tuberculosis available in a single database to facilitate corresponding analysis.","Medium","The TRP considers that this intervention to be medium priority as it increases the level of integration of disease specific system in to the the main health management information system platform. This intervention could increase data management efficiency and contribute to patient-centers care, but does not seem to be critical for the program performance.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Technical assistance to create the interface in the SEIS and SIS of the different forms for registration, diagnosis, notification and care and monitoring of established cases of TB and HIV.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Nepal","Nepal","PAI-5328","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Training on database management and data analysis at Central and peripheral levels to strengthen technical capacity in support of elimination.",11638,null,"Active","a6Q1R000000AJNO",0,0,0,0,11638,0,null,null,"Training on database management and data analysis at Central and peripheral levels to strengthen technical capacity in support of elimination.","High","Training on database management and data analysis at central and peripheral levels to strengthen technical capacity of information management and utilization is important, especially as the Malaria system gets linked up to the DHIS2.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5327","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Additional Technical assistance as required.",60000,null,"Active","a6Q1R000000AJNN",0,0,0,0,60000,0,null,null,"Additional Technical assistance as required.","High","Technical Assistance support for active case detection (ACD) surveillance systems is critical to case detection in elimination programmes, e.g. detecting symptomatic cases otherwise not detected by passive case detection (PCD), and asymptomatic cases in the community.","NA Original Intervention: Policy, planning, coordination and management","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5326","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Commemoration of World Malaria Day at Central and Districts levels Level to raise awareness and secure funding.",10386,null,"Active","a6Q1R000000AJNM",0,0,0,0,10386,0,null,null,"Commemoration of World Malaria Day at Central and Districts levels Level to raise awareness and secure funding.","Low","The contribution of World Malaria Day commemoration to malaria elimination is important to raise public awareness. However, such efforts have generally limited impact on intervention coverage, access or use, and the activity should be focused. Consequently, the costs for this activity are over-budgeted and the TRP recommends 10 percent of the requested amount as quality demand.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5325","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","Larval source management where vector breeding sites are ?few, fixed and findable? in order to maximize cost effectiveness and sustainability of operations.",1373,null,"Active","a6Q1R000000AJNL",0,0,0,0,1373,0,null,null,"Larval source management where vector breeding sites are ?few, fixed and findable? in order to maximize cost effectiveness and sustainability of operations.","Low","As larval source management requires a good infrastructure and strong entomological capacity and leadership, the program needs to establish feasibility of this strategy in elimination phase","NA Original Intervention: Other vector control measures","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5324","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Support broadcasting of IEC messages over radio/FM. Hold regular orientation meetings to maximize community involvement in malaria elimination.",70339,null,"Active","a6Q1R000000AJNK",0,0,0,0,70339,0,null,null,"Support broadcasting of IEC messages over radio/FM. Hold regular orientation meetings to maximize community involvement in malaria elimination.","Low","The yield expected from IEC messages over radio/FM seems to offer lower value for money compared to regular orientation meetings to maximize community involvement in malaria elimination, therefore the TRP recommends 20 percent of the requested amount.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5323","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Orientation meetings/trainings for community involvement in malaria elimination (massive scale-up of approach supported under the ?within allocation? amount).",60168,null,"Active","a6Q1R000000AJNJ",0,0,0,0,60168,0,null,null,"Orientation meetings/trainings for community involvement in malaria elimination (massive scale-up of approach supported under the ?within allocation? amount).","Low","This intervention covers gradual orientation meetings/trainings for community involvement in malaria elimination. Domestic resources should also be used for massive scale-up of approach supported, therefore the TRP recommends 20 percent of the requested amount.","NA Original Intervention: Policy, planning, coordination and management","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5322","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","International training on program reorientation towards malaria elimination; Capacity strengthening for malaria elimination by SMRU/WHO (this will upgrade the ToT and trickle down approach supported under the ?within allocation? amount, which was chosen for its economy); Supply motorcycles, office furniture and equipment, computers band photocopier/printers; and, External program evaluation.",153615,null,"Active","a6Q1R000000AJNI",0,0,0,0,153615,0,null,null,"International training on program reorientation towards malaria elimination; Capacity strengthening for malaria elimination by SMRU/WHO (this will upgrade the ToT and trickle down approach supported under the ?within allocation? amount, which was chosen for its economy); Supply motorcycles, office furniture and equipment, computers band photocopier/printers; and, External program evaluation.","Medium","Training on program reorientation towards malaria elimination can be done on-site instead of through multi-country training schemes. Logistical support for motorcycles, office furniture and equipment, computers band photocopier/printers is important, therefore the TRP recommends 50 percent of the requested amount.","NA Original Intervention: Policy, planning, coordination and management","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Malawi","Malawi","PAI-5224","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Continuation of current community PMTCT activities ($2.72M) Support will continue activities to raise community demand for PMTCT services and promote adherence to care and treatment for HIV positive mothers and children in all 290 TAs within all 28 districts. Current grant target is to increase percentage of HIV positive adults and children receiving ART from 50.4 % to 70% by December 2017.",2720000,null,"Active","a6Q1R000000AJLi",0,0,0,0,2720000,0,null,null,"Continuation of current community PMTCT activities ($2.72M) Support will continue activities to raise community demand for PMTCT services and promote adherence to care and treatment for HIV positive mothers and children in all 290 TAs within all 28 districts. Current grant target is to increase percentage of HIV positive adults and children receiving ART from 50.4 % to 70% by December 2017.","Medium","Coverage of Prong 3 is already very high in Malawi. This will complement it.","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5223","MCI-00000","Prevention programs for general population","MCI-00074","Male circumcision","VMMC | Integrated service delivery, demand creation and commodities ($16.77M) World Bank VMMC funding ends in June 2018. The funding request will provide 155,268 male circumcisions in 6 of the 14 VMMC priority districts (8 will continue to be supported by PEPFAR) between July 2018 and December 2020.",16770000,null,"Active","a6Q1R000000AJLh",9727716,2000000,0,0,5042284,0,null,null,"VMMC | Integrated service delivery, demand creation and commodities ($16.77M) World Bank VMMC funding ends in June 2018. The funding request will provide 155,268 male circumcisions in 6 of the 14 VMMC priority districts (8 will continue to be supported by PEPFAR) between July 2018 and December 2020.","Medium","PEPFAR is taking the lead in scaling up adult circumcision.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5222","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Enhanced linkages to care ($0.40M) Additional activities to strengthen FSW programming linkage to care and monitoring in current 11 districts.",400000,null,"Active","a6Q1R000000AJLg",0,0,0,0,400000,0,null,null,"Enhanced linkages to care ($0.40M) Additional activities to strengthen FSW programming linkage to care and monitoring in current 11 districts.","High","Increased comprehensive programming for key populations will be increasingly needed to control the epidemic as incidence among the general population declines.","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5221","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","HIV self-testing program and commodities ($3.50M) Malawi pilot results indicate HIVST is a promising intervention for expanding testing to hard to reach populations, especially men, youth and KPs. These funds will support commodity and program costs for 879,430 self-tests.",3500000,null,"Inactive","a6Q1R000000AJLf",500000,3000000,0,0,0,1,null,null,"HIV self-testing program and commodities ($3.50M) Malawi pilot results indicate HIVST is a promising intervention for expanding testing to hard to reach populations, especially men, youth and KPs. These funds will support commodity and program costs for 879,430 self-tests.","Medium","Increased testing through innovative approaches is one of the major changes in approach in this Funding request.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5220","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00170","Service organization and facility management","Integration of cervical cancer screenings in ART clinics for HIVpositive women ($0.56M) Yearly cervical cancer screening will be integrated in ART clinics for HIVpositive women aged 25 and above, important for the prevention and management of cervical cancer which is highly prevalent in Malawi. This investment will support the training of service providers and their supervision and mentoring.",560000,null,"Active","a6Q1R000000AJLe",311584.42,0,0,0,248415.58,0,null,null,"Integration of cervical cancer screenings in ART clinics for HIVpositive women ($0.56M) Yearly cervical cancer screening will be integrated in ART clinics for HIVpositive women aged 25 and above, important for the prevention and management of cervical cancer which is highly prevalent in Malawi. This investment will support the training of service providers and their supervision and mentoring.","Medium","Cervical cancer screening is recommended for all women.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5219","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Funding for HCW trainings, zonal data review meetings, and EID/VL testing orientation and supervision/mentorship visits ($2.22M) High importance for proper management of HIV; half of the need already funded within allocation; this covers the other half of the need and allows full training roll out to HCWs.",2220000,null,"Active","a6Q1R000000AJLd",939523.95,0,0,0,1280476.05,0,null,null,"Funding for HCW trainings, zonal data review meetings, and EID/VL testing orientation and supervision/mentorship visits ($2.22M) High importance for proper management of HIV; half of the need already funded within allocation; this covers the other half of the need and allows full training roll out to HCWs.","Medium","Increasing access to viral load supports maintenance of high national viral suppression rate of 90.8%.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Myanmar","Myanmar","PAI-5095","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00097","Needle and Syringe programs for PWID and their partners","The additional investment will support the program to reach more target population.",13080262,null,"Active","a6Q1R000000AJJd",10801471,0,0,0,2278791,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Needle and syringe programs for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5094","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00095","HIV testing services for PWID","The additional investment will support the program to reach more target population.",494025,null,"Active","a6Q1R000000AJJc",0,0,0,0,494025,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 534005 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: HIV testing services for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5093","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00096","Diagnosis and treatment of STIs and other sexual health services for PWID","The additional investment will support the program to reach more target population.",167956,null,"Active","a6Q1R000000AJJb",0,0,0,0,167956,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 801114 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5092","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00094","Condoms and lubricant programming for PWID","The additional investment will support the program to reach more target population.",464867,null,"Active","a6Q1R000000AJJa",383727,0,0,0,81140,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Condoms and lubricant programming for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5091","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","The additional investment will support the program to reach more target population.",3183156,null,"Active","a6Q1R000000AJJZ",0,0,0,0,3183156,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 3761207 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5090","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","The additional investment will support the program to reach more target population.",318113,null,"Active","a6Q1R000000AJJY",195184,0,0,0,122929,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4998","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Communities? mobilization and sensitization during Malaria day.",300000,null,"Active","a6Q1R000000AJI4",0,0,103584,0,196416,0,null,null,"Communities? mobilization and sensitization during Malaria day.","Medium","Community mobilization","Listed intervention does not match the one in UQD updated form. Original Intervention: World Malaria Day (Cambodia )","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4997","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Adding value to malaria outreach program.",3500000,null,"Inactive","a6Q1R000000AJI3",3500000,0,0,0,0,1,null,null,"Adding value to malaria outreach program.","Medium","Two parts of these proposed activities are high priority and add value to malaria outreach program. Microscopy training is lower priority , hence overall item downgraded to medium.","NA Original Intervention: Update microscopy training. Provide medical kits to village health workers (VHWs). Conduct mass Information Education Communication (IEC) / Behaviour Change Communication (BCC) (Viet Nam)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4996","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Conduct therapeutic efficacy studies of new drugs and drug combinations, and conduct a drug resistance mapping supplement DRS information- strengthening capacity of the NMCP and ODPC.",200000,null,"Inactive","a6Q1R000000AJI2",200000,0,0,0,0,1,null,null,"Conduct therapeutic efficacy studies of new drugs and drug combinations, and conduct a drug resistance mapping supplement DRS information- strengthening capacity of the NMCP and ODPC.","High","Will expands/strengthen DRS capacity for National Malaria Control Program (NMCP ) and ODCP.","NA Original Intervention: Drug resistance studies (DRS) and activities (Thailand)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4995","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Through DRS.",91000,null,"Inactive","a6Q1R000000AJI1",91000,0,0,0,0,1,null,null,"Through DRS.","High","Key to elimination of falciparum transmission.","NA Original Intervention: Ensure radical cure for all falciparum cases (Thailand)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4994","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","Adding value to malaria outreach program.",1500000,null,"Inactive","a6Q1R000000AJI0",1500000,0,0,0,0,1,null,null,"Adding value to malaria outreach program.","High","These are key activities that should be incorporated as part of regular allocation, if efficiencies are found during grant making.","NA Original Intervention: Promote LLIN among malaria risk population entering transmission areas (Thailand )","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4993","MCI-00071","Other module","MCI-00071","Other module","To enhance supervision in Zone 3 areas.",300000,null,"Inactive","a6Q1R000000AJHz",300000,0,0,0,0,1,null,null,"To enhance supervision in Zone 3 areas.","High","Strengthening supervision in Zone 3 areas.","NA Original Module: RSSH. Original Intervention: Additional supportive supervision by epi (Viet Nam )","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4867","MCI-00008","TB care and prevention","MCI-00128","Prevention","Updating the national guidelines on TB infection prevention and control in Jordan in English , translate to Arabic and printing",22444,null,"Active","a6Q1R000000AJFx",0,0,0,0,22444,0,null,null,"Updating the national guidelines on TB infection prevention and control in Jordan in English , translate to Arabic and printing","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4866","MCI-00022","RSSH: Health management information systems and M&E","MCI-00173","Other service delivery intervention(s)","PAAR is planned to be used for conducting IBBS and PSE for key populations in both southern part of Yemen and Syria. Results of this exercise will improve the planning capacities of program to delover services to these key populations. Also, results of these surveys will contribute to improving the two countries' estimates and projections. PSE will provide denomirators for monitoring the coverage of implemented services among key populations",500000,null,"Active","a6Q1R000000AJFw",0,0,0,0,500000,0,null,null,"PAAR is planned to be used for conducting IBBS and PSE for key populations in both southern part of Yemen and Syria. Results of this exercise will improve the planning capacities of program to delover services to these key populations. Also, results of these surveys will contribute to improving the two countries' estimates and projections. PSE will provide denomirators for monitoring the coverage of implemented services among key populations","Low","While the TRP recognises that up-to-date data would be very useful, the TRP doubts the feasibility of conducting IBBS or PSE in Syria and Yemen, given the volatile crisis situation in both countries and therefore considers this low priority.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4865","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","To cover the cost of the regular evaluation of TB dugs? management process in the five countries",145800,null,"Active","a6Q1R000000AJFv",0,0,0,0,145800,0,null,null,"To cover the cost of the regular evaluation of TB dugs? management process in the five countries","Low","The added value of this activity is low, given the COE,","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Other procurement and supply chain management intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4864","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","To undertake a national TB drug resistance survey in Syria",25000,null,"Active","a6Q1R000000AJFu",0,0,0,0,25000,0,null,null,"To undertake a national TB drug resistance survey in Syria","Low","Conducting national TB drug surveillance survey under the prevailing conditions would be very difficult, and would require significantly more resources than have been requested. Any findings therefrom would also not be applicable to the entire country.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4863","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To renovate the main drug warehouse in Baghdad",30000,null,"Active","a6Q1R000000AJFt",0,0,0,0,30000,0,null,null,"To renovate the main drug warehouse in Baghdad","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4862","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To purchase laptops\\desktops for the governorate TB coordination units with no computers or with dilapidated computers in the five countries",150000,null,"Active","a6Q1R000000AJFs",0,0,0,0,150000,0,null,null,"To purchase laptops\\desktops for the governorate TB coordination units with no computers or with dilapidated computers in the five countries","Low",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4861","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To procure computers for the NTP central units of Iraq, Yemen and Syria",75000,null,"Active","a6Q1R000000AJFr",0,0,0,0,75000,0,null,null,"To procure computers for the NTP central units of Iraq, Yemen and Syria","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4860","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To ensure a training on programmatic management in an international course for the relevant NTP staff from Central and governorate levels of the five countries.",35000,null,"Active","a6Q1R000000AJFq",0,0,0,0,35000,0,null,null,"To ensure a training on programmatic management in an international course for the relevant NTP staff from Central and governorate levels of the five countries.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4859","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","This activity focuses on improving facilities in hospitals. Treatment of MDR-TB in community is also to be considered.",250000,null,"Active","a6Q1R000000AJFp",0,0,0,0,250000,0,null,null,"This activity focuses on improving facilities in hospitals. Treatment of MDR-TB in community is also to be considered.","Low","This activity focuses on improving facilities in hospitals. The applicant should instead consider the treatment of MDR-TB in the community.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Morocco","Morocco","PAI-4758","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","Call for annual projects for NGOs in order to incorporate innovative HIV prevention and treatment actions and projects into their area of intervention; SR human resources.",610561.1,null,"Active","a6Q1R000000AJEC",124859.16,0,0,0,485701.94,0,null,null,"Call for annual projects for NGOs in order to incorporate innovative HIV prevention and treatment actions and projects into their area of intervention; SR human resources.","High","Funds for developing innovative prevention and treatment approaches by NGOs","NA Original Module: RSSH - Community responses and systems. Original Intervention: Social mobilization, building community linkages, collaboration and coordination; strengthening institutional, planning and management capacities","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Morocco","Morocco","PAI-4757","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of SRH provision and services meeting the specific needs of SWs, including STIs; acquire a stock of additional lubricants for SWs; awareness-raising day on GBV; SMS platform for prevention.",392825.72,null,"Active","a6Q1R000000AJEB",0,0,0,0,392825.72,0,null,null,"Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of SRH provision and services meeting the specific needs of SWs, including STIs; acquire a stock of additional lubricants for SWs; awareness-raising day on GBV; SMS platform for prevention.","High","Addresses drivers of the epidemic in a concentrated epidemic and critical for the extension of reach to new areas of need.","NA Original Intervention: Diagnosis and treatment of STIs and other sexual and reproductive health -related services for sex workers; condoms and lubricants-related interventions for sex workers; combating stigma, discrimination and violence against SWs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Morocco","Morocco","PAI-4756","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of sexual and reproductive health (SRH) provision and services meeting the specific needs of MSM, including STIs; acquire a stock of additional lubricants for MSM; establish a CBD network for distributing condoms (extended to a further 17 towns in 2019 and 2020).",186031.87,null,"Active","a6Q1R000000AJEA",45781.62,0,0,0,140250.25,0,null,null,"Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of sexual and reproductive health (SRH) provision and services meeting the specific needs of MSM, including STIs; acquire a stock of additional lubricants for MSM; establish a CBD network for distributing condoms (extended to a further 17 towns in 2019 and 2020).","High","Addresses drivers of the epidemic in a concentrated epidemic and critical for the extension of reach to new areas","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Diagnosis and treatment of STIs and other sexual and reproductive health -related services; condoms and lubricants-related interventions for men who have sex with men.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Morocco","Morocco","PAI-4755","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Review of migrant prevention programs; establishment of six community centers for migrant sexual and reproductive health; training of actors and representatives to carry out prevention work targeting truckers; constant presence at trucking sites; identification of sites of vulnerability linked to working environments; improve combined prevention coverage along corridors; women?s SRH; advocacy with managers of large companies; AIDS prevention awareness-raising tools adapted to different working environments; PE for manual workers, miners, sailors, fishermen and artisans; training and remuneration of actors involved and PEs; information, education and communication (IEC) sessions for female manual workers and other vulnerable women; prevention tools for the working environment; actors and PE manual workers, miners, sailors, fishermen and artisans; : Evaluation of youth prevention; review of kit for ongoing training on HIV, GBV and addictions in the school environment; coaching of young PEs in high schools and university, including through ICT; mapping of youth NGOs and networking and capacity development actions for youths so that they can be involved in HIV prevention; training guide on ?young people not in school? for facilitators; awareness-raising and training of ?youth? organizers; prevention materials for youths / ICT (tel. application, social networks).",717921.67,null,"Active","a6Q1R000000AJE9",21317.47,0,0,0,696604.2,0,null,null,"Review of migrant prevention programs; establishment of six community centers for migrant sexual and reproductive health; training of actors and representatives to carry out prevention work targeting truckers; constant presence at trucking sites; identification of sites of vulnerability linked to working environments; improve combined prevention coverage along corridors; women?s SRH; advocacy with managers of large companies; AIDS prevention awareness-raising tools adapted to different working environments; PE for manual workers, miners, sailors, fishermen and artisans; training and remuneration of actors involved and PEs; information, education and communication (IEC) sessions for female manual workers and other vulnerable women; prevention tools for the working environment; actors and PE manual workers, miners, sailors, fishermen and artisans; : Evaluation of youth prevention; review of kit for ongoing training on HIV, GBV and addictions in the school environment; coaching of young PEs in high schools and university, including through ICT; mapping of youth NGOs and networking and capacity development actions for youths so that they can be involved in HIV prevention; training guide on ?young people not in school? for facilitators; awareness-raising and training of ?youth? organizers; prevention materials for youths / ICT (tel. application, social networks).","High","The PAAR combines the requested amount for other vulnerable populations (including migrants) and the requested amount for youth in school. We cannot identify how much goes to each. The portion for other vulnerable population (OVP) is considered of high priority because there is a documented epidemic among migrants and it is important to increase HIV testing yield. Given limited funding, the portion for youth in school is considered low priority because this population is at low risk and not making a large contribution to epidemic spread. It is very important to reach young people in school with early interventions to increase life skills but it is not a population to be specially targeted for HIV prevention (condoms, STI treatment, differentiated testing)","In the grant sign-off form, the amounts for two identical interventions were combined. As the reallocated divided amount was not specified, they have been combined in the UQD register as well. Original Module: Prevention programs aimed at other vulnerable populations (migrants, lorry drivers, manual workers, miners) and Prevention programs for other vulnerable populations (youths). Original Intervention: Interventions aimed at behavior change among other vulnerable populations; HIV screening services for other vulnerable populations; other interventions targeting other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Morocco","Morocco","PAI-4754","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Implement targeted multi-disease screening campaigns; create new screening centers based on the geographic mapping and guide NGOs to areas not yet covered (concentration of key populations, strong HIV prevalence).",547356.07999999996,null,"Active","a6Q1R000000AJE8",410322.07,0,0,0,137034.01,0,null,null,"Implement targeted multi-disease screening campaigns; create new screening centers based on the geographic mapping and guide NGOs to areas not yet covered (concentration of key populations, strong HIV prevalence).","High","These improvements in screening are at the heart of the funding request and NSP strategic approach. These activities are to be implemented in new areas based on mapping. TRP recommends to move to within allocation if possible.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5870","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","High level priority: it is in line with FR one of the main objective ? to increase MDR-TB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services.",1071389,null,"Active","a6Q1R000000AJW8",0,0,0,0,1071389,0,null,null,"High level priority: it is in line with FR one of the main objective ? to increase MDR-TB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services.","High","High level priority: it is in line with FR one of the main objective ? to increase MDRTB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5869","MCI-00009","TB/HIV","MCI-00136","Community TB/HIV care delivery","High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: To develop and disseminate revised Village Multisectoral AIDS Committee guidelines.",116483,null,"Active","a6Q1R000000AJW7",0,0,0,0,116483,0,null,null,"High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: To develop and disseminate revised Village Multisectoral AIDS Committee guidelines.","High","High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: To develop and disseminate revised Village Multisectoral AIDS Committee guidelines",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5868","MCI-00009","TB/HIV","MCI-00138","Collaborative activities with other programs and sectors (TB/HIV)","High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: The remaining gap of 102,556 (10 percent) cartridges for X-pert are now requested as part of the Prioritized Above Allocation Request (PAAR).",1288103,null,"Active","a6Q1R000000AJW6",0,0,0,0,1288103,0,null,null,"High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: The remaining gap of 102,556 (10 percent) cartridges for X-pert are now requested as part of the Prioritized Above Allocation Request (PAAR).","High","High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: The remaining gap of 102,556 (10 percent) cartridges for Xpert are now requested as part of the Prioritized Above Allocation Request (PAAR)",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5867","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Scale up of TB case finding will be done amongst the following vulnerable populations for TB (children, miners, slum dwellers and fisher folk).",663833,null,"Active","a6Q1R000000AJW5",0,0,0,0,663833,0,null,null,"High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Scale up of TB case finding will be done amongst the following vulnerable populations for TB (children, miners, slum dwellers and fisher folk).","High","High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Scale up of TB case finding will be done amongst the following vulnerable populations for TB (children, miners, slum dwellers and fisher folk)","NA Original Intervention: Key populations?TB screening in other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5866","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","Using PEPFAR funds the country has scaled coverage of OST clinic to 3 sites in Dar es Salaam and there are plans to scale to 2 other regions (Mwanza and Mbeya). IBBS and geographical mapping has shown high presence of PWID in other regions e.g. Arusha, Morogoro, Dodoma and Tanga. This requested amount will be used to scale up in Dodoma.",2000000,null,"Active","a6Q1R000000AJW4",0,0,0,0,2000000,0,null,null,"Using PEPFAR funds the country has scaled coverage of OST clinic to 3 sites in Dar es Salaam and there are plans to scale to 2 other regions (Mwanza and Mbeya). IBBS and geographical mapping has shown high presence of PWID in other regions e.g. Arusha, Morogoro, Dodoma and Tanga. This requested amount will be used to scale up in Dodoma.","High","Using PEPFAR funds the country has scaled coverage of OST clinics to 3 sites in Dar el Salaam and there are plans to scale to 2 other regions (Mwanza and Mbeya). IBBS and geographical mapping has shown high presence of people who inject drugs in other regions e.g. Arusha, Morogoro, Dodoma and Tanga. This requested amount will be used to scale up in Dodoma.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Scale up Medically Assisted Therapy (MAT)/OST","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5781","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Transferring and sustainble into national program 2 models for TB and HIV program in prisoner and migrant and 13 models for HIV and TB in KPs by 13 ODPCs.",1149066,null,"Active","a6Q1R000000AJUh",0,0,0,0,1149066,0,null,null,"Transferring and sustainble into national program 2 models for TB and HIV program in prisoner and migrant and 13 models for HIV and TB in KPs by 13 ODPCs.","Low","The TRP considers the activity related to transferring and sustaining national program 2 models for TB and HIV program in prisoner and migrant and 13 models for HIV and TB in key population by 13 offices of disease prevention and controls (ODPC) to be a low priority for this request and should be supportable with domestic funding.","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5780","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","RTF BL 15-161. Community empowerment for migrants: Population group building (e.g. saving group, women group)2. Community empowerment for migrants: Population network strengthening",16342,null,"Active","a6Q1R000000AJUg",0,0,0,0,16342,0,null,null,"RTF BL 15-161. Community empowerment for migrants: Population group building (e.g. saving group, women group)2. Community empowerment for migrants: Population network strengthening","Low","This activity supports community empowerment for migrants. While this community is at increased risk for HIV the TRP does not believe this\nintervention to have substantial impact.","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5778","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","RTF BL 31-321. Twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii.  Field visit with stakeholders Units/Participants: 27 persons per day, 2 days. Locations: 2 provinces in year 1, year2 2. Fundraising specialist for CRM strategic plan. Contact professional consultant Units/Participants: 4 persons per team  Locations: 1 team in year 1, year 2, year 3.",43921,null,"Active","a6Q1R000000AJUe",0,0,0,0,43921,0,null,null,"RTF BL 31-321. Twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii.  Field visit with stakeholders Units/Participants: 27 persons per day, 2 days. Locations: 2 provinces in year 1, year2 2. Fundraising specialist for CRM strategic plan. Contact professional consultant Units/Participants: 4 persons per team  Locations: 1 team in year 1, year 2, year 3.","Medium","This intervention supports twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii and a fundraising specialist for the community response mobilization (CRM) strategic plan.","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5777","MCI-00534","Comprehensive prevention programs for MSM","MCI-00540","Pre-exposure prophylaxis (PrEP) for MSM","RTF BL 1Referral for PrEP for MSM & TGObjectives: Referral for PREP MSM/TG Units/Participants: 84  per year in year 1, year 2,year 3 Locations: 7 provinces year 1, year 2 , year 3 Costs: Travel cost Measurements:direct indicator record/report, referral form.",11916,null,"Active","a6Q1R000000AJUd",0,0,0,0,11916,0,null,null,"RTF BL 1Referral for PrEP for MSM & TGObjectives: Referral for PREP MSM/TG Units/Participants: 84  per year in year 1, year 2,year 3 Locations: 7 provinces year 1, year 2 , year 3 Costs: Travel cost Measurements:direct indicator record/report, referral form.","Medium","This activity supports additional referral costs for PrEP for men having sex with men & transgender people","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre-exposure prophylaxis (PrEP) for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5776","MCI-00534","Comprehensive prevention programs for MSM","MCI-00540","Pre-exposure prophylaxis (PrEP) for MSM","DDC BL 302-308Purchase  HIV testing ,Kidney function test , HepatitisB test, Urine pregnancy test, Syphilis test, ARV drug: TDF/FTC, (302-307)Activity : Set up PrEP service and included referral system (308).",367506,null,"Active","a6Q1R000000AJUc",0,0,0,0,367506,0,null,null,"DDC BL 302-308Purchase  HIV testing ,Kidney function test , HepatitisB test, Urine pregnancy test, Syphilis test, ARV drug: TDF/FTC, (302-307)Activity : Set up PrEP service and included referral system (308).","Medium","This activity supports purchasing HIV testing, kidney function test, Hepatitis B test, Syphilis test, ARV drug: TDF/FTC, (302-307). n","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre-exposure prophylaxis (PrEP) for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Zanzibar","Zanzibar","PAI-6019","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.",51510,null,"Active","a6Q1R000000AJYX",0,0,0,0,51510,0,null,null,"Data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","High","This activity is deemed quality demand as the data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Zanzibar","Zanzibar","PAI-6018","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","This activity will strengthen the monitoring and evaluation component for the entire program.",100233,null,"Active","a6Q1R000000AJYW",0,0,0,0,100233,0,null,null,"This activity will strengthen the monitoring and evaluation component for the entire program.","High","This activity is considered high priority as it will strengthen monitoring and evaluation for the entire program","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Zanzibar","Zanzibar","PAI-6017","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","The installation of network infrastructure will support and strengthen procurement and supply chain activities.",1548,null,"Active","a6Q1R000000AJYV",0,0,0,0,1548,0,null,null,"The installation of network infrastructure will support and strengthen procurement and supply chain activities.","High","The installation of network infrastructure is considered a high priority by the TRP because it will support and strengthen procurement and supply chain activities which TRP considers are critical","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Zanzibar","Zanzibar","PAI-6016","MCI-00012","Case management","MCI-00158","Therapeutic efficacy surveillance","This intervention aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.",104768,null,"Active","a6Q1R000000AJYU",0,0,0,0,104768,0,null,null,"This intervention aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.","High","The TRP considers this intervention as high priority as it aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Zanzibar","Zanzibar","PAI-6015","MCI-00012","Case management","MCI-00157","Active case detection and investigation (elimination phase)","This intervention is meant to ensure that every malaria case is reached in order to achieve elimination.",22624,null,"Active","a6Q1R000000AJYT",0,0,0,0,22624,0,null,null,"This intervention is meant to ensure that every malaria case is reached in order to achieve elimination.","High","This intervention is necessary in order to ensure that every malaria case is reached. This is critical in order to achieve elimination.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT South Africa","South Africa","PAI-6014","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00576","Addressing stigma, discrimination and legal barriers to care for adolescents and youth","Funding will support in providing mental health services to AGYW age 15-24, through the safe spaces that are prioritized in the allocation. Funding will support 24 registered psychologists (2 per district) who will rove between the safe spaces, providing counselling services to AGYW. Evidence in South Africa shows a clear link between depression and risky sexual behavior among AGYW (Barhafumwa et al., 2016).",5160689,null,"Active","a6Q1R000000AJYS",0,0,0,0,5160689,0,null,null,"Funding will support in providing mental health services to AGYW age 15-24, through the safe spaces that are prioritized in the allocation. Funding will support 24 registered psychologists (2 per district) who will rove between the safe spaces, providing counselling services to AGYW. Evidence in South Africa shows a clear link between depression and risky sexual behavior among AGYW (Barhafumwa et al., 2016).","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6013","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Funding will support expansion of access to HIV self-screening to support the treatment surge. South Africa aims to put an additional 2 million people on ART by the year 2020. In support of this target, funding will support procurement of an additional 4.7 million HIV self-screening kits, at the BMGF-negotiated price of $2/kit. This approach is primarily targeted at hard-to-reach populations such as men and young people. This investment will enable South Africa to identify an additional 300,000 people living with HIV over the three years, supporting their navigation into care and initiation onto treatment.",19682539,null,"Active","a6Q1R000000AJYR",0,0,0,0,19682539,0,null,null,"Funding will support expansion of access to HIV self-screening to support the treatment surge. South Africa aims to put an additional 2 million people on ART by the year 2020. In support of this target, funding will support procurement of an additional 4.7 million HIV self-screening kits, at the BMGF-negotiated price of $2/kit. This approach is primarily targeted at hard-to-reach populations such as men and young people. This investment will enable South Africa to identify an additional 300,000 people living with HIV over the three years, supporting their navigation into care and initiation onto treatment.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT Chad","Chad","PAI-5710","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Program Review HIV, Epidemiology and Impact Analysis\nThis review will assess the performance, impact, quality and effectiveness of HIV programs and link program funding, scaling up interventions and disease trends through systematic plausibility analysis\nThe costs provided here are historical costs related to past grants",51324.21,null,"Active","a6Q1R000000AJTY",0,0,0,0,51324.21,0,null,null,"Program Review HIV, Epidemiology and Impact Analysis\nThis review will assess the performance, impact, quality and effectiveness of HIV programs and link program funding, scaling up interventions and disease trends through systematic plausibility analysis\nThe costs provided here are historical costs related to past grants","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Central Africa",null,"Multi-component"]
["CT Chad","Chad","PAI-5709","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Review of the TB program, epidemiology and impact analysis\nThis review will make it possible to evaluate the performance, impact, quality and effectiveness of the TB programs and to establish a link between the program funding, the upscaling of the intervention and the disease trends by means of a systematic plausibility analysis.\nThe costs stated here are historic costs linked to previous grants.",51324.21,null,"Active","a6Q1R000000AJTX",0,0,0,0,51324.21,0,null,null,"Review of the TB program, epidemiology and impact analysis\nThis review will make it possible to evaluate the performance, impact, quality and effectiveness of the TB programs and to establish a link between the program funding, the upscaling of the intervention and the disease trends by means of a systematic plausibility analysis.\nThe costs stated here are historic costs linked to previous grants.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Central Africa",null,"Multi-component"]
["CT Chad","Chad","PAI-5708","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","HIV treatment cascade service analysis survey\nThe aim is to determine the extent to which the 90-90-90 targets have been achieved, together with the explanatory factors and bottlenecks relating to performance. This will require the following, specifically:\n- establishing the performance development profile for medical health care and the PMTCT;\n- determining the current treatment cascade and suggesting its development trend;\n- determining the current PMTCT cascade and suggesting its development trend;\n- identifying and analyzing success factors and bottlenecks of the cascade;\n- proposing modeling scenarios for development trends up to 2022.\nThe costs stated here are historic costs linked to previous grants.",51324.21,null,"Active","a6Q1R000000AJTW",0,0,0,0,51324.21,0,null,null,"HIV treatment cascade service analysis survey\nThe aim is to determine the extent to which the 90-90-90 targets have been achieved, together with the explanatory factors and bottlenecks relating to performance. This will require the following, specifically:\n- establishing the performance development profile for medical health care and the PMTCT;\n- determining the current treatment cascade and suggesting its development trend;\n- determining the current PMTCT cascade and suggesting its development trend;\n- identifying and analyzing success factors and bottlenecks of the cascade;\n- proposing modeling scenarios for development trends up to 2022.\nThe costs stated here are historic costs linked to previous grants.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Central Africa",null,"Multi-component"]
["CT Chad","Chad","PAI-5707","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In view of the under-reporting, this request includes a plan to carry out active screening for cases of tuberculosis among prisoners, refugees/displaced persons, nomads and children in the malnutrition treatment centers (TNUs) using 2 trucks equipped with screening and diagnostic resources (x-ray and GeneXpert). This active screening will be organized biannually, in accordance with specific focus points (see the supervision focus points). \nDuring the screening campaigns, all suspected cases of TB or MDR-TB will initially receive a chest x-ray and those exhibiting symptoms of TB will be given a GeneXpert examination to confirm the diagnosis. In addition, HIV screening will be carried out among these populations. Advocacy sessions will be carried out prior to and during these campaigns. The campaign team will be composed of: 1 x-ray operator, 1 laboratory technician, 1 health-care worker and 1 driver.",1292844.25,null,"Active","a6Q1R000000AJTV",0,0,0,0,1292844.25,0,null,null,"In view of the under-reporting, this request includes a plan to carry out active screening for cases of tuberculosis among prisoners, refugees/displaced persons, nomads and children in the malnutrition treatment centers (TNUs) using 2 trucks equipped with screening and diagnostic resources (x-ray and GeneXpert). This active screening will be organized biannually, in accordance with specific focus points (see the supervision focus points). \nDuring the screening campaigns, all suspected cases of TB or MDR-TB will initially receive a chest x-ray and those exhibiting symptoms of TB will be given a GeneXpert examination to confirm the diagnosis. In addition, HIV screening will be carried out among these populations. Advocacy sessions will be carried out prior to and during these campaigns. The campaign team will be composed of: 1 x-ray operator, 1 laboratory technician, 1 health-care worker and 1 driver.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Central Africa",null,"Multi-component"]
["CT Eswatini","Eswatini","PAI-5706","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Third year salary for 8 regional DR-TB doctors, 12 regional DR-TB nurses and 4 regional data clerks. The allocation amount covers salaries for the first two years of the grant. This investment will allow their work to continue for the full three years.",576000,null,"Active","a6Q1R000000AJTU",0,0,0,0,576000,0,null,null,"Third year salary for 8 regional DR-TB doctors, 12 regional DR-TB nurses and 4 regional data clerks. The allocation amount covers salaries for the first two years of the grant. This investment will allow their work to continue for the full three years.","High","Third year salary for 8 regional DR-TB doctors, 12 regional DR-TB nurses and 4 regional data clerks. The allocation amount covers salaries for the first two years of the grant. This investment will allow their work to continue for the full three years","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5705","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00575","Community mobilization and norms change","Develop a multi-sectoral model and costed operational plan to integrate health issues into other government services. The approach is to institutionalize health issues into multi-sector entry points in order to expand access to information and services provided in communities, schools, facilities and other places. Funding will support stakeholder consultations and technical assistance to develop the plan.",30750,null,"Active","a6Q1R000000AJTT",0,0,0,0,30750,0,null,null,"Develop a multi-sectoral model and costed operational plan to integrate health issues into other government services. The approach is to institutionalize health issues into multi-sector entry points in order to expand access to information and services provided in communities, schools, facilities and other places. Funding will support stakeholder consultations and technical assistance to develop the plan.","High","Integration of HIV programming into other sectors is\nimportant in order to enable HIV programs to reach\neveryone and embed these activities across all\nsectors of the government.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Somalia","Somalia","PAI-5605","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Additional training, co-ordination and case management activities for TB/HIV.",445170,null,"Active","a6Q1R000000AJRr",0,0,0,0,445170,0,null,null,"Additional training, co-ordination and case management activities for TB/HIV.","High","Additional training, co-ordination and case management activities for TB/HIV in areas no covered by the allocation funding request.","NA Original Intervention: Case management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT Somalia","Somalia","PAI-5604","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Expansion of access to GeneXpert and provision of additional GeneXpert cartridges. ? Case based-incentive for community providers and patient social support to manage additional detected MDR-TB cases.",1369941,null,"Inactive","a6Q1R000000AJRq",1163242,206699,0,0,0,1,null,null,"Expansion of access to GeneXpert and provision of additional GeneXpert cartridges. ? Case based-incentive for community providers and patient social support to manage additional detected MDR-TB cases.","High","? Expansion of access to GeneXpert in areas not covered by the allocation request and provision of additional GeneXpert cartridges. ? Case based-incentive for community providers and patient social support to manage additional detected MDR-TB cases.","NA Original Module: Multidrug-resistant TB. Original Intervention: MDR TB: Case detection and diagnosis treatment for key population programs","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT Somalia","Somalia","PAI-5603","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Additional community case finding activities, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. \nAdditional active case finding activities for high-risk groups and cross-border activities.",8066920,null,"Active","a6Q1R000000AJRp",1462184,1312920,0,0,5291816,0,null,null,"Additional community case finding activities, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. \nAdditional active case finding activities for high-risk groups and cross-border activities.","High","Additional community case finding activities in areas not covered by the allocation funding request, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. ? Additional active case finding activities for high-risk groups and cross-border activities in areas not covered by the allocation funding request.","NA Original Intervention: Case detection and diagnosis, treatment for key population programs","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT Somalia","Somalia","PAI-5602","MCI-00023","Program management","MCI-00207","Grant management","Focal persons for new states?this funding will support 1 new focal personal for each of the 4 new states.The four states are Hirshabelle, South West, Jubaland and Galmudug. These were established during the last election and have MOHs and Malaria Focal Points. Each focal point 800 USD per month for 36 months.",115200,null,"Active","a6Q1R000000AJRo",0,0,0,0,115200,0,null,null,"Focal persons for new states?this funding will support 1 new focal personal for each of the 4 new states.The four states are Hirshabelle, South West, Jubaland and Galmudug. These were established during the last election and have MOHs and Malaria Focal Points. Each focal point 800 USD per month for 36 months.","Medium","There is a need to support newly created states; however, the applicant did not mention how and who will sustain this. The TRP is concerned about sustainability of such activity",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5601","MCI-00071","Other module","MCI-00071","Other module","In the current context of Somalia, emergency mobile teams are used to target populations that are not able to come to health facilities, or in areas that have no functioning health facilities. This is exacerbated during the drought as well as during this period when EPHS services are severely limited. This includes mobile health team, car rental, stationary, communication, training and supervision. This is for three organizations, and each organization will have five mobile teams that reach hard-to-reach areas.",1774408,null,"Active","a6Q1R000000AJRn",0,0,0,0,1774408,0,null,null,"In the current context of Somalia, emergency mobile teams are used to target populations that are not able to come to health facilities, or in areas that have no functioning health facilities. This is exacerbated during the drought as well as during this period when EPHS services are severely limited. This includes mobile health team, car rental, stationary, communication, training and supervision. This is for three organizations, and each organization will have five mobile teams that reach hard-to-reach areas.","High","The TRP recommends this item as High priority considering significant challenges for IDPs, the nomadic and generally mobile population of Somalia to access to health facilities and potential impact that funding of this intervention would have on three diseases overall.","NA Original Module: Emergency mobile teams. Original Intervention: Emergency mobile teams","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5600","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","A consultant for NMCP Somaliland to develop and implement an exit strategy, as well as a fund-raising strategy for Somaliland.The consultant will work for 3 months (21 days per month) per year = 63 days per year x 3 years = 189 days.",96141,null,"Active","a6Q1R000000AJRm",0,0,0,0,96141,0,null,null,"A consultant for NMCP Somaliland to develop and implement an exit strategy, as well as a fund-raising strategy for Somaliland.The consultant will work for 3 months (21 days per month) per year = 63 days per year x 3 years = 189 days.","Medium","The country needs an exit strategy but the justification for having one consultant for 3 years is not clear. The applicant  may need to explore\nother modalities like having a mission consisting of many persons from different expertise for a shorter period along with a national workshop to\nensure that capacity is built in a wider area of expertise and to ensure sustainability",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Rwanda","Rwanda","PAI-5468","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Broaden utilization of GeneXpert is planned in the funding request. Above allocation will support the purchase of 50 ventilated workstations to improve biosafety of GeneXpert laboratories as recommended in the MTR.",157500,null,"Inactive","a6Q1R000000AJPe",157500,0,0,0,0,1,null,null,"Broaden utilization of GeneXpert is planned in the funding request. Above allocation will support the purchase of 50 ventilated workstations to improve biosafety of GeneXpert laboratories as recommended in the MTR.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Rwanda","Rwanda","PAI-5467","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Rwanda will undertake the next DHS in 2019-2020. This is a national activity implemented under the leadership of the National Institute of Statistic of Rwanda (NISR). The request will support the NMCP to ensure malaria is included in the DHS such as through the reading of blood smears for malaria prevalence. Part of the TA for this activity will be supported by PMI.",500000,null,"Active","a6Q1R000000AJPd",0,0,0,0,500000,0,null,null,"Rwanda will undertake the next DHS in 2019-2020. This is a national activity implemented under the leadership of the National Institute of Statistic of Rwanda (NISR). The request will support the NMCP to ensure malaria is included in the DHS such as through the reading of blood smears for malaria prevalence. Part of the TA for this activity will be supported by PMI.","Medium","The DHIS is an important piece in the\nrunning of the malaria program.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Support to the DHIS to support the malaria component","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Rwanda","Rwanda","PAI-5466","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","This budget requested will support the supervision of CHWs by health centre staff in their implementation of diagnosis and treatment of the population at the community level. This will support the program in strengthening the implementation of HBM by CHWs as this intervention has been scaled up since October 2016.",278788,null,"Active","a6Q1R000000AJPc",0,0,0,0,278788,0,null,null,"This budget requested will support the supervision of CHWs by health centre staff in their implementation of diagnosis and treatment of the population at the community level. This will support the program in strengthening the implementation of HBM by CHWs as this intervention has been scaled up since October 2016.","High","Supervision of CHWs by local health\nworkers is highly needed to have quality\ncase management in place","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Rwanda","Rwanda","PAI-5465","MCI-00011","Vector control","MCI-00152","Entomological monitoring","This cost will support the implementation of entomological monitoring in 12 sites and the insecticide resistance survey in 30 sites in 2020-2021 as they are not supported by neither the GF nor by PMI.  These  activities  are  important  are  the findings  will guide  the  program  on the decisions taken relative to which insecticide should be used in IRS and also inform on mosquito behaviour patterns.",487508,null,"Active","a6Q1R000000AJPb",0,0,0,0,487508,0,null,null,"This cost will support the implementation of entomological monitoring in 12 sites and the insecticide resistance survey in 30 sites in 2020-2021 as they are not supported by neither the GF nor by PMI.  These  activities  are  important  are  the findings  will guide  the  program  on the decisions taken relative to which insecticide should be used in IRS and also inform on mosquito behaviour patterns.","High","This is important for the timely\nimplementation of the resistance\nmanagement plan. Those activities are\nimportant are findings guide the\nprogram in the decision of insecticide to\nbe used in IRS and also the behaviour\nof mosquito",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Rwanda","Rwanda","PAI-5464","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Due to inadequate resources, no specific funding has been requested for funding SBCC. However, it?s anticipated that PMI will continue to support some specific SBCC activities. The MSP articulates specific SBCC interventions envisioned between 2018 and 2020. This  request  is  to  continue  to  sensitize  the population on malaria awareness, malaria prevention and care seeking with the aim of increasing  LLIN  use  and  reducing  malaria transmission.",1498026,null,"Active","a6Q1R000000AJPa",0,0,0,0,1498026,0,null,null,"Due to inadequate resources, no specific funding has been requested for funding SBCC. However, it?s anticipated that PMI will continue to support some specific SBCC activities. The MSP articulates specific SBCC interventions envisioned between 2018 and 2020. This  request  is  to  continue  to  sensitize  the population on malaria awareness, malaria prevention and care seeking with the aim of increasing  LLIN  use  and  reducing  malaria transmission.","High","Given the upsurge, the TRP considers\nthis essential for increasing utilization of\nthe available interventions e.g. LLINs,\nfree diagnostics and medications","NA Original Module: Specific prevention interventions. Original Intervention: Information, education, communication/behavior change communications (vector control)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Rwanda","Rwanda","PAI-5463","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.",19077346,null,"Active","a6Q1R000000AJPZ",0,13626690,0,2723056,2727600,0,null,null,"This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.","High","IRS is an effective intervention to\ncontain the upsurge of malaria in highly\nendemic areas. However, it?s important\nthat if this is to be pursued then the\ncountry has enough resources to\nprovide for long term implementation.\nOtherwise, with the proposed budget,\nLLINs may be more useful considering\nthe durability of the net.","15/10/2018: at Oct GAC 2018, $ 13,626,690 is from the Portfolio optimization funds and $   2,723,056 the cost of the insecticides donated from Madagascar. This budget will support the country to spray 5 districts with the PAA funding in FY 18-19 and 4 districts in FY 19-20. The donated insecticides from Madagascar will support the country to spray 2 districts in FY 18-19. The gap of 2.7 million USD if available, will support to cover 2 districts in FY 20-21. The grant budget did not include $2.7m as they were not addtl funds but insecticides given Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Panama","Panama","PAI-5370","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","The MoniTARV system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future. system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future.",94500,null,"Active","a6Q1R000000AJO4",0,0,0,0,94500,0,null,null,"The MoniTARV system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future. system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future.","Medium","The TRP considers the digitalization of existing medical records of patients on ART as a strategic investment, although the amount requested by the applicant deems high. The TRP suggests reallocating efficiency gains to other priorities, such as PSM","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Recruitment of data entry staff to update MoniTARV records","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Panama","Panama","PAI-5369","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","The conceptual proposal would enable the Minsitry of Public Health to create a tool to identify cases of TB and TB/HIV in order to design the range of resources and services in line with actual needs in the future, ensuring a more effective response in the sustainability phase.",34000,null,"Active","a6Q1R000000AJO3",0,0,0,0,34000,0,null,null,"The conceptual proposal would enable the Minsitry of Public Health to create a tool to identify cases of TB and TB/HIV in order to design the range of resources and services in line with actual needs in the future, ensuring a more effective response in the sustainability phase.","Medium","The TRP considers this intervention to be medium priority as it improves the health information systems ability to trace the tuberculosis cases geographically. The TRP considers this investment could benefit the active case detection but is not critical for its success.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Technical assistance to create a conceptual proposal for a geo-referencing tool for cases of tuberculosis, cases of TB/HIV (200 cases, approx. 10% of TB/HIV cases nationwide (1900 cases in 2017)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Panama","Panama","PAI-5368","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00177","Other health and community workforce intervention(s)","The community education program will supplement individual TB prevention actions that are implemented by tuberculosis health promoters in indigenous areas, enhancing the capacity of health regions with indigenous populations to continue with health promotion programs with an intercultural approach, including the prevention of TB.",60000,null,"Active","a6Q1R000000AJO2",0,0,0,0,60000,0,null,null,"The community education program will supplement individual TB prevention actions that are implemented by tuberculosis health promoters in indigenous areas, enhancing the capacity of health regions with indigenous populations to continue with health promotion programs with an intercultural approach, including the prevention of TB.","Medium","The TRP considers that this intervention to be medium priority as it represents an investment in the capacity building of health promoters (for interpersonal communication) at the community level. This investment is valuable but not critical for the performance of the program.","NA Original Module: SRSS: Human Resources including community health workers. Original Intervention: Intercultural education program for the health of communities with messages on controlling tuberculosis infections using different national, regional and local resources, including mass media and different forms of interpersonal and group communication.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Panama","Panama","PAI-5367","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Goal 3 of the End TB strategy is to reach 0 catastrophic costs in terms of tuberculosis. Panama has no information to measure progress; therefore, this survey would need to be performed in the first two years in which the 2018-2022 PENTB is implemented.",70000,null,"Active","a6Q1R000000AJO1",0,0,0,0,70000,0,null,null,"Goal 3 of the End TB strategy is to reach 0 catastrophic costs in terms of tuberculosis. Panama has no information to measure progress; therefore, this survey would need to be performed in the first two years in which the 2018-2022 PENTB is implemented.","High","The TRP considers that this intervention to be high priority at it addresses the gap in strategic information for evidence-informed decision making (although by nature it is recurrent cost","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Survey on catastrophic costs related to tuberculosis.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Panama","Panama","PAI-5366","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","The pilot project will contribute to guaranteeing the ability of national institutions to offer one of the most innovative interventions of combined prevention in the future.",70000,null,"Active","a6Q1R000000AJO0",0,0,0,0,70000,0,null,null,"The pilot project will contribute to guaranteeing the ability of national institutions to offer one of the most innovative interventions of combined prevention in the future.","High","The TRP considers the pilot project on PrEP to be high priority for PAAR. It is aligned with the transition workplan priorities and an important component of HIV prevention programming for key populations for key populations.","NA Original Module: Comprehensive prevention programs for key populations (MSM, FSW, transgender population). Original Intervention: Pilot project to provide pre-exposure prophylaxis to HIV (PrEP) to MSM and transgender populationsPrEP) to MSM and transgender populations.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Nepal","Nepal","PAI-5321","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Assessment of BCC methodology and approaches to guide policy revision in light of requirements for elimination.",20259,null,"Active","a6Q1R000000AJNH",0,0,0,0,20259,0,null,null,"Assessment of BCC methodology and approaches to guide policy revision in light of requirements for elimination.","High","Proper case management in times of preand elimination phases is crucial. For this reason, the BCC methodology and approaches to guide policy revision must be assessed accordingly.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5320","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Provide training on leadership and management at Central, Regional and District levels.",2044,null,"Active","a6Q1R000000AJNG",0,0,0,0,2044,0,null,null,"Provide training on leadership and management at Central, Regional and District levels.","Medium","As the burden of disease reduces, strong training on leadership and management at Central, Regional and District levels will be important.","NA Original Intervention: Policy, planning, coordination and management","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5319","MCI-00011","Vector control","MCI-00152","Entomological monitoring","Monitoring the durability and efficacy of LLINs to inform future procurement.",16110,null,"Active","a6Q1R000000AJNF",0,0,0,0,16110,0,null,null,"Monitoring the durability and efficacy of LLINs to inform future procurement.","Medium","Tracking LLIN durability will support management of resupply and inform procurement decisions that take into account the number of years of protection as opposed to unit cost of LLINs.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5318","MCI-00012","Case management","MCI-00162","Ensuring drug and other health product quality","Support facility visits by enforcement teams in cases where inappropriate drugs are identified.",11742,null,"Active","a6Q1R000000AJNE",0,0,0,0,11742,0,null,null,"Support facility visits by enforcement teams in cases where inappropriate drugs are identified.","Medium","Monitoring drug quality (e.g. facility visits by enforcement teams in cases where inappropriate drugs are identified) is essential to improve the quality of health care.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5317","MCI-00012","Case management","MCI-00154","Facility-based treatment","Procure and supply 15 new replacement microscopes (Y2); Refurbish Surkhet microscopy laboratory (Y2).",34440,null,"Active","a6Q1R000000AJND",0,0,0,0,34440,0,null,null,"Procure and supply 15 new replacement microscopes (Y2); Refurbish Surkhet microscopy laboratory (Y2).","Medium","Diagnostic equipment [new replacement microscopes (Year 2)] are needed for facility -based providers to improve the quality of healthcare provision.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5316","MCI-00011","Vector control","MCI-00152","Entomological monitoring","On-going longitudinal surveys of vector distribution, abundance and bionomics in Y2&3.",44472,null,"Active","a6Q1R000000AJNC",0,0,0,0,44472,0,null,null,"On-going longitudinal surveys of vector distribution, abundance and bionomics in Y2&3.","Medium","This intervention allows for the updating of insecticide resistance information, vector distribution, abundance and bionomics in sentinel sites, and spot surveys (for Years 1 and 2). Insecticide resistance monitoring and management is a key strategy advocated by GPIRM (WHO 2011) and Global Vector Control Response 2017 - 2030",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5315","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","External program evaluation to review progress and inform programme direction (Y3).",33428,null,"Active","a6Q1R000000AJNB",0,0,0,0,33428,0,null,null,"External program evaluation to review progress and inform programme direction (Y3).","Medium","Training on database management and data analysis is important, as well as mid - term evaluation to guide the program. This is however considered medium priority especially as it is not a country wide epidemics.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5314","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","TA for development of IEC documents for elimination; Production and dissemination of IEC materials.",20138,null,"Active","a6Q1R000000AJNA",0,0,0,0,20138,0,null,null,"TA for development of IEC documents for elimination; Production and dissemination of IEC materials.","Medium","Advocacy activities and IEC documents are a powerful tool to support the long -term political and financial commitment necessary for malaria elimination.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5313","MCI-00011","Vector control","MCI-00152","Entomological monitoring","Provide training on basic malaria entomology for support workers to maximize capacity of entomological teams to support elimination.",61050,null,"Active","a6Q1R000000AJN9",0,0,0,0,61050,0,null,null,"Provide training on basic malaria entomology for support workers to maximize capacity of entomological teams to support elimination.","Medium","This intervention provides training on basic malaria entomology for district staff to support foci investigations on receptivity and outbreak response. This is consistent with the Global Vector Control Response 2017 -2030, which puts an emphasis on renewed focus on improved human capacity at national and subnational levels and repositions vector control as a key approach to prevent and eliminate vector - borne diseases.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Malawi","Malawi","PAI-5218","MCI-00007","Treatment, care and support","MCI-00121","Prevention, diagnosis and treatment of opportunistic infections","Funds to support switching from single dose to fixed dose ($11.66M) The program has prioritized implementation of Isoniazid Preventive Therapy in the five districts with highest TB prevalence. The FR includes a request for separate formulations of Co-trimoxazole, Isoniazid and Pyridoxine. This will increase the pill burden for the patients hence the request for additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine as per MOH Clinical guidelines. The fixed dose combination will be given to 40% of the ART patient cohort. Additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine per MOH policy.",11660000,null,"Active","a6Q1R000000AJLc",5504341,0,0,0,6155659,0,null,null,"Funds to support switching from single dose to fixed dose ($11.66M) The program has prioritized implementation of Isoniazid Preventive Therapy in the five districts with highest TB prevalence. The FR includes a request for separate formulations of Co-trimoxazole, Isoniazid and Pyridoxine. This will increase the pill burden for the patients hence the request for additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine as per MOH Clinical guidelines. The fixed dose combination will be given to 40% of the ART patient cohort. Additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine per MOH policy.","Medium","A switch to fixed dose IPT will increase adherence.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5217","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Point of care for VL/EID ($7.62M) Point of Care is critical for patient monitoring and early provision of lifesaving interventions The Ministry of Health with support from CHAI conducted a POC mapping and identified 99 Health facilities that would benefit from Point of Care for VL/EID. High volume sites will be considered for deployment of POC, because of availability of infrastructure and linkage to care for higher throughput. This will enable providers make timely clinical decisions to switch failing patients to second/third line ART. This request will enable the Ministry of Health to procure an additional 15 platforms and procure 50,000 viral load tests and 15,000 EID tests. This will complement existing POC investments available in country including funding from UNITAID for 2017 to 2019.",7620000,null,"Active","a6Q1R000000AJLb",3674497.99,0,0,0,3945502.01,0,null,null,"Point of care for VL/EID ($7.62M) Point of Care is critical for patient monitoring and early provision of lifesaving interventions The Ministry of Health with support from CHAI conducted a POC mapping and identified 99 Health facilities that would benefit from Point of Care for VL/EID. High volume sites will be considered for deployment of POC, because of availability of infrastructure and linkage to care for higher throughput. This will enable providers make timely clinical decisions to switch failing patients to second/third line ART. This request will enable the Ministry of Health to procure an additional 15 platforms and procure 50,000 viral load tests and 15,000 EID tests. This will complement existing POC investments available in country including funding from UNITAID for 2017 to 2019.","Medium","Increasing access to viral load supports maintenance of high national viral suppression rate of 90.8%","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5216","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","The activities within this module are linked to the HSSPII objective to generate quality information, and increase quality information accessibility to all intended users for evidence-based decision-making, through standardized and harmonized tools that avoids duplication across all programmes. These activities encourage the adoption of ICT systems for routine data management including data collection, data analysis, use and dissemination. These activities include procurement of IT equipment for all levels, and procurement of 10 vehicles to support programme implementation. Funding Request: Tailored to Material Change 15 December 2016? 39 An inventory of all vehicles has been created and priority will be given to those government departments who have critical supervision/audit responsibilities A pooled system is in force at Headquarters level.",502437,null,"Active","a6Q1R000000AJLa",30487.32,0,0,0,471949.68,0,null,null,"The activities within this module are linked to the HSSPII objective to generate quality information, and increase quality information accessibility to all intended users for evidence-based decision-making, through standardized and harmonized tools that avoids duplication across all programmes. These activities encourage the adoption of ICT systems for routine data management including data collection, data analysis, use and dissemination. These activities include procurement of IT equipment for all levels, and procurement of 10 vehicles to support programme implementation. Funding Request: Tailored to Material Change 15 December 2016? 39 An inventory of all vehicles has been created and priority will be given to those government departments who have critical supervision/audit responsibilities A pooled system is in force at Headquarters level.","High","Allows for evidence based decision making and action","NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5215","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","These funds will be used to cover M&E printing costs and CMED activities that build on activities found both within allocation and in the catalytic investment funding.",873425,null,"Active","a6Q1R000000AJLZ",0,0,0,0,873425,0,null,null,"These funds will be used to cover M&E printing costs and CMED activities that build on activities found both within allocation and in the catalytic investment funding.","High","Integral part of project management and monitoring","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5214","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","These funds will be used to conduct operational research on program activities within allocation. Outcomes of this research can be used to optimize program performance.",227740,null,"Active","a6Q1R000000AJLY",0,0,0,0,227740,0,null,null,"These funds will be used to conduct operational research on program activities within allocation. Outcomes of this research can be used to optimize program performance.","High","Necessary for performance and mid-course corrections","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Analysis, evaluations, review and transparency","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5213","MCI-00019","RSSH: Financial management systems","MCI-00187","Public financial management (PFM) strengthening","The activities prioritized in this intervention are central to financial management strengthening for the Government of Malawi. Linked to the HSSPII, these activities will strengthen the capacity of the finance staff in terms of skills and necessary equipment needed to improve overall management. These activities coupled with the support from other donors and the Government of Malawi itself will improve financial management capacity specifically through improved planning, and budget execution. Specific activities in this intervention include: ? Training on bank reconciliation ? Management training ? Office furniture and equipment.",4026804,null,"Active","a6Q1R000000AJLX",0,0,0,0,4026804,0,null,null,"The activities prioritized in this intervention are central to financial management strengthening for the Government of Malawi. Linked to the HSSPII, these activities will strengthen the capacity of the finance staff in terms of skills and necessary equipment needed to improve overall management. These activities coupled with the support from other donors and the Government of Malawi itself will improve financial management capacity specifically through improved planning, and budget execution. Specific activities in this intervention include: ? Training on bank reconciliation ? Management training ? Office furniture and equipment.","High","Fiduciary capacity strengthening is essential","NA Original Module: RSSH - Financial management systems. Original Intervention: Public financial management strengthening","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Myanmar","Myanmar","PAI-5089","MCI-00001","Prevention programs for MSM and TGs","MCI-00083","HIV testing and counseling as part of programs for MSM and TGs","The additional investment will support the program to reach more target population.",579579,null,"Active","a6Q1R000000AJJX",0,0,0,0,579579,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 1177031 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Prevention programs for men who have sex with men and transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5088","MCI-00001","Prevention programs for MSM and TGs","MCI-00086","Other interventions for MSM and TGs","The additional investment will support the program to reach more target population.",136363,null,"Active","a6Q1R000000AJJW",0,0,0,0,136363,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 139,090 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Prevention programs for men who have sex with men and transgender people. Original Intervention: Diagnosis and treatment of STIs as part of High programs for MSM and TGs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5087","MCI-00001","Prevention programs for MSM and TGs","MCI-00082","Condoms as part of programs for MSM and TGs","The additional investment will support the program to reach more target population.",1076812,null,"Active","a6Q1R000000AJJV",849697,0,0,0,227115,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Module: Prevention programs for men who have sex with men and transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5086","MCI-00001","Prevention programs for MSM and TGs","MCI-00081","Behavioral change as part of programs for MSM and TGs","The additional investment will support the program to reach more target population.",9468402,null,"Active","a6Q1R000000AJJU",6796313,0,0,0,2672089,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Module: Prevention programs for men who have sex with men and transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5085","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Addressing limited capacity of health and community workforce will help remove bottlenecks for program implementation.",13815383,null,"Active","a6Q1R000000AJJT",4747070,0,0,0,9068313,0,null,null,"Addressing limited capacity of health and community workforce will help remove bottlenecks for program implementation.","High","Limited capacity of health and community workforce is identified as a bottleneck in CN","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Mali","Mali","PAI-5084","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Since 2016 SMC  is carried out in the whole country.  It should continue to be scaled up for greater impact on the target population (children under 5) because evaluation shows  its protective effectiveness in reducing the number of malaria cases. UQD not needed anymore as funds were found in efficiency gains during malaria grant making.",4054116.26,null,"Inactive","a6Q1R000000AJJS",4054116.26,0,0,0,0,1,null,null,"Since 2016 SMC  is carried out in the whole country.  It should continue to be scaled up for greater impact on the target population (children under 5) because evaluation shows  its protective effectiveness in reducing the number of malaria cases. UQD not needed anymore as funds were found in efficiency gains during malaria grant making.","High","Please ensure that whatever PAAR amount gets funded for Mali is split according to the current 3.3 : 1 ratio for LLINs : SMC respectively.","NA Original Module: Specific prevention interventions","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 1","2021-12-31","Malaria"]
["CT Mali","Mali","PAI-5083","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Routine and campaign LLIN distribution improved results and impact indicators;  LLIN possession rate increased from 84% in 2013 (DHS-V) to 92% in 2015 (EIPM),  usage rate increased from 75.2% in 2013 (DHS-V) to 78 percent in 2015 (EIPM) and malaria prevalence decreased from 52 percent in 2013 (DHS-V) to 36 percent in 2015 (EIPM).\nUQD not anymore needed as funds have been obtained on an \"In principle endorsement\" award from the Portfolio Optimization Wave 2.",13378479.41,null,"Active","a6Q1R000000AJJR",1047678.15,8851102,0,0,3479699.26,0,null,null,"Routine and campaign LLIN distribution improved results and impact indicators;  LLIN possession rate increased from 84% in 2013 (DHS-V) to 92% in 2015 (EIPM),  usage rate increased from 75.2% in 2013 (DHS-V) to 78 percent in 2015 (EIPM) and malaria prevalence decreased from 52 percent in 2013 (DHS-V) to 36 percent in 2015 (EIPM).\nUQD not anymore needed as funds have been obtained on an \"In principle endorsement\" award from the Portfolio Optimization Wave 2.","High","Please ensure that whatever PAAR amount gets funded for Mali is split according to the current 3.3 : 1 ratio for LLINs : SMC respectively.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 1","2021-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4986","MCI-00071","Other module","MCI-00071","Other module","Additional VMV training to improve data collection and reporting, electronic equipment to improve capacity for reporting, training at central and province level on DHIS2 usage, and supplementary training to improve outbreak preparedness and response.",700000,null,"Inactive","a6Q1R000000AJHs",700000,0,0,0,0,1,null,null,"Additional VMV training to improve data collection and reporting, electronic equipment to improve capacity for reporting, training at central and province level on DHIS2 usage, and supplementary training to improve outbreak preparedness and response.","High","The TRP considers these as key activities that should be incorporated as part of regular allocation, if efficiencies are found during grant making.","NA Original Module: RSSH. Original Intervention: Strengthening of the Surveillance System (Lao PDR )","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4858","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","To undertake any rehabilitation work in the wards where MDR/XDR-TB patients are hospitalized in order to fulfill the infection control requirements.",12500,null,"Active","a6Q1R000000AJFo",0,0,0,0,12500,0,null,null,"To undertake any rehabilitation work in the wards where MDR/XDR-TB patients are hospitalized in order to fulfill the infection control requirements.","Low","Infection control activities in five countries would require larger amount of funding and appropriate planning","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4857","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","To support the development and printing of the national guidelines on TB infection control in Iraq, Lebanon, Yemen, Syria and Jordan",25000,null,"Active","a6Q1R000000AJFn",0,0,0,0,25000,0,null,null,"To support the development and printing of the national guidelines on TB infection control in Iraq, Lebanon, Yemen, Syria and Jordan","Low","This is considered as low priority in the context of a COE and the time-frame required for this activity","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4856","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To provide support to all the five countries to implement the DHIS2 (TB Tracker) in the settings where it should be implemented",20000,null,"Active","a6Q1R000000AJFm",0,0,0,0,20000,0,null,null,"To provide support to all the five countries to implement the DHIS2 (TB Tracker) in the settings where it should be implemented","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4855","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","Similar to the MSM module, this is to include parts of Yemen and expand the services in the other countries. Through the within allocation fund, 23% of the FSW will be tested for HIV. It is expected to increase the HIV testing among FSW to 50% through PAAR fund.",2500000,null,"Active","a6Q1R000000AJFl",0,0,0,0,2500000,0,null,null,"Similar to the MSM module, this is to include parts of Yemen and expand the services in the other countries. Through the within allocation fund, 23% of the FSW will be tested for HIV. It is expected to increase the HIV testing among FSW to 50% through PAAR fund.","High","In this Funding Request there is a focus on testing of key populations, which the TRP believes to be crucial. Given the importance of this activity, and the fact that prevention and testing programs for female sex workers in Yemen are not included in the allocation request, we recommend that a portion of this amount should move to the allocation for prevention activities among FSW in Yemen and be funded through savings made during grant making.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4854","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To organize at regional level a workshop on the utilization of the DHIS2. Will attend this course the relevant central unit staff of the NTPs as well as the staff of NGOs and FBOs operating in settings with IDPs and refugees",35000,null,"Active","a6Q1R000000AJFk",0,0,0,0,35000,0,null,null,"To organize at regional level a workshop on the utilization of the DHIS2. Will attend this course the relevant central unit staff of the NTPs as well as the staff of NGOs and FBOs operating in settings with IDPs and refugees","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4853","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In order to strengthen culture and DST activities, 6 Bactec MGIT960 kits with immunochromatographic assays need to be acquired:  4 for Iraq and 2 for Yemen",20000,null,"Active","a6Q1R000000AJFj",0,0,0,0,20000,0,null,null,"In order to strengthen culture and DST activities, 6 Bactec MGIT960 kits with immunochromatographic assays need to be acquired:  4 for Iraq and 2 for Yemen","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4852","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","To rehabilitate the microscopy laboratories of the health facilities damaged by the fighting in Iraq, Yemen and Syria",450000,null,"Active","a6Q1R000000AJFi",0,0,0,0,450000,0,null,null,"To rehabilitate the microscopy laboratories of the health facilities damaged by the fighting in Iraq, Yemen and Syria","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4851","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In order to enhance TB microscopy activities in Iraq, yemen and Syria 3 LED microscopes need to be acquired",13534,null,"Active","a6Q1R000000AJFh",0,0,0,0,13534,0,null,null,"In order to enhance TB microscopy activities in Iraq, yemen and Syria 3 LED microscopes need to be acquired","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Lesotho","Lesotho","PAI-4753","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","The funding will be used to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA) as part of community systems strengthening. This will include development of key users manuals, procurement of key infrastructure, and training of stakeholders to enable full operation of LOMSHA.",53318,null,"Active","a6Q1R000000AJE7",0,0,0,0,53318,0,null,null,"The funding will be used to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA) as part of community systems strengthening. This will include development of key users manuals, procurement of key infrastructure, and training of stakeholders to enable full operation of LOMSHA.","Medium","This is to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA).","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4752","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","The funding will be used to support coordination of activities in the prisons and factories to address the high risk of TB and HIV infection in the target population. The activities will be funded through the re-investment of the efficiencies identified during the grant making.",20000,null,"Inactive","a6Q1R000000AJE6",20000,0,0,0,0,1,null,null,"The funding will be used to support coordination of activities in the prisons and factories to address the high risk of TB and HIV infection in the target population. The activities will be funded through the re-investment of the efficiencies identified during the grant making.","High","To support coordination of activities in the prisons and factories. This is prioritized given the risk of TB and HIV infection in the target population.","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4751","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00573","Gender-based violence prevention and treatment programs for adolescents and youth","The funding will be used for multimedia platforms, including social media, to enhance service uptake by adolescents and young people. The activities will include establishing a hotline for survivors of gender based violence and design of webpages and databases. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.",16691,null,"Inactive","a6Q1R000000AJE5",16691,0,0,0,0,1,null,null,"The funding will be used for multimedia platforms, including social media, to enhance service uptake by adolescents and young people. The activities will include establishing a hotline for survivors of gender based violence and design of webpages and databases. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.","High","This will enhance service uptake by adolescents and young people and also establish a hotline for survivors of gender based violence.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4750","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","Funding will support coordination and supervision of interventions across the programs for adolescents and young people in and out of schools in the eight districts. This will help programs to synergize and ensure coordinated services delivery and sharing of lessons learnt. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.",66323,null,"Inactive","a6Q1R000000AJE4",66323,0,0,0,0,1,null,null,"Funding will support coordination and supervision of interventions across the programs for adolescents and young people in and out of schools in the eight districts. This will help programs to synergize and ensure coordinated services delivery and sharing of lessons learnt. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.","High","This will support coordination and supervision of interventions across the programs for adolescents and young people in and out of schools.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4749","MCI-00000","Prevention programs for general population","MCI-00079","Gender-based violence prevention and treatment programs for general population","Funding will be used to support integration of human rights and prevention of sexual and gender-based violence among adolescents as part of HIV and TB prevention intervention to address structural issues and expand geographical coverage to eight districts. The activity will be funded through the reinvestment of the efficiencies identified during the grant making.",351805,null,"Inactive","a6Q1R000000AJE3",351805,0,0,0,0,1,null,null,"Funding will be used to support integration of human rights and prevention of sexual and gender-based violence among adolescents as part of HIV and TB prevention intervention to address structural issues and expand geographical coverage to eight districts. The activity will be funded through the reinvestment of the efficiencies identified during the grant making.","High","Human rights violations and sexual and gender based violence are key interventions required to address structural issues in the HIV epidemic.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4748","MCI-00000","Prevention programs for general population","MCI-00072","Behavioral interventions as part of programs for general population","The funding will support sensitization and prevention of sexual and gender based violence to reduce HIV transmission among vulnerable populations. It will include production and dissemination of education materials and simplified laws for training of law enforcement agencies. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.",196037,null,"Inactive","a6Q1R000000AJE2",196037,0,0,0,0,1,null,null,"The funding will support sensitization and prevention of sexual and gender based violence to reduce HIV transmission among vulnerable populations. It will include production and dissemination of education materials and simplified laws for training of law enforcement agencies. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.","High","Sensitization and prevention of sexual and gender based violence will help reduce the HIV transmission risk among vulnerable populations.","NA Original Intervention: Behavioral interventions as part of programs for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5865","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","High level priority: it is in line with FR of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.",45694,null,"Active","a6Q1R000000AJW3",0,0,0,0,45694,0,null,null,"High level priority: it is in line with FR of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.","High","High level priority: it is in line with FR of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5864","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: To support coordination mechanisms at the community level.",457414,null,"Active","a6Q1R000000AJW2",413915,0,0,0,43499,0,null,null,"High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: To support coordination mechanisms at the community level.","High","High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: To support coordination mechanisms at the community level.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5863","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","For enhanced access to specific services (including screening for malignancies, management of Opportunistic Infections, STIs and other important diagnostic and medical services), clients will be sensitized to enroll in Community Health Insurance Scheme. The PAAR funds will help cover demand creation and advocacy activities. The availability of this scheme will improve timely access to affordable quality medical services and contribute to the sustainability of GF investments for HIV, TB and Malaria.",300000,null,"Active","a6Q1R000000AJW1",0,0,0,0,300000,0,null,null,"For enhanced access to specific services (including screening for malignancies, management of Opportunistic Infections, STIs and other important diagnostic and medical services), clients will be sensitized to enroll in Community Health Insurance Scheme. The PAAR funds will help cover demand creation and advocacy activities. The availability of this scheme will improve timely access to affordable quality medical services and contribute to the sustainability of GF investments for HIV, TB and Malaria.","Low","For enhanced access to specific services (including screening for malignancies, management of Opportunistic Infections, STIs and other important diagnostic and medical services), clients will be sensitized to enrol in Community Health Insurance Scheme. The PAAR funds will help cover demand creation and advocacy activities. The availability of this scheme will improve timely access to affordable quality medical services and contribute to the sustainability of the Global Fund investments for HIV, TB and Malaria.","NA Original Intervention: Delivering sustainable HIV care services through Community Health Insurance Scheme","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5862","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Tanzania is planning to improve referrals and linkages from HTC to care and treatment using the Unique Identifier Code biometric technology. This will reduce duplications, and reduce loss to follow up. It will also help to track and return clients back into care. The planned unique identification biometric system (in the RSSH grant) and the related funds are to pilot a small scale in one region-Dar es Salaam. The funding requested in the PAAR for this activity will be used to scale up use of unique identifier (biometric) in all CTCs in the country.",1500000,null,"Active","a6Q1R000000AJW0",0,0,0,0,1500000,0,null,null,"Tanzania is planning to improve referrals and linkages from HTC to care and treatment using the Unique Identifier Code biometric technology. This will reduce duplications, and reduce loss to follow up. It will also help to track and return clients back into care. The planned unique identification biometric system (in the RSSH grant) and the related funds are to pilot a small scale in one region-Dar es Salaam. The funding requested in the PAAR for this activity will be used to scale up use of unique identifier (biometric) in all CTCs in the country.","Low","Tanzania is planning to improve referrals and linkages from HTC to care and treatment using the Unique Identifier Code biometric technology. This will reduce duplications, and reduce loss to follow up. It will also help to track and return clients back into care. The planned unique identification biometric system (in the RSSH grant) and the related funds are to pilot a small scale in one region-Dar es Salaam. The funding requested in the PAAR for this activity will be used to scale up use of unique identifier (biometric) in all Community Treatment Centers (CTCs) in the country.","NA Original Intervention: Scale up of biometric identification system at CTC for clients already enrolled into care","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5861","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Tanzania is planning to conduct screening of HBV and HCV to PLHIV and put them on appropriate regimen. Data from National Blood Transfusion services, has shown an increasing prevalence of HBV and HCV among blood donors. This activity will also be used to estimate the magnitude of the HBV/HIV co-infections among clients attending CTC.",800000,null,"Active","a6Q1R000000AJVz",0,0,0,0,800000,0,null,null,"Tanzania is planning to conduct screening of HBV and HCV to PLHIV and put them on appropriate regimen. Data from National Blood Transfusion services, has shown an increasing prevalence of HBV and HCV among blood donors. This activity will also be used to estimate the magnitude of the HBV/HIV co-infections among clients attending CTC.","Low","Tanzania is planning to conduct screening of HBV and HCV to People Living with HIV and put them on appropriate regimen. Data from National Blood Transfusion services, has shown an increasing prevalence of HBV and HIV Testing and Counselling (HCV) among blood donors. This activity will also be used to estimate the magnitude of the HBV/HIV coinfections among clients attending Community Treatment Centers (CTC).","NA Original Intervention: The program planned to screen for HBV and HCV coinfection to client attending CTC","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5775","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","RTF BL 45:Support monitor for Public-Private-Mix collaboration in TB control activitiesTo ensure that the TB control is effectively implemented in the community.",47495,null,"Active","a6Q1R000000AJUb",0,0,0,0,47495,0,null,null,"RTF BL 45:Support monitor for Public-Private-Mix collaboration in TB control activitiesTo ensure that the TB control is effectively implemented in the community.","Medium","This intervention will support monitoring of public-private collaborations",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5774","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","DDC BL 289:Support of 3 small mobile x-ray vans, including read and digital CXR scanner set to render regular mobile services for prisoners and prisoner guards in 20 high TB burden prisons (2 prisons for one van) with prompt referral of symptomatic patients or patients with abnormal CXR to facilities with GeneXpert for TB confirmation and TB treatment. This demonstrationproject is hoped to generate evidence of TB disease burden in prisons and feasibility for prevention and care in order to support policy decision.Small mobile x-ray van, including read and digital CXR scanner set to provide services for the prisons that have the narrow entry/entrance.",723486,null,"Inactive","a6Q1R000000AJUa",0,723486,0,0,0,1,null,null,"DDC BL 289:Support of 3 small mobile x-ray vans, including read and digital CXR scanner set to render regular mobile services for prisoners and prisoner guards in 20 high TB burden prisons (2 prisons for one van) with prompt referral of symptomatic patients or patients with abnormal CXR to facilities with GeneXpert for TB confirmation and TB treatment. This demonstrationproject is hoped to generate evidence of TB disease burden in prisons and feasibility for prevention and care in order to support policy decision.Small mobile x-ray van, including read and digital CXR scanner set to provide services for the prisons that have the narrow entry/entrance.","Medium","This intervention will support increase TB case finding in 20 high TB burden prisons and will generate evidences of TB burden and prevention and care feasibility to support policy decisions","NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5773","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","RTF BL 43: $28,372.01Modeling for community-based sputum transportation ?ConsultantRTF BL 44: $43,406.34Modeling for community-based sputum transportation -Consultation workshop with LAO, CSO, community, and health facilitiesRationale: To engage the local stakeholder to initiate the community-based sputum transportation.",71778,null,"Active","a6Q1R000000AJUZ",0,0,0,0,71778,0,null,null,"RTF BL 43: $28,372.01Modeling for community-based sputum transportation ?ConsultantRTF BL 44: $43,406.34Modeling for community-based sputum transportation -Consultation workshop with LAO, CSO, community, and health facilitiesRationale: To engage the local stakeholder to initiate the community-based sputum transportation.","High","This intervention will contribute to improved treatment outcomes due to patient centred care by engaging CSO in sputum transport systems",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5772","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","DDC BL 273:Support renovation of isolation TB room and DOT corner for prisoners including UV light in order to prevent TB/MDR transmission in prison in 70 prisons.The prisons are the closed setting areas and crowded, provision of molecular test by GeneXpert will detect more TB patients. Good management for infectious TB control will prevent and cut off transmission in prisons.Emphasizing on infection control and environment management control that is important both for prisoners and prison guards.",397208,null,"Inactive","a6Q1R000000AJUY",0,397208,0,0,0,1,null,null,"DDC BL 273:Support renovation of isolation TB room and DOT corner for prisoners including UV light in order to prevent TB/MDR transmission in prison in 70 prisons.The prisons are the closed setting areas and crowded, provision of molecular test by GeneXpert will detect more TB patients. Good management for infectious TB control will prevent and cut off transmission in prisons.Emphasizing on infection control and environment management control that is important both for prisoners and prison guards.","High","This infection control intervention will contribute to decrease the transmission of TB in prisons","NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5771","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","DDC BL 288: This will support the implementation in 62 prisons in 41 provinces, continuing  from the funding request in year 2-3, by using CXR and Xpert MTB/RIF in order to early detect and cut of TB transmission and to increase case finding to cover over the country.This will increase number of prisoners reached, i.e. 157,351 persons in addition, increase coverage to 85%The prison is partially of high risk group that has high prevalence that more TB cases detected and treated.CXR is the way to make it faster than as usual 5-10%, verbal screening 6-10% to be positive, X-Ray 12-20% will be expected to see abnormal CXR 22,000 cases, then testing by GeneXpert will find2,200 TB patients in prisons.",470298,null,"Inactive","a6Q1R000000AJUX",470298,0,0,0,0,1,null,null,"DDC BL 288: This will support the implementation in 62 prisons in 41 provinces, continuing  from the funding request in year 2-3, by using CXR and Xpert MTB/RIF in order to early detect and cut of TB transmission and to increase case finding to cover over the country.This will increase number of prisoners reached, i.e. 157,351 persons in addition, increase coverage to 85%The prison is partially of high risk group that has high prevalence that more TB cases detected and treated.CXR is the way to make it faster than as usual 5-10%, verbal screening 6-10% to be positive, X-Ray 12-20% will be expected to see abnormal CXR 22,000 cases, then testing by GeneXpert will find2,200 TB patients in prisons.","High","This intervention will support activities to increase TB case finding in prisoners using CXR and GeneXpert as per the new national TB diagnostic algorithm for high risk populations. The faster diagnostic will also contribute to decrease TB transmission. Prisoners are the population with the highest TB incidence in the country, estimated at 13 times higher than the national incidence","NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5770","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","RTF BL 42:Support TB patient group activitiesTo establish a group to share past experiences, communicate and inform on counter effects of medicines and on the different forms of care and support present in the community for the benefit and of both KPs and care takers.",16342,null,"Active","a6Q1R000000AJUW",0,0,0,0,16342,0,null,null,"RTF BL 42:Support TB patient group activitiesTo establish a group to share past experiences, communicate and inform on counter effects of medicines and on the different forms of care and support present in the community for the benefit and of both KPs and care takers.","High","This intervention will support TB patient support groups",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6012","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","Funding will support expansion of the TB screening and testing services in facilities and community hot spots by supporting fee-for-service agreements for 264,000 digital chest x-rays and 66,000 Xpert tests. This will catalyze the impact of both the allocation (in facilities) and the matching funds request (in community hot spots), to find an estimated additional 5,280 missing TB patients.",5834695,null,"Active","a6Q1R000000AJYQ",0,0,0,0,5834695,0,null,null,"Funding will support expansion of the TB screening and testing services in facilities and community hot spots by supporting fee-for-service agreements for 264,000 digital chest x-rays and 66,000 Xpert tests. This will catalyze the impact of both the allocation (in facilities) and the matching funds request (in community hot spots), to find an estimated additional 5,280 missing TB patients.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6011","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00573","Gender-based violence prevention and treatment programs for adolescents and youth","Funding will support the 13 existing Thuthuzela Care Centres (TCCs) that are supported by the current Global Fund grant. The TCCs are a one-stop GBV model. Through this intervention, clients of TCCs will be tested for HIV, and either offered PEP (if eligible) or linked to treatment and care (as appropriate). The requested above allocation investment will reach 40,204 AGYW who are survivors of gender-based violence (including 20,017 survivors reached with HTS). It is estimated that 20?25% of new HIV infections in young women in South Africa are attributable to GBV.  It has also been (conservatively) estimated that gender-based violence costs South Africa between R28.4 billion and R42.4 billion per year ? or between 0.9% and 1.3% of GDP annually.",9566346,null,"Inactive","a6Q1R000000AJYP",9566346,0,0,0,0,1,null,null,"Funding will support the 13 existing Thuthuzela Care Centres (TCCs) that are supported by the current Global Fund grant. The TCCs are a one-stop GBV model. Through this intervention, clients of TCCs will be tested for HIV, and either offered PEP (if eligible) or linked to treatment and care (as appropriate). The requested above allocation investment will reach 40,204 AGYW who are survivors of gender-based violence (including 20,017 survivors reached with HTS). It is estimated that 20?25% of new HIV infections in young women in South Africa are attributable to GBV.  It has also been (conservatively) estimated that gender-based violence costs South Africa between R28.4 billion and R42.4 billion per year ? or between 0.9% and 1.3% of GDP annually.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6010","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","New HIV infections do occur among adolescents and young people age 10-14 (though risk is substantially increased among those age 15-24). While the allocation focuses on those at highest risk (AGYW age 15-24), the PAAR will support implementation of the school health program in primary schools, to reach 60,612 among the 10-14-year-old age group.",42731460,null,"Active","a6Q1R000000AJYO",0,0,0,0,42731460,0,null,null,"New HIV infections do occur among adolescents and young people age 10-14 (though risk is substantially increased among those age 15-24). While the allocation focuses on those at highest risk (AGYW age 15-24), the PAAR will support implementation of the school health program in primary schools, to reach 60,612 among the 10-14-year-old age group.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6009","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","PAAR funding will support development of information systems/data analytics for the AGYW program, in order to:\n1) enable grant-wide analytics by allowing data from all PRs to be merged and analyzed together;\n2) enable PRs to perform rich analysis on their data, including being able to disaggregate data easily, quickly generate new indicators, easily collect new data elements when needed, and take a case-based approach to tracking beneficiaries so that an individual?s history in relationship to interventions can be easily viewed;\n3) reduce potential for data entry errors by leveraging user-friendly digital data entry forms, having multiple pathways to capture data, and multiple identification methods for uniquely identifying beneficiaries in the program.",6000000,null,"Active","a6Q1R000000AJYN",2640000,0,0,0,3360000,0,null,null,"PAAR funding will support development of information systems/data analytics for the AGYW program, in order to:\n1) enable grant-wide analytics by allowing data from all PRs to be merged and analyzed together;\n2) enable PRs to perform rich analysis on their data, including being able to disaggregate data easily, quickly generate new indicators, easily collect new data elements when needed, and take a case-based approach to tracking beneficiaries so that an individual?s history in relationship to interventions can be easily viewed;\n3) reduce potential for data entry errors by leveraging user-friendly digital data entry forms, having multiple pathways to capture data, and multiple identification methods for uniquely identifying beneficiaries in the program.","High",null,"NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6008","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00574","Pre-exposure prophylaxis (PrEP) for adolescents and youth","According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for AGYW is 18%. For the Global Fund program, this equates to 25,919 AGYW age 15-24 years. 7,273 AGYW will be given PrEP through the allocation funding. PAAR funding will provide an additional 18,646 AGYW with PrEP. This will increase PrEP coverage in the target districts from 5% to 18%, and decrease the national programmatic gap for AGYW PrEP by 16%.",4719523,null,"Inactive","a6Q1R000000AJYM",4719523,0,0,0,0,1,null,null,"According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for AGYW is 18%. For the Global Fund program, this equates to 25,919 AGYW age 15-24 years. 7,273 AGYW will be given PrEP through the allocation funding. PAAR funding will provide an additional 18,646 AGYW with PrEP. This will increase PrEP coverage in the target districts from 5% to 18%, and decrease the national programmatic gap for AGYW PrEP by 16%.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6007","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00589","Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","This PAAR request is for technical and operational support to the Department of Women to complete the development of the National Strategic Plan for Gender Based Violence. A process to develop this plan has been started, but the human rights baseline assessment notes that a stalemate has been reached between civil society and the relevant governmental department. As such, implementing this activity is dependent on successful advocacy within the program to enable the process of developing the plan to continue.",400000,null,"Active","a6Q1R000000AJYL",0,0,0,0,400000,0,null,null,"This PAAR request is for technical and operational support to the Department of Women to complete the development of the National Strategic Plan for Gender Based Violence. A process to develop this plan has been started, but the human rights baseline assessment notes that a stalemate has been reached between civil society and the relevant governmental department. As such, implementing this activity is dependent on successful advocacy within the program to enable the process of developing the plan to continue.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6006","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","This PAAR request is for additional Hepatitis C treatment scale up among PWID, building on the lessons learned from the small pilot project planned in the allocation amount. PAAR investment will reach an additional 388 PWID with Hepatitis C treatment, through procurement of drugs and some diagnostics. Shared program costs for the delivery of the treatment are already covered through Hep C treatment pilot in the allocation.",5612651,null,"Active","a6Q1R000000AJYK",0,0,0,0,5612651,0,null,null,"This PAAR request is for additional Hepatitis C treatment scale up among PWID, building on the lessons learned from the small pilot project planned in the allocation amount. PAAR investment will reach an additional 388 PWID with Hepatitis C treatment, through procurement of drugs and some diagnostics. Shared program costs for the delivery of the treatment are already covered through Hep C treatment pilot in the allocation.","Low",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Prevention and management of co-infections and comorbidities for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5704","MCI-00000","Prevention programs for general population","MCI-00072","Behavioral interventions as part of programs for general population","evelop a directory of sector HIV, SRH, TB and social services interventions available in the different target population areas for different target population groups: This shall be an overall directory of sectors interventionsto guide implementers and target populations on what is available in different sectors for different targetpopulations that they can refer clients to. This will assist service providers in platforms such as the U-report to know what is available and guide target populationstowards those services.",35750,null,"Active","a6Q1R000000AJTS",0,0,0,0,35750,0,null,null,"evelop a directory of sector HIV, SRH, TB and social services interventions available in the different target population areas for different target population groups: This shall be an overall directory of sectors interventionsto guide implementers and target populations on what is available in different sectors for different targetpopulations that they can refer clients to. This will assist service providers in platforms such as the U-report to know what is available and guide target populationstowards those services.","High","A directory of service providers will enable the country to assess key gaps and better inform the programming in response.","NA Original Intervention: Behavioral interventions as part of programs for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5703","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Funding is requested to conduct an evaluation of the mentor mother program ($20,000). Next, funding is requested for the development and distribution of registers and IEC materials, biannual review meetings for sharing reports/data and experiences at regional level, recruitment of 4 regional supervisors for the PMTCT/mentor mothers program.",339632,null,"Active","a6Q1R000000AJTR",0,0,0,0,339632,0,null,null,"Funding is requested to conduct an evaluation of the mentor mother program ($20,000). Next, funding is requested for the development and distribution of registers and IEC materials, biannual review meetings for sharing reports/data and experiences at regional level, recruitment of 4 regional supervisors for the PMTCT/mentor mothers program.","High","This evaluation is needed in order to be able to scale up the above prioritized innovative intervention","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5702","MCI-00022","RSSH: Health management information systems and M&E","MCI-00203","Administrative and finance data sources","Update and maintain MIS information databank on all social welfare grants and in the future also social work case management. It will allow DPMO to have real-time statistics on social welfare grants, for better evidence-based management and better advocacy for sustained social budgeting. It will also support the matching funds activity to support 1000 AGYW (by year 3) with educational subsidies and other ?cash plus care? models, as prioritized in Swaziland?s investment case.",2800000,null,"Active","a6Q1R000000AJTQ",0,0,0,0,2800000,0,null,null,"Update and maintain MIS information databank on all social welfare grants and in the future also social work case management. It will allow DPMO to have real-time statistics on social welfare grants, for better evidence-based management and better advocacy for sustained social budgeting. It will also support the matching funds activity to support 1000 AGYW (by year 3) with educational subsidies and other ?cash plus care? models, as prioritized in Swaziland?s investment case.","Low","This program is linked with the OVC cash transfer program which has been found to be of low priority given the many other competing priorities in the funding request. This social protection programme is therefore of lower priority within the HIV/TB programme and can only be funded if other higher priority areas have been covered and efficiencies are found within the grant or through alternate funding sources.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Administrative and financial data sources","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5701","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Support for 3 TB program staff and 3 HIV program staff to attend relevant international conferences.This will enable the program to share the lessons learned from Swaziland?s response, as well as learn from other countries an contexts to improve innovation.",26664,null,"Active","a6Q1R000000AJTP",0,0,0,0,26664,0,null,null,"Support for 3 TB program staff and 3 HIV program staff to attend relevant international conferences.This will enable the program to share the lessons learned from Swaziland?s response, as well as learn from other countries an contexts to improve innovation.","Low","This intervention proposes sharing of information on the HIV and TB programs at relevant international conferences. Information exchange is important but the resource constrained setting of the Swaziland program means that the intervention is deemed of low priority.","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5700","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Recruit and retain four regional sexual and reproductive health coordinators/mentors to enhance regional-level coordination of AGYW investments across Global Fund, PEPFAR, UN family, government and others. It is expected that this investment will help address some of the HRH-related implementation bottlenecks, especially for programmatic interventions requiring an integrated approach.",296471,null,"Active","a6Q1R000000AJTO",0,0,0,0,296471,0,null,null,"Recruit and retain four regional sexual and reproductive health coordinators/mentors to enhance regional-level coordination of AGYW investments across Global Fund, PEPFAR, UN family, government and others. It is expected that this investment will help address some of the HRH-related implementation bottlenecks, especially for programmatic interventions requiring an integrated approach.","High","This intervention will allow for Innovative use of sexual and reproductive health (SRH) to improve ART coverage and testing.","NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5699","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Additional support for targeting the ACF?s approach towards key populations, including mapping and screening of Key affected populations by ACFs, including comprehensive training of ACFs and training of peer educators and caregivers to support TB key populations (factories, prisoners, orphanages, day care centers).",166667,null,"Active","a6Q1R000000AJTN",0,0,0,0,166667,0,null,null,"Additional support for targeting the ACF?s approach towards key populations, including mapping and screening of Key affected populations by ACFs, including comprehensive training of ACFs and training of peer educators and caregivers to support TB key populations (factories, prisoners, orphanages, day care centers).","Low","While key populations are crucial to the response, this activity should be integrated into routine ACF activities and the populations be covered within the existing ACF program.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Somalia","Somalia","PAI-5599","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","ICCMis an important intervention for CU5 and will focus on the three priority preventable diseases for children ?pneumonia, diarrhea and malaria, as well as screening and referrals for malnutrition. This intervention is for three organizations, and will cover training, malaria supplies, supervision and incentives for 90 volunteers (30 in three areas). This intervention is for 3 years.",1341593,null,"Active","a6Q1R000000AJRl",0,0,0,0,1341593,0,null,null,"ICCMis an important intervention for CU5 and will focus on the three priority preventable diseases for children ?pneumonia, diarrhea and malaria, as well as screening and referrals for malnutrition. This intervention is for three organizations, and will cover training, malaria supplies, supervision and incentives for 90 volunteers (30 in three areas). This intervention is for 3 years.","Medium","The request is for iCCM targeting children under\n5 years and targeting 3 areas (90 volunteers).\nHowever, the request stated that part of the fund\nwill be for incentive but without linking that to\nissue 3 of the review and recommendation form\nfor Somalia Malaria (in April 2017).","NA Original Intervention: Integrated community case management (iCCM)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5598","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","There are three operational research planned, specifically for Puntland, to be better able to understand the malaria in Puntland and plan for pre-elimination, as well as outbreaks such as that in Bossaso. The research are: Malaria Vector Identification and geographical distribution of main source of breeding sites including vector behaviour study in Bossaso District; Risk mapping and cases distribution malaria cases density by villages and providing appropriate anti-malaria interventions for both vector control and case management as well as surveillance; and Relation of malaria in pregnancy and Obstetric problems (LPW, Apportions, Stillbirths, Anemia including maternity deaths) among pregnancy mother in Bossaso.",128652,null,"Active","a6Q1R000000AJRk",0,0,0,0,128652,0,null,null,"There are three operational research planned, specifically for Puntland, to be better able to understand the malaria in Puntland and plan for pre-elimination, as well as outbreaks such as that in Bossaso. The research are: Malaria Vector Identification and geographical distribution of main source of breeding sites including vector behaviour study in Bossaso District; Risk mapping and cases distribution malaria cases density by villages and providing appropriate anti-malaria interventions for both vector control and case management as well as surveillance; and Relation of malaria in pregnancy and Obstetric problems (LPW, Apportions, Stillbirths, Anemia including maternity deaths) among pregnancy mother in Bossaso.","High","Operational research would contribute to a\nbetter understanding on low utilization of\neffective interventions such LLINs, rapid\ndiagnostic tests (RDTs) and artemisin-based\ncombination therapy (ACTs) by women and\nchildren under 5 years old","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5597","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Supervisory visit by NMCPs. Supervisory visits will include visits to private sector facilities, visits to IEC/BCC and to supervise LLIN distribution, amongst others.This is one visit per MOHper quarter (total 3 visits per quarter as there are three MOHs). Total costs = 850 USD per supervision x 3 MOH x 12 quarters = 30,600 USD. The NMCPs will use their own vehicles and only require fuel costs.",30600,null,"Active","a6Q1R000000AJRj",0,0,0,0,30600,0,null,null,"Supervisory visit by NMCPs. Supervisory visits will include visits to private sector facilities, visits to IEC/BCC and to supervise LLIN distribution, amongst others.This is one visit per MOHper quarter (total 3 visits per quarter as there are three MOHs). Total costs = 850 USD per supervision x 3 MOH x 12 quarters = 30,600 USD. The NMCPs will use their own vehicles and only require fuel costs.","High","To improve quality of diagnosis and treatment\nthere is a need for frequent supervision and onsite\ntraining (low-dose high frequency training).\nThis also will be useful for avoiding stock-out of\ndrugs and diagnostics","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5596","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN distribution and procurement/supply costs for road inaccessible areas. These sites are not accessible by road but there are partners available to undertake distribution if the nets are made available (via air charters).These areas are three districts in Bay, three districts in Bakool, four districts in Middle Juba, and two districts in Lower Juba.",4330385,null,"Active","a6Q1R000000AJRi",0,2165193,0,0,2165192,0,null,null,"LLIN distribution and procurement/supply costs for road inaccessible areas. These sites are not accessible by road but there are partners available to undertake distribution if the nets are made available (via air charters).These areas are three districts in Bay, three districts in Bakool, four districts in Middle Juba, and two districts in Lower Juba.","High","The requested fund is for procurement,\ntransportation and distribution of LLINs in 5\ndistricts which are inaccessible by road.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5595","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN for distribution to internally displaced persons (IDPs). The average IDPs in Somalia for May and June 2017 was 34,000 (IOM data). Assume that there will be a similar number coming per month for 24 months. The total number required is 453,333 LLINs but 304,580 LLINs are covered. Thus, the PAAR request is for 148,753 nets.",608900,null,"Active","a6Q1R000000AJRh",0,387770,0,0,221130,0,null,null,"LLIN for distribution to internally displaced persons (IDPs). The average IDPs in Somalia for May and June 2017 was 34,000 (IOM data). Assume that there will be a similar number coming per month for 24 months. The total number required is 453,333 LLINs but 304,580 LLINs are covered. Thus, the PAAR request is for 148,753 nets.","High","The fund is for procurement and distribution of LLINs for one of the vulnerable groups: IDPs (148,753 individuals).","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5594","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","World Malaria Day commemoration by implementing partners. Each SR in South and Central Somalia will receive funding for one event. There are five SRs in South Central Somalia.",13500,null,"Active","a6Q1R000000AJRg",0,0,0,0,13500,0,null,null,"World Malaria Day commemoration by implementing partners. Each SR in South and Central Somalia will receive funding for one event. There are five SRs in South Central Somalia.","Low","The proposed activity ?World Malaria Day\ncommemoration by implementing partners? is\nneeded and considered as an important event\nfor advocacy and raising the awareness of\npopulation but still it is an on-off activity. The\nTRP only approved funding for one event NOT\n3 events.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Romania","Romania","PAI-5462","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Capacity building for implementers of the National TB Strategy (Marius Nasta Institute staff, county coordinators, central and local authority representatives) in programmatic, financial management, and procurement, participation at international capacity building events (trainings, conferences), regional and national management meetings for TB stakeholders for improving the capacity of strategic planning based on collected data.",448883.4,null,"Active","a6Q1R000000AJPY",0,0,0,0,448883.4,0,null,null,"Capacity building for implementers of the National TB Strategy (Marius Nasta Institute staff, county coordinators, central and local authority representatives) in programmatic, financial management, and procurement, participation at international capacity building events (trainings, conferences), regional and national management meetings for TB stakeholders for improving the capacity of strategic planning based on collected data.","Medium",null,"NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-03-31","Tuberculosis"]
["CT Romania","Romania","PAI-5461","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Organisation of trainings, workshops and conferences by National TB Program (Marius Nasta Institute) to improve TB healthcare providers' communication skills with TB patients and sensitize them about patients rights, establish a feedback loop between patients and care providers, and contribute to internal evaluation and re-design of programmatic approaches for the National TB Strategy.",336662.55,null,"Active","a6Q1R000000AJPX",0,0,0,0,336662.55,0,null,null,"Organisation of trainings, workshops and conferences by National TB Program (Marius Nasta Institute) to improve TB healthcare providers' communication skills with TB patients and sensitize them about patients rights, establish a feedback loop between patients and care providers, and contribute to internal evaluation and re-design of programmatic approaches for the National TB Strategy.","Medium",null,"NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-03-31","Tuberculosis"]
["CT Romania","Romania","PAI-5460","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Optima HIV analysis to inform Government's strategic decision making in resource allocation for HIV/AIDS, thus finding a sustainable way of financing HIV prevention among key affected populations.",65443.83,null,"Active","a6Q1R000000AJPW",0,0,0,0,65443.83,0,null,null,"Optima HIV analysis to inform Government's strategic decision making in resource allocation for HIV/AIDS, thus finding a sustainable way of financing HIV prevention among key affected populations.","High",null,"NA Original Module: RSSH - National health strategies","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-03-31","Tuberculosis"]
["CT Romania","Romania","PAI-5459","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","This investment is intended to support stakeholder engagement in implementing ambulatory care reform developed through the grant.",361329.82,null,"Active","a6Q1R000000AJPV",0,0,0,0,361329.82,0,null,null,"This investment is intended to support stakeholder engagement in implementing ambulatory care reform developed through the grant.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-03-31","Tuberculosis"]
["CT Romania","Romania","PAI-5458","MCI-00008","TB care and prevention","MCI-00140","Case detection and diagnosis: MDR-TB","Procurement of 10 GeneXpert + 1 GeneXpert® Infinity-48s + 12,000 Genexpert Ultra tests to enhance rapid testing (currently, only 40% of patients receive a GeneXpert test). This investment will complement the EU/Norway grant which foresees the procurement of 16 additional GeneXpert equipments.",802693.3,null,"Active","a6Q1R000000AJPU",0,0,0,0,802693.3,0,null,null,"Procurement of 10 GeneXpert + 1 GeneXpert® Infinity-48s + 12,000 Genexpert Ultra tests to enhance rapid testing (currently, only 40% of patients receive a GeneXpert test). This investment will complement the EU/Norway grant which foresees the procurement of 16 additional GeneXpert equipments.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-03-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5457","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Acquisition of portable rapid molecular diagnosis devices.\nPurchase of two portable rapid molecular diagnosis devices and consumables is deemed necessary, mainly for visits to several remote indigenous communities or settlement, such as the regions of Pte. Hayes and Boquerón.\nThis will allow active detection of cases in key geographically hard-to-reach communities, bringing diagnosis to them and immediate start of treatment, whether simple or RR.\nThis has no budget yet, but it is expected that soon, in the second quarter of 2018, these will launched for sale to the public.",35149.949999999997,null,"Active","a6Q1R000000AJPT",0,0,0,0,35149.949999999997,0,null,null,"Acquisition of portable rapid molecular diagnosis devices.\nPurchase of two portable rapid molecular diagnosis devices and consumables is deemed necessary, mainly for visits to several remote indigenous communities or settlement, such as the regions of Pte. Hayes and Boquerón.\nThis will allow active detection of cases in key geographically hard-to-reach communities, bringing diagnosis to them and immediate start of treatment, whether simple or RR.\nThis has no budget yet, but it is expected that soon, in the second quarter of 2018, these will launched for sale to the public.","Low",null,"NA Original Module: SRSS: Provision of integrated services and quality improvement. Original Intervention: Laboratory systems for disease prevention, monitoring, treatment and surveillance","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5456","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Hiring staff for PNCT statistics department.\nHiring is needed to cover a vacancy in the statistics department as currently there are two professionals actively working (reduced from 3 to 2 due to resignation). These staff will monitor data input in the expert system until hired by the MSPBS.",28500,null,"Active","a6Q1R000000AJPS",0,0,0,0,28500,0,null,null,"Hiring staff for PNCT statistics department.\nHiring is needed to cover a vacancy in the statistics department as currently there are two professionals actively working (reduced from 3 to 2 due to resignation). These staff will monitor data input in the expert system until hired by the MSPBS.","Medium",null,"NA Original Module: SRSS: Program management. Original Intervention: National disease monitoring policies, planning, coordination and program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5365","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: LHWs are to be engaged in contact tracing, promote screening of the elderly and screening of children for TB. 30% of LHWs will be engaged mainly in rural districts by 2020.  37,500 cases (0.75 case per LHW/annually) will be detected through this engagement.\nRational:  Pakistan has 150,000 LHWs based in the community, paid for by Provincial programs & they play a major role in MNCH, including immunization. This workforce will be utilized for early case detection and treatment adherence.",2300000,null,"Active","a6Q1R000000AJNz",0,0,0,0,2300000,0,null,null,"Action: LHWs are to be engaged in contact tracing, promote screening of the elderly and screening of children for TB. 30% of LHWs will be engaged mainly in rural districts by 2020.  37,500 cases (0.75 case per LHW/annually) will be detected through this engagement.\nRational:  Pakistan has 150,000 LHWs based in the community, paid for by Provincial programs & they play a major role in MNCH, including immunization. This workforce will be utilized for early case detection and treatment adherence.","Medium","LHWs are to be engaged in contact tracing, promote screening of the elderly and screening of children for TB. 0.75 cases per LHW per year would be detected through this engagement. Considering other needs this intervention is considered as medium priority as it offers high value for money","NA Original Intervention: Engaging lady health workers (LHWs)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5364","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: To engage additional 2,500 GPs, 210 NGOs (from current 240 to 450), 50 private hospitals (from 70 to120) and 50 parastatal hospital (from 70 to 120) with enablers (training, incentives 400 PKR/ case.\nRational: Currently 3-5% of private health care providers are engaged with NTP. Engaging private practitioners (PPM-1 model) will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines. Case notification will increase by 30,000/year.",4300000,null,"Active","a6Q1R000000AJNy",0,2358315,0,0,1941685,0,null,null,"Action: To engage additional 2,500 GPs, 210 NGOs (from current 240 to 450), 50 private hospitals (from 70 to120) and 50 parastatal hospital (from 70 to 120) with enablers (training, incentives 400 PKR/ case.\nRational: Currently 3-5% of private health care providers are engaged with NTP. Engaging private practitioners (PPM-1 model) will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines. Case notification will increase by 30,000/year.","High","Private practitioners play a major role in health care in Pakistan. Engaging them will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines.","NA Original Intervention: Engagement with private practitioners","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5363","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Action: To introduce a comprehensive TB detection, care & prevention package in District Hafizabad (Punjab) and Mirpurkhas (Sindh). The package includes scaling up of PPM interventions, involving GPs in CHTB case detection & management, active case finding through organizing mobile screening chest camps using chest x-rays algorithm, implementing FAST (Finding TB cases Actively, Separating Safely, and Treating effectively) intervention at the District Headquarter Hospitals (DHQ) in 2 districts. \nRational: The selected districts have high yield of patients in the current NFM grant and the high influx of patients to these districts from nearby areas. The  proposed  interventions  will  help  to provide  a  rationale  to  scale  up  this  package  of activities in other districts to achieve END TB strategy goals to detect over 90% of cases. Additional 3,000 DS-TB cases and around 385 MDR-TB cases will be detected in three years.",1630000,null,"Active","a6Q1R000000AJNx",0,0,0,0,1630000,0,null,null,"Action: To introduce a comprehensive TB detection, care & prevention package in District Hafizabad (Punjab) and Mirpurkhas (Sindh). The package includes scaling up of PPM interventions, involving GPs in CHTB case detection & management, active case finding through organizing mobile screening chest camps using chest x-rays algorithm, implementing FAST (Finding TB cases Actively, Separating Safely, and Treating effectively) intervention at the District Headquarter Hospitals (DHQ) in 2 districts. \nRational: The selected districts have high yield of patients in the current NFM grant and the high influx of patients to these districts from nearby areas. The  proposed  interventions  will  help  to provide  a  rationale  to  scale  up  this  package  of activities in other districts to achieve END TB strategy goals to detect over 90% of cases. Additional 3,000 DS-TB cases and around 385 MDR-TB cases will be detected in three years.","High","This intervention is a comprehensive TB care package implementing the FAST intervention (Find cases Actively, Separate temporarily and Treat effectively) across 2 districts aimed at promoting early detection of cases in target areas. The TRP considers this a 6 high priority intervention","NA Original Module: Multidrug-resistant TB. Original Intervention: Zero TB Initiative in Hafizabad and Mirpurkhas districts","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5362","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Action: With this funding HIV testing of TB patients will increase up to 60% in 260 additional sites by 2020 as planned in the NSP (30% - 2018, 45% - 2019, 60% - 2020 tested, i.e., 130, 220, 300 total sites/annually).\nRational: The allocation-funding request includes scale up of HIV testing among TB patients from 1 percent to 10 percent. TB patients have 6% HIV higher rate than the general population. 3,303 HIV/TB cases will be detected.",730000,null,"Active","a6Q1R000000AJNw",0,0,0,0,730000,0,null,null,"Action: With this funding HIV testing of TB patients will increase up to 60% in 260 additional sites by 2020 as planned in the NSP (30% - 2018, 45% - 2019, 60% - 2020 tested, i.e., 130, 220, 300 total sites/annually).\nRational: The allocation-funding request includes scale up of HIV testing among TB patients from 1 percent to 10 percent. TB patients have 6% HIV higher rate than the general population. 3,303 HIV/TB cases will be detected.","High","The allocation funding request includes scale up of HIV testing among TB patients from 1 percent to 10 percent. Additional funding will allow further scale up of testing.","NA Original Intervention: Expand TB/HIV collaborative activities to 220 additional sites","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5361","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: STP facilitates improving synergy and coordinating the efforts between partners at national and provincial levels. Rationale: The intervention will help to secure additional funds for TB control activities in the country. \nThe inervention will sensitize communities/stakeholders in TB control, will facilitate policy change & resources mobilization at national/provincial levels towards sustainability of the program.",130000,null,"Active","a6Q1R000000AJNv",0,0,0,0,130000,0,null,null,"Action: STP facilitates improving synergy and coordinating the efforts between partners at national and provincial levels. Rationale: The intervention will help to secure additional funds for TB control activities in the country. \nThe inervention will sensitize communities/stakeholders in TB control, will facilitate policy change & resources mobilization at national/provincial levels towards sustainability of the program.","High","Efforts aimed at strengthening the national partnership for TB care through advocacy and coordinated efforts are expected to improve synergy between partners.","NA Original Intervention: Strengthening STOP TB Partnership (STP), Pakistan","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5360","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: PR Mercy Corps will develop a sputum transport mechanism in 6 districts of Punjab (Gujranwala, Hafizabad, Khanewal, Multan, Mandi Bahauddin, Vehari) & 6 districts of Sindh (Dadu, Ghotki, Khairpur, Mirpurkhas, Sanghar and Umerkot).\nRational: About 1/3 of TB cases in Pakistan are missing to be diagnozed/annually (with 4% of DR-TB cases). Notificaiton through mobile phones & timely samples transportation to the nearest GeneXpert sites will facilitate this. \nThe scheduling & monitoring of pick up/drop off are managed automatically, reducing costs & improving accuracy over manual approaches ensuring access of rural communities to quality TB diagnosis. \n6,525 all type TB cases will be notified and treated in 3 years. Early DR-TB case detection & treatment will improve.",600000,null,"Active","a6Q1R000000AJNu",0,0,0,0,600000,0,null,null,"Action: PR Mercy Corps will develop a sputum transport mechanism in 6 districts of Punjab (Gujranwala, Hafizabad, Khanewal, Multan, Mandi Bahauddin, Vehari) & 6 districts of Sindh (Dadu, Ghotki, Khairpur, Mirpurkhas, Sanghar and Umerkot).\nRational: About 1/3 of TB cases in Pakistan are missing to be diagnozed/annually (with 4% of DR-TB cases). Notificaiton through mobile phones & timely samples transportation to the nearest GeneXpert sites will facilitate this. \nThe scheduling & monitoring of pick up/drop off are managed automatically, reducing costs & improving accuracy over manual approaches ensuring access of rural communities to quality TB diagnosis. \n6,525 all type TB cases will be notified and treated in 3 years. Early DR-TB case detection & treatment will improve.","High","Unified approach and joint monitoring between private and public sector is a key step to ensure universal access to rapid diagnosis of TB and DR-TB.","NA Original Intervention: Develop linkages between public and private sectors & the GeneXpert sites for GeneXpert testing in twelve districts in Punjab and Sindh Provinces","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Nepal","Nepal","PAI-5312","MCI-00012","Case management","MCI-00162","Ensuring drug and other health product quality","Procure Minilab® test kits and supplies to allow routine point of sale testing of antimalarials by DDA (targeting PS).",6431,null,"Active","a6Q1R000000AJN8",0,0,0,0,6431,0,null,null,"Procure Minilab® test kits and supplies to allow routine point of sale testing of antimalarials by DDA (targeting PS).","Medium","Minilab® test kits are useful for evaluating the quality of anti -malarial drugs used in the PS and empower national health authorities to improve regulatory requirements and consolidate regulatory functions, as recommend by WHO",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5311","MCI-00012","Case management","MCI-00154","Facility-based treatment","Kits for community-based healthcare providers to improve the quality of service provision.",32286,null,"Active","a6Q1R000000AJN7",0,0,0,0,32286,0,null,null,"Kits for community-based healthcare providers to improve the quality of service provision.","Medium","Commodities (antimalarial medication and diagnostics) are needed for community - based healthcare providers to improve the quality of outreach service provision.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5310","MCI-00012","Case management","MCI-00161","Private sector case management","HR cost at SR for engaging the private sector provider; Orientation cost for SR for engaging the private sector provider; Field visit for engaging the private sector provider; and, Operational costs for the SR.",557208,null,"Active","a6Q1R000000AJN6",0,0,0,0,557208,0,null,null,"HR cost at SR for engaging the private sector provider; Orientation cost for SR for engaging the private sector provider; Field visit for engaging the private sector provider; and, Operational costs for the SR.","High","Good case management is improved by engaging with PS providers resulting in improved adherence to national guidelines for anti-malarial prescription and strong linkages/routine interaction between the national malaria programme, public providers and private provider. These are part of comprehensive PS strategies to get data on PS services (access and coverage) and come up with plans for service delivery and data reporting.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Nepal","Nepal","PAI-5309","MCI-00071","Other module","MCI-00071","Other module","Migration is recognised as source of infection. However, it is likely that changes in health seeking behaviour and migration patterns over the last decade have implications for HIV transmission and access to HIV services, which assessment will explore. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.",50000,null,"Active","a6Q1R000000AJN5",0,0,0,0,50000,0,null,null,"Migration is recognised as source of infection. However, it is likely that changes in health seeking behaviour and migration patterns over the last decade have implications for HIV transmission and access to HIV services, which assessment will explore. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.","Low","Originally proposed as a single module with two interventions, the TRP recommends to split the interventions; this one is low priority because a cascade assessment has recently been completed and assessment of cascade information should be routine program monitoring.","NA Original Module: Study and assessment. Original Intervention: Cascade assessment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Nepal","Nepal","PAI-5308","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","Harm reduction interventions, including the OST scale up, have often been challenged by issues related to quality of service, coordination, institutionalisation and monitoring. Technical assistance is sought to expedite solutions to the challenges. This will build on the GF investment in OST by informing efforts to increase uptake, retention and quality.",2000000,null,"Active","a6Q1R000000AJN4",0,0,0,0,2000000,0,null,null,"Harm reduction interventions, including the OST scale up, have often been challenged by issues related to quality of service, coordination, institutionalisation and monitoring. Technical assistance is sought to expedite solutions to the challenges. This will build on the GF investment in OST by informing efforts to increase uptake, retention and quality.","Low","The TA proposed is to improve OST coverage. This is quality demand because it addresses a serious weakness in the HIV response (as described in the funding request and addressed within the allocation). However the TRP does not consider that the cost of the TA proposed provides good value for money, and thus considers this low priority.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: TA to strengthen the programme","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Nepal","Nepal","PAI-5307","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","DHIS2 is a government priority: the NHSS anticipates its roll-out throughout the country by 2020. GoN resources are available for this, alongside support from DFID, GAVI, KOIKA and GiZ. Intermittent technical assistance is anticipated to accelerate and scale up the process, and ensure quality.",3000000,null,"Active","a6Q1R000000AJN3",300000,0,0,0,2700000,0,null,null,"DHIS2 is a government priority: the NHSS anticipates its roll-out throughout the country by 2020. GoN resources are available for this, alongside support from DFID, GAVI, KOIKA and GiZ. Intermittent technical assistance is anticipated to accelerate and scale up the process, and ensure quality.","Low","Many other donors already supporting this and therefore this is considered as a low priority","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Technical Assistance (TA) to support roll-out of DHIS2","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Malawi","Malawi","PAI-5212","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Aligned with the HSSPII objective to reduce environmental and social risk factors that have a direct impact on health, the PAAR activity within this intervention aims to engage key departments (Fisheries, Tourism, Local Government, and Agriculture) to foster multi-sectoral collaboration on improved utilization of malaria interventions. Engaging with these departments in a coordinated manner can support overall delivery of the Basic Healthcare Package. This activity is aimed at reducing the incidence and prevalence of malaria and other Funding Request: Tailored to Material Change 15 December 2016? 38 key diseases of public health importance through improved collaboration and better use of resources.",30000,null,"Active","a6Q1R000000AJLW",0,0,0,0,30000,0,null,null,"Aligned with the HSSPII objective to reduce environmental and social risk factors that have a direct impact on health, the PAAR activity within this intervention aims to engage key departments (Fisheries, Tourism, Local Government, and Agriculture) to foster multi-sectoral collaboration on improved utilization of malaria interventions. Engaging with these departments in a coordinated manner can support overall delivery of the Basic Healthcare Package. This activity is aimed at reducing the incidence and prevalence of malaria and other Funding Request: Tailored to Material Change 15 December 2016? 38 key diseases of public health importance through improved collaboration and better use of resources.","High","Cross-sectoral coordination","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5211","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Enhanced linkages to care ($0.29M) Additional activities to strengthen MSM programming linkage to care and monitoring in current 8 districts.",290000,null,"Active","a6Q1R000000AJLV",0,0,0,0,290000,0,null,null,"Enhanced linkages to care ($0.29M) Additional activities to strengthen MSM programming linkage to care and monitoring in current 8 districts.","High","Increased comprehensive programming for key populations will be increasingly needed to control the epidemic as incidence among the general population declines.","Amount for this component is combined. Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5210","MCI-00071","Other module","MCI-00071","Other module","These funds will be used towards salaries and benefits for two additional data clerks per facility for 600 facilities and builds on M&E capacity development plans within allocation.",4846588,null,"Active","a6Q1R000000AJLU",1431628.88,0,0,0,3414959.12,0,null,null,"These funds will be used towards salaries and benefits for two additional data clerks per facility for 600 facilities and builds on M&E capacity development plans within allocation.","High","Critical support for data information staff","NA Original Module: Other modules. Original Intervention: Other","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5209","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","These activities build on the activities within allocation in that once hired, health care workers require routine trainings and opportunities for specialization given Malawi?s needs. These activities are expected to improve overall quality of care and health care worker capacity. Specific activities included in this intervention: ? Continuous professional development ? Specialization courses ? Trainings ? Upgrading.",271252,null,"Active","a6Q1R000000AJLT",0,0,0,0,271252,0,null,null,"These activities build on the activities within allocation in that once hired, health care workers require routine trainings and opportunities for specialization given Malawi?s needs. These activities are expected to improve overall quality of care and health care worker capacity. Specific activities included in this intervention: ? Continuous professional development ? Specialization courses ? Trainings ? Upgrading.","High","Continued in-service training is a critical factor for implementation","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5208","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00178","National costed supply chain master plan, and implementation","These activities will also build on HSSP strategies to expand both the scope of the drug theft investigations unit, and continue to support capacity development of pharmacy assistants. Expected outcomes includes improved rational used of essential medicine, and reduced leakages through theft and medicines management. Specific activities included in this intervention: ? DTIU implementation of transparency and accountability mechanisms on commodities ? Integrated supervision and mentorship on medicines management in health facilities ? Tuition support for pre-service training of pharmacy assistants.",1089187,null,"Active","a6Q1R000000AJLS",0,0,0,0,1089187,0,null,null,"These activities will also build on HSSP strategies to expand both the scope of the drug theft investigations unit, and continue to support capacity development of pharmacy assistants. Expected outcomes includes improved rational used of essential medicine, and reduced leakages through theft and medicines management. Specific activities included in this intervention: ? DTIU implementation of transparency and accountability mechanisms on commodities ? Integrated supervision and mentorship on medicines management in health facilities ? Tuition support for pre-service training of pharmacy assistants.","High","Major building block for roll out of the costed national supply chain plan","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5207","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","This intervention builds on activities that have been requested within allocation. While a portion of the co-financing minimum commitment is expected to cover HRH gaps, the following activities have been included in the PAAR to address addition areas that will complete the full package from recruitment to profession development for hired health workers. In line with the HSSPII these activities support the HRH system that is essential to Malawi?s functioning health system. Specific activities included in this intervention: ? Induction costs ? Orientation on government performance appraisal system.",488382,null,"Active","a6Q1R000000AJLR",0,0,0,0,488382,0,null,null,"This intervention builds on activities that have been requested within allocation. While a portion of the co-financing minimum commitment is expected to cover HRH gaps, the following activities have been included in the PAAR to address addition areas that will complete the full package from recruitment to profession development for hired health workers. In line with the HSSPII these activities support the HRH system that is essential to Malawi?s functioning health system. Specific activities included in this intervention: ? Induction costs ? Orientation on government performance appraisal system.","High","Enhancement of frontline and community health workers is critical for intervention impact","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Mali","Mali","PAI-5082","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00170","Service organization and facility management","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",474097,null,"Inactive","a6Q1R000000AJJQ",0,474097,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Medium","Considered Medium as operational funding should ideally come from GoM, but in this case may provide some additional operational and/or start-up funding to support the functioning of CHWs and their supervision, as well as support monitoring of the implementation of the integrated community-based service delivery system. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 1",null,"RSSH"]
["CT Mali","Mali","PAI-5081","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",2000000,null,"Inactive","a6Q1R000000AJJP",0,2000000,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Low","Support should/could be provided through the iNGOs who operate as PRs or provided under other mechanisms from the other multi- and bilateral development partners.  The same applies for the studies and mapping. Priority low. ","Validaed by meeting the PO on 03/06/2019 Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 1",null,"RSSH"]
["CT Mali","Mali","PAI-5080","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",342157,null,"Inactive","a6Q1R000000AJJO",0,342157,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Medium","The upgrading of the CSComs has been split into several cost categories. Though the complete CSCom service package is seen as quality demand to extend community health services, the total costs for the upgrading, remains high (US$80,400) for a basic health center to serve at the community level. Therefore, most of these items are considered medium priority; if funding is available, the solar panels could be prioritized as they can be used to keep fridges and lights running and could also generate income through charging of cell phones and other small equipment. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 1",null,"RSSH"]
["CT Mali","Mali","PAI-5079","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",213848,null,"Inactive","a6Q1R000000AJJN",0,213848,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","High","The upgrading of the CSComs has been split into several cost categories. Though the complete CSCom service package is seen as quality demand to extend community health services, the total costs for the upgrading, remains high (US$80,400) for a basic health center to serve at the community level. Therefore, most of these items are considered medium priority; if funding is available, the solar panels could be prioritized as they can be used to keep fridges and lights running and could also generate income through charging of cell phones and other small equipment. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 1",null,"RSSH"]
["CT Mali","Mali","PAI-5078","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",1325857,null,"Inactive","a6Q1R000000AJJM",0,1325857,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Medium","The upgrading of the CSComs has been split into several cost categories. Though the complete CSCom service package is seen as quality demand to extend community health services, the total costs for the upgrading, remains high (US$80,400) for a basic health center to serve at the community level. Therefore, most of these items are considered medium priority; if funding is available, the solar panels could be prioritized as they can be used to keep fridges and lights running and could also generate income through charging of cell phones and other small equipment. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 1",null,"RSSH"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4850","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To rehabilitate the TB centers/hospitals damaged in the conflicts in Iraq and Syria (including Ibn Zohr Hospital in Baghdad, Iraq and Al-Hareth Hospital in Homs, Syria), so as to support the provision of admission facilities for patients admitted with TB.",100000,null,"Active","a6Q1R000000AJFg",0,0,0,0,100000,0,null,null,"To rehabilitate the TB centers/hospitals damaged in the conflicts in Iraq and Syria (including Ibn Zohr Hospital in Baghdad, Iraq and Al-Hareth Hospital in Homs, Syria), so as to support the provision of admission facilities for patients admitted with TB.","High","This activity has been reprioritized as high to support the provision of admission facilities for patients admitted with TB",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4849","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In order to strengthen TB services for affected women, food supplementation is needed for women with TB who are treated in IDP and refugee settings",1335000,null,"Active","a6Q1R000000AJFf",0,0,0,0,1335000,0,null,null,"In order to strengthen TB services for affected women, food supplementation is needed for women with TB who are treated in IDP and refugee settings","High","Nutritional support for TB patients in IDP and refugee camps is an important intervention given the prevailing food situation in these settings",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4848","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To organize, at regional level, a workshop for the staff of the NRLs of the five countries; the workshop will be facilitated by an international consultant and will cover the key aspects inherent to the management of a national TB laboratory network.",50000,null,"Active","a6Q1R000000AJFe",0,0,0,0,50000,0,null,null,"To organize, at regional level, a workshop for the staff of the NRLs of the five countries; the workshop will be facilitated by an international consultant and will cover the key aspects inherent to the management of a national TB laboratory network.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4847","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To organize, at regional level, a training course on data management for the relevant staff of the NTPs of the five countries (ex.: NTP managers and monitoring and evaluation officers). The course will be facilitated by two international consultants and will cover the following issues: i) epidemiological surveillance principles, ii) the establishment of data sets, iii) data analysis procedures and methods, iv) utilization of the data analysis results for the purposes of epidemiological surveillance and programmatic management, v) evaluation of TB prevention, care and control strategies and activities implemented, and vi) identification of hypotheses for operational research",75000,null,"Active","a6Q1R000000AJFd",0,0,0,0,75000,0,null,null,"To organize, at regional level, a training course on data management for the relevant staff of the NTPs of the five countries (ex.: NTP managers and monitoring and evaluation officers). The course will be facilitated by two international consultants and will cover the following issues: i) epidemiological surveillance principles, ii) the establishment of data sets, iii) data analysis procedures and methods, iv) utilization of the data analysis results for the purposes of epidemiological surveillance and programmatic management, v) evaluation of TB prevention, care and control strategies and activities implemented, and vi) identification of hypotheses for operational research","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4846","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In order to enhance Xpert testing activities, one additional Xpert machine is needed for Iraq  and 4 additional Xpert machine are needed for Yemen",85000,null,"Active","a6Q1R000000AJFc",0,0,0,0,85000,0,null,null,"In order to enhance Xpert testing activities, one additional Xpert machine is needed for Iraq  and 4 additional Xpert machine are needed for Yemen","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4845","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","To procure 7 digital X-ray machines for TB facilities: 4 for Iraq and 3 for Jordan; these machines will cover the needs in TB screening, evaluation and diagnosis for IDPs, refugees and hard-to-reach populations scattered in Iraq and for refugees in Jordan",980000,null,"Active","a6Q1R000000AJFb",0,0,0,0,980000,0,null,null,"To procure 7 digital X-ray machines for TB facilities: 4 for Iraq and 3 for Jordan; these machines will cover the needs in TB screening, evaluation and diagnosis for IDPs, refugees and hard-to-reach populations scattered in Iraq and for refugees in Jordan","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4844","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","This is to include parts of Yemen in this intervention and also expand the services for the other three countries (Syria, Lebanon, Jordan). As the coverage of HIV testing among MSM is expected to reach 31% by funds within the allocation, it is expected that it will approach 60% with PAAR fund.",3000000,null,"Active","a6Q1R000000AJFa",0,0,0,0,3000000,0,null,null,"This is to include parts of Yemen in this intervention and also expand the services for the other three countries (Syria, Lebanon, Jordan). As the coverage of HIV testing among MSM is expected to reach 31% by funds within the allocation, it is expected that it will approach 60% with PAAR fund.","High","In this Funding Request there is a focus on prevention and testing of KP, which the TRP believes to be crucial. Given the importance of this activity, and the fact that prevention programs for MSM in Yemen are not included in the allocation request, we recommend that a portion of this amount should move to the allocation for prevention and testing activities among men who have sex with men in Yemen and be funded through savings made during grant making.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria"," Middle East and North Africa","2021-12-31","Multi-component"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4843","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Y3: Expand referral platform  being built by Ministry of Public Health for drugs  to include other KPs.",10000,null,"Active","a6Q1R000000AJFZ",0,0,0,0,10000,0,null,null,"Y3: Expand referral platform  being built by Ministry of Public Health for drugs  to include other KPs.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Lesotho","Lesotho","PAI-4747","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","The funding will support adherence and economic empowerment through support groups to overcome the suboptimal retention level. 31 support groups comprising 620 members are expected to be trained on various livelihood options, such as voluntary savings, loans and access to microfinance, in three high burden districts. The activity will be partially funded through the reinvestment of the efficiencies identified during the grant making.",436283,null,"Active","a6Q1R000000AJE1",128960,0,0,0,307323,0,null,null,"The funding will support adherence and economic empowerment through support groups to overcome the suboptimal retention level. 31 support groups comprising 620 members are expected to be trained on various livelihood options, such as voluntary savings, loans and access to microfinance, in three high burden districts. The activity will be partially funded through the reinvestment of the efficiencies identified during the grant making.","High","The existing retention level is suboptimal. Support adherence and economic empowerment of the support groups is essential. This should be implemented in ways that seek maximum integration with existing structures.","NA Original Intervention: Other interventions for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4746","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","The Government of Lesotho, with the support from Global Fund and GAVI, constructed 30 health posts in underserved areas in the five highland districts. The key objectives of the health posts are: (i) support primary health activities conducted by community-based cadres, and also outreaches from the health centres and (ii) improve the quality of health services in the hard to reach areas in the Country.\n\nCurrently the 30 health posts are not optimally utilised due to the lack of medical equipment to improve universal health coverage, increase accessibility to the Essential Service Package (ESP) of health services and efficiently and effectively provide services to unreached populations, hence support is required to fully operationalise the health posts to provide the following services:\n? Health education, promotion and awareness creation\n? Child survival including Immunization, Nutrition and ANC services\n? Environmental Health through the promotion of, good sanitation, safe drinking water and good environmental and personal hygiene\n? Outpatient services, including prenatal and postnatal care, family planning, HIV testing and counselling, TB screening and treatment, ART refills and other services included in the ESP",69050,null,"Active","a6Q1R000000AJE0",0,0,0,0,69050,0,null,null,"The Government of Lesotho, with the support from Global Fund and GAVI, constructed 30 health posts in underserved areas in the five highland districts. The key objectives of the health posts are: (i) support primary health activities conducted by community-based cadres, and also outreaches from the health centres and (ii) improve the quality of health services in the hard to reach areas in the Country.\n\nCurrently the 30 health posts are not optimally utilised due to the lack of medical equipment to improve universal health coverage, increase accessibility to the Essential Service Package (ESP) of health services and efficiently and effectively provide services to unreached populations, hence support is required to fully operationalise the health posts to provide the following services:\n? Health education, promotion and awareness creation\n? Child survival including Immunization, Nutrition and ANC services\n? Environmental Health through the promotion of, good sanitation, safe drinking water and good environmental and personal hygiene\n? Outpatient services, including prenatal and postnatal care, family planning, HIV testing and counselling, TB screening and treatment, ART refills and other services included in the ESP","Low","Additional resources for health posts were determined to be low priority as the proposed services to be provided in health posts were largely unrelated to HIV and TB.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4745","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Availability of high-quality routine data is critical for regular targeted program planning, monitoring effectiveness of responses, and measure progress towards 90-90-90 the HIV epidemic control targets. Resources solicited from global fund to support data clerks, equipment, and connectivity in the five highland districts and support from other SI stakeholder, DHIS 2 rollout expand to facility level at 177 facilities (169 public and 8 private facilities) for reporting and data use. The support provided improved the quality of routine report, for example, completeness of data improved from 78% in October 2015 to 100% in January 2018; timeliness of data improved from 29% in October 2015 to 92% in October 2018. \n\nDespite the improvement in the completeness and timeliness of HIV care and treatment data reported through DHIS2, there is a significant discrepancy between program data and population survey data. The under-reporting emanating from multiple errors related to paper-based documentation and manual data processing remains a challenge. To address these inherent challenges, MoH with the support of partners made a bold decision to adopt, develop and rollout simple open source client level electronic system for HIV and TB services to 177 public health facilities providing ART across 10 districts. The current support from partners including the Global Fund, the e-registers are rolled out to 70 public health facilities leaving a gap of 107 facilities. The following support is required to implement interventions to consolidate and expand the eRegister; \n? Hardware and connectivity, \n? Human resources (trained and retained, motivated and strategically placed central and district levels technical staff\n? Skill building Training and Mentorship (Advanced system development and administration, System use for data entry, analysis and use), \n? Reliable transport and logistics.  Key areas of interventions to consolidate and expand the eRegister",2548713,null,"Active","a6Q1R000000AJDz",0,0,0,0,2548713,0,null,null,"Availability of high-quality routine data is critical for regular targeted program planning, monitoring effectiveness of responses, and measure progress towards 90-90-90 the HIV epidemic control targets. Resources solicited from global fund to support data clerks, equipment, and connectivity in the five highland districts and support from other SI stakeholder, DHIS 2 rollout expand to facility level at 177 facilities (169 public and 8 private facilities) for reporting and data use. The support provided improved the quality of routine report, for example, completeness of data improved from 78% in October 2015 to 100% in January 2018; timeliness of data improved from 29% in October 2015 to 92% in October 2018. \n\nDespite the improvement in the completeness and timeliness of HIV care and treatment data reported through DHIS2, there is a significant discrepancy between program data and population survey data. The under-reporting emanating from multiple errors related to paper-based documentation and manual data processing remains a challenge. To address these inherent challenges, MoH with the support of partners made a bold decision to adopt, develop and rollout simple open source client level electronic system for HIV and TB services to 177 public health facilities providing ART across 10 districts. The current support from partners including the Global Fund, the e-registers are rolled out to 70 public health facilities leaving a gap of 107 facilities. The following support is required to implement interventions to consolidate and expand the eRegister; \n? Hardware and connectivity, \n? Human resources (trained and retained, motivated and strategically placed central and district levels technical staff\n? Skill building Training and Mentorship (Advanced system development and administration, System use for data entry, analysis and use), \n? Reliable transport and logistics.  Key areas of interventions to consolidate and expand the eRegister","Medium","For CCM/Disease Program consideration: Better data systems are essential, but additional justification for this level of investment would be useful. This is a suggestion to improve this intervention; the country does not have to respond to it.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4744","MCI-00000","Prevention programs for general population","MCI-00072","Behavioral interventions as part of programs for general population","The activity will support educational resources for peer educators and general population as Lesotho rolls out self-testing and pre-exposure prophylaxis (PrEP).  The activity will be funded through the reinvestment of the efficiencies identified during the grant making.",20000,null,"Inactive","a6Q1R000000AJDy",20000,0,0,0,0,1,null,null,"The activity will support educational resources for peer educators and general population as Lesotho rolls out self-testing and pre-exposure prophylaxis (PrEP).  The activity will be funded through the reinvestment of the efficiencies identified during the grant making.","High","The activity is high priority as it provides educational resource for peer educators and the general population as the country rolls out self- testing, pre-exposure prophylaxis (PrEP).","NA Original Intervention: Behavioral interventions as part of programs for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5860","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","It is hypothesized that Low TB case notification among PLHIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among PLHIV disaggregated by age, gender and pregnancy status.",356600,null,"Active","a6Q1R000000AJVy",0,0,0,0,356600,0,null,null,"It is hypothesized that Low TB case notification among PLHIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among PLHIV disaggregated by age, gender and pregnancy status.","Low","It is hypothesized that Low TB case notification among People Living with HIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among People Living with HIV disaggregated by age, gender and pregnancy status.","NA Original Intervention: Operational research to improve TB case notification among people living with HIV in HIV care and treatment services","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5859","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Installation of Blood Established Computer System (BECS) in 10 regional blood collection and coordination centres to scale up collection of blood transfusion information. Collected Data will be used for decision making and safe blood service strengthening.",207500,null,"Active","a6Q1R000000AJVx",0,0,0,0,207500,0,null,null,"Installation of Blood Established Computer System (BECS) in 10 regional blood collection and coordination centres to scale up collection of blood transfusion information. Collected Data will be used for decision making and safe blood service strengthening.","Medium","Installation of Blood Established Computer System (BECS) in 10 regional blood collection and coordination centres to scale up collection of blood transfusion information. Collected Data will be used for decision making and safe blood service strengthening.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Scale up collection and utilization of blood donation and utilization by strengthening HMIS system in blood collection satellite sites","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5858","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","NBTS is currently using a technology that requires 6 blood donors to generate one unit of platelets. With a country requirement of 17500 platelet units it requires 105,000 blood donors which is almost 1/3 of annual blood collection. With available human resource and technology, NBTS is not able to supply this quantity of platelets and hence making patients receive inefficacious platelets treatment. With an apheresis machine which is proposed to be procured, they will be able to scale up platelets production, enhance efficacy of treatment and reduce risk of infection transmission through platelet transfusion.",310000,null,"Active","a6Q1R000000AJVw",0,0,0,0,310000,0,null,null,"NBTS is currently using a technology that requires 6 blood donors to generate one unit of platelets. With a country requirement of 17500 platelet units it requires 105,000 blood donors which is almost 1/3 of annual blood collection. With available human resource and technology, NBTS is not able to supply this quantity of platelets and hence making patients receive inefficacious platelets treatment. With an apheresis machine which is proposed to be procured, they will be able to scale up platelets production, enhance efficacy of treatment and reduce risk of infection transmission through platelet transfusion.","Low","Tanzania National Blood Transfusion (NBTS) is currently using a technology that requires 6 blood donors to generate one unit of platelets. With a country requirement of 17500 platelet units it requires 105,000 blood donors which is almost 1/3 of annual blood collection. With available human resource and technology, NBTS is not able to supply this quantity of platelets and hence making patients receive inefficacious platelets treatment. With an apheresis machine which is proposed to be procured, they will be able to scale up platelets production, enhance efficacy of treatment and reduce risk of infection transmission through platelet transfusion.","NA Original Intervention: Adapting modern technology for production of blood components (platelets) to enhance efficacy of platelets treatment and reduce risk of infection transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5857","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Tanzania is planning to scale up establishment of centers of excellence for management of advanced cases of pediatric and adults living with HIV.",1800000,null,"Active","a6Q1R000000AJVv",0,0,0,0,1800000,0,null,null,"Tanzania is planning to scale up establishment of centers of excellence for management of advanced cases of pediatric and adults living with HIV.","Medium","Tanzania is planning to scale up establishment of centers of excellence for management of advanced cases of paediatric and adults living with HIV.","NA Original Intervention: Support establishment of centre of excellence in Mtwara, Kagera, Katavi","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5856","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Timely, reliable and comprehensive information for the management of the national response enables the country to estimate resource flows and expenditures in support of the Multisectoral response to HIV and AIDS. Tanzania therefore plans to conduct the National AIDS Spending Assessment (NASA) study to track expenditure among, Public sources, External sources, Providers of HIV and AIDS services (Public and Private), Out of pocket (Individual spending). The NASA report is expected to form a basis for leveraging both technical and financial support for national HIV response based on available resources.",157600,null,"Active","a6Q1R000000AJVu",0,0,0,0,157600,0,null,null,"Timely, reliable and comprehensive information for the management of the national response enables the country to estimate resource flows and expenditures in support of the Multisectoral response to HIV and AIDS. Tanzania therefore plans to conduct the National AIDS Spending Assessment (NASA) study to track expenditure among, Public sources, External sources, Providers of HIV and AIDS services (Public and Private), Out of pocket (Individual spending). The NASA report is expected to form a basis for leveraging both technical and financial support for national HIV response based on available resources.","Medium","Timely, reliable and comprehensive information for the management of the national response enables the country to estimate resource flows and expenditures in support of the multisectoral response to HIV and AIDS. Tanzania therefore plans to conduct the National AIDS Spending Assessment (NASA) study to track expenditure among, Public sources, External sources, Providers of HIV and AIDS services (Public and Private), Out of pocket (Individual spending). The NASA report is expected to form a basis for leveraging both technical and financial support for national HIV response based on available resources.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Conduct National AIDS Spending Assessment (NASA)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5769","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","RTF BL 40Counselling and psychosocial group support for PWID-PLHIV.  Meeting with PWID PLHIV Units/Participants: 20 person per day Locations: 21 areas 1 quarters in year 1, 2 quarters in year 2, year 3.",23832,null,"Active","a6Q1R000000AJUV",0,0,0,0,23832,0,null,null,"RTF BL 40Counselling and psychosocial group support for PWID-PLHIV.  Meeting with PWID PLHIV Units/Participants: 20 person per day Locations: 21 areas 1 quarters in year 1, 2 quarters in year 2, year 3.","High","This activity supports counselling and psychosocial group support for people who inject drugs.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5768","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00099","Prevention and management of coinfections and co-morbidities for PWID","RTF BL 12-14,411. Hep C advisory board2. Hep C advisory board meeting3. HCV test kit procurement for 17 provinces -in addition to Community led4. Direct acting anti-viral treatment (DAA) dialogue for HEP C-group for HEP C following up during the intensive.",124245,null,"Active","a6Q1R000000AJUU",0,0,0,0,124245,0,null,null,"RTF BL 12-14,411. Hep C advisory board2. Hep C advisory board meeting3. HCV test kit procurement for 17 provinces -in addition to Community led4. Direct acting anti-viral treatment (DAA) dialogue for HEP C-group for HEP C following up during the intensive.","High","This activity supports a Hepatitis C advisory board; HCV test kit procurement for 17 provinces - in addition to Community led Direct acting anti-viral treatment (DAA) dialogue for HEP C-group for HEP C following up during the intensive","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Prevention and management of co-infections and co-morbidities for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5767","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00551","Interventions for young people who inject drugs","RTF BL 11Pathway to recovery -PWIDs and their families, Event for PWID and family Units/Participants: 32 person (16 families) per day.",64580,null,"Active","a6Q1R000000AJUT",0,0,0,0,64580,0,null,null,"RTF BL 11Pathway to recovery -PWIDs and their families, Event for PWID and family Units/Participants: 32 person (16 families) per day.","High","This activity supports the Pathway to recovery program for young people who inject drugs and their families,","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5766","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00548","Community empowerment for PWID","RTF BL 6-101. PWID Women group support, violence, gender, and mental-health2. Study on 1) Single model of Reach-Recruit-Test for PWID  2) N&S campaign and secondary distribution  3) MMT distribution at community level(Demonstration sites)3.Harm Reduction program assessment at local community to outline the best practice of the service provided 4. Set up HTC for Community led in PWID -additional for 1 site -operation5. Set up HTC for Community led in PWID -additional for 1 site -technical staff.",158826,null,"Active","a6Q1R000000AJUS",0,0,0,0,158826,0,null,null,"RTF BL 6-101. PWID Women group support, violence, gender, and mental-health2. Study on 1) Single model of Reach-Recruit-Test for PWID  2) N&S campaign and secondary distribution  3) MMT distribution at community level(Demonstration sites)3.Harm Reduction program assessment at local community to outline the best practice of the service provided 4. Set up HTC for Community led in PWID -additional for 1 site -operation5. Set up HTC for Community led in PWID -additional for 1 site -technical staff.","High","This intervention supports people who inject drugs women groups, violence, gender, and mental -health issues; a study on 1) Single model of Reach - Recruit -Test for people who inject drugs 2) N&S campaign and secondary distribution 3) MMT distribution at community level; a Harm Reduction program assessment at local community to outline the best practice of the service provided; and additional set up sites for HTC for Community led in people who inject drugs","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Community empowerment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5765","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","RTF BL 2-51. Prevention of HCV re-infection for PWID. Meeting of PWID HCV patient . Units/Participants: 10 person per day Locations: 21 areas 1 quarter in year 1, year 2, year 3 2. Relapse prevention workshop.  Workshop of PE, OW, PWID Units/Participants: 50 person per day Locations: Annual for 5 days in year 2, year 3 3. Incentive for peer recruitment to testUnits/Participants: 30% of target  test of PWID per year4. Data system to collect coupon from peer/volunteer recruiting including maintenance. consultantfee for  data system coupon for PWID (Year 1 for system development, Year 2, Year 3 for system maintenance).",98876,null,"Active","a6Q1R000000AJUR",0,0,0,0,98876,0,null,null,"RTF BL 2-51. Prevention of HCV re-infection for PWID. Meeting of PWID HCV patient . Units/Participants: 10 person per day Locations: 21 areas 1 quarter in year 1, year 2, year 3 2. Relapse prevention workshop.  Workshop of PE, OW, PWID Units/Participants: 50 person per day Locations: Annual for 5 days in year 2, year 3 3. Incentive for peer recruitment to testUnits/Participants: 30% of target  test of PWID per year4. Data system to collect coupon from peer/volunteer recruiting including maintenance. consultantfee for  data system coupon for PWID (Year 1 for system development, Year 2, Year 3 for system maintenance).","High","The intervention will support prevention of Hepatitis C virus (HCV) re -infection for people who inject drugs, relapse prevention, incentives for peer recruitment to HIV testing and a data system to collect coupons from peer/volunteer recruiting including maintenance. consultant fee for data system coupon for people who inject drugs","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5764","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00567","Pre-exposure prophylaxis (PrEP) for people in prisons and other closed settings","DDC BL 366-373TRC-PWID in prison.  Demonstrate sitesonPrEP , 2 sites in BKK and nearby. 300 prisons for screening and selected prisoner 100 person on PrEP.",29875,null,"Active","a6Q1R000000AJUQ",0,0,0,0,29875,0,null,null,"DDC BL 366-373TRC-PWID in prison.  Demonstrate sitesonPrEP , 2 sites in BKK and nearby. 300 prisons for screening and selected prisoner 100 person on PrEP.","High","This intervention will support 2 demonstration prison sites in Bangkok and a nearby location. 300 prisoners will be screened and 100 persons will be administered PrEP.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6118","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00572","Other intervention(s) for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",251100,null,"Active","a6Q1R000000AJa8",0,0,0,0,251100,0,null,null,"Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","High","Some of the budget in this budget line should be reserved for condom programming in prisons, because it is not included, whereas the funding request mentions negotiated sex in prisons.","NA Original Intervention: Other interventions for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6117","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00565","Behavioral interventions for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",11700,null,"Active","a6Q1R000000AJa7",0,0,0,0,11700,0,null,null,"Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","High","Prisoners are identified as an important KP group and a comprehensive program exists targeting this KPs",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT South Africa","South Africa","PAI-6005","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00097","Needle and Syringe programs for PWID and their partners","This PAAR request is to augment the Needle and Syringe kits provided to PWID to include personal cookers. This investment will reduce the likelihood of Hep C transmission, which is heightened with the use of make-shift cookers. This will reach each PWID in the program with 1 sterile personal cooker per day.",1790040,null,"Active","a6Q1R000000AJYJ",0,0,0,0,1790040,0,null,null,"This PAAR request is to augment the Needle and Syringe kits provided to PWID to include personal cookers. This investment will reduce the likelihood of Hep C transmission, which is heightened with the use of make-shift cookers. This will reach each PWID in the program with 1 sterile personal cooker per day.","Low",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Needle and syringe programs for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6004","MCI-00531","Comprehensive prevention programs for TGs","MCI-00553","Addressing stigma, discrimination and violence against TGs","This PAAR request is for hormone replacement therapy for 840 transgender people (50% of those reached through the program). It is expected that this intervention will help address gender-related barriers for transgender people. It is also linked with improved attainment of the 90-90-90 targets, since global data suggests that ART initiation and treatment adherence improves among transwomen in a gender affirming context.",1628308,null,"Active","a6Q1R000000AJYI",0,0,0,0,1628308,0,null,null,"This PAAR request is for hormone replacement therapy for 840 transgender people (50% of those reached through the program). It is expected that this intervention will help address gender-related barriers for transgender people. It is also linked with improved attainment of the 90-90-90 targets, since global data suggests that ART initiation and treatment adherence improves among transwomen in a gender affirming context.","Low",null,"NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Addressing stigma, discrimination and violence against transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6003","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00097","Needle and Syringe programs for PWID and their partners","The request is for procurement of personal sharps containers for PWID, to complement the within allocation investment in sharps containers for peer educators. The current policy environment is restricting distribution of harm reduction packs in certain areas. The additional investment in personal sharps containers will help to improve the legal and policy environment, helping to remove human rights barriers to accessing harm reduction services. The quantification of personal sharps containers in the PAAR is based on the number of needles requested within allocation, totaling 5 needles per drug user per day.",2632605,null,"Active","a6Q1R000000AJYH",0,0,0,0,2632605,0,null,null,"The request is for procurement of personal sharps containers for PWID, to complement the within allocation investment in sharps containers for peer educators. The current policy environment is restricting distribution of harm reduction packs in certain areas. The additional investment in personal sharps containers will help to improve the legal and policy environment, helping to remove human rights barriers to accessing harm reduction services. The quantification of personal sharps containers in the PAAR is based on the number of needles requested within allocation, totaling 5 needles per drug user per day.","Low",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Needle and syringe programs for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6002","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","This additional funding will support the roll out of 3HP for people living with HIV and household contacts of TB patients. 6% of the total country need is covered by the allocation request, with the PAAR filling the rest of the national request (20% of total national projected need). This total investment (main allocation and PAAR) will avert 9,159 TB cases.",12486210,null,"Inactive","a6Q1R000000AJYG",12486210,0,0,0,0,1,null,null,"This additional funding will support the roll out of 3HP for people living with HIV and household contacts of TB patients. 6% of the total country need is covered by the allocation request, with the PAAR filling the rest of the national request (20% of total national projected need). This total investment (main allocation and PAAR) will avert 9,159 TB cases.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6001","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00546","Prevention and management of coinfections and co-morbidities for sex workers","PAAR investment will support in reaching 3,385 sex workers with in-patient alcohol and drug treatment programs (3% of sex workers reached through the allocation amount) in districts and sub-districts where referrals to these services are not possible since they are not available. A 2009 study among sex workers in Pretoria found that 3% of SW tried but were unable to enter alcohol and drug treatment programs in the past year (Wechsberg et al., 2009).",3934721,null,"Active","a6Q1R000000AJYF",0,0,0,0,3934721,0,null,null,"PAAR investment will support in reaching 3,385 sex workers with in-patient alcohol and drug treatment programs (3% of sex workers reached through the allocation amount) in districts and sub-districts where referrals to these services are not possible since they are not available. A 2009 study among sex workers in Pretoria found that 3% of SW tried but were unable to enter alcohol and drug treatment programs in the past year (Wechsberg et al., 2009).","Low",null,"NA Original Intervention: Prevention and management of co-infections and co-morbidities for sex workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-6000","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","PAAR request will provide remuneration for an additional 1,000 CHWs (R3,500/month), which when added to the 400 supported through the allocation equates to 10% of the CHW registered workforce in the target 10 districts for the Global Fund program. This additional support will help NDOH to retain more of the existing cadre. There are currently 49 344 CHWs registered in the NDoH CHW database, of which 33,333 are already funded by treasury, 8000 funded by PEPFAR and 400 funded through the Global Fund allocation amount. These are active CHWs who have been validated by the provincial departments. This investment complements the significant commitment from Treasury, which has allocated R4.4 billion for the CHW programme over a three year period with R1.4 billion allocated for the financial year starting in April 2018/19, 1.4 Billion for April 2019/2020 and 1.5 Billion for the April 2020/21 financial year.",9901301,null,"Inactive","a6Q1R000000AJYE",9901301,0,0,0,0,1,null,null,"PAAR request will provide remuneration for an additional 1,000 CHWs (R3,500/month), which when added to the 400 supported through the allocation equates to 10% of the CHW registered workforce in the target 10 districts for the Global Fund program. This additional support will help NDOH to retain more of the existing cadre. There are currently 49 344 CHWs registered in the NDoH CHW database, of which 33,333 are already funded by treasury, 8000 funded by PEPFAR and 400 funded through the Global Fund allocation amount. These are active CHWs who have been validated by the provincial departments. This investment complements the significant commitment from Treasury, which has allocated R4.4 billion for the CHW programme over a three year period with R1.4 billion allocated for the financial year starting in April 2018/19, 1.4 Billion for April 2019/2020 and 1.5 Billion for the April 2020/21 financial year.","High",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5698","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Increase ACF salaries to enhance motivation and performance.",40700,null,"Active","a6Q1R000000AJTM",0,0,0,0,40700,0,null,null,"Increase ACF salaries to enhance motivation and performance.","Low","While addressing the motivation of ACF workers is important, this is a one-off increase in salary and it is unclear from the funding request on how this will be sustained long term. This activity should ideally be funded through more sustainable sources.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5697","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Adding an additional day to the annual review meetings for ACFs, screening officers, adherence officers and expert clients (all TB lay cadres).  The allocation amount covers annual 2-day review meetings, though ideally the reviews should be three days to cover additional topics, particularly given the integration these cadres are pursuing in this grant.",120000,null,"Active","a6Q1R000000AJTL",0,0,0,0,120000,0,null,null,"Adding an additional day to the annual review meetings for ACFs, screening officers, adherence officers and expert clients (all TB lay cadres).  The allocation amount covers annual 2-day review meetings, though ideally the reviews should be three days to cover additional topics, particularly given the integration these cadres are pursuing in this grant.","Low","The meetings for ACF are covered within the grant. Funding for additional meeting days is considered of low priority given competing activities.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5696","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Additional working tools for HTS providers (lab coats) and further learning and experience sharing(conferences, exchanges) to share results from innovative testing modalities.",30893,null,"Active","a6Q1R000000AJTK",0,0,0,0,30893,0,null,null,"Additional working tools for HTS providers (lab coats) and further learning and experience sharing(conferences, exchanges) to share results from innovative testing modalities.","Low","This activity can be covered within the existing testing program.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5695","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Chemistry and hematology testing for ART patients to monitor drug toxicity.",1136288,null,"Inactive","a6Q1R000000AJTJ",1136288,0,0,0,0,1,null,null,"Chemistry and hematology testing for ART patients to monitor drug toxicity.","Low","While an understandable and essential need, this should be prioritized for coverage within the program from the Ministry of Health (MOH).","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5694","MCI-00000","Prevention programs for general population","MCI-00578","Keeping girls in school","Dignity packs for an additional 16,500 girls, covering all school-going girls in the 20 Global Fund Tinkhundla.",2227500,null,"Active","a6Q1R000000AJTI",0,0,0,0,2227500,0,null,null,"Dignity packs for an additional 16,500 girls, covering all school-going girls in the 20 Global Fund Tinkhundla.","Low","While dignity packs are evidence-based to keep girls in school, this activity might provide a challenge to a long-term sustainability of the program",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5693","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Development of a national community health strategy.",50000,null,"Active","a6Q1R000000AJTH",0,0,0,0,50000,0,null,null,"Development of a national community health strategy.","Medium","Community health strategy development to strengthen the capacity of community groups to address accountability and oversight issues in the local health system.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5692","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Support establishment and operationalization of community Maternal Death Surveillance and Response (MDSR) committees, orient communities on MDSR and support the establishment of referral networks between MDSR focal points at community and at health facility level.",840000,null,"Active","a6Q1R000000AJTG",0,0,0,0,840000,0,null,null,"Support establishment and operationalization of community Maternal Death Surveillance and Response (MDSR) committees, orient communities on MDSR and support the establishment of referral networks between MDSR focal points at community and at health facility level.","Medium","Maternal Death Surveillance and Response Committees, which will strengthen the oversight of maternal deaths and may support links to the TB and HIV programme.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5691","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Information and communication technology (ICT) system support for the TB program, including licenses, maintenance and upgrades for software and hardware.",105044,null,"Active","a6Q1R000000AJTF",0,0,0,0,105044,0,null,null,"Information and communication technology (ICT) system support for the TB program, including licenses, maintenance and upgrades for software and hardware.","Medium","Additional IT support for the TB program.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Somalia","Somalia","PAI-5593","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","IRS campaigns are proposed for three new areas that are outbreak prone. Each campaign costs 24,510 USD. The funds will cover IRS campaigns in response to epidemic.",110295,null,"Active","a6Q1R000000AJRf",0,0,0,0,110295,0,null,null,"IRS campaigns are proposed for three new areas that are outbreak prone. Each campaign costs 24,510 USD. The funds will cover IRS campaigns in response to epidemic.","Low","The TRP only approved budget to cover\ncampaign in response to epidemic NOT three\nrounds as proposed by the applicant (issue 2).","NA Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5592","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Regional trainings through WHO EMRO. Additional $18,000 to come from WHO. The PAAR amount will support Somali participation in regional IVM training, Surveillance Training and Elimination training.",9000,null,"Active","a6Q1R000000AJRe",0,0,0,0,9000,0,null,null,"Regional trainings through WHO EMRO. Additional $18,000 to come from WHO. The PAAR amount will support Somali participation in regional IVM training, Surveillance Training and Elimination training.","Low","Apart from training in surveillance, the proposed training is not linked with the identified module and intervention","NA Original Intervention: Facility-based management","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5591","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLINs for lowest priority mass campaign areas not covered by the allocation request and priority gaps for the continuous distribution areas, prioritizing high burden area and/or key and vulnerable populations.",6057807,null,"Active","a6Q1R000000AJRd",0,0,0,0,6057807,0,null,null,"LLINs for lowest priority mass campaign areas not covered by the allocation request and priority gaps for the continuous distribution areas, prioritizing high burden area and/or key and vulnerable populations.","High","The LLINs distribution should prioritize high burden areas and/or key- and vulnerable populations, and not low transmission areas.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Somalia","Somalia","PAI-5590","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","WHO P5 position (50%) and 3 national counterparts who provide critical national level capacity building, QA, supervision and support routine reporting/surveillance. Immediate ceasing of the fudning would create critical technical gaps. At a minimum $707,907 is sought to cover a two year transition period where further national capacity building would be implemented.",1061860,null,"Active","a6Q1R000000AJRc",913289.25,0,0,0,148570.75,0,null,null,"WHO P5 position (50%) and 3 national counterparts who provide critical national level capacity building, QA, supervision and support routine reporting/surveillance. Immediate ceasing of the fudning would create critical technical gaps. At a minimum $707,907 is sought to cover a two year transition period where further national capacity building would be implemented.","High","WHO P5 position (50%) and 3 national counterparts to provide critical national level capacity building, QA, supervision and support routine reporting/surveillance should be retained. Immediate ceasing of the funding would create critical technical gaps.","NA Original Intervention: IPTCS Technical Assistance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5589","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","This supports the majority of health services delivery. HIV services are managed or supported by INGOs and NGOs. These organisations to date have received support costs to enable the oversight, capacity building, and delivery of programs. Without this support there is a high risk of discontinuing this support and urgent transition arrangements will need to be implemented. This is for three years, but a minimum of $460,000 is sought to cover 2018 operations and allow effective and appropriate transition arrangements to be put in place.",1380000,null,"Active","a6Q1R000000AJRb",519810,0,0,0,860190,0,null,null,"This supports the majority of health services delivery. HIV services are managed or supported by INGOs and NGOs. These organisations to date have received support costs to enable the oversight, capacity building, and delivery of programs. Without this support there is a high risk of discontinuing this support and urgent transition arrangements will need to be implemented. This is for three years, but a minimum of $460,000 is sought to cover 2018 operations and allow effective and appropriate transition arrangements to be put in place.","High","This supports the majority of health facilities delivery . HIV services are managed or supported by INGOs and NGOs","NA Original Intervention: IPTCS Partner Support Costs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5588","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. This will build on the 2016/2017 Stigma Survey and provide a means of measuring outcomes of community and health worker stigma reduction efforts.",72000,null,"Inactive","a6Q1R000000AJRa",72000,0,0,0,0,1,null,null,"Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. This will build on the 2016/2017 Stigma Survey and provide a means of measuring outcomes of community and health worker stigma reduction efforts.","High","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of people living with HIV and their families and affects treatment adherence. This will build on the 2016/2017 Stigma Survey and provide a means of measuring outcomes of community and health worker stigma reduction efforts. Proposed to be included in a Community Based Stigma Reduction Package at line 2 above.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Paraguay","Paraguay","PAI-5455","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Consultation for implementation of the Health Region Training Plan.\nHR are required for this since the PNCT has a deficit of physicians available for trips to the interior to carry out this duty.",3259.85,null,"Active","a6Q1R000000AJPR",0,0,0,0,3259.85,0,null,null,"Consultation for implementation of the Health Region Training Plan.\nHR are required for this since the PNCT has a deficit of physicians available for trips to the interior to carry out this duty.","Medium",null,"NA Original Module: SRSS: Program management. Original Intervention: National disease monitoring policies, planning, coordination and program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5454","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Lab Dept (LCSP) management\nImplementation of new diagnostic algorithms including cultures and PSD for all cases of Pulmonary TB and universal rapid molecular diagnosis.\nThis requires hiring of HR who can carry out cultures and rapid molecular diagnosis on all samples arriving at LCSP.",50386,null,"Active","a6Q1R000000AJPQ",0,0,0,0,50386,0,null,null,"Lab Dept (LCSP) management\nImplementation of new diagnostic algorithms including cultures and PSD for all cases of Pulmonary TB and universal rapid molecular diagnosis.\nThis requires hiring of HR who can carry out cultures and rapid molecular diagnosis on all samples arriving at LCSP.","Medium",null,"NA Original Intervention: National disease monitoring policies, planning, coordination and program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5453","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Health Regions - Program Management\nExecution and coordination of activities, funding applications and financial reporting/funds return. Application of preventive and corrective controls on recording forms and reports in the expert system.\nThe intention with this intervention is to effectively execute the proposed activities and ensure proper data management.",60590.66,null,"Active","a6Q1R000000AJPP",0,0,0,0,60590.66,0,null,null,"Health Regions - Program Management\nExecution and coordination of activities, funding applications and financial reporting/funds return. Application of preventive and corrective controls on recording forms and reports in the expert system.\nThe intention with this intervention is to effectively execute the proposed activities and ensure proper data management.","Medium",null,"NA Original Module: SRSS: Provision of integrated services and quality improvement. Original Intervention: Organization or health and management services","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5452","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Strengthening of TB Expert System input with provision of computer equipment\nNot all districts have computer equipment to input symptomatic respirotary cases data and other cases into the system. It is important to note that from this year, PNCT will implement reporting in the Expert System as a source for official information. This implies that if the local service has no equipment and/or Internet access, the district must manage the data input.\nAcquisition of equipment will ensure timely and correct data input, analysis of the same at every care level and official reporting of indicators at the national level.",129138.5,null,"Active","a6Q1R000000AJPO",0,0,0,0,129138.5,0,null,null,"Strengthening of TB Expert System input with provision of computer equipment\nNot all districts have computer equipment to input symptomatic respirotary cases data and other cases into the system. It is important to note that from this year, PNCT will implement reporting in the Expert System as a source for official information. This implies that if the local service has no equipment and/or Internet access, the district must manage the data input.\nAcquisition of equipment will ensure timely and correct data input, analysis of the same at every care level and official reporting of indicators at the national level.","Medium",null,"NA Original Module: SRSS: Health information systems and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5451","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","National TB Programme (PNCT) - Program Management. Technical-administrative management for optimum implementation of this project, including execution and monitoring of the proposed activities. Production and verification of the funding application for execution of PNCT activities in the context of the project, and provision of the same to the RP. The intention here is to appropriately monitor activities to be implemented and as such to assure effective execution of the same.\nPNCT monitoring management of data quality, indicator compliance and recording in expert system. Technical-programmatic management relating to monitoring and follow-up on indicators and activities included in the working plan. Data quality management, use of corrective controls, monitoring for optimum implementation of the Expert System, which will serve from this year as the main source of information for reporting indicators.\n\nThe intention here is to efficiently monitor indicators and activities, promptly identify bottlenecks that could affect execution of the project and offer recommendations.",210724.74,null,"Active","a6Q1R000000AJPN",0,0,0,0,210724.74,0,null,null,"National TB Programme (PNCT) - Program Management. Technical-administrative management for optimum implementation of this project, including execution and monitoring of the proposed activities. Production and verification of the funding application for execution of PNCT activities in the context of the project, and provision of the same to the RP. The intention here is to appropriately monitor activities to be implemented and as such to assure effective execution of the same.\nPNCT monitoring management of data quality, indicator compliance and recording in expert system. Technical-programmatic management relating to monitoring and follow-up on indicators and activities included in the working plan. Data quality management, use of corrective controls, monitoring for optimum implementation of the Expert System, which will serve from this year as the main source of information for reporting indicators.\n\nThe intention here is to efficiently monitor indicators and activities, promptly identify bottlenecks that could affect execution of the project and offer recommendations.","High",null,"NA Original Module: SRSS: Program management. Original Intervention: National disease monitoring policies, planning, coordination and program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5450","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Assurance of mobility for active searches for TB cases\nHealth Regions have no mobility for the search symptomatic respiratory cases in indigenous communities and settlements with difficult access. This includes prompt transfer of samples to be processed, mainly for cultures and PSD at the Lab Dept (LCSP) or network laboratories. The Regions to be strengthened are:\n? Caaguazú with an area of 11,474 km2 expects approximately 3,337 respiratory symptomatic cases and 255 cases annually.\n? Pte. Hayes with an area of 72,907 km2 expects approximately 4,454 respiratory symptomatic cases and 356 cases annually.\n? Boquerón with an area of 91,669 km2 expects approximately 2,278 respiratory symptomatic cases and 174 cases annually.\n? Canindeyú with an area of 14,667 km2 expects approximately 1,368 respiratory symptomatic cases and 104 cases annually.\n? Central with an area of 2,465 km2 expects approximately 12,793 respiratory symptomatic cases annually.\n? San Pedro with an area of 20,002 km2 expects approximately 2,569 respiratory symptomatic cases annually.\n\nAssuring mobility to regions with difficult geographic access will guarantee active SR search and prompt diagnosis of TB cases, reducing the disparity between forecasts and notifications.",371036.7,null,"Active","a6Q1R000000AJPM",0,185546,0,0,185490.7,0,null,null,"Assurance of mobility for active searches for TB cases\nHealth Regions have no mobility for the search symptomatic respiratory cases in indigenous communities and settlements with difficult access. This includes prompt transfer of samples to be processed, mainly for cultures and PSD at the Lab Dept (LCSP) or network laboratories. The Regions to be strengthened are:\n? Caaguazú with an area of 11,474 km2 expects approximately 3,337 respiratory symptomatic cases and 255 cases annually.\n? Pte. Hayes with an area of 72,907 km2 expects approximately 4,454 respiratory symptomatic cases and 356 cases annually.\n? Boquerón with an area of 91,669 km2 expects approximately 2,278 respiratory symptomatic cases and 174 cases annually.\n? Canindeyú with an area of 14,667 km2 expects approximately 1,368 respiratory symptomatic cases and 104 cases annually.\n? Central with an area of 2,465 km2 expects approximately 12,793 respiratory symptomatic cases annually.\n? San Pedro with an area of 20,002 km2 expects approximately 2,569 respiratory symptomatic cases annually.\n\nAssuring mobility to regions with difficult geographic access will guarantee active SR search and prompt diagnosis of TB cases, reducing the disparity between forecasts and notifications.","High",null,"NA Original Module: SRSS: Provision of integrated services and quality improvement. Original Intervention: Organization or health and management services","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5359","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: To scale up a mobile based TB case notification system to initial 50, then to 90 districts. \nRational: This will facilitate TB cases notification in private sector. The majority of the population is seeking care in the private sector. Legislation for mandatory case notification will facilitate that. 35,000 additional cases are expected to be identified anually for year 2 and 3.\nThe pilot intervention is proposed through catalytic funding. After evaluation, the intervention will be scaled up throughout the country based on phased approach, selecting additional 50 districts in year 2019 & rest 90 in year 2020.",1500000,null,"Active","a6Q1R000000AJNt",0,0,0,0,1500000,0,null,null,"Action: To scale up a mobile based TB case notification system to initial 50, then to 90 districts. \nRational: This will facilitate TB cases notification in private sector. The majority of the population is seeking care in the private sector. Legislation for mandatory case notification will facilitate that. 35,000 additional cases are expected to be identified anually for year 2 and 3.\nThe pilot intervention is proposed through catalytic funding. After evaluation, the intervention will be scaled up throughout the country based on phased approach, selecting additional 50 districts in year 2019 & rest 90 in year 2020.","High","The majority of the population is seeking care in the private sector. Mandatory case notification is a critical component to strengthen case notification from the private sector.","NA Original Intervention: Mandatory case notification through mobile application & web based system","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5358","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Action: Scale-up of Xpert testing of B positive cases Rationale:The expansion of Xpert network across the country has a throughput  to test additional B-positive TB cases to reach up to 90% of B positives cases. This will give a yield of additional 16% of RR-TB cases. The major reason for putting it into  PAAR being requirement of additional resources for Xpert cartridges  and  second line Drugs and social support to reach 55% of all pulmonary MDR cases ( which is  70%.(2019)  90%  (2020) of B positive cases, 1000 + 2150 =3150 additional Cases over three years.Cost implications: SLDs for 3150 MDR cases (4300/case)  US 13,545,000100,000 cartridges:  (US 1 million (diagnostics)Social support  (528 US per patient)  US 1,663,200.",16208000,null,"Active","a6Q1R000000AJNs",0,0,0,0,16208000,0,null,null,"Action: Scale-up of Xpert testing of B positive cases Rationale:The expansion of Xpert network across the country has a throughput  to test additional B-positive TB cases to reach up to 90% of B positives cases. This will give a yield of additional 16% of RR-TB cases. The major reason for putting it into  PAAR being requirement of additional resources for Xpert cartridges  and  second line Drugs and social support to reach 55% of all pulmonary MDR cases ( which is  70%.(2019)  90%  (2020) of B positive cases, 1000 + 2150 =3150 additional Cases over three years.Cost implications: SLDs for 3150 MDR cases (4300/case)  US 13,545,000100,000 cartridges:  (US 1 million (diagnostics)Social support  (528 US per patient)  US 1,663,200.","High","Allocation funding estimates only 10 percent increase for RR-TB case detection rate. Additional activities boosting the MDR-TB case detection should be prioritized.","NA Original Module: Multidrug-resistant TB. Original Intervention: Accelerated MDR detection and treatment to reach 90 percent of bacteriologically positive cases by 2020. (3,150 additional MDR cases)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5357","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: To provide enhanced case finding screening algorithm to all patients in 175 large public sector hospitals with digital X-ray (CAD4TB) followed by X-pert.  Confirmation for enhanced case finding and increased diagnostic quality.\nRational: 30% of prevalent TB cases are asymptomatic & not detected using current tools and algorithms. X-ray followed by X-pert is the most sensitive test to detect these cases, in pursuit of END TB targets of detecting over 90% of cases. Implementation of TB X-ray screening followed by X-pert. Gradual scale up so over 3 years, 10 million patients X-ray screened in  200 large hospitals, detecting 103,750 additional  bacteriologically confirmed TB cases and  4358 RR cases  (4.2%) from a proposed budget of US$118 million. This seems to offer low value for money at US$1,147/case detected.",17842500,null,"Active","a6Q1R000000AJNr",0,0,0,0,17842500,0,null,null,"Action: To provide enhanced case finding screening algorithm to all patients in 175 large public sector hospitals with digital X-ray (CAD4TB) followed by X-pert.  Confirmation for enhanced case finding and increased diagnostic quality.\nRational: 30% of prevalent TB cases are asymptomatic & not detected using current tools and algorithms. X-ray followed by X-pert is the most sensitive test to detect these cases, in pursuit of END TB targets of detecting over 90% of cases. Implementation of TB X-ray screening followed by X-pert. Gradual scale up so over 3 years, 10 million patients X-ray screened in  200 large hospitals, detecting 103,750 additional  bacteriologically confirmed TB cases and  4358 RR cases  (4.2%) from a proposed budget of US$118 million. This seems to offer low value for money at US$1,147/case detected.","Low","The expected yield from the intervention is 103,750 cases from a proposed budget of US$118 million. This seems to offer low value for money at US$1,147/case detected. The TRP recommends that US$ 17,842,500 out of the US$118M requested for this intervention considered quality demand, but of low priority. The TRP recommends that the amount be targeted at initiating the introduction of this intervention in pilot sites to learn lessons and document costs in relation to yield.","NA Original Intervention: Implementing enhanced case finding algorithm in 175 hospitals X-ray screening followed by GeneXpert algorithm on all new patients (treated as TB risk group)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5356","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Action: To establish 11 more PMDT sites in Public and private sector in an equitable manner.\nRationale: These PMDT sites will facilitate the enrollment of DR-TB patients near their residences for better treatment adherence.",3200000,null,"Active","a6Q1R000000AJNq",0,0,0,0,3200000,0,null,null,"Action: To establish 11 more PMDT sites in Public and private sector in an equitable manner.\nRationale: These PMDT sites will facilitate the enrollment of DR-TB patients near their residences for better treatment adherence.","High","While allocation funding supports an increase of 6 PMDT sites from 34 to 40, additional support is sought to scale up PMDT sites from 40 to 51. The TRP deems that his is a core MDR-TB intervention to facilitate case management.","NA Original Module: Multidrug-resistant TB. Original Intervention: Scale up network of PMDT sites from 40 to 51","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Pakistan","Pakistan","PAI-5355","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","The Malaria Indicator survey (MIS) showed only 35% utilization of LLIN by the community during high transmission season. Mass media campaign will be conducted for all 66 districts and aired in the malaria transmission season to encourage LLINs utilization and achieve maximum impact. In addition, the campaign will raise awareness amongst the population for utilization of most famous intervention of LLINs and early care seeking by malaria suspects to reduce morbidity and mortality.",300000,null,"Active","a6Q1R000000AJNp",0,0,0,0,300000,0,null,null,"The Malaria Indicator survey (MIS) showed only 35% utilization of LLIN by the community during high transmission season. Mass media campaign will be conducted for all 66 districts and aired in the malaria transmission season to encourage LLINs utilization and achieve maximum impact. In addition, the campaign will raise awareness amongst the population for utilization of most famous intervention of LLINs and early care seeking by malaria suspects to reduce morbidity and mortality.","Low","This additional funding will support target mass media\nactivities addressing specific bottlenecks. A 30% of the original request is being recommended under PAAR.","NA Original Intervention: Mass media campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Nepal","Nepal","PAI-5306","MCI-00071","Other module","MCI-00071","Other module","The GoN commitment to increase resources for treatment, care and support includes capacity strengthening of medical personnel at ART sites. Intermittent short-term technical assistance would augment the GoN efforts and complement the capacity support available from other partners (AHF, WHO, Linkages), as well as maximise Global Fund investments in TCS.",2000000,null,"Active","a6Q1R000000AJN2",0,0,0,0,2000000,0,null,null,"The GoN commitment to increase resources for treatment, care and support includes capacity strengthening of medical personnel at ART sites. Intermittent short-term technical assistance would augment the GoN efforts and complement the capacity support available from other partners (AHF, WHO, Linkages), as well as maximise Global Fund investments in TCS.","Low","There is already significant investment on capacity building in the allocation (see Section 4.3.2 above). As domestic funding is planned to rise, it should cover interventions such as this","NA Original Module: RSSH. Original Intervention: Capacity building of medical personnel at ART sties","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Nepal","Nepal","PAI-5305","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Studies have indicated that a number of young people (under the age of 20) engage in sex or sell sex, begin using illicit drugs and ultimately progress to injecting. Youth groups and youth-led organisations anticipate that engaging young people in prevention and behaviour change can have positive and lasting impacts. This work would complement the in-reach interventions for young key populations in the main allocation.",100000,null,"Active","a6Q1R000000AJN1",0,0,0,0,100000,0,null,null,"Studies have indicated that a number of young people (under the age of 20) engage in sex or sell sex, begin using illicit drugs and ultimately progress to injecting. Youth groups and youth-led organisations anticipate that engaging young people in prevention and behaviour change can have positive and lasting impacts. This work would complement the in-reach interventions for young key populations in the main allocation.","High","To reach young people at risk through youth groups and youthled organizations in addition to interventions already in the allocation","NA Original Intervention: Prevention activities for young key populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Nepal","Nepal","PAI-5304","MCI-00001","Prevention programs for MSM and TGs","MCI-00086","Other interventions for MSM and TGs","To date, USAID-FHI360 has supported some MSM/TG interventions in 5 non-GF districts but will not commit funding beyond 2018-19, Since there is still a strong need from the community, and other external resources are not envisaged, support is requested for the continuation of services in 2019-201 and 2020-21.",600000,null,"Active","a6Q1R000000AJN0",0,0,0,0,600000,0,null,null,"To date, USAID-FHI360 has supported some MSM/TG interventions in 5 non-GF districts but will not commit funding beyond 2018-19, Since there is still a strong need from the community, and other external resources are not envisaged, support is requested for the continuation of services in 2019-201 and 2020-21.","High","Men who have sex with men are also a key population identified in the national strategy; PEPFAR funding is not planned to continue beyond 2018-19. These funds would replace geographic coverage lost when funding from other partners ends (but the Global Fund grant also covers men who have sex with men and transgender people within the allocation amount).","NA Original Module: Prevention programs for men who have sex with men and transgender people. Original Intervention: Continuation of services for men who have sex with men and transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Nepal","Nepal","PAI-5303","MCI-00071","Other module","MCI-00071","Other module","Migration to India, particularly to states where HIV prevalence among FSW is high, is recognised as source of infection. The main source of information for targeting HIV interventions among migrants is a 2007 study by UNFPA. However, it is likely that changes in health seeking behaviour and migration patterns (e.g. the shift to Gulf countries as the preferred destination) over the last decade have implications for HIV transmission and access to HIV services, which will be explored in the assessment. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.",50000,null,"Inactive","a6Q1R000000AJMz",50000,0,0,0,0,1,null,null,"Migration to India, particularly to states where HIV prevalence among FSW is high, is recognised as source of infection. The main source of information for targeting HIV interventions among migrants is a 2007 study by UNFPA. However, it is likely that changes in health seeking behaviour and migration patterns (e.g. the shift to Gulf countries as the preferred destination) over the last decade have implications for HIV transmission and access to HIV services, which will be explored in the assessment. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.","High","Originally proposed as a single module with two interventions, the TRP suggests to split the interventions; the TRP considers this one to be a high priority because the main information source is dated (2007).","NA Original Module: Study and assessment. Original Intervention: Migration and HIV vulnerability","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Nepal","Nepal","PAI-5302","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","To date, FSW have been covered USAID-FHI360 (80% coverage). USAID-FHI360 has not committed any funding for the continuation of the program beyond 2018-19.  Support through PAAR would therefore enable the country to meet the NHIP targets of 87% and 90% coverage of FSW in 2019-20 and 2020-21, with prevention programming and HIV testing.",4000000,null,"Active","a6Q1R000000AJMy",150000,0,0,0,3850000,0,null,null,"To date, FSW have been covered USAID-FHI360 (80% coverage). USAID-FHI360 has not committed any funding for the continuation of the program beyond 2018-19.  Support through PAAR would therefore enable the country to meet the NHIP targets of 87% and 90% coverage of FSW in 2019-20 and 2020-21, with prevention programming and HIV testing.","High","The TRP considers this to be a high priority. As described in Section 4.3.3 above, female sex workers are one of the key populations identified in the national strategy; coverage is essential and PEPFAR funding is not planned to continue beyond 2018-19, so there is a risk of discontinuation.","NA Original Intervention: Core Identify Reach-Test-Treat Retain package","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-03-15","HIV/AIDS"]
["CT Malawi","Malawi","PAI-5206","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","This intervention is linked to a number of objectives and strategies articulated in the draft HSSPII which include improving the availability, quality, and utilization of medicines and medical supplies as well as strengthening the capacity and increasing availability of qualified pharmacy staff at all levels This intervention also includes funding for essential infrastructure and equipment linked to the HSSPII. The plan highlights critical activities to improve the availability and quality of health infrastructure and medical equipment. The activities below build on the activities listed within allocation with the hope that Malawi will achieve improved storage and management of commodities, and improved pharmaceutical waste management. Specific activities included in this intervention: ? Procurement of medical equipment ? Acquiring infrastructure for safe disposal of pharmaceutical wastes ? Development of an automated asset management tool ? Construction of an additional CMST central warehouse ? Strengthening of pharmaceutical storage infrastructure in health facilities ? Procurement and installation of solar panels at 600 facilities.",31333760,null,"Active","a6Q1R000000AJLQ",0,0,0,0,31333760,0,null,null,"This intervention is linked to a number of objectives and strategies articulated in the draft HSSPII which include improving the availability, quality, and utilization of medicines and medical supplies as well as strengthening the capacity and increasing availability of qualified pharmacy staff at all levels This intervention also includes funding for essential infrastructure and equipment linked to the HSSPII. The plan highlights critical activities to improve the availability and quality of health infrastructure and medical equipment. The activities below build on the activities listed within allocation with the hope that Malawi will achieve improved storage and management of commodities, and improved pharmaceutical waste management. Specific activities included in this intervention: ? Procurement of medical equipment ? Acquiring infrastructure for safe disposal of pharmaceutical wastes ? Development of an automated asset management tool ? Construction of an additional CMST central warehouse ? Strengthening of pharmaceutical storage infrastructure in health facilities ? Procurement and installation of solar panels at 600 facilities.","High","Malawi is considered a focused supply chain transformation country. Building on the Global Fund supply chain initiative concept.","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5205","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","MDR TB Prevention (USD 600,000): With the increase in TB diagnosis and treatment that will occur through the emphasis on case detection and diagnosis in this FR, effective infection control measures must be put in place. This line item will be used for the upgrading of MDR-TB wards in three central hospitals to include negative pressure isolation rooms.",600000,null,"Active","a6Q1R000000AJLP",0,0,0,0,600000,0,null,null,"MDR TB Prevention (USD 600,000): With the increase in TB diagnosis and treatment that will occur through the emphasis on case detection and diagnosis in this FR, effective infection control measures must be put in place. This line item will be used for the upgrading of MDR-TB wards in three central hospitals to include negative pressure isolation rooms.","High","MDR-TB infection control activities","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5204","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Key Affected Populations (USD 300,000): The usefulness of digital chest X-rays for screening and diagnosis of TB is considerably limited by lack of trained healthcare workers. Computer-aided detection (CAD) programs constitute a viable alternative, and initial studies have indicated that CAD programs have potential high sensitivity.31,32 CAD is particularly useful in high volume screening settings, such as OPD in high burden hospitals. While digital X-rays have been procured through the NFM grant, complementing them with CAD will enhance their effectiveness. This line item will cover the cost of procurement and utilization of CAD software for TB diagnosis, in particular concentrating on screening urban poor populations in high volume sites, complementing the within allocation strategy for reaching this high risk group by improving standardization, sensitivity and speed of diagnosis. Utilization of CAD will also contribute to the generating evidence on this innovative technology, to inform policy on usage in resource constrained settings with high TB burden. Finally, imaging generated by CAD can be repurposed for teaching in health colleges.",300000,null,"Active","a6Q1R000000AJLO",50000,0,0,0,250000,0,null,null,"Key Affected Populations (USD 300,000): The usefulness of digital chest X-rays for screening and diagnosis of TB is considerably limited by lack of trained healthcare workers. Computer-aided detection (CAD) programs constitute a viable alternative, and initial studies have indicated that CAD programs have potential high sensitivity.31,32 CAD is particularly useful in high volume screening settings, such as OPD in high burden hospitals. While digital X-rays have been procured through the NFM grant, complementing them with CAD will enhance their effectiveness. This line item will cover the cost of procurement and utilization of CAD software for TB diagnosis, in particular concentrating on screening urban poor populations in high volume sites, complementing the within allocation strategy for reaching this high risk group by improving standardization, sensitivity and speed of diagnosis. Utilization of CAD will also contribute to the generating evidence on this innovative technology, to inform policy on usage in resource constrained settings with high TB burden. Finally, imaging generated by CAD can be repurposed for teaching in health colleges.","High","DXR with CAD for targeted screening of urban poor populations","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Intervention: Key populations (TB care and prevention) ? Others","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5203","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Survey, analysis, review and transparency (USD 2,175,000) Building upon M&E activities in the within allocation request, this line item will expand TB M&E activities to include conducting: 1) a national TB prevalence study in 2020 to update current prevalence estimate from the 2014 TB Prevalence Survey, 2) routine operational research on new intervention areas implemented through this FR, in order to provide real-time learning, 3) routine and end-line program and epidemiological reviews, and 4) WHO Standards and Checklist for TB Surveillance and Vital Registration System. Prevalence data are now 5-years old and therefore there is an urgent need of updating data through a new prevalence survey in 2020. Overall, the development of robust M&E systems will contribute to more granular data, which can allow for programme strengthening both in the long-run and course correction for identified problems during grant implementation. Access to such real-time data would allow for better geographic and/or facility prioritization of activities, better data Funding Request: Tailored to Material Change 15 December 2016? 35 sharing with districts and facilities to monitor sub-national targets for case detection or treatment outcomes, and deployment of intensified support and supervision based on data to identify poorperforming facilities.",2175000,null,"Active","a6Q1R000000AJLN",200000,0,0,0,1975000,0,null,null,"Survey, analysis, review and transparency (USD 2,175,000) Building upon M&E activities in the within allocation request, this line item will expand TB M&E activities to include conducting: 1) a national TB prevalence study in 2020 to update current prevalence estimate from the 2014 TB Prevalence Survey, 2) routine operational research on new intervention areas implemented through this FR, in order to provide real-time learning, 3) routine and end-line program and epidemiological reviews, and 4) WHO Standards and Checklist for TB Surveillance and Vital Registration System. Prevalence data are now 5-years old and therefore there is an urgent need of updating data through a new prevalence survey in 2020. Overall, the development of robust M&E systems will contribute to more granular data, which can allow for programme strengthening both in the long-run and course correction for identified problems during grant implementation. Access to such real-time data would allow for better geographic and/or facility prioritization of activities, better data Funding Request: Tailored to Material Change 15 December 2016? 35 sharing with districts and facilities to monitor sub-national targets for case detection or treatment outcomes, and deployment of intensified support and supervision based on data to identify poorperforming facilities.","High","TB Prevalence survey planned in 2020","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Survey, analysis, review and transparency","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5202","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","MDR-TB Treatment (USD 977,066): This line item will cover treatment costs for an additional 102 MDR/RR-TB cases, including drugs and ancillary medicines, nutritional supplements, and social support for patients. Through above allocation, the MDR-TB CDR will increase to 50% of the estimated country need (85% of the NSP target), reaching 95% of expected re-treatment cases. Additionally, with the phased roll out of shorter treatment regimen elaborated in the MDR-TB within allocation request, the above allocation request includes necessary equipment investments, such as 10 of each of the following HumaLyte Plus 5, Chemistry Analyzer, Hormonal Assay, ECG, ECHO, and CBC machines, as well as respective reagents.",977066,null,"Active","a6Q1R000000AJLM",0,0,0,0,977066,0,null,null,"MDR-TB Treatment (USD 977,066): This line item will cover treatment costs for an additional 102 MDR/RR-TB cases, including drugs and ancillary medicines, nutritional supplements, and social support for patients. Through above allocation, the MDR-TB CDR will increase to 50% of the estimated country need (85% of the NSP target), reaching 95% of expected re-treatment cases. Additionally, with the phased roll out of shorter treatment regimen elaborated in the MDR-TB within allocation request, the above allocation request includes necessary equipment investments, such as 10 of each of the following HumaLyte Plus 5, Chemistry Analyzer, Hormonal Assay, ECG, ECHO, and CBC machines, as well as respective reagents.","High","Management of 102 MDR-TB cases","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5201","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","MDR-TB Case Detection (USD 740,365): The national policy is to test re-treatment patients, contacts of MDR-TB patients and seriously ill patients for MDR-TB. Within allocation, 67,131 cases will be notified in 2018-20, of which approximately 10% (or 6,700) are expected to be re-treatment cases. Of these, 6.4% (or 430) are expected to be MDR-TB cases. From within allocation, 381 MDR-TB patients are targeted for treatment, representing 88.6% of expected retreatment cases. The remaining 49 of 430 cases, along with the new MDR-TB cases that will be identified from the additional 9,784 TB cases found through the above allocation request above, will be covered through these above allocation funds (See Target Assumption Table attached). To support increased case detection rates, an additional 2,060 Xpert cartridges will be procured, alongside orientation for HCWs on Xpert diagnostic algorithms, as well as supervision and mentorship for HCWs in high burden MDR-TB facilities to encourage screening of patients using Xpert.",740365,null,"Active","a6Q1R000000AJLL",215894,0,0,0,524471,0,null,null,"MDR-TB Case Detection (USD 740,365): The national policy is to test re-treatment patients, contacts of MDR-TB patients and seriously ill patients for MDR-TB. Within allocation, 67,131 cases will be notified in 2018-20, of which approximately 10% (or 6,700) are expected to be re-treatment cases. Of these, 6.4% (or 430) are expected to be MDR-TB cases. From within allocation, 381 MDR-TB patients are targeted for treatment, representing 88.6% of expected retreatment cases. The remaining 49 of 430 cases, along with the new MDR-TB cases that will be identified from the additional 9,784 TB cases found through the above allocation request above, will be covered through these above allocation funds (See Target Assumption Table attached). To support increased case detection rates, an additional 2,060 Xpert cartridges will be procured, alongside orientation for HCWs on Xpert diagnostic algorithms, as well as supervision and mentorship for HCWs in high burden MDR-TB facilities to encourage screening of patients using Xpert.","High","102 MDR-TB case diagnosis in PAAR","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Mali","Mali","PAI-5077","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",2138479,null,"Inactive","a6Q1R000000AJJL",0,2138479,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Medium","The upgrading of the CSComs has been split into several cost categories. Though the complete CSCom service package is seen as quality demand to extend community health services, the total costs for the upgrading, remains high (US$80,400) for a basic health center to serve at the community level. Therefore, most of these items are considered medium priority; if funding is available, the solar panels could be prioritized as they can be used to keep fridges and lights running and could also generate income through charging of cell phones and other small equipment. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 1",null,"RSSH"]
["CT Mali","Mali","PAI-5076","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",773862,null,"Inactive","a6Q1R000000AJJK",0,773862,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","High",null,"Validaed by meeting the PO on 03/06/2019 Original Module: RSSH: Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 1",null,"RSSH"]
["CT Mali","Mali","PAI-5075","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",2731700,null,"Inactive","a6Q1R000000AJJJ",0,2731700,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","High",null,"Validaed by meeting the PO on 03/06/2019 Original Module: RSSH: Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 1",null,"RSSH"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4975","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","For strengthening  the M&E system, the disease surveillance and outbreak response system and the provision of continued TA. In addition to work plans for Mobile Malaria Teams (MMTs) and associated field visits to detect and treat patients, activities to improve quality controls for anti-malarials.",1000000,null,"Inactive","a6Q1R000000AJHh",1000000,0,0,0,0,1,null,null,"For strengthening  the M&E system, the disease surveillance and outbreak response system and the provision of continued TA. In addition to work plans for Mobile Malaria Teams (MMTs) and associated field visits to detect and treat patients, activities to improve quality controls for anti-malarials.","High","The TRP considers these as key activities, which should be incorporated as part of the regular allocation, if efficiencies are found during grant making. However microscopes and microscopy training and supplies are not supported.","NA Original Intervention: Strengthening Health Sector Case Management (Lao PDR)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4972","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","To accelerate malaria elimination.",25000,null,"Inactive","a6Q1R000000AJHe",0,0,25000,0,0,1,null,null,"To accelerate malaria elimination.","Low","Low priority.","NA Original Intervention: Promote intensive personal protection where drug is resistant (Thailand)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4971","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Contingency measure for new foci in anticipation of occurrence in drug resistant villages.",64000,null,"Inactive","a6Q1R000000AJHd",64000,0,0,0,0,1,null,null,"Contingency measure for new foci in anticipation of occurrence in drug resistant villages.","Low","Low priority.","NA Original Intervention: Vector control and elimination of transmission foci in villages where drug resistant patients are reported (Thailand)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4970","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","The program would like to support the overall health system strengthening by enhancing adverse drug reaction control and monitoring.",67000,null,"Active","a6Q1R000000AJHc",0,0,0,0,67000,0,null,null,"The program would like to support the overall health system strengthening by enhancing adverse drug reaction control and monitoring.","Low","Low priority.","NA Original Intervention: Pharmacovigilance for antimalarial drugs (Viet Nam)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4969","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","1. The semi-annual meetings are to review 6 months activities and adjust annual workplan based on results 2. WHO TA fees in 2018 and 2019 are included in within allocation budget. In 2020, even though it is expected that the program's capacity has been strengthened, TA from WHO will still be necessary to develop elimination strategies for 2021 - 2025 period.",464727,null,"Active","a6Q1R000000AJHb",155727,0,0,0,309000,0,null,null,"1. The semi-annual meetings are to review 6 months activities and adjust annual workplan based on results 2. WHO TA fees in 2018 and 2019 are included in within allocation budget. In 2020, even though it is expected that the program's capacity has been strengthened, TA from WHO will still be necessary to develop elimination strategies for 2021 - 2025 period.","Low","Low priority.","NA Original Intervention: Conduct semi - annual meetings. Maintain technical assistance from WHO in 2020 (Viet Nam)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4968","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","To conduct a study on the efficacy of IEC/BCC materials in order to improve the efficacy and targeting.",26000,null,"Inactive","a6Q1R000000AJHa",26000,0,0,0,0,1,null,null,"To conduct a study on the efficacy of IEC/BCC materials in order to improve the efficacy and targeting.","Low","Low priority.","NA Original Intervention: Evaluation of IEC/BCC (Lao PDR )","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4842","MCI-00023","Program management","MCI-00207","Grant management","PR Management Dashboard",90000,null,"Active","a6Q1R000000AJFY",0,0,0,0,90000,0,null,null,"PR Management Dashboard","Medium","The TRP assessed that this request as important but of medium priority as it would refer to activities not directly associated to direct interventions. This type of expenditure could be covered through efficiencies and other types of savings.","NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4841","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Capacity building for resource mobilization: Regional training on proposal development, grant accountability and identifying mechanisms for fund raising for CSOs and KP networks.",94300,null,"Active","a6Q1R000000AJFX",0,0,0,0,94300,0,null,null,"Capacity building for resource mobilization: Regional training on proposal development, grant accountability and identifying mechanisms for fund raising for CSOs and KP networks.","High",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4840","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Organize national and regional workshops to develop advocacy plans focused on removal of legal barriers to KP access to services.",40400,null,"Inactive","a6Q1R000000AJFW",40400,0,0,0,0,1,null,null,"Organize national and regional workshops to develop advocacy plans focused on removal of legal barriers to KP access to services.","High",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4839","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Development of a regional advocacy strategy and operational plan, including activities for advocacy for local partners towards transition to sustainable funding; Regional learning and planning for national level domestic resource mobilization advocacy plans to increase national governments? commitment for domestic financing of HIV programs for key populations.",155550,null,"Inactive","a6Q1R000000AJFV",155550,0,0,0,0,1,null,null,"Development of a regional advocacy strategy and operational plan, including activities for advocacy for local partners towards transition to sustainable funding; Regional learning and planning for national level domestic resource mobilization advocacy plans to increase national governments? commitment for domestic financing of HIV programs for key populations.","High",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4838","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","KP-led participatory assessment of legal, social, cultural and human-rights related barriers and current responses to equitable access and uptake of HIV services for key populations",108570,null,"Inactive","a6Q1R000000AJFU",108570,0,0,0,0,1,null,null,"KP-led participatory assessment of legal, social, cultural and human-rights related barriers and current responses to equitable access and uptake of HIV services for key populations","High",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4837","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Expand piloting of an electronic reporting system for violations of KP rights and occurrence of stigma and discrimination.",11000,null,"Inactive","a6Q1R000000AJFT",11000,0,0,0,0,1,null,null,"Expand piloting of an electronic reporting system for violations of KP rights and occurrence of stigma and discrimination.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4836","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Conduct a consultation for Jordanian CSOs that work on HIV to share good practice and innovations to improve current HIV programming and service delivery for  key populations",15000,null,"Inactive","a6Q1R000000AJFS",15000,0,0,0,0,1,null,null,"Conduct a consultation for Jordanian CSOs that work on HIV to share good practice and innovations to improve current HIV programming and service delivery for  key populations","Low",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4835","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Integrate the use of social networking apps into drop-in and outreach services to improve access and as a tool for monitoring and user-feedback on quality of services.",35000,null,"Active","a6Q1R000000AJFR",0,0,0,0,35000,0,null,null,"Integrate the use of social networking apps into drop-in and outreach services to improve access and as a tool for monitoring and user-feedback on quality of services.","Low",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Lesotho","Lesotho","PAI-4743","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Based on the observation study currently rolled out, increased monitoring and management of patients with adverse side effects is required. Furthermore, an opportunity for the decentralisation of MDR-TB services is presented with the use of all oral medications. To increase monitoring and management of patients with adverse side effects, and decentralise the MDR-TB services, the following gaps need to be addressed:\n? Two additional physicians to facilitate accurate diagnosis and follow up at district level as well training, mentorship and supervision of district teams. \n? Four registered nurses are needed for the intensive clinical care for those admitted and ambulatory patients. \n? To closely monitor, document and report as well as provide expert interventions to address the adverse effects. two pharmacy technicians and one pharmacist are needed \n\nThe key outcome of increasing the human resource capacity will be: \n? Increased community implementation and providing support and case management to remote districts. \n? Increased number of treatment initiation sites and strengthening treatment literacy. \n? Sustainability as the doctors (especially Basotho doctors for sustainability) at district level will be trained to build a team of experts who can continue the management or even the PMDT in a sustainable manner.\n\nThe use of all oral medications is an opportunity to further decentralize MDR services having removed the complicated aspect of treatment of administering the injectable. The very clinicians and nurses will serve as resource persons for the envisaged consillium aimed at providing remote support to districts as they manage the cases. It means that it will be feasible to increase initiation sites and treatment literacy strengthened through additional pharmacist and Pharmacy Technicians",560840,null,"Active","a6Q1R000000AJDx",0,0,0,0,560840,0,null,null,"Based on the observation study currently rolled out, increased monitoring and management of patients with adverse side effects is required. Furthermore, an opportunity for the decentralisation of MDR-TB services is presented with the use of all oral medications. To increase monitoring and management of patients with adverse side effects, and decentralise the MDR-TB services, the following gaps need to be addressed:\n? Two additional physicians to facilitate accurate diagnosis and follow up at district level as well training, mentorship and supervision of district teams. \n? Four registered nurses are needed for the intensive clinical care for those admitted and ambulatory patients. \n? To closely monitor, document and report as well as provide expert interventions to address the adverse effects. two pharmacy technicians and one pharmacist are needed \n\nThe key outcome of increasing the human resource capacity will be: \n? Increased community implementation and providing support and case management to remote districts. \n? Increased number of treatment initiation sites and strengthening treatment literacy. \n? Sustainability as the doctors (especially Basotho doctors for sustainability) at district level will be trained to build a team of experts who can continue the management or even the PMDT in a sustainable manner.\n\nThe use of all oral medications is an opportunity to further decentralize MDR services having removed the complicated aspect of treatment of administering the injectable. The very clinicians and nurses will serve as resource persons for the envisaged consillium aimed at providing remote support to districts as they manage the cases. It means that it will be feasible to increase initiation sites and treatment literacy strengthened through additional pharmacist and Pharmacy Technicians","High","For CCM/Disease Program consideration: HRH needs are high in Lesotho, decentralization of MDR TB treatment is also important. This is a suggestion to improve this intervention; the country does not have to respond to it.","In country optimization Original Module: RSSH: Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4742","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","The allocation under NFM2 is $3,838,505 and includes $2,444, 985.00 for SLD and procurement costs $420,059, and one monitoring test for TSH. Other services linked to supervision of patients, transport reimbursements, food packages, hygiene packages and programme administration costs is adequately covered under NFM2. To provide prompt and more effective management of MDR-TB the gap identified is as follows:\n? To assess the success of the all oral shorter regime as per the WHO 2018 Guidelines, operational research will be undertaken.\n? Additional monitoring tests will be undertaken with respect to Hepatis B antigens, haemoglobin A1C to monitor diabetic patients, two Electro- Cardio Gram machine (ECG), electrodes and paper.\n? Reagents are required to perform the first line and second line DST for all eligible patients",426262,null,"Active","a6Q1R000000AJDw",0,0,0,0,426262,0,null,null,"The allocation under NFM2 is $3,838,505 and includes $2,444, 985.00 for SLD and procurement costs $420,059, and one monitoring test for TSH. Other services linked to supervision of patients, transport reimbursements, food packages, hygiene packages and programme administration costs is adequately covered under NFM2. To provide prompt and more effective management of MDR-TB the gap identified is as follows:\n? To assess the success of the all oral shorter regime as per the WHO 2018 Guidelines, operational research will be undertaken.\n? Additional monitoring tests will be undertaken with respect to Hepatis B antigens, haemoglobin A1C to monitor diabetic patients, two Electro- Cardio Gram machine (ECG), electrodes and paper.\n? Reagents are required to perform the first line and second line DST for all eligible patients","High","For CCM/Disease Program consideration: Support needs for patients with MDR TB are high. Greater clarification of evaluation related to oral short-course regimen would be useful.","In country otpimization Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4741","MCI-00000","Prevention programs for general population","MCI-00074","Male circumcision","Programme data reported a national target of 311,335 men need to be circumcised of which 178,976 men have been medically circumcised. The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) 2017, reported that 30.7% of men between ages of 15-59 are still uncircumcised and 33.8% of HIV positive men between the ages 15-59 are uncircumcised. Furthermore, neonatal circumcisions taking place are minimal.  Although funding under NFM2 was received, the program was besieged by a number of challenges including limited funding under NFM2 to implement the program, high staff turn-over of MOH VMMC trained staff, poor understanding of VMMC by the district health management teams, absence of a core team dedicated for VMMC at the facilities and the suspension of incentives for staff to conduct VMMC. To mitigate these challenges, the GOL will adopt the model implemented by PEPFAR in the lowland districts which is reported to be successful with the uptake of VMMC. The annual target for VMMC is 50,000 which will be adequately covered for 2019/2020 by NFM2 (14,000) and PEPFAR (36,000). The gap identified is for 2020/2021 as PEPFAR will support 30,000 circumcisions leaving a gap of 20,000.  To address this gap following is proposed: \n? Health facility capacity  \no VMMC core team located at each of the 8 health facilities in the 5 districts, made up of 3 nurses and 1 counsellor and cleaner\no VMMC site assessments conducted at identified health facilities to ensure the minimum required standards for VMMC are met. \no Recruitment and training of new clinical staff and refresher courses for existing staff \no Recruitment and training of community health advocates including traditional chiefs, traditional initiators, councillors and religious leaders\n? Advocacy and Demand Creation \no Advocacy initiatives to be implemented with key stakeholders at national level, VMMC stakeholder: parliamentarians (HIV Cluster), government line ministries, NAC, Religious bodies and Civil Society Organisations for ownership \no Orientation of health facility staff (hospitals and health centres) on VMMC, communication skills, differentiated approaches to HTS and linkage to other services\no Mobilisation campaigns and sensitisation sessions in communities through door to door campaigns, school visits, meetings of traditional leaders, distribution of promotional packages to targeted community groups and at service delivery points \no Use of media platforms to promote VMMC \n? M&E and Research - For monitoring, evaluation and research and to manage the data, human resources will be required for VMMC administrative assistants and to conduct operational research",2800000,null,"Active","a6Q1R000000AJDv",0,0,0,0,2800000,0,null,null,"Programme data reported a national target of 311,335 men need to be circumcised of which 178,976 men have been medically circumcised. The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) 2017, reported that 30.7% of men between ages of 15-59 are still uncircumcised and 33.8% of HIV positive men between the ages 15-59 are uncircumcised. Furthermore, neonatal circumcisions taking place are minimal.  Although funding under NFM2 was received, the program was besieged by a number of challenges including limited funding under NFM2 to implement the program, high staff turn-over of MOH VMMC trained staff, poor understanding of VMMC by the district health management teams, absence of a core team dedicated for VMMC at the facilities and the suspension of incentives for staff to conduct VMMC. To mitigate these challenges, the GOL will adopt the model implemented by PEPFAR in the lowland districts which is reported to be successful with the uptake of VMMC. The annual target for VMMC is 50,000 which will be adequately covered for 2019/2020 by NFM2 (14,000) and PEPFAR (36,000). The gap identified is for 2020/2021 as PEPFAR will support 30,000 circumcisions leaving a gap of 20,000.  To address this gap following is proposed: \n? Health facility capacity  \no VMMC core team located at each of the 8 health facilities in the 5 districts, made up of 3 nurses and 1 counsellor and cleaner\no VMMC site assessments conducted at identified health facilities to ensure the minimum required standards for VMMC are met. \no Recruitment and training of new clinical staff and refresher courses for existing staff \no Recruitment and training of community health advocates including traditional chiefs, traditional initiators, councillors and religious leaders\n? Advocacy and Demand Creation \no Advocacy initiatives to be implemented with key stakeholders at national level, VMMC stakeholder: parliamentarians (HIV Cluster), government line ministries, NAC, Religious bodies and Civil Society Organisations for ownership \no Orientation of health facility staff (hospitals and health centres) on VMMC, communication skills, differentiated approaches to HTS and linkage to other services\no Mobilisation campaigns and sensitisation sessions in communities through door to door campaigns, school visits, meetings of traditional leaders, distribution of promotional packages to targeted community groups and at service delivery points \no Use of media platforms to promote VMMC \n? M&E and Research - For monitoring, evaluation and research and to manage the data, human resources will be required for VMMC administrative assistants and to conduct operational research","High","For CCM/Disease Program consideration: Recent epidemiology analyses suggest High transmission from uncircumcised men.  Program should ensure that proposed budget is rationalized and aligned to the target of 20,000 circumcisions to ensure value for money.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4740","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","The activities detailed below are for both MSM and FSWs\nMajority of HTS providers in both the Public and CSOs are not trained to provide Key population friendly health services. There is limited provision of HTS services to MSM/FSWs due to stigmatising and discriminating attitudes displayed by staff in health facilities.  The absence of key population user-friendly facilities has resulted in the low uptake of HTS and poor post-test referral and patient tracking systems. The NFM2 currently provides for the mobilisation of MSM/FSWs through the interpersonal communication curriculum (IPC) for the uptake of heath care services, in particular, HTS services as an entry point to the prevention and treatment services. Although MSM/FSWs reached with IPC are referred for HTS services to public health facilities, the linkage rate is very low due to the lack of KP friendly services in these facilities. To mitigate the low uptake of HIV services amongst MSM/FSW the following is proposed:\n\n? Training of peer educators as HTS Lay Counsellors at identified community facilities to provide onsite community testing and counselling, self-testing to MSM/FSW and link them to either PrEP or ART services \n? Training of Health Care Workers in health facilities to provide key population friendly services and create a welcoming environment at the facilities thus increasing confidence in MSM/FSWs to use such facilities; increased use of mobile clinics \n? Facilitate outreach campaigns to sensitise MSM/FSWs on new HTS approaches and mobilising MSM/FSW for testing in established health facilities and community based and or mobile facilities to enable access to comprehensive service package for MSM/FSW in a safe space \n? Facilitate Peer navigation through trained MSM/FSW Peer Educators to actively link those reached with IPC sessions to HTS and linkages to treatment services, further support on adherence to treatment \n? Use of health posts that are not utilised to provide MSM/FSW friendly services, for provision of HIV education, condom distribution, HTS, PrEP and ART initiation. \n? Sensitise Health Authorities to review and align health policies to standards that promote inclusivity and the right of every citizen to receiving medical services to enforce KP friendly services in service delivery points. \n? Promotion of HTS campaign strategy through multiple media platforms such as Facebook, print and electronic media to ensure effective reach to MSM/FSW and interactive engagement for motivation and uptake of health care services.",376919,null,"Active","a6Q1R000000AJDu",0,0,0,0,376919,0,null,null,"The activities detailed below are for both MSM and FSWs\nMajority of HTS providers in both the Public and CSOs are not trained to provide Key population friendly health services. There is limited provision of HTS services to MSM/FSWs due to stigmatising and discriminating attitudes displayed by staff in health facilities.  The absence of key population user-friendly facilities has resulted in the low uptake of HTS and poor post-test referral and patient tracking systems. The NFM2 currently provides for the mobilisation of MSM/FSWs through the interpersonal communication curriculum (IPC) for the uptake of heath care services, in particular, HTS services as an entry point to the prevention and treatment services. Although MSM/FSWs reached with IPC are referred for HTS services to public health facilities, the linkage rate is very low due to the lack of KP friendly services in these facilities. To mitigate the low uptake of HIV services amongst MSM/FSW the following is proposed:\n\n? Training of peer educators as HTS Lay Counsellors at identified community facilities to provide onsite community testing and counselling, self-testing to MSM/FSW and link them to either PrEP or ART services \n? Training of Health Care Workers in health facilities to provide key population friendly services and create a welcoming environment at the facilities thus increasing confidence in MSM/FSWs to use such facilities; increased use of mobile clinics \n? Facilitate outreach campaigns to sensitise MSM/FSWs on new HTS approaches and mobilising MSM/FSW for testing in established health facilities and community based and or mobile facilities to enable access to comprehensive service package for MSM/FSW in a safe space \n? Facilitate Peer navigation through trained MSM/FSW Peer Educators to actively link those reached with IPC sessions to HTS and linkages to treatment services, further support on adherence to treatment \n? Use of health posts that are not utilised to provide MSM/FSW friendly services, for provision of HIV education, condom distribution, HTS, PrEP and ART initiation. \n? Sensitise Health Authorities to review and align health policies to standards that promote inclusivity and the right of every citizen to receiving medical services to enforce KP friendly services in service delivery points. \n? Promotion of HTS campaign strategy through multiple media platforms such as Facebook, print and electronic media to ensure effective reach to MSM/FSW and interactive engagement for motivation and uptake of health care services.","High","Strengthened support to KP programming, a group with a very high HIV prevalence.","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4739","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","UNICEF. MOH, PACT and CHAI and funding received under NFM2 will be used to map the services for adolescents and young people and develop a service directory. The service directory will guide all implementers and mitigate against duplication of services. To enhance implementation and coordination of service delivery amongst implementing partners the following needs to be strengthened:\n? Documentation of a standardised and harmonised referral system to provide guidance for services to adolescents and young people\n? Induction of implementing partners on the utilisation of the harmonised referral system across the 8 districts\n? Facilitate coordination of quarterly meetings (in total 32 meetings annually) at district level to monitor implementation and outcomes of the harmonised referral system",25916,null,"Active","a6Q1R000000AJDt",0,0,0,0,25916,0,null,null,"UNICEF. MOH, PACT and CHAI and funding received under NFM2 will be used to map the services for adolescents and young people and develop a service directory. The service directory will guide all implementers and mitigate against duplication of services. To enhance implementation and coordination of service delivery amongst implementing partners the following needs to be strengthened:\n? Documentation of a standardised and harmonised referral system to provide guidance for services to adolescents and young people\n? Induction of implementing partners on the utilisation of the harmonised referral system across the 8 districts\n? Facilitate coordination of quarterly meetings (in total 32 meetings annually) at district level to monitor implementation and outcomes of the harmonised referral system","Medium","For CCM/Disease Program consideration: Improved service delivery mapping could be covered by existing resources. This is a suggestion to improve this intervention; the country does not have to respond to it.","NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4738","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","The Government of Lesotho has adopted differentiated care models to enhance adherence to ART. Different models have been piloted and implemented in Lesotho and the evidence demonstrates their effectiveness in ensuring that People Living with HIV, in particular young people can adhere to treatment when supported. The network/teen-clubs? model that supports treatment adherence for adolescents and young people have been implemented by both Baylor and Sentebale with positive results on the level of adherence and the improved viral load suppression. An assessment of this model implemented in Maseru, Mafeteng and Mohale's Hoek showed an increase in the number of adolescents and young people with good (95 to 105%) adherence to ART. The same study presented an increase in viral load suppression among the AGY enrolled in the adherence support program.\n\nCurrently USAID supports implementation of AGY adherence support in three (Maseru, Mafeteng and Mohale's Hoek) of the 10 districts. Although NFM2, provides adherence support in districts not supported by PEPFAR however, this support does not cover the comprehensive implementation of the intervention/model. A key intervention to increase ART adherence and viral load suppression AGY across the remaining districts is operationalising the network/teen-clubs?. The requirement in this regard includes: (i) provision of a stipend for the club facilitators, (ii) transport for the facilitators and children on ART to attend club session; (iii) meals and refreshments for the club sessions and (iv) procurement of art equipment and stationary for children participating in the adherence clubs. The key outcomes for this intervention will be increased adherence to treatment and viral load suppression among adolescents and young people",624379,null,"Active","a6Q1R000000AJDs",0,0,0,0,624379,0,null,null,"The Government of Lesotho has adopted differentiated care models to enhance adherence to ART. Different models have been piloted and implemented in Lesotho and the evidence demonstrates their effectiveness in ensuring that People Living with HIV, in particular young people can adhere to treatment when supported. The network/teen-clubs? model that supports treatment adherence for adolescents and young people have been implemented by both Baylor and Sentebale with positive results on the level of adherence and the improved viral load suppression. An assessment of this model implemented in Maseru, Mafeteng and Mohale's Hoek showed an increase in the number of adolescents and young people with good (95 to 105%) adherence to ART. The same study presented an increase in viral load suppression among the AGY enrolled in the adherence support program.\n\nCurrently USAID supports implementation of AGY adherence support in three (Maseru, Mafeteng and Mohale's Hoek) of the 10 districts. Although NFM2, provides adherence support in districts not supported by PEPFAR however, this support does not cover the comprehensive implementation of the intervention/model. A key intervention to increase ART adherence and viral load suppression AGY across the remaining districts is operationalising the network/teen-clubs?. The requirement in this regard includes: (i) provision of a stipend for the club facilitators, (ii) transport for the facilitators and children on ART to attend club session; (iii) meals and refreshments for the club sessions and (iv) procurement of art equipment and stationary for children participating in the adherence clubs. The key outcomes for this intervention will be increased adherence to treatment and viral load suppression among adolescents and young people","High","Support for viral load suppression needed in children.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5855","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","During 2018-2020 Global fund grant application only 7201996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44% of the blood recipients to be at risk of infections through blood transfusion.",5769918,null,"Active","a6Q1R000000AJVt",0,0,0,0,5769918,0,null,null,"During 2018-2020 Global fund grant application only 7201996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44% of the blood recipients to be at risk of infections through blood transfusion.","High","Under the current application only 7,201,996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44 percent of the blood recipients are at risk of infections through blood transfusion","NA Original Intervention: Scale up availability and accessibility of safe blood to patients in need of blood transfusion therapy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5854","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00599","National product selection, registration and quality monitoring","This intervention will complement the Global Fund investment but is an upstream investment.",2341931,null,"Active","a6Q1R000000AJVs",0,0,0,0,2341931,0,null,null,"This intervention will complement the Global Fund investment but is an upstream investment.","Medium","This intervention will complement the Global Fund investment but is an upstream investment","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 2","2020-12-31","RSSH"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5853","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","This intervention will complement Global Fund investment.",6514356,null,"Active","a6Q1R000000AJVr",0,0,0,0,6514356,0,null,null,"This intervention will complement Global Fund investment.","Medium","This intervention will complement Global Fund investment","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 2","2020-12-31","RSSH"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5852","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00177","Other health and community workforce intervention(s)","The intervention is aimed at supporting the provision of additional essential health workers for the delivery of CEmONC serives and services for AIDS, Tuberculosis and Malaria in a setting of severe human resource shortages.",3402374,null,"Active","a6Q1R000000AJVq",0,0,0,0,3402374,0,null,null,"The intervention is aimed at supporting the provision of additional essential health workers for the delivery of CEmONC serives and services for AIDS, Tuberculosis and Malaria in a setting of severe human resource shortages.","High","The intervention is aimed at supporting the provision of additional essential health workers for the delivery of CEmONC serives and services for AIDS, Tuberculosis and Malaria in a setting of severe human resource shortages","NA Original Module: RSSH - Human resources for health, including community health workers. Original Intervention: Retention and scale up of health workers including CHWs: Specialized training for medical specialists, Health workers","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 2","2020-12-31","RSSH"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5851","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","The intervention includes essential inputs to improve the functionality of the local health system.",12886522,null,"Active","a6Q1R000000AJVp",6419820,0,0,0,6466702,0,null,null,"The intervention includes essential inputs to improve the functionality of the local health system.","High","he intervention includes essential inputs to improve the functionality of the local health system.","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Improved efficiency of service delivery including referral: Renovation and upgrading of infrastructure for comprehensive emergency obstetric and newborn care (CEmONC), basic emergency obstetric and newborn care (BEmONC) and MDR TB treatment; Procurement of digital X-ray for 24 District hospitals","Shalini Mitra","2019-10-30","2017-2019","RSSH"," High Impact Africa 2","2020-12-31","RSSH"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5850","MCI-00012","Case management","MCI-00154","Facility-based treatment","This fund is requested to continue funding distance learning on integrated management of childhood diseases. Value added for this activity at this relatively high cost is not sufficiently justified to be considered high priority.",2034750,null,"Active","a6Q1R000000AJVo",0,0,0,0,2034750,0,null,null,"This fund is requested to continue funding distance learning on integrated management of childhood diseases. Value added for this activity at this relatively high cost is not sufficiently justified to be considered high priority.","Medium","This fund is requested to continue funding distance learning on integrated management of childhood diseases. Value added for this activity at this relatively high cost is not sufficiently justified to be considered high priority",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria, RSSH"," High Impact Africa 2",null,"Multi-component"]
["CT Thailand","Thailand","PAI-5763","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00571","Prevention and management of coinfections and co-morbidities for people in prisons and other closed settings","DDC BL 365Technical support for Prevention program of PWID in Prison in 36 provinces.",171126,null,"Inactive","a6Q1R000000AJUP",171126,0,0,0,0,1,null,null,"DDC BL 365Technical support for Prevention program of PWID in Prison in 36 provinces.","High","This intervention will provide technical support for prevention programming for people who inject drugs in prison in 36 provinces","NA Original Intervention: Prevention and management of co-infections and co-morbidities for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5762","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00569","HIV testing services for people in prisons and other closed settings","DDC BL 359HIV testing services for Prisoner by using oral fluidHIV testing  for Prisoner is set 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.",355100,null,"Inactive","a6Q1R000000AJUO",355100,0,0,0,0,1,null,null,"DDC BL 359HIV testing services for Prisoner by using oral fluidHIV testing  for Prisoner is set 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.","High","This intervention will support HIV oral fluid testing services for prisoners in order to reach 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5761","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00563","Community empowerment for people in prisons and other closed settings","DDC BL 358TB-HIV in PrisonsTelemedicine to improve and follow up patient' s clinical from hospital to prison in order to improve TB, HIV, IPT and OST service in 5 prisons in each year.",63270,null,"Active","a6Q1R000000AJUN",0,0,0,0,63270,0,null,null,"DDC BL 358TB-HIV in PrisonsTelemedicine to improve and follow up patient' s clinical from hospital to prison in order to improve TB, HIV, IPT and OST service in 5 prisons in each year.","High","This intervention will support the use of telemedicine to improve and follow up on a patient?s clinical status from hospital to prison in order to improve TB, HIV, IPT and OST service in 5 prisons in each year.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5760","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","DDC BL 374:XDR-TB drug procuring for XDR-TB patients;Y1,2018 = 10 casesY2,2019 = 15 casesY3,2020 = 20 cases.This request will be support for the expansion of XDR-TB treatment by the national TB program. NTP will be expanding diagnosis capacity in 12 ODPCs that will increase number of XDR detection. BTB will put more investment on treatment of those increasing but it may not reach the same diagnosis XDR-TB cases which expected to be 58, 70  and 82 cases in 2018, 2019, 2020 respectively.",174960,null,"Inactive","a6Q1R000000AJUM",174960,0,0,0,0,1,null,null,"DDC BL 374:XDR-TB drug procuring for XDR-TB patients;Y1,2018 = 10 casesY2,2019 = 15 casesY3,2020 = 20 cases.This request will be support for the expansion of XDR-TB treatment by the national TB program. NTP will be expanding diagnosis capacity in 12 ODPCs that will increase number of XDR detection. BTB will put more investment on treatment of those increasing but it may not reach the same diagnosis XDR-TB cases which expected to be 58, 70  and 82 cases in 2018, 2019, 2020 respectively.","High","This intervention will support treatment for 45 XDR patients to complement domestic resources. The TRP recommends that this activity be funded under the within allocation should efficiencies be found.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5759","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","DDC BL 274:IPT service fee for Data recorder 400 Baht per time, 4 times per month for 27 hospitals, 54 hospitals and 108 hospitals in 2018, 2019 and 2020 respectively.",102956,null,"Active","a6Q1R000000AJUL",0,0,0,0,102956,0,null,null,"DDC BL 274:IPT service fee for Data recorder 400 Baht per time, 4 times per month for 27 hospitals, 54 hospitals and 108 hospitals in 2018, 2019 and 2020 respectively.","High","This intervention supports isoniazid preventive therapy (IPT) data recording service in hospitals","NA Original Intervention: Key populations (TB/HIV) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5758","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","RTF BL 18Platform for policy dialogue and campaign at sub-national level. Meeting PWID, local governmentagencies related to HR Units/Participants: 50 person per day.",36884,null,"Active","a6Q1R000000AJUK",0,0,0,0,36884,0,null,null,"RTF BL 18Platform for policy dialogue and campaign at sub-national level. Meeting PWID, local governmentagencies related to HR Units/Participants: 50 person per day.","High","Sensitization of law makers and law enforcement agents will complement the stigma and discrimination reduction and human rights awareness efforts. This intervention will support the organization of a workshop on advocacy and policy to lobby for community leaders and authorities in the community to establish good practices and drive policy changes in favor of key populations.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5757","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00586","HIV and HIV/TB-related legal services","RTF BL 17Meeting on legal services related HIV-TB. Meeting police, MOI, CSO Units/Participants: 37 person per day.",30235,null,"Active","a6Q1R000000AJUJ",0,0,0,0,30235,0,null,null,"RTF BL 17Meeting on legal services related HIV-TB. Meeting police, MOI, CSO Units/Participants: 37 person per day.","High","Sensitization of law makers and law enforcement agents will complement the stigma and discrimination reduction and human rights awareness efforts. This intervention will support the organization of a meeting on legal services related HIV -TB with police, the Ministry of Interior and CSOs. To ensure the ongoing efforts, meetings on legal services related to HIV/TB will be held regularly",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6116","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00564","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",76500,null,"Active","a6Q1R000000AJa6",0,0,0,0,76500,0,null,null,"Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","High","Prisoners are identified as an important KP group and a comprehensive program exists targeting this KPs",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6114","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00563","Community empowerment for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",184701,null,"Active","a6Q1R000000AJa4",0,0,0,0,184701,0,null,null,"Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","High","Prisoners are identified as an important Key Population (KP) group and a comprehensive program exists targeting this KPs",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6113","MCI-00019","RSSH: Financial management systems","MCI-00188","Other financial management intervention(s)","Additional scale up through extended outreach from fixed and mobile sites.",3446640,null,"Active","a6Q1R000000AJa3",0,0,0,0,3446640,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Global Fund Additional Safeguards regarding financial accountability applies in Zimbabwe","NA Original Module: RSSH - Financial management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6112","MCI-00019","RSSH: Financial management systems","MCI-00603","Routine financial management improvement (non-PFM)","Additional scale up through extended outreach from fixed and mobile sites.",929559,null,"Active","a6Q1R000000AJa2",0,0,0,0,929559,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Global Fund Additional Safeguards regarding financial accountability applies in Zimbabwe","NA Original Module: RSSH - Financial management systems. Original Intervention: Routine financial management improvement (non-public financial management)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6111","MCI-00019","RSSH: Financial management systems","MCI-00187","Public financial management (PFM) strengthening","Additional scale up through extended outreach from fixed and mobile sites.",254910,null,"Active","a6Q1R000000AJa1",0,0,0,0,254910,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Global Fund Additional Safeguards regarding financial accountability applies in Zimbabwe","NA Original Module: RSSH - Financial management systems. Original Intervention: Public financial management strengthening","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6110","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).",3132000,null,"Active","a6Q1R000000AJa0",0,0,0,0,3132000,0,null,null,"Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).","High","Support for the expanded CCS framework is needed to broaden access and CHW workload","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT South Africa","South Africa","PAI-5999","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","PAAR request will support in reaching 4,535 AGYW with in-patient alcohol and drug treatment programs, based on an estimated demand among young people for these services. Studies show that demand for alcohol and drug treatment programs in South Africa is approximately 16,986 individuals, of whom 26.7% are young people below the age of 22 years (Peltzer et al., 2011). The 2017 HSRC survey found the use of recreational drugs and excessive alcohol use were factors negatively associated with SBCC exposure (pg. xxxvii). Funding of this intervention in the PAAR is therefore expected to enhance the impact of the peer education and CSE activities in the allocation request.",9423892,null,"Active","a6Q1R000000AJYD",0,0,0,0,9423892,0,null,null,"PAAR request will support in reaching 4,535 AGYW with in-patient alcohol and drug treatment programs, based on an estimated demand among young people for these services. Studies show that demand for alcohol and drug treatment programs in South Africa is approximately 16,986 individuals, of whom 26.7% are young people below the age of 22 years (Peltzer et al., 2011). The 2017 HSRC survey found the use of recreational drugs and excessive alcohol use were factors negatively associated with SBCC exposure (pg. xxxvii). Funding of this intervention in the PAAR is therefore expected to enhance the impact of the peer education and CSE activities in the allocation request.","Medium",null,"NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-5998","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","PAAR funding will support provision of an additional 825,000 Xpert tests in the six priority TB districts. Several cross-sectional studies have reported a high yield of a universal TB testing strategy; one which tests everyone irrespective of the presence of TB symptoms. Examples of populations in whom targeted universal testing has been implemented are: adults admitted to hospital, HIV-infected pregnant women, household contacts of a TB patient. A cluster randomized study is about to commence to test this strategy in South African. If results of this study support this intervention; funding is requested for targeted universal testing for TB (TUTT) for PLHIV, pregnant women and TB household contacts.",13290140,null,"Active","a6Q1R000000AJYC",0,0,0,0,13290140,0,null,null,"PAAR funding will support provision of an additional 825,000 Xpert tests in the six priority TB districts. Several cross-sectional studies have reported a high yield of a universal TB testing strategy; one which tests everyone irrespective of the presence of TB symptoms. Examples of populations in whom targeted universal testing has been implemented are: adults admitted to hospital, HIV-infected pregnant women, household contacts of a TB patient. A cluster randomized study is about to commence to test this strategy in South African. If results of this study support this intervention; funding is requested for targeted universal testing for TB (TUTT) for PLHIV, pregnant women and TB household contacts.","Low","The TRP considers this request to be low priority, as a significant number of GeneXpert tests are already available through existing resources. Expanding universal coverage to GeneXpert testing can be coordinated through the available resources.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-5997","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Funding will support in providing child care for children of sex workers, by supporting 26 entry-level child and youth care workers (R3,500/month), 2 per sex worker district. Children of sex workers have been identified as an area of need. FSW in South Africa are responsible for four child or adult dependents (on average), while MSW and TGSW are responsible for two.  A research study on the basic demographics, living arrangements, risk factors and supervision is underway in the current grant, with findings anticipated in February 2019. Allocation funding will support defining and providing parenting programs suitable for sex workers who have children living with them. The PAAR request to provide direct childcare services for children who live at home with sex workers will be a value add to the parenting programs prioritized in the allocation request.",1210436,null,"Active","a6Q1R000000AJYB",0,0,0,0,1210436,0,null,null,"Funding will support in providing child care for children of sex workers, by supporting 26 entry-level child and youth care workers (R3,500/month), 2 per sex worker district. Children of sex workers have been identified as an area of need. FSW in South Africa are responsible for four child or adult dependents (on average), while MSW and TGSW are responsible for two.  A research study on the basic demographics, living arrangements, risk factors and supervision is underway in the current grant, with findings anticipated in February 2019. Allocation funding will support defining and providing parenting programs suitable for sex workers who have children living with them. The PAAR request to provide direct childcare services for children who live at home with sex workers will be a value add to the parenting programs prioritized in the allocation request.","Medium",null,"NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-5996","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00098","OST and other drug dependence treatment for PWID","Funding will support in placing an additional 500 drug users on OST. With the allocation amount, 300 people will be placed on OST by year three of the grant. If PAAR is granted, OST coverage will increase from 4% of PWID reached, to 10%. Note: This PAAR request is only for the OST procurement, since human resources for OST and site costs are provided for in the allocation request.",2602628,null,"Active","a6Q1R000000AJYA",0,0,0,0,2602628,0,null,null,"Funding will support in placing an additional 500 drug users on OST. With the allocation amount, 300 people will be placed on OST by year three of the grant. If PAAR is granted, OST coverage will increase from 4% of PWID reached, to 10%. Note: This PAAR request is only for the OST procurement, since human resources for OST and site costs are provided for in the allocation request.","High",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-5995","MCI-00008","TB care and prevention","MCI-00127","Treatment","This PAAR investment will support innovative TB treatment adherence models, including mHealth app development, adherence supporters, and medication devices. 40% of coverage is requested in the allocation budget for DR-TB adherence support. Another 60% is requested in PAAR for DS-TB adherence to ensure that the missing patients found with Global Fund and increased national efforts are supported to complete TB treatment to limit transmission, TB relapse and the development of resistance. There is an international move away from Directly Observed Treatment (DOT) towards more patient-centred adherence support which is modified to patient's need.",4999175,null,"Active","a6Q1R000000AJY9",0,0,0,0,4999175,0,null,null,"This PAAR investment will support innovative TB treatment adherence models, including mHealth app development, adherence supporters, and medication devices. 40% of coverage is requested in the allocation budget for DR-TB adherence support. Another 60% is requested in PAAR for DS-TB adherence to ensure that the missing patients found with Global Fund and increased national efforts are supported to complete TB treatment to limit transmission, TB relapse and the development of resistance. There is an international move away from Directly Observed Treatment (DOT) towards more patient-centred adherence support which is modified to patient's need.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT South Africa","South Africa","PAI-5994","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00545","Pre-exposure prophylaxis (PrEP) for sex workers","According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for sex workers is 95%. For the Global Fund program, this equates to 19,192 sex workers. 3,439 sex workers will be given PrEP through the allocation funding. PAAR funding will fill the gap between the allocation and optimal coverage, providing an additional 15,753 sex workers with PrEP. This will be paired with an intensive and targeted knowledge campaign to increase demand for PrEP among sex workers. PAAR will increase PrEP coverage in the target districts from 17% to 95%, and decrease the national programmatic gap for AGYW PrEP by 32% (from 49,420 to 33,667).",4013576,null,"Active","a6Q1R000000AJY8",0,0,0,0,4013576,0,null,null,"According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for sex workers is 95%. For the Global Fund program, this equates to 19,192 sex workers. 3,439 sex workers will be given PrEP through the allocation funding. PAAR funding will fill the gap between the allocation and optimal coverage, providing an additional 15,753 sex workers with PrEP. This will be paired with an intensive and targeted knowledge campaign to increase demand for PrEP among sex workers. PAAR will increase PrEP coverage in the target districts from 17% to 95%, and decrease the national programmatic gap for AGYW PrEP by 32% (from 49,420 to 33,667).","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5690","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Conduct regular coordination and review meetings at community level by all service providers.",50000,null,"Active","a6Q1R000000AJTE",0,0,0,0,50000,0,null,null,"Conduct regular coordination and review meetings at community level by all service providers.","Medium","Coordination meetings at local level to strengthen the responsiveness to the needs of the local health environment.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5689","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","Procure syphilis test kits to cover 50% of the country need. This builds on the 50% which is contained in the allocation amount.",81800,null,"Inactive","a6Q1R000000AJTD",81800,0,0,0,0,1,null,null,"Procure syphilis test kits to cover 50% of the country need. This builds on the 50% which is contained in the allocation amount.","High","Syphilis testing and treatment is an important intervention to improve outcomes for affected children. This additional allocation will stretch coverage from 50% to a 100%.","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5688","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Scale up advocacy for youth friendly ASRHR services especially targeting adolescent & young girls.",20000,null,"Active","a6Q1R000000AJTC",0,0,0,0,20000,0,null,null,"Scale up advocacy for youth friendly ASRHR services especially targeting adolescent & young girls.","Medium","Advocacy for youth friendly health services.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5687","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Printing of TB registers to complement the commitment from partners (PEPFAR/CDC) to support the program with this activity.",128000,null,"Active","a6Q1R000000AJTB",0,0,0,0,128000,0,null,null,"Printing of TB registers to complement the commitment from partners (PEPFAR/CDC) to support the program with this activity.","Medium","The funding request mentions additional funding and support from other partners such as the CDC in order to pursue and support this activity; therefore it is viewed as medium priority for this disbursement.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5686","MCI-00010","MDR-TB","MCI-00144","Community MDR-TB care delivery","Strengthen ambulatory/community MDR-TB care and establish four regional sprinter ambulance costs. The ambulance will include a bed, oxygen cylinder, tubes, masks, stretcher, endotrachial tubes, IVs, cardio resuscitation, drug cabinets, fire extinguisher.",540000,null,"Active","a6Q1R000000AJTA",0,0,0,0,540000,0,null,null,"Strengthen ambulatory/community MDR-TB care and establish four regional sprinter ambulance costs. The ambulance will include a bed, oxygen cylinder, tubes, masks, stretcher, endotrachial tubes, IVs, cardio resuscitation, drug cabinets, fire extinguisher.","Medium","Four regional sprinter ambulance costs would be beneficial, but it is not considered a high priority activity comparing to other interventions","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5685","MCI-00008","TB care and prevention","MCI-00127","Treatment","Funding is requested to support Swaziland?s TB hospital to become a center of excellence. Specifically, funding will support a benchmarking exercise with Kimberly Hospital (Cape Town in South Africa), curriculum development  and workshops for in-country and international trainings, partitioning and extending the mechanical ventilation to operationalize the dialysis machine), and technical assistance to ensure the certification of the hospital as center of excellence.",30000,null,"Active","a6Q1R000000AJT9",0,0,0,0,30000,0,null,null,"Funding is requested to support Swaziland?s TB hospital to become a center of excellence. Specifically, funding will support a benchmarking exercise with Kimberly Hospital (Cape Town in South Africa), curriculum development  and workshops for in-country and international trainings, partitioning and extending the mechanical ventilation to operationalize the dialysis machine), and technical assistance to ensure the certification of the hospital as center of excellence.","Medium","It would be beneficial to establish a Centre of excellence in Swaziland, but this is not considered as a high priority comparing to other interventions.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5684","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","Additional ready-to-use supplementary nutrition for TB/HIV co-infected patients. This will expand the criteria beyond the allocation (which only focuses on co-infected patients with BMI of 18.5 or lower. Evidence in Swaziland suggests that there is need for nutritional support even for those who are not extremely malnourished.",1501934,null,"Active","a6Q1R000000AJT8",0,0,0,0,1501934,0,null,null,"Additional ready-to-use supplementary nutrition for TB/HIV co-infected patients. This will expand the criteria beyond the allocation (which only focuses on co-infected patients with BMI of 18.5 or lower. Evidence in Swaziland suggests that there is need for nutritional support even for those who are not extremely malnourished.","Medium","Supplementary nutrition is important but not a high priority.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Somalia","Somalia","PAI-5587","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence.",270000,null,"Active","a6Q1R000000AJRZ",193876,0,0,0,76124,0,null,null,"Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence.","High","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of people living with HIV and their families and affects treatment adherence. Proposed to be included in a Community Based Stigma Reduction Package at line 2 above .",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5586","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. Campaigns to normalize HIV and improve knowledge about HIV treatment are important to reduce stigma.",63306,null,"Active","a6Q1R000000AJRY",0,0,0,0,63306,0,null,null,"Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. Campaigns to normalize HIV and improve knowledge about HIV treatment are important to reduce stigma.","High","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of people living with HIV and their families and affects treatment adherence. Campaigns to normalize HIV and improve knowledge about HIV treatment are important interventions to reduce stigma.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5585","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Support the mid term review of the 2017 to 2021 HSSPs.",142240,null,"Active","a6Q1R000000AJRX",0,0,0,0,142240,0,null,null,"Support the mid term review of the 2017 to 2021 HSSPs.","Medium","Support the mid-term review of the 2017 to 2021 HSSPs.","NA Original Module: RSSH - National health strategies. Original Intervention: Mid-term review of the Health Sector Strategic Plan","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5584","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Improve the collection and dissemination of strategic information, to better inform program planning and review.",73620,null,"Active","a6Q1R000000AJRW",0,0,0,0,73620,0,null,null,"Improve the collection and dissemination of strategic information, to better inform program planning and review.","Medium","Improve the collection and dissemination of strategic information, to better inform program planning and review.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Strategic information planning and capacity building","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5583","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To implement hospital Data Assistants to improve hospital based data collection and reporting. One per region.",463600,null,"Active","a6Q1R000000AJRV",0,0,0,0,463600,0,null,null,"To implement hospital Data Assistants to improve hospital based data collection and reporting. One per region.","Medium","To implement hospital Data Assistants to improve hospital based data collection and reporting. One per region.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Strengthen hospital data collection and quality assurance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5582","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.",119520,null,"Active","a6Q1R000000AJRU",0,0,0,0,119520,0,null,null,"Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.","Medium","Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Supply Chain Working Group","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5581","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. Working with decision-makers to educate them on HIV/AIDS is important to change norms around HIV-related stigma.",110700,null,"Active","a6Q1R000000AJRT",0,0,0,0,110700,0,null,null,"Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. Working with decision-makers to educate them on HIV/AIDS is important to change norms around HIV-related stigma.","High","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of people living with HIV and their families and affects treatment adherence. Working with decision-makers to educate them on HIV/AIDS is an important intervention in changing norms around HIV - related stigma.","NA Original Intervention: Sensitization of lawmakers and law enforcement agents","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Paraguay","Paraguay","PAI-5449","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Analysis, review and disclosure.\nThe considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required the monitor the grant, which is why these financial resources are required to comply with this duty with the required technical accuracy.",98262,null,"Active","a6Q1R000000AJPL",0,93833,0,0,4429,0,null,null,"Analysis, review and disclosure.\nThe considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required the monitor the grant, which is why these financial resources are required to comply with this duty with the required technical accuracy.","Low",null,"NA Original Module: SRSS: Health information systems and monitoring and evaluation. Original Intervention: Analysis, review and disclosure","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5448","MCI-00023","Program management","MCI-00207","Grant management","Grant management. \nThe considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required at the main receiver, which is why these financial resources are required to retain most of the staff currently comprising the working team.",147392.84,null,"Active","a6Q1R000000AJPK",0,0,0,0,147392.84,0,null,null,"Grant management. \nThe considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required at the main receiver, which is why these financial resources are required to retain most of the staff currently comprising the working team.","Low","Budget for grant management is also included within the allocation funding request. The proportion of the allocation budget committed to program management could increase following the reclassification of budget-line categories during grant making ? and depending on this, the Secretariat may reprioritize this additional request, as needed.","NA Original Module: SRSS: Program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5447","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Expansion of laboratory network with rapid molecular diagnostic devices and consumables.\nAcquisition of 3 rapid molecular diagnosis devices and consumables is deemed necessary, by means of this grant, for districts with a high load of TB cases. It should be noted that for universal diagnosis approximately 35 devices will be required across the country, and in order for this to be effective, the State must acquire them gradually.\nIn accordance with the indications of the Global Laboratory Initiative (GLI), this test must be used in place of conventional microscopy and cultures for initial diagnostic testing in all adults and children with suspected pulmonary tuberculosis. Chiefly, for initial diagnosis for adults and children with suspected MDR tuberculosis or HIV / TB (GLI Practical Guide to TB Laboratory Strengthening - March 2017)\nThis is aimed at universal diagnosis of TB in districts with this technology.",93832.7,null,"Active","a6Q1R000000AJPJ",0,0,0,0,93832.7,0,null,null,"Expansion of laboratory network with rapid molecular diagnostic devices and consumables.\nAcquisition of 3 rapid molecular diagnosis devices and consumables is deemed necessary, by means of this grant, for districts with a high load of TB cases. It should be noted that for universal diagnosis approximately 35 devices will be required across the country, and in order for this to be effective, the State must acquire them gradually.\nIn accordance with the indications of the Global Laboratory Initiative (GLI), this test must be used in place of conventional microscopy and cultures for initial diagnostic testing in all adults and children with suspected pulmonary tuberculosis. Chiefly, for initial diagnosis for adults and children with suspected MDR tuberculosis or HIV / TB (GLI Practical Guide to TB Laboratory Strengthening - March 2017)\nThis is aimed at universal diagnosis of TB in districts with this technology.","High",null,"NA Original Module: SRSS: Provision of integrated services and quality improvement. Original Intervention: Laboratory systems for disease prevention, monitoring, treatment and surveillance","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2021-12-31","Tuberculosis"]
["CT Paraguay","Paraguay","PAI-5446","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Acquisition of portable viral load and CD4 equipment in the community Voluntary Counceling and Testing Center. These teams will facilitate the follow-up of people diagnosed in the community viral loadT as part of the strategy to improve access to comprehensive care. The implementation of the community Voluntary Counceling and Testing Center complements the provision of testing services and the monitoring of reactive persons, since it works in extended hours and facilitates access to people of the target population who do not want or are not able go to the public services of MSPyBS.",32624,null,"Active","a6Q1R000000AJPI",0,0,0,0,32624,0,null,null,"Acquisition of portable viral load and CD4 equipment in the community Voluntary Counceling and Testing Center. These teams will facilitate the follow-up of people diagnosed in the community viral loadT as part of the strategy to improve access to comprehensive care. The implementation of the community Voluntary Counceling and Testing Center complements the provision of testing services and the monitoring of reactive persons, since it works in extended hours and facilitates access to people of the target population who do not want or are not able go to the public services of MSPyBS.","High","The requested equipment is necessary to ensure proper treatment monitoring thus it is recommended as high priority. However, the TRP requests the applicant to clarify how many units of the requested equipment; and the allocation be based on the anticipated use rate of the equipment",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-02-28","HIV/AIDS"]
["CT Paraguay","Paraguay","PAI-5445","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Recruitment of consultancy to carry out the Study of People that continue to 12, 24, 36, 60 months of initiation of therapy, with a new cohort for 2012, and 12 months of initiation of therapy for the cohort of 2014, 2015 and 2016. At the request of UNAIDS, it is necessary to modify the cohorts of people who annually initiate treatment with ARV, in order to adapt them to the annual fiscal cut. Currently, the cohorts begin on August 1 of the year and close on July 31 of the following year. As of 2016, PRONASIDA has decided to report fiscal year cohorts; therefore, with this consultancy we could have information of 24, 36 and 60 months that can be compared with the new cohorts. Having this information will inform the country the state of adherence to ART over time in the different annual cohorts.",3000,null,"Active","a6Q1R000000AJPH",0,0,0,0,3000,0,null,null,"Recruitment of consultancy to carry out the Study of People that continue to 12, 24, 36, 60 months of initiation of therapy, with a new cohort for 2012, and 12 months of initiation of therapy for the cohort of 2014, 2015 and 2016. At the request of UNAIDS, it is necessary to modify the cohorts of people who annually initiate treatment with ARV, in order to adapt them to the annual fiscal cut. Currently, the cohorts begin on August 1 of the year and close on July 31 of the following year. As of 2016, PRONASIDA has decided to report fiscal year cohorts; therefore, with this consultancy we could have information of 24, 36 and 60 months that can be compared with the new cohorts. Having this information will inform the country the state of adherence to ART over time in the different annual cohorts.","High","ART adherence monitoring is relevant for HIV treatment effectiveness. Noting the connection between this item and the next one, the TRP suggests the applicant combine the consultancy with shift cohort tracking below to ensure consistency, compatibility of data/ information/ methodology and prioritize M&E for this activity.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-02-28","HIV/AIDS"]
["CT Paraguay","Paraguay","PAI-5444","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Cohort study of the evolution of the response to ART in Paraguay. This study, to be carried out for the first time in the country will allow monitoring of a cohort from 2018 to 2020 to evaluate the durability of viral load suppression, factors of adherence (and non-adherence), OI frequency and the toxicity of ART. The information gathered aims to identify the different factors that affect PLWHIV during treatment and affect adherence and the corresponding Viral suppression. It is also intended to have relevant information to make decisions about the prioritization of treatment schemes and other actions that facilitate adherence to treatment. Finally, the information could also imply an update in the treatment protocols. This information will be very useful for monitoring the fourth, fifth and sixth pillar of the waterfall.",36000,null,"Active","a6Q1R000000AJPG",0,0,0,0,36000,0,null,null,"Cohort study of the evolution of the response to ART in Paraguay. This study, to be carried out for the first time in the country will allow monitoring of a cohort from 2018 to 2020 to evaluate the durability of viral load suppression, factors of adherence (and non-adherence), OI frequency and the toxicity of ART. The information gathered aims to identify the different factors that affect PLWHIV during treatment and affect adherence and the corresponding Viral suppression. It is also intended to have relevant information to make decisions about the prioritization of treatment schemes and other actions that facilitate adherence to treatment. Finally, the information could also imply an update in the treatment protocols. This information will be very useful for monitoring the fourth, fifth and sixth pillar of the waterfall.","High","ART adherence monitoring is relevant for HIV treatment effectiveness. Noting the connection between this item and the next one, the TRP suggests the applicant combine the consultancy with shift cohort tracking below to ensure consistency, compatibility of data/information/ 4 methodology and prioritize M&E for this activity","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-02-28","HIV/AIDS"]
["CT Pakistan","Pakistan","PAI-5354","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","WHO technical assistance is continuously required for supporting the provincial malaria control programs. The NPOs will be based in WHO provincial sub-offices and will provide technical guidance and support to the provincial government in minimizing the public health impact resulting from epidemics of communicable diseases mainly malaria, HIV/AIDS and TB.",200000,null,"Active","a6Q1R000000AJNo",0,0,0,0,200000,0,null,null,"WHO technical assistance is continuously required for supporting the provincial malaria control programs. The NPOs will be based in WHO provincial sub-offices and will provide technical guidance and support to the provincial government in minimizing the public health impact resulting from epidemics of communicable diseases mainly malaria, HIV/AIDS and TB.","Low","This funding request is to support the technical\nassistance provided by WHO at the provincial level. A 25% of the original request is being recommended for PAAR.","NA Original Intervention: Provincial NPOs ? WHO","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Pakistan","Pakistan","PAI-5353","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Current National Malaria Strategic Plan was developed in 2014 for 2015-2020, guided by the MPR led by WHO. National and provincial strategic plans need to be updated to align with GTS 2016 ? 2030. Findings from malaria programmatic review in 2018 and malaria prevalence survey would guide for strategizing interventions (quality case management, prompt and effective treatment, selective vector control, scaling up of treated LLINs use and epidemic preparedness, detection and response) according to disease endemicity.",100000,null,"Active","a6Q1R000000AJNn",0,0,0,0,100000,0,null,null,"Current National Malaria Strategic Plan was developed in 2014 for 2015-2020, guided by the MPR led by WHO. National and provincial strategic plans need to be updated to align with GTS 2016 ? 2030. Findings from malaria programmatic review in 2018 and malaria prevalence survey would guide for strategizing interventions (quality case management, prompt and effective treatment, selective vector control, scaling up of treated LLINs use and epidemic preparedness, detection and response) according to disease endemicity.","Medium","This additional support will helpto develop new national and\nprovincial plans for the 2021-2025 and their alignment with\nthe Global Technical Strategy 2016-2030.","NA Original Intervention: Updating national and provincial strategic plans for (2021-2025)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Pakistan","Pakistan","PAI-5352","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","MPR objectives are to review in 2018 the malaria program structure and capacity in each province and at national level, identify challenges and have the epidemiological outlook of malaria per province. Furthermore, this will assess current program performance and help redefine strategic direction, including revision of policies and strategic plans at provincial levels.",100000,null,"Active","a6Q1R000000AJNm",0,0,0,0,100000,0,null,null,"MPR objectives are to review in 2018 the malaria program structure and capacity in each province and at national level, identify challenges and have the epidemiological outlook of malaria per province. Furthermore, this will assess current program performance and help redefine strategic direction, including revision of policies and strategic plans at provincial levels.","Medium","This funding will cover theimplementation of the malaria programmatic review in the country.","NA Original Intervention: Malaria programmatic review (MPR)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Pakistan","Pakistan","PAI-5351","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.",5200000,null,"Active","a6Q1R000000AJNl",0,599101,0,0,4600899,0,null,null,"In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.","High","LLIN requirement for mass distribution of LLINs in seven\nStratum-IA districts (N.Waziristan, Kurram, Tharpakar,Khairpur, Kech, Sibi, and Noushki) that are currently not receiving funding to support","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Pakistan","Pakistan","PAI-5350","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The grant funds cover the distribution of LLINs for pregnant women (high risk population) through ANC clinics for 2018 only. Due to the funding limitations, LLINs required for pregnant women for 2019 and 2020 are being requested through PAAR. A total of 653,464 LLINs (298,937 in 2019 and 354,527 in 2020) would be required for distribution to cover the pregnant women's needs.",1500000,null,"Active","a6Q1R000000AJNk",0,0,0,0,1500000,0,null,null,"The grant funds cover the distribution of LLINs for pregnant women (high risk population) through ANC clinics for 2018 only. Due to the funding limitations, LLINs required for pregnant women for 2019 and 2020 are being requested through PAAR. A total of 653,464 LLINs (298,937 in 2019 and 354,527 in 2020) would be required for distribution to cover the pregnant women's needs.","High","This request aimed to addressimplementation gaps in the\nLLINs continuous distributionthrough antenatal clinics for2019 and 2020.","NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Lesotho","Lesotho","PAI-4737","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","The HIV prevalence for Adolescents and young people is 13% among young women and 6% among young men (Avert 2016). One of the key drivers for the high prevalence among adolescents and young people is limited knowledge of HIV prevention and available services. This is evidence by the LDHS (2013) that indicated for persons aged 15 -24 years, comprehensive knowledge was as low at 30.9% and the LePHIA (2017) report indicated that awareness of HIV and status among the same age group is at 56.2% for males and 61.4 % for the females.  \n\nSocial marketing has been established as an effective behavioural change model for several public health issues. To increase the comprehensive knowledge, several interventions are funded including the development of the SBCC strategy by UNICEF and the  social marketing strategy under NFM 2. The main gap identified is the operationalisation of these strategies, in particular is the social marketing strategy. The intervention bridges the skills gap in delivering comprehensive prevention services for adolescents and young people through understanding the barriers and the factors accounting for the low knowledge on HIV and uptake of health care services among AGY. The focus will be on:\n? Training of PR and SRs on delivering SBCC interventions for AGY. This will include market insights and analysis for target segments based on behavioural insights (for differentiated messaging) obtained from phase one (informative assessment).\n? Defining the communication strategy and develop specific massages, compelling visuals and custom channels for AGY. This exercise will produce the campaign assets for communicating to young people.\n? Deliver and test the SBCC marketing campaign in pre-determined pilot area and presentation of evaluation for full scale implementation.",860000,null,"Active","a6Q1R000000AJDr",0,0,0,0,860000,0,null,null,"The HIV prevalence for Adolescents and young people is 13% among young women and 6% among young men (Avert 2016). One of the key drivers for the high prevalence among adolescents and young people is limited knowledge of HIV prevention and available services. This is evidence by the LDHS (2013) that indicated for persons aged 15 -24 years, comprehensive knowledge was as low at 30.9% and the LePHIA (2017) report indicated that awareness of HIV and status among the same age group is at 56.2% for males and 61.4 % for the females.  \n\nSocial marketing has been established as an effective behavioural change model for several public health issues. To increase the comprehensive knowledge, several interventions are funded including the development of the SBCC strategy by UNICEF and the  social marketing strategy under NFM 2. The main gap identified is the operationalisation of these strategies, in particular is the social marketing strategy. The intervention bridges the skills gap in delivering comprehensive prevention services for adolescents and young people through understanding the barriers and the factors accounting for the low knowledge on HIV and uptake of health care services among AGY. The focus will be on:\n? Training of PR and SRs on delivering SBCC interventions for AGY. This will include market insights and analysis for target segments based on behavioural insights (for differentiated messaging) obtained from phase one (informative assessment).\n? Defining the communication strategy and develop specific massages, compelling visuals and custom channels for AGY. This exercise will produce the campaign assets for communicating to young people.\n? Deliver and test the SBCC marketing campaign in pre-determined pilot area and presentation of evaluation for full scale implementation.","Medium","For CCM/Disease Program consideration: SBCC could require additional justification. Amount seems high given Lesotho?s size, and heavily focused on training. This is a suggestion to improve this intervention; the country does not have to respond to it.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4736","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00573","Gender-based violence prevention and treatment programs for adolescents and youth","Under NFM 2, the country provides services to adolescents and young people in the 8 districts, however, the provision of these services is not supported by a harmonised and standardised vulnerability assessment, resulting in a non-differentiated approach. This is currently a gap and the country seek to address this issue. To ensure a more targeted response to the needs of the individual, the following is proposed:\n\n? Review and adapt existing tools (e.g. Ministry of Social Development Vulnerability tools, FHI 360 and population council) towards the development of an algorithm to assess HIV vulnerability amongst young people. The algorithm will be applied nationally and will enable the country to provide tailored interventions to reduce the risk of HIV among young people. \n? Train 191 peer educators to administer the vulnerability assessment tool and conduct the assessment of 70,000 young people across the eight districts supported by the Global Fund. \n? The country has a defined package of services for AGYW, however not all adolescents and young people require a full package of service to prevent HIV. Based on the identified needs emerging from the vulnerability assessment, components from defined package of services for AGYW will be used for a more tailored and targeted approach, thereby maximising the impact of services for the AGYW. A total of 28,000 (40% based on the current assessment practices) adolescents and young people will be reached with this response based approach.\n? The intervention will contribute to improved efficiencies of the allocation funding by ensuring that are most responsive to the identified needs are addressed by liking the most vulnerable adolescents to appropriate services in an equitable manner in all 8 districts.",58810,null,"Active","a6Q1R000000AJDq",0,0,0,0,58810,0,null,null,"Under NFM 2, the country provides services to adolescents and young people in the 8 districts, however, the provision of these services is not supported by a harmonised and standardised vulnerability assessment, resulting in a non-differentiated approach. This is currently a gap and the country seek to address this issue. To ensure a more targeted response to the needs of the individual, the following is proposed:\n\n? Review and adapt existing tools (e.g. Ministry of Social Development Vulnerability tools, FHI 360 and population council) towards the development of an algorithm to assess HIV vulnerability amongst young people. The algorithm will be applied nationally and will enable the country to provide tailored interventions to reduce the risk of HIV among young people. \n? Train 191 peer educators to administer the vulnerability assessment tool and conduct the assessment of 70,000 young people across the eight districts supported by the Global Fund. \n? The country has a defined package of services for AGYW, however not all adolescents and young people require a full package of service to prevent HIV. Based on the identified needs emerging from the vulnerability assessment, components from defined package of services for AGYW will be used for a more tailored and targeted approach, thereby maximising the impact of services for the AGYW. A total of 28,000 (40% based on the current assessment practices) adolescents and young people will be reached with this response based approach.\n? The intervention will contribute to improved efficiencies of the allocation funding by ensuring that are most responsive to the identified needs are addressed by liking the most vulnerable adolescents to appropriate services in an equitable manner in all 8 districts.","High","GBV addition complements existing activities.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4735","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) reported that the country is making good progress towards the UNAIDS 90-90-90 targets with 81% of PLHIV knowing their status, 92% of those who know their status on treatment, and 88% of those on treatment being virally suppressed. Despite tremendous efforts in scaling up HTS in Lesotho still 82, 000 PLHIV do not know their status, among these men, adolescents and young people, key populations and partners of people living with HIV (PLHIV). A key strategy to addressing this gap in the abovementioned target group is the provision of HIV self-testing (HIVST). In support of MOH Lesotho (MOHL), Unitaid funded the introduction and scale up of HIV self-testing in 2017. In 2018 a total of 58, 000 HIVST were distributed, mainly through community-based distribution. During this period majority of the self-testers were high-risk men (58%), adolescents 15-24 (35%) and key populations (7%). Furthermore, the Unitaid supported project reported that the number of HIV positive cases increased. The HTS Strategy has since been developed (Annex 1).\n\nIn 2019 Unitaid will fund 43,342 HIVST kits and 64, 000 will be funded by CDC. The implementation of the differentiated strategy for HTS will require scaling up of HIVST, i.e. to expand HIVST across the entire country a substantial increase in the procurement of HIVST kit is needed. The estimated gap in HIVST kit commodities for the period 2020 is 240,000 and 2021 is 200,000 to cover all geographic areas. In particular the focus will be on:\n? Hot spots, male dominated workplaces, places frequented by adolescents and young people, market places, taxi ranks, door to door distribution and campaign style distribution. \n? Key populations (MSM, Sex workers) - based on current trends, it is estimated that 2000 HIVST kits would be distributed annually to these populations.\n? Antenatal clinics (ANC) - based on current trends for this target group, an estimated 34, 560 test kits will be required to reach male sexual partners of ANC clinic attendees. \n? Distribution through index patients (ART initiations at public sector hospitals): the current trends indicate that uptake by positive index patients and by sexual partner, estimates the requirement of 15, 000 test kits annually.\n? Direct distribution to Outpatients departments: Based on current trends indicates that annually an estimated 72, 000 test kits would be required.",3520000,null,"Inactive","a6Q1R000000AJDp",3520000,0,0,0,0,1,null,null,"The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) reported that the country is making good progress towards the UNAIDS 90-90-90 targets with 81% of PLHIV knowing their status, 92% of those who know their status on treatment, and 88% of those on treatment being virally suppressed. Despite tremendous efforts in scaling up HTS in Lesotho still 82, 000 PLHIV do not know their status, among these men, adolescents and young people, key populations and partners of people living with HIV (PLHIV). A key strategy to addressing this gap in the abovementioned target group is the provision of HIV self-testing (HIVST). In support of MOH Lesotho (MOHL), Unitaid funded the introduction and scale up of HIV self-testing in 2017. In 2018 a total of 58, 000 HIVST were distributed, mainly through community-based distribution. During this period majority of the self-testers were high-risk men (58%), adolescents 15-24 (35%) and key populations (7%). Furthermore, the Unitaid supported project reported that the number of HIV positive cases increased. The HTS Strategy has since been developed (Annex 1).\n\nIn 2019 Unitaid will fund 43,342 HIVST kits and 64, 000 will be funded by CDC. The implementation of the differentiated strategy for HTS will require scaling up of HIVST, i.e. to expand HIVST across the entire country a substantial increase in the procurement of HIVST kit is needed. The estimated gap in HIVST kit commodities for the period 2020 is 240,000 and 2021 is 200,000 to cover all geographic areas. In particular the focus will be on:\n? Hot spots, male dominated workplaces, places frequented by adolescents and young people, market places, taxi ranks, door to door distribution and campaign style distribution. \n? Key populations (MSM, Sex workers) - based on current trends, it is estimated that 2000 HIVST kits would be distributed annually to these populations.\n? Antenatal clinics (ANC) - based on current trends for this target group, an estimated 34, 560 test kits will be required to reach male sexual partners of ANC clinic attendees. \n? Distribution through index patients (ART initiations at public sector hospitals): the current trends indicate that uptake by positive index patients and by sexual partner, estimates the requirement of 15, 000 test kits annually.\n? Direct distribution to Outpatients departments: Based on current trends indicates that annually an estimated 72, 000 test kits would be required.","High","Better case finding strategies needed to ensure efficient use of resources.","Email from CT says that the this intervention is funded, through budget revisions","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4734","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","The funding will be used for the procurement of two additional vehicles to support program implementation by the sub-recipients of the adolescent girls and young women activities in eight districts.",88000,null,"Active","a6Q1R000000AJDo",0,0,0,0,88000,0,null,null,"The funding will be used for the procurement of two additional vehicles to support program implementation by the sub-recipients of the adolescent girls and young women activities in eight districts.","Medium","Though the activity is important, optimal management and coordination of available fleet is essential for efficiency.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Lesotho","Lesotho","PAI-4733","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","The prevalence survey will enable the program to improve the quality of data, planning, reporting and forecasting. The survey was initiated in 2017, however, could not be continued due to a number of reasons, including the need to improve the National Reference Lab and procure X-ray machines. Both activities are to be completed with the World Bank support in June 2018. The prevalence survey will be funded through the reinvestment of the efficiencies identified during the grant making.",2200000,null,"Inactive","a6Q1R000000AJDn",2200000,0,0,0,0,1,null,null,"The prevalence survey will enable the program to improve the quality of data, planning, reporting and forecasting. The survey was initiated in 2017, however, could not be continued due to a number of reasons, including the need to improve the National Reference Lab and procure X-ray machines. Both activities are to be completed with the World Bank support in June 2018. The prevalence survey will be funded through the reinvestment of the efficiencies identified during the grant making.","High","This activity is high priority. The prevalence survey will enable the program use the data for effective planning.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-06-30","TB/HIV"]
["CT Sri Lanka","Sri Lanka","PAI-4732","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Procurement &  Installation of  3 nos of Digital X-ray machines for National Hospital of Sri Lanka, Colombo North teaching hospital, Kandy teaching hospital.",69000,null,"Active","a6Q1R000000AJDm",0,0,0,0,69000,0,null,null,"Procurement &  Installation of  3 nos of Digital X-ray machines for National Hospital of Sri Lanka, Colombo North teaching hospital, Kandy teaching hospital.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2021-12-31","Tuberculosis"]
["CT Nigeria","Nigeria","PAI-5301","MCI-00010","MDR-TB","MCI-00126","Case detection and diagnosis","Communication and transportation support for contact tracing per index DR TB case and linkage to treatment:\n2,592 are targeted using above allocation. The intervention is for contact tracing per index DR TB case notified for additional 1,659 patients. Research shows that 10% of contacts of index TB cases would be TB patients. Assuming 4 contacts per index DR TB case this would result to additional 662 TB cases.",8144,null,"Active","a6Q1R000000AJMx",0,0,0,0,8144,0,"2020-01-29T12:52:00",null,"Communication and transportation support for contact tracing per index DR TB case and linkage to treatment:\n2,592 are targeted using above allocation. The intervention is for contact tracing per index DR TB case notified for additional 1,659 patients. Research shows that 10% of contacts of index TB cases would be TB patients. Assuming 4 contacts per index DR TB case this would result to additional 662 TB cases.","High",null,"NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Nigeria","Nigeria","PAI-5300","MCI-00010","MDR-TB","MCI-00126","Case detection and diagnosis","Drug Resistant TB Survey:\nThe increasing case notification of PreXDR and XDR TB has been an issue and the country is yet to conduct an analysis of the reasons for the increase. The survey will assess changes in epidemiological trend of DR TB, prevalence of XDR TB, HIV among DR TB patients, develop evidence based recommendations for the NTBLCP to control and prevent DR TB.",3643207,null,"Active","a6Q1R000000AJMw",0,0,0,0,3643207,0,"2020-01-29T12:52:00",null,"Drug Resistant TB Survey:\nThe increasing case notification of PreXDR and XDR TB has been an issue and the country is yet to conduct an analysis of the reasons for the increase. The survey will assess changes in epidemiological trend of DR TB, prevalence of XDR TB, HIV among DR TB patients, develop evidence based recommendations for the NTBLCP to control and prevent DR TB.","High",null,"NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Nigeria","Nigeria","PAI-5299","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Procurement of SLDs including PSM costs:\n10,183 DRTB cases will be notified with the allocation. An estimated 49.1% (5,000 patients) have been budgeted within the allocation. For the remaining, 5183 patients, the GON will provide SLDs for 50%(2592) while the GF will provide drugs for the remaining 50%(2592). This includes procurement fees, Insurance, Freight, in-country distribution (+ Last Mile), QA/QC charges and packaging materials.",5152151,null,"Active","a6Q1R000000AJMv",0,0,0,0,5152151,0,"2020-01-29T12:52:00",null,"Procurement of SLDs including PSM costs:\n10,183 DRTB cases will be notified with the allocation. An estimated 49.1% (5,000 patients) have been budgeted within the allocation. For the remaining, 5183 patients, the GON will provide SLDs for 50%(2592) while the GF will provide drugs for the remaining 50%(2592). This includes procurement fees, Insurance, Freight, in-country distribution (+ Last Mile), QA/QC charges and packaging materials.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Nigeria","Nigeria","PAI-5298","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Conduct end-term evaluation for the TB NSP 2015-2020:\nThe country is implementing TB strategic plan that covers a period of 2015 to 2020. The requested funds under above allocation will facilitate evaluation of the strategic plan to inform implementation achievement and gaps for the new strategic plan.",125919,null,"Active","a6Q1R000000AJMu",0,0,0,0,125919,0,"2020-01-29T12:52:00",null,"Conduct end-term evaluation for the TB NSP 2015-2020:\nThe country is implementing TB strategic plan that covers a period of 2015 to 2020. The requested funds under above allocation will facilitate evaluation of the strategic plan to inform implementation achievement and gaps for the new strategic plan.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Nigeria","Nigeria","PAI-5297","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Conduct survey to determine TB catastrophic costs:\nBaseline survey was conducted in 2017 and findings revealed 71% of TB patients and their households experienced catastrophic cost. With the scale up of innovative interventions, most patient related cost might be mitigated and monitoring this is necessary to alleviate burden on TB patients. The follow up catastrophic cost survey is proposed in 2020 using above allocation.",305982,null,"Active","a6Q1R000000AJMt",0,0,0,0,305982,0,"2020-01-29T12:52:00",null,"Conduct survey to determine TB catastrophic costs:\nBaseline survey was conducted in 2017 and findings revealed 71% of TB patients and their households experienced catastrophic cost. With the scale up of innovative interventions, most patient related cost might be mitigated and monitoring this is necessary to alleviate burden on TB patients. The follow up catastrophic cost survey is proposed in 2020 using above allocation.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Nigeria","Nigeria","PAI-5296","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","Increase engagement of private providers in TB control in additional 10 states (Kano, Kwara, Kogi, Niger, Ebonyi, Akwa Ibom, Bauchi, Cross rivers, Taraba and Imo).\nThe program has identified 63 LGAs in 15 States to engage private providers in TB control using the allocation which will result to 52,444 cases notified. Above allocation will scale up engagement of private providers in 10 additional states.",3829500,null,"Active","a6Q1R000000AJMs",0,0,0,0,3829500,0,"2020-01-29T12:52:00",null,"Increase engagement of private providers in TB control in additional 10 states (Kano, Kwara, Kogi, Niger, Ebonyi, Akwa Ibom, Bauchi, Cross rivers, Taraba and Imo).\nThe program has identified 63 LGAs in 15 States to engage private providers in TB control using the allocation which will result to 52,444 cases notified. Above allocation will scale up engagement of private providers in 10 additional states.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Nigeria","Nigeria","PAI-5295","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Establish TB services in additional 2,445 PHCs: \nThe country plans to expand TB services from 35% in 2018 to 50% by 2020 by engaging additional 3,372 PHCs resulting to a total yield of 134,782 included in the allocation.  With above allocation, TB services will be expanded to additional 2,445 PHC to reach 60% coverage resulting to an additional 26,955 additional cases.",865292,null,"Active","a6Q1R000000AJMr",552267,0,0,0,313025,0,"2020-01-29T12:52:00",null,"Establish TB services in additional 2,445 PHCs: \nThe country plans to expand TB services from 35% in 2018 to 50% by 2020 by engaging additional 3,372 PHCs resulting to a total yield of 134,782 included in the allocation.  With above allocation, TB services will be expanded to additional 2,445 PHC to reach 60% coverage resulting to an additional 26,955 additional cases.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Malawi","Malawi","PAI-5200","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","HTS trainings ($6.20M) Covers half of the need for skills intensive training. Also covers in full: 1) trainings to allow expansion of HDAs to non-PEPFAR-supported facilities. HDAs have proven instrumental in expansion of HTS for reaching 1st 90; 2) orientation in Bioline rapid test kit. This has been endorsed as the first test in the national HIV testing algorithm; 3) district quarterly reviews; and 4) district mentorship.",6200000,null,"Active","a6Q1R000000AJLK",2387275.39,0,0,0,3812724.61,0,null,null,"HTS trainings ($6.20M) Covers half of the need for skills intensive training. Also covers in full: 1) trainings to allow expansion of HDAs to non-PEPFAR-supported facilities. HDAs have proven instrumental in expansion of HTS for reaching 1st 90; 2) orientation in Bioline rapid test kit. This has been endorsed as the first test in the national HIV testing algorithm; 3) district quarterly reviews; and 4) district mentorship.","High","Increased testing through innovative approaches is one of the major changes in approach in this Funding request.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5199","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","TB/HIV collaborative interventions (USD 528,233) Above allocation resources will be used to improve screening for TB in ART and PMTCT clinics. In particular, this will be used for hiring and training of a designated cadre placed in 60 high volume district hospitals, and CHAM facilities, which will scale up systematic TB screening. This cadre will also contribute to overall improved case funding in clinical settings. TB/HIV above allocation funds will also be used for the procurement of Omni Xpert machines and cartridges. As small, portable and batterypowered point of care (POC) devices, Omni machines will decentralize Xpert testing capability to nonXpert sites which currently rely on microscopy. This POC technology is expected to provide greater Funding Request: Tailored to Material Change 15 December 2016? 34 incentive for HCWs to conduct TB screening among HIV patients as they will be able to deliver results rapidly; the machines contain both HIV and TB testing capacity; and are relatively easy to use. Omni machines will be prioritized for remote, rural settings, piloted as mobile equipment at selected CSCPs, and to integrate EID and VL testing. Funds will also be used for corresponding training of HCWs, and routine monitoring of this activity through regular review meetings.",528233,null,"Active","a6Q1R000000AJLJ",0,0,0,0,528233,0,null,null,"TB/HIV collaborative interventions (USD 528,233) Above allocation resources will be used to improve screening for TB in ART and PMTCT clinics. In particular, this will be used for hiring and training of a designated cadre placed in 60 high volume district hospitals, and CHAM facilities, which will scale up systematic TB screening. This cadre will also contribute to overall improved case funding in clinical settings. TB/HIV above allocation funds will also be used for the procurement of Omni Xpert machines and cartridges. As small, portable and batterypowered point of care (POC) devices, Omni machines will decentralize Xpert testing capability to nonXpert sites which currently rely on microscopy. This POC technology is expected to provide greater Funding Request: Tailored to Material Change 15 December 2016? 34 incentive for HCWs to conduct TB screening among HIV patients as they will be able to deliver results rapidly; the machines contain both HIV and TB testing capacity; and are relatively easy to use. Omni machines will be prioritized for remote, rural settings, piloted as mobile equipment at selected CSCPs, and to integrate EID and VL testing. Funds will also be used for corresponding training of HCWs, and routine monitoring of this activity through regular review meetings.","High","Omni expert machines for TB testing among PLHIV cases",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5198","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","TB Case Detection Diagnosis and Treatment (USD 620,280): Building on TB treatment targets within allocation, this line item would support case detection and treatment of an additional 9,784 TB patients. This additional coverage will increase the case detection rate from 60%, 63% and 65% in Y1, Y2, and Y3, to 70%, 70% and 75%, respectively, over three years, leading to the full achievement of the NSP target. These additional 9,784 cases will be detected and diagnosed through a combination of the scale-up strategies outlined in line items 2, and 3, whereby: a) additional private for-profit facilities will be engaged, contributing a projected 7% of TB cases notified; and b) additional CSCPs will be established in rural areas contributing an additional 4% of TB cases notified. Additional funds will be applied to screening all HCWs and testing approximately 900 annually, assuming 6% of all HCWs screen positive.",620280,null,"Active","a6Q1R000000AJLI",217140,0,0,0,403140,0,null,null,"TB Case Detection Diagnosis and Treatment (USD 620,280): Building on TB treatment targets within allocation, this line item would support case detection and treatment of an additional 9,784 TB patients. This additional coverage will increase the case detection rate from 60%, 63% and 65% in Y1, Y2, and Y3, to 70%, 70% and 75%, respectively, over three years, leading to the full achievement of the NSP target. These additional 9,784 cases will be detected and diagnosed through a combination of the scale-up strategies outlined in line items 2, and 3, whereby: a) additional private for-profit facilities will be engaged, contributing a projected 7% of TB cases notified; and b) additional CSCPs will be established in rural areas contributing an additional 4% of TB cases notified. Additional funds will be applied to screening all HCWs and testing approximately 900 annually, assuming 6% of all HCWs screen positive.","High","Core TB case detection and diagnosis to find missing TB cases","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5197","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","Community TB Care (USD 1,688,069): Through the within allocation request, funds will be used to maintain and expand community TB care strategies including CSCPs in rural areas and house-to-house screening in urban areas. These activities will contribute a projected 18% of TB case notifications. Through the above allocation request: 1) an additional 700 CSCPs will be established and maintained with supplies and consumables, 2) an additional 7,000 CSCP volunteers will be trained to conduct community mobilization and sensitization, 3) refresher trainings will be conducted with house-to-house screening volunteers and CSCP volunteers. Deployment of these 700 additional CSCPs will increase coverage of CSCPs to 85% of the estimated country need. Establishment of CSCPs are critical to a human rights-based approach that prioritizes investments to reach the most rural and remote. These interventions will contribute approximately 4% of the additional 9,784 TB patients that will be reached through line item 1 above.",1688069,null,"Active","a6Q1R000000AJLH",555373,0,0,0,1132696,0,null,null,"Community TB Care (USD 1,688,069): Through the within allocation request, funds will be used to maintain and expand community TB care strategies including CSCPs in rural areas and house-to-house screening in urban areas. These activities will contribute a projected 18% of TB case notifications. Through the above allocation request: 1) an additional 700 CSCPs will be established and maintained with supplies and consumables, 2) an additional 7,000 CSCP volunteers will be trained to conduct community mobilization and sensitization, 3) refresher trainings will be conducted with house-to-house screening volunteers and CSCP volunteers. Deployment of these 700 additional CSCPs will increase coverage of CSCPs to 85% of the estimated country need. Establishment of CSCPs are critical to a human rights-based approach that prioritizes investments to reach the most rural and remote. These interventions will contribute approximately 4% of the additional 9,784 TB patients that will be reached through line item 1 above.","High","CSSPs will facilitate finding additional 9784 TB cases","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5196","MCI-00008","TB care and prevention","MCI-00135","Engaging all care providers (TB/HIV)","Engage All Care Providers (USD 1,005,475): Malawi?s PPM National Action Plan (2016-2020), endorsed by Global Fund and WHO, and elaborates a series of strategies for engagement and linkage between public and private practitioners. MoH?s support to CHAM facilities led to these sites generating 18% of all TB notifications in 2015, indicating that engagement of private facilities is a promising strategy to increase TB notifications. Building on continued support to CHAM facilities in the within allocation request, this above allocation request will engage additional for-profit private facilities in 13 districts over 3 years (3 districts in Y1 and 5 districts in both Y2 and Y3). Activities within this area will include: 1) orientation for private practitioners, 2) provision of a package of TB recording and reporting tools, 3) training private healthcare workers on comprehensive TB/HIV integration and TB microscopic techniques, 4) providing TB diagnostic equipment and supplies, microscopes, and lab reagent, 5) providing job aides and national guidelines; 6) supportive supervision, EQA and review meetings, and 7) engagement of traditional healers. Implementation of this new strategy for private sector engagement will contribute 7% of TB notifications.",1005475,null,"Active","a6Q1R000000AJLG",319922.03999999998,0,0,0,685552.96,0,null,null,"Engage All Care Providers (USD 1,005,475): Malawi?s PPM National Action Plan (2016-2020), endorsed by Global Fund and WHO, and elaborates a series of strategies for engagement and linkage between public and private practitioners. MoH?s support to CHAM facilities led to these sites generating 18% of all TB notifications in 2015, indicating that engagement of private facilities is a promising strategy to increase TB notifications. Building on continued support to CHAM facilities in the within allocation request, this above allocation request will engage additional for-profit private facilities in 13 districts over 3 years (3 districts in Y1 and 5 districts in both Y2 and Y3). Activities within this area will include: 1) orientation for private practitioners, 2) provision of a package of TB recording and reporting tools, 3) training private healthcare workers on comprehensive TB/HIV integration and TB microscopic techniques, 4) providing TB diagnostic equipment and supplies, microscopes, and lab reagent, 5) providing job aides and national guidelines; 6) supportive supervision, EQA and review meetings, and 7) engagement of traditional healers. Implementation of this new strategy for private sector engagement will contribute 7% of TB notifications.","High","Engaging all care provider a high impact intervention, will facilitate finding missing TB cases",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5195","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","Continuation of general population community activities ($2.45M) Support will continue activities within current grant for general population prevention, including raising community demand for HIV testing and referral to care especially among high prevalence populations and communities. Other activities include mapping of condom distribution outlets and orientation of condom distributors, training of marriage counselors, and community progress review meetings.",2450000,null,"Active","a6Q1R000000AJLF",0,0,0,0,2450000,0,null,null,"Continuation of general population community activities ($2.45M) Support will continue activities within current grant for general population prevention, including raising community demand for HIV testing and referral to care especially among high prevalence populations and communities. Other activities include mapping of condom distribution outlets and orientation of condom distributors, training of marriage counselors, and community progress review meetings.","High","Community demand for testing needs to be increased.","NA Original Intervention: Other interventions for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Madagascar","Madagascar","PAI-5070","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Improved IPT coverage, will be implemented in all health care facilities.  This above allocation request will therefore allow the continued provision of sulfadoxine-pyrimethamine (SP) in 2021. This intervention will help achieve the NSP target to protect at least 80 percent of women through IPT, and to reduce the risk of low birth weight by approximately 21 percent and neonatal mortality by 61 percent.",1074953,null,"Active","a6Q1R000000AJJE",0,0,0,0,1074953,0,null,null,"Improved IPT coverage, will be implemented in all health care facilities.  This above allocation request will therefore allow the continued provision of sulfadoxine-pyrimethamine (SP) in 2021. This intervention will help achieve the NSP target to protect at least 80 percent of women through IPT, and to reduce the risk of low birth weight by approximately 21 percent and neonatal mortality by 61 percent.","High",null,"NA Original Module: Specific prevention interventions. Original Intervention: Intermittent preventive treatment ? In pregnancy","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Madagascar","Madagascar","PAI-5068","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","To maintain the level of coverage achieved during the mass distribution campaign, continuous distribution will be implemented in 2019 in districts with a high level of endemicity, using the allocation amount. Implementing this intervention using the above allocation amount in 2020 will therefore help to maintain the expected annual progress, to reduce incidence by 40 percent in districts with a high level of endemicity.",2648756,null,"Active","a6Q1R000000AJJC",0,0,0,0,2648756,0,null,null,"To maintain the level of coverage achieved during the mass distribution campaign, continuous distribution will be implemented in 2019 in districts with a high level of endemicity, using the allocation amount. Implementing this intervention using the above allocation amount in 2020 will therefore help to maintain the expected annual progress, to reduce incidence by 40 percent in districts with a high level of endemicity.","High","The TRP recommends this request as quality demand, but notes that the funds will not be required until after the mapping planned by applicant is complete. The TRP recommends that, should resources become available to fund this intervention, the Secretariat should ensure the action plan for implementation is aligned with the results of the mapping.","NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Madagascar","Madagascar","PAI-5067","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","This component covers both monitoring of activities and rational management of supplies. It will involve running six-monthly reviews in the 22 regions to monitor the quality and reliability of health data through a technical analysis of the data and reports issued by local health care facilities. A review/workshop will be organized to analyze/interpret/discuss/address aspects of data or findings from the implementation of activities in order to inform decision-making, steering or planning. Costs related to reviews cover transport, allowances, room hire, stationery, coffee breaks, and organizational costs.",18132,null,"Active","a6Q1R000000AJJB",0,0,0,0,18132,0,null,null,"This component covers both monitoring of activities and rational management of supplies. It will involve running six-monthly reviews in the 22 regions to monitor the quality and reliability of health data through a technical analysis of the data and reports issued by local health care facilities. A review/workshop will be organized to analyze/interpret/discuss/address aspects of data or findings from the implementation of activities in order to inform decision-making, steering or planning. Costs related to reviews cover transport, allowances, room hire, stationery, coffee breaks, and organizational costs.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2020-12-31","HIV/AIDS"]
["CT Madagascar","Madagascar","PAI-5066","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","The activity consists of organizing discussion groups and an observance club to provide information sessions within associations in order to reduce stigma toward PLHIV. This activity is run twice a year, with one session covered under the allocation amount and one under the above allocation amount.The budget item relates to transport, allowances and refreshments.",25274,null,"Active","a6Q1R000000AJJA",0,0,0,0,25274,0,null,null,"The activity consists of organizing discussion groups and an observance club to provide information sessions within associations in order to reduce stigma toward PLHIV. This activity is run twice a year, with one session covered under the allocation amount and one under the above allocation amount.The budget item relates to transport, allowances and refreshments.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2020-12-31","HIV/AIDS"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4967","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","Adding value to malaria outreach program.",500000,null,"Inactive","a6Q1R000000AJHZ",500000,0,0,0,0,1,null,null,"Adding value to malaria outreach program.","Low","Additional activities. Focus on core allocation implementation is important.","NA Original Intervention: Vector control activities (Lao PDR )","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4966","MCI-00071","Other module","MCI-00071","Other module","Training for VHWs and commune staff on IRS and treatment of bednets will ensure a wide coverage of vector control interventions and reduced numbers of foci.",500000,null,"Inactive","a6Q1R000000AJHY",500000,0,0,0,0,1,null,null,"Training for VHWs and commune staff on IRS and treatment of bednets will ensure a wide coverage of vector control interventions and reduced numbers of foci.","Medium","Increased outreach for indoor residual spraying (IRS ) and bed -net treatment.","NA Original Module: RSSH. Original Intervention: Conduct training on vector control measures for all levels (Viet Nam )","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4965","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To supplement existing activities and  enable improved implementation and overall program management.",700000,null,"Inactive","a6Q1R000000AJHX",700000,0,0,0,0,1,null,null,"To supplement existing activities and  enable improved implementation and overall program management.","Medium","Although important, these activities are already heavily funded in the allocation proposal. Further justification is needed.","NA Original Intervention: Program management (Lao PDR )","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4964","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","For patients with confirmed P. falciparum or mixed infection, a slide is collected at D28 to ascertain efficacy of treatment with full parasitological clearance. If positive, the patient will receive second line treatment according to NTG. Investigation of all positives cases found during reactive case detection to prevent ongoing local transmission.",500000,null,"Active","a6Q1R000000AJHW",0,0,385844,0,114156,0,null,null,"For patients with confirmed P. falciparum or mixed infection, a slide is collected at D28 to ascertain efficacy of treatment with full parasitological clearance. If positive, the patient will receive second line treatment according to NTG. Investigation of all positives cases found during reactive case detection to prevent ongoing local transmission.","High","Pilot approach in areas with lower Annual Parasite Incidence (API).","Listed intervention does not match the one in UQD updated form. Original Intervention: Day 28/42 followup (Cambodia)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4963","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Regional workshop on Social Protection in TB. This event will bring together representatives of government, cooperating and multilateral organizations and civil society from the 8 LAC countries to exchange experiences and new agreements.",40550,null,"Inactive","a6Q1R000000AJHV",40550,0,0,0,0,1,null,null,"Regional workshop on Social Protection in TB. This event will bring together representatives of government, cooperating and multilateral organizations and civil society from the 8 LAC countries to exchange experiences and new agreements.","High"," The TRP considers that this intervention should have high priority as it would inform the Social Observatories for TB. The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4962","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Study to identify social protection programs associated with TB. Activity seeking to describe the existing state and private social protection programs in each country, and their relationship and the gaps in access for people affected by TB to these programs.",88000,null,"Inactive","a6Q1R000000AJHU",88000,0,0,0,0,1,null,null,"Study to identify social protection programs associated with TB. Activity seeking to describe the existing state and private social protection programs in each country, and their relationship and the gaps in access for people affected by TB to these programs.","High","The TRP considers that this intervention should have high priority as it would inform the Social Observatories for TB. The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4961","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Regional workshop to validate tools on stigma, legal environment and gender in TB.  Prior to the implementation of the instruments in each country, we will conduct training for key implementers in each country, as well as experts on each of the topics, including representatives from the Stop TB Partnership and PAHO/WHO.",53700,null,"Inactive","a6Q1R000000AJHT",53700,0,0,0,0,1,null,null,"Regional workshop to validate tools on stigma, legal environment and gender in TB.  Prior to the implementation of the instruments in each country, we will conduct training for key implementers in each country, as well as experts on each of the topics, including representatives from the Stop TB Partnership and PAHO/WHO.","High","The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4833","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Y3: Conduct participatory workshops on Global and regional guidance to build knowege of (1) MSM, (2) PWID, (3) Sex Workers to improve national level programming.Lebanon\ncan host these workshops for the region-wide learning activity.",80000,null,"Inactive","a6Q1R000000AJFP",80000,0,0,0,0,1,null,null,"Y3: Conduct participatory workshops on Global and regional guidance to build knowege of (1) MSM, (2) PWID, (3) Sex Workers to improve national level programming.Lebanon\ncan host these workshops for the region-wide learning activity.","Low",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4828","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Sensitization of media practitioners, social media bloggers, religious leaders and other key influencers to the challenges, needs and issues of stigma and discrimination towards KPs and PLHIV.",78000,null,"Inactive","a6Q1R000000AJFK",78000,0,0,0,0,1,null,null,"Sensitization of media practitioners, social media bloggers, religious leaders and other key influencers to the challenges, needs and issues of stigma and discrimination towards KPs and PLHIV.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Multicountry EECA PAS","Multicountry EECA PAS","PAI-4942","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Oversight committee meetings to ensure effective project implementation.",45000,null,"Active","a6Q1R000000AJHA",0,0,0,0,45000,0,null,null,"Oversight committee meetings to ensure effective project implementation.","Medium",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-12-31","Tuberculosis"]
["CT Multicountry EECA PAS","Multicountry EECA PAS","PAI-4941","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Mid-term project assessment to assess the progress of the project, define the interim project results and implementation performance.",50000,null,"Active","a6Q1R000000AJH9",0,0,0,0,50000,0,null,null,"Mid-term project assessment to assess the progress of the project, define the interim project results and implementation performance.","Medium",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-12-31","Tuberculosis"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5849","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","This fund supports ongoing monitoring of population coverage with utilization of LLINs.",300000,null,"Active","a6Q1R000000AJVn",248111,0,0,0,51889,0,null,null,"This fund supports ongoing monitoring of population coverage with utilization of LLINs.","High","This fund supports ongoing monitoring of population coverage with utilization of LLINs","NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Shalini Mitra","2019-10-30","2017-2019","Malaria, RSSH"," High Impact Africa 2",null,"Multi-component"]
["CT Thailand","Thailand","PAI-5755","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00585","Training of health care providers on human rights and medical ethics related to HIV and HIV/TB","DDC BL 277Monitoring and coaching on S&D reduction related to HIV and HIV/TB in hospitals by central team.",10404,null,"Active","a6Q1R000000AJUH",0,0,0,0,10404,0,null,null,"DDC BL 277Monitoring and coaching on S&D reduction related to HIV and HIV/TB in hospitals by central team.","High","This intervention supports monitoring and coaching on stigma and discrimination reduction related to HIV and HIV/TB in hospitals.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6108","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations? and women?s networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).",8410509,null,"Active","a6Q1R000000AJZy",0,0,0,0,8410509,0,null,null,"Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations? and women?s networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","High","Better collaboration with CSO and other community structures will allow for more effective consolidation of effort and valuefor-money","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6107","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations? and women?s networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).",850295,null,"Active","a6Q1R000000AJZx",0,0,0,0,850295,0,null,null,"Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations? and women?s networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","High","Integration of mobile outreach and development of a CSO portal will contribute to integrated efforts","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT South Africa","South Africa","PAI-5993","MCI-00008","TB care and prevention","MCI-00132","Collaborative activities with other programs and sectors (TB care and prevention)","Funding is requested to support the National Institute for Communicable Diseases (NICD) to create a South African Node for Tuberculosis Epidemiology based at the Centre for Tuberculosis, NICD. The overarching goal of the unit is to provide rapid, reliable and up-to-date spatial and epidemiological information on the TB epidemic in South Africa to inform, guide and monitor the TB program at all levels of the healthcare system from facility-level up to the National Department of Health across the TB care cascade. The proposal will a) Enhance monitoring and evaluation using an integrated TB surveillance system b) Provide geospatial modelling to identify emerging transmission hotspots c) Conduct a prospective study to validate and refine the geospatial models d) Build skills capacity to monitor outcomes and institute public health responses.",581232,null,"Active","a6Q1R000000AJY7",0,0,0,0,581232,0,null,null,"Funding is requested to support the National Institute for Communicable Diseases (NICD) to create a South African Node for Tuberculosis Epidemiology based at the Centre for Tuberculosis, NICD. The overarching goal of the unit is to provide rapid, reliable and up-to-date spatial and epidemiological information on the TB epidemic in South Africa to inform, guide and monitor the TB program at all levels of the healthcare system from facility-level up to the National Department of Health across the TB care cascade. The proposal will a) Enhance monitoring and evaluation using an integrated TB surveillance system b) Provide geospatial modelling to identify emerging transmission hotspots c) Conduct a prospective study to validate and refine the geospatial models d) Build skills capacity to monitor outcomes and institute public health responses.","Low","The TRP considers the proposed activities for M&E, integrated TB surveillance system, geospatial modelling, and building capacities to monitor outcomes are lower priority for additional funding, as they are covered under existing resources.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2022-03-31","TB/HIV"]
["CT Kosovo","Kosovo","PAI-5988","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","Additional funds will be used to intensify efforts of policy dialogue aiming at removing existing legal barriers.",8248.23,null,"Active","a6Q1R000000AJY2",0,0,0,0,8248.23,0,null,null,"Additional funds will be used to intensify efforts of policy dialogue aiming at removing existing legal barriers.","High","Any additional funds will be used to support policy dialogue about existing legal challenges and harmonise legislation to remove HIV service barriers The additional funds will allow intensifying efforts supported by limited within-allocation amount.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Eswatini","Eswatini","PAI-5679","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Additional treatment literacy support, including social and transitional media campaigns, recruitment of Community Outreach Workers (5 men per region and 5 AGYW). These groups are prioritized as outreach workers based on data that shows limited ART uptake among men (Table 3) and limited viral load suppression among young people. Lastly, funding will support the procurement of two vehicles to support the national PLHIV network SWANNEPHA. Funding is requested to recruit community outreach workers, with five men and five AGYW per region.",417688,null,"Active","a6Q1R000000AJT3",0,0,0,0,417688,0,null,null,"Additional treatment literacy support, including social and transitional media campaigns, recruitment of Community Outreach Workers (5 men per region and 5 AGYW). These groups are prioritized as outreach workers based on data that shows limited ART uptake among men (Table 3) and limited viral load suppression among young people. Lastly, funding will support the procurement of two vehicles to support the national PLHIV network SWANNEPHA. Funding is requested to recruit community outreach workers, with five men and five AGYW per region.","Medium","There is a lot of funding in the request for various cadres of CHW - efficiencies can be found within the already allocated amount to avoid overly vertical programs",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5678","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Additional demand creation for ART among groups with low treatment coverage (i.e. men in their twenties ?recall Table 3). This will include social marketing through social media, IEC materials, billboards, radio and TVadverts and other communication channels. This may beintegrated with peer-led outreach among other vulnerable groups (i.e. transport operators) and with the TB active case finding.",205714,null,"Active","a6Q1R000000AJT2",0,0,0,0,205714,0,null,null,"Additional demand creation for ART among groups with low treatment coverage (i.e. men in their twenties ?recall Table 3). This will include social marketing through social media, IEC materials, billboards, radio and TVadverts and other communication channels. This may beintegrated with peer-led outreach among other vulnerable groups (i.e. transport operators) and with the TB active case finding.","High","Given the low testing yield, additional strategies to reach untested populations are essential for the response","NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Somalia","Somalia","PAI-5577","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care.",809829,null,"Active","a6Q1R000000AJRP",0,0,0,0,809829,0,null,null,"Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care.","Medium","Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care","NA Original Intervention: ART Buffer Stock for 2021","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Paraguay","Paraguay","PAI-5442","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","Visit to Tacumbu prison for PLWH monitoring. This activity contributes to improving the adherence of PLHIV who are in the Tacumbú penitentiary, the country's main confinement institution in which the largest number of PPLs are living with HIV. These visits contribute to providing medical care, information and follow-up and consolidate the ART of the PPL, achieving an undetectable viral load. It should be noted that this activity is part of the Vencer Foundation's self-help program, in which its counselor interacts with the inmates reinforcing them with information about HIV, nutrition, care, and managing their hospitalization when they are critically ill because of some IO in addition to carrying out follow-ups (and bringing medicines) to the inmates who need it, even outside the visiting days. The visits to the prison are also accompanied by a doctor and 1 IMT (Institute of Tropical Medicine) social worker.",4133,null,"Active","a6Q1R000000AJPE",0,0,0,0,4133,0,null,null,"Visit to Tacumbu prison for PLWH monitoring. This activity contributes to improving the adherence of PLHIV who are in the Tacumbú penitentiary, the country's main confinement institution in which the largest number of PPLs are living with HIV. These visits contribute to providing medical care, information and follow-up and consolidate the ART of the PPL, achieving an undetectable viral load. It should be noted that this activity is part of the Vencer Foundation's self-help program, in which its counselor interacts with the inmates reinforcing them with information about HIV, nutrition, care, and managing their hospitalization when they are critically ill because of some IO in addition to carrying out follow-ups (and bringing medicines) to the inmates who need it, even outside the visiting days. The visits to the prison are also accompanied by a doctor and 1 IMT (Institute of Tropical Medicine) social worker.","High","The TRP considers prison people living with HIV treatment monitoring a high priority. However, during the Paraguay program continuation window 1 application, the TRP was informed that prison HIV services & personnel are covered by the government resources. There is a need to ensure no duplication of services and there is a clearly agreed arrangement between the Vencer Foundation, the Ministry of Health, and the prison authority. The TRP also requests clarification as to what 6types of self -help a 7ctivities are being proposed, how will they complement the government?s HIV interventions in prisons, in addition to the level of freedom of individual prisoners for self -help actions and availability of needed commodities in the enclosed settings. What is the plan for the longer -term sustainability of such program? Please note that this item, if shown to be effective, should be considered in the public financing planning beyond this funding period",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-02-28","HIV/AIDS"]
["CT Sri Lanka","Sri Lanka","PAI-4731","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","4 nos of mobile x ray units to be mounted to vehicles",52000,null,"Active","a6Q1R000000AJDl",0,0,0,0,52000,0,null,null,"4 nos of mobile x ray units to be mounted to vehicles","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2021-12-31","Tuberculosis"]
["CT Sri Lanka","Sri Lanka","PAI-4730","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","NGO involvement",13500,null,"Active","a6Q1R000000AJDk",0,0,0,0,13500,0,null,null,"NGO involvement","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2021-12-31","Tuberculosis"]
["CT Sri Lanka","Sri Lanka","PAI-4725","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Requested for conducting advocacy programmes for health directors in 2020. This activity is necessary to keep malaria on the radar to ensure funds at regional level from provicial health authorities to ensure that existing funds are not diverted to other disease control programmes and will facilitate integration of activities between disease control programmes.",7873,null,"Active","a6Q1R000000AJDf",0,0,0,0,7873,0,null,null,"Requested for conducting advocacy programmes for health directors in 2020. This activity is necessary to keep malaria on the radar to ensure funds at regional level from provicial health authorities to ensure that existing funds are not diverted to other disease control programmes and will facilitate integration of activities between disease control programmes.","High",null,"NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-12-31","Malaria"]
["CT Nigeria","Nigeria","PAI-5292","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00126","Case detection and diagnosis","Support site level joint lab-clinic patient education program for increased lab services uptake-develop IEC materials, health talk, and awareness creation for uptake of laboratory services.",209626,null,"Active","a6Q1R000000AJMo",0,0,0,0,209626,0,"2020-01-29T12:52:00",null,"Support site level joint lab-clinic patient education program for increased lab services uptake-develop IEC materials, health talk, and awareness creation for uptake of laboratory services.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Malawi","Malawi","PAI-5194","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Double investment for school-based RFHS referral agents ($0.33M) Catalytic funding will allow initial roll out of 400 referral agents. Above allocation funding will provide sufficient funding for an additional 400 (800 total).",330000,null,"Active","a6Q1R000000AJLE",0,0,0,0,330000,0,null,null,"Double investment for school-based RFHS referral agents ($0.33M) Catalytic funding will allow initial roll out of 400 referral agents. Above allocation funding will provide sufficient funding for an additional 400 (800 total).","High","This will increase the effectiveness and efficiency of catalytic funding that has also been recommended.","NA Original Intervention: Linkages of HIV, RMNCH, and TB programs for adolescents, girls and young women","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5193","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Double investment for adolescent girls and boys and young women men to distribute condoms ($0.16M) Catalytic funding is currently funding incentives for the first 250. Above allocation funding will provide sufficient funding for an additional 250 (500 total).",160000,null,"Active","a6Q1R000000AJLD",0,0,0,0,160000,0,null,null,"Double investment for adolescent girls and boys and young women men to distribute condoms ($0.16M) Catalytic funding is currently funding incentives for the first 250. Above allocation funding will provide sufficient funding for an additional 250 (500 total).","High","This will increase the effectiveness and efficiency of catalytic funding that has also been recommended.","NA Original Intervention: Male and female condoms for adolescents and youth, in and out of school","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Madagascar","Madagascar","PAI-5065","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","The activity consists of providing social and financial support to patients living in extreme poverty. This amount would provide medical care for those testing HIV-positive throughout the country, estimated at 50 patients a year on average, covering both hospitalization and outpatients.\nThe average cost is 1 million Malagasy ariary per PLHIV per year. This covers drugs other than ARVs, paraclinical examinations (including imagery), non-subsidized additional tests, food, transport and medical waste disposal.",94403,null,"Active","a6Q1R000000AJJ9",0,0,0,0,94403,0,null,null,"The activity consists of providing social and financial support to patients living in extreme poverty. This amount would provide medical care for those testing HIV-positive throughout the country, estimated at 50 patients a year on average, covering both hospitalization and outpatients.\nThe average cost is 1 million Malagasy ariary per PLHIV per year. This covers drugs other than ARVs, paraclinical examinations (including imagery), non-subsidized additional tests, food, transport and medical waste disposal.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2020-12-31","HIV/AIDS"]
["CT Madagascar","Madagascar","PAI-5058","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","This activity involves holding an annual meeting to draft the DLIS work plan, to act as a dashboard for all stakeholders in the response. This workshop will be attended by partners and regional teams.\nThe costs of holding the meeting cover transport, allowances, room hire, stationery, coffee breaks and organizational costs.",12268,null,"Active","a6Q1R000000AJJ2",0,0,0,0,12268,0,null,null,"This activity involves holding an annual meeting to draft the DLIS work plan, to act as a dashboard for all stakeholders in the response. This workshop will be attended by partners and regional teams.\nThe costs of holding the meeting cover transport, allowances, room hire, stationery, coffee breaks and organizational costs.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2020-12-31","HIV/AIDS"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4957","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Adaptation of the module on the analysis of the legal environment that limits the rights of people with TB. Based on the module produced by the Stop TB Partnership and the UNDP, we will validate and adapt this module to the LAC context.",14000,null,"Inactive","a6Q1R000000AJHP",14000,0,0,0,0,1,null,null,"Adaptation of the module on the analysis of the legal environment that limits the rights of people with TB. Based on the module produced by the Stop TB Partnership and the UNDP, we will validate and adapt this module to the LAC context.","High","The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4956","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Technical assistance for TB stigma measurement. With the support of technical members of the National Social TB Observatories, a standardized protocol will be developed, and the survey will be carried out in each of the 8 countries participating in the grant.",86000,null,"Inactive","a6Q1R000000AJHO",86000,0,0,0,0,1,null,null,"Technical assistance for TB stigma measurement. With the support of technical members of the National Social TB Observatories, a standardized protocol will be developed, and the survey will be carried out in each of the 8 countries participating in the grant.","High","The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4823","MCI-00023","Program management","MCI-00207","Grant management","Additional resources for baseline, mid term and evaluation and learning and sharing events.",360000,null,"Active","a6Q1R000000AJFF",0,0,0,0,360000,0,null,null,"Additional resources for baseline, mid term and evaluation and learning and sharing events.","High",null,"NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Viet Nam","Viet Nam","PAI-5935","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Events for community initiatives to reduce Stigma & Discrimination in five Global-Fund supported provinces.",10588,null,"Active","a6Q1R000000AJXB",0,0,0,0,10588,0,null,null,"Events for community initiatives to reduce Stigma & Discrimination in five Global-Fund supported provinces.","Low","Low priority which could be covered from existing funds.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5845","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","This funds will cover active disease surveillance activities, screening of populations irrespective of the presence of fever or any other signs or symptoms of malaria to detect infections and residual parasite carriers in the low transmission regions nearing malaria elimination.",400000,null,"Inactive","a6Q1R000000AJVj",400000,0,0,0,0,1,null,null,"This funds will cover active disease surveillance activities, screening of populations irrespective of the presence of fever or any other signs or symptoms of malaria to detect infections and residual parasite carriers in the low transmission regions nearing malaria elimination.","High","This funds will cover active disease surveillance activities, screening of populations irrespective of the presence of fever or any other signs or symptoms of malaria to detect infections and residual parasite carriers in the low transmission regions nearing malaria elimination","NA Original Intervention: Other vector control measures","Shalini Mitra","2019-10-30","2017-2019","Malaria, RSSH"," High Impact Africa 2",null,"Multi-component"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5844","MCI-00012","Case management","MCI-00158","Therapeutic efficacy surveillance","These funds are critical for covering therapeutic efficacy studies (TES), and detection of any other evidence of treatment failures or emerging drug resistance.",600000,null,"Active","a6Q1R000000AJVi",360000,0,0,0,240000,0,null,null,"These funds are critical for covering therapeutic efficacy studies (TES), and detection of any other evidence of treatment failures or emerging drug resistance.","High","This funds are critical for covering therapeutic efficacy studies (TES), and detection of any other evidence of treatment failures or emerging drug resistance.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria, RSSH"," High Impact Africa 2",null,"Multi-component"]
["CT Tunisia","Tunisia","PAI-5839","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00564","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Strengthening the conditions for addressing stigma, discrimination and violence against people in prisons and other closed settings through the establishment of an accreditation mechanism for HIV screening by community actors and by raising awareness of the rights of key populations will, in the long term, have a positive and sustainable impact on HIV control.",130065,null,"Active","a6Q1R000000AJVd",122904,0,0,0,7161,0,null,null,"Strengthening the conditions for addressing stigma, discrimination and violence against people in prisons and other closed settings through the establishment of an accreditation mechanism for HIV screening by community actors and by raising awareness of the rights of key populations will, in the long term, have a positive and sustainable impact on HIV control.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Togo","Togo","PAI-5746","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Pre-treatment assessments and biological monitoring.\n2Biological assessments make it possible to determine the suitable treatment  scheme,  monitor  the  effectiveness  and  safety  of  the treatments and, consequently, to improve the quality of life of the patients.",2211534.06,null,"Active","a6Q1R000000AJU8",0,0,0,0,2211534.06,0,null,null,"Pre-treatment assessments and biological monitoring.\n2Biological assessments make it possible to determine the suitable treatment  scheme,  monitor  the  effectiveness  and  safety  of  the treatments and, consequently, to improve the quality of life of the patients.","High","Togo has ambitious targets to reach the HIV epidemic control but national resources are very limited. The funding gaps are substantial. Thus, any available resources should be made available to support HIV testing and counselling services, antiretroviral treatment, and access to viral load monitoring. The PAAR clearly targets key and priority populations to benefit from these resources; men who have sex with men, female sex workers as well as pregnant women with prevention of mother-to-child transmission (PMTCT) of HIV.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6099","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.",9450,null,"Active","a6Q1R000000AJZp",0,0,0,0,9450,0,null,null,"PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","High","Prisoners are important key populations. High impact intervention","NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6098","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.",374255,null,"Active","a6Q1R000000AJZo",0,0,0,0,374255,0,null,null,"PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","High","Community based active case finding is critically important.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Kosovo","Kosovo","PAI-5985","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","Given limited amount allocated to HIV prevention services among sex workers in the grant, these additional resources will be used for additional outreach workers and peer educators. It will help to attain targets set.",10099.879999999999,null,"Active","a6Q1R000000AJXz",0,0,0,0,10099.879999999999,0,null,null,"Given limited amount allocated to HIV prevention services among sex workers in the grant, these additional resources will be used for additional outreach workers and peer educators. It will help to attain targets set.","High","These additional resources for Sex Worker programs will be used for additional outreach workers and Peer educators beyond the withinallocation amount: this will contribute to attaining the targets, as it will be difficult to do so with the limited number of staff and volunteers financed through the within-allocation amount.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Eswatini","Eswatini","PAI-5675","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Interventions to address quality of care issues specific to Adolescent Friendly Health Services (AFHS). These include technical assistance for incorporation of AFHS standards into quality audit forms, quarterly joint technical working group meetings between relevant MOH departments and incorporating the AFHS component into the quality audits conductedby the ministry of health in the 20 priority Tinkundla.",253000,null,"Active","a6Q1R000000AJSz",0,0,0,0,253000,0,null,null,"Interventions to address quality of care issues specific to Adolescent Friendly Health Services (AFHS). These include technical assistance for incorporation of AFHS standards into quality audit forms, quarterly joint technical working group meetings between relevant MOH departments and incorporating the AFHS component into the quality audits conductedby the ministry of health in the 20 priority Tinkundla.","High","This funding for technical assistance to integrate adolescent services into routine care through quarterly joint technical working group meetings between relevant MOH departments and incorporating the AFHS component into the quality audits conducted by the ministry of health in the 20 priority Tinkundla is essential for the continued success of the program.","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Supportive policy and programmatic environment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Somalia","Somalia","PAI-5573","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00177","Other health and community workforce intervention(s)","Health Professional Councils as part of the Health Sector Strategic Plans (HSSPs) are key to addressing the lack of oversight and regulation of different health sectors and will support standards.",356400,null,"Inactive","a6Q1R000000AJRL",356400,0,0,0,0,1,null,null,"Health Professional Councils as part of the Health Sector Strategic Plans (HSSPs) are key to addressing the lack of oversight and regulation of different health sectors and will support standards.","High","Health Professional Councils as part of the Health Sector Strategic Plans (HSSPs ) are key to addressing the lack of oversight and regulation of different health sectors and will support standards.","NA Original Module: RSSH - Human resources for health, including community health workers. Original Intervention: Support the establishment of health professional councils","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5572","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","Building on the national and sub national efforts to strengthen supply chain capacity, this would further strengthen regional supply chain capacity.",250744,null,"Active","a6Q1R000000AJRK",0,0,0,0,250744,0,null,null,"Building on the national and sub national efforts to strengthen supply chain capacity, this would further strengthen regional supply chain capacity.","High","Building on the national and sub national efforts to strengthen supply chain capacity, this would further strengthen regional supply chain capacity.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Strengthened Regional supply Chain Capacity Building to Regional Level","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Sierra Leone","Sierra Leone","PAI-5537","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Sierra Leone adopted the following three regimen design options for the management of MDR-TB: (i)Shorter regimen with Amikacin: 4-6 Am-Mfx-Pto-Cfz-Z-high-dose H-E/5 Mfx-Cfz-Z-E; (ii) Modified shorter regimen under operational research, oral regimen: 9 Lfx-Bdq-Lzd-Cfz-Z; and (iii)  Fully oral longer regimen: 18 Lfx-Bdq-Lzd-Cfz-Z. The second regimen - modified shorter regimen, is expected to be implemented under operational research. In this regard, additional funding is needed for clinical training for health care workers; pharmacovigilance training; patient care including monitoring tests and patient support; technical assistance missions to support the development of protocol and its implementation; data management, documentation and dissemination of results.",560000,null,"Active","a6Q1R000000AJQl",0,0,0,0,560000,0,null,null,"Sierra Leone adopted the following three regimen design options for the management of MDR-TB: (i)Shorter regimen with Amikacin: 4-6 Am-Mfx-Pto-Cfz-Z-high-dose H-E/5 Mfx-Cfz-Z-E; (ii) Modified shorter regimen under operational research, oral regimen: 9 Lfx-Bdq-Lzd-Cfz-Z; and (iii)  Fully oral longer regimen: 18 Lfx-Bdq-Lzd-Cfz-Z. The second regimen - modified shorter regimen, is expected to be implemented under operational research. In this regard, additional funding is needed for clinical training for health care workers; pharmacovigilance training; patient care including monitoring tests and patient support; technical assistance missions to support the development of protocol and its implementation; data management, documentation and dissemination of results.","High",null,"TRP June Retreat 2019 Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, Malaria, RSSH"," Western Africa","2021-06-30","Multi-component"]
["CT Sierra Leone","Sierra Leone","PAI-5532","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","WFP estimates, 6184 adult PLHIVs, positive pregnant women and OVCs in need of nutritional support from 2018-2020. The within allocation budget will provide nutritional support for 1,797 positive pregnant women, adults PLHIVs and OVCs in 2018.\nThe PAAR will be used to procure and distribute food for an additional 4,351 positive pregnant women, adults PLHIVs and OVCs in 2018 plus 6148 additional PLHIVs in 2019 and 6148 in 2020 respectively.",3756370,null,"Active","a6Q1R000000AJQg",770000,700000,0,0,2286370,0,null,null,"WFP estimates, 6184 adult PLHIVs, positive pregnant women and OVCs in need of nutritional support from 2018-2020. The within allocation budget will provide nutritional support for 1,797 positive pregnant women, adults PLHIVs and OVCs in 2018.\nThe PAAR will be used to procure and distribute food for an additional 4,351 positive pregnant women, adults PLHIVs and OVCs in 2018 plus 6148 additional PLHIVs in 2019 and 6148 in 2020 respectively.","High","If efficiencies are found within the grant, this item can be reconsidered for funding as an expansion of the food programme, contingent upon assessment of how these investments fit in the overall HIV program and the national framework for provision of food supplements to improve HIV treatment outcomes. However, the TRP considers scale-up of ART and PMTCT as very high priority should additional resources become available.","NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Western Africa","2020-12-31","HIV/AIDS"]
["CT Paraguay","Paraguay","PAI-5434","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Acquisition of merchandising for vulnerable populations and PLWH, in order to, within the framework of the Communication Plan, implement promotions with those who access the test. The acquisition of attractive and useful materials for the key populations is proposed in order to carry out promotions that encourage the testing between them. These materials will support the implementation of peer-to-peer activities, on which the achievement of test goals depends.",39160,null,"Active","a6Q1R000000AJP6",0,0,0,0,39160,0,null,null,"Acquisition of merchandising for vulnerable populations and PLWH, in order to, within the framework of the Communication Plan, implement promotions with those who access the test. The acquisition of attractive and useful materials for the key populations is proposed in order to carry out promotions that encourage the testing between them. These materials will support the implementation of peer-to-peer activities, on which the achievement of test goals depends.","Medium","Provision of merchandise needed by key populations encourages their engagement in HIV testing and treatment monitoring. However, to guard against coercion and to ensure equitable distribution, the TRP suggests the applicant to monitor and document this activity so as to have information on the cost effectiveness of this approach for future program reference",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-02-28","HIV/AIDS"]
["CT Paraguay","Paraguay","PAI-5433","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Awareness visits and the planning of a joint and articulated work agenda between representatives of the Health Regions (RS), PRONASIDA and civil society (CS), at the local level. These visits have the objective of empowering local actors to carry out activities related to the national response to HIV, in addition to promoting an articulated work with the CS and the local level. It is suggested that with these visits, regional work plans would be developed and then followed up.",16090,null,"Active","a6Q1R000000AJP5",0,0,0,0,16090,0,null,null,"Awareness visits and the planning of a joint and articulated work agenda between representatives of the Health Regions (RS), PRONASIDA and civil society (CS), at the local level. These visits have the objective of empowering local actors to carry out activities related to the national response to HIV, in addition to promoting an articulated work with the CS and the local level. It is suggested that with these visits, regional work plans would be developed and then followed up.","Medium","Sound regional plans facilitate decentralized monitoring and management, thus the TRP ranks this item as medium priority",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-02-28","HIV/AIDS"]
["CT Nepal","Nepal","PAI-5338","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To review the implementation of the NSP, recommend mid-course corrections and provide inputs for better planning and preparation for the next phase.",78300,null,"Active","a6Q1R000000AJNY",0,0,0,0,78300,0,null,null,"To review the implementation of the NSP, recommend mid-course corrections and provide inputs for better planning and preparation for the next phase.","High","This is an important activity that will enable an evaluation of the implementation of the NSP, recommend mid-course corrections and provide inputs for better planning and preparation for the next phase.","NA Original Intervention: Mid-term evaluation of NSP","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2021-03-15","Tuberculosis"]
["CT Sri Lanka","Sri Lanka","PAI-4718","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","Others tests and consumables to the Mobile HIV testing vehicles- Unable to predict at this stage, detailed cost breakdown will be informed during grant making.",100000,null,"Inactive","a6Q1R000000AJDY",100000,0,0,0,0,1,null,null,"Others tests and consumables to the Mobile HIV testing vehicles- Unable to predict at this stage, detailed cost breakdown will be informed during grant making.","High","As outlined under issue 1, this will be used for additional testing and consumables related to the Mobile HIV testing vehicles, which is also critical to the success of the program","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-12-31","HIV/AIDS"]
["CT Nigeria","Nigeria","PAI-5284","MCI-00010","MDR-TB","MCI-00126","Case detection and diagnosis","Patient support for additional 2,592 patients to be commenced on treatment:\nThe request is for patient support for 50% (2,592 patients) of the deficit while the GON will cover the remaining 2592 (50%). This includes, inpatient feeding, social support, inpatient allowance, hearing aids, support for adverse reactions and comorbid conditions, treatment supporters, social support, baseline and follow up investigations, support for hospitalization in private health facilities.",1075425,null,"Active","a6Q1R000000AJMg",0,0,0,0,1075425,0,"2020-01-29T12:52:00",null,"Patient support for additional 2,592 patients to be commenced on treatment:\nThe request is for patient support for 50% (2,592 patients) of the deficit while the GON will cover the remaining 2592 (50%). This includes, inpatient feeding, social support, inpatient allowance, hearing aids, support for adverse reactions and comorbid conditions, treatment supporters, social support, baseline and follow up investigations, support for hospitalization in private health facilities.","High",null,"NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Nigeria","Nigeria","PAI-5281","MCI-00010","MDR-TB","MCI-00126","Case detection and diagnosis","Procurement of lab reagents and consumables for first and second line LPA:\nThe request is for procurement of Lab reagents and consumables, PPEs, etc. (including consumables for healthcare workers) for additional 2,592 patients (50% of the remaining gap).This will also improve surveillance and diagnosis of XDR TB. This also includes procurement fee, Insurance, Freight, in country distribution, QA charges and in country QA/QC.",3437667,null,"Active","a6Q1R000000AJMd",0,0,0,0,3437667,0,"2020-01-29T12:52:00",null,"Procurement of lab reagents and consumables for first and second line LPA:\nThe request is for procurement of Lab reagents and consumables, PPEs, etc. (including consumables for healthcare workers) for additional 2,592 patients (50% of the remaining gap).This will also improve surveillance and diagnosis of XDR TB. This also includes procurement fee, Insurance, Freight, in country distribution, QA charges and in country QA/QC.","High",null,"NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Malawi","Malawi","PAI-5185","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","To ensure GF and development partner supported efforts in 2018 and 2019 towards increase of ANC uptake of at least three doses of IPTp from 12% in 2014 (MIS) to 60% by 2022 through supportive supervision this request is for continued funding in 2020.",46395,null,"Active","a6Q1R000000AJL5",0,0,0,0,46395,0,null,null,"To ensure GF and development partner supported efforts in 2018 and 2019 towards increase of ANC uptake of at least three doses of IPTp from 12% in 2014 (MIS) to 60% by 2022 through supportive supervision this request is for continued funding in 2020.","Medium","To ensure vulnerable groups prioritised","NA Original Module: Specific prevention interventions. Original Intervention: Intermittent preventive treatment ? In pregnancy","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2020-12-31","Malaria"]
["CT Madagascar","Madagascar","PAI-5055","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00108","HIV testing services for adolescents and youth, in and out of school","This refers to activities to accompany young people who agree to testing. This funding will cover monitoring of targets for testing at health centers, with a view to achieving testing coverage of 36 per cent in 2018 and 45 per cent in 2020. It will also provide for activities to accompany young people who test positive to referral doctors, in order to reduce the number of initial patients lost to follow-up and improve retention from 127 cases in 2018 to 168 cases in 2020, thus helping to achieve the enrolment target of 65 per cent of new cases on ART. There will also be mobile testing targeting young people, ensuring local service provision through mobile clinics. The above allocation amount will cover 27 per cent of the target for accompanying during testing, representing an additional 198,114 young people tested.",131082,null,"Active","a6Q1R000000AJIz",0,0,0,0,131082,0,null,null,"This refers to activities to accompany young people who agree to testing. This funding will cover monitoring of targets for testing at health centers, with a view to achieving testing coverage of 36 per cent in 2018 and 45 per cent in 2020. It will also provide for activities to accompany young people who test positive to referral doctors, in order to reduce the number of initial patients lost to follow-up and improve retention from 127 cases in 2018 to 168 cases in 2020, thus helping to achieve the enrolment target of 65 per cent of new cases on ART. There will also be mobile testing targeting young people, ensuring local service provision through mobile clinics. The above allocation amount will cover 27 per cent of the target for accompanying during testing, representing an additional 198,114 young people tested.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2020-12-31","HIV/AIDS"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4954","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Civil society participation in regional and global TB events. Considering the advocacy and surveillance role of social TB observatories, it is necessary to promote the participation of civil society representatives in important events, such as the UNION Conference, the PAHO Regional TB Meeting, and/or the follow-up meetings to be scheduled at the UN General Assembly High-Level Meeting on Ending TB.",72000,null,"Inactive","a6Q1R000000AJHM",72000,0,0,0,0,1,null,null,"Civil society participation in regional and global TB events. Considering the advocacy and surveillance role of social TB observatories, it is necessary to promote the participation of civil society representatives in important events, such as the UNION Conference, the PAHO Regional TB Meeting, and/or the follow-up meetings to be scheduled at the UN General Assembly High-Level Meeting on Ending TB.","Medium",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4953","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","National workshops on Social Protection in TB. This event will bring together government and civil society representatives from each country to exchange experiences and learn from opportunities in other countries.",150800,null,"Inactive","a6Q1R000000AJHL",150800,0,0,0,0,1,null,null,"National workshops on Social Protection in TB. This event will bring together government and civil society representatives from each country to exchange experiences and learn from opportunities in other countries.","Medium",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Multicountry EECA PAS","Multicountry EECA PAS","PAI-4948","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Annual workplan meetings for effective multi-partner coordination of the project implementation.",45000,null,"Inactive","a6Q1R000000AJHG",45000,0,0,0,0,1,null,null,"Annual workplan meetings for effective multi-partner coordination of the project implementation.","High","This item is considered as the highest priority and proposed activities should be included into the core grant through efficiencies  identified. Producing work plans is an essential tool to facilitate multi partner coordination and should be a core activity.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-12-31","Tuberculosis"]
["CT Multicountry HIV CB-PANCAP-CVCCOIN","Multicountry HIV Caribbean PCC Consortium","PAI-4816","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Improve knowledge, generation and use of strategic information on key populations for decision-making through Advocacy and inclusion of these sites as part of the regional HIV/STI testing network to ensure sustainability and recognition of CSO testing sites as key players in the regional HIV response. This will include regional quality oversight and negotiated pricing arrangements for HIV and STI testing reagents, supplies and equipment in order to improve CSO testing quality and access to cost-effective supplies. A regional repository will also be estbalished to identify, document, share and promote best practices for effective regional HIV and STI testing sites through the establishment of a repository which will include materials innovatively developed and customised to share best practices and models related to 1) Assessments conducted of selected HIV/STI testing sites (technical, quality and operational) to identify critical success factors for these Caribbean sites that serve key populations 2) HIV and STI algorithms, validated under the OECS GF grant and in collaboration with PAHO/WHO 3) A regional HIV testing policy that addresses HIV self-testing, validated through conduct of a self-testing pilot with triage 4) Regional standardised tools for quality monitoring, customised for key population sites (both technical as well as stigma and discrimination monitoring).",200000,null,"Active","a6Q1R000000AJF8",0,0,0,0,200000,0,null,null,"Improve knowledge, generation and use of strategic information on key populations for decision-making through Advocacy and inclusion of these sites as part of the regional HIV/STI testing network to ensure sustainability and recognition of CSO testing sites as key players in the regional HIV response. This will include regional quality oversight and negotiated pricing arrangements for HIV and STI testing reagents, supplies and equipment in order to improve CSO testing quality and access to cost-effective supplies. A regional repository will also be estbalished to identify, document, share and promote best practices for effective regional HIV and STI testing sites through the establishment of a repository which will include materials innovatively developed and customised to share best practices and models related to 1) Assessments conducted of selected HIV/STI testing sites (technical, quality and operational) to identify critical success factors for these Caribbean sites that serve key populations 2) HIV and STI algorithms, validated under the OECS GF grant and in collaboration with PAHO/WHO 3) A regional HIV testing policy that addresses HIV self-testing, validated through conduct of a self-testing pilot with triage 4) Regional standardised tools for quality monitoring, customised for key population sites (both technical as well as stigma and discrimination monitoring).","High",null,"Name is: CT Multicountry LAC CARICOM-PANCAP / Review approach Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-09-30","HIV/AIDS"]
["CT Viet Nam","Viet Nam","PAI-5928","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Organize workshops on sharing experiences, best practices and lessons learned in terms of strengthening and developing networks; service delivery, M&E etc. for CBOs in 15 Global Fundprovinces VNGOs' on-site (provinces/district) monitoring and mentoring to provide technical assistance in HIV/AIDS prevention programs and organizational development to CBOs Provincial focal points conduct monitoring trips and provide technical assistance as needed to CBOs in 15 provinces Provide peer mentoring support to CBOs engaged in prevention in provinces to monitor progress and provide technical assistance as needed.",205604,null,"Active","a6Q1R000000AJX4",0,0,0,0,205604,0,null,null,"Organize workshops on sharing experiences, best practices and lessons learned in terms of strengthening and developing networks; service delivery, M&E etc. for CBOs in 15 Global Fundprovinces VNGOs' on-site (provinces/district) monitoring and mentoring to provide technical assistance in HIV/AIDS prevention programs and organizational development to CBOs Provincial focal points conduct monitoring trips and provide technical assistance as needed to CBOs in 15 provinces Provide peer mentoring support to CBOs engaged in prevention in provinces to monitor progress and provide technical assistance as needed.","Medium","Community participation is very important in this area.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Viet Nam","Viet Nam","PAI-5927","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Advocacy for preferential tax policy for CSO.",33380,null,"Active","a6Q1R000000AJX3",0,0,0,0,33380,0,null,null,"Advocacy for preferential tax policy for CSO.","Medium","It will be important for the CSOs involved in the funding request to be recipients of funding and this intervention may facilitate that.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Tunisia","Tunisia","PAI-5836","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","Screening activities for MSM will contribute to continued achievement of objectives relating to elimination of the disease, which is concentrated among key populations in Tunisia.",29005,null,"Inactive","a6Q1R000000AJVa",29005,0,0,0,0,1,null,null,"Screening activities for MSM will contribute to continued achievement of objectives relating to elimination of the disease, which is concentrated among key populations in Tunisia.","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Togo","Togo","PAI-5741","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Nutritional support and transport fees for MDR-TB patients.",476537.99,null,"Active","a6Q1R000000AJU3",0,0,0,0,476537.99,0,null,null,"Nutritional support and transport fees for MDR-TB patients.","High","Nutritional support and transport of patients with multi-drug-resistant tuberculosis (MDR-TB) including 52 MDR cases treated under the allocation funding and for 112 expected MDR-TB cases during the out-patient treatment.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6094","MCI-00023","Program management","MCI-00207","Grant management","PR (7%) and SR (3%) costs for implementation of the total PAAR request.",8953015,null,"Active","a6Q1R000000AJZk",8925327,0,0,0,27688,0,null,null,"PR (7%) and SR (3%) costs for implementation of the total PAAR request.","High","Program costs seem too high",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6093","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Additional scale up through extended outreach from fixed and mobile sites.",1938840,null,"Active","a6Q1R000000AJZj",0,0,0,0,1938840,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Comprehensive program for SW exists - high impact intervention","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6088","MCI-00534","Comprehensive prevention programs for MSM","MCI-00539","Addressing stigma, discrimination and violence against MSM","Additional scale up through extended outreach from fixed and mobile sites.",72600,null,"Active","a6Q1R000000AJZe",0,0,0,0,72600,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Comprehensive program exists for MSM","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Addressing stigma, discrimination and violence against men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Kosovo","Kosovo","PAI-5978","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Additional funds will be used to further develop and support networking of community groups, particularly of key populations, to ensure social mobilisation, representation and advocacy at national level.",20704.75,null,"Active","a6Q1R000000AJXs",0,0,0,0,20704.75,0,null,null,"Additional funds will be used to further develop and support networking of community groups, particularly of key populations, to ensure social mobilisation, representation and advocacy at national level.","High","Additional funds will be used to further develop and support networking of community groups, particularly of key populations, to ensure social mobilisation, representation and advocacy at national level ? given limited funding in the withinallocation amount.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Eswatini","Eswatini","PAI-5668","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conduct several additional surveys, including: a Cohort Nutrition Assessment, do a PMTCT Effectiveness Survey, Conduct the next demographic and health survey, Conduct an Integrated Bio Behavioural Survey (IBBS) (building on the one currently being done by OIM), evaluate the Socio-economic impact of HIV and TB and do an HIV DR survey.",2145000,null,"Active","a6Q1R000000AJSs",0,0,0,0,2145000,0,null,null,"Conduct several additional surveys, including: a Cohort Nutrition Assessment, do a PMTCT Effectiveness Survey, Conduct the next demographic and health survey, Conduct an Integrated Bio Behavioural Survey (IBBS) (building on the one currently being done by OIM), evaluate the Socio-economic impact of HIV and TB and do an HIV DR survey.","High","Only half of the requested amount of this\nintervention has been recommended to fund the\nproposed Cohort Nutritional Assessment, the\nPMTCT Effectiveness Survey, the demographic and\nhealth survey and the next Integrated Biobehavioural\nSurvey (IBBS). In the resource\nconstrained setting of Swaziland the evaluation of\nthe socio-economic impact of HIV and TB is not\nincluded as it will have limited direct strategic impact\non the national response to HIV/TB","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5667","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","This funding will be utilised to conduct trainings (of trainers) in provider initiated HIV testing services (PIHTS) as well as in-service training on the new HTS guidelines, in all four regions. This will be paired with provider initiated HIV testing services (PIHTS) training counselling to facilities (in close coordination with PEPFAR, which is also funding portions of this activity). Along with training, funding will support the procurement of working tools as well as psychosocial support for the HTS providers.",121544,null,"Active","a6Q1R000000AJSr",0,0,0,0,121544,0,null,null,"This funding will be utilised to conduct trainings (of trainers) in provider initiated HIV testing services (PIHTS) as well as in-service training on the new HTS guidelines, in all four regions. This will be paired with provider initiated HIV testing services (PIHTS) training counselling to facilities (in close coordination with PEPFAR, which is also funding portions of this activity). Along with training, funding will support the procurement of working tools as well as psychosocial support for the HTS providers.","High","Differentiated testing strategies are important and this allocation will enable the development of a supportive policy environment for key populations in Swaziland in order to implement these and find new patients needing care",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Somalia","Somalia","PAI-5564","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","If no MRA funding is secured through GF or other sources, the continuation of the Medicines Steering Committees will be needed to fill the gap of coordination and oversight of medicines management.",109806,null,"Active","a6Q1R000000AJRC",0,0,0,0,109806,0,null,null,"If no MRA funding is secured through GF or other sources, the continuation of the Medicines Steering Committees will be needed to fill the gap of coordination and oversight of medicines management.","High","If no magnetic resonance angiography (MRA) funding is secured through Global Fund or other sources, the continuation of the Medicines Steering Committees will be needed to fill the gap of coordination and oversight of medicines management.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Medicines Steering Committees","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Sierra Leone","Sierra Leone","PAI-5529","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","Currently 170 health facilities provide comprehensive TB/HIV services (12-13% of TB/HIV co-infection). The PAAR will be utilized to:\n? Increase the number of health facilities providing TB/HIV services by 150 and train 300 health care providers in these facilities\n? Supportive supervision and monitoring to all the targeted health facilities at least once every quarter\n? Provide one-stop care for co-infected patients",240000,null,"Active","a6Q1R000000AJQd",0,0,0,0,240000,0,null,null,"Currently 170 health facilities provide comprehensive TB/HIV services (12-13% of TB/HIV co-infection). The PAAR will be utilized to:\n? Increase the number of health facilities providing TB/HIV services by 150 and train 300 health care providers in these facilities\n? Supportive supervision and monitoring to all the targeted health facilities at least once every quarter\n? Provide one-stop care for co-infected patients","High","Given the epidemiology of TB and HIV in the country, it is essential to maximize the integration and joint supervision of TB and HIV, especially after the health system collapse during the EVD outbreak.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Western Africa","2020-12-31","HIV/AIDS"]
["CT Paraguay","Paraguay","PAI-5431","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Implementation of small groups to FSW with the offer of beauty services. This initiative seeks to access the FSW that are reluctant to access information and offer testing through the conventional approach. This activity contributes to the achievement of testing goals for FSW proposed in the project framework. The implementation of this strategy seeks to obtain the consent of the owners of premises as well as the interest of FSW that do not access the offer of testing in the premises, providing them with an additional service, with the delivery of information about HIV and STIs. This strategy has been implemented in a pilot way with important results since the information is delivered in a more enjoyable way, within the framework of a conversation between the educator and the FSW.",29493,null,"Active","a6Q1R000000AJP3",0,0,0,0,29493,0,null,null,"Implementation of small groups to FSW with the offer of beauty services. This initiative seeks to access the FSW that are reluctant to access information and offer testing through the conventional approach. This activity contributes to the achievement of testing goals for FSW proposed in the project framework. The implementation of this strategy seeks to obtain the consent of the owners of premises as well as the interest of FSW that do not access the offer of testing in the premises, providing them with an additional service, with the delivery of information about HIV and STIs. This strategy has been implemented in a pilot way with important results since the information is delivered in a more enjoyable way, within the framework of a conversation between the educator and the FSW.","Medium","This is an incentive scheme, the TRP ranks it as medium priority",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-02-28","HIV/AIDS"]
["CT Paraguay","Paraguay","PAI-5430","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Acquisition of plate agitators, centrifuges, portable viral load and CD4 equipment with their reagents for 1 year. In the framework of the Comprehensive Plan for HIV Approach and Intervention, the main strategy proposed is decentralization / deconcentration of HIV care, and therefore, the response to the user is at the point of care (Comprehensive Care Service), for  diagnosis (second pillar) with the acquisition of plate agitators and centrifuges for WB, and for monitoring (third and fourth pillar) with the acquisition of equipment for viral load and CD4. The installation of such equipment in the selected establishments will reduce the waiting time of people either for the confirmation of a reactive result (for the beginning of treatment), or for follow-up of the viral load and CD4 of the PLWHIV. This intervention will contribute to reduce barriers to access to diagnosis and follow-up, favoring both the linkage and retention of people with reactive results and the rapid start of ART, with a corresponding decrease in viral load in them. It is worth noting that under the current subsidy, 3 viral load equipment were acquired and installed in the SAIs of Central, Itapúa and Alto Paraná, respectively; and 6 of CD4 have been acquired for the SAI of Concepción, Caaguazú, San Pedro, Boquerón, Canindeyú and Guairá. This purchase seeks to provide key regions (Asunción / IMT (Institute of Tropical Medicine), Ñeembucú and Cordillera, for their geographical location and / or number of patients in follow-up with the necessary equipment to reduce the barrier of geographical distance. The strengthening of point-of-care laboratories is a necessity to facilitate access to timely diagnosis as well as to the monitoring of PLWHIV.",322491,null,"Active","a6Q1R000000AJP2",0,0,0,0,322491,0,null,null,"Acquisition of plate agitators, centrifuges, portable viral load and CD4 equipment with their reagents for 1 year. In the framework of the Comprehensive Plan for HIV Approach and Intervention, the main strategy proposed is decentralization / deconcentration of HIV care, and therefore, the response to the user is at the point of care (Comprehensive Care Service), for  diagnosis (second pillar) with the acquisition of plate agitators and centrifuges for WB, and for monitoring (third and fourth pillar) with the acquisition of equipment for viral load and CD4. The installation of such equipment in the selected establishments will reduce the waiting time of people either for the confirmation of a reactive result (for the beginning of treatment), or for follow-up of the viral load and CD4 of the PLWHIV. This intervention will contribute to reduce barriers to access to diagnosis and follow-up, favoring both the linkage and retention of people with reactive results and the rapid start of ART, with a corresponding decrease in viral load in them. It is worth noting that under the current subsidy, 3 viral load equipment were acquired and installed in the SAIs of Central, Itapúa and Alto Paraná, respectively; and 6 of CD4 have been acquired for the SAI of Concepción, Caaguazú, San Pedro, Boquerón, Canindeyú and Guairá. This purchase seeks to provide key regions (Asunción / IMT (Institute of Tropical Medicine), Ñeembucú and Cordillera, for their geographical location and / or number of patients in follow-up with the necessary equipment to reduce the barrier of geographical distance. The strengthening of point-of-care laboratories is a necessity to facilitate access to timely diagnosis as well as to the monitoring of PLWHIV.","Medium","The requested equipment and supply are necessary for monitoring treatment effectiveness, thus a medium quality demand. However, the TRP suggests that the equipment and supplies be prioritized for high use -rate locations",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-02-28","HIV/AIDS"]
["CT Liberia","Liberia","PAI-4715","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","TB increases the risk of HIV infection and vice versa, and TB is the leading cause of death among HIV patients. AIDS is a major cause of death among TB patients. About 16% of TB patients are co-infected with HIV. Joint HIV and TB collaborative activities produce better and improved outcomes for both TB and HIV programs and in patients co-infected with HIV and TB. This PAAR investment is intended to strengthen TB HIV integration at the subnational, particularly at health facility and community levels.",792000,null,"Active","a6Q1R000000AJDV",0,0,0,0,792000,0,null,null,"TB increases the risk of HIV infection and vice versa, and TB is the leading cause of death among HIV patients. AIDS is a major cause of death among TB patients. About 16% of TB patients are co-infected with HIV. Joint HIV and TB collaborative activities produce better and improved outcomes for both TB and HIV programs and in patients co-infected with HIV and TB. This PAAR investment is intended to strengthen TB HIV integration at the subnational, particularly at health facility and community levels.","Medium","The TRP was unable to discern what additional interventions would be undertaken for this module in the PAAR. It was assumed that the additional funds will help to plug gaps for TB/HIV collaborative activities covered under the allocation amount","NA Original Intervention: TB/HIV integration","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Liberia","Liberia","PAI-4712","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Ensuring quality programing in challenging operating environment where skills are limited and chances of frauds and wrongdoing are high, requires a high-quality response and management. It has not been easy to establish a key population friendly program in  Liberia given the environment of phobia, stigma and discrimination and criminalization. There are challenges of finding adequate staff, infrastructure (rental spaces), human resources and security to implement key population program. It is important that the program delivers the intended results in a timely and quality manner. Adequate staff and infrastructure is required for the same. In the current allocationa limited amount is available to manage the\nprograms specially for the civil society PR. This request is to ensure adequate management support to deliver a high quality program in a scaled up fashion. The key population program was initiated only in second half of 2016. It is requested that adequate program management support is provided scaling and delivering tangible results. The support requested is as follows: a. Grant management and office running costs including but not limited to: Office security, legal counsel, annual external and internal audit, office equipment, communication and internet, fuel for vehicles and generator, maintenance of office equipment and vehicles, office equipment and rent, vehicle insurance. Amount requested is USD 1,448,771 b. Staff training on finance and technical issues: Such  opportunities allow PSI staff to ensure the highest quality of technical and financial/administrative management of the project by allowing them remain on the cutting-edge as regards technical issues, new policies and procedures, as well as attend trainings to enhance their own skills in technical and programmatic areas, including new prevention technologies like self-testing, PrEP, and other such innovations. The amount requested is USD 86,938 Human Resource: The current allocation does not provide enough to over the following positions that are required to deliver the program: Country Representative, Grants and Contracts Manager, Program Director, Internal Auditor (in country), M&E manager, Finance manager, M&E officer, Finance Coordinator, warehouse manager, drivers and similar positions. These positions have proven themselves crucial in the current grant to ensure technical quality and oversight, financial and administrative compliance, and fraud management and prevention; the program would be impossible to implement without them. Some of the common cost positions and other positions will be phased out as the program scales down for general population. The total amount requested is USD 2,365,724.",1300477,null,"Active","a6Q1R000000AJDS",0,0,0,0,1300477,0,null,null,"Ensuring quality programing in challenging operating environment where skills are limited and chances of frauds and wrongdoing are high, requires a high-quality response and management. It has not been easy to establish a key population friendly program in  Liberia given the environment of phobia, stigma and discrimination and criminalization. There are challenges of finding adequate staff, infrastructure (rental spaces), human resources and security to implement key population program. It is important that the program delivers the intended results in a timely and quality manner. Adequate staff and infrastructure is required for the same. In the current allocationa limited amount is available to manage the\nprograms specially for the civil society PR. This request is to ensure adequate management support to deliver a high quality program in a scaled up fashion. The key population program was initiated only in second half of 2016. It is requested that adequate program management support is provided scaling and delivering tangible results. The support requested is as follows: a. Grant management and office running costs including but not limited to: Office security, legal counsel, annual external and internal audit, office equipment, communication and internet, fuel for vehicles and generator, maintenance of office equipment and vehicles, office equipment and rent, vehicle insurance. Amount requested is USD 1,448,771 b. Staff training on finance and technical issues: Such  opportunities allow PSI staff to ensure the highest quality of technical and financial/administrative management of the project by allowing them remain on the cutting-edge as regards technical issues, new policies and procedures, as well as attend trainings to enhance their own skills in technical and programmatic areas, including new prevention technologies like self-testing, PrEP, and other such innovations. The amount requested is USD 86,938 Human Resource: The current allocation does not provide enough to over the following positions that are required to deliver the program: Country Representative, Grants and Contracts Manager, Program Director, Internal Auditor (in country), M&E manager, Finance manager, M&E officer, Finance Coordinator, warehouse manager, drivers and similar positions. These positions have proven themselves crucial in the current grant to ensure technical quality and oversight, financial and administrative compliance, and fraud management and prevention; the program would be impossible to implement without them. Some of the common cost positions and other positions will be phased out as the program scales down for general population. The total amount requested is USD 2,365,724.","High","The TRP considered that a third of the funds requested (US$ 3, 901, 431) would be adequate to manage this grant in this Challenging Operating Environment.","NA Original Intervention: Grant management, staff training, human resources","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Nigeria","Nigeria","PAI-5274","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Intensified Case Finding (ICF) among urban slum dweller in 10 additional states (Benue, Plateau, Rivers, Edo, Nassarawa, Niger, Taraba, Akwa Ibom, Zamfara and Ondo). Ten States have been prioritized for intensified case finding in slums within allocation. The scale up of ICF will complement PPM expansion. The ICF will increase awareness, health education and create demand for services and increase TB case notification.",330762,null,"Active","a6Q1R000000AJMW",0,0,0,0,330762,0,"2020-01-29T12:52:00",null,"Intensified Case Finding (ICF) among urban slum dweller in 10 additional states (Benue, Plateau, Rivers, Edo, Nassarawa, Niger, Taraba, Akwa Ibom, Zamfara and Ondo). Ten States have been prioritized for intensified case finding in slums within allocation. The scale up of ICF will complement PPM expansion. The ICF will increase awareness, health education and create demand for services and increase TB case notification.","High",null,"NA Original Intervention: Key populations (TB care and prevention) ? Others","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Malawi","Malawi","PAI-5182","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Malawi requests for funding in 2020 to continue to support monitoring and evaluation so as to build upon global fund and partners? investments and sustain the gains achieved in the first two years. This support will maintain the routine disease surveillance systems and enable Malawi to collect robust, timely, and accurate data for improved program management. Thus enabling the National Malaria Control program and development partners to assess implementation progress and reprogram as maybe required in addition to providing evidence for allocation of resources so as to support achievement of maximum impact.",42437,null,"Active","a6Q1R000000AJL2",0,0,0,0,42437,0,null,null,"Malawi requests for funding in 2020 to continue to support monitoring and evaluation so as to build upon global fund and partners? investments and sustain the gains achieved in the first two years. This support will maintain the routine disease surveillance systems and enable Malawi to collect robust, timely, and accurate data for improved program management. Thus enabling the National Malaria Control program and development partners to assess implementation progress and reprogram as maybe required in addition to providing evidence for allocation of resources so as to support achievement of maximum impact.","High","This activity is very important for M&E improvement","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2020-12-31","Malaria"]
["CT Malawi","Malawi","PAI-5177","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Additional funding is being requested for 2020 to ensure that the key SBCC activities are maintained in order to ensure maintained uptake and utilization of the malaria interventions implemented during this period. Specifically, this will include the following activities: Support National Malaria Commemorative Days(SADC Week and World Malaria Day); Identify and orient media team on emerging issues, successes and challenges in malaria programming; Document malaria success stories through Media visits to different communities; Conduct School Based Malaria Awareness Campaign; Conduct training of Primary Teachers as Malaria School Patrons/Matrons; Conduct Community Meetings with Malaria Champions; Conduct malaria information dissemination sessions (malaria open days and community dialogues). Train Community Structures (CLANS) in Care Group Model for dissemination of Malaria messages.",768086,null,"Active","a6Q1R000000AJKx",0,0,0,0,768086,0,null,null,"Additional funding is being requested for 2020 to ensure that the key SBCC activities are maintained in order to ensure maintained uptake and utilization of the malaria interventions implemented during this period. Specifically, this will include the following activities: Support National Malaria Commemorative Days(SADC Week and World Malaria Day); Identify and orient media team on emerging issues, successes and challenges in malaria programming; Document malaria success stories through Media visits to different communities; Conduct School Based Malaria Awareness Campaign; Conduct training of Primary Teachers as Malaria School Patrons/Matrons; Conduct Community Meetings with Malaria Champions; Conduct malaria information dissemination sessions (malaria open days and community dialogues). Train Community Structures (CLANS) in Care Group Model for dissemination of Malaria messages.","Low","Insufficient justification for effectiveness from previous funding and for increase","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2020-12-31","Malaria"]
["CT Madagascar","Madagascar","PAI-5046","MCI-00007","Treatment, care and support","MCI-00121","Prevention, diagnosis and treatment of opportunistic infections","Opportunistic infections increase mortality in PLHIV. The incidence of opportunistic infection in Madagascar is 16 per cent. Due to insufficient funds under the allocation amount, testing and treatment had to be included under the above allocation amount and the procurement of ARVs was prioritized. Moreover, the 16 per cent represents about 300 people per year in absolute terms.",658930,null,"Active","a6Q1R000000AJIq",0,0,0,0,658930,0,null,null,"Opportunistic infections increase mortality in PLHIV. The incidence of opportunistic infection in Madagascar is 16 per cent. Due to insufficient funds under the allocation amount, testing and treatment had to be included under the above allocation amount and the procurement of ARVs was prioritized. Moreover, the 16 per cent represents about 300 people per year in absolute terms.","Low","The cost per OI as stated is $2,196 and not backed by categorization of OI's in reference. Inadequate information to gauge this demand.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2020-12-31","HIV/AIDS"]
["CT Multicountry HIV CB-PANCAP-CVCCOIN","Multicountry HIV Caribbean PCC Consortium","PAI-4813","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","(To be read in conjunction with the SW intervention) Developing more effective models to reach DL MSM and 2.3 Developing more effective models to reach female partners of MSM. Throughout this module CVC would institute 4 axis to ensure more effective sub-population HIV prevention programs: (i) strengthened programmatic and contextual understanding, especially of the heterogeneity of sex work and complexity of closeted MSM behaviour; (ii) intensified program implementation and delivery of comprehensive, proven interventions; (iii) improved program monitoring and evaluation, including greater use of real-time monitoring for continuous program improvement and constant strategic and tactical adaptations and rigorous program evaluation, to refine understanding of what works, under what circumstances and how; and (iv) predictable, sustained financing for key population HIV prevention programmes for specific sub-groups, including increased domestic financing where feasible. Furthermore, this module will pay special attention to strengthening community-based monitoring and evaluation systems as they pertain to MSM, transgender women, and Female Sex Workers sub-groups and their respective HIV related issues in the Caribbean; document model interventions with technical briefs that have practical, ?how-to? examples for strengthening critical enablers and service delivery for key populations subgroups; and to strengthen commitment to a sustainable CBO response in relation to Key Populations post transition.",200000,null,"Active","a6Q1R000000AJF5",0,0,0,0,200000,0,null,null,"(To be read in conjunction with the SW intervention) Developing more effective models to reach DL MSM and 2.3 Developing more effective models to reach female partners of MSM. Throughout this module CVC would institute 4 axis to ensure more effective sub-population HIV prevention programs: (i) strengthened programmatic and contextual understanding, especially of the heterogeneity of sex work and complexity of closeted MSM behaviour; (ii) intensified program implementation and delivery of comprehensive, proven interventions; (iii) improved program monitoring and evaluation, including greater use of real-time monitoring for continuous program improvement and constant strategic and tactical adaptations and rigorous program evaluation, to refine understanding of what works, under what circumstances and how; and (iv) predictable, sustained financing for key population HIV prevention programmes for specific sub-groups, including increased domestic financing where feasible. Furthermore, this module will pay special attention to strengthening community-based monitoring and evaluation systems as they pertain to MSM, transgender women, and Female Sex Workers sub-groups and their respective HIV related issues in the Caribbean; document model interventions with technical briefs that have practical, ?how-to? examples for strengthening critical enablers and service delivery for key populations subgroups; and to strengthen commitment to a sustainable CBO response in relation to Key Populations post transition.","Low","This activity is largely service delivery which falls outside of the scope of this RFP, the TRP therefore does not recommend this intervention.","Name is: CT Multicountry LAC CARICOM-PANCAP / Review approach Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-09-30","HIV/AIDS"]
["CT Multicountry HIV CB-PANCAP-CVCCOIN","Multicountry HIV Caribbean PCC Consortium","PAI-4812","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00572","Other intervention(s) for people in prisons and other closed settings","Under the PANCAP Round 9 grant CVC supported some model prison-based programmes, and CVC is currently conducting work in prisons in the OECS multi-country grant in relation to TB and prison health in general. Through this module CVC seeks to foster partnerships between national health authorities, and civil society organizations to improve health care delivery for prisoners and develop and document model programmes that can be scaled up by national governments to reduce HIV prevalence in the prison settings.  This will be achiveed through Proposed Activities:\n1.1 Offer inmate orientation and training\n? Provide all new inmates with information on HIV, drug use, and other relevant issues to increase their capacity to safely navigate the prison environment \n? Train inmates as peer educators\n1.2 Build the capacity of prison staff\n?Train prison staff on HIV, drug use, and other relevant issues to increase their understanding and appropriate management of issues related to sexuality, HIV transmission, and drug use\n1.3 Institute pre-release programs\n? Develop and implement orientation and information programs for inmates who are about to be released to enable a smooth transition and reintegration into society \n?  Enable NGOs and CBOs to work in prisons to create links between prison health services and community health services, which will facilitate transition and reintegration\n1.3 Ensure continuity of care after discharge\n? Establish protocols and referral systems to ensure that discharged inmates have continued access to antiretroviral therapy and medical care \n? Provide inmates with social service cards for free medical care for a defined period (e.g., 4 to 6 months), with provision for renewal should they remain unemployed",200000,null,"Active","a6Q1R000000AJF4",0,0,0,0,200000,0,null,null,"Under the PANCAP Round 9 grant CVC supported some model prison-based programmes, and CVC is currently conducting work in prisons in the OECS multi-country grant in relation to TB and prison health in general. Through this module CVC seeks to foster partnerships between national health authorities, and civil society organizations to improve health care delivery for prisoners and develop and document model programmes that can be scaled up by national governments to reduce HIV prevalence in the prison settings.  This will be achiveed through Proposed Activities:\n1.1 Offer inmate orientation and training\n? Provide all new inmates with information on HIV, drug use, and other relevant issues to increase their capacity to safely navigate the prison environment \n? Train inmates as peer educators\n1.2 Build the capacity of prison staff\n?Train prison staff on HIV, drug use, and other relevant issues to increase their understanding and appropriate management of issues related to sexuality, HIV transmission, and drug use\n1.3 Institute pre-release programs\n? Develop and implement orientation and information programs for inmates who are about to be released to enable a smooth transition and reintegration into society \n?  Enable NGOs and CBOs to work in prisons to create links between prison health services and community health services, which will facilitate transition and reintegration\n1.3 Ensure continuity of care after discharge\n? Establish protocols and referral systems to ensure that discharged inmates have continued access to antiretroviral therapy and medical care \n? Provide inmates with social service cards for free medical care for a defined period (e.g., 4 to 6 months), with provision for renewal should they remain unemployed","Low","This activity is largely service delivery which falls outside of the scope of this RFP, the TRP therefore does not recommend this intervention.","Name is: CT Multicountry LAC CARICOM-PANCAP / Review approach Original Intervention: Other interventions for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-09-30","HIV/AIDS"]
["CT Multicountry EECA APH","Multicountry HIV EECA APH","PAI-4807","MCI-00019","RSSH: Financial management systems","MCI-00187","Public financial management (PFM) strengthening","Activities:\n- Sharing good practices on transition in Macedonia and Montenegro across EECA ;\n- Documenting good SEE country practices on financial and political sustainability within the countries of EECA region ;\n- Organizing annual coordination regional meeting of SEE RCM;\n- Technical assistance on Budget advocacy, Public Finance and Budget Policy, formation and implementation of Social Policy  in 5 SEE countries;\n- Training for budget advocacy in 5 SEE countries and common regional advocacy;\n- Technical assistance to the SEE national decision-makers and civil society representatives in the revision, development and institutionalization of unified unit-costs for standard HIV-prevention and HIV-care services packages for PLHIV and KPs; \n- Development of budget advocacy plan at national level in 5 SEE countries;\n- Implementation of budget advocacy plan at national level in 5 SEE countries;\n- Investigate, develop and promote innovative models and sources of funding, to complement social contracting in 5 SEE countries;\n- Online tool for monitoring transition plans in EECA region developed by ECOM; \n- Analyse allocations, produce report and disseminate it in regional consultation on best prectices on implementation of transition plans in EECA by EHRA, using data from ECOM developed online tool;\n- Hold 4th regional forum for MSM and TG by ECOM.\n\nExpected results:\n- Strengthened governance of the SEE regional level through national response to HIV through formalized good practices of operation and decision-making of the National governance bodies;   \n- Best practices identified and shared within EECA region in terms of CCM role and evolution and Macedonian and Montenegro case in transition;\n- Optimized budgets for HIV prevention programs for different KAPs are developed and used in budgeting of national HIV programs in 5 SEE countries;\n- Generated strategic information, including on the treatment cascade, cascade of HIV services, prevalence and behavioral data to feed into planning of the national HIV programs and strategic plans and into civil society and community-based advocacy for adequate funding and scale-up of services in 5 SEE countries;\n- Civil society and community representatives are meaningfully engaged in annual program and budget planning of national HIV programs in 5 SEE coutries;\n- CSOs in all 5 SEE countries receive national funding to implement HIV programs for key populations;\n- At least 1 M USD is released additionally for key populations programs in 5 SEE countries in total in the lifetime of the grant;\n- Community monitoring tools are developed and implemented in 5 SEE countries; \n- Developed national guidance for continuous and reliable provision of ARVs for Ministry of Health in 5 SEE countries;\n- Transition plans are effectively and systematically monitored across EECA.",1695500,null,"Active","a6Q1R000000AJEz",1314616,0,0,0,380884,0,null,null,"Activities:\n- Sharing good practices on transition in Macedonia and Montenegro across EECA ;\n- Documenting good SEE country practices on financial and political sustainability within the countries of EECA region ;\n- Organizing annual coordination regional meeting of SEE RCM;\n- Technical assistance on Budget advocacy, Public Finance and Budget Policy, formation and implementation of Social Policy  in 5 SEE countries;\n- Training for budget advocacy in 5 SEE countries and common regional advocacy;\n- Technical assistance to the SEE national decision-makers and civil society representatives in the revision, development and institutionalization of unified unit-costs for standard HIV-prevention and HIV-care services packages for PLHIV and KPs; \n- Development of budget advocacy plan at national level in 5 SEE countries;\n- Implementation of budget advocacy plan at national level in 5 SEE countries;\n- Investigate, develop and promote innovative models and sources of funding, to complement social contracting in 5 SEE countries;\n- Online tool for monitoring transition plans in EECA region developed by ECOM; \n- Analyse allocations, produce report and disseminate it in regional consultation on best prectices on implementation of transition plans in EECA by EHRA, using data from ECOM developed online tool;\n- Hold 4th regional forum for MSM and TG by ECOM.\n\nExpected results:\n- Strengthened governance of the SEE regional level through national response to HIV through formalized good practices of operation and decision-making of the National governance bodies;   \n- Best practices identified and shared within EECA region in terms of CCM role and evolution and Macedonian and Montenegro case in transition;\n- Optimized budgets for HIV prevention programs for different KAPs are developed and used in budgeting of national HIV programs in 5 SEE countries;\n- Generated strategic information, including on the treatment cascade, cascade of HIV services, prevalence and behavioral data to feed into planning of the national HIV programs and strategic plans and into civil society and community-based advocacy for adequate funding and scale-up of services in 5 SEE countries;\n- Civil society and community representatives are meaningfully engaged in annual program and budget planning of national HIV programs in 5 SEE coutries;\n- CSOs in all 5 SEE countries receive national funding to implement HIV programs for key populations;\n- At least 1 M USD is released additionally for key populations programs in 5 SEE countries in total in the lifetime of the grant;\n- Community monitoring tools are developed and implemented in 5 SEE countries; \n- Developed national guidance for continuous and reliable provision of ARVs for Ministry of Health in 5 SEE countries;\n- Transition plans are effectively and systematically monitored across EECA.","High",null,"NA Original Module: RSSH - Financial management systems. Original Intervention: Public financial management strengthening","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT Viet Nam","Viet Nam","PAI-5920","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","With above allocation funding, VUSTA proposes to extend the coverage of PWID reached with the defined package of prevention and harm reduction services. Activities will still focus on Hanoi, Thai Nguyen, Hai Duong, Vinh Phuc, Nam Dinh, and Ho Chi Minh City. With above allocation funding VUSTA will reach the following number of additional PWID: 2018: 7,247 2019: 7,747 2020: 8,147 Of those reached with prevention services, 75% will also be referred for HTS by 2020.",576523,null,"Active","a6Q1R000000AJWw",0,0,0,0,576523,0,null,null,"With above allocation funding, VUSTA proposes to extend the coverage of PWID reached with the defined package of prevention and harm reduction services. Activities will still focus on Hanoi, Thai Nguyen, Hai Duong, Vinh Phuc, Nam Dinh, and Ho Chi Minh City. With above allocation funding VUSTA will reach the following number of additional PWID: 2018: 7,247 2019: 7,747 2020: 8,147 Of those reached with prevention services, 75% will also be referred for HTS by 2020.","High","Extended coverage of prevention for people who inject drugs is of high priority if funding allows.","NA Original Module: Comprehensive prevention programs for key populations. Original Intervention: People who inject drugs activities","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Tunisia","Tunisia","PAI-5830","MCI-00534","Comprehensive prevention programs for MSM","MCI-00608","Diagnosis and treatment of STIs and other sexual health services for MSM","The setting up of new community centers in accordance with mapping and the installation of a hot line will improve treatment conditions for key MSM populations in the context of HIV control",306723,null,"Active","a6Q1R000000AJVU",122932,0,0,0,183791,0,null,null,"The setting up of new community centers in accordance with mapping and the installation of a hot line will improve treatment conditions for key MSM populations in the context of HIV control","Medium","Setting up new community centers and as specific hotline for treatment for key men who have sex with men populations has not been evaluated on a cost utilization basis.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Zimbabwe","Zimbabwe","PAI-6086","MCI-00534","Comprehensive prevention programs for MSM","MCI-00606","Condoms and lubricant programming for MSM","Additional scale up through extended outreach from fixed and mobile sites.",800,null,"Active","a6Q1R000000AJZc",0,0,0,0,800,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Comprehensive program exists for MSM","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Condoms and lubricant programming for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6081","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","Third, above allocation funding is requested to fill gaps in opportunistic infections medicines and related commodities including cotimoxisole, IPT, Ampotericin, kaposi sarcoma and gastric lavage.",4897537.32,null,"Active","a6Q1R000000AJZX",0.32,0,0,0,4897537,0,null,null,"Third, above allocation funding is requested to fill gaps in opportunistic infections medicines and related commodities including cotimoxisole, IPT, Ampotericin, kaposi sarcoma and gastric lavage.","High","Medicines for Opportunistic Infections are essential, but there is a gap",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Kosovo","Kosovo","PAI-5975","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Additional funds will be used to conduct additional advocacy activities at local level in support of enabling environments for service delivery among KAPs.",33666.26,null,"Active","a6Q1R000000AJXp",0,0,0,0,33666.26,0,null,null,"Additional funds will be used to conduct additional advocacy activities at local level in support of enabling environments for service delivery among KAPs.","High","In addition to already supported advocacy activities within the allocation, additional funds will be used to conduct additional advocacy activities at local level in support of enabling environments for key population (KP) service delivery","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Viet Nam","Viet Nam","PAI-5970","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","The estimated MDR-TB suspects in the country for 2018, 2019, and 2020 are 75,332, 80,893, and 86,401, respectively. The allocation amount covers the number of Xpert cartridges to detect for 50,000 suspects in 2018, 55,000 suspects in 2019, and 60,000 suspects in 2020. The PAAR amount will support to buy the necessary cartridges to detect the remaining 77,626 suspects over the three years. - Other related costs for case detection and diagnosis include: ? sSample transportation ? Equipment for one more LPA lab and 2 culture labs ? Updated standard operating procedures (SOPs), TA, equipment, and training for the new panel phenotypic DST ? Equipment, bio-products, and consumables to maintain WGS and related TA.",2550198,null,"Active","a6Q1R000000AJXk",0,0,0,0,2550198,0,null,null,"The estimated MDR-TB suspects in the country for 2018, 2019, and 2020 are 75,332, 80,893, and 86,401, respectively. The allocation amount covers the number of Xpert cartridges to detect for 50,000 suspects in 2018, 55,000 suspects in 2019, and 60,000 suspects in 2020. The PAAR amount will support to buy the necessary cartridges to detect the remaining 77,626 suspects over the three years. - Other related costs for case detection and diagnosis include: ? sSample transportation ? Equipment for one more LPA lab and 2 culture labs ? Updated standard operating procedures (SOPs), TA, equipment, and training for the new panel phenotypic DST ? Equipment, bio-products, and consumables to maintain WGS and related TA.","High","This intervention covers additional cartridges and associated management costs for existing machines to detect an estimated 77,626 suspects above the target of the allocation over a period of three years.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Eswatini","Eswatini","PAI-5664","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Procurement of ear tips used for the Kuduwave to monitor for ototoxicity and Procurement of 2 additional pediatric audiology equipment, GSI audiometer and audio booth for Manzini and Lubombo region.",80160,null,"Active","a6Q1R000000AJSo",0,0,0,0,80160,0,null,null,"Procurement of ear tips used for the Kuduwave to monitor for ototoxicity and Procurement of 2 additional pediatric audiology equipment, GSI audiometer and audio booth for Manzini and Lubombo region.","High","Audiometry equipment, including for children, is essential for prevention of disabilities caused by DRTB treatment.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Eswatini","Eswatini","PAI-5659","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Procurement of digital x-rays and 6 biosafety cabinets(2 per year) to replace retiring equipment (5 year lifespan).",905332,null,"Active","a6Q1R000000AJSj",0,0,0,0,905332,0,null,null,"Procurement of digital x-rays and 6 biosafety cabinets(2 per year) to replace retiring equipment (5 year lifespan).","High","Procurement of digital X-rays is an important intervention for ACF and early case detection.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2021-09-30","TB/HIV"]
["CT Somalia","Somalia","PAI-5558","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Recent improvements in strategic information are improving the reliability and confidence in spectrum results. Annual spectrum is required to be maintained as an essential component.",75000,null,"Active","a6Q1R000000AJR6",0,0,0,0,75000,0,null,null,"Recent improvements in strategic information are improving the reliability and confidence in spectrum results. Annual spectrum is required to be maintained as an essential component.","High","Recent improvements in strategic information are improving the reliability and confidence in spectrum results. Annual spectrum is required to be maintained as an essential component.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Spectrum Analysis","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Senegal","Senegal","PAI-5522","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Given the need to prioritize, the applicant plans to  use  the  allocation  amount  to  implement  the new  strategy  of  using  GeneXpert  as  a  first-line test in the six regions of the country that are home to 81% of missing cases. The additional investment enables this strategy to be extended to the whole country to obtain maximum impact.",2244417.0099999998,null,"Active","a6Q1R000000AJQW",0,0,0,0,2244417.0099999998,0,null,null,"Given the need to prioritize, the applicant plans to  use  the  allocation  amount  to  implement  the new  strategy  of  using  GeneXpert  as  a  first-line test in the six regions of the country that are home to 81% of missing cases. The additional investment enables this strategy to be extended to the whole country to obtain maximum impact.","High","This request relates to expanding the use of GeneXpert as a first-line diagnostic test to all regions of the country. Prioritization for roll-out of this expansion should carefully consider service availability in all\nsub-national regions and equity of care.","NA Original Intervention: Disease screening and diagnosis (Extending the use of GeneXpert as a first-line diagnostic test to all regions of the country)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH"," Western Africa",null,"Multi-component"]
["CT Senegal","Senegal","PAI-5521","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conducting a national survey  into the prevalence of drug-resistant TB. The conclusions would enable subsequent interventions in the MDR-TB response to be strategically orientated.",100799.01,null,"Active","a6Q1R000000AJQV",0,0,0,0,100799.01,0,null,null,"Conducting a national survey  into the prevalence of drug-resistant TB. The conclusions would enable subsequent interventions in the MDR-TB response to be strategically orientated.","High","A drug-resistant survey (DRS) should be conducted every 5 years. This is of high importance in a country with a significant risk for primary drug resistance.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH"," Western Africa",null,"Multi-component"]
["CT Korea (Democratic Peoples Republic)","Korea (Democratic Peoples Republic)","PAI-5423","MCI-00071","Other module","MCI-00071","Other module","Current NRL infrastructure is inadequate to ensure the quality of LPA diagnosis while current C&DST capacity (NRL and 1 RRL (Hamhung RRL)) is too limited to cater for country needs. Under the above allocation the expansion of NRL and establishment of 2 RRLs will be done to strengthen the C&DST capacity and LPA tests.",2040304,null,"Active","a6Q1R000000AJOv",0,0,0,0,2040304,0,null,null,"Current NRL infrastructure is inadequate to ensure the quality of LPA diagnosis while current C&DST capacity (NRL and 1 RRL (Hamhung RRL)) is too limited to cater for country needs. Under the above allocation the expansion of NRL and establishment of 2 RRLs will be done to strengthen the C&DST capacity and LPA tests.","High","Laboratory capability is critical to the identification of MDR patients.","NA Original Module: Strengthen the nation-wide TB diagnosis network and actively find the missing TB cases. Original Intervention: Strengthening capacity of C&DST centres","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2021-06-30","Tuberculosis"]
["CT Liberia","Liberia","PAI-4707","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Nutritional support for adherence to treatment. Empirical evidence and program implementation experience have shown that good nutrition improves treatment outcomes for TB and HIV and AIDS, including increase in treatment uptake and retention in care. Considering most of these affected population fall below the poverty line, nutrition support is a necessary and imperative complementary TB-HIV intervention. Providing ART to patients is not only a good treatment strategy but is also an important strategy for preventing HIV infections, preventing opportunistic infections, and reducing AIDSrelated deaths (Treatment as Prevention strategy). It is expected that additional 2,499 in Yr1, 7,461 for Yr2 and 9,647 Yr3 will be placed on treatment. Once funded these additional persons will add to the numbers of people who positive and receiving ART to help in meeting the second 90% of the global target. Private sector is a significant service provider in some counties of Liberia. Private sector comprises NGO, faith based (not for profit), faith based (for profit), private sector (corporate social responsibility) and private sector (for profit). It is proposed to engage the private sector in Montserrado (around 20 facilities) in a more comprehensive way that cuts across many diseases and areas for health intervention including TB and HIV.\n1. Reviewing current partnerships: Undertake a comprehensive review of current partnerships with private providers in the health sector, which may include but not be limited to (a) outputs specifications, (b) pricing; (c) partner selection mechanisms, (d) contracting mechanisms, (e) management information system and monitoring mechanisms, (f) payment administration mechanisms, (g) fraud control measures; and (h) contract management capacity. The review shall be aimed at documenting the as-is process,\nidentifying systemic gaps and challenges, assessing user and provider perceptions and perceptions of the government.\n2. Reviewing Service Package: Undertake an assessment of the services for which the private providers are currently being engaged.\nSome of the key questions that will be answered at this stage are: a. Are the current sets of services being offered through the private partners adequate? Is there a need to expand the service package through additional\nproducts and services? b. Is there a willingness among the private sector to offer the entire service package through one-stop health kiosks; and if no, what are the services / products that can be clustered?\n3. Assessing Private Sector Readiness: Assess the readiness of the private sector to partner with the government including the scope and extent of partnership.\n4. Structuring Partnership Options: Based on the above assessment, identify options for engagement with the private sector in a social franchising model. The options may be generated based on role of the government, demand strategies, financing models and extent of risk sharing. Each option shall be assessed for its relevance with pros and cons allowing the government to make an informed choice.\n5. Drafting an Integrated Social Franchising\nStrategy: Based on the options assessment outlined above, develop a draft integrated. Social Franchising Strategy which will include among other details institutional structures, systems and capacities required at different  levels to implement the strategy. The draft strategy will be discussed at the national level to seek inputs, align it with the health policy objectives of the Ministry and arrive at a consensus on other operational aspects including, but not limited to, who would be the holding agency within the Ministry.\n6. Set up a Centralized Facilitating Agency (CFA): The institutional structure could include a centralized facilitating agency for procurement, supply chain management, franchisee partner selection, standardization of processes, capacity building and monitoring. The CFA shall be recruited / appointed by the Ministry. For the pilot phase PSI may assume that role for quick implementation.\n7. Develop Standard Operating Procedures\n(SOP) for Operationalizing the Strategy: Develop a detailed SOP for operationalizing the strategy. The SOP shall among a range of other areas include guidelines on: a. interface between the National Drug Service, the CFA and other stakeholders b. inventory management c. supply chain management d. record management, MIS and reporting The SOP shall be approved by the Ministry.\n8. Partner identification and management: The CFA shall, as per the detailed SOP, identify a set of interested and eligible partners; enter into contracting arrangements with private partners as per the SOP of the SF Strategy.\nThe CFA shall develop the capacity of the identified partners and will ensure that the partners start delivering the services as per the contracting arrangement. The CFA shall build capacity and assist in projecting quarterly inventory requirements for each facility and ensuring availability of supplies through the NDS. It shall also establish the MIS system that can be integrated with the DHIS2.\n9. The establishment of additional 50 ART sites to scale up care, treatment and support services.",7545187,null,"Active","a6Q1R000000AJDN",0,0,0,0,7545187,0,null,null,"Nutritional support for adherence to treatment. Empirical evidence and program implementation experience have shown that good nutrition improves treatment outcomes for TB and HIV and AIDS, including increase in treatment uptake and retention in care. Considering most of these affected population fall below the poverty line, nutrition support is a necessary and imperative complementary TB-HIV intervention. Providing ART to patients is not only a good treatment strategy but is also an important strategy for preventing HIV infections, preventing opportunistic infections, and reducing AIDSrelated deaths (Treatment as Prevention strategy). It is expected that additional 2,499 in Yr1, 7,461 for Yr2 and 9,647 Yr3 will be placed on treatment. Once funded these additional persons will add to the numbers of people who positive and receiving ART to help in meeting the second 90% of the global target. Private sector is a significant service provider in some counties of Liberia. Private sector comprises NGO, faith based (not for profit), faith based (for profit), private sector (corporate social responsibility) and private sector (for profit). It is proposed to engage the private sector in Montserrado (around 20 facilities) in a more comprehensive way that cuts across many diseases and areas for health intervention including TB and HIV.\n1. Reviewing current partnerships: Undertake a comprehensive review of current partnerships with private providers in the health sector, which may include but not be limited to (a) outputs specifications, (b) pricing; (c) partner selection mechanisms, (d) contracting mechanisms, (e) management information system and monitoring mechanisms, (f) payment administration mechanisms, (g) fraud control measures; and (h) contract management capacity. The review shall be aimed at documenting the as-is process,\nidentifying systemic gaps and challenges, assessing user and provider perceptions and perceptions of the government.\n2. Reviewing Service Package: Undertake an assessment of the services for which the private providers are currently being engaged.\nSome of the key questions that will be answered at this stage are: a. Are the current sets of services being offered through the private partners adequate? Is there a need to expand the service package through additional\nproducts and services? b. Is there a willingness among the private sector to offer the entire service package through one-stop health kiosks; and if no, what are the services / products that can be clustered?\n3. Assessing Private Sector Readiness: Assess the readiness of the private sector to partner with the government including the scope and extent of partnership.\n4. Structuring Partnership Options: Based on the above assessment, identify options for engagement with the private sector in a social franchising model. The options may be generated based on role of the government, demand strategies, financing models and extent of risk sharing. Each option shall be assessed for its relevance with pros and cons allowing the government to make an informed choice.\n5. Drafting an Integrated Social Franchising\nStrategy: Based on the options assessment outlined above, develop a draft integrated. Social Franchising Strategy which will include among other details institutional structures, systems and capacities required at different  levels to implement the strategy. The draft strategy will be discussed at the national level to seek inputs, align it with the health policy objectives of the Ministry and arrive at a consensus on other operational aspects including, but not limited to, who would be the holding agency within the Ministry.\n6. Set up a Centralized Facilitating Agency (CFA): The institutional structure could include a centralized facilitating agency for procurement, supply chain management, franchisee partner selection, standardization of processes, capacity building and monitoring. The CFA shall be recruited / appointed by the Ministry. For the pilot phase PSI may assume that role for quick implementation.\n7. Develop Standard Operating Procedures\n(SOP) for Operationalizing the Strategy: Develop a detailed SOP for operationalizing the strategy. The SOP shall among a range of other areas include guidelines on: a. interface between the National Drug Service, the CFA and other stakeholders b. inventory management c. supply chain management d. record management, MIS and reporting The SOP shall be approved by the Ministry.\n8. Partner identification and management: The CFA shall, as per the detailed SOP, identify a set of interested and eligible partners; enter into contracting arrangements with private partners as per the SOP of the SF Strategy.\nThe CFA shall develop the capacity of the identified partners and will ensure that the partners start delivering the services as per the contracting arrangement. The CFA shall build capacity and assist in projecting quarterly inventory requirements for each facility and ensuring availability of supplies through the NDS. It shall also establish the MIS system that can be integrated with the DHIS2.\n9. The establishment of additional 50 ART sites to scale up care, treatment and support services.","High","Subcomponents have different priorities. ART treatment is high priority for its life prolonging and quality of life enhancing effects in addition to its impact on HIV prevention. Development of a standard operationalization procedure (SOP) for operationalization of the strategy is high priority. Nutritional support is high priority for MDR-TB and malnourished patients with drug susceptible TB. It is a low priority for HIV and TB patients with susceptible TB who are not malnourished. Applicant is advised to consider cash transfers instead of food packages. Private sector readiness is low priority.","NA Original Intervention: Nutritional support, private sector treatment, more ART sites","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Nigeria","Nigeria","PAI-5271","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","6 States in 2020 will be due for LLINs mass replacement campaigns requiring 16,619,549 LLINs. This is highly prioritized to ensure continued coverage of the population in these States in line with the WHO universal coverage for LLIN, and to ensure that gains made are not lost due to decline in net ownership.",67309174,null,"Inactive","a6Q1R000000AJMT",67309174,0,0,0,0,1,"2020-01-29T12:52:00",null,"6 States in 2020 will be due for LLINs mass replacement campaigns requiring 16,619,549 LLINs. This is highly prioritized to ensure continued coverage of the population in these States in line with the WHO universal coverage for LLIN, and to ensure that gains made are not lost due to decline in net ownership.","High","LLIN distribution for 6 states on 2020. Considered mission critical to continue to build on the programmatic impact gains made.","28/06/2018: Changed module from LLINs - continuous distribution to LLINs - mass campaign as per email from Malaria team as part of portfolio optimization process. Also from CT, Bianca email from the 10 July 201 : Back in 2017, the original UQD amount was USD 67,309,174.  Through efficiency analysis, the CT determined the need for the implementation of the 6 mass campaigns to be approximately USD 53,479,314. Grant savings will be used to cover the costs. Second aprt of the email: from Anouk: I have also included the revised UQD template for Nigeria Malaria. However, please note that for entomological monitoring and LLIN mass campaigns, the Excel does not allow me to change the remaining UQD amount to zero as these cells are protected. I leave it to you to make the correct adjustments based on the table included in this email. Counting here the 13M of extra saving as effiency, this is to aligned with SC slide. Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Nigeria","Nigeria","PAI-5268","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Know Your Rights Programme for PLHIV and Key Populations \nRecommendations of Stigma Index will be used to develop a nation wide but targeted \"Know Your Rights Programme\" aimed at empowering PLHIV and KPs. This project will be coordinated by the KP secretariat and PLHIV Network (NEPWHAN). This is also be used to sensitize PLHIV on usefulness of knowing viral suppression status and supporting them to demand for VL tests",2500000,null,"Active","a6Q1R000000AJMQ",0,0,0,0,2500000,0,"2020-01-29T12:52:00",null,"Know Your Rights Programme for PLHIV and Key Populations \nRecommendations of Stigma Index will be used to develop a nation wide but targeted \"Know Your Rights Programme\" aimed at empowering PLHIV and KPs. This project will be coordinated by the KP secretariat and PLHIV Network (NEPWHAN). This is also be used to sensitize PLHIV on usefulness of knowing viral suppression status and supporting them to demand for VL tests","High",null,"NA Original Intervention: Legal literacy (?Know Your Rights?)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 1","2020-12-31","HIV/AIDS"]
["CT Mauritius","Mauritius","PAI-5172","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","This request is to cover the coverage gap for the PWIDs population in the current allocation including scaling up the NSP program. This is of critical importance to halt the spread of HIV in Mauritius and to move towards ending the epidemic largely driven by this population. This cost covers for outreach programs, condoms, HIV testing and NSP.",873603,null,"Active","a6Q1R000000AJKs",0,0,0,0,873603,0,null,null,"This request is to cover the coverage gap for the PWIDs population in the current allocation including scaling up the NSP program. This is of critical importance to halt the spread of HIV in Mauritius and to move towards ending the epidemic largely driven by this population. This cost covers for outreach programs, condoms, HIV testing and NSP.","High","Since HIV concentrates mostly in PWID, with an HIV prevalence rate of 44%, interventions for PWID are highly strategic. The proposed intervention helps the program reach targets for not only prevention but also testing, treatment and care.","NA Original Module: Prevention programs for key populations. Original Intervention: Defined prevention package of services for PWIDS","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2020-12-31","HIV/AIDS"]
["CT Madagascar","Madagascar","PAI-5041","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Given the economic status of PLHIV, it is vital to provide support for families taking care of orphans and vulnerable children (OVC). Half of the activities will be charged to the above allocation amount.",39295,null,"Active","a6Q1R000000AJIl",0,0,0,0,39295,0,null,null,"Given the economic status of PLHIV, it is vital to provide support for families taking care of orphans and vulnerable children (OVC). Half of the activities will be charged to the above allocation amount.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2020-12-31","HIV/AIDS"]
["CT Multicountry HIAF1 LSDI","Multicountry Southern Africa MOSASWA","PAI-4930","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","This request will cover the cost of IRS and IEC/BCC in Gaza and Inhambane provinces in southern Mozambique, specifically in the following districts: Limpopo (2020), Xai-Xai (2020-2022), Zavala (2020), Panda (2020-2022), and Inharrime (2020-2022). These districts have a strong epidemiological and entomological indication that IRS would be impactful (due to high burden of disease, proliferation of A. funestus vector, and pyrethroid resistance). Due to budgetary constraints, key districts in Gaza and Inhambane provinces have been excluded from the within allocation budget.  Without funding these districts, the potentially historical impact of this grant will be compromised.",3936699,null,"Active","a6Q1R000000AJGy",0,0,0,0,3936699,0,null,null,"This request will cover the cost of IRS and IEC/BCC in Gaza and Inhambane provinces in southern Mozambique, specifically in the following districts: Limpopo (2020), Xai-Xai (2020-2022), Zavala (2020), Panda (2020-2022), and Inharrime (2020-2022). These districts have a strong epidemiological and entomological indication that IRS would be impactful (due to high burden of disease, proliferation of A. funestus vector, and pyrethroid resistance). Due to budgetary constraints, key districts in Gaza and Inhambane provinces have been excluded from the within allocation budget.  Without funding these districts, the potentially historical impact of this grant will be compromised.","High","Insecticide for Maputo Province from 2020?2022","NA Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2022-12-31","Malaria"]
["CT Multicountry HIAF1 LSDI","Multicountry Southern Africa MOSASWA","PAI-4929","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","This request will cover the cost of LLINs and distribution as well and post-distribution IEC/BCC to promote uptake of the interventions in the Maputo Province of Mozambique. Following aggressive and blanket IRS in Maputo from 2017 to 2019, there is expected to be a significant decline in the case burden in the province. The country will move to focal IRS in Maputo in 2020 based on epidemiological and entomological data. Current country grant does not cover for all the LLINs required in Maputo province when the 2020 universal coverage campaign will be conducted. This requirement of LLINs is therefore essential in ensuring total coverage of the population at risk in Maputo province with at least LLIN or IRS in a complimentary manner without any form of overlap.\nThe distribution of LLIN in Maputo will sustain the gains and progress being made in ensuring southern Mozambique attain pre-elimination status hence providing a greater buffer zone for attainment of elimination in South Africa and Eswatini. There will be 100% coverage of the population with at least one vector control intervention, without overlapping interventions. While focal IRS in the epidemiologically heterogeneous and low burden province of Maputo will allow sustained and even accelerated gains to be realized, there is a risk of resurgence if the population is left without any potent vector control intervention.",5371892,null,"Active","a6Q1R000000AJGx",0,0,0,0,5371892,0,null,null,"This request will cover the cost of LLINs and distribution as well and post-distribution IEC/BCC to promote uptake of the interventions in the Maputo Province of Mozambique. Following aggressive and blanket IRS in Maputo from 2017 to 2019, there is expected to be a significant decline in the case burden in the province. The country will move to focal IRS in Maputo in 2020 based on epidemiological and entomological data. Current country grant does not cover for all the LLINs required in Maputo province when the 2020 universal coverage campaign will be conducted. This requirement of LLINs is therefore essential in ensuring total coverage of the population at risk in Maputo province with at least LLIN or IRS in a complimentary manner without any form of overlap.\nThe distribution of LLIN in Maputo will sustain the gains and progress being made in ensuring southern Mozambique attain pre-elimination status hence providing a greater buffer zone for attainment of elimination in South Africa and Eswatini. There will be 100% coverage of the population with at least one vector control intervention, without overlapping interventions. While focal IRS in the epidemiologically heterogeneous and low burden province of Maputo will allow sustained and even accelerated gains to be realized, there is a risk of resurgence if the population is left without any potent vector control intervention.","Medium","Support for LLIN mass distribution campaign in 2020 for the 60% of the population that would not benefit from the IRS (as IRS targeted for 40%)","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2022-12-31","Malaria"]
["CT Multicountry EECA APH","Multicountry HIV EECA APH","PAI-4806","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","Activities:\n- Assessments of legal and regulatory barriers for access to services for KPs in SEE;\n- Advocacy plan on national level related to key legal and policy barriers regarding challenges for implementing social contracting mechanism within Ministry of Health in SEE;\n- Implementation of advocacy plan and social contracting mechanism put in place for financing CSO?s preventive services for key population in SEE;\n- ENPUD, SWAN, ECOM oversee documentation of human rights and access to service barriers (developed by EHRA) in  Balkans countries for their respective KPs;\n- SEE countries regional training on documentation and reporting on human right violation by community and situation analysis by EHRA;\n- Workshop for Country Coordination Mechanism  in SEE on strengthening the role and imfluence of key populations representatives, by ECOM;\n- EECA platform for PWID partners with EURONPUD and conducts annual regional forums;\n- Community mobilization and empowerment of SW in SEE by SWAN\n\nExpected results:\n- Social contracting mechanism within MoH is regulated with appropriate by-laws and procedures in all 5 SEE countries, pertaining to minimum criteria for implementing organizations, selection procedures, contracting and payments and reporting, monitoring and evaluation;\n- CSOs are formally recognized as service providers for HIV prevention and support in the legislation of 5 SEE countries;\n- Developed manuals and protocols for implementation of new standards in 5 SEE countries;\n- PWID, SW and MSM communities are strengthened in SEE to play a meaningful role in national dialogues on programming, transition, and to receive national resources to support their ongoing activities.",982000,null,"Active","a6Q1R000000AJEy",816881,0,0,0,165119,0,null,null,"Activities:\n- Assessments of legal and regulatory barriers for access to services for KPs in SEE;\n- Advocacy plan on national level related to key legal and policy barriers regarding challenges for implementing social contracting mechanism within Ministry of Health in SEE;\n- Implementation of advocacy plan and social contracting mechanism put in place for financing CSO?s preventive services for key population in SEE;\n- ENPUD, SWAN, ECOM oversee documentation of human rights and access to service barriers (developed by EHRA) in  Balkans countries for their respective KPs;\n- SEE countries regional training on documentation and reporting on human right violation by community and situation analysis by EHRA;\n- Workshop for Country Coordination Mechanism  in SEE on strengthening the role and imfluence of key populations representatives, by ECOM;\n- EECA platform for PWID partners with EURONPUD and conducts annual regional forums;\n- Community mobilization and empowerment of SW in SEE by SWAN\n\nExpected results:\n- Social contracting mechanism within MoH is regulated with appropriate by-laws and procedures in all 5 SEE countries, pertaining to minimum criteria for implementing organizations, selection procedures, contracting and payments and reporting, monitoring and evaluation;\n- CSOs are formally recognized as service providers for HIV prevention and support in the legislation of 5 SEE countries;\n- Developed manuals and protocols for implementation of new standards in 5 SEE countries;\n- PWID, SW and MSM communities are strengthened in SEE to play a meaningful role in national dialogues on programming, transition, and to receive national resources to support their ongoing activities.","High",null,"NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT Multicountry HIAF2 ECSA-HC","Multicountry Africa ECSA-HC","PAI-4801","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Funds for eLIMS adaptation for NRLs in line with the WHO End TB strategy. The SRL-Uganda has developed and deployed the eLIMS suitable for NRLs in two countries and can expand to other countries if additional funds become available.",34708,null,"Active","a6Q1R000000AJEt",0,0,0,0,34708,0,null,null,"Funds for eLIMS adaptation for NRLs in line with the WHO End TB strategy. The SRL-Uganda has developed and deployed the eLIMS suitable for NRLs in two countries and can expand to other countries if additional funds become available.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 2","2022-06-30","Tuberculosis"]
["CT Uzbekistan","Uzbekistan","PAI-5916","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00098","OST and other drug dependence treatment for PWID","Drugs and Opiate tests to expand the OST program for 50 PLHIV / IDUs receiving ART.",249690,null,"Active","a6Q1R000000AJWs",124866,0,0,0,124824,0,null,null,"Drugs and Opiate tests to expand the OST program for 50 PLHIV / IDUs receiving ART.","Medium",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-06-30","HIV/AIDS"]
["CT Uzbekistan","Uzbekistan","PAI-5915","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Condoms for HIV prevention among discordant couples and food packages for social support for socially unprotected PLHIV.",82869,null,"Inactive","a6Q1R000000AJWr",82869,0,0,0,0,1,null,null,"Condoms for HIV prevention among discordant couples and food packages for social support for socially unprotected PLHIV.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-06-30","HIV/AIDS"]
["CT Timor-Leste","Timor-Leste","PAI-5827","MCI-00012","Case management","MCI-00154","Facility-based treatment","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Leste?s transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector",71100,null,"Active","a6Q1R000000AJVR",0,0,0,0,71100,0,null,null,"Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Leste?s transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector","Low","Malaria elimination activities commenced in Timor-Leste over a year ago and the country has a fairly strong laboratory system that is equipped and manned by skilled personnel. Recruitment of specialised external technical assistance (TA) for quality assurance and control as well is not indicated in relation to the activities prioritized above.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Zimbabwe","Zimbabwe","PAI-6075","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","Scale up the modified DREAMS package to an additional 4 districts.",3174288,null,"Active","a6Q1R000000AJZR",0,0,0,0,3174288,0,null,null,"Scale up the modified DREAMS package to an additional 4 districts.","Low","Interventions already exist elsewhere",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6070","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Following test kits, filling gaps in viral load scale-up and other patient monitoring and quality of care gaps (CD4, EID, Haematology, etc.) is the second priority for the PAAR. Increasingly phasing out CD4 testing and scaling up viral load testing (to move to the maintenance phase of the VL scale up plan) is prioritized to ensure 90% of PLHIV who are on sustained ART are virally supressed by 2020.",66987154.369999997,null,"Active","a6Q1R000000AJZM",0.37,0,0,0,66987154,0,null,null,"Following test kits, filling gaps in viral load scale-up and other patient monitoring and quality of care gaps (CD4, EID, Haematology, etc.) is the second priority for the PAAR. Increasingly phasing out CD4 testing and scaling up viral load testing (to move to the maintenance phase of the VL scale up plan) is prioritized to ensure 90% of PLHIV who are on sustained ART are virally supressed by 2020.","High","Viral Load testing is essential, but there is a gap (also early infant diagnosis (EID,), hematology)","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6069","MCI-00004","Prevention programs for other vulnerable populations","MCI-00072","Behavioral interventions as part of programs for general population","Supporting existing behavior change facilitators in 46 districts and extend their work to workplaces (including informal sector) to reach men with out of facility prevention, testing and linkage to care.",1969253,null,"Active","a6Q1R000000AJZL",1111163,0,0,0,858090,0,null,null,"Supporting existing behavior change facilitators in 46 districts and extend their work to workplaces (including informal sector) to reach men with out of facility prevention, testing and linkage to care.","High","Addresses reaching more men","NA Original Intervention: Behavioral interventions as part of programs for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Viet Nam","Viet Nam","PAI-5965","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","Zero TB city in 2 provinces - Scaling up two provinces implementing a model of early TB detection and two additional provinces implementing m-Heallth by the Farmers? Union - Implementing ACSM for stigma reduction through TB literacy and use of social media.",633069,null,"Active","a6Q1R000000AJXf",0,0,0,0,633069,0,null,null,"Zero TB city in 2 provinces - Scaling up two provinces implementing a model of early TB detection and two additional provinces implementing m-Heallth by the Farmers? Union - Implementing ACSM for stigma reduction through TB literacy and use of social media.","Low","This activity extends TB care delivery to an additional number of patients. The funding request is very ambitious as is. This is an addition to what is included in the allocation funding request and may not be needed. It is given a low priority in the PAAR.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used.","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Suriname","Suriname","PAI-5654","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","Outreach activities in the Gold-Mining Areas of the Interior of Suriname. Each of the gold-mining sites receive 2 outreach sessions per year with the  minimum package of services (BCC, condom distribution and lubricants, and HIV, STI, TB, SRH). In addition, on each of the outreach sessions, a tester is there to make testing available to people reached via the outreach.",11000,null,"Active","a6Q1R000000AJSe",0,0,0,0,11000,0,null,null,"Outreach activities in the Gold-Mining Areas of the Interior of Suriname. Each of the gold-mining sites receive 2 outreach sessions per year with the  minimum package of services (BCC, condom distribution and lubricants, and HIV, STI, TB, SRH). In addition, on each of the outreach sessions, a tester is there to make testing available to people reached via the outreach.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Somalia","Somalia","PAI-5555","MCI-00533","HIV Testing Services","MCI-00071","Other module","Focusing on areas with key populations. Men are more likely to seek services from private facilities. This will support delivery of training and supervision to the private sector.",120000,null,"Active","a6Q1R000000AJR3",30000,0,0,0,90000,0,null,null,"Focusing on areas with key populations. Men are more likely to seek services from private facilities. This will support delivery of training and supervision to the private sector.","High","Focusing on areas with key populations. Men are more likely to seek services from private facilities. This will support delivery of training and supervision to the private sector. This should be moved to allocation per TRP Recommended Action for Issue #1","NA Original Intervention: Private sector engagement for HCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5554","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","WHO technical assistance P3 level ? currently funded through the grant. Proposal is 50% from Malaria and 50% from RSSH to support essential medicines oversight for all health areas.",375432,null,"Active","a6Q1R000000AJR2",0,0,0,0,375432,0,null,null,"WHO technical assistance P3 level ? currently funded through the grant. Proposal is 50% from Malaria and 50% from RSSH to support essential medicines oversight for all health areas.","Medium","WHO technical assistance P3 level ? currently funded through the grant. Proposal is 50% from Malaria and 50% from RSSH to support essential medicines oversight for all health areas.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Essential Medicines TA","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Senegal","Senegal","PAI-5518","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Some community management activities are already included in the grant, however ? due to limited funding - this additional  investment  proposes  scaling  up community  activities  (increased  home  visits  to find  contacts,  informal  discussions,  systematic sampling  in  hard-to-reach  areas,  increased awareness-raising in crossborder areas, etc.) and expanding  the  network of CBOs involved in TB.",1683312.76,null,"Active","a6Q1R000000AJQS",0,0,0,0,1683312.76,0,null,null,"Some community management activities are already included in the grant, however ? due to limited funding - this additional  investment  proposes  scaling  up community  activities  (increased  home  visits  to find  contacts,  informal  discussions,  systematic sampling  in  hard-to-reach  areas,  increased awareness-raising in crossborder areas, etc.) and expanding  the  network of CBOs involved in TB.","High","The TRP considers this intervention as high priority as this funding would support strengthening community services, which would enhance case finding and treatment outcomes for TB. However, this intervention would require greater clarity about the role and employment status of community health workers.","NA Original Intervention: Community management of tuberculosis (Scaling up community interventions)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH"," Western Africa",null,"Multi-component"]
["CT Korea (Democratic Peoples Republic)","Korea (Democratic Peoples Republic)","PAI-5421","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Additional financial support is required to provide overarching programmatic management and to maximise national capacity in policy planning, coordination and management as the country transitions to elimination. While not directly linked to program impact / outcome it will provide an enabling environment for the program to implement more effectively and efficiently. Above allocation funding will be utilised for 1) training on programme management in the elimination phase, and 2) International Conferences on the elimination of malaria (4 persons 2018-2020).",252755,null,"Active","a6Q1R000000AJOt",0,0,0,0,252755,0,null,null,"Additional financial support is required to provide overarching programmatic management and to maximise national capacity in policy planning, coordination and management as the country transitions to elimination. While not directly linked to program impact / outcome it will provide an enabling environment for the program to implement more effectively and efficiently. Above allocation funding will be utilised for 1) training on programme management in the elimination phase, and 2) International Conferences on the elimination of malaria (4 persons 2018-2020).","Low","To support cost related to programmatic management and training within Democratic People?s Republic of Korea and locally. This amount might be adjusted based on revised programmatic costs.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-02-28","Malaria"]
["CT Papua New Guinea","Papua New Guinea","PAI-5416","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Full-time Coordinator for each of the three national KP/HIV networks ? Igat Hope, the national network of PLHIV; Friends Frangipani, the national network of sex workers and Kapul Champions ? the national network of MSM and TG people. Core funding for these organizations ceased in December 2016 due to a change in donor strategic direction. It will allow the national networks to strengthen provincial and district chapters and participate in national advocacy in the response to HIV.",207264,null,"Inactive","a6Q1R000000AJOo",207264,0,0,0,0,1,null,null,"Full-time Coordinator for each of the three national KP/HIV networks ? Igat Hope, the national network of PLHIV; Friends Frangipani, the national network of sex workers and Kapul Champions ? the national network of MSM and TG people. Core funding for these organizations ceased in December 2016 due to a change in donor strategic direction. It will allow the national networks to strengthen provincial and district chapters and participate in national advocacy in the response to HIV.","Medium","The TRP considers community advocacy important, but recommends emphasis on community service delivery; therefore, this is a medium priority.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," South East Asia","2020-12-31","TB/HIV"]
["CT Liberia","Liberia","PAI-4704","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00601","Supportive policy and programmatic environment","This activity is meant to provide technical assistance at district level in the form of one Quality Assurance Officer (QAO) for each of the 33 districts in River Gee, Sinoe, Maryland, Grand Kru, Gbarpolu counties to support NCHA Program implementation, supervision, monitoring, and documentation",791700,null,"Active","a6Q1R000000AJDK",0,0,0,0,791700,0,null,null,"This activity is meant to provide technical assistance at district level in the form of one Quality Assurance Officer (QAO) for each of the 33 districts in River Gee, Sinoe, Maryland, Grand Kru, Gbarpolu counties to support NCHA Program implementation, supervision, monitoring, and documentation","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Nigeria","Nigeria","PAI-5267","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00154","Facility-based treatment","Stigma index 2.0 for patient community and Key Populations \nLast stigma index was conducted in 2013 and a new Stigma Index Survey, with expanded focus to include KP, is needed. This will also establish effects of the Stigma and discrimination law on programming and to cover indicators on stigma reduction. This survey will bring better understand barriers to access and retention in HIV/AIDS services and identify how to address these to improve access and retention in care.",861317,null,"Active","a6Q1R000000AJMP",0,0,0,0,861317,0,"2020-01-29T12:52:00",null,"Stigma index 2.0 for patient community and Key Populations \nLast stigma index was conducted in 2013 and a new Stigma Index Survey, with expanded focus to include KP, is needed. This will also establish effects of the Stigma and discrimination law on programming and to cover indicators on stigma reduction. This survey will bring better understand barriers to access and retention in HIV/AIDS services and identify how to address these to improve access and retention in care.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 1","2020-12-31","HIV/AIDS"]
["CT Nigeria","Nigeria","PAI-5262","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00570","Diagnosis and treatment of STIs and other sexual and reproductive health services for people in prisons and other closed settings","HIV/AIDS Services in Prisons and other Closed Settings \nFacilitate delivery of comprehensive HIV services in prisons, centered around the continuum of care with a policy dialogue on possible expansion of the range of services. Specifically, establish 3 comprehensive centres with continuum of care, HIV education, GBV management, PMTCT, psychosocial support and data management. This includes:\n- HIV commodities \n- coordination of HIV services delivery within prison settings and strengthened referral arrangements with national healthcare system \n- further assessment of prisons and closed settings HIV/health services situation",5930208,null,"Active","a6Q1R000000AJMK",0,0,0,0,5930208,0,"2020-01-29T12:52:00",null,"HIV/AIDS Services in Prisons and other Closed Settings \nFacilitate delivery of comprehensive HIV services in prisons, centered around the continuum of care with a policy dialogue on possible expansion of the range of services. Specifically, establish 3 comprehensive centres with continuum of care, HIV education, GBV management, PMTCT, psychosocial support and data management. This includes:\n- HIV commodities \n- coordination of HIV services delivery within prison settings and strengthened referral arrangements with national healthcare system \n- further assessment of prisons and closed settings HIV/health services situation","High",null,"NA Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual and reproductive health services for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 1","2020-12-31","HIV/AIDS"]
["CT Mauritania","Mauritania","PAI-5166","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Screening activities for the key populations will make it possible/will continue to achieve the objectives of the End TB Strategy, in particular the search for subjects having had contact with contagious cases, children under 5 years of age, PLHIV, refugees, nomads, prisoners, diabetics, miners and the populations of the shanty towns in large cities. There are plans to open 5 new TTCs and to renovate 5 other TTCs to broaden access to diagnosis and to improve health care and the training of personnel.",415730,null,"Active","a6Q1R000000AJKm",0,0,0,0,415730,0,null,null,"Screening activities for the key populations will make it possible/will continue to achieve the objectives of the End TB Strategy, in particular the search for subjects having had contact with contagious cases, children under 5 years of age, PLHIV, refugees, nomads, prisoners, diabetics, miners and the populations of the shanty towns in large cities. There are plans to open 5 new TTCs and to renovate 5 other TTCs to broaden access to diagnosis and to improve health care and the training of personnel.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Middle East and North Africa","2021-12-31","Tuberculosis"]
["CT Mauritania","Mauritania","PAI-5165","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Operating costs of the LLIN mass distribution campaign",565020,null,"Active","a6Q1R000000AJKl",0,0,0,0,565020,0,null,null,"Operating costs of the LLIN mass distribution campaign","High","Given that this is a high impact intervention, this needs to be prioritised and covered under the current grant (based on the Allocation Request). The TRP notes therefore that efficiencies should be sought from IRS budget cut (within allocation budget planned under the funding request) as IRS is not recommended by the TRP due to no demonstrated capacity for implementation of IRS.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2021-12-31","Malaria"]
["CT Madagascar","Madagascar","PAI-5034","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Logistics management is very important, as is quantification of supplies. Training is allocated for the central level. Under NFM 2, training will be extended to the regional level.",9275,null,"Active","a6Q1R000000AJIe",0,0,0,0,9275,0,null,null,"Logistics management is very important, as is quantification of supplies. Training is allocated for the central level. Under NFM 2, training will be extended to the regional level.","High","This small amount requested to support extension to the regional level of training in logistics management and quantification of supplies was different and justified in support of this highly commoditized overall grant request (in the opposite of the other interventions of program management, which were considered medium or low). Training is allocated for the central level only in the within allocation funding.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2020-12-31","HIV/AIDS"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4922","MCI-00017","HSS - Policy and governance","MCI-00183","Other policy and governance intervention(s)","Develop National strategic plan for HIV",28055,null,"Active","a6Q1R000000AJGq",0,0,0,0,28055,0,null,null,"Develop National strategic plan for HIV","High",null,"NA Original Module: RSSH: Health sector governance and planning. Original Intervention: RSSH: Health sector governance and planning","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry HIAF2 ECSA-HC","Multicountry Africa ECSA-HC","PAI-4799","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Funds to strengthen exchange amongst laboratories, which is noted as a strength of the project in the Mid-term Review. Specific activities may include peer-to-peer capacity building, twinning of country NRLs (National Reference Laboratories), and peer mentoring.",48828,null,"Active","a6Q1R000000AJEr",0,0,0,0,48828,0,null,null,"Funds to strengthen exchange amongst laboratories, which is noted as a strength of the project in the Mid-term Review. Specific activities may include peer-to-peer capacity building, twinning of country NRLs (National Reference Laboratories), and peer mentoring.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 2","2022-06-30","Tuberculosis"]
["CT Multicountry HIAF2 ECSA-HC","Multicountry Africa ECSA-HC","PAI-4798","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Funds that may be used to extend the work to three additional countries, e.g. Angola, Ethiopia, and Liberia.  The SRL-Kampala has been supporting these countries to a limited extent. The countries requested to be engaged as full members of the ECSA-SRL project for comprehensive technical assistance and to upgrade the quality of the national TB reference Laboratories to ISO 15189 2012.",352289,null,"Active","a6Q1R000000AJEq",0,0,0,0,352289,0,null,null,"Funds that may be used to extend the work to three additional countries, e.g. Angola, Ethiopia, and Liberia.  The SRL-Kampala has been supporting these countries to a limited extent. The countries requested to be engaged as full members of the ECSA-SRL project for comprehensive technical assistance and to upgrade the quality of the national TB reference Laboratories to ISO 15189 2012.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 2","2022-06-30","Tuberculosis"]
["CT Uzbekistan","Uzbekistan","PAI-5912","MCI-00007","Treatment, care and support","MCI-00121","Prevention, diagnosis and treatment of opportunistic infections","Cartridge for GeneXpert  for TB  diagnostics.",45012,null,"Inactive","a6Q1R000000AJWo",45012,0,0,0,0,1,null,null,"Cartridge for GeneXpert  for TB  diagnostics.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-06-30","HIV/AIDS"]
["CT Uzbekistan","Uzbekistan","PAI-5907","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","Laboratory tests, antiretroviral drugs, etc. to provide high-grade treatment and psycho-social support for PLHIV.",1248523,null,"Inactive","a6Q1R000000AJWj",1248523,0,0,0,0,1,null,null,"Laboratory tests, antiretroviral drugs, etc. to provide high-grade treatment and psycho-social support for PLHIV.","High",null,"NA Original Intervention: Differentiated antiretroviral therapy service delivery","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-06-30","HIV/AIDS"]
["CT Timor-Leste","Timor-Leste","PAI-5821","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Provision of LLIN procurement and routine ANC distribution to maximise coverage in and utilization by pregnant women to prevent the acquisition of malaria with complications. It would complement the above (Priority 1 request) in ensuring complementary coverage would provide the outcome of Universal Access to Coverage (90%) amongst a wider population denominator and would ensure targets are achieved across all 4 Impact Indicators.",309536,null,"Inactive","a6Q1R000000AJVL",309536,0,0,0,0,1,null,null,"Provision of LLIN procurement and routine ANC distribution to maximise coverage in and utilization by pregnant women to prevent the acquisition of malaria with complications. It would complement the above (Priority 1 request) in ensuring complementary coverage would provide the outcome of Universal Access to Coverage (90%) amongst a wider population denominator and would ensure targets are achieved across all 4 Impact Indicators.","High","Pregnant women are one of the most vulnerable groups for malaria with the highest risk of severe complications, and malaria in pregnancy puts unborn children at high risk for premature, underweight or even still birth. Funds aimed at expanding coverage for this group are high priority and should be included in the allocation despite the extremely low risk in most of the country.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Timor-Leste","Timor-Leste","PAI-5820","MCI-00012","Case management","MCI-00157","Active case detection and investigation (elimination phase)","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Leste?s transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector.",39881,null,"Active","a6Q1R000000AJVK",0,0,0,0,39881,0,null,null,"Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Leste?s transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector.","Low","Active case and foci detection are central to elimination programs, but are covered in the allocation request. Technical Assistance to ensure skills transfer for program staff who will run the ACD is useful if focused and specific, but lower priority compared to other requests above.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Zimbabwe","Zimbabwe","PAI-6066","MCI-00531","Comprehensive prevention programs for TGs","MCI-00562","Other intervention(s) for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.",394920,null,"Active","a6Q1R000000AJZI",0,0,0,0,394920,0,null,null,"While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","High","Transfer an appropriate sum of money from this budget line to implement meaningful condom and lubricant programming for TG, such that an impact on HIV prevention in this group can be expected.","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Other interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Viet Nam","Viet Nam","PAI-5962","MCI-00023","Program management","MCI-00207","Grant management","Salary, operational costs, and office equipment of new SRs who will be involved in the project (Senior Affair Group, MOLISA) - PAAR will support independent audits for new SRs by PR, and fund of supervision for new interventions proposed by KNCV and MOLISA.",430368,null,"Active","a6Q1R000000AJXc",0,0,0,0,430368,0,null,null,"Salary, operational costs, and office equipment of new SRs who will be involved in the project (Senior Affair Group, MOLISA) - PAAR will support independent audits for new SRs by PR, and fund of supervision for new interventions proposed by KNCV and MOLISA.","Low","This includes costs for salaries, office equipment and operational costs for new sub -recipients in the project (Senior Affair Group and Molisa). It also supports independent audits and supervision costs for sub -recipients. The TRP believes that associated priority sub -recipients management costs should be incorporated into the program management budget in the allocation, although some costs, like equipment, may be low priority in the PAAR.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used.","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Suriname","Suriname","PAI-5649","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Create a repository of reports, including strategic plans, annual reports, evaluations and assessments.",10500,null,"Active","a6Q1R000000AJSZ",0,0,0,0,10500,0,null,null,"Create a repository of reports, including strategic plans, annual reports, evaluations and assessments.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Suriname","Suriname","PAI-5648","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Development of SOPs and protocols for oversight and quality control of laboratories in Suriname, specifically for HIV,TB and malaria.",7500,null,"Active","a6Q1R000000AJSY",0,0,0,0,7500,0,null,null,"Development of SOPs and protocols for oversight and quality control of laboratories in Suriname, specifically for HIV,TB and malaria.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Sao Tome and Principe","Sao Tome and Principe","PAI-5643","MCI-00071","Other module","MCI-00071","Other module","The process has been launched with support from WHO; this represents a contribution by the Global Fund to the development process.",22444.17,null,"Inactive","a6Q1R000000AJST",22444.17,0,0,0,0,1,null,null,"The process has been launched with support from WHO; this represents a contribution by the Global Fund to the development process.","Medium","This request will support the development of the national health funding strategy.","NA Original Module: RSSH. Original Intervention: Logistical support for teams responsible for developing the national health funding strategy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH"," Central Africa",null,"Multi-component"]
["CT El Salvador","El Salvador","PAI-5546","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","For the execution of the Debt 2 Health grant it is necessary to contract human resources for the implementation of the Debt 2 Health grant as detailed: 1 financial technician who keeps the register, control and monitoring of funds in the Financial Unit of External Funds, 1 administrative technician in the NRL, 1 infrastructure technician for follow-up and verification of the adaptation of areas and a technician for monitoring laboratory equipment; these resources will strengthen the Global Fund Support Unit. Salaries are defined in compliance with the current institutional Salary Law in force and there is no commitment to absorb them at the end of the project.\n\nA contribution of $25,000.00 per year is required for office supplies and materials for the NRL, which will be the office that implements the Debt 2 Health project.\n\nThe contracting of external audit services during the implementation of the Debt 2 Health is included in this module. The assurance mechanism includes an annual audit conducted by an independent auditor, the Debt 2 Health is subject to constant monitoring, verification and reporting throughout the implementation period.\n\nIt includes the fees of the procurement agent related to health equipment management and/or furniture expenses.",246930.51,null,"Inactive","a6Q1R000000AJQu",0,0,246931,0,0,1,null,null,"For the execution of the Debt 2 Health grant it is necessary to contract human resources for the implementation of the Debt 2 Health grant as detailed: 1 financial technician who keeps the register, control and monitoring of funds in the Financial Unit of External Funds, 1 administrative technician in the NRL, 1 infrastructure technician for follow-up and verification of the adaptation of areas and a technician for monitoring laboratory equipment; these resources will strengthen the Global Fund Support Unit. Salaries are defined in compliance with the current institutional Salary Law in force and there is no commitment to absorb them at the end of the project.\n\nA contribution of $25,000.00 per year is required for office supplies and materials for the NRL, which will be the office that implements the Debt 2 Health project.\n\nThe contracting of external audit services during the implementation of the Debt 2 Health is included in this module. The assurance mechanism includes an annual audit conducted by an independent auditor, the Debt 2 Health is subject to constant monitoring, verification and reporting throughout the implementation period.\n\nIt includes the fees of the procurement agent related to health equipment management and/or furniture expenses.","High",null,"NA Original Module: SRSS: Program management. Original Intervention: Policies, planning, coordination and management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Senegal","Senegal","PAI-5510","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","In the three target districts for this project (Touba, Diourbel and Passy), disease incidence is high.\nWithin each district, criteria for selecting areas are defined based on the intensity of transmission (more than 10 cases per 1,000 population) and the feasibility of the intervention (predominant type of housing and population behavior). The area is demarcated at the health-post level, according to the degree of incidence reported by each health post.\n\nOne treatment cycle per district (hot spots) is planned per year, to be carried out just before the main malaria transmission period (rainy season). \nThe insecticide used will be chosen based on the susceptibility of the vectors in the intervention areas. \nIRS activities will be carried out based on the World Health Organization (WHO) IRS operational manual and adapted to the local context, but also based on the country?s ten years of experience with IRS.",11917841.99,null,"Active","a6Q1R000000AJQK",0,0,0,0,11917841.99,0,null,null,"In the three target districts for this project (Touba, Diourbel and Passy), disease incidence is high.\nWithin each district, criteria for selecting areas are defined based on the intensity of transmission (more than 10 cases per 1,000 population) and the feasibility of the intervention (predominant type of housing and population behavior). The area is demarcated at the health-post level, according to the degree of incidence reported by each health post.\n\nOne treatment cycle per district (hot spots) is planned per year, to be carried out just before the main malaria transmission period (rainy season). \nThe insecticide used will be chosen based on the susceptibility of the vectors in the intervention areas. \nIRS activities will be carried out based on the World Health Organization (WHO) IRS operational manual and adapted to the local context, but also based on the country?s ten years of experience with IRS.","Medium","The availability of existing funding for IRS in malaria hotspots\nis considered of higher priority than in other locations, where\nmalaria is of lower endemicity. The TRP graded this item as\nMedium priority and relies on the Global Fund Secretariat to\nverify the detailed budget.","Amount validated by CT Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2020-12-31","Malaria"]
["CT Senegal","Senegal","PAI-5509","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Two operational research studies will be undertaken on adolescents and key populations to guide the program toward these targets.",56707.44,null,"Active","a6Q1R000000AJQJ",0,0,0,0,56707.44,0,null,null,"Two operational research studies will be undertaken on adolescents and key populations to guide the program toward these targets.","Medium",null,"Amount validated by CT Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Western Africa","2020-12-31","HIV/AIDS"]
["CT Papua New Guinea","Papua New Guinea","PAI-5412","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","Outreach: additional 10 MSM peer outreach workers (into existing multi-peer teams) ? 4 in NCD, 2 in Jiwaka, 2 in Madang, 2 in Western Highland. Peer outreach in Jiwaka and Madang ceased in 2016 and 2017 respectively, so this will re-start these important programs. Increased coverage with a package of prevention programs: Y1-1,467; Y2-2,269; Y3-3,112. HIV testing access targets: Y1-440; Y2-907; Y3-1,559).",65002,null,"Active","a6Q1R000000AJOk",0,0,0,0,65002,0,null,null,"Outreach: additional 10 MSM peer outreach workers (into existing multi-peer teams) ? 4 in NCD, 2 in Jiwaka, 2 in Madang, 2 in Western Highland. Peer outreach in Jiwaka and Madang ceased in 2016 and 2017 respectively, so this will re-start these important programs. Increased coverage with a package of prevention programs: Y1-1,467; Y2-2,269; Y3-3,112. HIV testing access targets: Y1-440; Y2-907; Y3-1,559).","High","The TRP considers this highly relevant because of the low coverage with prevention intervention among men who have sex with men (11.1 per cent ) This allocation will increase by 10 the number of peer outreach workers in 4 high burden focus districts.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," South East Asia","2020-12-31","TB/HIV"]
["CT Niger","Niger","PAI-5259","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2020 Niger intends to run a mass LLIN distribution campaign in the hypoendemic districts of Tahoua and Agadez regions (1,246,595 people) to protect the population against vector-borne diseases such as malaria and Rift Valley fever. These zones have not been covered since 2009.",2601638.42,null,"Active","a6Q1R000000AJMH",0,0,0,0,2601638.42,0,null,null,"In 2020 Niger intends to run a mass LLIN distribution campaign in the hypoendemic districts of Tahoua and Agadez regions (1,246,595 people) to protect the population against vector-borne diseases such as malaria and Rift Valley fever. These zones have not been covered since 2009.","High","LLINs in a COE are value for money and necessary for epidemic-prone areas.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2020-12-31","Malaria"]
["CT Niger","Niger","PAI-5257","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","The mass LLIN distribution campaign has been implemented on a cyclical basis in the seven eligible regions of Niger.  In 2017 LLINs were distributed in the hyper/mesoendemic districts in Diffa, Dosso and Tillabéri regions. These same districts (7,200,422 people) will need to be included in the 2020 distribution campaign in order to comply with the WHO recommendations on universal access and the three-year distribution cycle.",15027252.83,null,"Active","a6Q1R000000AJMF",0,14186562,0,0,840690.83,0,null,null,"The mass LLIN distribution campaign has been implemented on a cyclical basis in the seven eligible regions of Niger.  In 2017 LLINs were distributed in the hyper/mesoendemic districts in Diffa, Dosso and Tillabéri regions. These same districts (7,200,422 people) will need to be included in the 2020 distribution campaign in order to comply with the WHO recommendations on universal access and the three-year distribution cycle.","High","LLIN deployment is a WHO-recommended priority intervention, and for this population, LLIN replenishment is due. Also in this challenging operating environment (COE) where access to continuous services may be disrupted this intervention is appropriate.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2020-12-31","Malaria"]
["CT Mauritania","Mauritania","PAI-5160","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Covering the school costs of 280 infected and affected children with the aim of improving patient retention (39%) and decreasing patients abandoning treatment (50.8%). This strategy has shown its merit in the past and has made it possible to achieve a good level of treatment adherence among PLHIV. The recipients of this coverage are selected through a committee, which includes PLHIV, the NACP, the NESAC and representatives of the OTC and the CUs.",247200,null,"Active","a6Q1R000000AJKg",0,0,0,0,247200,0,null,null,"Covering the school costs of 280 infected and affected children with the aim of improving patient retention (39%) and decreasing patients abandoning treatment (50.8%). This strategy has shown its merit in the past and has made it possible to achieve a good level of treatment adherence among PLHIV. The recipients of this coverage are selected through a committee, which includes PLHIV, the NACP, the NESAC and representatives of the OTC and the CUs.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Mongolia","Mongolia","PAI-5137","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Mongolian government gives full support for the first line drugs. Within this proposal, the case detection will be increased to 65% in 2020, which will require more funds for the drugs. As the country faces increasing number of patients with PDR (on average, 400 cases/year; 1.5 times higher than MDR-TB cases), government funds may not be sufficient to meet the demand.",56496,null,"Active","a6Q1R000000AJKJ",0,0,0,0,56496,0,null,null,"Mongolian government gives full support for the first line drugs. Within this proposal, the case detection will be increased to 65% in 2020, which will require more funds for the drugs. As the country faces increasing number of patients with PDR (on average, 400 cases/year; 1.5 times higher than MDR-TB cases), government funds may not be sufficient to meet the demand.","High","Treatment for MDR-TB- ancillary drugs required to support MDR-TB treatment care and is a high impact intervention","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2020-12-31","Tuberculosis"]
["CT Moldova","Moldova","PAI-5031","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","In April 2017 the Ministry of Health has adopted a roadmap to modernize the TB service through people-centered model of TB care. In this context there is a need to increase communities support and to decrease stigma toward people with TB in the communities. This above allocation budget will support broadcasting audio and video materials on the local and national TV and radio spots.",67332.509999999995,null,"Active","a6Q1R000000AJIb",0,0,0,0,67332.509999999995,0,null,null,"In April 2017 the Ministry of Health has adopted a roadmap to modernize the TB service through people-centered model of TB care. In this context there is a need to increase communities support and to decrease stigma toward people with TB in the communities. This above allocation budget will support broadcasting audio and video materials on the local and national TV and radio spots.","Medium","The TRP considers this intervention of medium priority and quality demand. Moldova has one of the highest rate of MDR-TB in the world and the TRP noted that the Ministry of Health has adopted a roadmap to modernize the TB service towards people-centred approach shifting to the outpatient community-based care and adopting new hospitalization criteria In April 2017. Considering this, the TRP considers that it is important to increase communities support providing ambulatory treatment of TB patients, to strengthen awareness about this model and to decrease stigma toward people with TB in the communities.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: Multidrug-resistant TB. Original Intervention: IEC materials for DR-TB prevention and control: audio and video materials broadcasting","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","Tuberculosis"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4917","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Support and strengthen the HIV and STDs surveillance system including, trainings etc.",168331,null,"Active","a6Q1R000000AJGl",0,0,0,0,168331,0,null,null,"Support and strengthen the HIV and STDs surveillance system including, trainings etc.","Medium","It is unclear if the proposed surveillance in this population is necessary, and given that routine services will be enhanced, such data can be obtained from routine data.","NA Original Module: RSSH: Health Management Information Systems and M&E. Original Intervention: RSSH: Health Management Information Systems and M&E","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4916","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Procure ARV (1st line and second line) for PLHIV",56110,null,"Active","a6Q1R000000AJGk",0,0,0,0,56110,0,null,null,"Procure ARV (1st line and second line) for PLHIV","High",null,"NA Original Module: Treatment, care, and support. Original Intervention: Treatment, care, and support","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4911","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Develop SOPs/strategy for patient linkage with healthcare services, treatment retention and adherence, and follow-up",22444,null,"Active","a6Q1R000000AJGf",0,0,0,0,22444,0,null,null,"Develop SOPs/strategy for patient linkage with healthcare services, treatment retention and adherence, and follow-up","High",null,"NA Original Module: Treatment, care, and support. Original Intervention: Treatment, care, and support","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry LAC MCC","Multicountry Caribbean MCC","PAI-4790","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","The development of an emergency response for treatment services in the event of natural disasters is seen as vital given the high risk of the region to climate change. Builiding from the experience of Dominica it is essentail that disaster plans be developed to provide access to essential services in line with local capacity, resources and international health regulations. This emergency disaster plan aims to increase patient acces to medication, food and  essential services that is aligned with the national disaster response plan and will reduce the interruption of essential services (access to medicines) post natural disasters.",50000,null,"Active","a6Q1R000000AJEi",0,0,0,0,50000,0,null,null,"The development of an emergency response for treatment services in the event of natural disasters is seen as vital given the high risk of the region to climate change. Builiding from the experience of Dominica it is essentail that disaster plans be developed to provide access to essential services in line with local capacity, resources and international health regulations. This emergency disaster plan aims to increase patient acces to medication, food and  essential services that is aligned with the national disaster response plan and will reduce the interruption of essential services (access to medicines) post natural disasters.","High","This item is very important to build a resilient and sustainable system that can ride out natural disasters and continue to provide care for affected populations. Given recent events in the region, this item needs to be highly prioritized if efficiencies are to be found in the grant.","NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2022-03-31","TB/HIV"]
["CT Ukraine","Ukraine","PAI-5902","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00098","OST and other drug dependence treatment for PWID","The suuplementary services for current MPSS patienst (10,000) under OST progranmme.",2437913,null,"Active","a6Q1R000000AJWe",2109345,0,0,0,328568,0,null,null,"The suuplementary services for current MPSS patienst (10,000) under OST progranmme.","High","This population has the highest infection rates.This intervention will provide MPSS for current patients on OST (10000) to keep retention in treatment high (the costs for drugs will be covered by the State budget).","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","TB/HIV"]
["CT Ukraine","Ukraine","PAI-5901","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00095","HIV testing services for PWID","The activities are oriented to procure PIMA cartridges.",267830,null,"Active","a6Q1R000000AJWd",0,0,0,0,267830,0,null,null,"The activities are oriented to procure PIMA cartridges.","High","The HIV detection component for NGCA Donetsk and Luhansk is considered a high priority and if possible should be moved to within allocation","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: HIV testing services for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","TB/HIV"]
["CT Timor-Leste","Timor-Leste","PAI-5815","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Funding is requested in this category to support program management technical advice and policy, planning and advocacy technical assistance.",142735,null,"Active","a6Q1R000000AJVF",0,0,0,0,142735,0,null,null,"Funding is requested in this category to support program management technical advice and policy, planning and advocacy technical assistance.","Low","The TRP requests the applicant to work with technical partners and the Secretariat to develop a plan to ensure that technical capacity is transferred to local staff and that there is an exit strategy by which external Technical Assistance is discontinued by the end of grant implementation.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2020-12-31","HIV/AIDS"]
["CT Zimbabwe","Zimbabwe","PAI-6062","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00573","Gender-based violence prevention and treatment programs for adolescents and youth","Funding is requested for community infrastructure, technology and transport systems to establish six additional one-stop centres (in addition to the four requested in the matching funds application) for HIV/SRHR/GBV, building on successes of existing centres in Rusape General Hospital (Makoni), Harare and Gweru. As more than 1 in 3 Zimbabwean women experience physical violence, the 17,000 GBV survivors served by the current centres is an enormous service gap. The need to decentralize access to GBV services and strengthen linkages to communities is vital.",1617630,null,"Active","a6Q1R000000AJZE",0,0,0,0,1617630,0,null,null,"Funding is requested for community infrastructure, technology and transport systems to establish six additional one-stop centres (in addition to the four requested in the matching funds application) for HIV/SRHR/GBV, building on successes of existing centres in Rusape General Hospital (Makoni), Harare and Gweru. As more than 1 in 3 Zimbabwean women experience physical violence, the 17,000 GBV survivors served by the current centres is an enormous service gap. The need to decentralize access to GBV services and strengthen linkages to communities is vital.","High","Gender-based Violence is a high priority in the country",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Zimbabwe","Zimbabwe","PAI-6057","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLINs will be distributed to at risk population where IRS is not implemented, targeting every sleeping space in prioritized wards with API <5/1000 population. The MSP requires mass campaign every three years to replace obsolete LLINs. The 2020 mass campaign aimed at replacing the LLINs distributed in 2017 projected to protect a population of 516053 persons living in highly endemic areas. This gap would leave a total of 7.2% of total population at risk without any intervention if not supported. This will lead to poor coverage and increase in areas with high local transmission.",1827070,null,"Inactive","a6Q1R000000AJZ9",1827070,0,0,0,0,1,null,null,"LLINs will be distributed to at risk population where IRS is not implemented, targeting every sleeping space in prioritized wards with API <5/1000 population. The MSP requires mass campaign every three years to replace obsolete LLINs. The 2020 mass campaign aimed at replacing the LLINs distributed in 2017 projected to protect a population of 516053 persons living in highly endemic areas. This gap would leave a total of 7.2% of total population at risk without any intervention if not supported. This will lead to poor coverage and increase in areas with high local transmission.","High","Half of 2020 mass campaign LLINS, to replace 2017 nets.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Zambia","Zambia","PAI-6056","MCI-00000","Prevention programs for general population","MCI-00074","Male circumcision","Voluntary medical male circumcision reusable and consumables kits, early infant male circumcision training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly.",10862539,null,"Active","a6Q1R000000AJZ8",119180,0,0,0,10743359,0,null,null,"Voluntary medical male circumcision reusable and consumables kits, early infant male circumcision training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly.","Medium","Voluntary medical male circumcision (VMMC) reusable and consumables kits, early infant male circumcision (EIMC) training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Africa 2",null,"Multi-component"]
["CT Viet Nam","Viet Nam","PAI-5954","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","An introduction workshop with relevant partners at the national level about joint utilization of GeneXpert for TB and HIV tests in selected prisons, raining for prison staff on implementation of Xpert tests for TB and HIV, and scaling up MDR-TB management in prisons by MPS and KNCV (renovation of MDR-TB wards and TBIC laboratories, patient support, etc.).",362013,null,"Active","a6Q1R000000AJXU",0,0,0,0,362013,0,null,null,"An introduction workshop with relevant partners at the national level about joint utilization of GeneXpert for TB and HIV tests in selected prisons, raining for prison staff on implementation of Xpert tests for TB and HIV, and scaling up MDR-TB management in prisons by MPS and KNCV (renovation of MDR-TB wards and TBIC laboratories, patient support, etc.).","High","Training for prison staff on the use of GeneXpert, and MDR TB care in prisons.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Module: Multidrug-resistant TB. Original Intervention: Key populations (MDR-TB) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT South Sudan","South Sudan","PAI-5638","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","The NFM TB grant already supports the strengthening and sustaining of the technical and managerial capacity of the National TB program at all levels through: training in TB management; financial management; provision of salary support; and training of County Health Department teams. A coordinating body could only be considered once all the positions have been filled.",785616,null,"Active","a6Q1R000000AJSO",0,0,0,0,785616,0,null,null,"The NFM TB grant already supports the strengthening and sustaining of the technical and managerial capacity of the National TB program at all levels through: training in TB management; financial management; provision of salary support; and training of County Health Department teams. A coordinating body could only be considered once all the positions have been filled.","High","The New Funding Model (NFM) TB grant supports strengthening and sustaining the technical and managerial capacity of the National TB program at all levels through: training in TB management; financial management; provision of salary support; and training of County Health Department (CHD) teams.","NA Original Intervention: Setting up and strengthening a coordinating body for collaborative TB/HIV activities at all levels","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT Sierra Leone","Sierra Leone","PAI-5541","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Funding is needed for nutritional support to be provided for all TB cases, about 20,000 TB cases per year, during the intensive phase of treatment. MDR-TB cases, 300 cases per year, will receive the nutritional support throughout the course of treatment. The estimated cost will cover the nutritional support for TB patients for two years and this intervention will support the program to improve adherence to treatment.",1200000,null,"Active","a6Q1R000000AJQp",0,0,0,0,1200000,0,null,null,"Funding is needed for nutritional support to be provided for all TB cases, about 20,000 TB cases per year, during the intensive phase of treatment. MDR-TB cases, 300 cases per year, will receive the nutritional support throughout the course of treatment. The estimated cost will cover the nutritional support for TB patients for two years and this intervention will support the program to improve adherence to treatment.","High",null,"TRP June Retreat 2019 / Component multi","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, Malaria, RSSH"," Western Africa","2021-06-30","Multi-component"]
["CT Sierra Leone","Sierra Leone","PAI-5540","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Resources are needed for the following activities to upgrades CHCs to TB diagnostic sites: training of health care workers, training of microscopists, procurement of consumables and sputum containers , orientation of DHMT & local councils on the implementation of universal access for TB care, support six monthly min-campaign/sensitization  at slum and hard to reach areas, printing  of Xpert tools , support specimen transportation to lakka and SRL, support printing of registers and monitoring tools for district activities, dissemination of Xpert tools, and support international training of staff and study tours.",1500000,null,"Active","a6Q1R000000AJQo",0,0,0,0,1500000,0,null,null,"Resources are needed for the following activities to upgrades CHCs to TB diagnostic sites: training of health care workers, training of microscopists, procurement of consumables and sputum containers , orientation of DHMT & local councils on the implementation of universal access for TB care, support six monthly min-campaign/sensitization  at slum and hard to reach areas, printing  of Xpert tools , support specimen transportation to lakka and SRL, support printing of registers and monitoring tools for district activities, dissemination of Xpert tools, and support international training of staff and study tours.","High",null,"TRP June Retreat 2019 / Component multi","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, Malaria, RSSH"," Western Africa","2021-06-30","Multi-component"]
["CT Senegal","Senegal","PAI-5505","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","In line with the international community, Senegal has developed a business plan to expedite the elimination of mother-to-child transmission of HIV. To this end, a partnership with midwives has been established. This strategy will be strengthened by the coaching system and support will be provided for finding patients lost to follow-up, as will assistance for transport and checkup costs.",111851.64,null,"Active","a6Q1R000000AJQF",0,0,0,0,111851.64,0,null,null,"In line with the international community, Senegal has developed a business plan to expedite the elimination of mother-to-child transmission of HIV. To this end, a partnership with midwives has been established. This strategy will be strengthened by the coaching system and support will be provided for finding patients lost to follow-up, as will assistance for transport and checkup costs.","High",null,"Amount validated by CT Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Western Africa","2020-12-31","HIV/AIDS"]
["CT Papua New Guinea","Papua New Guinea","PAI-5409","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","Support to testing and follow-up services in clinics: This allocation also includes continuation into Y3 of support to NCD clinics to improve connection between outreach and clinical services. This allocation is for additional nurses and CHWs.",50847,null,"Inactive","a6Q1R000000AJOh",0,50847,0,0,0,1,null,null,"Support to testing and follow-up services in clinics: This allocation also includes continuation into Y3 of support to NCD clinics to improve connection between outreach and clinical services. This allocation is for additional nurses and CHWs.","High","The TRP considers this highly relevant because of the low HIV testing reach (2 per cent) among sex workers. This allocation will fund additional nurses and community health workers in year 3 to improve links between outreach services and clinics in the national capital district.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," South East Asia","2020-12-31","TB/HIV"]
["CT Papua New Guinea","Papua New Guinea","PAI-5404","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","This allocation provides for six-monthly TB/HIV program review in 5 provinces: Western Highlands, Enga, Jiwaka, Morobe and Madang. This will assist provinces to embed the new TB-HIV coordination mechanisms and review and planning cycles.",266268,null,"Active","a6Q1R000000AJOc",0,0,0,0,266268,0,null,null,"This allocation provides for six-monthly TB/HIV program review in 5 provinces: Western Highlands, Enga, Jiwaka, Morobe and Madang. This will assist provinces to embed the new TB-HIV coordination mechanisms and review and planning cycles.","Medium","While the TRP recognizes the importance of joint program review meetings these are of medium priority relative to the higher priority activities","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," South East Asia","2020-12-31","TB/HIV"]
["CT Namibia","Namibia","PAI-5255","MCI-00009","TB/HIV","MCI-00136","Community TB/HIV care delivery","These activities support TB/ HIV increased integration at both national and district level. Through these integrated services, TB HIV co-infected people are more likely to receive enhanced treatment. This will result in people being more adherent to treatment and better treatment outcomes, including retention of people on ART.",2358757,null,"Active","a6Q1R000000AJMD",0,0,0,0,2358757,0,null,null,"These activities support TB/ HIV increased integration at both national and district level. Through these integrated services, TB HIV co-infected people are more likely to receive enhanced treatment. This will result in people being more adherent to treatment and better treatment outcomes, including retention of people on ART.","Low","TB/HIV integration is very important, but it is not clear what activities and results this item will entail.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Mauritania","Mauritania","PAI-5154","MCI-00007","Treatment, care and support","MCI-00119","Treatment monitoring - Drug resistance surveillance","Acquiring a genotyping machine (sequencer) for the NIPHR reference laboratory.",34503,null,"Active","a6Q1R000000AJKa",0,0,0,0,34503,0,null,null,"Acquiring a genotyping machine (sequencer) for the NIPHR reference laboratory.","Low","This intervention is not considered a high priority at this stage of the ART scale up. The priorities should be placed on increasing coverage of testing and of treatment among those in need, and on improving adherence as of now.","NA Original Intervention: Treatment monitoring - drug resistance surveillance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2021-12-31","HIV/AIDS"]
["CT Mozambique","Mozambique","PAI-5151","MCI-00071","Other module","MCI-00071","Other module","The PAAR for RSSH addresses critical gaps in management of health system risks to program implementation by providing adequate storage and distribution conditions for the supply chain, training of health workers and human resource managers, development of community based monitoring of disease management data, expansion of financial management systems and health information systems and supportive policy and programmatic environment for integrated service delivery of TB and HIV.",67016662,null,"Active","a6Q1R000000AJKX",3500000,0,0,0,63516662,0,null,null,"The PAAR for RSSH addresses critical gaps in management of health system risks to program implementation by providing adequate storage and distribution conditions for the supply chain, training of health workers and human resource managers, development of community based monitoring of disease management data, expansion of financial management systems and health information systems and supportive policy and programmatic environment for integrated service delivery of TB and HIV.","High","The interventions are considered high priority as they address critically important areas in view of bringing improvements to the supply chain infrastructure, staffing, staff capacity,HMIS and community systems capacity, which have been identified as critical risks for the Program.","NA Original Module: RSSH. Original Intervention: PSM; QA HMIS M&E; Community: HRH","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Montenegro","Montenegro","PAI-5127","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","In case of secured funding, this will be the fifth study on HIV prevalence and risky behavior among commercial sex workers. Earlier attempts to provide data by Respondent Driven Sample did not give results due to insufficient sex workers network. Surveys were implemented successfully by using ?snowball sample? method, however they did not provide the information on the population size. This research will therefore help to estimate the SW population size.",61721.47,null,"Active","a6Q1R000000AJK9",0,61721,0,0,0.47,0,null,null,"In case of secured funding, this will be the fifth study on HIV prevalence and risky behavior among commercial sex workers. Earlier attempts to provide data by Respondent Driven Sample did not give results due to insufficient sex workers network. Surveys were implemented successfully by using ?snowball sample? method, however they did not provide the information on the population size. This research will therefore help to estimate the SW population size.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT Montenegro","Montenegro","PAI-5126","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","The previous three bio-behavioural surveys (BBS) conducted among PWID in 2009, 2011 and 2013 complied with the Respondent Driven Sampling (RDS) principles. In case funding is obtained for the fourth BBS, planned for 2019, PWID population size would be estimated for the first time in Montenegro.",61721.47,null,"Active","a6Q1R000000AJK8",0,61721,0,0,0.47,0,null,null,"The previous three bio-behavioural surveys (BBS) conducted among PWID in 2009, 2011 and 2013 complied with the Respondent Driven Sampling (RDS) principles. In case funding is obtained for the fourth BBS, planned for 2019, PWID population size would be estimated for the first time in Montenegro.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT Moldova","Moldova","PAI-5023","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","This intervention is very important to recruit additional new SW, by providing peer-to-peer educational session and referring them to access services.Estimated 500 additional clients to be reached each year. Taking into consideration the new estimations and the established targets, this intervention will contribute to cover more SW with prevention services",40399.51,null,"Active","a6Q1R000000AJIT",0,0,0,0,40399.51,0,null,null,"This intervention is very important to recruit additional new SW, by providing peer-to-peer educational session and referring them to access services.Estimated 500 additional clients to be reached each year. Taking into consideration the new estimations and the established targets, this intervention will contribute to cover more SW with prevention services","High","The TRP considers this intervention high priority, as peer -driven interventions are an essential part of the package for services that target sex workers.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Intervention: Develop and provide peer driven interventions for sex workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4906","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Procure RDTs for testing",22444,null,"Active","a6Q1R000000AJGa",0,0,0,0,22444,0,null,null,"Procure RDTs for testing","High","Commodities are needed to implement the activities planned.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Comprehensive prevention programs for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry LAC MCC","Multicountry Caribbean MCC","PAI-4787","MCI-00022","RSSH: Health management information systems and M&E","MCI-00174","Capacity building for health workers, including those at community level","Expand telecommunication capacity in all countries to reduce the cost of conducting country level and regional trainings, improve communication between and among country teams, save costs on travel and accommodation and improve overall coordination. This can facilitate access to more training for community teams who would be able to participate in their local settings.The Governments will cover the cost of internet access and space with designated space being made available to civil society. -",90000,null,"Active","a6Q1R000000AJEf",0,0,0,0,90000,0,null,null,"Expand telecommunication capacity in all countries to reduce the cost of conducting country level and regional trainings, improve communication between and among country teams, save costs on travel and accommodation and improve overall coordination. This can facilitate access to more training for community teams who would be able to participate in their local settings.The Governments will cover the cost of internet access and space with designated space being made available to civil society. -","High","This item would introduce a significant efficiency into the grant in terms of cost-savings for travel and meetings. Therefore it should be prioritized if efficiencies are found during grant-making.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2022-03-31","TB/HIV"]
["CT Multicountry LAC MCC","Multicountry Caribbean MCC","PAI-4786","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Implement a social contracting model in the six OECS countries, involving the conduct of an assessment of the types of services and capacity of Civil Society Organizations (CSO) to provide these services; Government?s willingness/political will to contractually engage civil society; a legal environment assessment to review impediments relating to registration of CSOs, determine government procurement procedures, applicable service standards and licensing among other issues.",150000,null,"Active","a6Q1R000000AJEe",87470,0,0,0,62530,0,null,null,"Implement a social contracting model in the six OECS countries, involving the conduct of an assessment of the types of services and capacity of Civil Society Organizations (CSO) to provide these services; Government?s willingness/political will to contractually engage civil society; a legal environment assessment to review impediments relating to registration of CSOs, determine government procurement procedures, applicable service standards and licensing among other issues.","High","Social contracting with CSO's is the cornerstone of a sustainable approach to reaching key populations. The TRP recommends shifting this PAAR item into allocation, using funding set aside for the PrEP request in the allocation.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2022-03-31","TB/HIV"]
["CT Ukraine","Ukraine","PAI-5898","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","1. Improving technical capacity of the laboratories\n2. Developing  technical compliance and biological safety and security.\n3. Building of 4 regional reference centers (This was considered as low priority by TRP).\n4. Capacity building and support to the national surveillance system.",11317522,null,"Active","a6Q1R000000AJWa",0,0,0,0,11317522,0,null,null,"1. Improving technical capacity of the laboratories\n2. Developing  technical compliance and biological safety and security.\n3. Building of 4 regional reference centers (This was considered as low priority by TRP).\n4. Capacity building and support to the national surveillance system.","High","1. Improving technical capacity of the laboratories. 2. Development of technical compliance and biological safety and security. 3. Buildings of 4 regional reference centres. (* This is considered as low priority) 4. Capacity building and support to the national surveillance system.","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","TB/HIV"]
["CT Ukraine","Ukraine","PAI-5893","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","TB case detection and diagnosis among general population in Non-Government Controlled Areas (NGCA) Donetsk and Luhansk. It is planned to cover about 3,800 additional MDR-TB cases implementing rapid testing. In addition, a total of 3,100 Xpert cartridges will be procured (1,800 for Donetsk and 1,300 for Luhansk).",220643,null,"Inactive","a6Q1R000000AJWV",220643,0,0,0,0,1,null,null,"TB case detection and diagnosis among general population in Non-Government Controlled Areas (NGCA) Donetsk and Luhansk. It is planned to cover about 3,800 additional MDR-TB cases implementing rapid testing. In addition, a total of 3,100 Xpert cartridges will be procured (1,800 for Donetsk and 1,300 for Luhansk).","High","This is considered a high priority and if possible should be moved to within allocation.","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","TB/HIV"]
["CT Turkmenistan","Turkmenistan","PAI-5806","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Two among five regions of Turkmenistan, Balkan and  Akhal,  do  not  have  laboratory  capacity  to perform   liquid   culture   and   drug   susceptibility testing. In 2012-2017 the Government invested into large renovation works of the Akhal regional TB hospital and   its   laboratory,   including   modernization   of infrastructure   (water,   sewage,   electricity).   The Government also procured general lab equipment (autoclaves,  etc).    However,  procurement  of Bactec  MGIT  and  LPA  equipment  is  still  being delayed.  At  present,  due  to  proximity  of  Akhal regional  TB  lab  to  the  capital  Ashgabat,  DST  is done  by  the  NRL.  However,  this  is  an  interim solution as it adds workload on the NRL staff. Procurement  of  lab  equipment  for  Balkan  and Akhal  regional  TB  labs  was  planned  within  the cost-sharing   agreements   between   UNDP   and MoH  for  2018,  but  due  to  large  investment  into procurement   of   TB   reagents   and   drugs   the Government   decided   to   postpone   funding   the procurement of equipment. The  current Prioritized  Above  Allocation  Requestincludes procurement of some equipment required for  two regional TB labs  in case the Government funding will not be available in 2018.",340383,null,"Inactive","a6Q1R000000AJV6",176,340207,0,0,0,1,null,null,"Two among five regions of Turkmenistan, Balkan and  Akhal,  do  not  have  laboratory  capacity  to perform   liquid   culture   and   drug   susceptibility testing. In 2012-2017 the Government invested into large renovation works of the Akhal regional TB hospital and   its   laboratory,   including   modernization   of infrastructure   (water,   sewage,   electricity).   The Government also procured general lab equipment (autoclaves,  etc).    However,  procurement  of Bactec  MGIT  and  LPA  equipment  is  still  being delayed.  At  present,  due  to  proximity  of  Akhal regional  TB  lab  to  the  capital  Ashgabat,  DST  is done  by  the  NRL.  However,  this  is  an  interim solution as it adds workload on the NRL staff. Procurement  of  lab  equipment  for  Balkan  and Akhal  regional  TB  labs  was  planned  within  the cost-sharing   agreements   between   UNDP   and MoH  for  2018,  but  due  to  large  investment  into procurement   of   TB   reagents   and   drugs   the Government   decided   to   postpone   funding   the procurement of equipment. The  current Prioritized  Above  Allocation  Requestincludes procurement of some equipment required for  two regional TB labs  in case the Government funding will not be available in 2018.","High","The TRP considers this intervention quality demand as it will to contribute to improved patient management and implementation after transition. Because of its importance, the TRP recommends this module to move into allocation.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-06-30","Tuberculosis"]
["CT Tajikistan","Tajikistan","PAI-5804","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00598","Procurement strategy","Development and operationalization of the medicines QA/QC system",350000,null,"Inactive","a6Q1R000000AJV4",350000,0,0,0,0,1,null,null,"Development and operationalization of the medicines QA/QC system","High","-","28/05/2019: Email from CT mentioned that they will ask for a lower amount (300k). UQD will be funded by Country Optimization under PO wave 3 with reallocated funds","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-03-31","Tuberculosis"]
["CT Zambia","Zambia","PAI-6051","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","These are RSSH PSM strengthening activities although labelled as viral load and monitoring. The request will further strengthen PSM quality of health products, and improve rational use of medicines.",14942654,null,"Active","a6Q1R000000AJZ3",7082734,0,0,0,7859920,0,null,null,"These are RSSH PSM strengthening activities although labelled as viral load and monitoring. The request will further strengthen PSM quality of health products, and improve rational use of medicines.","High","These are RSSH PSM strengthening activities although labelled as viral load (VL ) and monitoring. The request will further strengthen PSM quality of health products, and improve rational use of medicines.","25/02/2019: According to the email form Paul McCarrick on the 17 October 2018 :The full gap in viral load commodities and a portion of the gap in male condoms have been incorporated into a grant. The IL will be available in November.\" According to an email from Paul McCarrick sent to Bianca only 7M were used as in Country Optimization. Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Africa 2",null,"Multi-component"]
["CT Viet Nam","Viet Nam","PAI-5951","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Under-served populations have a higher prevalence which requires ACF on a large scale. The allocation does not cover these activities. PAAR will reach the estimated additional cases based on the TIME model for these populations: about 33,000 patients per year. - PAAR will further support: ? Scaling up ACF in four districts per year with large populations and high TB prevalence ? TB screening and preventive treatment for 4000 immigrants per year ? Routine screening for 6000 patients per year at the Methadone centers and at voluntary drug detoxication centers. ? Screening for 7000 miners per year in Quang Ninh. ? Screening for 7000 health workers with high risk of TB. ? Establishment of a comprehensive model for TB detection and control in social protection centers in 3 provinces by MOLISA. ? Procurement of 2 digital mobile X-ray machines to scale ACF in 3 border provinces.",2034765,null,"Active","a6Q1R000000AJXR",0,0,0,0,2034765,0,null,null,"Under-served populations have a higher prevalence which requires ACF on a large scale. The allocation does not cover these activities. PAAR will reach the estimated additional cases based on the TIME model for these populations: about 33,000 patients per year. - PAAR will further support: ? Scaling up ACF in four districts per year with large populations and high TB prevalence ? TB screening and preventive treatment for 4000 immigrants per year ? Routine screening for 6000 patients per year at the Methadone centers and at voluntary drug detoxication centers. ? Screening for 7000 miners per year in Quang Ninh. ? Screening for 7000 health workers with high risk of TB. ? Establishment of a comprehensive model for TB detection and control in social protection centers in 3 provinces by MOLISA. ? Procurement of 2 digital mobile X-ray machines to scale ACF in 3 border provinces.","High","This supports active case finding activities amongst multiple populations and areas including immigrants, miners, health care workers, in methadone clinics and in border areas, estimated to yield 33,000 patients a year. 5 The TRP requests the applicant to also include ethnic minorities and migrants in this intervention.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Intervention: Under -served populations: remote and border areas, urban poor, miners, health care workers, other","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Togo","Togo","PAI-5736","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Condoms and lubricants for key populations: The budget for this intervention will make it possible to prevent HIV infection among sex workers and MSM.-According  to  the  results  of  the  recent  bio-behavioral  study among sex workers (SWs) in 2015, seroprevalence is 11.7%, which   is   significantly   higher   than   among   the   general population  (2.5%,  TDHS  2013-2014).  As  regards  sexual practices, according to the results of the bio-behavioral study, 90%  of  SWs  reported  having  used  condoms  systematically during    their    most    recent    working    week.    Given    this epidemiological situation, SWs have been chosen as priority targets for systematic inclusion in the treatment cascade of the various  HIV  prevention  services.  Thus,  under  the  next  grant for 2018-2020, there are plans for 90% of SWs to receive the minimum  prevention  package  in  2020.    The  sum  allocated permitsonly the acquisition of 7,961,468 units of condoms for SWs, out  of   a  requirement  of  19,903,667.  The  above allocation   resources   to   be   mobilized   will   allow   for   the acquisition of 11,942,000 units of condoms (EUR 1,056,417) and 10,856,546 units of gel (EUR 528,566) for distribution to SWs,  as  part  of  the  range  of  servicesof  the  prevention package.-According  to  the  results  of  the  recent  bio-behavioral  study among   MSM   in   2015,   seroprevalence   is   13%   (Second Generation   Monitoring   Survey   [SGMS],   2015),   which   is significantly higher than among the general population (2.5%, TDHS 2013-2014). According to the same results of the bio-behavioral  study,  74.5%  of  MSM  consider  condoms  as  a means  of  protection  against  HIV  and  68.5%  regularly  used condoms  during  active  anal  sex.  The  statistic  is  71.9%  for passive  anal  sex.  Given  this  epidemiological  situation,  the National Strategic Plan for HIV (2016-2020 NSP) aims for 90% of  the  key  populations  (SWs,  MSM,  IDUs  and  Prisoners)  to adopt less risky behaviors in relation to HIV by 2020. The sum allocated  permitonlythe  acquisition  of  1,422,878  units  of condoms for MSM, out of a requirement of 3,557,196.  Thus, the  above  allocation  resources  to  be  mobilized  will  make  it possible to acquire 2,134,318 units of condoms (EUR 58,209) and  2,134,318  units  of  gel  (EUR  103.912)  for  distribution  to MSM as part of the range of servicesduring the activities for peer education, social involvement and fixed and advanced-mobile strategy.",1960614.97,null,"Active","a6Q1R000000AJTy",0,0,0,0,1960614.97,0,null,null,"Condoms and lubricants for key populations: The budget for this intervention will make it possible to prevent HIV infection among sex workers and MSM.-According  to  the  results  of  the  recent  bio-behavioral  study among sex workers (SWs) in 2015, seroprevalence is 11.7%, which   is   significantly   higher   than   among   the   general population  (2.5%,  TDHS  2013-2014).  As  regards  sexual practices, according to the results of the bio-behavioral study, 90%  of  SWs  reported  having  used  condoms  systematically during    their    most    recent    working    week.    Given    this epidemiological situation, SWs have been chosen as priority targets for systematic inclusion in the treatment cascade of the various  HIV  prevention  services.  Thus,  under  the  next  grant for 2018-2020, there are plans for 90% of SWs to receive the minimum  prevention  package  in  2020.    The  sum  allocated permitsonly the acquisition of 7,961,468 units of condoms for SWs, out  of   a  requirement  of  19,903,667.  The  above allocation   resources   to   be   mobilized   will   allow   for   the acquisition of 11,942,000 units of condoms (EUR 1,056,417) and 10,856,546 units of gel (EUR 528,566) for distribution to SWs,  as  part  of  the  range  of  servicesof  the  prevention package.-According  to  the  results  of  the  recent  bio-behavioral  study among   MSM   in   2015,   seroprevalence   is   13%   (Second Generation   Monitoring   Survey   [SGMS],   2015),   which   is significantly higher than among the general population (2.5%, TDHS 2013-2014). According to the same results of the bio-behavioral  study,  74.5%  of  MSM  consider  condoms  as  a means  of  protection  against  HIV  and  68.5%  regularly  used condoms  during  active  anal  sex.  The  statistic  is  71.9%  for passive  anal  sex.  Given  this  epidemiological  situation,  the National Strategic Plan for HIV (2016-2020 NSP) aims for 90% of  the  key  populations  (SWs,  MSM,  IDUs  and  Prisoners)  to adopt less risky behaviors in relation to HIV by 2020. The sum allocated  permitonlythe  acquisition  of  1,422,878  units  of condoms for MSM, out of a requirement of 3,557,196.  Thus, the  above  allocation  resources  to  be  mobilized  will  make  it possible to acquire 2,134,318 units of condoms (EUR 58,209) and  2,134,318  units  of  gel  (EUR  103.912)  for  distribution  to MSM as part of the range of servicesduring the activities for peer education, social involvement and fixed and advanced-mobile strategy.","High","HIV prevention interventions have not received substantial support from the main request, thus, PAAR would be helpful to support preventions interventions that target the important populations drivers of the HIV epidemic.","NA Original Intervention: Interventions concerning condoms and lubricants for key populations (sex workers and men who have sex with men)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Togo","Togo","PAI-5735","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","Range of services for IDUs:  (i)  minimum  prevention  package  and, (ii) establishment of a needle exchange program (a new syringe in exchange for a used syringe) , so that IDUs adopt less risky sexual behavior and safer behavior regarding injection.",62517.11,null,"Active","a6Q1R000000AJTx",0,0,0,0,62517.11,0,null,null,"Range of services for IDUs:  (i)  minimum  prevention  package  and, (ii) establishment of a needle exchange program (a new syringe in exchange for a used syringe) , so that IDUs adopt less risky sexual behavior and safer behavior regarding injection.","High","HIV prevention interventions have not received substantial support from the main request, thus, PAAR would be helpful to support preventions interventions that target the important populations drivers of the HIV epidemic.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT South Sudan","South Sudan","PAI-5632","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","The allocation makes provision for ARVs for 35,000 people while this above allocation would cover additional demand. This funding includes procurement of drugs for opportunistic infections, training facility staff and those from Internally Displaced Persons (IDPs) and refugee camps and Protection of Civilian sites (PoCs) in HIV and TB treatment and care, establishing of 4 mobile lab services and operational support.",4230795,null,"Inactive","a6Q1R000000AJSI",0,4230795,0,0,0,1,null,null,"The allocation makes provision for ARVs for 35,000 people while this above allocation would cover additional demand. This funding includes procurement of drugs for opportunistic infections, training facility staff and those from Internally Displaced Persons (IDPs) and refugee camps and Protection of Civilian sites (PoCs) in HIV and TB treatment and care, establishing of 4 mobile lab services and operational support.","Medium","This will improve the ART coverage in South Sudan. However, there is sufficient budget within allocation for the country to focus on addressing current gaps in the HIV care cascade before pursuing ambitious targets of further ART scale up before addressing critical gaps in the quality of ART (e.g. high LTFU)","NA Original Intervention: Differentiated antiretroviral therapy service delivery","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Sudan","Sudan","PAI-5497","MCI-00011","Vector control","MCI-00152","Entomological monitoring","Entomological monitoring is crucial to guide and feed the national strategies for Integrated Vector Management and Insecticide Resistance Management. UQD will equip the entomological labs in both IRS and LLINs targeted states with the necessary supplies and equipment to enable states to carry out the susceptibility, bioassay and bio efficacy tests.",545532,null,"Active","a6Q1R000000AJQ7",0,0,0,0,545532,0,null,null,"Entomological monitoring is crucial to guide and feed the national strategies for Integrated Vector Management and Insecticide Resistance Management. UQD will equip the entomological labs in both IRS and LLINs targeted states with the necessary supplies and equipment to enable states to carry out the susceptibility, bioassay and bio efficacy tests.","Medium",null,"Sudan has only 1 integrated funding request, and the UQD component is Malaria","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Papua New Guinea","Papua New Guinea","PAI-5402","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","This allocation provides TB/HIV/STI M&E Officers at provincial level in Western Highlands, Enga, Jiwaka, Morobe and Madang. These officers will assist the TB/HIV Coordinators to improve data collecting and reporting, assist in providing up to date information to the TB-HIV Provincial Coordinating Committee and assist in disseminating data and information to services to assist them in service review and planning.",388013,null,"Active","a6Q1R000000AJOa",0,0,0,0,388013,0,null,null,"This allocation provides TB/HIV/STI M&E Officers at provincial level in Western Highlands, Enga, Jiwaka, Morobe and Madang. These officers will assist the TB/HIV Coordinators to improve data collecting and reporting, assist in providing up to date information to the TB-HIV Provincial Coordinating Committee and assist in disseminating data and information to services to assist them in service review and planning.","Medium","The TRP considers strengthening of coordination between TB and HIV staff and non governmental organizations important, but recommends consideration of more emphasis on service delivery, making this a medium priority.","NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," South East Asia","2020-12-31","TB/HIV"]
["CT Papua New Guinea","Papua New Guinea","PAI-5401","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","The investment aims to exceed national targets (93% coverage for case detection vs. 90% target) by reducing misdiagnosis, delays in diagnosis and under reporting. The investment would be used to i) empower communities to refer patients suspected of having presumptive TB; ii) provide monthly incentives to CHWs for active tracing of LTFU patients and treatment completion monitoring; iii) conduct social mobilization for TB interventions using social mobilization approaches of proven effectiveness and iv) conduct advocacy for increased TB financial resources.",809694,null,"Active","a6Q1R000000AJOZ",0,0,0,0,809694,0,null,null,"The investment aims to exceed national targets (93% coverage for case detection vs. 90% target) by reducing misdiagnosis, delays in diagnosis and under reporting. The investment would be used to i) empower communities to refer patients suspected of having presumptive TB; ii) provide monthly incentives to CHWs for active tracing of LTFU patients and treatment completion monitoring; iii) conduct social mobilization for TB interventions using social mobilization approaches of proven effectiveness and iv) conduct advocacy for increased TB financial resources.","High","The TRP considers community strengthening very important, and thus gives this high priority. Community system strengthening to increase efficiency and accuracy of TB case detection yield is a strategic priority identified in the allocation. This additional intervention is additive to allocation funding for community TB care for key populations, including children, and will help ensure improved community mobilization, advocacy and referral for services.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community responses and systems: Strengthen community based organization capacity and implementation (50 per cent each year)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," South East Asia","2020-12-31","TB/HIV"]
["CT Namibia","Namibia","PAI-5247","MCI-00000","Prevention programs for general population","MCI-00073","Condoms as part of programs for general population","The activities are meant to support PPP for condom distribution, facilitate the availability and therefore usage of condoms and reduce the number of new HIV infections.",127833,null,"Active","a6Q1R000000AJM5",0,0,0,0,127833,0,null,null,"The activities are meant to support PPP for condom distribution, facilitate the availability and therefore usage of condoms and reduce the number of new HIV infections.","Low","National actors and partners providing HIV care are expected to cover this.","NA Original Intervention: Condoms as part of programs for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Namibia","Namibia","PAI-5242","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","These targeted activities are expected to result in increasing number of PHIV remaining on treatment.",383662,null,"Active","a6Q1R000000AJM0",0,0,0,0,383662,0,null,null,"These targeted activities are expected to result in increasing number of PHIV remaining on treatment.","Low","Patient monitoring and support are included in the programme supported by the government and other partners.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Mozambique","Mozambique","PAI-5144","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","To ensure proper implementation of the Quality Assurance and Quality Control mechanism, bi-annual supervisory visits to laboratories will be conducted.",160685.17000000001,null,"Active","a6Q1R000000AJKQ",0,0,0,0,160685.17000000001,0,null,null,"To ensure proper implementation of the Quality Assurance and Quality Control mechanism, bi-annual supervisory visits to laboratories will be conducted.","High","Support to laboritories across the country will allow quality training of the Agentes Polivalentes Elementares (APEs), the key community health workers responsible for almost 12% of malaria diagniosis and treatment.","NA Original Intervention: Case management (Supervision of laboratories)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Montenegro","Montenegro","PAI-5124","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Purchase of one CD4 counter for the Infectious Disease Clinic (IDC) which is a front line to help PLHIV. The expected outcome is contributing to reaching the set targets and indicators. The expected impact is greater reach of the PLHIV and greater service delivery, and decreased level of stigma and discrimination towards this population.",3366.63,null,"Active","a6Q1R000000AJK6",0,0,0,0,3366.63,0,null,null,"Purchase of one CD4 counter for the Infectious Disease Clinic (IDC) which is a front line to help PLHIV. The expected outcome is contributing to reaching the set targets and indicators. The expected impact is greater reach of the PLHIV and greater service delivery, and decreased level of stigma and discrimination towards this population.","Medium",null,"NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-12-31","HIV/AIDS"]
["CT Myanmar","Myanmar","PAI-5119","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","This intervention will allow improving existing Ministry of Health warehousing infrastructure and storage conditions which are currently inadequate",87751,null,"Inactive","a6Q1R000000AJK1",87751,0,0,0,0,1,null,null,"This intervention will allow improving existing Ministry of Health warehousing infrastructure and storage conditions which are currently inadequate","High","Existing Ministry of Health warehousing infrastructure is deficient and storage conditions inadequate as indicated in the concept note.","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Moldova","Moldova","PAI-5018","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","This   new   intervention   to   scale-up   HIV   preventive services  has  been  piloted  in  Balti  city.  In  order  to increase   the   coverage   of   PWID   with   prevention program   and   to   ensure diversityandattractive services it is important to continue this kind of service provision.",141766.35999999999,null,"Active","a6Q1R000000AJIO",0,0,0,0,141766.35999999999,0,null,null,"This   new   intervention   to   scale-up   HIV   preventive services  has  been  piloted  in  Balti  city.  In  order  to increase   the   coverage   of   PWID   with   prevention program   and   to   ensure diversityandattractive services it is important to continue this kind of service provision.","High","Harm reduction services through a network of pharmacies is an innovative way of providing these services that allows for an extended linkage of people who inject drugs to services. This is a high priority in this hard to reach group.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Provide harm reduction services through the network of pharmacies","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4898","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Evaluation of NTP to assist NTP staff monitor progress toward program goals, learn from the lessons resulted during the program implementation, make needed actions to improve quality and evalute the program in achieving its short-term, intermediate, and long-term outcomes.",22444,null,"Active","a6Q1R000000AJGS",0,0,0,0,22444,0,null,null,"Evaluation of NTP to assist NTP staff monitor progress toward program goals, learn from the lessons resulted during the program implementation, make needed actions to improve quality and evalute the program in achieving its short-term, intermediate, and long-term outcomes.","Low","Although the objective of this budget line is commendable, it is unclear what activities are proposed and how they were costed.","NA Original Module: RSSH: Health Management Information Systems and M&E. Original Intervention: Analysis, evaluations, review, and transparency","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4897","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Develop checklist and conduct systematic supervision visits to the chest diseases centers to supervise, monitor and evaluate the provided services for TB and MDR and to the peripheral laboratories in these centers for QC .",29177,null,"Active","a6Q1R000000AJGR",0,0,0,0,29177,0,null,null,"Develop checklist and conduct systematic supervision visits to the chest diseases centers to supervise, monitor and evaluate the provided services for TB and MDR and to the peripheral laboratories in these centers for QC .","High",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry SEAS UNDP-Migrants","Multicountry TB Asia UNDP","PAI-4780","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","Training of service providers on human rights based approach, updated guidelines and referral services (development of e-learning module and integration within the training curriculum of health providers).",100000,null,"Active","a6Q1R000000AJEY",0,0,0,0,100000,0,null,null,"Training of service providers on human rights based approach, updated guidelines and referral services (development of e-learning module and integration within the training curriculum of health providers).","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2021-12-31","Tuberculosis"]
["CT Multicountry HIV Latin America ALEP","Multicountry HIV Latin America ALEP","PAI-4775","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Venezuela would contribute to strengthening the desired regional impact. Civil society is facing many difficulties in continuing its community work, due to severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the social mobilization they consider necessary in addressing the aforementioned activities, in line with the regional activities emerging from this module.\nDesign and implementation of a strategy to share resource mobilization initiatives for key populations, with an emphasis on PLHIV, and advocacy to strengthen the social contracting processes for the HIV response. \nThe aim is to establish or strengthen links with state programs that will enable support for the creation of entrepreneurial ventures for PLHIV.\nTo contribute to developing and monitoring community-based adherence models and to monitor integrated care models for PLHIV (taking into account key populations and including women and migrants living with HIV).",21867,null,"Active","a6Q1R000000AJET",0,0,0,0,21867,0,null,null,"Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Venezuela would contribute to strengthening the desired regional impact. Civil society is facing many difficulties in continuing its community work, due to severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the social mobilization they consider necessary in addressing the aforementioned activities, in line with the regional activities emerging from this module.\nDesign and implementation of a strategy to share resource mobilization initiatives for key populations, with an emphasis on PLHIV, and advocacy to strengthen the social contracting processes for the HIV response. \nThe aim is to establish or strengthen links with state programs that will enable support for the creation of entrepreneurial ventures for PLHIV.\nTo contribute to developing and monitoring community-based adherence models and to monitor integrated care models for PLHIV (taking into account key populations and including women and migrants living with HIV).","Low","The TRP recognizes the deterioration of the social and health situation in Venezuela and the increasingly unmet needs in access to basic HIV services. However, the current political and social context in Venezuela significantly diminishes the likelihood that the proposed activities such as ?Social mobilization, building community linkages, collaboration and coordination? in the PAAR with a total value of US$ 21,867 in the proposed budget will be impactful to address ?Sustainability of services for key populations in Venezuela?. As such it is considered low priority for funding within this catalytic envelope. The applicant should reconsider the strategic choice of activities that would have the potential for impact in the revised PAAR.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-09-30","HIV/AIDS"]
["CT Uganda","Uganda","PAI-5887","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Additional funding will support capacity enhancement for PLHIV community groups to deliver interventions that are intended to further increase uptake of PMTCT services, increase male partner testing, reduce loss to follow up for mother-baby pairs, and improve treatment adherence.",913488,null,"Active","a6Q1R000000AJWP",0,0,0,0,913488,0,null,null,"Additional funding will support capacity enhancement for PLHIV community groups to deliver interventions that are intended to further increase uptake of PMTCT services, increase male partner testing, reduce loss to follow up for mother-baby pairs, and improve treatment adherence.","Medium","Additional funding will support capacity enhancement for people living with HIV community groups to deliver interventions that are intended to further increase uptake of PMTCT services, increase male partner testing, reduce loss to follow up for motherbaby pairs, and improve treatment adherence.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: PMTCT quality improvement --capacity enhancement for community groups","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Tajikistan","Tajikistan","PAI-5803","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","The activities under this intervention will be oriented to further development the roles and strengthening capacity of key affected populations and communities, community organizations, NGOs and networks in the design, delivery, monitoring and evaluation of services and activities. Particularly, The Global Fund sources are requested to support the activities oriented to build PR-ship capacity of the National Stop TB partnership coalition to take over activities related to community support and involvement. The coalition includes under his umbrella local NGOs involved in realization of TB control activities under NSP 2015-2020 in country. The National Stop TB Coalition will develop its capacities to coordinate community involvement on local and central level. In this respect, a series of capacity building events should be planned for civil society in service provision, advocacy, communication and social mobilization, organizational development, etc. Estimated costs per years 50,000 USD.",150000,null,"Active","a6Q1R000000AJV3",0,0,0,0,150000,0,null,null,"The activities under this intervention will be oriented to further development the roles and strengthening capacity of key affected populations and communities, community organizations, NGOs and networks in the design, delivery, monitoring and evaluation of services and activities. Particularly, The Global Fund sources are requested to support the activities oriented to build PR-ship capacity of the National Stop TB partnership coalition to take over activities related to community support and involvement. The coalition includes under his umbrella local NGOs involved in realization of TB control activities under NSP 2015-2020 in country. The National Stop TB Coalition will develop its capacities to coordinate community involvement on local and central level. In this respect, a series of capacity building events should be planned for civil society in service provision, advocacy, communication and social mobilization, organizational development, etc. Estimated costs per years 50,000 USD.","Medium","TRP considers this as a medium priority. The proposed interventions are not clearly described. TRP recommends the applicant to clarify details of the proposed activities during the grant ? making in cooperation with the Secretariat.","NA Original Module: Multidrug-resistant TB. Original Intervention: Institutional capacity building, planning and leadership development of the National Stop TB partnership coalition","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-03-31","Tuberculosis"]
["CT Zambia","Zambia","PAI-6045","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Due to the changes that have been made to the Drug Resistant-TB guidelines, the gap has increased as the drugs being introduced are more expensive. Most of the patients will be on Bedaquiline which will no longer be a donation and a few on Delamanide which is more costly. Note that the Bedaquiline gap is in 2020.",1033887.39,null,"Active","a6Q1R000000AJYx",0,0,0,0,1033887.39,0,null,null,"Due to the changes that have been made to the Drug Resistant-TB guidelines, the gap has increased as the drugs being introduced are more expensive. Most of the patients will be on Bedaquiline which will no longer be a donation and a few on Delamanide which is more costly. Note that the Bedaquiline gap is in 2020.","High",null,"TRP June Retreat 2019 Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 2","2020-12-31","HIV/AIDS"]
["CT Zambia","Zambia","PAI-6040","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","Additional 100 Xpert machines, with related cartridges, printers and UPS, and 4 digital X-Ray machines. The TRP considers this low priority as there are 200 machines within allocation funding that need to be phased in while ensuring optimum utilisation.",8137710,null,"Active","a6Q1R000000AJYs",0,0,0,0,8137710,0,null,null,"Additional 100 Xpert machines, with related cartridges, printers and UPS, and 4 digital X-Ray machines. The TRP considers this low priority as there are 200 machines within allocation funding that need to be phased in while ensuring optimum utilisation.","Low","Additional 100 Xpert machines, with related cartridges, printers and UPS, and 4 digital X -Ray machines. The TRP considers this low priority as there are 200 machines within allocation funding that need to be phased in while ensuring optimum utilisation.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Africa 2",null,"Multi-component"]
["CT Viet Nam","Viet Nam","PAI-5943","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","With above allocation funding, VUSTA will reach22,796 PLWH over three years (2018:7,924; 2019: 7,628; 2020: 7,244) in 11 provinces/cities to provide advice and support to negotiate SHI enrolment procedures and use of health insurance cards to access ART, as well as to address challenges for PLWH in transition from OPCs to hospitals in terms of ARV treatment (e.g. stigma and discrimination, lack of suitable ID for SHI enrolment). Focus provinces will be: Nghe An, Hai Phong, Quang Ninh, Ninh Binh, Thai Binh, HCMC, Hanoi, Nam Dinh, Thai Nguyen, Hai Duong and Vinh Phuc.",410710,null,"Active","a6Q1R000000AJXJ",248340,0,0,0,162370,0,null,null,"With above allocation funding, VUSTA will reach22,796 PLWH over three years (2018:7,924; 2019: 7,628; 2020: 7,244) in 11 provinces/cities to provide advice and support to negotiate SHI enrolment procedures and use of health insurance cards to access ART, as well as to address challenges for PLWH in transition from OPCs to hospitals in terms of ARV treatment (e.g. stigma and discrimination, lack of suitable ID for SHI enrolment). Focus provinces will be: Nghe An, Hai Phong, Quang Ninh, Ninh Binh, Thai Binh, HCMC, Hanoi, Nam Dinh, Thai Nguyen, Hai Duong and Vinh Phuc.","High","SHI enrollment is so important in this period of transition that this activity should be moved into the allocation.","NA Original Intervention: People living with HIV activities (to be defined by VUSTA)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Togo","Togo","PAI-5734","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","Elimination of Mother to Child Transmission of HIV:\nIn 2016, with the aim of achieving the objectives of eliminating the mother to child transmission of HIV, the NACP introduced the use of HIV/Syphilis DUO test at the sites for the prevention of mother to  child  transmission  of  HIV  (PMTCT).  This  intervention will contribute to achieving coverage of screening for syphilis, one of the certification criteria for Togo for the elimination of mother to child transmission of HIV.",699585.91,null,"Active","a6Q1R000000AJTw",0,0,0,0,699585.91,0,null,null,"Elimination of Mother to Child Transmission of HIV:\nIn 2016, with the aim of achieving the objectives of eliminating the mother to child transmission of HIV, the NACP introduced the use of HIV/Syphilis DUO test at the sites for the prevention of mother to  child  transmission  of  HIV  (PMTCT).  This  intervention will contribute to achieving coverage of screening for syphilis, one of the certification criteria for Togo for the elimination of mother to child transmission of HIV.","High","Togo has ambitious targets to reach the HIV epidemic control but national resources are very limited. The funding gaps are substantial. Thus, any available resources should be made available to support HIV testing and counselling services, antiretroviral treatment, and access to viral load monitoring. The PAAR clearly targets key and priority populations to benefit from these resources; men who have sex with men, female sex workers as well as pregnant women with prevention of mother-to-child transmission (PMTCT) of HIV.","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Togo","Togo","PAI-5729","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","In 2016, the MoH started a national rollout of DHIS 2 in all its 40 health districts. A roadmap for this was drawn up and is currently being implemented with funding from the World Bank and technical assistance from AEDES. In accordance with the national health development plan (2017-2022) the scale-up of DHIS2 will be completed in 2018 and expanded at community level during the NFM2 in partnership with the GF. The funding request will support the reproduction of standardized tools for data collection including at community level.",1402760.63,null,"Active","a6Q1R000000AJTr",0,0,0,0,1402760.63,0,null,null,"In 2016, the MoH started a national rollout of DHIS 2 in all its 40 health districts. A roadmap for this was drawn up and is currently being implemented with funding from the World Bank and technical assistance from AEDES. In accordance with the national health development plan (2017-2022) the scale-up of DHIS2 will be completed in 2018 and expanded at community level during the NFM2 in partnership with the GF. The funding request will support the reproduction of standardized tools for data collection including at community level.","High","The TRP has ranked this module as a high priority because it will ensure quality of data, enabling timely decision","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Serbia","Serbia","PAI-5626","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","CSW Training of outreach workers",6425.77,null,"Active","a6Q1R000000AJSC",0,0,0,0,6425.77,0,null,null,"CSW Training of outreach workers","High","Expansion of services to reach more sex workers and\ntheir clients is essential for improving the impact of the\ninterventions on the epidemic in Serbia.","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2022-06-30","HIV/AIDS"]
["CT Sudan","Sudan","PAI-5489","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Funding to replace 976,130 LLIN with  Quality issues (DawaPlus 2.0 commercialized byTana Nettings Co Ltd REF: quality notice of 01.02.2019)  that were distributed in south Darfur state ( prevelance  9.2 %MIS 2016). Request to replace these bed nets will ensure the needed protection is provided for south Darfur population where the LLINS is the main vector control intervention.",2903401,null,"Active","a6Q1R000000AJPz",0,0,0,0,2903401,0,null,null,"Funding to replace 976,130 LLIN with  Quality issues (DawaPlus 2.0 commercialized byTana Nettings Co Ltd REF: quality notice of 01.02.2019)  that were distributed in south Darfur state ( prevelance  9.2 %MIS 2016). Request to replace these bed nets will ensure the needed protection is provided for south Darfur population where the LLINS is the main vector control intervention.","Low","The affected nets still constitute a physical barrier. It remains\nto be seen what the actual deltamethrin content of these\naffected nets was at distribution. The issue of belowspecification\ninsecticide content is minor compared to more\nimportant problems affecting the effectiveness of LLINs,\nparticularly the non-use.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign (replacement of Dawa 2.0 nets)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Papua New Guinea","Papua New Guinea","PAI-5397","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Carry out priority entomological and operational work which feeds into malaria program decisions, particularly factor which can reduce man vector contact.",150000,null,"Active","a6Q1R000000AJOV",0,0,0,0,150000,0,null,null,"Carry out priority entomological and operational work which feeds into malaria program decisions, particularly factor which can reduce man vector contact.","High","The TRP recommended in its review of the Program Continuation Request that the monitoring of insecticide resistance be sustained.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Entomology research","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Namibia","Namibia","PAI-5238","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Surveillance officers at district-level will provide an opportunity to collect, analyse and use data at local level. The amount covers district surveillance officers for Zambezi, Kavango Eeat and West, and Ohangwena regions in Years 1 & 2 to strengthen surveillance as per National Strategic Plan (2017-2022).",264498,null,"Active","a6Q1R000000AJLw",0,0,0,0,264498,0,null,null,"Surveillance officers at district-level will provide an opportunity to collect, analyse and use data at local level. The amount covers district surveillance officers for Zambezi, Kavango Eeat and West, and Ohangwena regions in Years 1 & 2 to strengthen surveillance as per National Strategic Plan (2017-2022).","Medium","Surveillance is critical for malaria elimination in Namibia particularly at district level. Surveillance officers at district-level will provide an opportunity to collect, analyse and use data at local level and to allow for timely intervention could be possible","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: District Surveillance Officers implementation and coordination of malaria surveillance","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2020-12-31","Malaria"]
["CT Mongolia","Mongolia","PAI-5141","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","For joint training and capacity building of all health care workers in Mongolia on TB screening, diagnosis and treatment, as well as increased awareness on TB through joint information, education and communication activities contributing towards increased TB case detection. The Global Fund will leverage on the Asian Development Bank Technical Assistance to Mongolia for improving the screening for viral hepatitis.",500000,null,"Inactive","a6Q1R000000AJKN",0,500000,0,0,0,1,null,null,"For joint training and capacity building of all health care workers in Mongolia on TB screening, diagnosis and treatment, as well as increased awareness on TB through joint information, education and communication activities contributing towards increased TB case detection. The Global Fund will leverage on the Asian Development Bank Technical Assistance to Mongolia for improving the screening for viral hepatitis.","High","While the TRP considers this intervention\nappropriate and of high priority, the TRP was not\nprovided with enough information to make a\ndefinitive decision. Therefore, the TRP\nrecommends that the applicant be required to\ndevelop an implementation plan for the\nproposed intervention, as a condition to\naccessing the PAAR funds, should these funds\nbecome available.\nMore specifically, the implementation plan\nshould include a detailed strategy for equipping\nhealth care workers with the knowledge and\nskills of TB screening, diagnosis and treatment,\nand a clear understanding of the roles of key\npartners (ADB and Government) in combined\ntraining and capacity building activities.\nFollowing the TRP Window 2 Issue 5\nrecommendation, the implementation plan needs\nto be based on a national human resources for\nhealth strategy that outlines interventions to fill\ngaps of health care human resources, ensure\nthe retention of health workforce and promote\nthe use of community health volunteers.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2020-12-31","Tuberculosis"]
["CT Myanmar","Myanmar","PAI-5116","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","This intervention will provide data to support Program activities.",835427,null,"Inactive","a6Q1R000000AJJy",835427,0,0,0,0,1,null,null,"This intervention will provide data to support Program activities.","High","There is a severe lack of valid information on which to base plans and activities.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5115","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","This intervention will target dispersed rural communities to provide increased case finding and adherence to treatment in both HIV and TB.",5402257,null,"Active","a6Q1R000000AJJx",2220428,0,0,0,3181829,0,null,null,"This intervention will target dispersed rural communities to provide increased case finding and adherence to treatment in both HIV and TB.","High","The dispersed rural communities have been severely neglected and are needed to provide increased case finding ad adherence to treatment in both HIV/TB","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Moldova","Moldova","PAI-5015","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","To continue the development of the roles and capacity of key affected populations and communities and to ensure the good quality of services provision and in organizing the advocacy activitites, communications, social mobilization, etc it is important to have at list two training per year for civil society representatives and KAP organizations.",12565.37,null,"Active","a6Q1R000000AJIL",0,0,0,0,12565.37,0,null,null,"To continue the development of the roles and capacity of key affected populations and communities and to ensure the good quality of services provision and in organizing the advocacy activitites, communications, social mobilization, etc it is important to have at list two training per year for civil society representatives and KAP organizations.","High","The TRP considers this intervention high priority as strengthening of community systems is important for the HIV response when it involves key populations.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: RSSH - Community responses and systems. Original Intervention: Capacity building for community involvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4892","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Training recording and reporting to NTP staff on the updates registers according to the WHO case definition and on the Electronic National Registration System and TB surveillance",8978,null,"Active","a6Q1R000000AJGM",0,0,0,0,8978,0,null,null,"Training recording and reporting to NTP staff on the updates registers according to the WHO case definition and on the Electronic National Registration System and TB surveillance","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4887","MCI-00008","TB care and prevention","MCI-00127","Treatment","TB cohort review; staff from the 12 governorates will meet to systematically review the management of patients with TB and their contacts to improve TB case management and the identification of contacts; the review will be done for all cases including refugees and migrants",13467,null,"Active","a6Q1R000000AJGH",0,0,0,0,13467,0,null,null,"TB cohort review; staff from the 12 governorates will meet to systematically review the management of patients with TB and their contacts to improve TB case management and the identification of contacts; the review will be done for all cases including refugees and migrants","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4886","MCI-00008","TB care and prevention","MCI-00127","Treatment","Workshop for representatives of civil society organizations and tuberculosis patients to improve the quality of provided treatment services. Training course for private doctors, hospitals and doctors of the chest diseases centers on TB diagnosis, treatment and Training of staff of non-governmental organizations concerned with TB management.workshop for representatives of civil society organizations and TB patients to improve the quality of treatment services. Training pharmacists on TB treatments first and second line.",31422,null,"Active","a6Q1R000000AJGG",0,0,0,0,31422,0,null,null,"Workshop for representatives of civil society organizations and tuberculosis patients to improve the quality of provided treatment services. Training course for private doctors, hospitals and doctors of the chest diseases centers on TB diagnosis, treatment and Training of staff of non-governmental organizations concerned with TB management.workshop for representatives of civil society organizations and TB patients to improve the quality of treatment services. Training pharmacists on TB treatments first and second line.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry HIV Latin America ALEP","Multicountry HIV Latin America ALEP","PAI-4770","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Nicaragua would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in addressing stigma and discrimination within health services, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the reforms they consider necessary, in line with the regional activities emerging from this module.\nEstablishment of strategic partnerships with other sectors representing the intersectionality of HIV to address social determinants and the development and implementation of regional, subregional and national programs to tackle stigma and discrimination of PLHIV, from a gender, multiethnic and rights-based approach, based on findings from the stigma indices.",19201,null,"Inactive","a6Q1R000000AJEO",19201,0,0,0,0,1,null,null,"Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Nicaragua would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in addressing stigma and discrimination within health services, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the reforms they consider necessary, in line with the regional activities emerging from this module.\nEstablishment of strategic partnerships with other sectors representing the intersectionality of HIV to address social determinants and the development and implementation of regional, subregional and national programs to tackle stigma and discrimination of PLHIV, from a gender, multiethnic and rights-based approach, based on findings from the stigma indices.","High","The TRP recommends that the activities for Nicaragua in the PAAR to be embedded in the revised proposal.  It is requested that the Secretariat ensures that the proposed activities leverage existing resources for the technical areas",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-09-30","HIV/AIDS"]
["CT Uganda","Uganda","PAI-5882","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Private sector ACT subsidy covered under current grant will be maintained under this Application to maintain high levels of treatment with quality assured ACTs and crowd out counterfeits. The need for the first two years is requested within Allocation while the need for 2020 is requested under PAAR.",12668499,null,"Active","a6Q1R000000AJWK",0,0,0,0,12668499,0,null,null,"Private sector ACT subsidy covered under current grant will be maintained under this Application to maintain high levels of treatment with quality assured ACTs and crowd out counterfeits. The need for the first two years is requested within Allocation while the need for 2020 is requested under PAAR.","High","To maintain high levels of treatment with quality assured ACTs and crowd out counterfeit; this request will cover the need for part of 2019- 2020.","NA Original Intervention: Private sector co-payments (50% of need)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Zambia","Zambia","PAI-6037","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The number of LLINs to be distributed through routine channel to targeted  at risk populations is 2,158,203  and 1,948,203 in 2019 and 2020 respectively.",5778982.7999999998,null,"Active","a6Q1R000000AJYp",0,0,0,0,5778982.7999999998,0,null,null,"The number of LLINs to be distributed through routine channel to targeted  at risk populations is 2,158,203  and 1,948,203 in 2019 and 2020 respectively.","High","The proposed action is in line with the national strategic plan and vector control interventions for significant reduction in malaria by 2020.","NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Zambia","Zambia","PAI-6035","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","The target number of structures in 2019 is 3,376,196 translating in estimated 14,585,167 people protected at an average of 4.32 persons per structure. For 2020 the target is 3,474,106 structures translating in 15,008,138 people protected.",12437067,null,"Inactive","a6Q1R000000AJYn",0,12437067,0,0,0,1,null,null,"The target number of structures in 2019 is 3,376,196 translating in estimated 14,585,167 people protected at an average of 4.32 persons per structure. For 2020 the target is 3,474,106 structures translating in 15,008,138 people protected.","High","The proposed action is in line with the national strategic plan and vector control interventions for significant reduction in malaria by 2020.","NA Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Viet Nam","Viet Nam","PAI-5940","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","FSW network was established in 2012. The number of CBOs engaged in the HIV response accounts for roughly 42 in 28 provinces/cities nationwide. Over the past 05 years, the significant roles and contribution of CBOs in HIV/AIDS control and prevention have been recognized by VAAC, PACs as well as local authorities. Members of CBOs have actively participated in community activity such as: community mobilization, community ?based monitoring, prevention of stigma, discrimination and gender-based violence. VUSTA intends to encourage FSW community in engaging more in HIV/AIDS response by providing initiatives packages focusing on prioritized, specific topics: Addressing stigma, discrimination and violence against FSW; Pre-exposure prophylaxis (PrEP).",16511,null,"Active","a6Q1R000000AJXG",0,0,0,0,16511,0,null,null,"FSW network was established in 2012. The number of CBOs engaged in the HIV response accounts for roughly 42 in 28 provinces/cities nationwide. Over the past 05 years, the significant roles and contribution of CBOs in HIV/AIDS control and prevention have been recognized by VAAC, PACs as well as local authorities. Members of CBOs have actively participated in community activity such as: community mobilization, community ?based monitoring, prevention of stigma, discrimination and gender-based violence. VUSTA intends to encourage FSW community in engaging more in HIV/AIDS response by providing initiatives packages focusing on prioritized, specific topics: Addressing stigma, discrimination and violence against FSW; Pre-exposure prophylaxis (PrEP).","High","Female sex worker CBOs that are providing many of the prevention interventions and capacity building should be part of the main allocation.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Capacity building for VNSW","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Chad","Chad","PAI-5726","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","93% of the population in Chad religious (composed of Muslims, Catholics and Protestants). These three religions are well-structured with national coordinating bodies: the Higher Council of Islamic Affairs for Muslims, the Episcopal Conference of Chad for Catholics and the Agreement of Evangelical Churches and Missions for Protestants. In addition, there is a peaceful coexistence between these three religious congregations with regular consultations at all levels between the various officials.\nThis structuring of religious congregations is a powerful means to spread health messages. The country plans to use their support to sensitize community members on the fight against malaria, HIV/AIDS and tuberculosis. The requested funding has the following objectives:\n? Ensure the training of 438 trainers / leaders from 146 health districts in the country\n? Train 9,000 women and 9,000 young people as malaria awareness agents\n? Organize broadcasts on 10 community radio stations\n? Support the monitoring of the activities implemented by the religious congregations",593576.11,null,"Active","a6Q1R000000AJTo",0,0,0,0,593576.11,0,null,null,"93% of the population in Chad religious (composed of Muslims, Catholics and Protestants). These three religions are well-structured with national coordinating bodies: the Higher Council of Islamic Affairs for Muslims, the Episcopal Conference of Chad for Catholics and the Agreement of Evangelical Churches and Missions for Protestants. In addition, there is a peaceful coexistence between these three religious congregations with regular consultations at all levels between the various officials.\nThis structuring of religious congregations is a powerful means to spread health messages. The country plans to use their support to sensitize community members on the fight against malaria, HIV/AIDS and tuberculosis. The requested funding has the following objectives:\n? Ensure the training of 438 trainers / leaders from 146 health districts in the country\n? Train 9,000 women and 9,000 young people as malaria awareness agents\n? Organize broadcasts on 10 community radio stations\n? Support the monitoring of the activities implemented by the religious congregations","Low","93% of the population in Chad religious (composed of Muslims, Catholics and Protestants). These three religions are well-structured with national coordinating bodies: the Higher Council of Islamic Affairs for Muslims, the Episcopal Conference of Chad for Catholics and the Agreement of Evangelical Churches and Missions for Protestants. In addition, there is a peaceful coexistence between these three religious congregations with regular consultations at all levels between the various officials.\nThis structuring of religious congregations is a powerful means to spread health messages. The country plans to use their support to sensitize community members on the fight against malaria, HIV/AIDS and tuberculosis. The requested funding has the following objectives:\n? Ensure the training of 438 trainers / leaders from 146 health districts in the country\n? Train 9,000 women and 9,000 young people as malaria awareness agents\n? Organize broadcasts on 10 community radio stations\n? Support the monitoring of the activities implemented by the religious congregations","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2021-06-30","Malaria"]
["CT Serbia","Serbia","PAI-5622","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Bio-BBS tracking the trends in behaviour and HIV-prevalence should be conducted every 2-3 years. The last Bio-BBS was conducted in 2013 and Serbia is missing data on outcome and impact indicators, which helps to evaluate the efforts in controlling the HIV/AIDS epidemic. IBBS to be conducted in 2019 to evaluate the services provided and make improvements in 2020. Second round is planned in 2021.",71190.66,null,"Active","a6Q1R000000AJS8",0,0,0,0,71190.66,0,null,null,"Bio-BBS tracking the trends in behaviour and HIV-prevalence should be conducted every 2-3 years. The last Bio-BBS was conducted in 2013 and Serbia is missing data on outcome and impact indicators, which helps to evaluate the efforts in controlling the HIV/AIDS epidemic. IBBS to be conducted in 2019 to evaluate the services provided and make improvements in 2020. Second round is planned in 2021.","High","Expansion of services for men who have sex with men\nshould be prioritized given the epidemiological\nbackground in the country as well as the coverage\ncurrently reported in this population","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2022-06-30","HIV/AIDS"]
["CT Serbia","Serbia","PAI-5621","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Training for service providers on community based VCT for MSM",3212.88,null,"Active","a6Q1R000000AJS7",0,0,0,0,3212.88,0,null,null,"Training for service providers on community based VCT for MSM","High","Expansion of services for sex workers and their clients\nshould be prioritized given the epidemiological\nbackground in the country as well as the coverage\ncurrently reported in this population.","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2022-06-30","HIV/AIDS"]
["CT Sudan","Sudan","PAI-5485","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN to replace LLIN distributed in 2017 to maintain universal coverage in the 12 targeted states (5 Darfur states, 3 Kordofan states, White Nile, Blue Nile, Kassala and Gadarif states). Ongoing advocacy and awareness campaigns to sensitize targeted communities to increase the bed net utilization.",12317771,null,"Active","a6Q1R000000AJPv",0,0,0,0,12317771,0,null,null,"LLIN to replace LLIN distributed in 2017 to maintain universal coverage in the 12 targeted states (5 Darfur states, 3 Kordofan states, White Nile, Blue Nile, Kassala and Gadarif states). Ongoing advocacy and awareness campaigns to sensitize targeted communities to increase the bed net utilization.","High","The TRP notes that the estimated costs per net are relatively high for this budget line, and that this needs careful review during grant-making to confirm the actual above-allocation amount required.","Sudan has only 1 integrated funding request, and the UQD component is Malaria. Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Philippines","Philippines","PAI-5389","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","This is an expansion of coverage of the systematic screening among vulnerable/ high risk population groups to find the missing cases.",2500000,null,"Active","a6Q1R000000AJON",0,0,0,0,2500000,0,null,null,"This is an expansion of coverage of the systematic screening among vulnerable/ high risk population groups to find the missing cases.","Low","Although the link between DM and TB is important, it has less priority compared to the previous modules","NA Original Intervention: Systematic screening for TBDM","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Nepal","Nepal","PAI-5336","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","To provide high-end international technical assistance to the NTP.",1180000,null,"Active","a6Q1R000000AJNW",0,0,0,0,1180000,0,null,null,"To provide high-end international technical assistance to the NTP.","High","Access to quality technical assistance is necessary due to high turnover in key NTP personnel. However, the cost should be brought into alignment with international development agency standards.","NA Original Intervention: TA (1-international)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2021-03-15","Tuberculosis"]
["CT Namibia","Namibia","PAI-5235","MCI-00012","Case management","MCI-00154","Facility-based treatment","Case management provided by clinical mentors should be maintained and strengthened in the non-prioritized regions to shrink further the geographic area of transmission.\nThis amount includes salaries for 4 clinical mentors, as well as their mentorship visits to the health facility and to community health workers in the non-prioritized regions in year 1 and 2 to ensure smooth transition in line with the ongoing government restructuring.",295848,null,"Active","a6Q1R000000AJLt",0,0,0,0,295848,0,null,null,"Case management provided by clinical mentors should be maintained and strengthened in the non-prioritized regions to shrink further the geographic area of transmission.\nThis amount includes salaries for 4 clinical mentors, as well as their mentorship visits to the health facility and to community health workers in the non-prioritized regions in year 1 and 2 to ensure smooth transition in line with the ongoing government restructuring.","Medium","The TRP recommends that facilities are chosen from the districts/ zones from the geographical regions where the grant will be implemented to allow for sustainability of services after the grant.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2020-12-31","Malaria"]
["CT Myanmar","Myanmar","PAI-5110","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.",1164938,null,"Inactive","a6Q1R000000AJJs",1164938,0,0,0,0,1,null,null,"HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.","High","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately. For both decreased mortality and decreased HIV transmission HIV treatment is a high priority.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5105","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","The funds are requested for diagnosis and treatment for Tuberculosis and interruption of transmission of TB.",5941683,null,"Active","a6Q1R000000AJJn",5904939,0,0,0,36744,0,null,null,"The funds are requested for diagnosis and treatment for Tuberculosis and interruption of transmission of TB.","High","The funds are requested for diagnosis and treatment for Tuberculosis and interruption of transmission of TB has a high priority.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Moldova","Moldova","PAI-5009","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","Taking  into  consideration  the  need  to  cover  more PWID  with  prevention  programs  (according  to  new estimations)  and  the  flow  of  employed  persons,  it  is crucial   to   have   an   opportunity   to   train   the   new employed  persons  (most  of  them  outreach)onbasic harm   reduction issuesto   ensure   quality   service provision and minimal standards of services.",20981.93,null,"Active","a6Q1R000000AJIF",0,0,0,0,20981.93,0,null,null,"Taking  into  consideration  the  need  to  cover  more PWID  with  prevention  programs  (according  to  new estimations)  and  the  flow  of  employed  persons,  it  is crucial   to   have   an   opportunity   to   train   the   new employed  persons  (most  of  them  outreach)onbasic harm   reduction issuesto   ensure   quality   service provision and minimal standards of services.","High","The TRP considers harm reduction interventions and other inventions for people who inject drugs and their partners as high priority given the epidemiology of HIV in Moldova. In order to start expanded services, it will be necessary to train service providers in order to safeguard the quality of the services to be provided. Additionally, to the requested amount of EUR 11,197 for this activity, the TRP recommends 50% of the requested amount for the participation of members of the civil society in International events (EUR 7,500) to be allocated to extra training in harm reduction services or service provision","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Train service providers in basic harm reduction interventions","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2020-12-31","HIV/AIDS"]
["CT Multicountry HIAF1 WHC","Multicountry Southern Africa WHC","PAI-5008","MCI-00008","TB care and prevention","MCI-00591","Removing human rights and gender related barriers to TB care and prevention","Within allocation funding focuses on human rights and gender barriers among ASM. PAAR focuses on three aspects:(i)Human rights and gender awareness raising among LSMs and communities:This intervention will improve LSM mining companies, as well as labour unions, miners and ex-miners?, peri-mining and labour-sending communities? awareness about  worker rights and access to occupational and public health services. This will include mine health legal provision adoption and mineworkers? entitlements through training of trainers (ToT) by regional CSOs.",468228,null,"Active","a6Q1R000000AJIE",0,0,0,0,468228,0,null,null,"Within allocation funding focuses on human rights and gender barriers among ASM. PAAR focuses on three aspects:(i)Human rights and gender awareness raising among LSMs and communities:This intervention will improve LSM mining companies, as well as labour unions, miners and ex-miners?, peri-mining and labour-sending communities? awareness about  worker rights and access to occupational and public health services. This will include mine health legal provision adoption and mineworkers? entitlements through training of trainers (ToT) by regional CSOs.","High","The TRP recommends the full amount\nbudgeted under this intervention as\nquality demand, noting that the budget\nwill be used to address and change laws\nand regulations to remove legal barriers\nto access to TB, HIV and occupational\nhealth and safety services.","CT did not update UQD description, but confirmed the amount. The description from PAAR seems right though & does not require further followup Original Intervention: Removing human rights- and gender-related barriers to TB care and prevention","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 2","2020-12-31","Tuberculosis"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4882","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Trainings for laboratory technicians at the sub-level on microscopy, culture, quality control and safety in the laboratoryand infection control and health risk management for TB.",15711,null,"Active","a6Q1R000000AJGC",0,0,0,0,15711,0,null,null,"Trainings for laboratory technicians at the sub-level on microscopy, culture, quality control and safety in the laboratoryand infection control and health risk management for TB.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry HIV Latin America ALEP","Multicountry HIV Latin America ALEP","PAI-4769","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","Given its social and political situation, it is felt that Nicaragua cannot guarantee implementation of the full program planned for the other countries. However, implementation of this selection of some of the same activities as the other countries, and the inclusion of Nicaragua in the regional activities, would ensure that the regional objectives of this multicountry funding request are achieved. For evidence of the situation in Nicaragua, see the report by the Organization of American States (OAS) at: http://www.oas.org/en/iachr/reports/pdfs/Nicaragua2018-en.pdf\nCivil society is facing difficulties in addressing the necessary legislative, regulatory and policy changes, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of people living with HIV (PLHIV) and other key populations achieve the reforms they consider necessary, in line with the regional activities emerging from this module.\nTo provide an effective HIV response, open data strategies are being designed and implemented, along with oversight and social control of public policies, and legal barriers related to intellectual property are being analyzed. Strategies to overcome these are being designed and implemented.",8628,null,"Inactive","a6Q1R000000AJEN",8628,0,0,0,0,1,null,null,"Given its social and political situation, it is felt that Nicaragua cannot guarantee implementation of the full program planned for the other countries. However, implementation of this selection of some of the same activities as the other countries, and the inclusion of Nicaragua in the regional activities, would ensure that the regional objectives of this multicountry funding request are achieved. For evidence of the situation in Nicaragua, see the report by the Organization of American States (OAS) at: http://www.oas.org/en/iachr/reports/pdfs/Nicaragua2018-en.pdf\nCivil society is facing difficulties in addressing the necessary legislative, regulatory and policy changes, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of people living with HIV (PLHIV) and other key populations achieve the reforms they consider necessary, in line with the regional activities emerging from this module.\nTo provide an effective HIV response, open data strategies are being designed and implemented, along with oversight and social control of public policies, and legal barriers related to intellectual property are being analyzed. Strategies to overcome these are being designed and implemented.","High","The TRP recommends that the activities for Nicaragua in the PAAR to be embedded in the revised proposal.  It is requested that the secretariat ensure that the proposed activities leverage existing resources for the technical areas.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-09-30","HIV/AIDS"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5880","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","To enhance government strategy on strengthening linkage and retention in care among PLHIV, it is proposed that some form of transport facilitation will help Community based health service providers (CBHS) follow up PLHIV within communities. The requested fund is to provide bicycles for 5000 CBHS providers to enhance tracking of clients who have missed their CTC appointments, conduct home and community visits as well as ensure timely responses for provision of first aid in the community for PLHIV as well as other general population.",564844,null,"Active","a6Q1R000000AJWI",0,0,0,0,564844,0,null,null,"To enhance government strategy on strengthening linkage and retention in care among PLHIV, it is proposed that some form of transport facilitation will help Community based health service providers (CBHS) follow up PLHIV within communities. The requested fund is to provide bicycles for 5000 CBHS providers to enhance tracking of clients who have missed their CTC appointments, conduct home and community visits as well as ensure timely responses for provision of first aid in the community for PLHIV as well as other general population.","Medium","To enhance government strategy on strengthening linkage and retention in care among people living with HIV, it is proposed that some form of transport facilitation will help Community based health service providers (CBHS) follow up people living with HIV within communities. The requested fund is to provide bicycles for 5000 CBHS providers to enhance tracking of clients who have missed their CTC appointments, conduct home and community visits as well as ensure timely responses for provision of first aid in the community for people living with HIV as well as other general population.","NA Original Intervention: Enhance efficiency of the CBHS providers to deliver community services","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5879","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Testing of TB patients? partners for HIV is also an important component of HIV prevention services for TB patients. Partner/ Couple testing and partner notification remain low in our settings. Few TB clinics have systems in place to adequately document partner testing. This requested funding is to provide minimal additional training in line with the Couple Counselling refresher training package and HTC tools for documentation. It is expected that through this, existing cadres of skilled medical staff will be able to extend HIV testing Tanzania Funding Request: Full review 22 May 2017 | 43 and counselling to the partners of their TB patients.",350000,null,"Active","a6Q1R000000AJWH",0,0,0,0,350000,0,null,null,"Testing of TB patients? partners for HIV is also an important component of HIV prevention services for TB patients. Partner/ Couple testing and partner notification remain low in our settings. Few TB clinics have systems in place to adequately document partner testing. This requested funding is to provide minimal additional training in line with the Couple Counselling refresher training package and HTC tools for documentation. It is expected that through this, existing cadres of skilled medical staff will be able to extend HIV testing Tanzania Funding Request: Full review 22 May 2017 | 43 and counselling to the partners of their TB patients.","Medium","Testing of TB patients? partners for HIV is also an important component of HIV prevention services for TB patients. Partner/ Couple testing and partner notification remain low in our settings. Few TB clinics have systems in place to adequately document partner testing. This requested funding is to provide minimal additional training in line with the Couple Counselling refresher training package and HTC tools for documentation. It is expected that through this, existing cadres of skilled medical staff will be able to extend HIV testing and counselling to the partners of their TB patients.","NA Original Intervention: Strengthening Couple HIV Testing for TB/HIV patients? partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5792","MCI-00531","Comprehensive prevention programs for TGs","MCI-00562","Other intervention(s) for TGs","DDC BL 309-311Having hormone services (counseling, hormone level measurement, hormone therapy, lipid/liver function test) available as key service in health package could certainly bring and retain TGW in the program.  7 provinces pilots1. Training staff of CSO and health care staff 1 time per year, 2. Lessonslearned3. TG Hormone level.",71659,null,"Active","a6Q1R000000AJUs",0,0,0,0,71659,0,null,null,"DDC BL 309-311Having hormone services (counseling, hormone level measurement, hormone therapy, lipid/liver function test) available as key service in health package could certainly bring and retain TGW in the program.  7 provinces pilots1. Training staff of CSO and health care staff 1 time per year, 2. Lessonslearned3. TG Hormone level.","High","This intervention will support training for hospital and community staff on transgender people -specific package of services. Hormone services are an integral part of the package and availability of these services will likely improve service uptake and retention of transgender people clients into health system.","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Other interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Zanzibar","Zanzibar","PAI-6032","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Enhancing TB prevention activities and case detection is in line with program needs.  However with the purchase and institution of GeneXpert from within the allocation budget, it is rated as medium priority.",52308,null,"Active","a6Q1R000000AJYk",0,0,0,0,52308,0,null,null,"Enhancing TB prevention activities and case detection is in line with program needs.  However with the purchase and institution of GeneXpert from within the allocation budget, it is rated as medium priority.","Medium","Enhancing TB prevention activities and case detection is in line with program needs identified during prior TRP reviews. This module is however rated as a medium priority since purchase and institution of GeneXpert as provided for within the allocation amount is potentially of higher priority rating for TB case detection than solid culture capacity.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Zanzibar","Zanzibar","PAI-6027","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","This activity will complement program scale-up by availing and enabling data use for implementation.",82716,null,"Active","a6Q1R000000AJYf",0,0,0,0,82716,0,null,null,"This activity will complement program scale-up by availing and enabling data use for implementation.","High","This activity will complement program scale-up by availing and enabling data use for implementation.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Chad","Chad","PAI-5721","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","The country successfully implemented (IRS) in the Moissala locality and intends to expand it in 3 districts with the highest malaria mortality.",2220048.25,null,"Active","a6Q1R000000AJTj",0,0,0,0,2220048.25,0,null,null,"The country successfully implemented (IRS) in the Moissala locality and intends to expand it in 3 districts with the highest malaria mortality.","High","The country successfully implemented indoor residual spraying (IRS) in the Moissala locality and intends to expand in 3 districts with the highest malaria mortality.","NA Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2021-06-30","Malaria"]
["CT Serbia","Serbia","PAI-5617","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00090","Diagnosis and treatment of STIs and other sexual and reproductive health services for sex workers","STI test kit -syphilis",343.4,null,"Active","a6Q1R000000AJS3",0,0,0,0,343.4,0,null,null,"STI test kit -syphilis","Low","While sexually transmitted infections (STI) testing kits\nare important, the amount requested could potentially be\ncovered from other sources rather than by this allocation\nrequest though efficiencies.","NA Original Intervention: Diagnosis and treatment of sexually transmittedinfections and othersexual and reproductivehealth services for sex workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2022-06-30","HIV/AIDS"]
["CT Rwanda","Rwanda","PAI-5481","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Above allocation will: a) cover the purchase of computers to replace those distributed to health facilities in 2012 - to complement interventions on improved access and quality of surveillance data contained in the funding; b) support the NTP for conducting joint sessions with the national Institute of Statistics for analysing causes of TB deaths using available data from the national vital registration system.",388195,null,"Active","a6Q1R000000AJPr",0,0,0,0,388195,0,null,null,"Above allocation will: a) cover the purchase of computers to replace those distributed to health facilities in 2012 - to complement interventions on improved access and quality of surveillance data contained in the funding; b) support the NTP for conducting joint sessions with the national Institute of Statistics for analysing causes of TB deaths using available data from the national vital registration system.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Rwanda","Rwanda","PAI-5476","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Catastrophic Cost Survey:  This survey was a recommendation from the November 2016 Mid-Term Review of the NSP, and is in line with the End TB Strategy. The survey is expected to determine the magnitude of costs incurred so as to establish a baseline for the End TB indicator #5 (where the goal is: zero families face catastrophic costs related to TB by 2020). The determination of costs would allow the country to work towards a national policy on reducing TB patient costs that could lead to further improvements in diagnosis and treatment adherence. The National TB Program is currently drafting the protocol for the survey, that could be implemented within 3 months if funding is confirmed.",150000,null,"Inactive","a6Q1R000000AJPm",0,150000,0,0,0,1,null,null,"Catastrophic Cost Survey:  This survey was a recommendation from the November 2016 Mid-Term Review of the NSP, and is in line with the End TB Strategy. The survey is expected to determine the magnitude of costs incurred so as to establish a baseline for the End TB indicator #5 (where the goal is: zero families face catastrophic costs related to TB by 2020). The determination of costs would allow the country to work towards a national policy on reducing TB patient costs that could lead to further improvements in diagnosis and treatment adherence. The National TB Program is currently drafting the protocol for the survey, that could be implemented within 3 months if funding is confirmed.","High","The budget proposed is considered the standard costing for conducting a catastrophic survey based on studies conducted in similar settings. The costs include printing of study materials, recruitment and training of temporary survey teams (enumerators to join NTP team), field administration of the survey, data entry and analysis, report writing and results dissemination.","CT Validation : The text in the form is not changed however CT said it was updated. To be follow-up Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Southern and Eastern Africa","2021-06-30","Tuberculosis"]
["CT Rwanda","Rwanda","PAI-5475","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Above allocation will support participation in international conferences for experience sharing and capacity building of HIV program staff. It will also support the functioning of central agencies for coordination and monitoring of the national HIV response. Strengthened program management will directly improve the quality and effectiveness of HIV services.",115796,null,"Active","a6Q1R000000AJPl",0,0,0,0,115796,0,null,null,"Above allocation will support participation in international conferences for experience sharing and capacity building of HIV program staff. It will also support the functioning of central agencies for coordination and monitoring of the national HIV response. Strengthened program management will directly improve the quality and effectiveness of HIV services.","Low","No direct liaison with impact","NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Philippines","Philippines","PAI-5381","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","This will ensure that higher risk MSM are reached with prevention programs.",1077934.3999999999,null,"Active","a6Q1R000000AJOF",381960.4,0,0,0,695974,0,null,null,"This will ensure that higher risk MSM are reached with prevention programs.","Medium","The intervention is already included in the allocation request and targeting most at risk MSM and could be achieved with lower funding and efficiencies found during grant implementation. The rationale provided by the applicant does not make for a compelling case how the additional funding will impact the epidemic and raises some feasibility concerns. Extension of PrEP demonstration does not demonstrate well the added value and is not recommended.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioural interventions addressing stigma and discrimination and violence against MSM condoms and lubricant programming HIV testing services PrEP other interventions","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Nepal","Nepal","PAI-5333","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Prepare annual HR development plan.",10512,null,"Active","a6Q1R000000AJNT",0,0,0,0,10512,0,null,null,"Prepare annual HR development plan.","High","In line with the issue 2 below, emphasis on long term human resource capacity to be prepared for elimination requirement is needed.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-03-15","Malaria"]
["CT Malawi","Malawi","PAI-5230","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Expanding FSW programming to additional districts ($1.28M) Expansion of FSW programming to 4 additional priority districts, including enhanced linkage to care.",1280000,null,"Active","a6Q1R000000AJLo",0,0,0,0,1280000,0,null,null,"Expanding FSW programming to additional districts ($1.28M) Expansion of FSW programming to 4 additional priority districts, including enhanced linkage to care.","High","Increased comprehensive programming for key populations will be increasingly needed to control the epidemic as incidence among the general population declines.","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Malawi","Malawi","PAI-5229","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Expanding MSM programming to additional districts ($1.11M) Expansion of MSM programming to 4 additional priority districts, including enhanced linkage to care and drop-in centers.",1110000,null,"Active","a6Q1R000000AJLn",0,0,0,0,1110000,0,null,null,"Expanding MSM programming to additional districts ($1.11M) Expansion of MSM programming to 4 additional priority districts, including enhanced linkage to care and drop-in centers.","High","Increased comprehensive programming for key populations will be increasingly needed to control the epidemic as incidence among the general population declines.","Amount for this component is combined. Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa","2020-12-31","TB/HIV"]
["CT Myanmar","Myanmar","PAI-5102","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","This intervention will fund critical activities to ensure the program is implemented and designed with quality.",25628432,null,"Active","a6Q1R000000AJJk",21634536,0,0,0,3993896,0,null,null,"This intervention will fund critical activities to ensure the program is implemented and designed with quality.","High","Program management is critical to ensuring that program is implemented as designed with quality. It is necessary to ensure that program management costs are appropriate, however.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Myanmar","Myanmar","PAI-5097","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00098","OST and other drug dependence treatment for PWID","The additional investment will support the program to reach more target population.",4855164,null,"Active","a6Q1R000000AJJf",4446836,0,0,0,408328,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia",null,"TB/HIV"]
["CT Multicountry HIAS AFAIDS","Multicountry South-Eastern Asia AFAO","PAI-5003","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 187 for Philippines for year 2 second round grants",119652.38,null,"Active","a6Q1R000000AJI9",0,0,0,0,119652.38,0,null,null,"Additional amount to add to Within Allocation Budget Line 187 for Philippines for year 2 second round grants","High",null,"NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-12-31","HIV/AIDS"]
["CT Multicountry HIAS AFAIDS","Multicountry South-Eastern Asia AFAO","PAI-5002","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 186 for Mongolia for year 2 second round grants",119652.38,null,"Active","a6Q1R000000AJI8",0,0,0,0,119652.38,0,null,null,"Additional amount to add to Within Allocation Budget Line 186 for Mongolia for year 2 second round grants","High",null,"NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-12-31","HIV/AIDS"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4875","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Maintain and enhance the transport of specimens between chest diseases centers in the 11 governorates in Jordan to the National reference laboratory in Amman and conduct external quaility assurance between Supra national Lab and the NRL (including courier service, samples containers, laboratory forms etc.)",10100,null,"Active","a6Q1R000000AJG5",0,0,0,0,10100,0,null,null,"Maintain and enhance the transport of specimens between chest diseases centers in the 11 governorates in Jordan to the National reference laboratory in Amman and conduct external quaility assurance between Supra national Lab and the NRL (including courier service, samples containers, laboratory forms etc.)","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4870","MCI-00008","TB care and prevention","MCI-00128","Prevention","Development of IEC materials in different languages of the migrants countries and coordination with relevant embassies to address the language barrier and deliver educational messages on TB among migrant workers in the industrial zones in Jordan",19639,null,"Active","a6Q1R000000AJG0",0,0,0,0,19639,0,null,null,"Development of IEC materials in different languages of the migrants countries and coordination with relevant embassies to address the language barrier and deliver educational messages on TB among migrant workers in the industrial zones in Jordan","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Middle East and North Africa",null,"Multi-component"]
["CT Morocco","Morocco","PAI-4762","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Regional NSP workshop; NSP review; production of national reports; situational study on disabled people?s vulnerability to HIV and STIs; socioeconomic study on PLHIV, SWs, MSM and people who inject drugs; annual program and financial audits of NSP implementation; supervision of ?above allocation? activities; qualitative situational study on the vulnerability of street children; procurement of equipment and IT services for health centers and community centers.",128743.13,null,"Active","a6Q1R000000AJEG",0,0,0,0,128743.13,0,null,null,"Regional NSP workshop; NSP review; production of national reports; situational study on disabled people?s vulnerability to HIV and STIs; socioeconomic study on PLHIV, SWs, MSM and people who inject drugs; annual program and financial audits of NSP implementation; supervision of ?above allocation? activities; qualitative situational study on the vulnerability of street children; procurement of equipment and IT services for health centers and community centers.","High","While some of these activities are important (regular program reviews, key populations qualitative situational vulnerability studies), this request includes equipment & IT procurement which are not considered to be quality demand.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Analysis, evaluations, review and transparency","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Morocco","Morocco","PAI-4759","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Present and analyze the HIV transition preparation plan with the different institutional actors and TFPs; produce and implement a resource mobilization plan in line with the needs of the 2017-2021 NSP; conduct a study into mobilizable innovative financing in the HIV response; establish an intersectoral financial committee to identify NSP funding opportunities (Ministry of Health, Ministry of Finance, CCM, etc.); hold discussions with the National Agency of Health insurance (ANAM) on treatment and care funding mechanisms; conduct a feasibility study into funding HIV case management within the health insurance scheme.",70290.649999999994,null,"Inactive","a6Q1R000000AJED",70290.649999999994,0,0,0,0,1,null,null,"Present and analyze the HIV transition preparation plan with the different institutional actors and TFPs; produce and implement a resource mobilization plan in line with the needs of the 2017-2021 NSP; conduct a study into mobilizable innovative financing in the HIV response; establish an intersectoral financial committee to identify NSP funding opportunities (Ministry of Health, Ministry of Finance, CCM, etc.); hold discussions with the National Agency of Health insurance (ANAM) on treatment and care funding mechanisms; conduct a feasibility study into funding HIV case management within the health insurance scheme.","High","An important feature of this funding request is to move further towards sustainability and this request presents a reasonable step in this direction","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5872","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Medium level priority. Children under 5 years age is belong to KAP in Tanzania. Therefore it would be important to scale up Integrated Management of Childhood Diseases ( d-IMCI) in four other regions of Kagera, Kilimanjaro, Mara and Mtwara where the childhood notification rates are below national average. A total of 2,400 healthcare workers will be trained using the innovative distance learning method.",1283583,null,"Active","a6Q1R000000AJWA",0,0,0,0,1283583,0,null,null,"Medium level priority. Children under 5 years age is belong to KAP in Tanzania. Therefore it would be important to scale up Integrated Management of Childhood Diseases ( d-IMCI) in four other regions of Kagera, Kilimanjaro, Mara and Mtwara where the childhood notification rates are below national average. A total of 2,400 healthcare workers will be trained using the innovative distance learning method.","High","Medium level priority. Children under 5 years age is belong to KAP in Tanzania. Therefore it would be important to scale up Integrated Management of Childhood Diseases ( d-IMCI) in four other regions of Kagera, Kilimanjaro, Mara and Mtwara where the childhood notification rates are below national average. A total of 2,400 healthcare workers will be trained using the innovative distance learning method","NA Original Intervention: Key populations? Expanding the IMCI initiative for training of health care workers for notification of TB in children","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2","2020-12-31","TB/HIV"]
["CT Thailand","Thailand","PAI-5783","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","DDC BL 284-285Improve surveillance system1 Support devices for collecting data for IBBS, -Tablets 100 sets2 Contract consultant for initiate surveillance survey among prisoners.",31209,null,"Active","a6Q1R000000AJUj",0,0,0,0,31209,0,null,null,"DDC BL 284-285Improve surveillance system1 Support devices for collecting data for IBBS, -Tablets 100 sets2 Contract consultant for initiate surveillance survey among prisoners.","Low","The TRP considers improvement in surveillance system by funding devices for collecting data for IBBS, and a contract consultant for initiate surveillance survey among prisoners to be a low priority under this funding request and should be supported through domestic resources","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Zanzibar","Zanzibar","PAI-6023","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","This activity will cover the cost for trainings and meeting attendances.",28775,null,"Active","a6Q1R000000AJYb",0,0,0,0,28775,0,null,null,"This activity will cover the cost for trainings and meeting attendances.","Medium","This activity is for various trainings and meeting attendances and therefore, is not as critical as other prioritized activities. As such, the TRP is only recommending half (50 percent) of the request as quality demand","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Zanzibar","Zanzibar","PAI-6022","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","This item will cover interventions to support improving the accuracy of data collection and analysis to inform decision making.",17308,null,"Active","a6Q1R000000AJYa",0,0,0,0,17308,0,null,null,"This item will cover interventions to support improving the accuracy of data collection and analysis to inform decision making.","Medium","This activity is only partially (50 percent) recommended by the TRP as this is already partially covered by other activities","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 2","2020-12-31","Malaria"]
["CT Chad","Chad","PAI-5715","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","The other vulnerable populations taken into consideration by this PAAR are the Lake Chad island populations, as they still do not receive any interventions to fight HIV and TB. \nAccess to the island population requires a differentiated strategy. Given the limits of the available budget and in view of the specific nature of the Lake Chad region (prevalence of 5.5% in the island area, according to the 2012 LCBI survey), we have concluded that it is necessary to request additional funding to cover this target population. \nThe 2018-2022 NSP contains plans to provide coverage for at least 70% of the island population living on the islands and islets in the Chadian part of Lake Chad, in terms of access to combined preventive services, by 2021. In view of the difficult security context for obtaining access to this population, the humanitarian stakeholders present (MSF, the IRC, UNICEF, etc.) on the ground will be asked to implement this module. \nThe justifications of this request concern all of the interventions included for the island populations.\nAccording to the seroprevalence survey carried out by the Lake Chad Basin Initiative (LCBI) among individuals of the priority vulnerable groups in this conventional basin, HIV seroprevalence is 5.5% on the islands and islets, which is 4 times higher than the prevalence among the general population.\nThe interventions by humanitarian stakeholders currently do not provide sufficient coverage for the fight against HIV/AIDS and TB for these populations and their host populations.\nThe current island populations, which numbered 230,000 people in 2017, move between the islands and the mainland in accordance with the security situation. They come from the following 18 islands: Banagori, (10,332 inhabitants), Blangui (8,955 inhabitants), Finikim (7,055 inhabitants), Kargulim (8,250 inhabitants), Tchongolé (9,900 inhabitants), Kinasserom (7,194 inhabitants), Tétchoua (10,137 inhabitants), Choara (7,692 inhabitants), Tchoukoultaya (18,321 inhabitants), Bol Urbain (34,023 inhabitants), Milea 18,848 (inhabitants), Gougoua (18,445 inhabitants), Ameroun (10,070 inhabitants), Iserom (17,704 inhabitants), Kakigou (4,123 inhabitants), Yourtou (9,114 inhabitants), Makarati (11,011 inhabitants) and Kirkira (9,262 inhabitants).\n\nIn order to rectify this inequality in access to health-care services, the government has recently established a National Health Program for Nomadic and Island Populations and Populations in Hard-to-Reach Areas (NHPN). \nTherefore, the interventions to fight HIV and TB in the Lake Chad region are of sub-regional interest, as the foreign populations that frequent this area are there for economic reasons, primarily in relation to fishing. Their toing and froing between their countries of origin and Lake Chad is a factor in the propagation of the HIV epidemic in this sub-region.\nThis above-allocation funding request for Chad will make it possible to provide services to fight HIV and TB to these populations (native and island populations).\nIndicators: i) Percentage of the vulnerable populations who have benefited from the HIV prevention program - defined package of services (islands populations, refugees and nomads)\nCountry targets: 20% (46,000/230,000) in 2019; 40% (95,233/238,084) in 2020; 60% (147,897/246,494) in 2021. All of these targets are assigned to the Global Fund.",1024440.86,null,"Active","a6Q1R000000AJTd",0,0,0,0,1024440.86,0,null,null,"The other vulnerable populations taken into consideration by this PAAR are the Lake Chad island populations, as they still do not receive any interventions to fight HIV and TB. \nAccess to the island population requires a differentiated strategy. Given the limits of the available budget and in view of the specific nature of the Lake Chad region (prevalence of 5.5% in the island area, according to the 2012 LCBI survey), we have concluded that it is necessary to request additional funding to cover this target population. \nThe 2018-2022 NSP contains plans to provide coverage for at least 70% of the island population living on the islands and islets in the Chadian part of Lake Chad, in terms of access to combined preventive services, by 2021. In view of the difficult security context for obtaining access to this population, the humanitarian stakeholders present (MSF, the IRC, UNICEF, etc.) on the ground will be asked to implement this module. \nThe justifications of this request concern all of the interventions included for the island populations.\nAccording to the seroprevalence survey carried out by the Lake Chad Basin Initiative (LCBI) among individuals of the priority vulnerable groups in this conventional basin, HIV seroprevalence is 5.5% on the islands and islets, which is 4 times higher than the prevalence among the general population.\nThe interventions by humanitarian stakeholders currently do not provide sufficient coverage for the fight against HIV/AIDS and TB for these populations and their host populations.\nThe current island populations, which numbered 230,000 people in 2017, move between the islands and the mainland in accordance with the security situation. They come from the following 18 islands: Banagori, (10,332 inhabitants), Blangui (8,955 inhabitants), Finikim (7,055 inhabitants), Kargulim (8,250 inhabitants), Tchongolé (9,900 inhabitants), Kinasserom (7,194 inhabitants), Tétchoua (10,137 inhabitants), Choara (7,692 inhabitants), Tchoukoultaya (18,321 inhabitants), Bol Urbain (34,023 inhabitants), Milea 18,848 (inhabitants), Gougoua (18,445 inhabitants), Ameroun (10,070 inhabitants), Iserom (17,704 inhabitants), Kakigou (4,123 inhabitants), Yourtou (9,114 inhabitants), Makarati (11,011 inhabitants) and Kirkira (9,262 inhabitants).\n\nIn order to rectify this inequality in access to health-care services, the government has recently established a National Health Program for Nomadic and Island Populations and Populations in Hard-to-Reach Areas (NHPN). \nTherefore, the interventions to fight HIV and TB in the Lake Chad region are of sub-regional interest, as the foreign populations that frequent this area are there for economic reasons, primarily in relation to fishing. Their toing and froing between their countries of origin and Lake Chad is a factor in the propagation of the HIV epidemic in this sub-region.\nThis above-allocation funding request for Chad will make it possible to provide services to fight HIV and TB to these populations (native and island populations).\nIndicators: i) Percentage of the vulnerable populations who have benefited from the HIV prevention program - defined package of services (islands populations, refugees and nomads)\nCountry targets: 20% (46,000/230,000) in 2019; 40% (95,233/238,084) in 2020; 60% (147,897/246,494) in 2021. All of these targets are assigned to the Global Fund.","High","It is unclear if this package included treatment and care or only behavioural interventions, noting that HIV testing and condoms are included as separate items on the PAAR. The applicant should work with the secretariat to clarify the interventions needed by this population to ensure best value for the investment.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Central Africa",null,"Multi-component"]
["CT Serbia","Serbia","PAI-5612","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","PLWH Training of outreach workers",6425.77,null,"Active","a6Q1R000000AJRy",0,0,0,0,6425.77,0,null,null,"PLWH Training of outreach workers","High","Given the focus on prevention in this funding request,\nthe TRP recommends this item should be covered\nthrough existing resources for the care and treatment\nprogram",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2022-06-30","HIV/AIDS"]
["CT Somalia","Somalia","PAI-5607","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Intensified training and monitoring activities for central level staff to improve managerial capacity.",362380,null,"Active","a6Q1R000000AJRt",324510,0,0,0,37870,0,null,null,"Intensified training and monitoring activities for central level staff to improve managerial capacity.","High","Intensified training and monitoring activities for central level staff to improve managerial capacity",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT Somalia","Somalia","PAI-5606","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Develop legislation for TB services in the private sector, expand and strengthen on-going in-service training for all health workers involved in the implementation of TB Control.  ? Drug Resistance Survey, country-wide implementation of eTB-Manager, research fund for operational research activities.",874360,null,"Active","a6Q1R000000AJRs",0,0,0,0,874360,0,null,null,"Develop legislation for TB services in the private sector, expand and strengthen on-going in-service training for all health workers involved in the implementation of TB Control.  ? Drug Resistance Survey, country-wide implementation of eTB-Manager, research fund for operational research activities.","High","Develop legislation for TB services in the private sector, expand and strengthen on-going in-service training for all health workers involved in the implementation of TB Control. ? Drug Resistance Survey, countrywide implementation of eTBManager, research fund for operational research activities. The drug resistance survey is not high priority at this point in time. The TRP recommends monitoring the levels of drug resistance from routine surveillance","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT Belize","Belize","PAI-3899","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Mini grants of USD 5,000 each for Civil Society Organisations (CSO) to build their capacity to be sustainable beyond the Global Fund. This could include strategic sustainability planning, social networking advocacy and negotiation, non-traditional income generation, developing proposals for external funding and any other activity or progamme that would contribute to their sustainability beyond 2021.",50000,null,"Active","a6Q1R000000AJ0L",0,0,0,0,50000,0,null,null,"Mini grants of USD 5,000 each for Civil Society Organisations (CSO) to build their capacity to be sustainable beyond the Global Fund. This could include strategic sustainability planning, social networking advocacy and negotiation, non-traditional income generation, developing proposals for external funding and any other activity or progamme that would contribute to their sustainability beyond 2021.","High","The TRP considers this intervention highly relevant to prevent stock-out of medication and recommends that this intervention should be moved into within the allocation request.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Burkina Faso","Burkina Faso","PAI-3836","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Holding a workshop to approve the training modules for community RSSH counsellors.",4950.0600000000004,null,"Active","a6Q1R000000AIzK",0,0,0,0,4950.0600000000004,0,null,null,"Holding a workshop to approve the training modules for community RSSH counsellors.","Medium","The activity includes holding a workshop to approve the training modules for community RSSH counsellors. It should be part of the previous activity related to reviewing the training module","amount is against different module/intervention in application. UQD description matches the amount line and needs to be validated definitely Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 1","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3762","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:\n(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)\nThe residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.",126598.59,null,"Active","a6Q1R000000AIy8",0,0,0,0,126598.59,0,null,null,"Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:\n(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)\nThe residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.","High","Well quantified and targets clearly outlined. This is a last mile intervention to enhance efforts towards elimination of MTCT and merits higher priority rating","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3761","MCI-00531","Comprehensive prevention programs for TGs","MCI-00562","Other intervention(s) for TGs","Studies were not budgeted for within the allocation amount. The studies (size estimation and SGSS) will provide data to better monitor the impact of the interventions: \n-A gender-sensitive study that includes adolescents and young people to estimate the size of the transgender population in Benin and map it (?11,771)\n-Production of 30 copies of the study to estimate the size of the transgender population in Benin and map it (?228)\n-Recruitment of a consultant to conduct a gender-sensitive SGSS for the transgender population (?19,683)\n- An SGSS for transgender people (?11,771)\n-Production of 30 copies of the report on the SGSS for the transgender population (?228)",49022.559999999998,null,"Active","a6Q1R000000AIy7",0,0,0,0,49022.559999999998,0,null,null,"Studies were not budgeted for within the allocation amount. The studies (size estimation and SGSS) will provide data to better monitor the impact of the interventions: \n-A gender-sensitive study that includes adolescents and young people to estimate the size of the transgender population in Benin and map it (?11,771)\n-Production of 30 copies of the study to estimate the size of the transgender population in Benin and map it (?228)\n-Recruitment of a consultant to conduct a gender-sensitive SGSS for the transgender population (?19,683)\n- An SGSS for transgender people (?11,771)\n-Production of 30 copies of the report on the SGSS for the transgender population (?228)","High",null,"NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Other interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Cambodia","Cambodia","PAI-4629","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Co-infection with HCV is a significant contributor to morbidity and mortality among PLHIV. Request for HCV testing and treatment for 262 cases is included within the allocation request. Above allocation funding is requested for drugs, commodities and PSM to provide treatment to a further 261 in 2019 and 262 in 2020 PLHIV with chronic HCV co-infection (F3-F4) to cover all estimated need and to reduce mortality and morbidity among PLHIV in Cambodia. The TRP ranked this activity as low priority but also considers that this activity cannot be funded using Global Fund funding as the conditions of the Global Fund policy on this subject are not met. See link https://www.theglobalfund.org/media/41 67/bm33_11-co-infectionsandcomorbidities_report_en.pdf",329505,null,"Active","a6Q1R000000AJC7",0,0,0,0,329505,0,null,null,"Co-infection with HCV is a significant contributor to morbidity and mortality among PLHIV. Request for HCV testing and treatment for 262 cases is included within the allocation request. Above allocation funding is requested for drugs, commodities and PSM to provide treatment to a further 261 in 2019 and 262 in 2020 PLHIV with chronic HCV co-infection (F3-F4) to cover all estimated need and to reduce mortality and morbidity among PLHIV in Cambodia. The TRP ranked this activity as low priority but also considers that this activity cannot be funded using Global Fund funding as the conditions of the Global Fund policy on this subject are not met. See link https://www.theglobalfund.org/media/41 67/bm33_11-co-infectionsandcomorbidities_report_en.pdf","Low","The TRP ranked this activity as low priority but also considers that this activity cannot be funded using Global Fund funding as the conditions of the Global Fund policy on this subject are not met. See link https://www.theglobalfund.org/media/41 67/bm33_11-co-infectionsandcomorbidities_report_en.pdf","NA Original Intervention: Management of HIV-HCV co-infection","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Cambodia","Cambodia","PAI-4624","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To support NASA 2020.",60000,null,"Active","a6Q1R000000AJC2",0,0,0,0,60000,0,null,null,"To support NASA 2020.","Low","The TRP considers this low priority as the applicant can mobilize other sources of funding to cover the need, for example, the proposed request may likely be covered with PEPFAR support in 2018.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: National AIDS spending accounts","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4605","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Funding to support the operation and maintenance (recurrent cost) of a new Osh lab expected to be installed in Osh in 2019, with support from USAID Challenge TB project",148305,null,"Active","a6Q1R000000AJBj",0,0,0,0,148305,0,null,null,"Funding to support the operation and maintenance (recurrent cost) of a new Osh lab expected to be installed in Osh in 2019, with support from USAID Challenge TB project","Low","The TRP notes that the applicant\nintends to support operation and\nmaintenance of a laboratory at Osh to be funded by USAID and\nconstitutes recurrent costs for the\nlaboratory. The TRP considered that these recurrent costs had a lower priority than items included in the PAAR for MDR-TB above, which were categorized as Medium priority. Additionally, the TRP recommends consideration of\nintegration of laboratory operations, facilities and maintenance management wherever feasible to reduce duplicative infrastructure and\noperations.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Eastern Europe and Central Asia",null,"Multi-component"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4604","MCI-00010","MDR-TB","MCI-00144","Community MDR-TB care delivery","This funding is for procurement and establishing Video-Dot system that promotes patient?s treatment adherence, reduce the rate of lost to follow up patients",170000,null,"Active","a6Q1R000000AJBi",0,0,0,0,170000,0,null,null,"This funding is for procurement and establishing Video-Dot system that promotes patient?s treatment adherence, reduce the rate of lost to follow up patients","Low","The TRP notes that the applicant\nintends to use these resources for treatment support activities. These activities have already been included in other interventions.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Eastern Europe and Central Asia",null,"Multi-component"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4599","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Development of GX Alert system nationwide to expedite the availability of GeneXpert results for clinicians",35176,null,"Active","a6Q1R000000AJBd",0,0,0,0,35176,0,null,null,"Development of GX Alert system nationwide to expedite the availability of GeneXpert results for clinicians","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Eastern Europe and Central Asia",null,"Multi-component"]
["CT Kenya","Kenya","PAI-4587","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","This above allocation funding (UQD) aims to operationalize infrastructure for electronic medical records in 5 counties and on interoperability of the different Electronic Medical Records/Electronic Health Records (EMRs/EHRs) developed for HIV and TB programmes and development of a health ID policy framework. Within allocation, routine data collection is mainly ensured by the availability of printed M&E tools. This remains a short to medium term strategy since the overall goal is to introduce electronic health systems to enhance efficiency and sustainability.",6674032,null,"Active","a6Q1R000000AJBR",1994806,0,0,0,4679226,0,null,null,"This above allocation funding (UQD) aims to operationalize infrastructure for electronic medical records in 5 counties and on interoperability of the different Electronic Medical Records/Electronic Health Records (EMRs/EHRs) developed for HIV and TB programmes and development of a health ID policy framework. Within allocation, routine data collection is mainly ensured by the availability of printed M&E tools. This remains a short to medium term strategy since the overall goal is to introduce electronic health systems to enhance efficiency and sustainability.","High","Operationalisation of electronic medical records in 5 counties and interoperability of the different Electronic Medical Records/Electronic Health Records (EMRs/EHRs) developed for HIV and TB programmes and development of a health ID policy framework. The Secretariat to check for duplication with the CDC supported EMR funding","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Kenya","Kenya","PAI-4582","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","This funding (above allocation UQD) aims to support management of procurement of the new regimen and ART treatment for 377,850 people living with HIV (PLHIV). The allocation funding will support ART treatment for 893,742 PLHIV (320,786 PLHIV in year 1; 319,652 in year 2 and 253,304 in year 3). UQD will allow puting of the additional 377,850 on ART (69,760 PLHIV in year 1; 137,188 in year 2 and 170,902 in year 3) to reach the 90% target of PLHIV on ART (this includes adults and children). UQD will also provide nutritional suplement support, treatment adherence and monitoring, and counselling and psychosocial support for the additional PLHIV on ART (Adults and children).\nInterventions to be funded under this module (UQD) are: Differentiated ART service delivery (adult and children): US $ 65,674,400; Nutrition support: US $ 8,517,759; Treatment adherence: US$ 898,787; Treatment monitoring: US$ 392,712; Prevention, diagnosis and treatment of opportunistic infections: US$ 296,033; Counselling and psychosocial support US$ 580,518.",76360209,null,"Active","a6Q1R000000AJBM",0,0,3954564,0,72405645,0,null,null,"This funding (above allocation UQD) aims to support management of procurement of the new regimen and ART treatment for 377,850 people living with HIV (PLHIV). The allocation funding will support ART treatment for 893,742 PLHIV (320,786 PLHIV in year 1; 319,652 in year 2 and 253,304 in year 3). UQD will allow puting of the additional 377,850 on ART (69,760 PLHIV in year 1; 137,188 in year 2 and 170,902 in year 3) to reach the 90% target of PLHIV on ART (this includes adults and children). UQD will also provide nutritional suplement support, treatment adherence and monitoring, and counselling and psychosocial support for the additional PLHIV on ART (Adults and children).\nInterventions to be funded under this module (UQD) are: Differentiated ART service delivery (adult and children): US $ 65,674,400; Nutrition support: US $ 8,517,759; Treatment adherence: US$ 898,787; Treatment monitoring: US$ 392,712; Prevention, diagnosis and treatment of opportunistic infections: US$ 296,033; Counselling and psychosocial support US$ 580,518.","High","Assist management of the procurement of the new regimen and put an additional 377,850 People Living with HIV (PLHIV) on ART.","Additional funds $3,954,564 got approved by March 08 2018 GAC meeting. Original Intervention: Differentiated antiretroviral therapy service delivery","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Kenya","Kenya","PAI-4581","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","This funding (above allocation UQD) aims to support expansion of the sample transport network by supporting courier services to every peripheral site and networking peripheral sites to gene xpert sites. In addition it is planned to procure triple packaging containers; 2 for every TB treatment and gene xpert site for transport of samples to the xpert site or the Tb reference lab.",3755038,null,"Inactive","a6Q1R000000AJBL",3755038,0,0,0,0,1,null,null,"This funding (above allocation UQD) aims to support expansion of the sample transport network by supporting courier services to every peripheral site and networking peripheral sites to gene xpert sites. In addition it is planned to procure triple packaging containers; 2 for every TB treatment and gene xpert site for transport of samples to the xpert site or the Tb reference lab.","High","These interventions improve access of Universal DST, additional GeneXpert machines and cartridges, as well as mechanisms for sputum transport.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Jamaica","Jamaica","PAI-4567","MCI-00534","Comprehensive prevention programs for MSM","MCI-00606","Condoms and lubricant programming for MSM","Expand campaigns on condom use among KPs to improve condom uptake and reduce risk. This will improve reach especially to higher socioeconic groups to improve condom use and reduce risk for HIV.",120000,null,"Active","a6Q1R000000AJB7",0,0,0,0,120000,0,null,null,"Expand campaigns on condom use among KPs to improve condom uptake and reduce risk. This will improve reach especially to higher socioeconic groups to improve condom use and reduce risk for HIV.","Medium",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Condoms and lubricant programming for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Jamaica","Jamaica","PAI-4560","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00088","Condoms and lubricant programming for sex workers","Develop and roll out campaigns to glamorize condom use to target KPs to improve condom uptake and reduce risk  especially among sex workers (SW) and clients to improve  improve condom use and reduce risk for HIV.",100000,null,"Active","a6Q1R000000AJB0",0,0,0,0,100000,0,null,null,"Develop and roll out campaigns to glamorize condom use to target KPs to improve condom uptake and reduce risk  especially among sex workers (SW) and clients to improve  improve condom use and reduce risk for HIV.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Jamaica","Jamaica","PAI-4555","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Review and update National Health Information System and E-Health Strategic Plan 2014-2018.",35000,null,"Active","a6Q1R000000AJAv",0,0,0,0,35000,0,null,null,"Review and update National Health Information System and E-Health Strategic Plan 2014-2018.","Medium",null,"NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Jamaica","Jamaica","PAI-4554","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","Pilot introduction of hormone replacement therapy (HRT) services for transgender (TG) women to test efficacy of HRT as complementary to support RIC and Viral suppression among TG .",200000,null,"Active","a6Q1R000000AJAu",0,0,0,0,200000,0,null,null,"Pilot introduction of hormone replacement therapy (HRT) services for transgender (TG) women to test efficacy of HRT as complementary to support RIC and Viral suppression among TG .","Medium",null,"NA Original Intervention: Differentiated antiretroviral therapy service delivery","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Indonesia","Indonesia","PAI-4510","MCI-00023","Program management","MCI-00207","Grant management","Cover 72 and 81 priority districts in 2019 and 2020 as addition to the 271 districts covered by allocation. The additional data officer and financial assistant will strengthen the monitoring of the districts.",1886633,null,"Active","a6Q1R000000AJAC",0,0,0,0,1886633,0,null,null,"Cover 72 and 81 priority districts in 2019 and 2020 as addition to the 271 districts covered by allocation. The additional data officer and financial assistant will strengthen the monitoring of the districts.","Medium","Will contribute to improved programme management and monitoring at district level.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Asia",null,"Multi-component"]
["CT Burundi","Burundi","PAI-3716","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Former activity n ° 63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validated\nBurundi has a total of 11 prisons with infirmary.\nWith the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.",10463,null,"Active","a6Q1R000000AIxO",0,0,0,0,10463,0,null,null,"Former activity n ° 63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validated\nBurundi has a total of 11 prisons with infirmary.\nWith the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.","High",null,"NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3679","MCI-00023","Program management","MCI-00207","Grant management","Activity: Pay the performance bonuses of the PNLS:\nThis is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.",238919,null,"Active","a6Q1R000000AIwn",0,0,0,0,238919,0,null,null,"Activity: Pay the performance bonuses of the PNLS:\nThis is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.","Medium",null,"NA Original Module: RSSH: Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3678","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Activity: Make a study on the prevalence of HIV-viral hepatitis coinfection.\nIn Burundi, the seroprevalence of HIV-viral hepatitis co-infection is not known because no study has been conducted for the determined. Or, currently, it is well known that viral hepatitis is the main cause of complications in PLHIV where they can have very serious consequences in accelerating the progression of HIV to AIDS disease and vice versa. It is in this context that a seroprevalence survey of HIV-hepatitis co-infection is essential in order to make a global care planning for co-infected PLHIV based on evidence in order to improve the care that is offered to them.",32221,null,"Active","a6Q1R000000AIwm",0,0,0,0,32221,0,null,null,"Activity: Make a study on the prevalence of HIV-viral hepatitis coinfection.\nIn Burundi, the seroprevalence of HIV-viral hepatitis co-infection is not known because no study has been conducted for the determined. Or, currently, it is well known that viral hepatitis is the main cause of complications in PLHIV where they can have very serious consequences in accelerating the progression of HIV to AIDS disease and vice versa. It is in this context that a seroprevalence survey of HIV-hepatitis co-infection is essential in order to make a global care planning for co-infected PLHIV based on evidence in order to improve the care that is offered to them.","Medium",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Azerbaijan","Azerbaijan","PAI-3646","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Joint TB Program Review led by the WHO Country Offices and conducted jointly with international experts.",50000,null,"Active","a6Q1R000000AIwG",0,0,0,0,50000,0,null,null,"Joint TB Program Review led by the WHO Country Offices and conducted jointly with international experts.","High","The TRP considers this intervention quality demand as a program review will be useful for course correction in a view of sustainability. With the assistance of WHO Country Office and in close coordination with the national TB Control Program and with the financial support of the Global Fund and 5 participation of partners including United States Agency for International Development (USAID), United States Centres for Disease Prevention and Control (CDC), Global Drug Facility (GDF) among others, a team of international experts will conduct the country program review.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","Tuberculosis"]
["CT Azerbaijan","Azerbaijan","PAI-3641","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Procurement of HIV Viral Load tests and CD4 tests for regular laboratory and clinical examination of PLHIV in civil sector. Treatment monittoring is critical considering increasing treatment coverage and low VL suppression in the country.",1272512,null,"Active","a6Q1R000000AIwB",0,0,0,0,1272512,0,null,null,"Procurement of HIV Viral Load tests and CD4 tests for regular laboratory and clinical examination of PLHIV in civil sector. Treatment monittoring is critical considering increasing treatment coverage and low VL suppression in the country.","High","The applicant suggests increasing treatment coverage and treatment monitoring is critical given the low viral load suppression.","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-06-30","HIV/AIDS"]
["CT Angola","Angola","PAI-3566","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","HIS Governance Strengthening: Support Expanded Terms of Reference by the National Technical Team for inclusion in OpenLMIS; Support creation of municipal technical teams.",34224,null,"Active","a6Q1R000000AIuy",0,0,0,0,34224,0,null,null,"HIS Governance Strengthening: Support Expanded Terms of Reference by the National Technical Team for inclusion in OpenLMIS; Support creation of municipal technical teams.","High",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","RSSH"," Southern and Eastern Africa","2021-12-31","RSSH"]
["CT Angola","Angola","PAI-3565","MCI-00071","Other module","MCI-00071","Other module","In order to ensure epidemiological surveillance, monitoring and evaluation of malaria activities are implemented at the operational level (provincial, municipal, health and community units), particularly in the regions of the country where the Multiple Indicators and Health Survey IIMS 2015/16 showed a high prevalence of malaria, , an amount for the payment of salaries of 6 OPPMs for the last year of the 2018-2021 grant is requested in the above allocation. It should be noted that the number of OPPMs was 18 in the current GF 2016-2017 grant, and will be reduced to 6 in be financed under the first 2 years of the FG 2018-2021 grant. The annual salary of each OPPM is USD 47,994.48 and the annual cost of the 6 OPPMs for the last year of the grant is USD 287,966.88. The provincial focal points are to maintain active epidemiological surveillance in these high prevalence provinces to mitigate the emergence of possible malaria epidemics and thereby have quality data and evidence to allow for better quantification and programming of resources.",287967,null,"Active","a6Q1R000000AIux",0,0,0,0,287967,0,null,null,"In order to ensure epidemiological surveillance, monitoring and evaluation of malaria activities are implemented at the operational level (provincial, municipal, health and community units), particularly in the regions of the country where the Multiple Indicators and Health Survey IIMS 2015/16 showed a high prevalence of malaria, , an amount for the payment of salaries of 6 OPPMs for the last year of the 2018-2021 grant is requested in the above allocation. It should be noted that the number of OPPMs was 18 in the current GF 2016-2017 grant, and will be reduced to 6 in be financed under the first 2 years of the FG 2018-2021 grant. The annual salary of each OPPM is USD 47,994.48 and the annual cost of the 6 OPPMs for the last year of the grant is USD 287,966.88. The provincial focal points are to maintain active epidemiological surveillance in these high prevalence provinces to mitigate the emergence of possible malaria epidemics and thereby have quality data and evidence to allow for better quantification and programming of resources.","Low","While M&E is an important area requiring further investment for the program to function effectively, these salaries are a high cost investment in comparison to other areas of pressing need.","NA Original Module: RSSH. Original Intervention: RSSH: Health management information systems and Monitoring and Evaluation (M&E)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Congo","Congo","PAI-4053","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Conduct 6 training/refresher training sessions lasting 3 days at the 4 centers on co-infection management (25 participants: 2 sessions in year 1, 2 sessions in year 2 and 2 sessions in year 3).",7992.37,null,"Active","a6Q1R000000AJ2p",0,0,0,0,7992.37,0,null,null,"Conduct 6 training/refresher training sessions lasting 3 days at the 4 centers on co-infection management (25 participants: 2 sessions in year 1, 2 sessions in year 2 and 2 sessions in year 3).","High","This activity will enhance the capacity of staff in the integrated TB/HIV centers","NA Original Intervention: Improvement in treatment for TB/HIV cases and simplified care continuum (one-stop center)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Congo","Congo","PAI-4048","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","The mapping that is currently being validated revealed a population of 450 people who inject drugs. To offer complete prevention to people who inject drugs, some of the existing resources will be used to start providing basic services to this community, and the above allocation resources will be used to implement a pilot project for this target population.",448883.4,null,"Active","a6Q1R000000AJ2k",0,0,0,0,448883.4,0,null,null,"The mapping that is currently being validated revealed a population of 450 people who inject drugs. To offer complete prevention to people who inject drugs, some of the existing resources will be used to start providing basic services to this community, and the above allocation resources will be used to implement a pilot project for this target population.","Low","The mapping that is currently being validated revealed a population of 450 people who inject drugs. To offer complete prevention to people who inject drugs, some of the existing resources will be used to start providing basic services to this community, and the above allocation resources will be used to implement a pilot project for this target population","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Pilot project for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4004","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Treatment for people living with HIV (purchase of antiretrovirals - ARVs) This amount represents 24,399 patients to enroll on antiretroviral therapy (ART), including 1,078 children. It includes the cost of the test, ARVs, biological monitoring and procurement and supply management (PSM).",28619968,null,"Active","a6Q1R000000AJ22",0,8700000,0,0,19919968,0,null,null,"Treatment for people living with HIV (purchase of antiretrovirals - ARVs) This amount represents 24,399 patients to enroll on antiretroviral therapy (ART), including 1,078 children. It includes the cost of the test, ARVs, biological monitoring and procurement and supply management (PSM).","High","High need / High impact","NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4003","MCI-00009","TB/HIV","MCI-00135","Engaging all care providers (TB/HIV)","Involvement of churches, CBOs and civil society This investment will be used to improve case-finding by involving churches, CBOs and civil society, through the following activities: - Organize 729 awareness-raising sessions for church, CBO and civil society leaders, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one meeting per year per HZ). - Deliver training to church, CBO and civil society members, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one training session per year per HZ): four people per HZ per year. Total 972 per year, one day, 2,916 over three years. - Buy 2,916 education and awareness-raising kits for each trained member.",368874,null,"Active","a6Q1R000000AJ21",0,0,0,0,368874,0,null,null,"Involvement of churches, CBOs and civil society This investment will be used to improve case-finding by involving churches, CBOs and civil society, through the following activities: - Organize 729 awareness-raising sessions for church, CBO and civil society leaders, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one meeting per year per HZ). - Deliver training to church, CBO and civil society members, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one training session per year per HZ): four people per HZ per year. Total 972 per year, one day, 2,916 over three years. - Buy 2,916 education and awareness-raising kits for each trained member.","High","High need / High impact",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Cameroon","Cameroon","PAI-3979","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","This would be used to fund various studies and evaluations, including updated mapping of key and vulnerable populations, and the midterm review of the NSP. It would also be used to fund the development of a monitoring and evaluation plan for the HIV NSP.",556386.49,null,"Active","a6Q1R000000AJ1d",0,0,0,0,556386.49,0,null,null,"This would be used to fund various studies and evaluations, including updated mapping of key and vulnerable populations, and the midterm review of the NSP. It would also be used to fund the development of a monitoring and evaluation plan for the HIV NSP.","Medium","Mid-term review would be important to make course corrections in the national response. However, there is little details as to the role of ?various studies and evaluations?. Determining the purpose of these studies, establishing their relative priority and the funding amount should be adjusted upon presentation of these details","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Djibouti","Djibouti","PAI-4152","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","See line 44 (diseemination of report).",4237,null,"Active","a6Q1R000000AJ4Q",0,0,0,0,4237,0,null,null,"See line 44 (diseemination of report).","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4147","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","A bio-behavioral study of young people (international consultant) will also allow an improvement of program's focus and a better monitoring of indicators.",54000,null,"Active","a6Q1R000000AJ4L",0,0,0,0,54000,0,null,null,"A bio-behavioral study of young people (international consultant) will also allow an improvement of program's focus and a better monitoring of indicators.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Belize","Belize","PAI-3897","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","Develop an electronic information system to track demand and supply of medicines and commodities at the facility level. This is a key component of the roadmap for Treat All to ensure that challenges presently experienced with stock outs are minimized.",30000,null,"Active","a6Q1R000000AJ0J",0,0,0,0,30000,0,null,null,"Develop an electronic information system to track demand and supply of medicines and commodities at the facility level. This is a key component of the roadmap for Treat All to ensure that challenges presently experienced with stock outs are minimized.","High","The TRP considers this intervention highly relevant to prevent stock-out of medication and recommends that this intervention should be moved into within the allocation request.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Other procurement and supply chain management intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Burkina Faso","Burkina Faso","PAI-3832","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00572","Other intervention(s) for people in prisons and other closed settings","Equip infirmaries in 7 detention centers. 14 have been already equipped with Rd 10 and NFM.",51503.76,null,"Active","a6Q1R000000AIzG",0,0,0,0,51503.76,0,null,null,"Equip infirmaries in 7 detention centers. 14 have been already equipped with Rd 10 and NFM.","High","It addresses concerns raised by the TRP related to prioritization of key populations and provide additional detail for differentiated strategies for key populations and may address the sharp decrease in coverage targets for prisoners observed in recent years.","NA Original Intervention: Other interventions for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 1","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3827","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",290834.92,null,"Active","a6Q1R000000AIzB",0,0,0,0,290834.92,0,null,null,"Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.","High","Reconditioning of 6 Centers for diagnosis and treatment (CDT) laboratories will contribute to the enhancement of laboratory diagnostic capacity",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Benin","Benin","PAI-3752","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","This intervention aims to facilitate access to prevention, care and treatment services for people who inject drugs. In addition to the quarterly meeting with the Interministerial Committee for Combating Narcotic Drugs and Psychotropic Substances Abuse (CILAS) budgeted as part of the catalytic funds, this intervention will take place twice a year during the first two years and in three quarters during the final year. These studies were not budgeted for as part of the allocation amount or the catalytic funds.\n This intervention comprises the following activities:\n\n-Quarterly advocacy meetings with CILAS to promote a favorable, non-discriminatory, inclusive environment that takes the gender perspective into account (?10,561)\n-Recruiting a consultant for a gender-sensitive update study that will estimate the number of people who inject drugs and map them (?23,212)\n-A gender-sensitive update study that will estimate the number of people who inject drugs and map them (?13,348)\n-Producing 50 copies of the report on the gender-sensitive update study that will estimate the number of people who inject drugs and map them (?381)\n-Recruiting a consultant to conduct a satisfaction survey of the beneficiaries of the program?s interventions throughout the country and in the service delivery areas (?30,623)\n-A satisfaction survey of the beneficiaries of the program?s interventions throughout the country and in the service delivery areas (?10,556)\n-Producing 50 copies of the report on the satisfaction survey completed by the beneficiaries of the program?s interventions throughout the country and in the service delivery areas (?228)\n-Recruiting a consultant to conduct a Second-Generation Surveillance Survey (SGSS) for people who inject drugs (?23,159)\n-An SGSS for people who inject drugs (?11,771)\n-Producing 30 copies of the report on the SGSS for people who inject drugs (?228)\n-A workshop to draw up and validate training modules to train 75 staff members on treatment for opioid users (?8,590)\n-Training for 75 health workers on treatment for opioid users (?28,298)\n-Recruiting a consultant to carry out a baseline (feasibility) study into treatment for opioid users (?14,403)\n-Elaborating and validating a document setting out the regulations and procedures for the treatment of opioid users (?9,101)\n-The procurement of methadone and other substitutes, amounting to one box (seven 1-mg capsules per box) per month per person who injects drugs over two years (?20,428)\n-Treatment costs for people who inject drugs for the treatment of opioid addiction (?69,516)\n-A baseline (feasibility) study into treatment for opioid users (?11,396)",320735.05,null,"Active","a6Q1R000000AIxy",0,0,0,0,320735.05,0,null,null,"This intervention aims to facilitate access to prevention, care and treatment services for people who inject drugs. In addition to the quarterly meeting with the Interministerial Committee for Combating Narcotic Drugs and Psychotropic Substances Abuse (CILAS) budgeted as part of the catalytic funds, this intervention will take place twice a year during the first two years and in three quarters during the final year. These studies were not budgeted for as part of the allocation amount or the catalytic funds.\n This intervention comprises the following activities:\n\n-Quarterly advocacy meetings with CILAS to promote a favorable, non-discriminatory, inclusive environment that takes the gender perspective into account (?10,561)\n-Recruiting a consultant for a gender-sensitive update study that will estimate the number of people who inject drugs and map them (?23,212)\n-A gender-sensitive update study that will estimate the number of people who inject drugs and map them (?13,348)\n-Producing 50 copies of the report on the gender-sensitive update study that will estimate the number of people who inject drugs and map them (?381)\n-Recruiting a consultant to conduct a satisfaction survey of the beneficiaries of the program?s interventions throughout the country and in the service delivery areas (?30,623)\n-A satisfaction survey of the beneficiaries of the program?s interventions throughout the country and in the service delivery areas (?10,556)\n-Producing 50 copies of the report on the satisfaction survey completed by the beneficiaries of the program?s interventions throughout the country and in the service delivery areas (?228)\n-Recruiting a consultant to conduct a Second-Generation Surveillance Survey (SGSS) for people who inject drugs (?23,159)\n-An SGSS for people who inject drugs (?11,771)\n-Producing 30 copies of the report on the SGSS for people who inject drugs (?228)\n-A workshop to draw up and validate training modules to train 75 staff members on treatment for opioid users (?8,590)\n-Training for 75 health workers on treatment for opioid users (?28,298)\n-Recruiting a consultant to carry out a baseline (feasibility) study into treatment for opioid users (?14,403)\n-Elaborating and validating a document setting out the regulations and procedures for the treatment of opioid users (?9,101)\n-The procurement of methadone and other substitutes, amounting to one box (seven 1-mg capsules per box) per month per person who injects drugs over two years (?20,428)\n-Treatment costs for people who inject drugs for the treatment of opioid addiction (?69,516)\n-A baseline (feasibility) study into treatment for opioid users (?11,396)","High",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4615","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Vitamin B6 is part of the MDR TB regimen but it  cannot be procured with domestic funding as it is not available in local market in mono doses (not combined with other vitamins). The MoH and NTP have initiated a process to establish mechanisms of drug?s procurement through international suppliers. However, the process may need long time for agreement and approval.",44009,null,"Active","a6Q1R000000AJBt",0,0,0,0,44009,0,null,null,"Vitamin B6 is part of the MDR TB regimen but it  cannot be procured with domestic funding as it is not available in local market in mono doses (not combined with other vitamins). The MoH and NTP have initiated a process to establish mechanisms of drug?s procurement through international suppliers. However, the process may need long time for agreement and approval.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Eastern Europe and Central Asia",null,"Multi-component"]
["CT Kenya","Kenya","PAI-4577","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00546","Prevention and management of coinfections and co-morbidities for sex workers","Funding within allocation and catalytic funding is supporting interventions reaching 35,000 sex workers with a package of services including behaviour change, condoms, HTS, linkage to ART and STI screening. This above allocation funding (UQD) will support interventions to reach the same target with management of co-infections, specifically hepatitis B screening and vaccination.",9420921,null,"Active","a6Q1R000000AJBH",0,0,0,0,9420921,0,null,null,"Funding within allocation and catalytic funding is supporting interventions reaching 35,000 sex workers with a package of services including behaviour change, condoms, HTS, linkage to ART and STI screening. This above allocation funding (UQD) will support interventions to reach the same target with management of co-infections, specifically hepatitis B screening and vaccination.","Medium","Reaching 35,000 FSW with management of co -infections, specifically hepatitis B screening and vaccination.","NA Original Intervention: Prevention and management of co-infections and co-morbidities for sex workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Kenya","Kenya","PAI-4572","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","This funding (above allocation UQD) aims to improve Lab networking and access to universal DST through procuring larger capacity gene xpert machines for facilities with highest workload/ more than 80% utilization instead of the 4 modular machines; and mobile gene xpert/ omni xpert to increase physical access to xpert. Funding also aims to facilitate trainings to the facilities receiving the new equipment and to procure additional cartridges to ensure availability of cartridges to support utilization of equipment procured. Aditional power inverters to ensure there is no service interruption caused by power outages will also be procured; this is key to improving access to DST.",9250390,null,"Active","a6Q1R000000AJBC",0,0,0,0,9250390,0,null,null,"This funding (above allocation UQD) aims to improve Lab networking and access to universal DST through procuring larger capacity gene xpert machines for facilities with highest workload/ more than 80% utilization instead of the 4 modular machines; and mobile gene xpert/ omni xpert to increase physical access to xpert. Funding also aims to facilitate trainings to the facilities receiving the new equipment and to procure additional cartridges to ensure availability of cartridges to support utilization of equipment procured. Aditional power inverters to ensure there is no service interruption caused by power outages will also be procured; this is key to improving access to DST.","High","These interventions improve access of Universal DST, additional GeneXpert machines and cartridges, as well as mechanisms for sputum transport.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT India","India","PAI-4551","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","ICT enabled monitoring of DRTB patients to enhance adherence & disseminate real time information to concerned health worker. Few tested ICT technologies can be used for selected group of patients to monitor treatment outcome.\n? Drug will be provided in digital box enabled with chip which captures information. \n? Technology captures patient-wise adherence information in real time through digital box when it is connected to server/internet. \n? Has long battery backup and provided with charging cable. \n? Will be used only for selected type of patients who require additional support. \nOutcome: 10-20k patients will be enrolled in selected states. PAAR request: USD 0.91 M.",910000,null,"Active","a6Q1R000000AJAr",0,0,0,0,910000,0,null,null,"ICT enabled monitoring of DRTB patients to enhance adherence & disseminate real time information to concerned health worker. Few tested ICT technologies can be used for selected group of patients to monitor treatment outcome.\n? Drug will be provided in digital box enabled with chip which captures information. \n? Technology captures patient-wise adherence information in real time through digital box when it is connected to server/internet. \n? Has long battery backup and provided with charging cable. \n? Will be used only for selected type of patients who require additional support. \nOutcome: 10-20k patients will be enrolled in selected states. PAAR request: USD 0.91 M.","Low","More evidence is needed about digital medicines boxes effectiveness in monitoring treatment adherence","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2021-03-31","Tuberculosis"]
["CT India","India","PAI-4550","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","A DRTB counselling Project has been implemented under NFM in 4 states by SR (TISS) to improve treatment outcomes in DRTB patients and reduce the 6 months attrition rate. The results have been encouraging. Continuation of the project is proposed within allocation request while PAAR will cover scale up of the intervention with additional 475 Counsellors across country. Outcome: improve treatment success rates by 50%.",8500000,null,"Active","a6Q1R000000AJAq",0,0,0,0,8500000,0,null,null,"A DRTB counselling Project has been implemented under NFM in 4 states by SR (TISS) to improve treatment outcomes in DRTB patients and reduce the 6 months attrition rate. The results have been encouraging. Continuation of the project is proposed within allocation request while PAAR will cover scale up of the intervention with additional 475 Counsellors across country. Outcome: improve treatment success rates by 50%.","Medium","MDR-TB treatment adherence support through counsellors' project","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2021-03-31","Tuberculosis"]
["CT India","India","PAI-4539","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Following the pilot of self -testing, it is important to scale up self-testing for HIV. This is being considered in 60 districts under this budget.",4500000,null,"Active","a6Q1R000000AJAf",0,0,0,0,4500000,0,null,null,"Following the pilot of self -testing, it is important to scale up self-testing for HIV. This is being considered in 60 districts under this budget.","Medium","If self -testing poilot pilot successful this should be scaled up from domestic resources",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-03-31","HIV/AIDS"]
["CT India","India","PAI-4531","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Proposed for refresher training of all SRs and SSRs to update them on new trends of treatment policies and other related latest information.",277573,null,"Active","a6Q1R000000AJAX",0,0,0,0,277573,0,null,null,"Proposed for refresher training of all SRs and SSRs to update them on new trends of treatment policies and other related latest information.","Low","This should be covered from other or domestic resources","NA Original Intervention: Training of SR and SSRs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-03-31","HIV/AIDS"]
["CT India","India","PAI-4526","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","The project is planning to conduct 2 operational research studies as part of EMTCT towards elimination. This will be conducted in coordination with the National Health System.",45455,null,"Active","a6Q1R000000AJAS",0,0,0,0,45455,0,null,null,"The project is planning to conduct 2 operational research studies as part of EMTCT towards elimination. This will be conducted in coordination with the National Health System.","Low","Should be covered from other resources","NA Original Module: PPTCT (Plan International India Chapter). Original Intervention: Operational research","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-03-31","HIV/AIDS"]
["CT India","India","PAI-4525","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","The project team organised DRT refresher trainings under the current grant to improve the provision of PPTCT services through periphery health care providers. This facilitated to improve the overall performance of the project. The project is proposing a similar activity under the new grant.",300000,null,"Active","a6Q1R000000AJAR",0,0,0,0,300000,0,null,null,"The project team organised DRT refresher trainings under the current grant to improve the provision of PPTCT services through periphery health care providers. This facilitated to improve the overall performance of the project. The project is proposing a similar activity under the new grant.","Low","Technical assistance and capacity building for PPTCT should be covered from other resources","NA Original Module: PPTCT (Plan International India Chapter). Original Intervention: DRT ? Refresher","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-03-31","HIV/AIDS"]
["CT Indonesia","Indonesia","PAI-4480","MCI-00023","Program management","MCI-00209","Other program management intervention(s)",null,301800,null,"Active","a6Q1R000000AJ9i",0,0,0,0,301800,0,null,null,null,"High","Support to strengthen the management of the program in additional districts.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Asia",null,"Multi-component"]
["CT Indonesia","Indonesia","PAI-4475","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","The additional 8,682 patients above will also receive prevention, diagnosis and treatment of opportunistic infections. Activities include OI and STI drugs procurement, trainings, mentoring session, home-based care of PLHIV.",775733,null,"Active","a6Q1R000000AJ9d",0,0,0,0,775733,0,null,null,"The additional 8,682 patients above will also receive prevention, diagnosis and treatment of opportunistic infections. Activities include OI and STI drugs procurement, trainings, mentoring session, home-based care of PLHIV.","High","As above, high priority because of the need for the applicant to increase the treatment coverage for impact.","NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Asia",null,"Multi-component"]
["CT Burundi","Burundi","PAI-3672","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","Activity: Provide formative supervision of 20 pharmacovigilance-trained hospitals and the adverse event reporting system\nFormative supervision will involve 10 regional and national hospitals and 10 other district hospitals. The aim will be to evaluate the challenges that arise in the reporting of adverse events while retraining staff on the system of pharmacovigilance in general and the use of reporting tools in particular. This will improve the quality of notifications and promote patient safety.",7335,null,"Active","a6Q1R000000AIwg",0,0,0,0,7335,0,null,null,"Activity: Provide formative supervision of 20 pharmacovigilance-trained hospitals and the adverse event reporting system\nFormative supervision will involve 10 regional and national hospitals and 10 other district hospitals. The aim will be to evaluate the challenges that arise in the reporting of adverse events while retraining staff on the system of pharmacovigilance in general and the use of reporting tools in particular. This will improve the quality of notifications and promote patient safety.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3671","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","Activity: Provide pharmacovigilance training for providers in 40 district hospitals at 5 per hospital\nThis training will enable hospital providers to gain knowledge of the basics of pharmacovigilance and the system for reporting adverse events, which events will be transmitted to the International Vaccine Monitoring Database (VigiBase) for surveillance. The training will be organized at peripheral level for 200 participants at a rate of 25 participants per session for 4 days.",48001,null,"Active","a6Q1R000000AIwf",0,0,0,0,48001,0,null,null,"Activity: Provide pharmacovigilance training for providers in 40 district hospitals at 5 per hospital\nThis training will enable hospital providers to gain knowledge of the basics of pharmacovigilance and the system for reporting adverse events, which events will be transmitted to the International Vaccine Monitoring Database (VigiBase) for surveillance. The training will be organized at peripheral level for 200 participants at a rate of 25 participants per session for 4 days.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Azerbaijan","Azerbaijan","PAI-3638","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","PDI, Optimized HIV case finding and HIV case management interventions with focus on men who have sex with men",30441,null,"Active","a6Q1R000000AIw8",0,0,0,0,30441,0,null,null,"PDI, Optimized HIV case finding and HIV case management interventions with focus on men who have sex with men","High","The TRP recommends moving this within the allocation in case efficiencies can be found during grant-making, or savings made during grant-implementation To achieve quality service scale up and reach the suggested coverage, the interventions should come as a package inclusive of all the behavioral interventions","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Eastern Europe and Central Asia","2021-06-30","HIV/AIDS"]
["CT Angola","Angola","PAI-3562","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Improving ANC attendance and increasing IPTp coverage is a priority for the NMCP, to improve health outcomes for the pregnant women and her unborn child. The IIMS (2015/2016) showed that only 19% of pregnant women had received 3 or more doses of IPTp during ANC visits. Stock-out have been a major reason for this low coverage.\n The gap analysis shows a gap in the aquisition of Sulfadoxine + Pyrimethamine (SP) for intermittent Preventative treatment for pregnant woman, one of the MoH target groups.. The MoH and PMI will acquire a total of 31,146 bottles of 1000 tablets during the 3 years. The gap is 7166 bottles of 1000 SP tablets which is requested from the FG in this above allocation. The expected impact is the reduction of maternal morbidity and mortality from malaria and improved outcomes for newborn child. The cost is estimated at 27 USD per bottle of 1000 tablets + PSM (35%). The total is 261,267.00 USD",261267,null,"Active","a6Q1R000000AIuu",0,0,0,0,261267,0,null,null,"Improving ANC attendance and increasing IPTp coverage is a priority for the NMCP, to improve health outcomes for the pregnant women and her unborn child. The IIMS (2015/2016) showed that only 19% of pregnant women had received 3 or more doses of IPTp during ANC visits. Stock-out have been a major reason for this low coverage.\n The gap analysis shows a gap in the aquisition of Sulfadoxine + Pyrimethamine (SP) for intermittent Preventative treatment for pregnant woman, one of the MoH target groups.. The MoH and PMI will acquire a total of 31,146 bottles of 1000 tablets during the 3 years. The gap is 7166 bottles of 1000 SP tablets which is requested from the FG in this above allocation. The expected impact is the reduction of maternal morbidity and mortality from malaria and improved outcomes for newborn child. The cost is estimated at 27 USD per bottle of 1000 tablets + PSM (35%). The total is 261,267.00 USD","High","IPTp coverage is low and burden is high among pregnant women. This is a critical intervention to reduce maternal mortality and the impact on infants. The TRP requests, therefore, that this intervention be moved to the allocation, in line with the recommendation under issue 2.","NA Original Module: Specific prevention interventions. Original Intervention: Acquisition of sulphadoxinepyrimethamine for IPTp","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-06-30","Malaria"]
["CT Congo","Congo","PAI-4046","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Viral load testing for 50% of the new enrollments under PMTCT. Increase in Early Infant Diagnosis (EID) coverage from 6% to 30% by 2020; and increase pediatric ART coverage from 37% to 49% (with additional 269 cases).",790791.16,null,"Inactive","a6Q1R000000AJ2i",455791.16,335000,0,0,0,1,null,null,"Viral load testing for 50% of the new enrollments under PMTCT. Increase in Early Infant Diagnosis (EID) coverage from 6% to 30% by 2020; and increase pediatric ART coverage from 37% to 49% (with additional 269 cases).","High",null,"05/12/2018: This did not undergo a TRP review but was approved by the TRP to be included in the UQD register, as per Shreya and Bianca's email. Amount adjusted by 0.561104253050871 to make the UQD inactive Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Congo","Congo","PAI-4045","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","HIV testing for pregnant women in Antenatal clinics and treatment of additional 4,807 HIV positive pregnant women by 2020 (48% of estimated PMTCT needs at national level);",1178681.4099999999,null,"Inactive","a6Q1R000000AJ2h",843681.41,335000,0,0,0,1,null,null,"HIV testing for pregnant women in Antenatal clinics and treatment of additional 4,807 HIV positive pregnant women by 2020 (48% of estimated PMTCT needs at national level);","High",null,"05/12/2018: This did not undergo a TRP review but was approved by the TRP to be included in the UQD register, as per Shreya and Bianca's email. Amount adjusted by 0.561104253050871 to make the UQD inactive Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Cameroon","Cameroon","PAI-3976","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","This would be used to fund the following activities: -Activities to actively search for TB in additional (existing) health  care  facilities,  identified  as  having  high  potential for  suspected  TB  cases  and  receiving  high  numbers of adults   and  children   (primary   target   for  active case finding)-Performance incentives (different to top-ups for program managers;  this  is  an  incentive  for  service  providers  at health  care facilities with  high  potential  for  suspected cases)  for health care providers involved in the routine screening  activities  at health care facilities identified  as having high potential for suspected TB cases.",340419.71,null,"Active","a6Q1R000000AJ1a",0,0,0,0,340419.71,0,null,null,"This would be used to fund the following activities: -Activities to actively search for TB in additional (existing) health  care  facilities,  identified  as  having  high  potential for  suspected  TB  cases  and  receiving  high  numbers of adults   and  children   (primary   target   for  active case finding)-Performance incentives (different to top-ups for program managers;  this  is  an  incentive  for  service  providers  at health  care facilities with  high  potential  for  suspected cases)  for health care providers involved in the routine screening  activities  at health care facilities identified  as having high potential for suspected TB cases.","Medium","The funds will expand active case finding for TB in hospital settings. However clarity on the provision of incentives for health staff is requested.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Cameroon","Cameroon","PAI-3971","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.",163372.24,null,"Active","a6Q1R000000AJ1V",0,0,0,0,163372.24,0,null,null,"Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Training workshops for health area managers on malaria surveillance","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Djibouti","Djibouti","PAI-4142","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","The organization of monthly outpatients visits of the mobile team for TB / HIV screening in Djibouti-city and quarterly in the regions of the interior, will allow the identification and treatment (Test and treat) of new HIV and TB in rural communities and vulnerable urban communities.",4271,null,"Active","a6Q1R000000AJ4G",0,0,0,0,4271,0,null,null,"The organization of monthly outpatients visits of the mobile team for TB / HIV screening in Djibouti-city and quarterly in the regions of the interior, will allow the identification and treatment (Test and treat) of new HIV and TB in rural communities and vulnerable urban communities.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4141","MCI-00007","Treatment, care and support","MCI-00117","HIV care","The development of volunteer counselling and testing  / TTC at the level of health facilities and parapublic and private health facilities (allowances), will allow the identification and treatment - tester - treat - (TT) new cases of HIV and TB at the level of regions.",10763,null,"Active","a6Q1R000000AJ4F",0,0,0,0,10763,0,null,null,"The development of volunteer counselling and testing  / TTC at the level of health facilities and parapublic and private health facilities (allowances), will allow the identification and treatment - tester - treat - (TT) new cases of HIV and TB at the level of regions.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Bangladesh","Bangladesh","PAI-3889","MCI-00011","Vector control","MCI-00152","Entomological monitoring","Entomological monitoring. In-line with the recommendations of the last two programme reviews,extensive support to revitalize entomological services will be conducted including: set-up, running and maintenance costs for an insectary; Technical Assistance; purchasing a training microscope. Vector incrimination surveys will be conducted in 3 sentinel sites. This work should serve to better guide and more effectively target the vector control and a personal protection approach.",207367,null,"Active","a6Q1R000000AJ0B",0,0,0,0,207367,0,null,null,"Entomological monitoring. In-line with the recommendations of the last two programme reviews,extensive support to revitalize entomological services will be conducted including: set-up, running and maintenance costs for an insectary; Technical Assistance; purchasing a training microscope. Vector incrimination surveys will be conducted in 3 sentinel sites. This work should serve to better guide and more effectively target the vector control and a personal protection approach.","Medium","Entomological monitoring is part of both malaria reduction and elimination efforts.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Benin","Benin","PAI-3824","MCI-00008","TB care and prevention","MCI-00127","Treatment","Objective : To reduce the fatality rate of TB patients who have any other associated comorbidities (HIV, Diabetes, Anaemia, Viral hepatitis B and C). The mortality rate is 14% among TB/HIV co-infected patients vs 6% for all patients. A well-equipped technical block will be established at the main hospital in Cotonou, treatment protocols will be created and disseminated in all treatment centers. As part of the quality assurance policy, a portable spectroscope and a highperformance liquid chromatograph will be procured to ensure more regular monitoring of the quality of anti-tuberculosis medication.",342159.13,null,"Active","a6Q1R000000AIz8",0,0,0,0,342159.13,0,null,null,"Objective : To reduce the fatality rate of TB patients who have any other associated comorbidities (HIV, Diabetes, Anaemia, Viral hepatitis B and C). The mortality rate is 14% among TB/HIV co-infected patients vs 6% for all patients. A well-equipped technical block will be established at the main hospital in Cotonou, treatment protocols will be created and disseminated in all treatment centers. As part of the quality assurance policy, a portable spectroscope and a highperformance liquid chromatograph will be procured to ensure more regular monitoring of the quality of anti-tuberculosis medication.","High","Establishing of a technical block for the integrated care of TB and other co-morbidities will allow better management of severe TB patients and reduce mortality among coinfected patients",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Benin","Benin","PAI-3750","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00088","Condoms and lubricant programming for sex workers","Procure male condoms for sex workers: planned for year 3.",90107.73,null,"Active","a6Q1R000000AIxw",0,0,0,0,90107.73,0,null,null,"Procure male condoms for sex workers: planned for year 3.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3749","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00572","Other intervention(s) for people in prisons and other closed settings","Pay the travel costs of facilitators from NGOs working with prisoners: planned for year 3. Travel by actors on the ground working with prisoners.",5542.59,null,"Active","a6Q1R000000AIxv",0,0,0,0,5542.59,0,null,null,"Pay the travel costs of facilitators from NGOs working with prisoners: planned for year 3. Travel by actors on the ground working with prisoners.","High",null,"NA Original Intervention: Other interventions for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3744","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Cover the monthly travel costs of facilitators from NGOs working with sex workers: planned for year 3. Travel by actors on the ground working with key populations.",47546.85,null,"Active","a6Q1R000000AIxq",0,0,0,0,47546.85,0,null,null,"Cover the monthly travel costs of facilitators from NGOs working with sex workers: planned for year 3. Travel by actors on the ground working with key populations.","High",null,"NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4591","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","This amount is requested to train engineers in inventory and maintenance of equipment for HIV diagnostic laboratories throughout the country (there are 36 HIV diagnostic laboratories in the country in AIDS centers, at the primary and secondary levels of health care). Currently maintenance of equipment is carried out by specialists from foreign countries. At the stage of transition to public financing, these trained professionals will be further providing services to medical institutions at the expense of public funds.",101400,null,"Active","a6Q1R000000AJBV",0,0,0,0,101400,0,null,null,"This amount is requested to train engineers in inventory and maintenance of equipment for HIV diagnostic laboratories throughout the country (there are 36 HIV diagnostic laboratories in the country in AIDS centers, at the primary and secondary levels of health care). Currently maintenance of equipment is carried out by specialists from foreign countries. At the stage of transition to public financing, these trained professionals will be further providing services to medical institutions at the expense of public funds.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," Eastern Europe and Central Asia",null,"Multi-component"]
["CT India","India","PAI-4535","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","To further expand and reach the third 90, additional funds are sought for viral load testing kits.",11200000,null,"Active","a6Q1R000000AJAb",3007009,0,0,0,8192991,0,null,null,"To further expand and reach the third 90, additional funds are sought for viral load testing kits.","High","While the priority is high, the TRP considers half of the proposed amount to be quality demand and recommends matching from domestic resources. The TRP is concerned that with investment in procurement of Polymerase chain reaction (PCR ) machines , without appropriate supply of kits from domestic sources is a sustainability risk .","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-03-31","HIV/AIDS"]
["CT India","India","PAI-4520","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","The project is aiming to share the standardized short message service on importance to ANMs in a periodical manner.",172800,null,"Active","a6Q1R000000AJAM",0,0,0,0,172800,0,null,null,"The project is aiming to share the standardized short message service on importance to ANMs in a periodical manner.","Low","Effectiveness of this approach not clear.","NA Original Module: PPTCT (Plan International India Chapter). Original Intervention: Monthly SMS to all ANMs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-03-31","HIV/AIDS"]
["CT India","India","PAI-4515","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Evidence generation for policy change.",3000000,null,"Active","a6Q1R000000AJAH",0,0,0,0,3000000,0,null,null,"Evidence generation for policy change.","Low","The amount included in the allocation after prioritization should be sufficient","NA Original Module: RSSH - National health strategies","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-03-31","HIV/AIDS"]
["CT Indonesia","Indonesia","PAI-4498","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00543","Community empowerment for sex workers","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.",985773,null,"Active","a6Q1R000000AJA0",0,0,0,0,985773,0,null,null,"Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","Medium","Expansion of Comprehensive program to reach additional 19,040 female sex workers for testing and 1,276 for treatment",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Asia",null,"Multi-component"]
["CT Indonesia","Indonesia","PAI-4493","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.",106212,null,"Active","a6Q1R000000AJ9v",0,0,0,0,106212,0,null,null,"Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","High","Expansion of Comprehensive program to reach additional 19,040 female sex workers for testing and 1,276 for treatment",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Asia",null,"Multi-component"]
["CT Indonesia","Indonesia","PAI-4492","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Mobile clinic to screen for TB in urban poor population in 10, 12, 15 high burdened cities in 2018, 2019, 2020. Additional 1000 patients from urban poor is expected per year. Technical mentoring of TB ICF in 34 provinces, printing of TB ICF materials. Printing IEC material for vulnerable population at workplace.",947184,null,"Active","a6Q1R000000AJ9u",0,0,0,0,947184,0,null,null,"Mobile clinic to screen for TB in urban poor population in 10, 12, 15 high burdened cities in 2018, 2019, 2020. Additional 1000 patients from urban poor is expected per year. Technical mentoring of TB ICF in 34 provinces, printing of TB ICF materials. Printing IEC material for vulnerable population at workplace.","High","The urban poor have a three times higher risk of acquiring TB. Currently insufficient case finding among this population. Additional case finding among urban poor.","NA Original Intervention: Key populations (TB care and prevention) ? Others","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Asia",null,"Multi-component"]
["CT Haiti","Haiti","PAI-4455","MCI-00007","Treatment, care and support","MCI-00119","Treatment monitoring - Drug resistance surveillance","HIV resistance to ARV treatment is a threat to achieving 90-90-90 objectives and eradicating HIV by 2030. In Haiti, there have not been any national surveys of the prevalence of resistance (RDP-RDA) of HIV-1 to ARV treatment. \nRecommendation:\n? Develop a National Plan for Surveillance and Response to HIVDR  \n? Develop guidelines for surveillance of HIVDR \n? Train healthcare managers on surveillance and prevention of HIVDR, including systematic monitoring of EWIs.",400000,null,"Inactive","a6Q1R000000AJ9J",0,400000,0,0,0,1,null,null,"HIV resistance to ARV treatment is a threat to achieving 90-90-90 objectives and eradicating HIV by 2030. In Haiti, there have not been any national surveys of the prevalence of resistance (RDP-RDA) of HIV-1 to ARV treatment. \nRecommendation:\n? Develop a National Plan for Surveillance and Response to HIVDR  \n? Develop guidelines for surveillance of HIVDR \n? Train healthcare managers on surveillance and prevention of HIVDR, including systematic monitoring of EWIs.","High","The TRP recommends the first three activities:\n? Development of a National Plan for Surveillance and Response to HIV drug resistance [HIVDR]; (US$40,000)\n? Development of guidelines for surveillance of HIVDR; (US$20,000)\n? Training of healthcare managers on surveillance and prevention of HIVDR, including systematic monitoring of Early Warning Indicators; (US$340,000).The TRP notes the other activities are not well justified. According to new WHO Guidelines, non-nucleoside reverse-transcriptase inhibitors (NNRTIs) are being phased out as first line treatment, and resistance studies in treatment settings are not recommended.","NA Original Intervention: Treatment monitoring - drug resistance surveillance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2020-12-31","TB/HIV"]
["CT Burundi","Burundi","PAI-3667","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Activity: Establish a panel of sera for reagent validation (especially for HIV), HBV and HCV)\nThis activity is done in four (4) steps: sensitization of sites involved in sample collection, sample collection, sample analysis, aliquoting and sample conservation. The sensitization will inform providers about the importance of making this panel and how to do it to obtain good quality samples for the constitution of this panel. This panel will evaluate testing and quality control.",17535,null,"Active","a6Q1R000000AIwb",0,0,0,0,17535,0,null,null,"Activity: Establish a panel of sera for reagent validation (especially for HIV), HBV and HCV)\nThis activity is done in four (4) steps: sensitization of sites involved in sample collection, sample collection, sample analysis, aliquoting and sample conservation. The sensitization will inform providers about the importance of making this panel and how to do it to obtain good quality samples for the constitution of this panel. This panel will evaluate testing and quality control.","High",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Armenia","Armenia","PAI-3630","MCI-00004","Prevention programs for other vulnerable populations","MCI-00103","HIV testing services for other vulnerable populations","The total number of urban migrants in Armenia can be as high as 60,000. Therefore, although coverage of 5000 migrants and their sexual partners has been included in the main allocation request, covering additional 5000 is needed in particular if the Russian aid program fails to continue. So additional amount of funds is planned to be spent on this program component if available.",200000,null,"Inactive","a6Q1R000000AIw0",0,200000,0,0,0,1,null,null,"The total number of urban migrants in Armenia can be as high as 60,000. Therefore, although coverage of 5000 migrants and their sexual partners has been included in the main allocation request, covering additional 5000 is needed in particular if the Russian aid program fails to continue. So additional amount of funds is planned to be spent on this program component if available.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2021-09-30","TB/HIV"]
["CT Albania","Albania","PAI-3620","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conduct next round of IBBS in KPs; IBBS will be done in late 2019. Given the high cost, the Transition grant cannot finance it, but if available, PAAR could finance the next round in 2022.",137335,null,"Active","a6Q1R000000AIvq",0,0,0,0,137335,0,null,null,"Conduct next round of IBBS in KPs; IBBS will be done in late 2019. Given the high cost, the Transition grant cannot finance it, but if available, PAAR could finance the next round in 2022.","Medium","Depending on the results of the IBBS in 2019 there may not be a need for a repeat IBBS in two years. Routine programme data should suffice to monitor the trajectory of the concentrated epidemic. This activity is considered of medium priority.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2022-12-31","TB/HIV"]
["CT Afghanistan","Afghanistan","PAI-3557","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","To enhance diagnostic capacities and provide high quality laboratory services, the preferred LPA DST equipment is being proposed for 3 RRLs. The cost of each LPA with PCR is US$ 50,000 or US$ 150,000 for 3 RRLs. US$ 10,000 per laboratory per year is necessary for the diagnostic kits (US$ 10,000 X 3 X 3 = US$ 90,000) for a total of US$ 240,000.",240000,null,"Active","a6Q1R000000AIup",0,0,0,0,240000,0,null,null,"To enhance diagnostic capacities and provide high quality laboratory services, the preferred LPA DST equipment is being proposed for 3 RRLs. The cost of each LPA with PCR is US$ 50,000 or US$ 150,000 for 3 RRLs. US$ 10,000 per laboratory per year is necessary for the diagnostic kits (US$ 10,000 X 3 X 3 = US$ 90,000) for a total of US$ 240,000.","High","This is an important investment that is needed to inform MDR patient management. The intervention would enhance diagnostic capacity by purchasing line probe assay (LPA) drug susceptibility testing (DST) equipment and consumables for three regional laboratories.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH"," South East Asia",null,"Multi-component"]
["CT Congo","Congo","PAI-4040","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Organize a six-day training workshop in Brazzaville for 12 participants from the four GeneXpert centers on the use of GeneXpert, culture and sensitivity tests in year 1.",7309.2,null,"Active","a6Q1R000000AJ2c",0,0,0,0,7309.2,0,null,null,"Organize a six-day training workshop in Brazzaville for 12 participants from the four GeneXpert centers on the use of GeneXpert, culture and sensitivity tests in year 1.","High","The activity will expand access to GeneXpert","NA Original Module: Multidrug-resistant TB. Original Intervention: Improvement in the quality of diagnosis of TB, MDR-TB and laboratory-based monitoring of MDR-TB cases through training of laboratory staff in the use of GeneXpert","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Cameroon","Cameroon","PAI-3967","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Malaria control strategies are evolving at the global level, given the innovations in this area. To this end, the Program will undergo several phases  of  change  in  program  and  financial management  policies  and  procedures.  For example, NMCP is  considering assessments of current  strategies,  revision  of  the  national strategic  plan,  capacity  building  of  staff  in different areas of specialization and updating of  normative  documents.  To  this  end,  all normative  documents will be up to date and at least  80%  of  the  qualified staff in the specialties  required  for  the  performance of their duties.",56110.43,null,"Active","a6Q1R000000AJ1R",0,0,0,0,56110.43,0,null,null,"Malaria control strategies are evolving at the global level, given the innovations in this area. To this end, the Program will undergo several phases  of  change  in  program  and  financial management  policies  and  procedures.  For example, NMCP is  considering assessments of current  strategies,  revision  of  the  national strategic  plan,  capacity  building  of  staff  in different areas of specialization and updating of  normative  documents.  To  this  end,  all normative  documents will be up to date and at least  80%  of  the  qualified staff in the specialties  required  for  the  performance of their duties.","High","While the TRP considers this activity a high priority, The TRP is of the view that the amount requested for the activity is relatively high. The TRP therefore recommends 25% of the original amount under PAAR.","NA Original Intervention: Mid-Term Review Malaria NSP 2018-2022","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Cameroon","Cameroon","PAI-3966","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.",841692.29,null,"Active","a6Q1R000000AJ1Q",0,0,0,0,841692.29,0,null,null,"Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Malaria Indicator Survey (MIS)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Bangladesh","Bangladesh","PAI-3881","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Scale-up ICT based data collection system in the HIV/AIDS program to integrate with the national Health Management Information System (HMIS). A pilot initiative will introduce a ICT based data collection system using tablets with mobile apps. The ICT based data collection system will be scaled-up for the entire program and to be integrated into MIS system of HIV/AIDS program, contributing to the national HMIS.",142272,null,"Active","a6Q1R000000AJ03",0,0,0,0,142272,0,null,null,"Scale-up ICT based data collection system in the HIV/AIDS program to integrate with the national Health Management Information System (HMIS). A pilot initiative will introduce a ICT based data collection system using tablets with mobile apps. The ICT based data collection system will be scaled-up for the entire program and to be integrated into MIS system of HIV/AIDS program, contributing to the national HMIS.","Low","Support introduction of information communication technology (ICT)-based data collection system using tablet with mobile apps. The ICT based date collection system will be scaled up for entire program and to be integrated into MIS system of HIV/AIDS program contributing to national HMIS.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Undefined","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-11-30","HIV/AIDS"]
["CT Benin","Benin","PAI-3815","MCI-00012","Case management","MCI-00595","Removing human rights and gender related barriers to case management","Specific new actions will enable approximately 7,000 persons deprived of liberty to access quality treatment services and thus guarantee their right to health.\nThese actions are: i) Training / supervision of prison medical staff; ii) Provision of treatment; iii) Provision of prison health centers in Inputs Malaria control for the free care; and iiii) Consultative meetings with the concerned ministries for a good coordination of activities",48261.7,null,"Active","a6Q1R000000AIyz",0,0,0,0,48261.7,0,null,null,"Specific new actions will enable approximately 7,000 persons deprived of liberty to access quality treatment services and thus guarantee their right to health.\nThese actions are: i) Training / supervision of prison medical staff; ii) Provision of treatment; iii) Provision of prison health centers in Inputs Malaria control for the free care; and iiii) Consultative meetings with the concerned ministries for a good coordination of activities","High",null,"NA Original Intervention: Removing human rights- and gender-related barriers to case management","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Jamaica","Jamaica","PAI-4568","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Evaluate Peer Navigation Programme to identify gaps in service delivery to improve adherence and retention.",150000,null,"Active","a6Q1R000000AJB8",0,0,0,0,150000,0,null,null,"Evaluate Peer Navigation Programme to identify gaps in service delivery to improve adherence and retention.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Indonesia","Indonesia","PAI-4503","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Develop capacity of the primary care level to diagnose childhood TB using sputum induction to about 25000 presumptive TB patients. It will also optimize the use of Xpert MTB/RIF and boost DRTB detection among children. Development of integrated TB services through UKBM (community health based services) for children, elderly, and other chronic diseases.",525335,null,"Active","a6Q1R000000AJA5",0,0,0,0,525335,0,null,null,"Develop capacity of the primary care level to diagnose childhood TB using sputum induction to about 25000 presumptive TB patients. It will also optimize the use of Xpert MTB/RIF and boost DRTB detection among children. Development of integrated TB services through UKBM (community health based services) for children, elderly, and other chronic diseases.","High","Necessary to increase capacity of the primary care level to diagnose childhood TB and development of integrated TB services. Contributes to adequate paediatric TB treatment",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Asia",null,"Multi-component"]
["CT Indonesia","Indonesia","PAI-4484","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Provision of services through Mobile Clinics and lab consumable for HIV testing for 1,303,588 KAPs.",3096079,null,"Active","a6Q1R000000AJ9m",0,0,0,0,3096079,0,null,null,"Provision of services through Mobile Clinics and lab consumable for HIV testing for 1,303,588 KAPs.","High","Contribute to increase HIV testing among key populations. Targeted testing including mobile testing to reach 1,303,588 key populations.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH"," High Impact Asia",null,"Multi-component"]
["CT Indonesia","Indonesia","PAI-4468","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Needed for collaboration with Malaysia (Kalimantan), Timor Leste (NTT), and PNG (Papua).\nEstimate requirement for each collaboration meeting would be US$ 20,000 with total 10 times of meeting/workshop.\nKalimantan-Malaysia : 3 times\nNTT-Timor Leste : 4 times\nPapua-PNG  : 4 times\nEach activity will involve Ministry of Health (NMP, Foreign Affair Bureau, Surveillance program, maternal and child health program), Ministry of Finance, Ministry of Foreign Affair, Ministry of Home Affair, PHO, DHO, Private Sector, Local NGOs",200000,null,"Active","a6Q1R000000AJ9W",0,0,0,0,200000,0,null,null,"Needed for collaboration with Malaysia (Kalimantan), Timor Leste (NTT), and PNG (Papua).\nEstimate requirement for each collaboration meeting would be US$ 20,000 with total 10 times of meeting/workshop.\nKalimantan-Malaysia : 3 times\nNTT-Timor Leste : 4 times\nPapua-PNG  : 4 times\nEach activity will involve Ministry of Health (NMP, Foreign Affair Bureau, Surveillance program, maternal and child health program), Ministry of Finance, Ministry of Foreign Affair, Ministry of Home Affair, PHO, DHO, Private Sector, Local NGOs","Medium","Efforts to support cross border collaboration and joint planning activities, to ensure joint surveillance, vector control management, data sharing, and prevention activities can be useful. However, the TRP recommends that this support be contingent on the inclusion of similar cross-border collaboration activities in the Timor Leste and Papua New Guinea work plan Indonesia-Malaysia collaboration may be better coordinated through existing regional networks that has the mandate to coordinate such activities, e.g. ASEAN, MaPhilIndo, APMENs",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4331","MCI-00071","Other module","MCI-00071","Other module","Conduct a Resistance Surveillance Survey (Studying the drug resistance of HIV to ARVs - Estimate the level of primary resistance, classify resistance levels of HIV-1 to ARVs and describe the types of mutations encountered). This study is essential for evaluating the resistance levels of HIV to ARVs, together with the types of mutations. The results of this study will enable better use of ARVs, thereby improving the survival rate for patients.",23846.93,null,"Active","a6Q1R000000AJ7J",0,0,0,0,23846.93,0,null,null,"Conduct a Resistance Surveillance Survey (Studying the drug resistance of HIV to ARVs - Estimate the level of primary resistance, classify resistance levels of HIV-1 to ARVs and describe the types of mutations encountered). This study is essential for evaluating the resistance levels of HIV to ARVs, together with the types of mutations. The results of this study will enable better use of ARVs, thereby improving the survival rate for patients.","Medium","While this is a recommended intervention, it may not be the highest priority at this stage in Guinea-Bissau.","NA Original Module: RSSH. Original Intervention: Analysis, reviews ? consultant for Resistance Surveillance Survey","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4330","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","For the purpose of Information, Education and Communication for Behavioral Change (IEC/CCC) under the current grant, the number of people (men in uniform, drivers, young street sellers) who are supposed to be sensitized and referred to the health centers for voluntary testing, is 15,000, 23,760, and 9,000, respectively, for a total number of 47,760. For other projects such as FEVE  (Borders and Vulnerabilities to HIV in West Africa), which is managed by the NGO ENDA, and the INCLUSIPH sub-regional project, managed by the NGO Humanity and Inclusion (formerly Handicap International), 3,600 prisoners and drug-users, and 4,000 people living with disabilities were targeted by the same activities.\nNevertheless, tests to cover these vulnerable populations were not specified under the current grant due to budgetary constraints.\nIn addition, and in accordance with the TRP recommendations to meet the 90-90-90 targets in the ?HIV Services Differentiated Approaches?, 26,000 hospitalized patients and 38,000 others (general population) not part of the aforementioned vulnerable groups, have been targeted for testing. In total, the portion of the targeted population that is not covered is 119,360 who are supposed to be tested twice per year and this amounts to 238,720 tests over 2 years (2019-2020).\nThis amount is requested in order to cover the very large testing gap (quantification of additional ARV requirements and HIV tests - Appendix 7). In fact, the PSM plan quantities were approved on the basis of budgetary constraints and were not based on the actual needs of the country. This quantification only specifies pregnant women and key populations (MSM, SW).\nThe catch up plan, developed under 90-90-90 target, seeks to address the general population, to propose systematic testing of hospital patients, both adults and children, children admitted in nutritional rehabilitation centers (CRENI, CRENAS, CRENAM), people living with disabilities, prisoners, drug-users, men in uniform, young street sellers, drivers, and also the volunteers who come to do the tests in the country?s various Voluntary Counseling and Testing centers. In contrast with this, at the community level, the program will conduct testing campaigns for vulnerable groups, especially men in uniform, young saleswomen, and drivers. ?Self-testing? is also planned, at the community level, for key populations.\nIt is also important to specify that the behavioral bio-study, conducted by Humanity and Inclusion (HI), revealed a prevalence of 7.3% in the population of people living with disabilities and, on that basis, HI plans to perform 2,000 tests per year in this group. It is within this context that the program has found the essential necessity of testing these other groups, cited above, in order to improve the performance of the cascade which is currently very low.",355318.26,null,"Inactive","a6Q1R000000AJ7I",0,355318.26,0,0,0,1,null,null,"For the purpose of Information, Education and Communication for Behavioral Change (IEC/CCC) under the current grant, the number of people (men in uniform, drivers, young street sellers) who are supposed to be sensitized and referred to the health centers for voluntary testing, is 15,000, 23,760, and 9,000, respectively, for a total number of 47,760. For other projects such as FEVE  (Borders and Vulnerabilities to HIV in West Africa), which is managed by the NGO ENDA, and the INCLUSIPH sub-regional project, managed by the NGO Humanity and Inclusion (formerly Handicap International), 3,600 prisoners and drug-users, and 4,000 people living with disabilities were targeted by the same activities.\nNevertheless, tests to cover these vulnerable populations were not specified under the current grant due to budgetary constraints.\nIn addition, and in accordance with the TRP recommendations to meet the 90-90-90 targets in the ?HIV Services Differentiated Approaches?, 26,000 hospitalized patients and 38,000 others (general population) not part of the aforementioned vulnerable groups, have been targeted for testing. In total, the portion of the targeted population that is not covered is 119,360 who are supposed to be tested twice per year and this amounts to 238,720 tests over 2 years (2019-2020).\nThis amount is requested in order to cover the very large testing gap (quantification of additional ARV requirements and HIV tests - Appendix 7). In fact, the PSM plan quantities were approved on the basis of budgetary constraints and were not based on the actual needs of the country. This quantification only specifies pregnant women and key populations (MSM, SW).\nThe catch up plan, developed under 90-90-90 target, seeks to address the general population, to propose systematic testing of hospital patients, both adults and children, children admitted in nutritional rehabilitation centers (CRENI, CRENAS, CRENAM), people living with disabilities, prisoners, drug-users, men in uniform, young street sellers, drivers, and also the volunteers who come to do the tests in the country?s various Voluntary Counseling and Testing centers. In contrast with this, at the community level, the program will conduct testing campaigns for vulnerable groups, especially men in uniform, young saleswomen, and drivers. ?Self-testing? is also planned, at the community level, for key populations.\nIt is also important to specify that the behavioral bio-study, conducted by Humanity and Inclusion (HI), revealed a prevalence of 7.3% in the population of people living with disabilities and, on that basis, HI plans to perform 2,000 tests per year in this group. It is within this context that the program has found the essential necessity of testing these other groups, cited above, in order to improve the performance of the cascade which is currently very low.","High",null,"Grant revision: PO recommanded at the GAC meeting of the 24/01/2019","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Armenia","Armenia","PAI-3625","MCI-00534","Comprehensive prevention programs for MSM","MCI-00608","Diagnosis and treatment of STIs and other sexual health services for MSM","STI testing and treatment for MSM (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment.\n \nScreening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.",19555,null,"Inactive","a6Q1R000000AIvv",8778,10777,0,0,0,1,null,null,"STI testing and treatment for MSM (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment.\n \nScreening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","High",null,"26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2021-09-30","TB/HIV"]
["CT Albania","Albania","PAI-3612","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Prepare a training program for HIV for district epidemiologists. The training of district-level epidemiologists will support the overal decentralisation of health services, and HIV services in particular.",7250,null,"Active","a6Q1R000000AIvi",0,0,0,0,7250,0,null,null,"Prepare a training program for HIV for district epidemiologists. The training of district-level epidemiologists will support the overal decentralisation of health services, and HIV services in particular.","High","Upgrading and motivating this cadre has a multipronged effect on the quality of health information systems and should be considered for funding within allocation if efficiency savings are realised.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2022-12-31","TB/HIV"]
["CT Congo","Congo","PAI-4037","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Procure 6 UPS 3000 VA - 210V for GeneXpert (Gdf diagnosis no. 106081).",24474.65,null,"Active","a6Q1R000000AJ2Z",0,0,0,0,24474.65,0,null,null,"Procure 6 UPS 3000 VA - 210V for GeneXpert (Gdf diagnosis no. 106081).","High","The activity provides for extra 6 GeneXpert to bring the total in the country to 14.","NA Original Module: Multidrug-resistant TB. Original Intervention: Improve access to rapid diagnosis for MDR-TB through procurement of 6 GeneXperts and cartridges","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Bangladesh","Bangladesh","PAI-3880","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).",940181,null,"Active","a6Q1R000000AJ02",0,0,0,0,940181,0,null,null,"Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).","Low","Given the low number of HIV cases initiating ART, and the fact that Pre-exposure prophylaxis (PreP) should only be considered for sero-discordant couples where partner is initiating treatment or has detectable viral load in the Bangladesh epidemic, this is not a priority.","NA Original Intervention: Other interventions for treatment: PrEP","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-11-30","HIV/AIDS"]
["CT Benin","Benin","PAI-3809","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Undertake mentoring on PMTCT/IMPC and early diagnosis through dried blood spots.",26971.16,null,"Active","a6Q1R000000AIyt",0,0,0,0,26971.16,0,null,null,"Undertake mentoring on PMTCT/IMPC and early diagnosis through dried blood spots.","High",null,"NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3740","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Installation and handling (operator training) for all equipment.",25900,null,"Active","a6Q1R000000AIxm",0,0,0,0,25900,0,null,null,"Installation and handling (operator training) for all equipment.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Indonesia","Indonesia","PAI-4463","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Total of 1,474,793 bed nets will be distributed to selected areas in Sumatera, Kalimantan, and Sulawesi. The costs include bed net procurement, custom and distribution costs, and field distribution cost.",7400000,null,"Active","a6Q1R000000AJ9R",4150000,0,0,0,3250000,0,null,null,"Total of 1,474,793 bed nets will be distributed to selected areas in Sumatera, Kalimantan, and Sulawesi. The costs include bed net procurement, custom and distribution costs, and field distribution cost.","High","LLIN for focus areas including MMPs to support universal coverage and equal access to a key intervention in the prevention of malaria is a high priority. In addition, the TRP suggests consideration of Long Lasting Insecticide Treated Hammock Nets for the MMP, if it can be a more appropriate intervention for this key vulnerable group.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Indonesia","Indonesia","PAI-4462","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","IVM (IRS and environment management) and community engagement in additional 12 high endemic districts with API > 50 and < 100 (Yapen, Waropen, Asmat, Arfak) and API > 20 and < 50 (Supiori, Mappi, Nabire, Deiyai, Lembata, Tambraw, Teluk Wondama, Kota Jayapura). Activities will include insecticide procurement and IRS at 120 villages in 12 districts. The target population will be approximately 120,000 people (200 households per village @5 person per house)\nIVM will cover following activities:\n- Feasibility assessment of IVM application (USD 50,000/district = USD 600,000 for 12 districts)\n- Environment Management ? larval habitat reduction via drainage works where feasible (USD 50,000 per district = USD 600,000 for 12 districts). \n- Larvaciding (@ US$ 50,000 per district = US$ 600,000 for 12 districts)\n- Insecticide for 24,000 houses: US$ 250,000\n- IRS for 120 villages: US$ 250,000 (@US$ 2,000 per village)\nTotal amount for this activity is USD 2,300,000",2300000,null,"Inactive","a6Q1R000000AJ9Q",2300000,0,0,0,0,1,null,null,"IVM (IRS and environment management) and community engagement in additional 12 high endemic districts with API > 50 and < 100 (Yapen, Waropen, Asmat, Arfak) and API > 20 and < 50 (Supiori, Mappi, Nabire, Deiyai, Lembata, Tambraw, Teluk Wondama, Kota Jayapura). Activities will include insecticide procurement and IRS at 120 villages in 12 districts. The target population will be approximately 120,000 people (200 households per village @5 person per house)\nIVM will cover following activities:\n- Feasibility assessment of IVM application (USD 50,000/district = USD 600,000 for 12 districts)\n- Environment Management ? larval habitat reduction via drainage works where feasible (USD 50,000 per district = USD 600,000 for 12 districts). \n- Larvaciding (@ US$ 50,000 per district = US$ 600,000 for 12 districts)\n- Insecticide for 24,000 houses: US$ 250,000\n- IRS for 120 villages: US$ 250,000 (@US$ 2,000 per village)\nTotal amount for this activity is USD 2,300,000","High","This amount will support determining epidemiological impact of Integrated Vector Management (IVM) in accelerating transmission reduction in 12 additional high endemic districts with API > 20. The TRP did not agree with the IVM activities proposed for migrant and mobile populations (MMPs), so $2,800,000 was removed from the budget line submitted (see Table 6 below).","NA Original Intervention: Other vector control measures","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2020-12-31","Malaria"]
["CT Haiti","Haiti","PAI-4457","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","The PNLT anticipates developing strategies to increase screening for new cases.  Improve Screening for paediatric TB:introduction of the Determine LAM strip urine test for diagnosing tuberculosis in HIV-positive children under 15 years + GeneXpert stool sample test for children under 5 suspected of having pulmonary tuberculosis. The active search for cases will be conducted during home visits ASCP. \nEvery ASCP screens at least 3 cases per quarter for a total of 1,248 additional new cases; this target will double in the second year.",1932922,null,"Active","a6Q1R000000AJ9L",0,375000,539250,0,1018672,0,null,null,"The PNLT anticipates developing strategies to increase screening for new cases.  Improve Screening for paediatric TB:introduction of the Determine LAM strip urine test for diagnosing tuberculosis in HIV-positive children under 15 years + GeneXpert stool sample test for children under 5 suspected of having pulmonary tuberculosis. The active search for cases will be conducted during home visits ASCP. \nEvery ASCP screens at least 3 cases per quarter for a total of 1,248 additional new cases; this target will double in the second year.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2020-12-31","TB/HIV"]
["CT Albania","Albania","PAI-3608","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Support the ageing PLHIV; Drive support and education for older people with HIV, emotional, psychological and social support for people aging with HIV/AIDS and offering support in order to have access on HIV services to ensure a good quality of life",15000,null,"Active","a6Q1R000000AIve",0,0,0,0,15000,0,null,null,"Support the ageing PLHIV; Drive support and education for older people with HIV, emotional, psychological and social support for people aging with HIV/AIDS and offering support in order to have access on HIV services to ensure a good quality of life","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2022-12-31","TB/HIV"]
["CT Albania","Albania","PAI-3603","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","Establish guidelines and provide KP-specific friendly health services (PWID, sex workers,  Roma)",1500,null,"Active","a6Q1R000000AIvZ",0,0,0,0,1500,0,null,null,"Establish guidelines and provide KP-specific friendly health services (PWID, sex workers,  Roma)","Low",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2022-12-31","TB/HIV"]
["CT Afghanistan","Afghanistan","PAI-3554","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","5 GeneXpert machines are already deployed. Ten machines will be deployed by CTB and 10 are included GF TB grant for Provincial Hospitals. This UQD includes additional 10 GeneXpert machines for Provincial and District Hospital TB diagnostic centers. This requires installation costs ($25,000 per machine X 10 = $250,000) and testing kits ($24,000 per unit X 10 units x 3 years = $720,000).",970000,null,"Active","a6Q1R000000AIum",0,0,0,0,970000,0,null,null,"5 GeneXpert machines are already deployed. Ten machines will be deployed by CTB and 10 are included GF TB grant for Provincial Hospitals. This UQD includes additional 10 GeneXpert machines for Provincial and District Hospital TB diagnostic centers. This requires installation costs ($25,000 per machine X 10 = $250,000) and testing kits ($24,000 per unit X 10 units x 3 years = $720,000).","High","It is desirable to purchase 10 additional GeneXperts to increase the diagnostic capacity of the country to detect drug-resistant tuberculosis. However, the funds available within the allocation amount are insufficient to include this item and the intervention is listed in the PAAR. The PAAR includes 10 GeneXpert machines in Provincial and District Hospital TB diagnostic centres that are additional to those requested in the allocation.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH"," South East Asia",null,"Multi-component"]
["CT Congo","Congo","PAI-4034","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS for refugees.",95756.93,null,"Active","a6Q1R000000AJ2W",0,0,0,0,95756.93,0,null,null,"Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS for refugees.","High","This activity will improve the management of TB for refuges.","NA Original Intervention: Integration of TB treatment and the application of the DOTS strategy for refugees","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Cameroon","Cameroon","PAI-3964","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","These activities will allow for work to ensure communication around the use of LLINs and  IPT activities for  the prevention of malaria in pregnant women a,  infant  and neonatal health through the routine distribution LLINs, the implementation of  the refocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.",270101,null,"Active","a6Q1R000000AJ1O",0,0,0,0,270101,0,null,null,"These activities will allow for work to ensure communication around the use of LLINs and  IPT activities for  the prevention of malaria in pregnant women a,  infant  and neonatal health through the routine distribution LLINs, the implementation of  the refocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.","High",null,"NA Original Intervention: Communication activities on the use of LLINs and IPT","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Bangladesh","Bangladesh","PAI-3877","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","Piloting different ART service delivery models for key and general populations will allow improved linkages to treatment, care and support for people living with HIV.",332408,null,"Active","a6Q1R000000AIzz",0,0,0,0,332408,0,null,null,"Piloting different ART service delivery models for key and general populations will allow improved linkages to treatment, care and support for people living with HIV.","Medium","Better models for improving linkages to treatment, care and support for people living with HIV are necessary to combatting the epidemic.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-11-30","HIV/AIDS"]
["CT Benin","Benin","PAI-3805","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","Mobilize therapeutic assistants via two DAT consultants to draw up the community care strategy. With the adoption of the ?test and treat? strategy, a significant active file is anticipated, which will place pressure on the health system.",19052.86,null,"Active","a6Q1R000000AIyp",0,0,0,0,19052.86,0,null,null,"Mobilize therapeutic assistants via two DAT consultants to draw up the community care strategy. With the adoption of the ?test and treat? strategy, a significant active file is anticipated, which will place pressure on the health system.","Low",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Other other community responses and systems intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3802","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Coaching and mentoring on ART in civilian prisons by neighboring care facilities\n(10 days: one experienced prescriber, one CIPEC, one SPECS and a driver).\nHIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. Given the lack of experience of these nurses and the noted organizational difficulties, coaching and mentorship should be organized to improve care quality. This will be undertaken by an experienced prescriber, along with a departmental and national supervisor.",12325.22,null,"Active","a6Q1R000000AIym",0,0,0,0,12325.22,0,null,null,"Coaching and mentoring on ART in civilian prisons by neighboring care facilities\n(10 days: one experienced prescriber, one CIPEC, one SPECS and a driver).\nHIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. Given the lack of experience of these nurses and the noted organizational difficulties, coaching and mentorship should be organized to improve care quality. This will be undertaken by an experienced prescriber, along with a departmental and national supervisor.","Low",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Haiti","Haiti","PAI-4448","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Screening for the side effects of MDR-TB treatments at vestibular/cochlear and cardiac level will be conducted systematically while the treatment of MDR patients is being monitored. MDR treatment extension sites will be fitted out with the appropriate equipment, an Audiogram System, Software, computer and ECG with automatic interpretation.",45000,null,"Active","a6Q1R000000AJ9C",0,0,0,0,45000,0,null,null,"Screening for the side effects of MDR-TB treatments at vestibular/cochlear and cardiac level will be conducted systematically while the treatment of MDR patients is being monitored. MDR treatment extension sites will be fitted out with the appropriate equipment, an Audiogram System, Software, computer and ECG with automatic interpretation.","High","The TRP recommends to reprioritize this intervention to high. It potentially prevents irreversible side-effects of MDR-TB treatment, such as hearing loss, that have an enormous impact on lives of patients with MDR-TB.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2020-12-31","TB/HIV"]
["CT Haiti","Haiti","PAI-4439","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Scale up the pilot project to increase epidemiological surveillance of malaria which is being implemented in 116 sites. This scaling up covers purchase of equipment for stratum 3 sites and purchase of equipment to replace 20% of the equipment purchased during the pilot phase.\nexpected result: all sites for epidemiological surveillance in stratum 3 have adequate equipment;\nimpact: data quality is improving significantly, with reporting on time.",876934,null,"Active","a6Q1R000000AJ93",0,0,0,0,876934,0,null,null,"Scale up the pilot project to increase epidemiological surveillance of malaria which is being implemented in 116 sites. This scaling up covers purchase of equipment for stratum 3 sites and purchase of equipment to replace 20% of the equipment purchased during the pilot phase.\nexpected result: all sites for epidemiological surveillance in stratum 3 have adequate equipment;\nimpact: data quality is improving significantly, with reporting on time.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Latin America and Caribbean","2020-12-31","Malaria"]
["CT Haiti","Haiti","PAI-4438","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Purchase of LLINs for populations in towns bordering areas in stratum 3 (to contain the progression of the endemic near strata which beneficiate from mass campaign). The number of towns concerned is estimated at 23 for a population estimated at about 2,285,101 inhabitants.\nexpected result: 90% of populations living in towns bordering areas in \"red\" stratum 3 will be covered by a LLIN;\nimpact: morbidity in towns bordering areas in \"red\" stratum 3 is halving from one year to the next.",3850393.5,null,"Active","a6Q1R000000AJ92",0,0,0,0,3850393.5,0,null,null,"Purchase of LLINs for populations in towns bordering areas in stratum 3 (to contain the progression of the endemic near strata which beneficiate from mass campaign). The number of towns concerned is estimated at 23 for a population estimated at about 2,285,101 inhabitants.\nexpected result: 90% of populations living in towns bordering areas in \"red\" stratum 3 will be covered by a LLIN;\nimpact: morbidity in towns bordering areas in \"red\" stratum 3 is halving from one year to the next.","High",null,"NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Latin America and Caribbean","2020-12-31","Malaria"]
["CT Albania","Albania","PAI-3602","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Establish a quality assurance monitoring system of HIV prevention, treatment care and support services  ",12350,null,"Active","a6Q1R000000AIvY",0,0,0,0,12350,0,null,null,"Establish a quality assurance monitoring system of HIV prevention, treatment care and support services  ","Low",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2022-12-31","TB/HIV"]
["CT Afghanistan","Afghanistan","PAI-3550","MCI-00012","Case management","MCI-00157","Active case detection and investigation (elimination phase)","To  prevent  the  spread  of  malaria  in  Category  2&3   provinces,  early  detection  ,  prompt  treatment  and  case  based  surveillance  are  considered  as  the  top  priority  by  the  program.  \nThese measures are not costed in allocated  funding  request.  In the revised National Malaria Strategy, for the areas in Category 2 & 3 (low or malaria elimination areas), it is recommended to strengthen  malaria  surveillance  through case-based investigation.",96000,null,"Active","a6Q1R000000AIui",0,0,0,0,96000,0,null,null,"To  prevent  the  spread  of  malaria  in  Category  2&3   provinces,  early  detection  ,  prompt  treatment  and  case  based  surveillance  are  considered  as  the  top  priority  by  the  program.  \nThese measures are not costed in allocated  funding  request.  In the revised National Malaria Strategy, for the areas in Category 2 & 3 (low or malaria elimination areas), it is recommended to strengthen  malaria  surveillance  through case-based investigation.","Medium","Although the priority might not be very high at the moment, the case-based investigation will achieve strengthening of malaria surveillance system which is indispensable for the elimination of malaria. This should be incorporated in the PAAR.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Congo","Congo","PAI-4026","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","The intervention of this module will focus on the routine distribution of 589,164 LLINs to pregnant women and children under one year of age during antenatal clinics, seasonal malaria chemoprevention (SMC), and/or linked to vaccination. In effect, these population groups are the most vulnerable to malaria but do not currently benefit from LLINs. The Chinese Government has signed a donation agreement with Congo to provide 200,000 LLINs per year for five years. However, programmatic gap analysis shows that there will be a 48 percent shortage of LLINs in 2018, 6 percent in 2019 and 51 percent in 2020 for the routine provision of nets, equivalent to a shortage of 589,164 LLINs. The household coverage rate of LLINs in 2015 is 36.7 percent. The rates of use are respectively 60.5 percent among children under one year of age and 60.3 percent among pregnant women, also for 2015. The above allocation funding by the Global Fund will cover the gap in LLINs and improve the rate of coverage (99 percent among pregnant women and 90 percent among children under one year of age), and the rate of use of LLINs to at least 80 percent in these two vulnerable groups. The expected impact will be a reduction of the burden of malaria morbidity among these vulnerable groups.",1931320.84,null,"Active","a6Q1R000000AJ2O",0,0,0,0,1931320.84,0,null,null,"The intervention of this module will focus on the routine distribution of 589,164 LLINs to pregnant women and children under one year of age during antenatal clinics, seasonal malaria chemoprevention (SMC), and/or linked to vaccination. In effect, these population groups are the most vulnerable to malaria but do not currently benefit from LLINs. The Chinese Government has signed a donation agreement with Congo to provide 200,000 LLINs per year for five years. However, programmatic gap analysis shows that there will be a 48 percent shortage of LLINs in 2018, 6 percent in 2019 and 51 percent in 2020 for the routine provision of nets, equivalent to a shortage of 589,164 LLINs. The household coverage rate of LLINs in 2015 is 36.7 percent. The rates of use are respectively 60.5 percent among children under one year of age and 60.3 percent among pregnant women, also for 2015. The above allocation funding by the Global Fund will cover the gap in LLINs and improve the rate of coverage (99 percent among pregnant women and 90 percent among children under one year of age), and the rate of use of LLINs to at least 80 percent in these two vulnerable groups. The expected impact will be a reduction of the burden of malaria morbidity among these vulnerable groups.","Medium","To meet the full need of routine distribution of LLINs for vulnerable groups: pregnant women and children in EPI","NA Original Intervention: Procurement of routine LLINs","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Congo","Congo","PAI-4025","MCI-00012","Case management","MCI-00164","Other case management intervention(s)",null,325440.46999999997,null,"Active","a6Q1R000000AJ2N",0,0,0,0,325440.46999999997,0,null,null,null,"High","To maintain high level of treatment with ACTs, quality assurance in the private sector (included in the training) and critical for the improvements of malaria diagnosis, treatment, and surveillance","NA Original Module: Community case management. Original Intervention: Training of community health workers (CHWs)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Benin","Benin","PAI-3800","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Procure 100 extra cupboards for care facilities that have not yet been equipped:\n(?610 per cupboard)\nDuring the first part of the grant, 43 cupboards with shelves were procured for care facilities to improve storage conditions for ARVs. The intention is to procure more for the remaining facilities and for the new facilities that will be set up.",68431.149999999994,null,"Active","a6Q1R000000AIyk",0,0,0,0,68431.149999999994,0,null,null,"Procure 100 extra cupboards for care facilities that have not yet been equipped:\n(?610 per cupboard)\nDuring the first part of the grant, 43 cupboards with shelves were procured for care facilities to improve storage conditions for ARVs. The intention is to procure more for the remaining facilities and for the new facilities that will be set up.","Low",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Haiti","Haiti","PAI-4430","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Reproduction of data collection tools for agents on the ground\nexpected result: all agents on the ground, including ones at community level, have tools for collection, on paper, in a sufficient quantity\nimpact: no shortage of stock of tools for collecting data over 3 years",30000,null,"Active","a6Q1R000000AJ8u",0,0,0,0,30000,0,null,null,"Reproduction of data collection tools for agents on the ground\nexpected result: all agents on the ground, including ones at community level, have tools for collection, on paper, in a sufficient quantity\nimpact: no shortage of stock of tools for collecting data over 3 years","Low","This funding will support reproduction of data collection tools for agents - field work. The TRP recommends this activity with low priority as it represents low value for money.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Latin America and Caribbean","2020-12-31","Malaria"]
["CT Liberia","Liberia","PAI-4683","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","This activity is to increase community involvement and participation in the implementation of the Revised Community Health policy in Liberia and it is part of the policy requirement to work with the Health Facility Development Committees (HFDC) in Community Health program or integrated community case management (iCCM) interventions.  The HFDCs are representatives of the communities in the catchment of the health facilities. These HFDC are the linkage between communities and health facilities and will provide support to the CHAs and TTM by promoting the work of the TTM and CHAs, and the health facilities.",964634,null,"Active","a6Q1R000000AJCz",0,0,47780,0,916854,0,null,null,"This activity is to increase community involvement and participation in the implementation of the Revised Community Health policy in Liberia and it is part of the policy requirement to work with the Health Facility Development Committees (HFDC) in Community Health program or integrated community case management (iCCM) interventions.  The HFDCs are representatives of the communities in the catchment of the health facilities. These HFDC are the linkage between communities and health facilities and will provide support to the CHAs and TTM by promoting the work of the TTM and CHAs, and the health facilities.","High",null,"NA Original Intervention: Integrated community case management (iCCM)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4682","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","In Liberia, Malaria is placed under passive surveillance under the Integrated Disease Surveillance and Response strategy.  In 2013, two surveillance sites were opened however, the sites did not function as the result of the outbreak of the Ebola Virus Disease outbreak which plagued the Country in 2014 and 2015.  Post Ebola, the Program decided to expand to three other health facilities in order to geographically balance the surveillance activities.  The requested fund is to set up the five sites (US$100,000) and another one hundred thousand dollars per year to run the sites for three years.",400000,null,"Active","a6Q1R000000AJCy",0,0,0,0,400000,0,null,null,"In Liberia, Malaria is placed under passive surveillance under the Integrated Disease Surveillance and Response strategy.  In 2013, two surveillance sites were opened however, the sites did not function as the result of the outbreak of the Ebola Virus Disease outbreak which plagued the Country in 2014 and 2015.  Post Ebola, the Program decided to expand to three other health facilities in order to geographically balance the surveillance activities.  The requested fund is to set up the five sites (US$100,000) and another one hundred thousand dollars per year to run the sites for three years.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4310","MCI-00071","Other module","MCI-00071","Other module","Bridge the funding gap for capacity building activities of MOH. Most of the personnel involved in the NMCP have been newly recruited (since 2016) and are responsible for the various positions within the NMCP, however they have not received any training.",244858.04,null,"Active","a6Q1R000000AJ6y",0,0,0,0,244858.04,0,null,null,"Bridge the funding gap for capacity building activities of MOH. Most of the personnel involved in the NMCP have been newly recruited (since 2016) and are responsible for the various positions within the NMCP, however they have not received any training.","Low","While acknowledged that MOH capacity is a challenge, it is unclear what specific capacity is going to be strengthened with this PAAR request.","NA Original Module: RSSH. Original Intervention: MOH capacity strengthening","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2020-12-31","Malaria"]
["CT Eritrea","Eritrea","PAI-4229","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.",270000,null,"Active","a6Q1R000000AJ5f",0,0,0,0,270000,0,null,null,"As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","High","Routine data collection will assist with ongoing monitoring of the program. The newly upgraded District Health Information System (DHIS - 2 ) system is expected to be rolled out to the lowest health facility using this funding.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Côte d'Ivoire","Côte d'Ivoire","PAI-3957","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Pilot project for the use of new technologies in the active search for TB and among contact cases With regard to contact cases, a pilot project is planned for Abidjan with the use of awarenessraising/educational videos on tablets during surveys of patient contacts, and registration of all contact cases on an electronic database.",90501.1,null,"Active","a6Q1R000000AJ1H",0,0,0,0,90501.1,0,null,null,"Pilot project for the use of new technologies in the active search for TB and among contact cases With regard to contact cases, a pilot project is planned for Abidjan with the use of awarenessraising/educational videos on tablets during surveys of patient contacts, and registration of all contact cases on an electronic database.","Medium","A pilot project on community motivation ? aimed at case contacts","NA Original Intervention: Key populations","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Côte d'Ivoire","Côte d'Ivoire","PAI-3956","MCI-00008","TB care and prevention","MCI-00132","Collaborative activities with other programs and sectors (TB care and prevention)","Involvement of practitioners of traditional medicine in the treatment of tuberculosis: The funding for 2016-17 is intended to be used for capacity building for the technical and operational capabilities of 50 leading practitioners of traditional medicine and 400 practitioners from 20 health districts in relation to tuberculosis. The 2018-2020 funding above allocation amount aims to ensure their mentoring and the collection and management of data. The funding above allocation amount provides for the extension of this strategy to 50 new traditional leaders and 400 new practitioners of traditional medicine per year.",95015.08,null,"Active","a6Q1R000000AJ1G",0,0,0,0,95015.08,0,null,null,"Involvement of practitioners of traditional medicine in the treatment of tuberculosis: The funding for 2016-17 is intended to be used for capacity building for the technical and operational capabilities of 50 leading practitioners of traditional medicine and 400 practitioners from 20 health districts in relation to tuberculosis. The 2018-2020 funding above allocation amount aims to ensure their mentoring and the collection and management of data. The funding above allocation amount provides for the extension of this strategy to 50 new traditional leaders and 400 new practitioners of traditional medicine per year.","Medium","Engaging all care providers, including traditional healers, was recommended by the previous TRP. However this item is assigned medium priority because no sufficient evidence in provided in the FR regarding the role of the practitioners of traditional medicine in referral and counterreferral of patients and any related targets are not specified.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Burkina Faso","Burkina Faso","PAI-3872","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Acquiring complete office computers for electronic registration of TB patients in 20 CDT. this will include complete office computers: monitor, central unit, uninterruptable power supply and printer. and will be allocated to the 20 TTCs with the highest numbers of patients that will take part in this electronic registration pilot phase.",33360.519999999997,null,"Active","a6Q1R000000AIzu",0,0,0,0,33360.519999999997,0,null,null,"Acquiring complete office computers for electronic registration of TB patients in 20 CDT. this will include complete office computers: monitor, central unit, uninterruptable power supply and printer. and will be allocated to the 20 TTCs with the highest numbers of patients that will take part in this electronic registration pilot phase.","Medium","The benefit of this electronic registration: minimising duplications, the activity report is generated more quickly and with a higher quality, it provides a greater opportunity for registering patient data.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Haiti","Haiti","PAI-4442","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Sign contracts with 23 new radio stations to broadcast messages on eliminating malaria in towns bordering areas in stratum 3\nexpected results: increase efforts againts progression of malaria; 2/ populations in towns bordering red areas are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localities\nimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.",8280,null,"Active","a6Q1R000000AJ96",0,0,0,0,8280,0,null,null,"Sign contracts with 23 new radio stations to broadcast messages on eliminating malaria in towns bordering areas in stratum 3\nexpected results: increase efforts againts progression of malaria; 2/ populations in towns bordering red areas are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localities\nimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.","Low","This request is meant to support broadcasting of mass media messages via radio. The contribution to impact of this additional request is not well substantiated and only 30% of the original request is being recommended under PAAR.","NA Original Module: Specific prevention interventions. Original Intervention: Information, education, communication/Behavior change communications (specific prevention interventions)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Latin America and Caribbean","2020-12-31","Malaria"]
["CT Lao (Peoples Democratic Republic)","Lao (Peoples Democratic Republic)","PAI-4674","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Current limitation in access and offer of services by the primary health care network requires reaching more vulnerable and isolated populations by mobile active case finding teams equipped with portables digital X-ray and GeneXpert for using efficient diagnosis algorithm. Provinces and districts health staffs who participated in outreach camps, are aware of local TB epidemics, and learned how to conduct TB screening themselves if provided with portable digital X-ray and technical support at start. 2 additional provincial teams will be established in high TB burden provinces with demonstrated management capacity. Including equipment per team (1 portable digital X-ray system, 1 GeneXpert 4 modules machine, 1 pickup car, 20% PSM). In average, one team in one site (6 days including travel and installation) can screen 600 persons, test 150 presumptive TB patients by Xpert and start on treatment 30 new TB patients (15 bacteriologically confirmed and 15 clinical TB) x 12 sites x 2 teams. Total 720 additional new TB patients each year can be diagnosed and started on treatment, over 10% additional notification of new TB cases above the allocation targets each year in 2018-20.",818472,null,"Active","a6Q1R000000AJCq",9903,659259,0,0,149310,0,null,null,"Current limitation in access and offer of services by the primary health care network requires reaching more vulnerable and isolated populations by mobile active case finding teams equipped with portables digital X-ray and GeneXpert for using efficient diagnosis algorithm. Provinces and districts health staffs who participated in outreach camps, are aware of local TB epidemics, and learned how to conduct TB screening themselves if provided with portable digital X-ray and technical support at start. 2 additional provincial teams will be established in high TB burden provinces with demonstrated management capacity. Including equipment per team (1 portable digital X-ray system, 1 GeneXpert 4 modules machine, 1 pickup car, 20% PSM). In average, one team in one site (6 days including travel and installation) can screen 600 persons, test 150 presumptive TB patients by Xpert and start on treatment 30 new TB patients (15 bacteriologically confirmed and 15 clinical TB) x 12 sites x 2 teams. Total 720 additional new TB patients each year can be diagnosed and started on treatment, over 10% additional notification of new TB cases above the allocation targets each year in 2018-20.","High","High impact intervention","NA Original Intervention: Case detection and diagnosis: mobile active case finding (ACF) teams outreach","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2020-12-31","Tuberculosis"]
["CT Lao (Peoples Democratic Republic)","Lao (Peoples Democratic Republic)","PAI-4673","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","The fundiing will support the strengthening of lower level management needed to enable ownership and sustainability at the lower levels.  Management structures are the District Committee for the Control of AIDS,and Provincial Committee for the Control of AIDS through capacity building, staffing.",344882,null,"Active","a6Q1R000000AJCp",0,0,0,0,344882,0,null,null,"The fundiing will support the strengthening of lower level management needed to enable ownership and sustainability at the lower levels.  Management structures are the District Committee for the Control of AIDS,and Provincial Committee for the Control of AIDS through capacity building, staffing.","Low","To show its commitment, the government should finance these activities","NA Original Intervention: Strengthening of Districtl Committee for the Control of AIDS and Provincial Committee for the Control of AIDS through capacity building, staffing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2020-12-31","HIV/AIDS"]
["CT Ghana","Ghana","PAI-4276","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Current death rates among the MDR cohort will reduce from 25%-15% as MDR treatment adherence and end-of-life care with reduced transmission of MDR/XDR TB will improve by the $1.1million refurbishment of a health facility with 20-bed isolation rooms, pediatric wards, and negative pressure airflow facilities treating 180 patients/year. MoH will provide of beds, equipment, staffing, maintenance costs and running costs.",1100000,null,"Active","a6Q1R000000AJ6Q",0,0,0,0,1100000,0,null,null,"Current death rates among the MDR cohort will reduce from 25%-15% as MDR treatment adherence and end-of-life care with reduced transmission of MDR/XDR TB will improve by the $1.1million refurbishment of a health facility with 20-bed isolation rooms, pediatric wards, and negative pressure airflow facilities treating 180 patients/year. MoH will provide of beds, equipment, staffing, maintenance costs and running costs.","High","1. In view of the burden of childhood TB in the country, the applicant is encouraged to devote one ward to pediatric patients and adapt it to their specific needs. \n2. Applicant should ensure that adequate infection control measures are incorporated in the design and operation of the Center of Excellence including the laboratory to reduce the risk of transmission from DR-TB patients and their samples to staff and visitors to the facility and dissemination of Mycobacterium tuberculosis to the environment.","TRP June Retreat 2019 Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Albania","Albania","PAI-3597","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Evaluate pilot of PREP for MSM to assess its impact",10100,null,"Active","a6Q1R000000AIvT",0,0,0,0,10100,0,null,null,"Evaluate pilot of PREP for MSM to assess its impact","Low","Within this module, this activity is of lower priority compared to other activities.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Eastern Europe and Central Asia","2022-12-31","TB/HIV"]
["CT Afghanistan","Afghanistan","PAI-3547","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Based on the Malaria  Program  Review recommendation, National Strategy was revised  in  March  2017, it stratified the country into 3 categories with category 1 consisting of high malaria endemicity provinces. LLINs is the only vector control measure used.  \nFunding was requested to procure LLINs  to  cover  category  1  districts  but  not  all  districts were covered.  Therefore, funds are needed to procure more LLINs. Distribution will   be   done   as   per   WHO   recommendation. No. of LLINs required = 1,615,363.",4846090,null,"Inactive","a6Q1R000000AIuf",0,4846090,0,0,0,1,null,null,"Based on the Malaria  Program  Review recommendation, National Strategy was revised  in  March  2017, it stratified the country into 3 categories with category 1 consisting of high malaria endemicity provinces. LLINs is the only vector control measure used.  \nFunding was requested to procure LLINs  to  cover  category  1  districts  but  not  all  districts were covered.  Therefore, funds are needed to procure more LLINs. Distribution will   be   done   as   per   WHO   recommendation. No. of LLINs required = 1,615,363.","High","It was already noted in the Program Continuation Request that not all Category 1 (high endemicity) districts were covered by LLINs, due to budget limitations ? the shortfall to cover all districts is now covered through this PAAR.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Afghanistan","Afghanistan","PAI-3546","MCI-00012","Case management","MCI-00154","Facility-based treatment","To focus on enhancing case confirmation and reduction of  clinical  malaria  cases  specifically  in  high  burden  province  bordering Pakistan,  it  is  needed  to  distribute RDT and have a regular coordination meeting with   health   facilities   staff   and   Community   Health   Supervisors to  share  the  surveillance  gaps, guidance on improvement of ?on the spot data quality?, and review the implementation of malaria case management    by    conducting    Biannual meetings with staff from   7   high-risk   malaria   provinces   bordering  Pakistan.",100044,null,"Active","a6Q1R000000AIue",0,0,0,0,100044,0,null,null,"To focus on enhancing case confirmation and reduction of  clinical  malaria  cases  specifically  in  high  burden  province  bordering Pakistan,  it  is  needed  to  distribute RDT and have a regular coordination meeting with   health   facilities   staff   and   Community   Health   Supervisors to  share  the  surveillance  gaps, guidance on improvement of ?on the spot data quality?, and review the implementation of malaria case management    by    conducting    Biannual meetings with staff from   7   high-risk   malaria   provinces   bordering  Pakistan.","High","Border issues with Pakistan to\nbe addressed particularly by\nmanaging the cases on the spot\nby RDTs",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2020-12-31","Malaria"]
["CT Cabo Verde","Cabo Verde","PAI-4095","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","A study is expected to be conducted on the impact of HIV within individuals, families and Cape Verdean society in general.",27610.82,null,"Active","a6Q1R000000AJ3V",0,0,0,0,27610.82,0,null,null,"A study is expected to be conducted on the impact of HIV within individuals, families and Cape Verdean society in general.","Low","The TRP considers this activity of low priority, as\nthe information can be obtained through routine\nhealth system reports and records.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Survey (HIV component)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH"," Central Africa",null,"Multi-component"]
["CT Comoros","Comoros","PAI-4080","MCI-00012","Case management","MCI-00154","Facility-based treatment","\"Development and dissemination of algorithms at all levels:\nThrough its supervision and monitoring activities, the program has noted that some health care providers are experiencing difficulties in correctly managing cases. One of the reasons for this is the lack of knowledge and the lack of a malaria treatment protocol.\nTo address this, the program intends to produce and disseminate treatment algorithms in all health care facilities.\"",5719.9,null,"Active","a6Q1R000000AJ3G",0,0,0,0,5719.9,0,null,null,"\"Development and dissemination of algorithms at all levels:\nThrough its supervision and monitoring activities, the program has noted that some health care providers are experiencing difficulties in correctly managing cases. One of the reasons for this is the lack of knowledge and the lack of a malaria treatment protocol.\nTo address this, the program intends to produce and disseminate treatment algorithms in all health care facilities.\"","Low","This activity is for material\ndevelopment for case\nmanagement algorithms. Since it\nmay not be covered in material\ndevelopment for IEC, it may be\nfunded.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-12-31","Malaria"]
["CT Benin","Benin","PAI-3797","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Monitor the care provided at each facility on a quarterly basis: \nOne medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.",243274.6,null,"Active","a6Q1R000000AIyh",0,0,0,0,243274.6,0,null,null,"Monitor the care provided at each facility on a quarterly basis: \nOne medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.","Low",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3796","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Exchange and working visit with the sex workers? network of Côte d?Ivoire",16821.91,null,"Active","a6Q1R000000AIyg",0,0,0,0,16821.91,0,null,null,"Exchange and working visit with the sex workers? network of Côte d?Ivoire","Low",null,"NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Lao (Peoples Democratic Republic)","Lao (Peoples Democratic Republic)","PAI-4670","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Allocation funding will reach female sex workers with prevention packages in 5 priority provinces only, leaving a 27% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address a 39% gap in condom supply.",549986,null,"Active","a6Q1R000000AJCm",0,0,0,0,549986,0,null,null,"Allocation funding will reach female sex workers with prevention packages in 5 priority provinces only, leaving a 27% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address a 39% gap in condom supply.","High","Essential services for key populations in this concentrated epidemic","NA Original Intervention: Expansion to other provinces, condom programming","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2020-12-31","HIV/AIDS"]
["CT Cambodia","Cambodia","PAI-4646","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","eMTCT Roadmap implementation\nIn 2018 the MoH launched the national roadmap for elimination of Mother To Child Transmission (MTCT) of HIV & syphilis. The suggested intervention will support enhanced service delivery, including HIV testing and treatment, to reach the global impact indicators.  \nExpected:\n- Coverage of pregnant women who know their status of ? 95%\n- Antiretroviral treatment coverage of HIV-positive pregnant women of ? 95%\n- Antenatal coverage (at least one visit) of ? 95%\n- Infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth of ? 90%\n- Coverage of syphilis testing of pregnant women of ? 95\n- Treatment of syphilis-seropositive pregnant women ? 95%",285000,null,"Active","a6Q1R000000AJCO",0,0,0,0,285000,0,null,null,"eMTCT Roadmap implementation\nIn 2018 the MoH launched the national roadmap for elimination of Mother To Child Transmission (MTCT) of HIV & syphilis. The suggested intervention will support enhanced service delivery, including HIV testing and treatment, to reach the global impact indicators.  \nExpected:\n- Coverage of pregnant women who know their status of ? 95%\n- Antiretroviral treatment coverage of HIV-positive pregnant women of ? 95%\n- Antenatal coverage (at least one visit) of ? 95%\n- Infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth of ? 90%\n- Coverage of syphilis testing of pregnant women of ? 95\n- Treatment of syphilis-seropositive pregnant women ? 95%","High",null,"NA Original Module: Prevention of mother -to -child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4325","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Nutritional support for people living with HIV. According to the vulnerability study carried out in December 2016, 23% of the patients on ART are malnourished. Therefore, this nutritional support forms an integral part of the optimum health care package for these patients. The amount requested will allow health care for 2,730 PLHIV for 180 days per year, in accordance with the specified inclusion criteria.",340003.37,null,"Active","a6Q1R000000AJ7D",0,0,0,0,340003.37,0,null,null,"Nutritional support for people living with HIV. According to the vulnerability study carried out in December 2016, 23% of the patients on ART are malnourished. Therefore, this nutritional support forms an integral part of the optimum health care package for these patients. The amount requested will allow health care for 2,730 PLHIV for 180 days per year, in accordance with the specified inclusion criteria.","High","This intervention is a priority if the nutrition support is part of a comprehensive support program for people living with HIV on ART (e.g. included in home-based care) but not as a stand-alone intervention.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4324","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Develop and reproduce communication materials (leaflets, posters and charter of the patient). This amount is planned to renew the reproduction of the communication materials to be used for advocacy and BCC among the populations.",5254.18,null,"Active","a6Q1R000000AJ7C",0,0,0,0,5254.18,0,null,null,"Develop and reproduce communication materials (leaflets, posters and charter of the patient). This amount is planned to renew the reproduction of the communication materials to be used for advocacy and BCC among the populations.","High","Communication material is important, but seems underfunded","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Cambodia","Cambodia","PAI-4632","MCI-00531","Comprehensive prevention programs for TGs","MCI-00554","Behavioral interventions for TGs","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Transgender (TG).  \nProlonging the working hours of outreach workers until midnight will allow for greater reach and will offer HIV and syphilis testing to TGs. \nExpected outcome:  177 TGs reached with defined package of services",45000,null,"Inactive","a6Q1R000000AJCA",0,45000,0,0,0,1,null,null,"Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Transgender (TG).  \nProlonging the working hours of outreach workers until midnight will allow for greater reach and will offer HIV and syphilis testing to TGs. \nExpected outcome:  177 TGs reached with defined package of services","High",null,"NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Afghanistan","Afghanistan","PAI-3542","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00094","Condoms and lubricant programming for PWID","There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.",172108,null,"Active","a6Q1R000000AIua",0,0,0,0,172108,0,null,null,"There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.","High","The TRP considers this intervention to be an important additional activity that builds and scales up harm reduction and HIV testing and counselling activities in Section 3 of the Applicant Self Assessment for Programme Continuation. As part of efforts to maximize impact towards ending the epidemic, the applicant proposes to use a dedicated mobile team to reach out to catchment areas that are missed by existing outreach teams in the major cities as well as out of reach non-urban areas in need of services","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Condoms and lubricant programming for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2020-12-31","HIV/AIDS"]
["CT Cuba","Cuba","PAI-4115","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","The national storage network and distribution management require maintaining appropriate standards that guarantee the preservation and quality of medicines and reagents used for the care, diagnosis and treatment of HIV; this requires covering the demand for warehouse infrastructure and means of transportation used for these purposes and reinforcing the infrastructure. Likewise, the improvements to logistics and to the conditions of the importing company will have a beneficial impact on supply chain management flow.",250000,null,"Active","a6Q1R000000AJ3p",0,0,0,0,250000,0,null,null,"The national storage network and distribution management require maintaining appropriate standards that guarantee the preservation and quality of medicines and reagents used for the care, diagnosis and treatment of HIV; this requires covering the demand for warehouse infrastructure and means of transportation used for these purposes and reinforcing the infrastructure. Likewise, the improvements to logistics and to the conditions of the importing company will have a beneficial impact on supply chain management flow.","Medium","Will ensure a beneficial impact on supply chain management flow.","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Cuba","Cuba","PAI-4114","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","HIV prevention indicator surveys are expensive and may not have enough resources so that they can be performed periodically.",175000,null,"Inactive","a6Q1R000000AJ3o",175000,0,0,0,0,1,null,null,"HIV prevention indicator surveys are expensive and may not have enough resources so that they can be performed periodically.","Medium","Prevention surveys are important to monitor, yet since they are already fully integrate in the health structure, should also be part of the regular flow.","NA Original Module: Strengthening community response and systems. Original Intervention: Monitoring by the community","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Cabo Verde","Cabo Verde","PAI-4094","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","These interventions are intended to improve the psychological support provided to vulnerable children and orphans within the ICCA drop-in centre in Praia.",14654.92,null,"Active","a6Q1R000000AJ3U",0,0,0,0,14654.92,0,null,null,"These interventions are intended to improve the psychological support provided to vulnerable children and orphans within the ICCA drop-in centre in Praia.","Low","These activities should be possible to fund from\nsavings in existing budgets for psychological\nsupport and assistance to the orphan home.","NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH"," Central Africa",null,"Multi-component"]
["CT Comoros","Comoros","PAI-4079","MCI-00012","Case management","MCI-00162","Ensuring drug and other health product quality","\"Slide exchanges with internal and external laboratories for quality assurance: \nAccording to World Health Organization recommendations, slide quality control is essential in a country that is moving toward elimination, as is the case for the Union of the Comoros.  A correct reading of the slides is of paramount importance to avoid any misdiagnosis that may lead to the spread of the disease. Indeed, a positive slide read as negative may lead to an epidemic and undermine all efforts made so far toward eliminating the disease. \nAs a result, the training supervision of quality control officials has been included in the budget to enable continuous training on the theoretical and practical aspects of quality diagnosis. The NMCP requests funding under the PAAR for the following: the exchange of slides internally (from the islands to the NMCP reference laboratory) and from the NMCP laboratory to an external accredited laboratory. This would ensure that these slides are read correctly to avoid this kind of situation and would also be a means of assessing other laboratories in the country from which the NMCP collects data, in order to ensure reliable results and avoid any step that might hinder the elimination process.\"",12126.59,null,"Active","a6Q1R000000AJ3F",0,0,0,0,12126.59,0,null,null,"\"Slide exchanges with internal and external laboratories for quality assurance: \nAccording to World Health Organization recommendations, slide quality control is essential in a country that is moving toward elimination, as is the case for the Union of the Comoros.  A correct reading of the slides is of paramount importance to avoid any misdiagnosis that may lead to the spread of the disease. Indeed, a positive slide read as negative may lead to an epidemic and undermine all efforts made so far toward eliminating the disease. \nAs a result, the training supervision of quality control officials has been included in the budget to enable continuous training on the theoretical and practical aspects of quality diagnosis. The NMCP requests funding under the PAAR for the following: the exchange of slides internally (from the islands to the NMCP reference laboratory) and from the NMCP laboratory to an external accredited laboratory. This would ensure that these slides are read correctly to avoid this kind of situation and would also be a means of assessing other laboratories in the country from which the NMCP collects data, in order to ensure reliable results and avoid any step that might hinder the elimination process.\"","Low","Confirmation of slides for quality\nassurance is important. Given\nthat training for microscopy is\nprioritized, this intervention is\njustified.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-12-31","Malaria"]
["CT Côte d'Ivoire","Côte d'Ivoire","PAI-3949","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Strengthen nutritional monitoring among people living with HIV/AIDS and orphans and vulnerable children This intervention will provide nutritional support to 671 households of orphans and vulnerable children experiencing food insecurity. Moreover, 2 additional post-distribution evaluations will be done during 2019-2020 in order to quantify the impact of this nutritional assistance. Tools to raise awareness will be produced in order to increase the impact of nutritional interventions included in the within-allocation demand, with a view to more patient adherence to the program.",629775.18000000005,null,"Inactive","a6Q1R000000AJ19",629775.18000000005,0,0,0,0,1,null,null,"Strengthen nutritional monitoring among people living with HIV/AIDS and orphans and vulnerable children This intervention will provide nutritional support to 671 households of orphans and vulnerable children experiencing food insecurity. Moreover, 2 additional post-distribution evaluations will be done during 2019-2020 in order to quantify the impact of this nutritional assistance. Tools to raise awareness will be produced in order to increase the impact of nutritional interventions included in the within-allocation demand, with a view to more patient adherence to the program.","Medium","Provide nutritional support to 671 households of orphans and vulnerable children experiencing food insecurity. This is a WHO recommendation which can directly improve treatment outcomes. However, this is medium priority because the applicant does not provide any justification on adequacy of the targets set.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 1","2020-12-31","HIV/AIDS"]
["CT Burkina Faso","Burkina Faso","PAI-3869","MCI-00008","TB care and prevention","MCI-00128","Prevention","Broadcasting each of the adverts 3 times per week and per language (French, Mossi, Dyula and Fula) on the 3 television channels. In fact, the radio adverts will be broadcast from 2018 until the first quarter of 2019, so that the KAP survey planned for the second quarter of 2019 will be used to measure their impact, among other things.",400326.23,null,"Active","a6Q1R000000AIzr",0,0,0,0,400326.23,0,null,null,"Broadcasting each of the adverts 3 times per week and per language (French, Mossi, Dyula and Fula) on the 3 television channels. In fact, the radio adverts will be broadcast from 2018 until the first quarter of 2019, so that the KAP survey planned for the second quarter of 2019 will be used to measure their impact, among other things.","Medium","TV adverts were chosen because they constitute an efficient manner of reaching a large number of people among the urban population, The review of the directives of the NTBCP involves updating these adverts.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Benin","Benin","PAI-3793","MCI-00023","Program management","MCI-00207","Grant management","Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):\nThis will motivate actors at the peripheral level.",92382.45,null,"Active","a6Q1R000000AIyd",0,0,0,0,92382.45,0,null,null,"Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):\nThis will motivate actors at the peripheral level.","Low","This is not instrumental in delivery of other activities therefore it is a low priority rating",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Cambodia","Cambodia","PAI-4666","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","A local lab consultant and lab technician will be recruited to ensure the quality of TB, maintenance lab equipment and support GeneXpert troubleshooting. Recruitment of one full time effort WHO Medical Office and short term TA will assist the program to ensure quality services. TRP only recommends 20% of the request.",180862,null,"Active","a6Q1R000000AJCi",0,0,0,0,180862,0,null,null,"A local lab consultant and lab technician will be recruited to ensure the quality of TB, maintenance lab equipment and support GeneXpert troubleshooting. Recruitment of one full time effort WHO Medical Office and short term TA will assist the program to ensure quality services. TRP only recommends 20% of the request.","Low","The TRP considers the support of a lab consultant, lab technician, maintenance of lab equipment, Gx troubleshooting, one fulltime WHO staff, and short-term technical assistance of this request to be relevant.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4320","MCI-00071","Other module","MCI-00071","Other module","Elaborate a combination prevention plan for vulnerable populations. It is essential to have a national strategy, which is adapted through a plan, to guide the various interventions by stakeholders. The funds will be used to recruit an international consultant to propose and adapt the plan and to have it approved by all stakeholders at national level.",20614.97,null,"Active","a6Q1R000000AJ78",0,0,0,0,20614.97,0,null,null,"Elaborate a combination prevention plan for vulnerable populations. It is essential to have a national strategy, which is adapted through a plan, to guide the various interventions by stakeholders. The funds will be used to recruit an international consultant to propose and adapt the plan and to have it approved by all stakeholders at national level.","High","This intervention is important, but it is crucial that it be integrated in a comprehensive plan for combination prevention","NA Original Module: Prevention. Original Intervention: Vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4319","MCI-00007","Treatment, care and support","MCI-00117","HIV care","The TB/HIV/HSS performance framework foresees that 12,000 patients will be treated with ARVs in 2018, 13,000 in 2019, and 14,000 in 2020. Nevertheless, in the PUDR, as at 31 December 2017, 11,985 ARV-treated patients had been monitored, which represents 99.8% of the 2018 target. This situation presents a risk of premature stock-outs of ARVs with the inclusion of a significant number of patients not being specified in the approved quantification.\nAlso, it is important to consider the fact that the country is under a ?treat everyone? strategy which requires the testing of persons within the general population as well as the priority populations included in the quantification. In fact, the historical data for 2013 to 2017 reveals that, since 2013, the ARV coverage is low as it was less than one-third of what was required due to, among other things, insufficient access to testing and problems with retaining the patients. Nevertheless, over that same period, there was an increase in the proportion of patients on ART from 16% to 28%. Notwithstanding this growth, beginning in 2018, and considering the budgetary constraints, the country has been obliged to adjust its ?patient cohort? targets to match the available funds, i.e., 27.6% in 2018, 29.3% in 2019, and 31.1% in 2020, with respect to the requirements estimated by Spectrum 2018 and in contrast with the NSP targets for the same years, of 66%, 78%, and 90%. \nConsidering the number of ART patients as at 30 June 2018 (13,103), as well as the capacity of the current health structures, the country decided to increase the performance framework targets approved under the current grant to 14,035, 16,063, and 18,080 (PLHIV on ART) for 2018, 2019, and 2020, respectively. In fact, for the purpose of health care decentralization and delegation of tasks, 24 treatment centers and 118 outpatient treatment units (former PMTCT sites) initiated ART. In addition, the Differentiated Approach for Services includes community ART and this will help to reinforce the enrolment capacity and retention of HIV+ patients within the health care circuit. As a result of these new targets, additional purchases of ARV drugs are required in order to treat 2,035, 3,063, and 4,080 patients, respectively, which represents 16.9% in 2018, 23.6% in 2019, and 29.1% in 2020. \nThe purpose of the requested amount is to avoid a stock-out in the ARV treatment of patients and to facilitate the treatment of persons who test positive under the coverage plan with a 90-90-90 strategy.",1082666.1100000001,null,"Inactive","a6Q1R000000AJ77",0,1082666.1100000001,0,0,0,1,null,null,"The TB/HIV/HSS performance framework foresees that 12,000 patients will be treated with ARVs in 2018, 13,000 in 2019, and 14,000 in 2020. Nevertheless, in the PUDR, as at 31 December 2017, 11,985 ARV-treated patients had been monitored, which represents 99.8% of the 2018 target. This situation presents a risk of premature stock-outs of ARVs with the inclusion of a significant number of patients not being specified in the approved quantification.\nAlso, it is important to consider the fact that the country is under a ?treat everyone? strategy which requires the testing of persons within the general population as well as the priority populations included in the quantification. In fact, the historical data for 2013 to 2017 reveals that, since 2013, the ARV coverage is low as it was less than one-third of what was required due to, among other things, insufficient access to testing and problems with retaining the patients. Nevertheless, over that same period, there was an increase in the proportion of patients on ART from 16% to 28%. Notwithstanding this growth, beginning in 2018, and considering the budgetary constraints, the country has been obliged to adjust its ?patient cohort? targets to match the available funds, i.e., 27.6% in 2018, 29.3% in 2019, and 31.1% in 2020, with respect to the requirements estimated by Spectrum 2018 and in contrast with the NSP targets for the same years, of 66%, 78%, and 90%. \nConsidering the number of ART patients as at 30 June 2018 (13,103), as well as the capacity of the current health structures, the country decided to increase the performance framework targets approved under the current grant to 14,035, 16,063, and 18,080 (PLHIV on ART) for 2018, 2019, and 2020, respectively. In fact, for the purpose of health care decentralization and delegation of tasks, 24 treatment centers and 118 outpatient treatment units (former PMTCT sites) initiated ART. In addition, the Differentiated Approach for Services includes community ART and this will help to reinforce the enrolment capacity and retention of HIV+ patients within the health care circuit. As a result of these new targets, additional purchases of ARV drugs are required in order to treat 2,035, 3,063, and 4,080 patients, respectively, which represents 16.9% in 2018, 23.6% in 2019, and 29.1% in 2020. \nThe purpose of the requested amount is to avoid a stock-out in the ARV treatment of patients and to facilitate the treatment of persons who test positive under the coverage plan with a 90-90-90 strategy.","High",null,"Grant revision: PO recommanded at the GAC meeting of the 24/01/2019","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Guinea","Guinea","PAI-4294","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Advocacy platform bringing together the TB and HIV programs, the government, elected members, TFPs and representatives from the various sectors; advocacy before the government and the partners in order to mobilise resources and to achieve the adoption of legislation beneficial to the effort to combat tuberculosis.",6069,null,"Active","a6Q1R000000AJ6i",0,0,0,0,6069,0,null,null,"Advocacy platform bringing together the TB and HIV programs, the government, elected members, TFPs and representatives from the various sectors; advocacy before the government and the partners in order to mobilise resources and to achieve the adoption of legislation beneficial to the effort to combat tuberculosis.","Low","Implementation of a ?TB TEAM? platform is of low priority","NA Original Intervention: Implementation of a ?TB TEAM? platform","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Western Africa","2020-12-31","Tuberculosis"]
["CT Eritrea","Eritrea","PAI-4221","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","As part of this module, ARV providing sites will be scaled up to improve access and reduce transport cost and increase retention. More CD4 and viral load point of care machines will be procured. Additional equipment and reagents to strengthen the existing molecular laboratory, will be procured. To enhance the care and support activities positive living training for new Bidho members, support IGA activities to PLHIV and long term economic support will be supported.",515000,null,"Active","a6Q1R000000AJ5X",0,0,0,0,515000,0,null,null,"As part of this module, ARV providing sites will be scaled up to improve access and reduce transport cost and increase retention. More CD4 and viral load point of care machines will be procured. Additional equipment and reagents to strengthen the existing molecular laboratory, will be procured. To enhance the care and support activities positive living training for new Bidho members, support IGA activities to PLHIV and long term economic support will be supported.","High","This request will expand access to ART by increasing ART sites. More CD4 and VL point of care machines will be procured. Additional equipment and reagents to strengthen the existing molecular laboratory, will be procured. To enhance the care and support activities positive living training for new Bidho members, support IGA activities to people living with HIV and long term economic support will be supported.","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Honduras","Honduras","PAI-4417","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Contracting a coordinator and workers for organizations that intervene in prisoners population",120292.8,null,"Active","a6Q1R000000AJ8h",0,0,0,0,120292.8,0,null,null,"Contracting a coordinator and workers for organizations that intervene in prisoners population","Low","TRP recommends that the applicant further develop an efficient coordination structure for implementation of the key populations programs, avoiding when possible to have coordinators and staff for each key population sub-groups. The TRP furthermore recommends the applicant to consider integrating the roles of coordinator for key populations in only one position and including that position within-allocation if efficiencies are found during grant-making.","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-07-31","HIV/AIDS"]
["CT Honduras","Honduras","PAI-4416","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Contracting a coordinator and workers for organizations that intervene in the Garifuna population",102570,null,"Active","a6Q1R000000AJ8g",0,0,0,0,102570,0,null,null,"Contracting a coordinator and workers for organizations that intervene in the Garifuna population","Low","TRP recommends that the applicant further develop an efficient coordination structure for implementation of the key populations programs, avoiding when possible to have coordinators and staff for each key population sub-groups. The TRP furthermore recommends the applicant to consider integrating the roles of coordinator for key populations in only one position and including that position within-allocation if efficiencies are found during grant making.","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-07-31","HIV/AIDS"]
["CT Honduras","Honduras","PAI-4411","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Contracting a coordinator and workers for organizations that intervene in the MSM population",36196.46,null,"Active","a6Q1R000000AJ8b",0,0,0,0,36196.46,0,null,null,"Contracting a coordinator and workers for organizations that intervene in the MSM population","Low","TRP recommends that the applicant further develop an efficient coordination structure for implementation of the key populations programs, avoiding when possible to have coordinators and staff for each key population sub-groups. The TRP furthermore recommends the applicant to consider integrating the roles of coordinator for key populations in only one position and including that position within-allocation if efficiencies are found during grant-making.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-07-31","HIV/AIDS"]
["CT Cabo Verde","Cabo Verde","PAI-4105","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","These interventions are  directed  towards: 1)  150 vulnerable children and adolescents who are received at day centres by facilitators from ICCA; 2) 80 vulnerable youths and adolescents in Praia with training and psychological support; 3) 620 peer educators within 21 secondary schools and, additionally, the coordination and follow-up of the activities performed by peer educators. These will supplement activities considered in the allocation amount.",141119.96,null,"Active","a6Q1R000000AJ3f",0,0,0,0,141119.96,0,null,null,"These interventions are  directed  towards: 1)  150 vulnerable children and adolescents who are received at day centres by facilitators from ICCA; 2) 80 vulnerable youths and adolescents in Praia with training and psychological support; 3) 620 peer educators within 21 secondary schools and, additionally, the coordination and follow-up of the activities performed by peer educators. These will supplement activities considered in the allocation amount.","High","Adolescents are an important risk group and\ntraining of peer mentors is a key strategy in\npreventing HIV infection. For this reason, the TRP\nconsiders this intervention of high priority.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH"," Central Africa",null,"Multi-component"]
["CT Comoros","Comoros","PAI-4071","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Holding youth training days on counseling and screening: \nThe grant allocation amount will cover training for 70 young people in the first year. \nThis two-day session will introduce them to different techniques to raise awareness among their peers, counseling strategies, referrals for HIV screening and generally prepare them to lead the awareness-raising sessions. \nThis training will cover only the island of Grande Comore and will provide only partial cover. To cover the remaining islands, we plan to use this above allocation funding request to cover the whole of the island of Grande Comore by organizing two additional training courses for 20 young people each in the second year, three training courses on Mohéli (60 young people) and five training courses on Anjouan (100 young people). These training courses will enable the country to strengthen the peer educator mechanism for young people by adding 200 more young people, who will increase the number of awareness-raising and screening sessions and improve progress towards the first UNAIDS target on testing.",22444.17,null,"Active","a6Q1R000000AJ37",0,0,0,0,22444.17,0,null,null,"Holding youth training days on counseling and screening: \nThe grant allocation amount will cover training for 70 young people in the first year. \nThis two-day session will introduce them to different techniques to raise awareness among their peers, counseling strategies, referrals for HIV screening and generally prepare them to lead the awareness-raising sessions. \nThis training will cover only the island of Grande Comore and will provide only partial cover. To cover the remaining islands, we plan to use this above allocation funding request to cover the whole of the island of Grande Comore by organizing two additional training courses for 20 young people each in the second year, three training courses on Mohéli (60 young people) and five training courses on Anjouan (100 young people). These training courses will enable the country to strengthen the peer educator mechanism for young people by adding 200 more young people, who will increase the number of awareness-raising and screening sessions and improve progress towards the first UNAIDS target on testing.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Comoros","Comoros","PAI-4070","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","Organizing awareness-raising sessions and screening in schools and communities:\nAmong young people aged 15?24, the rate of regular condom use is low, at only 12 percent and the rate of HIV screening among the same group was less than 7 percent in 2014. Of 11 new HIV-positive cases reported in the Union of the Comoros in 2013, almost half were aged between 15 and 24 years.\nThe allocation amount provides for contracting five youth NGOs (FCAS, RNFD, CAP, Stop AIDS, CRCO) to carry out 400 awareness-raising and screening sessions for young people aged 10?24 in schools and communities in the first year, 500 sessions in the second year and 600 sessions in the third year. To contribute to the goal of halving new infections, particularly among young people, this above allocation grant will be used to provide an additional 300 sessions  in the second year and an additional 600 sessions in the third year.",11989.68,null,"Active","a6Q1R000000AJ36",0,0,0,0,11989.68,0,null,null,"Organizing awareness-raising sessions and screening in schools and communities:\nAmong young people aged 15?24, the rate of regular condom use is low, at only 12 percent and the rate of HIV screening among the same group was less than 7 percent in 2014. Of 11 new HIV-positive cases reported in the Union of the Comoros in 2013, almost half were aged between 15 and 24 years.\nThe allocation amount provides for contracting five youth NGOs (FCAS, RNFD, CAP, Stop AIDS, CRCO) to carry out 400 awareness-raising and screening sessions for young people aged 10?24 in schools and communities in the first year, 500 sessions in the second year and 600 sessions in the third year. To contribute to the goal of halving new infections, particularly among young people, this above allocation grant will be used to provide an additional 300 sessions  in the second year and an additional 600 sessions in the third year.","High",null,"NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Burkina Faso","Burkina Faso","PAI-3862","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.",25470.81,null,"Active","a6Q1R000000AIzk",0,0,0,0,25470.81,0,null,null,"Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.","Medium","A customized World Health Organisation (WHO ) software will be used for registering TB patients, including multi -drug resistant TB (MDR /TB ) patients. Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three month s during the first year and every six months in year 2.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Africa 1","2020-12-31","Tuberculosis"]
["CT Benin","Benin","PAI-3788","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","Although prevalence remains low among adolescents and young people aged 15?24, levels of knowledge of prevention measures (61 percent) and access to testing (23.4 percent) remain critical and must be improved. This intervention was not budgeted for within the above allocation amount.\nIt relates to capacity building for young leaders and adolescents to provide quality interventions for other young people and adolescents. This intervention involves\nproviding training to 60 young leaders and adolescents and eight facilitators during three two-day sessions on peer education, the package of interventions that are based on a human rights and gender perspective (intervention strategies and SC/BCC) and data reporting tools.",23782.959999999999,null,"Active","a6Q1R000000AIyY",0,0,0,0,23782.959999999999,0,null,null,"Although prevalence remains low among adolescents and young people aged 15?24, levels of knowledge of prevention measures (61 percent) and access to testing (23.4 percent) remain critical and must be improved. This intervention was not budgeted for within the above allocation amount.\nIt relates to capacity building for young leaders and adolescents to provide quality interventions for other young people and adolescents. This intervention involves\nproviding training to 60 young leaders and adolescents and eight facilitators during three two-day sessions on peer education, the package of interventions that are based on a human rights and gender perspective (intervention strategies and SC/BCC) and data reporting tools.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Cambodia","Cambodia","PAI-4643","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Strengthening and linking HIV health information systems in Cambodia\nTo collate data from contributing databases in a national repository, the existing Master Patient Index (MPI) will be operationalized and the Universal Unique ID Code (U-UIC) will be used as an identifier across databases (B-IACM, ART and VL). At the same time efforts will be made to develop interoperability between the all date bases so clients are followed longitudinally from diagnosis until viral suppression. It is complementary to CDC support through the new PEPFAR ROP19.\nExpected: An integrated HIV information system for patients tracking across the HIV cascade to support sustained HIV epidemic control in Cambodia",500000,null,"Inactive","a6Q1R000000AJCL",0,500000,0,0,0,1,null,null,"Strengthening and linking HIV health information systems in Cambodia\nTo collate data from contributing databases in a national repository, the existing Master Patient Index (MPI) will be operationalized and the Universal Unique ID Code (U-UIC) will be used as an identifier across databases (B-IACM, ART and VL). At the same time efforts will be made to develop interoperability between the all date bases so clients are followed longitudinally from diagnosis until viral suppression. It is complementary to CDC support through the new PEPFAR ROP19.\nExpected: An integrated HIV information system for patients tracking across the HIV cascade to support sustained HIV epidemic control in Cambodia","High",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Guinea","Guinea","PAI-4302","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","The DPSs will supervise activities relating to the combating of TB in the CDTs and Health Centres within their catchment zones.",195636,null,"Active","a6Q1R000000AJ6q",0,0,0,0,195636,0,null,null,"The DPSs will supervise activities relating to the combating of TB in the CDTs and Health Centres within their catchment zones.","High","This will enable the Direction Préfectorale de la Santé (DPS, district health authority) to supervise activities in the centers for the diagnosis and treatment (CDTs) and health centers within their catchment zones.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Decentralised supervision by the DPSs","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Western Africa","2020-12-31","Tuberculosis"]
["CT Guinea","Guinea","PAI-4289","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","3. Request for additional funding for financing the construction of a WIB store for the Central Pharmacy.\nIn addition to the approved contribution, the PCG has asked the GF to finance/take over installation, transport, insurance and contingencies charges. \nThe construction of the WIB warehouse will contribute to improving the efficiency and performance of the medical products supply chain in Guinea which will benefit GF grants.",700000,null,"Active","a6Q1R000000AJ6d",0,0,0,0,700000,0,null,null,"3. Request for additional funding for financing the construction of a WIB store for the Central Pharmacy.\nIn addition to the approved contribution, the PCG has asked the GF to finance/take over installation, transport, insurance and contingencies charges. \nThe construction of the WIB warehouse will contribute to improving the efficiency and performance of the medical products supply chain in Guinea which will benefit GF grants.","High","The TRP considers this as a high priority, given the urgent need to improve the\nsupply chain and the reduced capacity of the Central Medical Warehouse due to a\nfire in 2017.","Amount validated and description updated by CT Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2020-12-31","Malaria"]
["CT Ghana","Ghana","PAI-4284","MCI-00071","Other module","MCI-00071","Other module","The GDHS provides updated estimates on various demographic indices including HIV prevalence among adults. This information is essential for making informed policy decisions and for planning, monitoring and evaluating health programmes and strategies at national and regional levels for improving the health of Ghana?s population. This request includes funds to determine HIV prevalence among children under 15 years of age.",500000,null,"Active","a6Q1R000000AJ6Y",0,0,0,0,500000,0,null,null,"The GDHS provides updated estimates on various demographic indices including HIV prevalence among adults. This information is essential for making informed policy decisions and for planning, monitoring and evaluating health programmes and strategies at national and regional levels for improving the health of Ghana?s population. This request includes funds to determine HIV prevalence among children under 15 years of age.","High","The GDHS provides important updated estimates o f various demographic indices including HIV prevalence among adults including information essential to making informed policy decisions and for planning, monitoring and evaluating health programmes and strategies at national and regional levels. The TRP recommends partial funding of the requested amount for the survey ( see the table below) as implementation should be cost-shared with other health activities and diseases and donors as the survey addresses multiple other health factors.. The Global Fund should not bear all the local costs.","NA Original Module: GDHS 2019. Original Intervention: Study - Ghana Health and Demographic Survey","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Ghana","Ghana","PAI-4271","MCI-00071","Other module","MCI-00071","Other module","Differentiated models of care (DMOC) are an important intervention for achieving 90 90 90.  DMOC, introduced in 2017, will be continued during the 2018-2020 funding cycle with support from EQUIP at 20 existing ART sites. USAID will support 10 facilities in 2017 and 2018 while the Global Fund will support 10 sites in 2018 and all 20 sites in 2019-2020.",1500000,null,"Inactive","a6Q1R000000AJ6L",1500000,0,0,0,0,1,null,null,"Differentiated models of care (DMOC) are an important intervention for achieving 90 90 90.  DMOC, introduced in 2017, will be continued during the 2018-2020 funding cycle with support from EQUIP at 20 existing ART sites. USAID will support 10 facilities in 2017 and 2018 while the Global Fund will support 10 sites in 2018 and all 20 sites in 2019-2020.","High","Differentiated models of care (DMOC) are an important Intervention for achieving 90-90- 90. The USAID will support 10 facilities in 2017 and 2018 while the Global Fund will support 10 sites in 2018 and all 20 sites in 2019-2020.","NA Original Module: ART - Differentiated Models of Care - adults and children. Original Intervention: Training and mentoring in DMOC","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Ghana","Ghana","PAI-4270","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","This request will cover a population of 1,180,463 (203,528 households) in 13 districts UER (2018-2020) recently moved to LLINs but with high pyrethroid resistance and an upsurge of malaria parasitemia among the poor and vulnerable population. There will be no overlap between IRS and ITNs.",24253344,null,"Active","a6Q1R000000AJ6K",0,0,0,0,24253344,0,null,null,"This request will cover a population of 1,180,463 (203,528 households) in 13 districts UER (2018-2020) recently moved to LLINs but with high pyrethroid resistance and an upsurge of malaria parasitemia among the poor and vulnerable population. There will be no overlap between IRS and ITNs.","Low","This introduces IRS back into a population recently moved to LLINS, but with high pyrethroid resistance.","NA Original Intervention: IRS - Upper East (2018-2020)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Gabon","Gabon","PAI-4262","MCI-00009","TB/HIV","MCI-00138","Collaborative activities with other programs and sectors (TB/HIV)","To strengthen the collaboration between the TB and HIV programs and decrease TB / HIV co-infection mortality through TB / HIV coordination meetings at both national and regional levels and the creation of six new single wards for joint management of both TB and HIV pathologies among the 12 new CDTs.",6569.41,null,"Active","a6Q1R000000AJ6C",0,0,0,0,6569.41,0,null,null,"To strengthen the collaboration between the TB and HIV programs and decrease TB / HIV co-infection mortality through TB / HIV coordination meetings at both national and regional levels and the creation of six new single wards for joint management of both TB and HIV pathologies among the 12 new CDTs.","High","?The funding request identifies the following weaknesses in TB/HIV collaboration: inadequate service provider training, stock-outs of reagents, a shortage of one-stop shops and weaknesses in supervision. Strengthening of TB/HIV coordination at the national/regional levels and facilities for joint management of TB and HIV are in line with the efforts to improve TB case finding and adherence to TB treatment among PLHIV and thus are considered high priority.?",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2021-12-31","Tuberculosis"]
["CT Eritrea","Eritrea","PAI-4245","MCI-00009","TB/HIV","MCI-00135","Engaging all care providers (TB/HIV)","In this section heath care workers working in TB clinics will be trained on comprehensive HIV care and treatment and on HIV counselling and testing skills in order to provide a one-stop service.",33840,null,"Active","a6Q1R000000AJ5v",0,0,0,0,33840,0,null,null,"In this section heath care workers working in TB clinics will be trained on comprehensive HIV care and treatment and on HIV counselling and testing skills in order to provide a one-stop service.","High","The above allocation will support the procurement and maintenance cost of a van for transporting MDR-TB patients from diagnostic centres to the MDR hospital in order to reduce transmission. It will also enhance electronic surveillance for the programmatic management of MDRTB.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Middle East and North Africa","2020-12-31","Tuberculosis"]
["CT Dominican Republic","Dominican Republic","PAI-4188","MCI-00004","Prevention programs for other vulnerable populations","MCI-00103","HIV testing services for other vulnerable populations","Community testing for Socially Vulnerable Women resident in Bateyes does not always take place in areas where prevalence is supposed to be higher (Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.",332500,null,"Inactive","a6Q1R000000AJ50",332500,0,0,0,0,1,null,null,"Community testing for Socially Vulnerable Women resident in Bateyes does not always take place in areas where prevalence is supposed to be higher (Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.","High","In light of the difficulties in achieving coverage of socially vulnerable women living in Bateyes with HIV testing efforts and the need to better coordinate in order to close the gap in diagnosing unidentified cases in this population, the TRP considers that additional resources for this population should be considered as high priority.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Dominican Republic","Dominican Republic","PAI-4187","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","The practices of self-care, prevention of HIV and other STIs in Socially-Vulnerable Women Resident in Bateyes and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources would be allocated to increasing the targets that can be reached to improve self-care and prevention practices.",592400,null,"Inactive","a6Q1R000000AJ4z",592400,0,0,0,0,1,null,null,"The practices of self-care, prevention of HIV and other STIs in Socially-Vulnerable Women Resident in Bateyes and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources would be allocated to increasing the targets that can be reached to improve self-care and prevention practices.","High","In light of the difficulties in achieving coverage of socially vulnerable women living in Bateyes with prevention efforts, the TRP considers that additional resources for this population should be considered as high priority",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4377","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Quetzaltenango health area department (planning pending).",9677.42,null,"Active","a6Q1R000000AJ83",0,0,0,0,9677.42,0,null,null,"Quetzaltenango health area department (planning pending).","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Cabo Verde","Cabo Verde","PAI-4102","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","These interventions are aimed at strengthening the capacity of NGO members working for TB / HIV prevention at the community level.",16689.48,null,"Active","a6Q1R000000AJ3c",0,0,0,0,16689.48,0,null,null,"These interventions are aimed at strengthening the capacity of NGO members working for TB / HIV prevention at the community level.","High","The TRP considers these interventions as high\nquality demand as the activities to be funded relate\nto HIV testing of TB cases and TB screening of HIV\npositives ? these are important strategies.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH"," Central Africa",null,"Multi-component"]
["CT Comoros","Comoros","PAI-4067","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00091","Harm reduction interventions for sex workers who inject drugs","Providing performance bonuses for midwives undertaking PMTCT activities:\nThe funding request also plans to give midwives more responsibility for PMTCT activities and in monitoring babies born to HIV-positive mothers, prior to Polymerase Chain Reaction (PCR) testing being carried out when the child is 18 months old. This funding request will cover the cost of performance bonuses for midwives who manage 12 HIV-positive pregnant women in 2019 and 13 HIV-positive pregnant women in 2020 and 2021. This funding is being requested in order to implement the performance bonus. Performance criteria will relate to the number of women monitored up until the child?s PCR test is carried out at age 18 months. Once a report certified by a referring physician and validated by the DNLS has been submitted, midwifes will be paid a nominal amount for each HIV-positive pregnant woman they monitor.",3332.96,null,"Active","a6Q1R000000AJ33",0,0,0,0,3332.96,0,null,null,"Providing performance bonuses for midwives undertaking PMTCT activities:\nThe funding request also plans to give midwives more responsibility for PMTCT activities and in monitoring babies born to HIV-positive mothers, prior to Polymerase Chain Reaction (PCR) testing being carried out when the child is 18 months old. This funding request will cover the cost of performance bonuses for midwives who manage 12 HIV-positive pregnant women in 2019 and 13 HIV-positive pregnant women in 2020 and 2021. This funding is being requested in order to implement the performance bonus. Performance criteria will relate to the number of women monitored up until the child?s PCR test is carried out at age 18 months. Once a report certified by a referring physician and validated by the DNLS has been submitted, midwifes will be paid a nominal amount for each HIV-positive pregnant woman they monitor.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Comoros","Comoros","PAI-4066","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","Organizing quarterly awareness-raising and screening sessions for pregnant women via an outreach strategy:   \nThe country is committed to eliminating mother-to-child transmission by 2021. The gap analysis of the prevention of mother-to-child transmission (PMTCT) cascade shows that in 2017, 58 percent of HIV-positive pregnant women took ARVs during their pregnancy. Despite the acceptable rate of adherence to screening at antenatal clinics among pregnant women, there is a high number of positive test results and many challenges in PMTCT. These challenges include the number of HIV-positive women lost to follow-up during pregnancy and after childbirth, insufficient systems to share results, a lack of partner involvement, inadequate mother and child monitoring, inadequate early screening for exposed newborns, poor treatment adherence by parturient women, and persistent stigmatization. \nThis funding request aims to ensure 100 percent coverage from 2019. \nAs part of this above allocation funding request, there are therefore plans to hold twice-yearly awareness-raising and screening sessions via an outreach strategy in  30 PMTCT sites: 6 on Mohéli, 9 on Anjouan and 15 on Grande Comore.",11109.86,null,"Active","a6Q1R000000AJ32",0,0,0,0,11109.86,0,null,null,"Organizing quarterly awareness-raising and screening sessions for pregnant women via an outreach strategy:   \nThe country is committed to eliminating mother-to-child transmission by 2021. The gap analysis of the prevention of mother-to-child transmission (PMTCT) cascade shows that in 2017, 58 percent of HIV-positive pregnant women took ARVs during their pregnancy. Despite the acceptable rate of adherence to screening at antenatal clinics among pregnant women, there is a high number of positive test results and many challenges in PMTCT. These challenges include the number of HIV-positive women lost to follow-up during pregnancy and after childbirth, insufficient systems to share results, a lack of partner involvement, inadequate mother and child monitoring, inadequate early screening for exposed newborns, poor treatment adherence by parturient women, and persistent stigmatization. \nThis funding request aims to ensure 100 percent coverage from 2019. \nAs part of this above allocation funding request, there are therefore plans to hold twice-yearly awareness-raising and screening sessions via an outreach strategy in  30 PMTCT sites: 6 on Mohéli, 9 on Anjouan and 15 on Grande Comore.","High",null,"NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Cambodia","Cambodia","PAI-4638","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","KPs self-testing & access to Pre-exposure Prophylaxis (PreP) \nBuilding on HIV self-testing in PrEP pilot initiated in Phnom Penh in 2018, this intervention will expand access to self-testing and PrEP in Phnom Phnom Penh,  Battambang, Siem Reap\nExpected outcomes:\n- At least 1,500 MSM enrolled in PrEP\n- Approx. 7% HIV+ at initial screen or 105 HIV+ enrolled in care \n- Reduced transmission of HIV among MSM\n- Increased referrals to VCCT\n- Increased repeated testing",350000,null,"Inactive","a6Q1R000000AJCG",0,350000,0,0,0,1,null,null,"KPs self-testing & access to Pre-exposure Prophylaxis (PreP) \nBuilding on HIV self-testing in PrEP pilot initiated in Phnom Penh in 2018, this intervention will expand access to self-testing and PrEP in Phnom Phnom Penh,  Battambang, Siem Reap\nExpected outcomes:\n- At least 1,500 MSM enrolled in PrEP\n- Approx. 7% HIV+ at initial screen or 105 HIV+ enrolled in care \n- Reduced transmission of HIV among MSM\n- Increased referrals to VCCT\n- Increased repeated testing","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre -exposure prophylaxis (PrEP) for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Ethiopia","Ethiopia","PAI-4256","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","Community based care has been main strategy to access health services in Ethiopia. 53 NTP has implemented intensified community based interventions in 257 woredas/districts in 15 Zones with low TB case notification, through NFM GF grant incentive funding. Based on 18 months of data, the proportion of health posts implementing full package CBTB care has raised from 30% to 60%, with increased proportion of notified TB cases, in these woredas, by 7-10% of the national average. This above allocation request will expand this initiative to additional low performing and high burden 543 woredas, enabling the program to detect and treat additional 16,709 TB cases over the three years grant period. The packages of CBTB interventions include community based TB symptom screening and referral linkage, contact screening, community based DOT and patient support, tracing LTFU, and strengthening program monitoring and human resource capacity.",7615756,null,"Active","a6Q1R000000AJ66",0,0,0,0,7615756,0,null,null,"Community based care has been main strategy to access health services in Ethiopia. 53 NTP has implemented intensified community based interventions in 257 woredas/districts in 15 Zones with low TB case notification, through NFM GF grant incentive funding. Based on 18 months of data, the proportion of health posts implementing full package CBTB care has raised from 30% to 60%, with increased proportion of notified TB cases, in these woredas, by 7-10% of the national average. This above allocation request will expand this initiative to additional low performing and high burden 543 woredas, enabling the program to detect and treat additional 16,709 TB cases over the three years grant period. The packages of CBTB interventions include community based TB symptom screening and referral linkage, contact screening, community based DOT and patient support, tracing LTFU, and strengthening program monitoring and human resource capacity.","High","Essential community TB care interventions are high impact interventions",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Eritrea","Eritrea","PAI-4237","MCI-00012","Case management","MCI-00154","Facility-based treatment","Monitoring activities at field level/facility level on stock of supplies, adherence of health workers to various guidelines as well as supervision of implementation of QA/QC of malaria diagnosis are all important activities that should complement production of guidelines and provision of medicines/laboratory supplies. Moreover, training health professionals on safety monitoring of anti-malarial medicines augments delivery of quality assured malaria services. Hence, additional investments of USD 610,950.00 are estimated to cover costs of executing the above activities.",610950,null,"Active","a6Q1R000000AJ5n",0,399078,0,0,211872,0,null,null,"Monitoring activities at field level/facility level on stock of supplies, adherence of health workers to various guidelines as well as supervision of implementation of QA/QC of malaria diagnosis are all important activities that should complement production of guidelines and provision of medicines/laboratory supplies. Moreover, training health professionals on safety monitoring of anti-malarial medicines augments delivery of quality assured malaria services. Hence, additional investments of USD 610,950.00 are estimated to cover costs of executing the above activities.","High","Investment will support monitoring of activities at field level; stock of supplies, training and adherence of health workers to guidelines; supervision of QA/QC, medical/laboratory supplies, etc",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Eritrea","Eritrea","PAI-4236","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","This funding request covers several IEC/BCC activities including the following;\n? Production of audio-visual materials, print materials and production of malaria drama (USD 126,400)\n? Conduct of KAP study (USD 80,000) \n? Development of malaria communication strategy (USD 11,200)\n? Procurement of Mobile Video Units (MVUs) (USD 174,200) ? Commemoration of annual National Malaria Week(USD 205,668)\n? Provision of incentives to different community groups and training of women malaria action groups on malaria prevention (USD 660,000)\n?  In addition, activities proposed by local malaria partners aimed at promoting malaria knowledge and practice need to be funded. These include \no Promotional activities by junior and secondary schools and sensitization of teachers (USD 188,000) \no Commemoration of World Malaria Day and National Malaria Week by Ministry of Education (1,739,200)\no Train representative of Association of Women on malaria prevention and early treatment (USD 470,000)\n A total of USD 3,654,668 is estimated to cover implementation of the above stated activities.",730933,null,"Active","a6Q1R000000AJ5m",0,0,0,0,730933,0,null,null,"This funding request covers several IEC/BCC activities including the following;\n? Production of audio-visual materials, print materials and production of malaria drama (USD 126,400)\n? Conduct of KAP study (USD 80,000) \n? Development of malaria communication strategy (USD 11,200)\n? Procurement of Mobile Video Units (MVUs) (USD 174,200) ? Commemoration of annual National Malaria Week(USD 205,668)\n? Provision of incentives to different community groups and training of women malaria action groups on malaria prevention (USD 660,000)\n?  In addition, activities proposed by local malaria partners aimed at promoting malaria knowledge and practice need to be funded. These include \no Promotional activities by junior and secondary schools and sensitization of teachers (USD 188,000) \no Commemoration of World Malaria Day and National Malaria Week by Ministry of Education (1,739,200)\no Train representative of Association of Women on malaria prevention and early treatment (USD 470,000)\n A total of USD 3,654,668 is estimated to cover implementation of the above stated activities.","High","IEC/BCC will ensure ongoing awareness to reduce the incidence of malaria and to maximise the use of LLINs, diagnostics , and treatment . Though the Applicant?s request included a budget for IEC/BCC of $3,654,668, the TRP recommends only 20% ($730,933) of that amount for approval, leaving $2,923,735 unfunded.","NA Original Intervention: Information, education, communication/behavior change communications (vector control)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Eritrea","Eritrea","PAI-4215","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00170","Service organization and facility management","In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x-rays, ECGs, etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas.",87210,null,"Active","a6Q1R000000AJ5R",0,0,0,0,87210,0,null,null,"In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x-rays, ECGs, etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas.","High","In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x -rays, electrocardiogram s (ECGs ), etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas. Given the geographical constraints on reaching the population and lack of other donor funding this request is considered to be of high priority","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3713","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","General training in all sectors (malariology, monitoring and evaluation, finances and community health workers). This is a range of vital training to strengthen the program which has not been funded under the allocation amount. In particular, it involves (i) an international malariology course for two people each year, which is vital for strengthening the malaria response; (ii) training at the international level in the monitoring and evaluation of malaria response programs, given in Ouagadougou or Senegal; (iii) training at the international level in financial management; (iv) refresher training for community health workers providing iCCM in the health districts funded by the Global Fund, planned for 2019.",296091,null,"Active","a6Q1R000000AIxL",0,0,0,0,296091,0,null,null,"General training in all sectors (malariology, monitoring and evaluation, finances and community health workers). This is a range of vital training to strengthen the program which has not been funded under the allocation amount. In particular, it involves (i) an international malariology course for two people each year, which is vital for strengthening the malaria response; (ii) training at the international level in the monitoring and evaluation of malaria response programs, given in Ouagadougou or Senegal; (iii) training at the international level in financial management; (iv) refresher training for community health workers providing iCCM in the health districts funded by the Global Fund, planned for 2019.","High",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Angola","Angola","PAI-3588","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","PAAR to support procurement of additional laboratory  materials and consumable in  2019, 2020 and 2021 to reach targets. The items will include sputum containers and protection masks(3M N95) and reagents. Expected outcome will be increase in CNR.",499050,null,"Active","a6Q1R000000AIvK",0,0,0,0,499050,0,null,null,"PAAR to support procurement of additional laboratory  materials and consumable in  2019, 2020 and 2021 to reach targets. The items will include sputum containers and protection masks(3M N95) and reagents. Expected outcome will be increase in CNR.","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Angola","Angola","PAI-3587","MCI-00009","TB/HIV","MCI-00135","Engaging all care providers (TB/HIV)","PAAR investment will support activities of engaging public and private/CSO providers (PPP/PPM)  in TB/HIV control activities (screening, diagnosis, treatment and follow-up of patients), CBOs will be supported to connect people at risk of HIV and/or TB with information and services.  Activities will include training of service providers, certification and accreditation, quality assurance, supervision and monitoring, advocacy and communication. \nPAAR investment will support training in cases management of TB  and directly observed short treatment among TB cases detected and followed up by  prisons health teams, mines and oil companies, and  NGOs who work with TB high risk groups. Expected outcome will be increase in TB CNR and TSR.\nExpected outcome will be increase in coverage targets and quality of TB/HIV services.",750000,null,"Active","a6Q1R000000AIvJ",0,0,0,0,750000,0,null,null,"PAAR investment will support activities of engaging public and private/CSO providers (PPP/PPM)  in TB/HIV control activities (screening, diagnosis, treatment and follow-up of patients), CBOs will be supported to connect people at risk of HIV and/or TB with information and services.  Activities will include training of service providers, certification and accreditation, quality assurance, supervision and monitoring, advocacy and communication. \nPAAR investment will support training in cases management of TB  and directly observed short treatment among TB cases detected and followed up by  prisons health teams, mines and oil companies, and  NGOs who work with TB high risk groups. Expected outcome will be increase in TB CNR and TSR.\nExpected outcome will be increase in coverage targets and quality of TB/HIV services.","High","If this activity results in increased case finding and retention, it is important to implement this intervention.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Benin","Benin","PAI-3782","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Quarterly supervision of adherence clubs by ReBAP+ and the NACP:\nThe establishment of adherence clubs requires regular monitoring by ReBAP+ and the program during the first few years.",35926.379999999997,null,"Active","a6Q1R000000AIyS",0,0,0,0,35926.379999999997,0,null,null,"Quarterly supervision of adherence clubs by ReBAP+ and the NACP:\nThe establishment of adherence clubs requires regular monitoring by ReBAP+ and the program during the first few years.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4336","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","The country deployed significant efforts to obtain data on the key and vulnerable populations obtained from the various bio-behavioral studies. The country is asking for financial support in the amount of 25,460 euros to perform the in-depth epidemiological analyses using all the data collected over the past 2 years (Budget for an HIV Epidemiological Review - Appendix 9). The results of this analysis will help us to better understand the epidemic?s decisive factors in these groups and also in the general population and this will help to define better strategies for an effective and efficient national strategy.\nIn addition, in order to understand the source of these new infections, we wish to perform a study of the HIV transmission dynamics within our country and this will cost 72,583 euros (HIV Transmission Dynamics Study Budget - Appendix 10).\nIn order to evaluate the quality of the HIV health care, we also would like to perform a study of the retention of PLHIV, who are undergoing treatment, at 12, 24, and 36 months, for a total cost of 21,398 euros for 2019 and 2020. (PLHIV Under-Going Treatment Retention Study Budget - Appendix 11).",134037.71,null,"Active","a6Q1R000000AJ7O",0,0,0,0,134037.71,0,null,null,"The country deployed significant efforts to obtain data on the key and vulnerable populations obtained from the various bio-behavioral studies. The country is asking for financial support in the amount of 25,460 euros to perform the in-depth epidemiological analyses using all the data collected over the past 2 years (Budget for an HIV Epidemiological Review - Appendix 9). The results of this analysis will help us to better understand the epidemic?s decisive factors in these groups and also in the general population and this will help to define better strategies for an effective and efficient national strategy.\nIn addition, in order to understand the source of these new infections, we wish to perform a study of the HIV transmission dynamics within our country and this will cost 72,583 euros (HIV Transmission Dynamics Study Budget - Appendix 10).\nIn order to evaluate the quality of the HIV health care, we also would like to perform a study of the retention of PLHIV, who are undergoing treatment, at 12, 24, and 36 months, for a total cost of 21,398 euros for 2019 and 2020. (PLHIV Under-Going Treatment Retention Study Budget - Appendix 11).","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Eritrea","Eritrea","PAI-4231","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","This above allocation will be used to strengthen the referral from the community to the health facilities for services, Print and disseminate the referral tools, Advocacy meetings to engage influential people.",155250,null,"Active","a6Q1R000000AJ5h",0,0,0,0,155250,0,null,null,"This above allocation will be used to strengthen the referral from the community to the health facilities for services, Print and disseminate the referral tools, Advocacy meetings to engage influential people.","High","Linkage to care from community is very high priority, especially given the plans for more differentiated models of HIV testing and care. This will be used to strengthen the referral from the community to the health facilities for services, Print and disseminate the referral tools, advocacy meetings to engage influential people (community leaders) in all regions of the country","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Eritrea","Eritrea","PAI-4224","MCI-00000","Prevention programs for general population","MCI-00122","Counseling and psycho-social support","The OVCs that need critical financial support is estimated at 4,200. Only 820 (20%) are catered in the under allocation. With is above allocation more OVCs will be provided with monthly monetary, school uniforms and books support, community outreaches in all villages and catchment areas to sensitize communities and caregivers on the rights of the OVC will be supported. Community based group homes & Orphanage centers will be supported to reduce vulnerability to HIV infection.",2748000,null,"Active","a6Q1R000000AJ5a",0,0,0,0,2748000,0,null,null,"The OVCs that need critical financial support is estimated at 4,200. Only 820 (20%) are catered in the under allocation. With is above allocation more OVCs will be provided with monthly monetary, school uniforms and books support, community outreaches in all villages and catchment areas to sensitize communities and caregivers on the rights of the OVC will be supported. Community based group homes & Orphanage centers will be supported to reduce vulnerability to HIV infection.","Low","20% of orphans and vulnerable children (OVC) program is in the allocation. This covers the remaining 80% and is really providing a social security fund for government. However considering funding constraints this is still considered appropriate use if other activities are funded",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2020-12-31","HIV/AIDS"]
["CT Egypt","Egypt","PAI-4205","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","PMTCT. A pilot was implemented and was nationally owned and received wide acceptance and helped in addressing stigma among healthcare providers and spreading awareness to women in child bearing age. This model will be evaluated and refined for scale up near hot spots of KPs where testing is expected to have greater yield.",150000,null,"Active","a6Q1R000000AJ5H",0,0,0,0,150000,0,null,null,"PMTCT. A pilot was implemented and was nationally owned and received wide acceptance and helped in addressing stigma among healthcare providers and spreading awareness to women in child bearing age. This model will be evaluated and refined for scale up near hot spots of KPs where testing is expected to have greater yield.","Low",null,"NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2022-03-31","TB/HIV"]
["CT Dominican Republic","Dominican Republic","PAI-4183","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","The practices of self-care, prevention of HIV and other STIs in sex workers and their clients, and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources will be allocated to increasing the targets that can be reached to improve self-care and prevention practices.",592400,null,"Active","a6Q1R000000AJ4v",235065.98,0,0,0,357334.02,0,null,null,"The practices of self-care, prevention of HIV and other STIs in sex workers and their clients, and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources will be allocated to increasing the targets that can be reached to improve self-care and prevention practices.","High",null,"NA Original Intervention: Behabioral interventions for sex workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3707","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","This LLIN campaign is aimed at key populations (special groups, including boarding schools, military camps, prisons and orphanages that were not included in the mass campaign). The requested amount will cover (i) procurements costs for 182,000 LLINs and (ii) implementation costs for the special groups. This amount includes procurement costs and implementation costs. This activity is planned for 2020.",520475,null,"Active","a6Q1R000000AIxF",0,0,0,0,520475,0,null,null,"This LLIN campaign is aimed at key populations (special groups, including boarding schools, military camps, prisons and orphanages that were not included in the mass campaign). The requested amount will cover (i) procurements costs for 182,000 LLINs and (ii) implementation costs for the special groups. This amount includes procurement costs and implementation costs. This activity is planned for 2020.","High",null,"NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Burundi","Burundi","PAI-3706","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Activity: Support for health districts and health provinces in the supervision of malaria-related activities. The costs include per diems, fuel for supervision vehicles and motorcycles used by health districts and provincial health offices, as well as communication costs.",1003636,null,"Active","a6Q1R000000AIxE",0,0,0,0,1003636,0,null,null,"Activity: Support for health districts and health provinces in the supervision of malaria-related activities. The costs include per diems, fuel for supervision vehicles and motorcycles used by health districts and provincial health offices, as well as communication costs.","Medium","For sustainability reason and given supervision is an ongoing health system activity, this activity should be rated medium. The TRP recommends the Secretariat to reach out to the CCM to reassess the cost component of this activity and reduce the total cost. Most importantly, the TRP believes supervision should not be included in the PAAR moving forward, but rather in the allocation.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Angola","Angola","PAI-3584","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","Current ART coverage for Angola according to the revised program  data (2016) from a recent program data assessment standards at  21.4% (adults and children). The allocation amount in this application plus domestic contribution will only scale up this up to 45% which is still far below the global 90-90-90 targets. The PAAR will aim to scale up ART coverage to 33% in 2018; 39% in 2019, 46% in 2019 and 50% in 2021 respectively ( 100,404 in 2018; 121,281 in 2019; 146,008 in 2020; and 161,871 in 2021). Expected outcome will be increase in percentage of adults and children receiving antiretroviral therapy.",3000000,null,"Active","a6Q1R000000AIvG",0,0,0,0,3000000,0,null,null,"Current ART coverage for Angola according to the revised program  data (2016) from a recent program data assessment standards at  21.4% (adults and children). The allocation amount in this application plus domestic contribution will only scale up this up to 45% which is still far below the global 90-90-90 targets. The PAAR will aim to scale up ART coverage to 33% in 2018; 39% in 2019, 46% in 2019 and 50% in 2021 respectively ( 100,404 in 2018; 121,281 in 2019; 146,008 in 2020; and 161,871 in 2021). Expected outcome will be increase in percentage of adults and children receiving antiretroviral therapy.","High","Given the low ART coverage, activities to support the scaleup of the ART program are important.","NA Original Intervention: Differentiated antiretroviral therapy service delivery","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Côte d'Ivoire","Côte d'Ivoire","PAI-3948","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Develop the ?Husband School? approach Implement the ?husband school? approach in the Sud-Comoé region. This innovative approach has a double benefit?it increases the Funding request: Full review 15 February 2017 | 57 involvement of men in reducing barriers to access of PMTCT services as well improving the retention of seropositive pregnant women in care. Also, it fill the gaps on the vulnerable population of men over 35 by ensuring their access to screening through the front door of the PMTCT service. This intervention will involve the training of community actors in this approach so that they can implement the activities in 3 health districts in the Sud-Comoé region. It also involves the supplying of kits and guidance documents concerning this approach as well as workshops, missions, and supervisory visits.",150720.51,null,"Inactive","a6Q1R000000AJ18",150720.51,0,0,0,0,1,null,null,"Develop the ?Husband School? approach Implement the ?husband school? approach in the Sud-Comoé region. This innovative approach has a double benefit?it increases the Funding request: Full review 15 February 2017 | 57 involvement of men in reducing barriers to access of PMTCT services as well improving the retention of seropositive pregnant women in care. Also, it fill the gaps on the vulnerable population of men over 35 by ensuring their access to screening through the front door of the PMTCT service. This intervention will involve the training of community actors in this approach so that they can implement the activities in 3 health districts in the Sud-Comoé region. It also involves the supplying of kits and guidance documents concerning this approach as well as workshops, missions, and supervisory visits.","High","Development of the ?Husband School? approach in the SudComoé region should contribute to PMTCT as well as reduce GBV/ High priority because men are often gatekeepers to health care for women and children, and ?Husband Schools? can reduce barriers to access to treatment and care, especially for PMTCT, as shown by international normative guidance.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 1","2020-12-31","HIV/AIDS"]
["CT Central African Republic","Central African Republic","PAI-3945","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.",37637.75,null,"Active","a6Q1R000000AJ15",0,0,0,0,37637.75,0,null,null,"These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","High","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Lao (Peoples Democratic Republic)","Lao (Peoples Democratic Republic)","PAI-4677","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Extension of MDR-TB wards in 2 provinces (1 unit in Y1 and 2) including intensive cares and equipment for infection control.",150000,null,"Active","a6Q1R000000AJCt",0,15600,0,0,134400,0,null,null,"Extension of MDR-TB wards in 2 provinces (1 unit in Y1 and 2) including intensive cares and equipment for infection control.","High","High impact intervention","NA Original Module: Multidrug-resistant TB. Original Intervention: Treatment: 2 Multi Drug Resistance Tuberculosis (MDRTB) units in province","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2020-12-31","Tuberculosis"]
["CT Central African Republic","Central African Republic","PAI-3931","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","Prevention of MDR-TB highly relevant to prevent escalation of the MDR-TB situation.",126116.04,null,"Active","a6Q1R000000AJ0r",0,0,0,0,126116.04,0,null,null,"Prevention of MDR-TB highly relevant to prevent escalation of the MDR-TB situation.","High","The TRP considers prevention of MDR -TB highly relevant to prevent escalation of the MDR -TB situation.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Benin","Benin","PAI-3778","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Organize a consultation meeting between the various actors from NGOs working with sex workers\n(based on 25,758 actors each year for the three years): \nThis intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.",86716.42,null,"Active","a6Q1R000000AIyO",0,0,0,0,86716.42,0,null,null,"Organize a consultation meeting between the various actors from NGOs working with sex workers\n(based on 25,758 actors each year for the three years): \nThis intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","Medium",null,"NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4316","MCI-00071","Other module","MCI-00071","Other module","Real Time Monitoring (RTM) to improve the collection of HMIS data, the timeliness and completeness of reports and the analysis and performance of actions for improvement at all levels for all of the health programs via the DHIS2. This will involve the use of an interface between the data production site and the DHIS2 at regional level in order to allow the latter to be provided with data concerning malaria and other health programs from 137 sites in real time. An automated feedback system will enable decisions to be made with regard to the quality of data at the site.",393804.29,null,"Inactive","a6Q1R000000AJ74",0,0,0,393804,0,1,null,null,"Real Time Monitoring (RTM) to improve the collection of HMIS data, the timeliness and completeness of reports and the analysis and performance of actions for improvement at all levels for all of the health programs via the DHIS2. This will involve the use of an interface between the data production site and the DHIS2 at regional level in order to allow the latter to be provided with data concerning malaria and other health programs from 137 sites in real time. An automated feedback system will enable decisions to be made with regard to the quality of data at the site.","High","The TRP notes this previously approved intervention will be fully funded by the World Bank.","25/10/2018: As per email by CT, this previously approved intervention will be fully funded by the World Bank. This was done prior to GNB-M coming for GAC Original Module: RSSH. Original Intervention: Tools to allow service providers to provide feedback","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2020-12-31","Malaria"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4315","MCI-00071","Other module","MCI-00071","Other module","Strengthening of the supply chain management system. It is essential that a strict monitoring system and dedicated technical assistance are put in place to guarantee the rational use of the drugs and health products provided under the three grants. The direct collection of information regarding consumption in real time as well as on-the-job training provide additional safeguards for the national PSM system.",704749.19,null,"Active","a6Q1R000000AJ73",0,0,0,0,704749.19,0,null,null,"Strengthening of the supply chain management system. It is essential that a strict monitoring system and dedicated technical assistance are put in place to guarantee the rational use of the drugs and health products provided under the three grants. The direct collection of information regarding consumption in real time as well as on-the-job training provide additional safeguards for the national PSM system.","High","Given Guinea-Bissau?s status as COE, and given that commodity investments to reduce the burden of HIV, TB and malaria will be substantial, strengthening the PSM capacity of the MOH is crucial. Attention should be paid to ensuring that procurement and supply management funding is coordinated across all Global Fund grants and - inasmuch as possible- benefits all three priority diseases","NA Original Module: RSSH. Original Intervention: MOH PSM strengthening","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2020-12-31","Malaria"]
["CT Egypt","Egypt","PAI-4208","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Case detection and diagnosis: (1) Procurement of additional 6 XpertMTB/Rif modules (four-cartridge module) and 850 cartridges per module per year; (2) Lab supplies for solid and liquid cultures",607500,null,"Active","a6Q1R000000AJ5K",0,0,0,0,607500,0,null,null,"Case detection and diagnosis: (1) Procurement of additional 6 XpertMTB/Rif modules (four-cartridge module) and 850 cartridges per module per year; (2) Lab supplies for solid and liquid cultures","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2022-03-31","TB/HIV"]
["CT Egypt","Egypt","PAI-4199","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Integration of TB/HIV services into existing structures (e.g. the existing Hepatitis C program): Quarterly coordination meetings for HIV and TB managers and focal points on governorates level",36728.74,null,"Active","a6Q1R000000AJ5B",9832,0,0,0,26896.74,0,null,null,"Integration of TB/HIV services into existing structures (e.g. the existing Hepatitis C program): Quarterly coordination meetings for HIV and TB managers and focal points on governorates level","High","Integration of the TB/HIV services with the HEP-C program. This is an important intervention, for which little funding is allocated. The TRP recommends that this amount is included in the main allocation.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2022-03-31","TB/HIV"]
["CT Cambodia","Cambodia","PAI-4623","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","QC/QA will be implemented in collaboration with DDF and CMS and sampling will be undertaken using current SOP employing a risk based approach in product selection. TRP recommends 10% of the request.",40000,null,"Active","a6Q1R000000AJC1",0,0,0,0,40000,0,null,null,"QC/QA will be implemented in collaboration with DDF and CMS and sampling will be undertaken using current SOP employing a risk based approach in product selection. TRP recommends 10% of the request.","Low","The TRP notes that synergies across programs, e.g. with the malaria RSSH Window 1 grant could generate efficiencies to cover this request.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Quality assessment of medicines and commodities / supply chain","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Cambodia","Cambodia","PAI-4622","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Replace or update NGO/CSO laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information.TRP recommends only 15% of the request.",60000,null,"Active","a6Q1R000000AJC0",0,0,0,0,60000,0,null,null,"Replace or update NGO/CSO laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information.TRP recommends only 15% of the request.","Low","This intervention has excessive unit costs that are not justified in the funding request and is therefore not a priority.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Computer replacement /office equipment nongovernmental organization and civil society organization","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4387","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conducting a second KAP survey to respond to the indicators in the performance framework (on LLIN use).",77000,null,"Inactive","a6Q1R000000AJ8D",77000,0,0,0,0,1,null,null,"Conducting a second KAP survey to respond to the indicators in the performance framework (on LLIN use).","High","This activity is very important for M&E performance as the LLIN use needs to be reported in 2020 as part of the impact indicator. This activity may be funded from the main allocation through savings.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Latin America and Caribbean","2021-06-30","Malaria"]
["CT Burundi","Burundi","PAI-3736","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Purchase of 2 vehicles to transport digital radiology devices to screening sites.",100000,null,"Active","a6Q1R000000AIxi",0,0,0,0,100000,0,null,null,"Purchase of 2 vehicles to transport digital radiology devices to screening sites.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3701","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Activity: Organize training sessions on the psychosocial care of children and adolescents living with HIV for providers at ARV sites.\nThis activity, begun during the past grant, will be continued because the low antiretroviral treatment coverage of children and adolescents living with HIV requires special monitoring for this population. The psychosocial care of children and adolescents living with HIV will facilitate the announcement of seropositivity to patients which will increase adherence to treatment and retention rate. Providers will also be able to help strengthen family caring as a strategy to reach more children and adolescents.",45109,null,"Active","a6Q1R000000AIx9",0,0,0,0,45109,0,null,null,"Activity: Organize training sessions on the psychosocial care of children and adolescents living with HIV for providers at ARV sites.\nThis activity, begun during the past grant, will be continued because the low antiretroviral treatment coverage of children and adolescents living with HIV requires special monitoring for this population. The psychosocial care of children and adolescents living with HIV will facilitate the announcement of seropositivity to patients which will increase adherence to treatment and retention rate. Providers will also be able to help strengthen family caring as a strategy to reach more children and adolescents.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3700","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Activity: Conduct a study on estimating mother-to-child transmission rate of HIV\nThe estimate of the mother-to-child transmission rate is an indicator of the NHP, the current grant performance framework, but also an indicator of the progress of PMTCT. Until then the indicator was estimated by the Spectrum. In order to obtain an indicator that is as close as possible to the reality of the scope of the interventions we propose to carry out this study which in addition to the transmission rate makes it possible to evaluate the quality, availability and accessibility of PMTCT services.\nThis is a study that will be conducted in 2019 and will cover the entire country according to a methodology that will be proposed by the consultant / firm and validated by the steering committee.",36348,null,"Active","a6Q1R000000AIx8",0,0,0,0,36348,0,null,null,"Activity: Conduct a study on estimating mother-to-child transmission rate of HIV\nThe estimate of the mother-to-child transmission rate is an indicator of the NHP, the current grant performance framework, but also an indicator of the progress of PMTCT. Until then the indicator was estimated by the Spectrum. In order to obtain an indicator that is as close as possible to the reality of the scope of the interventions we propose to carry out this study which in addition to the transmission rate makes it possible to evaluate the quality, availability and accessibility of PMTCT services.\nThis is a study that will be conducted in 2019 and will cover the entire country according to a methodology that will be proposed by the consultant / firm and validated by the steering committee.","High",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3661","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Activity: Support DHIS2 hosting for 2 years\nThe DHIS2 is hosted by a house that provides maintenance and regular back up of the base. A contract is signed between the MSPLS and the said house for a monthly amount of US $ 650",15600,null,"Active","a6Q1R000000AIwV",0,0,0,0,15600,0,null,null,"Activity: Support DHIS2 hosting for 2 years\nThe DHIS2 is hosted by a house that provides maintenance and regular back up of the base. A contract is signed between the MSPLS and the said house for a monthly amount of US $ 650","High",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-3999","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","This sum will consist of buying in services from the structures/Programs of the Ministry of Health, which can contribute to achieving the objectives linked to the 3 diseases. For example: FOSAs, DPSs, CDRs, PNAM, 3workers DEP,IGs). This involves defining a package of support for services affected in exchange for results, which have a proven impact on the performance of the fight against the threediseases. It will be possible to use these sums in a co-financing arrangement with domestic funds or with other partners such as the World Bank or the European Union.",22300000,null,"Active","a6Q1R000000AJ1x",0,0,0,0,22300000,0,null,null,"This sum will consist of buying in services from the structures/Programs of the Ministry of Health, which can contribute to achieving the objectives linked to the 3 diseases. For example: FOSAs, DPSs, CDRs, PNAM, 3workers DEP,IGs). This involves defining a package of support for services affected in exchange for results, which have a proven impact on the performance of the fight against the threediseases. It will be possible to use these sums in a co-financing arrangement with domestic funds or with other partners such as the World Bank or the European Union.","High","The strengthening of community health system is important for the implementation and roll out of malaria /integrated community case management","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Central African Republic","Central African Republic","PAI-3942","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Acquisition of ARVs for 4,909 pregnant women who are HIV positive, reagents and consumables for screening pregnant women and advocacy campaigns directed towards women of childbearing age. This high priority given the low coverage of PMTCT services.",121466.73,null,"Inactive","a6Q1R000000AJ12",0,121467,0,0,0,1,null,null,"Acquisition of ARVs for 4,909 pregnant women who are HIV positive, reagents and consumables for screening pregnant women and advocacy campaigns directed towards women of childbearing age. This high priority given the low coverage of PMTCT services.","High","Acquisition of ARVs for 4,909 pregnant women who are HIV positive, reagents and consumables for screening pregnant women and advocacy campaigns directed towards women of childbearing age. This high priority given the low coverage of PMTCT services","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Central African Republic","Central African Republic","PAI-3941","MCI-00007","Treatment, care and support","MCI-00121","Prevention, diagnosis and treatment of opportunistic infections","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.",216656.94,null,"Inactive","a6Q1R000000AJ11",216656.94,0,0,0,0,1,null,null,"The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.","High","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa","2020-12-31","TB/HIV"]
["CT Cambodia","Cambodia","PAI-4664","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","TRP recommends enablers for DOTS watchers for MDR-TB and packages for covering MDR-TB patients. The recommendation is 35% of the request.",291389,null,"Active","a6Q1R000000AJCg",0,0,0,0,291389,0,null,null,"TRP recommends enablers for DOTS watchers for MDR-TB and packages for covering MDR-TB patients. The recommendation is 35% of the request.","Medium","The TRP considers enablers for village health support groups (VHSGs) as DOT watchers for MDR TB and the package for covering MDR TB patients relevant for supporting MDR-TB patients.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," High Impact Asia","2020-12-31","Tuberculosis"]
["CT Cambodia","Cambodia","PAI-4659","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Operational Research",100000,null,"Active","a6Q1R000000AJCb",0,0,0,0,100000,0,null,null,"Operational Research","Low","-","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Bhutan","Bhutan","PAI-3927","MCI-00071","Other module","MCI-00126","Case detection and diagnosis","Training of medical doctors on management of TB/HIV co-infection, training of TB and VCT focal persons on TB/HIV collaborative guidelines.",41670,null,"Active","a6Q1R000000AJ0n",0,0,0,0,41670,0,null,null,"Training of medical doctors on management of TB/HIV co-infection, training of TB and VCT focal persons on TB/HIV collaborative guidelines.","High","Although HIV levels are low in Bhutan at the present, it remains critical to maintain the surveillance in TB patients to monitor the epidemic transmission characteristics.","NA Original Module: TB/HIV collaborative intervention. Original Intervention: Case detection and management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2021-06-30","Tuberculosis"]
["CT Bhutan","Bhutan","PAI-3926","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Funds for conducting operational research, establishing internet connectivity for web-based reporting and funding for an external review of the TB program",52600,null,"Inactive","a6Q1R000000AJ0m",0,52600,0,0,0,1,null,null,"Funds for conducting operational research, establishing internet connectivity for web-based reporting and funding for an external review of the TB program","High","The TRP has removed the cost of the master's degree program. The funds remaining in this module are to increase internet connectivity to support use of the electronic medical reporting system and has maintained the cost of support for internet connectivity improvements to support reporting efforts. This is value for money and will amplify the impact of the within allocation request.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," South East Asia","2021-06-30","Tuberculosis"]
["CT Burkina Faso","Burkina Faso","PAI-3854","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The current funding (World Fund, USAID and State) covers needs from 2018 to 2020 except for routine LLIN for pregnant women in 2019. This Gap is included in the above allocation to acquire 886,517 MILDA. The mass distribution campaign is planned for the first half of 2019.",2530411.85,null,"Active","a6Q1R000000AIzc",0,0,0,0,2530411.85,0,null,null,"The current funding (World Fund, USAID and State) covers needs from 2018 to 2020 except for routine LLIN for pregnant women in 2019. This Gap is included in the above allocation to acquire 886,517 MILDA. The mass distribution campaign is planned for the first half of 2019.","High","To fill in the gap for long-lasting insecticide nets (LLIN) routine distribution to pregnant women and children in 2019; intervention aimed at reducing morbidity and mortality among vulnerable groups.","NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Benin","Benin","PAI-3772","MCI-00023","Program management","MCI-00207","Grant management","Organize quarterly five-day missions to validate the accounts of private clinics for the payment of services, undertaken by two teams of three people:\nThis activity aims to improve the quality of accounts and prevent ineligible amounts.",24225.119999999999,null,"Active","a6Q1R000000AIyI",0,0,0,0,24225.119999999999,0,null,null,"Organize quarterly five-day missions to validate the accounts of private clinics for the payment of services, undertaken by two teams of three people:\nThis activity aims to improve the quality of accounts and prevent ineligible amounts.","Medium",null,"NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Ghana","Ghana","PAI-4283","MCI-00071","Other module","MCI-00071","Other module","This study to be conducted in 2019 provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the e-tracker. This cohort analysis will include women initiated on ART during pregnancy for the first time.",300000,null,"Active","a6Q1R000000AJ6X",0,0,0,0,300000,0,null,null,"This study to be conducted in 2019 provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the e-tracker. This cohort analysis will include women initiated on ART during pregnancy for the first time.","High","This study will provide data on factors contributing to ART retention, loss to follow -up and survival to complement data from the e -tracker. This cohort analysis will include women initiated on ART during pregnancy for the first time. The TRP recommends partial funding due to cost of following large cohort and availability of program data through e -tracker for analysis.","NA Original Module: ART - Cohort analysis. Original Intervention: Study ? analysis of cohort of people living with HIV initiated on ART","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Ghana","Ghana","PAI-4282","MCI-00071","Other module","MCI-00071","Other module","Viral load is the key outcome measure for the third 90. At present its use is very limited. The amount requested is necessary to support implementation of the viral load scale-up plan (that is being finalized) for three years.",731076,null,"Inactive","a6Q1R000000AJ6W",731076,0,0,0,0,1,null,null,"Viral load is the key outcome measure for the third 90. At present its use is very limited. The amount requested is necessary to support implementation of the viral load scale-up plan (that is being finalized) for three years.","High","Viral load is the key outcome measure for the third 90. At present its use is very limited. The amount requested is necessary to support implementation of the viral load scale -up plan that is being finalized, for three years","NA Original Module: ART - Viral load scale -up. Original Intervention: Implementation of viral load sample collection, transportation and feedback system","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Algeria","Algeria","PAI-4193","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","The prevalence among female sex workers is 72 times higher than the national average. Several factors contribute to this situation, including limited access to prevention, care and treatment services and the lack of coverage of certain areas by Community Systems Organisation (CSOs). This additional investment will provide services to 6248 Commercial Sex Workers (CSWs) in areas currently not covered by CSOs based on the results of the mapping of key populations that will be available before the start of the transition grant.",234098.55,null,"Active","a6Q1R000000AJ55",0,0,0,0,234098.55,0,null,null,"The prevalence among female sex workers is 72 times higher than the national average. Several factors contribute to this situation, including limited access to prevention, care and treatment services and the lack of coverage of certain areas by Community Systems Organisation (CSOs). This additional investment will provide services to 6248 Commercial Sex Workers (CSWs) in areas currently not covered by CSOs based on the results of the mapping of key populations that will be available before the start of the transition grant.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Middle East and North Africa","2022-12-31","HIV/AIDS"]
["CT Dominican Republic","Dominican Republic","PAI-4178","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","The national storageand distribution management  network need to maintain appropriate standards to guarantee conservation and quality of the medicines and reagents, which requires covering the demand in terms of infrastructure for warehouses and transport resources, as well as strengthening the infrastructure. In addition, improvement of logistics and improvement of the conditions of the importing entity will determine the flow of the supply management chain.",500000,null,"Active","a6Q1R000000AJ4q",0,0,0,0,500000,0,null,null,"The national storageand distribution management  network need to maintain appropriate standards to guarantee conservation and quality of the medicines and reagents, which requires covering the demand in terms of infrastructure for warehouses and transport resources, as well as strengthening the infrastructure. In addition, improvement of logistics and improvement of the conditions of the importing entity will determine the flow of the supply management chain.","Medium",null,"NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Dominican Republic","Dominican Republic","PAI-4173","MCI-00531","Comprehensive prevention programs for TGs","MCI-00554","Behavioral interventions for TGs","The practices of self-care, prevention of HIV and other STIs in transgender people and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources would be allocated to increasing the targets that can be reached to improve self-care and prevention practices.",290000,null,"Inactive","a6Q1R000000AJ4l",290000,0,0,0,0,1,null,null,"The practices of self-care, prevention of HIV and other STIs in transgender people and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources would be allocated to increasing the targets that can be reached to improve self-care and prevention practices.","Medium","In light of the success in achieving high coverage of transgender people with prevention efforts and relatively low HIV sero-positivity rate in newly tested cases, under the existing allocation request, the TRP considers additional resources for this population to be medium priority.","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Cambodia","Cambodia","PAI-4620","MCI-00533","HIV Testing Services","MCI-00071","Other module","Introduction of Alere DETERMINE Ab/Ag Combo 4th generation RDT. TRP  recommends 10% of the requested amount.",106321,null,"Active","a6Q1R000000AJBy",0,0,0,0,106321,0,null,null,"Introduction of Alere DETERMINE Ab/Ag Combo 4th generation RDT. TRP  recommends 10% of the requested amount.","Low","This test is presently not part of WHO guidelines.","NA Original Intervention: New generation rapid diagnostic tests","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Honduras","Honduras","PAI-4410","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Montly salaries of staff included in the budget of the future grant (the number of monthly salaries were reduced at the beginning and end of the grant due to the reduction of funding)",181598,null,"Inactive","a6Q1R000000AJ8a",181598,0,0,0,0,1,null,null,"Montly salaries of staff included in the budget of the future grant (the number of monthly salaries were reduced at the beginning and end of the grant due to the reduction of funding)","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-07-31","HIV/AIDS"]
["CT Honduras","Honduras","PAI-4405","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","? Preventive maintenance for the IT equipment following the implementation of the integrated health information system\n? Website maintenance\n? Training health personnel in the processes and information system\n? Study of HIV cases? notifications and compliance with the HIV diagnostic algorithm \n? KAP study with serology in the Miskito population and intravenous drug users\n? Prevalence study in young people between the ages of 15 and 30\n? Study on the HIV vulnerability factors in young girls\n? Study of HIV and TB prevalence in migrants\n? Study on the characterization of Opportunistic Infections in persons with HIV and \n? Study on the main causes of death in persons with HIV in hospitals",584939.68999999994,null,"Active","a6Q1R000000AJ8V",154000,0,0,0,430939.69,0,null,null,"? Preventive maintenance for the IT equipment following the implementation of the integrated health information system\n? Website maintenance\n? Training health personnel in the processes and information system\n? Study of HIV cases? notifications and compliance with the HIV diagnostic algorithm \n? KAP study with serology in the Miskito population and intravenous drug users\n? Prevalence study in young people between the ages of 15 and 30\n? Study on the HIV vulnerability factors in young girls\n? Study of HIV and TB prevalence in migrants\n? Study on the characterization of Opportunistic Infections in persons with HIV and \n? Study on the main causes of death in persons with HIV in hospitals","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-07-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4382","MCI-00534","Comprehensive prevention programs for MSM","MCI-00606","Condoms and lubricant programming for MSM","3,430,381 condoms to cover 82 percent of the programmatic gap in 2019.",102911,null,"Active","a6Q1R000000AJ88",0,0,0,0,102911,0,null,null,"3,430,381 condoms to cover 82 percent of the programmatic gap in 2019.","High",null,"All the interventions for 'Condoms and lubricant programming for men who have sex with men' under module 'Comprehensive prevention programs for men who have sex with men' are merged in the TRP form Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Condoms and lubricant programming for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4381","MCI-00531","Comprehensive prevention programs for TGs","MCI-00558","HIV testing services for TGs","2,234 HIV tests to cover 100 percent of the programmatic gap in 2020.",3530,null,"Active","a6Q1R000000AJ87",0,0,0,0,3530,0,null,null,"2,234 HIV tests to cover 100 percent of the programmatic gap in 2020.","High",null,"Both the interventions for 'HIV testing services for transgender people' under module 'Comprehensive prevention programs for transgender people' are merged in the TRP form Original Module: Comprehensive prevention programs for transgender people. Original Intervention: HIV testing services for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4362","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Pedro de Bethancourt Hospital, Antigua Guatemala. Renovation of a 70.20 m² facility, including: \npreliminary work; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; erecting a plasterboard wall; supplying ceramic flooring; metal structure; suspended ceiling; installing water and electricity; two metal doors, three MDF doors, six windows; pavement and outside steps; paintwork.",10775,null,"Active","a6Q1R000000AJ7o",0,0,0,0,10775,0,null,null,"Pedro de Bethancourt Hospital, Antigua Guatemala. Renovation of a 70.20 m² facility, including: \npreliminary work; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; erecting a plasterboard wall; supplying ceramic flooring; metal structure; suspended ceiling; installing water and electricity; two metal doors, three MDF doors, six windows; pavement and outside steps; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4352","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","70,963 HIV tests to cover 100 percent of the programmatic gap in 2019.",112122,null,"Active","a6Q1R000000AJ7e",0,0,0,0,112122,0,null,null,"70,963 HIV tests to cover 100 percent of the programmatic gap in 2019.","High",null,"Both the interventions for 'HIV testing services for transgender people' under module 'Comprehensive prevention programs for men who have sex with men' are merged in the TRP form Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT India","India","PAI-4541","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","This includes procurement and distribution cost of LLINs for Odisha which need to be replaced in 2020 to sustain the impact of LLINs distributed in 2017. Odisha accounts for more than 40% of malaria in India. Maintaining LLINs coverage in Odisha would reduce malaria morbidity & mortality by 70% in 2020 compared to 2015, similar to NE states. 90% of LLNs are assumed to be used by population in coverage areas.",31700000,null,"Active","a6Q1R000000AJAh",5899275,0,0,0,25800725,0,null,null,"This includes procurement and distribution cost of LLINs for Odisha which need to be replaced in 2020 to sustain the impact of LLINs distributed in 2017. Odisha accounts for more than 40% of malaria in India. Maintaining LLINs coverage in Odisha would reduce malaria morbidity & mortality by 70% in 2020 compared to 2015, similar to NE states. 90% of LLNs are assumed to be used by population in coverage areas.","High","LLINs requirement for mass net replacement for Odisha in 2020 to sustain impact of LLIN distributed in 2017. Odisha is contributing to 40% of total malaria cases in the country, therefore this intervention is considered high priority.","NA Original Intervention: LLINs","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Asia","2021-03-31","Malaria"]
["CT India","India","PAI-4540","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Procurement of a portion of the country's requirement for the triple combination TLE.",30000000,null,"Active","a6Q1R000000AJAg",0,0,0,0,30000000,0,null,null,"Procurement of a portion of the country's requirement for the triple combination TLE.","Medium","The additional identified cases to be put on treatment will likely emerge at the end of this funding period, given the current pace of implementation and absorption and gradual take over.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2021-03-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3732","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Gap to be filled in relation to the activity on the provincial coordination TB / HIV:\nThe frequency of holding TB / HIV coordination meetings is quarterly.",30355,null,"Active","a6Q1R000000AIxe",0,0,0,0,30355,0,null,null,"Gap to be filled in relation to the activity on the provincial coordination TB / HIV:\nThe frequency of holding TB / HIV coordination meetings is quarterly.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3727","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00599","National product selection, registration and quality monitoring","Drug Registration Support (Cross-Cutting RSS): Drug registration is one of the pillars of drug quality assurance. In the past 3 years, just over 700 drug application files have been filed with the Department of Pharmacy, Medicines and Laboratories (DPML), which acts as the Burundian Agency for Drug Regulation. These files concern both products financed by the Global Fund and essential drugs imported into Burundi. To date, only 200 files have been processed. The requested support will mobilize the probate commission to process the 500 files registered to date at the DPML. Subsequently, the commission will be able to process new files as they arrive.",46922,null,"Active","a6Q1R000000AIxZ",0,0,0,0,46922,0,null,null,"Drug Registration Support (Cross-Cutting RSS): Drug registration is one of the pillars of drug quality assurance. In the past 3 years, just over 700 drug application files have been filed with the Department of Pharmacy, Medicines and Laboratories (DPML), which acts as the Burundian Agency for Drug Regulation. These files concern both products financed by the Global Fund and essential drugs imported into Burundi. To date, only 200 files have been processed. The requested support will mobilize the probate commission to process the 500 files registered to date at the DPML. Subsequently, the commission will be able to process new files as they arrive.","High",null,"NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3692","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structures\nCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.",250000,null,"Active","a6Q1R000000AIx0",0,0,0,0,250000,0,null,null,"Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structures\nCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.","High",null,"NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3691","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Establishment of a quality control unit for medical devices\nThe LNCQM does not perform quality control of medical devices (gloves, condoms, needles and others) .Technical staff does not have experience in quality control of medical devices",62000,null,"Active","a6Q1R000000AIwz",0,0,0,0,62000,0,null,null,"Activity: Establishment of a quality control unit for medical devices\nThe LNCQM does not perform quality control of medical devices (gloves, condoms, needles and others) .Technical staff does not have experience in quality control of medical devices","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3657","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Activity: Providing sites with support for adequate computer equipment for data management\nFor the moment, the CDS make the data entry themselves in DHI2. Field visits show that most CDS have a single laptop. This computer is used for the administrative activities of the CDS. It is necessary that the SIS service of the FOSA who take care of the data regularly has its own computer. In total, we have 750 support structures. In the past grant, the computer support concerned only about 170 structures.",762756,null,"Active","a6Q1R000000AIwR",0,0,0,0,762756,0,null,null,"Activity: Providing sites with support for adequate computer equipment for data management\nFor the moment, the CDS make the data entry themselves in DHI2. Field visits show that most CDS have a single laptop. This computer is used for the administrative activities of the CDS. It is necessary that the SIS service of the FOSA who take care of the data regularly has its own computer. In total, we have 750 support structures. In the past grant, the computer support concerned only about 170 structures.","High",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Angola","Angola","PAI-3578","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","Additional PAAR investment for activities to contribute to the 90-90-90 targets will include intensifying peer adherence counseling and provision of psychosocial support to PLHIV at ART sites and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities. Expected out will be number of PLHIV retained in care and virally suppressed.",600000,null,"Active","a6Q1R000000AIvA",0,0,0,0,600000,0,null,null,"Additional PAAR investment for activities to contribute to the 90-90-90 targets will include intensifying peer adherence counseling and provision of psychosocial support to PLHIV at ART sites and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities. Expected out will be number of PLHIV retained in care and virally suppressed.","High","Antiviral treatment adherence is important given the low rates of retention and viral suppression.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Djibouti","Djibouti","PAI-4131","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Training supervision of technicians on the radiology machine (per diem related to awareness / transport / meeting / and other costs). (See line 21).",678,null,"Active","a6Q1R000000AJ45",0,0,0,0,678,0,null,null,"Training supervision of technicians on the radiology machine (per diem related to awareness / transport / meeting / and other costs). (See line 21).","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4129","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","It involves the development of a communication plan and a comprehensive advocacy dossier that will be addressed to national authorities and the private sector in order to:\n- increase the financial contributions of the State to the fight against TB and HIV\n- increase the participation of the private sector at the programmatic and financial level\n- obtain support for the implementation of operational plans\n- ensure respect for human rights and equity in services for key and vulnerable populations (SW-clients, detainees, migrants, disadvantaged communities, etc.)\n- ensure the delegation of tasks and other interventions provided for in the plans\nThe expected results are: More funding from the state and the private sector; Plans implemented; Increased access to RTTR (Reach, Test, Treat, Retain) services for key and vulnerable populations.",18000,null,"Active","a6Q1R000000AJ43",0,0,0,0,18000,0,null,null,"It involves the development of a communication plan and a comprehensive advocacy dossier that will be addressed to national authorities and the private sector in order to:\n- increase the financial contributions of the State to the fight against TB and HIV\n- increase the participation of the private sector at the programmatic and financial level\n- obtain support for the implementation of operational plans\n- ensure respect for human rights and equity in services for key and vulnerable populations (SW-clients, detainees, migrants, disadvantaged communities, etc.)\n- ensure the delegation of tasks and other interventions provided for in the plans\nThe expected results are: More funding from the state and the private sector; Plans implemented; Increased access to RTTR (Reach, Test, Treat, Retain) services for key and vulnerable populations.","High",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Cabo Verde","Cabo Verde","PAI-4098","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","A study was conducted within the general population in 2017 on knowledge of attitudes towards and practices in connection with methods for preventing malaria and its transmission. Nevertheless, it is essential that an initial study is conducted within migrant population in 2018. It is expected that the KAP study will be carried out again within the general population in 2020 to update these data.",44737.96,null,"Active","a6Q1R000000AJ3Y",0,0,0,0,44737.96,0,null,null,"A study was conducted within the general population in 2017 on knowledge of attitudes towards and practices in connection with methods for preventing malaria and its transmission. Nevertheless, it is essential that an initial study is conducted within migrant population in 2018. It is expected that the KAP study will be carried out again within the general population in 2020 to update these data.","Low","Given that the explanation states that the\nKnowledge, Attitude and Practice survey within the\nmigrant population is funded within allocation and\nthat the Knowledge, Attitude and Practice survey in\nthe general population was done in 2017, the TRP\ndoes not see a repeat of the latter as a priority.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Survey (malaria component)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH"," Central Africa",null,"Multi-component"]
["CT Comoros","Comoros","PAI-4061","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Organizing a multisectoral coordination and follow-up meeting with all stakeholders (education, justice, law enforcement, etc.):\nIn order to take into account the multisectoral dimension of AIDS control, the DNLS plans to hold twice-yearly meetings involving all stakeholders (education, justice, law enforcement, etc.). These meetings provide an opportunity to share the status of both grant implementation and planning.",7321.29,null,"Active","a6Q1R000000AJ2x",0,0,0,0,7321.29,0,null,null,"Organizing a multisectoral coordination and follow-up meeting with all stakeholders (education, justice, law enforcement, etc.):\nIn order to take into account the multisectoral dimension of AIDS control, the DNLS plans to hold twice-yearly meetings involving all stakeholders (education, justice, law enforcement, etc.). These meetings provide an opportunity to share the status of both grant implementation and planning.","Medium",null,"NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Congo","Congo","PAI-4019","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.",32544.05,null,"Active","a6Q1R000000AJ2H",0,0,0,0,32544.05,0,null,null,"This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.","Low","Needed to monitor the status of malaria drug efficacy, not covered in the allocation","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: ACT therapeutic efficacy test","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Congo","Congo","PAI-4018","MCI-00012","Case management","MCI-00164","Other case management intervention(s)",null,1711367.97,null,"Active","a6Q1R000000AJ2G",0,0,0,0,1711367.97,0,null,null,null,"Low","Stipend for CHW and equipment needed to expand malaria community case management are not covered in the allocation","NA Original Module: Community case management. Original Intervention: Stipend for CHW and equipment","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-3992","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Mass distribution campaigns involving 20,934,506 LLINs in eight (8) DPSs (Kongo Central, Kasaï, Kinshasa, Maniema, Tshopo, Ituri, Haut-Uele and Bas-Uele) with a total estimated population of 34,234,164, representing 30% of the country.  The average cost is USD 4.15 per LLIN distributed. The total estimated cost is USD 86,878,200. This will make it possible to maintain adequate universal coverage among these populations, in line with WHO recommendations, and to ensure that the gains made are not lost because of the decrease in mosquito net ownership.",86878200,null,"Active","a6Q1R000000AJ1q",21280986,26000000,3403543,0,36193670.549999997,0,null,null,"Mass distribution campaigns involving 20,934,506 LLINs in eight (8) DPSs (Kongo Central, Kasaï, Kinshasa, Maniema, Tshopo, Ituri, Haut-Uele and Bas-Uele) with a total estimated population of 34,234,164, representing 30% of the country.  The average cost is USD 4.15 per LLIN distributed. The total estimated cost is USD 86,878,200. This will make it possible to maintain adequate universal coverage among these populations, in line with WHO recommendations, and to ensure that the gains made are not lost because of the decrease in mosquito net ownership.","High","The country is requesting funds to procure and distribute through a mass campaign 20,934,506 LLINs in 8 Divisions provinciales de la santé (DPSs) (Kongo Central, Kasaï, Kinshasa, Maniema, Tshopo, Ituri, Haut-Uele and Bas-Uele) with a total estimated population of 34,234,164, representing 30% of the country. This is a high impact malaria control intervention that will increase LLINs coverage and hence reduce malaria burden in DRC.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Cambodia","Cambodia","PAI-4654","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","This is aimed to expand the implementation of TB active case finding (ACF) activities including implementation of C-DOTS, ACF in prisons and hospital linkages to cover 30 operational districts (30 ODs). Currently, TB active case finding activities are limited to 46 ODs. Expansion to the 30 ODs will contribute to detection of 5,240 by the end of 2020.",2081316,null,"Active","a6Q1R000000AJCW",0,1966353,0,0,114963,0,null,null,"This is aimed to expand the implementation of TB active case finding (ACF) activities including implementation of C-DOTS, ACF in prisons and hospital linkages to cover 30 operational districts (30 ODs). Currently, TB active case finding activities are limited to 46 ODs. Expansion to the 30 ODs will contribute to detection of 5,240 by the end of 2020.","High","-",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Asia","2020-12-31","TB/HIV"]
["CT Cambodia","Cambodia","PAI-4649","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Contribution to HEF to cover HIV service packages: HIV and STI Testing and Counselling at Health Centres, HIV Testing and Counselling at VCCT Centres,Adult and Paediatric Pre-ART and ART Service, and transportation fees to ART patients in need.",1824459,null,"Active","a6Q1R000000AJCR",0,0,0,0,1824459,0,null,null,"Contribution to HEF to cover HIV service packages: HIV and STI Testing and Counselling at Health Centres, HIV Testing and Counselling at VCCT Centres,Adult and Paediatric Pre-ART and ART Service, and transportation fees to ART patients in need.","High","To expand access to the HEF-financed package of HIV and TB services through the Health Equity Fund for the poor, vulnerable groups. An evaluation of how the HEF can adequately support HIV and TB services should be included. In addition, the evaluation should include an estimation of how many HIV/TB, HIV or TB patients will be (or are) covered by the HEF as a consequence of this investment. In so doing, it is suggested that the program track the package of services (specific medications, laboratory tests, consultation with doctors, nurses, transportation to attend clinical appointments, etc.) received by HIV/TB, HIV or TB patients under this\narrangement and to review in order to\nensure the services provided are in line\nwith the treatment algorithm adopted by\nthe country. In addition, there should be a rapid follow-up survey of HIV/TB, HIV, TB patients and their care givers to get feedback on perceived service quality, patient satisfaction and any perceived discrimination or stigma. Providers should identify if there are any challenges and if there were any stock out of health care commodities or medications, and the length of waiting time, etc. Consider feeding the findings\nto the HEF steering committee for quality assurance and to facilitate continued  mprovement of the HEF services. (if it is feasible, to include type of patients served to ascertain if there is a barrier for people of different self-identities or any specific key populations.","NA Original Intervention: HEF","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Asia","2020-12-31","HIV/AIDS"]
["CT Bhutan","Bhutan","PAI-3923","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Establishment of web-based reporting system and improving cross-border data sharing.",133960,null,"Inactive","a6Q1R000000AJ0j",0,133960,0,0,0,1,null,null,"Establishment of web-based reporting system and improving cross-border data sharing.","High","Innovative web-based real time reporting to promote rapid case detection and treatment, which is vital feature for avoiding local transmission and resurgence.","23/05/2018: As per email of CT (Lindsey Cole),  module\"RSSH: Health management information systems and M&E\" were seperated with 2 interventions on the grant-sign off form during grant negotiations:  \"routine reporting\" with remaning UQD 79,960 and \"other health information systems and M&E interventions\" with remaning UQD 54,000 Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Strengthening of routine reporting. Analyses, review and transparency; M&E real time - web-based","Shalini Mitra","2019-10-30","2017-2019","Malaria"," South East Asia","2021-06-30","Malaria"]
["CT Bhutan","Bhutan","PAI-3918","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","This funding will be used to build the capacity of the National HIV/AIDS Commission in order to create an enabling policy environment and improve long-term impact.",35000,null,"Active","a6Q1R000000AJ0e",0,0,0,0,35000,0,null,null,"This funding will be used to build the capacity of the National HIV/AIDS Commission in order to create an enabling policy environment and improve long-term impact.","Medium","Vehicle will be used for supervision as well\nas delivery of commodities in pooled system\nbenefiting integrated health services","NA Original Module: RSSH - Program management. Original Intervention: Health systems development","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," South East Asia","2021-06-30","HIV/AIDS"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3913","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Activity 46: Training for nurses from the Bolivian Amazon Region (Riberalta)",30533.15,null,"Active","a6Q1R000000AJ0Z",0,0,0,0,30533.15,0,null,null,"Activity 46: Training for nurses from the Bolivian Amazon Region (Riberalta)","Medium",null,"The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Intervention: Treatment in health facility","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Latin America and Caribbean","2021-12-31","Malaria"]
["CT Burkina Faso","Burkina Faso","PAI-3851","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Expand IMCI-REC in 12 new health districts. As of 31 December 2017, 16 health districts will have the capacity to implement integrated child care through the use of the electronic tool (IMCI-REC).",3091978.07,null,"Inactive","a6Q1R000000AIzZ",0,3091978.07,0,0,0,1,null,null,"Expand IMCI-REC in 12 new health districts. As of 31 December 2017, 16 health districts will have the capacity to implement integrated child care through the use of the electronic tool (IMCI-REC).","Low","For the expansion of the implementation of IMCI-REC in 12 new districts in Eastern regions, the Sahel and North Center; to improve the capacity of the health districts in implementing IMCI using the electronic tool. Propose applicant to request UNICEF and/or the Government to provide additional funds. Within the 12 new Districts include two Districts where MEDSINC is implemented for comparison","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Expand IMCI-REC in 12 new districts","Shalini Mitra","2019-10-30","2017-2019","Malaria"," High Impact Africa 1","2020-12-31","Malaria"]
["CT Burkina Faso","Burkina Faso","PAI-3849","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Equip 11 community organizations that offer HIV treatment and care with basic medical equipment.",152466.60999999999,null,"Active","a6Q1R000000AIzX",0,0,0,0,152466.60999999999,0,null,null,"Equip 11 community organizations that offer HIV treatment and care with basic medical equipment.","High","This activity will equip 11 community health centres with medical equipment for people living with HIV and likely to offer quality services to people living with HIV.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 1","2020-12-31","HIV/AIDS"]
["CT Burkina Faso","Burkina Faso","PAI-3844","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.",80404,null,"Active","a6Q1R000000AIzS",0,0,0,0,80404,0,null,null,"Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.","High","This activity aims to provide monitoring of peer support to people living with HIV, pregnant women and their babies in the context of task shifting and involving people living with HIV themselves and is considered a high priority given that supportive supervision is critical after training and important to ensure corrective measures and quality of care.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Carrying out a quarterly monitoring mission concerning the activities carried out by the associations for PLHIV in relation to the eMTCT plan and community support","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," High Impact Africa 1","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3770","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):\nImprovement of the biological monitoring of people living with HIV (PLHIV).",19066.32,null,"Active","a6Q1R000000AIyG",0,0,0,0,19066.32,0,null,null,"Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):\nImprovement of the biological monitoring of people living with HIV (PLHIV).","Medium",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3765","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.",146149.70000000001,null,"Active","a6Q1R000000AIyB",0,0,0,0,146149.70000000001,0,null,null,"Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.","High",null,"NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Benin","Benin","PAI-3764","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: \n-Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (?2,103.80) \n-Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (?4,315.07)\n-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (?4,573.47) \n-Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (?7,546.23) \n-Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (?1,632.73) \n-Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (?6,585.80) \n-The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (?4,102.40) \n-Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (?5,460.72) \n-Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (?3,430.10)\n-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for OVC and PLHIV in all departments (plan) (?343.01) \n-Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (?4,573.47) \n-Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (?332,582.78) \n-Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (?10,425.99) \n-Covering the costs of the ReBAP+ helpline (?1,646.45) \n-Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (?4,573.47) \n-Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (?42,807.68) \n-Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?8,479.21) \n-Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?9,878.70) \n-Producing badges for the peer educators/health mediators involved in the projects (?1,524.49)",71292.78,null,"Active","a6Q1R000000AIyA",0,0,0,0,71292.78,0,null,null,"These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: \n-Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (?2,103.80) \n-Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (?4,315.07)\n-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (?4,573.47) \n-Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (?7,546.23) \n-Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (?1,632.73) \n-Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (?6,585.80) \n-The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (?4,102.40) \n-Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (?5,460.72) \n-Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (?3,430.10)\n-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for OVC and PLHIV in all departments (plan) (?343.01) \n-Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (?4,573.47) \n-Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (?332,582.78) \n-Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (?10,425.99) \n-Covering the costs of the ReBAP+ helpline (?1,646.45) \n-Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (?4,573.47) \n-Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (?42,807.68) \n-Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?8,479.21) \n-Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?9,878.70) \n-Producing badges for the peer educators/health mediators involved in the projects (?1,524.49)","Medium","Substantial resources allocated to procurement and distribution of nutritional kits as a psychosocial support measure. Evidence of the utility of nutritional kits is better for children than general adult populations on ART especially in a test and treat approach to ART. The TRP is also concerned about the sustainability of this measure in the long term as cessation of these programs could affect long-term adherence. The TRP requests to clarify how suitable this intervention is in the epidemic context of Benin and whether this is sustainable in the long-run. This explains the medium priority rating for these activities The remaining activities are maintained in the ?High? category.","NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Ethiopia","Ethiopia","PAI-4254","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","FCSWs are key population group with 23% HIV prevalence, and difficult to reach. Peer education is one of the successful SBCC intervention to effectively address and result in behavioral change.",1364000,null,"Inactive","a6Q1R000000AJ64",1364000,0,0,0,0,1,null,null,"FCSWs are key population group with 23% HIV prevalence, and difficult to reach. Peer education is one of the successful SBCC intervention to effectively address and result in behavioral change.","High","The TRP recommends that this sum move within allocation and is used for testing and treatment for key populations","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 2",null,"TB/HIV"]
["CT Honduras","Honduras","PAI-4428","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","? Procurement of equipment for audiometry and electrocardiograms to strengthen the active drug monitoring of adverse events to TB second-line drugs.\n? Monitoring of the implementation of active pharmacovigilance in Health Facilities that manage MDR TB patients on an outpatient basis. \n? Support the active search for TB patients activities carried out by health personnel with the involvement of community staff.",100738.79,null,"Active","a6Q1R000000AJ8s",8723,0,0,0,92015.79,0,null,null,"? Procurement of equipment for audiometry and electrocardiograms to strengthen the active drug monitoring of adverse events to TB second-line drugs.\n? Monitoring of the implementation of active pharmacovigilance in Health Facilities that manage MDR TB patients on an outpatient basis. \n? Support the active search for TB patients activities carried out by health personnel with the involvement of community staff.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-07-31","Tuberculosis"]
["CT Honduras","Honduras","PAI-4423","MCI-00008","TB care and prevention","MCI-00591","Removing human rights and gender related barriers to TB care and prevention","Training for health care personnel on a) stigma and discrimination against people with TB; b) infection control measures to reduce the risk of becoming infected with TB in their workplace.",42675.41,null,"Active","a6Q1R000000AJ8n",21365,0,0,0,21310.41,0,null,null,"Training for health care personnel on a) stigma and discrimination against people with TB; b) infection control measures to reduce the risk of becoming infected with TB in their workplace.","High",null,"NA Original Intervention: Removing human rights- and gender-related barriers to TB care and prevention","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-07-31","Tuberculosis"]
["CT Honduras","Honduras","PAI-4421","MCI-00008","TB care and prevention","MCI-00132","Collaborative activities with other programs and sectors (TB care and prevention)","? Activities to raise awareness of legislators, judges, law enforcement agents since they play an important role in protecting and enforcing the rights of tuberculosis patients and their families. \n? Activities relating to referring prisoner patients to health facilities when obtaining their release letter or when transferred to another penitentiary center.\n? Social audits: involve civil society in the monitoring and tracking of TB control activities in the prioritized Health Regions with the highest TB load.",25004.36,null,"Active","a6Q1R000000AJ8l",0,0,0,0,25004.36,0,null,null,"? Activities to raise awareness of legislators, judges, law enforcement agents since they play an important role in protecting and enforcing the rights of tuberculosis patients and their families. \n? Activities relating to referring prisoner patients to health facilities when obtaining their release letter or when transferred to another penitentiary center.\n? Social audits: involve civil society in the monitoring and tracking of TB control activities in the prioritized Health Regions with the highest TB load.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-07-31","Tuberculosis"]
["CT Honduras","Honduras","PAI-4401","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Contracting a coordinator and workers for organizations that intervene in the Garifuna population",122711,null,"Active","a6Q1R000000AJ8R",0,0,0,0,122711,0,null,null,"Contracting a coordinator and workers for organizations that intervene in the Garifuna population","High",null,"NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-07-31","HIV/AIDS"]
["CT Honduras","Honduras","PAI-4400","MCI-00023","Program management","MCI-00207","Grant management","Monitoring and Evaluation Officer (includes all the benefits)",118850.91,null,"Active","a6Q1R000000AJ8Q",0,0,0,0,118850.91,0,null,null,"Monitoring and Evaluation Officer (includes all the benefits)","High","TRP recommends that the applicant further develop an efficient coordination structure for implementation the key populations programs, avoiding when possible to have coordinators and staff for each key population sub-groups. The TRP furthermore recommends the applicant to consider integrating the roles of coordinator for key populations in only one position and including that position within-allocation if efficiencies are found during grant-making.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2022-07-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4399","MCI-00010","MDR-TB","MCI-00146","Collaborative activities with other programs and sectors (MDR-TB)","Local and regional meetings on the implementation of differentiated models for treatment adherence and support at community, family and personal levels (peer strategies, mentoring, patient support groups etc.).",137829.66,null,"Active","a6Q1R000000AJ8P",31134.61,0,0,0,106695.05,0,null,null,"Local and regional meetings on the implementation of differentiated models for treatment adherence and support at community, family and personal levels (peer strategies, mentoring, patient support groups etc.).","Medium",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Guatemala","Guatemala","PAI-4398","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Secretary chair.",229,null,"Active","a6Q1R000000AJ8O",0,0,0,0,229,0,null,null,"Secretary chair.","Medium","The interventions in lines 5 to 8 of this table correspond to office material that should be consolidated in a single intervention line.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Guatemala","Guatemala","PAI-4397","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Modular office furniture with overhead storage cabinets.",1032,null,"Active","a6Q1R000000AJ8N",921.45,0,0,0,110.55,0,null,null,"Modular office furniture with overhead storage cabinets.","Medium","The interventions in lines 5 to 8 of this table correspond to office material that should be consolidated in a single intervention line.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Guatemala","Guatemala","PAI-4396","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Multifunctional desktop printer.",688,null,"Inactive","a6Q1R000000AJ8M",688,0,0,0,0,1,null,null,"Multifunctional desktop printer.","Medium","The interventions in lines 5 to 8 of this table correspond to office material that should be consolidated in a single intervention line.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Guatemala","Guatemala","PAI-4395","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Desktop computers.",3408,null,"Active","a6Q1R000000AJ8L",0,0,0,0,3408,0,null,null,"Desktop computers.","Medium","The interventions in lines 5 to 8 of this table correspond to office material that should be consolidated in a single intervention line.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Guatemala","Guatemala","PAI-4394","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Refurbishment of the laboratory at the Justo Rufino Barrios Health Center.",26842.5,null,"Inactive","a6Q1R000000AJ8K",26842.5,0,0,0,0,1,null,null,"Refurbishment of the laboratory at the Justo Rufino Barrios Health Center.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Guatemala","Guatemala","PAI-4393","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","First aid kits.",2999,null,"Inactive","a6Q1R000000AJ8J",2999,0,0,0,0,1,null,null,"First aid kits.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Guatemala","Guatemala","PAI-4392","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Regional training in line probe assays (LPAs) at the Rodolfo Robles Hospital.",1025.76,null,"Active","a6Q1R000000AJ8I",0,0,0,0,1025.76,0,null,null,"Regional training in line probe assays (LPAs) at the Rodolfo Robles Hospital.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Guatemala","Guatemala","PAI-4391","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","International consultancy services for technical assistance and GxAlert platform support.",4500,null,"Inactive","a6Q1R000000AJ8H",4500,0,0,0,0,1,null,null,"International consultancy services for technical assistance and GxAlert platform support.","High","A functional GxAlert platform allows a rapid communication of tuberculosis tests results to care providers.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Latin America and Caribbean","2022-06-30","Tuberculosis"]
["CT Guatemala","Guatemala","PAI-4372","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","San Marcos health area department. Renovation of a 25.52 m² facility, including: \nerecting a plasterboard wall; installing lighting; power sockets; two wooden doors; two aluminum windows; fitting adhesive vinyl; four fixed furniture units; paintwork.",9677.42,null,"Active","a6Q1R000000AJ7y",0,0,0,0,9677.42,0,null,null,"San Marcos health area department. Renovation of a 25.52 m² facility, including: \nerecting a plasterboard wall; installing lighting; power sockets; two wooden doors; two aluminum windows; fitting adhesive vinyl; four fixed furniture units; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4371","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Retalhuleu health area department. Renovation of a 51.53 m² facility, including: \nremoving and supplying sliding aluminum door; nine windows; three lights; six power sockets; four fixed furniture units; paintwork; installing an 18,000 BTU air conditioning unit.",9677.42,null,"Active","a6Q1R000000AJ7x",0,0,0,0,9677.42,0,null,null,"Retalhuleu health area department. Renovation of a 51.53 m² facility, including: \nremoving and supplying sliding aluminum door; nine windows; three lights; six power sockets; four fixed furniture units; paintwork; installing an 18,000 BTU air conditioning unit.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4370","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Central Guatemala health department. Renovation of a 44.18 m² facility, including: \nRemove existing metal structure and fit  a new structure; remove a suspended ceiling; erect and repair walls; make furniture units; two wooden doors; one aluminum door; installing electricity; paintwork; renovate balconies and 1 metal door; replace mechanisms and adhesive vinyl for 3 aluminum window; fit ducting for electrical wiring; install a 18,000 BTU ACU.",9677.42,null,"Active","a6Q1R000000AJ7w",0,0,0,0,9677.42,0,null,null,"Central Guatemala health department. Renovation of a 44.18 m² facility, including: \nRemove existing metal structure and fit  a new structure; remove a suspended ceiling; erect and repair walls; make furniture units; two wooden doors; one aluminum door; installing electricity; paintwork; renovate balconies and 1 metal door; replace mechanisms and adhesive vinyl for 3 aluminum window; fit ducting for electrical wiring; install a 18,000 BTU ACU.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4369","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Elisa Martínez National Hospital, Puerto Barrios, Izabal (planning pending)",10775,null,"Active","a6Q1R000000AJ7v",0,0,0,0,10775,0,null,null,"Elisa Martínez National Hospital, Puerto Barrios, Izabal (planning pending)","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4368","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Zacapa Regional Hospital (planning pending).",10775,null,"Active","a6Q1R000000AJ7u",0,0,0,0,10775,0,null,null,"Zacapa Regional Hospital (planning pending).","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4367","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Huehuetenango National Hospital (planning pending).",10775,null,"Active","a6Q1R000000AJ7t",0,0,0,0,10775,0,null,null,"Huehuetenango National Hospital (planning pending).","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4366","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Escuintla National Hospital (planning pending).",10755,null,"Active","a6Q1R000000AJ7s",0,0,0,0,10755,0,null,null,"Escuintla National Hospital (planning pending).","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4359","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","San Marcos health area department.  Renovation of XX  m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.",6000,null,"Active","a6Q1R000000AJ7l",0,0,0,0,6000,0,null,null,"San Marcos health area department.  Renovation of XX  m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4358","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Coban Health Center, Alta Verapaz. Renovation of a 13.91 m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.",6000,null,"Active","a6Q1R000000AJ7k",0,0,0,0,6000,0,null,null,"Coban Health Center, Alta Verapaz. Renovation of a 13.91 m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4357","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Flores Health Center, Petén. Renovation of a 52.37 m² laboratory, including: \ndemolishing fixed concrete furniture; removing and replacing door, installing water and electricity; laying ceramic flooring; renovating four doors; fitting suspended ceiling; making three fixed furniture units and two overhead furniture units; fitting two sinks and one washbasin; installing insulated waterproof roof sheeting; paintwork.",6000,null,"Active","a6Q1R000000AJ7j",0,0,0,0,6000,0,null,null,"Flores Health Center, Petén. Renovation of a 52.37 m² laboratory, including: \ndemolishing fixed concrete furniture; removing and replacing door, installing water and electricity; laying ceramic flooring; renovating four doors; fitting suspended ceiling; making three fixed furniture units and two overhead furniture units; fitting two sinks and one washbasin; installing insulated waterproof roof sheeting; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4356","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Quetzaltenango Health Center. Renovation of a 20.98 m² laboratory, including: \nerecting a block wall and a plasterboard wall; finishing for walls; laying ceramic flooring; four windows; installing water and electricity; one washbasin, one sink; making fixed furniture units; one metal door; one wooden door; metal structure; suspended ceiling; paintwork.",6000,null,"Active","a6Q1R000000AJ7i",0,0,0,0,6000,0,null,null,"Quetzaltenango Health Center. Renovation of a 20.98 m² laboratory, including: \nerecting a block wall and a plasterboard wall; finishing for walls; laying ceramic flooring; four windows; installing water and electricity; one washbasin, one sink; making fixed furniture units; one metal door; one wooden door; metal structure; suspended ceiling; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4355","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Poptún Health Center, Petén. Renovation of a 44.34 m² laboratory, including: erecting a plasterboard wall; fitting suspended ceiling, two washbasins; replacing existing sink fittings; making fixed furniture units; installing water and electricity; laying ceramic flooring; two windows; paintwork.",4000,null,"Active","a6Q1R000000AJ7h",0,0,0,0,4000,0,null,null,"Poptún Health Center, Petén. Renovation of a 44.34 m² laboratory, including: erecting a plasterboard wall; fitting suspended ceiling, two washbasins; replacing existing sink fittings; making fixed furniture units; installing water and electricity; laying ceramic flooring; two windows; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4351","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Drug-resistance prevalence study for 2020:\n? Develop a HIV drug-resistance plan\n? Develop an ARV drug-resistance protocol \n? Analyze acquired resistance profiles in second-line regimen (ART).",200000,null,"Inactive","a6Q1R000000AJ7d",200000,0,0,0,0,1,null,null,"Drug-resistance prevalence study for 2020:\n? Develop a HIV drug-resistance plan\n? Develop an ARV drug-resistance protocol \n? Analyze acquired resistance profiles in second-line regimen (ART).","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4350","MCI-00004","Prevention programs for other vulnerable populations","MCI-00104","Diagnosis and treatment of STIs and other sexual health services for other vulnerable populations",null,500000,null,"Active","a6Q1R000000AJ7c",0,0,0,0,500000,0,null,null,null,"High","TRP recommend to use STI evidence-based test (Duo HIV-syphilis test or rapid syphilis test).","NA Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4349","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00088","Condoms and lubricant programming for sex workers","12,951,220 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.",518049,null,"Active","a6Q1R000000AJ7b",0,0,0,0,518049,0,null,null,"12,951,220 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","High",null,"Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'Condoms and lubricant programming for sex workers' are merged in the TRP form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4348","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00088","Condoms and lubricant programming for sex workers","10,900,316 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.",436013,null,"Active","a6Q1R000000AJ7a",0,0,0,0,436013,0,null,null,"10,900,316 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.","High",null,"Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'Condoms and lubricant programming for sex workers' are merged in the TRP form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4347","MCI-00531","Comprehensive prevention programs for TGs","MCI-00555","Condoms and lubricant programming for TGs","2,975,714 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.",119029,null,"Active","a6Q1R000000AJ7Z",0,0,0,0,119029,0,null,null,"2,975,714 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","High",null,"All the interventions for 'Condoms and lubricant programming for transgender people' under module 'Comprehensive prevention programs for transgender people' are merged in the TRP form Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Condoms and lubricant programming for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4346","MCI-00531","Comprehensive prevention programs for TGs","MCI-00555","Condoms and lubricant programming for TGs","2,767,550 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.",110702,null,"Active","a6Q1R000000AJ7Y",0,0,0,0,110702,0,null,null,"2,767,550 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.","High",null,"All the interventions for 'Condoms and lubricant programming for transgender people' under module 'Comprehensive prevention programs for transgender people' are merged in the TRP form Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Condoms and lubricant programming for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4345","MCI-00534","Comprehensive prevention programs for MSM","MCI-00606","Condoms and lubricant programming for MSM","5,802,056 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.",232082.24,null,"Active","a6Q1R000000AJ7X",0,0,0,0,232082.24,0,null,null,"5,802,056 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","High",null,"All the interventions for 'Condoms and lubricant programming for men who have sex with men' under module 'Comprehensive prevention programs for men who have sex with men' are merged in the TRP form Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Condoms and lubricant programming for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4344","MCI-00534","Comprehensive prevention programs for MSM","MCI-00606","Condoms and lubricant programming for MSM","3,430,381 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.",137215.22,null,"Active","a6Q1R000000AJ7W",0,0,0,0,137215.22,0,null,null,"3,430,381 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.","High",null,"All the interventions for 'Condoms and lubricant programming for men who have sex with men' under module 'Comprehensive prevention programs for men who have sex with men' are merged in the TRP form Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Condoms and lubricant programming for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4343","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","12,951,220 condoms to cover 82 percent of the programmatic gap in 2020.",388537,null,"Active","a6Q1R000000AJ7V",0,0,0,0,388537,0,null,null,"12,951,220 condoms to cover 82 percent of the programmatic gap in 2020.","High",null,"Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'HIV testing services for sex workers' are merged in the TRP form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4342","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","10,900,316 condoms to cover 82 percent of the programmatic gap in 2019.",327009,null,"Active","a6Q1R000000AJ7U",0,0,0,0,327009,0,null,null,"10,900,316 condoms to cover 82 percent of the programmatic gap in 2019.","High",null,"Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'HIV testing services for sex workers' are merged in the TRP form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guatemala","Guatemala","PAI-4341","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Migration of 25% of the ART patient cohort to the new preferred regimen: (Tenofovir+Emtricitabine+Dolutegravir 10+200+50 mg pill).\nThe NACP will contribute to migrating 25 percent of the ART patient cohort to the new preferred first-line regimen in 2020. This above allocation budget includes a contribution to the migration of a further 25 percent of the ART cohort. The new preferred regimen is more cost-effective.",254961,null,"Inactive","a6Q1R000000AJ7T",254961,0,0,0,0,1,null,null,"Migration of 25% of the ART patient cohort to the new preferred regimen: (Tenofovir+Emtricitabine+Dolutegravir 10+200+50 mg pill).\nThe NACP will contribute to migrating 25 percent of the ART patient cohort to the new preferred first-line regimen in 2020. This above allocation budget includes a contribution to the migration of a further 25 percent of the ART cohort. The new preferred regimen is more cost-effective.","High",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4340","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Ensure communication costs of PMTCT sites for follow-up of deadlines. Credit for communication is provided to communicate with women as part of PMTCT.",40956.120000000003,null,"Active","a6Q1R000000AJ7S",0,0,0,0,40956.120000000003,0,null,null,"Ensure communication costs of PMTCT sites for follow-up of deadlines. Credit for communication is provided to communicate with women as part of PMTCT.","High","Reducing loss to follow-up of women in PMTCT is important. The TRP suggests to also look into private-public partnership for mHealth.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Component 4","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4339","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Ensure viral load testing for all patients on ART. For better management of treatment failures, each patient must have at least one viral load test per year. However, the PSM plan takes into account only 2,000 patients per year, for a target of 12,000, 13,000 and 14,000 patients for the three years of the grant. The acquisition of these additional tests will make it possible to cover 30% in 2018, 40% in 2019 and 50% in 2020.",2629135.9,null,"Active","a6Q1R000000AJ7R",0,0,0,0,2629135.9,0,null,null,"Ensure viral load testing for all patients on ART. For better management of treatment failures, each patient must have at least one viral load test per year. However, the PSM plan takes into account only 2,000 patients per year, for a target of 12,000, 13,000 and 14,000 patients for the three years of the grant. The acquisition of these additional tests will make it possible to cover 30% in 2018, 40% in 2019 and 50% in 2020.","High","Viral load is important in the followup of people on ART.","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4338","MCI-00071","Other module","MCI-00071","Other module","Recruit an international laboratory specialist to strengthen the capacities of the Directorate for Pharmaceutical, Laboratory and Drug Services/Ministry for Public Health and the National Health Institute [INASA] to draw up regulatory documents for the laboratory system.  In addition, the specialist will contribute to improving the quality of the laboratory services involved in health care for the three diseases.",201997.53,null,"Active","a6Q1R000000AJ7Q",0,0,0,0,201997.53,0,null,null,"Recruit an international laboratory specialist to strengthen the capacities of the Directorate for Pharmaceutical, Laboratory and Drug Services/Ministry for Public Health and the National Health Institute [INASA] to draw up regulatory documents for the laboratory system.  In addition, the specialist will contribute to improving the quality of the laboratory services involved in health care for the three diseases.","High","Reinforcing the lab with a specialist is extremely important given the weakness of the lab system.","NA Original Module: RSSH. Original Intervention: Service organisation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Western Africa","2020-12-31","TB/HIV"]
["CT Dominican Republic","Dominican Republic","PAI-4172","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","The practices of self-care, prevention of HIV and other STIs in MSM and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources will be allocated to increasing the targets that can be reached to improve self-care and prevention practices.",592400,null,"Active","a6Q1R000000AJ4k",430230.04,0,0,0,162169.96,0,null,null,"The practices of self-care, prevention of HIV and other STIs in MSM and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources will be allocated to increasing the targets that can be reached to improve self-care and prevention practices.","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Djibouti","Djibouti","PAI-4171","MCI-00009","TB/HIV","MCI-00135","Engaging all care providers (TB/HIV)","Handling costs of Genexpert machines to measure the Viral Load (VL) (Cost of the service agent). This will allow the permanent use of the machines and thus increase the percentage of PLHIV having access to the VL.",39000,null,"Active","a6Q1R000000AJ4j",0,0,0,0,39000,0,null,null,"Handling costs of Genexpert machines to measure the Viral Load (VL) (Cost of the service agent). This will allow the permanent use of the machines and thus increase the percentage of PLHIV having access to the VL.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4170","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Establishment of an efficient transport system in the Testing and Treatment Centers in Djibouti (includes daily allowances related to awareness (transport / meeting / and other costs)).",16949,null,"Active","a6Q1R000000AJ4i",0,0,0,0,16949,0,null,null,"Establishment of an efficient transport system in the Testing and Treatment Centers in Djibouti (includes daily allowances related to awareness (transport / meeting / and other costs)).","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4169","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Extended warranty of digital radiology equipment (See line 21).",39000,null,"Active","a6Q1R000000AJ4h",0,0,0,0,39000,0,null,null,"Extended warranty of digital radiology equipment (See line 21).","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4168","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Staff training in the use of digital radiology equipment (See line 21).",3763,null,"Active","a6Q1R000000AJ4g",0,0,0,0,3763,0,null,null,"Staff training in the use of digital radiology equipment (See line 21).","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4167","MCI-00009","TB/HIV","MCI-00581","Key populations (TB/HIV) - Prisoners","Provide clinical screening for TB and free HIV testing (DIPS). (Per diems related to awareness of prisoners and other populations (transport / meeting / and other costs)).",41993,null,"Active","a6Q1R000000AJ4f",0,0,0,0,41993,0,null,null,"Provide clinical screening for TB and free HIV testing (DIPS). (Per diems related to awareness of prisoners and other populations (transport / meeting / and other costs)).","High",null,"NA Original Intervention: Key populations (TB/HIV) ? prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4166","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Recruit the national technical assistant for capacity assessment for the transfer (Fees related to technical assistance - Consultants).",85831,null,"Active","a6Q1R000000AJ4e",0,0,0,0,85831,0,null,null,"Recruit the national technical assistant for capacity assessment for the transfer (Fees related to technical assistance - Consultants).","Low","While the TRP considers this activity to be quality demand, it is not as high a priority as other activities in PAAR.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4165","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","See previous itervention - line 54.",169,null,"Active","a6Q1R000000AJ4d",0,0,0,0,169,0,null,null,"See previous itervention - line 54.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4164","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","The analysis of performance of the TB program and, following that, following up with the resulting recommendations will allow reaching the program's objectives.",678,null,"Active","a6Q1R000000AJ4c",0,0,0,0,678,0,null,null,"The analysis of performance of the TB program and, following that, following up with the resulting recommendations will allow reaching the program's objectives.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Burundi","Burundi","PAI-3726","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.",160535,null,"Active","a6Q1R000000AIxY",0,0,0,0,160535,0,null,null,"Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3725","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.",501858,null,"Active","a6Q1R000000AIxX",0,0,0,0,501858,0,null,null,"Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3724","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.",170205,null,"Active","a6Q1R000000AIxW",0,0,0,0,170205,0,null,null,"Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3723","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Purchase a teleconference device.",4069,null,"Active","a6Q1R000000AIxV",0,0,0,0,4069,0,null,null,"Purchase a teleconference device.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3722","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Purchase of computer equipment.",68600,null,"Active","a6Q1R000000AIxU",0,0,0,0,68600,0,null,null,"Purchase of computer equipment.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3721","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.",73811,null,"Active","a6Q1R000000AIxT",0,0,0,0,73811,0,null,null,"A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.","High",null,"NA Original Module: RSSH - National health strategies","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3720","MCI-00023","Program management","MCI-00207","Grant management","Performance bonuses.\nThe motivation of the staff is essential to maintain the achievements and safeguard the performance of the Program\nThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.",30183,null,"Active","a6Q1R000000AIxS",0,0,0,0,30183,0,null,null,"Performance bonuses.\nThe motivation of the staff is essential to maintain the achievements and safeguard the performance of the Program\nThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3719","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Data validation and dissemination activity.\nVerification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.",161830,null,"Active","a6Q1R000000AIxR",0,0,0,0,161830,0,null,null,"Data validation and dissemination activity.\nVerification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis"," Central Africa","2020-12-31","Tuberculosis"]
["CT Burundi","Burundi","PAI-3689","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","Activity: Buy three trucks for active distribution of health inputs\nThese trucks will be used to transport drugs from CAMEBU to district pharmacies.",438366,null,"Active","a6Q1R000000AIwx",0,0,0,0,438366,0,null,null,"Activity: Buy three trucks for active distribution of health inputs\nThese trucks will be used to transport drugs from CAMEBU to district pharmacies.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3688","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance plan\nQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.",130925,null,"Active","a6Q1R000000AIww",0,0,0,0,130925,0,null,null,"Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance plan\nQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3687","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Activity: Ensuring the maintenance of the AUTOMATE (GAS)\nThe CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.",35069,null,"Active","a6Q1R000000AIwv",0,0,0,0,35069,0,null,null,"Activity: Ensuring the maintenance of the AUTOMATE (GAS)\nThe CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.","Low",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3686","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:\nFollowing the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.",24888,null,"Active","a6Q1R000000AIwu",0,0,0,0,24888,0,null,null,"Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:\nFollowing the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.","Low",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3685","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training in quality control of associated molecules (ARV, anti-TB).\nTraining in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.",12000,null,"Active","a6Q1R000000AIwt",0,0,0,0,12000,0,null,null,"Activity: Training in quality control of associated molecules (ARV, anti-TB).\nTraining in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3684","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:\nThe DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days",27237,null,"Active","a6Q1R000000AIws",0,0,0,0,27237,0,null,null,"Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:\nThe DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days","Medium",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3683","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session",65947,null,"Active","a6Q1R000000AIwr",0,0,0,0,65947,0,null,null,"Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session","Medium",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3654","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)\nNutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. \nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond\nActivity is related to indicator #: TCS-1 (M)",173582,null,"Active","a6Q1R000000AIwO",0,0,0,0,173582,0,null,null,"Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)\nNutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. \nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond\nActivity is related to indicator #: TCS-1 (M)","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3653","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)\nGiven the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond",560962,null,"Active","a6Q1R000000AIwN",0,0,0,0,560962,0,null,null,"Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)\nGiven the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3652","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)\nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond",25343,null,"Active","a6Q1R000000AIwM",0,0,0,0,25343,0,null,null,"Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)\nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3651","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)\nThis activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target",202134,null,"Active","a6Q1R000000AIwL",0,0,0,0,202134,0,null,null,"Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)\nThis activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3650","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.\nThis activity aims to reduce new infections by facilitating PS to access prevention and care services.",4350,null,"Active","a6Q1R000000AIwK",0,0,0,0,4350,0,null,null,"Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.\nThis activity aims to reduce new infections by facilitating PS to access prevention and care services.","High",null,"NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3649","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00548","Community empowerment for PWID","Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDU\nThis activity aims to improve the living conditions of key populations.",43274,null,"Active","a6Q1R000000AIwJ",0,0,0,0,43274,0,null,null,"Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDU\nThis activity aims to improve the living conditions of key populations.","High",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Community empowerment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Burundi","Burundi","PAI-3648","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Activity: Acquire the complement of reagents for the viral load.\nThe 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. \nThis funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.",1432738,null,"Active","a6Q1R000000AIwI",0,0,0,0,1432738,0,null,null,"Activity: Acquire the complement of reagents for the viral load.\nThe 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. \nThis funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.","High",null,"NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Central Africa","2020-12-31","HIV/AIDS"]
["CT Angola","Angola","PAI-3575","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","PAAR investment will support activities for TB/ HIV increased integration at both national and district level by  supporting  TWG quarterly meeting at  provincial and municipality levels, joint TB/ HIV planning and supervision of integrated delivery of TB and HIV services.",360000,null,"Active","a6Q1R000000AIv7",0,0,0,0,360000,0,null,null,"PAAR investment will support activities for TB/ HIV increased integration at both national and district level by  supporting  TWG quarterly meeting at  provincial and municipality levels, joint TB/ HIV planning and supervision of integrated delivery of TB and HIV services.","High","This is important to improve TB -HIV outcomes and integration.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Angola","Angola","PAI-3574","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.",355500,null,"Active","a6Q1R000000AIv6",0,0,0,0,355500,0,null,null,"The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Angola","Angola","PAI-3573","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","PAAR will support refresher training of Laboratory staff  in  diagnosis of MDRTB in 2019  and reagents for solid and liquid culture, three (3) LPA (Line Probe Assay) equipment?s and their respective reagents. Expected outcome will be increase in MDR TB cases detected and notified.",177750,null,"Active","a6Q1R000000AIv5",0,0,0,0,177750,0,null,null,"PAAR will support refresher training of Laboratory staff  in  diagnosis of MDRTB in 2019  and reagents for solid and liquid culture, three (3) LPA (Line Probe Assay) equipment?s and their respective reagents. Expected outcome will be increase in MDR TB cases detected and notified.","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Angola","Angola","PAI-3572","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","The PAAR will support development of IEC Materials and  training  for community workers and Social mobilization on Community TB Care  in 18 provinces (210 agents for 84 municipalities)\nPAAR investment  will support Treatment Adherence  interventions (TAIs) catalytic to achieving the ambitious CNR and TSR targets, focusing on strengthening community  and peer support (ex-TB patients etc), food vouchers and transport refunds , home visits and others initiatives to mitigate the castrophic  costs from TB and improve treatment outcomes. Expected outcome will be increase in CNR and TSR.",260000,null,"Active","a6Q1R000000AIv4",0,0,0,0,260000,0,null,null,"The PAAR will support development of IEC Materials and  training  for community workers and Social mobilization on Community TB Care  in 18 provinces (210 agents for 84 municipalities)\nPAAR investment  will support Treatment Adherence  interventions (TAIs) catalytic to achieving the ambitious CNR and TSR targets, focusing on strengthening community  and peer support (ex-TB patients etc), food vouchers and transport refunds , home visits and others initiatives to mitigate the castrophic  costs from TB and improve treatment outcomes. Expected outcome will be increase in CNR and TSR.","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Angola","Angola","PAI-3571","MCI-00008","TB care and prevention","MCI-00127","Treatment","PAAR to support the printing  of  handbooks on (i) TB cases management (ii) TB in children; (iii) MDR-TB management and control; (iv) TB/HIV coinfection control; (iv) tasks of DOTS-C agents  in 2019. Expected outcome will be increase in quality of TB services in line with international standard for TB care (ISTC).",150000,null,"Active","a6Q1R000000AIv3",0,0,0,0,150000,0,null,null,"PAAR to support the printing  of  handbooks on (i) TB cases management (ii) TB in children; (iii) MDR-TB management and control; (iv) TB/HIV coinfection control; (iv) tasks of DOTS-C agents  in 2019. Expected outcome will be increase in quality of TB services in line with international standard for TB care (ISTC).","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Southern and Eastern Africa",null,"TB/HIV"]
["CT Djibouti","Djibouti","PAI-4125","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","This activity is regarding the routine distribution for pregnant women, children under 5, refugees and migrants.",205450,null,"Active","a6Q1R000000AJ3z",15405,0,0,0,190045,0,null,null,"This activity is regarding the routine distribution for pregnant women, children under 5, refugees and migrants.","High",null,"NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Middle East and North Africa","2020-12-31","Malaria"]
["CT Cuba","Cuba","PAI-4124","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Insufficient outreach to PLHIV for VC tests, affected by the interruptions of regional laboratory services, especially due to equipment breakdown and maladjustment caused by years of continuous operation. Likewise, the centralization of blood tests for VL studies hinders follow-up on PLHIV follow-up and limits the capacity of the PCS, especially as regards the Polyclinic to mobilize the PLHIV under their care. The additional resources will be dedicated to increasing the number of PLHIV with undetectable VL by gradual replacement of obsolete equipment and increasing access to blood testing points.",450000,null,"Inactive","a6Q1R000000AJ3y",0,450000,0,0,0,1,null,null,"Insufficient outreach to PLHIV for VC tests, affected by the interruptions of regional laboratory services, especially due to equipment breakdown and maladjustment caused by years of continuous operation. Likewise, the centralization of blood tests for VL studies hinders follow-up on PLHIV follow-up and limits the capacity of the PCS, especially as regards the Polyclinic to mobilize the PLHIV under their care. The additional resources will be dedicated to increasing the number of PLHIV with undetectable VL by gradual replacement of obsolete equipment and increasing access to blood testing points.","High","Will allow improve access and coverage with Viral Load testing","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Cuba","Cuba","PAI-4123","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Insufficient degrees of adherence to ART to have a sustainable impact on the rate of new infections and mortality caused by AIDS. Specialized counseling in ART adherence is not systematic, and follow-up by the health care team and other Polyclinic services to take on adherence and serodiscordance is weak.",84450,null,"Active","a6Q1R000000AJ3x",0,0,0,0,84450,0,null,null,"Insufficient degrees of adherence to ART to have a sustainable impact on the rate of new infections and mortality caused by AIDS. Specialized counseling in ART adherence is not systematic, and follow-up by the health care team and other Polyclinic services to take on adherence and serodiscordance is weak.","High","Will allow improve adherence rates",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Cuba","Cuba","PAI-4122","MCI-00007","Treatment, care and support","MCI-00119","Treatment monitoring - Drug resistance surveillance","There is insufficient knowledge of the magnitude of the problem of resistance to ARVs, which could impact treatment efficacy. Once the levels and causes of resistance are identified, the treatment protocols can be adapted or the therapy adjusted in individual cases to obtain undetectable viral load. In addition, the processes for certification of resistance-testing laboratories by the WHO will be studied to obtain a quality indicator of results.",525000,null,"Active","a6Q1R000000AJ3w",0,0,0,0,525000,0,null,null,"There is insufficient knowledge of the magnitude of the problem of resistance to ARVs, which could impact treatment efficacy. Once the levels and causes of resistance are identified, the treatment protocols can be adapted or the therapy adjusted in individual cases to obtain undetectable viral load. In addition, the processes for certification of resistance-testing laboratories by the WHO will be studied to obtain a quality indicator of results.","High","Will allow study the magnitude of the problem of resistance to ARVs, which could impact treatment efficacy and proceed with certification of resistance-testing laboratories by the WHO","NA Original Intervention: Treatment monitoring - drug resistance surveillance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Cuba","Cuba","PAI-4121","MCI-00531","Comprehensive prevention programs for TGs","MCI-00558","HIV testing services for TGs","The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.",9500,null,"Active","a6Q1R000000AJ3v",6300,0,0,0,3200,0,null,null,"The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.","High","Has the potential to increase the both prevention of new infections and treatment adherence","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: HIV testing services for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Cuba","Cuba","PAI-4120","MCI-00531","Comprehensive prevention programs for TGs","MCI-00554","Behavioral interventions for TGs","Self-care practices, prevention of HIV and other STIs in TGs and changes in behavior are not sufficient to achieve the necessary impact. The additional resources will be dedicated to increase the outreach goals to improve self-care and prevention.",17000,null,"Inactive","a6Q1R000000AJ3u",17000,0,0,0,0,1,null,null,"Self-care practices, prevention of HIV and other STIs in TGs and changes in behavior are not sufficient to achieve the necessary impact. The additional resources will be dedicated to increase the outreach goals to improve self-care and prevention.","High","Has the potential to increase the both prevention of new infections and treatment adherence","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Cuba","Cuba","PAI-4119","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.",80500,null,"Active","a6Q1R000000AJ3t",17000,0,0,0,63500,0,null,null,"The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.","High","Will support reaching testing coverage of highest risk sex workers",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2020-12-31","HIV/AIDS"]
["CT Comoros","Comoros","PAI-4059","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Supporting the operation of the Network for People Infected with or Affected by HIV: TAS \nTAS is a community-based organization engaged in HIV prevention and caring for PLHIV. Given the weak performance in the area of treatment and the ambitious targets of this funding request for ART (from 35 percent in 2019 to 65 percent in 2022), the DNLS recommended making TAS a sub-recipient to take part in family screening strategies (partner and child), the search for people lost to follow-up, the referral of HIV-positive people (test and treat), the distribution of nutritional kits and mediation for treatment of TB/HIV co-infection. Given the importance of this organization in the HIV response, the government has provided a building for TAS to use as its premises.\nThis activity supports TAS?s equipment needs (refurbishment of premises, chairs, tables, photocopiers, computers, office supplies, maintenance of equipment, Internet connection, etc.) in order to improve its results efficiency.",43796.43,null,"Active","a6Q1R000000AJ2v",0,0,0,0,43796.43,0,null,null,"Supporting the operation of the Network for People Infected with or Affected by HIV: TAS \nTAS is a community-based organization engaged in HIV prevention and caring for PLHIV. Given the weak performance in the area of treatment and the ambitious targets of this funding request for ART (from 35 percent in 2019 to 65 percent in 2022), the DNLS recommended making TAS a sub-recipient to take part in family screening strategies (partner and child), the search for people lost to follow-up, the referral of HIV-positive people (test and treat), the distribution of nutritional kits and mediation for treatment of TB/HIV co-infection. Given the importance of this organization in the HIV response, the government has provided a building for TAS to use as its premises.\nThis activity supports TAS?s equipment needs (refurbishment of premises, chairs, tables, photocopiers, computers, office supplies, maintenance of equipment, Internet connection, etc.) in order to improve its results efficiency.","Medium","Although the funding request\nproposes to provide bonuses for\nimproved tracking of mother/child, it is not clear how this will be sustained and how existing community structures will be leveraged for efficiency.","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Comoros","Comoros","PAI-4058","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Organizing seven training courses for untrained teachers and teaching supervisors per year on the three islands \nThe current grant has introduced STIs and HIV into the curriculum. \nIt has also provided training for 200 teachers and pedagogical supervisors on the three islands. However, this training has covered only 45 percent of needs. The allocation amount provides for three training courses for 60 teachers in the first year. Funding is therefore requested to cover 35 percent of the gap and to cover the needs of seven additional first-year training courses for teachers and teaching supervisors, to build their capacities to teach participants about STI and HIV prevention messages.",20406.240000000002,null,"Active","a6Q1R000000AJ2u",0,0,0,0,20406.240000000002,0,null,null,"Organizing seven training courses for untrained teachers and teaching supervisors per year on the three islands \nThe current grant has introduced STIs and HIV into the curriculum. \nIt has also provided training for 200 teachers and pedagogical supervisors on the three islands. However, this training has covered only 45 percent of needs. The allocation amount provides for three training courses for 60 teachers in the first year. Funding is therefore requested to cover 35 percent of the gap and to cover the needs of seven additional first-year training courses for teachers and teaching supervisors, to build their capacities to teach participants about STI and HIV prevention messages.","High","This is an important opportunity for the HIV managers to have six-monthly meetings to review the progress of the grant and to make course corrections when implementing approaches so as\nto achieve optimal progress and return Global Fund investments.","NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Comoros","Comoros","PAI-4057","MCI-00023","Program management","MCI-00207","Grant management","Carry out twice-yearly quality control for HIV screening by community staff specializing in key population and general population screening campaigns: \nThe community sector is important in the HIV response, in terms of both ART and screening and monitoring. Screening, which is a priority entry point, is organized through community sector campaigns.\nThis activity hopes to ensure that the results produced by the community actors during screening campaigns are reliable. Once every six months, health workers will visit screening campaign sites to ensure the quality of sampling and technical procedures for analyzing and interpreting screening results. This activity also provides an opportunity to strengthen training skills/supervisions. Finally, samples analyzed will be transported to reference laboratories to ensure that quality control produces reliable results.",17820.669999999998,null,"Active","a6Q1R000000AJ2t",0,0,0,0,17820.669999999998,0,null,null,"Carry out twice-yearly quality control for HIV screening by community staff specializing in key population and general population screening campaigns: \nThe community sector is important in the HIV response, in terms of both ART and screening and monitoring. Screening, which is a priority entry point, is organized through community sector campaigns.\nThis activity hopes to ensure that the results produced by the community actors during screening campaigns are reliable. Once every six months, health workers will visit screening campaign sites to ensure the quality of sampling and technical procedures for analyzing and interpreting screening results. This activity also provides an opportunity to strengthen training skills/supervisions. Finally, samples analyzed will be transported to reference laboratories to ensure that quality control produces reliable results.","High",null,"NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Comoros","Comoros","PAI-4056","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","Arrange a midterm evaluation of the national strategic plan (NSP) in 2022\nThe country will develop a new strategic plan 2020?2024. This plan, which will serve as the basis for planning the entire HIV program, will require a midterm (2022) evaluation to adjust interventions.  \nA budget for arranging this midterm evaluation is included in the PAAR.",29858.6,null,"Active","a6Q1R000000AJ2s",0,0,0,0,29858.6,0,null,null,"Arrange a midterm evaluation of the national strategic plan (NSP) in 2022\nThe country will develop a new strategic plan 2020?2024. This plan, which will serve as the basis for planning the entire HIV program, will require a midterm (2022) evaluation to adjust interventions.  \nA budget for arranging this midterm evaluation is included in the PAAR.","High","Critical intervention given the centrality of teachers in communicating with adolescents, and the importance of integrating HIV prevention into school health programs.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Comoros","Comoros","PAI-4055","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","Providing training on PMTCT to 60 providers at public and private health posts to scale up the elimination of mother-to-child transmission (eMTCT):  \nThe country has set itself the challenge of eliminating mother-to child transmission by 2021. The current grant provided for PMTCT scale-up at 30 sites. This increase is coupled with a need for capacity building among untrained staff at antenatal clinics. This activity involves 60 providers at public and private health posts in the first year. This above allocation funding request will cover the additional training of 60 other PMTCT providers in the second year and 60 in the third year. These health workers at antenatal sites, including midwives, will be responsible for Pillar 1 of PMTCT and for monitoring HIV-positive pregnant women until early childhood diagnosis.",29727.3,null,"Active","a6Q1R000000AJ2r",0,0,0,0,29727.3,0,null,null,"Providing training on PMTCT to 60 providers at public and private health posts to scale up the elimination of mother-to-child transmission (eMTCT):  \nThe country has set itself the challenge of eliminating mother-to child transmission by 2021. The current grant provided for PMTCT scale-up at 30 sites. This increase is coupled with a need for capacity building among untrained staff at antenatal clinics. This activity involves 60 providers at public and private health posts in the first year. This above allocation funding request will cover the additional training of 60 other PMTCT providers in the second year and 60 in the third year. These health workers at antenatal sites, including midwives, will be responsible for Pillar 1 of PMTCT and for monitoring HIV-positive pregnant women until early childhood diagnosis.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Comoros","Comoros","PAI-4054","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Implementing community-based condom distribution points in villages and towns: \nAn unreliable supply of condoms at the community level was reported as a major constraint that could hinder prevention interventions. As part of this grant, the DNLS therefore initiated the implementation of community-based condom distribution points in villages and towns run by community workers, as recommended in the national community health strategy. Mapping of villages shows that there are 331 villages to cover: 214 on Grande Comore (Ngazidja), 91 on Anjouan (Ndzuwani) and 26 on Mohéli (Mwali). \nThis above allocation funding request should cover 10 percent of the villages on each island in the first year, 20 percent in the second year and 35 percent in the third year. In each village, one distribution point will be selected in the first year, which will increase to three distribution points in the second and third years.   \nA total of 579 distribution points will be established in 215 villages over the three-year period: 372 on Grande Comore, 159 on Anjouan and 48 on Mohéli.",12995.17,null,"Active","a6Q1R000000AJ2q",0,0,0,0,12995.17,0,null,null,"Implementing community-based condom distribution points in villages and towns: \nAn unreliable supply of condoms at the community level was reported as a major constraint that could hinder prevention interventions. As part of this grant, the DNLS therefore initiated the implementation of community-based condom distribution points in villages and towns run by community workers, as recommended in the national community health strategy. Mapping of villages shows that there are 331 villages to cover: 214 on Grande Comore (Ngazidja), 91 on Anjouan (Ndzuwani) and 26 on Mohéli (Mwali). \nThis above allocation funding request should cover 10 percent of the villages on each island in the first year, 20 percent in the second year and 35 percent in the third year. In each village, one distribution point will be selected in the first year, which will increase to three distribution points in the second and third years.   \nA total of 579 distribution points will be established in 215 villages over the three-year period: 372 on Grande Comore, 159 on Anjouan and 48 on Mohéli.","High",null,"NA Original Intervention: Male and female condoms for adolescents and youth, in and out of school","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Southern and Eastern Africa","2022-06-30","HIV/AIDS"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4015","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Pediatric TB training for maternal, neonatal and child health (MNCH) and diabetes providers The investment will be used to better incorporate pediatric TB screening and case management into the following activities: - Delivering pediatric TB training to two service providers per MNCH and malnutrition treatment center (TT)/TTC (2,068 x 2); - Delivering training to 516 diabetes and malnutrition treatment service providers.",224064,null,"Active","a6Q1R000000AJ2D",0,0,0,0,224064,0,null,null,"Pediatric TB training for maternal, neonatal and child health (MNCH) and diabetes providers The investment will be used to better incorporate pediatric TB screening and case management into the following activities: - Delivering pediatric TB training to two service providers per MNCH and malnutrition treatment center (TT)/TTC (2,068 x 2); - Delivering training to 516 diabetes and malnutrition treatment service providers.","High","High need / High impact","NA Original Intervention: Key populations (TB care and prevention) ? Others","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4014","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Improved treatment of side effects for DR-TB patients This investment is expected to improve DR-TB case management by: - Extending permanent technical assistance to six more provinces (on top of the five high-priority provinces included under the allocation amount), thereby covering a total of 11 provinces with high DR-TB prevalence rates); - Procuring 243 portable hearing test devices to assess DR-TB patients in the 243 health zones (HZs) in the 11 high-priority provinces, and purchasing 642 hearing aids for patients; - Building the capacities of DR-TB health workers through sending them to scientific symposia and on study trips; - Developing partnerships with universities.",854250,null,"Active","a6Q1R000000AJ2C",0,0,0,0,854250,0,null,null,"Improved treatment of side effects for DR-TB patients This investment is expected to improve DR-TB case management by: - Extending permanent technical assistance to six more provinces (on top of the five high-priority provinces included under the allocation amount), thereby covering a total of 11 provinces with high DR-TB prevalence rates); - Procuring 243 portable hearing test devices to assess DR-TB patients in the 243 health zones (HZs) in the 11 high-priority provinces, and purchasing 642 hearing aids for patients; - Building the capacities of DR-TB health workers through sending them to scientific symposia and on study trips; - Developing partnerships with universities.","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4013","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","Pharmacovigilance and laboratory strengthening This additional investment is intended to address rising drug resistance in the country and respond to the introduction of new drugs, initially to treat XDR-TB cases. It will be used to help establish a pharmacovigilance system to monitor and manage DR-TB drug side effects, with a view to future extension of the new drugs to treat DR-TB (non-XDR-TB).",2083840,null,"Active","a6Q1R000000AJ2B",0,0,0,0,2083840,0,null,null,"Pharmacovigilance and laboratory strengthening This additional investment is intended to address rising drug resistance in the country and respond to the introduction of new drugs, initially to treat XDR-TB cases. It will be used to help establish a pharmacovigilance system to monitor and manage DR-TB drug side effects, with a view to future extension of the new drugs to treat DR-TB (non-XDR-TB).","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4012","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Supply chain and quality assurance strengthening This investment will significantly improve the TB drugs supply chain, through the following activities: - Have the Programme National d?Approvisionnement en Médicaments essentiels [National Program for the Procurement of Essential Medicines ? PNAM] and the National Tuberculosis Control Program (NTCP) take part in PSM monitoring and supervision missions at the Centrale de Distribution Régionale des Médicaments [Regional Drug Distribution Center ? CDR]; - Organize drug sample collection missions at all levels of the supply chain for quality control, in conjunction with the Direction de la Pharmacie et du Médicament [Directorate of Pharmacy and Drugs ? DPM]; - Cover the costs of having the samples analyzed by a foreign laboratory prequalified by the World Health Organization (WHO) to analyze first-line drugs. (10 percent of the drug?s value ? see Quality Assurance Plan); - Create and configure databases, produce reports and deliver training on Apisoft to the central and provincial levels; - Cover handling costs for drugs and other supplies; - Deliver TB drug management training to service providers.",2421488,null,"Inactive","a6Q1R000000AJ2A",2421488,0,0,0,0,1,null,null,"Supply chain and quality assurance strengthening This investment will significantly improve the TB drugs supply chain, through the following activities: - Have the Programme National d?Approvisionnement en Médicaments essentiels [National Program for the Procurement of Essential Medicines ? PNAM] and the National Tuberculosis Control Program (NTCP) take part in PSM monitoring and supervision missions at the Centrale de Distribution Régionale des Médicaments [Regional Drug Distribution Center ? CDR]; - Organize drug sample collection missions at all levels of the supply chain for quality control, in conjunction with the Direction de la Pharmacie et du Médicament [Directorate of Pharmacy and Drugs ? DPM]; - Cover the costs of having the samples analyzed by a foreign laboratory prequalified by the World Health Organization (WHO) to analyze first-line drugs. (10 percent of the drug?s value ? see Quality Assurance Plan); - Create and configure databases, produce reports and deliver training on Apisoft to the central and provincial levels; - Cover handling costs for drugs and other supplies; - Deliver TB drug management training to service providers.","High","High need / High impact","13/11/17: Shreya forwarded emails from Naboundou Toure-Fadiga on 13/10/17 that this activity was removed during grant negotiations. Made this intervention inactive by artifically changing the $ amount","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4011","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","Infection control measures Administrative, environmental and personal infection control measures will be needed to help prevent the transmission of TB (and DR-TB in particular), as defined in (Le Guide du Contrôle de l?infection et le guide de prise en charge de la TB-PR). The additional investment will be used to renovate 26 incinerators at testing and treatment centers (TTCs) with a high DR-TB burden in the 11 high-priority provinces (two per high-priority province plus four extra incinerators in Kinshasa), and to carry out minor renovation work at 708 TTCs selected on the basis of their TB/HIV co-infection burden. There are also plans to monitor and evaluate the implementation of these measures. This intervention should help avoid 250 new infections at the TTCs in question.",1169800,null,"Active","a6Q1R000000AJ29",0,0,0,0,1169800,0,null,null,"Infection control measures Administrative, environmental and personal infection control measures will be needed to help prevent the transmission of TB (and DR-TB in particular), as defined in (Le Guide du Contrôle de l?infection et le guide de prise en charge de la TB-PR). The additional investment will be used to renovate 26 incinerators at testing and treatment centers (TTCs) with a high DR-TB burden in the 11 high-priority provinces (two per high-priority province plus four extra incinerators in Kinshasa), and to carry out minor renovation work at 708 TTCs selected on the basis of their TB/HIV co-infection burden. There are also plans to monitor and evaluate the implementation of these measures. This intervention should help avoid 250 new infections at the TTCs in question.","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4010","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Renovation of DR-TB in-patient facilities The purpose of the additional investment is to renovate three in-patient treatment centers for drug-resistant TB (DR-TB) patients presenting with complications or severe side effects during treatment. The three centers will be located in DR-TB hot spots. The unit cost of US$ 115,000 is a historical cost from the current grants.",449550,null,"Active","a6Q1R000000AJ28",0,0,0,0,449550,0,null,null,"Renovation of DR-TB in-patient facilities The purpose of the additional investment is to renovate three in-patient treatment centers for drug-resistant TB (DR-TB) patients presenting with complications or severe side effects during treatment. The three centers will be located in DR-TB hot spots. The unit cost of US$ 115,000 is a historical cost from the current grants.","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4009","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Diagnosis and treatment of XDR-TB cases This additional request would allow treatment to begin for 62 patients with extensively drug-resistant TB (XDR-TB) in 2018, 75 in 2019 and 88 in 2020. The activities concerned are the purchase of drugs, the corresponding PSM costs and three technical assistance activities for managing XDR-TB patients.",2364088,null,"Active","a6Q1R000000AJ27",0,0,0,0,2364088,0,null,null,"Diagnosis and treatment of XDR-TB cases This additional request would allow treatment to begin for 62 patients with extensively drug-resistant TB (XDR-TB) in 2018, 75 in 2019 and 88 in 2020. The activities concerned are the purchase of drugs, the corresponding PSM costs and three technical assistance activities for managing XDR-TB patients.","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," High Impact Africa 1","2020-12-31","TB/HIV"]
["CT Cameroon","Cameroon","PAI-3988","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","This would be used to support the following activities: -Additional six-monthly mass   TB/HIV   campaigns   in prisons with more than 1,000 inmates and on a quarterlybasisin   institutions   with   less   than   1,000   inmates. Purchase   of   additional   supplies   for   TB   and   HIV prevention (infection control, safe shaving) for prisoners and support for the coordination of these activities, which will  help  to  ensure  TB  is  diagnosed  earlier  and  avoid  it being spread. In  addition,  it  would  facilitate  the  purchase  of  two  mobile digital X-ray machines exclusively for prisoners, which would significantly improve the rate of return for screening.",708964.2,null,"Active","a6Q1R000000AJ1m",248008.08,0,0,0,460956.12,0,null,null,"This would be used to support the following activities: -Additional six-monthly mass   TB/HIV   campaigns   in prisons with more than 1,000 inmates and on a quarterlybasisin   institutions   with   less   than   1,000   inmates. Purchase   of   additional   supplies   for   TB   and   HIV prevention (infection control, safe shaving) for prisoners and support for the coordination of these activities, which will  help  to  ensure  TB  is  diagnosed  earlier  and  avoid  it being spread. In  addition,  it  would  facilitate  the  purchase  of  two  mobile digital X-ray machines exclusively for prisoners, which would significantly improve the rate of return for screening.","High","This funding is important to support activities to conduct TB/HIV massscreening campaigns in prisons and to purchase two mobile digital X-ray machines for use in prisons. This intervention is part of active case finding strategy for key populations and with potential to identify the undiagnosed TB and HIV cases. In addition to proposed screening of prisoners, the TRP recommends that during the screening 6 campaigns, the prison staff be screened as well.","NA Original Intervention: Key populations (TB/HIV) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Cameroon","Cameroon","PAI-3987","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","This  funding  would  be  used  to  renovate  hospital  wards  for MDR-TB/RR-TB   patients   in five hospital   (Limbé,   Maroua, Bafoussam,  Bertoua  and  Garoua)  in  Year  2.  The  funding wouldalso provide community care for 100 additional MDR-TB/RR-TB patients between Year 1 and Year 3.",25148.69,null,"Active","a6Q1R000000AJ1l",0,0,0,0,25148.69,0,null,null,"This  funding  would  be  used  to  renovate  hospital  wards  for MDR-TB/RR-TB   patients   in five hospital   (Limbé,   Maroua, Bafoussam,  Bertoua  and  Garoua)  in  Year  2.  The  funding wouldalso provide community care for 100 additional MDR-TB/RR-TB patients between Year 1 and Year 3.","High","The funds will renovate existing hospitals in Limbé, Maroua, Bafoussam, Bertoua and Garoua to provide for treatment of MDR-TB patients requiring hospitalization as well as provide community care for 100 additional MDR-TB/RR-TB patients.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Cameroon","Cameroon","PAI-3986","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","This would be used for the following activities: -Support for community DOTS (home-based treatment by a  qualified  nurse)  for  daily  administration  of  MDR-TB drugs     to     240  additional  MDR-TB  outpatients; hospitalization costs.-Purchase of ten audiometer machines for MDR-TB in the year.",534321.62,null,"Active","a6Q1R000000AJ1k",170726.07,0,0,0,363595.55,0,null,null,"This would be used for the following activities: -Support for community DOTS (home-based treatment by a  qualified  nurse)  for  daily  administration  of  MDR-TB drugs     to     240  additional  MDR-TB  outpatients; hospitalization costs.-Purchase of ten audiometer machines for MDR-TB in the year.","High","These funds will enable the treatment of additional MDR TB patients by supporting community DOTS (home-based treatment by a qualified nurse) for daily administration of MDR-TB drugs to 240 additional MDR-TB outpatients; as well as purchasing ten audiometer machines for MDR-TB","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Cameroon","Cameroon","PAI-3985","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","This funding would be used to purchase tests for initial check-up and follow-up of 100 additional MDR-TB patients between Year  1  and  Year 3.  It  would  also  cover  screening  for  MDR-TB/RR-TB among new TB cases. This would be after having tested 100 percent of the primary group at higher risk, which is patients with a history of previous treatment.",49771.07,null,"Active","a6Q1R000000AJ1j",0,0,0,0,49771.07,0,null,null,"This funding would be used to purchase tests for initial check-up and follow-up of 100 additional MDR-TB patients between Year  1  and  Year 3.  It  would  also  cover  screening  for  MDR-TB/RR-TB among new TB cases. This would be after having tested 100 percent of the primary group at higher risk, which is patients with a history of previous treatment.","High","The funds will enable expansion of testing for MDR, including screening of new TB patients.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Cameroon","Cameroon","PAI-3984","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00549","Addressing stigma, discrimination and violence against PWID","This   funding   would   be   used   to   run   additional   training workshops for magistrates on the subject of access to health services for MSM, people who inject drugs and sex workers.",15746.83,null,"Active","a6Q1R000000AJ1i",0,0,0,0,15746.83,0,null,null,"This   funding   would   be   used   to   run   additional   training workshops for magistrates on the subject of access to health services for MSM, people who inject drugs and sex workers.","Low","Such interventions are already included in the proposed activities and the added value of an additional training is difficult to assess.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Addressing stigma, discrimination and violence against people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Cameroon","Cameroon","PAI-3983","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","This funding would be used to purchase two mobile digital X-ray  machines  for  PLHIV  who  cannot  pay  for  X-rays,  in  the Douala   and   Yaoundé   regions.   This   would   significantly improve the rate of return for TB screening in these patients. TRP recommends swaping between X-Ray equipment for hospital currently budgeted in the allocation.",248008.08,null,"Inactive","a6Q1R000000AJ1h",248008.08,0,0,0,0,1,null,null,"This funding would be used to purchase two mobile digital X-ray  machines  for  PLHIV  who  cannot  pay  for  X-rays,  in  the Douala   and   Yaoundé   regions.   This   would   significantly improve the rate of return for TB screening in these patients. TRP recommends swaping between X-Ray equipment for hospital currently budgeted in the allocation.","High","This funding is considered of high importance in order to increase screening for TB among disadvantaged PLHIV by purchasing digital X-ray machines in the Douala and Yaoundé regions. The TRP recommends that this intervention is swapped for the procurement of hospital-based X-rays within allocation as mobile X-ray has a higher potential to contribute to TB screening and diagnosis","NA Original Intervention: Community management of TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Central Africa",null,"TB/HIV"]
["CT Djibouti","Djibouti","PAI-4163","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","The activities of analysis and quarterly validation of data with stakeholders and service providers ensure data quality and a better follow-up of performance indicators.",18576,null,"Active","a6Q1R000000AJ4b",0,0,0,0,18576,0,null,null,"The activities of analysis and quarterly validation of data with stakeholders and service providers ensure data quality and a better follow-up of performance indicators.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4162","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Purchase of 3 x-ray digital X-ray machine with printer including one for the diagnosis of TB in children at the level of the Hopital Chakib Saad (HPPCSO) and two others for the community health centers with an important activity  on the outskirts of Djibouti city (Balbala 1 and Balbala 2) These devices will reduce the cost and are transportable. The expected result is an improved screening of new TB cases  especially at children level.",302024,null,"Active","a6Q1R000000AJ4a",0,0,0,0,302024,0,null,null,"Purchase of 3 x-ray digital X-ray machine with printer including one for the diagnosis of TB in children at the level of the Hopital Chakib Saad (HPPCSO) and two others for the community health centers with an important activity  on the outskirts of Djibouti city (Balbala 1 and Balbala 2) These devices will reduce the cost and are transportable. The expected result is an improved screening of new TB cases  especially at children level.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4161","MCI-00008","TB care and prevention","MCI-00128","Prevention","The study on TB/diabetes co-infection will allow better identification of new cases of TB and of diabetes.",8475,null,"Active","a6Q1R000000AJ4Z",0,0,0,0,8475,0,null,null,"The study on TB/diabetes co-infection will allow better identification of new cases of TB and of diabetes.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4160","MCI-00008","TB care and prevention","MCI-00128","Prevention","The sample study at national level on the correlation between TB and malnutrition and HIV and malnutrition in healh centers will contribute to identify new cases of TB and HIV.",8475,null,"Active","a6Q1R000000AJ4Y",0,0,0,0,8475,0,null,null,"The sample study at national level on the correlation between TB and malnutrition and HIV and malnutrition in healh centers will contribute to identify new cases of TB and HIV.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4159","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","The integration of TB and HIV testing into Ministry of Health's advanced strategy activities will need supervision to improve the quality of interventions.  These interventions will allow identifying and treating new cases of TB and HIV.",8475,null,"Active","a6Q1R000000AJ4X",0,0,0,0,8475,0,null,null,"The integration of TB and HIV testing into Ministry of Health's advanced strategy activities will need supervision to improve the quality of interventions.  These interventions will allow identifying and treating new cases of TB and HIV.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4158","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","The service providers and community workers will be trained on the quality of services and RTTR(Reach, test, treat, and retain)-HIV-TB-Human Rights. They will contribute to identifing and referring suspect HIV and TB cases (index and contacts).",8475,null,"Active","a6Q1R000000AJ4W",0,0,0,0,8475,0,null,null,"The service providers and community workers will be trained on the quality of services and RTTR(Reach, test, treat, and retain)-HIV-TB-Human Rights. They will contribute to identifing and referring suspect HIV and TB cases (index and contacts).","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4157","MCI-00006","PMTCT","MCI-00201","Analysis, review and transparency","The peer educators- traning is meant to contribute to  the action plan in the context of the RTTR (Reach, test, treat, and retain) TB-HIV-Human Rights strategy, the enrollment and retaining of patients and data collection.",24585,null,"Active","a6Q1R000000AJ4V",0,0,0,0,24585,0,null,null,"The peer educators- traning is meant to contribute to  the action plan in the context of the RTTR (Reach, test, treat, and retain) TB-HIV-Human Rights strategy, the enrollment and retaining of patients and data collection.","High",null,"NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4156","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","The implementation of the national strategy of condom distribution for young people will allow prevention of STIs (sexually-transmitted infections) and HIV and prevention of unintended pregnancies.",3763,null,"Active","a6Q1R000000AJ4U",0,0,0,0,3763,0,null,null,"The implementation of the national strategy of condom distribution for young people will allow prevention of STIs (sexually-transmitted infections) and HIV and prevention of unintended pregnancies.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Djibouti","Djibouti","PAI-4155","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","Monitoring, coaching and supervision of peer educators'activities will  allow improvement of quality of intervention and reaching the program's objectives.",2822,null,"Active","a6Q1R000000AJ4T",0,0,0,0,2822,0,null,null,"Monitoring, coaching and supervision of peer educators'activities will  allow improvement of quality of intervention and reaching the program's objectives.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Middle East and North Africa","2020-12-31","TB/HIV"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3909","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the region?s needs.",62117.18,null,"Active","a6Q1R000000AJ0V",0,0,0,0,62117.18,0,null,null,"Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the region?s needs.","High",null,"The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Module: Monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Latin America and Caribbean","2021-12-31","Malaria"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3908","MCI-00012","Case management","MCI-00157","Active case detection and investigation (elimination phase)","Activity 59: Amazon Region Meeting to consolidate the AOP for each municipality. (Participants: organized civil population, municipality, regional authorities) prior to preparation of the AOP (July each year) in Cobija.\nActivity mentioned in the diagnosis for transition as part of the negotiation with municipalities.",52155,null,"Active","a6Q1R000000AJ0U",0,0,0,0,52155,0,null,null,"Activity 59: Amazon Region Meeting to consolidate the AOP for each municipality. (Participants: organized civil population, municipality, regional authorities) prior to preparation of the AOP (July each year) in Cobija.\nActivity mentioned in the diagnosis for transition as part of the negotiation with municipalities.","High",null,"The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number.","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Latin America and Caribbean","2021-12-31","Malaria"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3907","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Conducting of a study of primary resistance to ARV in new patients is planned as a critical element of strategic information in order to strengthen management, decision-making in terms of antiretroviral drug policies, sustainability and progress towards the goal of suppressing viral loads. A total cost of USD 100,000 is estimated.",100000,null,"Active","a6Q1R000000AJ0T",0,0,0,0,100000,0,null,null,"Conducting of a study of primary resistance to ARV in new patients is planned as a critical element of strategic information in order to strengthen management, decision-making in terms of antiretroviral drug policies, sustainability and progress towards the goal of suppressing viral loads. A total cost of USD 100,000 is estimated.","High","As the last sex worker study was conducted in 2010, the TRP considers this proposed study to be a high priority for PAAR. Should additional resources become available through efficiencies or other sources, the TRP recommends prioritization of IBBS for sex workers (including moving this activity into the allocation) so that the applicant can assess if interventions for sex workers are working by having a trend to analyze.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3906","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.",50000,null,"Active","a6Q1R000000AJ0S",0,0,0,0,50000,0,null,null,"Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3905","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.",5808,null,"Active","a6Q1R000000AJ0R",0,0,0,0,5808,0,null,null,"Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS"," Latin America and Caribbean","2021-12-31","HIV/AIDS"]
["CT Belize","Belize","PAI-3904","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","The operationalization of the non-discrimination law is key.  Once the non-discrimination law is introduced by Cabinet there will be need for mass education on this new legislation to make it effective. This is a key activity of the funding request based on the Transition Readiness Assessment findings to improve the legislative environment.",50000,null,"Active","a6Q1R000000AJ0Q",0,0,0,0,50000,0,null,null,"The operationalization of the non-discrimination law is key.  Once the non-discrimination law is introduced by Cabinet there will be need for mass education on this new legislation to make it effective. This is a key activity of the funding request based on the Transition Readiness Assessment findings to improve the legislative environment.","Low","The TRP considers television spots as low relevance because there is little evidence that TV spots contribute to reducing human rights-related barriers to HIV services.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis"," Latin America and Caribbean","2021-12-31","TB/HIV"]
["CT Romania","Romania","PAI-6134","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",862153.52,862153.52,"Active","a6Q1R000000AJd3",{"$nulls":4},862153.52,0,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2021-03-31","Tuberculosis"]
["CT Moldova","Moldova","PAI-6124","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1074153.67,1074153.67,"Inactive","a6Q1R000000AJcF",392670.86,1074153.67,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Tuberculosis"," Eastern Europe and Central Asia","2020-12-31","Tuberculosis"]
["CT Comoros","Comoros","PAI-6181","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","IRS for indigenous cases in elimination areas (5 km radius): In the elimination areas, malaria cases should undergo both epidemiological and entomological investigations to determine the origin of the case. Once the case is declared indigenous, case management (treatment) and interruption of parasite transmission by the vector (IRS) are the two main response interventions used to prevent epidemics. This activity will take place following the results of the prior entomological investigations. A total of nine IRS interventions are planned based on an expected 5 percent of imported cases over the three years in elimination areas. Thus, nine cases are expected in total  two cases in 2019, four cases in 2020 and three cases in 2021. Expected outcome: interruption of transmission. Expected impact: prevention of re-introduction of the disease.",419652,419652,"Active","a6Q1R000000AJmn",{"$nulls":4},419652,0,null,"High","IRS for indigenous cases in elimination areas (5 km radius): In the elimination areas, malaria cases should undergo both epidemiological and entomological investigations to determine the origin of the case. Once the case is declared indigenous, case management (treatment) and interruption of parasite transmission by the vector (IRS) are the two main response interventions used to prevent epidemics. This activity will take place following the results of the prior entomological investigations. A total of nine IRS interventions are planned based on an expected 5 percent of imported cases over the three years in elimination areas. Thus, nine cases are expected in total  two cases in 2019, four cases in 2020 and three cases in 2021. Expected outcome: interruption of transmission. Expected impact: prevention of re-introduction of the disease.","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Malaria"," Southern and Eastern Africa","2021-12-31","Malaria"]
["CT Central African Republic","Central African Republic","PAI-6196","MCI-00012","Case management","MCI-00154","Facility-based treatment","Dans le cadre d'une bonne gestion de stocks des intrants de santé et de rendre disponible les intrants financés par le Fonds Mondial en RCA, il a été opté de chercher un partenaire ayant une expertise et une capacité logistique qui est le ??Programme Alimentaire Mondial (PAM). Les couts y relatifs couvrent le transport des intrants à l'intérieur du pays, l'assurance des intrants, les frais de manutention, la sécurité et les coûts d?opérations de support. Le budget qui était initialement prévu pour les trois années de la subvention était estimé à 2,100,000 Euros seulement et ne prenait en compte les frais de gestion payés au PAM. Cependant, il s'avère que ce budget soit insuffisant vu les factures du PAM jusqu?en Décembre 2019 estimé à 2,326,922 Euros d'où un dépassement de 226,922 euros, soit 10% du budget initialement prévu à cet effet. Ce budget est seulement pour la logistique des produits de santé excluant les moustiquaires. Notons que pour l'année 2019 le Fonds Mondial avait recommandé que ces frais ne devraient pas dépasse 1,260,000 euros. \n\nPour l'année 2020, il y aura une augmentation des Formations Sanitaires qui passeront de 736 à 838, ce qui va occasionner une augmentation des besoins en intrants (antipaludéens et TDR; mais leur achat sera couvert par les économies des autres lignes), des frais de transport (surtout qu'ils sont estimés en terme de volume transporté), de manutention et assurance. Ainsi, les prévisions budgétaires pour le PAM pour l'année 2020, estimées sur la base des dépenses actuelles, s'élèvent à 1,653, 302 Euros. Considérant le déficit actuel de 226,922 euros sur cette ligne budgétaire, il se dégage un gap financier cumulatif de 1,880,224 euros. Toutefois, sur base des économies dégagées sur les autres lignes budgétaires, le gap à combler s'élève à 1,673,649.68 euros.",1878183,1878183,"Inactive","a6Q1R000000AJnI",null,1878183,null,null,0,1,null,"High","To ensure sound management of commodities procured with Global Fund grant funds and their availability in CAR, the World Food Program (WFP) was selected as SCM partner, given their known expertise and logistical capacity. WFP?s budget and costs cover transportation of inputs in country, insurance, warehousing, handling, security and support costs. The original budget that was estimated to cover their services during three years of implementation reached EUR 2,100,000 and did not include management fees paid to WFP. Given WFP?s budget rate consumption so far and projected level of expenses at the end of 2019, EUR 2,326,922, it results in a EUR 226,922 over expenditure (10% above original budget planned for this purpose). This budget only covers logistics of health products excluding mosquito nets. Note that for the year 2019 the Global Fund had recommended that these costs should not exceed EUR 1,260,000.\n\nDuring year 2020, there will be an increase of number of functional health facilities (going from 736 to 838) in the country that will result in an increase demand of commodities (ACTs and RDTs, partly covered with grant savings), transportation costs (especially considering that their estimation is based on volume), warehousing and insurance. Adding this, the projected budget needs for WFP in 2020 (which are estimated on current budget absorption) raise up to EUR 1,653,302. If we consider the above mentioned 10% over expense, the funding gap is EUR 1,880,224. However, some efficiencies in country (identified in other budget lines) will contribute to cover part of the gap. Which results in a final gap of EUR 1,673,649.68.","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Central African Republic","Central African Republic","PAI-6195","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Il était prévu la distribution des MILD dans les régions 1, 2 et 3 en 2019 pour protéger les populations contre le paludisme, car la dernière campagne dans ces 3 régions remonte à 2014. \n\nLe rapport de la micro planification dans ces régions révèle que la population a augmenté de 49% par rapport aux chiffres de macro planification. Etant donné que les MILDs disponibles pour la campagne au niveau du pays ne sont que 1,800,700, alors que le besoin avec l'augmentation exige d'avoir 2,552,998 MILD afin de pouvoir couvrir ces régions, entrainant ainsi un gap de 752,300 MILDs qui couteront 1,847,798 euros.\n\nLe budget initialement prévue pour la campagne était seulement 3,325,097euros (coût opérationnel). L?augmentation de la population a engendré non seulement le gap en moustiquaires mais aussi un gap financier exorbitant relatif au cout opérationnel s'élevant à 3,864,538 euros. Il se trouve que pour couvrir les trois régions, le pays aura besoin de 7,189,635 euros incluant les couts liés aux ONG de mise en ?uvre; ce qui dégage ainsi un gap de 5,712,336 Euros incluant les moustiquaires additionnelles, leur distribution et les couts opérationnels. \n\nSi ce gap n'est pas comblé, le pays ne pourra pas faire la campagne dans ces trois régions et par conséquent il ne pourra pas atteindre l'objectif de la distribution de masse pour l'année 2019-2020.",6410432,6410432,"Inactive","a6Q1R000000AJnH",null,6410432,null,null,0,1,null,"High","The distribution of LLINs in Regions 1, 2 and 3 in 2019 was planned to protect populations against malaria, as the last campaign in these 3 regions was in 2014.\n\nThe report of micro planning in these areas reveals that the population has increased by 49% compared to macro planning figures. Given that the LLINs available in country for the campaign are only 1,800,700, while the need resulting from population increase requires 2,552,998 LLINs to cover these areas, there is a resulting gap of 752,300 LLINs that will cost EUR 1,847,798.\n\nThe initial budget for the campaign was only EUR 3,325,097(operational cost). The increase of the population has generated not only a gap in nets but also an exorbitant financial gap related to operational costs amounting to EUR 3,864,538. In order to keep covering the three regions within the mass campaing, the new budget would reach EUR 7,189,635 (including costs related to implementing NGOs). With the current level of funding, this results in a gap of EUR 5,712,336 including additional nets and respective distribution and operational costs.\n\nIf this gap is not filled, the country will not be able to implement the campaign in the 3 regions and will not be able to achieve coverage targets of mass distribution for the year 2019-2020.","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Central African Republic","Central African Republic","PAI-6197","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","Une des stratégies de la prise en charge du paludisme en temps réel est la création des Points Paludisme avec le soutien technique de MSF dans leurs zones d'intervention.  Cette stratégie va faire augmenter la demande de service au niveau communautaire et par conséquent la demande accrue des ACTs. Le nombre des points palu gérés par le groupe MSF est 78 avec une consommation mensuelle moyenne de 420 doses. La dose totale estimée est de 589,680 incluant un stock de sécurité de 6 mois. Pour l'acquisition de ces intrants, 272,974.67 euros sont nécessaires. Le coût de transport et d'assurance depuis chez le fournisseur/fabriquant jusqu' à Bangui est de 185,788 euros.   \n\nCe qui donne un budget global d'achat de 458,762.67 Euros faisant objet de demande additionnelle.",514827,514827,"Inactive","a6Q1R000000AJnJ",null,514827,null,null,0,1,null,"High","One of the strategies that will strengthen real-time malaria case management is the creation of Malaria Points (?palu points?) with MSF's technical support within their areas of intervention. This strategy will increase the demand for services at the community level and consequently the demand of commodities. The number of ?palu points? managed by MSF is 78 with an average monthly consumption of 420 doses of ACTs. The total estimated dose is therefore 589,680 (including a 6-month buffer stock). The procurement of these inputs (EUR 272,974.67) also requires the estimation of transport and insurance costs from the supplier / manufacturer to Bangui, which were estimated to raise EUR 185,788.\nThis gives an overall budget of EUR 458,762.67 for this intervention.","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Malaria"," Central Africa","2020-12-31","Malaria"]
["CT Liberia","Liberia","PAI-4695","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","The cost is to cover the training of the District Health Officers in the 14 counties except Montserrado in Monitoring and Evaluation.",157890,null,"Active","a6Q1R000000AJDB",0,0,0,0,157890,0,null,null,"The cost is to cover the training of the District Health Officers in the 14 counties except Montserrado in Monitoring and Evaluation.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4690","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00601","Supportive policy and programmatic environment","County level capacity building in all counties, minus the 4 counties in the South Eastern region where UNICEF is already providing capacity building.  The capacity building efforts will be led by specialists in the field for CHTs that require capacity building. Exact details of capacity building will be finalized once capacity assessments are be completed.",3000000,null,"Active","a6Q1R000000AJD6",0,0,676139,0,2323861,0,null,null,"County level capacity building in all counties, minus the 4 counties in the South Eastern region where UNICEF is already providing capacity building.  The capacity building efforts will be led by specialists in the field for CHTs that require capacity building. Exact details of capacity building will be finalized once capacity assessments are be completed.","High","The TRP considers the ?country-level capacity building? intervention following the previous ?capacity assessments? intervention, as highly relevant to strengthen the health system.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4689","MCI-00012","Case management","MCI-00154","Facility-based treatment","The request amount is intended to improve targeted health facilities for better provision of malaria, HIV and TB services aimed at improving maternal and child health services for increased mother and child survival. Adopting a facility shall include the provision of relevant equipment as per targeted health facility type, upgrading some existing health facility for improved capacity, strengthen emergency, preparedness and response.",1482080,null,"Active","a6Q1R000000AJD5",0,0,0,0,1482080,0,null,null,"The request amount is intended to improve targeted health facilities for better provision of malaria, HIV and TB services aimed at improving maternal and child health services for increased mother and child survival. Adopting a facility shall include the provision of relevant equipment as per targeted health facility type, upgrading some existing health facility for improved capacity, strengthen emergency, preparedness and response.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4692","MCI-00023","Program management","MCI-00207","Grant management","This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria during the 2021 Mass Distribution Campaign. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.",91440,null,"Active","a6Q1R000000AJD8",0,0,0,0,91440,0,null,null,"This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria during the 2021 Mass Distribution Campaign. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]
["CT Liberia","Liberia","PAI-4691","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","The matching funds requested to support integrated service delivery, seek to focus on investments in the platform for serviced delivery and strengthening clinical systems for integrated screening, diagnosis, and care, in-service skills building of clinicians to be able to deliver both TB and HIV services including management of late-stage HIV infection, and capacitating the community platform for support of TB treatment adherence and HIV supportive care.  The proposed site for initial intervention through matching fund investments is Liberia?s national referral facility for TB ? The TB Annex, based in Monrovia. As the country?s national referral center for TB services, all forms of TB including management of TB and co-morbidities like diabetes, DR-TB, and TB/HIV co-infection are managed at the facility, where integrated service delivery can serve as a model to further scale this approach at all levels from primary care through hospital-based treatment, at the county and regional levels.",742905,null,"Active","a6Q1R000000AJD7",0,0,0,0,742905,0,null,null,"The matching funds requested to support integrated service delivery, seek to focus on investments in the platform for serviced delivery and strengthening clinical systems for integrated screening, diagnosis, and care, in-service skills building of clinicians to be able to deliver both TB and HIV services including management of late-stage HIV infection, and capacitating the community platform for support of TB treatment adherence and HIV supportive care.  The proposed site for initial intervention through matching fund investments is Liberia?s national referral facility for TB ? The TB Annex, based in Monrovia. As the country?s national referral center for TB services, all forms of TB including management of TB and co-morbidities like diabetes, DR-TB, and TB/HIV co-infection are managed at the facility, where integrated service delivery can serve as a model to further scale this approach at all levels from primary care through hospital-based treatment, at the county and regional levels.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria"," Western Africa","2021-06-30","Malaria"]

{"sheet":"GOS UQD Report 04022020","index":4,"n_rows":2671,"n_cols":30,"rows_kept":1125,"cut":true,"hidden":true,"merged":[],"bounds":{"rows_first":500,"rows_last":125,"rows_between":500,"halvings":2}}
["Organization Name","PAAR Name","PAAR Intervention Name","Module Reference Id: Name ID","Module Reference Id: Name","Intervention Reference Id: Name ID","Intervention Reference Id: Name","Brief Rationale","TRP Approved","Requested Amount","Status","PAAR Intervention ID","UQD Funded Savings","UQD Funded PO","UQD Funded D2H PSC","UQD Funded Other","Remaining UQD","No Longer In Demand","Last Submitted Date Time","Applicant Priority Rating","Brief Rationale (Translated)","TRP Priority Rating","TRP Comment","Comment","Last Modified By: Full Name","Last Modified Date","Allocation Cycle Name","Components Name","Region","End_Date_Current"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4992","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Cost reductions should be obtainable through efficiencies and synergies with RSSH.",6560172,null,"Inactive","a6Q1R000000AJHy",6560172,0,0,0,0,1,null,null,"Cost reductions should be obtainable through efficiencies and synergies with RSSH.","High","Cost reductions should be obtainable through efficiencies and synergies with RSSH.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Policy, planning, coordination and management of national disease control programs (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4991","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Essential to continue trajectory of malaria reduction and avert outbreaks.",10716712,null,"Active","a6Q1R000000AJHx",9300308,0,0,0,1416404,0,null,null,"Essential to continue trajectory of malaria reduction and avert outbreaks.","High","Proportional to rest of above allocation amount","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Grant management (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4990","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Secondary importance to intensified routine M&E.",1531789,null,"Inactive","a6Q1R000000AJHw",1531789,0,0,0,0,1,null,null,"Secondary importance to intensified routine M&E.","High","Secondary importance to intensified routine M&E","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Surveys (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4989","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","Essential to continue trajectory of malaria reduction and avert outbreaks.",2494919,null,"Inactive","a6Q1R000000AJHv",2494919,0,0,0,0,1,null,null,"Essential to continue trajectory of malaria reduction and avert outbreaks.","High","For epidemic containment, but no evidence of local effectiveness or experience in use.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Indoor residual spraying (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4988","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Essential to continue trajectory of malaria reduction and avert outbreaks.",4505000,null,"Inactive","a6Q1R000000AJHu",4505000,0,0,0,0,1,null,null,"Essential to continue trajectory of malaria reduction and avert outbreaks.","High","Lacking in detail to determine priority.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Epidemic preparedness (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4987","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Ensuring drug and other health product quality.",1758000,null,"Inactive","a6Q1R000000AJHt",1758000,0,0,0,0,1,null,null,"Ensuring drug and other health product quality.","High","Large private sector with limited governance, and known falsified products in surrounding countries.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Ensuring drug and other health product quality (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4985","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","IEC/BCC also covered under iCCM. However, the mass media campaign is not fully optimized.",2689000,null,"Active","a6Q1R000000AJHr",959187,0,0,0,1729813,0,null,null,"IEC/BCC also covered under iCCM. However, the mass media campaign is not fully optimized.","High","IEC/BCC also covered under iCCM. It should be determined whether this additional funding will provide proportional benefit.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Information, education, communication/behavior change communication (case management) (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4984","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","Essential to continue trajectory of malaria reduction and avert outbreaks.",1617680,null,"Inactive","a6Q1R000000AJHq",1617680,0,0,0,0,1,null,null,"Essential to continue trajectory of malaria reduction and avert outbreaks.","High","Assessment of LLIN effectiveness","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Entomological monitoring (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4983","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Essential to monitor known delayed parasite clearance times.",720000,null,"Active","a6Q1R000000AJHp",0,0,0,0,720000,0,null,null,"Essential to monitor known delayed parasite clearance times.","High","Essential to monitor known delayed parasite clearance times","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Therapeutic efficacy surveillance (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4982","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To carry out Malaria Indicator Survey.",13545382,null,"Active","a6Q1R000000AJHo",11545382,0,0,0,2000000,0,null,null,"To carry out Malaria Indicator Survey.","High","Includes large number of WHO national staff to support implementation","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form.\n Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Analysis, review and transparency (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4981","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Strengthening national procurement and supply chain systems.",250000,null,"Active","a6Q1R000000AJHn",0,0,0,0,250000,0,null,null,"Strengthening national procurement and supply chain systems.","High","This area appears underaddressed.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. \nRemaining UQD is more than TRP recommended amount.\n24/12/17; replaced remaining UQD after GAC of 1M with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Intervention: Supporting procurement and supply management (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4980","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","A lot of investment is budgeted to improve the malaria surveillance system and the overall HMIS in the country. There are efforts to adopt DHIS2 all over the country. Under PR1, NMCP requires USD 1 million to expand case based surveillance with DHIS2 to all over the country (specifically in parts that are not covered under allocation).",15895181,null,"Active","a6Q1R000000AJHm",14895181,0,0,0,1000000,0,null,null,"A lot of investment is budgeted to improve the malaria surveillance system and the overall HMIS in the country. There are efforts to adopt DHIS2 all over the country. Under PR1, NMCP requires USD 1 million to expand case based surveillance with DHIS2 to all over the country (specifically in parts that are not covered under allocation).","High","Routine reporting (M&E) budget within allocation is low, need is high","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Routine reporting (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4979","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Microscopy, G6PD mapping, private hospitals, pharmacies and border screening are important, but of lesser priority than above interventions at this stage in the control program.",12528048,null,"Active","a6Q1R000000AJHl",6407722,0,0,0,6120326,0,null,null,"Microscopy, G6PD mapping, private hospitals, pharmacies and border screening are important, but of lesser priority than above interventions at this stage in the control program.","High","Microscopy, G6PD mapping and border screening are important, but of lesser priority than above interventions at this stage in the control program.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Facility-based treatment (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4978","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","As moving towards elimination, 3 types of ACD will be required; 1) RACD (Reactive Case Detection), 2) Proactive Case Detection and 3) routine active case detection. Additional requirement could cover either of the three in both elimination and transmission reduction areas.",340000,null,"Active","a6Q1R000000AJHk",183274,0,0,0,156726,0,null,null,"As moving towards elimination, 3 types of ACD will be required; 1) RACD (Reactive Case Detection), 2) Proactive Case Detection and 3) routine active case detection. Additional requirement could cover either of the three in both elimination and transmission reduction areas.","High","Needs to start in eliminated areas.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Active case detection and investigation (elimination phase) (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4977","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","With allocation amount, the program is likely to reach 20,000 villages through ICMVs. However, in order to ensure 100% universal coverage for all the villages which are 5 km or more away from the nearest health facility, there is a need to establish another 20,000 ICMVs.",22358810,null,"Active","a6Q1R000000AJHj",9519639,0,1485572,0,11353599,0,null,null,"With allocation amount, the program is likely to reach 20,000 villages through ICMVs. However, in order to ensure 100% universal coverage for all the villages which are 5 km or more away from the nearest health facility, there is a need to establish another 20,000 ICMVs.","High","iCCM is vital to reach vulnerable groups, though this level of community empowerment meetings may not be necessary","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Integrated community case management (iCCM) (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4976","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","There will be no more oAMT replacement project funded for 2018 - 2020 under RAI2E. If funds are available, this project should continue until there is zero oAMT in the country.",3804000,null,"Active","a6Q1R000000AJHi",1041963,0,0,0,2762037,0,null,null,"There will be no more oAMT replacement project funded for 2018 - 2020 under RAI2E. If funds are available, this project should continue until there is zero oAMT in the country.","High","Important area of health delivery, with relatively little allocation.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Private sector case management (Myanmar)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4974","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Essential to continue trajectory of malaria reduction and avert outbreaks.",32921545,null,"Inactive","a6Q1R000000AJHg",32921545,0,0,0,0,1,null,null,"Essential to continue trajectory of malaria reduction and avert outbreaks.","High","Essential to continue trajectory of malaria reduction and avert outbreaks","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4973","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Essential to continue trajectory of malaria reduction and avert outbreaks.",28475555,null,"Inactive","a6Q1R000000AJHf",28475555,0,0,0,0,1,null,null,"Essential to continue trajectory of malaria reduction and avert outbreaks.","High","Essential to continue trajectory of malaria reduction and avert outbreaks","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Asia"]
["CT Zimbabwe","Zimbabwe","PAI-6115","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","Phase II: Construction of Harare NatPharm Central warehouse and purchase of equipment. Previously TRP cleared in 2013, transferred from NFM grant (2014-2017) due to transition policy.",22737584,null,"Active","a6Q1R000000AJa5",0,0,0,0,22737584,0,null,null,"Phase II: Construction of Harare NatPharm Central warehouse and purchase of equipment. Previously TRP cleared in 2013, transferred from NFM grant (2014-2017) due to transition policy.",null,null,"8/3/2018: recvd email from Jacqueline conveying the message of CT that this intervention that was approved in 2014-16 has been approved by Mark Eddington & Adda Faye to be included in the 2017-19 register. 9/3/2018: Jacqueline confirmed to Bianca that no further TRP approvals are required, and as an exception this intervention must be recorded in the register with TRP priorty rating =\"Undefined\", The TRP approved date as TRP review date of the other Zimbabwe interventions. Also, to see this intervention with other ZMB interventions and to get the expiry date, the GAC approval date is made same as others. The remaining UQD in BUD is also updated. As the CT asked us to include the amount, it is assumed to be validated by them and no further validation is required Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Africa 2"]
["CT Multicountry HIAF1 LSDI","Multicountry Southern Africa MOSASWA","PAI-4935","MCI-00023","Program management","MCI-00207","Grant management","This request is to cover for grant management costs in order for the program to expand to 4 new districts in Gaza and Inhambane Provinces in Southern Mozambique.",150000,null,"Inactive","a6Q1R000000AJH3",0,0,150000,0,0,1,null,null,"This request is to cover for grant management costs in order for the program to expand to 4 new districts in Gaza and Inhambane Provinces in Southern Mozambique.","Low","The need for additional funds is not well substantiated given existing allocation for this multi country grant and other resources","This is from the 2014-2016 allocation cycle which has been added to the 2017-2019 Register, as suggested by Silvio. This is part of the standalone PAAR request that came for Window 6\n07/12/2018: As per email from CT, the entire UQD activities totalling 2,773,492 are funded by Gates funding (even though the Grant-making sign off form says 2,773,488). The $4 difference is due to adjustments during grant negotiations","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Africa 2"]
["CT Multicountry HIAF1 LSDI","Multicountry Southern Africa MOSASWA","PAI-4934","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","The PAAR request entails expansion of IEC/BCC programs into Gaza and Inhambane Provinces in Southern Mozambique in order to strengthen uptake of IRS within the districts.",31894,null,"Inactive","a6Q1R000000AJH2",0,0,31894,0,0,1,null,null,"The PAAR request entails expansion of IEC/BCC programs into Gaza and Inhambane Provinces in Southern Mozambique in order to strengthen uptake of IRS within the districts.","Low","The need for additional funds is not well substantiated given existing allocation for this multi country grant and other resources","This is from the 2014-2016 allocation cycle which has been added to the 2017-2019 Register, as suggested by Silvio. This is part of the standalone PAAR request that came for Window 6\n07/12/2018: As per email from CT, the entire UQD activities totalling 2,773,492 are funded by Gates funding (even though the Grant-making sign off form says 2,773,488). The $4 difference is due to adjustments during grant negotiations Original Intervention: Information, education, communication/Behavior change communications (vector control)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Africa 2"]
["CT Multicountry HIAF1 LSDI","Multicountry Southern Africa MOSASWA","PAI-4933","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","The PAAR request entails expansion of IRS operations into 4 new districts in Gaza and Inhambane Provinces in Southern Mozambique. Regional epidemiological analyses clearly demonstrate the urgency by which activities must be expanded to Gaza and Inhambane provinces if the MOSASWA sub-region hopes to accelerate its pathway to elimination.",2278106,null,"Inactive","a6Q1R000000AJH1",0,0,2278106,0,0,1,null,null,"The PAAR request entails expansion of IRS operations into 4 new districts in Gaza and Inhambane Provinces in Southern Mozambique. Regional epidemiological analyses clearly demonstrate the urgency by which activities must be expanded to Gaza and Inhambane provinces if the MOSASWA sub-region hopes to accelerate its pathway to elimination.","Low","The need for additional funds is not well substantiated given existing allocation for this multi country grant and other resources","This is from the 2014-2016 allocation cycle which has been added to the 2017-2019 Register, as suggested by Silvio. This is part of the standalone PAAR request that came for Window 6\n07/12/2018: As per email from CT, the entire UQD activities totalling 2,773,492 are funded by Gates funding (even though the Grant-making sign off form says 2,773,488). The $4 difference is due to adjustments during grant negotiations Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Africa 2"]
["CT Multicountry HIAF1 LSDI","Multicountry Southern Africa MOSASWA","PAI-4932","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","This PAAR request is to expand APEs into 4 key districts in Gaza and Inhambane provinces of Southern Mozambique in order serve new geographies receiving IRS.",313492,null,"Inactive","a6Q1R000000AJH0",0,0,313492,0,0,1,null,null,"This PAAR request is to expand APEs into 4 key districts in Gaza and Inhambane provinces of Southern Mozambique in order serve new geographies receiving IRS.","Low","The need for additional funds is not well substantiated given existing allocation for this multi country grant and other resources","This is from the 2014-2016 allocation cycle which has been added to the 2017-2019 Register, as suggested by Silvio. This is part of the standalone PAAR request that came for Window 6\n07/12/2018: As per email from CT, the entire UQD activities totalling 2,773,492 are funded by Gates funding (even though the Grant-making sign off form says 2,773,488). The $4 difference is due to adjustments during grant negotiations\n Original Intervention: Integrated community case management (iCCM)","Shalini Mitra","2019-10-30","2014-2016",null,"RT High Impact Africa 2"]
["CT Pakistan","Pakistan","PAI-6121","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Treatment services for general population in Sindh: Funding for ARVs, Management of Opportunistic infections, Provision of psychosocial  and nutritional support. Improving retention on ART through outreach support. Training of counsellors and health workers and case managers.",600000,600000,"Inactive","a6Q1R000000AJaa",null,600000,null,null,0,1,null,"High","Treatment services for general population in Sindh: Funding for ARVs, Management of Opportunistic infections, Provision of psychosocial  and nutritional support. Improving retention on ART through outreach support. Training of counsellors and health workers and case managers.","High",null,null,"Alana Sharp","2019-11-29","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-6120","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Outreach and Community Based testing in Sindh Province. Outreach workers, Counsellors and Test kits and consummables.",200000,200000,"Inactive","a6Q1R000000AJaZ",null,200000,null,null,0,1,null,"High","Outreach and Community Based testing in Sindh Province. Outreach workers, Counsellors and Test kits and consummables.","High",null,null,"Alana Sharp","2019-11-29","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-6119","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Surveillance system through sentinel sites in Sindh Province after the HIV outbreak (as recommended by WHO led investigation): \na. HIV screening in all TB centres\nb. Screening in all registered blood banks (public and private)\nc. Screening of all Ante Natal clinics attendee in all BHUs in Sindh (Done by PPHI).\nd. Screening in all PPTCT centres in Larkana and Ratodero, \ne.HIV screening in sentinel sites in Larkana (Urban setting) and Ratodero (Rural settings)\nf. support for routine reporting, improving reporting.",100000,100000,"Inactive","a6Q1R000000AJaY",null,100000,null,null,0,1,null,"High","Surveillance system through sentinel sites in Sindh Province after the HIV outbreak (as recommended by WHO led investigation): \na. HIV screening in all TB centres\nb. Screening in all registered blood banks (public and private)\nc. Screening of all Ante Natal clinics attendee in all BHUs in Sindh (Done by PPHI).\nd. Screening in all PPTCT centres in Larkana and Ratodero, \ne.HIV screening in sentinel sites in Larkana (Urban setting) and Ratodero (Rural settings)\nf. support for routine reporting, improving reporting.","High",null,null,"Alana Sharp","2019-11-29","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Uzbekistan","Uzbekistan","PAI-6136","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",2958638,2958638,"Active","a6Q1R000000AJdD",null,0,null,null,2958638,0,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2019-11-28","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-06-30"]
["CT Belarus","Belarus","PAI-6171","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. \nAs a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. \nIn line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD).\n MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.",986668,986668,"Active","a6Q1R000000AJiu",{"$nulls":4},986668,0,null,"High","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. \nAs a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. \nIn line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD).\n MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.","High","The TRP applauds the recipients efforts to reduce the costs of DTG and the cost-savings that this has resulted in, and urges the country to continue to work with GF and others to achieve the best price. Gaps in the treatment cascade, especially in the second 90 are still marked and the TRP requests that these additional resources be prioritized to closing that gap and enabling more PLWH to access ART.",null,"Alana Sharp","2019-11-25","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Belarus","Belarus","PAI-6170","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.",556161.96,556161.96,"Active","a6Q1R000000AJit",{"$nulls":4},556161.96,0,null,"High","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.","High","Linkage-to care is a critical gap in the treatment cascade and therefore this activity is especially welcome. The TRP requests that active linkage to care and retention should be included int eh psychosocial support and the impact monitored. The TRP would also encourage the expansion of OST within this framework as this has been shown to assist with linkage and retention.",null,"Alana Sharp","2019-11-25","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Belarus","Belarus","PAI-6169","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00551","Interventions for young people who inject drugs","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.\nIn Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".",98759.99,98759.99,"Active","a6Q1R000000AJis",{"$nulls":4},98759.99,0,null,"High","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.\nIn Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".","High","This activity is in line with the main allocation and provides additional prevention programming which is technically sound and strategically focussed",null,"Alana Sharp","2019-11-25","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT South Sudan","South Sudan","PAI-6166","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Cordaid shall support the Ministry of Health to improve MDR-TB and TB data management (eTBr, customize and install GenEX software)",20000,20000,"Active","a6Q1R000000AJgy",{"$nulls":4},20000,0,null,"High","Cordaid shall support the Ministry of Health to improve MDR-TB and TB data management (eTBr, customize and install GenEX software)","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6165","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Cordaid shall support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, intergrate TB services at new health facilities.",56993,56993,"Active","a6Q1R000000AJgx",{"$nulls":4},56993,0,null,"High","Cordaid shall support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, intergrate TB services at new health facilities.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6164","MCI-00023","Program management","MCI-00207","Grant management","This is to cover the costs of key technical project personnel under Cordaid who are required to continue providing technical backup to the project in 2020.  The two key staff will continue to provide supervision, oversight and mentoring to the local staff and to ensure smooth handing over to local authorities at project termination. These staff also undertake grant management functions related to the Sub-Recipient Agreement.",109822,109822,"Active","a6Q1R000000AJgw",{"$nulls":4},109822,0,null,"High","This is to cover the costs of key technical project personnel under Cordaid who are required to continue providing technical backup to the project in 2020.  The two key staff will continue to provide supervision, oversight and mentoring to the local staff and to ensure smooth handing over to local authorities at project termination. These staff also undertake grant management functions related to the Sub-Recipient Agreement.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6163","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Given the challenges of limited government support to the health sector, there is a risk of service interruption if additional funding is not provided. There is a need to maintain essential clinical and laboratory staff at selected facilties.  With additional funding, Cordaid will continue to support direct service delivery for key TB diagnostic and treatment services and its presence is critical especially is high volume facilities such as these facilities such Munuki PHCC, Torit State  Hospital, Nyong PHCC, Hiyala PHCC, Hileu PHCC, Lowoi PHCC, Chukudum Hospital,  Nimule Hospital ,  Bentiu state Hospital,  Kapoeta Mission Hospital, Kapoeta State Hospital, Mary Help Hospital, Tharkueng PHCC, Achong Chong PHCC and Marial Bai PHCC.  These facilities are mostly in localities where Cordaid has presence with other health projects ongoing.  This is so because it will help cut down on running costs by cost-sharing with other projects. Under this budget line, Cordaid shall also support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, and intergrate TB services at new health facilities.",209003,209003,"Active","a6Q1R000000AJgv",{"$nulls":4},209003,0,null,"High","Given the challenges of limited government support to the health sector, there is a risk of service interruption if additional funding is not provided. There is a need to maintain essential clinical and laboratory staff at selected facilties.  With additional funding, Cordaid will continue to support direct service delivery for key TB diagnostic and treatment services and its presence is critical especially is high volume facilities such as these facilities such Munuki PHCC, Torit State  Hospital, Nyong PHCC, Hiyala PHCC, Hileu PHCC, Lowoi PHCC, Chukudum Hospital,  Nimule Hospital ,  Bentiu state Hospital,  Kapoeta Mission Hospital, Kapoeta State Hospital, Mary Help Hospital, Tharkueng PHCC, Achong Chong PHCC and Marial Bai PHCC.  These facilities are mostly in localities where Cordaid has presence with other health projects ongoing.  This is so because it will help cut down on running costs by cost-sharing with other projects. Under this budget line, Cordaid shall also support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, and intergrate TB services at new health facilities.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6162","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","Community TB care delivery continues to be an important intervention.  Cordaid works closely with the Home Health Promoters (HHPs) to conduct outreach activities, including contact tracing, treatment support and community sensitisation.  These resources will go towards continuing support for incentives for HHPs. This budget line is increased to support the intergration of TB services to more health facilities.",21812,21812,"Active","a6Q1R000000AJgu",{"$nulls":4},21812,0,null,"High","Community TB care delivery continues to be an important intervention.  Cordaid works closely with the Home Health Promoters (HHPs) to conduct outreach activities, including contact tracing, treatment support and community sensitisation.  These resources will go towards continuing support for incentives for HHPs. This budget line is increased to support the intergration of TB services to more health facilities.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6161","MCI-00023","Program management","MCI-00207","Grant management","General Management Service (GMS) Fee for UNDP",212469,212469,"Active","a6Q1R000000AJgt",{"$nulls":4},212469,0,null,"High","General Management Service (GMS) Fee for UNDP","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6160","MCI-00008","TB care and prevention","MCI-00127","Treatment","This is to cater for the PSM-related costs for the drugs, laboratory reagents and other supplies for FY2020.   These costs include:  \n? Procurement agent and handling fees\n? Freight and insurance costs \n? Warehouse Storage Costs, i.e. insurance for commodities\n? In-country distribution costs\n? Quality assurance and quality control costs (QA/QC)\n? PSM Customs clearance, i.e. clearance agent fees; Drug and Food Control Authority Fees",438674,438674,"Active","a6Q1R000000AJgs",{"$nulls":4},438674,0,null,"High","This is to cater for the PSM-related costs for the drugs, laboratory reagents and other supplies for FY2020.   These costs include:  \n? Procurement agent and handling fees\n? Freight and insurance costs \n? Warehouse Storage Costs, i.e. insurance for commodities\n? In-country distribution costs\n? Quality assurance and quality control costs (QA/QC)\n? PSM Customs clearance, i.e. clearance agent fees; Drug and Food Control Authority Fees","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6159","MCI-00008","TB care and prevention","MCI-00127","Treatment","With the operationalisation of the Wau Warehouse ? starting January 2020, health commodities for the selected states will be prepositioned in this location thereby greatly reducing the delivery timeliness of health commodities to facilities and overall enhancing the supply chain management support to this region.  In addition, procured commodities meant for this region will in due course be delivered directly to the Wau Regional Warehouse thereby reducing the distribution costs currently being incurred from Juba.  Following the integration of the malaria commodities HIV and TB grant health commodities under the Juba Riverside Warehouse, this integration will also be decentralized to the Wau Regional Warehouse.  Going forward, it is expected that there will be a gradual integration of other health commodities by being procured by other partners.",422163,422163,"Active","a6Q1R000000AJgr",{"$nulls":4},422163,0,null,"High","With the operationalisation of the Wau Warehouse ? starting January 2020, health commodities for the selected states will be prepositioned in this location thereby greatly reducing the delivery timeliness of health commodities to facilities and overall enhancing the supply chain management support to this region.  In addition, procured commodities meant for this region will in due course be delivered directly to the Wau Regional Warehouse thereby reducing the distribution costs currently being incurred from Juba.  Following the integration of the malaria commodities HIV and TB grant health commodities under the Juba Riverside Warehouse, this integration will also be decentralized to the Wau Regional Warehouse.  Going forward, it is expected that there will be a gradual integration of other health commodities by being procured by other partners.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6158","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","In order to strengthen the capacity of the National TB Program in PMDT, it is important that central-level staff who are charged with the responsibility of providing oversight, supervision and mentorship are adequately trained.  As the country is currently scaling up the implementation and coverage of MDR TB services, this training is critical. 3 staff will be undergo international training in PMDT at a cost of USD22,820.00.  As this intervention is already approved, the country has updated the intervention highlighting the training in PMDT as a priority.",22820,22820,"Active","a6Q1R000000AJgq",{"$nulls":4},22820,0,null,"High","In order to strengthen the capacity of the National TB Program in PMDT, it is important that central-level staff who are charged with the responsibility of providing oversight, supervision and mentorship are adequately trained.  As the country is currently scaling up the implementation and coverage of MDR TB services, this training is critical. 3 staff will be undergo international training in PMDT at a cost of USD22,820.00.  As this intervention is already approved, the country has updated the intervention highlighting the training in PMDT as a priority.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6157","MCI-00010","MDR-TB","MCI-00143","Engaging all care providers (MDR-TB)","In order to optimize the utilization of GeneXpert platforms, improve diagnostic access for TB and undertake patient monitoring; quarterly focused supervisory and mentorship site level visits will be undertaken by team composed of 1 clinician, 1 laboratory staff and 1 State TB/HIV Coordinator.  These field visits will also include the orientation of staff in the recently developed PMDT guidelines and DR Recording and Reporting tools and strengthening prompt linkage to treatment for all detected cases. PMDT job aids have also been developed.",30464,30464,"Active","a6Q1R000000AJgp",{"$nulls":4},30464,0,null,"High","In order to optimize the utilization of GeneXpert platforms, improve diagnostic access for TB and undertake patient monitoring; quarterly focused supervisory and mentorship site level visits will be undertaken by team composed of 1 clinician, 1 laboratory staff and 1 State TB/HIV Coordinator.  These field visits will also include the orientation of staff in the recently developed PMDT guidelines and DR Recording and Reporting tools and strengthening prompt linkage to treatment for all detected cases. PMDT job aids have also been developed.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6156","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","The number of MDR-TB cases being diagnosed is currently below the set target.  Currently, there are 17 GeneXpert MTB/RIF machines deployed at 16 sites across the country - 10 of these machines were procured using Global Fund resources.  The rollout of this GeneXpert MTB/RIF test highlights the existing need for strong testing site networks, good infrastructure, robust quality assurance systems and uninterrupted supplies. With the projected number of 220 MDR cases to be notified in 2020, there is need to procure adequate cartridges ($252,160), LPA and liquid culture reagents, and other laboratory supplies and consumables valued at ($194,688).  To ensure optimal functionality of these machines, it is necessary that a maintenance and technical support contract with the Cephied is in place to cover the year 2020.  This contract is valued at $38,776. In additional $6,679 will be used to cover the travel, lodging and facilitation feed of the Cepheid certified trainer and in-country training expenses for participants.  An additional 7 super users will be trained to support the roll-out and in-country trouble shooting of the GeneXpert platforms across the country for accurate and timely diagnosis.  This covers the cost of the trainer, A total of 10 super users were trained in May 2019.   A separate maintenance contract for the maintenance of other equipment such as the BD BACTEC MGIT 960 System, LPA machine, medical refrigerators is being also being finalized at a cost of $37,930.",531171,531171,"Active","a6Q1R000000AJgo",{"$nulls":4},531171,0,null,"High","The number of MDR-TB cases being diagnosed is currently below the set target.  Currently, there are 17 GeneXpert MTB/RIF machines deployed at 16 sites across the country - 10 of these machines were procured using Global Fund resources.  The rollout of this GeneXpert MTB/RIF test highlights the existing need for strong testing site networks, good infrastructure, robust quality assurance systems and uninterrupted supplies. With the projected number of 220 MDR cases to be notified in 2020, there is need to procure adequate cartridges ($252,160), LPA and liquid culture reagents, and other laboratory supplies and consumables valued at ($194,688).  To ensure optimal functionality of these machines, it is necessary that a maintenance and technical support contract with the Cephied is in place to cover the year 2020.  This contract is valued at $38,776. In additional $6,679 will be used to cover the travel, lodging and facilitation feed of the Cepheid certified trainer and in-country training expenses for participants.  An additional 7 super users will be trained to support the roll-out and in-country trouble shooting of the GeneXpert platforms across the country for accurate and timely diagnosis.  This covers the cost of the trainer, A total of 10 super users were trained in May 2019.   A separate maintenance contract for the maintenance of other equipment such as the BD BACTEC MGIT 960 System, LPA machine, medical refrigerators is being also being finalized at a cost of $37,930.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6155","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","The updated forecasting and quantification of Second Line Anti-TB drugs (SLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments of 220 for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnership?s Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the requires resources for SLD up to the end of the grant with 6 months buffer is USD122,794.  \nThe National TB Program at central level now has on board the Inspector for Management of Multi-Drug Resistant TB who is mandated to provide oversight, monitoring and support to the implementation of the PMDT program. With this newly created position, it is expected that the proposed critical intensive case detection and treatment activities being proposed for support under this application will improve case notification and linkage to treatment.",122794,122794,"Active","a6Q1R000000AJgn",{"$nulls":4},122794,0,null,"High","The updated forecasting and quantification of Second Line Anti-TB drugs (SLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments of 220 for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnership?s Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the requires resources for SLD up to the end of the grant with 6 months buffer is USD122,794.  \nThe National TB Program at central level now has on board the Inspector for Management of Multi-Drug Resistant TB who is mandated to provide oversight, monitoring and support to the implementation of the PMDT program. With this newly created position, it is expected that the proposed critical intensive case detection and treatment activities being proposed for support under this application will improve case notification and linkage to treatment.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-6154","MCI-00008","TB care and prevention","MCI-00127","Treatment","The updated forecasting and quantification of First Line Anti-TB drugs (FLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnership?s Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the budget required the FLD is USD1,049,562 to cover the treatment needs up to the end of 2020.  By the end of 2018, a total of 14,362 cases were notified against a set target of 12,678. Similarly, an increasing trend was reported as at June 2019 - 8,566 cases notified which is above the set target of 6,973 by 23%. It is projected that by the end of 2020, the number of notified cases will increase to 20,832.",1049562,1049562,"Active","a6Q1R000000AJgm",{"$nulls":4},1049562,0,null,"Low","The updated forecasting and quantification of First Line Anti-TB drugs (FLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnership?s Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the budget required the FLD is USD1,049,562 to cover the treatment needs up to the end of 2020.  By the end of 2018, a total of 14,362 cases were notified against a set target of 12,678. Similarly, an increasing trend was reported as at June 2019 - 8,566 cases notified which is above the set target of 6,973 by 23%. It is projected that by the end of 2020, the number of notified cases will increase to 20,832.","High",null,null,"Alana Sharp","2019-11-18","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Mongolia","Mongolia","PAI-6201","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","MDR-TB Regimen change",350000,350000,"Inactive","a6Q1R000000AJph",null,350000,null,null,0,1,null,"High","MDR-TB Regimen change","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis","RT South East Asia","2020-12-31"]
["CT Turkmenistan","Turkmenistan","PAI-6203","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Increase of funding needs for XDR-TB due to WHO recommendation to increase treatment with Bedaquilin/Delamanit to 12-18m instead of 6m, this amount is expected to cover 2020-2021 needs. This comes in addition to previously approved Portfolio Optimization Amount. Module: MDR-TB; Intervention: Treatment",1460500,1460500,"Inactive","a6Q1R000000AJpr",null,1460500,null,null,0,1,null,"High","Increase of funding needs for XDR-TB due to WHO recommendation to increase treatment with Bedaquilin/Delamanit to 12-18m instead of 6m, this amount is expected to cover 2020-2021 needs. This comes in addition to previously approved Portfolio Optimization Amount. Module: MDR-TB; Intervention: Treatment","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-06-30"]
["CT Mongolia","Mongolia","PAI-6198","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.",832198,832198,"Inactive","a6Q1R000000AJpS",null,832198,null,null,0,1,null,"High","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis","RT South East Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-6202","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","MDR-TB regimen change",500000,500000,"Inactive","a6Q1R000000AJpm",null,500000,null,null,0,1,null,"High","MDR-TB regimen change","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-6200","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",3020000,3020000,"Inactive","a6Q1R000000AJpc",null,3020000,null,null,0,1,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Belarus","Belarus","PAI-6199","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO",3400000,3400000,"Inactive","a6Q1R000000AJpX",null,3400000,null,null,0,1,null,"High","Regimen Change: introduction of new treatment regimen approved by WHO","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Nepal","Nepal","PAI-6209","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","As described above, the following prioritized interventions of US$ 2,150,000 are requested to strenghten TB case detection and diagnosis and address existing gaps: \n i) the expansion of GenXperts and sputum transportation to expand access to rapid diagnosis (US$950,000); ii) strengthening two regional laboratories to make them fully operational and efficient to strengthen case detection and expand TB diagnosis also at the regional level (US$800,000); iii) strengthening drug susceptibility testing (DST) at the regional level to scale-up MDR-TB diagnosis (US$200,000), and; iv) supporting the development of a structured quality improvement program based on SLMTA model designed for resource limited settings (US$200,000).  \nSustainability of activities: these activities represent a 12-month investment of predominantly products to be procured to strengthen the existing laboratory system.\nExpected outcomes: increased case notification by 25% as compared to current achievement resulting in 8,000 additional TB cases notified and linked to treatment by the end of the grant; expanded access to early TB diagnosis; improved treatment monitoring and outcomes for DR-TB; strengthened laboratory system at the regional level to deliver timely TB diagnostic services, and; a SLMTA program design and costed implementation plan in place as well as the training of a core quality management team.  \n\nPF Indicator: \nTCP-1 (M): Number of notified cases of all forms of TB-(i.e. bacteriologically confirmed + clinically diagnosed), includes new and relapse cases\nTargets will be revised upwards for 2020. Revised target for 2020: 40,451.",2150000,2150000,"Inactive","a6Q1R000000AJsb",null,2150000,null,null,0,1,null,"High","As described above, the following prioritized interventions of US$ 2,150,000 are requested to strenghten TB case detection and diagnosis and address existing gaps: \n i) the expansion of GenXperts and sputum transportation to expand access to rapid diagnosis (US$950,000); ii) strengthening two regional laboratories to make them fully operational and efficient to strengthen case detection and expand TB diagnosis also at the regional level (US$800,000); iii) strengthening drug susceptibility testing (DST) at the regional level to scale-up MDR-TB diagnosis (US$200,000), and; iv) supporting the development of a structured quality improvement program based on SLMTA model designed for resource limited settings (US$200,000).  \nSustainability of activities: these activities represent a 12-month investment of predominantly products to be procured to strengthen the existing laboratory system.\nExpected outcomes: increased case notification by 25% as compared to current achievement resulting in 8,000 additional TB cases notified and linked to treatment by the end of the grant; expanded access to early TB diagnosis; improved treatment monitoring and outcomes for DR-TB; strengthened laboratory system at the regional level to deliver timely TB diagnostic services, and; a SLMTA program design and costed implementation plan in place as well as the training of a core quality management team.  \n\nPF Indicator: \nTCP-1 (M): Number of notified cases of all forms of TB-(i.e. bacteriologically confirmed + clinically diagnosed), includes new and relapse cases\nTargets will be revised upwards for 2020. Revised target for 2020: 40,451.","High","The PAAR is strategically sound and scientifically based to support increased access to diagnostic testing, based on the recent surveillance survey identifying a larger gap in undiagnosed cases than previously predicted.",null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis","RT South East Asia","2021-03-15"]
["CT Papua New Guinea","Papua New Guinea","PAI-6210","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","Switch the cohort of 29,420 PHIV on ART to DTG based regiment to respond to very high ART drug resistance and replenish the ART buffer stock back to the required minimum of 12 months to ensure the linkage between the currently supported prevention activities and treatment and care. No change in the targets for the treatment indicator.",2975000,2975000,"Active","a6Q1R000000AJsg",null,2919868,null,null,55132,0,null,"High","Switch the cohort of 29,420 PHIV on ART to DTG based regiment to respond to very high ART drug resistance and replenish the ART buffer stock back to the required minimum of 12 months to ensure the linkage between the currently supported prevention activities and treatment and care. No change in the targets for the treatment indicator.","High","This funding request is critical to procure needed drugs and buffer stocks to prevent ART resistance and to align the PNG to the current ART recommendations. The rationale and description indicate that this is a much needed expenditure within the context of on-going technical and programmatic support provided by the Global Fund, WHO and other partners, and it is therefore approved by the TRP",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis","RT South East Asia","2020-12-31"]
["CT Nepal","Nepal","PAI-6208","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","National Malaria Program needs to strengthen activities to eliminate malaria and address malaria outbreaks in 2018-2019 in areas originally classified ?malaria-free?. Additional funding is therefore needed to support LLINs where due to decentralization, Government funding for LLINs for continuous distribution for 2020 has not been realized.\nOutcome: coverage with LLINs of vulnerable and in-risk populations, approximately 180,000 persons will be covered with LLINs.\n\nNo increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.",320000,320000,"Inactive","a6Q1R000000AJsX",null,320000,null,null,0,1,null,"High","National Malaria Program needs to strengthen activities to eliminate malaria and address malaria outbreaks in 2018-2019 in areas originally classified ?malaria-free?. Additional funding is therefore needed to support LLINs where due to decentralization, Government funding for LLINs for continuous distribution for 2020 has not been realized.\nOutcome: coverage with LLINs of vulnerable and in-risk populations, approximately 180,000 persons will be covered with LLINs.\n\nNo increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.","High","This intervention is appropriate for the endemic situation in country and for control of the epidemic through a dual net distribution scheme. The vulnerable groups are identified and the distribution method are adequate. The TRP approves this intervention and recommends on-going monitoring of factors  which could influence the epidemic such as climate or seasonal migration to ensure that the continuous distribution to target groups is conducted at appropriate times.",null,"Alana Sharp","2020-01-14","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-6207","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","National Malaria Program needs to strengthen activities to eliminate malaria including rolling out a community-based response. Additional funding is therefore needed to support  a critical gap in RDTs for the roll-out of community-based testing of in-risk and vulnerable populations. \nOutcome: strengthened case management at the community level; approximately 88,000 persons will be tested for malaria at the community level.\n\nNo increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.",88000,88000,"Inactive","a6Q1R000000AJsW",null,88000,null,null,0,1,null,"High","National Malaria Program needs to strengthen activities to eliminate malaria including rolling out a community-based response. Additional funding is therefore needed to support  a critical gap in RDTs for the roll-out of community-based testing of in-risk and vulnerable populations. \nOutcome: strengthened case management at the community level; approximately 88,000 persons will be tested for malaria at the community level.\n\nNo increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.","High","A community intervention to control malaria is very important in a country such as Nepal where health centers are remote and difficult to access. Rolling out a community based response is a productive way to control malaria in hard to reach communities where malaria risk is still present; therefore the TRP approves this intervention.",null,"Alana Sharp","2020-01-27","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-6206","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","Prevention services for prisoners with linkages to testing & treatment. \nThis is a high risk group and no prevention services are currently provided to them. \nAs mentioned above, in order to ensure meaningful scale-up of coverage with comprehensive HIV prevention services for this population, additional funding is requested by the country. \nExpected outcome: coverage of 14,000 with HIV prevention services and linkages of HIV+ prisoners to treatment and care.\n\nKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 14,000\nKP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 11,200",100000,100000,"Inactive","a6Q1R000000AJsS",null,100000,null,null,0,1,null,"High","Prevention services for prisoners with linkages to testing & treatment. \nThis is a high risk group and no prevention services are currently provided to them. \nAs mentioned above, in order to ensure meaningful scale-up of coverage with comprehensive HIV prevention services for this population, additional funding is requested by the country. \nExpected outcome: coverage of 14,000 with HIV prevention services and linkages of HIV+ prisoners to treatment and care.\n\nKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 14,000\nKP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 11,200","High","While approving this intervention, the TRP considers that prevention services for prisoners are very high priority. According to the funding request, out of 14,000 prisoners, 11,200 will be tested, indicating one-time testing rather than ongoing access (taking into account prisoner turnover). The TRP suggests that, should any efficiencies be identified in the the migrants' intervention (row above), funds should be re-programmed to expand the prisoners intervention, to increase number of tests and improve ongoing access to testing and services to ensure linkage to treatment.",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-6205","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","Differentiated service package for migrants with linkages to testing & treatment. \nThis key population is the driver of new HIV infections, however, currently not covered with HIV prevention services. \nAs mentioned above, in order to ensure meaning scale-up of coverage with comprehensive HIV prevention services for this population  and roll-out of the differentiated service package from 2020, additional funding is requested by the country. \nExpected outcome: coverage of 100,000 migrants with HIV prevention services and linkages of HIV+ migrants to treatment and care. \n\nMigrants\nKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 100,000\nKP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 80,000",860000,860000,"Inactive","a6Q1R000000AJsR",null,860000,null,null,0,1,null,"High","Differentiated service package for migrants with linkages to testing & treatment. \nThis key population is the driver of new HIV infections, however, currently not covered with HIV prevention services. \nAs mentioned above, in order to ensure meaning scale-up of coverage with comprehensive HIV prevention services for this population  and roll-out of the differentiated service package from 2020, additional funding is requested by the country. \nExpected outcome: coverage of 100,000 migrants with HIV prevention services and linkages of HIV+ migrants to treatment and care. \n\nMigrants\nKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 100,000\nKP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 80,000","High","The TRP considers prevention services for Migrants as high priority as migration is a key driver of new HIV infections in Nepal. However, few HIV services have been tailored to migrants. Therefore, it's  important to ensure coverage for this population.",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Lesotho","Lesotho","PAI-6204","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery",null,9212649,9212649,"Active","a6Q1R000000AJs2",null,8544633,null,null,668016,0,null,"High","The Ministry of Health conducted quantifications for health products in order to inform the government 2019/2020 finacial year budget for health products. From the quantification, it was determined that the national need for ARVs would need LSL 444,172,844.54 (approximately US$ 32 million). It was already known that the Global Fund contribution for ARVs for the 2019/2020 financial year is LSL 68,536,085.87. Due to fiscus challenges, the Ministry of Health was only allocated LSL 236,775,819 for the ARVs and this led to a funding gap of LSL 138,860,939.67. Efforts were made by both the Ministry of Health and Ministry of Finance to mobilise the funds but the resource mobilisation did not yield positive results. \nIt is against this background that the country is requesting support from the Global Fund towards procurement of ARVs in order to close the eminent funding gap. \nThe funds that are being sought will go a long way in ensuring that there is availability of commodities (ARVs) so tht there is continuity of treatment for People Living with HIV. The ARVs to be procured with the funds being sought will take ARV stock holding to December 2020 and this will give the Government of Lesotho ample time to mobilise adequate resources to ensure there will not be any shortages going forward.","High","The TRP supports the additional request for ARVs, given that the programme?s shift in strategic approaches with an increased focus on test and start towards the targets of 95/95/95 have led to an increased in expected need for ARVs.",null,"Alana Sharp","2020-01-17","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2021-06-30"]
["CT Ghana","Ghana","PAI-6178","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","The funds are required to ensure continued VC coverage by procuring LLIN for the 2021 Q1 mass distribution campaign. The funds for the 2021 campaign were not included in the current grant. The bed nets used for the 2018 mass distribution campaign where procured in 2017 with NFM1 grant budget.",23000000,23000000,"Active","a6Q1R000000AJjU",{"$nulls":4},23000000,0,null,"High","The funds are required to ensure continued VC coverage by procuring LLIN for the 2021 Q1 mass distribution campaign. The funds for the 2021 campaign were not included in the current grant. The bed nets used for the 2018 mass distribution campaign where procured in 2017 with NFM1 grant budget.","High","The TRP recommends that only pre-qualified nets be considered, and that the optimization exercise is informed by entomological information on the type, intensity and geographic spread of pyrethroid resistance, durability as well as unit costs. In addition, the TRP recommends that the Secretariat ensures that, by the time the intervention is incorporated into the grant, data on entomological stratification support the use of PBOs and new nets in appropriate locations.",null,"Alana Sharp","2019-11-26","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Philippines","Philippines","PAI-6177","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","The current allocation is mostly focused on prevention but the GF investment to the treatment is minimal due to limited allocation. The grant has a high absorption as 92% and has limited savings for reprogramming to support treatment related activities. The Philippines is prepared to fast track the  transition to TLD regimen from 2020, under the strong encouragement from the partners and request from the communities. The Government funding covers ARV and VL but faces gaps for 2020 for transition to new TLD regimen. The CCM would like to request the Global Fund to fund this fast-tracked transition. This additional funding will support the transition of 13,000 patients to TLD regimen in Philippines and cover up to 40,000 VL tests. This will bridge the gap in 2020 so the  Government could plan the budget for procurement for TLD from 2021 onwards. This investment will also be supported by the TA provided by PEPFAR project to start from 2020, to assist the national program in developing the new treatment guideline, fast tracking the FDA registration and training of facilities to adopt the new treatment guidelines.",2500000,2500000,"Inactive","a6Q1R000000AJjF",null,2500000,null,null,0,1,null,null,"This additional investment will help transitioning 13,000 patients to TLD regimen","High","The PAAR request is aligned with and complements the within-allocation program, and increases the overall contribution of funding support to maximize impact in the fight against HIV in Philippines. The request is strategically focused and technically sound, aiming to scale up an optimized antiretroviral treatment regimen in accordance with WHO recommendations. The TRP recommends the country continue working on strengthening the HIV cascade specially focusing on linkage to care as recommended in the TRP form dated 2 May 2017.",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Philippines","Philippines","PAI-6125","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","This amount is needed in order to allow the roll-out of the new MDR-TB treatment regimen from Q2 2019 for a target of 10,000 patients (42% of new enrollment taking long oral regimen, 45% taking on the modified shorter regimen (replacing KM with AM), and the remaining 13% of patients to be enrolled in an OR with a modified shorter regimen with BDQ, which is already registered in country). The transition has been carefully planned in consultation with national stakeholders and with the support from partners.Regimen Change: introduction of new treatment \nregimen approved by WHO",20000000,20000000,"Inactive","a6Q1R000000AJcK",null,20000000,null,null,0,1,null,"High","This amount is needed in order to allow the roll-out of the new MDR-TB treatment regimen from Q2 2019 for a target of 10,000 patients (42% of new enrollment taking long oral regimen, 45% taking on the modified shorter regimen (replacing KM with AM), and the remaining 13% of patients to be enrolled in an OR with a modified shorter regimen with BDQ, which is already registered in country). The transition has been carefully planned in consultation with national stakeholders and with the support from partners.Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Tajikistan","Tajikistan","PAI-6219","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Request for additional funding for PreP. Rationale: PEPFAR is in the process of initiating a work with in country stakeholders in understanding programing of innovative prevention strategies, namely Pre Exposure Prophylaxes (PrEP) among MSM and developing an engagement strategy for the design and roll-out of the pilot programme. According to the new estimates, in order to offer the pre-exposure prophylaxis to key population, there is a need of USD 173K as opposed to the originally planned USD 100K.",73561,73561,"Inactive","a6Q1R000000AK0B",null,73561,null,null,0,1,null,"High",null,"High",null,null,"Alana Sharp","2020-01-29","2017-2019","HIV/AIDS, RSSH","RT Eastern Europe and Central Asia"]
["CT Burundi","Burundi","PAI-6217","MCI-00012","Case management","MCI-00154","Facility-based treatment","Les bases de quantification nationale des intrants antipaludiques pour la période 2020-2021 au Burundi tiennent compte de l'évolution des cas sur 5 ans (2017-2021). La demande soumise pour le financement au-delà prend en compte la période 2020 et 6 mois de stock de sécurité correspondant à la période de transition entre 2 subventions. En plus, l'Arthemether-Luméfantrine étant une nouvelle molécule, la reconstitution des stocks à tous les niveaux de la pyramide sanitaire est indispensable. Les données épidémiologiques de la période en cours corroborent les besoins exprimés (voir Fichier de quantification sénario moyen). Les engagements déjà reçus des partenaires restent ceux inventoriés : Allocation du FM pour l'année 2020, la contribution de PMI et celle du gouvernement. L'analyse des gaps en intrants nous conduit à la demande de financement au-delà . Une fois que la demandée soumise est approuvée, les intrants de prise en charge seront disponibles dans toutes les formations sanitaires à la satisfaction des malades. Nous anticipons en disant que les épisodes de paludisme seront réduits au sein de la communauté, par conséquent réduction de la morbidité liée au paludisme.",5328486,5328486,"Inactive","a6Q1R000000AK01",28486,5300000,null,null,0,1,null,"High","National quantification of antimalarial drugs for the period 2020-2021 takes into account the evolution of cases over 5 years (2017-2021). The request submitted for this above allocation funds takes into account the 2020 period and 6 months of security stock corresponding to the transition period between two allocations. In addition, since Arthemether-Lumefantrine is a new molecule, stocks rebuilding at all levels of the health pyramid is essential. Epidemiological data for the current period corroborate the expressed needs (see Quantification File - average scenario). The commitments already received from partners remain those inventoried: Global Fund, PMI and government contributions. The gap analysis related to antimalarians drugs leads us to this demand for funds above allocation. Once the submitted application is approved, the treatment inputs will be available in all facilities to the benefit of patients. We anticipate that new cases of malaria will be reduced within the community, thus reducing the morbidity associated with malaria.","High","o The request is justified as a bridge between two allocation periods, to build appropriate stock of the newly introduced drug in all facilities, and (by the CT) as a critical measure to cope with current upsurge of malaria in the country. \no The quantification provided appears technically sound. It takes into account epidemiological data, projected according to the expected evolution, choosing a medium scenario. \no The request for funding takes into account the resources allocated by other funding parties including the government (mostly zero for this need).   \no The absorption rate of external resources ? as communicated by the CT ? is acceptable, at 69%, and for expected to reach 98%.  \no Assets and capacities for drug storage, management, distribution and data are provided through the already approved PAAR, implementation currently ongoing: upgrade of drug stores, LMIS, vehicles for drug transport. The allocation and approved PAAR also cover vector control activities, presumably appropriate to cope with current malaria upsurge.",null,"Alana Sharp","2020-01-14","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Tajikistan","Tajikistan","PAI-6218","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Intervention planned to strengthen control of nosocomial infection, strengthening lab capacity, and human resources, assess and improve infection control measures, assess and improve QA and QC of the center of blood safety, health facilities providing blood transfusions, waste management. Establishing greater integration and improve linkage to HIV services, Integrate and offer HIV tests in all levels of the national health care system. Different modalities including Facility based HIV testing, Community based testing.",1626520,1626520,"Inactive","a6Q1R000000AK06",null,1626520,null,null,0,1,null,"High",null,"Medium","The TRP notes that some elements included in the request are considered as high priority ( trainings for CHW, development of ME tools, evaluation of QA and QC of center for blood safety and health facilities). The TRP rates this request overall as medium priority based on the limited information available with regards to numberous items such as justification on the proposed location of EIA lab facilities and , justification for creation and use of software (ie development of an EMR software vs exploring opportunities to use a commercialised version), overall IT support, etc. Additionally, the TRP considers that some elements (purchase of cars and renovation of warehouse) should be of a low priority and can potentially be funded from domestic sources. In addition, the TRP considers the request for funds to establish and further enhance systems for medical waste disposal & management a priority, ensuring (future) compliance with international environmental health standards.\n\nThe TRP would like to note the following recommendations, should the funding become available:\n1) The TRP recommends that the applicant review the practice of pediatric blood transfusions to ensure practices are conforming to the WHO guidelines and standards as well as revise practices that deviate from the WHO guidelines. 2) The implementation of the proposed system strengthening through expansion of access to testing and enhanced blood safety to the existing district and city health polyclinics would require close monitoring. The TRP recommends build-in regular monitoring with plans for system improvement. 3) The request for funds to improve medical waste disposal & management is a priority.",null,"Alana Sharp","2020-01-21","2017-2019","HIV/AIDS, RSSH","RT Eastern Europe and Central Asia"]
["CT Viet Nam","Viet Nam","PAI-6137","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1500000,1500000,"Inactive","a6Q1R000000AJdI",null,1500000,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-28","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Belarus","Belarus","PAI-6122","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1150000,1150000,"Inactive","a6Q1R000000AJc5",0,1149999.92,0,0,0.08,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Thailand","Thailand","PAI-5779","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","DDC BL 291:Purchasing of IGRA supply for LTBI diagnosis in children.Objective:  above allocation-To support LTBI diagnosis in children especially in contact tracing-To prevent tuberculosis in children.How: Purchasing of IGRA supply for LTBI diagnosis in children by NTRLTarget:  to cover 90% of close contact (children)Frequency: 1 time per year.",1089674,null,"Inactive","a6Q1R000000AJUf",0,1089674,0,0,0,1,null,null,"DDC BL 291:Purchasing of IGRA supply for LTBI diagnosis in children.Objective:  above allocation-To support LTBI diagnosis in children especially in contact tracing-To prevent tuberculosis in children.How: Purchasing of IGRA supply for LTBI diagnosis in children by NTRLTarget:  to cover 90% of close contact (children)Frequency: 1 time per year.","Medium","This activity supports purchasing IGRAs to screen 90% of close contacts (children) for LTBI during contact investigations, to prevent active TB among children",null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5074","MCI-00011","Vector control","MCI-00152","Entomological monitoring","It has been noted that between 2013 and 2016, the amount of endophagic vectors became increasingly lower. This could lead to a major change in the use of indoor residual spraying campaigns (IRSCs) in certain areas. Changes of times at which mosquitoes bite have also been observed, with the insects becoming aggressive increasingly earlier. This amount will be used to continue the surveillance program.",180529,null,"Inactive","a6Q1R000000AJJI",180529,0,0,0,0,1,null,null,"It has been noted that between 2013 and 2016, the amount of endophagic vectors became increasingly lower. This could lead to a major change in the use of indoor residual spraying campaigns (IRSCs) in certain areas. Changes of times at which mosquitoes bite have also been observed, with the insects becoming aggressive increasingly earlier. This amount will be used to continue the surveillance program.","Medium",null,null,"Alana Sharp","2020-01-14","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Madagascar","Madagascar","PAI-5073","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conducting national surveys on malaria indicators will be essential for measuring progress toward achieving the objectives and expected outcomes of implementation. A survey on malaria indicators in Madagascar (MIS) will therefore be scheduled every three years, to reorient the program based on the outcomes achieved. Part of the funding for this survey is requested from the above allocation amount, with the remainder funded by PMI.",836000,null,"Inactive","a6Q1R000000AJJH",0,0,0,836000,0,1,null,null,"Conducting national surveys on malaria indicators will be essential for measuring progress toward achieving the objectives and expected outcomes of implementation. A survey on malaria indicators in Madagascar (MIS) will therefore be scheduled every three years, to reorient the program based on the outcomes achieved. Part of the funding for this survey is requested from the above allocation amount, with the remainder funded by PMI.","High","Malaria surveys, particularly Malaria Indicator Survey (MIS) is a very important activity that represents quality demand. Data from MIS are needed every two years, not only for future programming, but are also key for periodic measurement of the performance of the program.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Alana Sharp","2020-01-14","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Madagascar","Madagascar","PAI-5072","MCI-00012","Case management","MCI-00158","Therapeutic efficacy surveillance","Long-term surveillance of the therapeutic efficacy of antimalarial drugs is one of the objectives of the NSP and should provide annual data on any potential therapeutic failures that could result in a resurgence of malaria. This amount will help to maintain surveillance during the final two years of the grant. In 2018, it will be implemented with funding from the President?s Malaria Initiative (PMI).",325607,null,"Active","a6Q1R000000AJJG",35715,0,0,0,289892,0,null,null,"Long-term surveillance of the therapeutic efficacy of antimalarial drugs is one of the objectives of the NSP and should provide annual data on any potential therapeutic failures that could result in a resurgence of malaria. This amount will help to maintain surveillance during the final two years of the grant. In 2018, it will be implemented with funding from the President?s Malaria Initiative (PMI).","High","Therapeutic efficacy of anti-malaria drugs is an important study that generates data to ensure quality of malaria treatment and avoid drugs resistance. Per WHO guidelines, therapeutic efficacy study should be conducted every two years",null,"Alana Sharp","2020-01-14","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Pakistan","Pakistan","PAI-5349","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","PR Nai Zindagi has now been allowed to work in the major agglomerations of Punjab. Based on the Punjab IBBS 2014, the number of PWID mapped in 8 cities of Lahore, Faisalabad, Sargodha, Sialkot, Gujranwala, Sheikhupura, Mandi Bahaudin and DG Khan is 25,929. As per the IBBS, 9,715 (37.46%) based on city wise prevalence were HIV positive in 2014. In the absence of services since 2016, this number is now likely to reach 60% if not more. \n\nOutcomes of the proposed intervention:\n? By end of 2020 appr. 20,743 (80%) of mapped PWID will be enrolled in CoPc+ services (complete package) in those cities\n? By end of 2020 appr. 7772 (80%) of HIV+ PWID will be channeled through AAU and put on ART\n? Similarly, spouses and all partners will receive prevention, treatment and life support\n? No additional costs on management (like PR staffing  costs) \n? By end of 2020, NZT will cover 23% of PWID in Pakistan",5012397,null,"Active","a6Q1R000000AJNj",0,5012000,0,0,397,0,null,null,"PR Nai Zindagi has now been allowed to work in the major agglomerations of Punjab. Based on the Punjab IBBS 2014, the number of PWID mapped in 8 cities of Lahore, Faisalabad, Sargodha, Sialkot, Gujranwala, Sheikhupura, Mandi Bahaudin and DG Khan is 25,929. As per the IBBS, 9,715 (37.46%) based on city wise prevalence were HIV positive in 2014. In the absence of services since 2016, this number is now likely to reach 60% if not more. \n\nOutcomes of the proposed intervention:\n? By end of 2020 appr. 20,743 (80%) of mapped PWID will be enrolled in CoPc+ services (complete package) in those cities\n? By end of 2020 appr. 7772 (80%) of HIV+ PWID will be channeled through AAU and put on ART\n? Similarly, spouses and all partners will receive prevention, treatment and life support\n? No additional costs on management (like PR staffing  costs) \n? By end of 2020, NZT will cover 23% of PWID in Pakistan","High","These activities will provide crucial support for the programming for people who inject drugs, and will enable this vulnerable population and their partners to access quality services, thereby positively impacting the epidemic","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Prevention and Treatment services for IDUs ","Alana Sharp","2020-01-27","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5071","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.",7711695,null,"Inactive","a6Q1R000000AJJF",122437,7711695,0,0,0,1,null,null,"Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.","High","The applicant requests an amount US$7,711,695 for LLINs for mass campaign in 2021 under the PAAR. While the TRP considers this to be quality demand, the TRP notes that these nets are to be used outside the grant utilization period of the current allocation cycle. As such the TRP requests the Global Fund?s Grants Approval Committee (GAC) to decide whether this component of the request can be placed on the current register of Unfunded Quality Demand.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-14","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Madagascar","Madagascar","PAI-5069","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","To provide appropriate treatment for at least 95 percent of diagnosed malaria cases, continuous availability of treatment supplies ? including artemisinin-based combination therapy (ACT) and rapid diagnostic tests (RDTs) ? in the various health care facilities is essential. This sum from the above allocation amount will cover these requirements for 2021. This intervention will also contribute to achieving the target of zero malaria-related deaths by 2022.",2148828,null,"Inactive","a6Q1R000000AJJD",2148828,0,0,0,0,1,null,null,"To provide appropriate treatment for at least 95 percent of diagnosed malaria cases, continuous availability of treatment supplies ? including artemisinin-based combination therapy (ACT) and rapid diagnostic tests (RDTs) ? in the various health care facilities is essential. This sum from the above allocation amount will cover these requirements for 2021. This intervention will also contribute to achieving the target of zero malaria-related deaths by 2022.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Thailand","Thailand","PAI-5754","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","DDC BL 292, 293, 294, 295, 296, 297, 298, 299, 300, 301:Support intensive case finding and comprehensive treatment and care of migrant refugees at border area, including·Case detection (passive and Targeted Active Case detection), diagnostic capacity, case holding and case management·Access to care and TB treatment for all TB cases including MDR-TB and TB/HIV co-infected patients·Care and support for TB patient with transportation, and psychosocial care or patients and care takers in residential TB center located on Thai side·Continue and strengthen partnership with Mae Tao Clinic for TB control activities among Migrants who attend MTC.",769377,null,"Inactive","a6Q1R000000AJUG",0,769377,0,0,0,1,null,null,"DDC BL 292, 293, 294, 295, 296, 297, 298, 299, 300, 301:Support intensive case finding and comprehensive treatment and care of migrant refugees at border area, including·Case detection (passive and Targeted Active Case detection), diagnostic capacity, case holding and case management·Access to care and TB treatment for all TB cases including MDR-TB and TB/HIV co-infected patients·Care and support for TB patient with transportation, and psychosocial care or patients and care takers in residential TB center located on Thai side·Continue and strengthen partnership with Mae Tao Clinic for TB control activities among Migrants who attend MTC.","High","This intervention integrates various activities needed for improving the access to TB services of migrant refugees at border area. The better TB control in this vulnerable population will also contribute to prevent TB and MDRTB transmission at borders","NA Original Module: Multidrug-resistant TB","Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5348","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Cost of reaching additional 33,200 FSW with prevention package. It is prioritized because prevalence rate for this population is growing at the fastest rate amongst KP for whom the primary means of transmission is sexual. Unit costs ($71) have been fixed with reference to those used for the AEM modelling. Proposed coverage would amount to 42% of the annual gap for this population through this grant.",2357200,null,"Active","a6Q1R000000AJNi",250000,131900,0,0,1975300,0,null,null,"Cost of reaching additional 33,200 FSW with prevention package. It is prioritized because prevalence rate for this population is growing at the fastest rate amongst KP for whom the primary means of transmission is sexual. Unit costs ($71) have been fixed with reference to those used for the AEM modelling. Proposed coverage would amount to 42% of the annual gap for this population through this grant.","Low","The funding request allocation already provides adequate coverage and resources and priority should go to diagnosis and treatment of sexually transmitted infections and other sexual health services for female sex workers.","NA Original Intervention: Condoms and lubricant programming for female sex workers HIV testing services for female sex workers. Diagnosis and treatment of sexually transmitted infections and other sexual health services for female sex workers","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5347","MCI-00531","Comprehensive prevention programs for TGs","MCI-00562","Other intervention(s) for TGs","Cost of reaching additional 7,200 TG with prevention package. It is prioritized because prevalence rate for this population is the highest (7.1%) amongst KP for whom the primary mode of transmission is sexual. \nUnit costs ($71) were fixed with reference to those used for the AEM modelling. \nProposed additional coverage would amount to 100% of the annual gap.",511200,null,"Active","a6Q1R000000AJNh",100000,184660,0,0,226540,0,null,null,"Cost of reaching additional 7,200 TG with prevention package. It is prioritized because prevalence rate for this population is the highest (7.1%) amongst KP for whom the primary mode of transmission is sexual. \nUnit costs ($71) were fixed with reference to those used for the AEM modelling. \nProposed additional coverage would amount to 100% of the annual gap.","Medium","Proposed interventions in the funding request adequately addressed needs of transgender people and above allocation funds should focus on quality of the proposed interventions.","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Condoms and lubricant programming for transgender people HIV testing services for transgender people with men. Diagnosis and treatment of sexually transmitted infections and other sexual health services for transgender people","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5345","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Cost of reaching additional 100,000 MSM with prevention package. \nProposed additional coverage would amount to 13% of the annual gap for MSM through the grant period.  Since this expansion of prevention program coverage for MSM would imply an increase in the numbers of MSM being identified as positive we consider it to be joint first priority with the Treatment, Care and Support item in the following row.",7100000,null,"Active","a6Q1R000000AJNf",450000,1002442,0,0,5647558,0,null,null,"Cost of reaching additional 100,000 MSM with prevention package. \nProposed additional coverage would amount to 13% of the annual gap for MSM through the grant period.  Since this expansion of prevention program coverage for MSM would imply an increase in the numbers of MSM being identified as positive we consider it to be joint first priority with the Treatment, Care and Support item in the following row.","Medium","Proposed modules and interventions in particular a) HIV testing services, and b) diagnosis and treatment of sexually transmitted infections and other sexual health services for men who have sex with men will strengthen and scale up existing interventions proposed for men having sex with men and male sex workers.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Condoms and lubricant programming for men who have sex with men, HIV testing services for men who have sex with men. Diagnosis and treatment of sexually transmitted infections and other sexual health services for men who have sex with men.","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5344","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Cost of treating additional 20,000 PLHA or 12% of the annual gap. This will help the program to: \n1. Mitigate risk if PC1 budgets don?t materialize timely to supply the projected quantities of ARVs. \n2. Address potential surge in demand for ARTs if numbers of current pre-ART (i.e. CD4 >500) are higher than originally anticipated when treatment-for-all is implemented. \n3. Cover additional treatment demand that would result from increased coverage in MSM programs under PAAR.",4940000,null,"Active","a6Q1R000000AJNe",700000,1140998,0,0,3099002,0,null,null,"Cost of treating additional 20,000 PLHA or 12% of the annual gap. This will help the program to: \n1. Mitigate risk if PC1 budgets don?t materialize timely to supply the projected quantities of ARVs. \n2. Address potential surge in demand for ARTs if numbers of current pre-ART (i.e. CD4 >500) are higher than originally anticipated when treatment-for-all is implemented. \n3. Cover additional treatment demand that would result from increased coverage in MSM programs under PAAR.","High","Existing low level of coverage in the existing proposal should be addressed by expanding the coverage and increase number of HIV positive people to HIV care, Differentiated ARV therapy service delivery, Treatment monitoring ? Viral load and Treatment adherence counselling","NA Original Intervention: HIV care differentiated ARV therapy service delivery treatment monitoring ? Viral load Treatment adherence Counseling and psychosocial support","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5343","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","Cost of implementing national level HIV communication strategy. The plan targets policy makers, opinion leaders, key populations, PLHA, media, healthcare service providers, men and women of reproductive age, and young people. Main objectives are to: \n? strengthen information and knowledge, thus leading to behaviour change and motivation (awareness) \n? generate an enabling environment (advocacy) \n? reinforce social and community support (social support) \n? enhance access to quality services (ability to act)",96100,null,"Active","a6Q1R000000AJNd",0,0,0,0,96100,0,null,null,"Cost of implementing national level HIV communication strategy. The plan targets policy makers, opinion leaders, key populations, PLHA, media, healthcare service providers, men and women of reproductive age, and young people. Main objectives are to: \n? strengthen information and knowledge, thus leading to behaviour change and motivation (awareness) \n? generate an enabling environment (advocacy) \n? reinforce social and community support (social support) \n? enhance access to quality services (ability to act)","High","Will allow to reduce stigma and discrimination towards people living with HIV and cover existing gap of the funding request. Recommend to move into allocation category.","The funds on this intervention in the UQD form  is higher by 487387 USD because of the cost. PO replied: \"this amount refers to the associated costs to support the interventions, targeting the activities in the UQD description\". As the TRP looked at the full program there is an agreement on this cost. Original Intervention: Stigma and discrimination reduction. Sensitization of lawmakers and law enforcement agents Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","Alana Sharp","2019-11-29","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Eswatini","Eswatini","PAI-5666","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Scale up CMIS to 142 additional small volume facilities. This will enable CMIS to be operational in all facilities in the country. The more facilities where CMIS is operational, the better the functionality of the system as a whole. In other words, this PAAR activity is acatalytic one to the allocation CMIS scale-up. This means clients can move from one facility to another, and continue to be captured on the live system.",3424843,null,"Inactive","a6Q1R000000AJSq",1157037,2267806,0,0,0,1,null,null,"Scale up CMIS to 142 additional small volume facilities. This will enable CMIS to be operational in all facilities in the country. The more facilities where CMIS is operational, the better the functionality of the system as a whole. In other words, this PAAR activity is acatalytic one to the allocation CMIS scale-up. This means clients can move from one facility to another, and continue to be captured on the live system.","High","This intervention will enable client management information system (CMIS) to be operational in all facilities across the country","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Alana Sharp","2019-12-05","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Mongolia","Mongolia","PAI-5134","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.",367802,null,"Inactive","a6Q1R000000AJKG",0,367802,0,0,0,1,null,null,"ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.","High","TB diagnostic, GeneXpert and TB lamp proposed to support active case finding interventions. Improved diagnosis to TB is a high impact intervention. TB-LAMP investments from the proposed amount needs to be deprioritized.",null,"Alana Sharp","2020-01-14","2017-2019","Tuberculosis","RT South East Asia","2020-12-31"]
["CT Sao Tome and Principe","Sao Tome and Principe","PAI-5642","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","Focalized spraying planned for 2020, but due to lack of funds, we are requesting this important support in the PAAR. The amount requested in the PAAR for effective implementation of IRS in 2020 will cover procurement of insecticide, transport, storage, payment of sprayers and operating costs.",831143.53,null,"Active","a6Q1R000000AJSS",196360.68,565655,0,0,69127.850000000006,0,null,null,"Focalized spraying planned for 2020, but due to lack of funds, we are requesting this important support in the PAAR. The amount requested in the PAAR for effective implementation of IRS in 2020 will cover procurement of insecticide, transport, storage, payment of sprayers and operating costs.","High","This funding is requested to support IRS gaps (procurement of insecticides and implementation costs). This prioritization is also conditional of TRP approval as stated in issue 7","NA Original Intervention: Indoor residual spraying","Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH","RT Central Africa"]
["CT Mozambique","Mozambique","PAI-5150","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","PAAR investment is requested to support reaching the following outcomes and impact: Increase in the proportion of PLHIV receiving ART from 54% in 2014 to 80% in 2020, and increased ART retention rates from 70% at 12 months in 2016 to 80% in 2020. This will lead to reduction in AIDS related mortality by 40% by 2020 and reduction in incidence by 40% by 2020.",70795813,null,"Active","a6Q1R000000AJKW",3118755,37794658,0,0,29882400,0,null,null,"PAAR investment is requested to support reaching the following outcomes and impact: Increase in the proportion of PLHIV receiving ART from 54% in 2014 to 80% in 2020, and increased ART retention rates from 70% at 12 months in 2016 to 80% in 2020. This will lead to reduction in AIDS related mortality by 40% by 2020 and reduction in incidence by 40% by 2020.","High","The interventions are considered high priority as they address critical interventions which plan to increase the proportion of people living with HIV/AIDS receiving ART from 54% in 2014 to 80% in 2020, increase ART retention rates from 70% at 12 months in 2016 to 80% in 2020 and reduce AIDS-related mortality by 40% by 2020 and incidence by 40% by 2020.","NA Original Intervention: Differenditated ART for people living with HIV/AIDS","Alana Sharp","2020-01-17","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Turkmenistan","Turkmenistan","PAI-5805","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Community involvement to TB care is weak due to the  lack  of  social  contracting  mechanisms.  Civil society formally   participates in  the Country Coordinating  Mechanism.  Proper  involvement  of CSOs is stipulated in the National Programme for TB Prevention and Control, 2016-2020. However, the only CSO with meaningful engagement to TB care is the National Red Crescent Society through the  Global  Fund  grant,  and its  role is  limited to service provision. The transitional grant includes  technical  support  with  establishing  legal and  financial  mechanisms  for  direct  contracting and building  capacities  of  CSOs  as  to  enhance  their contribution to the national TB response. In order to  increase the number of CSO involved in  providing   TB  prevention  and  treatment adherence support interventions, under Prioritized Above Allocation Budget CCM is asking to fund  a Small grants? program for CSOs. The project will support the first grants aiming at involvement of the CSOs in TB control activities, including  work  on  reducing stigma, dissemination of information, advocacy for ambulatory  model,  or support to patients  during ambulatory treatment (focus on women patients or other vulnerable groups).",100000,null,"Inactive","a6Q1R000000AJV5",0,100000,0,0,0,1,null,null,"Community involvement to TB care is weak due to the  lack  of  social  contracting  mechanisms.  Civil society formally   participates in  the Country Coordinating  Mechanism.  Proper  involvement  of CSOs is stipulated in the National Programme for TB Prevention and Control, 2016-2020. However, the only CSO with meaningful engagement to TB care is the National Red Crescent Society through the  Global  Fund  grant,  and its  role is  limited to service provision. The transitional grant includes  technical  support  with  establishing  legal and  financial  mechanisms  for  direct  contracting and building  capacities  of  CSOs  as  to  enhance  their contribution to the national TB response. In order to  increase the number of CSO involved in  providing   TB  prevention  and  treatment adherence support interventions, under Prioritized Above Allocation Budget CCM is asking to fund  a Small grants? program for CSOs. The project will support the first grants aiming at involvement of the CSOs in TB control activities, including  work  on  reducing stigma, dissemination of information, advocacy for ambulatory  model,  or support to patients  during ambulatory treatment (focus on women patients or other vulnerable groups).","High","The TRP considers this\nintervention quality demand as it\nwill to contribute to improved\nprogram management and\nimplementation after transition.\nBecause of its importance, the\nTRP recommends this module to\nmove into allocation.","NA Original Module: RSSH - Community responses and systems","Alana Sharp","2020-01-14","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-06-30"]
["CT Uganda","Uganda","PAI-5889","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","This is to support procurement of cartridges for operationalizing Xpert MTB/Rif machines to enhance the finding of missed cases including in key populations such as prisons and PLHIV. Secondly, approximately $1.7m is for procuring digital X-rays.",18652070,null,"Active","a6Q1R000000AJWR",0,6500000,0,0,12152070,0,null,null,"This is to support procurement of cartridges for operationalizing Xpert MTB/Rif machines to enhance the finding of missed cases including in key populations such as prisons and PLHIV. Secondly, approximately $1.7m is for procuring digital X-rays.","Medium","This is to support expansion of GeneXpert through procurement of cartridges in addition to procurement and deployment of digital X-rays. The applicant is attempting to respond to the findings of the TB disease prevalence survey in which nearly half of the identified TB cases had no symptoms and to take advantage of the better sensitivity of the Xpert test to find missing cases.",null,"Alana Sharp","2020-01-27","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Tajikistan","Tajikistan","PAI-5800","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","With PAAR, the project will improve the quality and expand the NSEP and OST services for PWID by the end of the project cycle. The expected outcome is to contain the spread of the HIV infection among the key population and eventually general population. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.",2000000,null,"Active","a6Q1R000000AJV0",154368,961565,0,0,884067,0,null,null,"With PAAR, the project will improve the quality and expand the NSEP and OST services for PWID by the end of the project cycle. The expected outcome is to contain the spread of the HIV infection among the key population and eventually general population. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.","Medium","This intervention will allow to improve the quality and expand the needle and syringe exchange program and opioid substitution treatment services for people who inject drugs. It will allow as well to conduct an integrated biobehavioral survey (IBBS) among peope who inject drugs.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Provide needle and syringe exchange program, HIV testing and counselling and opioid substitution treatmentto people who inject drugs","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Tajikistan","Tajikistan","PAI-5799","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","Involving government and civil society organizations to support key populations and understand their rights. Reducing vilifications against women, girls and gender violation. Improving acceptable service for key population and PLWH. Degreasing social, cultural, legal, and self-stigma and discrimination against key populations and PLWH.",250000,null,"Inactive","a6Q1R000000AJUz",0,250000,0,0,0,1,null,null,"Involving government and civil society organizations to support key populations and understand their rights. Reducing vilifications against women, girls and gender violation. Improving acceptable service for key population and PLWH. Degreasing social, cultural, legal, and self-stigma and discrimination against key populations and PLWH.","Medium","This intervention will allow to involve government and civil society organizations to support key populations and understand their rights, to reduce vilifications against women, girls and gender violation, tomprove acceptable service for key population and people living with HIV, and to decrease social, cultural, legal, and self-stigma and discrimination against key populations and people living with HIV.","NA Original Intervention: Legal/patients? rights' literacy trainings for women, girls and key populations ? Training of health care providers on nondiscrimination, duty to treat and rights based approach. ? Human Rights roundtable and workshop for parliamentarians, ministries of justice, judges, prosecutors, police, law expert and religious leaders.","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Sudan","Sudan","PAI-5492","MCI-00012","Case management","MCI-00154","Facility-based treatment","During the year 2018 remarkable increase in the consumption of malaria first line (AL) were report (2.9m vs 3.9m reported) The increase is attributed to: Increase in malaria cases trend reported through DHIS2, shifting in the patient seeking behaver toward public sector due to inflation, Shifting in National health Insurance  policy from providing the services to paying for service in the public sector",5937480.6900000004,null,"Inactive","a6Q1R000000AJQ2",1005700,4931779,0,0,1.69,1,null,null,"During the year 2018 remarkable increase in the consumption of malaria first line (AL) were report (2.9m vs 3.9m reported) The increase is attributed to: Increase in malaria cases trend reported through DHIS2, shifting in the patient seeking behaver toward public sector due to inflation, Shifting in National health Insurance  policy from providing the services to paying for service in the public sector","High",null,null,"Alana Sharp","2019-12-05","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Sudan","Sudan","PAI-5488","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","Funding to maintain the scope and scale of The global Fund investment in malaria control in Sudan, IRS  for Y3 should be  continued  in the irrigated scheme namely Gazira and Sinnar state  (in 2018 Population protected  3811881/household covered 727967 considering 10% increase in 2020 ) IVM Is advocating for supporting other localities from the irrigated scheme",11538304.939999999,null,"Active","a6Q1R000000AJPy",2000000,9052453.5800000001,0,0,485851.36,0,null,null,"Funding to maintain the scope and scale of The global Fund investment in malaria control in Sudan, IRS  for Y3 should be  continued  in the irrigated scheme namely Gazira and Sinnar state  (in 2018 Population protected  3811881/household covered 727967 considering 10% increase in 2020 ) IVM Is advocating for supporting other localities from the irrigated scheme","High",null,"NA Original Intervention: Indoor residual spraying","Alana Sharp","2019-12-05","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5395","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This allows a further year of Insecticide Resistance Monitoring in four site in year two which are presently not possible in the present grant allocation.",101609,null,"Active","a6Q1R000000AJOT",0,0,100000,0,1609,0,null,null,"This allows a further year of Insecticide Resistance Monitoring in four site in year two which are presently not possible in the present grant allocation.","High","The TRP recommended in its review of the Program Continuation Request that the monitoring of insecticide resistance be sustained.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Additional year of Insecticide Resistance Monitoring in 4 sites","Alana Sharp","2020-01-14","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5394","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Review progress of the malaria program to establish recommendations for the new Malaria Strategic Plan for 2021-2025.",200100,null,"Active","a6Q1R000000AJOS",0,0,200000,0,100,0,null,null,"Review progress of the malaria program to establish recommendations for the new Malaria Strategic Plan for 2021-2025.","High","In its review of the Program Continuation Request, the TRP expressed concern that the epidemiology of malaria in PNG is changing and P. vivax is assuming a more prominent role. The TRP recommended an early review of the national malaria program with a view to establish recommendations for the new Malaria Strategic Plan for 2021-2025 and a possible evidence-based request to the Global Fund for re-programming if the data suggests.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: National Malaria Programme Review","Alana Sharp","2020-01-14","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5393","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","These are relatively low risk malaria zone where epidemics might occur at 1600 meters altitude and P.vivax predominates at higher altitudes. Long Lasting Insecticide Treated Nets have been distributed in these areas since 2006 but will not continue past 2017 due to lack of funds. These funds are needed to distribute a total of 649,300 Long Lasting Insecticide Treated Nets for household distribution.",3765940,null,"Active","a6Q1R000000AJOR",0,0,300000,0,3465940,0,null,null,"These are relatively low risk malaria zone where epidemics might occur at 1600 meters altitude and P.vivax predominates at higher altitudes. Long Lasting Insecticide Treated Nets have been distributed in these areas since 2006 but will not continue past 2017 due to lack of funds. These funds are needed to distribute a total of 649,300 Long Lasting Insecticide Treated Nets for household distribution.","High","Use of grant savings to increase coverage of LLIN was recommended by the TRP in its review of the Program Continuation Request","NA Original Intervention: Distribution of LLINs to people living in the 1600 to 2000m zone of PNG","Alana Sharp","2020-01-14","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Tajikistan","Tajikistan","PAI-5798","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Condom and counselling will be expanded to SW to improve the accessibility of services. Violation against women, SW, girls will be reported. Client will receive psycho-social support. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.",900000,null,"Active","a6Q1R000000AJUy",82541,352491,0,0,464968,0,null,null,"Condom and counselling will be expanded to SW to improve the accessibility of services. Violation against women, SW, girls will be reported. Client will receive psycho-social support. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.","Medium","This intervention will allow scale up of condoms distributions and counselling to sex workers, reporting of violation against women, sex workers, girls, provision of psychosocial support to sex workers. Within this intervention, an integrated bio-behavioral survey (IBBS) among sex workers will be conducted .","NA Original Module: Comprehensive prevention programs and support for sex workers. Original Intervention: Provide standard package of services to sex workers and their clients (condoms, HIV testing, information, education and communication material and sexually treansmitted infections treatment)","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Tajikistan","Tajikistan","PAI-5796","MCI-00071","Other module","MCI-00071","Other module","This will be pilot based on the result of the study the PR will develop strategy and action plan to offer PrEP.",100000,null,"Inactive","a6Q1R000000AJUw",0,100000,0,0,0,1,null,null,"This will be pilot based on the result of the study the PR will develop strategy and action plan to offer PrEP.","High","This intervention will allow to accelerate prevention among key populations in particular among men who have sex with men.","NA Original Module: Pre-exposure prophylaxis. Original Intervention: Offering counselling and pre-exposure prophylaxis to key populations","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Tajikistan","Tajikistan","PAI-5795","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Aiming to scale up to reach 73.9% (10,800 individuals) of PLWH who aware their status, on ART. The cost also includes VL and CD4 testing. The expected outcome is to achieve viral suppression as per treatment as prevention initiative.",2800000,null,"Active","a6Q1R000000AJUv",69515,1704235,0,0,1026250,0,null,null,"Aiming to scale up to reach 73.9% (10,800 individuals) of PLWH who aware their status, on ART. The cost also includes VL and CD4 testing. The expected outcome is to achieve viral suppression as per treatment as prevention initiative.","High","This intervention will allow the program to reach people who inject drugs who are aware of their status, to scale up antiretroviral therapy, and viral load and CD4 testing, and to achieve viral suppression as per treatment as prevention initiative.","NA Original Module: Treatment, care and support for adults, adolescents, and children. Original Intervention: Enroll 2000 people living with HIV to antiretroviral treatment, counselling and support to increase adherence. Viral loas test and CD4 count test.","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Tajikistan","Tajikistan","PAI-5794","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Improve overall health outcomes, reduce costs and gain efficiencies. Offering service in different modalities to increase clients and reduce workload. Scale up access in nationwide in any location.",350000,null,"Inactive","a6Q1R000000AJUu",94064,255936,0,0,0,1,null,null,"Improve overall health outcomes, reduce costs and gain efficiencies. Offering service in different modalities to increase clients and reduce workload. Scale up access in nationwide in any location.","High","This intervention will allow to support innovative approaches, and integration of services.","NA Original Module: Resilent and Sustainable Systems of Health (RSSH) and Integration of HIV services to primary Health care system and differentiated HIV Testing Services.. Original Intervention: Establishing greater integration and improve linkage to HIV services, Integrate and offer HIV tests in all levels of the national health care system. Different modalities including Facilitybased HIV testing, Communitybased testing (including outreach, mobile, home-based, targeted campaigns, partner testing) ? Provider- and client-initiated testing based on voluntary and informed consent","Alana Sharp","2020-01-21","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Zambia","Zambia","PAI-6036","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","The number of LLINs to be distributed to at risk population through mass campaign in 2020 is 7,512,678.",19215531.5,null,"Active","a6Q1R000000AJYo",1010899,11490376,0,0,6714256.5,0,null,null,"The number of LLINs to be distributed to at risk population through mass campaign in 2020 is 7,512,678.","High","The proposed action is in line with the national strategic plan and vector control interventions for significant reduction in malaria by 2020.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-14","2017-2019","Malaria","RT High Impact Africa 2","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5392","MCI-00071","Other module","MCI-00071","Other module","Home Based Management of Malaria (HMM) has been previously supported through three non-governmental organizations in three provinces in the country but will not continue past 2017. Funds are to develop national policies for HMM to be implemented by staff in health centers, supporting National Department of Health to work with provinces (particularly the three provinces) to integrate these programs at the health facility level.",600000,null,"Inactive","a6Q1R000000AJOQ",0,0,600000,0,0,1,null,null,"Home Based Management of Malaria (HMM) has been previously supported through three non-governmental organizations in three provinces in the country but will not continue past 2017. Funds are to develop national policies for HMM to be implemented by staff in health centers, supporting National Department of Health to work with provinces (particularly the three provinces) to integrate these programs at the health facility level.","Low","Home Based Management of Malaria (HMM) extended through national policies for HMM for implementation by health staff in health centers throughout the country where communities live in difficult to reach areas. However, the TRP considers that more work is required before this program can be implemented. In particular, the TRP recommends that the applicant, supported by the Secretariat, considers the implications of the government program of decentralization of health responsibilities and seeks to safeguard arrangements for the extension of HMM accordingly","NA Original Module: Community based treatment. Original Intervention: Integration of home based management of malaria into the national health system","Alana Sharp","2020-01-14","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5390","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","This program delivers antenatal nets to about 50% of pregnant women each year. This protects both  pregnant women and newly born children from malaria. Delivery to pregnant women is done through health centers. Nets are also distributed every three years to prisons and boarding pupils in boarding schools.",1723192,null,"Active","a6Q1R000000AJOO",0,0,1720000,0,3192,0,null,null,"This program delivers antenatal nets to about 50% of pregnant women each year. This protects both  pregnant women and newly born children from malaria. Delivery to pregnant women is done through health centers. Nets are also distributed every three years to prisons and boarding pupils in boarding schools.","High","Use of grant savings to increase coverage of LLIN was recommended by the TRP in its review of the Program Continuation Request","NA Original Intervention: Distribution of Long Lasting Insecticidal Nets (LLINs) to Vulnerable Groups","Alana Sharp","2020-01-14","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Chad","Chad","PAI-5723","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.\n\nIn order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.",6883375.54,null,"Active","a6Q1R000000AJTl",0,6338971,0,0,544404.54,0,null,null,"The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.\n\nIn order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.","High","The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.\n\nIn order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-23","2017-2019","Malaria","RT Central Africa","2021-06-30"]
["CT Chad","Chad","PAI-5722","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN mass distribution campaigns represent the most important vector control strategy. With the exception of the desert region in the far north, all other regions are eligible for this strategy, i.e. 19 out of the 23 regions. The Global Fund?s continuous financial support resulted in carrying out 3 campaigns in the country at a regular interval of 3 years (2011, 2014 and 2017). These, respectively, allowed covering 44%, 73% and 69.1% of the total population of the country. The support provided by the government and other partners was very limited, and resulted in covering only one region in 2011 (Logone Occidental: 6.2% of the population) and 3 regions in 2014 (Batha, Ouaddai and Barh El Gazel: 12.7%). The 2017 campaign was possible only thanks to the support of the Global Fund.\n \nThe next mass distribution campaign is planned in 2020. Due to reduced resources allocated to the country by the Global Fund for the Malaria Grant, only 6 regions (Tandjilé, Logone Oriental, Mandoul, Moyen Chari, Salamat and Lac) will benefit from the next campaign. This represents 31.3% of the total population living in endemic regions. Conscious of the importance of the mass campaign for malaria prevention, and in order to avoid a resurgence of cases in the 13 regions that have already benefited from mass campaigns in 2017, the country wishes to sustain the gains. The requested amount will provide 3,931,586 LLINs, cover for logistics and other operational costs to carry out the campaign in 7 regions with 6,433,505 inhabitants (37.8% of the population of the malaria endemic regions). This will ensure that all 13 regions that were covered by the 2017 mass distribution campaign supported by the Global Fund will benefit from the 2020 mass distribution campaign.",13715315.310000001,null,"Active","a6Q1R000000AJTk",0,13432297.279999999,0,0,283018.03000000003,0,null,null,"LLIN mass distribution campaigns represent the most important vector control strategy. With the exception of the desert region in the far north, all other regions are eligible for this strategy, i.e. 19 out of the 23 regions. The Global Fund?s continuous financial support resulted in carrying out 3 campaigns in the country at a regular interval of 3 years (2011, 2014 and 2017). These, respectively, allowed covering 44%, 73% and 69.1% of the total population of the country. The support provided by the government and other partners was very limited, and resulted in covering only one region in 2011 (Logone Occidental: 6.2% of the population) and 3 regions in 2014 (Batha, Ouaddai and Barh El Gazel: 12.7%). The 2017 campaign was possible only thanks to the support of the Global Fund.\n \nThe next mass distribution campaign is planned in 2020. Due to reduced resources allocated to the country by the Global Fund for the Malaria Grant, only 6 regions (Tandjilé, Logone Oriental, Mandoul, Moyen Chari, Salamat and Lac) will benefit from the next campaign. This represents 31.3% of the total population living in endemic regions. Conscious of the importance of the mass campaign for malaria prevention, and in order to avoid a resurgence of cases in the 13 regions that have already benefited from mass campaigns in 2017, the country wishes to sustain the gains. The requested amount will provide 3,931,586 LLINs, cover for logistics and other operational costs to carry out the campaign in 7 regions with 6,433,505 inhabitants (37.8% of the population of the malaria endemic regions). This will ensure that all 13 regions that were covered by the 2017 mass distribution campaign supported by the Global Fund will benefit from the 2020 mass distribution campaign.","High","LLIN mass distribution campaigns represent the most important vector control strategy. With the exception of the desert region in the far north, all other regions are eligible for this strategy, i.e. 19 out of the 23 regions. The Global Fund?s continuous financial support resulted in carrying out 3 campaigns in the country at a regular interval of 3 years (2011, 2014 and 2017). These, respectively, allowed covering 44%, 73% and 69.1% of the total population of the country. The support provided by the government and other partners was very limited, and resulted in covering only one region in 2011 (Logone Occidental: 6.2% of the population) and 3 regions in 2014 (Batha, Ouaddai and Barh El Gazel: 12.7%). The 2017 campaign was possible only thanks to the support of the Global Fund.\n \nThe next mass distribution campaign is planned in 2020. Due to reduced resources allocated to the country by the Global Fund for the Malaria Grant, only 6 regions (Tandjilé, Logone Oriental, Mandoul, Moyen Chari, Salamat and Lac) will benefit from the next campaign. This represents 31.3% of the total population living in endemic regions. Conscious of the importance of the mass campaign for malaria prevention, and in order to avoid a resurgence of cases in the 13 regions that have already benefited from mass campaigns in 2017, the country wishes to sustain the gains. The requested amount will provide 3,931,586 LLINs, cover for logistics and other operational costs to carry out the campaign in 7 regions with 6,433,505 inhabitants (37.8% of the population of the malaria endemic regions). This will ensure that all 13 regions that were covered by the 2017 mass distribution campaign supported by the Global Fund will benefit from the 2020 mass distribution campaign.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-23","2017-2019","Malaria","RT Central Africa","2021-06-30"]
["CT Thailand","Thailand","PAI-5787","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","The request is based on the current number of modules (600 modules) in country (125 machines) @ 3 tests per module (assuming 3 runs per day per site)/ day X 600 modules X 255 days a year (excluding weekends and public holidays) = 459,000 tests.",5278500,null,"Active","a6Q1R000000AJUn",0,4309548,0,0,968952,0,null,null,"The request is based on the current number of modules (600 modules) in country (125 machines) @ 3 tests per module (assuming 3 runs per day per site)/ day X 600 modules X 255 days a year (excluding weekends and public holidays) = 459,000 tests.","High","The request is based on the current number of modules (600 modules) in country (125 machines) @ 3 tests per module (assuming 3 runs per day per site)/ day X 600 modules X 255 days a year (excluding weekends and public holidays) = 459,000 tests.","Amount validated and description updated by CT Original Module: Multidrug-resistant TB. Original Intervention: Case detection and diagnosis: MDR-TB ","Alana Sharp","2020-01-14","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Bangladesh","Bangladesh","PAI-3892","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Additional community case finding activities in hard-to reach areas not covered by the allocation and/or matching fund request, introduction of the new diagnostic algorithm in additional upazilas in remote areas, establishment of additional diagnostic facilities (X-ray, FNAC, X-pert) to improve the diagnosis of smear-negative, Child-TB and Extra Pulmoniary cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.",41348864,null,"Active","a6Q1R000000AJ0E",22232521,14701807,0,0,4414536,0,null,null,"Additional community case finding activities in hard-to reach areas not covered by the allocation and/or matching fund request, introduction of the new diagnostic algorithm in additional upazilas in remote areas, establishment of additional diagnostic facilities (X-ray, FNAC, X-pert) to improve the diagnosis of smear-negative, Child-TB and Extra Pulmoniary cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","High","Expands evidence-based and appropriate interventions for increased case finding.",null,"Alana Sharp","2020-01-17","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Benin","Benin","PAI-3755","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.",441113.23,null,"Active","a6Q1R000000AIy1",0,221000,0,0,220113.23,0,null,null,"These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4614","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","The request for funding to GF for 2018-2020 (allocated amount) includes SLD coverage through the end of 2020. Additional SLD supply for 2021 is requested from PAAR to cover SLDs for patients who have started MDR TB treatment through the end of 2020 and will continue in 2021. Totally, 1040 MDR TB patients will be covered. The additional SLD supply will ensure the continuum of care for MDR TB patients started treatment during 2019-2020 within GF grant for bridging the potential treatment gap for period January- September 2021.",1609942,null,"Active","a6Q1R000000AJBs",null,null,0,0,1609942,0,null,null,"The request for funding to GF for 2018-2020 (allocated amount) includes SLD coverage through the end of 2020. Additional SLD supply for 2021 is requested from PAAR to cover SLDs for patients who have started MDR TB treatment through the end of 2020 and will continue in 2021. Totally, 1040 MDR TB patients will be covered. The additional SLD supply will ensure the continuum of care for MDR TB patients started treatment during 2019-2020 within GF grant for bridging the potential treatment gap for period January- September 2021.","High","The TRP was not able to distinguish this from the intervention above. It is\ntherefore not clear to the TRP what the funding shortfall is (is it 1,609, 942 plus 746,393)? This said, the TRP re-iterates the importance of identifying other sources of financing\nto forestall MDR-TB medicines/\nSLDs shortages by 2020.","NA Original Module: Multidrug-resistant TB","Alana Sharp","2019-12-10","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Eastern Europe and Central Asia"]
["CT Bangladesh","Bangladesh","PAI-3887","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN ? Mass campaign. The within allocation request covers the absolute, high and medium priority areas. There are a significant number of people at risk in low priority areas that will be left uncovered. Free LLINs will be expanded to cover the entire population residing in targeted established settlements. This will complement the within allocation LLIN approach and result in reduced transmission.",2198599,null,"Inactive","a6Q1R000000AJ09",876518,1322081,0,0,0,1,null,null,"LLIN ? Mass campaign. The within allocation request covers the absolute, high and medium priority areas. There are a significant number of people at risk in low priority areas that will be left uncovered. Free LLINs will be expanded to cover the entire population residing in targeted established settlements. This will complement the within allocation LLIN approach and result in reduced transmission.","High","There are a significant number of people at risk in low priority areas that will be left uncovered.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-17","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Bangladesh","Bangladesh","PAI-3885","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Mapping can significantly strengthen the management of malaria elimination efforts. Health Information Systems in elimination districts will be upgraded to include a GIS component with mapping down to household level. Selected healthcare providers will be equipped with a smartphone so that they can report the geographical position of all confirmed malaria cases. The Government will strengthen the pharmacovigilance system.",438173,null,"Inactive","a6Q1R000000AJ07",438173,0,0,0,0,1,null,null,"Mapping can significantly strengthen the management of malaria elimination efforts. Health Information Systems in elimination districts will be upgraded to include a GIS component with mapping down to household level. Selected healthcare providers will be equipped with a smartphone so that they can report the geographical position of all confirmed malaria cases. The Government will strengthen the pharmacovigilance system.","High","Mapping can significantly strengthen the management of malaria elimination efforts, especially in malaria elimination districts.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Alana Sharp","2020-01-17","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Benin","Benin","PAI-3813","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","The gap of 315 000 LLIN has been filled",1739000.11,null,"Inactive","a6Q1R000000AIyx",1739000.11,0,0,0,0,1,null,null,"The gap of 315 000 LLIN has been filled","High",null,"NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Alana Sharp","2020-01-14","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Benin","Benin","PAI-3743","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.",4729341.26,null,"Active","a6Q1R000000AIxp",1400000,1400000,0,0,1929341.26,0,null,null,"Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Bangladesh","Bangladesh","PAI-3874","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00098","OST and other drug dependence treatment for PWID","Further scale-up Opioid Substitution Therapy (OST) in 3 priority districts: Considering the HIV and HCV epidemic, another 1,000 PWID will be targeted for OST in selected districts by 2020, which will increase the national coverage to 11%. This harm reduction intervention is critical in the fight against the transmission of HIV/HCV.",935188,null,"Inactive","a6Q1R000000AIzw",665925,269263,0,0,0,1,null,null,"Further scale-up Opioid Substitution Therapy (OST) in 3 priority districts: Considering the HIV and HCV epidemic, another 1,000 PWID will be targeted for OST in selected districts by 2020, which will increase the national coverage to 11%. This harm reduction intervention is critical in the fight against the transmission of HIV/HCV.","High","Increases and impacts transmission of HIV/HCV among people who inject drugs.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","Alana Sharp","2020-01-17","2017-2019","HIV/AIDS","RT High Impact Asia","2020-11-30"]
["CT Bangladesh","Bangladesh","PAI-3873","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00099","Prevention and management of coinfections and co-morbidities for PWID","Prevention, screening, diagnosis and management for Hepatitis C virus (HCV): Information Education Communication/Behaviour Change Communication activities for the prevention of HCV will be conducted among targeted People Who Inject Drugs (PWID). PWID will be routinely screened for HCV and around 200 HCV positive PWID will be provided medicine support. Trained physicians will be responsible for screening, diagnosis and management of HCV from Drop-In-Centres. The impact will be to reduce morbidity and mortality for PWID who may be co-infected with HIV.",431028,null,"Inactive","a6Q1R000000AIzv",100723,330305,0,0,0,1,null,null,"Prevention, screening, diagnosis and management for Hepatitis C virus (HCV): Information Education Communication/Behaviour Change Communication activities for the prevention of HCV will be conducted among targeted People Who Inject Drugs (PWID). PWID will be routinely screened for HCV and around 200 HCV positive PWID will be provided medicine support. Trained physicians will be responsible for screening, diagnosis and management of HCV from Drop-In-Centres. The impact will be to reduce morbidity and mortality for PWID who may be co-infected with HIV.","Medium","Increases coverage and impact of hepatitis C virus (HCV) intervention to reduce morbidity and mortality in people who inject drugs.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Prevention and management of co-infections and co-morbidities for people who inject drugs","Alana Sharp","2020-01-17","2017-2019","HIV/AIDS","RT High Impact Asia","2020-11-30"]
["CT Afghanistan","Afghanistan","PAI-3548","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Pregnant women living in malaria endemic areas (category 1) require protection and will receive LLIN.  It is recommended  to provide a LLIN to all pregnant women visiting ANC  in  areas of Category 1 which are not covered in the malaria funding  request.  Due to inaccurate data the LLIN numbers are insufficient. No. of LLINs estimated to be distributed among  pregnant women visiting ANCs  (calculated  based  on  the ANC visits in those areas) = 364,307.",1092920,null,"Inactive","a6Q1R000000AIug",0,1092920,0,0,0,1,null,null,"Pregnant women living in malaria endemic areas (category 1) require protection and will receive LLIN.  It is recommended  to provide a LLIN to all pregnant women visiting ANC  in  areas of Category 1 which are not covered in the malaria funding  request.  Due to inaccurate data the LLIN numbers are insufficient. No. of LLINs estimated to be distributed among  pregnant women visiting ANCs  (calculated  based  on  the ANC visits in those areas) = 364,307.","High","In the context of the human rights and gender issues, the disproportionately high malaria burden among women and girls is to be reduced. In particular, pregnant women are the most vulnerable population targeted for protection, thus those visiting ANC in Category 1 areas should receive LLINs. However, the TRP recommends that this procurement and distribution should be coordinated to complement and not overlap with the LLIN distribution already in place in Category 1 areas","NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Alana Sharp","2020-01-14","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4233","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","IRS is conducted in three out of six regions of the country to control malaria. Bendiocarb 80% WP is one of the insecticides used. A total of 22,104kgs of the insecticide are estimated to cover spraying operation for the year 2018. The product costs USD 1,923,048 (CIF cost) at USD 87.0 per kg. Since this is an expensive chemical and that the Global Fund allocation made for the next funding cycle is less-than-expected, the Global Fund was requested for no-objection for the country to use existing savings to cover the above cost. As the request was not approved, this request is being included under PAAR and funding this activity will contribute in preventing malaria as part of IVM strategy.",1923048,null,"Active","a6Q1R000000AJ5j",197680,1000000,0,0,725368,0,null,null,"IRS is conducted in three out of six regions of the country to control malaria. Bendiocarb 80% WP is one of the insecticides used. A total of 22,104kgs of the insecticide are estimated to cover spraying operation for the year 2018. The product costs USD 1,923,048 (CIF cost) at USD 87.0 per kg. Since this is an expensive chemical and that the Global Fund allocation made for the next funding cycle is less-than-expected, the Global Fund was requested for no-objection for the country to use existing savings to cover the above cost. As the request was not approved, this request is being included under PAAR and funding this activity will contribute in preventing malaria as part of IVM strategy.","High","IRS is planned to complement the distribution of nets, though funds in the initial Program Continuation request were inadequate due to a reduce allocation amount. These funds will cover the budget shortfall for IRS insecticide.","Comment from CT: As mentioned above, priority was given to procure country needs for LLINs within the allocation and accordingly budget for IRS was decreased in allocation but increased under PAAR (3,770,679.50). MS: Update data for GAC section from Grant sign off form Original Intervention: Indoor residual spraying","Alana Sharp","2019-12-09","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Burkina Faso","Burkina Faso","PAI-3850","MCI-00071","Other module","MCI-00071","Other module","Acquiring artesunate injectables for the management of severe malaria in patients aged 5 and above (except pregnant women) in 2019 and 2020.",5300153.74,null,"Inactive","a6Q1R000000AIzY",0,5300153.74,0,0,0,1,null,null,"Acquiring artesunate injectables for the management of severe malaria in patients aged 5 and above (except pregnant women) in 2019 and 2020.","High","For the procurement of medicines for the treatment of severe malaria cases 2019-2020. To ensure availability and increase access to quality medicines, consequently, reducing fatality from severe malaria","NA Original Module: Support. Original Intervention: Medicines for the treatment of severe malaria","Alana Sharp","2020-01-15","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6151","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","IEC actions (information, education and communication) to develop a strategy to promote safe and responsible sexual practices (consultancy fees)\n\nIndicators:\nReduce the gap of 2016 on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",20000,20000,"Active","a6Q1R000000AJeE",{"$nulls":4},20000,0,null,"High","IEC actions (information, education and communication) to develop a strategy to promote safe and responsible sexual practices (consultancy fees)\n\nIndicators:\nReduce the gap of 2016 on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Alana Sharp","2019-11-08","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6150","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Consultancy to develop a follow-up strategy for new-born babies to HIV-positive mothers and ensure adequate care (resources for mobilization, promoters, linkage to strategies already in progress)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)",20000,20000,"Active","a6Q1R000000AJeD",{"$nulls":4},20000,0,null,"High","Consultancy to develop a follow-up strategy for new-born babies to HIV-positive mothers and ensure adequate care (resources for mobilization, promoters, linkage to strategies already in progress)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","High",null,null,"Alana Sharp","2019-11-08","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6141","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Special TA for the expansion of ETMI interventions progressively to establishments of all levels of care, prioritizing the first and second levels to increase the coverage of prenatal, delivery and puerperium care with qualified personnel within the framework of the primary health care strategy.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",10395,10395,"Active","a6Q1R000000AJe4",{"$nulls":4},10395,0,null,"High","Special TA for the expansion of ETMI interventions progressively to establishments of all levels of care, prioritizing the first and second levels to increase the coverage of prenatal, delivery and puerperium care with qualified personnel within the framework of the primary health care strategy.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Alana Sharp","2019-11-08","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-6132","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",1197668,1197668,"Inactive","a6Q1R000000AJct",null,1197668,null,null,0,1,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2019-12-10","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Ukraine","Ukraine","PAI-6128","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1600000,1600000,"Inactive","a6Q1R000000AJcZ",null,1600000,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Turkmenistan","Turkmenistan","PAI-6135","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Turkmenistan plans to make the transition to the new WHO guidelines from July 2019 and would require additional funding for 2019 and 2020. Over 1000 RR/MDR TB patients are expected to transition to the new RR/MDR TB treatment regimens in next 1.5 years, leading to an estimated gap to be funded through portfolio optimization.",786793,786793,"Inactive","a6Q1R000000AJd8",null,786793,null,null,0,1,null,"High","Turkmenistan plans to make the transition to the new WHO guidelines from July 2019 and would require additional funding for 2019 and 2020. Over 1000 RR/MDR TB patients are expected to transition to the new RR/MDR TB treatment regimens in next 1.5 years, leading to an estimated gap to be funded through portfolio optimization.","High",null,null,"Alana Sharp","2019-11-28","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-06-30"]
["CT Namibia","Namibia","PAI-6133","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1059911,1059911,"Inactive","a6Q1R000000AJcy",null,1059911,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Tajikistan","Tajikistan","PAI-6126","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1419703,1419703,"Active","a6Q1R000000AJcP",null,1419701.93,null,null,1.07,0,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Ethiopia","Ethiopia","PAI-6130","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",3000000,3000000,"Active","a6Q1R000000AJcj",{"$nulls":4},3000000,0,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2019-11-06","2017-2019","Tuberculosis","RT High Impact Africa 2","2021-06-30"]
["CT Kenya","Kenya","PAI-6131","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",1578834,1578834,"Active","a6Q1R000000AJco",{"$nulls":4},1578834,0,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Alana Sharp","2019-11-06","2017-2019","Tuberculosis","RT High Impact Africa 2","2021-06-30"]
["CT Azerbaijan","Azerbaijan","PAI-6129","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",2227664,2227664,"Inactive","a6Q1R000000AJce",null,2227664,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Uganda","Uganda","PAI-6127","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",2000000,2000000,"Inactive","a6Q1R000000AJcU",null,2000000,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Alana Sharp","2019-11-27","2017-2019","Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Pakistan","Pakistan","PAI-6184","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.",206900,206900,"Active","a6Q1R000000AJn2",{"$nulls":4},206900,0,null,"High","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Rwanda","Rwanda","PAI-6194","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","This request is for alignment of grant.",2100000,2100000,"Active","a6Q1R000000AJnG",{"$nulls":4},2100000,0,null,"High","This request is for alignment of grant.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-6193","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","This request is for alignment of grant.",1003118,1003118,"Active","a6Q1R000000AJnF",{"$nulls":4},1003118,0,null,"High","This request is for alignment of grant.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-6192","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","This request is for alignment of grant.",5166187,5166187,"Active","a6Q1R000000AJnE",{"$nulls":4},5166187,0,null,"High","This request is for alignment of grant.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-6191","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","This request is for alignment of grant.",11617393,11617393,"Active","a6Q1R000000AJnD",{"$nulls":4},11617393,0,null,"High","This request is for alignment of grant.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-6190","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.",10958103,10958103,"Active","a6Q1R000000AJnC",{"$nulls":4},10958103,0,null,"High","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","HIV/AIDS, Malaria","RT Southern and Eastern Africa"]
["CT Madagascar","Madagascar","PAI-6182","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.",16758100,16758100,"Inactive","a6Q1R000000AJms",null,16758100,null,null,0,1,null,"High","Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.","High",null,null,"Alana Sharp","2020-01-14","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Nigeria","Nigeria","PAI-6183","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.",9515528,9515528,"Active","a6Q1R000000AJmx",{"$nulls":4},9515528,0,"2020-01-29T12:52:00","High","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.","High",null,null,"Alana Sharp","2019-12-04","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Namibia","Namibia","PAI-6180","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Procure essential   350 000 LLIN's to cover cover the gap currently experieneced with populations living in Zinc Structures.   The Zinc structures were earmarked for IRS as well but it was found that IRS is not best suited for Zinc Structures.  The programme is currently testing the residual efficacy of insecticides (Actelic) on Zinc structures, while collecting this data, people residing in these structure should be protected by mosquito nets. The 300,000  Nets constitute the gap since these population were not targeted  for nets before. Price includes PSM costs",1384600,1384600,"Active","a6Q1R000000AJkm",{"$nulls":4},1384600,0,null,"High","Procure essential   350 000 LLIN's to cover cover the gap currently experieneced with populations living in Zinc Structures.   The Zinc structures were earmarked for IRS as well but it was found that IRS is not best suited for Zinc Structures.  The programme is currently testing the residual efficacy of insecticides (Actelic) on Zinc structures, while collecting this data, people residing in these structure should be protected by mosquito nets. The 300,000  Nets constitute the gap since these population were not targeted  for nets before. Price includes PSM costs","High","Population at risk to malaria  should always be protected. As zinc structure is not sprayable and as the change from zink structure to sprayable surfaces is not possible now and as research is going on to find  a solution for this problem; it isjustified to shift to LLINs to protect at risk population",null,"Malgorzata Matysek","2019-11-29","2017-2019","Malaria","RT Southern and Eastern Africa","2020-12-31"]
["CT Nigeria","Nigeria","PAI-6213","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",10000000,10000000,"Inactive","a6Q1R000000AJtZ",null,10000000,null,null,0,1,"2020-01-29T12:52:00","High","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Anouk Chevalier Plante","2020-01-29","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Nigeria","Nigeria","PAI-5270","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Across the country, 227 LGAs in Nine States are eligible for SMC. With funding from UNITAID, 37 LGAs will be covered up to 2018 and PMI plans to fund SMC in 58 LGAs across 3 states in 2018.according to the state selection document, 122 LGAs (4 states) are eligible for SMC within the 13 GF supported states. To cover the eligible children over the next 3 years, in selected LGAs for SMC implementation under the GF grant, 13,977,294 children need to be reached with SMC. Being able to implement SMC will lead to rapid decline in malaria prevalence, contributing to overall goals of Nigeria?s malaria control programme",15400000,null,"Inactive","a6Q1R000000AJMS",0,15400000,0,0,0,1,"2020-01-29T12:52:00",null,"Across the country, 227 LGAs in Nine States are eligible for SMC. With funding from UNITAID, 37 LGAs will be covered up to 2018 and PMI plans to fund SMC in 58 LGAs across 3 states in 2018.according to the state selection document, 122 LGAs (4 states) are eligible for SMC within the 13 GF supported states. To cover the eligible children over the next 3 years, in selected LGAs for SMC implementation under the GF grant, 13,977,294 children need to be reached with SMC. Being able to implement SMC will lead to rapid decline in malaria prevalence, contributing to overall goals of Nigeria?s malaria control programme","High","High impact intervention for SMC-eligible Global Fund states, complementing PMI and UNITAID investment in 5 states.","From email from Bianca on the 10/07/2019 frpm CT: This UQD amount will cover 3.56m children under 5 in 2020 in Jigawa (with DFID)(100%), Kano (38%), Katsina (100%),  and Yobe (100%). Last week, SPAQ worth of 5,967,166 US$ needed for 2020 SMC were ordered. Grant savings will be used to cover the costs. The remaining UQD amount is needed to cover 2020 SMC operational costs. Original Module: Specific prevention interventions. Original Intervention: Seasonal Malaria Chemoprevention (SMC)","Anouk Chevalier Plante","2020-01-29","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6152","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","Interinstitutional Articulation National Program of STIs, HIV and AIDS - Comprehensive Health System - National Reproductive Health Plan - Health Areas Directorate - National Health Laboratory - Hospitals; IGSS, APROFAM, Military Health, Association of private hospitals among others and non-governmental organizations that work on the subject, to support the sustainability of interventions.\n\nCovers the cost of consultancy to facilitate this\n\nIndicators:\nReduce the gap of 2016 on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 2000",2069,2069,"Inactive","a6Q1R000000AJeF",null,null,2069,null,0,1,null,"High","Interinstitutional Articulation National Program of STIs, HIV and AIDS - Comprehensive Health System - National Reproductive Health Plan - Health Areas Directorate - National Health Laboratory - Hospitals; IGSS, APROFAM, Military Health, Association of private hospitals among others and non-governmental organizations that work on the subject, to support the sustainability of interventions.\n\nCovers the cost of consultancy to facilitate this\n\nIndicators:\nReduce the gap of 2016 on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 2000","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6153","MCI-00023","Program management","MCI-00207","Grant management","Operational support of personnel for the MSPAS and INCAP consisting of:\n1- A facilitator for the ETMI hired for the PNS.\n2- Officer dedicated to the Monitoring and Evaluation of the ETMI component in the PNS\n3- Responsible for ETMI\n4- Secretarial support\n\nTo this is added the percentage of operational expenses of INCAP (1% for the acquisition of tests and 5% for the rest of the items)\nTransversal contribution to the indicators related to prevention and treatment. This item was updated in October 2019 to increment the original approaved amount of 211260",261834,261834,"Inactive","a6Q1R000000AJeG",null,null,261834,null,0,1,null,"High","Operational support of personnel for the MSPAS and INCAP consisting of:\n1- A facilitator for the ETMI hired for the PNS.\n2- Officer dedicated to the Monitoring and Evaluation of the ETMI component in the PNS\n3- Responsible for ETMI\n4- Secretarial support\n\nTo this is added the percentage of operational expenses of INCAP (1% for the acquisition of tests and 5% for the rest of the items)\nTransversal contribution to the indicators related to prevention and treatment. This item was updated in October 2019 to increment the original approaved amount of 211260","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6148","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Strategy for tracking positive cases lost and improving the link (mobilization vouchers, health promoters, mobile phones) (will investigate possible synergies with existing strategies such as multisectoral networks. (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017). This item was updated in October 2019 to increment the original approaved amount of 20000",30000,30000,"Inactive","a6Q1R000000AJeB",null,null,30000,null,0,1,null,"High","Strategy for tracking positive cases lost and improving the link (mobilization vouchers, health promoters, mobile phones) (will investigate possible synergies with existing strategies such as multisectoral networks. (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017). This item was updated in October 2019 to increment the original approaved amount of 20000","High","The TRP recommends this activity to be included in the ongoing program submitted under the Program Continuation modality, to be funded with the savings / efficiencies found from ?within allocation? funds.",null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6149","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Based on official guidelines, design a training protocol to ensure readiness of health services to attend pregnant women arriving to health facilities at the moment of delivery without having attended previously ANC. (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)",20000,20000,"Inactive","a6Q1R000000AJeC",null,null,20000,null,0,1,null,"High","Based on official guidelines, design a training protocol to ensure readiness of health services to attend pregnant women arriving to health facilities at the moment of delivery without having attended previously ANC. (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","High","The TRP recommends this activity to be included in the proposed activities to \"Strengthening of capacities, improvement of sensitivity and quality care to all health providers in topics related to orientation, screening and the approach of pregnant women with HIV, Syphilis and Hepatitis B? as detailed in the eighth item recommended in this Review Form.",null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6140","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Pilot to articulate and integrate test screening into midwives and other community actors EMTCT activities.\nIncludes; consultancy fees for the design of the pilot program (tools, pedagogic materials, monitoring and evaluation system, includes syphilis, Hep B and HIV tests, as well as costs to evaluate the program and a final consultancy to analyze the sustainability of this strategy and potential absorption by MSPAS.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 70211",119938,119938,"Inactive","a6Q1R000000AJe3",null,null,119938,null,0,1,null,"High","Pilot to articulate and integrate test screening into midwives and other community actors EMTCT activities.\nIncludes; consultancy fees for the design of the pilot program (tools, pedagogic materials, monitoring and evaluation system, includes syphilis, Hep B and HIV tests, as well as costs to evaluate the program and a final consultancy to analyze the sustainability of this strategy and potential absorption by MSPAS.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 70211","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6147","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Establishment of a routine system for measuring the quality of care in NC services through measurement of user satisfaction and provision of services (mystery clients) (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)",25000,25000,"Active","a6Q1R000000AJeA",null,null,10000,null,15000,0,null,"High","Establishment of a routine system for measuring the quality of care in NC services through measurement of user satisfaction and provision of services (mystery clients) (consultancy fees)\n\nIndicators:\nReduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)\nReduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","Low","The TRP recommends this activity to be embedded in the scope of work for the \"Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women? as detailed in the second item recommended in this Review Form.",null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6146","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","onsultancy fees to develop a strategy to strengthen the system for monitoring compliance and achieving results through a non-economic recognition system.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",15000,15000,"Active","a6Q1R000000AJe9",null,null,10000,null,5000,0,null,"High","onsultancy fees to develop a strategy to strengthen the system for monitoring compliance and achieving results through a non-economic recognition system.\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6145","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Assurance of availability and access to screening tests for HIV, syphilis and hepatitis B for women in pregnancy, delivery and puerperium\nIncludes HIV and Syphilis tests to cover the gap of pregnant women not receiving an HIV or syphilis test (PSM costs included)\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 808989",913060,913060,"Inactive","a6Q1R000000AJe8",null,null,913060,null,0,1,null,"High","Assurance of availability and access to screening tests for HIV, syphilis and hepatitis B for women in pregnancy, delivery and puerperium\nIncludes HIV and Syphilis tests to cover the gap of pregnant women not receiving an HIV or syphilis test (PSM costs included)\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 808989","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6144","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Strengthening of capacities, improvement of sensitivity and quality care to all health providers in topics related to orientation, screening and the approach of pregnant women with HIV, Sifilis and Hepatitis B, integrating these topics into the routine work of health services. Health\n\nIncludes: pedagogical material for trainings, training costs (accomodation, food and transportation),  consultancy fees to provide support conducting the trainings that are scheduled and reduce the work volumen for the National HIV program (a total of 87 trainings) and development of an online training module through a consultancy\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)",517363,517363,"Active","a6Q1R000000AJe7",null,null,399798,null,117565,0,null,"High","Strengthening of capacities, improvement of sensitivity and quality care to all health providers in topics related to orientation, screening and the approach of pregnant women with HIV, Sifilis and Hepatitis B, integrating these topics into the routine work of health services. Health\n\nIncludes: pedagogical material for trainings, training costs (accomodation, food and transportation),  consultancy fees to provide support conducting the trainings that are scheduled and reduce the work volumen for the National HIV program (a total of 87 trainings) and development of an online training module through a consultancy\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6143","MCI-00006","PMTCT",null,null,"Expand the resolution capacity of the health service network of the second and third level of care, for the diagnosis of HIV, syphilis and hepatitis B in pregnant women, as well as ensuring the link of newborns exposed to HIV to the UAI that corresponds to them .\n\nIncludes: TA to conduct the needs assessment and 2 other sums to cover; (i) design of a costed strengthening plan based on the assessment and (ii) fund to implement actions of the stenghtening plan\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",1129912,1129912,"Active","a6Q1R000000AJe6",null,null,486642,null,643270,0,null,"High","Expand the resolution capacity of the health service network of the second and third level of care, for the diagnosis of HIV, syphilis and hepatitis B in pregnant women, as well as ensuring the link of newborns exposed to HIV to the UAI that corresponds to them .\n\nIncludes: TA to conduct the needs assessment and 2 other sums to cover; (i) design of a costed strengthening plan based on the assessment and (ii) fund to implement actions of the stenghtening plan\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6142","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Update and implement protocols, care guides and standards for prenatal monitoring and follow-up of pregnant women with HIV, syphilis and hepatitis B and feeding children exposed to HIV with breast milk substitutes, to children exposed to HIV.\nIncludes funds to print all the updated materials for all services accross the EMTCT care continuum\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",75000,75000,"Active","a6Q1R000000AJe5",null,null,62216,null,12784,0,null,"High","Update and implement protocols, care guides and standards for prenatal monitoring and follow-up of pregnant women with HIV, syphilis and hepatitis B and feeding children exposed to HIV with breast milk substitutes, to children exposed to HIV.\nIncludes funds to print all the updated materials for all services accross the EMTCT care continuum\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6139","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Involve key community actors (organized networks of women and departmental networks of responsible paternity and HIV and HIV), leaders, promoters, auxiliary mayors and midwives to search and recruit of pregnant women and in the promotion of screening in pregnant women.\n\nIncludes consultancy fees to do a mapping exercice of actors, and costs for meetings and training sessions for community leaders and midwives, as well as training kits for midwives (to facilitate the implementation of renewed EMTCT scope of work)\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",349001,349001,"Active","a6Q1R000000AJe2",null,null,236745,null,112256,0,null,"High","Involve key community actors (organized networks of women and departmental networks of responsible paternity and HIV and HIV), leaders, promoters, auxiliary mayors and midwives to search and recruit of pregnant women and in the promotion of screening in pregnant women.\n\nIncludes consultancy fees to do a mapping exercice of actors, and costs for meetings and training sessions for community leaders and midwives, as well as training kits for midwives (to facilitate the implementation of renewed EMTCT scope of work)\n\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-6138","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women, adapted to needs. This plan must be specific for clearly identified target groups and with translation into the local language, including people's rights approaches .\nThe same TA will be used to conduct end user surveys to evaluate the impact of messages devliered by the campaign\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 119290",142697,142697,"Inactive","a6Q1R000000AJe1",null,null,142697,null,0,1,null,"High","Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women, adapted to needs. This plan must be specific for clearly identified target groups and with translation into the local language, including people's rights approaches .\nThe same TA will be used to conduct end user surveys to evaluate the impact of messages devliered by the campaign\nIndicators:\nReduce the 2016 gap on the access of pregnant women to ANC (32% gap)\nReduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 119290","High",null,null,"Guillaume De La Fons","2019-11-28","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Congo","Congo","PAI-6123","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",391999.78,391999.78,"Inactive","a6Q1R000000AJcA",null,391999.78,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Togo","Togo","PAI-6214","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",309000,309000,"Inactive","a6Q1R000000AJte",null,309000,null,null,0,1,null,"High","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Shalini Mitra","2020-01-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Belarus","Belarus","PAI-6168","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00097","Needle and Syringe programs for PWID and their partners","When planning the BLR-C-RSPCMT grant for 2019-2021, it was assumed that, starting in 2020, Belarus will purchase supplies (syringes, condoms, etc.) for HIV prevention cabinets for PWID at the expense of the state budget. An analysis of the existing legislative framework showed that legislative amendments are required to conduct such purchases. Changes can be made to the rulemaking plan only for 2021, adopted - not earlier than 2022. Thus, we consider it necessary to include the provision of supplies for HIV prevention cabinets for PWID at the expense of the grant BLR-C-RSPCMT.",185040.65,185040.65,"Active","a6Q1R000000AJir",{"$nulls":4},185040.65,0,null,"High","When planning the BLR-C-RSPCMT grant for 2019-2021, it was assumed that, starting in 2020, Belarus will purchase supplies (syringes, condoms, etc.) for HIV prevention cabinets for PWID at the expense of the state budget. An analysis of the existing legislative framework showed that legislative amendments are required to conduct such purchases. Changes can be made to the rulemaking plan only for 2021, adopted - not earlier than 2022. Thus, we consider it necessary to include the provision of supplies for HIV prevention cabinets for PWID at the expense of the grant BLR-C-RSPCMT.","High","This activity is in line with the main allocation and provides additional prevention programming which is technically sound and strategically focussed",null,"Shalini Mitra","2019-12-03","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Belarus","Belarus","PAI-6167","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. \nFrom 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the client?s desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant ?Sustainability of Services for Key Populations in the EECA Region?, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.",331819.28000000003,331819.28000000003,"Active","a6Q1R000000AJiq",{"$nulls":4},331819.28000000003,0,null,"High","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. \nFrom 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the client?s desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant ?Sustainability of Services for Key Populations in the EECA Region?, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.","High","The TRP agrees that some oral fluid based tests may be needed, especially for self-screening or CSO based screening programmes. The TRP notes that it is important to ensure that adequate information is available emphasising the need for  confirmation of any positive oral fluid tests with blood-based rapid tests.",null,"Shalini Mitra","2019-12-03","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Liberia","Liberia","PAI-4698","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","High Specific prevention interventions (SPI) IEC/BCC (SPI) 488,160 This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.   ? Year 3 cost for program continuation (within allocation); 3 years cost for additional 5 counties including 2 additional districts in Margibi (iCCM priority gaps recognized by the LCM, MOH and other iCCM partners in the implementation of the Revised National Community Health program in Liberia.",2234920,null,"Active","a6Q1R000000AJDE",0,0,9600,0,2225320,0,null,null,"High Specific prevention interventions (SPI) IEC/BCC (SPI) 488,160 This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.   ? Year 3 cost for program continuation (within allocation); 3 years cost for additional 5 counties including 2 additional districts in Margibi (iCCM priority gaps recognized by the LCM, MOH and other iCCM partners in the implementation of the Revised National Community Health program in Liberia.","High",null,"NA Original Module: Specific prevention interventions. Original Intervention: Information, education, communication/Behavior change communications (specific prevention interventions)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-6215","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","SMC was initiated in Guinea Bissau in 2016 by the MOH in partnership with MSF, UNDP and AIFO covering 50% of the Bafata Region (7 of 14 ADS = Area de Saud = Health Districts) and 74% of the Gabu region (14 of 19 ADS). Over 85% (37,379 / 43,715) children aged 3-59 months in the 21 ADS received at least 1 dose of SMC. In 2017, SMC was expanded to geographically cover 100% of the 2 high malaria prevalence regions. Over 99% of 83,667 children received at least 1 dose, 82% received 3 doses and 61% of children received 4 doses, with a high level of acceptability and tolerance by the community. WHO recommends an SMC coverage with 3 to 4 doses for an effective impact. It is essential to maintain SMC in these regions to ensure a sustainable impact of the intervention.The operational costs for SMC have been significantly reduced by changing the strategy from Fixed Point to Door to Door. In 2019 and 2020 the MOH has planned the SMC campaigns to be implemented without International NGOs only by regional health departments, further reducing costs. Despite these efforts the country has a gap of 523,683 EUR for SMC operational costs, including UNDP GMS.",312318,312318,"Active","a6Q1R000000AJtj",{"$nulls":4},312318,0,null,"High","SMC was initiated in Guinea Bissau in 2016 by the MOH in partnership with MSF, UNDP and AIFO covering 50% of the Bafata Region (7 of 14 ADS = Area de Saud = Health Districts) and 74% of the Gabu region (14 of 19 ADS). Over 85% (37,379 / 43,715) children aged 3-59 months in the 21 ADS received at least 1 dose of SMC. In 2017, SMC was expanded to geographically cover 100% of the 2 high malaria prevalence regions. Over 99% of 83,667 children received at least 1 dose, 82% received 3 doses and 61% of children received 4 doses, with a high level of acceptability and tolerance by the community. WHO recommends an SMC coverage with 3 to 4 doses for an effective impact. It is essential to maintain SMC in these regions to ensure a sustainable impact of the intervention.The operational costs for SMC have been significantly reduced by changing the strategy from Fixed Point to Door to Door. In 2019 and 2020 the MOH has planned the SMC campaigns to be implemented without International NGOs only by regional health departments, further reducing costs. Despite these efforts the country has a gap of 523,683 EUR for SMC operational costs, including UNDP GMS.","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Shalini Mitra","2020-01-30","2017-2019","Malaria","RT Western Africa","2020-12-31"]
["CT Benin","Benin","PAI-6211","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",750000,750000,"Active","a6Q1R000000AJtP",{"$nulls":4},750000,0,null,"High","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Shalini Mitra","2020-01-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Chad","Chad","PAI-6212","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",5400000,5400000,"Active","a6Q1R000000AJtU",null,4000000,null,null,1400000,0,null,"High","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","High","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. \nThe TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"Shalini Mitra","2020-01-30","2017-2019","Malaria","RT Central Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4693","MCI-00023","Program management","MCI-00207","Grant management","This activity will add quality to the community health program implementation.  The activity (program review) for which the request is made creates opportunity for quarterly program review and planning where field staff, county health teams and program staff at county and central levels meet to discuss and find solutions to program implementation challenges where they exist or strategize for quality implementation for the period ahead. Performance against achievement is discussed at the meetings and the meetings contribute to the program data review and report writing issues. The also creates opportunity for review of compliance issues related to finance, program technical areas, policies and grant agreement. It also promotes, learning and sharing, coordination and effective collaboration as different stakeholders are brought together to discuss and work in a coordinated manner.",56100,null,"Active","a6Q1R000000AJD9",0,0,9540,0,46560,0,null,null,"This activity will add quality to the community health program implementation.  The activity (program review) for which the request is made creates opportunity for quarterly program review and planning where field staff, county health teams and program staff at county and central levels meet to discuss and find solutions to program implementation challenges where they exist or strategize for quality implementation for the period ahead. Performance against achievement is discussed at the meetings and the meetings contribute to the program data review and report writing issues. The also creates opportunity for review of compliance issues related to finance, program technical areas, policies and grant agreement. It also promotes, learning and sharing, coordination and effective collaboration as different stakeholders are brought together to discuss and work in a coordinated manner.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4687","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","The MOH is working towards a transition to the new warehouse. Funding request is for building additional office space for the essential CMS staff.  The total estimated cost for the office building is set at $882,500. Out of this amount, the MOH has internally mobilized $200,000.00 and have also secured a $50,000.00 commitment from GAVI against the cost of the building. This leaves a balance of $632,500.00 to be sourced through external partners, including the Global Fund.",635000,null,"Active","a6Q1R000000AJD3",0,0,0,0,635000,0,null,null,"The MOH is working towards a transition to the new warehouse. Funding request is for building additional office space for the essential CMS staff.  The total estimated cost for the office building is set at $882,500. Out of this amount, the MOH has internally mobilized $200,000.00 and have also secured a $50,000.00 commitment from GAVI against the cost of the building. This leaves a balance of $632,500.00 to be sourced through external partners, including the Global Fund.","Medium","While the Global Fund has already invested in infrastructure and within a context of major persisting gaps, the TRP considers gaps in service delivery are more pressing.","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4697","MCI-00012","Case management","MCI-00161","Private sector case management","Quarterly Feedback Meeting PSACT implementation together to provide feedback about the program. The meeting will seek to understand the impression of the proprietors of the program and get feedback on the community reaction to the testing and treatment as well as the overall program. Also the forum will be used to provide feedback to proprietors on their performance and adherence to the program rules as well as recognize best practice pharmaceutical outlets to engender competition among the proprietors. The forum will also be used to identify pharmaceutical outlets that are noncompliant and depending on the degree of noncompliance inform them on the actions that will be taken on the non-compliant proprietor. This will further improve the quality of the PSACT program.",40000,null,"Active","a6Q1R000000AJDD",0,0,0,0,40000,0,null,null,"Quarterly Feedback Meeting PSACT implementation together to provide feedback about the program. The meeting will seek to understand the impression of the proprietors of the program and get feedback on the community reaction to the testing and treatment as well as the overall program. Also the forum will be used to provide feedback to proprietors on their performance and adherence to the program rules as well as recognize best practice pharmaceutical outlets to engender competition among the proprietors. The forum will also be used to identify pharmaceutical outlets that are noncompliant and depending on the degree of noncompliance inform them on the actions that will be taken on the non-compliant proprietor. This will further improve the quality of the PSACT program.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4696","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Although the LMHRA has worked strongly with other agencies and developing partners to develop capacity in medicine quality regulations, quality control, and data generation and post market quality surveillance, these efforts are challenged with limited funding from the Government of Liberia, developing partners and other agencies to support the operation and implementation of medicines regulatory policies. This intervention has been earmarked for the first time in the National Malaria Control monitoring and evaluation plan 2016 ? 2020 as one of the Program?s monitoring mechanisms to be implemented by the LHMRA.",90000,null,"Active","a6Q1R000000AJDC",0,0,0,0,90000,0,null,null,"Although the LMHRA has worked strongly with other agencies and developing partners to develop capacity in medicine quality regulations, quality control, and data generation and post market quality surveillance, these efforts are challenged with limited funding from the Government of Liberia, developing partners and other agencies to support the operation and implementation of medicines regulatory policies. This intervention has been earmarked for the first time in the National Malaria Control monitoring and evaluation plan 2016 ? 2020 as one of the Program?s monitoring mechanisms to be implemented by the LHMRA.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4688","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","The perfect functioning of the GeneXpert machine will support the case detection of Multi Drug Resistance (MDR/RIF) cases.  All the Genexpert machines warranty will expire in 2019. Therefore. updating the warranty of these machines will ensure perfect mantiance by Chepid for the following reasons: module replacement and fan replacement. If there is a major problem on a machine with the updated warranty, Chepid can be replace the machine at no cost.",89772,null,"Active","a6Q1R000000AJD4",0,0,0,0,89772,0,null,null,"The perfect functioning of the GeneXpert machine will support the case detection of Multi Drug Resistance (MDR/RIF) cases.  All the Genexpert machines warranty will expire in 2019. Therefore. updating the warranty of these machines will ensure perfect mantiance by Chepid for the following reasons: module replacement and fan replacement. If there is a major problem on a machine with the updated warranty, Chepid can be replace the machine at no cost.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4694","MCI-00023","Program management","MCI-00207","Grant management","This covers program HR cost for the PR including salaries & benefits working on or supporting the program management and implementation.  This is for implementing in additional 2 districts in Margibi and gap in Lofa - 3 existing GF supported districts (2 M & E Officers for Margibi  - 1 & Lofa - 1)",1967591,null,"Active","a6Q1R000000AJDA",0,0,256490,0,1711101,0,null,null,"This covers program HR cost for the PR including salaries & benefits working on or supporting the program management and implementation.  This is for implementing in additional 2 districts in Margibi and gap in Lofa - 3 existing GF supported districts (2 M & E Officers for Margibi  - 1 & Lofa - 1)","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Rwanda","Rwanda","PAI-5474","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Above allocation will support salaries for M&E staff at central level and in health facilities. Data collection, reporting and analysis are essential for informed decision making and efficient program management.",328260,null,"Active","a6Q1R000000AJPk",0,0,0,0,328260,0,null,null,"Above allocation will support salaries for M&E staff at central level and in health facilities. Data collection, reporting and analysis are essential for informed decision making and efficient program management.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-5473","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Above allocation will ensure adequate maintenance of infrastructures and equipment as well as ambulance and other vehicles necessary for supervision and sample transportation. Capacity building of laboratory technologists will also be supported. These expenses are essential to ensure quality of HIV services in the long term.",2764891,null,"Active","a6Q1R000000AJPj",0,0,0,0,2764891,0,null,null,"Above allocation will ensure adequate maintenance of infrastructures and equipment as well as ambulance and other vehicles necessary for supervision and sample transportation. Capacity building of laboratory technologists will also be supported. These expenses are essential to ensure quality of HIV services in the long term.","Medium","Not an essential service for impact","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-5472","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","Above allocation (USD 3,218,722) will provide educational support to Most Vulnerable Children (particularly vocational training). Economic empowerment and life skills building will reduce the risk of HIV infection for these vulnerable children. The other support covered by above allocation amount in this programmatic area is salary for service providers at decentralized level , which will improve quality of prevention services. (USD 1,396,104)",4614826,null,"Active","a6Q1R000000AJPi",0,0,0,0,4614826,0,null,null,"Above allocation (USD 3,218,722) will provide educational support to Most Vulnerable Children (particularly vocational training). Economic empowerment and life skills building will reduce the risk of HIV infection for these vulnerable children. The other support covered by above allocation amount in this programmatic area is salary for service providers at decentralized level , which will improve quality of prevention services. (USD 1,396,104)","Medium","OVCs are not driving the epidemic","NA Original Intervention: Support for orphans and vulnerable children minimum package","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-5471","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00177","Other health and community workforce intervention(s)","Since 2012, the HRH Program has trained specialists in different medical fields. USD 2,356,241 is earmarked for the program?s continuation to ensure that the current cohort of trainees can complete the training program within 3 years thereby ensuring sustainability and the quality of care in HIV and co-morbidities? (Malaria, TB, Hepatitis). Efficiencies have been generated in the program through the use of local faculty trainers",4059303,null,"Active","a6Q1R000000AJPh",1349931,0,0,0,2709372,0,null,null,"Since 2012, the HRH Program has trained specialists in different medical fields. USD 2,356,241 is earmarked for the program?s continuation to ensure that the current cohort of trainees can complete the training program within 3 years thereby ensuring sustainability and the quality of care in HIV and co-morbidities? (Malaria, TB, Hepatitis). Efficiencies have been generated in the program through the use of local faculty trainers","Medium","Sustainability issue","NA Original Module: RSSH - Human resources for health, including community health workers. Original Intervention: Capacity building for health workers and scale up of health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-5470","MCI-00007","Treatment, care and support","MCI-00117","HIV care","The nutrition support included in the allocation will only cover the needs of the most vulnerable patients. The above allocation will cover nutrition support for PLHIV suffering from malnutrition (USD 3,441,205) (23% for CSB+ and 60% for RUTF). USD 112,232 is earmarked for training and start-up capital for 27 PLHIV cooperatives. Also USD 1,641,299 is included for human resources support to health care providers.",5194737,null,"Active","a6Q1R000000AJPg",1179126,0,0,0,4015611,0,null,null,"The nutrition support included in the allocation will only cover the needs of the most vulnerable patients. The above allocation will cover nutrition support for PLHIV suffering from malnutrition (USD 3,441,205) (23% for CSB+ and 60% for RUTF). USD 112,232 is earmarked for training and start-up capital for 27 PLHIV cooperatives. Also USD 1,641,299 is included for human resources support to health care providers.","Medium","No strong scientific evidence that nutrition support the outcome of TB treatment",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-5469","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Above allocation will provide payment of Community-based health insurance (CBHI) for vulnerable groups which are not able to pay for themselves therefore removing financial barriers for access to basic health services in general and HIV services in particular. It is estimated that around 1,926, 292 people/ 3years (CBHI fee=3.43 USD /person/year ) will benefit from the support.",6607183,null,"Active","a6Q1R000000AJPf",0,0,0,0,6607183,0,null,null,"Above allocation will provide payment of Community-based health insurance (CBHI) for vulnerable groups which are not able to pay for themselves therefore removing financial barriers for access to basic health services in general and HIV services in particular. It is estimated that around 1,926, 292 people/ 3years (CBHI fee=3.43 USD /person/year ) will benefit from the support.","Medium","Concerns about issues of sustainability","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Supportive policy and programmatic environment (Community-based health insurance)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Philippines","Philippines","PAI-5378","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Constitutes prevention, testing and treatment costs for 14 sites out of the 39 high disease burden sites identified as FR sites.",554152.41,null,"Inactive","a6Q1R000000AJOC",554152.41,0,0,0,0,1,null,null,"Constitutes prevention, testing and treatment costs for 14 sites out of the 39 high disease burden sites identified as FR sites.","High","The motivational support to help enrol and maintain new people into HIV treatment has the potential to improve the leakages in the treatment cascade.","NA Original Module: Access to treatment, care and support. Original Intervention: Counselling and psycho-social support (treatment hub care agents, transportation and meal for support visits)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Philippines","Philippines","PAI-5377","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","The war on drugs makes it even more difficult for PWID to access services. An expanded options for PWID, coupled with high level advocacy, will contribute to increased access of PWIDs to services.",507799.52,null,"Inactive","a6Q1R000000AJOB",507799.52,0,0,0,0,1,null,null,"The war on drugs makes it even more difficult for PWID to access services. An expanded options for PWID, coupled with high level advocacy, will contribute to increased access of PWIDs to services.","High","The PWID interventions face the largest funding gap in both national and allocation responses, therefore need prioritization as one of the key affected populations with the most challenging access to evidencebased package of services","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioural interventions for PWID condom lubricant and programming HIV testing services","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Peru","Peru","PAI-5376","MCI-00008","TB care and prevention","MCI-00128","Prevention","Implementation of updated national guidelines for management of pediatric TB at the primary health care level",54800,null,"Inactive","a6Q1R000000AJOA",54800,0,0,0,0,1,null,null,"Implementation of updated national guidelines for management of pediatric TB at the primary health care level","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Peru","Peru","PAI-5375","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","Systematization of the experience with the prison population in the 12 prisons targeted by interventions",20000,null,"Inactive","a6Q1R000000AJO9",20000,0,0,0,0,1,null,null,"Systematization of the experience with the prison population in the 12 prisons targeted by interventions","High",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Other other community responses and systems intervention(s)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Peru","Peru","PAI-5374","MCI-00010","MDR-TB","MCI-00144","Community MDR-TB care delivery","Capacity-building workshops to train CHWs on MDR-TB management and treatment adherence",142500,null,"Inactive","a6Q1R000000AJO8",142500,0,0,0,0,1,null,null,"Capacity-building workshops to train CHWs on MDR-TB management and treatment adherence","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Peru","Peru","PAI-5373","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Strengthening of local government capacities to ensure timely delivery of the PANTBC package",25000,null,"Inactive","a6Q1R000000AJO7",25000,0,0,0,0,1,null,null,"Strengthening of local government capacities to ensure timely delivery of the PANTBC package","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Peru","Peru","PAI-5372","MCI-00010","MDR-TB","MCI-00144","Community MDR-TB care delivery","Evaluation of CHW contribution to the TB response in order to justify its absorption with the national budget",10000,null,"Inactive","a6Q1R000000AJO6",10000,0,0,0,0,1,null,null,"Evaluation of CHW contribution to the TB response in order to justify its absorption with the national budget","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Panama","Panama","PAI-5371","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This request includes the integration of the Ministry of Public Helath (SIS) and Social Security Fund (SEIS) care and epidemiological surveillance systems. Integration of both systems would make all national information on HIV and tuberculosis available in a single database to facilitate corresponding analysis.",48000,null,"Active","a6Q1R000000AJO5",0,0,0,0,48000,0,null,null,"This request includes the integration of the Ministry of Public Helath (SIS) and Social Security Fund (SEIS) care and epidemiological surveillance systems. Integration of both systems would make all national information on HIV and tuberculosis available in a single database to facilitate corresponding analysis.","Medium","The TRP considers that this intervention to be medium priority as it increases the level of integration of disease specific system in to the the main health management information system platform. This intervention could increase data management efficiency and contribute to patient-centers care, but does not seem to be critical for the program performance.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Technical assistance to create the interface in the SEIS and SIS of the different forms for registration, diagnosis, notification and care and monitoring of established cases of TB and HIV.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Nepal","Nepal","PAI-5328","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Training on database management and data analysis at Central and peripheral levels to strengthen technical capacity in support of elimination.",11638,null,"Active","a6Q1R000000AJNO",0,0,0,0,11638,0,null,null,"Training on database management and data analysis at Central and peripheral levels to strengthen technical capacity in support of elimination.","High","Training on database management and data analysis at central and peripheral levels to strengthen technical capacity of information management and utilization is important, especially as the Malaria system gets linked up to the DHIS2.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5327","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Additional Technical assistance as required.",60000,null,"Active","a6Q1R000000AJNN",0,0,0,0,60000,0,null,null,"Additional Technical assistance as required.","High","Technical Assistance support for active case detection (ACD) surveillance systems is critical to case detection in elimination programmes, e.g. detecting symptomatic cases otherwise not detected by passive case detection (PCD), and asymptomatic cases in the community.","NA Original Intervention: Policy, planning, coordination and management","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5326","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Commemoration of World Malaria Day at Central and Districts levels Level to raise awareness and secure funding.",10386,null,"Active","a6Q1R000000AJNM",0,0,0,0,10386,0,null,null,"Commemoration of World Malaria Day at Central and Districts levels Level to raise awareness and secure funding.","Low","The contribution of World Malaria Day commemoration to malaria elimination is important to raise public awareness. However, such efforts have generally limited impact on intervention coverage, access or use, and the activity should be focused. Consequently, the costs for this activity are over-budgeted and the TRP recommends 10 percent of the requested amount as quality demand.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5325","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","Larval source management where vector breeding sites are ?few, fixed and findable? in order to maximize cost effectiveness and sustainability of operations.",1373,null,"Active","a6Q1R000000AJNL",0,0,0,0,1373,0,null,null,"Larval source management where vector breeding sites are ?few, fixed and findable? in order to maximize cost effectiveness and sustainability of operations.","Low","As larval source management requires a good infrastructure and strong entomological capacity and leadership, the program needs to establish feasibility of this strategy in elimination phase","NA Original Intervention: Other vector control measures","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5324","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Support broadcasting of IEC messages over radio/FM. Hold regular orientation meetings to maximize community involvement in malaria elimination.",70339,null,"Active","a6Q1R000000AJNK",0,0,0,0,70339,0,null,null,"Support broadcasting of IEC messages over radio/FM. Hold regular orientation meetings to maximize community involvement in malaria elimination.","Low","The yield expected from IEC messages over radio/FM seems to offer lower value for money compared to regular orientation meetings to maximize community involvement in malaria elimination, therefore the TRP recommends 20 percent of the requested amount.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5323","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Orientation meetings/trainings for community involvement in malaria elimination (massive scale-up of approach supported under the ?within allocation? amount).",60168,null,"Active","a6Q1R000000AJNJ",0,0,0,0,60168,0,null,null,"Orientation meetings/trainings for community involvement in malaria elimination (massive scale-up of approach supported under the ?within allocation? amount).","Low","This intervention covers gradual orientation meetings/trainings for community involvement in malaria elimination. Domestic resources should also be used for massive scale-up of approach supported, therefore the TRP recommends 20 percent of the requested amount.","NA Original Intervention: Policy, planning, coordination and management","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5322","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","International training on program reorientation towards malaria elimination; Capacity strengthening for malaria elimination by SMRU/WHO (this will upgrade the ToT and trickle down approach supported under the ?within allocation? amount, which was chosen for its economy); Supply motorcycles, office furniture and equipment, computers band photocopier/printers; and, External program evaluation.",153615,null,"Active","a6Q1R000000AJNI",0,0,0,0,153615,0,null,null,"International training on program reorientation towards malaria elimination; Capacity strengthening for malaria elimination by SMRU/WHO (this will upgrade the ToT and trickle down approach supported under the ?within allocation? amount, which was chosen for its economy); Supply motorcycles, office furniture and equipment, computers band photocopier/printers; and, External program evaluation.","Medium","Training on program reorientation towards malaria elimination can be done on-site instead of through multi-country training schemes. Logistical support for motorcycles, office furniture and equipment, computers band photocopier/printers is important, therefore the TRP recommends 50 percent of the requested amount.","NA Original Intervention: Policy, planning, coordination and management","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Malawi","Malawi","PAI-5224","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Continuation of current community PMTCT activities ($2.72M) Support will continue activities to raise community demand for PMTCT services and promote adherence to care and treatment for HIV positive mothers and children in all 290 TAs within all 28 districts. Current grant target is to increase percentage of HIV positive adults and children receiving ART from 50.4 % to 70% by December 2017.",2720000,null,"Active","a6Q1R000000AJLi",0,0,0,0,2720000,0,null,null,"Continuation of current community PMTCT activities ($2.72M) Support will continue activities to raise community demand for PMTCT services and promote adherence to care and treatment for HIV positive mothers and children in all 290 TAs within all 28 districts. Current grant target is to increase percentage of HIV positive adults and children receiving ART from 50.4 % to 70% by December 2017.","Medium","Coverage of Prong 3 is already very high in Malawi. This will complement it.","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5223","MCI-00000","Prevention programs for general population","MCI-00074","Male circumcision","VMMC | Integrated service delivery, demand creation and commodities ($16.77M) World Bank VMMC funding ends in June 2018. The funding request will provide 155,268 male circumcisions in 6 of the 14 VMMC priority districts (8 will continue to be supported by PEPFAR) between July 2018 and December 2020.",16770000,null,"Active","a6Q1R000000AJLh",9727716,2000000,0,0,5042284,0,null,null,"VMMC | Integrated service delivery, demand creation and commodities ($16.77M) World Bank VMMC funding ends in June 2018. The funding request will provide 155,268 male circumcisions in 6 of the 14 VMMC priority districts (8 will continue to be supported by PEPFAR) between July 2018 and December 2020.","Medium","PEPFAR is taking the lead in scaling up adult circumcision.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5222","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Enhanced linkages to care ($0.40M) Additional activities to strengthen FSW programming linkage to care and monitoring in current 11 districts.",400000,null,"Active","a6Q1R000000AJLg",0,0,0,0,400000,0,null,null,"Enhanced linkages to care ($0.40M) Additional activities to strengthen FSW programming linkage to care and monitoring in current 11 districts.","High","Increased comprehensive programming for key populations will be increasingly needed to control the epidemic as incidence among the general population declines.","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5221","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","HIV self-testing program and commodities ($3.50M) Malawi pilot results indicate HIVST is a promising intervention for expanding testing to hard to reach populations, especially men, youth and KPs. These funds will support commodity and program costs for 879,430 self-tests.",3500000,null,"Inactive","a6Q1R000000AJLf",500000,3000000,0,0,0,1,null,null,"HIV self-testing program and commodities ($3.50M) Malawi pilot results indicate HIVST is a promising intervention for expanding testing to hard to reach populations, especially men, youth and KPs. These funds will support commodity and program costs for 879,430 self-tests.","Medium","Increased testing through innovative approaches is one of the major changes in approach in this Funding request.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5220","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00170","Service organization and facility management","Integration of cervical cancer screenings in ART clinics for HIVpositive women ($0.56M) Yearly cervical cancer screening will be integrated in ART clinics for HIVpositive women aged 25 and above, important for the prevention and management of cervical cancer which is highly prevalent in Malawi. This investment will support the training of service providers and their supervision and mentoring.",560000,null,"Active","a6Q1R000000AJLe",311584.42,0,0,0,248415.58,0,null,null,"Integration of cervical cancer screenings in ART clinics for HIVpositive women ($0.56M) Yearly cervical cancer screening will be integrated in ART clinics for HIVpositive women aged 25 and above, important for the prevention and management of cervical cancer which is highly prevalent in Malawi. This investment will support the training of service providers and their supervision and mentoring.","Medium","Cervical cancer screening is recommended for all women.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5219","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Funding for HCW trainings, zonal data review meetings, and EID/VL testing orientation and supervision/mentorship visits ($2.22M) High importance for proper management of HIV; half of the need already funded within allocation; this covers the other half of the need and allows full training roll out to HCWs.",2220000,null,"Active","a6Q1R000000AJLd",939523.95,0,0,0,1280476.05,0,null,null,"Funding for HCW trainings, zonal data review meetings, and EID/VL testing orientation and supervision/mentorship visits ($2.22M) High importance for proper management of HIV; half of the need already funded within allocation; this covers the other half of the need and allows full training roll out to HCWs.","Medium","Increasing access to viral load supports maintenance of high national viral suppression rate of 90.8%.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Myanmar","Myanmar","PAI-5095","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00097","Needle and Syringe programs for PWID and their partners","The additional investment will support the program to reach more target population.",13080262,null,"Active","a6Q1R000000AJJd",10801471,0,0,0,2278791,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Needle and syringe programs for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5094","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00095","HIV testing services for PWID","The additional investment will support the program to reach more target population.",494025,null,"Active","a6Q1R000000AJJc",0,0,0,0,494025,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 534005 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: HIV testing services for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5093","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00096","Diagnosis and treatment of STIs and other sexual health services for PWID","The additional investment will support the program to reach more target population.",167956,null,"Active","a6Q1R000000AJJb",0,0,0,0,167956,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 801114 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5092","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00094","Condoms and lubricant programming for PWID","The additional investment will support the program to reach more target population.",464867,null,"Active","a6Q1R000000AJJa",383727,0,0,0,81140,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Condoms and lubricant programming for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5091","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","The additional investment will support the program to reach more target population.",3183156,null,"Active","a6Q1R000000AJJZ",0,0,0,0,3183156,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 3761207 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5090","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","The additional investment will support the program to reach more target population.",318113,null,"Active","a6Q1R000000AJJY",195184,0,0,0,122929,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4998","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Communities? mobilization and sensitization during Malaria day.",300000,null,"Active","a6Q1R000000AJI4",0,0,103584,0,196416,0,null,null,"Communities? mobilization and sensitization during Malaria day.","Medium","Community mobilization","Listed intervention does not match the one in UQD updated form. Original Intervention: World Malaria Day (Cambodia )","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4997","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Adding value to malaria outreach program.",3500000,null,"Inactive","a6Q1R000000AJI3",3500000,0,0,0,0,1,null,null,"Adding value to malaria outreach program.","Medium","Two parts of these proposed activities are high priority and add value to malaria outreach program. Microscopy training is lower priority , hence overall item downgraded to medium.","NA Original Intervention: Update microscopy training. Provide medical kits to village health workers (VHWs). Conduct mass Information Education Communication (IEC) / Behaviour Change Communication (BCC) (Viet Nam)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4996","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Conduct therapeutic efficacy studies of new drugs and drug combinations, and conduct a drug resistance mapping supplement DRS information- strengthening capacity of the NMCP and ODPC.",200000,null,"Inactive","a6Q1R000000AJI2",200000,0,0,0,0,1,null,null,"Conduct therapeutic efficacy studies of new drugs and drug combinations, and conduct a drug resistance mapping supplement DRS information- strengthening capacity of the NMCP and ODPC.","High","Will expands/strengthen DRS capacity for National Malaria Control Program (NMCP ) and ODCP.","NA Original Intervention: Drug resistance studies (DRS) and activities (Thailand)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4995","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Through DRS.",91000,null,"Inactive","a6Q1R000000AJI1",91000,0,0,0,0,1,null,null,"Through DRS.","High","Key to elimination of falciparum transmission.","NA Original Intervention: Ensure radical cure for all falciparum cases (Thailand)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4994","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","Adding value to malaria outreach program.",1500000,null,"Inactive","a6Q1R000000AJI0",1500000,0,0,0,0,1,null,null,"Adding value to malaria outreach program.","High","These are key activities that should be incorporated as part of regular allocation, if efficiencies are found during grant making.","NA Original Intervention: Promote LLIN among malaria risk population entering transmission areas (Thailand )","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4993","MCI-00071","Other module","MCI-00071","Other module","To enhance supervision in Zone 3 areas.",300000,null,"Inactive","a6Q1R000000AJHz",300000,0,0,0,0,1,null,null,"To enhance supervision in Zone 3 areas.","High","Strengthening supervision in Zone 3 areas.","NA Original Module: RSSH. Original Intervention: Additional supportive supervision by epi (Viet Nam )","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4867","MCI-00008","TB care and prevention","MCI-00128","Prevention","Updating the national guidelines on TB infection prevention and control in Jordan in English , translate to Arabic and printing",22444,null,"Active","a6Q1R000000AJFx",0,0,0,0,22444,0,null,null,"Updating the national guidelines on TB infection prevention and control in Jordan in English , translate to Arabic and printing","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4866","MCI-00022","RSSH: Health management information systems and M&E","MCI-00173","Other service delivery intervention(s)","PAAR is planned to be used for conducting IBBS and PSE for key populations in both southern part of Yemen and Syria. Results of this exercise will improve the planning capacities of program to delover services to these key populations. Also, results of these surveys will contribute to improving the two countries' estimates and projections. PSE will provide denomirators for monitoring the coverage of implemented services among key populations",500000,null,"Active","a6Q1R000000AJFw",0,0,0,0,500000,0,null,null,"PAAR is planned to be used for conducting IBBS and PSE for key populations in both southern part of Yemen and Syria. Results of this exercise will improve the planning capacities of program to delover services to these key populations. Also, results of these surveys will contribute to improving the two countries' estimates and projections. PSE will provide denomirators for monitoring the coverage of implemented services among key populations","Low","While the TRP recognises that up-to-date data would be very useful, the TRP doubts the feasibility of conducting IBBS or PSE in Syria and Yemen, given the volatile crisis situation in both countries and therefore considers this low priority.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4865","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","To cover the cost of the regular evaluation of TB dugs? management process in the five countries",145800,null,"Active","a6Q1R000000AJFv",0,0,0,0,145800,0,null,null,"To cover the cost of the regular evaluation of TB dugs? management process in the five countries","Low","The added value of this activity is low, given the COE,","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Other procurement and supply chain management intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4864","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","To undertake a national TB drug resistance survey in Syria",25000,null,"Active","a6Q1R000000AJFu",0,0,0,0,25000,0,null,null,"To undertake a national TB drug resistance survey in Syria","Low","Conducting national TB drug surveillance survey under the prevailing conditions would be very difficult, and would require significantly more resources than have been requested. Any findings therefrom would also not be applicable to the entire country.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4863","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To renovate the main drug warehouse in Baghdad",30000,null,"Active","a6Q1R000000AJFt",0,0,0,0,30000,0,null,null,"To renovate the main drug warehouse in Baghdad","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4862","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To purchase laptops\\desktops for the governorate TB coordination units with no computers or with dilapidated computers in the five countries",150000,null,"Active","a6Q1R000000AJFs",0,0,0,0,150000,0,null,null,"To purchase laptops\\desktops for the governorate TB coordination units with no computers or with dilapidated computers in the five countries","Low",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4861","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To procure computers for the NTP central units of Iraq, Yemen and Syria",75000,null,"Active","a6Q1R000000AJFr",0,0,0,0,75000,0,null,null,"To procure computers for the NTP central units of Iraq, Yemen and Syria","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4860","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To ensure a training on programmatic management in an international course for the relevant NTP staff from Central and governorate levels of the five countries.",35000,null,"Active","a6Q1R000000AJFq",0,0,0,0,35000,0,null,null,"To ensure a training on programmatic management in an international course for the relevant NTP staff from Central and governorate levels of the five countries.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4859","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","This activity focuses on improving facilities in hospitals. Treatment of MDR-TB in community is also to be considered.",250000,null,"Active","a6Q1R000000AJFp",0,0,0,0,250000,0,null,null,"This activity focuses on improving facilities in hospitals. Treatment of MDR-TB in community is also to be considered.","Low","This activity focuses on improving facilities in hospitals. The applicant should instead consider the treatment of MDR-TB in the community.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Morocco","Morocco","PAI-4758","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","Call for annual projects for NGOs in order to incorporate innovative HIV prevention and treatment actions and projects into their area of intervention; SR human resources.",610561.1,null,"Active","a6Q1R000000AJEC",124859.16,0,0,0,485701.94,0,null,null,"Call for annual projects for NGOs in order to incorporate innovative HIV prevention and treatment actions and projects into their area of intervention; SR human resources.","High","Funds for developing innovative prevention and treatment approaches by NGOs","NA Original Module: RSSH - Community responses and systems. Original Intervention: Social mobilization, building community linkages, collaboration and coordination; strengthening institutional, planning and management capacities","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Morocco","Morocco","PAI-4757","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of SRH provision and services meeting the specific needs of SWs, including STIs; acquire a stock of additional lubricants for SWs; awareness-raising day on GBV; SMS platform for prevention.",392825.72,null,"Active","a6Q1R000000AJEB",0,0,0,0,392825.72,0,null,null,"Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of SRH provision and services meeting the specific needs of SWs, including STIs; acquire a stock of additional lubricants for SWs; awareness-raising day on GBV; SMS platform for prevention.","High","Addresses drivers of the epidemic in a concentrated epidemic and critical for the extension of reach to new areas of need.","NA Original Intervention: Diagnosis and treatment of STIs and other sexual and reproductive health -related services for sex workers; condoms and lubricants-related interventions for sex workers; combating stigma, discrimination and violence against SWs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Morocco","Morocco","PAI-4756","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of sexual and reproductive health (SRH) provision and services meeting the specific needs of MSM, including STIs; acquire a stock of additional lubricants for MSM; establish a CBD network for distributing condoms (extended to a further 17 towns in 2019 and 2020).",186031.87,null,"Active","a6Q1R000000AJEA",45781.62,0,0,0,140250.25,0,null,null,"Establish 2 new sexual health clinics (prioritized according to the programmatic mapping) with a package of sexual and reproductive health (SRH) provision and services meeting the specific needs of MSM, including STIs; acquire a stock of additional lubricants for MSM; establish a CBD network for distributing condoms (extended to a further 17 towns in 2019 and 2020).","High","Addresses drivers of the epidemic in a concentrated epidemic and critical for the extension of reach to new areas","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Diagnosis and treatment of STIs and other sexual and reproductive health -related services; condoms and lubricants-related interventions for men who have sex with men.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Morocco","Morocco","PAI-4755","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Review of migrant prevention programs; establishment of six community centers for migrant sexual and reproductive health; training of actors and representatives to carry out prevention work targeting truckers; constant presence at trucking sites; identification of sites of vulnerability linked to working environments; improve combined prevention coverage along corridors; women?s SRH; advocacy with managers of large companies; AIDS prevention awareness-raising tools adapted to different working environments; PE for manual workers, miners, sailors, fishermen and artisans; training and remuneration of actors involved and PEs; information, education and communication (IEC) sessions for female manual workers and other vulnerable women; prevention tools for the working environment; actors and PE manual workers, miners, sailors, fishermen and artisans; : Evaluation of youth prevention; review of kit for ongoing training on HIV, GBV and addictions in the school environment; coaching of young PEs in high schools and university, including through ICT; mapping of youth NGOs and networking and capacity development actions for youths so that they can be involved in HIV prevention; training guide on ?young people not in school? for facilitators; awareness-raising and training of ?youth? organizers; prevention materials for youths / ICT (tel. application, social networks).",717921.67,null,"Active","a6Q1R000000AJE9",21317.47,0,0,0,696604.2,0,null,null,"Review of migrant prevention programs; establishment of six community centers for migrant sexual and reproductive health; training of actors and representatives to carry out prevention work targeting truckers; constant presence at trucking sites; identification of sites of vulnerability linked to working environments; improve combined prevention coverage along corridors; women?s SRH; advocacy with managers of large companies; AIDS prevention awareness-raising tools adapted to different working environments; PE for manual workers, miners, sailors, fishermen and artisans; training and remuneration of actors involved and PEs; information, education and communication (IEC) sessions for female manual workers and other vulnerable women; prevention tools for the working environment; actors and PE manual workers, miners, sailors, fishermen and artisans; : Evaluation of youth prevention; review of kit for ongoing training on HIV, GBV and addictions in the school environment; coaching of young PEs in high schools and university, including through ICT; mapping of youth NGOs and networking and capacity development actions for youths so that they can be involved in HIV prevention; training guide on ?young people not in school? for facilitators; awareness-raising and training of ?youth? organizers; prevention materials for youths / ICT (tel. application, social networks).","High","The PAAR combines the requested amount for other vulnerable populations (including migrants) and the requested amount for youth in school. We cannot identify how much goes to each. The portion for other vulnerable population (OVP) is considered of high priority because there is a documented epidemic among migrants and it is important to increase HIV testing yield. Given limited funding, the portion for youth in school is considered low priority because this population is at low risk and not making a large contribution to epidemic spread. It is very important to reach young people in school with early interventions to increase life skills but it is not a population to be specially targeted for HIV prevention (condoms, STI treatment, differentiated testing)","In the grant sign-off form, the amounts for two identical interventions were combined. As the reallocated divided amount was not specified, they have been combined in the UQD register as well. Original Module: Prevention programs aimed at other vulnerable populations (migrants, lorry drivers, manual workers, miners) and Prevention programs for other vulnerable populations (youths). Original Intervention: Interventions aimed at behavior change among other vulnerable populations; HIV screening services for other vulnerable populations; other interventions targeting other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Morocco","Morocco","PAI-4754","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Implement targeted multi-disease screening campaigns; create new screening centers based on the geographic mapping and guide NGOs to areas not yet covered (concentration of key populations, strong HIV prevalence).",547356.07999999996,null,"Active","a6Q1R000000AJE8",410322.07,0,0,0,137034.01,0,null,null,"Implement targeted multi-disease screening campaigns; create new screening centers based on the geographic mapping and guide NGOs to areas not yet covered (concentration of key populations, strong HIV prevalence).","High","These improvements in screening are at the heart of the funding request and NSP strategic approach. These activities are to be implemented in new areas based on mapping. TRP recommends to move to within allocation if possible.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5870","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","High level priority: it is in line with FR one of the main objective ? to increase MDR-TB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services.",1071389,null,"Active","a6Q1R000000AJW8",0,0,0,0,1071389,0,null,null,"High level priority: it is in line with FR one of the main objective ? to increase MDR-TB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services.","High","High level priority: it is in line with FR one of the main objective ? to increase MDRTB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5869","MCI-00009","TB/HIV","MCI-00136","Community TB/HIV care delivery","High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: To develop and disseminate revised Village Multisectoral AIDS Committee guidelines.",116483,null,"Active","a6Q1R000000AJW7",0,0,0,0,116483,0,null,null,"High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: To develop and disseminate revised Village Multisectoral AIDS Committee guidelines.","High","High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: To develop and disseminate revised Village Multisectoral AIDS Committee guidelines",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5868","MCI-00009","TB/HIV","MCI-00138","Collaborative activities with other programs and sectors (TB/HIV)","High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: The remaining gap of 102,556 (10 percent) cartridges for X-pert are now requested as part of the Prioritized Above Allocation Request (PAAR).",1288103,null,"Active","a6Q1R000000AJW6",0,0,0,0,1288103,0,null,null,"High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: The remaining gap of 102,556 (10 percent) cartridges for X-pert are now requested as part of the Prioritized Above Allocation Request (PAAR).","High","High level priority: it is in line with FR one of the main objective ? to strengthen collaborative TB/HIV activities and module 2 TB/HIV: The remaining gap of 102,556 (10 percent) cartridges for Xpert are now requested as part of the Prioritized Above Allocation Request (PAAR)",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5867","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Scale up of TB case finding will be done amongst the following vulnerable populations for TB (children, miners, slum dwellers and fisher folk).",663833,null,"Active","a6Q1R000000AJW5",0,0,0,0,663833,0,null,null,"High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Scale up of TB case finding will be done amongst the following vulnerable populations for TB (children, miners, slum dwellers and fisher folk).","High","High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Scale up of TB case finding will be done amongst the following vulnerable populations for TB (children, miners, slum dwellers and fisher folk)","NA Original Intervention: Key populations?TB screening in other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5866","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","Using PEPFAR funds the country has scaled coverage of OST clinic to 3 sites in Dar es Salaam and there are plans to scale to 2 other regions (Mwanza and Mbeya). IBBS and geographical mapping has shown high presence of PWID in other regions e.g. Arusha, Morogoro, Dodoma and Tanga. This requested amount will be used to scale up in Dodoma.",2000000,null,"Active","a6Q1R000000AJW4",0,0,0,0,2000000,0,null,null,"Using PEPFAR funds the country has scaled coverage of OST clinic to 3 sites in Dar es Salaam and there are plans to scale to 2 other regions (Mwanza and Mbeya). IBBS and geographical mapping has shown high presence of PWID in other regions e.g. Arusha, Morogoro, Dodoma and Tanga. This requested amount will be used to scale up in Dodoma.","High","Using PEPFAR funds the country has scaled coverage of OST clinics to 3 sites in Dar el Salaam and there are plans to scale to 2 other regions (Mwanza and Mbeya). IBBS and geographical mapping has shown high presence of people who inject drugs in other regions e.g. Arusha, Morogoro, Dodoma and Tanga. This requested amount will be used to scale up in Dodoma.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Scale up Medically Assisted Therapy (MAT)/OST","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Thailand","Thailand","PAI-5781","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Transferring and sustainble into national program 2 models for TB and HIV program in prisoner and migrant and 13 models for HIV and TB in KPs by 13 ODPCs.",1149066,null,"Active","a6Q1R000000AJUh",0,0,0,0,1149066,0,null,null,"Transferring and sustainble into national program 2 models for TB and HIV program in prisoner and migrant and 13 models for HIV and TB in KPs by 13 ODPCs.","Low","The TRP considers the activity related to transferring and sustaining national program 2 models for TB and HIV program in prisoner and migrant and 13 models for HIV and TB in key population by 13 offices of disease prevention and controls (ODPC) to be a low priority for this request and should be supportable with domestic funding.","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5780","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","RTF BL 15-161. Community empowerment for migrants: Population group building (e.g. saving group, women group)2. Community empowerment for migrants: Population network strengthening",16342,null,"Active","a6Q1R000000AJUg",0,0,0,0,16342,0,null,null,"RTF BL 15-161. Community empowerment for migrants: Population group building (e.g. saving group, women group)2. Community empowerment for migrants: Population network strengthening","Low","This activity supports community empowerment for migrants. While this community is at increased risk for HIV the TRP does not believe this\nintervention to have substantial impact.","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5778","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","RTF BL 31-321. Twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii.  Field visit with stakeholders Units/Participants: 27 persons per day, 2 days. Locations: 2 provinces in year 1, year2 2. Fundraising specialist for CRM strategic plan. Contact professional consultant Units/Participants: 4 persons per team  Locations: 1 team in year 1, year 2, year 3.",43921,null,"Active","a6Q1R000000AJUe",0,0,0,0,43921,0,null,null,"RTF BL 31-321. Twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii.  Field visit with stakeholders Units/Participants: 27 persons per day, 2 days. Locations: 2 provinces in year 1, year2 2. Fundraising specialist for CRM strategic plan. Contact professional consultant Units/Participants: 4 persons per team  Locations: 1 team in year 1, year 2, year 3.","Medium","This intervention supports twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii and a fundraising specialist for the community response mobilization (CRM) strategic plan.","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5777","MCI-00534","Comprehensive prevention programs for MSM","MCI-00540","Pre-exposure prophylaxis (PrEP) for MSM","RTF BL 1Referral for PrEP for MSM & TGObjectives: Referral for PREP MSM/TG Units/Participants: 84  per year in year 1, year 2,year 3 Locations: 7 provinces year 1, year 2 , year 3 Costs: Travel cost Measurements:direct indicator record/report, referral form.",11916,null,"Active","a6Q1R000000AJUd",0,0,0,0,11916,0,null,null,"RTF BL 1Referral for PrEP for MSM & TGObjectives: Referral for PREP MSM/TG Units/Participants: 84  per year in year 1, year 2,year 3 Locations: 7 provinces year 1, year 2 , year 3 Costs: Travel cost Measurements:direct indicator record/report, referral form.","Medium","This activity supports additional referral costs for PrEP for men having sex with men & transgender people","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre-exposure prophylaxis (PrEP) for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5776","MCI-00534","Comprehensive prevention programs for MSM","MCI-00540","Pre-exposure prophylaxis (PrEP) for MSM","DDC BL 302-308Purchase  HIV testing ,Kidney function test , HepatitisB test, Urine pregnancy test, Syphilis test, ARV drug: TDF/FTC, (302-307)Activity : Set up PrEP service and included referral system (308).",367506,null,"Active","a6Q1R000000AJUc",0,0,0,0,367506,0,null,null,"DDC BL 302-308Purchase  HIV testing ,Kidney function test , HepatitisB test, Urine pregnancy test, Syphilis test, ARV drug: TDF/FTC, (302-307)Activity : Set up PrEP service and included referral system (308).","Medium","This activity supports purchasing HIV testing, kidney function test, Hepatitis B test, Syphilis test, ARV drug: TDF/FTC, (302-307). n","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre-exposure prophylaxis (PrEP) for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Zanzibar","Zanzibar","PAI-6019","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.",51510,null,"Active","a6Q1R000000AJYX",0,0,0,0,51510,0,null,null,"Data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","High","This activity is deemed quality demand as the data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2020-12-31"]
["CT Zanzibar","Zanzibar","PAI-6018","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","This activity will strengthen the monitoring and evaluation component for the entire program.",100233,null,"Active","a6Q1R000000AJYW",0,0,0,0,100233,0,null,null,"This activity will strengthen the monitoring and evaluation component for the entire program.","High","This activity is considered high priority as it will strengthen monitoring and evaluation for the entire program","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2020-12-31"]
["CT Zanzibar","Zanzibar","PAI-6017","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","The installation of network infrastructure will support and strengthen procurement and supply chain activities.",1548,null,"Active","a6Q1R000000AJYV",0,0,0,0,1548,0,null,null,"The installation of network infrastructure will support and strengthen procurement and supply chain activities.","High","The installation of network infrastructure is considered a high priority by the TRP because it will support and strengthen procurement and supply chain activities which TRP considers are critical","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2020-12-31"]
["CT Zanzibar","Zanzibar","PAI-6016","MCI-00012","Case management","MCI-00158","Therapeutic efficacy surveillance","This intervention aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.",104768,null,"Active","a6Q1R000000AJYU",0,0,0,0,104768,0,null,null,"This intervention aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.","High","The TRP considers this intervention as high priority as it aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2020-12-31"]
["CT Zanzibar","Zanzibar","PAI-6015","MCI-00012","Case management","MCI-00157","Active case detection and investigation (elimination phase)","This intervention is meant to ensure that every malaria case is reached in order to achieve elimination.",22624,null,"Active","a6Q1R000000AJYT",0,0,0,0,22624,0,null,null,"This intervention is meant to ensure that every malaria case is reached in order to achieve elimination.","High","This intervention is necessary in order to ensure that every malaria case is reached. This is critical in order to achieve elimination.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2020-12-31"]
["CT South Africa","South Africa","PAI-6014","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00576","Addressing stigma, discrimination and legal barriers to care for adolescents and youth","Funding will support in providing mental health services to AGYW age 15-24, through the safe spaces that are prioritized in the allocation. Funding will support 24 registered psychologists (2 per district) who will rove between the safe spaces, providing counselling services to AGYW. Evidence in South Africa shows a clear link between depression and risky sexual behavior among AGYW (Barhafumwa et al., 2016).",5160689,null,"Active","a6Q1R000000AJYS",0,0,0,0,5160689,0,null,null,"Funding will support in providing mental health services to AGYW age 15-24, through the safe spaces that are prioritized in the allocation. Funding will support 24 registered psychologists (2 per district) who will rove between the safe spaces, providing counselling services to AGYW. Evidence in South Africa shows a clear link between depression and risky sexual behavior among AGYW (Barhafumwa et al., 2016).","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6013","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Funding will support expansion of access to HIV self-screening to support the treatment surge. South Africa aims to put an additional 2 million people on ART by the year 2020. In support of this target, funding will support procurement of an additional 4.7 million HIV self-screening kits, at the BMGF-negotiated price of $2/kit. This approach is primarily targeted at hard-to-reach populations such as men and young people. This investment will enable South Africa to identify an additional 300,000 people living with HIV over the three years, supporting their navigation into care and initiation onto treatment.",19682539,null,"Active","a6Q1R000000AJYR",0,0,0,0,19682539,0,null,null,"Funding will support expansion of access to HIV self-screening to support the treatment surge. South Africa aims to put an additional 2 million people on ART by the year 2020. In support of this target, funding will support procurement of an additional 4.7 million HIV self-screening kits, at the BMGF-negotiated price of $2/kit. This approach is primarily targeted at hard-to-reach populations such as men and young people. This investment will enable South Africa to identify an additional 300,000 people living with HIV over the three years, supporting their navigation into care and initiation onto treatment.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT Chad","Chad","PAI-5710","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Program Review HIV, Epidemiology and Impact Analysis\nThis review will assess the performance, impact, quality and effectiveness of HIV programs and link program funding, scaling up interventions and disease trends through systematic plausibility analysis\nThe costs provided here are historical costs related to past grants",51324.21,null,"Active","a6Q1R000000AJTY",0,0,0,0,51324.21,0,null,null,"Program Review HIV, Epidemiology and Impact Analysis\nThis review will assess the performance, impact, quality and effectiveness of HIV programs and link program funding, scaling up interventions and disease trends through systematic plausibility analysis\nThe costs provided here are historical costs related to past grants","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Central Africa"]
["CT Chad","Chad","PAI-5709","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Review of the TB program, epidemiology and impact analysis\nThis review will make it possible to evaluate the performance, impact, quality and effectiveness of the TB programs and to establish a link between the program funding, the upscaling of the intervention and the disease trends by means of a systematic plausibility analysis.\nThe costs stated here are historic costs linked to previous grants.",51324.21,null,"Active","a6Q1R000000AJTX",0,0,0,0,51324.21,0,null,null,"Review of the TB program, epidemiology and impact analysis\nThis review will make it possible to evaluate the performance, impact, quality and effectiveness of the TB programs and to establish a link between the program funding, the upscaling of the intervention and the disease trends by means of a systematic plausibility analysis.\nThe costs stated here are historic costs linked to previous grants.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Central Africa"]
["CT Chad","Chad","PAI-5708","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","HIV treatment cascade service analysis survey\nThe aim is to determine the extent to which the 90-90-90 targets have been achieved, together with the explanatory factors and bottlenecks relating to performance. This will require the following, specifically:\n- establishing the performance development profile for medical health care and the PMTCT;\n- determining the current treatment cascade and suggesting its development trend;\n- determining the current PMTCT cascade and suggesting its development trend;\n- identifying and analyzing success factors and bottlenecks of the cascade;\n- proposing modeling scenarios for development trends up to 2022.\nThe costs stated here are historic costs linked to previous grants.",51324.21,null,"Active","a6Q1R000000AJTW",0,0,0,0,51324.21,0,null,null,"HIV treatment cascade service analysis survey\nThe aim is to determine the extent to which the 90-90-90 targets have been achieved, together with the explanatory factors and bottlenecks relating to performance. This will require the following, specifically:\n- establishing the performance development profile for medical health care and the PMTCT;\n- determining the current treatment cascade and suggesting its development trend;\n- determining the current PMTCT cascade and suggesting its development trend;\n- identifying and analyzing success factors and bottlenecks of the cascade;\n- proposing modeling scenarios for development trends up to 2022.\nThe costs stated here are historic costs linked to previous grants.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Central Africa"]
["CT Chad","Chad","PAI-5707","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In view of the under-reporting, this request includes a plan to carry out active screening for cases of tuberculosis among prisoners, refugees/displaced persons, nomads and children in the malnutrition treatment centers (TNUs) using 2 trucks equipped with screening and diagnostic resources (x-ray and GeneXpert). This active screening will be organized biannually, in accordance with specific focus points (see the supervision focus points). \nDuring the screening campaigns, all suspected cases of TB or MDR-TB will initially receive a chest x-ray and those exhibiting symptoms of TB will be given a GeneXpert examination to confirm the diagnosis. In addition, HIV screening will be carried out among these populations. Advocacy sessions will be carried out prior to and during these campaigns. The campaign team will be composed of: 1 x-ray operator, 1 laboratory technician, 1 health-care worker and 1 driver.",1292844.25,null,"Active","a6Q1R000000AJTV",0,0,0,0,1292844.25,0,null,null,"In view of the under-reporting, this request includes a plan to carry out active screening for cases of tuberculosis among prisoners, refugees/displaced persons, nomads and children in the malnutrition treatment centers (TNUs) using 2 trucks equipped with screening and diagnostic resources (x-ray and GeneXpert). This active screening will be organized biannually, in accordance with specific focus points (see the supervision focus points). \nDuring the screening campaigns, all suspected cases of TB or MDR-TB will initially receive a chest x-ray and those exhibiting symptoms of TB will be given a GeneXpert examination to confirm the diagnosis. In addition, HIV screening will be carried out among these populations. Advocacy sessions will be carried out prior to and during these campaigns. The campaign team will be composed of: 1 x-ray operator, 1 laboratory technician, 1 health-care worker and 1 driver.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Central Africa"]
["CT Eswatini","Eswatini","PAI-5706","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Third year salary for 8 regional DR-TB doctors, 12 regional DR-TB nurses and 4 regional data clerks. The allocation amount covers salaries for the first two years of the grant. This investment will allow their work to continue for the full three years.",576000,null,"Active","a6Q1R000000AJTU",0,0,0,0,576000,0,null,null,"Third year salary for 8 regional DR-TB doctors, 12 regional DR-TB nurses and 4 regional data clerks. The allocation amount covers salaries for the first two years of the grant. This investment will allow their work to continue for the full three years.","High","Third year salary for 8 regional DR-TB doctors, 12 regional DR-TB nurses and 4 regional data clerks. The allocation amount covers salaries for the first two years of the grant. This investment will allow their work to continue for the full three years","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5705","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00575","Community mobilization and norms change","Develop a multi-sectoral model and costed operational plan to integrate health issues into other government services. The approach is to institutionalize health issues into multi-sector entry points in order to expand access to information and services provided in communities, schools, facilities and other places. Funding will support stakeholder consultations and technical assistance to develop the plan.",30750,null,"Active","a6Q1R000000AJTT",0,0,0,0,30750,0,null,null,"Develop a multi-sectoral model and costed operational plan to integrate health issues into other government services. The approach is to institutionalize health issues into multi-sector entry points in order to expand access to information and services provided in communities, schools, facilities and other places. Funding will support stakeholder consultations and technical assistance to develop the plan.","High","Integration of HIV programming into other sectors is\nimportant in order to enable HIV programs to reach\neveryone and embed these activities across all\nsectors of the government.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Somalia","Somalia","PAI-5605","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Additional training, co-ordination and case management activities for TB/HIV.",445170,null,"Active","a6Q1R000000AJRr",0,0,0,0,445170,0,null,null,"Additional training, co-ordination and case management activities for TB/HIV.","High","Additional training, co-ordination and case management activities for TB/HIV in areas no covered by the allocation funding request.","NA Original Intervention: Case management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5604","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Expansion of access to GeneXpert and provision of additional GeneXpert cartridges. ? Case based-incentive for community providers and patient social support to manage additional detected MDR-TB cases.",1369941,null,"Inactive","a6Q1R000000AJRq",1163242,206699,0,0,0,1,null,null,"Expansion of access to GeneXpert and provision of additional GeneXpert cartridges. ? Case based-incentive for community providers and patient social support to manage additional detected MDR-TB cases.","High","? Expansion of access to GeneXpert in areas not covered by the allocation request and provision of additional GeneXpert cartridges. ? Case based-incentive for community providers and patient social support to manage additional detected MDR-TB cases.","NA Original Module: Multidrug-resistant TB. Original Intervention: MDR TB: Case detection and diagnosis treatment for key population programs","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5603","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Additional community case finding activities, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. \nAdditional active case finding activities for high-risk groups and cross-border activities.",8066920,null,"Active","a6Q1R000000AJRp",1462184,1312920,0,0,5291816,0,null,null,"Additional community case finding activities, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. \nAdditional active case finding activities for high-risk groups and cross-border activities.","High","Additional community case finding activities in areas not covered by the allocation funding request, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. ? Additional active case finding activities for high-risk groups and cross-border activities in areas not covered by the allocation funding request.","NA Original Intervention: Case detection and diagnosis, treatment for key population programs","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5602","MCI-00023","Program management","MCI-00207","Grant management","Focal persons for new states?this funding will support 1 new focal personal for each of the 4 new states.The four states are Hirshabelle, South West, Jubaland and Galmudug. These were established during the last election and have MOHs and Malaria Focal Points. Each focal point 800 USD per month for 36 months.",115200,null,"Active","a6Q1R000000AJRo",0,0,0,0,115200,0,null,null,"Focal persons for new states?this funding will support 1 new focal personal for each of the 4 new states.The four states are Hirshabelle, South West, Jubaland and Galmudug. These were established during the last election and have MOHs and Malaria Focal Points. Each focal point 800 USD per month for 36 months.","Medium","There is a need to support newly created states; however, the applicant did not mention how and who will sustain this. The TRP is concerned about sustainability of such activity",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5601","MCI-00071","Other module","MCI-00071","Other module","In the current context of Somalia, emergency mobile teams are used to target populations that are not able to come to health facilities, or in areas that have no functioning health facilities. This is exacerbated during the drought as well as during this period when EPHS services are severely limited. This includes mobile health team, car rental, stationary, communication, training and supervision. This is for three organizations, and each organization will have five mobile teams that reach hard-to-reach areas.",1774408,null,"Active","a6Q1R000000AJRn",0,0,0,0,1774408,0,null,null,"In the current context of Somalia, emergency mobile teams are used to target populations that are not able to come to health facilities, or in areas that have no functioning health facilities. This is exacerbated during the drought as well as during this period when EPHS services are severely limited. This includes mobile health team, car rental, stationary, communication, training and supervision. This is for three organizations, and each organization will have five mobile teams that reach hard-to-reach areas.","High","The TRP recommends this item as High priority considering significant challenges for IDPs, the nomadic and generally mobile population of Somalia to access to health facilities and potential impact that funding of this intervention would have on three diseases overall.","NA Original Module: Emergency mobile teams. Original Intervention: Emergency mobile teams","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5600","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","A consultant for NMCP Somaliland to develop and implement an exit strategy, as well as a fund-raising strategy for Somaliland.The consultant will work for 3 months (21 days per month) per year = 63 days per year x 3 years = 189 days.",96141,null,"Active","a6Q1R000000AJRm",0,0,0,0,96141,0,null,null,"A consultant for NMCP Somaliland to develop and implement an exit strategy, as well as a fund-raising strategy for Somaliland.The consultant will work for 3 months (21 days per month) per year = 63 days per year x 3 years = 189 days.","Medium","The country needs an exit strategy but the justification for having one consultant for 3 years is not clear. The applicant  may need to explore\nother modalities like having a mission consisting of many persons from different expertise for a shorter period along with a national workshop to\nensure that capacity is built in a wider area of expertise and to ensure sustainability",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Rwanda","Rwanda","PAI-5468","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Broaden utilization of GeneXpert is planned in the funding request. Above allocation will support the purchase of 50 ventilated workstations to improve biosafety of GeneXpert laboratories as recommended in the MTR.",157500,null,"Inactive","a6Q1R000000AJPe",157500,0,0,0,0,1,null,null,"Broaden utilization of GeneXpert is planned in the funding request. Above allocation will support the purchase of 50 ventilated workstations to improve biosafety of GeneXpert laboratories as recommended in the MTR.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-5467","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Rwanda will undertake the next DHS in 2019-2020. This is a national activity implemented under the leadership of the National Institute of Statistic of Rwanda (NISR). The request will support the NMCP to ensure malaria is included in the DHS such as through the reading of blood smears for malaria prevalence. Part of the TA for this activity will be supported by PMI.",500000,null,"Active","a6Q1R000000AJPd",0,0,0,0,500000,0,null,null,"Rwanda will undertake the next DHS in 2019-2020. This is a national activity implemented under the leadership of the National Institute of Statistic of Rwanda (NISR). The request will support the NMCP to ensure malaria is included in the DHS such as through the reading of blood smears for malaria prevalence. Part of the TA for this activity will be supported by PMI.","Medium","The DHIS is an important piece in the\nrunning of the malaria program.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Support to the DHIS to support the malaria component","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Rwanda","Rwanda","PAI-5466","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","This budget requested will support the supervision of CHWs by health centre staff in their implementation of diagnosis and treatment of the population at the community level. This will support the program in strengthening the implementation of HBM by CHWs as this intervention has been scaled up since October 2016.",278788,null,"Active","a6Q1R000000AJPc",0,0,0,0,278788,0,null,null,"This budget requested will support the supervision of CHWs by health centre staff in their implementation of diagnosis and treatment of the population at the community level. This will support the program in strengthening the implementation of HBM by CHWs as this intervention has been scaled up since October 2016.","High","Supervision of CHWs by local health\nworkers is highly needed to have quality\ncase management in place","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Rwanda","Rwanda","PAI-5465","MCI-00011","Vector control","MCI-00152","Entomological monitoring","This cost will support the implementation of entomological monitoring in 12 sites and the insecticide resistance survey in 30 sites in 2020-2021 as they are not supported by neither the GF nor by PMI.  These  activities  are  important  are  the findings  will guide  the  program  on the decisions taken relative to which insecticide should be used in IRS and also inform on mosquito behaviour patterns.",487508,null,"Active","a6Q1R000000AJPb",0,0,0,0,487508,0,null,null,"This cost will support the implementation of entomological monitoring in 12 sites and the insecticide resistance survey in 30 sites in 2020-2021 as they are not supported by neither the GF nor by PMI.  These  activities  are  important  are  the findings  will guide  the  program  on the decisions taken relative to which insecticide should be used in IRS and also inform on mosquito behaviour patterns.","High","This is important for the timely\nimplementation of the resistance\nmanagement plan. Those activities are\nimportant are findings guide the\nprogram in the decision of insecticide to\nbe used in IRS and also the behaviour\nof mosquito",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Rwanda","Rwanda","PAI-5464","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Due to inadequate resources, no specific funding has been requested for funding SBCC. However, it?s anticipated that PMI will continue to support some specific SBCC activities. The MSP articulates specific SBCC interventions envisioned between 2018 and 2020. This  request  is  to  continue  to  sensitize  the population on malaria awareness, malaria prevention and care seeking with the aim of increasing  LLIN  use  and  reducing  malaria transmission.",1498026,null,"Active","a6Q1R000000AJPa",0,0,0,0,1498026,0,null,null,"Due to inadequate resources, no specific funding has been requested for funding SBCC. However, it?s anticipated that PMI will continue to support some specific SBCC activities. The MSP articulates specific SBCC interventions envisioned between 2018 and 2020. This  request  is  to  continue  to  sensitize  the population on malaria awareness, malaria prevention and care seeking with the aim of increasing  LLIN  use  and  reducing  malaria transmission.","High","Given the upsurge, the TRP considers\nthis essential for increasing utilization of\nthe available interventions e.g. LLINs,\nfree diagnostics and medications","NA Original Module: Specific prevention interventions. Original Intervention: Information, education, communication/behavior change communications (vector control)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Rwanda","Rwanda","PAI-5463","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.",19077346,null,"Active","a6Q1R000000AJPZ",0,13626690,0,2723056,2727600,0,null,null,"This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.","High","IRS is an effective intervention to\ncontain the upsurge of malaria in highly\nendemic areas. However, it?s important\nthat if this is to be pursued then the\ncountry has enough resources to\nprovide for long term implementation.\nOtherwise, with the proposed budget,\nLLINs may be more useful considering\nthe durability of the net.","15/10/2018: at Oct GAC 2018, $ 13,626,690 is from the Portfolio optimization funds and $   2,723,056 the cost of the insecticides donated from Madagascar. This budget will support the country to spray 5 districts with the PAA funding in FY 18-19 and 4 districts in FY 19-20. The donated insecticides from Madagascar will support the country to spray 2 districts in FY 18-19. The gap of 2.7 million USD if available, will support to cover 2 districts in FY 20-21. The grant budget did not include $2.7m as they were not addtl funds but insecticides given Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Panama","Panama","PAI-5370","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","The MoniTARV system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future. system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future.",94500,null,"Active","a6Q1R000000AJO4",0,0,0,0,94500,0,null,null,"The MoniTARV system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future. system currently includes all new patients starting ART. The entry of old patients would make it possible to optimize care for all patients at ART clinics, in addition to providing strategic historic data that facilitates informed decision-making in the future.","Medium","The TRP considers the digitalization of existing medical records of patients on ART as a strategic investment, although the amount requested by the applicant deems high. The TRP suggests reallocating efficiency gains to other priorities, such as PSM","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Recruitment of data entry staff to update MoniTARV records","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Panama","Panama","PAI-5369","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","The conceptual proposal would enable the Minsitry of Public Health to create a tool to identify cases of TB and TB/HIV in order to design the range of resources and services in line with actual needs in the future, ensuring a more effective response in the sustainability phase.",34000,null,"Active","a6Q1R000000AJO3",0,0,0,0,34000,0,null,null,"The conceptual proposal would enable the Minsitry of Public Health to create a tool to identify cases of TB and TB/HIV in order to design the range of resources and services in line with actual needs in the future, ensuring a more effective response in the sustainability phase.","Medium","The TRP considers this intervention to be medium priority as it improves the health information systems ability to trace the tuberculosis cases geographically. The TRP considers this investment could benefit the active case detection but is not critical for its success.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Technical assistance to create a conceptual proposal for a geo-referencing tool for cases of tuberculosis, cases of TB/HIV (200 cases, approx. 10% of TB/HIV cases nationwide (1900 cases in 2017)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Panama","Panama","PAI-5368","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00177","Other health and community workforce intervention(s)","The community education program will supplement individual TB prevention actions that are implemented by tuberculosis health promoters in indigenous areas, enhancing the capacity of health regions with indigenous populations to continue with health promotion programs with an intercultural approach, including the prevention of TB.",60000,null,"Active","a6Q1R000000AJO2",0,0,0,0,60000,0,null,null,"The community education program will supplement individual TB prevention actions that are implemented by tuberculosis health promoters in indigenous areas, enhancing the capacity of health regions with indigenous populations to continue with health promotion programs with an intercultural approach, including the prevention of TB.","Medium","The TRP considers that this intervention to be medium priority as it represents an investment in the capacity building of health promoters (for interpersonal communication) at the community level. This investment is valuable but not critical for the performance of the program.","NA Original Module: SRSS: Human Resources including community health workers. Original Intervention: Intercultural education program for the health of communities with messages on controlling tuberculosis infections using different national, regional and local resources, including mass media and different forms of interpersonal and group communication.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Panama","Panama","PAI-5367","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Goal 3 of the End TB strategy is to reach 0 catastrophic costs in terms of tuberculosis. Panama has no information to measure progress; therefore, this survey would need to be performed in the first two years in which the 2018-2022 PENTB is implemented.",70000,null,"Active","a6Q1R000000AJO1",0,0,0,0,70000,0,null,null,"Goal 3 of the End TB strategy is to reach 0 catastrophic costs in terms of tuberculosis. Panama has no information to measure progress; therefore, this survey would need to be performed in the first two years in which the 2018-2022 PENTB is implemented.","High","The TRP considers that this intervention to be high priority at it addresses the gap in strategic information for evidence-informed decision making (although by nature it is recurrent cost","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Survey on catastrophic costs related to tuberculosis.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Panama","Panama","PAI-5366","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","The pilot project will contribute to guaranteeing the ability of national institutions to offer one of the most innovative interventions of combined prevention in the future.",70000,null,"Active","a6Q1R000000AJO0",0,0,0,0,70000,0,null,null,"The pilot project will contribute to guaranteeing the ability of national institutions to offer one of the most innovative interventions of combined prevention in the future.","High","The TRP considers the pilot project on PrEP to be high priority for PAAR. It is aligned with the transition workplan priorities and an important component of HIV prevention programming for key populations for key populations.","NA Original Module: Comprehensive prevention programs for key populations (MSM, FSW, transgender population). Original Intervention: Pilot project to provide pre-exposure prophylaxis to HIV (PrEP) to MSM and transgender populationsPrEP) to MSM and transgender populations.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Nepal","Nepal","PAI-5321","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Assessment of BCC methodology and approaches to guide policy revision in light of requirements for elimination.",20259,null,"Active","a6Q1R000000AJNH",0,0,0,0,20259,0,null,null,"Assessment of BCC methodology and approaches to guide policy revision in light of requirements for elimination.","High","Proper case management in times of preand elimination phases is crucial. For this reason, the BCC methodology and approaches to guide policy revision must be assessed accordingly.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5320","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Provide training on leadership and management at Central, Regional and District levels.",2044,null,"Active","a6Q1R000000AJNG",0,0,0,0,2044,0,null,null,"Provide training on leadership and management at Central, Regional and District levels.","Medium","As the burden of disease reduces, strong training on leadership and management at Central, Regional and District levels will be important.","NA Original Intervention: Policy, planning, coordination and management","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5319","MCI-00011","Vector control","MCI-00152","Entomological monitoring","Monitoring the durability and efficacy of LLINs to inform future procurement.",16110,null,"Active","a6Q1R000000AJNF",0,0,0,0,16110,0,null,null,"Monitoring the durability and efficacy of LLINs to inform future procurement.","Medium","Tracking LLIN durability will support management of resupply and inform procurement decisions that take into account the number of years of protection as opposed to unit cost of LLINs.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5318","MCI-00012","Case management","MCI-00162","Ensuring drug and other health product quality","Support facility visits by enforcement teams in cases where inappropriate drugs are identified.",11742,null,"Active","a6Q1R000000AJNE",0,0,0,0,11742,0,null,null,"Support facility visits by enforcement teams in cases where inappropriate drugs are identified.","Medium","Monitoring drug quality (e.g. facility visits by enforcement teams in cases where inappropriate drugs are identified) is essential to improve the quality of health care.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5317","MCI-00012","Case management","MCI-00154","Facility-based treatment","Procure and supply 15 new replacement microscopes (Y2); Refurbish Surkhet microscopy laboratory (Y2).",34440,null,"Active","a6Q1R000000AJND",0,0,0,0,34440,0,null,null,"Procure and supply 15 new replacement microscopes (Y2); Refurbish Surkhet microscopy laboratory (Y2).","Medium","Diagnostic equipment [new replacement microscopes (Year 2)] are needed for facility -based providers to improve the quality of healthcare provision.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5316","MCI-00011","Vector control","MCI-00152","Entomological monitoring","On-going longitudinal surveys of vector distribution, abundance and bionomics in Y2&3.",44472,null,"Active","a6Q1R000000AJNC",0,0,0,0,44472,0,null,null,"On-going longitudinal surveys of vector distribution, abundance and bionomics in Y2&3.","Medium","This intervention allows for the updating of insecticide resistance information, vector distribution, abundance and bionomics in sentinel sites, and spot surveys (for Years 1 and 2). Insecticide resistance monitoring and management is a key strategy advocated by GPIRM (WHO 2011) and Global Vector Control Response 2017 - 2030",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5315","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","External program evaluation to review progress and inform programme direction (Y3).",33428,null,"Active","a6Q1R000000AJNB",0,0,0,0,33428,0,null,null,"External program evaluation to review progress and inform programme direction (Y3).","Medium","Training on database management and data analysis is important, as well as mid - term evaluation to guide the program. This is however considered medium priority especially as it is not a country wide epidemics.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5314","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","TA for development of IEC documents for elimination; Production and dissemination of IEC materials.",20138,null,"Active","a6Q1R000000AJNA",0,0,0,0,20138,0,null,null,"TA for development of IEC documents for elimination; Production and dissemination of IEC materials.","Medium","Advocacy activities and IEC documents are a powerful tool to support the long -term political and financial commitment necessary for malaria elimination.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5313","MCI-00011","Vector control","MCI-00152","Entomological monitoring","Provide training on basic malaria entomology for support workers to maximize capacity of entomological teams to support elimination.",61050,null,"Active","a6Q1R000000AJN9",0,0,0,0,61050,0,null,null,"Provide training on basic malaria entomology for support workers to maximize capacity of entomological teams to support elimination.","Medium","This intervention provides training on basic malaria entomology for district staff to support foci investigations on receptivity and outbreak response. This is consistent with the Global Vector Control Response 2017 -2030, which puts an emphasis on renewed focus on improved human capacity at national and subnational levels and repositions vector control as a key approach to prevent and eliminate vector - borne diseases.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Malawi","Malawi","PAI-5218","MCI-00007","Treatment, care and support","MCI-00121","Prevention, diagnosis and treatment of opportunistic infections","Funds to support switching from single dose to fixed dose ($11.66M) The program has prioritized implementation of Isoniazid Preventive Therapy in the five districts with highest TB prevalence. The FR includes a request for separate formulations of Co-trimoxazole, Isoniazid and Pyridoxine. This will increase the pill burden for the patients hence the request for additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine as per MOH Clinical guidelines. The fixed dose combination will be given to 40% of the ART patient cohort. Additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine per MOH policy.",11660000,null,"Active","a6Q1R000000AJLc",5504341,0,0,0,6155659,0,null,null,"Funds to support switching from single dose to fixed dose ($11.66M) The program has prioritized implementation of Isoniazid Preventive Therapy in the five districts with highest TB prevalence. The FR includes a request for separate formulations of Co-trimoxazole, Isoniazid and Pyridoxine. This will increase the pill burden for the patients hence the request for additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine as per MOH Clinical guidelines. The fixed dose combination will be given to 40% of the ART patient cohort. Additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine per MOH policy.","Medium","A switch to fixed dose IPT will increase adherence.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5217","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Point of care for VL/EID ($7.62M) Point of Care is critical for patient monitoring and early provision of lifesaving interventions The Ministry of Health with support from CHAI conducted a POC mapping and identified 99 Health facilities that would benefit from Point of Care for VL/EID. High volume sites will be considered for deployment of POC, because of availability of infrastructure and linkage to care for higher throughput. This will enable providers make timely clinical decisions to switch failing patients to second/third line ART. This request will enable the Ministry of Health to procure an additional 15 platforms and procure 50,000 viral load tests and 15,000 EID tests. This will complement existing POC investments available in country including funding from UNITAID for 2017 to 2019.",7620000,null,"Active","a6Q1R000000AJLb",3674497.99,0,0,0,3945502.01,0,null,null,"Point of care for VL/EID ($7.62M) Point of Care is critical for patient monitoring and early provision of lifesaving interventions The Ministry of Health with support from CHAI conducted a POC mapping and identified 99 Health facilities that would benefit from Point of Care for VL/EID. High volume sites will be considered for deployment of POC, because of availability of infrastructure and linkage to care for higher throughput. This will enable providers make timely clinical decisions to switch failing patients to second/third line ART. This request will enable the Ministry of Health to procure an additional 15 platforms and procure 50,000 viral load tests and 15,000 EID tests. This will complement existing POC investments available in country including funding from UNITAID for 2017 to 2019.","Medium","Increasing access to viral load supports maintenance of high national viral suppression rate of 90.8%","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5216","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","The activities within this module are linked to the HSSPII objective to generate quality information, and increase quality information accessibility to all intended users for evidence-based decision-making, through standardized and harmonized tools that avoids duplication across all programmes. These activities encourage the adoption of ICT systems for routine data management including data collection, data analysis, use and dissemination. These activities include procurement of IT equipment for all levels, and procurement of 10 vehicles to support programme implementation. Funding Request: Tailored to Material Change 15 December 2016? 39 An inventory of all vehicles has been created and priority will be given to those government departments who have critical supervision/audit responsibilities A pooled system is in force at Headquarters level.",502437,null,"Active","a6Q1R000000AJLa",30487.32,0,0,0,471949.68,0,null,null,"The activities within this module are linked to the HSSPII objective to generate quality information, and increase quality information accessibility to all intended users for evidence-based decision-making, through standardized and harmonized tools that avoids duplication across all programmes. These activities encourage the adoption of ICT systems for routine data management including data collection, data analysis, use and dissemination. These activities include procurement of IT equipment for all levels, and procurement of 10 vehicles to support programme implementation. Funding Request: Tailored to Material Change 15 December 2016? 39 An inventory of all vehicles has been created and priority will be given to those government departments who have critical supervision/audit responsibilities A pooled system is in force at Headquarters level.","High","Allows for evidence based decision making and action","NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5215","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","These funds will be used to cover M&E printing costs and CMED activities that build on activities found both within allocation and in the catalytic investment funding.",873425,null,"Active","a6Q1R000000AJLZ",0,0,0,0,873425,0,null,null,"These funds will be used to cover M&E printing costs and CMED activities that build on activities found both within allocation and in the catalytic investment funding.","High","Integral part of project management and monitoring","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5214","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","These funds will be used to conduct operational research on program activities within allocation. Outcomes of this research can be used to optimize program performance.",227740,null,"Active","a6Q1R000000AJLY",0,0,0,0,227740,0,null,null,"These funds will be used to conduct operational research on program activities within allocation. Outcomes of this research can be used to optimize program performance.","High","Necessary for performance and mid-course corrections","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Analysis, evaluations, review and transparency","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5213","MCI-00019","RSSH: Financial management systems","MCI-00187","Public financial management (PFM) strengthening","The activities prioritized in this intervention are central to financial management strengthening for the Government of Malawi. Linked to the HSSPII, these activities will strengthen the capacity of the finance staff in terms of skills and necessary equipment needed to improve overall management. These activities coupled with the support from other donors and the Government of Malawi itself will improve financial management capacity specifically through improved planning, and budget execution. Specific activities in this intervention include: ? Training on bank reconciliation ? Management training ? Office furniture and equipment.",4026804,null,"Active","a6Q1R000000AJLX",0,0,0,0,4026804,0,null,null,"The activities prioritized in this intervention are central to financial management strengthening for the Government of Malawi. Linked to the HSSPII, these activities will strengthen the capacity of the finance staff in terms of skills and necessary equipment needed to improve overall management. These activities coupled with the support from other donors and the Government of Malawi itself will improve financial management capacity specifically through improved planning, and budget execution. Specific activities in this intervention include: ? Training on bank reconciliation ? Management training ? Office furniture and equipment.","High","Fiduciary capacity strengthening is essential","NA Original Module: RSSH - Financial management systems. Original Intervention: Public financial management strengthening","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Myanmar","Myanmar","PAI-5089","MCI-00001","Prevention programs for MSM and TGs","MCI-00083","HIV testing and counseling as part of programs for MSM and TGs","The additional investment will support the program to reach more target population.",579579,null,"Active","a6Q1R000000AJJX",0,0,0,0,579579,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 1177031 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Prevention programs for men who have sex with men and transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5088","MCI-00001","Prevention programs for MSM and TGs","MCI-00086","Other interventions for MSM and TGs","The additional investment will support the program to reach more target population.",136363,null,"Active","a6Q1R000000AJJW",0,0,0,0,136363,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","24/12/17: replaced GAC UQD remaining amount of 139,090 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Prevention programs for men who have sex with men and transgender people. Original Intervention: Diagnosis and treatment of STIs as part of High programs for MSM and TGs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5087","MCI-00001","Prevention programs for MSM and TGs","MCI-00082","Condoms as part of programs for MSM and TGs","The additional investment will support the program to reach more target population.",1076812,null,"Active","a6Q1R000000AJJV",849697,0,0,0,227115,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Module: Prevention programs for men who have sex with men and transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5086","MCI-00001","Prevention programs for MSM and TGs","MCI-00081","Behavioral change as part of programs for MSM and TGs","The additional investment will support the program to reach more target population.",9468402,null,"Active","a6Q1R000000AJJU",6796313,0,0,0,2672089,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?","NA Original Module: Prevention programs for men who have sex with men and transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5085","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Addressing limited capacity of health and community workforce will help remove bottlenecks for program implementation.",13815383,null,"Active","a6Q1R000000AJJT",4747070,0,0,0,9068313,0,null,null,"Addressing limited capacity of health and community workforce will help remove bottlenecks for program implementation.","High","Limited capacity of health and community workforce is identified as a bottleneck in CN","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Mali","Mali","PAI-5084","MCI-00013","Specific prevention interventions (SPI)","MCI-00167","Seasonal malaria chemoprevention","Since 2016 SMC  is carried out in the whole country.  It should continue to be scaled up for greater impact on the target population (children under 5) because evaluation shows  its protective effectiveness in reducing the number of malaria cases. UQD not needed anymore as funds were found in efficiency gains during malaria grant making.",4054116.26,null,"Inactive","a6Q1R000000AJJS",4054116.26,0,0,0,0,1,null,null,"Since 2016 SMC  is carried out in the whole country.  It should continue to be scaled up for greater impact on the target population (children under 5) because evaluation shows  its protective effectiveness in reducing the number of malaria cases. UQD not needed anymore as funds were found in efficiency gains during malaria grant making.","High","Please ensure that whatever PAAR amount gets funded for Mali is split according to the current 3.3 : 1 ratio for LLINs : SMC respectively.","NA Original Module: Specific prevention interventions","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2021-12-31"]
["CT Mali","Mali","PAI-5083","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Routine and campaign LLIN distribution improved results and impact indicators;  LLIN possession rate increased from 84% in 2013 (DHS-V) to 92% in 2015 (EIPM),  usage rate increased from 75.2% in 2013 (DHS-V) to 78 percent in 2015 (EIPM) and malaria prevalence decreased from 52 percent in 2013 (DHS-V) to 36 percent in 2015 (EIPM).\nUQD not anymore needed as funds have been obtained on an \"In principle endorsement\" award from the Portfolio Optimization Wave 2.",13378479.41,null,"Active","a6Q1R000000AJJR",1047678.15,8851102,0,0,3479699.26,0,null,null,"Routine and campaign LLIN distribution improved results and impact indicators;  LLIN possession rate increased from 84% in 2013 (DHS-V) to 92% in 2015 (EIPM),  usage rate increased from 75.2% in 2013 (DHS-V) to 78 percent in 2015 (EIPM) and malaria prevalence decreased from 52 percent in 2013 (DHS-V) to 36 percent in 2015 (EIPM).\nUQD not anymore needed as funds have been obtained on an \"In principle endorsement\" award from the Portfolio Optimization Wave 2.","High","Please ensure that whatever PAAR amount gets funded for Mali is split according to the current 3.3 : 1 ratio for LLINs : SMC respectively.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2021-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4986","MCI-00071","Other module","MCI-00071","Other module","Additional VMV training to improve data collection and reporting, electronic equipment to improve capacity for reporting, training at central and province level on DHIS2 usage, and supplementary training to improve outbreak preparedness and response.",700000,null,"Inactive","a6Q1R000000AJHs",700000,0,0,0,0,1,null,null,"Additional VMV training to improve data collection and reporting, electronic equipment to improve capacity for reporting, training at central and province level on DHIS2 usage, and supplementary training to improve outbreak preparedness and response.","High","The TRP considers these as key activities that should be incorporated as part of regular allocation, if efficiencies are found during grant making.","NA Original Module: RSSH. Original Intervention: Strengthening of the Surveillance System (Lao PDR )","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4858","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","To undertake any rehabilitation work in the wards where MDR/XDR-TB patients are hospitalized in order to fulfill the infection control requirements.",12500,null,"Active","a6Q1R000000AJFo",0,0,0,0,12500,0,null,null,"To undertake any rehabilitation work in the wards where MDR/XDR-TB patients are hospitalized in order to fulfill the infection control requirements.","Low","Infection control activities in five countries would require larger amount of funding and appropriate planning","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4857","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","To support the development and printing of the national guidelines on TB infection control in Iraq, Lebanon, Yemen, Syria and Jordan",25000,null,"Active","a6Q1R000000AJFn",0,0,0,0,25000,0,null,null,"To support the development and printing of the national guidelines on TB infection control in Iraq, Lebanon, Yemen, Syria and Jordan","Low","This is considered as low priority in the context of a COE and the time-frame required for this activity","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4856","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To provide support to all the five countries to implement the DHIS2 (TB Tracker) in the settings where it should be implemented",20000,null,"Active","a6Q1R000000AJFm",0,0,0,0,20000,0,null,null,"To provide support to all the five countries to implement the DHIS2 (TB Tracker) in the settings where it should be implemented","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4855","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","Similar to the MSM module, this is to include parts of Yemen and expand the services in the other countries. Through the within allocation fund, 23% of the FSW will be tested for HIV. It is expected to increase the HIV testing among FSW to 50% through PAAR fund.",2500000,null,"Active","a6Q1R000000AJFl",0,0,0,0,2500000,0,null,null,"Similar to the MSM module, this is to include parts of Yemen and expand the services in the other countries. Through the within allocation fund, 23% of the FSW will be tested for HIV. It is expected to increase the HIV testing among FSW to 50% through PAAR fund.","High","In this Funding Request there is a focus on testing of key populations, which the TRP believes to be crucial. Given the importance of this activity, and the fact that prevention and testing programs for female sex workers in Yemen are not included in the allocation request, we recommend that a portion of this amount should move to the allocation for prevention activities among FSW in Yemen and be funded through savings made during grant making.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4854","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To organize at regional level a workshop on the utilization of the DHIS2. Will attend this course the relevant central unit staff of the NTPs as well as the staff of NGOs and FBOs operating in settings with IDPs and refugees",35000,null,"Active","a6Q1R000000AJFk",0,0,0,0,35000,0,null,null,"To organize at regional level a workshop on the utilization of the DHIS2. Will attend this course the relevant central unit staff of the NTPs as well as the staff of NGOs and FBOs operating in settings with IDPs and refugees","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4853","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In order to strengthen culture and DST activities, 6 Bactec MGIT960 kits with immunochromatographic assays need to be acquired:  4 for Iraq and 2 for Yemen",20000,null,"Active","a6Q1R000000AJFj",0,0,0,0,20000,0,null,null,"In order to strengthen culture and DST activities, 6 Bactec MGIT960 kits with immunochromatographic assays need to be acquired:  4 for Iraq and 2 for Yemen","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4852","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","To rehabilitate the microscopy laboratories of the health facilities damaged by the fighting in Iraq, Yemen and Syria",450000,null,"Active","a6Q1R000000AJFi",0,0,0,0,450000,0,null,null,"To rehabilitate the microscopy laboratories of the health facilities damaged by the fighting in Iraq, Yemen and Syria","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4851","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In order to enhance TB microscopy activities in Iraq, yemen and Syria 3 LED microscopes need to be acquired",13534,null,"Active","a6Q1R000000AJFh",0,0,0,0,13534,0,null,null,"In order to enhance TB microscopy activities in Iraq, yemen and Syria 3 LED microscopes need to be acquired","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Lesotho","Lesotho","PAI-4753","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","The funding will be used to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA) as part of community systems strengthening. This will include development of key users manuals, procurement of key infrastructure, and training of stakeholders to enable full operation of LOMSHA.",53318,null,"Active","a6Q1R000000AJE7",0,0,0,0,53318,0,null,null,"The funding will be used to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA) as part of community systems strengthening. This will include development of key users manuals, procurement of key infrastructure, and training of stakeholders to enable full operation of LOMSHA.","Medium","This is to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA).","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4752","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","The funding will be used to support coordination of activities in the prisons and factories to address the high risk of TB and HIV infection in the target population. The activities will be funded through the re-investment of the efficiencies identified during the grant making.",20000,null,"Inactive","a6Q1R000000AJE6",20000,0,0,0,0,1,null,null,"The funding will be used to support coordination of activities in the prisons and factories to address the high risk of TB and HIV infection in the target population. The activities will be funded through the re-investment of the efficiencies identified during the grant making.","High","To support coordination of activities in the prisons and factories. This is prioritized given the risk of TB and HIV infection in the target population.","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4751","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00573","Gender-based violence prevention and treatment programs for adolescents and youth","The funding will be used for multimedia platforms, including social media, to enhance service uptake by adolescents and young people. The activities will include establishing a hotline for survivors of gender based violence and design of webpages and databases. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.",16691,null,"Inactive","a6Q1R000000AJE5",16691,0,0,0,0,1,null,null,"The funding will be used for multimedia platforms, including social media, to enhance service uptake by adolescents and young people. The activities will include establishing a hotline for survivors of gender based violence and design of webpages and databases. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.","High","This will enhance service uptake by adolescents and young people and also establish a hotline for survivors of gender based violence.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4750","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","Funding will support coordination and supervision of interventions across the programs for adolescents and young people in and out of schools in the eight districts. This will help programs to synergize and ensure coordinated services delivery and sharing of lessons learnt. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.",66323,null,"Inactive","a6Q1R000000AJE4",66323,0,0,0,0,1,null,null,"Funding will support coordination and supervision of interventions across the programs for adolescents and young people in and out of schools in the eight districts. This will help programs to synergize and ensure coordinated services delivery and sharing of lessons learnt. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.","High","This will support coordination and supervision of interventions across the programs for adolescents and young people in and out of schools.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4749","MCI-00000","Prevention programs for general population","MCI-00079","Gender-based violence prevention and treatment programs for general population","Funding will be used to support integration of human rights and prevention of sexual and gender-based violence among adolescents as part of HIV and TB prevention intervention to address structural issues and expand geographical coverage to eight districts. The activity will be funded through the reinvestment of the efficiencies identified during the grant making.",351805,null,"Inactive","a6Q1R000000AJE3",351805,0,0,0,0,1,null,null,"Funding will be used to support integration of human rights and prevention of sexual and gender-based violence among adolescents as part of HIV and TB prevention intervention to address structural issues and expand geographical coverage to eight districts. The activity will be funded through the reinvestment of the efficiencies identified during the grant making.","High","Human rights violations and sexual and gender based violence are key interventions required to address structural issues in the HIV epidemic.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4748","MCI-00000","Prevention programs for general population","MCI-00072","Behavioral interventions as part of programs for general population","The funding will support sensitization and prevention of sexual and gender based violence to reduce HIV transmission among vulnerable populations. It will include production and dissemination of education materials and simplified laws for training of law enforcement agencies. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.",196037,null,"Inactive","a6Q1R000000AJE2",196037,0,0,0,0,1,null,null,"The funding will support sensitization and prevention of sexual and gender based violence to reduce HIV transmission among vulnerable populations. It will include production and dissemination of education materials and simplified laws for training of law enforcement agencies. The activities will be funded through the reinvestment of the efficiencies identified during the grant making.","High","Sensitization and prevention of sexual and gender based violence will help reduce the HIV transmission risk among vulnerable populations.","NA Original Intervention: Behavioral interventions as part of programs for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5865","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","High level priority: it is in line with FR of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.",45694,null,"Active","a6Q1R000000AJW3",0,0,0,0,45694,0,null,null,"High level priority: it is in line with FR of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.","High","High level priority: it is in line with FR of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5864","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: To support coordination mechanisms at the community level.",457414,null,"Active","a6Q1R000000AJW2",413915,0,0,0,43499,0,null,null,"High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: To support coordination mechanisms at the community level.","High","High level priority: it is in line with FR one of the main objective ? to intensify TB case notification ? and module 1 TB care and prevention: To support coordination mechanisms at the community level.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5863","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","For enhanced access to specific services (including screening for malignancies, management of Opportunistic Infections, STIs and other important diagnostic and medical services), clients will be sensitized to enroll in Community Health Insurance Scheme. The PAAR funds will help cover demand creation and advocacy activities. The availability of this scheme will improve timely access to affordable quality medical services and contribute to the sustainability of GF investments for HIV, TB and Malaria.",300000,null,"Active","a6Q1R000000AJW1",0,0,0,0,300000,0,null,null,"For enhanced access to specific services (including screening for malignancies, management of Opportunistic Infections, STIs and other important diagnostic and medical services), clients will be sensitized to enroll in Community Health Insurance Scheme. The PAAR funds will help cover demand creation and advocacy activities. The availability of this scheme will improve timely access to affordable quality medical services and contribute to the sustainability of GF investments for HIV, TB and Malaria.","Low","For enhanced access to specific services (including screening for malignancies, management of Opportunistic Infections, STIs and other important diagnostic and medical services), clients will be sensitized to enrol in Community Health Insurance Scheme. The PAAR funds will help cover demand creation and advocacy activities. The availability of this scheme will improve timely access to affordable quality medical services and contribute to the sustainability of the Global Fund investments for HIV, TB and Malaria.","NA Original Intervention: Delivering sustainable HIV care services through Community Health Insurance Scheme","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5862","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Tanzania is planning to improve referrals and linkages from HTC to care and treatment using the Unique Identifier Code biometric technology. This will reduce duplications, and reduce loss to follow up. It will also help to track and return clients back into care. The planned unique identification biometric system (in the RSSH grant) and the related funds are to pilot a small scale in one region-Dar es Salaam. The funding requested in the PAAR for this activity will be used to scale up use of unique identifier (biometric) in all CTCs in the country.",1500000,null,"Active","a6Q1R000000AJW0",0,0,0,0,1500000,0,null,null,"Tanzania is planning to improve referrals and linkages from HTC to care and treatment using the Unique Identifier Code biometric technology. This will reduce duplications, and reduce loss to follow up. It will also help to track and return clients back into care. The planned unique identification biometric system (in the RSSH grant) and the related funds are to pilot a small scale in one region-Dar es Salaam. The funding requested in the PAAR for this activity will be used to scale up use of unique identifier (biometric) in all CTCs in the country.","Low","Tanzania is planning to improve referrals and linkages from HTC to care and treatment using the Unique Identifier Code biometric technology. This will reduce duplications, and reduce loss to follow up. It will also help to track and return clients back into care. The planned unique identification biometric system (in the RSSH grant) and the related funds are to pilot a small scale in one region-Dar es Salaam. The funding requested in the PAAR for this activity will be used to scale up use of unique identifier (biometric) in all Community Treatment Centers (CTCs) in the country.","NA Original Intervention: Scale up of biometric identification system at CTC for clients already enrolled into care","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5861","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Tanzania is planning to conduct screening of HBV and HCV to PLHIV and put them on appropriate regimen. Data from National Blood Transfusion services, has shown an increasing prevalence of HBV and HCV among blood donors. This activity will also be used to estimate the magnitude of the HBV/HIV co-infections among clients attending CTC.",800000,null,"Active","a6Q1R000000AJVz",0,0,0,0,800000,0,null,null,"Tanzania is planning to conduct screening of HBV and HCV to PLHIV and put them on appropriate regimen. Data from National Blood Transfusion services, has shown an increasing prevalence of HBV and HCV among blood donors. This activity will also be used to estimate the magnitude of the HBV/HIV co-infections among clients attending CTC.","Low","Tanzania is planning to conduct screening of HBV and HCV to People Living with HIV and put them on appropriate regimen. Data from National Blood Transfusion services, has shown an increasing prevalence of HBV and HIV Testing and Counselling (HCV) among blood donors. This activity will also be used to estimate the magnitude of the HBV/HIV coinfections among clients attending Community Treatment Centers (CTC).","NA Original Intervention: The program planned to screen for HBV and HCV coinfection to client attending CTC","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Thailand","Thailand","PAI-5775","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","RTF BL 45:Support monitor for Public-Private-Mix collaboration in TB control activitiesTo ensure that the TB control is effectively implemented in the community.",47495,null,"Active","a6Q1R000000AJUb",0,0,0,0,47495,0,null,null,"RTF BL 45:Support monitor for Public-Private-Mix collaboration in TB control activitiesTo ensure that the TB control is effectively implemented in the community.","Medium","This intervention will support monitoring of public-private collaborations",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5774","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","DDC BL 289:Support of 3 small mobile x-ray vans, including read and digital CXR scanner set to render regular mobile services for prisoners and prisoner guards in 20 high TB burden prisons (2 prisons for one van) with prompt referral of symptomatic patients or patients with abnormal CXR to facilities with GeneXpert for TB confirmation and TB treatment. This demonstrationproject is hoped to generate evidence of TB disease burden in prisons and feasibility for prevention and care in order to support policy decision.Small mobile x-ray van, including read and digital CXR scanner set to provide services for the prisons that have the narrow entry/entrance.",723486,null,"Inactive","a6Q1R000000AJUa",0,723486,0,0,0,1,null,null,"DDC BL 289:Support of 3 small mobile x-ray vans, including read and digital CXR scanner set to render regular mobile services for prisoners and prisoner guards in 20 high TB burden prisons (2 prisons for one van) with prompt referral of symptomatic patients or patients with abnormal CXR to facilities with GeneXpert for TB confirmation and TB treatment. This demonstrationproject is hoped to generate evidence of TB disease burden in prisons and feasibility for prevention and care in order to support policy decision.Small mobile x-ray van, including read and digital CXR scanner set to provide services for the prisons that have the narrow entry/entrance.","Medium","This intervention will support increase TB case finding in 20 high TB burden prisons and will generate evidences of TB burden and prevention and care feasibility to support policy decisions","NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5773","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","RTF BL 43: $28,372.01Modeling for community-based sputum transportation ?ConsultantRTF BL 44: $43,406.34Modeling for community-based sputum transportation -Consultation workshop with LAO, CSO, community, and health facilitiesRationale: To engage the local stakeholder to initiate the community-based sputum transportation.",71778,null,"Active","a6Q1R000000AJUZ",0,0,0,0,71778,0,null,null,"RTF BL 43: $28,372.01Modeling for community-based sputum transportation ?ConsultantRTF BL 44: $43,406.34Modeling for community-based sputum transportation -Consultation workshop with LAO, CSO, community, and health facilitiesRationale: To engage the local stakeholder to initiate the community-based sputum transportation.","High","This intervention will contribute to improved treatment outcomes due to patient centred care by engaging CSO in sputum transport systems",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5772","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","DDC BL 273:Support renovation of isolation TB room and DOT corner for prisoners including UV light in order to prevent TB/MDR transmission in prison in 70 prisons.The prisons are the closed setting areas and crowded, provision of molecular test by GeneXpert will detect more TB patients. Good management for infectious TB control will prevent and cut off transmission in prisons.Emphasizing on infection control and environment management control that is important both for prisoners and prison guards.",397208,null,"Inactive","a6Q1R000000AJUY",0,397208,0,0,0,1,null,null,"DDC BL 273:Support renovation of isolation TB room and DOT corner for prisoners including UV light in order to prevent TB/MDR transmission in prison in 70 prisons.The prisons are the closed setting areas and crowded, provision of molecular test by GeneXpert will detect more TB patients. Good management for infectious TB control will prevent and cut off transmission in prisons.Emphasizing on infection control and environment management control that is important both for prisoners and prison guards.","High","This infection control intervention will contribute to decrease the transmission of TB in prisons","NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5771","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","DDC BL 288: This will support the implementation in 62 prisons in 41 provinces, continuing  from the funding request in year 2-3, by using CXR and Xpert MTB/RIF in order to early detect and cut of TB transmission and to increase case finding to cover over the country.This will increase number of prisoners reached, i.e. 157,351 persons in addition, increase coverage to 85%The prison is partially of high risk group that has high prevalence that more TB cases detected and treated.CXR is the way to make it faster than as usual 5-10%, verbal screening 6-10% to be positive, X-Ray 12-20% will be expected to see abnormal CXR 22,000 cases, then testing by GeneXpert will find2,200 TB patients in prisons.",470298,null,"Inactive","a6Q1R000000AJUX",470298,0,0,0,0,1,null,null,"DDC BL 288: This will support the implementation in 62 prisons in 41 provinces, continuing  from the funding request in year 2-3, by using CXR and Xpert MTB/RIF in order to early detect and cut of TB transmission and to increase case finding to cover over the country.This will increase number of prisoners reached, i.e. 157,351 persons in addition, increase coverage to 85%The prison is partially of high risk group that has high prevalence that more TB cases detected and treated.CXR is the way to make it faster than as usual 5-10%, verbal screening 6-10% to be positive, X-Ray 12-20% will be expected to see abnormal CXR 22,000 cases, then testing by GeneXpert will find2,200 TB patients in prisons.","High","This intervention will support activities to increase TB case finding in prisoners using CXR and GeneXpert as per the new national TB diagnostic algorithm for high risk populations. The faster diagnostic will also contribute to decrease TB transmission. Prisoners are the population with the highest TB incidence in the country, estimated at 13 times higher than the national incidence","NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5770","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","RTF BL 42:Support TB patient group activitiesTo establish a group to share past experiences, communicate and inform on counter effects of medicines and on the different forms of care and support present in the community for the benefit and of both KPs and care takers.",16342,null,"Active","a6Q1R000000AJUW",0,0,0,0,16342,0,null,null,"RTF BL 42:Support TB patient group activitiesTo establish a group to share past experiences, communicate and inform on counter effects of medicines and on the different forms of care and support present in the community for the benefit and of both KPs and care takers.","High","This intervention will support TB patient support groups",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT South Africa","South Africa","PAI-6012","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","Funding will support expansion of the TB screening and testing services in facilities and community hot spots by supporting fee-for-service agreements for 264,000 digital chest x-rays and 66,000 Xpert tests. This will catalyze the impact of both the allocation (in facilities) and the matching funds request (in community hot spots), to find an estimated additional 5,280 missing TB patients.",5834695,null,"Active","a6Q1R000000AJYQ",0,0,0,0,5834695,0,null,null,"Funding will support expansion of the TB screening and testing services in facilities and community hot spots by supporting fee-for-service agreements for 264,000 digital chest x-rays and 66,000 Xpert tests. This will catalyze the impact of both the allocation (in facilities) and the matching funds request (in community hot spots), to find an estimated additional 5,280 missing TB patients.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6011","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00573","Gender-based violence prevention and treatment programs for adolescents and youth","Funding will support the 13 existing Thuthuzela Care Centres (TCCs) that are supported by the current Global Fund grant. The TCCs are a one-stop GBV model. Through this intervention, clients of TCCs will be tested for HIV, and either offered PEP (if eligible) or linked to treatment and care (as appropriate). The requested above allocation investment will reach 40,204 AGYW who are survivors of gender-based violence (including 20,017 survivors reached with HTS). It is estimated that 20?25% of new HIV infections in young women in South Africa are attributable to GBV.  It has also been (conservatively) estimated that gender-based violence costs South Africa between R28.4 billion and R42.4 billion per year ? or between 0.9% and 1.3% of GDP annually.",9566346,null,"Inactive","a6Q1R000000AJYP",9566346,0,0,0,0,1,null,null,"Funding will support the 13 existing Thuthuzela Care Centres (TCCs) that are supported by the current Global Fund grant. The TCCs are a one-stop GBV model. Through this intervention, clients of TCCs will be tested for HIV, and either offered PEP (if eligible) or linked to treatment and care (as appropriate). The requested above allocation investment will reach 40,204 AGYW who are survivors of gender-based violence (including 20,017 survivors reached with HTS). It is estimated that 20?25% of new HIV infections in young women in South Africa are attributable to GBV.  It has also been (conservatively) estimated that gender-based violence costs South Africa between R28.4 billion and R42.4 billion per year ? or between 0.9% and 1.3% of GDP annually.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6010","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","New HIV infections do occur among adolescents and young people age 10-14 (though risk is substantially increased among those age 15-24). While the allocation focuses on those at highest risk (AGYW age 15-24), the PAAR will support implementation of the school health program in primary schools, to reach 60,612 among the 10-14-year-old age group.",42731460,null,"Active","a6Q1R000000AJYO",0,0,0,0,42731460,0,null,null,"New HIV infections do occur among adolescents and young people age 10-14 (though risk is substantially increased among those age 15-24). While the allocation focuses on those at highest risk (AGYW age 15-24), the PAAR will support implementation of the school health program in primary schools, to reach 60,612 among the 10-14-year-old age group.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6009","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","PAAR funding will support development of information systems/data analytics for the AGYW program, in order to:\n1) enable grant-wide analytics by allowing data from all PRs to be merged and analyzed together;\n2) enable PRs to perform rich analysis on their data, including being able to disaggregate data easily, quickly generate new indicators, easily collect new data elements when needed, and take a case-based approach to tracking beneficiaries so that an individual?s history in relationship to interventions can be easily viewed;\n3) reduce potential for data entry errors by leveraging user-friendly digital data entry forms, having multiple pathways to capture data, and multiple identification methods for uniquely identifying beneficiaries in the program.",6000000,null,"Active","a6Q1R000000AJYN",2640000,0,0,0,3360000,0,null,null,"PAAR funding will support development of information systems/data analytics for the AGYW program, in order to:\n1) enable grant-wide analytics by allowing data from all PRs to be merged and analyzed together;\n2) enable PRs to perform rich analysis on their data, including being able to disaggregate data easily, quickly generate new indicators, easily collect new data elements when needed, and take a case-based approach to tracking beneficiaries so that an individual?s history in relationship to interventions can be easily viewed;\n3) reduce potential for data entry errors by leveraging user-friendly digital data entry forms, having multiple pathways to capture data, and multiple identification methods for uniquely identifying beneficiaries in the program.","High",null,"NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6008","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00574","Pre-exposure prophylaxis (PrEP) for adolescents and youth","According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for AGYW is 18%. For the Global Fund program, this equates to 25,919 AGYW age 15-24 years. 7,273 AGYW will be given PrEP through the allocation funding. PAAR funding will provide an additional 18,646 AGYW with PrEP. This will increase PrEP coverage in the target districts from 5% to 18%, and decrease the national programmatic gap for AGYW PrEP by 16%.",4719523,null,"Inactive","a6Q1R000000AJYM",4719523,0,0,0,0,1,null,null,"According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for AGYW is 18%. For the Global Fund program, this equates to 25,919 AGYW age 15-24 years. 7,273 AGYW will be given PrEP through the allocation funding. PAAR funding will provide an additional 18,646 AGYW with PrEP. This will increase PrEP coverage in the target districts from 5% to 18%, and decrease the national programmatic gap for AGYW PrEP by 16%.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6007","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00589","Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","This PAAR request is for technical and operational support to the Department of Women to complete the development of the National Strategic Plan for Gender Based Violence. A process to develop this plan has been started, but the human rights baseline assessment notes that a stalemate has been reached between civil society and the relevant governmental department. As such, implementing this activity is dependent on successful advocacy within the program to enable the process of developing the plan to continue.",400000,null,"Active","a6Q1R000000AJYL",0,0,0,0,400000,0,null,null,"This PAAR request is for technical and operational support to the Department of Women to complete the development of the National Strategic Plan for Gender Based Violence. A process to develop this plan has been started, but the human rights baseline assessment notes that a stalemate has been reached between civil society and the relevant governmental department. As such, implementing this activity is dependent on successful advocacy within the program to enable the process of developing the plan to continue.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6006","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","This PAAR request is for additional Hepatitis C treatment scale up among PWID, building on the lessons learned from the small pilot project planned in the allocation amount. PAAR investment will reach an additional 388 PWID with Hepatitis C treatment, through procurement of drugs and some diagnostics. Shared program costs for the delivery of the treatment are already covered through Hep C treatment pilot in the allocation.",5612651,null,"Active","a6Q1R000000AJYK",0,0,0,0,5612651,0,null,null,"This PAAR request is for additional Hepatitis C treatment scale up among PWID, building on the lessons learned from the small pilot project planned in the allocation amount. PAAR investment will reach an additional 388 PWID with Hepatitis C treatment, through procurement of drugs and some diagnostics. Shared program costs for the delivery of the treatment are already covered through Hep C treatment pilot in the allocation.","Low",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Prevention and management of co-infections and comorbidities for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT Eswatini","Eswatini","PAI-5704","MCI-00000","Prevention programs for general population","MCI-00072","Behavioral interventions as part of programs for general population","evelop a directory of sector HIV, SRH, TB and social services interventions available in the different target population areas for different target population groups: This shall be an overall directory of sectors interventionsto guide implementers and target populations on what is available in different sectors for different targetpopulations that they can refer clients to. This will assist service providers in platforms such as the U-report to know what is available and guide target populationstowards those services.",35750,null,"Active","a6Q1R000000AJTS",0,0,0,0,35750,0,null,null,"evelop a directory of sector HIV, SRH, TB and social services interventions available in the different target population areas for different target population groups: This shall be an overall directory of sectors interventionsto guide implementers and target populations on what is available in different sectors for different targetpopulations that they can refer clients to. This will assist service providers in platforms such as the U-report to know what is available and guide target populationstowards those services.","High","A directory of service providers will enable the country to assess key gaps and better inform the programming in response.","NA Original Intervention: Behavioral interventions as part of programs for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5703","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Funding is requested to conduct an evaluation of the mentor mother program ($20,000). Next, funding is requested for the development and distribution of registers and IEC materials, biannual review meetings for sharing reports/data and experiences at regional level, recruitment of 4 regional supervisors for the PMTCT/mentor mothers program.",339632,null,"Active","a6Q1R000000AJTR",0,0,0,0,339632,0,null,null,"Funding is requested to conduct an evaluation of the mentor mother program ($20,000). Next, funding is requested for the development and distribution of registers and IEC materials, biannual review meetings for sharing reports/data and experiences at regional level, recruitment of 4 regional supervisors for the PMTCT/mentor mothers program.","High","This evaluation is needed in order to be able to scale up the above prioritized innovative intervention","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5702","MCI-00022","RSSH: Health management information systems and M&E","MCI-00203","Administrative and finance data sources","Update and maintain MIS information databank on all social welfare grants and in the future also social work case management. It will allow DPMO to have real-time statistics on social welfare grants, for better evidence-based management and better advocacy for sustained social budgeting. It will also support the matching funds activity to support 1000 AGYW (by year 3) with educational subsidies and other ?cash plus care? models, as prioritized in Swaziland?s investment case.",2800000,null,"Active","a6Q1R000000AJTQ",0,0,0,0,2800000,0,null,null,"Update and maintain MIS information databank on all social welfare grants and in the future also social work case management. It will allow DPMO to have real-time statistics on social welfare grants, for better evidence-based management and better advocacy for sustained social budgeting. It will also support the matching funds activity to support 1000 AGYW (by year 3) with educational subsidies and other ?cash plus care? models, as prioritized in Swaziland?s investment case.","Low","This program is linked with the OVC cash transfer program which has been found to be of low priority given the many other competing priorities in the funding request. This social protection programme is therefore of lower priority within the HIV/TB programme and can only be funded if other higher priority areas have been covered and efficiencies are found within the grant or through alternate funding sources.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Administrative and financial data sources","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5701","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Support for 3 TB program staff and 3 HIV program staff to attend relevant international conferences.This will enable the program to share the lessons learned from Swaziland?s response, as well as learn from other countries an contexts to improve innovation.",26664,null,"Active","a6Q1R000000AJTP",0,0,0,0,26664,0,null,null,"Support for 3 TB program staff and 3 HIV program staff to attend relevant international conferences.This will enable the program to share the lessons learned from Swaziland?s response, as well as learn from other countries an contexts to improve innovation.","Low","This intervention proposes sharing of information on the HIV and TB programs at relevant international conferences. Information exchange is important but the resource constrained setting of the Swaziland program means that the intervention is deemed of low priority.","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5700","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Recruit and retain four regional sexual and reproductive health coordinators/mentors to enhance regional-level coordination of AGYW investments across Global Fund, PEPFAR, UN family, government and others. It is expected that this investment will help address some of the HRH-related implementation bottlenecks, especially for programmatic interventions requiring an integrated approach.",296471,null,"Active","a6Q1R000000AJTO",0,0,0,0,296471,0,null,null,"Recruit and retain four regional sexual and reproductive health coordinators/mentors to enhance regional-level coordination of AGYW investments across Global Fund, PEPFAR, UN family, government and others. It is expected that this investment will help address some of the HRH-related implementation bottlenecks, especially for programmatic interventions requiring an integrated approach.","High","This intervention will allow for Innovative use of sexual and reproductive health (SRH) to improve ART coverage and testing.","NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5699","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Additional support for targeting the ACF?s approach towards key populations, including mapping and screening of Key affected populations by ACFs, including comprehensive training of ACFs and training of peer educators and caregivers to support TB key populations (factories, prisoners, orphanages, day care centers).",166667,null,"Active","a6Q1R000000AJTN",0,0,0,0,166667,0,null,null,"Additional support for targeting the ACF?s approach towards key populations, including mapping and screening of Key affected populations by ACFs, including comprehensive training of ACFs and training of peer educators and caregivers to support TB key populations (factories, prisoners, orphanages, day care centers).","Low","While key populations are crucial to the response, this activity should be integrated into routine ACF activities and the populations be covered within the existing ACF program.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Somalia","Somalia","PAI-5599","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","ICCMis an important intervention for CU5 and will focus on the three priority preventable diseases for children ?pneumonia, diarrhea and malaria, as well as screening and referrals for malnutrition. This intervention is for three organizations, and will cover training, malaria supplies, supervision and incentives for 90 volunteers (30 in three areas). This intervention is for 3 years.",1341593,null,"Active","a6Q1R000000AJRl",0,0,0,0,1341593,0,null,null,"ICCMis an important intervention for CU5 and will focus on the three priority preventable diseases for children ?pneumonia, diarrhea and malaria, as well as screening and referrals for malnutrition. This intervention is for three organizations, and will cover training, malaria supplies, supervision and incentives for 90 volunteers (30 in three areas). This intervention is for 3 years.","Medium","The request is for iCCM targeting children under\n5 years and targeting 3 areas (90 volunteers).\nHowever, the request stated that part of the fund\nwill be for incentive but without linking that to\nissue 3 of the review and recommendation form\nfor Somalia Malaria (in April 2017).","NA Original Intervention: Integrated community case management (iCCM)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5598","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","There are three operational research planned, specifically for Puntland, to be better able to understand the malaria in Puntland and plan for pre-elimination, as well as outbreaks such as that in Bossaso. The research are: Malaria Vector Identification and geographical distribution of main source of breeding sites including vector behaviour study in Bossaso District; Risk mapping and cases distribution malaria cases density by villages and providing appropriate anti-malaria interventions for both vector control and case management as well as surveillance; and Relation of malaria in pregnancy and Obstetric problems (LPW, Apportions, Stillbirths, Anemia including maternity deaths) among pregnancy mother in Bossaso.",128652,null,"Active","a6Q1R000000AJRk",0,0,0,0,128652,0,null,null,"There are three operational research planned, specifically for Puntland, to be better able to understand the malaria in Puntland and plan for pre-elimination, as well as outbreaks such as that in Bossaso. The research are: Malaria Vector Identification and geographical distribution of main source of breeding sites including vector behaviour study in Bossaso District; Risk mapping and cases distribution malaria cases density by villages and providing appropriate anti-malaria interventions for both vector control and case management as well as surveillance; and Relation of malaria in pregnancy and Obstetric problems (LPW, Apportions, Stillbirths, Anemia including maternity deaths) among pregnancy mother in Bossaso.","High","Operational research would contribute to a\nbetter understanding on low utilization of\neffective interventions such LLINs, rapid\ndiagnostic tests (RDTs) and artemisin-based\ncombination therapy (ACTs) by women and\nchildren under 5 years old","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5597","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Supervisory visit by NMCPs. Supervisory visits will include visits to private sector facilities, visits to IEC/BCC and to supervise LLIN distribution, amongst others.This is one visit per MOHper quarter (total 3 visits per quarter as there are three MOHs). Total costs = 850 USD per supervision x 3 MOH x 12 quarters = 30,600 USD. The NMCPs will use their own vehicles and only require fuel costs.",30600,null,"Active","a6Q1R000000AJRj",0,0,0,0,30600,0,null,null,"Supervisory visit by NMCPs. Supervisory visits will include visits to private sector facilities, visits to IEC/BCC and to supervise LLIN distribution, amongst others.This is one visit per MOHper quarter (total 3 visits per quarter as there are three MOHs). Total costs = 850 USD per supervision x 3 MOH x 12 quarters = 30,600 USD. The NMCPs will use their own vehicles and only require fuel costs.","High","To improve quality of diagnosis and treatment\nthere is a need for frequent supervision and onsite\ntraining (low-dose high frequency training).\nThis also will be useful for avoiding stock-out of\ndrugs and diagnostics","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5596","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN distribution and procurement/supply costs for road inaccessible areas. These sites are not accessible by road but there are partners available to undertake distribution if the nets are made available (via air charters).These areas are three districts in Bay, three districts in Bakool, four districts in Middle Juba, and two districts in Lower Juba.",4330385,null,"Active","a6Q1R000000AJRi",0,2165193,0,0,2165192,0,null,null,"LLIN distribution and procurement/supply costs for road inaccessible areas. These sites are not accessible by road but there are partners available to undertake distribution if the nets are made available (via air charters).These areas are three districts in Bay, three districts in Bakool, four districts in Middle Juba, and two districts in Lower Juba.","High","The requested fund is for procurement,\ntransportation and distribution of LLINs in 5\ndistricts which are inaccessible by road.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5595","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN for distribution to internally displaced persons (IDPs). The average IDPs in Somalia for May and June 2017 was 34,000 (IOM data). Assume that there will be a similar number coming per month for 24 months. The total number required is 453,333 LLINs but 304,580 LLINs are covered. Thus, the PAAR request is for 148,753 nets.",608900,null,"Active","a6Q1R000000AJRh",0,387770,0,0,221130,0,null,null,"LLIN for distribution to internally displaced persons (IDPs). The average IDPs in Somalia for May and June 2017 was 34,000 (IOM data). Assume that there will be a similar number coming per month for 24 months. The total number required is 453,333 LLINs but 304,580 LLINs are covered. Thus, the PAAR request is for 148,753 nets.","High","The fund is for procurement and distribution of LLINs for one of the vulnerable groups: IDPs (148,753 individuals).","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5594","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","World Malaria Day commemoration by implementing partners. Each SR in South and Central Somalia will receive funding for one event. There are five SRs in South Central Somalia.",13500,null,"Active","a6Q1R000000AJRg",0,0,0,0,13500,0,null,null,"World Malaria Day commemoration by implementing partners. Each SR in South and Central Somalia will receive funding for one event. There are five SRs in South Central Somalia.","Low","The proposed activity ?World Malaria Day\ncommemoration by implementing partners? is\nneeded and considered as an important event\nfor advocacy and raising the awareness of\npopulation but still it is an on-off activity. The\nTRP only approved funding for one event NOT\n3 events.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Romania","Romania","PAI-5462","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Capacity building for implementers of the National TB Strategy (Marius Nasta Institute staff, county coordinators, central and local authority representatives) in programmatic, financial management, and procurement, participation at international capacity building events (trainings, conferences), regional and national management meetings for TB stakeholders for improving the capacity of strategic planning based on collected data.",448883.4,null,"Active","a6Q1R000000AJPY",0,0,0,0,448883.4,0,null,null,"Capacity building for implementers of the National TB Strategy (Marius Nasta Institute staff, county coordinators, central and local authority representatives) in programmatic, financial management, and procurement, participation at international capacity building events (trainings, conferences), regional and national management meetings for TB stakeholders for improving the capacity of strategic planning based on collected data.","Medium",null,"NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Romania","Romania","PAI-5461","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Organisation of trainings, workshops and conferences by National TB Program (Marius Nasta Institute) to improve TB healthcare providers' communication skills with TB patients and sensitize them about patients rights, establish a feedback loop between patients and care providers, and contribute to internal evaluation and re-design of programmatic approaches for the National TB Strategy.",336662.55,null,"Active","a6Q1R000000AJPX",0,0,0,0,336662.55,0,null,null,"Organisation of trainings, workshops and conferences by National TB Program (Marius Nasta Institute) to improve TB healthcare providers' communication skills with TB patients and sensitize them about patients rights, establish a feedback loop between patients and care providers, and contribute to internal evaluation and re-design of programmatic approaches for the National TB Strategy.","Medium",null,"NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Romania","Romania","PAI-5460","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Optima HIV analysis to inform Government's strategic decision making in resource allocation for HIV/AIDS, thus finding a sustainable way of financing HIV prevention among key affected populations.",65443.83,null,"Active","a6Q1R000000AJPW",0,0,0,0,65443.83,0,null,null,"Optima HIV analysis to inform Government's strategic decision making in resource allocation for HIV/AIDS, thus finding a sustainable way of financing HIV prevention among key affected populations.","High",null,"NA Original Module: RSSH - National health strategies","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Romania","Romania","PAI-5459","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","This investment is intended to support stakeholder engagement in implementing ambulatory care reform developed through the grant.",361329.82,null,"Active","a6Q1R000000AJPV",0,0,0,0,361329.82,0,null,null,"This investment is intended to support stakeholder engagement in implementing ambulatory care reform developed through the grant.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Romania","Romania","PAI-5458","MCI-00008","TB care and prevention","MCI-00140","Case detection and diagnosis: MDR-TB","Procurement of 10 GeneXpert + 1 GeneXpert® Infinity-48s + 12,000 Genexpert Ultra tests to enhance rapid testing (currently, only 40% of patients receive a GeneXpert test). This investment will complement the EU/Norway grant which foresees the procurement of 16 additional GeneXpert equipments.",802693.3,null,"Active","a6Q1R000000AJPU",0,0,0,0,802693.3,0,null,null,"Procurement of 10 GeneXpert + 1 GeneXpert® Infinity-48s + 12,000 Genexpert Ultra tests to enhance rapid testing (currently, only 40% of patients receive a GeneXpert test). This investment will complement the EU/Norway grant which foresees the procurement of 16 additional GeneXpert equipments.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Paraguay","Paraguay","PAI-5457","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Acquisition of portable rapid molecular diagnosis devices.\nPurchase of two portable rapid molecular diagnosis devices and consumables is deemed necessary, mainly for visits to several remote indigenous communities or settlement, such as the regions of Pte. Hayes and Boquerón.\nThis will allow active detection of cases in key geographically hard-to-reach communities, bringing diagnosis to them and immediate start of treatment, whether simple or RR.\nThis has no budget yet, but it is expected that soon, in the second quarter of 2018, these will launched for sale to the public.",35149.949999999997,null,"Active","a6Q1R000000AJPT",0,0,0,0,35149.949999999997,0,null,null,"Acquisition of portable rapid molecular diagnosis devices.\nPurchase of two portable rapid molecular diagnosis devices and consumables is deemed necessary, mainly for visits to several remote indigenous communities or settlement, such as the regions of Pte. Hayes and Boquerón.\nThis will allow active detection of cases in key geographically hard-to-reach communities, bringing diagnosis to them and immediate start of treatment, whether simple or RR.\nThis has no budget yet, but it is expected that soon, in the second quarter of 2018, these will launched for sale to the public.","Low",null,"NA Original Module: SRSS: Provision of integrated services and quality improvement. Original Intervention: Laboratory systems for disease prevention, monitoring, treatment and surveillance","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Paraguay","Paraguay","PAI-5456","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Hiring staff for PNCT statistics department.\nHiring is needed to cover a vacancy in the statistics department as currently there are two professionals actively working (reduced from 3 to 2 due to resignation). These staff will monitor data input in the expert system until hired by the MSPBS.",28500,null,"Active","a6Q1R000000AJPS",0,0,0,0,28500,0,null,null,"Hiring staff for PNCT statistics department.\nHiring is needed to cover a vacancy in the statistics department as currently there are two professionals actively working (reduced from 3 to 2 due to resignation). These staff will monitor data input in the expert system until hired by the MSPBS.","Medium",null,"NA Original Module: SRSS: Program management. Original Intervention: National disease monitoring policies, planning, coordination and program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Pakistan","Pakistan","PAI-5365","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: LHWs are to be engaged in contact tracing, promote screening of the elderly and screening of children for TB. 30% of LHWs will be engaged mainly in rural districts by 2020.  37,500 cases (0.75 case per LHW/annually) will be detected through this engagement.\nRational:  Pakistan has 150,000 LHWs based in the community, paid for by Provincial programs & they play a major role in MNCH, including immunization. This workforce will be utilized for early case detection and treatment adherence.",2300000,null,"Active","a6Q1R000000AJNz",0,0,0,0,2300000,0,null,null,"Action: LHWs are to be engaged in contact tracing, promote screening of the elderly and screening of children for TB. 30% of LHWs will be engaged mainly in rural districts by 2020.  37,500 cases (0.75 case per LHW/annually) will be detected through this engagement.\nRational:  Pakistan has 150,000 LHWs based in the community, paid for by Provincial programs & they play a major role in MNCH, including immunization. This workforce will be utilized for early case detection and treatment adherence.","Medium","LHWs are to be engaged in contact tracing, promote screening of the elderly and screening of children for TB. 0.75 cases per LHW per year would be detected through this engagement. Considering other needs this intervention is considered as medium priority as it offers high value for money","NA Original Intervention: Engaging lady health workers (LHWs)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5364","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: To engage additional 2,500 GPs, 210 NGOs (from current 240 to 450), 50 private hospitals (from 70 to120) and 50 parastatal hospital (from 70 to 120) with enablers (training, incentives 400 PKR/ case.\nRational: Currently 3-5% of private health care providers are engaged with NTP. Engaging private practitioners (PPM-1 model) will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines. Case notification will increase by 30,000/year.",4300000,null,"Active","a6Q1R000000AJNy",0,2358315,0,0,1941685,0,null,null,"Action: To engage additional 2,500 GPs, 210 NGOs (from current 240 to 450), 50 private hospitals (from 70 to120) and 50 parastatal hospital (from 70 to 120) with enablers (training, incentives 400 PKR/ case.\nRational: Currently 3-5% of private health care providers are engaged with NTP. Engaging private practitioners (PPM-1 model) will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines. Case notification will increase by 30,000/year.","High","Private practitioners play a major role in health care in Pakistan. Engaging them will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines.","NA Original Intervention: Engagement with private practitioners","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5363","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Action: To introduce a comprehensive TB detection, care & prevention package in District Hafizabad (Punjab) and Mirpurkhas (Sindh). The package includes scaling up of PPM interventions, involving GPs in CHTB case detection & management, active case finding through organizing mobile screening chest camps using chest x-rays algorithm, implementing FAST (Finding TB cases Actively, Separating Safely, and Treating effectively) intervention at the District Headquarter Hospitals (DHQ) in 2 districts. \nRational: The selected districts have high yield of patients in the current NFM grant and the high influx of patients to these districts from nearby areas. The  proposed  interventions  will  help  to provide  a  rationale  to  scale  up  this  package  of activities in other districts to achieve END TB strategy goals to detect over 90% of cases. Additional 3,000 DS-TB cases and around 385 MDR-TB cases will be detected in three years.",1630000,null,"Active","a6Q1R000000AJNx",0,0,0,0,1630000,0,null,null,"Action: To introduce a comprehensive TB detection, care & prevention package in District Hafizabad (Punjab) and Mirpurkhas (Sindh). The package includes scaling up of PPM interventions, involving GPs in CHTB case detection & management, active case finding through organizing mobile screening chest camps using chest x-rays algorithm, implementing FAST (Finding TB cases Actively, Separating Safely, and Treating effectively) intervention at the District Headquarter Hospitals (DHQ) in 2 districts. \nRational: The selected districts have high yield of patients in the current NFM grant and the high influx of patients to these districts from nearby areas. The  proposed  interventions  will  help  to provide  a  rationale  to  scale  up  this  package  of activities in other districts to achieve END TB strategy goals to detect over 90% of cases. Additional 3,000 DS-TB cases and around 385 MDR-TB cases will be detected in three years.","High","This intervention is a comprehensive TB care package implementing the FAST intervention (Find cases Actively, Separate temporarily and Treat effectively) across 2 districts aimed at promoting early detection of cases in target areas. The TRP considers this a 6 high priority intervention","NA Original Module: Multidrug-resistant TB. Original Intervention: Zero TB Initiative in Hafizabad and Mirpurkhas districts","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5362","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Action: With this funding HIV testing of TB patients will increase up to 60% in 260 additional sites by 2020 as planned in the NSP (30% - 2018, 45% - 2019, 60% - 2020 tested, i.e., 130, 220, 300 total sites/annually).\nRational: The allocation-funding request includes scale up of HIV testing among TB patients from 1 percent to 10 percent. TB patients have 6% HIV higher rate than the general population. 3,303 HIV/TB cases will be detected.",730000,null,"Active","a6Q1R000000AJNw",0,0,0,0,730000,0,null,null,"Action: With this funding HIV testing of TB patients will increase up to 60% in 260 additional sites by 2020 as planned in the NSP (30% - 2018, 45% - 2019, 60% - 2020 tested, i.e., 130, 220, 300 total sites/annually).\nRational: The allocation-funding request includes scale up of HIV testing among TB patients from 1 percent to 10 percent. TB patients have 6% HIV higher rate than the general population. 3,303 HIV/TB cases will be detected.","High","The allocation funding request includes scale up of HIV testing among TB patients from 1 percent to 10 percent. Additional funding will allow further scale up of testing.","NA Original Intervention: Expand TB/HIV collaborative activities to 220 additional sites","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5361","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: STP facilitates improving synergy and coordinating the efforts between partners at national and provincial levels. Rationale: The intervention will help to secure additional funds for TB control activities in the country. \nThe inervention will sensitize communities/stakeholders in TB control, will facilitate policy change & resources mobilization at national/provincial levels towards sustainability of the program.",130000,null,"Active","a6Q1R000000AJNv",0,0,0,0,130000,0,null,null,"Action: STP facilitates improving synergy and coordinating the efforts between partners at national and provincial levels. Rationale: The intervention will help to secure additional funds for TB control activities in the country. \nThe inervention will sensitize communities/stakeholders in TB control, will facilitate policy change & resources mobilization at national/provincial levels towards sustainability of the program.","High","Efforts aimed at strengthening the national partnership for TB care through advocacy and coordinated efforts are expected to improve synergy between partners.","NA Original Intervention: Strengthening STOP TB Partnership (STP), Pakistan","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5360","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: PR Mercy Corps will develop a sputum transport mechanism in 6 districts of Punjab (Gujranwala, Hafizabad, Khanewal, Multan, Mandi Bahauddin, Vehari) & 6 districts of Sindh (Dadu, Ghotki, Khairpur, Mirpurkhas, Sanghar and Umerkot).\nRational: About 1/3 of TB cases in Pakistan are missing to be diagnozed/annually (with 4% of DR-TB cases). Notificaiton through mobile phones & timely samples transportation to the nearest GeneXpert sites will facilitate this. \nThe scheduling & monitoring of pick up/drop off are managed automatically, reducing costs & improving accuracy over manual approaches ensuring access of rural communities to quality TB diagnosis. \n6,525 all type TB cases will be notified and treated in 3 years. Early DR-TB case detection & treatment will improve.",600000,null,"Active","a6Q1R000000AJNu",0,0,0,0,600000,0,null,null,"Action: PR Mercy Corps will develop a sputum transport mechanism in 6 districts of Punjab (Gujranwala, Hafizabad, Khanewal, Multan, Mandi Bahauddin, Vehari) & 6 districts of Sindh (Dadu, Ghotki, Khairpur, Mirpurkhas, Sanghar and Umerkot).\nRational: About 1/3 of TB cases in Pakistan are missing to be diagnozed/annually (with 4% of DR-TB cases). Notificaiton through mobile phones & timely samples transportation to the nearest GeneXpert sites will facilitate this. \nThe scheduling & monitoring of pick up/drop off are managed automatically, reducing costs & improving accuracy over manual approaches ensuring access of rural communities to quality TB diagnosis. \n6,525 all type TB cases will be notified and treated in 3 years. Early DR-TB case detection & treatment will improve.","High","Unified approach and joint monitoring between private and public sector is a key step to ensure universal access to rapid diagnosis of TB and DR-TB.","NA Original Intervention: Develop linkages between public and private sectors & the GeneXpert sites for GeneXpert testing in twelve districts in Punjab and Sindh Provinces","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Nepal","Nepal","PAI-5312","MCI-00012","Case management","MCI-00162","Ensuring drug and other health product quality","Procure Minilab® test kits and supplies to allow routine point of sale testing of antimalarials by DDA (targeting PS).",6431,null,"Active","a6Q1R000000AJN8",0,0,0,0,6431,0,null,null,"Procure Minilab® test kits and supplies to allow routine point of sale testing of antimalarials by DDA (targeting PS).","Medium","Minilab® test kits are useful for evaluating the quality of anti -malarial drugs used in the PS and empower national health authorities to improve regulatory requirements and consolidate regulatory functions, as recommend by WHO",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5311","MCI-00012","Case management","MCI-00154","Facility-based treatment","Kits for community-based healthcare providers to improve the quality of service provision.",32286,null,"Active","a6Q1R000000AJN7",0,0,0,0,32286,0,null,null,"Kits for community-based healthcare providers to improve the quality of service provision.","Medium","Commodities (antimalarial medication and diagnostics) are needed for community - based healthcare providers to improve the quality of outreach service provision.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5310","MCI-00012","Case management","MCI-00161","Private sector case management","HR cost at SR for engaging the private sector provider; Orientation cost for SR for engaging the private sector provider; Field visit for engaging the private sector provider; and, Operational costs for the SR.",557208,null,"Active","a6Q1R000000AJN6",0,0,0,0,557208,0,null,null,"HR cost at SR for engaging the private sector provider; Orientation cost for SR for engaging the private sector provider; Field visit for engaging the private sector provider; and, Operational costs for the SR.","High","Good case management is improved by engaging with PS providers resulting in improved adherence to national guidelines for anti-malarial prescription and strong linkages/routine interaction between the national malaria programme, public providers and private provider. These are part of comprehensive PS strategies to get data on PS services (access and coverage) and come up with plans for service delivery and data reporting.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5309","MCI-00071","Other module","MCI-00071","Other module","Migration is recognised as source of infection. However, it is likely that changes in health seeking behaviour and migration patterns over the last decade have implications for HIV transmission and access to HIV services, which assessment will explore. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.",50000,null,"Active","a6Q1R000000AJN5",0,0,0,0,50000,0,null,null,"Migration is recognised as source of infection. However, it is likely that changes in health seeking behaviour and migration patterns over the last decade have implications for HIV transmission and access to HIV services, which assessment will explore. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.","Low","Originally proposed as a single module with two interventions, the TRP recommends to split the interventions; this one is low priority because a cascade assessment has recently been completed and assessment of cascade information should be routine program monitoring.","NA Original Module: Study and assessment. Original Intervention: Cascade assessment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5308","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","Harm reduction interventions, including the OST scale up, have often been challenged by issues related to quality of service, coordination, institutionalisation and monitoring. Technical assistance is sought to expedite solutions to the challenges. This will build on the GF investment in OST by informing efforts to increase uptake, retention and quality.",2000000,null,"Active","a6Q1R000000AJN4",0,0,0,0,2000000,0,null,null,"Harm reduction interventions, including the OST scale up, have often been challenged by issues related to quality of service, coordination, institutionalisation and monitoring. Technical assistance is sought to expedite solutions to the challenges. This will build on the GF investment in OST by informing efforts to increase uptake, retention and quality.","Low","The TA proposed is to improve OST coverage. This is quality demand because it addresses a serious weakness in the HIV response (as described in the funding request and addressed within the allocation). However the TRP does not consider that the cost of the TA proposed provides good value for money, and thus considers this low priority.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: TA to strengthen the programme","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5307","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","DHIS2 is a government priority: the NHSS anticipates its roll-out throughout the country by 2020. GoN resources are available for this, alongside support from DFID, GAVI, KOIKA and GiZ. Intermittent technical assistance is anticipated to accelerate and scale up the process, and ensure quality.",3000000,null,"Active","a6Q1R000000AJN3",300000,0,0,0,2700000,0,null,null,"DHIS2 is a government priority: the NHSS anticipates its roll-out throughout the country by 2020. GoN resources are available for this, alongside support from DFID, GAVI, KOIKA and GiZ. Intermittent technical assistance is anticipated to accelerate and scale up the process, and ensure quality.","Low","Many other donors already supporting this and therefore this is considered as a low priority","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Technical Assistance (TA) to support roll-out of DHIS2","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Malawi","Malawi","PAI-5212","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Aligned with the HSSPII objective to reduce environmental and social risk factors that have a direct impact on health, the PAAR activity within this intervention aims to engage key departments (Fisheries, Tourism, Local Government, and Agriculture) to foster multi-sectoral collaboration on improved utilization of malaria interventions. Engaging with these departments in a coordinated manner can support overall delivery of the Basic Healthcare Package. This activity is aimed at reducing the incidence and prevalence of malaria and other Funding Request: Tailored to Material Change 15 December 2016? 38 key diseases of public health importance through improved collaboration and better use of resources.",30000,null,"Active","a6Q1R000000AJLW",0,0,0,0,30000,0,null,null,"Aligned with the HSSPII objective to reduce environmental and social risk factors that have a direct impact on health, the PAAR activity within this intervention aims to engage key departments (Fisheries, Tourism, Local Government, and Agriculture) to foster multi-sectoral collaboration on improved utilization of malaria interventions. Engaging with these departments in a coordinated manner can support overall delivery of the Basic Healthcare Package. This activity is aimed at reducing the incidence and prevalence of malaria and other Funding Request: Tailored to Material Change 15 December 2016? 38 key diseases of public health importance through improved collaboration and better use of resources.","High","Cross-sectoral coordination","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5211","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Enhanced linkages to care ($0.29M) Additional activities to strengthen MSM programming linkage to care and monitoring in current 8 districts.",290000,null,"Active","a6Q1R000000AJLV",0,0,0,0,290000,0,null,null,"Enhanced linkages to care ($0.29M) Additional activities to strengthen MSM programming linkage to care and monitoring in current 8 districts.","High","Increased comprehensive programming for key populations will be increasingly needed to control the epidemic as incidence among the general population declines.","Amount for this component is combined. Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5210","MCI-00071","Other module","MCI-00071","Other module","These funds will be used towards salaries and benefits for two additional data clerks per facility for 600 facilities and builds on M&E capacity development plans within allocation.",4846588,null,"Active","a6Q1R000000AJLU",1431628.88,0,0,0,3414959.12,0,null,null,"These funds will be used towards salaries and benefits for two additional data clerks per facility for 600 facilities and builds on M&E capacity development plans within allocation.","High","Critical support for data information staff","NA Original Module: Other modules. Original Intervention: Other","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5209","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","These activities build on the activities within allocation in that once hired, health care workers require routine trainings and opportunities for specialization given Malawi?s needs. These activities are expected to improve overall quality of care and health care worker capacity. Specific activities included in this intervention: ? Continuous professional development ? Specialization courses ? Trainings ? Upgrading.",271252,null,"Active","a6Q1R000000AJLT",0,0,0,0,271252,0,null,null,"These activities build on the activities within allocation in that once hired, health care workers require routine trainings and opportunities for specialization given Malawi?s needs. These activities are expected to improve overall quality of care and health care worker capacity. Specific activities included in this intervention: ? Continuous professional development ? Specialization courses ? Trainings ? Upgrading.","High","Continued in-service training is a critical factor for implementation","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5208","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00178","National costed supply chain master plan, and implementation","These activities will also build on HSSP strategies to expand both the scope of the drug theft investigations unit, and continue to support capacity development of pharmacy assistants. Expected outcomes includes improved rational used of essential medicine, and reduced leakages through theft and medicines management. Specific activities included in this intervention: ? DTIU implementation of transparency and accountability mechanisms on commodities ? Integrated supervision and mentorship on medicines management in health facilities ? Tuition support for pre-service training of pharmacy assistants.",1089187,null,"Active","a6Q1R000000AJLS",0,0,0,0,1089187,0,null,null,"These activities will also build on HSSP strategies to expand both the scope of the drug theft investigations unit, and continue to support capacity development of pharmacy assistants. Expected outcomes includes improved rational used of essential medicine, and reduced leakages through theft and medicines management. Specific activities included in this intervention: ? DTIU implementation of transparency and accountability mechanisms on commodities ? Integrated supervision and mentorship on medicines management in health facilities ? Tuition support for pre-service training of pharmacy assistants.","High","Major building block for roll out of the costed national supply chain plan","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5207","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","This intervention builds on activities that have been requested within allocation. While a portion of the co-financing minimum commitment is expected to cover HRH gaps, the following activities have been included in the PAAR to address addition areas that will complete the full package from recruitment to profession development for hired health workers. In line with the HSSPII these activities support the HRH system that is essential to Malawi?s functioning health system. Specific activities included in this intervention: ? Induction costs ? Orientation on government performance appraisal system.",488382,null,"Active","a6Q1R000000AJLR",0,0,0,0,488382,0,null,null,"This intervention builds on activities that have been requested within allocation. While a portion of the co-financing minimum commitment is expected to cover HRH gaps, the following activities have been included in the PAAR to address addition areas that will complete the full package from recruitment to profession development for hired health workers. In line with the HSSPII these activities support the HRH system that is essential to Malawi?s functioning health system. Specific activities included in this intervention: ? Induction costs ? Orientation on government performance appraisal system.","High","Enhancement of frontline and community health workers is critical for intervention impact","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Mali","Mali","PAI-5082","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00170","Service organization and facility management","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",474097,null,"Inactive","a6Q1R000000AJJQ",0,474097,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Medium","Considered Medium as operational funding should ideally come from GoM, but in this case may provide some additional operational and/or start-up funding to support the functioning of CHWs and their supervision, as well as support monitoring of the implementation of the integrated community-based service delivery system. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 1"]
["CT Mali","Mali","PAI-5081","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",2000000,null,"Inactive","a6Q1R000000AJJP",0,2000000,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Low","Support should/could be provided through the iNGOs who operate as PRs or provided under other mechanisms from the other multi- and bilateral development partners.  The same applies for the studies and mapping. Priority low. ","Validaed by meeting the PO on 03/06/2019 Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 1"]
["CT Mali","Mali","PAI-5080","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",342157,null,"Inactive","a6Q1R000000AJJO",0,342157,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Medium","The upgrading of the CSComs has been split into several cost categories. Though the complete CSCom service package is seen as quality demand to extend community health services, the total costs for the upgrading, remains high (US$80,400) for a basic health center to serve at the community level. Therefore, most of these items are considered medium priority; if funding is available, the solar panels could be prioritized as they can be used to keep fridges and lights running and could also generate income through charging of cell phones and other small equipment. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 1"]
["CT Mali","Mali","PAI-5079","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",213848,null,"Inactive","a6Q1R000000AJJN",0,213848,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","High","The upgrading of the CSComs has been split into several cost categories. Though the complete CSCom service package is seen as quality demand to extend community health services, the total costs for the upgrading, remains high (US$80,400) for a basic health center to serve at the community level. Therefore, most of these items are considered medium priority; if funding is available, the solar panels could be prioritized as they can be used to keep fridges and lights running and could also generate income through charging of cell phones and other small equipment. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 1"]
["CT Mali","Mali","PAI-5078","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",1325857,null,"Inactive","a6Q1R000000AJJM",0,1325857,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Medium","The upgrading of the CSComs has been split into several cost categories. Though the complete CSCom service package is seen as quality demand to extend community health services, the total costs for the upgrading, remains high (US$80,400) for a basic health center to serve at the community level. Therefore, most of these items are considered medium priority; if funding is available, the solar panels could be prioritized as they can be used to keep fridges and lights running and could also generate income through charging of cell phones and other small equipment. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 1"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4850","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To rehabilitate the TB centers/hospitals damaged in the conflicts in Iraq and Syria (including Ibn Zohr Hospital in Baghdad, Iraq and Al-Hareth Hospital in Homs, Syria), so as to support the provision of admission facilities for patients admitted with TB.",100000,null,"Active","a6Q1R000000AJFg",0,0,0,0,100000,0,null,null,"To rehabilitate the TB centers/hospitals damaged in the conflicts in Iraq and Syria (including Ibn Zohr Hospital in Baghdad, Iraq and Al-Hareth Hospital in Homs, Syria), so as to support the provision of admission facilities for patients admitted with TB.","High","This activity has been reprioritized as high to support the provision of admission facilities for patients admitted with TB",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4849","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In order to strengthen TB services for affected women, food supplementation is needed for women with TB who are treated in IDP and refugee settings",1335000,null,"Active","a6Q1R000000AJFf",0,0,0,0,1335000,0,null,null,"In order to strengthen TB services for affected women, food supplementation is needed for women with TB who are treated in IDP and refugee settings","High","Nutritional support for TB patients in IDP and refugee camps is an important intervention given the prevailing food situation in these settings",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4848","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To organize, at regional level, a workshop for the staff of the NRLs of the five countries; the workshop will be facilitated by an international consultant and will cover the key aspects inherent to the management of a national TB laboratory network.",50000,null,"Active","a6Q1R000000AJFe",0,0,0,0,50000,0,null,null,"To organize, at regional level, a workshop for the staff of the NRLs of the five countries; the workshop will be facilitated by an international consultant and will cover the key aspects inherent to the management of a national TB laboratory network.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4847","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To organize, at regional level, a training course on data management for the relevant staff of the NTPs of the five countries (ex.: NTP managers and monitoring and evaluation officers). The course will be facilitated by two international consultants and will cover the following issues: i) epidemiological surveillance principles, ii) the establishment of data sets, iii) data analysis procedures and methods, iv) utilization of the data analysis results for the purposes of epidemiological surveillance and programmatic management, v) evaluation of TB prevention, care and control strategies and activities implemented, and vi) identification of hypotheses for operational research",75000,null,"Active","a6Q1R000000AJFd",0,0,0,0,75000,0,null,null,"To organize, at regional level, a training course on data management for the relevant staff of the NTPs of the five countries (ex.: NTP managers and monitoring and evaluation officers). The course will be facilitated by two international consultants and will cover the following issues: i) epidemiological surveillance principles, ii) the establishment of data sets, iii) data analysis procedures and methods, iv) utilization of the data analysis results for the purposes of epidemiological surveillance and programmatic management, v) evaluation of TB prevention, care and control strategies and activities implemented, and vi) identification of hypotheses for operational research","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4846","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","In order to enhance Xpert testing activities, one additional Xpert machine is needed for Iraq  and 4 additional Xpert machine are needed for Yemen",85000,null,"Active","a6Q1R000000AJFc",0,0,0,0,85000,0,null,null,"In order to enhance Xpert testing activities, one additional Xpert machine is needed for Iraq  and 4 additional Xpert machine are needed for Yemen","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4845","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","To procure 7 digital X-ray machines for TB facilities: 4 for Iraq and 3 for Jordan; these machines will cover the needs in TB screening, evaluation and diagnosis for IDPs, refugees and hard-to-reach populations scattered in Iraq and for refugees in Jordan",980000,null,"Active","a6Q1R000000AJFb",0,0,0,0,980000,0,null,null,"To procure 7 digital X-ray machines for TB facilities: 4 for Iraq and 3 for Jordan; these machines will cover the needs in TB screening, evaluation and diagnosis for IDPs, refugees and hard-to-reach populations scattered in Iraq and for refugees in Jordan","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4844","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","This is to include parts of Yemen in this intervention and also expand the services for the other three countries (Syria, Lebanon, Jordan). As the coverage of HIV testing among MSM is expected to reach 31% by funds within the allocation, it is expected that it will approach 60% with PAAR fund.",3000000,null,"Active","a6Q1R000000AJFa",0,0,0,0,3000000,0,null,null,"This is to include parts of Yemen in this intervention and also expand the services for the other three countries (Syria, Lebanon, Jordan). As the coverage of HIV testing among MSM is expected to reach 31% by funds within the allocation, it is expected that it will approach 60% with PAAR fund.","High","In this Funding Request there is a focus on prevention and testing of KP, which the TRP believes to be crucial. Given the importance of this activity, and the fact that prevention programs for MSM in Yemen are not included in the allocation request, we recommend that a portion of this amount should move to the allocation for prevention and testing activities among men who have sex with men in Yemen and be funded through savings made during grant making.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4843","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Y3: Expand referral platform  being built by Ministry of Public Health for drugs  to include other KPs.",10000,null,"Active","a6Q1R000000AJFZ",0,0,0,0,10000,0,null,null,"Y3: Expand referral platform  being built by Ministry of Public Health for drugs  to include other KPs.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Lesotho","Lesotho","PAI-4747","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","The funding will support adherence and economic empowerment through support groups to overcome the suboptimal retention level. 31 support groups comprising 620 members are expected to be trained on various livelihood options, such as voluntary savings, loans and access to microfinance, in three high burden districts. The activity will be partially funded through the reinvestment of the efficiencies identified during the grant making.",436283,null,"Active","a6Q1R000000AJE1",128960,0,0,0,307323,0,null,null,"The funding will support adherence and economic empowerment through support groups to overcome the suboptimal retention level. 31 support groups comprising 620 members are expected to be trained on various livelihood options, such as voluntary savings, loans and access to microfinance, in three high burden districts. The activity will be partially funded through the reinvestment of the efficiencies identified during the grant making.","High","The existing retention level is suboptimal. Support adherence and economic empowerment of the support groups is essential. This should be implemented in ways that seek maximum integration with existing structures.","NA Original Intervention: Other interventions for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4746","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","The Government of Lesotho, with the support from Global Fund and GAVI, constructed 30 health posts in underserved areas in the five highland districts. The key objectives of the health posts are: (i) support primary health activities conducted by community-based cadres, and also outreaches from the health centres and (ii) improve the quality of health services in the hard to reach areas in the Country.\n\nCurrently the 30 health posts are not optimally utilised due to the lack of medical equipment to improve universal health coverage, increase accessibility to the Essential Service Package (ESP) of health services and efficiently and effectively provide services to unreached populations, hence support is required to fully operationalise the health posts to provide the following services:\n? Health education, promotion and awareness creation\n? Child survival including Immunization, Nutrition and ANC services\n? Environmental Health through the promotion of, good sanitation, safe drinking water and good environmental and personal hygiene\n? Outpatient services, including prenatal and postnatal care, family planning, HIV testing and counselling, TB screening and treatment, ART refills and other services included in the ESP",69050,null,"Active","a6Q1R000000AJE0",0,0,0,0,69050,0,null,null,"The Government of Lesotho, with the support from Global Fund and GAVI, constructed 30 health posts in underserved areas in the five highland districts. The key objectives of the health posts are: (i) support primary health activities conducted by community-based cadres, and also outreaches from the health centres and (ii) improve the quality of health services in the hard to reach areas in the Country.\n\nCurrently the 30 health posts are not optimally utilised due to the lack of medical equipment to improve universal health coverage, increase accessibility to the Essential Service Package (ESP) of health services and efficiently and effectively provide services to unreached populations, hence support is required to fully operationalise the health posts to provide the following services:\n? Health education, promotion and awareness creation\n? Child survival including Immunization, Nutrition and ANC services\n? Environmental Health through the promotion of, good sanitation, safe drinking water and good environmental and personal hygiene\n? Outpatient services, including prenatal and postnatal care, family planning, HIV testing and counselling, TB screening and treatment, ART refills and other services included in the ESP","Low","Additional resources for health posts were determined to be low priority as the proposed services to be provided in health posts were largely unrelated to HIV and TB.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4745","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Availability of high-quality routine data is critical for regular targeted program planning, monitoring effectiveness of responses, and measure progress towards 90-90-90 the HIV epidemic control targets. Resources solicited from global fund to support data clerks, equipment, and connectivity in the five highland districts and support from other SI stakeholder, DHIS 2 rollout expand to facility level at 177 facilities (169 public and 8 private facilities) for reporting and data use. The support provided improved the quality of routine report, for example, completeness of data improved from 78% in October 2015 to 100% in January 2018; timeliness of data improved from 29% in October 2015 to 92% in October 2018. \n\nDespite the improvement in the completeness and timeliness of HIV care and treatment data reported through DHIS2, there is a significant discrepancy between program data and population survey data. The under-reporting emanating from multiple errors related to paper-based documentation and manual data processing remains a challenge. To address these inherent challenges, MoH with the support of partners made a bold decision to adopt, develop and rollout simple open source client level electronic system for HIV and TB services to 177 public health facilities providing ART across 10 districts. The current support from partners including the Global Fund, the e-registers are rolled out to 70 public health facilities leaving a gap of 107 facilities. The following support is required to implement interventions to consolidate and expand the eRegister; \n? Hardware and connectivity, \n? Human resources (trained and retained, motivated and strategically placed central and district levels technical staff\n? Skill building Training and Mentorship (Advanced system development and administration, System use for data entry, analysis and use), \n? Reliable transport and logistics.  Key areas of interventions to consolidate and expand the eRegister",2548713,null,"Active","a6Q1R000000AJDz",0,0,0,0,2548713,0,null,null,"Availability of high-quality routine data is critical for regular targeted program planning, monitoring effectiveness of responses, and measure progress towards 90-90-90 the HIV epidemic control targets. Resources solicited from global fund to support data clerks, equipment, and connectivity in the five highland districts and support from other SI stakeholder, DHIS 2 rollout expand to facility level at 177 facilities (169 public and 8 private facilities) for reporting and data use. The support provided improved the quality of routine report, for example, completeness of data improved from 78% in October 2015 to 100% in January 2018; timeliness of data improved from 29% in October 2015 to 92% in October 2018. \n\nDespite the improvement in the completeness and timeliness of HIV care and treatment data reported through DHIS2, there is a significant discrepancy between program data and population survey data. The under-reporting emanating from multiple errors related to paper-based documentation and manual data processing remains a challenge. To address these inherent challenges, MoH with the support of partners made a bold decision to adopt, develop and rollout simple open source client level electronic system for HIV and TB services to 177 public health facilities providing ART across 10 districts. The current support from partners including the Global Fund, the e-registers are rolled out to 70 public health facilities leaving a gap of 107 facilities. The following support is required to implement interventions to consolidate and expand the eRegister; \n? Hardware and connectivity, \n? Human resources (trained and retained, motivated and strategically placed central and district levels technical staff\n? Skill building Training and Mentorship (Advanced system development and administration, System use for data entry, analysis and use), \n? Reliable transport and logistics.  Key areas of interventions to consolidate and expand the eRegister","Medium","For CCM/Disease Program consideration: Better data systems are essential, but additional justification for this level of investment would be useful. This is a suggestion to improve this intervention; the country does not have to respond to it.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4744","MCI-00000","Prevention programs for general population","MCI-00072","Behavioral interventions as part of programs for general population","The activity will support educational resources for peer educators and general population as Lesotho rolls out self-testing and pre-exposure prophylaxis (PrEP).  The activity will be funded through the reinvestment of the efficiencies identified during the grant making.",20000,null,"Inactive","a6Q1R000000AJDy",20000,0,0,0,0,1,null,null,"The activity will support educational resources for peer educators and general population as Lesotho rolls out self-testing and pre-exposure prophylaxis (PrEP).  The activity will be funded through the reinvestment of the efficiencies identified during the grant making.","High","The activity is high priority as it provides educational resource for peer educators and the general population as the country rolls out self- testing, pre-exposure prophylaxis (PrEP).","NA Original Intervention: Behavioral interventions as part of programs for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5860","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","It is hypothesized that Low TB case notification among PLHIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among PLHIV disaggregated by age, gender and pregnancy status.",356600,null,"Active","a6Q1R000000AJVy",0,0,0,0,356600,0,null,null,"It is hypothesized that Low TB case notification among PLHIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among PLHIV disaggregated by age, gender and pregnancy status.","Low","It is hypothesized that Low TB case notification among People Living with HIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among People Living with HIV disaggregated by age, gender and pregnancy status.","NA Original Intervention: Operational research to improve TB case notification among people living with HIV in HIV care and treatment services","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5859","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Installation of Blood Established Computer System (BECS) in 10 regional blood collection and coordination centres to scale up collection of blood transfusion information. Collected Data will be used for decision making and safe blood service strengthening.",207500,null,"Active","a6Q1R000000AJVx",0,0,0,0,207500,0,null,null,"Installation of Blood Established Computer System (BECS) in 10 regional blood collection and coordination centres to scale up collection of blood transfusion information. Collected Data will be used for decision making and safe blood service strengthening.","Medium","Installation of Blood Established Computer System (BECS) in 10 regional blood collection and coordination centres to scale up collection of blood transfusion information. Collected Data will be used for decision making and safe blood service strengthening.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Scale up collection and utilization of blood donation and utilization by strengthening HMIS system in blood collection satellite sites","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5858","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","NBTS is currently using a technology that requires 6 blood donors to generate one unit of platelets. With a country requirement of 17500 platelet units it requires 105,000 blood donors which is almost 1/3 of annual blood collection. With available human resource and technology, NBTS is not able to supply this quantity of platelets and hence making patients receive inefficacious platelets treatment. With an apheresis machine which is proposed to be procured, they will be able to scale up platelets production, enhance efficacy of treatment and reduce risk of infection transmission through platelet transfusion.",310000,null,"Active","a6Q1R000000AJVw",0,0,0,0,310000,0,null,null,"NBTS is currently using a technology that requires 6 blood donors to generate one unit of platelets. With a country requirement of 17500 platelet units it requires 105,000 blood donors which is almost 1/3 of annual blood collection. With available human resource and technology, NBTS is not able to supply this quantity of platelets and hence making patients receive inefficacious platelets treatment. With an apheresis machine which is proposed to be procured, they will be able to scale up platelets production, enhance efficacy of treatment and reduce risk of infection transmission through platelet transfusion.","Low","Tanzania National Blood Transfusion (NBTS) is currently using a technology that requires 6 blood donors to generate one unit of platelets. With a country requirement of 17500 platelet units it requires 105,000 blood donors which is almost 1/3 of annual blood collection. With available human resource and technology, NBTS is not able to supply this quantity of platelets and hence making patients receive inefficacious platelets treatment. With an apheresis machine which is proposed to be procured, they will be able to scale up platelets production, enhance efficacy of treatment and reduce risk of infection transmission through platelet transfusion.","NA Original Intervention: Adapting modern technology for production of blood components (platelets) to enhance efficacy of platelets treatment and reduce risk of infection transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5857","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Tanzania is planning to scale up establishment of centers of excellence for management of advanced cases of pediatric and adults living with HIV.",1800000,null,"Active","a6Q1R000000AJVv",0,0,0,0,1800000,0,null,null,"Tanzania is planning to scale up establishment of centers of excellence for management of advanced cases of pediatric and adults living with HIV.","Medium","Tanzania is planning to scale up establishment of centers of excellence for management of advanced cases of paediatric and adults living with HIV.","NA Original Intervention: Support establishment of centre of excellence in Mtwara, Kagera, Katavi","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5856","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Timely, reliable and comprehensive information for the management of the national response enables the country to estimate resource flows and expenditures in support of the Multisectoral response to HIV and AIDS. Tanzania therefore plans to conduct the National AIDS Spending Assessment (NASA) study to track expenditure among, Public sources, External sources, Providers of HIV and AIDS services (Public and Private), Out of pocket (Individual spending). The NASA report is expected to form a basis for leveraging both technical and financial support for national HIV response based on available resources.",157600,null,"Active","a6Q1R000000AJVu",0,0,0,0,157600,0,null,null,"Timely, reliable and comprehensive information for the management of the national response enables the country to estimate resource flows and expenditures in support of the Multisectoral response to HIV and AIDS. Tanzania therefore plans to conduct the National AIDS Spending Assessment (NASA) study to track expenditure among, Public sources, External sources, Providers of HIV and AIDS services (Public and Private), Out of pocket (Individual spending). The NASA report is expected to form a basis for leveraging both technical and financial support for national HIV response based on available resources.","Medium","Timely, reliable and comprehensive information for the management of the national response enables the country to estimate resource flows and expenditures in support of the multisectoral response to HIV and AIDS. Tanzania therefore plans to conduct the National AIDS Spending Assessment (NASA) study to track expenditure among, Public sources, External sources, Providers of HIV and AIDS services (Public and Private), Out of pocket (Individual spending). The NASA report is expected to form a basis for leveraging both technical and financial support for national HIV response based on available resources.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Conduct National AIDS Spending Assessment (NASA)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Thailand","Thailand","PAI-5769","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","RTF BL 40Counselling and psychosocial group support for PWID-PLHIV.  Meeting with PWID PLHIV Units/Participants: 20 person per day Locations: 21 areas 1 quarters in year 1, 2 quarters in year 2, year 3.",23832,null,"Active","a6Q1R000000AJUV",0,0,0,0,23832,0,null,null,"RTF BL 40Counselling and psychosocial group support for PWID-PLHIV.  Meeting with PWID PLHIV Units/Participants: 20 person per day Locations: 21 areas 1 quarters in year 1, 2 quarters in year 2, year 3.","High","This activity supports counselling and psychosocial group support for people who inject drugs.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5768","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00099","Prevention and management of coinfections and co-morbidities for PWID","RTF BL 12-14,411. Hep C advisory board2. Hep C advisory board meeting3. HCV test kit procurement for 17 provinces -in addition to Community led4. Direct acting anti-viral treatment (DAA) dialogue for HEP C-group for HEP C following up during the intensive.",124245,null,"Active","a6Q1R000000AJUU",0,0,0,0,124245,0,null,null,"RTF BL 12-14,411. Hep C advisory board2. Hep C advisory board meeting3. HCV test kit procurement for 17 provinces -in addition to Community led4. Direct acting anti-viral treatment (DAA) dialogue for HEP C-group for HEP C following up during the intensive.","High","This activity supports a Hepatitis C advisory board; HCV test kit procurement for 17 provinces - in addition to Community led Direct acting anti-viral treatment (DAA) dialogue for HEP C-group for HEP C following up during the intensive","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Prevention and management of co-infections and co-morbidities for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5767","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00551","Interventions for young people who inject drugs","RTF BL 11Pathway to recovery -PWIDs and their families, Event for PWID and family Units/Participants: 32 person (16 families) per day.",64580,null,"Active","a6Q1R000000AJUT",0,0,0,0,64580,0,null,null,"RTF BL 11Pathway to recovery -PWIDs and their families, Event for PWID and family Units/Participants: 32 person (16 families) per day.","High","This activity supports the Pathway to recovery program for young people who inject drugs and their families,","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5766","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00548","Community empowerment for PWID","RTF BL 6-101. PWID Women group support, violence, gender, and mental-health2. Study on 1) Single model of Reach-Recruit-Test for PWID  2) N&S campaign and secondary distribution  3) MMT distribution at community level(Demonstration sites)3.Harm Reduction program assessment at local community to outline the best practice of the service provided 4. Set up HTC for Community led in PWID -additional for 1 site -operation5. Set up HTC for Community led in PWID -additional for 1 site -technical staff.",158826,null,"Active","a6Q1R000000AJUS",0,0,0,0,158826,0,null,null,"RTF BL 6-101. PWID Women group support, violence, gender, and mental-health2. Study on 1) Single model of Reach-Recruit-Test for PWID  2) N&S campaign and secondary distribution  3) MMT distribution at community level(Demonstration sites)3.Harm Reduction program assessment at local community to outline the best practice of the service provided 4. Set up HTC for Community led in PWID -additional for 1 site -operation5. Set up HTC for Community led in PWID -additional for 1 site -technical staff.","High","This intervention supports people who inject drugs women groups, violence, gender, and mental -health issues; a study on 1) Single model of Reach - Recruit -Test for people who inject drugs 2) N&S campaign and secondary distribution 3) MMT distribution at community level; a Harm Reduction program assessment at local community to outline the best practice of the service provided; and additional set up sites for HTC for Community led in people who inject drugs","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Community empowerment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5765","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","RTF BL 2-51. Prevention of HCV re-infection for PWID. Meeting of PWID HCV patient . Units/Participants: 10 person per day Locations: 21 areas 1 quarter in year 1, year 2, year 3 2. Relapse prevention workshop.  Workshop of PE, OW, PWID Units/Participants: 50 person per day Locations: Annual for 5 days in year 2, year 3 3. Incentive for peer recruitment to testUnits/Participants: 30% of target  test of PWID per year4. Data system to collect coupon from peer/volunteer recruiting including maintenance. consultantfee for  data system coupon for PWID (Year 1 for system development, Year 2, Year 3 for system maintenance).",98876,null,"Active","a6Q1R000000AJUR",0,0,0,0,98876,0,null,null,"RTF BL 2-51. Prevention of HCV re-infection for PWID. Meeting of PWID HCV patient . Units/Participants: 10 person per day Locations: 21 areas 1 quarter in year 1, year 2, year 3 2. Relapse prevention workshop.  Workshop of PE, OW, PWID Units/Participants: 50 person per day Locations: Annual for 5 days in year 2, year 3 3. Incentive for peer recruitment to testUnits/Participants: 30% of target  test of PWID per year4. Data system to collect coupon from peer/volunteer recruiting including maintenance. consultantfee for  data system coupon for PWID (Year 1 for system development, Year 2, Year 3 for system maintenance).","High","The intervention will support prevention of Hepatitis C virus (HCV) re -infection for people who inject drugs, relapse prevention, incentives for peer recruitment to HIV testing and a data system to collect coupons from peer/volunteer recruiting including maintenance. consultant fee for data system coupon for people who inject drugs","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5764","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00567","Pre-exposure prophylaxis (PrEP) for people in prisons and other closed settings","DDC BL 366-373TRC-PWID in prison.  Demonstrate sitesonPrEP , 2 sites in BKK and nearby. 300 prisons for screening and selected prisoner 100 person on PrEP.",29875,null,"Active","a6Q1R000000AJUQ",0,0,0,0,29875,0,null,null,"DDC BL 366-373TRC-PWID in prison.  Demonstrate sitesonPrEP , 2 sites in BKK and nearby. 300 prisons for screening and selected prisoner 100 person on PrEP.","High","This intervention will support 2 demonstration prison sites in Bangkok and a nearby location. 300 prisoners will be screened and 100 persons will be administered PrEP.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Zimbabwe","Zimbabwe","PAI-6118","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00572","Other intervention(s) for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",251100,null,"Active","a6Q1R000000AJa8",0,0,0,0,251100,0,null,null,"Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","High","Some of the budget in this budget line should be reserved for condom programming in prisons, because it is not included, whereas the funding request mentions negotiated sex in prisons.","NA Original Intervention: Other interventions for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6117","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00565","Behavioral interventions for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",11700,null,"Active","a6Q1R000000AJa7",0,0,0,0,11700,0,null,null,"Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","High","Prisoners are identified as an important KP group and a comprehensive program exists targeting this KPs",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT South Africa","South Africa","PAI-6005","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00097","Needle and Syringe programs for PWID and their partners","This PAAR request is to augment the Needle and Syringe kits provided to PWID to include personal cookers. This investment will reduce the likelihood of Hep C transmission, which is heightened with the use of make-shift cookers. This will reach each PWID in the program with 1 sterile personal cooker per day.",1790040,null,"Active","a6Q1R000000AJYJ",0,0,0,0,1790040,0,null,null,"This PAAR request is to augment the Needle and Syringe kits provided to PWID to include personal cookers. This investment will reduce the likelihood of Hep C transmission, which is heightened with the use of make-shift cookers. This will reach each PWID in the program with 1 sterile personal cooker per day.","Low",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Needle and syringe programs for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6004","MCI-00531","Comprehensive prevention programs for TGs","MCI-00553","Addressing stigma, discrimination and violence against TGs","This PAAR request is for hormone replacement therapy for 840 transgender people (50% of those reached through the program). It is expected that this intervention will help address gender-related barriers for transgender people. It is also linked with improved attainment of the 90-90-90 targets, since global data suggests that ART initiation and treatment adherence improves among transwomen in a gender affirming context.",1628308,null,"Active","a6Q1R000000AJYI",0,0,0,0,1628308,0,null,null,"This PAAR request is for hormone replacement therapy for 840 transgender people (50% of those reached through the program). It is expected that this intervention will help address gender-related barriers for transgender people. It is also linked with improved attainment of the 90-90-90 targets, since global data suggests that ART initiation and treatment adherence improves among transwomen in a gender affirming context.","Low",null,"NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Addressing stigma, discrimination and violence against transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6003","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00097","Needle and Syringe programs for PWID and their partners","The request is for procurement of personal sharps containers for PWID, to complement the within allocation investment in sharps containers for peer educators. The current policy environment is restricting distribution of harm reduction packs in certain areas. The additional investment in personal sharps containers will help to improve the legal and policy environment, helping to remove human rights barriers to accessing harm reduction services. The quantification of personal sharps containers in the PAAR is based on the number of needles requested within allocation, totaling 5 needles per drug user per day.",2632605,null,"Active","a6Q1R000000AJYH",0,0,0,0,2632605,0,null,null,"The request is for procurement of personal sharps containers for PWID, to complement the within allocation investment in sharps containers for peer educators. The current policy environment is restricting distribution of harm reduction packs in certain areas. The additional investment in personal sharps containers will help to improve the legal and policy environment, helping to remove human rights barriers to accessing harm reduction services. The quantification of personal sharps containers in the PAAR is based on the number of needles requested within allocation, totaling 5 needles per drug user per day.","Low",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Needle and syringe programs for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6002","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","This additional funding will support the roll out of 3HP for people living with HIV and household contacts of TB patients. 6% of the total country need is covered by the allocation request, with the PAAR filling the rest of the national request (20% of total national projected need). This total investment (main allocation and PAAR) will avert 9,159 TB cases.",12486210,null,"Inactive","a6Q1R000000AJYG",12486210,0,0,0,0,1,null,null,"This additional funding will support the roll out of 3HP for people living with HIV and household contacts of TB patients. 6% of the total country need is covered by the allocation request, with the PAAR filling the rest of the national request (20% of total national projected need). This total investment (main allocation and PAAR) will avert 9,159 TB cases.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6001","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00546","Prevention and management of coinfections and co-morbidities for sex workers","PAAR investment will support in reaching 3,385 sex workers with in-patient alcohol and drug treatment programs (3% of sex workers reached through the allocation amount) in districts and sub-districts where referrals to these services are not possible since they are not available. A 2009 study among sex workers in Pretoria found that 3% of SW tried but were unable to enter alcohol and drug treatment programs in the past year (Wechsberg et al., 2009).",3934721,null,"Active","a6Q1R000000AJYF",0,0,0,0,3934721,0,null,null,"PAAR investment will support in reaching 3,385 sex workers with in-patient alcohol and drug treatment programs (3% of sex workers reached through the allocation amount) in districts and sub-districts where referrals to these services are not possible since they are not available. A 2009 study among sex workers in Pretoria found that 3% of SW tried but were unable to enter alcohol and drug treatment programs in the past year (Wechsberg et al., 2009).","Low",null,"NA Original Intervention: Prevention and management of co-infections and co-morbidities for sex workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-6000","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","PAAR request will provide remuneration for an additional 1,000 CHWs (R3,500/month), which when added to the 400 supported through the allocation equates to 10% of the CHW registered workforce in the target 10 districts for the Global Fund program. This additional support will help NDOH to retain more of the existing cadre. There are currently 49 344 CHWs registered in the NDoH CHW database, of which 33,333 are already funded by treasury, 8000 funded by PEPFAR and 400 funded through the Global Fund allocation amount. These are active CHWs who have been validated by the provincial departments. This investment complements the significant commitment from Treasury, which has allocated R4.4 billion for the CHW programme over a three year period with R1.4 billion allocated for the financial year starting in April 2018/19, 1.4 Billion for April 2019/2020 and 1.5 Billion for the April 2020/21 financial year.",9901301,null,"Inactive","a6Q1R000000AJYE",9901301,0,0,0,0,1,null,null,"PAAR request will provide remuneration for an additional 1,000 CHWs (R3,500/month), which when added to the 400 supported through the allocation equates to 10% of the CHW registered workforce in the target 10 districts for the Global Fund program. This additional support will help NDOH to retain more of the existing cadre. There are currently 49 344 CHWs registered in the NDoH CHW database, of which 33,333 are already funded by treasury, 8000 funded by PEPFAR and 400 funded through the Global Fund allocation amount. These are active CHWs who have been validated by the provincial departments. This investment complements the significant commitment from Treasury, which has allocated R4.4 billion for the CHW programme over a three year period with R1.4 billion allocated for the financial year starting in April 2018/19, 1.4 Billion for April 2019/2020 and 1.5 Billion for the April 2020/21 financial year.","High",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT Eswatini","Eswatini","PAI-5698","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Increase ACF salaries to enhance motivation and performance.",40700,null,"Active","a6Q1R000000AJTM",0,0,0,0,40700,0,null,null,"Increase ACF salaries to enhance motivation and performance.","Low","While addressing the motivation of ACF workers is important, this is a one-off increase in salary and it is unclear from the funding request on how this will be sustained long term. This activity should ideally be funded through more sustainable sources.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5697","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Adding an additional day to the annual review meetings for ACFs, screening officers, adherence officers and expert clients (all TB lay cadres).  The allocation amount covers annual 2-day review meetings, though ideally the reviews should be three days to cover additional topics, particularly given the integration these cadres are pursuing in this grant.",120000,null,"Active","a6Q1R000000AJTL",0,0,0,0,120000,0,null,null,"Adding an additional day to the annual review meetings for ACFs, screening officers, adherence officers and expert clients (all TB lay cadres).  The allocation amount covers annual 2-day review meetings, though ideally the reviews should be three days to cover additional topics, particularly given the integration these cadres are pursuing in this grant.","Low","The meetings for ACF are covered within the grant. Funding for additional meeting days is considered of low priority given competing activities.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5696","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Additional working tools for HTS providers (lab coats) and further learning and experience sharing(conferences, exchanges) to share results from innovative testing modalities.",30893,null,"Active","a6Q1R000000AJTK",0,0,0,0,30893,0,null,null,"Additional working tools for HTS providers (lab coats) and further learning and experience sharing(conferences, exchanges) to share results from innovative testing modalities.","Low","This activity can be covered within the existing testing program.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5695","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Chemistry and hematology testing for ART patients to monitor drug toxicity.",1136288,null,"Inactive","a6Q1R000000AJTJ",1136288,0,0,0,0,1,null,null,"Chemistry and hematology testing for ART patients to monitor drug toxicity.","Low","While an understandable and essential need, this should be prioritized for coverage within the program from the Ministry of Health (MOH).","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5694","MCI-00000","Prevention programs for general population","MCI-00578","Keeping girls in school","Dignity packs for an additional 16,500 girls, covering all school-going girls in the 20 Global Fund Tinkhundla.",2227500,null,"Active","a6Q1R000000AJTI",0,0,0,0,2227500,0,null,null,"Dignity packs for an additional 16,500 girls, covering all school-going girls in the 20 Global Fund Tinkhundla.","Low","While dignity packs are evidence-based to keep girls in school, this activity might provide a challenge to a long-term sustainability of the program",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5693","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Development of a national community health strategy.",50000,null,"Active","a6Q1R000000AJTH",0,0,0,0,50000,0,null,null,"Development of a national community health strategy.","Medium","Community health strategy development to strengthen the capacity of community groups to address accountability and oversight issues in the local health system.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5692","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Support establishment and operationalization of community Maternal Death Surveillance and Response (MDSR) committees, orient communities on MDSR and support the establishment of referral networks between MDSR focal points at community and at health facility level.",840000,null,"Active","a6Q1R000000AJTG",0,0,0,0,840000,0,null,null,"Support establishment and operationalization of community Maternal Death Surveillance and Response (MDSR) committees, orient communities on MDSR and support the establishment of referral networks between MDSR focal points at community and at health facility level.","Medium","Maternal Death Surveillance and Response Committees, which will strengthen the oversight of maternal deaths and may support links to the TB and HIV programme.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5691","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Information and communication technology (ICT) system support for the TB program, including licenses, maintenance and upgrades for software and hardware.",105044,null,"Active","a6Q1R000000AJTF",0,0,0,0,105044,0,null,null,"Information and communication technology (ICT) system support for the TB program, including licenses, maintenance and upgrades for software and hardware.","Medium","Additional IT support for the TB program.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Somalia","Somalia","PAI-5593","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","IRS campaigns are proposed for three new areas that are outbreak prone. Each campaign costs 24,510 USD. The funds will cover IRS campaigns in response to epidemic.",110295,null,"Active","a6Q1R000000AJRf",0,0,0,0,110295,0,null,null,"IRS campaigns are proposed for three new areas that are outbreak prone. Each campaign costs 24,510 USD. The funds will cover IRS campaigns in response to epidemic.","Low","The TRP only approved budget to cover\ncampaign in response to epidemic NOT three\nrounds as proposed by the applicant (issue 2).","NA Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5592","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Regional trainings through WHO EMRO. Additional $18,000 to come from WHO. The PAAR amount will support Somali participation in regional IVM training, Surveillance Training and Elimination training.",9000,null,"Active","a6Q1R000000AJRe",0,0,0,0,9000,0,null,null,"Regional trainings through WHO EMRO. Additional $18,000 to come from WHO. The PAAR amount will support Somali participation in regional IVM training, Surveillance Training and Elimination training.","Low","Apart from training in surveillance, the proposed training is not linked with the identified module and intervention","NA Original Intervention: Facility-based management","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5591","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLINs for lowest priority mass campaign areas not covered by the allocation request and priority gaps for the continuous distribution areas, prioritizing high burden area and/or key and vulnerable populations.",6057807,null,"Active","a6Q1R000000AJRd",0,0,0,0,6057807,0,null,null,"LLINs for lowest priority mass campaign areas not covered by the allocation request and priority gaps for the continuous distribution areas, prioritizing high burden area and/or key and vulnerable populations.","High","The LLINs distribution should prioritize high burden areas and/or key- and vulnerable populations, and not low transmission areas.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5590","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","WHO P5 position (50%) and 3 national counterparts who provide critical national level capacity building, QA, supervision and support routine reporting/surveillance. Immediate ceasing of the fudning would create critical technical gaps. At a minimum $707,907 is sought to cover a two year transition period where further national capacity building would be implemented.",1061860,null,"Active","a6Q1R000000AJRc",913289.25,0,0,0,148570.75,0,null,null,"WHO P5 position (50%) and 3 national counterparts who provide critical national level capacity building, QA, supervision and support routine reporting/surveillance. Immediate ceasing of the fudning would create critical technical gaps. At a minimum $707,907 is sought to cover a two year transition period where further national capacity building would be implemented.","High","WHO P5 position (50%) and 3 national counterparts to provide critical national level capacity building, QA, supervision and support routine reporting/surveillance should be retained. Immediate ceasing of the funding would create critical technical gaps.","NA Original Intervention: IPTCS Technical Assistance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5589","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","This supports the majority of health services delivery. HIV services are managed or supported by INGOs and NGOs. These organisations to date have received support costs to enable the oversight, capacity building, and delivery of programs. Without this support there is a high risk of discontinuing this support and urgent transition arrangements will need to be implemented. This is for three years, but a minimum of $460,000 is sought to cover 2018 operations and allow effective and appropriate transition arrangements to be put in place.",1380000,null,"Active","a6Q1R000000AJRb",519810,0,0,0,860190,0,null,null,"This supports the majority of health services delivery. HIV services are managed or supported by INGOs and NGOs. These organisations to date have received support costs to enable the oversight, capacity building, and delivery of programs. Without this support there is a high risk of discontinuing this support and urgent transition arrangements will need to be implemented. This is for three years, but a minimum of $460,000 is sought to cover 2018 operations and allow effective and appropriate transition arrangements to be put in place.","High","This supports the majority of health facilities delivery . HIV services are managed or supported by INGOs and NGOs","NA Original Intervention: IPTCS Partner Support Costs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5588","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. This will build on the 2016/2017 Stigma Survey and provide a means of measuring outcomes of community and health worker stigma reduction efforts.",72000,null,"Inactive","a6Q1R000000AJRa",72000,0,0,0,0,1,null,null,"Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. This will build on the 2016/2017 Stigma Survey and provide a means of measuring outcomes of community and health worker stigma reduction efforts.","High","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of people living with HIV and their families and affects treatment adherence. This will build on the 2016/2017 Stigma Survey and provide a means of measuring outcomes of community and health worker stigma reduction efforts. Proposed to be included in a Community Based Stigma Reduction Package at line 2 above.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Paraguay","Paraguay","PAI-5455","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Consultation for implementation of the Health Region Training Plan.\nHR are required for this since the PNCT has a deficit of physicians available for trips to the interior to carry out this duty.",3259.85,null,"Active","a6Q1R000000AJPR",0,0,0,0,3259.85,0,null,null,"Consultation for implementation of the Health Region Training Plan.\nHR are required for this since the PNCT has a deficit of physicians available for trips to the interior to carry out this duty.","Medium",null,"NA Original Module: SRSS: Program management. Original Intervention: National disease monitoring policies, planning, coordination and program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Paraguay","Paraguay","PAI-5454","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Lab Dept (LCSP) management\nImplementation of new diagnostic algorithms including cultures and PSD for all cases of Pulmonary TB and universal rapid molecular diagnosis.\nThis requires hiring of HR who can carry out cultures and rapid molecular diagnosis on all samples arriving at LCSP.",50386,null,"Active","a6Q1R000000AJPQ",0,0,0,0,50386,0,null,null,"Lab Dept (LCSP) management\nImplementation of new diagnostic algorithms including cultures and PSD for all cases of Pulmonary TB and universal rapid molecular diagnosis.\nThis requires hiring of HR who can carry out cultures and rapid molecular diagnosis on all samples arriving at LCSP.","Medium",null,"NA Original Intervention: National disease monitoring policies, planning, coordination and program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Paraguay","Paraguay","PAI-5453","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Health Regions - Program Management\nExecution and coordination of activities, funding applications and financial reporting/funds return. Application of preventive and corrective controls on recording forms and reports in the expert system.\nThe intention with this intervention is to effectively execute the proposed activities and ensure proper data management.",60590.66,null,"Active","a6Q1R000000AJPP",0,0,0,0,60590.66,0,null,null,"Health Regions - Program Management\nExecution and coordination of activities, funding applications and financial reporting/funds return. Application of preventive and corrective controls on recording forms and reports in the expert system.\nThe intention with this intervention is to effectively execute the proposed activities and ensure proper data management.","Medium",null,"NA Original Module: SRSS: Provision of integrated services and quality improvement. Original Intervention: Organization or health and management services","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Paraguay","Paraguay","PAI-5452","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Strengthening of TB Expert System input with provision of computer equipment\nNot all districts have computer equipment to input symptomatic respirotary cases data and other cases into the system. It is important to note that from this year, PNCT will implement reporting in the Expert System as a source for official information. This implies that if the local service has no equipment and/or Internet access, the district must manage the data input.\nAcquisition of equipment will ensure timely and correct data input, analysis of the same at every care level and official reporting of indicators at the national level.",129138.5,null,"Active","a6Q1R000000AJPO",0,0,0,0,129138.5,0,null,null,"Strengthening of TB Expert System input with provision of computer equipment\nNot all districts have computer equipment to input symptomatic respirotary cases data and other cases into the system. It is important to note that from this year, PNCT will implement reporting in the Expert System as a source for official information. This implies that if the local service has no equipment and/or Internet access, the district must manage the data input.\nAcquisition of equipment will ensure timely and correct data input, analysis of the same at every care level and official reporting of indicators at the national level.","Medium",null,"NA Original Module: SRSS: Health information systems and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Paraguay","Paraguay","PAI-5451","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","National TB Programme (PNCT) - Program Management. Technical-administrative management for optimum implementation of this project, including execution and monitoring of the proposed activities. Production and verification of the funding application for execution of PNCT activities in the context of the project, and provision of the same to the RP. The intention here is to appropriately monitor activities to be implemented and as such to assure effective execution of the same.\nPNCT monitoring management of data quality, indicator compliance and recording in expert system. Technical-programmatic management relating to monitoring and follow-up on indicators and activities included in the working plan. Data quality management, use of corrective controls, monitoring for optimum implementation of the Expert System, which will serve from this year as the main source of information for reporting indicators.\n\nThe intention here is to efficiently monitor indicators and activities, promptly identify bottlenecks that could affect execution of the project and offer recommendations.",210724.74,null,"Active","a6Q1R000000AJPN",0,0,0,0,210724.74,0,null,null,"National TB Programme (PNCT) - Program Management. Technical-administrative management for optimum implementation of this project, including execution and monitoring of the proposed activities. Production and verification of the funding application for execution of PNCT activities in the context of the project, and provision of the same to the RP. The intention here is to appropriately monitor activities to be implemented and as such to assure effective execution of the same.\nPNCT monitoring management of data quality, indicator compliance and recording in expert system. Technical-programmatic management relating to monitoring and follow-up on indicators and activities included in the working plan. Data quality management, use of corrective controls, monitoring for optimum implementation of the Expert System, which will serve from this year as the main source of information for reporting indicators.\n\nThe intention here is to efficiently monitor indicators and activities, promptly identify bottlenecks that could affect execution of the project and offer recommendations.","High",null,"NA Original Module: SRSS: Program management. Original Intervention: National disease monitoring policies, planning, coordination and program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Paraguay","Paraguay","PAI-5450","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Assurance of mobility for active searches for TB cases\nHealth Regions have no mobility for the search symptomatic respiratory cases in indigenous communities and settlements with difficult access. This includes prompt transfer of samples to be processed, mainly for cultures and PSD at the Lab Dept (LCSP) or network laboratories. The Regions to be strengthened are:\n? Caaguazú with an area of 11,474 km2 expects approximately 3,337 respiratory symptomatic cases and 255 cases annually.\n? Pte. Hayes with an area of 72,907 km2 expects approximately 4,454 respiratory symptomatic cases and 356 cases annually.\n? Boquerón with an area of 91,669 km2 expects approximately 2,278 respiratory symptomatic cases and 174 cases annually.\n? Canindeyú with an area of 14,667 km2 expects approximately 1,368 respiratory symptomatic cases and 104 cases annually.\n? Central with an area of 2,465 km2 expects approximately 12,793 respiratory symptomatic cases annually.\n? San Pedro with an area of 20,002 km2 expects approximately 2,569 respiratory symptomatic cases annually.\n\nAssuring mobility to regions with difficult geographic access will guarantee active SR search and prompt diagnosis of TB cases, reducing the disparity between forecasts and notifications.",371036.7,null,"Active","a6Q1R000000AJPM",0,185546,0,0,185490.7,0,null,null,"Assurance of mobility for active searches for TB cases\nHealth Regions have no mobility for the search symptomatic respiratory cases in indigenous communities and settlements with difficult access. This includes prompt transfer of samples to be processed, mainly for cultures and PSD at the Lab Dept (LCSP) or network laboratories. The Regions to be strengthened are:\n? Caaguazú with an area of 11,474 km2 expects approximately 3,337 respiratory symptomatic cases and 255 cases annually.\n? Pte. Hayes with an area of 72,907 km2 expects approximately 4,454 respiratory symptomatic cases and 356 cases annually.\n? Boquerón with an area of 91,669 km2 expects approximately 2,278 respiratory symptomatic cases and 174 cases annually.\n? Canindeyú with an area of 14,667 km2 expects approximately 1,368 respiratory symptomatic cases and 104 cases annually.\n? Central with an area of 2,465 km2 expects approximately 12,793 respiratory symptomatic cases annually.\n? San Pedro with an area of 20,002 km2 expects approximately 2,569 respiratory symptomatic cases annually.\n\nAssuring mobility to regions with difficult geographic access will guarantee active SR search and prompt diagnosis of TB cases, reducing the disparity between forecasts and notifications.","High",null,"NA Original Module: SRSS: Provision of integrated services and quality improvement. Original Intervention: Organization or health and management services","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Pakistan","Pakistan","PAI-5359","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: To scale up a mobile based TB case notification system to initial 50, then to 90 districts. \nRational: This will facilitate TB cases notification in private sector. The majority of the population is seeking care in the private sector. Legislation for mandatory case notification will facilitate that. 35,000 additional cases are expected to be identified anually for year 2 and 3.\nThe pilot intervention is proposed through catalytic funding. After evaluation, the intervention will be scaled up throughout the country based on phased approach, selecting additional 50 districts in year 2019 & rest 90 in year 2020.",1500000,null,"Active","a6Q1R000000AJNt",0,0,0,0,1500000,0,null,null,"Action: To scale up a mobile based TB case notification system to initial 50, then to 90 districts. \nRational: This will facilitate TB cases notification in private sector. The majority of the population is seeking care in the private sector. Legislation for mandatory case notification will facilitate that. 35,000 additional cases are expected to be identified anually for year 2 and 3.\nThe pilot intervention is proposed through catalytic funding. After evaluation, the intervention will be scaled up throughout the country based on phased approach, selecting additional 50 districts in year 2019 & rest 90 in year 2020.","High","The majority of the population is seeking care in the private sector. Mandatory case notification is a critical component to strengthen case notification from the private sector.","NA Original Intervention: Mandatory case notification through mobile application & web based system","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5358","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Action: Scale-up of Xpert testing of B positive cases Rationale:The expansion of Xpert network across the country has a throughput  to test additional B-positive TB cases to reach up to 90% of B positives cases. This will give a yield of additional 16% of RR-TB cases. The major reason for putting it into  PAAR being requirement of additional resources for Xpert cartridges  and  second line Drugs and social support to reach 55% of all pulmonary MDR cases ( which is  70%.(2019)  90%  (2020) of B positive cases, 1000 + 2150 =3150 additional Cases over three years.Cost implications: SLDs for 3150 MDR cases (4300/case)  US 13,545,000100,000 cartridges:  (US 1 million (diagnostics)Social support  (528 US per patient)  US 1,663,200.",16208000,null,"Active","a6Q1R000000AJNs",0,0,0,0,16208000,0,null,null,"Action: Scale-up of Xpert testing of B positive cases Rationale:The expansion of Xpert network across the country has a throughput  to test additional B-positive TB cases to reach up to 90% of B positives cases. This will give a yield of additional 16% of RR-TB cases. The major reason for putting it into  PAAR being requirement of additional resources for Xpert cartridges  and  second line Drugs and social support to reach 55% of all pulmonary MDR cases ( which is  70%.(2019)  90%  (2020) of B positive cases, 1000 + 2150 =3150 additional Cases over three years.Cost implications: SLDs for 3150 MDR cases (4300/case)  US 13,545,000100,000 cartridges:  (US 1 million (diagnostics)Social support  (528 US per patient)  US 1,663,200.","High","Allocation funding estimates only 10 percent increase for RR-TB case detection rate. Additional activities boosting the MDR-TB case detection should be prioritized.","NA Original Module: Multidrug-resistant TB. Original Intervention: Accelerated MDR detection and treatment to reach 90 percent of bacteriologically positive cases by 2020. (3,150 additional MDR cases)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5357","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Action: To provide enhanced case finding screening algorithm to all patients in 175 large public sector hospitals with digital X-ray (CAD4TB) followed by X-pert.  Confirmation for enhanced case finding and increased diagnostic quality.\nRational: 30% of prevalent TB cases are asymptomatic & not detected using current tools and algorithms. X-ray followed by X-pert is the most sensitive test to detect these cases, in pursuit of END TB targets of detecting over 90% of cases. Implementation of TB X-ray screening followed by X-pert. Gradual scale up so over 3 years, 10 million patients X-ray screened in  200 large hospitals, detecting 103,750 additional  bacteriologically confirmed TB cases and  4358 RR cases  (4.2%) from a proposed budget of US$118 million. This seems to offer low value for money at US$1,147/case detected.",17842500,null,"Active","a6Q1R000000AJNr",0,0,0,0,17842500,0,null,null,"Action: To provide enhanced case finding screening algorithm to all patients in 175 large public sector hospitals with digital X-ray (CAD4TB) followed by X-pert.  Confirmation for enhanced case finding and increased diagnostic quality.\nRational: 30% of prevalent TB cases are asymptomatic & not detected using current tools and algorithms. X-ray followed by X-pert is the most sensitive test to detect these cases, in pursuit of END TB targets of detecting over 90% of cases. Implementation of TB X-ray screening followed by X-pert. Gradual scale up so over 3 years, 10 million patients X-ray screened in  200 large hospitals, detecting 103,750 additional  bacteriologically confirmed TB cases and  4358 RR cases  (4.2%) from a proposed budget of US$118 million. This seems to offer low value for money at US$1,147/case detected.","Low","The expected yield from the intervention is 103,750 cases from a proposed budget of US$118 million. This seems to offer low value for money at US$1,147/case detected. The TRP recommends that US$ 17,842,500 out of the US$118M requested for this intervention considered quality demand, but of low priority. The TRP recommends that the amount be targeted at initiating the introduction of this intervention in pilot sites to learn lessons and document costs in relation to yield.","NA Original Intervention: Implementing enhanced case finding algorithm in 175 hospitals X-ray screening followed by GeneXpert algorithm on all new patients (treated as TB risk group)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5356","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Action: To establish 11 more PMDT sites in Public and private sector in an equitable manner.\nRationale: These PMDT sites will facilitate the enrollment of DR-TB patients near their residences for better treatment adherence.",3200000,null,"Active","a6Q1R000000AJNq",0,0,0,0,3200000,0,null,null,"Action: To establish 11 more PMDT sites in Public and private sector in an equitable manner.\nRationale: These PMDT sites will facilitate the enrollment of DR-TB patients near their residences for better treatment adherence.","High","While allocation funding supports an increase of 6 PMDT sites from 34 to 40, additional support is sought to scale up PMDT sites from 40 to 51. The TRP deems that his is a core MDR-TB intervention to facilitate case management.","NA Original Module: Multidrug-resistant TB. Original Intervention: Scale up network of PMDT sites from 40 to 51","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5355","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","The Malaria Indicator survey (MIS) showed only 35% utilization of LLIN by the community during high transmission season. Mass media campaign will be conducted for all 66 districts and aired in the malaria transmission season to encourage LLINs utilization and achieve maximum impact. In addition, the campaign will raise awareness amongst the population for utilization of most famous intervention of LLINs and early care seeking by malaria suspects to reduce morbidity and mortality.",300000,null,"Active","a6Q1R000000AJNp",0,0,0,0,300000,0,null,null,"The Malaria Indicator survey (MIS) showed only 35% utilization of LLIN by the community during high transmission season. Mass media campaign will be conducted for all 66 districts and aired in the malaria transmission season to encourage LLINs utilization and achieve maximum impact. In addition, the campaign will raise awareness amongst the population for utilization of most famous intervention of LLINs and early care seeking by malaria suspects to reduce morbidity and mortality.","Low","This additional funding will support target mass media\nactivities addressing specific bottlenecks. A 30% of the original request is being recommended under PAAR.","NA Original Intervention: Mass media campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Nepal","Nepal","PAI-5306","MCI-00071","Other module","MCI-00071","Other module","The GoN commitment to increase resources for treatment, care and support includes capacity strengthening of medical personnel at ART sites. Intermittent short-term technical assistance would augment the GoN efforts and complement the capacity support available from other partners (AHF, WHO, Linkages), as well as maximise Global Fund investments in TCS.",2000000,null,"Active","a6Q1R000000AJN2",0,0,0,0,2000000,0,null,null,"The GoN commitment to increase resources for treatment, care and support includes capacity strengthening of medical personnel at ART sites. Intermittent short-term technical assistance would augment the GoN efforts and complement the capacity support available from other partners (AHF, WHO, Linkages), as well as maximise Global Fund investments in TCS.","Low","There is already significant investment on capacity building in the allocation (see Section 4.3.2 above). As domestic funding is planned to rise, it should cover interventions such as this","NA Original Module: RSSH. Original Intervention: Capacity building of medical personnel at ART sties","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5305","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Studies have indicated that a number of young people (under the age of 20) engage in sex or sell sex, begin using illicit drugs and ultimately progress to injecting. Youth groups and youth-led organisations anticipate that engaging young people in prevention and behaviour change can have positive and lasting impacts. This work would complement the in-reach interventions for young key populations in the main allocation.",100000,null,"Active","a6Q1R000000AJN1",0,0,0,0,100000,0,null,null,"Studies have indicated that a number of young people (under the age of 20) engage in sex or sell sex, begin using illicit drugs and ultimately progress to injecting. Youth groups and youth-led organisations anticipate that engaging young people in prevention and behaviour change can have positive and lasting impacts. This work would complement the in-reach interventions for young key populations in the main allocation.","High","To reach young people at risk through youth groups and youthled organizations in addition to interventions already in the allocation","NA Original Intervention: Prevention activities for young key populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5304","MCI-00001","Prevention programs for MSM and TGs","MCI-00086","Other interventions for MSM and TGs","To date, USAID-FHI360 has supported some MSM/TG interventions in 5 non-GF districts but will not commit funding beyond 2018-19, Since there is still a strong need from the community, and other external resources are not envisaged, support is requested for the continuation of services in 2019-201 and 2020-21.",600000,null,"Active","a6Q1R000000AJN0",0,0,0,0,600000,0,null,null,"To date, USAID-FHI360 has supported some MSM/TG interventions in 5 non-GF districts but will not commit funding beyond 2018-19, Since there is still a strong need from the community, and other external resources are not envisaged, support is requested for the continuation of services in 2019-201 and 2020-21.","High","Men who have sex with men are also a key population identified in the national strategy; PEPFAR funding is not planned to continue beyond 2018-19. These funds would replace geographic coverage lost when funding from other partners ends (but the Global Fund grant also covers men who have sex with men and transgender people within the allocation amount).","NA Original Module: Prevention programs for men who have sex with men and transgender people. Original Intervention: Continuation of services for men who have sex with men and transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5303","MCI-00071","Other module","MCI-00071","Other module","Migration to India, particularly to states where HIV prevalence among FSW is high, is recognised as source of infection. The main source of information for targeting HIV interventions among migrants is a 2007 study by UNFPA. However, it is likely that changes in health seeking behaviour and migration patterns (e.g. the shift to Gulf countries as the preferred destination) over the last decade have implications for HIV transmission and access to HIV services, which will be explored in the assessment. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.",50000,null,"Inactive","a6Q1R000000AJMz",50000,0,0,0,0,1,null,null,"Migration to India, particularly to states where HIV prevalence among FSW is high, is recognised as source of infection. The main source of information for targeting HIV interventions among migrants is a 2007 study by UNFPA. However, it is likely that changes in health seeking behaviour and migration patterns (e.g. the shift to Gulf countries as the preferred destination) over the last decade have implications for HIV transmission and access to HIV services, which will be explored in the assessment. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.","High","Originally proposed as a single module with two interventions, the TRP suggests to split the interventions; the TRP considers this one to be a high priority because the main information source is dated (2007).","NA Original Module: Study and assessment. Original Intervention: Migration and HIV vulnerability","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5302","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","To date, FSW have been covered USAID-FHI360 (80% coverage). USAID-FHI360 has not committed any funding for the continuation of the program beyond 2018-19.  Support through PAAR would therefore enable the country to meet the NHIP targets of 87% and 90% coverage of FSW in 2019-20 and 2020-21, with prevention programming and HIV testing.",4000000,null,"Active","a6Q1R000000AJMy",150000,0,0,0,3850000,0,null,null,"To date, FSW have been covered USAID-FHI360 (80% coverage). USAID-FHI360 has not committed any funding for the continuation of the program beyond 2018-19.  Support through PAAR would therefore enable the country to meet the NHIP targets of 87% and 90% coverage of FSW in 2019-20 and 2020-21, with prevention programming and HIV testing.","High","The TRP considers this to be a high priority. As described in Section 4.3.3 above, female sex workers are one of the key populations identified in the national strategy; coverage is essential and PEPFAR funding is not planned to continue beyond 2018-19, so there is a risk of discontinuation.","NA Original Intervention: Core Identify Reach-Test-Treat Retain package","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-03-15"]
["CT Malawi","Malawi","PAI-5206","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","This intervention is linked to a number of objectives and strategies articulated in the draft HSSPII which include improving the availability, quality, and utilization of medicines and medical supplies as well as strengthening the capacity and increasing availability of qualified pharmacy staff at all levels This intervention also includes funding for essential infrastructure and equipment linked to the HSSPII. The plan highlights critical activities to improve the availability and quality of health infrastructure and medical equipment. The activities below build on the activities listed within allocation with the hope that Malawi will achieve improved storage and management of commodities, and improved pharmaceutical waste management. Specific activities included in this intervention: ? Procurement of medical equipment ? Acquiring infrastructure for safe disposal of pharmaceutical wastes ? Development of an automated asset management tool ? Construction of an additional CMST central warehouse ? Strengthening of pharmaceutical storage infrastructure in health facilities ? Procurement and installation of solar panels at 600 facilities.",31333760,null,"Active","a6Q1R000000AJLQ",0,0,0,0,31333760,0,null,null,"This intervention is linked to a number of objectives and strategies articulated in the draft HSSPII which include improving the availability, quality, and utilization of medicines and medical supplies as well as strengthening the capacity and increasing availability of qualified pharmacy staff at all levels This intervention also includes funding for essential infrastructure and equipment linked to the HSSPII. The plan highlights critical activities to improve the availability and quality of health infrastructure and medical equipment. The activities below build on the activities listed within allocation with the hope that Malawi will achieve improved storage and management of commodities, and improved pharmaceutical waste management. Specific activities included in this intervention: ? Procurement of medical equipment ? Acquiring infrastructure for safe disposal of pharmaceutical wastes ? Development of an automated asset management tool ? Construction of an additional CMST central warehouse ? Strengthening of pharmaceutical storage infrastructure in health facilities ? Procurement and installation of solar panels at 600 facilities.","High","Malawi is considered a focused supply chain transformation country. Building on the Global Fund supply chain initiative concept.","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5205","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","MDR TB Prevention (USD 600,000): With the increase in TB diagnosis and treatment that will occur through the emphasis on case detection and diagnosis in this FR, effective infection control measures must be put in place. This line item will be used for the upgrading of MDR-TB wards in three central hospitals to include negative pressure isolation rooms.",600000,null,"Active","a6Q1R000000AJLP",0,0,0,0,600000,0,null,null,"MDR TB Prevention (USD 600,000): With the increase in TB diagnosis and treatment that will occur through the emphasis on case detection and diagnosis in this FR, effective infection control measures must be put in place. This line item will be used for the upgrading of MDR-TB wards in three central hospitals to include negative pressure isolation rooms.","High","MDR-TB infection control activities","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5204","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Key Affected Populations (USD 300,000): The usefulness of digital chest X-rays for screening and diagnosis of TB is considerably limited by lack of trained healthcare workers. Computer-aided detection (CAD) programs constitute a viable alternative, and initial studies have indicated that CAD programs have potential high sensitivity.31,32 CAD is particularly useful in high volume screening settings, such as OPD in high burden hospitals. While digital X-rays have been procured through the NFM grant, complementing them with CAD will enhance their effectiveness. This line item will cover the cost of procurement and utilization of CAD software for TB diagnosis, in particular concentrating on screening urban poor populations in high volume sites, complementing the within allocation strategy for reaching this high risk group by improving standardization, sensitivity and speed of diagnosis. Utilization of CAD will also contribute to the generating evidence on this innovative technology, to inform policy on usage in resource constrained settings with high TB burden. Finally, imaging generated by CAD can be repurposed for teaching in health colleges.",300000,null,"Active","a6Q1R000000AJLO",50000,0,0,0,250000,0,null,null,"Key Affected Populations (USD 300,000): The usefulness of digital chest X-rays for screening and diagnosis of TB is considerably limited by lack of trained healthcare workers. Computer-aided detection (CAD) programs constitute a viable alternative, and initial studies have indicated that CAD programs have potential high sensitivity.31,32 CAD is particularly useful in high volume screening settings, such as OPD in high burden hospitals. While digital X-rays have been procured through the NFM grant, complementing them with CAD will enhance their effectiveness. This line item will cover the cost of procurement and utilization of CAD software for TB diagnosis, in particular concentrating on screening urban poor populations in high volume sites, complementing the within allocation strategy for reaching this high risk group by improving standardization, sensitivity and speed of diagnosis. Utilization of CAD will also contribute to the generating evidence on this innovative technology, to inform policy on usage in resource constrained settings with high TB burden. Finally, imaging generated by CAD can be repurposed for teaching in health colleges.","High","DXR with CAD for targeted screening of urban poor populations","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Intervention: Key populations (TB care and prevention) ? Others","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5203","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Survey, analysis, review and transparency (USD 2,175,000) Building upon M&E activities in the within allocation request, this line item will expand TB M&E activities to include conducting: 1) a national TB prevalence study in 2020 to update current prevalence estimate from the 2014 TB Prevalence Survey, 2) routine operational research on new intervention areas implemented through this FR, in order to provide real-time learning, 3) routine and end-line program and epidemiological reviews, and 4) WHO Standards and Checklist for TB Surveillance and Vital Registration System. Prevalence data are now 5-years old and therefore there is an urgent need of updating data through a new prevalence survey in 2020. Overall, the development of robust M&E systems will contribute to more granular data, which can allow for programme strengthening both in the long-run and course correction for identified problems during grant implementation. Access to such real-time data would allow for better geographic and/or facility prioritization of activities, better data Funding Request: Tailored to Material Change 15 December 2016? 35 sharing with districts and facilities to monitor sub-national targets for case detection or treatment outcomes, and deployment of intensified support and supervision based on data to identify poorperforming facilities.",2175000,null,"Active","a6Q1R000000AJLN",200000,0,0,0,1975000,0,null,null,"Survey, analysis, review and transparency (USD 2,175,000) Building upon M&E activities in the within allocation request, this line item will expand TB M&E activities to include conducting: 1) a national TB prevalence study in 2020 to update current prevalence estimate from the 2014 TB Prevalence Survey, 2) routine operational research on new intervention areas implemented through this FR, in order to provide real-time learning, 3) routine and end-line program and epidemiological reviews, and 4) WHO Standards and Checklist for TB Surveillance and Vital Registration System. Prevalence data are now 5-years old and therefore there is an urgent need of updating data through a new prevalence survey in 2020. Overall, the development of robust M&E systems will contribute to more granular data, which can allow for programme strengthening both in the long-run and course correction for identified problems during grant implementation. Access to such real-time data would allow for better geographic and/or facility prioritization of activities, better data Funding Request: Tailored to Material Change 15 December 2016? 35 sharing with districts and facilities to monitor sub-national targets for case detection or treatment outcomes, and deployment of intensified support and supervision based on data to identify poorperforming facilities.","High","TB Prevalence survey planned in 2020","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Survey, analysis, review and transparency","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5202","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","MDR-TB Treatment (USD 977,066): This line item will cover treatment costs for an additional 102 MDR/RR-TB cases, including drugs and ancillary medicines, nutritional supplements, and social support for patients. Through above allocation, the MDR-TB CDR will increase to 50% of the estimated country need (85% of the NSP target), reaching 95% of expected re-treatment cases. Additionally, with the phased roll out of shorter treatment regimen elaborated in the MDR-TB within allocation request, the above allocation request includes necessary equipment investments, such as 10 of each of the following HumaLyte Plus 5, Chemistry Analyzer, Hormonal Assay, ECG, ECHO, and CBC machines, as well as respective reagents.",977066,null,"Active","a6Q1R000000AJLM",0,0,0,0,977066,0,null,null,"MDR-TB Treatment (USD 977,066): This line item will cover treatment costs for an additional 102 MDR/RR-TB cases, including drugs and ancillary medicines, nutritional supplements, and social support for patients. Through above allocation, the MDR-TB CDR will increase to 50% of the estimated country need (85% of the NSP target), reaching 95% of expected re-treatment cases. Additionally, with the phased roll out of shorter treatment regimen elaborated in the MDR-TB within allocation request, the above allocation request includes necessary equipment investments, such as 10 of each of the following HumaLyte Plus 5, Chemistry Analyzer, Hormonal Assay, ECG, ECHO, and CBC machines, as well as respective reagents.","High","Management of 102 MDR-TB cases","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5201","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","MDR-TB Case Detection (USD 740,365): The national policy is to test re-treatment patients, contacts of MDR-TB patients and seriously ill patients for MDR-TB. Within allocation, 67,131 cases will be notified in 2018-20, of which approximately 10% (or 6,700) are expected to be re-treatment cases. Of these, 6.4% (or 430) are expected to be MDR-TB cases. From within allocation, 381 MDR-TB patients are targeted for treatment, representing 88.6% of expected retreatment cases. The remaining 49 of 430 cases, along with the new MDR-TB cases that will be identified from the additional 9,784 TB cases found through the above allocation request above, will be covered through these above allocation funds (See Target Assumption Table attached). To support increased case detection rates, an additional 2,060 Xpert cartridges will be procured, alongside orientation for HCWs on Xpert diagnostic algorithms, as well as supervision and mentorship for HCWs in high burden MDR-TB facilities to encourage screening of patients using Xpert.",740365,null,"Active","a6Q1R000000AJLL",215894,0,0,0,524471,0,null,null,"MDR-TB Case Detection (USD 740,365): The national policy is to test re-treatment patients, contacts of MDR-TB patients and seriously ill patients for MDR-TB. Within allocation, 67,131 cases will be notified in 2018-20, of which approximately 10% (or 6,700) are expected to be re-treatment cases. Of these, 6.4% (or 430) are expected to be MDR-TB cases. From within allocation, 381 MDR-TB patients are targeted for treatment, representing 88.6% of expected retreatment cases. The remaining 49 of 430 cases, along with the new MDR-TB cases that will be identified from the additional 9,784 TB cases found through the above allocation request above, will be covered through these above allocation funds (See Target Assumption Table attached). To support increased case detection rates, an additional 2,060 Xpert cartridges will be procured, alongside orientation for HCWs on Xpert diagnostic algorithms, as well as supervision and mentorship for HCWs in high burden MDR-TB facilities to encourage screening of patients using Xpert.","High","102 MDR-TB case diagnosis in PAAR","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization. Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Mali","Mali","PAI-5077","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",2138479,null,"Inactive","a6Q1R000000AJJL",0,2138479,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Medium","The upgrading of the CSComs has been split into several cost categories. Though the complete CSCom service package is seen as quality demand to extend community health services, the total costs for the upgrading, remains high (US$80,400) for a basic health center to serve at the community level. Therefore, most of these items are considered medium priority; if funding is available, the solar panels could be prioritized as they can be used to keep fridges and lights running and could also generate income through charging of cell phones and other small equipment. ","Validaed by meeting the PO on 03/06/2019","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 1"]
["CT Mali","Mali","PAI-5076","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",773862,null,"Inactive","a6Q1R000000AJJK",0,773862,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","High",null,"Validaed by meeting the PO on 03/06/2019 Original Module: RSSH: Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 1"]
["CT Mali","Mali","PAI-5075","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom",2731700,null,"Inactive","a6Q1R000000AJJJ",0,2731700,0,0,0,1,null,null,"Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.\nSignificant direct impact on 3 diseases:\nMalaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.\nMalaria: Increased SP3 coverage among pregnant women from 40% to 60%.\nHIV: Increased PMTCT testing coverage from 50% to 70%.\nHIV: Increased PMTCT treatment coverage from 85% to 95%.\nTB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","High",null,"Validaed by meeting the PO on 03/06/2019 Original Module: RSSH: Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 1"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4975","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","For strengthening  the M&E system, the disease surveillance and outbreak response system and the provision of continued TA. In addition to work plans for Mobile Malaria Teams (MMTs) and associated field visits to detect and treat patients, activities to improve quality controls for anti-malarials.",1000000,null,"Inactive","a6Q1R000000AJHh",1000000,0,0,0,0,1,null,null,"For strengthening  the M&E system, the disease surveillance and outbreak response system and the provision of continued TA. In addition to work plans for Mobile Malaria Teams (MMTs) and associated field visits to detect and treat patients, activities to improve quality controls for anti-malarials.","High","The TRP considers these as key activities, which should be incorporated as part of the regular allocation, if efficiencies are found during grant making. However microscopes and microscopy training and supplies are not supported.","NA Original Intervention: Strengthening Health Sector Case Management (Lao PDR)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4972","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","To accelerate malaria elimination.",25000,null,"Inactive","a6Q1R000000AJHe",0,0,25000,0,0,1,null,null,"To accelerate malaria elimination.","Low","Low priority.","NA Original Intervention: Promote intensive personal protection where drug is resistant (Thailand)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4971","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Contingency measure for new foci in anticipation of occurrence in drug resistant villages.",64000,null,"Inactive","a6Q1R000000AJHd",64000,0,0,0,0,1,null,null,"Contingency measure for new foci in anticipation of occurrence in drug resistant villages.","Low","Low priority.","NA Original Intervention: Vector control and elimination of transmission foci in villages where drug resistant patients are reported (Thailand)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4970","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","The program would like to support the overall health system strengthening by enhancing adverse drug reaction control and monitoring.",67000,null,"Active","a6Q1R000000AJHc",0,0,0,0,67000,0,null,null,"The program would like to support the overall health system strengthening by enhancing adverse drug reaction control and monitoring.","Low","Low priority.","NA Original Intervention: Pharmacovigilance for antimalarial drugs (Viet Nam)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4969","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","1. The semi-annual meetings are to review 6 months activities and adjust annual workplan based on results 2. WHO TA fees in 2018 and 2019 are included in within allocation budget. In 2020, even though it is expected that the program's capacity has been strengthened, TA from WHO will still be necessary to develop elimination strategies for 2021 - 2025 period.",464727,null,"Active","a6Q1R000000AJHb",155727,0,0,0,309000,0,null,null,"1. The semi-annual meetings are to review 6 months activities and adjust annual workplan based on results 2. WHO TA fees in 2018 and 2019 are included in within allocation budget. In 2020, even though it is expected that the program's capacity has been strengthened, TA from WHO will still be necessary to develop elimination strategies for 2021 - 2025 period.","Low","Low priority.","NA Original Intervention: Conduct semi - annual meetings. Maintain technical assistance from WHO in 2020 (Viet Nam)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4968","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","To conduct a study on the efficacy of IEC/BCC materials in order to improve the efficacy and targeting.",26000,null,"Inactive","a6Q1R000000AJHa",26000,0,0,0,0,1,null,null,"To conduct a study on the efficacy of IEC/BCC materials in order to improve the efficacy and targeting.","Low","Low priority.","NA Original Intervention: Evaluation of IEC/BCC (Lao PDR )","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4842","MCI-00023","Program management","MCI-00207","Grant management","PR Management Dashboard",90000,null,"Active","a6Q1R000000AJFY",0,0,0,0,90000,0,null,null,"PR Management Dashboard","Medium","The TRP assessed that this request as important but of medium priority as it would refer to activities not directly associated to direct interventions. This type of expenditure could be covered through efficiencies and other types of savings.","NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4841","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Capacity building for resource mobilization: Regional training on proposal development, grant accountability and identifying mechanisms for fund raising for CSOs and KP networks.",94300,null,"Active","a6Q1R000000AJFX",0,0,0,0,94300,0,null,null,"Capacity building for resource mobilization: Regional training on proposal development, grant accountability and identifying mechanisms for fund raising for CSOs and KP networks.","High",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4840","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Organize national and regional workshops to develop advocacy plans focused on removal of legal barriers to KP access to services.",40400,null,"Inactive","a6Q1R000000AJFW",40400,0,0,0,0,1,null,null,"Organize national and regional workshops to develop advocacy plans focused on removal of legal barriers to KP access to services.","High",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4839","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Development of a regional advocacy strategy and operational plan, including activities for advocacy for local partners towards transition to sustainable funding; Regional learning and planning for national level domestic resource mobilization advocacy plans to increase national governments? commitment for domestic financing of HIV programs for key populations.",155550,null,"Inactive","a6Q1R000000AJFV",155550,0,0,0,0,1,null,null,"Development of a regional advocacy strategy and operational plan, including activities for advocacy for local partners towards transition to sustainable funding; Regional learning and planning for national level domestic resource mobilization advocacy plans to increase national governments? commitment for domestic financing of HIV programs for key populations.","High",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4838","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","KP-led participatory assessment of legal, social, cultural and human-rights related barriers and current responses to equitable access and uptake of HIV services for key populations",108570,null,"Inactive","a6Q1R000000AJFU",108570,0,0,0,0,1,null,null,"KP-led participatory assessment of legal, social, cultural and human-rights related barriers and current responses to equitable access and uptake of HIV services for key populations","High",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4837","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Expand piloting of an electronic reporting system for violations of KP rights and occurrence of stigma and discrimination.",11000,null,"Inactive","a6Q1R000000AJFT",11000,0,0,0,0,1,null,null,"Expand piloting of an electronic reporting system for violations of KP rights and occurrence of stigma and discrimination.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4836","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Conduct a consultation for Jordanian CSOs that work on HIV to share good practice and innovations to improve current HIV programming and service delivery for  key populations",15000,null,"Inactive","a6Q1R000000AJFS",15000,0,0,0,0,1,null,null,"Conduct a consultation for Jordanian CSOs that work on HIV to share good practice and innovations to improve current HIV programming and service delivery for  key populations","Low",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4835","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Integrate the use of social networking apps into drop-in and outreach services to improve access and as a tool for monitoring and user-feedback on quality of services.",35000,null,"Active","a6Q1R000000AJFR",0,0,0,0,35000,0,null,null,"Integrate the use of social networking apps into drop-in and outreach services to improve access and as a tool for monitoring and user-feedback on quality of services.","Low",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Lesotho","Lesotho","PAI-4743","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Based on the observation study currently rolled out, increased monitoring and management of patients with adverse side effects is required. Furthermore, an opportunity for the decentralisation of MDR-TB services is presented with the use of all oral medications. To increase monitoring and management of patients with adverse side effects, and decentralise the MDR-TB services, the following gaps need to be addressed:\n? Two additional physicians to facilitate accurate diagnosis and follow up at district level as well training, mentorship and supervision of district teams. \n? Four registered nurses are needed for the intensive clinical care for those admitted and ambulatory patients. \n? To closely monitor, document and report as well as provide expert interventions to address the adverse effects. two pharmacy technicians and one pharmacist are needed \n\nThe key outcome of increasing the human resource capacity will be: \n? Increased community implementation and providing support and case management to remote districts. \n? Increased number of treatment initiation sites and strengthening treatment literacy. \n? Sustainability as the doctors (especially Basotho doctors for sustainability) at district level will be trained to build a team of experts who can continue the management or even the PMDT in a sustainable manner.\n\nThe use of all oral medications is an opportunity to further decentralize MDR services having removed the complicated aspect of treatment of administering the injectable. The very clinicians and nurses will serve as resource persons for the envisaged consillium aimed at providing remote support to districts as they manage the cases. It means that it will be feasible to increase initiation sites and treatment literacy strengthened through additional pharmacist and Pharmacy Technicians",560840,null,"Active","a6Q1R000000AJDx",0,0,0,0,560840,0,null,null,"Based on the observation study currently rolled out, increased monitoring and management of patients with adverse side effects is required. Furthermore, an opportunity for the decentralisation of MDR-TB services is presented with the use of all oral medications. To increase monitoring and management of patients with adverse side effects, and decentralise the MDR-TB services, the following gaps need to be addressed:\n? Two additional physicians to facilitate accurate diagnosis and follow up at district level as well training, mentorship and supervision of district teams. \n? Four registered nurses are needed for the intensive clinical care for those admitted and ambulatory patients. \n? To closely monitor, document and report as well as provide expert interventions to address the adverse effects. two pharmacy technicians and one pharmacist are needed \n\nThe key outcome of increasing the human resource capacity will be: \n? Increased community implementation and providing support and case management to remote districts. \n? Increased number of treatment initiation sites and strengthening treatment literacy. \n? Sustainability as the doctors (especially Basotho doctors for sustainability) at district level will be trained to build a team of experts who can continue the management or even the PMDT in a sustainable manner.\n\nThe use of all oral medications is an opportunity to further decentralize MDR services having removed the complicated aspect of treatment of administering the injectable. The very clinicians and nurses will serve as resource persons for the envisaged consillium aimed at providing remote support to districts as they manage the cases. It means that it will be feasible to increase initiation sites and treatment literacy strengthened through additional pharmacist and Pharmacy Technicians","High","For CCM/Disease Program consideration: HRH needs are high in Lesotho, decentralization of MDR TB treatment is also important. This is a suggestion to improve this intervention; the country does not have to respond to it.","In country optimization Original Module: RSSH: Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4742","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","The allocation under NFM2 is $3,838,505 and includes $2,444, 985.00 for SLD and procurement costs $420,059, and one monitoring test for TSH. Other services linked to supervision of patients, transport reimbursements, food packages, hygiene packages and programme administration costs is adequately covered under NFM2. To provide prompt and more effective management of MDR-TB the gap identified is as follows:\n? To assess the success of the all oral shorter regime as per the WHO 2018 Guidelines, operational research will be undertaken.\n? Additional monitoring tests will be undertaken with respect to Hepatis B antigens, haemoglobin A1C to monitor diabetic patients, two Electro- Cardio Gram machine (ECG), electrodes and paper.\n? Reagents are required to perform the first line and second line DST for all eligible patients",426262,null,"Active","a6Q1R000000AJDw",0,0,0,0,426262,0,null,null,"The allocation under NFM2 is $3,838,505 and includes $2,444, 985.00 for SLD and procurement costs $420,059, and one monitoring test for TSH. Other services linked to supervision of patients, transport reimbursements, food packages, hygiene packages and programme administration costs is adequately covered under NFM2. To provide prompt and more effective management of MDR-TB the gap identified is as follows:\n? To assess the success of the all oral shorter regime as per the WHO 2018 Guidelines, operational research will be undertaken.\n? Additional monitoring tests will be undertaken with respect to Hepatis B antigens, haemoglobin A1C to monitor diabetic patients, two Electro- Cardio Gram machine (ECG), electrodes and paper.\n? Reagents are required to perform the first line and second line DST for all eligible patients","High","For CCM/Disease Program consideration: Support needs for patients with MDR TB are high. Greater clarification of evaluation related to oral short-course regimen would be useful.","In country otpimization Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4741","MCI-00000","Prevention programs for general population","MCI-00074","Male circumcision","Programme data reported a national target of 311,335 men need to be circumcised of which 178,976 men have been medically circumcised. The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) 2017, reported that 30.7% of men between ages of 15-59 are still uncircumcised and 33.8% of HIV positive men between the ages 15-59 are uncircumcised. Furthermore, neonatal circumcisions taking place are minimal.  Although funding under NFM2 was received, the program was besieged by a number of challenges including limited funding under NFM2 to implement the program, high staff turn-over of MOH VMMC trained staff, poor understanding of VMMC by the district health management teams, absence of a core team dedicated for VMMC at the facilities and the suspension of incentives for staff to conduct VMMC. To mitigate these challenges, the GOL will adopt the model implemented by PEPFAR in the lowland districts which is reported to be successful with the uptake of VMMC. The annual target for VMMC is 50,000 which will be adequately covered for 2019/2020 by NFM2 (14,000) and PEPFAR (36,000). The gap identified is for 2020/2021 as PEPFAR will support 30,000 circumcisions leaving a gap of 20,000.  To address this gap following is proposed: \n? Health facility capacity  \no VMMC core team located at each of the 8 health facilities in the 5 districts, made up of 3 nurses and 1 counsellor and cleaner\no VMMC site assessments conducted at identified health facilities to ensure the minimum required standards for VMMC are met. \no Recruitment and training of new clinical staff and refresher courses for existing staff \no Recruitment and training of community health advocates including traditional chiefs, traditional initiators, councillors and religious leaders\n? Advocacy and Demand Creation \no Advocacy initiatives to be implemented with key stakeholders at national level, VMMC stakeholder: parliamentarians (HIV Cluster), government line ministries, NAC, Religious bodies and Civil Society Organisations for ownership \no Orientation of health facility staff (hospitals and health centres) on VMMC, communication skills, differentiated approaches to HTS and linkage to other services\no Mobilisation campaigns and sensitisation sessions in communities through door to door campaigns, school visits, meetings of traditional leaders, distribution of promotional packages to targeted community groups and at service delivery points \no Use of media platforms to promote VMMC \n? M&E and Research - For monitoring, evaluation and research and to manage the data, human resources will be required for VMMC administrative assistants and to conduct operational research",2800000,null,"Active","a6Q1R000000AJDv",0,0,0,0,2800000,0,null,null,"Programme data reported a national target of 311,335 men need to be circumcised of which 178,976 men have been medically circumcised. The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) 2017, reported that 30.7% of men between ages of 15-59 are still uncircumcised and 33.8% of HIV positive men between the ages 15-59 are uncircumcised. Furthermore, neonatal circumcisions taking place are minimal.  Although funding under NFM2 was received, the program was besieged by a number of challenges including limited funding under NFM2 to implement the program, high staff turn-over of MOH VMMC trained staff, poor understanding of VMMC by the district health management teams, absence of a core team dedicated for VMMC at the facilities and the suspension of incentives for staff to conduct VMMC. To mitigate these challenges, the GOL will adopt the model implemented by PEPFAR in the lowland districts which is reported to be successful with the uptake of VMMC. The annual target for VMMC is 50,000 which will be adequately covered for 2019/2020 by NFM2 (14,000) and PEPFAR (36,000). The gap identified is for 2020/2021 as PEPFAR will support 30,000 circumcisions leaving a gap of 20,000.  To address this gap following is proposed: \n? Health facility capacity  \no VMMC core team located at each of the 8 health facilities in the 5 districts, made up of 3 nurses and 1 counsellor and cleaner\no VMMC site assessments conducted at identified health facilities to ensure the minimum required standards for VMMC are met. \no Recruitment and training of new clinical staff and refresher courses for existing staff \no Recruitment and training of community health advocates including traditional chiefs, traditional initiators, councillors and religious leaders\n? Advocacy and Demand Creation \no Advocacy initiatives to be implemented with key stakeholders at national level, VMMC stakeholder: parliamentarians (HIV Cluster), government line ministries, NAC, Religious bodies and Civil Society Organisations for ownership \no Orientation of health facility staff (hospitals and health centres) on VMMC, communication skills, differentiated approaches to HTS and linkage to other services\no Mobilisation campaigns and sensitisation sessions in communities through door to door campaigns, school visits, meetings of traditional leaders, distribution of promotional packages to targeted community groups and at service delivery points \no Use of media platforms to promote VMMC \n? M&E and Research - For monitoring, evaluation and research and to manage the data, human resources will be required for VMMC administrative assistants and to conduct operational research","High","For CCM/Disease Program consideration: Recent epidemiology analyses suggest High transmission from uncircumcised men.  Program should ensure that proposed budget is rationalized and aligned to the target of 20,000 circumcisions to ensure value for money.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4740","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","The activities detailed below are for both MSM and FSWs\nMajority of HTS providers in both the Public and CSOs are not trained to provide Key population friendly health services. There is limited provision of HTS services to MSM/FSWs due to stigmatising and discriminating attitudes displayed by staff in health facilities.  The absence of key population user-friendly facilities has resulted in the low uptake of HTS and poor post-test referral and patient tracking systems. The NFM2 currently provides for the mobilisation of MSM/FSWs through the interpersonal communication curriculum (IPC) for the uptake of heath care services, in particular, HTS services as an entry point to the prevention and treatment services. Although MSM/FSWs reached with IPC are referred for HTS services to public health facilities, the linkage rate is very low due to the lack of KP friendly services in these facilities. To mitigate the low uptake of HIV services amongst MSM/FSW the following is proposed:\n\n? Training of peer educators as HTS Lay Counsellors at identified community facilities to provide onsite community testing and counselling, self-testing to MSM/FSW and link them to either PrEP or ART services \n? Training of Health Care Workers in health facilities to provide key population friendly services and create a welcoming environment at the facilities thus increasing confidence in MSM/FSWs to use such facilities; increased use of mobile clinics \n? Facilitate outreach campaigns to sensitise MSM/FSWs on new HTS approaches and mobilising MSM/FSW for testing in established health facilities and community based and or mobile facilities to enable access to comprehensive service package for MSM/FSW in a safe space \n? Facilitate Peer navigation through trained MSM/FSW Peer Educators to actively link those reached with IPC sessions to HTS and linkages to treatment services, further support on adherence to treatment \n? Use of health posts that are not utilised to provide MSM/FSW friendly services, for provision of HIV education, condom distribution, HTS, PrEP and ART initiation. \n? Sensitise Health Authorities to review and align health policies to standards that promote inclusivity and the right of every citizen to receiving medical services to enforce KP friendly services in service delivery points. \n? Promotion of HTS campaign strategy through multiple media platforms such as Facebook, print and electronic media to ensure effective reach to MSM/FSW and interactive engagement for motivation and uptake of health care services.",376919,null,"Active","a6Q1R000000AJDu",0,0,0,0,376919,0,null,null,"The activities detailed below are for both MSM and FSWs\nMajority of HTS providers in both the Public and CSOs are not trained to provide Key population friendly health services. There is limited provision of HTS services to MSM/FSWs due to stigmatising and discriminating attitudes displayed by staff in health facilities.  The absence of key population user-friendly facilities has resulted in the low uptake of HTS and poor post-test referral and patient tracking systems. The NFM2 currently provides for the mobilisation of MSM/FSWs through the interpersonal communication curriculum (IPC) for the uptake of heath care services, in particular, HTS services as an entry point to the prevention and treatment services. Although MSM/FSWs reached with IPC are referred for HTS services to public health facilities, the linkage rate is very low due to the lack of KP friendly services in these facilities. To mitigate the low uptake of HIV services amongst MSM/FSW the following is proposed:\n\n? Training of peer educators as HTS Lay Counsellors at identified community facilities to provide onsite community testing and counselling, self-testing to MSM/FSW and link them to either PrEP or ART services \n? Training of Health Care Workers in health facilities to provide key population friendly services and create a welcoming environment at the facilities thus increasing confidence in MSM/FSWs to use such facilities; increased use of mobile clinics \n? Facilitate outreach campaigns to sensitise MSM/FSWs on new HTS approaches and mobilising MSM/FSW for testing in established health facilities and community based and or mobile facilities to enable access to comprehensive service package for MSM/FSW in a safe space \n? Facilitate Peer navigation through trained MSM/FSW Peer Educators to actively link those reached with IPC sessions to HTS and linkages to treatment services, further support on adherence to treatment \n? Use of health posts that are not utilised to provide MSM/FSW friendly services, for provision of HIV education, condom distribution, HTS, PrEP and ART initiation. \n? Sensitise Health Authorities to review and align health policies to standards that promote inclusivity and the right of every citizen to receiving medical services to enforce KP friendly services in service delivery points. \n? Promotion of HTS campaign strategy through multiple media platforms such as Facebook, print and electronic media to ensure effective reach to MSM/FSW and interactive engagement for motivation and uptake of health care services.","High","Strengthened support to KP programming, a group with a very high HIV prevalence.","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4739","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","UNICEF. MOH, PACT and CHAI and funding received under NFM2 will be used to map the services for adolescents and young people and develop a service directory. The service directory will guide all implementers and mitigate against duplication of services. To enhance implementation and coordination of service delivery amongst implementing partners the following needs to be strengthened:\n? Documentation of a standardised and harmonised referral system to provide guidance for services to adolescents and young people\n? Induction of implementing partners on the utilisation of the harmonised referral system across the 8 districts\n? Facilitate coordination of quarterly meetings (in total 32 meetings annually) at district level to monitor implementation and outcomes of the harmonised referral system",25916,null,"Active","a6Q1R000000AJDt",0,0,0,0,25916,0,null,null,"UNICEF. MOH, PACT and CHAI and funding received under NFM2 will be used to map the services for adolescents and young people and develop a service directory. The service directory will guide all implementers and mitigate against duplication of services. To enhance implementation and coordination of service delivery amongst implementing partners the following needs to be strengthened:\n? Documentation of a standardised and harmonised referral system to provide guidance for services to adolescents and young people\n? Induction of implementing partners on the utilisation of the harmonised referral system across the 8 districts\n? Facilitate coordination of quarterly meetings (in total 32 meetings annually) at district level to monitor implementation and outcomes of the harmonised referral system","Medium","For CCM/Disease Program consideration: Improved service delivery mapping could be covered by existing resources. This is a suggestion to improve this intervention; the country does not have to respond to it.","NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4738","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","The Government of Lesotho has adopted differentiated care models to enhance adherence to ART. Different models have been piloted and implemented in Lesotho and the evidence demonstrates their effectiveness in ensuring that People Living with HIV, in particular young people can adhere to treatment when supported. The network/teen-clubs? model that supports treatment adherence for adolescents and young people have been implemented by both Baylor and Sentebale with positive results on the level of adherence and the improved viral load suppression. An assessment of this model implemented in Maseru, Mafeteng and Mohale's Hoek showed an increase in the number of adolescents and young people with good (95 to 105%) adherence to ART. The same study presented an increase in viral load suppression among the AGY enrolled in the adherence support program.\n\nCurrently USAID supports implementation of AGY adherence support in three (Maseru, Mafeteng and Mohale's Hoek) of the 10 districts. Although NFM2, provides adherence support in districts not supported by PEPFAR however, this support does not cover the comprehensive implementation of the intervention/model. A key intervention to increase ART adherence and viral load suppression AGY across the remaining districts is operationalising the network/teen-clubs?. The requirement in this regard includes: (i) provision of a stipend for the club facilitators, (ii) transport for the facilitators and children on ART to attend club session; (iii) meals and refreshments for the club sessions and (iv) procurement of art equipment and stationary for children participating in the adherence clubs. The key outcomes for this intervention will be increased adherence to treatment and viral load suppression among adolescents and young people",624379,null,"Active","a6Q1R000000AJDs",0,0,0,0,624379,0,null,null,"The Government of Lesotho has adopted differentiated care models to enhance adherence to ART. Different models have been piloted and implemented in Lesotho and the evidence demonstrates their effectiveness in ensuring that People Living with HIV, in particular young people can adhere to treatment when supported. The network/teen-clubs? model that supports treatment adherence for adolescents and young people have been implemented by both Baylor and Sentebale with positive results on the level of adherence and the improved viral load suppression. An assessment of this model implemented in Maseru, Mafeteng and Mohale's Hoek showed an increase in the number of adolescents and young people with good (95 to 105%) adherence to ART. The same study presented an increase in viral load suppression among the AGY enrolled in the adherence support program.\n\nCurrently USAID supports implementation of AGY adherence support in three (Maseru, Mafeteng and Mohale's Hoek) of the 10 districts. Although NFM2, provides adherence support in districts not supported by PEPFAR however, this support does not cover the comprehensive implementation of the intervention/model. A key intervention to increase ART adherence and viral load suppression AGY across the remaining districts is operationalising the network/teen-clubs?. The requirement in this regard includes: (i) provision of a stipend for the club facilitators, (ii) transport for the facilitators and children on ART to attend club session; (iii) meals and refreshments for the club sessions and (iv) procurement of art equipment and stationary for children participating in the adherence clubs. The key outcomes for this intervention will be increased adherence to treatment and viral load suppression among adolescents and young people","High","Support for viral load suppression needed in children.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5855","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","During 2018-2020 Global fund grant application only 7201996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44% of the blood recipients to be at risk of infections through blood transfusion.",5769918,null,"Active","a6Q1R000000AJVt",0,0,0,0,5769918,0,null,null,"During 2018-2020 Global fund grant application only 7201996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44% of the blood recipients to be at risk of infections through blood transfusion.","High","Under the current application only 7,201,996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44 percent of the blood recipients are at risk of infections through blood transfusion","NA Original Intervention: Scale up availability and accessibility of safe blood to patients in need of blood transfusion therapy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5854","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00599","National product selection, registration and quality monitoring","This intervention will complement the Global Fund investment but is an upstream investment.",2341931,null,"Active","a6Q1R000000AJVs",0,0,0,0,2341931,0,null,null,"This intervention will complement the Global Fund investment but is an upstream investment.","Medium","This intervention will complement the Global Fund investment but is an upstream investment","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5853","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","This intervention will complement Global Fund investment.",6514356,null,"Active","a6Q1R000000AJVr",0,0,0,0,6514356,0,null,null,"This intervention will complement Global Fund investment.","Medium","This intervention will complement Global Fund investment","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5852","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00177","Other health and community workforce intervention(s)","The intervention is aimed at supporting the provision of additional essential health workers for the delivery of CEmONC serives and services for AIDS, Tuberculosis and Malaria in a setting of severe human resource shortages.",3402374,null,"Active","a6Q1R000000AJVq",0,0,0,0,3402374,0,null,null,"The intervention is aimed at supporting the provision of additional essential health workers for the delivery of CEmONC serives and services for AIDS, Tuberculosis and Malaria in a setting of severe human resource shortages.","High","The intervention is aimed at supporting the provision of additional essential health workers for the delivery of CEmONC serives and services for AIDS, Tuberculosis and Malaria in a setting of severe human resource shortages","NA Original Module: RSSH - Human resources for health, including community health workers. Original Intervention: Retention and scale up of health workers including CHWs: Specialized training for medical specialists, Health workers","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5851","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","The intervention includes essential inputs to improve the functionality of the local health system.",12886522,null,"Active","a6Q1R000000AJVp",6419820,0,0,0,6466702,0,null,null,"The intervention includes essential inputs to improve the functionality of the local health system.","High","he intervention includes essential inputs to improve the functionality of the local health system.","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Improved efficiency of service delivery including referral: Renovation and upgrading of infrastructure for comprehensive emergency obstetric and newborn care (CEmONC), basic emergency obstetric and newborn care (BEmONC) and MDR TB treatment; Procurement of digital X-ray for 24 District hospitals","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5850","MCI-00012","Case management","MCI-00154","Facility-based treatment","This fund is requested to continue funding distance learning on integrated management of childhood diseases. Value added for this activity at this relatively high cost is not sufficiently justified to be considered high priority.",2034750,null,"Active","a6Q1R000000AJVo",0,0,0,0,2034750,0,null,null,"This fund is requested to continue funding distance learning on integrated management of childhood diseases. Value added for this activity at this relatively high cost is not sufficiently justified to be considered high priority.","Medium","This fund is requested to continue funding distance learning on integrated management of childhood diseases. Value added for this activity at this relatively high cost is not sufficiently justified to be considered high priority",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria, RSSH","RT High Impact Africa 2"]
["CT Thailand","Thailand","PAI-5763","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00571","Prevention and management of coinfections and co-morbidities for people in prisons and other closed settings","DDC BL 365Technical support for Prevention program of PWID in Prison in 36 provinces.",171126,null,"Inactive","a6Q1R000000AJUP",171126,0,0,0,0,1,null,null,"DDC BL 365Technical support for Prevention program of PWID in Prison in 36 provinces.","High","This intervention will provide technical support for prevention programming for people who inject drugs in prison in 36 provinces","NA Original Intervention: Prevention and management of co-infections and co-morbidities for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5762","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00569","HIV testing services for people in prisons and other closed settings","DDC BL 359HIV testing services for Prisoner by using oral fluidHIV testing  for Prisoner is set 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.",355100,null,"Inactive","a6Q1R000000AJUO",355100,0,0,0,0,1,null,null,"DDC BL 359HIV testing services for Prisoner by using oral fluidHIV testing  for Prisoner is set 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.","High","This intervention will support HIV oral fluid testing services for prisoners in order to reach 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5761","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00563","Community empowerment for people in prisons and other closed settings","DDC BL 358TB-HIV in PrisonsTelemedicine to improve and follow up patient' s clinical from hospital to prison in order to improve TB, HIV, IPT and OST service in 5 prisons in each year.",63270,null,"Active","a6Q1R000000AJUN",0,0,0,0,63270,0,null,null,"DDC BL 358TB-HIV in PrisonsTelemedicine to improve and follow up patient' s clinical from hospital to prison in order to improve TB, HIV, IPT and OST service in 5 prisons in each year.","High","This intervention will support the use of telemedicine to improve and follow up on a patient?s clinical status from hospital to prison in order to improve TB, HIV, IPT and OST service in 5 prisons in each year.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5760","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","DDC BL 374:XDR-TB drug procuring for XDR-TB patients;Y1,2018 = 10 casesY2,2019 = 15 casesY3,2020 = 20 cases.This request will be support for the expansion of XDR-TB treatment by the national TB program. NTP will be expanding diagnosis capacity in 12 ODPCs that will increase number of XDR detection. BTB will put more investment on treatment of those increasing but it may not reach the same diagnosis XDR-TB cases which expected to be 58, 70  and 82 cases in 2018, 2019, 2020 respectively.",174960,null,"Inactive","a6Q1R000000AJUM",174960,0,0,0,0,1,null,null,"DDC BL 374:XDR-TB drug procuring for XDR-TB patients;Y1,2018 = 10 casesY2,2019 = 15 casesY3,2020 = 20 cases.This request will be support for the expansion of XDR-TB treatment by the national TB program. NTP will be expanding diagnosis capacity in 12 ODPCs that will increase number of XDR detection. BTB will put more investment on treatment of those increasing but it may not reach the same diagnosis XDR-TB cases which expected to be 58, 70  and 82 cases in 2018, 2019, 2020 respectively.","High","This intervention will support treatment for 45 XDR patients to complement domestic resources. The TRP recommends that this activity be funded under the within allocation should efficiencies be found.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5759","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","DDC BL 274:IPT service fee for Data recorder 400 Baht per time, 4 times per month for 27 hospitals, 54 hospitals and 108 hospitals in 2018, 2019 and 2020 respectively.",102956,null,"Active","a6Q1R000000AJUL",0,0,0,0,102956,0,null,null,"DDC BL 274:IPT service fee for Data recorder 400 Baht per time, 4 times per month for 27 hospitals, 54 hospitals and 108 hospitals in 2018, 2019 and 2020 respectively.","High","This intervention supports isoniazid preventive therapy (IPT) data recording service in hospitals","NA Original Intervention: Key populations (TB/HIV) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5758","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","RTF BL 18Platform for policy dialogue and campaign at sub-national level. Meeting PWID, local governmentagencies related to HR Units/Participants: 50 person per day.",36884,null,"Active","a6Q1R000000AJUK",0,0,0,0,36884,0,null,null,"RTF BL 18Platform for policy dialogue and campaign at sub-national level. Meeting PWID, local governmentagencies related to HR Units/Participants: 50 person per day.","High","Sensitization of law makers and law enforcement agents will complement the stigma and discrimination reduction and human rights awareness efforts. This intervention will support the organization of a workshop on advocacy and policy to lobby for community leaders and authorities in the community to establish good practices and drive policy changes in favor of key populations.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5757","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00586","HIV and HIV/TB-related legal services","RTF BL 17Meeting on legal services related HIV-TB. Meeting police, MOI, CSO Units/Participants: 37 person per day.",30235,null,"Active","a6Q1R000000AJUJ",0,0,0,0,30235,0,null,null,"RTF BL 17Meeting on legal services related HIV-TB. Meeting police, MOI, CSO Units/Participants: 37 person per day.","High","Sensitization of law makers and law enforcement agents will complement the stigma and discrimination reduction and human rights awareness efforts. This intervention will support the organization of a meeting on legal services related HIV -TB with police, the Ministry of Interior and CSOs. To ensure the ongoing efforts, meetings on legal services related to HIV/TB will be held regularly",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Zimbabwe","Zimbabwe","PAI-6116","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00564","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",76500,null,"Active","a6Q1R000000AJa6",0,0,0,0,76500,0,null,null,"Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","High","Prisoners are identified as an important KP group and a comprehensive program exists targeting this KPs",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6114","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00563","Community empowerment for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",184701,null,"Active","a6Q1R000000AJa4",0,0,0,0,184701,0,null,null,"Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwe?s 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","High","Prisoners are identified as an important Key Population (KP) group and a comprehensive program exists targeting this KPs",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6113","MCI-00019","RSSH: Financial management systems","MCI-00188","Other financial management intervention(s)","Additional scale up through extended outreach from fixed and mobile sites.",3446640,null,"Active","a6Q1R000000AJa3",0,0,0,0,3446640,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Global Fund Additional Safeguards regarding financial accountability applies in Zimbabwe","NA Original Module: RSSH - Financial management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6112","MCI-00019","RSSH: Financial management systems","MCI-00603","Routine financial management improvement (non-PFM)","Additional scale up through extended outreach from fixed and mobile sites.",929559,null,"Active","a6Q1R000000AJa2",0,0,0,0,929559,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Global Fund Additional Safeguards regarding financial accountability applies in Zimbabwe","NA Original Module: RSSH - Financial management systems. Original Intervention: Routine financial management improvement (non-public financial management)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6111","MCI-00019","RSSH: Financial management systems","MCI-00187","Public financial management (PFM) strengthening","Additional scale up through extended outreach from fixed and mobile sites.",254910,null,"Active","a6Q1R000000AJa1",0,0,0,0,254910,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Global Fund Additional Safeguards regarding financial accountability applies in Zimbabwe","NA Original Module: RSSH - Financial management systems. Original Intervention: Public financial management strengthening","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6110","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).",3132000,null,"Active","a6Q1R000000AJa0",0,0,0,0,3132000,0,null,null,"Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).","High","Support for the expanded CCS framework is needed to broaden access and CHW workload","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT South Africa","South Africa","PAI-5999","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","PAAR request will support in reaching 4,535 AGYW with in-patient alcohol and drug treatment programs, based on an estimated demand among young people for these services. Studies show that demand for alcohol and drug treatment programs in South Africa is approximately 16,986 individuals, of whom 26.7% are young people below the age of 22 years (Peltzer et al., 2011). The 2017 HSRC survey found the use of recreational drugs and excessive alcohol use were factors negatively associated with SBCC exposure (pg. xxxvii). Funding of this intervention in the PAAR is therefore expected to enhance the impact of the peer education and CSE activities in the allocation request.",9423892,null,"Active","a6Q1R000000AJYD",0,0,0,0,9423892,0,null,null,"PAAR request will support in reaching 4,535 AGYW with in-patient alcohol and drug treatment programs, based on an estimated demand among young people for these services. Studies show that demand for alcohol and drug treatment programs in South Africa is approximately 16,986 individuals, of whom 26.7% are young people below the age of 22 years (Peltzer et al., 2011). The 2017 HSRC survey found the use of recreational drugs and excessive alcohol use were factors negatively associated with SBCC exposure (pg. xxxvii). Funding of this intervention in the PAAR is therefore expected to enhance the impact of the peer education and CSE activities in the allocation request.","Medium",null,"NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-5998","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","PAAR funding will support provision of an additional 825,000 Xpert tests in the six priority TB districts. Several cross-sectional studies have reported a high yield of a universal TB testing strategy; one which tests everyone irrespective of the presence of TB symptoms. Examples of populations in whom targeted universal testing has been implemented are: adults admitted to hospital, HIV-infected pregnant women, household contacts of a TB patient. A cluster randomized study is about to commence to test this strategy in South African. If results of this study support this intervention; funding is requested for targeted universal testing for TB (TUTT) for PLHIV, pregnant women and TB household contacts.",13290140,null,"Active","a6Q1R000000AJYC",0,0,0,0,13290140,0,null,null,"PAAR funding will support provision of an additional 825,000 Xpert tests in the six priority TB districts. Several cross-sectional studies have reported a high yield of a universal TB testing strategy; one which tests everyone irrespective of the presence of TB symptoms. Examples of populations in whom targeted universal testing has been implemented are: adults admitted to hospital, HIV-infected pregnant women, household contacts of a TB patient. A cluster randomized study is about to commence to test this strategy in South African. If results of this study support this intervention; funding is requested for targeted universal testing for TB (TUTT) for PLHIV, pregnant women and TB household contacts.","Low","The TRP considers this request to be low priority, as a significant number of GeneXpert tests are already available through existing resources. Expanding universal coverage to GeneXpert testing can be coordinated through the available resources.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-5997","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Funding will support in providing child care for children of sex workers, by supporting 26 entry-level child and youth care workers (R3,500/month), 2 per sex worker district. Children of sex workers have been identified as an area of need. FSW in South Africa are responsible for four child or adult dependents (on average), while MSW and TGSW are responsible for two.  A research study on the basic demographics, living arrangements, risk factors and supervision is underway in the current grant, with findings anticipated in February 2019. Allocation funding will support defining and providing parenting programs suitable for sex workers who have children living with them. The PAAR request to provide direct childcare services for children who live at home with sex workers will be a value add to the parenting programs prioritized in the allocation request.",1210436,null,"Active","a6Q1R000000AJYB",0,0,0,0,1210436,0,null,null,"Funding will support in providing child care for children of sex workers, by supporting 26 entry-level child and youth care workers (R3,500/month), 2 per sex worker district. Children of sex workers have been identified as an area of need. FSW in South Africa are responsible for four child or adult dependents (on average), while MSW and TGSW are responsible for two.  A research study on the basic demographics, living arrangements, risk factors and supervision is underway in the current grant, with findings anticipated in February 2019. Allocation funding will support defining and providing parenting programs suitable for sex workers who have children living with them. The PAAR request to provide direct childcare services for children who live at home with sex workers will be a value add to the parenting programs prioritized in the allocation request.","Medium",null,"NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-5996","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00098","OST and other drug dependence treatment for PWID","Funding will support in placing an additional 500 drug users on OST. With the allocation amount, 300 people will be placed on OST by year three of the grant. If PAAR is granted, OST coverage will increase from 4% of PWID reached, to 10%. Note: This PAAR request is only for the OST procurement, since human resources for OST and site costs are provided for in the allocation request.",2602628,null,"Active","a6Q1R000000AJYA",0,0,0,0,2602628,0,null,null,"Funding will support in placing an additional 500 drug users on OST. With the allocation amount, 300 people will be placed on OST by year three of the grant. If PAAR is granted, OST coverage will increase from 4% of PWID reached, to 10%. Note: This PAAR request is only for the OST procurement, since human resources for OST and site costs are provided for in the allocation request.","High",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-5995","MCI-00008","TB care and prevention","MCI-00127","Treatment","This PAAR investment will support innovative TB treatment adherence models, including mHealth app development, adherence supporters, and medication devices. 40% of coverage is requested in the allocation budget for DR-TB adherence support. Another 60% is requested in PAAR for DS-TB adherence to ensure that the missing patients found with Global Fund and increased national efforts are supported to complete TB treatment to limit transmission, TB relapse and the development of resistance. There is an international move away from Directly Observed Treatment (DOT) towards more patient-centred adherence support which is modified to patient's need.",4999175,null,"Active","a6Q1R000000AJY9",0,0,0,0,4999175,0,null,null,"This PAAR investment will support innovative TB treatment adherence models, including mHealth app development, adherence supporters, and medication devices. 40% of coverage is requested in the allocation budget for DR-TB adherence support. Another 60% is requested in PAAR for DS-TB adherence to ensure that the missing patients found with Global Fund and increased national efforts are supported to complete TB treatment to limit transmission, TB relapse and the development of resistance. There is an international move away from Directly Observed Treatment (DOT) towards more patient-centred adherence support which is modified to patient's need.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT South Africa","South Africa","PAI-5994","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00545","Pre-exposure prophylaxis (PrEP) for sex workers","According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for sex workers is 95%. For the Global Fund program, this equates to 19,192 sex workers. 3,439 sex workers will be given PrEP through the allocation funding. PAAR funding will fill the gap between the allocation and optimal coverage, providing an additional 15,753 sex workers with PrEP. This will be paired with an intensive and targeted knowledge campaign to increase demand for PrEP among sex workers. PAAR will increase PrEP coverage in the target districts from 17% to 95%, and decrease the national programmatic gap for AGYW PrEP by 32% (from 49,420 to 33,667).",4013576,null,"Active","a6Q1R000000AJY8",0,0,0,0,4013576,0,null,null,"According to the cost-effectiveness analysis in South Africa's PrEP Investment Case, the optimal coverage of PrEP for sex workers is 95%. For the Global Fund program, this equates to 19,192 sex workers. 3,439 sex workers will be given PrEP through the allocation funding. PAAR funding will fill the gap between the allocation and optimal coverage, providing an additional 15,753 sex workers with PrEP. This will be paired with an intensive and targeted knowledge campaign to increase demand for PrEP among sex workers. PAAR will increase PrEP coverage in the target districts from 17% to 95%, and decrease the national programmatic gap for AGYW PrEP by 32% (from 49,420 to 33,667).","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2022-03-31"]
["CT Eswatini","Eswatini","PAI-5690","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Conduct regular coordination and review meetings at community level by all service providers.",50000,null,"Active","a6Q1R000000AJTE",0,0,0,0,50000,0,null,null,"Conduct regular coordination and review meetings at community level by all service providers.","Medium","Coordination meetings at local level to strengthen the responsiveness to the needs of the local health environment.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5689","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","Procure syphilis test kits to cover 50% of the country need. This builds on the 50% which is contained in the allocation amount.",81800,null,"Inactive","a6Q1R000000AJTD",81800,0,0,0,0,1,null,null,"Procure syphilis test kits to cover 50% of the country need. This builds on the 50% which is contained in the allocation amount.","High","Syphilis testing and treatment is an important intervention to improve outcomes for affected children. This additional allocation will stretch coverage from 50% to a 100%.","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5688","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Scale up advocacy for youth friendly ASRHR services especially targeting adolescent & young girls.",20000,null,"Active","a6Q1R000000AJTC",0,0,0,0,20000,0,null,null,"Scale up advocacy for youth friendly ASRHR services especially targeting adolescent & young girls.","Medium","Advocacy for youth friendly health services.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5687","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Printing of TB registers to complement the commitment from partners (PEPFAR/CDC) to support the program with this activity.",128000,null,"Active","a6Q1R000000AJTB",0,0,0,0,128000,0,null,null,"Printing of TB registers to complement the commitment from partners (PEPFAR/CDC) to support the program with this activity.","Medium","The funding request mentions additional funding and support from other partners such as the CDC in order to pursue and support this activity; therefore it is viewed as medium priority for this disbursement.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5686","MCI-00010","MDR-TB","MCI-00144","Community MDR-TB care delivery","Strengthen ambulatory/community MDR-TB care and establish four regional sprinter ambulance costs. The ambulance will include a bed, oxygen cylinder, tubes, masks, stretcher, endotrachial tubes, IVs, cardio resuscitation, drug cabinets, fire extinguisher.",540000,null,"Active","a6Q1R000000AJTA",0,0,0,0,540000,0,null,null,"Strengthen ambulatory/community MDR-TB care and establish four regional sprinter ambulance costs. The ambulance will include a bed, oxygen cylinder, tubes, masks, stretcher, endotrachial tubes, IVs, cardio resuscitation, drug cabinets, fire extinguisher.","Medium","Four regional sprinter ambulance costs would be beneficial, but it is not considered a high priority activity comparing to other interventions","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5685","MCI-00008","TB care and prevention","MCI-00127","Treatment","Funding is requested to support Swaziland?s TB hospital to become a center of excellence. Specifically, funding will support a benchmarking exercise with Kimberly Hospital (Cape Town in South Africa), curriculum development  and workshops for in-country and international trainings, partitioning and extending the mechanical ventilation to operationalize the dialysis machine), and technical assistance to ensure the certification of the hospital as center of excellence.",30000,null,"Active","a6Q1R000000AJT9",0,0,0,0,30000,0,null,null,"Funding is requested to support Swaziland?s TB hospital to become a center of excellence. Specifically, funding will support a benchmarking exercise with Kimberly Hospital (Cape Town in South Africa), curriculum development  and workshops for in-country and international trainings, partitioning and extending the mechanical ventilation to operationalize the dialysis machine), and technical assistance to ensure the certification of the hospital as center of excellence.","Medium","It would be beneficial to establish a Centre of excellence in Swaziland, but this is not considered as a high priority comparing to other interventions.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5684","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","Additional ready-to-use supplementary nutrition for TB/HIV co-infected patients. This will expand the criteria beyond the allocation (which only focuses on co-infected patients with BMI of 18.5 or lower. Evidence in Swaziland suggests that there is need for nutritional support even for those who are not extremely malnourished.",1501934,null,"Active","a6Q1R000000AJT8",0,0,0,0,1501934,0,null,null,"Additional ready-to-use supplementary nutrition for TB/HIV co-infected patients. This will expand the criteria beyond the allocation (which only focuses on co-infected patients with BMI of 18.5 or lower. Evidence in Swaziland suggests that there is need for nutritional support even for those who are not extremely malnourished.","Medium","Supplementary nutrition is important but not a high priority.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Somalia","Somalia","PAI-5587","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence.",270000,null,"Active","a6Q1R000000AJRZ",193876,0,0,0,76124,0,null,null,"Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence.","High","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of people living with HIV and their families and affects treatment adherence. Proposed to be included in a Community Based Stigma Reduction Package at line 2 above .",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5586","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. Campaigns to normalize HIV and improve knowledge about HIV treatment are important to reduce stigma.",63306,null,"Active","a6Q1R000000AJRY",0,0,0,0,63306,0,null,null,"Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. Campaigns to normalize HIV and improve knowledge about HIV treatment are important to reduce stigma.","High","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of people living with HIV and their families and affects treatment adherence. Campaigns to normalize HIV and improve knowledge about HIV treatment are important interventions to reduce stigma.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5585","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Support the mid term review of the 2017 to 2021 HSSPs.",142240,null,"Active","a6Q1R000000AJRX",0,0,0,0,142240,0,null,null,"Support the mid term review of the 2017 to 2021 HSSPs.","Medium","Support the mid-term review of the 2017 to 2021 HSSPs.","NA Original Module: RSSH - National health strategies. Original Intervention: Mid-term review of the Health Sector Strategic Plan","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5584","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Improve the collection and dissemination of strategic information, to better inform program planning and review.",73620,null,"Active","a6Q1R000000AJRW",0,0,0,0,73620,0,null,null,"Improve the collection and dissemination of strategic information, to better inform program planning and review.","Medium","Improve the collection and dissemination of strategic information, to better inform program planning and review.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Strategic information planning and capacity building","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5583","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To implement hospital Data Assistants to improve hospital based data collection and reporting. One per region.",463600,null,"Active","a6Q1R000000AJRV",0,0,0,0,463600,0,null,null,"To implement hospital Data Assistants to improve hospital based data collection and reporting. One per region.","Medium","To implement hospital Data Assistants to improve hospital based data collection and reporting. One per region.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Strengthen hospital data collection and quality assurance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5582","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.",119520,null,"Active","a6Q1R000000AJRU",0,0,0,0,119520,0,null,null,"Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.","Medium","Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Supply Chain Working Group","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Somalia","Somalia","PAI-5581","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. Working with decision-makers to educate them on HIV/AIDS is important to change norms around HIV-related stigma.",110700,null,"Active","a6Q1R000000AJRT",0,0,0,0,110700,0,null,null,"Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. Working with decision-makers to educate them on HIV/AIDS is important to change norms around HIV-related stigma.","High","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of people living with HIV and their families and affects treatment adherence. Working with decision-makers to educate them on HIV/AIDS is an important intervention in changing norms around HIV - related stigma.","NA Original Intervention: Sensitization of lawmakers and law enforcement agents","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Paraguay","Paraguay","PAI-5449","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Analysis, review and disclosure.\nThe considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required the monitor the grant, which is why these financial resources are required to comply with this duty with the required technical accuracy.",98262,null,"Active","a6Q1R000000AJPL",0,93833,0,0,4429,0,null,null,"Analysis, review and disclosure.\nThe considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required the monitor the grant, which is why these financial resources are required to comply with this duty with the required technical accuracy.","Low",null,"NA Original Module: SRSS: Health information systems and monitoring and evaluation. Original Intervention: Analysis, review and disclosure","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Paraguay","Paraguay","PAI-5448","MCI-00023","Program management","MCI-00207","Grant management","Grant management. \nThe considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required at the main receiver, which is why these financial resources are required to retain most of the staff currently comprising the working team.",147392.84,null,"Active","a6Q1R000000AJPK",0,0,0,0,147392.84,0,null,null,"Grant management. \nThe considerable reduction in resources with the allocated funding makes it difficult to have enough human resources to meet the key duties required at the main receiver, which is why these financial resources are required to retain most of the staff currently comprising the working team.","Low","Budget for grant management is also included within the allocation funding request. The proportion of the allocation budget committed to program management could increase following the reclassification of budget-line categories during grant making ? and depending on this, the Secretariat may reprioritize this additional request, as needed.","NA Original Module: SRSS: Program management","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Paraguay","Paraguay","PAI-5447","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Expansion of laboratory network with rapid molecular diagnostic devices and consumables.\nAcquisition of 3 rapid molecular diagnosis devices and consumables is deemed necessary, by means of this grant, for districts with a high load of TB cases. It should be noted that for universal diagnosis approximately 35 devices will be required across the country, and in order for this to be effective, the State must acquire them gradually.\nIn accordance with the indications of the Global Laboratory Initiative (GLI), this test must be used in place of conventional microscopy and cultures for initial diagnostic testing in all adults and children with suspected pulmonary tuberculosis. Chiefly, for initial diagnosis for adults and children with suspected MDR tuberculosis or HIV / TB (GLI Practical Guide to TB Laboratory Strengthening - March 2017)\nThis is aimed at universal diagnosis of TB in districts with this technology.",93832.7,null,"Active","a6Q1R000000AJPJ",0,0,0,0,93832.7,0,null,null,"Expansion of laboratory network with rapid molecular diagnostic devices and consumables.\nAcquisition of 3 rapid molecular diagnosis devices and consumables is deemed necessary, by means of this grant, for districts with a high load of TB cases. It should be noted that for universal diagnosis approximately 35 devices will be required across the country, and in order for this to be effective, the State must acquire them gradually.\nIn accordance with the indications of the Global Laboratory Initiative (GLI), this test must be used in place of conventional microscopy and cultures for initial diagnostic testing in all adults and children with suspected pulmonary tuberculosis. Chiefly, for initial diagnosis for adults and children with suspected MDR tuberculosis or HIV / TB (GLI Practical Guide to TB Laboratory Strengthening - March 2017)\nThis is aimed at universal diagnosis of TB in districts with this technology.","High",null,"NA Original Module: SRSS: Provision of integrated services and quality improvement. Original Intervention: Laboratory systems for disease prevention, monitoring, treatment and surveillance","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Paraguay","Paraguay","PAI-5446","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Acquisition of portable viral load and CD4 equipment in the community Voluntary Counceling and Testing Center. These teams will facilitate the follow-up of people diagnosed in the community viral loadT as part of the strategy to improve access to comprehensive care. The implementation of the community Voluntary Counceling and Testing Center complements the provision of testing services and the monitoring of reactive persons, since it works in extended hours and facilitates access to people of the target population who do not want or are not able go to the public services of MSPyBS.",32624,null,"Active","a6Q1R000000AJPI",0,0,0,0,32624,0,null,null,"Acquisition of portable viral load and CD4 equipment in the community Voluntary Counceling and Testing Center. These teams will facilitate the follow-up of people diagnosed in the community viral loadT as part of the strategy to improve access to comprehensive care. The implementation of the community Voluntary Counceling and Testing Center complements the provision of testing services and the monitoring of reactive persons, since it works in extended hours and facilitates access to people of the target population who do not want or are not able go to the public services of MSPyBS.","High","The requested equipment is necessary to ensure proper treatment monitoring thus it is recommended as high priority. However, the TRP requests the applicant to clarify how many units of the requested equipment; and the allocation be based on the anticipated use rate of the equipment",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-02-28"]
["CT Paraguay","Paraguay","PAI-5445","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Recruitment of consultancy to carry out the Study of People that continue to 12, 24, 36, 60 months of initiation of therapy, with a new cohort for 2012, and 12 months of initiation of therapy for the cohort of 2014, 2015 and 2016. At the request of UNAIDS, it is necessary to modify the cohorts of people who annually initiate treatment with ARV, in order to adapt them to the annual fiscal cut. Currently, the cohorts begin on August 1 of the year and close on July 31 of the following year. As of 2016, PRONASIDA has decided to report fiscal year cohorts; therefore, with this consultancy we could have information of 24, 36 and 60 months that can be compared with the new cohorts. Having this information will inform the country the state of adherence to ART over time in the different annual cohorts.",3000,null,"Active","a6Q1R000000AJPH",0,0,0,0,3000,0,null,null,"Recruitment of consultancy to carry out the Study of People that continue to 12, 24, 36, 60 months of initiation of therapy, with a new cohort for 2012, and 12 months of initiation of therapy for the cohort of 2014, 2015 and 2016. At the request of UNAIDS, it is necessary to modify the cohorts of people who annually initiate treatment with ARV, in order to adapt them to the annual fiscal cut. Currently, the cohorts begin on August 1 of the year and close on July 31 of the following year. As of 2016, PRONASIDA has decided to report fiscal year cohorts; therefore, with this consultancy we could have information of 24, 36 and 60 months that can be compared with the new cohorts. Having this information will inform the country the state of adherence to ART over time in the different annual cohorts.","High","ART adherence monitoring is relevant for HIV treatment effectiveness. Noting the connection between this item and the next one, the TRP suggests the applicant combine the consultancy with shift cohort tracking below to ensure consistency, compatibility of data/ information/ methodology and prioritize M&E for this activity.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-02-28"]
["CT Paraguay","Paraguay","PAI-5444","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Cohort study of the evolution of the response to ART in Paraguay. This study, to be carried out for the first time in the country will allow monitoring of a cohort from 2018 to 2020 to evaluate the durability of viral load suppression, factors of adherence (and non-adherence), OI frequency and the toxicity of ART. The information gathered aims to identify the different factors that affect PLWHIV during treatment and affect adherence and the corresponding Viral suppression. It is also intended to have relevant information to make decisions about the prioritization of treatment schemes and other actions that facilitate adherence to treatment. Finally, the information could also imply an update in the treatment protocols. This information will be very useful for monitoring the fourth, fifth and sixth pillar of the waterfall.",36000,null,"Active","a6Q1R000000AJPG",0,0,0,0,36000,0,null,null,"Cohort study of the evolution of the response to ART in Paraguay. This study, to be carried out for the first time in the country will allow monitoring of a cohort from 2018 to 2020 to evaluate the durability of viral load suppression, factors of adherence (and non-adherence), OI frequency and the toxicity of ART. The information gathered aims to identify the different factors that affect PLWHIV during treatment and affect adherence and the corresponding Viral suppression. It is also intended to have relevant information to make decisions about the prioritization of treatment schemes and other actions that facilitate adherence to treatment. Finally, the information could also imply an update in the treatment protocols. This information will be very useful for monitoring the fourth, fifth and sixth pillar of the waterfall.","High","ART adherence monitoring is relevant for HIV treatment effectiveness. Noting the connection between this item and the next one, the TRP suggests the applicant combine the consultancy with shift cohort tracking below to ensure consistency, compatibility of data/information/ 4 methodology and prioritize M&E for this activity","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-02-28"]
["CT Pakistan","Pakistan","PAI-5354","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","WHO technical assistance is continuously required for supporting the provincial malaria control programs. The NPOs will be based in WHO provincial sub-offices and will provide technical guidance and support to the provincial government in minimizing the public health impact resulting from epidemics of communicable diseases mainly malaria, HIV/AIDS and TB.",200000,null,"Active","a6Q1R000000AJNo",0,0,0,0,200000,0,null,null,"WHO technical assistance is continuously required for supporting the provincial malaria control programs. The NPOs will be based in WHO provincial sub-offices and will provide technical guidance and support to the provincial government in minimizing the public health impact resulting from epidemics of communicable diseases mainly malaria, HIV/AIDS and TB.","Low","This funding request is to support the technical\nassistance provided by WHO at the provincial level. A 25% of the original request is being recommended for PAAR.","NA Original Intervention: Provincial NPOs ? WHO","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5353","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Current National Malaria Strategic Plan was developed in 2014 for 2015-2020, guided by the MPR led by WHO. National and provincial strategic plans need to be updated to align with GTS 2016 ? 2030. Findings from malaria programmatic review in 2018 and malaria prevalence survey would guide for strategizing interventions (quality case management, prompt and effective treatment, selective vector control, scaling up of treated LLINs use and epidemic preparedness, detection and response) according to disease endemicity.",100000,null,"Active","a6Q1R000000AJNn",0,0,0,0,100000,0,null,null,"Current National Malaria Strategic Plan was developed in 2014 for 2015-2020, guided by the MPR led by WHO. National and provincial strategic plans need to be updated to align with GTS 2016 ? 2030. Findings from malaria programmatic review in 2018 and malaria prevalence survey would guide for strategizing interventions (quality case management, prompt and effective treatment, selective vector control, scaling up of treated LLINs use and epidemic preparedness, detection and response) according to disease endemicity.","Medium","This additional support will helpto develop new national and\nprovincial plans for the 2021-2025 and their alignment with\nthe Global Technical Strategy 2016-2030.","NA Original Intervention: Updating national and provincial strategic plans for (2021-2025)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5352","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","MPR objectives are to review in 2018 the malaria program structure and capacity in each province and at national level, identify challenges and have the epidemiological outlook of malaria per province. Furthermore, this will assess current program performance and help redefine strategic direction, including revision of policies and strategic plans at provincial levels.",100000,null,"Active","a6Q1R000000AJNm",0,0,0,0,100000,0,null,null,"MPR objectives are to review in 2018 the malaria program structure and capacity in each province and at national level, identify challenges and have the epidemiological outlook of malaria per province. Furthermore, this will assess current program performance and help redefine strategic direction, including revision of policies and strategic plans at provincial levels.","Medium","This funding will cover theimplementation of the malaria programmatic review in the country.","NA Original Intervention: Malaria programmatic review (MPR)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5351","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.",5200000,null,"Active","a6Q1R000000AJNl",0,599101,0,0,4600899,0,null,null,"In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.","High","LLIN requirement for mass distribution of LLINs in seven\nStratum-IA districts (N.Waziristan, Kurram, Tharpakar,Khairpur, Kech, Sibi, and Noushki) that are currently not receiving funding to support","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Pakistan","Pakistan","PAI-5350","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The grant funds cover the distribution of LLINs for pregnant women (high risk population) through ANC clinics for 2018 only. Due to the funding limitations, LLINs required for pregnant women for 2019 and 2020 are being requested through PAAR. A total of 653,464 LLINs (298,937 in 2019 and 354,527 in 2020) would be required for distribution to cover the pregnant women's needs.",1500000,null,"Active","a6Q1R000000AJNk",0,0,0,0,1500000,0,null,null,"The grant funds cover the distribution of LLINs for pregnant women (high risk population) through ANC clinics for 2018 only. Due to the funding limitations, LLINs required for pregnant women for 2019 and 2020 are being requested through PAAR. A total of 653,464 LLINs (298,937 in 2019 and 354,527 in 2020) would be required for distribution to cover the pregnant women's needs.","High","This request aimed to addressimplementation gaps in the\nLLINs continuous distributionthrough antenatal clinics for2019 and 2020.","NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Lesotho","Lesotho","PAI-4737","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","The HIV prevalence for Adolescents and young people is 13% among young women and 6% among young men (Avert 2016). One of the key drivers for the high prevalence among adolescents and young people is limited knowledge of HIV prevention and available services. This is evidence by the LDHS (2013) that indicated for persons aged 15 -24 years, comprehensive knowledge was as low at 30.9% and the LePHIA (2017) report indicated that awareness of HIV and status among the same age group is at 56.2% for males and 61.4 % for the females.  \n\nSocial marketing has been established as an effective behavioural change model for several public health issues. To increase the comprehensive knowledge, several interventions are funded including the development of the SBCC strategy by UNICEF and the  social marketing strategy under NFM 2. The main gap identified is the operationalisation of these strategies, in particular is the social marketing strategy. The intervention bridges the skills gap in delivering comprehensive prevention services for adolescents and young people through understanding the barriers and the factors accounting for the low knowledge on HIV and uptake of health care services among AGY. The focus will be on:\n? Training of PR and SRs on delivering SBCC interventions for AGY. This will include market insights and analysis for target segments based on behavioural insights (for differentiated messaging) obtained from phase one (informative assessment).\n? Defining the communication strategy and develop specific massages, compelling visuals and custom channels for AGY. This exercise will produce the campaign assets for communicating to young people.\n? Deliver and test the SBCC marketing campaign in pre-determined pilot area and presentation of evaluation for full scale implementation.",860000,null,"Active","a6Q1R000000AJDr",0,0,0,0,860000,0,null,null,"The HIV prevalence for Adolescents and young people is 13% among young women and 6% among young men (Avert 2016). One of the key drivers for the high prevalence among adolescents and young people is limited knowledge of HIV prevention and available services. This is evidence by the LDHS (2013) that indicated for persons aged 15 -24 years, comprehensive knowledge was as low at 30.9% and the LePHIA (2017) report indicated that awareness of HIV and status among the same age group is at 56.2% for males and 61.4 % for the females.  \n\nSocial marketing has been established as an effective behavioural change model for several public health issues. To increase the comprehensive knowledge, several interventions are funded including the development of the SBCC strategy by UNICEF and the  social marketing strategy under NFM 2. The main gap identified is the operationalisation of these strategies, in particular is the social marketing strategy. The intervention bridges the skills gap in delivering comprehensive prevention services for adolescents and young people through understanding the barriers and the factors accounting for the low knowledge on HIV and uptake of health care services among AGY. The focus will be on:\n? Training of PR and SRs on delivering SBCC interventions for AGY. This will include market insights and analysis for target segments based on behavioural insights (for differentiated messaging) obtained from phase one (informative assessment).\n? Defining the communication strategy and develop specific massages, compelling visuals and custom channels for AGY. This exercise will produce the campaign assets for communicating to young people.\n? Deliver and test the SBCC marketing campaign in pre-determined pilot area and presentation of evaluation for full scale implementation.","Medium","For CCM/Disease Program consideration: SBCC could require additional justification. Amount seems high given Lesotho?s size, and heavily focused on training. This is a suggestion to improve this intervention; the country does not have to respond to it.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4736","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00573","Gender-based violence prevention and treatment programs for adolescents and youth","Under NFM 2, the country provides services to adolescents and young people in the 8 districts, however, the provision of these services is not supported by a harmonised and standardised vulnerability assessment, resulting in a non-differentiated approach. This is currently a gap and the country seek to address this issue. To ensure a more targeted response to the needs of the individual, the following is proposed:\n\n? Review and adapt existing tools (e.g. Ministry of Social Development Vulnerability tools, FHI 360 and population council) towards the development of an algorithm to assess HIV vulnerability amongst young people. The algorithm will be applied nationally and will enable the country to provide tailored interventions to reduce the risk of HIV among young people. \n? Train 191 peer educators to administer the vulnerability assessment tool and conduct the assessment of 70,000 young people across the eight districts supported by the Global Fund. \n? The country has a defined package of services for AGYW, however not all adolescents and young people require a full package of service to prevent HIV. Based on the identified needs emerging from the vulnerability assessment, components from defined package of services for AGYW will be used for a more tailored and targeted approach, thereby maximising the impact of services for the AGYW. A total of 28,000 (40% based on the current assessment practices) adolescents and young people will be reached with this response based approach.\n? The intervention will contribute to improved efficiencies of the allocation funding by ensuring that are most responsive to the identified needs are addressed by liking the most vulnerable adolescents to appropriate services in an equitable manner in all 8 districts.",58810,null,"Active","a6Q1R000000AJDq",0,0,0,0,58810,0,null,null,"Under NFM 2, the country provides services to adolescents and young people in the 8 districts, however, the provision of these services is not supported by a harmonised and standardised vulnerability assessment, resulting in a non-differentiated approach. This is currently a gap and the country seek to address this issue. To ensure a more targeted response to the needs of the individual, the following is proposed:\n\n? Review and adapt existing tools (e.g. Ministry of Social Development Vulnerability tools, FHI 360 and population council) towards the development of an algorithm to assess HIV vulnerability amongst young people. The algorithm will be applied nationally and will enable the country to provide tailored interventions to reduce the risk of HIV among young people. \n? Train 191 peer educators to administer the vulnerability assessment tool and conduct the assessment of 70,000 young people across the eight districts supported by the Global Fund. \n? The country has a defined package of services for AGYW, however not all adolescents and young people require a full package of service to prevent HIV. Based on the identified needs emerging from the vulnerability assessment, components from defined package of services for AGYW will be used for a more tailored and targeted approach, thereby maximising the impact of services for the AGYW. A total of 28,000 (40% based on the current assessment practices) adolescents and young people will be reached with this response based approach.\n? The intervention will contribute to improved efficiencies of the allocation funding by ensuring that are most responsive to the identified needs are addressed by liking the most vulnerable adolescents to appropriate services in an equitable manner in all 8 districts.","High","GBV addition complements existing activities.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4735","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) reported that the country is making good progress towards the UNAIDS 90-90-90 targets with 81% of PLHIV knowing their status, 92% of those who know their status on treatment, and 88% of those on treatment being virally suppressed. Despite tremendous efforts in scaling up HTS in Lesotho still 82, 000 PLHIV do not know their status, among these men, adolescents and young people, key populations and partners of people living with HIV (PLHIV). A key strategy to addressing this gap in the abovementioned target group is the provision of HIV self-testing (HIVST). In support of MOH Lesotho (MOHL), Unitaid funded the introduction and scale up of HIV self-testing in 2017. In 2018 a total of 58, 000 HIVST were distributed, mainly through community-based distribution. During this period majority of the self-testers were high-risk men (58%), adolescents 15-24 (35%) and key populations (7%). Furthermore, the Unitaid supported project reported that the number of HIV positive cases increased. The HTS Strategy has since been developed (Annex 1).\n\nIn 2019 Unitaid will fund 43,342 HIVST kits and 64, 000 will be funded by CDC. The implementation of the differentiated strategy for HTS will require scaling up of HIVST, i.e. to expand HIVST across the entire country a substantial increase in the procurement of HIVST kit is needed. The estimated gap in HIVST kit commodities for the period 2020 is 240,000 and 2021 is 200,000 to cover all geographic areas. In particular the focus will be on:\n? Hot spots, male dominated workplaces, places frequented by adolescents and young people, market places, taxi ranks, door to door distribution and campaign style distribution. \n? Key populations (MSM, Sex workers) - based on current trends, it is estimated that 2000 HIVST kits would be distributed annually to these populations.\n? Antenatal clinics (ANC) - based on current trends for this target group, an estimated 34, 560 test kits will be required to reach male sexual partners of ANC clinic attendees. \n? Distribution through index patients (ART initiations at public sector hospitals): the current trends indicate that uptake by positive index patients and by sexual partner, estimates the requirement of 15, 000 test kits annually.\n? Direct distribution to Outpatients departments: Based on current trends indicates that annually an estimated 72, 000 test kits would be required.",3520000,null,"Inactive","a6Q1R000000AJDp",3520000,0,0,0,0,1,null,null,"The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) reported that the country is making good progress towards the UNAIDS 90-90-90 targets with 81% of PLHIV knowing their status, 92% of those who know their status on treatment, and 88% of those on treatment being virally suppressed. Despite tremendous efforts in scaling up HTS in Lesotho still 82, 000 PLHIV do not know their status, among these men, adolescents and young people, key populations and partners of people living with HIV (PLHIV). A key strategy to addressing this gap in the abovementioned target group is the provision of HIV self-testing (HIVST). In support of MOH Lesotho (MOHL), Unitaid funded the introduction and scale up of HIV self-testing in 2017. In 2018 a total of 58, 000 HIVST were distributed, mainly through community-based distribution. During this period majority of the self-testers were high-risk men (58%), adolescents 15-24 (35%) and key populations (7%). Furthermore, the Unitaid supported project reported that the number of HIV positive cases increased. The HTS Strategy has since been developed (Annex 1).\n\nIn 2019 Unitaid will fund 43,342 HIVST kits and 64, 000 will be funded by CDC. The implementation of the differentiated strategy for HTS will require scaling up of HIVST, i.e. to expand HIVST across the entire country a substantial increase in the procurement of HIVST kit is needed. The estimated gap in HIVST kit commodities for the period 2020 is 240,000 and 2021 is 200,000 to cover all geographic areas. In particular the focus will be on:\n? Hot spots, male dominated workplaces, places frequented by adolescents and young people, market places, taxi ranks, door to door distribution and campaign style distribution. \n? Key populations (MSM, Sex workers) - based on current trends, it is estimated that 2000 HIVST kits would be distributed annually to these populations.\n? Antenatal clinics (ANC) - based on current trends for this target group, an estimated 34, 560 test kits will be required to reach male sexual partners of ANC clinic attendees. \n? Distribution through index patients (ART initiations at public sector hospitals): the current trends indicate that uptake by positive index patients and by sexual partner, estimates the requirement of 15, 000 test kits annually.\n? Direct distribution to Outpatients departments: Based on current trends indicates that annually an estimated 72, 000 test kits would be required.","High","Better case finding strategies needed to ensure efficient use of resources.","Email from CT says that the this intervention is funded, through budget revisions","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4734","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","The funding will be used for the procurement of two additional vehicles to support program implementation by the sub-recipients of the adolescent girls and young women activities in eight districts.",88000,null,"Active","a6Q1R000000AJDo",0,0,0,0,88000,0,null,null,"The funding will be used for the procurement of two additional vehicles to support program implementation by the sub-recipients of the adolescent girls and young women activities in eight districts.","Medium","Though the activity is important, optimal management and coordination of available fleet is essential for efficiency.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Lesotho","Lesotho","PAI-4733","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","The prevalence survey will enable the program to improve the quality of data, planning, reporting and forecasting. The survey was initiated in 2017, however, could not be continued due to a number of reasons, including the need to improve the National Reference Lab and procure X-ray machines. Both activities are to be completed with the World Bank support in June 2018. The prevalence survey will be funded through the reinvestment of the efficiencies identified during the grant making.",2200000,null,"Inactive","a6Q1R000000AJDn",2200000,0,0,0,0,1,null,null,"The prevalence survey will enable the program to improve the quality of data, planning, reporting and forecasting. The survey was initiated in 2017, however, could not be continued due to a number of reasons, including the need to improve the National Reference Lab and procure X-ray machines. Both activities are to be completed with the World Bank support in June 2018. The prevalence survey will be funded through the reinvestment of the efficiencies identified during the grant making.","High","This activity is high priority. The prevalence survey will enable the program use the data for effective planning.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-06-30"]
["CT Sri Lanka","Sri Lanka","PAI-4732","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Procurement &  Installation of  3 nos of Digital X-ray machines for National Hospital of Sri Lanka, Colombo North teaching hospital, Kandy teaching hospital.",69000,null,"Active","a6Q1R000000AJDm",0,0,0,0,69000,0,null,null,"Procurement &  Installation of  3 nos of Digital X-ray machines for National Hospital of Sri Lanka, Colombo North teaching hospital, Kandy teaching hospital.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT South East Asia","2021-12-31"]
["CT Nigeria","Nigeria","PAI-5301","MCI-00010","MDR-TB","MCI-00126","Case detection and diagnosis","Communication and transportation support for contact tracing per index DR TB case and linkage to treatment:\n2,592 are targeted using above allocation. The intervention is for contact tracing per index DR TB case notified for additional 1,659 patients. Research shows that 10% of contacts of index TB cases would be TB patients. Assuming 4 contacts per index DR TB case this would result to additional 662 TB cases.",8144,null,"Active","a6Q1R000000AJMx",0,0,0,0,8144,0,"2020-01-29T12:52:00",null,"Communication and transportation support for contact tracing per index DR TB case and linkage to treatment:\n2,592 are targeted using above allocation. The intervention is for contact tracing per index DR TB case notified for additional 1,659 patients. Research shows that 10% of contacts of index TB cases would be TB patients. Assuming 4 contacts per index DR TB case this would result to additional 662 TB cases.","High",null,"NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Nigeria","Nigeria","PAI-5299","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Procurement of SLDs including PSM costs:\n10,183 DRTB cases will be notified with the allocation. An estimated 49.1% (5,000 patients) have been budgeted within the allocation. For the remaining, 5183 patients, the GON will provide SLDs for 50%(2592) while the GF will provide drugs for the remaining 50%(2592). This includes procurement fees, Insurance, Freight, in-country distribution (+ Last Mile), QA/QC charges and packaging materials.",5152151,null,"Active","a6Q1R000000AJMv",0,0,0,0,5152151,0,"2020-01-29T12:52:00",null,"Procurement of SLDs including PSM costs:\n10,183 DRTB cases will be notified with the allocation. An estimated 49.1% (5,000 patients) have been budgeted within the allocation. For the remaining, 5183 patients, the GON will provide SLDs for 50%(2592) while the GF will provide drugs for the remaining 50%(2592). This includes procurement fees, Insurance, Freight, in-country distribution (+ Last Mile), QA/QC charges and packaging materials.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Malawi","Malawi","PAI-5200","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","HTS trainings ($6.20M) Covers half of the need for skills intensive training. Also covers in full: 1) trainings to allow expansion of HDAs to non-PEPFAR-supported facilities. HDAs have proven instrumental in expansion of HTS for reaching 1st 90; 2) orientation in Bioline rapid test kit. This has been endorsed as the first test in the national HIV testing algorithm; 3) district quarterly reviews; and 4) district mentorship.",6200000,null,"Active","a6Q1R000000AJLK",2387275.39,0,0,0,3812724.61,0,null,null,"HTS trainings ($6.20M) Covers half of the need for skills intensive training. Also covers in full: 1) trainings to allow expansion of HDAs to non-PEPFAR-supported facilities. HDAs have proven instrumental in expansion of HTS for reaching 1st 90; 2) orientation in Bioline rapid test kit. This has been endorsed as the first test in the national HIV testing algorithm; 3) district quarterly reviews; and 4) district mentorship.","High","Increased testing through innovative approaches is one of the major changes in approach in this Funding request.","26/12/2019: Efficiencies (fiels ?Further efficiencies applied after reprogramming (US$) ?column AC) due to Portfolio Optimization.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5195","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","Continuation of general population community activities ($2.45M) Support will continue activities within current grant for general population prevention, including raising community demand for HIV testing and referral to care especially among high prevalence populations and communities. Other activities include mapping of condom distribution outlets and orientation of condom distributors, training of marriage counselors, and community progress review meetings.",2450000,null,"Active","a6Q1R000000AJLF",0,0,0,0,2450000,0,null,null,"Continuation of general population community activities ($2.45M) Support will continue activities within current grant for general population prevention, including raising community demand for HIV testing and referral to care especially among high prevalence populations and communities. Other activities include mapping of condom distribution outlets and orientation of condom distributors, training of marriage counselors, and community progress review meetings.","High","Community demand for testing needs to be increased.","NA Original Intervention: Other interventions for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5070","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Improved IPT coverage, will be implemented in all health care facilities.  This above allocation request will therefore allow the continued provision of sulfadoxine-pyrimethamine (SP) in 2021. This intervention will help achieve the NSP target to protect at least 80 percent of women through IPT, and to reduce the risk of low birth weight by approximately 21 percent and neonatal mortality by 61 percent.",1074953,null,"Active","a6Q1R000000AJJE",0,0,0,0,1074953,0,null,null,"Improved IPT coverage, will be implemented in all health care facilities.  This above allocation request will therefore allow the continued provision of sulfadoxine-pyrimethamine (SP) in 2021. This intervention will help achieve the NSP target to protect at least 80 percent of women through IPT, and to reduce the risk of low birth weight by approximately 21 percent and neonatal mortality by 61 percent.","High",null,"NA Original Module: Specific prevention interventions. Original Intervention: Intermittent preventive treatment ? In pregnancy","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Multicountry HIAS RAI","Multicountry East Asia and Pacific RAI","PAI-4966","MCI-00071","Other module","MCI-00071","Other module","Training for VHWs and commune staff on IRS and treatment of bednets will ensure a wide coverage of vector control interventions and reduced numbers of foci.",500000,null,"Inactive","a6Q1R000000AJHY",500000,0,0,0,0,1,null,null,"Training for VHWs and commune staff on IRS and treatment of bednets will ensure a wide coverage of vector control interventions and reduced numbers of foci.","Medium","Increased outreach for indoor residual spraying (IRS ) and bed -net treatment.","NA Original Module: RSSH. Original Intervention: Conduct training on vector control measures for all levels (Viet Nam )","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4961","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Regional workshop to validate tools on stigma, legal environment and gender in TB.  Prior to the implementation of the instruments in each country, we will conduct training for key implementers in each country, as well as experts on each of the topics, including representatives from the Stop TB Partnership and PAHO/WHO.",53700,null,"Inactive","a6Q1R000000AJHT",53700,0,0,0,0,1,null,null,"Regional workshop to validate tools on stigma, legal environment and gender in TB.  Prior to the implementation of the instruments in each country, we will conduct training for key implementers in each country, as well as experts on each of the topics, including representatives from the Stop TB Partnership and PAHO/WHO.","High","The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4830","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Advocacy planning workshops at regional and country level (utilizing findings of the participatory mapping and analysis exercise)",91434,null,"Inactive","a6Q1R000000AJFM",91434,0,0,0,0,1,null,null,"Advocacy planning workshops at regional and country level (utilizing findings of the participatory mapping and analysis exercise)","Medium",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4829","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Implement activities under the operational plan of the regional and national advocacy strategies",76650,null,"Active","a6Q1R000000AJFL",0,0,0,0,76650,0,null,null,"Implement activities under the operational plan of the regional and national advocacy strategies","Medium",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Multicountry EECA PAS","Multicountry EECA PAS","PAI-4943","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Presence and active participation in international conferences. TB Europe Coalition in partnership with Global TB Caucus will help to press for policy change, National Caucuses to host parliamentary dialogues and events.",35000,null,"Active","a6Q1R000000AJHB",0,0,0,0,35000,0,null,null,"Presence and active participation in international conferences. TB Europe Coalition in partnership with Global TB Caucus will help to press for policy change, National Caucuses to host parliamentary dialogues and events.","Medium",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Multicountry EECA PAS","Multicountry EECA PAS","PAI-4938","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","WHO Barcelona course on health systems strengthening and health financing (additional course in Y3). Building capacity of national TB and health systems counterpart to design and sustain efficient, people-centered TB care models and advance reforms.",100000,null,"Active","a6Q1R000000AJH6",0,0,0,0,100000,0,null,null,"WHO Barcelona course on health systems strengthening and health financing (additional course in Y3). Building capacity of national TB and health systems counterpart to design and sustain efficient, people-centered TB care models and advance reforms.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Thailand","Thailand","PAI-5756","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","RTF BL 19-211.Training of Trainer (ToT) to document violence and other human rights violation in all KPs2. Training OW and PE in all KPs to document violence and other human rights violation3. Policy advocacy concerning AIDS issues in workplace and educational institution, set up employer alliance to end S&D against HIV and TB.",264886,null,"Active","a6Q1R000000AJUI",0,0,0,0,264886,0,null,null,"RTF BL 19-211.Training of Trainer (ToT) to document violence and other human rights violation in all KPs2. Training OW and PE in all KPs to document violence and other human rights violation3. Policy advocacy concerning AIDS issues in workplace and educational institution, set up employer alliance to end S&D against HIV and TB.","High","This intervention will address stigma and discrimination among key populations through training community members to document violence and other human rights violations; empowering and increasing involvement of key population communities at sub -national and regional levels to improve policies; establishing a platform for policy dialogue and funding of a campaign. In addition, the PR will lead the establishment of Human Rights Defenders watch group to support and defend community members from human rights breaches and abuses",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Thailand","Thailand","PAI-5755","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00585","Training of health care providers on human rights and medical ethics related to HIV and HIV/TB","DDC BL 277Monitoring and coaching on S&D reduction related to HIV and HIV/TB in hospitals by central team.",10404,null,"Active","a6Q1R000000AJUH",0,0,0,0,10404,0,null,null,"DDC BL 277Monitoring and coaching on S&D reduction related to HIV and HIV/TB in hospitals by central team.","High","This intervention supports monitoring and coaching on stigma and discrimination reduction related to HIV and HIV/TB in hospitals.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Zimbabwe","Zimbabwe","PAI-6108","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations? and women?s networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).",8410509,null,"Active","a6Q1R000000AJZy",0,0,0,0,8410509,0,null,null,"Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations? and women?s networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","High","Better collaboration with CSO and other community structures will allow for more effective consolidation of effort and valuefor-money","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6103","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Above allocation funding is requested for the procurement of self-test kits. Self-testing is prioritized in this funding request based on lessons learned about its effectiveness in reaching young people and men, as well as evidence from pilot programs which show this is a high yield method at more than 20% positivity",9014947,null,"Active","a6Q1R000000AJZt",0,0,0,0,9014947,0,null,null,"Above allocation funding is requested for the procurement of self-test kits. Self-testing is prioritized in this funding request based on lessons learned about its effectiveness in reaching young people and men, as well as evidence from pilot programs which show this is a high yield method at more than 20% positivity","High","Crucial for filling testing gap among young people and men",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Kosovo","Kosovo","PAI-5989","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","Additional funds will be used to amend the legislation for social sub-contracting of NGOs and advocate for HIV prevention service delivery by NGOs using domestic financing.",12680.96,null,"Active","a6Q1R000000AJY3",0,0,0,0,12680.96,0,null,null,"Additional funds will be used to amend the legislation for social sub-contracting of NGOs and advocate for HIV prevention service delivery by NGOs using domestic financing.","High","Based on the results of the planned analysis of CSO contracting mechanisms (within allocation), any additional funds will be used to support government in the subsequent development and adoption of detailed by-laws and regulations describing the rules and procedures for contracting CSOs for HIV service delivery by public funding.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Kosovo","Kosovo","PAI-5988","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","Additional funds will be used to intensify efforts of policy dialogue aiming at removing existing legal barriers.",8248.23,null,"Active","a6Q1R000000AJY2",0,0,0,0,8248.23,0,null,null,"Additional funds will be used to intensify efforts of policy dialogue aiming at removing existing legal barriers.","High","Any additional funds will be used to support policy dialogue about existing legal challenges and harmonise legislation to remove HIV service barriers The additional funds will allow intensifying efforts supported by limited within-allocation amount.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Eswatini","Eswatini","PAI-5679","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Additional treatment literacy support, including social and transitional media campaigns, recruitment of Community Outreach Workers (5 men per region and 5 AGYW). These groups are prioritized as outreach workers based on data that shows limited ART uptake among men (Table 3) and limited viral load suppression among young people. Lastly, funding will support the procurement of two vehicles to support the national PLHIV network SWANNEPHA. Funding is requested to recruit community outreach workers, with five men and five AGYW per region.",417688,null,"Active","a6Q1R000000AJT3",0,0,0,0,417688,0,null,null,"Additional treatment literacy support, including social and transitional media campaigns, recruitment of Community Outreach Workers (5 men per region and 5 AGYW). These groups are prioritized as outreach workers based on data that shows limited ART uptake among men (Table 3) and limited viral load suppression among young people. Lastly, funding will support the procurement of two vehicles to support the national PLHIV network SWANNEPHA. Funding is requested to recruit community outreach workers, with five men and five AGYW per region.","Medium","There is a lot of funding in the request for various cadres of CHW - efficiencies can be found within the already allocated amount to avoid overly vertical programs",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Somalia","Somalia","PAI-5578","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Support national, sub national and regional coordination meetings to ensure joint programming and review issues affecting HIV/TB collaborative activities",48618,null,"Inactive","a6Q1R000000AJRQ",48618,0,0,0,0,1,null,null,"Support national, sub national and regional coordination meetings to ensure joint programming and review issues affecting HIV/TB collaborative activities","Medium","Support national, sub national and regional coordination meetings to ensure joint programming and review issues affecting HIV/TB collaborative activities","NA Original Intervention: TB/HIV coordination meetings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Paraguay","Paraguay","PAI-5443","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Installation of a patient care system for HIV clinics in the Asunción SAI. This system will improve the monitoring of consultations and improve the quality of care for PLWH, since it is linked to the call system, whereby the identity of PLWH will be protected, respecting confidentiality. In addition, this system will allow the organization and monitoring of the number of first-time consultations to follow up on the linkage and retention to ART, the length of time for each consultation to identify needs for improvement, among others. It should be noted that the Institute of Tropical Medicine (IMT) is the main reference center for care of this pathology, which provides care to 78% of all PLHIVs in the country.",10000,null,"Active","a6Q1R000000AJPF",0,0,0,0,10000,0,null,null,"Installation of a patient care system for HIV clinics in the Asunción SAI. This system will improve the monitoring of consultations and improve the quality of care for PLWH, since it is linked to the call system, whereby the identity of PLWH will be protected, respecting confidentiality. In addition, this system will allow the organization and monitoring of the number of first-time consultations to follow up on the linkage and retention to ART, the length of time for each consultation to identify needs for improvement, among others. It should be noted that the Institute of Tropical Medicine (IMT) is the main reference center for care of this pathology, which provides care to 78% of all PLHIVs in the country.","High","Strong monitoring and evaluation of HIV responses, especially for key populations, is critical for effective epidemic control in Paraguay, thus the TRP considers this a high priority demand. However, the TRP suggests a comprehensive approach to patient care monitoring system by the applicant to provide a clear description on how the proposed registry will be positioned in the overall patient care system for HIV in Paraguay. Refer to Issue 1 of Section 6.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-02-28"]
["CT Paraguay","Paraguay","PAI-5442","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","Visit to Tacumbu prison for PLWH monitoring. This activity contributes to improving the adherence of PLHIV who are in the Tacumbú penitentiary, the country's main confinement institution in which the largest number of PPLs are living with HIV. These visits contribute to providing medical care, information and follow-up and consolidate the ART of the PPL, achieving an undetectable viral load. It should be noted that this activity is part of the Vencer Foundation's self-help program, in which its counselor interacts with the inmates reinforcing them with information about HIV, nutrition, care, and managing their hospitalization when they are critically ill because of some IO in addition to carrying out follow-ups (and bringing medicines) to the inmates who need it, even outside the visiting days. The visits to the prison are also accompanied by a doctor and 1 IMT (Institute of Tropical Medicine) social worker.",4133,null,"Active","a6Q1R000000AJPE",0,0,0,0,4133,0,null,null,"Visit to Tacumbu prison for PLWH monitoring. This activity contributes to improving the adherence of PLHIV who are in the Tacumbú penitentiary, the country's main confinement institution in which the largest number of PPLs are living with HIV. These visits contribute to providing medical care, information and follow-up and consolidate the ART of the PPL, achieving an undetectable viral load. It should be noted that this activity is part of the Vencer Foundation's self-help program, in which its counselor interacts with the inmates reinforcing them with information about HIV, nutrition, care, and managing their hospitalization when they are critically ill because of some IO in addition to carrying out follow-ups (and bringing medicines) to the inmates who need it, even outside the visiting days. The visits to the prison are also accompanied by a doctor and 1 IMT (Institute of Tropical Medicine) social worker.","High","The TRP considers prison people living with HIV treatment monitoring a high priority. However, during the Paraguay program continuation window 1 application, the TRP was informed that prison HIV services & personnel are covered by the government resources. There is a need to ensure no duplication of services and there is a clearly agreed arrangement between the Vencer Foundation, the Ministry of Health, and the prison authority. The TRP also requests clarification as to what 6types of self -help a 7ctivities are being proposed, how will they complement the government?s HIV interventions in prisons, in addition to the level of freedom of individual prisoners for self -help actions and availability of needed commodities in the enclosed settings. What is the plan for the longer -term sustainability of such program? Please note that this item, if shown to be effective, should be considered in the public financing planning beyond this funding period",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-02-28"]
["CT Sri Lanka","Sri Lanka","PAI-4731","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","4 nos of mobile x ray units to be mounted to vehicles",52000,null,"Active","a6Q1R000000AJDl",0,0,0,0,52000,0,null,null,"4 nos of mobile x ray units to be mounted to vehicles","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT South East Asia","2021-12-31"]
["CT Sri Lanka","Sri Lanka","PAI-4724","MCI-00012","Case management","MCI-00154","Facility-based treatment","Requested for RMO training in 2020. This activity will involve training of RMOs in supervision, monitoring and evaluation, case management and PoR updates to enable the programme to be implemented in a systematic manner in all parts of the country and to ensure cooperation between regions.",3100,null,"Active","a6Q1R000000AJDe",0,0,0,0,3100,0,null,null,"Requested for RMO training in 2020. This activity will involve training of RMOs in supervision, monitoring and evaluation, case management and PoR updates to enable the programme to be implemented in a systematic manner in all parts of the country and to ensure cooperation between regions.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-12-31"]
["CT Nigeria","Nigeria","PAI-5292","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00126","Case detection and diagnosis","Support site level joint lab-clinic patient education program for increased lab services uptake-develop IEC materials, health talk, and awareness creation for uptake of laboratory services.",209626,null,"Active","a6Q1R000000AJMo",0,0,0,0,209626,0,"2020-01-29T12:52:00",null,"Support site level joint lab-clinic patient education program for increased lab services uptake-develop IEC materials, health talk, and awareness creation for uptake of laboratory services.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Nigeria","Nigeria","PAI-5291","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Supportive supervision and mentoring laboratories on biosafety and biosecurity compliance:\nBeyond monitoring, the labs will be supported by experts from the National Laboratory Technical Working Group (NLTWG) through periodic hands-on mentoring support to the 111 labs implement the standard biosafety and biosecurity procedures and processes. This will promote compliance and efficiency among the participating labs and their staff.",113184,null,"Inactive","a6Q1R000000AJMn",113184,0,0,0,0,1,"2020-01-29T12:52:00",null,"Supportive supervision and mentoring laboratories on biosafety and biosecurity compliance:\nBeyond monitoring, the labs will be supported by experts from the National Laboratory Technical Working Group (NLTWG) through periodic hands-on mentoring support to the 111 labs implement the standard biosafety and biosecurity procedures and processes. This will promote compliance and efficiency among the participating labs and their staff.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Malawi","Malawi","PAI-5193","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Double investment for adolescent girls and boys and young women men to distribute condoms ($0.16M) Catalytic funding is currently funding incentives for the first 250. Above allocation funding will provide sufficient funding for an additional 250 (500 total).",160000,null,"Active","a6Q1R000000AJLD",0,0,0,0,160000,0,null,null,"Double investment for adolescent girls and boys and young women men to distribute condoms ($0.16M) Catalytic funding is currently funding incentives for the first 250. Above allocation funding will provide sufficient funding for an additional 250 (500 total).","High","This will increase the effectiveness and efficiency of catalytic funding that has also been recommended.","NA Original Intervention: Male and female condoms for adolescents and youth, in and out of school","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5065","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","The activity consists of providing social and financial support to patients living in extreme poverty. This amount would provide medical care for those testing HIV-positive throughout the country, estimated at 50 patients a year on average, covering both hospitalization and outpatients.\nThe average cost is 1 million Malagasy ariary per PLHIV per year. This covers drugs other than ARVs, paraclinical examinations (including imagery), non-subsidized additional tests, food, transport and medical waste disposal.",94403,null,"Active","a6Q1R000000AJJ9",0,0,0,0,94403,0,null,null,"The activity consists of providing social and financial support to patients living in extreme poverty. This amount would provide medical care for those testing HIV-positive throughout the country, estimated at 50 patients a year on average, covering both hospitalization and outpatients.\nThe average cost is 1 million Malagasy ariary per PLHIV per year. This covers drugs other than ARVs, paraclinical examinations (including imagery), non-subsidized additional tests, food, transport and medical waste disposal.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5060","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","This is already a very popular topic on the global stage, especially in the context of demedicalized screening. The technicians would like to receive training on this topic in countries with prior experience.  \nThis would be an exchange trip on the topic of demedicalized screening, with countries advanced in using a community approach to control HIV/AIDS.\nThe activity costs cover travel and allowances.",16047,null,"Active","a6Q1R000000AJJ4",0,0,0,0,16047,0,null,null,"This is already a very popular topic on the global stage, especially in the context of demedicalized screening. The technicians would like to receive training on this topic in countries with prior experience.  \nThis would be an exchange trip on the topic of demedicalized screening, with countries advanced in using a community approach to control HIV/AIDS.\nThe activity costs cover travel and allowances.","Low",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5059","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","The technical capacity of the DLIS team needs strengthening. To ensure that monitoring and evaluation activities are properly implemented, the DLIS technicians wish to attend training in monitoring and evaluation.",6252,null,"Active","a6Q1R000000AJJ3",0,0,0,0,6252,0,null,null,"The technical capacity of the DLIS team needs strengthening. To ensure that monitoring and evaluation activities are properly implemented, the DLIS technicians wish to attend training in monitoring and evaluation.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4957","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Adaptation of the module on the analysis of the legal environment that limits the rights of people with TB. Based on the module produced by the Stop TB Partnership and the UNDP, we will validate and adapt this module to the LAC context.",14000,null,"Inactive","a6Q1R000000AJHP",14000,0,0,0,0,1,null,null,"Adaptation of the module on the analysis of the legal environment that limits the rights of people with TB. Based on the module produced by the Stop TB Partnership and the UNDP, we will validate and adapt this module to the LAC context.","High","The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Multicountry MENA IHAA","Multicountry HIV MENA IHAA","PAI-4824","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Design of a nation-wide process of identifying and addressing barriers (including gender and sexual orientation) to services for KPs",20000,null,"Inactive","a6Q1R000000AJFG",20000,0,0,0,0,1,null,null,"Design of a nation-wide process of identifying and addressing barriers (including gender and sexual orientation) to services for KPs","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Viet Nam","Viet Nam","PAI-5936","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","Information and sensitization programs for legal aid providers on critical health and human rights aspects of HIV response, with emphasis on those that pertain to key populations.",12488,null,"Active","a6Q1R000000AJXC",0,0,0,0,12488,0,null,null,"Information and sensitization programs for legal aid providers on critical health and human rights aspects of HIV response, with emphasis on those that pertain to key populations.","Low","Low priority which could be covered from existing funds.","NA Original Intervention: Sensitization of lawmakers and law enforcement agents","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Viet Nam","Viet Nam","PAI-5935","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Events for community initiatives to reduce Stigma & Discrimination in five Global-Fund supported provinces.",10588,null,"Active","a6Q1R000000AJXB",0,0,0,0,10588,0,null,null,"Events for community initiatives to reduce Stigma & Discrimination in five Global-Fund supported provinces.","Low","Low priority which could be covered from existing funds.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Tunisia","Tunisia","PAI-5843","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Strengthening the HIV control data collection and analysis system will enable improved monitoring of the activities implemented to achieve objectives relating to elimination of the disease. This will be achieved through regional supervision and coordination, updating of the active file and unique codification of PLHIV, including aspects relating to confidentiality.",230768,null,"Active","a6Q1R000000AJVh",12052,0,0,0,218716,0,null,null,"Strengthening the HIV control data collection and analysis system will enable improved monitoring of the activities implemented to achieve objectives relating to elimination of the disease. This will be achieved through regional supervision and coordination, updating of the active file and unique codification of PLHIV, including aspects relating to confidentiality.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Tunisia","Tunisia","PAI-5839","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00564","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Strengthening the conditions for addressing stigma, discrimination and violence against people in prisons and other closed settings through the establishment of an accreditation mechanism for HIV screening by community actors and by raising awareness of the rights of key populations will, in the long term, have a positive and sustainable impact on HIV control.",130065,null,"Active","a6Q1R000000AJVd",122904,0,0,0,7161,0,null,null,"Strengthening the conditions for addressing stigma, discrimination and violence against people in prisons and other closed settings through the establishment of an accreditation mechanism for HIV screening by community actors and by raising awareness of the rights of key populations will, in the long term, have a positive and sustainable impact on HIV control.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Togo","Togo","PAI-5746","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Pre-treatment assessments and biological monitoring.\n2Biological assessments make it possible to determine the suitable treatment  scheme,  monitor  the  effectiveness  and  safety  of  the treatments and, consequently, to improve the quality of life of the patients.",2211534.06,null,"Active","a6Q1R000000AJU8",0,0,0,0,2211534.06,0,null,null,"Pre-treatment assessments and biological monitoring.\n2Biological assessments make it possible to determine the suitable treatment  scheme,  monitor  the  effectiveness  and  safety  of  the treatments and, consequently, to improve the quality of life of the patients.","High","Togo has ambitious targets to reach the HIV epidemic control but national resources are very limited. The funding gaps are substantial. Thus, any available resources should be made available to support HIV testing and counselling services, antiretroviral treatment, and access to viral load monitoring. The PAAR clearly targets key and priority populations to benefit from these resources; men who have sex with men, female sex workers as well as pregnant women with prevention of mother-to-child transmission (PMTCT) of HIV.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Togo","Togo","PAI-5745","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","This funding will make  it  possible  to  provide  viral  load  testing  for  the  PLHIV  on ARVs, so as to increase coverage from 20% under the allocation funding  to  50%  by  the  end  of  2020.  The  number  of  PLHIV on ARVs who will receive viral load testing will be 23,126, 30,890 and 39,346 in 2018, 2019 and 2020, respectively.",2872542.92,null,"Active","a6Q1R000000AJU7",769496,796884.75,0,0,1306162.17,0,null,null,"This funding will make  it  possible  to  provide  viral  load  testing  for  the  PLHIV  on ARVs, so as to increase coverage from 20% under the allocation funding  to  50%  by  the  end  of  2020.  The  number  of  PLHIV on ARVs who will receive viral load testing will be 23,126, 30,890 and 39,346 in 2018, 2019 and 2020, respectively.","High","Togo has ambitious targets to reach the HIV epidemic control but national resources are very limited. The funding gaps are substantial. Thus, any available resources should be made available to support HIV testing and counselling services, antiretroviral treatment, and access to viral load monitoring. The PAAR clearly targets key and priority populations to benefit from these resources; men who have sex with men, female sex workers as well as pregnant women with prevention of mother-to-child transmission (PMTCT) of HIV.","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Zimbabwe","Zimbabwe","PAI-6098","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.",374255,null,"Active","a6Q1R000000AJZo",0,0,0,0,374255,0,null,null,"PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","High","Community based active case finding is critically important.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Kosovo","Kosovo","PAI-5985","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","Given limited amount allocated to HIV prevention services among sex workers in the grant, these additional resources will be used for additional outreach workers and peer educators. It will help to attain targets set.",10099.879999999999,null,"Active","a6Q1R000000AJXz",0,0,0,0,10099.879999999999,0,null,null,"Given limited amount allocated to HIV prevention services among sex workers in the grant, these additional resources will be used for additional outreach workers and peer educators. It will help to attain targets set.","High","These additional resources for Sex Worker programs will be used for additional outreach workers and Peer educators beyond the withinallocation amount: this will contribute to attaining the targets, as it will be difficult to do so with the limited number of staff and volunteers financed through the within-allocation amount.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Eswatini","Eswatini","PAI-5675","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Interventions to address quality of care issues specific to Adolescent Friendly Health Services (AFHS). These include technical assistance for incorporation of AFHS standards into quality audit forms, quarterly joint technical working group meetings between relevant MOH departments and incorporating the AFHS component into the quality audits conductedby the ministry of health in the 20 priority Tinkundla.",253000,null,"Active","a6Q1R000000AJSz",0,0,0,0,253000,0,null,null,"Interventions to address quality of care issues specific to Adolescent Friendly Health Services (AFHS). These include technical assistance for incorporation of AFHS standards into quality audit forms, quarterly joint technical working group meetings between relevant MOH departments and incorporating the AFHS component into the quality audits conductedby the ministry of health in the 20 priority Tinkundla.","High","This funding for technical assistance to integrate adolescent services into routine care through quarterly joint technical working group meetings between relevant MOH departments and incorporating the AFHS component into the quality audits conducted by the ministry of health in the 20 priority Tinkundla is essential for the continued success of the program.","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Supportive policy and programmatic environment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Eswatini","Eswatini","PAI-5674","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","Additional LIS support and Laboratory Personnel to support and strengthen the Quality Assurance Unit and to support the supply chain system.",696078,null,"Active","a6Q1R000000AJSy",0,0,0,0,696078,0,null,null,"Additional LIS support and Laboratory Personnel to support and strengthen the Quality Assurance Unit and to support the supply chain system.","High","Along with the investments in linking the lab systems and supply chain this fund will allow for Additional LIS support and Laboratory Personnel to support and strengthen the Quality Assurance Unit and to support the supply chain system","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Somalia","Somalia","PAI-5572","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","Building on the national and sub national efforts to strengthen supply chain capacity, this would further strengthen regional supply chain capacity.",250744,null,"Active","a6Q1R000000AJRK",0,0,0,0,250744,0,null,null,"Building on the national and sub national efforts to strengthen supply chain capacity, this would further strengthen regional supply chain capacity.","High","Building on the national and sub national efforts to strengthen supply chain capacity, this would further strengthen regional supply chain capacity.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Strengthened Regional supply Chain Capacity Building to Regional Level","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Sierra Leone","Sierra Leone","PAI-5537","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Sierra Leone adopted the following three regimen design options for the management of MDR-TB: (i)Shorter regimen with Amikacin: 4-6 Am-Mfx-Pto-Cfz-Z-high-dose H-E/5 Mfx-Cfz-Z-E; (ii) Modified shorter regimen under operational research, oral regimen: 9 Lfx-Bdq-Lzd-Cfz-Z; and (iii)  Fully oral longer regimen: 18 Lfx-Bdq-Lzd-Cfz-Z. The second regimen - modified shorter regimen, is expected to be implemented under operational research. In this regard, additional funding is needed for clinical training for health care workers; pharmacovigilance training; patient care including monitoring tests and patient support; technical assistance missions to support the development of protocol and its implementation; data management, documentation and dissemination of results.",560000,null,"Active","a6Q1R000000AJQl",0,0,0,0,560000,0,null,null,"Sierra Leone adopted the following three regimen design options for the management of MDR-TB: (i)Shorter regimen with Amikacin: 4-6 Am-Mfx-Pto-Cfz-Z-high-dose H-E/5 Mfx-Cfz-Z-E; (ii) Modified shorter regimen under operational research, oral regimen: 9 Lfx-Bdq-Lzd-Cfz-Z; and (iii)  Fully oral longer regimen: 18 Lfx-Bdq-Lzd-Cfz-Z. The second regimen - modified shorter regimen, is expected to be implemented under operational research. In this regard, additional funding is needed for clinical training for health care workers; pharmacovigilance training; patient care including monitoring tests and patient support; technical assistance missions to support the development of protocol and its implementation; data management, documentation and dissemination of results.","High",null,"TRP June Retreat 2019 Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, Malaria, RSSH","RT Western Africa","2021-06-30"]
["CT Sierra Leone","Sierra Leone","PAI-5532","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","WFP estimates, 6184 adult PLHIVs, positive pregnant women and OVCs in need of nutritional support from 2018-2020. The within allocation budget will provide nutritional support for 1,797 positive pregnant women, adults PLHIVs and OVCs in 2018.\nThe PAAR will be used to procure and distribute food for an additional 4,351 positive pregnant women, adults PLHIVs and OVCs in 2018 plus 6148 additional PLHIVs in 2019 and 6148 in 2020 respectively.",3756370,null,"Active","a6Q1R000000AJQg",770000,700000,0,0,2286370,0,null,null,"WFP estimates, 6184 adult PLHIVs, positive pregnant women and OVCs in need of nutritional support from 2018-2020. The within allocation budget will provide nutritional support for 1,797 positive pregnant women, adults PLHIVs and OVCs in 2018.\nThe PAAR will be used to procure and distribute food for an additional 4,351 positive pregnant women, adults PLHIVs and OVCs in 2018 plus 6148 additional PLHIVs in 2019 and 6148 in 2020 respectively.","High","If efficiencies are found within the grant, this item can be reconsidered for funding as an expansion of the food programme, contingent upon assessment of how these investments fit in the overall HIV program and the national framework for provision of food supplements to improve HIV treatment outcomes. However, the TRP considers scale-up of ART and PMTCT as very high priority should additional resources become available.","NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Western Africa","2020-12-31"]
["CT Paraguay","Paraguay","PAI-5436","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Training course / update on TB / HIV with \"The Union\" for health professionals. Co-financing with TB project resources is proposed from the MDR HIV / TB course for doctors, biochemists and nursing graduates who provide care for TB / HIV co-infection. 2 similar courses have been carried out with excellent results, among which we can mention the implementation of isoniazid prophylaxis, the implementation of a referral mechanism and counter reference among the different services for care of people with co-infection, updates on the timing of initiation of treatment in coinfection and on advances in new drugs and alternative schemes. A new edition of the course is required in order to keep up-to-date with the latest advances to the main service providers, in addition to the need to train new providers.",20000,null,"Active","a6Q1R000000AJP8",0,0,0,0,20000,0,null,null,"Training course / update on TB / HIV with \"The Union\" for health professionals. Co-financing with TB project resources is proposed from the MDR HIV / TB course for doctors, biochemists and nursing graduates who provide care for TB / HIV co-infection. 2 similar courses have been carried out with excellent results, among which we can mention the implementation of isoniazid prophylaxis, the implementation of a referral mechanism and counter reference among the different services for care of people with co-infection, updates on the timing of initiation of treatment in coinfection and on advances in new drugs and alternative schemes. A new edition of the course is required in order to keep up-to-date with the latest advances to the main service providers, in addition to the need to train new providers.","Medium","Keeping abreast on TB, HIV information can contribute to improving quality of care. However, the TRP note support for this activity be granted only for training within Paraguay","NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-02-28"]
["CT Nepal","Nepal","PAI-5342","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","Under community-based monitoring by HFOMC to assess stigma, discrimination and staff attitude toward patients at selected health facilities.",60000,null,"Active","a6Q1R000000AJNc",0,0,0,0,60000,0,null,null,"Under community-based monitoring by HFOMC to assess stigma, discrimination and staff attitude toward patients at selected health facilities.","Low","These surveys contribute to improve the quality of the services provided to the clients, and can be designed to identify and address human rights issues related to TB prevention and care","NA Original Module: RSSH - Community responses and systems. Original Intervention: Conduct patient satisfaction surveys","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT South East Asia","2021-03-15"]
["CT Sri Lanka","Sri Lanka","PAI-4722","MCI-00007","Treatment, care and support","MCI-00119","Treatment monitoring - Drug resistance surveillance","Drug resistance surveillance - Consultative meetings & preliminary survey / Proposal development meetings, ethical clearence, data collector's training, data collection cost, data collection related travel, data entry, data analysis, preliminary dissamination meetings, final dissamination meeting & (Per diem,Airfaire & Visa Fee). - 3200000LKR.",21078,null,"Inactive","a6Q1R000000AJDc",21078,0,0,0,0,1,null,null,"Drug resistance surveillance - Consultative meetings & preliminary survey / Proposal development meetings, ethical clearence, data collector's training, data collection cost, data collection related travel, data entry, data analysis, preliminary dissamination meetings, final dissamination meeting & (Per diem,Airfaire & Visa Fee). - 3200000LKR.","Low","preliminary dissemination meetings, final dissemination meeting & (Per diem, Airfare & Visa Fee)\n(same rationale as above)For: Consultative meetings & preliminary survey / Proposal development meetings, ethical clearance, data collector's training, data collection cost, data collection related travel, data entry, data analysis,","NA Original Intervention: Treatment monitoring - drug resistance surveillance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-12-31"]
["CT Sri Lanka","Sri Lanka","PAI-4717","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","The NSACP targets Ending AIDS by 2025. The NSACP have taken steps to strengthen HIV testing by introducing and providing Rapid HIV testing services to district health care institutions such as general and base hospitals. Moreover, there are plans to establish STD clinics in many Base hospitals. Although the PSE of MSM is 7551 which may differ with the new size estimation, high risk behaviours have been reported among many groups and these groups are among the general population thus posing difficulty in identifying them as separate MSM group. If Sri Lanka to achieve Ending AIDS in 2025 testing need to be widen to reach these hidden MSM groups among the general population. Therefore, approximately 500,000 HIV RDT have been requested through this FR. \nThe NSACP have finalized the HIV testing algorithm. The RDT is used for screening purpose only, due to the reasons that in low HIV prevalence setting RDT will have high NPV (100%) when the tests are negative they are true negative. whereas low PPV (9%), that mean if the tests become positive high possibility that is false positive. Even adding a second RDT wil not exclude all false positives.To overcome this challenge Western Blot will be used for confirmation. \nMonitoring of testing and data maintenance will be coordinated by the district STD clinic.",708848,null,"Inactive","a6Q1R000000AJDX",708848,0,0,0,0,1,null,null,"The NSACP targets Ending AIDS by 2025. The NSACP have taken steps to strengthen HIV testing by introducing and providing Rapid HIV testing services to district health care institutions such as general and base hospitals. Moreover, there are plans to establish STD clinics in many Base hospitals. Although the PSE of MSM is 7551 which may differ with the new size estimation, high risk behaviours have been reported among many groups and these groups are among the general population thus posing difficulty in identifying them as separate MSM group. If Sri Lanka to achieve Ending AIDS in 2025 testing need to be widen to reach these hidden MSM groups among the general population. Therefore, approximately 500,000 HIV RDT have been requested through this FR. \nThe NSACP have finalized the HIV testing algorithm. The RDT is used for screening purpose only, due to the reasons that in low HIV prevalence setting RDT will have high NPV (100%) when the tests are negative they are true negative. whereas low PPV (9%), that mean if the tests become positive high possibility that is false positive. Even adding a second RDT wil not exclude all false positives.To overcome this challenge Western Blot will be used for confirmation. \nMonitoring of testing and data maintenance will be coordinated by the district STD clinic.","High","As outlined under issue 1, the CCM proposes to procure 500,000 RDTs with this funding. Whilst the priority is high the basis of the 500,000 RDTs needs to be explained. Ref Issue 1","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-12-31"]
["CT Nigeria","Nigeria","PAI-5287","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Infrastructural upgrade of selected labs in targets states for lab services integration:\nBased on the findings and recommendations of the baseline assessment of infrastructural amenities at the labs, the prioritised labs and recommendations of the report will be supported with infrastructural upgrade to raise their standard for effective service provision.",1803279,null,"Active","a6Q1R000000AJMj",0,0,0,0,1803279,0,"2020-01-29T12:52:00",null,"Infrastructural upgrade of selected labs in targets states for lab services integration:\nBased on the findings and recommendations of the baseline assessment of infrastructural amenities at the labs, the prioritised labs and recommendations of the report will be supported with infrastructural upgrade to raise their standard for effective service provision.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Nigeria","Nigeria","PAI-5282","MCI-00010","MDR-TB","MCI-00126","Case detection and diagnosis","Optimization of Existing TB Ref Labs:\nAn estimated 29% of the need for these TB Reference Laboratories has been budgeted within allocation. This intervention will provide the remaining 71% optimization need to improve functionality, support monitoring of patients on shorter regimen and new drug, improve communication between laboratories and treatment centres and improve surveillance for XDR TB.",202243,null,"Active","a6Q1R000000AJMe",0,0,0,0,202243,0,"2020-01-29T12:52:00",null,"Optimization of Existing TB Ref Labs:\nAn estimated 29% of the need for these TB Reference Laboratories has been budgeted within allocation. This intervention will provide the remaining 71% optimization need to improve functionality, support monitoring of patients on shorter regimen and new drug, improve communication between laboratories and treatment centres and improve surveillance for XDR TB.","High",null,"NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Malawi","Malawi","PAI-5185","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","To ensure GF and development partner supported efforts in 2018 and 2019 towards increase of ANC uptake of at least three doses of IPTp from 12% in 2014 (MIS) to 60% by 2022 through supportive supervision this request is for continued funding in 2020.",46395,null,"Active","a6Q1R000000AJL5",0,0,0,0,46395,0,null,null,"To ensure GF and development partner supported efforts in 2018 and 2019 towards increase of ANC uptake of at least three doses of IPTp from 12% in 2014 (MIS) to 60% by 2022 through supportive supervision this request is for continued funding in 2020.","Medium","To ensure vulnerable groups prioritised","NA Original Module: Specific prevention interventions. Original Intervention: Intermittent preventive treatment ? In pregnancy","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5055","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00108","HIV testing services for adolescents and youth, in and out of school","This refers to activities to accompany young people who agree to testing. This funding will cover monitoring of targets for testing at health centers, with a view to achieving testing coverage of 36 per cent in 2018 and 45 per cent in 2020. It will also provide for activities to accompany young people who test positive to referral doctors, in order to reduce the number of initial patients lost to follow-up and improve retention from 127 cases in 2018 to 168 cases in 2020, thus helping to achieve the enrolment target of 65 per cent of new cases on ART. There will also be mobile testing targeting young people, ensuring local service provision through mobile clinics. The above allocation amount will cover 27 per cent of the target for accompanying during testing, representing an additional 198,114 young people tested.",131082,null,"Active","a6Q1R000000AJIz",0,0,0,0,131082,0,null,null,"This refers to activities to accompany young people who agree to testing. This funding will cover monitoring of targets for testing at health centers, with a view to achieving testing coverage of 36 per cent in 2018 and 45 per cent in 2020. It will also provide for activities to accompany young people who test positive to referral doctors, in order to reduce the number of initial patients lost to follow-up and improve retention from 127 cases in 2018 to 168 cases in 2020, thus helping to achieve the enrolment target of 65 per cent of new cases on ART. There will also be mobile testing targeting young people, ensuring local service provision through mobile clinics. The above allocation amount will cover 27 per cent of the target for accompanying during testing, representing an additional 198,114 young people tested.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5054","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","The activity involves strengthening the managerial capacity of the team coordinating the HIV/AIDS control program. Training is conducted annually, either locally or externally.\nThe topics cover various areas, such as programming, finance, monitoring and evaluation, and PSM.\nThe activity costs cover travel costs, registration fees and allowances.",15033,null,"Active","a6Q1R000000AJIy",0,0,0,0,15033,0,null,null,"The activity involves strengthening the managerial capacity of the team coordinating the HIV/AIDS control program. Training is conducted annually, either locally or externally.\nThe topics cover various areas, such as programming, finance, monitoring and evaluation, and PSM.\nThe activity costs cover travel costs, registration fees and allowances.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Multicountry TB LAC PIH","Multicountry TB LAC PIH","PAI-4953","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","National workshops on Social Protection in TB. This event will bring together government and civil society representatives from each country to exchange experiences and learn from opportunities in other countries.",150800,null,"Inactive","a6Q1R000000AJHL",150800,0,0,0,0,1,null,null,"National workshops on Social Protection in TB. This event will bring together government and civil society representatives from each country to exchange experiences and learn from opportunities in other countries.","Medium",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Multicountry EECA PAS","Multicountry EECA PAS","PAI-4948","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Annual workplan meetings for effective multi-partner coordination of the project implementation.",45000,null,"Inactive","a6Q1R000000AJHG",45000,0,0,0,0,1,null,null,"Annual workplan meetings for effective multi-partner coordination of the project implementation.","High","This item is considered as the highest priority and proposed activities should be included into the core grant through efficiencies  identified. Producing work plans is an essential tool to facilitate multi partner coordination and should be a core activity.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Multicountry HIV CB-PANCAP-CVCCOIN","Multicountry HIV Caribbean PCC Consortium","PAI-4818","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","Small grants to support national and regional anti-stigma and \"know your rights\" campaigns. Training in basic advocacy skills and legal literacy for CSOs.",100000,null,"Inactive","a6Q1R000000AJFA",100000,0,0,0,0,1,null,null,"Small grants to support national and regional anti-stigma and \"know your rights\" campaigns. Training in basic advocacy skills and legal literacy for CSOs.","High","The TRP suggests to move this intervention within the allocation by reprioritizing sub-section C. This activity is considered of high priority to reduce human rights related barriers to HIV services (see Issue 3).","Name is: CT Multicountry LAC CARICOM-PANCAP / Review approach Original Intervention: Legal literacy (?Know Your Rights?)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-09-30"]
["CT Multicountry HIV CB-PANCAP-CVCCOIN","Multicountry HIV Caribbean PCC Consortium","PAI-4814","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Developing more effective models to reach informal sex workers, male and transgender sex workers, and mobile and internet-based sex workers;  As with the MSM intervention, throughout this module CVC would institute 4 axis to ensure more effective sub-population HIV prevention programs: (i) strengthened programmatic and contextual understanding, especially of the heterogeneity of sex work and complexity of closeted MSM behaviour; (ii) intensified program implementation and delivery of comprehensive, proven interventions; (iii) improved program monitoring and evaluation, including greater use of real-time monitoring for continuous program improvement and constant strategic and tactical adaptations and rigorous program evaluation, to refine understanding of what works, under what circumstances and how; and (iv) predictable, sustained financing for key population HIV prevention programmes for specific sub-groups, including increased domestic financing where feasible. Furthermore, this module will pay special attention to strengthening community-based monitoring and evaluation systems as they pertain to MSM, transgender women, and Female Sex Workers sub-groups and their respective HIV related issues in the Caribbean; document model interventions with technical briefs that have practical, ?how-to? examples for strengthening critical enablers and service delivery for key populations subgroups; and to strengthen commitment to a sustainable CBO response in relation to Key Populations post transition.",200000,null,"Active","a6Q1R000000AJF6",0,0,0,0,200000,0,null,null,"Developing more effective models to reach informal sex workers, male and transgender sex workers, and mobile and internet-based sex workers;  As with the MSM intervention, throughout this module CVC would institute 4 axis to ensure more effective sub-population HIV prevention programs: (i) strengthened programmatic and contextual understanding, especially of the heterogeneity of sex work and complexity of closeted MSM behaviour; (ii) intensified program implementation and delivery of comprehensive, proven interventions; (iii) improved program monitoring and evaluation, including greater use of real-time monitoring for continuous program improvement and constant strategic and tactical adaptations and rigorous program evaluation, to refine understanding of what works, under what circumstances and how; and (iv) predictable, sustained financing for key population HIV prevention programmes for specific sub-groups, including increased domestic financing where feasible. Furthermore, this module will pay special attention to strengthening community-based monitoring and evaluation systems as they pertain to MSM, transgender women, and Female Sex Workers sub-groups and their respective HIV related issues in the Caribbean; document model interventions with technical briefs that have practical, ?how-to? examples for strengthening critical enablers and service delivery for key populations subgroups; and to strengthen commitment to a sustainable CBO response in relation to Key Populations post transition.","Low","This activity is largely service delivery which falls outside of the scope of this RFP, the TRP therefore does not recommend this intervention.","Name is: CT Multicountry LAC CARICOM-PANCAP / Review approach Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-09-30"]
["CT Viet Nam","Viet Nam","PAI-5926","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00604","Other intervention(s) to reduce human rights-related barriers to HIV services","KP demand for legal aid is still high. Incidents of stigma, discrimination, violence against KP including gender-based violence, and human rights abuses have been recorded. In collaboration and coordination with centres for legal support in each province, VUSTA will provide legal aid for KP in selected 15 provinces.",69173,null,"Active","a6Q1R000000AJX2",0,0,0,0,69173,0,null,null,"KP demand for legal aid is still high. Incidents of stigma, discrimination, violence against KP including gender-based violence, and human rights abuses have been recorded. In collaboration and coordination with centres for legal support in each province, VUSTA will provide legal aid for KP in selected 15 provinces.","Medium","Legal literacy for key populations is important and the TRP suggests ensuring inclusion of information on SHI and ID card issues that may arise in the SHI transition.","NA Original Intervention: Legal literacy (?Know Your Rights?)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Tunisia","Tunisia","PAI-5835","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","The development of a regulatory manual on sexual health among young people (girls and boys) and risk reduction associated with STIs/HIV, HIV awareness-raising campaigns aimed at young people, training of peer educators (PEs) and awareness-raising activities targeting migrants will strengthen HIV control outcomes among young people and migrants, a vulnerable population.",314138,null,"Active","a6Q1R000000AJVZ",0,0,0,0,314138,0,null,null,"The development of a regulatory manual on sexual health among young people (girls and boys) and risk reduction associated with STIs/HIV, HIV awareness-raising campaigns aimed at young people, training of peer educators (PEs) and awareness-raising activities targeting migrants will strengthen HIV control outcomes among young people and migrants, a vulnerable population.","Low","The development of a regulatory manual on sexual health among young people (girls and boys) and risk reduction associated with STIs/HIV, HIV awareness-raising campaigns aimed at young people, training of peer educators (PEs) and awareness-raising activities targeting migrants is a low priority given the key population focus of the epidemic and the lack of information on the migrant population which would be needed for appropriate messaging.","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Togo","Togo","PAI-5740","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Analysis  of  the  range  of  services  in  the  HIV  treatment cascade:\nCarry out a study to analyze the range of services in the  HIV  treatment  cascade. The results  of  this  analysis  will  make  it  possible  to  analyze  the progress  made  in  relation  to  the  90-90-90  targets  by  2020, through the identification of the shortcomings of each stage of the HIV   treatment   cascade   concerning   the   different   population groups and sub-national units (health regions and districts).",121499.27,null,"Active","a6Q1R000000AJU2",0,0,0,0,121499.27,0,null,null,"Analysis  of  the  range  of  services  in  the  HIV  treatment cascade:\nCarry out a study to analyze the range of services in the  HIV  treatment  cascade. The results  of  this  analysis  will  make  it  possible  to  analyze  the progress  made  in  relation  to  the  90-90-90  targets  by  2020, through the identification of the shortcomings of each stage of the HIV   treatment   cascade   concerning   the   different   population groups and sub-national units (health regions and districts).","Medium","Although surveys are needed, the TRP ranked it ?medium? so that resources be primarily dedicated to interventions.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Togo","Togo","PAI-5739","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Bio-behavioral monitoring surveys:  Conduct a  bio-behavioral study in 2019 to provide information for the impact indicators (percentage of   key   populations   living   with   HIV)   and   effect   indicators (percentage of key populations whoclaim to have used a condom with their latest client/sexual partner) to better assess the impact of the interventions carried out concerning these key populations.",168703.85,null,"Active","a6Q1R000000AJU1",0,0,0,0,168703.85,0,null,null,"Bio-behavioral monitoring surveys:  Conduct a  bio-behavioral study in 2019 to provide information for the impact indicators (percentage of   key   populations   living   with   HIV)   and   effect   indicators (percentage of key populations whoclaim to have used a condom with their latest client/sexual partner) to better assess the impact of the interventions carried out concerning these key populations.","Medium","Although surveys are needed, the TRP ranked it ?medium? so that resources be primarily dedicated to interventions.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Zimbabwe","Zimbabwe","PAI-6092","MCI-00000","Prevention programs for general population","MCI-00074","Male circumcision","Building on the targeted and tailored prevention packages for AGYW and key populations which have been prioritized for within allocation request, high impact prevention interventions for the general population also have the potential for significant impact. Prevention is a strong focus of this funding request. In line with Zimbabwe?s new Roadmap to Revitalise HIV Prevention in Zimbabwe (2016). Above allocation funding is requested to scale up of VMMC, prioritizing the 7 underserved districts not covered by PEPFAR (Inyanga, Chimanimani, Bikita, Rushinga, Uzumba-MarambaPfungwe, Kariba and Binga) prioritized first, scaling up to other underserved areas from there. Funding is requested both for VMMC commodities ($4,496,750.00) and programming ($1,202,027.72).Robust impact modelling in the country?s Accelerated Strategic and Operational Plan on VMMC shows that scaling up this activity will avert 212,000 HIV infections by 2025 and reduce prevalence by 3%. Achieving the target of circumcising 1.3 million men will result in more than $1 billion in financial savings.",5698778,null,"Active","a6Q1R000000AJZi",0,0,0,0,5698778,0,null,null,"Building on the targeted and tailored prevention packages for AGYW and key populations which have been prioritized for within allocation request, high impact prevention interventions for the general population also have the potential for significant impact. Prevention is a strong focus of this funding request. In line with Zimbabwe?s new Roadmap to Revitalise HIV Prevention in Zimbabwe (2016). Above allocation funding is requested to scale up of VMMC, prioritizing the 7 underserved districts not covered by PEPFAR (Inyanga, Chimanimani, Bikita, Rushinga, Uzumba-MarambaPfungwe, Kariba and Binga) prioritized first, scaling up to other underserved areas from there. Funding is requested both for VMMC commodities ($4,496,750.00) and programming ($1,202,027.72).Robust impact modelling in the country?s Accelerated Strategic and Operational Plan on VMMC shows that scaling up this activity will avert 212,000 HIV infections by 2025 and reduce prevalence by 3%. Achieving the target of circumcising 1.3 million men will result in more than $1 billion in financial savings.","High","Highly effective intervention",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6087","MCI-00534","Comprehensive prevention programs for MSM","MCI-00538","Community empowerment for MSM","Additional scale up through extended outreach from fixed and mobile sites.",534032,null,"Active","a6Q1R000000AJZd",0,0,0,0,534032,0,null,null,"Additional scale up through extended outreach from fixed and mobile sites.","High","Comprehensive program exists for MSM","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Community empowerment for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Kosovo","Kosovo","PAI-5977","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Additional funds will be used to further support the participation of community actors (including key populations) in local and national decision-making/consultative bodies.",1009.99,null,"Active","a6Q1R000000AJXr",0,0,0,0,1009.99,0,null,null,"Additional funds will be used to further support the participation of community actors (including key populations) in local and national decision-making/consultative bodies.","High","Additional funds will be used to further support the participation of community actors (including key populations) in local and national decision making/consultative bodies ? given limited funding in the within-allocation amount.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Kosovo","Kosovo","PAI-5976","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Additional funds will be used to support planning for community sector-led service delivery including monitoring, supervision, quality assurance, and integration with other services.",3029.96,null,"Active","a6Q1R000000AJXq",0,0,0,0,3029.96,0,null,null,"Additional funds will be used to support planning for community sector-led service delivery including monitoring, supervision, quality assurance, and integration with other services.","High","Additional funds will be used to support planning for community sector led service delivery including monitoring, supervision, quality assurance, and linkages and referrals with other services.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Eswatini","Eswatini","PAI-5665","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Conduct the joint end-term HIV, TB and PMTCT program review, following up on the mid-term review which was done in May 2017. These will help guide integrated panning across the three programs.",450000,null,"Active","a6Q1R000000AJSp",0,0,0,0,450000,0,null,null,"Conduct the joint end-term HIV, TB and PMTCT program review, following up on the mid-term review which was done in May 2017. These will help guide integrated panning across the three programs.","High","Conduct the joint end-term HIV, TB and PMTCT program review, following up on the mid-term review which was done in May 2017. These will help guide integrated panning across the three programs","NA Original Module: Integrated service delivery and quality improvement. Original Intervention: Supportive policy and programmatic environment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Somalia","Somalia","PAI-5565","MCI-00533","HIV Testing Services","MCI-00071","Other module","To implement quality assurance of HCT counsellors to ensure quality of care and service delivery are of a high standard. To address the issues of availability of services but address key gaps in readiness and capacity. To allow ongoing monitoring and capacity building where most need.",195000,null,"Inactive","a6Q1R000000AJRD",195000,0,0,0,0,1,null,null,"To implement quality assurance of HCT counsellors to ensure quality of care and service delivery are of a high standard. To address the issues of availability of services but address key gaps in readiness and capacity. To allow ongoing monitoring and capacity building where most need.","High","To implement quality assurance of HCT counsellors to ensure quality of care and service delivery are of a high standard. To address the issues of availability of services but address key gaps in readiness and capacity. To allow ongoing monitoring and capacity building where most need.","NA Original Intervention: HCT Quality Assurance Measures ? VCT Counsellor Proficiency Testing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Sierra Leone","Sierra Leone","PAI-5527","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","The grant has ART targets respectively at 46%, 52% and 56% of PLHIVs for  2018, 2019 and 2020, which the current funding landscape cannot meet. \nWith the PAAR funding the country will correspondingly increase the ART to reach these targets.\nKey activities will include:\n? Procurement of ARVs and drugs for treatment of OIs.\n? Strengthen the quality of services in the existing 156 ART facilities country.",3936056,null,"Active","a6Q1R000000AJQb",0,0,0,0,3936056,0,null,null,"The grant has ART targets respectively at 46%, 52% and 56% of PLHIVs for  2018, 2019 and 2020, which the current funding landscape cannot meet. \nWith the PAAR funding the country will correspondingly increase the ART to reach these targets.\nKey activities will include:\n? Procurement of ARVs and drugs for treatment of OIs.\n? Strengthen the quality of services in the existing 156 ART facilities country.","High","Given the impact of Ebola virus disease (EVD) on the provision of services, it will be important for the country to prioritize investments to scale up and improve ART coverage in order to achieve the Catch Up Plan targets..","NA Original Intervention: Differentiated antiretroviral therapy service delivery","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Western Africa","2020-12-31"]
["CT Senegal","Senegal","PAI-5526","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","ScalingScaling up case-finding requires improvements in the   capacity   and   quality   of   the   microscopy network. The  following  activities  are  proposed:\n? Purchase  of microscopes  for  regional laboratories;\n? Training of service providers;\n? Supervision and quality assurance. \nThis additional financing should ensure the improved effectiveness of TB screening.\n up case-finding requires improvements in the   capacity   and   quality   of   the   microscopy network.",106480.75,null,"Active","a6Q1R000000AJQa",0,0,0,0,106480.75,0,null,null,"ScalingScaling up case-finding requires improvements in the   capacity   and   quality   of   the   microscopy network. The  following  activities  are  proposed:\n? Purchase  of microscopes  for  regional laboratories;\n? Training of service providers;\n? Supervision and quality assurance. \nThis additional financing should ensure the improved effectiveness of TB screening.\n up case-finding requires improvements in the   capacity   and   quality   of   the   microscopy network.","Medium","This intervention aims to scaling up TB case-finding by improving the capacity and quality of the microscopy network. WHO Recommended Diagnostics (e.g. GeneXpert) should be applied for TB diagnosis instead of microscopy. However, microscopes are also used for monitoring of treatment and therefore this intervention is ranked as medium priority as opposed to low.","NA Original Intervention: Disease screening and diagnosis (Strengthening the microscopy network)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH","RT Western Africa"]
["CT Paraguay","Paraguay","PAI-5428","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Recruitment of consultancy to study the adequacy of the legal framework, including the tax area for contracting by the state, services and products made by CS. Include the drafting of adjustment proposals. Consulting contract to update the Political Advocacy Plan. Monitoring of the advocacy plan designed in 2017 and its updating, which includes monitoring progress of Law 4313 (Budgetary Assurance of Sexual and Reproductive Health), Law 3940, TB Act, Access to Justice Act, Sexual and Reproductive Health, Law against all forms of discrimination, among others. Recruitment of Consultancy in Political incidence. Recruitment of Consultancy to design and establish a Plan of Institutional Communication of the CSOs and the agreed goals and objectives. Implement the Institutional Communication Plan to inform and sensitize the general population and leaders of different sectors, in particular, about the social work of organizations, especially CSOs of key populations.\nDevelop a training plan on public financing models of civil society and determine their applicability in the national context. Design and implement a fundraising plan for CS. These activities are the gaps identified in the framework of the TA funded by the GF through the CRAT, which sought to identify the key activities required to advance the sustainability of civil society organizations linked to the national response to HIV, and of the interventions implemented by them.",41920,null,"Active","a6Q1R000000AJP0",0,0,0,0,41920,0,null,null,"Recruitment of consultancy to study the adequacy of the legal framework, including the tax area for contracting by the state, services and products made by CS. Include the drafting of adjustment proposals. Consulting contract to update the Political Advocacy Plan. Monitoring of the advocacy plan designed in 2017 and its updating, which includes monitoring progress of Law 4313 (Budgetary Assurance of Sexual and Reproductive Health), Law 3940, TB Act, Access to Justice Act, Sexual and Reproductive Health, Law against all forms of discrimination, among others. Recruitment of Consultancy in Political incidence. Recruitment of Consultancy to design and establish a Plan of Institutional Communication of the CSOs and the agreed goals and objectives. Implement the Institutional Communication Plan to inform and sensitize the general population and leaders of different sectors, in particular, about the social work of organizations, especially CSOs of key populations.\nDevelop a training plan on public financing models of civil society and determine their applicability in the national context. Design and implement a fundraising plan for CS. These activities are the gaps identified in the framework of the TA funded by the GF through the CRAT, which sought to identify the key activities required to advance the sustainability of civil society organizations linked to the national response to HIV, and of the interventions implemented by them.","High","The TRP ranks the activity on public financing of civil society organization (CSO) for sexual and reproductive health activity under this module as of high quality demand and suggests moving its corresponding cost to the high quality ranking under this PAAR","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-02-28"]
["CT Liberia","Liberia","PAI-4713","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","IBBSS: The rationale for this activity is to monitor the HIV positivity rate among key population and vulnerable groups with the interventions that will be conducted during the funding cycle. This activity is currently being implemented and expected to be conducted in 2020. Although this is a priority intervention, it is placed in PAAR due to limited funding within allocation.",240624,null,"Active","a6Q1R000000AJDT",0,0,0,0,240624,0,null,null,"IBBSS: The rationale for this activity is to monitor the HIV positivity rate among key population and vulnerable groups with the interventions that will be conducted during the funding cycle. This activity is currently being implemented and expected to be conducted in 2020. Although this is a priority intervention, it is placed in PAAR due to limited funding within allocation.","High","The TRP considered that one fifth of amount requested (US$ 1, 203, 122) would be adequate to fund an IBBS study of key populations.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: IBBS in 2020","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Western Africa","2020-12-31"]
["CT Nigeria","Nigeria","PAI-5278","MCI-00010","MDR-TB","MCI-00126","Case detection and diagnosis","Inverters and Solar Panels for 280 Xpert MTB/Rif Sites and 237 existing Xpert MTB/Rif Sites: \nThe plan is to procure inverters and Solar panels for additional 280, 4-modular Xpert MTB/Rif sites and 237 existing Xpert MTB/Rif Sites to ensure availability of electricity to run the machines.",4728000,null,"Active","a6Q1R000000AJMa",0,0,0,0,4728000,0,"2020-01-29T12:52:00",null,"Inverters and Solar Panels for 280 Xpert MTB/Rif Sites and 237 existing Xpert MTB/Rif Sites: \nThe plan is to procure inverters and Solar panels for additional 280, 4-modular Xpert MTB/Rif sites and 237 existing Xpert MTB/Rif Sites to ensure availability of electricity to run the machines.","High",null,"NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Nigeria","Nigeria","PAI-5277","MCI-00010","MDR-TB","MCI-00126","Case detection and diagnosis","Training of 560 healthcare workers at 280 Xpert MTB/Rif Machines (including Gxalert):\nIf 280 additional Xpert machines are procured, operationalization of the sites would require capacity building of the HCWs. The above allocation will be used to train 2 staff per GeneXpert site (560 HCWs) for additional 280 GeneXpert sites. This will ensure that staff have requisite skills to operate these machines and optimize utilization.",346920,null,"Active","a6Q1R000000AJMZ",0,0,0,0,346920,0,"2020-01-29T12:52:00",null,"Training of 560 healthcare workers at 280 Xpert MTB/Rif Machines (including Gxalert):\nIf 280 additional Xpert machines are procured, operationalization of the sites would require capacity building of the HCWs. The above allocation will be used to train 2 staff per GeneXpert site (560 HCWs) for additional 280 GeneXpert sites. This will ensure that staff have requisite skills to operate these machines and optimize utilization.","High",null,"NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Malawi","Malawi","PAI-5181","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Malawi requests for funding in 2020 to continue to support monitoring and evaluation so as to build upon global fund and partners? investments and sustain the gains achieved in the first two years. This support will maintain the routine disease surveillance systems and enable Malawi to collect robust, timely, and accurate data for improved program management. Thus enabling the National Malaria Control program and development partners to assess implementation progress and reprogram as maybe required in addition to providing evidence for allocation of resources so as to support achievement of maximum impact.",380318,null,"Active","a6Q1R000000AJL1",0,0,0,0,380318,0,null,null,"Malawi requests for funding in 2020 to continue to support monitoring and evaluation so as to build upon global fund and partners? investments and sustain the gains achieved in the first two years. This support will maintain the routine disease surveillance systems and enable Malawi to collect robust, timely, and accurate data for improved program management. Thus enabling the National Malaria Control program and development partners to assess implementation progress and reprogram as maybe required in addition to providing evidence for allocation of resources so as to support achievement of maximum impact.","High","This activity is very important for M&E improvement","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5050","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","This refers to consultancy costs for supervising activities carried out by peer educators for the HIV program.",11887,null,"Active","a6Q1R000000AJIu",0,0,0,0,11887,0,null,null,"This refers to consultancy costs for supervising activities carried out by peer educators for the HIV program.","Low","The TRP recommends that peer educators for ?adolescents and youth? is not a high-impact program in this epidemic setting.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5045","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","The allocation amount covers 73 per cent of needs for BCC among young people in or out of school to mobilize demand for counseling and testing services. This funding would cover the remaining 23 per cent, representing awareness-raising for 490,402 young people. This would enable the country to achieve its goal of providing awareness-raising to a total of 1,816,303 young people by the end of the three years, including an increase in the number of young people covered, to meet the targets for BCC and testing.  Also included will be periodic events to identify young people and provide outreach and mobile testing, develop teaching kits for awareness-raising activities, reproduce testing referral slips and refer positive case.",541494,null,"Active","a6Q1R000000AJIp",0,0,0,0,541494,0,null,null,"The allocation amount covers 73 per cent of needs for BCC among young people in or out of school to mobilize demand for counseling and testing services. This funding would cover the remaining 23 per cent, representing awareness-raising for 490,402 young people. This would enable the country to achieve its goal of providing awareness-raising to a total of 1,816,303 young people by the end of the three years, including an increase in the number of young people covered, to meet the targets for BCC and testing.  Also included will be periodic events to identify young people and provide outreach and mobile testing, develop teaching kits for awareness-raising activities, reproduce testing referral slips and refer positive case.","Low","73% coverage among the at-risk youth is covered by within allocation funds and should be quite a significant intervention scope for a country with low/declining incidence in the general population.  It is expected that with program continuation, nothing has materially changed to require 100% coverage of young people with BCC services. It is also expected that within-allocation prioritizes the higher prevalence regions and cities.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Multicountry EECA PAS","Multicountry EECA PAS","PAI-4946","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Collect evidence on access barriers through patient pathway analysis (additional countries). Better data on who is missed (geographically and by key populations) and analysis of pathway barriers and bottlenecks with development of subnational differentiated responses.",80000,null,"Active","a6Q1R000000AJHE",10250,0,0,0,69750,0,null,null,"Collect evidence on access barriers through patient pathway analysis (additional countries). Better data on who is missed (geographically and by key populations) and analysis of pathway barriers and bottlenecks with development of subnational differentiated responses.","High","This item is considered as the highest priority and proposed activities should be included into the core grant through efficiencies  identified.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Multicountry HIV CB-PANCAP-CVCCOIN","Multicountry HIV Caribbean PCC Consortium","PAI-4812","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00572","Other intervention(s) for people in prisons and other closed settings","Under the PANCAP Round 9 grant CVC supported some model prison-based programmes, and CVC is currently conducting work in prisons in the OECS multi-country grant in relation to TB and prison health in general. Through this module CVC seeks to foster partnerships between national health authorities, and civil society organizations to improve health care delivery for prisoners and develop and document model programmes that can be scaled up by national governments to reduce HIV prevalence in the prison settings.  This will be achiveed through Proposed Activities:\n1.1 Offer inmate orientation and training\n? Provide all new inmates with information on HIV, drug use, and other relevant issues to increase their capacity to safely navigate the prison environment \n? Train inmates as peer educators\n1.2 Build the capacity of prison staff\n?Train prison staff on HIV, drug use, and other relevant issues to increase their understanding and appropriate management of issues related to sexuality, HIV transmission, and drug use\n1.3 Institute pre-release programs\n? Develop and implement orientation and information programs for inmates who are about to be released to enable a smooth transition and reintegration into society \n?  Enable NGOs and CBOs to work in prisons to create links between prison health services and community health services, which will facilitate transition and reintegration\n1.3 Ensure continuity of care after discharge\n? Establish protocols and referral systems to ensure that discharged inmates have continued access to antiretroviral therapy and medical care \n? Provide inmates with social service cards for free medical care for a defined period (e.g., 4 to 6 months), with provision for renewal should they remain unemployed",200000,null,"Active","a6Q1R000000AJF4",0,0,0,0,200000,0,null,null,"Under the PANCAP Round 9 grant CVC supported some model prison-based programmes, and CVC is currently conducting work in prisons in the OECS multi-country grant in relation to TB and prison health in general. Through this module CVC seeks to foster partnerships between national health authorities, and civil society organizations to improve health care delivery for prisoners and develop and document model programmes that can be scaled up by national governments to reduce HIV prevalence in the prison settings.  This will be achiveed through Proposed Activities:\n1.1 Offer inmate orientation and training\n? Provide all new inmates with information on HIV, drug use, and other relevant issues to increase their capacity to safely navigate the prison environment \n? Train inmates as peer educators\n1.2 Build the capacity of prison staff\n?Train prison staff on HIV, drug use, and other relevant issues to increase their understanding and appropriate management of issues related to sexuality, HIV transmission, and drug use\n1.3 Institute pre-release programs\n? Develop and implement orientation and information programs for inmates who are about to be released to enable a smooth transition and reintegration into society \n?  Enable NGOs and CBOs to work in prisons to create links between prison health services and community health services, which will facilitate transition and reintegration\n1.3 Ensure continuity of care after discharge\n? Establish protocols and referral systems to ensure that discharged inmates have continued access to antiretroviral therapy and medical care \n? Provide inmates with social service cards for free medical care for a defined period (e.g., 4 to 6 months), with provision for renewal should they remain unemployed","Low","This activity is largely service delivery which falls outside of the scope of this RFP, the TRP therefore does not recommend this intervention.","Name is: CT Multicountry LAC CARICOM-PANCAP / Review approach Original Intervention: Other interventions for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-09-30"]
["CT Viet Nam","Viet Nam","PAI-5923","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Within the allocation VAAC has requested Global Fund support for training for MCH staff in 160 districts with high HIV burden to intensively identify pregnant women with HIV; link HIV positive pregnant women to immediate ART; and to provide early diagnose to new-borns to initiate ART. To contribute towards the national goal to reduce the vertical transmission rate of HIV to less than 5% by 2015 and to",700159,null,"Active","a6Q1R000000AJWz",0,0,0,0,700159,0,null,null,"Within the allocation VAAC has requested Global Fund support for training for MCH staff in 160 districts with high HIV burden to intensively identify pregnant women with HIV; link HIV positive pregnant women to immediate ART; and to provide early diagnose to new-borns to initiate ART. To contribute towards the national goal to reduce the vertical transmission rate of HIV to less than 5% by 2015 and to","Medium","This will be necessary with the above intervention and should therefore be considered in conjunction with this. The TRP has recommended the full amount to allow training in the first year.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Training for health staff on PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Tunisia","Tunisia","PAI-5833","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conducting assessment surveys on resistance to antiretrovirals (ARVs) at the four treatment sites, conducting a study on adherence to treatment, conducting a community bio-behavioral study (MSM, people who inject drugs, SWs) to measure the impact of prevention interventions, and updating the estimated sizes of key population (mapping/studies estimating the population size of MSM/SW/people who inject drugs) will all help to better guide the planning of HIV control activities, thereby guaranteeing an improved impact of disease control activities in Tunisia.",155796,null,"Active","a6Q1R000000AJVX",69196,0,0,0,86600,0,null,null,"Conducting assessment surveys on resistance to antiretrovirals (ARVs) at the four treatment sites, conducting a study on adherence to treatment, conducting a community bio-behavioral study (MSM, people who inject drugs, SWs) to measure the impact of prevention interventions, and updating the estimated sizes of key population (mapping/studies estimating the population size of MSM/SW/people who inject drugs) will all help to better guide the planning of HIV control activities, thereby guaranteeing an improved impact of disease control activities in Tunisia.","Medium","Conducting assessment surveys on resistance to antiretroviral (ARVs) at the four treatment sites, conducting a study on adherence to treatment, conducting a community bio-behavioural study men who have sex with men people who inject drugs, sex workers to measure the impact of prevention interventions, and updating the estimated sizes of key population (mapping/studies estimating the population size of men who have sex with men /sex workers/people who inject drugs) are medium priorities as this information can also be captured to some extent through activities in the allocation","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Tunisia","Tunisia","PAI-5832","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Reproducing and making available copies of harmonized data collection tools to Centers for Anonymous and Free Testing and Counseling (CCDAGs), laboratories, treatment centers and nongovernmental organizations (NGOs), and printing service provider and PE data collection registers will make it possible to report and save reliable information relating to services aimed at consolidating HIV control outcomes.",93439,null,"Active","a6Q1R000000AJVW",15117,0,0,0,78322,0,null,null,"Reproducing and making available copies of harmonized data collection tools to Centers for Anonymous and Free Testing and Counseling (CCDAGs), laboratories, treatment centers and nongovernmental organizations (NGOs), and printing service provider and PE data collection registers will make it possible to report and save reliable information relating to services aimed at consolidating HIV control outcomes.","Medium","While reproducing and making available copies of harmonized data collection tools to Centres for Anonymous and Free Testing and Counselling (CCDAGs), laboratories, treatment centres and non-governmental organizations (NGOs), and printing service provider and PE data collection registers is important for reporting and saving reliable information, the TRP considers this intervention not to be a high priority.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Zimbabwe","Zimbabwe","PAI-6084","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Funding is requested for additional PMTCT activities, supporting the country?s eMTCT validation.",375900,null,"Active","a6Q1R000000AJZa",0,0,0,0,375900,0,null,null,"Funding is requested for additional PMTCT activities, supporting the country?s eMTCT validation.","High","PMTCT is a high priority given the country is close to meeting elimination targets","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6079","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00575","Community mobilization and norms change","Youth Centers (Multi-sectoral approach model).",1300000,null,"Active","a6Q1R000000AJZV",0,0,0,0,1300000,0,null,null,"Youth Centers (Multi-sectoral approach model).","Low","Interventions already exist elsewhere",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Kosovo","Kosovo","PAI-5973","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","Given limited amount allocated to HIV prevention services among MSM in the grant, additional funds will be used to expand VCT delivered by NGOs. It will help to attain targets set.",24522.5,null,"Active","a6Q1R000000AJXn",0,0,0,0,24522.5,0,null,null,"Given limited amount allocated to HIV prevention services among MSM in the grant, additional funds will be used to expand VCT delivered by NGOs. It will help to attain targets set.","High","Any additional resources for men who have sex with (MSM) programs will be primarily used for increasing HIV counselling and testing by nongovernment organizations (NGO), medical staff, as well as through outreach workers. This will contribute to attaining the targets, as it will be difficult to do so with the limited number of staff and volunteers financed through the within-allocation amount.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Viet Nam","Viet Nam","PAI-5972","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","To support expansion of childhood TB activities, the PAAR will support revision of the diagnosis, treatment, and prevention training materials. NTP will also develop, print, and distribute IEC materials (poster, leaflets, etc.) for community awareness and support health workers on IPT and childhood TB management, with the ambition to detect and treat about 3,000 more cases per year.",75243,null,"Active","a6Q1R000000AJXm",0,0,0,0,75243,0,null,null,"To support expansion of childhood TB activities, the PAAR will support revision of the diagnosis, treatment, and prevention training materials. NTP will also develop, print, and distribute IEC materials (poster, leaflets, etc.) for community awareness and support health workers on IPT and childhood TB management, with the ambition to detect and treat about 3,000 more cases per year.","High","This includes essential revisions of training materials for diagnosis, prevention and treatment of paediatric TB. The TRP recommends that these costs be moved to the allocation. The community information, education and communication materials are also a high priority in the PAAR, but given their relatively low cost, may be absorbed in the allocation.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Intervention: Key populations - Children","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Eswatini","Eswatini","PAI-5662","MCI-00010","MDR-TB","MCI-00144","Community MDR-TB care delivery","Training of community treatment supporters in basic facts on TB, ethical considerations (privacy, patient confidentiality), infection control,treatment adherence and psychosocial support.This training helps them to execute their patient support duties with greater knowledge and broader understanding of their clients? needs.",135000,null,"Active","a6Q1R000000AJSm",0,0,0,0,135000,0,null,null,"Training of community treatment supporters in basic facts on TB, ethical considerations (privacy, patient confidentiality), infection control,treatment adherence and psychosocial support.This training helps them to execute their patient support duties with greater knowledge and broader understanding of their clients? needs.","High","Training of community treatment supporters is crucial for quality MDR-TB care.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Somalia","Somalia","PAI-5561","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Required to allow the continuation of essential strategic information collection to guide programming and measure outcomes. Studies will examine key bottlenecks and barriers to PMTCT and integration of services.",55454,null,"Active","a6Q1R000000AJR9",0,0,0,0,55454,0,null,null,"Required to allow the continuation of essential strategic information collection to guide programming and measure outcomes. Studies will examine key bottlenecks and barriers to PMTCT and integration of services.","High","Required to allow the continuation of essential strategic information collection to guide programming and measure outcomes. Studies will examine key bottlenecks and barriers to PMTCT and integration of services.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Operational research","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Senegal","Senegal","PAI-5525","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","The country has never undertaken a national TB prevalence survey. Such a survey would enable better knowledge to be gained of the epidemiological context and help orient the response more toward interventions that will have the maximum impact.",1122208.51,null,"Active","a6Q1R000000AJQZ",0,0,0,0,1122208.51,0,null,null,"The country has never undertaken a national TB prevalence survey. Such a survey would enable better knowledge to be gained of the epidemiological context and help orient the response more toward interventions that will have the maximum impact.","Medium","Senegal is not a high TB burden country and a prevalence survey is not considered of highest priority in this context.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH","RT Western Africa"]
["CT Senegal","Senegal","PAI-5523","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Monitoring is a management tool that uses tracer indicators for each program to ensure regular monitoring of activities. This activity is financed within the allocation until 2020 due to lack of funding.",80326.559999999998,null,"Active","a6Q1R000000AJQX",0,0,0,0,80326.559999999998,0,null,null,"Monitoring is a management tool that uses tracer indicators for each program to ensure regular monitoring of activities. This activity is financed within the allocation until 2020 due to lack of funding.","Medium","This intervention is not considered of highest priority at this point in relation to activities directly related to prevention and treatment. However, improving health management information system (HMIS) may result in strengthening monitoring and evaluation data by gender, age and risk factors, thus the medium-level ranking.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH","RT Western Africa"]
["CT Korea (Democratic Peoples Republic)","Korea (Democratic Peoples Republic)","PAI-5425","MCI-00071","Other module","MCI-00071","Other module","Under the above allocation, the NTP plans provide LTBI treatment to adult close contacts including TB health care workers, adults in high-risk groups and all family members of smear positive cases to substantially lower the curve of the TB epidemic.",2156267,null,"Active","a6Q1R000000AJOx",0,0,0,0,2156267,0,null,null,"Under the above allocation, the NTP plans provide LTBI treatment to adult close contacts including TB health care workers, adults in high-risk groups and all family members of smear positive cases to substantially lower the curve of the TB epidemic.","Low","This intervention is designed as a campaign to provide isoniazid preventive therapy (IPT) to adults (healthcare workers, adult family contacts, and high risk groups). This general approach to IPT is a low priority compared to other 4 interventions. However, the program plans to perform active case finding to diagnosis the missing cases. As notification rates rise, contact investigations as planned will lead to identification of children less than 5 years of age living in the homes of notified cases. These children are a program priority to screen and either treat for active TB or to administer IPT to prevent the development of TB disease. The TRP considers 10 percent of the requested amount of 21,562,673 to be quality demand; this 10 percent is targeted to be used in the context of contact investigation and IPT for children exposed to TB within their households. Funding recommendation has been adjusted.","NA Original Module: Improve the quality of treatment services through patientcentred integrated services focused on ambulatory care and social support. Original Intervention: Uninterrupted supply of qualityassured anti-TB drugs","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT South East Asia","2021-06-30"]
["CT Liberia","Liberia","PAI-4709","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Prevention of Mother-To-Child Transmission\n(PMTCT) has been prioritized in the NSP 2015 -2020 as a high impact intervention for clinical prevention of HIV infection aimed at achieving an HIV-free generation. Additional 75 PLHIV mothers will be trained in adherence support, prevention and tracing of lost to follow up, and psychosocial counselling to increase retention of mother-baby pairs in care. Although this is a priority intervention, it is placed in PAAR due to limited funding within allocation.",108014.41,null,"Active","a6Q1R000000AJDP",0,0,0,0,108014.41,0,null,null,"Prevention of Mother-To-Child Transmission\n(PMTCT) has been prioritized in the NSP 2015 -2020 as a high impact intervention for clinical prevention of HIV infection aimed at achieving an HIV-free generation. Additional 75 PLHIV mothers will be trained in adherence support, prevention and tracing of lost to follow up, and psychosocial counselling to increase retention of mother-baby pairs in care. Although this is a priority intervention, it is placed in PAAR due to limited funding within allocation.","High","While only training is noted as an activity, the TRP assumes that this activity will be used to support mothers living with HIV.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Training mothers living with HIV as adherence counsellors","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Western Africa","2020-12-31"]
["CT Nigeria","Nigeria","PAI-5273","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","The ACTs through the PSCM has helped to balance the price of antimalarials ACTs in the country and ensuring equitable access to quality-assured first line treatment. In Nigeria, 62% of the population seek care in the private sector therefore the. availability and affordability of quality assured ACTs will improve malaria case management and To complements the case management in the public sector, funds are required to procure 107,924,392 doses of ACTs through PSCM, (at national scale), over a 3-year period.This meets 50% of full private sector needs.. The country also proposes to increase co-payment contribution for from 20% to 40% over the lifetime of the grant.",82022538,null,"Active","a6Q1R000000AJMV",0,0,0,0,82022538,0,"2020-01-29T12:52:00",null,"The ACTs through the PSCM has helped to balance the price of antimalarials ACTs in the country and ensuring equitable access to quality-assured first line treatment. In Nigeria, 62% of the population seek care in the private sector therefore the. availability and affordability of quality assured ACTs will improve malaria case management and To complements the case management in the public sector, funds are required to procure 107,924,392 doses of ACTs through PSCM, (at national scale), over a 3-year period.This meets 50% of full private sector needs.. The country also proposes to increase co-payment contribution for from 20% to 40% over the lifetime of the grant.","Medium","To meet 50% of private sector co-payment need.","NA Original Intervention: ACT co-payment","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Nigeria","Nigeria","PAI-5272","MCI-00011","Vector control","MCI-00152","Entomological monitoring","Entomological monitoring is required to generate information sufficient to enable country-level planning of insecticide resistance management (IRM) and re-engineering of vector control strategies. Insecticide resistance has currently been reported across the five ecological zones of the country, and this poses a threat to vector control interventions. There are 14 sentinel sites for entomological surveillance across the country. Funding from PMI is supporting 6 sites (Ebonyi, Nasarawa, Bauchi, Sokoto, Akwa Ibom, and Oyo). As part of the process to strengthen the malaria vector surveillance and insecticide resistance monitoring and management in the country, Nigeria plans to cover the remaining sentinel sites. The country also plans to pilot innovative vector control interventions including PBO LLINs in selected sites in line with WHO recommendations and the NMSP 2014-2020. Funding Request: Full review 15 December 2016 | 33 This is important to provide the needed evidence towards effective management of Insecticide resistance in the country.",1300000,null,"Inactive","a6Q1R000000AJMU",0,0,0,1300000,0,1,"2020-01-29T12:52:00",null,"Entomological monitoring is required to generate information sufficient to enable country-level planning of insecticide resistance management (IRM) and re-engineering of vector control strategies. Insecticide resistance has currently been reported across the five ecological zones of the country, and this poses a threat to vector control interventions. There are 14 sentinel sites for entomological surveillance across the country. Funding from PMI is supporting 6 sites (Ebonyi, Nasarawa, Bauchi, Sokoto, Akwa Ibom, and Oyo). As part of the process to strengthen the malaria vector surveillance and insecticide resistance monitoring and management in the country, Nigeria plans to cover the remaining sentinel sites. The country also plans to pilot innovative vector control interventions including PBO LLINs in selected sites in line with WHO recommendations and the NMSP 2014-2020. Funding Request: Full review 15 December 2016 | 33 This is important to provide the needed evidence towards effective management of Insecticide resistance in the country.","Medium","To Complement PMI-supported insecticide resistance monitoring efforts.","The Global Fund in close collaboration with PMI Nigeria has been able to meet Nigeria entomological monitoring needs for the current implementation period. The Global Fund total contribution is USD 850,895. The CT does not anticipate additional country needs for this intervention, as such this UQD can be considered as met.","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Malawi","Malawi","PAI-5175","MCI-00071","Other module","MCI-00071","Other module","To support management of severe malaria cases at health facility level, a request is made in PAAR for procurement and distribution of 5,718,270 injectable Artesunate doses.",9523109,null,"Active","a6Q1R000000AJKv",5906811,0,0,0,3616298,0,null,null,"To support management of severe malaria cases at health facility level, a request is made in PAAR for procurement and distribution of 5,718,270 injectable Artesunate doses.","High","This is a critical intervention which is the highest priority for moving into the allocation funding request in view of the high prevalence and corresponding importance of managing severe childhood malaria. This should therefore be prioritised when efficiencies are found.","NA Original Module: Artesunate procurement and distribution. Original Intervention: Ensure availability of severe malaria treatment","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5044","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00088","Condoms and lubricant programming for sex workers","This refers to purchase costs and procurement and supply management (PSM) costs for 7,547,267 male condoms, to cover the total quantified needs for all the target groups (difference between the total needs of 39,902,574 and the 32,355,307 scheduled under the allocation amount).",159481,null,"Active","a6Q1R000000AJIo",0,0,0,0,159481,0,null,null,"This refers to purchase costs and procurement and supply management (PSM) costs for 7,547,267 male condoms, to cover the total quantified needs for all the target groups (difference between the total needs of 39,902,574 and the 32,355,307 scheduled under the allocation amount).","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5039","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","The country is planning to introduce a unique identification system to avoid duplication among beneficiaries. To maintain confidentiality and ensure continuum of care, especially within services, PSI is going to introduce a unique identifier code (UIC) system to monitor beneficiaries. it will be crucial to run an exchange visit to another country with experience in using the system. This request also covers international technical assistance to provide technical support to the team, particularly for the programmatic and monitoring and evaluation components, due to the complexity of the interventions under this continuation and the strategic reorientation of HIV activities. Throughout implementation, it will be vitally important to strengthen coordination through a regular meeting between the PRs, SRs and partners with the objective to closely monitor progress and to address bottlenecks, and to improve collaboration and harmonization in implementation on the ground. The request also includes training to provide capacity building for peer educator supervisors and district managers.The total budget for this activity falls within the above allocation amount, so it will be completely dependent on approval of this request.",280931,null,"Active","a6Q1R000000AJIj",0,0,0,0,280931,0,null,null,"The country is planning to introduce a unique identification system to avoid duplication among beneficiaries. To maintain confidentiality and ensure continuum of care, especially within services, PSI is going to introduce a unique identifier code (UIC) system to monitor beneficiaries. it will be crucial to run an exchange visit to another country with experience in using the system. This request also covers international technical assistance to provide technical support to the team, particularly for the programmatic and monitoring and evaluation components, due to the complexity of the interventions under this continuation and the strategic reorientation of HIV activities. Throughout implementation, it will be vitally important to strengthen coordination through a regular meeting between the PRs, SRs and partners with the objective to closely monitor progress and to address bottlenecks, and to improve collaboration and harmonization in implementation on the ground. The request also includes training to provide capacity building for peer educator supervisors and district managers.The total budget for this activity falls within the above allocation amount, so it will be completely dependent on approval of this request.","Medium","Establishing a unique identifier system and related TA are quality demand. An exchange visit to another country and supplementary coordination activities are not quality demand.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Madagascar","Madagascar","PAI-5038","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","This refers to a contribution from the Global Fund grant toward the Madagascar HIV/AIDS seroprevalence study. Discussions about practical methodology for running and financing the study are ongoing with the various technical and financial partners (TFPs). \nTotal estimated cost of the survey is US$ 1 million.",500000,null,"Active","a6Q1R000000AJIi",0,0,0,0,500000,0,null,null,"This refers to a contribution from the Global Fund grant toward the Madagascar HIV/AIDS seroprevalence study. Discussions about practical methodology for running and financing the study are ongoing with the various technical and financial partners (TFPs). \nTotal estimated cost of the survey is US$ 1 million.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4927","MCI-00071","Other module","MCI-00071","Other module","\"Contribute to the Jordan Health Fund for Refugees (JHFR); \"\"In exchange for a GoJ commitment to provide quality primary and secondary health care services for Syrian refugees in MOH facilities at the same rate as for uninsured Jordanians, contributions to the JHFR will off-set the following component costs of the MOH's annual budget related to providing subsidized primary and secondary health care services in MOH facilities to Syrian refugees: ( I) primary health care; (2) secondary health care; and (3) medicines, medical solutions, consumables, and supplies. \"",5611043,null,"Active","a6Q1R000000AJGv",0,0,0,0,5611043,0,null,null,"\"Contribute to the Jordan Health Fund for Refugees (JHFR); \"\"In exchange for a GoJ commitment to provide quality primary and secondary health care services for Syrian refugees in MOH facilities at the same rate as for uninsured Jordanians, contributions to the JHFR will off-set the following component costs of the MOH's annual budget related to providing subsidized primary and secondary health care services in MOH facilities to Syrian refugees: ( I) primary health care; (2) secondary health care; and (3) medicines, medical solutions, consumables, and supplies. \"","High","Very high priority intervention to sum up current efforts to avoid catastrophic health costs for Syrian refugees, improve health access, harmonize with other key donors and contribute to national efforts.","NA Original Module: RSSH. Original Intervention: RSSH","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry HIAF2 ECSA-HC","Multicountry Africa ECSA-HC","PAI-4803","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Funds to strengthen joint visits to project countries to all 22 countries to determine progress and provide support. Ideally, new entrants to the project will be visited twice including a first visit to conduct a baseline assessment.",65792,null,"Active","a6Q1R000000AJEv",0,0,0,0,65792,0,null,null,"Funds to strengthen joint visits to project countries to all 22 countries to determine progress and provide support. Ideally, new entrants to the project will be visited twice including a first visit to conduct a baseline assessment.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 2","2022-06-30"]
["CT Viet Nam","Viet Nam","PAI-5918","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","Assessment of Supply Chain Management System Funding requested to conduct an assessment of the national supply chain management system. This will include technical assistance, site visits to selected provinces to collect data, and information, and technical meetings. Support for one or two workshops to review the results of the assessment is also included in this request. Implementing e-LMIS Support for hardware and software as well as training for procurement and supply officers to implement electronic LIMS at provincial level is included within the allocation request (section 2.1). In order to optimize e-LMIS, above allocation support is requested for the following: (i) Computers and software for implementing e-LMIS at service delivery sites (ii) Technical assistance for implementing drugs and commodities LMIS by CPMU (iii) Technical assistance for implementing drugs and commodities LMIS by PPMU (iv) Fee for data collection and input Develop national plan for supply chain management Above allocation funding is requested to develop a national plan for supply chain management, including technical assistance, technical meetings and one workshop to review and finalise the plan. Implement quality assurance/quality monitoring Support is requested to develop a plan for quality assurance/quality monitoring of selected drugs and commodities (ARV, syringes, condoms), including technical assistance, technical meetings and one workshop to review and finalise the plan. Once the Supply Chain QA Plan is developed, support is requested to engage a specialist company to implement the plan. This budget request includes procurement of ARV to replace drugs that are sent from service delivery sites to be tested for quality.",1435676,null,"Active","a6Q1R000000AJWu",997485,0,0,0,438191,0,null,null,"Assessment of Supply Chain Management System Funding requested to conduct an assessment of the national supply chain management system. This will include technical assistance, site visits to selected provinces to collect data, and information, and technical meetings. Support for one or two workshops to review the results of the assessment is also included in this request. Implementing e-LMIS Support for hardware and software as well as training for procurement and supply officers to implement electronic LIMS at provincial level is included within the allocation request (section 2.1). In order to optimize e-LMIS, above allocation support is requested for the following: (i) Computers and software for implementing e-LMIS at service delivery sites (ii) Technical assistance for implementing drugs and commodities LMIS by CPMU (iii) Technical assistance for implementing drugs and commodities LMIS by PPMU (iv) Fee for data collection and input Develop national plan for supply chain management Above allocation funding is requested to develop a national plan for supply chain management, including technical assistance, technical meetings and one workshop to review and finalise the plan. Implement quality assurance/quality monitoring Support is requested to develop a plan for quality assurance/quality monitoring of selected drugs and commodities (ARV, syringes, condoms), including technical assistance, technical meetings and one workshop to review and finalise the plan. Once the Supply Chain QA Plan is developed, support is requested to engage a specialist company to implement the plan. This budget request includes procurement of ARV to replace drugs that are sent from service delivery sites to be tested for quality.","High","The supply chain management system is of high quality at the moment. However, with the transition in funding and a move to more decentralization of services to lower levels of the health system, it will be very important to ensure that there is no disruption in the supply chain. The TRP recommends that this is moved to the allocation.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Strengthening of national supply chain management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Uzbekistan","Uzbekistan","PAI-5917","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00095","HIV testing services for PWID","Encouraging packages for attracting representatives of vulnerable groups to HIV testing (for testing 19,200  PWID).",403200,null,"Inactive","a6Q1R000000AJWt",403200,0,0,0,0,1,null,null,"Encouraging packages for attracting representatives of vulnerable groups to HIV testing (for testing 19,200  PWID).","Medium",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: HIV testing services for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-06-30"]
["CT Tunisia","Tunisia","PAI-5829","MCI-00534","Comprehensive prevention programs for MSM","MCI-00539","Addressing stigma, discrimination and violence against MSM","In accordance with the outcomes of previous analyses, MSM often encounter a lack of understanding and intolerance from law enforcement and security forces and those operating in the health care system responsible for treating key populations. The activities included in the modules and interventions opposite will contribute to building the capacity and knowledge of these different categories (law enforcement officers and health workers) with respect to the human rights of populations in the context of HIV control.",151089,null,"Active","a6Q1R000000AJVT",0,0,0,0,151089,0,null,null,"In accordance with the outcomes of previous analyses, MSM often encounter a lack of understanding and intolerance from law enforcement and security forces and those operating in the health care system responsible for treating key populations. The activities included in the modules and interventions opposite will contribute to building the capacity and knowledge of these different categories (law enforcement officers and health workers) with respect to the human rights of populations in the context of HIV control.","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Addressing stigma, discrimination and violence against men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Timor-Leste","Timor-Leste","PAI-5824","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Enhancing the National Malaria Elimination logistical capabilities to conduct ?real-time? case / and foci investigations and to provide a rapid response (Reactive based Case Detection Support and Supervision of Focal IRS spraying) to mitigate malaria outbreaks. This will indirectly support the programme to meet impact indicators. Funding would be utilised to Purchase four-wheel drive double cabs with rear fiberglass canopies in the first two years of the allocation and support their fuel and maintenance as well as new driver?s salaries. The vehicles used by the national and municipalities were procured in 2010 and will be more than 9 years old by 2019. Most of the vehicles are not serviceable and the cost for repair is high and investment would be more efficiently used to purchase new vehicles. These vehicles are vital if data is used to warrant rapid case / foci investigations and to mount effective IRS / Reactive based case detection responses.",821577,null,"Active","a6Q1R000000AJVO",0,0,0,0,821577,0,null,null,"Enhancing the National Malaria Elimination logistical capabilities to conduct ?real-time? case / and foci investigations and to provide a rapid response (Reactive based Case Detection Support and Supervision of Focal IRS spraying) to mitigate malaria outbreaks. This will indirectly support the programme to meet impact indicators. Funding would be utilised to Purchase four-wheel drive double cabs with rear fiberglass canopies in the first two years of the allocation and support their fuel and maintenance as well as new driver?s salaries. The vehicles used by the national and municipalities were procured in 2010 and will be more than 9 years old by 2019. Most of the vehicles are not serviceable and the cost for repair is high and investment would be more efficiently used to purchase new vehicles. These vehicles are vital if data is used to warrant rapid case / foci investigations and to mount effective IRS / Reactive based case detection responses.","Medium","The cars are needed for ACD and response which currently can no longer be serviced. In addition this will indirectly help to achieve programme impact indicators.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Zimbabwe","Zimbabwe","PAI-6072","MCI-00000","Prevention programs for general population","MCI-00079","Gender-based violence prevention and treatment programs for general population","Primary gender-based violence prevention programs to protect vulnerable women and girls. Specifically, funding is requested to roll out the MenEngage Padere model in 25 districts (Note: Piloting of the SASA! model is prioritized in the matching funds request for AGYW).",355668,null,"Active","a6Q1R000000AJZO",0,0,0,0,355668,0,null,null,"Primary gender-based violence prevention programs to protect vulnerable women and girls. Specifically, funding is requested to roll out the MenEngage Padere model in 25 districts (Note: Piloting of the SASA! model is prioritized in the matching funds request for AGYW).","Medium","Intervention designed for impact",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6071","MCI-00000","Prevention programs for general population","MCI-00076","Diagnosis and treatment of STIs and other sexual health services for general population","HIV prevention-related STI services, including for the provision of dual HIV and syphilis testing, STI screening and treatment, referrals for HPV vaccines and cervical cancer services.",3568111,null,"Active","a6Q1R000000AJZN",0,0,0,0,3568111,0,null,null,"HIV prevention-related STI services, including for the provision of dual HIV and syphilis testing, STI screening and treatment, referrals for HPV vaccines and cervical cancer services.","Medium","Cervical cancer screening is a priority intervention and should preferably be integrated with Sexual and Reproductive Health services","NA Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Viet Nam","Viet Nam","PAI-5967","MCI-00010","MDR-TB","MCI-00143","Engaging all care providers (MDR-TB)","Workshop about anti-TB drug (FL, SL, new) management in the market - Baseline survey on feasibility and acceptability of using mobile phone interventions for TB patient.",61547,null,"Active","a6Q1R000000AJXh",0,0,0,0,61547,0,null,null,"Workshop about anti-TB drug (FL, SL, new) management in the market - Baseline survey on feasibility and acceptability of using mobile phone interventions for TB patient.","High","Workshop on anti -TB drug management in the market and a base -line feasibility study on mobile phone interventions for TB cases. This intervention should be incorporated into MDR TB activities through budget efficiencies","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Eswatini","Eswatini","PAI-5656","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Additional funding for demand creation, clinical activities and overhead costs to perform an additional 7040 medical male circumcisions. This above allocation request will enable the country to deliver 11,720 procedures over the three years.",2274777,null,"Inactive","a6Q1R000000AJSg",1548839,725938,0,0,0,1,null,null,"Additional funding for demand creation, clinical activities and overhead costs to perform an additional 7040 medical male circumcisions. This above allocation request will enable the country to deliver 11,720 procedures over the three years.","High","This should be prioritized as an intervention given that VMMC plays an important role in Swaziland?s success in HIV prevention based on the investment case and should be moved to the within allocation funding if efficiencies are found.","NA Original Intervention: Medical male circumcision","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Suriname","Suriname","PAI-5651","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Develop / standardize a mechanism for cost recovery of public sector to recover costs for services provided by them, to patients with private health insurance.",5250,null,"Active","a6Q1R000000AJSb",0,0,0,0,5250,0,null,null,"Develop / standardize a mechanism for cost recovery of public sector to recover costs for services provided by them, to patients with private health insurance.","High",null,"NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Somalia","Somalia","PAI-5556","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Package of ANC Surveillance, Spectrum Analysis, MOT study, Operational research. These will complement the HIV allocation studies (IBBS and Cohort Analysis) to ensure key critical data for program planning and outcome/impact of programming can be continued.",455454,null,"Inactive","a6Q1R000000AJR4",455454,0,0,0,0,1,null,null,"Package of ANC Surveillance, Spectrum Analysis, MOT study, Operational research. These will complement the HIV allocation studies (IBBS and Cohort Analysis) to ensure key critical data for program planning and outcome/impact of programming can be continued.","High","Package of 4.1.4c ANC Surveillance, 4.1.4d Spectrum Analysis, 4.1.4g, MOT study 4.1.4f Operational research. These will complement the HIV allocation studies (IBBS and Cohort Analysis) to ensure key critical data for program planning and outcome/impact of programming can be continued .","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: HIV strategic information package","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Senegal","Senegal","PAI-5519","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","As part of the End TB strategy, Senegal is moving towards using GeneXpert  as  a  first-line  test  in  the  six  regions that  are  home  to  81 %  of  missing  cases. Following grant making discussions it has been agreed that the grant will purchase 28 new GeneXpert machines and cover some of the procurement of cartridges. The World Bank and other partners will need to finance some of the remaining cartridge needs.\nThe   additional   investment   requested   would enable   all   estimated   needs   for   GeneXpert and cartridges to be covered. A condition has been inserted in the grant agreement for the expansion plan and will be supported by WHO.",3024573,null,"Active","a6Q1R000000AJQT",0,0,0,0,3024573,0,null,null,"As part of the End TB strategy, Senegal is moving towards using GeneXpert  as  a  first-line  test  in  the  six  regions that  are  home  to  81 %  of  missing  cases. Following grant making discussions it has been agreed that the grant will purchase 28 new GeneXpert machines and cover some of the procurement of cartridges. The World Bank and other partners will need to finance some of the remaining cartridge needs.\nThe   additional   investment   requested   would enable   all   estimated   needs   for   GeneXpert and cartridges to be covered. A condition has been inserted in the grant agreement for the expansion plan and will be supported by WHO.","High","The TRP considers this intervention as high priority as it will lead to increased case finding among high priority regions.","NA Original Intervention: Disease screening and diagnosis (Meeting the need for GeneXpert cartridges for firstline tests in highmorbidity regions)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH","RT Western Africa"]
["CT Senegal","Senegal","PAI-5514","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","In addition to improving the PNA?s storage capacity, the capacities of the medical regions will need to be strengthened by setting up storage facilities for storing antimalarial supplies as well as supplies for other programs, in order to achieve local health objectives (70,000*1,000 m2*14 regions).",1676579.51,null,"Active","a6Q1R000000AJQO",0,0,0,0,1676579.51,0,null,null,"In addition to improving the PNA?s storage capacity, the capacities of the medical regions will need to be strengthened by setting up storage facilities for storing antimalarial supplies as well as supplies for other programs, in order to achieve local health objectives (70,000*1,000 m2*14 regions).","Medium",null,"Amount validated by CT Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2020-12-31"]
["CT Korea (Democratic Peoples Republic)","Korea (Democratic Peoples Republic)","PAI-5417","MCI-00012","Case management","MCI-00154","Facility-based treatment","As the country moves into elimination, comprehensive coverage wtih quality diagnostics is critical.  Funding will  ensure microscopy services are quality assured and includes  strengthening the national reference laboratory for microscopy and provision of a slide bank for 8 Provincial Hygiene and Anti-Epidemic Institutes (HAEIs) to ensure training / quality control of Ri-level cluster based microscopy and ensure confirmatory diagnosis. This will indirectly contribute to providing more accurate reports of both The Testing Positivity Rate and the Number of Confirmed Cases Impact indicators.",240348,null,"Active","a6Q1R000000AJOp",0,0,0,0,240348,0,null,null,"As the country moves into elimination, comprehensive coverage wtih quality diagnostics is critical.  Funding will  ensure microscopy services are quality assured and includes  strengthening the national reference laboratory for microscopy and provision of a slide bank for 8 Provincial Hygiene and Anti-Epidemic Institutes (HAEIs) to ensure training / quality control of Ri-level cluster based microscopy and ensure confirmatory diagnosis. This will indirectly contribute to providing more accurate reports of both The Testing Positivity Rate and the Number of Confirmed Cases Impact indicators.","High","In an elimination setting comprehensive coverage with quality diagnostic is critical.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-02-28"]
["CT Papua New Guinea","Papua New Guinea","PAI-5416","MCI-00021","RSSH: Community responses and systems","MCI-00196","Community led advocacy","Full-time Coordinator for each of the three national KP/HIV networks ? Igat Hope, the national network of PLHIV; Friends Frangipani, the national network of sex workers and Kapul Champions ? the national network of MSM and TG people. Core funding for these organizations ceased in December 2016 due to a change in donor strategic direction. It will allow the national networks to strengthen provincial and district chapters and participate in national advocacy in the response to HIV.",207264,null,"Inactive","a6Q1R000000AJOo",207264,0,0,0,0,1,null,null,"Full-time Coordinator for each of the three national KP/HIV networks ? Igat Hope, the national network of PLHIV; Friends Frangipani, the national network of sex workers and Kapul Champions ? the national network of MSM and TG people. Core funding for these organizations ceased in December 2016 due to a change in donor strategic direction. It will allow the national networks to strengthen provincial and district chapters and participate in national advocacy in the response to HIV.","Medium","The TRP considers community advocacy important, but recommends emphasis on community service delivery; therefore, this is a medium priority.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT South East Asia","2020-12-31"]
["CT Liberia","Liberia","PAI-4700","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00601","Supportive policy and programmatic environment","The request amount in this cost category and intervention aimes to ensur community health workforce retention. It includes:\n? 3 years of monthly compensation/salary for 110 CHAs and 11 CHSS for 2 additional districts in Margibi (a priority national ICCM gap)\n? 3 years of monthly compensation/salary for 202 CHAs and 23 CHSS for Lofa county (3 districts) with gap in the implementation of the Revised National Community Health Policy in Liberia.  \nThe Revised National Community Health Policy requires payment of the monthly compensation of US$70 per CHA and US$269 per CHSS working in counties included in this activity.",3506474,null,"Active","a6Q1R000000AJDG",0,0,250217,0,3256257,0,null,null,"The request amount in this cost category and intervention aimes to ensur community health workforce retention. It includes:\n? 3 years of monthly compensation/salary for 110 CHAs and 11 CHSS for 2 additional districts in Margibi (a priority national ICCM gap)\n? 3 years of monthly compensation/salary for 202 CHAs and 23 CHSS for Lofa county (3 districts) with gap in the implementation of the Revised National Community Health Policy in Liberia.  \nThe Revised National Community Health Policy requires payment of the monthly compensation of US$70 per CHA and US$269 per CHSS working in counties included in this activity.","High","The TRP considers the third and fourth interventions, ?scaling up health systems support appropriately focused on Community Health workers in different additional districts?, as highly relevant in the context of an underfunded health sector with significant gaps identified in the funding landscape.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Nigeria","Nigeria","PAI-5264","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Point of Care for EID and Viral Load testing \nThe gap between PMTCT and EID represents a missed opportunity for diagnosis of known HIV exposed infants. Up to two-thirds of vertical HIV infections are estimated to occur from mothers who are not enrolled in PMTCT and uptake of EID testing at non-PMTCT entry points remains low. \nExpanding EID testing at non-PMTCT entry points is critical to finding HIV+ infants. This includes introduction of POC EID and VL LIMS for GeneXpert and mPima devices to: \n- Improve EID coverage through near-POC/POC testing\n- improve VL coverage and early clinical decision making by introducing TB-HIV VL integrated testing on existing GeneXpert",3259523,null,"Active","a6Q1R000000AJMM",0,0,0,0,3259523,0,"2020-01-29T12:52:00",null,"Point of Care for EID and Viral Load testing \nThe gap between PMTCT and EID represents a missed opportunity for diagnosis of known HIV exposed infants. Up to two-thirds of vertical HIV infections are estimated to occur from mothers who are not enrolled in PMTCT and uptake of EID testing at non-PMTCT entry points remains low. \nExpanding EID testing at non-PMTCT entry points is critical to finding HIV+ infants. This includes introduction of POC EID and VL LIMS for GeneXpert and mPima devices to: \n- Improve EID coverage through near-POC/POC testing\n- improve VL coverage and early clinical decision making by introducing TB-HIV VL integrated testing on existing GeneXpert","High",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Africa 1","2020-12-31"]
["CT Mauritania","Mauritania","PAI-5168","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","It has been proposed to provide for the managers of the TTCs as part of this request and in order to build on the progress made under the grant currently being implemented. This also takes the programmatic gaps into account and will make it possible to achieve the greatest impact on expanding access to effective tuberculosis diagnosis and treatment by reducing the incidence of the disease among the population.",156494,null,"Active","a6Q1R000000AJKo",0,0,0,0,156494,0,null,null,"It has been proposed to provide for the managers of the TTCs as part of this request and in order to build on the progress made under the grant currently being implemented. This also takes the programmatic gaps into account and will make it possible to achieve the greatest impact on expanding access to effective tuberculosis diagnosis and treatment by reducing the incidence of the disease among the population.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2021-12-31"]
["CT Mauritania","Mauritania","PAI-5167","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","The improvement of TB control activities for prisoners through training for health-care providers in prisons and the use of mobile x-ray machines.",14546,null,"Active","a6Q1R000000AJKn",0,0,0,0,14546,0,null,null,"The improvement of TB control activities for prisoners through training for health-care providers in prisons and the use of mobile x-ray machines.","High",null,"NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2021-12-31"]
["CT Madagascar","Madagascar","PAI-5036","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","This refers to consultancy costs for supervising activities carried out by peer educators for the HIV program.  The request includes: running advocacy workshops, training and capacity building for outreach workers (peer educators or their supervisors), a midterm evaluation and a final evaluation of the pilot scheme.",5943,null,"Active","a6Q1R000000AJIg",0,0,0,0,5943,0,null,null,"This refers to consultancy costs for supervising activities carried out by peer educators for the HIV program.  The request includes: running advocacy workshops, training and capacity building for outreach workers (peer educators or their supervisors), a midterm evaluation and a final evaluation of the pilot scheme.","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2020-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4924","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00177","Other health and community workforce intervention(s)","NAP and Key Population participation in international trainings, conferences, workshops etc.",22444,null,"Active","a6Q1R000000AJGs",0,0,0,0,22444,0,null,null,"NAP and Key Population participation in international trainings, conferences, workshops etc.","Low","International workshops and training can also be accessed remotely.","NA Original Module: RSSH: Human resources for health, including community health workers. Original Intervention: RSSH: Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4919","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Form a National HIV Committee that will include members representing various entities , develop on annual basis a work agenda and will meet at least every 6 months and on ad hoc basis",11222,null,"Active","a6Q1R000000AJGn",0,0,0,0,11222,0,null,null,"Form a National HIV Committee that will include members representing various entities , develop on annual basis a work agenda and will meet at least every 6 months and on ad hoc basis","High",null,"NA Original Intervention: Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry HIAF2 ECSA-HC","Multicountry Africa ECSA-HC","PAI-4799","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Funds to strengthen exchange amongst laboratories, which is noted as a strength of the project in the Mid-term Review. Specific activities may include peer-to-peer capacity building, twinning of country NRLs (National Reference Laboratories), and peer mentoring.",48828,null,"Active","a6Q1R000000AJEr",0,0,0,0,48828,0,null,null,"Funds to strengthen exchange amongst laboratories, which is noted as a strength of the project in the Mid-term Review. Specific activities may include peer-to-peer capacity building, twinning of country NRLs (National Reference Laboratories), and peer mentoring.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 2","2022-06-30"]
["CT Multicountry HIAF2 E8S","Multicountry Southern Africa E8","PAI-4794","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Activity: Support for the provision of E8 border health posts in Southern Angola after the 18-month transition period has ended (1 April 2020 - 30 September 2021)\n\nDescription: This funding request includes continued support for the provision of health services through the E8  border health posts in Southern Angola following the 18-month integration period included in the formal funding request. This additional support is assuming the integration will not be feasible for Angola?s national health system after the 18-month transition period ends given the limited health infrustructure in Southern Angola.  \n\nRationale: A core strategy of the E8 is to reduce importation from the second line countries to the frontline countries through the establishment of its own border health posts along five priority borders. Positivity rates from the E8 border health posts along the Angola-Namibia border have been as high as 40% in some areas. In most cases, these border posts are located in areas where no other health facilities are present. Maintaining these services for the entirety of the E8 grant will be important to prevent further cross-border transmission into neighbouring countries and to provide access to care to underserve populations living in proximity to these border posts. With significantly higher burden in the northern districts of Angola, it is anticipated that the border health posts along Angola's southern border (established with E8 funding) will not be able to continue without renewed support from the E8. Through the implementation of the E8 border posts to date, national programmes have been able to test and treat vulnerable populations that would have otherwise gone untreated.\n\nExpected Outcomes/Impact: Improving access to malaria prevention and treatment to high risk populations (e.g. MMPs, border communities) through the use of border health posts is expected to substantially reduce cross-border importation into neighbouring countries such as Namibia, Zambia, and Botswana. The eight E8 border health posts located in Angola along the Angola-Namibia border have been operational since September 2017. Since launching, they have tested 124,092 people and have confirmed 17,412 cases. Given that the border posts are capturing additional cases after less than a year of operation suggests that continued investment is needed as they are filling critical gaps in Angola's health system which are perpetuating on-going transmission into neighbouring countries. \n\nBudget: Costs associated with this activity will include human resources, operations, and commodities for the remaining 21 months of this investment (1 April 2020 - 30 September 2021). The total cost of this activity is therefore estimated to US$ 475,000 for the 21 month period.\n\n*Note - the intervention category does not provide all intervention options in the dropdown menu. The correct intervention for this activity is \"Facility-based treatment.\" However, this is not an option in the dropdown menu of this template.",475000,null,"Active","a6Q1R000000AJEm",0,0,0,0,475000,0,null,null,"Activity: Support for the provision of E8 border health posts in Southern Angola after the 18-month transition period has ended (1 April 2020 - 30 September 2021)\n\nDescription: This funding request includes continued support for the provision of health services through the E8  border health posts in Southern Angola following the 18-month integration period included in the formal funding request. This additional support is assuming the integration will not be feasible for Angola?s national health system after the 18-month transition period ends given the limited health infrustructure in Southern Angola.  \n\nRationale: A core strategy of the E8 is to reduce importation from the second line countries to the frontline countries through the establishment of its own border health posts along five priority borders. Positivity rates from the E8 border health posts along the Angola-Namibia border have been as high as 40% in some areas. In most cases, these border posts are located in areas where no other health facilities are present. Maintaining these services for the entirety of the E8 grant will be important to prevent further cross-border transmission into neighbouring countries and to provide access to care to underserve populations living in proximity to these border posts. With significantly higher burden in the northern districts of Angola, it is anticipated that the border health posts along Angola's southern border (established with E8 funding) will not be able to continue without renewed support from the E8. Through the implementation of the E8 border posts to date, national programmes have been able to test and treat vulnerable populations that would have otherwise gone untreated.\n\nExpected Outcomes/Impact: Improving access to malaria prevention and treatment to high risk populations (e.g. MMPs, border communities) through the use of border health posts is expected to substantially reduce cross-border importation into neighbouring countries such as Namibia, Zambia, and Botswana. The eight E8 border health posts located in Angola along the Angola-Namibia border have been operational since September 2017. Since launching, they have tested 124,092 people and have confirmed 17,412 cases. Given that the border posts are capturing additional cases after less than a year of operation suggests that continued investment is needed as they are filling critical gaps in Angola's health system which are perpetuating on-going transmission into neighbouring countries. \n\nBudget: Costs associated with this activity will include human resources, operations, and commodities for the remaining 21 months of this investment (1 April 2020 - 30 September 2021). The total cost of this activity is therefore estimated to US$ 475,000 for the 21 month period.\n\n*Note - the intervention category does not provide all intervention options in the dropdown menu. The correct intervention for this activity is \"Facility-based treatment.\" However, this is not an option in the dropdown menu of this template.","High","The TRP recommends moving this intervention from PAAR to within-allocation because it is essential to reduce transmission and reach the malaria elimination goal",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2021-09-30"]
["CT Uzbekistan","Uzbekistan","PAI-5908","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","Encouraging packages to attract representatives of vulnerable groups to HIV testing (for testing 10500 SW).",220500,null,"Inactive","a6Q1R000000AJWk",220500,0,0,0,0,1,null,null,"Encouraging packages to attract representatives of vulnerable groups to HIV testing (for testing 10500 SW).","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-06-30"]
["CT Timor-Leste","Timor-Leste","PAI-5822","MCI-00012","Case management","MCI-00157","Active case detection and investigation (elimination phase)","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Leste?s transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector",1192,null,"Inactive","a6Q1R000000AJVM",1192,0,0,0,0,1,null,null,"Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Leste?s transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector","High","Guidelines for ACD must be available to staff at the central and district levels to ensure case and foci investigation protocols are strictly adhered to (i.e. 2 days for case investigation, 5 days for Mass Blood Survey, and 10 days for response package). These funds will facilitate the printing of the guidelines.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Timor-Leste","Timor-Leste","PAI-5821","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Provision of LLIN procurement and routine ANC distribution to maximise coverage in and utilization by pregnant women to prevent the acquisition of malaria with complications. It would complement the above (Priority 1 request) in ensuring complementary coverage would provide the outcome of Universal Access to Coverage (90%) amongst a wider population denominator and would ensure targets are achieved across all 4 Impact Indicators.",309536,null,"Inactive","a6Q1R000000AJVL",309536,0,0,0,0,1,null,null,"Provision of LLIN procurement and routine ANC distribution to maximise coverage in and utilization by pregnant women to prevent the acquisition of malaria with complications. It would complement the above (Priority 1 request) in ensuring complementary coverage would provide the outcome of Universal Access to Coverage (90%) amongst a wider population denominator and would ensure targets are achieved across all 4 Impact Indicators.","High","Pregnant women are one of the most vulnerable groups for malaria with the highest risk of severe complications, and malaria in pregnancy puts unborn children at high risk for premature, underweight or even still birth. Funds aimed at expanding coverage for this group are high priority and should be included in the allocation despite the extremely low risk in most of the country.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Zimbabwe","Zimbabwe","PAI-6067","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.",142164,null,"Active","a6Q1R000000AJZJ",0,0,0,0,142164,0,null,null,"Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","High","People with disabilities are identified as an important KP",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Viet Nam","Viet Nam","PAI-5963","MCI-00008","TB care and prevention","MCI-00127","Treatment","Scaling up mHEalthin four provinces and piloting mHealth for MDR-TB - Renovating to improve TBIC for five TB/HIV patient care facilities per year and training in TBIC for general hospital and prison staff.",424820,null,"Active","a6Q1R000000AJXd",0,0,0,0,424820,0,null,null,"Scaling up mHEalthin four provinces and piloting mHealth for MDR-TB - Renovating to improve TBIC for five TB/HIV patient care facilities per year and training in TBIC for general hospital and prison staff.","Low","Scaling up eHealth and mHealth interventions for MDR TB along with renovation and training for TB infection control. Given competing priorities this is given a lower priority.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used.","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Suriname","Suriname","PAI-5650","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Analyze which services related to HIV, TB and malaria can be targeted for cost recovery.",5250,null,"Active","a6Q1R000000AJSa",0,0,0,0,5250,0,null,null,"Analyze which services related to HIV, TB and malaria can be targeted for cost recovery.","High",null,"NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Suriname","Suriname","PAI-5649","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Create a repository of reports, including strategic plans, annual reports, evaluations and assessments.",10500,null,"Active","a6Q1R000000AJSZ",0,0,0,0,10500,0,null,null,"Create a repository of reports, including strategic plans, annual reports, evaluations and assessments.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Sao Tome and Principe","Sao Tome and Principe","PAI-5644","MCI-00019","RSSH: Financial management systems","MCI-00188","Other financial management intervention(s)","This is the assessment of the TB/HIV/malaria grant.",16833.13,null,"Inactive","a6Q1R000000AJSU",16833.13,0,0,0,0,1,null,null,"This is the assessment of the TB/HIV/malaria grant.","Low","Funding requested to support technical assistance to conduct an end of project assessment","NA Original Module: RSSH - Financial management systems. Original Intervention: Assessment at end of project (international consultant)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH","RT Central Africa"]
["CT El Salvador","El Salvador","PAI-5547","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","With this component several interventions will be carried out:\n1- Development of the SUIS (Sistema Único de Información de Salud = Unique Health Information System): the SUIS laboratory modules will be updated to standardise the information platform of the laboratories at the local level, regional laboratories and NRL that will allow there to be consolidated information for local and national reports.\n\n2- Implementation process: to use the SUIS, it is necessary for the Information and Communication Technologies Directorate of the Ministry to provide the laboratories with computer equipment and establish the virtual communication network, as well as maintain the network. This requires the training of laboratory staff in the use of tools, the changing of equipment that is on loan for analysis or testing and the deployment of laboratory modules.\n\n3-Management tool: when updated, the platform will allow the transmission of tests and results, which will increase the resolution capacity of the establishments and the timely delivery of results for decision-making.\n\n4- With the generation of information, specific reports or national reports will be developed whose data quality will be verified at the NRL.",450000,null,"Inactive","a6Q1R000000AJQv",0,0,450000,0,0,1,null,null,"With this component several interventions will be carried out:\n1- Development of the SUIS (Sistema Único de Información de Salud = Unique Health Information System): the SUIS laboratory modules will be updated to standardise the information platform of the laboratories at the local level, regional laboratories and NRL that will allow there to be consolidated information for local and national reports.\n\n2- Implementation process: to use the SUIS, it is necessary for the Information and Communication Technologies Directorate of the Ministry to provide the laboratories with computer equipment and establish the virtual communication network, as well as maintain the network. This requires the training of laboratory staff in the use of tools, the changing of equipment that is on loan for analysis or testing and the deployment of laboratory modules.\n\n3-Management tool: when updated, the platform will allow the transmission of tests and results, which will increase the resolution capacity of the establishments and the timely delivery of results for decision-making.\n\n4- With the generation of information, specific reports or national reports will be developed whose data quality will be verified at the NRL.","High",null,"NA Original Module: SRSS: Health information systems and monitoring and evaluation. Original Intervention: Quality of the programs and data","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT El Salvador","El Salvador","PAI-5545","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","The National Institute of Health is made up of three areas: 1) Government School, 2) Department of Health Research and 3) Department of Specialised Laboratories. The first two operate in a single building and the National Reference Laboratory (NRL) that is part of the Department of Specialised Laboratories operates in a separate building. The proposal intends to integrate these areas into a single physical place, so that the relationship between them integrates the topics of research, health surveillance and training, achieving optimum performance and better organisation.\n\nThe NRL operates with 4 technical areas: the Health Surveillance Laboratory Area, Toxicology and Food Quality Control Laboratory Area, Health and Environment Laboratory Area and Cytology Laboratory. So it also has an administrative area.\n\nThe analyses carried out by the NRL are accredited according to ISO/IEC 17025: 2005 standards and develop a Quality Management System in accordance with ISO 15189: 2012. Likewise, it has implemented an internal quality control programme and participates in international external quality control programmes. It provides direct and indirect quality control programmes and an external quality assessment programme to the National Network of Clinical Laboratories, National Network of Blood Banks, and the different sectors of the National Health System, including the Salvadoran Social Security Institute. This allows the country to guarantee epidemiological surveillance at a national level in humans, food, water and the environment, quality control of diagnostic tests and to respond to events that may constitute a Public Health emergency of national and international importance in compliance with International Health Regulations.\n\nWith the project there will be the progressive dismantling of the different areas of the NRL, its transfer to, and assembly in the new facilities; the methodology to follow will allow us to maintain the provision of services with the least possible interruption, in some cases new equipment will need to be purchased since, due to biosecurity, it is unusable when dismantled.\n\nThe relocation and equipping of the National Reference Laboratory will allow the country to have safe technological and scientific infrastructure, so that the biosafety processes are compliant with the international guidelines already defined and in response to health problems, especially HIV, tuberculosis and malaria, with a comprehensive vision of public health, integrated into the regional response of the Health Plan of Central America and the Dominican Republic.",6294855.3700000001,null,"Inactive","a6Q1R000000AJQt",0,0,6294855.3700000001,0,0,1,null,null,"The National Institute of Health is made up of three areas: 1) Government School, 2) Department of Health Research and 3) Department of Specialised Laboratories. The first two operate in a single building and the National Reference Laboratory (NRL) that is part of the Department of Specialised Laboratories operates in a separate building. The proposal intends to integrate these areas into a single physical place, so that the relationship between them integrates the topics of research, health surveillance and training, achieving optimum performance and better organisation.\n\nThe NRL operates with 4 technical areas: the Health Surveillance Laboratory Area, Toxicology and Food Quality Control Laboratory Area, Health and Environment Laboratory Area and Cytology Laboratory. So it also has an administrative area.\n\nThe analyses carried out by the NRL are accredited according to ISO/IEC 17025: 2005 standards and develop a Quality Management System in accordance with ISO 15189: 2012. Likewise, it has implemented an internal quality control programme and participates in international external quality control programmes. It provides direct and indirect quality control programmes and an external quality assessment programme to the National Network of Clinical Laboratories, National Network of Blood Banks, and the different sectors of the National Health System, including the Salvadoran Social Security Institute. This allows the country to guarantee epidemiological surveillance at a national level in humans, food, water and the environment, quality control of diagnostic tests and to respond to events that may constitute a Public Health emergency of national and international importance in compliance with International Health Regulations.\n\nWith the project there will be the progressive dismantling of the different areas of the NRL, its transfer to, and assembly in the new facilities; the methodology to follow will allow us to maintain the provision of services with the least possible interruption, in some cases new equipment will need to be purchased since, due to biosecurity, it is unusable when dismantled.\n\nThe relocation and equipping of the National Reference Laboratory will allow the country to have safe technological and scientific infrastructure, so that the biosafety processes are compliant with the international guidelines already defined and in response to health problems, especially HIV, tuberculosis and malaria, with a comprehensive vision of public health, integrated into the regional response of the Health Plan of Central America and the Dominican Republic.","High",null,"NA Original Module: SRSS: Provision of integrated services and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Senegal","Senegal","PAI-5509","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Two operational research studies will be undertaken on adolescents and key populations to guide the program toward these targets.",56707.44,null,"Active","a6Q1R000000AJQJ",0,0,0,0,56707.44,0,null,null,"Two operational research studies will be undertaken on adolescents and key populations to guide the program toward these targets.","Medium",null,"Amount validated by CT Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Western Africa","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5412","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","Outreach: additional 10 MSM peer outreach workers (into existing multi-peer teams) ? 4 in NCD, 2 in Jiwaka, 2 in Madang, 2 in Western Highland. Peer outreach in Jiwaka and Madang ceased in 2016 and 2017 respectively, so this will re-start these important programs. Increased coverage with a package of prevention programs: Y1-1,467; Y2-2,269; Y3-3,112. HIV testing access targets: Y1-440; Y2-907; Y3-1,559).",65002,null,"Active","a6Q1R000000AJOk",0,0,0,0,65002,0,null,null,"Outreach: additional 10 MSM peer outreach workers (into existing multi-peer teams) ? 4 in NCD, 2 in Jiwaka, 2 in Madang, 2 in Western Highland. Peer outreach in Jiwaka and Madang ceased in 2016 and 2017 respectively, so this will re-start these important programs. Increased coverage with a package of prevention programs: Y1-1,467; Y2-2,269; Y3-3,112. HIV testing access targets: Y1-440; Y2-907; Y3-1,559).","High","The TRP considers this highly relevant because of the low coverage with prevention intervention among men who have sex with men (11.1 per cent ) This allocation will increase by 10 the number of peer outreach workers in 4 high burden focus districts.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT South East Asia","2020-12-31"]
["CT Niger","Niger","PAI-5259","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2020 Niger intends to run a mass LLIN distribution campaign in the hypoendemic districts of Tahoua and Agadez regions (1,246,595 people) to protect the population against vector-borne diseases such as malaria and Rift Valley fever. These zones have not been covered since 2009.",2601638.42,null,"Active","a6Q1R000000AJMH",0,0,0,0,2601638.42,0,null,null,"In 2020 Niger intends to run a mass LLIN distribution campaign in the hypoendemic districts of Tahoua and Agadez regions (1,246,595 people) to protect the population against vector-borne diseases such as malaria and Rift Valley fever. These zones have not been covered since 2009.","High","LLINs in a COE are value for money and necessary for epidemic-prone areas.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2020-12-31"]
["CT Mauritania","Mauritania","PAI-5162","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Acquiring equipment for the biological diagnosis of OIs at the health-care site; (4 microscopes, 4 incubators,  4 immunoassay analyzers and 4 GENEXPERT machines).",213791,null,"Active","a6Q1R000000AJKi",0,0,0,0,213791,0,null,null,"Acquiring equipment for the biological diagnosis of OIs at the health-care site; (4 microscopes, 4 incubators,  4 immunoassay analyzers and 4 GENEXPERT machines).","Medium",null,"NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Mauritania","Mauritania","PAI-5161","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","IGA feasibility study for PLHIV: Ensuring the independence of PLHIV requires the creation of conditions that enable them to provide for their health needs and to cover a certain cost linked to ARV treatment. Experiments have been carried out through IGAs, but they have not been documented. This request in the above allocation amount will make it possible to conduct a feasibility study and provide the country with clarity regarding the effectiveness of this strategy.",7540,null,"Active","a6Q1R000000AJKh",0,0,0,0,7540,0,null,null,"IGA feasibility study for PLHIV: Ensuring the independence of PLHIV requires the creation of conditions that enable them to provide for their health needs and to cover a certain cost linked to ARV treatment. Experiments have been carried out through IGAs, but they have not been documented. This request in the above allocation amount will make it possible to conduct a feasibility study and provide the country with clarity regarding the effectiveness of this strategy.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Mauritania","Mauritania","PAI-5156","MCI-00534","Comprehensive prevention programs for MSM","MCI-00542","Interventions for young men who have sex with men","Contracting 1 NGO for managing and monitoring the activities carried out by CSOs and MSM outreach workers The PAAR amount will allow for the extension to 3 other regions from year 2 for greater geographical coverage of the interventions and requiring the recruitment of an additional NGO to guarantee the quality of the interventions by the community outreach workers.",35657,null,"Active","a6Q1R000000AJKc",0,0,0,0,35657,0,null,null,"Contracting 1 NGO for managing and monitoring the activities carried out by CSOs and MSM outreach workers The PAAR amount will allow for the extension to 3 other regions from year 2 for greater geographical coverage of the interventions and requiring the recruitment of an additional NGO to guarantee the quality of the interventions by the community outreach workers.","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2021-12-31"]
["CT Montenegro","Montenegro","PAI-5132","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","Opening of the new or improved social spaces for MSM community in order to improve well-being and increase the network with the community. As a result it is expected to achieve higher coverage and reaching the targets (impact, outcome and coverage indicators) both related to preventive services and testing.",44888.34,null,"Inactive","a6Q1R000000AJKE",44888.34,0,0,0,0,1,null,null,"Opening of the new or improved social spaces for MSM community in order to improve well-being and increase the network with the community. As a result it is expected to achieve higher coverage and reaching the targets (impact, outcome and coverage indicators) both related to preventive services and testing.","Medium",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Moldova","Moldova","PAI-5027","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","To support the adjustment and maintenance of the National Information System for Monitoring and Evaluation of TB (SYME-TB) in 2020.The national authorities partially cover the costs (staff, introducing and validating data, etc.). Periodically adjustments of program, as per request of NTP  (depending of the new data to be included in soft and/or reports to be performed), and maintenance have not been fully covered by NTP.",15710.92,null,"Active","a6Q1R000000AJIX",0,0,0,0,15710.92,0,null,null,"To support the adjustment and maintenance of the National Information System for Monitoring and Evaluation of TB (SYME-TB) in 2020.The national authorities partially cover the costs (staff, introducing and validating data, etc.). Periodically adjustments of program, as per request of NTP  (depending of the new data to be included in soft and/or reports to be performed), and maintenance have not been fully covered by NTP.","High","The TRP considers this intervention of high priority and quality demand. Support of the adjustments and maintenance of the National 3 Information System for Monitoring and evaluation of the TB care and prevention program are crucial for strengthening TB and MDR-TB control in the country. Periodical adjustments of SYME program and the costs of maintenance have not been fully covered by the NTP yet.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Intervention: SYME TB software adjustment and maintenance","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4917","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Support and strengthen the HIV and STDs surveillance system including, trainings etc.",168331,null,"Active","a6Q1R000000AJGl",0,0,0,0,168331,0,null,null,"Support and strengthen the HIV and STDs surveillance system including, trainings etc.","Medium","It is unclear if the proposed surveillance in this population is necessary, and given that routine services will be enhanced, such data can be obtained from routine data.","NA Original Module: RSSH: Health Management Information Systems and M&E. Original Intervention: RSSH: Health Management Information Systems and M&E","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4912","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Capacity building for health staff in NAP and identified staff in primary and secondary care services and VCTs to ensure sustainable support for PLHIV in the context of Jordan to address the stigma and discrimination",28055,null,"Active","a6Q1R000000AJGg",0,0,0,0,28055,0,null,null,"Capacity building for health staff in NAP and identified staff in primary and secondary care services and VCTs to ensure sustainable support for PLHIV in the context of Jordan to address the stigma and discrimination","High",null,"NA Original Module: Treatment, care, and support. Original Intervention: Treatment, care, and support","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry LAC MCC","Multicountry Caribbean MCC","PAI-4789","MCI-00009","TB/HIV","MCI-00583","Stigma and discrimination reduction","Develop, implement and educate Health Care Providers on a Code of Conduct and Patient Bill of Rights following the model or programme in St. Kitts and Nevis. Develop targeted material to educate or sensitize patients and other persons accessing health services on a Bill of Rights including the right to confidentiality. This will result in greater respect for confidentiality and higher number of complaints based on stigma and discrimination being resolved.",50000,null,"Active","a6Q1R000000AJEh",0,0,0,0,50000,0,null,null,"Develop, implement and educate Health Care Providers on a Code of Conduct and Patient Bill of Rights following the model or programme in St. Kitts and Nevis. Develop targeted material to educate or sensitize patients and other persons accessing health services on a Bill of Rights including the right to confidentiality. This will result in greater respect for confidentiality and higher number of complaints based on stigma and discrimination being resolved.","High","Stigma and discrimination are important elements for access to care. While this item would be important for the program, there might be more efficient ways of delivering this training, or other sources of funding can be sought.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2022-03-31"]
["CT Ukraine","Ukraine","PAI-5902","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00098","OST and other drug dependence treatment for PWID","The suuplementary services for current MPSS patienst (10,000) under OST progranmme.",2437913,null,"Active","a6Q1R000000AJWe",2109345,0,0,0,328568,0,null,null,"The suuplementary services for current MPSS patienst (10,000) under OST progranmme.","High","This population has the highest infection rates.This intervention will provide MPSS for current patients on OST (10000) to keep retention in treatment high (the costs for drugs will be covered by the State budget).","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Ukraine","Ukraine","PAI-5901","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00095","HIV testing services for PWID","The activities are oriented to procure PIMA cartridges.",267830,null,"Active","a6Q1R000000AJWd",0,0,0,0,267830,0,null,null,"The activities are oriented to procure PIMA cartridges.","High","The HIV detection component for NGCA Donetsk and Luhansk is considered a high priority and if possible should be moved to within allocation","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: HIV testing services for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Timor-Leste","Timor-Leste","PAI-5815","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Funding is requested in this category to support program management technical advice and policy, planning and advocacy technical assistance.",142735,null,"Active","a6Q1R000000AJVF",0,0,0,0,142735,0,null,null,"Funding is requested in this category to support program management technical advice and policy, planning and advocacy technical assistance.","Low","The TRP requests the applicant to work with technical partners and the Secretariat to develop a plan to ensure that technical capacity is transferred to local staff and that there is an exit strategy by which external Technical Assistance is discontinued by the end of grant implementation.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2020-12-31"]
["CT Zimbabwe","Zimbabwe","PAI-6062","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00573","Gender-based violence prevention and treatment programs for adolescents and youth","Funding is requested for community infrastructure, technology and transport systems to establish six additional one-stop centres (in addition to the four requested in the matching funds application) for HIV/SRHR/GBV, building on successes of existing centres in Rusape General Hospital (Makoni), Harare and Gweru. As more than 1 in 3 Zimbabwean women experience physical violence, the 17,000 GBV survivors served by the current centres is an enormous service gap. The need to decentralize access to GBV services and strengthen linkages to communities is vital.",1617630,null,"Active","a6Q1R000000AJZE",0,0,0,0,1617630,0,null,null,"Funding is requested for community infrastructure, technology and transport systems to establish six additional one-stop centres (in addition to the four requested in the matching funds application) for HIV/SRHR/GBV, building on successes of existing centres in Rusape General Hospital (Makoni), Harare and Gweru. As more than 1 in 3 Zimbabwean women experience physical violence, the 17,000 GBV survivors served by the current centres is an enormous service gap. The need to decentralize access to GBV services and strengthen linkages to communities is vital.","High","Gender-based Violence is a high priority in the country",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Zimbabwe","Zimbabwe","PAI-6057","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLINs will be distributed to at risk population where IRS is not implemented, targeting every sleeping space in prioritized wards with API <5/1000 population. The MSP requires mass campaign every three years to replace obsolete LLINs. The 2020 mass campaign aimed at replacing the LLINs distributed in 2017 projected to protect a population of 516053 persons living in highly endemic areas. This gap would leave a total of 7.2% of total population at risk without any intervention if not supported. This will lead to poor coverage and increase in areas with high local transmission.",1827070,null,"Inactive","a6Q1R000000AJZ9",1827070,0,0,0,0,1,null,null,"LLINs will be distributed to at risk population where IRS is not implemented, targeting every sleeping space in prioritized wards with API <5/1000 population. The MSP requires mass campaign every three years to replace obsolete LLINs. The 2020 mass campaign aimed at replacing the LLINs distributed in 2017 projected to protect a population of 516053 persons living in highly endemic areas. This gap would leave a total of 7.2% of total population at risk without any intervention if not supported. This will lead to poor coverage and increase in areas with high local transmission.","High","Half of 2020 mass campaign LLINS, to replace 2017 nets.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2020-12-31"]
["CT Zambia","Zambia","PAI-6056","MCI-00000","Prevention programs for general population","MCI-00074","Male circumcision","Voluntary medical male circumcision reusable and consumables kits, early infant male circumcision training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly.",10862539,null,"Active","a6Q1R000000AJZ8",119180,0,0,0,10743359,0,null,null,"Voluntary medical male circumcision reusable and consumables kits, early infant male circumcision training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly.","Medium","Voluntary medical male circumcision (VMMC) reusable and consumables kits, early infant male circumcision (EIMC) training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Africa 2"]
["CT Viet Nam","Viet Nam","PAI-5954","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","An introduction workshop with relevant partners at the national level about joint utilization of GeneXpert for TB and HIV tests in selected prisons, raining for prison staff on implementation of Xpert tests for TB and HIV, and scaling up MDR-TB management in prisons by MPS and KNCV (renovation of MDR-TB wards and TBIC laboratories, patient support, etc.).",362013,null,"Active","a6Q1R000000AJXU",0,0,0,0,362013,0,null,null,"An introduction workshop with relevant partners at the national level about joint utilization of GeneXpert for TB and HIV tests in selected prisons, raining for prison staff on implementation of Xpert tests for TB and HIV, and scaling up MDR-TB management in prisons by MPS and KNCV (renovation of MDR-TB wards and TBIC laboratories, patient support, etc.).","High","Training for prison staff on the use of GeneXpert, and MDR TB care in prisons.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Module: Multidrug-resistant TB. Original Intervention: Key populations (MDR-TB) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT South Sudan","South Sudan","PAI-5638","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","The NFM TB grant already supports the strengthening and sustaining of the technical and managerial capacity of the National TB program at all levels through: training in TB management; financial management; provision of salary support; and training of County Health Department teams. A coordinating body could only be considered once all the positions have been filled.",785616,null,"Active","a6Q1R000000AJSO",0,0,0,0,785616,0,null,null,"The NFM TB grant already supports the strengthening and sustaining of the technical and managerial capacity of the National TB program at all levels through: training in TB management; financial management; provision of salary support; and training of County Health Department teams. A coordinating body could only be considered once all the positions have been filled.","High","The New Funding Model (NFM) TB grant supports strengthening and sustaining the technical and managerial capacity of the National TB program at all levels through: training in TB management; financial management; provision of salary support; and training of County Health Department (CHD) teams.","NA Original Intervention: Setting up and strengthening a coordinating body for collaborative TB/HIV activities at all levels","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Sierra Leone","Sierra Leone","PAI-5541","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Funding is needed for nutritional support to be provided for all TB cases, about 20,000 TB cases per year, during the intensive phase of treatment. MDR-TB cases, 300 cases per year, will receive the nutritional support throughout the course of treatment. The estimated cost will cover the nutritional support for TB patients for two years and this intervention will support the program to improve adherence to treatment.",1200000,null,"Active","a6Q1R000000AJQp",0,0,0,0,1200000,0,null,null,"Funding is needed for nutritional support to be provided for all TB cases, about 20,000 TB cases per year, during the intensive phase of treatment. MDR-TB cases, 300 cases per year, will receive the nutritional support throughout the course of treatment. The estimated cost will cover the nutritional support for TB patients for two years and this intervention will support the program to improve adherence to treatment.","High",null,"TRP June Retreat 2019 / Component multi","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, Malaria, RSSH","RT Western Africa","2021-06-30"]
["CT Sierra Leone","Sierra Leone","PAI-5540","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Resources are needed for the following activities to upgrades CHCs to TB diagnostic sites: training of health care workers, training of microscopists, procurement of consumables and sputum containers , orientation of DHMT & local councils on the implementation of universal access for TB care, support six monthly min-campaign/sensitization  at slum and hard to reach areas, printing  of Xpert tools , support specimen transportation to lakka and SRL, support printing of registers and monitoring tools for district activities, dissemination of Xpert tools, and support international training of staff and study tours.",1500000,null,"Active","a6Q1R000000AJQo",0,0,0,0,1500000,0,null,null,"Resources are needed for the following activities to upgrades CHCs to TB diagnostic sites: training of health care workers, training of microscopists, procurement of consumables and sputum containers , orientation of DHMT & local councils on the implementation of universal access for TB care, support six monthly min-campaign/sensitization  at slum and hard to reach areas, printing  of Xpert tools , support specimen transportation to lakka and SRL, support printing of registers and monitoring tools for district activities, dissemination of Xpert tools, and support international training of staff and study tours.","High",null,"TRP June Retreat 2019 / Component multi","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, Malaria, RSSH","RT Western Africa","2021-06-30"]
["CT Senegal","Senegal","PAI-5502","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","The analysis of the cohort of children and adolescents monitored showed a high failure rate, mainly due to limited access to treatment services (owing, for the most part, to the cost of transport and medical expenses), failure to inform adolescents of their HIV status, inadequacy of the treatment adherence support program and limited access to viral load testing. At the same time, there is a lack of support for health care providers at the decentralized level. The plan is therefore to develop a support program for adolescents who have been informed of their HIV status, strengthen ART adherence among children, establish treatment follow-up committees, strengthen coaching for decentralized facilities, subsidize treatment and transport costs for children attending facilities for follow-up, and help establish a national pediatric cohort.",439236.9,null,"Active","a6Q1R000000AJQC",0,0,0,0,439236.9,0,null,null,"The analysis of the cohort of children and adolescents monitored showed a high failure rate, mainly due to limited access to treatment services (owing, for the most part, to the cost of transport and medical expenses), failure to inform adolescents of their HIV status, inadequacy of the treatment adherence support program and limited access to viral load testing. At the same time, there is a lack of support for health care providers at the decentralized level. The plan is therefore to develop a support program for adolescents who have been informed of their HIV status, strengthen ART adherence among children, establish treatment follow-up committees, strengthen coaching for decentralized facilities, subsidize treatment and transport costs for children attending facilities for follow-up, and help establish a national pediatric cohort.","High",null,"Amount validated by CT Original Intervention: Orphan and vulnerable children package","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Western Africa","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5408","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This will enable to strengthen the provincial level quality review of the Programme including engaging private sector providers through PPM.",196095,null,"Active","a6Q1R000000AJOg",0,0,0,0,196095,0,null,null,"This will enable to strengthen the provincial level quality review of the Programme including engaging private sector providers through PPM.","Low","The TRP recognizes the importance of program review meetings, however, it is not clear what the contribution of public-private mix (PPM) includes. The TRP considers the PPM program review in year 2 could be integrated into other program reviews. The health management information system portion of this request though is a priority intervention and should remain on the prioritized list.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Health management information systems and M&E Bi annual program review at the provincial level with PPM (year II)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT South East Asia","2020-12-31"]
["CT Namibia","Namibia","PAI-5255","MCI-00009","TB/HIV","MCI-00136","Community TB/HIV care delivery","These activities support TB/ HIV increased integration at both national and district level. Through these integrated services, TB HIV co-infected people are more likely to receive enhanced treatment. This will result in people being more adherent to treatment and better treatment outcomes, including retention of people on ART.",2358757,null,"Active","a6Q1R000000AJMD",0,0,0,0,2358757,0,null,null,"These activities support TB/ HIV increased integration at both national and district level. Through these integrated services, TB HIV co-infected people are more likely to receive enhanced treatment. This will result in people being more adherent to treatment and better treatment outcomes, including retention of people on ART.","Low","TB/HIV integration is very important, but it is not clear what activities and results this item will entail.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Namibia","Namibia","PAI-5254","MCI-00534","Comprehensive prevention programs for MSM","MCI-00540","Pre-exposure prophylaxis (PrEP) for MSM","This activity includes training so that care workers are trained in PrEP and are able to offer care and support to MSM.",63237,null,"Active","a6Q1R000000AJMC",0,0,0,0,63237,0,null,null,"This activity includes training so that care workers are trained in PrEP and are able to offer care and support to MSM.","Medium","PrEP interventions are important, if not covered by other actors.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre-exposure prophylaxis (PrEP) for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Namibia","Namibia","PAI-5249","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00108","HIV testing services for adolescents and youth, in and out of school","This activity is expected to expand the accessibility and quality of PITC and therefore encourage more AGYW to access to HIV testing and know their results. Specific numbers in terms of targets to be reached and the minimum package of interventions are yet to be formulated. This is expected to be completed within the next two months.",150000,null,"Active","a6Q1R000000AJM7",0,0,0,0,150000,0,null,null,"This activity is expected to expand the accessibility and quality of PITC and therefore encourage more AGYW to access to HIV testing and know their results. Specific numbers in terms of targets to be reached and the minimum package of interventions are yet to be formulated. This is expected to be completed within the next two months.","High","The TRP supports the increased coverage of adolescent girls and young women, who are one of the identified vulnerable populations.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Mozambique","Mozambique","PAI-5151","MCI-00071","Other module","MCI-00071","Other module","The PAAR for RSSH addresses critical gaps in management of health system risks to program implementation by providing adequate storage and distribution conditions for the supply chain, training of health workers and human resource managers, development of community based monitoring of disease management data, expansion of financial management systems and health information systems and supportive policy and programmatic environment for integrated service delivery of TB and HIV.",67016662,null,"Active","a6Q1R000000AJKX",3500000,0,0,0,63516662,0,null,null,"The PAAR for RSSH addresses critical gaps in management of health system risks to program implementation by providing adequate storage and distribution conditions for the supply chain, training of health workers and human resource managers, development of community based monitoring of disease management data, expansion of financial management systems and health information systems and supportive policy and programmatic environment for integrated service delivery of TB and HIV.","High","The interventions are considered high priority as they address critically important areas in view of bringing improvements to the supply chain infrastructure, staffing, staff capacity,HMIS and community systems capacity, which have been identified as critical risks for the Program.","NA Original Module: RSSH. Original Intervention: PSM; QA HMIS M&E; Community: HRH","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Montenegro","Montenegro","PAI-5127","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","In case of secured funding, this will be the fifth study on HIV prevalence and risky behavior among commercial sex workers. Earlier attempts to provide data by Respondent Driven Sample did not give results due to insufficient sex workers network. Surveys were implemented successfully by using ?snowball sample? method, however they did not provide the information on the population size. This research will therefore help to estimate the SW population size.",61721.47,null,"Active","a6Q1R000000AJK9",0,61721,0,0,0.47,0,null,null,"In case of secured funding, this will be the fifth study on HIV prevalence and risky behavior among commercial sex workers. Earlier attempts to provide data by Respondent Driven Sample did not give results due to insufficient sex workers network. Surveys were implemented successfully by using ?snowball sample? method, however they did not provide the information on the population size. This research will therefore help to estimate the SW population size.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Montenegro","Montenegro","PAI-5126","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","The previous three bio-behavioural surveys (BBS) conducted among PWID in 2009, 2011 and 2013 complied with the Respondent Driven Sampling (RDS) principles. In case funding is obtained for the fourth BBS, planned for 2019, PWID population size would be estimated for the first time in Montenegro.",61721.47,null,"Active","a6Q1R000000AJK8",0,61721,0,0,0.47,0,null,null,"The previous three bio-behavioural surveys (BBS) conducted among PWID in 2009, 2011 and 2013 complied with the Respondent Driven Sampling (RDS) principles. In case funding is obtained for the fourth BBS, planned for 2019, PWID population size would be estimated for the first time in Montenegro.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Moldova","Moldova","PAI-5023","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","This intervention is very important to recruit additional new SW, by providing peer-to-peer educational session and referring them to access services.Estimated 500 additional clients to be reached each year. Taking into consideration the new estimations and the established targets, this intervention will contribute to cover more SW with prevention services",40399.51,null,"Active","a6Q1R000000AJIT",0,0,0,0,40399.51,0,null,null,"This intervention is very important to recruit additional new SW, by providing peer-to-peer educational session and referring them to access services.Estimated 500 additional clients to be reached each year. Taking into consideration the new estimations and the established targets, this intervention will contribute to cover more SW with prevention services","High","The TRP considers this intervention high priority, as peer -driven interventions are an essential part of the package for services that target sex workers.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Intervention: Develop and provide peer driven interventions for sex workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4906","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Procure RDTs for testing",22444,null,"Active","a6Q1R000000AJGa",0,0,0,0,22444,0,null,null,"Procure RDTs for testing","High","Commodities are needed to implement the activities planned.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Comprehensive prevention programs for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry LAC MCC","Multicountry Caribbean MCC","PAI-4787","MCI-00022","RSSH: Health management information systems and M&E","MCI-00174","Capacity building for health workers, including those at community level","Expand telecommunication capacity in all countries to reduce the cost of conducting country level and regional trainings, improve communication between and among country teams, save costs on travel and accommodation and improve overall coordination. This can facilitate access to more training for community teams who would be able to participate in their local settings.The Governments will cover the cost of internet access and space with designated space being made available to civil society. -",90000,null,"Active","a6Q1R000000AJEf",0,0,0,0,90000,0,null,null,"Expand telecommunication capacity in all countries to reduce the cost of conducting country level and regional trainings, improve communication between and among country teams, save costs on travel and accommodation and improve overall coordination. This can facilitate access to more training for community teams who would be able to participate in their local settings.The Governments will cover the cost of internet access and space with designated space being made available to civil society. -","High","This item would introduce a significant efficiency into the grant in terms of cost-savings for travel and meetings. Therefore it should be prioritized if efficiencies are found during grant-making.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2022-03-31"]
["CT Multicountry HIAS UNOPS","Multicountry TB Asia UNOPS","PAI-4783","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Proposed approaches supporting sputum\ntransportation, results feedback and\nfinancial support to referred patients; and\nACF targeting migrants are required to\nmaximize impact of proposed\ninterventions",1670950,null,"Active","a6Q1R000000AJEb",0,0,0,0,1670950,0,null,null,"Proposed approaches supporting sputum\ntransportation, results feedback and\nfinancial support to referred patients; and\nACF targeting migrants are required to\nmaximize impact of proposed\ninterventions","High","Proposed approaches supporting sputum transportation, results feedback and financial support to referred patients; and ACF targeting migrants are required to maximize impact of proposed interventions.","NA Original Intervention: Support referred migrant TB patients in Myanmar","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2021-12-31"]
["CT Ukraine","Ukraine","PAI-5897","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","The intervention includes support for basic package on prevention for sex partners of PLHIV, HIV and HBV rapid test kits.",861640,null,"Active","a6Q1R000000AJWZ",0,0,0,0,861640,0,null,null,"The intervention includes support for basic package on prevention for sex partners of PLHIV, HIV and HBV rapid test kits.","Medium","This intervention supports military personnel.60,000 uniformed services are on active status as a result of the ongoing conflict in Eastern Ukraine. The allocation amount will cover 83% by 2020. Many interventions used in other key populations can be used since military are not always mutually exclusive from other key populations above.","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Timor-Leste","Timor-Leste","PAI-5810","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","This request includes for TA support for a mid-term review of the program/NSP in 2019/2020.",54694,null,"Inactive","a6Q1R000000AJVA",54694,0,0,0,0,1,null,null,"This request includes for TA support for a mid-term review of the program/NSP in 2019/2020.","High","Strengthening program and data quality is important as it builds local M&E capacity at National AIDS and STI Program and service delivery sites and promotes sustainability and selfreliance. This intervention should be transferred to the allocation amount and supported through cost savings","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2020-12-31"]
["CT Tajikistan","Tajikistan","PAI-5804","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00598","Procurement strategy","Development and operationalization of the medicines QA/QC system",350000,null,"Inactive","a6Q1R000000AJV4",350000,0,0,0,0,1,null,null,"Development and operationalization of the medicines QA/QC system","High","-","28/05/2019: Email from CT mentioned that they will ask for a lower amount (300k). UQD will be funded by Country Optimization under PO wave 3 with reallocated funds","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Zambia","Zambia","PAI-6055","MCI-00023","Program management","MCI-00207","Grant management","Funding will provide additional risk mitigation for the management of the expanded scope of the program, particularly the additional civil society and community sub-recipients.",974242,null,"Active","a6Q1R000000AJZ7",0,0,0,0,974242,0,null,null,"Funding will provide additional risk mitigation for the management of the expanded scope of the program, particularly the additional civil society and community sub-recipients.","High","Risk mitigation for program management",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Africa 2"]
["CT Zambia","Zambia","PAI-6050","MCI-00008","TB care and prevention","MCI-00127","Treatment","Second line drugs for additional MDR-TB patients and improvement of Treatment Success Rate.",3887235,null,"Active","a6Q1R000000AJZ2",1399928,0,0,0,2487307,0,null,null,"Second line drugs for additional MDR-TB patients and improvement of Treatment Success Rate.","High","Second line drugs (SLD ) for additional MDR -TB patients and improvement of Treatment Success Rate.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Africa 2"]
["CT Viet Nam","Viet Nam","PAI-5950","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","With regard to this key population, PAAR will support scaling up entry TB screening for more 7000 new prisoners, IC of MDR-TB for MDR treatment areas in 07 prisons, examination and screening for prisoners of two prisons for LTBI treatment, peer education training for temporary detention centers, and support for prisoners with active disease.",419016,null,"Active","a6Q1R000000AJXQ",0,0,0,0,419016,0,null,null,"With regard to this key population, PAAR will support scaling up entry TB screening for more 7000 new prisoners, IC of MDR-TB for MDR treatment areas in 07 prisons, examination and screening for prisoners of two prisons for LTBI treatment, peer education training for temporary detention centers, and support for prisoners with active disease.","High","This includes entry screening for 7,000 prisoners along with other costs for this key population.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Togo","Togo","PAI-5735","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","Range of services for IDUs:  (i)  minimum  prevention  package  and, (ii) establishment of a needle exchange program (a new syringe in exchange for a used syringe) , so that IDUs adopt less risky sexual behavior and safer behavior regarding injection.",62517.11,null,"Active","a6Q1R000000AJTx",0,0,0,0,62517.11,0,null,null,"Range of services for IDUs:  (i)  minimum  prevention  package  and, (ii) establishment of a needle exchange program (a new syringe in exchange for a used syringe) , so that IDUs adopt less risky sexual behavior and safer behavior regarding injection.","High","HIV prevention interventions have not received substantial support from the main request, thus, PAAR would be helpful to support preventions interventions that target the important populations drivers of the HIV epidemic.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT South Sudan","South Sudan","PAI-5636","MCI-00007","Treatment, care and support","MCI-00126","Case detection and diagnosis","Training and outreach activities to remote areas are critical. The outreach activities will target prisons, military, IDP and cattle camps where there are no diagnosis and treatment services for TB. An outreach activity will include a team of 1 lab technician, 1 nurse, 1 counsellor, 1 clinician and 1 driver for a three day visit.",1081603,null,"Active","a6Q1R000000AJSM",0,0,0,0,1081603,0,null,null,"Training and outreach activities to remote areas are critical. The outreach activities will target prisons, military, IDP and cattle camps where there are no diagnosis and treatment services for TB. An outreach activity will include a team of 1 lab technician, 1 nurse, 1 counsellor, 1 clinician and 1 driver for a three day visit.","High","Training and outreach activities to remote areas are critical. The outreach activities will target prisons, military, internally displaced people, and cattle camps, where there are no diagnosis and treatment services for TB.","NA Original Intervention: Case detection","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-5631","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","Conduct training of community based organisations, peer counsellors, and civil society coordinators and do outreach to key populations and the general population to ensure treatment adherence. Treatment adherence usually decreases at 24 and 36 months resulting in an increase in AIDS related deaths. With the on-going insecurity and displacement of people, treatment adherence is vitally important.",1059733,null,"Active","a6Q1R000000AJSH",0,0,0,0,1059733,0,null,null,"Conduct training of community based organisations, peer counsellors, and civil society coordinators and do outreach to key populations and the general population to ensure treatment adherence. Treatment adherence usually decreases at 24 and 36 months resulting in an increase in AIDS related deaths. With the on-going insecurity and displacement of people, treatment adherence is vitally important.","High","This will further support reduction of the very high loss to follow-up (LTFU) among people living with HIV on ART, and improve quality of ART care. This additional funding will enable scale up of viral load testing and help improve effectiveness of the HIV cascade monitoring.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Sudan","Sudan","PAI-5496","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Target population: Refugees. This activity is intended to equip more than 30 service delivery points providing treatment and prevention services to the refugees from South Sudan, in camps that currently are not getting sufficient services.",749360,null,"Active","a6Q1R000000AJQ6",0,0,0,0,749360,0,null,null,"Target population: Refugees. This activity is intended to equip more than 30 service delivery points providing treatment and prevention services to the refugees from South Sudan, in camps that currently are not getting sufficient services.","High",null,"Sudan has only 1 integrated funding request, and the UQD component is Malaria Original Intervention: Other case management intervention(s)-Extension of case management for refugees through new facilities","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5400","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This is considered a good alternative to prevalence surveys and may give good information at a very low cost.",65000,null,"Active","a6Q1R000000AJOY",0,0,0,0,65000,0,null,null,"This is considered a good alternative to prevalence surveys and may give good information at a very low cost.","Medium","This is considered a good alternative to prevalence surveys and may give good information at a very low cost","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Malaria surveillance: Testing ANC pregnant women for malaria","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5399","MCI-00071","Other module","MCI-00071","Other module","This is for the procurement of 800,000 Rapid Diagnostic Tests and 400,000 Artemisinin-based combination therapy per year. This is an emergency amount in the case that the National Department of Health fails to procure drugs.",2800000,null,"Inactive","a6Q1R000000AJOX",0,2800000,0,0,0,1,null,null,"This is for the procurement of 800,000 Rapid Diagnostic Tests and 400,000 Artemisinin-based combination therapy per year. This is an emergency amount in the case that the National Department of Health fails to procure drugs.","Medium","This is for the procurement of 800,000 RDTs and 400,000 ACTs per year. This is an emergency amount in the case that the National Department of Health fails to procure drugs and rapid tests.","NA Original Module: Facility based treatment. Original Intervention: Procurement of emergency drugs","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Namibia","Namibia","PAI-5245","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","These activities which include awareness creation for HIV and TB activities are expected to increase the numbers of people with TB seeking treatment and will also encourage contact tracing.",692631,null,"Active","a6Q1R000000AJM3",0,0,0,0,692631,0,null,null,"These activities which include awareness creation for HIV and TB activities are expected to increase the numbers of people with TB seeking treatment and will also encourage contact tracing.","Low","This intervention should be integrated in primary care services.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Mozambique","Mozambique","PAI-5148","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","All 11 Procvincial Directorates of Health have a gap of vehicles to ensure implementation of supervision activities. The motorbikes included in this UQD are to be used exclusively by National Malaria Control Program staff at provincial and district level, to ensure implementation of routine activities such as supervision visits to health facilities and community health workers.",801546.08,null,"Active","a6Q1R000000AJKU",0,0,0,0,801546.08,0,null,null,"All 11 Procvincial Directorates of Health have a gap of vehicles to ensure implementation of supervision activities. The motorbikes included in this UQD are to be used exclusively by National Malaria Control Program staff at provincial and district level, to ensure implementation of routine activities such as supervision visits to health facilities and community health workers.","Low","Transport is key to addressing many of the key problems around access. However purchase of motorbikes and vehicles should be prioritized ?on need basis.","NA Original Intervention: Procurement of motorbikes","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2020-12-31"]
["CT Montenegro","Montenegro","PAI-5124","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Purchase of one CD4 counter for the Infectious Disease Clinic (IDC) which is a front line to help PLHIV. The expected outcome is contributing to reaching the set targets and indicators. The expected impact is greater reach of the PLHIV and greater service delivery, and decreased level of stigma and discrimination towards this population.",3366.63,null,"Active","a6Q1R000000AJK6",0,0,0,0,3366.63,0,null,null,"Purchase of one CD4 counter for the Infectious Disease Clinic (IDC) which is a front line to help PLHIV. The expected outcome is contributing to reaching the set targets and indicators. The expected impact is greater reach of the PLHIV and greater service delivery, and decreased level of stigma and discrimination towards this population.","Medium",null,"NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Montenegro","Montenegro","PAI-5123","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","In case of secured funding, this will be the third bio-behavioural survey (BBS) implemented among MSM in Montenegro. The research, planned for 2020, will aim to estimate the population size, based on a representative sample. Previous surveys were aimed at providing basic data related to population size, HIV status, prevalence of STIs, condom use etc. However, Montenegro is a highly homophobic country where LGBT community is hard to reach, which has affected success of the previous surveys.",56110.43,null,"Active","a6Q1R000000AJK5",0,56110,0,0,0.43,0,null,null,"In case of secured funding, this will be the third bio-behavioural survey (BBS) implemented among MSM in Montenegro. The research, planned for 2020, will aim to estimate the population size, based on a representative sample. Previous surveys were aimed at providing basic data related to population size, HIV status, prevalence of STIs, condom use etc. However, Montenegro is a highly homophobic country where LGBT community is hard to reach, which has affected success of the previous surveys.","High","The TRP considers that this activity should receive the highest priority in the PAAR in order to further focus activities in the future. Furthermore the TRP recommend that specific attention be paid to including data on transgender people in these surveys.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-12-31"]
["CT Myanmar","Myanmar","PAI-5118","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.",341440,null,"Inactive","a6Q1R000000AJK0",341440,0,0,0,0,1,null,null,"This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","High","HMIS was identified as a major constrain in the NSP II review in 2015 with high impact in the three programs and beyond","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Moldova","Moldova","PAI-5017","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","In order to assess the existing NAP, the achieved targets and the existinginterventions and formulate proposals for improvement it is important to have aninternational technical assistance.",56110.43,null,"Active","a6Q1R000000AJIN",0,0,0,0,56110.43,0,null,null,"In order to assess the existing NAP, the achieved targets and the existinginterventions and formulate proposals for improvement it is important to have aninternational technical assistance.","Low","The TRP is aware that other funding sources may be available for evaluation of the National Aids Program (NAP), and therefore considers this activity as low priority for the Global Fund. Since it is still quality demand in an absolute sense, the TRP wishes to put the review here, only in the event other funding sources will not become available to conduct the midterm review.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: RSSH - Program management. Original Intervention: National Aids Program (NAP) mid-term review","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4897","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Develop checklist and conduct systematic supervision visits to the chest diseases centers to supervise, monitor and evaluate the provided services for TB and MDR and to the peripheral laboratories in these centers for QC .",29177,null,"Active","a6Q1R000000AJGR",0,0,0,0,29177,0,null,null,"Develop checklist and conduct systematic supervision visits to the chest diseases centers to supervise, monitor and evaluate the provided services for TB and MDR and to the peripheral laboratories in these centers for QC .","High",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4896","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conduct an assessment of the health status of labour migrants and develop a plan of supervision, coordination and adress the tuberculosis and other health issues related to migration among migrants in industrial zones",22444,null,"Active","a6Q1R000000AJGQ",0,0,0,0,22444,0,null,null,"Conduct an assessment of the health status of labour migrants and develop a plan of supervision, coordination and adress the tuberculosis and other health issues related to migration among migrants in industrial zones","High","(i) It is essential to avoid overlapping and foster synergies with other existing or proposed surveys going on in the country through Global Fund grants or other funds. (ii) Populations will need to be clearly defined and existing data reviewed, e.g., if these surveys intend to cover labor migrants, this information may already exist for Syrian refugees.  (iii) A systematic review and meta-analysis of data already captured may help identify rising health needs among migrants or other key populations, and assist in better focusing the questions within the surveys. (iv) Regarding other health issues, health education/promotion needs, chronic disease risk prevention, smoking cessation, and mental health are of special interest among migrant populations. Humanization of care and population perceptions of clinical attitudes might also be useful.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry SEAS UNDP-Migrants","Multicountry TB Asia UNDP","PAI-4779","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00601","Supportive policy and programmatic environment","Strengthening partnership/collaboration of civil society and government institutions through greater integration of CSOs in national systems and domestically financed programs. Existing legislation, policies and practices of CSO contracting mechanisms will be analyzed with a particular attention on sustainability of migrant/refugee TB programs. Technical assistance to be provided to support the transition and sustainability of cross-border referrals and information exchange between the three countries.",150000,null,"Active","a6Q1R000000AJEX",0,0,0,0,150000,0,null,null,"Strengthening partnership/collaboration of civil society and government institutions through greater integration of CSOs in national systems and domestically financed programs. Existing legislation, policies and practices of CSO contracting mechanisms will be analyzed with a particular attention on sustainability of migrant/refugee TB programs. Technical assistance to be provided to support the transition and sustainability of cross-border referrals and information exchange between the three countries.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT South East Asia","2021-12-31"]
["CT Uganda","Uganda","PAI-5891","MCI-00009","TB/HIV","MCI-00136","Community TB/HIV care delivery","The additional funding will support capacity building for the providers under the TB/HIV activities, to enhance TB-HIV collaborative activities at community level.",492737,null,"Active","a6Q1R000000AJWT",0,0,0,0,492737,0,null,null,"The additional funding will support capacity building for the providers under the TB/HIV activities, to enhance TB-HIV collaborative activities at community level.","Low","The additional funding will support capacity building for the providers involved in TB/HIV activities, to enhance TB-HIV collaborative activities at community level",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Tajikistan","Tajikistan","PAI-5802","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","The Rasht region is situated in east part of the country, composed from 5 rayons with a total population of 370,000 people. Around 40,000 people are seasonal labor migrants. There are 5 microscopic center that performed sputum microscopy and one Xpert equipment installed in Rasht city that assure investigations of symptomatics from all region. Due its geographical characteristics: situated in mountain area, 400 km distance from Dushanbe, with full isolation from the center during winter time for 4-5 months, there are big challenges related to the bacteriological investigations of the patients, diagnosis on time of the resistant TB cases, early beginning of the MDR/XDR-TB treatments and possibilities to monitor the efficiency of anti-tuberculosis medication. The number of TB cases in region increased during last years, from 201 in 2015 to 255 in 2016, situation characteristic and for MDR-TB cases registered: 20 and 26 cases respectively. Under above allocation budget sources are requested from the Global Fund to organize level 2 laboratory for the region. The local authorities are ready to provide building for the laboratory, sources being necessary or renovation of the building, laboratory equipment and some staff training. The estimated costs includes 150,000 USD for renovation, 240,000 for equipment, and training of staff 20,000 USD. The impact of this activity result in timely diagnosis of the all forms (including resistant) of TB for patients from region, timely administration of the treatment, and it adequate monitoring.",410000,null,"Active","a6Q1R000000AJV2",0,0,0,0,410000,0,null,null,"The Rasht region is situated in east part of the country, composed from 5 rayons with a total population of 370,000 people. Around 40,000 people are seasonal labor migrants. There are 5 microscopic center that performed sputum microscopy and one Xpert equipment installed in Rasht city that assure investigations of symptomatics from all region. Due its geographical characteristics: situated in mountain area, 400 km distance from Dushanbe, with full isolation from the center during winter time for 4-5 months, there are big challenges related to the bacteriological investigations of the patients, diagnosis on time of the resistant TB cases, early beginning of the MDR/XDR-TB treatments and possibilities to monitor the efficiency of anti-tuberculosis medication. The number of TB cases in region increased during last years, from 201 in 2015 to 255 in 2016, situation characteristic and for MDR-TB cases registered: 20 and 26 cases respectively. Under above allocation budget sources are requested from the Global Fund to organize level 2 laboratory for the region. The local authorities are ready to provide building for the laboratory, sources being necessary or renovation of the building, laboratory equipment and some staff training. The estimated costs includes 150,000 USD for renovation, 240,000 for equipment, and training of staff 20,000 USD. The impact of this activity result in timely diagnosis of the all forms (including resistant) of TB for patients from region, timely administration of the treatment, and it adequate monitoring.","High","Due to the geographical characteristics of the Rasht region, which is situated in a mountainous area, at 400 km distance from Dushanbe, with full isolation from the center during winter time for 4-5 months, there are big challenges related to the bacteriological investigations of patients, diagnosis on time of the resistant TB cases, early beginning of the MDR/XDR-TB treatments and possibilities to monitor the efficiency of anti-tuberculosis medication. TRP considers it as a high priority to ensure countrywide access to early diagnosis and adequate treatment monitoring","NA Original Module: Multidrug-resistant TB. Original Intervention: Organization of the Level 2 bacteriological laboratory in Rasht Region","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Tajikistan","Tajikistan","PAI-5801","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","There are one NRL, one 3 level laboratory and 4 level 2 bacteriological laboratories for TB diagnosis. The NRL and level 3 NPHRL in Dushanbe have been fully renovated or built and equipped under German Government and Global Fund sources. The level 2 bacteriological laboratories have been equipped under Global Fund grants. Donors have covered the maintenance costs of equipment and ventilation systems of the NRL and NPHRL under in previous years. For the next period there are not secured resources to support the maintenance, repairs and spare parts for laboratory equipment at the NRL and oblast-level TB laboratories (laboratory testing equipment, biosafety cabinets, and ventilation system) in the national budget. As a result support to maintenance and servicing of laboratory equipment in bacteriological laboratories is requested under above allocation budget. The estimated costs for all 6 laboratories per year are around 210,000 USD. From the Global Fund are requested sources to cover 90% of needs in 2018, 70% of needs in 2019, and 50% of needs in 2020. The impact of this activity will be well and safety functioning bacteriological laboratory at all levels; timely diagnosed cases of sensitive and resistant TB.",441000,null,"Active","a6Q1R000000AJV1",0,0,0,0,441000,0,null,null,"There are one NRL, one 3 level laboratory and 4 level 2 bacteriological laboratories for TB diagnosis. The NRL and level 3 NPHRL in Dushanbe have been fully renovated or built and equipped under German Government and Global Fund sources. The level 2 bacteriological laboratories have been equipped under Global Fund grants. Donors have covered the maintenance costs of equipment and ventilation systems of the NRL and NPHRL under in previous years. For the next period there are not secured resources to support the maintenance, repairs and spare parts for laboratory equipment at the NRL and oblast-level TB laboratories (laboratory testing equipment, biosafety cabinets, and ventilation system) in the national budget. As a result support to maintenance and servicing of laboratory equipment in bacteriological laboratories is requested under above allocation budget. The estimated costs for all 6 laboratories per year are around 210,000 USD. From the Global Fund are requested sources to cover 90% of needs in 2018, 70% of needs in 2019, and 50% of needs in 2020. The impact of this activity will be well and safety functioning bacteriological laboratory at all levels; timely diagnosed cases of sensitive and resistant TB.","High","For the next period, there are no resources secured to support the maintenance, repairs and spare parts for laboratory equipment at the National Reference Laboratory and oblast-level (regional-level) TB laboratories (laboratory testing equipment, biosafety cabinets, and ventilation system) in the national budget. TRP considers the maintenance of laboratory equipment a high priority to ensure the quality of diagnostic performance. *Should be put in the main allocation","NA Original Module: Multidrug-resistant TB. Original Intervention: Maintenance and servicing of laboratory equipment from NRL and levels 3 and 2 bacteriological laboratories","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Zambia","Zambia","PAI-6043","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","National ART guidelines for 2018 have changed towards the new regimens.  This has altered the gap analysis for ARVs, leading to the need for increased Global Fund resources. Global Fund had initially committed $47,078,326 towards ARVs to cover 3 years 2018-2020. However, Global Fund exhausted all its obligation before 2020.",14289750,null,"Active","a6Q1R000000AJYv",0,0,0,0,14289750,0,null,null,"National ART guidelines for 2018 have changed towards the new regimens.  This has altered the gap analysis for ARVs, leading to the need for increased Global Fund resources. Global Fund had initially committed $47,078,326 towards ARVs to cover 3 years 2018-2020. However, Global Fund exhausted all its obligation before 2020.","High",null,"TRP June Retreat 2019 Original Intervention: Differentiated antiretroviral therapy service delivery","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Africa 2","2020-12-31"]
["CT Viet Nam","Viet Nam","PAI-5946","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conduct a behavioural survey and size estimate of transgender women in eight provinces in Vietnam: HIV/STIs risk behaviours, stigma & discrimination, gender base violence and health care needs. Budget includes consultant fee, survey implementation costs.",64292,null,"Active","a6Q1R000000AJXM",0,0,0,0,64292,0,null,null,"Conduct a behavioural survey and size estimate of transgender women in eight provinces in Vietnam: HIV/STIs risk behaviours, stigma & discrimination, gender base violence and health care needs. Budget includes consultant fee, survey implementation costs.","High","With the start of services for transgender populations, it will be important to conduct a behavioral survey and size estimation within the allocation.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Togo","Togo","PAI-5733","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Equipment for new  MDR-TB  care center  will  improve  iMDR-TB diagnostic    capacity    by    making    it    possible    to    perform bronchoalveolar lavage, induced sputum testing and gastric tubing.",138748.74,null,"Active","a6Q1R000000AJTv",0,0,0,0,138748.74,0,null,null,"Equipment for new  MDR-TB  care center  will  improve  iMDR-TB diagnostic    capacity    by    making    it    possible    to    perform bronchoalveolar lavage, induced sputum testing and gastric tubing.","High","Additional six GeneXpert machines to improve diagnostic capacity in the northern region of Togo.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Togo","Togo","PAI-5732","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Strengthening human resources for health (HRH) management capacity initiated during the NFM1:\n- Institutionalization of HRH: 1) updating the HRH management database (12,000 health staff and 11,000 CHWs); 2) linking the iHRIS 4.2 software with District Health Information System (DHIS2); 3) preparing and periodically updating the country profile on HRH; 4) producing statistical yearbooks on HRH; 5) decentralizing the use of iHRIS to enable decision-making at the regional and health district levels.\n- Improvement of quality and promptness of malaria data reporting through trainings and supervisions.",327527.77,null,"Active","a6Q1R000000AJTu",0,0,0,0,327527.77,0,null,null,"Strengthening human resources for health (HRH) management capacity initiated during the NFM1:\n- Institutionalization of HRH: 1) updating the HRH management database (12,000 health staff and 11,000 CHWs); 2) linking the iHRIS 4.2 software with District Health Information System (DHIS2); 3) preparing and periodically updating the country profile on HRH; 4) producing statistical yearbooks on HRH; 5) decentralizing the use of iHRIS to enable decision-making at the regional and health district levels.\n- Improvement of quality and promptness of malaria data reporting through trainings and supervisions.","Medium","Capacity building is an essential component of service delivery.","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT South Sudan","South Sudan","PAI-5629","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","Training of peer educators and health workers to deliver services to key populations and MSM in particular.This will expand HIV testing services (HTS) and reduce gaps in the first 90 of the HIV care cascade (90% of people knowing their HIV status by 2020).",238262,null,"Active","a6Q1R000000AJSF",0,0,0,0,238262,0,null,null,"Training of peer educators and health workers to deliver services to key populations and MSM in particular.This will expand HIV testing services (HTS) and reduce gaps in the first 90 of the HIV care cascade (90% of people knowing their HIV status by 2020).","High","This will expand HIV testing services (HTS) and reduce gaps in the first 90 of the HIV care cascade (90% of people knowing their HIV status by 2020).","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Sudan","Sudan","PAI-5493","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Target population: Refugees and other vulnerable populations including miners and nomads. The total number of bed net procured for refugees in 2017 was 573,672 LLINs (526,572 for South Sudan Refugees and 47,100 for East Sudan Refugees). FMOH, UNDP and UNHCR jointly distributed LLIN.",3344426,null,"Active","a6Q1R000000AJQ3",3220925,0,0,0,123501,0,null,null,"Target population: Refugees and other vulnerable populations including miners and nomads. The total number of bed net procured for refugees in 2017 was 573,672 LLINs (526,572 for South Sudan Refugees and 47,100 for East Sudan Refugees). FMOH, UNDP and UNHCR jointly distributed LLIN.","High","The TRP notes that 20 percent of this PAAR request is intended for LLINs for populations in refugee areas. These populations may also be covered under the current grant (based on the within allocation request). The TRP notes therefore that efficiencies should be sought by avoiding duplication of net distribution within the refugee population. Remaining under-served vulnerable populations identified in the within allocation funding request should also be addressed by this activity where possible. If the planned Emergency\nFund request is successful for this activity, consideration should be given to continuing sufficient funding for the remaining under-served vulnerable populations identified, notably nomads and miners. The TRP also notes that the estimated costs per net are relatively high for this budget line, and that this needs careful review at the time of grant-making to confirm the actual above-allocation amount required.","Sudan has only 1 integrated funding request, and the UQD component is Malaria\n01/11/2018: As per email from Colin (forwarded by Lindsay), this activity has been partly funded from Emergency Fund, prior to coming for GAC Original Intervention: Long-lasting insecticidal nets ? Mass campaign (refugees)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Papua New Guinea","Papua New Guinea","PAI-5396","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This allows Polymerase Chain Reaction (PCR) analysis of all samples taken from the Malaria Information System. At present this is not possible but PCR gives a much better idea of prevalence of malaria than either microscopy or Rapid Diagnostic Tests can supply.",146851,null,"Active","a6Q1R000000AJOU",0,0,0,0,146851,0,null,null,"This allows Polymerase Chain Reaction (PCR) analysis of all samples taken from the Malaria Information System. At present this is not possible but PCR gives a much better idea of prevalence of malaria than either microscopy or Rapid Diagnostic Tests can supply.","High","Recommended, in fact, by the TRP at the time of Program Continuation Review to support monitoring of the prevalence of P. vivax by some very sensitive diagnostic methods such as PCR technique.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Polymerase Chain Reaction (PCR) diagnosis in malaria infection","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Namibia","Namibia","PAI-5241","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Support for the HSS evaluation and support for a database for tracking donor funding. This should provide high quality information, resulting in better programme decisions and implementation of corrective action.",322195,null,"Active","a6Q1R000000AJLz",0,0,0,0,322195,0,null,null,"Support for the HSS evaluation and support for a database for tracking donor funding. This should provide high quality information, resulting in better programme decisions and implementation of corrective action.","High","Strengthening the Health Management Information Systems (HMIS) addresses a clear weakness of the system, and it is instrumental for better impact of disease control programmes.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Mozambique","Mozambique","PAI-5143","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Includes annual central level action plan meeting and provincial and district level coordination meetings, with all Quality Assurance (QA) participants, to ensure proper functioning of the QA system; provincial task forces will be created to implement and coordinate the QA activities.",1297563.3899999999,null,"Active","a6Q1R000000AJKP",0,0,0,0,1297563.3899999999,0,null,null,"Includes annual central level action plan meeting and provincial and district level coordination meetings, with all Quality Assurance (QA) participants, to ensure proper functioning of the QA system; provincial task forces will be created to implement and coordinate the QA activities.","High","Ensuring that there is quality community based diagnosis and treatment will go a long way in improving malaria treatment in the North ? where the burden is high and access to services is limited.","NA Original Intervention: Case management (National meetings on quality services)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2020-12-31"]
["CT Mongolia","Mongolia","PAI-5138","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Technical assistance is required to improve the NTP clinical management when shortened MDR-TB regimen will be introduced in 2018 in UB, to assist drug management, laboratory assistance and infection control. TA will be required at least once a year for the clinical management and laboratory assistance.",50000,null,"Active","a6Q1R000000AJKK",0,0,0,0,50000,0,null,null,"Technical assistance is required to improve the NTP clinical management when shortened MDR-TB regimen will be introduced in 2018 in UB, to assist drug management, laboratory assistance and infection control. TA will be required at least once a year for the clinical management and laboratory assistance.","Medium","Technical assistance to support drug management, lab assistance, infection control. Technical assistance is essential to fill capacity gaps in NTP for enhanced program performance.","NA Original Intervention: Technical assistance","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT South East Asia","2020-12-31"]
["CT Myanmar","Myanmar","PAI-5113","MCI-00007","Treatment, care and support","MCI-00121","Prevention, diagnosis and treatment of opportunistic infections","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.",675559,null,"Inactive","a6Q1R000000AJJv",675559,0,0,0,0,1,null,null,"HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.","High","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately. For both decreased mortality and decreased HIV transmission HIV treatment is a high priority.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Myanmar","Myanmar","PAI-5112","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.",2743598,null,"Inactive","a6Q1R000000AJJu",2743598,0,0,0,0,1,null,null,"HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.","High","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately. For both decreased mortality and decreased HIV transmission HIV treatment is a high priority.","NA Original Intervention: Pre-ART care","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Moldova","Moldova","PAI-5013","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","In order to ensure good adherence to ARV treatment and taking into consideration the ambitious targets for enrollment in ARV treatment, it be necessary to involve more specialist in case management provision and update the information and abilities for the involved staff. The training course on HIV case management willensure quality service provisionand in the end will support ARV treatment adherence.",12565.37,null,"Active","a6Q1R000000AJIJ",0,0,0,0,12565.37,0,null,null,"In order to ensure good adherence to ARV treatment and taking into consideration the ambitious targets for enrollment in ARV treatment, it be necessary to involve more specialist in case management provision and update the information and abilities for the involved staff. The training course on HIV case management willensure quality service provisionand in the end will support ARV treatment adherence.","High","The TRP considers this intervention high priority as enrolment into antiretroviral therapy (ART) and adherence, which are aims of this training, are both essential parts of the treatment cascade.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Intervention: Training on HIV case management for service providers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4890","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Training workshop for program managers and TB program coordinators to develop SOPs for MDR TB treatment and develop PMDT guidlines. Training of health staff (doctors) on tuberculosis and its side effects in cooperation with Annoor Sanatorium.",15711,null,"Active","a6Q1R000000AJGK",0,0,0,0,15711,0,null,null,"Training workshop for program managers and TB program coordinators to develop SOPs for MDR TB treatment and develop PMDT guidlines. Training of health staff (doctors) on tuberculosis and its side effects in cooperation with Annoor Sanatorium.","High",null,"NA Original Module: Multidrugresistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry HIV Latin America ALEP","Multicountry HIV Latin America ALEP","PAI-4774","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Venezuela would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in addressing stigma and discrimination within health services, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the changes they consider necessary, in line with the regional activities emerging from this module.\nEstablishment of strategic partnerships with other sectors representing the intersectionality of HIV to address social determinants and the development and implementation of regional, subregional and national programs to tackle stigma and discrimination of PLHIV, from a gender, multiethnic and rights-based approach, based on findings from the stigma indices.",17923,null,"Active","a6Q1R000000AJES",0,0,0,0,17923,0,null,null,"Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Venezuela would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in addressing stigma and discrimination within health services, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the changes they consider necessary, in line with the regional activities emerging from this module.\nEstablishment of strategic partnerships with other sectors representing the intersectionality of HIV to address social determinants and the development and implementation of regional, subregional and national programs to tackle stigma and discrimination of PLHIV, from a gender, multiethnic and rights-based approach, based on findings from the stigma indices.","Low","The TRP recognizes the deterioration of the social and health situation in Venezuela and the increasingly unmet needs in access to basic HIV services. However, the current political and social context in Venezuela significantly diminishes the likelihood that the proposed activities such as ?Stigma and discrimination reduction? in the PAAR with a total value of US$ 17,923 in the proposed budget will be impactful to address ?Sustainability of services for key populations in Venezuela?. As such it is considered low priority for funding within this catalytic envelope. The applicant should reconsider the strategic choice of activities that would have the potential for impact in the revised PAAR.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-09-30"]
["CT Multicountry HIV Latin America ALEP","Multicountry HIV Latin America ALEP","PAI-4773","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","Given its social and political situation, it is felt that Venezuela cannot guarantee implementation of the full program planned for the other countries. In addition, Venezuela is not eligible for Global Fund funding. However, implementation of this selection of some of the same activities as the other countries, and its inclusion into the regional activities would ensure that the regional objectives of this multicountry funding request are achieved.\nFor an overview of the political situation in Venezuela, see the OAS Resolution on its last election at: http://www.oas.org/en/media_center/press_release.asp?sCodigo=S-032/18\nCivil society is facing difficulties in addressing the necessary legislative, regulatory and policy changes, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the reforms they consider necessary, in line with the regional activities emerging from this module.\nTo provide an effective HIV response, open data strategies are being designed and implemented, along with oversight and social control of public policies, and legal barriers related to intellectual property are being analyzed. Strategies to overcome these are being designed and implemented.",8994,null,"Active","a6Q1R000000AJER",0,0,0,0,8994,0,null,null,"Given its social and political situation, it is felt that Venezuela cannot guarantee implementation of the full program planned for the other countries. In addition, Venezuela is not eligible for Global Fund funding. However, implementation of this selection of some of the same activities as the other countries, and its inclusion into the regional activities would ensure that the regional objectives of this multicountry funding request are achieved.\nFor an overview of the political situation in Venezuela, see the OAS Resolution on its last election at: http://www.oas.org/en/media_center/press_release.asp?sCodigo=S-032/18\nCivil society is facing difficulties in addressing the necessary legislative, regulatory and policy changes, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the reforms they consider necessary, in line with the regional activities emerging from this module.\nTo provide an effective HIV response, open data strategies are being designed and implemented, along with oversight and social control of public policies, and legal barriers related to intellectual property are being analyzed. Strategies to overcome these are being designed and implemented.","Low","The TRP recognizes the deterioration of the social and health situation in Venezuela and the increasingly unmet needs in access to basic HIV services. However, the current political and social context in Venezuela significantly diminishes the likelihood that the proposed activities such as ?improving laws, regulations and policies related to HIV and HIV/TB in Venezuela? in the PAAR with a total value of US$ 8,994.00 in the proposed budget will be impactful to address ?Sustainability of services for key populations in Venezuela?. As such it is considered low priority for funding within this catalytic envelope. The applicant should reconsider the strategic choice of activities that would have the potential for impact in the revised PAAR.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-09-30"]
["CT Uganda","Uganda","PAI-5885","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","The above allocation for MDR-TB is mainly for laboratory supplies ($20.4m).and $5.4m for procuring second line drugs.",31112381,null,"Active","a6Q1R000000AJWN",0,0,0,0,31112381,0,null,null,"The above allocation for MDR-TB is mainly for laboratory supplies ($20.4m).and $5.4m for procuring second line drugs.","High","The above allocation for MDR-TB is mainly for laboratory supplies (US$20.4m) and US$5.4m for procuring second line drugs. With expansion of Xpert testing, more cases of RR/MDRTB are expected to be identified and will need to be treated.","NA Original Module: Multidrug-resistant TB. Original Intervention: Ensure early detection of drug resistant TB (DR-TB) through enhanced access to DST for TB patients and ?Increase enrolment and improve DR-TB patient management?","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Tajikistan","Tajikistan","PAI-5797","MCI-00531","Comprehensive prevention programs for TGs","MCI-00562","Other intervention(s) for TGs","As there is currently a lack of information on the TG population, this request will develop IBBS and GIS to create mappings to guide interventions for TG persons.",50000,null,"Inactive","a6Q1R000000AJUx",50000,0,0,0,0,1,null,null,"As there is currently a lack of information on the TG population, this request will develop IBBS and GIS to create mappings to guide interventions for TG persons.","High","This intervention will allow to develop mappings to guide interventions for transgender persons, and to conduct an integrated bio-behavioral survey (IBBS) among transgenders persons.","NA Original Module: Programs and support for transgender persons. Original Intervention: Mapping survey, situation analyses, needs assessment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Zambia","Zambia","PAI-6033","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","This is a relevant component of the country?s elimination strategy that is critical as the burden progressively declines. This strategy will support the development of case-based surveillance in areas with low malaria transmission.",10686696,null,"Active","a6Q1R000000AJYl",0,0,0,0,10686696,0,null,null,"This is a relevant component of the country?s elimination strategy that is critical as the burden progressively declines. This strategy will support the development of case-based surveillance in areas with low malaria transmission.","High","This is a relevant component of the country?s elimination strategy that is critical as the burden progressively declines; this strategy will support the development of case-based surveillance in areas with low malaria transmission","NA Original Intervention: Community case investigation and transmission containment","Shalini Mitra","2019-10-30","2017-2019","Malaria, RSSH","RT High Impact Africa 2"]
["CT Viet Nam","Viet Nam","PAI-5942","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","Due to the preference for anonymity when it comes to accessing healthcare, communication through social media and technology is essential to provide HIV prevention information to MSM. The Global Fund is requested to support communication on HIV prevention for MSM, HIV/HCV (Hep-C Virus) co-infection and Sexually Transmitted Infection (STI).",100000,null,"Active","a6Q1R000000AJXI",0,0,0,0,100000,0,null,null,"Due to the preference for anonymity when it comes to accessing healthcare, communication through social media and technology is essential to provide HIV prevention information to MSM. The Global Fund is requested to support communication on HIV prevention for MSM, HIV/HCV (Hep-C Virus) co-infection and Sexually Transmitted Infection (STI).","Medium",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Togo","Togo","PAI-5728","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","The funding request will allow the Ministry of Health to conduct the following surveys:\n- Malaria Indicators Survey in 2020 with technical support from MEASURE Evaluation\n- Prevalence study of molecular markers of Plasmodium falciparum resistance to sulfadoxine- pyrimethamine (SP) and amodiaquine (AQ) in 2018\n- Evaluation of the therapeutic effectiveness of artemisinin-based combination therapies (ACTs) to treat uncomplicated malaria \n- Review of data quality and quality of care in public facilities",2214569.63,null,"Active","a6Q1R000000AJTq",0,0,0,0,2214569.63,0,null,null,"The funding request will allow the Ministry of Health to conduct the following surveys:\n- Malaria Indicators Survey in 2020 with technical support from MEASURE Evaluation\n- Prevalence study of molecular markers of Plasmodium falciparum resistance to sulfadoxine- pyrimethamine (SP) and amodiaquine (AQ) in 2018\n- Evaluation of the therapeutic effectiveness of artemisinin-based combination therapies (ACTs) to treat uncomplicated malaria \n- Review of data quality and quality of care in public facilities","High","M&E, in terms of quality and availability of data, was identified as a major bottleneck in the malaria response with very low budgetary allocation. Real time information for planning purposes is very important to make appropriate decision and achieve significant impact, which is why the TRP considers this module","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Serbia","Serbia","PAI-5624","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","PWID Training for outreach workers",6425.77,null,"Active","a6Q1R000000AJSA",0,0,0,0,6425.77,0,null,null,"PWID Training for outreach workers","High","Expansion of services to reach people who inject drugs\nis essential for improving the impact of the interventions\non the epidemic in Serbia.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2022-06-30"]
["CT Serbia","Serbia","PAI-5619","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","This requested amount includes coverage with preventive package of additional 15% of MSM (578 people) in 2019, 1080 people in 2020 and 10% (1275 people) in 2021 (from existing gap).",116103.69,null,"Inactive","a6Q1R000000AJS5",116103.69,0,0,0,0,1,null,null,"This requested amount includes coverage with preventive package of additional 15% of MSM (578 people) in 2019, 1080 people in 2020 and 10% (1275 people) in 2021 (from existing gap).","High","Expansion of services for men who have sex with men\nshould be prioritized given the epidemiological\nbackground in the country as well as the coverage\ncurrently reported in this population.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2022-06-30"]
["CT Sudan","Sudan","PAI-5487","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN to replace LLIN distributed in 2017 to maintain universal coverage in the 12 targeted states (5 Darfur states, 3 Kordofan states, White Nile, Blue Nile, Kassala and Gadarif states). Advocacy and awareness campaigns are ongoing to sensitize targeted communities to increase the bed net utilization.",2916646,null,"Active","a6Q1R000000AJPx",0,0,0,0,2916646,0,null,null,"LLIN to replace LLIN distributed in 2017 to maintain universal coverage in the 12 targeted states (5 Darfur states, 3 Kordofan states, White Nile, Blue Nile, Kassala and Gadarif states). Advocacy and awareness campaigns are ongoing to sensitize targeted communities to increase the bed net utilization.","High",null,"NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign (in replacement of larviciding activities in rural areas)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Rwanda","Rwanda","PAI-5482","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00599","National product selection, registration and quality monitoring","Above allocation funding will support NRL quality improvement towards accreditation as well as a research (TB-NSP page 65).",56207,null,"Active","a6Q1R000000AJPs",0,0,0,0,56207,0,null,null,"Above allocation funding will support NRL quality improvement towards accreditation as well as a research (TB-NSP page 65).","Medium","Quality improvement approach is not clearly defined","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Philippines","Philippines","PAI-5386","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Additional investment will ensure detection and enrollment of 100% attainment of the PhilSTEP1 target.",17104095,null,"Active","a6Q1R000000AJOK",0,7000000,0,0,10104095,0,null,null,"Additional investment will ensure detection and enrollment of 100% attainment of the PhilSTEP1 target.","High","Proper identification and treatment contributes to a decline of the MDR-TB burden","Portfolio optimization funds of $7m from July 2018 PO meeting approved for inclusion in grants on 20 Sept 2018 GAC Original Module: Multidrug-resistant TB. Original Intervention: Detection and enrolment of additional 8,366 DRTB cases on top of allocation and catalytic funding request","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Namibia","Namibia","PAI-5233","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","In order to coordinate the MOHSS strategies on malaria elimination with the community response, the NVDCP proposes the recruitment of a Community-based Interventions Coordinator to ensure increased acceptance of indoor residual spraying and use of long lasting insecticide treated nets. This amount includes the salary of this individual for Years 1 & 2 of the grant.",48692,null,"Active","a6Q1R000000AJLr",0,0,0,0,48692,0,null,null,"In order to coordinate the MOHSS strategies on malaria elimination with the community response, the NVDCP proposes the recruitment of a Community-based Interventions Coordinator to ensure increased acceptance of indoor residual spraying and use of long lasting insecticide treated nets. This amount includes the salary of this individual for Years 1 & 2 of the grant.","High","The TRP finds that community mobilization will be important for malaria elimination ? especially given the remoteness of some of the vulnerable populations. It is expected that this coordinator would work with all stakeholders including the CSOs to mobilize communities in malaria elimination efforts.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Recruitment of a community based coordinator","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2020-12-31"]
["CT Namibia","Namibia","PAI-5232","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Good surveillance data is the backbone of Namibia?s elimination programme, allowing robust targeting of all other interventions designed at halting transmission in all foci.\nThis amount includes continued support for implementation of surveillance by 4 surveillance officers in the non-prioritized regions in year 1 and 2 to ensure adequate transmission time to the government structures in line with the ongoing government restructuring.",177136,null,"Active","a6Q1R000000AJLq",0,0,0,0,177136,0,null,null,"Good surveillance data is the backbone of Namibia?s elimination programme, allowing robust targeting of all other interventions designed at halting transmission in all foci.\nThis amount includes continued support for implementation of surveillance by 4 surveillance officers in the non-prioritized regions in year 1 and 2 to ensure adequate transmission time to the government structures in line with the ongoing government restructuring.","High","The TRP recommends that this activity is prioritized as surveillance data is important for malaria elimination. Good data would allow for effective targeting of interventions.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2020-12-31"]
["CT Myanmar","Myanmar","PAI-5107","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.",836304,null,"Inactive","a6Q1R000000AJJp",836304,0,0,0,0,1,null,null,"This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","High","HMIS was identified as a major constrain in the NSP II review in 2015 with high impact in the three programs and beyond","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Moldova","Moldova","PAI-5010","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","This intervention is very important to recruit additional new MSM, by providing peer-to-peer educational session and referring them to access services. Estimated 500 additional clients to be reached each year. Taking into consideration the new estimations and the established targets, this intervention will contribute to cover more MSM with prevention services.",20199.75,null,"Active","a6Q1R000000AJIG",0,0,0,0,20199.75,0,null,null,"This intervention is very important to recruit additional new MSM, by providing peer-to-peer educational session and referring them to access services. Estimated 500 additional clients to be reached each year. Taking into consideration the new estimations and the established targets, this intervention will contribute to cover more MSM with prevention services.","High","The TRP considers this intervention high priority, as peer -driven interventions are an essential part of the package for services that target men who have sex with men.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Develop and provide peer driven interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4884","MCI-00008","TB care and prevention","MCI-00127","Treatment","FLD for Jordan (Pharmaceutical Products)",14589,null,"Active","a6Q1R000000AJGE",0,0,0,0,14589,0,null,null,"FLD for Jordan (Pharmaceutical Products)","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4883","MCI-00008","TB care and prevention","MCI-00127","Treatment","Translate and print the national guidelines on TB treatment in Jordan to Arabic",6733,null,"Active","a6Q1R000000AJGD",0,0,0,0,6733,0,null,null,"Translate and print the national guidelines on TB treatment in Jordan to Arabic","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4878","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Install and pilot the Computer-Aided Detection for Tuberculosis (CAD4TB) software at the NTP center/s. More than 6000 Xrays/month are conducted in Amman only. CAD4TB works with a pay-per-screening model and is supplied in bundles, where customers pay for bundles of CXR analyses up front. The software has been proven to help readers detect TB more accurately and quickly and it is recommended to pilot the software in the NTP.",107732,null,"Active","a6Q1R000000AJG8",0,0,0,0,107732,0,null,null,"Install and pilot the Computer-Aided Detection for Tuberculosis (CAD4TB) software at the NTP center/s. More than 6000 Xrays/month are conducted in Amman only. CAD4TB works with a pay-per-screening model and is supplied in bundles, where customers pay for bundles of CXR analyses up front. The software has been proven to help readers detect TB more accurately and quickly and it is recommended to pilot the software in the NTP.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Morocco","Morocco","PAI-4766","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","The TB Technical Committee provides essential support to the NTCP?s Central Unit on strategic focus, defining and developing NTCP strategies, and other matters (for details, see the introductory paragraph to NSP objective 4, intervention 4.5). Committee meetings will be essential to its support work in 2018, 2019 and 2020. Each year, an international expert will review the national network of TB laboratories to determine the relevance of technical and management practices within the network and to help develop strategies that are consistent with the NTCP?s laboratory activity needs.",80693.52,null,"Active","a6Q1R000000AJEK",71878.58,0,0,0,8814.94,0,null,null,"The TB Technical Committee provides essential support to the NTCP?s Central Unit on strategic focus, defining and developing NTCP strategies, and other matters (for details, see the introductory paragraph to NSP objective 4, intervention 4.5). Committee meetings will be essential to its support work in 2018, 2019 and 2020. Each year, an international expert will review the national network of TB laboratories to determine the relevance of technical and management practices within the network and to help develop strategies that are consistent with the NTCP?s laboratory activity needs.","High","Each year, an international expert will review the national network of TB laboratories to determine the relevance of technical and management practices within the network and to help develop strategies that are consistent with the NTCP?s laboratory activity needs.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5877","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Tanzania plans to achieve elimination of MTCT by 2020. The funding request ensures pregnant and lactating women are enrolled and retained on ART. If the request above allocation is available, the country will scale up of Point of Care (POC) services to expand early HIV diagnosis in regions with high volume of HIV + pregnant women will be prioritized. To improve MTCT surveillance and early diagnosis targeted Nucleic Acid Test (NAT) will be established in at least 20 pregnant women in a year. This is expected to capture more children who need ART much earlier and put them on care.",1304000,null,"Active","a6Q1R000000AJWF",0,0,0,0,1304000,0,null,null,"Tanzania plans to achieve elimination of MTCT by 2020. The funding request ensures pregnant and lactating women are enrolled and retained on ART. If the request above allocation is available, the country will scale up of Point of Care (POC) services to expand early HIV diagnosis in regions with high volume of HIV + pregnant women will be prioritized. To improve MTCT surveillance and early diagnosis targeted Nucleic Acid Test (NAT) will be established in at least 20 pregnant women in a year. This is expected to capture more children who need ART much earlier and put them on care.","Medium","Tanzania plans to achieve elimination of Mother-To-Child Transmission (MTCT) by 2020. The funding request ensures pregnant and lactating women are enrolled and retained on ART. If funding for the request above allocation is available, the country will scale up of Point of Care (POC) services to expand early HIV diagnosis in regions with high volume of HIV + pregnant women will be prioritized. To improve MTCT surveillance and early diagnosis targeted Nucleic Acid Test (NAT) will be established in at least 20 pregnant women in a year. This is expected to capture more children who need ART much earlier and put them on care","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Scale up POC services for testing DNAPCR for HIV Early Infant Diagnosis as well as testing at birth for HIV exposed infants in targeted health facilities from priority regions.","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5876","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","A scale up plan for HVL testing is being implemented in Tanzania. The funding request has set ambitious target to enrol 95% of PLHIV on ART by 2020. To achieve the third ninety of the 90-90-90 strategy, scale up of HVL testing to district level will be crucial. The PAAR will be used to procure HVL reagents and build capacity of health care workers including laboratory personnel to conduct Viral Load tests and EID testing. This will also involve strengthening lab systems and providing technical assistance for accreditation of new sites. The aim is to increase coverage and reduce the turnaround time.",1612000,null,"Active","a6Q1R000000AJWE",0,0,0,0,1612000,0,null,null,"A scale up plan for HVL testing is being implemented in Tanzania. The funding request has set ambitious target to enrol 95% of PLHIV on ART by 2020. To achieve the third ninety of the 90-90-90 strategy, scale up of HVL testing to district level will be crucial. The PAAR will be used to procure HVL reagents and build capacity of health care workers including laboratory personnel to conduct Viral Load tests and EID testing. This will also involve strengthening lab systems and providing technical assistance for accreditation of new sites. The aim is to increase coverage and reduce the turnaround time.","Medium","A scale up plan for HIV viral load testing is being implemented in Tanzania. The funding request has set ambitious target to enrol 95 percent of People Living with HIV on ART by 2020. To achieve the third ninety of the 90-90-90 strategy, scale up of viral load testing to district level will be crucial. The PAAR will be used to procure viral load reagents and build capacity of health care workers including laboratory personnel to conduct viral load tests and Early Infant Diagnosis (EID) testing. This will also involve strengthening lab systems and providing technical assistance for accreditation of new sites. The aim is to increase coverage and reduce the turnaround time.","NA Original Intervention: Scale up HIV viral load and early infant diagnosis testing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Thailand","Thailand","PAI-5789","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","10 (4module) = 10 provinces currently without any rapid diagnostics available 4 (16 module) =  For active case finding campaignactivity  in KPs ( 132 Prisons)   This investment was consistent with the recommendation of the recently concluded Mini Review of the TB program (2016), which urged Thailand to invest in at least 150 machines to cover the whole country  where at least every province and high burden district has at least one Xpert machine available. Molecular technique(GeneXpert) is faster than AFB smear with both sensitivity and suspect that increasing TB patients in high risk group.",671131,null,"Active","a6Q1R000000AJUp",0,0,0,0,671131,0,null,null,"10 (4module) = 10 provinces currently without any rapid diagnostics available 4 (16 module) =  For active case finding campaignactivity  in KPs ( 132 Prisons)   This investment was consistent with the recommendation of the recently concluded Mini Review of the TB program (2016), which urged Thailand to invest in at least 150 machines to cover the whole country  where at least every province and high burden district has at least one Xpert machine available. Molecular technique(GeneXpert) is faster than AFB smear with both sensitivity and suspect that increasing TB patients in high risk group.","High","Provision of additional GeneXpert machines will allow to expand the access of key populations to rapid TB molecular diagnostic tests, including prisoners and other key populations in provinces where rapid diagnostics are not available yet","NA Original Intervention: Key populations (TB care and prevention) ? Others","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Zanzibar","Zanzibar","PAI-6029","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women.",544241,null,"Active","a6Q1R000000AJYh",0,0,0,0,544241,0,null,null,"This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women.","High","This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Chad","Chad","PAI-5719","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","A National Public Health Laboratory (NPHL) was established by Law No. 13/PR/2008 of June 10, 2008, on the creation of a National Public Health Laboratory. The government has provided premises for this laboratory. It is currently in the process of being made operational. Via the German government, G5 Sahel has made a mobile device available to the NPHL. The World Bank is currently purchasing a portion of the equipment.  \nIn order to support the health system strengthening included in the allocation amount, this above-allocation funding request aims to upgrade the NPHL from level 1 to level 2. It is necessary to renovate the premises supplied, to provide capacity building for the NPHL personnel and to supplement the equipment to improve its performance. \nThis intervention is linked to focus point 4 of the DGPL Strategic Plan.\nThe establishment of this laboratory will make it possible to improve quality control for pharmaceutical products and biological analysis at national level.   This intervention will be implemented by the DGPL.",1507474.16,null,"Active","a6Q1R000000AJTh",0,0,0,0,1507474.16,0,null,null,"A National Public Health Laboratory (NPHL) was established by Law No. 13/PR/2008 of June 10, 2008, on the creation of a National Public Health Laboratory. The government has provided premises for this laboratory. It is currently in the process of being made operational. Via the German government, G5 Sahel has made a mobile device available to the NPHL. The World Bank is currently purchasing a portion of the equipment.  \nIn order to support the health system strengthening included in the allocation amount, this above-allocation funding request aims to upgrade the NPHL from level 1 to level 2. It is necessary to renovate the premises supplied, to provide capacity building for the NPHL personnel and to supplement the equipment to improve its performance. \nThis intervention is linked to focus point 4 of the DGPL Strategic Plan.\nThe establishment of this laboratory will make it possible to improve quality control for pharmaceutical products and biological analysis at national level.   This intervention will be implemented by the DGPL.","Medium","While strengthening the lab services overall is a good initiative, activities that would directly impact the patient outcome should be prioritized ahead of this activity","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Central Africa"]
["CT Chad","Chad","PAI-5718","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","Prevention and health care for HIV/early marriage/GBV among adolescents aged 10-19 and young women aged 20-24. This intervention will make it possible to carry out structural activities relating to early marriage and GBV, community screening and counseling, psycho-social health care for cases and the participation of adolescents and young women through the Ureport and Upartner platform. Strengthening the young people?s network, in particular the monitoring of adolescents living with HIV.",953877.23,null,"Active","a6Q1R000000AJTg",0,0,0,0,953877.23,0,null,null,"Prevention and health care for HIV/early marriage/GBV among adolescents aged 10-19 and young women aged 20-24. This intervention will make it possible to carry out structural activities relating to early marriage and GBV, community screening and counseling, psycho-social health care for cases and the participation of adolescents and young women through the Ureport and Upartner platform. Strengthening the young people?s network, in particular the monitoring of adolescents living with HIV.","High","This activity is considered the highest priority of the HIV related items in the PAAR and if efficiencies are found during grant-making it should be moved into the allocation if possible.","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Central Africa"]
["CT Rwanda","Rwanda","PAI-5481","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Above allocation will: a) cover the purchase of computers to replace those distributed to health facilities in 2012 - to complement interventions on improved access and quality of surveillance data contained in the funding; b) support the NTP for conducting joint sessions with the national Institute of Statistics for analysing causes of TB deaths using available data from the national vital registration system.",388195,null,"Active","a6Q1R000000AJPr",0,0,0,0,388195,0,null,null,"Above allocation will: a) cover the purchase of computers to replace those distributed to health facilities in 2012 - to complement interventions on improved access and quality of surveillance data contained in the funding; b) support the NTP for conducting joint sessions with the national Institute of Statistics for analysing causes of TB deaths using available data from the national vital registration system.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Rwanda","Rwanda","PAI-5477","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Above allocation will allow purchasing of 5 digital radiography machines for some district hospitals, thereby increasing access to CXR screening for defined HRGs (new PLHIVs and TB contacts) and improving diagnosis capacities of bacteriologically negative TB. The expected impact is to improve early detection and treatment of TB and TB/HIV and contribute to the reduction of TB mortality.",813603,null,"Inactive","a6Q1R000000AJPn",0,813603,0,0,0,1,null,null,"Above allocation will allow purchasing of 5 digital radiography machines for some district hospitals, thereby increasing access to CXR screening for defined HRGs (new PLHIVs and TB contacts) and improving diagnosis capacities of bacteriologically negative TB. The expected impact is to improve early detection and treatment of TB and TB/HIV and contribute to the reduction of TB mortality.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Philippines","Philippines","PAI-5383","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","The funding will further enhance and sustain mapping of KP venues, as well as generate strategic information needed for program planning and implementation.",263918.28999999998,null,"Active","a6Q1R000000AJOH",0.28999999999999998,0,0,0,263918,0,null,null,"The funding will further enhance and sustain mapping of KP venues, as well as generate strategic information needed for program planning and implementation.","Low","Mapping and remapping needed to adjust the intervention should be part of the DOH approach in the allocation request already included.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information system routine reporting","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Philippines","Philippines","PAI-5382","MCI-00071","Other module","MCI-00071","Other module","This will ensure that higher risk TGW are reached with prevention programs.",126146.7,null,"Active","a6Q1R000000AJOG",0,0,0,0,126146.7,0,null,null,"This will ensure that higher risk TGW are reached with prevention programs.","Medium","The intervention is already included in the allocation request and targeting most at risk MSM and could be achieved with lower funding and efficiencies found during grant implementation. The rationale provided by the applicant does not make for a compelling case how the additional funding will impact the epidemic and raises some feasibility concerns.","NA Original Module: Comprehensive prevention programs. Original Intervention: Behavioural interventions addressing stigma and discrimination and violence against MSM condoms and lubricant programming HIV testing services other interventions","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Nepal","Nepal","PAI-5334","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Capacity building of the staff & improvement of the facilities would boost the NRL capacity to perform up to 10,000 smears, 5,000 cultures, 1,000 ? 2,000 LPAs, and 500 DSTs per year. This is important considering wide network of rapid molecular diagnostics, DR-TB management with newer regimen and newer drugs requiring quality assured uninterrupted culture/DST facilities.",252000,null,"Active","a6Q1R000000AJNU",86458,0,0,0,165542,0,null,null,"Capacity building of the staff & improvement of the facilities would boost the NRL capacity to perform up to 10,000 smears, 5,000 cultures, 1,000 ? 2,000 LPAs, and 500 DSTs per year. This is important considering wide network of rapid molecular diagnostics, DR-TB management with newer regimen and newer drugs requiring quality assured uninterrupted culture/DST facilities.","High","Technical consultation for laboratory development will allow the Central laboratory to develop, Line probe assay for second line drugs which is required for rollout of short MDR TB treatment and will allow development of quality assurance programs to promote both GeneXpert and Smear microscopy where GeneXpert is not available for diagnosis.","NA Original Intervention: Provision of a Senior Lab Expert","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT South East Asia","2021-03-15"]
["CT Nepal","Nepal","PAI-5329","MCI-00023","Program management","MCI-00208","Supporting procurement and supply management","Support QA/QC of Health Product/Pharmaceuticals (as per GFATM rules); Provide LMIS training workshops for RHDs, DHOs, DPHO, storekeepers, accountants and other officers for GFATM activities to strengthen capacity in-line with the additional workload associated with elimination.",54640,null,"Active","a6Q1R000000AJNP",0,0,0,0,54640,0,null,null,"Support QA/QC of Health Product/Pharmaceuticals (as per GFATM rules); Provide LMIS training workshops for RHDs, DHOs, DPHO, storekeepers, accountants and other officers for GFATM activities to strengthen capacity in-line with the additional workload associated with elimination.","High","As the program will gradually move from control to elimination mode, it is important that a robust QA/QC system is in in place.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2021-03-15"]
["CT Malawi","Malawi","PAI-5226","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Malawi has recently adopted the WHO guidelines on treatment monitoring (annual viral load tests), until now viral load tests had been conducted every two years. This has resulted in a gap in commodities (especially reagents). Based on existing and targeted patients to be reached between 2019 and 2020 and taking into consideration existing resources (reagents for 1.36 million tests), the potential reagents? gap is for 518,000 tests. The scale-up plan for treatment monitoring and optimized laboratory network was completed and the annual testing policy is now in effect. The required amount to cover the gap is US$ 8 million. This is in addition to existing resources from PEPFAR committed to investments in laboratory capacity strengthening under COP 18. The gap is therefore in 2020 and orders will have to be placed in January 2020 to full coverage of all patients.",8054327,null,"Active","a6Q1R000000AJLk",0,0,0,0,8054327,0,null,null,"Malawi has recently adopted the WHO guidelines on treatment monitoring (annual viral load tests), until now viral load tests had been conducted every two years. This has resulted in a gap in commodities (especially reagents). Based on existing and targeted patients to be reached between 2019 and 2020 and taking into consideration existing resources (reagents for 1.36 million tests), the potential reagents? gap is for 518,000 tests. The scale-up plan for treatment monitoring and optimized laboratory network was completed and the annual testing policy is now in effect. The required amount to cover the gap is US$ 8 million. This is in addition to existing resources from PEPFAR committed to investments in laboratory capacity strengthening under COP 18. The gap is therefore in 2020 and orders will have to be placed in January 2020 to full coverage of all patients.","High","-","Amount validated and description updated by CT Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Malawi","Malawi","PAI-5225","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","Business case for investment\na. Transition to new regimens: Based on WHO updated treatment guideline and other evaluated evidence on NNRTI resistance, it is imperative that Malawi transition and shift to the new treatment regimen. The full transition is planned to start in October 2019 for both adult and pediatrics.  The total estimated gap is US$ 7,144,985.\nb. Program scale-up: In February 2019 the quantification was revised to reflect current program realities.  As of 31 December 2018, the country had surpassed the original target (755,967 patients alive and on ART), reaching 805,000 patients. The program expects to put 128,000 more patients on treatment by 31 December 2020 (total of 928,000 patients alive and on ART compared to original target). As a result, the gap is estimated at US$ 12,356,242.  The ARV gap is for 2020, for which, orders must be made in January 2020 at the latest (grant revision in October 2019) to ensure full transition of all patients and avoid any treatment disruption.",19501227,null,"Active","a6Q1R000000AJLj",0,0,0,0,19501227,0,null,null,"Business case for investment\na. Transition to new regimens: Based on WHO updated treatment guideline and other evaluated evidence on NNRTI resistance, it is imperative that Malawi transition and shift to the new treatment regimen. The full transition is planned to start in October 2019 for both adult and pediatrics.  The total estimated gap is US$ 7,144,985.\nb. Program scale-up: In February 2019 the quantification was revised to reflect current program realities.  As of 31 December 2018, the country had surpassed the original target (755,967 patients alive and on ART), reaching 805,000 patients. The program expects to put 128,000 more patients on treatment by 31 December 2020 (total of 928,000 patients alive and on ART compared to original target). As a result, the gap is estimated at US$ 12,356,242.  The ARV gap is for 2020, for which, orders must be made in January 2020 at the latest (grant revision in October 2019) to ensure full transition of all patients and avoid any treatment disruption.","High","-","Amount validated and description updated by CT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa","2020-12-31"]
["CT Myanmar","Myanmar","PAI-5098","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","The additional investment will support the program to reach more target population.",4795917,null,"Active","a6Q1R000000AJJg",3816363,0,0,0,979554,0,null,null,"The additional investment will support the program to reach more target population.","High","Based on the Optima conclusions that ?even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up?",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia"]
["CT Multicountry HIAS AFAIDS","Multicountry South-Eastern Asia AFAO","PAI-5004","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 188 for Papua New Guinea for year 2 second round grants",119652.38,null,"Active","a6Q1R000000AJIA",0,0,0,0,119652.38,0,null,null,"Additional amount to add to Within Allocation Budget Line 188 for Papua New Guinea for year 2 second round grants","High",null,"NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2021-12-31"]
["CT Multicountry HIAS AFAIDS","Multicountry South-Eastern Asia AFAO","PAI-4999","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 183 for Bhutan for year 2 second round grants",119652.38,null,"Active","a6Q1R000000AJI5",0,0,0,0,119652.38,0,null,null,"Additional amount to add to Within Allocation Budget Line 183 for Bhutan for year 2 second round grants","High",null,"NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2021-12-31"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4874","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Expansion of the national reference laboratory NRL and the development of new sub-laboratories",56110,null,"Active","a6Q1R000000AJG4",0,0,0,0,56110,0,null,null,"Expansion of the national reference laboratory NRL and the development of new sub-laboratories","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Multicountry MENA MER","Multicountry Middle East MER","PAI-4870","MCI-00008","TB care and prevention","MCI-00128","Prevention","Development of IEC materials in different languages of the migrants countries and coordination with relevant embassies to address the language barrier and deliver educational messages on TB among migrant workers in the industrial zones in Jordan",19639,null,"Active","a6Q1R000000AJG0",0,0,0,0,19639,0,null,null,"Development of IEC materials in different languages of the migrants countries and coordination with relevant embassies to address the language barrier and deliver educational messages on TB among migrant workers in the industrial zones in Jordan","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Middle East and North Africa"]
["CT Morocco","Morocco","PAI-4762","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Regional NSP workshop; NSP review; production of national reports; situational study on disabled people?s vulnerability to HIV and STIs; socioeconomic study on PLHIV, SWs, MSM and people who inject drugs; annual program and financial audits of NSP implementation; supervision of ?above allocation? activities; qualitative situational study on the vulnerability of street children; procurement of equipment and IT services for health centers and community centers.",128743.13,null,"Active","a6Q1R000000AJEG",0,0,0,0,128743.13,0,null,null,"Regional NSP workshop; NSP review; production of national reports; situational study on disabled people?s vulnerability to HIV and STIs; socioeconomic study on PLHIV, SWs, MSM and people who inject drugs; annual program and financial audits of NSP implementation; supervision of ?above allocation? activities; qualitative situational study on the vulnerability of street children; procurement of equipment and IT services for health centers and community centers.","High","While some of these activities are important (regular program reviews, key populations qualitative situational vulnerability studies), this request includes equipment & IT procurement which are not considered to be quality demand.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Analysis, evaluations, review and transparency","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5874","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Demonstration studies are underway. Findings will inform scale up plan. Funding within allocated amount will be used to coordinate development of a national guidelines and a scale up plan for PreP and Self-testing. This request is expected to support scale up of PrEP and self-testing for MSM, FSW, PWIDs and discordant couples.",2000000,null,"Active","a6Q1R000000AJWC",0,0,0,0,2000000,0,null,null,"Demonstration studies are underway. Findings will inform scale up plan. Funding within allocated amount will be used to coordinate development of a national guidelines and a scale up plan for PreP and Self-testing. This request is expected to support scale up of PrEP and self-testing for MSM, FSW, PWIDs and discordant couples.","High","Demonstration studies are underway. Findings will inform scale up plan. Funding within the allocation amount will be used to coordinate development of a national guidelines and a scale up plan for PreP and Self-testing. This request is expected to support scale up of PrEP and self-testing for men having sex with men, female sex workers, people who inject drugs and discordant couples.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Scale Preexposure prophylaxis m (PrEP) and HIV self-testing among men who have sex with men, people who inject drugs and female sex workers into two regions based on the findings from demonstration sites to be done by PEPFAR in 2017-2018","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Tanzania (United Republic)","Tanzania (United Republic)","PAI-5873","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Low level priority. The scale up of GeneXpert should be done according to the WHO recommendations. The country plan to include outreach mobile screening units in the 25 targeted regions and extra 552 iLED microscopes and associated reagents will be procured to improve quality of the TB diagnostic network in the lower health facilities.",10874531,null,"Inactive","a6Q1R000000AJWB",182105,10692426,0,0,0,1,null,null,"Low level priority. The scale up of GeneXpert should be done according to the WHO recommendations. The country plan to include outreach mobile screening units in the 25 targeted regions and extra 552 iLED microscopes and associated reagents will be procured to improve quality of the TB diagnostic network in the lower health facilities.","Low","Low level priority. The scale up of GeneXpert should be done according to the WHO recommendations. The country plan to include outreach mobile screening units in the 25 targeted regions and extra 552 iLED microscopes and associated reagents will be procured to improve quality of the TB diagnostic network in the lower health facilities",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Thailand","Thailand","PAI-5784","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","DDC BL 356-357M&E and PCM coordinator 13 staffs  (Full time ) in order to implement follow to BATS activitiesat 13 ODPCs and Severance payment.",276476,null,"Active","a6Q1R000000AJUk",0,0,0,0,276476,0,null,null,"DDC BL 356-357M&E and PCM coordinator 13 staffs  (Full time ) in order to implement follow to BATS activitiesat 13 ODPCs and Severance payment.","Low","The TRP considers the activity to support an M&E and PCM coordinator 13 staff (Full time) in order to implement follow-on to BATS activities at 13 ODPCs and Severance payment to be a low priority to be supported through domestic resources","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Zanzibar","Zanzibar","PAI-6024","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","The intervention will fund treatment of opportunistic infections, toxicity monitoring and home-based care interventions in view of maintaining safety and efficacy of ART and improve survival and overall impact of ART scale up.",1029107,null,"Active","a6Q1R000000AJYc",0,0,0,0,1029107,0,null,null,"The intervention will fund treatment of opportunistic infections, toxicity monitoring and home-based care interventions in view of maintaining safety and efficacy of ART and improve survival and overall impact of ART scale up.","High","Treatment of opportunistic infections, toxicity monitoring and home-based care interventions are highly valuable interventions for maintaining safety and efficacy of ART and will improve survival and overall impact of ART scale up.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2","2020-12-31"]
["CT Chad","Chad","PAI-5717","MCI-00004","Prevention programs for other vulnerable populations","MCI-00103","HIV testing services for other vulnerable populations","Voluntary counseling and testing (VCT) for HIV: - Differentiated screening: with the aid of the task delegation standards, the peer educators will be trained to screen their peers during advocacy sessions on the islands and islets. The first screening sessions will be carried out under the supervision of a health worker. If a person tests positive for HIV, the peer educator will refer him/her to a health-care center for confirmation and treatment using a referral sheet. He/she will then be made aware of family screening. Having tested positive, he/she will be given repeat supplies by the association or health center on which he/she depends. Actions to be carried out: i) advocacy, ii) HIV screening, iii) training, iv) availability of screening kits, v) waste management (peer educators will be given safety boxes to collect waste and transport it to the reporting health center for destruction) and vi) reporting of cases to the health-care center.- Advanced strategy screening: Advocacy and screening teams will be composed as follows: 1 peer educator, 1 nurse, 1 midwife and 1 community leader. Advocacy activities and TB and HIV screening for the island populations will be carried out by the teams, which will each complete a day-long visit to cover 1,000 people per quarter. ii) Percentage of the island population who have had a HIV test and know the results during the reporting period.Country targets: 14% (32,200/230,000) in 2019; 17% (39,387/238,084) in 2020; 19% (47,397/246,494) in 2021. All of these targets are assigned to the Global Fund.",348461.12,null,"Active","a6Q1R000000AJTf",0,0,0,0,348461.12,0,null,null,"Voluntary counseling and testing (VCT) for HIV: - Differentiated screening: with the aid of the task delegation standards, the peer educators will be trained to screen their peers during advocacy sessions on the islands and islets. The first screening sessions will be carried out under the supervision of a health worker. If a person tests positive for HIV, the peer educator will refer him/her to a health-care center for confirmation and treatment using a referral sheet. He/she will then be made aware of family screening. Having tested positive, he/she will be given repeat supplies by the association or health center on which he/she depends. Actions to be carried out: i) advocacy, ii) HIV screening, iii) training, iv) availability of screening kits, v) waste management (peer educators will be given safety boxes to collect waste and transport it to the reporting health center for destruction) and vi) reporting of cases to the health-care center.- Advanced strategy screening: Advocacy and screening teams will be composed as follows: 1 peer educator, 1 nurse, 1 midwife and 1 community leader. Advocacy activities and TB and HIV screening for the island populations will be carried out by the teams, which will each complete a day-long visit to cover 1,000 people per quarter. ii) Percentage of the island population who have had a HIV test and know the results during the reporting period.Country targets: 14% (32,200/230,000) in 2019; 17% (39,387/238,084) in 2020; 19% (47,397/246,494) in 2021. All of these targets are assigned to the Global Fund.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Central Africa"]
["CT Chad","Chad","PAI-5716","MCI-00004","Prevention programs for other vulnerable populations","MCI-00102","Male and female condoms for other vulnerable populations","The justification for the selection of this intervention is the same as that described above. The plan is to provide a box of 144 condoms per person receiving advocacy.\nCountry targets: 14% (33,120/230,000) in 2019; 16% (36,925/238,084) in 2020; 16% (40,024/246,494) in 2021. All of these targets are assigned to the Global Fund.",851056.41,null,"Active","a6Q1R000000AJTe",0,0,0,0,851056.41,0,null,null,"The justification for the selection of this intervention is the same as that described above. The plan is to provide a box of 144 condoms per person receiving advocacy.\nCountry targets: 14% (33,120/230,000) in 2019; 16% (36,925/238,084) in 2020; 16% (40,024/246,494) in 2021. All of these targets are assigned to the Global Fund.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Central Africa"]
["CT Chad","Chad","PAI-5711","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","This sum will be needed by the stakeholders involved in implementation for the administrative management of the interventions for the island populations, equating to 7% of the total amount for the interventions.",155677.07999999999,null,"Active","a6Q1R000000AJTZ",0,0,0,0,155677.07999999999,0,null,null,"This sum will be needed by the stakeholders involved in implementation for the administrative management of the interventions for the island populations, equating to 7% of the total amount for the interventions.","Low","This refers to the administrative costs to deliver associated interventions for the Lac region. While these are deemed high priority interventions, the administrative costs associated should be ideally found through realizing efficiencies within the budgets themselves.","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Central Africa"]
["CT Serbia","Serbia","PAI-5609","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","This amount includes coverage with preventive package of  additional 7% of CSW (from existing gap). 8 people in 2019;19 people in 2020 and 52 people in 2021",11993.04,null,"Active","a6Q1R000000AJRv",0,0,0,0,11993.04,0,null,null,"This amount includes coverage with preventive package of  additional 7% of CSW (from existing gap). 8 people in 2019;19 people in 2020 and 52 people in 2021","High","Expansion of services to reach more sex workers and\ntheir clients is essential for improving the impact of the\ninterventions on the epidemic in Serbia.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2022-06-30"]
["CT Belize","Belize","PAI-3900","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","HIV testing will be provided by a Civil Society Organisation (CSO) through the CSO Hub.  This activity will fund stipends of peer educators to reach more hard-to-reach Men who have sex with Men (MSM) and transgender people (TG) for testing. The activity will also include support for staff members conducting testing.",40000,null,"Active","a6Q1R000000AJ0M",0,0,0,0,40000,0,null,null,"HIV testing will be provided by a Civil Society Organisation (CSO) through the CSO Hub.  This activity will fund stipends of peer educators to reach more hard-to-reach Men who have sex with Men (MSM) and transgender people (TG) for testing. The activity will also include support for staff members conducting testing.","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Belize","Belize","PAI-3899","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Mini grants of USD 5,000 each for Civil Society Organisations (CSO) to build their capacity to be sustainable beyond the Global Fund. This could include strategic sustainability planning, social networking advocacy and negotiation, non-traditional income generation, developing proposals for external funding and any other activity or progamme that would contribute to their sustainability beyond 2021.",50000,null,"Active","a6Q1R000000AJ0L",0,0,0,0,50000,0,null,null,"Mini grants of USD 5,000 each for Civil Society Organisations (CSO) to build their capacity to be sustainable beyond the Global Fund. This could include strategic sustainability planning, social networking advocacy and negotiation, non-traditional income generation, developing proposals for external funding and any other activity or progamme that would contribute to their sustainability beyond 2021.","High","The TRP considers this intervention highly relevant to prevent stock-out of medication and recommends that this intervention should be moved into within the allocation request.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Burkina Faso","Burkina Faso","PAI-3836","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Holding a workshop to approve the training modules for community RSSH counsellors.",4950.0600000000004,null,"Active","a6Q1R000000AIzK",0,0,0,0,4950.0600000000004,0,null,null,"Holding a workshop to approve the training modules for community RSSH counsellors.","Medium","The activity includes holding a workshop to approve the training modules for community RSSH counsellors. It should be part of the previous activity related to reviewing the training module","amount is against different module/intervention in application. UQD description matches the amount line and needs to be validated definitely Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Africa 1","2020-12-31"]
["CT Benin","Benin","PAI-3762","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:\n(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)\nThe residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.",126598.59,null,"Active","a6Q1R000000AIy8",0,0,0,0,126598.59,0,null,null,"Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:\n(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)\nThe residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.","High","Well quantified and targets clearly outlined. This is a last mile intervention to enhance efforts towards elimination of MTCT and merits higher priority rating","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4630","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Men who have Sex with Men (MSM).\nProlonging the working hours of outreach workers will allow for a greater reach and will offer HIV and syphilis testing to MSM. \nExpected outcome:  additional 438 MSM reached with defined package of services",45000,null,"Inactive","a6Q1R000000AJC8",0,45000,0,0,0,1,null,null,"Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Men who have Sex with Men (MSM).\nProlonging the working hours of outreach workers will allow for a greater reach and will offer HIV and syphilis testing to MSM. \nExpected outcome:  additional 438 MSM reached with defined package of services","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4629","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Co-infection with HCV is a significant contributor to morbidity and mortality among PLHIV. Request for HCV testing and treatment for 262 cases is included within the allocation request. Above allocation funding is requested for drugs, commodities and PSM to provide treatment to a further 261 in 2019 and 262 in 2020 PLHIV with chronic HCV co-infection (F3-F4) to cover all estimated need and to reduce mortality and morbidity among PLHIV in Cambodia. The TRP ranked this activity as low priority but also considers that this activity cannot be funded using Global Fund funding as the conditions of the Global Fund policy on this subject are not met. See link https://www.theglobalfund.org/media/41 67/bm33_11-co-infectionsandcomorbidities_report_en.pdf",329505,null,"Active","a6Q1R000000AJC7",0,0,0,0,329505,0,null,null,"Co-infection with HCV is a significant contributor to morbidity and mortality among PLHIV. Request for HCV testing and treatment for 262 cases is included within the allocation request. Above allocation funding is requested for drugs, commodities and PSM to provide treatment to a further 261 in 2019 and 262 in 2020 PLHIV with chronic HCV co-infection (F3-F4) to cover all estimated need and to reduce mortality and morbidity among PLHIV in Cambodia. The TRP ranked this activity as low priority but also considers that this activity cannot be funded using Global Fund funding as the conditions of the Global Fund policy on this subject are not met. See link https://www.theglobalfund.org/media/41 67/bm33_11-co-infectionsandcomorbidities_report_en.pdf","Low","The TRP ranked this activity as low priority but also considers that this activity cannot be funded using Global Fund funding as the conditions of the Global Fund policy on this subject are not met. See link https://www.theglobalfund.org/media/41 67/bm33_11-co-infectionsandcomorbidities_report_en.pdf","NA Original Intervention: Management of HIV-HCV co-infection","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4624","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To support NASA 2020.",60000,null,"Active","a6Q1R000000AJC2",0,0,0,0,60000,0,null,null,"To support NASA 2020.","Low","The TRP considers this low priority as the applicant can mobilize other sources of funding to cover the need, for example, the proposed request may likely be covered with PEPFAR support in 2018.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: National AIDS spending accounts","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4605","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Funding to support the operation and maintenance (recurrent cost) of a new Osh lab expected to be installed in Osh in 2019, with support from USAID Challenge TB project",148305,null,"Active","a6Q1R000000AJBj",0,0,0,0,148305,0,null,null,"Funding to support the operation and maintenance (recurrent cost) of a new Osh lab expected to be installed in Osh in 2019, with support from USAID Challenge TB project","Low","The TRP notes that the applicant\nintends to support operation and\nmaintenance of a laboratory at Osh to be funded by USAID and\nconstitutes recurrent costs for the\nlaboratory. The TRP considered that these recurrent costs had a lower priority than items included in the PAAR for MDR-TB above, which were categorized as Medium priority. Additionally, the TRP recommends consideration of\nintegration of laboratory operations, facilities and maintenance management wherever feasible to reduce duplicative infrastructure and\noperations.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Eastern Europe and Central Asia"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4600","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","Similarly, to interventions for PWID, this amount  is to recruit additional outreach workers to cover gaps for human resources for health (reduce the HRH gap for outreach workers by 10 percent) to enable the\napplicant to reach a coverage target of 80 percent of sex workers by 2020. This cadre of workers will provide various services including HIV testing and counselling and adherence support.",123075,null,"Active","a6Q1R000000AJBe",0,0,0,0,123075,0,null,null,"Similarly, to interventions for PWID, this amount  is to recruit additional outreach workers to cover gaps for human resources for health (reduce the HRH gap for outreach workers by 10 percent) to enable the\napplicant to reach a coverage target of 80 percent of sex workers by 2020. This cadre of workers will provide various services including HIV testing and counselling and adherence support.","High","The TRP notes that the applicant\nintends to recruit additional outreach workers to cover HRH gaps (reduce the HRH gap for outreach workers by 10 percent) to enable the applicant to reach a coverage target of 80 percent of sex workers by 2020. This cadre of workers will provide various services including HIV testing and counselling and adherence support. While the TRP\nrecognises the importance of this\ncadre of healthcare workers, the\nTRP strongly recommends that\ncareful consideration be given to the sustainability of these healthcare workers in terms of payment of salaries and incentives.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Eastern Europe and Central Asia"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4599","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Development of GX Alert system nationwide to expedite the availability of GeneXpert results for clinicians",35176,null,"Active","a6Q1R000000AJBd",0,0,0,0,35176,0,null,null,"Development of GX Alert system nationwide to expedite the availability of GeneXpert results for clinicians","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Eastern Europe and Central Asia"]
["CT Kenya","Kenya","PAI-4588","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","This above allocation funding (UQD) aims to expand the Field Epidemiology and Laboratory Training Programme (FELTP) that has been instrumental in building high level capacity for epidemiology and laboratory science whose graduates largely support the HIV, TB and Malaria programmes. The scope has been limited by the available resources from the Centres for Disease Control yet there is a greater need. In order to expand access to this program to county HIV and TB coordinators, this above allocation funding is proposed to meet this gap.",1032896,null,"Active","a6Q1R000000AJBS",392100,0,0,0,640796,0,null,null,"This above allocation funding (UQD) aims to expand the Field Epidemiology and Laboratory Training Programme (FELTP) that has been instrumental in building high level capacity for epidemiology and laboratory science whose graduates largely support the HIV, TB and Malaria programmes. The scope has been limited by the available resources from the Centres for Disease Control yet there is a greater need. In order to expand access to this program to county HIV and TB coordinators, this above allocation funding is proposed to meet this gap.","High","To expand the Field Epidemiology and Laboratory Training Programme (FELTP) to county HIV and TB coordinators.","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Kenya","Kenya","PAI-4581","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","This funding (above allocation UQD) aims to support expansion of the sample transport network by supporting courier services to every peripheral site and networking peripheral sites to gene xpert sites. In addition it is planned to procure triple packaging containers; 2 for every TB treatment and gene xpert site for transport of samples to the xpert site or the Tb reference lab.",3755038,null,"Inactive","a6Q1R000000AJBL",3755038,0,0,0,0,1,null,null,"This funding (above allocation UQD) aims to support expansion of the sample transport network by supporting courier services to every peripheral site and networking peripheral sites to gene xpert sites. In addition it is planned to procure triple packaging containers; 2 for every TB treatment and gene xpert site for transport of samples to the xpert site or the Tb reference lab.","High","These interventions improve access of Universal DST, additional GeneXpert machines and cartridges, as well as mechanisms for sputum transport.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Jamaica","Jamaica","PAI-4566","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Cross training of service providers in psychosocial support and motivational interviewing to improve adherence and retention outcomes.",250000,null,"Active","a6Q1R000000AJB6",0,0,0,0,250000,0,null,null,"Cross training of service providers in psychosocial support and motivational interviewing to improve adherence and retention outcomes.","Medium",null,"NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Jamaica","Jamaica","PAI-4565","MCI-00534","Comprehensive prevention programs for MSM","MCI-00540","Pre-exposure prophylaxis (PrEP) for MSM","Based on the Pilot of PrEP being supported under the allocation, scale-up to provide for at least 1500 additional MSM on PrEP by project end.",350000,null,"Active","a6Q1R000000AJB5",177704,0,0,0,172296,0,null,null,"Based on the Pilot of PrEP being supported under the allocation, scale-up to provide for at least 1500 additional MSM on PrEP by project end.","Medium",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre-exposure prophylaxis (PrEP) for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Jamaica","Jamaica","PAI-4560","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00088","Condoms and lubricant programming for sex workers","Develop and roll out campaigns to glamorize condom use to target KPs to improve condom uptake and reduce risk  especially among sex workers (SW) and clients to improve  improve condom use and reduce risk for HIV.",100000,null,"Active","a6Q1R000000AJB0",0,0,0,0,100000,0,null,null,"Develop and roll out campaigns to glamorize condom use to target KPs to improve condom uptake and reduce risk  especially among sex workers (SW) and clients to improve  improve condom use and reduce risk for HIV.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Jamaica","Jamaica","PAI-4555","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","Review and update National Health Information System and E-Health Strategic Plan 2014-2018.",35000,null,"Active","a6Q1R000000AJAv",0,0,0,0,35000,0,null,null,"Review and update National Health Information System and E-Health Strategic Plan 2014-2018.","Medium",null,"NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Indonesia","Indonesia","PAI-4511","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Piloting Rifapentin (3HP) for LTBI in 2 hospitals in 5 provinces for 200 children in 2018, then gradually increase 5 provinces per year. The distribution of healthy life style education materials will facilitate TB prevention in community based.",395356,null,"Active","a6Q1R000000AJAD",0,0,0,0,395356,0,null,null,"Piloting Rifapentin (3HP) for LTBI in 2 hospitals in 5 provinces for 200 children in 2018, then gradually increase 5 provinces per year. The distribution of healthy life style education materials will facilitate TB prevention in community based.","Medium","Treatment regimens for latent TB infection(LTBI) treatment for children","NA Original Intervention: Key populations (TB care and prevention) ? Others","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Indonesia","Indonesia","PAI-4510","MCI-00023","Program management","MCI-00207","Grant management","Cover 72 and 81 priority districts in 2019 and 2020 as addition to the 271 districts covered by allocation. The additional data officer and financial assistant will strengthen the monitoring of the districts.",1886633,null,"Active","a6Q1R000000AJAC",0,0,0,0,1886633,0,null,null,"Cover 72 and 81 priority districts in 2019 and 2020 as addition to the 271 districts covered by allocation. The additional data officer and financial assistant will strengthen the monitoring of the districts.","Medium","Will contribute to improved programme management and monitoring at district level.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Burundi","Burundi","PAI-3716","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Former activity n ° 63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validated\nBurundi has a total of 11 prisons with infirmary.\nWith the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.",10463,null,"Active","a6Q1R000000AIxO",0,0,0,0,10463,0,null,null,"Former activity n ° 63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validated\nBurundi has a total of 11 prisons with infirmary.\nWith the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.","High",null,"NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3679","MCI-00023","Program management","MCI-00207","Grant management","Activity: Pay the performance bonuses of the PNLS:\nThis is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.",238919,null,"Active","a6Q1R000000AIwn",0,0,0,0,238919,0,null,null,"Activity: Pay the performance bonuses of the PNLS:\nThis is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.","Medium",null,"NA Original Module: RSSH: Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Azerbaijan","Azerbaijan","PAI-3647","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","Participation in training courses and conferences in various aspects of TB control including of TB control in prisons, for knowledge update and experience exchange",42000,null,"Active","a6Q1R000000AIwH",0,0,0,0,42000,0,null,null,"Participation in training courses and conferences in various aspects of TB control including of TB control in prisons, for knowledge update and experience exchange","Medium","This intervention includes participation in international training courses and conferences on various aspects of TB control, including of TB control in prisons, for knowledge update and experience exchange. This is important for local capacity building; however, considering other needs, the TRP considers this intervention of medium importance","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Azerbaijan","Azerbaijan","PAI-3642","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00174","Capacity building for health workers, including those at community level","1. Training for community health workers on ARV treatment.\n2. Participation in trainings, international conferences for Republican AIDS Centre, MoJ staff and NGOs in priority issues of HIV/AIDS.",97684,null,"Active","a6Q1R000000AIwC",0,0,0,0,97684,0,null,null,"1. Training for community health workers on ARV treatment.\n2. Participation in trainings, international conferences for Republican AIDS Centre, MoJ staff and NGOs in priority issues of HIV/AIDS.","High","Given the need to decentralize services for improved access, the role of community health workers is critical. The TRP considers this intervention as high quality demand.","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-06-30"]
["CT Angola","Angola","PAI-3570","MCI-00008","TB care and prevention","MCI-00128","Prevention","PAAR application will support procurement  INH for IPT among eligible  PLHIV and children of contacts with TB patients who test negative for TB screening in years 2019, 2020 and 2021. (see TB/HIV collaboration). Expected outcome will reduction in TB incidence.",536058,null,"Active","a6Q1R000000AIv2",0,0,0,0,536058,0,null,null,"PAAR application will support procurement  INH for IPT among eligible  PLHIV and children of contacts with TB patients who test negative for TB screening in years 2019, 2020 and 2021. (see TB/HIV collaboration). Expected outcome will reduction in TB incidence.","High","It addresses a specific need for latent tuberculosis infection (LTBI) treatment in a program that has not yet reported any LTBI treatment.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Angola","Angola","PAI-3565","MCI-00071","Other module","MCI-00071","Other module","In order to ensure epidemiological surveillance, monitoring and evaluation of malaria activities are implemented at the operational level (provincial, municipal, health and community units), particularly in the regions of the country where the Multiple Indicators and Health Survey IIMS 2015/16 showed a high prevalence of malaria, , an amount for the payment of salaries of 6 OPPMs for the last year of the 2018-2021 grant is requested in the above allocation. It should be noted that the number of OPPMs was 18 in the current GF 2016-2017 grant, and will be reduced to 6 in be financed under the first 2 years of the FG 2018-2021 grant. The annual salary of each OPPM is USD 47,994.48 and the annual cost of the 6 OPPMs for the last year of the grant is USD 287,966.88. The provincial focal points are to maintain active epidemiological surveillance in these high prevalence provinces to mitigate the emergence of possible malaria epidemics and thereby have quality data and evidence to allow for better quantification and programming of resources.",287967,null,"Active","a6Q1R000000AIux",0,0,0,0,287967,0,null,null,"In order to ensure epidemiological surveillance, monitoring and evaluation of malaria activities are implemented at the operational level (provincial, municipal, health and community units), particularly in the regions of the country where the Multiple Indicators and Health Survey IIMS 2015/16 showed a high prevalence of malaria, , an amount for the payment of salaries of 6 OPPMs for the last year of the 2018-2021 grant is requested in the above allocation. It should be noted that the number of OPPMs was 18 in the current GF 2016-2017 grant, and will be reduced to 6 in be financed under the first 2 years of the FG 2018-2021 grant. The annual salary of each OPPM is USD 47,994.48 and the annual cost of the 6 OPPMs for the last year of the grant is USD 287,966.88. The provincial focal points are to maintain active epidemiological surveillance in these high prevalence provinces to mitigate the emergence of possible malaria epidemics and thereby have quality data and evidence to allow for better quantification and programming of resources.","Low","While M&E is an important area requiring further investment for the program to function effectively, these salaries are a high cost investment in comparison to other areas of pressing need.","NA Original Module: RSSH. Original Intervention: RSSH: Health management information systems and Monitoring and Evaluation (M&E)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-06-30"]
["CT Congo","Congo","PAI-4053","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Conduct 6 training/refresher training sessions lasting 3 days at the 4 centers on co-infection management (25 participants: 2 sessions in year 1, 2 sessions in year 2 and 2 sessions in year 3).",7992.37,null,"Active","a6Q1R000000AJ2p",0,0,0,0,7992.37,0,null,null,"Conduct 6 training/refresher training sessions lasting 3 days at the 4 centers on co-infection management (25 participants: 2 sessions in year 1, 2 sessions in year 2 and 2 sessions in year 3).","High","This activity will enhance the capacity of staff in the integrated TB/HIV centers","NA Original Intervention: Improvement in treatment for TB/HIV cases and simplified care continuum (one-stop center)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Congo","Congo","PAI-4052","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Provide 3-day training/refresher training sessions to 25 members of associations of cured TB patients and NGOs/liaison workers on community DOTS.",19163.650000000001,null,"Active","a6Q1R000000AJ2o",0,0,0,0,19163.650000000001,0,null,null,"Provide 3-day training/refresher training sessions to 25 members of associations of cured TB patients and NGOs/liaison workers on community DOTS.","High","The high rate of loss to follow up for TB patients requires greater involvement of the community in TB care and treatment. This activity will raise awareness of TB and train community workers","NA Original Intervention: Improve communitybased treatment of TB by training community workers and leaders","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4008","MCI-00008","TB care and prevention","MCI-00128","Prevention","Prevention: TV and radio adverts and billboard posters in large cities This investment will cover general population prevention activities (mass communication) in an effort to improve disease prevention knowledge and practices.",1731060,null,"Active","a6Q1R000000AJ26",0,0,0,0,1731060,0,null,null,"Prevention: TV and radio adverts and billboard posters in large cities This investment will cover general population prevention activities (mass communication) in an effort to improve disease prevention knowledge and practices.","Low","Public reach with TB/HIV information through radio and posters is not considered of high impact",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4003","MCI-00009","TB/HIV","MCI-00135","Engaging all care providers (TB/HIV)","Involvement of churches, CBOs and civil society This investment will be used to improve case-finding by involving churches, CBOs and civil society, through the following activities: - Organize 729 awareness-raising sessions for church, CBO and civil society leaders, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one meeting per year per HZ). - Deliver training to church, CBO and civil society members, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one training session per year per HZ): four people per HZ per year. Total 972 per year, one day, 2,916 over three years. - Buy 2,916 education and awareness-raising kits for each trained member.",368874,null,"Active","a6Q1R000000AJ21",0,0,0,0,368874,0,null,null,"Involvement of churches, CBOs and civil society This investment will be used to improve case-finding by involving churches, CBOs and civil society, through the following activities: - Organize 729 awareness-raising sessions for church, CBO and civil society leaders, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one meeting per year per HZ). - Deliver training to church, CBO and civil society members, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one training session per year per HZ): four people per HZ per year. Total 972 per year, one day, 2,916 over three years. - Buy 2,916 education and awareness-raising kits for each trained member.","High","High need / High impact",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Cameroon","Cameroon","PAI-3979","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","This would be used to fund various studies and evaluations, including updated mapping of key and vulnerable populations, and the midterm review of the NSP. It would also be used to fund the development of a monitoring and evaluation plan for the HIV NSP.",556386.49,null,"Active","a6Q1R000000AJ1d",0,0,0,0,556386.49,0,null,null,"This would be used to fund various studies and evaluations, including updated mapping of key and vulnerable populations, and the midterm review of the NSP. It would also be used to fund the development of a monitoring and evaluation plan for the HIV NSP.","Medium","Mid-term review would be important to make course corrections in the national response. However, there is little details as to the role of ?various studies and evaluations?. Determining the purpose of these studies, establishing their relative priority and the funding amount should be adjusted upon presentation of these details","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Cameroon","Cameroon","PAI-3978","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","This  would  be  used  to  fund  training  for  some  of  the  peer educators   for  people   who inject drugs,  and  to   develop additional  BCC  activities  (educational  talks,  conferences, etc.).",95945.46,null,"Active","a6Q1R000000AJ1c",0,0,0,0,95945.46,0,null,null,"This  would  be  used  to  fund  training  for  some  of  the  peer educators   for  people   who inject drugs,  and  to   develop additional  BCC  activities  (educational  talks,  conferences, etc.).","Medium","Since the size of the people who inject drugs is not known and is likely to be very small, and there is an overlap between the categories of people who use drugs with the other categories (men who have sex with men, sex workers). Note: only half of the requested amount has been recommended since there is a matching fund request already covering the module.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Djibouti","Djibouti","PAI-4151","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Associated to the procurement of 20 microscopes for selected health facilities under the RTTR strategy framework.",3899,null,"Active","a6Q1R000000AJ4P",0,0,0,0,3899,0,null,null,"Associated to the procurement of 20 microscopes for selected health facilities under the RTTR strategy framework.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Belize","Belize","PAI-3897","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","Develop an electronic information system to track demand and supply of medicines and commodities at the facility level. This is a key component of the roadmap for Treat All to ensure that challenges presently experienced with stock outs are minimized.",30000,null,"Active","a6Q1R000000AJ0J",0,0,0,0,30000,0,null,null,"Develop an electronic information system to track demand and supply of medicines and commodities at the facility level. This is a key component of the roadmap for Treat All to ensure that challenges presently experienced with stock outs are minimized.","High","The TRP considers this intervention highly relevant to prevent stock-out of medication and recommends that this intervention should be moved into within the allocation request.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Other procurement and supply chain management intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Burkina Faso","Burkina Faso","PAI-3832","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00572","Other intervention(s) for people in prisons and other closed settings","Equip infirmaries in 7 detention centers. 14 have been already equipped with Rd 10 and NFM.",51503.76,null,"Active","a6Q1R000000AIzG",0,0,0,0,51503.76,0,null,null,"Equip infirmaries in 7 detention centers. 14 have been already equipped with Rd 10 and NFM.","High","It addresses concerns raised by the TRP related to prioritization of key populations and provide additional detail for differentiated strategies for key populations and may address the sharp decrease in coverage targets for prisoners observed in recent years.","NA Original Intervention: Other interventions for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Africa 1","2020-12-31"]
["CT Benin","Benin","PAI-3830","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Objective: to conduct an evaluation of the catastrophic costs borne by the patients and their households, for the introduction of appropriate measures (WHO protocol: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/ meetings/tf6_background_5a_patient_cost_surveys_protocol.pdf).",61537.43,null,"Active","a6Q1R000000AIzE",0,0,0,0,61537.43,0,null,null,"Objective: to conduct an evaluation of the catastrophic costs borne by the patients and their households, for the introduction of appropriate measures (WHO protocol: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/ meetings/tf6_background_5a_patient_cost_surveys_protocol.pdf).","High","Survey on evaluation of catastrophic costs borne by TB patients and their households can inform on how to address the financial barriers to care.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Benin","Benin","PAI-3756","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV.",121722.59,null,"Active","a6Q1R000000AIy2",0,0,0,0,121722.59,0,null,null,"These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV.","High","Substantial resources allocated to procurement and distribution of nutritional kits as a psychosocial support measure. Evidence of the utility of nutritional kits is better for children than general adult populations on ART especially in a test and treat approach to ART. The TRP is also concerned about the sustainability of this measure in the long term as cessation of these programs could affect long-term adherence. The TRP requests to clarify how suitable this intervention is in the epidemic context of Benin and whether this is sustainable in the long run. This explains the medium priority rating The remaining funds for costs related to Beninese Network of Associations of Persons living with HIV (ReBAP+) and key populations psychosocial training, medical ethics and human rights refresher trainings are maintained as high priorities.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4615","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Vitamin B6 is part of the MDR TB regimen but it  cannot be procured with domestic funding as it is not available in local market in mono doses (not combined with other vitamins). The MoH and NTP have initiated a process to establish mechanisms of drug?s procurement through international suppliers. However, the process may need long time for agreement and approval.",44009,null,"Active","a6Q1R000000AJBt",0,0,0,0,44009,0,null,null,"Vitamin B6 is part of the MDR TB regimen but it  cannot be procured with domestic funding as it is not available in local market in mono doses (not combined with other vitamins). The MoH and NTP have initiated a process to establish mechanisms of drug?s procurement through international suppliers. However, the process may need long time for agreement and approval.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Eastern Europe and Central Asia"]
["CT Kenya","Kenya","PAI-4577","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00546","Prevention and management of coinfections and co-morbidities for sex workers","Funding within allocation and catalytic funding is supporting interventions reaching 35,000 sex workers with a package of services including behaviour change, condoms, HTS, linkage to ART and STI screening. This above allocation funding (UQD) will support interventions to reach the same target with management of co-infections, specifically hepatitis B screening and vaccination.",9420921,null,"Active","a6Q1R000000AJBH",0,0,0,0,9420921,0,null,null,"Funding within allocation and catalytic funding is supporting interventions reaching 35,000 sex workers with a package of services including behaviour change, condoms, HTS, linkage to ART and STI screening. This above allocation funding (UQD) will support interventions to reach the same target with management of co-infections, specifically hepatitis B screening and vaccination.","Medium","Reaching 35,000 FSW with management of co -infections, specifically hepatitis B screening and vaccination.","NA Original Intervention: Prevention and management of co-infections and co-morbidities for sex workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Kenya","Kenya","PAI-4576","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","This above allocation funding (UQD) will scale up the comprehensive package of services provided under allocation funding to reach 10,000 (44%) MSM in year; and 6,000 (26%) MSM in year 2 to address the total gap.   \nInterventions to be funded include: \nCommunity empowerment for MSM and their clients: US$ 304,085; Behavioral interventions for MSM and their clients: US$ 1,236,217; HIV testing services for MSM and their clients: US$ 213,126; Prevention and management of co-infections and comorbidities: US$ 3,216,415; Addressing stigma, discrimination and violence among MSM and their clients: US$ 153,541; Planning, administration and coordination: US$ 105,753.",5229137,null,"Active","a6Q1R000000AJBG",0,0,0,0,5229137,0,null,null,"This above allocation funding (UQD) will scale up the comprehensive package of services provided under allocation funding to reach 10,000 (44%) MSM in year; and 6,000 (26%) MSM in year 2 to address the total gap.   \nInterventions to be funded include: \nCommunity empowerment for MSM and their clients: US$ 304,085; Behavioral interventions for MSM and their clients: US$ 1,236,217; HIV testing services for MSM and their clients: US$ 213,126; Prevention and management of co-infections and comorbidities: US$ 3,216,415; Addressing stigma, discrimination and violence among MSM and their clients: US$ 153,541; Planning, administration and coordination: US$ 105,753.","Medium","Expansion of HIV care to MSM and their partners.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Prevention and management of co-infections and co-morbidities men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Kenya","Kenya","PAI-4571","MCI-00071","Other module","MCI-00071","Other module","The above allocation funding (UQD) aims to maintain high levels of treatmnet with quality assured ACTs in private sector and for improvemnet of malaria diagnosis, treatmnet and surveilance. Activities wil include: update of the curriculum and the guidelines to be undertaken in the next one-year. This will be followed up with training to strengthen surveillance and reporting. A total of 282 ToTs, 7960 health workers at county, sub-county and facility levels are targeted for training. Within the allocation 282 ToTs and 3050 have been budgeted for, the balance of 4910 health workers is requested in the above allocation (UQD - $1,020,164). The other request is to facilitate one Private Sector QoC survey (US$ 152,670).",1172834,null,"Inactive","a6Q1R000000AJBB",1172834,0,0,0,0,1,null,null,"The above allocation funding (UQD) aims to maintain high levels of treatmnet with quality assured ACTs in private sector and for improvemnet of malaria diagnosis, treatmnet and surveilance. Activities wil include: update of the curriculum and the guidelines to be undertaken in the next one-year. This will be followed up with training to strengthen surveillance and reporting. A total of 282 ToTs, 7960 health workers at county, sub-county and facility levels are targeted for training. Within the allocation 282 ToTs and 3050 have been budgeted for, the balance of 4910 health workers is requested in the above allocation (UQD - $1,020,164). The other request is to facilitate one Private Sector QoC survey (US$ 152,670).","High","To maintain high levels of treatment with quality assured ACTs in the private sector and critical for the improvements of malaria diagnosis, treatment, and surveillance","NA Original Module: RSSH. Original Intervention: Private sector QoC and training and surveillance","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 2","2021-06-30"]
["CT India","India","PAI-4550","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","A DRTB counselling Project has been implemented under NFM in 4 states by SR (TISS) to improve treatment outcomes in DRTB patients and reduce the 6 months attrition rate. The results have been encouraging. Continuation of the project is proposed within allocation request while PAAR will cover scale up of the intervention with additional 475 Counsellors across country. Outcome: improve treatment success rates by 50%.",8500000,null,"Active","a6Q1R000000AJAq",0,0,0,0,8500000,0,null,null,"A DRTB counselling Project has been implemented under NFM in 4 states by SR (TISS) to improve treatment outcomes in DRTB patients and reduce the 6 months attrition rate. The results have been encouraging. Continuation of the project is proposed within allocation request while PAAR will cover scale up of the intervention with additional 475 Counsellors across country. Outcome: improve treatment success rates by 50%.","Medium","MDR-TB treatment adherence support through counsellors' project","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2021-03-31"]
["CT India","India","PAI-4539","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Following the pilot of self -testing, it is important to scale up self-testing for HIV. This is being considered in 60 districts under this budget.",4500000,null,"Active","a6Q1R000000AJAf",0,0,0,0,4500000,0,null,null,"Following the pilot of self -testing, it is important to scale up self-testing for HIV. This is being considered in 60 districts under this budget.","Medium","If self -testing poilot pilot successful this should be scaled up from domestic resources",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2021-03-31"]
["CT India","India","PAI-4538","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","Following the pilot of community based testing (CBT), scale up of CBT would be the next step. It is proposed to scale up CBT to 300 high priority districts under this budget.",4500000,null,"Active","a6Q1R000000AJAe",0,0,0,0,4500000,0,null,null,"Following the pilot of community based testing (CBT), scale up of CBT would be the next step. It is proposed to scale up CBT to 300 high priority districts under this budget.","Medium","If CBT pilot successful this should be scaled up from domestic resources",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2021-03-31"]
["CT India","India","PAI-4530","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Alliance India aims to enhance the reach to prioritized PLHIV on ART to be provided with differentiated care and support services by additional 10% each in 1st year, 2nd year and 3rd year of the grant respectively. The differentiated care services provision by these additional CSCs being proposed is to ensure treatment preparedness, side effect management and treatment adherence and retention in HIV care.",4536602,null,"Active","a6Q1R000000AJAW",0,0,0,0,4536602,0,null,null,"Alliance India aims to enhance the reach to prioritized PLHIV on ART to be provided with differentiated care and support services by additional 10% each in 1st year, 2nd year and 3rd year of the grant respectively. The differentiated care services provision by these additional CSCs being proposed is to ensure treatment preparedness, side effect management and treatment adherence and retention in HIV care.","Low","This should be covered from domestic resources","NA Original Intervention: Care Support Centres (45) with effect from January 2018 onwards and additional Care and Support Centre (108) which will be phasing out from January to December 2020","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2021-03-31"]
["CT India","India","PAI-4525","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","The project team organised DRT refresher trainings under the current grant to improve the provision of PPTCT services through periphery health care providers. This facilitated to improve the overall performance of the project. The project is proposing a similar activity under the new grant.",300000,null,"Active","a6Q1R000000AJAR",0,0,0,0,300000,0,null,null,"The project team organised DRT refresher trainings under the current grant to improve the provision of PPTCT services through periphery health care providers. This facilitated to improve the overall performance of the project. The project is proposing a similar activity under the new grant.","Low","Technical assistance and capacity building for PPTCT should be covered from other resources","NA Original Module: PPTCT (Plan International India Chapter). Original Intervention: DRT ? Refresher","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2021-03-31"]
["CT Indonesia","Indonesia","PAI-4479","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","Support for 3,000 patients who lost to follow up.",2708604,null,"Active","a6Q1R000000AJ9h",1354302,0,0,0,1354302,0,null,null,"Support for 3,000 patients who lost to follow up.","High","Allow for tracking of patients on Antiretroviral Therapy (ART). Will contribute to improvements along the cascade in additional districts",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Indonesia","Indonesia","PAI-4478","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Procurement of additional buffer stock of ARVs.",2867677,null,"Inactive","a6Q1R000000AJ9g",2867677,0,0,0,0,1,null,null,"Procurement of additional buffer stock of ARVs.","High","Buffer antiretroviral (ARV). Required for the additional targets to move the country towards the trajectory of epidemic control","NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Indonesia","Indonesia","PAI-4473","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","This intervention covers Tanah Papua area, targeting general population, on top of interventions in the within allocation targeting pregnant women, TB patients and KAPs. This would target a number of 75,000 general population tested with a projected 1,725 additional persons starting treatment. The activities include trainings, mentoring session, home-based care of PLHIV, tracing of pre and in treatment list of patients by health cadres, as well as monthly coordination meetings.",2780009,null,"Inactive","a6Q1R000000AJ9b",2780009,0,0,0,0,1,null,null,"This intervention covers Tanah Papua area, targeting general population, on top of interventions in the within allocation targeting pregnant women, TB patients and KAPs. This would target a number of 75,000 general population tested with a projected 1,725 additional persons starting treatment. The activities include trainings, mentoring session, home-based care of PLHIV, tracing of pre and in treatment list of patients by health cadres, as well as monthly coordination meetings.","High","This covers Tanah Papua area. This is an important epidemic different from the rest of Indonesia. This is considered a high priority and it should be moved within the allocation when cost efficiencies are identified during grant making.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Burundi","Burundi","PAI-3670","MCI-00000","Prevention programs for general population","MCI-00080","Other intervention(s) for general population","Activity: Security stock of prevention inputs (condom and lubricating gel)\nThe 2018-2020 grant does not provide security stocks for prevention inputs.\nThis funding will allow the country to have a 4-month security stock representing 25% of annual needs. This will prevent any stockouts. For the 2018-2020 grant, the expected input quantities (male condoms, female condoms and lubricant gels) are 26,931,063; 870,979 and 29,938,622 with an aggregate amount of US $ 2,027,089.37.",225232,null,"Active","a6Q1R000000AIwe",0,0,0,0,225232,0,null,null,"Activity: Security stock of prevention inputs (condom and lubricating gel)\nThe 2018-2020 grant does not provide security stocks for prevention inputs.\nThis funding will allow the country to have a 4-month security stock representing 25% of annual needs. This will prevent any stockouts. For the 2018-2020 grant, the expected input quantities (male condoms, female condoms and lubricant gels) are 26,931,063; 870,979 and 29,938,622 with an aggregate amount of US $ 2,027,089.37.","High",null,"NA Original Intervention: Other interventions for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Azerbaijan","Azerbaijan","PAI-3637","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services (currently HIV services are only provided in Yerevan). The vision is to further expand Echo in other areas of health in collaboration with the recent Asian Development Bank (ADB) program focused on health sector policy reforms to strengthen efficient utilization of resources and to improve quality of services.",70148,null,"Active","a6Q1R000000AIw7",0,0,0,0,70148,0,null,null,"Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services (currently HIV services are only provided in Yerevan). The vision is to further expand Echo in other areas of health in collaboration with the recent Asian Development Bank (ADB) program focused on health sector policy reforms to strengthen efficient utilization of resources and to improve quality of services.","High","The TRP recommends moving this within the allocation in case efficiencies can be found during grant-making, or savings made during grant-implementation. To achieve quality service scale up and reach the suggested coverage targets for this group, a package inclusive of all the behavioral interventions should be implemented.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-06-30"]
["CT Azerbaijan","Azerbaijan","PAI-3636","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00098","OST and other drug dependence treatment for PWID","Training for service providers from OST sites.",6798,null,"Active","a6Q1R000000AIw6",0,0,0,0,6798,0,null,null,"Training for service providers from OST sites.","High","The TRP recommends moving this within the allocation in case efficiencies can be found during grant-making, or savings made during grant-implementation. The major thrust of the funding request is interventions for people who inject drugs. This intervention will increase the suggested coverage and is part of an inclusive package of all the behavioral interventions","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Eastern Europe and Central Asia","2021-06-30"]
["CT Afghanistan","Afghanistan","PAI-3560","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","To promote engagement of the large private sector, 10 Private Public Partnerships (PPPs) are being requested through the TB-RSSH Funding Request within the allocation. An additional 40 PPPs are being proposed for UQD funding to expand pilot testing and enrich the data in diverse geographical and cultural settings in 4 remaining Regions. This UQD includes renovation of selected facilities, supplies and equipment, monitoring visits and operational costs.",400752,null,"Active","a6Q1R000000AIus",0,0,0,0,400752,0,null,null,"To promote engagement of the large private sector, 10 Private Public Partnerships (PPPs) are being requested through the TB-RSSH Funding Request within the allocation. An additional 40 PPPs are being proposed for UQD funding to expand pilot testing and enrich the data in diverse geographical and cultural settings in 4 remaining Regions. This UQD includes renovation of selected facilities, supplies and equipment, monitoring visits and operational costs.","Low","This request would fund an additional 40 PPPs to expand pilot testing and enrich the data in four regions that are different to those included in the allocation. This PAAR includes renovation of selected facilities, supplies and equipment, monitoring visits and operational costs. Without a detailed implementation plan this would be considered low quality demand.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH","RT South East Asia"]
["CT Congo","Congo","PAI-4044","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Train 43 laboratory technicians in acid-alcohol fast bacillus microscopy and rapid HIV tests. One training session will be organized per Center, with 4 training centers in year 1 (Brazzaville Center, 12; Pointe-Noire Center, 11; Owando Center, 10; Impfondo Center, 10).",226861.18,null,"Active","a6Q1R000000AJ2g",0,0,0,0,226861.18,0,null,null,"Train 43 laboratory technicians in acid-alcohol fast bacillus microscopy and rapid HIV tests. One training session will be organized per Center, with 4 training centers in year 1 (Brazzaville Center, 12; Pointe-Noire Center, 11; Owando Center, 10; Impfondo Center, 10).","Low","With the plan to scale up on availability of GeneXpert extensive training on smear microscopy is not needed, noting however, that expertise on smear microscopy needs to be maintained for monitoring patients on treatment.","NA Original Intervention: Improve disease detection and diagnosis through training in AFB for 4 centers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Cameroon","Cameroon","PAI-3975","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","This  would  fund  activities  to  extend  drug  dispensing  and monitoring  software  to  40 additional  health  care  facilities between 2018 and 2020.It would also cover the validation of community data, and the harmonization  and  production  of  community  data  collection tools for MSM, SWs, people who inject drugs and transgender people.",281062.73,null,"Active","a6Q1R000000AJ1Z",0,0,0,0,281062.73,0,null,null,"This  would  fund  activities  to  extend  drug  dispensing  and monitoring  software  to  40 additional  health  care  facilities between 2018 and 2020.It would also cover the validation of community data, and the harmonization  and  production  of  community  data  collection tools for MSM, SWs, people who inject drugs and transgender people.","High","The activities to expand software to 40 health care facilities for drug dispensing is needed to support decentralisation of care and differentiated treatment services. Activities for community data tools and their validation is part of routine data reporting process and should be covered as part of domestic efforts, thus the TRP recommends half of the amount.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Cameroon","Cameroon","PAI-3974","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","This  funding  would  be  used for the  construction  of  a  new central medical  store or renovation of Regional Store, with  other  technical  and  financial partners (IDB, USAID, etc.): purchase of land and construction (EUR  9,000,000). Investment in the supply chain is conditional to recommendation of the supply chain report. In  addition,  it  will  provide  funding  for technical assistance (EUR 649,440) for national coordination (a team of one international and one national expert)  for the three programs, to improve quantification and procurement of supplies, and to reduce instances of stock-outs.",10828683.65,null,"Active","a6Q1R000000AJ1Y",0,0,0,0,10828683.65,0,null,null,"This  funding  would  be  used for the  construction  of  a  new central medical  store or renovation of Regional Store, with  other  technical  and  financial partners (IDB, USAID, etc.): purchase of land and construction (EUR  9,000,000). Investment in the supply chain is conditional to recommendation of the supply chain report. In  addition,  it  will  provide  funding  for technical assistance (EUR 649,440) for national coordination (a team of one international and one national expert)  for the three programs, to improve quantification and procurement of supplies, and to reduce instances of stock-outs.","High","The country has made a case of the need for a warehouse. There is an ongoing assessment that would inform the Global Fund?s decision and it would be a multipartner involvement. Priority is high, but conditional to the results of the assessment and the decision of all the partners","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Procurement and supply management systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Djibouti","Djibouti","PAI-4144","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Capacity-building of service-providers on pregnant women enriollment, including treating STIs, notably syphillis, will contribute to reduce vulerability to HIV and mother-to-child-transmission of HIV.",7322,null,"Active","a6Q1R000000AJ4I",0,0,0,0,7322,0,null,null,"Capacity-building of service-providers on pregnant women enriollment, including treating STIs, notably syphillis, will contribute to reduce vulerability to HIV and mother-to-child-transmission of HIV.","High",null,"NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4139","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","Sensitization on the prevention of tuberculosis for the population through the media will allow the identification of new cases of TB.",16949,null,"Active","a6Q1R000000AJ4D",0,0,0,0,16949,0,null,null,"Sensitization on the prevention of tuberculosis for the population through the media will allow the identification of new cases of TB.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Bangladesh","Bangladesh","PAI-3888","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Quarterly meetings will be held at district level to support planning, coordination and management. The HR development plan will be updated, key staff will be recruited for the Program Managment Unit to support the reorientation of the programme, and needs-based training will be provided as necessary. Equipment will be maintained. Furniture (medium priority) and office equipment will be replaced where necessary. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programme?s elimination goal.",1692852,null,"Active","a6Q1R000000AJ0A",0,0,0,0,1692852,0,null,null,"Quarterly meetings will be held at district level to support planning, coordination and management. The HR development plan will be updated, key staff will be recruited for the Program Managment Unit to support the reorientation of the programme, and needs-based training will be provided as necessary. Equipment will be maintained. Furniture (medium priority) and office equipment will be replaced where necessary. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programme?s elimination goal.","Medium","The general management of the program requires support that goes beyond that covered by the ?within allocation? request.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Bangladesh","Bangladesh","PAI-3886","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Target-group-specific, locally appropriate, Behaviour Change Communication (BCC) materials and methodologies will be developed and produced for all high-risk groups, as well as for communities approaching elimination. Border-specific packages will also be produced. A mobile phone-based BCC programme  will be developed. Where appropriate work will be carried out in partnership with a commercial advertising agency. This should result in significant improvements in LLIIN utilization in forest goers and treatment seeking in elimination areas, leading to impact in terms of burden reduction and elimination.",1524883,null,"Active","a6Q1R000000AJ08",0,0,0,0,1524883,0,null,null,"Target-group-specific, locally appropriate, Behaviour Change Communication (BCC) materials and methodologies will be developed and produced for all high-risk groups, as well as for communities approaching elimination. Border-specific packages will also be produced. A mobile phone-based BCC programme  will be developed. Where appropriate work will be carried out in partnership with a commercial advertising agency. This should result in significant improvements in LLIIN utilization in forest goers and treatment seeking in elimination areas, leading to impact in terms of burden reduction and elimination.","High","Support for behavior change communication (BCC) under the ?within allocation? amount is limited to interpersonal communication (IPC) and community mobilization.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Benin","Benin","PAI-3822","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","The additional investment will make it possible to cover 65 percent of needs (from 47% with only allocation and matching funds): recruitment, training, incentivization, equipment, provision of tools, and monitoring of 4,147 community health workers implementing the complete package of interventions.",2569275.0499999998,null,"Active","a6Q1R000000AIz6",0,0,0,0,2569275.0499999998,0,null,null,"The additional investment will make it possible to cover 65 percent of needs (from 47% with only allocation and matching funds): recruitment, training, incentivization, equipment, provision of tools, and monitoring of 4,147 community health workers implementing the complete package of interventions.","High",null,"NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","RSSH","RT Central Africa","2022-06-30"]
["CT Benin","Benin","PAI-3748","MCI-00532","Comprehensive programs for people in prisons and other closed settings","MCI-00572","Other intervention(s) for people in prisons and other closed settings","Pay allowances for facilitators from NGOs working with prisoners: planned for year 3. Remuneration for actors on the ground working with prisoners.",27715.18,null,"Active","a6Q1R000000AIxu",0,0,0,0,27715.18,0,null,null,"Pay allowances for facilitators from NGOs working with prisoners: planned for year 3. Remuneration for actors on the ground working with prisoners.","High",null,"NA Original Intervention: Other interventions for people in prisons and other closed settings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4595","MCI-00004","Prevention programs for other vulnerable populations","MCI-00103","HIV testing services for other vulnerable populations","This funds is for the coordinating group (doctor, nurse and community worker) to conduct information campaign for motivation for HIV testing in cooperation with local communities, health committees and self-government bodies in Chu oblast. Additionally, this amount includes purchasing additional 10,000 express-tests of 3-4th generation for capillary blood to test for HIV along with traditionally used ELISA to expand testing in small settlements of Chui oblast with the highest rates of epidemic growth.",180000,null,"Active","a6Q1R000000AJBZ",0,0,0,0,180000,0,null,null,"This funds is for the coordinating group (doctor, nurse and community worker) to conduct information campaign for motivation for HIV testing in cooperation with local communities, health committees and self-government bodies in Chu oblast. Additionally, this amount includes purchasing additional 10,000 express-tests of 3-4th generation for capillary blood to test for HIV along with traditionally used ELISA to expand testing in small settlements of Chui oblast with the highest rates of epidemic growth.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Eastern Europe and Central Asia"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4594","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","This funding is to support social institutions\n(7) to provide learning, adherence and psychosocial support for PWID, SWs, MSM, PLHIV, persons released from prisons.",393750,null,"Active","a6Q1R000000AJBY",0,0,0,0,393750,0,null,null,"This funding is to support social institutions\n(7) to provide learning, adherence and psychosocial support for PWID, SWs, MSM, PLHIV, persons released from prisons.","Medium","The TRP notes that the applicant\nintends to support social institutions (7) to provide learning, adherence and psychosocial support. However, there is no clarity on the scope of these interventions.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Eastern Europe and Central Asia"]
["CT Kyrgyzstan","Kyrgyzstan","PAI-4589","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00093","Behavioral interventions for PWID","This amount is to recruit additional outreach and social workers to cover gaps for human resources for health gaps to enable the applicant to reach a\ncoverage target of 75 percent of people who inject drugs by 2020. This cadre of workers will provide\nvarious services including HIV testing and counselling and adherence support.",936168,null,"Active","a6Q1R000000AJBT",0,0,0,0,936168,0,null,null,"This amount is to recruit additional outreach and social workers to cover gaps for human resources for health gaps to enable the applicant to reach a\ncoverage target of 75 percent of people who inject drugs by 2020. This cadre of workers will provide\nvarious services including HIV testing and counselling and adherence support.","High","The TRP notes that the applicant\nintends to recruit additional outreach and social workers to cover human resources for health gaps (HRH) to enable the applicant to reach a coverage target of 75 percent of people who inject drugs by 2020. This cadre of workers will provide various services including HIV testing and counselling and adherence support. While the TRP\nrecognises the importance of this\ncadre of healthcare workers, the\nTRP strongly recommends that\ncareful consideration be given to the sustainability of these healthcare workers in terms of payment of salaries and incentives.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT Eastern Europe and Central Asia"]
["CT India","India","PAI-4519","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","To review and strengthen the EPTCT activities in a systematic and periodical manner, review meetings will be organized at District level. The District Health Chief will chair the meeting and review the performance of uptake of EPTCT with Block Medical Officers and Block Programme Managers.",75000,null,"Active","a6Q1R000000AJAL",0,0,0,0,75000,0,null,null,"To review and strengthen the EPTCT activities in a systematic and periodical manner, review meetings will be organized at District level. The District Health Chief will chair the meeting and review the performance of uptake of EPTCT with Block Medical Officers and Block Programme Managers.","Low","Technical assistance and capacity building for PPTCT should be covered from other resources","NA Original Module: PPTCT (Plan International India Chapter). Original Intervention: District level meeting","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2021-03-31"]
["CT India","India","PAI-4514","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","This budget is towards addressing the gap for additional ICTCs proposed in the NSP. As a part of integration of MIS systems, moving from manual record maintenance to electronic mode is important. Funds proposed under the above allocation will help further strengthen and fill the need for the balance of ICTC centers that need tablets.",500000,null,"Active","a6Q1R000000AJAG",0,0,0,0,500000,0,null,null,"This budget is towards addressing the gap for additional ICTCs proposed in the NSP. As a part of integration of MIS systems, moving from manual record maintenance to electronic mode is important. Funds proposed under the above allocation will help further strengthen and fill the need for the balance of ICTC centers that need tablets.","Low","This interventions should be covered as part of the intervention included in the allocation through finding efficiencies.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2021-03-31"]
["CT Indonesia","Indonesia","PAI-4500","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.",47545,null,"Active","a6Q1R000000AJA2",0,0,0,0,47545,0,null,null,"Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","Medium","Will support expansion of comprehensive program to reach additional 19,040 female sex workers for testing and 1,276 for treatment","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Indonesia","Indonesia","PAI-4495","MCI-00531","Comprehensive prevention programs for TGs","MCI-00554","Behavioral interventions for TGs","Expansion of Comprehensive program to reach additional 5,250 TG for testing and 756 for treatment.",167883,null,"Active","a6Q1R000000AJ9x",0,0,0,0,167883,0,null,null,"Expansion of Comprehensive program to reach additional 5,250 TG for testing and 756 for treatment.","Medium","To allow provision of targeted prevention programs in additional priority districts: Expansion of Comprehensive program to reach additional 5,250 transgender people for testing and 756 for treatment","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Indonesia","Indonesia","PAI-4490","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00554","Behavioral interventions for TGs","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.",238921,null,"Active","a6Q1R000000AJ9s",0,0,0,0,238921,0,null,null,"Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","High","Expansion of Comprehensive program to reach additional 19,040 female sex workers for testing and 1,276 for treatment","NA Original Intervention: Behavioural interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Haiti","Haiti","PAI-4453","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","A few surveys will be conducted to include the causes of under-declaration of cases, patients on treatment lost, and the extrapulmonary TB profile in the departments.",160000,null,"Active","a6Q1R000000AJ9H",0,0,0,0,160000,0,null,null,"A few surveys will be conducted to include the causes of under-declaration of cases, patients on treatment lost, and the extrapulmonary TB profile in the departments.","Low",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2020-12-31"]
["CT Haiti","Haiti","PAI-4452","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Direct contacts of MDR-TB patients on treatment are at risk of infection. The WHO recommends that they are monitored periodically for at least two years to track any development of resistant germ tuberculosis-type infection or disease. ASCPs must receive appropriate training so that they can conduct this task correctly.",9216,null,"Active","a6Q1R000000AJ9G",0,0,0,0,9216,0,null,null,"Direct contacts of MDR-TB patients on treatment are at risk of infection. The WHO recommends that they are monitored periodically for at least two years to track any development of resistant germ tuberculosis-type infection or disease. ASCPs must receive appropriate training so that they can conduct this task correctly.","Medium","The TRP has reprioritized this intervention from low to medium. According to WHO recommendations periodic monitoring of MDR patients is a priority for TB and MDR-TB control.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2020-12-31"]
["CT Armenia","Armenia","PAI-3632","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","USD 200,000 to support the roll out of ECHO project (tele-medecine platform) in Armenia in cooperation with the ADB. Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services.",200000,null,"Inactive","a6Q1R000000AIw2",0,200000,0,0,0,1,null,null,"USD 200,000 to support the roll out of ECHO project (tele-medecine platform) in Armenia in cooperation with the ADB. Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services.","High",null,"CT validation: description was updated and amounts are confirmed Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health infomration systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2021-09-30"]
["CT Albania","Albania","PAI-3618","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Update HIV / AIDS / TB reporting forms to ensure consistency with proposed joint HIV / TB database  ",3750,null,"Active","a6Q1R000000AIvo",0,0,0,0,3750,0,null,null,"Update HIV / AIDS / TB reporting forms to ensure consistency with proposed joint HIV / TB database  ","High","The updating of the forms is considered of high priority to improve the surveillance system and should be considered for funding within allocation if efficiency savings are realised.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2022-12-31"]
["CT Afghanistan","Afghanistan","PAI-3555","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","Based on effective results, scale up CB-DOTS in additional 15 provinces to expand case notifications and broaden efforts to reduce stigma. This expansion should identify another 1,000 cases per year. This UQD includes training  ($5,000 per training X 15 provinces = $75,000) and incentives for case-finding and treatment support ($3 each to two persons per case X 1,000 cases x 3 years = $18,000).",93000,null,"Active","a6Q1R000000AIun",0,0,0,0,93000,0,null,null,"Based on effective results, scale up CB-DOTS in additional 15 provinces to expand case notifications and broaden efforts to reduce stigma. This expansion should identify another 1,000 cases per year. This UQD includes training  ($5,000 per training X 15 provinces = $75,000) and incentives for case-finding and treatment support ($3 each to two persons per case X 1,000 cases x 3 years = $18,000).","High","This intervention is required to scale up community based directly observed treatment, short-course (DOTS) coverage in 10 additional provinces following the approach described in allocation request. It is considered that this intervention will most likely extend the services to populations with limited access.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis, RSSH","RT South East Asia"]
["CT Congo","Congo","PAI-4042","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Organize 2 training/refresher training sessions lasting 5 days for 80 heads of TTC (2 nurses per TTC) on TB treatment for adults and children (including drug management), with 4 training centers in years 1 and 2.",117831.89,null,"Active","a6Q1R000000AJ2e",0,0,0,0,117831.89,0,null,null,"Organize 2 training/refresher training sessions lasting 5 days for 80 heads of TTC (2 nurses per TTC) on TB treatment for adults and children (including drug management), with 4 training centers in years 1 and 2.","Medium","Improvement in the reporting of treated TB cases and application of protocols in accordance with national guidelines","NA Original Intervention: Improve reporting of TB cases through training in reporting according to national guidelines","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Cameroon","Cameroon","PAI-3969","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","These activities will allow for work to train the  remaining  492  CHWs  through  periodic recycling not funded under the new grant due to budget constraint.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.",164309.28,null,"Active","a6Q1R000000AJ1T",0,0,0,0,164309.28,0,null,null,"These activities will allow for work to train the  remaining  492  CHWs  through  periodic recycling not funded under the new grant due to budget constraint.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","Medium","Community case management is a high impact intervention; however, the TRP considers that the contribution to impact of this additional request is not well substantiated. Given that the information provided at this stage is limited, should additional resources become available, the TRP recommends that the Secretariat reviews the budget and justification of proposed activities to ensure that they are appropriate in scope and scale for the funds requested and are positioned to achieve impact.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Training of 492 CHW on revised modules","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Bangladesh","Bangladesh","PAI-3884","MCI-00012","Case management","MCI-00157","Active case detection and investigation (elimination phase)","There are considerable additional demands associated with the elimination effort. A substantial increase in manpower will allow the programme to accelerate progress towards its targets, taking full advantage of this critical window of opportunity to eliminate malaria from Bangladesh.",3384120,null,"Active","a6Q1R000000AJ06",2099616,0,0,0,1284504,0,null,null,"There are considerable additional demands associated with the elimination effort. A substantial increase in manpower will allow the programme to accelerate progress towards its targets, taking full advantage of this critical window of opportunity to eliminate malaria from Bangladesh.","High","Active case detection is a critical part of malaria elimination efforts and should be included in the malaria elimination efforts in Bangladesh.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Bangladesh","Bangladesh","PAI-3882","MCI-00012","Case management","MCI-00154","Facility-based treatment","Quality Assurnce (QA) of diagnosis needs improvement and will be strengthened through expansion and upgrading of the Central Medical Reference Laboratory and collaborating laboratories. A QA database and support for external competency testing will be conducted every 3 years. Sensitivity and specificity of diagnosis will increase as a result, improving rationality of treatment.",25795,null,"Active","a6Q1R000000AJ04",0,0,0,0,25795,0,null,null,"Quality Assurnce (QA) of diagnosis needs improvement and will be strengthened through expansion and upgrading of the Central Medical Reference Laboratory and collaborating laboratories. A QA database and support for external competency testing will be conducted every 3 years. Sensitivity and specificity of diagnosis will increase as a result, improving rationality of treatment.","High","Quality assurance of diagnosis needs improvement and should be strengthened through expansion. If efficiencies and saving are identified during grantmaking, this activity should be included in the ?Allocation Budget?.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Benin","Benin","PAI-3816","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","To be effective in vector control, it is necessary to carry out vector susceptibility tests to determine the status of the vector against insecticides available on the international market. This study is conducted as a prelude to IDP campaigns to select the appropriate insecticide. The latest study conducted in 2017 noted that pyrimiphos methyl remains the sensitive insecticide from which it was chosen during the 2017 IRS campaign",110260.35,null,"Active","a6Q1R000000AIz0",0,0,0,0,110260.35,0,null,null,"To be effective in vector control, it is necessary to carry out vector susceptibility tests to determine the status of the vector against insecticides available on the international market. This study is conducted as a prelude to IDP campaigns to select the appropriate insecticide. The latest study conducted in 2017 noted that pyrimiphos methyl remains the sensitive insecticide from which it was chosen during the 2017 IRS campaign","High","TRP considers that the monitoring of insecticide resistance and efficacy testing of vector control products (nets and insecticides) should be considered high priority as up-to-date insecticide resistance data will guide appropriate choice of efficacious vector control interventions.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Indonesia","Indonesia","PAI-4506","MCI-00023","Program management","MCI-00207","Grant management","Support for human resource for MSM and TG comprehensive program at (32 districts for MSM, and 50 districts for TG).",372827,null,"Active","a6Q1R000000AJA8",0,0,0,0,372827,0,null,null,"Support for human resource for MSM and TG comprehensive program at (32 districts for MSM, and 50 districts for TG).","Low","Support for staff. Low priority because this is the same activity as within allocation but simply in additional districts",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Indonesia","Indonesia","PAI-4487","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","Expansion of Comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts).",820996,null,"Active","a6Q1R000000AJ9p",0,0,0,0,820996,0,null,null,"Expansion of Comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts).","High","To support additional districts with targeted prevention programs, Expansion of comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts)","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Indonesia","Indonesia","PAI-4482","MCI-00009","TB/HIV","MCI-00135","Engaging all care providers (TB/HIV)","Health Provider Training on HIV Testing, Care, Support and Treatment for 243 ?basic? districts.",147756,null,"Active","a6Q1R000000AJ9k",0,0,0,0,147756,0,null,null,"Health Provider Training on HIV Testing, Care, Support and Treatment for 243 ?basic? districts.","High","Will contribute to increase HIV testing among TB patients, care, support and treatment in 243 ?basic? districts.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Indonesia","Indonesia","PAI-4481","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","The activities include ? Part of MDR treatment package ? Provision of treatment shelter by MoH ? Provision of nutritional subsidy by communities ? Evaluation of clinical mentoring in referral/ sub-referral hospitals ? Assessment and capacity building for new MDR-TB referral sites Treatment package is planned for: 1,433 (25%), 1,873 (20%), 1,380 (10%) of MDR TB patients in 2018, 2019, 2020 Treatment shelter will be provided closed to the provincial referral hospitals. In 10 provinces where the community PR do not provide shelters, MoH will provide. PR Aisyiyah and LKNU will provide nutritional subsidy to MDR TB patients who need temporary shelters.",7315984,null,"Active","a6Q1R000000AJ9j",3343568,0,0,0,3972416,0,null,null,"The activities include ? Part of MDR treatment package ? Provision of treatment shelter by MoH ? Provision of nutritional subsidy by communities ? Evaluation of clinical mentoring in referral/ sub-referral hospitals ? Assessment and capacity building for new MDR-TB referral sites Treatment package is planned for: 1,433 (25%), 1,873 (20%), 1,380 (10%) of MDR TB patients in 2018, 2019, 2020 Treatment shelter will be provided closed to the provincial referral hospitals. In 10 provinces where the community PR do not provide shelters, MoH will provide. PR Aisyiyah and LKNU will provide nutritional subsidy to MDR TB patients who need temporary shelters.","High","Will contribute to improved DR TB treatment. The activities include: Part of MDR treatment package; pprovision of treatment shelter by MoH; provision of nutritional subsidy by communities; evaluation of clinical mentoring inreferral/ sub-referral hospitals; aassessment and capacity building for new MDR-TB referral sites. Will ensure treatment package for1,433 (25%), 1,873 (20%), 1,380 (10%) of MDR TB patients in 2018, 2019, 2020.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Indonesia","Indonesia","PAI-4465","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Determine to what extent oxidase-based resistance mechanisms are prevalent in insecticide resistance via bottle bioassay synergist assays. The research will be done in 10 district sites in Eastern Indonesia. Will cost US$ 50,000 per each site (Total US$ 500,000).",500000,null,"Inactive","a6Q1R000000AJ9T",500000,0,0,0,0,1,null,null,"Determine to what extent oxidase-based resistance mechanisms are prevalent in insecticide resistance via bottle bioassay synergist assays. The research will be done in 10 district sites in Eastern Indonesia. Will cost US$ 50,000 per each site (Total US$ 500,000).","High","Resistance mechanisms for insecticides is an important adjunct activity to insecticide resistance monitoring. However, the cost proposed for the bottle bioassay is too high and the TRP highly recommends that the recipient consider including LLIN durability/survivability monitoring in the Eastern Provinces.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2020-12-31"]
["CT Armenia","Armenia","PAI-3628","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","IBBS (Integrated Biology and Behavioural Survey) among PWID, MSM, TG, SW, Migrants in Y2 in order to assess the situation and measure progress in HIV prevention and treatment.\nThe previous IBBS studies have been funded by the Global Fund grants. The government has not yet assumed this function, hence funding for IBBS studies is included in the above allocation request.",120000,null,"Inactive","a6Q1R000000AIvy",0,120000,0,0,0,1,null,null,"IBBS (Integrated Biology and Behavioural Survey) among PWID, MSM, TG, SW, Migrants in Y2 in order to assess the situation and measure progress in HIV prevention and treatment.\nThe previous IBBS studies have been funded by the Global Fund grants. The government has not yet assumed this function, hence funding for IBBS studies is included in the above allocation request.","High","The continued ability to conduct such surveys, or alternative sources of information should be considered for future sustainability after this grant","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2021-09-30"]
["CT Albania","Albania","PAI-3615","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Evaluate pilot of a new technology in TB and HIV care, such as Video Dots",9350,null,"Active","a6Q1R000000AIvl",0,0,0,0,9350,0,null,null,"Evaluate pilot of a new technology in TB and HIV care, such as Video Dots","Low",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2022-12-31"]
["CT Albania","Albania","PAI-3614","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Update surveillance guideline system",10200,null,"Active","a6Q1R000000AIvk",0,0,0,0,10200,0,null,null,"Update surveillance guideline system","Low",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2022-12-31"]
["CT Bangladesh","Bangladesh","PAI-3880","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).",940181,null,"Active","a6Q1R000000AJ02",0,0,0,0,940181,0,null,null,"Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).","Low","Given the low number of HIV cases initiating ART, and the fact that Pre-exposure prophylaxis (PreP) should only be considered for sero-discordant couples where partner is initiating treatment or has detectable viral load in the Bangladesh epidemic, this is not a priority.","NA Original Intervention: Other interventions for treatment: PrEP","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-11-30"]
["CT Benin","Benin","PAI-3811","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Train medical and paramedical staff in treatment for sexually transmitted infections (STIs) and disseminate the algorithm.",282796.53999999998,null,"Active","a6Q1R000000AIyv",0,0,0,0,282796.53999999998,0,null,null,"Train medical and paramedical staff in treatment for sexually transmitted infections (STIs) and disseminate the algorithm.","High",null,"NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3742","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Purchase of 9 ultrasound machines with accessories. The mapping of ultrasound machines performed in 2016 showed a need for 9 devices instead of 11. The purchase of these devices completes the technical platform so to strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA, the diagnosis of multidrug-resistant tuberculosis.",90000,null,"Active","a6Q1R000000AIxo",0,0,0,0,90000,0,null,null,"Purchase of 9 ultrasound machines with accessories. The mapping of ultrasound machines performed in 2016 showed a need for 9 devices instead of 11. The purchase of these devices completes the technical platform so to strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA, the diagnosis of multidrug-resistant tuberculosis.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3741","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Equipment maintenance (package: 10% of the cost). As the devices come with a one year warranty, it would be worthwhile to purchase a 3 year warranty extension as we did for GeneXpert devices.",62500,null,"Active","a6Q1R000000AIxn",0,0,0,0,62500,0,null,null,"Equipment maintenance (package: 10% of the cost). As the devices come with a one year warranty, it would be worthwhile to purchase a 3 year warranty extension as we did for GeneXpert devices.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Indonesia","Indonesia","PAI-4470","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Procurement of 200 Xpert MTB/RIF (800 modules)and 650 Xpert MTB/RIF omni with the cartridge to do 266,363 test. This machine will support additional effort to find more cases planned in this activities (mobile clinic, mass screening) and increase the diagnostic capacity for regular health service. It is expected to detect additional 1500 MDR TB patients.",10897856,null,"Active","a6Q1R000000AJ9Y",3400000,0,0,0,7497856,0,null,null,"Procurement of 200 Xpert MTB/RIF (800 modules)and 650 Xpert MTB/RIF omni with the cartridge to do 266,363 test. This machine will support additional effort to find more cases planned in this activities (mobile clinic, mass screening) and increase the diagnostic capacity for regular health service. It is expected to detect additional 1500 MDR TB patients.","High","High priority due to high rates of MDR TB increase rapid diagnostic capacity and will detect additional 1,500 multi drug resistant tuberculosis (MDR TB) patients",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, RSSH","RT High Impact Asia"]
["CT Haiti","Haiti","PAI-4459","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Refurbishment of structures reserved for treating and isolating detainees with tuberculosis in three prisons. The existing isolation structures will be refitted in a sensitive TB space with a room for contagious TB in its intensive treatment phase, a room for non-contagious TB in its treatment maintenance phase and an MDR-TB space where people can be isolated. Works will also be conducted in consultation room to bring it up to infection control standards.",125000,null,"Inactive","a6Q1R000000AJ9N",0,125000,0,0,0,1,null,null,"Refurbishment of structures reserved for treating and isolating detainees with tuberculosis in three prisons. The existing isolation structures will be refitted in a sensitive TB space with a room for contagious TB in its intensive treatment phase, a room for non-contagious TB in its treatment maintenance phase and an MDR-TB space where people can be isolated. Works will also be conducted in consultation room to bring it up to infection control standards.","High",null,"NA Original Intervention: Key populations (TB care and prevention) ? Others","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2020-12-31"]
["CT Albania","Albania","PAI-3622","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","Review and update the PEP and PrEP guidelines pilot PrEP for MSM",3925,null,"Active","a6Q1R000000AIvs",0,0,0,0,3925,0,null,null,"Review and update the PEP and PrEP guidelines pilot PrEP for MSM","Medium",null,"NA Original Intervention: Differentiated antiretroviral therapy service delivery","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2022-12-31"]
["CT Albania","Albania","PAI-3621","MCI-00007","Treatment, care and support","MCI-00118","Differentiated ART service delivery","Provide TA to further strengthen Patient monitoring system for adherence. A partient-monitoring system is in place, but additional TA can further strengthen it.",7350,null,"Active","a6Q1R000000AIvr",0,0,0,0,7350,0,null,null,"Provide TA to further strengthen Patient monitoring system for adherence. A partient-monitoring system is in place, but additional TA can further strengthen it.","Medium",null,"NA Original Intervention: Differentiated antiretroviral therapy service delivery","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2022-12-31"]
["CT Albania","Albania","PAI-3604","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00100","Other intervention(s) for IDUs and their partners","Establish auditing programs for KP (sex workers, LGBTQ, PWID) health and social services offered by all stakeholders",2250,null,"Active","a6Q1R000000AIva",0,0,0,0,2250,0,null,null,"Establish auditing programs for KP (sex workers, LGBTQ, PWID) health and social services offered by all stakeholders","Low",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2022-12-31"]
["CT Congo","Congo","PAI-4036","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Procure 6 GeneXpert machines: 6.",519.32000000000005,null,"Active","a6Q1R000000AJ2Y",0,0,0,0,519.32000000000005,0,null,null,"Procure 6 GeneXpert machines: 6.","High","The activity provides for extra 6 GeneXpert to bring the total in the country to 14.","NA Original Module: Multidrug-resistant TB. Original Intervention: Improve access to rapid diagnosis for MDR-TB through procurement of 6 GeneXperts and cartridges","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Congo","Congo","PAI-4031","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","Care providers will be trained to support the supply of ACT and artesunate as well as supervision at different levels of the health system. The above allocation funding request will enable the gap in drugs to be met and the support activities to be implemented",534171.25,null,"Active","a6Q1R000000AJ2T",0,0,0,0,534171.25,0,null,null,"Care providers will be trained to support the supply of ACT and artesunate as well as supervision at different levels of the health system. The above allocation funding request will enable the gap in drugs to be met and the support activities to be implemented","Medium","Health workers training needed to improve case management are not covered by the allocation","NA Original Intervention: Training of health workers","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Cameroon","Cameroon","PAI-3962","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","These activities will allow for work to support the new   4'500  CHWs. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to recruit 4500  CHWs additonal through  and  to  extend  the  response  to  80 additional  health districts by ensuring adequate  equipment  for the smooth  running of  the  activity.  In  addition,  a  performance-based funding mechanism for CHW accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.",8784908.5399999991,null,"Active","a6Q1R000000AJ1M",0,0,0,0,8784908.5399999991,0,null,null,"These activities will allow for work to support the new   4'500  CHWs. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to recruit 4500  CHWs additonal through  and  to  extend  the  response  to  80 additional  health districts by ensuring adequate  equipment  for the smooth  running of  the  activity.  In  addition,  a  performance-based funding mechanism for CHW accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","Low","While community case management is a high impact intervention, the TRP notes that the applicant should first consolidate their existing community health system and achieve impact, and review lessons learned before expansion. The advocacy meetings can be included also within the main allocation (community case management and program management). Given that the information provided at this stage is limited, should additional resources become available, the TRP recommends that the Secretariat reviews the budget and justification of proposed activities to ensure that they are appropriate in scope and scale for the funds requested and are positioned to achieve impact.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Support the additional 4,500 community health workers (ACS) in the implementation of Community Interventions (ISDC)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Bangladesh","Bangladesh","PAI-3877","MCI-00007","Treatment, care and support","MCI-00120","Treatment adherence","Piloting different ART service delivery models for key and general populations will allow improved linkages to treatment, care and support for people living with HIV.",332408,null,"Active","a6Q1R000000AIzz",0,0,0,0,332408,0,null,null,"Piloting different ART service delivery models for key and general populations will allow improved linkages to treatment, care and support for people living with HIV.","Medium","Better models for improving linkages to treatment, care and support for people living with HIV are necessary to combatting the epidemic.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-11-30"]
["CT Benin","Benin","PAI-3804","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Organize an advocacy meeting on the community care strategy: With the adoption of the ?test and treat? strategy, a significant active file is anticipated, which will place pressure on the health system. It is important to involve all actors in defining the basis for community involvement.",11883.07,null,"Active","a6Q1R000000AIyo",0,0,0,0,11883.07,0,null,null,"Organize an advocacy meeting on the community care strategy: With the adoption of the ?test and treat? strategy, a significant active file is anticipated, which will place pressure on the health system. It is important to involve all actors in defining the basis for community involvement.","Low",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Haiti","Haiti","PAI-4450","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","This proposal for the PAAR will bring the following added value to the current grant: 3,480 PLHIV per year will benefit from Individual Counselling Services/Psychological Support; 2,800 more PLHIV/per year who will benefit from support groups; 5,084 more Home Visits; 2,300 patients on ARV/per year will receive ARV treatment at community level; 2,584 more Visits searching for people lost to follow up; 920 HIV+ women lost to follow up after childbirth, who will benefit from active detection; starting of community relay points for ARV treatment provisioning of PLHIV; community distribution of ARV treatment through PLHIV Peers-Trainers.",675354,null,"Active","a6Q1R000000AJ9E",0,0,0,0,675354,0,null,null,"This proposal for the PAAR will bring the following added value to the current grant: 3,480 PLHIV per year will benefit from Individual Counselling Services/Psychological Support; 2,800 more PLHIV/per year who will benefit from support groups; 5,084 more Home Visits; 2,300 patients on ARV/per year will receive ARV treatment at community level; 2,584 more Visits searching for people lost to follow up; 920 HIV+ women lost to follow up after childbirth, who will benefit from active detection; starting of community relay points for ARV treatment provisioning of PLHIV; community distribution of ARV treatment through PLHIV Peers-Trainers.","Medium",null,"NA Original Module: RSSH - Community responses and systems. Original Intervention: Other other community responses and systems intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2020-12-31"]
["CT Haiti","Haiti","PAI-4449","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","This amount is requested for visits to co-ordinate and supervise treatment of TB/HIV co-infection in departments conducted under TB and HIV programmes. These visits were financed by USAID/LMG until June 2017. The half-yearly visit to each department takes a full day and enables central and departmental managers to assess implementation of the treatment of TB/HIV co-infection and deal with situations encountered.",250000,null,"Active","a6Q1R000000AJ9D",0,0,0,0,250000,0,null,null,"This amount is requested for visits to co-ordinate and supervise treatment of TB/HIV co-infection in departments conducted under TB and HIV programmes. These visits were financed by USAID/LMG until June 2017. The half-yearly visit to each department takes a full day and enables central and departmental managers to assess implementation of the treatment of TB/HIV co-infection and deal with situations encountered.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2020-12-31"]
["CT Haiti","Haiti","PAI-4444","MCI-00007","Treatment, care and support","MCI-00117","HIV care","At 7 February 2018, PEPFAR Haiti does not know the amount of COP Haiti 2018 funding. The amount requested is hypothetical and based on a hypothetical 15% reduction in PEPFAR ARV treatment budget and covering this financial gap with grant HTI-C-PSI 2018-20.  The amount allocated to finance ARV treatment will be made available by PEPFAR towards end of April 2018 following COP Haiti 2018 negotiations.",2000000,null,"Active","a6Q1R000000AJ98",0,0,0,0,2000000,0,null,null,"At 7 February 2018, PEPFAR Haiti does not know the amount of COP Haiti 2018 funding. The amount requested is hypothetical and based on a hypothetical 15% reduction in PEPFAR ARV treatment budget and covering this financial gap with grant HTI-C-PSI 2018-20.  The amount allocated to finance ARV treatment will be made available by PEPFAR towards end of April 2018 following COP Haiti 2018 negotiations.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2020-12-31"]
["CT Haiti","Haiti","PAI-4435","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Strengthen central supervision of health institutions.\nExpected outcome: Field activity monitoring is improved.\nImpact: Better implementation monitoring.",35650,null,"Active","a6Q1R000000AJ8z",0,0,0,0,35650,0,null,null,"Strengthen central supervision of health institutions.\nExpected outcome: Field activity monitoring is improved.\nImpact: Better implementation monitoring.","High","The TRP recommends that the activity be\nshould be primarily focused on high\ntransmission areas","CT Validation : data is correct - no description update Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Latin America and Caribbean","2020-12-31"]
["CT Albania","Albania","PAI-3599","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Assess current Viral Hepatitis treatment capacities and capabilities (drugs, guidelines, services etc)  for Albanian population and especially risk groups",20000,null,"Active","a6Q1R000000AIvV",0,0,0,0,20000,0,null,null,"Assess current Viral Hepatitis treatment capacities and capabilities (drugs, guidelines, services etc)  for Albanian population and especially risk groups","Low",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2022-12-31"]
["CT Afghanistan","Afghanistan","PAI-3551","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","Category  2&3  provinces  prone  for  malaria  epidemics lack vector  control measure (LLINs) Population here is mostly  not immune, so single  malaria  case  carries high transmission risk (especially considering  migration and movement of internally   displaced population).   It is proposed to procure the stock of insecticide for IRS and larvaciding, cosnidering   geographic and  logistical challenges of re-supply.    This will facilitate immediate response to   outbreak   investigation   and   response   in   the   elimination areas.",300000,null,"Active","a6Q1R000000AIuj",0,0,0,0,300000,0,null,null,"Category  2&3  provinces  prone  for  malaria  epidemics lack vector  control measure (LLINs) Population here is mostly  not immune, so single  malaria  case  carries high transmission risk (especially considering  migration and movement of internally   displaced population).   It is proposed to procure the stock of insecticide for IRS and larvaciding, cosnidering   geographic and  logistical challenges of re-supply.    This will facilitate immediate response to   outbreak   investigation   and   response   in   the   elimination areas.","Low","TRP is of the opinion that the IRS in receptive areas in Category 2 and 3 will lead to a sustainable intervention approach to the elimination of malaria in Afghanistan by 2030.","NA Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Congo","Congo","PAI-4027","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)",null,506116.04,null,"Active","a6Q1R000000AJ2P",0,0,0,0,506116.04,0,null,null,null,"Medium","Improve the quality and monitor the implementation of malaria control interventions at all levels of health system. Activity not covered in the allocation","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: Supervision visits","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Côte d'Ivoire","Côte d'Ivoire","PAI-3958","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Active search for TB among drug users With regard to drug users, the activities proposed in collaboration with Médecins du Monde are the following: - Awareness-raising sessions by community outreach agents in ? fumoirs7 ? (smoking rooms) to reduce the stigma and discrimination that are associated with them; - Screening by active search for tuberculosis in the community of approximately 1,800 drug users over the three years of screening; - Community support for the 135 drug users with TB treated in eight prisons (1 per 6 drug users with TB).",158231.4,null,"Active","a6Q1R000000AJ1I",0,0,0,0,158231.4,0,null,null,"Active search for TB among drug users With regard to drug users, the activities proposed in collaboration with Médecins du Monde are the following: - Awareness-raising sessions by community outreach agents in ? fumoirs7 ? (smoking rooms) to reduce the stigma and discrimination that are associated with them; - Screening by active search for tuberculosis in the community of approximately 1,800 drug users over the three years of screening; - Community support for the 135 drug users with TB treated in eight prisons (1 per 6 drug users with TB).","High","One of the possible reasons for the gap between the estimated incidence and the notification rate may be due to underdetection in key and vulnerable populations. People who use drugs are a priority key population and this intervention is likely to have a good yield. Additionally, participation of Médecins du Monde is a good example of partner collaboration and likely to result in successful implementation.","NA Original Intervention: Key populations","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Haiti","Haiti","PAI-4433","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Conduct 40 quarterly meetings to monitor program performance (Budget increase to intervention already previously approved in the original PAAR). Facilitate quarterly validation meetings with institutions. Hold validation meetings with OSE and on microstratification.\nExpected outcome: Level of implementation of the new elimination guidelines and the operational plan within health departments is assessed.\nImpact: Improved results in relation to performance indicators.",1151634,null,"Active","a6Q1R000000AJ8x",0,0,0,0,1151634,0,null,null,"Conduct 40 quarterly meetings to monitor program performance (Budget increase to intervention already previously approved in the original PAAR). Facilitate quarterly validation meetings with institutions. Hold validation meetings with OSE and on microstratification.\nExpected outcome: Level of implementation of the new elimination guidelines and the operational plan within health departments is assessed.\nImpact: Improved results in relation to performance indicators.","High","The TRP recommends that the activity be\nonly focused the communes of high\nmalaria transmission.","CT Validation : data is correct - no description update Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Latin America and Caribbean","2020-12-31"]
["CT Haiti","Haiti","PAI-4430","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Reproduction of data collection tools for agents on the ground\nexpected result: all agents on the ground, including ones at community level, have tools for collection, on paper, in a sufficient quantity\nimpact: no shortage of stock of tools for collecting data over 3 years",30000,null,"Active","a6Q1R000000AJ8u",0,0,0,0,30000,0,null,null,"Reproduction of data collection tools for agents on the ground\nexpected result: all agents on the ground, including ones at community level, have tools for collection, on paper, in a sufficient quantity\nimpact: no shortage of stock of tools for collecting data over 3 years","Low","This funding will support reproduction of data collection tools for agents - field work. The TRP recommends this activity with low priority as it represents low value for money.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Latin America and Caribbean","2020-12-31"]
["CT Liberia","Liberia","PAI-4683","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","This activity is to increase community involvement and participation in the implementation of the Revised Community Health policy in Liberia and it is part of the policy requirement to work with the Health Facility Development Committees (HFDC) in Community Health program or integrated community case management (iCCM) interventions.  The HFDCs are representatives of the communities in the catchment of the health facilities. These HFDC are the linkage between communities and health facilities and will provide support to the CHAs and TTM by promoting the work of the TTM and CHAs, and the health facilities.",964634,null,"Active","a6Q1R000000AJCz",0,0,47780,0,916854,0,null,null,"This activity is to increase community involvement and participation in the implementation of the Revised Community Health policy in Liberia and it is part of the policy requirement to work with the Health Facility Development Committees (HFDC) in Community Health program or integrated community case management (iCCM) interventions.  The HFDCs are representatives of the communities in the catchment of the health facilities. These HFDC are the linkage between communities and health facilities and will provide support to the CHAs and TTM by promoting the work of the TTM and CHAs, and the health facilities.","High",null,"NA Original Intervention: Integrated community case management (iCCM)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4311","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","PSM: We are requesting 433,481 EUR for the new warehouse, in addition to the 628,002 EUR already approved by the TRP in Nov 2017, bringing the total PAAR UQD for PSM storage and distribution to 1,061,483 EUR.\nAlmost 50% of Global Fund NFC grants in Guinea Bissau consist of medical supplies and commodities. The GF Risk Matrix Action Plan identified numerous PSM distribution and storage issues during a review in 2016-2017.  The TRP approved 628,002 EUR for additional supply chain monitors (to trace GF funded medical supplies to end user level) and international technical assistance for the national medical stores-CECOME.\nAs part of the reprogramming of the NFM M grant, GF authorized UNDP to purchase a Warehouse In a Box (WIB) from WFP, to replace the existing warehouse which had several fires in the last 3 years due to improper construction (frail walls, insufficient ventilation, electrical wires for air conditioners of 1.5 mm instead of 3 mms, etc). To assemble and construct a fully operational WIB would require 1.4 m EUR - breakdown provided.\nThe existing NFC M grant has 0.4 m EUR in funding for the new warehouse, sufficient to cover the design, construction of the base and assembly of the WIB. We anticipate having savings from PSM purchases in the amount of 0.5 m EUR (which will cover the walls, insulation, multifold doors, air conditioners, and machine equipment). This leaves a gap of 433,481 EUR (for the racking, solar pannels, Warehouse Information System hardware, UNDP GMS, etc.), which is being requested now.",486456.07,null,"Active","a6Q1R000000AJ6z",0,0,0,0,486456.07,0,null,null,"PSM: We are requesting 433,481 EUR for the new warehouse, in addition to the 628,002 EUR already approved by the TRP in Nov 2017, bringing the total PAAR UQD for PSM storage and distribution to 1,061,483 EUR.\nAlmost 50% of Global Fund NFC grants in Guinea Bissau consist of medical supplies and commodities. The GF Risk Matrix Action Plan identified numerous PSM distribution and storage issues during a review in 2016-2017.  The TRP approved 628,002 EUR for additional supply chain monitors (to trace GF funded medical supplies to end user level) and international technical assistance for the national medical stores-CECOME.\nAs part of the reprogramming of the NFM M grant, GF authorized UNDP to purchase a Warehouse In a Box (WIB) from WFP, to replace the existing warehouse which had several fires in the last 3 years due to improper construction (frail walls, insufficient ventilation, electrical wires for air conditioners of 1.5 mm instead of 3 mms, etc). To assemble and construct a fully operational WIB would require 1.4 m EUR - breakdown provided.\nThe existing NFC M grant has 0.4 m EUR in funding for the new warehouse, sufficient to cover the design, construction of the base and assembly of the WIB. We anticipate having savings from PSM purchases in the amount of 0.5 m EUR (which will cover the walls, insulation, multifold doors, air conditioners, and machine equipment). This leaves a gap of 433,481 EUR (for the racking, solar pannels, Warehouse Information System hardware, UNDP GMS, etc.), which is being requested now.","High",null,"NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4230","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.",110000,null,"Active","a6Q1R000000AJ5g",0,0,0,0,110000,0,null,null,"As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","High","Routine data collection will assist with ongoing monitoring of the program. The newly upgraded District Health Information System (DHIS - 2 ) system is expected to be rolled out to the lowest health facility using this funding.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4229","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.",270000,null,"Active","a6Q1R000000AJ5f",0,0,0,0,270000,0,null,null,"As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","High","Routine data collection will assist with ongoing monitoring of the program. The newly upgraded District Health Information System (DHIS - 2 ) system is expected to be rolled out to the lowest health facility using this funding.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Côte d'Ivoire","Côte d'Ivoire","PAI-3957","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Pilot project for the use of new technologies in the active search for TB and among contact cases With regard to contact cases, a pilot project is planned for Abidjan with the use of awarenessraising/educational videos on tablets during surveys of patient contacts, and registration of all contact cases on an electronic database.",90501.1,null,"Active","a6Q1R000000AJ1H",0,0,0,0,90501.1,0,null,null,"Pilot project for the use of new technologies in the active search for TB and among contact cases With regard to contact cases, a pilot project is planned for Abidjan with the use of awarenessraising/educational videos on tablets during surveys of patient contacts, and registration of all contact cases on an electronic database.","Medium","A pilot project on community motivation ? aimed at case contacts","NA Original Intervention: Key populations","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Bhutan","Bhutan","PAI-3924","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Procurement of additional laboratory equipment for MDR-TB diagnosis and drugs for XDR-TB treatment.",174994,null,"Inactive","a6Q1R000000AJ0k",174994,0,0,0,0,1,null,null,"Procurement of additional laboratory equipment for MDR-TB diagnosis and drugs for XDR-TB treatment.","High","Training of Medical officers around the introduction of the new MDR regimen as well as the procurement of Laboratory equipment (1 GeneXpert and Culture/drug susceptibility capacity) is critical to the TB control goals of this FR. This module qualifies as value for money.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT South East Asia","2021-06-30"]
["CT Haiti","Haiti","PAI-4443","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Sign contracts with 17 television stations to broadcast messages to towns bordering areas in stratum 3\nexpected results:  to broadcast messages to towns bordering areas in stratum 3; 2/ populations in towns bordering areas in stratum 3 are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localities\nimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.",26520,null,"Active","a6Q1R000000AJ97",0,0,15157,0,11363,0,null,null,"Sign contracts with 17 television stations to broadcast messages to towns bordering areas in stratum 3\nexpected results:  to broadcast messages to towns bordering areas in stratum 3; 2/ populations in towns bordering areas in stratum 3 are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localities\nimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.","Low","This additional funding will support mass media activities (broadcasting messages in television). This represents low value for money and only 30% of the original request is being recommended under PAAR.","17/12/2018: As confirmed by FPM, 15,157 which was incorrectly recorded against the 1st activity on the UQD Update template is used to fund this intervention Original Module: Specific prevention interventions. Original Intervention: Information, education, communication/Behavior change communications (specific prevention interventions)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Latin America and Caribbean","2020-12-31"]
["CT Haiti","Haiti","PAI-4442","MCI-00013","Specific prevention interventions (SPI)","MCI-00169","Other specific prevention intervention(s)","Sign contracts with 23 new radio stations to broadcast messages on eliminating malaria in towns bordering areas in stratum 3\nexpected results: increase efforts againts progression of malaria; 2/ populations in towns bordering red areas are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localities\nimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.",8280,null,"Active","a6Q1R000000AJ96",0,0,0,0,8280,0,null,null,"Sign contracts with 23 new radio stations to broadcast messages on eliminating malaria in towns bordering areas in stratum 3\nexpected results: increase efforts againts progression of malaria; 2/ populations in towns bordering red areas are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localities\nimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.","Low","This request is meant to support broadcasting of mass media messages via radio. The contribution to impact of this additional request is not well substantiated and only 30% of the original request is being recommended under PAAR.","NA Original Module: Specific prevention interventions. Original Intervention: Information, education, communication/Behavior change communications (specific prevention interventions)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Latin America and Caribbean","2020-12-31"]
["CT Lao (Peoples Democratic Republic)","Lao (Peoples Democratic Republic)","PAI-4674","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Current limitation in access and offer of services by the primary health care network requires reaching more vulnerable and isolated populations by mobile active case finding teams equipped with portables digital X-ray and GeneXpert for using efficient diagnosis algorithm. Provinces and districts health staffs who participated in outreach camps, are aware of local TB epidemics, and learned how to conduct TB screening themselves if provided with portable digital X-ray and technical support at start. 2 additional provincial teams will be established in high TB burden provinces with demonstrated management capacity. Including equipment per team (1 portable digital X-ray system, 1 GeneXpert 4 modules machine, 1 pickup car, 20% PSM). In average, one team in one site (6 days including travel and installation) can screen 600 persons, test 150 presumptive TB patients by Xpert and start on treatment 30 new TB patients (15 bacteriologically confirmed and 15 clinical TB) x 12 sites x 2 teams. Total 720 additional new TB patients each year can be diagnosed and started on treatment, over 10% additional notification of new TB cases above the allocation targets each year in 2018-20.",818472,null,"Active","a6Q1R000000AJCq",9903,659259,0,0,149310,0,null,null,"Current limitation in access and offer of services by the primary health care network requires reaching more vulnerable and isolated populations by mobile active case finding teams equipped with portables digital X-ray and GeneXpert for using efficient diagnosis algorithm. Provinces and districts health staffs who participated in outreach camps, are aware of local TB epidemics, and learned how to conduct TB screening themselves if provided with portable digital X-ray and technical support at start. 2 additional provincial teams will be established in high TB burden provinces with demonstrated management capacity. Including equipment per team (1 portable digital X-ray system, 1 GeneXpert 4 modules machine, 1 pickup car, 20% PSM). In average, one team in one site (6 days including travel and installation) can screen 600 persons, test 150 presumptive TB patients by Xpert and start on treatment 30 new TB patients (15 bacteriologically confirmed and 15 clinical TB) x 12 sites x 2 teams. Total 720 additional new TB patients each year can be diagnosed and started on treatment, over 10% additional notification of new TB cases above the allocation targets each year in 2018-20.","High","High impact intervention","NA Original Intervention: Case detection and diagnosis: mobile active case finding (ACF) teams outreach","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT South East Asia","2020-12-31"]
["CT Ghana","Ghana","PAI-4278","MCI-00071","Other module","MCI-00071","Other module","Activities to contribute to the 90-90-90 targets will include intensifying peer adherence counselling and provision of psychosocial support to PLHIV at ART centres and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities.",753836,null,"Inactive","a6Q1R000000AJ6S",753836,0,0,0,0,1,null,null,"Activities to contribute to the 90-90-90 targets will include intensifying peer adherence counselling and provision of psychosocial support to PLHIV at ART centres and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities.","High","Activities will contribute to the 90- 90-90 targets through intensifying peer adherence counselling and provision of psychosocial support to people living with HIV at ART centres and in the community; models of care tracing people living with HIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities.","NA Original Module: ART - Models of Hope. Original Intervention: Peer adherence counselling and tracing of people living with HIV lost to follow up","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Albania","Albania","PAI-3596","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Support for documenting human rights violations and train community-based groups on their rights, to facilitate access to justice for key populations and to enforce their rights.",3000,null,"Active","a6Q1R000000AIvS",0,0,0,0,3000,0,null,null,"Support for documenting human rights violations and train community-based groups on their rights, to facilitate access to justice for key populations and to enforce their rights.","Medium","This work is considered to be useful to lift barriers to access to services for key populations",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2022-12-31"]
["CT Albania","Albania","PAI-3595","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Establish standards for Key population social and health services (sex workers, LGBTI)",15250,null,"Active","a6Q1R000000AIvR",0,0,0,0,15250,0,null,null,"Establish standards for Key population social and health services (sex workers, LGBTI)","Medium","These standards are important serve to improve quality of services","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Eastern Europe and Central Asia","2022-12-31"]
["CT Afghanistan","Afghanistan","PAI-3547","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Based on the Malaria  Program  Review recommendation, National Strategy was revised  in  March  2017, it stratified the country into 3 categories with category 1 consisting of high malaria endemicity provinces. LLINs is the only vector control measure used.  \nFunding was requested to procure LLINs  to  cover  category  1  districts  but  not  all  districts were covered.  Therefore, funds are needed to procure more LLINs. Distribution will   be   done   as   per   WHO   recommendation. No. of LLINs required = 1,615,363.",4846090,null,"Inactive","a6Q1R000000AIuf",0,4846090,0,0,0,1,null,null,"Based on the Malaria  Program  Review recommendation, National Strategy was revised  in  March  2017, it stratified the country into 3 categories with category 1 consisting of high malaria endemicity provinces. LLINs is the only vector control measure used.  \nFunding was requested to procure LLINs  to  cover  category  1  districts  but  not  all  districts were covered.  Therefore, funds are needed to procure more LLINs. Distribution will   be   done   as   per   WHO   recommendation. No. of LLINs required = 1,615,363.","High","It was already noted in the Program Continuation Request that not all Category 1 (high endemicity) districts were covered by LLINs, due to budget limitations ? the shortfall to cover all districts is now covered through this PAAR.","NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT South East Asia","2020-12-31"]
["CT Cabo Verde","Cabo Verde","PAI-4096","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","The aim of these interventions is to support door-to-door awareness campaigns regarding the fight against malaria, the transmission routes, symptoms and other preventive measures in partnership with NGOs and community associations, health delegations and the INSP.",30531.93,null,"Active","a6Q1R000000AJ3W",0,0,0,0,30531.93,0,null,null,"The aim of these interventions is to support door-to-door awareness campaigns regarding the fight against malaria, the transmission routes, symptoms and other preventive measures in partnership with NGOs and community associations, health delegations and the INSP.","Low","The TRP does not consider this approach to be a\nvalid need given the importance of identifying\nmigrants who are at higher risk of carrying malaria.\nIt can be considered a low quality demand.","NA Original Intervention: Information, education, communication/behavior change communications (vector control)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH","RT Central Africa"]
["CT Comoros","Comoros","PAI-4081","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","\"Development of the Program Performance Review and the strategic plan:\nThe Program Performance Review helps identify progress in terms of outcomes and impact, best practices, lessons learned, and bottlenecks and their causes. This information can then be used to propose solutions for improving program implementation and revising the strategic plan. Such an exercise was carried out in 2011 and 2017 and resulted in the formulation of new program directions.\nIn addition, the review brings together national and regional managers from the public health system, implementation partners and technical and financial partners. At the end of each review, specific recommendations will be made. It should be noted that before this review is held at the central level, it is first organized on each island. This ensures mutual accountability among the implementers.\"",51558.75,null,"Active","a6Q1R000000AJ3H",0,0,0,0,51558.75,0,null,null,"\"Development of the Program Performance Review and the strategic plan:\nThe Program Performance Review helps identify progress in terms of outcomes and impact, best practices, lessons learned, and bottlenecks and their causes. This information can then be used to propose solutions for improving program implementation and revising the strategic plan. Such an exercise was carried out in 2011 and 2017 and resulted in the formulation of new program directions.\nIn addition, the review brings together national and regional managers from the public health system, implementation partners and technical and financial partners. At the end of each review, specific recommendations will be made. It should be noted that before this review is held at the central level, it is first organized on each island. This ensures mutual accountability among the implementers.\"","High","Development of the Program\nPerformance Review and the\nstrategic plan. This is high\nquality demand, especially given\nthat the program review will\nidentify progress and bottlenecks\nof the implementation of malaria\ncontrol interventions, and will\npropose solutions for improving\nprogram implementation and\nrevising the Malaria Strategic\nPlan.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-12-31"]
["CT Comoros","Comoros","PAI-4080","MCI-00012","Case management","MCI-00154","Facility-based treatment","\"Development and dissemination of algorithms at all levels:\nThrough its supervision and monitoring activities, the program has noted that some health care providers are experiencing difficulties in correctly managing cases. One of the reasons for this is the lack of knowledge and the lack of a malaria treatment protocol.\nTo address this, the program intends to produce and disseminate treatment algorithms in all health care facilities.\"",5719.9,null,"Active","a6Q1R000000AJ3G",0,0,0,0,5719.9,0,null,null,"\"Development and dissemination of algorithms at all levels:\nThrough its supervision and monitoring activities, the program has noted that some health care providers are experiencing difficulties in correctly managing cases. One of the reasons for this is the lack of knowledge and the lack of a malaria treatment protocol.\nTo address this, the program intends to produce and disseminate treatment algorithms in all health care facilities.\"","Low","This activity is for material\ndevelopment for case\nmanagement algorithms. Since it\nmay not be covered in material\ndevelopment for IEC, it may be\nfunded.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-12-31"]
["CT Benin","Benin","PAI-3797","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Monitor the care provided at each facility on a quarterly basis: \nOne medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.",243274.6,null,"Active","a6Q1R000000AIyh",0,0,0,0,243274.6,0,null,null,"Monitor the care provided at each facility on a quarterly basis: \nOne medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.","Low",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Lao (Peoples Democratic Republic)","Lao (Peoples Democratic Republic)","PAI-4671","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Allocation funding will reach men who have sex with men  with prevention packages in 2 priority provinces only.  Partners provide services in 3 other provinces but this is to end December 2017, leaving a 94% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address 24% gap in condom supply",251963,null,"Active","a6Q1R000000AJCn",0,0,0,0,251963,0,null,null,"Allocation funding will reach men who have sex with men  with prevention packages in 2 priority provinces only.  Partners provide services in 3 other provinces but this is to end December 2017, leaving a 94% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address 24% gap in condom supply","High","Essential services for key populations in this concentrated epidemic","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Expansion to other provinces, condom programming","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4647","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","To deploy the B-IACM dashboards (national, provincial, OD and daily CMA) nationally in order to improve data management, link HIV related databases and to improve overall tracking of patients throughout the cascade. In addition NCHADS will scale-up systems for patient identification, sample tracking and remote services. Primarily this request is for training in the use of new technologies and for hardware to support the deployment is requested.",250000,null,"Inactive","a6Q1R000000AJCP",250000,0,0,0,0,1,null,null,"To deploy the B-IACM dashboards (national, provincial, OD and daily CMA) nationally in order to improve data management, link HIV related databases and to improve overall tracking of patients throughout the cascade. In addition NCHADS will scale-up systems for patient identification, sample tracking and remote services. Primarily this request is for training in the use of new technologies and for hardware to support the deployment is requested.","High","Given the success and central place of B-IACM in the response to HIV in the country, tools to monitor its indicators and track its results are important.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: HIV dashboards and patient tracking systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4646","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","eMTCT Roadmap implementation\nIn 2018 the MoH launched the national roadmap for elimination of Mother To Child Transmission (MTCT) of HIV & syphilis. The suggested intervention will support enhanced service delivery, including HIV testing and treatment, to reach the global impact indicators.  \nExpected:\n- Coverage of pregnant women who know their status of ? 95%\n- Antiretroviral treatment coverage of HIV-positive pregnant women of ? 95%\n- Antenatal coverage (at least one visit) of ? 95%\n- Infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth of ? 90%\n- Coverage of syphilis testing of pregnant women of ? 95\n- Treatment of syphilis-seropositive pregnant women ? 95%",285000,null,"Active","a6Q1R000000AJCO",0,0,0,0,285000,0,null,null,"eMTCT Roadmap implementation\nIn 2018 the MoH launched the national roadmap for elimination of Mother To Child Transmission (MTCT) of HIV & syphilis. The suggested intervention will support enhanced service delivery, including HIV testing and treatment, to reach the global impact indicators.  \nExpected:\n- Coverage of pregnant women who know their status of ? 95%\n- Antiretroviral treatment coverage of HIV-positive pregnant women of ? 95%\n- Antenatal coverage (at least one visit) of ? 95%\n- Infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth of ? 90%\n- Coverage of syphilis testing of pregnant women of ? 95\n- Treatment of syphilis-seropositive pregnant women ? 95%","High",null,"NA Original Module: Prevention of mother -to -child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4325","MCI-00007","Treatment, care and support","MCI-00117","HIV care","Nutritional support for people living with HIV. According to the vulnerability study carried out in December 2016, 23% of the patients on ART are malnourished. Therefore, this nutritional support forms an integral part of the optimum health care package for these patients. The amount requested will allow health care for 2,730 PLHIV for 180 days per year, in accordance with the specified inclusion criteria.",340003.37,null,"Active","a6Q1R000000AJ7D",0,0,0,0,340003.37,0,null,null,"Nutritional support for people living with HIV. According to the vulnerability study carried out in December 2016, 23% of the patients on ART are malnourished. Therefore, this nutritional support forms an integral part of the optimum health care package for these patients. The amount requested will allow health care for 2,730 PLHIV for 180 days per year, in accordance with the specified inclusion criteria.","High","This intervention is a priority if the nutrition support is part of a comprehensive support program for people living with HIV on ART (e.g. included in home-based care) but not as a stand-alone intervention.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Western Africa","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4632","MCI-00531","Comprehensive prevention programs for TGs","MCI-00554","Behavioral interventions for TGs","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Transgender (TG).  \nProlonging the working hours of outreach workers until midnight will allow for greater reach and will offer HIV and syphilis testing to TGs. \nExpected outcome:  177 TGs reached with defined package of services",45000,null,"Inactive","a6Q1R000000AJCA",0,45000,0,0,0,1,null,null,"Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Transgender (TG).  \nProlonging the working hours of outreach workers until midnight will allow for greater reach and will offer HIV and syphilis testing to TGs. \nExpected outcome:  177 TGs reached with defined package of services","High",null,"NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Afghanistan","Afghanistan","PAI-3542","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00094","Condoms and lubricant programming for PWID","There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.",172108,null,"Active","a6Q1R000000AIua",0,0,0,0,172108,0,null,null,"There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.","High","The TRP considers this intervention to be an important additional activity that builds and scales up harm reduction and HIV testing and counselling activities in Section 3 of the Applicant Self Assessment for Programme Continuation. As part of efforts to maximize impact towards ending the epidemic, the applicant proposes to use a dedicated mobile team to reach out to catchment areas that are missed by existing outreach teams in the major cities as well as out of reach non-urban areas in need of services","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Condoms and lubricant programming for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2020-12-31"]
["CT Afghanistan","Afghanistan","PAI-3541","MCI-00023","Program management","MCI-00207","Grant management","This refers to the PR 7% Grant Management Services (GMS) cost and Sub-recipient 5% overhead cost.",214501,null,"Active","a6Q1R000000AIuZ",0,0,0,0,214501,0,null,null,"This refers to the PR 7% Grant Management Services (GMS) cost and Sub-recipient 5% overhead cost.","High","The TRP considers this intervention to be appropriate given the amount requested and the challenges with grant management in a Challenging operating Environment",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2020-12-31"]
["CT Cuba","Cuba","PAI-4114","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","HIV prevention indicator surveys are expensive and may not have enough resources so that they can be performed periodically.",175000,null,"Inactive","a6Q1R000000AJ3o",175000,0,0,0,0,1,null,null,"HIV prevention indicator surveys are expensive and may not have enough resources so that they can be performed periodically.","Medium","Prevention surveys are important to monitor, yet since they are already fully integrate in the health structure, should also be part of the regular flow.","NA Original Module: Strengthening community response and systems. Original Intervention: Monitoring by the community","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Cabo Verde","Cabo Verde","PAI-4094","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","These interventions are intended to improve the psychological support provided to vulnerable children and orphans within the ICCA drop-in centre in Praia.",14654.92,null,"Active","a6Q1R000000AJ3U",0,0,0,0,14654.92,0,null,null,"These interventions are intended to improve the psychological support provided to vulnerable children and orphans within the ICCA drop-in centre in Praia.","Low","These activities should be possible to fund from\nsavings in existing budgets for psychological\nsupport and assistance to the orphan home.","NA Original Intervention: Other interventions for adolescent and youth","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH","RT Central Africa"]
["CT Comoros","Comoros","PAI-4079","MCI-00012","Case management","MCI-00162","Ensuring drug and other health product quality","\"Slide exchanges with internal and external laboratories for quality assurance: \nAccording to World Health Organization recommendations, slide quality control is essential in a country that is moving toward elimination, as is the case for the Union of the Comoros.  A correct reading of the slides is of paramount importance to avoid any misdiagnosis that may lead to the spread of the disease. Indeed, a positive slide read as negative may lead to an epidemic and undermine all efforts made so far toward eliminating the disease. \nAs a result, the training supervision of quality control officials has been included in the budget to enable continuous training on the theoretical and practical aspects of quality diagnosis. The NMCP requests funding under the PAAR for the following: the exchange of slides internally (from the islands to the NMCP reference laboratory) and from the NMCP laboratory to an external accredited laboratory. This would ensure that these slides are read correctly to avoid this kind of situation and would also be a means of assessing other laboratories in the country from which the NMCP collects data, in order to ensure reliable results and avoid any step that might hinder the elimination process.\"",12126.59,null,"Active","a6Q1R000000AJ3F",0,0,0,0,12126.59,0,null,null,"\"Slide exchanges with internal and external laboratories for quality assurance: \nAccording to World Health Organization recommendations, slide quality control is essential in a country that is moving toward elimination, as is the case for the Union of the Comoros.  A correct reading of the slides is of paramount importance to avoid any misdiagnosis that may lead to the spread of the disease. Indeed, a positive slide read as negative may lead to an epidemic and undermine all efforts made so far toward eliminating the disease. \nAs a result, the training supervision of quality control officials has been included in the budget to enable continuous training on the theoretical and practical aspects of quality diagnosis. The NMCP requests funding under the PAAR for the following: the exchange of slides internally (from the islands to the NMCP reference laboratory) and from the NMCP laboratory to an external accredited laboratory. This would ensure that these slides are read correctly to avoid this kind of situation and would also be a means of assessing other laboratories in the country from which the NMCP collects data, in order to ensure reliable results and avoid any step that might hinder the elimination process.\"","Low","Confirmation of slides for quality\nassurance is important. Given\nthat training for microscopy is\nprioritized, this intervention is\njustified.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-12-31"]
["CT Comoros","Comoros","PAI-4078","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","\"Organization of staff training on program management:\nIn recent years (following the new funding model), the NMCP has been selected by the Comoros Country Coordinating Mechanism as the Principal Recipient for the malaria control component. Capacity building is required for all staff on several aspects relating to program management. A grant management unit will be set up that should have the same level of understanding and be at the same grant implementation level. As such, training, supervision and performance monitoring sessions will be organized for each staff member.\"",36829.760000000002,null,"Active","a6Q1R000000AJ3E",0,0,0,0,36829.760000000002,0,null,null,"\"Organization of staff training on program management:\nIn recent years (following the new funding model), the NMCP has been selected by the Comoros Country Coordinating Mechanism as the Principal Recipient for the malaria control component. Capacity building is required for all staff on several aspects relating to program management. A grant management unit will be set up that should have the same level of understanding and be at the same grant implementation level. As such, training, supervision and performance monitoring sessions will be organized for each staff member.\"","Low","Comoros is set to eliminate\nmalaria by 2021. The need to\ntrain a large number of\npersonnel for the NMCP is not\nnecessary since most of the\ncurrent staff may need to be\nredeployed to other departments of the health system. To\nmaintain a team that will support\nmaintenance of the NMCP, the\nTRP recommends only 25\npercent (32,819.50) of the\nrequested amount, if funds\nbecome available.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-12-31"]
["CT Burkina Faso","Burkina Faso","PAI-3869","MCI-00008","TB care and prevention","MCI-00128","Prevention","Broadcasting each of the adverts 3 times per week and per language (French, Mossi, Dyula and Fula) on the 3 television channels. In fact, the radio adverts will be broadcast from 2018 until the first quarter of 2019, so that the KAP survey planned for the second quarter of 2019 will be used to measure their impact, among other things.",400326.23,null,"Active","a6Q1R000000AIzr",0,0,0,0,400326.23,0,null,null,"Broadcasting each of the adverts 3 times per week and per language (French, Mossi, Dyula and Fula) on the 3 television channels. In fact, the radio adverts will be broadcast from 2018 until the first quarter of 2019, so that the KAP survey planned for the second quarter of 2019 will be used to measure their impact, among other things.","Medium","TV adverts were chosen because they constitute an efficient manner of reaching a large number of people among the urban population, The review of the directives of the NTBCP involves updating these adverts.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Benin","Benin","PAI-3793","MCI-00023","Program management","MCI-00207","Grant management","Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):\nThis will motivate actors at the peripheral level.",92382.45,null,"Active","a6Q1R000000AIyd",0,0,0,0,92382.45,0,null,null,"Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):\nThis will motivate actors at the peripheral level.","Low","This is not instrumental in delivery of other activities therefore it is a low priority rating",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4666","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","A local lab consultant and lab technician will be recruited to ensure the quality of TB, maintenance lab equipment and support GeneXpert troubleshooting. Recruitment of one full time effort WHO Medical Office and short term TA will assist the program to ensure quality services. TRP only recommends 20% of the request.",180862,null,"Active","a6Q1R000000AJCi",0,0,0,0,180862,0,null,null,"A local lab consultant and lab technician will be recruited to ensure the quality of TB, maintenance lab equipment and support GeneXpert troubleshooting. Recruitment of one full time effort WHO Medical Office and short term TA will assist the program to ensure quality services. TRP only recommends 20% of the request.","Low","The TRP considers the support of a lab consultant, lab technician, maintenance of lab equipment, Gx troubleshooting, one fulltime WHO staff, and short-term technical assistance of this request to be relevant.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4642","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Improve HIV/STI referral and counselling via SwipeRx Mobile App\nSwipeRx is a free mobile application for pharmacy professionals. It?s online network of over 1,600 pharmacists. SwipeRx will give NCHADS the ability to communicate with pharmacies to improve awareness, education, prevention & treatment of STIs, including HIV, which may be improved by increasing provider-level awareness on referral pathways to testing facilities.\nExpected outcome: 5,000 STI patients refer to HIV testing and 5% diagnose HIV positive",80000,null,"Inactive","a6Q1R000000AJCK",0,80000,0,0,0,1,null,null,"Improve HIV/STI referral and counselling via SwipeRx Mobile App\nSwipeRx is a free mobile application for pharmacy professionals. It?s online network of over 1,600 pharmacists. SwipeRx will give NCHADS the ability to communicate with pharmacies to improve awareness, education, prevention & treatment of STIs, including HIV, which may be improved by increasing provider-level awareness on referral pathways to testing facilities.\nExpected outcome: 5,000 STI patients refer to HIV testing and 5% diagnose HIV positive","High",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4318","MCI-00071","Other module","MCI-00071","Other module","Malaria Indicator Survey (MIS): This survey, which is carried out once every three years, provides the principal household indicators associated with all of the modules for the malaria control interventions. \nBridge funding gap for the MIS 2020. The MIS will include the impact indicators relating to the mass distribution of LLINs, the SMC campaign and case management at community level.",88039.5,null,"Active","a6Q1R000000AJ76",0,0,0,0,88039.5,0,null,null,"Malaria Indicator Survey (MIS): This survey, which is carried out once every three years, provides the principal household indicators associated with all of the modules for the malaria control interventions. \nBridge funding gap for the MIS 2020. The MIS will include the impact indicators relating to the mass distribution of LLINs, the SMC campaign and case management at community level.","High","TRP acknowledges that this is high priority.","24/10/2018: TRP changed the priority rating from low to high. Original Module: RSSH. Original Intervention: Survey","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2020-12-31"]
["CT Guinea","Guinea","PAI-4294","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","Advocacy platform bringing together the TB and HIV programs, the government, elected members, TFPs and representatives from the various sectors; advocacy before the government and the partners in order to mobilise resources and to achieve the adoption of legislation beneficial to the effort to combat tuberculosis.",6069,null,"Active","a6Q1R000000AJ6i",0,0,0,0,6069,0,null,null,"Advocacy platform bringing together the TB and HIV programs, the government, elected members, TFPs and representatives from the various sectors; advocacy before the government and the partners in order to mobilise resources and to achieve the adoption of legislation beneficial to the effort to combat tuberculosis.","Low","Implementation of a ?TB TEAM? platform is of low priority","NA Original Intervention: Implementation of a ?TB TEAM? platform","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Western Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4221","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","As part of this module, ARV providing sites will be scaled up to improve access and reduce transport cost and increase retention. More CD4 and viral load point of care machines will be procured. Additional equipment and reagents to strengthen the existing molecular laboratory, will be procured. To enhance the care and support activities positive living training for new Bidho members, support IGA activities to PLHIV and long term economic support will be supported.",515000,null,"Active","a6Q1R000000AJ5X",0,0,0,0,515000,0,null,null,"As part of this module, ARV providing sites will be scaled up to improve access and reduce transport cost and increase retention. More CD4 and viral load point of care machines will be procured. Additional equipment and reagents to strengthen the existing molecular laboratory, will be procured. To enhance the care and support activities positive living training for new Bidho members, support IGA activities to PLHIV and long term economic support will be supported.","High","This request will expand access to ART by increasing ART sites. More CD4 and VL point of care machines will be procured. Additional equipment and reagents to strengthen the existing molecular laboratory, will be procured. To enhance the care and support activities positive living training for new Bidho members, support IGA activities to people living with HIV and long term economic support will be supported.","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4220","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00545","Pre-exposure prophylaxis (PrEP) for sex workers","The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.",56880,null,"Active","a6Q1R000000AJ5W",0,0,0,0,56880,0,null,null,"The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.","Medium","The allocation request contains funding for the pilot activities. Depending on the success of this additional funding could be considered and therefore this is of medium priority.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Honduras","Honduras","PAI-4416","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Contracting a coordinator and workers for organizations that intervene in the Garifuna population",102570,null,"Active","a6Q1R000000AJ8g",0,0,0,0,102570,0,null,null,"Contracting a coordinator and workers for organizations that intervene in the Garifuna population","Low","TRP recommends that the applicant further develop an efficient coordination structure for implementation of the key populations programs, avoiding when possible to have coordinators and staff for each key population sub-groups. The TRP furthermore recommends the applicant to consider integrating the roles of coordinator for key populations in only one position and including that position within-allocation if efficiencies are found during grant making.","NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-07-31"]
["CT Honduras","Honduras","PAI-4411","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Contracting a coordinator and workers for organizations that intervene in the MSM population",36196.46,null,"Active","a6Q1R000000AJ8b",0,0,0,0,36196.46,0,null,null,"Contracting a coordinator and workers for organizations that intervene in the MSM population","Low","TRP recommends that the applicant further develop an efficient coordination structure for implementation of the key populations programs, avoiding when possible to have coordinators and staff for each key population sub-groups. The TRP furthermore recommends the applicant to consider integrating the roles of coordinator for key populations in only one position and including that position within-allocation if efficiencies are found during grant-making.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-07-31"]
["CT Cabo Verde","Cabo Verde","PAI-4105","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","These interventions are  directed  towards: 1)  150 vulnerable children and adolescents who are received at day centres by facilitators from ICCA; 2) 80 vulnerable youths and adolescents in Praia with training and psychological support; 3) 620 peer educators within 21 secondary schools and, additionally, the coordination and follow-up of the activities performed by peer educators. These will supplement activities considered in the allocation amount.",141119.96,null,"Active","a6Q1R000000AJ3f",0,0,0,0,141119.96,0,null,null,"These interventions are  directed  towards: 1)  150 vulnerable children and adolescents who are received at day centres by facilitators from ICCA; 2) 80 vulnerable youths and adolescents in Praia with training and psychological support; 3) 620 peer educators within 21 secondary schools and, additionally, the coordination and follow-up of the activities performed by peer educators. These will supplement activities considered in the allocation amount.","High","Adolescents are an important risk group and\ntraining of peer mentors is a key strategy in\npreventing HIV infection. For this reason, the TRP\nconsiders this intervention of high priority.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH","RT Central Africa"]
["CT Cabo Verde","Cabo Verde","PAI-4104","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","For the TB/HIV component, a study is expected to be carried out in 2020 to update the bio-behavioral data for key HIV populations (sex workers, drug users and men who have sex with men).",58289.75,null,"Active","a6Q1R000000AJ3e",0,0,0,0,58289.75,0,null,null,"For the TB/HIV component, a study is expected to be carried out in 2020 to update the bio-behavioral data for key HIV populations (sex workers, drug users and men who have sex with men).","High","An updated bio-behavioral survey (BBS) is\nimportant to monitor the changes within the highest\nrisk key populations. The TRP considers this\nintervention of high priority.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH","RT Central Africa"]
["CT Comoros","Comoros","PAI-4070","MCI-00006","PMTCT","MCI-00112","Prong 1: Primary prevention of HIV infection among women of childbearing age","Organizing awareness-raising sessions and screening in schools and communities:\nAmong young people aged 15?24, the rate of regular condom use is low, at only 12 percent and the rate of HIV screening among the same group was less than 7 percent in 2014. Of 11 new HIV-positive cases reported in the Union of the Comoros in 2013, almost half were aged between 15 and 24 years.\nThe allocation amount provides for contracting five youth NGOs (FCAS, RNFD, CAP, Stop AIDS, CRCO) to carry out 400 awareness-raising and screening sessions for young people aged 10?24 in schools and communities in the first year, 500 sessions in the second year and 600 sessions in the third year. To contribute to the goal of halving new infections, particularly among young people, this above allocation grant will be used to provide an additional 300 sessions  in the second year and an additional 600 sessions in the third year.",11989.68,null,"Active","a6Q1R000000AJ36",0,0,0,0,11989.68,0,null,null,"Organizing awareness-raising sessions and screening in schools and communities:\nAmong young people aged 15?24, the rate of regular condom use is low, at only 12 percent and the rate of HIV screening among the same group was less than 7 percent in 2014. Of 11 new HIV-positive cases reported in the Union of the Comoros in 2013, almost half were aged between 15 and 24 years.\nThe allocation amount provides for contracting five youth NGOs (FCAS, RNFD, CAP, Stop AIDS, CRCO) to carry out 400 awareness-raising and screening sessions for young people aged 10?24 in schools and communities in the first year, 500 sessions in the second year and 600 sessions in the third year. To contribute to the goal of halving new infections, particularly among young people, this above allocation grant will be used to provide an additional 300 sessions  in the second year and an additional 600 sessions in the third year.","High",null,"NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2022-06-30"]
["CT Burkina Faso","Burkina Faso","PAI-3862","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.",25470.81,null,"Active","a6Q1R000000AIzk",0,0,0,0,25470.81,0,null,null,"Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.","Medium","A customized World Health Organisation (WHO ) software will be used for registering TB patients, including multi -drug resistant TB (MDR /TB ) patients. Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three month s during the first year and every six months in year 2.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Benin","Benin","PAI-3787","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","Sessions for the above.",514120.75,null,"Active","a6Q1R000000AIyX",0,0,0,0,514120.75,0,null,null,"Sessions for the above.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Benin","Benin","PAI-3786","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","The interventions involve the updating of modules, refresher training for actors, the editing of tools and consultation sessions. They will intensify prevention activities for truck drivers to ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 90?90?90 targets. This intervention was not budgeted for within the allocation amount.\nThis intervention comprises the following activities:\n-Updating the training modules for truck driver peer educators using a human rights and gender-transformative perspective. These include modules on health education, new forms of masculinity and the prevention of gender-based violence (?2,939.22)\n-Refresher training for 75 truck driver peer educators and 20 facilitators during four two-day sessions with 30 participants on the package of interventions (intervention strategies, Social Change and Behavior Change Communication (SC/BCC), pre- and post-test counseling) and data reporting tools (?15,726.64)\n-Producing 100 registers of people who have undergone awareness training and of the distribution of condoms and lubricants for truck drivers, and 3,500 fact sheets (?922.32)\n-Producing 90 visual aids based on a human rights and gender perspective for truck driver peer educators, including on health education, new forms of masculinity and the prevention of gender-based violence (?1,372.04)\n-Providing truck driver peer educators with one meal per day of the intervention, two days a month (outreach, communication and follow-up activities, distribution of condoms) (?38,417.15)\n-Recruiting consultants for the SGSS for truck drivers (?27,451)\n-An SGSS for truck drivers (?4,610)\n-A one-day consultation session with haulage trade unions (room hire, coffee break, administration and travel for 30 participants, supplies and photocopying) every six months, totaling six sessions over the three years by the sub-recipient (?8,378.60)\n-Producing 30 copies of the report on the SGSS for truck drivers (?228.67)\n-Covering the costs of the supply, storage, quality control and distribution of condoms for truck drivers (?6,146.74)\n-Producing 100 training manuals based on a human rights and gender perspective for truck driver peer educators (?381.12)",119598.25,null,"Active","a6Q1R000000AIyW",0,0,0,0,119598.25,0,null,null,"The interventions involve the updating of modules, refresher training for actors, the editing of tools and consultation sessions. They will intensify prevention activities for truck drivers to ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 90?90?90 targets. This intervention was not budgeted for within the allocation amount.\nThis intervention comprises the following activities:\n-Updating the training modules for truck driver peer educators using a human rights and gender-transformative perspective. These include modules on health education, new forms of masculinity and the prevention of gender-based violence (?2,939.22)\n-Refresher training for 75 truck driver peer educators and 20 facilitators during four two-day sessions with 30 participants on the package of interventions (intervention strategies, Social Change and Behavior Change Communication (SC/BCC), pre- and post-test counseling) and data reporting tools (?15,726.64)\n-Producing 100 registers of people who have undergone awareness training and of the distribution of condoms and lubricants for truck drivers, and 3,500 fact sheets (?922.32)\n-Producing 90 visual aids based on a human rights and gender perspective for truck driver peer educators, including on health education, new forms of masculinity and the prevention of gender-based violence (?1,372.04)\n-Providing truck driver peer educators with one meal per day of the intervention, two days a month (outreach, communication and follow-up activities, distribution of condoms) (?38,417.15)\n-Recruiting consultants for the SGSS for truck drivers (?27,451)\n-An SGSS for truck drivers (?4,610)\n-A one-day consultation session with haulage trade unions (room hire, coffee break, administration and travel for 30 participants, supplies and photocopying) every six months, totaling six sessions over the three years by the sub-recipient (?8,378.60)\n-Producing 30 copies of the report on the SGSS for truck drivers (?228.67)\n-Covering the costs of the supply, storage, quality control and distribution of condoms for truck drivers (?6,146.74)\n-Producing 100 training manuals based on a human rights and gender perspective for truck driver peer educators (?381.12)","Medium",null,"NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Guinea","Guinea","PAI-4301","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Improving the capacity to monitor and treat patients of MDR-TB (Bactec MGIT 960 device: USD 38,950; other equipment: USD 180; reagents USD 37,688 over the 3-year period).",76818,null,"Active","a6Q1R000000AJ6p",0,0,0,0,76818,0,null,null,"Improving the capacity to monitor and treat patients of MDR-TB (Bactec MGIT 960 device: USD 38,950; other equipment: USD 180; reagents USD 37,688 over the 3-year period).","High","This intervention will improve the capacity to monitor MDRTB patients.","NA Original Module: Care and prevention/testing and diagnostics. Original Intervention: Introduction of liquid culture at the LNRM","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Western Africa","2020-12-31"]
["CT Guinea","Guinea","PAI-4288","MCI-00023","Program management","MCI-00207","Grant management","6. Request for additional funding for the rehabilitation of the NMCP offices as per the studies carried out by UNOPS. The geotechnical and technical studies in preparations for the renovation work were financed by CRS (with the subsidy NFM 2015-2017).  The requested funding is to cover the gap in the costs of renovation that were initially budgeted prior to the finalization of the UNOPS studies.",275000,null,"Active","a6Q1R000000AJ6c",0,0,0,0,275000,0,null,null,"6. Request for additional funding for the rehabilitation of the NMCP offices as per the studies carried out by UNOPS. The geotechnical and technical studies in preparations for the renovation work were financed by CRS (with the subsidy NFM 2015-2017).  The requested funding is to cover the gap in the costs of renovation that were initially budgeted prior to the finalization of the UNOPS studies.","High",null,"Amount validated and description updated by CT Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2020-12-31"]
["CT Ghana","Ghana","PAI-4275","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","This will be undertaken to determine the actual MTCT rate at 6 weeks and at 18 months. It provides the opportunity to access the uptake of HIV testing and ART in pregnancy at the population level. HIV positive mothers and their children will be followed until 18 months to determine final MTCT. HIV positive children will be enrolled in care.",138309,null,"Active","a6Q1R000000AJ6P",0,0,0,0,138309,0,null,null,"This will be undertaken to determine the actual MTCT rate at 6 weeks and at 18 months. It provides the opportunity to access the uptake of HIV testing and ART in pregnancy at the population level. HIV positive mothers and their children will be followed until 18 months to determine final MTCT. HIV positive children will be enrolled in care.","Low","The need for this sentinel surveillance approach is not clearly articulated, given the existence of other approaches to estimate rates of HIV transmission to infants","NA Original Module: PMTCT - Early Infant HIV surveillance. Original Intervention: Establishment of infant HIV sentinel surveillance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Ghana","Ghana","PAI-4274","MCI-00071","Other module","MCI-00071","Other module","HIV vulnerabilities and barriers to access to HIV services among the physically challenged are unknown. This study aims to identify these and articulate options to address them as part of addressing human rights issues.",150000,null,"Active","a6Q1R000000AJ6O",0,0,0,0,150000,0,null,null,"HIV vulnerabilities and barriers to access to HIV services among the physically challenged are unknown. This study aims to identify these and articulate options to address them as part of addressing human rights issues.","Medium","HIV vulnerabilities and barriers to access to HIV services among the physically challenged are unknown. This study aims to identify these and articulate options to address them as part of addressing human rights issues and would be an aid to advocacy based on the outcomes of the study.","NA Original Module: Assessment of HIV vulnerabilities among physically challenged individuals. Original Intervention: Study ? assessment of vulnerabilities and access to HIV services in a neglected population group","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Ghana","Ghana","PAI-4266","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","This request is for the development of a transition plan that addresses Service Level Agreements, maintenance procedures, and training for supply chain managers on the Logistics Management Information System (LMIS). This will ensure sustained and optimal functioning of the LMIS, thus contributing to increased data visibility and reduced expiries.",970000,null,"Inactive","a6Q1R000000AJ6G",970000,0,0,0,0,1,null,null,"This request is for the development of a transition plan that addresses Service Level Agreements, maintenance procedures, and training for supply chain managers on the Logistics Management Information System (LMIS). This will ensure sustained and optimal functioning of the LMIS, thus contributing to increased data visibility and reduced expiries.","High","PSM weakness has been a significant factor in retarding program effectiveness in achieving impact","NA Original Module: RSSH - Procurement and supply chain management systems","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Gabon","Gabon","PAI-4261","MCI-00008","TB care and prevention","MCI-00127","Treatment","This amount represents the costs to ensure the availability of a safety stock for the first year and the availability of all first-line drugs for the second year. The immediate result is the absence of drug stockouts in the first two years. This will allow the program to make some adjustments to the resources of the state that do not always arrive at the desired time",175648.08,null,"Active","a6Q1R000000AJ6B",0,0,0,0,175648.08,0,null,null,"This amount represents the costs to ensure the availability of a safety stock for the first year and the availability of all first-line drugs for the second year. The immediate result is the absence of drug stockouts in the first two years. This will allow the program to make some adjustments to the resources of the state that do not always arrive at the desired time","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2021-12-31"]
["CT Eritrea","Eritrea","PAI-4244","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","The above allocation will support the procurement and maintenance cost of van for transporting MDR-TB patients from diagnostic centers to MDR hospital in order to reduce transmission. It will also enhance electronic surveillance for the programmatic management of MDR-TB.",148800,null,"Active","a6Q1R000000AJ5u",0,0,0,0,148800,0,null,null,"The above allocation will support the procurement and maintenance cost of van for transporting MDR-TB patients from diagnostic centers to MDR hospital in order to reduce transmission. It will also enhance electronic surveillance for the programmatic management of MDR-TB.","High","The above allocation will support the procurement and maintenance cost of van for transporting MDR-TB patients from diagnostic centres to MDR hospital in order to reduce transmission. It will also enhance electronic surveillance for the programmatic management of MDRTB.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4243","MCI-00008","TB care and prevention","MCI-00127","Treatment","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.",165600,null,"Active","a6Q1R000000AJ5t",0,0,0,0,165600,0,null,null,"The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.","High","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of GeneXpert in the peripheral hospitals in the country over the coming years. *The TRP recommends moving the activity on scaling up GeneXpert to the allocation budget through efficiencies identified during grantmaking.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Dominican Republic","Dominican Republic","PAI-4186","MCI-00004","Prevention programs for other vulnerable populations","MCI-00103","HIV testing services for other vulnerable populations","Community testing for Haitian migrants does not always take place in areas where prevalence is supposed to be higher (Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.",332500,null,"Active","a6Q1R000000AJ4y",0,0,0,0,332500,0,null,null,"Community testing for Haitian migrants does not always take place in areas where prevalence is supposed to be higher (Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Guatemala","Guatemala","PAI-4375","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Izabal health area department (planning pending).",9677.42,null,"Active","a6Q1R000000AJ81",0,0,0,0,9677.42,0,null,null,"Izabal health area department (planning pending).","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Comoros","Comoros","PAI-4089","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Activity 1: Replacement of TB focal points? motorbikes. \nRationale: The available motorbikes ? facilitating home visits and program outreach strategies ? have depreciated and are in poor condition. Result: Home visits for the systematic investigation of case contacts will not be hampered by logistical constraints. \nImpact: Increase in the number of identified and expected TB cases, with reduced TB transmission and also reduced morbidity and mortality.",30109.98,null,"Active","a6Q1R000000AJ3P",0,0,0,0,30109.98,0,null,null,"Activity 1: Replacement of TB focal points? motorbikes. \nRationale: The available motorbikes ? facilitating home visits and program outreach strategies ? have depreciated and are in poor condition. Result: Home visits for the systematic investigation of case contacts will not be hampered by logistical constraints. \nImpact: Increase in the number of identified and expected TB cases, with reduced TB transmission and also reduced morbidity and mortality.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Southern and Eastern Africa","2021-09-30"]
["CT Comoros","Comoros","PAI-4088","MCI-00023","Program management","MCI-00209","Other program management intervention(s)","\"Organization of a research trip for NMCP officials (national and island-specific) to share experiences from an island country at the elimination phase: \nExperience-sharing meetings and/or capacity-building workshops are held regularly abroad and the NMCP is often invited to participate.\nThe importance that the NMCP attributes to this component justifies the corresponding funding allocation under the PAAR. The budget is based on a trip to Dakar in November 2016, which involved the focal point, the monitoring and evaluation manager and a member of the accounts department. The same number (three people) was budgeted for for each remaining year in the grant.\nThe Union of the Comoros hopes to eliminate malaria by 2020. To achieve this objective, the NMCP should capitalize on the experiences of other countries and the knowledge of various experts to improve its performance.\"",15477.5,null,"Active","a6Q1R000000AJ3O",0,0,0,0,15477.5,0,null,null,"\"Organization of a research trip for NMCP officials (national and island-specific) to share experiences from an island country at the elimination phase: \nExperience-sharing meetings and/or capacity-building workshops are held regularly abroad and the NMCP is often invited to participate.\nThe importance that the NMCP attributes to this component justifies the corresponding funding allocation under the PAAR. The budget is based on a trip to Dakar in November 2016, which involved the focal point, the monitoring and evaluation manager and a member of the accounts department. The same number (three people) was budgeted for for each remaining year in the grant.\nThe Union of the Comoros hopes to eliminate malaria by 2020. To achieve this objective, the NMCP should capitalize on the experiences of other countries and the knowledge of various experts to improve its performance.\"","High","Trips for learnings or\nconferences to share\nexperiences and peer reviewed\ninformation is important and\nshould be funded.",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-12-31"]
["CT Burkina Faso","Burkina Faso","PAI-3858","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Training for providers of districts in clinical IMCI. Previous training have not met all the needs. The planning involves the training of an average of 25 staff per health district in the 8 regions not covered by the IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center-Sud, Center-East, Central): 25 sessions of 25 agents on average for 11 days in 2018 and 2020.",568340.06000000006,null,"Active","a6Q1R000000AIzg",0,0,0,0,568340.06000000006,0,null,null,"Training for providers of districts in clinical IMCI. Previous training have not met all the needs. The planning involves the training of an average of 25 staff per health district in the 8 regions not covered by the IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center-Sud, Center-East, Central): 25 sessions of 25 agents on average for 11 days in 2018 and 2020.","Medium","To enhance skills of health workers on clinical IMCI in the 8 regions not covered by IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center Sud, Center-East, Central), to improve care of children under 5, resulting in reduced infant and child mortality","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Organization of services and management institutions Train providers of districts in clinical IMCI","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4637","MCI-00531","Comprehensive prevention programs for TGs","MCI-00554","Behavioral interventions for TGs","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)\nReproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) \nExpected outcome: at least 2,160 hidden KPs reached",15500,null,"Active","a6Q1R000000AJCF",0,15000,0,0,500,0,null,null,"Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)\nReproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) \nExpected outcome: at least 2,160 hidden KPs reached","High",null,"NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4241","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.",90406,null,"Active","a6Q1R000000AJ5r",0,0,0,0,90406,0,null,null,"The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.","High","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of GeneXpert in the peripheral hospitals in the country over the coming years. *The TRP recommends moving the activity on scaling up GeneXpert to the allocation budget through efficiencies identified during grantmaking.","NA Original Intervention: Key populations (TB care and prevention)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4240","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.",1148780,null,"Active","a6Q1R000000AJ5q",0,0,0,0,1148780,0,null,null,"The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.","High","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of GeneXpert in the peripheral hospitals in the country over the coming years. *The TRP recommends moving the activity on scaling up GeneXpert to the allocation budget through efficiencies identified during grantmaking.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4227","MCI-00006","PMTCT","MCI-00115","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","To support the activities under allocation and expand the EID sites to the peripheral health facilities and provide family planning to women living with HIV as prong 2, more RH commodities including family planning commodities and Point of care PCR for EID services will be procured.",150000,null,"Active","a6Q1R000000AJ5d",0,0,0,0,150000,0,null,null,"To support the activities under allocation and expand the EID sites to the peripheral health facilities and provide family planning to women living with HIV as prong 2, more RH commodities including family planning commodities and Point of care PCR for EID services will be procured.","High","Improving access to early infant diagnosis (EID) is considered high priority, due to the geographical barriers that exist in Eritrea.","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4214","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x-rays, ECGs, etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas.",14100,null,"Active","a6Q1R000000AJ5Q",0,0,0,0,14100,0,null,null,"In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x-rays, ECGs, etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas.","High","In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x -rays, electrocardiogram s (ECGs ), etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas. Given the geographical constraints on reaching the population and lack of other donor funding this request is considered to be of high priority","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3712","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Partner coordination/policy drafting and dissemination \nThe budget is intended for (i) partner coordination meetings, particularly transnational meetings, and strengthening the coordination of the private sector not addressed by other partners; (ii) a fund mobilization meeting; (iii) meetings to draw up plans of action and annual and six-monthly reports. \nThe needs for 2018 are covered.",49614,null,"Active","a6Q1R000000AIxK",0,0,0,0,49614,0,null,null,"Partner coordination/policy drafting and dissemination \nThe budget is intended for (i) partner coordination meetings, particularly transnational meetings, and strengthening the coordination of the private sector not addressed by other partners; (ii) a fund mobilization meeting; (iii) meetings to draw up plans of action and annual and six-monthly reports. \nThe needs for 2018 are covered.","High",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Angola","Angola","PAI-3589","MCI-00008","TB care and prevention","MCI-00127","Treatment","PAAR to support quarterly supervision to health facilities (84 DOT sites in 18 provinces and communities)  in 2019, 2020 and, 2021. Expected outcome will be increase in TSR of TB cases.",238560,null,"Active","a6Q1R000000AIvL",0,0,0,0,238560,0,null,null,"PAAR to support quarterly supervision to health facilities (84 DOT sites in 18 provinces and communities)  in 2019, 2020 and, 2021. Expected outcome will be increase in TSR of TB cases.","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Benin","Benin","PAI-3785","MCI-00004","Prevention programs for other vulnerable populations","MCI-00103","HIV testing services for other vulnerable populations","This screening intervention will intensify prevention activities for truck drivers to provide better coverage of screening and protection among the target group, with a view to improving the framework for achieving the 90?90?90 targets. This activity was not budgeted for within the allocation amount. This intervention entails \na quarterly ten-day screening mission undertaken by four people, including a driver, aimed at truck drivers.",24388.959999999999,null,"Active","a6Q1R000000AIyV",0,0,0,0,24388.959999999999,0,null,null,"This screening intervention will intensify prevention activities for truck drivers to provide better coverage of screening and protection among the target group, with a view to improving the framework for achieving the 90?90?90 targets. This activity was not budgeted for within the allocation amount. This intervention entails \na quarterly ten-day screening mission undertaken by four people, including a driver, aimed at truck drivers.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4636","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)\nReproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) \nExpected outcome: at least 2,160 hidden KPs reached",15500,null,"Active","a6Q1R000000AJCE",0,15000,0,0,500,0,null,null,"Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)\nReproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) \nExpected outcome: at least 2,160 hidden KPs reached","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4235","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Different training programs are proposed by the Ministry of Health in order to improve capacity of malaria health workforce. Such programs include training on Malaria Elimination, Surveillance for Elimination or WHO Malariology course. Funding for such training sessions with familiarize the staff members with up-to-date malaria knowledge and latest WHO technical guidance.",42300,null,"Active","a6Q1R000000AJ5l",0,0,0,0,42300,0,null,null,"Different training programs are proposed by the Ministry of Health in order to improve capacity of malaria health workforce. Such programs include training on Malaria Elimination, Surveillance for Elimination or WHO Malariology course. Funding for such training sessions with familiarize the staff members with up-to-date malaria knowledge and latest WHO technical guidance.","High","Capacity enhancement with health workforce will sustain efforts to reduce the impact of malaria; e.g., training on malaria elimination, surveillance, etc.","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4234","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","Conduct of review meetings is of paramount importance to make assessment of IRS activities at the end each round of spraying. Moreover, provision of milk to spraymen will help them carry out the operation efficiently and with less hazards. A total of USD 38,019 estimated to cover the above two IRS related activities which have been well funded in the previous funding cycle.",38019,null,"Active","a6Q1R000000AJ5k",0,0,0,0,38019,0,null,null,"Conduct of review meetings is of paramount importance to make assessment of IRS activities at the end each round of spraying. Moreover, provision of milk to spraymen will help them carry out the operation efficiently and with less hazards. A total of USD 38,019 estimated to cover the above two IRS related activities which have been well funded in the previous funding cycle.","High","Review meetings after each round of spraying will improve overall effectiveness.","NA Original Intervention: Indoor residual spraying","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Eritrea","Eritrea","PAI-4222","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00577","Socioeconomic approaches","The allocation will support the scale up of life skills education for out of school adolescents to acquire life skills. In order to address GBV in addition to creating awareness among the population and law enforcements more women headed households in 6 zoba will be assisted through income generating activities/ microcredit loan.",517800,null,"Active","a6Q1R000000AJ5Y",0,0,0,0,517800,0,null,null,"The allocation will support the scale up of life skills education for out of school adolescents to acquire life skills. In order to address GBV in addition to creating awareness among the population and law enforcements more women headed households in 6 zoba will be assisted through income generating activities/ microcredit loan.","Medium","The allocation will support the scale up of life skills education for out of school adolescents to acquire life skills. In order to address gender-based violence (GBV) in addition to creating awareness among the population and law enforcements more women headed households in 6 Zoba will be assisted through income generating activities/ microcredit loan. This activity is considered of high priority only if it addresses comprehensive sexuality and linkages to reproductive health services and HIV testing","NA Original Intervention: Socio-economic approaches","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2020-12-31"]
["CT Egypt","Egypt","PAI-4203","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","(1) Teams of peer educators will conduct outreach with men who have sex with men to deliver information, education and communication messages regarding HIV prevention and care. These outreach programs are to be implemented by civil society organizations. Individuals are referred to either a voluntary counselling/testing service provider or a drop-in center for testing, counselling, and access to condoms and lubricants; (2) Gharbya: peer outreach program to MSM and PWID; with referral to government-run VCT services; (3) Condoms and Lubricants; (4) HIV Kits for VCTs & PITC",700025.52,null,"Active","a6Q1R000000AJ5F",0,0,0,0,700025.52,0,null,null,"(1) Teams of peer educators will conduct outreach with men who have sex with men to deliver information, education and communication messages regarding HIV prevention and care. These outreach programs are to be implemented by civil society organizations. Individuals are referred to either a voluntary counselling/testing service provider or a drop-in center for testing, counselling, and access to condoms and lubricants; (2) Gharbya: peer outreach program to MSM and PWID; with referral to government-run VCT services; (3) Condoms and Lubricants; (4) HIV Kits for VCTs & PITC","High","In the spirit of increasing the coverage of key populations through outreach and other activities as for the groups above, the TRP has re-prioritized these interventions for Men who Have Sex with Men from medium to high and to move the peer education and outreach component (1) to the allocation.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2022-03-31"]
["CT Dominican Republic","Dominican Republic","PAI-4181","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","There is a need to strengthen legal approaches, so that PLHIV, MSM and Trans networks can create social accountability platforms through a process of consensus, dialogue and advocacy to deal with discrimination, stigma, gender inequality and sustainable funding for their actions as social transformation networks.",320000,null,"Active","a6Q1R000000AJ4t",0,0,0,0,320000,0,null,null,"There is a need to strengthen legal approaches, so that PLHIV, MSM and Trans networks can create social accountability platforms through a process of consensus, dialogue and advocacy to deal with discrimination, stigma, gender inequality and sustainable funding for their actions as social transformation networks.","Low",null,"NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Burundi","Burundi","PAI-3709","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","This budget is required to cover for technical assistance  to support the implementation of the next LLIN campaign in 2020. It comprises international and domestic technical assistance to support the entire process of the 2020 mass campaign, up to the final report. Given the complexity of the organization on the ground, ongoing technical assistance is required throughout the campaign.",206160,null,"Active","a6Q1R000000AIxH",0,0,0,0,206160,0,null,null,"This budget is required to cover for technical assistance  to support the implementation of the next LLIN campaign in 2020. It comprises international and domestic technical assistance to support the entire process of the 2020 mass campaign, up to the final report. Given the complexity of the organization on the ground, ongoing technical assistance is required throughout the campaign.","High",null,"NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3704","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","This budget is required to: \n(i) Bridge a gap of 466,000 LLINs to meet all of the needs of the 2019 mass campaign. Of the total 6,997,954 LLINs required, taking into account an increase of 15 percent linked to counts and to logistical security, 6,531,828 have been provided using the allocation amount; (ii) The amount requested includes procurement costs and procurement and supply management/pooled procurement mechanism costs; (iii) The gap in the implementation costs that have not been included in the allocation amount (US$ 1,600,000); (iv) Expected outcomes: this funding will provide universal coverage of LLINs during the 2019 campaign.",2658053,null,"Active","a6Q1R000000AIxC",0,0,0,0,2658053,0,null,null,"This budget is required to: \n(i) Bridge a gap of 466,000 LLINs to meet all of the needs of the 2019 mass campaign. Of the total 6,997,954 LLINs required, taking into account an increase of 15 percent linked to counts and to logistical security, 6,531,828 have been provided using the allocation amount; (ii) The amount requested includes procurement costs and procurement and supply management/pooled procurement mechanism costs; (iii) The gap in the implementation costs that have not been included in the allocation amount (US$ 1,600,000); (iv) Expected outcomes: this funding will provide universal coverage of LLINs during the 2019 campaign.","High",null,"NA Original Intervention: Long-lasting insecticidal nets ? Mass campaign","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Angola","Angola","PAI-3582","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","This study to be conducted in 2019 and 2021  provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the DHIS2. This cohort analysis will include adults, children and women initiated on ART during pregnancy for the first time. The impact will be increased availability of strategic information to inform programming and implementation",300000,null,"Active","a6Q1R000000AIvE",0,0,0,0,300000,0,null,null,"This study to be conducted in 2019 and 2021  provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the DHIS2. This cohort analysis will include adults, children and women initiated on ART during pregnancy for the first time. The impact will be increased availability of strategic information to inform programming and implementation","Low","Given resource constrains, a cohort study is not a priority. Program -level data should be used to understand and make improvements in achieving treatment results.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Intervention: Study ? analysis of cohort of people living with HIV initiated on ART","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Côte d'Ivoire","Côte d'Ivoire","PAI-3948","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Develop the ?Husband School? approach Implement the ?husband school? approach in the Sud-Comoé region. This innovative approach has a double benefit?it increases the Funding request: Full review 15 February 2017 | 57 involvement of men in reducing barriers to access of PMTCT services as well improving the retention of seropositive pregnant women in care. Also, it fill the gaps on the vulnerable population of men over 35 by ensuring their access to screening through the front door of the PMTCT service. This intervention will involve the training of community actors in this approach so that they can implement the activities in 3 health districts in the Sud-Comoé region. It also involves the supplying of kits and guidance documents concerning this approach as well as workshops, missions, and supervisory visits.",150720.51,null,"Inactive","a6Q1R000000AJ18",150720.51,0,0,0,0,1,null,null,"Develop the ?Husband School? approach Implement the ?husband school? approach in the Sud-Comoé region. This innovative approach has a double benefit?it increases the Funding request: Full review 15 February 2017 | 57 involvement of men in reducing barriers to access of PMTCT services as well improving the retention of seropositive pregnant women in care. Also, it fill the gaps on the vulnerable population of men over 35 by ensuring their access to screening through the front door of the PMTCT service. This intervention will involve the training of community actors in this approach so that they can implement the activities in 3 health districts in the Sud-Comoé region. It also involves the supplying of kits and guidance documents concerning this approach as well as workshops, missions, and supervisory visits.","High","Development of the ?Husband School? approach in the SudComoé region should contribute to PMTCT as well as reduce GBV/ High priority because men are often gatekeepers to health care for women and children, and ?Husband Schools? can reduce barriers to access to treatment and care, especially for PMTCT, as shown by international normative guidance.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Africa 1","2020-12-31"]
["CT Central African Republic","Central African Republic","PAI-3944","MCI-00004","Prevention programs for other vulnerable populations","MCI-00101","Behavioral interventions for other vulnerable populations","Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.",39758.730000000003,null,"Inactive","a6Q1R000000AJ14",39758.730000000003,0,0,0,0,1,null,null,"Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.","High","Prevention activities are dramatically under-financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention program are severely underfunded and are considered high priority",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Central African Republic","Central African Republic","PAI-3934","MCI-00023","Program management","MCI-00207","Grant management","Increase treatment coverage and expand prevention services beyond the stated priority districts the allocation will support additional program management costs.",2958424.42,null,"Active","a6Q1R000000AJ0u",443762.77,0,0,0,2514661.65,0,null,null,"Increase treatment coverage and expand prevention services beyond the stated priority districts the allocation will support additional program management costs.","High","Given the recommendation from the TRP to increase treatment coverage and expand prevention services beyond the stated priority districts the allocation will support additional program management t costs.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Central African Republic","Central African Republic","PAI-3929","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","These activities are under-financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.",8553.4699999999993,null,"Inactive","a6Q1R000000AJ0p",8553.4699999999993,0,0,0,0,1,null,null,"These activities are under-financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","High","These activities are under -financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations .",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4333","MCI-00023","Program management","MCI-00207","Grant management","Equipment (laptop) for the National Secretariat to fight against HIV/AIDS.",940.41,null,"Active","a6Q1R000000AJ7L",0,0,0,0,940.41,0,null,null,"Equipment (laptop) for the National Secretariat to fight against HIV/AIDS.","Low","A purchase of laptop should be included in the management fees.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Western Africa","2020-12-31"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4332","MCI-00071","Other module","MCI-00071","Other module","Conduct a PMTCT services quality survey and provide qualitative indicators (Calculation of effective coverage indicators); as well as a health care quality survey, and provide indicators on quality of care (calculation of indicators of effective coverage of patients).",36541.35,null,"Active","a6Q1R000000AJ7K",0,0,0,0,36541.35,0,null,null,"Conduct a PMTCT services quality survey and provide qualitative indicators (Calculation of effective coverage indicators); as well as a health care quality survey, and provide indicators on quality of care (calculation of indicators of effective coverage of patients).","Medium","This may not be the best use of resources at this stage, given the many known challenges and the recommendations made by the TRP in the Program Continuation funding request for the improvement of service delivery. The proposed consultant can instead provide support to implement said recommendations, which would be of high priority. Consequently, the TRP recommends as quality demand with medium priority ?32,562 out of the ?65,124 requested for the international consultant to conduct the two proposed surveys (PMTCT services quality survey and health care quality survey).","NA Original Module: RSSH. Original Intervention: Analysis, review ? consultant for PMTCT services and health care quality surveys","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Western Africa","2020-12-31"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4313","MCI-00071","Other module","MCI-00071","Other module","Provision of integrated community case management.",1827666.93,null,"Inactive","a6Q1R000000AJ71",0,0,0,1827666.93,0,1,null,null,"Provision of integrated community case management.","High","The TRP notes this previously approved intervention will be fully funded by the World Bank.","25/10/2018: As per email by CT, this previously approved intervention will be fully funded by the World Bank. This was done prior to GNB-M coming for GAC Original Module: Health care. Original Intervention: Community-based health care and Information Education Communication / Behaviour Change Communication (IEC/BCC)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2020-12-31"]
["CT Egypt","Egypt","PAI-4206","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","TB case detection and diagnosis: (1) Increasing case detection through revising access to diagnosis pathway and implementing access to new and more sensitive diagnostic technology; revision of program guidelines; revision of diagnostic algorithm; (2) Increasing notification from university hospitals; (3) Increasing notification from the private sector",30841.96,null,"Active","a6Q1R000000AJ5I",0,0,0,0,30841.96,0,null,null,"TB case detection and diagnosis: (1) Increasing case detection through revising access to diagnosis pathway and implementing access to new and more sensitive diagnostic technology; revision of program guidelines; revision of diagnostic algorithm; (2) Increasing notification from university hospitals; (3) Increasing notification from the private sector","High","Planning the implementation of more sensitive technologies for diagnosis and drug sensitivity testing is a priority to meet current normative guidance for the country?s epidemiological situation. This intervention should be moved to the main allocation and funded through efficiencies identified during grant implementation.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2022-03-31"]
["CT Egypt","Egypt","PAI-4197","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","90-90-90 HIV services cascade analysis + ART cohort analysis for each of the focus key populations (PWID, MSM and FSW)",250000,null,"Active","a6Q1R000000AJ59",0,0,0,0,250000,0,null,null,"90-90-90 HIV services cascade analysis + ART cohort analysis for each of the focus key populations (PWID, MSM and FSW)","High","To the extent possible, as for example the cohort analysis proposed under this intervention should be included in the allocation request as accurate data is necessary for strategic and program planning and monitoring results.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2022-03-31"]
["CT Egypt","Egypt","PAI-4196","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Strengthen national HIV surveillance system starting with an assessment and building its capacity to address bottlenecks",15288.52,null,"Active","a6Q1R000000AJ58",0,0,0,0,15288.52,0,null,null,"Strengthen national HIV surveillance system starting with an assessment and building its capacity to address bottlenecks","High","This activity requires a small amount and should be moved to the allocation as a well-functioning national surveillance system is imperative for the strategic and program planning and monitoring results.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2022-03-31"]
["CT Guatemala","Guatemala","PAI-4390","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","Meetings on the development, approval and dissemination of plans regarding TB/HIV co-infection, to establish implementation approaches at the regional and local levels.",25554.44,null,"Active","a6Q1R000000AJ8G",18740.07,0,0,0,6814.37,0,null,null,"Meetings on the development, approval and dissemination of plans regarding TB/HIV co-infection, to establish implementation approaches at the regional and local levels.","Medium","Plans need to be established and disseminated for the optimal implementation of the interventions.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4387","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Conducting a second KAP survey to respond to the indicators in the performance framework (on LLIN use).",77000,null,"Inactive","a6Q1R000000AJ8D",77000,0,0,0,0,1,null,null,"Conducting a second KAP survey to respond to the indicators in the performance framework (on LLIN use).","High","This activity is very important for M&E performance as the LLIN use needs to be reported in 2020 as part of the impact indicator. This activity may be funded from the main allocation through savings.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Latin America and Caribbean","2021-06-30"]
["CT Burundi","Burundi","PAI-3703","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Activity: Strengthen the capacity of men champions (PLHIV) to raise men's awareness of the support and support of pregnant and lactating women for PMTCT\nThis activity aims to reduce new infections by reducing the transmission of HIV from mother to child.",17146,null,"Active","a6Q1R000000AIxB",0,0,0,0,17146,0,null,null,"Activity: Strengthen the capacity of men champions (PLHIV) to raise men's awareness of the support and support of pregnant and lactating women for PMTCT\nThis activity aims to reduce new infections by reducing the transmission of HIV from mother to child.","High",null,"NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3702","MCI-00534","Comprehensive prevention programs for MSM","MCI-00610","Other intervention(s) for MSM","Activity: Organizing at the national level, an advocacy workshop with different actors for LGBT mainstreaming in program design and LGBT interaction with the general population.\nThis activity helps to improve the prevention of HIV / AIDS and STIs among LGBT people and create an enabling environment to facilitate access of this population to prevention and care services.",4776,null,"Active","a6Q1R000000AIxA",0,0,0,0,4776,0,null,null,"Activity: Organizing at the national level, an advocacy workshop with different actors for LGBT mainstreaming in program design and LGBT interaction with the general population.\nThis activity helps to improve the prevention of HIV / AIDS and STIs among LGBT people and create an enabling environment to facilitate access of this population to prevention and care services.","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3697","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthening Quality Assurance at the National Reference Laboratory of INSP\nThis involves acquiring equipment maintenance contracts (HPLC, Spectrophotometer), equipment calibration with BBN, and participating in the rendering of inter-laboratory test results. This will allow the reliability of the results and ensure the reliability of the results and the performance of the laboratory compared to WHO / Accredited Prequalified Loboratory. This will serve to know if the prescribed drugs are of good quality and have positive effects for the patients.",60800,null,"Active","a6Q1R000000AIx5",0,0,0,0,60800,0,null,null,"Activity: Strengthening Quality Assurance at the National Reference Laboratory of INSP\nThis involves acquiring equipment maintenance contracts (HPLC, Spectrophotometer), equipment calibration with BBN, and participating in the rendering of inter-laboratory test results. This will allow the reliability of the results and ensure the reliability of the results and the performance of the laboratory compared to WHO / Accredited Prequalified Loboratory. This will serve to know if the prescribed drugs are of good quality and have positive effects for the patients.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Cabo Verde","Cabo Verde","PAI-4101","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00087","Behavioral interventions for sex workers","These activities are aimed at strengthening training sessions among  SWs, field sessions and interpersonal communication on HIV and other STIs by SWs peer educators  included in the budget of the allocation amount. They will complement activities that have already been taken into account in the allocation amount.",24781.73,null,"Active","a6Q1R000000AJ3b",0,0,0,0,24781.73,0,null,null,"These activities are aimed at strengthening training sessions among  SWs, field sessions and interpersonal communication on HIV and other STIs by SWs peer educators  included in the budget of the allocation amount. They will complement activities that have already been taken into account in the allocation amount.","High","The TRP considers this intervention of high quality\ndemand this another important key population group\nwho needs these interventions to reduce risk.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH","RT Central Africa"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-3996","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","The community system makes use of a network of community based organizations. It will fulfill the role of supporting community based organizations with their advocacy work in communities, to ensure: monitoring of activities at community level by its members, including audience analysis of broadcast communication campaigns, monitoring of service quality by means of mini satisfaction surveys for grantees, a link between the CHCSs and the PR and advocacy at various levels. The data will be captured directly by community level organizations and reported in the health system by means of the community based NHIS. In this manner, it provides significant support for community based monitoring activities, helping to make them higher quality.",2200000,null,"Active","a6Q1R000000AJ1u",0,0,0,0,2200000,0,null,null,"The community system makes use of a network of community based organizations. It will fulfill the role of supporting community based organizations with their advocacy work in communities, to ensure: monitoring of activities at community level by its members, including audience analysis of broadcast communication campaigns, monitoring of service quality by means of mini satisfaction surveys for grantees, a link between the CHCSs and the PR and advocacy at various levels. The data will be captured directly by community level organizations and reported in the health system by means of the community based NHIS. In this manner, it provides significant support for community based monitoring activities, helping to make them higher quality.","High","The community system makes use of a network of community-based organizations. It will fulfil the role of supporting community-based organizations with their advocacy work in communities, to ensure: monitoring of activities at community level by its members, including audience analysis of broadcast communication campaigns, monitoring of service quality by means of mini-satisfaction surveys for grantees and advocacy at various levels. The data will be captured directly by community-level organizations and reported in the health system by means of the community-based National Health Information System (NHIS). In this manner, it provides significant support for community-based monitoring activities, helping to make them be of higher quality",null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-3995","MCI-00012","Case management","MCI-00164","Other case management intervention(s)","The NSP provides for the following in the SBCC activities: advocating for meaningful engagement from the state, notably in terms of direct matching funding (>5%), a ban of drugs not recommended by the NMCP, tax relief/removal, strengthening the area of communication, which involves resource mobilization, actor and grantee  information so that they change their behavior and take ownership of all elements of the fight against malaria. It is within this framework that $800,000 is requested as part of the PAAR.",800000,null,"Active","a6Q1R000000AJ1t",0,0,0,0,800000,0,null,null,"The NSP provides for the following in the SBCC activities: advocating for meaningful engagement from the state, notably in terms of direct matching funding (>5%), a ban of drugs not recommended by the NMCP, tax relief/removal, strengthening the area of communication, which involves resource mobilization, actor and grantee  information so that they change their behavior and take ownership of all elements of the fight against malaria. It is within this framework that $800,000 is requested as part of the PAAR.","High","The funding will support the DRC to implement Social and Behavioural Change Communication (SBCC) activities that are in the National Strategic Planning (NSP). These activities will enhance a ban of drugs not recommended by the National Malaria Control Plan (NMCP) and support the increased participation of all players in malaria control.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Central African Republic","Central African Republic","PAI-3938","MCI-00015","RSSH: Human resources for health (HRH), including community health workers","MCI-00175","Retention and scale-up of health workers, including for community health workers","Ensure availability of human resources for the provision of services.",77875.66,null,"Active","a6Q1R000000AJ0y",0,0,0,0,77875.66,0,null,null,"Ensure availability of human resources for the provision of services.","High","Ensure availability of human resources for the provision of services.","NA Original Module: RSSH - Human resources for health, including community health workers","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4661","MCI-00008","TB care and prevention","MCI-00129","Engaging all care providers (TB care and prevention)","Contribution to HEF TB service package. TRP recommends evaluation of HEF before natinal scale up.",2100000,null,"Active","a6Q1R000000AJCd",0,0,0,0,2100000,0,null,null,"Contribution to HEF TB service package. TRP recommends evaluation of HEF before natinal scale up.","High","The TRP considers the contribution to HEF a high-quality investment to gain experience with this financing mechanism. The TRP recommends a thorough evaluation before considering national scale-up.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4656","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","ACF in prisons",96330,null,"Active","a6Q1R000000AJCY",0,0,0,0,96330,0,null,null,"ACF in prisons","High","-","NA Original Intervention: Key populations (TB care and prevention) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Central African Republic","Central African Republic","PAI-3928","MCI-00007","Treatment, care and support","MCI-00117","HIV care","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.",10560118.949999999,null,"Active","a6Q1R000000AJ0o",306571.65000000002,8264649.3099999996,0,0,1988897.99,0,null,null,"The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.","High","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burkina Faso","Burkina Faso","PAI-3856","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","BAcquire reagents and consumables for the production of labile blood products (PSL). The request is to support the procurement of kits consisting of serological reagents, blood bags, tubes, etc.",4603524.41,null,"Active","a6Q1R000000AIze",0,0,0,0,4603524.41,0,null,null,"BAcquire reagents and consumables for the production of labile blood products (PSL). The request is to support the procurement of kits consisting of serological reagents, blood bags, tubes, etc.","High","Requested amount is to cover 50% of unmet needs for testing labile blood products (covering HIV, hepatitis and syphilis); to ensure safety of blood for transfusion","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Benin","Benin","PAI-3774","MCI-00023","Program management","MCI-00207","Grant management","Organize a six-monthly, ten-day mission to validate the use of rapid diagnostic tests in the activities in the following six-month period (two teams of four people: one manager, one accountant, one monitoring and evaluation specialist and one driver):\nThis activity facilitates the implementation of activities, particularly at the CIPEC level.",27971.05,null,"Active","a6Q1R000000AIyK",0,0,0,0,27971.05,0,null,null,"Organize a six-monthly, ten-day mission to validate the use of rapid diagnostic tests in the activities in the following six-month period (two teams of four people: one manager, one accountant, one monitoring and evaluation specialist and one driver):\nThis activity facilitates the implementation of activities, particularly at the CIPEC level.","Medium",null,"NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Guinea","Guinea","PAI-4296","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Four GeneXpert machines will be purchased. Three of these will be placed in the heavily used CDTs in the municipalities of Matoto and Ratoma, which are the most populated and cover the largest area; the 4th machine will be sited in the CDT in Maciré (municipality of Dixin), near to the CHU which is home to a large paediatrics department. Impact: increase in the detection of cases of TB, TB-HIV, MDR-TB, childhood TB. The cost includes the purchase of the four machines, their calibration in years 2 and 3 and the provision of 1200 cartridges per machine per year.",220983,null,"Active","a6Q1R000000AJ6k",0,0,0,0,220983,0,null,null,"Four GeneXpert machines will be purchased. Three of these will be placed in the heavily used CDTs in the municipalities of Matoto and Ratoma, which are the most populated and cover the largest area; the 4th machine will be sited in the CDT in Maciré (municipality of Dixin), near to the CHU which is home to a large paediatrics department. Impact: increase in the detection of cases of TB, TB-HIV, MDR-TB, childhood TB. The cost includes the purchase of the four machines, their calibration in years 2 and 3 and the provision of 1200 cartridges per machine per year.","High","This is important to increase the detection of cases of TB, TB-HIV and MDR-TB.","NA Original Module: Care and prevention/testing and diagnostics. Original Intervention: Extending GeneXpert coverage into the municipalities of Conakry","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Western Africa","2020-12-31"]
["CT Guinea","Guinea","PAI-4295","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","The renovation of the LNRM planned for 2017 will not include upgrading it to bring it into compliance with the biosecurity standards. Cost in USD, based on a quotation.",480000,null,"Active","a6Q1R000000AJ6j",0,0,0,0,480000,0,null,null,"The renovation of the LNRM planned for 2017 will not include upgrading it to bring it into compliance with the biosecurity standards. Cost in USD, based on a quotation.","High","The renovation of the LNRM is a key activity in order to ensure biosecurity. *It should be included in the main allocation (Efficiencies within the allocation budget should be sought to enable the activities outlined in this module to be conducted, i.e. to renovate the National Mycobacterium Reference Laboratory (LNRM) and ensure compliance with biosecurity standards.)","NA Original Module: Care and prevention/testing and diagnostics. Original Intervention: Making the national reference laboratory (LNRM) compliant with the biosecurity standards","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Western Africa","2020-12-31"]
["CT Egypt","Egypt","PAI-4195","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00180","Other procurement supply chain management intervention(s)","Conduct of a Procurement and Supply Chain Management workshop",6610.64,null,"Active","a6Q1R000000AJ57",0,0,0,0,6610.64,0,null,null,"Conduct of a Procurement and Supply Chain Management workshop","Low",null,"NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Other procurement and supply chain management intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2022-03-31"]
["CT Algeria","Algeria","PAI-4190","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00583","Stigma and discrimination reduction","Stigma and discrimination in care settings for PLHIV and key populations is a reality in Algeria, as evidenced by the results of the \"Index stigma\" study. These behaviors are an obstacle to key populations accessing services, especially treatment. Thus, it is planned to train the staff of 60 testing centers and 15 reference centers on medical ethics to raise their awareness about challenges faced by KPs, reduce social rejection and discrimination within care structures as well as improve the quality of care on the one hand and on the other hand organize meetings periodically to handle complaints in accordance with Article 28 of the new law on health.",252540.1,null,"Active","a6Q1R000000AJ52",0,0,0,0,252540.1,0,null,null,"Stigma and discrimination in care settings for PLHIV and key populations is a reality in Algeria, as evidenced by the results of the \"Index stigma\" study. These behaviors are an obstacle to key populations accessing services, especially treatment. Thus, it is planned to train the staff of 60 testing centers and 15 reference centers on medical ethics to raise their awareness about challenges faced by KPs, reduce social rejection and discrimination within care structures as well as improve the quality of care on the one hand and on the other hand organize meetings periodically to handle complaints in accordance with Article 28 of the new law on health.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Middle East and North Africa","2022-12-31"]
["CT Dominican Republic","Dominican Republic","PAI-4175","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00585","Training of health care providers on human rights and medical ethics related to HIV and HIV/TB","The groups with the highest prevalence and incidence have limited access to prevention, treatment, care and support services. Underlying factors include: i) lack of respect that leads to their socially and financially marginalized status; ii) stigma and discrimination by the public and by social work activity and healthcare personnel; iii) deficiencies of the legal and institutional system; iv) low participation of the population in the design, supervision and evaluation of the services.**",161000,null,"Active","a6Q1R000000AJ4n",0,0,0,0,161000,0,null,null,"The groups with the highest prevalence and incidence have limited access to prevention, treatment, care and support services. Underlying factors include: i) lack of respect that leads to their socially and financially marginalized status; ii) stigma and discrimination by the public and by social work activity and healthcare personnel; iii) deficiencies of the legal and institutional system; iv) low participation of the population in the design, supervision and evaluation of the services.**","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Dominican Republic","Dominican Republic","PAI-4174","MCI-00531","Comprehensive prevention programs for TGs","MCI-00558","HIV testing services for TGs","Community testing does not always take place in areas where prevalence is supposed to be higher (according to the Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.",161000,null,"Inactive","a6Q1R000000AJ4m",161000,0,0,0,0,1,null,null,"Community testing does not always take place in areas where prevalence is supposed to be higher (according to the Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.","Medium","In light of the success in achieving high coverage of transgender people with prevention efforts and a relatively low HIV sero=positivity rate in newly tested cases, under the existing allocation request, the TRP considers additional resources for this population to be medium priority.","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: HIV testing services for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Cambodia","Cambodia","PAI-4617","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","To facilitate the transition of the KP-friendly clinic, Chuuk Sor, previously funded through PEPFAR, one year of support (2018) is requested within allocation.",120000,null,"Inactive","a6Q1R000000AJBv",120000,0,0,0,0,1,null,null,"To facilitate the transition of the KP-friendly clinic, Chuuk Sor, previously funded through PEPFAR, one year of support (2018) is requested within allocation.","High","Specialised care for HIV positive key populations, formerly funded by PEPFAR. The applicant should consider moving this above allocation request into the allocation amount in order to complement the allocation funding in Year 1 that is directed towards this intervention.","NA Original Intervention: Chuuk Sor key population-friendly clinic","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Honduras","Honduras","PAI-4407","MCI-00534","Comprehensive prevention programs for MSM","MCI-00608","Diagnosis and treatment of STIs and other sexual health services for MSM","Rapid testing to detect Hepatitis B Surface Antigen (HBsAg) and hepatitis C for the key population",42503.07,null,"Active","a6Q1R000000AJ8X",0,0,0,0,42503.07,0,null,null,"Rapid testing to detect Hepatitis B Surface Antigen (HBsAg) and hepatitis C for the key population","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-07-31"]
["CT Honduras","Honduras","PAI-4402","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","Activities to a) improve coordination with the main centers of reference for people with HIV; b) guarantee compliance with preventive therapy regulations with Isoniazid and c) other collaborating activities for TB and HIV.\nThese activities include work meetings with the Logistics Unit for medicines, supplies and equipment (ULMIE), General Directorate of Integrated Health Networks (DGRISS) and Health Surveillance Unit (UVS) teams for screening and programing drugs, distribution plans and tracking of regulatory compliance",58492.800000000003,null,"Active","a6Q1R000000AJ8S",0,0,0,0,58492.800000000003,0,null,null,"Activities to a) improve coordination with the main centers of reference for people with HIV; b) guarantee compliance with preventive therapy regulations with Isoniazid and c) other collaborating activities for TB and HIV.\nThese activities include work meetings with the Logistics Unit for medicines, supplies and equipment (ULMIE), General Directorate of Integrated Health Networks (DGRISS) and Health Surveillance Unit (UVS) teams for screening and programing drugs, distribution plans and tracking of regulatory compliance","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-07-31"]
["CT Guatemala","Guatemala","PAI-4365","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Malacatán Hospital, San Marcos. Renovation of a 416 m² facility, including: \nwaterproof treatment of floor; paintwork for walls; epoxy paint in laboratory; making fixed furniture units; removing and replacing 13 wooden doors; fitting one aluminum door; installing two 2 x 32 lights; three washbasins; installing water; replacing fittings for eight washbasins; replacing one existing door lock; supplying ten fluorescent light tubes.",10775,null,"Active","a6Q1R000000AJ7r",0,0,0,0,10775,0,null,null,"Malacatán Hospital, San Marcos. Renovation of a 416 m² facility, including: \nwaterproof treatment of floor; paintwork for walls; epoxy paint in laboratory; making fixed furniture units; removing and replacing 13 wooden doors; fitting one aluminum door; installing two 2 x 32 lights; three washbasins; installing water; replacing fittings for eight washbasins; replacing one existing door lock; supplying ten fluorescent light tubes.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4363","MCI-00534","Comprehensive prevention programs for MSM","MCI-00607","HIV testing services for MSM","70,108 HIV tests to cover 100 percent of the programmatic gap in 2020.",110771,null,"Active","a6Q1R000000AJ7p",0,0,0,0,110771,0,null,null,"70,108 HIV tests to cover 100 percent of the programmatic gap in 2020.","High",null,"Both the interventions for 'HIV testing services for transgender people' under module 'Comprehensive prevention programs for men who have sex with men' are merged in the TRP form Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4353","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Asunción Mita Health Center, Jutiapa. Renovation of a 16 m² clinic, including: preliminary work; foundations; structural elements; erecting a block wall; laying reinforced concrete floor; finishing for walls and floor; laying ceramic flooring; installing one door, five windows, one washbasin; installing water and electricity; concrete bench; pavement; outer metal structure; paintwork.",10000,null,"Active","a6Q1R000000AJ7f",0,0,0,0,10000,0,null,null,"Asunción Mita Health Center, Jutiapa. Renovation of a 16 m² clinic, including: preliminary work; foundations; structural elements; erecting a block wall; laying reinforced concrete floor; finishing for walls and floor; laying ceramic flooring; installing one door, five windows, one washbasin; installing water and electricity; concrete bench; pavement; outer metal structure; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT India","India","PAI-4542","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","HMIS will be used for real-time collection and compilation of data to strengthen monitoring, supervision and data quality. It would encompass epidemiological, logistics, and human resource management. Moving towards malaria elimination, it would enhance the real-time monitoring at different levels. Moreover, the proper implementation of HMIS tool on PAN India basis would enhance disease control leading to reduction in morbidity and mortality, and ensure proper use of logistics. Dashboard would have provision for other implementing partners too.",17700000,null,"Active","a6Q1R000000AJAi",823615,0,0,0,16876385,0,null,null,"HMIS will be used for real-time collection and compilation of data to strengthen monitoring, supervision and data quality. It would encompass epidemiological, logistics, and human resource management. Moving towards malaria elimination, it would enhance the real-time monitoring at different levels. Moreover, the proper implementation of HMIS tool on PAN India basis would enhance disease control leading to reduction in morbidity and mortality, and ensure proper use of logistics. Dashboard would have provision for other implementing partners too.","High","This intervention will strengthen the monitoring and supervision and ensure data quality; to enhance real-time reporting at the different levels; for proper implementation of HMIS tool in India, which is considered high priority","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2021-03-31"]
["CT India","India","PAI-4541","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","This includes procurement and distribution cost of LLINs for Odisha which need to be replaced in 2020 to sustain the impact of LLINs distributed in 2017. Odisha accounts for more than 40% of malaria in India. Maintaining LLINs coverage in Odisha would reduce malaria morbidity & mortality by 70% in 2020 compared to 2015, similar to NE states. 90% of LLNs are assumed to be used by population in coverage areas.",31700000,null,"Active","a6Q1R000000AJAh",5899275,0,0,0,25800725,0,null,null,"This includes procurement and distribution cost of LLINs for Odisha which need to be replaced in 2020 to sustain the impact of LLINs distributed in 2017. Odisha accounts for more than 40% of malaria in India. Maintaining LLINs coverage in Odisha would reduce malaria morbidity & mortality by 70% in 2020 compared to 2015, similar to NE states. 90% of LLNs are assumed to be used by population in coverage areas.","High","LLINs requirement for mass net replacement for Odisha in 2020 to sustain impact of LLIN distributed in 2017. Odisha is contributing to 40% of total malaria cases in the country, therefore this intervention is considered high priority.","NA Original Intervention: LLINs","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Asia","2021-03-31"]
["CT Burundi","Burundi","PAI-3733","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Purchase of 17 vehicles and their insurance.\nSupervision is a priority activity in the fight against tuberculosis. The available supervision vehicles are old and most of them were acquired more than ten years ago. With depreciation and rugged terrain, repair costs become more and more huge.",520200,null,"Active","a6Q1R000000AIxf",0,0,0,0,520200,0,null,null,"Purchase of 17 vehicles and their insurance.\nSupervision is a priority activity in the fight against tuberculosis. The available supervision vehicles are old and most of them were acquired more than ten years ago. With depreciation and rugged terrain, repair costs become more and more huge.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3728","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Installation and implementation of GxAlert (or similar system) / networking of GeneXpert devices: The PNILT has acquired 18 GeneXpert devices from the Global Fund, which it has installed on strategic sites throughout the country. These devices were added to 6 acquired with funding from the World Bank, a fleet of 24 devices in total. To achieve the full value of the investments made in Xpert, the results must be transmitted from the machine to the service provider in a timely manner. However, xpert results are currently reported on paper. This reporting system is time consuming and limits the potential for optimizing patient care and management.",150000,null,"Active","a6Q1R000000AIxa",0,0,0,0,150000,0,null,null,"Installation and implementation of GxAlert (or similar system) / networking of GeneXpert devices: The PNILT has acquired 18 GeneXpert devices from the Global Fund, which it has installed on strategic sites throughout the country. These devices were added to 6 acquired with funding from the World Bank, a fleet of 24 devices in total. To achieve the full value of the investments made in Xpert, the results must be transmitted from the machine to the service provider in a timely manner. However, xpert results are currently reported on paper. This reporting system is time consuming and limits the potential for optimizing patient care and management.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3693","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on preventive maintenance and qualification of the HPLC chain\nLack of expertise on the qualification of the HPLC chain. No local expertise in this area. It would be good to train 2 units",12000,null,"Active","a6Q1R000000AIx1",0,0,0,0,12000,0,null,null,"Activity: Training on preventive maintenance and qualification of the HPLC chain\nLack of expertise on the qualification of the HPLC chain. No local expertise in this area. It would be good to train 2 units","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3692","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structures\nCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.",250000,null,"Active","a6Q1R000000AIx0",0,0,0,0,250000,0,null,null,"Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structures\nCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.","High",null,"NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3658","MCI-00022","RSSH: Health management information systems and M&E","MCI-00203","Administrative and finance data sources","Activity: Review the tools for collecting HIV data\nThe set of HIV tools will be revised by integrating all the indicators of the new strategic plan 2018-2022 and the adequacy of the new guidelines for the care of PLHIV. This will provide data for monitoring the strategic plan. Two workshops of 25 people for 4 days will be carried out inside the country.",8287,null,"Active","a6Q1R000000AIwS",0,0,0,0,8287,0,null,null,"Activity: Review the tools for collecting HIV data\nThe set of HIV tools will be revised by integrating all the indicators of the new strategic plan 2018-2022 and the adequacy of the new guidelines for the care of PLHIV. This will provide data for monitoring the strategic plan. Two workshops of 25 people for 4 days will be carried out inside the country.","High",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Administrative and financial data sources","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Angola","Angola","PAI-3579","MCI-00534","Comprehensive prevention programs for MSM","MCI-00539","Addressing stigma, discrimination and violence against MSM","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate MSM to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of MSM reached with services.",30000,null,"Active","a6Q1R000000AIvB",0,0,0,0,30000,0,null,null,"The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate MSM to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of MSM reached with services.","Low","Interventions for men who have sex with men in the funding request already cover sufficient interventions for men who have sex with men.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Addressing stigma, discrimination and violence against men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Djibouti","Djibouti","PAI-4132","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","Retrain / train doctors, nurses and pharmacists, including the parapublic and private sector, on the monitoring and evaluation system and on TB and coinfection TB HIV (as part of the RTTR Strategy). The expected result is the harmonization of the M & E system among stakeholders.",169,null,"Active","a6Q1R000000AJ46",0,0,0,0,169,0,null,null,"Retrain / train doctors, nurses and pharmacists, including the parapublic and private sector, on the monitoring and evaluation system and on TB and coinfection TB HIV (as part of the RTTR Strategy). The expected result is the harmonization of the M & E system among stakeholders.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4130","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Coaching and transfer of competence in multi drug resistant TB (Daily allowance related to supervision / investigation / data collection / transport / other costs).\nThis is to ensure the quality of services, including the identification of MDR TB patients to improve the inclusion rate of these patients put on treatment and retention until recovery.",14237,null,"Active","a6Q1R000000AJ44",0,0,0,0,14237,0,null,null,"Coaching and transfer of competence in multi drug resistant TB (Daily allowance related to supervision / investigation / data collection / transport / other costs).\nThis is to ensure the quality of services, including the identification of MDR TB patients to improve the inclusion rate of these patients put on treatment and retention until recovery.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Cabo Verde","Cabo Verde","PAI-4099","MCI-00000","Prevention programs for general population","MCI-00073","Condoms as part of programs for general population","HIV is transmitted during unprotected sex. In this regards, this investment is to acquire 9,000,000 condoms (total for 3 years) to prevent the transmission of HIV and other STIs within the populations.",295043.21000000002,null,"Active","a6Q1R000000AJ3Z",0,0,0,0,295043.21000000002,0,null,null,"HIV is transmitted during unprotected sex. In this regards, this investment is to acquire 9,000,000 condoms (total for 3 years) to prevent the transmission of HIV and other STIs within the populations.","Low","The TRP considers the procurement and\ndistribution of free condoms to the \"general\npopulation\" as a low priority. The TRP\nacknowledges that this was the practice in the past.\nHowever, the TRP recommends this intervention to\nbe strategically rethought. The TRP recommends\nexploring the feasibility of a pilot study of social\nmarketing or alternative means of providing\ncondoms in a more sustainable way","NA Original Intervention: Condoms as part of programs for the general population","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis, Malaria, RSSH","RT Central Africa"]
["CT Comoros","Comoros","PAI-4062","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Involving DNLS managers and PLHIV in the annual Indian Ocean Symposium on HIV:\nThe annual Indian Ocean Symposium on HIV provides a forum for discussion and an opportunity for stakeholders involved in HIV management to learn about the most up-to-date strategies in order to adapt interventions in their countries. This funding enables six people from the public sector, civil society and key populations (SWs, MSM) and PLHIV to participate in this event every year.",31296.15,null,"Active","a6Q1R000000AJ2y",0,0,0,0,31296.15,0,null,null,"Involving DNLS managers and PLHIV in the annual Indian Ocean Symposium on HIV:\nThe annual Indian Ocean Symposium on HIV provides a forum for discussion and an opportunity for stakeholders involved in HIV management to learn about the most up-to-date strategies in order to adapt interventions in their countries. This funding enables six people from the public sector, civil society and key populations (SWs, MSM) and PLHIV to participate in this event every year.","Medium",null,"NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2022-06-30"]
["CT Congo","Congo","PAI-4020","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This intervention will focus on the organization of a mid-term review of the NSP 2018-2022. This will assess the NSP mid-term, with the potential to adjust the interventions. This intervention will be funded by the above allocation funding from the Global Fund. The expected impact of this module will be better planning and better coordination of malaria control interventions.",74065.759999999995,null,"Active","a6Q1R000000AJ2I",0,0,0,0,74065.759999999995,0,null,null,"This intervention will focus on the organization of a mid-term review of the NSP 2018-2022. This will assess the NSP mid-term, with the potential to adjust the interventions. This intervention will be funded by the above allocation funding from the Global Fund. The expected impact of this module will be better planning and better coordination of malaria control interventions.","Low","Needed to monitor the status of the Malaria Strategic Plan (MSP) implementation and performance level m not allocated in the allocation","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: Mid-term review of the NSP","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Congo","Congo","PAI-4019","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.",32544.05,null,"Active","a6Q1R000000AJ2H",0,0,0,0,32544.05,0,null,null,"This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.","Low","Needed to monitor the status of malaria drug efficacy, not covered in the allocation","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: ACT therapeutic efficacy test","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-3993","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","Remoteness and natural barriers are among the main obstacles to accessibility to health care, as only 35% of the population of the DRC live within 5 km of a health center. In order to resolve these problems, the country set up community health care sites since 2005, which make up one of the components of the Integrated Management of Childhood Illness (IMCI). The aim is to provide health care for simple cases of malaria, diarrhea and acute respiratory infections in the community with a community agent who is trained and supervised for this purpose. In this way, community health care sites help to improve access to early care and to quality drugs for those populations with a barrier to accessing the FOSAs. The CHCS also provides referrals to the FOSAs, improves the availability and rational use of quality drugs, improves monitoring of cases and of side effects of drugs, as well as key practices conducive to health. The funding of $3,354,836 requested will make possible to cover 34% of the needs in the IMCI?s national guidelines (Annex 1), as proposed in the national strategic plan (Annex 2). The sites would be rolled out in 7 DPSs: Mai Ndombe, Kwango, Kongo Central, Nord Kivu, Nord Ubangi, Sud Ubangi and Equateur.Partnerships will be sought with other actors in order to complete the package of services for the two other diseases.",3354836,null,"Active","a6Q1R000000AJ1r",0,0,0,0,3354836,0,null,null,"Remoteness and natural barriers are among the main obstacles to accessibility to health care, as only 35% of the population of the DRC live within 5 km of a health center. In order to resolve these problems, the country set up community health care sites since 2005, which make up one of the components of the Integrated Management of Childhood Illness (IMCI). The aim is to provide health care for simple cases of malaria, diarrhea and acute respiratory infections in the community with a community agent who is trained and supervised for this purpose. In this way, community health care sites help to improve access to early care and to quality drugs for those populations with a barrier to accessing the FOSAs. The CHCS also provides referrals to the FOSAs, improves the availability and rational use of quality drugs, improves monitoring of cases and of side effects of drugs, as well as key practices conducive to health. The funding of $3,354,836 requested will make possible to cover 34% of the needs in the IMCI?s national guidelines (Annex 1), as proposed in the national strategic plan (Annex 2). The sites would be rolled out in 7 DPSs: Mai Ndombe, Kwango, Kongo Central, Nord Kivu, Nord Ubangi, Sud Ubangi and Equateur.Partnerships will be sought with other actors in order to complete the package of services for the two other diseases.","High","This funding will support the expansion of community management of malaria, diarrhoea and pneumonia. In the country, only 35% of the population lives within 5 km of a health centre, hence this approach is bound to increase the availability of services and prevent deaths. The sites would be rolled out in 7 DPSs: Mai Ndombe, Kwango, Kongo Central, Nord Kivu, Nord Ubangi, Sud Ubangi and Equateur. This is a high impact malaria control intervention that will increase access to childhood illnesses including malaria and improve malaria case management.","NA Original Intervention: Integrated community case management (iCCM)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4655","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Currently, the country implements TB prevention using Isoniazid Preventive Therapy (IPT). The National TB Program has now committed to adopting and implementing the new WHO recommendations for latent TB infection management. This request will facilitate building of capacity for screening, treatment, including the use of new drugs combinations for high risk groups targeting contacts of TB patients and PLHIV.",695147,null,"Inactive","a6Q1R000000AJCX",0,695147,0,0,0,1,null,null,"Currently, the country implements TB prevention using Isoniazid Preventive Therapy (IPT). The National TB Program has now committed to adopting and implementing the new WHO recommendations for latent TB infection management. This request will facilitate building of capacity for screening, treatment, including the use of new drugs combinations for high risk groups targeting contacts of TB patients and PLHIV.","High","-",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Asia","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4650","MCI-00021","RSSH: Community responses and systems","MCI-00199","Other community responses and systems intervention(s)","Funding is requested to Increase the number of CSO (peer PLHIV) located at ART sites to help support differentiated ART delivery and to provide support for PLHIV in greatest need.",295732,null,"Active","a6Q1R000000AJCS",0,0,0,0,295732,0,null,null,"Funding is requested to Increase the number of CSO (peer PLHIV) located at ART sites to help support differentiated ART delivery and to provide support for PLHIV in greatest need.","Medium","To further support the already strong second 90 target, i.e. put 90 percent of people who are diagnosed with HIV on ART.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community action","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Cambodia","Cambodia","PAI-4649","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","Contribution to HEF to cover HIV service packages: HIV and STI Testing and Counselling at Health Centres, HIV Testing and Counselling at VCCT Centres,Adult and Paediatric Pre-ART and ART Service, and transportation fees to ART patients in need.",1824459,null,"Active","a6Q1R000000AJCR",0,0,0,0,1824459,0,null,null,"Contribution to HEF to cover HIV service packages: HIV and STI Testing and Counselling at Health Centres, HIV Testing and Counselling at VCCT Centres,Adult and Paediatric Pre-ART and ART Service, and transportation fees to ART patients in need.","High","To expand access to the HEF-financed package of HIV and TB services through the Health Equity Fund for the poor, vulnerable groups. An evaluation of how the HEF can adequately support HIV and TB services should be included. In addition, the evaluation should include an estimation of how many HIV/TB, HIV or TB patients will be (or are) covered by the HEF as a consequence of this investment. In so doing, it is suggested that the program track the package of services (specific medications, laboratory tests, consultation with doctors, nurses, transportation to attend clinical appointments, etc.) received by HIV/TB, HIV or TB patients under this\narrangement and to review in order to\nensure the services provided are in line\nwith the treatment algorithm adopted by\nthe country. In addition, there should be a rapid follow-up survey of HIV/TB, HIV, TB patients and their care givers to get feedback on perceived service quality, patient satisfaction and any perceived discrimination or stigma. Providers should identify if there are any challenges and if there were any stock out of health care commodities or medications, and the length of waiting time, etc. Consider feeding the findings\nto the HEF steering committee for quality assurance and to facilitate continued  mprovement of the HEF services. (if it is feasible, to include type of patients served to ascertain if there is a barrier for people of different self-identities or any specific key populations.","NA Original Intervention: HEF","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Asia","2020-12-31"]
["CT Bhutan","Bhutan","PAI-3919","MCI-00017","HSS - Policy and governance","MCI-00183","Other policy and governance intervention(s)","This funding will be used to purchase a vehicle to suport program monitoring and evaluation and to transport pharmaceutical and health products between the centers.",55000,null,"Active","a6Q1R000000AJ0f",0,0,0,0,55000,0,null,null,"This funding will be used to purchase a vehicle to suport program monitoring and evaluation and to transport pharmaceutical and health products between the centers.","Low","While role of National AIDS Commission is\nimportant, the need for additional resources\nto support policy development is not clearly\ndeveloped.","NA Original Module: RSSH - Policy and planning. Original Intervention: National HIV/AIDS Commission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT South East Asia","2021-06-30"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3914","MCI-00011","Vector control","MCI-00151","Other vector control measure(s)","Activity 137: Strategy for elimination and recycling of waste, with communication actions",64315.13,null,"Active","a6Q1R000000AJ0a",0,0,0,0,64315.13,0,null,null,"Activity 137: Strategy for elimination and recycling of waste, with communication actions","Medium",null,"The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Intervention: IEC/CCC","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Latin America and Caribbean","2021-12-31"]
["CT Burkina Faso","Burkina Faso","PAI-3851","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","Expand IMCI-REC in 12 new health districts. As of 31 December 2017, 16 health districts will have the capacity to implement integrated child care through the use of the electronic tool (IMCI-REC).",3091978.07,null,"Inactive","a6Q1R000000AIzZ",0,3091978.07,0,0,0,1,null,null,"Expand IMCI-REC in 12 new health districts. As of 31 December 2017, 16 health districts will have the capacity to implement integrated child care through the use of the electronic tool (IMCI-REC).","Low","For the expansion of the implementation of IMCI-REC in 12 new districts in Eastern regions, the Sahel and North Center; to improve the capacity of the health districts in implementing IMCI using the electronic tool. Propose applicant to request UNICEF and/or the Government to provide additional funds. Within the 12 new Districts include two Districts where MEDSINC is implemented for comparison","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Expand IMCI-REC in 12 new districts","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT High Impact Africa 1","2020-12-31"]
["CT Burkina Faso","Burkina Faso","PAI-3849","MCI-00021","RSSH: Community responses and systems","MCI-00198","Institutional capacity building, planning and leadership development","Equip 11 community organizations that offer HIV treatment and care with basic medical equipment.",152466.60999999999,null,"Active","a6Q1R000000AIzX",0,0,0,0,152466.60999999999,0,null,null,"Equip 11 community organizations that offer HIV treatment and care with basic medical equipment.","High","This activity will equip 11 community health centres with medical equipment for people living with HIV and likely to offer quality services to people living with HIV.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Africa 1","2020-12-31"]
["CT Burkina Faso","Burkina Faso","PAI-3844","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.",80404,null,"Active","a6Q1R000000AIzS",0,0,0,0,80404,0,null,null,"Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.","High","This activity aims to provide monitoring of peer support to people living with HIV, pregnant women and their babies in the context of task shifting and involving people living with HIV themselves and is considered a high priority given that supportive supervision is critical after training and important to ensure corrective measures and quality of care.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Carrying out a quarterly monitoring mission concerning the activities carried out by the associations for PLHIV in relation to the eMTCT plan and community support","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT High Impact Africa 1","2020-12-31"]
["CT Benin","Benin","PAI-3770","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):\nImprovement of the biological monitoring of people living with HIV (PLHIV).",19066.32,null,"Active","a6Q1R000000AIyG",0,0,0,0,19066.32,0,null,null,"Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):\nImprovement of the biological monitoring of people living with HIV (PLHIV).","Medium",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Benin","Benin","PAI-3765","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.",146149.70000000001,null,"Active","a6Q1R000000AIyB",0,0,0,0,146149.70000000001,0,null,null,"Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.","High",null,"NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Benin","Benin","PAI-3764","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: \n-Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (?2,103.80) \n-Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (?4,315.07)\n-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (?4,573.47) \n-Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (?7,546.23) \n-Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (?1,632.73) \n-Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (?6,585.80) \n-The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (?4,102.40) \n-Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (?5,460.72) \n-Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (?3,430.10)\n-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for OVC and PLHIV in all departments (plan) (?343.01) \n-Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (?4,573.47) \n-Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (?332,582.78) \n-Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (?10,425.99) \n-Covering the costs of the ReBAP+ helpline (?1,646.45) \n-Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (?4,573.47) \n-Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (?42,807.68) \n-Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?8,479.21) \n-Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?9,878.70) \n-Producing badges for the peer educators/health mediators involved in the projects (?1,524.49)",71292.78,null,"Active","a6Q1R000000AIyA",0,0,0,0,71292.78,0,null,null,"These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: \n-Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (?2,103.80) \n-Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (?4,315.07)\n-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (?4,573.47) \n-Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (?7,546.23) \n-Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (?1,632.73) \n-Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (?6,585.80) \n-The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (?4,102.40) \n-Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (?5,460.72) \n-Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (?3,430.10)\n-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the program?s indicators for OVC and PLHIV in all departments (plan) (?343.01) \n-Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (?4,573.47) \n-Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (?332,582.78) \n-Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (?10,425.99) \n-Covering the costs of the ReBAP+ helpline (?1,646.45) \n-Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (?4,573.47) \n-Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (?42,807.68) \n-Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?8,479.21) \n-Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (?9,878.70) \n-Producing badges for the peer educators/health mediators involved in the projects (?1,524.49)","Medium","Substantial resources allocated to procurement and distribution of nutritional kits as a psychosocial support measure. Evidence of the utility of nutritional kits is better for children than general adult populations on ART especially in a test and treat approach to ART. The TRP is also concerned about the sustainability of this measure in the long term as cessation of these programs could affect long-term adherence. The TRP requests to clarify how suitable this intervention is in the epidemic context of Benin and whether this is sustainable in the long-run. This explains the medium priority rating for these activities The remaining activities are maintained in the ?High? category.","NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Ethiopia","Ethiopia","PAI-4254","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","FCSWs are key population group with 23% HIV prevalence, and difficult to reach. Peer education is one of the successful SBCC intervention to effectively address and result in behavioral change.",1364000,null,"Inactive","a6Q1R000000AJ64",1364000,0,0,0,0,1,null,null,"FCSWs are key population group with 23% HIV prevalence, and difficult to reach. Peer education is one of the successful SBCC intervention to effectively address and result in behavioral change.","High","The TRP recommends that this sum move within allocation and is used for testing and treatment for key populations","NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 2"]
["CT Honduras","Honduras","PAI-4428","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","? Procurement of equipment for audiometry and electrocardiograms to strengthen the active drug monitoring of adverse events to TB second-line drugs.\n? Monitoring of the implementation of active pharmacovigilance in Health Facilities that manage MDR TB patients on an outpatient basis. \n? Support the active search for TB patients activities carried out by health personnel with the involvement of community staff.",100738.79,null,"Active","a6Q1R000000AJ8s",8723,0,0,0,92015.79,0,null,null,"? Procurement of equipment for audiometry and electrocardiograms to strengthen the active drug monitoring of adverse events to TB second-line drugs.\n? Monitoring of the implementation of active pharmacovigilance in Health Facilities that manage MDR TB patients on an outpatient basis. \n? Support the active search for TB patients activities carried out by health personnel with the involvement of community staff.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-07-31"]
["CT Honduras","Honduras","PAI-4423","MCI-00008","TB care and prevention","MCI-00591","Removing human rights and gender related barriers to TB care and prevention","Training for health care personnel on a) stigma and discrimination against people with TB; b) infection control measures to reduce the risk of becoming infected with TB in their workplace.",42675.41,null,"Active","a6Q1R000000AJ8n",21365,0,0,0,21310.41,0,null,null,"Training for health care personnel on a) stigma and discrimination against people with TB; b) infection control measures to reduce the risk of becoming infected with TB in their workplace.","High",null,"NA Original Intervention: Removing human rights- and gender-related barriers to TB care and prevention","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-07-31"]
["CT Honduras","Honduras","PAI-4421","MCI-00008","TB care and prevention","MCI-00132","Collaborative activities with other programs and sectors (TB care and prevention)","? Activities to raise awareness of legislators, judges, law enforcement agents since they play an important role in protecting and enforcing the rights of tuberculosis patients and their families. \n? Activities relating to referring prisoner patients to health facilities when obtaining their release letter or when transferred to another penitentiary center.\n? Social audits: involve civil society in the monitoring and tracking of TB control activities in the prioritized Health Regions with the highest TB load.",25004.36,null,"Active","a6Q1R000000AJ8l",0,0,0,0,25004.36,0,null,null,"? Activities to raise awareness of legislators, judges, law enforcement agents since they play an important role in protecting and enforcing the rights of tuberculosis patients and their families. \n? Activities relating to referring prisoner patients to health facilities when obtaining their release letter or when transferred to another penitentiary center.\n? Social audits: involve civil society in the monitoring and tracking of TB control activities in the prioritized Health Regions with the highest TB load.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-07-31"]
["CT Honduras","Honduras","PAI-4401","MCI-00004","Prevention programs for other vulnerable populations","MCI-00105","Other intervention(s) for other vulnerable populations","Contracting a coordinator and workers for organizations that intervene in the Garifuna population",122711,null,"Active","a6Q1R000000AJ8R",0,0,0,0,122711,0,null,null,"Contracting a coordinator and workers for organizations that intervene in the Garifuna population","High",null,"NA Original Intervention: Other interventions for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-07-31"]
["CT Honduras","Honduras","PAI-4400","MCI-00023","Program management","MCI-00207","Grant management","Monitoring and Evaluation Officer (includes all the benefits)",118850.91,null,"Active","a6Q1R000000AJ8Q",0,0,0,0,118850.91,0,null,null,"Monitoring and Evaluation Officer (includes all the benefits)","High","TRP recommends that the applicant further develop an efficient coordination structure for implementation the key populations programs, avoiding when possible to have coordinators and staff for each key population sub-groups. The TRP furthermore recommends the applicant to consider integrating the roles of coordinator for key populations in only one position and including that position within-allocation if efficiencies are found during grant-making.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2022-07-31"]
["CT Guatemala","Guatemala","PAI-4399","MCI-00010","MDR-TB","MCI-00146","Collaborative activities with other programs and sectors (MDR-TB)","Local and regional meetings on the implementation of differentiated models for treatment adherence and support at community, family and personal levels (peer strategies, mentoring, patient support groups etc.).",137829.66,null,"Active","a6Q1R000000AJ8P",31134.61,0,0,0,106695.05,0,null,null,"Local and regional meetings on the implementation of differentiated models for treatment adherence and support at community, family and personal levels (peer strategies, mentoring, patient support groups etc.).","Medium",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4398","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Secretary chair.",229,null,"Active","a6Q1R000000AJ8O",0,0,0,0,229,0,null,null,"Secretary chair.","Medium","The interventions in lines 5 to 8 of this table correspond to office material that should be consolidated in a single intervention line.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4397","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Modular office furniture with overhead storage cabinets.",1032,null,"Active","a6Q1R000000AJ8N",921.45,0,0,0,110.55,0,null,null,"Modular office furniture with overhead storage cabinets.","Medium","The interventions in lines 5 to 8 of this table correspond to office material that should be consolidated in a single intervention line.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4396","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Multifunctional desktop printer.",688,null,"Inactive","a6Q1R000000AJ8M",688,0,0,0,0,1,null,null,"Multifunctional desktop printer.","Medium","The interventions in lines 5 to 8 of this table correspond to office material that should be consolidated in a single intervention line.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4395","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Desktop computers.",3408,null,"Active","a6Q1R000000AJ8L",0,0,0,0,3408,0,null,null,"Desktop computers.","Medium","The interventions in lines 5 to 8 of this table correspond to office material that should be consolidated in a single intervention line.",null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4394","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Refurbishment of the laboratory at the Justo Rufino Barrios Health Center.",26842.5,null,"Inactive","a6Q1R000000AJ8K",26842.5,0,0,0,0,1,null,null,"Refurbishment of the laboratory at the Justo Rufino Barrios Health Center.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4393","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","First aid kits.",2999,null,"Inactive","a6Q1R000000AJ8J",2999,0,0,0,0,1,null,null,"First aid kits.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4392","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Regional training in line probe assays (LPAs) at the Rodolfo Robles Hospital.",1025.76,null,"Active","a6Q1R000000AJ8I",0,0,0,0,1025.76,0,null,null,"Regional training in line probe assays (LPAs) at the Rodolfo Robles Hospital.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4391","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","International consultancy services for technical assistance and GxAlert platform support.",4500,null,"Inactive","a6Q1R000000AJ8H",4500,0,0,0,0,1,null,null,"International consultancy services for technical assistance and GxAlert platform support.","High","A functional GxAlert platform allows a rapid communication of tuberculosis tests results to care providers.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Latin America and Caribbean","2022-06-30"]
["CT Guatemala","Guatemala","PAI-4372","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","San Marcos health area department. Renovation of a 25.52 m² facility, including: \nerecting a plasterboard wall; installing lighting; power sockets; two wooden doors; two aluminum windows; fitting adhesive vinyl; four fixed furniture units; paintwork.",9677.42,null,"Active","a6Q1R000000AJ7y",0,0,0,0,9677.42,0,null,null,"San Marcos health area department. Renovation of a 25.52 m² facility, including: \nerecting a plasterboard wall; installing lighting; power sockets; two wooden doors; two aluminum windows; fitting adhesive vinyl; four fixed furniture units; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4371","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Retalhuleu health area department. Renovation of a 51.53 m² facility, including: \nremoving and supplying sliding aluminum door; nine windows; three lights; six power sockets; four fixed furniture units; paintwork; installing an 18,000 BTU air conditioning unit.",9677.42,null,"Active","a6Q1R000000AJ7x",0,0,0,0,9677.42,0,null,null,"Retalhuleu health area department. Renovation of a 51.53 m² facility, including: \nremoving and supplying sliding aluminum door; nine windows; three lights; six power sockets; four fixed furniture units; paintwork; installing an 18,000 BTU air conditioning unit.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4370","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Central Guatemala health department. Renovation of a 44.18 m² facility, including: \nRemove existing metal structure and fit  a new structure; remove a suspended ceiling; erect and repair walls; make furniture units; two wooden doors; one aluminum door; installing electricity; paintwork; renovate balconies and 1 metal door; replace mechanisms and adhesive vinyl for 3 aluminum window; fit ducting for electrical wiring; install a 18,000 BTU ACU.",9677.42,null,"Active","a6Q1R000000AJ7w",0,0,0,0,9677.42,0,null,null,"Central Guatemala health department. Renovation of a 44.18 m² facility, including: \nRemove existing metal structure and fit  a new structure; remove a suspended ceiling; erect and repair walls; make furniture units; two wooden doors; one aluminum door; installing electricity; paintwork; renovate balconies and 1 metal door; replace mechanisms and adhesive vinyl for 3 aluminum window; fit ducting for electrical wiring; install a 18,000 BTU ACU.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4369","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Elisa Martínez National Hospital, Puerto Barrios, Izabal (planning pending)",10775,null,"Active","a6Q1R000000AJ7v",0,0,0,0,10775,0,null,null,"Elisa Martínez National Hospital, Puerto Barrios, Izabal (planning pending)","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4368","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Zacapa Regional Hospital (planning pending).",10775,null,"Active","a6Q1R000000AJ7u",0,0,0,0,10775,0,null,null,"Zacapa Regional Hospital (planning pending).","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4367","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Huehuetenango National Hospital (planning pending).",10775,null,"Active","a6Q1R000000AJ7t",0,0,0,0,10775,0,null,null,"Huehuetenango National Hospital (planning pending).","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4366","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Escuintla National Hospital (planning pending).",10755,null,"Active","a6Q1R000000AJ7s",0,0,0,0,10755,0,null,null,"Escuintla National Hospital (planning pending).","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4359","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","San Marcos health area department.  Renovation of XX  m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.",6000,null,"Active","a6Q1R000000AJ7l",0,0,0,0,6000,0,null,null,"San Marcos health area department.  Renovation of XX  m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4358","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Coban Health Center, Alta Verapaz. Renovation of a 13.91 m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.",6000,null,"Active","a6Q1R000000AJ7k",0,0,0,0,6000,0,null,null,"Coban Health Center, Alta Verapaz. Renovation of a 13.91 m² laboratory, including: \npreliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4357","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Flores Health Center, Petén. Renovation of a 52.37 m² laboratory, including: \ndemolishing fixed concrete furniture; removing and replacing door, installing water and electricity; laying ceramic flooring; renovating four doors; fitting suspended ceiling; making three fixed furniture units and two overhead furniture units; fitting two sinks and one washbasin; installing insulated waterproof roof sheeting; paintwork.",6000,null,"Active","a6Q1R000000AJ7j",0,0,0,0,6000,0,null,null,"Flores Health Center, Petén. Renovation of a 52.37 m² laboratory, including: \ndemolishing fixed concrete furniture; removing and replacing door, installing water and electricity; laying ceramic flooring; renovating four doors; fitting suspended ceiling; making three fixed furniture units and two overhead furniture units; fitting two sinks and one washbasin; installing insulated waterproof roof sheeting; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4356","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Quetzaltenango Health Center. Renovation of a 20.98 m² laboratory, including: \nerecting a block wall and a plasterboard wall; finishing for walls; laying ceramic flooring; four windows; installing water and electricity; one washbasin, one sink; making fixed furniture units; one metal door; one wooden door; metal structure; suspended ceiling; paintwork.",6000,null,"Active","a6Q1R000000AJ7i",0,0,0,0,6000,0,null,null,"Quetzaltenango Health Center. Renovation of a 20.98 m² laboratory, including: \nerecting a block wall and a plasterboard wall; finishing for walls; laying ceramic flooring; four windows; installing water and electricity; one washbasin, one sink; making fixed furniture units; one metal door; one wooden door; metal structure; suspended ceiling; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4355","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00172","Improving service delivery infrastructure","Poptún Health Center, Petén. Renovation of a 44.34 m² laboratory, including: erecting a plasterboard wall; fitting suspended ceiling, two washbasins; replacing existing sink fittings; making fixed furniture units; installing water and electricity; laying ceramic flooring; two windows; paintwork.",4000,null,"Active","a6Q1R000000AJ7h",0,0,0,0,4000,0,null,null,"Poptún Health Center, Petén. Renovation of a 44.34 m² laboratory, including: erecting a plasterboard wall; fitting suspended ceiling, two washbasins; replacing existing sink fittings; making fixed furniture units; installing water and electricity; laying ceramic flooring; two windows; paintwork.","Medium","Infrastructure improvement justified for improving service delivery.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4351","MCI-00022","RSSH: Health management information systems and M&E","MCI-00202","Surveys","Drug-resistance prevalence study for 2020:\n? Develop a HIV drug-resistance plan\n? Develop an ARV drug-resistance protocol \n? Analyze acquired resistance profiles in second-line regimen (ART).",200000,null,"Inactive","a6Q1R000000AJ7d",200000,0,0,0,0,1,null,null,"Drug-resistance prevalence study for 2020:\n? Develop a HIV drug-resistance plan\n? Develop an ARV drug-resistance protocol \n? Analyze acquired resistance profiles in second-line regimen (ART).","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4350","MCI-00004","Prevention programs for other vulnerable populations","MCI-00104","Diagnosis and treatment of STIs and other sexual health services for other vulnerable populations",null,500000,null,"Active","a6Q1R000000AJ7c",0,0,0,0,500000,0,null,null,null,"High","TRP recommend to use STI evidence-based test (Duo HIV-syphilis test or rapid syphilis test).","NA Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for other vulnerable populations","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4349","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00088","Condoms and lubricant programming for sex workers","12,951,220 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.",518049,null,"Active","a6Q1R000000AJ7b",0,0,0,0,518049,0,null,null,"12,951,220 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","High",null,"Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'Condoms and lubricant programming for sex workers' are merged in the TRP form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4348","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00088","Condoms and lubricant programming for sex workers","10,900,316 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.",436013,null,"Active","a6Q1R000000AJ7a",0,0,0,0,436013,0,null,null,"10,900,316 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.","High",null,"Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'Condoms and lubricant programming for sex workers' are merged in the TRP form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4347","MCI-00531","Comprehensive prevention programs for TGs","MCI-00555","Condoms and lubricant programming for TGs","2,975,714 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.",119029,null,"Active","a6Q1R000000AJ7Z",0,0,0,0,119029,0,null,null,"2,975,714 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","High",null,"All the interventions for 'Condoms and lubricant programming for transgender people' under module 'Comprehensive prevention programs for transgender people' are merged in the TRP form Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Condoms and lubricant programming for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4346","MCI-00531","Comprehensive prevention programs for TGs","MCI-00555","Condoms and lubricant programming for TGs","2,767,550 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.",110702,null,"Active","a6Q1R000000AJ7Y",0,0,0,0,110702,0,null,null,"2,767,550 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.","High",null,"All the interventions for 'Condoms and lubricant programming for transgender people' under module 'Comprehensive prevention programs for transgender people' are merged in the TRP form Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Condoms and lubricant programming for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4345","MCI-00534","Comprehensive prevention programs for MSM","MCI-00606","Condoms and lubricant programming for MSM","5,802,056 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.",232082.24,null,"Active","a6Q1R000000AJ7X",0,0,0,0,232082.24,0,null,null,"5,802,056 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","High",null,"All the interventions for 'Condoms and lubricant programming for men who have sex with men' under module 'Comprehensive prevention programs for men who have sex with men' are merged in the TRP form Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Condoms and lubricant programming for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4344","MCI-00534","Comprehensive prevention programs for MSM","MCI-00606","Condoms and lubricant programming for MSM","3,430,381 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.",137215.22,null,"Active","a6Q1R000000AJ7W",0,0,0,0,137215.22,0,null,null,"3,430,381 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.","High",null,"All the interventions for 'Condoms and lubricant programming for men who have sex with men' under module 'Comprehensive prevention programs for men who have sex with men' are merged in the TRP form Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Condoms and lubricant programming for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4343","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","12,951,220 condoms to cover 82 percent of the programmatic gap in 2020.",388537,null,"Active","a6Q1R000000AJ7V",0,0,0,0,388537,0,null,null,"12,951,220 condoms to cover 82 percent of the programmatic gap in 2020.","High",null,"Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'HIV testing services for sex workers' are merged in the TRP form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4342","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","10,900,316 condoms to cover 82 percent of the programmatic gap in 2019.",327009,null,"Active","a6Q1R000000AJ7U",0,0,0,0,327009,0,null,null,"10,900,316 condoms to cover 82 percent of the programmatic gap in 2019.","High",null,"Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'HIV testing services for sex workers' are merged in the TRP form","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guatemala","Guatemala","PAI-4341","MCI-00007","Treatment, care and support","MCI-00125","Other intervention(s) for treatment","Migration of 25% of the ART patient cohort to the new preferred regimen: (Tenofovir+Emtricitabine+Dolutegravir 10+200+50 mg pill).\nThe NACP will contribute to migrating 25 percent of the ART patient cohort to the new preferred first-line regimen in 2020. This above allocation budget includes a contribution to the migration of a further 25 percent of the ART cohort. The new preferred regimen is more cost-effective.",254961,null,"Inactive","a6Q1R000000AJ7T",254961,0,0,0,0,1,null,null,"Migration of 25% of the ART patient cohort to the new preferred regimen: (Tenofovir+Emtricitabine+Dolutegravir 10+200+50 mg pill).\nThe NACP will contribute to migrating 25 percent of the ART patient cohort to the new preferred first-line regimen in 2020. This above allocation budget includes a contribution to the migration of a further 25 percent of the ART cohort. The new preferred regimen is more cost-effective.","High",null,"NA Original Intervention: Other interventions for treatment","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4340","MCI-00006","PMTCT","MCI-00116","Other intervention(s) for PMTCT","Ensure communication costs of PMTCT sites for follow-up of deadlines. Credit for communication is provided to communicate with women as part of PMTCT.",40956.120000000003,null,"Active","a6Q1R000000AJ7S",0,0,0,0,40956.120000000003,0,null,null,"Ensure communication costs of PMTCT sites for follow-up of deadlines. Credit for communication is provided to communicate with women as part of PMTCT.","High","Reducing loss to follow-up of women in PMTCT is important. The TRP suggests to also look into private-public partnership for mHealth.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Component 4","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Western Africa","2020-12-31"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4339","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Ensure viral load testing for all patients on ART. For better management of treatment failures, each patient must have at least one viral load test per year. However, the PSM plan takes into account only 2,000 patients per year, for a target of 12,000, 13,000 and 14,000 patients for the three years of the grant. The acquisition of these additional tests will make it possible to cover 30% in 2018, 40% in 2019 and 50% in 2020.",2629135.9,null,"Active","a6Q1R000000AJ7R",0,0,0,0,2629135.9,0,null,null,"Ensure viral load testing for all patients on ART. For better management of treatment failures, each patient must have at least one viral load test per year. However, the PSM plan takes into account only 2,000 patients per year, for a target of 12,000, 13,000 and 14,000 patients for the three years of the grant. The acquisition of these additional tests will make it possible to cover 30% in 2018, 40% in 2019 and 50% in 2020.","High","Viral load is important in the followup of people on ART.","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Western Africa","2020-12-31"]
["CT Guinea-Bissau","Guinea-Bissau","PAI-4338","MCI-00071","Other module","MCI-00071","Other module","Recruit an international laboratory specialist to strengthen the capacities of the Directorate for Pharmaceutical, Laboratory and Drug Services/Ministry for Public Health and the National Health Institute [INASA] to draw up regulatory documents for the laboratory system.  In addition, the specialist will contribute to improving the quality of the laboratory services involved in health care for the three diseases.",201997.53,null,"Active","a6Q1R000000AJ7Q",0,0,0,0,201997.53,0,null,null,"Recruit an international laboratory specialist to strengthen the capacities of the Directorate for Pharmaceutical, Laboratory and Drug Services/Ministry for Public Health and the National Health Institute [INASA] to draw up regulatory documents for the laboratory system.  In addition, the specialist will contribute to improving the quality of the laboratory services involved in health care for the three diseases.","High","Reinforcing the lab with a specialist is extremely important given the weakness of the lab system.","NA Original Module: RSSH. Original Intervention: Service organisation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Western Africa","2020-12-31"]
["CT Dominican Republic","Dominican Republic","PAI-4172","MCI-00534","Comprehensive prevention programs for MSM","MCI-00605","Behavioral interventions for MSM","The practices of self-care, prevention of HIV and other STIs in MSM and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources will be allocated to increasing the targets that can be reached to improve self-care and prevention practices.",592400,null,"Active","a6Q1R000000AJ4k",430230.04,0,0,0,162169.96,0,null,null,"The practices of self-care, prevention of HIV and other STIs in MSM and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources will be allocated to increasing the targets that can be reached to improve self-care and prevention practices.","High",null,"NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Djibouti","Djibouti","PAI-4171","MCI-00009","TB/HIV","MCI-00135","Engaging all care providers (TB/HIV)","Handling costs of Genexpert machines to measure the Viral Load (VL) (Cost of the service agent). This will allow the permanent use of the machines and thus increase the percentage of PLHIV having access to the VL.",39000,null,"Active","a6Q1R000000AJ4j",0,0,0,0,39000,0,null,null,"Handling costs of Genexpert machines to measure the Viral Load (VL) (Cost of the service agent). This will allow the permanent use of the machines and thus increase the percentage of PLHIV having access to the VL.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4170","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Establishment of an efficient transport system in the Testing and Treatment Centers in Djibouti (includes daily allowances related to awareness (transport / meeting / and other costs)).",16949,null,"Active","a6Q1R000000AJ4i",0,0,0,0,16949,0,null,null,"Establishment of an efficient transport system in the Testing and Treatment Centers in Djibouti (includes daily allowances related to awareness (transport / meeting / and other costs)).","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4169","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Extended warranty of digital radiology equipment (See line 21).",39000,null,"Active","a6Q1R000000AJ4h",0,0,0,0,39000,0,null,null,"Extended warranty of digital radiology equipment (See line 21).","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4168","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Staff training in the use of digital radiology equipment (See line 21).",3763,null,"Active","a6Q1R000000AJ4g",0,0,0,0,3763,0,null,null,"Staff training in the use of digital radiology equipment (See line 21).","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4167","MCI-00009","TB/HIV","MCI-00581","Key populations (TB/HIV) - Prisoners","Provide clinical screening for TB and free HIV testing (DIPS). (Per diems related to awareness of prisoners and other populations (transport / meeting / and other costs)).",41993,null,"Active","a6Q1R000000AJ4f",0,0,0,0,41993,0,null,null,"Provide clinical screening for TB and free HIV testing (DIPS). (Per diems related to awareness of prisoners and other populations (transport / meeting / and other costs)).","High",null,"NA Original Intervention: Key populations (TB/HIV) ? prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4166","MCI-00021","RSSH: Community responses and systems","MCI-00197","Social mobilization, building community linkages, collaboration and coordination","Recruit the national technical assistant for capacity assessment for the transfer (Fees related to technical assistance - Consultants).",85831,null,"Active","a6Q1R000000AJ4e",0,0,0,0,85831,0,null,null,"Recruit the national technical assistant for capacity assessment for the transfer (Fees related to technical assistance - Consultants).","Low","While the TRP considers this activity to be quality demand, it is not as high a priority as other activities in PAAR.","NA Original Module: RSSH - Community responses and systems","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4165","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","See previous itervention - line 54.",169,null,"Active","a6Q1R000000AJ4d",0,0,0,0,169,0,null,null,"See previous itervention - line 54.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4164","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","The analysis of performance of the TB program and, following that, following up with the resulting recommendations will allow reaching the program's objectives.",678,null,"Active","a6Q1R000000AJ4c",0,0,0,0,678,0,null,null,"The analysis of performance of the TB program and, following that, following up with the resulting recommendations will allow reaching the program's objectives.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3726","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.",160535,null,"Active","a6Q1R000000AIxY",0,0,0,0,160535,0,null,null,"Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3725","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.",501858,null,"Active","a6Q1R000000AIxX",0,0,0,0,501858,0,null,null,"Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3724","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.",170205,null,"Active","a6Q1R000000AIxW",0,0,0,0,170205,0,null,null,"Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.","High",null,"NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3723","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Purchase a teleconference device.",4069,null,"Active","a6Q1R000000AIxV",0,0,0,0,4069,0,null,null,"Purchase a teleconference device.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3722","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Purchase of computer equipment.",68600,null,"Active","a6Q1R000000AIxU",0,0,0,0,68600,0,null,null,"Purchase of computer equipment.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3721","MCI-00536","RSSH: National health strategies","MCI-00612","Other policy and governance intervention(s)","A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.",73811,null,"Active","a6Q1R000000AIxT",0,0,0,0,73811,0,null,null,"A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.","High",null,"NA Original Module: RSSH - National health strategies","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3720","MCI-00023","Program management","MCI-00207","Grant management","Performance bonuses.\nThe motivation of the staff is essential to maintain the achievements and safeguard the performance of the Program\nThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.",30183,null,"Active","a6Q1R000000AIxS",0,0,0,0,30183,0,null,null,"Performance bonuses.\nThe motivation of the staff is essential to maintain the achievements and safeguard the performance of the Program\nThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3719","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Data validation and dissemination activity.\nVerification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.",161830,null,"Active","a6Q1R000000AIxR",0,0,0,0,161830,0,null,null,"Data validation and dissemination activity.\nVerification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Tuberculosis","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3689","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","Activity: Buy three trucks for active distribution of health inputs\nThese trucks will be used to transport drugs from CAMEBU to district pharmacies.",438366,null,"Active","a6Q1R000000AIwx",0,0,0,0,438366,0,null,null,"Activity: Buy three trucks for active distribution of health inputs\nThese trucks will be used to transport drugs from CAMEBU to district pharmacies.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3688","MCI-00016","RSSH: Procurement and supply chain management systems","MCI-00179","Supply chain infrastructure and development of tools","Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance plan\nQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.",130925,null,"Active","a6Q1R000000AIww",0,0,0,0,130925,0,null,null,"Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance plan\nQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.","Low",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3687","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","Activity: Ensuring the maintenance of the AUTOMATE (GAS)\nThe CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.",35069,null,"Active","a6Q1R000000AIwv",0,0,0,0,35069,0,null,null,"Activity: Ensuring the maintenance of the AUTOMATE (GAS)\nThe CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.","Low",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3686","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:\nFollowing the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.",24888,null,"Active","a6Q1R000000AIwu",0,0,0,0,24888,0,null,null,"Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:\nFollowing the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.","Low",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3685","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00171","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training in quality control of associated molecules (ARV, anti-TB).\nTraining in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.",12000,null,"Active","a6Q1R000000AIwt",0,0,0,0,12000,0,null,null,"Activity: Training in quality control of associated molecules (ARV, anti-TB).\nTraining in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.","Medium",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3684","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:\nThe DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days",27237,null,"Active","a6Q1R000000AIws",0,0,0,0,27237,0,null,null,"Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:\nThe DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days","Medium",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3683","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session",65947,null,"Active","a6Q1R000000AIwr",0,0,0,0,65947,0,null,null,"Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session","Medium",null,"NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3654","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)\nNutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. \nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond\nActivity is related to indicator #: TCS-1 (M)",173582,null,"Active","a6Q1R000000AIwO",0,0,0,0,173582,0,null,null,"Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)\nNutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. \nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond\nActivity is related to indicator #: TCS-1 (M)","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3653","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)\nGiven the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond",560962,null,"Active","a6Q1R000000AIwN",0,0,0,0,560962,0,null,null,"Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)\nGiven the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3652","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)\nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond",25343,null,"Active","a6Q1R000000AIwM",0,0,0,0,25343,0,null,null,"Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)\nGiven the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3651","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)\nThis activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target",202134,null,"Active","a6Q1R000000AIwL",0,0,0,0,202134,0,null,null,"Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)\nThis activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3650","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00092","Other intervention(s) for sex workers and their clients","Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.\nThis activity aims to reduce new infections by facilitating PS to access prevention and care services.",4350,null,"Active","a6Q1R000000AIwK",0,0,0,0,4350,0,null,null,"Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.\nThis activity aims to reduce new infections by facilitating PS to access prevention and care services.","High",null,"NA Original Intervention: Other interventions for sex workers and their clients","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3649","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00548","Community empowerment for PWID","Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDU\nThis activity aims to improve the living conditions of key populations.",43274,null,"Active","a6Q1R000000AIwJ",0,0,0,0,43274,0,null,null,"Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDU\nThis activity aims to improve the living conditions of key populations.","High",null,"NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Community empowerment for people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Burundi","Burundi","PAI-3648","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Activity: Acquire the complement of reagents for the viral load.\nThe 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. \nThis funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.",1432738,null,"Active","a6Q1R000000AIwI",0,0,0,0,1432738,0,null,null,"Activity: Acquire the complement of reagents for the viral load.\nThe 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. \nThis funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.","High",null,"NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Central Africa","2020-12-31"]
["CT Angola","Angola","PAI-3575","MCI-00009","TB/HIV","MCI-00134","TB/HIV collaborative interventions","PAAR investment will support activities for TB/ HIV increased integration at both national and district level by  supporting  TWG quarterly meeting at  provincial and municipality levels, joint TB/ HIV planning and supervision of integrated delivery of TB and HIV services.",360000,null,"Active","a6Q1R000000AIv7",0,0,0,0,360000,0,null,null,"PAAR investment will support activities for TB/ HIV increased integration at both national and district level by  supporting  TWG quarterly meeting at  provincial and municipality levels, joint TB/ HIV planning and supervision of integrated delivery of TB and HIV services.","High","This is important to improve TB -HIV outcomes and integration.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Angola","Angola","PAI-3574","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.",355500,null,"Active","a6Q1R000000AIv6",0,0,0,0,355500,0,null,null,"The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Angola","Angola","PAI-3573","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","PAAR will support refresher training of Laboratory staff  in  diagnosis of MDRTB in 2019  and reagents for solid and liquid culture, three (3) LPA (Line Probe Assay) equipment?s and their respective reagents. Expected outcome will be increase in MDR TB cases detected and notified.",177750,null,"Active","a6Q1R000000AIv5",0,0,0,0,177750,0,null,null,"PAAR will support refresher training of Laboratory staff  in  diagnosis of MDRTB in 2019  and reagents for solid and liquid culture, three (3) LPA (Line Probe Assay) equipment?s and their respective reagents. Expected outcome will be increase in MDR TB cases detected and notified.","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Angola","Angola","PAI-3572","MCI-00008","TB care and prevention","MCI-00130","Community TB care delivery","The PAAR will support development of IEC Materials and  training  for community workers and Social mobilization on Community TB Care  in 18 provinces (210 agents for 84 municipalities)\nPAAR investment  will support Treatment Adherence  interventions (TAIs) catalytic to achieving the ambitious CNR and TSR targets, focusing on strengthening community  and peer support (ex-TB patients etc), food vouchers and transport refunds , home visits and others initiatives to mitigate the castrophic  costs from TB and improve treatment outcomes. Expected outcome will be increase in CNR and TSR.",260000,null,"Active","a6Q1R000000AIv4",0,0,0,0,260000,0,null,null,"The PAAR will support development of IEC Materials and  training  for community workers and Social mobilization on Community TB Care  in 18 provinces (210 agents for 84 municipalities)\nPAAR investment  will support Treatment Adherence  interventions (TAIs) catalytic to achieving the ambitious CNR and TSR targets, focusing on strengthening community  and peer support (ex-TB patients etc), food vouchers and transport refunds , home visits and others initiatives to mitigate the castrophic  costs from TB and improve treatment outcomes. Expected outcome will be increase in CNR and TSR.","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Angola","Angola","PAI-3571","MCI-00008","TB care and prevention","MCI-00127","Treatment","PAAR to support the printing  of  handbooks on (i) TB cases management (ii) TB in children; (iii) MDR-TB management and control; (iv) TB/HIV coinfection control; (iv) tasks of DOTS-C agents  in 2019. Expected outcome will be increase in quality of TB services in line with international standard for TB care (ISTC).",150000,null,"Active","a6Q1R000000AIv3",0,0,0,0,150000,0,null,null,"PAAR to support the printing  of  handbooks on (i) TB cases management (ii) TB in children; (iii) MDR-TB management and control; (iv) TB/HIV coinfection control; (iv) tasks of DOTS-C agents  in 2019. Expected outcome will be increase in quality of TB services in line with international standard for TB care (ISTC).","High","This activity will allow the program to reach the ambitious targets set out in the funding request.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Southern and Eastern Africa"]
["CT Djibouti","Djibouti","PAI-4125","MCI-00011","Vector control","MCI-00149","Long-lasting insecticidal nets (LLIN) - Continuous distribution","This activity is regarding the routine distribution for pregnant women, children under 5, refugees and migrants.",205450,null,"Active","a6Q1R000000AJ3z",15405,0,0,0,190045,0,null,null,"This activity is regarding the routine distribution for pregnant women, children under 5, refugees and migrants.","High",null,"NA Original Intervention: Long-lasting insecticidal nets ? Continuous distribution","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Middle East and North Africa","2020-12-31"]
["CT Cuba","Cuba","PAI-4124","MCI-00007","Treatment, care and support","MCI-00580","Treatment monitoring - Viral load","Insufficient outreach to PLHIV for VC tests, affected by the interruptions of regional laboratory services, especially due to equipment breakdown and maladjustment caused by years of continuous operation. Likewise, the centralization of blood tests for VL studies hinders follow-up on PLHIV follow-up and limits the capacity of the PCS, especially as regards the Polyclinic to mobilize the PLHIV under their care. The additional resources will be dedicated to increasing the number of PLHIV with undetectable VL by gradual replacement of obsolete equipment and increasing access to blood testing points.",450000,null,"Inactive","a6Q1R000000AJ3y",0,450000,0,0,0,1,null,null,"Insufficient outreach to PLHIV for VC tests, affected by the interruptions of regional laboratory services, especially due to equipment breakdown and maladjustment caused by years of continuous operation. Likewise, the centralization of blood tests for VL studies hinders follow-up on PLHIV follow-up and limits the capacity of the PCS, especially as regards the Polyclinic to mobilize the PLHIV under their care. The additional resources will be dedicated to increasing the number of PLHIV with undetectable VL by gradual replacement of obsolete equipment and increasing access to blood testing points.","High","Will allow improve access and coverage with Viral Load testing","NA Original Intervention: Treatment monitoring ? Viral load","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Cuba","Cuba","PAI-4123","MCI-00007","Treatment, care and support","MCI-00122","Counseling and psycho-social support","Insufficient degrees of adherence to ART to have a sustainable impact on the rate of new infections and mortality caused by AIDS. Specialized counseling in ART adherence is not systematic, and follow-up by the health care team and other Polyclinic services to take on adherence and serodiscordance is weak.",84450,null,"Active","a6Q1R000000AJ3x",0,0,0,0,84450,0,null,null,"Insufficient degrees of adherence to ART to have a sustainable impact on the rate of new infections and mortality caused by AIDS. Specialized counseling in ART adherence is not systematic, and follow-up by the health care team and other Polyclinic services to take on adherence and serodiscordance is weak.","High","Will allow improve adherence rates",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Cuba","Cuba","PAI-4122","MCI-00007","Treatment, care and support","MCI-00119","Treatment monitoring - Drug resistance surveillance","There is insufficient knowledge of the magnitude of the problem of resistance to ARVs, which could impact treatment efficacy. Once the levels and causes of resistance are identified, the treatment protocols can be adapted or the therapy adjusted in individual cases to obtain undetectable viral load. In addition, the processes for certification of resistance-testing laboratories by the WHO will be studied to obtain a quality indicator of results.",525000,null,"Active","a6Q1R000000AJ3w",0,0,0,0,525000,0,null,null,"There is insufficient knowledge of the magnitude of the problem of resistance to ARVs, which could impact treatment efficacy. Once the levels and causes of resistance are identified, the treatment protocols can be adapted or the therapy adjusted in individual cases to obtain undetectable viral load. In addition, the processes for certification of resistance-testing laboratories by the WHO will be studied to obtain a quality indicator of results.","High","Will allow study the magnitude of the problem of resistance to ARVs, which could impact treatment efficacy and proceed with certification of resistance-testing laboratories by the WHO","NA Original Intervention: Treatment monitoring - drug resistance surveillance","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Cuba","Cuba","PAI-4121","MCI-00531","Comprehensive prevention programs for TGs","MCI-00558","HIV testing services for TGs","The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.",9500,null,"Active","a6Q1R000000AJ3v",6300,0,0,0,3200,0,null,null,"The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.","High","Has the potential to increase the both prevention of new infections and treatment adherence","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: HIV testing services for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Cuba","Cuba","PAI-4120","MCI-00531","Comprehensive prevention programs for TGs","MCI-00554","Behavioral interventions for TGs","Self-care practices, prevention of HIV and other STIs in TGs and changes in behavior are not sufficient to achieve the necessary impact. The additional resources will be dedicated to increase the outreach goals to improve self-care and prevention.",17000,null,"Inactive","a6Q1R000000AJ3u",17000,0,0,0,0,1,null,null,"Self-care practices, prevention of HIV and other STIs in TGs and changes in behavior are not sufficient to achieve the necessary impact. The additional resources will be dedicated to increase the outreach goals to improve self-care and prevention.","High","Has the potential to increase the both prevention of new infections and treatment adherence","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Cuba","Cuba","PAI-4119","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.",80500,null,"Active","a6Q1R000000AJ3t",17000,0,0,0,63500,0,null,null,"The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.","High","Will support reaching testing coverage of highest risk sex workers",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2020-12-31"]
["CT Comoros","Comoros","PAI-4059","MCI-00006","PMTCT","MCI-00114","Prong 3: Preventing vertical HIV transmission","Supporting the operation of the Network for People Infected with or Affected by HIV: TAS \nTAS is a community-based organization engaged in HIV prevention and caring for PLHIV. Given the weak performance in the area of treatment and the ambitious targets of this funding request for ART (from 35 percent in 2019 to 65 percent in 2022), the DNLS recommended making TAS a sub-recipient to take part in family screening strategies (partner and child), the search for people lost to follow-up, the referral of HIV-positive people (test and treat), the distribution of nutritional kits and mediation for treatment of TB/HIV co-infection. Given the importance of this organization in the HIV response, the government has provided a building for TAS to use as its premises.\nThis activity supports TAS?s equipment needs (refurbishment of premises, chairs, tables, photocopiers, computers, office supplies, maintenance of equipment, Internet connection, etc.) in order to improve its results efficiency.",43796.43,null,"Active","a6Q1R000000AJ2v",0,0,0,0,43796.43,0,null,null,"Supporting the operation of the Network for People Infected with or Affected by HIV: TAS \nTAS is a community-based organization engaged in HIV prevention and caring for PLHIV. Given the weak performance in the area of treatment and the ambitious targets of this funding request for ART (from 35 percent in 2019 to 65 percent in 2022), the DNLS recommended making TAS a sub-recipient to take part in family screening strategies (partner and child), the search for people lost to follow-up, the referral of HIV-positive people (test and treat), the distribution of nutritional kits and mediation for treatment of TB/HIV co-infection. Given the importance of this organization in the HIV response, the government has provided a building for TAS to use as its premises.\nThis activity supports TAS?s equipment needs (refurbishment of premises, chairs, tables, photocopiers, computers, office supplies, maintenance of equipment, Internet connection, etc.) in order to improve its results efficiency.","Medium","Although the funding request\nproposes to provide bonuses for\nimproved tracking of mother/child, it is not clear how this will be sustained and how existing community structures will be leveraged for efficiency.","NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2022-06-30"]
["CT Comoros","Comoros","PAI-4058","MCI-00023","Program management","MCI-00206","Policy, planning, coordination and management of national disease control programs","Organizing seven training courses for untrained teachers and teaching supervisors per year on the three islands \nThe current grant has introduced STIs and HIV into the curriculum. \nIt has also provided training for 200 teachers and pedagogical supervisors on the three islands. However, this training has covered only 45 percent of needs. The allocation amount provides for three training courses for 60 teachers in the first year. Funding is therefore requested to cover 35 percent of the gap and to cover the needs of seven additional first-year training courses for teachers and teaching supervisors, to build their capacities to teach participants about STI and HIV prevention messages.",20406.240000000002,null,"Active","a6Q1R000000AJ2u",0,0,0,0,20406.240000000002,0,null,null,"Organizing seven training courses for untrained teachers and teaching supervisors per year on the three islands \nThe current grant has introduced STIs and HIV into the curriculum. \nIt has also provided training for 200 teachers and pedagogical supervisors on the three islands. However, this training has covered only 45 percent of needs. The allocation amount provides for three training courses for 60 teachers in the first year. Funding is therefore requested to cover 35 percent of the gap and to cover the needs of seven additional first-year training courses for teachers and teaching supervisors, to build their capacities to teach participants about STI and HIV prevention messages.","High","This is an important opportunity for the HIV managers to have six-monthly meetings to review the progress of the grant and to make course corrections when implementing approaches so as\nto achieve optimal progress and return Global Fund investments.","NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2022-06-30"]
["CT Comoros","Comoros","PAI-4057","MCI-00023","Program management","MCI-00207","Grant management","Carry out twice-yearly quality control for HIV screening by community staff specializing in key population and general population screening campaigns: \nThe community sector is important in the HIV response, in terms of both ART and screening and monitoring. Screening, which is a priority entry point, is organized through community sector campaigns.\nThis activity hopes to ensure that the results produced by the community actors during screening campaigns are reliable. Once every six months, health workers will visit screening campaign sites to ensure the quality of sampling and technical procedures for analyzing and interpreting screening results. This activity also provides an opportunity to strengthen training skills/supervisions. Finally, samples analyzed will be transported to reference laboratories to ensure that quality control produces reliable results.",17820.669999999998,null,"Active","a6Q1R000000AJ2t",0,0,0,0,17820.669999999998,0,null,null,"Carry out twice-yearly quality control for HIV screening by community staff specializing in key population and general population screening campaigns: \nThe community sector is important in the HIV response, in terms of both ART and screening and monitoring. Screening, which is a priority entry point, is organized through community sector campaigns.\nThis activity hopes to ensure that the results produced by the community actors during screening campaigns are reliable. Once every six months, health workers will visit screening campaign sites to ensure the quality of sampling and technical procedures for analyzing and interpreting screening results. This activity also provides an opportunity to strengthen training skills/supervisions. Finally, samples analyzed will be transported to reference laboratories to ensure that quality control produces reliable results.","High",null,"NA Original Module: RSSH - Program management","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2022-06-30"]
["CT Comoros","Comoros","PAI-4056","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","Arrange a midterm evaluation of the national strategic plan (NSP) in 2022\nThe country will develop a new strategic plan 2020?2024. This plan, which will serve as the basis for planning the entire HIV program, will require a midterm (2022) evaluation to adjust interventions.  \nA budget for arranging this midterm evaluation is included in the PAAR.",29858.6,null,"Active","a6Q1R000000AJ2s",0,0,0,0,29858.6,0,null,null,"Arrange a midterm evaluation of the national strategic plan (NSP) in 2022\nThe country will develop a new strategic plan 2020?2024. This plan, which will serve as the basis for planning the entire HIV program, will require a midterm (2022) evaluation to adjust interventions.  \nA budget for arranging this midterm evaluation is included in the PAAR.","High","Critical intervention given the centrality of teachers in communicating with adolescents, and the importance of integrating HIV prevention into school health programs.",null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2022-06-30"]
["CT Comoros","Comoros","PAI-4055","MCI-00002","Comprehensive prevention programs for sex workers and their clients","MCI-00089","HIV testing services for sex workers","Providing training on PMTCT to 60 providers at public and private health posts to scale up the elimination of mother-to-child transmission (eMTCT):  \nThe country has set itself the challenge of eliminating mother-to child transmission by 2021. The current grant provided for PMTCT scale-up at 30 sites. This increase is coupled with a need for capacity building among untrained staff at antenatal clinics. This activity involves 60 providers at public and private health posts in the first year. This above allocation funding request will cover the additional training of 60 other PMTCT providers in the second year and 60 in the third year. These health workers at antenatal sites, including midwives, will be responsible for Pillar 1 of PMTCT and for monitoring HIV-positive pregnant women until early childhood diagnosis.",29727.3,null,"Active","a6Q1R000000AJ2r",0,0,0,0,29727.3,0,null,null,"Providing training on PMTCT to 60 providers at public and private health posts to scale up the elimination of mother-to-child transmission (eMTCT):  \nThe country has set itself the challenge of eliminating mother-to child transmission by 2021. The current grant provided for PMTCT scale-up at 30 sites. This increase is coupled with a need for capacity building among untrained staff at antenatal clinics. This activity involves 60 providers at public and private health posts in the first year. This above allocation funding request will cover the additional training of 60 other PMTCT providers in the second year and 60 in the third year. These health workers at antenatal sites, including midwives, will be responsible for Pillar 1 of PMTCT and for monitoring HIV-positive pregnant women until early childhood diagnosis.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2022-06-30"]
["CT Comoros","Comoros","PAI-4054","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00111","Other intervention(s) for adolescent and youth","Implementing community-based condom distribution points in villages and towns: \nAn unreliable supply of condoms at the community level was reported as a major constraint that could hinder prevention interventions. As part of this grant, the DNLS therefore initiated the implementation of community-based condom distribution points in villages and towns run by community workers, as recommended in the national community health strategy. Mapping of villages shows that there are 331 villages to cover: 214 on Grande Comore (Ngazidja), 91 on Anjouan (Ndzuwani) and 26 on Mohéli (Mwali). \nThis above allocation funding request should cover 10 percent of the villages on each island in the first year, 20 percent in the second year and 35 percent in the third year. In each village, one distribution point will be selected in the first year, which will increase to three distribution points in the second and third years.   \nA total of 579 distribution points will be established in 215 villages over the three-year period: 372 on Grande Comore, 159 on Anjouan and 48 on Mohéli.",12995.17,null,"Active","a6Q1R000000AJ2q",0,0,0,0,12995.17,0,null,null,"Implementing community-based condom distribution points in villages and towns: \nAn unreliable supply of condoms at the community level was reported as a major constraint that could hinder prevention interventions. As part of this grant, the DNLS therefore initiated the implementation of community-based condom distribution points in villages and towns run by community workers, as recommended in the national community health strategy. Mapping of villages shows that there are 331 villages to cover: 214 on Grande Comore (Ngazidja), 91 on Anjouan (Ndzuwani) and 26 on Mohéli (Mwali). \nThis above allocation funding request should cover 10 percent of the villages on each island in the first year, 20 percent in the second year and 35 percent in the third year. In each village, one distribution point will be selected in the first year, which will increase to three distribution points in the second and third years.   \nA total of 579 distribution points will be established in 215 villages over the three-year period: 372 on Grande Comore, 159 on Anjouan and 48 on Mohéli.","High",null,"NA Original Intervention: Male and female condoms for adolescents and youth, in and out of school","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Southern and Eastern Africa","2022-06-30"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4015","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Pediatric TB training for maternal, neonatal and child health (MNCH) and diabetes providers The investment will be used to better incorporate pediatric TB screening and case management into the following activities: - Delivering pediatric TB training to two service providers per MNCH and malnutrition treatment center (TT)/TTC (2,068 x 2); - Delivering training to 516 diabetes and malnutrition treatment service providers.",224064,null,"Active","a6Q1R000000AJ2D",0,0,0,0,224064,0,null,null,"Pediatric TB training for maternal, neonatal and child health (MNCH) and diabetes providers The investment will be used to better incorporate pediatric TB screening and case management into the following activities: - Delivering pediatric TB training to two service providers per MNCH and malnutrition treatment center (TT)/TTC (2,068 x 2); - Delivering training to 516 diabetes and malnutrition treatment service providers.","High","High need / High impact","NA Original Intervention: Key populations (TB care and prevention) ? Others","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4014","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Improved treatment of side effects for DR-TB patients This investment is expected to improve DR-TB case management by: - Extending permanent technical assistance to six more provinces (on top of the five high-priority provinces included under the allocation amount), thereby covering a total of 11 provinces with high DR-TB prevalence rates); - Procuring 243 portable hearing test devices to assess DR-TB patients in the 243 health zones (HZs) in the 11 high-priority provinces, and purchasing 642 hearing aids for patients; - Building the capacities of DR-TB health workers through sending them to scientific symposia and on study trips; - Developing partnerships with universities.",854250,null,"Active","a6Q1R000000AJ2C",0,0,0,0,854250,0,null,null,"Improved treatment of side effects for DR-TB patients This investment is expected to improve DR-TB case management by: - Extending permanent technical assistance to six more provinces (on top of the five high-priority provinces included under the allocation amount), thereby covering a total of 11 provinces with high DR-TB prevalence rates); - Procuring 243 portable hearing test devices to assess DR-TB patients in the 243 health zones (HZs) in the 11 high-priority provinces, and purchasing 642 hearing aids for patients; - Building the capacities of DR-TB health workers through sending them to scientific symposia and on study trips; - Developing partnerships with universities.","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4013","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","Pharmacovigilance and laboratory strengthening This additional investment is intended to address rising drug resistance in the country and respond to the introduction of new drugs, initially to treat XDR-TB cases. It will be used to help establish a pharmacovigilance system to monitor and manage DR-TB drug side effects, with a view to future extension of the new drugs to treat DR-TB (non-XDR-TB).",2083840,null,"Active","a6Q1R000000AJ2B",0,0,0,0,2083840,0,null,null,"Pharmacovigilance and laboratory strengthening This additional investment is intended to address rising drug resistance in the country and respond to the introduction of new drugs, initially to treat XDR-TB cases. It will be used to help establish a pharmacovigilance system to monitor and manage DR-TB drug side effects, with a view to future extension of the new drugs to treat DR-TB (non-XDR-TB).","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4012","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","Supply chain and quality assurance strengthening This investment will significantly improve the TB drugs supply chain, through the following activities: - Have the Programme National d?Approvisionnement en Médicaments essentiels [National Program for the Procurement of Essential Medicines ? PNAM] and the National Tuberculosis Control Program (NTCP) take part in PSM monitoring and supervision missions at the Centrale de Distribution Régionale des Médicaments [Regional Drug Distribution Center ? CDR]; - Organize drug sample collection missions at all levels of the supply chain for quality control, in conjunction with the Direction de la Pharmacie et du Médicament [Directorate of Pharmacy and Drugs ? DPM]; - Cover the costs of having the samples analyzed by a foreign laboratory prequalified by the World Health Organization (WHO) to analyze first-line drugs. (10 percent of the drug?s value ? see Quality Assurance Plan); - Create and configure databases, produce reports and deliver training on Apisoft to the central and provincial levels; - Cover handling costs for drugs and other supplies; - Deliver TB drug management training to service providers.",2421488,null,"Inactive","a6Q1R000000AJ2A",2421488,0,0,0,0,1,null,null,"Supply chain and quality assurance strengthening This investment will significantly improve the TB drugs supply chain, through the following activities: - Have the Programme National d?Approvisionnement en Médicaments essentiels [National Program for the Procurement of Essential Medicines ? PNAM] and the National Tuberculosis Control Program (NTCP) take part in PSM monitoring and supervision missions at the Centrale de Distribution Régionale des Médicaments [Regional Drug Distribution Center ? CDR]; - Organize drug sample collection missions at all levels of the supply chain for quality control, in conjunction with the Direction de la Pharmacie et du Médicament [Directorate of Pharmacy and Drugs ? DPM]; - Cover the costs of having the samples analyzed by a foreign laboratory prequalified by the World Health Organization (WHO) to analyze first-line drugs. (10 percent of the drug?s value ? see Quality Assurance Plan); - Create and configure databases, produce reports and deliver training on Apisoft to the central and provincial levels; - Cover handling costs for drugs and other supplies; - Deliver TB drug management training to service providers.","High","High need / High impact","13/11/17: Shreya forwarded emails from Naboundou Toure-Fadiga on 13/10/17 that this activity was removed during grant negotiations. Made this intervention inactive by artifically changing the $ amount","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4011","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","Infection control measures Administrative, environmental and personal infection control measures will be needed to help prevent the transmission of TB (and DR-TB in particular), as defined in (Le Guide du Contrôle de l?infection et le guide de prise en charge de la TB-PR). The additional investment will be used to renovate 26 incinerators at testing and treatment centers (TTCs) with a high DR-TB burden in the 11 high-priority provinces (two per high-priority province plus four extra incinerators in Kinshasa), and to carry out minor renovation work at 708 TTCs selected on the basis of their TB/HIV co-infection burden. There are also plans to monitor and evaluate the implementation of these measures. This intervention should help avoid 250 new infections at the TTCs in question.",1169800,null,"Active","a6Q1R000000AJ29",0,0,0,0,1169800,0,null,null,"Infection control measures Administrative, environmental and personal infection control measures will be needed to help prevent the transmission of TB (and DR-TB in particular), as defined in (Le Guide du Contrôle de l?infection et le guide de prise en charge de la TB-PR). The additional investment will be used to renovate 26 incinerators at testing and treatment centers (TTCs) with a high DR-TB burden in the 11 high-priority provinces (two per high-priority province plus four extra incinerators in Kinshasa), and to carry out minor renovation work at 708 TTCs selected on the basis of their TB/HIV co-infection burden. There are also plans to monitor and evaluate the implementation of these measures. This intervention should help avoid 250 new infections at the TTCs in question.","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4010","MCI-00010","MDR-TB","MCI-00147","Other MDR-TB intervention(s)","Renovation of DR-TB in-patient facilities The purpose of the additional investment is to renovate three in-patient treatment centers for drug-resistant TB (DR-TB) patients presenting with complications or severe side effects during treatment. The three centers will be located in DR-TB hot spots. The unit cost of US$ 115,000 is a historical cost from the current grants.",449550,null,"Active","a6Q1R000000AJ28",0,0,0,0,449550,0,null,null,"Renovation of DR-TB in-patient facilities The purpose of the additional investment is to renovate three in-patient treatment centers for drug-resistant TB (DR-TB) patients presenting with complications or severe side effects during treatment. The three centers will be located in DR-TB hot spots. The unit cost of US$ 115,000 is a historical cost from the current grants.","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Congo (Democratic Republic)","Congo (Democratic Republic)","PAI-4009","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","Diagnosis and treatment of XDR-TB cases This additional request would allow treatment to begin for 62 patients with extensively drug-resistant TB (XDR-TB) in 2018, 75 in 2019 and 88 in 2020. The activities concerned are the purchase of drugs, the corresponding PSM costs and three technical assistance activities for managing XDR-TB patients.",2364088,null,"Active","a6Q1R000000AJ27",0,0,0,0,2364088,0,null,null,"Diagnosis and treatment of XDR-TB cases This additional request would allow treatment to begin for 62 patients with extensively drug-resistant TB (XDR-TB) in 2018, 75 in 2019 and 88 in 2020. The activities concerned are the purchase of drugs, the corresponding PSM costs and three technical assistance activities for managing XDR-TB patients.","High","High need / High impact","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT High Impact Africa 1","2020-12-31"]
["CT Cameroon","Cameroon","PAI-3988","MCI-00009","TB/HIV","MCI-00139","Other TB/HIV intervention(s)","This would be used to support the following activities: -Additional six-monthly mass   TB/HIV   campaigns   in prisons with more than 1,000 inmates and on a quarterlybasisin   institutions   with   less   than   1,000   inmates. Purchase   of   additional   supplies   for   TB   and   HIV prevention (infection control, safe shaving) for prisoners and support for the coordination of these activities, which will  help  to  ensure  TB  is  diagnosed  earlier  and  avoid  it being spread. In  addition,  it  would  facilitate  the  purchase  of  two  mobile digital X-ray machines exclusively for prisoners, which would significantly improve the rate of return for screening.",708964.2,null,"Active","a6Q1R000000AJ1m",248008.08,0,0,0,460956.12,0,null,null,"This would be used to support the following activities: -Additional six-monthly mass   TB/HIV   campaigns   in prisons with more than 1,000 inmates and on a quarterlybasisin   institutions   with   less   than   1,000   inmates. Purchase   of   additional   supplies   for   TB   and   HIV prevention (infection control, safe shaving) for prisoners and support for the coordination of these activities, which will  help  to  ensure  TB  is  diagnosed  earlier  and  avoid  it being spread. In  addition,  it  would  facilitate  the  purchase  of  two  mobile digital X-ray machines exclusively for prisoners, which would significantly improve the rate of return for screening.","High","This funding is important to support activities to conduct TB/HIV massscreening campaigns in prisons and to purchase two mobile digital X-ray machines for use in prisons. This intervention is part of active case finding strategy for key populations and with potential to identify the undiagnosed TB and HIV cases. In addition to proposed screening of prisoners, the TRP recommends that during the screening 6 campaigns, the prison staff be screened as well.","NA Original Intervention: Key populations (TB/HIV) ? Prisoners","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Cameroon","Cameroon","PAI-3987","MCI-00010","MDR-TB","MCI-00142","Prevention for MDR-TB","This  funding  would  be  used  to  renovate  hospital  wards  for MDR-TB/RR-TB   patients   in five hospital   (Limbé,   Maroua, Bafoussam,  Bertoua  and  Garoua)  in  Year  2.  The  funding wouldalso provide community care for 100 additional MDR-TB/RR-TB patients between Year 1 and Year 3.",25148.69,null,"Active","a6Q1R000000AJ1l",0,0,0,0,25148.69,0,null,null,"This  funding  would  be  used  to  renovate  hospital  wards  for MDR-TB/RR-TB   patients   in five hospital   (Limbé,   Maroua, Bafoussam,  Bertoua  and  Garoua)  in  Year  2.  The  funding wouldalso provide community care for 100 additional MDR-TB/RR-TB patients between Year 1 and Year 3.","High","The funds will renovate existing hospitals in Limbé, Maroua, Bafoussam, Bertoua and Garoua to provide for treatment of MDR-TB patients requiring hospitalization as well as provide community care for 100 additional MDR-TB/RR-TB patients.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Cameroon","Cameroon","PAI-3986","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","This would be used for the following activities: -Support for community DOTS (home-based treatment by a  qualified  nurse)  for  daily  administration  of  MDR-TB drugs     to     240  additional  MDR-TB  outpatients; hospitalization costs.-Purchase of ten audiometer machines for MDR-TB in the year.",534321.62,null,"Active","a6Q1R000000AJ1k",170726.07,0,0,0,363595.55,0,null,null,"This would be used for the following activities: -Support for community DOTS (home-based treatment by a  qualified  nurse)  for  daily  administration  of  MDR-TB drugs     to     240  additional  MDR-TB  outpatients; hospitalization costs.-Purchase of ten audiometer machines for MDR-TB in the year.","High","These funds will enable the treatment of additional MDR TB patients by supporting community DOTS (home-based treatment by a qualified nurse) for daily administration of MDR-TB drugs to 240 additional MDR-TB outpatients; as well as purchasing ten audiometer machines for MDR-TB","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Cameroon","Cameroon","PAI-3985","MCI-00010","MDR-TB","MCI-00140","Case detection and diagnosis: MDR-TB","This funding would be used to purchase tests for initial check-up and follow-up of 100 additional MDR-TB patients between Year  1  and  Year 3.  It  would  also  cover  screening  for  MDR-TB/RR-TB among new TB cases. This would be after having tested 100 percent of the primary group at higher risk, which is patients with a history of previous treatment.",49771.07,null,"Active","a6Q1R000000AJ1j",0,0,0,0,49771.07,0,null,null,"This funding would be used to purchase tests for initial check-up and follow-up of 100 additional MDR-TB patients between Year  1  and  Year 3.  It  would  also  cover  screening  for  MDR-TB/RR-TB among new TB cases. This would be after having tested 100 percent of the primary group at higher risk, which is patients with a history of previous treatment.","High","The funds will enable expansion of testing for MDR, including screening of new TB patients.","NA Original Module: Multidrug-resistant TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Cameroon","Cameroon","PAI-3984","MCI-00003","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","MCI-00549","Addressing stigma, discrimination and violence against PWID","This   funding   would   be   used   to   run   additional   training workshops for magistrates on the subject of access to health services for MSM, people who inject drugs and sex workers.",15746.83,null,"Active","a6Q1R000000AJ1i",0,0,0,0,15746.83,0,null,null,"This   funding   would   be   used   to   run   additional   training workshops for magistrates on the subject of access to health services for MSM, people who inject drugs and sex workers.","Low","Such interventions are already included in the proposed activities and the added value of an additional training is difficult to assess.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Addressing stigma, discrimination and violence against people who inject drugs","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Cameroon","Cameroon","PAI-3983","MCI-00008","TB care and prevention","MCI-00133","Other TB care and prevention intervention(s)","This funding would be used to purchase two mobile digital X-ray  machines  for  PLHIV  who  cannot  pay  for  X-rays,  in  the Douala   and   Yaoundé   regions.   This   would   significantly improve the rate of return for TB screening in these patients. TRP recommends swaping between X-Ray equipment for hospital currently budgeted in the allocation.",248008.08,null,"Inactive","a6Q1R000000AJ1h",248008.08,0,0,0,0,1,null,null,"This funding would be used to purchase two mobile digital X-ray  machines  for  PLHIV  who  cannot  pay  for  X-rays,  in  the Douala   and   Yaoundé   regions.   This   would   significantly improve the rate of return for TB screening in these patients. TRP recommends swaping between X-Ray equipment for hospital currently budgeted in the allocation.","High","This funding is considered of high importance in order to increase screening for TB among disadvantaged PLHIV by purchasing digital X-ray machines in the Douala and Yaoundé regions. The TRP recommends that this intervention is swapped for the procurement of hospital-based X-rays within allocation as mobile X-ray has a higher potential to contribute to TB screening and diagnosis","NA Original Intervention: Community management of TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Central Africa"]
["CT Djibouti","Djibouti","PAI-4163","MCI-00022","RSSH: Health management information systems and M&E","MCI-00600","Program and data quality","The activities of analysis and quarterly validation of data with stakeholders and service providers ensure data quality and a better follow-up of performance indicators.",18576,null,"Active","a6Q1R000000AJ4b",0,0,0,0,18576,0,null,null,"The activities of analysis and quarterly validation of data with stakeholders and service providers ensure data quality and a better follow-up of performance indicators.","Medium",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4162","MCI-00008","TB care and prevention","MCI-00126","Case detection and diagnosis","Purchase of 3 x-ray digital X-ray machine with printer including one for the diagnosis of TB in children at the level of the Hopital Chakib Saad (HPPCSO) and two others for the community health centers with an important activity  on the outskirts of Djibouti city (Balbala 1 and Balbala 2) These devices will reduce the cost and are transportable. The expected result is an improved screening of new TB cases  especially at children level.",302024,null,"Active","a6Q1R000000AJ4a",0,0,0,0,302024,0,null,null,"Purchase of 3 x-ray digital X-ray machine with printer including one for the diagnosis of TB in children at the level of the Hopital Chakib Saad (HPPCSO) and two others for the community health centers with an important activity  on the outskirts of Djibouti city (Balbala 1 and Balbala 2) These devices will reduce the cost and are transportable. The expected result is an improved screening of new TB cases  especially at children level.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4161","MCI-00008","TB care and prevention","MCI-00128","Prevention","The study on TB/diabetes co-infection will allow better identification of new cases of TB and of diabetes.",8475,null,"Active","a6Q1R000000AJ4Z",0,0,0,0,8475,0,null,null,"The study on TB/diabetes co-infection will allow better identification of new cases of TB and of diabetes.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4160","MCI-00008","TB care and prevention","MCI-00128","Prevention","The sample study at national level on the correlation between TB and malnutrition and HIV and malnutrition in healh centers will contribute to identify new cases of TB and HIV.",8475,null,"Active","a6Q1R000000AJ4Y",0,0,0,0,8475,0,null,null,"The sample study at national level on the correlation between TB and malnutrition and HIV and malnutrition in healh centers will contribute to identify new cases of TB and HIV.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4159","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","The integration of TB and HIV testing into Ministry of Health's advanced strategy activities will need supervision to improve the quality of interventions.  These interventions will allow identifying and treating new cases of TB and HIV.",8475,null,"Active","a6Q1R000000AJ4X",0,0,0,0,8475,0,null,null,"The integration of TB and HIV testing into Ministry of Health's advanced strategy activities will need supervision to improve the quality of interventions.  These interventions will allow identifying and treating new cases of TB and HIV.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4158","MCI-00533","HIV Testing Services","MCI-00579","Differentiated HIV testing services","The service providers and community workers will be trained on the quality of services and RTTR(Reach, test, treat, and retain)-HIV-TB-Human Rights. They will contribute to identifing and referring suspect HIV and TB cases (index and contacts).",8475,null,"Active","a6Q1R000000AJ4W",0,0,0,0,8475,0,null,null,"The service providers and community workers will be trained on the quality of services and RTTR(Reach, test, treat, and retain)-HIV-TB-Human Rights. They will contribute to identifing and referring suspect HIV and TB cases (index and contacts).","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4157","MCI-00006","PMTCT","MCI-00201","Analysis, review and transparency","The peer educators- traning is meant to contribute to  the action plan in the context of the RTTR (Reach, test, treat, and retain) TB-HIV-Human Rights strategy, the enrollment and retaining of patients and data collection.",24585,null,"Active","a6Q1R000000AJ4V",0,0,0,0,24585,0,null,null,"The peer educators- traning is meant to contribute to  the action plan in the context of the RTTR (Reach, test, treat, and retain) TB-HIV-Human Rights strategy, the enrollment and retaining of patients and data collection.","High",null,"NA Original Module: Prevention of mother-to-child transmission","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4156","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","The implementation of the national strategy of condom distribution for young people will allow prevention of STIs (sexually-transmitted infections) and HIV and prevention of unintended pregnancies.",3763,null,"Active","a6Q1R000000AJ4U",0,0,0,0,3763,0,null,null,"The implementation of the national strategy of condom distribution for young people will allow prevention of STIs (sexually-transmitted infections) and HIV and prevention of unintended pregnancies.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Djibouti","Djibouti","PAI-4155","MCI-00005","Prevention programs for adolescents and youth, in and out of school","MCI-00106","Behavioral change as part of programs for adolescent and youth","Monitoring, coaching and supervision of peer educators'activities will  allow improvement of quality of intervention and reaching the program's objectives.",2822,null,"Active","a6Q1R000000AJ4T",0,0,0,0,2822,0,null,null,"Monitoring, coaching and supervision of peer educators'activities will  allow improvement of quality of intervention and reaching the program's objectives.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Middle East and North Africa","2020-12-31"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3909","MCI-00022","RSSH: Health management information systems and M&E","MCI-00201","Analysis, review and transparency","Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the region?s needs.",62117.18,null,"Active","a6Q1R000000AJ0V",0,0,0,0,62117.18,0,null,null,"Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the region?s needs.","High",null,"The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Module: Monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Latin America and Caribbean","2021-12-31"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3908","MCI-00012","Case management","MCI-00157","Active case detection and investigation (elimination phase)","Activity 59: Amazon Region Meeting to consolidate the AOP for each municipality. (Participants: organized civil population, municipality, regional authorities) prior to preparation of the AOP (July each year) in Cobija.\nActivity mentioned in the diagnosis for transition as part of the negotiation with municipalities.",52155,null,"Active","a6Q1R000000AJ0U",0,0,0,0,52155,0,null,null,"Activity 59: Amazon Region Meeting to consolidate the AOP for each municipality. (Participants: organized civil population, municipality, regional authorities) prior to preparation of the AOP (July each year) in Cobija.\nActivity mentioned in the diagnosis for transition as part of the negotiation with municipalities.","High",null,"The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number.","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Latin America and Caribbean","2021-12-31"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3907","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Conducting of a study of primary resistance to ARV in new patients is planned as a critical element of strategic information in order to strengthen management, decision-making in terms of antiretroviral drug policies, sustainability and progress towards the goal of suppressing viral loads. A total cost of USD 100,000 is estimated.",100000,null,"Active","a6Q1R000000AJ0T",0,0,0,0,100000,0,null,null,"Conducting of a study of primary resistance to ARV in new patients is planned as a critical element of strategic information in order to strengthen management, decision-making in terms of antiretroviral drug policies, sustainability and progress towards the goal of suppressing viral loads. A total cost of USD 100,000 is estimated.","High","As the last sex worker study was conducted in 2010, the TRP considers this proposed study to be a high priority for PAAR. Should additional resources become available through efficiencies or other sources, the TRP recommends prioritization of IBBS for sex workers (including moving this activity into the allocation) so that the applicant can assess if interventions for sex workers are working by having a trend to analyze.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3906","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.",50000,null,"Active","a6Q1R000000AJ0S",0,0,0,0,50000,0,null,null,"Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Bolivia (Plurinational State)","Bolivia (Plurinational State)","PAI-3905","MCI-00022","RSSH: Health management information systems and M&E","MCI-00200","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.",5808,null,"Active","a6Q1R000000AJ0R",0,0,0,0,5808,0,null,null,"Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS","RT Latin America and Caribbean","2021-12-31"]
["CT Belize","Belize","PAI-3904","MCI-00535","Programs to reduce human rights-related barriers to HIV services","MCI-00588","Improving laws, regulations and polices relating to HIV and HIV/TB","The operationalization of the non-discrimination law is key.  Once the non-discrimination law is introduced by Cabinet there will be need for mass education on this new legislation to make it effective. This is a key activity of the funding request based on the Transition Readiness Assessment findings to improve the legislative environment.",50000,null,"Active","a6Q1R000000AJ0Q",0,0,0,0,50000,0,null,null,"The operationalization of the non-discrimination law is key.  Once the non-discrimination law is introduced by Cabinet there will be need for mass education on this new legislation to make it effective. This is a key activity of the funding request based on the Transition Readiness Assessment findings to improve the legislative environment.","Low","The TRP considers television spots as low relevance because there is little evidence that TV spots contribute to reducing human rights-related barriers to HIV services.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Shalini Mitra","2019-10-30","2017-2019","HIV/AIDS, Tuberculosis","RT Latin America and Caribbean","2021-12-31"]
["CT Romania","Romania","PAI-6134","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",862153.52,862153.52,"Active","a6Q1R000000AJd3",{"$nulls":4},862153.52,0,null,"High","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2021-03-31"]
["CT Moldova","Moldova","PAI-6124","MCI-00010","MDR-TB","MCI-00141","Treatment: MDR-TB","Regimen Change: introduction of new treatment \nregimen approved by WHO",1074153.67,1074153.67,"Inactive","a6Q1R000000AJcF",392670.86,1074153.67,null,null,0,1,null,"High","Regimen Change: introduction of new treatment \nregimen approved by WHO","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Tuberculosis","RT Eastern Europe and Central Asia","2020-12-31"]
["CT Comoros","Comoros","PAI-6181","MCI-00011","Vector control","MCI-00150","Indoor residual spraying (IRS)","IRS for indigenous cases in elimination areas (5 km radius): In the elimination areas, malaria cases should undergo both epidemiological and entomological investigations to determine the origin of the case. Once the case is declared indigenous, case management (treatment) and interruption of parasite transmission by the vector (IRS) are the two main response interventions used to prevent epidemics. This activity will take place following the results of the prior entomological investigations. A total of nine IRS interventions are planned based on an expected 5 percent of imported cases over the three years in elimination areas. Thus, nine cases are expected in total  two cases in 2019, four cases in 2020 and three cases in 2021. Expected outcome: interruption of transmission. Expected impact: prevention of re-introduction of the disease.",419652,419652,"Active","a6Q1R000000AJmn",{"$nulls":4},419652,0,null,"High","IRS for indigenous cases in elimination areas (5 km radius): In the elimination areas, malaria cases should undergo both epidemiological and entomological investigations to determine the origin of the case. Once the case is declared indigenous, case management (treatment) and interruption of parasite transmission by the vector (IRS) are the two main response interventions used to prevent epidemics. This activity will take place following the results of the prior entomological investigations. A total of nine IRS interventions are planned based on an expected 5 percent of imported cases over the three years in elimination areas. Thus, nine cases are expected in total  two cases in 2019, four cases in 2020 and three cases in 2021. Expected outcome: interruption of transmission. Expected impact: prevention of re-introduction of the disease.","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Malaria","RT Southern and Eastern Africa","2021-12-31"]
["CT Central African Republic","Central African Republic","PAI-6196","MCI-00012","Case management","MCI-00154","Facility-based treatment","Dans le cadre d'une bonne gestion de stocks des intrants de santé et de rendre disponible les intrants financés par le Fonds Mondial en RCA, il a été opté de chercher un partenaire ayant une expertise et une capacité logistique qui est le ??Programme Alimentaire Mondial (PAM). Les couts y relatifs couvrent le transport des intrants à l'intérieur du pays, l'assurance des intrants, les frais de manutention, la sécurité et les coûts d?opérations de support. Le budget qui était initialement prévu pour les trois années de la subvention était estimé à 2,100,000 Euros seulement et ne prenait en compte les frais de gestion payés au PAM. Cependant, il s'avère que ce budget soit insuffisant vu les factures du PAM jusqu?en Décembre 2019 estimé à 2,326,922 Euros d'où un dépassement de 226,922 euros, soit 10% du budget initialement prévu à cet effet. Ce budget est seulement pour la logistique des produits de santé excluant les moustiquaires. Notons que pour l'année 2019 le Fonds Mondial avait recommandé que ces frais ne devraient pas dépasse 1,260,000 euros. \n\nPour l'année 2020, il y aura une augmentation des Formations Sanitaires qui passeront de 736 à 838, ce qui va occasionner une augmentation des besoins en intrants (antipaludéens et TDR; mais leur achat sera couvert par les économies des autres lignes), des frais de transport (surtout qu'ils sont estimés en terme de volume transporté), de manutention et assurance. Ainsi, les prévisions budgétaires pour le PAM pour l'année 2020, estimées sur la base des dépenses actuelles, s'élèvent à 1,653, 302 Euros. Considérant le déficit actuel de 226,922 euros sur cette ligne budgétaire, il se dégage un gap financier cumulatif de 1,880,224 euros. Toutefois, sur base des économies dégagées sur les autres lignes budgétaires, le gap à combler s'élève à 1,673,649.68 euros.",1878183,1878183,"Inactive","a6Q1R000000AJnI",null,1878183,null,null,0,1,null,"High","To ensure sound management of commodities procured with Global Fund grant funds and their availability in CAR, the World Food Program (WFP) was selected as SCM partner, given their known expertise and logistical capacity. WFP?s budget and costs cover transportation of inputs in country, insurance, warehousing, handling, security and support costs. The original budget that was estimated to cover their services during three years of implementation reached EUR 2,100,000 and did not include management fees paid to WFP. Given WFP?s budget rate consumption so far and projected level of expenses at the end of 2019, EUR 2,326,922, it results in a EUR 226,922 over expenditure (10% above original budget planned for this purpose). This budget only covers logistics of health products excluding mosquito nets. Note that for the year 2019 the Global Fund had recommended that these costs should not exceed EUR 1,260,000.\n\nDuring year 2020, there will be an increase of number of functional health facilities (going from 736 to 838) in the country that will result in an increase demand of commodities (ACTs and RDTs, partly covered with grant savings), transportation costs (especially considering that their estimation is based on volume), warehousing and insurance. Adding this, the projected budget needs for WFP in 2020 (which are estimated on current budget absorption) raise up to EUR 1,653,302. If we consider the above mentioned 10% over expense, the funding gap is EUR 1,880,224. However, some efficiencies in country (identified in other budget lines) will contribute to cover part of the gap. Which results in a final gap of EUR 1,673,649.68.","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Central African Republic","Central African Republic","PAI-6195","MCI-00011","Vector control","MCI-00148","Long-lasting insecticidal nets (LLIN) - Mass campaign","Il était prévu la distribution des MILD dans les régions 1, 2 et 3 en 2019 pour protéger les populations contre le paludisme, car la dernière campagne dans ces 3 régions remonte à 2014. \n\nLe rapport de la micro planification dans ces régions révèle que la population a augmenté de 49% par rapport aux chiffres de macro planification. Etant donné que les MILDs disponibles pour la campagne au niveau du pays ne sont que 1,800,700, alors que le besoin avec l'augmentation exige d'avoir 2,552,998 MILD afin de pouvoir couvrir ces régions, entrainant ainsi un gap de 752,300 MILDs qui couteront 1,847,798 euros.\n\nLe budget initialement prévue pour la campagne était seulement 3,325,097euros (coût opérationnel). L?augmentation de la population a engendré non seulement le gap en moustiquaires mais aussi un gap financier exorbitant relatif au cout opérationnel s'élevant à 3,864,538 euros. Il se trouve que pour couvrir les trois régions, le pays aura besoin de 7,189,635 euros incluant les couts liés aux ONG de mise en ?uvre; ce qui dégage ainsi un gap de 5,712,336 Euros incluant les moustiquaires additionnelles, leur distribution et les couts opérationnels. \n\nSi ce gap n'est pas comblé, le pays ne pourra pas faire la campagne dans ces trois régions et par conséquent il ne pourra pas atteindre l'objectif de la distribution de masse pour l'année 2019-2020.",6410432,6410432,"Inactive","a6Q1R000000AJnH",null,6410432,null,null,0,1,null,"High","The distribution of LLINs in Regions 1, 2 and 3 in 2019 was planned to protect populations against malaria, as the last campaign in these 3 regions was in 2014.\n\nThe report of micro planning in these areas reveals that the population has increased by 49% compared to macro planning figures. Given that the LLINs available in country for the campaign are only 1,800,700, while the need resulting from population increase requires 2,552,998 LLINs to cover these areas, there is a resulting gap of 752,300 LLINs that will cost EUR 1,847,798.\n\nThe initial budget for the campaign was only EUR 3,325,097(operational cost). The increase of the population has generated not only a gap in nets but also an exorbitant financial gap related to operational costs amounting to EUR 3,864,538. In order to keep covering the three regions within the mass campaing, the new budget would reach EUR 7,189,635 (including costs related to implementing NGOs). With the current level of funding, this results in a gap of EUR 5,712,336 including additional nets and respective distribution and operational costs.\n\nIf this gap is not filled, the country will not be able to implement the campaign in the 3 regions and will not be able to achieve coverage targets of mass distribution for the year 2019-2020.","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Central African Republic","Central African Republic","PAI-6197","MCI-00012","Case management","MCI-00156","Integrated community case management (ICCM)","Une des stratégies de la prise en charge du paludisme en temps réel est la création des Points Paludisme avec le soutien technique de MSF dans leurs zones d'intervention.  Cette stratégie va faire augmenter la demande de service au niveau communautaire et par conséquent la demande accrue des ACTs. Le nombre des points palu gérés par le groupe MSF est 78 avec une consommation mensuelle moyenne de 420 doses. La dose totale estimée est de 589,680 incluant un stock de sécurité de 6 mois. Pour l'acquisition de ces intrants, 272,974.67 euros sont nécessaires. Le coût de transport et d'assurance depuis chez le fournisseur/fabriquant jusqu' à Bangui est de 185,788 euros.   \n\nCe qui donne un budget global d'achat de 458,762.67 Euros faisant objet de demande additionnelle.",514827,514827,"Inactive","a6Q1R000000AJnJ",null,514827,null,null,0,1,null,"High","One of the strategies that will strengthen real-time malaria case management is the creation of Malaria Points (?palu points?) with MSF's technical support within their areas of intervention. This strategy will increase the demand for services at the community level and consequently the demand of commodities. The number of ?palu points? managed by MSF is 78 with an average monthly consumption of 420 doses of ACTs. The total estimated dose is therefore 589,680 (including a 6-month buffer stock). The procurement of these inputs (EUR 272,974.67) also requires the estimation of transport and insurance costs from the supplier / manufacturer to Bangui, which were estimated to raise EUR 185,788.\nThis gives an overall budget of EUR 458,762.67 for this intervention.","High",null,null,"Shalini Mitra","2020-01-30","2017-2019","Malaria","RT Central Africa","2020-12-31"]
["CT Liberia","Liberia","PAI-4695","MCI-00022","RSSH: Health management information systems and M&E","MCI-00205","Other health information systems and M&E intervention(s)","The cost is to cover the training of the District Health Officers in the 14 counties except Montserrado in Monitoring and Evaluation.",157890,null,"Active","a6Q1R000000AJDB",0,0,0,0,157890,0,null,null,"The cost is to cover the training of the District Health Officers in the 14 counties except Montserrado in Monitoring and Evaluation.","High",null,"NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4690","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00601","Supportive policy and programmatic environment","County level capacity building in all counties, minus the 4 counties in the South Eastern region where UNICEF is already providing capacity building.  The capacity building efforts will be led by specialists in the field for CHTs that require capacity building. Exact details of capacity building will be finalized once capacity assessments are be completed.",3000000,null,"Active","a6Q1R000000AJD6",0,0,676139,0,2323861,0,null,null,"County level capacity building in all counties, minus the 4 counties in the South Eastern region where UNICEF is already providing capacity building.  The capacity building efforts will be led by specialists in the field for CHTs that require capacity building. Exact details of capacity building will be finalized once capacity assessments are be completed.","High","The TRP considers the ?country-level capacity building? intervention following the previous ?capacity assessments? intervention, as highly relevant to strengthen the health system.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4689","MCI-00012","Case management","MCI-00154","Facility-based treatment","The request amount is intended to improve targeted health facilities for better provision of malaria, HIV and TB services aimed at improving maternal and child health services for increased mother and child survival. Adopting a facility shall include the provision of relevant equipment as per targeted health facility type, upgrading some existing health facility for improved capacity, strengthen emergency, preparedness and response.",1482080,null,"Active","a6Q1R000000AJD5",0,0,0,0,1482080,0,null,null,"The request amount is intended to improve targeted health facilities for better provision of malaria, HIV and TB services aimed at improving maternal and child health services for increased mother and child survival. Adopting a facility shall include the provision of relevant equipment as per targeted health facility type, upgrading some existing health facility for improved capacity, strengthen emergency, preparedness and response.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4692","MCI-00023","Program management","MCI-00207","Grant management","This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria during the 2021 Mass Distribution Campaign. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.",91440,null,"Active","a6Q1R000000AJD8",0,0,0,0,91440,0,null,null,"This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria during the 2021 Mass Distribution Campaign. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.","High",null,null,"Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]
["CT Liberia","Liberia","PAI-4691","MCI-00014","RSSH: Integrated service delivery and quality improvement","MCI-00173","Other service delivery intervention(s)","The matching funds requested to support integrated service delivery, seek to focus on investments in the platform for serviced delivery and strengthening clinical systems for integrated screening, diagnosis, and care, in-service skills building of clinicians to be able to deliver both TB and HIV services including management of late-stage HIV infection, and capacitating the community platform for support of TB treatment adherence and HIV supportive care.  The proposed site for initial intervention through matching fund investments is Liberia?s national referral facility for TB ? The TB Annex, based in Monrovia. As the country?s national referral center for TB services, all forms of TB including management of TB and co-morbidities like diabetes, DR-TB, and TB/HIV co-infection are managed at the facility, where integrated service delivery can serve as a model to further scale this approach at all levels from primary care through hospital-based treatment, at the county and regional levels.",742905,null,"Active","a6Q1R000000AJD7",0,0,0,0,742905,0,null,null,"The matching funds requested to support integrated service delivery, seek to focus on investments in the platform for serviced delivery and strengthening clinical systems for integrated screening, diagnosis, and care, in-service skills building of clinicians to be able to deliver both TB and HIV services including management of late-stage HIV infection, and capacitating the community platform for support of TB treatment adherence and HIV supportive care.  The proposed site for initial intervention through matching fund investments is Liberia?s national referral facility for TB ? The TB Annex, based in Monrovia. As the country?s national referral center for TB services, all forms of TB including management of TB and co-morbidities like diabetes, DR-TB, and TB/HIV co-infection are managed at the facility, where integrated service delivery can serve as a model to further scale this approach at all levels from primary care through hospital-based treatment, at the county and regional levels.","High",null,"NA Original Module: RSSH - Integrated service delivery and quality improvement","Shalini Mitra","2019-10-30","2017-2019","Malaria","RT Western Africa","2021-06-30"]

{"sheet":"User Information","index":5,"n_rows":5,"n_cols":3,"rows_kept":5,"cut":false,"hidden":false,"merged":[[3,2,3,7],[4,2,4,7]]}
[]
[]
[]
[null,null,"Register of Unfunded Quality Demand "]
[null,null,"Instructions for use and interpretation of the register"]

{"sheet":"UQD register NEW (2)","index":6,"n_rows":2354,"n_cols":8,"rows_kept":1125,"cut":true,"hidden":false,"merged":[[4,0,4,7],[5,0,5,7]],"bounds":{"rows_first":500,"rows_last":125,"rows_between":500,"halvings":2}}
[]
["2017-2019 Register of Unfunded Quality Demand, Updated: 16/03/2020"]
["Please refer to the 'User Information' for essential information on interpreting the Register of UQD"]
[]
["UQD Register Analysis - 2017-2019 Funding Cycle"]
{"$rows_empty":10}
[null,"Applicant","Component ","Module","Intervention","UQD description","UQD expiry date ","UQD amount (USD)"]
[null,"Afghanistan","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Condoms and lubricant programming for PWID","The activity for female injecting drug users will be started in four provinces i.e. Kabul, Nangarhar, Balkh and Herat provinces. The initiation of this activity will be subject to the assessment results by the end of the year 2017. Currently, there is no intervention for FIDU in the 3 country by any partners.","2020-12-31",423465]
[null,"Afghanistan","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Condoms and lubricant programming for PWID","There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.","2020-12-31",172108]
[null,"Afghanistan","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Sub-recipient NGOs  could mobilize food items for PWID in Drop In Centers (DICs) from other sources.  Considering the status of 5 mentioned clients, it was necessary to provide cooked food; therefore, it was needed to hire six cooks in six provinces. The provinces include: Badakhshan, Kunduz, Ghazni, Kandahar, Nimroz, and Farah.","2020-12-31",28770]
[null,"Afghanistan","HIV/AIDS","Program management","Grant management","This refers to the PR 7% Grant Management Services (GMS) cost and Sub-recipient 5% overhead cost.","2020-12-31",214501]
[null,"Afghanistan","HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Currently there were 6 provincial coordinators, 5 CDC focal points, 6 drivers and their PPHO running costs. The running cost included maintenance & fuel of vehicles and mobile phone top ups.  This module helped coordinate program activities at sub national level, therefore, it is proposed under above allocation but with some changes. The change aims to increase the number of CDC focal points from 5 to 11 and drop the provincial coordinators and PPHO related costs.","2020-12-31",377846]
[null,"Afghanistan","HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","7-10% total grant budget can be allocated to M&E & surveillance related activities. Hence, the NACP encounters numerous issues in terms of data quality, verification, collection, capacity building in terms of trainings for the M&E and Surveillance staff. Need to recruit three national epidemiologists short-term basis to train staff. Assessment on FIDUs is a critical component of the programs as previously recommended by the TRP to be further strengthened to ensure that the country needs are met.","2020-12-31",483280]
[null,"Afghanistan","HIV/AIDS","Treatment, care and support","Treatment adherence","In order to increase adherence of patients to treatment certain social support pckages are proposed.","2020-12-31",768060]
[null,"Afghanistan","Malaria","Case management","Active case detection and investigation (elimination phase)","To  prevent  the  spread  of  malaria  in  Category  2&3   provinces,  early  detection  ,  prompt  treatment  and  case  based  surveillance  are  considered  as  the  top  priority  by  the  program.  These measures are not costed in allocated  funding  request.  In the revised National Malaria Strategy, for the areas in Category 2 & 3 (low or malaria elimination areas), it is recommended to strengthen  malaria  surveillance  through case-based investigation.","2020-12-31",96000]
[null,"Afghanistan","Malaria","Case management","Facility-based treatment","Studies show variation of G6PD deficiency in areas with high malaria endemicity. 95%   of   cases   are   due   to   Plasmodium   Vivax   whose recurrence results in PV malaria case increase. The cure is a full dose of Primaquine save for G6PD deficiency cases which require supply of G6PD care tests to health facilities. To deploy the testing, a training will be conducted on administration of tests in malaria endemic areas. Estimated test cost $: 2*370,347 = 740,694. Workshop (# of people 1351*51= 68901.Total= 740,694+68901=809,595.","2020-12-31",809595]
[null,"Afghanistan","Malaria","Case management","Facility-based treatment","To focus on enhancing case confirmation and reduction of  clinical  malaria  cases  specifically  in  high  burden  province  bordering Pakistan,  it  is  needed  to  distribute RDT and have a regular coordination meeting with   health   facilities   staff   and   Community   Health   Supervisors to  share  the  surveillance  gaps, guidance on improvement of on the spot data quality, and review the implementation of malaria case management    by    conducting    Biannual meetings with staff from   7   high-risk   malaria   provinces   bordering  Pakistan.","2020-12-31",100044]
[null,"Afghanistan","Malaria","RSSH: Health management information systems and M&E","Routine reporting","Under   the   2015-2017 grant,   Malaria   &   Leishmaniosis Information Systems (MLIS) have been piloted in 4 provinces, evidence based scale up of MLIS is planned for the next grant period.  Required activities are;  training session for HMIS  officers  from  PHDs  &  BPHS  implementers, Malaria  Control  officers  and heads of health facilities.  Lower  health  facilities level,  which   are   considered   for   RDTs   distribution  under  allocation  request,  planned  to  be  oriented on MLIS reporting system in RDT use training sessions.","2020-12-31",36520]
[null,"Afghanistan","Malaria","Vector control","Indoor residual spraying (IRS)","Category  2&3  provinces  prone  for  malaria  epidemics lack vector  control measure (LLINs) Population here is mostly  not immune, so single  malaria  case  carries high transmission risk (especially considering  migration and movement of internally   displaced population).   It is proposed to procure the stock of insecticide for IRS and larvaciding, cosnidering   geographic and  logistical challenges of re-supply.    This will facilitate immediate response to   outbreak   investigation   and   response   in   the   elimination areas.","2020-12-31",300000]
[null,"Afghanistan","Multi-component","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","To promote engagement of the large private sector, 10 Private Public Partnerships (PPPs) are being requested through the TB-RSSH Funding Request within the allocation. An additional 40 PPPs are being proposed for UQD funding to expand pilot testing and enrich the data in diverse geographical and cultural settings in 4 remaining Regions. This UQD includes renovation of selected facilities, supplies and equipment, monitoring visits and operational costs.","2020-12-31",400752]
[null,"Afghanistan","Multi-component","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","To address high Maternal Mortality, the Citizen Charter proposes a few thousand FHHs. All partners indicated support for the expansion of FHHs. The TB-RSSH grant includes 35 FHHs and this UQD includes additional 15 FHHs. This UQD includes medical kits ($39,525), socialization and awareness in communities for site mapping ($78,026), basic supplies, equipment, medicines, staff support, training expenses, operational/maintenance costs ($493,525) and transportation of renovation materials ($2,239).","2020-12-31",613315]
[null,"Afghanistan","Multi-component","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The nations only Quality Control Laboratory for pharmaceuticals and medical products has limited capacity, staff and resources although there is a huge private sector importing pharmaceuticals. A second Regional Laboratory is requested in TB-RSSH Funding Request including training and the development of a National Strategy, SOPs and Quality Assurance Guidelines. This UQD includes functionalization of another Regional Pharmaceutical Quality Control Laboratory.","2020-12-31",756132]
[null,"Afghanistan","Multi-component","TB care and prevention","Case detection and diagnosis","5 GeneXpert machines are already deployed. Ten machines will be deployed by CTB and 10 are included GF TB grant for Provincial Hospitals. This UQD includes additional 10 GeneXpert machines for Provincial and District Hospital TB diagnostic centers. This requires installation costs ($25,000 per machine X 10 = $250,000) and testing kits ($24,000 per unit X 10 units x 3 years = $720,000).","2020-12-31",970000]
[null,"Afghanistan","Multi-component","TB care and prevention","Case detection and diagnosis","The TB grant incudes active contact management through household visits for smear-positive cases. To maximize impact, active contact management of all cases is required. This expansion should identify an additional 1,000 cases per year. This UQD includes the costs of household visits for an additional 20,000 smear-negative and extra-pulmonary cases per year ($20 per visit X 20,000 cases = $400,000 per year or $1,200,000 for 3 years).","2020-12-31",1200000]
[null,"Afghanistan","Multi-component","TB care and prevention","Case detection and diagnosis","To enhance diagnostic capacities and provide high quality laboratory services, the preferred LPA DST equipment is being proposed for 3 RRLs. The cost of each LPA with PCR is US$ 50,000 or US$ 150,000 for 3 RRLs. US$ 10,000 per laboratory per year is necessary for the diagnostic kits (US$ 10,000 X 3 X 3 = US$ 90,000) for a total of US$ 240,000.","2020-12-31",240000]
[null,"Afghanistan","Multi-component","TB care and prevention","Collaborative activities with other programs and sectors (TB care and prevention)","Expanding PPM DOTS will further increase case notifications while engaging the private sector. The NTP proposes to scale-up 10 additional cities with significant numbers of private practitioners. This expansion should identify an additional 600 cases per year. This PAAR includes costs for site preparation in 10 provinces (US$ 1,500 X 10 = US$ 15,000) and costs for private practitioner orientation (US$ 1,800 X 10 = US$ 18,000).","2020-12-31",33000]
[null,"Afghanistan","Multi-component","TB care and prevention","Community TB care delivery","Based on effective results, scale up CB-DOTS in additional 15 provinces to expand case notifications and broaden efforts to reduce stigma. This expansion should identify another 1,000 cases per year. This UQD includes training  ($5,000 per training X 15 provinces = $75,000) and incentives for case-finding and treatment support ($3 each to two persons per case X 1,000 cases x 3 years = $18,000).","2020-12-31",93000]
[null,"Afghanistan","Multi-component","TB care and prevention","Community TB care delivery","TB Patient Associations in 12 provinces have been supported by GF and are included in the allocation to reduce stigma, address gender-related issues and support community empowerment. This UQD includes expansion to all remaining provinces ($400 per Association X 22 X 3 years = $26,400) and incentives for case-finding and treatment support.","2020-12-31",31800]
[null,"Afghanistan Total",{"$nulls":5},8148188]
[null,"Albania","TB/HIV","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Offer IEM for KPs health for communities and offer continuous community education programs (LGBTI, sex workers)","2022-12-31",24850]
[null,"Albania","TB/HIV","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Assess behaviour change and influence of stigma, discrimination and social exclusion in certain KPs (LGBTQ / sex workers) in Albania through a national study","2022-12-31",32000]
[null,"Albania","TB/HIV","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish online resource centre with materials and training courses (in Albanian) for professionals and NGOs on KP (sex worker, LGBTI) health and social services","2022-12-31",9500]
[null,"Albania","TB/HIV","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish standards for Key population social and health services (sex workers, LGBTI)","2022-12-31",15250]
[null,"Albania","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish auditing programmes for MMT services","2022-12-31",750]
[null,"Albania","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish auditing programs for KP (sex workers, LGBTQ, PWID) health and social services offered by all stakeholders","2022-12-31",2250]
[null,"Albania","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish guidelines and provide KP-specific friendly health services (PWID, sex workers,  Roma)","2022-12-31",1500]
[null,"Albania","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Assess sex worker conditions and legislation and implications for their security and health","2022-12-31",9750]
[null,"Albania","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Prepare Sex worker monitoring health guidelines","2022-12-31",7000]
[null,"Albania","TB/HIV","HIV Testing Services","Differentiated HIV testing services","Establish outreach programmes of VCT services in most-at-risk communities","2022-12-31",40344]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Administrative and finance data sources","Implement OneHealth tool to harmonize and strengthen health system analysis, costing and financing scenarios at the country level","2022-12-31",33500]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Analysis, review and transparency","Evaluate pilot of a new technology in TB and HIV care, such as Video Dots","2022-12-31",9350]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Analysis, review and transparency","Evaluate pilot of PREP for MSM to assess its impact","2022-12-31",10100]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Prepare a training program for HIV for district epidemiologists. The training of district-level epidemiologists will support the overal decentralisation of health services, and HIV services in particular.","2022-12-31",7250]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Program and data quality","Establish service performance indicators and their measurement","2022-12-31",7500]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Program and data quality","Establish a quality assurance monitoring system of HIV prevention, treatment care and support services ","2022-12-31",12350]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Routine reporting","Improve the database system for HIV by web linking of laboratory and epidemiological data. This would further strengthen the HIV database that is already being developed.","2022-12-31",11600]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Routine reporting","Update surveillance guideline system","2022-12-31",10200]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Routine reporting","Update HIV / AIDS / TB reporting forms to ensure consistency with proposed joint HIV / TB database ","2022-12-31",3750]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Surveys","Establish a sustainable sentinel surveillance system for HIV/STI/Viral Hepatitis in KPs (MSM, sex workers, prisoners) by a partnership of government structures with civil society and other partners","2022-12-31",9750]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Surveys","TB knowledge, attitude and practice (KAP) study","2022-12-31",19350]
[null,"Albania","TB/HIV","RSSH: Health management information systems and M&E","Surveys","Conduct next round of IBBSin KPs; IBBS will be done in late 2019. Given the high cost, the Transition grant cannot finance it, but if available, PAAR could finance the next round in 2022.","2022-12-31",137335]
[null,"Albania","TB/HIV","TB care and prevention","Community TB care delivery","Training of Social workers on support for TB patients (is NOT a No 1 priority: 1-day training of 25 social workers in Tirana","2022-12-31",1713]
[null,"Albania","TB/HIV","TB care and prevention","Community TB care delivery","Implement ACSM activities during the World TB Days. Various ACSM activities, including the organization of a nation-wide conference for TB professionals, will be conducted on and around the World TB Day 24 March, following the topics will be  proposed for each years campaign","2022-12-31",6000]
[null,"Albania","TB/HIV","Treatment, care and support","Counseling and psycho-social support","Support for documenting human rights violations and train community-based groups on their rights, to facilitate access to justice for key populations and to enforce their rights.","2022-12-31",3000]
[null,"Albania","TB/HIV","Treatment, care and support","Counseling and psycho-social support","Support the ageing PLHIV; Drive support and education for older people with HIV, emotional, psychological and social support for people aging with HIV/AIDS and offering support in order to have access on HIV services to ensure a good quality of life","2022-12-31",15000]
[null,"Albania","TB/HIV","Treatment, care and support","Counseling and psycho-social support","Provide counselling for children and adolescents LHIV services on HIV status disclosure, ART adherence, healthy nutrition, coping with emotions etc.Strengthening the quality of Counselling will contribute to higher utilisation of HIV testing services.","2022-12-31",15000]
[null,"Albania","TB/HIV","Treatment, care and support","Counseling and psycho-social support","Counselling Services: Counselling support fordiscordant couples","2022-12-31",6724]
[null,"Albania","TB/HIV","Treatment, care and support","Differentiated ART service delivery","Provide TA to further strengthen Patient monitoring system for adherence. A partient-monitoring system is in place, but additional TA can further strengthen it.","2022-12-31",7350]
[null,"Albania","TB/HIV","Treatment, care and support","Differentiated ART service delivery","Review and update the PEP and PrEP guidelines pilot PrEP for MSM","2022-12-31",3925]
[null,"Albania","TB/HIV","Treatment, care and support","HIV care","Provide support services to increase and improve women knowledge and skills for the information and education on issue related to women LHIV; and develop I&E materials on strengthening and the building capacities of HIV women group on their gender, SRH and treatment issues","2022-12-31",15000]
[null,"Albania","TB/HIV","Treatment, care and support","Other intervention(s) for treatment","Assess current Viral Hepatitis treatment capacities and capabilities (drugs, guidelines, services etc)  for Albanian population and especially risk groups","2022-12-31",20000]
[null,"Albania","TB/HIV","Treatment, care and support","Prevention, diagnosis and treatment of opportunistic infections","Improve diagnostic capacities for OI (according to guidelines) by Training of microbiologist and ID for diagnosis of OI","2022-12-31",7850]
[null,"Albania Total",{"$nulls":5},516791]
[null,"Algeria","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","The prevalence among female sex workers is 72 times higher than the national average. Several factors contribute to this situation, including limited access to prevention, care and treatment services and the lack of coverage of certain areas by Community Systems Organisation (CSOs). This additional investment will provide services to 6248 Commercial Sex Workers (CSWs) in areas currently not covered by CSOs based on the results of the mapping of key populations that will be available before the start of the transition grant.","2022-12-31",234098.55]
[null,"Algeria","HIV/AIDS","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Migrants are classified as a priority population. However, to date they have not benefited from structured prevention activities and the 2019 IBBS results confirmed a HIV prevalence rate of 2.2% among migrants, similar to the rate among Men having sex with Men (MSMs). Migrants' access to care is difficult due to their lack of awareness about available prevention programs and HIV treatment centers. This access is also made difficult due to their fear to consult public health structures, given their illegal status and rumors that public structures poison people with AIDS. Thus, this request will provide at least the 1,500 migrants who participated in the IBBS with prevention, screening and treatment activities in collaboration with the International Organisation for Migration (IOM) and other technical partners.","2022-12-31",720342]
[null,"Algeria","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Stigma and discrimination in care settings for PLHIV and key populations is a reality in Algeria, as evidenced by the results of the \"Index stigma\" study. These behaviors are an obstacle to key populations accessing services, especially treatment. Thus, it is planned to train the staff of 60 testing centers and 15 reference centers on medical ethics to raise their awareness about challenges faced by KPs, reduce social rejection and discrimination within care structures as well as improve the quality of care on the one hand and on the other hand organize meetings periodically to handle complaints in accordance with Article 28 of the new law on health.","2022-12-31",252540.1]
[null,"Algeria","HIV/AIDS","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","The adoption of the community-based testing strategy will allow the community-based organizations and structures to test key populations with the objective of extending access to testing services. In light of the modest resources for the transition funding request (2.3 million), it is planned to organize a training for a reduced number of staff (15 persons, 3 per Community Service Organisation/CSO). This will allow to train a critical number of staff, with a planned government contribution to increase the number of staff trained to the 123 outreach CSO workers (Peer educators, Supervisors and Social health workers) who will contribute to implementing activities included in the transition grant.","2022-12-31",114469.88]
[null,"Algeria Total",{"$nulls":5},1321450.5300000003]
[null,"Angola","Malaria","Case management","Other case management intervention(s)","Increasing access to primary health care services(iCCM) through ADECOs is seen as a priority by the GoA. In this above allocation, iCCM will be expanded to a further six (6) municipalities, distributed as follows: Moxico (1), Malange (3) and Uige Province(2). These Provinces were chosen for increased coverage due to their malaria burden, access to health care and population   The total ADECOS expected to be trained under this above allocation will be 240. Children less than 5 years of age that have access to health care will  increase from 11% to 20% by the end of the Grant. The total cost is 500.000 USD, to cover, five days training for ADECOS ( ToT and ADECOS training) visibility materials( t-shirts, cups, boots, cup rain, smartphones, mobile data service.","2021-06-30",500000]
[null,"Angola","Malaria","Other module","Other module","In order to ensure epidemiological surveillance, monitoring and evaluation of malaria activities are implemented at the operational level (provincial, municipal, health and community units), particularly in the regions of the country where the Multiple Indicators and Health Survey IIMS 2015/16 showed a high prevalence of malaria, , an amount for the payment of salaries of 6 OPPMs for the last year of the 2018-2021 grant is requested in the above allocation. It should be noted that the number of OPPMs was 18 in the current GF 2016-2017 grant, and will be reduced to 6 in be financed under the first 2 years of the FG 2018-2021 grant. The annual salary of each OPPM is USD 47,994.48 and the annual cost of the 6 OPPMs for the last year of the grant is USD 287,966.88. The provincial focal points are to maintain active epidemiological surveillance in these high prevalence provinces to mitigate the emergence of possible malaria epidemics and thereby have quality data and evidence to allow for better quantification and programming of resources.","2021-06-30",287967]
[null,"Angola","Malaria","Other module","Other module","The survey to determine the epidemiological stratification of the country was conducted in the early 1980s, sampling at Provincial rather than municipality level. Recent surveys have shown a shift in prevalence patterns and malaria burden  that requires that the country epidemiological profile is updated to facilitate the planning and geographical targeting of types of interventions and decision-making.To this end, an amount of US $ 355,378.12 is requested to carry out a. study in 2019.","2021-06-30",355378]
[null,"Angola","Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Improving ANC attendance and increasing IPTp coverage is a priority for the NMCP, to improve health outcomes for the pregnant women and her unborn child. The IIMS (2015/2016) showed that only 19% of pregnant women had received 3 or more doses of IPTp during ANC visits. Stock-out have been a major reason for this low coverage. The gap analysis shows a gap in the aquisition of Sulfadoxine + Pyrimethamine (SP) for intermittent Preventative treatment for pregnant woman, one of the MoH target groups.. The MoH and PMI will acquire a total of 31,146 bottles of 1000 tablets during the 3 years. The gap is 7166 bottles of 1000 SP tablets which is requested from the FG in this above allocation. The expected impact is the reduction of maternal morbidity and mortality from malaria and improved outcomes for newborn child. The cost is estimated at 27 USD per bottle of 1000 tablets + PSM (35%). The total is 261,267.00 USD","2021-06-30",261267]
[null,"Angola","RSSH","RSSH: Health management information systems and M&E","Program and data quality","RSSH: DHIS 2: The issue of maintenance of the IT equipment, and IT capacity to use DHIS 2 risks limiting the sustainability of DHIS 2 if it is not adequately addressed. There is an urgent need to assess to what extent Municipalities have access to IT expertise. Once identified, IT Focal Points should be hired in each of the 164 Municipalities, and motivated, to provide maintenance and data insertion services. The Focal Points will also ensure access to Internet and address some difficulties inherent to IT in all provinces.RSSH: LMIS: OpenLMIS requires a functioning national PSM system to be sustainable. Therefore, systemic issues identified through this Funding Request need to be addressed for OpenLMIS to function as intended. At provincial level, a comprehensive support to warehouses should be given which includes 1) support to rehabilitation; 2) facilitation of access to alternative sources of energy, such as solar energy; 3) development of Procedures Manual; acquisition of standard warehousing equipment including temperature and humidity monitors, air conditioners, pallets, forklifts, shelves. At central level, CECOMA should also be supported with a similar package involving infrastructure rehabilitation, development of a Procedures Manual, acquisition of air conditioners. Opportunities for review and validation of the stock data from OpenLMIS, involving central and provincial level warehouse managers should also be created and funded. Still at central level, advocacy and technical assistance to DNME is required for the validation of the national List of Essential Medicines, the creation of an effective drug registration system and a national pharmaco vigilance system.","2021-12-31",2383489]
[null,"Angola","RSSH","RSSH: Health management information systems and M&E","Program and data quality","Geographic and historic expansion of DHIS2: Training on the health information system and on how to use DHIS2 has been provided to health technicians in all of the countrys 164 Municipalities. However, only selected municipalities in 7 provinces currently report through DHIS. Funding is required to ensure national coverage (11 remaining provinces) to fund equipment provision, data quality assurance and supervision of reporting through DHIS 2 from all 164 Municipalities. DHIS 2 deployment will be gradual in accordance with the Road map agreed between MoH and its development partners. While current and future data is being entered into DHIS 2, there is a need to capture and archive historic data before data collection instruments are destroyed or disappear. Migration of historic, Excel based data available at municipal level into DHIS 2 (2016-2017 data) is therefore urgent.","2021-12-31",274440]
[null,"Angola","RSSH","RSSH: Health management information systems and M&E","Routine reporting","HIS Governance Strengthening: Support Expanded Terms of Reference by the National Technical Team for inclusion in OpenLMIS; Support creation of municipal technical teams.","2021-12-31",34224]
[null,"Angola","RSSH","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","For effective public health decision-making, morbidity and logistics data have to be available, analysed and interpreted jointly. Interoperability and integration of the two DHIS2 and OpenLMIS platforms is therefore essential.This allocation will allow the installation of OpenLMIS on the HIS platform and of DHIS2 on Amazon Web Services (AWS, a cloud-based infrastructure). Most importantly, the human resources involved in entering and using data in the two systems will require adequate training.","2021-12-31",86062]
[null,"Angola","TB/HIV","Comprehensive prevention programs for MSM","Addressing stigma, discrimination and violence against MSM","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate MSM to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of MSM reached with services.","2021-12-31",30000]
[null,"Angola","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Addressing stigma, discrimination and violence against sex workers","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate sex workers to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of sex workers reached with services.","2021-12-31",30000]
[null,"Angola","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","Presently, sex workers have weak organizations and networks to organize and mobilize their members. The PAAR  application  will  strengthen KP organizations to organize and mobilize members for KP service delivery including advocacy.  Activities will include community mobilization, training on sexuality, strengthening and supporting organizing of sex workers , providing safe spaces/drop in centres. Expected outcome will be increase in sex worker  reached with programs through sex workers networks and organizations.","2021-12-31",600000]
[null,"Angola","TB/HIV","MDR-TB","Case detection and diagnosis: MDR-TB","PAAR will support refresher training of Laboratory staff  in  diagnosis of MDRTB in 2019  and reagents for solid and liquid culture, three (3) LPA (Line Probe Assay) equipments and their respective reagents. Expected outcome will be increase in MDR TB cases detected and notified.","2021-12-31",177750]
[null,"Angola","TB/HIV","MDR-TB","Treatment: MDR-TB","The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.","2021-12-31",355500]
[null,"Angola","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","This is a program still in its infancy in the current grant with only 1,764  youth and adolescent -out of school  who had been reached by program implemented by UNFPA (SSR)  that started in July 2016 in three provinces of Luanda, Benguela, Cunene and  Huila.The allocation amount in this application plus domestic contribution will only scale up this up to 31% (400,559) of country need. The PAAR will aim to expand  coverage to six  more provinces (Cuando-Cubango, Moxico,Lunda Sul, Lunda Norte, Cuanza Norte and Bie) and scale up targets  to 15% in 2018; 20% in 2019, 30% in 2019 and 40% in 2021 respectively ( 172,289 in 2018; 239,596 in 2019; 375,070 in 2020; and 587,341 in 2021). Expected outcome will be increase in percentage of adolescent and young girls out of school reached with a package of prevention services and linked to care and treatment.","2021-12-31",1000000]
[null,"Angola","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Socioeconomic approaches","The PAAR application will support social grants and cash transfers to support out- of -school young girls and women with  income generating activities (IGAs) grants. This activity will provide training in vocational skills and grants  through SR/SSR targeting young and women working in markets and vocational jobs like knitting, saloons, tailoring, poultry farming, piggery projects, etc to reduce their  economic vulnerability.","2021-12-31",400000]
[null,"Angola","TB/HIV","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Implementation of activities will commence in this application as the current grant is only planned to conduct  an IBBS study among truck drivers. The allocation amount in this application plus domestic contribution will only scale up targets in this module up to 40% (8,219) of country need. The PAAR will aim to scale up  coverage to 30% in 2018; 35% in 2019, 40% in 2019 and 50% in 2021 respectively (5,414 in 2018; 6,676 in 2019; 7,918 in 2020; and 10,278 in 2021). Expected outcome will be increase in percentage of truck drivers  reached with a package of prevention services and linked to care and treatment.","2021-12-31",580000]
[null,"Angola","TB/HIV","TB care and prevention","Case detection and diagnosis","PAAR to support procurement of additional laboratory  materials and consumable in  2019, 2020 and 2021 to reach targets. The items will include sputum containers and protection masks(3M N95) and reagents. Expected outcome will be increase in CNR.","2021-12-31",499050]
[null,"Angola","TB/HIV","TB care and prevention","Community TB care delivery","The PAAR will support development of IEC Materials and  training  for community workers and Social mobilization on Community TB Care  in 18 provinces (210 agents for 84 municipalities)PAAR investment  will support Treatment Adherence  interventions (TAIs) catalytic to achieving the ambitious CNR and TSR targets, focusing on strengthening community  and peer support (ex-TB patients etc), food vouchers and transport refunds , home visits and others initiatives to mitigate the castrophic  costs from TB and improve treatment outcomes. Expected outcome will be increase in CNR and TSR.","2021-12-31",260000]
[null,"Angola","TB/HIV","TB care and prevention","Prevention","PAAR application will support procurement  INH for IPT among eligible  PLHIV and children of contacts with TB patients who test negative for TB screening in years 2019, 2020 and 2021. (see TB/HIV collaboration). Expected outcome will reduction in TB incidence.","2021-12-31",536058]
[null,"Angola","TB/HIV","TB care and prevention","Treatment","PAAR to support quarterly supervision to health facilities (84 DOT sites in 18 provinces and communities)  in 2019, 2020 and, 2021. Expected outcome will be increase in TSR of TB cases.","2021-12-31",238560]
[null,"Angola","TB/HIV","TB care and prevention","Treatment","PAAR to support the printing  of  handbooks on (i) TB cases management (ii) TB in children; (iii) MDR-TB management and control; (iv) TB/HIV coinfection control; (iv) tasks of DOTS-C agents  in 2019. Expected outcome will be increase in quality of TB services in line with international standard for TB care (ISTC).","2021-12-31",150000]
[null,"Angola","TB/HIV","TB/HIV","Engaging all care providers (TB/HIV)","PAAR investment will support activities of engaging public and private/CSO providers (PPP/PPM)  in TB/HIV control activities (screening, diagnosis, treatment and follow-up of patients), CBOs will be supported to connect people at risk of HIV and/or TB with information and services.  Activities will include training of service providers, certification and accreditation, quality assurance, supervision and monitoring, advocacy and communication. PAAR investment will support training in cases management of TB  and directly observed short treatment among TB cases detected and followed up by  prisons health teams, mines and oil companies, and  NGOs who work with TB high risk groups. Expected outcome will be increase in TB CNR and TSR.Expected outcome will be increase in coverage targets and quality of TB/HIV services.","2021-12-31",750000]
[null,"Angola","TB/HIV","TB/HIV","TB/HIV collaborative interventions","PAAR investment will support activities for TB/ HIV increased integration at both national and district level by  supporting  TWG quarterly meeting at  provincial and municipality levels, joint TB/ HIV planning and supervision of integrated delivery of TB and HIV services.","2021-12-31",360000]
[null,"Angola","TB/HIV","Treatment, care and support","Differentiated ART service delivery","Current ART coverage for Angola according to the revised program  data (2016) from a recent program data assessment standards at  21.4% (adults and children). The allocation amount in this application plus domestic contribution will only scale up this up to 45% which is still far below the global 90-90-90 targets. The PAAR will aim to scale up ART coverage to 33% in 2018; 39% in 2019, 46% in 2019 and 50% in 2021 respectively ( 100,404 in 2018; 121,281 in 2019; 146,008 in 2020; and 161,871 in 2021). Expected outcome will be increase in percentage of adults and children receiving antiretroviral therapy.","2021-12-31",3000000]
[null,"Angola","TB/HIV","Treatment, care and support","Other intervention(s) for treatment","This study to be conducted in 2019 and 2021  provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the DHIS2. This cohort analysis will include adults, children and women initiated on ART during pregnancy for the first time. The impact will be increased availability of strategic information to inform programming and implementation","2021-12-31",300000]
[null,"Angola","TB/HIV","Treatment, care and support","Treatment adherence","Additional PAAR investment for activities to contribute to the 90-90-90 targets will include intensifying peer adherence counseling and provision of psychosocial support to PLHIV at ART sites and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities. Expected out will be number of PLHIV retained in care and virally suppressed.","2021-12-31",600000]
[null,"Angola","TB/HIV","Treatment, care and support","Treatment monitoring - Viral load","The investment in the allocation amount is able to support one Viral load platform in Luanda and is inadequate to achieve viral load testing targets. PAAR in this module is request to support the three additional viral load testing  platforms to be able to meet all targets ( see Annex 17 on projections of viral load testing). The expected outcome will be number of PLHIV on ART test for viral load and improved monitoring of the 90-90-90 care and treatment cascade.","2021-12-31",1000000]
[null,"Angola Total",{"$nulls":5},15049745]
[null,"Armenia","TB/HIV","Treatment, care and support","Other intervention(s) for treatment","HCV treatment procurement for HIV positive and HCV treatment monitoring for 600 persons during the 2,5 years periodSocial support program (cash-incentives for adherence to treatment) for patients with DS (regular) TB.HCV represents a growing concern with the prevalence among seasonal urban migrants found to be 3.3% in 2018 IBBS study. MoH and NCAP have piloted DAA HCV treatment with medicines donated by the Georgian government and MSF. MoH and NCAP are currently negotiating continued HCV treatment programmes with producers and suppliers of DAA medications. While these negotiations are under was modest number of treatment courses required to treat HIV/HCV coinfected patients is included in the above allocation request.","2021-09-30",495000]
[null,"Armenia Total",{"$nulls":5},495000]
[null,"Azerbaijan","HIV/AIDS","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","PDI, Optimized HIV case finding and HIV case management interventions with focus on men who have sex with men","2021-06-30",30441]
[null,"Azerbaijan","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Echo is a tele-medicine platform developed at the University of New Mexico to serve rural populations, and which has been used by US CDC as a method for introducing new approaches in clinical practice in elimination of HIV and Hep C, and then has been also extended for TB. It was successfully introduced in Georgia for these three diseases. It links expert specialist teams at an academic hub with primary care clinicians in local communities. It allows primary care clinicians/TB or HIV doctors from multiple sites present patient cases to the specialist teams and to each other, discuss new developments relating to their patients, and determine treatment.","2021-06-30",328814]
[null,"Azerbaijan","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Training for service providers from OST sites.","2021-06-30",6798]
[null,"Azerbaijan","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services (currently HIV services are only provided in Yerevan). The vision is to further expand Echo in other areas of health in collaboration with the recent Asian Development Bank (ADB) program focused on health sector policy reforms to strengthen efficient utilization of resources and to improve quality of services.","2021-06-30",70148]
[null,"Azerbaijan","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Build awareness of key decision makers on evidence-based HIV prevention interventions in penitentiary sector. Activities include information and advocacy meetings (round tables/workshops) to increase awareness about evidence-based HIV prevention intervention in prisons.","2021-06-30",13595]
[null,"Azerbaijan","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Behavioral interventions for people in prisons and other closed settings","Proposed funding will cover the Echo start-up activities: (a) Establishing Echo network hub in Yerevan; (b) Training of medical staff in using the web-based software; (c) Tele-echo clinics in AIDS and TB curated by ECHO team from University of New Mexico; (d) Case-based learning and guided practice in TB and AIDS; e) Access to specialist knowledge in AIDS, TB, infectious diseases, pharmacology.","2021-06-30",99000]
[null,"Azerbaijan","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","1. Strengthen stigma related capacity for medical personnel of ART centres.2. Organization of 2 communication campaigns organized per year in the eve of notable days (WAD, Candlelight) to build public awareness and reduce stigma and discrimination.","2021-06-30",48927]
[null,"Azerbaijan","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Procurement of AIDS software as part of National HIS support.","2021-06-30",20991]
[null,"Azerbaijan","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Operational research: Surveys among detainees in 23 penitentiary facilities to evaluate the efficiency of the implemented HIV prevention interventions in penitentiary sector.","2021-06-30",20812]
[null,"Azerbaijan","HIV/AIDS","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","1. Training for community health workers on ARV treatment.2. Participation in trainings, international conferences for Republican AIDS Centre, MoJ staff and NGOs in priority issues of HIV/AIDS.","2021-06-30",97684]
[null,"Azerbaijan","HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Procurement of HIV Viral Load tests and CD4 tests for regular laboratory and clinical examination of PLHIV in civil sector. Treatment monittoring is critical considering increasing treatment coverage and low VL suppression in the country.","2021-06-30",1272512]
[null,"Azerbaijan","Tuberculosis","MDR-TB","Community MDR-TB care delivery","Procurement and operation of mobile mini-lab unit for TB case finding and treatment monitoring. About 1000 new TB cases to be detected annuallyGeographical coverage: southern regions of Azerbaijan that are the most affected by TB and HIV, migration and drug use and distantly located from the rayon center (Djilalibad, Massaly, Lenkoran, Astara, Lerik)","2020-12-31",195518]
[null,"Azerbaijan","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","1. Procurement of additional 1000 Xpert cartridges/year;2. Operational research on prevalence of the latent TB infection among prison population and revising the algorithm for active case finding for penitentiary sector","2020-12-31",59269]
[null,"Azerbaijan","Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Joint TB Program Review led by the WHO Country Offices and conducted jointly with international experts.","2020-12-31",50000]
[null,"Azerbaijan","Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Participation in training courses and conferences in various aspects of TB control including of TB control in prisons, for knowledge update and experience exchange","2020-12-31",42000]
[null,"Azerbaijan Total",{"$nulls":5},2356509]
[null,"Bangladesh","HIV/AIDS","Other module","Routine reporting","Under the Government funded Health Sector Program, there is provision for establishing 150 service delivery points  throughout the country. Above allocation funding will allow the National AIDS/STI Program (NASP) to set up a digital data collection and management system. NASP will receive regular data from service delivery points which will help monitor the progress of program implementation and further decision-making.","2020-11-30",450000]
[null,"Bangladesh","HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Technical assistance will be requested from WHO to assist in developing different protocols, guidelines, conducting quality research and training to complement updating/developing various guidelines.","2020-11-30",110000]
[null,"Bangladesh","HIV/AIDS","RSSH: Health management information systems and M&E","Analysis, review and transparency","Bi-annual monitoring survey among People Who Inject Drugs (PWID): Recent rise of HIV prevalence in Dhaka requires in-depth, routine and systematic monitoring of injecting and sexual behaviour of PWID, drug context, drug taking frequency etc. Routine monitoring survey will be conducted to strengthen the reach, quality of services, and to revalidate spot-wise size estimates so that program can be more responsive to the community needs.","2020-11-30",431006]
[null,"Bangladesh","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Scale-up ICT based data collection system in the HIV/AIDS program to integrate with the national Health Management Information System (HMIS). A pilot initiative will introduce a ICT based data collection system using tablets with mobile apps. The ICT based data collection system will be scaled-up for the entire program and to be integrated into MIS system of HIV/AIDS program, contributing to the national HMIS.","2020-11-30",142272]
[null,"Bangladesh","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","HIV surveillance is important for key population monitoring at regular intervals.","2020-11-30",1163391]
[null,"Bangladesh","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).","2020-11-30",940181]
[null,"Bangladesh","HIV/AIDS","Treatment, care and support","Treatment adherence","Piloting different ART service delivery models for key and general populations will allow improved linkages to treatment, care and support for people living with HIV.","2020-11-30",332408]
[null,"Bangladesh","Malaria","Case management","Active case detection and investigation (elimination phase)","There are considerable additional demands associated with the elimination effort. A substantial increase in manpower will allow the programme to accelerate progress towards its targets, taking full advantage of this critical window of opportunity to eliminate malaria from Bangladesh.","2020-12-31",1284504]
[null,"Bangladesh","Malaria","Case management","Facility-based treatment","Quality Assurnce (QA) of diagnosis needs improvement and will be strengthened through expansion and upgrading of the Central Medical Reference Laboratory and collaborating laboratories. A QA database and support for external competency testing will be conducted every 3 years. Sensitivity and specificity of diagnosis will increase as a result, improving rationality of treatment.","2020-12-31",25795]
[null,"Bangladesh","Malaria","Case management","Other case management intervention(s)","Target-group-specific, locally appropriate, Behaviour Change Communication (BCC) materials and methodologies will be developed and produced for all high-risk groups, as well as for communities approaching elimination. Border-specific packages will also be produced. A mobile phone-based BCC programme  will be developed. Where appropriate work will be carried out in partnership with a commercial advertising agency. This should result in significant improvements in LLIIN utilization in forest goers and treatment seeking in elimination areas, leading to impact in terms of burden reduction and elimination.","2020-12-31",1524883]
[null,"Bangladesh","Malaria","Program management","Grant management","The general management of the programme requires support that goes beyond that covered by the within allocation request. WHO will provide Technical Assistance. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programmes elimination goal.","2020-12-31",190443]
[null,"Bangladesh","Malaria","Program management","Policy, planning, coordination and management of national disease control programs","Quarterly meetings will be held at district level to support planning, coordination and management. The HR development plan will be updated, key staff will be recruited for the Program Managment Unit to support the reorientation of the programme, and needs-based training will be provided as necessary. Equipment will be maintained. Furniture (medium priority) and office equipment will be replaced where necessary. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programmes elimination goal.","2020-12-31",1692852]
[null,"Bangladesh","Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","A comprehensive package of needs-based operational research will be conducted in collaboration with WHO and national and international experts and institutes. Equipment will be procured as required. LLIN utilization surveys will be carried out in different risk populations and resulting data will be used to fine-tune strategies and thereby improve impact.","2020-12-31",72698]
[null,"Bangladesh","Malaria","Vector control","Entomological monitoring","Entomological monitoring. In-line with the recommendations of the last two programme reviews,extensive support to revitalize entomological services will be conducted including: set-up, running and maintenance costs for an insectary; Technical Assistance; purchasing a training microscope. Vector incrimination surveys will be conducted in 3 sentinel sites. This work should serve to better guide and more effectively target the vector control and a personal protection approach.","2020-12-31",207367]
[null,"Bangladesh","Malaria","Vector control","Other vector control measure(s)","The protection provided by LLINs is limited to some extent by the early outdoor biting habit of local vectors. Personal protection measures could improve impact, especially for populations at increased occupational risk. Investigations into the effectiveness of personal repellents for reducing residual malaria transmission (RMT) in Bangladesh will be carried out. If repellents prove effective, a roll-out of this intervention will be effected to complement the LLIN approach and result in reduced vectorial capacity and reduced transmission.","2020-12-31",57600]
[null,"Bangladesh","Tuberculosis","MDR-TB","Treatment: MDR-TB","Provision of second-line drugs, case based-incentives for community providers and patient social support to manage additional detected MDR-TB cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","2020-12-31",4296821]
[null,"Bangladesh","Tuberculosis","TB care and prevention","Case detection and diagnosis","Additional community case finding activities in hard-to reach areas not covered by the allocation and/or matching fund request, introduction of the new diagnostic algorithm in additional upazilas in remote areas, establishment of additional diagnostic facilities (X-ray, FNAC, X-pert) to improve the diagnosis of smear-negative, Child-TB and Extra Pulmoniary cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","2020-12-31",4414536]
[null,"Bangladesh","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Further expansion of case finding activities targeting specific risk groups (urban poor, factory workers, garment workers, brick field workers, miners, elderly people, pregnant women) in areas not covered by the allocation and/or matching fund request, additional IEC activities targeting high-risk groups in urban- and sub-district areas. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","2020-12-31",408949]
[null,"Bangladesh","Tuberculosis","TB/HIV","TB/HIV collaborative interventions","Establishment and running costs of additional VCT centers in hard-to reach areas, social support for additional detected TB/HIV patients Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","2020-12-31",195225]
[null,"Bangladesh Total",{"$nulls":5},17940931]
[null,"Belarus","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.","2021-12-31",556161.96]
[null,"Belarus","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Interventions for young people who inject drugs","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.In Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".","2021-12-31",98759.99]
[null,"Belarus","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Needle and Syringe programs for PWID and their partners","When planning the BLR-C-RSPCMT grant for 2019-2021, it was assumed that, starting in 2020, Belarus will purchase supplies (syringes, condoms, etc.) for HIV prevention cabinets for PWID at the expense of the state budget. An analysis of the existing legislative framework showed that legislative amendments are required to conduct such purchases. Changes can be made to the rulemaking plan only for 2021, adopted - not earlier than 2022. Thus, we consider it necessary to include the provision of supplies for HIV prevention cabinets for PWID at the expense of the grant BLR-C-RSPCMT.","2021-12-31",185040.65]
[null,"Belarus","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. From 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the clients desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant Sustainability of Services for Key Populations in the EECA Region, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.","2021-12-31",331819.28000000003]
[null,"Belarus","HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. As a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. In line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD). MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.","2021-12-31",986668]
[null,"Belarus Total",{"$nulls":5},2158449.88]
[null,"Belize","TB/HIV","Comprehensive prevention programs for MSM","HIV testing services for MSM","HIV testing will be provided by a Civil Society Organisation (CSO) through the CSO Hub.  This activity will fund stipends of peer educators to reach more hard-to-reach Men who have sex with Men (MSM) and transgender people (TG) for testing. The activity will also include support for staff members conducting testing.","2021-12-31",40000]
[null,"Belize","TB/HIV","Program management","Other program management intervention(s)","The role of the Civil Society Organizations Hub (CSO Hub) as coordinator is an important component of this grant.  This intervention will enable regular Monitoring and Evaluation visits by the CSO hub, and includes the development of M&E Tools, the preparation of reports, the development of and implementation of a mechanism for project coordination including in terms of operational planning.","2021-12-31",100000]
[null,"Belize","TB/HIV","Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","The operationalization of the non-discrimination law is key.  Once the non-discrimination law is introduced by Cabinet there will be need for mass education on this new legislation to make it effective. This is a key activity of the funding request based on the Transition Readiness Assessment findings to improve the legislative environment.","2021-12-31",50000]
[null,"Belize","TB/HIV","Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","This intervention proposes to conduct an assessment of the implementation of the HIV/AIDS Policy of the Public Service of Belize and revise the policy based on the recommendations of the assessment. This is important to strengthen the capacity of the Employee Assistance Program to enforce the implementation of the HIV policy which addresses issues like non-discrimination among public officers.","2021-12-31",20000]
[null,"Belize","TB/HIV","RSSH: Community responses and systems","Community led advocacy","The capacity of Civil Society Hubs members in human rights, legal and anti-stigma discrimination is key as communities must play an integral role in advocating for policy change and legal reform at all levels of the public system (including the Attorney Generals Office, Ministries of Finance and Economic Development) on issues like the non-discrimination law, social contracting and other key populations human rights issues.","2021-12-31",50000]
[null,"Belize","TB/HIV","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Mini grants of USD 10,000 each for Civil Society Organisations (CSO) to build their institutional capacity necessary to carry out the work of the CSO Hub in the 4 different areas beyond the Global Fund grant. The need will vary among the CSOs, but will evolve around needs for equipment, furnitures or/and to pay stipends.","2021-12-31",50000]
[null,"Belize","TB/HIV","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Mini grants of USD 5,000 each for Civil Society Organisations (CSO) to build their capacity to be sustainable beyond the Global Fund. This could include strategic sustainability planning, social networking advocacy and negotiation, non-traditional income generation, developing proposals for external funding and any other activity or progamme that would contribute to their sustainability beyond 2021.","2021-12-31",50000]
[null,"Belize","TB/HIV","RSSH: Health management information systems and M&E","Analysis, review and transparency","A major recommendation of the Transition Readiness Assessment is to collect and report updated HIV/TB sero-prevalence data on transgender persons, sex workers (SWs), prisoners, uniformed personnel and undocumented persons to be complemented by a Knowledge, Attitude and Practices (KAP) study with the same key populations. This will provide evidence for future programming especially within the context of sustainability.","2021-12-31",200000]
[null,"Belize","TB/HIV","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Develop an electronic information system to track demand and supply of medicines and commodities at the facility level. This is a key component of the roadmap for Treat All to ensure that challenges presently experienced with stock outs are minimized.","2021-12-31",30000]
[null,"Belize Total",{"$nulls":5},590000]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","This is a demonstration study into the scaling-up of pre-exposure prophylaxis (PrEP) to prevent HIV infection among MSM in Benin (PrEP/MSM). We will continue to provide PrEP to maximize the reduction in HIV transmission within the MSM population.This is a HIV prevention method that involves people who do not have the infection, but who are at a high risk of it. They receive ART with Truvada to protect against potential exposure to HIV in order to reduce the risk of infection. The effectiveness of this strategy has been widely documented through several randomized trials. It reduces HIV transmission among MSM by more than 86 percent. It is a very promising preventive biomedical intervention that has a high impact on combating the HIV pandemic. This demonstration study will involve around 250 MSM.The main cost categories are: -Consultant costs (national and international) -Laboratory studies (including HIV, creatinemia, gonorrhea/chlamydia, hepatitis B serology and hepatitis C serology) -Transporting of study samples from laboratories (the Johns Hopkins University Laboratory with ARV dosage of Truvada, including the transport of samples) -Management of the monitoring and research teams -Management of the participants travel at project launch and during the four monitoring phases -Workshops to draft and validate protocols and provisional and definitive reports","2020-12-31",647037.37]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Run three-day training/refresher training sessions for 180 health workers, including those working with men who have sex with men (MSM), on the revised algorithms for STI treatment. One session per former department will take place in 2019:Planned for 2019, this intervention will support treatment for STIs in adapted services, a reference point for the targets addressed by NGOs.","2020-12-31",39863.089999999997]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","This intervention aims to facilitate access to prevention, care and treatment services for people who inject drugs. In addition to the quarterly meeting with the Interministerial Committee for Combating Narcotic Drugs and Psychotropic Substances Abuse (CILAS) budgeted as part of the catalytic funds, this intervention will take place twice a year during the first two years and in three quarters during the final year. These studies were not budgeted for as part of the allocation amount or the catalytic funds. This intervention comprises the following activities:-Quarterly advocacy meetings with CILAS to promote a favorable, non-discriminatory, inclusive environment that takes the gender perspective into account (10,561)-Recruiting a consultant for a gender-sensitive update study that will estimate the number of people who inject drugs and map them (23,212)-A gender-sensitive update study that will estimate the number of people who inject drugs and map them (13,348)-Producing 50 copies of the report on the gender-sensitive update study that will estimate the number of people who inject drugs and map them (381)-Recruiting a consultant to conduct a satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (30,623)-A satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (10,556)-Producing 50 copies of the report on the satisfaction survey completed by the beneficiaries of the programs interventions throughout the country and in the service delivery areas (228)-Recruiting a consultant to conduct a Second-Generation Surveillance Survey (SGSS) for people who inject drugs (23,159)-An SGSS for people who inject drugs (11,771)-Producing 30 copies of the report on the SGSS for people who inject drugs (228)-A workshop to draw up and validate training modules to train 75 staff members on treatment for opioid users (8,590)-Training for 75 health workers on treatment for opioid users (28,298)-Recruiting a consultant to carry out a baseline (feasibility) study into treatment for opioid users (14,403)-Elaborating and validating a document setting out the regulations and procedures for the treatment of opioid users (9,101)-The procurement of methadone and other substitutes, amounting to one box (seven 1-mg capsules per box) per month per person who injects drugs over two years (20,428)-Treatment costs for people who inject drugs for the treatment of opioid addiction (69,516)-A baseline (feasibility) study into treatment for opioid users (11,396)","2020-12-31",320735.05]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Condoms and lubricant programming for sex workers","Procure male condoms for sex workers: planned for year 3.","2020-12-31",90107.73]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Organize a six-monthly community-based screening campaign among sex workers, under the supervision of adapted services and NGOs to de-medicalize screening and provides better access to the service for sex workers.","2020-12-31",52692.18]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Sessions for the above.","2020-12-31",514120.75]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Supplies for screening sex workers: to address those sex workers and clients who do not attend adapted services, screening at this level will be carried out by sex worker peer educators (de-medicalized approach).","2020-12-31",486623.27]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Cover the monthly travel costs of facilitators from NGOs working with sex workers: planned for year 3. Travel by actors on the ground working with key populations.","2020-12-31",47546.85]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Organize training/refresher training sessions for peer educators working with sex workers: planned for year 3. This intervention will build the capacities of peer educators for holding awareness-raising sessions addressing the target populations.","2020-12-31",30837.17]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Provide monthly remuneration for facilitators and peer educators from NGOs working with sex workers: planned for year 3. Remuneration for actors on the ground working with key populations.","2020-12-31",197597.35]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Train medical and paramedical staff in treatment for sexually transmitted infections (STIs) and disseminate the algorithm.","2020-12-31",282796.53999999998]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Implement a network for sex workers associations in Benin:iInterventions that aim to provide more space and more capacity for the sex workers network to improve their involvement in the national response.","2020-12-31",17894.740000000002]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","This intervention aims to reduce HIV prevalence within this target group. This intervention was not budgeted for within the allocation amount. This intervention entailsprocuring male condoms to raise awareness among female bar workers.","2020-12-31",17947.48]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Organize a consultation meeting between the various actors from NGOs working with sex workers(based on 25,758 actors each year for the three years): This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","2020-12-31",86716.42]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Six-monthly supervision of prevention activities implemented by the sex workers network in areas frequented by sex workers","2020-12-31",17963.189999999999]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Exchange and working visit with the sex workers network of Cte dIvoire","2020-12-31",16821.91]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for TGs","Behavioral interventions for TGs","The management of transgender peer educators and support groups aims to intensify prevention activities for transgender people and ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention comprises the activities listed below. The management of transgender peer educators was planned for two years and nine months only, using the allocation amount and catalytic funds. It is planned for the final quarter as part of the prioritized above allocation request. The various activities are detailed below:-Five support groups per quarter that take a human rights-based and gender-transformative approach for 20 transgender people (educational session followed by condom distribution) (1,295)-Management of ten transgender peer educators as part of SC/BCC activities (1,097)","2020-12-31",2685.44]
[null,"Benin","HIV/AIDS","Comprehensive prevention programs for TGs","Other intervention(s) for TGs","Studies were not budgeted for within the allocation amount. The studies (size estimation and SGSS) will provide data to better monitor the impact of the interventions: -A gender-sensitive study that includes adolescents and young people to estimate the size of the transgender population in Benin and map it (11,771)-Production of 30 copies of the study to estimate the size of the transgender population in Benin and map it (228)-Recruitment of a consultant to conduct a gender-sensitive SGSS for the transgender population (19,683)- An SGSS for transgender people (11,771)-Production of 30 copies of the report on the SGSS for the transgender population (228)","2020-12-31",49022.559999999998]
[null,"Benin","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Organize an annual two-day information meeting of 40 actors from the Ministry of Health and the Ministry of Justice on interventions in the prison system: This activity is planned to raise awareness among actors from the Ministries of Justice and Health so as to increase the impact of HIV interventions on prisoners.","2020-12-31",18758.84]
[null,"Benin","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Pay allowances for facilitators from NGOs working with prisoners: planned for year 3. Remuneration for actors on the ground working with prisoners.","2020-12-31",27715.18]
[null,"Benin","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Pay the travel costs of facilitators from NGOs working with prisoners: planned for year 3. Travel by actors on the ground working with prisoners.","2020-12-31",5542.59]
[null,"Benin","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Organize a quarterly consultation meeting between the various actors from NGOs working with prisoners:Planned for year 3. This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","2020-12-31",4585.34]
[null,"Benin","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.","2020-12-31",146149.70000000001]
[null,"Benin","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Undertake mentoring on PMTCT/IMPC and early diagnosis through dried blood spots.","2020-12-31",26971.16]
[null,"Benin","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)The residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.","2020-12-31",126598.59]
[null,"Benin","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Train 20 auxiliary nurses in each health district on PMTCT/IMPC and early diagnosis through dried blood spots in the health districts not covered by UNICEF (25) during 15 three-day sessions with 20 participants (plus two facilitators, one supervisor, one driver and one accountant) in 2018 and 2020:This is an important activity for the program that will help achieve universal coverage of PMTCT and contribute to the ETME.","2020-12-31",27184.38]
[null,"Benin","HIV/AIDS","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Although prevalence remains low among adolescents and young people aged 1524, levels of knowledge of prevention measures (61 percent) and access to testing (23.4 percent) remain critical and must be improved. This intervention was not budgeted for within the above allocation amount.It relates to capacity building for young leaders and adolescents to provide quality interventions for other young people and adolescents. This intervention involvesproviding training to 60 young leaders and adolescents and eight facilitators during three two-day sessions on peer education, the package of interventions that are based on a human rights and gender perspective (intervention strategies and SC/BCC) and data reporting tools.","2020-12-31",23782.959999999999]
[null,"Benin","HIV/AIDS","Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","This screening intervention will intensify prevention activities for truck drivers to provide better coverage of screening and protection among the target group, with a view to improving the framework for achieving the 909090 targets. This activity was not budgeted for within the allocation amount. This intervention entails a quarterly ten-day screening mission undertaken by four people, including a driver, aimed at truck drivers.","2020-12-31",24388.959999999999]
[null,"Benin","HIV/AIDS","Prevention programs for other vulnerable populations","Male and female condoms for other vulnerable populations","This intervention aims to reduce HIV prevalence within this target group. Condoms were not budgeted for within the allocation amount. This intervention entailsprocuring male and female condoms for truck drivers.","2020-12-31",86223.77]
[null,"Benin","HIV/AIDS","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","The interventions involve the updating of modules, refresher training for actors, the editing of tools and consultation sessions. They will intensify prevention activities for truck drivers to ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention was not budgeted for within the allocation amount.This intervention comprises the following activities:-Updating the training modules for truck driver peer educators using a human rights and gender-transformative perspective. These include modules on health education, new forms of masculinity and the prevention of gender-based violence (2,939.22)-Refresher training for 75 truck driver peer educators and 20 facilitators during four two-day sessions with 30 participants on the package of interventions (intervention strategies, Social Change and Behavior Change Communication (SC/BCC), pre- and post-test counseling) and data reporting tools (15,726.64)-Producing 100 registers of people who have undergone awareness training and of the distribution of condoms and lubricants for truck drivers, and 3,500 fact sheets (922.32)-Producing 90 visual aids based on a human rights and gender perspective for truck driver peer educators, including on health education, new forms of masculinity and the prevention of gender-based violence (1,372.04)-Providing truck driver peer educators with one meal per day of the intervention, two days a month (outreach, communication and follow-up activities, distribution of condoms) (38,417.15)-Recruiting consultants for the SGSS for truck drivers (27,451)-An SGSS for truck drivers (4,610)-A one-day consultation session with haulage trade unions (room hire, coffee break, administration and travel for 30 participants, supplies and photocopying) every six months, totaling six sessions over the three years by the sub-recipient (8,378.60)-Producing 30 copies of the report on the SGSS for truck drivers (228.67)-Covering the costs of the supply, storage, quality control and distribution of condoms for truck drivers (6,146.74)-Producing 100 training manuals based on a human rights and gender perspective for truck driver peer educators (381.12)","2020-12-31",119598.25]
[null,"Benin","HIV/AIDS","Program management","Grant management","Organize quarterly five-day missions to validate the accounts of private clinics for the payment of services, undertaken by two teams of three people:This activity aims to improve the quality of accounts and prevent ineligible amounts.","2020-12-31",24225.119999999999]
[null,"Benin","HIV/AIDS","Program management","Grant management","Organize a six-monthly, ten-day mission to validate the use of rapid diagnostic tests in the activities in the following six-month period (two teams of four people: one manager, one accountant, one monitoring and evaluation specialist and one driver):This activity facilitates the implementation of activities, particularly at the CIPEC level.","2020-12-31",27971.05]
[null,"Benin","HIV/AIDS","Program management","Grant management","Organize a six-monthly, ten-day mission to validate the financial documents and accounts of NGOs and the six CIPEC from the previous six-month period (two teams of four people: one manager, one accountant, one fiduciary management agency and drivers):This activity aims to improve the quality of accounts and prevent ineligible amounts.","2020-12-31",27971.05]
[null,"Benin","HIV/AIDS","Program management","Grant management","Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):This will motivate actors at the peripheral level.","2020-12-31",92382.45]
[null,"Benin","HIV/AIDS","Program management","Other program management intervention(s)","Ensure the participation of ten actors from the system each year in discussions and seminars:This activity aims to provide actors from the program and from facilities with information on progress relating to HIV and also to allow them to share their experiences with actors from other countries.","2020-12-31",51324.21]
[null,"Benin","HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Other external services. This intervention comprises two activities that were not budgeted for in the last three quarters of the final year (2020):-The provision of a driver to the Executive Secretariat of the National AIDS Committee so that it may implement and monitor activities on the ground (management of the National AIDS, Tuberculosis, Malaria, STIs and Epidemics Committee driver) (2,744)-Support for the costs of a monitoring and evaluation intern (60,000 CFA francs per month for three years) to promote learning among adolescents and young people (823)","2020-12-31",4002.92]
[null,"Benin","HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Draw up an annual list of suppliers: This activity allows for the preselection of providers and facilitates the implementation of activities.","2020-12-31",8418.81]
[null,"Benin","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","With regard to women and girls in Benin, according to the national gender promotion policy that has been developed, socioeconomic factors in the country tend to confer inferior status to women compared with men, particularly in the areas of education, employment, health and access to land and finance. Stereotypes and gender roles increase the vulnerability of women and girls to HIV and AIDS and restrict their access to existing information and services. The submission of women and girls demanded by tradition makes them subject to certain types of violence: levirate, early or forced marriage, sexual violence, sexual relations with older partners, etc. In addition, the imbalance of power makes women less able to negotiate the use of condoms or to choose their sexual partner.Education sessions on gender-based violence and training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence are aimed at reducing HIV prevalence within this group. The sessions will address gender discrimination, harmful gender norms and all types of violence against women and girls in relation to HIV.In detail, this intervention comprises the following activities:-Training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence (six sessions with 25 participants each, lasting two days) (20,754)-Educational sessions on HIV, health education, sexual and reproductive health and rights, new forms of masculinity and the prevention of gender-based violence for Plan International Benin staff members (session with one coffee break for 30 people per month and for five teams) (1,372)-Recruitment of a consultant to undertake an evaluation study of the legal setting for key populations (13,500)","2020-12-31",39980.92]
[null,"Benin","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","The study to evaluate the legal setting for key populations aims to provide data to better target interventions for them.","2020-12-31",12532.82]
[null,"Benin","HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Mobilize therapeutic assistants via two DAT consultants to draw up the community care strategy. With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.","2020-12-31",19052.86]
[null,"Benin","HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Organize a meeting to validate the community care strategy:(45 participants)With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.","2020-12-31",11883.07]
[null,"Benin","HIV/AIDS","RSSH: Health management information systems and M&E","Administrative and finance data sources","The financial monitoring of sub-sub-recipients will ensure that the resources allocated to them are managed correctly. This intervention entails the on-site monitoring of financial management at the sub-sub-recipient level, at a cost of 2,881.29.","2020-12-31",3233.08]
[null,"Benin","HIV/AIDS","RSSH: Health management information systems and M&E","Analysis, review and transparency","Contribute to the annual three-day regional consultation workshop held by the National AIDS Control Program (NACP) with actors from the departments (CIPEC, Departmental Health Directorate, District Health Management Team), involving 45 participants and 17 drivers:This supports the monitoring of activities by actors on the ground and allows for actors at the intermediary and operational levels to better take ownership of HIV interventions.","2020-12-31",40887.67]
[null,"Benin","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Procure 125 desktop computers and printers for care facilities:The availability of IT equipment will improve the follow-up of the active file and medical files  monitoring software (ESOPE) and dispensing software (Mdistock).","2020-12-31",171079.56]
[null,"Benin","HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Update the PLHIV biometric database periodically","2020-12-31",17963.189999999999]
[null,"Benin","HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","The following activities relate to data quality (quality control, supervision and the review of progress update and disbursement requests), as well as planning and other activities linked to information systems and management, with the aim of improving the quality of the program: -Ensuring the participation of grant actors in discussions and short training sessions each year (44,820) -Six-monthly quality control of the data collected by each team working on the ground, including the data disaggregated by sex and by age produced within their intervention areas (6,105) -Six-day supervision, carried out by the Principal Recipient every six months, of actors on the ground at the departmental level (sub-sub-recipients and others) and at the commune level (NGOs and others), in terms of monitoring and evaluation (two three-person teams, including a driver) based on human rights and gender standards (2,309) -The drafting of a six-monthly gender-sensitive report on the results obtained and the progress made in implementing the grant (6,469) -Six-monthly quality control exercises carried out by the Principal Recipient to monitor data from teams working on the ground and NGOs, peer educators (MSM, people who inject drugs, young people who no longer attend, or have never attended, school and truck drivers, disaggregated by sex and by age) via two three-person teams. These exercises will last six days and take place in the 12 departments (5,282) -Six-monthly monitoring and traceability of condoms, from wholesaler to the final distributers, carried out by two three-person teams over six days (5,241)-An annual on-site data verification exercise at the sub-recipient level carried out by three three-person teams over six days (7,923) -A six-monthly review of the progress update and disbursement requests of the two sub-recipients and the teams on the ground by the Principal Recipient -A six-monthly planning and review workshop with teams on the ground lasting four days (administration of 31 participants, including seven drivers, over four days) (5,230)-The six-monthly maintenance of the integrated system of community data (SIDOC) by the developer (six days consultancy every six months) (2,552)","2020-12-31",104237.46]
[null,"Benin","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Procure tablets to record the biometric data of PLHIV (to avoid duplication and ensure the procurement of biological services is well documented) and contract Internet services for facilities","2020-12-31",360415.22]
[null,"Benin","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","These activities combine community data collected by NGOs and peer educators and allow for experiences to be shared between sub-sub-recipients and teams on the ground. They aim to produce quality data and strengthen interventions on the ground:-Six-monthly, two-day consultation meetings between sub-sub-recipients working with adolescents and young people who no longer attend, or who have never attended, school and adolescent and youth leaders to combine community data (room hire, coffee break, administration and travel of participants, supplies and photocopies) (1,474)-Twelve two-day, gender-sensitive and inclusive consultation meetings with 30 implementation actors to improve the coordination of interventions for key and vulnerable populations (MSM, people who inject drugs, PLHIV, sex workers, adolescents, young people, transgender people, truck drivers and those close to them, and community-based organizations that include women and girls) (10,281)-Six-monthly, two-day consultation meetings between sub-sub-recipients and peer educators working with people who inject drugs to combine community data disaggregated by sex and age (room hire, coffee break, administration and travel of participants, supplies and photocopies) (7,299.19)-Monthly outreach supervision sessions for peer educators working with people who inject drugs and MSM, led by NGO facilitators (3,366)-A six-monthly, two-day meeting for teams working on the ground to combine data and share the results of interventions for young people, MSM, people who inject drugs, and support for OVC and PLHIV with CPS, decentralized financial systems (SFD), ART facility managers, NGO facilitators, psychological support workers and legal experts (20,361)","2020-12-31",56022.89]
[null,"Benin","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","HIV surveillance survey among pregnant women: this is an important activity for epidemiological surveillance and also for SPECTRUM projections. This activity has been undertaken for more than 20 years.","2020-12-31",63712.27]
[null,"Benin","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Study to evaluate the prevalence of hepatitis B among PLHIV:After tuberculosis, hepatitis B is the biggest threat to the care of PLHIV. This study will identify those with co-infections (so as to provide better care for them) and evaluate prevalence.","2020-12-31",68431.149999999994]
[null,"Benin","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Organize two six-monthly consultation meetings per year for each region (north and south), a total of four two-day meetings of 40 people, including actors from treatment and prevention of mother-to-child transmission (PMTCT) facilities:This activity should allow for the sharing of experiences and good practice, as well as any difficulties encountered so that they may be resolved.","2020-12-31",75035.350000000006]
[null,"Benin","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Organize workshops on establishing ARV treatment adherence clubs in each care facility with the support of the Benin Action Network for People living with HIV (ReBAP+) and care facilities (to reduce the number of appointments at care facilities for stable patients receiving treatment).","2020-12-31",53582.09]
[null,"Benin","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV.","2020-12-31",121722.59]
[null,"Benin","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities:-Refresher training for 400 people (health workers, social workers, health mediators, therapeutic educators, MSM and transgender associations and other social organizations) during 20 sessions with 30 participants each. This training will address the specific needs of key and vulnerable populations (psychological support for improved referral and care for key and vulnerable populations), human rights and medical ethics linked to combating HIV and tuberculosis (49,430.07)-Procuring nutritional kits to support the most vulnerable PLHIV on ART (men, women, boys and girls) to help improve their nutrition and their adherence to ART (356,730) -Repackaging nutritional kits and distributing them to beneficiary PLHIV (men, women, boys and girls) on a quarterly basis. These kits are gender-specific, non-discriminatory and inclusive (9,146.94)-Paying the salaries of ReBAP+ staff (program lead, administrative assistant, accountant and monitoring and evaluation specialist) (16,670)-Paying health insurance for ReBAP+ staff (4,390.53)-Contributing to the running costs of ReBAP+ (office rent, water, electricity, communications and supplies) (3,978)","2020-12-31",417326.9]
[null,"Benin","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Quarterly supervision of adherence clubs by ReBAP+ and the NACP:The establishment of adherence clubs requires regular monitoring by ReBAP+ and the program during the first few years.","2020-12-31",35926.379999999997]
[null,"Benin","HIV/AIDS","Treatment, care and support","HIV care","Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.","2020-12-31",1929341.26]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: -Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (2,103.80) -Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (4,315.07)-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (4,573.47) -Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (7,546.23) -Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (1,632.73) -Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (6,585.80) -The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (4,102.40) -Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (5,460.72) -Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (3,430.10)-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for OVC and PLHIV in all departments (plan) (343.01) -Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (4,573.47) -Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (332,582.78) -Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (10,425.99) -Covering the costs of the ReBAP+ helpline (1,646.45) -Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (4,573.47) -Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (42,807.68) -Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (8,479.21) -Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (9,878.70) -Producing badges for the peer educators/health mediators involved in the projects (1,524.49)","2020-12-31",467496.35]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Train 250 paramedics and medics in care for patients receiving antiretroviral therapy (ART) (184 providers from the 92 former sites, 24 from the new sites and 42 participants from the central level and the Information and Support Centers for STIs, HIV and AIDS (CIPEC)). The training will take place over ten sessions with 25 participants, two facilitators, one supervisor, one manager and two drivers: This activity is important for the delegation of tasks to paramedics and ensuring the quality of care despite the limited number of doctors in care facilities.","2020-12-31",51518.35]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):Improvement of the biological monitoring of people living with HIV (PLHIV).","2020-12-31",19066.32]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Hold 18 five-day training sessions for 450 doctors and paramedics in care facilities on pediatric care (25 participants, three trainers and one supervisor per session), following the new World Health Organization recommendations:This activity aims to improve pediatric care.","2020-12-31",59423.18]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Train providers on the use of tools to assist treatment adherence during six three-day sessions:This activity aims to improve care, given the risk of patients abandoning treatment linked to early diagnosis and the improved survival rate of PLHIV.","2020-12-31",30821.46]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Monitor the care provided at each facility on a quarterly basis: One medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.","2020-12-31",243274.6]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Procure 100 extra cupboards for care facilities that have not yet been equipped:(610 per cupboard)During the first part of the grant, 43 cupboards with shelves were procured for care facilities to improve storage conditions for ARVs. The intention is to procure more for the remaining facilities and for the new facilities that will be set up.","2020-12-31",68431.149999999994]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Give each care facility a means of communicating so that they may offer differentiated services (to communicate results, make appointments and undertake follow-up) (One smartphone per facility costing 100,000 CFA francs each, for 150 facilities) In December 2016, Benin adopted the test and treat approach and anticipates a substantial increase to the active file, placing increased pressure on the health system. To prepare for this, the country changed the schedule for dispensing ARVs to every three months, and every six months for medical consultations. To ensure the quality of care while empowering patients, the country plans to establish a system for communication between health workers and patients to deliver results, make appointments and undertake remote follow-up.","2020-12-31",25650.32]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Coaching and mentoring on ART in civilian prisons by neighboring care facilities(10 days: one experienced prescriber, one CIPEC, one SPECS and a driver).HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. Given the lack of experience of these nurses and the noted organizational difficulties, coaching and mentorship should be organized to improve care quality. This will be undertaken by an experienced prescriber, along with a departmental and national supervisor.","2020-12-31",12325.22]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Six-monthly supervision and monitoring of care in prisons(one NACP representative plus driver, one CIPEC, one prescriber from a neighboring facility, registered prison nurse)HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. The intention is now to scale this up and involve all ten prisons. Regular supervision and monitoring is therefore vital in the initial years to ensure that the care is given properly.","2020-12-31",8725.17]
[null,"Benin","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Organize an advocacy meeting on the community care strategy: With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system. It is important to involve all actors in defining the basis for community involvement.","2020-12-31",11883.07]
[null,"Benin","HIV/AIDS","Treatment, care and support","Treatment adherence","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.","2020-12-31",220113.23]
[null,"Benin","HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Transport viral load samples from care facilities to molecular biology platforms on a monthly basis: Provide access to viral load testing for facilities located far from the molecular biology platform.","2020-12-31",83144.429999999993]
[null,"Benin","Malaria","Case management","Private sector case management","Given the contribution of the private sector (20.7%) in the attendance of health services (SNIGS 2015), it is proposed to continue activities started in the 2016-2017 grant and the partnership between the PNLP and the Private Sector Platform (PSB). This will improve the quality of malaria management through training / supervision of stakeholders, dissemination of care / prevention protocols, reporting of data, provision of subsidized inputs.","2020-12-31",801942.54]
[null,"Benin","Malaria","Case management","Removing human rights and gender related barriers to case management","Specific new actions will enable approximately 7,000 persons deprived of liberty to access quality treatment services and thus guarantee their right to health.These actions are: i) Training / supervision of prison medical staff; ii) Provision of treatment; iii) Provision of prison health centers in Inputs Malaria control for the free care; and iiii) Consultative meetings with the concerned ministries for a good coordination of activities","2020-12-31",48261.7]
[null,"Benin","Malaria","Program management","Policy, planning, coordination and management of national disease control programs","In order to achieve the objectives assigned to it, to improve its performance in terms of financial management, administrative and to be up to standard, the NMCP plans to upgrade its staff.The different training courses proposed in this funding match the needs according to the profile of the agents available for the implementation of the program's activities.","2020-12-31",196762.43]
[null,"Benin","Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","The last program's performance review in 2016 noted that indicators related to the annual incidence of malaria and lethality have evolved positively. However, it was noted the weak involvement of the private sector in the fight against malaria, the failure to comply with the guidelines for the management of malaria cases despite the availability ILPs and weaknesses related to the use of DHIS2 software. The next review is scheduled for 2019.","2020-12-31",68946.25]
[null,"Benin","Malaria","RSSH: Health management information systems and M&E","Surveys","Mandatory test that follows mass distribution campaigns and provides information on the effectiveness of distributed LLINs, it also guides the choice of LLINs for subsequent campaigns, and the next one is for 2020. It is therefore necessary that this monitoring be carried out as recommended by the international scientific committee. The NMCP must therefore carry out these studies in 2019 and 2020.","2020-12-31",68432.27]
[null,"Benin","Malaria","RSSH: Health management information systems and M&E","Surveys","To be effective in vector control, it is necessary to carry out vector susceptibility tests to determine the status of the vector against insecticides available on the international market. This study is conducted as a prelude to IDP campaigns to select the appropriate insecticide. The latest study conducted in 2017 noted that pyrimiphos methyl remains the sensitive insecticide from which it was chosen during the 2017 IRS campaign","2020-12-31",110260.35]
[null,"Benin","Malaria","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","2020-12-31",750000]
[null,"Benin","Malaria","Vector control","Indoor residual spraying (IRS)","The NMCP proposes to implement the extension of the IRS to other communes eligible for a pre-elimination of malaria in the medium and long term. The area of Dassa Glazou in the hills department is chosen for funding beyond.This choice is mainly based on scientific evidence in terms of short transmission period and the abundance of vectors and their infectivity in this area.","2020-12-31",5023248.79]
[null,"Benin","RSSH","RSSH: Health management information systems and M&E","Routine reporting","Strategy for community health workers can be expanded, through the use of community data applications. Procurement of 3,312 smartphones and accessories, and training of 3,312 community health workers already active in partner programs.","2022-06-30",2180230.0499999998]
[null,"Benin","RSSH","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","The additional investment will make it possible to cover 65 percent of needs (from 47% with only allocation and matching funds): recruitment, training, incentivization, equipment, provision of tools, and monitoring of 4,147 community health workers implementing the complete package of interventions.","2022-06-30",2569275.0499999998]
[null,"Benin","RSSH","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","10 percent of health care facilities are renovated and fitted out, based on the assessment outcomes, in order to improve drug quality at the local level.","2022-06-30",1112017.73]
[null,"Benin","Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","Objective: to conduct research work on the mathematic modelling of the transmission of tuberculosis in Benin, to obtain a better estimate of the number of cases of tuberculosis in the population, in partnership with the University of Liverpool and the National University Hospital Centre for Pneumo-Phthisiology in Cotonou.","2020-12-31",67332.509999999995]
[null,"Benin","Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Objective: to conduct an evaluation of the catastrophic costs borne by the patients and their households, for the introduction of appropriate measures (WHO protocol: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/ meetings/tf6_background_5a_patient_cost_surveys_protocol.pdf).","2020-12-31",61537.43]
[null,"Benin","Tuberculosis","TB care and prevention","Case detection and diagnosis","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.","2020-12-31",3534458.53]
[null,"Benin","Tuberculosis","TB care and prevention","Treatment","Objective : To reduce the fatality rate of TB patients who have any other associated comorbidities (HIV, Diabetes, Anaemia, Viral hepatitis B and C). The mortality rate is 14% among TB/HIV co-infected patients vs 6% for all patients. A well-equipped technical block will be established at the main hospital in Cotonou, treatment protocols will be created and disseminated in all treatment centers. As part of the quality assurance policy, a portable spectroscope and a highperformance liquid chromatograph will be procured to ensure more regular monitoring of the quality of anti-tuberculosis medication.","2020-12-31",342159.13]
[null,"Benin Total",{"$nulls":5},25631908.760000002]
[null,"Bhutan","HIV/AIDS","HSS - Policy and governance","Other policy and governance intervention(s)","This funding will be used to purchase a vehicle to suport program monitoring and evaluation and to transport pharmaceutical and health products between the centers.","2021-06-30",55000]
[null,"Bhutan","HIV/AIDS","Program management","Other program management intervention(s)","This funding will be used to build the capacity of the National HIV/AIDS Commission in order to create an enabling policy environment and improve long-term impact.","2021-06-30",35000]
[null,"Bhutan","HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Given the critical future role of community organizations in service delivery, competency and organizational development of relevant CSOs will have a benefit on the national program.","2021-06-30",76173]
[null,"Bhutan","Malaria","Case management","Other case management intervention(s)","Introduction of new diagnostic tools, improving quality of diagnostics.","2021-06-30",121018]
[null,"Bhutan","Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Further development/strengthening community action groups at the block level.","2021-06-30",42225]
[null,"Bhutan","Malaria","Vector control","Other vector control measure(s)","Strengthening community action groups, establishing cross-border information sharing on vector species, improving program capacity for prevention of re-establishment","2021-06-30",51181]
[null,"Bhutan","Tuberculosis","Other module","Case detection and diagnosis","Training of medical doctors on management of TB/HIV co-infection, training of TB and VCT focal persons on TB/HIV collaborative guidelines.","2021-06-30",41670]
[null,"Bhutan","Tuberculosis","TB care and prevention","Case detection and diagnosis","Procurement of biosafety cabinets, training interdisciplinary team on tb screening, contact tracing and follow-up for MDR-TB patients.","2021-06-30",155236]
[null,"Bhutan Total",{"$nulls":5},577503]
[null,"Bolivia (Plurinational State)","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Conducting of a study of primary resistance to ARV in new patients is planned as a critical element of strategic information in order to strengthen management, decision-making in terms of antiretroviral drug policies, sustainability and progress towards the goal of suppressing viral loads. A total cost of USD 100,000 is estimated.","2021-12-31",100000]
[null,"Bolivia (Plurinational State)","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.","2021-12-31",50000]
[null,"Bolivia (Plurinational State)","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.","2021-12-31",5808]
[null,"Bolivia (Plurinational State)","Malaria","Case management","Active case detection and investigation (elimination phase)","Activity 59: Amazon Region Meeting to consolidate the AOP for each municipality. (Participants: organized civil population, municipality, regional authorities) prior to preparation of the AOP (July each year) in Cobija.Activity mentioned in the diagnosis for transition as part of the negotiation with municipalities.","2021-12-31",52155]
[null,"Bolivia (Plurinational State)","Malaria","Case management","Other case management intervention(s)","Activity 45: Training of medical personnel in clinical handling of malaria cases (2 events per year, from different health services in the endemic area) Riberalta","2021-12-31",55788]
[null,"Bolivia (Plurinational State)","Malaria","Case management","Other case management intervention(s)","Activity 46: Training for nurses from the Bolivian Amazon Region (Riberalta)","2021-12-31",30533.15]
[null,"Bolivia (Plurinational State)","Malaria","Case management","Other case management intervention(s)","Activity 31: Training plan for microscopists in low parasitaemia and strengthening of quality control (Guayaramern)","2021-12-31",47377.5]
[null,"Bolivia (Plurinational State)","Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","Activity 299: Review of the purchasing process, delivery documents, official receipts from end users in the different regions. Support is required from a person to conclude the processes within time limits appropriate to the intervention.","2021-12-31",30172.41]
[null,"Bolivia (Plurinational State)","Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the regions needs.","2021-12-31",62117.18]
[null,"Bolivia (Plurinational State)","Malaria","RSSH: Health management information systems and M&E","Routine reporting","Activity 269.1: Quarterly supervision of municipalities or lower levels  for healthcare establishments that carry out diagnosis and treatment (laboratory, hospital, pharmacy); IRS activities and distribution of LLINs in priority locations. Due to reduce allocation, it is essential for the regional authorities to have these resources, especially since the municipalities that intervene in the Amazon region are the poorest in the country and do not receive in equal proportion to the other municipalities the amounts that would contribute to the monitoring of malaria in the Amazon region.","2021-12-31",367286]
[null,"Bolivia (Plurinational State)","Malaria","Vector control","Other vector control measure(s)","Activity 137: Strategy for elimination and recycling of waste, with communication actions","2021-12-31",64315.13]
[null,"Bolivia (Plurinational State) Total",{"$nulls":5},865552.37]
[null,"Burkina Faso","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Equip infirmaries in 7 detention centers. 14 have been already equipped with Rd 10 and NFM.","2020-12-31",51503.76]
[null,"Burkina Faso","HIV/AIDS","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Renovating the infirmaries and social services in 20 detention centers. 3 have been already renovated. It addresses concerns raised by the TRP issue 2.","2020-12-31",149753.10999999999]
[null,"Burkina Faso","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Organize trainings for counsellors (RSSH) regarding community screening.","2020-12-31",88955.22]
[null,"Burkina Faso","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Organize yearly workshop for pediatricians on early infant diagnosis (EID) and pediatric HIV care.","2020-12-31",107062.06]
[null,"Burkina Faso","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Performing quality control mission every six months on the HIV testing carried out by community personnel during testing campaigns among the key populations and the general population. New Activity.","2020-12-31",86121.65]
[null,"Burkina Faso","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Scaling-up EWI in health regions through maternity facilities for them to measure early warning indicators (EWI) each year.","2020-12-31",149023.67999999999]
[null,"Burkina Faso","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Training care providers in each of the 3 health regions for them to measure early warning indicators (EWI) each year.","2020-12-31",19434.41]
[null,"Burkina Faso","HIV/AIDS","PMTCT","Prong 3: Preventing vertical HIV transmission","Holding an annual national forum on the elimination of mother-to-child transmission of HIV in Burkina Faso (each year).","2020-12-31",24006.28]
[null,"Burkina Faso","HIV/AIDS","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Monitoring/support for pregnant women who have recently tested positive, provided by pairs of peer educators.100 couples who are PLHIV will be trained and will provide peer support. Based on a UNICEF pilot activity.","2020-12-31",1026431.38]
[null,"Burkina Faso","HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Equip 11 community organizations that offer HIV treatment and care with basic medical equipment.","2020-12-31",152466.60999999999]
[null,"Burkina Faso","HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Equipment 36 non-governmental testing sites (including the 13 rehabilitated) with client oriented equipment.","2020-12-31",218639.88]
[null,"Burkina Faso","HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Holding a workshop to approve the training modules for community RSSH counsellors.","2020-12-31",4950.0600000000004]
[null,"Burkina Faso","HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","TProviding operational support for the national coordination of the Network for Greater Involvement of People Infected with HIV (NEGIPIH).","2020-12-31",121637.3]
[null,"Burkina Faso","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.","2020-12-31",80404]
[null,"Burkina Faso","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Study on the stigmatization index in Burkina Faso.","2020-12-31",61094.15]
[null,"Burkina Faso","HIV/AIDS","Treatment, care and support","HIV care","Training and retraining of service providers to provide health services to key populations in 13 regions.","2020-12-31",53325.1]
[null,"Burkina Faso","HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Procure part of the reagents for biological follow up to provide free access to ARV patients in need (50%b of people in treatment).","2020-12-31",1529674.56]
[null,"Burkina Faso","HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Workshop to review the training modules for the counsellors (RSSH) regarding community screening.","2020-12-31",17198.97]
[null,"Burkina Faso","Malaria","Other module","Other module","Training/refresher of public and private sector health workers on case management of malaria. IMC/USAID-PMI will fund training for 2/3 of the 8,554 agents to (5,782 agents) and the remaining shall be funded by the above allocation (2,891 agents).","2020-12-31",358872.18]
[null,"Burkina Faso","Malaria","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Training / refresher training CHWs s on the community-based response package (including the use of RDTs). This will involve training / refresher training for all the CHWs of the remaining 42 remaining districts on integrated ICCM package in 2018 in 6 days with 2 trainers per CSPS.","2020-12-31",928007.52]
[null,"Burkina Faso","Malaria","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","BAcquire reagents and consumables for the production of labile blood products (PSL). The request is to support the procurement of kits consisting of serological reagents, blood bags, tubes, etc.","2020-12-31",4603524.41]
[null,"Burkina Faso","Malaria","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","For the period 2018-2020, the CNTS needs 617,009 kits.","2020-12-31",188647.62]
[null,"Burkina Faso","Malaria","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Implement a pilot project to improve the quality of the integrated management of childhood illnesses by the CHWs and data flow using the MEDSINC tool.","2020-12-31",157109.19]
[null,"Burkina Faso","Malaria","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Training for providers of districts in clinical IMCI. Previous training have not met all the needs. The planning involves the training of an average of 25 staff per health district in the 8 regions not covered by the IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center-Sud, Center-East, Central): 25 sessions of 25 agents on average for 11 days in 2018 and 2020.","2020-12-31",568340.06000000006]
[null,"Burkina Faso","Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Acquire SPAQ doses for the implementation of SMC in 49 districts in 2020 and carry out the campaign in the same year.","2020-12-31",1034984.3]
[null,"Burkina Faso","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The current funding (World Fund, USAID and State) covers needs from 2018 to 2020 except for routine LLIN for pregnant women in 2019. This Gap is included in the above allocation to acquire 886,517 MILDA. The mass distribution campaign is planned for the first half of 2019.","2020-12-31",2530411.85]
[null,"Burkina Faso","Tuberculosis","MDR-TB","Treatment: MDR-TB","Equipping 2 medical units specialized in MDR-TB treatment: The 2 pneumology centres of CHUYO and CHUSS (16 beds in Ouagadougou and 9 beds in Bobo) are under construction in the 2 hospitals, planned for completion in late 2017. The equipment include: Medical bed, orthopaedic mattress, 2-section viewbox, separate lighting, office desk, air conditioning unit, fan, office chair, visitor chair, side table, wardrobe, examination table...","2020-12-31",56199.64]
[null,"Burkina Faso","Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Acquiring complete office computers for electronic registration of TB patients in 20 CDT. this will include complete office computers: monitor, central unit, uninterruptable power supply and printer. and will be allocated to the 20 TTCs with the highest numbers of patients that will take part in this electronic registration pilot phase.","2020-12-31",33360.519999999997]
[null,"Burkina Faso","Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Conduct a training of the NTBCP workers by WHO and a training of TTC staff. This will be done during support mission  at the start of the period and a second follow-up mission six months later.","2020-12-31",9922.61]
[null,"Burkina Faso","Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.","2020-12-31",25470.81]
[null,"Burkina Faso","Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Training CDT patients in electronic TB registration. The training will target the  24 structures (20 TTCs and 4 reference centres) involved in the pilot phase of TB electronic registration. The estimated duration of this training is 3 days. The content of the training will be the following: One and a half days on general aspects of the IT and the second half of the training will concern the use of the software itself.","2020-12-31",7031.55]
[null,"Burkina Faso","Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Organize a 3-day training session in 2020 to train 100 (centres dinformation et des statistiques sanitaires, CISSE) and (services de planification de linformation hospitalire SPIH) workers regarding the new directives and the analysis of data concerning the fight against tuberculosis  the target will be: 100 CISSE and SPIH workers : 1 x 70 HD + 1 x 13 RHD + 1 x 8 CHR + 1 x 5 CHU + 4 central workers (DSS = 3 and DLM = 1).","2020-12-31",28937.09]
[null,"Burkina Faso","Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Carry out a new survey in order to assess the impact of the communication strategy of the 2013-2017 of national tuberculosis control program (NTBCP) that is being implemented, in terms of knowledge, attitudes and practices among the population in relation to tuberculosis. This second KAP survey, planned for the second quarter of 2019.","2020-12-31",55600.86]
[null,"Burkina Faso","Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Conduct a feasibility study of the integration of active screening for TB among children aged 3 to 59 months seen during the SMC campaigns. This innovative, integrated approach is expected to boost active TB screening and to improve the performance of the 4 NTBCP in relation to tuberculosis among children. Location: 2 of the 12 health regions covered by the SMC. Study period: 2018 Partners: NMCP, Paediatricians, WHO/RDT.","2020-12-31",85539.79]
[null,"Burkina Faso","Tuberculosis","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Refurbishing 9 Centre for the Diagnosis and Treatment of TB in 2019. The selection of the 9 sites was based on findings from the supervision with major refurbishment needs as: cramped, lack of ventilation, watertightness, dilapidated roof, etc. These CDT are the following: D, Dori, Orodara, Pama, Dedougou, Mangodara, Manni, Sapouy and Bokin","2020-12-31",391767.47]
[null,"Burkina Faso","Tuberculosis","TB care and prevention","Prevention","Broadcasting each of the adverts 3 times per week and per language (French, Mossi, Dyula and Fula) on the 3 television channels. In fact, the radio adverts will be broadcast from 2018 until the first quarter of 2019, so that the KAP survey planned for the second quarter of 2019 will be used to measure their impact, among other things.","2020-12-31",400326.23]
[null,"Burkina Faso","Tuberculosis","TB care and prevention","Prevention","Broadcasting each year, 6 times per week, the radio adverts in French, Mossi, Dyula and Fula concerning the fight against tuberculosis on the stations of the 25 radio partners. The 3 broadcasts per week are due to the need to take advantage of the 2 weekend days during which the audience is larger .","2020-12-31",427014.64]
[null,"Burkina Faso","Tuberculosis","TB care and prevention","Prevention","Produce 3 TV adverts on the fight against tuberculosis in the following languages: French, Dyula, Mossi and Fula in order to reach a large number of people among the urban population (27.53% of the total population in 2015)","2020-12-31",8211.82]
[null,"Burkina Faso","Tuberculosis","TB care and prevention","Treatment","Provision of nutritional support to 20% of drug sensitive TB patients, with expected outcome to increase the tuberculosis treatment success rate (currently at 78%). Since 2010 When nutritional support stopped), the rate of patients lost to follow-up has been on the rise (6.4% in 2010 to 7.4% in 2015). The target for this support: 1165 in 2018, 1202 in 2019 and 1250 in 2020 for a monthly ration cost: 35,000 CFA francs, or 53.36 euros. Composition of a ration: protein-rich foods, cereals, vegetables, oil and sugar.","2020-12-31",1652182.26]
[null,"Burkina Faso Total",{"$nulls":5},17493144.600000001]
[null,"Burundi","HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Activity: Organizing at the national level, an advocacy workshop with different actors for LGBT mainstreaming in program design and LGBT interaction with the general population.This activity helps to improve the prevention of HIV / AIDS and STIs among LGBT people and create an enabling environment to facilitate access of this population to prevention and care services.","2020-12-31",4776]
[null,"Burundi","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Activity: Training / retraining Peer Educators of IDUs at the national level on the HIV prevention and harm reduction package related to drug use.This activity helps to improve the prevention of HIV / AIDS and STIs among IDUs and to increase their knowledge of the concepts of HIV prevention and harm reduction.","2020-12-31",31542]
[null,"Burundi","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Community empowerment for PWID","Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDUThis activity aims to improve the living conditions of key populations.","2020-12-31",43274]
[null,"Burundi","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.This activity aims to reduce new infections by facilitating PS to access prevention and care services.","2020-12-31",4350]
[null,"Burundi","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Activity: Acquire reagents for HIV testingThe 2018-2020 grant and other partners (FM, UNICEF, PEPFAR) are planning to acquire HIV testing reagents to cover the various screening tests for $ 165,979.77, with a total requirement of 4,066 730,3USD is a Gaps of 2 443853USDThis funding beyond this will enable the country to reach screening coverage for the different types of Country Target Testing.","2020-12-31",2443853]
[null,"Burundi","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Activity: Strengthen the capacity of men champions (PLHIV) to raise men's awareness of the support and support of pregnant and lactating women for PMTCTThis activity aims to reduce new infections by reducing the transmission of HIV from mother to child.","2020-12-31",17146]
[null,"Burundi","HIV/AIDS","Prevention programs for general population","Other intervention(s) for general population","Activity: Security stock of prevention inputs (condom and lubricating gel)The 2018-2020 grant does not provide security stocks for prevention inputs.This funding will allow the country to have a 4-month security stock representing 25% of annual needs. This will prevent any stockouts. For the 2018-2020 grant, the expected input quantities (male condoms, female condoms and lubricant gels) are 26,931,063; 870,979 and 29,938,622 with an aggregate amount of US $ 2,027,089.37.","2020-12-31",225232]
[null,"Burundi","HIV/AIDS","Program management","Grant management","Activity: Pay the performance bonuses of the PNLS:This is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.","2020-12-31",238919]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Review the tools for collecting HIV dataThe set of HIV tools will be revised by integrating all the indicators of the new strategic plan 2018-2022 and the adequacy of the new guidelines for the care of PLHIV. This will provide data for monitoring the strategic plan. Two workshops of 25 people for 4 days will be carried out inside the country.","2020-12-31",8287]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Multiply standardized tools for collecting health dataThe unit price of the black and white photocopies of the different houses is 60 Fbu the copy and the binding is 2000 Fbu per document. The standard tools are integrated and are multiplied throughout the grant to reason to have data for different indicators. These are patient records, CPN registers, CPoN, Childbirth, PEC, STA, Lab, CDV, TB / HIV Coinfection. These registries will be multiplied once a year for the 750 sites of care for PLHIV that patients will be multiplied once a year for the PLHIV expected.","2020-12-31",605529]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Acquire the equipment for archiving patient records at the sites of care (mettallic cabinets and files to hang).Patient records must be kept secure and confidential. To do this, each of the 750 care sites needs at least one metallicall cabinet for the preservation of patient records. In addition to the wardrobes, there will be a need for suspends for every patient file estimated at 65,000 PLHIV across the country.","2020-12-31",371150]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session","2020-12-31",65947]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Train 210 users on the AIDS-INFO database at all levelsThe training will be organized for the 210 sites of care of the PVIH by favoring those who have a large active girl. In the current grant we had the budget to train only 100 people. The training will be 30 participants per session for 4 days so a total of 7 training sessions. This activity will improve the monitoring of PLHIV and the quality of the data.","2020-12-31",31197]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Ensuring a link between AIDS-INFO and central, intermediate and peripheral DHIS 2 levelsThe Server for networking has already been acquired and installed at the level of the PNLS / IST. This link can not be done without all patient records being entered in AIDS-INFO. This amount will enable data entry in AIDS-INFO to update all patient records for an activity queue of 65,000 PLHIV.","2020-12-31",37992]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Providing sites with support for adequate computer equipment for data managementFor the moment, the CDS make the data entry themselves in DHI2. Field visits show that most CDS have a single laptop. This computer is used for the administrative activities of the CDS. It is necessary that the SIS service of the FOSA who take care of the data regularly has its own computer. In total, we have 750 support structures. In the past grant, the computer support concerned only about 170 structures.","2020-12-31",762756]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Ensuring DHIS2-GIS interconnection for georeferenced data analysis:DSNIS has developed a health map that is interconnected to DHIS2. However, the interconnection stopped at the level of the BDS and BPS coordinates for lack of skills to integrate the geographic coordinates of health facilities. This interconnection requires international consultancy","2020-12-31",10667]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Support DHIS2 hosting for 2 yearsThe DHIS2 is hosted by a house that provides maintenance and regular back up of the base. A contract is signed between the MSPLS and the said house for a monthly amount of US $ 650","2020-12-31",15600]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Train 3 people by BPS, by BDS and by hospitals / CDT on the tracker integrated in the DHIS2 for the follow-up of the tuberculous patient.The DSNIS, in collaboration with the TB program, intends to strengthen the capacities of the BPS, the BDS and the hospitals / CDT (Director, DACS and chief of the nursing) in the follow-up of the CDTs to the use of the integrated tracker in the DHIS2 in 1 mission per quarter for 2 years. Each mission lasts 6 days","2020-12-31",78499]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:The DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days","2020-12-31",27237]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:Following the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.","2020-12-31",24888]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Activity: Buying Reagents and Consumables for the Automaton for the Screening of Blood Transfusion Transmitted Disease (GAS) MarkersIn the previous grant, the Global Fund delivered the AUTOMATE with the reagents for only 3 months considered as starting. As these three months have elapsed, for the moment the reagents are broken and the appariel is not operational. These reagents will allow the use of the device for a period of 2 years and this will improve the benefits of the CNTS.","2020-12-31",1592613]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Activity: Training 210 people in biomedical equipment maintenanceThis training is intended for laboratory technicians. It involves training 210 laboratory technicians for 4 days for the 7 training sessions. This will enable these laboratory technicians to do the preventive and curative maintenance of laboratory equipment. This improves the quality of the analyzes for the follow-up of PLHIV.","2020-12-31",40826]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Activity: Establish a panel of sera for reagent validation (especially for HIV), HBV and HCV)This activity is done in four (4) steps: sensitization of sites involved in sample collection, sample collection, sample analysis, aliquoting and sample conservation. The sensitization will inform providers about the importance of making this panel and how to do it to obtain good quality samples for the constitution of this panel. This panel will evaluate testing and quality control.","2020-12-31",17535]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","Activity: Ensuring the maintenance of the AUTOMATE (GAS)The CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.","2020-12-31",35069]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Activity: Implementation of the LMIS system and its maintenance for 3 years.","2020-12-31",433080]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Activity: Make a study on the prevalence of HIV-viral hepatitis coinfection.In Burundi, the seroprevalence of HIV-viral hepatitis co-infection is not known because no study has been conducted for the determined. Or, currently, it is well known that viral hepatitis is the main cause of complications in PLHIV where they can have very serious consequences in accelerating the progression of HIV to AIDS disease and vice versa. It is in this context that a seroprevalence survey of HIV-hepatitis co-infection is essential in order to make a global care planning for co-infected PLHIV based on evidence in order to improve the care that is offered to them.","2020-12-31",32221]
[null,"Burundi","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Activity: Conduct a study on estimating mother-to-child transmission rate of HIVThe estimate of the mother-to-child transmission rate is an indicator of the NHP, the current grant performance framework, but also an indicator of the progress of PMTCT. Until then the indicator was estimated by the Spectrum. In order to obtain an indicator that is as close as possible to the reality of the scope of the interventions we propose to carry out this study which in addition to the transmission rate makes it possible to evaluate the quality, availability and accessibility of PMTCT services.This is a study that will be conducted in 2019 and will cover the entire country according to a methodology that will be proposed by the consultant / firm and validated by the steering committee.","2020-12-31",36348]
[null,"Burundi","HIV/AIDS","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Activity: Train 45 pharmacy managers from 45 districts on HIV / TB drug management in two sessionsThe training will target 46 district pharmacy managers to strengthen them on the rational management of medicines and the supply chain. The training will be done in two training sessions. \"","2020-12-31",9770]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Activity: shelf purchase and warehouse upgrades where Global Fund products are stored: District 10 stores upgraded and part of Main Compound","2020-12-31",641923]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Activity: Maintain viral load and PCR equipmentIn order to ensure the achievement of CVs and PCRs among PLHIV and children born to HIV-positive mothers, machine functionality is a prerequisite.This subsidy is currently being implemented and includes the maintenance of 2 viral load devices for 2019. As in 2020, the OPP-ERA project will be closed, maintenance will be extended on the other 4 Opp-era machines. (Muyinga, ANSS, CHUK, Gitega). For the two Abboth machines, we have a Gap of $ 10,000 a year and for the machines provided by OPP-ERA we have a gap of $ 32,000. This makes a total gap of $ 52,000 for the period from 2019 to 2020.","2020-12-31",52000]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on Good Laboratory Practice (GLP)Since LNCQM's inception, staff have not had this opportunity. To be comfortable when performing tasks all staff must be trained / recycled on this standard","2020-12-31",10069]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training in quality control of associated molecules (ARV, anti-TB).Training in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.","2020-12-31",12000]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on Microbiological Control of DrugsThe training would complete the physico-chemical analyzes of drugs by microbiological analyzes","2020-12-31",12000]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Establishment of a quality control unit for medical devicesThe LNCQM does not perform quality control of medical devices (gloves, condoms, needles and others) .Technical staff does not have experience in quality control of medical devices","2020-12-31",62000]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on preventive maintenance and qualification of the HPLC chainLack of expertise on the qualification of the HPLC chain. No local expertise in this area. It would be good to train 2 units","2020-12-31",12000]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Need technical assistance to accompany the quality control laboratory of the drug towards the pre-qualificationThe laboratory is implementing the ISO 17025 standard and is in the process of applying for prequalification by WHO. - The laboratory wants to be prequalified by WHO or accredited. A technical assistant is required to accompany the laboratory to apply the related requirements. He would provide technical coaching to better prepare for evaluations","2020-12-31",40500]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Supply of equipment and materials for microbiological controlThe National Laboratory does not have equipment, consumables and equipment for the microbiological control of drugs. Some molecules require microbiological procedures and can not be controlled in the laboratory.","2020-12-31",81828]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthen the technical platform of the NPHI National Reference LaboratoryThe National Laboratory needs to expand the range of analysis as a national laboratory to meet the national need. For this, he needs modern and diversified equipment to ensure his missions.","2020-12-31",358767]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthening Quality Assurance at the National Reference Laboratory of INSPThis involves acquiring equipment maintenance contracts (HPLC, Spectrophotometer), equipment calibration with BBN, and participating in the rendering of inter-laboratory test results. This will allow the reliability of the results and ensure the reliability of the results and the performance of the laboratory compared to WHO / Accredited Prequalified Loboratory. This will serve to know if the prescribed drugs are of good quality and have positive effects for the patients.","2020-12-31",60800]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthen the biological diagnosis of viral hepatitisThe National Laboratory does not have an external maintenance contract for certain equipment. Some lab equipment needs to be serviced by external experts \"","2020-12-31",114000]
[null,"Burundi","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Activity: Provide training to 3 members of the Quantification Committee on the management of the GAS PlanThis training will allow these people to know the tools of quantification and input management.","2020-12-31",30300]
[null,"Burundi","HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Assure the subscription to the WHO Pharmacovigilance Center (Uppsalla Monitoring Center) to access the VIGIFLOW softwareThe Vigiflow makes it possible to transmit the cases of undesirable events in the international database (VigiBase). The VigiFlow software and the Base are managed by the WHO International Center (Uppsala Monitoring Center). To have access to this software and to be able to transmit the cases, you need a subscription. The subscription fee is 1500 USD per year","2020-12-31",3139]
[null,"Burundi","HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: To train 3 users of DPML on the WHO Pharmacovigilance Software (VIGIFLOW) for two weeksThe training will allow users of VigiFlow software to have basic knowledge of pharmacovigilance and especially the use of VigiFlow to ensure the transmission of adverse event cases to the WHO international base. \"","2020-12-31",26999]
[null,"Burundi","HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Provide pharmacovigilance training for providers in 40 district hospitals at 5 per hospitalThis training will enable hospital providers to gain knowledge of the basics of pharmacovigilance and the system for reporting adverse events, which events will be transmitted to the International Vaccine Monitoring Database (VigiBase) for surveillance. The training will be organized at peripheral level for 200 participants at a rate of 25 participants per session for 4 days.","2020-12-31",48001]
[null,"Burundi","HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Provide formative supervision of 20 pharmacovigilance-trained hospitals and the adverse event reporting systemFormative supervision will involve 10 regional and national hospitals and 10 other district hospitals. The aim will be to evaluate the challenges that arise in the reporting of adverse events while retraining staff on the system of pharmacovigilance in general and the use of reporting tools in particular. This will improve the quality of notifications and promote patient safety.","2020-12-31",7335]
[null,"Burundi","HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance planQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.","2020-12-31",130925]
[null,"Burundi","HIV/AIDS","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Buy three trucks for active distribution of health inputsThese trucks will be used to transport drugs from CAMEBU to district pharmacies.","2020-12-31",438366]
[null,"Burundi","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)This activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target","2020-12-31",202134]
[null,"Burundi","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond","2020-12-31",25343]
[null,"Burundi","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)Given the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond","2020-12-31",560962]
[null,"Burundi","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)Nutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyondActivity is related to indicator #: TCS-1 (M)","2020-12-31",173582]
[null,"Burundi","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Activity: Organize training sessions on the psychosocial care of children and adolescents living with HIV for providers at ARV sites.This activity, begun during the past grant, will be continued because the low antiretroviral treatment coverage of children and adolescents living with HIV requires special monitoring for this population. The psychosocial care of children and adolescents living with HIV will facilitate the announcement of seropositivity to patients which will increase adherence to treatment and retention rate. Providers will also be able to help strengthen family caring as a strategy to reach more children and adolescents.","2020-12-31",45109]
[null,"Burundi","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Activity: Acquire ARVs to fill the GAPTo cover the country's ARV targets for the year 2019 and 2020 on the different categories of PLHIV (Adults, children, PMTCT children and adults, post-exposure prophylaxis).","2020-12-31",7575400]
[null,"Burundi","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Activity: Organization of PLHIV in community solidarity network (supervision, monitoring, legal capacity building).This activity contributes to reducing the socio-economic impact of HIV infectionPromoting / empowering PLHIV through capacity building on cluster management, business learning, micro-project initiation and management will contribute to reducing the socio-economic impact of HIV . It is an activity that will be done through the organization of PLHIV network community solidarity (supervision, monitoring, strengthening legal capacity). It will increase ARV coverage and retention rate.","2020-12-31",3822]
[null,"Burundi","HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Activity: Acquire the complement of reagents for the viral load.The 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. This funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.","2020-12-31",1432738]
[null,"Burundi","HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structuresCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.","2020-12-31",250000]
[null,"Burundi","Malaria","Program management","Policy, planning, coordination and management of national disease control programs","This amount includes bonuses for 12 iNMCP staff involved in implementing the grant, and maintenance, fuel and insurance for 11 extra vehicles not covered by the allocation amount and are required for supervision and training activities on the ground as well as implementing the 2019 LLIN distribution campaign support for the National Health Information System Directorate, information, education and communication and the transport of central level staff during the different stages of campaign implementation, including the census, micro-planning, pre-positioning of LLINs and supervision of distribution).","2020-12-31",111628]
[null,"Burundi","Malaria","Program management","Policy, planning, coordination and management of national disease control programs","This budget is required to cover for technical assistance  to support the implementation of the next LLIN campaign in 2020. It comprises international and domestic technical assistance to support the entire process of the 2020 mass campaign, up to the final report. Given the complexity of the organization on the ground, ongoing technical assistance is required throughout the campaign.","2020-12-31",206160]
[null,"Burundi","Malaria","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","General training in all sectors (malariology, monitoring and evaluation, finances and community health workers). This is a range of vital training to strengthen the program which has not been funded under the allocation amount. In particular, it involves (i) an international malariology course for two people each year, which is vital for strengthening the malaria response; (ii) training at the international level in the monitoring and evaluation of malaria response programs, given in Ouagadougou or Senegal; (iii) training at the international level in financial management; (iv) refresher training for community health workers providing iCCM in the health districts funded by the Global Fund, planned for 2019.","2020-12-31",296091]
[null,"Burundi","Malaria","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Partner coordination/policy drafting and dissemination The budget is intended for (i) partner coordination meetings, particularly transnational meetings, and strengthening the coordination of the private sector not addressed by other partners; (ii) a fund mobilization meeting; (iii) meetings to draw up plans of action and annual and six-monthly reports. The needs for 2018 are covered.","2020-12-31",49614]
[null,"Burundi","Malaria","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Implementing the following innovative strategies to combat malaria:(i) A communication strategy in primary schools; (ii) Outreach communication for the Batwa community; (iii) The production of communication media and contracts with the media: Expected outcomes: This budget is requested as part of efforts to strengthen communication in order to provide regular guidance for the population on the correct use of LLINs and the early use of health care services. The activities relate to procuring communication media and contracts with the media, such as mobile telephone companies.","2020-12-31",328510]
[null,"Burundi","Malaria","RSSH: Health management information systems and M&E","Program and data quality","Activity: Support for health districts and health provinces in the supervision of malaria-related activities. The costs include per diems, fuel for supervision vehicles and motorcycles used by health districts and provincial health offices, as well as communication costs.","2020-12-31",1003636]
[null,"Burundi","Malaria","RSSH: Health management information systems and M&E","Program and data quality","Activity:  Provide quarterly supervision missions for quality control of slides and rapid diagnostic tests in health care facilities in the 46 health districts.(i) The allocation amount covers 12 health districts per quarter. Supervision is undertaken in three facilities per mission per health district, covering a maximum of 72 facilities over the year, equivalent to 10 percent of the total. (ii) Additional funding is therefore requested to be able to cover 12 health districts per quarter so as to sample 20 percent of health care facility laboratories each year.","2020-12-31",32834]
[null,"Burundi","Malaria","RSSH: Health management information systems and M&E","Surveys","This budget is required to cover a survey on the current malaria epidemic in Burundi. A survey on the underlying causes of the epidemiological setting to understand the causes of the epidemic and thus evaluate what type of response would be appropriate and effective, and what measures should be adopted after the epidemic. This epidemic survey will assist the program in guiding the response appropriately.","2020-12-31",172237]
[null,"Burundi","Malaria","Vector control","Indoor residual spraying (IRS)","In order to comply with the TRPs decisions, the Integrated National Malaria Program (iNMCP) asked the Global Fund to finance for the 20182020 period the 11 health districts already validated by the TRP in 20162017 (not included in the grant due to budget constraints).  This budget is required to cover: (i) Supply costs, (ii) Implementation costs,(iii) Technical assistance, for IRS activities in 11 health districts.  The total requested budget for IRS is US$ 17,037,235, of which US$ 6,787,954 is for the four health districts covered by the Global Fund under the NFM, and US$ 10,249,281 is for the other seven health districts requiring resistance management.CT update (Aug. 2018): The country has been awared 4.9m USD to implement IRS in the 4 districts previously supported by the GF.","2020-12-31",12166628]
[null,"Burundi","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This LLIN campaign is aimed at key populations (special groups, including boarding schools, military camps, prisons and orphanages that were not included in the mass campaign). The requested amount will cover (i) procurements costs for 182,000 LLINs and (ii) implementation costs for the special groups. This amount includes procurement costs and implementation costs. This activity is planned for 2020.","2020-12-31",520475]
[null,"Burundi","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This budget is required to: (i) Bridge a gap of 466,000 LLINs to meet all of the needs of the 2019 mass campaign. Of the total 6,997,954 LLINs required, taking into account an increase of 15 percent linked to counts and to logistical security, 6,531,828 have been provided using the allocation amount; (ii) The amount requested includes procurement costs and procurement and supply management/pooled procurement mechanism costs; (iii) The gap in the implementation costs that have not been included in the allocation amount (US$ 1,600,000); (iv) Expected outcomes: this funding will provide universal coverage of LLINs during the 2019 campaign.","2020-12-31",2658053]
[null,"Burundi","Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Acquire a PSM class II microbiological safety cabinet hood: The National Reference Laboratory (LNR) is equipped with an old safety hood that has just been out of service for a few months. The consultant sent for his repair recommends the purchase of a new hood. The cost includes transportation and installation.","2020-12-31",25000]
[null,"Burundi","Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Acquisition, installation and formation of sites for the utilization of LPA technology for National Reference Laboratory (LNR). This cost includes the layout of the laboratory, the purchase of equipment, reagents and consumables, the training of personnel.","2020-12-31",200000]
[null,"Burundi","Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.","2020-12-31",501858]
[null,"Burundi","Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Operational research on the use of oral forms in the treatment of MDR-TB. Development of an operational research protocol and conduct over a period of 3 years operational research on \"the tolerance and effectiveness of a short treatment 9 months without injectable for patients with MDR-TB. \"The overall goal of the project will be to evaluate the treatment outcomes and adverse effects of a new 9-month, non-injectable, short-course regimen for MDR-TB.","2020-12-31",150000]
[null,"Burundi","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Gap to be filled in relation to the activity on the provincial coordination TB / HIV:The frequency of holding TB / HIV coordination meetings is quarterly.","2020-12-31",30355]
[null,"Burundi","Tuberculosis","MDR-TB","Treatment: MDR-TB","Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.","2020-12-31",170205]
[null,"Burundi","Tuberculosis","Program management","Grant management","Performance bonuses.The motivation of the staff is essential to maintain the achievements and safeguard the performance of the ProgramThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.","2020-12-31",30183]
[null,"Burundi","Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Installation and implementation of GxAlert (or similar system) / networking of GeneXpert devices: The PNILT has acquired 18 GeneXpert devices from the Global Fund, which it has installed on strategic sites throughout the country. These devices were added to 6 acquired with funding from the World Bank, a fleet of 24 devices in total. To achieve the full value of the investments made in Xpert, the results must be transmitted from the machine to the service provider in a timely manner. However, xpert results are currently reported on paper. This reporting system is time consuming and limits the potential for optimizing patient care and management.","2020-12-31",150000]
[null,"Burundi","Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Purchase a teleconference device.","2020-12-31",4069]
[null,"Burundi","Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Data validation and dissemination activity.Verification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.","2020-12-31",161830]
[null,"Burundi","Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","Supervision by TB / HIV coordinators. The budget covers vehicle and fuel insurance costs.The budget for the 2018-2020 grant is 661,500 BIF, per quarter and per BPS, to cover fuel costs only.The said budget omits the costs of insurance, vehicle repair and technical control, which, for most of them, are already obsolete and amortized.","2020-12-31",102239]
[null,"Burundi","Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Purchase of computer equipment.","2020-12-31",68600]
[null,"Burundi","Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Purchase of 17 vehicles and their insurance.Supervision is a priority activity in the fight against tuberculosis. The available supervision vehicles are old and most of them were acquired more than ten years ago. With depreciation and rugged terrain, repair costs become more and more huge.","2020-12-31",520200]
[null,"Burundi","Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Prevalence and anti-tuberculosis drug resistance study: The PNILT is preparing for the start of the TB drug resistance survey. On the basis of this review, a detailed budget was agreed between the PNILT, the Global Fund and Damien Action, which provides technical support and project management. The preparatory activities have already started as, among other things, the validation of the study protocol by the National Technical Committee.  The requested budget will complete the existing budget and bring the overall budget of the study to USD 251,838 (the existing USD 171,838 and a gap of USD 80,000).","2020-12-31",80000]
[null,"Burundi","Tuberculosis","RSSH: National health strategies","Other policy and governance intervention(s)","A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.","2020-12-31",73811]
[null,"Burundi","Tuberculosis","RSSH: Procurement and supply chain management systems","National product selection, registration and quality monitoring","Drug Registration Support (Cross-Cutting RSS): Drug registration is one of the pillars of drug quality assurance. In the past 3 years, just over 700 drug application files have been filed with the Department of Pharmacy, Medicines and Laboratories (DPML), which acts as the Burundian Agency for Drug Regulation. These files concern both products financed by the Global Fund and essential drugs imported into Burundi. To date, only 200 files have been processed. The requested support will mobilize the probate commission to process the 500 files registered to date at the DPML. Subsequently, the commission will be able to process new files as they arrive.","2020-12-31",46922]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Equipment maintenance (package: 10% of the cost). As the devices come with a one year warranty, it would be worthwhile to purchase a 3 year warranty extension as we did for GeneXpert devices.","2020-12-31",62500]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Extend the technical platform by purchasing radiology equipment and ultrasound scanners. To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, tuberculosis in children, tuberculosis in PLWHA and multidrug-resistant tuberculosis, the PNILT intends to expand the technical platform by purchasing radiology equipment and ultrasound. It should be noted that the main reasons for the poor performance in the reporting of tuberculosis cases are mainly: the insufficiency of a technical platform for the para- clinical diagnosis of TPB- and PET cases (RX, Ultrasound); the difficulty of early diagnosis of TB in PLWHIV by lack of effective diagnostic means (GeneXpert); the absence of policies / strategic approach directed at vulnerable and vulnerable groups: prisoners, refugees, Batwa, children, PHAs (screening), the weak investigation of cases contacts TPB +.","2020-12-31",330600]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Installation and handling (operator training) for all equipment.","2020-12-31",25900]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Meeting of TB coordinators. It aims to anticipate possible blockages in order to improve the performance of the implementation of the TB grant. It is planned once a quarter.","2020-12-31",28224]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.","2020-12-31",160535]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 2 power generators 5KVA energy source for 2 mobile radiology devices for use on sites without power source (cost includes transport if imported).","2020-12-31",5000]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 2 vehicles to transport digital radiology devices to screening sites.","2020-12-31",100000]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 6 Horizon G2 laser reprograms codonics: These are devices for printing X-ray images produced by the 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile X-ray devices).","2020-12-31",33995]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 6 kits of 500 codicon films in 3 sizes: These are films for printing radiology radiographs produced by 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile radiology devices).","2020-12-31",12996]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Purchase of 9 ultrasound machines with accessories. The mapping of ultrasound machines performed in 2016 showed a need for 9 devices instead of 11. The purchase of these devices completes the technical platform so to strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA, the diagnosis of multidrug-resistant tuberculosis.","2020-12-31",90000]
[null,"Burundi","Tuberculosis","TB care and prevention","Case detection and diagnosis","Training of laboratory technicians / microscopists.The PNILT intends to form one unit per CDT (170 CDT) with 60 units in 2018, 60 units in 2019 and 50 units in 2020:","2020-12-31",34166]
[null,"Burundi","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Former activity n  63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validatedBurundi has a total of 11 prisons with infirmary.With the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.","2020-12-31",10463]
[null,"Burundi Total",{"$nulls":5},40413862]
[null,"Cabo Verde","Multi-component","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Men who have sex with men represent a key population in the fight against HIV. The proposed activities are linked to interventions that will be conducted in the community and to training. These will complement activities that have already been taken into account in the allocation amount.","2020-12-31",42331.95]
[null,"Cabo Verde","Multi-component","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","These activities are aimed at strengthening training sessions among  SWs, field sessions and interpersonal communication on HIV and other STIs by SWs peer educators  included in the budget of the allocation amount. They will complement activities that have already been taken into account in the allocation amount.","2020-12-31",24781.73]
[null,"Cabo Verde","Multi-component","HIV Testing Services","Differentiated HIV testing services","These are consumables and laboratory reagents to complement the diagnostic and follow-up services. They refer, in particular, to the strengthening of blood safety during the 3rd year of the grant.","2020-12-31",81308.5]
[null,"Cabo Verde","Multi-component","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","These interventions are  directed  towards: 1)  150 vulnerable children and adolescents who are received at day centres by facilitators from ICCA; 2) 80 vulnerable youths and adolescents in Praia with training and psychological support; 3) 620 peer educators within 21 secondary schools and, additionally, the coordination and follow-up of the activities performed by peer educators. These will supplement activities considered in the allocation amount.","2020-12-31",141119.96]
[null,"Cabo Verde","Multi-component","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","These interventions are intended to improve the psychological support provided to vulnerable children and orphans within the ICCA drop-in centre in Praia.","2020-12-31",14654.92]
[null,"Cabo Verde","Multi-component","Prevention programs for general population","Condoms as part of programs for general population","HIV is transmitted during unprotected sex. In this regards, this investment is to acquire 9,000,000 condoms (total for 3 years) to prevent the transmission of HIV and other STIs within the populations.","2020-12-31",295043.21000000002]
[null,"Cabo Verde","Multi-component","RSSH: Health management information systems and M&E","Analysis, review and transparency","To have a better understanding of modes of transmission of new HIV infections and to better use these data, a study on the modes of HIV transmission is planned, to orient strategic decisions for HIV prevention. Also, an audit of patient data will be performed and ART cascade will be determined to provide baseline data that will enable to measure progress toward achieving the three 90s by 2020.","2020-12-31",86358.43]
[null,"Cabo Verde","Multi-component","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","A study is expected to be conducted on the impact of HIV within individuals, families and Cape Verdean society in general.","2020-12-31",27610.82]
[null,"Cabo Verde","Multi-component","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","A study was conducted within the general population in 2017 on knowledge of attitudes towards and practices in connection with methods for preventing malaria and its transmission. Nevertheless, it is essential that an initial study is conducted within migrant population in 2018. It is expected that the KAP study will be carried out again within the general population in 2020 to update these data.","2020-12-31",44737.96]
[null,"Cabo Verde","Multi-component","RSSH: Health management information systems and M&E","Program and data quality","The exchange visit to a country that is in the process of obtaining certification of malaria elimination will strengthen the skills of the technicians working on the malaria program in Cape Verde, particularly when it comes to monitoring and documenting the elimination process.","2020-12-31",29051.73]
[null,"Cabo Verde","Multi-component","RSSH: Health management information systems and M&E","Routine reporting","The program so far reports data in Excel and/or Word documents, which are sometimes incomplete and submitted late. For this, with the introduction of the DHIS2 application, promptness and completeness of reports will be improved, which will ensure better disease surveillance. This is for an upgrade of the existing system.","2020-12-31",14817.64]
[null,"Cabo Verde","Multi-component","RSSH: Health management information systems and M&E","Surveys","For the TB/HIV component, a study is expected to be carried out in 2020 to update the bio-behavioral data for key HIV populations (sex workers, drug users and men who have sex with men).","2020-12-31",58289.75]
[null,"Cabo Verde","Multi-component","TB care and prevention","Other TB care and prevention intervention(s)","These interventions aim at sensitizing 10 TB patients to ensure adherence and good compliance to treatment and adoption of preventive standards.","2020-12-31",5373.13]
[null,"Cabo Verde","Multi-component","TB/HIV","TB/HIV collaborative interventions","These interventions are aimed at strengthening the capacity of NGO members working for TB / HIV prevention at the community level.","2020-12-31",16689.48]
[null,"Cabo Verde","Multi-component","Treatment, care and support","Treatment adherence","Good adherence to antiretroviral treatment is key condition for the suppression of a patients viral load. Therefore, it is intended to appoint 12 mediators in 10 health facilities with the largest volume of patients.  The role of these mediators will include provision of counseling to people living with HIV newly tested positive, providing them with information on treatment and provide adherence support.","2020-12-31",136296.71]
[null,"Cabo Verde","Multi-component","Vector control","Entomological monitoring","With support from WHO, the Global Fund and partners, the INSP has recently established a medical entomology laboratory, which enables monitoring the distribution and density of vector mosquitoes within the country. It is expected to acquire equipment to improve entomological monitoring to ensure that the response is as efficient as possible. These acquisitions are intended to supplement those taken into account in the allocation amount.","2020-12-31",177571.54]
[null,"Cabo Verde","Multi-component","Vector control","Other vector control measure(s)","The aim of these interventions is to support door-to-door awareness campaigns regarding the fight against malaria, the transmission routes, symptoms and other preventive measures in partnership with NGOs and community associations, health delegations and the INSP.","2020-12-31",30531.93]
[null,"Cabo Verde Total",{"$nulls":5},1226569.3899999997]
[null,"Cambodia","HIV/AIDS","HIV Testing Services","Other module","Introduction of Alere DETERMINE Ab/Ag Combo 4th generation RDT. TRP  recommends 10% of the requested amount.","2020-12-31",106321]
[null,"Cambodia","HIV/AIDS","Other module","Other module","Above allocation funding is requested for technical assistance from WHO, as well as for a Procurement Agent and forecasting. TRP only approves 10% of the request.","2020-12-31",226500]
[null,"Cambodia","HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested for a Case Management Assistant (CMA) within each of 67 Funding Request: Full review 23 May 2017 | 42 Provincial AIDS and STI Programs (PASP). TRP only recommends 30% of original reqeust of $849,070.","2020-12-31",254721]
[null,"Cambodia","HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested to Increase the number of CSO (peer PLHIV) located at ART sites to help support differentiated ART delivery and to provide support for PLHIV in greatest need.","2020-12-31",295732]
[null,"Cambodia","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Replace or update 67 ART sites & 68 VCCT and NCHADS with laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information. TRP recomends only 15% of the request.","2020-12-31",60000]
[null,"Cambodia","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Replace or update NGO/CSO laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information.TRP recommends only 15% of the request.","2020-12-31",60000]
[null,"Cambodia","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To improve understanding of epidemic status and collection of pathology information in Cambodia. TRP recommends 20% of the request.","2020-12-31",60000]
[null,"Cambodia","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To support NASA 2020.","2020-12-31",60000]
[null,"Cambodia","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","TRP recommended funding 25% of requested amount of $300,000 to conduct the survey proposed to feed into development of policies and targeted interventions.","2020-12-31",75000]
[null,"Cambodia","HIV/AIDS","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","QC/QA will be implemented in collaboration with DDF and CMS and sampling will be undertaken using current SOP employing a risk based approach in product selection. TRP recommends 10% of the request.","2020-12-31",40000]
[null,"Cambodia","HIV/AIDS","TB/HIV","Other TB/HIV intervention(s)","Contribution to HEF to cover HIV service packages: HIV and STI Testing and Counselling at Health Centres, HIV Testing and Counselling at VCCT Centres,Adult and Paediatric Pre-ART and ART Service, and transportation fees to ART patients in need.","2020-12-31",1824459]
[null,"Cambodia","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Co-infection with HCV is a significant contributor to morbidity and mortality among PLHIV. Request for HCV testing and treatment for 262 cases is included within the allocation request. Above allocation funding is requested for drugs, commodities and PSM to provide treatment to a further 261 in 2019 and 262 in 2020 PLHIV with chronic HCV co-infection (F3-F4) to cover all estimated need and to reduce mortality and morbidity among PLHIV in Cambodia. The TRP ranked this activity as low priority but also considers that this activity cannot be funded using Global Fund funding as the conditions of the Global Fund policy on this subject are not met. See link https://www.theglobalfund.org/media/41 67/bm33_11-co-infectionsandcomorbidities_report_en.pdf","2020-12-31",329505]
[null,"Cambodia","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of Sihanouk Hospital Centre of Hope,  funding is requested to provide additional year for staffing and lab costs after 2018.","2020-12-31",400000]
[null,"Cambodia","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of the AHF clinic which provides HIV services at 12 sites,  funding is requested to provide an additional year after 2018 for staffing (estimated total cost USD 400,000 for 2019).","2020-12-31",400000]
[null,"Cambodia","HIV/AIDS","Treatment, care and support","Payment for results","A bonus payment based on results to all PHDs to help improve B-IACM.TRP recommends only 10% of the request.","2020-12-31",157862]
[null,"Cambodia","TB/HIV","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)Reproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) Expected outcome: at least 2,160 hidden KPs reached","2020-12-31",500]
[null,"Cambodia","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)Reproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) Expected outcome: at least 2,160 hidden KPs reached","2020-12-31",500]
[null,"Cambodia","TB/HIV","Comprehensive prevention programs for TGs","Behavioral interventions for TGs","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)Reproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) Expected outcome: at least 2,160 hidden KPs reached","2020-12-31",500]
[null,"Cambodia","TB/HIV","PMTCT","Other intervention(s) for PMTCT","eMTCT Roadmap implementationIn 2018 the MoH launched the national roadmap for elimination of Mother To Child Transmission (MTCT) of HIV & syphilis. The suggested intervention will support enhanced service delivery, including HIV testing and treatment, to reach the global impact indicators.  Expected:- Coverage of pregnant women who know their status of = 95%- Antiretroviral treatment coverage of HIV-positive pregnant women of = 95%- Antenatal coverage (at least one visit) of = 95%- Infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth of = 90%- Coverage of syphilis testing of pregnant women of = 95- Treatment of syphilis-seropositive pregnant women = 95%","2020-12-31",285000]
[null,"Cambodia","TB/HIV","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Operational Research","2020-12-31",100000]
[null,"Cambodia","TB/HIV","TB care and prevention","Case detection and diagnosis","This is aimed to expand the implementation of TB active case finding (ACF) activities including implementation of C-DOTS, ACF in prisons and hospital linkages to cover 30 operational districts (30 ODs). Currently, TB active case finding activities are limited to 46 ODs. Expansion to the 30 ODs will contribute to detection of 5,240 by the end of 2020.","2020-12-31",114963]
[null,"Cambodia","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","ACF in prisons","2020-12-31",96330]
[null,"Cambodia","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","Advocacy, strategic communicaton and Mass Media","2020-12-31",414000]
[null,"Cambodia","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","Logistics and Commodities: Mobile TB Vans with GeneXpert and digital X ray","2020-12-31",1854180]
[null,"Cambodia","Tuberculosis","MDR-TB","Prevention for MDR-TB","Minor renovations to wards including installation and maintenance of UVGI to reduce TB transmission.","2020-12-31",33000]
[null,"Cambodia","Tuberculosis","MDR-TB","Treatment: MDR-TB","TRP recommends enablers for DOTS watchers for MDR-TB and packages for covering MDR-TB patients. The recommendation is 35% of the request.","2020-12-31",291389]
[null,"Cambodia","Tuberculosis","Program management","Grant management","Support NGO SSI to implement C-DOTS activities to cover additional 18 ODs to enhance case notification. TRP recommends 30% of the reqeust of $ 544,630.","2020-12-31",163389]
[null,"Cambodia","Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","A local lab consultant and lab technician will be recruited to ensure the quality of TB, maintenance lab equipment and support GeneXpert troubleshooting. Recruitment of one full time effort WHO Medical Office and short term TA will assist the program to ensure quality services. TRP only recommends 20% of the request.","2020-12-31",180862]
[null,"Cambodia","Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Prevalence survey is planned for 2019. Operational research and TA for joint program review.","2020-12-31",2440344]
[null,"Cambodia","Tuberculosis","TB care and prevention","Engaging all care providers (TB care and prevention)","Contribution to HEF TB service package. TRP recommends evaluation of HEF before natinal scale up.","2020-12-31",2100000]
[null,"Cambodia","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","To scale up to the remaining 10 prisons due to high burden of TB case notification rate and crowded/overloaded prison conditions.","2020-12-31",118125]
[null,"Cambodia","Tuberculosis","TB care and prevention","Prevention","This will facilitate scale up of CI and IPT for children the high burden 18 ODs.","2020-12-31",125460]
[null,"Cambodia Total",{"$nulls":5},12668642]
[null,"Cameroon","Malaria","Case management","Other case management intervention(s)","Failure to follow guidelines on case management of malaria by health providers is a major challenge to achieving program objectives. This situation is linked to the lack of mastery of certain providers of good practices  in  terms  of  taking charge  and  also to  the  low  capacity of pharmacy clerks  to ensure a permanent  availability of qualityrapid diagnostic tests (RDTs) and  anti-malarials.  In addition, we found poor quality of microscopic examinations and interpretation of TDR results. Planned activities will improve the  management of malaria  through quality control and quality assurance activities for diagnosis,  training of health personnel  for proper management of malaria inputs and adverse effects. Thus, diagnostic coverage in the general population will be improved from 78% to at least 95% and free treatment from 52% to at least 95% by 2020.","2020-12-31",2677508.7000000002]
[null,"Cameroon","Malaria","Case management","Other case management intervention(s)","Failure to follow guidelines on case management of malaria by health providers is a major challenge to achieving program objectives. This situation is linked to the lack of mastery of certain providers of good practices  in  terms  of  taking charge  and  also to  the  low  capacity of pharmacy clerks  to ensure a permanent  availability of quality rapid diagnostic tests (RDTs) and  anti-malarials.  In addition, there is a poor quality of microscopic examinations and interpretation of TDR results. Planned activities will improve the  management of malaria  through quality control and quality assurance activities for diagnosis,  training of health personnel  for proper management of malaria inputs and adverse effects. Thus, diagnostic coverage in the general population will be improved from 78% to at least 95% and free treatment from 52% to at least 95% by 2020.","2020-12-31",665209.29]
[null,"Cameroon","Malaria","Program management","Other program management intervention(s)","Malaria control strategies are evolving at the global level, given the innovations in this area. To this end, the Program will undergo several phases  of  change  in  program  and  financial management  policies  and  procedures.  For example, NMCP is  considering assessments of current  strategies,  revision  of  the  national strategic  plan,  capacity  building  of  staff  in different areas of specialization and updating of  normative  documents.  To  this  end,  all normative  documents will be up to date and at least  80%  of  the  qualified staff in the specialties  required  for  the  performance of their duties.","2020-12-31",56110.43]
[null,"Cameroon","Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to advocacy at city/distric/region level to put in place transition plan for the current 4'400 CHW to be funded in the future by local authorities.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country.","2020-12-31",265816.40999999997]
[null,"Cameroon","Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to support the new   4'500  CHWs. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to recruit 4500  CHWs additonal through  and  to  extend  the  response  to  80 additional  health districts by ensuring adequate  equipment  for the smooth  running of  the  activity.  In  addition,  a  performance-based funding mechanism for CHW accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","2020-12-31",8784908.5399999991]
[null,"Cameroon","Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to train the  remaining  492  CHWs  through  periodic recycling not funded under the new grant due to budget constraint.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","2020-12-31",164309.28]
[null,"Cameroon","Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to maintain the  remaining  492  CHWs not funded under the new grant due to budget constraint only  4400 Community Health Workers (CHW) out of  the 4892 operational  will  be supported. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country.  In  addition,  due  to  budget constraints .  To  achieve universal coverage, it is important to maintain the  remaining  492  CHWs.  In  addition,  a  performance-based funding mechanism for Community Health Workers accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","2020-12-31",959726.18]
[null,"Cameroon","Malaria","RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to train the  new  4'500  CHWs  through  periodic recycling. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to extend  the  response  to  80 additional  health districts.Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","2020-12-31",1288703.8500000001]
[null,"Cameroon","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.","2020-12-31",1005064.53]
[null,"Cameroon","Malaria","Vector control","Other vector control measure(s)","These activities will allow for work to ensure communication around the use of LLINs and  IPT activities for  the prevention of malaria in pregnant women a,  infant  and neonatal health through the routine distribution LLINs, the implementation of  the refocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.","2020-12-31",270101]
[null,"Cameroon","Malaria","Vector control","Other vector control measure(s)","These activities will allow for work to ensure  the prevention of malaria in pregnant women and improve access to promotional and preventive services for maternal,  infant  and neonatal health through the routine distribution LLINs, the implementation of  therefocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.","2020-12-31",4233348.67]
[null,"Cameroon","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Addressing stigma, discrimination and violence against PWID","This   funding   would   be   used   to   run   additional   training workshops for magistrates on the subject of access to health services for MSM, people who inject drugs and sex workers.","2020-12-31",15746.83]
[null,"Cameroon","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","This  would  be  used  to  fund  training  for  some  of  the  peer educators   for  people   who inject drugs,  and  to   develop additional  BCC  activities  (educational  talks,  conferences, etc.).","2020-12-31",95945.46]
[null,"Cameroon","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","HIV testing services for PWID","This would be used to fund training for some of the self-help groups  for  people  who  use  drugs,  and  to  develop  additional testing activities for people who inject drugs.It would also be used to supplement performance-based incentivesfor cases tested positive by peer educators among the group of people who inject drugs.","2020-12-31",38799.24]
[null,"Cameroon","TB/HIV","MDR-TB","Case detection and diagnosis: MDR-TB","This funding would be used to purchase tests for initial check-up and follow-up of 100 additional MDR-TB patients between Year  1  and  Year 3.  It  would  also  cover  screening  for  MDR-TB/RR-TB among new TB cases. This would be after having tested 100 percent of the primary group at higher risk, which is patients with a history of previous treatment.","2020-12-31",49771.07]
[null,"Cameroon","TB/HIV","MDR-TB","Prevention for MDR-TB","This  funding  would  be  used  to  renovate  hospital  wards  for MDR-TB/RR-TB   patients   in five hospital   (Limb,   Maroua, Bafoussam,  Bertoua  and  Garoua)  in  Year  2.  The  funding wouldalso provide community care for 100 additional MDR-TB/RR-TB patients between Year 1 and Year 3.","2020-12-31",25148.69]
[null,"Cameroon","TB/HIV","MDR-TB","Treatment: MDR-TB","This would be used for the following activities: -Support for community DOTS (home-based treatment by a  qualified  nurse)  for  daily  administration  of  MDR-TB drugs     to     240  additional  MDR-TB  outpatients; hospitalization costs.-Purchase of ten audiometer machines for MDR-TB in the year.","2020-12-31",363595.55]
[null,"Cameroon","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Keeping girls in school","This  would  be  used  towards supporting activities  for  1,500 adolescent  girls  and  young  women  in  highly  vulnerable situations. Conditionned to evidence that the activities budgeted under the alloacation are  effective.","2020-12-31",787564.81]
[null,"Cameroon","TB/HIV","RSSH: Health management information systems and M&E","Program and data quality","This would be used to fund regional evaluation TB/HIV meetings, and partially to fund regional data verification visits by central supervisors.","2020-12-31",78756.59]
[null,"Cameroon","TB/HIV","RSSH: Health management information systems and M&E","Routine reporting","This  would  fund  activities  to  extend  drug  dispensing  and monitoring  software  to  40 additional  health  care  facilities between 2018 and 2020.It would also cover the validation of community data, and the harmonization  and  production  of  community  data  collection tools for MSM, SWs, people who inject drugs and transgender people.","2020-12-31",281062.73]
[null,"Cameroon","TB/HIV","RSSH: Health management information systems and M&E","Surveys","This would be used to fund various studies and evaluations, including updated mapping of key and vulnerable populations, and the midterm review of the NSP. It would also be used to fund the development of a monitoring and evaluation plan for the HIV NSP.","2020-12-31",556386.49]
[null,"Cameroon","TB/HIV","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","This  funding  would  be  used for the  construction  of  a  new central medical  store or renovation of Regional Store, with  other  technical  and  financial partners (IDB, USAID, etc.): purchase of land and construction (EUR  9,000,000). Investment in the supply chain is conditional to recommendation of the supply chain report. In  addition,  it  will  provide  funding  for technical assistance (EUR 649,440) for national coordination (a team of one international and one national expert)  for the three programs, to improve quantification and procurement of supplies, and to reduce instances of stock-outs.","2020-12-31",10828683.65]
[null,"Cameroon","TB/HIV","TB care and prevention","Case detection and diagnosis","This would be used for the following activities:  -Procurement   and   distribution   of   culture   laboratory products, consumables and  reagents  for LPA/Hain and TB LAM,andfor additional cases (solid and liquid).  -Improvement/refurbishment  of  culture  laboratories  (old and new).-Additional   maintenance   and   equipment   for   culture laboratories in order to retain certification.In  addition,  it  would  enable  the  purchase  of  four  new GeneXpert machines, calibration kits and waste filters for all the machines, seven  TB  LAM  machines  and  accessories in 2020,   and   25,000   additional   cartridges   for   GeneXpert MTB/RIF tests. This  activity  will  focus  on  the  second  population  at  risk  of MDR-TB -new cases with positive microscopy -whowill have a sensitivity test(GeneXpert).","2020-12-31",2260063.9700000002]
[null,"Cameroon","TB/HIV","TB care and prevention","Engaging all care providers (TB care and prevention)","This would be used to fund the following activities: -Activities to actively search for TB in additional (existing) health  care  facilities,  identified  as  having  high  potential for  suspected  TB  cases  and  receiving  high  numbers of adults   and  children   (primary   target   for  active case finding)-Performance incentives (different to top-ups for program managers;  this  is  an  incentive  for  service  providers  at health  care facilities with  high  potential  for  suspected cases)  for health care providers involved in the routine screening  activities  at health care facilities identified  as having high potential for suspected TB cases.","2020-12-31",340419.71]
[null,"Cameroon","TB/HIV","TB/HIV","Other TB/HIV intervention(s)","This would be used to support the following activities: -Additional six-monthly mass   TB/HIV   campaigns   in prisons with more than 1,000 inmates and on a quarterlybasisin   institutions   with   less   than   1,000   inmates. Purchase   of   additional   supplies   for   TB   and   HIV prevention (infection control, safe shaving) for prisoners and support for the coordination of these activities, which will  help  to  ensure  TB  is  diagnosed  earlier  and  avoid  it being spread. In  addition,  it  would  facilitate  the  purchase  of  two  mobile digital X-ray machines exclusively for prisoners, which would significantly improve the rate of return for screening.","2020-12-31",460956.12]
[null,"Cameroon","TB/HIV","Treatment, care and support","Differentiated ART service delivery","This  funding  would  be  used  to  put an additional 38,600 HIV-positive patients on treatment by 2020. This budget line also include maintenance.","2020-12-31",10637439.119999999]
[null,"Cameroon","TB/HIV","Treatment, care and support","HIV care","This funding would enable the country's cohort to be increased from  320,000  to  358,000 patients by 2020.  It  would  support 38,000 patients to be enrolled on ART using EUR 9.3 million of Spanish funding via the Debt2Health initiative.","2020-12-31",420.83]
[null,"Cameroon","TB/HIV","Treatment, care and support","Treatment adherence","This funding would be used to improve treatment adherence for children and adolescents during the grant period, through the production of additional treatment education manuals and tools,  to  improve  treatment  education  at  the  CBOs  and PMTCTsites wherethe manuals and toolsalready exist.","2020-12-31",34216.14]
[null,"Cameroon","TB/HIV","Treatment, care and support","Treatment monitoring - Drug resistance surveillance","This funding would be used to carry out a study into initial and acquired resistance to ARVs among infectedadult and child patients, in Year 1.","2020-12-31",427698.35]
[null,"Cameroon Total",{"$nulls":5},47653482.229999989]
[null,"Central African Republic","TB/HIV","MDR-TB","Prevention for MDR-TB","Prevention of MDR-TB highly relevant to prevent escalation of the MDR-TB situation.","2020-12-31",126116.04]
[null,"Central African Republic","TB/HIV","Program management","Grant management","Increase treatment coverage and expand prevention services beyond the stated priority districts the allocation will support additional program management costs.","2020-12-31",2514661.65]
[null,"Central African Republic","TB/HIV","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","2020-12-31",80065.09]
[null,"Central African Republic","TB/HIV","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Ensure availability of human resources for the provision of services.","2020-12-31",77875.66]
[null,"Central African Republic","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","Addressing key populations important.","2020-12-31",940.41]
[null,"Central African Republic","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","Expansion of diagnostic activities important in as large a part of the country as possible.","2020-12-31",25709.8]
[null,"Central African Republic","TB/HIV","TB/HIV","Other TB/HIV intervention(s)","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","2020-12-31",37637.75]
[null,"Central African Republic","TB/HIV","Treatment, care and support","HIV care","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.","2020-12-31",1988897.99]
[null,"Central African Republic Total",{"$nulls":5},4851904.3899999997]
[null,"Chad","Malaria","Case management","Integrated community case management (ICCM)","The country has successfully implemented iCCM in 2 regions and intends to expand this intervention in 2 other regions with high malaria burden. This intervention will increase malaria diagnostic and treatment services among vulnerable groups and, hence, improve coverage of malaria treatment seeking among children under five. This will have an impact on the reduction of malaria mortality which continues to be considerable.","2021-06-30",2534322.41]
[null,"Chad","Malaria","Case management","Removing human rights and gender related barriers to case management","The security context in Chad and in the countries of the subregion results in a population movement with its corollaries of internally displaced persons, refugees, returnees and even asylum seekers. This situation affects nearly 450,000 people whose health situation is increasingly precarious. One of the major challenges facing organizations supporting refugees is the difficulty of ensuring access for these populations to malaria prevention and case management services. Currently, only 35% of needs are regularly covered by UNHCR. The NFM II budget also plans to cover 15% of refugees' needs. This additional demand will cover 50% of the remaining needs, to ensure full coverage.","2021-06-30",295056.78999999998]
[null,"Chad","Malaria","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","93% of the population in Chad religious (composed of Muslims, Catholics and Protestants). These three religions are well-structured with national coordinating bodies: the Higher Council of Islamic Affairs for Muslims, the Episcopal Conference of Chad for Catholics and the Agreement of Evangelical Churches and Missions for Protestants. In addition, there is a peaceful coexistence between these three religious congregations with regular consultations at all levels between the various officials.This structuring of religious congregations is a powerful means to spread health messages. The country plans to use their support to sensitize community members on the fight against malaria, HIV/AIDS and tuberculosis. The requested funding has the following objectives: Ensure the training of 438 trainers / leaders from 146 health districts in the country Train 9,000 women and 9,000 young people as malaria awareness agents Organize broadcasts on 10 community radio stations Support the monitoring of the activities implemented by the religious congregations","2021-06-30",593576.11]
[null,"Chad","Malaria","RSSH: Health management information systems and M&E","Program and data quality","The Ministry of Public Health has developed their 2018-2022 National Strategic Plan for the development of the Health Information System which was integrated in the 2019-2021 Triennial Operational Plan, to make information available with the purpose of ensuring the effective management of the interventions by health system actors. The Operational Plan for Strengthening the Health Information System will allow Chad to have a well-functioning health information system, producing quality health information in real time at all levels, accessible and used by all stakeholders for evidence-based decision-making on health issues in order to improve the health of populations. The achievement of such an ambition requires the implementation of interventions that revolve around two axes namely:1. Improving the quality of the routine health information system to make readily available information tailored to the needs of the health system's implementing partners;2. Improved coordination of all elements of the health information system. The total cost of the National Strategic Plan for the development of the Health Information System (2018-2022) is 10,580,535 euros (6,940,375,997 FCFA). Of this amount, 8,031,620 euros are being mobilized through other funding sources. The remainder of 2,548,915 euros are requested through the UQD.","2021-06-30",2860414.02]
[null,"Chad","Malaria","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","2021-06-30",1400000]
[null,"Chad","Malaria","Vector control","Indoor residual spraying (IRS)","The country successfully implemented (IRS) in the Moissala locality and intends to expand it in 3 districts with the highest malaria mortality.","2021-06-30",2220048.25]
[null,"Chad","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN mass distribution campaigns represent the most important vector control strategy. With the exception of the desert region in the far north, all other regions are eligible for this strategy, i.e. 19 out of the 23 regions. The Global Funds continuous financial support resulted in carrying out 3 campaigns in the country at a regular interval of 3 years (2011, 2014 and 2017). These, respectively, allowed covering 44%, 73% and 69.1% of the total population of the country. The support provided by the government and other partners was very limited, and resulted in covering only one region in 2011 (Logone Occidental: 6.2% of the population) and 3 regions in 2014 (Batha, Ouaddai and Barh El Gazel: 12.7%). The 2017 campaign was possible only thanks to the support of the Global Fund. The next mass distribution campaign is planned in 2020. Due to reduced resources allocated to the country by the Global Fund for the Malaria Grant, only 6 regions (Tandjil, Logone Oriental, Mandoul, Moyen Chari, Salamat and Lac) will benefit from the next campaign. This represents 31.3% of the total population living in endemic regions. Conscious of the importance of the mass campaign for malaria prevention, and in order to avoid a resurgence of cases in the 13 regions that have already benefited from mass campaigns in 2017, the country wishes to sustain the gains. The requested amount will provide 3,931,586 LLINs, cover for logistics and other operational costs to carry out the campaign in 7 regions with 6,433,505 inhabitants (37.8% of the population of the malaria endemic regions). This will ensure that all 13 regions that were covered by the 2017 mass distribution campaign supported by the Global Fund will benefit from the 2020 mass distribution campaign.","2021-06-30",283018.03000000003]
[null,"Chad","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.In order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.","2021-06-30",544404.54]
[null,"Chad","Multi-component","MDR-TB","Treatment: MDR-TB","This request will make it possible to obtain all of the reagents and consumables necessary for carrying out the MDR-TB culture and sensitivity tests.","2021-12-31",335434.87]
[null,"Chad","Multi-component","MDR-TB","Treatment: MDR-TB","401 patients (106 in 2019, 132 in 2020 and 163 in 2021) must be screened and administered treatment between 2019 and 2021. Each patient must provide 5 culture samples (2 culture tubes per patient, equating to 4,010 culture tubes). Allowing a contamination margin of 5% would result in 4,211 culture tubes to be tested over the 3 years.Each patient must complete a sensitivity test at the start of treatment, equating to 401 sensitivity tests. Looking at the data for 2017, 2 of 60 MDR-TB cases remained positive in the 4th month, equating to 3.3%. This provides an estimate of 414 (401 x 3.3%+401).All of the targets for the culture and sensitivity tests will be covered in full by the Global Fund.The NTBCP in Chad is in the process of implementing a 2016-2018 extension plan for health care for RR-TB/MDR-TB cases. This plan aims to improve health care for these cases.At present, the tuberculosis drug sensitivity profile of the screened RR-TB/MDR-TB patients who are receiving treatment is unknown. In addition, the monitoring of these patients, which requires periodic culture tests and antibiogram tests, is still not carried out. Consequently, this monitoring is carried out only by the clinic, using microscopy. Culture confirmation tests for recovery are still not carried out. In addition, as yet, no RR-TB/MDR-TB patient who has completed a course of treatment has been reported as cured.The configuration of the premises of the NRL does not allow for the establishment of a functional culture laboratory that meets the minimum standards for the number of rooms required. The request is based on the recommendations resulting from the technical assistance mission report of the WHO Regional Green Light Committee (rGLC), which took place between November 4 and November 9, 2015.This funding request for a pre-fabricated culture laboratory will enable the NTBCP to:- perform culture tests and determine the sensitivity profile of patients screened for RR-TB/MDR-TB;- perform follow-up culture tests for RR-TB/MDR-TB patients receiving treatment.This funding will make it possible to acquire a prefabricated container for the culture of mycobacteria (ref: Specification LabMobile MCL WHO) including:- laminar flow hoods;- an autoclave;- a refrigeration unit at -4C;- a refrigeration unit at -20C;- two incubators;- a decontamination system;- the installation cost (preparatory work and earthworks);- a WHO evaluation mission;- annual maintenance for 2019-2020-2021;- power supply using a solar kit;- the administrative cost (shipping, training and assistance).","2021-12-31",437625.41]
[null,"Chad","Multi-component","Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","Voluntary counseling and testing (VCT) for HIV: - Differentiated screening: with the aid of the task delegation standards, the peer educators will be trained to screen their peers during advocacy sessions on the islands and islets. The first screening sessions will be carried out under the supervision of a health worker. If a person tests positive for HIV, the peer educator will refer him/her to a health-care center for confirmation and treatment using a referral sheet. He/she will then be made aware of family screening. Having tested positive, he/she will be given repeat supplies by the association or health center on which he/she depends. Actions to be carried out: i) advocacy, ii) HIV screening, iii) training, iv) availability of screening kits, v) waste management (peer educators will be given safety boxes to collect waste and transport it to the reporting health center for destruction) and vi) reporting of cases to the health-care center.- Advanced strategy screening: Advocacy and screening teams will be composed as follows: 1 peer educator, 1 nurse, 1 midwife and 1 community leader. Advocacy activities and TB and HIV screening for the island populations will be carried out by the teams, which will each complete a day-long visit to cover 1,000 people per quarter. ii) Percentage of the island population who have had a HIV test and know the results during the reporting period.Country targets: 14% (32,200/230,000) in 2019; 17% (39,387/238,084) in 2020; 19% (47,397/246,494) in 2021. All of these targets are assigned to the Global Fund.","2021-12-31",348461.12]
[null,"Chad","Multi-component","RSSH: Health management information systems and M&E","Surveys","Program Review HIV, Epidemiology and Impact AnalysisThis review will assess the performance, impact, quality and effectiveness of HIV programs and link program funding, scaling up interventions and disease trends through systematic plausibility analysisThe costs provided here are historical costs related to past grants","2021-12-31",51324.21]
[null,"Chad Total",{"$nulls":5},18609608.469999999]
[null,"Comoros","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Harm reduction interventions for sex workers who inject drugs","Providing performance bonuses for midwives undertaking PMTCT activities:The funding request also plans to give midwives more responsibility for PMTCT activities and in monitoring babies born to HIV-positive mothers, prior to Polymerase Chain Reaction (PCR) testing being carried out when the child is 18 months old. This funding request will cover the cost of performance bonuses for midwives who manage 12 HIV-positive pregnant women in 2019 and 13 HIV-positive pregnant women in 2020 and 2021. This funding is being requested in order to implement the performance bonus. Performance criteria will relate to the number of women monitored up until the childs PCR test is carried out at age 18 months. Once a report certified by a referring physician and validated by the DNLS has been submitted, midwifes will be paid a nominal amount for each HIV-positive pregnant woman they monitor.","2022-06-30",3332.96]
[null,"Comoros","HIV/AIDS","PMTCT","Prong 3: Preventing vertical HIV transmission","Supporting the operation of the Network for People Infected with or Affected by HIV: TAS TAS is a community-based organization engaged in HIV prevention and caring for PLHIV. Given the weak performance in the area of treatment and the ambitious targets of this funding request for ART (from 35 percent in 2019 to 65 percent in 2022), the DNLS recommended making TAS a sub-recipient to take part in family screening strategies (partner and child), the search for people lost to follow-up, the referral of HIV-positive people (test and treat), the distribution of nutritional kits and mediation for treatment of TB/HIV co-infection. Given the importance of this organization in the HIV response, the government has provided a building for TAS to use as its premises.This activity supports TASs equipment needs (refurbishment of premises, chairs, tables, photocopiers, computers, office supplies, maintenance of equipment, Internet connection, etc.) in order to improve its results efficiency.","2022-06-30",43796.43]
[null,"Comoros","HIV/AIDS","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Implementing community-based condom distribution points in villages and towns: An unreliable supply of condoms at the community level was reported as a major constraint that could hinder prevention interventions. As part of this grant, the DNLS therefore initiated the implementation of community-based condom distribution points in villages and towns run by community workers, as recommended in the national community health strategy. Mapping of villages shows that there are 331 villages to cover: 214 on Grande Comore (Ngazidja), 91 on Anjouan (Ndzuwani) and 26 on Mohli (Mwali). This above allocation funding request should cover 10 percent of the villages on each island in the first year, 20 percent in the second year and 35 percent in the third year. In each village, one distribution point will be selected in the first year, which will increase to three distribution points in the second and third years.   A total of 579 distribution points will be established in 215 villages over the three-year period: 372 on Grande Comore, 159 on Anjouan and 48 on Mohli.","2022-06-30",12995.17]
[null,"Comoros","HIV/AIDS","Program management","Grant management","Carry out twice-yearly quality control for HIV screening by community staff specializing in key population and general population screening campaigns: The community sector is important in the HIV response, in terms of both ART and screening and monitoring. Screening, which is a priority entry point, is organized through community sector campaigns.This activity hopes to ensure that the results produced by the community actors during screening campaigns are reliable. Once every six months, health workers will visit screening campaign sites to ensure the quality of sampling and technical procedures for analyzing and interpreting screening results. This activity also provides an opportunity to strengthen training skills/supervisions. Finally, samples analyzed will be transported to reference laboratories to ensure that quality control produces reliable results.","2022-06-30",17820.669999999998]
[null,"Comoros","HIV/AIDS","RSSH: Health management information systems and M&E","Analysis, review and transparency","Holding youth training days on counseling and screening: The grant allocation amount will cover training for 70 young people in the first year. This two-day session will introduce them to different techniques to raise awareness among their peers, counseling strategies, referrals for HIV screening and generally prepare them to lead the awareness-raising sessions. This training will cover only the island of Grande Comore and will provide only partial cover. To cover the remaining islands, we plan to use this above allocation funding request to cover the whole of the island of Grande Comore by organizing two additional training courses for 20 young people each in the second year, three training courses on Mohli (60 young people) and five training courses on Anjouan (100 young people). These training courses will enable the country to strengthen the peer educator mechanism for young people by adding 200 more young people, who will increase the number of awareness-raising and screening sessions and improve progress towards the first UNAIDS target on testing.","2022-06-30",22444.17]
[null,"Comoros","Malaria","Case management","Ensuring drug and other health product quality","\"Slide exchanges with internal and external laboratories for quality assurance: According to World Health Organization recommendations, slide quality control is essential in a country that is moving toward elimination, as is the case for the Union of the Comoros. A correct reading of the slides is of paramount importance to avoid any misdiagnosis that may lead to the spread of the disease. Indeed, a positive slide read as negative may lead to an epidemic and undermine all efforts made so far toward eliminating the disease. As a result, the training supervision of quality control officials has been included in the budget to enable continuous training on the theoretical and practical aspects of quality diagnosis. The NMCP requests funding under the PAAR for the following: the exchange of slides internally (from the islands to the NMCP reference laboratory) and from the NMCP laboratory to an external accredited laboratory. This would ensure that these slides are read correctly to avoid this kind of situation and would also be a means of assessing other laboratories in the country from which the NMCP collects data, in order to ensure reliable results and avoid any step that might hinder the elimination process.\"","2021-12-31",12126.59]
[null,"Comoros","Malaria","Program management","Policy, planning, coordination and management of national disease control programs","\"Organization of staff training on program management:In recent years (following the new funding model), the NMCP has been selected by the Comoros Country Coordinating Mechanism as the Principal Recipient for the malaria control component. Capacity building is required for all staff on several aspects relating to program management. A grant management unit will be set up that should have the same level of understanding and be at the same grant implementation level. As such, training, supervision and performance monitoring sessions will be organized for each staff member.\"","2021-12-31",36829.760000000002]
[null,"Comoros","Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","\"Organization of annual implementation reviews:Annual reviews will be organized to assess the implementation status of the strategic plan. This will be an opportunity to bring together all stakeholders (NGOs, health districts, regional health directorates, community health workers, technical and financial partners) to work on all the program objectives set for the year. It will also be an opportunity to examine all facets of activity implementation  vector control, monitoring and evaluation, program management and finances. At the end of the review, recommendations will be made for boosting activity implementation.\"","2021-12-31",23273.48]
[null,"Comoros","Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","\"Organization of mass awareness-raising sessions in villages:At the current stage of malaria control  the elimination phase  mass awareness-raising must be strengthened to consolidate the country's progress in this process. The population is encouraged to adopt behavior conducive to malaria control by adhering to treatment protocol and attending health care facilities. By way of example, the latest survey in 2014 showed LLIN coverage of more than 80 percent, but a low usage rate, at 56 percent. The Union of the Comoros has two transmission seasons: one high transmission and one low transmission. It is advisable to raise public awareness before the start and during the high transmission season (rainy season). The grant budget only takes into account mass awareness-raising sessions in year 1. Thus, the suggestion is that years 2 and 3 be covered by the Prioritized Above Allocation Request (PAAR) budget.\"","2021-12-31",382076.09]
[null,"Comoros","Malaria","Vector control","Indoor residual spraying (IRS)","IRS for indigenous cases in elimination areas (5 km radius): In the elimination areas, malaria cases should undergo both epidemiological and entomological investigations to determine the origin of the case. Once the case is declared indigenous, case management (treatment) and interruption of parasite transmission by the vector (IRS) are the two main response interventions used to prevent epidemics. This activity will take place following the results of the prior entomological investigations. A total of nine IRS interventions are planned based on an expected 5 percent of imported cases over the three years in elimination areas. Thus, nine cases are expected in total  two cases in 2019, four cases in 2020 and three cases in 2021. Expected outcome: interruption of transmission. Expected impact: prevention of re-introduction of the disease.","2021-12-31",649999.88]
[null,"Comoros","Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Activity 2: Replace the four program cars (1/coordination, 3/islands). Rationale: At the end of the new grant period, the cars purchased in 2015 will be six years old and will have depreciated and be in poor condition (with a mileage of up to 50,000 km/year on degraded roads). Result: The NTCP will have four new cars available for its supervision, monitoring and evaluation activities, outreach strategies, contact investigation and coordination, unhindered by major logistical obstacles for a prolonged period of time. Impact: One of the essential prerequisites for effective TB control in the Union of the Comoros is guaranteed.","2021-09-30",150549.88]
[null,"Congo","Malaria","Case management","Other case management intervention(s)","Care providers will be trained to support the supply of ACT and artesunate as well as supervision at different levels of the health system. The above allocation funding request will enable the gap in drugs to be met and the support activities to be implemented","2020-12-31",534171.25]
[null,"Congo","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.","2020-12-31",32544.05]
[null,"Congo","Malaria","Vector control","Other vector control measure(s)","The intervention of this module will focus on the routine distribution of 589,164 LLINs to pregnant women and children under one year of age during antenatal clinics, seasonal malaria chemoprevention (SMC), and/or linked to vaccination. In effect, these population groups are the most vulnerable to malaria but do not currently benefit from LLINs. The Chinese Government has signed a donation agreement with Congo to provide 200,000 LLINs per year for five years. However, programmatic gap analysis shows that there will be a 48 percent shortage of LLINs in 2018, 6 percent in 2019 and 51 percent in 2020 for the routine provision of nets, equivalent to a shortage of 589,164 LLINs. The household coverage rate of LLINs in 2015 is 36.7 percent. The rates of use are respectively 60.5 percent among children under one year of age and 60.3 percent among pregnant women, also for 2015. The above allocation funding by the Global Fund will cover the gap in LLINs and improve the rate of coverage (99 percent among pregnant women and 90 percent among children under one year of age), and the rate of use of LLINs to at least 80 percent in these two vulnerable groups. The expected impact will be a reduction of the burden of malaria morbidity among these vulnerable groups.","2020-12-31",1931320.84]
[null,"Congo","TB/HIV","MDR-TB","Other MDR-TB intervention(s)","Organize one training session (doctors, nurses and laboratory technicians) on MDR-TB treatment in Brazzaville for 20 people.","2020-12-31",7283.54]
[null,"Congo","TB/HIV","MDR-TB","Other MDR-TB intervention(s)","Procure 190 cartridge kits for GeneXpert MTB/RIFGDF diagnosis CGXMTB-RIF-50 in years 1, 2 and 3.","2020-12-31",2348.75]
[null,"Congo","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","Organize 2 training/refresher training sessions lasting 5 days for 80 heads of TTC (2 nurses per TTC) on TB treatment for adults and children (including drug management), with 4 training centers in years 1 and 2.","2020-12-31",117831.89]
[null,"Congo","TB/HIV","TB/HIV","Other TB/HIV intervention(s)","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS for refugees.","2020-12-31",95756.93]
[null,"Congo","TB/HIV","TB/HIV","Other TB/HIV intervention(s)","Provide 2 training/refresher training sessions to 50 community liaison workers and community leaders in Brazzaville.","2020-12-31",25699.919999999998]
[null,"Congo","TB/HIV","Treatment, care and support","Other intervention(s) for treatment","The three months of buffer stock constitute a supplement to the adult ARV drugs which will be procured from the allocated funds in order to have 6 months as a standard quantity.","2020-12-31",1180280.55]
[null,"Congo (Democratic Republic)","Malaria","Case management","Severe malaria","The WHO recommends the preferential use of injectable artesunate in cases of severe malaria. A total of 33,997 deaths linked to malaria were recorded in 2016 out of 96.166 deaths recorded in health facilities, i.e. a proportional mortality rate of 35%. Given that the funds for purchasing injectable artesunate for children under five years of age have already been secured, we are requesting a budget of an extra $13,800,000, which will be used to complete the purchase, transportation and storage of injectable artesunate for treating adolescents and adults suffering from severe malaria.Only the needs of children under five years of age are covered in the allocation.","2020-12-31",13800000]
[null,"Congo (Democratic Republic)","Malaria","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","This sum will consist of buying in services from the structures/Programs of the Ministry of Health, which can contribute to achieving the objectives linked to the 3 diseases. For example: FOSAs, DPSs, CDRs, PNAM, 3workers DEP,IGs). This involves defining a package of support for services affected in exchange for results, which have a proven impact on the performance of the fight against the threediseases. It will be possible to use these sums in a co-financing arrangement with domestic funds or with other partners such as the World Bank or the European Union.","2020-12-31",22300000]
[null,"Congo (Democratic Republic)","TB/HIV","MDR-TB","Prevention for MDR-TB","Pharmacovigilance and laboratory strengthening This additional investment is intended to address rising drug resistance in the country and respond to the introduction of new drugs, initially to treat XDR-TB cases. It will be used to help establish a pharmacovigilance system to monitor and manage DR-TB drug side effects, with a view to future extension of the new drugs to treat DR-TB (non-XDR-TB).","2020-12-31",2083840]
[null,"Congo (Democratic Republic)","TB/HIV","RSSH: Health management information systems and M&E","Surveys","Completion of the serosurveillance survey among pregnant women.","2020-12-31",1093358]
[null,"Congo (Democratic Republic)","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","Pediatric TB training for maternal, neonatal and child health (MNCH) and diabetes providers The investment will be used to better incorporate pediatric TB screening and case management into the following activities: - Delivering pediatric TB training to two service providers per MNCH and malnutrition treatment center (TT)/TTC (2,068 x 2); - Delivering training to 516 diabetes and malnutrition treatment service providers.","2020-12-31",224064]
[null,"Congo (Democratic Republic)","TB/HIV","TB/HIV","Collaborative activities with other programs and sectors (TB/HIV)","Psychosocial support from CBOs The aim of this intervention is to improve patient care by signing performance contracts with community-based organizations (CBOs) to provide psychosocial support to co-infected patients.","2020-12-31",533640]
[null,"Côte d'Ivoire","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Pilot project for the use of new technologies in the active search for TB and among contact cases With regard to contact cases, a pilot project is planned for Abidjan with the use of awarenessraising/educational videos on tablets during surveys of patient contacts, and registration of all contact cases on an electronic database.","2020-12-31",90501.1]
[null,"Côte d'Ivoire","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Purchase eight automated slide stainers and eight incinerators for eight new regional coordination and maintenance centers All 17 existing regional coordination centers have incinerators and automated slide stainers. These devices are requested for the eight new regional coordination centers. The automated slide stainers not only make it easier to read the slides, but also allow standardization of procedures for better quality control.","2020-12-31",312628.09000000003]
[null,"Cuba","HIV/AIDS","Comprehensive prevention programs for MSM","HIV testing services for MSM","The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources  will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.","2020-12-31",166250]
[null,"Cuba","HIV/AIDS","Other module","Other module","Reinforcement of primary and secondary health care will contribute to maintaining the achievements in mother-to-child transmission and the control of opportunistic diseases.","2020-12-31",475000]
[null,"Cuba","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Insufficient degrees of adherence to ART to have a sustainable impact on the rate of new infections and mortality caused by AIDS. Specialized counseling in ART adherence is not systematic, and follow-up by the health care team and other Polyclinic services to take on adherence and serodiscordance is weak.","2020-12-31",84450]
[null,"Djibouti","Malaria","Case management","Facility-based treatment","This is an important activity to ensure effective management of malaria that is based on a good quality diagnosis.","2020-12-31",11948]
[null,"Djibouti","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","This activity is regarding the routine distribution for pregnant women, children under 5, refugees and migrants.","2020-12-31",190045]
[null,"Djibouti","TB/HIV","MDR-TB","Case detection and diagnosis: MDR-TB","Establishment of an efficient transport system in the Testing and Treatment Centers in Djibouti (includes daily allowances related to awareness (transport / meeting / and other costs)).","2020-12-31",16949]
[null,"Djibouti","TB/HIV","PMTCT","Analysis, review and transparency","The peer educators- traning is meant to contribute to  the action plan in the context of the RTTR (Reach, test, treat, and retain) TB-HIV-Human Rights strategy, the enrollment and retaining of patients and data collection.","2020-12-31",24585]
[null,"Djibouti","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","A bio-behavioral study of young people (international consultant) will also allow an improvement of program's focus and a better monitoring of indicators.","2020-12-31",54000]
[null,"Djibouti","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","See line 44 (diseemination of report).","2020-12-31",4237]
[null,"Djibouti","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","The mapping of key and vulnerable populations, namely young people, at national level (consultant) will allow a better focus of interventions for identifying new HIV and TB cases.","2020-12-31",11085]
[null,"Djibouti","TB/HIV","RSSH: Health management information systems and M&E","Analysis, review and transparency","See previous itervention - line 54.","2020-12-31",169]
[null,"Djibouti","TB/HIV","RSSH: Health management information systems and M&E","Analysis, review and transparency","The analysis of performance of the TB program and, following that, following up with the resulting recommendations will allow reaching the program's objectives.","2020-12-31",678]
[null,"Djibouti","TB/HIV","TB care and prevention","Case detection and diagnosis","Staff training in the use of digital radiology equipment (See line 21).","2020-12-31",3763]
[null,"Djibouti","TB/HIV","TB care and prevention","Prevention","The study on TB/diabetes co-infection will allow better identification of new cases of TB and of diabetes.","2020-12-31",8475]
[null,"Djibouti","TB/HIV","TB/HIV","Key populations (TB/HIV) - Prisoners","It involves identifying peer educators and training them on the prevention package using the guide (this cost is allowances) (see line 32). The expected result is the identification and treatment/care of new HIV and TB cases among prisoners.","2020-12-31",16949]
[null,"Djibouti","TB/HIV","TB/HIV","Key populations (TB/HIV) - Prisoners","Through peer education, inform and educate inmates and prison staff on HIV, sexually transmitted infections, viral hepatitis and tuberculosis. The expected result is the identification and treatment/care of new HIV and TB cases among prisoners.","2020-12-31",8475]
[null,"Djibouti","TB/HIV","TB/HIV","TB/HIV collaborative interventions","The organization of monthly outpatients visits of the mobile team for TB / HIV screening in Djibouti-city and quarterly in the regions of the interior, will allow the identification and treatment (Test and treat) of new HIV and TB in rural communities and vulnerable urban communities.","2020-12-31",4271]
[null,"Djibouti Total",{"$nulls":5},1832153]
[null,"Dominican Republic","HIV/AIDS","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","The practices of self-care, prevention of HIV and other STIs in immigrant populations (Haitian migrants) in the Dominican Republic and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources would be allocated to increasing the targets that can be reached to improve self-care and prevention practices.","2021-12-31",592400]
[null,"Dominican Republic","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Training of health care providers on human rights and medical ethics related to HIV and HIV/TB","The groups with the highest prevalence and incidence have limited access to prevention, treatment, care and support services. Underlying factors include: i) lack of respect that leads to their socially and financially marginalized status; ii) stigma and discrimination by the public and by social work activity and healthcare personnel; iii) deficiencies of the legal and institutional system; iv) low participation of the population in the design, supervision and evaluation of the services.**","2021-12-31",161000]
[null,"Dominican Republic","HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Need to strengthen legal advice and legal literacy (training in legal rights for PLHIV, MSM, Trans, SW and young people; as well as community-based legal advice programs -Observatories). Covering this demand will take the form of empowering the key populations, as well as providing them with a channel for processing violations of their rights.","2021-12-31",130000]
[null,"Dominican Republic","HIV/AIDS","RSSH: Procurement and supply chain management systems","Improving service delivery infrastructure","Strengthening of primary and secondary health care will contribute to maintaining the successes achieved in mother to child transmission and control of other opportunistic diseases.","2021-12-31",950000]
[null,"Egypt","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","(1) One drop-in center model program in Cairo; (2) One peer education outreach model programme in Alexandria","2022-03-31",195000.18]
[null,"Egypt","TB/HIV","MDR-TB","Other MDR-TB intervention(s)","Treatment (MDR-TB): Microscops","2022-03-31",70000]
[null,"Egypt","TB/HIV","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","90-90-90 HIV services cascade analysis + ART cohort analysis for each of the focus key populations (PWID, MSM and FSW)","2022-03-31",250000]
[null,"Egypt","TB/HIV","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Integration of TB/HIV services into existing structures (e.g. the existing Hepatitis C program): Quarterly coordination meetings for HIV and TB managers and focal points on governorates level","2022-03-31",26896.74]
[null,"Eritrea","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.","2020-12-31",179720]
[null,"Eritrea","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Prevention and management of coinfections and co-morbidities for sex workers","The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.","2020-12-31",270000]
[null,"Eritrea","HIV/AIDS","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","To support the activities under allocation and expand the EID sites to the peripheral health facilities and provide family planning to women living with HIV as prong 2, more RH commodities including family planning commodities and Point of care PCR for EID services will be procured.","2020-12-31",150000]
[null,"Eritrea","HIV/AIDS","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","This above allocation will be used to strengthen the referral from the community to the health facilities for services, Print and disseminate the referral tools, Advocacy meetings to engage influential people.","2020-12-31",155250]
[null,"Eritrea","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","2020-12-31",110000]
[null,"Eritrea","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x-rays, ECGs, etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas.","2020-12-31",824700]
[null,"Eritrea","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","As part of this module, ARV providing sites will be scaled up to improve access and reduce transport cost and increase retention. More CD4 and viral load point of care machines will be procured. Additional equipment and reagents to strengthen the existing molecular laboratory, will be procured. To enhance the care and support activities positive living training for new Bidho members, support IGA activities to PLHIV and long term economic support will be supported.","2020-12-31",2578250]
[null,"Eritrea","Malaria","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Different training programs are proposed by the Ministry of Health in order to improve capacity of malaria health workforce. Such programs include training on Malaria Elimination, Surveillance for Elimination or WHO Malariology course. Funding for such training sessions with familiarize the staff members with up-to-date malaria knowledge and latest WHO technical guidance.","2020-12-31",42300]
[null,"Eritrea","Malaria","Vector control","Other vector control measure(s)","In line with the above request, operational cost of larviciding has been included within Allocation Amount partially. However, for the intervention to function optimally and bring about the desired impact, an additional funding of USD 430,000 will be required. This will ensure full coverage of the intervention wherever suitable or relevant. In addition, select health workforce need to be trained on IVM regularly. For this purpose, USD 65,424 will be required to organize the training every other year.","2020-12-31",396979]
[null,"Eritrea","Malaria","Vector control","Other vector control measure(s)","Use of larviciding as supplementary intervention to control malaria vectors at infancy stage is believed to have an impact on reduction of malaria infections. Additional funding of USD 480,000 is being requested for the procurement of biocides (Bti/Bs) at USD160 per sack of 18kgs (1,000 sacks every year). Provision of these biocides and use of chemical larvicides (included within Allocation Amount) is expected to contribute to reducing vector density substantially in areas suitable to execute the intervention and delay emergence of resistance to the larvicide that has been deployed in Eritrea for many years.","2020-12-31",384000]
[null,"Eritrea","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","The above allocation is to enhance the request already made in this funding by mainly increasing case detection through improving the radiological diagnosis of TB by procuring more fixed and mobile digital x-rays and scaling up of Gene/Xperts in the peripheral hospitals in the country over the coming years.","2020-12-31",90406]
[null,"Eritrea","Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","In this section heath care workers working in TB clinics will be trained on comprehensive HIV care and treatment and on HIV counselling and testing skills in order to provide a one-stop service.","2020-12-31",156510]
[null,"Eswatini","Malaria","Case management","Active case detection and investigation (elimination phase)","This investment which includes salaries of (155,674.09) Survey gear (USD 3,104.09) and (USD 6,593.15) communication, will facilitate scale up of the case investigation rate to 48 hours and implement weekend shift patterns. Six more surveillance agents who will be covered by this investment will be absorbed by the government beyond 2020.","2020-12-31",165371]
[null,"Eswatini","TB/HIV","MDR-TB","Community MDR-TB care delivery","Strengthen ambulatory/community MDR-TB care and establish four regional sprinter ambulance costs. The ambulance will include a bed, oxygen cylinder, tubes, masks, stretcher, endotrachial tubes, IVs, cardio resuscitation, drug cabinets, fire extinguisher.","2021-09-30",540000]
[null,"Eswatini","TB/HIV","MDR-TB","Treatment: MDR-TB","Recruitment and retention of two doctors and 4 nurses at regional level, in Shiselweni and Manzini, to support the MSF transition in these areas.","2021-09-30",450486]
[null,"Eswatini","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","Conduct a half day orientation for 1300 head teachers and deputies on the LSE curriculum in primary schools.","2021-09-30",32500]
[null,"Eswatini","TB/HIV","RSSH: Community responses and systems","Community led advocacy","Scale up advocacy for youth friendly ASRHR services especially targeting adolescent & young girls.","2021-09-30",20000]
[null,"Eswatini","TB/HIV","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Support establishment and operationalization of community Maternal Death Surveillance and Response (MDSR) committees, orient communities on MDSR and support the establishment of referral networks between MDSR focal points at community and at health facility level.","2021-09-30",840000]
[null,"Eswatini","TB/HIV","RSSH: Health management information systems and M&E","Administrative and finance data sources","Update and maintain MIS information databank on all social welfare grants and in the future also social work case management. It will allow DPMO to have real-time statistics on social welfare grants, for better evidence-based management and better advocacy for sustained social budgeting. It will also support the matching funds activity to support 1000 AGYW (by year 3) with educational subsidies and other cash plus care models, as prioritized in Swazilands investment case.","2021-09-30",2800000]
[null,"Eswatini","TB/HIV","RSSH: Health management information systems and M&E","Routine reporting","Printing of TB registers to complement the commitment from partners (PEPFAR/CDC) to support the program with this activity.","2021-09-30",128000]
[null,"Eswatini","TB/HIV","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","This funding will be utilised to integrate CMIS with the lab information system (LIS). In addition, funding will go towards training at least 100 health workers on LIS, quality management systems and safety, disease prevention and surveillance. This training will respond to finding from the 2016 Report on Assessment of Quality of Maternal and Neonatal Care in Swaziland. In particular, it will respond to the finding that infection prevention practice of health workers was poor and there was no mechanism to monitor adherence of providers to IP principles in assessed facilities.","2021-09-30",189306]
[null,"Eswatini","TB/HIV","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Additional hardware, software and annual refresher trainings to support extended scale up of the warehouse management system to additional sites.","2021-09-30",1437262]
[null,"Eswatini","TB/HIV","TB care and prevention","Case detection and diagnosis","Increase ACF salaries to enhance motivation and performance.","2021-09-30",40700]
[null,"Eswatini","TB/HIV","TB care and prevention","Treatment","Recruit a clinical psychologist to support the TB program.","2021-09-30",84000]
[null,"Eswatini","TB/HIV","TB/HIV","TB/HIV collaborative interventions","Annual joint TB/HIV planning meetings (2.5 day residential meetings) to ensure greater integration of activities.","2021-09-30",36000]
[null,"Eswatini","TB/HIV","Treatment, care and support","Other intervention(s) for treatment","Additional demand creation for ART among groups with low treatment coverage (i.e. men in their twenties recall Table 3). This will include social marketing through social media, IEC materials, billboards, radio and TVadverts and other communication channels. This may beintegrated with peer-led outreach among other vulnerable groups (i.e. transport operators) and with the TB active case finding.","2021-09-30",205714]
[null,"Eswatini Total",{"$nulls":5},23476459]
[null,"Ethiopia","TB/HIV","TB care and prevention","Community TB care delivery","Community based care has been main strategy to access health services in Ethiopia. 53 NTP has implemented intensified community based interventions in 257 woredas/districts in 15 Zones with low TB case notification, through NFM GF grant incentive funding. Based on 18 months of data, the proportion of health posts implementing full package CBTB care has raised from 30% to 60%, with increased proportion of notified TB cases, in these woredas, by 7-10% of the national average. This above allocation request will expand this initiative to additional low performing and high burden 543 woredas, enabling the program to detect and treat additional 16,709 TB cases over the three years grant period. The packages of CBTB interventions include community based TB symptom screening and referral linkage, contact screening, community based DOT and patient support, tracing LTFU, and strengthening program monitoring and human resource capacity.","2021-06-30",7615756]
[null,"Ethiopia","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","The TB national survey indicates high prevalence among pastoralist communities. Routine program data also shows lower TSR, compared to the national average. Through NFM incentive funding, the country will implement mobile van services in this settings, in the second half of 2017. This above allocation supports an extension of the current mobile van project, targeting all pastoralist communities.","2021-06-30",250000]
[null,"Ethiopia","TB/HIV","Treatment, care and support","Treatment monitoring - Viral load","Out of the estimated cost for viral load testing, 25%, 20% and 15% of the costs for 2018, 2019 and 2020 couldnt be covered within the allocation. Viral load testing is the key intervention of treatment outcome monitoring and to track the progress towards the achievement of the third 90s of the 90-90-90 global targets.","2021-06-30",67934253]
[null,"Gabon","Tuberculosis","TB care and prevention","Treatment","This amount represents the costs to ensure the availability of a safety stock for the first year and the availability of all first-line drugs for the second year. The immediate result is the absence of drug stockouts in the first two years. This will allow the program to make some adjustments to the resources of the state that do not always arrive at the desired time","2021-12-31",175648.08]
[null,"Gambia","Malaria","Case management","Integrated community case management (ICCM)","Integrated Community Case Management of childhood diseases is an integral part of village health Services system. Strengthening iCCM will enhance the childhood disease management at village and community levels, and further improve efficiency in malaria diagnosis and treatment.  Although detecting and treating every case of malaria in communities will be the core architect and guiding principles as the country moves towards malaria elimination, currently there is no strategy to transformed malaria case management into Integrated Community Case Management (iCCM).Both Integrated community case management strategy and guidelines will be developed with reference from the existing Malaria Case Management strategy (MCM) to incorporate and enhance community diagnosis and management of malaria and other childhood diseases.  Under this request, Village Health Workers (VHW) will be trained to conduct reactive and active case detection at community level.  The above allocation request of U$ 749,062 is being made for implementation of the planned introduction of iCCM strategy within the context of the national Primary Health Care structure. The request will cover the following:1. In service training of village health workers on iCCM2. Revise and print iCCM reporting tools3. Print iCCM strategy and guidelines4. Logistics support for supervision at regional level5. Monitoring the iCCM activities by central level UNICEF as a key partner has highighted in its annual Plan Of Action (POA) that the institution will provide non anti malaria medicines for village health services. Further to that, it will provide technical assistance to develop iCCM strategy, guidelines and protocols. In order to initaive discussion on this, NMCP has proposed stakeholders consultative meeting for July, 2018 when partners will meet to discuss the modalities and way forward for start of work on iCCM strategy development.","2021-06-30",749062]
[null,"Gambia","Malaria","Vector control","Indoor residual spraying (IRS)","Indoor Residual Spraying is used as a complementary vector control strategy to mitigate the effects of vector resistance to insecticides. Over the past years, IRS implementation was limited to 2 regions of central river region and upper river region due to funding gap. The 2017 HMIS data have shown regional changes in incidences of malaria where LRR (27/1000 cases) and WR2 (36/1000 cases) have recorded higher incidences compared to other regions. The preliminary results of 2017 MIS have also shown similar trends of parasite prevalence by regions. It has been prioritized for inclusion in the prioritised above allocation request to mitigate effect of insecticide resistance on LLINs in these regions. Therefore, IRS will be scaled up to cover LRR and rural settlements of WR2 using the above allocation request. The request will cover the cost of insecticides, logistics, operational cost and implementation and it amounts to U$1,215,424.  As the Gambia continues to implement IRS in the targeted regions (URR/CRR), and as part of the the two country collaboration clustering of border communities will be conducted to line list villages in the Senegalese side (2 km from the Gambian Border) for posible coverage by the Gambia IRS teams.Insecticide resistance monitoring in the IRS program and LLINs are covered in the program continuation request recently approved.","2021-06-30",1215424]
[null,"Gambia Total",{"$nulls":5},11599559]
[null,"Ghana","Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","This request is to cover 609,393 children under five in the Northern region with SMC from 2018-2020.","2020-12-31",10488896]
[null,"Ghana","TB/HIV","Other module","Other module","Scale up of intensified case finding (ICF) and TB GeneXpert tests are key interventions to identify the missed cases in Ghana. Currently those interventions are limited to 113 districts (of 216 total). This budget will be used to procure 20 additional GeneXpert machines with three years running cost to be deployed in 20 district hospitals. This will increase the geographical coverage of grant intervention sites by 10%. As NTP is applying decentralized ambulatory MDR TB treatment, GeneXpert MTB/RIF test will have vital role in diagnosing drug resistant TB.","2020-12-31",4400000]
[null,"Ghana","TB/HIV","Other module","Other module","The GDHS provides updated estimates on various demographic indices including HIV prevalence among adults. This information is essential for making informed policy decisions and for planning, monitoring and evaluating health programmes and strategies at national and regional levels for improving the health of Ghanas population. This request includes funds to determine HIV prevalence among children under 15 years of age.","2020-12-31",500000]
[null,"Ghana Total",{"$nulls":5},74880314]
[null,"Guatemala","HIV/AIDS","Comprehensive prevention programs for MSM","Condoms and lubricant programming for MSM","5,802,056 condoms to cover 82 percent of the programmatic gap in 2020.","2020-12-31",174062]
[null,"Guatemala","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Condoms and lubricant programming for sex workers","12,951,220 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","2020-12-31",518049]
[null,"Guatemala","HIV/AIDS","Comprehensive prevention programs for TGs","Condoms and lubricant programming for TGs","2,767,550 sachets of lubricant to cover 82 percent of the programmatic gap in 2019.","2020-12-31",110702]
[null,"Guatemala","HIV/AIDS","Comprehensive prevention programs for TGs","HIV testing services for TGs","2,234 HIV tests to cover 100 percent of the programmatic gap in 2020.","2020-12-31",3530]
[null,"Guatemala","HIV/AIDS","PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","IEC actions (information, education and communication) to develop a strategy to promote safe and responsible sexual practices (consultancy fees)Indicators:Reduce the gap of 2016 on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","2020-12-31",20000]
[null,"Guatemala","HIV/AIDS","PMTCT","Prong 3: Preventing vertical HIV transmission","Update and implement protocols, care guides and standards for prenatal monitoring and follow-up of pregnant women with HIV, syphilis and hepatitis B and feeding children exposed to HIV with breast milk substitutes, to children exposed to HIV.Includes funds to print all the updated materials for all services accross the EMTCT care continuumIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","2020-12-31",12784]
[null,"Guatemala","HIV/AIDS","Prevention programs for other vulnerable populations","Diagnosis and treatment of STIs and other sexual health services for other vulnerable populations","(blank)","2020-12-31",500000]
[null,"Guatemala","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Alta Verapaz health area department (planning pending)","2020-12-31",9677.42]
[null,"Guatemala","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Huehuetenango National Hospital (planning pending).","2020-12-31",10775]
[null,"Guatemala","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Coban Regional Hospital, Alta Verapaz. Renovation of a 43.71 m clinic, including: demolishing, dismantling and removing existing sanitary items and prefabricated walls; erecting plasterboard walls; laying granite floor; tiling; installing one metal door, four wooden doors, two windows; installing water and electricity; two washbasins, two toilets; paintwork.","2020-12-31",10000]
[null,"Guatemala","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Coban Health Center, Alta Verapaz. Renovation of a 13.91 m laboratory, including: preliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.","2020-12-31",6000]
[null,"Guatemala","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Coatepeque Hospital, Quetzaltenango. Renovation of 187.20 m facility, including: repairing plasterboard wall; paintwork; replace suspended ceiling and four washbasins; replace two toilets; fitting eight wooden doors; restoring one wooden door and one metal door; fitting an aluminum sliding door, one window; changing the window chain mechanism; installing water and electricity; supplying and installing a 36,000 BTU air conditioning unit; paintwork.","2020-12-31",10775]
[null,"Guatemala","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Pedro de Bethancourt Hospital, Antigua Guatemala. Renovation of a 70.20 m facility, including: preliminary work; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; erecting a plasterboard wall; supplying ceramic flooring; metal structure; suspended ceiling; installing water and electricity; two metal doors, three MDF doors, six windows; pavement and outside steps; paintwork.","2020-12-31",10775]
[null,"Guatemala","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Retalhuleu health area department. Renovation of a 51.53 m facility, including: removing and supplying sliding aluminum door; nine windows; three lights; six power sockets; four fixed furniture units; paintwork; installing an 18,000 BTU air conditioning unit.","2020-12-31",9677.42]
[null,"Guatemala","HIV/AIDS","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Petn Sur health area department (planning pending).","2020-12-31",9677.42]
[null,"Guatemala","Tuberculosis","TB care and prevention","Case detection and diagnosis","Desktop computers.","2022-06-30",3408]
[null,"Guatemala","Tuberculosis","TB/HIV","TB/HIV collaborative interventions","Meetings on the development, approval and dissemination of plans regarding TB/HIV co-infection, to establish implementation approaches at the regional and local levels.","2022-06-30",6814.37]
[null,"Guinea","Malaria","RSSH: Health management information systems and M&E","Long-lasting insecticidal nets (LLIN) - Mass campaign","5. Request for financing to improve the quality of services and data of LLIN mass campaigns in 2019.The MoH is proposing the introduction of new information technologies in the implementation of the 2019 LLIN campaign, building on the successes in The Gambia and Nigeria. It will receive technical assistance from CRS that will accompany the implementation of the pilot phase and the scaling up.","2020-12-31",750000]
[null,"Guinea","Malaria","Vector control","Other vector control measure(s)","7. Request for financing to strengthen the communication and visibility activities of the grant. The amount allocated to budget line 511 in the approved grant needs to be increased to allow the production of media programs. This will require an increase in the number of broadcast and broadcaster media (increase of budget line 666). Budget line 667 also requires the roll out of additional activities.","2020-12-31",475000]
[null,"Guinea","Tuberculosis","Program management","Other program management intervention(s)","Advocacy platform bringing together the TB and HIV programs, the government, elected members, TFPs and representatives from the various sectors; advocacy before the government and the partners in order to mobilise resources and to achieve the adoption of legislation beneficial to the effort to combat tuberculosis.","2020-12-31",6069]
[null,"Guinea","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Extension of the community DOTS into 12 administrative districts, in order to provide coverage in the 33 administrative districts and 2 municipalities of Conakry by 2020, as stated in the NSP.","2020-12-31",922800]
[null,"Guinea","Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","Six-monthly meetings of the national and regional TB/HIV committees; joint, half-yearly supervisory visits.","2020-12-31",34182]
[null,"Guinea-Bissau","Malaria","Other module","Other module","Bridge the funding gap for capacity building activities of MOH. Most of the personnel involved in the NMCP have been newly recruited (since 2016) and are responsible for the various positions within the NMCP, however they have not received any training.","2020-12-31",244858.04]
[null,"Guinea-Bissau","Malaria","Other module","Other module","Malaria Indicator Survey (MIS): This survey, which is carried out once every three years, provides the principal household indicators associated with all of the modules for the malaria control interventions. Bridge funding gap for the MIS 2020. The MIS will include the impact indicators relating to the mass distribution of LLINs, the SMC campaign and case management at community level.","2020-12-31",88039.5]
[null,"Guinea-Bissau","Malaria","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","SMC was initiated in Guinea Bissau in 2016 by the MOH in partnership with MSF, UNDP and AIFO covering 50% of the Bafata Region (7 of 14 ADS = Area de Saud = Health Districts) and 74% of the Gabu region (14 of 19 ADS). Over 85% (37,379 / 43,715) children aged 3-59 months in the 21 ADS received at least 1 dose of SMC. In 2017, SMC was expanded to geographically cover 100% of the 2 high malaria prevalence regions. Over 99% of 83,667 children received at least 1 dose, 82% received 3 doses and 61% of children received 4 doses, with a high level of acceptability and tolerance by the community. WHO recommends an SMC coverage with 3 to 4 doses for an effective impact. It is essential to maintain SMC in these regions to ensure a sustainable impact of the intervention.The operational costs for SMC have been significantly reduced by changing the strategy from Fixed Point to Door to Door. In 2019 and 2020 the MOH has planned the SMC campaigns to be implemented without International NGOs only by regional health departments, further reducing costs. Despite these efforts the country has a gap of 523,683 EUR for SMC operational costs, including UNDP GMS.","2020-12-31",312318]
[null,"Guinea-Bissau","TB/HIV","Other module","Other module","Conduct a Resistance Surveillance Survey (Studying the drug resistance of HIV to ARVs - Estimate the level of primary resistance, classify resistance levels of HIV-1 to ARVs and describe the types of mutations encountered). This study is essential for evaluating the resistance levels of HIV to ARVs, together with the types of mutations. The results of this study will enable better use of ARVs, thereby improving the survival rate for patients.","2020-12-31",23846.93]
[null,"Guinea-Bissau","TB/HIV","Other module","Other module","Update the national list of Generic Essential Medicines. Organize 2 workshops to revise and update the national list of generic essential medicines and the national form of essential medicines in 3 days in 2018 and 2020.","2020-12-31",2596.79]
[null,"Guinea-Bissau","TB/HIV","Program management","Grant management","Equipment (laptop) for the National Secretariat to fight against HIV/AIDS.","2020-12-31",940.41]
[null,"Guinea-Bissau","TB/HIV","RSSH: Health management information systems and M&E","Surveys","Conduct a Tuberculosis Prevalence Survey in Guinea-Bissau. This study will provide the information for this indicator, to be reported as part of the performance framework for this grant.","2020-12-31",1122208.51]
[null,"Guinea-Bissau","TB/HIV","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Thanks to the NFM TB grant, a new TB reference laboratory has been built. In order to render it functional, a negative-pressure system must be installed (to respect the bio-safety norms) and a few other corrections must be made (Mechanical and Civil Budgets costs of NTRL Guinea Bissau, WHO Expert Mission - Appendix B). For this reason, the WHO hired an international expert to perform an evaluation and implementation of his recommendations will require the requested amounts.Once this laboratory is functional, it will be used to perform the necessary exams to fight tuberculosis including the multi-resistant version. The agents will work there under optimum bio-safety conditions.","2020-12-31",743538.91]
[null,"Haiti","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Organise a 2-day workshop to review the PNCM (National Programme for Malaria Control) supervision guideexpected result: the supervision guide is being reviewed to consider systematic integration of on-site data verifications and aspects relating to case management at all levels, including at community level.impact: the programme has quality data on time to guide decision-making.","2020-12-31",2170]
[null,"Haiti","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Organise 40 quarterly meetings to track performance between the 10 departments and healthcare institutions Expected results: These meetings will enable the PNCM and departmental directors to examine and discuss the overall performance of the programme in each department, track indicators, data management and the work plan for quarterly activities. impact: Co-ordinating activities and ensuring that national directives are actually taken into account by departmental actors.","2020-12-31",259664.86]
[null,"Haiti","Malaria","RSSH: Health management information systems and M&E","Program and data quality","Scale up the pilot project to increase epidemiological surveillance of malaria which is being implemented in 116 sites. This scaling up covers purchase of equipment for stratum 3 sites and purchase of equipment to replace 20% of the equipment purchased during the pilot phase.expected result: all sites for epidemiological surveillance in stratum 3 have adequate equipment;impact: data quality is improving significantly, with reporting on time.","2020-12-31",876934]
[null,"Haiti","Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Sign contracts with 17 television stations to broadcast messages to towns bordering areas in stratum 3expected results:  to broadcast messages to towns bordering areas in stratum 3; 2/ populations in towns bordering areas in stratum 3 are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localitiesimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.","2020-12-31",11363]
[null,"Haiti","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Purchase of LLINs for populations in towns bordering areas in stratum 3 (to contain the progression of the endemic near strata which beneficiate from mass campaign). The number of towns concerned is estimated at 23 for a population estimated at about 2,285,101 inhabitants.expected result: 90% of populations living in towns bordering areas in \"red\" stratum 3 will be covered by a LLIN;impact: morbidity in towns bordering areas in \"red\" stratum 3 is halving from one year to the next.","2020-12-31",3850393.5]
[null,"Haiti","TB/HIV","MDR-TB","Case detection and diagnosis: MDR-TB","Direct contacts of MDR-TB patients on treatment are at risk of infection. The WHO recommends that they are monitored periodically for at least two years to track any development of resistant germ tuberculosis-type infection or disease. ASCPs must receive appropriate training so that they can conduct this task correctly.","2020-12-31",9216]
[null,"Haiti","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","The intervention proposed the chance to pursue learning and social integration for OVC and fight structural factors. The 2018-2020 grant will fund 3,400 OVC in 2018, 2,000 in 2019 and 900 in 2020. At $150 per OVC per year, the amount requested will take the level of educational support to OVC to the level of the 2015-2017 grant, guaranteeing the educational costs of 4,520 OVC for the term of the grant.","2020-12-31",198500]
[null,"Haiti","TB/HIV","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","To ensure availability of medicines and quality medical intrants  at all care sites, the DPMMT has adopted a SNADI development plan. One of the plan's priorities is to set up a Logistic Management Computer System (SIGL) for input to ensure unique, rational and transparent management of intrants at all system levels.Activities: Diagnostic study of the Logistic Management Computer System      IT and technical support Trainings  Supervisions   Organisation of a workshop","2020-12-31",280000]
[null,"Haiti","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","TB patients will be screened for diabetes: 35 people from the most frequented DCTs and conversely, screening for tuberculosis in diabetic patients will be systematically conducted by the FHADIMAC (Haitian Foundation for Diabetes and Cardiovascular Diseases) and the 10 departmental hospitals. It will reduce risk factors of diabetes through screening for diabetes amongst TB patients and integrated treatment of patients suffering from this comorbidity.","2020-12-31",60000]
[null,"Haiti","TB/HIV","Treatment, care and support","Engaging all care providers (TB care and prevention)","Rehabilitation of many health sites damaged by Hurricane Matthew in 2016 where patients are seen in the courtyard, and examinations are also conducted outside, in an unventilated room or in a container. In slum areas there are not enough space to receive patients with respiratory diseases without exposing other at-risk patients (child, HIV, diabetic).","2020-12-31",92500]
[null,"Honduras","HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Contracting a coordinator and workers for organizations that intervene in the MSM population","2022-07-31",36196.46]
[null,"Honduras","HIV/AIDS","Comprehensive prevention programs for TGs","Other intervention(s) for TGs","Contracting a coordinator and workers for organizations that intervene in the Trans population","2022-07-31",21326.28]
[null,"Honduras","HIV/AIDS","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Training for health-care personnel that provide services for HIV and STI in penitentiaries centers","2022-07-31",18758]
[null,"Honduras","HIV/AIDS","Program management","Grant management","Monitoring and Evaluation Officer (includes all the benefits)","2022-07-31",118850.91]
[null,"Honduras","Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Improving adherence of hospitalized MDRTB patients who present poor nutritional conditions and with significant weight loss, through food supplements, in order to contribute to the improvement of their health condition and thus decrease the lost to follow-up in this population.","2022-07-31",0.27]
[null,"Honduras","Tuberculosis","TB care and prevention","Community TB care delivery","Activities to increase the participation of community personnel, including midwives and CBOs, in TB prevention and advocacy activities, with the objective of improving detection at community level and timely referral to Health Facilities; and raising awareness among the general population of the importance of their involvement in their own health care.","2022-07-31",42619.17]
[null,"Honduras Total",{"$nulls":5},2353328.3200000003]
[null,"India","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","As per the organisation policy, all new project staff will be trained in Plan International operations at the beginning of the project.","2021-03-31",5664]
[null,"India","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","State based PR staff will be sent to other States to learn and implement EPTCT in their respective regions.","2021-03-31",11327]
[null,"India","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","The project printed and disseminated 4 types of IEC materials which is facilitating the increase om demand for PPTCT within the community and health system. There has been a huge demand for these IEC materials in the field. The project is proposing to print and disseminate the same materials in local languages in 7 new project states.","2021-03-31",60000]
[null,"India","HIV/AIDS","RSSH: Health management information systems and M&E","Program and data quality","This budget is towards addressing the gap for additional ICTCs proposed in the NSP. As a part of integration of MIS systems, moving from manual record maintenance to electronic mode is important. Funds proposed under the above allocation will help further strengthen and fill the need for the balance of ICTC centers that need tablets.","2021-03-31",500000]
[null,"India","HIV/AIDS","RSSH: National health strategies","Other policy and governance intervention(s)","Evidence generation for policy change.","2021-03-31",3000000]
[null,"India","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Alliance India aims to enhance the reach to prioritized PLHIV on ART to be provided with differentiated care and support services by additional 10% each in 1st year, 2nd year and 3rd year of the grant respectively. The differentiated care services provision by these additional CSCs being proposed is to ensure treatment preparedness, side effect management and treatment adherence and retention in HIV care.","2021-03-31",4536602]
[null,"India","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","This conference aims at re-enforcing the commitment towards accomplishing the national strategy of 90:90:90 and sustaining the gains as part of the national health policy. Its al the more pertinent in the wake of HIV bill which has been recently passed by Parliament. It is now to ensure its operationalization towards improving quality of lives of PLHIV.","2021-03-31",16276]
[null,"India","Tuberculosis","MDR-TB","Treatment: MDR-TB","Management of DRTB patients - SLD: An above allocation grant with funding amounting to USD 29.85 million is requested to initiate additional 20,000 MDR-TB patients on treatment.","2021-03-31",29850000]
[null,"India","Tuberculosis","Program management","Other program management intervention(s)","Programme-provided daily FDC will be available for free to patients in private sector. Establishing effective provider/patient linkages will ensure accessibility to those drugs, and increase uptake of free services offered by program.  Additionally, new aspirational \"brand\" would be introduced, promoted, marketed and owned by RNTCP. Experience from large scale social marketing will be leveraged to generate demand and ensure access to quality anti-TB drugs in private sector in line with program recommended regimen. Incentives will be provided to distributors/pharmacies to cover their costs of stocking, distributing and dispensing, and to ensure drugs are dispensed at affordable cost from qualified private retailers.Implementing organizations will use supply chain, retailers and distributors for supplying the socially marketed drugs at the door step of chemists and Private Providers. Request: USD 1.59million for 5 cities.","2021-03-31",1590000]
[null,"India","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Enabler to patient and honorarium to provider through Direct Benefit transfers (DBT) to reduce catastrophic costs and help with capturing notification of all TB cases from the private sector. INR-500/month/patient will be transferred to patient on completion of each month of treatment to cover out-of-pocket expenses and nutritional support. It will be linked with ICT platform to ensure accountability and transparency. Total estimated need is USD 527million. PAAR covers USD 72.39 million (~13%) or 9.55 million patient-months (~1.34m patients). The remaining USD 544.61million USD (87%) would come from domestic resources including 190m from domestic budgetary resources and expected GF supported WB loan-buy-down.","2021-03-31",44257407]
[null,"Indonesia","Malaria","RSSH: Health management information systems and M&E","Surveys","Needed to determine in what limited circumstances MDA may be needed in the final stages of malaria elimination. MDA research will be done in 10 sites, with US$ 50,000 per each site (Total US$ 500,000).","2020-12-31",500000]
[null,"Indonesia","Multi-component","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Expansion of Comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts).","2020-12-31",1563502]
[null,"Indonesia","Multi-component","Comprehensive prevention programs for MSM","Community empowerment for MSM","Expansion of Comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts).","2020-12-31",57652]
[null,"Indonesia","Multi-component","Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","2020-12-31",985773]
[null,"Indonesia","Multi-component","Comprehensive prevention programs for TGs","Community empowerment for TGs","Expansion of Comprehensive program to reach additional 5,250 TG for testing and 756 for treatment.","2020-12-31",88604]
[null,"Indonesia","Multi-component","Program management","Grant management","Cover 72 and 81 priority districts in 2019 and 2020 as addition to the 271 districts covered by allocation. The additional data officer and financial assistant will strengthen the monitoring of the districts.","2020-12-31",1886633]
[null,"Indonesia","Multi-component","Program management","Other program management intervention(s)","(blank)","2020-12-31",301800]
[null,"Indonesia","Multi-component","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Scaling-up ARV Decentralization: sub-national level training, and mentoring & Monitoring ARV Decentralization.","2020-12-31",101957]
[null,"Indonesia","Multi-component","TB care and prevention","Other TB care and prevention intervention(s)","Additional 100 patients per year (the entry and cough surveillance will detect already more cases, about 1,500 cases per year). The mass screening will detect the patients which are missed during routine surveillance). Joint prison TB-HIV planning and ICF workshop at national level for 9 provinces. Joint supervision for TB control implementation in prison by DG of correctional services MoLHR, NTP, and NAP.","2020-12-31",361848]
[null,"Indonesia","Multi-component","TB/HIV","Engaging all care providers (TB/HIV)","Health Provider Training on HIV Testing, Care, Support and Treatment for 243 basic districts.","2020-12-31",147756]
[null,"Indonesia","Multi-component","TB/HIV","Other TB/HIV intervention(s)","Training for 80 districts not supported by CSO intervention. MoH will be responsible to provide training in these districts. The above allocation is requested to finance the setting up or revitalize TB HIV working group at district level not supported by HIV program, while the main allocation is requested to support TB HIV working group in provincial level, which is considered more strategic and cost effective. Transport for case manager to assure TB HIV patient access HIV clinics is included.","2020-12-31",1262018]
[null,"Indonesia","Multi-component","Treatment, care and support","Other intervention(s) for treatment","The additional 8,682 patients above will also receive prevention, diagnosis and treatment of opportunistic infections. Activities include OI and STI drugs procurement, trainings, mentoring session, home-based care of PLHIV.","2020-12-31",775733]
[null,"Jamaica","HIV/AIDS","Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","Based on the Pilot of PrEP being supported under the allocation, scale-up to provide for at least 1500 additional MSM on PrEP by project end.","2021-12-31",172296]
[null,"Jamaica","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Development and roll out of a communication campaign  (including E-posters) in treatment sites to scale up treatment literacy, educate clients on available services and their rights as well as redress opportunities. This will seek to build capacity among KP service users to know their rights and demand quality services, thereby reducing stigma and discrimination in  health facilities.","2021-12-31",250000]
[null,"Jamaica","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Conduct adherence and time use study to inform program planning and improve retention in care among PLHIV .","2021-12-31",75000]
[null,"Jamaica","HIV/AIDS","RSSH: National health strategies","Other policy and governance intervention(s)","Review and update National Health Information System and E-Health Strategic Plan 2014-2018.","2021-12-31",35000]
[null,"Kenya","Malaria","Vector control","Indoor residual spraying (IRS)","This above allocation funding (UQD) aims to support Kenya meet its IRS funding gap. Kenya conducts IRS insecticide resistance management (IRM) using a non-pyrethroid insecticide in counties of the lake endemic zone, where LLINs are distributed and pyrethroid resistance in malaria vectors has been documented. Total requirement for targeted areas is $ 34.2 million and PMI will support $ 21 million (61% of need). The gap of $ 13.2 million (38.6%) is requested through this above allocation request (UQD).","2021-06-30",13220483]
[null,"Kenya","TB/HIV","HIV Testing Services","Differentiated HIV testing services","This above allocation funding (UQD) aims to support quality assurance and systems strengthening to ensure effective HIV Testing Services ( HTS) program. Overall, above allocation funding will procure testing kits to support 7 million tests. The within allocation funding is supporting innovative HTS strategies such as self-testing, assisted partner services and capacity building for service providers as well as procurement of testing kits.","2021-06-30",9611854]
[null,"Kenya","TB/HIV","MDR-TB","Case detection and diagnosis: MDR-TB","This funding (above allocation UQD) aims to improve Lab networking and access to universal DST through procuring larger capacity gene xpert machines for facilities with highest workload/ more than 80% utilization instead of the 4 modular machines; and mobile gene xpert/ omni xpert to increase physical access to xpert. Funding also aims to facilitate trainings to the facilities receiving the new equipment and to procure additional cartridges to ensure availability of cartridges to support utilization of equipment procured. Aditional power inverters to ensure there is no service interruption caused by power outages will also be procured; this is key to improving access to DST.","2021-06-30",9250390]
[null,"Kenya","TB/HIV","RSSH: Health management information systems and M&E","Routine reporting","This above allocation funding (UQD) aims to operationalize infrastructure for electronic medical records in 5 counties and on interoperability of the different Electronic Medical Records/Electronic Health Records (EMRs/EHRs) developed for HIV and TB programmes and development of a health ID policy framework. Within allocation, routine data collection is mainly ensured by the availability of printed M&E tools. This remains a short to medium term strategy since the overall goal is to introduce electronic health systems to enhance efficiency and sustainability.","2021-06-30",4679226]
[null,"Kenya","TB/HIV","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","This above allocation funding (UQD) aims to scale-up the interventions initiated within allocation: strengthening of Ante Natal Care (ANC), Intergated Community Case Management (iCCM), integrated service delivery for infants and young children and postnatal care.","2021-06-30",374870]
[null,"Kenya Total",{"$nulls":5},143012892]
[null,"Korea (Democratic Peoples Republic)","Malaria","Program management","Grant management","These are the Management Cost Recovery costs for PR UNICEF and SR WHO and the associated freight costs for Above allocation prioritised activities.","2021-02-28",211052]
[null,"Korea (Democratic Peoples Republic)","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Provision of LLIN procurement and mass-distribution (2018) with top-up campaigns in 2019/2020 to maximise coverage in and utilisation amongst populations in Stratum 1a villages that did not record cases in the preceding 3 years but are in highly receptive foci. Allocation funding prioritises investment for maximum impact targets the most vulnerable population in Stratum 1a, additional funding will maintain core preventative measures in highly receptive areas which could confer a high risk of malaria resurgence once the operational effectiveness of current LLINs has diminished. Ensuring extended coverage would provide for Universal Access  Coverage  of 90% amongst a wider population denominator and would contribute in reaching or exceeding targets across all 4 Impact Indicators. Funding provides for associated training.","2021-02-28",1582263]
[null,"Korea (Democratic Peoples Republic) Total",{"$nulls":5},15784612]
[null,"Kosovo","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","HIV testing services for PWID","Additional funds for PWID programmes will be used for increasing counselling and testing for HIV, HBV and HCV in NGO centres in Pristina, Prizren and Gjilan.","2020-12-31",148362.70000000001]
[null,"Kosovo","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Given limited amount allocated to HIV prevention services among sex workers in the grant, these additional resources will be used for additional outreach workers and peer educators. It will help to attain targets set.","2020-12-31",10099.879999999999]
[null,"Kosovo","HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Additional funds will be used to support the development of transition plan to absorb HIV human resources-related costs (i.e. staff currently supported by the grant).","2020-12-31",3366.63]
[null,"Kyrgyzstan","Multi-component","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Similarly, to interventions for PWID and SW, the number of outreach workers for the MSM group in the framework of additional funding covers the deficit from 27% in 2018 to 58% of the demand in 2020.As a result, together with the main grant, 65% of MSM will be covered by quality prevention, treatment, care and support services, and 80% of them will be tested for HIV.","2020-12-31",463052]
[null,"Kyrgyzstan","Multi-component","MDR-TB","Community MDR-TB care delivery","Motivation support for patients with both susceptible (2018-2020) and resistant TB forms (2020)","2020-12-31",647677]
[null,"Kyrgyzstan","Multi-component","MDR-TB","Community MDR-TB care delivery","This funding is for procurement and establishing Video-Dot system that promotes patients treatment adherence, reduce the rate of lost to follow up patients","2020-12-31",170000]
[null,"Kyrgyzstan","Multi-component","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","This funding is to support social institutions(7) to provide learning, adherence and psychosocial support for PWID, SWs, MSM, PLHIV, persons released from prisons.","2020-12-31",393750]
[null,"Kyrgyzstan","Multi-component","Program management","Other program management intervention(s)","This is a fixed 7 percent cost. Amount was calculated based on the revised budget. Final amount will be revised based on actual budget allocated.","2020-12-31",608133]
[null,"Kyrgyzstan","Multi-component","RSSH: Health management information systems and M&E","Routine reporting","Development of GX Alert system nationwide to expedite the availability of GeneXpert results for clinicians","2020-12-31",35176]
[null,"Kyrgyzstan","Multi-component","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Trainings on the new clinical protocols, new algorithms for HIV testing, the introduction of new clinical protocols at the PHC level, issues of early detection of HIV infection, decentralization of services and funding based on the MHIF","2020-12-31",50000]
[null,"Kyrgyzstan","Multi-component","TB care and prevention","Case detection and diagnosis","Funding to support the operation and maintenance (recurrent cost) of a new Osh lab expected to be installed in Osh in 2019, with support from USAID Challenge TB project","2020-12-31",148305]
[null,"Kyrgyzstan Total",{"$nulls":5},10066161]
[null,"Lao (Peoples Democratic Republic)","HIV/AIDS","Other module","Other module","Population Mapping, Integrated Bio Behavorial Surveillance (IBBS), research and program design on key populatinos for which data is currently not available or out of date eg - People who Inject Drugs, prisoners and other vulnerable populations. Additional investments are need to improve the ability of the Program to analysis data and strengthen M and E in order to enable timely program decision making.","2020-12-31",536494]
[null,"Lao (Peoples Democratic Republic)","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Extension of MDR-TB wards in 2 provinces (1 unit in Y1 and 2) including intensive cares and equipment for infection control.","2020-12-31",134400]
[null,"Lao (Peoples Democratic Republic)","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Current limitation in access and offer of services by the primary health care network requires reaching more vulnerable and isolated populations by mobile active case finding teams equipped with portables digital X-ray and GeneXpert for using efficient diagnosis algorithm. Provinces and districts health staffs who participated in outreach camps, are aware of local TB epidemics, and learned how to conduct TB screening themselves if provided with portable digital X-ray and technical support at start. 2 additional provincial teams will be established in high TB burden provinces with demonstrated management capacity. Including equipment per team (1 portable digital X-ray system, 1 GeneXpert 4 modules machine, 1 pickup car, 20% PSM). In average, one team in one site (6 days including travel and installation) can screen 600 persons, test 150 presumptive TB patients by Xpert and start on treatment 30 new TB patients (15 bacteriologically confirmed and 15 clinical TB) x 12 sites x 2 teams. Total 720 additional new TB patients each year can be diagnosed and started on treatment, over 10% additional notification of new TB cases above the allocation targets each year in 2018-20.","2020-12-31",149310]
[null,"Lesotho","TB/HIV","MDR-TB","Treatment: MDR-TB","The allocation under NFM2 is $3,838,505 and includes $2,444, 985.00 for SLD and procurement costs $420,059, and one monitoring test for TSH. Other services linked to supervision of patients, transport reimbursements, food packages, hygiene packages and programme administration costs is adequately covered under NFM2. To provide prompt and more effective management of MDR-TB the gap identified is as follows: To assess the success of the all oral shorter regime as per the WHO 2018 Guidelines, operational research will be undertaken. Additional monitoring tests will be undertaken with respect to Hepatis B antigens, haemoglobin A1C to monitor diabetic patients, two Electro- Cardio Gram machine (ECG), electrodes and paper. Reagents are required to perform the first line and second line DST for all eligible patients","2021-06-30",426262]
[null,"Lesotho","TB/HIV","Prevention programs for general population","Male circumcision","Programme data reported a national target of 311,335 men need to be circumcised of which 178,976 men have been medically circumcised. The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) 2017, reported that 30.7% of men between ages of 15-59 are still uncircumcised and 33.8% of HIV positive men between the ages 15-59 are uncircumcised. Furthermore, neonatal circumcisions taking place are minimal.  Although funding under NFM2 was received, the program was besieged by a number of challenges including limited funding under NFM2 to implement the program, high staff turn-over of MOH VMMC trained staff, poor understanding of VMMC by the district health management teams, absence of a core team dedicated for VMMC at the facilities and the suspension of incentives for staff to conduct VMMC. To mitigate these challenges, the GOL will adopt the model implemented by PEPFAR in the lowland districts which is reported to be successful with the uptake of VMMC. The annual target for VMMC is 50,000 which will be adequately covered for 2019/2020 by NFM2 (14,000) and PEPFAR (36,000). The gap identified is for 2020/2021 as PEPFAR will support 30,000 circumcisions leaving a gap of 20,000.  To address this gap following is proposed:  Health facility capacity  o VMMC core team located at each of the 8 health facilities in the 5 districts, made up of 3 nurses and 1 counsellor and cleanero VMMC site assessments conducted at identified health facilities to ensure the minimum required standards for VMMC are met. o Recruitment and training of new clinical staff and refresher courses for existing staff o Recruitment and training of community health advocates including traditional chiefs, traditional initiators, councillors and religious leaders Advocacy and Demand Creation o Advocacy initiatives to be implemented with key stakeholders at national level, VMMC stakeholder: parliamentarians (HIV Cluster), government line ministries, NAC, Religious bodies and Civil Society Organisations for ownership o Orientation of health facility staff (hospitals and health centres) on VMMC, communication skills, differentiated approaches to HTS and linkage to other serviceso Mobilisation campaigns and sensitisation sessions in communities through door to door campaigns, school visits, meetings of traditional leaders, distribution of promotional packages to targeted community groups and at service delivery points o Use of media platforms to promote VMMC  M&E and Research - For monitoring, evaluation and research and to manage the data, human resources will be required for VMMC administrative assistants and to conduct operational research","2021-06-30",2800000]
[null,"Lesotho","TB/HIV","Prevention programs for general population","Other intervention(s) for general population","The funding will support adherence and economic empowerment through support groups to overcome the suboptimal retention level. 31 support groups comprising 620 members are expected to be trained on various livelihood options, such as voluntary savings, loans and access to microfinance, in three high burden districts. The activity will be partially funded through the reinvestment of the efficiencies identified during the grant making.","2021-06-30",307323]
[null,"Lesotho","TB/HIV","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Based on the observation study currently rolled out, increased monitoring and management of patients with adverse side effects is required. Furthermore, an opportunity for the decentralisation of MDR-TB services is presented with the use of all oral medications. To increase monitoring and management of patients with adverse side effects, and decentralise the MDR-TB services, the following gaps need to be addressed: Two additional physicians to facilitate accurate diagnosis and follow up at district level as well training, mentorship and supervision of district teams.  Four registered nurses are needed for the intensive clinical care for those admitted and ambulatory patients.  To closely monitor, document and report as well as provide expert interventions to address the adverse effects. two pharmacy technicians and one pharmacist are needed The key outcome of increasing the human resource capacity will be:  Increased community implementation and providing support and case management to remote districts.  Increased number of treatment initiation sites and strengthening treatment literacy.  Sustainability as the doctors (especially Basotho doctors for sustainability) at district level will be trained to build a team of experts who can continue the management or even the PMDT in a sustainable manner.The use of all oral medications is an opportunity to further decentralize MDR services having removed the complicated aspect of treatment of administering the injectable. The very clinicians and nurses will serve as resource persons for the envisaged consillium aimed at providing remote support to districts as they manage the cases. It means that it will be feasible to increase initiation sites and treatment literacy strengthened through additional pharmacist and Pharmacy Technicians","2021-06-30",560840]
[null,"Liberia","Malaria","Case management","Facility-based treatment","The request amount is intended to improve targeted health facilities for better provision of malaria, HIV and TB services aimed at improving maternal and child health services for increased mother and child survival. Adopting a facility shall include the provision of relevant equipment as per targeted health facility type, upgrading some existing health facility for improved capacity, strengthen emergency, preparedness and response.","2021-06-30",1482080]
[null,"Liberia","Malaria","Case management","Private sector case management","Quarterly Feedback Meeting PSACT implementation together to provide feedback about the program. The meeting will seek to understand the impression of the proprietors of the program and get feedback on the community reaction to the testing and treatment as well as the overall program. Also the forum will be used to provide feedback to proprietors on their performance and adherence to the program rules as well as recognize best practice pharmaceutical outlets to engender competition among the proprietors. The forum will also be used to identify pharmaceutical outlets that are noncompliant and depending on the degree of noncompliance inform them on the actions that will be taken on the non-compliant proprietor. This will further improve the quality of the PSACT program.","2021-06-30",40000]
[null,"Liberia","Malaria","Program management","Grant management","This covers program HR cost for the PR including salaries & benefits working on or supporting the program management and implementation.  This is for implementing in additional 2 districts in Margibi and gap in Lofa - 3 existing GF supported districts (2 M & E Officers for Margibi  - 1 & Lofa - 1)","2021-06-30",1711101]
[null,"Liberia","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The vehicles and motorbikes, being requested, will support quarterly field visits, Joint Support Supervisions, Last Mile Delivery of commodities, Surveys, etc... The benefits of the planned procurement are: i. To increase the number of vehicles, thus assisting the PR to improve its programmatic performance; ii. Supporting the PR in reducing the cost of vehicle rental, thus allowing unspent funds to be reprogrammed for service delivery activities. iii. Improved operational efficiency, through the replacement of vehicles which have already be retained longer than the five years period.   Currently, there are limited number of vehicles to conduct program activities and the PR has to rent additional vehicles to support program activities. An analysis was done which demonstrates that procuring the vehicles represents better value for money than rental in the current vehicle market. The rationale to buy vs renting is entirely to ensure value for money and long term sustainability.","2021-06-30",704110]
[null,"Liberia","Malaria","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","The matching funds requested to support integrated service delivery, seek to focus on investments in the platform for serviced delivery and strengthening clinical systems for integrated screening, diagnosis, and care, in-service skills building of clinicians to be able to deliver both TB and HIV services including management of late-stage HIV infection, and capacitating the community platform for support of TB treatment adherence and HIV supportive care.  The proposed site for initial intervention through matching fund investments is Liberias national referral facility for TB  The TB Annex, based in Monrovia. As the countrys national referral center for TB services, all forms of TB including management of TB and co-morbidities like diabetes, DR-TB, and TB/HIV co-infection are managed at the facility, where integrated service delivery can serve as a model to further scale this approach at all levels from primary care through hospital-based treatment, at the county and regional levels.","2021-06-30",742905]
[null,"Liberia","Malaria","RSSH: Integrated service delivery and quality improvement","Supportive policy and programmatic environment","County level capacity building in all counties, minus the 4 counties in the South Eastern region where UNICEF is already providing capacity building.  The capacity building efforts will be led by specialists in the field for CHTs that require capacity building. Exact details of capacity building will be finalized once capacity assessments are be completed.","2021-06-30",2323861]
[null,"Liberia","Malaria","RSSH: Integrated service delivery and quality improvement","Supportive policy and programmatic environment","This activity provides dedicated management support to the CHSD (Community health services division) via an international TA which would work together with CHSD on topics such as: NCHA program financing sustainability, resource mapping and coordination, NCHA program management.","2021-06-30",144000]
[null,"Liberia","Malaria","RSSH: Integrated service delivery and quality improvement","Supportive policy and programmatic environment","Of the countrys total population of 4,148.567, Montserrado County accounts for 1,362,395 approximately 65% of Liberias entire population for FY 2017/2018 with a projected annual growth rate of 2.1%.  The MOH plans to contract-in with the Montserrado County Health Team to implement a differentiated service delivery approach to provide HIV, TB and Malaria prevention, care, and treatment service. With differentiated care, stable patients may receive key services in a community setting rather than in health facilities, enabling them to make less frequent visits to clinics and pharmacies. In addition to streamlining their care and making it more convenient, this approach will allow health workers to spend more time with less stable patients and those with advanced disease, increasing efficiency and improving quality of care. Services will be tailored for other groups with diverse needs, such as adolescents and young people, pregnant and breast-feeding women, mobile and migrant populations, and others. The goal is to place the client at the center of service delivery while maximizing health system efficiency.The expected outcomes will be a marked reduction in overcrowding at health facilities, reduction in wait times for patients, reduction in workload for clinicians, improvement in program quality such as increased retention rates, overall satisfactory patient outcome and public health goal, and improved supply chain performance.","2021-06-30",1060304]
[null,"Liberia","TB/HIV","MDR-TB","Other MDR-TB intervention(s)","The supply of drugs, lab consumables and reagents for culture and DST and AFB microscopy and PSM cost for year 3. A year Technical Assistance for decentralization of services, assessment, and training on Infection Control. Though these interventions are priorities for the program, they are placed in PAAR due to limited funding within allocation. This intervention also complements the investment within allocation for this module.","2020-12-31",350000.57]
[null,"Liberia","TB/HIV","Prevention programs for general population","Other intervention(s) for general population","Currently condoms are provided by partners and this contribution may not continue beyond 2017. This cause is placed under PAAR to ensure no stock out of condoms in the country in the event that the current partner supply is discontinued beyond 2017.","2020-12-31",1685586]
[null,"Liberia","TB/HIV","Program management","Other program management intervention(s)","Ensuring quality programing in challenging operating environment where skills are limited and chances of frauds and wrongdoing are high, requires a high-quality response and management. It has not been easy to establish a key population friendly program in  Liberia given the environment of phobia, stigma and discrimination and criminalization. There are challenges of finding adequate staff, infrastructure (rental spaces), human resources and security to implement key population program. It is important that the program delivers the intended results in a timely and quality manner. Adequate staff and infrastructure is required for the same. In the current allocationa limited amount is available to manage theprograms specially for the civil society PR. This request is to ensure adequate management support to deliver a high quality program in a scaled up fashion. The key population program was initiated only in second half of 2016. It is requested that adequate program management support is provided scaling and delivering tangible results. The support requested is as follows: a. Grant management and office running costs including but not limited to: Office security, legal counsel, annual external and internal audit, office equipment, communication and internet, fuel for vehicles and generator, maintenance of office equipment and vehicles, office equipment and rent, vehicle insurance. Amount requested is USD 1,448,771 b. Staff training on finance and technical issues: Such  opportunities allow PSI staff to ensure the highest quality of technical and financial/administrative management of the project by allowing them remain on the cutting-edge as regards technical issues, new policies and procedures, as well as attend trainings to enhance their own skills in technical and programmatic areas, including new prevention technologies like self-testing, PrEP, and other such innovations. The amount requested is USD 86,938 Human Resource: The current allocation does not provide enough to over the following positions that are required to deliver the program: Country Representative, Grants and Contracts Manager, Program Director, Internal Auditor (in country), M&E manager, Finance manager, M&E officer, Finance Coordinator, warehouse manager, drivers and similar positions. These positions have proven themselves crucial in the current grant to ensure technical quality and oversight, financial and administrative compliance, and fraud management and prevention; the program would be impossible to implement without them. Some of the common cost positions and other positions will be phased out as the program scales down for general population. The total amount requested is USD 2,365,724.","2020-12-31",1300477]
[null,"Madagascar","HIV/AIDS","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","This refers to consultancy costs for supervising activities carried out by peer educators for the HIV program.  The request includes: running advocacy workshops, training and capacity building for outreach workers (peer educators or their supervisors), a midterm evaluation and a final evaluation of the pilot scheme.","2020-12-31",5943]
[null,"Madagascar","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","This refers to packaging production costs for condoms for social marketing (Yes and Protector Plus).","2020-12-31",74995]
[null,"Madagascar","HIV/AIDS","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","The allocation amount covers 73 per cent of needs for BCC among young people in or out of school to mobilize demand for counseling and testing services. This funding would cover the remaining 23 per cent, representing awareness-raising for 490,402 young people. This would enable the country to achieve its goal of providing awareness-raising to a total of 1,816,303 young people by the end of the three years, including an increase in the number of young people covered, to meet the targets for BCC and testing.  Also included will be periodic events to identify young people and provide outreach and mobile testing, develop teaching kits for awareness-raising activities, reproduce testing referral slips and refer positive case.","2020-12-31",541494]
[null,"Madagascar","HIV/AIDS","Prevention programs for adolescents and youth, in and out of school","HIV testing services for adolescents and youth, in and out of school","This refers to costs for piloting the new prevention strategy on community rapid diagnostic tests (TROD) to accelerate the response.The request includes:- running workshops on advocacy and for updating the screening protocol;- running training and capacity building for outreach workers (peer educators or their supervisors);- implementation at pilot sites;- supervision and quality control of service provision;- midterm evaluation and final evaluation of the pilot scheme;- study trip on TROD. The country will pilot the new strategy under this additional funding.","2020-12-31",465029]
[null,"Madagascar","HIV/AIDS","Program management","Grant management","This will cover a proportion of the running costs and human resources of the PR and the SRs implementing the grant. The allocation amount is not sufficient to cover the direct costs of managing the grant over the three years. This would also cover supervision of the SRs by the PR (Finance team), to support the SRs and implementation teams on the ground and ensure good mastery and understanding of the finance component down to the community level.","2020-12-31",378071]
[null,"Madagascar","HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","The activity involves strengthening the managerial capacity of the team coordinating the HIV/AIDS control program. Training is conducted annually, either locally or externally.The topics cover various areas, such as programming, finance, monitoring and evaluation, and PSM.The activity costs cover travel costs, registration fees and allowances.","2020-12-31",15033]
[null,"Madagascar","HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","This activity involves holding an annual meeting to draft the DLIS work plan, to act as a dashboard for all stakeholders in the response. This workshop will be attended by partners and regional teams.The costs of holding the meeting cover transport, allowances, room hire, stationery, coffee breaks and organizational costs.","2020-12-31",12268]
[null,"Madagascar","HIV/AIDS","RSSH: Health management information systems and M&E","Analysis, review and transparency","This is already a very popular topic on the global stage, especially in the context of demedicalized screening. The technicians would like to receive training on this topic in countries with prior experience.  This would be an exchange trip on the topic of demedicalized screening, with countries advanced in using a community approach to control HIV/AIDS.The activity costs cover travel and allowances.","2020-12-31",16047]
[null,"Madagascar","HIV/AIDS","RSSH: Health management information systems and M&E","Routine reporting","Given the poor quality and inconsistency of data, and the stock-outs of supplies, it is essential that managers receive training in monitoring and evaluation. This training should also improve the completeness of reports.","2020-12-31",7345]
[null,"Madagascar","HIV/AIDS","Treatment, care and support","HIV care","This refers to the procurement of laboratory supplies (biochemistry and hematology). This purchasing was originally planned under health systems strengthening (HSS), but had to be omitted following the prioritization of activities and also due to lack of funding.","2020-12-31",869057]
[null,"Madagascar","Malaria","Case management","Therapeutic efficacy surveillance","Long-term surveillance of the therapeutic efficacy of antimalarial drugs is one of the objectives of the NSP and should provide annual data on any potential therapeutic failures that could result in a resurgence of malaria. This amount will help to maintain surveillance during the final two years of the grant. In 2018, it will be implemented with funding from the Presidents Malaria Initiative (PMI).","2021-06-30",289892]
[null,"Madagascar","Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Improved IPT coverage, will be implemented in all health care facilities.  This above allocation request will therefore allow the continued provision of sulfadoxine-pyrimethamine (SP) in 2021. This intervention will help achieve the NSP target to protect at least 80 percent of women through IPT, and to reduce the risk of low birth weight by approximately 21 percent and neonatal mortality by 61 percent.","2021-06-30",1074953]
[null,"Malawi","Malaria","Case management","Integrated community case management (ICCM)","In order to improve competences of the HSAs manning village clinics, the programme will continue to conduct quarterly supportive supervision and mentorship on case management at Community level (iCCM supervision & mentorship).","2020-12-31",80000]
[null,"Malawi","Malaria","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Additional funding is being requested for 2020 to ensure that the key SBCC activities are maintained in order to ensure maintained uptake and utilization of the malaria interventions implemented during this period. Specifically, this will include the following activities: Support National Malaria Commemorative Days(SADC Week and World Malaria Day); Identify and orient media team on emerging issues, successes and challenges in malaria programming; Document malaria success stories through Media visits to different communities; Conduct School Based Malaria Awareness Campaign; Conduct training of Primary Teachers as Malaria School Patrons/Matrons; Conduct Community Meetings with Malaria Champions; Conduct malaria information dissemination sessions (malaria open days and community dialogues). Train Community Structures (CLANS) in Care Group Model for dissemination of Malaria messages.","2020-12-31",1580592]
[null,"Malawi","Malaria","Specific prevention interventions (SPI)","Other specific prevention intervention(s)","To ensure GF and development partner supported efforts in 2018 and 2019 towards increase of ANC uptake of at least three doses of IPTp from 12% in 2014 (MIS) to 60% by 2022 through supportive supervision this request is for continued funding in 2020.","2020-12-31",46395]
[null,"Malawi","TB/HIV","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Drop-in centers for MSM ($1.08M) Establish one drop-in center per district to facilitate provision and linkages of non-biomedical and biomedical services.","2020-12-31",1080000]
[null,"Malawi","TB/HIV","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Expanding MSM programming to additional districts ($1.11M) Expansion of MSM programming to 4 additional priority districts, including enhanced linkage to care and drop-in centers.","2020-12-31",1110000]
[null,"Malawi","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","FSW coordination structure and CRS activities ($0.31M) Activities include standardizing the budget and introducing stronger coordination structures for FSW activities across districts, development and stakeholder review of tools, policy briefs and guidelines for advocacy on human rights, gender, access to services and legal environment, review meetings on laws with punitive effects on KPs and orientation of law enforcers and HCWs.","2020-12-31",310000]
[null,"Malawi","TB/HIV","HIV Testing Services","Differentiated HIV testing services","HTS trainings ($6.20M) Covers half of the need for skills intensive training. Also covers in full: 1) trainings to allow expansion of HDAs to non-PEPFAR-supported facilities. HDAs have proven instrumental in expansion of HTS for reaching 1st 90; 2) orientation in Bioline rapid test kit. This has been endorsed as the first test in the national HIV testing algorithm; 3) district quarterly reviews; and 4) district mentorship.","2020-12-31",3812724.61]
[null,"Malawi","TB/HIV","MDR-TB","Treatment: MDR-TB","MDR-TB Treatment (USD 977,066): This line item will cover treatment costs for an additional 102 MDR/RR-TB cases, including drugs and ancillary medicines, nutritional supplements, and social support for patients. Through above allocation, the MDR-TB CDR will increase to 50% of the estimated country need (85% of the NSP target), reaching 95% of expected re-treatment cases. Additionally, with the phased roll out of shorter treatment regimen elaborated in the MDR-TB within allocation request, the above allocation request includes necessary equipment investments, such as 10 of each of the following HumaLyte Plus 5, Chemistry Analyzer, Hormonal Assay, ECG, ECHO, and CBC machines, as well as respective reagents.","2020-12-31",977066]
[null,"Malawi","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Double investment for school-based RFHS referral agents ($0.33M) Catalytic funding will allow initial roll out of 400 referral agents. Above allocation funding will provide sufficient funding for an additional 400 (800 total).","2020-12-31",330000]
[null,"Malawi","TB/HIV","Program management","Policy, planning, coordination and management of national disease control programs","The activities within this module are linked to the HSSPII objective to generate quality information, and increase quality information accessibility to all intended users for evidence-based decision-making, through standardized and harmonized tools that avoids duplication across all programmes. These activities encourage the adoption of ICT systems for routine data management including data collection, data analysis, use and dissemination. These activities include procurement of IT equipment for all levels, and procurement of 10 vehicles to support programme implementation. Funding Request: Tailored to Material Change 15 December 2016 39 An inventory of all vehicles has been created and priority will be given to those government departments who have critical supervision/audit responsibilities A pooled system is in force at Headquarters level.","2020-12-31",471949.68]
[null,"Malawi","TB/HIV","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Survey, analysis, review and transparency (USD 2,175,000) Building upon M&E activities in the within allocation request, this line item will expand TB M&E activities to include conducting: 1) a national TB prevalence study in 2020 to update current prevalence estimate from the 2014 TB Prevalence Survey, 2) routine operational research on new intervention areas implemented through this FR, in order to provide real-time learning, 3) routine and end-line program and epidemiological reviews, and 4) WHO Standards and Checklist for TB Surveillance and Vital Registration System. Prevalence data are now 5-years old and therefore there is an urgent need of updating data through a new prevalence survey in 2020. Overall, the development of robust M&E systems will contribute to more granular data, which can allow for programme strengthening both in the long-run and course correction for identified problems during grant implementation. Access to such real-time data would allow for better geographic and/or facility prioritization of activities, better data Funding Request: Tailored to Material Change 15 December 2016 35 sharing with districts and facilities to monitor sub-national targets for case detection or treatment outcomes, and deployment of intensified support and supervision based on data to identify poorperforming facilities.","2020-12-31",1975000]
[null,"Malawi","TB/HIV","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","These activities build on the activities within allocation in that once hired, health care workers require routine trainings and opportunities for specialization given Malawis needs. These activities are expected to improve overall quality of care and health care worker capacity. Specific activities included in this intervention: ? Continuous professional development ? Specialization courses ? Trainings ? Upgrading.","2020-12-31",271252]
[null,"Malawi","TB/HIV","TB care and prevention","Case detection and diagnosis","TB Case Detection Diagnosis and Treatment (USD 620,280): Building on TB treatment targets within allocation, this line item would support case detection and treatment of an additional 9,784 TB patients. This additional coverage will increase the case detection rate from 60%, 63% and 65% in Y1, Y2, and Y3, to 70%, 70% and 75%, respectively, over three years, leading to the full achievement of the NSP target. These additional 9,784 cases will be detected and diagnosed through a combination of the scale-up strategies outlined in line items 2, and 3, whereby: a) additional private for-profit facilities will be engaged, contributing a projected 7% of TB cases notified; and b) additional CSCPs will be established in rural areas contributing an additional 4% of TB cases notified. Additional funds will be applied to screening all HCWs and testing approximately 900 annually, assuming 6% of all HCWs screen positive.","2020-12-31",403140]
[null,"Malawi","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","Key Affected Populations (USD 300,000): The usefulness of digital chest X-rays for screening and diagnosis of TB is considerably limited by lack of trained healthcare workers. Computer-aided detection (CAD) programs constitute a viable alternative, and initial studies have indicated that CAD programs have potential high sensitivity.31,32 CAD is particularly useful in high volume screening settings, such as OPD in high burden hospitals. While digital X-rays have been procured through the NFM grant, complementing them with CAD will enhance their effectiveness. This line item will cover the cost of procurement and utilization of CAD software for TB diagnosis, in particular concentrating on screening urban poor populations in high volume sites, complementing the within allocation strategy for reaching this high risk group by improving standardization, sensitivity and speed of diagnosis. Utilization of CAD will also contribute to the generating evidence on this innovative technology, to inform policy on usage in resource constrained settings with high TB burden. Finally, imaging generated by CAD can be repurposed for teaching in health colleges.","2020-12-31",250000]
[null,"Malawi","TB/HIV","Treatment, care and support","Prevention, diagnosis and treatment of opportunistic infections","Funds to support switching from single dose to fixed dose ($11.66M) The program has prioritized implementation of Isoniazid Preventive Therapy in the five districts with highest TB prevalence. The FR includes a request for separate formulations of Co-trimoxazole, Isoniazid and Pyridoxine. This will increase the pill burden for the patients hence the request for additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine as per MOH Clinical guidelines. The fixed dose combination will be given to 40% of the ART patient cohort. Additional funds to support switching from separate doses of IPT, CPT and Pyridoxine to fixed dose combination IPT/CPT/Pyridoxine per MOH policy.","2020-12-31",6155659]
[null,"Malawi","TB/HIV","Treatment, care and support","Treatment monitoring - Viral load","Point of care for VL/EID ($7.62M) Point of Care is critical for patient monitoring and early provision of lifesaving interventions The Ministry of Health with support from CHAI conducted a POC mapping and identified 99 Health facilities that would benefit from Point of Care for VL/EID. High volume sites will be considered for deployment of POC, because of availability of infrastructure and linkage to care for higher throughput. This will enable providers make timely clinical decisions to switch failing patients to second/third line ART. This request will enable the Ministry of Health to procure an additional 15 platforms and procure 50,000 viral load tests and 15,000 EID tests. This will complement existing POC investments available in country including funding from UNITAID for 2017 to 2019.","2020-12-31",3945502.01]
[null,"Mauritania","HIV/AIDS","Comprehensive prevention programs for MSM","Interventions for young men who have sex with men","Contracting 1 NGO for managing and monitoring the activities carried out by CSOs and MSM outreach workers The PAAR amount will allow for the extension to 3 other regions from year 2 for greater geographical coverage of the interventions and requiring the recruitment of an additional NGO to guarantee the quality of the interventions by the community outreach workers.","2021-12-31",35657]
[null,"Mauritania","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","Covering the school costs of 280 infected and affected children with the aim of improving patient retention (39%) and decreasing patients abandoning treatment (50.8%). This strategy has shown its merit in the past and has made it possible to achieve a good level of treatment adherence among PLHIV. The recipients of this coverage are selected through a committee, which includes PLHIV, the NACP, the NESAC and representatives of the OTC and the CUs.","2021-12-31",247200]
[null,"Mauritania","HIV/AIDS","Treatment, care and support","Treatment adherence","IGA feasibility study for PLHIV: Ensuring the independence of PLHIV requires the creation of conditions that enable them to provide for their health needs and to cover a certain cost linked to ARV treatment. Experiments have been carried out through IGAs, but they have not been documented. This request in the above allocation amount will make it possible to conduct a feasibility study and provide the country with clarity regarding the effectiveness of this strategy.","2021-12-31",7540]
[null,"Mauritania","Malaria","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","In order to implement this intervention, guidelines and handbooks will be drawn up, training will take place and agents will be provided with medicines. Annual assessment of operations will be carried out.","2021-12-31",2463468]
[null,"Mauritania","Tuberculosis","MDR-TB","Prevention for MDR-TB","It has been proposed to provide for the managers of the TTCs as part of this request and in order to build on the progress made under the grant currently being implemented. This also takes the programmatic gaps into account and will make it possible to achieve the greatest impact on expanding access to effective tuberculosis diagnosis and treatment by reducing the incidence of the disease among the population.","2021-12-31",156494]
[null,"Mauritania","Tuberculosis","TB care and prevention","Case detection and diagnosis","Screening activities for the key populations will make it possible/will continue to achieve the objectives of the End TB Strategy, in particular the search for subjects having had contact with contagious cases, children under 5 years of age, PLHIV, refugees, nomads, prisoners, diabetics, miners and the populations of the shanty towns in large cities. There are plans to open 5 new TTCs and to renovate 5 other TTCs to broaden access to diagnosis and to improve health care and the training of personnel.","2021-12-31",415730]
[null,"Mauritius","HIV/AIDS","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","This request is to cover the coverage gap in the current allocation for the CSW population and their clients. This is the second major driver of the epidemic in Mauritius and provides a bridge to the larger population which if not addressed could reverse the gains made to date. Note that Mauritius is a tourist country and remains vulnerable through this bridge population.","2020-12-31",853740]
[null,"Mauritius Total",{"$nulls":5},2432928]
[null,"Moldova","HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","This activity greatly improves the relationship between LGBT and their parents and contributes to parental support by reducing their stigmatization and helping to reduce the spread of HIV / STIs among LGBT people. Inthese activities, parents have the opportunity to discuss common problems encountered and how to solve them. The main purpose of working with parents is to create an active group of LGBT parents who support their children.","2020-12-31",13377.85]
[null,"Moldova","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","The OST services in Moldova are notcovering the whole countryand takinginto consideration the new planned sites, the new specialists to be involved it is very important to ensure with a minimum a training per year for existing and new staff to ensure quality service provision and minimal standards of services.","2020-12-31",12565.37]
[null,"Moldova","HIV/AIDS","Program management","Other program management intervention(s)","In order to assess the existing NAP, the achieved targets and the existinginterventions and formulate proposals for improvement it is important to have aninternational technical assistance.","2020-12-31",56110.43]
[null,"Moldova","HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","To continue the development of the roles and capacity of key affected populations and communities and to ensure the good quality of services provision and in organizing the advocacy activitites, communications, social mobilization, etc it is important to have at list two training per year for civil society representatives and KAP organizations.","2020-12-31",12565.37]
[null,"Moldova","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","In April 2017 the Ministry of Health has adopted a roadmap to modernize the TB service through people-centered model of TB care. In this context there is a need to increase communities support and to decrease stigma toward people with TB in the communities. This above allocation budget will support broadcasting audio and video materials on the local and national TV and radio spots.","2020-12-31",67332.509999999995]
[null,"Moldova","Tuberculosis","Program management","Other program management intervention(s)","Regular central and regional (in Transnistria) supervision visits will be conducted by the NTP teams to TB service and PHC facilities at the district level.  These visits will cover case detection, laboratory diagnosis, treatment and patient support, TB/HIV collaboration, etc. The supervision will focus on service interactions in ambulatory management of TB cases and local partnerships for provision of adherence support and community involvement.","2020-12-31",22348.5]
[null,"Moldova","Tuberculosis","Program management","Other program management intervention(s)","To support realization of the three operation researches realized by PI Institute of Phthysio-pneumology Chiril Draganiuc in 2019-2020. It will look into the issues of TB control activities in country and aim to: \"Evaluate resistance to new anti-TB drugs in Moldova\", \"MDR-TB at children in Moldova\" and \"Minimal inhibitory concentration of the anti-TB drugs\". The results should help to update treatment guidelines and national protocols using evidence-based data.","2020-12-31",89451.24]
[null,"Mongolia","Tuberculosis","MDR-TB","Treatment: MDR-TB","Mongolian government gives full support for the first line drugs. Within this proposal, the case detection will be increased to 65% in 2020, which will require more funds for the drugs. As the country faces increasing number of patients with PDR (on average, 400 cases/year; 1.5 times higher than MDR-TB cases), government funds may not be sufficient to meet the demand.","2020-12-31",183895]
[null,"Montenegro","HIV/AIDS","Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","Preparing the methodology and piloting PrEP and PeP programs among MSM. As a result, the growth of HIV epidemics among MSM is expected to decrease.","2021-12-31",44888.34]
[null,"Montenegro","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","In case of secured funding, the second bio-behavioural survey (BBS) will be implemented in 2020 in prisons. The first and the only BBS was implemented by the Institute of Public Health in March 2012. Results of the new survey will be compared with the one from 2012.","2021-12-31",107.17]
[null,"Montenegro","HIV/AIDS","Treatment, care and support","HIV care","Purchase bronchoscopy machine for the Infectious Disease Clinic (IDC). Currently available machine is at the Clinical Center which is highly overused. PLHIV are forced to wait treatment for months. The expected outcome is reaching the set targets with a greater reach of the PLHIV, better service and decreasing stigma and discrimination. This would enable PLHIV to access complete diagnostics at one place.","2021-12-31",3366.63]
[null,"Montenegro","HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Purchase of one CD4 counter for the Infectious Disease Clinic (IDC) which is a front line to help PLHIV. The expected outcome is contributing to reaching the set targets and indicators. The expected impact is greater reach of the PLHIV and greater service delivery, and decreased level of stigma and discrimination towards this population.","2021-12-31",3366.63]
[null,"Morocco","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Implement the eMTCT certification process.","2020-12-31",42601.279999999999]
[null,"Morocco","HIV/AIDS","RSSH: Health management information systems and M&E","Analysis, review and transparency","Regional NSP workshop; NSP review; production of national reports; situational study on disabled peoples vulnerability to HIV and STIs; socioeconomic study on PLHIV, SWs, MSM and people who inject drugs; annual program and financial audits of NSP implementation; supervision of above allocation activities; qualitative situational study on the vulnerability of street children; procurement of equipment and IT services for health centers and community centers.","2020-12-31",445736.73]
[null,"Morocco","Tuberculosis","RSSH: Community responses and systems","Other community responses and systems intervention(s)","The NSP adopts a human-rights based approach to TBrelated stigma and discrimination and to equitable access to TB control services. A workshop will be held to determine the corresponding intervention pathways and to develop a strategy document (activity 4.8.1), and 500 copies of this document will be printed (activity 4.8.2). This document will be used to produce TB and human rights information and awareness-raising documents for health workers (sub-sub-activity 4.8.4.1.2), directors and managers of industrial, commercial and other companies (sub-sub-activity 4.8.4.2.2), and primary school, secondary school and college teaching staff (sub-subactivity 4.8.4.3.2).","2020-12-31",28193.25]
[null,"Morocco","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","TB incidence is considerably higher in cities than elsewhere, with some urban prefectures seeing notification rates in excess of 170 cases per 100,000 population and some urban constituencies recording figures in excess of 250 per 100,000 population. There are plans to hold a meeting to discuss how to adapt TB control activities to large urban areas (activity 1.7.1). After this meeting, a framework document will be produced (activity 1.7.2) and printed (activity 1.7.3). The document will be used at four training workshops for medical and paramedical managers at CDTMRs in the countrys largest urban areas (activity 1.7.4). These four activities will enable activities 1.7.5 to 1.7.10, for which no funding is required, to be implemented. The Army is a longstanding NTCP partner, and has signed an agreement with the Ministry of Health under the Plan national sur lAcclration de la Rduction de lIncidence de la Tuberculose au Maroc 2013-2016 [National Plan to Accelerate the Reduction of TB Incidence in Morocco 2013-2016]. However, its doctors and nurses have not received refresher training for around 15 years. The NSP includes plans for a three-day refresher training workshop for Army doctors (subactivity 1.6.14.3) and a further two-day workshop for nurses (sub-activity 1.6.14.4) in Q2 2018. The Caisse Nationale de Scurit Sociale [National Social Security Fund  CNSS] runs 13 polyclinics in nine cities throughout Morocco, including eight in five of the six regions that account for more than 85 percent of notified TB cases. These polyclinics offer a wide range of inpatient and outpatient health care services to social security scheme members and their families, as well as to patients with or without coverage from a funding organization. Although these polyclinics and the CDTMRs cooperate, there is no formal framework governing their relationship. The NSP 2017-2021 includes plans to establish an official cooperation framework between the NTCP and the CNSS (activity 1.6.15, sub-activities 1.6.15.1 to 1.6.15.9). However, this concept note includes a request for the funds needed to implement sub-activities 1.6.15.3, 1.6.15.6, 1.6.15.7 and 1.6.15.8. Targeting high-risk groups and vulnerable populations is one of the priorities of the NTCPs new strategic focus and a key component of the NSP 2017-2021. However, the NTCP has yet to clearly define: (i) how high-risk groups and vulnerable populations will be identified; and (ii) the procedures that will need to be followed to ensure appropriate action. The NTCP has therefore identified six key measures in the new NSP. This concept note includes a request for funding for the measures identified in sub-activities 1.8.1.3, 1.8.1.4, 1.8.1.5 and 1.8.1.6 only. The NTCPs TB control policy includes IPT for children under 5 who are exposed to index cases and for PLHIV who are free from progressive TB. However, the NTCP has yet to clearly define its latent TB infection (LTBI) treatment policy in light of the new WHO End TB Strategy. The new NSP includes plans to hold a two-day national consultation meeting to determine the LTBI treatment approach (sub-activity 1.11.1), to draw up a framework document based on the outcomes of this meeting (sub-activity 1.11.2), and to print and distribute copies of the document (sub-activity 1.11.3). This concept note includes a request for funding for these three sub-activities (1.11.1 to 1.11.3). The meeting will be key to Moroccos nine medical schools committing to include the NTCPs guidelines in their curricula. This means that, in the future, the NTCP will not need to invest as much effort in delivering refresher training to doctors (see this process developing through implementation of activities 4.9.2 to 4.9.6, for which no funding is required (see operational plan)). Mobile X-ray equipment will be purchased so that interventions can be targeted at key populations. Further symposia will be held with private sector health stakeholders and additional testing campaigns will take place to cover more needs. Community-based interventions to tackle stigma and discrimination will help improve the setting for TB control activities.","2020-12-31",565907.31000000006]
[null,"Mozambique","Malaria","Program management","Other program management intervention(s)","All 11 Procvincial Directorates of Health have a gap of vehicles to ensure implementation of supervision activities. The motorbikes included in this UQD are to be used exclusively by National Malaria Control Program staff at provincial and district level, to ensure implementation of routine activities such as supervision visits to health facilities and community health workers.","2020-12-31",801546.08]
[null,"Mozambique","TB/HIV","Other module","Other module","The PAAR for RSSH addresses critical gaps in management of health system risks to program implementation by providing adequate storage and distribution conditions for the supply chain, training of health workers and human resource managers, development of community based monitoring of disease management data, expansion of financial management systems and health information systems and supportive policy and programmatic environment for integrated service delivery of TB and HIV.","2020-12-31",63516662]
[null,"Multicountry Africa ECSA-HC","Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Funds for eLIMS adaptation for NRLs in line with the WHO End TB strategy. The SRL-Uganda has developed and deployed the eLIMS suitable for NRLs in two countries and can expand to other countries if additional funds become available.","2022-06-30",34708]
[null,"Multicountry Africa ECSA-HC","Tuberculosis","TB care and prevention","Case detection and diagnosis","Funds to further enhance the capacity of SRL-Uganda staff through mentors in the WHO-SNRL network. For example, in the recently endorsed Next Generation Sequencing Technologies for TB surveillance.","2022-06-30",20000]
[null,"Multicountry Africa ECSA-HC","Tuberculosis","TB care and prevention","Case detection and diagnosis","Funds to strengthen joint visits to project countries to all 22 countries to determine progress and provide support. Ideally, new entrants to the project will be visited twice including a first visit to conduct a baseline assessment.","2022-06-30",65792]
[null,"Multicountry Americas EMMIE","Malaria","Other module","Other module","Additional technical assiatnce to support countries.","2023-12-31",1500000]
[null,"Multicountry Caribbean MCC","TB/HIV","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Implement a social contracting model in the six OECS countries, involving the conduct of an assessment of the types of services and capacity of Civil Society Organizations (CSO) to provide these services; Governments willingness/political will to contractually engage civil society; a legal environment assessment to review impediments relating to registration of CSOs, determine government procurement procedures, applicable service standards and licensing among other issues.","2022-03-31",62530]
[null,"Multicountry Caribbean MCC","TB/HIV","TB/HIV","Stigma and discrimination reduction","Develop, implement and educate Health Care Providers on a Code of Conduct and Patient Bill of Rights following the model or programme in St. Kitts and Nevis. Develop targeted material to educate or sensitize patients and other persons accessing health services on a Bill of Rights including the right to confidentiality. This will result in greater respect for confidentiality and higher number of complaints based on stigma and discrimination being resolved.","2022-03-31",50000]
[null,"Multicountry East Asia and Pacific RAI","Malaria","Case management","Other case management intervention(s)","Communities mobilization and sensitization during Malaria day.","2020-12-31",196416]
[null,"Multicountry East Asia and Pacific RAI","Malaria","Case management","Other case management intervention(s)","There will be no more oAMT replacement project funded for 2018 - 2020 under RAI2E. If funds are available, this project should continue until there is zero oAMT in the country.","2020-12-31",2762037]
[null,"Multicountry East Asia and Pacific RAI","Malaria","Program management","Other program management intervention(s)","Strengthening national procurement and supply chain systems.","2020-12-31",250000]
[null,"Multicountry East Asia and Pacific RAI Total",{"$nulls":5},28195477]
[null,"Multicountry EECA PAS","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Conduct regulatory framework assessment encapsulating the elements, including health financing (HF), Human Resources in Health (HRH) and Health System Delivery (HSD), self- assessment of the regulatory documents, to enable implementation of people-centered model of TB care.","2021-12-31",60000]
[null,"Multicountry EECA PAS","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Mid-term project assessment to assess the progress of the project, define the interim project results and implementation performance.","2021-12-31",50000]
[null,"Multicountry EECA PAS","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Regional and country work to improve clinical practice and review and update clinical/patient pathways to be adopted as part of TB practice.","2021-12-31",51900]
[null,"Multicountry EECA PAS","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Support development and implementation of evaluation of health services delivery transformations to ensure sustainable changes of TB care model. Existing tools on evaluation of health services delivery will be applied to TB care to monitor development and implementation of people-centered TB care model.","2021-12-31",30000]
[null,"Multicountry HIV Caribbean PCC Consortium","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Developing more effective models to reach informal sex workers, male and transgender sex workers, and mobile and internet-based sex workers;  As with the MSM intervention, throughout this module CVC would institute 4 axis to ensure more effective sub-population HIV prevention programs: (i) strengthened programmatic and contextual understanding, especially of the heterogeneity of sex work and complexity of closeted MSM behaviour; (ii) intensified program implementation and delivery of comprehensive, proven interventions; (iii) improved program monitoring and evaluation, including greater use of real-time monitoring for continuous program improvement and constant strategic and tactical adaptations and rigorous program evaluation, to refine understanding of what works, under what circumstances and how; and (iv) predictable, sustained financing for key population HIV prevention programmes for specific sub-groups, including increased domestic financing where feasible. Furthermore, this module will pay special attention to strengthening community-based monitoring and evaluation systems as they pertain to MSM, transgender women, and Female Sex Workers sub-groups and their respective HIV related issues in the Caribbean; document model interventions with technical briefs that have practical, how-to examples for strengthening critical enablers and service delivery for key populations subgroups; and to strengthen commitment to a sustainable CBO response in relation to Key Populations post transition.","2022-09-30",200000]
[null,"Multicountry HIV Caribbean PCC Consortium","HIV/AIDS","RSSH: Community responses and systems","Community led advocacy","Social mobilization campaigns at regional and national level for increase in domestic resources to address the needs of KP will be undertaken using advocacy videos and other IEC tools developed to target Ministries of Health and Finance and used in training sessions with CSOs. Support will also be provided for partcipation of KPs to high level national and regional meetings to undertake community-based advocacy and moniytoring a=for policy and law reform related to HIV.","2022-09-30",60000]
[null,"Multicountry HIV Caribbean PCC Consortium","HIV/AIDS","RSSH: National health strategies","Other policy and governance intervention(s)","1.a. Strengthening of national strategic plans to ensure inclusion of KP issues in select countries;1.b.  Documenting KP issues and ensuring their inclusion  in the national strategic plans of select countriesThis will be done in the expectation of increasing awareness of government officials and stakeholders on the benefits of adequate funding for HIV programming for KPs.  This in turn should lead to Sustainable Prevention, Treatment and Care services for Key Populations in the Caribbean Region.  Strengthening NSPs by ensuing inclusion of KP issues and increasing awareness of the benefits of adequate funding of HIV services for KPs cannot be achieved without the participation of the Key populations themselves.  This in turn requires KP organizations and networks that are strong enough to challenge their exclusion and participate fully in the necessary processes.   It will also seek to strengthen KP capacity to participate in national strategic plan dialogue through activities targeting their advocacy capacity and strengthening their knowledge to enable effective participation.    The sucess of this activity will be measured by accessing:A. The Number of countries with KP participation in national strategic plan dialogueB. Increased capacity of KPs to participate in national strategic plan dialogue","2022-09-30",50000]
[null,"Multicountry HIV Caribbean PCC Consortium Total",{"$nulls":5},1238000]
[null,"Multicountry HIV Latin America ALEP","HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Venezuela would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in developing its institutional capacities, in an environment of severe social instability and even faces persecution of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the strengthening they consider necessary in addressing the aforementioned activities, in line with the regional activities emerging from this module.Literacy on antiretroviral therapy (ART) and improved quality of life for PLHIV. The leadership skills and capacities of each network are strengthened.Generation and analysis of strategic information from and for key populations.Design and implementation of external and internal communication strategies for networks and for national organizations of PLHIV.","2022-09-30",32220]
[null,"Multicountry HIV MENA IHAA","HIV/AIDS","Program management","Grant management","Additional resources for baseline, mid term and evaluation and learning and sharing events.","2021-12-31",360000]
[null,"Multicountry HIV MENA IHAA","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Conduct KP-led sensitivity training for health care service providers, based on findings from 'mystery shopper' surveys to evaluate services to key populations","2021-12-31",24000]
[null,"Multicountry HIV MENA IHAA","HIV/AIDS","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Capacity building for resource mobilization: Regional training on proposal development, grant accountability and identifying mechanisms for fund raising for CSOs and KP networks.","2021-12-31",94300]
[null,"Multicountry HIV MENA IHAA Total",{"$nulls":5},903390]
[null,"Multicountry Middle East MER","Multi-component","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Procure RDTs for testing","2020-12-31",22444]
[null,"Multicountry Middle East MER","Multi-component","MDR-TB","Treatment: MDR-TB","Procurement of Second Line Drugs SLD","2020-12-31",31422]
[null,"Multicountry Middle East MER","Multi-component","MDR-TB","Treatment: MDR-TB","To undertake a national TB drug resistance survey in Syria","2021-12-31",25000]
[null,"Multicountry Middle East MER","Multi-component","MDR-TB","Treatment: MDR-TB","Training workshop for program managers and TB program coordinators to develop SOPs for MDR TB treatment and develop PMDT guidlines. Training of health staff (doctors) on tuberculosis and its side effects in cooperation with Annoor Sanatorium.","2020-12-31",15711]
[null,"Multicountry Middle East MER","Multi-component","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Procurement of OI medications","2020-12-31",11222]
[null,"Multicountry Middle East MER","Multi-component","Program management","Other program management intervention(s)","Refurbishment of existing facilities, offices furniture and IT equipment in all governorates","2020-12-31",123443]
[null,"Multicountry Middle East MER","Multi-component","Program management","Other program management intervention(s)","To organize, at regional level, a training course on data management for the relevant staff of the NTPs of the five countries (ex.: NTP managers and monitoring and evaluation officers). The course will be facilitated by two international consultants and will cover the following issues: i) epidemiological surveillance principles, ii) the establishment of data sets, iii) data analysis procedures and methods, iv) utilization of the data analysis results for the purposes of epidemiological surveillance and programmatic management, v) evaluation of TB prevention, care and control strategies and activities implemented, and vi) identification of hypotheses for operational research","2021-12-31",75000]
[null,"Multicountry Middle East MER","Multi-component","Program management","Other program management intervention(s)","To rehabilitate the TB centers/hospitals damaged in the conflicts in Iraq and Syria (including Ibn Zohr Hospital in Baghdad, Iraq and Al-Hareth Hospital in Homs, Syria), so as to support the provision of admission facilities for patients admitted with TB.","2021-12-31",100000]
[null,"Multicountry Middle East MER","Multi-component","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Support and strengthen the HIV and STDs surveillance system including, trainings etc.","2020-12-31",168331]
[null,"Multicountry Middle East MER","Multi-component","RSSH: Health management information systems and M&E","Policy, planning, coordination and management of national disease control programs","This intervention is of great importance to build the capacity of eDEWS sentinel sites to determine the alert and outbreak thresholds and develop a preparedness and prompt response plan to contain malaria outbreak. It fosters the collaboration and coordination with the surveillance department and eDEWS programme and ensure the flow of malaria case management data on weekly basis from 2000 HFs in the country","2021-12-31",462000]
[null,"Multicountry Middle East MER","Multi-component","RSSH: Health management information systems and M&E","Routine reporting","Training recording and reporting to NTP staff on the updates registers according to the WHO case definition and on the Electronic National Registration System and TB surveillance","2020-12-31",8978]
[null,"Multicountry Middle East MER","Multi-component","RSSH: Health management information systems and M&E","Surveys","Conduct capture recapture study to estimate TB burden and reporting in Jordan.","2020-12-31",448883]
[null,"Multicountry Middle East MER","Multi-component","RSSH: Human resources for health (HRH), including community health workers","Other health and community workforce intervention(s)","NAP and Key Population participation in international trainings, conferences, workshops etc.","2020-12-31",22444]
[null,"Multicountry Middle East MER","Multi-component","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","To cover the cost of the regular evaluation of TB dugs management process in the five countries","2021-12-31",145800]
[null,"Multicountry Middle East MER","Multi-component","TB care and prevention","Case detection and diagnosis","Digital Xrays 12 that will be placed as follows: 2 in Amman center (~6000 screening per month), 1 in Karak center, 1 Ma'an center, 1 Madabah, 1 Jarash, 1 Ajloun, 1 in Delail and 1 in Sahab.","2020-12-31",782545]
[null,"Multicountry Middle East MER","Multi-component","TB care and prevention","Case detection and diagnosis","In order to strengthen TB services for affected women, food supplementation is needed for women with TB who are treated in IDP and refugee settings","2021-12-31",1335000]
[null,"Multicountry Middle East MER","Multi-component","TB care and prevention","Case detection and diagnosis","Maintain and enhance the transport of specimens between chest diseases centers in the 11 governorates in Jordan to the National reference laboratory in Amman and conduct external quaility assurance between Supra national Lab and the NRL (including courier service, samples containers, laboratory forms etc.)","2020-12-31",10100]
[null,"Multicountry Middle East MER","Multi-component","TB care and prevention","Case detection and diagnosis","To rehabilitate the microscopy laboratories of the health facilities damaged by the fighting in Iraq, Yemen and Syria","2021-12-31",450000]
[null,"Multicountry Middle East MER","Multi-component","TB care and prevention","Case detection and diagnosis","Trainings for laboratory technicians at the sub-level on microscopy, culture, quality control and safety in the laboratoryand infection control and health risk management for TB.","2020-12-31",15711]
[null,"Multicountry Middle East MER","Multi-component","TB care and prevention","Prevention","Updating the national guidelines on TB infection prevention and control in Jordan in English , translate to Arabic and printing","2020-12-31",22444]
[null,"Multicountry Middle East MER","Multi-component","TB care and prevention","Treatment","Workshop for representatives of civil society organizations and tuberculosis patients to improve the quality of provided treatment services. Training course for private doctors, hospitals and doctors of the chest diseases centers on TB diagnosis, treatment and Training of staff of non-governmental organizations concerned with TB management.workshop for representatives of civil society organizations and TB patients to improve the quality of treatment services. Training pharmacists on TB treatments first and second line.","2020-12-31",31422]
[null,"Multicountry Middle East MER","Multi-component","Treatment, care and support","Other intervention(s) for treatment","Design and develop a comprehensive treatment retention and adherence strategy","2020-12-31",16833]
[null,"Multicountry Middle East MER","Multi-component","Treatment, care and support","Other intervention(s) for treatment","Introduce blood samples transportation service through courier provider to the cental lab in the MOH for PLHIV","2020-12-31",8978]
[null,"Multicountry Middle East MER","Multi-component","Vector control","Indoor residual spraying (IRS)","This intervention focuses on protecting the people in high transmission, pyrethroid resistance areas, as part of insecticide resistance management, at an altitude less than 1000 meter. It also aims to protect IDPs and Refugees in several camps and those living in epidemic prone areas. The PAAR will cover the cost  of insecticides and field operating spraying).","2021-12-31",4628873]
[null,"Multicountry South-Eastern Asia AFAO","HIV/AIDS","RSSH: National health strategies","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 183 for Bhutan for year 2 second round grants","2021-12-31",119652.38]
[null,"Multicountry South-Eastern Asia AFAO","HIV/AIDS","RSSH: National health strategies","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 187 for Philippines for year 2 second round grants","2021-12-31",119652.38]
[null,"Multicountry South-Eastern Asia AFAO","HIV/AIDS","RSSH: National health strategies","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 190 for Sri Lanka for year 2 second round grants","2021-12-31",119653.38]
[null,"Multicountry Southern Africa E8","Malaria","Case management","Epidemic preparedness","Activity: Establishment of Country Level Situation Rooms Description: This funding request includes the establishment of country level Situation Rooms supported by the regional E8 Situation Room. This support will provide additional funding for internal meetings of the national malaria programes and their country level partners to ensure they are adequately prepared for the upcoming transmission season each year. These meetings will consist of 15 people meeting two times per year  once at the beginning of the transmission season (Oct/Nov) and then again towards the end (Feb/Mar) to assess progress, trends, response, etc. This support has been requested from Zimbabwe, Namibia, Angola, and Mozambique for the full three years of this investment. The remaining E8 countries will convene similar meetings through other means.Rationale: Country level Situaiton Rooms will allow for improved internal coordination before and during peak transmission seasons. National malaria programmes will be more prepared and responsive to increases in cases if and when they occur. Expected Outcomes/Impact: The result of increased internal coordination will be improve preparedness and response at the national level. This increased EPD is especially important following the most recent transmission seasons in which significant outbreaks occurred across the entire E8 region. Budget: Costs associated with this activity include travel expenses and per diems for the 15 situation team members in each respective country to meet at the onset and close of the malaria season to review outbreak response and outcomes. Travel also includes E8 Regional Situation team members to join the meetings to support capacity building of situation rooms across the region. The total cost of this activity is therefore estimated to US$ 112,580 for the three year period.","2021-09-30",112580]
[null,"Multicountry Southern Africa E8","Malaria","RSSH: Health management information systems and M&E","Surveys","Activity: Evaluation of E8 Malaria Border Health Posts Description: This funding request includes support for Phase 2 (end-line survey) of the E8 impact evaluation of the border health posts to be completed in 2020/2021. Phase 1 will be completed in early 2019 with funding from other E8 sources.Rationale: The aim of the impact evaluation is to assess the effect of two years of border health post implementation on 1) access to malaria testing and treatment in border areas of the E8 and 2) malaria transmission among residents and MMPs, and malaria importation rates and patterns in frontline countries. While border posts are used as a malaria elimination strategy in other regions of the world, little evidence exists on their impact as compared to other interventions. While the establishment of the E8 border health posts was funded under the E8's previous Global Fund grant, funding for a comprehensive evaluation of this intervention was not. Funds to establish a baseline for the evaluation were mobilised through the University of California San Francisco with sponsorship from the Bill & Melinda Gates Foundation to fill this gap. However, the end-line survey remains unfunded and therefore included in this above allocation request. In addition to providing valuable data to inform future programming of the border health posts in the E8 region, this impact evaluation (if completed) would also be filling a critical gap in the global evidence base surrounding border posts as a malaria elimination approach. Border posts have been used in other regions of the world without conducting a systematic assessment on their impact. Given that Phase 1 of the impact evaluation will have already been completed in early 2019, it will be a missed opportunity to allow for the impact evaluation to remain incomplete due to lack of funding for Phased 2.Expected Outcomes/Impact: The results of this impact evluation (if completed) will show the effect of two years of border health post implementation on 1) access to malaria testing and treatment in border areas of the E8 and 2) malaria transmission among residents and MMPs, and malaria importation rates and patterns in frontline countries.Budget: Costs associated with this activity include maintaining a Research Manager (50% effort) to provide stufy oversight and full time study coordinator. Additional costs include implementation subcontracts to the seven E8 country research institutions to carry out the data collection activities (KAP questionnaires, Health facility survey, Qualitative interviews and MMP prevalance survey). The total cost of this activity is therefore estimated to US$ 781,864 for between the period 2019-2020.","2021-09-30",390932]
[null,"Multicountry Southern Africa WHC","Tuberculosis","TB care and prevention","Removing human rights and gender related barriers to TB care and prevention","Within allocation funding focuses on human rights and gender barriers among ASM. PAAR focuses on three aspects:(i)Human rights and gender awareness raising among LSMs and communities:This intervention will improve LSM mining companies, as well as labour unions, miners and ex-miners, peri-mining and labour-sending communities awareness about  worker rights and access to occupational and public health services. This will include mine health legal provision adoption and mineworkers entitlements through training of trainers (ToT) by regional CSOs.","2020-12-31",468228]
[null,"Multicountry TB Asia UNDP","Tuberculosis","RSSH: Integrated service delivery and quality improvement","Supportive policy and programmatic environment","Strengthening partnership/collaboration of civil society and government institutions through greater integration of CSOs in national systems and domestically financed programs. Existing legislation, policies and practices of CSO contracting mechanisms will be analyzed with a particular attention on sustainability of migrant/refugee TB programs. Technical assistance to be provided to support the transition and sustainability of cross-border referrals and information exchange between the three countries.","2021-12-31",150000]
[null,"Multicountry TB Asia UNDP","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","This intervention will focus on expansion of active case finding (screening and contact tracing) activities amongst refugee, returnee and migrant communities, as well as provision of IPT at all TB care facilities that reach out to refugees, returnees and migrants.","2021-12-31",750000]
[null,"Multicountry TB Asia UNOPS","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Pilot testing of pre-departure screening isneeded to ensure effectiveness beforeprogrammatic expansion, aimed atbenefiting all migrant categories, includingattempting efforts to target irregularmigrants, acknowledging limitations, ifany","2021-12-31",419085]
[null,"Myanmar","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Condoms and lubricant programming for PWID","The additional investment will support the program to reach more target population.","2020-12-31",81140]
[null,"Myanmar","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Needle and Syringe programs for PWID and their partners","The additional investment will support the program to reach more target population.","2020-12-31",2278791]
[null,"Myanmar","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","The additional investment will support the program to reach more target population.","2020-12-31",979554]
[null,"Myanmar","TB/HIV","Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","The additional investment will support the program to reach more target population.","2020-12-31",135434]
[null,"Myanmar","TB/HIV","Prevention programs for MSM and TGs","Condoms as part of programs for MSM and TGs","The additional investment will support the program to reach more target population.","2020-12-31",227115]
[null,"Myanmar","TB/HIV","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","The additional investment will support the program to reach more target population.","2020-12-31",122929]
[null,"Myanmar","TB/HIV","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","This intervention includes key areas such as EQAS expansion, capacity, VL quality assurance, sample collection, transport, documentation with high potential to improve the HIV and other programs.","2020-12-31",108000]
[null,"Myanmar Total",{"$nulls":5},33358079]
[null,"Namibia","Malaria","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","The Namibia Malaria Communications and Advocacy Strategy was developed in 2009 to provide guidance and cohesion to malaria communications.  We propose to update this strategy.This amount includes a consultation meeting, writing sessions, and final printing of the document.","2020-12-31",8353]
[null,"Namibia","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Given the remoteness and mobile nature of the San people and the cattle herders, having community health workers (CHWs) that are embedded with the community will improve community level access and targeting for hard to reach areas, as well as ensure timely reporting of data. This amount includes CHW salaries, CHW supervisor salaries, regional coordinator salaries, and the necessary SMS/transport reimbursements for these staff in Omusati region.","2020-12-31",62479]
[null,"Namibia","Malaria","Vector control","Entomological monitoring","Entomological capacity has been identified as a key gap in Namibias vector control landscape.  In order, to improve this, the National Vector and Disease Control Programme (NVDCP) proposes training on basic entomology for Environmental Health Practitioners.This amount includes course fees, travel, and per diem.","2020-12-31",14717]
[null,"Namibia","TB/HIV","Prevention programs for adolescents and youth, in and out of school","HIV testing services for adolescents and youth, in and out of school","This activity is expected to expand the accessibility and quality of PITC and therefore encourage more AGYW to access to HIV testing and know their results. Specific numbers in terms of targets to be reached and the minimum package of interventions are yet to be formulated. This is expected to be completed within the next two months.","2020-12-31",150000]
[null,"Namibia","TB/HIV","Prevention programs for general population","Diagnosis and treatment of STIs and other sexual health services for general population","The development of an STI strategy and encouraging treatment seeking behavior should result in less HIV infections.","2020-12-31",17689]
[null,"Namibia","TB/HIV","RSSH: Health management information systems and M&E","Surveys","Support for the HSS evaluation and support for a database for tracking donor funding. This should provide high quality information, resulting in better programme decisions and implementation of corrective action.","2020-12-31",322195]
[null,"Namibia","TB/HIV","Treatment, care and support","Treatment adherence","These targeted activities are expected to result in increasing number of PHIV remaining on treatment.","2020-12-31",383662]
[null,"Nepal","HIV/AIDS","Other module","Other module","Migration is recognised as source of infection. However, it is likely that changes in health seeking behaviour and migration patterns over the last decade have implications for HIV transmission and access to HIV services, which assessment will explore. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.","2021-03-15",50000]
[null,"Nepal","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","DHIS2 is a government priority: the NHSS anticipates its roll-out throughout the country by 2020. GoN resources are available for this, alongside support from DFID, GAVI, KOIKA and GiZ. Intermittent technical assistance is anticipated to accelerate and scale up the process, and ensure quality.","2021-03-15",2700000]
[null,"Nepal","Malaria","Case management","Facility-based treatment","Kits for community-based healthcare providers to improve the quality of service provision.","2021-03-15",32286]
[null,"Nepal","Malaria","Case management","Other case management intervention(s)","Additional Technical assistance as required.","2021-03-15",60000]
[null,"Nepal","Malaria","Case management","Other case management intervention(s)","Support broadcasting of IEC messages over radio/FM. Hold regular orientation meetings to maximize community involvement in malaria elimination.","2021-03-15",70339]
[null,"Nepal","Malaria","Program management","Other program management intervention(s)","Orientation meetings/trainings for community involvement in malaria elimination (massive scale-up of approach supported under the within allocation amount).","2021-03-15",60168]
[null,"Nepal","Malaria","Program management","Supporting procurement and supply management","Support QA/QC of Health Product/Pharmaceuticals (as per GFATM rules); Provide LMIS training workshops for RHDs, DHOs, DPHO, storekeepers, accountants and other officers for GFATM activities to strengthen capacity in-line with the additional workload associated with elimination.","2021-03-15",54640]
[null,"Nepal","Malaria","RSSH: Health management information systems and M&E","Surveys","External program evaluation to review progress and inform programme direction (Y3).","2021-03-15",33428]
[null,"Nepal","Malaria","Vector control","Other vector control measure(s)","Larval source management where vector breeding sites are few, fixed and findable in order to maximize cost effectiveness and sustainability of operations.","2021-03-15",1373]
[null,"Nepal","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","For improving access, enabling early diagnosis with introduction of the pay for performance for the diagnosis, DOT provision and further expansion to the remaining districts. This can further improve the notification of additional 5,000 cases over 3 years.","2021-03-15",100000]
[null,"Nepal","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","To provide high-end international technical assistance to the NTP.","2021-03-15",1180000]
[null,"Niger","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2020 Niger intends to run a mass LLIN distribution campaign in the hypoendemic districts of Tahoua and Agadez regions (1,246,595 people) to protect the population against vector-borne diseases such as malaria and Rift Valley fever. These zones have not been covered since 2009.","2020-12-31",2601638.42]
[null,"Niger Total",{"$nulls":5},5897878.2599999998]
[null,"Nigeria","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Facility-based treatment","Stigma index 2.0 for patient community and Key Populations Last stigma index was conducted in 2013 and a new Stigma Index Survey, with expanded focus to include KP, is needed. This will also establish effects of the Stigma and discrimination law on programming and to cover indicators on stigma reduction. This survey will bring better understand barriers to access and retention in HIV/AIDS services and identify how to address these to improve access and retention in care.","2020-12-31",861317]
[null,"Nigeria","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Improving Turn Around Time (TAT) for Viral load and EID results to improve patient careTransportation of HIV and TB diagnostic samples to testing laboratories is challenging, resulting in long TAT. Scale up of National Integrated Specimen Referral Network will improve sample delivery at PCR laboratories, but results return remains a challenge which can be addressed by use of technology to:- Reduce TAT and patient LTFU through effective Sample Tracking and Results delivery solutions using Unstructured Supplementary Service Data (USSD) - Reduce TAT through instant email push system- Enable remote sample log-in and results download from LIMS- Improve in linkage to care, patient monitoring and management","2020-12-31",2054772]
[null,"Nigeria","Malaria","Case management","Other case management intervention(s)","The ACTs through the PSCM has helped to balance the price of antimalarials ACTs in the country and ensuring equitable access to quality-assured first line treatment. In Nigeria, 62% of the population seek care in the private sector therefore the. availability and affordability of quality assured ACTs will improve malaria case management and To complements the case management in the public sector, funds are required to procure 107,924,392 doses of ACTs through PSCM, (at national scale), over a 3-year period.This meets 50% of full private sector needs.. The country also proposes to increase co-payment contribution for from 20% to 40% over the lifetime of the grant.","2020-12-31",82022538]
[null,"Nigeria","Tuberculosis","MDR-TB","Case detection and diagnosis","Inverters and Solar Panels for 280 Xpert MTB/Rif Sites and 237 existing Xpert MTB/Rif Sites: The plan is to procure inverters and Solar panels for additional 280, 4-modular Xpert MTB/Rif sites and 237 existing Xpert MTB/Rif Sites to ensure availability of electricity to run the machines.","2020-12-31",4728000]
[null,"Nigeria","Tuberculosis","MDR-TB","Case detection and diagnosis","Optimization of Existing TB Ref Labs:An estimated 29% of the need for these TB Reference Laboratories has been budgeted within allocation. This intervention will provide the remaining 71% optimization need to improve functionality, support monitoring of patients on shorter regimen and new drug, improve communication between laboratories and treatment centres and improve surveillance for XDR TB.","2020-12-31",202243]
[null,"Nigeria","Tuberculosis","MDR-TB","Case detection and diagnosis","Capacity building of health workers on TB management for 7 additional DR TB Treatment centres:This request is to support the community expansion in the hospitalized management of critically ill and comorbid DR TB patients, or patients with severe adverse reactions. There are 31 DR TB treatment centres existing in 30 states leaving a gap of 7 States yet to have treatment centres.","2020-12-31",561781]
[null,"Nigeria","Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.","2020-12-31",9515528]
[null,"Nigeria","Tuberculosis","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Baseline and follow-on assessment of target GF supported labs enrolled into the Continuous quality improvement program:The consensus to establish a national CQI programme require a detailed baseline assessment to better understand what gaps exist and use it to inform priorities for investment. The report will be used to guide future investments by government and other partners and also used as an advocacy tool.","2020-12-31",2044830]
[null,"Nigeria","Tuberculosis","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Support the training of lab professionals within the National Lab network on the standard biosafety and biosecurity procedures and processes:All the GF supported PCR and TB Reference laboratories will be supported to achieve local and international accreditation through this activity.  The Global fund will support the implementation of standard biosafety and biosecurity requirements in all supported laboratories within the network of 111 laboratories.","2020-12-31",254384]
[null,"Nigeria","Tuberculosis","TB care and prevention","Case detection and diagnosis","Establish TB services in additional 2,445 PHCs: The country plans to expand TB services from 35% in 2018 to 50% by 2020 by engaging additional 3,372 PHCs resulting to a total yield of 134,782 included in the allocation.  With above allocation, TB services will be expanded to additional 2,445 PHC to reach 60% coverage resulting to an additional 26,955 additional cases.","2020-12-31",313025]
[null,"Nigeria","Tuberculosis","TB care and prevention","Treatment","First Line Medicines:The budget for First Line medicines under allocation provide for 59% (288,486) of total number of cases targeted in the PF (492,411).  $3,530,072 of the remained 40% will be covered by the GON. The Country is requesting the costs for TB medicine for the remaining amount of $ 8,293,937 under above allocation.","2020-12-31",8293937]
[null,"Pakistan","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","PR Nai Zindagi has now been allowed to work in the major agglomerations of Punjab. Based on the Punjab IBBS 2014, the number of PWID mapped in 8 cities of Lahore, Faisalabad, Sargodha, Sialkot, Gujranwala, Sheikhupura, Mandi Bahaudin and DG Khan is 25,929. As per the IBBS, 9,715 (37.46%) based on city wise prevalence were HIV positive in 2014. In the absence of services since 2016, this number is now likely to reach 60% if not more. Outcomes of the proposed intervention: By end of 2020 appr. 20,743 (80%) of mapped PWID will be enrolled in CoPc+ services (complete package) in those cities By end of 2020 appr. 7772 (80%) of HIV+ PWID will be channeled through AAU and put on ART Similarly, spouses and all partners will receive prevention, treatment and life support No additional costs on management (like PR staffing  costs)  By end of 2020, NZT will cover 23% of PWID in Pakistan","2020-12-31",397]
[null,"Pakistan","HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Cost of treating additional 20,000 PLHA or 12% of the annual gap. This will help the program to: 1. Mitigate risk if PC1 budgets dont materialize timely to supply the projected quantities of ARVs. 2. Address potential surge in demand for ARTs if numbers of current pre-ART (i.e. CD4 >500) are higher than originally anticipated when treatment-for-all is implemented. 3. Cover additional treatment demand that would result from increased coverage in MSM programs under PAAR.","2020-12-31",3099002]
[null,"Pakistan","Malaria","Case management","Other case management intervention(s)","The Malaria Indicator survey (MIS) showed only 35% utilization of LLIN by the community during high transmission season. Mass media campaign will be conducted for all 66 districts and aired in the malaria transmission season to encourage LLINs utilization and achieve maximum impact. In addition, the campaign will raise awareness amongst the population for utilization of most famous intervention of LLINs and early care seeking by malaria suspects to reduce morbidity and mortality.","2020-12-31",300000]
[null,"Pakistan","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The grant funds cover the distribution of LLINs for pregnant women (high risk population) through ANC clinics for 2018 only. Due to the funding limitations, LLINs required for pregnant women for 2019 and 2020 are being requested through PAAR. A total of 653,464 LLINs (298,937 in 2019 and 354,527 in 2020) would be required for distribution to cover the pregnant women's needs.","2020-12-31",1500000]
[null,"Pakistan","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Action: To establish 11 more PMDT sites in Public and private sector in an equitable manner.Rationale: These PMDT sites will facilitate the enrollment of DR-TB patients near their residences for better treatment adherence.","2020-12-31",3200000]
[null,"Pakistan","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Action: To engage additional 2,500 GPs, 210 NGOs (from current 240 to 450), 50 private hospitals (from 70 to120) and 50 parastatal hospital (from 70 to 120) with enablers (training, incentives 400 PKR/ case.Rational: Currently 3-5% of private health care providers are engaged with NTP. Engaging private practitioners (PPM-1 model) will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines. Case notification will increase by 30,000/year.","2020-12-31",1941685]
[null,"Pakistan","Tuberculosis","TB/HIV","Other TB/HIV intervention(s)","Action: With this funding HIV testing of TB patients will increase up to 60% in 260 additional sites by 2020 as planned in the NSP (30% - 2018, 45% - 2019, 60% - 2020 tested, i.e., 130, 220, 300 total sites/annually).Rational: The allocation-funding request includes scale up of HIV testing among TB patients from 1 percent to 10 percent. TB patients have 6% HIV higher rate than the general population. 3,303 HIV/TB cases will be detected.","2020-12-31",730000]
[null,"Panama","TB/HIV","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Goal 3 of the End TB strategy is to reach 0 catastrophic costs in terms of tuberculosis. Panama has no information to measure progress; therefore, this survey would need to be performed in the first two years in which the 2018-2022 PENTB is implemented.","2021-12-31",70000]
[null,"Panama Total",{"$nulls":5},376500]
[null,"Papua New Guinea","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The Institute of Medical Research has funding for its malaria sentinel sites until 2018. These funds are included here to extend the sentinel sites until 2020 if necessary.","2020-12-31",200000]
[null,"Papua New Guinea","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This allows a further year of Insecticide Resistance Monitoring in four site in year two which are presently not possible in the present grant allocation.","2020-12-31",1609]
[null,"Papua New Guinea","Malaria","Vector control","Other vector control measure(s)","This program delivers antenatal nets to about 50% of pregnant women each year. This protects both  pregnant women and newly born children from malaria. Delivery to pregnant women is done through health centers. Nets are also distributed every three years to prisons and boarding pupils in boarding schools.","2020-12-31",3192]
[null,"Papua New Guinea","TB/HIV","Program management","Policy, planning, coordination and management of national disease control programs","This allocation provides TB/HIV/STI M&E Officers at provincial level in Western Highlands, Enga, Jiwaka, Morobe and Madang. These officers will assist the TB/HIV Coordinators to improve data collecting and reporting, assist in providing up to date information to the TB-HIV Provincial Coordinating Committee and assist in disseminating data and information to services to assist them in service review and planning.","2020-12-31",388013]
[null,"Papua New Guinea","TB/HIV","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","a) Strategic information: support for 9 positions in Y3 for TB/HIV/STI surveillance and logistics team (shared positions for KP database support; national HIV/STI/TB testing policy and practice support, logistics support and data entry). b) HIV Patient database training: This will provide for an annual HIV patient database training for 10 participants. The HIV patient database will eventually be integrated into the national e-NHIS. c) KPMIS training: Key staff will also be trained in the use of the KPMIS system, collecting data on KP outreach and KP attendance at STI, HIV and TB services.","2020-12-31",196097]
[null,"Papua New Guinea","TB/HIV","TB care and prevention","Prevention","BMU refresher training in 5 provinces. The HIV allocation is converging TB refresher training in the HIV focus provinces - Morobe, Madang, Jiwaka, Western Highlands and Enga.","2020-12-31",249208]
[null,"Paraguay","HIV/AIDS","Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","To carry out a cost / effectiveness study of the PREp in Paraguay using a mathematical model, by an international expert. To carry out a clinical and therapeutic guide for the PREp by an international expert. Consultancy with the international expert for the elaboration of the protocol and manuals of implementation of the Study of feasibility (acceptability, adherence, behaviors and risk behavior, side effects) of a combined HIV prevention intervention with PREp in MSM in Paraguay, Training and sensitization of HR in PREp. 3 days of training for 30 people. Implementation of the feasibility study (acceptability, adherence, behavior and risk behavior, side effects) of an HIV prevention intervention combined with PREp in the MSM population in Paraguay. The PREp is part of the combined prevention package promoted by PAHO / WHO. It is proposed to carry out the aforementioned activities in order to have information for decision-making regarding its full implementation in the short term. The objective of the effectiveness and feasibility study is to demonstrate, numerically, that PREP implementation is cost / effective as a public health strategy. In addition, the study implementation will allow us to have information on the PREP response in the Paraguayan cultural context, on the conditions necessary for its implementation, the situations that may arise and that will require action by the MPyBS, among others. We hope that with the implementation of these activities, the country will have enough information and experience to complete the implementation of all the strategies that form part of Combined Prevention in the short term.","2021-02-28",255371]
[null,"Paraguay","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Implementation of small groups to FSW with the offer of beauty services. This initiative seeks to access the FSW that are reluctant to access information and offer testing through the conventional approach. This activity contributes to the achievement of testing goals for FSW proposed in the project framework. The implementation of this strategy seeks to obtain the consent of the owners of premises as well as the interest of FSW that do not access the offer of testing in the premises, providing them with an additional service, with the delivery of information about HIV and STIs. This strategy has been implemented in a pilot way with important results since the information is delivered in a more enjoyable way, within the framework of a conversation between the educator and the FSW.","2021-02-28",29493]
[null,"Paraguay","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Cohort study of the evolution of the response to ART in Paraguay. This study, to be carried out for the first time in the country will allow monitoring of a cohort from 2018 to 2020 to evaluate the durability of viral load suppression, factors of adherence (and non-adherence), OI frequency and the toxicity of ART. The information gathered aims to identify the different factors that affect PLWHIV during treatment and affect adherence and the corresponding Viral suppression. It is also intended to have relevant information to make decisions about the prioritization of treatment schemes and other actions that facilitate adherence to treatment. Finally, the information could also imply an update in the treatment protocols. This information will be very useful for monitoring the fourth, fifth and sixth pillar of the waterfall.","2021-02-28",36000]
[null,"Paraguay","HIV/AIDS","Treatment, care and support","Counseling and psycho-social support","PLWH bi-annual meeting 2019 for PLWH empowerment, joint work CS/ State / cooperation agencies and quality of life. There is a need to carry out, on a bi-annual basis, an in-depth study on the various thematic axes associated with comprehensive care for PLWH, access to justice and human rights, stigma and discrimination, promoting the greater involvement of people living with HIV in terms of their health, dignity and prevention needs in all aspects of the policies and programs that affect them. This meeting will be national since it will involve PLWH from all over the country, in addition to local actors linked to the National Response to HIV, such as representatives of international organizations, cooperation agencies, public institutions, CS, among others.","2021-02-28",7669]
[null,"Paraguay","HIV/AIDS","Treatment, care and support","HIV care","Acquisition of plate agitators, centrifuges, portable viral load and CD4 equipment with their reagents for 1 year. In the framework of the Comprehensive Plan for HIV Approach and Intervention, the main strategy proposed is decentralization / deconcentration of HIV care, and therefore, the response to the user is at the point of care (Comprehensive Care Service), for  diagnosis (second pillar) with the acquisition of plate agitators and centrifuges for WB, and for monitoring (third and fourth pillar) with the acquisition of equipment for viral load and CD4. The installation of such equipment in the selected establishments will reduce the waiting time of people either for the confirmation of a reactive result (for the beginning of treatment), or for follow-up of the viral load and CD4 of the PLWHIV. This intervention will contribute to reduce barriers to access to diagnosis and follow-up, favoring both the linkage and retention of people with reactive results and the rapid start of ART, with a corresponding decrease in viral load in them. It is worth noting that under the current subsidy, 3 viral load equipment were acquired and installed in the SAIs of Central, Itapa and Alto Paran, respectively; and 6 of CD4 have been acquired for the SAI of Concepcin, Caaguaz, San Pedro, Boquern, Canindey and Guair. This purchase seeks to provide key regions (Asuncin / IMT (Institute of Tropical Medicine), eembuc and Cordillera, for their geographical location and / or number of patients in follow-up with the necessary equipment to reduce the barrier of geographical distance. The strengthening of point-of-care laboratories is a necessity to facilitate access to timely diagnosis as well as to the monitoring of PLWHIV.","2021-02-28",322491]
[null,"Paraguay","Tuberculosis","Program management","Other program management intervention(s)","National TB Programme (PNCT) - Program Management. Technical-administrative management for optimum implementation of this project, including execution and monitoring of the proposed activities. Production and verification of the funding application for execution of PNCT activities in the context of the project, and provision of the same to the RP. The intention here is to appropriately monitor activities to be implemented and as such to assure effective execution of the same.PNCT monitoring management of data quality, indicator compliance and recording in expert system. Technical-programmatic management relating to monitoring and follow-up on indicators and activities included in the working plan. Data quality management, use of corrective controls, monitoring for optimum implementation of the Expert System, which will serve from this year as the main source of information for reporting indicators.The intention here is to efficiently monitor indicators and activities, promptly identify bottlenecks that could affect execution of the project and offer recommendations.","2021-12-31",210724.74]
[null,"Paraguay","Tuberculosis","Program management","Other program management intervention(s)","Hiring staff for PNCT statistics department.Hiring is needed to cover a vacancy in the statistics department as currently there are two professionals actively working (reduced from 3 to 2 due to resignation). These staff will monitor data input in the expert system until hired by the MSPBS.","2021-12-31",28500]
[null,"Paraguay","Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Strengthening of TB Expert System input with provision of computer equipmentNot all districts have computer equipment to input symptomatic respirotary cases data and other cases into the system. It is important to note that from this year, PNCT will implement reporting in the Expert System as a source for official information. This implies that if the local service has no equipment and/or Internet access, the district must manage the data input.Acquisition of equipment will ensure timely and correct data input, analysis of the same at every care level and official reporting of indicators at the national level.","2021-12-31",129138.5]
[null,"Philippines","HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","This will ensure that higher risk MSM are reached with prevention programs.","2020-12-31",695974]
[null,"Philippines","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Additional investment will ensure detection and enrollment of 100% attainment of the PhilSTEP1 target.","2020-12-31",10104095]
[null,"Philippines","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","This is an expansion of coverage of the systematic screening among vulnerable/ high risk population groups to find the missing cases.","2020-12-31",2500000]
[null,"Philippines","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","This will ensure GX results are recorded and released real time to support immediate patient enrollment.","2020-12-31",836915]
[null,"Romania","Tuberculosis","RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Organisation of trainings, workshops and conferences by National TB Program (Marius Nasta Institute) to improve TB healthcare providers' communication skills with TB patients and sensitize them about patients rights, establish a feedback loop between patients and care providers, and contribute to internal evaluation and re-design of programmatic approaches for the National TB Strategy.","2021-03-31",336662.55]
[null,"Romania Total",{"$nulls":5},2877166.42]
[null,"Rwanda","Malaria","Vector control","Indoor residual spraying (IRS)","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.","2021-06-30",2727600]
[null,"Rwanda","Multi-component","PMTCT","Other intervention(s) for PMTCT","This request is for alignment of grant.","2021-06-30",1003118]
[null,"Rwanda","TB/HIV","Prevention programs for general population","Other intervention(s) for general population","Above allocation (USD 3,218,722) will provide educational support to Most Vulnerable Children (particularly vocational training). Economic empowerment and life skills building will reduce the risk of HIV infection for these vulnerable children. The other support covered by above allocation amount in this programmatic area is salary for service providers at decentralized level , which will improve quality of prevention services. (USD 1,396,104)","2021-06-30",4614826]
[null,"Rwanda","TB/HIV","RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Above allocation will ensure adequate maintenance of infrastructures and equipment as well as ambulance and other vehicles necessary for supervision and sample transportation. Capacity building of laboratory technologists will also be supported. These expenses are essential to ensure quality of HIV services in the long term.","2021-06-30",2764891]
[null,"Rwanda","TB/HIV","TB care and prevention","Engaging all care providers (TB care and prevention)","Above allocation will support additional capacity building activities including strengthening knowledge of health care workers in management of TB, infection control and community DOTS.","2021-06-30",265622]
[null,"Rwanda","TB/HIV","TB care and prevention","Treatment","With above allocation, NTP will extend the beneficiaries of nutritional support to the moderately malnourished drug-susceptible TB patients (based on BMI) as malnutrition is likely among the causes of deaths.","2021-06-30",115415]
[null,"Sao Tome and Principe","Multi-component","Vector control","Indoor residual spraying (IRS)","Focalized spraying planned for 2020, but due to lack of funds, we are requesting this important support in the PAAR. The amount requested in the PAAR for effective implementation of IRS in 2020 will cover procurement of insecticide, transport, storage, payment of sprayers and operating costs.","2021-03-31",69127.850000000006]
[null,"Senegal","HIV/AIDS","Prevention programs for other vulnerable populations","Male and female condoms for other vulnerable populations","Analysis of the response has revealed insufficient screening coverage to reach the 909090 targets, so advanced strategies will be strengthened for vulnerable groups and those living in high-risk areas.  Similarly, cross-border activities will be strengthened.","2020-12-31",654892.82999999996]
[null,"Senegal","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Two operational research studies will be undertaken on adolescents and key populations to guide the program toward these targets.","2020-12-31",56707.44]
[null,"Senegal","HIV/AIDS","Treatment, care and support","Treatment monitoring - Viral load","Viral load testing coverage is one of the obstacles to achieving the 909090 targets. Therefore, in addition to support from CHAI for optimizing GeneXpert testing and POC assays, 20 machines will be procured to be distributed to the most remote areas.","2020-12-31",1028096.73]
[null,"Senegal","Multi-component","RSSH: Health management information systems and M&E","Analysis, review and transparency","Monitoring is a management tool that uses tracer indicators for each program to ensure regular monitoring of activities. This activity is financed within the allocation until 2020 due to lack of funding.","2020-12-31",80326.559999999998]
[null,"Senegal","Multi-component","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","IImplementation of the Integrated Package of Services (IPS) is budgeted within the allocation for 2018 and 2019, however due to limited funding 2020 is not budgeted.  The IPS ensures a better quality of service for the three diseases and for reproductive, maternal and neonatal health. It also supports the integration of TB, HIV, malaria and reproductive health/MNCH materials to be produced and a workshop organized to quantify the need for drugs and other health supplies in the 14 regions and at the national level.","2020-12-31",182654.02]
[null,"Senegal","Multi-component","TB care and prevention","Other TB care and prevention intervention(s)","To reduce the gap in missing cases in high-burden regions, this amount would enable implementation strategies to be scaled up through the purchase of five mobile digital X-ray machines and a fixed X-ray machine for a second prison in the country to conduct screening upon entry.","2020-12-31",536957.68999999994]
[null,"Senegal","Multi-component","TB care and prevention","Other TB care and prevention intervention(s)","ScalingScaling up case-finding requires improvements in the   capacity   and   quality   of   the   microscopy network. The  following  activities  are  proposed: Purchase  of microscopes  for  regional laboratories; Training of service providers; Supervision and quality assurance. This additional financing should ensure the improved effectiveness of TB screening. up case-finding requires improvements in the   capacity   and   quality   of   the   microscopy network.","2020-12-31",106480.75]
[null,"Serbia","HIV/AIDS","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","MSM Training for outreach workers","2022-06-30",9638.65]
[null,"Serbia","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","PWID Training for outreach workers","2022-06-30",6425.77]
[null,"Serbia","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Comprehensive prevention programs for sex workers and their clients","2022-06-30",3212.88]
[null,"Serbia","HIV/AIDS","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.","2022-06-30",5510.04]
[null,"Sierra Leone","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","The total targeted testing need is 913,700 in 2018, 1,011,543 in 2019 and 1,115,506 in 2020.The in-allocation budget covers 620,843 in 2018, 682,972 in 2019 and 751,220 in 2020 respectively. Testing interventions are focused on key and vulnerable populations conducted through static clinics and outreaches.The PAAR will support pilot study among key populations and discordant couples on self-testing to cover 5%of PF target for MSMs and PWID and 2% of PF target for FSW for 2018-2020.","2020-12-31",505000]
[null,"Sierra Leone","HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","The grant has ART targets respectively at 46%, 52% and 56% of PLHIVs for  2018, 2019 and 2020, which the current funding landscape cannot meet. With the PAAR funding the country will correspondingly increase the ART to reach these targets.Key activities will include: Procurement of ARVs and drugs for treatment of OIs. Strengthen the quality of services in the existing 156 ART facilities country.","2020-12-31",3936056]
[null,"Sierra Leone","Multi-component","MDR-TB","Treatment: MDR-TB","The treatment of MDR-TB is highly centralized in Lakka government hospital. The program is planning to decentralize the programmatic management of drug resistant and needs funding for capacity building training on PMDT, technical monitoring missions, development of tools for PMDT, allowances and transport for PMDT nurses, adaptation and printing of PMDT tools, quarterly and annual monitoring meetings, advocacy and sensitization activities. In the phase of scale-up of Gene Xpert testing, more MDR-TB cases are expected to be notified and the request additional funding will enable the programme to meet the target of enrolling all detected RR/MDR-TB.","2021-06-30",600000]
[null,"Sierra Leone","Multi-component","Program management","Policy, planning, coordination and management of national disease control programs","Resources are needed to strengthen the TB programme management at district level through supporting monthly DHMT meetings, support DHMT supportive supervisions to PHUs and office supplies (stationary and communication).","2021-06-30",400000]
[null,"Sierra Leone","Multi-component","TB care and prevention","Other TB care and prevention intervention(s)","NLPT plans to scale-up the TB services in all prison by supporting the health facilities in the prisons to effectively identify and treat all cases of TB, TB-HIV co-infected and DR-TB cases, establishing TB/HIV screening on entry including capacity building, increase access to diagnostic facilities, improve screening among inmates, create awareness and also build a solid infection control model. The TB care in prisons will be also integrated into the national surveillance framework with proper disaggregation and support printing and updating of tools for correctional sites.","2021-06-30",500000]
[null,"Somalia","HIV/AIDS","HIV Testing Services","Other module","Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care.","2020-12-31",395623]
[null,"Somalia","HIV/AIDS","Program management","Other program management intervention(s)","Provision of funding to support the development of a new NSP for 2021 to 2025.","2020-12-31",106192]
[null,"Somalia","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence. Leadership in addressing rights violations and knowledge of legal protections is important for PLHIV to address access to service issues.","2020-12-31",53616]
[null,"Somalia","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence.","2020-12-31",76124]
[null,"Somalia","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Improve the collection and dissemination of strategic information, to better inform program planning and review.","2020-12-31",73620]
[null,"Somalia","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To address gaps in regional and local capacity to ensure effective monitoring evaluation training will be provided to key regional personnel in MoHs and program partners.","2020-12-31",110580]
[null,"Somalia","HIV/AIDS","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To implement hospital Data Assistants to improve hospital based data collection and reporting. One per region.","2020-12-31",463600]
[null,"Somalia","HIV/AIDS","RSSH: National health strategies","Other policy and governance intervention(s)","Support the mid term review of the 2017 to 2021 HSSPs.","2020-12-31",142240]
[null,"Somalia","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","Funding to support cash payments to the 30% most malnourished PLHIV to obtain essential foods and hygiene commodities. Provided through the networks these cash payments also support treatment adherence.","2020-12-31",844664]
[null,"Somalia","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","This supports the majority of health services delivery. HIV services are managed or supported by INGOs and NGOs. These organisations to date have received support costs to enable the oversight, capacity building, and delivery of programs. Without this support there is a high risk of discontinuing this support and urgent transition arrangements will need to be implemented. This is for three years, but a minimum of $460,000 is sought to cover 2018 operations and allow effective and appropriate transition arrangements to be put in place.","2020-12-31",860190]
[null,"Somalia","HIV/AIDS","Treatment, care and support","Socioeconomic approaches","Funding to support the other 70% of PLHIV (see above for $0.99 M). Continue to support cash payments for food and hygiene products which have been a key part of improved treatment adherence and continuing to support PLHIV engage in the PLHIV networks and support groups.","2020-12-31",2162884]
[null,"Somalia","Malaria","Program management","Policy, planning, coordination and management of national disease control programs","A consultant for NMCP Somaliland to develop and implement an exit strategy, as well as a fund-raising strategy for Somaliland.The consultant will work for 3 months (21 days per month) per year = 63 days per year x 3 years = 189 days.","2020-12-31",96141]
[null,"Somalia","Malaria","Vector control","Indoor residual spraying (IRS)","IRS campaigns are proposed for three new areas that are outbreak prone. Each campaign costs 24,510 USD. The funds will cover IRS campaigns in response to epidemic.","2020-12-31",110295]
[null,"Somalia","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN for distribution to internally displaced persons (IDPs). The average IDPs in Somalia for May and June 2017 was 34,000 (IOM data). Assume that there will be a similar number coming per month for 24 months. The total number required is 453,333 LLINs but 304,580 LLINs are covered. Thus, the PAAR request is for 148,753 nets.","2020-12-31",221130]
[null,"Somalia","Tuberculosis","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Develop legislation for TB services in the private sector, expand and strengthen on-going in-service training for all health workers involved in the implementation of TB Control.  ? Drug Resistance Survey, country-wide implementation of eTB-Manager, research fund for operational research activities.","2020-12-31",874360]
[null,"South Africa","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Needle and Syringe programs for PWID and their partners","Consultation with the drug user community in South Africa during country dialogue suggest optimal coverage of this intervention is 1,825 needles per drug user per year (5 per day). This need is far higher than the WHO recommendation of 200 per drug user per year. The need for more needles in South Africa is linked to quality of heroin and the need for more regular injection. The allocation provides for harm reduction packs containing 724 needles per drug user per year (2 per day). Responding to community needs, funding is requested ensure that PWID reached with the program will receive 5 needles per day through provision of additional harm reduction kits (which includes swabs, sterile water and return systems). These kits are procured by the program and distributed and collected by the PWID peer educators.","2022-03-31",1651361]
[null,"South Africa","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Funding will support in providing child care for children of sex workers, by supporting 26 entry-level child and youth care workers (R3,500/month), 2 per sex worker district. Children of sex workers have been identified as an area of need. FSW in South Africa are responsible for four child or adult dependents (on average), while MSW and TGSW are responsible for two.  A research study on the basic demographics, living arrangements, risk factors and supervision is underway in the current grant, with findings anticipated in February 2019. Allocation funding will support defining and providing parenting programs suitable for sex workers who have children living with them. The PAAR request to provide direct childcare services for children who live at home with sex workers will be a value add to the parenting programs prioritized in the allocation request.","2022-03-31",1210436]
[null,"South Africa","TB/HIV","Comprehensive prevention programs for TGs","Addressing stigma, discrimination and violence against TGs","This PAAR request is for hormone replacement therapy for 840 transgender people (50% of those reached through the program). It is expected that this intervention will help address gender-related barriers for transgender people. It is also linked with improved attainment of the 90-90-90 targets, since global data suggests that ART initiation and treatment adherence improves among transwomen in a gender affirming context.","2022-03-31",1628308]
[null,"South Africa","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Addressing stigma, discrimination and legal barriers to care for adolescents and youth","Funding will support in providing mental health services to AGYW age 15-24, through the safe spaces that are prioritized in the allocation. Funding will support 24 registered psychologists (2 per district) who will rove between the safe spaces, providing counselling services to AGYW. Evidence in South Africa shows a clear link between depression and risky sexual behavior among AGYW (Barhafumwa et al., 2016).","2022-03-31",5160689]
[null,"South Africa","TB/HIV","TB care and prevention","Case detection and diagnosis","PAAR funding will support provision of an additional 825,000 Xpert tests in the six priority TB districts. Several cross-sectional studies have reported a high yield of a universal TB testing strategy; one which tests everyone irrespective of the presence of TB symptoms. Examples of populations in whom targeted universal testing has been implemented are: adults admitted to hospital, HIV-infected pregnant women, household contacts of a TB patient. A cluster randomized study is about to commence to test this strategy in South African. If results of this study support this intervention; funding is requested for targeted universal testing for TB (TUTT) for PLHIV, pregnant women and TB household contacts.","2022-03-31",13290140]
[null,"South Africa","TB/HIV","TB care and prevention","Treatment","This PAAR investment will support innovative TB treatment adherence models, including mHealth app development, adherence supporters, and medication devices. 40% of coverage is requested in the allocation budget for DR-TB adherence support. Another 60% is requested in PAAR for DS-TB adherence to ensure that the missing patients found with Global Fund and increased national efforts are supported to complete TB treatment to limit transmission, TB relapse and the development of resistance. There is an international move away from Directly Observed Treatment (DOT) towards more patient-centred adherence support which is modified to patient's need.","2022-03-31",4999175]
[null,"South Sudan","HIV/AIDS","Prevention programs for general population","Behavioral interventions as part of programs for general population","Procurement of condoms and promotional material and equipment, radio clips, refresher training for 187 community counsellors and supportive supervision to address low knowledge levels and awareness of amongst the general population, in particular adolescents and young people.","2020-12-31",800081]
[null,"South Sudan","HIV/AIDS","Treatment, care and support","Treatment adherence","Conduct training of community based organisations, peer counsellors, and civil society coordinators and do outreach to key populations and the general population to ensure treatment adherence. Treatment adherence usually decreases at 24 and 36 months resulting in an increase in AIDS related deaths. With the on-going insecurity and displacement of people, treatment adherence is vitally important.","2020-12-31",1059733]
[null,"South Sudan","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Procurement and distribution of LLINs are crucial to sustain and build on the gains in malaria prevention. In comparison to other interventions, this is the only one that can ensure universal coverage.","2020-12-31",5041994]
[null,"South Sudan","Tuberculosis","Program management","Grant management","This is to cover the costs of key technical project personnel under Cordaid who are required to continue providing technical backup to the project in 2020.  The two key staff will continue to provide supervision, oversight and mentoring to the local staff and to ensure smooth handing over to local authorities at project termination. These staff also undertake grant management functions related to the Sub-Recipient Agreement.","2020-12-31",109822]
[null,"South Sudan","Tuberculosis","TB care and prevention","Community TB care delivery","Community TB care delivery continues to be an important intervention.  Cordaid works closely with the Home Health Promoters (HHPs) to conduct outreach activities, including contact tracing, treatment support and community sensitisation.  These resources will go towards continuing support for incentives for HHPs. This budget line is increased to support the intergration of TB services to more health facilities.","2020-12-31",21812]
[null,"South Sudan","Tuberculosis","Treatment, care and support","Case detection and diagnosis","Training and outreach activities to remote areas are critical. The outreach activities will target prisons, military, IDP and cattle camps where there are no diagnosis and treatment services for TB. An outreach activity will include a team of 1 lab technician, 1 nurse, 1 counsellor, 1 clinician and 1 driver for a three day visit.","2020-12-31",1081603]
[null,"Sri Lanka","HIV/AIDS","Comprehensive prevention programs for MSM","HIV testing services for MSM","To promote early detection of HIV, community-based HIV testing will be carried out through mobile   testing service. As KP intervention activity is going to be piloted by NSACP in 2018, and the same is proposed under the Funding Request HIV testing using a vehicle is planned for the first time. This vehicle will be equipped with clinical facilities to conduct testing of rapid HIV and syphilis and others testing facilities according to the need.- 2 such vehicles are requested to cover Western Province. These 2 will be managed by the project office with the NSACP staff and KPs.","2021-12-31",171392]
[null,"Sri Lanka","Tuberculosis","TB care and prevention","Case detection and diagnosis","4 nos of mobile x ray units to be mounted to vehicles","2021-12-31",52000]
[null,"Sri Lanka Total",{"$nulls":5},413509]
[null,"Sudan","Malaria","Case management","Facility-based treatment","Target population: Refugees. This component is intended to provide malaria case management services mainly ACTs and RDTs to South Sudan Refugees.","2020-12-31",2100470]
[null,"Sudan","Malaria","Program management","Grant management","This amount represents 4% handling fee for UNICEF as procurement agent for bed net, ACTs and RDTs. It may be noted that a small proportion of the 4% is considered as cost recovery for UNICEF Country office.","2020-12-31",1114747]
[null,"Sudan","Malaria","Vector control","Indoor residual spraying (IRS)","Funding to maintain the scope and scale of The global Fund investment in malaria control in Sudan, IRS  for Y3 should be  continued  in the irrigated scheme namely Gazira and Sinnar state  (in 2018 Population protected  3811881/household covered 727967 considering 10% increase in 2020 ) IVM Is advocating for supporting other localities from the irrigated scheme","2020-12-31",485851.36]
[null,"Sudan","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN to replace LLIN distributed in 2017 to maintain universal coverage in the 12 targeted states (5 Darfur states, 3 Kordofan states, White Nile, Blue Nile, Kassala and Gadarif states). Advocacy and awareness campaigns are ongoing to sensitize targeted communities to increase the bed net utilization.","2020-12-31",2916646]
[null,"Sudan","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Target population: Refugees and other vulnerable populations including miners and nomads. The total number of bed net procured for refugees in 2017 was 573,672 LLINs (526,572 for South Sudan Refugees and 47,100 for East Sudan Refugees). FMOH, UNDP and UNHCR jointly distributed LLIN.","2020-12-31",123501]
[null,"Suriname","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Condoms and lubricant programming for sex workers","Outreach activities in the Gold-Mining Areas of the Interior of Suriname. Each of the gold-mining sites receive 2 outreach sessions per year with the  minimum package of services (BCC, condom distribution and lubricants, and HIV, STI, TB, SRH). In addition, on each of the outreach sessions, a tester is there to make testing available to people reached via the outreach.","2021-12-31",10000]
[null,"Suriname","TB/HIV","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Development of SOPs and protocols for oversight and quality control of laboratories in Suriname, specifically for HIV,TB and malaria.","2021-12-31",7500]
[null,"Suriname","TB/HIV","RSSH: National health strategies","Other policy and governance intervention(s)","Develop / standardize a mechanism for cost recovery of public sector to recover costs for services provided by them, to patients with private health insurance.","2021-12-31",5250]
[null,"Tajikistan","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","With PAAR, the project will improve the quality and expand the NSEP and OST services for PWID by the end of the project cycle. The expected outcome is to contain the spread of the HIV infection among the key population and eventually general population. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.","2020-12-31",884067]
[null,"Tajikistan","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","There are one NRL, one 3 level laboratory and 4 level 2 bacteriological laboratories for TB diagnosis. The NRL and level 3 NPHRL in Dushanbe have been fully renovated or built and equipped under German Government and Global Fund sources. The level 2 bacteriological laboratories have been equipped under Global Fund grants. Donors have covered the maintenance costs of equipment and ventilation systems of the NRL and NPHRL under in previous years. For the next period there are not secured resources to support the maintenance, repairs and spare parts for laboratory equipment at the NRL and oblast-level TB laboratories (laboratory testing equipment, biosafety cabinets, and ventilation system) in the national budget. As a result support to maintenance and servicing of laboratory equipment in bacteriological laboratories is requested under above allocation budget. The estimated costs for all 6 laboratories per year are around 210,000 USD. From the Global Fund are requested sources to cover 90% of needs in 2018, 70% of needs in 2019, and 50% of needs in 2020. The impact of this activity will be well and safety functioning bacteriological laboratory at all levels; timely diagnosed cases of sensitive and resistant TB.","2021-03-31",441000]
[null,"Tanzania (United Republic)","Multi-component","Case management","Integrated community case management (ICCM)","This funds critical activities to accelerate access to care for high burdened, hard to reach populations, through community-based workers. The program will address service gaps through expanding health services beyond formal health services.","2020-12-31",900000]
[null,"Tanzania (United Republic)","Multi-component","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","To cover mass LLIN replacement campaigns in low prevalence areas to maintain high coverage and continue protection to the population.","2020-12-31",13203120]
[null,"Tanzania (United Republic)","RSSH","RSSH: Human resources for health (HRH), including community health workers","Other health and community workforce intervention(s)","The intervention is aimed at supporting the provision of additional essential health workers for the delivery of CEmONC serives and services for AIDS, Tuberculosis and Malaria in a setting of severe human resource shortages.","2020-12-31",3402374]
[null,"Tanzania (United Republic)","TB/HIV","MDR-TB","Prevention for MDR-TB","High level priority: it is in line with FR one of the main objective  to increase MDR-TB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services.","2020-12-31",1071389]
[null,"Tanzania (United Republic)","TB/HIV","Other module","Other module","Screening of all pregnant women for HIV and syphilis at the first antenatal care visit is strongly recommended by WHO and will need scale up action by countries committed to eliminating mother-to-child transmission (EMTCT) of HIV and syphilis. Tanzania will use the experience from a pilot carried out in Shinyanga region, to influence change in testing policy including National testing Algorithms, treatment policies for pregnant women with reactive syphilis tests, and procurement of kits and medicines .Initially there will be activities for building consensus from stakeholders, development of training materials ,Guidelines and SOPs, their printing, distribution and dissemination and eventually capacity building of health care workers during the roll out, starting with priority regions ( Ones with high volume of pregnant women with HIV and Syphilis).","2020-12-31",1116050]
[null,"Tanzania (United Republic)","TB/HIV","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Timely, reliable and comprehensive information for the management of the national response enables the country to estimate resource flows and expenditures in support of the Multisectoral response to HIV and AIDS. Tanzania therefore plans to conduct the National AIDS Spending Assessment (NASA) study to track expenditure among, Public sources, External sources, Providers of HIV and AIDS services (Public and Private), Out of pocket (Individual spending). The NASA report is expected to form a basis for leveraging both technical and financial support for national HIV response based on available resources.","2020-12-31",157600]
[null,"Tanzania (United Republic)","TB/HIV","RSSH: Health management information systems and M&E","Routine reporting","High level priority: it is in line with FR one of the main objective  to improve health information system and module 4: Estimation of regional TB burden.Assessment of notification levels among the elderly: Digitalization of the supportive supervision tool.Revision of the program management Manual and Strategic plan.","2020-12-31",431858]
[null,"Tanzania (United Republic)","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","High level priority: it is in line with FR one of the main objective  to intensify TB case notification  and module 1 TB care and prevention: Scale up of TB case finding will be done amongst the following vulnerable populations for TB (children, miners, slum dwellers and fisher folk).","2020-12-31",663833]
[null,"Tanzania (United Republic)","TB/HIV","TB/HIV","Other TB/HIV intervention(s)","Testing of TB patients partners for HIV is also an important component of HIV prevention services for TB patients. Partner/ Couple testing and partner notification remain low in our settings. Few TB clinics have systems in place to adequately document partner testing. This requested funding is to provide minimal additional training in line with the Couple Counselling refresher training package and HTC tools for documentation. It is expected that through this, existing cadres of skilled medical staff will be able to extend HIV testing Tanzania Funding Request: Full review 22 May 2017 | 43 and counselling to the partners of their TB patients.","2020-12-31",350000]
[null,"Tanzania (United Republic)","TB/HIV","Treatment, care and support","Other intervention(s) for treatment","Tanzania is planning to scale up establishment of centers of excellence for management of advanced cases of pediatric and adults living with HIV.","2020-12-31",1800000]
[null,"Thailand","TB/HIV","Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","DDC BL 302-308Purchase  HIV testing ,Kidney function test , HepatitisB test, Urine pregnancy test, Syphilis test, ARV drug: TDF/FTC, (302-307)Activity : Set up PrEP service and included referral system (308).","2020-12-31",367506]
[null,"Thailand","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","RTF BL 2-51. Prevention of HCV re-infection for PWID. Meeting of PWID HCV patient . Units/Participants: 10 person per day Locations: 21 areas 1 quarter in year 1, year 2, year 3 2. Relapse prevention workshop.  Workshop of PE, OW, PWID Units/Participants: 50 person per day Locations: Annual for 5 days in year 2, year 3 3. Incentive for peer recruitment to testUnits/Participants: 30% of target  test of PWID per year4. Data system to collect coupon from peer/volunteer recruiting including maintenance. consultantfee for  data system coupon for PWID (Year 1 for system development, Year 2, Year 3 for system maintenance).","2020-12-31",98876]
[null,"Thailand","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Prevention and management of coinfections and co-morbidities for PWID","RTF BL 12-14,411. Hep C advisory board2. Hep C advisory board meeting3. HCV test kit procurement for 17 provinces -in addition to Community led4. Direct acting anti-viral treatment (DAA) dialogue for HEP C-group for HEP C following up during the intensive.","2020-12-31",124245]
[null,"Thailand","TB/HIV","Programs to reduce human rights-related barriers to HIV services","HIV and HIV/TB-related legal services","RTF BL 17Meeting on legal services related HIV-TB. Meeting police, MOI, CSO Units/Participants: 37 person per day.","2020-12-31",30235]
[null,"Thailand","TB/HIV","Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","RTF BL 18Platform for policy dialogue and campaign at sub-national level. Meeting PWID, local governmentagencies related to HR Units/Participants: 50 person per day.","2020-12-31",36884]
[null,"Thailand","TB/HIV","RSSH: Community responses and systems","Community led advocacy","RTF BL 22Training on Information and Data system  and specific topic for all KPs e.g. RTCM, Application, other digital platforms, and specific issue (organized by TA): Train project staff Units/Participants: 15 persons per day, 2 days  Locations: 36 provinces in year 1, year 2.","2020-12-31",68842]
[null,"Thailand","TB/HIV","RSSH: Health management information systems and M&E","Analysis, review and transparency","DDC BL 356-357M&E and PCM coordinator 13 staffs  (Full time ) in order to implement follow to BATS activitiesat 13 ODPCs and Severance payment.","2020-12-31",276476]
[null,"Thailand","TB/HIV","RSSH: National health strategies","Other policy and governance intervention(s)","DDC BL 360-364Preparing Thailand for effective and sustainable transition from GFATM using domestic funding and efficient implementation system through a partnership between communities, private and public sectors, 1. Setting up management unit of the Thai Fund, a public-private resource mobilization.","2020-12-31",725656]
[null,"Thailand","TB/HIV","RSSH: National health strategies","Other policy and governance intervention(s)","Transferring and sustainble into national program 2 models for TB and HIV program in prisoner and migrant and 13 models for HIV and TB in KPs by 13 ODPCs.","2020-12-31",1149066]
[null,"Thailand","TB/HIV","TB/HIV","Other TB/HIV intervention(s)","DDC BL 274:IPT service fee for Data recorder 400 Baht per time, 4 times per month for 27 hospitals, 54 hospitals and 108 hospitals in 2018, 2019 and 2020 respectively.","2020-12-31",102956]
[null,"Thailand Total",{"$nulls":5},8696748]
[null,"Timor-Leste","HIV/AIDS","Program management","Policy, planning, coordination and management of national disease control programs","Funding is requested in this category to support program management technical advice and policy, planning and advocacy technical assistance.","2020-12-31",142735]
[null,"Timor-Leste","HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","This request includes for TA support for TB/HIV and ART treatment in 2019 and 2020.","2020-12-31",97847]
[null,"Timor-Leste","Malaria","Program management","Policy, planning, coordination and management of national disease control programs","Additional financial support is required to provide overarching programmatical management and to expand upon communication channels between the national administration and municipalities as the country transitions to elimination. This is not directly linked to programme impact and outcomes but provides an enabling environment in which the programme can implement more effectively and efficiently. Above allocation funding will be utilised for 1) Conducting Annual meetings with Hospital authorities to monitor progress and ensure referral mechanisms are functioning (Years 1-3), 2) Conducting Programme Management training for upskilling of long-term committed staff (Year 2) and 3) Recruitment of a Programme Management Advisor (Year 2 & 3) and continued funding for a WHO Technical & Programme Implementation Advisor (7 months of year 3).","2020-12-31",20977]
[null,"Timor-Leste Total",{"$nulls":5},1515632]
[null,"Togo","Malaria","RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Togo launched a project in 2017 to improve the quality of integrated HIV, tuberculosis (TB) and malaria care in antenatal and postnatal services, with technical assistance from the Liverpool School of Tropical Medicine. This project aims to introduce quality standards in public health care facilities that will in time be established as centers of excellence. The funding requested will enable follow-up with the initial critical phase, to inform new health policies and steer national rollout.","2020-12-31",1854046.68]
[null,"Togo","Malaria","RSSH: Procurement and supply chain management systems","National costed supply chain master plan, and implementation","The MoH is planning to develop a national strategy aimed at strengthening the national supply chain around five thematic areas: (i) availability and accessibility of drugs and health products; (ii) structure of the supply system for drugs and health products; (iii) regulation of the health product supply chain and quality of health products; (iv) human, financial and material resources; and (v) governance of the system. The new strategy will address the weaknesses of the distribution system as well as guide a domestic finance mobilization initiative planned by the MoH.","2020-12-31",68196.61]
[null,"Togo","TB/HIV","MDR-TB","Treatment: MDR-TB","Nutritional support and transport fees for MDR-TB patients.","2020-12-31",476537.99]
[null,"Togo","TB/HIV","PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Elimination of Mother to Child Transmission of HIV:In 2016, with the aim of achieving the objectives of eliminating the mother to child transmission of HIV, the NACP introduced the use of HIV/Syphilis DUO test at the sites for the prevention of mother to  child  transmission  of  HIV  (PMTCT).  This  intervention will contribute to achieving coverage of screening for syphilis, one of the certification criteria for Togo for the elimination of mother to child transmission of HIV.","2020-12-31",699585.91]
[null,"Togo","TB/HIV","TB care and prevention","Case detection and diagnosis","Broadcast adverts on 17 local radio stations within the high-prevalence areas in order to improve the programs performance in terms of TB screening and treatment results in Togo.","2020-12-31",100512.85]
[null,"Togo","TB/HIV","Treatment, care and support","HIV care","Purchase of ARVs for People Living with HIV (PLHIV). In  order  to maintain the upscaling dynamic implemented under the NFM, and in  accordance  with  the  objectives  of  the  NSP/acceleration  plan, this  intervention  will  make  it  possible  to  place  67,031  patients (67%)  on  treatment  in  2018,  73,112  (73%)  in  2019  and  78,691 (79%) in 2020.","2020-12-31",1005744.38]
[null,"Togo Total",{"$nulls":5},14993506.810000002]
[null,"Tunisia","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Addressing stigma, discrimination and violence against PWID","Strengthening the conditions for addressing stigma, discrimination and violence against IDUs through the establishment of an accreditation mechanism for HIV screening by community actors and by raising awareness of the rights of key populations will, in the long term, have a positive and sustainable impact on HIV control.","2021-12-31",16417]
[null,"Tunisia","HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","The involvement of the community system will effectively support HIV control activities within the health/government component.","2021-12-31",7741]
[null,"Tunisia","HIV/AIDS","RSSH: Health management information systems and M&E","Surveys","Conducting assessment surveys on resistance to antiretrovirals (ARVs) at the four treatment sites, conducting a study on adherence to treatment, conducting a community bio-behavioral study (MSM, people who inject drugs, SWs) to measure the impact of prevention interventions, and updating the estimated sizes of key population (mapping/studies estimating the population size of MSM/SW/people who inject drugs) will all help to better guide the planning of HIV control activities, thereby guaranteeing an improved impact of disease control activities in Tunisia.","2021-12-31",86600]
[null,"Tunisia","HIV/AIDS","Treatment, care and support","HIV care","Treatment for people living with HIV (PLHIV) and key populations is an important pillar in HIV control.","2021-12-31",303968]
[null,"Uganda","Malaria","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Prioritization on the printing and distribution of the HMIS reporting tools to reach out to all 116 districts and all health facilities in the country with these updated HMIS reporting tools. Due to limited funding, this was placed under PAAR for any savings in the first year (2018) to contribute to at least 30% of the country required HMIS tools.","2020-12-31",1042566]
[null,"Uganda","TB/HIV","PMTCT","Other intervention(s) for PMTCT","Additional funding will support capacity enhancement for PLHIV community groups to deliver interventions that are intended to further increase uptake of PMTCT services, increase male partner testing, reduce loss to follow up for mother-baby pairs, and improve treatment adherence.","2020-12-31",913488]
[null,"Uganda","TB/HIV","TB care and prevention","Case detection and diagnosis","This is to support procurement of cartridges for operationalizing Xpert MTB/Rif machines to enhance the finding of missed cases including in key populations such as prisons and PLHIV. Secondly, approximately $1.7m is for procuring digital X-rays.","2020-12-31",12152070]
[null,"Uganda Total",{"$nulls":5},250124101]
[null,"Ukraine","TB/HIV","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","The suuplementary services for current MPSS patienst (10,000) under OST progranmme.","2020-12-31",328568]
[null,"Ukraine","TB/HIV","MDR-TB","Treatment: MDR-TB","Procurement of equipment: stationary and mobile X-rays for uniformed services and Isoniazid Preventive Therapy IDP.TB services quality for oblast medical institutions and infrastructure improvement.","2020-12-31",13775864]
[null,"Ukraine","TB/HIV","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","The intervention includes support for basic package on prevention for sex partners of PLHIV, HIV and HBV rapid test kits.","2020-12-31",861640]
[null,"Viet Nam","HIV/AIDS","Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Due to the preference for anonymity when it comes to accessing healthcare, communication through social media and technology is essential to provide HIV prevention information to MSM. The Global Fund is requested to support communication on HIV prevention for MSM, HIV/HCV (Hep-C Virus) co-infection and Sexually Transmitted Infection (STI).","2020-12-31",100000]
[null,"Viet Nam","HIV/AIDS","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Buprenorphine results in fewer adverse effects than methadone, especially among ART patients, and enables less frequent clinic visits and allows take-home doses (weekly, then once every few weeks or every month). This offers a considerable advantage in promoting adherence, particularly in remote areas, where an estimated 50% of PWID live (REF). Two pharmaceutical companies have imported buprenorphine raw material but it will take two to three years for the domestic supply to reach the market. In 2016, adherence among MMT clients was lower in remote and mountainous areas (50-80%) compared with urban areas (97%)(REF). In remote areas, villages may be located up to 150km away from the commune where the MMT clinic is located, making it very challenging to maintain treatment. As such, many clients stop treatment after only one or two months. The introduction of buprenorphine is likely to promote better adherence among PWID living in these areas. In order to assess the suitability of buprenorphine in the Vietnam context and with Global Fund support, VAAC proposes to introduce buprenorphine as a drug treatment option of heroin-addicted PWID in three to five remote areas where daily access to health clinicsis challenging (12 months to end 2018). The Ministry of Health has asked pharmaceutical companies to produce buprenorphine domestically. Two pharmaceutical companies have imported buprenorphine raw material but it will take two to three years for the domestic supply to reach the market. As such, Global Fund support is still required for the introductory phase. From 2020, Vietnam can allocate national budget to procure buprenorphine, using funds that have already been earmarked for OST for the 2016-2020 period. Procurement of buprenorphine for 2,000patients per year for three years is requested to support this transition period.","2020-12-31",600963]
[null,"Viet Nam","HIV/AIDS","HIV Testing Services","Other module","To contribute to the national goal to reduce mortality among PLHIV, VAAC requests support for annual HCV testing among PWID in the 32 Global Fund-Focus profit, prioritizing newly identified PLHIV. PLHIV who are identified as coinfected with HCV will either receive treatment under SHI or will self-fund their treatment. With above allocation funding, Vietnam will test 74,814 PWID in four provinces with high PWID population and high burden of HIV and HCV infection.","2020-12-31",416071]
[null,"Viet Nam","HIV/AIDS","PMTCT","Other intervention(s) for PMTCT","Within the allocation VAAC has requested Global Fund support for training for MCH staff in 160 districts with high HIV burden to intensively identify pregnant women with HIV; link HIV positive pregnant women to immediate ART; and to provide early diagnose to new-borns to initiate ART. To contribute towards the national goal to reduce the vertical transmission rate of HIV to less than 5% by 2015 and to","2020-12-31",700159]
[null,"Viet Nam","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","Community opinion assessment on management of drug users post rehabilitation - consultant fee. Organize national level workshop to discuss policy relating to KP - Advocate for removal of barriers for KAP's access to HIV/AIDS services and CSO's participation. One national dialogue between CSO and VAAC and government agencies on HIV/AIDS response.","2020-12-31",67063]
[null,"Viet Nam","HIV/AIDS","Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Events for community initiatives to reduce Stigma & Discrimination in five Global-Fund supported provinces.","2020-12-31",10588]
[null,"Viet Nam","HIV/AIDS","RSSH: Community responses and systems","Other community responses and systems intervention(s)","FSW network was established in 2012. The number of CBOs engaged in the HIV response accounts for roughly 42 in 28 provinces/cities nationwide. Over the past 05 years, the significant roles and contribution of CBOs in HIV/AIDS control and prevention have been recognized by VAAC, PACs as well as local authorities. Members of CBOs have actively participated in community activity such as: community mobilization, community based monitoring, prevention of stigma, discrimination and gender-based violence. VUSTA intends to encourage FSW community in engaging more in HIV/AIDS response by providing initiatives packages focusing on prioritized, specific topics: Addressing stigma, discrimination and violence against FSW; Pre-exposure prophylaxis (PrEP).","2020-12-31",16511]
[null,"Viet Nam","HIV/AIDS","RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Facilitate meetings among key CBOs, VNGOs and local stakeholders to review progress of CBO's outreach activities, and discuss about challenges/barriers, needs for further support and improvement. Organize community events through small grants to CBOs to mobilize and encourage active lifestyles for KP.","2020-12-31",44131]
[null,"Viet Nam","HIV/AIDS","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Assessment of Supply Chain Management System Funding requested to conduct an assessment of the national supply chain management system. This will include technical assistance, site visits to selected provinces to collect data, and information, and technical meetings. Support for one or two workshops to review the results of the assessment is also included in this request. Implementing e-LMIS Support for hardware and software as well as training for procurement and supply officers to implement electronic LIMS at provincial level is included within the allocation request (section 2.1). In order to optimize e-LMIS, above allocation support is requested for the following: (i) Computers and software for implementing e-LMIS at service delivery sites (ii) Technical assistance for implementing drugs and commodities LMIS by CPMU (iii) Technical assistance for implementing drugs and commodities LMIS by PPMU (iv) Fee for data collection and input Develop national plan for supply chain management Above allocation funding is requested to develop a national plan for supply chain management, including technical assistance, technical meetings and one workshop to review and finalise the plan. Implement quality assurance/quality monitoring Support is requested to develop a plan for quality assurance/quality monitoring of selected drugs and commodities (ARV, syringes, condoms), including technical assistance, technical meetings and one workshop to review and finalise the plan. Once the Supply Chain QA Plan is developed, support is requested to engage a specialist company to implement the plan. This budget request includes procurement of ARV to replace drugs that are sent from service delivery sites to be tested for quality.","2020-12-31",438191]
[null,"Viet Nam","HIV/AIDS","Treatment, care and support","Other intervention(s) for treatment","HIV epidemic in Vietnam is driven by people who inject drugs (PWID). Since sharing injecting equipment is a major transmission route for Hepatitis C, prevalence among PWID is very high ranging from 31% to 98% as reported in previous study (Sereno L et all, 2012). Among HIV patients, data from IBBS show prevalence of HCV coinfection at 27% (Nadol P et al 2015). There is remarkable development of direct-acting agents (DAAs) as break-through medicines for hepatitis C treatment in recent years. Up to 95% of people with hepatitis C infection can be cured in 3 to 6 months. These new medicines are more efficacious, having less adverse effects and convenient for patients, compared to older medicines, e.g. interferon or pegylated interferon with ribavirin. Hepatitis C is major cause of cirrhosis, liver cancer in Vietnam. Without treatment, HIV/HCV co-infected patients could die because of advanced hepatitis such as decompensated cirrhosis and liver cancer. However, as new medicines, DAA has not been included for reimbursement by health insurance, thus access to the lifesaving treatment of HCV is not yet available for HIV/HCV co-infected patients. VAAC proposes to provide treatment for 1,000 HIV/HCV co-infected patients with SOF/LDV for 3 months. Estimated at least 900 patients will be cured from hepatitis C. Providing hepatitis C treatment service will be capacitated for 40 doctors and nurses at 10 selected OPCs in 2 provinces.","2020-12-31",1200000]
[null,"Viet Nam","Tuberculosis","MDR-TB","Case detection and diagnosis: MDR-TB","The estimated MDR-TB suspects in the country for 2018, 2019, and 2020 are 75,332, 80,893, and 86,401, respectively. The allocation amount covers the number of Xpert cartridges to detect for 50,000 suspects in 2018, 55,000 suspects in 2019, and 60,000 suspects in 2020. The PAAR amount will support to buy the necessary cartridges to detect the remaining 77,626 suspects over the three years. - Other related costs for case detection and diagnosis include:  sSample transportation  Equipment for one more LPA lab and 2 culture labs  Updated standard operating procedures (SOPs), TA, equipment, and training for the new panel phenotypic DST  Equipment, bio-products, and consumables to maintain WGS and related TA.","2020-12-31",2550198]
[null,"Viet Nam","Tuberculosis","MDR-TB","Engaging all care providers (MDR-TB)","Workshop about anti-TB drug (FL, SL, new) management in the market - Baseline survey on feasibility and acceptability of using mobile phone interventions for TB patient.","2020-12-31",61547]
[null,"Viet Nam","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","An introduction workshop with relevant partners at the national level about joint utilization of GeneXpert for TB and HIV tests in selected prisons, raining for prison staff on implementation of Xpert tests for TB and HIV, and scaling up MDR-TB management in prisons by MPS and KNCV (renovation of MDR-TB wards and TBIC laboratories, patient support, etc.).","2020-12-31",362013]
[null,"Viet Nam","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","Expansion of MDR-TB palliative care in three provinces by RCSCH, contributing to the MDR-TB treatment outcome in these provinces.","2020-12-31",362335]
[null,"Viet Nam","Tuberculosis","MDR-TB","Other MDR-TB intervention(s)","With the expansion of PMDT sites, strengthening laboratory and MDR-TB treatment facility infrastructure is will be crucial to support PMDT implementation. PAAR will support this activity in 5 provinces/year and support development of IEC materials for home-based TB-IC.","2020-12-31",277956]
[null,"Viet Nam","Tuberculosis","MDR-TB","Treatment: MDR-TB","The allocation amount is currently covering 60% of MDR-TB cases targeted for treatment (1950 cases in 2018, 2190 cases in 2019 and 2130 cases in 2020). The PAAR will support the remaining 40% of estimated MDR-TB cases enrolled for treatment. NTP will use PAAR to procure SLDs for 9-month and 20-month regimens and patient support for MDR-TB patients. : 1300 cases in 2018, 1460 cases in 2019, and 1420 cases in 2020 - PAAR will also support supervision by community staff for supporting MDR-TB patients, essential to ensure treatment adherence and treatment success. - The aDSM model is also crucial to detect, manage and report suspected or confirmed drug toxicities drugs at all MDR-TB sites, manage adverse drug reactions (ADRs), and relieve patient suffering and improve treatment outcomes. Related PAAR-supported activities include: developing materials, training, assessing current situation, and consolidating aDSM data electronically.","2020-12-31",3694973]
[null,"Viet Nam","Tuberculosis","Program management","Grant management","Salary, operational costs, and office equipment of new SRs who will be involved in the project (Senior Affair Group, MOLISA) - PAAR will support independent audits for new SRs by PR, and fund of supervision for new interventions proposed by KNCV and MOLISA.","2020-12-31",430368]
[null,"Viet Nam","Tuberculosis","Program management","Policy, planning, coordination and management of national disease control programs","Integration of TB prevention and control education into school extra-curricular activities in 2018 - E-learning to screen potential candidates for MECOR course and maintenance for the e-learning system for MECOR Supervision of GX including EQA and on-site technical support for GX implementation - Updates to the NTP guidelines and training in updated guidelines/ techniques (testing, GX, etc.) - Development of remote coordination and connectivity for clinical discussions and program support (i.e. ECHO system).","2020-12-31",204866]
[null,"Viet Nam","Tuberculosis","RSSH: Health management information systems and M&E","Analysis, review and transparency","The goals of the NSP is to apply/use innovative approach for TB detection and management. For effective implementation of innovative methods, studies, reviews and assessment are needed including: - Survey of TB prevalence among diabetes patients - Evaluation of backto-back service provision for TB/HIV, diagnosis of TB using induced sputum in patents who do not have productive cough or who are smear negative through a randomized controlled clinical trial.","2020-12-31",298591]
[null,"Viet Nam","Tuberculosis","RSSH: Health management information systems and M&E","Program and data quality","TA and supervision of data collection, data quality assessments, and one staff to participate in a regional TB/HIV conference.","2020-12-31",14299]
[null,"Viet Nam","Tuberculosis","RSSH: Health management information systems and M&E","Routine reporting","Procurement of 400 computers and printers for VITIMES/ ETB Manager implementation and two training courses per year for PPM facilities delivering TB services.","2020-12-31",283264]
[null,"Viet Nam","Tuberculosis","RSSH: Health management information systems and M&E","Surveys","Study of the LTBI prevalence among child contacts and their characteristics (contact, index patient and environmental) associated with infection.","2020-12-31",25000]
[null,"Viet Nam","Tuberculosis","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Annual maintenance, calibration, and testing of equipment to meet requirements to maintain the ISO certification - Training for QMS lecturers for NRL, RRLs, PRLs laboratories.","2020-12-31",18935]
[null,"Viet Nam","Tuberculosis","RSSH: Procurement and supply chain management systems","National costed supply chain master plan, and implementation","Upgrades to VITIMES and E-TB Manager to meet the supply chain management needs and link to health insurance, training, connect GeneXpert to eTB manager, and using GxAlert TA to support key provinces. - Development of \"Guidelines of supervision and technical support of management of supplying system at the facilities\", training on supply operation procedure (SOP) and supply statistic report, building a costing toolkit for quarterly needs and tentative needs for first line drugs, compile TB handbook \"what you need to know\" for drug resistant TB patients, and training on using TB drugs rationally and safely - Enhancing the application of information technology in medical stores by procuring computers, printer and uninterrupted power supply (UPS), and management of central and regional store software - Needs assessment and development of SOPs for supplying free drugs to MDR-TB patients in the private sector.","2020-12-31",296644]
[null,"Viet Nam","Tuberculosis","TB care and prevention","Case detection and diagnosis","In order to use Xpert for all TB suspects by 2020, the procurement and adaptation of GeneXpert machines is essential. The allocation amount covers procurement of 30 GX machines to scale up Xpert capacity. PAAR will cover a) 20 additional 4-module GX machines and 40 Xpert Omni per year, b) 100k cartridges in 2018, 150k in 2019, and 237k in 2020 (+ consumables and testing fee), and c) training for TB units receiving new machines, and for transition to Ultra cartridges. This will cover Xpert testing among 12,000 people per year with an abnormal CXR. - Additional costs will include:  Two ILEDs per year, ILED maintenance & repair, and EQA for microscope's smear  Three digital X-ray cars per year (total 9 cars) to contribute to I/ACF  Implementation of the FAST strategy.","2020-12-31",9710510]
[null,"Viet Nam","Tuberculosis","TB care and prevention","Community TB care delivery","Zero TB city in 2 provinces - Scaling up two provinces implementing a model of early TB detection and two additional provinces implementing m-Heallth by the Farmers Union - Implementing ACSM for stigma reduction through TB literacy and use of social media.","2020-12-31",633069]
[null,"Viet Nam","Tuberculosis","TB care and prevention","Engaging all care providers (TB care and prevention)","Scaling up two additional PPM-DOTS provinces by NTP and 3 additional PPMDOTS provinces by RCSCH - Development of guidelines for PPM of Childhood TB, for working with pediatric hospitals and pediatric departments of general/infectious diseases hospitals, covering 20 provinces and cities Scaling up PAL to 20 provinces by NTP and 6 provinces by CCHD.","2020-12-31",805783]
[null,"Viet Nam","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","The elderly in Vietnam have a high prevalence of TB. According to the TIME model, about 10,000 elderly cases can be detected with large scale ACF. The PAAR will provide screening for 6000 elderly in community, 2000 in mental health institutions, and 2000 in in some social protection centers in 0seven provinces per year using CXR and Xpert . PAAR will also support workshops to improve awareness of TB among the elderly.","2020-12-31",316820]
[null,"Viet Nam","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","To support expansion of childhood TB activities, the PAAR will support revision of the diagnosis, treatment, and prevention training materials. NTP will also develop, print, and distribute IEC materials (poster, leaflets, etc.) for community awareness and support health workers on IPT and childhood TB management, with the ambition to detect and treat about 3,000 more cases per year.","2020-12-31",75243]
[null,"Viet Nam","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","With regard to this key population, PAAR will support scaling up entry TB screening for more 7000 new prisoners, IC of MDR-TB for MDR treatment areas in 07 prisons, examination and screening for prisoners of two prisons for LTBI treatment, peer education training for temporary detention centers, and support for prisoners with active disease.","2020-12-31",419016]
[null,"Viet Nam","Tuberculosis","TB care and prevention","Other TB care and prevention intervention(s)","Under-served populations have a higher prevalence which requires ACF on a large scale. The allocation does not cover these activities. PAAR will reach the estimated additional cases based on the TIME model for these populations: about 33,000 patients per year. - PAAR will further support:  Scaling up ACF in four districts per year with large populations and high TB prevalence  TB screening and preventive treatment for 4000 immigrants per year  Routine screening for 6000 patients per year at the Methadone centers and at voluntary drug detoxication centers.  Screening for 7000 miners per year in Quang Ninh.  Screening for 7000 health workers with high risk of TB.  Establishment of a comprehensive model for TB detection and control in social protection centers in 3 provinces by MOLISA.  Procurement of 2 digital mobile X-ray machines to scale ACF in 3 border provinces.","2020-12-31",2034765]
[null,"Viet Nam","Tuberculosis","TB care and prevention","Treatment","Scaling up mHEalthin four provinces and piloting mHealth for MDR-TB - Renovating to improve TBIC for five TB/HIV patient care facilities per year and training in TBIC for general hospital and prison staff.","2020-12-31",424820]
[null,"Viet Nam","Tuberculosis","TB/HIV","TB/HIV collaborative interventions","The current allocation amount covers 30,000 Xpert tests in 2018, 35,000 tests in 2019, and 50,000 tests in 2020. The PAAR will provide 20,000 additional tests in 2018, 25,000 tests in 2019, and 40,000 tests in 2020. PAAR scale-up of TB screening 5000 newly detected HIV patients per year. (Current allocation for the 2018-2020 period is 37,000 patients)\\ - Additional PAAR-supported costs are:  TB/HIV training for TB and HIV staff  Conference and training on ARV and CPT, including monitoring for HIV positive TB patients  Reagents, consumables, and test kit supplies to maintain LF-LAM in 2020.","2020-12-31",688328]
[null,"Viet Nam Total",{"$nulls":5},37768999]
[null,"Zambia","HIV/AIDS","HIV Testing Services","Differentiated HIV testing services","Due to changes in funding landscape, additional funding is required to maintain and scale up HIV testing","2020-12-31",2806426]
[null,"Zambia","HIV/AIDS","TB care and prevention","Case detection and diagnosis","Finding missing cases (People with TB) using campaign based model. This concerns heightened activities for 8 weeks once every quarter using digital x-ray mounted vehicles and GeneXpert machines.","2020-12-31",2372764]
[null,"Zambia","HIV/AIDS","TB care and prevention","Other TB care and prevention intervention(s)","Fully oral shorter regimen implemented under operational research conditions.","2020-12-31",100000]
[null,"Zambia","HIV/AIDS","Treatment, care and support","Differentiated ART service delivery","National ART guidelines for 2018 have changed towards the new regimens.  This has altered the gap analysis for ARVs, leading to the need for increased Global Fund resources. Global Fund had initially committed $47,078,326 towards ARVs to cover 3 years 2018-2020. However, Global Fund exhausted all its obligation before 2020.","2020-12-31",4458908]
[null,"Zambia","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The number of LLINs to be distributed through routine channel to targeted  at risk populations is 2,158,203  and 1,948,203 in 2019 and 2020 respectively.","2020-12-31",5778982.7999999998]
[null,"Zambia","Malaria","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The number of LLINs to be distributed to at risk population through mass campaign in 2020 is 7,512,678.","2020-12-31",6714256.5]
[null,"Zambia","Multi-component","HIV Testing Services","Differentiated HIV testing services","To scale up self-testing (200,000 test/year). Aligns with accelerated prevention interventions for AGYW.","2020-12-31",1365570]
[null,"Zambia","Multi-component","Prevention programs for general population","Condoms as part of programs for general population","For male and female condoms. There is an anticipated funding shortfall due to reduced funding from other partners over the implementation period.","2020-12-31",4967855]
[null,"Zambia","Multi-component","Prevention programs for general population","Male circumcision","Voluntary medical male circumcision reusable and consumables kits, early infant male circumcision training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly.","2020-12-31",10743359]
[null,"Zambia","Multi-component","Program management","Grant management","Funding will provide additional risk mitigation for the management of the expanded scope of the program, particularly the additional civil society and community sub-recipients.","2020-12-31",974242]
[null,"Zambia","Multi-component","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Recruitment and placement of additonal 1400 nurses in rural areas and disease hotspots. Only 600 nurses could be covered by the allocation, whereas 2000 new nurses are required to achieve treatment targets for the implementation period.","2020-12-31",41076000]
[null,"Zambia","Multi-component","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","These funds will support health care waste management systems. The funds will be used for 5 incinerators, 10 air samplers, a laptop for integrated inventory management, supervision, M&E, and quality control.","2020-12-31",2349640]
[null,"Zambia","Multi-component","TB care and prevention","Treatment","First line drugs for additional patients in view of scaled up diagnostics in addition to external quality assessment activities for smear microscopies. This will support expanded diagnostic capacity.","2020-12-31",902660]
[null,"Zambia","Multi-component","TB care and prevention","Treatment","Second line drugs for additional MDR-TB patients and improvement of Treatment Success Rate.","2020-12-31",1599751]
[null,"Zambia","Multi-component","TB/HIV","TB/HIV collaborative interventions","Additional 100 Xpert machines, with related cartridges, printers and UPS, and 4 digital X-Ray machines. The TRP considers this low priority as there are 200 machines within allocation funding that need to be phased in while ensuring optimum utilisation.","2020-12-31",8137710]
[null,"Zambia","Multi-component","Treatment, care and support","Treatment adherence","Radio programs on treatment literacy, incentives for 2000 Adherence Support Workers (ASW) per year. The TRP recommends that these resources be leveraged to also support TB/HIV collaborative activities  i.e. MDR-TB.","2020-12-31",79996]
[null,"Zambia","Multi-component","Treatment, care and support","Treatment monitoring - Viral load","These are RSSH PSM strengthening activities although labelled as viral load and monitoring. The request will further strengthen PSM quality of health products, and improve rational use of medicines.","2020-12-31",7859920]
[null,"Zambia","Multi-component","Vector control","Other vector control measure(s)","This will complement the support for entomological surveillance to ensure quality and effectiveness of the vector control operations, particularly IRS.","2020-12-31",900000]
[null,"Zambia","Multi-component","Vector control","Other vector control measure(s)","This is a relevant component of the countrys elimination strategy that is critical as the burden progressively declines. This strategy will support the development of case-based surveillance in areas with low malaria transmission.","2020-12-31",10686696]
[null,"Zambia Total",{"$nulls":5},113874736.3]
[null,"Zanzibar","Malaria","Case management","Active case detection and investigation (elimination phase)","This intervention is meant to ensure that every malaria case is reached in order to achieve elimination.","2020-12-31",22624]
[null,"Zanzibar","Malaria","Case management","Therapeutic efficacy surveillance","This intervention aims to ensure that drugs are working, resistance is checked, and any potential adverse events are mitigated as necessary.","2020-12-31",104768]
[null,"Zanzibar","Malaria","Program management","Grant management","This item covers program management activities to ensure effective and smooth undertaking of the program's operational plan, monitoring of program budget and implementation of the planned activities.","2020-12-31",13100]
[null,"Zanzibar","Malaria","Program management","Policy, planning, coordination and management of national disease control programs","This activity will cover the cost for trainings and meeting attendances.","2020-12-31",28775]
[null,"Zanzibar","Malaria","RSSH: Health management information systems and M&E","Analysis, review and transparency","This activity will strengthen the monitoring and evaluation component for the entire program.","2020-12-31",100233]
[null,"Zanzibar","Malaria","RSSH: Health management information systems and M&E","Program and data quality","This item will cover interventions to support improving the accuracy of data collection and analysis to inform decision making.","2020-12-31",17308]
[null,"Zanzibar","Malaria","RSSH: Health management information systems and M&E","Routine reporting","This activity will cover the cost to monitor and support regular and timely reporting of all activities conducted at various levels of implementation.","2020-12-31",58909]
[null,"Zanzibar","Malaria","RSSH: Health management information systems and M&E","Surveys","Data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","2020-12-31",51510]
[null,"Zanzibar","Malaria","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The installation of network infrastructure will support and strengthen procurement and supply chain activities.","2020-12-31",1548]
[null,"Zanzibar","TB/HIV","PMTCT","Prong 3: Preventing vertical HIV transmission","This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women.","2020-12-31",544241]
[null,"Zanzibar","TB/HIV","Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","The intervention will fund Hepatitis B screening as an adjunct to the HIV testing programs among key populations.","2020-12-31",44445]
[null,"Zanzibar","TB/HIV","Program management","Policy, planning, coordination and management of national disease control programs","Procurement and supply chain management (PSM) capacity was identified as a potential bottleneck to program scale-up. These funds will cover capacity building for PSM, including necessary technical assistance, in line with the needs of the program expansion.","2020-12-31",121042]
[null,"Zanzibar","TB/HIV","RSSH: Health management information systems and M&E","Analysis, review and transparency","This activity will complement program scale-up by availing and enabling data use for implementation.","2020-12-31",82716]
[null,"Zanzibar","TB/HIV","RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention is meant improve the overall quality and monitoring of health data in the expanded program. It will serve to extend the institution of the electronic medical records through the increase in the number of health facilities and capacity building for the health workforce.","2020-12-31",186665]
[null,"Zanzibar","TB/HIV","RSSH: Health management information systems and M&E","Routine reporting","This intervention will improve routine data collection and data quality in light of the planned scale-up of Zanzibars treatment programs.","2020-12-31",217227]
[null,"Zanzibar","TB/HIV","RSSH: Health management information systems and M&E","Surveys","These funds would enable an implementation research study on the bottlenecks to access opioid substitution therapy for people who inject drugs, which is a key programmatic gap. These funds would also fund a study on adherence to ART. Both studies are likely to inform program strategy.","2020-12-31",43915]
[null,"Zanzibar","TB/HIV","TB care and prevention","Case detection and diagnosis","Enhancing TB prevention activities and case detection is in line with program needs.  However with the purchase and institution of GeneXpert from within the allocation budget, it is rated as medium priority.","2020-12-31",52308]
[null,"Zanzibar","TB/HIV","Treatment, care and support","Treatment adherence","The intervention will fund treatment of opportunistic infections, toxicity monitoring and home-based care interventions in view of maintaining safety and efficacy of ART and improve survival and overall impact of ART scale up.","2020-12-31",1029107]
[null,"Zanzibar Total",{"$nulls":5},2720441]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for MSM","Addressing stigma, discrimination and violence against MSM","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",72600]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for MSM","Community empowerment for MSM","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",534032]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for MSM","Condoms and lubricant programming for MSM","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",800]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",402785]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Addressing stigma, discrimination and violence against sex workers","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",81125]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",2463120]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",1938840]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for TGs","Addressing stigma, discrimination and violence against TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","2020-12-31",5240]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for TGs","Community empowerment for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","2020-12-31",224561]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for TGs","Condoms and lubricant programming for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","2020-12-31",1200]
[null,"Zimbabwe","TB/HIV","Comprehensive prevention programs for TGs","Other intervention(s) for TGs","While no national data exists on HIV burden among transgender people, global statistics suggest that transwomen are up to 49 times more likely to contract HIV than the general population.vi A small study of transwomen in Bulawayo found that HIV risk perception was very low despite high risk sexual behaviours, and that the majority of transwomen never practised safe-sex, rarely sought HTS, and reported high levels of violence, including forced sexual experiences.vii Informed by this evidence, funding is requested to improve prevention, treatment and support services for this high-risk, underserved group through two sites in Harare and Bulawayo, and in a new drop-in centre in Victoria Falls.","2020-12-31",394920]
[null,"Zimbabwe","TB/HIV","Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","2020-12-31",76500]
[null,"Zimbabwe","TB/HIV","Comprehensive programs for people in prisons and other closed settings","Behavioral interventions for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","2020-12-31",11700]
[null,"Zimbabwe","TB/HIV","Comprehensive programs for people in prisons and other closed settings","Community empowerment for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","2020-12-31",184701]
[null,"Zimbabwe","TB/HIV","Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","2020-12-31",251100]
[null,"Zimbabwe","TB/HIV","HIV Testing Services","Differentiated HIV testing services","Above allocation funding is requested for the procurement of self-test kits. Self-testing is prioritized in this funding request based on lessons learned about its effectiveness in reaching young people and men, as well as evidence from pilot programs which show this is a high yield method at more than 20% positivity","2020-12-31",9014947]
[null,"Zimbabwe","TB/HIV","HIV Testing Services","Differentiated HIV testing services","Filling gaps in standard test kit procurement for year 3 is the top priority request in the PAAR.","2020-12-31",2092061]
[null,"Zimbabwe","TB/HIV","MDR-TB","Other MDR-TB intervention(s)","The final proposed investment will support prevention for MDR-TB and will include activities to strengthen and support TB infection control (IC) at community levels. Specifically the investment will support IC assessments for homes of diagnosed DR-TB patients and provide education on transmission risk reduction to family members, as well as initiate investigation of contacts. Engaging community leaders will place DR-TB on the agenda and facilitate a cascade of information within communities as part of the broader community TB care intervention. Decentralization of DR-TB treatment has meant that the majority of diagnosed patients are managed from their homes, justifying the rationale for these interventions, aimed at empowering community members to protect themselves and other vulnerable groups such as children, the elderly and PLHIV from acquiring TB.","2020-12-31",493087]
[null,"Zimbabwe","TB/HIV","PMTCT","Other intervention(s) for PMTCT","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","2020-12-31",2403200]
[null,"Zimbabwe","TB/HIV","PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","2020-12-31",230400]
[null,"Zimbabwe","TB/HIV","PMTCT","Prong 3: Preventing vertical HIV transmission","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","2020-12-31",568000]
[null,"Zimbabwe","TB/HIV","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","2020-12-31",375900]
[null,"Zimbabwe","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Community adolescent treatment supporters in 6 additional districts.","2020-12-31",1300000]
[null,"Zimbabwe","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Scale up the modified DREAMS package to an additional 4 districts.","2020-12-31",3174288]
[null,"Zimbabwe","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","Brother2brother pilot: 10 Districts.","2020-12-31",900000]
[null,"Zimbabwe","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","In school and tertiary programme.","2020-12-31",3000000]
[null,"Zimbabwe","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","Youth Centers (Multi-sectoral approach model).","2020-12-31",1300000]
[null,"Zimbabwe","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Gender-based violence prevention and treatment programs for adolescents and youth","Funding is requested for community infrastructure, technology and transport systems to establish six additional one-stop centres (in addition to the four requested in the matching funds application) for HIV/SRHR/GBV, building on successes of existing centres in Rusape General Hospital (Makoni), Harare and Gweru. As more than 1 in 3 Zimbabwean women experience physical violence, the 17,000 GBV survivors served by the current centres is an enormous service gap. The need to decentralize access to GBV services and strengthen linkages to communities is vital.","2020-12-31",1617630]
[null,"Zimbabwe","TB/HIV","Prevention programs for adolescents and youth, in and out of school","Keeping girls in school","Doubling the education subsidies in the existing 4 DREAMS districts to reach at least 30% of the vulnerable AGYW in those districts.","2020-12-31",2160000]
[null,"Zimbabwe","TB/HIV","Prevention programs for general population","Condoms as part of programs for general population","Close gaps in male and female condom programming when delivering the comprehensive prevention package of services at community levels. The expected impact is based on continuing trends which show that an estimated 2 million HIV infections were averted by the increase in actual condom use between 1990 and 2016, compared to a scenario in which condom use levels stagnated in 1990. This investment will also complement PEPFARs investment in condom procurement by prioritizing filling the gaps in social marketing, including TV, radio and community sensitization. $299,700 is requested for demonstration models and dispensers while $1,064,316 is requested for programming. The US government continues to invest significant amounts in the procurement of male and female condoms, with Global Fund resources intended to complement these investments.","2020-12-31",1364016]
[null,"Zimbabwe","TB/HIV","Prevention programs for general population","Diagnosis and treatment of STIs and other sexual health services for general population","HIV prevention-related STI services, including for the provision of dual HIV and syphilis testing, STI screening and treatment, referrals for HPV vaccines and cervical cancer services.","2020-12-31",3568111]
[null,"Zimbabwe","TB/HIV","Prevention programs for general population","Gender-based violence prevention and treatment programs for general population","Primary gender-based violence prevention programs to protect vulnerable women and girls. Specifically, funding is requested to roll out the MenEngage Padere model in 25 districts (Note: Piloting of the SASA! model is prioritized in the matching funds request for AGYW).","2020-12-31",355668]
[null,"Zimbabwe","TB/HIV","Prevention programs for general population","Male circumcision","Building on the targeted and tailored prevention packages for AGYW and key populations which have been prioritized for within allocation request, high impact prevention interventions for the general population also have the potential for significant impact. Prevention is a strong focus of this funding request. In line with Zimbabwes new Roadmap to Revitalise HIV Prevention in Zimbabwe (2016). Above allocation funding is requested to scale up of VMMC, prioritizing the 7 underserved districts not covered by PEPFAR (Inyanga, Chimanimani, Bikita, Rushinga, Uzumba-MarambaPfungwe, Kariba and Binga) prioritized first, scaling up to other underserved areas from there. Funding is requested both for VMMC commodities ($4,496,750.00) and programming ($1,202,027.72).Robust impact modelling in the countrys Accelerated Strategic and Operational Plan on VMMC shows that scaling up this activity will avert 212,000 HIV infections by 2025 and reduce prevalence by 3%. Achieving the target of circumcising 1.3 million men will result in more than $1 billion in financial savings.","2020-12-31",5698778]
[null,"Zimbabwe","TB/HIV","Prevention programs for general population","Other intervention(s) for general population","Other prevention activities including program coordination, learning and support.","2020-12-31",939252]
[null,"Zimbabwe","TB/HIV","Prevention programs for general population","Other intervention(s) for general population","Positive health dignity and prevention (PHDP) activities.","2020-12-31",10185]
[null,"Zimbabwe","TB/HIV","Prevention programs for general population","Other intervention(s) for general population","Procure and provide targeted PrEP for populations at elevated risk, prioritizing PrEP for serodiscordant couples ($3,413,954.14) and scaling up through a phased approach.","2020-12-31",1495731]
[null,"Zimbabwe","TB/HIV","Prevention programs for other vulnerable populations","Behavioral interventions as part of programs for general population","Supporting existing behavior change facilitators in 46 districts and extend their work to workplaces (including informal sector) to reach men with out of facility prevention, testing and linkage to care.","2020-12-31",858090]
[null,"Zimbabwe","TB/HIV","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","2020-12-31",142164]
[null,"Zimbabwe","TB/HIV","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","2020-12-31",276588]
[null,"Zimbabwe","TB/HIV","Program management","Grant management","PR (7%) and SR (3%) costs for implementation of the total PAAR request.","2020-12-31",27688]
[null,"Zimbabwe","TB/HIV","RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations and womens networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","2020-12-31",850295]
[null,"Zimbabwe","TB/HIV","RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations and womens networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","2020-12-31",8410509]
[null,"Zimbabwe","TB/HIV","RSSH: Financial management systems","Other financial management intervention(s)","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",3446640]
[null,"Zimbabwe","TB/HIV","RSSH: Financial management systems","Public financial management (PFM) strengthening","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",254910]
[null,"Zimbabwe","TB/HIV","RSSH: Financial management systems","Routine financial management improvement (non-PFM)","Additional scale up through extended outreach from fixed and mobile sites.","2020-12-31",929559]
[null,"Zimbabwe","TB/HIV","RSSH: Health management information systems and M&E","Program and data quality","Funding is requested to support an additional 267 data entry clerks for the ePMS and DHIS2 systems.","2020-12-31",1922400]
[null,"Zimbabwe","TB/HIV","RSSH: Health management information systems and M&E","Routine reporting","Support and maintenance for the ePMS, DHIS2 and plans for greater integration with HIV, TB and RMNCAH indicators, including improving patient-level tracking","2020-12-31",1328850]
[null,"Zimbabwe","TB/HIV","RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).","2020-12-31",3132000]
[null,"Zimbabwe","TB/HIV","RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Funding is requested for the delivery of quality integrated services across the continuum of care for HIV/TB/Malaria/SRH. Activities will include revision of the SRH/HIV Linkages Guidelines to include TB and malaria. Second, the requested investment will strengthen outreach as part of decentralized service delivery models. Activities will include establishing new cervical cancer screening and management centers and revise EPI service provision package to include HIV testing at 18 months. Closely linked with the above activities, funding is requested to boost differentiated care across the continuum of care, based on profiling by age and retention in care. This will include the development and implementation of service guidelines for linkages and referrals between health facilities, schools and community service delivery points to provide integrated HIV/TB/malaria/SRH (including family planning) services to adolescents. Lastly, funding is requested for activities to buttress the school health program (and catalyze impact from the proposed investments in HIV prevention among AGYW).","2020-12-31",1063192]
[null,"Zimbabwe","TB/HIV","RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Additional PSM strengthening to scale up viral load monitoring, optimize the use of GeneXpert, strengthen LMIS and links it to patient monitoring, and ensure quality medicines and diagnostics.","2020-12-31",7312508]
[null,"Zimbabwe","TB/HIV","RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Phase II: Construction of Harare NatPharm Central warehouse and purchase of equipment. Previously TRP cleared in 2013, transferred from NFM grant (2014-2017) due to transition policy.","2020-12-31",22737584]
[null,"Zimbabwe","TB/HIV","TB care and prevention","Case detection and diagnosis","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","2020-12-31",374255]
[null,"Zimbabwe","TB/HIV","TB care and prevention","Other TB care and prevention intervention(s)","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","2020-12-31",2438660]
[null,"Zimbabwe","TB/HIV","TB/HIV","Collaborative activities with other programs and sectors (TB/HIV)","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.","2020-12-31",975000]
[null,"Zimbabwe","TB/HIV","TB/HIV","Other TB/HIV intervention(s)","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.","2020-12-31",1475266]
[null,"Zimbabwe","TB/HIV","TB/HIV","TB/HIV collaborative interventions","Above allocation funding is requested to scale up quality integrated TB-HIV treatment (ITHC) and care all under one roof. Funding will support renovation of 65 hospitals/clinics (40 for HIV and 25 for TB) to enable one-stop-shop service provision for TB/HIV/MNCH services with an aim to colocate family planning, STI, and cervical cancer screening in OI/ART. It is expected that this approach will increase uptake for both HIV and TB services towards national targets of 100% HIV testing for TB patients, 100% CPT and ART initiation among co-infected people by 2020. Funding will also promote TB Infection Prevention and Control (IPC) practices in TB/HIV care settings. Health care workers will be trained on good IPC practices including periodic TB screening as part of a comprehensive workplace wellness program. Procurement of respirators will be supported for personal care provider protection during patient consults. This investment will provide a safer environment by reducing nosocomial transmission of TB within health facilities and raise confidence levels among health care workers who provide care. Funding will optimize community systems for TB/HIV service delivery. Community activities to create demand for TB-HIV services will be supported through successful models of community empowerment such as the Community Mobilisation and Empowerment for Improved Access to Care, Support and Treatment (CMEIACST) supported in Round 8 of the Global Fund grant. It is expected that fully utilizing community systems will potentially impact positively on health seeking behaviour and access to health services for the general public and marginalised groups (ie. women and children). Above allocation funding is also requested to engage all care providers. Mapping existing private service providers will be undertaken to determine synergies within TB and HIV programmes. Strengthening public-private mix approach could contribute to reaching a significant proportion of missed TB cases, and improve case holding for better treatment outcomes. In some settings the contribution of PPM to case notifications has been as high as 48%.","2020-12-31",106700]
[null,"Zimbabwe","TB/HIV","TB/HIV","TB/HIV collaborative interventions","Third, above allocation funding is requested to fill gaps in opportunistic infections medicines and related commodities including cotimoxisole, IPT, Ampotericin, kaposi sarcoma and gastric lavage.","2020-12-31",4897537]
[null,"Zimbabwe","TB/HIV","Treatment, care and support","Treatment monitoring - Viral load","Following test kits, filling gaps in viral load scale-up and other patient monitoring and quality of care gaps (CD4, EID, Haematology, etc.) is the second priority for the PAAR. Increasingly phasing out CD4 testing and scaling up viral load testing (to move to the maintenance phase of the VL scale up plan) is prioritized to ensure 90% of PLHIV who are on sustained ART are virally supressed by 2020.","2020-12-31",66987154]
[null,"Zimbabwe Total",{"$nulls":5},178652027]
[null,"Grand Total",{"$nulls":5},2984621279.1100001]

{"sheet":"PAAR_UQD report","index":7,"n_rows":2671,"n_cols":54,"rows_kept":1125,"cut":true,"hidden":false,"merged":[],"bounds":{"rows_first":500,"rows_last":125,"rows_between":500,"halvings":2}}
["ID","UQD ID","Status","Old UQD ID","Allocation Cycle","Region","Country or Multicountry","Component","FR Component","FR Name","Applicant Priority Rating","Requested PAAR Amount","Module","Intervention","Brief Rationale","Brief Rationale (Translated)","Comment","TRP Priority Rating","Recommended PAAR Amount","TRP Comment","UQD Funded - Savings","UQD Funded - Portfolio Optimization","UQD Funded - D2H or PSC","UQD Funded - Other","Remaining UQD Amount","No Longer in Demand","Last Notify A2F","Last Modified","Created Date","URL","End Date","High level component","Remaining UQD (value)","Region (value)","FR Component copy","FR Component 1","FR component 2","FR component 3","FR component 4","FR component 2 trim","FR component 3 trim","FR component 4 trim","AUP end date Component 1","AUP end date Component 2","AUP end date Component 3","AUP end date Component 4","AUP end date for country","Final AUP end date to use","AUP start date Component 1","AUP start date Component 2","AUP start date Component 3","AUP start date Component 4","AUP start date for country","Final AUP start date to use"]
["a6Q1R000000AIuWUAW","PAI-3538","Active","AFG-HIV/AIDS-1","2017-2019","RT South East Asia","Afghanistan","HIV/AIDS","HIV/AIDS","FR443-AFG-H",null,null,"RSSH: Health management information systems and M&E","Program and data quality","7-10% total grant budget can be allocated to M&E & surveillance related activities. Hence, the NACP encounters numerous issues in terms of data quality, verification, collection, capacity building in terms of trainings for the M&E and Surveillance staff. Need to recruit three national epidemiologists short-term basis to train staff. Assessment on FIDUs is a critical component of the programs as previously recommended by the TRP to be further strengthened to ensure that the country needs are met.","7-10% total grant budget can be allocated to M&E & surveillance related activities. Hence, the NACP encounters numerous issues in terms of data quality, verification, collection, capacity building in terms of trainings for the M&E and Surveillance staff. Need to recruit three national epidemiologists short-term basis to train staff. Assessment on FIDUs is a critical component of the programs as previously recommended by the TRP to be further strengthened to ensure that the country needs are met.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","483280","The TRP considers this intervention to be an important additional activity that builds on activities in Section 4 - Objective 2 to Build Resilient and Sustainable Systems for Health Applicant SelfAssessment To Inform Program Continuation and supports the success of other activities in the funding request.","0","0","0","0","483280","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuW/view","2020-12-31",{"$f":"IF(OR(I2=\"HIV/AIDS\",I2=\"Tuberculosis\",I2=\"Malaria\",I2=\"RSSH\"),I2, IF(I2=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"HIV/AIDS"},{"$f":"VALUE(Y2)","v":483280},{"$f":"RIGHT(F2,LEN(F2)-2)","v":" South East Asia"},"HIV/AIDS","HIV/AIDS",null,null,null,{"$f":"TRIM(AK2)","v":""},{"$f":"TRIM(AL2)","v":""},{"$f":"TRIM(AM2)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713=AN2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713=AO2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713=AP2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE2<>\"\",AE2,IF(MAX(AQ2,AR2,AS2,AT2)<>0,MAX(AQ2,AR2,AS2,AT2),AU2))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713=AN2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713=AO2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713=AP2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE2<>\"\",AE2,IF(MAX(AW2,AX2,AY2,AZ2)<>0,MAX(AW2,AX2,AY2,AZ2),BA2))","v":"2020-12-31"}]
["a6Q1R000000AIuXUAW","PAI-3539","Active","AFG-HIV/AIDS-2","2017-2019","RT South East Asia","Afghanistan","HIV/AIDS","HIV/AIDS","FR443-AFG-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Condoms and lubricant programming for PWID","The activity for female injecting drug users will be started in four provinces i.e. Kabul, Nangarhar, Balkh and Herat provinces. The initiation of this activity will be subject to the assessment results by the end of the year 2017. Currently, there is no intervention for FIDU in the 3 country by any partners.","The activity for female injecting drug users will be started in four provinces i.e. Kabul, Nangarhar, Balkh and Herat provinces. The initiation of this activity will be subject to the assessment results by the end of the year 2017. Currently, there is no intervention for FIDU in the 3 country by any partners.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Condoms and lubricant programming for people who inject drugs","High","423465","The TRP considers this intervention to be an important additional activity addresses Issue 2 - Lack of Services for women who inject drugs  raised by the TRP in the Program Continuation Validation Form and supports the activities outlined by the applicant in the TRP Clarifications Form response tothis issue.","0","0","0","0","423465","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuX/view","2020-12-31",{"$f":"IF(OR(I3=\"HIV/AIDS\",I3=\"Tuberculosis\",I3=\"Malaria\",I3=\"RSSH\"),I3, IF(I3=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"HIV/AIDS"},{"$f":"VALUE(Y3)","v":423465},{"$f":"RIGHT(F3,LEN(F3)-2)","v":" South East Asia"},"HIV/AIDS","HIV/AIDS",null,null,null,{"$f":"TRIM(AK3)","v":""},{"$f":"TRIM(AL3)","v":""},{"$f":"TRIM(AM3)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713=AN3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713=AO3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713=AP3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE3<>\"\",AE3,IF(MAX(AQ3,AR3,AS3,AT3)<>0,MAX(AQ3,AR3,AS3,AT3),AU3))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713=AJ3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713=AN3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713=AO3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713=AP3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G3)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE3<>\"\",AE3,IF(MAX(AW3,AX3,AY3,AZ3)<>0,MAX(AW3,AX3,AY3,AZ3),BA3))","v":"2020-12-31"}]
["a6Q1R000000AIuYUAW","PAI-3540","Active","AFG-HIV/AIDS-3","2017-2019","RT South East Asia","Afghanistan","HIV/AIDS","HIV/AIDS","FR443-AFG-H",null,null,"Treatment, care and support","Treatment adherence","In order to increase adherence of patients to treatment certain social support pckages are proposed.","In order to increase adherence of patients to treatment certain social support pckages are proposed.",null,"High","768060","The TRP considers this intervention to be an important additional activity that builds on activities in Section 3 - Investing to maximize impact towards ending the epidemics in the Applicant SelfAssessment to Inform Program Continuation and supports the success of other activities related to scaling up ART for people living with HIV in the funding request.","0","0","0","0","768060","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuY/view","2020-12-31","HIV/AIDS",768060," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713=AN4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713=AO4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713=AP4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE4<>\"\",AE4,IF(MAX(AQ4,AR4,AS4,AT4)<>0,MAX(AQ4,AR4,AS4,AT4),AU4))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713=AJ4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713=AN4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713=AO4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713=AP4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G4)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIuZUAW","PAI-3541","Active","AFG-HIV/AIDS-4","2017-2019","RT South East Asia","Afghanistan","HIV/AIDS","HIV/AIDS","FR443-AFG-H",null,null,"Program management","Grant management","This refers to the PR 7% Grant Management Services (GMS) cost and Sub-recipient 5% overhead cost.","This refers to the PR 7% Grant Management Services (GMS) cost and Sub-recipient 5% overhead cost.",null,"High","214501","The TRP considers this intervention to be appropriate given the amount requested and the challenges with grant management in a Challenging operating Environment","0","0","0","0","214501","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuZ/view","2020-12-31","HIV/AIDS",214501," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713=AN5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713=AO5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713=AP5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713=AJ5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713=AN5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713=AO5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713=AP5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G5)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIuaUAG","PAI-3542","Active","AFG-HIV/AIDS-5","2017-2019","RT South East Asia","Afghanistan","HIV/AIDS","HIV/AIDS","FR443-AFG-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Condoms and lubricant programming for PWID","There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.","There is one mobile outreach team comprising a doctor, social worker,  counselor and  lab technician with dedicated vehicle transportation to reach out to rural population to perform community education and HIV Counseling and Testing Services in Kabul, Balkh, Herat, and Nangarhar. In the mentioned provinces, the SEHAT project already provides the HR services to PWID. Thus, the mobile teams will cover out of reach areas and those who are missed from the SEHAT outreach teams within the cities.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Condoms and lubricant programming for people who inject drugs","High","172108","The TRP considers this intervention to be an important additional activity that builds and scales up harm reduction and HIV testing and counselling activities in Section 3 of the Applicant Self Assessment for Programme Continuation. As part of efforts to maximize impact towards ending the epidemic, the applicant proposes to use a dedicated mobile team to reach out to catchment areas that are missed by existing outreach teams in the major cities as well as out of reach non-urban areas in need of services","0","0","0","0","172108","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIua/view","2020-12-31","HIV/AIDS",172108," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713=AN6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713=AO6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713=AP6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713=AJ6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713=AN6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713=AO6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713=AP6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G6)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIubUAG","PAI-3543","Active","AFG-HIV/AIDS-6","2017-2019","RT South East Asia","Afghanistan","HIV/AIDS","HIV/AIDS","FR443-AFG-H",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Currently there were 6 provincial coordinators, 5 CDC focal points, 6 drivers and their PPHO running costs. The running cost included maintenance & fuel of vehicles and mobile phone top ups.  This module helped coordinate program activities at sub national level, therefore, it is proposed under above allocation but with some changes. The change aims to increase the number of CDC focal points from 5 to 11 and drop the provincial coordinators and PPHO related costs.","Currently there were 6 provincial coordinators, 5 CDC focal points, 6 drivers and their PPHO running costs. The running cost included maintenance & fuel of vehicles and mobile phone top ups.  This module helped coordinate program activities at sub national level, therefore, it is proposed under above allocation but with some changes. The change aims to increase the number of CDC focal points from 5 to 11 and drop the provincial coordinators and PPHO related costs.",null,"High","377846","The TRP considers this an important intervention as the proposed staffing changes reflect the expansion from 8 to 11 provinces in the funding request.","0","0","0","0","377846","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIub/view","2020-12-31","HIV/AIDS",377846," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713=AN7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713=AO7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713=AP7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713=AJ7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713=AN7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713=AO7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713=AP7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G7)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIucUAG","PAI-3544","Active","AFG-HIV/AIDS-7","2017-2019","RT South East Asia","Afghanistan","HIV/AIDS","HIV/AIDS","FR443-AFG-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Sub-recipient NGOs  could mobilize food items for PWID in Drop In Centers (DICs) from other sources.  Considering the status of 5 mentioned clients, it was necessary to provide cooked food; therefore, it was needed to hire six cooks in six provinces. The provinces include: Badakhshan, Kunduz, Ghazni, Kandahar, Nimroz, and Farah.","Sub-recipient NGOs  could mobilize food items for PWID in Drop In Centers (DICs) from other sources.  Considering the status of 5 mentioned clients, it was necessary to provide cooked food; therefore, it was needed to hire six cooks in six provinces. The provinces include: Badakhshan, Kunduz, Ghazni, Kandahar, Nimroz, and Farah.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","High","28770","The TRP supports this intervention as it is needed when other resources are leveraged to support the rollout of PWID services.","0","0","0","0","28770","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuc/view","2020-12-31","HIV/AIDS",28770," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713=AN8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713=AO8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713=AP8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713=AJ8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713=AN8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713=AO8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713=AP8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G8)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIudUAG","PAI-3545","Active","AFG-Malaria-1","2017-2019","RT South East Asia","Afghanistan","Malaria","Malaria","FR439-AFG-M",null,null,"Case management","Facility-based treatment","Studies show variation of G6PD deficiency in areas with high malaria endemicity. 95%   of   cases   are   due   to   Plasmodium   Vivax   whose recurrence results in PV malaria case increase. The cure is a full dose of Primaquine save for G6PD deficiency cases which require supply of G6PD care tests to health facilities. To deploy the testing, a training will be conducted on administration of tests in malaria endemic areas. Estimated test cost $: 2*370,347 = 740,694. Workshop (# of people 1351*51= 68901.Total= 740,694+68901=809,595.","Studies show variation of G6PD deficiency in areas with high malaria endemicity. 95%   of   cases   are   due   to   Plasmodium   Vivax   whose recurrence results in PV malaria case increase. The cure is a full dose of Primaquine save for G6PD deficiency cases which require supply of G6PD care tests to health facilities. To deploy the testing, a training will be conducted on administration of tests in malaria endemic areas. Estimated test cost $: 2*370,347 = 740,694. Workshop (# of people 1351*51= 68901.Total= 740,694+68901=809,595.",null,"High","809595","Considering that 95% of malaria cases are due to P. vivax, a rollout plan for G6PD testing and primaquine for radical treatment is encouraged.","0","0","0","0","809595","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIud/view","2020-12-31","Malaria",809595," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713=AN9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713=AO9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713=AP9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713=AJ9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713=AN9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713=AO9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713=AP9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G9)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIueUAG","PAI-3546","Active","AFG-Malaria-2","2017-2019","RT South East Asia","Afghanistan","Malaria","Malaria","FR439-AFG-M",null,null,"Case management","Facility-based treatment","To focus on enhancing case confirmation and reduction of  clinical  malaria  cases  specifically  in  high  burden  province  bordering Pakistan,  it  is  needed  to  distribute RDT and have a regular coordination meeting with   health   facilities   staff   and   Community   Health   Supervisors to  share  the  surveillance  gaps, guidance on improvement of on the spot data quality, and review the implementation of malaria case management    by    conducting    Biannual meetings with staff from   7   high-risk   malaria   provinces   bordering  Pakistan.","To focus on enhancing case confirmation and reduction of  clinical  malaria  cases  specifically  in  high  burden  province  bordering Pakistan,  it  is  needed  to  distribute RDT and have a regular coordination meeting with   health   facilities   staff   and   Community   Health   Supervisors to  share  the  surveillance  gaps, guidance on improvement of on the spot data quality, and review the implementation of malaria case management    by    conducting    Biannual meetings with staff from   7   high-risk   malaria   provinces   bordering  Pakistan.",null,"High","100044","Border issues with Pakistan tobe addressed particularly bymanaging the cases on the spotby RDTs","0","0","0","0","100044","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIue/view","2020-12-31","Malaria",100044," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713=AN10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713=AO10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713=AP10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713=AJ10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713=AN10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713=AO10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713=AP10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G10)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIufUAG","PAI-3547","Inactive","AFG-Malaria-3","2017-2019","RT South East Asia","Afghanistan","Malaria","Malaria","FR439-AFG-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Based on the Malaria  Program  Review recommendation, National Strategy was revised  in  March  2017, it stratified the country into 3 categories with category 1 consisting of high malaria endemicity provinces. LLINs is the only vector control measure used.  Funding was requested to procure LLINs  to  cover  category  1  districts  but  not  all  districts were covered.  Therefore, funds are needed to procure more LLINs. Distribution will   be   done   as   per   WHO   recommendation. No. of LLINs required = 1,615,363.","Based on the Malaria  Program  Review recommendation, National Strategy was revised  in  March  2017, it stratified the country into 3 categories with category 1 consisting of high malaria endemicity provinces. LLINs is the only vector control measure used.  Funding was requested to procure LLINs  to  cover  category  1  districts  but  not  all  districts were covered.  Therefore, funds are needed to procure more LLINs. Distribution will   be   done   as   per   WHO   recommendation. No. of LLINs required = 1,615,363.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","4846090","It was already noted in the Program Continuation Request that not all Category 1 (high endemicity) districts were covered by LLINs, due to budget limitations  the shortfall to cover all districts is now covered through this PAAR.","0","4846090","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuf/view","2020-12-31","Malaria",0," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713=AN11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713=AO11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713=AP11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713=AJ11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713=AN11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713=AO11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713=AP11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G11)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIugUAG","PAI-3548","Inactive","AFG-Malaria-4","2017-2019","RT South East Asia","Afghanistan","Malaria","Malaria","FR439-AFG-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Pregnant women living in malaria endemic areas (category 1) require protection and will receive LLIN.  It is recommended  to provide a LLIN to all pregnant women visiting ANC  in  areas of Category 1 which are not covered in the malaria funding  request.  Due to inaccurate data the LLIN numbers are insufficient. No. of LLINs estimated to be distributed among  pregnant women visiting ANCs  (calculated  based  on  the ANC visits in those areas) = 364,307.","Pregnant women living in malaria endemic areas (category 1) require protection and will receive LLIN.  It is recommended  to provide a LLIN to all pregnant women visiting ANC  in  areas of Category 1 which are not covered in the malaria funding  request.  Due to inaccurate data the LLIN numbers are insufficient. No. of LLINs estimated to be distributed among  pregnant women visiting ANCs  (calculated  based  on  the ANC visits in those areas) = 364,307.","NA Original Intervention: Long-lasting insecticidal nets  Continuous distribution","High","1092920","In the context of the human rights and gender issues, the disproportionately high malaria burden among women and girls is to be reduced. In particular, pregnant women are the most vulnerable population targeted for protection, thus those visiting ANC in Category 1 areas should receive LLINs. However, the TRP recommends that this procurement and distribution should be coordinated to complement and not overlap with the LLIN distribution already in place in Category 1 areas","0","1092920","0","0","0","1","0","2020-01-14 12:17:06","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIug/view","2020-12-31","Malaria",0," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713=AN12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713=AO12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713=AP12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713=AJ12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713=AN12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713=AO12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713=AP12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G12)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIuhUAG","PAI-3549","Active","AFG-Malaria-5","2017-2019","RT South East Asia","Afghanistan","Malaria","Malaria","FR439-AFG-M",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Under   the   2015-2017 grant,   Malaria   &   Leishmaniosis Information Systems (MLIS) have been piloted in 4 provinces, evidence based scale up of MLIS is planned for the next grant period.  Required activities are;  training session for HMIS  officers  from  PHDs  &  BPHS  implementers, Malaria  Control  officers  and heads of health facilities.  Lower  health  facilities level,  which   are   considered   for   RDTs   distribution  under  allocation  request,  planned  to  be  oriented on MLIS reporting system in RDT use training sessions.","Under   the   2015-2017 grant,   Malaria   &   Leishmaniosis Information Systems (MLIS) have been piloted in 4 provinces, evidence based scale up of MLIS is planned for the next grant period.  Required activities are;  training session for HMIS  officers  from  PHDs  &  BPHS  implementers, Malaria  Control  officers  and heads of health facilities.  Lower  health  facilities level,  which   are   considered   for   RDTs   distribution  under  allocation  request,  planned  to  be  oriented on MLIS reporting system in RDT use training sessions.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","36520","As the 2016 Malaria Program Review recommended, there should be a shift in the surveillance paradigm, in that the case-based surveillance and reporting system should be first established in priority provinces / districts eligible forelimination. In this regard, thebudget for routine reporting is tobe rationalized.","0","0","0","0","36520","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuh/view","2020-12-31","Malaria",36520," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713=AN13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713=AO13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713=AP13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713=AJ13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713=AN13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713=AO13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713=AP13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G13)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIuiUAG","PAI-3550","Active","AFG-Malaria-6","2017-2019","RT South East Asia","Afghanistan","Malaria","Malaria","FR439-AFG-M",null,null,"Case management","Active case detection and investigation (elimination phase)","To  prevent  the  spread  of  malaria  in  Category  2&3   provinces,  early  detection  ,  prompt  treatment  and  case  based  surveillance  are  considered  as  the  top  priority  by  the  program.  These measures are not costed in allocated  funding  request.  In the revised National Malaria Strategy, for the areas in Category 2 & 3 (low or malaria elimination areas), it is recommended to strengthen  malaria  surveillance  through case-based investigation.","To  prevent  the  spread  of  malaria  in  Category  2&3   provinces,  early  detection  ,  prompt  treatment  and  case  based  surveillance  are  considered  as  the  top  priority  by  the  program.  These measures are not costed in allocated  funding  request.  In the revised National Malaria Strategy, for the areas in Category 2 & 3 (low or malaria elimination areas), it is recommended to strengthen  malaria  surveillance  through case-based investigation.",null,"Medium","96000","Although the priority might not be very high at the moment, the case-based investigation will achieve strengthening of malaria surveillance system which is indispensable for the elimination of malaria. This should be incorporated in the PAAR.","0","0","0","0","96000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIui/view","2020-12-31","Malaria",96000," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713=AN14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713=AO14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713=AP14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713=AJ14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713=AN14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713=AO14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713=AP14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G14)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIujUAG","PAI-3551","Active","AFG-Malaria-7","2017-2019","RT South East Asia","Afghanistan","Malaria","Malaria","FR439-AFG-M",null,null,"Vector control","Indoor residual spraying (IRS)","Category  2&3  provinces  prone  for  malaria  epidemics lack vector  control measure (LLINs) Population here is mostly  not immune, so single  malaria  case  carries high transmission risk (especially considering  migration and movement of internally   displaced population).   It is proposed to procure the stock of insecticide for IRS and larvaciding, cosnidering   geographic and  logistical challenges of re-supply.    This will facilitate immediate response to   outbreak   investigation   and   response   in   the   elimination areas.","Category  2&3  provinces  prone  for  malaria  epidemics lack vector  control measure (LLINs) Population here is mostly  not immune, so single  malaria  case  carries high transmission risk (especially considering  migration and movement of internally   displaced population).   It is proposed to procure the stock of insecticide for IRS and larvaciding, cosnidering   geographic and  logistical challenges of re-supply.    This will facilitate immediate response to   outbreak   investigation   and   response   in   the   elimination areas.","NA Original Intervention: Indoor residual spraying","Low","3e+05","TRP is of the opinion that the IRS in receptive areas in Category 2 and 3 will lead to a sustainable intervention approach to the elimination of malaria in Afghanistan by 2030.","0","0","0","0","3e+05","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuj/view","2020-12-31","Malaria",300000," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713=AN15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713=AO15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713=AP15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713=AJ15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713=AN15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713=AO15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713=AP15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G15)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIukUAG","PAI-3552","Active","AFG-Tuberculosis-1","2017-2019","RT South East Asia","Afghanistan","Tuberculosis","Tuberculosis, RSSH","FR100-AFG-Z",null,null,"TB care and prevention","Community TB care delivery","TB Patient Associations in 12 provinces have been supported by GF and are included in the allocation to reduce stigma, address gender-related issues and support community empowerment. This UQD includes expansion to all remaining provinces ($400 per Association X 22 X 3 years = $26,400) and incentives for case-finding and treatment support.","TB Patient Associations in 12 provinces have been supported by GF and are included in the allocation to reduce stigma, address gender-related issues and support community empowerment. This UQD includes expansion to all remaining provinces ($400 per Association X 22 X 3 years = $26,400) and incentives for case-finding and treatment support.",null,"High","31800","This intervention will provide funds for orientation workshops for TB Patient Associations in 12 provinces (these are additional to those requested in the allocation). Funds are required to cover training costs and incentives for casefinding and treatment support for 300 patients over three years. This is an important activity that, if possible, should be moved to the main allocation.","0","0","0","0","31800","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuk/view",null,"Multi-component",31800," South East Asia","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713=AN16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713=AO16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713=AP16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713=AJ16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713=AN16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713=AO16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713=AP16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G16)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AIulUAG","PAI-3553","Active","AFG-Tuberculosis-2","2017-2019","RT South East Asia","Afghanistan","Tuberculosis","Tuberculosis, RSSH","FR100-AFG-Z",null,null,"RSSH: Integrated service delivery and quality improvement","Service organization and facility management","To address high Maternal Mortality, the Citizen Charter proposes a few thousand FHHs. All partners indicated support for the expansion of FHHs. The TB-RSSH grant includes 35 FHHs and this UQD includes additional 15 FHHs. This UQD includes medical kits ($39,525), socialization and awareness in communities for site mapping ($78,026), basic supplies, equipment, medicines, staff support, training expenses, operational/maintenance costs ($493,525) and transportation of renovation materials ($2,239).","To address high Maternal Mortality, the Citizen Charter proposes a few thousand FHHs. All partners indicated support for the expansion of FHHs. The TB-RSSH grant includes 35 FHHs and this UQD includes additional 15 FHHs. This UQD includes medical kits ($39,525), socialization and awareness in communities for site mapping ($78,026), basic supplies, equipment, medicines, staff support, training expenses, operational/maintenance costs ($493,525) and transportation of renovation materials ($2,239).","NA Original Module: RSSH - Integrated service delivery and quality improvement","High","613315","This intervention would allow the Ministry of Public Health setting up additional 15 FHHs. These are additional to the 35 FHHs funded though the TB RSSH allocation. The PAAR includes funds for medical kits, support for socialization and awareness in communities for site mapping, basic supplies and equipment, medicines, staff support, training expenses, operational and maintenance and transportation costs of renovation materials (USD 2,239).This is considered a very important activity that is essential for effective implementation of FHH which will improve reproductive health outcomes. It is suggested this should be the top priority of the PAAR after intervention 1.","0","0","0","0","613315","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIul/view",null,"Multi-component",613315," South East Asia","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713=AN17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713=AO17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713=AP17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713=AJ17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713=AN17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713=AO17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713=AP17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G17)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AIumUAG","PAI-3554","Active","AFG-Tuberculosis-3","2017-2019","RT South East Asia","Afghanistan","Tuberculosis","Tuberculosis, RSSH","FR100-AFG-Z",null,null,"TB care and prevention","Case detection and diagnosis","5 GeneXpert machines are already deployed. Ten machines will be deployed by CTB and 10 are included GF TB grant for Provincial Hospitals. This UQD includes additional 10 GeneXpert machines for Provincial and District Hospital TB diagnostic centers. This requires installation costs ($25,000 per machine X 10 = $250,000) and testing kits ($24,000 per unit X 10 units x 3 years = $720,000).","5 GeneXpert machines are already deployed. Ten machines will be deployed by CTB and 10 are included GF TB grant for Provincial Hospitals. This UQD includes additional 10 GeneXpert machines for Provincial and District Hospital TB diagnostic centers. This requires installation costs ($25,000 per machine X 10 = $250,000) and testing kits ($24,000 per unit X 10 units x 3 years = $720,000).",null,"High","970000","It is desirable to purchase 10 additional GeneXperts to increase the diagnostic capacity of the country to detect drug-resistant tuberculosis. However, the funds available within the allocation amount are insufficient to include this item and the intervention is listed in the PAAR. The PAAR includes 10 GeneXpert machines in Provincial and District Hospital TB diagnostic centres that are additional to those requested in the allocation.","0","0","0","0","970000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIum/view",null,"Multi-component",970000," South East Asia","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713=AN18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713=AO18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713=AP18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713=AJ18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713=AN18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713=AO18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713=AP18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G18)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AIunUAG","PAI-3555","Active","AFG-Tuberculosis-4","2017-2019","RT South East Asia","Afghanistan","Tuberculosis","Tuberculosis, RSSH","FR100-AFG-Z",null,null,"TB care and prevention","Community TB care delivery","Based on effective results, scale up CB-DOTS in additional 15 provinces to expand case notifications and broaden efforts to reduce stigma. This expansion should identify another 1,000 cases per year. This UQD includes training  ($5,000 per training X 15 provinces = $75,000) and incentives for case-finding and treatment support ($3 each to two persons per case X 1,000 cases x 3 years = $18,000).","Based on effective results, scale up CB-DOTS in additional 15 provinces to expand case notifications and broaden efforts to reduce stigma. This expansion should identify another 1,000 cases per year. This UQD includes training  ($5,000 per training X 15 provinces = $75,000) and incentives for case-finding and treatment support ($3 each to two persons per case X 1,000 cases x 3 years = $18,000).",null,"High","93000","This intervention is required to scale up community based directly observed treatment, short-course (DOTS) coverage in 10 additional provinces following the approach described in allocation request. It is considered that this intervention will most likely extend the services to populations with limited access.","0","0","0","0","93000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIun/view",null,"Multi-component",93000," South East Asia","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713=AN19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713=AO19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713=AP19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713=AJ19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713=AN19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713=AO19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713=AP19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G19)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AIuoUAG","PAI-3556","Active","AFG-Tuberculosis-5","2017-2019","RT South East Asia","Afghanistan","Tuberculosis","Tuberculosis, RSSH","FR100-AFG-Z",null,null,"TB care and prevention","Collaborative activities with other programs and sectors (TB care and prevention)","Expanding PPM DOTS will further increase case notifications while engaging the private sector. The NTP proposes to scale-up 10 additional cities with significant numbers of private practitioners. This expansion should identify an additional 600 cases per year. This PAAR includes costs for site preparation in 10 provinces (US$ 1,500 X 10 = US$ 15,000) and costs for private practitioner orientation (US$ 1,800 X 10 = US$ 18,000).","Expanding PPM DOTS will further increase case notifications while engaging the private sector. The NTP proposes to scale-up 10 additional cities with significant numbers of private practitioners. This expansion should identify an additional 600 cases per year. This PAAR includes costs for site preparation in 10 provinces (US$ 1,500 X 10 = US$ 15,000) and costs for private practitioner orientation (US$ 1,800 X 10 = US$ 18,000).",null,"High","33000","This intervention would provide funds for orientation of private practitioners in 10 provinces, which are additional to those requested in the allocation. Funds are required to cover site preparations in 10 new cities and orientation for the practitioners.","0","0","0","0","33000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuo/view",null,"Multi-component",33000," South East Asia","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713=AN20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713=AO20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713=AP20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713=AJ20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713=AN20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713=AO20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713=AP20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G20)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AIupUAG","PAI-3557","Active","AFG-Tuberculosis-6","2017-2019","RT South East Asia","Afghanistan","Tuberculosis","Tuberculosis, RSSH","FR100-AFG-Z",null,null,"TB care and prevention","Case detection and diagnosis","To enhance diagnostic capacities and provide high quality laboratory services, the preferred LPA DST equipment is being proposed for 3 RRLs. The cost of each LPA with PCR is US$ 50,000 or US$ 150,000 for 3 RRLs. US$ 10,000 per laboratory per year is necessary for the diagnostic kits (US$ 10,000 X 3 X 3 = US$ 90,000) for a total of US$ 240,000.","To enhance diagnostic capacities and provide high quality laboratory services, the preferred LPA DST equipment is being proposed for 3 RRLs. The cost of each LPA with PCR is US$ 50,000 or US$ 150,000 for 3 RRLs. US$ 10,000 per laboratory per year is necessary for the diagnostic kits (US$ 10,000 X 3 X 3 = US$ 90,000) for a total of US$ 240,000.",null,"High","240000","This is an important investment that is needed to inform MDR patient management. The intervention would enhance diagnostic capacity by purchasing line probe assay (LPA) drug susceptibility testing (DST) equipment and consumables for three regional laboratories.","0","0","0","0","240000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIup/view",null,"Multi-component",240000," South East Asia","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713=AN21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713=AO21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713=AP21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713=AJ21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713=AN21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713=AO21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713=AP21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G21)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AIuqUAG","PAI-3558","Active","AFG-Tuberculosis-7","2017-2019","RT South East Asia","Afghanistan","Tuberculosis","Tuberculosis, RSSH","FR100-AFG-Z",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The nations only Quality Control Laboratory for pharmaceuticals and medical products has limited capacity, staff and resources although there is a huge private sector importing pharmaceuticals. A second Regional Laboratory is requested in TB-RSSH Funding Request including training and the development of a National Strategy, SOPs and Quality Assurance Guidelines. This UQD includes functionalization of another Regional Pharmaceutical Quality Control Laboratory.","The nations only Quality Control Laboratory for pharmaceuticals and medical products has limited capacity, staff and resources although there is a huge private sector importing pharmaceuticals. A second Regional Laboratory is requested in TB-RSSH Funding Request including training and the development of a National Strategy, SOPs and Quality Assurance Guidelines. This UQD includes functionalization of another Regional Pharmaceutical Quality Control Laboratory.","NA Original Module: RSSH - Procurement and supply chain management systems","High","756132","This funding would support the oversight of quality pharmaceuticals and health products. Currently there is only one Quality Control Laboratory for pharmaceuticals and medical products, and a second one will be funded through the allocation amount. The PAAR requests funds for a third Regional Pharmaceutical Quality Control Laboratory.","0","0","0","0","756132","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuq/view",null,"Multi-component",756132," South East Asia","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713=AN22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713=AO22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713=AP22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713=AJ22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713=AN22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713=AO22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713=AP22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G22)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AIurUAG","PAI-3559","Active","AFG-Tuberculosis-8","2017-2019","RT South East Asia","Afghanistan","Tuberculosis","Tuberculosis, RSSH","FR100-AFG-Z",null,null,"TB care and prevention","Case detection and diagnosis","The TB grant incudes active contact management through household visits for smear-positive cases. To maximize impact, active contact management of all cases is required. This expansion should identify an additional 1,000 cases per year. This UQD includes the costs of household visits for an additional 20,000 smear-negative and extra-pulmonary cases per year ($20 per visit X 20,000 cases = $400,000 per year or $1,200,000 for 3 years).","The TB grant incudes active contact management through household visits for smear-positive cases. To maximize impact, active contact management of all cases is required. This expansion should identify an additional 1,000 cases per year. This UQD includes the costs of household visits for an additional 20,000 smear-negative and extra-pulmonary cases per year ($20 per visit X 20,000 cases = $400,000 per year or $1,200,000 for 3 years).",null,"Medium","1200000","This intervention includes the costs of household visits of index cases with smear-negative or extrapulmonary TB, to identify further TB cases. Funds would facilitate visiting an additional 20,000 smearnegative and extra-pulmonary cases per year. Although this is desirable, smear-negative cases are less infectious and it is considered that, for now, the main emphasis should be on the visit of household contacts or other close contacts of smear-positive cases and therefore this intervention was considered to be a medium priority.","0","0","0","0","1200000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIur/view",null,"Multi-component",1200000," South East Asia","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713=AN23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713=AO23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713=AP23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713=AJ23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713=AN23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713=AO23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713=AP23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G23)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AIusUAG","PAI-3560","Active","AFG-Tuberculosis-9","2017-2019","RT South East Asia","Afghanistan","Tuberculosis","Tuberculosis, RSSH","FR100-AFG-Z",null,null,"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","To promote engagement of the large private sector, 10 Private Public Partnerships (PPPs) are being requested through the TB-RSSH Funding Request within the allocation. An additional 40 PPPs are being proposed for UQD funding to expand pilot testing and enrich the data in diverse geographical and cultural settings in 4 remaining Regions. This UQD includes renovation of selected facilities, supplies and equipment, monitoring visits and operational costs.","To promote engagement of the large private sector, 10 Private Public Partnerships (PPPs) are being requested through the TB-RSSH Funding Request within the allocation. An additional 40 PPPs are being proposed for UQD funding to expand pilot testing and enrich the data in diverse geographical and cultural settings in 4 remaining Regions. This UQD includes renovation of selected facilities, supplies and equipment, monitoring visits and operational costs.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Low","400752","This request would fund an additional 40 PPPs to expand pilot testing and enrich the data in four regions that are different to those included in the allocation. This PAAR includes renovation of selected facilities, supplies and equipment, monitoring visits and operational costs. Without a detailed implementation plan this would be considered low quality demand.","0","0","0","0","400752","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIus/view",null,"Multi-component",400752," South East Asia","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713=AN24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713=AO24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713=AP24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713=AJ24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713=AN24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713=AO24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713=AP24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G24)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AIutUAG","PAI-3561","Inactive","AGO-Malaria-1","2017-2019","RT Southern and Eastern Africa","Angola","Malaria","Malaria","FR211-AGO-M",null,null,"Case management","Other case management intervention(s)","This above allocation is to support the procurement of injectable artesunate and injectable artemether for treatment of severe malaria over the 3 years of this grant. In 2018, 2019 and 2020 respectively 442,275; 482,813 and 490,296 estimated cases of severe malaria will occur. In Angola severe malaria is treated in the following proportion: 50% receive injectable Artesunate, 33% injectable Artemether and 17% quinine. The GOA has prioritized increasing access to diagnosis and treatment in the most vulnerable groups shown by their increased domestic allocation for both RDTs and ACTs. Increasing access to early and correct diagnosis and treatment in the community through ADECOS will in turn reduce the number of severe malaria cases and therefore mortality from severe malaria in hospitals. Injectable artesunate requested is intended for the treatment of the vulnerable population of children <5 years of age, that represent 17% of severe malaria cases per year is requested under this concept note. The MoH will procure the rest of injectable artesunate for patients> 5 years. The purchase cost of 1 ampoule of 70mg / ml is estimated at 2.52 USD (price) + PSM (35%). For injectable Artemether, Angola is requesting sufficient to treat 33% of all severe malaria  cases  from  all age groups with severe malaria. The cost of purchasing an ampoule of 80 mg / ml is estimated at $ 0.46 (price) + PSM (35%). The TOTAL of these purchases is USD 4,895,388 requested in this above allocation.","This above allocation is to support the procurement of injectable artesunate and injectable artemether for treatment of severe malaria over the 3 years of this grant. In 2018, 2019 and 2020 respectively 442,275; 482,813 and 490,296 estimated cases of severe malaria will occur. In Angola severe malaria is treated in the following proportion: 50% receive injectable Artesunate, 33% injectable Artemether and 17% quinine. The GOA has prioritized increasing access to diagnosis and treatment in the most vulnerable groups shown by their increased domestic allocation for both RDTs and ACTs. Increasing access to early and correct diagnosis and treatment in the community through ADECOS will in turn reduce the number of severe malaria cases and therefore mortality from severe malaria in hospitals. Injectable artesunate requested is intended for the treatment of the vulnerable population of children <5 years of age, that represent 17% of severe malaria cases per year is requested under this concept note. The MoH will procure the rest of injectable artesunate for patients> 5 years. The purchase cost of 1 ampoule of 70mg / ml is estimated at 2.52 USD (price) + PSM (35%). For injectable Artemether, Angola is requesting sufficient to treat 33% of all severe malaria  cases  from  all age groups with severe malaria. The cost of purchasing an ampoule of 80 mg / ml is estimated at $ 0.46 (price) + PSM (35%). The TOTAL of these purchases is USD 4,895,388 requested in this above allocation.","NA Original Intervention: Facility-based treatment for severe malaria in children under 5 years","High","4895388","This is essential to begin reducing the very high malaria mortality among infants and young children. The TRP requests, therefore, that this intervention be moved to the allocation, in line with the recommendation under issue 1.","4895388","0","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIut/view","2021-06-30","Malaria",0," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713=AN25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713=AO25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713=AP25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713=AJ25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713=AN25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713=AO25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713=AP25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G25)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-06-30"]
["a6Q1R000000AIuuUAG","PAI-3562","Active","AGO-Malaria-2","2017-2019","RT Southern and Eastern Africa","Angola","Malaria","Malaria","FR211-AGO-M",null,null,"Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Improving ANC attendance and increasing IPTp coverage is a priority for the NMCP, to improve health outcomes for the pregnant women and her unborn child. The IIMS (2015/2016) showed that only 19% of pregnant women had received 3 or more doses of IPTp during ANC visits. Stock-out have been a major reason for this low coverage. The gap analysis shows a gap in the aquisition of Sulfadoxine + Pyrimethamine (SP) for intermittent Preventative treatment for pregnant woman, one of the MoH target groups.. The MoH and PMI will acquire a total of 31,146 bottles of 1000 tablets during the 3 years. The gap is 7166 bottles of 1000 SP tablets which is requested from the FG in this above allocation. The expected impact is the reduction of maternal morbidity and mortality from malaria and improved outcomes for newborn child. The cost is estimated at 27 USD per bottle of 1000 tablets + PSM (35%). The total is 261,267.00 USD","Improving ANC attendance and increasing IPTp coverage is a priority for the NMCP, to improve health outcomes for the pregnant women and her unborn child. The IIMS (2015/2016) showed that only 19% of pregnant women had received 3 or more doses of IPTp during ANC visits. Stock-out have been a major reason for this low coverage. The gap analysis shows a gap in the aquisition of Sulfadoxine + Pyrimethamine (SP) for intermittent Preventative treatment for pregnant woman, one of the MoH target groups.. The MoH and PMI will acquire a total of 31,146 bottles of 1000 tablets during the 3 years. The gap is 7166 bottles of 1000 SP tablets which is requested from the FG in this above allocation. The expected impact is the reduction of maternal morbidity and mortality from malaria and improved outcomes for newborn child. The cost is estimated at 27 USD per bottle of 1000 tablets + PSM (35%). The total is 261,267.00 USD","NA Original Module: Specific prevention interventions. Original Intervention: Acquisition of sulphadoxinepyrimethamine for IPTp","High","261267","IPTp coverage is low and burden is high among pregnant women. This is a critical intervention to reduce maternal mortality and the impact on infants. The TRP requests, therefore, that this intervention be moved to the allocation, in line with the recommendation under issue 2.","0","0","0","0","261267","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuu/view","2021-06-30","Malaria",261267," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713=AN26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713=AO26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713=AP26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713=AJ26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713=AN26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713=AO26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713=AP26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G26)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-06-30"]
["a6Q1R000000AIuvUAG","PAI-3563","Active","AGO-Malaria-3","2017-2019","RT Southern and Eastern Africa","Angola","Malaria","Malaria","FR211-AGO-M",null,null,"Case management","Other case management intervention(s)","Increasing access to primary health care services(iCCM) through ADECOs is seen as a priority by the GoA. In this above allocation, iCCM will be expanded to a further six (6) municipalities, distributed as follows: Moxico (1), Malange (3) and Uige Province(2). These Provinces were chosen for increased coverage due to their malaria burden, access to health care and population   The total ADECOS expected to be trained under this above allocation will be 240. Children less than 5 years of age that have access to health care will  increase from 11% to 20% by the end of the Grant. The total cost is 500.000 USD, to cover, five days training for ADECOS ( ToT and ADECOS training) visibility materials( t-shirts, cups, boots, cup rain, smartphones, mobile data service.","Increasing access to primary health care services(iCCM) through ADECOs is seen as a priority by the GoA. In this above allocation, iCCM will be expanded to a further six (6) municipalities, distributed as follows: Moxico (1), Malange (3) and Uige Province(2). These Provinces were chosen for increased coverage due to their malaria burden, access to health care and population   The total ADECOS expected to be trained under this above allocation will be 240. Children less than 5 years of age that have access to health care will  increase from 11% to 20% by the end of the Grant. The total cost is 500.000 USD, to cover, five days training for ADECOS ( ToT and ADECOS training) visibility materials( t-shirts, cups, boots, cup rain, smartphones, mobile data service.","NA Original Intervention: Community-based treatment - expansion of ADECO programme (240) to a further 6 municipalities in high-burden areas","High","5e+05","In view of the poor access to facility-based treatment in high burden areas, and the association of poor access with increased burden, this intervention is of high importance of reducing the burden and improving equality of access to essential interventions","0","0","0","0","5e+05","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuv/view","2021-06-30","Malaria",500000," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713=AN27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713=AO27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713=AP27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713=AJ27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713=AN27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713=AO27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713=AP27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G27)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-06-30"]
["a6Q1R000000AIuwUAG","PAI-3564","Active","AGO-Malaria-4","2017-2019","RT Southern and Eastern Africa","Angola","Malaria","Malaria","FR211-AGO-M",null,null,"Other module","Other module","The survey to determine the epidemiological stratification of the country was conducted in the early 1980s, sampling at Provincial rather than municipality level. Recent surveys have shown a shift in prevalence patterns and malaria burden  that requires that the country epidemiological profile is updated to facilitate the planning and geographical targeting of types of interventions and decision-making.To this end, an amount of US $ 355,378.12 is requested to carry out a. study in 2019.","The survey to determine the epidemiological stratification of the country was conducted in the early 1980s, sampling at Provincial rather than municipality level. Recent surveys have shown a shift in prevalence patterns and malaria burden  that requires that the country epidemiological profile is updated to facilitate the planning and geographical targeting of types of interventions and decision-making.To this end, an amount of US $ 355,378.12 is requested to carry out a. study in 2019.","NA Original Module: RSSH. Original Intervention: Updating of the national epidemiological profile through operational research","Medium","355378","While a re-stratification of the country is overdue, the very high burden of disease at present, coupled with the high prevalence across the country and the lack of budget for essential interventions, makes other priorities to directly reduce burden a higher priority at this time. The scale-up of the Health Management Information Systems (HMIS) planned in the RSSH Funding Request in 2018 should be designed to improve reporting and data management enabling empirical rather than predictive stratification.","0","0","0","0","355378","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuw/view","2021-06-30","Malaria",355378," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713=AN28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713=AO28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713=AP28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713=AJ28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713=AN28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713=AO28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713=AP28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G28)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-06-30"]
["a6Q1R000000AIuxUAG","PAI-3565","Active","AGO-Malaria-5","2017-2019","RT Southern and Eastern Africa","Angola","Malaria","Malaria","FR211-AGO-M",null,null,"Other module","Other module","In order to ensure epidemiological surveillance, monitoring and evaluation of malaria activities are implemented at the operational level (provincial, municipal, health and community units), particularly in the regions of the country where the Multiple Indicators and Health Survey IIMS 2015/16 showed a high prevalence of malaria, , an amount for the payment of salaries of 6 OPPMs for the last year of the 2018-2021 grant is requested in the above allocation. It should be noted that the number of OPPMs was 18 in the current GF 2016-2017 grant, and will be reduced to 6 in be financed under the first 2 years of the FG 2018-2021 grant. The annual salary of each OPPM is USD 47,994.48 and the annual cost of the 6 OPPMs for the last year of the grant is USD 287,966.88. The provincial focal points are to maintain active epidemiological surveillance in these high prevalence provinces to mitigate the emergence of possible malaria epidemics and thereby have quality data and evidence to allow for better quantification and programming of resources.","In order to ensure epidemiological surveillance, monitoring and evaluation of malaria activities are implemented at the operational level (provincial, municipal, health and community units), particularly in the regions of the country where the Multiple Indicators and Health Survey IIMS 2015/16 showed a high prevalence of malaria, , an amount for the payment of salaries of 6 OPPMs for the last year of the 2018-2021 grant is requested in the above allocation. It should be noted that the number of OPPMs was 18 in the current GF 2016-2017 grant, and will be reduced to 6 in be financed under the first 2 years of the FG 2018-2021 grant. The annual salary of each OPPM is USD 47,994.48 and the annual cost of the 6 OPPMs for the last year of the grant is USD 287,966.88. The provincial focal points are to maintain active epidemiological surveillance in these high prevalence provinces to mitigate the emergence of possible malaria epidemics and thereby have quality data and evidence to allow for better quantification and programming of resources.","NA Original Module: RSSH. Original Intervention: RSSH: Health management information systems and Monitoring and Evaluation (M&E)","Low","287967","While M&E is an important area requiring further investment for the program to function effectively, these salaries are a high cost investment in comparison to other areas of pressing need.","0","0","0","0","287967","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIux/view","2021-06-30","Malaria",287967," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713=AN29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713=AO29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713=AP29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713=AJ29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713=AN29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713=AO29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713=AP29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G29)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-06-30"]
["a6Q1R000000AIuyUAG","PAI-3566","Active","AGO-RSSH-1","2017-2019","RT Southern and Eastern Africa","Angola","RSSH","RSSH","FR597-AGO-S",null,null,"RSSH: Health management information systems and M&E","Routine reporting","HIS Governance Strengthening: Support Expanded Terms of Reference by the National Technical Team for inclusion in OpenLMIS; Support creation of municipal technical teams.","HIS Governance Strengthening: Support Expanded Terms of Reference by the National Technical Team for inclusion in OpenLMIS; Support creation of municipal technical teams.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","34224",null,"0","0","0","0","34224","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuy/view","2021-12-31","RSSH",34224," Southern and Eastern Africa","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713=AN30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713=AO30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713=AP30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713=AJ30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713=AN30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713=AO30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713=AP30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G30)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AIuzUAG","PAI-3567","Active","AGO-RSSH-2","2017-2019","RT Southern and Eastern Africa","Angola","RSSH","RSSH","FR597-AGO-S",null,null,"RSSH: Health management information systems and M&E","Program and data quality","RSSH: DHIS 2: The issue of maintenance of the IT equipment, and IT capacity to use DHIS 2 risks limiting the sustainability of DHIS 2 if it is not adequately addressed. There is an urgent need to assess to what extent Municipalities have access to IT expertise. Once identified, IT Focal Points should be hired in each of the 164 Municipalities, and motivated, to provide maintenance and data insertion services. The Focal Points will also ensure access to Internet and address some difficulties inherent to IT in all provinces.RSSH: LMIS: OpenLMIS requires a functioning national PSM system to be sustainable. Therefore, systemic issues identified through this Funding Request need to be addressed for OpenLMIS to function as intended. At provincial level, a comprehensive support to warehouses should be given which includes 1) support to rehabilitation; 2) facilitation of access to alternative sources of energy, such as solar energy; 3) development of Procedures Manual; acquisition of standard warehousing equipment including temperature and humidity monitors, air conditioners, pallets, forklifts, shelves. At central level, CECOMA should also be supported with a similar package involving infrastructure rehabilitation, development of a Procedures Manual, acquisition of air conditioners. Opportunities for review and validation of the stock data from OpenLMIS, involving central and provincial level warehouse managers should also be created and funded. Still at central level, advocacy and technical assistance to DNME is required for the validation of the national List of Essential Medicines, the creation of an effective drug registration system and a national pharmaco vigilance system.","RSSH: DHIS 2: The issue of maintenance of the IT equipment, and IT capacity to use DHIS 2 risks limiting the sustainability of DHIS 2 if it is not adequately addressed. There is an urgent need to assess to what extent Municipalities have access to IT expertise. Once identified, IT Focal Points should be hired in each of the 164 Municipalities, and motivated, to provide maintenance and data insertion services. The Focal Points will also ensure access to Internet and address some difficulties inherent to IT in all provinces.RSSH: LMIS: OpenLMIS requires a functioning national PSM system to be sustainable. Therefore, systemic issues identified through this Funding Request need to be addressed for OpenLMIS to function as intended. At provincial level, a comprehensive support to warehouses should be given which includes 1) support to rehabilitation; 2) facilitation of access to alternative sources of energy, such as solar energy; 3) development of Procedures Manual; acquisition of standard warehousing equipment including temperature and humidity monitors, air conditioners, pallets, forklifts, shelves. At central level, CECOMA should also be supported with a similar package involving infrastructure rehabilitation, development of a Procedures Manual, acquisition of air conditioners. Opportunities for review and validation of the stock data from OpenLMIS, involving central and provincial level warehouse managers should also be created and funded. Still at central level, advocacy and technical assistance to DNME is required for the validation of the national List of Essential Medicines, the creation of an effective drug registration system and a national pharmaco vigilance system.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","2383489",null,"0","0","0","0","2383489","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIuz/view","2021-12-31","RSSH",2383489," Southern and Eastern Africa","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713=AN31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713=AO31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713=AP31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713=AJ31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713=AN31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713=AO31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713=AP31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G31)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AIv0UAG","PAI-3568","Active","AGO-RSSH-3","2017-2019","RT Southern and Eastern Africa","Angola","RSSH","RSSH","FR597-AGO-S",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Geographic and historic expansion of DHIS2: Training on the health information system and on how to use DHIS2 has been provided to health technicians in all of the countrys 164 Municipalities. However, only selected municipalities in 7 provinces currently report through DHIS. Funding is required to ensure national coverage (11 remaining provinces) to fund equipment provision, data quality assurance and supervision of reporting through DHIS 2 from all 164 Municipalities. DHIS 2 deployment will be gradual in accordance with the Road map agreed between MoH and its development partners. While current and future data is being entered into DHIS 2, there is a need to capture and archive historic data before data collection instruments are destroyed or disappear. Migration of historic, Excel based data available at municipal level into DHIS 2 (2016-2017 data) is therefore urgent.","Geographic and historic expansion of DHIS2: Training on the health information system and on how to use DHIS2 has been provided to health technicians in all of the countrys 164 Municipalities. However, only selected municipalities in 7 provinces currently report through DHIS. Funding is required to ensure national coverage (11 remaining provinces) to fund equipment provision, data quality assurance and supervision of reporting through DHIS 2 from all 164 Municipalities. DHIS 2 deployment will be gradual in accordance with the Road map agreed between MoH and its development partners. While current and future data is being entered into DHIS 2, there is a need to capture and archive historic data before data collection instruments are destroyed or disappear. Migration of historic, Excel based data available at municipal level into DHIS 2 (2016-2017 data) is therefore urgent.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","274440",null,"0","0","0","0","274440","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv0/view","2021-12-31","RSSH",274440," Southern and Eastern Africa","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713=AN32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713=AO32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713=AP32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713=AJ32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713=AN32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713=AO32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713=AP32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G32)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AIv1UAG","PAI-3569","Active","AGO-RSSH-4","2017-2019","RT Southern and Eastern Africa","Angola","RSSH","RSSH","FR597-AGO-S",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","For effective public health decision-making, morbidity and logistics data have to be available, analysed and interpreted jointly. Interoperability and integration of the two DHIS2 and OpenLMIS platforms is therefore essential.This allocation will allow the installation of OpenLMIS on the HIS platform and of DHIS2 on Amazon Web Services (AWS, a cloud-based infrastructure). Most importantly, the human resources involved in entering and using data in the two systems will require adequate training.","For effective public health decision-making, morbidity and logistics data have to be available, analysed and interpreted jointly. Interoperability and integration of the two DHIS2 and OpenLMIS platforms is therefore essential.This allocation will allow the installation of OpenLMIS on the HIS platform and of DHIS2 on Amazon Web Services (AWS, a cloud-based infrastructure). Most importantly, the human resources involved in entering and using data in the two systems will require adequate training.",null,"High","86062",null,"0","0","0","0","86062","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv1/view","2021-12-31","RSSH",86062," Southern and Eastern Africa","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713=AN33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713=AO33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713=AP33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713=AJ33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713=AN33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713=AO33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713=AP33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G33)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AIv2UAG","PAI-3570","Active","AGO-TB/HIV-1","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"TB care and prevention","Prevention","PAAR application will support procurement  INH for IPT among eligible  PLHIV and children of contacts with TB patients who test negative for TB screening in years 2019, 2020 and 2021. (see TB/HIV collaboration). Expected outcome will reduction in TB incidence.","PAAR application will support procurement  INH for IPT among eligible  PLHIV and children of contacts with TB patients who test negative for TB screening in years 2019, 2020 and 2021. (see TB/HIV collaboration). Expected outcome will reduction in TB incidence.",null,"High","536058","It addresses a specific need for latent tuberculosis infection (LTBI) treatment in a program that has not yet reported any LTBI treatment.","0","0","0","0","536058","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv2/view",null,"TB/HIV",536058," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713=AN34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713=AO34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713=AP34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713=AJ34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713=AN34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713=AO34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713=AP34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G34)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIv3UAG","PAI-3571","Active","AGO-TB/HIV-10","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"TB care and prevention","Treatment","PAAR to support the printing  of  handbooks on (i) TB cases management (ii) TB in children; (iii) MDR-TB management and control; (iv) TB/HIV coinfection control; (iv) tasks of DOTS-C agents  in 2019. Expected outcome will be increase in quality of TB services in line with international standard for TB care (ISTC).","PAAR to support the printing  of  handbooks on (i) TB cases management (ii) TB in children; (iii) MDR-TB management and control; (iv) TB/HIV coinfection control; (iv) tasks of DOTS-C agents  in 2019. Expected outcome will be increase in quality of TB services in line with international standard for TB care (ISTC).","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","High","150000","This activity will allow the program to reach the ambitious targets set out in the funding request.","0","0","0","0","150000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv3/view",null,"TB/HIV",150000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713=AN35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713=AO35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713=AP35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713=AJ35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713=AN35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713=AO35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713=AP35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G35)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIv4UAG","PAI-3572","Active","AGO-TB/HIV-11","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"TB care and prevention","Community TB care delivery","The PAAR will support development of IEC Materials and  training  for community workers and Social mobilization on Community TB Care  in 18 provinces (210 agents for 84 municipalities)PAAR investment  will support Treatment Adherence  interventions (TAIs) catalytic to achieving the ambitious CNR and TSR targets, focusing on strengthening community  and peer support (ex-TB patients etc), food vouchers and transport refunds , home visits and others initiatives to mitigate the castrophic  costs from TB and improve treatment outcomes. Expected outcome will be increase in CNR and TSR.","The PAAR will support development of IEC Materials and  training  for community workers and Social mobilization on Community TB Care  in 18 provinces (210 agents for 84 municipalities)PAAR investment  will support Treatment Adherence  interventions (TAIs) catalytic to achieving the ambitious CNR and TSR targets, focusing on strengthening community  and peer support (ex-TB patients etc), food vouchers and transport refunds , home visits and others initiatives to mitigate the castrophic  costs from TB and improve treatment outcomes. Expected outcome will be increase in CNR and TSR.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","High","260000","This activity will allow the program to reach the ambitious targets set out in the funding request.","0","0","0","0","260000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv4/view",null,"TB/HIV",260000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713=AN36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713=AO36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713=AP36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713=AJ36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713=AN36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713=AO36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713=AP36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G36)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIv5UAG","PAI-3573","Active","AGO-TB/HIV-12","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","PAAR will support refresher training of Laboratory staff  in  diagnosis of MDRTB in 2019  and reagents for solid and liquid culture, three (3) LPA (Line Probe Assay) equipments and their respective reagents. Expected outcome will be increase in MDR TB cases detected and notified.","PAAR will support refresher training of Laboratory staff  in  diagnosis of MDRTB in 2019  and reagents for solid and liquid culture, three (3) LPA (Line Probe Assay) equipments and their respective reagents. Expected outcome will be increase in MDR TB cases detected and notified.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Module: Multidrug-resistant TB","High","177750","This activity will allow the program to reach the ambitious targets set out in the funding request.","0","0","0","0","177750","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv5/view",null,"TB/HIV",177750," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713=AN37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713=AO37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713=AP37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713=AJ37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713=AN37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713=AO37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713=AP37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G37)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIv6UAG","PAI-3574","Active","AGO-TB/HIV-13","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"MDR-TB","Treatment: MDR-TB","The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.","The allocation amount in this application plus domestic contribution will only scale up MDR TB detection and treatment up to 63%( 2,379) by 2021 which is far below achieving End TB global  targets. PAAR will increase MDR TB detection and treatment to 60% (2,296) in 2019, 70%(2,551) in 2020 and 75% (2,819) in 2021 to achieve the national targets. PAAR  will support refresher  training for MDR TB detection and management in Sanatorium Hospitals, DATs and UDT in 2019, 2020 and 2021. The expected outcome will be increase in MDRTB cases detected and successfully treated.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Module: Multidrug-resistant TB","High","355500","This activity will allow the program to reach the ambitious targets set out in the funding request.","0","0","0","0","355500","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv6/view",null,"TB/HIV",355500," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713=AN38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713=AO38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713=AP38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713=AJ38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713=AN38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713=AO38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713=AP38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G38)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIv7UAG","PAI-3575","Active","AGO-TB/HIV-14","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"TB/HIV","TB/HIV collaborative interventions","PAAR investment will support activities for TB/ HIV increased integration at both national and district level by  supporting  TWG quarterly meeting at  provincial and municipality levels, joint TB/ HIV planning and supervision of integrated delivery of TB and HIV services.","PAAR investment will support activities for TB/ HIV increased integration at both national and district level by  supporting  TWG quarterly meeting at  provincial and municipality levels, joint TB/ HIV planning and supervision of integrated delivery of TB and HIV services.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","High","360000","This is important to improve TB -HIV outcomes and integration.","0","0","0","0","360000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv7/view",null,"TB/HIV",360000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713=AN39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713=AO39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713=AP39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713=AJ39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713=AN39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713=AO39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713=AP39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G39)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIv8UAG","PAI-3576","Active","AGO-TB/HIV-15","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Implementation of activities will commence in this application as the current grant is only planned to conduct  an IBBS study among truck drivers. The allocation amount in this application plus domestic contribution will only scale up targets in this module up to 40% (8,219) of country need. The PAAR will aim to scale up  coverage to 30% in 2018; 35% in 2019, 40% in 2019 and 50% in 2021 respectively (5,414 in 2018; 6,676 in 2019; 7,918 in 2020; and 10,278 in 2021). Expected outcome will be increase in percentage of truck drivers  reached with a package of prevention services and linked to care and treatment.","Implementation of activities will commence in this application as the current grant is only planned to conduct  an IBBS study among truck drivers. The allocation amount in this application plus domestic contribution will only scale up targets in this module up to 40% (8,219) of country need. The PAAR will aim to scale up  coverage to 30% in 2018; 35% in 2019, 40% in 2019 and 50% in 2021 respectively (5,414 in 2018; 6,676 in 2019; 7,918 in 2020; and 10,278 in 2021). Expected outcome will be increase in percentage of truck drivers  reached with a package of prevention services and linked to care and treatment.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Module: Comprehensive prevention programs for truck drivers. Original Intervention: i)Behavioural interventions for other vulnerable populations ii)Diagnosis and treatment of sexually transmitted infections and other sexual health services for other vulnerable populations","High","580000","This intervention should be refined depending on findings of the IBBS (if the HIV prevalence among truck drivers is lower than that of men who have sex with men, this intervention would not be a high priority.","0","0","0","0","580000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv8/view",null,"TB/HIV",580000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713=AN40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713=AO40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713=AP40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713=AJ40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713=AN40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713=AO40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713=AP40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G40)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIv9UAG","PAI-3577","Active","AGO-TB/HIV-16","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Treatment, care and support","Treatment monitoring - Viral load","The investment in the allocation amount is able to support one Viral load platform in Luanda and is inadequate to achieve viral load testing targets. PAAR in this module is request to support the three additional viral load testing  platforms to be able to meet all targets ( see Annex 17 on projections of viral load testing). The expected outcome will be number of PLHIV on ART test for viral load and improved monitoring of the 90-90-90 care and treatment cascade.","The investment in the allocation amount is able to support one Viral load platform in Luanda and is inadequate to achieve viral load testing targets. PAAR in this module is request to support the three additional viral load testing  platforms to be able to meet all targets ( see Annex 17 on projections of viral load testing). The expected outcome will be number of PLHIV on ART test for viral load and improved monitoring of the 90-90-90 care and treatment cascade.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Intervention: Treatment monitoring  Viral load","High","1e+06","Viral load monitoring will assist with program improvement and quality.","0","0","0","0","1e+06","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIv9/view",null,"TB/HIV",1000000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713=AN41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713=AO41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713=AP41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713=AJ41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713=AN41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713=AO41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713=AP41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G41)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvAUAW","PAI-3578","Active","AGO-TB/HIV-17","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Treatment, care and support","Treatment adherence","Additional PAAR investment for activities to contribute to the 90-90-90 targets will include intensifying peer adherence counseling and provision of psychosocial support to PLHIV at ART sites and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities. Expected out will be number of PLHIV retained in care and virally suppressed.","Additional PAAR investment for activities to contribute to the 90-90-90 targets will include intensifying peer adherence counseling and provision of psychosocial support to PLHIV at ART sites and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities. Expected out will be number of PLHIV retained in care and virally suppressed.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","High","6e+05","Antiviral treatment adherence is important given the low rates of retention and viral suppression.","0","0","0","0","6e+05","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvA/view",null,"TB/HIV",600000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713=AN42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713=AO42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713=AP42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713=AJ42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713=AN42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713=AO42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713=AP42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G42)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvBUAW","PAI-3579","Active","AGO-TB/HIV-18","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Comprehensive prevention programs for MSM","Addressing stigma, discrimination and violence against MSM","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate MSM to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of MSM reached with services.","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate MSM to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of MSM reached with services.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Addressing stigma, discrimination and violence against men who have sex with men","Low","30000","Interventions for men who have sex with men in the funding request already cover sufficient interventions for men who have sex with men.","0","0","0","0","30000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvB/view",null,"TB/HIV",30000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713=AN43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713=AO43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713=AP43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713=AJ43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713=AN43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713=AO43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713=AP43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G43)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvCUAW","PAI-3580","Active","AGO-TB/HIV-19","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","This is a program still in its infancy in the current grant with only 1,764  youth and adolescent -out of school  who had been reached by program implemented by UNFPA (SSR)  that started in July 2016 in three provinces of Luanda, Benguela, Cunene and  Huila.The allocation amount in this application plus domestic contribution will only scale up this up to 31% (400,559) of country need. The PAAR will aim to expand  coverage to six  more provinces (Cuando-Cubango, Moxico,Lunda Sul, Lunda Norte, Cuanza Norte and Bie) and scale up targets  to 15% in 2018; 20% in 2019, 30% in 2019 and 40% in 2021 respectively ( 172,289 in 2018; 239,596 in 2019; 375,070 in 2020; and 587,341 in 2021). Expected outcome will be increase in percentage of adolescent and young girls out of school reached with a package of prevention services and linked to care and treatment.","This is a program still in its infancy in the current grant with only 1,764  youth and adolescent -out of school  who had been reached by program implemented by UNFPA (SSR)  that started in July 2016 in three provinces of Luanda, Benguela, Cunene and  Huila.The allocation amount in this application plus domestic contribution will only scale up this up to 31% (400,559) of country need. The PAAR will aim to expand  coverage to six  more provinces (Cuando-Cubango, Moxico,Lunda Sul, Lunda Norte, Cuanza Norte and Bie) and scale up targets  to 15% in 2018; 20% in 2019, 30% in 2019 and 40% in 2021 respectively ( 172,289 in 2018; 239,596 in 2019; 375,070 in 2020; and 587,341 in 2021). Expected outcome will be increase in percentage of adolescent and young girls out of school reached with a package of prevention services and linked to care and treatment.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","Low","1e+06","Behaviour change communication (BCC ) is not the strongest evidence -based approach to influenc e behaviour change among this population","0","0","0","0","1e+06","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvC/view",null,"TB/HIV",1000000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713=AN44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713=AO44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713=AP44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713=AJ44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713=AN44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713=AO44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713=AP44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G44)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvDUAW","PAI-3581","Inactive","AGO-TB/HIV-2","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"PMTCT","Other intervention(s) for PMTCT","The investment in the allocation amount is able to support one Early Infant diagnosis (EID) platform in Luanda and is inadequate to achieve all PMTCT targets in this application. PAAR in this module is requested to support IEC, Rapid test , M& E tools and the two additional viral load/IED testing  platforms to be able to meet PMTCT targets ( see Annex 17 on projections of viral load testing). The expected outcome will increase in number of children diagnosed of HIV and initiated on antiretroviral therapy.","The investment in the allocation amount is able to support one Early Infant diagnosis (EID) platform in Luanda and is inadequate to achieve all PMTCT targets in this application. PAAR in this module is requested to support IEC, Rapid test , M& E tools and the two additional viral load/IED testing  platforms to be able to meet PMTCT targets ( see Annex 17 on projections of viral load testing). The expected outcome will increase in number of children diagnosed of HIV and initiated on antiretroviral therapy.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Early infant diagnosis","High","3e+05","Early infant diagnosis (EID) is an important activity. However, the deployment of this modality should be positioned in one of the focus provinces based on disease burden","3e+05","0","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvD/view",null,"TB/HIV",0," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713=AN45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713=AO45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713=AP45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713=AJ45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713=AN45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713=AO45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713=AP45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G45)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvEUAW","PAI-3582","Active","AGO-TB/HIV-20","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","This study to be conducted in 2019 and 2021  provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the DHIS2. This cohort analysis will include adults, children and women initiated on ART during pregnancy for the first time. The impact will be increased availability of strategic information to inform programming and implementation","This study to be conducted in 2019 and 2021  provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the DHIS2. This cohort analysis will include adults, children and women initiated on ART during pregnancy for the first time. The impact will be increased availability of strategic information to inform programming and implementation","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings Original Intervention: Study  analysis of cohort of people living with HIV initiated on ART","Low","3e+05","Given resource constrains, a cohort study is not a priority. Program -level data should be used to understand and make improvements in achieving treatment results.","0","0","0","0","3e+05","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvE/view",null,"TB/HIV",300000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713=AN46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713=AO46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713=AP46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713=AJ46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713=AN46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713=AO46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713=AP46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G46)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvFUAW","PAI-3583","Active","AGO-TB/HIV-3","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","Presently, sex workers have weak organizations and networks to organize and mobilize their members. The PAAR  application  will  strengthen KP organizations to organize and mobilize members for KP service delivery including advocacy.  Activities will include community mobilization, training on sexuality, strengthening and supporting organizing of sex workers , providing safe spaces/drop in centres. Expected outcome will be increase in sex worker  reached with programs through sex workers networks and organizations.","Presently, sex workers have weak organizations and networks to organize and mobilize their members. The PAAR  application  will  strengthen KP organizations to organize and mobilize members for KP service delivery including advocacy.  Activities will include community mobilization, training on sexuality, strengthening and supporting organizing of sex workers , providing safe spaces/drop in centres. Expected outcome will be increase in sex worker  reached with programs through sex workers networks and organizations.",null,"High","6e+05","Female sex workers have the highest rates of infection. Support for interventions to address barriers to their care and access to services are imperative to control the HIV epidemic.","0","0","0","0","6e+05","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvF/view",null,"TB/HIV",600000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713=AN47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713=AO47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713=AP47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713=AJ47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713=AN47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713=AO47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713=AP47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G47)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvGUAW","PAI-3584","Active","AGO-TB/HIV-4","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Treatment, care and support","Differentiated ART service delivery","Current ART coverage for Angola according to the revised program  data (2016) from a recent program data assessment standards at  21.4% (adults and children). The allocation amount in this application plus domestic contribution will only scale up this up to 45% which is still far below the global 90-90-90 targets. The PAAR will aim to scale up ART coverage to 33% in 2018; 39% in 2019, 46% in 2019 and 50% in 2021 respectively ( 100,404 in 2018; 121,281 in 2019; 146,008 in 2020; and 161,871 in 2021). Expected outcome will be increase in percentage of adults and children receiving antiretroviral therapy.","Current ART coverage for Angola according to the revised program  data (2016) from a recent program data assessment standards at  21.4% (adults and children). The allocation amount in this application plus domestic contribution will only scale up this up to 45% which is still far below the global 90-90-90 targets. The PAAR will aim to scale up ART coverage to 33% in 2018; 39% in 2019, 46% in 2019 and 50% in 2021 respectively ( 100,404 in 2018; 121,281 in 2019; 146,008 in 2020; and 161,871 in 2021). Expected outcome will be increase in percentage of adults and children receiving antiretroviral therapy.","NA Original Intervention: Differentiated antiretroviral therapy service delivery","High","3e+06","Given the low ART coverage, activities to support the scaleup of the ART program are important.","0","0","0","0","3e+06","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvG/view",null,"TB/HIV",3000000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713=AN48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713=AO48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713=AP48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713=AJ48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713=AN48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713=AO48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713=AP48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G48)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvHUAW","PAI-3585","Active","AGO-TB/HIV-5","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Socioeconomic approaches","The PAAR application will support social grants and cash transfers to support out- of -school young girls and women with  income generating activities (IGAs) grants. This activity will provide training in vocational skills and grants  through SR/SSR targeting young and women working in markets and vocational jobs like knitting, saloons, tailoring, poultry farming, piggery projects, etc to reduce their  economic vulnerability.","The PAAR application will support social grants and cash transfers to support out- of -school young girls and women with  income generating activities (IGAs) grants. This activity will provide training in vocational skills and grants  through SR/SSR targeting young and women working in markets and vocational jobs like knitting, saloons, tailoring, poultry farming, piggery projects, etc to reduce their  economic vulnerability.","NA Original Intervention: Socio-economic approaches","High","4e+05","This intervention is high priority if targeted to the most vulnerable members of the population.","0","0","0","0","4e+05","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvH/view",null,"TB/HIV",400000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713=AN49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713=AO49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713=AP49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713=AJ49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713=AN49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713=AO49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713=AP49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G49)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvIUAW","PAI-3586","Active","AGO-TB/HIV-6","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"Comprehensive prevention programs for sex workers and their clients","Addressing stigma, discrimination and violence against sex workers","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate sex workers to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of sex workers reached with services.","The PAAR application will support  an enabling and legislative environment that allows key populations to be reached with services through advocacy meetings for legal and policy reform to facilitate sex workers to access services and for targeted campaigns to be developed and implemented. The outcome of these activities is to increase the number of sex workers reached with services.",null,"High","30000","There is a discrepancy between title and content of the activity. However, if this activity relates to female sex workers and not men who have sex with men then this should be prioritized.","0","0","0","0","30000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvI/view",null,"TB/HIV",30000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713=AN50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713=AO50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713=AP50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713=AJ50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713=AN50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713=AO50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713=AP50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G50)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvJUAW","PAI-3587","Active","AGO-TB/HIV-7","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"TB/HIV","Engaging all care providers (TB/HIV)","PAAR investment will support activities of engaging public and private/CSO providers (PPP/PPM)  in TB/HIV control activities (screening, diagnosis, treatment and follow-up of patients), CBOs will be supported to connect people at risk of HIV and/or TB with information and services.  Activities will include training of service providers, certification and accreditation, quality assurance, supervision and monitoring, advocacy and communication. PAAR investment will support training in cases management of TB  and directly observed short treatment among TB cases detected and followed up by  prisons health teams, mines and oil companies, and  NGOs who work with TB high risk groups. Expected outcome will be increase in TB CNR and TSR.Expected outcome will be increase in coverage targets and quality of TB/HIV services.","PAAR investment will support activities of engaging public and private/CSO providers (PPP/PPM)  in TB/HIV control activities (screening, diagnosis, treatment and follow-up of patients), CBOs will be supported to connect people at risk of HIV and/or TB with information and services.  Activities will include training of service providers, certification and accreditation, quality assurance, supervision and monitoring, advocacy and communication. PAAR investment will support training in cases management of TB  and directly observed short treatment among TB cases detected and followed up by  prisons health teams, mines and oil companies, and  NGOs who work with TB high risk groups. Expected outcome will be increase in TB CNR and TSR.Expected outcome will be increase in coverage targets and quality of TB/HIV services.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","High","750000","If this activity results in increased case finding and retention, it is important to implement this intervention.","0","0","0","0","750000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvJ/view",null,"TB/HIV",750000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713=AN51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713=AO51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713=AP51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713=AJ51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713=AN51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713=AO51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713=AP51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G51)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvKUAW","PAI-3588","Active","AGO-TB/HIV-8","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"TB care and prevention","Case detection and diagnosis","PAAR to support procurement of additional laboratory  materials and consumable in  2019, 2020 and 2021 to reach targets. The items will include sputum containers and protection masks(3M N95) and reagents. Expected outcome will be increase in CNR.","PAAR to support procurement of additional laboratory  materials and consumable in  2019, 2020 and 2021 to reach targets. The items will include sputum containers and protection masks(3M N95) and reagents. Expected outcome will be increase in CNR.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","High","499050","This activity will allow the program to reach the ambitious targets set out in the funding request.","0","0","0","0","499050","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvK/view",null,"TB/HIV",499050," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713=AN52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713=AO52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713=AP52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713=AJ52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713=AN52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713=AO52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713=AP52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G52)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvLUAW","PAI-3589","Active","AGO-TB/HIV-9","2017-2019","RT Southern and Eastern Africa","Angola","HIV/TB","HIV/AIDS, Tuberculosis","FR258-AGO-C",null,null,"TB care and prevention","Treatment","PAAR to support quarterly supervision to health facilities (84 DOT sites in 18 provinces and communities)  in 2019, 2020 and, 2021. Expected outcome will be increase in TSR of TB cases.","PAAR to support quarterly supervision to health facilities (84 DOT sites in 18 provinces and communities)  in 2019, 2020 and, 2021. Expected outcome will be increase in TSR of TB cases.","13/4/18: While the PAAR was for TB/HIV combined ($11,166,918), Angola only entered HIV amount (8,950,000) as TRP approved in the grant sign off form submitted to 18 April 2018 GAC. The TB PAAR amount will apparently be part of the TB grant form when it comes to GAC. However, for reporting purposes, we are only tracking the total remaining UQD and not per component. FOr 18 April GAC thus, the remaining UQD will be 11,166,918 minus 300,000 of identified savings","High","238560","This activity will allow the program to reach the ambitious targets set out in the funding request.","0","0","0","0","238560","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvL/view",null,"TB/HIV",238560," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713=AN53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713=AO53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713=AP53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713=AJ53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713=AN53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713=AO53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713=AP53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G53)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AIvMUAW","PAI-3590","Active","ALB-TB/HIV-1","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Improve the database system for HIV by web linking of laboratory and epidemiological data. This would further strengthen the HIV database that is already being developed.","Improve the database system for HIV by web linking of laboratory and epidemiological data. This would further strengthen the HIV database that is already being developed.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","11600","This activity should be considered for funding within allocation if efficiency savings are realised.","0","0","0","0","11600","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvM/view","2022-12-31","TB/HIV",11600," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713=AN54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713=AO54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713=AP54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713=AJ54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713=AN54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713=AO54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713=AP54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G54)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvNUAW","PAI-3591","Active","ALB-TB/HIV-10","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Treatment, care and support","Counseling and psycho-social support","Provide counselling for children and adolescents LHIV services on HIV status disclosure, ART adherence, healthy nutrition, coping with emotions etc.Strengthening the quality of Counselling will contribute to higher utilisation of HIV testing services.","Provide counselling for children and adolescents LHIV services on HIV status disclosure, ART adherence, healthy nutrition, coping with emotions etc.Strengthening the quality of Counselling will contribute to higher utilisation of HIV testing services.",null,"Medium","15000",null,"0","0","0","0","15000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvN/view","2022-12-31","TB/HIV",15000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713=AN55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713=AO55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713=AP55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713=AJ55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713=AN55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713=AO55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713=AP55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G55)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvOUAW","PAI-3592","Active","ALB-TB/HIV-11","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish auditing programmes for MMT services","Establish auditing programmes for MMT services","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","Medium","750",null,"0","0","0","0","750","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvO/view","2022-12-31","TB/HIV",750," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713=AN56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713=AO56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713=AP56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713=AJ56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713=AN56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713=AO56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713=AP56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G56)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvPUAW","PAI-3593","Active","ALB-TB/HIV-12","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Offer IEM for KPs health for communities and offer continuous community education programs (LGBTI, sex workers)","Offer IEM for KPs health for communities and offer continuous community education programs (LGBTI, sex workers)","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Medium","24850",null,"0","0","0","0","24850","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvP/view","2022-12-31","TB/HIV",24850," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713=AN57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713=AO57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713=AP57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713=AJ57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713=AN57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713=AO57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713=AP57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G57)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvQUAW","PAI-3594","Active","ALB-TB/HIV-13","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Assess sex worker conditions and legislation and implications for their security and health","Assess sex worker conditions and legislation and implications for their security and health","NA Original Intervention: Other interventions for sex workers and their clients","Medium","9750","Given the challenges in accessing sex workers this assessment is considered to be of medium priority","0","0","0","0","9750","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvQ/view","2022-12-31","TB/HIV",9750," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713=AN58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713=AO58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713=AP58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713=AJ58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713=AN58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713=AO58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713=AP58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G58)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvRUAW","PAI-3595","Active","ALB-TB/HIV-14","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish standards for Key population social and health services (sex workers, LGBTI)","Establish standards for Key population social and health services (sex workers, LGBTI)","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Medium","15250","These standards are important serve to improve quality of services","0","0","0","0","15250","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvR/view","2022-12-31","TB/HIV",15250," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713=AN59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713=AO59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713=AP59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713=AJ59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713=AN59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713=AO59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713=AP59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G59)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvSUAW","PAI-3596","Active","ALB-TB/HIV-15","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Treatment, care and support","Counseling and psycho-social support","Support for documenting human rights violations and train community-based groups on their rights, to facilitate access to justice for key populations and to enforce their rights.","Support for documenting human rights violations and train community-based groups on their rights, to facilitate access to justice for key populations and to enforce their rights.",null,"Medium","3000","This work is considered to be useful to lift barriers to access to services for key populations","0","0","0","0","3000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvS/view","2022-12-31","TB/HIV",3000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713=AN60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713=AO60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713=AP60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713=AJ60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713=AN60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713=AO60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713=AP60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G60)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvTUAW","PAI-3597","Active","ALB-TB/HIV-16","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","Evaluate pilot of PREP for MSM to assess its impact","Evaluate pilot of PREP for MSM to assess its impact","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Low","10100","Within this module, this activity is of lower priority compared to other activities.","0","0","0","0","10100","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvT/view","2022-12-31","TB/HIV",10100," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713=AN61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713=AO61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713=AP61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713=AJ61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713=AN61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713=AO61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713=AP61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G61)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvUUAW","PAI-3598","Active","ALB-TB/HIV-17","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Assess behaviour change and influence of stigma, discrimination and social exclusion in certain KPs (LGBTQ / sex workers) in Albania through a national study","Assess behaviour change and influence of stigma, discrimination and social exclusion in certain KPs (LGBTQ / sex workers) in Albania through a national study","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Low","32000","The proposed assessment is not considered of high priority at this stage to ensure service delivery for KPs","0","0","0","0","32000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvU/view","2022-12-31","TB/HIV",32000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713=AN62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713=AO62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713=AP62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713=AJ62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713=AN62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713=AO62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713=AP62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G62)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvVUAW","PAI-3599","Active","ALB-TB/HIV-18","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","Assess current Viral Hepatitis treatment capacities and capabilities (drugs, guidelines, services etc)  for Albanian population and especially risk groups","Assess current Viral Hepatitis treatment capacities and capabilities (drugs, guidelines, services etc)  for Albanian population and especially risk groups","NA Original Intervention: Other interventions for treatment","Low","20000",null,"0","0","0","0","20000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvV/view","2022-12-31","TB/HIV",20000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713=AN63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713=AO63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713=AP63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713=AJ63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713=AN63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713=AO63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713=AP63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G63)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvWUAW","PAI-3600","Active","ALB-TB/HIV-19","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Treatment, care and support","Prevention, diagnosis and treatment of opportunistic infections","Improve diagnostic capacities for OI (according to guidelines) by Training of microbiologist and ID for diagnosis of OI","Improve diagnostic capacities for OI (according to guidelines) by Training of microbiologist and ID for diagnosis of OI",null,"Low","7850",null,"0","0","0","0","7850","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvW/view","2022-12-31","TB/HIV",7850," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713=AN64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713=AO64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713=AP64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713=AJ64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713=AN64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713=AO64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713=AP64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G64)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvXUAW","PAI-3601","Active","ALB-TB/HIV-2","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Surveys","Establish a sustainable sentinel surveillance system for HIV/STI/Viral Hepatitis in KPs (MSM, sex workers, prisoners) by a partnership of government structures with civil society and other partners","Establish a sustainable sentinel surveillance system for HIV/STI/Viral Hepatitis in KPs (MSM, sex workers, prisoners) by a partnership of government structures with civil society and other partners","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","9750","Strengthening the surveillance systems is considered a sound investment going forwards and should be considered for funding within allocation if efficiency savings are realised.","0","0","0","0","9750","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvX/view","2022-12-31","TB/HIV",9750," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713=AN65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713=AO65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713=AP65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713=AJ65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713=AN65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713=AO65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713=AP65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G65)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvYUAW","PAI-3602","Active","ALB-TB/HIV-20","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Establish a quality assurance monitoring system of HIV prevention, treatment care and support services ","Establish a quality assurance monitoring system of HIV prevention, treatment care and support services ","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Low","12350",null,"0","0","0","0","12350","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvY/view","2022-12-31","TB/HIV",12350," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713=AN66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713=AO66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713=AP66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713=AJ66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713=AN66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713=AO66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713=AP66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G66)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvZUAW","PAI-3603","Active","ALB-TB/HIV-21","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish guidelines and provide KP-specific friendly health services (PWID, sex workers,  Roma)","Establish guidelines and provide KP-specific friendly health services (PWID, sex workers,  Roma)","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","Low","1500",null,"0","0","0","0","1500","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvZ/view","2022-12-31",{"$f":"IF(OR(I67=\"HIV/AIDS\",I67=\"Tuberculosis\",I67=\"Malaria\",I67=\"RSSH\"),I67, IF(I67=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"TB/HIV"},{"$f":"VALUE(Y67)","v":1500},{"$f":"RIGHT(F67,LEN(F67)-2)","v":" Eastern Europe and Central Asia"},"HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,{"$f":"TRIM(AK67)","v":"Tuberculosis"},{"$f":"TRIM(AL67)","v":""},{"$f":"TRIM(AM67)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713=AN67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713=AO67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713=AP67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IF(AE67<>\"\",AE67,IF(MAX(AQ67,AR67,AS67,AT67)<>0,MAX(AQ67,AR67,AS67,AT67),AU67))","v":"2022-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713=AJ67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713=AN67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713=AO67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713=AP67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G67)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IF(AE67<>\"\",AE67,IF(MAX(AW67,AX67,AY67,AZ67)<>0,MAX(AW67,AX67,AY67,AZ67),BA67))","v":"2022-12-31"}]
["a6Q1R000000AIvaUAG","PAI-3604","Active","ALB-TB/HIV-22","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Establish auditing programs for KP (sex workers, LGBTQ, PWID) health and social services offered by all stakeholders","Establish auditing programs for KP (sex workers, LGBTQ, PWID) health and social services offered by all stakeholders","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","Low","2250",null,"0","0","0","0","2250","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIva/view","2022-12-31","TB/HIV",2250," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713=AN68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713=AO68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713=AP68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713=AJ68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713=AN68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713=AO68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713=AP68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G68)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvbUAG","PAI-3605","Active","ALB-TB/HIV-23","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Establish online resource centre with materials and training courses (in Albanian) for professionals and NGOs on KP (sex worker, LGBTI) health and social services","Establish online resource centre with materials and training courses (in Albanian) for professionals and NGOs on KP (sex worker, LGBTI) health and social services","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Low","9500",null,"0","0","0","0","9500","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvb/view","2022-12-31","TB/HIV",9500," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713=AN69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713=AO69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713=AP69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713=AJ69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713=AN69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713=AO69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713=AP69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G69)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvcUAG","PAI-3606","Active","ALB-TB/HIV-24","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Prepare Sex worker monitoring health guidelines","Prepare Sex worker monitoring health guidelines","NA Original Intervention: Other interventions for sex workers and their clients","Low","7000",null,"0","0","0","0","7000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvc/view","2022-12-31","TB/HIV",7000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713=AN70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713=AO70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713=AP70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713=AJ70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713=AN70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713=AO70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713=AP70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G70)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvdUAG","PAI-3607","Active","ALB-TB/HIV-25","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Treatment, care and support","Counseling and psycho-social support","Counselling Services: Counselling support fordiscordant couples","Counselling Services: Counselling support fordiscordant couples",null,"Low","6724",null,"0","0","0","0","6724","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvd/view","2022-12-31","TB/HIV",6724," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713=AN71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713=AO71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713=AP71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713=AJ71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713=AN71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713=AO71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713=AP71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G71)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIveUAG","PAI-3608","Active","ALB-TB/HIV-26","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Treatment, care and support","Counseling and psycho-social support","Support the ageing PLHIV; Drive support and education for older people with HIV, emotional, psychological and social support for people aging with HIV/AIDS and offering support in order to have access on HIV services to ensure a good quality of life","Support the ageing PLHIV; Drive support and education for older people with HIV, emotional, psychological and social support for people aging with HIV/AIDS and offering support in order to have access on HIV services to ensure a good quality of life",null,"Low","15000",null,"0","0","0","0","15000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIve/view","2022-12-31","TB/HIV",15000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713=AN72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713=AO72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713=AP72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713=AJ72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713=AN72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713=AO72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713=AP72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G72)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvfUAG","PAI-3609","Active","ALB-TB/HIV-27","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Treatment, care and support","HIV care","Provide support services to increase and improve women knowledge and skills for the information and education on issue related to women LHIV; and develop I&E materials on strengthening and the building capacities of HIV women group on their gender, SRH and treatment issues","Provide support services to increase and improve women knowledge and skills for the information and education on issue related to women LHIV; and develop I&E materials on strengthening and the building capacities of HIV women group on their gender, SRH and treatment issues",null,"Low","15000",null,"0","0","0","0","15000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvf/view","2022-12-31","TB/HIV",15000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713=AN73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713=AO73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713=AP73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713=AJ73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713=AN73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713=AO73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713=AP73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G73)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvgUAG","PAI-3610","Active","ALB-TB/HIV-28","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"TB care and prevention","Community TB care delivery","Training of Social workers on support for TB patients (is NOT a No 1 priority: 1-day training of 25 social workers in Tirana","Training of Social workers on support for TB patients (is NOT a No 1 priority: 1-day training of 25 social workers in Tirana",null,"Low","1713",null,"0","0","0","0","1713","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvg/view","2022-12-31","TB/HIV",1713," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713=AN74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713=AO74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713=AP74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713=AJ74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713=AN74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713=AO74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713=AP74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G74)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvhUAG","PAI-3611","Active","ALB-TB/HIV-29","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"TB care and prevention","Community TB care delivery","Implement ACSM activities during the World TB Days. Various ACSM activities, including the organization of a nation-wide conference for TB professionals, will be conducted on and around the World TB Day 24 March, following the topics will be  proposed for each years campaign","Implement ACSM activities during the World TB Days. Various ACSM activities, including the organization of a nation-wide conference for TB professionals, will be conducted on and around the World TB Day 24 March, following the topics will be  proposed for each years campaign",null,"Low","6000",null,"0","0","0","0","6000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvh/view","2022-12-31","TB/HIV",6000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713=AN75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713=AO75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713=AP75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713=AJ75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713=AN75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713=AO75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713=AP75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G75)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIviUAG","PAI-3612","Active","ALB-TB/HIV-3","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Prepare a training program for HIV for district epidemiologists. The training of district-level epidemiologists will support the overal decentralisation of health services, and HIV services in particular.","Prepare a training program for HIV for district epidemiologists. The training of district-level epidemiologists will support the overal decentralisation of health services, and HIV services in particular.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","7250","Upgrading and motivating this cadre has a multipronged effect on the quality of health information systems and should be considered for funding within allocation if efficiency savings are realised.","0","0","0","0","7250","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvi/view","2022-12-31","TB/HIV",7250," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713=AN76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713=AO76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713=AP76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713=AJ76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713=AN76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713=AO76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713=AP76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G76)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvjUAG","PAI-3613","Active","ALB-TB/HIV-30","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Surveys","TB knowledge, attitude and practice (KAP) study","TB knowledge, attitude and practice (KAP) study","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Low","19350",null,"0","0","0","0","19350","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvj/view","2022-12-31","TB/HIV",19350," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713=AN77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713=AO77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713=AP77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713=AJ77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713=AN77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713=AO77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713=AP77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G77)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvkUAG","PAI-3614","Active","ALB-TB/HIV-31","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Update surveillance guideline system","Update surveillance guideline system","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Low","10200",null,"0","0","0","0","10200","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvk/view","2022-12-31","TB/HIV",10200," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713=AN78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713=AO78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713=AP78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713=AJ78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713=AN78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713=AO78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713=AP78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G78)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvlUAG","PAI-3615","Active","ALB-TB/HIV-32","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","Evaluate pilot of a new technology in TB and HIV care, such as Video Dots","Evaluate pilot of a new technology in TB and HIV care, such as Video Dots","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Low","9350",null,"0","0","0","0","9350","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvl/view","2022-12-31","TB/HIV",9350," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713=AN79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713=AO79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713=AP79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713=AJ79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713=AN79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713=AO79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713=AP79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G79)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvmUAG","PAI-3616","Active","ALB-TB/HIV-33","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Establish service performance indicators and their measurement","Establish service performance indicators and their measurement","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Low","7500",null,"0","0","0","0","7500","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvm/view","2022-12-31","TB/HIV",7500," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713=AN80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713=AO80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713=AP80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713=AJ80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713=AN80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713=AO80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713=AP80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G80)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvnUAG","PAI-3617","Active","ALB-TB/HIV-4","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"HIV Testing Services","Differentiated HIV testing services","Establish outreach programmes of VCT services in most-at-risk communities","Establish outreach programmes of VCT services in most-at-risk communities",null,"High","40344","The proposed outreach program is considered of high priority given low testing coverage","0","0","0","0","40344","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvn/view","2022-12-31","TB/HIV",40344," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713=AN81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713=AO81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713=AP81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713=AJ81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713=AN81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713=AO81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713=AP81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G81)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvoUAG","PAI-3618","Active","ALB-TB/HIV-5","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Update HIV / AIDS / TB reporting forms to ensure consistency with proposed joint HIV / TB database ","Update HIV / AIDS / TB reporting forms to ensure consistency with proposed joint HIV / TB database ","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","3750","The updating of the forms is considered of high priority to improve the surveillance system and should be considered for funding within allocation if efficiency savings are realised.","0","0","0","0","3750","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvo/view","2022-12-31","TB/HIV",3750," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713=AN82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713=AO82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713=AP82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713=AJ82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713=AN82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713=AO82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713=AP82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G82)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvpUAG","PAI-3619","Active","ALB-TB/HIV-6","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Administrative and finance data sources","Implement OneHealth tool to harmonize and strengthen health system analysis, costing and financing scenarios at the country level","Implement OneHealth tool to harmonize and strengthen health system analysis, costing and financing scenarios at the country level","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Administrative and financial data sources","High","33500","This tool would provide useful data to cost the NSPs and should be considered for funding within allocation if efficiency savings are realised.","0","0","0","0","33500","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvp/view","2022-12-31","TB/HIV",33500," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713=AN83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713=AO83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713=AP83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713=AJ83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713=AN83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713=AO83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713=AP83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G83)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvqUAG","PAI-3620","Active","ALB-TB/HIV-7","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"RSSH: Health management information systems and M&E","Surveys","Conduct next round of IBBSin KPs; IBBS will be done in late 2019. Given the high cost, the Transition grant cannot finance it, but if available, PAAR could finance the next round in 2022.","Conduct next round of IBBSin KPs; IBBS will be done in late 2019. Given the high cost, the Transition grant cannot finance it, but if available, PAAR could finance the next round in 2022.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Medium","137335","Depending on the results of the IBBS in 2019 there may not be a need for a repeat IBBS in two years. Routine programme data should suffice to monitor the trajectory of the concentrated epidemic. This activity is considered of medium priority.","0","0","0","0","137335","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvq/view","2022-12-31","TB/HIV",137335," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713=AN84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713=AO84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713=AP84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713=AJ84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713=AN84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713=AO84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713=AP84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G84)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvrUAG","PAI-3621","Active","ALB-TB/HIV-8","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Treatment, care and support","Differentiated ART service delivery","Provide TA to further strengthen Patient monitoring system for adherence. A partient-monitoring system is in place, but additional TA can further strengthen it.","Provide TA to further strengthen Patient monitoring system for adherence. A partient-monitoring system is in place, but additional TA can further strengthen it.","NA Original Intervention: Differentiated antiretroviral therapy service delivery","Medium","7350",null,"0","0","0","0","7350","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvr/view","2022-12-31","TB/HIV",7350," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713=AN85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713=AO85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713=AP85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713=AJ85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713=AN85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713=AO85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713=AP85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G85)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvsUAG","PAI-3622","Active","ALB-TB/HIV-9","2017-2019","RT Eastern Europe and Central Asia","Albania","HIV/TB","HIV/AIDS, Tuberculosis","FR452-ALB-C",null,null,"Treatment, care and support","Differentiated ART service delivery","Review and update the PEP and PrEP guidelines pilot PrEP for MSM","Review and update the PEP and PrEP guidelines pilot PrEP for MSM","NA Original Intervention: Differentiated antiretroviral therapy service delivery","Medium","3925",null,"0","0","0","0","3925","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvs/view","2022-12-31","TB/HIV",3925," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713=AN86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713=AO86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713=AP86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713=AJ86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713=AN86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713=AO86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713=AP86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G86)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AIvtUAG","PAI-3623","Inactive","ARM-HIV/AIDS-1","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR538-ARM-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Procurement of HCV rapid tests (for 1390 tests in Y1, 1748 tests in Y2 and 1600 tests in Y3 based on the assumptions that 50% of PWIDs tested for HIV will be tested for HCV).","Procurement of HCV rapid tests (for 1390 tests in Y1, 1748 tests in Y2 and 1600 tests in Y3 based on the assumptions that 50% of PWIDs tested for HIV will be tested for HCV).","29/10/2018: The TRP recommended amount is US$1 less than what the TRP review form mentions. This is due to the rounding error which added up the total TRP recommended Armenia PAAR to more than the requested amount by US$1. 26/12/2019: Efficiencies (fiels Further efficiencies applied after reprogramming (US$) column AC) due to Portfolio Optimization. Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","High","4864","This appears to be well explained however it depends on the ability for individuals to be treated for HCV and whether national resources are available or whether this will be permitted in line with the Global Fund policy on co-infections","4864","0","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvt/view","2021-09-30","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713=AN87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713=AO87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713=AP87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713=AJ87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713=AN87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713=AO87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713=AP87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G87)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIvuUAG","PAI-3624","Inactive","ARM-HIV/AIDS-2","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR538-ARM-C",null,null,"Comprehensive prevention programs for sex workers and their clients","Diagnosis and treatment of STIs and other sexual and reproductive health services for sex workers","STI testing and treatment for Sex Workers (SW) (medical staff salaries, procurement of medical supplies for STI and STI drugs): 30% of reached clients will receive referral for STI testing and 18% of reached clients are expected to require STI treatment.Screening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","STI testing and treatment for Sex Workers (SW) (medical staff salaries, procurement of medical supplies for STI and STI drugs): 30% of reached clients will receive referral for STI testing and 18% of reached clients are expected to require STI treatment.Screening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","26/12/2019: Efficiencies (fiels Further efficiencies applied after reprogramming (US$) column AC) due to Portfolio Optimization. Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual and reproductive health services for sex workers","High","46934",null,"46934","0","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvu/view","2021-09-30","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713=AN88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713=AO88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713=AP88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713=AJ88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713=AN88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713=AO88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713=AP88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G88)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIvvUAG","PAI-3625","Inactive","ARM-HIV/AIDS-3","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR538-ARM-C",null,null,"Comprehensive prevention programs for MSM","Diagnosis and treatment of STIs and other sexual health services for MSM","STI testing and treatment for MSM (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment. Screening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","STI testing and treatment for MSM (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment. Screening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","26/12/2019: Efficiencies (fiels Further efficiencies applied after reprogramming (US$) column AC) due to Portfolio Optimization. Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for men who have sex with men","High","19555",null,"8778","10777","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvv/view","2021-09-30","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713=AN89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713=AO89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713=AP89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713=AJ89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713=AN89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713=AO89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713=AP89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G89)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIvwUAG","PAI-3626","Inactive","ARM-HIV/AIDS-4","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR538-ARM-C",null,null,"Comprehensive prevention programs for TGs","Diagnosis and treatment of STIs and sexual health services for TGs","STI testing and treatment for Transgender (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment. Screening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","STI testing and treatment for Transgender (procurement of medical supplies for STI and STI drugs): 30% of reached clients will be referred for STI testing and 18% of reached clients are expected to require STI treatment. Screening, diagnosis and treatment of STIs are crucial parts of a comprehensive response to HIV. STI services attract clients to HIV programmes and reduce susceptibility to HIV infection. Introduction of STI services will strengthen the relatively modest package of services included in the allocation request thus increasing the quality and effectiveness of the offered service combination.","26/12/2019: Efficiencies (fiels Further efficiencies applied after reprogramming (US$) column AC) due to Portfolio Optimization. Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Diagnosis and treatment of sexually transmitted infections and sexual health services for transgender people","High","352",null,"352","0","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvw/view","2021-09-30","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713=AN90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713=AO90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713=AP90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713=AJ90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713=AN90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713=AO90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713=AP90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G90)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIvxUAG","PAI-3627","Inactive","ARM-HIV/AIDS-5","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR538-ARM-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Improvement of client registration, unification of coding system and integration of programme monitoring data into common database. Training regarding stigma and discrimination - in total 5 trainings were budgeted. Trainings for outreach workers - in total 5 trainings were budgeted.In order to strengthen programme monitoring and reporting accuracy and avoid potential duplication of efforts (e.g. of Men who have Sex with Men (MSM), SW and PWID activities funded by the Global Fund and EJAF) Principal Recipient will introduce uniform Unique Identification Code across projects and organisations and pursue integration of monitoring systems and introduction of a shared database. Accurate programme reporting is essential for adequate target setting and precise measurements of achievements in the response to the epidemic. Introduction of these innovations will require training for field workers.","Improvement of client registration, unification of coding system and integration of programme monitoring data into common database. Training regarding stigma and discrimination - in total 5 trainings were budgeted. Trainings for outreach workers - in total 5 trainings were budgeted.In order to strengthen programme monitoring and reporting accuracy and avoid potential duplication of efforts (e.g. of Men who have Sex with Men (MSM), SW and PWID activities funded by the Global Fund and EJAF) Principal Recipient will introduce uniform Unique Identification Code across projects and organisations and pursue integration of monitoring systems and introduction of a shared database. Accurate programme reporting is essential for adequate target setting and precise measurements of achievements in the response to the epidemic. Introduction of these innovations will require training for field workers.","26/12/2019: Efficiencies (fiels Further efficiencies applied after reprogramming (US$) column AC) due to Portfolio Optimization. Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","58000",null,"13790","44210","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvx/view","2021-09-30","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713=AN91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713=AO91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713=AP91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713=AJ91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713=AN91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713=AO91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713=AP91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G91)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIvyUAG","PAI-3628","Inactive","ARM-HIV/AIDS-6","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR538-ARM-C",null,null,"RSSH: Health management information systems and M&E","Surveys","IBBS (Integrated Biology and Behavioural Survey) among PWID, MSM, TG, SW, Migrants in Y2 in order to assess the situation and measure progress in HIV prevention and treatment.The previous IBBS studies have been funded by the Global Fund grants. The government has not yet assumed this function, hence funding for IBBS studies is included in the above allocation request.","IBBS (Integrated Biology and Behavioural Survey) among PWID, MSM, TG, SW, Migrants in Y2 in order to assess the situation and measure progress in HIV prevention and treatment.The previous IBBS studies have been funded by the Global Fund grants. The government has not yet assumed this function, hence funding for IBBS studies is included in the above allocation request.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","120000","The continued ability to conduct such surveys, or alternative sources of information should be considered for future sustainability after this grant","0","120000","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvy/view","2021-09-30","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713=AN92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713=AO92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713=AP92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713=AJ92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713=AN92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713=AO92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713=AP92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G92)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIvzUAG","PAI-3629","Active","ARM-HIV/AIDS-7","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR538-ARM-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","HCV treatment procurement for HIV positive and HCV treatment monitoring for 600 persons during the 2,5 years periodSocial support program (cash-incentives for adherence to treatment) for patients with DS (regular) TB.HCV represents a growing concern with the prevalence among seasonal urban migrants found to be 3.3% in 2018 IBBS study. MoH and NCAP have piloted DAA HCV treatment with medicines donated by the Georgian government and MSF. MoH and NCAP are currently negotiating continued HCV treatment programmes with producers and suppliers of DAA medications. While these negotiations are under was modest number of treatment courses required to treat HIV/HCV coinfected patients is included in the above allocation request.","HCV treatment procurement for HIV positive and HCV treatment monitoring for 600 persons during the 2,5 years periodSocial support program (cash-incentives for adherence to treatment) for patients with DS (regular) TB.HCV represents a growing concern with the prevalence among seasonal urban migrants found to be 3.3% in 2018 IBBS study. MoH and NCAP have piloted DAA HCV treatment with medicines donated by the Georgian government and MSF. MoH and NCAP are currently negotiating continued HCV treatment programmes with producers and suppliers of DAA medications. While these negotiations are under was modest number of treatment courses required to treat HIV/HCV coinfected patients is included in the above allocation request.","NA Original Intervention: Other interventions for treatment","High","540000","Please note as per Global Fund policy HCV treatment can only be provided for HIV/HCV co-infected individuals, however the TRP understands that this is the case in this situation","45000","0","0","0","495000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIvz/view","2021-09-30","TB/HIV",495000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713=AN93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713=AO93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713=AP93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713=AJ93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713=AN93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713=AO93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713=AP93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G93)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIw0UAG","PAI-3630","Inactive","ARM-HIV/AIDS-8","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR538-ARM-C",null,null,"Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","The total number of urban migrants in Armenia can be as high as 60,000. Therefore, although coverage of 5000 migrants and their sexual partners has been included in the main allocation request, covering additional 5000 is needed in particular if the Russian aid program fails to continue. So additional amount of funds is planned to be spent on this program component if available.","The total number of urban migrants in Armenia can be as high as 60,000. Therefore, although coverage of 5000 migrants and their sexual partners has been included in the main allocation request, covering additional 5000 is needed in particular if the Russian aid program fails to continue. So additional amount of funds is planned to be spent on this program component if available.",null,"High","2e+05",null,"0","2e+05","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw0/view","2021-09-30","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713=AN94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713=AO94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713=AP94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713=AJ94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713=AN94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713=AO94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713=AP94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G94)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIw1UAG","PAI-3631","Inactive","ARM-HIV/AIDS-9","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR538-ARM-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","Social support program to incentivise treatment adherence among patient with drug-susceptible tuberculosis in addition to the social support of patients with drug-resistant TB covered under the TB grant program.","Social support program to incentivise treatment adherence among patient with drug-susceptible tuberculosis in addition to the social support of patients with drug-resistant TB covered under the TB grant program.","NA Original Intervention: Other interventions for treatment","High","3e+05",null,"0","3e+05","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw1/view","2021-09-30","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713=AN95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713=AO95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713=AP95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713=AJ95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713=AN95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713=AO95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713=AP95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G95)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIw2UAG","PAI-3632","Inactive","ARM-TB/HIV-1","2017-2019","RT Eastern Europe and Central Asia","Armenia","HIV/TB","HIV/AIDS, Tuberculosis","FR581-ARM-C",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","USD 200,000 to support the roll out of ECHO project (tele-medecine platform) in Armenia in cooperation with the ADB. Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services.","USD 200,000 to support the roll out of ECHO project (tele-medecine platform) in Armenia in cooperation with the ADB. Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services.","CT validation: description was updated and amounts are confirmed Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health infomration systems and monitoring and evaluation intervention(s)","High","2e+05",null,"0","2e+05","0","0","0","1","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw2/view","2021-09-30","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713=AN96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713=AO96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713=AP96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713=AJ96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713=AN96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713=AO96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713=AP96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G96)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AIw3UAG","PAI-3633","Active","AZE-HIV/AIDS-1","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Echo is a tele-medicine platform developed at the University of New Mexico to serve rural populations, and which has been used by US CDC as a method for introducing new approaches in clinical practice in elimination of HIV and Hep C, and then has been also extended for TB. It was successfully introduced in Georgia for these three diseases. It links expert specialist teams at an academic hub with primary care clinicians in local communities. It allows primary care clinicians/TB or HIV doctors from multiple sites present patient cases to the specialist teams and to each other, discuss new developments relating to their patients, and determine treatment.","Echo is a tele-medicine platform developed at the University of New Mexico to serve rural populations, and which has been used by US CDC as a method for introducing new approaches in clinical practice in elimination of HIV and Hep C, and then has been also extended for TB. It was successfully introduced in Georgia for these three diseases. It links expert specialist teams at an academic hub with primary care clinicians in local communities. It allows primary care clinicians/TB or HIV doctors from multiple sites present patient cases to the specialist teams and to each other, discuss new developments relating to their patients, and determine treatment.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","High","328814","The TRP recommends moving this within the allocation in case efficiencies can be found during grant-making, or savings made during grant-implementation. The major strengths of the funding request are the interventions for people who inject drugs. By including these interventions, it will increase the suggested coverage targets and is part of an inclusive package of all the behavioral interventions.","0","0","0","0","328814","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw3/view","2021-06-30","HIV/AIDS",328814," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713=AN97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713=AO97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713=AP97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713=AJ97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713=AN97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713=AO97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713=AP97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G97)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIw4UAG","PAI-3634","Active","AZE-HIV/AIDS-10","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","1. Strengthen stigma related capacity for medical personnel of ART centres.2. Organization of 2 communication campaigns organized per year in the eve of notable days (WAD, Candlelight) to build public awareness and reduce stigma and discrimination.","1. Strengthen stigma related capacity for medical personnel of ART centres.2. Organization of 2 communication campaigns organized per year in the eve of notable days (WAD, Candlelight) to build public awareness and reduce stigma and discrimination.",null,"Low","48927","Sufficient funding is already allocated to this activity; the TRP considers this intervention as of low priority.","0","0","0","0","48927","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw4/view","2021-06-30","HIV/AIDS",48927," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713=AN98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713=AO98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713=AP98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713=AJ98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713=AN98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713=AO98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713=AP98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G98)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIw5UAG","PAI-3635","Active","AZE-HIV/AIDS-11","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"RSSH: Health management information systems and M&E","Surveys","Operational research: Surveys among detainees in 23 penitentiary facilities to evaluate the efficiency of the implemented HIV prevention interventions in penitentiary sector.","Operational research: Surveys among detainees in 23 penitentiary facilities to evaluate the efficiency of the implemented HIV prevention interventions in penitentiary sector.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","20812","Sufficient funding is already allocated to this activity; the TRP considers this intervention as of low priority.","0","0","0","0","20812","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw5/view","2021-06-30","HIV/AIDS",20812," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713=AN99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713=AO99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713=AP99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713=AJ99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713=AN99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713=AO99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713=AP99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G99)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIw6UAG","PAI-3636","Active","AZE-HIV/AIDS-2","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Training for service providers from OST sites.","Training for service providers from OST sites.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","High","6798","The TRP recommends moving this within the allocation in case efficiencies can be found during grant-making, or savings made during grant-implementation. The major thrust of the funding request is interventions for people who inject drugs. This intervention will increase the suggested coverage and is part of an inclusive package of all the behavioral interventions","0","0","0","0","6798","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw6/view","2021-06-30","HIV/AIDS",6798," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713=AN100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713=AO100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713=AP100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713=AJ100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713=AN100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713=AO100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713=AP100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIw7UAG","PAI-3637","Active","AZE-HIV/AIDS-3","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services (currently HIV services are only provided in Yerevan). The vision is to further expand Echo in other areas of health in collaboration with the recent Asian Development Bank (ADB) program focused on health sector policy reforms to strengthen efficient utilization of resources and to improve quality of services.","Echo in Armenia aims for improvement of TB and HIV case management, as well as to manage co-infection and co-morbidities, by providing access to specialist knowledge (in the context of shifting to new TB treatment regimens, rollout of Hep C treatment considering high HIV/Hep C rates, etc). It will also address issues related to loss of patients, late start of treatment or weak treatment monitoring by allowing decentralization of services (currently HIV services are only provided in Yerevan). The vision is to further expand Echo in other areas of health in collaboration with the recent Asian Development Bank (ADB) program focused on health sector policy reforms to strengthen efficient utilization of resources and to improve quality of services.",null,"High","70148","The TRP recommends moving this within the allocation in case efficiencies can be found during grant-making, or savings made during grant-implementation. To achieve quality service scale up and reach the suggested coverage targets for this group, a package inclusive of all the behavioral interventions should be implemented.","0","0","0","0","70148","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw7/view","2021-06-30","HIV/AIDS",70148," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713=AN101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713=AO101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713=AP101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713=AJ101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713=AN101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713=AO101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713=AP101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIw8UAG","PAI-3638","Active","AZE-HIV/AIDS-4","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","PDI, Optimized HIV case finding and HIV case management interventions with focus on men who have sex with men","PDI, Optimized HIV case finding and HIV case management interventions with focus on men who have sex with men","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","High","30441","The TRP recommends moving this within the allocation in case efficiencies can be found during grant-making, or savings made during grant-implementation To achieve quality service scale up and reach the suggested coverage, the interventions should come as a package inclusive of all the behavioral interventions","0","0","0","0","30441","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw8/view","2021-06-30","HIV/AIDS",30441," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713=AN102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713=AO102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713=AP102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713=AJ102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713=AN102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713=AO102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713=AP102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIw9UAG","PAI-3639","Active","AZE-HIV/AIDS-5","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Behavioral interventions for people in prisons and other closed settings","Proposed funding will cover the Echo start-up activities: (a) Establishing Echo network hub in Yerevan; (b) Training of medical staff in using the web-based software; (c) Tele-echo clinics in AIDS and TB curated by ECHO team from University of New Mexico; (d) Case-based learning and guided practice in TB and AIDS; e) Access to specialist knowledge in AIDS, TB, infectious diseases, pharmacology.","Proposed funding will cover the Echo start-up activities: (a) Establishing Echo network hub in Yerevan; (b) Training of medical staff in using the web-based software; (c) Tele-echo clinics in AIDS and TB curated by ECHO team from University of New Mexico; (d) Case-based learning and guided practice in TB and AIDS; e) Access to specialist knowledge in AIDS, TB, infectious diseases, pharmacology.",null,"High","99000","The TRP recommends moving this within the allocation in case efficiencies can be found during grant-making, or savings made during grant-implementation To achieve quality service scale up and reach the suggested coverage the interventions should come as a package inclusive of all the behavioral interventions","0","0","0","0","99000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIw9/view","2021-06-30","HIV/AIDS",99000," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713=AN103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713=AO103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713=AP103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713=AJ103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713=AN103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713=AO103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713=AP103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G103)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIwAUAW","PAI-3640","Active","AZE-HIV/AIDS-6","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Build awareness of key decision makers on evidence-based HIV prevention interventions in penitentiary sector. Activities include information and advocacy meetings (round tables/workshops) to increase awareness about evidence-based HIV prevention intervention in prisons.","Build awareness of key decision makers on evidence-based HIV prevention interventions in penitentiary sector. Activities include information and advocacy meetings (round tables/workshops) to increase awareness about evidence-based HIV prevention intervention in prisons.",null,"High","13595","The TRP recommends moving this within the allocation in case efficiencies can be found during grant-making, or savings made during grant-implementation. The prisons have a high prevalence and yet there is high stigma and discrimination, which makes this activity high priority.","0","0","0","0","13595","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwA/view","2021-06-30","HIV/AIDS",13595," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713=AN104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713=AO104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713=AP104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713=AJ104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713=AN104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713=AO104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713=AP104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G104)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIwBUAW","PAI-3641","Active","AZE-HIV/AIDS-7","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"Treatment, care and support","Treatment monitoring - Viral load","Procurement of HIV Viral Load tests and CD4 tests for regular laboratory and clinical examination of PLHIV in civil sector. Treatment monittoring is critical considering increasing treatment coverage and low VL suppression in the country.","Procurement of HIV Viral Load tests and CD4 tests for regular laboratory and clinical examination of PLHIV in civil sector. Treatment monittoring is critical considering increasing treatment coverage and low VL suppression in the country.","NA Original Intervention: Treatment monitoring  Viral load","High","1272512","The applicant suggests increasing treatment coverage and treatment monitoring is critical given the low viral load suppression.","0","0","0","0","1272512","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwB/view","2021-06-30","HIV/AIDS",1272512," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713=AN105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713=AO105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713=AP105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713=AJ105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713=AN105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713=AO105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713=AP105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G105)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIwCUAW","PAI-3642","Active","AZE-HIV/AIDS-8","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","1. Training for community health workers on ARV treatment.2. Participation in trainings, international conferences for Republican AIDS Centre, MoJ staff and NGOs in priority issues of HIV/AIDS.","1. Training for community health workers on ARV treatment.2. Participation in trainings, international conferences for Republican AIDS Centre, MoJ staff and NGOs in priority issues of HIV/AIDS.","NA Original Module: RSSH - Human resources for health, including community health workers","High","97684","Given the need to decentralize services for improved access, the role of community health workers is critical. The TRP considers this intervention as high quality demand.","0","0","0","0","97684","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwC/view","2021-06-30","HIV/AIDS",97684," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713=AN106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713=AO106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713=AP106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713=AJ106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713=AN106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713=AO106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713=AP106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIwDUAW","PAI-3643","Active","AZE-HIV/AIDS-9","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","HIV/AIDS","HIV/AIDS","FR316-AZE-H",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Procurement of AIDS software as part of National HIS support.","Procurement of AIDS software as part of National HIS support.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","20991","There are funds within allocation for this activity and therefore these additional funds are of medium priority.","0","0","0","0","20991","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwD/view","2021-06-30","HIV/AIDS",20991," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713=AN107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713=AO107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713=AP107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713=AJ107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713=AN107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713=AO107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713=AP107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AIwEUAW","PAI-3644","Active","AZE-Tuberculosis-1","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","Tuberculosis","Tuberculosis","FR317-AZE-T",null,null,"MDR-TB","Other MDR-TB intervention(s)","1. Procurement of additional 1000 Xpert cartridges/year;2. Operational research on prevalence of the latent TB infection among prison population and revising the algorithm for active case finding for penitentiary sector","1. Procurement of additional 1000 Xpert cartridges/year;2. Operational research on prevalence of the latent TB infection among prison population and revising the algorithm for active case finding for penitentiary sector","NA Original Module: Multidrug-resistant TB. Original Intervention: Key populations (MDR-TB)  Prisoners","High","59269","Following activities are planned: 1) Additional procurement of 1000 Xpert cartridges/year; 2) Operational research on prevalence of the latent TB infection among prison population and formation (revising of the current) of the new algorithm for active case finding. This will guide the introduction of additional evidence-based measures to prevent inmates with latent TB infection (LTBI) from developing active and infectious TB disease. The ultimate goal is to improve the TB control Program in prisons to ensure the highest attainable TB services to inmates and to decrease the TB burden in prisons and consequently in the country overall. For these reasons, the TRP considers these activities of high priority","0","0","0","0","59269","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwE/view","2020-12-31","Tuberculosis",59269," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713=AN108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713=AO108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713=AP108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713=AJ108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713=AN108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713=AO108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713=AP108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G108)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AIwFUAW","PAI-3645","Active","AZE-Tuberculosis-2","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","Tuberculosis","Tuberculosis","FR317-AZE-T",null,null,"MDR-TB","Community MDR-TB care delivery","Procurement and operation of mobile mini-lab unit for TB case finding and treatment monitoring. About 1000 new TB cases to be detected annuallyGeographical coverage: southern regions of Azerbaijan that are the most affected by TB and HIV, migration and drug use and distantly located from the rayon center (Djilalibad, Massaly, Lenkoran, Astara, Lerik)","Procurement and operation of mobile mini-lab unit for TB case finding and treatment monitoring. About 1000 new TB cases to be detected annuallyGeographical coverage: southern regions of Azerbaijan that are the most affected by TB and HIV, migration and drug use and distantly located from the rayon center (Djilalibad, Massaly, Lenkoran, Astara, Lerik)","NA Original Module: Multidrug-resistant TB","High","195518","The TRP considers this intervention quality demand as it will ensure rapid access to patient-centred services","0","0","0","0","195518","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwF/view","2020-12-31","Tuberculosis",195518," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713=AN109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713=AO109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713=AP109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713=AJ109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713=AN109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713=AO109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713=AP109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G109)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AIwGUAW","PAI-3646","Active","AZE-Tuberculosis-3","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","Tuberculosis","Tuberculosis","FR317-AZE-T",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Joint TB Program Review led by the WHO Country Offices and conducted jointly with international experts.","Joint TB Program Review led by the WHO Country Offices and conducted jointly with international experts.",null,"High","50000","The TRP considers this intervention quality demand as a program review will be useful for course correction in a view of sustainability. With the assistance of WHO Country Office and in close coordination with the national TB Control Program and with the financial support of the Global Fund and 5 participation of partners including United States Agency for International Development (USAID), United States Centres for Disease Prevention and Control (CDC), Global Drug Facility (GDF) among others, a team of international experts will conduct the country program review.","0","0","0","0","50000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwG/view","2020-12-31","Tuberculosis",50000," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713=AN110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713=AO110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713=AP110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713=AJ110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713=AN110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713=AO110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713=AP110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G110)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AIwHUAW","PAI-3647","Active","AZE-Tuberculosis-4","2017-2019","RT Eastern Europe and Central Asia","Azerbaijan","Tuberculosis","Tuberculosis","FR317-AZE-T",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Participation in training courses and conferences in various aspects of TB control including of TB control in prisons, for knowledge update and experience exchange","Participation in training courses and conferences in various aspects of TB control including of TB control in prisons, for knowledge update and experience exchange","NA Original Module: RSSH - Human resources for health, including community health workers","Medium","42000","This intervention includes participation in international training courses and conferences on various aspects of TB control, including of TB control in prisons, for knowledge update and experience exchange. This is important for local capacity building; however, considering other needs, the TRP considers this intervention of medium importance","0","0","0","0","42000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwH/view","2020-12-31","Tuberculosis",42000," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713=AN111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713=AO111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713=AP111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713=AJ111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713=AN111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713=AO111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713=AP111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AIwIUAW","PAI-3648","Active","BDI-HIV/AIDS-1","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Treatment, care and support","Treatment monitoring - Viral load","Activity: Acquire the complement of reagents for the viral load.The 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. This funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.","Activity: Acquire the complement of reagents for the viral load.The 2018-2020 grant plans to acquire viral load reagents. For the year 2019 and 2020, the targets to be covered are respectively 57 100 Test and 65 469 Test for an amount of US $ 3,235,376.8. However, available financing in the country (FM, OPP-ERA, PEPFAR) covers 80413 Test for an amount of 1 526 314,1 USD or a Gaps of 1432737,8 USD. This funding beyond will enable the country to reach coverage in viral load of 85% in 2019 and 90% in 2020.","NA Original Intervention: Treatment monitoring  Viral load","High","1432738",null,"0","0","0","0","1432738","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwI/view","2020-12-31","HIV/AIDS",1432738," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713=AN112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713=AO112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713=AP112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713=AJ112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713=AN112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713=AO112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713=AP112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwJUAW","PAI-3649","Active","BDI-HIV/AIDS-10","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Community empowerment for PWID","Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDUThis activity aims to improve the living conditions of key populations.","Activity: Train Leaders of Cluster Populations in Micro-Project Development and Management (RMI): MSM, PS, Transgender, IDUThis activity aims to improve the living conditions of key populations.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Community empowerment for people who inject drugs","High","43274",null,"0","0","0","0","43274","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwJ/view","2020-12-31","HIV/AIDS",43274," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713=AN113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713=AO113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713=AP113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713=AJ113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713=AN113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713=AO113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713=AP113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G113)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwKUAW","PAI-3650","Active","BDI-HIV/AIDS-11","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.This activity aims to reduce new infections by facilitating PS to access prevention and care services.","Activity: Organize a biannual national coordination meeting of interventions for sex workers and for human rights and access to services for this key population.This activity aims to reduce new infections by facilitating PS to access prevention and care services.","NA Original Intervention: Other interventions for sex workers and their clients","High","4350",null,"0","0","0","0","4350","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwK/view","2020-12-31","HIV/AIDS",4350," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713=AN114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713=AO114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713=AP114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713=AJ114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713=AN114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713=AO114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713=AP114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G114)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwLUAW","PAI-3651","Active","BDI-HIV/AIDS-12","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)This activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target","Activity: Provide nutritional support to the poorest people living with HIV who are in the middle of acute malnutrition (for any clarification please see the Nutritional support sheet)This activity aims to reduce undernutrition and the economic impact of HIV / AIDS. It comes in addition to 50% of the untargeted target",null,"High","202134",null,"0","0","0","0","202134","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwL/view","2020-12-31","HIV/AIDS",202134," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713=AN115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713=AO115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713=AP115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713=AJ115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713=AN115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713=AO115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713=AP115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G115)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwMUAW","PAI-3652","Active","BDI-HIV/AIDS-13","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond","Activity: Provide nutritional support to the poorest PLWHIV in the severe acute malnutrion phase (for any clarification please see the Nutritional Support sheet)Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyond",null,"High","25343",null,"0","0","0","0","25343","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwM/view","2020-12-31","HIV/AIDS",25343," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713=AN116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713=AO116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713=AP116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713=AJ116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713=AN116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713=AO116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713=AP116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwNUAW","PAI-3653","Active","BDI-HIV/AIDS-14","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Treatment, care and support","Counseling and psycho-social support","Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)Given the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond","Activity: The nutritional support of women under PMTCT covers 9 months and concerns 25% of those newly enrolled in PMTCT each year. (For any clarification, see the Nutritional support sheet)Given the budget constraints, 50% of thetarget has been budgeted and the rest has been sent in funding beyond",null,"High","560962",null,"0","0","0","0","560962","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwN/view","2020-12-31","HIV/AIDS",560962," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713=AN117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713=AO117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713=AP117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713=AJ117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713=AN117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713=AO117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713=AP117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwOUAW","PAI-3654","Active","BDI-HIV/AIDS-15","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Treatment, care and support","Counseling and psycho-social support","Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)Nutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyondActivity is related to indicator #: TCS-1 (M)","Activity: Provide nutritional support to eligible children in the context of PMTCT (for any clarification see the Nutritional Support sheet)Nutritional support for children born to HIV-positive women covers 4 months (according to the national protocol for integrated management of acute malnutrition 2014, age 70) and covers 25% of those expected each year. Given the budget constraints, 50% of the target has been budgeted and the rest has been sent in funding beyondActivity is related to indicator #: TCS-1 (M)",null,"High","173582",null,"0","0","0","0","173582","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwO/view","2020-12-31","HIV/AIDS",173582," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713=AN118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713=AO118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713=AP118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713=AJ118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713=AN118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713=AO118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713=AP118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwPUAW","PAI-3655","Active","BDI-HIV/AIDS-16","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Train 210 users on the AIDS-INFO database at all levelsThe training will be organized for the 210 sites of care of the PVIH by favoring those who have a large active girl. In the current grant we had the budget to train only 100 people. The training will be 30 participants per session for 4 days so a total of 7 training sessions. This activity will improve the monitoring of PLHIV and the quality of the data.","Activity: Train 210 users on the AIDS-INFO database at all levelsThe training will be organized for the 210 sites of care of the PVIH by favoring those who have a large active girl. In the current grant we had the budget to train only 100 people. The training will be 30 participants per session for 4 days so a total of 7 training sessions. This activity will improve the monitoring of PLHIV and the quality of the data.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","31197",null,"0","0","0","0","31197","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwP/view","2020-12-31","HIV/AIDS",31197," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713=AN119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713=AO119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713=AP119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713=AJ119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713=AN119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713=AO119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713=AP119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G119)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwQUAW","PAI-3656","Active","BDI-HIV/AIDS-17","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Ensuring a link between AIDS-INFO and central, intermediate and peripheral DHIS 2 levelsThe Server for networking has already been acquired and installed at the level of the PNLS / IST. This link can not be done without all patient records being entered in AIDS-INFO. This amount will enable data entry in AIDS-INFO to update all patient records for an activity queue of 65,000 PLHIV.","Activity: Ensuring a link between AIDS-INFO and central, intermediate and peripheral DHIS 2 levelsThe Server for networking has already been acquired and installed at the level of the PNLS / IST. This link can not be done without all patient records being entered in AIDS-INFO. This amount will enable data entry in AIDS-INFO to update all patient records for an activity queue of 65,000 PLHIV.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","37992",null,"0","0","0","0","37992","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwQ/view","2020-12-31","HIV/AIDS",37992," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713=AN120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713=AO120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713=AP120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713=AJ120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713=AN120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713=AO120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713=AP120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G120)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwRUAW","PAI-3657","Active","BDI-HIV/AIDS-18","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Providing sites with support for adequate computer equipment for data managementFor the moment, the CDS make the data entry themselves in DHI2. Field visits show that most CDS have a single laptop. This computer is used for the administrative activities of the CDS. It is necessary that the SIS service of the FOSA who take care of the data regularly has its own computer. In total, we have 750 support structures. In the past grant, the computer support concerned only about 170 structures.","Activity: Providing sites with support for adequate computer equipment for data managementFor the moment, the CDS make the data entry themselves in DHI2. Field visits show that most CDS have a single laptop. This computer is used for the administrative activities of the CDS. It is necessary that the SIS service of the FOSA who take care of the data regularly has its own computer. In total, we have 750 support structures. In the past grant, the computer support concerned only about 170 structures.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","762756",null,"0","0","0","0","762756","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwR/view","2020-12-31","HIV/AIDS",762756," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713=AN121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713=AO121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713=AP121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713=AJ121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713=AN121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713=AO121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713=AP121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G121)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwSUAW","PAI-3658","Active","BDI-HIV/AIDS-19","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Review the tools for collecting HIV dataThe set of HIV tools will be revised by integrating all the indicators of the new strategic plan 2018-2022 and the adequacy of the new guidelines for the care of PLHIV. This will provide data for monitoring the strategic plan. Two workshops of 25 people for 4 days will be carried out inside the country.","Activity: Review the tools for collecting HIV dataThe set of HIV tools will be revised by integrating all the indicators of the new strategic plan 2018-2022 and the adequacy of the new guidelines for the care of PLHIV. This will provide data for monitoring the strategic plan. Two workshops of 25 people for 4 days will be carried out inside the country.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Administrative and financial data sources","High","8287",null,"0","0","0","0","8287","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwS/view","2020-12-31","HIV/AIDS",8287," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713=AN122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713=AO122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713=AP122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713=AJ122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713=AN122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713=AO122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713=AP122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwTUAW","PAI-3659","Active","BDI-HIV/AIDS-2","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Activity: Acquire reagents for HIV testingThe 2018-2020 grant and other partners (FM, UNICEF, PEPFAR) are planning to acquire HIV testing reagents to cover the various screening tests for $ 165,979.77, with a total requirement of 4,066 730,3USD is a Gaps of 2 443853USDThis funding beyond this will enable the country to reach screening coverage for the different types of Country Target Testing.","Activity: Acquire reagents for HIV testingThe 2018-2020 grant and other partners (FM, UNICEF, PEPFAR) are planning to acquire HIV testing reagents to cover the various screening tests for $ 165,979.77, with a total requirement of 4,066 730,3USD is a Gaps of 2 443853USDThis funding beyond this will enable the country to reach screening coverage for the different types of Country Target Testing.",null,"High","2443853",null,"0","0","0","0","2443853","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwT/view","2020-12-31","HIV/AIDS",2443853," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713=AN123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713=AO123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713=AP123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713=AJ123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713=AN123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713=AO123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713=AP123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G123)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwUUAW","PAI-3660","Active","BDI-HIV/AIDS-20","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Ensuring DHIS2-GIS interconnection for georeferenced data analysis:DSNIS has developed a health map that is interconnected to DHIS2. However, the interconnection stopped at the level of the BDS and BPS coordinates for lack of skills to integrate the geographic coordinates of health facilities. This interconnection requires international consultancy","Activity: Ensuring DHIS2-GIS interconnection for georeferenced data analysis:DSNIS has developed a health map that is interconnected to DHIS2. However, the interconnection stopped at the level of the BDS and BPS coordinates for lack of skills to integrate the geographic coordinates of health facilities. This interconnection requires international consultancy","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","10667",null,"0","0","0","0","10667","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwU/view","2020-12-31","HIV/AIDS",10667," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713=AN124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713=AO124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713=AP124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713=AJ124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713=AN124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713=AO124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713=AP124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G124)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwVUAW","PAI-3661","Active","BDI-HIV/AIDS-21","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Support DHIS2 hosting for 2 yearsThe DHIS2 is hosted by a house that provides maintenance and regular back up of the base. A contract is signed between the MSPLS and the said house for a monthly amount of US $ 650","Activity: Support DHIS2 hosting for 2 yearsThe DHIS2 is hosted by a house that provides maintenance and regular back up of the base. A contract is signed between the MSPLS and the said house for a monthly amount of US $ 650","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","15600",null,"0","0","0","0","15600","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwV/view","2020-12-31","HIV/AIDS",15600," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713=AN125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713=AO125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713=AP125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713=AJ125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713=AN125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713=AO125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713=AP125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G125)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwWUAW","PAI-3662","Active","BDI-HIV/AIDS-22","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Train 3 people by BPS, by BDS and by hospitals / CDT on the tracker integrated in the DHIS2 for the follow-up of the tuberculous patient.The DSNIS, in collaboration with the TB program, intends to strengthen the capacities of the BPS, the BDS and the hospitals / CDT (Director, DACS and chief of the nursing) in the follow-up of the CDTs to the use of the integrated tracker in the DHIS2 in 1 mission per quarter for 2 years. Each mission lasts 6 days","Activity: Train 3 people by BPS, by BDS and by hospitals / CDT on the tracker integrated in the DHIS2 for the follow-up of the tuberculous patient.The DSNIS, in collaboration with the TB program, intends to strengthen the capacities of the BPS, the BDS and the hospitals / CDT (Director, DACS and chief of the nursing) in the follow-up of the CDTs to the use of the integrated tracker in the DHIS2 in 1 mission per quarter for 2 years. Each mission lasts 6 days","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","78499",null,"0","0","0","0","78499","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwW/view","2020-12-31","HIV/AIDS",78499," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713=AN126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713=AO126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713=AP126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713=AJ126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713=AN126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713=AO126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713=AP126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwXUAW","PAI-3663","Active","BDI-HIV/AIDS-23","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Multiply standardized tools for collecting health dataThe unit price of the black and white photocopies of the different houses is 60 Fbu the copy and the binding is 2000 Fbu per document. The standard tools are integrated and are multiplied throughout the grant to reason to have data for different indicators. These are patient records, CPN registers, CPoN, Childbirth, PEC, STA, Lab, CDV, TB / HIV Coinfection. These registries will be multiplied once a year for the 750 sites of care for PLHIV that patients will be multiplied once a year for the PLHIV expected.","Activity: Multiply standardized tools for collecting health dataThe unit price of the black and white photocopies of the different houses is 60 Fbu the copy and the binding is 2000 Fbu per document. The standard tools are integrated and are multiplied throughout the grant to reason to have data for different indicators. These are patient records, CPN registers, CPoN, Childbirth, PEC, STA, Lab, CDV, TB / HIV Coinfection. These registries will be multiplied once a year for the 750 sites of care for PLHIV that patients will be multiplied once a year for the PLHIV expected.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Administrative and financial data sources","High","605529",null,"0","0","0","0","605529","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwX/view","2020-12-31","HIV/AIDS",605529," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713=AN127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713=AO127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713=AP127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713=AJ127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713=AN127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713=AO127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713=AP127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwYUAW","PAI-3664","Active","BDI-HIV/AIDS-24","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Administrative and finance data sources","Activity: Acquire the equipment for archiving patient records at the sites of care (mettallic cabinets and files to hang).Patient records must be kept secure and confidential. To do this, each of the 750 care sites needs at least one metallicall cabinet for the preservation of patient records. In addition to the wardrobes, there will be a need for suspends for every patient file estimated at 65,000 PLHIV across the country.","Activity: Acquire the equipment for archiving patient records at the sites of care (mettallic cabinets and files to hang).Patient records must be kept secure and confidential. To do this, each of the 750 care sites needs at least one metallicall cabinet for the preservation of patient records. In addition to the wardrobes, there will be a need for suspends for every patient file estimated at 65,000 PLHIV across the country.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Administrative and financial data sources","High","371150",null,"0","0","0","0","371150","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwY/view","2020-12-31","HIV/AIDS",371150," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713=AN128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713=AO128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713=AP128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713=AJ128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713=AN128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713=AO128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713=AP128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G128)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwZUAW","PAI-3665","Active","BDI-HIV/AIDS-25","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Activity: Buying Reagents and Consumables for the Automaton for the Screening of Blood Transfusion Transmitted Disease (GAS) MarkersIn the previous grant, the Global Fund delivered the AUTOMATE with the reagents for only 3 months considered as starting. As these three months have elapsed, for the moment the reagents are broken and the appariel is not operational. These reagents will allow the use of the device for a period of 2 years and this will improve the benefits of the CNTS.","Activity: Buying Reagents and Consumables for the Automaton for the Screening of Blood Transfusion Transmitted Disease (GAS) MarkersIn the previous grant, the Global Fund delivered the AUTOMATE with the reagents for only 3 months considered as starting. As these three months have elapsed, for the moment the reagents are broken and the appariel is not operational. These reagents will allow the use of the device for a period of 2 years and this will improve the benefits of the CNTS.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","1592613",null,"0","0","0","0","1592613","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwZ/view","2020-12-31","HIV/AIDS",1592613," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713=AN129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713=AO129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713=AP129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713=AJ129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713=AN129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713=AO129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713=AP129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwaUAG","PAI-3666","Active","BDI-HIV/AIDS-26","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Activity: Training 210 people in biomedical equipment maintenanceThis training is intended for laboratory technicians. It involves training 210 laboratory technicians for 4 days for the 7 training sessions. This will enable these laboratory technicians to do the preventive and curative maintenance of laboratory equipment. This improves the quality of the analyzes for the follow-up of PLHIV.","Activity: Training 210 people in biomedical equipment maintenanceThis training is intended for laboratory technicians. It involves training 210 laboratory technicians for 4 days for the 7 training sessions. This will enable these laboratory technicians to do the preventive and curative maintenance of laboratory equipment. This improves the quality of the analyzes for the follow-up of PLHIV.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","40826",null,"0","0","0","0","40826","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwa/view","2020-12-31","HIV/AIDS",40826," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713=AN130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713=AO130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713=AP130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713=AJ130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713=AN130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713=AO130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713=AP130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G130)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwbUAG","PAI-3667","Active","BDI-HIV/AIDS-27","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Activity: Establish a panel of sera for reagent validation (especially for HIV), HBV and HCV)This activity is done in four (4) steps: sensitization of sites involved in sample collection, sample collection, sample analysis, aliquoting and sample conservation. The sensitization will inform providers about the importance of making this panel and how to do it to obtain good quality samples for the constitution of this panel. This panel will evaluate testing and quality control.","Activity: Establish a panel of sera for reagent validation (especially for HIV), HBV and HCV)This activity is done in four (4) steps: sensitization of sites involved in sample collection, sample collection, sample analysis, aliquoting and sample conservation. The sensitization will inform providers about the importance of making this panel and how to do it to obtain good quality samples for the constitution of this panel. This panel will evaluate testing and quality control.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","17535",null,"0","0","0","0","17535","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwb/view","2020-12-31",{"$f":"IF(OR(I131=\"HIV/AIDS\",I131=\"Tuberculosis\",I131=\"Malaria\",I131=\"RSSH\"),I131, IF(I131=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"HIV/AIDS"},{"$f":"VALUE(Y131)","v":17535},{"$f":"RIGHT(F131,LEN(F131)-2)","v":" Central Africa"},"HIV/AIDS","HIV/AIDS",null,null,null,{"$f":"TRIM(AK131)","v":""},{"$f":"TRIM(AL131)","v":""},{"$f":"TRIM(AM131)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713=AN131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713=AO131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713=AP131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE131<>\"\",AE131,IF(MAX(AQ131,AR131,AS131,AT131)<>0,MAX(AQ131,AR131,AS131,AT131),AU131))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713=AJ131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713=AN131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713=AO131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713=AP131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G131)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE131<>\"\",AE131,IF(MAX(AW131,AX131,AY131,AZ131)<>0,MAX(AW131,AX131,AY131,AZ131),BA131))","v":"2020-12-31"}]
["a6Q1R000000AIwcUAG","PAI-3668","Active","BDI-HIV/AIDS-28","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Assure the subscription to the WHO Pharmacovigilance Center (Uppsalla Monitoring Center) to access the VIGIFLOW softwareThe Vigiflow makes it possible to transmit the cases of undesirable events in the international database (VigiBase). The VigiFlow software and the Base are managed by the WHO International Center (Uppsala Monitoring Center). To have access to this software and to be able to transmit the cases, you need a subscription. The subscription fee is 1500 USD per year","Activity: Assure the subscription to the WHO Pharmacovigilance Center (Uppsalla Monitoring Center) to access the VIGIFLOW softwareThe Vigiflow makes it possible to transmit the cases of undesirable events in the international database (VigiBase). The VigiFlow software and the Base are managed by the WHO International Center (Uppsala Monitoring Center). To have access to this software and to be able to transmit the cases, you need a subscription. The subscription fee is 1500 USD per year",null,"High","3139",null,"0","0","0","0","3139","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwc/view","2020-12-31","HIV/AIDS",3139," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713=AN132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713=AO132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713=AP132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713=AJ132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713=AN132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713=AO132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713=AP132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwdUAG","PAI-3669","Active","BDI-HIV/AIDS-29","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: To train 3 users of DPML on the WHO Pharmacovigilance Software (VIGIFLOW) for two weeksThe training will allow users of VigiFlow software to have basic knowledge of pharmacovigilance and especially the use of VigiFlow to ensure the transmission of adverse event cases to the WHO international base. \"","Activity: To train 3 users of DPML on the WHO Pharmacovigilance Software (VIGIFLOW) for two weeksThe training will allow users of VigiFlow software to have basic knowledge of pharmacovigilance and especially the use of VigiFlow to ensure the transmission of adverse event cases to the WHO international base. \"",null,"High","26999",null,"0","0","0","0","26999","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwd/view","2020-12-31","HIV/AIDS",26999," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713=AN133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713=AO133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713=AP133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713=AJ133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713=AN133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713=AO133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713=AP133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIweUAG","PAI-3670","Active","BDI-HIV/AIDS-3","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Prevention programs for general population","Other intervention(s) for general population","Activity: Security stock of prevention inputs (condom and lubricating gel)The 2018-2020 grant does not provide security stocks for prevention inputs.This funding will allow the country to have a 4-month security stock representing 25% of annual needs. This will prevent any stockouts. For the 2018-2020 grant, the expected input quantities (male condoms, female condoms and lubricant gels) are 26,931,063; 870,979 and 29,938,622 with an aggregate amount of US $ 2,027,089.37.","Activity: Security stock of prevention inputs (condom and lubricating gel)The 2018-2020 grant does not provide security stocks for prevention inputs.This funding will allow the country to have a 4-month security stock representing 25% of annual needs. This will prevent any stockouts. For the 2018-2020 grant, the expected input quantities (male condoms, female condoms and lubricant gels) are 26,931,063; 870,979 and 29,938,622 with an aggregate amount of US $ 2,027,089.37.","NA Original Intervention: Other interventions for the general population","High","225232",null,"0","0","0","0","225232","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwe/view","2020-12-31","HIV/AIDS",225232," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713=AN134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713=AO134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713=AP134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713=AJ134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713=AN134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713=AO134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713=AP134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwfUAG","PAI-3671","Active","BDI-HIV/AIDS-30","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Provide pharmacovigilance training for providers in 40 district hospitals at 5 per hospitalThis training will enable hospital providers to gain knowledge of the basics of pharmacovigilance and the system for reporting adverse events, which events will be transmitted to the International Vaccine Monitoring Database (VigiBase) for surveillance. The training will be organized at peripheral level for 200 participants at a rate of 25 participants per session for 4 days.","Activity: Provide pharmacovigilance training for providers in 40 district hospitals at 5 per hospitalThis training will enable hospital providers to gain knowledge of the basics of pharmacovigilance and the system for reporting adverse events, which events will be transmitted to the International Vaccine Monitoring Database (VigiBase) for surveillance. The training will be organized at peripheral level for 200 participants at a rate of 25 participants per session for 4 days.",null,"High","48001",null,"0","0","0","0","48001","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwf/view","2020-12-31","HIV/AIDS",48001," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713=AN135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713=AO135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713=AP135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713=AJ135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713=AN135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713=AO135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713=AP135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwgUAG","PAI-3672","Active","BDI-HIV/AIDS-31","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Provide formative supervision of 20 pharmacovigilance-trained hospitals and the adverse event reporting systemFormative supervision will involve 10 regional and national hospitals and 10 other district hospitals. The aim will be to evaluate the challenges that arise in the reporting of adverse events while retraining staff on the system of pharmacovigilance in general and the use of reporting tools in particular. This will improve the quality of notifications and promote patient safety.","Activity: Provide formative supervision of 20 pharmacovigilance-trained hospitals and the adverse event reporting systemFormative supervision will involve 10 regional and national hospitals and 10 other district hospitals. The aim will be to evaluate the challenges that arise in the reporting of adverse events while retraining staff on the system of pharmacovigilance in general and the use of reporting tools in particular. This will improve the quality of notifications and promote patient safety.",null,"High","7335",null,"0","0","0","0","7335","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwg/view","2020-12-31","HIV/AIDS",7335," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713=AN136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713=AO136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713=AP136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713=AJ136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713=AN136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713=AO136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713=AP136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G136)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwhUAG","PAI-3673","Active","BDI-HIV/AIDS-32","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Activity: Train 45 pharmacy managers from 45 districts on HIV / TB drug management in two sessionsThe training will target 46 district pharmacy managers to strengthen them on the rational management of medicines and the supply chain. The training will be done in two training sessions. \"","Activity: Train 45 pharmacy managers from 45 districts on HIV / TB drug management in two sessionsThe training will target 46 district pharmacy managers to strengthen them on the rational management of medicines and the supply chain. The training will be done in two training sessions. \"","NA Original Module: RSSH: Human resources for health, including community health workers","High","9770",null,"0","0","0","0","9770","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwh/view","2020-12-31","HIV/AIDS",9770," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713=AN137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713=AO137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713=AP137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713=AJ137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713=AN137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713=AO137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713=AP137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G137)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwiUAG","PAI-3674","Active","BDI-HIV/AIDS-33","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on Good Laboratory Practice (GLP)Since LNCQM's inception, staff have not had this opportunity. To be comfortable when performing tasks all staff must be trained / recycled on this standard","Activity: Training on Good Laboratory Practice (GLP)Since LNCQM's inception, staff have not had this opportunity. To be comfortable when performing tasks all staff must be trained / recycled on this standard",null,"High","10069",null,"0","0","0","0","10069","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwi/view","2020-12-31","HIV/AIDS",10069," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713=AN138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713=AO138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713=AP138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713=AJ138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713=AN138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713=AO138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713=AP138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwjUAG","PAI-3675","Active","BDI-HIV/AIDS-34","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Activity: Maintain viral load and PCR equipmentIn order to ensure the achievement of CVs and PCRs among PLHIV and children born to HIV-positive mothers, machine functionality is a prerequisite.This subsidy is currently being implemented and includes the maintenance of 2 viral load devices for 2019. As in 2020, the OPP-ERA project will be closed, maintenance will be extended on the other 4 Opp-era machines. (Muyinga, ANSS, CHUK, Gitega). For the two Abboth machines, we have a Gap of $ 10,000 a year and for the machines provided by OPP-ERA we have a gap of $ 32,000. This makes a total gap of $ 52,000 for the period from 2019 to 2020.","Activity: Maintain viral load and PCR equipmentIn order to ensure the achievement of CVs and PCRs among PLHIV and children born to HIV-positive mothers, machine functionality is a prerequisite.This subsidy is currently being implemented and includes the maintenance of 2 viral load devices for 2019. As in 2020, the OPP-ERA project will be closed, maintenance will be extended on the other 4 Opp-era machines. (Muyinga, ANSS, CHUK, Gitega). For the two Abboth machines, we have a Gap of $ 10,000 a year and for the machines provided by OPP-ERA we have a gap of $ 32,000. This makes a total gap of $ 52,000 for the period from 2019 to 2020.",null,"High","52000",null,"0","0","0","0","52000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwj/view","2020-12-31","HIV/AIDS",52000," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713=AN139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713=AO139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713=AP139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713=AJ139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713=AN139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713=AO139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713=AP139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G139)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwkUAG","PAI-3676","Active","BDI-HIV/AIDS-35","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Activity: shelf purchase and warehouse upgrades where Global Fund products are stored: District 10 stores upgraded and part of Main Compound","Activity: shelf purchase and warehouse upgrades where Global Fund products are stored: District 10 stores upgraded and part of Main Compound",null,"High","641923",null,"0","0","0","0","641923","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwk/view","2020-12-31","HIV/AIDS",641923," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713=AN140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713=AO140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713=AP140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713=AJ140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713=AN140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713=AO140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713=AP140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwlUAG","PAI-3677","Active","BDI-HIV/AIDS-36","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Activity: Implementation of the LMIS system and its maintenance for 3 years.","Activity: Implementation of the LMIS system and its maintenance for 3 years.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","433080",null,"0","0","0","0","433080","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwl/view","2020-12-31","HIV/AIDS",433080," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713=AN141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713=AO141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713=AP141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713=AJ141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713=AN141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713=AO141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713=AP141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G141)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwmUAG","PAI-3678","Active","BDI-HIV/AIDS-37","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Surveys","Activity: Make a study on the prevalence of HIV-viral hepatitis coinfection.In Burundi, the seroprevalence of HIV-viral hepatitis co-infection is not known because no study has been conducted for the determined. Or, currently, it is well known that viral hepatitis is the main cause of complications in PLHIV where they can have very serious consequences in accelerating the progression of HIV to AIDS disease and vice versa. It is in this context that a seroprevalence survey of HIV-hepatitis co-infection is essential in order to make a global care planning for co-infected PLHIV based on evidence in order to improve the care that is offered to them.","Activity: Make a study on the prevalence of HIV-viral hepatitis coinfection.In Burundi, the seroprevalence of HIV-viral hepatitis co-infection is not known because no study has been conducted for the determined. Or, currently, it is well known that viral hepatitis is the main cause of complications in PLHIV where they can have very serious consequences in accelerating the progression of HIV to AIDS disease and vice versa. It is in this context that a seroprevalence survey of HIV-hepatitis co-infection is essential in order to make a global care planning for co-infected PLHIV based on evidence in order to improve the care that is offered to them.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Medium","32221",null,"0","0","0","0","32221","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwm/view","2020-12-31","HIV/AIDS",32221," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713=AN142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713=AO142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713=AP142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713=AJ142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713=AN142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713=AO142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713=AP142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G142)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwnUAG","PAI-3679","Active","BDI-HIV/AIDS-38","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Program management","Grant management","Activity: Pay the performance bonuses of the PNLS:This is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.","Activity: Pay the performance bonuses of the PNLS:This is a former activity of the 2016-2017 grant. To achieve the results of the performance framework, key people in the NAP / STI need to be always motivated as a performance bonus because they work even outside the hours of service.","NA Original Module: RSSH: Program management","Medium","238919",null,"0","0","0","0","238919","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwn/view","2020-12-31","HIV/AIDS",238919," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713=AN143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713=AO143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713=AP143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713=AJ143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713=AN143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713=AO143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713=AP143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwoUAG","PAI-3680","Active","BDI-HIV/AIDS-39","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Activity: Training / retraining Peer Educators of IDUs at the national level on the HIV prevention and harm reduction package related to drug use.This activity helps to improve the prevention of HIV / AIDS and STIs among IDUs and to increase their knowledge of the concepts of HIV prevention and harm reduction.","Activity: Training / retraining Peer Educators of IDUs at the national level on the HIV prevention and harm reduction package related to drug use.This activity helps to improve the prevention of HIV / AIDS and STIs among IDUs and to increase their knowledge of the concepts of HIV prevention and harm reduction.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Medium","31542",null,"0","0","0","0","31542","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwo/view","2020-12-31","HIV/AIDS",31542," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713=AN144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713=AO144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713=AP144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713=AJ144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713=AN144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713=AO144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713=AP144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G144)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwpUAG","PAI-3681","Active","BDI-HIV/AIDS-4","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Activity: Acquire ARVs to fill the GAPTo cover the country's ARV targets for the year 2019 and 2020 on the different categories of PLHIV (Adults, children, PMTCT children and adults, post-exposure prophylaxis).","Activity: Acquire ARVs to fill the GAPTo cover the country's ARV targets for the year 2019 and 2020 on the different categories of PLHIV (Adults, children, PMTCT children and adults, post-exposure prophylaxis).","NA Original Intervention: Other interventions for treatment","High","7575400",null,"0","0","0","0","7575400","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwp/view","2020-12-31","HIV/AIDS",7575400," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713=AN145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713=AO145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713=AP145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713=AJ145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713=AN145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713=AO145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713=AP145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwqUAG","PAI-3682","Active","BDI-HIV/AIDS-40","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Activity: Organization of PLHIV in community solidarity network (supervision, monitoring, legal capacity building).This activity contributes to reducing the socio-economic impact of HIV infectionPromoting / empowering PLHIV through capacity building on cluster management, business learning, micro-project initiation and management will contribute to reducing the socio-economic impact of HIV . It is an activity that will be done through the organization of PLHIV network community solidarity (supervision, monitoring, strengthening legal capacity). It will increase ARV coverage and retention rate.","Activity: Organization of PLHIV in community solidarity network (supervision, monitoring, legal capacity building).This activity contributes to reducing the socio-economic impact of HIV infectionPromoting / empowering PLHIV through capacity building on cluster management, business learning, micro-project initiation and management will contribute to reducing the socio-economic impact of HIV . It is an activity that will be done through the organization of PLHIV network community solidarity (supervision, monitoring, strengthening legal capacity). It will increase ARV coverage and retention rate.","NA Original Intervention: Other interventions for treatment","Medium","3822",null,"0","0","0","0","3822","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwq/view","2020-12-31","HIV/AIDS",3822," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713=AN146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713=AO146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713=AP146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713=AJ146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713=AN146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713=AO146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713=AP146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G146)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwrUAG","PAI-3683","Active","BDI-HIV/AIDS-41","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session","Activity: Organize 2 regional data analysis workshops per year in 5 sessions of 6 days each with 45 participants per session","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Medium","65947",null,"0","0","0","0","65947","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwr/view","2020-12-31","HIV/AIDS",65947," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713=AN147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713=AO147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713=AP147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713=AJ147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713=AN147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713=AO147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713=AP147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G147)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwsUAG","PAI-3684","Active","BDI-HIV/AIDS-42","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:The DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days","Activity: Organize 4 missions of 6 days per year for 2 years to monitor BPS, BDS and hospitals in the use of the DHIS2-integrated OMS analysis tool for Malaria and HIV data including for Community data:The DSNIS, in collaboration with the programs, intends to ensure supervisions for the follow-up of the BPS, BDS and hospitals in the use of the analysis tool integrated in the DHIS2 in 1 mission per quarter during 2 years. Each mission lasts 6 days","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Medium","27237",null,"0","0","0","0","27237","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIws/view","2020-12-31","HIV/AIDS",27237," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713=AN148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713=AO148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713=AP148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713=AJ148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713=AN148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713=AO148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713=AP148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G148)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwtUAG","PAI-3685","Active","BDI-HIV/AIDS-43","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training in quality control of associated molecules (ARV, anti-TB).Training in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.","Activity: Training in quality control of associated molecules (ARV, anti-TB).Training in ARV analysis techniques would enable the laboratory to analyze the associated molecules (ARVs and antituberculous drugs, etc.) and extend the range of molecules that could be analyzed.",null,"Medium","12000",null,"0","0","0","0","12000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwt/view","2020-12-31","HIV/AIDS",12000," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713=AN149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713=AO149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713=AP149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713=AJ149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713=AN149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713=AO149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713=AP149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwuUAG","PAI-3686","Active","BDI-HIV/AIDS-44","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:Following the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.","Activity: Support a 14-day mission from an international consultant to ensure DHIS2 appetite:Following the creation of a new sanitary province of Rumonge, there were duplicates of the data set in the DHIS2 due to lack of skills on the parameterization of the DHIS2. This mission will help remove these duplicates.","NA Original Module: RSSH: Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Low","24888",null,"0","0","0","0","24888","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwu/view","2020-12-31","HIV/AIDS",24888," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713=AN150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713=AO150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713=AP150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713=AJ150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713=AN150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713=AO150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713=AP150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwvUAG","PAI-3687","Active","BDI-HIV/AIDS-45","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Activity: Ensuring the maintenance of the AUTOMATE (GAS)The CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.","Activity: Ensuring the maintenance of the AUTOMATE (GAS)The CNTS AUTOMATE does not have a local maintenance officer. In the event of a breakdown, foreign expertise should be used for maintenance and maintenance. The CNTS will make a service contract for the maintenance and maintenance of this device. This will limit the cessation of benefits in the event of a breakdown and ensures the quality of the results of the various tests (HIV, Hepatitis B, C and syphilis) for donations of blood.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Low","35069",null,"0","0","0","0","35069","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwv/view","2020-12-31","HIV/AIDS",35069," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713=AN151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713=AO151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713=AP151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713=AJ151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713=AN151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713=AO151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713=AP151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwwUAG","PAI-3688","Active","BDI-HIV/AIDS-46","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance planQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.","Activity: Organize once a six-month period a quality control of TB / HIV by sampling at the peripheral level in accordance with the quality assurance planQuality control of medicines is one of the main regulatory functions of the pharmaceutical sector, as part of the quality assurance of the drug. Quality control of TB and HIV inputs will ensure the quality of these drugs. Every six months, a sampling will be organized for the collection of samples that will be sent to quality control laboratories.",null,"Low","130925",null,"0","0","0","0","130925","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIww/view","2020-12-31","HIV/AIDS",130925," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713=AN152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713=AO152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713=AP152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713=AJ152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713=AN152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713=AO152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713=AP152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G152)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwxUAG","PAI-3689","Active","BDI-HIV/AIDS-47","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Activity: Buy three trucks for active distribution of health inputsThese trucks will be used to transport drugs from CAMEBU to district pharmacies.","Activity: Buy three trucks for active distribution of health inputsThese trucks will be used to transport drugs from CAMEBU to district pharmacies.",null,"Low","438366",null,"0","0","0","0","438366","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwx/view","2020-12-31","HIV/AIDS",438366," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713=AN153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713=AO153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713=AP153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713=AJ153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713=AN153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713=AO153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713=AP153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G153)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwyUAG","PAI-3690","Active","BDI-HIV/AIDS-48","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on Microbiological Control of DrugsThe training would complete the physico-chemical analyzes of drugs by microbiological analyzes","Activity: Training on Microbiological Control of DrugsThe training would complete the physico-chemical analyzes of drugs by microbiological analyzes",null,"Low","12000",null,"0","0","0","0","12000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwy/view","2020-12-31","HIV/AIDS",12000," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713=AN154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713=AO154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713=AP154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713=AJ154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713=AN154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713=AO154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713=AP154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G154)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIwzUAG","PAI-3691","Active","BDI-HIV/AIDS-49","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Establishment of a quality control unit for medical devicesThe LNCQM does not perform quality control of medical devices (gloves, condoms, needles and others) .Technical staff does not have experience in quality control of medical devices","Activity: Establishment of a quality control unit for medical devicesThe LNCQM does not perform quality control of medical devices (gloves, condoms, needles and others) .Technical staff does not have experience in quality control of medical devices",null,"Low","62000",null,"0","0","0","0","62000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIwz/view","2020-12-31","HIV/AIDS",62000," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713=AN155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713=AO155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713=AP155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713=AJ155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713=AN155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713=AO155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713=AP155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx0UAG","PAI-3692","Active","BDI-HIV/AIDS-5","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Treatment, care and support","Treatment monitoring - Viral load","Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structuresCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.","Activity: Pay the costs related to the services (consultations, hospitalizations and follow-up report for PLHIV) provided by the health care structuresCompleted with the 2016-2017 grant, as part of improving the care and follow-up of PLHIV. Thus a PLHIV under ARV needs to be followed through consultations, examinations (Biological Assessment) and special hospitalizations that is not the case for any other patient. In the 2016-2017 grant (2 years), the amount of this budget line was $ 3,033,350 while the current budget on this line is $ 1,124,965 or about 1/3. This shows an underestimation of the cost of this budget line.","NA Original Intervention: Treatment monitoring  Viral load","High","250000",null,"0","0","0","0","250000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx0/view","2020-12-31","HIV/AIDS",250000," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713=AN156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713=AO156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713=AP156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713=AJ156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713=AN156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713=AO156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713=AP156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx1UAG","PAI-3693","Active","BDI-HIV/AIDS-50","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Training on preventive maintenance and qualification of the HPLC chainLack of expertise on the qualification of the HPLC chain. No local expertise in this area. It would be good to train 2 units","Activity: Training on preventive maintenance and qualification of the HPLC chainLack of expertise on the qualification of the HPLC chain. No local expertise in this area. It would be good to train 2 units",null,"Low","12000",null,"0","0","0","0","12000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx1/view","2020-12-31","HIV/AIDS",12000," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713=AN157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713=AO157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713=AP157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713=AJ157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713=AN157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713=AO157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713=AP157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G157)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx2UAG","PAI-3694","Active","BDI-HIV/AIDS-51","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Need technical assistance to accompany the quality control laboratory of the drug towards the pre-qualificationThe laboratory is implementing the ISO 17025 standard and is in the process of applying for prequalification by WHO. - The laboratory wants to be prequalified by WHO or accredited. A technical assistant is required to accompany the laboratory to apply the related requirements. He would provide technical coaching to better prepare for evaluations","Activity: Need technical assistance to accompany the quality control laboratory of the drug towards the pre-qualificationThe laboratory is implementing the ISO 17025 standard and is in the process of applying for prequalification by WHO. - The laboratory wants to be prequalified by WHO or accredited. A technical assistant is required to accompany the laboratory to apply the related requirements. He would provide technical coaching to better prepare for evaluations",null,"Low","40500",null,"0","0","0","0","40500","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx2/view","2020-12-31","HIV/AIDS",40500," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713=AN158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713=AO158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713=AP158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713=AJ158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713=AN158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713=AO158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713=AP158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G158)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx3UAG","PAI-3695","Active","BDI-HIV/AIDS-52","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Supply of equipment and materials for microbiological controlThe National Laboratory does not have equipment, consumables and equipment for the microbiological control of drugs. Some molecules require microbiological procedures and can not be controlled in the laboratory.","Activity: Supply of equipment and materials for microbiological controlThe National Laboratory does not have equipment, consumables and equipment for the microbiological control of drugs. Some molecules require microbiological procedures and can not be controlled in the laboratory.",null,"Low","81828",null,"0","0","0","0","81828","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx3/view","2020-12-31","HIV/AIDS",81828," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713=AN159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713=AO159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713=AP159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713=AJ159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713=AN159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713=AO159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713=AP159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G159)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx4UAG","PAI-3696","Active","BDI-HIV/AIDS-53","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthen the technical platform of the NPHI National Reference LaboratoryThe National Laboratory needs to expand the range of analysis as a national laboratory to meet the national need. For this, he needs modern and diversified equipment to ensure his missions.","Activity: Strengthen the technical platform of the NPHI National Reference LaboratoryThe National Laboratory needs to expand the range of analysis as a national laboratory to meet the national need. For this, he needs modern and diversified equipment to ensure his missions.",null,"Low","358767",null,"0","0","0","0","358767","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx4/view","2020-12-31","HIV/AIDS",358767," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713=AN160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713=AO160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713=AP160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713=AJ160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713=AN160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713=AO160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713=AP160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx5UAG","PAI-3697","Active","BDI-HIV/AIDS-54","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthening Quality Assurance at the National Reference Laboratory of INSPThis involves acquiring equipment maintenance contracts (HPLC, Spectrophotometer), equipment calibration with BBN, and participating in the rendering of inter-laboratory test results. This will allow the reliability of the results and ensure the reliability of the results and the performance of the laboratory compared to WHO / Accredited Prequalified Loboratory. This will serve to know if the prescribed drugs are of good quality and have positive effects for the patients.","Activity: Strengthening Quality Assurance at the National Reference Laboratory of INSPThis involves acquiring equipment maintenance contracts (HPLC, Spectrophotometer), equipment calibration with BBN, and participating in the rendering of inter-laboratory test results. This will allow the reliability of the results and ensure the reliability of the results and the performance of the laboratory compared to WHO / Accredited Prequalified Loboratory. This will serve to know if the prescribed drugs are of good quality and have positive effects for the patients.",null,"Low","60800",null,"0","0","0","0","60800","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx5/view","2020-12-31","HIV/AIDS",60800," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713=AN161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713=AO161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713=AP161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713=AJ161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713=AN161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713=AO161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713=AP161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx6UAG","PAI-3698","Active","BDI-HIV/AIDS-55","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Activity: Strengthen the biological diagnosis of viral hepatitisThe National Laboratory does not have an external maintenance contract for certain equipment. Some lab equipment needs to be serviced by external experts \"","Activity: Strengthen the biological diagnosis of viral hepatitisThe National Laboratory does not have an external maintenance contract for certain equipment. Some lab equipment needs to be serviced by external experts \"",null,"Low","114000",null,"0","0","0","0","114000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx6/view","2020-12-31","HIV/AIDS",114000," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713=AN162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713=AO162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713=AP162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713=AJ162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713=AN162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713=AO162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713=AP162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G162)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx7UAG","PAI-3699","Active","BDI-HIV/AIDS-56","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Activity: Provide training to 3 members of the Quantification Committee on the management of the GAS PlanThis training will allow these people to know the tools of quantification and input management.","Activity: Provide training to 3 members of the Quantification Committee on the management of the GAS PlanThis training will allow these people to know the tools of quantification and input management.",null,"Low","30300",null,"0","0","0","0","30300","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx7/view","2020-12-31","HIV/AIDS",30300," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713=AN163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713=AO163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713=AP163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713=AJ163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713=AN163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713=AO163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713=AP163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G163)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx8UAG","PAI-3700","Active","BDI-HIV/AIDS-6","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"RSSH: Health management information systems and M&E","Surveys","Activity: Conduct a study on estimating mother-to-child transmission rate of HIVThe estimate of the mother-to-child transmission rate is an indicator of the NHP, the current grant performance framework, but also an indicator of the progress of PMTCT. Until then the indicator was estimated by the Spectrum. In order to obtain an indicator that is as close as possible to the reality of the scope of the interventions we propose to carry out this study which in addition to the transmission rate makes it possible to evaluate the quality, availability and accessibility of PMTCT services.This is a study that will be conducted in 2019 and will cover the entire country according to a methodology that will be proposed by the consultant / firm and validated by the steering committee.","Activity: Conduct a study on estimating mother-to-child transmission rate of HIVThe estimate of the mother-to-child transmission rate is an indicator of the NHP, the current grant performance framework, but also an indicator of the progress of PMTCT. Until then the indicator was estimated by the Spectrum. In order to obtain an indicator that is as close as possible to the reality of the scope of the interventions we propose to carry out this study which in addition to the transmission rate makes it possible to evaluate the quality, availability and accessibility of PMTCT services.This is a study that will be conducted in 2019 and will cover the entire country according to a methodology that will be proposed by the consultant / firm and validated by the steering committee.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","36348",null,"0","0","0","0","36348","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx8/view","2020-12-31","HIV/AIDS",36348," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713=AN164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713=AO164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713=AP164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713=AJ164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713=AN164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713=AO164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713=AP164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G164)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIx9UAG","PAI-3701","Active","BDI-HIV/AIDS-7","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Treatment, care and support","Counseling and psycho-social support","Activity: Organize training sessions on the psychosocial care of children and adolescents living with HIV for providers at ARV sites.This activity, begun during the past grant, will be continued because the low antiretroviral treatment coverage of children and adolescents living with HIV requires special monitoring for this population. The psychosocial care of children and adolescents living with HIV will facilitate the announcement of seropositivity to patients which will increase adherence to treatment and retention rate. Providers will also be able to help strengthen family caring as a strategy to reach more children and adolescents.","Activity: Organize training sessions on the psychosocial care of children and adolescents living with HIV for providers at ARV sites.This activity, begun during the past grant, will be continued because the low antiretroviral treatment coverage of children and adolescents living with HIV requires special monitoring for this population. The psychosocial care of children and adolescents living with HIV will facilitate the announcement of seropositivity to patients which will increase adherence to treatment and retention rate. Providers will also be able to help strengthen family caring as a strategy to reach more children and adolescents.",null,"High","45109",null,"0","0","0","0","45109","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIx9/view","2020-12-31","HIV/AIDS",45109," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713=AN165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713=AO165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713=AP165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713=AJ165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713=AN165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713=AO165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713=AP165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxAUAW","PAI-3702","Active","BDI-HIV/AIDS-8","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Activity: Organizing at the national level, an advocacy workshop with different actors for LGBT mainstreaming in program design and LGBT interaction with the general population.This activity helps to improve the prevention of HIV / AIDS and STIs among LGBT people and create an enabling environment to facilitate access of this population to prevention and care services.","Activity: Organizing at the national level, an advocacy workshop with different actors for LGBT mainstreaming in program design and LGBT interaction with the general population.This activity helps to improve the prevention of HIV / AIDS and STIs among LGBT people and create an enabling environment to facilitate access of this population to prevention and care services.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","High","4776",null,"0","0","0","0","4776","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxA/view","2020-12-31","HIV/AIDS",4776," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713=AN166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713=AO166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713=AP166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713=AJ166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713=AN166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713=AO166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713=AP166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxBUAW","PAI-3703","Active","BDI-HIV/AIDS-9","2017-2019","RT Central Africa","Burundi","HIV/AIDS","HIV/AIDS","FR577-BDI-H",null,null,"PMTCT","Other intervention(s) for PMTCT","Activity: Strengthen the capacity of men champions (PLHIV) to raise men's awareness of the support and support of pregnant and lactating women for PMTCTThis activity aims to reduce new infections by reducing the transmission of HIV from mother to child.","Activity: Strengthen the capacity of men champions (PLHIV) to raise men's awareness of the support and support of pregnant and lactating women for PMTCTThis activity aims to reduce new infections by reducing the transmission of HIV from mother to child.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","High","17146",null,"0","0","0","0","17146","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxB/view","2020-12-31","HIV/AIDS",17146," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713=AN167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713=AO167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713=AP167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713=AJ167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713=AN167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713=AO167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713=AP167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G167)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxCUAW","PAI-3704","Active","BDI-Malaria-1","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This budget is required to: (i) Bridge a gap of 466,000 LLINs to meet all of the needs of the 2019 mass campaign. Of the total 6,997,954 LLINs required, taking into account an increase of 15 percent linked to counts and to logistical security, 6,531,828 have been provided using the allocation amount; (ii) The amount requested includes procurement costs and procurement and supply management/pooled procurement mechanism costs; (iii) The gap in the implementation costs that have not been included in the allocation amount (US$ 1,600,000); (iv) Expected outcomes: this funding will provide universal coverage of LLINs during the 2019 campaign.","This budget is required to: (i) Bridge a gap of 466,000 LLINs to meet all of the needs of the 2019 mass campaign. Of the total 6,997,954 LLINs required, taking into account an increase of 15 percent linked to counts and to logistical security, 6,531,828 have been provided using the allocation amount; (ii) The amount requested includes procurement costs and procurement and supply management/pooled procurement mechanism costs; (iii) The gap in the implementation costs that have not been included in the allocation amount (US$ 1,600,000); (iv) Expected outcomes: this funding will provide universal coverage of LLINs during the 2019 campaign.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","2658053",null,"0","0","0","0","2658053","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxC/view","2020-12-31","Malaria",2658053," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713=AN168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713=AO168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713=AP168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713=AJ168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713=AN168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713=AO168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713=AP168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G168)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxDUAW","PAI-3705","Active","BDI-Malaria-10","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","This amount includes bonuses for 12 iNMCP staff involved in implementing the grant, and maintenance, fuel and insurance for 11 extra vehicles not covered by the allocation amount and are required for supervision and training activities on the ground as well as implementing the 2019 LLIN distribution campaign support for the National Health Information System Directorate, information, education and communication and the transport of central level staff during the different stages of campaign implementation, including the census, micro-planning, pre-positioning of LLINs and supervision of distribution).","This amount includes bonuses for 12 iNMCP staff involved in implementing the grant, and maintenance, fuel and insurance for 11 extra vehicles not covered by the allocation amount and are required for supervision and training activities on the ground as well as implementing the 2019 LLIN distribution campaign support for the National Health Information System Directorate, information, education and communication and the transport of central level staff during the different stages of campaign implementation, including the census, micro-planning, pre-positioning of LLINs and supervision of distribution).","NA Original Module: RSSH - Program management","High","111628",null,"0","0","0","0","111628","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxD/view","2020-12-31","Malaria",111628," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713=AN169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713=AO169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713=AP169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713=AJ169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713=AN169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713=AO169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713=AP169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G169)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxEUAW","PAI-3706","Active","BDI-Malaria-11","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Activity: Support for health districts and health provinces in the supervision of malaria-related activities. The costs include per diems, fuel for supervision vehicles and motorcycles used by health districts and provincial health offices, as well as communication costs.","Activity: Support for health districts and health provinces in the supervision of malaria-related activities. The costs include per diems, fuel for supervision vehicles and motorcycles used by health districts and provincial health offices, as well as communication costs.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","1003636","For sustainability reason and given supervision is an ongoing health system activity, this activity should be rated medium. The TRP recommends the Secretariat to reach out to the CCM to reassess the cost component of this activity and reduce the total cost. Most importantly, the TRP believes supervision should not be included in the PAAR moving forward, but rather in the allocation.","0","0","0","0","1003636","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxE/view","2020-12-31","Malaria",1003636," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713=AN170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713=AO170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713=AP170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713=AJ170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713=AN170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713=AO170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713=AP170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxFUAW","PAI-3707","Active","BDI-Malaria-2","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This LLIN campaign is aimed at key populations (special groups, including boarding schools, military camps, prisons and orphanages that were not included in the mass campaign). The requested amount will cover (i) procurements costs for 182,000 LLINs and (ii) implementation costs for the special groups. This amount includes procurement costs and implementation costs. This activity is planned for 2020.","This LLIN campaign is aimed at key populations (special groups, including boarding schools, military camps, prisons and orphanages that were not included in the mass campaign). The requested amount will cover (i) procurements costs for 182,000 LLINs and (ii) implementation costs for the special groups. This amount includes procurement costs and implementation costs. This activity is planned for 2020.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","520475",null,"0","0","0","0","520475","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxF/view","2020-12-31","Malaria",520475," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713=AN171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713=AO171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713=AP171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713=AJ171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713=AN171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713=AO171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713=AP171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxGUAW","PAI-3708","Active","BDI-Malaria-3","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"Vector control","Indoor residual spraying (IRS)","In order to comply with the TRPs decisions, the Integrated National Malaria Program (iNMCP) asked the Global Fund to finance for the 20182020 period the 11 health districts already validated by the TRP in 20162017 (not included in the grant due to budget constraints).  This budget is required to cover: (i) Supply costs, (ii) Implementation costs,(iii) Technical assistance, for IRS activities in 11 health districts.  The total requested budget for IRS is US$ 17,037,235, of which US$ 6,787,954 is for the four health districts covered by the Global Fund under the NFM, and US$ 10,249,281 is for the other seven health districts requiring resistance management.CT update (Aug. 2018): The country has been awared 4.9m USD to implement IRS in the 4 districts previously supported by the GF.","In order to comply with the TRPs decisions, the Integrated National Malaria Program (iNMCP) asked the Global Fund to finance for the 20182020 period the 11 health districts already validated by the TRP in 20162017 (not included in the grant due to budget constraints).  This budget is required to cover: (i) Supply costs, (ii) Implementation costs,(iii) Technical assistance, for IRS activities in 11 health districts.  The total requested budget for IRS is US$ 17,037,235, of which US$ 6,787,954 is for the four health districts covered by the Global Fund under the NFM, and US$ 10,249,281 is for the other seven health districts requiring resistance management.CT update (Aug. 2018): The country has been awared 4.9m USD to implement IRS in the 4 districts previously supported by the GF.","NA Original Intervention: Indoor residual spraying","High","17037235",null,"0","4870607","0","0","12166628","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxG/view","2020-12-31","Malaria",12166628," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713=AN172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713=AO172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713=AP172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713=AJ172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713=AN172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713=AO172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713=AP172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G172)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxHUAW","PAI-3709","Active","BDI-Malaria-4","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","This budget is required to cover for technical assistance  to support the implementation of the next LLIN campaign in 2020. It comprises international and domestic technical assistance to support the entire process of the 2020 mass campaign, up to the final report. Given the complexity of the organization on the ground, ongoing technical assistance is required throughout the campaign.","This budget is required to cover for technical assistance  to support the implementation of the next LLIN campaign in 2020. It comprises international and domestic technical assistance to support the entire process of the 2020 mass campaign, up to the final report. Given the complexity of the organization on the ground, ongoing technical assistance is required throughout the campaign.","NA Original Module: RSSH - Program management","High","206160",null,"0","0","0","0","206160","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxH/view","2020-12-31","Malaria",206160," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713=AN173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713=AO173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713=AP173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713=AJ173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713=AN173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713=AO173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713=AP173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxIUAW","PAI-3710","Active","BDI-Malaria-5","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"RSSH: Health management information systems and M&E","Surveys","This budget is required to cover a survey on the current malaria epidemic in Burundi. A survey on the underlying causes of the epidemiological setting to understand the causes of the epidemic and thus evaluate what type of response would be appropriate and effective, and what measures should be adopted after the epidemic. This epidemic survey will assist the program in guiding the response appropriately.","This budget is required to cover a survey on the current malaria epidemic in Burundi. A survey on the underlying causes of the epidemiological setting to understand the causes of the epidemic and thus evaluate what type of response would be appropriate and effective, and what measures should be adopted after the epidemic. This epidemic survey will assist the program in guiding the response appropriately.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","172237",null,"0","0","0","0","172237","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxI/view","2020-12-31","Malaria",172237," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713=AN174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713=AO174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713=AP174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713=AJ174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713=AN174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713=AO174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713=AP174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G174)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxJUAW","PAI-3711","Active","BDI-Malaria-6","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Activity:  Provide quarterly supervision missions for quality control of slides and rapid diagnostic tests in health care facilities in the 46 health districts.(i) The allocation amount covers 12 health districts per quarter. Supervision is undertaken in three facilities per mission per health district, covering a maximum of 72 facilities over the year, equivalent to 10 percent of the total. (ii) Additional funding is therefore requested to be able to cover 12 health districts per quarter so as to sample 20 percent of health care facility laboratories each year.","Activity:  Provide quarterly supervision missions for quality control of slides and rapid diagnostic tests in health care facilities in the 46 health districts.(i) The allocation amount covers 12 health districts per quarter. Supervision is undertaken in three facilities per mission per health district, covering a maximum of 72 facilities over the year, equivalent to 10 percent of the total. (ii) Additional funding is therefore requested to be able to cover 12 health districts per quarter so as to sample 20 percent of health care facility laboratories each year.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","32834",null,"0","0","0","0","32834","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxJ/view","2020-12-31","Malaria",32834," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713=AN175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713=AO175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713=AP175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713=AJ175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713=AN175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713=AO175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713=AP175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G175)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxKUAW","PAI-3712","Active","BDI-Malaria-7","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Partner coordination/policy drafting and dissemination The budget is intended for (i) partner coordination meetings, particularly transnational meetings, and strengthening the coordination of the private sector not addressed by other partners; (ii) a fund mobilization meeting; (iii) meetings to draw up plans of action and annual and six-monthly reports. The needs for 2018 are covered.","Partner coordination/policy drafting and dissemination The budget is intended for (i) partner coordination meetings, particularly transnational meetings, and strengthening the coordination of the private sector not addressed by other partners; (ii) a fund mobilization meeting; (iii) meetings to draw up plans of action and annual and six-monthly reports. The needs for 2018 are covered.","NA Original Module: RSSH - Community responses and systems","High","49614",null,"0","0","0","0","49614","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxK/view","2020-12-31","Malaria",49614," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713=AN176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713=AO176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713=AP176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713=AJ176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713=AN176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713=AO176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713=AP176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxLUAW","PAI-3713","Active","BDI-Malaria-8","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","General training in all sectors (malariology, monitoring and evaluation, finances and community health workers). This is a range of vital training to strengthen the program which has not been funded under the allocation amount. In particular, it involves (i) an international malariology course for two people each year, which is vital for strengthening the malaria response; (ii) training at the international level in the monitoring and evaluation of malaria response programs, given in Ouagadougou or Senegal; (iii) training at the international level in financial management; (iv) refresher training for community health workers providing iCCM in the health districts funded by the Global Fund, planned for 2019.","General training in all sectors (malariology, monitoring and evaluation, finances and community health workers). This is a range of vital training to strengthen the program which has not been funded under the allocation amount. In particular, it involves (i) an international malariology course for two people each year, which is vital for strengthening the malaria response; (ii) training at the international level in the monitoring and evaluation of malaria response programs, given in Ouagadougou or Senegal; (iii) training at the international level in financial management; (iv) refresher training for community health workers providing iCCM in the health districts funded by the Global Fund, planned for 2019.","NA Original Module: RSSH - Community responses and systems","High","296091",null,"0","0","0","0","296091","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxL/view","2020-12-31","Malaria",296091," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713=AN177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713=AO177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713=AP177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713=AJ177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713=AN177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713=AO177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713=AP177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G177)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxMUAW","PAI-3714","Active","BDI-Malaria-9","2017-2019","RT Central Africa","Burundi","Malaria","Malaria","FR525-BDI-M",null,null,"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Implementing the following innovative strategies to combat malaria:(i) A communication strategy in primary schools; (ii) Outreach communication for the Batwa community; (iii) The production of communication media and contracts with the media: Expected outcomes: This budget is requested as part of efforts to strengthen communication in order to provide regular guidance for the population on the correct use of LLINs and the early use of health care services. The activities relate to procuring communication media and contracts with the media, such as mobile telephone companies.","Implementing the following innovative strategies to combat malaria:(i) A communication strategy in primary schools; (ii) Outreach communication for the Batwa community; (iii) The production of communication media and contracts with the media: Expected outcomes: This budget is requested as part of efforts to strengthen communication in order to provide regular guidance for the population on the correct use of LLINs and the early use of health care services. The activities relate to procuring communication media and contracts with the media, such as mobile telephone companies.","NA Original Module: RSSH - Community responses and systems","High","328510","A successful control of malaria transmission and even outbreaks depends on involvement from communities and observance of measures and adoption of health behavior among them. Thus, no sustainable results and outcomes can be achieved without social mobilization and communication efforts that target all the segments of the communities in all transmission settings. The TRP therefore recommends this priority as high.","0","0","0","0","328510","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxM/view","2020-12-31","Malaria",328510," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713=AN178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713=AO178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713=AP178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713=AJ178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713=AN178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713=AO178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713=AP178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxNUAW","PAI-3715","Active","BDI-Tuberculosis-1","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Extend the technical platform by purchasing radiology equipment and ultrasound scanners. To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, tuberculosis in children, tuberculosis in PLWHA and multidrug-resistant tuberculosis, the PNILT intends to expand the technical platform by purchasing radiology equipment and ultrasound. It should be noted that the main reasons for the poor performance in the reporting of tuberculosis cases are mainly: the insufficiency of a technical platform for the para- clinical diagnosis of TPB- and PET cases (RX, Ultrasound); the difficulty of early diagnosis of TB in PLWHIV by lack of effective diagnostic means (GeneXpert); the absence of policies / strategic approach directed at vulnerable and vulnerable groups: prisoners, refugees, Batwa, children, PHAs (screening), the weak investigation of cases contacts TPB +.","Extend the technical platform by purchasing radiology equipment and ultrasound scanners. To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, tuberculosis in children, tuberculosis in PLWHA and multidrug-resistant tuberculosis, the PNILT intends to expand the technical platform by purchasing radiology equipment and ultrasound. It should be noted that the main reasons for the poor performance in the reporting of tuberculosis cases are mainly: the insufficiency of a technical platform for the para- clinical diagnosis of TPB- and PET cases (RX, Ultrasound); the difficulty of early diagnosis of TB in PLWHIV by lack of effective diagnostic means (GeneXpert); the absence of policies / strategic approach directed at vulnerable and vulnerable groups: prisoners, refugees, Batwa, children, PHAs (screening), the weak investigation of cases contacts TPB +.",null,"High","330600",null,"0","0","0","0","330600","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxN/view","2020-12-31","Tuberculosis",330600," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713=AN179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713=AO179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713=AP179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713=AJ179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713=AN179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713=AO179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713=AP179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G179)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxOUAW","PAI-3716","Active","BDI-Tuberculosis-10","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Former activity n  63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validatedBurundi has a total of 11 prisons with infirmary.With the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.","Former activity n  63 (Train / recycle annually the nurses of the 7 prisons of the country to the screening, the notification and management of the tuberculosis in prison environment (at the rate of 3 nurses and the staff of the associations by prison) for a session of 3 days in each prison) of the reprogrammed budget validatedBurundi has a total of 11 prisons with infirmary.With the ongoing TB grant, a directed training for 7 prisons only was completed in 2016 and 2017.","NA Original Intervention: Key populations (TB care and prevention)  Prisoners","High","10463",null,"0","0","0","0","10463","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxO/view","2020-12-31","Tuberculosis",10463," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713=AN180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713=AO180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713=AP180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713=AJ180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713=AN180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713=AO180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713=AP180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G180)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxPUAW","PAI-3717","Active","BDI-Tuberculosis-11","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Meeting of TB coordinators. It aims to anticipate possible blockages in order to improve the performance of the implementation of the TB grant. It is planned once a quarter.","Meeting of TB coordinators. It aims to anticipate possible blockages in order to improve the performance of the implementation of the TB grant. It is planned once a quarter.",null,"High","28224",null,"0","0","0","0","28224","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxP/view","2020-12-31","Tuberculosis",28224," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713=AN181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713=AO181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713=AP181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713=AJ181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713=AN181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713=AO181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713=AP181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxQUAW","PAI-3718","Active","BDI-Tuberculosis-12","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Training of laboratory technicians / microscopists.The PNILT intends to form one unit per CDT (170 CDT) with 60 units in 2018, 60 units in 2019 and 50 units in 2020:","Training of laboratory technicians / microscopists.The PNILT intends to form one unit per CDT (170 CDT) with 60 units in 2018, 60 units in 2019 and 50 units in 2020:",null,"High","34166",null,"0","0","0","0","34166","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxQ/view","2020-12-31","Tuberculosis",34166," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713=AN182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713=AO182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713=AP182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713=AJ182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713=AN182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713=AO182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713=AP182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxRUAW","PAI-3719","Active","BDI-Tuberculosis-13","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Data validation and dissemination activity.Verification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.","Data validation and dissemination activity.Verification, validation and dissemination workshops  for 2 days. The frequency of validation workshops is quarterly.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","161830",null,"0","0","0","0","161830","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxR/view","2020-12-31","Tuberculosis",161830," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713=AN183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713=AO183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713=AP183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713=AJ183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713=AN183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713=AO183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713=AP183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxSUAW","PAI-3720","Active","BDI-Tuberculosis-14","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"Program management","Grant management","Performance bonuses.The motivation of the staff is essential to maintain the achievements and safeguard the performance of the ProgramThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.","Performance bonuses.The motivation of the staff is essential to maintain the achievements and safeguard the performance of the ProgramThe 2018-2020 grant budget only grants performance bonuses to Heads of Service.",null,"High","30183",null,"0","0","0","0","30183","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxS/view","2020-12-31","Tuberculosis",30183," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713=AN184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713=AO184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713=AP184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713=AJ184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713=AN184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713=AO184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713=AP184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxTUAW","PAI-3721","Active","BDI-Tuberculosis-15","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"RSSH: National health strategies","Other policy and governance intervention(s)","A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.","A study on catastrophic costs was recommended at the CARN workshop in Kinshasa organized by WHO. Burundi would like to carry out this study in 2019 in order to align itself with the other countries in CARN.","NA Original Module: RSSH - National health strategies","High","73811",null,"0","0","0","0","73811","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxT/view","2020-12-31","Tuberculosis",73811," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713=AN185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713=AO185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713=AP185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713=AJ185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713=AN185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713=AO185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713=AP185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G185)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxUUAW","PAI-3722","Active","BDI-Tuberculosis-16","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Purchase of computer equipment.","Purchase of computer equipment.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","68600",null,"0","0","0","0","68600","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxU/view","2020-12-31","Tuberculosis",68600," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713=AN186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713=AO186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713=AP186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713=AJ186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713=AN186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713=AO186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713=AP186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G186)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxVUAW","PAI-3723","Active","BDI-Tuberculosis-17","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Purchase a teleconference device.","Purchase a teleconference device.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","4069",null,"0","0","0","0","4069","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxV/view","2020-12-31","Tuberculosis",4069," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713=AN187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713=AO187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713=AP187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713=AJ187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713=AN187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713=AO187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713=AP187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxWUAW","PAI-3724","Active","BDI-Tuberculosis-18","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"MDR-TB","Treatment: MDR-TB","Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.","Multidrug-Resistant Tuberculosis: Revision, Validation, Multiplication, Dissemination of Guidelines and Training of 1080 Providers on Guidelines: The PNILT formally agreed to implement WHO recommendations related to the change of treatment protocols for tuberculosis and multidrug-resistant tuberculosis. Thus, a revision of the Guidelines and training of care providers on the use of these different Guidelines is very essential.","NA Original Module: Multidrug-resistant TB","High","170205",null,"0","0","0","0","170205","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxW/view","2020-12-31","Tuberculosis",170205," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713=AN188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713=AO188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713=AP188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713=AJ188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713=AN188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713=AO188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713=AP188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G188)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxXUAW","PAI-3725","Active","BDI-Tuberculosis-19","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.","Purchase of 2 GeneXpert devices module 16 for CATB and Yezu Mwiza sites & accessories: WHO recommends that countries adopt GeneXert as a means of diagnosing the first intuition of tuberculosis in presumed cases. With the implementation of the recommendation to pass to GeneXpert all samples of people living with HIV-AIDS before putting them under preventive treatment with isoniazid 300mg and better organization of transport of samples to GeneXpert sites that should follow, it is expected that devices in place will be quickly saturated especially on busy sites such as the Tuberculosis Center of Bujumbura and service Yezu Mwiza.","NA Original Module: Multidrug-resistant TB","High","501858",null,"0","0","0","0","501858","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxX/view","2020-12-31","Tuberculosis",501858," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713=AN189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713=AO189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713=AP189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713=AJ189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713=AN189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713=AO189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713=AP189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxYUAW","PAI-3726","Active","BDI-Tuberculosis-2","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.","Purchase of 2 mobile digital radiology devices. This is an innovation to complete the technical platform To strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA and diagnosis multidrug-resistant tuberculosis. The purchase of the 2 mobile radiology devices will mainly allow the mass diagnosis of TB in sites at high risk of contagion such as detention centers, refugee camps, IDP camps, schools, exploitation sites. mining etc.",null,"High","160535",null,"0","0","0","0","160535","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxY/view","2020-12-31","Tuberculosis",160535," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713=AN190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713=AO190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713=AP190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713=AJ190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713=AN190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713=AO190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713=AP190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G190)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxZUAW","PAI-3727","Active","BDI-Tuberculosis-20","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"RSSH: Procurement and supply chain management systems","National product selection, registration and quality monitoring","Drug Registration Support (Cross-Cutting RSS): Drug registration is one of the pillars of drug quality assurance. In the past 3 years, just over 700 drug application files have been filed with the Department of Pharmacy, Medicines and Laboratories (DPML), which acts as the Burundian Agency for Drug Regulation. These files concern both products financed by the Global Fund and essential drugs imported into Burundi. To date, only 200 files have been processed. The requested support will mobilize the probate commission to process the 500 files registered to date at the DPML. Subsequently, the commission will be able to process new files as they arrive.","Drug Registration Support (Cross-Cutting RSS): Drug registration is one of the pillars of drug quality assurance. In the past 3 years, just over 700 drug application files have been filed with the Department of Pharmacy, Medicines and Laboratories (DPML), which acts as the Burundian Agency for Drug Regulation. These files concern both products financed by the Global Fund and essential drugs imported into Burundi. To date, only 200 files have been processed. The requested support will mobilize the probate commission to process the 500 files registered to date at the DPML. Subsequently, the commission will be able to process new files as they arrive.","NA Original Module: RSSH - Procurement and supply chain management systems","High","46922",null,"0","0","0","0","46922","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxZ/view","2020-12-31","Tuberculosis",46922," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713=AN191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713=AO191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713=AP191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713=AJ191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713=AN191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713=AO191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713=AP191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G191)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxaUAG","PAI-3728","Active","BDI-Tuberculosis-21","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Installation and implementation of GxAlert (or similar system) / networking of GeneXpert devices: The PNILT has acquired 18 GeneXpert devices from the Global Fund, which it has installed on strategic sites throughout the country. These devices were added to 6 acquired with funding from the World Bank, a fleet of 24 devices in total. To achieve the full value of the investments made in Xpert, the results must be transmitted from the machine to the service provider in a timely manner. However, xpert results are currently reported on paper. This reporting system is time consuming and limits the potential for optimizing patient care and management.","Installation and implementation of GxAlert (or similar system) / networking of GeneXpert devices: The PNILT has acquired 18 GeneXpert devices from the Global Fund, which it has installed on strategic sites throughout the country. These devices were added to 6 acquired with funding from the World Bank, a fleet of 24 devices in total. To achieve the full value of the investments made in Xpert, the results must be transmitted from the machine to the service provider in a timely manner. However, xpert results are currently reported on paper. This reporting system is time consuming and limits the potential for optimizing patient care and management.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","150000",null,"0","0","0","0","150000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxa/view","2020-12-31","Tuberculosis",150000," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713=AN192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713=AO192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713=AP192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713=AJ192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713=AN192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713=AO192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713=AP192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G192)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxbUAG","PAI-3729","Active","BDI-Tuberculosis-22","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"RSSH: Health management information systems and M&E","Surveys","Prevalence and anti-tuberculosis drug resistance study: The PNILT is preparing for the start of the TB drug resistance survey. On the basis of this review, a detailed budget was agreed between the PNILT, the Global Fund and Damien Action, which provides technical support and project management. The preparatory activities have already started as, among other things, the validation of the study protocol by the National Technical Committee.  The requested budget will complete the existing budget and bring the overall budget of the study to USD 251,838 (the existing USD 171,838 and a gap of USD 80,000).","Prevalence and anti-tuberculosis drug resistance study: The PNILT is preparing for the start of the TB drug resistance survey. On the basis of this review, a detailed budget was agreed between the PNILT, the Global Fund and Damien Action, which provides technical support and project management. The preparatory activities have already started as, among other things, the validation of the study protocol by the National Technical Committee.  The requested budget will complete the existing budget and bring the overall budget of the study to USD 251,838 (the existing USD 171,838 and a gap of USD 80,000).","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","80000",null,"0","0","0","0","80000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxb/view","2020-12-31","Tuberculosis",80000," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713=AN193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713=AO193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713=AP193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713=AJ193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713=AN193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713=AO193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713=AP193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxcUAG","PAI-3730","Active","BDI-Tuberculosis-23","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","Acquisition, installation and formation of sites for the utilization of LPA technology for National Reference Laboratory (LNR). This cost includes the layout of the laboratory, the purchase of equipment, reagents and consumables, the training of personnel.","Acquisition, installation and formation of sites for the utilization of LPA technology for National Reference Laboratory (LNR). This cost includes the layout of the laboratory, the purchase of equipment, reagents and consumables, the training of personnel.","NA Original Module: Multidrug-resistant TB","High","2e+05",null,"0","0","0","0","2e+05","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxc/view","2020-12-31","Tuberculosis",200000," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713=AN194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713=AO194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713=AP194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713=AJ194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713=AN194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713=AO194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713=AP194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxdUAG","PAI-3731","Active","BDI-Tuberculosis-24","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","Operational research on the use of oral forms in the treatment of MDR-TB. Development of an operational research protocol and conduct over a period of 3 years operational research on \"the tolerance and effectiveness of a short treatment 9 months without injectable for patients with MDR-TB. \"The overall goal of the project will be to evaluate the treatment outcomes and adverse effects of a new 9-month, non-injectable, short-course regimen for MDR-TB.","Operational research on the use of oral forms in the treatment of MDR-TB. Development of an operational research protocol and conduct over a period of 3 years operational research on \"the tolerance and effectiveness of a short treatment 9 months without injectable for patients with MDR-TB. \"The overall goal of the project will be to evaluate the treatment outcomes and adverse effects of a new 9-month, non-injectable, short-course regimen for MDR-TB.","NA Original Module: Multidrug-resistant TB","High","150000",null,"0","0","0","0","150000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxd/view","2020-12-31",{"$f":"IF(OR(I195=\"HIV/AIDS\",I195=\"Tuberculosis\",I195=\"Malaria\",I195=\"RSSH\"),I195, IF(I195=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"Tuberculosis"},{"$f":"VALUE(Y195)","v":150000},{"$f":"RIGHT(F195,LEN(F195)-2)","v":" Central Africa"},"Tuberculosis","Tuberculosis",null,null,null,{"$f":"TRIM(AK195)","v":""},{"$f":"TRIM(AL195)","v":""},{"$f":"TRIM(AM195)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713=AN195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713=AO195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713=AP195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE195<>\"\",AE195,IF(MAX(AQ195,AR195,AS195,AT195)<>0,MAX(AQ195,AR195,AS195,AT195),AU195))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713=AJ195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713=AN195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713=AO195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713=AP195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G195)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE195<>\"\",AE195,IF(MAX(AW195,AX195,AY195,AZ195)<>0,MAX(AW195,AX195,AY195,AZ195),BA195))","v":"2020-12-31"}]
["a6Q1R000000AIxeUAG","PAI-3732","Active","BDI-Tuberculosis-25","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"MDR-TB","Other MDR-TB intervention(s)","Gap to be filled in relation to the activity on the provincial coordination TB / HIV:The frequency of holding TB / HIV coordination meetings is quarterly.","Gap to be filled in relation to the activity on the provincial coordination TB / HIV:The frequency of holding TB / HIV coordination meetings is quarterly.","NA Original Module: Multidrug-resistant TB","High","30355",null,"0","0","0","0","30355","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxe/view","2020-12-31","Tuberculosis",30355," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713=AN196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713=AO196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713=AP196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713=AJ196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713=AN196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713=AO196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713=AP196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G196)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxfUAG","PAI-3733","Active","BDI-Tuberculosis-26","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Purchase of 17 vehicles and their insurance.Supervision is a priority activity in the fight against tuberculosis. The available supervision vehicles are old and most of them were acquired more than ten years ago. With depreciation and rugged terrain, repair costs become more and more huge.","Purchase of 17 vehicles and their insurance.Supervision is a priority activity in the fight against tuberculosis. The available supervision vehicles are old and most of them were acquired more than ten years ago. With depreciation and rugged terrain, repair costs become more and more huge.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","520200",null,"0","0","0","0","520200","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxf/view","2020-12-31","Tuberculosis",520200," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713=AN197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713=AO197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713=AP197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713=AJ197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713=AN197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713=AO197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713=AP197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G197)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxgUAG","PAI-3734","Active","BDI-Tuberculosis-27","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Supervision by TB / HIV coordinators. The budget covers vehicle and fuel insurance costs.The budget for the 2018-2020 grant is 661,500 BIF, per quarter and per BPS, to cover fuel costs only.The said budget omits the costs of insurance, vehicle repair and technical control, which, for most of them, are already obsolete and amortized.","Supervision by TB / HIV coordinators. The budget covers vehicle and fuel insurance costs.The budget for the 2018-2020 grant is 661,500 BIF, per quarter and per BPS, to cover fuel costs only.The said budget omits the costs of insurance, vehicle repair and technical control, which, for most of them, are already obsolete and amortized.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","102239",null,"0","0","0","0","102239","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxg/view","2020-12-31","Tuberculosis",102239," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713=AN198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713=AO198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713=AP198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713=AJ198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713=AN198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713=AO198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713=AP198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxhUAG","PAI-3735","Active","BDI-Tuberculosis-28","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","Acquire a PSM class II microbiological safety cabinet hood: The National Reference Laboratory (LNR) is equipped with an old safety hood that has just been out of service for a few months. The consultant sent for his repair recommends the purchase of a new hood. The cost includes transportation and installation.","Acquire a PSM class II microbiological safety cabinet hood: The National Reference Laboratory (LNR) is equipped with an old safety hood that has just been out of service for a few months. The consultant sent for his repair recommends the purchase of a new hood. The cost includes transportation and installation.","NA Original Module: Multidrug-resistant TB","High","25000",null,"0","0","0","0","25000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxh/view","2020-12-31","Tuberculosis",25000," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713=AN199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713=AO199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713=AP199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713=AJ199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713=AN199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713=AO199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713=AP199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxiUAG","PAI-3736","Active","BDI-Tuberculosis-3","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Purchase of 2 vehicles to transport digital radiology devices to screening sites.","Purchase of 2 vehicles to transport digital radiology devices to screening sites.",null,"High","1e+05",null,"0","0","0","0","1e+05","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxi/view","2020-12-31","Tuberculosis",100000," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713=AN200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713=AO200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713=AP200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713=AJ200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713=AN200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713=AO200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713=AP200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxjUAG","PAI-3737","Active","BDI-Tuberculosis-4","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Purchase of 2 power generators 5KVA energy source for 2 mobile radiology devices for use on sites without power source (cost includes transport if imported).","Purchase of 2 power generators 5KVA energy source for 2 mobile radiology devices for use on sites without power source (cost includes transport if imported).",null,"High","5000",null,"0","0","0","0","5000","0","0","2019-10-30 15:32:33","2019-10-30 15:32:32","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxj/view","2020-12-31","Tuberculosis",5000," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713=AN201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713=AO201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713=AP201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713=AJ201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713=AN201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713=AO201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713=AP201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G201)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxkUAG","PAI-3738","Active","BDI-Tuberculosis-5","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Purchase of 6 Horizon G2 laser reprograms codonics: These are devices for printing X-ray images produced by the 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile X-ray devices).","Purchase of 6 Horizon G2 laser reprograms codonics: These are devices for printing X-ray images produced by the 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile X-ray devices).",null,"High","33995",null,"0","0","0","0","33995","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxk/view","2020-12-31","Tuberculosis",33995," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713=AN202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713=AO202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713=AP202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713=AJ202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713=AN202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713=AO202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713=AP202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G202)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxlUAG","PAI-3739","Active","BDI-Tuberculosis-6","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Purchase of 6 kits of 500 codicon films in 3 sizes: These are films for printing radiology radiographs produced by 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile radiology devices).","Purchase of 6 kits of 500 codicon films in 3 sizes: These are films for printing radiology radiographs produced by 6 digital radiology devices (4 fixed digital radiology devices and 2 mobile radiology devices).",null,"High","12996",null,"0","0","0","0","12996","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxl/view","2020-12-31","Tuberculosis",12996," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713=AN203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713=AO203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713=AP203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713=AJ203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713=AN203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713=AO203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713=AP203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G203)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxmUAG","PAI-3740","Active","BDI-Tuberculosis-7","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Installation and handling (operator training) for all equipment.","Installation and handling (operator training) for all equipment.",null,"High","25900",null,"0","0","0","0","25900","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxm/view","2020-12-31","Tuberculosis",25900," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713=AN204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713=AO204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713=AP204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713=AJ204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713=AN204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713=AO204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713=AP204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxnUAG","PAI-3741","Active","BDI-Tuberculosis-8","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Equipment maintenance (package: 10% of the cost). As the devices come with a one year warranty, it would be worthwhile to purchase a 3 year warranty extension as we did for GeneXpert devices.","Equipment maintenance (package: 10% of the cost). As the devices come with a one year warranty, it would be worthwhile to purchase a 3 year warranty extension as we did for GeneXpert devices.",null,"High","62500",null,"0","0","0","0","62500","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxn/view","2020-12-31","Tuberculosis",62500," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713=AN205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713=AO205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713=AP205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713=AJ205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713=AN205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713=AO205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713=AP205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxoUAG","PAI-3742","Active","BDI-Tuberculosis-9","2017-2019","RT Central Africa","Burundi","Tuberculosis","Tuberculosis","FR578-BDI-T",null,null,"TB care and prevention","Case detection and diagnosis","Purchase of 9 ultrasound machines with accessories. The mapping of ultrasound machines performed in 2016 showed a need for 9 devices instead of 11. The purchase of these devices completes the technical platform so to strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA, the diagnosis of multidrug-resistant tuberculosis.","Purchase of 9 ultrasound machines with accessories. The mapping of ultrasound machines performed in 2016 showed a need for 9 devices instead of 11. The purchase of these devices completes the technical platform so to strengthen the diagnosis of pulmonary tuberculosis, extra-pulmonary tuberculosis, the diagnosis of tuberculosis in children and the diagnosis of tuberculosis in PLWHA, the diagnosis of multidrug-resistant tuberculosis.",null,"High","90000",null,"0","0","0","0","90000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxo/view","2020-12-31","Tuberculosis",90000," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713=AN206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713=AO206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713=AP206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713=AJ206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713=AN206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713=AO206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713=AP206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G206)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIxpUAG","PAI-3743","Active","BEN-HIV/AIDS-1","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","HIV care","Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.","Acquire antiretrovirals (ARVs), supplies and reagents for treatment for the inclusion of 4,000 adults and 100 children per year.",null,"High","4729341.26",null,"1400000","1400000","0","0","1929341.26","0","0","2020-01-14 12:23:07","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxp/view","2020-12-31","HIV/AIDS",1929341.26," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713=AN207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713=AO207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713=AP207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713=AJ207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713=AN207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713=AO207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713=AP207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G207)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxqUAG","PAI-3744","Active","BEN-HIV/AIDS-10","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Cover the monthly travel costs of facilitators from NGOs working with sex workers: planned for year 3. Travel by actors on the ground working with key populations.","Cover the monthly travel costs of facilitators from NGOs working with sex workers: planned for year 3. Travel by actors on the ground working with key populations.","NA Original Intervention: Other interventions for sex workers and their clients","High","47546.85",null,"0","0","0","0","47546.85","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxq/view","2020-12-31","HIV/AIDS",47546.85," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713=AN208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713=AO208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713=AP208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713=AJ208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713=AN208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713=AO208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713=AP208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G208)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxrUAG","PAI-3745","Active","BEN-HIV/AIDS-11","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Organize training/refresher training sessions for peer educators working with sex workers: planned for year 3. This intervention will build the capacities of peer educators for holding awareness-raising sessions addressing the target populations.","Organize training/refresher training sessions for peer educators working with sex workers: planned for year 3. This intervention will build the capacities of peer educators for holding awareness-raising sessions addressing the target populations.","NA Original Intervention: Other interventions for sex workers and their clients","High","30837.17",null,"0","0","0","0","30837.17","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxr/view","2020-12-31","HIV/AIDS",30837.17," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713=AN209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713=AO209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713=AP209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713=AJ209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713=AN209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713=AO209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713=AP209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxsUAG","PAI-3746","Active","BEN-HIV/AIDS-12","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Implement a network for sex workers associations in Benin:iInterventions that aim to provide more space and more capacity for the sex workers network to improve their involvement in the national response.","Implement a network for sex workers associations in Benin:iInterventions that aim to provide more space and more capacity for the sex workers network to improve their involvement in the national response.","NA Original Intervention: Other interventions for sex workers and their clients","High","17894.74",null,"0","0","0","0","17894.74","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxs/view","2020-12-31","HIV/AIDS",17894.740000000002," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713=AN210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713=AO210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713=AP210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713=AJ210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713=AN210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713=AO210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713=AP210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxtUAG","PAI-3747","Active","BEN-HIV/AIDS-13","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Organize a six-monthly community-based screening campaign among sex workers, under the supervision of adapted services and NGOs to de-medicalize screening and provides better access to the service for sex workers.","Organize a six-monthly community-based screening campaign among sex workers, under the supervision of adapted services and NGOs to de-medicalize screening and provides better access to the service for sex workers.",null,"High","52692.18",null,"0","0","0","0","52692.18","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxt/view","2020-12-31","HIV/AIDS",52692.18," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713=AN211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713=AO211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713=AP211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713=AJ211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713=AN211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713=AO211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713=AP211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G211)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxuUAG","PAI-3748","Active","BEN-HIV/AIDS-14","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Pay allowances for facilitators from NGOs working with prisoners: planned for year 3. Remuneration for actors on the ground working with prisoners.","Pay allowances for facilitators from NGOs working with prisoners: planned for year 3. Remuneration for actors on the ground working with prisoners.","NA Original Intervention: Other interventions for people in prisons and other closed settings","High","27715.18",null,"0","0","0","0","27715.18","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxu/view","2020-12-31","HIV/AIDS",27715.18," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713=AN212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713=AO212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713=AP212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713=AJ212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713=AN212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713=AO212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713=AP212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G212)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxvUAG","PAI-3749","Active","BEN-HIV/AIDS-15","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Pay the travel costs of facilitators from NGOs working with prisoners: planned for year 3. Travel by actors on the ground working with prisoners.","Pay the travel costs of facilitators from NGOs working with prisoners: planned for year 3. Travel by actors on the ground working with prisoners.","NA Original Intervention: Other interventions for people in prisons and other closed settings","High","5542.59",null,"0","0","0","0","5542.59","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxv/view","2020-12-31","HIV/AIDS",5542.59," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713=AN213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713=AO213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713=AP213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713=AJ213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713=AN213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713=AO213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713=AP213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G213)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxwUAG","PAI-3750","Active","BEN-HIV/AIDS-16","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Condoms and lubricant programming for sex workers","Procure male condoms for sex workers: planned for year 3.","Procure male condoms for sex workers: planned for year 3.",null,"High","90107.73",null,"0","0","0","0","90107.73","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxw/view","2020-12-31","HIV/AIDS",90107.73," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713=AN214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713=AO214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713=AP214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713=AJ214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713=AN214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713=AO214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713=AP214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxxUAG","PAI-3751","Active","BEN-HIV/AIDS-17","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Counseling and psycho-social support","Organize workshops on establishing ARV treatment adherence clubs in each care facility with the support of the Benin Action Network for People living with HIV (ReBAP+) and care facilities (to reduce the number of appointments at care facilities for stable patients receiving treatment).","Organize workshops on establishing ARV treatment adherence clubs in each care facility with the support of the Benin Action Network for People living with HIV (ReBAP+) and care facilities (to reduce the number of appointments at care facilities for stable patients receiving treatment).",null,"High","53582.09",null,"0","0","0","0","53582.09","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxx/view","2020-12-31","HIV/AIDS",53582.09," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713=AN215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713=AO215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713=AP215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713=AJ215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713=AN215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713=AO215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713=AP215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxyUAG","PAI-3752","Active","BEN-HIV/AIDS-18","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","This intervention aims to facilitate access to prevention, care and treatment services for people who inject drugs. In addition to the quarterly meeting with the Interministerial Committee for Combating Narcotic Drugs and Psychotropic Substances Abuse (CILAS) budgeted as part of the catalytic funds, this intervention will take place twice a year during the first two years and in three quarters during the final year. These studies were not budgeted for as part of the allocation amount or the catalytic funds. This intervention comprises the following activities:-Quarterly advocacy meetings with CILAS to promote a favorable, non-discriminatory, inclusive environment that takes the gender perspective into account (10,561)-Recruiting a consultant for a gender-sensitive update study that will estimate the number of people who inject drugs and map them (23,212)-A gender-sensitive update study that will estimate the number of people who inject drugs and map them (13,348)-Producing 50 copies of the report on the gender-sensitive update study that will estimate the number of people who inject drugs and map them (381)-Recruiting a consultant to conduct a satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (30,623)-A satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (10,556)-Producing 50 copies of the report on the satisfaction survey completed by the beneficiaries of the programs interventions throughout the country and in the service delivery areas (228)-Recruiting a consultant to conduct a Second-Generation Surveillance Survey (SGSS) for people who inject drugs (23,159)-An SGSS for people who inject drugs (11,771)-Producing 30 copies of the report on the SGSS for people who inject drugs (228)-A workshop to draw up and validate training modules to train 75 staff members on treatment for opioid users (8,590)-Training for 75 health workers on treatment for opioid users (28,298)-Recruiting a consultant to carry out a baseline (feasibility) study into treatment for opioid users (14,403)-Elaborating and validating a document setting out the regulations and procedures for the treatment of opioid users (9,101)-The procurement of methadone and other substitutes, amounting to one box (seven 1-mg capsules per box) per month per person who injects drugs over two years (20,428)-Treatment costs for people who inject drugs for the treatment of opioid addiction (69,516)-A baseline (feasibility) study into treatment for opioid users (11,396)","This intervention aims to facilitate access to prevention, care and treatment services for people who inject drugs. In addition to the quarterly meeting with the Interministerial Committee for Combating Narcotic Drugs and Psychotropic Substances Abuse (CILAS) budgeted as part of the catalytic funds, this intervention will take place twice a year during the first two years and in three quarters during the final year. These studies were not budgeted for as part of the allocation amount or the catalytic funds. This intervention comprises the following activities:-Quarterly advocacy meetings with CILAS to promote a favorable, non-discriminatory, inclusive environment that takes the gender perspective into account (10,561)-Recruiting a consultant for a gender-sensitive update study that will estimate the number of people who inject drugs and map them (23,212)-A gender-sensitive update study that will estimate the number of people who inject drugs and map them (13,348)-Producing 50 copies of the report on the gender-sensitive update study that will estimate the number of people who inject drugs and map them (381)-Recruiting a consultant to conduct a satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (30,623)-A satisfaction survey of the beneficiaries of the programs interventions throughout the country and in the service delivery areas (10,556)-Producing 50 copies of the report on the satisfaction survey completed by the beneficiaries of the programs interventions throughout the country and in the service delivery areas (228)-Recruiting a consultant to conduct a Second-Generation Surveillance Survey (SGSS) for people who inject drugs (23,159)-An SGSS for people who inject drugs (11,771)-Producing 30 copies of the report on the SGSS for people who inject drugs (228)-A workshop to draw up and validate training modules to train 75 staff members on treatment for opioid users (8,590)-Training for 75 health workers on treatment for opioid users (28,298)-Recruiting a consultant to carry out a baseline (feasibility) study into treatment for opioid users (14,403)-Elaborating and validating a document setting out the regulations and procedures for the treatment of opioid users (9,101)-The procurement of methadone and other substitutes, amounting to one box (seven 1-mg capsules per box) per month per person who injects drugs over two years (20,428)-Treatment costs for people who inject drugs for the treatment of opioid addiction (69,516)-A baseline (feasibility) study into treatment for opioid users (11,396)","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","High","320735.05",null,"0","0","0","0","320735.05","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxy/view","2020-12-31","HIV/AIDS",320735.05," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713=AN216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713=AO216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713=AP216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713=AJ216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713=AN216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713=AO216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713=AP216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIxzUAG","PAI-3753","Active","BEN-HIV/AIDS-19","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","This intervention aims to reduce HIV prevalence within this target group. This intervention was not budgeted for within the allocation amount. This intervention entailsprocuring male condoms to raise awareness among female bar workers.","This intervention aims to reduce HIV prevalence within this target group. This intervention was not budgeted for within the allocation amount. This intervention entailsprocuring male condoms to raise awareness among female bar workers.","NA Original Intervention: Other interventions for sex workers and their clients","High","17947.48",null,"0","0","0","0","17947.48","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIxz/view","2020-12-31","HIV/AIDS",17947.48," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713=AN217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713=AO217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713=AP217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713=AJ217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713=AN217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713=AO217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713=AP217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy0UAG","PAI-3754","Active","BEN-HIV/AIDS-2","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Treatment monitoring - Viral load","Transport viral load samples from care facilities to molecular biology platforms on a monthly basis: Provide access to viral load testing for facilities located far from the molecular biology platform.","Transport viral load samples from care facilities to molecular biology platforms on a monthly basis: Provide access to viral load testing for facilities located far from the molecular biology platform.","NA Original Intervention: Treatment monitoring  Viral load","High","83144.43",null,"0","0","0","0","83144.43","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy0/view","2020-12-31","HIV/AIDS",83144.429999999993," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713=AN218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713=AO218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713=AP218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713=AJ218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713=AN218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713=AO218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713=AP218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G218)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy1UAG","PAI-3755","Active","BEN-HIV/AIDS-20","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Treatment adherence","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. These activities relate to training for therapeutic educators and their management, and to the organization of support groups for PLHIV.",null,"High","441113.23",null,"0","221000","0","0","220113.23","0","0","2020-01-14 12:21:27","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy1/view","2020-12-31","HIV/AIDS",220113.23," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713=AN219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713=AO219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713=AP219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713=AJ219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713=AN219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713=AO219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713=AP219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G219)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy2UAG","PAI-3756","Active","BEN-HIV/AIDS-21","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Counseling and psycho-social support","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV.","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV.",null,"High","121722.59","Substantial resources allocated to procurement and distribution of nutritional kits as a psychosocial support measure. Evidence of the utility of nutritional kits is better for children than general adult populations on ART especially in a test and treat approach to ART. The TRP is also concerned about the sustainability of this measure in the long term as cessation of these programs could affect long-term adherence. The TRP requests to clarify how suitable this intervention is in the epidemic context of Benin and whether this is sustainable in the long run. This explains the medium priority rating The remaining funds for costs related to Beninese Network of Associations of Persons living with HIV (ReBAP+) and key populations psychosocial training, medical ethics and human rights refresher trainings are maintained as high priorities.","0","0","0","0","121722.59","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy2/view","2020-12-31","HIV/AIDS",121722.59," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713=AN220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713=AO220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713=AP220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713=AJ220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713=AN220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713=AO220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713=AP220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy3UAG","PAI-3757","Active","BEN-HIV/AIDS-22","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: -Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (2,103.80) -Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (4,315.07)-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (4,573.47) -Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (7,546.23) -Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (1,632.73) -Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (6,585.80) -The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (4,102.40) -Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (5,460.72) -Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (3,430.10)-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for OVC and PLHIV in all departments (plan) (343.01) -Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (4,573.47) -Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (332,582.78) -Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (10,425.99) -Covering the costs of the ReBAP+ helpline (1,646.45) -Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (4,573.47) -Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (42,807.68) -Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (8,479.21) -Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (9,878.70) -Producing badges for the peer educators/health mediators involved in the projects (1,524.49)","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: -Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (2,103.80) -Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (4,315.07)-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (4,573.47) -Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (7,546.23) -Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (1,632.73) -Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (6,585.80) -The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (4,102.40) -Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (5,460.72) -Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (3,430.10)-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for OVC and PLHIV in all departments (plan) (343.01) -Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (4,573.47) -Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (332,582.78) -Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (10,425.99) -Covering the costs of the ReBAP+ helpline (1,646.45) -Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (4,573.47) -Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (42,807.68) -Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (8,479.21) -Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (9,878.70) -Producing badges for the peer educators/health mediators involved in the projects (1,524.49)","NA Original Intervention: Other interventions for treatment","High","396203.57","Substantial resources allocated to procurement and distribution of nutritional kits as a psychosocial support measure. Evidence of the utility of nutritional kits is better for children than general adult populations on ART especially in a test and treat approach to ART. The TRP is also concerned about the sustainability of this measure in the long term as cessation of these programs could affect long-term adherence. The TRP requests to clarify how suitable this intervention is in the epidemic context of Benin and whether this is sustainable in the long-run. This explains the medium priority rating for these activities The remaining activities are maintained in the High category.","0","0","0","0","396203.57","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy3/view","2020-12-31","HIV/AIDS",396203.57," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713=AN221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713=AO221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713=AP221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713=AJ221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713=AN221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713=AO221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713=AP221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G221)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy4UAG","PAI-3758","Active","BEN-HIV/AIDS-23","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Health management information systems and M&E","Program and data quality","The following activities relate to data quality (quality control, supervision and the review of progress update and disbursement requests), as well as planning and other activities linked to information systems and management, with the aim of improving the quality of the program: -Ensuring the participation of grant actors in discussions and short training sessions each year (44,820) -Six-monthly quality control of the data collected by each team working on the ground, including the data disaggregated by sex and by age produced within their intervention areas (6,105) -Six-day supervision, carried out by the Principal Recipient every six months, of actors on the ground at the departmental level (sub-sub-recipients and others) and at the commune level (NGOs and others), in terms of monitoring and evaluation (two three-person teams, including a driver) based on human rights and gender standards (2,309) -The drafting of a six-monthly gender-sensitive report on the results obtained and the progress made in implementing the grant (6,469) -Six-monthly quality control exercises carried out by the Principal Recipient to monitor data from teams working on the ground and NGOs, peer educators (MSM, people who inject drugs, young people who no longer attend, or have never attended, school and truck drivers, disaggregated by sex and by age) via two three-person teams. These exercises will last six days and take place in the 12 departments (5,282) -Six-monthly monitoring and traceability of condoms, from wholesaler to the final distributers, carried out by two three-person teams over six days (5,241)-An annual on-site data verification exercise at the sub-recipient level carried out by three three-person teams over six days (7,923) -A six-monthly review of the progress update and disbursement requests of the two sub-recipients and the teams on the ground by the Principal Recipient -A six-monthly planning and review workshop with teams on the ground lasting four days (administration of 31 participants, including seven drivers, over four days) (5,230)-The six-monthly maintenance of the integrated system of community data (SIDOC) by the developer (six days consultancy every six months) (2,552)","The following activities relate to data quality (quality control, supervision and the review of progress update and disbursement requests), as well as planning and other activities linked to information systems and management, with the aim of improving the quality of the program: -Ensuring the participation of grant actors in discussions and short training sessions each year (44,820) -Six-monthly quality control of the data collected by each team working on the ground, including the data disaggregated by sex and by age produced within their intervention areas (6,105) -Six-day supervision, carried out by the Principal Recipient every six months, of actors on the ground at the departmental level (sub-sub-recipients and others) and at the commune level (NGOs and others), in terms of monitoring and evaluation (two three-person teams, including a driver) based on human rights and gender standards (2,309) -The drafting of a six-monthly gender-sensitive report on the results obtained and the progress made in implementing the grant (6,469) -Six-monthly quality control exercises carried out by the Principal Recipient to monitor data from teams working on the ground and NGOs, peer educators (MSM, people who inject drugs, young people who no longer attend, or have never attended, school and truck drivers, disaggregated by sex and by age) via two three-person teams. These exercises will last six days and take place in the 12 departments (5,282) -Six-monthly monitoring and traceability of condoms, from wholesaler to the final distributers, carried out by two three-person teams over six days (5,241)-An annual on-site data verification exercise at the sub-recipient level carried out by three three-person teams over six days (7,923) -A six-monthly review of the progress update and disbursement requests of the two sub-recipients and the teams on the ground by the Principal Recipient -A six-monthly planning and review workshop with teams on the ground lasting four days (administration of 31 participants, including seven drivers, over four days) (5,230)-The six-monthly maintenance of the integrated system of community data (SIDOC) by the developer (six days consultancy every six months) (2,552)","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","104237.46",null,"0","0","0","0","104237.46","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy4/view","2020-12-31","HIV/AIDS",104237.46," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713=AN222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713=AO222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713=AP222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713=AJ222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713=AN222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713=AO222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713=AP222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy5UAG","PAI-3759","Active","BEN-HIV/AIDS-24","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","This is a demonstration study into the scaling-up of pre-exposure prophylaxis (PrEP) to prevent HIV infection among MSM in Benin (PrEP/MSM). We will continue to provide PrEP to maximize the reduction in HIV transmission within the MSM population.This is a HIV prevention method that involves people who do not have the infection, but who are at a high risk of it. They receive ART with Truvada to protect against potential exposure to HIV in order to reduce the risk of infection. The effectiveness of this strategy has been widely documented through several randomized trials. It reduces HIV transmission among MSM by more than 86 percent. It is a very promising preventive biomedical intervention that has a high impact on combating the HIV pandemic. This demonstration study will involve around 250 MSM.The main cost categories are: -Consultant costs (national and international) -Laboratory studies (including HIV, creatinemia, gonorrhea/chlamydia, hepatitis B serology and hepatitis C serology) -Transporting of study samples from laboratories (the Johns Hopkins University Laboratory with ARV dosage of Truvada, including the transport of samples) -Management of the monitoring and research teams -Management of the participants travel at project launch and during the four monitoring phases -Workshops to draft and validate protocols and provisional and definitive reports","This is a demonstration study into the scaling-up of pre-exposure prophylaxis (PrEP) to prevent HIV infection among MSM in Benin (PrEP/MSM). We will continue to provide PrEP to maximize the reduction in HIV transmission within the MSM population.This is a HIV prevention method that involves people who do not have the infection, but who are at a high risk of it. They receive ART with Truvada to protect against potential exposure to HIV in order to reduce the risk of infection. The effectiveness of this strategy has been widely documented through several randomized trials. It reduces HIV transmission among MSM by more than 86 percent. It is a very promising preventive biomedical intervention that has a high impact on combating the HIV pandemic. This demonstration study will involve around 250 MSM.The main cost categories are: -Consultant costs (national and international) -Laboratory studies (including HIV, creatinemia, gonorrhea/chlamydia, hepatitis B serology and hepatitis C serology) -Transporting of study samples from laboratories (the Johns Hopkins University Laboratory with ARV dosage of Truvada, including the transport of samples) -Management of the monitoring and research teams -Management of the participants travel at project launch and during the four monitoring phases -Workshops to draft and validate protocols and provisional and definitive reports","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","High","647037.37",null,"0","0","0","0","647037.37","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy5/view","2020-12-31","HIV/AIDS",647037.37," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713=AN223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713=AO223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713=AP223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713=AJ223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713=AN223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713=AO223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713=AP223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G223)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy6UAG","PAI-3760","Active","BEN-HIV/AIDS-25","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for TGs","Behavioral interventions for TGs","The management of transgender peer educators and support groups aims to intensify prevention activities for transgender people and ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention comprises the activities listed below. The management of transgender peer educators was planned for two years and nine months only, using the allocation amount and catalytic funds. It is planned for the final quarter as part of the prioritized above allocation request. The various activities are detailed below:-Five support groups per quarter that take a human rights-based and gender-transformative approach for 20 transgender people (educational session followed by condom distribution) (1,295)-Management of ten transgender peer educators as part of SC/BCC activities (1,097)","The management of transgender peer educators and support groups aims to intensify prevention activities for transgender people and ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention comprises the activities listed below. The management of transgender peer educators was planned for two years and nine months only, using the allocation amount and catalytic funds. It is planned for the final quarter as part of the prioritized above allocation request. The various activities are detailed below:-Five support groups per quarter that take a human rights-based and gender-transformative approach for 20 transgender people (educational session followed by condom distribution) (1,295)-Management of ten transgender peer educators as part of SC/BCC activities (1,097)","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","High","2685.44",null,"0","0","0","0","2685.44","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy6/view","2020-12-31","HIV/AIDS",2685.44," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713=AN224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713=AO224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713=AP224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713=AJ224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713=AN224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713=AO224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713=AP224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G224)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy7UAG","PAI-3761","Active","BEN-HIV/AIDS-26","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for TGs","Other intervention(s) for TGs","Studies were not budgeted for within the allocation amount. The studies (size estimation and SGSS) will provide data to better monitor the impact of the interventions: -A gender-sensitive study that includes adolescents and young people to estimate the size of the transgender population in Benin and map it (11,771)-Production of 30 copies of the study to estimate the size of the transgender population in Benin and map it (228)-Recruitment of a consultant to conduct a gender-sensitive SGSS for the transgender population (19,683)- An SGSS for transgender people (11,771)-Production of 30 copies of the report on the SGSS for the transgender population (228)","Studies were not budgeted for within the allocation amount. The studies (size estimation and SGSS) will provide data to better monitor the impact of the interventions: -A gender-sensitive study that includes adolescents and young people to estimate the size of the transgender population in Benin and map it (11,771)-Production of 30 copies of the study to estimate the size of the transgender population in Benin and map it (228)-Recruitment of a consultant to conduct a gender-sensitive SGSS for the transgender population (19,683)- An SGSS for transgender people (11,771)-Production of 30 copies of the report on the SGSS for the transgender population (228)","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Other interventions for transgender people","High","49022.56",null,"0","0","0","0","49022.56","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy7/view","2020-12-31","HIV/AIDS",49022.559999999998," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713=AN225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713=AO225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713=AP225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713=AJ225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713=AN225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713=AO225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713=AP225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy8UAG","PAI-3762","Active","BEN-HIV/AIDS-27","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"PMTCT","Other intervention(s) for PMTCT","Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)The residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.","Organize awareness-raising broadcasts on community radio on the involvement of spouses in PMTCT, screening for pregnant women and early diagnosis in children in the departments of Donga, Couffo, Littoral and Mono:(Messages will be developed in ten local languages at a cost of 200,000 CFA francs per language, and broadcast on five radio stations per department, totaling 20 stations in all, on three-year contracts costing 100,000 CFA francs per month)The residual rate of mother-to-child HIV transmission has plateaued, despite the progress made in care for pregnant women. The bottlenecks identified include the low involvement of spouses in PMTCT. Additionally, the low rate of initiation of ART among children reflects the difficulties in accessing early diagnosis. These issues will be addressed in local languages.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","High","126598.59","Well quantified and targets clearly outlined. This is a last mile intervention to enhance efforts towards elimination of MTCT and merits higher priority rating","0","0","0","0","126598.59","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy8/view","2020-12-31","HIV/AIDS",126598.59," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713=AN226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713=AO226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713=AP226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713=AJ226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713=AN226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713=AO226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713=AP226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G226)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIy9UAG","PAI-3763","Active","BEN-HIV/AIDS-28","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Counseling and psycho-social support","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities:-Refresher training for 400 people (health workers, social workers, health mediators, therapeutic educators, MSM and transgender associations and other social organizations) during 20 sessions with 30 participants each. This training will address the specific needs of key and vulnerable populations (psychological support for improved referral and care for key and vulnerable populations), human rights and medical ethics linked to combating HIV and tuberculosis (49,430.07)-Procuring nutritional kits to support the most vulnerable PLHIV on ART (men, women, boys and girls) to help improve their nutrition and their adherence to ART (356,730) -Repackaging nutritional kits and distributing them to beneficiary PLHIV (men, women, boys and girls) on a quarterly basis. These kits are gender-specific, non-discriminatory and inclusive (9,146.94)-Paying the salaries of ReBAP+ staff (program lead, administrative assistant, accountant and monitoring and evaluation specialist) (16,670)-Paying health insurance for ReBAP+ staff (4,390.53)-Contributing to the running costs of ReBAP+ (office rent, water, electricity, communications and supplies) (3,978)","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities:-Refresher training for 400 people (health workers, social workers, health mediators, therapeutic educators, MSM and transgender associations and other social organizations) during 20 sessions with 30 participants each. This training will address the specific needs of key and vulnerable populations (psychological support for improved referral and care for key and vulnerable populations), human rights and medical ethics linked to combating HIV and tuberculosis (49,430.07)-Procuring nutritional kits to support the most vulnerable PLHIV on ART (men, women, boys and girls) to help improve their nutrition and their adherence to ART (356,730) -Repackaging nutritional kits and distributing them to beneficiary PLHIV (men, women, boys and girls) on a quarterly basis. These kits are gender-specific, non-discriminatory and inclusive (9,146.94)-Paying the salaries of ReBAP+ staff (program lead, administrative assistant, accountant and monitoring and evaluation specialist) (16,670)-Paying health insurance for ReBAP+ staff (4,390.53)-Contributing to the running costs of ReBAP+ (office rent, water, electricity, communications and supplies) (3,978)",null,"Medium","417326.9","Substantial resources allocated to procurement and distribution of nutritional kits as a psychosocial support measure. Evidence of the utility of nutritional kits is better for children than general adult populations on ART especially in a test and treat approach to ART. The TRP is also concerned about the sustainability of this measure in the long term as cessation of these programs could affect long-term adherence. The TRP requests to clarify how suitable this intervention is in the epidemic context of Benin and whether this is sustainable in the long run. This explains the medium priority rating The remaining funds for costs related to Beninese Network of Associations of Persons living with HIV (ReBAP+) and key populations psychosocial training, medical ethics and human rights refresher trainings are maintained as high priorities.","0","0","0","0","417326.9","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIy9/view","2020-12-31","HIV/AIDS",417326.9," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713=AN227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713=AO227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713=AP227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713=AJ227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713=AN227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713=AO227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713=AP227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyAUAW","PAI-3764","Active","BEN-HIV/AIDS-29","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: -Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (2,103.80) -Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (4,315.07)-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (4,573.47) -Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (7,546.23) -Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (1,632.73) -Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (6,585.80) -The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (4,102.40) -Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (5,460.72) -Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (3,430.10)-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for OVC and PLHIV in all departments (plan) (343.01) -Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (4,573.47) -Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (332,582.78) -Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (10,425.99) -Covering the costs of the ReBAP+ helpline (1,646.45) -Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (4,573.47) -Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (42,807.68) -Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (8,479.21) -Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (9,878.70) -Producing badges for the peer educators/health mediators involved in the projects (1,524.49)","These various activities will facilitate the package of services to better reach PLHIV, ensuring better adherence to treatment and supporting the overall care of PLHIV. This intervention comprises the following activities: -Recruiting a consultant to create visual aids for PLHIV and facility users to be used by health mediators (2,103.80) -Meetings to select the consultant and to approve the visual aids for PLHIV and facility users to be used by health mediators (4,315.07)-Producing 400 visual aids for PLHIV and facility users to be used by health mediators (4,573.47) -Training for 350 health mediators on gender-specific and human rights-based intervention strategies and reporting tools during 14 two-day sessions, each addressing 25 health mediators (7,546.23) -Providing support over three days for two two-person ReBAP+ teams to organize six-monthly supervisions at the national level for interventions led by actors for PLHIV (men, women, adolescents and young people) (1,632.73) -Quarterly management of the 36 care facility managers and their teams involved in care, support and ongoing monitoring of PLHIV receiving different forms of support (distribution of nutritional kits, identification and ongoing monitoring of PLHIV) (6,585.80) -The use of an approved structure to contract a national organization to oversee quality control of the nutritional kits procured for PLHIV (4,102.40) -Missions by a (contracted) national organization to oversee quality control of the nutritional kits procured for PLHIV (5,460.72) -Covering the cost of  five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for orphans and vulnerable children (OVC) and PLHIV in all departments, disaggregated by sex and age (3,430.10)-Covering the travel costs of five data entry staff for five days per six-month period to enter data corresponding to the programs indicators for OVC and PLHIV in all departments (plan) (343.01) -Producing 40,000 copies of the individual forms for nutritional kits for PLHIV (men, women, girls and boys, both at school and not at school) (three self-copy paper sheets) (4,573.47) -Providing financial incentives for the 200 health mediators (60,600 CFA francs/month per health mediator) (332,582.78) -Procuring awareness-raising kits for the peer educators/health mediators involved in the projects (10,425.99) -Covering the costs of the ReBAP+ helpline (1,646.45) -Monthly on-site coaching for health mediators by specialists (doctors, midwives, social assistant, nurse) (4,573.47) -Covering the service delivery costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for the Planning and Statistics Unit (CPS) in the distribution of school and nutritional kits (42,807.68) -Covering the quarterly running costs of the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (8,479.21) -Covering the travel costs of facilitators from the six NGOs/sub-sub-recipients for the monitoring of health mediators and truck driver peer educators, capacity building, data collection, quality control, report drafting and support for CPS in the distribution of school and nutritional kits (9,878.70) -Producing badges for the peer educators/health mediators involved in the projects (1,524.49)","NA Original Intervention: Other interventions for treatment","Medium","71292.78","Substantial resources allocated to procurement and distribution of nutritional kits as a psychosocial support measure. Evidence of the utility of nutritional kits is better for children than general adult populations on ART especially in a test and treat approach to ART. The TRP is also concerned about the sustainability of this measure in the long term as cessation of these programs could affect long-term adherence. The TRP requests to clarify how suitable this intervention is in the epidemic context of Benin and whether this is sustainable in the long-run. This explains the medium priority rating for these activities The remaining activities are maintained in the High category.","0","0","0","0","71292.78","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyA/view","2020-12-31","HIV/AIDS",71292.78," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713=AN228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713=AO228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713=AP228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713=AJ228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713=AN228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713=AO228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713=AP228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G228)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyBUAW","PAI-3765","Active","BEN-HIV/AIDS-3","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"PMTCT","Other intervention(s) for PMTCT","Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.","Provide a two-day training course for 275 health workers from private clinics in PMTCT/Integrated Management of Pregnancy and Childbirth (IMPC) and ensure that they are mentored for two weeks. These workers will come from all departments.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","High","146149.7",null,"0","0","0","0","146149.7","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyB/view","2020-12-31","HIV/AIDS",146149.70000000001," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713=AN229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713=AO229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713=AP229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713=AJ229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713=AN229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713=AO229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713=AP229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G229)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyCUAW","PAI-3766","Active","BEN-HIV/AIDS-30","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Integrated service delivery and quality improvement","Service organization and facility management","Organize two six-monthly consultation meetings per year for each region (north and south), a total of four two-day meetings of 40 people, including actors from treatment and prevention of mother-to-child transmission (PMTCT) facilities:This activity should allow for the sharing of experiences and good practice, as well as any difficulties encountered so that they may be resolved.","Organize two six-monthly consultation meetings per year for each region (north and south), a total of four two-day meetings of 40 people, including actors from treatment and prevention of mother-to-child transmission (PMTCT) facilities:This activity should allow for the sharing of experiences and good practice, as well as any difficulties encountered so that they may be resolved.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Medium","75035.35",null,"0","0","0","0","75035.35","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyC/view","2020-12-31","HIV/AIDS",75035.350000000006," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713=AN230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713=AO230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713=AP230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713=AJ230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713=AN230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713=AO230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713=AP230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyDUAW","PAI-3767","Active","BEN-HIV/AIDS-31","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Organize an annual two-day information meeting of 40 actors from the Ministry of Health and the Ministry of Justice on interventions in the prison system: This activity is planned to raise awareness among actors from the Ministries of Justice and Health so as to increase the impact of HIV interventions on prisoners.","Organize an annual two-day information meeting of 40 actors from the Ministry of Health and the Ministry of Justice on interventions in the prison system: This activity is planned to raise awareness among actors from the Ministries of Justice and Health so as to increase the impact of HIV interventions on prisoners.",null,"Medium","18758.84",null,"0","0","0","0","18758.84","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyD/view","2020-12-31","HIV/AIDS",18758.84," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713=AN231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713=AO231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713=AP231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713=AJ231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713=AN231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713=AO231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713=AP231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G231)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyEUAW","PAI-3768","Active","BEN-HIV/AIDS-32","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"PMTCT","Other intervention(s) for PMTCT","Train 20 auxiliary nurses in each health district on PMTCT/IMPC and early diagnosis through dried blood spots in the health districts not covered by UNICEF (25) during 15 three-day sessions with 20 participants (plus two facilitators, one supervisor, one driver and one accountant) in 2018 and 2020:This is an important activity for the program that will help achieve universal coverage of PMTCT and contribute to the ETME.","Train 20 auxiliary nurses in each health district on PMTCT/IMPC and early diagnosis through dried blood spots in the health districts not covered by UNICEF (25) during 15 three-day sessions with 20 participants (plus two facilitators, one supervisor, one driver and one accountant) in 2018 and 2020:This is an important activity for the program that will help achieve universal coverage of PMTCT and contribute to the ETME.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","Medium","27184.38",null,"0","0","0","0","27184.38","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyE/view","2020-12-31","HIV/AIDS",27184.38," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713=AN232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713=AO232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713=AP232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713=AJ232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713=AN232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713=AO232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713=AP232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyFUAW","PAI-3769","Active","BEN-HIV/AIDS-33","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Train 250 paramedics and medics in care for patients receiving antiretroviral therapy (ART) (184 providers from the 92 former sites, 24 from the new sites and 42 participants from the central level and the Information and Support Centers for STIs, HIV and AIDS (CIPEC)). The training will take place over ten sessions with 25 participants, two facilitators, one supervisor, one manager and two drivers: This activity is important for the delegation of tasks to paramedics and ensuring the quality of care despite the limited number of doctors in care facilities.","Train 250 paramedics and medics in care for patients receiving antiretroviral therapy (ART) (184 providers from the 92 former sites, 24 from the new sites and 42 participants from the central level and the Information and Support Centers for STIs, HIV and AIDS (CIPEC)). The training will take place over ten sessions with 25 participants, two facilitators, one supervisor, one manager and two drivers: This activity is important for the delegation of tasks to paramedics and ensuring the quality of care despite the limited number of doctors in care facilities.","NA Original Intervention: Other interventions for treatment","Medium","51518.35",null,"0","0","0","0","51518.35","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyF/view","2020-12-31","HIV/AIDS",51518.35," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713=AN233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713=AO233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713=AP233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713=AJ233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713=AN233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713=AO233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713=AP233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyGUAW","PAI-3770","Active","BEN-HIV/AIDS-34","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):Improvement of the biological monitoring of people living with HIV (PLHIV).","Organize three sessions per year to provide training/refresher training for 90 laboratory technicians in HIV biology (three facilitators, one supervisor, one manager and two drivers for each session):Improvement of the biological monitoring of people living with HIV (PLHIV).","NA Original Intervention: Other interventions for treatment","Medium","19066.32",null,"0","0","0","0","19066.32","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyG/view","2020-12-31","HIV/AIDS",19066.32," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713=AN234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713=AO234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713=AP234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713=AJ234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713=AN234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713=AO234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713=AP234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G234)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyHUAW","PAI-3771","Active","BEN-HIV/AIDS-35","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Hold 18 five-day training sessions for 450 doctors and paramedics in care facilities on pediatric care (25 participants, three trainers and one supervisor per session), following the new World Health Organization recommendations:This activity aims to improve pediatric care.","Hold 18 five-day training sessions for 450 doctors and paramedics in care facilities on pediatric care (25 participants, three trainers and one supervisor per session), following the new World Health Organization recommendations:This activity aims to improve pediatric care.","NA Original Intervention: Other interventions for treatment","Medium","59423.18",null,"0","0","0","0","59423.18","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyH/view","2020-12-31","HIV/AIDS",59423.18," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713=AN235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713=AO235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713=AP235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713=AJ235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713=AN235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713=AO235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713=AP235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G235)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyIUAW","PAI-3772","Active","BEN-HIV/AIDS-36","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Program management","Grant management","Organize quarterly five-day missions to validate the accounts of private clinics for the payment of services, undertaken by two teams of three people:This activity aims to improve the quality of accounts and prevent ineligible amounts.","Organize quarterly five-day missions to validate the accounts of private clinics for the payment of services, undertaken by two teams of three people:This activity aims to improve the quality of accounts and prevent ineligible amounts.","NA Original Module: RSSH - Program management","Medium","24225.12",null,"0","0","0","0","24225.12","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyI/view","2020-12-31","HIV/AIDS",24225.119999999999," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713=AN236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713=AO236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713=AP236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713=AJ236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713=AN236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713=AO236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713=AP236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G236)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyJUAW","PAI-3773","Active","BEN-HIV/AIDS-37","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Train providers on the use of tools to assist treatment adherence during six three-day sessions:This activity aims to improve care, given the risk of patients abandoning treatment linked to early diagnosis and the improved survival rate of PLHIV.","Train providers on the use of tools to assist treatment adherence during six three-day sessions:This activity aims to improve care, given the risk of patients abandoning treatment linked to early diagnosis and the improved survival rate of PLHIV.","NA Original Intervention: Other interventions for treatment","Medium","30821.46",null,"0","0","0","0","30821.46","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyJ/view","2020-12-31","HIV/AIDS",30821.46," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713=AN237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713=AO237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713=AP237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713=AJ237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713=AN237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713=AO237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713=AP237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyKUAW","PAI-3774","Active","BEN-HIV/AIDS-38","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Program management","Grant management","Organize a six-monthly, ten-day mission to validate the use of rapid diagnostic tests in the activities in the following six-month period (two teams of four people: one manager, one accountant, one monitoring and evaluation specialist and one driver):This activity facilitates the implementation of activities, particularly at the CIPEC level.","Organize a six-monthly, ten-day mission to validate the use of rapid diagnostic tests in the activities in the following six-month period (two teams of four people: one manager, one accountant, one monitoring and evaluation specialist and one driver):This activity facilitates the implementation of activities, particularly at the CIPEC level.","NA Original Module: RSSH - Program management","Medium","27971.05",null,"0","0","0","0","27971.05","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyK/view","2020-12-31","HIV/AIDS",27971.05," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713=AN238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713=AO238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713=AP238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713=AJ238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713=AN238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713=AO238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713=AP238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyLUAW","PAI-3775","Active","BEN-HIV/AIDS-39","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","Contribute to the annual three-day regional consultation workshop held by the National AIDS Control Program (NACP) with actors from the departments (CIPEC, Departmental Health Directorate, District Health Management Team), involving 45 participants and 17 drivers:This supports the monitoring of activities by actors on the ground and allows for actors at the intermediary and operational levels to better take ownership of HIV interventions.","Contribute to the annual three-day regional consultation workshop held by the National AIDS Control Program (NACP) with actors from the departments (CIPEC, Departmental Health Directorate, District Health Management Team), involving 45 participants and 17 drivers:This supports the monitoring of activities by actors on the ground and allows for actors at the intermediary and operational levels to better take ownership of HIV interventions.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","40887.67",null,"0","0","0","0","40887.67","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyL/view","2020-12-31","HIV/AIDS",40887.67," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713=AN239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713=AO239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713=AP239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713=AJ239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713=AN239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713=AO239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713=AP239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G239)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyMUAW","PAI-3776","Active","BEN-HIV/AIDS-4","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Supplies for screening sex workers: to address those sex workers and clients who do not attend adapted services, screening at this level will be carried out by sex worker peer educators (de-medicalized approach).","Supplies for screening sex workers: to address those sex workers and clients who do not attend adapted services, screening at this level will be carried out by sex worker peer educators (de-medicalized approach).",null,"High","486623.27",null,"0","0","0","0","486623.27","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyM/view","2020-12-31","HIV/AIDS",486623.27," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713=AN240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713=AO240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713=AP240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713=AJ240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713=AN240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713=AO240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713=AP240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G240)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyNUAW","PAI-3777","Active","BEN-HIV/AIDS-40","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Program management","Other program management intervention(s)","Ensure the participation of ten actors from the system each year in discussions and seminars:This activity aims to provide actors from the program and from facilities with information on progress relating to HIV and also to allow them to share their experiences with actors from other countries.","Ensure the participation of ten actors from the system each year in discussions and seminars:This activity aims to provide actors from the program and from facilities with information on progress relating to HIV and also to allow them to share their experiences with actors from other countries.","NA Original Module: RSSH - Program management","Medium","51324.21",null,"0","0","0","0","51324.21","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyN/view","2020-12-31","HIV/AIDS",51324.21," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713=AN241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713=AO241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713=AP241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713=AJ241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713=AN241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713=AO241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713=AP241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G241)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyOUAW","PAI-3778","Active","BEN-HIV/AIDS-41","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Organize a consultation meeting between the various actors from NGOs working with sex workers(based on 25,758 actors each year for the three years): This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","Organize a consultation meeting between the various actors from NGOs working with sex workers(based on 25,758 actors each year for the three years): This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","NA Original Intervention: Other interventions for sex workers and their clients","Medium","86716.42",null,"0","0","0","0","86716.42","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyO/view","2020-12-31","HIV/AIDS",86716.42," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713=AN242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713=AO242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713=AP242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713=AJ242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713=AN242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713=AO242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713=AP242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyPUAW","PAI-3779","Active","BEN-HIV/AIDS-42","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Run three-day training/refresher training sessions for 180 health workers, including those working with men who have sex with men (MSM), on the revised algorithms for STI treatment. One session per former department will take place in 2019:Planned for 2019, this intervention will support treatment for STIs in adapted services, a reference point for the targets addressed by NGOs.","Run three-day training/refresher training sessions for 180 health workers, including those working with men who have sex with men (MSM), on the revised algorithms for STI treatment. One session per former department will take place in 2019:Planned for 2019, this intervention will support treatment for STIs in adapted services, a reference point for the targets addressed by NGOs.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","Medium","39863.09",null,"0","0","0","0","39863.09","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyP/view","2020-12-31","HIV/AIDS",39863.089999999997," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713=AN243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713=AO243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713=AP243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713=AJ243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713=AN243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713=AO243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713=AP243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyQUAW","PAI-3780","Active","BEN-HIV/AIDS-43","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Six-monthly supervision of prevention activities implemented by the sex workers network in areas frequented by sex workers","Six-monthly supervision of prevention activities implemented by the sex workers network in areas frequented by sex workers","NA Original Intervention: Other interventions for sex workers and their clients","Medium","17963.19",null,"0","0","0","0","17963.19","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyQ/view","2020-12-31","HIV/AIDS",17963.189999999999," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713=AN244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713=AO244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713=AP244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713=AJ244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713=AN244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713=AO244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713=AP244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G244)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyRUAW","PAI-3781","Active","BEN-HIV/AIDS-44","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Organize a quarterly consultation meeting between the various actors from NGOs working with prisoners:Planned for year 3. This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","Organize a quarterly consultation meeting between the various actors from NGOs working with prisoners:Planned for year 3. This intervention represents a space where actors can share experiences and strategies for implementing activities to improve performance.","NA Original Intervention: Other interventions for people in prisons and other closed settings","Medium","4585.34",null,"0","0","0","0","4585.34","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyR/view","2020-12-31","HIV/AIDS",4585.34," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713=AN245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713=AO245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713=AP245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713=AJ245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713=AN245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713=AO245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713=AP245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G245)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIySUAW","PAI-3782","Active","BEN-HIV/AIDS-45","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Counseling and psycho-social support","Quarterly supervision of adherence clubs by ReBAP+ and the NACP:The establishment of adherence clubs requires regular monitoring by ReBAP+ and the program during the first few years.","Quarterly supervision of adherence clubs by ReBAP+ and the NACP:The establishment of adherence clubs requires regular monitoring by ReBAP+ and the program during the first few years.",null,"Medium","35926.38",null,"0","0","0","0","35926.38","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyS/view","2020-12-31","HIV/AIDS",35926.379999999997," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713=AN246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713=AO246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713=AP246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713=AJ246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713=AN246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713=AO246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713=AP246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G246)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyTUAW","PAI-3783","Active","BEN-HIV/AIDS-46","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Health management information systems and M&E","Surveys","Study to evaluate the prevalence of hepatitis B among PLHIV:After tuberculosis, hepatitis B is the biggest threat to the care of PLHIV. This study will identify those with co-infections (so as to provide better care for them) and evaluate prevalence.","Study to evaluate the prevalence of hepatitis B among PLHIV:After tuberculosis, hepatitis B is the biggest threat to the care of PLHIV. This study will identify those with co-infections (so as to provide better care for them) and evaluate prevalence.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","68431.15",null,"0","0","0","0","68431.15","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyT/view","2020-12-31","HIV/AIDS",68431.149999999994," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713=AN247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713=AO247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713=AP247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713=AJ247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713=AN247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713=AO247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713=AP247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyUUAW","PAI-3784","Active","BEN-HIV/AIDS-47","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Prevention programs for other vulnerable populations","Male and female condoms for other vulnerable populations","This intervention aims to reduce HIV prevalence within this target group. Condoms were not budgeted for within the allocation amount. This intervention entailsprocuring male and female condoms for truck drivers.","This intervention aims to reduce HIV prevalence within this target group. Condoms were not budgeted for within the allocation amount. This intervention entailsprocuring male and female condoms for truck drivers.",null,"Medium","86223.77",null,"0","0","0","0","86223.77","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyU/view","2020-12-31","HIV/AIDS",86223.77," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713=AN248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713=AO248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713=AP248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713=AJ248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713=AN248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713=AO248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713=AP248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyVUAW","PAI-3785","Active","BEN-HIV/AIDS-48","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","This screening intervention will intensify prevention activities for truck drivers to provide better coverage of screening and protection among the target group, with a view to improving the framework for achieving the 909090 targets. This activity was not budgeted for within the allocation amount. This intervention entails a quarterly ten-day screening mission undertaken by four people, including a driver, aimed at truck drivers.","This screening intervention will intensify prevention activities for truck drivers to provide better coverage of screening and protection among the target group, with a view to improving the framework for achieving the 909090 targets. This activity was not budgeted for within the allocation amount. This intervention entails a quarterly ten-day screening mission undertaken by four people, including a driver, aimed at truck drivers.",null,"Medium","24388.96",null,"0","0","0","0","24388.96","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyV/view","2020-12-31","HIV/AIDS",24388.959999999999," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713=AN249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713=AO249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713=AP249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713=AJ249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713=AN249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713=AO249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713=AP249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyWUAW","PAI-3786","Active","BEN-HIV/AIDS-49","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","The interventions involve the updating of modules, refresher training for actors, the editing of tools and consultation sessions. They will intensify prevention activities for truck drivers to ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention was not budgeted for within the allocation amount.This intervention comprises the following activities:-Updating the training modules for truck driver peer educators using a human rights and gender-transformative perspective. These include modules on health education, new forms of masculinity and the prevention of gender-based violence (2,939.22)-Refresher training for 75 truck driver peer educators and 20 facilitators during four two-day sessions with 30 participants on the package of interventions (intervention strategies, Social Change and Behavior Change Communication (SC/BCC), pre- and post-test counseling) and data reporting tools (15,726.64)-Producing 100 registers of people who have undergone awareness training and of the distribution of condoms and lubricants for truck drivers, and 3,500 fact sheets (922.32)-Producing 90 visual aids based on a human rights and gender perspective for truck driver peer educators, including on health education, new forms of masculinity and the prevention of gender-based violence (1,372.04)-Providing truck driver peer educators with one meal per day of the intervention, two days a month (outreach, communication and follow-up activities, distribution of condoms) (38,417.15)-Recruiting consultants for the SGSS for truck drivers (27,451)-An SGSS for truck drivers (4,610)-A one-day consultation session with haulage trade unions (room hire, coffee break, administration and travel for 30 participants, supplies and photocopying) every six months, totaling six sessions over the three years by the sub-recipient (8,378.60)-Producing 30 copies of the report on the SGSS for truck drivers (228.67)-Covering the costs of the supply, storage, quality control and distribution of condoms for truck drivers (6,146.74)-Producing 100 training manuals based on a human rights and gender perspective for truck driver peer educators (381.12)","The interventions involve the updating of modules, refresher training for actors, the editing of tools and consultation sessions. They will intensify prevention activities for truck drivers to ensure better coverage and coordination of activities addressing the target group, with a view to improving the framework for achieving the 909090 targets. This intervention was not budgeted for within the allocation amount.This intervention comprises the following activities:-Updating the training modules for truck driver peer educators using a human rights and gender-transformative perspective. These include modules on health education, new forms of masculinity and the prevention of gender-based violence (2,939.22)-Refresher training for 75 truck driver peer educators and 20 facilitators during four two-day sessions with 30 participants on the package of interventions (intervention strategies, Social Change and Behavior Change Communication (SC/BCC), pre- and post-test counseling) and data reporting tools (15,726.64)-Producing 100 registers of people who have undergone awareness training and of the distribution of condoms and lubricants for truck drivers, and 3,500 fact sheets (922.32)-Producing 90 visual aids based on a human rights and gender perspective for truck driver peer educators, including on health education, new forms of masculinity and the prevention of gender-based violence (1,372.04)-Providing truck driver peer educators with one meal per day of the intervention, two days a month (outreach, communication and follow-up activities, distribution of condoms) (38,417.15)-Recruiting consultants for the SGSS for truck drivers (27,451)-An SGSS for truck drivers (4,610)-A one-day consultation session with haulage trade unions (room hire, coffee break, administration and travel for 30 participants, supplies and photocopying) every six months, totaling six sessions over the three years by the sub-recipient (8,378.60)-Producing 30 copies of the report on the SGSS for truck drivers (228.67)-Covering the costs of the supply, storage, quality control and distribution of condoms for truck drivers (6,146.74)-Producing 100 training manuals based on a human rights and gender perspective for truck driver peer educators (381.12)","NA Original Intervention: Other interventions for other vulnerable populations","Medium","119598.25",null,"0","0","0","0","119598.25","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyW/view","2020-12-31","HIV/AIDS",119598.25," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713=AN250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713=AO250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713=AP250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713=AJ250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713=AN250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713=AO250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713=AP250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G250)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyXUAW","PAI-3787","Active","BEN-HIV/AIDS-5","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Sessions for the above.","Sessions for the above.",null,"High","514120.75",null,"0","0","0","0","514120.75","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyX/view","2020-12-31","HIV/AIDS",514120.75," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713=AN251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713=AO251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713=AP251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713=AJ251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713=AN251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713=AO251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713=AP251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G251)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyYUAW","PAI-3788","Active","BEN-HIV/AIDS-50","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Although prevalence remains low among adolescents and young people aged 1524, levels of knowledge of prevention measures (61 percent) and access to testing (23.4 percent) remain critical and must be improved. This intervention was not budgeted for within the above allocation amount.It relates to capacity building for young leaders and adolescents to provide quality interventions for other young people and adolescents. This intervention involvesproviding training to 60 young leaders and adolescents and eight facilitators during three two-day sessions on peer education, the package of interventions that are based on a human rights and gender perspective (intervention strategies and SC/BCC) and data reporting tools.","Although prevalence remains low among adolescents and young people aged 1524, levels of knowledge of prevention measures (61 percent) and access to testing (23.4 percent) remain critical and must be improved. This intervention was not budgeted for within the above allocation amount.It relates to capacity building for young leaders and adolescents to provide quality interventions for other young people and adolescents. This intervention involvesproviding training to 60 young leaders and adolescents and eight facilitators during three two-day sessions on peer education, the package of interventions that are based on a human rights and gender perspective (intervention strategies and SC/BCC) and data reporting tools.",null,"Medium","23782.96",null,"0","0","0","0","23782.96","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyY/view","2020-12-31","HIV/AIDS",23782.959999999999," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713=AN252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713=AO252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713=AP252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713=AJ252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713=AN252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713=AO252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713=AP252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G252)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyZUAW","PAI-3789","Active","BEN-HIV/AIDS-51","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Health management information systems and M&E","Routine reporting","These activities combine community data collected by NGOs and peer educators and allow for experiences to be shared between sub-sub-recipients and teams on the ground. They aim to produce quality data and strengthen interventions on the ground:-Six-monthly, two-day consultation meetings between sub-sub-recipients working with adolescents and young people who no longer attend, or who have never attended, school and adolescent and youth leaders to combine community data (room hire, coffee break, administration and travel of participants, supplies and photocopies) (1,474)-Twelve two-day, gender-sensitive and inclusive consultation meetings with 30 implementation actors to improve the coordination of interventions for key and vulnerable populations (MSM, people who inject drugs, PLHIV, sex workers, adolescents, young people, transgender people, truck drivers and those close to them, and community-based organizations that include women and girls) (10,281)-Six-monthly, two-day consultation meetings between sub-sub-recipients and peer educators working with people who inject drugs to combine community data disaggregated by sex and age (room hire, coffee break, administration and travel of participants, supplies and photocopies) (7,299.19)-Monthly outreach supervision sessions for peer educators working with people who inject drugs and MSM, led by NGO facilitators (3,366)-A six-monthly, two-day meeting for teams working on the ground to combine data and share the results of interventions for young people, MSM, people who inject drugs, and support for OVC and PLHIV with CPS, decentralized financial systems (SFD), ART facility managers, NGO facilitators, psychological support workers and legal experts (20,361)","These activities combine community data collected by NGOs and peer educators and allow for experiences to be shared between sub-sub-recipients and teams on the ground. They aim to produce quality data and strengthen interventions on the ground:-Six-monthly, two-day consultation meetings between sub-sub-recipients working with adolescents and young people who no longer attend, or who have never attended, school and adolescent and youth leaders to combine community data (room hire, coffee break, administration and travel of participants, supplies and photocopies) (1,474)-Twelve two-day, gender-sensitive and inclusive consultation meetings with 30 implementation actors to improve the coordination of interventions for key and vulnerable populations (MSM, people who inject drugs, PLHIV, sex workers, adolescents, young people, transgender people, truck drivers and those close to them, and community-based organizations that include women and girls) (10,281)-Six-monthly, two-day consultation meetings between sub-sub-recipients and peer educators working with people who inject drugs to combine community data disaggregated by sex and age (room hire, coffee break, administration and travel of participants, supplies and photocopies) (7,299.19)-Monthly outreach supervision sessions for peer educators working with people who inject drugs and MSM, led by NGO facilitators (3,366)-A six-monthly, two-day meeting for teams working on the ground to combine data and share the results of interventions for young people, MSM, people who inject drugs, and support for OVC and PLHIV with CPS, decentralized financial systems (SFD), ART facility managers, NGO facilitators, psychological support workers and legal experts (20,361)","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","56022.89",null,"0","0","0","0","56022.89","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyZ/view","2020-12-31","HIV/AIDS",56022.89," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713=AN253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713=AO253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713=AP253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713=AJ253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713=AN253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713=AO253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713=AP253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyaUAG","PAI-3790","Active","BEN-HIV/AIDS-52","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","The study to evaluate the legal setting for key populations aims to provide data to better target interventions for them.","The study to evaluate the legal setting for key populations aims to provide data to better target interventions for them.",null,"Medium","12532.82",null,"0","0","0","0","12532.82","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIya/view","2020-12-31","HIV/AIDS",12532.82," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713=AN254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713=AO254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713=AP254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713=AJ254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713=AN254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713=AO254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713=AP254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIybUAG","PAI-3791","Active","BEN-HIV/AIDS-53","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","With regard to women and girls in Benin, according to the national gender promotion policy that has been developed, socioeconomic factors in the country tend to confer inferior status to women compared with men, particularly in the areas of education, employment, health and access to land and finance. Stereotypes and gender roles increase the vulnerability of women and girls to HIV and AIDS and restrict their access to existing information and services. The submission of women and girls demanded by tradition makes them subject to certain types of violence: levirate, early or forced marriage, sexual violence, sexual relations with older partners, etc. In addition, the imbalance of power makes women less able to negotiate the use of condoms or to choose their sexual partner.Education sessions on gender-based violence and training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence are aimed at reducing HIV prevalence within this group. The sessions will address gender discrimination, harmful gender norms and all types of violence against women and girls in relation to HIV.In detail, this intervention comprises the following activities:-Training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence (six sessions with 25 participants each, lasting two days) (20,754)-Educational sessions on HIV, health education, sexual and reproductive health and rights, new forms of masculinity and the prevention of gender-based violence for Plan International Benin staff members (session with one coffee break for 30 people per month and for five teams) (1,372)-Recruitment of a consultant to undertake an evaluation study of the legal setting for key populations (13,500)","With regard to women and girls in Benin, according to the national gender promotion policy that has been developed, socioeconomic factors in the country tend to confer inferior status to women compared with men, particularly in the areas of education, employment, health and access to land and finance. Stereotypes and gender roles increase the vulnerability of women and girls to HIV and AIDS and restrict their access to existing information and services. The submission of women and girls demanded by tradition makes them subject to certain types of violence: levirate, early or forced marriage, sexual violence, sexual relations with older partners, etc. In addition, the imbalance of power makes women less able to negotiate the use of condoms or to choose their sexual partner.Education sessions on gender-based violence and training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence are aimed at reducing HIV prevalence within this group. The sessions will address gender discrimination, harmful gender norms and all types of violence against women and girls in relation to HIV.In detail, this intervention comprises the following activities:-Training for facilitators from NGOs involved in medical care for women and girls who have been victims of sexual violence (six sessions with 25 participants each, lasting two days) (20,754)-Educational sessions on HIV, health education, sexual and reproductive health and rights, new forms of masculinity and the prevention of gender-based violence for Plan International Benin staff members (session with one coffee break for 30 people per month and for five teams) (1,372)-Recruitment of a consultant to undertake an evaluation study of the legal setting for key populations (13,500)",null,"Medium","39980.92",null,"0","0","0","0","39980.92","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyb/view","2020-12-31","HIV/AIDS",39980.92," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713=AN255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713=AO255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713=AP255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713=AJ255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713=AN255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713=AO255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713=AP255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G255)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIycUAG","PAI-3792","Active","BEN-HIV/AIDS-54","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Program management","Grant management","Organize a six-monthly, ten-day mission to validate the financial documents and accounts of NGOs and the six CIPEC from the previous six-month period (two teams of four people: one manager, one accountant, one fiduciary management agency and drivers):This activity aims to improve the quality of accounts and prevent ineligible amounts.","Organize a six-monthly, ten-day mission to validate the financial documents and accounts of NGOs and the six CIPEC from the previous six-month period (two teams of four people: one manager, one accountant, one fiduciary management agency and drivers):This activity aims to improve the quality of accounts and prevent ineligible amounts.",null,"Low","27971.05","This is not instrumental in delivery of other activities therefore; it is a low priority rating.","0","0","0","0","27971.05","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyc/view","2020-12-31","HIV/AIDS",27971.05," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713=AN256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713=AO256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713=AP256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713=AJ256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713=AN256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713=AO256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713=AP256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G256)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIydUAG","PAI-3793","Active","BEN-HIV/AIDS-55","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Program management","Grant management","Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):This will motivate actors at the peripheral level.","Pay a performance-related bonus to Departmental Health Directorates (12), Global Fund sub-recipients (12) and CIPEC managers (6) (50,000 CFA francs per person per month):This will motivate actors at the peripheral level.",null,"Low","92382.45","This is not instrumental in delivery of other activities therefore it is a low priority rating","0","0","0","0","92382.45","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyd/view","2020-12-31","HIV/AIDS",92382.45," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713=AN257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713=AO257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713=AP257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713=AJ257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713=AN257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713=AO257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713=AP257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G257)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyeUAG","PAI-3794","Active","BEN-HIV/AIDS-56","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Other external services. This intervention comprises two activities that were not budgeted for in the last three quarters of the final year (2020):-The provision of a driver to the Executive Secretariat of the National AIDS Committee so that it may implement and monitor activities on the ground (management of the National AIDS, Tuberculosis, Malaria, STIs and Epidemics Committee driver) (2,744)-Support for the costs of a monitoring and evaluation intern (60,000 CFA francs per month for three years) to promote learning among adolescents and young people (823)","Other external services. This intervention comprises two activities that were not budgeted for in the last three quarters of the final year (2020):-The provision of a driver to the Executive Secretariat of the National AIDS Committee so that it may implement and monitor activities on the ground (management of the National AIDS, Tuberculosis, Malaria, STIs and Epidemics Committee driver) (2,744)-Support for the costs of a monitoring and evaluation intern (60,000 CFA francs per month for three years) to promote learning among adolescents and young people (823)",null,"Low","4002.92","TRP does not consider the hiring of a driver and M&E intern to promote for adolescent programming to be  a high priority","0","0","0","0","4002.92","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIye/view","2020-12-31","HIV/AIDS",4002.92," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713=AN258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713=AO258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713=AP258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713=AJ258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713=AN258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713=AO258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713=AP258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyfUAG","PAI-3795","Active","BEN-HIV/AIDS-57","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Draw up an annual list of suppliers: This activity allows for the preselection of providers and facilitates the implementation of activities.","Draw up an annual list of suppliers: This activity allows for the preselection of providers and facilitates the implementation of activities.",null,"Low","8418.81",null,"0","0","0","0","8418.81","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyf/view","2020-12-31",{"$f":"IF(OR(I259=\"HIV/AIDS\",I259=\"Tuberculosis\",I259=\"Malaria\",I259=\"RSSH\"),I259, IF(I259=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"HIV/AIDS"},{"$f":"VALUE(Y259)","v":8418.81},{"$f":"RIGHT(F259,LEN(F259)-2)","v":" Central Africa"},"HIV/AIDS","HIV/AIDS",null,null,null,{"$f":"TRIM(AK259)","v":""},{"$f":"TRIM(AL259)","v":""},{"$f":"TRIM(AM259)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713=AN259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713=AO259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713=AP259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},{"$f":"IF(AE259<>\"\",AE259,IF(MAX(AQ259,AR259,AS259,AT259)<>0,MAX(AQ259,AR259,AS259,AT259),AU259))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713=AJ259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713=AN259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713=AO259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713=AP259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G259)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},{"$f":"IF(AE259<>\"\",AE259,IF(MAX(AW259,AX259,AY259,AZ259)<>0,MAX(AW259,AX259,AY259,AZ259),BA259))","v":"2020-12-31"}]
["a6Q1R000000AIygUAG","PAI-3796","Active","BEN-HIV/AIDS-58","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Exchange and working visit with the sex workers network of Cte dIvoire","Exchange and working visit with the sex workers network of Cte dIvoire","NA Original Intervention: Other interventions for sex workers and their clients","Low","16821.91",null,"0","0","0","0","16821.91","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyg/view","2020-12-31","HIV/AIDS",16821.91," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713=AN260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713=AO260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713=AP260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713=AJ260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713=AN260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713=AO260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713=AP260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyhUAG","PAI-3797","Active","BEN-HIV/AIDS-59","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Monitor the care provided at each facility on a quarterly basis: One medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.","Monitor the care provided at each facility on a quarterly basis: One medical specialist, one maternity specialist, one pediatric specialist, one vaccination specialist, two health mediation specialists, one administrative employee, over three days at 150 care facilities. In each care facility on a quarterly basis, the active file will be updated, files reviewed and an analysis of patients carried out, including those receiving ART, those lost to follow-up, the deceased, those who have been transferred, children born to HIV-positive mothers and patients with early diagnoses, in order to provide more reliable data and to improve the care continuum.","NA Original Intervention: Other interventions for treatment","Low","243274.6",null,"0","0","0","0","243274.6","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyh/view","2020-12-31","HIV/AIDS",243274.6," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713=AN261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713=AO261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713=AP261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713=AJ261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713=AN261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713=AO261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713=AP261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G261)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyiUAG","PAI-3798","Active","BEN-HIV/AIDS-6","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Health management information systems and M&E","Surveys","HIV surveillance survey among pregnant women: this is an important activity for epidemiological surveillance and also for SPECTRUM projections. This activity has been undertaken for more than 20 years.","HIV surveillance survey among pregnant women: this is an important activity for epidemiological surveillance and also for SPECTRUM projections. This activity has been undertaken for more than 20 years.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","63712.27",null,"0","0","0","0","63712.27","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyi/view","2020-12-31","HIV/AIDS",63712.27," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713=AN262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713=AO262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713=AP262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713=AJ262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713=AN262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713=AO262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713=AP262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G262)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyjUAG","PAI-3799","Active","BEN-HIV/AIDS-60","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Procure 125 desktop computers and printers for care facilities:The availability of IT equipment will improve the follow-up of the active file and medical files  monitoring software (ESOPE) and dispensing software (Mdistock).","Procure 125 desktop computers and printers for care facilities:The availability of IT equipment will improve the follow-up of the active file and medical files  monitoring software (ESOPE) and dispensing software (Mdistock).","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Low","171079.56",null,"0","0","0","0","171079.56","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyj/view","2020-12-31","HIV/AIDS",171079.56," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713=AN263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713=AO263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713=AP263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713=AJ263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713=AN263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713=AO263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713=AP263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIykUAG","PAI-3800","Active","BEN-HIV/AIDS-61","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Procure 100 extra cupboards for care facilities that have not yet been equipped:(610 per cupboard)During the first part of the grant, 43 cupboards with shelves were procured for care facilities to improve storage conditions for ARVs. The intention is to procure more for the remaining facilities and for the new facilities that will be set up.","Procure 100 extra cupboards for care facilities that have not yet been equipped:(610 per cupboard)During the first part of the grant, 43 cupboards with shelves were procured for care facilities to improve storage conditions for ARVs. The intention is to procure more for the remaining facilities and for the new facilities that will be set up.","NA Original Intervention: Other interventions for treatment","Low","68431.15",null,"0","0","0","0","68431.15","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyk/view","2020-12-31","HIV/AIDS",68431.149999999994," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713=AN264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713=AO264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713=AP264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713=AJ264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713=AN264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713=AO264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713=AP264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIylUAG","PAI-3801","Active","BEN-HIV/AIDS-62","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Give each care facility a means of communicating so that they may offer differentiated services (to communicate results, make appointments and undertake follow-up) (One smartphone per facility costing 100,000 CFA francs each, for 150 facilities) In December 2016, Benin adopted the test and treat approach and anticipates a substantial increase to the active file, placing increased pressure on the health system. To prepare for this, the country changed the schedule for dispensing ARVs to every three months, and every six months for medical consultations. To ensure the quality of care while empowering patients, the country plans to establish a system for communication between health workers and patients to deliver results, make appointments and undertake remote follow-up.","Give each care facility a means of communicating so that they may offer differentiated services (to communicate results, make appointments and undertake follow-up) (One smartphone per facility costing 100,000 CFA francs each, for 150 facilities) In December 2016, Benin adopted the test and treat approach and anticipates a substantial increase to the active file, placing increased pressure on the health system. To prepare for this, the country changed the schedule for dispensing ARVs to every three months, and every six months for medical consultations. To ensure the quality of care while empowering patients, the country plans to establish a system for communication between health workers and patients to deliver results, make appointments and undertake remote follow-up.","NA Original Intervention: Other interventions for treatment","Low","25650.32",null,"0","0","0","0","25650.32","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyl/view","2020-12-31","HIV/AIDS",25650.32," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713=AN265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713=AO265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713=AP265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713=AJ265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713=AN265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713=AO265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713=AP265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIymUAG","PAI-3802","Active","BEN-HIV/AIDS-63","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Coaching and mentoring on ART in civilian prisons by neighboring care facilities(10 days: one experienced prescriber, one CIPEC, one SPECS and a driver).HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. Given the lack of experience of these nurses and the noted organizational difficulties, coaching and mentorship should be organized to improve care quality. This will be undertaken by an experienced prescriber, along with a departmental and national supervisor.","Coaching and mentoring on ART in civilian prisons by neighboring care facilities(10 days: one experienced prescriber, one CIPEC, one SPECS and a driver).HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. Given the lack of experience of these nurses and the noted organizational difficulties, coaching and mentorship should be organized to improve care quality. This will be undertaken by an experienced prescriber, along with a departmental and national supervisor.","NA Original Intervention: Other interventions for treatment","Low","12325.22",null,"0","0","0","0","12325.22","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIym/view","2020-12-31","HIV/AIDS",12325.22," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713=AN266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713=AO266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713=AP266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713=AJ266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713=AN266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713=AO266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713=AP266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIynUAG","PAI-3803","Active","BEN-HIV/AIDS-64","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Six-monthly supervision and monitoring of care in prisons(one NACP representative plus driver, one CIPEC, one prescriber from a neighboring facility, registered prison nurse)HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. The intention is now to scale this up and involve all ten prisons. Regular supervision and monitoring is therefore vital in the initial years to ensure that the care is given properly.","Six-monthly supervision and monitoring of care in prisons(one NACP representative plus driver, one CIPEC, one prescriber from a neighboring facility, registered prison nurse)HIV care in prisons began in three prisons in the south of the country (Calavi, Cotonou and Ouidah), with the training of prison nurses. The intention is now to scale this up and involve all ten prisons. Regular supervision and monitoring is therefore vital in the initial years to ensure that the care is given properly.","NA Original Intervention: Other interventions for treatment","Low","8725.17",null,"0","0","0","0","8725.17","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyn/view","2020-12-31","HIV/AIDS",8725.17," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713=AN267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713=AO267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713=AP267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713=AJ267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713=AN267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713=AO267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713=AP267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G267)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyoUAG","PAI-3804","Active","BEN-HIV/AIDS-65","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Organize an advocacy meeting on the community care strategy: With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system. It is important to involve all actors in defining the basis for community involvement.","Organize an advocacy meeting on the community care strategy: With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system. It is important to involve all actors in defining the basis for community involvement.","NA Original Intervention: Other interventions for treatment","Low","11883.07",null,"0","0","0","0","11883.07","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyo/view","2020-12-31","HIV/AIDS",11883.07," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713=AN268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713=AO268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713=AP268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713=AJ268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713=AN268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713=AO268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713=AP268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G268)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIypUAG","PAI-3805","Active","BEN-HIV/AIDS-66","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Mobilize therapeutic assistants via two DAT consultants to draw up the community care strategy. With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.","Mobilize therapeutic assistants via two DAT consultants to draw up the community care strategy. With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Other other community responses and systems intervention(s)","Low","19052.86",null,"0","0","0","0","19052.86","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyp/view","2020-12-31","HIV/AIDS",19052.86," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713=AN269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713=AO269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713=AP269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713=AJ269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713=AN269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713=AO269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713=AP269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyqUAG","PAI-3806","Active","BEN-HIV/AIDS-67","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Organize a meeting to validate the community care strategy:(45 participants)With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.","Organize a meeting to validate the community care strategy:(45 participants)With the adoption of the test and treat strategy, a significant active file is anticipated, which will place pressure on the health system.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Other other community responses and systems intervention(s)","Low","11883.07",null,"0","0","0","0","11883.07","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyq/view","2020-12-31","HIV/AIDS",11883.07," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713=AN270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713=AO270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713=AP270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713=AJ270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713=AN270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713=AO270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713=AP270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G270)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyrUAG","PAI-3807","Active","BEN-HIV/AIDS-68","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Procure tablets to record the biometric data of PLHIV (to avoid duplication and ensure the procurement of biological services is well documented) and contract Internet services for facilities","Procure tablets to record the biometric data of PLHIV (to avoid duplication and ensure the procurement of biological services is well documented) and contract Internet services for facilities","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","360415.22",null,"0","0","0","0","360415.22","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyr/view","2020-12-31","HIV/AIDS",360415.22," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713=AN271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713=AO271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713=AP271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713=AJ271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713=AN271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713=AO271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713=AP271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIysUAG","PAI-3808","Active","BEN-HIV/AIDS-69","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Update the PLHIV biometric database periodically","Update the PLHIV biometric database periodically","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","17963.19",null,"0","0","0","0","17963.19","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIys/view","2020-12-31","HIV/AIDS",17963.189999999999," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713=AN272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713=AO272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713=AP272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713=AJ272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713=AN272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713=AO272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713=AP272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G272)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIytUAG","PAI-3809","Active","BEN-HIV/AIDS-7","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"PMTCT","Other intervention(s) for PMTCT","Undertake mentoring on PMTCT/IMPC and early diagnosis through dried blood spots.","Undertake mentoring on PMTCT/IMPC and early diagnosis through dried blood spots.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","High","26971.16",null,"0","0","0","0","26971.16","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyt/view","2020-12-31","HIV/AIDS",26971.16," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713=AN273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713=AO273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713=AP273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713=AJ273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713=AN273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713=AO273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713=AP273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G273)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyuUAG","PAI-3810","Active","BEN-HIV/AIDS-70","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"RSSH: Health management information systems and M&E","Administrative and finance data sources","The financial monitoring of sub-sub-recipients will ensure that the resources allocated to them are managed correctly. This intervention entails the on-site monitoring of financial management at the sub-sub-recipient level, at a cost of 2,881.29.","The financial monitoring of sub-sub-recipients will ensure that the resources allocated to them are managed correctly. This intervention entails the on-site monitoring of financial management at the sub-sub-recipient level, at a cost of 2,881.29.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Administrative and financial data sources","Low","3233.08",null,"0","0","0","0","3233.08","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyu/view","2020-12-31","HIV/AIDS",3233.08," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713=AN274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713=AO274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713=AP274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713=AJ274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713=AN274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713=AO274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713=AP274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyvUAG","PAI-3811","Active","BEN-HIV/AIDS-8","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Train medical and paramedical staff in treatment for sexually transmitted infections (STIs) and disseminate the algorithm.","Train medical and paramedical staff in treatment for sexually transmitted infections (STIs) and disseminate the algorithm.","NA Original Intervention: Other interventions for sex workers and their clients","High","282796.54",null,"0","0","0","0","282796.54","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyv/view","2020-12-31","HIV/AIDS",282796.53999999998," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713=AN275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713=AO275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713=AP275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713=AJ275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713=AN275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713=AO275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713=AP275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G275)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIywUAG","PAI-3812","Active","BEN-HIV/AIDS-9","2017-2019","RT Central Africa","Benin","HIV/AIDS","HIV/AIDS","FR520-BEN-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Provide monthly remuneration for facilitators and peer educators from NGOs working with sex workers: planned for year 3. Remuneration for actors on the ground working with key populations.","Provide monthly remuneration for facilitators and peer educators from NGOs working with sex workers: planned for year 3. Remuneration for actors on the ground working with key populations.","NA Original Intervention: Other interventions for sex workers and their clients","High","197597.35",null,"0","0","0","0","197597.35","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyw/view","2020-12-31","HIV/AIDS",197597.35," Central Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713=AN276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713=AO276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713=AP276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713=AJ276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713=AN276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713=AO276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713=AP276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyxUAG","PAI-3813","Inactive","BEN-Malaria-1","2017-2019","RT Central Africa","Benin","Malaria","Malaria","FR410-BEN-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The gap of 315 000 LLIN has been filled","The gap of 315 000 LLIN has been filled","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","1739000.11",null,"1739000.11","0","0","0","0","1","0","2020-01-14 12:22:15","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyx/view","2020-12-31","Malaria",0," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713=AN277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713=AO277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713=AP277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713=AJ277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713=AN277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713=AO277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713=AP277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyyUAG","PAI-3814","Active","BEN-Malaria-2","2017-2019","RT Central Africa","Benin","Malaria","Malaria","FR410-BEN-M",null,null,"Case management","Private sector case management","Given the contribution of the private sector (20.7%) in the attendance of health services (SNIGS 2015), it is proposed to continue activities started in the 2016-2017 grant and the partnership between the PNLP and the Private Sector Platform (PSB). This will improve the quality of malaria management through training / supervision of stakeholders, dissemination of care / prevention protocols, reporting of data, provision of subsidized inputs.","Given the contribution of the private sector (20.7%) in the attendance of health services (SNIGS 2015), it is proposed to continue activities started in the 2016-2017 grant and the partnership between the PNLP and the Private Sector Platform (PSB). This will improve the quality of malaria management through training / supervision of stakeholders, dissemination of care / prevention protocols, reporting of data, provision of subsidized inputs.",null,"High","801942.54",null,"0","0","0","0","801942.54","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyy/view","2020-12-31","Malaria",801942.54," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713=AN278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713=AO278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713=AP278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713=AJ278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713=AN278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713=AO278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713=AP278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G278)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIyzUAG","PAI-3815","Active","BEN-Malaria-3","2017-2019","RT Central Africa","Benin","Malaria","Malaria","FR410-BEN-M",null,null,"Case management","Removing human rights and gender related barriers to case management","Specific new actions will enable approximately 7,000 persons deprived of liberty to access quality treatment services and thus guarantee their right to health.These actions are: i) Training / supervision of prison medical staff; ii) Provision of treatment; iii) Provision of prison health centers in Inputs Malaria control for the free care; and iiii) Consultative meetings with the concerned ministries for a good coordination of activities","Specific new actions will enable approximately 7,000 persons deprived of liberty to access quality treatment services and thus guarantee their right to health.These actions are: i) Training / supervision of prison medical staff; ii) Provision of treatment; iii) Provision of prison health centers in Inputs Malaria control for the free care; and iiii) Consultative meetings with the concerned ministries for a good coordination of activities","NA Original Intervention: Removing human rights- and gender-related barriers to case management","High","48261.7",null,"0","0","0","0","48261.7","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIyz/view","2020-12-31","Malaria",48261.7," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713=AN279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713=AO279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713=AP279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713=AJ279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713=AN279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713=AO279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713=AP279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G279)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIz0UAG","PAI-3816","Active","BEN-Malaria-4","2017-2019","RT Central Africa","Benin","Malaria","Malaria","FR410-BEN-M",null,null,"RSSH: Health management information systems and M&E","Surveys","To be effective in vector control, it is necessary to carry out vector susceptibility tests to determine the status of the vector against insecticides available on the international market. This study is conducted as a prelude to IDP campaigns to select the appropriate insecticide. The latest study conducted in 2017 noted that pyrimiphos methyl remains the sensitive insecticide from which it was chosen during the 2017 IRS campaign","To be effective in vector control, it is necessary to carry out vector susceptibility tests to determine the status of the vector against insecticides available on the international market. This study is conducted as a prelude to IDP campaigns to select the appropriate insecticide. The latest study conducted in 2017 noted that pyrimiphos methyl remains the sensitive insecticide from which it was chosen during the 2017 IRS campaign","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","110260.35","TRP considers that the monitoring of insecticide resistance and efficacy testing of vector control products (nets and insecticides) should be considered high priority as up-to-date insecticide resistance data will guide appropriate choice of efficacious vector control interventions.","0","0","0","0","110260.35","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz0/view","2020-12-31","Malaria",110260.35," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713=AN280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713=AO280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713=AP280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713=AJ280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713=AN280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713=AO280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713=AP280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G280)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIz1UAG","PAI-3817","Active","BEN-Malaria-5","2017-2019","RT Central Africa","Benin","Malaria","Malaria","FR410-BEN-M",null,null,"RSSH: Health management information systems and M&E","Surveys","Mandatory test that follows mass distribution campaigns and provides information on the effectiveness of distributed LLINs, it also guides the choice of LLINs for subsequent campaigns, and the next one is for 2020. It is therefore necessary that this monitoring be carried out as recommended by the international scientific committee. The NMCP must therefore carry out these studies in 2019 and 2020.","Mandatory test that follows mass distribution campaigns and provides information on the effectiveness of distributed LLINs, it also guides the choice of LLINs for subsequent campaigns, and the next one is for 2020. It is therefore necessary that this monitoring be carried out as recommended by the international scientific committee. The NMCP must therefore carry out these studies in 2019 and 2020.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","68432.27",null,"0","0","0","0","68432.27","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz1/view","2020-12-31","Malaria",68432.27," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713=AN281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713=AO281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713=AP281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713=AJ281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713=AN281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713=AO281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713=AP281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIz2UAG","PAI-3818","Active","BEN-Malaria-6","2017-2019","RT Central Africa","Benin","Malaria","Malaria","FR410-BEN-M",null,null,"Vector control","Indoor residual spraying (IRS)","The NMCP proposes to implement the extension of the IRS to other communes eligible for a pre-elimination of malaria in the medium and long term. The area of Dassa Glazou in the hills department is chosen for funding beyond.This choice is mainly based on scientific evidence in terms of short transmission period and the abundance of vectors and their infectivity in this area.","The NMCP proposes to implement the extension of the IRS to other communes eligible for a pre-elimination of malaria in the medium and long term. The area of Dassa Glazou in the hills department is chosen for funding beyond.This choice is mainly based on scientific evidence in terms of short transmission period and the abundance of vectors and their infectivity in this area.","NA Original Intervention: Indoor residual spraying","Low","5023248.79","Taking into account limited information available, the TRP considers these interventions as low priority. The rationale of IRS prioritization (use and its expansion) is not well substantiated in the current transmission context and funding constraints.","0","0","0","0","5023248.79","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz2/view","2020-12-31","Malaria",5023248.79," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713=AN282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713=AO282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713=AP282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713=AJ282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713=AN282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713=AO282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713=AP282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIz3UAG","PAI-3819","Active","BEN-Malaria-7","2017-2019","RT Central Africa","Benin","Malaria","Malaria","FR410-BEN-M",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","The last program's performance review in 2016 noted that indicators related to the annual incidence of malaria and lethality have evolved positively. However, it was noted the weak involvement of the private sector in the fight against malaria, the failure to comply with the guidelines for the management of malaria cases despite the availability ILPs and weaknesses related to the use of DHIS2 software. The next review is scheduled for 2019.","The last program's performance review in 2016 noted that indicators related to the annual incidence of malaria and lethality have evolved positively. However, it was noted the weak involvement of the private sector in the fight against malaria, the failure to comply with the guidelines for the management of malaria cases despite the availability ILPs and weaknesses related to the use of DHIS2 software. The next review is scheduled for 2019.","NA Original Module: RSSH: Health management information system and monitoring and evaluation","Low","68946.25","Based on the rationale provided by the applicant, the TRP considers that issues and problems related to programme are known. The priority should be given for the implementation of the recommendations of the last MPR.","0","0","0","0","68946.25","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz3/view","2020-12-31","Malaria",68946.25," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713=AN283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713=AO283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713=AP283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713=AJ283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713=AN283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713=AO283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713=AP283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G283)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIz4UAG","PAI-3820","Active","BEN-Malaria-8","2017-2019","RT Central Africa","Benin","Malaria","Malaria","FR410-BEN-M",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","In order to achieve the objectives assigned to it, to improve its performance in terms of financial management, administrative and to be up to standard, the NMCP plans to upgrade its staff.The different training courses proposed in this funding match the needs according to the profile of the agents available for the implementation of the program's activities.","In order to achieve the objectives assigned to it, to improve its performance in terms of financial management, administrative and to be up to standard, the NMCP plans to upgrade its staff.The different training courses proposed in this funding match the needs according to the profile of the agents available for the implementation of the program's activities.",null,"Low","196762.43","The TRP is concerned about the capacity. It is not clear if it is part of comprehensive package or just training and what are the projected targets.","0","0","0","0","196762.43","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz4/view","2020-12-31","Malaria",196762.43," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713=AN284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713=AO284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713=AP284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713=AJ284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713=AN284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713=AO284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713=AP284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G284)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIz5UAG","PAI-3821","Active","BEN-RSSH-1","2017-2019","RT Central Africa","Benin","RSSH","RSSH","FR352-BEN-S-01",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Strategy for community health workers can be expanded, through the use of community data applications. Procurement of 3,312 smartphones and accessories, and training of 3,312 community health workers already active in partner programs.","Strategy for community health workers can be expanded, through the use of community data applications. Procurement of 3,312 smartphones and accessories, and training of 3,312 community health workers already active in partner programs.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","2180230.05",null,"0","0","0","0","2180230.05","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz5/view","2022-06-30","RSSH",2180230.0499999998," Central Africa","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713=AN285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713=AO285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713=AP285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713=AJ285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713=AN285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713=AO285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713=AP285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G285)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AIz6UAG","PAI-3822","Active","BEN-RSSH-2","2017-2019","RT Central Africa","Benin","RSSH","RSSH","FR352-BEN-S-01",null,null,"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","The additional investment will make it possible to cover 65 percent of needs (from 47% with only allocation and matching funds): recruitment, training, incentivization, equipment, provision of tools, and monitoring of 4,147 community health workers implementing the complete package of interventions.","The additional investment will make it possible to cover 65 percent of needs (from 47% with only allocation and matching funds): recruitment, training, incentivization, equipment, provision of tools, and monitoring of 4,147 community health workers implementing the complete package of interventions.","NA Original Module: RSSH - Human resources for health, including community health workers","High","2569275.05",null,"0","0","0","0","2569275.05","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz6/view","2022-06-30","RSSH",2569275.0499999998," Central Africa","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713=AN286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713=AO286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713=AP286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713=AJ286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713=AN286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713=AO286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713=AP286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AIz7UAG","PAI-3823","Active","BEN-RSSH-3","2017-2019","RT Central Africa","Benin","RSSH","RSSH","FR352-BEN-S-01",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","10 percent of health care facilities are renovated and fitted out, based on the assessment outcomes, in order to improve drug quality at the local level.","10 percent of health care facilities are renovated and fitted out, based on the assessment outcomes, in order to improve drug quality at the local level.","NA Original Module: RSSH - Procurement and supply chain management systems","High","1112017.73",null,"0","0","0","0","1112017.73","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz7/view","2022-06-30","RSSH",1112017.73," Central Africa","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713=AN287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713=AO287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713=AP287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713=AJ287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713=AN287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713=AO287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713=AP287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AIz8UAG","PAI-3824","Active","BEN-Tuberculosis-1","2017-2019","RT Central Africa","Benin","Tuberculosis","Tuberculosis","FR300-BEN-T",null,null,"TB care and prevention","Treatment","Objective : To reduce the fatality rate of TB patients who have any other associated comorbidities (HIV, Diabetes, Anaemia, Viral hepatitis B and C). The mortality rate is 14% among TB/HIV co-infected patients vs 6% for all patients. A well-equipped technical block will be established at the main hospital in Cotonou, treatment protocols will be created and disseminated in all treatment centers. As part of the quality assurance policy, a portable spectroscope and a highperformance liquid chromatograph will be procured to ensure more regular monitoring of the quality of anti-tuberculosis medication.","Objective : To reduce the fatality rate of TB patients who have any other associated comorbidities (HIV, Diabetes, Anaemia, Viral hepatitis B and C). The mortality rate is 14% among TB/HIV co-infected patients vs 6% for all patients. A well-equipped technical block will be established at the main hospital in Cotonou, treatment protocols will be created and disseminated in all treatment centers. As part of the quality assurance policy, a portable spectroscope and a highperformance liquid chromatograph will be procured to ensure more regular monitoring of the quality of anti-tuberculosis medication.",null,"High","342159.13","Establishing of a technical block for the integrated care of TB and other co-morbidities will allow better management of severe TB patients and reduce mortality among coinfected patients","0","0","0","0","342159.13","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz8/view","2020-12-31","Tuberculosis",342159.13," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713=AN288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713=AO288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713=AP288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713=AJ288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713=AN288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713=AO288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713=AP288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G288)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIz9UAG","PAI-3825","Active","BEN-Tuberculosis-2","2017-2019","RT Central Africa","Benin","Tuberculosis","Tuberculosis","FR300-BEN-T",null,null,"TB care and prevention","Case detection and diagnosis","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",null,"High","1223560.77","Expansion of TB diagnostic capacity is needed to enhance case finding. This intervention will allow procurement of 50 new GeneXpert machines and scale-up its use at peripheral level.","0","0","0","0","1223560.77","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIz9/view","2020-12-31","Tuberculosis",1223560.77," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713=AN289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713=AO289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713=AP289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713=AJ289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713=AN289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713=AO289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713=AP289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G289)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIzAUAW","PAI-3826","Active","BEN-Tuberculosis-3","2017-2019","RT Central Africa","Benin","Tuberculosis","Tuberculosis","FR300-BEN-T",null,null,"TB care and prevention","Case detection and diagnosis","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",null,"High","1831875.21","Acquiring GeneXpert consumables for the additional GeneXpert machines procured.","0","0","0","0","1831875.21","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzA/view","2020-12-31","Tuberculosis",1831875.21," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713=AN290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713=AO290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713=AP290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713=AJ290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713=AN290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713=AO290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713=AP290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G290)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIzBUAW","PAI-3827","Active","BEN-Tuberculosis-4","2017-2019","RT Central Africa","Benin","Tuberculosis","Tuberculosis","FR300-BEN-T",null,null,"TB care and prevention","Case detection and diagnosis","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",null,"High","290834.92","Reconditioning of 6 Centers for diagnosis and treatment (CDT) laboratories will contribute to the enhancement of laboratory diagnostic capacity","0","0","0","0","290834.92","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzB/view","2020-12-31","Tuberculosis",290834.92," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713=AN291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713=AO291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713=AP291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713=AJ291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713=AN291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713=AO291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713=AP291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIzCUAW","PAI-3828","Active","BEN-Tuberculosis-5","2017-2019","RT Central Africa","Benin","Tuberculosis","Tuberculosis","FR300-BEN-T",null,null,"TB care and prevention","Case detection and diagnosis","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",null,"High","85540.34","Introduction of digital chest X-ray (CXR) at the Center for Health Protection (CHPP) Akron will enhance diagnostic capacity of childhood TB, extrapulmonary TB, and other diseases.","0","0","0","0","85540.34","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzC/view","2020-12-31","Tuberculosis",85540.34," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713=AN292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713=AO292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713=AP292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713=AJ292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713=AN292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713=AO292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713=AP292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIzDUAW","PAI-3829","Active","BEN-Tuberculosis-6","2017-2019","RT Central Africa","Benin","Tuberculosis","Tuberculosis","FR300-BEN-T",null,null,"TB care and prevention","Case detection and diagnosis","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.","Objective: to upscale new diagnostic technique to improve the results of examinations. Currently, Benin has 9 GeneXpert devices. The acquisition of 50 new devices is planned (45 of which will be located in the laboratories with a heavy workload). The acquisition of GeneXpert consumables is also provided for in this above-allocation request.",null,"High","102647.29","Procurement of 1 portable digital CXR for TB testing will allow for intensified case finding among key population.","0","0","0","0","102647.29","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzD/view","2020-12-31","Tuberculosis",102647.29," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713=AN293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713=AO293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713=AP293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713=AJ293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713=AN293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713=AO293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713=AP293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G293)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIzEUAW","PAI-3830","Active","BEN-Tuberculosis-7","2017-2019","RT Central Africa","Benin","Tuberculosis","Tuberculosis","FR300-BEN-T",null,null,"RSSH: Health management information systems and M&E","Surveys","Objective: to conduct an evaluation of the catastrophic costs borne by the patients and their households, for the introduction of appropriate measures (WHO protocol: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/ meetings/tf6_background_5a_patient_cost_surveys_protocol.pdf).","Objective: to conduct an evaluation of the catastrophic costs borne by the patients and their households, for the introduction of appropriate measures (WHO protocol: http://www.who.int/tb/advisory_bodies/impact_measurement_taskforce/ meetings/tf6_background_5a_patient_cost_surveys_protocol.pdf).","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","61537.43","Survey on evaluation of catastrophic costs borne by TB patients and their households can inform on how to address the financial barriers to care.","0","0","0","0","61537.43","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzE/view","2020-12-31","Tuberculosis",61537.43," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713=AN294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713=AO294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713=AP294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713=AJ294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713=AN294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713=AO294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713=AP294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G294)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIzFUAW","PAI-3831","Active","BEN-Tuberculosis-8","2017-2019","RT Central Africa","Benin","Tuberculosis","Tuberculosis","FR300-BEN-T",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","Objective: to conduct research work on the mathematic modelling of the transmission of tuberculosis in Benin, to obtain a better estimate of the number of cases of tuberculosis in the population, in partnership with the University of Liverpool and the National University Hospital Centre for Pneumo-Phthisiology in Cotonou.","Objective: to conduct research work on the mathematic modelling of the transmission of tuberculosis in Benin, to obtain a better estimate of the number of cases of tuberculosis in the population, in partnership with the University of Liverpool and the National University Hospital Centre for Pneumo-Phthisiology in Cotonou.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","67332.51","Mathematic modelling of the transmission of TB in the country for assessment of the impact of the program, although sound, is not considered as high priority in the described context","0","0","0","0","67332.51","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzF/view","2020-12-31","Tuberculosis",67332.509999999995," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713=AN295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713=AO295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713=AP295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713=AJ295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713=AN295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713=AO295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713=AP295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G295)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AIzGUAW","PAI-3832","Active","BFA-HIV/AIDS-1","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Equip infirmaries in 7 detention centers. 14 have been already equipped with Rd 10 and NFM.","Equip infirmaries in 7 detention centers. 14 have been already equipped with Rd 10 and NFM.","NA Original Intervention: Other interventions for people in prisons and other closed settings","High","51503.76","It addresses concerns raised by the TRP related to prioritization of key populations and provide additional detail for differentiated strategies for key populations and may address the sharp decrease in coverage targets for prisoners observed in recent years.","0","0","0","0","51503.76","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzG/view","2020-12-31","HIV/AIDS",51503.76," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713=AN296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713=AO296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713=AP296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713=AJ296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713=AN296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713=AO296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713=AP296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzHUAW","PAI-3833","Active","BFA-HIV/AIDS-10","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"Treatment, care and support","Treatment monitoring - Viral load","Procure part of the reagents for biological follow up to provide free access to ARV patients in need (50%b of people in treatment).","Procure part of the reagents for biological follow up to provide free access to ARV patients in need (50%b of people in treatment).","NA Original Intervention: Treatment monitoring  Viral load","High","1529674.56","This activity seeks to ensure free non-specific biological monitoring examinations for 50% of the people living with HIV undergoing antiretroviral (ARV) to the poorest patients. This has the potential to support HIV monitoring and potential to influence treatment retention, thus considered a high priority. It should include all facilities where PLHIV are monitored, not only maternities","0","0","0","0","1529674.56","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzH/view","2020-12-31","HIV/AIDS",1529674.56," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713=AN297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713=AO297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713=AP297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713=AJ297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713=AN297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713=AO297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713=AP297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzIUAW","PAI-3834","Active","BFA-HIV/AIDS-11","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Equipment 36 non-governmental testing sites (including the 13 rehabilitated) with client oriented equipment.","Equipment 36 non-governmental testing sites (including the 13 rehabilitated) with client oriented equipment.","NA Original Module: RSSH - Community responses and systems","High","218639.88","This will help equip additional 36 HIV screening services with clientoriented equipment. Facility-based HIV screening has the potential to help achieve the first 90.","0","0","0","0","218639.88","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzI/view","2020-12-31","HIV/AIDS",218639.88," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713=AN298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713=AO298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713=AP298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713=AJ298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713=AN298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713=AO298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713=AP298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzJUAW","PAI-3835","Active","BFA-HIV/AIDS-12","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"Treatment, care and support","Treatment monitoring - Viral load","Workshop to review the training modules for the counsellors (RSSH) regarding community screening.","Workshop to review the training modules for the counsellors (RSSH) regarding community screening.","amount is against different module/intervention in application. UQD description matches the amount line and needs to be validated definitely Original Intervention: Treatment monitoring  Viral load","Medium","17198.97","The activity includes holding a workshop to review the training modules for the counsellors (RSSH) regarding community screening. Capacity building for community based testing is important, but the rationale does not detail how this is different from what is covered through allocation.","0","0","0","0","17198.97","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzJ/view","2020-12-31","HIV/AIDS",17198.97," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713=AN299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713=AO299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713=AP299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713=AJ299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713=AN299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713=AO299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713=AP299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G299)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzKUAW","PAI-3836","Active","BFA-HIV/AIDS-13","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Holding a workshop to approve the training modules for community RSSH counsellors.","Holding a workshop to approve the training modules for community RSSH counsellors.","amount is against different module/intervention in application. UQD description matches the amount line and needs to be validated definitely Original Module: RSSH - Community responses and systems","Medium","4950.06","The activity includes holding a workshop to approve the training modules for community RSSH counsellors. It should be part of the previous activity related to reviewing the training module","0","0","0","0","4950.06","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzK/view","2020-12-31","HIV/AIDS",4950.0600000000004," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713=AN300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713=AO300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713=AP300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713=AJ300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713=AN300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713=AO300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713=AP300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G300)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzLUAW","PAI-3837","Active","BFA-HIV/AIDS-14","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Organize trainings for counsellors (RSSH) regarding community screening.","Organize trainings for counsellors (RSSH) regarding community screening.",null,"Medium","88955.22","The third activity related to capacity building for community-based testing is to organize training for RSSH counsellors concerning the new training module. Capacity building for community-based testing is important but it is not clear how this links with allocation request to ensure appropriate testing and the additional added value","0","0","0","0","88955.22","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzL/view","2020-12-31","HIV/AIDS",88955.22," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713=AN301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713=AO301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713=AP301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713=AJ301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713=AN301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713=AO301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713=AP301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G301)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzMUAW","PAI-3838","Active","BFA-HIV/AIDS-15","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Training care providers in each of the 3 health regions for them to measure early warning indicators (EWI) each year.","Training care providers in each of the 3 health regions for them to measure early warning indicators (EWI) each year.","amount is against different module/intervention in application. UQD description matches the amount line and needs to be validated definitely","Medium","19434.41","This activity entails training care providers in each of the 3 health regions, for them to measure the early warning indicators (EWI) each year. Implementation of EWI is important, but it is not clear how it is 5 related to maternity health care, especially since the most important bottlenecks is early infant diagnosis and timely treatment initiation. This might not be the first priority.","0","0","0","0","19434.41","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzM/view","2020-12-31","HIV/AIDS",19434.41," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713=AN302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713=AO302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713=AP302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713=AJ302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713=AN302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713=AO302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713=AP302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzNUAW","PAI-3839","Active","BFA-HIV/AIDS-16","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Scaling-up EWI in health regions through maternity facilities for them to measure early warning indicators (EWI) each year.","Scaling-up EWI in health regions through maternity facilities for them to measure early warning indicators (EWI) each year.","amount is against different module/intervention in application. UQD description matches the amount line and needs to be validated definitely","Medium","149023.68","This activity entails scaling up implementation of EWI in health regions through maternity facilities, for them to measure the early warning indicators (EWI) each year. Implementation of EWI is important, but it is not clear how it is related to maternity health care. Especially since the most important bottlenecks are early infant diagnosis and timely treatment initiation. This might not be the first priority.","0","0","0","0","149023.68","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzN/view","2020-12-31","HIV/AIDS",149023.67999999999," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713=AN303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713=AO303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713=AP303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713=AJ303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713=AN303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713=AO303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713=AP303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G303)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzOUAW","PAI-3840","Active","BFA-HIV/AIDS-17","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","TProviding operational support for the national coordination of the Network for Greater Involvement of People Infected with HIV (NEGIPIH).","TProviding operational support for the national coordination of the Network for Greater Involvement of People Infected with HIV (NEGIPIH).","NA Original Module: RSSH - Community responses and systems","Medium","121637.3","The activity foresees providing operational support for the national coordination of the Network for Greater Involvement of People Infected with HIV (NEGIPIH). While Community Systems Strengthening (CSS) is important, the details and the rational is not clearly outlined, especially since it is meant to accelerate e-MTCT plan as other interventions with community engagement.","0","0","0","0","121637.3","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzO/view","2020-12-31","HIV/AIDS",121637.3," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713=AN304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713=AO304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713=AP304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713=AJ304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713=AN304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713=AO304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713=AP304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzPUAW","PAI-3841","Active","BFA-HIV/AIDS-18","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"PMTCT","Prong 3: Preventing vertical HIV transmission","Holding an annual national forum on the elimination of mother-to-child transmission of HIV in Burkina Faso (each year).","Holding an annual national forum on the elimination of mother-to-child transmission of HIV in Burkina Faso (each year).","NA Original Module: Prevention of mother-to-child transmission","Medium","24006.28","The activity entails holding an annual national forum on the elimination of mother-to-child transmission of HIV. The TRP considered it is an opportunity to discuss progress towards elimination of PMTCT and identify and address challenges, but is not directly linked to a tangible outcome","0","0","0","0","24006.28","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzP/view","2020-12-31","HIV/AIDS",24006.28," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713=AN305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713=AO305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713=AP305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713=AJ305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713=AN305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713=AO305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713=AP305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G305)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzQUAW","PAI-3842","Active","BFA-HIV/AIDS-2","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Renovating the infirmaries and social services in 20 detention centers. 3 have been already renovated. It addresses concerns raised by the TRP issue 2.","Renovating the infirmaries and social services in 20 detention centers. 3 have been already renovated. It addresses concerns raised by the TRP issue 2.","NA Original Intervention: Other interventions for people in prisons and other closed settings","High","149753.11","It addresses concerns raised by the TRP Issue 2 in our review form fromW1, and may address the sharp decrease in coverage targets forprisoners observed in recent years","0","0","0","0","149753.11","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzQ/view","2020-12-31","HIV/AIDS",149753.10999999999," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713=AN306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713=AO306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713=AP306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713=AJ306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713=AN306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713=AO306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713=AP306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G306)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzRUAW","PAI-3843","Active","BFA-HIV/AIDS-3","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Monitoring/support for pregnant women who have recently tested positive, provided by pairs of peer educators.100 couples who are PLHIV will be trained and will provide peer support. Based on a UNICEF pilot activity.","Monitoring/support for pregnant women who have recently tested positive, provided by pairs of peer educators.100 couples who are PLHIV will be trained and will provide peer support. Based on a UNICEF pilot activity.","NA Original Module: Prevention of mother-to-child transmission","High","1926431.38","It will advance peer-driven support for pregnant women who tested positive. It is based on a successful pilot and proposes scale-up to 100 sites. It has the potential to increase retention in treatment and care of both mothers and their babies and contribute to elimination of motherto-child transmission (eMTCT) goal","0","9e+05","0","0","1026431.38","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzR/view","2020-12-31","HIV/AIDS",1026431.38," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713=AN307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713=AO307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713=AP307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713=AJ307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713=AN307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713=AO307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713=AP307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzSUAW","PAI-3844","Active","BFA-HIV/AIDS-4","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.","Quarterly monitoring missions on the activities carried out by the associations for PLHIV on the e-MTCT plan and community support.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Carrying out a quarterly monitoring mission concerning the activities carried out by the associations for PLHIV in relation to the eMTCT plan and community support","High","80404","This activity aims to provide monitoring of peer support to people living with HIV, pregnant women and their babies in the context of task shifting and involving people living with HIV themselves and is considered a high priority given that supportive supervision is critical after training and important to ensure corrective measures and quality of care.","0","0","0","0","80404","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzS/view","2020-12-31","HIV/AIDS",80404," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713=AN308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713=AO308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713=AP308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713=AJ308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713=AN308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713=AO308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713=AP308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G308)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzTUAW","PAI-3845","Active","BFA-HIV/AIDS-5","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"Treatment, care and support","HIV care","Training and retraining of service providers to provide health services to key populations in 13 regions.","Training and retraining of service providers to provide health services to key populations in 13 regions.",null,"High","53325.1","The intervention would cover training and retraining of service providers to provide health services to key populations in 13 regions. This is high priority because it is one of the key weaknesses raised for the program continuation request, that there is a need for increasing acceptability of services and decreasing stigma and discrimination as well as reach out to key populations.","0","0","0","0","53325.1","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzT/view","2020-12-31","HIV/AIDS",53325.1," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713=AN309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713=AO309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713=AP309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713=AJ309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713=AN309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713=AO309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713=AP309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzUUAW","PAI-3846","Active","BFA-HIV/AIDS-6","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Organize yearly workshop for pediatricians on early infant diagnosis (EID) and pediatric HIV care.","Organize yearly workshop for pediatricians on early infant diagnosis (EID) and pediatric HIV care.",null,"High","107062.06","Increasing buy-in of paediatricians into early infant diagnosis (EID) and appropriate care and support is important and is likely to contribute to eMTCT goal.","0","0","0","0","107062.06","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzU/view","2020-12-31","HIV/AIDS",107062.06," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713=AN310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713=AO310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713=AP310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713=AJ310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713=AN310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713=AO310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713=AP310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G310)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzVUAW","PAI-3847","Active","BFA-HIV/AIDS-7","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"RSSH: Health management information systems and M&E","Surveys","Study on the stigmatization index in Burkina Faso.","Study on the stigmatization index in Burkina Faso.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","61094.15","This activity foresees carrying out index stigma survey. The recommendations may help design stigma reduction activities.","0","0","0","0","61094.15","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzV/view","2020-12-31","HIV/AIDS",61094.15," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713=AN311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713=AO311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713=AP311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713=AJ311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713=AN311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713=AO311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713=AP311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G311)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzWUAW","PAI-3848","Active","BFA-HIV/AIDS-8","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Performing quality control mission every six months on the HIV testing carried out by community personnel during testing campaigns among the key populations and the general population. New Activity.","Performing quality control mission every six months on the HIV testing carried out by community personnel during testing campaigns among the key populations and the general population. New Activity.",null,"High","86121.65","Performing quality control every six months on the HIV screening carried out by specialist community personnel during screening campaigns among the key populations and the general 4 population is likely to improve the quality of testing","0","0","0","0","86121.65","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzW/view","2020-12-31","HIV/AIDS",86121.65," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713=AN312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713=AO312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713=AP312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713=AJ312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713=AN312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713=AO312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713=AP312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzXUAW","PAI-3849","Active","BFA-HIV/AIDS-9","2017-2019","RT High Impact Africa 1","Burkina Faso","HIV/AIDS","HIV/AIDS","FR430-BFA-H",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Equip 11 community organizations that offer HIV treatment and care with basic medical equipment.","Equip 11 community organizations that offer HIV treatment and care with basic medical equipment.","NA Original Module: RSSH - Community responses and systems","High","152466.61","This activity will equip 11 community health centres with medical equipment for people living with HIV and likely to offer quality services to people living with HIV.","0","0","0","0","152466.61","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzX/view","2020-12-31","HIV/AIDS",152466.60999999999," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713=AN313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713=AO313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713=AP313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713=AJ313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713=AN313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713=AO313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713=AP313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzYUAW","PAI-3850","Inactive","BFA-Malaria-1","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"Other module","Other module","Acquiring artesunate injectables for the management of severe malaria in patients aged 5 and above (except pregnant women) in 2019 and 2020.","Acquiring artesunate injectables for the management of severe malaria in patients aged 5 and above (except pregnant women) in 2019 and 2020.","NA Original Module: Support. Original Intervention: Medicines for the treatment of severe malaria","High","5300153.74","For the procurement of medicines for the treatment of severe malaria cases 2019-2020. To ensure availability and increase access to quality medicines, consequently, reducing fatality from severe malaria","0","5300153.74","0","0","0","1","0","2020-01-15 13:30:22","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzY/view","2020-12-31","Malaria",0," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713=AN314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713=AO314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713=AP314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713=AJ314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713=AN314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713=AO314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713=AP314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzZUAW","PAI-3851","Inactive","BFA-Malaria-10","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Expand IMCI-REC in 12 new health districts. As of 31 December 2017, 16 health districts will have the capacity to implement integrated child care through the use of the electronic tool (IMCI-REC).","Expand IMCI-REC in 12 new health districts. As of 31 December 2017, 16 health districts will have the capacity to implement integrated child care through the use of the electronic tool (IMCI-REC).","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Expand IMCI-REC in 12 new districts","Low","3091978.07","For the expansion of the implementation of IMCI-REC in 12 new districts in Eastern regions, the Sahel and North Center; to improve the capacity of the health districts in implementing IMCI using the electronic tool. Propose applicant to request UNICEF and/or the Government to provide additional funds. Within the 12 new Districts include two Districts where MEDSINC is implemented for comparison","0","3091978.07","0","0","0","1","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzZ/view","2020-12-31","Malaria",0," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713=AN315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713=AO315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713=AP315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713=AJ315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713=AN315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713=AO315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713=AP315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzaUAG","PAI-3852","Active","BFA-Malaria-2","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"Other module","Other module","Training/refresher of public and private sector health workers on case management of malaria. IMC/USAID-PMI will fund training for 2/3 of the 8,554 agents to (5,782 agents) and the remaining shall be funded by the above allocation (2,891 agents).","Training/refresher of public and private sector health workers on case management of malaria. IMC/USAID-PMI will fund training for 2/3 of the 8,554 agents to (5,782 agents) and the remaining shall be funded by the above allocation (2,891 agents).","NA Original Module: Support. Original Intervention: Case management  In Hospitals","High","358872.58","To strengthen the skills of public and private health workers in the correctmanagement of malaria cases according to the national guidelines","0.4","0","0","0","358872.18","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIza/view","2020-12-31","Malaria",358872.18," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713=AN316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713=AO316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713=AP316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713=AJ316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713=AN316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713=AO316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713=AP316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G316)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzbUAG","PAI-3853","Active","BFA-Malaria-3","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Acquire SPAQ doses for the implementation of SMC in 49 districts in 2020 and carry out the campaign in the same year.","Acquire SPAQ doses for the implementation of SMC in 49 districts in 2020 and carry out the campaign in the same year.","NA Original Module: Specific prevention interventions. Original Intervention: Seasonal Malaria Chemoprevention","High","11183749.3","For the procurement of sulfadoxinepyrimethamine + amodiaquine (SP/AQ) doses for the continued implementation of SMC in 49 districts in 2020, for the prevention of malaria in children.","0","10148765","0","0","1034984.3","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzb/view","2020-12-31","Malaria",1034984.3," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713=AN317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713=AO317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713=AP317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713=AJ317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713=AN317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713=AO317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713=AP317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G317)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzcUAG","PAI-3854","Active","BFA-Malaria-4","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","The current funding (World Fund, USAID and State) covers needs from 2018 to 2020 except for routine LLIN for pregnant women in 2019. This Gap is included in the above allocation to acquire 886,517 MILDA. The mass distribution campaign is planned for the first half of 2019.","The current funding (World Fund, USAID and State) covers needs from 2018 to 2020 except for routine LLIN for pregnant women in 2019. This Gap is included in the above allocation to acquire 886,517 MILDA. The mass distribution campaign is planned for the first half of 2019.","NA Original Intervention: Long-lasting insecticidal nets  Continuous distribution","High","2530411.85","To fill in the gap for long-lasting insecticide nets (LLIN) routine distribution to pregnant women and children in 2019; intervention aimed at reducing morbidity and mortality among vulnerable groups.","0","0","0","0","2530411.85","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzc/view","2020-12-31","Malaria",2530411.85," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713=AN318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713=AO318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713=AP318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713=AJ318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713=AN318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713=AO318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713=AP318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzdUAG","PAI-3855","Active","BFA-Malaria-5","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Training / refresher training CHWs s on the community-based response package (including the use of RDTs). This will involve training / refresher training for all the CHWs of the remaining 42 remaining districts on integrated ICCM package in 2018 in 6 days with 2 trainers per CSPS.","Training / refresher training CHWs s on the community-based response package (including the use of RDTs). This will involve training / refresher training for all the CHWs of the remaining 42 remaining districts on integrated ICCM package in 2018 in 6 days with 2 trainers per CSPS.","NA Original Module: RSSH - Human resources for health, including community health workers","High","928007.52","For the continuous training of community health workers (CHWs) in the provision of quality health services, including malaria services (integrated community case management (iCCM) package) for the 42 remaining districts in 2018","0","0","0","0","928007.52","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzd/view","2020-12-31","Malaria",928007.52," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713=AN319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713=AO319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713=AP319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713=AJ319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713=AN319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713=AO319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713=AP319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G319)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzeUAG","PAI-3856","Active","BFA-Malaria-6","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","BAcquire reagents and consumables for the production of labile blood products (PSL). The request is to support the procurement of kits consisting of serological reagents, blood bags, tubes, etc.","BAcquire reagents and consumables for the production of labile blood products (PSL). The request is to support the procurement of kits consisting of serological reagents, blood bags, tubes, etc.","NA Original Module: RSSH - Integrated service delivery and quality improvement","High","4603524.41","Requested amount is to cover 50% of unmet needs for testing labile blood products (covering HIV, hepatitis and syphilis); to ensure safety of blood for transfusion","0","0","0","0","4603524.41","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIze/view","2020-12-31","Malaria",4603524.41," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713=AN320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713=AO320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713=AP320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713=AJ320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713=AN320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713=AO320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713=AP320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzfUAG","PAI-3857","Active","BFA-Malaria-7","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Implement a pilot project to improve the quality of the integrated management of childhood illnesses by the CHWs and data flow using the MEDSINC tool.","Implement a pilot project to improve the quality of the integrated management of childhood illnesses by the CHWs and data flow using the MEDSINC tool.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Medium","157109.19","Timeliness and completeness of data is a critical element, so it will be worthwhile to determine if the tool can improve data collection of IMCIC diseases and other childhood illnesses. However, funding should also be available for evaluation of MEDSINC, in terms of CHW adoption, assessing the relationship to other Burkina Faso data efforts, and institutional human costs compared to data quality benefits","0","0","0","0","157109.19","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzf/view","2020-12-31","Malaria",157109.19," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713=AN321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713=AO321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713=AP321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713=AJ321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713=AN321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713=AO321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713=AP321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzgUAG","PAI-3858","Active","BFA-Malaria-8","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Training for providers of districts in clinical IMCI. Previous training have not met all the needs. The planning involves the training of an average of 25 staff per health district in the 8 regions not covered by the IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center-Sud, Center-East, Central): 25 sessions of 25 agents on average for 11 days in 2018 and 2020.","Training for providers of districts in clinical IMCI. Previous training have not met all the needs. The planning involves the training of an average of 25 staff per health district in the 8 regions not covered by the IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center-Sud, Center-East, Central): 25 sessions of 25 agents on average for 11 days in 2018 and 2020.","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Organization of services and management institutions Train providers of districts in clinical IMCI","Medium","568340.06","To enhance skills of health workers on clinical IMCI in the 8 regions not covered by IMCI-REC (Center, Center-West, Southwest, Cascades, Hauts-Bassins, Center Sud, Center-East, Central), to improve care of children under 5, resulting in reduced infant and child mortality","0","0","0","0","568340.06","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzg/view","2020-12-31","Malaria",568340.06000000006," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713=AN322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713=AO322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713=AP322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713=AJ322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713=AN322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713=AO322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713=AP322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G322)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzhUAG","PAI-3859","Active","BFA-Malaria-9","2017-2019","RT High Impact Africa 1","Burkina Faso","Malaria","Malaria","FR433-BFA-M",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","For the period 2018-2020, the CNTS needs 617,009 kits.","For the period 2018-2020, the CNTS needs 617,009 kits.","NA Original Module: RSSH - Integrated service delivery and quality improvement","Medium","188647.62","For the dissemination of key messages to promote culture of altruism and increase regular blood donation among the population. However, informational education and communication (IEC) with respect to blood donations should be principally funded elsewhere","0","0","0","0","188647.62","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzh/view","2020-12-31",{"$f":"IF(OR(I323=\"HIV/AIDS\",I323=\"Tuberculosis\",I323=\"Malaria\",I323=\"RSSH\"),I323, IF(I323=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"Malaria"},{"$f":"VALUE(Y323)","v":188647.62},{"$f":"RIGHT(F323,LEN(F323)-2)","v":" High Impact Africa 1"},"Malaria","Malaria",null,null,null,{"$f":"TRIM(AK323)","v":""},{"$f":"TRIM(AL323)","v":""},{"$f":"TRIM(AM323)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713=AN323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713=AO323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713=AP323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE323<>\"\",AE323,IF(MAX(AQ323,AR323,AS323,AT323)<>0,MAX(AQ323,AR323,AS323,AT323),AU323))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713=AJ323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713=AN323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713=AO323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713=AP323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G323)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE323<>\"\",AE323,IF(MAX(AW323,AX323,AY323,AZ323)<>0,MAX(AW323,AX323,AY323,AZ323),BA323))","v":"2020-12-31"}]
["a6Q1R000000AIziUAG","PAI-3860","Active","BFA-Tuberculosis-1","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"TB care and prevention","Treatment","Provision of nutritional support to 20% of drug sensitive TB patients, with expected outcome to increase the tuberculosis treatment success rate (currently at 78%). Since 2010 When nutritional support stopped), the rate of patients lost to follow-up has been on the rise (6.4% in 2010 to 7.4% in 2015). The target for this support: 1165 in 2018, 1202 in 2019 and 1250 in 2020 for a monthly ration cost: 35,000 CFA francs, or 53.36 euros. Composition of a ration: protein-rich foods, cereals, vegetables, oil and sugar.","Provision of nutritional support to 20% of drug sensitive TB patients, with expected outcome to increase the tuberculosis treatment success rate (currently at 78%). Since 2010 When nutritional support stopped), the rate of patients lost to follow-up has been on the rise (6.4% in 2010 to 7.4% in 2015). The target for this support: 1165 in 2018, 1202 in 2019 and 1250 in 2020 for a monthly ration cost: 35,000 CFA francs, or 53.36 euros. Composition of a ration: protein-rich foods, cereals, vegetables, oil and sugar.",null,"High","1652182.26","The tuberculosis treatment success rate remains low (78%, cohort of new and relapse patients in 2015) in comparison with the target of at least 90%. Since 2010, drug-sensitive TB patients have no longer benefited from (previous Round 4) nutritional support and, during the same period, the rate of patients lost to follow-up has been on the rise (6.4% in 2010 to 7.4% in 2015). The hypothesis that the provisions of nutritional support contribute to improve significantly the adherence to treatment and, therefore, reduce the risk of death forms the basis of the proposal for 3 this activity as part of the above allocation request for funding.","0","0","0","0","1652182.26","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzi/view","2020-12-31","Tuberculosis",1652182.26," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713=AN324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713=AO324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713=AP324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713=AJ324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713=AN324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713=AO324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713=AP324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G324)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzjUAG","PAI-3861","Active","BFA-Tuberculosis-10","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Training CDT patients in electronic TB registration. The training will target the  24 structures (20 TTCs and 4 reference centres) involved in the pilot phase of TB electronic registration. The estimated duration of this training is 3 days. The content of the training will be the following: One and a half days on general aspects of the IT and the second half of the training will concern the use of the software itself.","Training CDT patients in electronic TB registration. The training will target the  24 structures (20 TTCs and 4 reference centres) involved in the pilot phase of TB electronic registration. The estimated duration of this training is 3 days. The content of the training will be the following: One and a half days on general aspects of the IT and the second half of the training will concern the use of the software itself.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","7031.55","The electronic registration of patients is an innovative activity that the NTBCP wishes to experiment through a pilot project in 24 structures (20 CDT and 4 reference centres). During the supervisions, it was noted that the majority of the CDT stakeholders have no computer and, therefore, do not know how to use the information technology (IT ) tool. Therefore, for the success of the aforementioned project, the training of the stakeholders concerned has proved necessary. The estimated duration of this training is 3 days. The content of the training will be the following: one and a half days on general aspects of the IT and the second half of the training will concern the use of the software itself.","0","0","0","0","7031.55","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzj/view","2020-12-31","Tuberculosis",7031.55," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713=AN325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713=AO325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713=AP325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713=AJ325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713=AN325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713=AO325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713=AP325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzkUAG","PAI-3862","Active","BFA-Tuberculosis-11","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.","Ensure continuos monitoring and oversight of the TB registration software.  Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three months during the first year and every six months in year 2.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","25470.81","A customized World Health Organisation (WHO ) software will be used for registering TB patients, including multi -drug resistant TB (MDR /TB ) patients. Monitoring will be carried out in the form of supervision by the NTBCP coordination team, which, in turn, will be trained by international level personnel. Closer monitoring (training supervision) will be conducted every three month s during the first year and every six months in year 2.","0","0","0","0","25470.81","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzk/view","2020-12-31","Tuberculosis",25470.81," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713=AN326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713=AO326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713=AP326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713=AJ326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713=AN326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713=AO326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713=AP326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G326)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzlUAG","PAI-3863","Active","BFA-Tuberculosis-12","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Conduct a training of the NTBCP workers by WHO and a training of TTC staff. This will be done during support mission  at the start of the period and a second follow-up mission six months later.","Conduct a training of the NTBCP workers by WHO and a training of TTC staff. This will be done during support mission  at the start of the period and a second follow-up mission six months later.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","9922.61","Experts will be identified by the WHO to train the NTBCP workers who, in turn, will train the CDT staff. A support mission will be planned at the start of the period for training and installation of the software and its use, then a second follow -up mission for six months later.","0","0","0","0","9922.61","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzl/view","2020-12-31","Tuberculosis",9922.61," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713=AN327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713=AO327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713=AP327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713=AJ327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713=AN327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713=AO327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713=AP327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G327)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzmUAG","PAI-3864","Active","BFA-Tuberculosis-13","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"MDR-TB","Treatment: MDR-TB","Equipping 2 medical units specialized in MDR-TB treatment: The 2 pneumology centres of CHUYO and CHUSS (16 beds in Ouagadougou and 9 beds in Bobo) are under construction in the 2 hospitals, planned for completion in late 2017. The equipment include: Medical bed, orthopaedic mattress, 2-section viewbox, separate lighting, office desk, air conditioning unit, fan, office chair, visitor chair, side table, wardrobe, examination table...","Equipping 2 medical units specialized in MDR-TB treatment: The 2 pneumology centres of CHUYO and CHUSS (16 beds in Ouagadougou and 9 beds in Bobo) are under construction in the 2 hospitals, planned for completion in late 2017. The equipment include: Medical bed, orthopaedic mattress, 2-section viewbox, separate lighting, office desk, air conditioning unit, fan, office chair, visitor chair, side table, wardrobe, examination table...","NA Original Module: Multidrug-resistant TB","Low","56199.64","Estimated percentage of TB cases with multi -drug resistant/ rifampicin resistant - tuberculosis (MDR/RR -TB) among previously treated patients is high at 21%. The 2 pneumology centres of Centre Hspitalier universitaire de Yalgado Ou draogo (CHUYO ) and Centre Hspitalier Universitaire Sourou Sanou (CHUSS) are the centres of reference for MDR -TB treatment. Equipment is requested in order to increase the capacity of these centres: although addressing MDR TB is important, the justification/rationale for the specific requested equipment is not very strong: medical bed 1 space for adult, orthopaedic mattress, 2 - 6 section viewbox, separate lighting, office desk, air conditioning unit, fan, office chair, visitor chair, side table, wardrobe, stainless steel stand, chair on casters, articulated walking frame, examination table with stainless steel rail, stepladder, medical lamp, padded chair for the patient room.","0","0","0","0","56199.64","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzm/view","2020-12-31","Tuberculosis",56199.64," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713=AN328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713=AO328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713=AP328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713=AJ328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713=AN328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713=AO328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713=AP328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G328)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIznUAG","PAI-3865","Active","BFA-Tuberculosis-2","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"RSSH: Health management information systems and M&E","Surveys","Conduct a feasibility study of the integration of active screening for TB among children aged 3 to 59 months seen during the SMC campaigns. This innovative, integrated approach is expected to boost active TB screening and to improve the performance of the 4 NTBCP in relation to tuberculosis among children. Location: 2 of the 12 health regions covered by the SMC. Study period: 2018 Partners: NMCP, Paediatricians, WHO/RDT.","Conduct a feasibility study of the integration of active screening for TB among children aged 3 to 59 months seen during the SMC campaigns. This innovative, integrated approach is expected to boost active TB screening and to improve the performance of the 4 NTBCP in relation to tuberculosis among children. Location: 2 of the 12 health regions covered by the SMC. Study period: 2018 Partners: NMCP, Paediatricians, WHO/RDT.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","85539.79","Under -notification is particularly important for children under 15, and even higher for children under 5. This is an innovative feasibility study (NB: not a survey, as stated in the request) which leverages pre -existing planned SMC campaigns to improve TB case detection among children, promoting value for money in human resource utilisation and disease integration at the community level","0","0","0","0","85539.79","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzn/view","2020-12-31","Tuberculosis",85539.79," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713=AN329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713=AO329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713=AP329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713=AJ329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713=AN329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713=AO329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713=AP329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzoUAG","PAI-3866","Active","BFA-Tuberculosis-3","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"RSSH: Health management information systems and M&E","Surveys","Carry out a new survey in order to assess the impact of the communication strategy of the 2013-2017 of national tuberculosis control program (NTBCP) that is being implemented, in terms of knowledge, attitudes and practices among the population in relation to tuberculosis. This second KAP survey, planned for the second quarter of 2019.","Carry out a new survey in order to assess the impact of the communication strategy of the 2013-2017 of national tuberculosis control program (NTBCP) that is being implemented, in terms of knowledge, attitudes and practices among the population in relation to tuberculosis. This second KAP survey, planned for the second quarter of 2019.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","55600.86","The previous KAP study was done in 2012 and revealed that, in general, the level of knowledge of tuberculosis among the population was 32.4%. The result was used to develop the communication strategy of the 2013 - 2017 of national tuberculosis control program (NTBCP ) that is being implemented. After 5 years of implementation of this communication strategy, it has proved necessary to carry out a new survey in order to assess its impact in terms of knowledge, attitudes and practices among the population in relation to tuberculosis. This request includes a second KAP survey, planned for the second quarter of 2019, which will be used to measure the impact of adverts requested under this PAAR.","0","0","0","0","55600.86","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzo/view","2020-12-31","Tuberculosis",55600.86," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713=AN330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713=AO330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713=AP330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713=AJ330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713=AN330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713=AO330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713=AP330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzpUAG","PAI-3867","Active","BFA-Tuberculosis-4","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Refurbishing 9 Centre for the Diagnosis and Treatment of TB in 2019. The selection of the 9 sites was based on findings from the supervision with major refurbishment needs as: cramped, lack of ventilation, watertightness, dilapidated roof, etc. These CDT are the following: D, Dori, Orodara, Pama, Dedougou, Mangodara, Manni, Sapouy and Bokin","Refurbishing 9 Centre for the Diagnosis and Treatment of TB in 2019. The selection of the 9 sites was based on findings from the supervision with major refurbishment needs as: cramped, lack of ventilation, watertightness, dilapidated roof, etc. These CDT are the following: D, Dori, Orodara, Pama, Dedougou, Mangodara, Manni, Sapouy and Bokin","NA Original Module: RSSH - Integrated service delivery and quality improvement","Medium","391767.47","Based on findings from the supervision, the treatment units of the following Centre for the Diagnosis and Treatment of TB (have been identified as in need of refurbishment: cramped, lack of ventilation, watertightness, dilapidated roof, etc. These CDT are the following: D, Dori, Orodara, Pama, Dedougou, Mangodara, Manni, Sapouy and Bokin","0","0","0","0","391767.47","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzp/view","2020-12-31","Tuberculosis",391767.47," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713=AN331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713=AO331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713=AP331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713=AJ331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713=AN331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713=AO331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713=AP331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzqUAG","PAI-3868","Active","BFA-Tuberculosis-5","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"TB care and prevention","Prevention","Produce 3 TV adverts on the fight against tuberculosis in the following languages: French, Dyula, Mossi and Fula in order to reach a large number of people among the urban population (27.53% of the total population in 2015)","Produce 3 TV adverts on the fight against tuberculosis in the following languages: French, Dyula, Mossi and Fula in order to reach a large number of people among the urban population (27.53% of the total population in 2015)",null,"Medium","8211.82","TV adverts were chosen because they constitute an efficient manner of reaching a large number of people among the urban population, The review of the directives of the NTBCP involves updating these adverts.","0","0","0","0","8211.82","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzq/view","2020-12-31","Tuberculosis",8211.82," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713=AN332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713=AO332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713=AP332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713=AJ332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713=AN332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713=AO332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713=AP332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G332)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzrUAG","PAI-3869","Active","BFA-Tuberculosis-6","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"TB care and prevention","Prevention","Broadcasting each of the adverts 3 times per week and per language (French, Mossi, Dyula and Fula) on the 3 television channels. In fact, the radio adverts will be broadcast from 2018 until the first quarter of 2019, so that the KAP survey planned for the second quarter of 2019 will be used to measure their impact, among other things.","Broadcasting each of the adverts 3 times per week and per language (French, Mossi, Dyula and Fula) on the 3 television channels. In fact, the radio adverts will be broadcast from 2018 until the first quarter of 2019, so that the KAP survey planned for the second quarter of 2019 will be used to measure their impact, among other things.",null,"Medium","400326.23","TV adverts were chosen because they constitute an efficient manner of reaching a large number of people among the urban population, The review of the directives of the NTBCP involves updating these adverts.","0","0","0","0","400326.23","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzr/view","2020-12-31","Tuberculosis",400326.23," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713=AN333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713=AO333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713=AP333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713=AJ333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713=AN333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713=AO333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713=AP333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G333)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzsUAG","PAI-3870","Active","BFA-Tuberculosis-7","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"TB care and prevention","Prevention","Broadcasting each year, 6 times per week, the radio adverts in French, Mossi, Dyula and Fula concerning the fight against tuberculosis on the stations of the 25 radio partners. The 3 broadcasts per week are due to the need to take advantage of the 2 weekend days during which the audience is larger .","Broadcasting each year, 6 times per week, the radio adverts in French, Mossi, Dyula and Fula concerning the fight against tuberculosis on the stations of the 25 radio partners. The 3 broadcasts per week are due to the need to take advantage of the 2 weekend days during which the audience is larger .",null,"Medium","427014.64","Radio is a means of mass communication in both the rural and urban environments. The program has had experience of working with radio stations, in particular local stations, since 2005. The NTBCP plans to sign a partnership agreement with 16 of the radio stations using the allocation amount. So as to improve population coverage, 20 other local radio stations will be involved using the above allocation funding.","0","0","0","0","427014.64","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzs/view","2020-12-31","Tuberculosis",427014.64," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713=AN334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713=AO334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713=AP334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713=AJ334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713=AN334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713=AO334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713=AP334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G334)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIztUAG","PAI-3871","Active","BFA-Tuberculosis-8","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Organize a 3-day training session in 2020 to train 100 (centres dinformation et des statistiques sanitaires, CISSE) and (services de planification de linformation hospitalire SPIH) workers regarding the new directives and the analysis of data concerning the fight against tuberculosis  the target will be: 100 CISSE and SPIH workers : 1 x 70 HD + 1 x 13 RHD + 1 x 8 CHR + 1 x 5 CHU + 4 central workers (DSS = 3 and DLM = 1).","Organize a 3-day training session in 2020 to train 100 (centres dinformation et des statistiques sanitaires, CISSE) and (services de planification de linformation hospitalire SPIH) workers regarding the new directives and the analysis of data concerning the fight against tuberculosis  the target will be: 100 CISSE and SPIH workers : 1 x 70 HD + 1 x 13 RHD + 1 x 8 CHR + 1 x 5 CHU + 4 central workers (DSS = 3 and DLM = 1).","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","28937.09","The technical guide to the fight against tuberculosis will be reviewed in 2019 (planned in the allocation amount) and a review of the operational definitions of cases of tuberculosis is expected. The aim of this training is to: i) improve their knowledge on these operational definitions of cases of tuberculosis, ii) improve their knowledge on the indicators of the fight against tuberculosis and their standard, iii) make them able to detect inconsistencies in the statistical reports of the CDT, before the data is captured with a view to propose corrective actions, iv) improve their ability to analyse the tuberculosis data. The expected result of this training is to have quality data.","0","0","0","0","28937.09","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzt/view","2020-12-31","Tuberculosis",28937.09," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713=AN335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713=AO335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713=AP335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713=AJ335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713=AN335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713=AO335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713=AP335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzuUAG","PAI-3872","Active","BFA-Tuberculosis-9","2017-2019","RT High Impact Africa 1","Burkina Faso","Tuberculosis","Tuberculosis","FR362-BFA-T",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Acquiring complete office computers for electronic registration of TB patients in 20 CDT. this will include complete office computers: monitor, central unit, uninterruptable power supply and printer. and will be allocated to the 20 TTCs with the highest numbers of patients that will take part in this electronic registration pilot phase.","Acquiring complete office computers for electronic registration of TB patients in 20 CDT. this will include complete office computers: monitor, central unit, uninterruptable power supply and printer. and will be allocated to the 20 TTCs with the highest numbers of patients that will take part in this electronic registration pilot phase.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","33360.52","The benefit of this electronic registration: minimising duplications, the activity report is generated more quickly and with a higher quality, it provides a greater opportunity for registering patient data.","0","0","0","0","33360.52","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzu/view","2020-12-31","Tuberculosis",33360.519999999997," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713=AN336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713=AO336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713=AP336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713=AJ336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713=AN336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713=AO336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713=AP336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AIzvUAG","PAI-3873","Inactive","BGD-HIV/AIDS-1","2017-2019","RT High Impact Asia","Bangladesh","HIV/AIDS","HIV/AIDS","FR100-BGD-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Prevention and management of coinfections and co-morbidities for PWID","Prevention, screening, diagnosis and management for Hepatitis C virus (HCV): Information Education Communication/Behaviour Change Communication activities for the prevention of HCV will be conducted among targeted People Who Inject Drugs (PWID). PWID will be routinely screened for HCV and around 200 HCV positive PWID will be provided medicine support. Trained physicians will be responsible for screening, diagnosis and management of HCV from Drop-In-Centres. The impact will be to reduce morbidity and mortality for PWID who may be co-infected with HIV.","Prevention, screening, diagnosis and management for Hepatitis C virus (HCV): Information Education Communication/Behaviour Change Communication activities for the prevention of HCV will be conducted among targeted People Who Inject Drugs (PWID). PWID will be routinely screened for HCV and around 200 HCV positive PWID will be provided medicine support. Trained physicians will be responsible for screening, diagnosis and management of HCV from Drop-In-Centres. The impact will be to reduce morbidity and mortality for PWID who may be co-infected with HIV.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Prevention and management of co-infections and co-morbidities for people who inject drugs","Medium","431028","Increases coverage and impact of hepatitis C virus (HCV) intervention to reduce morbidity and mortality in people who inject drugs.","100723","330305","0","0","0","1","0","2020-01-17 13:50:10","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzv/view","2020-11-30","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-11-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713=AN337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713=AO337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713=AP337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-11-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713=AJ337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2017-12-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713=AN337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713=AO337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713=AP337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G337)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-11-30"]
["a6Q1R000000AIzwUAG","PAI-3874","Inactive","BGD-HIV/AIDS-2","2017-2019","RT High Impact Asia","Bangladesh","HIV/AIDS","HIV/AIDS","FR100-BGD-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Further scale-up Opioid Substitution Therapy (OST) in 3 priority districts: Considering the HIV and HCV epidemic, another 1,000 PWID will be targeted for OST in selected districts by 2020, which will increase the national coverage to 11%. This harm reduction intervention is critical in the fight against the transmission of HIV/HCV.","Further scale-up Opioid Substitution Therapy (OST) in 3 priority districts: Considering the HIV and HCV epidemic, another 1,000 PWID will be targeted for OST in selected districts by 2020, which will increase the national coverage to 11%. This harm reduction intervention is critical in the fight against the transmission of HIV/HCV.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","High","935188","Increases and impacts transmission of HIV/HCV among people who inject drugs.","665925","269263","0","0","0","1","0","2020-01-17 13:51:12","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzw/view","2020-11-30","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-11-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713=AN338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713=AO338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713=AP338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-11-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713=AJ338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2017-12-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713=AN338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713=AO338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713=AP338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G338)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-11-30"]
["a6Q1R000000AIzxUAG","PAI-3875","Active","BGD-HIV/AIDS-3","2017-2019","RT High Impact Asia","Bangladesh","HIV/AIDS","HIV/AIDS","FR100-BGD-H",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","Bi-annual monitoring survey among People Who Inject Drugs (PWID): Recent rise of HIV prevalence in Dhaka requires in-depth, routine and systematic monitoring of injecting and sexual behaviour of PWID, drug context, drug taking frequency etc. Routine monitoring survey will be conducted to strengthen the reach, quality of services, and to revalidate spot-wise size estimates so that program can be more responsive to the community needs.","Bi-annual monitoring survey among People Who Inject Drugs (PWID): Recent rise of HIV prevalence in Dhaka requires in-depth, routine and systematic monitoring of injecting and sexual behaviour of PWID, drug context, drug taking frequency etc. Routine monitoring survey will be conducted to strengthen the reach, quality of services, and to revalidate spot-wise size estimates so that program can be more responsive to the community needs.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","431006","Strengthens the reach and quality of services and revalidates spotwise size estimates so that the program can be more responsive to community needs.","0","0","0","0","431006","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzx/view","2020-11-30","HIV/AIDS",431006," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-11-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713=AN339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713=AO339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713=AP339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-11-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713=AJ339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2017-12-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713=AN339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713=AO339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713=AP339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G339)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-11-30"]
["a6Q1R000000AIzyUAG","PAI-3876","Active","BGD-HIV/AIDS-4","2017-2019","RT High Impact Asia","Bangladesh","HIV/AIDS","HIV/AIDS","FR100-BGD-H",null,null,"Other module","Routine reporting","Under the Government funded Health Sector Program, there is provision for establishing 150 service delivery points  throughout the country. Above allocation funding will allow the National AIDS/STI Program (NASP) to set up a digital data collection and management system. NASP will receive regular data from service delivery points which will help monitor the progress of program implementation and further decision-making.","Under the Government funded Health Sector Program, there is provision for establishing 150 service delivery points  throughout the country. Above allocation funding will allow the National AIDS/STI Program (NASP) to set up a digital data collection and management system. NASP will receive regular data from service delivery points which will help monitor the progress of program implementation and further decision-making.","NA Original Module: RSSH - Digital data management system for 150 service delivery points for key populations under the 4th health sector program including data centre set-up and management, providing equipment and relevant training to the DIC/ HTS","Medium","450000","Site-level data will help monitor the progress of program implementation and further decision making.","0","0","0","0","450000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzy/view","2020-11-30","HIV/AIDS",450000," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-11-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713=AN340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713=AO340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713=AP340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-11-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713=AJ340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2017-12-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713=AN340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713=AO340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713=AP340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-11-30"]
["a6Q1R000000AIzzUAG","PAI-3877","Active","BGD-HIV/AIDS-5","2017-2019","RT High Impact Asia","Bangladesh","HIV/AIDS","HIV/AIDS","FR100-BGD-H",null,null,"Treatment, care and support","Treatment adherence","Piloting different ART service delivery models for key and general populations will allow improved linkages to treatment, care and support for people living with HIV.","Piloting different ART service delivery models for key and general populations will allow improved linkages to treatment, care and support for people living with HIV.",null,"Medium","332408","Better models for improving linkages to treatment, care and support for people living with HIV are necessary to combatting the epidemic.","0","0","0","0","332408","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AIzz/view","2020-11-30","HIV/AIDS",332408," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-11-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713=AN341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713=AO341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713=AP341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-11-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713=AJ341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2017-12-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713=AN341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713=AO341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713=AP341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-11-30"]
["a6Q1R000000AJ00UAG","PAI-3878","Active","BGD-HIV/AIDS-6","2017-2019","RT High Impact Asia","Bangladesh","HIV/AIDS","HIV/AIDS","FR100-BGD-H",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Technical assistance will be requested from WHO to assist in developing different protocols, guidelines, conducting quality research and training to complement updating/developing various guidelines.","Technical assistance will be requested from WHO to assist in developing different protocols, guidelines, conducting quality research and training to complement updating/developing various guidelines.","NA Original Module: RSSH - Program management: TA support from WHO will be requested to complement for updating/developing various guidelines if required","Low","170000","Updating normative guidance is important and the country should access all necessary expertise to accomplish this task.","60000","0","0","0","110000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ00/view","2020-11-30","HIV/AIDS",110000," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-11-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713=AN342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713=AO342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713=AP342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-11-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713=AJ342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2017-12-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713=AN342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713=AO342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713=AP342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G342)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-11-30"]
["a6Q1R000000AJ01UAG","PAI-3879","Active","BGD-HIV/AIDS-7","2017-2019","RT High Impact Asia","Bangladesh","HIV/AIDS","HIV/AIDS","FR100-BGD-H",null,null,"RSSH: Health management information systems and M&E","Surveys","HIV surveillance is important for key population monitoring at regular intervals.","HIV surveillance is important for key population monitoring at regular intervals.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","1500000","While HIV surveillance is important for key population monitoring in a regular interval, an additional survey to the one planned in the 4th health sector program of the GoB is not a priority","336609","0","0","0","1163391","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ01/view","2020-11-30","HIV/AIDS",1163391," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-11-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713=AN343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713=AO343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713=AP343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-11-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713=AJ343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2017-12-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713=AN343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713=AO343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713=AP343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G343)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-11-30"]
["a6Q1R000000AJ02UAG","PAI-3880","Active","BGD-HIV/AIDS-8","2017-2019","RT High Impact Asia","Bangladesh","HIV/AIDS","HIV/AIDS","FR100-BGD-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).","Pre-exposure Prophylaxis (PrEP) for key populations and sero-discordant couples: As a pilot, PrEP will be provided to 1,000 people who are in substantial risk of HIV infection (eg. adolescent FSW, sex partners of PWID, and sero-discordant couples).","NA Original Intervention: Other interventions for treatment: PrEP","Low","940181","Given the low number of HIV cases initiating ART, and the fact that Pre-exposure prophylaxis (PreP) should only be considered for sero-discordant couples where partner is initiating treatment or has detectable viral load in the Bangladesh epidemic, this is not a priority.","0","0","0","0","940181","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ02/view","2020-11-30","HIV/AIDS",940181," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-11-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713=AN344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713=AO344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713=AP344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-11-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713=AJ344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2017-12-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713=AN344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713=AO344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713=AP344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G344)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-11-30"]
["a6Q1R000000AJ03UAG","PAI-3881","Active","BGD-HIV/AIDS-9","2017-2019","RT High Impact Asia","Bangladesh","HIV/AIDS","HIV/AIDS","FR100-BGD-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Scale-up ICT based data collection system in the HIV/AIDS program to integrate with the national Health Management Information System (HMIS). A pilot initiative will introduce a ICT based data collection system using tablets with mobile apps. The ICT based data collection system will be scaled-up for the entire program and to be integrated into MIS system of HIV/AIDS program, contributing to the national HMIS.","Scale-up ICT based data collection system in the HIV/AIDS program to integrate with the national Health Management Information System (HMIS). A pilot initiative will introduce a ICT based data collection system using tablets with mobile apps. The ICT based data collection system will be scaled-up for the entire program and to be integrated into MIS system of HIV/AIDS program, contributing to the national HMIS.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Undefined","Low","142272","Support introduction of information communication technology (ICT)-based data collection system using tablet with mobile apps. The ICT based date collection system will be scaled up for entire program and to be integrated into MIS system of HIV/AIDS program contributing to national HMIS.","0","0","0","0","142272","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ03/view","2020-11-30","HIV/AIDS",142272," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-11-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713=AN345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713=AO345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713=AP345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-11-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713=AJ345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2017-12-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713=AN345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713=AO345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713=AP345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-11-30"]
["a6Q1R000000AJ04UAG","PAI-3882","Active","BGD-Malaria-1","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"Case management","Facility-based treatment","Quality Assurnce (QA) of diagnosis needs improvement and will be strengthened through expansion and upgrading of the Central Medical Reference Laboratory and collaborating laboratories. A QA database and support for external competency testing will be conducted every 3 years. Sensitivity and specificity of diagnosis will increase as a result, improving rationality of treatment.","Quality Assurnce (QA) of diagnosis needs improvement and will be strengthened through expansion and upgrading of the Central Medical Reference Laboratory and collaborating laboratories. A QA database and support for external competency testing will be conducted every 3 years. Sensitivity and specificity of diagnosis will increase as a result, improving rationality of treatment.",null,"High","25795","Quality assurance of diagnosis needs improvement and should be strengthened through expansion. If efficiencies and saving are identified during grantmaking, this activity should be included in the Allocation Budget.","0","0","0","0","25795","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ04/view","2020-12-31","Malaria",25795," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713=AN346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713=AO346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713=AP346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713=AJ346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713=AN346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713=AO346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713=AP346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ05UAG","PAI-3883","Active","BGD-Malaria-10","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"Vector control","Other vector control measure(s)","The protection provided by LLINs is limited to some extent by the early outdoor biting habit of local vectors. Personal protection measures could improve impact, especially for populations at increased occupational risk. Investigations into the effectiveness of personal repellents for reducing residual malaria transmission (RMT) in Bangladesh will be carried out. If repellents prove effective, a roll-out of this intervention will be effected to complement the LLIN approach and result in reduced vectorial capacity and reduced transmission.","The protection provided by LLINs is limited to some extent by the early outdoor biting habit of local vectors. Personal protection measures could improve impact, especially for populations at increased occupational risk. Investigations into the effectiveness of personal repellents for reducing residual malaria transmission (RMT) in Bangladesh will be carried out. If repellents prove effective, a roll-out of this intervention will be effected to complement the LLIN approach and result in reduced vectorial capacity and reduced transmission.","NA Original Intervention: Other vector control measures","Low","57600","This is to support investigations into the effectiveness of personal repellents for reducing residual malaria transmission (RMT).","0","0","0","0","57600","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ05/view","2020-12-31","Malaria",57600," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713=AN347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713=AO347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713=AP347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713=AJ347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713=AN347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713=AO347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713=AP347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ06UAG","PAI-3884","Active","BGD-Malaria-2","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"Case management","Active case detection and investigation (elimination phase)","There are considerable additional demands associated with the elimination effort. A substantial increase in manpower will allow the programme to accelerate progress towards its targets, taking full advantage of this critical window of opportunity to eliminate malaria from Bangladesh.","There are considerable additional demands associated with the elimination effort. A substantial increase in manpower will allow the programme to accelerate progress towards its targets, taking full advantage of this critical window of opportunity to eliminate malaria from Bangladesh.",null,"High","3384120","Active case detection is a critical part of malaria elimination efforts and should be included in the malaria elimination efforts in Bangladesh.","2099616","0","0","0","1284504","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ06/view","2020-12-31","Malaria",1284504," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713=AN348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713=AO348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713=AP348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713=AJ348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713=AN348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713=AO348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713=AP348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ07UAG","PAI-3885","Inactive","BGD-Malaria-3","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Mapping can significantly strengthen the management of malaria elimination efforts. Health Information Systems in elimination districts will be upgraded to include a GIS component with mapping down to household level. Selected healthcare providers will be equipped with a smartphone so that they can report the geographical position of all confirmed malaria cases. The Government will strengthen the pharmacovigilance system.","Mapping can significantly strengthen the management of malaria elimination efforts. Health Information Systems in elimination districts will be upgraded to include a GIS component with mapping down to household level. Selected healthcare providers will be equipped with a smartphone so that they can report the geographical position of all confirmed malaria cases. The Government will strengthen the pharmacovigilance system.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","438173","Mapping can significantly strengthen the management of malaria elimination efforts, especially in malaria elimination districts.","438173","0","0","0","0","1","0","2020-01-17 13:49:18","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ07/view","2020-12-31","Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713=AN349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713=AO349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713=AP349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713=AJ349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713=AN349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713=AO349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713=AP349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G349)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ08UAG","PAI-3886","Active","BGD-Malaria-4","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"Case management","Other case management intervention(s)","Target-group-specific, locally appropriate, Behaviour Change Communication (BCC) materials and methodologies will be developed and produced for all high-risk groups, as well as for communities approaching elimination. Border-specific packages will also be produced. A mobile phone-based BCC programme  will be developed. Where appropriate work will be carried out in partnership with a commercial advertising agency. This should result in significant improvements in LLIIN utilization in forest goers and treatment seeking in elimination areas, leading to impact in terms of burden reduction and elimination.","Target-group-specific, locally appropriate, Behaviour Change Communication (BCC) materials and methodologies will be developed and produced for all high-risk groups, as well as for communities approaching elimination. Border-specific packages will also be produced. A mobile phone-based BCC programme  will be developed. Where appropriate work will be carried out in partnership with a commercial advertising agency. This should result in significant improvements in LLIIN utilization in forest goers and treatment seeking in elimination areas, leading to impact in terms of burden reduction and elimination.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","High","1524883","Support for behavior change communication (BCC) under the within allocation amount is limited to interpersonal communication (IPC) and community mobilization.","0","0","0","0","1524883","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ08/view","2020-12-31","Malaria",1524883," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713=AN350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713=AO350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713=AP350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713=AJ350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713=AN350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713=AO350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713=AP350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G350)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ09UAG","PAI-3887","Inactive","BGD-Malaria-5","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","LLIN  Mass campaign. The within allocation request covers the absolute, high and medium priority areas. There are a significant number of people at risk in low priority areas that will be left uncovered. Free LLINs will be expanded to cover the entire population residing in targeted established settlements. This will complement the within allocation LLIN approach and result in reduced transmission.","LLIN  Mass campaign. The within allocation request covers the absolute, high and medium priority areas. There are a significant number of people at risk in low priority areas that will be left uncovered. Free LLINs will be expanded to cover the entire population residing in targeted established settlements. This will complement the within allocation LLIN approach and result in reduced transmission.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","2198599","There are a significant number of people at risk in low priority areas that will be left uncovered.","876518","1322081","0","0","0","1","0","2020-01-17 13:48:56","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ09/view","2020-12-31","Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713=AN351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713=AO351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713=AP351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713=AJ351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713=AN351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713=AO351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713=AP351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0AUAW","PAI-3888","Active","BGD-Malaria-6","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Quarterly meetings will be held at district level to support planning, coordination and management. The HR development plan will be updated, key staff will be recruited for the Program Managment Unit to support the reorientation of the programme, and needs-based training will be provided as necessary. Equipment will be maintained. Furniture (medium priority) and office equipment will be replaced where necessary. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programmes elimination goal.","Quarterly meetings will be held at district level to support planning, coordination and management. The HR development plan will be updated, key staff will be recruited for the Program Managment Unit to support the reorientation of the programme, and needs-based training will be provided as necessary. Equipment will be maintained. Furniture (medium priority) and office equipment will be replaced where necessary. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programmes elimination goal.",null,"Medium","1692852","The general management of the program requires support that goes beyond that covered by the within allocation request.","0","0","0","0","1692852","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0A/view","2020-12-31","Malaria",1692852," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713=AN352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713=AO352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713=AP352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713=AJ352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713=AN352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713=AO352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713=AP352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G352)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0BUAW","PAI-3889","Active","BGD-Malaria-7","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"Vector control","Entomological monitoring","Entomological monitoring. In-line with the recommendations of the last two programme reviews,extensive support to revitalize entomological services will be conducted including: set-up, running and maintenance costs for an insectary; Technical Assistance; purchasing a training microscope. Vector incrimination surveys will be conducted in 3 sentinel sites. This work should serve to better guide and more effectively target the vector control and a personal protection approach.","Entomological monitoring. In-line with the recommendations of the last two programme reviews,extensive support to revitalize entomological services will be conducted including: set-up, running and maintenance costs for an insectary; Technical Assistance; purchasing a training microscope. Vector incrimination surveys will be conducted in 3 sentinel sites. This work should serve to better guide and more effectively target the vector control and a personal protection approach.",null,"Medium","207367","Entomological monitoring is part of both malaria reduction and elimination efforts.","0","0","0","0","207367","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0B/view","2020-12-31","Malaria",207367," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713=AN353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713=AO353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713=AP353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713=AJ353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713=AN353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713=AO353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713=AP353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0CUAW","PAI-3890","Active","BGD-Malaria-8","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","A comprehensive package of needs-based operational research will be conducted in collaboration with WHO and national and international experts and institutes. Equipment will be procured as required. LLIN utilization surveys will be carried out in different risk populations and resulting data will be used to fine-tune strategies and thereby improve impact.","A comprehensive package of needs-based operational research will be conducted in collaboration with WHO and national and international experts and institutes. Equipment will be procured as required. LLIN utilization surveys will be carried out in different risk populations and resulting data will be used to fine-tune strategies and thereby improve impact.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","72698","Operational research is needed under the both disease burden reduction and malaria elimination efforts.","0","0","0","0","72698","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0C/view","2020-12-31","Malaria",72698," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713=AN354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713=AO354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713=AP354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713=AJ354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713=AN354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713=AO354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713=AP354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G354)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0DUAW","PAI-3891","Active","BGD-Malaria-9","2017-2019","RT High Impact Asia","Bangladesh","Malaria","Malaria","FR100-BGD-M",null,null,"Program management","Grant management","The general management of the programme requires support that goes beyond that covered by the within allocation request. WHO will provide Technical Assistance. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programmes elimination goal.","The general management of the programme requires support that goes beyond that covered by the within allocation request. WHO will provide Technical Assistance. This additional support will help to ensure that the programme is functioning at full capacity and this will accelerate progress towards the programmes elimination goal.",null,"Low","190443","This additional support will help to ensure that the program is functioning at full capacity and this will accelerate progress towards the programs elimination goal.","0","0","0","0","190443","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0D/view","2020-12-31","Malaria",190443," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713=AN355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713=AO355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713=AP355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713=AJ355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713=AN355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713=AO355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713=AP355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G355)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0EUAW","PAI-3892","Active","BGD-Tuberculosis-1","2017-2019","RT High Impact Asia","Bangladesh","Tuberculosis","Tuberculosis","FR100-BGD-T",null,null,"TB care and prevention","Case detection and diagnosis","Additional community case finding activities in hard-to reach areas not covered by the allocation and/or matching fund request, introduction of the new diagnostic algorithm in additional upazilas in remote areas, establishment of additional diagnostic facilities (X-ray, FNAC, X-pert) to improve the diagnosis of smear-negative, Child-TB and Extra Pulmoniary cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","Additional community case finding activities in hard-to reach areas not covered by the allocation and/or matching fund request, introduction of the new diagnostic algorithm in additional upazilas in remote areas, establishment of additional diagnostic facilities (X-ray, FNAC, X-pert) to improve the diagnosis of smear-negative, Child-TB and Extra Pulmoniary cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.",null,"High","41348864","Expands evidence-based and appropriate interventions for increased case finding.","22232521","14701807","0","0","4414536","0","0","2020-01-17 13:47:36","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0E/view","2020-12-31","Tuberculosis",4414536," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713=AN356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713=AO356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713=AP356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713=AJ356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713=AN356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713=AO356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713=AP356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0FUAW","PAI-3893","Active","BGD-Tuberculosis-2","2017-2019","RT High Impact Asia","Bangladesh","Tuberculosis","Tuberculosis","FR100-BGD-T",null,null,"MDR-TB","Treatment: MDR-TB","Provision of second-line drugs, case based-incentives for community providers and patient social support to manage additional detected MDR-TB cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","Provision of second-line drugs, case based-incentives for community providers and patient social support to manage additional detected MDR-TB cases. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","NA Original Module: Multidrug-resistant TB","High","4296821","Provision of SLDs and incentives for community providers to manage additional detected MDR TB cases.","0","0","0","0","4296821","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0F/view","2020-12-31","Tuberculosis",4296821," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713=AN357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713=AO357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713=AP357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713=AJ357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713=AN357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713=AO357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713=AP357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G357)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0GUAW","PAI-3894","Active","BGD-Tuberculosis-3","2017-2019","RT High Impact Asia","Bangladesh","Tuberculosis","Tuberculosis","FR100-BGD-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Further expansion of case finding activities targeting specific risk groups (urban poor, factory workers, garment workers, brick field workers, miners, elderly people, pregnant women) in areas not covered by the allocation and/or matching fund request, additional IEC activities targeting high-risk groups in urban- and sub-district areas. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","Further expansion of case finding activities targeting specific risk groups (urban poor, factory workers, garment workers, brick field workers, miners, elderly people, pregnant women) in areas not covered by the allocation and/or matching fund request, additional IEC activities targeting high-risk groups in urban- and sub-district areas. Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","NA Original Intervention: Key population programs","High","408949","Expands evidence based and appropriate interventions for increased case finding specifically in specific risk groups.","0","0","0","0","408949","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0G/view","2020-12-31","Tuberculosis",408949," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713=AN358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713=AO358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713=AP358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713=AJ358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713=AN358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713=AO358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713=AP358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0HUAW","PAI-3895","Active","BGD-Tuberculosis-4","2017-2019","RT High Impact Asia","Bangladesh","Tuberculosis","Tuberculosis","FR100-BGD-T",null,null,"TB/HIV","TB/HIV collaborative interventions","Establishment and running costs of additional VCT centers in hard-to reach areas, social support for additional detected TB/HIV patients Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.","Establishment and running costs of additional VCT centers in hard-to reach areas, social support for additional detected TB/HIV patients Expected outcome (in combination with activities under the other modules listed in this component): achievement of 100% of NSP targets for case detection and treatment outcomes.",null,"Medium","195225","Supports additional voluntary counselling and testing (VCT) centers in hard-to-reach areas and social support for TB/HIV patients.","0","0","0","0","195225","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0H/view","2020-12-31","Tuberculosis",195225," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713=AN359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713=AO359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713=AP359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713=AJ359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713=AN359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713=AO359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713=AP359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G359)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0IUAW","PAI-3896","Active","BLZ-TB/HIV-1","2017-2019","RT Latin America and Caribbean","Belize","HIV/TB","HIV/AIDS, Tuberculosis","FR375-BLZ-C",null,null,"RSSH: Community responses and systems","Community led advocacy","The capacity of Civil Society Hubs members in human rights, legal and anti-stigma discrimination is key as communities must play an integral role in advocating for policy change and legal reform at all levels of the public system (including the Attorney Generals Office, Ministries of Finance and Economic Development) on issues like the non-discrimination law, social contracting and other key populations human rights issues.","The capacity of Civil Society Hubs members in human rights, legal and anti-stigma discrimination is key as communities must play an integral role in advocating for policy change and legal reform at all levels of the public system (including the Attorney Generals Office, Ministries of Finance and Economic Development) on issues like the non-discrimination law, social contracting and other key populations human rights issues.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","High","50000",null,"0","0","0","0","50000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0I/view","2021-12-31","TB/HIV",50000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713=AN360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713=AO360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713=AP360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713=AJ360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713=AN360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713=AO360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713=AP360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G360)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ0JUAW","PAI-3897","Active","BLZ-TB/HIV-2","2017-2019","RT Latin America and Caribbean","Belize","HIV/TB","HIV/AIDS, Tuberculosis","FR375-BLZ-C",null,null,"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Develop an electronic information system to track demand and supply of medicines and commodities at the facility level. This is a key component of the roadmap for Treat All to ensure that challenges presently experienced with stock outs are minimized.","Develop an electronic information system to track demand and supply of medicines and commodities at the facility level. This is a key component of the roadmap for Treat All to ensure that challenges presently experienced with stock outs are minimized.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Other procurement and supply chain management intervention(s)","High","30000","The TRP considers this intervention highly relevant to prevent stock-out of medication and recommends that this intervention should be moved into within the allocation request.","0","0","0","0","30000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0J/view","2021-12-31","TB/HIV",30000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713=AN361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713=AO361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713=AP361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713=AJ361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713=AN361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713=AO361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713=AP361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ0KUAW","PAI-3898","Active","BLZ-TB/HIV-3","2017-2019","RT Latin America and Caribbean","Belize","HIV/TB","HIV/AIDS, Tuberculosis","FR375-BLZ-C",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Mini grants of USD 10,000 each for Civil Society Organisations (CSO) to build their institutional capacity necessary to carry out the work of the CSO Hub in the 4 different areas beyond the Global Fund grant. The need will vary among the CSOs, but will evolve around needs for equipment, furnitures or/and to pay stipends.","Mini grants of USD 10,000 each for Civil Society Organisations (CSO) to build their institutional capacity necessary to carry out the work of the CSO Hub in the 4 different areas beyond the Global Fund grant. The need will vary among the CSOs, but will evolve around needs for equipment, furnitures or/and to pay stipends.","NA Original Module: RSSH - Community responses and systems","High","1e+05","The TRP considers this intervention highly relevant for the capability of CSOs in providing services for TB and HIV and recommends that this intervention should be moved into within the allocation request","50000","0","0","0","50000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0K/view","2021-12-31","TB/HIV",50000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713=AN362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713=AO362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713=AP362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713=AJ362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713=AN362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713=AO362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713=AP362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ0LUAW","PAI-3899","Active","BLZ-TB/HIV-4","2017-2019","RT Latin America and Caribbean","Belize","HIV/TB","HIV/AIDS, Tuberculosis","FR375-BLZ-C",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Mini grants of USD 5,000 each for Civil Society Organisations (CSO) to build their capacity to be sustainable beyond the Global Fund. This could include strategic sustainability planning, social networking advocacy and negotiation, non-traditional income generation, developing proposals for external funding and any other activity or progamme that would contribute to their sustainability beyond 2021.","Mini grants of USD 5,000 each for Civil Society Organisations (CSO) to build their capacity to be sustainable beyond the Global Fund. This could include strategic sustainability planning, social networking advocacy and negotiation, non-traditional income generation, developing proposals for external funding and any other activity or progamme that would contribute to their sustainability beyond 2021.","NA Original Module: RSSH - Community responses and systems","High","50000","The TRP considers this intervention highly relevant to prevent stock-out of medication and recommends that this intervention should be moved into within the allocation request.","0","0","0","0","50000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0L/view","2021-12-31","TB/HIV",50000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713=AN363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713=AO363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713=AP363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713=AJ363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713=AN363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713=AO363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713=AP363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ0MUAW","PAI-3900","Active","BLZ-TB/HIV-5","2017-2019","RT Latin America and Caribbean","Belize","HIV/TB","HIV/AIDS, Tuberculosis","FR375-BLZ-C",null,null,"Comprehensive prevention programs for MSM","HIV testing services for MSM","HIV testing will be provided by a Civil Society Organisation (CSO) through the CSO Hub.  This activity will fund stipends of peer educators to reach more hard-to-reach Men who have sex with Men (MSM) and transgender people (TG) for testing. The activity will also include support for staff members conducting testing.","HIV testing will be provided by a Civil Society Organisation (CSO) through the CSO Hub.  This activity will fund stipends of peer educators to reach more hard-to-reach Men who have sex with Men (MSM) and transgender people (TG) for testing. The activity will also include support for staff members conducting testing.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","High","40000",null,"0","0","0","0","40000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0M/view","2021-12-31","TB/HIV",40000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713=AN364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713=AO364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713=AP364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713=AJ364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713=AN364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713=AO364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713=AP364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ0NUAW","PAI-3901","Active","BLZ-TB/HIV-6","2017-2019","RT Latin America and Caribbean","Belize","HIV/TB","HIV/AIDS, Tuberculosis","FR375-BLZ-C",null,null,"Program management","Other program management intervention(s)","The role of the Civil Society Organizations Hub (CSO Hub) as coordinator is an important component of this grant.  This intervention will enable regular Monitoring and Evaluation visits by the CSO hub, and includes the development of M&E Tools, the preparation of reports, the development of and implementation of a mechanism for project coordination including in terms of operational planning.","The role of the Civil Society Organizations Hub (CSO Hub) as coordinator is an important component of this grant.  This intervention will enable regular Monitoring and Evaluation visits by the CSO hub, and includes the development of M&E Tools, the preparation of reports, the development of and implementation of a mechanism for project coordination including in terms of operational planning.",null,"Medium","1e+05","The TRP considers this of medium relevance in a situation of transition.","0","0","0","0","1e+05","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0N/view","2021-12-31","TB/HIV",100000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713=AN365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713=AO365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713=AP365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713=AJ365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713=AN365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713=AO365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713=AP365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G365)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ0OUAW","PAI-3902","Active","BLZ-TB/HIV-7","2017-2019","RT Latin America and Caribbean","Belize","HIV/TB","HIV/AIDS, Tuberculosis","FR375-BLZ-C",null,null,"Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","This intervention proposes to conduct an assessment of the implementation of the HIV/AIDS Policy of the Public Service of Belize and revise the policy based on the recommendations of the assessment. This is important to strengthen the capacity of the Employee Assistance Program to enforce the implementation of the HIV policy which addresses issues like non-discrimination among public officers.","This intervention proposes to conduct an assessment of the implementation of the HIV/AIDS Policy of the Public Service of Belize and revise the policy based on the recommendations of the assessment. This is important to strengthen the capacity of the Employee Assistance Program to enforce the implementation of the HIV policy which addresses issues like non-discrimination among public officers.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Medium","20000",null,"0","0","0","0","20000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0O/view","2021-12-31","TB/HIV",20000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713=AN366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713=AO366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713=AP366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713=AJ366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713=AN366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713=AO366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713=AP366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ0PUAW","PAI-3903","Active","BLZ-TB/HIV-8","2017-2019","RT Latin America and Caribbean","Belize","HIV/TB","HIV/AIDS, Tuberculosis","FR375-BLZ-C",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","A major recommendation of the Transition Readiness Assessment is to collect and report updated HIV/TB sero-prevalence data on transgender persons, sex workers (SWs), prisoners, uniformed personnel and undocumented persons to be complemented by a Knowledge, Attitude and Practices (KAP) study with the same key populations. This will provide evidence for future programming especially within the context of sustainability.","A major recommendation of the Transition Readiness Assessment is to collect and report updated HIV/TB sero-prevalence data on transgender persons, sex workers (SWs), prisoners, uniformed personnel and undocumented persons to be complemented by a Knowledge, Attitude and Practices (KAP) study with the same key populations. This will provide evidence for future programming especially within the context of sustainability.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","2e+05","The TRP downgraded this request from high to medium because, although important, the activity is not directly related to monitoring the performance of the planned activities; as per the rationale provided by the applicant, this request is only for future use.","0","0","0","0","2e+05","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0P/view","2021-12-31","TB/HIV",200000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713=AN367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713=AO367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713=AP367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713=AJ367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713=AN367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713=AO367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713=AP367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G367)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ0QUAW","PAI-3904","Active","BLZ-TB/HIV-9","2017-2019","RT Latin America and Caribbean","Belize","HIV/TB","HIV/AIDS, Tuberculosis","FR375-BLZ-C",null,null,"Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","The operationalization of the non-discrimination law is key.  Once the non-discrimination law is introduced by Cabinet there will be need for mass education on this new legislation to make it effective. This is a key activity of the funding request based on the Transition Readiness Assessment findings to improve the legislative environment.","The operationalization of the non-discrimination law is key.  Once the non-discrimination law is introduced by Cabinet there will be need for mass education on this new legislation to make it effective. This is a key activity of the funding request based on the Transition Readiness Assessment findings to improve the legislative environment.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","Low","50000","The TRP considers television spots as low relevance because there is little evidence that TV spots contribute to reducing human rights-related barriers to HIV services.","0","0","0","0","50000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0Q/view","2021-12-31","TB/HIV",50000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713=AN368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713=AO368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713=AP368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713=AJ368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713=AN368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713=AO368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713=AP368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G368)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ0RUAW","PAI-3905","Active","BOL-HIV/AIDS-1","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","HIV/AIDS","HIV/AIDS","FR15-BOL-H",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, total cost is estimated to be USD 200,000. However, in the proposal USD 194,192.26 are budgeted, leaving a difference of USD 5,807.74.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","5808",null,"0","0","0","0","5808","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0R/view","2021-12-31","HIV/AIDS",5808," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713=AN369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713=AO369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713=AP369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713=AJ369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713=AN369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713=AO369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713=AP369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0SUAW","PAI-3906","Active","BOL-HIV/AIDS-2","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","HIV/AIDS","HIV/AIDS","FR15-BOL-H",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.","Second-generation epidemiological surveillance study for GB-MSM population is planned. This study will constitute a source of data for impact and outcome indicators. Based on the cost of previous studies, a total cost of USD 50,000 is estimated.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","50000",null,"0","0","0","0","50000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0S/view","2021-12-31","HIV/AIDS",50000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713=AN370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713=AO370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713=AP370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713=AJ370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713=AN370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713=AO370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713=AP370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G370)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0TUAW","PAI-3907","Active","BOL-HIV/AIDS-3","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","HIV/AIDS","HIV/AIDS","FR15-BOL-H",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Conducting of a study of primary resistance to ARV in new patients is planned as a critical element of strategic information in order to strengthen management, decision-making in terms of antiretroviral drug policies, sustainability and progress towards the goal of suppressing viral loads. A total cost of USD 100,000 is estimated.","Conducting of a study of primary resistance to ARV in new patients is planned as a critical element of strategic information in order to strengthen management, decision-making in terms of antiretroviral drug policies, sustainability and progress towards the goal of suppressing viral loads. A total cost of USD 100,000 is estimated.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","1e+05","As the last sex worker study was conducted in 2010, the TRP considers this proposed study to be a high priority for PAAR. Should additional resources become available through efficiencies or other sources, the TRP recommends prioritization of IBBS for sex workers (including moving this activity into the allocation) so that the applicant can assess if interventions for sex workers are working by having a trend to analyze.","0","0","0","0","1e+05","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0T/view","2021-12-31","HIV/AIDS",100000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713=AN371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713=AO371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713=AP371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713=AJ371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713=AN371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713=AO371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713=AP371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G371)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0UUAW","PAI-3908","Active","BOL-Malaria-1","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","Malaria","Malaria","FR17-BOL-M",null,null,"Case management","Active case detection and investigation (elimination phase)","Activity 59: Amazon Region Meeting to consolidate the AOP for each municipality. (Participants: organized civil population, municipality, regional authorities) prior to preparation of the AOP (July each year) in Cobija.Activity mentioned in the diagnosis for transition as part of the negotiation with municipalities.","Activity 59: Amazon Region Meeting to consolidate the AOP for each municipality. (Participants: organized civil population, municipality, regional authorities) prior to preparation of the AOP (July each year) in Cobija.Activity mentioned in the diagnosis for transition as part of the negotiation with municipalities.","The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number.","High","52155",null,"0","0","0","0","52155","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0U/view","2021-12-31","Malaria",52155," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713=AN372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713=AO372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713=AP372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713=AJ372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713=AN372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713=AO372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713=AP372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G372)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0VUAW","PAI-3909","Active","BOL-Malaria-2","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","Malaria","Malaria","FR17-BOL-M",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the regions needs.","Activity 272: Verification of Kardex, physical inventory, verification in database. There is a need to have stocks available in the field; due to the size of the Amazon region, travel is very expensive and therefore resources are required in order to attend to the regions needs.","The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Module: Monitoring and evaluation","High","62117.18",null,"0","0","0","0","62117.18","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0V/view","2021-12-31","Malaria",62117.18," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713=AN373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713=AO373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713=AP373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713=AJ373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713=AN373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713=AO373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713=AP373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0WUAW","PAI-3910","Active","BOL-Malaria-3","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","Malaria","Malaria","FR17-BOL-M",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","Activity 299: Review of the purchasing process, delivery documents, official receipts from end users in the different regions. Support is required from a person to conclude the processes within time limits appropriate to the intervention.","Activity 299: Review of the purchasing process, delivery documents, official receipts from end users in the different regions. Support is required from a person to conclude the processes within time limits appropriate to the intervention.","The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Module: Monitoring and evaluation","High","30172.41",null,"0","0","0","0","30172.41","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0W/view","2021-12-31","Malaria",30172.41," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713=AN374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713=AO374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713=AP374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713=AJ374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713=AN374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713=AO374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713=AP374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0XUAW","PAI-3911","Active","BOL-Malaria-4","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","Malaria","Malaria","FR17-BOL-M",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Activity 269.1: Quarterly supervision of municipalities or lower levels  for healthcare establishments that carry out diagnosis and treatment (laboratory, hospital, pharmacy); IRS activities and distribution of LLINs in priority locations. Due to reduce allocation, it is essential for the regional authorities to have these resources, especially since the municipalities that intervene in the Amazon region are the poorest in the country and do not receive in equal proportion to the other municipalities the amounts that would contribute to the monitoring of malaria in the Amazon region.","Activity 269.1: Quarterly supervision of municipalities or lower levels  for healthcare establishments that carry out diagnosis and treatment (laboratory, hospital, pharmacy); IRS activities and distribution of LLINs in priority locations. Due to reduce allocation, it is essential for the regional authorities to have these resources, especially since the municipalities that intervene in the Amazon region are the poorest in the country and do not receive in equal proportion to the other municipalities the amounts that would contribute to the monitoring of malaria in the Amazon region.","The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Module: Monitoring and evaluation","Medium","367286","This funding was requested to support the regional supervision of municipalities. The TRP recommends 50 percent of the original amount requested for funding under the PAAR, as it considers the activity to be of medium priority and the amount requested relatively high.","0","0","0","0","367286","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0X/view","2021-12-31","Malaria",367286," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713=AN375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713=AO375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713=AP375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713=AJ375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713=AN375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713=AO375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713=AP375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G375)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0YUAW","PAI-3912","Active","BOL-Malaria-5","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","Malaria","Malaria","FR17-BOL-M",null,null,"Case management","Other case management intervention(s)","Activity 45: Training of medical personnel in clinical handling of malaria cases (2 events per year, from different health services in the endemic area) Riberalta","Activity 45: Training of medical personnel in clinical handling of malaria cases (2 events per year, from different health services in the endemic area) Riberalta","The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Intervention: Treatment in health facility","Medium","55788",null,"0","0","0","0","55788","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0Y/view","2021-12-31","Malaria",55788," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713=AN376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713=AO376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713=AP376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713=AJ376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713=AN376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713=AO376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713=AP376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G376)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0ZUAW","PAI-3913","Active","BOL-Malaria-6","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","Malaria","Malaria","FR17-BOL-M",null,null,"Case management","Other case management intervention(s)","Activity 46: Training for nurses from the Bolivian Amazon Region (Riberalta)","Activity 46: Training for nurses from the Bolivian Amazon Region (Riberalta)","The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Intervention: Treatment in health facility","Medium","30533.15",null,"0","0","0","0","30533.15","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0Z/view","2021-12-31","Malaria",30533.15," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713=AN377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713=AO377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713=AP377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713=AJ377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713=AN377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713=AO377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713=AP377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G377)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0aUAG","PAI-3914","Active","BOL-Malaria-7","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","Malaria","Malaria","FR17-BOL-M",null,null,"Vector control","Other vector control measure(s)","Activity 137: Strategy for elimination and recycling of waste, with communication actions","Activity 137: Strategy for elimination and recycling of waste, with communication actions","The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Intervention: IEC/CCC","Medium","64315.13",null,"0","0","0","0","64315.13","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0a/view","2021-12-31","Malaria",64315.13," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713=AN378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713=AO378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713=AP378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713=AJ378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713=AN378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713=AO378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713=AP378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0bUAG","PAI-3915","Active","BOL-Malaria-8","2017-2019","RT Latin America and Caribbean","Bolivia (Plurinational State)","Malaria","Malaria","FR17-BOL-M",null,null,"Case management","Other case management intervention(s)","Activity 31: Training plan for microscopists in low parasitaemia and strengthening of quality control (Guayaramern)","Activity 31: Training plan for microscopists in low parasitaemia and strengthening of quality control (Guayaramern)","The TRP form of total UQD is 709,745, but the correct one should be 709,744. BUD and GOS has the correct number. Original Intervention: Treatment in health facility","Low","47377.5","This funding was requested to support training of microscopists in identification of cases with low parasitemia. The TRP considers this activity as low priority and also recommends 50 percent of the original request for funding under the PAAR.","0","0","0","0","47377.5","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0b/view","2021-12-31","Malaria",47377.5," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713=AN379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713=AO379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713=AP379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713=AJ379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713=AN379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713=AO379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713=AP379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2021-12-31"]
["a6Q1R000000AJ0cUAG","PAI-3916","Active","BTN-HIV/AIDS-1","2017-2019","RT South East Asia","Bhutan","HIV/AIDS","HIV/AIDS","FR397-BTN-H",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Given the critical future role of community organizations in service delivery, competency and organizational development of relevant CSOs will have a benefit on the national program.","Given the critical future role of community organizations in service delivery, competency and organizational development of relevant CSOs will have a benefit on the national program.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community systems development","High","145000","The support to civil society organisations(CSOs) is important for assuring both earlydetection and adherence to treatment.","68827","0","0","0","76173","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0c/view","2021-06-30","HIV/AIDS",76173," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713=AN380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713=AO380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713=AP380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713=AJ380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713=AN380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713=AO380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713=AP380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0dUAG","PAI-3917","Inactive","BTN-HIV/AIDS-2","2017-2019","RT South East Asia","Bhutan","HIV/AIDS","HIV/AIDS","FR397-BTN-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This funding will be used to establish a national surveillance system and address gaps in program knowledge related to data analysis for strategic decision-making.","This funding will be used to establish a national surveillance system and address gaps in program knowledge related to data analysis for strategic decision-making.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Research and surveillance","High","85500","Health management information system(HMIS) is well developed using district healthinformation software (DHIS2) but theapplicant should strengthen the surveillanceof HIV, sexual transmissible infections (STIs)and Hepatitis B, and use data by managersto strengthen the system","18250","67250","0","0","0","1","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0d/view","2021-06-30","HIV/AIDS",0," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713=AN381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713=AO381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713=AP381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713=AJ381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713=AN381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713=AO381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713=AP381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G381)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0eUAG","PAI-3918","Active","BTN-HIV/AIDS-3","2017-2019","RT South East Asia","Bhutan","HIV/AIDS","HIV/AIDS","FR397-BTN-H",null,null,"Program management","Other program management intervention(s)","This funding will be used to build the capacity of the National HIV/AIDS Commission in order to create an enabling policy environment and improve long-term impact.","This funding will be used to build the capacity of the National HIV/AIDS Commission in order to create an enabling policy environment and improve long-term impact.","NA Original Module: RSSH - Program management. Original Intervention: Health systems development","Medium","35000","Vehicle will be used for supervision as wellas delivery of commodities in pooled systembenefiting integrated health services","0","0","0","0","35000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0e/view","2021-06-30","HIV/AIDS",35000," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713=AN382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713=AO382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713=AP382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713=AJ382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713=AN382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713=AO382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713=AP382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G382)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0fUAG","PAI-3919","Active","BTN-HIV/AIDS-4","2017-2019","RT South East Asia","Bhutan","HIV/AIDS","HIV/AIDS","FR397-BTN-H",null,null,"HSS - Policy and governance","Other policy and governance intervention(s)","This funding will be used to purchase a vehicle to suport program monitoring and evaluation and to transport pharmaceutical and health products between the centers.","This funding will be used to purchase a vehicle to suport program monitoring and evaluation and to transport pharmaceutical and health products between the centers.","NA Original Module: RSSH - Policy and planning. Original Intervention: National HIV/AIDS Commission","Low","55000","While role of National AIDS Commission isimportant, the need for additional resourcesto support policy development is not clearlydeveloped.","0","0","0","0","55000","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0f/view","2021-06-30","HIV/AIDS",55000," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713=AN383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713=AO383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713=AP383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713=AJ383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713=AN383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713=AO383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713=AP383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G383)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0gUAG","PAI-3920","Active","BTN-Malaria-1","2017-2019","RT South East Asia","Bhutan","Malaria","Malaria","FR398-BTN-M",null,null,"Vector control","Other vector control measure(s)","Strengthening community action groups, establishing cross-border information sharing on vector species, improving program capacity for prevention of re-establishment","Strengthening community action groups, establishing cross-border information sharing on vector species, improving program capacity for prevention of re-establishment","NA Original Intervention: Entomological monitoring, IRS support/information education and communication/behaviour change communication (IEC/BCC)","High","136610","Given the extent of vector control activities and use of both LLIN and IRS, it is crucial to monitor insecticide resistance more widely in case insecticide choice needs to be modified.","85429","0","0","0","51181","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0g/view","2021-06-30","Malaria",51181," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713=AN384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713=AO384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713=AP384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713=AJ384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713=AN384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713=AO384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713=AP384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0hUAG","PAI-3921","Active","BTN-Malaria-2","2017-2019","RT South East Asia","Bhutan","Malaria","Malaria","FR398-BTN-M",null,null,"Case management","Other case management intervention(s)","Introduction of new diagnostic tools, improving quality of diagnostics.","Introduction of new diagnostic tools, improving quality of diagnostics.","23/05/2018: As per email of CT(Lindsey Cole),  module \"Case management\" were seperated with 2 interventions on the grant-sign off form during grant negotiations:  \"facility-based treatment\" with remaning UQD 115,495 and \" ICCM\" with remaning UQD 5,523 Original Intervention: Facility-based treatment, epidemic preparedness","High","121018","In the elimination context it is important to intensify detection and treatment of cases (including asymptomatic cases) to contain potential new transmission foci, prevent resurgence and prepare for potential epidemics.","0","0","0","0","121018","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0h/view","2021-06-30","Malaria",121018," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713=AN385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713=AO385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713=AP385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713=AJ385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713=AN385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713=AO385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713=AP385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0iUAG","PAI-3922","Active","BTN-Malaria-3","2017-2019","RT South East Asia","Bhutan","Malaria","Malaria","FR398-BTN-M",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Further development/strengthening community action groups at the block level.","Further development/strengthening community action groups at the block level.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community system strengthening; mobilization and ownership for collaboration","High","64684","This activity funds Community Action Groups (CAG) training for malaria. Community members contribution to control and awareness raising activities in the periphery, are important for strengthening prevention through vector control and for promoting early case detection and treatment in the elimination context.","22459","0","0","0","42225","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0i/view","2021-06-30","Malaria",42225," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713=AN386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713=AO386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713=AP386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713=AJ386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713=AN386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713=AO386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713=AP386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G386)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0jUAG","PAI-3923","Inactive","BTN-Malaria-4","2017-2019","RT South East Asia","Bhutan","Malaria","Malaria","FR398-BTN-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Establishment of web-based reporting system and improving cross-border data sharing.","Establishment of web-based reporting system and improving cross-border data sharing.","23/05/2018: As per email of CT (Lindsey Cole),  module\"RSSH: Health management information systems and M&E\" were seperated with 2 interventions on the grant-sign off form during grant negotiations:  \"routine reporting\" with remaning UQD 79,960 and \"other health information systems and M&E interventions\" with remaning UQD 54,000 Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Strengthening of routine reporting. Analyses, review and transparency; M&E real time - web-based","High","133960","Innovative web-based real time reporting to promote rapid case detection and treatment, which is vital feature for avoiding local transmission and resurgence.","0","133960","0","0","0","1","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0j/view","2021-06-30",{"$f":"IF(OR(I387=\"HIV/AIDS\",I387=\"Tuberculosis\",I387=\"Malaria\",I387=\"RSSH\"),I387, IF(I387=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"Malaria"},{"$f":"VALUE(Y387)","v":0},{"$f":"RIGHT(F387,LEN(F387)-2)","v":" South East Asia"},"Malaria","Malaria",null,null,null,{"$f":"TRIM(AK387)","v":""},{"$f":"TRIM(AL387)","v":""},{"$f":"TRIM(AM387)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713=AN387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713=AO387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713=AP387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IF(AE387<>\"\",AE387,IF(MAX(AQ387,AR387,AS387,AT387)<>0,MAX(AQ387,AR387,AS387,AT387),AU387))","v":"2021-06-30"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713=AJ387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713=AN387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713=AO387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713=AP387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G387)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IF(AE387<>\"\",AE387,IF(MAX(AW387,AX387,AY387,AZ387)<>0,MAX(AW387,AX387,AY387,AZ387),BA387))","v":"2021-06-30"}]
["a6Q1R000000AJ0kUAG","PAI-3924","Inactive","BTN-Tuberculosis-1","2017-2019","RT South East Asia","Bhutan","Tuberculosis","Tuberculosis","FR399-BTN-T",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","Procurement of additional laboratory equipment for MDR-TB diagnosis and drugs for XDR-TB treatment.","Procurement of additional laboratory equipment for MDR-TB diagnosis and drugs for XDR-TB treatment.","NA Original Module: Multidrug-resistant TB","High","174994","Training of Medical officers around the introduction of the new MDR regimen as well as the procurement of Laboratory equipment (1 GeneXpert and Culture/drug susceptibility capacity) is critical to the TB control goals of this FR. This module qualifies as value for money.","174994","0","0","0","0","1","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0k/view","2021-06-30","Tuberculosis",0," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713=AN388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713=AO388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713=AP388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713=AJ388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713=AN388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713=AO388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713=AP388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G388)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0lUAG","PAI-3925","Active","BTN-Tuberculosis-2","2017-2019","RT South East Asia","Bhutan","Tuberculosis","Tuberculosis","FR399-BTN-T",null,null,"TB care and prevention","Case detection and diagnosis","Procurement of biosafety cabinets, training interdisciplinary team on tb screening, contact tracing and follow-up for MDR-TB patients.","Procurement of biosafety cabinets, training interdisciplinary team on tb screening, contact tracing and follow-up for MDR-TB patients.",null,"High","186736","Intensification of DOT activities and early diagnosis through ACF will decrease MDRTB transmission and amplification. These activities are value for money and will amplify the impact of the within allocation request.","31500","0","0","0","155236","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0l/view","2021-06-30","Tuberculosis",155236," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713=AN389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713=AO389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713=AP389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713=AJ389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713=AN389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713=AO389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713=AP389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0mUAG","PAI-3926","Inactive","BTN-Tuberculosis-3","2017-2019","RT South East Asia","Bhutan","Tuberculosis","Tuberculosis","FR399-BTN-T",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","Funds for conducting operational research, establishing internet connectivity for web-based reporting and funding for an external review of the TB program","Funds for conducting operational research, establishing internet connectivity for web-based reporting and funding for an external review of the TB program","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","52600","The TRP has removed the cost of the master's degree program. The funds remaining in this module are to increase internet connectivity to support use of the electronic medical reporting system and has maintained the cost of support for internet connectivity improvements to support reporting efforts. This is value for money and will amplify the impact of the within allocation request.","0","52600","0","0","0","1","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0m/view","2021-06-30","Tuberculosis",0," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713=AN390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713=AO390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713=AP390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713=AJ390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713=AN390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713=AO390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713=AP390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G390)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0nUAG","PAI-3927","Active","BTN-Tuberculosis-4","2017-2019","RT South East Asia","Bhutan","Tuberculosis","Tuberculosis","FR399-BTN-T",null,null,"Other module","Case detection and diagnosis","Training of medical doctors on management of TB/HIV co-infection, training of TB and VCT focal persons on TB/HIV collaborative guidelines.","Training of medical doctors on management of TB/HIV co-infection, training of TB and VCT focal persons on TB/HIV collaborative guidelines.","NA Original Module: TB/HIV collaborative intervention. Original Intervention: Case detection and management","High","41670","Although HIV levels are low in Bhutan at the present, it remains critical to maintain the surveillance in TB patients to monitor the epidemic transmission characteristics.","0","0","0","0","41670","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0n/view","2021-06-30","Tuberculosis",41670," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713=AN391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713=AO391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713=AP391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713=AJ391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713=AN391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713=AO391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713=AP391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ0oUAG","PAI-3928","Active","CAF-TB/HIV-1","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"Treatment, care and support","HIV care","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.",null,"High","10560118.95","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority","306571.65","8264649.31","0","0","1988897.99","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0o/view","2020-12-31","TB/HIV",1988897.99," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713=AN392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713=AO392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713=AP392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713=AJ392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713=AN392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713=AO392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713=AP392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G392)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0pUAG","PAI-3929","Inactive","CAF-TB/HIV-10","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","These activities are under-financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","These activities are under-financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.",null,"High","8553.47","These activities are under -financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations .","8553.47","0","0","0","0","1","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0p/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713=AN393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713=AO393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713=AP393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713=AJ393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713=AN393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713=AO393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713=AP393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G393)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0qUAG","PAI-3930","Inactive","CAF-TB/HIV-11","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"Comprehensive prevention programs for MSM","Community empowerment for MSM","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Community empowerment for men who have sex with men","High","2394.79","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations","2394.79","0","0","0","0","1","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0q/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713=AN394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713=AO394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713=AP394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713=AJ394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713=AN394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713=AO394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713=AP394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0rUAG","PAI-3931","Active","CAF-TB/HIV-12","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"MDR-TB","Prevention for MDR-TB","Prevention of MDR-TB highly relevant to prevent escalation of the MDR-TB situation.","Prevention of MDR-TB highly relevant to prevent escalation of the MDR-TB situation.","NA Original Module: Multidrug-resistant TB","High","126116.04","The TRP considers prevention of MDR -TB highly relevant to prevent escalation of the MDR -TB situation.","0","0","0","0","126116.04","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0r/view","2020-12-31","TB/HIV",126116.04," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713=AN395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713=AO395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713=AP395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713=AJ395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713=AN395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713=AO395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713=AP395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0sUAG","PAI-3932","Active","CAF-TB/HIV-13","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Expansion of diagnostic activities important in as large a part of the country as possible.","Expansion of diagnostic activities important in as large a part of the country as possible.","NA Original Intervention: Screening and diagnosis of cases","High","25709.8","The TRP considers expansion of diagnostic activities important in as large a part of the country as possible.","0","0","0","0","25709.8","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0s/view","2020-12-31","TB/HIV",25709.8," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713=AN396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713=AO396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713=AP396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713=AJ396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713=AN396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713=AO396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713=AP396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0tUAG","PAI-3933","Active","CAF-TB/HIV-14","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Addressing key populations important.","Addressing key populations important.","NA Original Intervention: Key populations (TB care and prevention)  Others","High","940.41","The TRP considers addressing key populations important.","0","0","0","0","940.41","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0t/view","2020-12-31","TB/HIV",940.41," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713=AN397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713=AO397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713=AP397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713=AJ397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713=AN397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713=AO397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713=AP397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0uUAG","PAI-3934","Active","CAF-TB/HIV-15","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"Program management","Grant management","Increase treatment coverage and expand prevention services beyond the stated priority districts the allocation will support additional program management costs.","Increase treatment coverage and expand prevention services beyond the stated priority districts the allocation will support additional program management costs.",null,"High","2958424.42","Given the recommendation from the TRP to increase treatment coverage and expand prevention services beyond the stated priority districts the allocation will support additional program management t costs.","443762.77","0","0","0","2514661.65","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0u/view","2020-12-31","TB/HIV",2514661.65," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713=AN398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713=AO398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713=AP398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713=AJ398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713=AN398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713=AO398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713=AP398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G398)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0vUAG","PAI-3935","Inactive","CAF-TB/HIV-16","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"RSSH: Health management information systems and M&E","Program and data quality","The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","521475.7","Complementary efforts to ensure rigorous monitoring and evaluation in inaccessible zones: annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures; general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","521475.7","0","0","0","0","1","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0v/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713=AN399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713=AO399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713=AP399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713=AJ399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713=AN399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713=AO399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713=AP399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G399)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0wUAG","PAI-3936","Inactive","CAF-TB/HIV-17","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","463685.33","Complementary efforts to ensure rigorous monitoring and evaluation in inaccessible zones: annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures; general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","463685.33","0","0","0","0","1","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0w/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713=AN400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713=AO400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713=AP400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713=AJ400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713=AN400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713=AO400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713=AP400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0xUAG","PAI-3937","Active","CAF-TB/HIV-18","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","The national TB monitoring and evaluation system has not been spared by the crisis. The program seeks to ensure rigorous monitoring and evaluation in inaccessible zones. The additional resources requested will serve to fund an annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures, to ensure general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","80065.09","Complementary efforts to ensure rigorous monitoring and evaluation in inaccessible zones: annual workshop for the evaluation of HIV and TB health care in prisons and quarterly meetings to approve the data in the 16 prefectures; general supervision of the fight against TB and specific supervision of the activities to fight TB to be carried out by the CSOs.","0","0","0","0","80065.09","0","0","2019-10-30 15:32:51","2019-10-30 15:32:50","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0x/view","2020-12-31","TB/HIV",80065.09," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713=AN401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713=AO401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713=AP401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713=AJ401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713=AN401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713=AO401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713=AP401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G401)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0yUAG","PAI-3938","Active","CAF-TB/HIV-19","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Ensure availability of human resources for the provision of services.","Ensure availability of human resources for the provision of services.","NA Original Module: RSSH - Human resources for health, including community health workers","High","77875.66","Ensure availability of human resources for the provision of services.","0","0","0","0","77875.66","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0y/view","2020-12-31","TB/HIV",77875.66," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713=AN402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713=AO402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713=AP402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713=AJ402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713=AN402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713=AO402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713=AP402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ0zUAG","PAI-3939","Inactive","CAF-TB/HIV-2","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"Treatment, care and support","Treatment monitoring - Viral load","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.","NA Original Intervention: Treatment monitoring  Viral load","High","1443950.17","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority","0","1443950.17","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ0z/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713=AN403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713=AO403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713=AP403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713=AJ403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713=AN403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713=AO403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713=AP403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G403)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ10UAG","PAI-3940","Inactive","CAF-TB/HIV-3","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"PMTCT","Prong 3: Preventing vertical HIV transmission","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.","NA Original Module: Prevention of mother-to-child transmission","High","669933.79","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority","0","669934","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ10/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713=AN404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713=AO404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713=AP404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713=AJ404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713=AN404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713=AO404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713=AP404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G404)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ11UAG","PAI-3941","Inactive","CAF-TB/HIV-4","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"Treatment, care and support","Prevention, diagnosis and treatment of opportunistic infections","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority.",null,"High","216656.94","The allocation amount from the Global Fund will only allow for 39,752 people living with HIV to be kept under ARV treatment in 2018 and 2019. This above-allocation request will make it possible to include coverage for 24,000 new patients (pregnant women and PMTCT, children born HIV+, TB/HIV co-infected patients, key populations and pre-ARV treatment patients): giving totals of 47,752 PLHIV in 2018, 55,752 in 2019 and 63,752 in 2020, based on the growth of the active cohort, which is an average of 8,000 new patients per year. Given the huge treatment gap, these activities are considered high priority","216656.94","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ11/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713=AN405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713=AO405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713=AP405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713=AJ405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713=AN405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713=AO405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713=AP405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ12UAG","PAI-3942","Inactive","CAF-TB/HIV-5","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Acquisition of ARVs for 4,909 pregnant women who are HIV positive, reagents and consumables for screening pregnant women and advocacy campaigns directed towards women of childbearing age. This high priority given the low coverage of PMTCT services.","Acquisition of ARVs for 4,909 pregnant women who are HIV positive, reagents and consumables for screening pregnant women and advocacy campaigns directed towards women of childbearing age. This high priority given the low coverage of PMTCT services.","NA Original Module: Prevention of mother-to-child transmission","High","121466.73","Acquisition of ARVs for 4,909 pregnant women who are HIV positive, reagents and consumables for screening pregnant women and advocacy campaigns directed towards women of childbearing age. This high priority given the low coverage of PMTCT services","0","121467","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ12/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713=AN406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713=AO406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713=AP406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713=AJ406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713=AN406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713=AO406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713=AP406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G406)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ13UAG","PAI-3943","Inactive","CAF-TB/HIV-6","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"Comprehensive prevention programs for MSM","Community empowerment for MSM","Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.","Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Community empowerment for men who have sex with men","High","60562.23","Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority","60562.23","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ13/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713=AN407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713=AO407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713=AP407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713=AJ407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713=AN407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713=AO407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713=AP407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ14UAG","PAI-3944","Inactive","CAF-TB/HIV-7","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.","Prevention activities are dramatically under financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention programs are severely underfunded and are considered high priority.",null,"High","39758.73","Prevention activities are dramatically under-financed in the allocation request and these resources will support prevention interventions in additional Geographical locations. Prevention program are severely underfunded and are considered high priority","39758.73","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ14/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713=AN408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713=AO408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713=AP408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713=AJ408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713=AN408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713=AO408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713=AP408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G408)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ15UAG","PAI-3945","Active","CAF-TB/HIV-8","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"TB/HIV","Other TB/HIV intervention(s)","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.",null,"High","37637.75","These activities are under financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","0","0","0","0","37637.75","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ15/view","2020-12-31","TB/HIV",37637.75," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713=AN409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713=AO409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713=AP409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713=AJ409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713=AN409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713=AO409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713=AP409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G409)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ16UAG","PAI-3946","Inactive","CAF-TB/HIV-9","2017-2019","RT Central Africa","Central African Republic","HIV/TB","HIV/AIDS, Tuberculosis","FR100-CAF-C",null,null,"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","These activities are under-financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","These activities are under-financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","High","33227.47","These activities are under -financed in the allocation request and the additional resources will support prevention interventions in additional Geographical locations .","33227.47","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ16/view","2020-12-31","TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713=AN410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713=AO410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713=AP410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713=AJ410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713=AN410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713=AO410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713=AP410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ17UAG","PAI-3947","Inactive","CIV-HIV/AIDS-1","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","HIV/AIDS","HIV/AIDS","FR184-CIV-H",null,null,"Treatment, care and support","Treatment adherence","Organize biannual exchange meeting by district between health care workers in health facilities, traditional healers, and religious leaders in 28 health districts in order to increase referrals of PLWHA to health centers in order to have better program adherence and to reduce stigma.","Organize biannual exchange meeting by district between health care workers in health facilities, traditional healers, and religious leaders in 28 health districts in order to increase referrals of PLWHA to health centers in order to have better program adherence and to reduce stigma.","No amount assigned for UQD in sign-off form.","High","91972.38","Organize biannual exchange meeting by district between health care workers in health facilities, traditional healers, and religious leaders in 28 health districts to increase referrals of people living with HIV to health centers, with the objective of improving adherence to treatment and reducing stigma. High priority because TRP considers that community mobilization, particularly the involvement and buy-in of community leaders, is important in promoting adherence and achieving the 2nd and 3rd 90.","91972.38","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ17/view","2020-12-31","HIV/AIDS",0," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713=AN411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713=AO411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713=AP411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713=AJ411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713=AN411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713=AO411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713=AP411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G411)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ18UAG","PAI-3948","Inactive","CIV-HIV/AIDS-2","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","HIV/AIDS","HIV/AIDS","FR184-CIV-H",null,null,"PMTCT","Other intervention(s) for PMTCT","Develop the Husband School approach Implement the husband school approach in the Sud-Como region. This innovative approach has a double benefitit increases the Funding request: Full review 15 February 2017 | 57 involvement of men in reducing barriers to access of PMTCT services as well improving the retention of seropositive pregnant women in care. Also, it fill the gaps on the vulnerable population of men over 35 by ensuring their access to screening through the front door of the PMTCT service. This intervention will involve the training of community actors in this approach so that they can implement the activities in 3 health districts in the Sud-Como region. It also involves the supplying of kits and guidance documents concerning this approach as well as workshops, missions, and supervisory visits.","Develop the Husband School approach Implement the husband school approach in the Sud-Como region. This innovative approach has a double benefitit increases the Funding request: Full review 15 February 2017 | 57 involvement of men in reducing barriers to access of PMTCT services as well improving the retention of seropositive pregnant women in care. Also, it fill the gaps on the vulnerable population of men over 35 by ensuring their access to screening through the front door of the PMTCT service. This intervention will involve the training of community actors in this approach so that they can implement the activities in 3 health districts in the Sud-Como region. It also involves the supplying of kits and guidance documents concerning this approach as well as workshops, missions, and supervisory visits.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Other interventions for PMTCT","High","150720.51","Development of the Husband School approach in the SudComo region should contribute to PMTCT as well as reduce GBV/ High priority because men are often gatekeepers to health care for women and children, and Husband Schools can reduce barriers to access to treatment and care, especially for PMTCT, as shown by international normative guidance.","150720.51","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ18/view","2020-12-31","HIV/AIDS",0," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713=AN412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713=AO412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713=AP412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713=AJ412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713=AN412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713=AO412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713=AP412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ19UAG","PAI-3949","Inactive","CIV-HIV/AIDS-3","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","HIV/AIDS","HIV/AIDS","FR184-CIV-H",null,null,"Treatment, care and support","Counseling and psycho-social support","Strengthen nutritional monitoring among people living with HIV/AIDS and orphans and vulnerable children This intervention will provide nutritional support to 671 households of orphans and vulnerable children experiencing food insecurity. Moreover, 2 additional post-distribution evaluations will be done during 2019-2020 in order to quantify the impact of this nutritional assistance. Tools to raise awareness will be produced in order to increase the impact of nutritional interventions included in the within-allocation demand, with a view to more patient adherence to the program.","Strengthen nutritional monitoring among people living with HIV/AIDS and orphans and vulnerable children This intervention will provide nutritional support to 671 households of orphans and vulnerable children experiencing food insecurity. Moreover, 2 additional post-distribution evaluations will be done during 2019-2020 in order to quantify the impact of this nutritional assistance. Tools to raise awareness will be produced in order to increase the impact of nutritional interventions included in the within-allocation demand, with a view to more patient adherence to the program.",null,"Medium","629775.18","Provide nutritional support to 671 households of orphans and vulnerable children experiencing food insecurity. This is a WHO recommendation which can directly improve treatment outcomes. However, this is medium priority because the applicant does not provide any justification on adequacy of the targets set.","629775.18","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ19/view","2020-12-31","HIV/AIDS",0," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713=AN413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713=AO413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713=AP413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713=AJ413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713=AN413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713=AO413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713=AP413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1AUAW","PAI-3950","Inactive","CIV-HIV/AIDS-4","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","HIV/AIDS","HIV/AIDS","FR184-CIV-H",null,null,"Treatment, care and support","Counseling and psycho-social support","Establish savings and credit groups in order to empower those living with HIV/AIDS. This will include the training of community health workers to implement activities to strengthen the economic and sustainable development of households with people living with HIV/AIDS. This is expected to be done through regular monitoring and supervision of 56 savings and credit groups. Kits will be made available to these 56 groups to implement this approach. This activity will ensure the increase to access and adherence to treatment for a more robust impact of the interventions described in the within-allocation demand.","Establish savings and credit groups in order to empower those living with HIV/AIDS. This will include the training of community health workers to implement activities to strengthen the economic and sustainable development of households with people living with HIV/AIDS. This is expected to be done through regular monitoring and supervision of 56 savings and credit groups. Kits will be made available to these 56 groups to implement this approach. This activity will ensure the increase to access and adherence to treatment for a more robust impact of the interventions described in the within-allocation demand.",null,"Medium","264132.68","Establish savings and credit groups to empower people living with HIV/AIDS. Medium priority because the applicant does not provide sufficient details on how this intervention is tailored to wider efforts to address social determinants of wellbeing of PLHIV.","264132.68","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1A/view","2020-12-31","HIV/AIDS",0," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713=AN414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713=AO414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713=AP414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713=AJ414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713=AN414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713=AO414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713=AP414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G414)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1BUAW","PAI-3951","Inactive","CIV-HIV/AIDS-5","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","HIV/AIDS","HIV/AIDS","FR184-CIV-H",null,null,"PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Train CHWs to focus on the socio-cultural barriers to access to maternal and child health services This activity will consist of organizing one orientation session by health district in order to increase the number of pregnant women seeking PMTCT services and the retention rate of seropositive pregnant women to these services. This activity will strengthen the family-based approach to be implemented by CHWs in 28 districts as part of the within-allocation funding request.","Train CHWs to focus on the socio-cultural barriers to access to maternal and child health services This activity will consist of organizing one orientation session by health district in order to increase the number of pregnant women seeking PMTCT services and the retention rate of seropositive pregnant women to these services. This activity will strengthen the family-based approach to be implemented by CHWs in 28 districts as part of the within-allocation funding request.","NA Original Module: Prevention of mother-to-child transmission","Low","314578.54","Train community health workers to focus on the socio-cultural barriers to access to maternal and child health services. Low priority because TRP is concerned that this is presented as a one-off intervention lacking a longer-term strategy.","314578.54","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1B/view","2020-12-31","HIV/AIDS",0," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713=AN415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713=AO415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713=AP415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713=AJ415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713=AN415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713=AO415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713=AP415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1CUAW","PAI-3952","Inactive","CIV-Tuberculosis-1","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","Tuberculosis","Tuberculosis","FR37-CIV-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Acquire nine digital radiography devices and digitize the 17 old radiography tables Radiography remains an indispensable diagnostic tool for smear-negative pulmonary tuberculosis, and even extrapulmonary TB. Therefore, strengthening the diagnosis of TB in children requires the use of this technology. The NTCP has 17 standard radiography devices available, in 16 existing regional coordination centers and at Abidjan central prison (MACA). Of these devices, five date from 2004, three from 2009 and nine from 2016. The older devices require extensive maintenance with spare parts that are increasingly hard to find. This type of radiography is being gradually replaced by digital radiography. As part of this concept note, the NTCP also anticipates the purchase of nine digital radiography tables for the nine new regional coordination centers including Sgula, and the acquisition of 17 digitization devices to adapt older equipment. The funding also provides for the training of trainers and training sessions for users of digital radiography equipment.","Acquire nine digital radiography devices and digitize the 17 old radiography tables Radiography remains an indispensable diagnostic tool for smear-negative pulmonary tuberculosis, and even extrapulmonary TB. Therefore, strengthening the diagnosis of TB in children requires the use of this technology. The NTCP has 17 standard radiography devices available, in 16 existing regional coordination centers and at Abidjan central prison (MACA). Of these devices, five date from 2004, three from 2009 and nine from 2016. The older devices require extensive maintenance with spare parts that are increasingly hard to find. This type of radiography is being gradually replaced by digital radiography. As part of this concept note, the NTCP also anticipates the purchase of nine digital radiography tables for the nine new regional coordination centers including Sgula, and the acquisition of 17 digitization devices to adapt older equipment. The funding also provides for the training of trainers and training sessions for users of digital radiography equipment.","NA Original Intervention: Screening and diagnosis of tuberculosis","High","1937815.06","Digital radiography needed for new guidelines on TB case finding","0","1937815.06","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1C/view","2020-12-31","Tuberculosis",0," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713=AN416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713=AO416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713=AP416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713=AJ416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713=AN416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713=AO416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713=AP416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G416)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1DUAW","PAI-3953","Active","CIV-Tuberculosis-2","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","Tuberculosis","Tuberculosis","FR37-CIV-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Purchase eight automated slide stainers and eight incinerators for eight new regional coordination and maintenance centers All 17 existing regional coordination centers have incinerators and automated slide stainers. These devices are requested for the eight new regional coordination centers. The automated slide stainers not only make it easier to read the slides, but also allow standardization of procedures for better quality control.","Purchase eight automated slide stainers and eight incinerators for eight new regional coordination and maintenance centers All 17 existing regional coordination centers have incinerators and automated slide stainers. These devices are requested for the eight new regional coordination centers. The automated slide stainers not only make it easier to read the slides, but also allow standardization of procedures for better quality control.","NA Original Intervention: Screening and diagnosis of tuberculosis","High","312628.09","Needed for 8 new regional centers","0","0","0","0","312628.09","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1D/view","2020-12-31","Tuberculosis",312628.09000000003," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713=AN417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713=AO417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713=AP417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713=AJ417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713=AN417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713=AO417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713=AP417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1EUAW","PAI-3954","Inactive","CIV-Tuberculosis-3","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","Tuberculosis","Tuberculosis","FR37-CIV-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Purchase of 16 GeneXpert devices This request focuses on the acquisition of 16 additional GeneXpert devices in order to meet the needs of all regional laboratories. There are currently 13 GeneXpert devices, of which nine are located in nine regional laboratories (TB TCs) and four in the central laboratories (two at the Institut Pasteur de Cte dIvoire (IPCI) and two at the Research and Diagnosis Center for AIDS (CeDReS)). The NTCP plans to acquire 16 additional GeneXpert devices during this program continuation. Of these, eight will be purchased in 2018 to meet the needs of the eight existing regional laboratories and eight in 2019 for the eight new regional coordination centers opened in 2017. These GeneXpert devices will require maintenance and calibration each year. In addition, all machines require cartridges to operate. An average of 1,500 cartridges per machine per year is expected. These machines will strengthen the diagnosis of tuberculosis in general, and detection of the resistance profile in particular.","Purchase of 16 GeneXpert devices This request focuses on the acquisition of 16 additional GeneXpert devices in order to meet the needs of all regional laboratories. There are currently 13 GeneXpert devices, of which nine are located in nine regional laboratories (TB TCs) and four in the central laboratories (two at the Institut Pasteur de Cte dIvoire (IPCI) and two at the Research and Diagnosis Center for AIDS (CeDReS)). The NTCP plans to acquire 16 additional GeneXpert devices during this program continuation. Of these, eight will be purchased in 2018 to meet the needs of the eight existing regional laboratories and eight in 2019 for the eight new regional coordination centers opened in 2017. These GeneXpert devices will require maintenance and calibration each year. In addition, all machines require cartridges to operate. An average of 1,500 cartridges per machine per year is expected. These machines will strengthen the diagnosis of tuberculosis in general, and detection of the resistance profile in particular.","NA Original Intervention: Screening and diagnosis of tuberculosis","High","1621217.39","Needed for new regional diagnostic centers","1621217.39","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1E/view","2020-12-31","Tuberculosis",0," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713=AN418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713=AO418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713=AP418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713=AJ418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713=AN418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713=AO418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713=AP418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1FUAW","PAI-3955","Inactive","CIV-Tuberculosis-4","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","Tuberculosis","Tuberculosis","FR37-CIV-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Ensure the transportation of sputum samples from regional to central laboratories. All the regional laboratories will send GeneXpert positive sputum samples to the central laboratories for confirmation and to carry out 1st and 2nd line sensitivity tests. The rapid diagnosis of multi-resistant and ultra-resistant TB patients followed by appropriate treatment will slow transmission and reduce the number of cases in the long term.","Ensure the transportation of sputum samples from regional to central laboratories. All the regional laboratories will send GeneXpert positive sputum samples to the central laboratories for confirmation and to carry out 1st and 2nd line sensitivity tests. The rapid diagnosis of multi-resistant and ultra-resistant TB patients followed by appropriate treatment will slow transmission and reduce the number of cases in the long term.","NA Original Intervention: Screening and diagnosis of tuberculosis","High","147812.76","Sputum transport is essential for effective Diagnosis","147812.76","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1F/view","2020-12-31","Tuberculosis",0," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713=AN419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713=AO419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713=AP419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713=AJ419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713=AN419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713=AO419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713=AP419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G419)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1GUAW","PAI-3956","Active","CIV-Tuberculosis-5","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","Tuberculosis","Tuberculosis","FR37-CIV-T",null,null,"TB care and prevention","Collaborative activities with other programs and sectors (TB care and prevention)","Involvement of practitioners of traditional medicine in the treatment of tuberculosis: The funding for 2016-17 is intended to be used for capacity building for the technical and operational capabilities of 50 leading practitioners of traditional medicine and 400 practitioners from 20 health districts in relation to tuberculosis. The 2018-2020 funding above allocation amount aims to ensure their mentoring and the collection and management of data. The funding above allocation amount provides for the extension of this strategy to 50 new traditional leaders and 400 new practitioners of traditional medicine per year.","Involvement of practitioners of traditional medicine in the treatment of tuberculosis: The funding for 2016-17 is intended to be used for capacity building for the technical and operational capabilities of 50 leading practitioners of traditional medicine and 400 practitioners from 20 health districts in relation to tuberculosis. The 2018-2020 funding above allocation amount aims to ensure their mentoring and the collection and management of data. The funding above allocation amount provides for the extension of this strategy to 50 new traditional leaders and 400 new practitioners of traditional medicine per year.",null,"Medium","95015.08","Engaging all care providers, including traditional healers, was recommended by the previous TRP. However this item is assigned medium priority because no sufficient evidence in provided in the FR regarding the role of the practitioners of traditional medicine in referral and counterreferral of patients and any related targets are not specified.","0","0","0","0","95015.08","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1G/view","2020-12-31","Tuberculosis",95015.08," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713=AN420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713=AO420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713=AP420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713=AJ420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713=AN420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713=AO420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713=AP420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G420)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1HUAW","PAI-3957","Active","CIV-Tuberculosis-6","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","Tuberculosis","Tuberculosis","FR37-CIV-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Pilot project for the use of new technologies in the active search for TB and among contact cases With regard to contact cases, a pilot project is planned for Abidjan with the use of awarenessraising/educational videos on tablets during surveys of patient contacts, and registration of all contact cases on an electronic database.","Pilot project for the use of new technologies in the active search for TB and among contact cases With regard to contact cases, a pilot project is planned for Abidjan with the use of awarenessraising/educational videos on tablets during surveys of patient contacts, and registration of all contact cases on an electronic database.","NA Original Intervention: Key populations","Medium","90501.1","A pilot project on community motivation  aimed at case contacts","0","0","0","0","90501.1","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1H/view","2020-12-31","Tuberculosis",90501.1," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713=AN421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713=AO421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713=AP421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713=AJ421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713=AN421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713=AO421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713=AP421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G421)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1IUAW","PAI-3958","Active","CIV-Tuberculosis-7","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","Tuberculosis","Tuberculosis","FR37-CIV-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Active search for TB among drug users With regard to drug users, the activities proposed in collaboration with Mdecins du Monde are the following: - Awareness-raising sessions by community outreach agents in  fumoirs7  (smoking rooms) to reduce the stigma and discrimination that are associated with them; - Screening by active search for tuberculosis in the community of approximately 1,800 drug users over the three years of screening; - Community support for the 135 drug users with TB treated in eight prisons (1 per 6 drug users with TB).","Active search for TB among drug users With regard to drug users, the activities proposed in collaboration with Mdecins du Monde are the following: - Awareness-raising sessions by community outreach agents in  fumoirs7  (smoking rooms) to reduce the stigma and discrimination that are associated with them; - Screening by active search for tuberculosis in the community of approximately 1,800 drug users over the three years of screening; - Community support for the 135 drug users with TB treated in eight prisons (1 per 6 drug users with TB).","NA Original Intervention: Key populations","High","158231.4","One of the possible reasons for the gap between the estimated incidence and the notification rate may be due to underdetection in key and vulnerable populations. People who use drugs are a priority key population and this intervention is likely to have a good yield. Additionally, participation of Mdecins du Monde is a good example of partner collaboration and likely to result in successful implementation.","0","0","0","0","158231.4","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1I/view","2020-12-31","Tuberculosis",158231.4," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713=AN422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713=AO422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713=AP422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713=AJ422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713=AN422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713=AO422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713=AP422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1JUAW","PAI-3959","Active","CIV-Tuberculosis-8","2017-2019","RT High Impact Africa 1","Côte d'Ivoire","Tuberculosis","Tuberculosis","FR37-CIV-T",null,null,"MDR-TB","Treatment: MDR-TB","Psycho-social follow-up and nutritional support for 400 MDR-TB patients per year: MDR-TB patients do not benefit from community support in the current grant. The aim is to train at least two TB Community Counselors (CCs) per TB TC (for a total of 50 CCs) on MDR-TB and nutritional care, ensure home visits to MDR-TB patients to educate them and their families (follow-up to treatment, transmission control measures, nutrition), carry out patient contact surveys and provide psychosocial and nutritional support. The CCs will form the link between patients and health personnel who provide the daily DOT and will ensure absentees are returned to treatment where required.","Psycho-social follow-up and nutritional support for 400 MDR-TB patients per year: MDR-TB patients do not benefit from community support in the current grant. The aim is to train at least two TB Community Counselors (CCs) per TB TC (for a total of 50 CCs) on MDR-TB and nutritional care, ensure home visits to MDR-TB patients to educate them and their families (follow-up to treatment, transmission control measures, nutrition), carry out patient contact surveys and provide psychosocial and nutritional support. The CCs will form the link between patients and health personnel who provide the daily DOT and will ensure absentees are returned to treatment where required.","NA Original Module: Multidrug-resistant TB","High","694343.6","This intervention is in line with the updated WHO guidelines for patient care. Food may serve as an incentive and also improve outcome biologically due to reduction in malnutrition and consequent improvement in immune function.","0","0","0","0","694343.6","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1J/view","2020-12-31","Tuberculosis",694343.6," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713=AN423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713=AO423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713=AP423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713=AJ423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713=AN423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713=AO423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713=AP423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1KUAW","PAI-3960","Active","CMR-Malaria-1","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"Vector control","Other vector control measure(s)","These activities will allow for work to ensure  the prevention of malaria in pregnant women and improve access to promotional and preventive services for maternal,  infant  and neonatal health through the routine distribution LLINs, the implementation of  therefocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.","These activities will allow for work to ensure  the prevention of malaria in pregnant women and improve access to promotional and preventive services for maternal,  infant  and neonatal health through the routine distribution LLINs, the implementation of  therefocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.","NA Original Intervention: Purchase and routine distribution of LLIN to pregnant women","High","4233348.67",null,"0","0","0","0","4233348.67","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1K/view","2020-12-31","Malaria",4233348.67," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713=AN424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713=AO424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713=AP424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713=AJ424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713=AN424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713=AO424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713=AP424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G424)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1LUAW","PAI-3961","Active","CMR-Malaria-10","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"Case management","Other case management intervention(s)","Failure to follow guidelines on case management of malaria by health providers is a major challenge to achieving program objectives. This situation is linked to the lack of mastery of certain providers of good practices  in  terms  of  taking charge  and  also to  the  low  capacity of pharmacy clerks  to ensure a permanent  availability of qualityrapid diagnostic tests (RDTs) and  anti-malarials.  In addition, we found poor quality of microscopic examinations and interpretation of TDR results. Planned activities will improve the  management of malaria  through quality control and quality assurance activities for diagnosis,  training of health personnel  for proper management of malaria inputs and adverse effects. Thus, diagnostic coverage in the general population will be improved from 78% to at least 95% and free treatment from 52% to at least 95% by 2020.","Failure to follow guidelines on case management of malaria by health providers is a major challenge to achieving program objectives. This situation is linked to the lack of mastery of certain providers of good practices  in  terms  of  taking charge  and  also to  the  low  capacity of pharmacy clerks  to ensure a permanent  availability of qualityrapid diagnostic tests (RDTs) and  anti-malarials.  In addition, we found poor quality of microscopic examinations and interpretation of TDR results. Planned activities will improve the  management of malaria  through quality control and quality assurance activities for diagnosis,  training of health personnel  for proper management of malaria inputs and adverse effects. Thus, diagnostic coverage in the general population will be improved from 78% to at least 95% and free treatment from 52% to at least 95% by 2020.","NA Original Intervention: Support for quality control and quality assurance","Low","2677508.7","While quality control & quality assurance (QA) are important for case management, the TRP considers that the contribution to impact of this additional request is not well substantiated. Given that the information provided at this stage is limited, should additional resources become available, the TRP recommends that the Secretariat reviews the budget and justification of proposed activities to ensure that they are appropriate in scope and scale for the funds requested and are positioned to achieve impact.","0","0","0","0","2677508.7","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1L/view","2020-12-31","Malaria",2677508.7000000002," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713=AN425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713=AO425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713=AP425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713=AJ425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713=AN425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713=AO425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713=AP425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G425)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1MUAW","PAI-3962","Active","CMR-Malaria-11","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to support the new   4'500  CHWs. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to recruit 4500  CHWs additonal through  and  to  extend  the  response  to  80 additional  health districts by ensuring adequate  equipment  for the smooth  running of  the  activity.  In  addition,  a  performance-based funding mechanism for CHW accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","These activities will allow for work to support the new   4'500  CHWs. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to recruit 4500  CHWs additonal through  and  to  extend  the  response  to  80 additional  health districts by ensuring adequate  equipment  for the smooth  running of  the  activity.  In  addition,  a  performance-based funding mechanism for CHW accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Support the additional 4,500 community health workers (ACS) in the implementation of Community Interventions (ISDC)","Low","8784908.54","While community case management is a high impact intervention, the TRP notes that the applicant should first consolidate their existing community health system and achieve impact, and review lessons learned before expansion. The advocacy meetings can be included also within the main allocation (community case management and program management). Given that the information provided at this stage is limited, should additional resources become available, the TRP recommends that the Secretariat reviews the budget and justification of proposed activities to ensure that they are appropriate in scope and scale for the funds requested and are positioned to achieve impact.","0","0","0","0","8784908.54","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1M/view","2020-12-31","Malaria",8784908.5399999991," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713=AN426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713=AO426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713=AP426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713=AJ426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713=AN426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713=AO426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713=AP426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G426)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1NUAW","PAI-3963","Active","CMR-Malaria-12","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to advocacy at city/distric/region level to put in place transition plan for the current 4'400 CHW to be funded in the future by local authorities.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country.","These activities will allow for work to advocacy at city/distric/region level to put in place transition plan for the current 4'400 CHW to be funded in the future by local authorities.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Organize advocacy meetings for local, administrative and traditional authorities on the sustainability of ISDCs","Low","265816.41","While community case management is a high impact intervention, the TRP notes that the applicant should first consolidate their existing community health system and achieve impact. , and review lessons learned before expansion. The advocacy meetings can be included also within the main allocation (community case management and program management)","0","0","0","0","265816.41","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1N/view","2020-12-31","Malaria",265816.40999999997," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713=AN427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713=AO427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713=AP427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713=AJ427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713=AN427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713=AO427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713=AP427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1OUAW","PAI-3964","Active","CMR-Malaria-2","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"Vector control","Other vector control measure(s)","These activities will allow for work to ensure communication around the use of LLINs and  IPT activities for  the prevention of malaria in pregnant women a,  infant  and neonatal health through the routine distribution LLINs, the implementation of  the refocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.","These activities will allow for work to ensure communication around the use of LLINs and  IPT activities for  the prevention of malaria in pregnant women a,  infant  and neonatal health through the routine distribution LLINs, the implementation of  the refocused, advanced ANC  strategy and the contribution towards the   health   campaign (SASNIM) for pregnant women and children. As a result, LLIN   and   IPT   coverage   of pregnant  women  will  be improved  from 33% to at least 60% by 2020.","NA Original Intervention: Communication activities on the use of LLINs and IPT","High","270101",null,"0","0","0","0","270101","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1O/view","2020-12-31","Malaria",270101," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713=AN428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713=AO428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713=AP428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713=AJ428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713=AN428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713=AO428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713=AP428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1PUAW","PAI-3965","Active","CMR-Malaria-3","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to maintain the  remaining  492  CHWs not funded under the new grant due to budget constraint only  4400 Community Health Workers (CHW) out of  the 4892 operational  will  be supported. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country.  In  addition,  due  to  budget constraints .  To  achieve universal coverage, it is important to maintain the  remaining  492  CHWs.  In  addition,  a  performance-based funding mechanism for Community Health Workers accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","These activities will allow for work to maintain the  remaining  492  CHWs not funded under the new grant due to budget constraint only  4400 Community Health Workers (CHW) out of  the 4892 operational  will  be supported. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country.  In  addition,  due  to  budget constraints .  To  achieve universal coverage, it is important to maintain the  remaining  492  CHWs.  In  addition,  a  performance-based funding mechanism for Community Health Workers accompanying measures  (purchase of indicators)  to ensure  compliance with the guidelines and the effectiveness  of free provision. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Support the existing 492 community health workers (ACS) in the implementation of Community Interventions (ISDC)","High","959726.18","The objective of the community health workers (CHW) intervention to ensure better access to preventive and curative services in the context of malaria control. The 492 CHWs form part of the total of 4892 workforce delivering services at community level in the 69 initial districts. The funding for 4500 has been catered for within allocation.","0","0","0","0","959726.18","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1P/view","2020-12-31","Malaria",959726.18," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713=AN429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713=AO429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713=AP429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713=AJ429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713=AN429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713=AO429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713=AP429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1QUAW","PAI-3966","Active","CMR-Malaria-4","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.","Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Malaria Indicator Survey (MIS)","High","841692.29",null,"0","0","0","0","841692.29","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1Q/view","2020-12-31","Malaria",841692.29," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713=AN430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713=AO430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713=AP430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713=AJ430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713=AN430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713=AO430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713=AP430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G430)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1RUAW","PAI-3967","Active","CMR-Malaria-5","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"Program management","Other program management intervention(s)","Malaria control strategies are evolving at the global level, given the innovations in this area. To this end, the Program will undergo several phases  of  change  in  program  and  financial management  policies  and  procedures.  For example, NMCP is  considering assessments of current  strategies,  revision  of  the  national strategic  plan,  capacity  building  of  staff  in different areas of specialization and updating of  normative  documents.  To  this  end,  all normative  documents will be up to date and at least  80%  of  the  qualified staff in the specialties  required  for  the  performance of their duties.","Malaria control strategies are evolving at the global level, given the innovations in this area. To this end, the Program will undergo several phases  of  change  in  program  and  financial management  policies  and  procedures.  For example, NMCP is  considering assessments of current  strategies,  revision  of  the  national strategic  plan,  capacity  building  of  staff  in different areas of specialization and updating of  normative  documents.  To  this  end,  all normative  documents will be up to date and at least  80%  of  the  qualified staff in the specialties  required  for  the  performance of their duties.","NA Original Intervention: Mid-Term Review Malaria NSP 2018-2022","High","56110.43","While the TRP considers this activity a high priority, The TRP is of the view that the amount requested for the activity is relatively high. The TRP therefore recommends 25% of the original amount under PAAR.","0","0","0","0","56110.43","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1R/view","2020-12-31","Malaria",56110.43," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713=AN431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713=AO431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713=AP431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713=AJ431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713=AN431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713=AO431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713=AP431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G431)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1SUAW","PAI-3968","Active","CMR-Malaria-6","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"Case management","Other case management intervention(s)","Failure to follow guidelines on case management of malaria by health providers is a major challenge to achieving program objectives. This situation is linked to the lack of mastery of certain providers of good practices  in  terms  of  taking charge  and  also to  the  low  capacity of pharmacy clerks  to ensure a permanent  availability of quality rapid diagnostic tests (RDTs) and  anti-malarials.  In addition, there is a poor quality of microscopic examinations and interpretation of TDR results. Planned activities will improve the  management of malaria  through quality control and quality assurance activities for diagnosis,  training of health personnel  for proper management of malaria inputs and adverse effects. Thus, diagnostic coverage in the general population will be improved from 78% to at least 95% and free treatment from 52% to at least 95% by 2020.","Failure to follow guidelines on case management of malaria by health providers is a major challenge to achieving program objectives. This situation is linked to the lack of mastery of certain providers of good practices  in  terms  of  taking charge  and  also to  the  low  capacity of pharmacy clerks  to ensure a permanent  availability of quality rapid diagnostic tests (RDTs) and  anti-malarials.  In addition, there is a poor quality of microscopic examinations and interpretation of TDR results. Planned activities will improve the  management of malaria  through quality control and quality assurance activities for diagnosis,  training of health personnel  for proper management of malaria inputs and adverse effects. Thus, diagnostic coverage in the general population will be improved from 78% to at least 95% and free treatment from 52% to at least 95% by 2020.","NA Original Intervention: Training / refresher training of healthcare providers in diagnosis and case management of malaria","Medium","665209.29",null,"0","0","0","0","665209.29","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1S/view","2020-12-31","Malaria",665209.29," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713=AN432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713=AO432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713=AP432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713=AJ432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713=AN432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713=AO432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713=AP432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G432)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1TUAW","PAI-3969","Active","CMR-Malaria-7","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to train the  remaining  492  CHWs  through  periodic recycling not funded under the new grant due to budget constraint.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","These activities will allow for work to train the  remaining  492  CHWs  through  periodic recycling not funded under the new grant due to budget constraint.  The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Training of 492 CHW on revised modules","Medium","164309.28","Community case management is a high impact intervention; however, the TRP considers that the contribution to impact of this additional request is not well substantiated. Given that the information provided at this stage is limited, should additional resources become available, the TRP recommends that the Secretariat reviews the budget and justification of proposed activities to ensure that they are appropriate in scope and scale for the funds requested and are positioned to achieve impact.","0","0","0","0","164309.28","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1T/view","2020-12-31","Malaria",164309.28," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713=AN433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713=AO433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713=AP433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713=AJ433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713=AN433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713=AO433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713=AP433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1UUAW","PAI-3970","Active","CMR-Malaria-8","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","These activities will allow for work to train the  new  4'500  CHWs  through  periodic recycling. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to extend  the  response  to  80 additional  health districts.Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","These activities will allow for work to train the  new  4'500  CHWs  through  periodic recycling. The  strategy for the integrated management of common diseases is the indicated  intervention to ensure better access to preventive and curative services in the context of malaria control. This intervention is effective only in 69 of the 189 health districts in  the  country. To  achieve universal coverage, it is important to extend  the  response  to  80 additional  health districts.Diagnostic coverage in the general population  will   therefore  be  improved  from 78% to at least 95% and from 52% to at least 95% by 2020.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Training of up to 4,500 additional community health workers (ACS)","Medium","1288703.85",null,"0","0","0","0","1288703.85","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1U/view","2020-12-31","Malaria",1288703.8500000001," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713=AN434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713=AO434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713=AP434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713=AJ434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713=AN434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713=AO434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713=AP434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G434)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1VUAW","PAI-3971","Active","CMR-Malaria-9","2017-2019","RT Central Africa","Cameroon","Malaria","Malaria","FR446-CMR-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.","Payment for data transmission has improved the completeness of malaria control data. However,  the quality of the data transmitted remains unsatisfactory due to the incomplete and  incorrect  collection of  information and incorrect  calculations  of  certain  indicators. This situation results in the lack of control of the exact epidemiological situation in all the health districts which should guide the strategic  choices in the fight against this disease.  The proposed funding activities will ensure the  availability of quality  data.  In addition, an impact survey will be conducted at the end of the period to measure progress in the fight against malaria. This will allow us to provide 100%  coverage and impact indicators with quality data.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Training workshops for health area managers on malaria surveillance","Medium","163372.24",null,"0","0","0","0","163372.24","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1V/view","2020-12-31","Malaria",163372.24," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713=AN435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713=AO435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713=AP435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713=AJ435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713=AN435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713=AO435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713=AP435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G435)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1WUAW","PAI-3972","Active","CMR-TB/HIV-1","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"TB care and prevention","Case detection and diagnosis","This would be used for the following activities:  -Procurement   and   distribution   of   culture   laboratory products, consumables and  reagents  for LPA/Hain and TB LAM,andfor additional cases (solid and liquid).  -Improvement/refurbishment  of  culture  laboratories  (old and new).-Additional   maintenance   and   equipment   for   culture laboratories in order to retain certification.In  addition,  it  would  enable  the  purchase  of  four  new GeneXpert machines, calibration kits and waste filters for all the machines, seven  TB  LAM  machines  and  accessories in 2020,   and   25,000   additional   cartridges   for   GeneXpert MTB/RIF tests. This  activity  will  focus  on  the  second  population  at  risk  of MDR-TB -new cases with positive microscopy -whowill have a sensitivity test(GeneXpert).","This would be used for the following activities:  -Procurement   and   distribution   of   culture   laboratory products, consumables and  reagents  for LPA/Hain and TB LAM,andfor additional cases (solid and liquid).  -Improvement/refurbishment  of  culture  laboratories  (old and new).-Additional   maintenance   and   equipment   for   culture laboratories in order to retain certification.In  addition,  it  would  enable  the  purchase  of  four  new GeneXpert machines, calibration kits and waste filters for all the machines, seven  TB  LAM  machines  and  accessories in 2020,   and   25,000   additional   cartridges   for   GeneXpert MTB/RIF tests. This  activity  will  focus  on  the  second  population  at  risk  of MDR-TB -new cases with positive microscopy -whowill have a sensitivity test(GeneXpert).",null,"High","2260063.97","This request will increase detection of drug resistance among high risk populations by expanding capacity for drug sensitivity testing and diagnosis of TB. Funds will be utilized to purchase culture reagents, LPA/Hain and Urinary Lipoarabinomannan (LAM); four new GeneXpert machines and 25,000 cartridges that will enhance diagnosis of drug resistant TB and TB in people living with HIV.","0","0","0","0","2260063.97","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1W/view",null,"TB/HIV",2260063.9700000002," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713=AN436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713=AO436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713=AP436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713=AJ436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713=AN436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713=AO436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713=AP436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1XUAW","PAI-3973","Active","CMR-TB/HIV-10","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"Treatment, care and support","Treatment monitoring - Drug resistance surveillance","This funding would be used to carry out a study into initial and acquired resistance to ARVs among infectedadult and child patients, in Year 1.","This funding would be used to carry out a study into initial and acquired resistance to ARVs among infectedadult and child patients, in Year 1.","NA Original Intervention: Treatment monitoring - drug resistance surveillance","High","427698.35","Given that Cameroon has conducted a drug resistance survey previously, it would be important to repeat it after 3-4 years to determine trends, confirm current rates of resistance and make decisions related to prevention of drug resistance and the adoption of new treatment guidelines or the adjustment to treatment regimens, if needed","0","0","0","0","427698.35","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1X/view",null,"TB/HIV",427698.35," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713=AN437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713=AO437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713=AP437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713=AJ437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713=AN437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713=AO437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713=AP437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G437)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1YUAW","PAI-3974","Active","CMR-TB/HIV-11","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","This  funding  would  be  used for the  construction  of  a  new central medical  store or renovation of Regional Store, with  other  technical  and  financial partners (IDB, USAID, etc.): purchase of land and construction (EUR  9,000,000). Investment in the supply chain is conditional to recommendation of the supply chain report. In  addition,  it  will  provide  funding  for technical assistance (EUR 649,440) for national coordination (a team of one international and one national expert)  for the three programs, to improve quantification and procurement of supplies, and to reduce instances of stock-outs.","This  funding  would  be  used for the  construction  of  a  new central medical  store or renovation of Regional Store, with  other  technical  and  financial partners (IDB, USAID, etc.): purchase of land and construction (EUR  9,000,000). Investment in the supply chain is conditional to recommendation of the supply chain report. In  addition,  it  will  provide  funding  for technical assistance (EUR 649,440) for national coordination (a team of one international and one national expert)  for the three programs, to improve quantification and procurement of supplies, and to reduce instances of stock-outs.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Procurement and supply management systems","High","10828683.65","The country has made a case of the need for a warehouse. There is an ongoing assessment that would inform the Global Funds decision and it would be a multipartner involvement. Priority is high, but conditional to the results of the assessment and the decision of all the partners","0","0","0","0","10828683.65","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1Y/view",null,"TB/HIV",10828683.65," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713=AN438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713=AO438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713=AP438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713=AJ438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713=AN438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713=AO438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713=AP438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1ZUAW","PAI-3975","Active","CMR-TB/HIV-12","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","This  would  fund  activities  to  extend  drug  dispensing  and monitoring  software  to  40 additional  health  care  facilities between 2018 and 2020.It would also cover the validation of community data, and the harmonization  and  production  of  community  data  collection tools for MSM, SWs, people who inject drugs and transgender people.","This  would  fund  activities  to  extend  drug  dispensing  and monitoring  software  to  40 additional  health  care  facilities between 2018 and 2020.It would also cover the validation of community data, and the harmonization  and  production  of  community  data  collection tools for MSM, SWs, people who inject drugs and transgender people.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","281062.73","The activities to expand software to 40 health care facilities for drug dispensing is needed to support decentralisation of care and differentiated treatment services. Activities for community data tools and their validation is part of routine data reporting process and should be covered as part of domestic efforts, thus the TRP recommends half of the amount.","0","0","0","0","281062.73","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1Z/view",null,"TB/HIV",281062.73," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713=AN439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713=AO439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713=AP439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713=AJ439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713=AN439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713=AO439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713=AP439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G439)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1aUAG","PAI-3976","Active","CMR-TB/HIV-13","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"TB care and prevention","Engaging all care providers (TB care and prevention)","This would be used to fund the following activities: -Activities to actively search for TB in additional (existing) health  care  facilities,  identified  as  having  high  potential for  suspected  TB  cases  and  receiving  high  numbers of adults   and  children   (primary   target   for  active case finding)-Performance incentives (different to top-ups for program managers;  this  is  an  incentive  for  service  providers  at health  care facilities with  high  potential  for  suspected cases)  for health care providers involved in the routine screening  activities  at health care facilities identified  as having high potential for suspected TB cases.","This would be used to fund the following activities: -Activities to actively search for TB in additional (existing) health  care  facilities,  identified  as  having  high  potential for  suspected  TB  cases  and  receiving  high  numbers of adults   and  children   (primary   target   for  active case finding)-Performance incentives (different to top-ups for program managers;  this  is  an  incentive  for  service  providers  at health  care facilities with  high  potential  for  suspected cases)  for health care providers involved in the routine screening  activities  at health care facilities identified  as having high potential for suspected TB cases.",null,"Medium","340419.71","The funds will expand active case finding for TB in hospital settings. However clarity on the provision of incentives for health staff is requested.","0","0","0","0","340419.71","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1a/view",null,"TB/HIV",340419.71," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713=AN440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713=AO440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713=AP440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713=AJ440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713=AN440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713=AO440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713=AP440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1bUAG","PAI-3977","Active","CMR-TB/HIV-14","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","HIV testing services for PWID","This would be used to fund training for some of the self-help groups  for  people  who  use  drugs,  and  to  develop  additional testing activities for people who inject drugs.It would also be used to supplement performance-based incentivesfor cases tested positive by peer educators among the group of people who inject drugs.","This would be used to fund training for some of the self-help groups  for  people  who  use  drugs,  and  to  develop  additional testing activities for people who inject drugs.It would also be used to supplement performance-based incentivesfor cases tested positive by peer educators among the group of people who inject drugs.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: HIV testing services for people who inject drugs","Medium","38799.24","Overall, it would be important to ensure community-based testing for people who use drugs. However, since the size of people who inject drugs is not known, and there is an overlap of drug use behaviours in other key population modules (men who have sex with men, sex workers,), these costs could be covered from those modules in the allocation for the modules 7 for men who have sex with men and sex workers","0","0","0","0","38799.24","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1b/view",null,"TB/HIV",38799.24," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713=AN441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713=AO441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713=AP441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713=AJ441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713=AN441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713=AO441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713=AP441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G441)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1cUAG","PAI-3978","Active","CMR-TB/HIV-15","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","This  would  be  used  to  fund  training  for  some  of  the  peer educators   for  people   who inject drugs,  and  to   develop additional  BCC  activities  (educational  talks,  conferences, etc.).","This  would  be  used  to  fund  training  for  some  of  the  peer educators   for  people   who inject drugs,  and  to   develop additional  BCC  activities  (educational  talks,  conferences, etc.).","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","Medium","95945.46","Since the size of the people who inject drugs is not known and is likely to be very small, and there is an overlap between the categories of people who use drugs with the other categories (men who have sex with men, sex workers). Note: only half of the requested amount has been recommended since there is a matching fund request already covering the module.","0","0","0","0","95945.46","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1c/view",null,"TB/HIV",95945.46," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713=AN442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713=AO442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713=AP442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713=AJ442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713=AN442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713=AO442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713=AP442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G442)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1dUAG","PAI-3979","Active","CMR-TB/HIV-16","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"RSSH: Health management information systems and M&E","Surveys","This would be used to fund various studies and evaluations, including updated mapping of key and vulnerable populations, and the midterm review of the NSP. It would also be used to fund the development of a monitoring and evaluation plan for the HIV NSP.","This would be used to fund various studies and evaluations, including updated mapping of key and vulnerable populations, and the midterm review of the NSP. It would also be used to fund the development of a monitoring and evaluation plan for the HIV NSP.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","556386.49","Mid-term review would be important to make course corrections in the national response. However, there is little details as to the role of various studies and evaluations. Determining the purpose of these studies, establishing their relative priority and the funding amount should be adjusted upon presentation of these details","0","0","0","0","556386.49","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1d/view",null,"TB/HIV",556386.49," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713=AN443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713=AO443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713=AP443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713=AJ443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713=AN443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713=AO443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713=AP443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1eUAG","PAI-3980","Active","CMR-TB/HIV-17","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"RSSH: Health management information systems and M&E","Program and data quality","This would be used to fund regional evaluation TB/HIV meetings, and partially to fund regional data verification visits by central supervisors.","This would be used to fund regional evaluation TB/HIV meetings, and partially to fund regional data verification visits by central supervisors.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","78756.59","These funds will be used to support joint TB and HIV data verification and review meetings","0","0","0","0","78756.59","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1e/view",null,"TB/HIV",78756.59," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713=AN444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713=AO444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713=AP444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713=AJ444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713=AN444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713=AO444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713=AP444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1fUAG","PAI-3981","Active","CMR-TB/HIV-18","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"Treatment, care and support","Treatment adherence","This funding would be used to improve treatment adherence for children and adolescents during the grant period, through the production of additional treatment education manuals and tools,  to  improve  treatment  education  at  the  CBOs  and PMTCTsites wherethe manuals and toolsalready exist.","This funding would be used to improve treatment adherence for children and adolescents during the grant period, through the production of additional treatment education manuals and tools,  to  improve  treatment  education  at  the  CBOs  and PMTCTsites wherethe manuals and toolsalready exist.",null,"Low","34216.14","Treatment adherence in children and adolescents is important, however effectiveness of using education manuals and tools for such purpose is unknown","0","0","0","0","34216.14","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1f/view",null,"TB/HIV",34216.14," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713=AN445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713=AO445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713=AP445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713=AJ445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713=AN445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713=AO445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713=AP445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1gUAG","PAI-3982","Active","CMR-TB/HIV-19","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Keeping girls in school","This  would  be  used  towards supporting activities  for  1,500 adolescent  girls  and  young  women  in  highly  vulnerable situations. Conditionned to evidence that the activities budgeted under the alloacation are  effective.","This  would  be  used  towards supporting activities  for  1,500 adolescent  girls  and  young  women  in  highly  vulnerable situations. Conditionned to evidence that the activities budgeted under the alloacation are  effective.",null,"Low","787564.81","As this activity is included in the matching funds, evidence should be collected in the next allocation period for its effectiveness and based on that evidence, decision to scale-up will be taken.","0","0","0","0","787564.81","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1g/view",null,"TB/HIV",787564.81," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713=AN446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713=AO446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713=AP446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713=AJ446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713=AN446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713=AO446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713=AP446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1hUAG","PAI-3983","Inactive","CMR-TB/HIV-2","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","This funding would be used to purchase two mobile digital X-ray  machines  for  PLHIV  who  cannot  pay  for  X-rays,  in  the Douala   and   Yaound   regions.   This   would   significantly improve the rate of return for TB screening in these patients. TRP recommends swaping between X-Ray equipment for hospital currently budgeted in the allocation.","This funding would be used to purchase two mobile digital X-ray  machines  for  PLHIV  who  cannot  pay  for  X-rays,  in  the Douala   and   Yaound   regions.   This   would   significantly improve the rate of return for TB screening in these patients. TRP recommends swaping between X-Ray equipment for hospital currently budgeted in the allocation.","NA Original Intervention: Community management of TB","High","248008.08","This funding is considered of high importance in order to increase screening for TB among disadvantaged PLHIV by purchasing digital X-ray machines in the Douala and Yaound regions. The TRP recommends that this intervention is swapped for the procurement of hospital-based X-rays within allocation as mobile X-ray has a higher potential to contribute to TB screening and diagnosis","248008.08","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1h/view",null,"TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713=AN447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713=AO447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713=AP447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713=AJ447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713=AN447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713=AO447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713=AP447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G447)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1iUAG","PAI-3984","Active","CMR-TB/HIV-20","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Addressing stigma, discrimination and violence against PWID","This   funding   would   be   used   to   run   additional   training workshops for magistrates on the subject of access to health services for MSM, people who inject drugs and sex workers.","This   funding   would   be   used   to   run   additional   training workshops for magistrates on the subject of access to health services for MSM, people who inject drugs and sex workers.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Addressing stigma, discrimination and violence against people who inject drugs","Low","15746.83","Such interventions are already included in the proposed activities and the added value of an additional training is difficult to assess.","0","0","0","0","15746.83","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1i/view",null,"TB/HIV",15746.83," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713=AN448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713=AO448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713=AP448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713=AJ448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713=AN448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713=AO448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713=AP448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G448)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1jUAG","PAI-3985","Active","CMR-TB/HIV-3","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","This funding would be used to purchase tests for initial check-up and follow-up of 100 additional MDR-TB patients between Year  1  and  Year 3.  It  would  also  cover  screening  for  MDR-TB/RR-TB among new TB cases. This would be after having tested 100 percent of the primary group at higher risk, which is patients with a history of previous treatment.","This funding would be used to purchase tests for initial check-up and follow-up of 100 additional MDR-TB patients between Year  1  and  Year 3.  It  would  also  cover  screening  for  MDR-TB/RR-TB among new TB cases. This would be after having tested 100 percent of the primary group at higher risk, which is patients with a history of previous treatment.","NA Original Module: Multidrug-resistant TB","High","49771.07","The funds will enable expansion of testing for MDR, including screening of new TB patients.","0","0","0","0","49771.07","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1j/view",null,"TB/HIV",49771.07," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713=AN449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713=AO449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713=AP449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713=AJ449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713=AN449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713=AO449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713=AP449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1kUAG","PAI-3986","Active","CMR-TB/HIV-4","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"MDR-TB","Treatment: MDR-TB","This would be used for the following activities: -Support for community DOTS (home-based treatment by a  qualified  nurse)  for  daily  administration  of  MDR-TB drugs     to     240  additional  MDR-TB  outpatients; hospitalization costs.-Purchase of ten audiometer machines for MDR-TB in the year.","This would be used for the following activities: -Support for community DOTS (home-based treatment by a  qualified  nurse)  for  daily  administration  of  MDR-TB drugs     to     240  additional  MDR-TB  outpatients; hospitalization costs.-Purchase of ten audiometer machines for MDR-TB in the year.","NA Original Module: Multidrug-resistant TB","High","534321.62","These funds will enable the treatment of additional MDR TB patients by supporting community DOTS (home-based treatment by a qualified nurse) for daily administration of MDR-TB drugs to 240 additional MDR-TB outpatients; as well as purchasing ten audiometer machines for MDR-TB","170726.07","0","0","0","363595.55","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1k/view",null,"TB/HIV",363595.55," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713=AN450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713=AO450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713=AP450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713=AJ450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713=AN450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713=AO450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713=AP450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G450)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1lUAG","PAI-3987","Active","CMR-TB/HIV-5","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"MDR-TB","Prevention for MDR-TB","This  funding  would  be  used  to  renovate  hospital  wards  for MDR-TB/RR-TB   patients   in five hospital   (Limb,   Maroua, Bafoussam,  Bertoua  and  Garoua)  in  Year  2.  The  funding wouldalso provide community care for 100 additional MDR-TB/RR-TB patients between Year 1 and Year 3.","This  funding  would  be  used  to  renovate  hospital  wards  for MDR-TB/RR-TB   patients   in five hospital   (Limb,   Maroua, Bafoussam,  Bertoua  and  Garoua)  in  Year  2.  The  funding wouldalso provide community care for 100 additional MDR-TB/RR-TB patients between Year 1 and Year 3.","NA Original Module: Multidrug-resistant TB","High","25148.69","The funds will renovate existing hospitals in Limb, Maroua, Bafoussam, Bertoua and Garoua to provide for treatment of MDR-TB patients requiring hospitalization as well as provide community care for 100 additional MDR-TB/RR-TB patients.","0","0","0","0","25148.69","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1l/view",null,{"$f":"IF(OR(I451=\"HIV/AIDS\",I451=\"Tuberculosis\",I451=\"Malaria\",I451=\"RSSH\"),I451, IF(I451=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"TB/HIV"},{"$f":"VALUE(Y451)","v":25148.69},{"$f":"RIGHT(F451,LEN(F451)-2)","v":" Central Africa"},"HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,{"$f":"TRIM(AK451)","v":"Tuberculosis"},{"$f":"TRIM(AL451)","v":""},{"$f":"TRIM(AM451)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713=AN451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713=AO451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713=AP451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE451<>\"\",AE451,IF(MAX(AQ451,AR451,AS451,AT451)<>0,MAX(AQ451,AR451,AS451,AT451),AU451))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713=AJ451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713=AN451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713=AO451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713=AP451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE451<>\"\",AE451,IF(MAX(AW451,AX451,AY451,AZ451)<>0,MAX(AW451,AX451,AY451,AZ451),BA451))","v":"2018-01-01"}]
["a6Q1R000000AJ1mUAG","PAI-3988","Active","CMR-TB/HIV-6","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"TB/HIV","Other TB/HIV intervention(s)","This would be used to support the following activities: -Additional six-monthly mass   TB/HIV   campaigns   in prisons with more than 1,000 inmates and on a quarterlybasisin   institutions   with   less   than   1,000   inmates. Purchase   of   additional   supplies   for   TB   and   HIV prevention (infection control, safe shaving) for prisoners and support for the coordination of these activities, which will  help  to  ensure  TB  is  diagnosed  earlier  and  avoid  it being spread. In  addition,  it  would  facilitate  the  purchase  of  two  mobile digital X-ray machines exclusively for prisoners, which would significantly improve the rate of return for screening.","This would be used to support the following activities: -Additional six-monthly mass   TB/HIV   campaigns   in prisons with more than 1,000 inmates and on a quarterlybasisin   institutions   with   less   than   1,000   inmates. Purchase   of   additional   supplies   for   TB   and   HIV prevention (infection control, safe shaving) for prisoners and support for the coordination of these activities, which will  help  to  ensure  TB  is  diagnosed  earlier  and  avoid  it being spread. In  addition,  it  would  facilitate  the  purchase  of  two  mobile digital X-ray machines exclusively for prisoners, which would significantly improve the rate of return for screening.","NA Original Intervention: Key populations (TB/HIV)  Prisoners","High","708964.2","This funding is important to support activities to conduct TB/HIV massscreening campaigns in prisons and to purchase two mobile digital X-ray machines for use in prisons. This intervention is part of active case finding strategy for key populations and with potential to identify the undiagnosed TB and HIV cases. In addition to proposed screening of prisoners, the TRP recommends that during the screening 6 campaigns, the prison staff be screened as well.","248008.08","0","0","0","460956.12","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1m/view",null,"TB/HIV",460956.12," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713=AN452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713=AO452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713=AP452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713=AJ452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713=AN452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713=AO452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713=AP452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G452)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1nUAG","PAI-3989","Inactive","CMR-TB/HIV-7","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"Treatment, care and support","Treatment monitoring - Viral load","This  funding  would  be  used  for  additional  VL  tests  to  those covered  by  the  allocation  amount:  50,000  VL  tests in  2018, 60,000  in  2019  and  80,000  in  2020.  In  addition,  it  would  be used for annual corrective and preventive maintenance for ten  additional  Abbott  enclosed  platforms,  at  ten  reference laboratories","This  funding  would  be  used  for  additional  VL  tests  to  those covered  by  the  allocation  amount:  50,000  VL  tests in  2018, 60,000  in  2019  and  80,000  in  2020.  In  addition,  it  would  be used for annual corrective and preventive maintenance for ten  additional  Abbott  enclosed  platforms,  at  ten  reference laboratories","NA Original Intervention: Treatment monitoring  Viral load","High","687928.4","To achieve the third 90, it is important to ensure sufficient roll-out and access to viral load test. This interventions will expand the supply of viral load testing for an additional 190,000 tests, contributing directly to the number of people who have performed a viral load test. Maintenance is important to ensure quality of lab testing","0","687928.4","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1n/view",null,"TB/HIV",0," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713=AN453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713=AO453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713=AP453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713=AJ453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713=AN453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713=AO453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713=AP453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G453)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1oUAG","PAI-3990","Active","CMR-TB/HIV-8","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"Treatment, care and support","HIV care","This funding would enable the country's cohort to be increased from  320,000  to  358,000 patients by 2020.  It  would  support 38,000 patients to be enrolled on ART using EUR 9.3 million of Spanish funding via the Debt2Health initiative.","This funding would enable the country's cohort to be increased from  320,000  to  358,000 patients by 2020.  It  would  support 38,000 patients to be enrolled on ART using EUR 9.3 million of Spanish funding via the Debt2Health initiative.","This is probably fully funded.","High","10457343.73","The funding will provide additional coverage of 38,000 patients by releasing domestic funding via debt relief. This will scale-up treatment enrolment (second 90)","0","0","10456922.9","0","420.83","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1o/view",null,"TB/HIV",420.83," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713=AN454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713=AO454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713=AP454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713=AJ454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713=AN454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713=AO454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713=AP454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1pUAG","PAI-3991","Active","CMR-TB/HIV-9","2017-2019","RT Central Africa","Cameroon","HIV/TB","HIV/AIDS, Tuberculosis","FR215-CMR-C",null,null,"Treatment, care and support","Differentiated ART service delivery","This  funding  would  be  used  to  put an additional 38,600 HIV-positive patients on treatment by 2020. This budget line also include maintenance.","This  funding  would  be  used  to  put an additional 38,600 HIV-positive patients on treatment by 2020. This budget line also include maintenance.","NA Original Intervention: Differentiated antiretroviral therapy service delivery","High","10637439.12","The funding to increase access to ART for another 38,600 people each year is high priority, given the need to scale-up treatment enrolment (second 90). Note: The CD4 count maintenance should be separated from this funding and treated as medium priority, in line with the decreasing role of CD4 counts in treatment monitoring, which is needed only at treatment initiation stage to make decisions on preventive therapies for opportunistic infections.","0","0","0","0","10637439.12","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1p/view",null,"TB/HIV",10637439.119999999," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713=AN455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713=AO455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713=AP455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713=AJ455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713=AN455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713=AO455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713=AP455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G455)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ1qUAG","PAI-3992","Active","COD-Malaria-1","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","Malaria","Malaria","FR477-COD-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Mass distribution campaigns involving 20,934,506 LLINs in eight (8) DPSs (Kongo Central, Kasa, Kinshasa, Maniema, Tshopo, Ituri, Haut-Uele and Bas-Uele) with a total estimated population of 34,234,164, representing 30% of the country.  The average cost is USD 4.15 per LLIN distributed. The total estimated cost is USD 86,878,200. This will make it possible to maintain adequate universal coverage among these populations, in line with WHO recommendations, and to ensure that the gains made are not lost because of the decrease in mosquito net ownership.","Mass distribution campaigns involving 20,934,506 LLINs in eight (8) DPSs (Kongo Central, Kasa, Kinshasa, Maniema, Tshopo, Ituri, Haut-Uele and Bas-Uele) with a total estimated population of 34,234,164, representing 30% of the country.  The average cost is USD 4.15 per LLIN distributed. The total estimated cost is USD 86,878,200. This will make it possible to maintain adequate universal coverage among these populations, in line with WHO recommendations, and to ensure that the gains made are not lost because of the decrease in mosquito net ownership.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","86878200","The country is requesting funds to procure and distribute through a mass campaign 20,934,506 LLINs in 8 Divisions provinciales de la sant (DPSs) (Kongo Central, Kasa, Kinshasa, Maniema, Tshopo, Ituri, Haut-Uele and Bas-Uele) with a total estimated population of 34,234,164, representing 30% of the country. This is a high impact malaria control intervention that will increase LLINs coverage and hence reduce malaria burden in DRC.","21280986","2.6e+07","3403543.45","0","36193670.55","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1q/view","2020-12-31","Malaria",36193670.549999997," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713=AN456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713=AO456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713=AP456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713=AJ456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713=AN456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713=AO456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713=AP456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1rUAG","PAI-3993","Active","COD-Malaria-2","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","Malaria","Malaria","FR477-COD-M",null,null,"Case management","Integrated community case management (ICCM)","Remoteness and natural barriers are among the main obstacles to accessibility to health care, as only 35% of the population of the DRC live within 5 km of a health center. In order to resolve these problems, the country set up community health care sites since 2005, which make up one of the components of the Integrated Management of Childhood Illness (IMCI). The aim is to provide health care for simple cases of malaria, diarrhea and acute respiratory infections in the community with a community agent who is trained and supervised for this purpose. In this way, community health care sites help to improve access to early care and to quality drugs for those populations with a barrier to accessing the FOSAs. The CHCS also provides referrals to the FOSAs, improves the availability and rational use of quality drugs, improves monitoring of cases and of side effects of drugs, as well as key practices conducive to health. The funding of $3,354,836 requested will make possible to cover 34% of the needs in the IMCIs national guidelines (Annex 1), as proposed in the national strategic plan (Annex 2). The sites would be rolled out in 7 DPSs: Mai Ndombe, Kwango, Kongo Central, Nord Kivu, Nord Ubangi, Sud Ubangi and Equateur.Partnerships will be sought with other actors in order to complete the package of services for the two other diseases.","Remoteness and natural barriers are among the main obstacles to accessibility to health care, as only 35% of the population of the DRC live within 5 km of a health center. In order to resolve these problems, the country set up community health care sites since 2005, which make up one of the components of the Integrated Management of Childhood Illness (IMCI). The aim is to provide health care for simple cases of malaria, diarrhea and acute respiratory infections in the community with a community agent who is trained and supervised for this purpose. In this way, community health care sites help to improve access to early care and to quality drugs for those populations with a barrier to accessing the FOSAs. The CHCS also provides referrals to the FOSAs, improves the availability and rational use of quality drugs, improves monitoring of cases and of side effects of drugs, as well as key practices conducive to health. The funding of $3,354,836 requested will make possible to cover 34% of the needs in the IMCIs national guidelines (Annex 1), as proposed in the national strategic plan (Annex 2). The sites would be rolled out in 7 DPSs: Mai Ndombe, Kwango, Kongo Central, Nord Kivu, Nord Ubangi, Sud Ubangi and Equateur.Partnerships will be sought with other actors in order to complete the package of services for the two other diseases.","NA Original Intervention: Integrated community case management (iCCM)","High","3354836","This funding will support the expansion of community management of malaria, diarrhoea and pneumonia. In the country, only 35% of the population lives within 5 km of a health centre, hence this approach is bound to increase the availability of services and prevent deaths. The sites would be rolled out in 7 DPSs: Mai Ndombe, Kwango, Kongo Central, Nord Kivu, Nord Ubangi, Sud Ubangi and Equateur. This is a high impact malaria control intervention that will increase access to childhood illnesses including malaria and improve malaria case management.","0","0","0","0","3354836","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1r/view","2020-12-31","Malaria",3354836," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713=AN457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713=AO457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713=AP457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713=AJ457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713=AN457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713=AO457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713=AP457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G457)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1sUAG","PAI-3994","Active","COD-Malaria-3","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","Malaria","Malaria","FR477-COD-M",null,null,"Case management","Severe malaria","The WHO recommends the preferential use of injectable artesunate in cases of severe malaria. A total of 33,997 deaths linked to malaria were recorded in 2016 out of 96.166 deaths recorded in health facilities, i.e. a proportional mortality rate of 35%. Given that the funds for purchasing injectable artesunate for children under five years of age have already been secured, we are requesting a budget of an extra $13,800,000, which will be used to complete the purchase, transportation and storage of injectable artesunate for treating adolescents and adults suffering from severe malaria.Only the needs of children under five years of age are covered in the allocation.","The WHO recommends the preferential use of injectable artesunate in cases of severe malaria. A total of 33,997 deaths linked to malaria were recorded in 2016 out of 96.166 deaths recorded in health facilities, i.e. a proportional mortality rate of 35%. Given that the funds for purchasing injectable artesunate for children under five years of age have already been secured, we are requesting a budget of an extra $13,800,000, which will be used to complete the purchase, transportation and storage of injectable artesunate for treating adolescents and adults suffering from severe malaria.Only the needs of children under five years of age are covered in the allocation.",null,"High","13800000","Although WHO recommends the use of injectable artesunate in cases of severe malaria, DRC only has funding for management of severe malaria in children under five. The requested amount will be used to complete the purchase, transportation and storage of injectable artesunate for treating adolescents and adults suffering from severe malaria.","0","0","0","0","13800000","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1s/view","2020-12-31","Malaria",13800000," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713=AN458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713=AO458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713=AP458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713=AJ458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713=AN458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713=AO458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713=AP458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G458)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1tUAG","PAI-3995","Active","COD-Malaria-4","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","Malaria","Malaria","FR477-COD-M",null,null,"Case management","Other case management intervention(s)","The NSP provides for the following in the SBCC activities: advocating for meaningful engagement from the state, notably in terms of direct matching funding (>5%), a ban of drugs not recommended by the NMCP, tax relief/removal, strengthening the area of communication, which involves resource mobilization, actor and grantee  information so that they change their behavior and take ownership of all elements of the fight against malaria. It is within this framework that $800,000 is requested as part of the PAAR.","The NSP provides for the following in the SBCC activities: advocating for meaningful engagement from the state, notably in terms of direct matching funding (>5%), a ban of drugs not recommended by the NMCP, tax relief/removal, strengthening the area of communication, which involves resource mobilization, actor and grantee  information so that they change their behavior and take ownership of all elements of the fight against malaria. It is within this framework that $800,000 is requested as part of the PAAR.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","High","8e+05","The funding will support the DRC to implement Social and Behavioural Change Communication (SBCC) activities that are in the National Strategic Planning (NSP). These activities will enhance a ban of drugs not recommended by the National Malaria Control Plan (NMCP) and support the increased participation of all players in malaria control.","0","0","0","0","8e+05","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1t/view","2020-12-31","Malaria",800000," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713=AN459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713=AO459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713=AP459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713=AJ459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713=AN459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713=AO459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713=AP459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1uUAG","PAI-3996","Active","COD-Malaria-5","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","Malaria","Malaria","FR477-COD-M",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","The community system makes use of a network of community based organizations. It will fulfill the role of supporting community based organizations with their advocacy work in communities, to ensure: monitoring of activities at community level by its members, including audience analysis of broadcast communication campaigns, monitoring of service quality by means of mini satisfaction surveys for grantees, a link between the CHCSs and the PR and advocacy at various levels. The data will be captured directly by community level organizations and reported in the health system by means of the community based NHIS. In this manner, it provides significant support for community based monitoring activities, helping to make them higher quality.","The community system makes use of a network of community based organizations. It will fulfill the role of supporting community based organizations with their advocacy work in communities, to ensure: monitoring of activities at community level by its members, including audience analysis of broadcast communication campaigns, monitoring of service quality by means of mini satisfaction surveys for grantees, a link between the CHCSs and the PR and advocacy at various levels. The data will be captured directly by community level organizations and reported in the health system by means of the community based NHIS. In this manner, it provides significant support for community based monitoring activities, helping to make them higher quality.",null,"High","2200000","The community system makes use of a network of community-based organizations. It will fulfil the role of supporting community-based organizations with their advocacy work in communities, to ensure: monitoring of activities at community level by its members, including audience analysis of broadcast communication campaigns, monitoring of service quality by means of mini-satisfaction surveys for grantees and advocacy at various levels. The data will be captured directly by community-level organizations and reported in the health system by means of the community-based National Health Information System (NHIS). In this manner, it provides significant support for community-based monitoring activities, helping to make them be of higher quality","0","0","0","0","2200000","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1u/view","2020-12-31","Malaria",2200000," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713=AN460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713=AO460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713=AP460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713=AJ460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713=AN460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713=AO460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713=AP460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G460)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1vUAG","PAI-3997","Active","COD-Malaria-6","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","Malaria","Malaria","FR477-COD-M",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","The cost of implementing the NSP for 2016-2020 has been estimated as US$ 1,520,554,318. Analysis of the financial shortfalls after taking into account support from PMI, DFID, the Government and the allocation from The Global Fund in 2015-2017 and 2018-2020 shows an estimated shortfall of US$ 707,374,658. In order to bridge this gap, a process of internal resource mobilization within the Government and among private sector actors, both national and international. After the round table meeting which will take place on October 10, 2017, round table meetings are planned in the provinces (US$ 95,368) and externally (US$ 51,802).","The cost of implementing the NSP for 2016-2020 has been estimated as US$ 1,520,554,318. Analysis of the financial shortfalls after taking into account support from PMI, DFID, the Government and the allocation from The Global Fund in 2015-2017 and 2018-2020 shows an estimated shortfall of US$ 707,374,658. In order to bridge this gap, a process of internal resource mobilization within the Government and among private sector actors, both national and international. After the round table meeting which will take place on October 10, 2017, round table meetings are planned in the provinces (US$ 95,368) and externally (US$ 51,802).",null,"Medium","147170","This funding will fund meetings that are aimed at a process of internal resource mobilization within the Government and among private sector actors, both national and international.","0","0","0","0","147170","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1v/view","2020-12-31","Malaria",147170," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713=AN461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713=AO461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713=AP461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713=AJ461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713=AN461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713=AO461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713=AP461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1wUAG","PAI-3998","Active","COD-Malaria-7","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","Malaria","Malaria","FR477-COD-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","DHS: National study to determine the health-related and demographic indicators, including those involved in the fight against malaria. This study will be carried out in order to evaluate the evolution of the impact indicators and the result indicators and will be able to inform the various performance frameworks.","DHS: National study to determine the health-related and demographic indicators, including those involved in the fight against malaria. This study will be carried out in order to evaluate the evolution of the impact indicators and the result indicators and will be able to inform the various performance frameworks.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Studies","Medium","2470235","The Demographic Health Survey (DHS) is an important part of monitoring and evaluation of the response to malaria control, this survey is important to collect data on key malaria control indicators (LLINs coverage, access to malaria treatment, etc) aligned with international norms and standards. Whilst DHS covers other diseases, it is not clear whether this DHS will do so and whether funding will be appropriately shared.","0","0","0","0","2470235","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1w/view","2020-12-31","Malaria",2470235," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713=AN462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713=AO462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713=AP462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713=AJ462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713=AN462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713=AO462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713=AP462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1xUAG","PAI-3999","Active","COD-Malaria-8","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","Malaria","Malaria","FR477-COD-M",null,null,"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","This sum will consist of buying in services from the structures/Programs of the Ministry of Health, which can contribute to achieving the objectives linked to the 3 diseases. For example: FOSAs, DPSs, CDRs, PNAM, 3workers DEP,IGs). This involves defining a package of support for services affected in exchange for results, which have a proven impact on the performance of the fight against the threediseases. It will be possible to use these sums in a co-financing arrangement with domestic funds or with other partners such as the World Bank or the European Union.","This sum will consist of buying in services from the structures/Programs of the Ministry of Health, which can contribute to achieving the objectives linked to the 3 diseases. For example: FOSAs, DPSs, CDRs, PNAM, 3workers DEP,IGs). This involves defining a package of support for services affected in exchange for results, which have a proven impact on the performance of the fight against the threediseases. It will be possible to use these sums in a co-financing arrangement with domestic funds or with other partners such as the World Bank or the European Union.","NA Original Module: RSSH - Human resources for health, including community health workers","High","22300000","The strengthening of community health system is important for the implementation and roll out of malaria /integrated community case management","0","0","0","0","22300000","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1x/view","2020-12-31","Malaria",22300000," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713=AN463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713=AO463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713=AP463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713=AJ463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713=AN463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713=AO463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713=AP463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G463)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1yUAG","PAI-4000","Inactive","COD-Malaria-9","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","Malaria","Malaria","FR477-COD-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","During flare-ups of epidemics, various assessments indicate that the majority of deaths occur within the community. In order to reduce this risk, the Management of disease control has developed a community-based monitoring module. Putting it in place requires the skills of actors to be strengthened. It is planned that this will start in some of the HZs that are most affected by the flare-ups in the provinces of Haut-Uele and Bas-Uele with the 2015-2017 grant. The amount entered in the PAAR will make it possible to complete this process in these two provinces.","During flare-ups of epidemics, various assessments indicate that the majority of deaths occur within the community. In order to reduce this risk, the Management of disease control has developed a community-based monitoring module. Putting it in place requires the skills of actors to be strengthened. It is planned that this will start in some of the HZs that are most affected by the flare-ups in the provinces of Haut-Uele and Bas-Uele with the 2015-2017 grant. The amount entered in the PAAR will make it possible to complete this process in these two provinces.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Integrated community-based monitoring of diseases","High","525201","Given the upsurge of malaria in the DRC, monitoring of malaria diseases in the community is of paramount importance.","0","525201","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1y/view","2020-12-31","Malaria",0," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713=AN464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713=AO464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713=AP464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713=AJ464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713=AN464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713=AO464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713=AP464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G464)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ1zUAG","PAI-4001","Active","COD-TB/HIV-1","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Diagnosis and treatment of additional cases The requested funding (allocation amount), including the catalyst funding to identify missing cases, will make it possible to treat 439,784 patients with all forms of TB (TBAF). Using the strategies outlined in this funding request, the country believes it would be able to achieve more ambitious targets. However, the targets have been kept at a level commensurate with currently available funds from the government, the Global Fund and other partners. The additional investment would allow the country to cover an extra 65,297 TBAF patients. The activities involve purchasing supplies and drugs, as well as the corresponding procurement and supply management (PSM) and distribution costs (detailed breakdowns available).","Diagnosis and treatment of additional cases The requested funding (allocation amount), including the catalyst funding to identify missing cases, will make it possible to treat 439,784 patients with all forms of TB (TBAF). Using the strategies outlined in this funding request, the country believes it would be able to achieve more ambitious targets. However, the targets have been kept at a level commensurate with currently available funds from the government, the Global Fund and other partners. The additional investment would allow the country to cover an extra 65,297 TBAF patients. The activities involve purchasing supplies and drugs, as well as the corresponding procurement and supply management (PSM) and distribution costs (detailed breakdowns available).","NA Original Intervention: Case detection and diagnosis, treatment","High","8806628","High need / High impact","0","0","0","0","8806628","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ1z/view","2020-12-31","TB/HIV",8806628," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713=AN465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713=AO465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713=AP465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713=AJ465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713=AN465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713=AO465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713=AP465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G465)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ20UAG","PAI-4002","Active","COD-TB/HIV-10","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"TB/HIV","Collaborative activities with other programs and sectors (TB/HIV)","Psychosocial support from CBOs The aim of this intervention is to improve patient care by signing performance contracts with community-based organizations (CBOs) to provide psychosocial support to co-infected patients.","Psychosocial support from CBOs The aim of this intervention is to improve patient care by signing performance contracts with community-based organizations (CBOs) to provide psychosocial support to co-infected patients.",null,"High","533640","High need / High impact","0","0","0","0","533640","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ20/view","2020-12-31","TB/HIV",533640," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713=AN466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713=AO466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713=AP466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713=AJ466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713=AN466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713=AO466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713=AP466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ21UAG","PAI-4003","Active","COD-TB/HIV-11","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"TB/HIV","Engaging all care providers (TB/HIV)","Involvement of churches, CBOs and civil society This investment will be used to improve case-finding by involving churches, CBOs and civil society, through the following activities: - Organize 729 awareness-raising sessions for church, CBO and civil society leaders, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one meeting per year per HZ). - Deliver training to church, CBO and civil society members, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one training session per year per HZ): four people per HZ per year. Total 972 per year, one day, 2,916 over three years. - Buy 2,916 education and awareness-raising kits for each trained member.","Involvement of churches, CBOs and civil society This investment will be used to improve case-finding by involving churches, CBOs and civil society, through the following activities: - Organize 729 awareness-raising sessions for church, CBO and civil society leaders, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one meeting per year per HZ). - Deliver training to church, CBO and civil society members, to secure their involvement in TB, DR-TB, TB/HIV and HIV control efforts in 243 hot-spot HZs (one training session per year per HZ): four people per HZ per year. Total 972 per year, one day, 2,916 over three years. - Buy 2,916 education and awareness-raising kits for each trained member.",null,"High","368874","High need / High impact","0","0","0","0","368874","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ21/view","2020-12-31","TB/HIV",368874," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713=AN467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713=AO467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713=AP467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713=AJ467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713=AN467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713=AO467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713=AP467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ22UAG","PAI-4004","Active","COD-TB/HIV-12","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","Treatment for people living with HIV (purchase of antiretrovirals - ARVs) This amount represents 24,399 patients to enroll on antiretroviral therapy (ART), including 1,078 children. It includes the cost of the test, ARVs, biological monitoring and procurement and supply management (PSM).","Treatment for people living with HIV (purchase of antiretrovirals - ARVs) This amount represents 24,399 patients to enroll on antiretroviral therapy (ART), including 1,078 children. It includes the cost of the test, ARVs, biological monitoring and procurement and supply management (PSM).","NA Original Intervention: Other interventions for treatment","High","28619968","High need / High impact","0","8700000","0","0","19919968","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ22/view","2020-12-31","TB/HIV",19919968," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713=AN468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713=AO468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713=AP468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713=AJ468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713=AN468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713=AO468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713=AP468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G468)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ23UAG","PAI-4005","Inactive","COD-TB/HIV-13","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","Renovation of the national reference laboratory (NRL) for AIDS.","Renovation of the national reference laboratory (NRL) for AIDS.","13/11/17: Shreya forwarded emails from Naboundou Toure-Fadiga on 13/10/17 that this activity was removed during grant negotiations. Made this intervention inactive by changing the $ amount Original Intervention: Other interventions for treatment","High","350000","High need / High impact","350000","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ23/view","2020-12-31","TB/HIV",0," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713=AN469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713=AO469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713=AP469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713=AJ469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713=AN469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713=AO469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713=AP469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G469)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ24UAG","PAI-4006","Active","COD-TB/HIV-14","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"RSSH: Health management information systems and M&E","Surveys","Completion of the serosurveillance survey among pregnant women.","Completion of the serosurveillance survey among pregnant women.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","1093358","High need / High impact","0","0","0","0","1093358","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ24/view","2020-12-31","TB/HIV",1093358," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713=AN470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713=AO470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713=AP470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713=AJ470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713=AN470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713=AO470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713=AP470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G470)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ25UAG","PAI-4007","Active","COD-TB/HIV-15","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Prevalence survey, DRS, external review and training This additional investment covers essential activities to improve program outcomes and performance. However, these activities have been excluded from the allocation amount because of limited funding availability. The activities are as follows: - Organize mini Drug Resistance Survey (DRS) in the six provinces with high TB drug-resistance prevalence rates not included under the allocation amount; - Organize the general population TB prevalence survey in 2019.","Prevalence survey, DRS, external review and training This additional investment covers essential activities to improve program outcomes and performance. However, these activities have been excluded from the allocation amount because of limited funding availability. The activities are as follows: - Organize mini Drug Resistance Survey (DRS) in the six provinces with high TB drug-resistance prevalence rates not included under the allocation amount; - Organize the general population TB prevalence survey in 2019.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Survey (mini DRS and prevalence)","Low","3120000","A mini DRS is considered of low importance given that DRS has recently been conducted though only in a few provinces.","0","0","0","0","3120000","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ25/view","2020-12-31","TB/HIV",3120000," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713=AN471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713=AO471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713=AP471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713=AJ471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713=AN471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713=AO471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713=AP471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ26UAG","PAI-4008","Active","COD-TB/HIV-16","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"TB care and prevention","Prevention","Prevention: TV and radio adverts and billboard posters in large cities This investment will cover general population prevention activities (mass communication) in an effort to improve disease prevention knowledge and practices.","Prevention: TV and radio adverts and billboard posters in large cities This investment will cover general population prevention activities (mass communication) in an effort to improve disease prevention knowledge and practices.",null,"Low","1731060","Public reach with TB/HIV information through radio and posters is not considered of high impact","0","0","0","0","1731060","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ26/view","2020-12-31","TB/HIV",1731060," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713=AN472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713=AO472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713=AP472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713=AJ472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713=AN472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713=AO472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713=AP472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ27UAG","PAI-4009","Active","COD-TB/HIV-2","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","Diagnosis and treatment of XDR-TB cases This additional request would allow treatment to begin for 62 patients with extensively drug-resistant TB (XDR-TB) in 2018, 75 in 2019 and 88 in 2020. The activities concerned are the purchase of drugs, the corresponding PSM costs and three technical assistance activities for managing XDR-TB patients.","Diagnosis and treatment of XDR-TB cases This additional request would allow treatment to begin for 62 patients with extensively drug-resistant TB (XDR-TB) in 2018, 75 in 2019 and 88 in 2020. The activities concerned are the purchase of drugs, the corresponding PSM costs and three technical assistance activities for managing XDR-TB patients.","NA Original Module: Multidrug-resistant TB","High","2364088","High need / High impact","0","0","0","0","2364088","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ27/view","2020-12-31","TB/HIV",2364088," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713=AN473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713=AO473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713=AP473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713=AJ473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713=AN473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713=AO473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713=AP473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G473)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ28UAG","PAI-4010","Active","COD-TB/HIV-3","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"MDR-TB","Other MDR-TB intervention(s)","Renovation of DR-TB in-patient facilities The purpose of the additional investment is to renovate three in-patient treatment centers for drug-resistant TB (DR-TB) patients presenting with complications or severe side effects during treatment. The three centers will be located in DR-TB hot spots. The unit cost of US$ 115,000 is a historical cost from the current grants.","Renovation of DR-TB in-patient facilities The purpose of the additional investment is to renovate three in-patient treatment centers for drug-resistant TB (DR-TB) patients presenting with complications or severe side effects during treatment. The three centers will be located in DR-TB hot spots. The unit cost of US$ 115,000 is a historical cost from the current grants.","NA Original Module: Multidrug-resistant TB","High","449550","High need / High impact","0","0","0","0","449550","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ28/view","2020-12-31","TB/HIV",449550," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713=AN474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713=AO474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713=AP474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713=AJ474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713=AN474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713=AO474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713=AP474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G474)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ29UAG","PAI-4011","Active","COD-TB/HIV-4","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"MDR-TB","Prevention for MDR-TB","Infection control measures Administrative, environmental and personal infection control measures will be needed to help prevent the transmission of TB (and DR-TB in particular), as defined in (Le Guide du Contrle de linfection et le guide de prise en charge de la TB-PR). The additional investment will be used to renovate 26 incinerators at testing and treatment centers (TTCs) with a high DR-TB burden in the 11 high-priority provinces (two per high-priority province plus four extra incinerators in Kinshasa), and to carry out minor renovation work at 708 TTCs selected on the basis of their TB/HIV co-infection burden. There are also plans to monitor and evaluate the implementation of these measures. This intervention should help avoid 250 new infections at the TTCs in question.","Infection control measures Administrative, environmental and personal infection control measures will be needed to help prevent the transmission of TB (and DR-TB in particular), as defined in (Le Guide du Contrle de linfection et le guide de prise en charge de la TB-PR). The additional investment will be used to renovate 26 incinerators at testing and treatment centers (TTCs) with a high DR-TB burden in the 11 high-priority provinces (two per high-priority province plus four extra incinerators in Kinshasa), and to carry out minor renovation work at 708 TTCs selected on the basis of their TB/HIV co-infection burden. There are also plans to monitor and evaluate the implementation of these measures. This intervention should help avoid 250 new infections at the TTCs in question.","NA Original Module: Multidrug-resistant TB","High","1169800","High need / High impact","0","0","0","0","1169800","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ29/view","2020-12-31","TB/HIV",1169800," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713=AN475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713=AO475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713=AP475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713=AJ475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713=AN475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713=AO475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713=AP475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G475)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2AUAW","PAI-4012","Inactive","COD-TB/HIV-5","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Supply chain and quality assurance strengthening This investment will significantly improve the TB drugs supply chain, through the following activities: - Have the Programme National dApprovisionnement en Mdicaments essentiels [National Program for the Procurement of Essential Medicines  PNAM] and the National Tuberculosis Control Program (NTCP) take part in PSM monitoring and supervision missions at the Centrale de Distribution Rgionale des Mdicaments [Regional Drug Distribution Center  CDR]; - Organize drug sample collection missions at all levels of the supply chain for quality control, in conjunction with the Direction de la Pharmacie et du Mdicament [Directorate of Pharmacy and Drugs  DPM]; - Cover the costs of having the samples analyzed by a foreign laboratory prequalified by the World Health Organization (WHO) to analyze first-line drugs. (10 percent of the drugs value  see Quality Assurance Plan); - Create and configure databases, produce reports and deliver training on Apisoft to the central and provincial levels; - Cover handling costs for drugs and other supplies; - Deliver TB drug management training to service providers.","Supply chain and quality assurance strengthening This investment will significantly improve the TB drugs supply chain, through the following activities: - Have the Programme National dApprovisionnement en Mdicaments essentiels [National Program for the Procurement of Essential Medicines  PNAM] and the National Tuberculosis Control Program (NTCP) take part in PSM monitoring and supervision missions at the Centrale de Distribution Rgionale des Mdicaments [Regional Drug Distribution Center  CDR]; - Organize drug sample collection missions at all levels of the supply chain for quality control, in conjunction with the Direction de la Pharmacie et du Mdicament [Directorate of Pharmacy and Drugs  DPM]; - Cover the costs of having the samples analyzed by a foreign laboratory prequalified by the World Health Organization (WHO) to analyze first-line drugs. (10 percent of the drugs value  see Quality Assurance Plan); - Create and configure databases, produce reports and deliver training on Apisoft to the central and provincial levels; - Cover handling costs for drugs and other supplies; - Deliver TB drug management training to service providers.","13/11/17: Shreya forwarded emails from Naboundou Toure-Fadiga on 13/10/17 that this activity was removed during grant negotiations. Made this intervention inactive by artifically changing the $ amount","High","2421488","High need / High impact","2421488","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2A/view","2020-12-31","TB/HIV",0," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713=AN476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713=AO476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713=AP476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713=AJ476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713=AN476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713=AO476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713=AP476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2BUAW","PAI-4013","Active","COD-TB/HIV-6","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"MDR-TB","Prevention for MDR-TB","Pharmacovigilance and laboratory strengthening This additional investment is intended to address rising drug resistance in the country and respond to the introduction of new drugs, initially to treat XDR-TB cases. It will be used to help establish a pharmacovigilance system to monitor and manage DR-TB drug side effects, with a view to future extension of the new drugs to treat DR-TB (non-XDR-TB).","Pharmacovigilance and laboratory strengthening This additional investment is intended to address rising drug resistance in the country and respond to the introduction of new drugs, initially to treat XDR-TB cases. It will be used to help establish a pharmacovigilance system to monitor and manage DR-TB drug side effects, with a view to future extension of the new drugs to treat DR-TB (non-XDR-TB).","NA Original Module: Multidrug-resistant TB","High","2083840","High need / High impact","0","0","0","0","2083840","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2B/view","2020-12-31","TB/HIV",2083840," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713=AN477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713=AO477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713=AP477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713=AJ477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713=AN477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713=AO477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713=AP477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2CUAW","PAI-4014","Active","COD-TB/HIV-7","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"MDR-TB","Other MDR-TB intervention(s)","Improved treatment of side effects for DR-TB patients This investment is expected to improve DR-TB case management by: - Extending permanent technical assistance to six more provinces (on top of the five high-priority provinces included under the allocation amount), thereby covering a total of 11 provinces with high DR-TB prevalence rates); - Procuring 243 portable hearing test devices to assess DR-TB patients in the 243 health zones (HZs) in the 11 high-priority provinces, and purchasing 642 hearing aids for patients; - Building the capacities of DR-TB health workers through sending them to scientific symposia and on study trips; - Developing partnerships with universities.","Improved treatment of side effects for DR-TB patients This investment is expected to improve DR-TB case management by: - Extending permanent technical assistance to six more provinces (on top of the five high-priority provinces included under the allocation amount), thereby covering a total of 11 provinces with high DR-TB prevalence rates); - Procuring 243 portable hearing test devices to assess DR-TB patients in the 243 health zones (HZs) in the 11 high-priority provinces, and purchasing 642 hearing aids for patients; - Building the capacities of DR-TB health workers through sending them to scientific symposia and on study trips; - Developing partnerships with universities.","NA Original Module: Multidrug-resistant TB","High","854250","High need / High impact","0","0","0","0","854250","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2C/view","2020-12-31","TB/HIV",854250," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713=AN478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713=AO478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713=AP478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713=AJ478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713=AN478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713=AO478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713=AP478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G478)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2DUAW","PAI-4015","Active","COD-TB/HIV-8","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Pediatric TB training for maternal, neonatal and child health (MNCH) and diabetes providers The investment will be used to better incorporate pediatric TB screening and case management into the following activities: - Delivering pediatric TB training to two service providers per MNCH and malnutrition treatment center (TT)/TTC (2,068 x 2); - Delivering training to 516 diabetes and malnutrition treatment service providers.","Pediatric TB training for maternal, neonatal and child health (MNCH) and diabetes providers The investment will be used to better incorporate pediatric TB screening and case management into the following activities: - Delivering pediatric TB training to two service providers per MNCH and malnutrition treatment center (TT)/TTC (2,068 x 2); - Delivering training to 516 diabetes and malnutrition treatment service providers.","NA Original Intervention: Key populations (TB care and prevention)  Others","High","224064","High need / High impact","0","0","0","0","224064","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2D/view","2020-12-31","TB/HIV",224064," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713=AN479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713=AO479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713=AP479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713=AJ479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713=AN479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713=AO479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713=AP479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G479)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2EUAW","PAI-4016","Active","COD-TB/HIV-9","2017-2019","RT High Impact Africa 1","Congo (Democratic Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR100-COD-C",null,null,"TB/HIV","Collaborative activities with other programs and sectors (TB/HIV)","Involvement of private facilities and traditional medicine practitioners Scale up efforts to identify missing cases by training private care providers and traditional medicine practitioners (three providers trained in each of the 243 high-priority HZs).","Involvement of private facilities and traditional medicine practitioners Scale up efforts to identify missing cases by training private care providers and traditional medicine practitioners (three providers trained in each of the 243 high-priority HZs).",null,"High","374564","High need / High impact","0","0","0","0","374564","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2E/view","2020-12-31","TB/HIV",374564," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713=AN480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713=AO480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713=AP480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713=AJ480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713=AN480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713=AO480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713=AP480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2FUAW","PAI-4017","Inactive","COG-Malaria-1","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To assess the level of knowledge of the population on the modes of transmission and means of prevention of malaria, a KAP survey is planned as part of the above allocation funding request.","To assess the level of knowledge of the population on the modes of transmission and means of prevention of malaria, a KAP survey is planned as part of the above allocation funding request.","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: KAP survey","High","62843.68","Important to identify the possible barriers to achieving maximum impact from LLINs mass campaign, information needed to develop appropriate IEC/BCC tools","62843.68","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2F/view","2020-12-31","Malaria",0," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713=AN481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713=AO481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713=AP481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713=AJ481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713=AN481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713=AO481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713=AP481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G481)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2GUAW","PAI-4018","Active","COG-Malaria-10","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"Case management","Other case management intervention(s)",null,null,"NA Original Module: Community case management. Original Intervention: Stipend for CHW and equipment","Low","1711367.97","Stipend for CHW and equipment needed to expand malaria community case management are not covered in the allocation","0","0","0","0","1711367.97","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2G/view","2020-12-31","Malaria",1711367.97," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713=AN482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713=AO482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713=AP482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713=AJ482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713=AN482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713=AO482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713=AP482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2HUAW","PAI-4019","Active","COG-Malaria-11","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.","This intervention aims to ensure that the drugs used for the treatment of malaria are effective because the success of a treatment policy depends on the effectiveness of the drugs. Currently, studies have shown that these drugs are still effective, with figures indicating 98 percent for ACT (treatment effectiveness test report 2017). Just as with vector insecticide sensitivity tests, the financing of this intervention will support the current WHO funding for the NMCP which does not take into account effectiveness testing in all sites. For this reason, an above allocation funding request is being made. Given the age of the current epidemiological profile, this intervention will also enable it to be updated through the above allocation funding request to enable a better temporal and spatial understanding of malaria. Sentinel sites will also be established, taking into account the strata which will be retained.","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: ACT therapeutic efficacy test","Low","32544.05","Needed to monitor the status of malaria drug efficacy, not covered in the allocation","0","0","0","0","32544.05","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2H/view","2020-12-31","Malaria",32544.05," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713=AN483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713=AO483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713=AP483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713=AJ483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713=AN483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713=AO483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713=AP483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G483)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2IUAW","PAI-4020","Active","COG-Malaria-12","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention will focus on the organization of a mid-term review of the NSP 2018-2022. This will assess the NSP mid-term, with the potential to adjust the interventions. This intervention will be funded by the above allocation funding from the Global Fund. The expected impact of this module will be better planning and better coordination of malaria control interventions.","This intervention will focus on the organization of a mid-term review of the NSP 2018-2022. This will assess the NSP mid-term, with the potential to adjust the interventions. This intervention will be funded by the above allocation funding from the Global Fund. The expected impact of this module will be better planning and better coordination of malaria control interventions.","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: Mid-term review of the NSP","Low","74065.76","Needed to monitor the status of the Malaria Strategic Plan (MSP) implementation and performance level m not allocated in the allocation","0","0","0","0","74065.76","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2I/view","2020-12-31","Malaria",74065.759999999995," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713=AN484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713=AO484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713=AP484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713=AJ484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713=AN484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713=AO484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713=AP484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2JUAW","PAI-4021","Inactive","COG-Malaria-13","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention will enable insecticide sensitivity tests for vectors to be carried out with the updating of the sentinel surveillance system. The financing of this intervention will support the current WHO funding for the NMCP which has proved to be insufficient because it does not cover testing in all sites. For this reason, an above allocation funding request is being made.","This intervention will enable insecticide sensitivity tests for vectors to be carried out with the updating of the sentinel surveillance system. The financing of this intervention will support the current WHO funding for the NMCP which has proved to be insufficient because it does not cover testing in all sites. For this reason, an above allocation funding request is being made.","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: Assessment of vector sensitivity","Low","80799.01","Needed to monitor the status of mosquito insecticide resistance not covered in the allocation","80799.01","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2J/view","2020-12-31","Malaria",0," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713=AN485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713=AO485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713=AP485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713=AJ485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713=AN485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713=AO485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713=AP485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G485)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2KUAW","PAI-4022","Active","COG-Malaria-14","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention will focus on the organization of World Malaria Day on 25 April each year for three years, which constitutes an opportunity to raise awareness and mobilize, targeting decision makers and key players in the fight against malaria. The expected impact of this module will be a reduction in malaria morbidity among pregnant women, as well as increased awareness and mobilization of populations and decision-makers with regard to malaria control.","This intervention will focus on the organization of World Malaria Day on 25 April each year for three years, which constitutes an opportunity to raise awareness and mobilize, targeting decision makers and key players in the fight against malaria. The expected impact of this module will be a reduction in malaria morbidity among pregnant women, as well as increased awareness and mobilization of populations and decision-makers with regard to malaria control.","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: World Malaria Day celebrations","Low","72943.55","World Malaria Day celebrations are not covered in the allocation","0","0","0","0","72943.55","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2K/view","2020-12-31","Malaria",72943.55," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713=AN486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713=AO486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713=AP486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713=AJ486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713=AN486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713=AO486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713=AP486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G486)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2LUAW","PAI-4023","Active","COG-Malaria-15","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","For good adherence to treatment, pharmacovigilance should monitor the occurrence of adverse reactions in order to report these for more in-depth research. Since the process initiated in 2012 with R8 funding was not continued, the above allocation funding request will support this pharmacovigilance through the General Directorate of Pharmacies, Laboratories and Drugs. The expected impact of this module will be a reduction in the malaria mortality rate.","For good adherence to treatment, pharmacovigilance should monitor the occurrence of adverse reactions in order to report these for more in-depth research. Since the process initiated in 2012 with R8 funding was not continued, the above allocation funding request will support this pharmacovigilance through the General Directorate of Pharmacies, Laboratories and Drugs. The expected impact of this module will be a reduction in the malaria mortality rate.","NA Original Module: Epidemiological surveillance and M&E. Original Intervention: Training of health workers on pharmacovigilance","Low","39277.3","Training needed to initiate pharmacovigilance are not covered by the allocation","0","0","0","0","39277.3","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2L/view","2020-12-31","Malaria",39277.300000000003," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713=AN487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713=AO487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713=AP487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713=AJ487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713=AN487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713=AO487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713=AP487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2MUAW","PAI-4024","Active","COG-Malaria-2","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"Case management","Other case management intervention(s)",null,null,"NA Original Intervention: Procurement of Artesunate injectable","High","268207.83","To cover treatment of severe malaria and to improve treatment of severe malaria and reduce malaria mortality","0","0","0","0","268207.83","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2M/view","2020-12-31","Malaria",268207.83," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713=AN488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713=AO488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713=AP488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713=AJ488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713=AN488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713=AO488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713=AP488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G488)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2NUAW","PAI-4025","Active","COG-Malaria-3","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"Case management","Other case management intervention(s)",null,null,"NA Original Module: Community case management. Original Intervention: Training of community health workers (CHWs)","High","325440.47","To maintain high level of treatment with ACTs, quality assurance in the private sector (included in the training) and critical for the improvements of malaria diagnosis, treatment, and surveillance","0","0","0","0","325440.47","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2N/view","2020-12-31","Malaria",325440.46999999997," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713=AN489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713=AO489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713=AP489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713=AJ489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713=AN489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713=AO489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713=AP489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2OUAW","PAI-4026","Active","COG-Malaria-4","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"Vector control","Other vector control measure(s)","The intervention of this module will focus on the routine distribution of 589,164 LLINs to pregnant women and children under one year of age during antenatal clinics, seasonal malaria chemoprevention (SMC), and/or linked to vaccination. In effect, these population groups are the most vulnerable to malaria but do not currently benefit from LLINs. The Chinese Government has signed a donation agreement with Congo to provide 200,000 LLINs per year for five years. However, programmatic gap analysis shows that there will be a 48 percent shortage of LLINs in 2018, 6 percent in 2019 and 51 percent in 2020 for the routine provision of nets, equivalent to a shortage of 589,164 LLINs. The household coverage rate of LLINs in 2015 is 36.7 percent. The rates of use are respectively 60.5 percent among children under one year of age and 60.3 percent among pregnant women, also for 2015. The above allocation funding by the Global Fund will cover the gap in LLINs and improve the rate of coverage (99 percent among pregnant women and 90 percent among children under one year of age), and the rate of use of LLINs to at least 80 percent in these two vulnerable groups. The expected impact will be a reduction of the burden of malaria morbidity among these vulnerable groups.","The intervention of this module will focus on the routine distribution of 589,164 LLINs to pregnant women and children under one year of age during antenatal clinics, seasonal malaria chemoprevention (SMC), and/or linked to vaccination. In effect, these population groups are the most vulnerable to malaria but do not currently benefit from LLINs. The Chinese Government has signed a donation agreement with Congo to provide 200,000 LLINs per year for five years. However, programmatic gap analysis shows that there will be a 48 percent shortage of LLINs in 2018, 6 percent in 2019 and 51 percent in 2020 for the routine provision of nets, equivalent to a shortage of 589,164 LLINs. The household coverage rate of LLINs in 2015 is 36.7 percent. The rates of use are respectively 60.5 percent among children under one year of age and 60.3 percent among pregnant women, also for 2015. The above allocation funding by the Global Fund will cover the gap in LLINs and improve the rate of coverage (99 percent among pregnant women and 90 percent among children under one year of age), and the rate of use of LLINs to at least 80 percent in these two vulnerable groups. The expected impact will be a reduction of the burden of malaria morbidity among these vulnerable groups.","NA Original Intervention: Procurement of routine LLINs","Medium","1931320.84","To meet the full need of routine distribution of LLINs for vulnerable groups: pregnant women and children in EPI","0","0","0","0","1931320.84","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2O/view","2020-12-31","Malaria",1931320.84," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713=AN490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713=AO490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713=AP490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713=AJ490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713=AN490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713=AO490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713=AP490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G490)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2PUAW","PAI-4027","Active","COG-Malaria-5","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)",null,null,"NA Original Module: Epidemiological surveillance and M&E. Original Intervention: Supervision visits","Medium","506116.04","Improve the quality and monitor the implementation of malaria control interventions at all levels of health system. Activity not covered in the allocation","0","0","0","0","506116.04","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2P/view","2020-12-31","Malaria",506116.04," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713=AN491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713=AO491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713=AP491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713=AJ491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713=AN491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713=AO491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713=AP491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G491)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2QUAW","PAI-4028","Active","COG-Malaria-6","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)",null,null,"NA Original Module: Epidemiological surveillance and M&E. Original Intervention: M&E data manager workshops","Medium","3366.63","Training needed to improve data management are not covered by the allocation","0","0","0","0","3366.63","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2Q/view","2020-12-31","Malaria",3366.63," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713=AN492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713=AO492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713=AP492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713=AJ492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713=AN492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713=AO492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713=AP492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2RUAW","PAI-4029","Active","COG-Malaria-7","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"Other module","Other module","The current coverage of third dose intermittent preventive treatment (IPT 3) among pregnant woman is low, standing at 12 percent in 2016. The needs met by the country in terms of SP doses are 629,170 in 2018, 645,530 in 2019 and 662,314 in 2020, giving a total of 1,937,013 for the three years, or 100 percent. Only the support activities for this intervention, namely the development and validation of refocused antenatal clinic standards and directives, and training care providers in prenatal care, will be taken into account by the above allocation funding from the Global Fund. The availability of SP and the implementation of these support activities will increase IPT 3 to 80 percent in 2020.","The current coverage of third dose intermittent preventive treatment (IPT 3) among pregnant woman is low, standing at 12 percent in 2016. The needs met by the country in terms of SP doses are 629,170 in 2018, 645,530 in 2019 and 662,314 in 2020, giving a total of 1,937,013 for the three years, or 100 percent. Only the support activities for this intervention, namely the development and validation of refocused antenatal clinic standards and directives, and training care providers in prenatal care, will be taken into account by the above allocation funding from the Global Fund. The availability of SP and the implementation of these support activities will increase IPT 3 to 80 percent in 2020.","NA Original Module: Intermittent preventive treatment (IPT). Original Intervention: Policy revision workshops and health workers training","Medium","90898.89","Workshop related to the revision of IPTp policy not covered in the allocation","0","0","0","0","90898.89","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2R/view","2020-12-31","Malaria",90898.89," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713=AN493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713=AO493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713=AP493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713=AJ493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713=AN493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713=AO493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713=AP493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2SUAW","PAI-4030","Active","COG-Malaria-8","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"Other module","Other module",null,null,"NA Original Module: Diagnostic. Original Intervention: Policy revision workshops and health workers training","Medium","39277.3","Workshop related to the revision of diagnostic policy not covered in the allocation","0","0","0","0","39277.3","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2S/view","2020-12-31","Malaria",39277.300000000003," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713=AN494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713=AO494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713=AP494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713=AJ494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713=AN494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713=AO494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713=AP494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2TUAW","PAI-4031","Active","COG-Malaria-9","2017-2019","RT Central Africa","Congo","Malaria","Malaria","FR214-COG-M",null,null,"Case management","Other case management intervention(s)","Care providers will be trained to support the supply of ACT and artesunate as well as supervision at different levels of the health system. The above allocation funding request will enable the gap in drugs to be met and the support activities to be implemented","Care providers will be trained to support the supply of ACT and artesunate as well as supervision at different levels of the health system. The above allocation funding request will enable the gap in drugs to be met and the support activities to be implemented","NA Original Intervention: Training of health workers","Medium","534171.25","Health workers training needed to improve case management are not covered by the allocation","0","0","0","0","534171.25","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2T/view","2020-12-31","Malaria",534171.25," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713=AN495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713=AO495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713=AP495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713=AJ495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-05-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713=AN495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713=AO495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713=AP495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2UUAW","PAI-4032","Active","COG-TB/HIV-1","2017-2019","RT Central Africa","Congo","HIV/TB","HIV/AIDS, Tuberculosis","FR289-COG-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","The three months of buffer stock constitute a supplement to the adult ARV drugs which will be procured from the allocated funds in order to have 6 months as a standard quantity.","The three months of buffer stock constitute a supplement to the adult ARV drugs which will be procured from the allocated funds in order to have 6 months as a standard quantity.","NA Original Intervention: Three months buffer stock for adults living with HIV","High","1180280.55","The three months of buffer stock constitute a supplement to the adult ARV drugs which will be procured from the allocated funds in order to have 6 months as a standard quantity. This is high priority given the number of patients on treatment","0","0","0","0","1180280.55","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2U/view","2020-12-31","TB/HIV",1180280.55," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713=AN496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713=AO496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713=AP496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713=AJ496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713=AN496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713=AO496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713=AP496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G496)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2VUAW","PAI-4033","Active","COG-TB/HIV-10","2017-2019","RT Central Africa","Congo","HIV/TB","HIV/AIDS, Tuberculosis","FR289-COG-C",null,null,"TB/HIV","Other TB/HIV intervention(s)","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS in prisons.","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS in prisons.","NA Original Intervention: Integration of TB treatment and the application of the directly observed therapy (DOTS) strategy in prisons","High","1211.99","This activity will enhance the capacity for management of TB in prisons","0","0","0","0","1211.99","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2V/view","2020-12-31","TB/HIV",1211.99," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713=AN497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713=AO497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713=AP497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713=AJ497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713=AN497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713=AO497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713=AP497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G497)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2WUAW","PAI-4034","Active","COG-TB/HIV-11","2017-2019","RT Central Africa","Congo","HIV/TB","HIV/AIDS, Tuberculosis","FR289-COG-C",null,null,"TB/HIV","Other TB/HIV intervention(s)","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS for refugees.","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS for refugees.","NA Original Intervention: Integration of TB treatment and the application of the DOTS strategy for refugees","High","95756.93","This activity will improve the management of TB for refuges.","0","0","0","0","95756.93","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2W/view","2020-12-31","TB/HIV",95756.93," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713=AN498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713=AO498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713=AP498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713=AJ498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713=AN498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713=AO498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713=AP498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2XUAW","PAI-4035","Active","COG-TB/HIV-12","2017-2019","RT Central Africa","Congo","HIV/TB","HIV/AIDS, Tuberculosis","FR289-COG-C",null,null,"TB/HIV","Other TB/HIV intervention(s)","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS in prisons.","Conduct a training session lasting 3 days for 12 participants on TB management and the application of DOTS in prisons.","NA Original Intervention: Integration of TB treatment and the application of the DOTS strategy for refugees","High","5358.39","This activity will improve the management of TB for refuges.","0","0","0","0","5358.39","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2X/view","2020-12-31","TB/HIV",5358.39," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713=AN499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713=AO499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713=AP499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713=AJ499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713=AN499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713=AO499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713=AP499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G499)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2YUAW","PAI-4036","Active","COG-TB/HIV-13","2017-2019","RT Central Africa","Congo","HIV/TB","HIV/AIDS, Tuberculosis","FR289-COG-C",null,null,"MDR-TB","Other MDR-TB intervention(s)","Procure 6 GeneXpert machines: 6.","Procure 6 GeneXpert machines: 6.","NA Original Module: Multidrug-resistant TB. Original Intervention: Improve access to rapid diagnosis for MDR-TB through procurement of 6 GeneXperts and cartridges","High","519.32","The activity provides for extra 6 GeneXpert to bring the total in the country to 14.","0","0","0","0","519.32","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2Y/view","2020-12-31","TB/HIV",519.32000000000005," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713=AN500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713=AO500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713=AP500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713=AJ500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713=AN500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713=AO500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713=AP500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2aUAG","PAI-4038","Active","COG-TB/HIV-15","2017-2019","RT Central Africa","Congo","HIV/TB","HIV/AIDS, Tuberculosis","FR289-COG-C",null,null,"MDR-TB","Other MDR-TB intervention(s)","Procure 06 GeneXpert printers.","Procure 06 GeneXpert printers.","NA Original Module: Multidrug-resistant TB. Original Intervention: Improve access to rapid diagnosis for MDR-TB through procurement of 6 GeneXperts and cartridges","High","12237.32","The activity provides for extra 6 GeneXpert to bring the total in the country to 14.","0","0","0","0","12237.32","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2a/view","2020-12-31","TB/HIV",12237.32," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713=AN502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713=AO502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713=AP502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713=AJ502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713=AN502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713=AO502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713=AP502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G502)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2fUAG","PAI-4043","Active","COG-TB/HIV-2","2017-2019","RT Central Africa","Congo","HIV/TB","HIV/AIDS, Tuberculosis","FR289-COG-C",null,null,"Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","The embryonic structure that was put in place by the current concept note needs to be strengthened by the future project, to count, document and reduce the number of cases of violence towards the key populations.","The embryonic structure that was put in place by the current concept note needs to be strengthened by the future project, to count, document and reduce the number of cases of violence towards the key populations.","NA Original Intervention: Strengthen the community monitoring center in terms of organizational and institutional development for men who have sex with men, sex workers, and young people and adolescents","Medium","561104.25","The nascent structure that was put in place by the current Funding Request needs to be strengthened by the future project, to count, document and reduce the number of cases of violence towards the key populations.","0","0","0","0","561104.25","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2f/view","2020-12-31","TB/HIV",561104.25," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713=AN507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713=AO507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713=AP507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713=AJ507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713=AN507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713=AO507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713=AP507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G507)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2kUAG","PAI-4048","Active","COG-TB/HIV-4","2017-2019","RT Central Africa","Congo","HIV/TB","HIV/AIDS, Tuberculosis","FR289-COG-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","The mapping that is currently being validated revealed a population of 450 people who inject drugs. To offer complete prevention to people who inject drugs, some of the existing resources will be used to start providing basic services to this community, and the above allocation resources will be used to implement a pilot project for this target population.","The mapping that is currently being validated revealed a population of 450 people who inject drugs. To offer complete prevention to people who inject drugs, some of the existing resources will be used to start providing basic services to this community, and the above allocation resources will be used to implement a pilot project for this target population.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Pilot project for people who inject drugs","Low","448883.4","The mapping that is currently being validated revealed a population of 450 people who inject drugs. To offer complete prevention to people who inject drugs, some of the existing resources will be used to start providing basic services to this community, and the above allocation resources will be used to implement a pilot project for this target population","0","0","0","0","448883.4","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2k/view","2020-12-31","TB/HIV",448883.4," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713=AN512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713=AO512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713=AP512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713=AJ512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713=AN512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713=AO512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713=AP512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G512)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2lUAG","PAI-4049","Active","COG-TB/HIV-5","2017-2019","RT Central Africa","Congo","HIV/TB","HIV/AIDS, Tuberculosis","FR289-COG-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","The issue of sexual and reproductive health including HIV among female adolescents is not being covered adequately by health projects and programs. The current grant makes it a priority. This is why a bio-behavioral study for young people and adolescents is being conducted to mitigate these weaknesses.","The issue of sexual and reproductive health including HIV among female adolescents is not being covered adequately by health projects and programs. The current grant makes it a priority. This is why a bio-behavioral study for young people and adolescents is being conducted to mitigate these weaknesses.","NA Original Intervention: Conduct a bio-behavioral study for young people and adolescents","Low","336662.55","The issue of sexual and reproductive health including HIV among female adolescents is not being covered adequately by health projects and programs. The current grant makes it a priority. This is why a biobehavioral study for young people and adolescents is being conducted to mitigate these weaknesses.","0","0","0","0","336662.55","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2l/view","2020-12-31","TB/HIV",336662.55," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713=AN513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713=AO513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713=AP513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713=AJ513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713=AN513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713=AO513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713=AP513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G513)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ2qUAG","PAI-4054","Active","COM-HIV/AIDS-1","2017-2019","RT Southern and Eastern Africa","Comoros","HIV/AIDS","HIV/AIDS","FR552-COM-H",null,null,"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Implementing community-based condom distribution points in villages and towns: An unreliable supply of condoms at the community level was reported as a major constraint that could hinder prevention interventions. As part of this grant, the DNLS therefore initiated the implementation of community-based condom distribution points in villages and towns run by community workers, as recommended in the national community health strategy. Mapping of villages shows that there are 331 villages to cover: 214 on Grande Comore (Ngazidja), 91 on Anjouan (Ndzuwani) and 26 on Mohli (Mwali). This above allocation funding request should cover 10 percent of the villages on each island in the first year, 20 percent in the second year and 35 percent in the third year. In each village, one distribution point will be selected in the first year, which will increase to three distribution points in the second and third years.   A total of 579 distribution points will be established in 215 villages over the three-year period: 372 on Grande Comore, 159 on Anjouan and 48 on Mohli.","Implementing community-based condom distribution points in villages and towns: An unreliable supply of condoms at the community level was reported as a major constraint that could hinder prevention interventions. As part of this grant, the DNLS therefore initiated the implementation of community-based condom distribution points in villages and towns run by community workers, as recommended in the national community health strategy. Mapping of villages shows that there are 331 villages to cover: 214 on Grande Comore (Ngazidja), 91 on Anjouan (Ndzuwani) and 26 on Mohli (Mwali). This above allocation funding request should cover 10 percent of the villages on each island in the first year, 20 percent in the second year and 35 percent in the third year. In each village, one distribution point will be selected in the first year, which will increase to three distribution points in the second and third years.   A total of 579 distribution points will be established in 215 villages over the three-year period: 372 on Grande Comore, 159 on Anjouan and 48 on Mohli.","NA Original Intervention: Male and female condoms for adolescents and youth, in and out of school","High","12995.17",null,"0","0","0","0","12995.17","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2q/view","2022-06-30","HIV/AIDS",12995.17," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713=AN518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713=AO518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713=AP518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713=AJ518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713=AN518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713=AO518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713=AP518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G518)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJ2vUAG","PAI-4059","Active","COM-HIV/AIDS-14","2017-2019","RT Southern and Eastern Africa","Comoros","HIV/AIDS","HIV/AIDS","FR552-COM-H",null,null,"PMTCT","Prong 3: Preventing vertical HIV transmission","Supporting the operation of the Network for People Infected with or Affected by HIV: TAS TAS is a community-based organization engaged in HIV prevention and caring for PLHIV. Given the weak performance in the area of treatment and the ambitious targets of this funding request for ART (from 35 percent in 2019 to 65 percent in 2022), the DNLS recommended making TAS a sub-recipient to take part in family screening strategies (partner and child), the search for people lost to follow-up, the referral of HIV-positive people (test and treat), the distribution of nutritional kits and mediation for treatment of TB/HIV co-infection. Given the importance of this organization in the HIV response, the government has provided a building for TAS to use as its premises.This activity supports TASs equipment needs (refurbishment of premises, chairs, tables, photocopiers, computers, office supplies, maintenance of equipment, Internet connection, etc.) in order to improve its results efficiency.","Supporting the operation of the Network for People Infected with or Affected by HIV: TAS TAS is a community-based organization engaged in HIV prevention and caring for PLHIV. Given the weak performance in the area of treatment and the ambitious targets of this funding request for ART (from 35 percent in 2019 to 65 percent in 2022), the DNLS recommended making TAS a sub-recipient to take part in family screening strategies (partner and child), the search for people lost to follow-up, the referral of HIV-positive people (test and treat), the distribution of nutritional kits and mediation for treatment of TB/HIV co-infection. Given the importance of this organization in the HIV response, the government has provided a building for TAS to use as its premises.This activity supports TASs equipment needs (refurbishment of premises, chairs, tables, photocopiers, computers, office supplies, maintenance of equipment, Internet connection, etc.) in order to improve its results efficiency.","NA Original Module: Prevention of mother-to-child transmission","Medium","43796.43","Although the funding requestproposes to provide bonuses forimproved tracking of mother/child, it is not clear how this will be sustained and how existing community structures will be leveraged for efficiency.","0","0","0","0","43796.43","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ2v/view","2022-06-30","HIV/AIDS",43796.43," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713=AN523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713=AO523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713=AP523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713=AJ523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713=AN523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713=AO523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713=AP523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G523)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJ30UAG","PAI-4064","Active","COM-HIV/AIDS-2","2017-2019","RT Southern and Eastern Africa","Comoros","HIV/AIDS","HIV/AIDS","FR552-COM-H",null,null,"Comprehensive prevention programs for MSM","HIV testing services for MSM","Awareness-raising and HIV screening for clients of SWs on the three islands: It is estimated that partners of SWs account for 9 percent of new HIV infections. As part of this grant, the DNLS therefore intends to carry out innovative interventions for SWs partners, in addition to actions for SWs.  In the first year, the plan is to use the allocation amount to implement twice-yearly awareness-raising sessions and targeted screening sessions in order to cover 100 partners of SWs per half-year. This above allocation funding request will allow this strategy to be scaled up in the second year through awareness-raising and screening strategies across the three islands, in order to reach an additional 200 clients per half-year in the second year and an additional 400 clients per half-year in the third year. This strategy will cover 2,000 clients of SWs over the three years.","Awareness-raising and HIV screening for clients of SWs on the three islands: It is estimated that partners of SWs account for 9 percent of new HIV infections. As part of this grant, the DNLS therefore intends to carry out innovative interventions for SWs partners, in addition to actions for SWs.  In the first year, the plan is to use the allocation amount to implement twice-yearly awareness-raising sessions and targeted screening sessions in order to cover 100 partners of SWs per half-year. This above allocation funding request will allow this strategy to be scaled up in the second year through awareness-raising and screening strategies across the three islands, in order to reach an additional 200 clients per half-year in the second year and an additional 400 clients per half-year in the third year. This strategy will cover 2,000 clients of SWs over the three years.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","High","48385.14",null,"0","0","0","0","48385.14","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ30/view","2022-06-30","HIV/AIDS",48385.14," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713=AN528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713=AO528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713=AP528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713=AJ528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713=AN528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713=AO528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713=AP528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJ31UAG","PAI-4065","Active","COM-HIV/AIDS-3","2017-2019","RT Southern and Eastern Africa","Comoros","HIV/AIDS","HIV/AIDS","FR552-COM-H",null,null,"Treatment, care and support","HIV care","Training four referring physicians to improve the availability of treatment services across the three islands:At the end of 2017, 51 PLHIV were receiving ART, 38 of them on Moroni, 9 on Anjouan and 4 on Mohli. The countrys ART coverage was 19 percent in 2017 and it aims to use this grant to achieve 35 percent coverage in 2019 and 65 percent coverage in 2022. Each island has only one referring physician responsible for providing ART for PLHIV. Given the increasing number of PLHIV who require ART and continuity of care (in the absence of a referring physician), the country plans to improve the availability and quality of ART services by strengthening the PLHIV care team. This will involve training four additional referring physicians: two will be located on Grande Comore and one on each of the other islands.  The four new referring physicians would make it possible to maintain an average of less than 50 PLHIV undergoing ART per doctor, as is currently the case. The trained referring physicians will be used to strengthen the pool of trainers and supervisors across the three islands.","Training four referring physicians to improve the availability of treatment services across the three islands:At the end of 2017, 51 PLHIV were receiving ART, 38 of them on Moroni, 9 on Anjouan and 4 on Mohli. The countrys ART coverage was 19 percent in 2017 and it aims to use this grant to achieve 35 percent coverage in 2019 and 65 percent coverage in 2022. Each island has only one referring physician responsible for providing ART for PLHIV. Given the increasing number of PLHIV who require ART and continuity of care (in the absence of a referring physician), the country plans to improve the availability and quality of ART services by strengthening the PLHIV care team. This will involve training four additional referring physicians: two will be located on Grande Comore and one on each of the other islands.  The four new referring physicians would make it possible to maintain an average of less than 50 PLHIV undergoing ART per doctor, as is currently the case. The trained referring physicians will be used to strengthen the pool of trainers and supervisors across the three islands.",null,"High","26642.35",null,"0","0","0","0","26642.35","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ31/view","2022-06-30","HIV/AIDS",26642.35," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713=AN529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713=AO529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713=AP529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713=AJ529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713=AN529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713=AO529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713=AP529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G529)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJ36UAG","PAI-4070","Active","COM-HIV/AIDS-8","2017-2019","RT Southern and Eastern Africa","Comoros","HIV/AIDS","HIV/AIDS","FR552-COM-H",null,null,"PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Organizing awareness-raising sessions and screening in schools and communities:Among young people aged 1524, the rate of regular condom use is low, at only 12 percent and the rate of HIV screening among the same group was less than 7 percent in 2014. Of 11 new HIV-positive cases reported in the Union of the Comoros in 2013, almost half were aged between 15 and 24 years.The allocation amount provides for contracting five youth NGOs (FCAS, RNFD, CAP, Stop AIDS, CRCO) to carry out 400 awareness-raising and screening sessions for young people aged 1024 in schools and communities in the first year, 500 sessions in the second year and 600 sessions in the third year. To contribute to the goal of halving new infections, particularly among young people, this above allocation grant will be used to provide an additional 300 sessions  in the second year and an additional 600 sessions in the third year.","Organizing awareness-raising sessions and screening in schools and communities:Among young people aged 1524, the rate of regular condom use is low, at only 12 percent and the rate of HIV screening among the same group was less than 7 percent in 2014. Of 11 new HIV-positive cases reported in the Union of the Comoros in 2013, almost half were aged between 15 and 24 years.The allocation amount provides for contracting five youth NGOs (FCAS, RNFD, CAP, Stop AIDS, CRCO) to carry out 400 awareness-raising and screening sessions for young people aged 1024 in schools and communities in the first year, 500 sessions in the second year and 600 sessions in the third year. To contribute to the goal of halving new infections, particularly among young people, this above allocation grant will be used to provide an additional 300 sessions  in the second year and an additional 600 sessions in the third year.","NA Original Module: Prevention of mother-to-child transmission","High","11989.68",null,"0","0","0","0","11989.68","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ36/view","2022-06-30","HIV/AIDS",11989.68," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713=AN534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713=AO534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713=AP534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713=AJ534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713=AN534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713=AO534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713=AP534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G534)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJ3BUAW","PAI-4075","Active","COM-Malaria-12","2017-2019","RT Southern and Eastern Africa","Comoros","Malaria","Malaria","FR553-COM-M",null,null,"Case management","Active case detection and investigation (elimination phase)","\"Case monitoring:Once there is a very low number of indigenous malaria cases in a country, monitoring of drug effectiveness should be integrated into malaria surveillance at the national level, replacing traditional studies on treatment effectiveness. Once effectiveness monitoring has been combined with overall case monitoring, treatment should be administered to all patients (regardless of age and parasitemia) under direct supervision. Patients should undergo clinical and parasitological examinations on days 3, 7, 14, 21 and 28 for artemisinin-based combination therapy containing a long half-life partner drug. Integrating drug-effectiveness monitoring into overall malaria monitoring will facilitate data collection on effectiveness; additional information on the molecular markers of drug resistance will also be useful. As such, active case screening is proposed as an activity to be included in the PAAR.\"","\"Case monitoring:Once there is a very low number of indigenous malaria cases in a country, monitoring of drug effectiveness should be integrated into malaria surveillance at the national level, replacing traditional studies on treatment effectiveness. Once effectiveness monitoring has been combined with overall case monitoring, treatment should be administered to all patients (regardless of age and parasitemia) under direct supervision. Patients should undergo clinical and parasitological examinations on days 3, 7, 14, 21 and 28 for artemisinin-based combination therapy containing a long half-life partner drug. Integrating drug-effectiveness monitoring into overall malaria monitoring will facilitate data collection on effectiveness; additional information on the molecular markers of drug resistance will also be useful. As such, active case screening is proposed as an activity to be included in the PAAR.\"",null,"Medium","56312.42","Active case detection andintegrating treatmenteffectiveness monitoring in anelimination setting isrecommended to inform on curerates as well as treatmentfailures and the emergence ofdrug resistance. The applicantshould increase the sentinelsites for this activity and increasethe use of microscopy to enablethem to identify vectors speciesand classify all cases. Becausethe applicant has had mass drugadministration for malaria, thisactivity is important.","0","0","0","0","56312.42","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3B/view","2021-12-31","Malaria",56312.42," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713=AN539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713=AO539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713=AP539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713=AJ539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713=AN539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713=AO539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713=AP539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G539)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2021-12-31"]
["a6Q1R000000AJ3HUAW","PAI-4081","Active","COM-Malaria-2","2017-2019","RT Southern and Eastern Africa","Comoros","Malaria","Malaria","FR553-COM-M",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","\"Development of the Program Performance Review and the strategic plan:The Program Performance Review helps identify progress in terms of outcomes and impact, best practices, lessons learned, and bottlenecks and their causes. This information can then be used to propose solutions for improving program implementation and revising the strategic plan. Such an exercise was carried out in 2011 and 2017 and resulted in the formulation of new program directions.In addition, the review brings together national and regional managers from the public health system, implementation partners and technical and financial partners. At the end of each review, specific recommendations will be made. It should be noted that before this review is held at the central level, it is first organized on each island. This ensures mutual accountability among the implementers.\"","\"Development of the Program Performance Review and the strategic plan:The Program Performance Review helps identify progress in terms of outcomes and impact, best practices, lessons learned, and bottlenecks and their causes. This information can then be used to propose solutions for improving program implementation and revising the strategic plan. Such an exercise was carried out in 2011 and 2017 and resulted in the formulation of new program directions.In addition, the review brings together national and regional managers from the public health system, implementation partners and technical and financial partners. At the end of each review, specific recommendations will be made. It should be noted that before this review is held at the central level, it is first organized on each island. This ensures mutual accountability among the implementers.\"",null,"High","51558.75","Development of the ProgramPerformance Review and thestrategic plan. This is highquality demand, especially giventhat the program review willidentify progress and bottlenecksof the implementation of malariacontrol interventions, and willpropose solutions for improvingprogram implementation andrevising the Malaria StrategicPlan.","0","0","0","0","51558.75","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3H/view","2021-12-31","Malaria",51558.75," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713=AN545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713=AO545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713=AP545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713=AJ545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713=AN545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713=AO545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713=AP545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G545)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2021-12-31"]
["a6Q1R000000AJ3IUAW","PAI-4082","Active","COM-Malaria-3","2017-2019","RT Southern and Eastern Africa","Comoros","Malaria","Malaria","FR553-COM-M",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","\"Organization of a six-monthly, disease surveillance forum bringing together managers from the central, regional and district level who are involved in surveillance: the country does not have the same epidemiological stratum. All those responsible for program monitoring, from the district level on the three islands to the central level, need to be brought together so that the epidemiological situation in each area can be better understood and the relevant measures taken for each case.This meeting will bring together 34 people over the course of three days: 19 district surveillance officers, 3 island focal points, 3 island entomologists, 3 island laboratory focal points and 6 NMCP staff  the focal point, 3 monitoring and evaluation staff, 1 vector control manager and 1 treatment manager). It will be organized every six months to better analyze previous activities and plan future activities.The unit costs for this activity are shown in the initial budget.\"","\"Organization of a six-monthly, disease surveillance forum bringing together managers from the central, regional and district level who are involved in surveillance: the country does not have the same epidemiological stratum. All those responsible for program monitoring, from the district level on the three islands to the central level, need to be brought together so that the epidemiological situation in each area can be better understood and the relevant measures taken for each case.This meeting will bring together 34 people over the course of three days: 19 district surveillance officers, 3 island focal points, 3 island entomologists, 3 island laboratory focal points and 6 NMCP staff  the focal point, 3 monitoring and evaluation staff, 1 vector control manager and 1 treatment manager). It will be organized every six months to better analyze previous activities and plan future activities.The unit costs for this activity are shown in the initial budget.\"","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","89987.66","Six monthly disease surveillanceforums, regional and districtmanagers. In Window 4, theTRP noted that surveillance wasnot strong, and this is a usefulinitiative given that it will be anopportunity to discussepidemiological situation withdecentralized levels and adjustmalaria control interventionsbased on updated data.","0","0","0","0","89987.66","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3I/view","2021-12-31","Malaria",89987.66," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713=AN546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713=AO546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713=AP546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713=AJ546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713=AN546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713=AO546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713=AP546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G546)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2021-12-31"]
["a6Q1R000000AJ3NUAW","PAI-4087","Active","COM-Malaria-8","2017-2019","RT Southern and Eastern Africa","Comoros","Malaria","Malaria","FR553-COM-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","\"Routine LLIN distribution for pregnant women in the third year (30,582 LLINs):LLINs are a key intervention for reducingexposure to mosquito bites and vector survival, which considerably reducesvector capacity and transmission. Stopping LLIN distribution prematurely may lead to renewed malaria transmission at previous levels.High LLIN coverage can be rapidly achieved and maintained bymerging free mass distribution campaigns with routine distribution channels. Routine distribution channels includeprenatal care and vaccinations. There is a sufficient stock of LLINs to cover routine distribution for the first two years of the grant. Within the PAAR, funds are requested to cover procurement of LLINs for pregnant women for the third year of the grant. \"","\"Routine LLIN distribution for pregnant women in the third year (30,582 LLINs):LLINs are a key intervention for reducingexposure to mosquito bites and vector survival, which considerably reducesvector capacity and transmission. Stopping LLIN distribution prematurely may lead to renewed malaria transmission at previous levels.High LLIN coverage can be rapidly achieved and maintained bymerging free mass distribution campaigns with routine distribution channels. Routine distribution channels includeprenatal care and vaccinations. There is a sufficient stock of LLINs to cover routine distribution for the first two years of the grant. Within the PAAR, funds are requested to cover procurement of LLINs for pregnant women for the third year of the grant. \"","NA Original Intervention: Long-lasting insecticidal nets  Continuous distribution","High","64914.15","Ensuring high coverage of nets,especially in areas that may stillbe experiencing sporadictransmission, is important.","0","0","0","0","64914.15","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3N/view","2021-12-31","Malaria",64914.15," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713=AN551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713=AO551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713=AP551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713=AJ551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713=AN551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713=AO551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713=AP551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2021-12-31"]
["a6Q1R000000AJ3SUAW","PAI-4092","Active","CPV-Integrated-10","2017-2019","RT Central Africa","Cabo Verde","Malaria","HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z",null,null,"Vector control","Entomological monitoring","With support from WHO, the Global Fund and partners, the INSP has recently established a medical entomology laboratory, which enables monitoring the distribution and density of vector mosquitoes within the country. It is expected to acquire equipment to improve entomological monitoring to ensure that the response is as efficient as possible. These acquisitions are intended to supplement those taken into account in the allocation amount.","With support from WHO, the Global Fund and partners, the INSP has recently established a medical entomology laboratory, which enables monitoring the distribution and density of vector mosquitoes within the country. It is expected to acquire equipment to improve entomological monitoring to ensure that the response is as efficient as possible. These acquisitions are intended to supplement those taken into account in the allocation amount.",null,"Medium","177571.54","The new laboratory has been established and basicequipment provided. The TRP considers highestpriority the control of malaria in migrants and theircontacts. The further development of the laboratoryfor vector monitoring is of only medium importance.","0","0","0","0","177571.54","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3S/view",null,"Multi-component",177571.54," Central Africa","HIV/AIDS, Tuberculosis, Malaria, RSSH","HIV/AIDS"," Tuberculosis"," Malaria"," RSSH","Tuberculosis","Malaria","RSSH",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713=AN556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713=AO556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713=AP556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713=AJ556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713=AN556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713=AO556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713=AP556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ3XUAW","PAI-4097","Active","CPV-Integrated-15","2017-2019","RT Central Africa","Cabo Verde","RSSH","HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z",null,null,"RSSH: Health management information systems and M&E","Program and data quality","The exchange visit to a country that is in the process of obtaining certification of malaria elimination will strengthen the skills of the technicians working on the malaria program in Cape Verde, particularly when it comes to monitoring and documenting the elimination process.","The exchange visit to a country that is in the process of obtaining certification of malaria elimination will strengthen the skills of the technicians working on the malaria program in Cape Verde, particularly when it comes to monitoring and documenting the elimination process.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","29051.73","The TRP considers this of low priority given thecompeting priorities between significantly higherimpact interventions related to improvements of thehealth information as a whole and narrow programbased data system improvements.","0","0","0","0","29051.73","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3X/view",null,"Multi-component",29051.73," Central Africa","HIV/AIDS, Tuberculosis, Malaria, RSSH","HIV/AIDS"," Tuberculosis"," Malaria"," RSSH","Tuberculosis","Malaria","RSSH",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713=AN561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713=AO561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713=AP561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713=AJ561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713=AN561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713=AO561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713=AP561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ3YUAW","PAI-4098","Active","CPV-Integrated-16","2017-2019","RT Central Africa","Cabo Verde","RSSH","HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","A study was conducted within the general population in 2017 on knowledge of attitudes towards and practices in connection with methods for preventing malaria and its transmission. Nevertheless, it is essential that an initial study is conducted within migrant population in 2018. It is expected that the KAP study will be carried out again within the general population in 2020 to update these data.","A study was conducted within the general population in 2017 on knowledge of attitudes towards and practices in connection with methods for preventing malaria and its transmission. Nevertheless, it is essential that an initial study is conducted within migrant population in 2018. It is expected that the KAP study will be carried out again within the general population in 2020 to update these data.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Survey (malaria component)","Low","44737.96","Given that the explanation states that theKnowledge, Attitude and Practice survey within themigrant population is funded within allocation andthat the Knowledge, Attitude and Practice survey inthe general population was done in 2017, the TRPdoes not see a repeat of the latter as a priority.","0","0","0","0","44737.96","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3Y/view",null,"Multi-component",44737.96," Central Africa","HIV/AIDS, Tuberculosis, Malaria, RSSH","HIV/AIDS"," Tuberculosis"," Malaria"," RSSH","Tuberculosis","Malaria","RSSH",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713=AN562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713=AO562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713=AP562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713=AJ562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713=AN562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713=AO562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713=AP562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ3dUAG","PAI-4103","Active","CPV-Integrated-5","2017-2019","RT Central Africa","Cabo Verde","RSSH","HIV/AIDS, Tuberculosis, Malaria, RSSH","FR411-CPV-Z",null,null,"RSSH: Health management information systems and M&E","Routine reporting","The program so far reports data in Excel and/or Word documents, which are sometimes incomplete and submitted late. For this, with the introduction of the DHIS2 application, promptness and completeness of reports will be improved, which will ensure better disease surveillance. This is for an upgrade of the existing system.","The program so far reports data in Excel and/or Word documents, which are sometimes incomplete and submitted late. For this, with the introduction of the DHIS2 application, promptness and completeness of reports will be improved, which will ensure better disease surveillance. This is for an upgrade of the existing system.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","14817.64","Movement of data reporting to DHIS2 is ofconsiderable importance to strengthening programmanagement and is considered a high priority byTRP.","0","0","0","0","14817.64","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3d/view",null,"Multi-component",14817.64," Central Africa","HIV/AIDS, Tuberculosis, Malaria, RSSH","HIV/AIDS"," Tuberculosis"," Malaria"," RSSH","Tuberculosis","Malaria","RSSH",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713=AN567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713=AO567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713=AP567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713=AJ567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713=AN567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713=AO567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713=AP567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ3iUAG","PAI-4108","Inactive","CRI-HIV/AIDS-1","2017-2019","RT Latin America and Caribbean","Costa Rica","HIV/AIDS","HIV/AIDS","FR319-CRI-H",null,null,"Treatment, care and support","Differentiated ART service delivery","This intervention includes:- a cost-benefit analysis of incorporating PrEP into the offer of Social Security services for key  populations (especially important given the countrys constrained fiscal situation); and  - based  on  the results of that analysis, a Pilot Study on Availability of the PrEP in two HIV clinics, during which the  required  flow  of  services  will  be  analyzed. Both the  analysis  and  the  pilot  study  will  generate evidence to   analyze   the possibility  of  incorporating  PrEP  into  the  Social Security Institutes national offer of services for key populations.","This intervention includes:- a cost-benefit analysis of incorporating PrEP into the offer of Social Security services for key  populations (especially important given the countrys constrained fiscal situation); and  - based  on  the results of that analysis, a Pilot Study on Availability of the PrEP in two HIV clinics, during which the  required  flow  of  services  will  be  analyzed. Both the  analysis  and  the  pilot  study  will  generate evidence to   analyze   the possibility  of  incorporating  PrEP  into  the  Social Security Institutes national offer of services for key populations.","NA Original Intervention: Differentiated antiretroviral therapy service delivery","High","803034","This module is an integral part ofthe transition work plan andtherefore high priority. It focuseson PrEP, which will improverecruitment and retention acrossthe cascade.","0","220000","0","0","583034","1","0","2020-03-05 10:33:02","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3i/view","2021-06-30","HIV/AIDS",583034," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713=AN572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713=AO572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713=AP572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713=AJ572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713=AN572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713=AO572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713=AP572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJ3nUAG","PAI-4113","Active","CUB-HIV/AIDS-12","2017-2019","RT Latin America and Caribbean","Cuba","HIV/AIDS","HIV/AIDS","FR100-CUB-H",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Renewal of health care staff in primary healthcare requires systematic training of new human resources dedicated to the management of HIV/AIDS infection to improve healthcare quality.","Renewal of health care staff in primary healthcare requires systematic training of new human resources dedicated to the management of HIV/AIDS infection to improve healthcare quality.","NA Original Module: Strengthening community response and systems. Original Intervention: Social mobilization, building community bonds, collaboration and coordination","Medium","55000","Cuba has a strong medical education system that can provide regular updates as part of its continuous medical education","0","0","0","0","55000","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3n/view","2020-12-31","HIV/AIDS",55000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713=AN577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713=AO577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713=AP577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713=AJ577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713=AN577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713=AO577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713=AP577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ3oUAG","PAI-4114","Inactive","CUB-HIV/AIDS-13","2017-2019","RT Latin America and Caribbean","Cuba","HIV/AIDS","HIV/AIDS","FR100-CUB-H",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","HIV prevention indicator surveys are expensive and may not have enough resources so that they can be performed periodically.","HIV prevention indicator surveys are expensive and may not have enough resources so that they can be performed periodically.","NA Original Module: Strengthening community response and systems. Original Intervention: Monitoring by the community","Medium","175000","Prevention surveys are important to monitor, yet since they are already fully integrate in the health structure, should also be part of the regular flow.","175000","0","0","0","0","1","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3o/view","2020-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713=AN578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713=AO578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713=AP578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713=AJ578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713=AN578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713=AO578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713=AP578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ3tUAG","PAI-4119","Active","CUB-HIV/AIDS-4","2017-2019","RT Latin America and Caribbean","Cuba","HIV/AIDS","HIV/AIDS","FR100-CUB-H",null,null,"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.","The search for HIV cases through take-the-test community activities is not always carried out in locations where prevalence is assumed to be higher (according to stratification of the epidemic) due to lack of coordination between key population groups and health care staff. These resources will be dedicated to achieving better knowledge of meeting points and areas. Bridging the gap will result in testing of a higher number of cases and increasing knowledge of the serologic status.",null,"High","80500","Will support reaching testing coverage of highest risk sex workers","17000","0","0","0","63500","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ3t/view","2020-12-31","HIV/AIDS",63500," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713=AN583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713=AO583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713=AP583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713=AJ583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713=AN583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713=AO583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713=AP583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ40UAG","PAI-4126","Active","DJI-Malaria-2","2017-2019","RT Middle East and North Africa","Djibouti","Malaria","Malaria","FR261-DJI-M-01",null,null,"Case management","Therapeutic efficacy surveillance","Conduct a drug efficacy study. The latest study of therapeutic effectiveness dates to 2012 and this activity is essential. Efforts will be made to mobilize resources for this activity, particularly from WHO in the event that this activity can not benefit from prioritized above allocation.","Conduct a drug efficacy study. The latest study of therapeutic effectiveness dates to 2012 and this activity is essential. Efforts will be made to mobilize resources for this activity, particularly from WHO in the event that this activity can not benefit from prioritized above allocation.",null,"High","59713",null,"0","0","0","0","59713","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ40/view","2020-12-31","Malaria",59713," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713=AN590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713=AO590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713=AP590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713=AJ590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713=AN590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713=AO590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713=AP590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ44UAG","PAI-4130","Active","DJI-TB/HIV-10","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"MDR-TB","Treatment: MDR-TB","Coaching and transfer of competence in multi drug resistant TB (Daily allowance related to supervision / investigation / data collection / transport / other costs).This is to ensure the quality of services, including the identification of MDR TB patients to improve the inclusion rate of these patients put on treatment and retention until recovery.","Coaching and transfer of competence in multi drug resistant TB (Daily allowance related to supervision / investigation / data collection / transport / other costs).This is to ensure the quality of services, including the identification of MDR TB patients to improve the inclusion rate of these patients put on treatment and retention until recovery.","NA Original Module: Multidrug-resistant TB","High","14237",null,"0","0","0","0","14237","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ44/view","2020-12-31","TB/HIV",14237," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713=AN594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713=AO594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713=AP594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713=AJ594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713=AN594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713=AO594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713=AP594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ45UAG","PAI-4131","Active","DJI-TB/HIV-11","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"TB care and prevention","Case detection and diagnosis","Training supervision of technicians on the radiology machine (per diem related to awareness / transport / meeting / and other costs). (See line 21).","Training supervision of technicians on the radiology machine (per diem related to awareness / transport / meeting / and other costs). (See line 21).",null,"High","678",null,"0","0","0","0","678","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ45/view","2020-12-31","TB/HIV",678," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713=AN595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713=AO595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713=AP595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713=AJ595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713=AN595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713=AO595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713=AP595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4AUAW","PAI-4136","Active","DJI-TB/HIV-16","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"TB/HIV","Key populations (TB/HIV) - Prisoners","Through peer education, inform and educate inmates and prison staff on HIV, sexually transmitted infections, viral hepatitis and tuberculosis. The expected result is the identification and treatment/care of new HIV and TB cases among prisoners.","Through peer education, inform and educate inmates and prison staff on HIV, sexually transmitted infections, viral hepatitis and tuberculosis. The expected result is the identification and treatment/care of new HIV and TB cases among prisoners.","NA Original Intervention: Key populations (TB/HIV)  prisoners","High","8475",null,"0","0","0","0","8475","0","0","2019-10-30 15:32:56","2019-10-30 15:32:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4A/view","2020-12-31","TB/HIV",8475," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713=AN600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713=AO600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713=AP600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713=AJ600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713=AN600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713=AO600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713=AP600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4FUAW","PAI-4141","Active","DJI-TB/HIV-20","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"Treatment, care and support","HIV care","The development of volunteer counselling and testing  / TTC at the level of health facilities and parapublic and private health facilities (allowances), will allow the identification and treatment - tester - treat - (TT) new cases of HIV and TB at the level of regions.","The development of volunteer counselling and testing  / TTC at the level of health facilities and parapublic and private health facilities (allowances), will allow the identification and treatment - tester - treat - (TT) new cases of HIV and TB at the level of regions.",null,"High","10763",null,"0","0","0","0","10763","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4F/view","2020-12-31","TB/HIV",10763," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713=AN605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713=AO605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713=AP605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713=AJ605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713=AN605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713=AO605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713=AP605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4KUAW","PAI-4146","Active","DJI-TB/HIV-25","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","A size-estimation study and mapping of key and vulnerable popuklation within each health region (international consultant) will allow improving the focus (see line 42) and the performance indicators.","A size-estimation study and mapping of key and vulnerable popuklation within each health region (international consultant) will allow improving the focus (see line 42) and the performance indicators.",null,"High","85831",null,"0","0","0","0","85831","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4K/view","2020-12-31","TB/HIV",85831," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713=AN610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713=AO610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713=AP610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713=AJ610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713=AN610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713=AO610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713=AP610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4LUAW","PAI-4147","Active","DJI-TB/HIV-26","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","A bio-behavioral study of young people (international consultant) will also allow an improvement of program's focus and a better monitoring of indicators.","A bio-behavioral study of young people (international consultant) will also allow an improvement of program's focus and a better monitoring of indicators.",null,"High","54000",null,"0","0","0","0","54000","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4L/view","2020-12-31","TB/HIV",54000," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713=AN611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713=AO611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713=AP611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713=AJ611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713=AN611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713=AO611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713=AP611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4QUAW","PAI-4152","Active","DJI-TB/HIV-30","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","See line 44 (diseemination of report).","See line 44 (diseemination of report).",null,"High","4237",null,"0","0","0","0","4237","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4Q/view","2020-12-31","TB/HIV",4237," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713=AN616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713=AO616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713=AP616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713=AJ616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713=AN616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713=AO616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713=AP616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4VUAW","PAI-4157","Active","DJI-TB/HIV-35","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"PMTCT","Analysis, review and transparency","The peer educators- traning is meant to contribute to  the action plan in the context of the RTTR (Reach, test, treat, and retain) TB-HIV-Human Rights strategy, the enrollment and retaining of patients and data collection.","The peer educators- traning is meant to contribute to  the action plan in the context of the RTTR (Reach, test, treat, and retain) TB-HIV-Human Rights strategy, the enrollment and retaining of patients and data collection.","NA Original Module: Prevention of mother-to-child transmission","High","24585",null,"0","0","0","0","24585","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4V/view","2020-12-31","TB/HIV",24585," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713=AN621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713=AO621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713=AP621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713=AJ621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713=AN621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713=AO621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713=AP621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4aUAG","PAI-4162","Active","DJI-TB/HIV-4","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"TB care and prevention","Case detection and diagnosis","Purchase of 3 x-ray digital X-ray machine with printer including one for the diagnosis of TB in children at the level of the Hopital Chakib Saad (HPPCSO) and two others for the community health centers with an important activity  on the outskirts of Djibouti city (Balbala 1 and Balbala 2) These devices will reduce the cost and are transportable. The expected result is an improved screening of new TB cases  especially at children level.","Purchase of 3 x-ray digital X-ray machine with printer including one for the diagnosis of TB in children at the level of the Hopital Chakib Saad (HPPCSO) and two others for the community health centers with an important activity  on the outskirts of Djibouti city (Balbala 1 and Balbala 2) These devices will reduce the cost and are transportable. The expected result is an improved screening of new TB cases  especially at children level.",null,"High","302024",null,"0","0","0","0","302024","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4a/view","2020-12-31","TB/HIV",302024," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713=AN626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713=AO626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713=AP626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713=AJ626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713=AN626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713=AO626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713=AP626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4bUAG","PAI-4163","Active","DJI-TB/HIV-40","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"RSSH: Health management information systems and M&E","Program and data quality","The activities of analysis and quarterly validation of data with stakeholders and service providers ensure data quality and a better follow-up of performance indicators.","The activities of analysis and quarterly validation of data with stakeholders and service providers ensure data quality and a better follow-up of performance indicators.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","18576",null,"0","0","0","0","18576","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4b/view","2020-12-31","TB/HIV",18576," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713=AN627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713=AO627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713=AP627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713=AJ627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713=AN627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713=AO627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713=AP627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4iUAG","PAI-4170","Active","DJI-TB/HIV-8","2017-2019","RT Middle East and North Africa","Djibouti","HIV/TB","HIV/AIDS, Tuberculosis","FR264-DJI-C-01",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","Establishment of an efficient transport system in the Testing and Treatment Centers in Djibouti (includes daily allowances related to awareness (transport / meeting / and other costs)).","Establishment of an efficient transport system in the Testing and Treatment Centers in Djibouti (includes daily allowances related to awareness (transport / meeting / and other costs)).","NA Original Module: Multidrug-resistant TB","High","16949",null,"0","0","0","0","16949","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4i/view","2020-12-31","TB/HIV",16949," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713=AN634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713=AO634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713=AP634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713=AJ634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713=AN634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713=AO634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713=AP634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ4mUAG","PAI-4174","Inactive","DOM-HIV/AIDS-11","2017-2019","RT Latin America and Caribbean","Dominican Republic","HIV/AIDS","HIV/AIDS","FR39-DOM-H",null,null,"Comprehensive prevention programs for TGs","HIV testing services for TGs","Community testing does not always take place in areas where prevalence is supposed to be higher (according to the Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.","Community testing does not always take place in areas where prevalence is supposed to be higher (according to the Review and Update Report on the Strategic Plan for HIV Prevention and Control, 2015-2018), due to limitations in the coordination between key population groups and healthcare personnel. These additional resources will be channeled toward achieving better knowledge of the areas and meeting points, leading to a greater number of cases tested and knowledge of serological status.","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: HIV testing services for transgender people","Medium","161000","In light of the success in achieving high coverage of transgender people with prevention efforts and a relatively low HIV sero=positivity rate in newly tested cases, under the existing allocation request, the TRP considers additional resources for this population to be medium priority.","161000","0","0","0","0","1","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4m/view","2021-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713=AN638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713=AO638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713=AP638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713=AJ638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713=AN638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713=AO638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713=AP638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ4rUAG","PAI-4179","Active","DOM-HIV/AIDS-16","2017-2019","RT Latin America and Caribbean","Dominican Republic","HIV/AIDS","HIV/AIDS","FR39-DOM-H",null,null,"RSSH: Procurement and supply chain management systems","Improving service delivery infrastructure","Strengthening of primary and secondary health care will contribute to maintaining the successes achieved in mother to child transmission and control of other opportunistic diseases.","Strengthening of primary and secondary health care will contribute to maintaining the successes achieved in mother to child transmission and control of other opportunistic diseases.","NA Original Module: RSSH - Procurement and supply chain management systems","Medium","950000",null,"0","0","0","0","950000","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4r/view","2021-12-31",{"$f":"IF(OR(I643=\"HIV/AIDS\",I643=\"Tuberculosis\",I643=\"Malaria\",I643=\"RSSH\"),I643, IF(I643=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"HIV/AIDS"},{"$f":"VALUE(Y643)","v":950000},{"$f":"RIGHT(F643,LEN(F643)-2)","v":" Latin America and Caribbean"},"HIV/AIDS","HIV/AIDS",null,null,null,{"$f":"TRIM(AK643)","v":""},{"$f":"TRIM(AL643)","v":""},{"$f":"TRIM(AM643)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713=AN643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713=AO643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713=AP643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IF(AE643<>\"\",AE643,IF(MAX(AQ643,AR643,AS643,AT643)<>0,MAX(AQ643,AR643,AS643,AT643),AU643))","v":"2021-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713=AJ643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713=AN643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713=AO643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713=AP643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IF(AE643<>\"\",AE643,IF(MAX(AW643,AX643,AY643,AZ643)<>0,MAX(AW643,AX643,AY643,AZ643),BA643))","v":"2021-12-31"}]
["a6Q1R000000AJ4sUAG","PAI-4180","Active","DOM-HIV/AIDS-17","2017-2019","RT Latin America and Caribbean","Dominican Republic","HIV/AIDS","HIV/AIDS","FR39-DOM-H",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Need to strengthen legal advice and legal literacy (training in legal rights for PLHIV, MSM, Trans, SW and young people; as well as community-based legal advice programs -Observatories). Covering this demand will take the form of empowering the key populations, as well as providing them with a channel for processing violations of their rights.","Need to strengthen legal advice and legal literacy (training in legal rights for PLHIV, MSM, Trans, SW and young people; as well as community-based legal advice programs -Observatories). Covering this demand will take the form of empowering the key populations, as well as providing them with a channel for processing violations of their rights.","NA Original Module: RSSH - Community responses and systems","Low","130000",null,"0","0","0","0","130000","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4s/view","2021-12-31","HIV/AIDS",130000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713=AN644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713=AO644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713=AP644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713=AJ644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713=AN644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713=AO644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713=AP644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ4xUAG","PAI-4185","Active","DOM-HIV/AIDS-5","2017-2019","RT Latin America and Caribbean","Dominican Republic","HIV/AIDS","HIV/AIDS","FR39-DOM-H",null,null,"Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","The practices of self-care, prevention of HIV and other STIs in immigrant populations (Haitian migrants) in the Dominican Republic and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources would be allocated to increasing the targets that can be reached to improve self-care and prevention practices.","The practices of self-care, prevention of HIV and other STIs in immigrant populations (Haitian migrants) in the Dominican Republic and the behavioral changes achieved are not sufficient to obtain the required impact. The additional resources would be allocated to increasing the targets that can be reached to improve self-care and prevention practices.",null,"High","592400",null,"0","0","0","0","592400","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ4x/view","2021-12-31","HIV/AIDS",592400," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713=AN649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713=AO649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713=AP649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713=AJ649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713=AN649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713=AO649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713=AP649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ52UAG","PAI-4190","Active","DZA-HIV/AIDS-1","2017-2019","RT Middle East and North Africa","Algeria","HIV/AIDS","HIV/AIDS","FR393-DZA-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Stigma and discrimination in care settings for PLHIV and key populations is a reality in Algeria, as evidenced by the results of the \"Index stigma\" study. These behaviors are an obstacle to key populations accessing services, especially treatment. Thus, it is planned to train the staff of 60 testing centers and 15 reference centers on medical ethics to raise their awareness about challenges faced by KPs, reduce social rejection and discrimination within care structures as well as improve the quality of care on the one hand and on the other hand organize meetings periodically to handle complaints in accordance with Article 28 of the new law on health.","Stigma and discrimination in care settings for PLHIV and key populations is a reality in Algeria, as evidenced by the results of the \"Index stigma\" study. These behaviors are an obstacle to key populations accessing services, especially treatment. Thus, it is planned to train the staff of 60 testing centers and 15 reference centers on medical ethics to raise their awareness about challenges faced by KPs, reduce social rejection and discrimination within care structures as well as improve the quality of care on the one hand and on the other hand organize meetings periodically to handle complaints in accordance with Article 28 of the new law on health.",null,"High","252540.1",null,"0","0","0","0","252540.1","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ52/view","2022-12-31","HIV/AIDS",252540.1," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713=AN654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713=AO654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713=AP654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713=AJ654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713=AN654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713=AO654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713=AP654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AJ57UAG","PAI-4195","Active","EGY-TB/HIV-10","2017-2019","RT Middle East and North Africa","Egypt","HIV/TB","HIV/AIDS, Tuberculosis","FR534-EGY-C",null,null,"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Conduct of a Procurement and Supply Chain Management workshop","Conduct of a Procurement and Supply Chain Management workshop","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Other procurement and supply chain management intervention(s)","Low","6610.64",null,"0","0","0","0","6610.64","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ57/view","2022-03-31","TB/HIV",6610.64," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713=AN659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713=AO659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713=AP659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713=AJ659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713=AN659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713=AO659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713=AP659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJ58UAG","PAI-4196","Active","EGY-TB/HIV-11","2017-2019","RT Middle East and North Africa","Egypt","HIV/TB","HIV/AIDS, Tuberculosis","FR534-EGY-C",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Strengthen national HIV surveillance system starting with an assessment and building its capacity to address bottlenecks","Strengthen national HIV surveillance system starting with an assessment and building its capacity to address bottlenecks","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","15288.52","This activity requires a small amount and should be moved to the allocation as a well-functioning national surveillance system is imperative for the strategic and program planning and monitoring results.","0","0","0","0","15288.52","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ58/view","2022-03-31","TB/HIV",15288.52," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713=AN660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713=AO660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713=AP660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713=AJ660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713=AN660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713=AO660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713=AP660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJ5DUAW","PAI-4201","Active","EGY-TB/HIV-16","2017-2019","RT Middle East and North Africa","Egypt","HIV/TB","HIV/AIDS, Tuberculosis","FR534-EGY-C",null,null,"Program management","Other program management intervention(s)","Staff salaries, Audit fees and Admin %","Staff salaries, Audit fees and Admin %","NA Original Module: RSSH - Program management","Medium","793519","Given the funding gaps in data and programming, program management costs are not a high priority.","0","0","0","0","793519","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5D/view","2022-03-31","TB/HIV",793519," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713=AN665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713=AO665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713=AP665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713=AJ665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713=AN665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713=AO665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713=AP665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJ5IUAW","PAI-4206","Active","EGY-TB/HIV-6","2017-2019","RT Middle East and North Africa","Egypt","HIV/TB","HIV/AIDS, Tuberculosis","FR534-EGY-C",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","TB case detection and diagnosis: (1) Increasing case detection through revising access to diagnosis pathway and implementing access to new and more sensitive diagnostic technology; revision of program guidelines; revision of diagnostic algorithm; (2) Increasing notification from university hospitals; (3) Increasing notification from the private sector","TB case detection and diagnosis: (1) Increasing case detection through revising access to diagnosis pathway and implementing access to new and more sensitive diagnostic technology; revision of program guidelines; revision of diagnostic algorithm; (2) Increasing notification from university hospitals; (3) Increasing notification from the private sector",null,"High","30841.96","Planning the implementation of more sensitive technologies for diagnosis and drug sensitivity testing is a priority to meet current normative guidance for the countrys epidemiological situation. This intervention should be moved to the main allocation and funded through efficiencies identified during grant implementation.","0","0","0","0","30841.96","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5I/view","2022-03-31","TB/HIV",30841.96," Middle East and North Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713=AN670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713=AO670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713=AP670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713=AJ670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713=AN670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713=AO670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713=AP670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJ5NUAW","PAI-4211","Active","ERI-HIV/AIDS-10","2017-2019","RT Middle East and North Africa","Eritrea","HIV/AIDS","HIV/AIDS","FR285-ERI-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Community empowerment for sex workers","The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.","The activities will build on the interventions proposed in the under allocation and will put more FSWs on hepatitis and STI related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with IGA activities.",null,"High","179720","The activities will build on the interventions proposed in the under allocation and will put more female sex workers on hepatitis and sexually transmitted infections related activities and those sex workers who want to leave the profession will be provided with vocational training and basic tools and will be facilitated with Immunoglobulin A (IGA) activities.","0","0","0","0","179720","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5N/view","2020-12-31","HIV/AIDS",179720," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713=AN675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713=AO675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713=AP675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713=AJ675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713=AN675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713=AO675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713=AP675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ5QUAW","PAI-4214","Active","ERI-HIV/AIDS-13","2017-2019","RT Middle East and North Africa","Eritrea","HIV/AIDS","HIV/AIDS","FR285-ERI-H",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x-rays, ECGs, etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas.","In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x-rays, ECGs, etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas.","NA Original Module: RSSH - Integrated service delivery and quality improvement","High","14100","In order to improve the diagnostic capacity of the hospitals and improve the emergency services, additional medical equipment (Ultrasounds, digital x -rays, electrocardiogram s (ECGs ), etc.) and every year two ambulances will be procured to serve Zobas with large hard to reach areas. Given the geographical constraints on reaching the population and lack of other donor funding this request is considered to be of high priority","0","0","0","0","14100","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5Q/view","2020-12-31","HIV/AIDS",14100," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713=AN678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713=AO678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713=AP678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713=AJ678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713=AN678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713=AO678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713=AP678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G678)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ5UUAW","PAI-4218","Active","ERI-HIV/AIDS-17","2017-2019","RT Middle East and North Africa","Eritrea","HIV/AIDS","HIV/AIDS","FR285-ERI-H",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","In this above allocation request, the newly upgraded LMIS system is expected to be rolled out to all the outpatient and inpatient departments of the hospitals and will reach the lower health facilities.","In this above allocation request, the newly upgraded LMIS system is expected to be rolled out to all the outpatient and inpatient departments of the hospitals and will reach the lower health facilities.","NA Original Module: RSSH - Procurement and supply chain management systems","High","314134","In this above allocation request, the newly upgraded logistics management information system (LMIS) system is expected to be rolled out to all the outpatient and inpatient departments of the hospitals and will reach the lower health facilities. Given the geographical constraints and lack of other available funding this request is considered of high priority","0","0","0","0","314134","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5U/view","2020-12-31","HIV/AIDS",314134," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713=AN682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713=AO682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713=AP682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713=AJ682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713=AN682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713=AO682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713=AP682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G682)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ5ZUAW","PAI-4223","Active","ERI-HIV/AIDS-21","2017-2019","RT Middle East and North Africa","Eritrea","HIV/AIDS","HIV/AIDS","FR285-ERI-H",null,null,"HIV Testing Services","Differentiated HIV testing services","With this activity additional computers and printers will be procured to support HCT sites to support electronic data monitoring.","With this activity additional computers and printers will be procured to support HCT sites to support electronic data monitoring.",null,"Medium","96000","This is for computers but it will be important to link new HIV testing services (HTS) data","0","0","0","0","96000","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5Z/view","2020-12-31","HIV/AIDS",96000," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713=AN687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713=AO687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713=AP687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713=AJ687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713=AN687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713=AO687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713=AP687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G687)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ5eUAG","PAI-4228","Active","ERI-HIV/AIDS-6","2017-2019","RT Middle East and North Africa","Eritrea","HIV/AIDS","HIV/AIDS","FR285-ERI-H",null,null,"RSSH: Health management information systems and M&E","Surveys","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","535000","Surveys will be really important for getting updated data. Considering that there is funding for surveys included within the allocation, it is not clear which part will be covered by the allocation budget and which elements are included in PAAR. During grant making an assessment of costs should be made and if efficiencies are identified it would be better to include all necessary costs for the surveys within allocation.","0","0","0","0","535000","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5e/view","2020-12-31","HIV/AIDS",535000," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713=AN692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713=AO692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713=AP692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713=AJ692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713=AN692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713=AO692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713=AP692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G692)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ5fUAG","PAI-4229","Active","ERI-HIV/AIDS-7","2017-2019","RT Middle East and North Africa","Eritrea","HIV/AIDS","HIV/AIDS","FR285-ERI-H",null,null,"RSSH: Health management information systems and M&E","Program and data quality","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","As part of improving the quality of data and knowing the epidemic in the country this above allocation will be used to conduct AIDS Indicator survey during the funding cycle and if not it will contribute to conducting EPHS. Furthermore, the newly upgraded DHIS-2 system is expected to be rolled out to the lowest health facility.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","270000","Routine data collection will assist with ongoing monitoring of the program. The newly upgraded District Health Information System (DHIS - 2 ) system is expected to be rolled out to the lowest health facility using this funding.","0","0","0","0","270000","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5f/view","2020-12-31","HIV/AIDS",270000," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713=AN693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713=AO693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713=AP693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713=AJ693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713=AN693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713=AO693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713=AP693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G693)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ5kUAG","PAI-4234","Active","ERI-Malaria-3","2017-2019","RT Middle East and North Africa","Eritrea","Malaria","Malaria","FR384-ERI-M",null,null,"Vector control","Indoor residual spraying (IRS)","Conduct of review meetings is of paramount importance to make assessment of IRS activities at the end each round of spraying. Moreover, provision of milk to spraymen will help them carry out the operation efficiently and with less hazards. A total of USD 38,019 estimated to cover the above two IRS related activities which have been well funded in the previous funding cycle.","Conduct of review meetings is of paramount importance to make assessment of IRS activities at the end each round of spraying. Moreover, provision of milk to spraymen will help them carry out the operation efficiently and with less hazards. A total of USD 38,019 estimated to cover the above two IRS related activities which have been well funded in the previous funding cycle.","NA Original Intervention: Indoor residual spraying","High","38019","Review meetings after each round of spraying will improve overall effectiveness.","0","0","0","0","38019","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5k/view","2020-12-31","Malaria",38019," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713=AN698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713=AO698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713=AP698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713=AJ698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713=AN698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713=AO698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713=AP698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G698)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ5pUAG","PAI-4239","Active","ERI-Malaria-8","2017-2019","RT Middle East and North Africa","Eritrea","Malaria","Malaria","FR384-ERI-M",null,null,"Vector control","Other vector control measure(s)","In line with the above request, operational cost of larviciding has been included within Allocation Amount partially. However, for the intervention to function optimally and bring about the desired impact, an additional funding of USD 430,000 will be required. This will ensure full coverage of the intervention wherever suitable or relevant. In addition, select health workforce need to be trained on IVM regularly. For this purpose, USD 65,424 will be required to organize the training every other year.","In line with the above request, operational cost of larviciding has been included within Allocation Amount partially. However, for the intervention to function optimally and bring about the desired impact, an additional funding of USD 430,000 will be required. This will ensure full coverage of the intervention wherever suitable or relevant. In addition, select health workforce need to be trained on IVM regularly. For this purpose, USD 65,424 will be required to organize the training every other year.","NA Original Intervention: Other vector control measures","Low","396979","Considering the above-mentioned justification, operational costs for larviciding also did not have strong evidence of government commitment to support sustainability, nor justification for high priority designation. The TRP recommends funding no more than 80% of the $496,224 requested ($396,979), with the 20% balance ($99,245) of the requested budget for larviciding to be covered by the GoE.","0","0","0","0","396979","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5p/view","2020-12-31","Malaria",396979," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713=AN703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713=AO703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713=AP703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713=AJ703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713=AN703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713=AO703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713=AP703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G703)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ5uUAG","PAI-4244","Active","ERI-Tuberculosis-5","2017-2019","RT Middle East and North Africa","Eritrea","Tuberculosis","Tuberculosis","FR400-ERI-T",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","The above allocation will support the procurement and maintenance cost of van for transporting MDR-TB patients from diagnostic centers to MDR hospital in order to reduce transmission. It will also enhance electronic surveillance for the programmatic management of MDR-TB.","The above allocation will support the procurement and maintenance cost of van for transporting MDR-TB patients from diagnostic centers to MDR hospital in order to reduce transmission. It will also enhance electronic surveillance for the programmatic management of MDR-TB.","NA Original Module: Multidrug-resistant TB","High","148800","The above allocation will support the procurement and maintenance cost of van for transporting MDR-TB patients from diagnostic centres to MDR hospital in order to reduce transmission. It will also enhance electronic surveillance for the programmatic management of MDRTB.","0","0","0","0","148800","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5u/view","2020-12-31","Tuberculosis",148800," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713=AN708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713=AO708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713=AP708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713=AJ708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713=AN708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713=AO708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713=AP708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ5vUAG","PAI-4245","Active","ERI-Tuberculosis-6","2017-2019","RT Middle East and North Africa","Eritrea","Tuberculosis","Tuberculosis","FR400-ERI-T",null,null,"TB/HIV","Engaging all care providers (TB/HIV)","In this section heath care workers working in TB clinics will be trained on comprehensive HIV care and treatment and on HIV counselling and testing skills in order to provide a one-stop service.","In this section heath care workers working in TB clinics will be trained on comprehensive HIV care and treatment and on HIV counselling and testing skills in order to provide a one-stop service.",null,"High","33840","The above allocation will support the procurement and maintenance cost of a van for transporting MDR-TB patients from diagnostic centres to the MDR hospital in order to reduce transmission. It will also enhance electronic surveillance for the programmatic management of MDRTB.","0","0","0","0","33840","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ5v/view","2020-12-31","Tuberculosis",33840," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713=AN709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713=AO709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713=AP709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713=AJ709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713=AN709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713=AO709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713=AP709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G709)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ60UAG","PAI-4250","Inactive","ETH-RSSH-3","2017-2019","RT High Impact Africa 2","Ethiopia","RSSH","RSSH","FR268-ETH-S",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Out of the country's PAAR request for lab equipment to equip 4 labs in emreging regions (US 5,000,000), the TRP approved 50% (USD 2,500,000). As an outcome of the review of the proposed lab equipment and the reinvestment of savings, the Secretariat and PR were able to equip a total of 6 labs i.e. an addition of 3 to the 3 that were approved under the allocation funding request.","Out of the country's PAAR request for lab equipment to equip 4 labs in emreging regions (US 5,000,000), the TRP approved 50% (USD 2,500,000). As an outcome of the review of the proposed lab equipment and the reinvestment of savings, the Secretariat and PR were able to equip a total of 6 labs i.e. an addition of 3 to the 3 that were approved under the allocation funding request.","Debt 2 health confirmed by IMM. Original Module: RSSH - Integrated service delivery and quality improvement","High","2500000","Although the needs are not as well documented and the basis for the investment is not well explained, the TRP recognizes that substantial recentinvestment (GeneXpert, viral load, EID and PoC CD4 and TB DST, known and documented problems with utilisation, maintenance, sample transport)merit at least part of the demand to support furniture and equipment of newly constructed laboratories and therefore recommends as quality demand 50 percent of the total request of US$5M.","0","0","2500000","0","0","1","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ60/view","2021-06-30","RSSH",0," High Impact Africa 2","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713=AN714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713=AO714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713=AP714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713=AJ714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713=AN714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713=AO714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713=AP714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G714)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-06-30"]
["a6Q1R000000AJ65UAG","PAI-4255","Active","ETH-TB/HIV-5","2017-2019","RT High Impact Africa 2","Ethiopia","HIV/TB","HIV/AIDS, Tuberculosis","FR313-ETH-C",null,null,"Treatment, care and support","Treatment monitoring - Viral load","Out of the estimated cost for viral load testing, 25%, 20% and 15% of the costs for 2018, 2019 and 2020 couldnt be covered within the allocation. Viral load testing is the key intervention of treatment outcome monitoring and to track the progress towards the achievement of the third 90s of the 90-90-90 global targets.","Out of the estimated cost for viral load testing, 25%, 20% and 15% of the costs for 2018, 2019 and 2020 couldnt be covered within the allocation. Viral load testing is the key intervention of treatment outcome monitoring and to track the progress towards the achievement of the third 90s of the 90-90-90 global targets.","NA Original Intervention: Treatment monitoring  Viral load","High","67934253","Recommend that this full amount be prioritized to bridge the treatment gap","0","0","0","0","67934253","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ65/view",null,"TB/HIV",67934253," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713=AN719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713=AO719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713=AP719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713=AJ719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713=AN719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713=AO719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713=AP719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G719)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ68UAG","PAI-4258","Active","ETH-TB/HIV-8","2017-2019","RT High Impact Africa 2","Ethiopia","HIV/TB","HIV/AIDS, Tuberculosis","FR313-ETH-C",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Through engagement of all stakeholders and extensive consultative process, Ethiopia has prepared the second edition of a National Plan for TB Research, 2017 -2022. A second round TB prevalence survey is among the priority TB researches planned for 2020. Through this above allocation request, CCM/E plans to partially support the national TB prevalence survey as well as other priority researches. The grant will also partially support the annual national TB Research conference.","Through engagement of all stakeholders and extensive consultative process, Ethiopia has prepared the second edition of a National Plan for TB Research, 2017 -2022. A second round TB prevalence survey is among the priority TB researches planned for 2020. Through this above allocation request, CCM/E plans to partially support the national TB prevalence survey as well as other priority researches. The grant will also partially support the annual national TB Research conference.",null,"High","799008","Contact investigations are high-priority among the defined TB services quality improvement package. The remaining 6 proposed interventions are medium-priority","0","0","0","0","799008","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ68/view",null,"TB/HIV",799008," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713=AN722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713=AO722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713=AP722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713=AJ722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713=AN722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713=AO722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713=AP722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G722)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ6CUAW","PAI-4262","Active","GAB-Tuberculosis-3","2017-2019","RT Central Africa","Gabon","Tuberculosis","Tuberculosis","FR42-GAB-T-01",null,null,"TB/HIV","Collaborative activities with other programs and sectors (TB/HIV)","To strengthen the collaboration between the TB and HIV programs and decrease TB / HIV co-infection mortality through TB / HIV coordination meetings at both national and regional levels and the creation of six new single wards for joint management of both TB and HIV pathologies among the 12 new CDTs.","To strengthen the collaboration between the TB and HIV programs and decrease TB / HIV co-infection mortality through TB / HIV coordination meetings at both national and regional levels and the creation of six new single wards for joint management of both TB and HIV pathologies among the 12 new CDTs.",null,"High","6569.41","?The funding request identifies the following weaknesses in TB/HIV collaboration: inadequate service provider training, stock-outs of reagents, a shortage of one-stop shops and weaknesses in supervision. Strengthening of TB/HIV coordination at the national/regional levels and facilities for joint management of TB and HIV are in line with the efforts to improve TB case finding and adherence to TB treatment among PLHIV and thus are considered high priority.?","0","0","0","0","6569.41","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6C/view","2021-12-31","Tuberculosis",6569.41," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713=AN726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713=AO726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713=AP726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713=AJ726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713=AN726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713=AO726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713=AP726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G726)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJ6HUAW","PAI-4267","Active","GHA-Malaria-4","2017-2019","RT High Impact Africa 1","Ghana","Malaria","Malaria","FR218-GHA-M",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Programmes carry out periodic trainings on DHIMS2  usually centralised at the regional level with officers from district and facilities levels travelling long distances for such training. The aim is to digitise all DHIMS2 training modules making them accessible to all staff of Ghana Health Services. Implementation will involve curriculum and manual development and regular updates to reflect current needs, recording of all modules on DHIMS2, eTracker data capture and reporting, and capacity building of technical team, focal persons, and regional administrators.","Programmes carry out periodic trainings on DHIMS2  usually centralised at the regional level with officers from district and facilities levels travelling long distances for such training. The aim is to digitise all DHIMS2 training modules making them accessible to all staff of Ghana Health Services. Implementation will involve curriculum and manual development and regular updates to reflect current needs, recording of all modules on DHIMS2, eTracker data capture and reporting, and capacity building of technical team, focal persons, and regional administrators.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","4e+05","Routine reporting has been a weakness with broad implications on program impact.","0","0","0","0","4e+05","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6H/view","2020-12-31","Malaria",400000," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713=AN731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713=AO731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713=AP731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713=AJ731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713=AN731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713=AO731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713=AP731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G731)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6MUAW","PAI-4272","Active","GHA-TB/HIV-10","2017-2019","RT High Impact Africa 1","Ghana","HIV/TB","HIV/AIDS, Tuberculosis","FR222-GHA-C",null,null,"HIV Testing Services","Other module","Nationally representative sample of men and adolescents to assess the acceptability of the testing model in an effort to improve uptake of HIV testing in these two groups. Phase two will assess its feasibility in selected regions. Phase three will utilize findings from phases 1 and 2, and will be scaled up to other regions.","Nationally representative sample of men and adolescents to assess the acceptability of the testing model in an effort to improve uptake of HIV testing in these two groups. Phase two will assess its feasibility in selected regions. Phase three will utilize findings from phases 1 and 2, and will be scaled up to other regions.","NA Original Module: HTS - self - testing: Assessment of Acceptability, feasibility and implementation of self -testing in Ghana. Original Intervention: Study - Implementation research on HTS","High","1200000","This assessment will include a nationally representative sample of men and adolescents to assess their acceptability of the testing model in an effort to improve uptake of HIV testing in these two groups and will help address concerns about increasing access and co v erage of HIV testing for underserved populations","0","0","0","0","1200000","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6M/view","2020-12-31","TB/HIV",1200000," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713=AN736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713=AO736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713=AP736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713=AJ736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713=AN736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713=AO736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713=AP736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G736)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6RUAW","PAI-4277","Active","GHA-TB/HIV-2","2017-2019","RT High Impact Africa 1","Ghana","HIV/TB","HIV/AIDS, Tuberculosis","FR222-GHA-C",null,null,"PMTCT","Other intervention(s) for PMTCT","Technical assistance by Liverpool School of Tropical Medicine (LSTM) to increase integrated ANC+4 coverage to 95% by 2020 so that all pregnant women are tested, receive the results, start ART, adhere to treatment and are screened for TB. This is expected to facilitate achievement of PMTCT coverage and impact on mother-to-child transmission of HIV. After childbirth, this intervention will support all HIV positive women to continue on ART while their HIV-exposed infants receive ARV prophylaxis and early infant diagnosis.","Technical assistance by Liverpool School of Tropical Medicine (LSTM) to increase integrated ANC+4 coverage to 95% by 2020 so that all pregnant women are tested, receive the results, start ART, adhere to treatment and are screened for TB. This is expected to facilitate achievement of PMTCT coverage and impact on mother-to-child transmission of HIV. After childbirth, this intervention will support all HIV positive women to continue on ART while their HIV-exposed infants receive ARV prophylaxis and early infant diagnosis.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Training of nurses and midwives in integrated ANC+4","High","3e+06","Supports the move to integrated ANC+4 coverage to 95 percent by 2020 so that all pregnant women are tested, receive the results, start ART, adhere to treatment and are screened for TB. This is expected to facilitate achievement of PMTCT coverage and impact on mother-tochild transmission of HIV. After childbirth, this intervention will support all HIV positive women to continue on ART while their HIVexposed infants receive ARV prophylaxis and early infant diagnosis.","0","0","0","0","3e+06","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6R/view","2020-12-31","TB/HIV",3000000," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713=AN741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713=AO741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713=AP741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713=AJ741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713=AN741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713=AO741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713=AP741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G741)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6SUAW","PAI-4278","Inactive","GHA-TB/HIV-3","2017-2019","RT High Impact Africa 1","Ghana","HIV/TB","HIV/AIDS, Tuberculosis","FR222-GHA-C",null,null,"Other module","Other module","Activities to contribute to the 90-90-90 targets will include intensifying peer adherence counselling and provision of psychosocial support to PLHIV at ART centres and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities.","Activities to contribute to the 90-90-90 targets will include intensifying peer adherence counselling and provision of psychosocial support to PLHIV at ART centres and in the community; tracing PLHIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities.","NA Original Module: ART - Models of Hope. Original Intervention: Peer adherence counselling and tracing of people living with HIV lost to follow up","High","753836","Activities will contribute to the 90- 90-90 targets through intensifying peer adherence counselling and provision of psychosocial support to people living with HIV at ART centres and in the community; models of care tracing people living with HIV who are lost to follow-up; provision of health promotion activities towards PMTCT; monitor quality of service and ART availability at health facilities.","753836","0","0","0","0","1","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6S/view","2020-12-31","TB/HIV",0," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713=AN742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713=AO742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713=AP742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713=AJ742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713=AN742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713=AO742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713=AP742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G742)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6XUAW","PAI-4283","Active","GHA-TB/HIV-8","2017-2019","RT High Impact Africa 1","Ghana","HIV/TB","HIV/AIDS, Tuberculosis","FR222-GHA-C",null,null,"Other module","Other module","This study to be conducted in 2019 provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the e-tracker. This cohort analysis will include women initiated on ART during pregnancy for the first time.","This study to be conducted in 2019 provides data factors contributing to ART retention, loss to follow-up and survival to complement data from the e-tracker. This cohort analysis will include women initiated on ART during pregnancy for the first time.","NA Original Module: ART - Cohort analysis. Original Intervention: Study  analysis of cohort of people living with HIV initiated on ART","High","3e+05","This study will provide data on factors contributing to ART retention, loss to follow -up and survival to complement data from the e -tracker. This cohort analysis will include women initiated on ART during pregnancy for the first time. The TRP recommends partial funding due to cost of following large cohort and availability of program data through e -tracker for analysis.","0","0","0","0","3e+05","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6X/view","2020-12-31","TB/HIV",300000," High Impact Africa 1","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713=AN747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713=AO747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713=AP747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713=AJ747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713=AN747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713=AO747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713=AP747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G747)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6cUAG","PAI-4288","Active","GIN-Malaria-4","2017-2019","RT Western Africa","Guinea","Malaria","Malaria","FR561-GIN-M",null,null,"Program management","Grant management","6. Request for additional funding for the rehabilitation of the NMCP offices as per the studies carried out by UNOPS. The geotechnical and technical studies in preparations for the renovation work were financed by CRS (with the subsidy NFM 2015-2017).  The requested funding is to cover the gap in the costs of renovation that were initially budgeted prior to the finalization of the UNOPS studies.","6. Request for additional funding for the rehabilitation of the NMCP offices as per the studies carried out by UNOPS. The geotechnical and technical studies in preparations for the renovation work were financed by CRS (with the subsidy NFM 2015-2017).  The requested funding is to cover the gap in the costs of renovation that were initially budgeted prior to the finalization of the UNOPS studies.","Amount validated and description updated by CT Original Module: RSSH - Program management","High","275000",null,"0","0","0","0","275000","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6c/view","2020-12-31","Malaria",275000," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713=AN752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713=AO752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713=AP752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713=AJ752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713=AN752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713=AO752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713=AP752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G752)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6hUAG","PAI-4293","Active","GIN-Tuberculosis-10","2017-2019","RT Western Africa","Guinea","Tuberculosis","Tuberculosis","FR260-GIN-T",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","A further review in 2020.","A further review in 2020.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Review of the program","Medium","15000","Review of the program planned for 2020 is a lesser priority","0","0","0","0","15000","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6h/view","2020-12-31","Tuberculosis",15000," Western Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713=AN757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713=AO757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713=AP757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713=AJ757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713=AN757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713=AO757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713=AP757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6iUAG","PAI-4294","Active","GIN-Tuberculosis-11","2017-2019","RT Western Africa","Guinea","Tuberculosis","Tuberculosis","FR260-GIN-T",null,null,"Program management","Other program management intervention(s)","Advocacy platform bringing together the TB and HIV programs, the government, elected members, TFPs and representatives from the various sectors; advocacy before the government and the partners in order to mobilise resources and to achieve the adoption of legislation beneficial to the effort to combat tuberculosis.","Advocacy platform bringing together the TB and HIV programs, the government, elected members, TFPs and representatives from the various sectors; advocacy before the government and the partners in order to mobilise resources and to achieve the adoption of legislation beneficial to the effort to combat tuberculosis.","NA Original Intervention: Implementation of a TB TEAM platform","Low","6069","Implementation of a TB TEAM platform is of low priority","0","0","0","0","6069","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6i/view","2020-12-31","Tuberculosis",6069," Western Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713=AN758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713=AO758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713=AP758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713=AJ758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713=AN758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713=AO758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713=AP758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G758)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6nUAG","PAI-4299","Active","GIN-Tuberculosis-6","2017-2019","RT Western Africa","Guinea","Tuberculosis","Tuberculosis","FR260-GIN-T",null,null,"TB/HIV","Other TB/HIV intervention(s)","Six-monthly meetings of the national and regional TB/HIV committees; joint, half-yearly supervisory visits.","Six-monthly meetings of the national and regional TB/HIV committees; joint, half-yearly supervisory visits.","NA Original Intervention: Strengthening of the functionality of the TB-HIV committees","High","34182","This will improve the degree of collaboration of TB and HIV programs.","0","0","0","0","34182","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6n/view","2020-12-31","Tuberculosis",34182," Western Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713=AN763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713=AO763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713=AP763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713=AJ763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713=AN763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713=AO763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713=AP763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G763)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6qUAG","PAI-4302","Active","GIN-Tuberculosis-9","2017-2019","RT Western Africa","Guinea","Tuberculosis","Tuberculosis","FR260-GIN-T",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The DPSs will supervise activities relating to the combating of TB in the CDTs and Health Centres within their catchment zones.","The DPSs will supervise activities relating to the combating of TB in the CDTs and Health Centres within their catchment zones.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Decentralised supervision by the DPSs","High","195636","This will enable the Direction Prfectorale de la Sant (DPS, district health authority) to supervise activities in the centers for the diagnosis and treatment (CDTs) and health centers within their catchment zones.","0","0","0","0","195636","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6q/view","2020-12-31","Tuberculosis",195636," Western Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713=AN766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713=AO766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713=AP766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713=AJ766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713=AN766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713=AO766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713=AP766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G766)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6yUAG","PAI-4310","Active","GNB-Malaria-10","2017-2019","RT Western Africa","Guinea-Bissau","Malaria","Malaria","FR370-GNB-M",null,null,"Other module","Other module","Bridge the funding gap for capacity building activities of MOH. Most of the personnel involved in the NMCP have been newly recruited (since 2016) and are responsible for the various positions within the NMCP, however they have not received any training.","Bridge the funding gap for capacity building activities of MOH. Most of the personnel involved in the NMCP have been newly recruited (since 2016) and are responsible for the various positions within the NMCP, however they have not received any training.","NA Original Module: RSSH. Original Intervention: MOH capacity strengthening","Low","244858.04","While acknowledged that MOH capacity is a challenge, it is unclear what specific capacity is going to be strengthened with this PAAR request.","0","0","0","0","244858.04","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6y/view","2020-12-31","Malaria",244858.04," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713=AN774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713=AO774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713=AP774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713=AJ774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713=AN774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713=AO774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713=AP774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G774)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ6zUAG","PAI-4311","Active","GNB-Malaria-2","2017-2019","RT Western Africa","Guinea-Bissau","Malaria","Malaria","FR540-GNB-M",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","PSM: We are requesting 433,481 EUR for the new warehouse, in addition to the 628,002 EUR already approved by the TRP in Nov 2017, bringing the total PAAR UQD for PSM storage and distribution to 1,061,483 EUR.Almost 50% of Global Fund NFC grants in Guinea Bissau consist of medical supplies and commodities. The GF Risk Matrix Action Plan identified numerous PSM distribution and storage issues during a review in 2016-2017.  The TRP approved 628,002 EUR for additional supply chain monitors (to trace GF funded medical supplies to end user level) and international technical assistance for the national medical stores-CECOME.As part of the reprogramming of the NFM M grant, GF authorized UNDP to purchase a Warehouse In a Box (WIB) from WFP, to replace the existing warehouse which had several fires in the last 3 years due to improper construction (frail walls, insufficient ventilation, electrical wires for air conditioners of 1.5 mm instead of 3 mms, etc). To assemble and construct a fully operational WIB would require 1.4 m EUR - breakdown provided.The existing NFC M grant has 0.4 m EUR in funding for the new warehouse, sufficient to cover the design, construction of the base and assembly of the WIB. We anticipate having savings from PSM purchases in the amount of 0.5 m EUR (which will cover the walls, insulation, multifold doors, air conditioners, and machine equipment). This leaves a gap of 433,481 EUR (for the racking, solar pannels, Warehouse Information System hardware, UNDP GMS, etc.), which is being requested now.","PSM: We are requesting 433,481 EUR for the new warehouse, in addition to the 628,002 EUR already approved by the TRP in Nov 2017, bringing the total PAAR UQD for PSM storage and distribution to 1,061,483 EUR.Almost 50% of Global Fund NFC grants in Guinea Bissau consist of medical supplies and commodities. The GF Risk Matrix Action Plan identified numerous PSM distribution and storage issues during a review in 2016-2017.  The TRP approved 628,002 EUR for additional supply chain monitors (to trace GF funded medical supplies to end user level) and international technical assistance for the national medical stores-CECOME.As part of the reprogramming of the NFM M grant, GF authorized UNDP to purchase a Warehouse In a Box (WIB) from WFP, to replace the existing warehouse which had several fires in the last 3 years due to improper construction (frail walls, insufficient ventilation, electrical wires for air conditioners of 1.5 mm instead of 3 mms, etc). To assemble and construct a fully operational WIB would require 1.4 m EUR - breakdown provided.The existing NFC M grant has 0.4 m EUR in funding for the new warehouse, sufficient to cover the design, construction of the base and assembly of the WIB. We anticipate having savings from PSM purchases in the amount of 0.5 m EUR (which will cover the walls, insulation, multifold doors, air conditioners, and machine equipment). This leaves a gap of 433,481 EUR (for the racking, solar pannels, Warehouse Information System hardware, UNDP GMS, etc.), which is being requested now.","NA Original Module: RSSH - Procurement and supply chain management systems","High","486456.07",null,"0","0","0","0","486456.07","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ6z/view","2020-12-31","Malaria",486456.07," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713=AN775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713=AO775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713=AP775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713=AJ775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713=AN775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713=AO775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713=AP775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G775)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ74UAG","PAI-4316","Inactive","GNB-Malaria-7","2017-2019","RT Western Africa","Guinea-Bissau","Malaria","Malaria","FR370-GNB-M",null,null,"Other module","Other module","Real Time Monitoring (RTM) to improve the collection of HMIS data, the timeliness and completeness of reports and the analysis and performance of actions for improvement at all levels for all of the health programs via the DHIS2. This will involve the use of an interface between the data production site and the DHIS2 at regional level in order to allow the latter to be provided with data concerning malaria and other health programs from 137 sites in real time. An automated feedback system will enable decisions to be made with regard to the quality of data at the site.","Real Time Monitoring (RTM) to improve the collection of HMIS data, the timeliness and completeness of reports and the analysis and performance of actions for improvement at all levels for all of the health programs via the DHIS2. This will involve the use of an interface between the data production site and the DHIS2 at regional level in order to allow the latter to be provided with data concerning malaria and other health programs from 137 sites in real time. An automated feedback system will enable decisions to be made with regard to the quality of data at the site.","25/10/2018: As per email by CT, this previously approved intervention will be fully funded by the World Bank. This was done prior to GNB-M coming for GAC Original Module: RSSH. Original Intervention: Tools to allow service providers to provide feedback","High","393804.29","The TRP notes this previously approved intervention will be fully funded by the World Bank.","0","0","0","393804.29","0","1","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ74/view","2020-12-31","Malaria",0," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713=AN780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713=AO780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713=AP780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713=AJ780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713=AN780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713=AO780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713=AP780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G780)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ79UAG","PAI-4321","Active","GNB-TB/HIV-11","2017-2019","RT Western Africa","Guinea-Bissau","HIV/TB","HIV/AIDS, Tuberculosis","FR369-GNB-C",null,null,"RSSH: Health management information systems and M&E","Surveys","Organize 3 data collection missions to inform the indicator on the 12-month survival rate for 2018, 2019 and 2020. The information for this indicator is taken from the GARP report.","Organize 3 data collection missions to inform the indicator on the 12-month survival rate for 2018, 2019 and 2020. The information for this indicator is taken from the GARP report.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","567.84","The 12 month survival rate is an important indicator to inform the program","0","0","0","0","567.84","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ79/view","2020-12-31","TB/HIV",567.84," Western Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713=AN785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713=AO785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713=AP785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713=AJ785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713=AN785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713=AO785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713=AP785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G785)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ7EUAW","PAI-4326","Active","GNB-TB/HIV-16","2017-2019","RT Western Africa","Guinea-Bissau","HIV/TB","HIV/AIDS, Tuberculosis","FR369-GNB-C",null,null,"Other module","Other module","Update the national list of Generic Essential Medicines. Organize 2 workshops to revise and update the national list of generic essential medicines and the national form of essential medicines in 3 days in 2018 and 2020.","Update the national list of Generic Essential Medicines. Organize 2 workshops to revise and update the national list of generic essential medicines and the national form of essential medicines in 3 days in 2018 and 2020.","NA Original Module: RSSH. Original Intervention: Quality of products","High","2596.79","A generic essential medicine list is important","0","0","0","0","2596.79","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7E/view","2020-12-31","TB/HIV",2596.79," Western Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713=AN790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713=AO790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713=AP790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713=AJ790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713=AN790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713=AO790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713=AP790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ7FUAW","PAI-4327","Active","GNB-TB/HIV-17","2017-2019","RT Western Africa","Guinea-Bissau","HIV/TB","HIV/AIDS, Tuberculosis","FR369-GNB-C",null,null,"TB/HIV","Other TB/HIV intervention(s)","Acquire equipment for the Management Unit for TB/HIV collaboration activities and purchase IT tools for the management of the TB/HIV data by  treatment centers.","Acquire equipment for the Management Unit for TB/HIV collaboration activities and purchase IT tools for the management of the TB/HIV data by  treatment centers.",null,"High","13493.44","The TRP considers the two proposed activities within this 4 module to be of quality demand as it considers this intervention key for TB/HIV collaboration. The split within the intervention is as follows: 1,734: equipment for management unit for TB/HIV activities 10,290: Tools for management of TB/HIV database","0","0","0","0","13493.44","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7F/view","2020-12-31","TB/HIV",13493.44," Western Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713=AN791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713=AO791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713=AP791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713=AJ791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713=AN791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713=AO791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713=AP791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G791)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ7KUAW","PAI-4332","Active","GNB-TB/HIV-21","2017-2019","RT Western Africa","Guinea-Bissau","HIV/TB","HIV/AIDS, Tuberculosis","FR369-GNB-C",null,null,"Other module","Other module","Conduct a PMTCT services quality survey and provide qualitative indicators (Calculation of effective coverage indicators); as well as a health care quality survey, and provide indicators on quality of care (calculation of indicators of effective coverage of patients).","Conduct a PMTCT services quality survey and provide qualitative indicators (Calculation of effective coverage indicators); as well as a health care quality survey, and provide indicators on quality of care (calculation of indicators of effective coverage of patients).","NA Original Module: RSSH. Original Intervention: Analysis, review  consultant for PMTCT services and health care quality surveys","Medium","36541.35","This may not be the best use of resources at this stage, given the many known challenges and the recommendations made by the TRP in the Program Continuation funding request for the improvement of service delivery. The proposed consultant can instead provide support to implement said recommendations, which would be of high priority. Consequently, the TRP recommends as quality demand with medium priority 32,562 out of the 65,124 requested for the international consultant to conduct the two proposed surveys (PMTCT services quality survey and health care quality survey).","0","0","0","0","36541.35","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7K/view","2020-12-31","TB/HIV",36541.35," Western Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713=AN796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713=AO796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713=AP796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713=AJ796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713=AN796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713=AO796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713=AP796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G796)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ7PUAW","PAI-4337","Active","GNB-TB/HIV-6","2017-2019","RT Western Africa","Guinea-Bissau","HIV/TB","HIV/AIDS, Tuberculosis","FR541-GNB-C",null,null,"Prevention programs for other vulnerable populations","Diagnosis and treatment of STIs and other sexual health services for other vulnerable populations","In order to reinforce HIV prevention based on the UNAIDS five pillars, the country has developed plans such as the plan of Human Rights and Gender Plan which is designed to reduce the cultural, legal, and social barriers which are preventing access to health services for adolescents and young women (10 to 25 years of age), and the coverage plan and the HIV services differentiated approach plan which is designed for key and vulnerable populations as well as the general population.The amount requested here amounts to 151,971 euros and concerns the PrEP feasibility study (21,551 euros) (PrEP Feasibility Study Budget - Appendix 12) as well as the activities without which the coverage plans objectives could not be reached. These fees are associated with: i) implementation of the pilot phase among 500 persons (67,207 euros); ii) the IEC/CCC activities of targeted groups (25,225 euros); iii) the targeted testing of key and vulnerable populations (37,988 euros) (Drafting of the HIV Services Differentiated Approaches Plan - Appendix 6).With regards to the PrEP, after the pilot phase, we plan to perform a study to measure the impact of this intervention in order to help us to make the decision to launch full-scale operations.","In order to reinforce HIV prevention based on the UNAIDS five pillars, the country has developed plans such as the plan of Human Rights and Gender Plan which is designed to reduce the cultural, legal, and social barriers which are preventing access to health services for adolescents and young women (10 to 25 years of age), and the coverage plan and the HIV services differentiated approach plan which is designed for key and vulnerable populations as well as the general population.The amount requested here amounts to 151,971 euros and concerns the PrEP feasibility study (21,551 euros) (PrEP Feasibility Study Budget - Appendix 12) as well as the activities without which the coverage plans objectives could not be reached. These fees are associated with: i) implementation of the pilot phase among 500 persons (67,207 euros); ii) the IEC/CCC activities of targeted groups (25,225 euros); iii) the targeted testing of key and vulnerable populations (37,988 euros) (Drafting of the HIV Services Differentiated Approaches Plan - Appendix 6).With regards to the PrEP, after the pilot phase, we plan to perform a study to measure the impact of this intervention in order to help us to make the decision to launch full-scale operations.","NA Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for other vulnerable populations","High","170543.15",null,"0","0","0","0","170543.15","0","0","2019-10-30 15:33:23","2019-10-30 15:33:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7P/view","2020-12-31","TB/HIV",170543.15," Western Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713=AN801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713=AO801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713=AP801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713=AJ801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713=AN801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713=AO801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713=AP801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G801)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ7UUAW","PAI-4342","Active","GTM-HIV/AIDS-10","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","10,900,316 condoms to cover 82 percent of the programmatic gap in 2019.","10,900,316 condoms to cover 82 percent of the programmatic gap in 2019.","Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'HIV testing services for sex workers' are merged in the TRP form","High","327009",null,"0","0","0","0","327009","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7U/view","2020-12-31","HIV/AIDS",327009," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713=AN806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713=AO806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713=AP806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713=AJ806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713=AN806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713=AO806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713=AP806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ7VUAW","PAI-4343","Active","GTM-HIV/AIDS-11","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","12,951,220 condoms to cover 82 percent of the programmatic gap in 2020.","12,951,220 condoms to cover 82 percent of the programmatic gap in 2020.","Both interventions for module 'Comprehensive prevention programs for sex workers and their clients', intervention 'HIV testing services for sex workers' are merged in the TRP form","High","388537",null,"0","0","0","0","388537","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7V/view","2020-12-31","HIV/AIDS",388537," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713=AN807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713=AO807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713=AP807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713=AJ807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713=AN807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713=AO807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713=AP807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G807)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ7ZUAW","PAI-4347","Active","GTM-HIV/AIDS-15","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"Comprehensive prevention programs for TGs","Condoms and lubricant programming for TGs","2,975,714 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","2,975,714 sachets of lubricant to cover 82 percent of the programmatic gap in 2020.","All the interventions for 'Condoms and lubricant programming for transgender people' under module 'Comprehensive prevention programs for transgender people' are merged in the TRP form Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Condoms and lubricant programming for transgender people","High","119029",null,"0","0","0","0","119029","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7Z/view","2020-12-31","HIV/AIDS",119029," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713=AN811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713=AO811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713=AP811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713=AJ811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713=AN811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713=AO811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713=AP811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ7gUAG","PAI-4354","Active","GTM-HIV/AIDS-21","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Coban Regional Hospital, Alta Verapaz. Renovation of a 43.71 m clinic, including: demolishing, dismantling and removing existing sanitary items and prefabricated walls; erecting plasterboard walls; laying granite floor; tiling; installing one metal door, four wooden doors, two windows; installing water and electricity; two washbasins, two toilets; paintwork.","Coban Regional Hospital, Alta Verapaz. Renovation of a 43.71 m clinic, including: demolishing, dismantling and removing existing sanitary items and prefabricated walls; erecting plasterboard walls; laying granite floor; tiling; installing one metal door, four wooden doors, two windows; installing water and electricity; two washbasins, two toilets; paintwork.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Medium","10000","Infrastructure improvement justified for improving service delivery.","0","0","0","0","10000","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7g/view","2020-12-31","HIV/AIDS",10000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713=AN818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713=AO818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713=AP818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713=AJ818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713=AN818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713=AO818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713=AP818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G818)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ7lUAG","PAI-4359","Active","GTM-HIV/AIDS-26","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","San Marcos health area department.  Renovation of XX  m laboratory, including: preliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.","San Marcos health area department.  Renovation of XX  m laboratory, including: preliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; three windows; installing water and electricity; making fixed furniture units; installing one sink; relocating one sink; smoothing out concrete floor; outside pavement; metal structure; suspended ceiling; paintwork.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Medium","6000","Infrastructure improvement justified for improving service delivery.","0","0","0","0","6000","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7l/view","2020-12-31","HIV/AIDS",6000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713=AN823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713=AO823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713=AP823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713=AJ823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713=AN823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713=AO823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713=AP823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G823)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ7mUAG","PAI-4360","Active","GTM-HIV/AIDS-27","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Escuintla health area department. Renovation of a 23.79 m laboratory, including: preliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; erecting a plasterboard wall; eight windows; three balconies; one metal door; installing water and electricity; making fixed furniture units; one sink; laying ceramic flooring; perimeter pavement; metal structure; suspended ceiling; enclosure for gas cylinders; paintwork.","Escuintla health area department. Renovation of a 23.79 m laboratory, including: preliminary work; foundations; structural elements; erecting a block wall; demolishing a block wall; finishing for walls; erecting a plasterboard wall; eight windows; three balconies; one metal door; installing water and electricity; making fixed furniture units; one sink; laying ceramic flooring; perimeter pavement; metal structure; suspended ceiling; enclosure for gas cylinders; paintwork.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Medium","6000","Infrastructure improvement justified for improving service delivery.","0","0","0","0","6000","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7m/view","2020-12-31","HIV/AIDS",6000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713=AN824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713=AO824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713=AP824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713=AJ824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713=AN824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713=AO824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713=AP824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G824)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ7rUAG","PAI-4365","Active","GTM-HIV/AIDS-31","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Malacatn Hospital, San Marcos. Renovation of a 416 m facility, including: waterproof treatment of floor; paintwork for walls; epoxy paint in laboratory; making fixed furniture units; removing and replacing 13 wooden doors; fitting one aluminum door; installing two 2 x 32 lights; three washbasins; installing water; replacing fittings for eight washbasins; replacing one existing door lock; supplying ten fluorescent light tubes.","Malacatn Hospital, San Marcos. Renovation of a 416 m facility, including: waterproof treatment of floor; paintwork for walls; epoxy paint in laboratory; making fixed furniture units; removing and replacing 13 wooden doors; fitting one aluminum door; installing two 2 x 32 lights; three washbasins; installing water; replacing fittings for eight washbasins; replacing one existing door lock; supplying ten fluorescent light tubes.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Medium","10775","Infrastructure improvement justified for improving service delivery.","0","0","0","0","10775","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7r/view","2020-12-31","HIV/AIDS",10775," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713=AN829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713=AO829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713=AP829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713=AJ829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713=AN829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713=AO829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713=AP829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G829)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ7wUAG","PAI-4370","Active","GTM-HIV/AIDS-36","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Central Guatemala health department. Renovation of a 44.18 m facility, including: Remove existing metal structure and fit  a new structure; remove a suspended ceiling; erect and repair walls; make furniture units; two wooden doors; one aluminum door; installing electricity; paintwork; renovate balconies and 1 metal door; replace mechanisms and adhesive vinyl for 3 aluminum window; fit ducting for electrical wiring; install a 18,000 BTU ACU.","Central Guatemala health department. Renovation of a 44.18 m facility, including: Remove existing metal structure and fit  a new structure; remove a suspended ceiling; erect and repair walls; make furniture units; two wooden doors; one aluminum door; installing electricity; paintwork; renovate balconies and 1 metal door; replace mechanisms and adhesive vinyl for 3 aluminum window; fit ducting for electrical wiring; install a 18,000 BTU ACU.","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Medium","9677.42","Infrastructure improvement justified for improving service delivery.","0","0","0","0","9677.42","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ7w/view","2020-12-31","HIV/AIDS",9677.42," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713=AN834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713=AO834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713=AP834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713=AJ834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713=AN834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713=AO834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713=AP834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ81UAG","PAI-4375","Active","GTM-HIV/AIDS-40","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Izabal health area department (planning pending).","Izabal health area department (planning pending).","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Medium","9677.42","Infrastructure improvement justified for improving service delivery.","0","0","0","0","9677.42","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ81/view","2020-12-31","HIV/AIDS",9677.42," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713=AN839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713=AO839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713=AP839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713=AJ839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713=AN839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713=AO839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713=AP839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ82UAG","PAI-4376","Active","GTM-HIV/AIDS-41","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Petn Sur health area department (planning pending).","Petn Sur health area department (planning pending).","All the interventions for module 'RSSH: Integrated service delivery and quality improvement' are merged in the TRP form Original Module: RSSH - Integrated service delivery and quality improvement","Medium","9677.42","Infrastructure improvement justified for improving service delivery.","0","0","0","0","9677.42","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ82/view","2020-12-31","HIV/AIDS",9677.42," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713=AN840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713=AO840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713=AP840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713=AJ840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713=AN840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713=AO840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713=AP840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G840)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ87UAG","PAI-4381","Active","GTM-HIV/AIDS-5","2017-2019","RT Latin America and Caribbean","Guatemala","HIV/AIDS","HIV/AIDS","FR100-GTM-H-01",null,null,"Comprehensive prevention programs for TGs","HIV testing services for TGs","2,234 HIV tests to cover 100 percent of the programmatic gap in 2020.","2,234 HIV tests to cover 100 percent of the programmatic gap in 2020.","Both the interventions for 'HIV testing services for transgender people' under module 'Comprehensive prevention programs for transgender people' are merged in the TRP form Original Module: Comprehensive prevention programs for transgender people. Original Intervention: HIV testing services for transgender people","High","3530",null,"0","0","0","0","3530","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ87/view","2020-12-31","HIV/AIDS",3530," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713=AN845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713=AO845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713=AP845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713=AJ845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713=AN845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713=AO845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713=AP845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G845)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJ8CUAW","PAI-4386","Inactive","GTM-Malaria-1","2017-2019","RT Latin America and Caribbean","Guatemala","Malaria","Malaria","FR416-GTM-M-01",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Refurbishment and fitting out of 4 outlying microscope labs, with US$ 4,200 each to ensure their functionality (one in Suchitepquez, one in Retalhuleu and two in Izabal).","Refurbishment and fitting out of 4 outlying microscope labs, with US$ 4,200 each to ensure their functionality (one in Suchitepquez, one in Retalhuleu and two in Izabal).","NA Original Module: RSSH - Integrated service delivery and quality improvement","High","16800","This is a critical intervention which is the highest priority for moving into the allocation funding request. This should therefore be prioritised when efficiencies are found.","16800","0","0","0","0","1","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8C/view","2021-06-30","Malaria",0," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713=AN850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713=AO850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713=AP850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713=AJ850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713=AN850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713=AO850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713=AP850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G850)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2021-06-30"]
["a6Q1R000000AJ8HUAW","PAI-4391","Inactive","GTM-Tuberculosis-11","2017-2019","RT Latin America and Caribbean","Guatemala","Tuberculosis","Tuberculosis","FR417-GTM-T",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","International consultancy services for technical assistance and GxAlert platform support.","International consultancy services for technical assistance and GxAlert platform support.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","4500","A functional GxAlert platform allows a rapid communication of tuberculosis tests results to care providers.","4500","0","0","0","0","1","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8H/view","2022-06-30","Tuberculosis",0," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713=AN855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713=AO855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713=AP855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713=AJ855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713=AN855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713=AO855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713=AP855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJ8JUAW","PAI-4393","Inactive","GTM-Tuberculosis-3","2017-2019","RT Latin America and Caribbean","Guatemala","Tuberculosis","Tuberculosis","FR417-GTM-T",null,null,"TB care and prevention","Case detection and diagnosis","First aid kits.","First aid kits.",null,"High","2999",null,"2999","0","0","0","0","1","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8J/view","2022-06-30","Tuberculosis",0," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713=AN857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713=AO857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713=AP857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713=AJ857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713=AN857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713=AO857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713=AP857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G857)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJ8OUAW","PAI-4398","Active","GTM-Tuberculosis-8","2017-2019","RT Latin America and Caribbean","Guatemala","Tuberculosis","Tuberculosis","FR417-GTM-T",null,null,"TB care and prevention","Case detection and diagnosis","Secretary chair.","Secretary chair.",null,"Medium","229","The interventions in lines 5 to 8 of this table correspond to office material that should be consolidated in a single intervention line.","0","0","0","0","229","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8O/view","2022-06-30","Tuberculosis",229," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713=AN862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713=AO862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713=AP862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713=AJ862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713=AN862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713=AO862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713=AP862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G862)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJ8TUAW","PAI-4403","Inactive","HND-HIV/AIDS-12","2017-2019","RT Latin America and Caribbean","Honduras","HIV/AIDS","HIV/AIDS","FR61-HND-H",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM"," Training staff from HIV clinics and friendly services clinics, in the assisted notification strategy for couples.  Stipend for voluntary navigators in VICITS (Surveillance and Control of HIV and STI clinics) to strengthen adherence of MSM and Trans populations"," Training staff from HIV clinics and friendly services clinics, in the assisted notification strategy for couples.  Stipend for voluntary navigators in VICITS (Surveillance and Control of HIV and STI clinics) to strengthen adherence of MSM and Trans populations","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","High","107742.95",null,"107743","0","0","0","0","1","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8T/view","2022-07-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-07-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713=AN867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713=AO867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713=AP867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-07-31"},"2022-07-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713=AJ867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-08-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713=AN867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713=AO867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713=AP867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G867)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-08-01"},"2022-07-31"]
["a6Q1R000000AJ8YUAW","PAI-4408","Active","HND-HIV/AIDS-17","2017-2019","RT Latin America and Caribbean","Honduras","HIV/AIDS","HIV/AIDS","FR61-HND-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Training for HIV counselors to guarantee access to testing with counseling, in compliance with national standards","Training for HIV counselors to guarantee access to testing with counseling, in compliance with national standards",null,"Medium","9247.42",null,"0","0","0","0","9247.42","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8Y/view","2022-07-31","HIV/AIDS",9247.42," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-07-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713=AN872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713=AO872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713=AP872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-07-31"},"2022-07-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713=AJ872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-08-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713=AN872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713=AO872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713=AP872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G872)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-08-01"},"2022-07-31"]
["a6Q1R000000AJ8ZUAW","PAI-4409","Active","HND-HIV/AIDS-18","2017-2019","RT Latin America and Caribbean","Honduras","HIV/AIDS","HIV/AIDS","FR61-HND-H",null,null,"Program management","Grant management","Office related expenses","Office related expenses",null,"Medium","12510.05",null,"0","0","0","0","12510.05","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8Z/view","2022-07-31","HIV/AIDS",12510.05," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-07-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713=AN873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713=AO873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713=AP873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-07-31"},"2022-07-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713=AJ873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-08-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713=AN873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713=AO873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713=AP873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G873)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-08-01"},"2022-07-31"]
["a6Q1R000000AJ8eUAG","PAI-4414","Active","HND-HIV/AIDS-3","2017-2019","RT Latin America and Caribbean","Honduras","HIV/AIDS","HIV/AIDS","FR61-HND-H",null,null,"Comprehensive prevention programs for TGs","Other intervention(s) for TGs","Contracting a coordinator and workers for organizations that intervene in the Trans population","Contracting a coordinator and workers for organizations that intervene in the Trans population","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Other interventions for transgender people","Low","21326.28","TRP recommends that the applicant further develop an efficient coordination structure for implementation of the key populations programs, avoiding when possible to have coordinators and staff for each key population sub-groups. The TRP furthermore recommends the applicant to consider integrating the roles of coordinator for key populations in only one position and including that position within-allocation if efficiencies are found during-grant making.","0","0","0","0","21326.28","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8e/view","2022-07-31","HIV/AIDS",21326.28," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-07-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713=AN878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713=AO878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713=AP878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-07-31"},"2022-07-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713=AJ878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-08-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713=AN878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713=AO878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713=AP878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G878)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-08-01"},"2022-07-31"]
["a6Q1R000000AJ8jUAG","PAI-4419","Active","HND-HIV/AIDS-8","2017-2019","RT Latin America and Caribbean","Honduras","HIV/AIDS","HIV/AIDS","FR61-HND-H",null,null,"Comprehensive prevention programs for TGs","Behavioral interventions for TGs","Training leaders and monitoring of interventions for Trans population","Training leaders and monitoring of interventions for Trans population","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","Low","14130.41","The TRP recommends the applicant to consider integrating the training activities and use available technologies to promote more effective interventions.","0","0","0","0","14130.41","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8j/view","2022-07-31","HIV/AIDS",14130.41," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-07-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713=AN883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713=AO883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713=AP883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-07-31"},"2022-07-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713=AJ883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-08-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713=AN883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713=AO883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713=AP883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G883)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-08-01"},"2022-07-31"]
["a6Q1R000000AJ8oUAG","PAI-4424","Active","HND-Tuberculosis-4","2017-2019","RT Latin America and Caribbean","Honduras","Tuberculosis","Tuberculosis","FR62-HND-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Activities to improve prevention, advocacy, detection, diagnosis and timely treatment in TB key populations, such as people with diabetes, mental patients, kidney patients and tobacco users. Similarly, activities to improve the control of TB at the different levels of care and, subsequently, decrease the number of deaths due to TB in association with these pathologies.","Activities to improve prevention, advocacy, detection, diagnosis and timely treatment in TB key populations, such as people with diabetes, mental patients, kidney patients and tobacco users. Similarly, activities to improve the control of TB at the different levels of care and, subsequently, decrease the number of deaths due to TB in association with these pathologies.","NA Original Intervention: Key populations (TB care and prevention)  Others","High","429826.35","It is proposed to give this intervention a high priority (USD 429,826) to increase the prevention care and treatment for key and vulnerable populations (people living with diabetes, persons with mental health issues, renal patients and tobacco smokers), including at the different health levels. The TRP suggestion is to include people who use drugs and people with alcohol dependency to improve case holding/adherence.","0","0","0","0","429826.35","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8o/view","2022-07-31","Tuberculosis",429826.35," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-07-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713=AN888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713=AO888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713=AP888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-07-31"},"2022-07-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713=AJ888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-08-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713=AN888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713=AO888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713=AP888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-08-01"},"2022-07-31"]
["a6Q1R000000AJ8pUAG","PAI-4425","Active","HND-Tuberculosis-5","2017-2019","RT Latin America and Caribbean","Honduras","Tuberculosis","Tuberculosis","FR62-HND-T",null,null,"TB care and prevention","Community TB care delivery","Activities to increase the participation of community personnel, including midwives and CBOs, in TB prevention and advocacy activities, with the objective of improving detection at community level and timely referral to Health Facilities; and raising awareness among the general population of the importance of their involvement in their own health care.","Activities to increase the participation of community personnel, including midwives and CBOs, in TB prevention and advocacy activities, with the objective of improving detection at community level and timely referral to Health Facilities; and raising awareness among the general population of the importance of their involvement in their own health care.",null,"High","42619.17","Community Based-Organizations implement important aspects of case finding, prevention and treatment follow-up and are considered to be supported as high priority.","0","0","0","0","42619.17","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8p/view","2022-07-31","Tuberculosis",42619.17," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-07-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713=AN889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713=AO889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713=AP889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-07-31"},"2022-07-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713=AJ889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-08-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713=AN889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713=AO889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713=AP889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G889)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-08-01"},"2022-07-31"]
["a6Q1R000000AJ8uUAG","PAI-4430","Active","HTI-Malaria-10","2017-2019","RT Latin America and Caribbean","Haiti","Malaria","Malaria","FR472-HTI-M",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Reproduction of data collection tools for agents on the groundexpected result: all agents on the ground, including ones at community level, have tools for collection, on paper, in a sufficient quantityimpact: no shortage of stock of tools for collecting data over 3 years","Reproduction of data collection tools for agents on the groundexpected result: all agents on the ground, including ones at community level, have tools for collection, on paper, in a sufficient quantityimpact: no shortage of stock of tools for collecting data over 3 years","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","30000","This funding will support reproduction of data collection tools for agents - field work. The TRP recommends this activity with low priority as it represents low value for money.","0","0","0","0","30000","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ8u/view","2020-12-31","Malaria",30000," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713=AN894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713=AO894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713=AP894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713=AJ894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713=AN894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713=AO894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713=AP894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G894)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ90UAG","PAI-4436","Active","HTI-Malaria-2","2017-2019","RT Latin America and Caribbean","Haiti","Malaria","Malaria","FR472-HTI-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Purchase of LLINs for migrants: in 2015, about 76,293 people were repatriated to Haiti. Most of these people come from countries free of malaria (or low incidence). These people are \"new\" subjects vulnerable to malaria when they return to rural parts of Haiti.  Needs over three years are estimated at 114,450 LLINs.expected result: all people repatriated to Haiti receive a LLIN;impact: morbidity due to malaria has dropped considerably among migrants (by 90%).","Purchase of LLINs for migrants: in 2015, about 76,293 people were repatriated to Haiti. Most of these people come from countries free of malaria (or low incidence). These people are \"new\" subjects vulnerable to malaria when they return to rural parts of Haiti.  Needs over three years are estimated at 114,450 LLINs.expected result: all people repatriated to Haiti receive a LLIN;impact: morbidity due to malaria has dropped considerably among migrants (by 90%).","NA Original Intervention: Long-lasting insecticidal nets  Continuous distribution","High","385696.5",null,"0","0","0","0","385696.5","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ90/view","2020-12-31","Malaria",385696.5," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713=AN900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713=AO900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713=AP900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713=AJ900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713=AN900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713=AO900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713=AP900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G900)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ95UAG","PAI-4441","Active","HTI-Malaria-7","2017-2019","RT Latin America and Caribbean","Haiti","Malaria","Malaria","FR472-HTI-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Organise 40 quarterly meetings to track performance between the 10 departments and healthcare institutions Expected results: These meetings will enable the PNCM and departmental directors to examine and discuss the overall performance of the programme in each department, track indicators, data management and the work plan for quarterly activities. impact: Co-ordinating activities and ensuring that national directives are actually taken into account by departmental actors.","Organise 40 quarterly meetings to track performance between the 10 departments and healthcare institutions Expected results: These meetings will enable the PNCM and departmental directors to examine and discuss the overall performance of the programme in each department, track indicators, data management and the work plan for quarterly activities. impact: Co-ordinating activities and ensuring that national directives are actually taken into account by departmental actors.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Low","259664.86","This funding will support meetings to track performance between 10 departments and healthcare institutions. A 20% proportion of the original request is being recommended for PAAR as this element offers low value for money.","0","0","0","0","259664.86","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ95/view","2020-12-31","Malaria",259664.86," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713=AN905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713=AO905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713=AP905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713=AJ905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713=AN905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713=AO905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713=AP905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G905)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ96UAG","PAI-4442","Active","HTI-Malaria-8","2017-2019","RT Latin America and Caribbean","Haiti","Malaria","Malaria","FR472-HTI-M",null,null,"Specific prevention interventions (SPI)","Other specific prevention intervention(s)","Sign contracts with 23 new radio stations to broadcast messages on eliminating malaria in towns bordering areas in stratum 3expected results: increase efforts againts progression of malaria; 2/ populations in towns bordering red areas are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localitiesimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.","Sign contracts with 23 new radio stations to broadcast messages on eliminating malaria in towns bordering areas in stratum 3expected results: increase efforts againts progression of malaria; 2/ populations in towns bordering red areas are sufficiently informed and are taking all useful measures to prevent expansion of malaria to their localitiesimpact: reduction in the incidence of malaria in towns bordering areas in stratum 3.","NA Original Module: Specific prevention interventions. Original Intervention: Information, education, communication/Behavior change communications (specific prevention interventions)","Low","8280","This request is meant to support broadcasting of mass media messages via radio. The contribution to impact of this additional request is not well substantiated and only 30% of the original request is being recommended under PAAR.","0","0","0","0","8280","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ96/view","2020-12-31","Malaria",8280," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713=AN906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713=AO906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713=AP906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713=AJ906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713=AN906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713=AO906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713=AP906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G906)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ9BUAW","PAI-4447","Active","HTI-TB/HIV-12","2017-2019","RT Latin America and Caribbean","Haiti","HIV/TB","HIV/AIDS, Tuberculosis","FR476-HTI-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","The intervention proposed the chance to pursue learning and social integration for OVC and fight structural factors. The 2018-2020 grant will fund 3,400 OVC in 2018, 2,000 in 2019 and 900 in 2020. At $150 per OVC per year, the amount requested will take the level of educational support to OVC to the level of the 2015-2017 grant, guaranteeing the educational costs of 4,520 OVC for the term of the grant.","The intervention proposed the chance to pursue learning and social integration for OVC and fight structural factors. The 2018-2020 grant will fund 3,400 OVC in 2018, 2,000 in 2019 and 900 in 2020. At $150 per OVC per year, the amount requested will take the level of educational support to OVC to the level of the 2015-2017 grant, guaranteeing the educational costs of 4,520 OVC for the term of the grant.","NA Original Intervention: Other interventions for adolescent and youth","High","1089000","The TRP recommends to reprioritize activities targeting adolescents, from medium to high priority. Adolescents, and especially adolescent girls and young women (AGYW) are at increased risk for HIV and therefore interventions targeting this group are strategic and have a potential for impact. Therefore, an increased effort is necessary to reach this target group. The TRP considers that the scale of activities proposed in the PAAR for adolescents is not sufficient to maximize impact and as such recommends additional funds be added to the PAAR for interventions targeting adolescents. The TRP has recommended an additional amount to the line above (based on the total requested funding envelope for PAAR) with the expectation that, should additional funds become available, they should be invested in HIV testing services for adolescents and youth and Other interventions for adolescents and youth. The split between these two interventions is left to the discretion of the applicant and the Global Fund Secretariat should additional resources become available.","0","0","890500","0","198500","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9B/view","2020-12-31","TB/HIV",198500," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713=AN911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713=AO911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713=AP911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713=AJ911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713=AN911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713=AO911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713=AP911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G911)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ9GUAW","PAI-4452","Active","HTI-TB/HIV-17","2017-2019","RT Latin America and Caribbean","Haiti","HIV/TB","HIV/AIDS, Tuberculosis","FR476-HTI-C",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","Direct contacts of MDR-TB patients on treatment are at risk of infection. The WHO recommends that they are monitored periodically for at least two years to track any development of resistant germ tuberculosis-type infection or disease. ASCPs must receive appropriate training so that they can conduct this task correctly.","Direct contacts of MDR-TB patients on treatment are at risk of infection. The WHO recommends that they are monitored periodically for at least two years to track any development of resistant germ tuberculosis-type infection or disease. ASCPs must receive appropriate training so that they can conduct this task correctly.","NA Original Module: Multidrug-resistant TB","Medium","9216","The TRP has reprioritized this intervention from low to medium. According to WHO recommendations periodic monitoring of MDR patients is a priority for TB and MDR-TB control.","0","0","0","0","9216","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9G/view","2020-12-31","TB/HIV",9216," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713=AN916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713=AO916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713=AP916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713=AJ916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713=AN916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713=AO916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713=AP916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G916)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ9LUAW","PAI-4457","Active","HTI-TB/HIV-5","2017-2019","RT Latin America and Caribbean","Haiti","HIV/TB","HIV/AIDS, Tuberculosis","FR476-HTI-C",null,null,"TB care and prevention","Case detection and diagnosis","The PNLT anticipates developing strategies to increase screening for new cases.  Improve Screening for paediatric TB:introduction of the Determine LAM strip urine test for diagnosing tuberculosis in HIV-positive children under 15 years + GeneXpert stool sample test for children under 5 suspected of having pulmonary tuberculosis. The active search for cases will be conducted during home visits ASCP. Every ASCP screens at least 3 cases per quarter for a total of 1,248 additional new cases; this target will double in the second year.","The PNLT anticipates developing strategies to increase screening for new cases.  Improve Screening for paediatric TB:introduction of the Determine LAM strip urine test for diagnosing tuberculosis in HIV-positive children under 15 years + GeneXpert stool sample test for children under 5 suspected of having pulmonary tuberculosis. The active search for cases will be conducted during home visits ASCP. Every ASCP screens at least 3 cases per quarter for a total of 1,248 additional new cases; this target will double in the second year.",null,"High","1932922",null,"0","375000","539250","0","1018672","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9L/view","2020-12-31","TB/HIV",1018672," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713=AN921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713=AO921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713=AP921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713=AJ921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713=AN921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713=AO921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713=AP921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G921)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ9MUAW","PAI-4458","Active","HTI-TB/HIV-6","2017-2019","RT Latin America and Caribbean","Haiti","HIV/TB","HIV/AIDS, Tuberculosis","FR476-HTI-C",null,null,"Treatment, care and support","Engaging all care providers (TB care and prevention)","Rehabilitation of many health sites damaged by Hurricane Matthew in 2016 where patients are seen in the courtyard, and examinations are also conducted outside, in an unventilated room or in a container. In slum areas there are not enough space to receive patients with respiratory diseases without exposing other at-risk patients (child, HIV, diabetic).","Rehabilitation of many health sites damaged by Hurricane Matthew in 2016 where patients are seen in the courtyard, and examinations are also conducted outside, in an unventilated room or in a container. In slum areas there are not enough space to receive patients with respiratory diseases without exposing other at-risk patients (child, HIV, diabetic).",null,"High","92500",null,"0","0","0","0","92500","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9M/view","2020-12-31","TB/HIV",92500," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713=AN922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713=AO922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713=AP922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713=AJ922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713=AN922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713=AO922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713=AP922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G922)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ9RUAW","PAI-4463","Active","IDN-Malaria-2","2017-2019","RT High Impact Asia","Indonesia","Malaria","Malaria","FR396-IDN-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Total of 1,474,793 bed nets will be distributed to selected areas in Sumatera, Kalimantan, and Sulawesi. The costs include bed net procurement, custom and distribution costs, and field distribution cost.","Total of 1,474,793 bed nets will be distributed to selected areas in Sumatera, Kalimantan, and Sulawesi. The costs include bed net procurement, custom and distribution costs, and field distribution cost.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","7400000","LLIN for focus areas including MMPs to support universal coverage and equal access to a key intervention in the prevention of malaria is a high priority. In addition, the TRP suggests consideration of Long Lasting Insecticide Treated Hammock Nets for the MMP, if it can be a more appropriate intervention for this key vulnerable group.","4150000","0","0","0","3250000","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9R/view","2020-12-31","Malaria",3250000," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713=AN927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713=AO927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713=AP927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713=AJ927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713=AN927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713=AO927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713=AP927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G927)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ9WUAW","PAI-4468","Active","IDN-Malaria-7","2017-2019","RT High Impact Asia","Indonesia","Malaria","Malaria","FR396-IDN-M",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Needed for collaboration with Malaysia (Kalimantan), Timor Leste (NTT), and PNG (Papua).Estimate requirement for each collaboration meeting would be US$ 20,000 with total 10 times of meeting/workshop.Kalimantan-Malaysia : 3 timesNTT-Timor Leste : 4 timesPapua-PNG  : 4 timesEach activity will involve Ministry of Health (NMP, Foreign Affair Bureau, Surveillance program, maternal and child health program), Ministry of Finance, Ministry of Foreign Affair, Ministry of Home Affair, PHO, DHO, Private Sector, Local NGOs","Needed for collaboration with Malaysia (Kalimantan), Timor Leste (NTT), and PNG (Papua).Estimate requirement for each collaboration meeting would be US$ 20,000 with total 10 times of meeting/workshop.Kalimantan-Malaysia : 3 timesNTT-Timor Leste : 4 timesPapua-PNG  : 4 timesEach activity will involve Ministry of Health (NMP, Foreign Affair Bureau, Surveillance program, maternal and child health program), Ministry of Finance, Ministry of Foreign Affair, Ministry of Home Affair, PHO, DHO, Private Sector, Local NGOs",null,"Medium","2e+05","Efforts to support cross border collaboration and joint planning activities, to ensure joint surveillance, vector control management, data sharing, and prevention activities can be useful. However, the TRP recommends that this support be contingent on the inclusion of similar cross-border collaboration activities in the Timor Leste and Papua New Guinea work plan Indonesia-Malaysia collaboration may be better coordinated through existing regional networks that has the mandate to coordinate such activities, e.g. ASEAN, MaPhilIndo, APMENs","0","0","0","0","2e+05","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9W/view","2020-12-31","Malaria",200000," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713=AN932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713=AO932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713=AP932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713=AJ932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713=AN932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713=AO932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713=AP932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G932)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJ9bUAG","PAI-4473","Inactive","IDN-TB/HIV-12","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Program management","Other program management intervention(s)","This intervention covers Tanah Papua area, targeting general population, on top of interventions in the within allocation targeting pregnant women, TB patients and KAPs. This would target a number of 75,000 general population tested with a projected 1,725 additional persons starting treatment. The activities include trainings, mentoring session, home-based care of PLHIV, tracing of pre and in treatment list of patients by health cadres, as well as monthly coordination meetings.","This intervention covers Tanah Papua area, targeting general population, on top of interventions in the within allocation targeting pregnant women, TB patients and KAPs. This would target a number of 75,000 general population tested with a projected 1,725 additional persons starting treatment. The activities include trainings, mentoring session, home-based care of PLHIV, tracing of pre and in treatment list of patients by health cadres, as well as monthly coordination meetings.",null,"High","2780009","This covers Tanah Papua area. This is an important epidemic different from the rest of Indonesia. This is considered a high priority and it should be moved within the allocation when cost efficiencies are identified during grant making.","2780009","0","0","0","0","1","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9b/view",null,"Multi-component",0," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713=AN937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713=AO937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713=AP937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713=AJ937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713=AN937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713=AO937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713=AP937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ9cUAG","PAI-4474","Active","IDN-TB/HIV-13","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Treatment, care and support","Differentiated ART service delivery","This module covers pre-ART testing for an additional 8, 682 PLHIV from districts to be targeted above allocation. CST training at abive additional districts.","This module covers pre-ART testing for an additional 8, 682 PLHIV from districts to be targeted above allocation. CST training at abive additional districts.","NA Original Intervention: Differentiated antiretroviral therapy service delivery","High","808527","High priority because of the need for the applicant to increase the treatment coverage for impact. This is high priority and should move to allocation when cost efficiencies are identified during grant making.","0","0","0","0","808527","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9c/view",null,"Multi-component",808527," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713=AN938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713=AO938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713=AP938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713=AJ938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713=AN938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713=AO938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713=AP938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G938)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ9iUAG","PAI-4480","Active","IDN-TB/HIV-19","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Program management","Other program management intervention(s)",null,null,null,"High","301800","Support to strengthen the management of the program in additional districts.","0","0","0","0","301800","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9i/view",null,"Multi-component",301800," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713=AN944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713=AO944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713=AP944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713=AJ944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713=AN944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713=AO944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713=AP944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G944)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ9nUAG","PAI-4485","Active","IDN-TB/HIV-23","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Expansion of Comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts).","Expansion of Comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts).","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","High","1563502","To support additional districts with targeted prevention programs, Expansion of comprehensive program to reach additional 37,575 MSM tested and 6,651 treated. Community based screening (15 districts) and community clinics (5 districts)","0","0","0","0","1563502","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9n/view",null,"Multi-component",1563502," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713=AN949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713=AO949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713=AP949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713=AJ949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713=AN949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713=AO949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713=AP949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G949)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ9sUAG","PAI-4490","Active","IDN-TB/HIV-28","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for TGs","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","NA Original Intervention: Behavioural interventions for transgender people","High","238921","Expansion of Comprehensive program to reach additional 19,040 female sex workers for testing and 1,276 for treatment","0","0","0","0","238921","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9s/view",null,"Multi-component",238921," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713=AN954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713=AO954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713=AP954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713=AJ954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713=AN954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713=AO954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713=AP954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G954)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ9tUAG","PAI-4491","Active","IDN-TB/HIV-29","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Comprehensive prevention programs for sex workers and their clients","Community empowerment for TGs","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","Expansion of Comprehensive program to reach additional 19,040 FSW for testing and 1,276 for treatment.","NA Original Intervention: Community empowerment for transgender people","High","985773","Expansion of Comprehensive program to reach additional 19,040 female sex workers for testing and 1,276 for treatment","0","0","0","0","985773","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9t/view",null,"Multi-component",985773," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713=AN955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713=AO955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713=AP955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713=AJ955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713=AN955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713=AO955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713=AP955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G955)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJ9yUAG","PAI-4496","Active","IDN-TB/HIV-33","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Comprehensive prevention programs for TGs","Community empowerment for TGs","Expansion of Comprehensive program to reach additional 5,250 TG for testing and 756 for treatment.","Expansion of Comprehensive program to reach additional 5,250 TG for testing and 756 for treatment.","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Community empowerment for transgender people","Medium","44302","To allow provision of targeted prevention programs in additional priority districts: Expansion of Comprehensive program to reach additional 5,250 transgender people for testing and 756 for treatment","0","0","0","0","44302","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJ9y/view",null,"Multi-component",44302," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713=AN960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713=AO960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713=AP960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713=AJ960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713=AN960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713=AO960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713=AP960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G960)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJA3UAO","PAI-4501","Active","IDN-TB/HIV-38","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Treatment, care and support","Counseling and psycho-social support","Additional 75,000 PLHIV receiving psychosocial support.","Additional 75,000 PLHIV receiving psychosocial support.",null,"Low","151884","Low priority because this is the same activity as within allocation but simply to provide services in additional districts with low burden and low HIV prevalence","0","0","0","0","151884","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJA3/view",null,"Multi-component",151884," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713=AN965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713=AO965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713=AP965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713=AJ965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713=AN965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713=AO965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713=AP965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G965)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJA8UAO","PAI-4506","Active","IDN-TB/HIV-42","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Program management","Grant management","Support for human resource for MSM and TG comprehensive program at (32 districts for MSM, and 50 districts for TG).","Support for human resource for MSM and TG comprehensive program at (32 districts for MSM, and 50 districts for TG).",null,"Low","372827","Support for staff. Low priority because this is the same activity as within allocation but simply in additional districts","0","0","0","0","372827","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJA8/view",null,"Multi-component",372827," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713=AN970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713=AO970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713=AP970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713=AJ970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713=AN970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713=AO970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713=AP970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJA9UAO","PAI-4507","Active","IDN-TB/HIV-43","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Additional 5 SSR at new districts.","Additional 5 SSR at new districts.",null,"Low","1669","Additional 5 system status report(SSR) at new districts","0","0","0","0","1669","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJA9/view",null,"Multi-component",1669," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713=AN971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713=AO971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713=AP971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713=AJ971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713=AN971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713=AO971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713=AP971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G971)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJAEUA4","PAI-4512","Active","IDN-TB/HIV-9","2017-2019","RT High Impact Asia","Indonesia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR100-IDN-Z",null,null,"RSSH: Health management information systems and M&E","Collaborative activities with other programs and sectors (TB/HIV)","Support implementation of priority operational research at district or provincial level and stimulate the local research by universities or research institutions. The research should focus on improving TB case finding and notification. Training for the utilization of One Health tool for better planning at national and provincial level. The use of TIME model will be needed to develop TB elimination roadmap.","Support implementation of priority operational research at district or provincial level and stimulate the local research by universities or research institutions. The research should focus on improving TB case finding and notification. Training for the utilization of One Health tool for better planning at national and provincial level. The use of TIME model will be needed to develop TB elimination roadmap.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","712567","Contribute to improved service delivery by operational research (50 percent of requested amount)","0","0","0","0","712567","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAE/view",null,"Multi-component",712567," High Impact Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713=AN976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713=AO976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713=AP976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713=AJ976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713=AN976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713=AO976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713=AP976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G976)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJAJUA4","PAI-4517","Active","IND-HIV/AIDS-13","2017-2019","RT High Impact Asia","India","HIV/AIDS","HIV/AIDS","FR185-IND-H",null,null,"PMTCT","Other intervention(s) for PMTCT","Proposed for the provision of technical support to SACSs to improve the EMTCT services towards achieving the objective of Elimination of Mother to Child Transmission of HIV. The project will support 4 SACS with PPTCT consultants during the project life.","Proposed for the provision of technical support to SACSs to improve the EMTCT services towards achieving the objective of Elimination of Mother to Child Transmission of HIV. The project will support 4 SACS with PPTCT consultants during the project life.","NA Original Module: PPTCT (Plan International India Chapter). Original Intervention: Technical Support to State AIDS Control Society (SACS)","Low","285207","Technical assistance and capacity building for PPTCT should be covered from other resources","0","0","0","0","285207","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAJ/view","2021-03-31","HIV/AIDS",285207," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713=AN981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713=AO981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713=AP981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713=AJ981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713=AN981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713=AO981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713=AP981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G981)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-03-31"]
["a6Q1R000000AJAOUA4","PAI-4522","Active","IND-HIV/AIDS-18","2017-2019","RT High Impact Asia","India","HIV/AIDS","HIV/AIDS","FR185-IND-H",null,null,"PMTCT","Other intervention(s) for PMTCT","The Project Management Unit (PMU) will conduct a programme quality assurance activity to improve the ongoing project through an external agency. This will facilitate improving the quality of project activities based on field requirements.","The Project Management Unit (PMU) will conduct a programme quality assurance activity to improve the ongoing project through an external agency. This will facilitate improving the quality of project activities based on field requirements.","NA Original Module: PPTCT (Plan International India Chapter). Original Intervention: Programme quality assessment","Low","31818","Technical assistance and capacity building for PPTCT should be covered from other resources","0","0","0","0","31818","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAO/view","2021-03-31","HIV/AIDS",31818," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713=AN986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713=AO986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713=AP986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713=AJ986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713=AN986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713=AO986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713=AP986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-03-31"]
["a6Q1R000000AJAQUA4","PAI-4524","Inactive","IND-HIV/AIDS-2","2017-2019","RT High Impact Asia","India","HIV/AIDS","HIV/AIDS","FR185-IND-H",null,null,"RSSH: Procurement and supply chain management systems","Procurement strategy","As an extension to the comprehensive logistic strategy to supply mentioned under allocation, it is proposed to include HIV testing kits supply up to the peripheral centers.","As an extension to the comprehensive logistic strategy to supply mentioned under allocation, it is proposed to include HIV testing kits supply up to the peripheral centers.","NA Original Module: RSSH - Procurement and supply chain management systems","High","3e+06","Critical to strengthen both HIV testing and PSM system as part of targeting of peripheral centers. The TRP recommends that this should be moved to allocation","3e+06","0","0","0","0","1","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAQ/view","2021-03-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713=AN988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713=AO988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713=AP988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713=AJ988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713=AN988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713=AO988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713=AP988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G988)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-03-31"]
["a6Q1R000000AJAVUA4","PAI-4529","Active","IND-HIV/AIDS-24","2017-2019","RT High Impact Asia","India","HIV/AIDS","HIV/AIDS","FR185-IND-H",null,null,"PMTCT","Other intervention(s) for PMTCT","At end of the project, the project team will develop an end term documentation and disseminate it as part of the Elimination of Paediatric HIV in India.","At end of the project, the project team will develop an end term documentation and disseminate it as part of the Elimination of Paediatric HIV in India.","NA Original Module: PPTCT (Plan International India Chapter). Original Intervention: End term documentation","Low","27097","Should be covered from other resources","0","0","0","0","27097","0","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAV/view","2021-03-31","HIV/AIDS",27097," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713=AN993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713=AO993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713=AP993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713=AJ993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713=AN993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713=AO993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713=AP993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G993)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-03-31"]
["a6Q1R000000AJAaUAO","PAI-4534","Inactive","IND-HIV/AIDS-3","2017-2019","RT High Impact Asia","India","HIV/AIDS","HIV/AIDS","FR185-IND-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Additional confirmation sites - 3000 Integrated sustainable Model ICTC at CHCs. With this all CHCs will be covered.","Additional confirmation sites - 3000 Integrated sustainable Model ICTC at CHCs. With this all CHCs will be covered.",null,"High","6810000","In line with the strategy to increase access to testing and treatment enrolment. The TRP recommends that this should be moved to allocation.","6810000","0","0","0","0","1","0","2019-10-30 15:33:30","2019-10-30 15:33:29","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAa/view","2021-03-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713=AN998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713=AO998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713=AP998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713=AJ998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713=AN998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713=AO998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713=AP998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G998)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-03-31"]
["a6Q1R000000AJAfUAO","PAI-4539","Active","IND-HIV/AIDS-8","2017-2019","RT High Impact Asia","India","HIV/AIDS","HIV/AIDS","FR185-IND-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Following the pilot of self -testing, it is important to scale up self-testing for HIV. This is being considered in 60 districts under this budget.","Following the pilot of self -testing, it is important to scale up self-testing for HIV. This is being considered in 60 districts under this budget.",null,"Medium","4500000","If self -testing poilot pilot successful this should be scaled up from domestic resources","0","0","0","0","4500000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAf/view","2021-03-31","HIV/AIDS",4500000," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713=AN1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713=AO1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713=AP1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713=AN1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713=AO1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713=AP1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1003)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-03-31"]
["a6Q1R000000AJAgUAO","PAI-4540","Active","IND-HIV/AIDS-9","2017-2019","RT High Impact Asia","India","HIV/AIDS","HIV/AIDS","FR185-IND-H",null,null,"Treatment, care and support","HIV care","Procurement of a portion of the country's requirement for the triple combination TLE.","Procurement of a portion of the country's requirement for the triple combination TLE.",null,"Medium","3e+07","The additional identified cases to be put on treatment will likely emerge at the end of this funding period, given the current pace of implementation and absorption and gradual take over.","0","0","0","0","3e+07","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAg/view","2021-03-31","HIV/AIDS",30000000," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713=AN1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713=AO1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713=AP1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713=AN1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713=AO1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713=AP1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1004)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-03-31"]
["a6Q1R000000AJAlUAO","PAI-4545","Inactive","IND-Tuberculosis-2","2017-2019","RT High Impact Asia","India","Tuberculosis","Tuberculosis","FR187-IND-T",null,null,"Other module","Other module","NSP funding gap is US$ 1,408million. It is proposed to use USD40m under PAAR to buydown a World Bank loan of USD 400million, which will cover the programmatic gaps, linked to the prioritized activity indicators, especially boosting activities aimed to finding 1million missing cases, incentives to patient/providers, and reducing the diagnostic/treatment gap for DRTB. Details to be worked out at the time of World Bank Funding Project formulation. Outcome: 60% reduction in annual missing cases by end of Y3, and 60% improvement in treatment outcome of DR TB patients.","NSP funding gap is US$ 1,408million. It is proposed to use USD40m under PAAR to buydown a World Bank loan of USD 400million, which will cover the programmatic gaps, linked to the prioritized activity indicators, especially boosting activities aimed to finding 1million missing cases, incentives to patient/providers, and reducing the diagnostic/treatment gap for DRTB. Details to be worked out at the time of World Bank Funding Project formulation. Outcome: 60% reduction in annual missing cases by end of Y3, and 60% improvement in treatment outcome of DR TB patients.","04/07/2018: India CT updated the Loan buy down module for TB care and prevention and MDR-TB to include an additional US$ 2mil for admin costs, which will be provided to India in addition to $40m. This is a part of the prioritization exercise for Portfolio Optimisation.  11/04/2019: confirmation from TRP to increase the amount in the register to $41,600,000. Original Module: Loan BuyDown. Original Intervention: TB care and prevention;MDR-TB","High","41600000","It will leverage additional funds and provides funding sustainability","0","41600000","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAl/view","2021-03-31","Tuberculosis",0," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713=AN1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713=AO1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713=AP1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713=AN1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713=AO1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713=AP1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1009)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-03-31"]
["a6Q1R000000AJAqUAO","PAI-4550","Active","IND-Tuberculosis-7","2017-2019","RT High Impact Asia","India","Tuberculosis","Tuberculosis","FR187-IND-T",null,null,"MDR-TB","Treatment: MDR-TB","A DRTB counselling Project has been implemented under NFM in 4 states by SR (TISS) to improve treatment outcomes in DRTB patients and reduce the 6 months attrition rate. The results have been encouraging. Continuation of the project is proposed within allocation request while PAAR will cover scale up of the intervention with additional 475 Counsellors across country. Outcome: improve treatment success rates by 50%.","A DRTB counselling Project has been implemented under NFM in 4 states by SR (TISS) to improve treatment outcomes in DRTB patients and reduce the 6 months attrition rate. The results have been encouraging. Continuation of the project is proposed within allocation request while PAAR will cover scale up of the intervention with additional 475 Counsellors across country. Outcome: improve treatment success rates by 50%.","NA Original Module: Multidrug-resistant TB","Medium","8500000","MDR-TB treatment adherence support through counsellors' project","0","0","0","0","8500000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAq/view","2021-03-31","Tuberculosis",8500000," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713=AN1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713=AO1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713=AP1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713=AN1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713=AO1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713=AP1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1014)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-03-31"]
["a6Q1R000000AJAvUAO","PAI-4555","Active","JAM-HIV/AIDS-11","2017-2019","RT Latin America and Caribbean","Jamaica","HIV/AIDS","HIV/AIDS","FR66-JAM-H",null,null,"RSSH: National health strategies","Other policy and governance intervention(s)","Review and update National Health Information System and E-Health Strategic Plan 2014-2018.","Review and update National Health Information System and E-Health Strategic Plan 2014-2018.","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","Medium","35000",null,"0","0","0","0","35000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAv/view","2021-12-31","HIV/AIDS",35000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713=AN1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713=AO1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713=AP1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713=AN1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713=AO1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713=AP1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJAwUAO","PAI-4556","Active","JAM-HIV/AIDS-12","2017-2019","RT Latin America and Caribbean","Jamaica","HIV/AIDS","HIV/AIDS","FR66-JAM-H",null,null,"RSSH: Health management information systems and M&E","Surveys","Conduct adherence and time use study to inform program planning and improve retention in care among PLHIV .","Conduct adherence and time use study to inform program planning and improve retention in care among PLHIV .","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","75000",null,"0","0","0","0","75000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJAw/view","2021-12-31","HIV/AIDS",75000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713=AN1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713=AO1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713=AP1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713=AN1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713=AO1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713=AP1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1020)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJB1UAO","PAI-4561","Inactive","JAM-HIV/AIDS-2","2017-2019","RT Latin America and Caribbean","Jamaica","HIV/AIDS","HIV/AIDS","FR66-JAM-H",null,null,"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Scale up training of Health Care Workers (HCW) in Adolescent Girls and Young Women (AGYW) friendly services to address the specific needs of the different age groups within the population especially KP and PLHIV. Special attention will be given to the 15-19 age group where viral suppression is lowest.","Scale up training of Health Care Workers (HCW) in Adolescent Girls and Young Women (AGYW) friendly services to address the specific needs of the different age groups within the population especially KP and PLHIV. Special attention will be given to the 15-19 age group where viral suppression is lowest.","NA Original Intervention: Other interventions for adolescent and youth","High","150000",null,"150000","0","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJB1/view","2021-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713=AN1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713=AO1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713=AP1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713=AN1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713=AO1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713=AP1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1025)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJB6UAO","PAI-4566","Active","JAM-HIV/AIDS-7","2017-2019","RT Latin America and Caribbean","Jamaica","HIV/AIDS","HIV/AIDS","FR66-JAM-H",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Cross training of service providers in psychosocial support and motivational interviewing to improve adherence and retention outcomes.","Cross training of service providers in psychosocial support and motivational interviewing to improve adherence and retention outcomes.","NA Original Module: RSSH - Human resources for health, including community health workers","Medium","250000",null,"0","0","0","0","250000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJB6/view","2021-12-31","HIV/AIDS",250000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713=AN1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713=AO1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713=AP1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713=AN1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713=AO1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713=AP1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1030)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJB8UAO","PAI-4568","Active","JAM-HIV/AIDS-9","2017-2019","RT Latin America and Caribbean","Jamaica","HIV/AIDS","HIV/AIDS","FR66-JAM-H",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Evaluate Peer Navigation Programme to identify gaps in service delivery to improve adherence and retention.","Evaluate Peer Navigation Programme to identify gaps in service delivery to improve adherence and retention.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","150000",null,"0","0","0","0","150000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJB8/view","2021-12-31","HIV/AIDS",150000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713=AN1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713=AO1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713=AP1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713=AN1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713=AO1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713=AP1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1032)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJBDUA4","PAI-4573","Active","KEN-TB/HIV-10","2017-2019","RT High Impact Africa 2","Kenya","HIV/TB","HIV/AIDS, Tuberculosis","FR333-KEN-C",null,null,"Prevention programs for general population","Behavioral interventions as part of programs for general population","This above allocation funding (UQD) will increase coverage of men and women reached with comprehensive HIV prevention package (including education, HTS, condom use, GBV and treatment) through campaigns in informal private sector and mass media building on similar interventions under allocation funding.This funding is to enable the country address the low coverage in prevention among men and adolescents which will also contribute to scale up of PLHIV on ART.Interventions to be funded under this module (UQD) are: Behavioral interventions: US$ 1,441,473 (increase coverage of men and women reached with comprehensive HIV prevention package); Procurement of 40 million male Condoms, promotion and distribution: US$ 2,610,973; Male circumcision US$ 42,820 (funding will support the planning process for the roll out of Early Infant Male Circumcision (EIMC)); Gender based violence prevention and treatment program: US$ 101,962 (funding will support the development and dissemination of SGBV screening tool targeting 4 urban areas); Other interventions for general population: US$ 2,160,096 (scale up of PrEP for an additional total of 35,000 people and sustain the supply of blood safety reagents in year 3 of the program at the same funded under allocation funding for year 1 and 2).","This above allocation funding (UQD) will increase coverage of men and women reached with comprehensive HIV prevention package (including education, HTS, condom use, GBV and treatment) through campaigns in informal private sector and mass media building on similar interventions under allocation funding.This funding is to enable the country address the low coverage in prevention among men and adolescents which will also contribute to scale up of PLHIV on ART.Interventions to be funded under this module (UQD) are: Behavioral interventions: US$ 1,441,473 (increase coverage of men and women reached with comprehensive HIV prevention package); Procurement of 40 million male Condoms, promotion and distribution: US$ 2,610,973; Male circumcision US$ 42,820 (funding will support the planning process for the roll out of Early Infant Male Circumcision (EIMC)); Gender based violence prevention and treatment program: US$ 101,962 (funding will support the development and dissemination of SGBV screening tool targeting 4 urban areas); Other interventions for general population: US$ 2,160,096 (scale up of PrEP for an additional total of 35,000 people and sustain the supply of blood safety reagents in year 3 of the program at the same funded under allocation funding for year 1 and 2).","NA Original Intervention: Behavioral interventions as part of programs for the general population","Medium","6357324","To increase coverage of men and women reached with comprehensive HIV prevention package reaching an additional 40 million male condoms and scale up of PrEP for an additional total of 35,000 people","0","0","0","0","6357324","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBD/view",null,"TB/HIV",6357324," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713=AN1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713=AO1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713=AP1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713=AN1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713=AO1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713=AP1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1037)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBIUA4","PAI-4578","Active","KEN-TB/HIV-15","2017-2019","RT High Impact Africa 2","Kenya","HIV/TB","HIV/AIDS, Tuberculosis","FR333-KEN-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Overdose prevention and management","Funding within allocation and catalytic funding will support interventions to reach 12,000 PWID. This above allocation funding (UQD) will support interventions to reach the same target group with the following additional interventions: overdose prevention and management: US$ 200,147; prevention and management of co-infections and comorbidities: US$ 78,810; opioid substitution therapy and other drug dependence treatment for PWID: US$ 972,133.","Funding within allocation and catalytic funding will support interventions to reach 12,000 PWID. This above allocation funding (UQD) will support interventions to reach the same target group with the following additional interventions: overdose prevention and management: US$ 200,147; prevention and management of co-infections and comorbidities: US$ 78,810; opioid substitution therapy and other drug dependence treatment for PWID: US$ 972,133.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners","Medium","1251090","To reach the 12,000 PWID with additional interventions aimed at making the program comprehensive.","0","0","0","0","1251090","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBI/view",null,"TB/HIV",1251090," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713=AN1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713=AO1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713=AP1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713=AN1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713=AO1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713=AP1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1042)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBNUA4","PAI-4583","Active","KEN-TB/HIV-4","2017-2019","RT High Impact Africa 2","Kenya","HIV/TB","HIV/AIDS, Tuberculosis","FR333-KEN-C",null,null,"HIV Testing Services","Differentiated HIV testing services","This above allocation funding (UQD) aims to support quality assurance and systems strengthening to ensure effective HIV Testing Services ( HTS) program. Overall, above allocation funding will procure testing kits to support 7 million tests. The within allocation funding is supporting innovative HTS strategies such as self-testing, assisted partner services and capacity building for service providers as well as procurement of testing kits.","This above allocation funding (UQD) aims to support quality assurance and systems strengthening to ensure effective HIV Testing Services ( HTS) program. Overall, above allocation funding will procure testing kits to support 7 million tests. The within allocation funding is supporting innovative HTS strategies such as self-testing, assisted partner services and capacity building for service providers as well as procurement of testing kits.",null,"High","9611854","To support quality assurance and systems strengthening to ensure an effective HTS program and will procure testing kits to support 7 million tests.","0","0","0","0","9611854","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBN/view",null,"TB/HIV",9611854," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713=AN1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713=AO1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713=AP1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713=AN1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713=AO1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713=AP1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1047)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBSUA4","PAI-4588","Active","KEN-TB/HIV-9","2017-2019","RT High Impact Africa 2","Kenya","HIV/TB","HIV/AIDS, Tuberculosis","FR333-KEN-C",null,null,"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","This above allocation funding (UQD) aims to expand the Field Epidemiology and Laboratory Training Programme (FELTP) that has been instrumental in building high level capacity for epidemiology and laboratory science whose graduates largely support the HIV, TB and Malaria programmes. The scope has been limited by the available resources from the Centres for Disease Control yet there is a greater need. In order to expand access to this program to county HIV and TB coordinators, this above allocation funding is proposed to meet this gap.","This above allocation funding (UQD) aims to expand the Field Epidemiology and Laboratory Training Programme (FELTP) that has been instrumental in building high level capacity for epidemiology and laboratory science whose graduates largely support the HIV, TB and Malaria programmes. The scope has been limited by the available resources from the Centres for Disease Control yet there is a greater need. In order to expand access to this program to county HIV and TB coordinators, this above allocation funding is proposed to meet this gap.","NA Original Module: RSSH - Human resources for health, including community health workers","High","1032896","To expand the Field Epidemiology and Laboratory Training Programme (FELTP) to county HIV and TB coordinators.","392100","0","0","0","640796","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBS/view",null,"TB/HIV",640796," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713=AN1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713=AO1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713=AP1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713=AN1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713=AO1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713=AP1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1052)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBTUA4","PAI-4589","Active","KGZ-TB/HIV-1","2017-2019","RT Eastern Europe and Central Asia","Kyrgyzstan","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","This amount is to recruit additional outreach and social workers to cover gaps for human resources for health gaps to enable the applicant to reach acoverage target of 75 percent of people who inject drugs by 2020. This cadre of workers will providevarious services including HIV testing and counselling and adherence support.","This amount is to recruit additional outreach and social workers to cover gaps for human resources for health gaps to enable the applicant to reach acoverage target of 75 percent of people who inject drugs by 2020. This cadre of workers will providevarious services including HIV testing and counselling and adherence support.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","High","936168","The TRP notes that the applicantintends to recruit additional outreach and social workers to cover human resources for health gaps (HRH) to enable the applicant to reach a coverage target of 75 percent of people who inject drugs by 2020. This cadre of workers will provide various services including HIV testing and counselling and adherence support. While the TRPrecognises the importance of thiscadre of healthcare workers, theTRP strongly recommends thatcareful consideration be given to the sustainability of these healthcare workers in terms of payment of salaries and incentives.","0","0","0","0","936168","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBT/view",null,"Multi-component",936168," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713=AN1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713=AO1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713=AP1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713=AN1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713=AO1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713=AP1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1053)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBYUA4","PAI-4594","Active","KGZ-TB/HIV-14","2017-2019","RT Eastern Europe and Central Asia","Kyrgyzstan","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z",null,null,"Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","This funding is to support social institutions(7) to provide learning, adherence and psychosocial support for PWID, SWs, MSM, PLHIV, persons released from prisons.","This funding is to support social institutions(7) to provide learning, adherence and psychosocial support for PWID, SWs, MSM, PLHIV, persons released from prisons.",null,"Medium","393750","The TRP notes that the applicantintends to support social institutions (7) to provide learning, adherence and psychosocial support. However, there is no clarity on the scope of these interventions.","0","0","0","0","393750","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBY/view",null,"Multi-component",393750," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713=AN1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713=AO1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713=AP1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713=AN1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713=AO1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713=AP1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1058)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBdUAO","PAI-4599","Active","KGZ-TB/HIV-19","2017-2019","RT Eastern Europe and Central Asia","Kyrgyzstan","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Development of GX Alert system nationwide to expedite the availability of GeneXpert results for clinicians","Development of GX Alert system nationwide to expedite the availability of GeneXpert results for clinicians","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","35176",null,"0","0","0","0","35176","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBd/view",null,"Multi-component",35176," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713=AN1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713=AO1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713=AP1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713=AN1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713=AO1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713=AP1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1063)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBiUAO","PAI-4604","Active","KGZ-TB/HIV-23","2017-2019","RT Eastern Europe and Central Asia","Kyrgyzstan","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z",null,null,"MDR-TB","Community MDR-TB care delivery","This funding is for procurement and establishing Video-Dot system that promotes patients treatment adherence, reduce the rate of lost to follow up patients","This funding is for procurement and establishing Video-Dot system that promotes patients treatment adherence, reduce the rate of lost to follow up patients","NA Original Module: Multidrug-resistant TB","Low","170000","The TRP notes that the applicantintends to use these resources for treatment support activities. These activities have already been included in other interventions.","0","0","0","0","170000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBi/view",null,"Multi-component",170000," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713=AN1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713=AO1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713=AP1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713=AN1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713=AO1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713=AP1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBjUAO","PAI-4605","Active","KGZ-TB/HIV-24","2017-2019","RT Eastern Europe and Central Asia","Kyrgyzstan","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z",null,null,"TB care and prevention","Case detection and diagnosis","Funding to support the operation and maintenance (recurrent cost) of a new Osh lab expected to be installed in Osh in 2019, with support from USAID Challenge TB project","Funding to support the operation and maintenance (recurrent cost) of a new Osh lab expected to be installed in Osh in 2019, with support from USAID Challenge TB project",null,"Low","148305","The TRP notes that the applicantintends to support operation andmaintenance of a laboratory at Osh to be funded by USAID andconstitutes recurrent costs for thelaboratory. The TRP considered that these recurrent costs had a lower priority than items included in the PAAR for MDR-TB above, which were categorized as Medium priority. Additionally, the TRP recommends consideration ofintegration of laboratory operations, facilities and maintenance management wherever feasible to reduce duplicative infrastructure andoperations.","0","0","0","0","148305","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBj/view",null,"Multi-component",148305," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713=AN1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713=AO1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713=AP1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713=AN1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713=AO1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713=AP1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1069)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBoUAO","PAI-4610","Active","KGZ-TB/HIV-3","2017-2019","RT Eastern Europe and Central Asia","Kyrgyzstan","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR544-KGZ-Z",null,null,"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Similarly, to interventions for PWID and SW, the number of outreach workers for the MSM group in the framework of additional funding covers the deficit from 27% in 2018 to 58% of the demand in 2020.As a result, together with the main grant, 65% of MSM will be covered by quality prevention, treatment, care and support services, and 80% of them will be tested for HIV.","Similarly, to interventions for PWID and SW, the number of outreach workers for the MSM group in the framework of additional funding covers the deficit from 27% in 2018 to 58% of the demand in 2020.As a result, together with the main grant, 65% of MSM will be covered by quality prevention, treatment, care and support services, and 80% of them will be tested for HIV.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","High","463052","The TRP notes that the applicantintends to recruit additional outreach and social workers to cover HRH gaps to enable the applicant to reach a coverage target of 65 percent of men who have sex with men (HRH gap reduced by 31 percent) by 2020. This cadre of workers will provide various services including HIV testing and counselling and adherence support. While the TRP recognises the importance of this cadre of healthcare workers, the TRP strongly recommends that careful consideration be given to the sustainability of these healthcare workers in terms of payment of salaries and incentives. In addition, the TRP recommends that any incentive payment to personnel beperformance based and that there is careful monitoring to ensure quality and results.","0","0","0","0","463052","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBo/view",null,"Multi-component",463052," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713=AN1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713=AO1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713=AP1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713=AN1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713=AO1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713=AP1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1074)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJBvUAO","PAI-4617","Inactive","KHM-HIV/AIDS-1","2017-2019","RT High Impact Asia","Cambodia","HIV/AIDS","HIV/AIDS","FR100-KHM-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of the KP-friendly clinic, Chuuk Sor, previously funded through PEPFAR, one year of support (2018) is requested within allocation.","To facilitate the transition of the KP-friendly clinic, Chuuk Sor, previously funded through PEPFAR, one year of support (2018) is requested within allocation.","NA Original Intervention: Chuuk Sor key population-friendly clinic","High","120000","Specialised care for HIV positive key populations, formerly funded by PEPFAR. The applicant should consider moving this above allocation request into the allocation amount in order to complement the allocation funding in Year 1 that is directed towards this intervention.","120000","0","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBv/view","2020-12-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713=AN1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713=AO1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713=AP1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713=AN1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713=AO1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713=AP1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1081)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJBzUAO","PAI-4621","Active","KHM-HIV/AIDS-13","2017-2019","RT High Impact Asia","Cambodia","HIV/AIDS","HIV/AIDS","FR100-KHM-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Replace or update 67 ART sites & 68 VCCT and NCHADS with laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information. TRP recomends only 15% of the request.","Replace or update 67 ART sites & 68 VCCT and NCHADS with laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information. TRP recomends only 15% of the request.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Computer replacement /office equipment NCHADS/PHD /OD","Low","60000","This intervention has excessive unit costs that are not justified in the funding request and is therefore not a priority.","0","0","0","0","60000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJBz/view","2020-12-31","HIV/AIDS",60000," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713=AN1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713=AO1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713=AP1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713=AN1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713=AO1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713=AP1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1085)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJC0UAO","PAI-4622","Active","KHM-HIV/AIDS-14","2017-2019","RT High Impact Asia","Cambodia","HIV/AIDS","HIV/AIDS","FR100-KHM-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Replace or update NGO/CSO laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information.TRP recommends only 15% of the request.","Replace or update NGO/CSO laptops/PC and printers (average 2x per site) to facilitate electronic data collection for improved strategic information.TRP recommends only 15% of the request.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Computer replacement /office equipment nongovernmental organization and civil society organization","Low","60000","This intervention has excessive unit costs that are not justified in the funding request and is therefore not a priority.","0","0","0","0","60000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJC0/view","2020-12-31","HIV/AIDS",60000," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713=AN1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713=AO1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713=AP1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713=AN1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713=AO1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713=AP1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1086)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJC5UAO","PAI-4627","Active","KHM-HIV/AIDS-19","2017-2019","RT High Impact Asia","Cambodia","HIV/AIDS","HIV/AIDS","FR100-KHM-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","To facilitate the transition of Sihanouk Hospital Centre of Hope,  funding is requested to provide additional year for staffing and lab costs after 2018.","To facilitate the transition of Sihanouk Hospital Centre of Hope,  funding is requested to provide additional year for staffing and lab costs after 2018.","NA Original Intervention: Sihanouk Hospital Centre of Hope","Low","4e+05","To support transition of HIV treatment and care after 2018. To clarify how many patients there are and what the transition will be.","0","0","0","0","4e+05","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJC5/view","2020-12-31",{"$f":"IF(OR(I1091=\"HIV/AIDS\",I1091=\"Tuberculosis\",I1091=\"Malaria\",I1091=\"RSSH\"),I1091, IF(I1091=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"HIV/AIDS"},{"$f":"VALUE(Y1091)","v":400000},{"$f":"RIGHT(F1091,LEN(F1091)-2)","v":" High Impact Asia"},"HIV/AIDS","HIV/AIDS",null,null,null,{"$f":"TRIM(AK1091)","v":""},{"$f":"TRIM(AL1091)","v":""},{"$f":"TRIM(AM1091)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713=AN1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713=AO1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713=AP1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE1091<>\"\",AE1091,IF(MAX(AQ1091,AR1091,AS1091,AT1091)<>0,MAX(AQ1091,AR1091,AS1091,AT1091),AU1091))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713=AN1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713=AO1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713=AP1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1091)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE1091<>\"\",AE1091,IF(MAX(AW1091,AX1091,AY1091,AZ1091)<>0,MAX(AW1091,AX1091,AY1091,AZ1091),BA1091))","v":"2020-12-31"}]
["a6Q1R000000AJCAUA4","PAI-4632","Inactive","KHM-HIV/AIDS-23","2017-2019","RT High Impact Asia","Cambodia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR582-KHM-C",null,null,"Comprehensive prevention programs for TGs","Behavioral interventions for TGs","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Transgender (TG).  Prolonging the working hours of outreach workers until midnight will allow for greater reach and will offer HIV and syphilis testing to TGs. Expected outcome:  177 TGs reached with defined package of services","Expansion of night time outreach in Phnom Penh to optimize case detection and offer services to Transgender (TG).  Prolonging the working hours of outreach workers until midnight will allow for greater reach and will offer HIV and syphilis testing to TGs. Expected outcome:  177 TGs reached with defined package of services","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","High","45000",null,"0","45000","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCA/view","2020-12-31","TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713=AN1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713=AO1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713=AP1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713=AN1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713=AO1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713=AP1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1096)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCFUA4","PAI-4637","Active","KHM-HIV/AIDS-28","2017-2019","RT High Impact Asia","Cambodia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR582-KHM-C",null,null,"Comprehensive prevention programs for TGs","Behavioral interventions for TGs","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)Reproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) Expected outcome: at least 2,160 hidden KPs reached","Social media platforms entry points to reaching hidden key populations (MSM. male EWs, TGs)Reproductive Health Association of Cambodia (RHAC) will recruit three Online Counsellors in Battambang, Siem Reap & Banteay Meanchey to advice & promote access to HIV services through the RHAC hotline. Online information on HIV services, care & support will be developed for different social media platforms used by key populations (KP) in Cambodia (e.g, dating apps/media, Jeck-D, Blued, Grindr, BoyHoy, Tumblr, Guy Chat; Facebook chat, Instagram, MStyle website) Expected outcome: at least 2,160 hidden KPs reached","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Behavioral interventions for transgender people","High","15500",null,"0","15000","0","0","500","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCF/view","2020-12-31","TB/HIV",500," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713=AN1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713=AO1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713=AP1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713=AN1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713=AO1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713=AP1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1101)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCGUA4","PAI-4638","Inactive","KHM-HIV/AIDS-29","2017-2019","RT High Impact Asia","Cambodia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR582-KHM-C",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","KPs self-testing & access to Pre-exposure Prophylaxis (PreP) Building on HIV self-testing in PrEP pilot initiated in Phnom Penh in 2018, this intervention will expand access to self-testing and PrEP in Phnom Phnom Penh,  Battambang, Siem ReapExpected outcomes:- At least 1,500 MSM enrolled in PrEP- Approx. 7% HIV+ at initial screen or 105 HIV+ enrolled in care - Reduced transmission of HIV among MSM- Increased referrals to VCCT- Increased repeated testing","KPs self-testing & access to Pre-exposure Prophylaxis (PreP) Building on HIV self-testing in PrEP pilot initiated in Phnom Penh in 2018, this intervention will expand access to self-testing and PrEP in Phnom Phnom Penh,  Battambang, Siem ReapExpected outcomes:- At least 1,500 MSM enrolled in PrEP- Approx. 7% HIV+ at initial screen or 105 HIV+ enrolled in care - Reduced transmission of HIV among MSM- Increased referrals to VCCT- Increased repeated testing","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre -exposure prophylaxis (PrEP) for men who have sex with men","High","350000",null,"0","350000","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCG/view","2020-12-31","TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713=AN1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713=AO1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713=AP1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713=AN1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713=AO1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713=AP1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1102)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCLUA4","PAI-4643","Inactive","KHM-HIV/AIDS-33","2017-2019","RT High Impact Asia","Cambodia","HIV/AIDS","HIV/AIDS, Tuberculosis","FR582-KHM-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Strengthening and linking HIV health information systems in CambodiaTo collate data from contributing databases in a national repository, the existing Master Patient Index (MPI) will be operationalized and the Universal Unique ID Code (U-UIC) will be used as an identifier across databases (B-IACM, ART and VL). At the same time efforts will be made to develop interoperability between the all date bases so clients are followed longitudinally from diagnosis until viral suppression. It is complementary to CDC support through the new PEPFAR ROP19.Expected: An integrated HIV information system for patients tracking across the HIV cascade to support sustained HIV epidemic control in Cambodia","Strengthening and linking HIV health information systems in CambodiaTo collate data from contributing databases in a national repository, the existing Master Patient Index (MPI) will be operationalized and the Universal Unique ID Code (U-UIC) will be used as an identifier across databases (B-IACM, ART and VL). At the same time efforts will be made to develop interoperability between the all date bases so clients are followed longitudinally from diagnosis until viral suppression. It is complementary to CDC support through the new PEPFAR ROP19.Expected: An integrated HIV information system for patients tracking across the HIV cascade to support sustained HIV epidemic control in Cambodia","NA Original Module: RSSH: Health management information system and monitoring and evaluation","High","5e+05",null,"0","5e+05","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCL/view","2020-12-31","TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713=AN1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713=AO1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713=AP1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713=AN1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713=AO1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713=AP1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1107)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCQUA4","PAI-4648","Inactive","KHM-HIV/AIDS-5","2017-2019","RT High Impact Asia","Cambodia","HIV/AIDS","HIV/AIDS","FR100-KHM-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","To expand requested activities to provide legal services and case documentation of rights violations in KP. TRP recommends 50% of request of $ 300,000 and recommends more details on the content of interventions to be provided before this module can be funded.","To expand requested activities to provide legal services and case documentation of rights violations in KP. TRP recommends 50% of request of $ 300,000 and recommends more details on the content of interventions to be provided before this module can be funded.","NA Original Module: Removing human rights barriers. Original Intervention: Gender-based violence / Legal services and case documentation","High","150000","To support extension of an activity that is already in the allocation amount. The TRP recommends that before this module can be funded, the applicant should provide to the Secretariat more details on the content of the interventions for which additional funding is requested.","150000","0","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCQ/view","2020-12-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713=AN1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713=AO1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713=AP1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713=AN1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713=AO1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713=AP1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1112)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCVUA4","PAI-4653","Inactive","KHM-Tuberculosis-1","2017-2019","RT High Impact Asia","Cambodia","Tuberculosis","Tuberculosis","FR100-KHM-T",null,null,"RSSH: Health management information systems and M&E","Routine reporting","To further invest connectivity for GeneXpert platforms outside the 46 ODs.","To further invest connectivity for GeneXpert platforms outside the 46 ODs.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","747944","The TRP considers that Gx-Alert as connectivity for GeneXpert platforms will contribute to improved care.","747944","0","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCV/view","2020-12-31","Tuberculosis",0," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713=AN1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713=AO1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713=AP1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713=AN1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713=AO1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713=AP1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCWUA4","PAI-4654","Active","KHM-Tuberculosis-10","2017-2019","RT High Impact Asia","Cambodia","Tuberculosis","HIV/AIDS, Tuberculosis","FR582-KHM-C",null,null,"TB care and prevention","Case detection and diagnosis","This is aimed to expand the implementation of TB active case finding (ACF) activities including implementation of C-DOTS, ACF in prisons and hospital linkages to cover 30 operational districts (30 ODs). Currently, TB active case finding activities are limited to 46 ODs. Expansion to the 30 ODs will contribute to detection of 5,240 by the end of 2020.","This is aimed to expand the implementation of TB active case finding (ACF) activities including implementation of C-DOTS, ACF in prisons and hospital linkages to cover 30 operational districts (30 ODs). Currently, TB active case finding activities are limited to 46 ODs. Expansion to the 30 ODs will contribute to detection of 5,240 by the end of 2020.",null,"High","2081316","-","0","1966353","0","0","114963","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCW/view","2020-12-31","TB/HIV",114963," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713=AN1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713=AO1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713=AP1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713=AN1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713=AO1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713=AP1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1118)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCeUAO","PAI-4662","Active","KHM-Tuberculosis-3","2017-2019","RT High Impact Asia","Cambodia","Tuberculosis","Tuberculosis","FR100-KHM-T",null,null,"TB care and prevention","Prevention","This will facilitate scale up of CI and IPT for children the high burden 18 ODs.","This will facilitate scale up of CI and IPT for children the high burden 18 ODs.",null,"High","125460","The TRP considers contact tracing and preventive therapy for children important.","0","0","0","0","125460","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCe/view","2020-12-31","Tuberculosis",125460," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713=AN1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713=AO1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713=AP1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713=AN1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713=AO1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713=AP1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1126)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJChUAO","PAI-4665","Active","KHM-Tuberculosis-6","2017-2019","RT High Impact Asia","Cambodia","Tuberculosis","Tuberculosis","FR100-KHM-T",null,null,"Program management","Grant management","Support NGO SSI to implement C-DOTS activities to cover additional 18 ODs to enhance case notification. TRP recommends 30% of the reqeust of $ 544,630.","Support NGO SSI to implement C-DOTS activities to cover additional 18 ODs to enhance case notification. TRP recommends 30% of the reqeust of $ 544,630.",null,"Medium","163389","The TRP considers nongovernmental organization (NGO)- sustainable schools international (SSI) support to implement C-DOTS for 18 operational districts as quality demand.","0","0","0","0","163389","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCh/view","2020-12-31","Tuberculosis",163389," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713=AN1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713=AO1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713=AP1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713=AN1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713=AO1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713=AP1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1129)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCmUAO","PAI-4670","Active","LAO-HIV/AIDS-2","2017-2019","RT South East Asia","Lao (Peoples Democratic Republic)","HIV/AIDS","HIV/AIDS","FR100-LAO-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Allocation funding will reach female sex workers with prevention packages in 5 priority provinces only, leaving a 27% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address a 39% gap in condom supply.","Allocation funding will reach female sex workers with prevention packages in 5 priority provinces only, leaving a 27% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address a 39% gap in condom supply.","NA Original Intervention: Expansion to other provinces, condom programming","High","549986","Essential services for key populations in this concentrated epidemic","0","0","0","0","549986","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCm/view","2020-12-31","HIV/AIDS",549986," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713=AN1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713=AO1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713=AP1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713=AN1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713=AO1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713=AP1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1134)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCnUAO","PAI-4671","Active","LAO-HIV/AIDS-3","2017-2019","RT South East Asia","Lao (Peoples Democratic Republic)","HIV/AIDS","HIV/AIDS","FR100-LAO-H",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Allocation funding will reach men who have sex with men  with prevention packages in 2 priority provinces only.  Partners provide services in 3 other provinces but this is to end December 2017, leaving a 94% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address 24% gap in condom supply","Allocation funding will reach men who have sex with men  with prevention packages in 2 priority provinces only.  Partners provide services in 3 other provinces but this is to end December 2017, leaving a 94% program gap.  Additional funding will provide for expansion to other provinces, and needed condom programming to address 24% gap in condom supply","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Expansion to other provinces, condom programming","High","251963","Essential services for key populations in this concentrated epidemic","0","0","0","0","251963","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCn/view","2020-12-31","HIV/AIDS",251963," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713=AN1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713=AO1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713=AP1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713=AN1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713=AO1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713=AP1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1135)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCsUAO","PAI-4676","Active","LAO-Tuberculosis-3","2017-2019","RT South East Asia","Lao (Peoples Democratic Republic)","Tuberculosis","Tuberculosis","FR100-LAO-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Increasing the coverage in 50 additional private clinics and 90 pharmacies in high TB burden districts. Expected to increase the number of additional TB cases referred and diagnosed by private sector.","Increasing the coverage in 50 additional private clinics and 90 pharmacies in high TB burden districts. Expected to increase the number of additional TB cases referred and diagnosed by private sector.","NA Original Intervention: Community TB care delivery: Expand Public Private Mix (PPM) TB interventions","High","260896","High impact intervention","8255","40464","0","0","212177","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCs/view","2020-12-31","Tuberculosis",212177," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713=AN1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713=AO1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713=AP1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713=AN1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713=AO1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713=AP1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1140)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJCxUAO","PAI-4681","Active","LBR-Malaria-11","2017-2019","RT Western Africa","Liberia","Malaria","Malaria","FR532-LBR-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This request is targeted at piloting the use of mobile data collection using tablets. Tablets will be customized with applications for data reporting (treatment, diagnosis and communications for the 3 diseases and the name, and location of the person receiving the interventions, among others). The tablets will also contain an application for long distance training/ refresher of CHAs.","This request is targeted at piloting the use of mobile data collection using tablets. Tablets will be customized with applications for data reporting (treatment, diagnosis and communications for the 3 diseases and the name, and location of the person receiving the interventions, among others). The tablets will also contain an application for long distance training/ refresher of CHAs.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","652410",null,"0","0","0","0","652410","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJCx/view","2021-06-30","Malaria",652410," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713=AN1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713=AO1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713=AP1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713=AN1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713=AO1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713=AP1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1145)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJD2UAO","PAI-4686","Active","LBR-Malaria-16","2017-2019","RT Western Africa","Liberia","Malaria","Malaria","FR532-LBR-M",null,null,"Case management","Integrated community case management (ICCM)","funding need for equipment and materials to CHAs and CHSS for the scale-up counties and also includes replacement of motorbike tyres for 92 CHS in within allocation in the initial 4 GF supported counties.","funding need for equipment and materials to CHAs and CHSS for the scale-up counties and also includes replacement of motorbike tyres for 92 CHS in within allocation in the initial 4 GF supported counties.","NA Original Intervention: Integrated community case management (iCCM)","High","901210",null,"0","0","75649","0","825561","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD2/view","2021-06-30","Malaria",825561," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713=AN1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713=AO1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713=AP1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713=AN1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713=AO1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713=AP1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJD3UAO","PAI-4687","Active","LBR-Malaria-17","2017-2019","RT Western Africa","Liberia","Malaria","Malaria","FR532-LBR-M",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The MOH is working towards a transition to the new warehouse. Funding request is for building additional office space for the essential CMS staff.  The total estimated cost for the office building is set at $882,500. Out of this amount, the MOH has internally mobilized $200,000.00 and have also secured a $50,000.00 commitment from GAVI against the cost of the building. This leaves a balance of $632,500.00 to be sourced through external partners, including the Global Fund.","The MOH is working towards a transition to the new warehouse. Funding request is for building additional office space for the essential CMS staff.  The total estimated cost for the office building is set at $882,500. Out of this amount, the MOH has internally mobilized $200,000.00 and have also secured a $50,000.00 commitment from GAVI against the cost of the building. This leaves a balance of $632,500.00 to be sourced through external partners, including the Global Fund.","NA Original Module: RSSH - Procurement and supply chain management systems","Medium","635000","While the Global Fund has already invested in infrastructure and within a context of major persisting gaps, the TRP considers gaps in service delivery are more pressing.","0","0","0","0","635000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD3/view","2021-06-30","Malaria",635000," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713=AN1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713=AO1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713=AP1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713=AN1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713=AO1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713=AP1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1151)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJD8UAO","PAI-4692","Active","LBR-Malaria-21","2017-2019","RT Western Africa","Liberia","Malaria","Malaria","FR532-LBR-M",null,null,"Program management","Grant management","This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria during the 2021 Mass Distribution Campaign. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.","This activity is part of IEC/SBCC component which is aimed at increasing awareness on malaria among program community members with focus on causes, prevention and management of malaria during the 2021 Mass Distribution Campaign. This request will therefore cover production and airing of radio spot messages and folk songs in local languages at community level but also at national level.",null,"High","91440",null,"0","0","0","0","91440","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJD8/view","2021-06-30","Malaria",91440," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713=AN1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713=AO1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713=AP1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713=AN1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713=AO1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713=AP1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1156)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJDDUA4","PAI-4697","Active","LBR-Malaria-26","2017-2019","RT Western Africa","Liberia","Malaria","Malaria","FR532-LBR-M",null,null,"Case management","Private sector case management","Quarterly Feedback Meeting PSACT implementation together to provide feedback about the program. The meeting will seek to understand the impression of the proprietors of the program and get feedback on the community reaction to the testing and treatment as well as the overall program. Also the forum will be used to provide feedback to proprietors on their performance and adherence to the program rules as well as recognize best practice pharmaceutical outlets to engender competition among the proprietors. The forum will also be used to identify pharmaceutical outlets that are noncompliant and depending on the degree of noncompliance inform them on the actions that will be taken on the non-compliant proprietor. This will further improve the quality of the PSACT program.","Quarterly Feedback Meeting PSACT implementation together to provide feedback about the program. The meeting will seek to understand the impression of the proprietors of the program and get feedback on the community reaction to the testing and treatment as well as the overall program. Also the forum will be used to provide feedback to proprietors on their performance and adherence to the program rules as well as recognize best practice pharmaceutical outlets to engender competition among the proprietors. The forum will also be used to identify pharmaceutical outlets that are noncompliant and depending on the degree of noncompliance inform them on the actions that will be taken on the non-compliant proprietor. This will further improve the quality of the PSACT program.",null,"High","40000",null,"0","0","0","0","40000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDD/view","2021-06-30","Malaria",40000," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713=AN1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713=AO1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713=AP1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713=AN1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713=AO1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713=AP1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1161)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJDIUA4","PAI-4702","Active","LBR-Malaria-5","2017-2019","RT Western Africa","Liberia","Malaria","Malaria","FR532-LBR-M",null,null,"RSSH: Integrated service delivery and quality improvement","Supportive policy and programmatic environment","This activity provides dedicated management support to the CHSD (Community health services division) via an international TA which would work together with CHSD on topics such as: NCHA program financing sustainability, resource mapping and coordination, NCHA program management.","This activity provides dedicated management support to the CHSD (Community health services division) via an international TA which would work together with CHSD on topics such as: NCHA program financing sustainability, resource mapping and coordination, NCHA program management.","NA Original Module: RSSH - Integrated service delivery and quality improvement","High","144000",null,"0","0","0","0","144000","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDI/view","2021-06-30","Malaria",144000," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713=AN1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713=AO1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713=AP1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713=AN1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713=AO1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713=AP1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJDMUA4","PAI-4706","Active","LBR-Malaria-9","2017-2019","RT Western Africa","Liberia","Malaria","Malaria","FR532-LBR-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Amount represents 253,037 LLINs as 15% buffer of 2021 LLINs quantification that is within allocation.  Experience from the 2018 campaign show that more than 10% buffer is required. Hence the 15% target for 2021. Cost is inclusive of PSM cost, freight and insurance, quality assurance and quality control as well as custom clearance.","Amount represents 253,037 LLINs as 15% buffer of 2021 LLINs quantification that is within allocation.  Experience from the 2018 campaign show that more than 10% buffer is required. Hence the 15% target for 2021. Cost is inclusive of PSM cost, freight and insurance, quality assurance and quality control as well as custom clearance.","NA Original Intervention: Long-lasting insecticidal nets  Continuous distribution","High","1057001",null,"0","0","0","0","1057001","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDM/view","2021-06-30","Malaria",1057001," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713=AN1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713=AO1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713=AP1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713=AN1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713=AO1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713=AP1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1170)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJDPUA4","PAI-4709","Active","LBR-TB/HIV-2","2017-2019","RT Western Africa","Liberia","HIV/TB","HIV/AIDS, Tuberculosis","FR191-LBR-C",null,null,"PMTCT","Other intervention(s) for PMTCT","Prevention of Mother-To-Child Transmission(PMTCT) has been prioritized in the NSP 2015 -2020 as a high impact intervention for clinical prevention of HIV infection aimed at achieving an HIV-free generation. Additional 75 PLHIV mothers will be trained in adherence support, prevention and tracing of lost to follow up, and psychosocial counselling to increase retention of mother-baby pairs in care. Although this is a priority intervention, it is placed in PAAR due to limited funding within allocation.","Prevention of Mother-To-Child Transmission(PMTCT) has been prioritized in the NSP 2015 -2020 as a high impact intervention for clinical prevention of HIV infection aimed at achieving an HIV-free generation. Additional 75 PLHIV mothers will be trained in adherence support, prevention and tracing of lost to follow up, and psychosocial counselling to increase retention of mother-baby pairs in care. Although this is a priority intervention, it is placed in PAAR due to limited funding within allocation.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Training mothers living with HIV as adherence counsellors","High","108014.41","While only training is noted as an activity, the TRP assumes that this activity will be used to support mothers living with HIV.","0","0","0","0","108014.41","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDP/view","2020-12-31","TB/HIV",108014.41," Western Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713=AN1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713=AO1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713=AP1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713=AN1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713=AO1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713=AP1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1173)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJDUUA4","PAI-4714","Active","LBR-TB/HIV-7","2017-2019","RT Western Africa","Liberia","HIV/TB","HIV/AIDS, Tuberculosis","FR191-LBR-C",null,null,"Prevention programs for general population","Other intervention(s) for general population","Currently condoms are provided by partners and this contribution may not continue beyond 2017. This cause is placed under PAAR to ensure no stock out of condoms in the country in the event that the current partner supply is discontinued beyond 2017.","Currently condoms are provided by partners and this contribution may not continue beyond 2017. This cause is placed under PAAR to ensure no stock out of condoms in the country in the event that the current partner supply is discontinued beyond 2017.","NA Original Intervention: Backup supply of condoms in case other funding is discontinued after 2017","Medium","1685586","If supply runs out, condoms will be needed.","0","0","0","0","1685586","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDU/view","2020-12-31","TB/HIV",1685586," Western Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713=AN1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713=AO1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713=AP1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713=AN1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713=AO1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713=AP1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1178)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJDZUA4","PAI-4719","Active","LKA-HIV/AIDS-3","2017-2019","RT South East Asia","Sri Lanka","HIV/AIDS","HIV/AIDS","FR419-LKA-H",null,null,"Comprehensive prevention programs for MSM","HIV testing services for MSM","To promote early detection of HIV, community-based HIV testing will be carried out through mobile   testing service. As KP intervention activity is going to be piloted by NSACP in 2018, and the same is proposed under the Funding Request HIV testing using a vehicle is planned for the first time. This vehicle will be equipped with clinical facilities to conduct testing of rapid HIV and syphilis and others testing facilities according to the need.- 2 such vehicles are requested to cover Western Province. These 2 will be managed by the project office with the NSACP staff and KPs.","To promote early detection of HIV, community-based HIV testing will be carried out through mobile   testing service. As KP intervention activity is going to be piloted by NSACP in 2018, and the same is proposed under the Funding Request HIV testing using a vehicle is planned for the first time. This vehicle will be equipped with clinical facilities to conduct testing of rapid HIV and syphilis and others testing facilities according to the need.- 2 such vehicles are requested to cover Western Province. These 2 will be managed by the project office with the NSACP staff and KPs.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","Low","171392","For: HIV testing using a vehicle to be equipped with clinical facilities to conduct testing of rapid HIV and syphilis and others testing facilities according to the need.The TRP assessed this need to be less critical when compared to other activities in PAAR.","0","0","0","0","171392","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDZ/view","2021-12-31","HIV/AIDS",171392," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713=AN1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713=AO1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713=AP1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713=AN1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713=AO1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713=AP1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1183)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJDaUAO","PAI-4720","Inactive","LKA-HIV/AIDS-4","2017-2019","RT South East Asia","Sri Lanka","HIV/AIDS","HIV/AIDS","FR419-LKA-H",null,null,"Comprehensive prevention programs for MSM","HIV testing services for MSM","Consultant, 2 Nursing officers , 2 Office assistants & 2 drivers Salary for 3 yrs- KPs incentives are already included under the detail budget.","Consultant, 2 Nursing officers , 2 Office assistants & 2 drivers Salary for 3 yrs- KPs incentives are already included under the detail budget.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","High","19760","This relates to salaries of nurses, a consultant, office assistants & drivers.","19760","0","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDa/view","2021-12-31","HIV/AIDS",0," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713=AN1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713=AO1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713=AP1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713=AN1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713=AO1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713=AP1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1184)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJDfUAO","PAI-4725","Active","LKA-Malaria-2","2017-2019","RT South East Asia","Sri Lanka","Malaria","Malaria","FR420-LKA-M",null,null,"Case management","Other case management intervention(s)","Requested for conducting advocacy programmes for health directors in 2020. This activity is necessary to keep malaria on the radar to ensure funds at regional level from provicial health authorities to ensure that existing funds are not diverted to other disease control programmes and will facilitate integration of activities between disease control programmes.","Requested for conducting advocacy programmes for health directors in 2020. This activity is necessary to keep malaria on the radar to ensure funds at regional level from provicial health authorities to ensure that existing funds are not diverted to other disease control programmes and will facilitate integration of activities between disease control programmes.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","High","7873",null,"0","0","0","0","7873","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDf/view","2021-12-31","Malaria",7873," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713=AN1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713=AO1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713=AP1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713=AN1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713=AO1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713=AP1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1189)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJDkUAO","PAI-4730","Active","LKA-Tuberculosis-3","2017-2019","RT South East Asia","Sri Lanka","Tuberculosis","Tuberculosis","FR548-LKA-T",null,null,"TB care and prevention","Case detection and diagnosis","NGO involvement","NGO involvement",null,"High","13500",null,"0","0","0","0","13500","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDk/view","2021-12-31","Tuberculosis",13500," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713=AN1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713=AO1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713=AP1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713=AN1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713=AO1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713=AP1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1194)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJDpUAO","PAI-4735","Inactive","LSO-TB/HIV-11","2017-2019","RT Southern and Eastern Africa","Lesotho","HIV/TB","HIV/AIDS, Tuberculosis","FR579-LSO-C",null,null,"HIV Testing Services","Differentiated HIV testing services","The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) reported that the country is making good progress towards the UNAIDS 90-90-90 targets with 81% of PLHIV knowing their status, 92% of those who know their status on treatment, and 88% of those on treatment being virally suppressed. Despite tremendous efforts in scaling up HTS in Lesotho still 82, 000 PLHIV do not know their status, among these men, adolescents and young people, key populations and partners of people living with HIV (PLHIV). A key strategy to addressing this gap in the abovementioned target group is the provision of HIV self-testing (HIVST). In support of MOH Lesotho (MOHL), Unitaid funded the introduction and scale up of HIV self-testing in 2017. In 2018 a total of 58, 000 HIVST were distributed, mainly through community-based distribution. During this period majority of the self-testers were high-risk men (58%), adolescents 15-24 (35%) and key populations (7%). Furthermore, the Unitaid supported project reported that the number of HIV positive cases increased. The HTS Strategy has since been developed (Annex 1).In 2019 Unitaid will fund 43,342 HIVST kits and 64, 000 will be funded by CDC. The implementation of the differentiated strategy for HTS will require scaling up of HIVST, i.e. to expand HIVST across the entire country a substantial increase in the procurement of HIVST kit is needed. The estimated gap in HIVST kit commodities for the period 2020 is 240,000 and 2021 is 200,000 to cover all geographic areas. In particular the focus will be on: Hot spots, male dominated workplaces, places frequented by adolescents and young people, market places, taxi ranks, door to door distribution and campaign style distribution.  Key populations (MSM, Sex workers) - based on current trends, it is estimated that 2000 HIVST kits would be distributed annually to these populations. Antenatal clinics (ANC) - based on current trends for this target group, an estimated 34, 560 test kits will be required to reach male sexual partners of ANC clinic attendees.  Distribution through index patients (ART initiations at public sector hospitals): the current trends indicate that uptake by positive index patients and by sexual partner, estimates the requirement of 15, 000 test kits annually. Direct distribution to Outpatients departments: Based on current trends indicates that annually an estimated 72, 000 test kits would be required.","The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) reported that the country is making good progress towards the UNAIDS 90-90-90 targets with 81% of PLHIV knowing their status, 92% of those who know their status on treatment, and 88% of those on treatment being virally suppressed. Despite tremendous efforts in scaling up HTS in Lesotho still 82, 000 PLHIV do not know their status, among these men, adolescents and young people, key populations and partners of people living with HIV (PLHIV). A key strategy to addressing this gap in the abovementioned target group is the provision of HIV self-testing (HIVST). In support of MOH Lesotho (MOHL), Unitaid funded the introduction and scale up of HIV self-testing in 2017. In 2018 a total of 58, 000 HIVST were distributed, mainly through community-based distribution. During this period majority of the self-testers were high-risk men (58%), adolescents 15-24 (35%) and key populations (7%). Furthermore, the Unitaid supported project reported that the number of HIV positive cases increased. The HTS Strategy has since been developed (Annex 1).In 2019 Unitaid will fund 43,342 HIVST kits and 64, 000 will be funded by CDC. The implementation of the differentiated strategy for HTS will require scaling up of HIVST, i.e. to expand HIVST across the entire country a substantial increase in the procurement of HIVST kit is needed. The estimated gap in HIVST kit commodities for the period 2020 is 240,000 and 2021 is 200,000 to cover all geographic areas. In particular the focus will be on: Hot spots, male dominated workplaces, places frequented by adolescents and young people, market places, taxi ranks, door to door distribution and campaign style distribution.  Key populations (MSM, Sex workers) - based on current trends, it is estimated that 2000 HIVST kits would be distributed annually to these populations. Antenatal clinics (ANC) - based on current trends for this target group, an estimated 34, 560 test kits will be required to reach male sexual partners of ANC clinic attendees.  Distribution through index patients (ART initiations at public sector hospitals): the current trends indicate that uptake by positive index patients and by sexual partner, estimates the requirement of 15, 000 test kits annually. Direct distribution to Outpatients departments: Based on current trends indicates that annually an estimated 72, 000 test kits would be required.","Email from CT says that the this intervention is funded, through budget revisions","High","3520000","Better case finding strategies needed to ensure efficient use of resources.","3520000","0","0","0","0","1","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDp/view","2021-06-30","TB/HIV",0," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713=AN1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713=AO1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713=AP1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713=AN1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713=AO1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713=AP1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJDqUAO","PAI-4736","Active","LSO-TB/HIV-12","2017-2019","RT Southern and Eastern Africa","Lesotho","HIV/TB","HIV/AIDS, Tuberculosis","FR579-LSO-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Gender-based violence prevention and treatment programs for adolescents and youth","Under NFM 2, the country provides services to adolescents and young people in the 8 districts, however, the provision of these services is not supported by a harmonised and standardised vulnerability assessment, resulting in a non-differentiated approach. This is currently a gap and the country seek to address this issue. To ensure a more targeted response to the needs of the individual, the following is proposed: Review and adapt existing tools (e.g. Ministry of Social Development Vulnerability tools, FHI 360 and population council) towards the development of an algorithm to assess HIV vulnerability amongst young people. The algorithm will be applied nationally and will enable the country to provide tailored interventions to reduce the risk of HIV among young people.  Train 191 peer educators to administer the vulnerability assessment tool and conduct the assessment of 70,000 young people across the eight districts supported by the Global Fund.  The country has a defined package of services for AGYW, however not all adolescents and young people require a full package of service to prevent HIV. Based on the identified needs emerging from the vulnerability assessment, components from defined package of services for AGYW will be used for a more tailored and targeted approach, thereby maximising the impact of services for the AGYW. A total of 28,000 (40% based on the current assessment practices) adolescents and young people will be reached with this response based approach. The intervention will contribute to improved efficiencies of the allocation funding by ensuring that are most responsive to the identified needs are addressed by liking the most vulnerable adolescents to appropriate services in an equitable manner in all 8 districts.","Under NFM 2, the country provides services to adolescents and young people in the 8 districts, however, the provision of these services is not supported by a harmonised and standardised vulnerability assessment, resulting in a non-differentiated approach. This is currently a gap and the country seek to address this issue. To ensure a more targeted response to the needs of the individual, the following is proposed: Review and adapt existing tools (e.g. Ministry of Social Development Vulnerability tools, FHI 360 and population council) towards the development of an algorithm to assess HIV vulnerability amongst young people. The algorithm will be applied nationally and will enable the country to provide tailored interventions to reduce the risk of HIV among young people.  Train 191 peer educators to administer the vulnerability assessment tool and conduct the assessment of 70,000 young people across the eight districts supported by the Global Fund.  The country has a defined package of services for AGYW, however not all adolescents and young people require a full package of service to prevent HIV. Based on the identified needs emerging from the vulnerability assessment, components from defined package of services for AGYW will be used for a more tailored and targeted approach, thereby maximising the impact of services for the AGYW. A total of 28,000 (40% based on the current assessment practices) adolescents and young people will be reached with this response based approach. The intervention will contribute to improved efficiencies of the allocation funding by ensuring that are most responsive to the identified needs are addressed by liking the most vulnerable adolescents to appropriate services in an equitable manner in all 8 districts.",null,"High","58810","GBV addition complements existing activities.","0","0","0","0","58810","0","0","2019-10-30 15:33:36","2019-10-30 15:33:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDq/view","2021-06-30","TB/HIV",58810," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713=AN1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713=AO1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713=AP1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713=AN1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713=AO1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713=AP1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1200)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJDvUAO","PAI-4741","Active","LSO-TB/HIV-17","2017-2019","RT Southern and Eastern Africa","Lesotho","HIV/TB","HIV/AIDS, Tuberculosis","FR579-LSO-C",null,null,"Prevention programs for general population","Male circumcision","Programme data reported a national target of 311,335 men need to be circumcised of which 178,976 men have been medically circumcised. The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) 2017, reported that 30.7% of men between ages of 15-59 are still uncircumcised and 33.8% of HIV positive men between the ages 15-59 are uncircumcised. Furthermore, neonatal circumcisions taking place are minimal.  Although funding under NFM2 was received, the program was besieged by a number of challenges including limited funding under NFM2 to implement the program, high staff turn-over of MOH VMMC trained staff, poor understanding of VMMC by the district health management teams, absence of a core team dedicated for VMMC at the facilities and the suspension of incentives for staff to conduct VMMC. To mitigate these challenges, the GOL will adopt the model implemented by PEPFAR in the lowland districts which is reported to be successful with the uptake of VMMC. The annual target for VMMC is 50,000 which will be adequately covered for 2019/2020 by NFM2 (14,000) and PEPFAR (36,000). The gap identified is for 2020/2021 as PEPFAR will support 30,000 circumcisions leaving a gap of 20,000.  To address this gap following is proposed:  Health facility capacity  o VMMC core team located at each of the 8 health facilities in the 5 districts, made up of 3 nurses and 1 counsellor and cleanero VMMC site assessments conducted at identified health facilities to ensure the minimum required standards for VMMC are met. o Recruitment and training of new clinical staff and refresher courses for existing staff o Recruitment and training of community health advocates including traditional chiefs, traditional initiators, councillors and religious leaders Advocacy and Demand Creation o Advocacy initiatives to be implemented with key stakeholders at national level, VMMC stakeholder: parliamentarians (HIV Cluster), government line ministries, NAC, Religious bodies and Civil Society Organisations for ownership o Orientation of health facility staff (hospitals and health centres) on VMMC, communication skills, differentiated approaches to HTS and linkage to other serviceso Mobilisation campaigns and sensitisation sessions in communities through door to door campaigns, school visits, meetings of traditional leaders, distribution of promotional packages to targeted community groups and at service delivery points o Use of media platforms to promote VMMC  M&E and Research - For monitoring, evaluation and research and to manage the data, human resources will be required for VMMC administrative assistants and to conduct operational research","Programme data reported a national target of 311,335 men need to be circumcised of which 178,976 men have been medically circumcised. The Lesotho Population Based HIV/AIDS Impact Assessment (LePHIA) 2017, reported that 30.7% of men between ages of 15-59 are still uncircumcised and 33.8% of HIV positive men between the ages 15-59 are uncircumcised. Furthermore, neonatal circumcisions taking place are minimal.  Although funding under NFM2 was received, the program was besieged by a number of challenges including limited funding under NFM2 to implement the program, high staff turn-over of MOH VMMC trained staff, poor understanding of VMMC by the district health management teams, absence of a core team dedicated for VMMC at the facilities and the suspension of incentives for staff to conduct VMMC. To mitigate these challenges, the GOL will adopt the model implemented by PEPFAR in the lowland districts which is reported to be successful with the uptake of VMMC. The annual target for VMMC is 50,000 which will be adequately covered for 2019/2020 by NFM2 (14,000) and PEPFAR (36,000). The gap identified is for 2020/2021 as PEPFAR will support 30,000 circumcisions leaving a gap of 20,000.  To address this gap following is proposed:  Health facility capacity  o VMMC core team located at each of the 8 health facilities in the 5 districts, made up of 3 nurses and 1 counsellor and cleanero VMMC site assessments conducted at identified health facilities to ensure the minimum required standards for VMMC are met. o Recruitment and training of new clinical staff and refresher courses for existing staff o Recruitment and training of community health advocates including traditional chiefs, traditional initiators, councillors and religious leaders Advocacy and Demand Creation o Advocacy initiatives to be implemented with key stakeholders at national level, VMMC stakeholder: parliamentarians (HIV Cluster), government line ministries, NAC, Religious bodies and Civil Society Organisations for ownership o Orientation of health facility staff (hospitals and health centres) on VMMC, communication skills, differentiated approaches to HTS and linkage to other serviceso Mobilisation campaigns and sensitisation sessions in communities through door to door campaigns, school visits, meetings of traditional leaders, distribution of promotional packages to targeted community groups and at service delivery points o Use of media platforms to promote VMMC  M&E and Research - For monitoring, evaluation and research and to manage the data, human resources will be required for VMMC administrative assistants and to conduct operational research",null,"High","2800000","For CCM/Disease Program consideration: Recent epidemiology analyses suggest High transmission from uncircumcised men.  Program should ensure that proposed budget is rationalized and aligned to the target of 20,000 circumcisions to ensure value for money.","0","0","0","0","2800000","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJDv/view","2021-06-30","TB/HIV",2800000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713=AN1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713=AO1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713=AP1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713=AN1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713=AO1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713=AP1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1205)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJE0UAO","PAI-4746","Active","LSO-TB/HIV-21","2017-2019","RT Southern and Eastern Africa","Lesotho","HIV/TB","HIV/AIDS, Tuberculosis","FR579-LSO-C",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","The Government of Lesotho, with the support from Global Fund and GAVI, constructed 30 health posts in underserved areas in the five highland districts. The key objectives of the health posts are: (i) support primary health activities conducted by community-based cadres, and also outreaches from the health centres and (ii) improve the quality of health services in the hard to reach areas in the Country.Currently the 30 health posts are not optimally utilised due to the lack of medical equipment to improve universal health coverage, increase accessibility to the Essential Service Package (ESP) of health services and efficiently and effectively provide services to unreached populations, hence support is required to fully operationalise the health posts to provide the following services: Health education, promotion and awareness creation Child survival including Immunization, Nutrition and ANC services Environmental Health through the promotion of, good sanitation, safe drinking water and good environmental and personal hygiene Outpatient services, including prenatal and postnatal care, family planning, HIV testing and counselling, TB screening and treatment, ART refills and other services included in the ESP","The Government of Lesotho, with the support from Global Fund and GAVI, constructed 30 health posts in underserved areas in the five highland districts. The key objectives of the health posts are: (i) support primary health activities conducted by community-based cadres, and also outreaches from the health centres and (ii) improve the quality of health services in the hard to reach areas in the Country.Currently the 30 health posts are not optimally utilised due to the lack of medical equipment to improve universal health coverage, increase accessibility to the Essential Service Package (ESP) of health services and efficiently and effectively provide services to unreached populations, hence support is required to fully operationalise the health posts to provide the following services: Health education, promotion and awareness creation Child survival including Immunization, Nutrition and ANC services Environmental Health through the promotion of, good sanitation, safe drinking water and good environmental and personal hygiene Outpatient services, including prenatal and postnatal care, family planning, HIV testing and counselling, TB screening and treatment, ART refills and other services included in the ESP",null,"Low","69050","Additional resources for health posts were determined to be low priority as the proposed services to be provided in health posts were largely unrelated to HIV and TB.","0","0","0","0","69050","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJE0/view","2021-06-30","TB/HIV",69050," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713=AN1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713=AO1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713=AP1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713=AN1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713=AO1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713=AP1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1210)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJE6UAO","PAI-4752","Inactive","LSO-TB/HIV-8","2017-2019","RT Southern and Eastern Africa","Lesotho","HIV/TB","HIV/AIDS, Tuberculosis","FR509-LSO-C",null,null,"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","The funding will be used to support coordination of activities in the prisons and factories to address the high risk of TB and HIV infection in the target population. The activities will be funded through the re-investment of the efficiencies identified during the grant making.","The funding will be used to support coordination of activities in the prisons and factories to address the high risk of TB and HIV infection in the target population. The activities will be funded through the re-investment of the efficiencies identified during the grant making.","NA Original Intervention: Other interventions for other vulnerable populations","High","20000","To support coordination of activities in the prisons and factories. This is prioritized given the risk of TB and HIV infection in the target population.","20000","0","0","0","0","1","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJE6/view","2021-06-30","TB/HIV",0," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713=AN1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713=AO1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713=AP1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713=AN1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713=AO1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713=AP1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1216)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJE7UAO","PAI-4753","Active","LSO-TB/HIV-9","2017-2019","RT Southern and Eastern Africa","Lesotho","HIV/TB","HIV/AIDS, Tuberculosis","FR509-LSO-C",null,null,"RSSH: Health management information systems and M&E","Program and data quality","The funding will be used to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA) as part of community systems strengthening. This will include development of key users manuals, procurement of key infrastructure, and training of stakeholders to enable full operation of LOMSHA.","The funding will be used to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA) as part of community systems strengthening. This will include development of key users manuals, procurement of key infrastructure, and training of stakeholders to enable full operation of LOMSHA.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","53318","This is to facilitate the use and reporting of data using the Lesotho Output Monitoring System for HIV/AIDS (LOMSHA).","0","0","0","0","53318","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJE7/view","2021-06-30","TB/HIV",53318," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713=AN1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713=AO1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713=AP1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713=AN1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713=AO1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713=AP1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1217)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJECUA4","PAI-4758","Active","MAR-HIV/AIDS-4","2017-2019","RT Middle East and North Africa","Morocco","HIV/AIDS","HIV/AIDS","FR235-MAR-H",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Call for annual projects for NGOs in order to incorporate innovative HIV prevention and treatment actions and projects into their area of intervention; SR human resources.","Call for annual projects for NGOs in order to incorporate innovative HIV prevention and treatment actions and projects into their area of intervention; SR human resources.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Social mobilization, building community linkages, collaboration and coordination; strengthening institutional, planning and management capacities","High","610561.1","Funds for developing innovative prevention and treatment approaches by NGOs","124859.16","0","0","0","485701.94","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEC/view","2020-12-31","HIV/AIDS",485701.94," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713=AN1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713=AO1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713=AP1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713=AN1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713=AO1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713=AP1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1222)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJEHUA4","PAI-4763","Active","MAR-HIV/AIDS-9","2017-2019","RT Middle East and North Africa","Morocco","HIV/AIDS","HIV/AIDS","FR235-MAR-H",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","Regional NSP workshop; NSP review; production of national reports; situational study on disabled peoples vulnerability to HIV and STIs; socioeconomic study on PLHIV, SWs, MSM and people who inject drugs; annual program and financial audits of NSP implementation; supervision of above allocation activities; qualitative situational study on the vulnerability of street children; procurement of equipment and IT services for health centers and community centers.","Regional NSP workshop; NSP review; production of national reports; situational study on disabled peoples vulnerability to HIV and STIs; socioeconomic study on PLHIV, SWs, MSM and people who inject drugs; annual program and financial audits of NSP implementation; supervision of above allocation activities; qualitative situational study on the vulnerability of street children; procurement of equipment and IT services for health centers and community centers.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Analysis, evaluations, review and transparency","Low","316993.6","While some of these activities are important (regular program reviews, key populations qualitative situational vulnerability studies), this request includes equipment & IT procurement which are not considered to be quality demand.","0","0","0","0","316993.6","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEH/view","2020-12-31","HIV/AIDS",316993.59999999998," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713=AN1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713=AO1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713=AP1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713=AN1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713=AO1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713=AP1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1227)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJEMUA4","PAI-4768","Active","MAR-Tuberculosis-5","2017-2019","RT Middle East and North Africa","Morocco","Tuberculosis","Tuberculosis","FR256-MAR-T",null,null,"RSSH: National health strategies","Other policy and governance intervention(s)","NTCP managers will attend the annual conference of the International Union against Tuberculosis and Lung Disease, thereby helping strengthen their technical skills and capacities around TB control and forging new ties with potential international partners. Morocco has commemorated World Tuberculosis Day on 24 March for more than 20 years. The event is a unique opportunity to draw the attention of the public, communities, NGOs and political decision-makers to TB and efforts to control the disease in the country. Some authorities in large cities have provided material support to the CDTMRs to mark the occasion. This concept note includes a request for funding for World Tuberculosis Day commemorations in each of the three years covered.","NTCP managers will attend the annual conference of the International Union against Tuberculosis and Lung Disease, thereby helping strengthen their technical skills and capacities around TB control and forging new ties with potential international partners. Morocco has commemorated World Tuberculosis Day on 24 March for more than 20 years. The event is a unique opportunity to draw the attention of the public, communities, NGOs and political decision-makers to TB and efforts to control the disease in the country. Some authorities in large cities have provided material support to the CDTMRs to mark the occasion. This concept note includes a request for funding for World Tuberculosis Day commemorations in each of the three years covered.","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Low","120253.62","? Low priority intervention because its activities are not aligned directly with funding requests strategic objectives. However, it is quality demand because the mentioned activities will help to strengthen advocacy for TB control as well as to strengthen partnership and fundraising. ? NTCP managers will attend the annual conference of the International Union against Tuberculosis and Lung Disease, thereby helping strengthen their technical skills and capacities around TB control and forging new ties with potential international partners. ? Morocco has commemorated World Tuberculosis Day on 24 March for more than 20 years. The event is a unique opportunity to draw the attention of the public, communities, NGOs and political decision-makers to TB and efforts to control the disease in the country","0","0","0","0","120253.62","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEM/view","2020-12-31","Tuberculosis",120253.62," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713=AN1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713=AO1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713=AP1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713=AN1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713=AO1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713=AP1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1232)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJENUA4","PAI-4769","Inactive","MCALEP-HIV/AIDS-1","2017-2019","RT Latin America and Caribbean","Multicountry HIV Latin America ALEP","HIV/AIDS","HIV/AIDS","FR567-MCALEP-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Improving laws,regulations and polices relating to HIV and HIV/TB","Given its social and political situation, it is felt that Nicaragua cannot guarantee implementation of the full program planned for the other countries. However, implementation of this selection of some of the same activities as the other countries, and the inclusion of Nicaragua in the regional activities, would ensure that the regional objectives of this multicountry funding request are achieved. For evidence of the situation in Nicaragua, see the report by the Organization of American States (OAS) at: http://www.oas.org/en/iachr/reports/pdfs/Nicaragua2018-en.pdfCivil society is facing difficulties in addressing the necessary legislative, regulatory and policy changes, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of people living with HIV (PLHIV) and other key populations achieve the reforms they consider necessary, in line with the regional activities emerging from this module.To provide an effective HIV response, open data strategies are being designed and implemented, along with oversight and social control of public policies, and legal barriers related to intellectual property are being analyzed. Strategies to overcome these are being designed and implemented.","Given its social and political situation, it is felt that Nicaragua cannot guarantee implementation of the full program planned for the other countries. However, implementation of this selection of some of the same activities as the other countries, and the inclusion of Nicaragua in the regional activities, would ensure that the regional objectives of this multicountry funding request are achieved. For evidence of the situation in Nicaragua, see the report by the Organization of American States (OAS) at: http://www.oas.org/en/iachr/reports/pdfs/Nicaragua2018-en.pdfCivil society is facing difficulties in addressing the necessary legislative, regulatory and policy changes, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of people living with HIV (PLHIV) and other key populations achieve the reforms they consider necessary, in line with the regional activities emerging from this module.To provide an effective HIV response, open data strategies are being designed and implemented, along with oversight and social control of public policies, and legal barriers related to intellectual property are being analyzed. Strategies to overcome these are being designed and implemented.","NA Original Intervention: Improving laws, regulations and polices relating to HIV and HIV/TB","High","8628","The TRP recommends that the activities for Nicaragua in the PAAR to be embedded in the revised proposal.  It is requested that the secretariat ensure that the proposed activities leverage existing resources for the technical areas.","8628","0","0","0","0","1","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEN/view","2022-09-30","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713=AN1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713=AO1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713=AP1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2022-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713=AN1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713=AO1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713=AP1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2022-09-30"]
["a6Q1R000000AJESUA4","PAI-4774","Active","MCALEP-HIV/AIDS-6","2017-2019","RT Latin America and Caribbean","Multicountry HIV Latin America ALEP","HIV/AIDS","HIV/AIDS","FR567-MCALEP-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Venezuela would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in addressing stigma and discrimination within health services, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the changes they consider necessary, in line with the regional activities emerging from this module.Establishment of strategic partnerships with other sectors representing the intersectionality of HIV to address social determinants and the development and implementation of regional, subregional and national programs to tackle stigma and discrimination of PLHIV, from a gender, multiethnic and rights-based approach, based on findings from the stigma indices.","Like the other activities in this above allocation request, these interventions are included in the main request for the other countries. These activities are the result of a regional analysis and their implementation in Venezuela would contribute to reinforcing the desired regional impact. Civil society is facing difficulties in addressing stigma and discrimination within health services, in an environment of severe social instability and even faces persecutions of civil society members. Extra support for these interventions is therefore necessary to ensure that organizations of PLHIV and other key populations achieve the changes they consider necessary, in line with the regional activities emerging from this module.Establishment of strategic partnerships with other sectors representing the intersectionality of HIV to address social determinants and the development and implementation of regional, subregional and national programs to tackle stigma and discrimination of PLHIV, from a gender, multiethnic and rights-based approach, based on findings from the stigma indices.",null,"Low","17923","The TRP recognizes the deterioration of the social and health situation in Venezuela and the increasingly unmet needs in access to basic HIV services. However, the current political and social context in Venezuela significantly diminishes the likelihood that the proposed activities such as Stigma and discrimination reduction in the PAAR with a total value of US$ 17,923 in the proposed budgetwill be impactful to address Sustainability of services for key populations in Venezuela. As such it is considered low priority for funding within this catalytic envelope. The applicant should reconsider the strategic choice of activities that would have the potential for impact in the revised PAAR.","0","0","0","0","17923","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJES/view","2022-09-30","HIV/AIDS",17923," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713=AN1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713=AO1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713=AP1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2022-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713=AN1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713=AO1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713=AP1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1238)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2022-09-30"]
["a6Q1R000000AJEXUA4","PAI-4779","Active","MCASIAUNDP-Tuberculosis-3","2017-2019","RT South East Asia","Multicountry TB Asia UNDP","Tuberculosis","Tuberculosis","FR531-MCASIAUNDP-T",null,null,"RSSH: Integrated service delivery and quality improvement","Supportive policy and programmatic environment","Strengthening partnership/collaboration of civil society and government institutions through greater integration of CSOs in national systems and domestically financed programs. Existing legislation, policies and practices of CSO contracting mechanisms will be analyzed with a particular attention on sustainability of migrant/refugee TB programs. Technical assistance to be provided to support the transition and sustainability of cross-border referrals and information exchange between the three countries.","Strengthening partnership/collaboration of civil society and government institutions through greater integration of CSOs in national systems and domestically financed programs. Existing legislation, policies and practices of CSO contracting mechanisms will be analyzed with a particular attention on sustainability of migrant/refugee TB programs. Technical assistance to be provided to support the transition and sustainability of cross-border referrals and information exchange between the three countries.","NA Original Module: RSSH - Integrated service delivery and quality improvement","High","150000",null,"0","0","0","0","150000","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEX/view","2021-12-31","Tuberculosis",150000," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713=AN1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713=AO1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713=AP1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713=AN1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713=AO1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713=AP1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1243)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJEcUAO","PAI-4784","Active","MCASIAUNOPS-Tuberculosis-3","2017-2019","RT High Impact Asia","Multicountry TB Asia UNOPS","Tuberculosis","Tuberculosis","FR530-MCASIAUNOPS-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","One third of funds are to increase ACF and find more cases (2,154).  One third to address human rights and gender-related barriers to TB care, and one third for mix remaining actions (making diagnostic algorithm more sensitive with use of Xpert at DiCs, urban refugee screening, infection control by UVGI in immigration detention centres, engagement with employers, bilateral meetings with Cambodia, Lao, Myanmar and Malaysia).","One third of funds are to increase ACF and find more cases (2,154).  One third to address human rights and gender-related barriers to TB care, and one third for mix remaining actions (making diagnostic algorithm more sensitive with use of Xpert at DiCs, urban refugee screening, infection control by UVGI in immigration detention centres, engagement with employers, bilateral meetings with Cambodia, Lao, Myanmar and Malaysia).","NA Original Intervention: Active case finding efforts targeting migrants, and removing HRG barriers to TB care and prevention in Thailand.","High","3376787","Support ACF interventions, reducing human rights and gender barriers, and building diagnostic capacities including Xpert equipment and infection control equipment in immigration detention centres.","0","0","0","0","3376787","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEc/view","2021-12-31","Tuberculosis",3376787," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713=AN1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713=AO1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713=AP1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713=AN1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713=AO1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713=AP1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJEdUAO","PAI-4785","Active","MCASIAUNOPS-Tuberculosis-4","2017-2019","RT High Impact Asia","Multicountry TB Asia UNOPS","Tuberculosis","Tuberculosis","FR530-MCASIAUNOPS-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","To expand ACF to additional sites in the two provinces identified for support within the allocation.","To expand ACF to additional sites in the two provinces identified for support within the allocation.","NA Original Intervention: Active case finding in 2 pilot sites in Vietnam","High","781525","Expansion of ACF across additional sites in 2 provinces targeting migrant populations will maximize impact of proposed interventions.","0","0","0","0","781525","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEd/view","2021-12-31","Tuberculosis",781525," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713=AN1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713=AO1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713=AP1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713=AN1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713=AO1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713=AP1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1249)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJEiUAO","PAI-4790","Active","MCC-TB/HIV-5","2017-2019","RT Latin America and Caribbean","Multicountry Caribbean MCC","HIV/TB","HIV/AIDS, Tuberculosis","FR414-MCC-C",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","The development of an emergency response for treatment services in the event of natural disasters is seen as vital given the high risk of the region to climate change. Builiding from the experience of Dominica it is essentail that disaster plans be developed to provide access to essential services in line with local capacity, resources and international health regulations. This emergency disaster plan aims to increase patient acces to medication, food and  essential services that is aligned with the national disaster response plan and will reduce the interruption of essential services (access to medicines) post natural disasters.","The development of an emergency response for treatment services in the event of natural disasters is seen as vital given the high risk of the region to climate change. Builiding from the experience of Dominica it is essentail that disaster plans be developed to provide access to essential services in line with local capacity, resources and international health regulations. This emergency disaster plan aims to increase patient acces to medication, food and  essential services that is aligned with the national disaster response plan and will reduce the interruption of essential services (access to medicines) post natural disasters.","NA Original Module: RSSH - Program management","High","50000","This item is very important to build a resilient and sustainable system that can ride out natural disasters and continue to provide care for affected populations. Given recent events in the region, this item needs to be highly prioritized if efficiencies are to be found in the grant.","0","0","0","0","50000","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEi/view","2022-03-31","TB/HIV",50000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713=AN1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713=AO1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713=AP1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713=AN1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713=AO1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713=AP1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1254)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJEoUAO","PAI-4796","Active","MCE8-Malaria-6","2017-2019","RT High Impact Africa 2","Multicountry Southern Africa E8","Malaria","Malaria","FR500-MCE8-M",null,null,"Case management","Epidemic preparedness","Activity: Establishment of Country Level Situation Rooms Description: This funding request includes the establishment of country level Situation Rooms supported by the regional E8 Situation Room. This support will provide additional funding for internal meetings of the national malaria programes and their country level partners to ensure they are adequately prepared for the upcoming transmission season each year. These meetings will consist of 15 people meeting two times per year  once at the beginning of the transmission season (Oct/Nov) and then again towards the end (Feb/Mar) to assess progress, trends, response, etc. This support has been requested from Zimbabwe, Namibia, Angola, and Mozambique for the full three years of this investment. The remaining E8 countries will convene similar meetings through other means.Rationale: Country level Situaiton Rooms will allow for improved internal coordination before and during peak transmission seasons. National malaria programmes will be more prepared and responsive to increases in cases if and when they occur. Expected Outcomes/Impact: The result of increased internal coordination will be improve preparedness and response at the national level. This increased EPD is especially important following the most recent transmission seasons in which significant outbreaks occurred across the entire E8 region. Budget: Costs associated with this activity include travel expenses and per diems for the 15 situation team members in each respective country to meet at the onset and close of the malaria season to review outbreak response and outcomes. Travel also includes E8 Regional Situation team members to join the meetings to support capacity building of situation rooms across the region. The total cost of this activity is therefore estimated to US$ 112,580 for the three year period.","Activity: Establishment of Country Level Situation Rooms Description: This funding request includes the establishment of country level Situation Rooms supported by the regional E8 Situation Room. This support will provide additional funding for internal meetings of the national malaria programes and their country level partners to ensure they are adequately prepared for the upcoming transmission season each year. These meetings will consist of 15 people meeting two times per year  once at the beginning of the transmission season (Oct/Nov) and then again towards the end (Feb/Mar) to assess progress, trends, response, etc. This support has been requested from Zimbabwe, Namibia, Angola, and Mozambique for the full three years of this investment. The remaining E8 countries will convene similar meetings through other means.Rationale: Country level Situaiton Rooms will allow for improved internal coordination before and during peak transmission seasons. National malaria programmes will be more prepared and responsive to increases in cases if and when they occur. Expected Outcomes/Impact: The result of increased internal coordination will be improve preparedness and response at the national level. This increased EPD is especially important following the most recent transmission seasons in which significant outbreaks occurred across the entire E8 region. Budget: Costs associated with this activity include travel expenses and per diems for the 15 situation team members in each respective country to meet at the onset and close of the malaria season to review outbreak response and outcomes. Travel also includes E8 Regional Situation team members to join the meetings to support capacity building of situation rooms across the region. The total cost of this activity is therefore estimated to US$ 112,580 for the three year period.",null,"Low","112580","The TRP considers the regional situation room to be adequate to respond to issues coming from the country level. Additionally, the country programmes already have experience with early rapid response following the most recent outbreaks in the region. Therefore, in the E8 context this activity is considered as low priority as it is covered form alternative sources.","0","0","0","0","112580","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEo/view","2021-09-30","Malaria",112580," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713=AN1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713=AO1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713=AP1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713=AN1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713=AO1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713=AP1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1260)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJEtUAO","PAI-4801","Active","MCECSA-Tuberculosis-4","2017-2019","RT High Impact Africa 2","Multicountry Africa ECSA-HC","Tuberculosis","Tuberculosis","FR497-MCECSA-HC-T",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Funds for eLIMS adaptation for NRLs in line with the WHO End TB strategy. The SRL-Uganda has developed and deployed the eLIMS suitable for NRLs in two countries and can expand to other countries if additional funds become available.","Funds for eLIMS adaptation for NRLs in line with the WHO End TB strategy. The SRL-Uganda has developed and deployed the eLIMS suitable for NRLs in two countries and can expand to other countries if additional funds become available.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","34708",null,"0","0","0","0","34708","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEt/view","2022-06-30","Tuberculosis",34708," High Impact Africa 2","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713=AN1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713=AO1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713=AP1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713=AN1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713=AO1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713=AP1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1265)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJEuUAO","PAI-4802","Active","MCECSA-Tuberculosis-5","2017-2019","RT High Impact Africa 2","Multicountry Africa ECSA-HC","Tuberculosis","Tuberculosis","FR497-MCECSA-HC-T",null,null,"TB care and prevention","Case detection and diagnosis","Funds to strengthen Operational Research (OR) in line with the recommention of the Mid-term Review. The SRL-Uganda and other partners have already identified specific OR areas aiming to improve the efficiency of case detection and turn-around-times.","Funds to strengthen Operational Research (OR) in line with the recommention of the Mid-term Review. The SRL-Uganda and other partners have already identified specific OR areas aiming to improve the efficiency of case detection and turn-around-times.",null,"Medium","60020",null,"0","0","0","0","60020","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEu/view","2022-06-30","Tuberculosis",60020," High Impact Africa 2","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713=AN1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713=AO1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713=AP1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713=AN1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713=AO1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713=AP1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1266)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJEzUAO","PAI-4807","Active","MCEECAAPH-HIV/AIDS-2","2017-2019","RT Eastern Europe and Central Asia","Multicountry HIV EECA APH","HIV/AIDS","HIV/AIDS","FR545-MCEECAAPH-H-01",null,null,"RSSH: Financial management systems","Public financial management (PFM) strengthening","Activities:- Sharing good practices on transition in Macedonia and Montenegro across EECA ;- Documenting good SEE country practices on financial and political sustainability within the countries of EECA region ;- Organizing annual coordination regional meeting of SEE RCM;- Technical assistance on Budget advocacy, Public Finance and Budget Policy, formation and implementation of Social Policy  in 5 SEE countries;- Training for budget advocacy in 5 SEE countries and common regional advocacy;- Technical assistance to the SEE national decision-makers and civil society representatives in the revision, development and institutionalization of unified unit-costs for standard HIV-prevention and HIV-care services packages for PLHIV and KPs; - Development of budget advocacy plan at national level in 5 SEE countries;- Implementation of budget advocacy plan at national level in 5 SEE countries;- Investigate, develop and promote innovative models and sources of funding, to complement social contracting in 5 SEE countries;- Online tool for monitoring transition plans in EECA region developed by ECOM; - Analyse allocations, produce report and disseminate it in regional consultation on best prectices on implementation of transition plans in EECA by EHRA, using data from ECOM developed online tool;- Hold 4th regional forum for MSM and TG by ECOM.Expected results:- Strengthened governance of the SEE regional level through national response to HIV through formalized good practices of operation and decision-making of the National governance bodies;   - Best practices identified and shared within EECA region in terms of CCM role and evolution and Macedonian and Montenegro case in transition;- Optimized budgets for HIV prevention programs for different KAPs are developed and used in budgeting of national HIV programs in 5 SEE countries;- Generated strategic information, including on the treatment cascade, cascade of HIV services, prevalence and behavioral data to feed into planning of the national HIV programs and strategic plans and into civil society and community-based advocacy for adequate funding and scale-up of services in 5 SEE countries;- Civil society and community representatives are meaningfully engaged in annual program and budget planning of national HIV programs in 5 SEE coutries;- CSOs in all 5 SEE countries receive national funding to implement HIV programs for key populations;- At least 1 M USD is released additionally for key populations programs in 5 SEE countries in total in the lifetime of the grant;- Community monitoring tools are developed and implemented in 5 SEE countries; - Developed national guidance for continuous and reliable provision of ARVs for Ministry of Health in 5 SEE countries;- Transition plans are effectively and systematically monitored across EECA.","Activities:- Sharing good practices on transition in Macedonia and Montenegro across EECA ;- Documenting good SEE country practices on financial and political sustainability within the countries of EECA region ;- Organizing annual coordination regional meeting of SEE RCM;- Technical assistance on Budget advocacy, Public Finance and Budget Policy, formation and implementation of Social Policy  in 5 SEE countries;- Training for budget advocacy in 5 SEE countries and common regional advocacy;- Technical assistance to the SEE national decision-makers and civil society representatives in the revision, development and institutionalization of unified unit-costs for standard HIV-prevention and HIV-care services packages for PLHIV and KPs; - Development of budget advocacy plan at national level in 5 SEE countries;- Implementation of budget advocacy plan at national level in 5 SEE countries;- Investigate, develop and promote innovative models and sources of funding, to complement social contracting in 5 SEE countries;- Online tool for monitoring transition plans in EECA region developed by ECOM; - Analyse allocations, produce report and disseminate it in regional consultation on best prectices on implementation of transition plans in EECA by EHRA, using data from ECOM developed online tool;- Hold 4th regional forum for MSM and TG by ECOM.Expected results:- Strengthened governance of the SEE regional level through national response to HIV through formalized good practices of operation and decision-making of the National governance bodies;   - Best practices identified and shared within EECA region in terms of CCM role and evolution and Macedonian and Montenegro case in transition;- Optimized budgets for HIV prevention programs for different KAPs are developed and used in budgeting of national HIV programs in 5 SEE countries;- Generated strategic information, including on the treatment cascade, cascade of HIV services, prevalence and behavioral data to feed into planning of the national HIV programs and strategic plans and into civil society and community-based advocacy for adequate funding and scale-up of services in 5 SEE countries;- Civil society and community representatives are meaningfully engaged in annual program and budget planning of national HIV programs in 5 SEE coutries;- CSOs in all 5 SEE countries receive national funding to implement HIV programs for key populations;- At least 1 M USD is released additionally for key populations programs in 5 SEE countries in total in the lifetime of the grant;- Community monitoring tools are developed and implemented in 5 SEE countries; - Developed national guidance for continuous and reliable provision of ARVs for Ministry of Health in 5 SEE countries;- Transition plans are effectively and systematically monitored across EECA.","NA Original Module: RSSH - Financial management systems. Original Intervention: Public financial management strengthening","High","1695500",null,"1314616","0","0","0","380884","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJEz/view","2021-12-31","HIV/AIDS",380884," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713=AN1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713=AO1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713=AP1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713=AN1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713=AO1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713=AP1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1271)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJF4UAO","PAI-4812","Active","MCLACPCC-HIV/AIDS-10","2017-2019","RT Latin America and Caribbean","Multicountry HIV Caribbean PCC Consortium","HIV/AIDS","HIV/AIDS","FR562-MCLACPCC-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Under the PANCAP Round 9 grant CVC supported some model prison-based programmes, and CVC is currently conducting work in prisons in the OECS multi-country grant in relation to TB and prison health in general. Through this module CVC seeks to foster partnerships between national health authorities, and civil society organizations to improve health care delivery for prisoners and develop and document model programmes that can be scaled up by national governments to reduce HIV prevalence in the prison settings.  This will be achiveed through Proposed Activities:1.1 Offer inmate orientation and training Provide all new inmates with information on HIV, drug use, and other relevant issues to increase their capacity to safely navigate the prison environment  Train inmates as peer educators1.2 Build the capacity of prison staffTrain prison staff on HIV, drug use, and other relevant issues to increase their understanding and appropriate management of issues related to sexuality, HIV transmission, and drug use1.3 Institute pre-release programs Develop and implement orientation and information programs for inmates who are about to be released to enable a smooth transition and reintegration into society   Enable NGOs and CBOs to work in prisons to create links between prison health services and community health services, which will facilitate transition and reintegration1.3 Ensure continuity of care after discharge Establish protocols and referral systems to ensure that discharged inmates have continued access to antiretroviral therapy and medical care  Provide inmates with social service cards for free medical care for a defined period (e.g., 4 to 6 months), with provision for renewal should they remain unemployed","Under the PANCAP Round 9 grant CVC supported some model prison-based programmes, and CVC is currently conducting work in prisons in the OECS multi-country grant in relation to TB and prison health in general. Through this module CVC seeks to foster partnerships between national health authorities, and civil society organizations to improve health care delivery for prisoners and develop and document model programmes that can be scaled up by national governments to reduce HIV prevalence in the prison settings.  This will be achiveed through Proposed Activities:1.1 Offer inmate orientation and training Provide all new inmates with information on HIV, drug use, and other relevant issues to increase their capacity to safely navigate the prison environment  Train inmates as peer educators1.2 Build the capacity of prison staffTrain prison staff on HIV, drug use, and other relevant issues to increase their understanding and appropriate management of issues related to sexuality, HIV transmission, and drug use1.3 Institute pre-release programs Develop and implement orientation and information programs for inmates who are about to be released to enable a smooth transition and reintegration into society   Enable NGOs and CBOs to work in prisons to create links between prison health services and community health services, which will facilitate transition and reintegration1.3 Ensure continuity of care after discharge Establish protocols and referral systems to ensure that discharged inmates have continued access to antiretroviral therapy and medical care  Provide inmates with social service cards for free medical care for a defined period (e.g., 4 to 6 months), with provision for renewal should they remain unemployed","Name is: CT Multicountry LAC CARICOM-PANCAP / Review approach Original Intervention: Other interventions for people in prisons and other closed settings","Low","2e+05","This activity is largely service delivery which falls outside of the scope of this RFP, the TRP therefore does not recommend this intervention.","0","0","0","0","2e+05","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJF4/view","2022-09-30","HIV/AIDS",200000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713=AN1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713=AO1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713=AP1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2022-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713=AN1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713=AO1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713=AP1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1276)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2022-09-30"]
["a6Q1R000000AJF9UAO","PAI-4817","Active","MCLACPCC-HIV/AIDS-4","2017-2019","RT Latin America and Caribbean","Multicountry HIV Caribbean PCC Consortium","HIV/AIDS","HIV/AIDS","FR562-MCLACPCC-H",null,null,"RSSH: Community responses and systems","Community led advocacy","Social mobilization campaigns at regional and national level for increase in domestic resources to address the needs of KP will be undertaken using advocacy videos and other IEC tools developed to target Ministries of Health and Finance and used in training sessions with CSOs. Support will also be provided for partcipation of KPs to high level national and regional meetings to undertake community-based advocacy and moniytoring a=for policy and law reform related to HIV.","Social mobilization campaigns at regional and national level for increase in domestic resources to address the needs of KP will be undertaken using advocacy videos and other IEC tools developed to target Ministries of Health and Finance and used in training sessions with CSOs. Support will also be provided for partcipation of KPs to high level national and regional meetings to undertake community-based advocacy and moniytoring a=for policy and law reform related to HIV.","Name is: CT Multicountry LAC CARICOM-PANCAP / Review approach Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","High","60000",null,"0","0","0","0","60000","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJF9/view","2022-09-30","HIV/AIDS",60000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713=AN1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713=AO1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713=AP1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2022-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713=AN1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713=AO1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713=AP1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2022-09-30"]
["a6Q1R000000AJFAUA4","PAI-4818","Inactive","MCLACPCC-HIV/AIDS-5","2017-2019","RT Latin America and Caribbean","Multicountry HIV Caribbean PCC Consortium","HIV/AIDS","HIV/AIDS","FR562-MCLACPCC-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Small grants to support national and regional anti-stigma and \"know your rights\" campaigns. Training in basic advocacy skills and legal literacy for CSOs.","Small grants to support national and regional anti-stigma and \"know your rights\" campaigns. Training in basic advocacy skills and legal literacy for CSOs.","Name is: CT Multicountry LAC CARICOM-PANCAP / Review approach Original Intervention: Legal literacy (Know Your Rights)","High","1e+05","The TRP suggests to move this intervention within the allocation by reprioritizing sub-section C. This activity is considered of high priority to reduce human rights related barriers to HIV services (see Issue 3).","1e+05","0","0","0","0","1","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFA/view","2022-09-30","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713=AN1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713=AO1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713=AP1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2022-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713=AN1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713=AO1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713=AP1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1282)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2022-09-30"]
["a6Q1R000000AJFFUA4","PAI-4823","Active","MCMENAIHAA-HIV/AIDS-1","2017-2019","RT Middle East and North Africa","Multicountry HIV MENA IHAA","HIV/AIDS","HIV/AIDS","FR528-MCMENAIHAA-H",null,null,"Program management","Grant management","Additional resources for baseline, mid term and evaluation and learning and sharing events.","Additional resources for baseline, mid term and evaluation and learning and sharing events.","NA Original Module: RSSH - Program management","High","360000",null,"0","0","0","0","360000","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFF/view","2021-12-31","HIV/AIDS",360000," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713=AN1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713=AO1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713=AP1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713=AN1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713=AO1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713=AP1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1287)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFKUA4","PAI-4828","Inactive","MCMENAIHAA-HIV/AIDS-14","2017-2019","RT Middle East and North Africa","Multicountry HIV MENA IHAA","HIV/AIDS","HIV/AIDS","FR528-MCMENAIHAA-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Sensitization of media practitioners, social media bloggers, religious leaders and other key influencers to the challenges, needs and issues of stigma and discrimination towards KPs and PLHIV.","Sensitization of media practitioners, social media bloggers, religious leaders and other key influencers to the challenges, needs and issues of stigma and discrimination towards KPs and PLHIV.",null,"Medium","78000",null,"78000","0","0","0","0","1","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFK/view","2021-12-31","HIV/AIDS",0," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713=AN1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713=AO1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713=AP1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713=AN1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713=AO1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713=AP1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1292)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFPUA4","PAI-4833","Inactive","MCMENAIHAA-HIV/AIDS-19","2017-2019","RT Middle East and North Africa","Multicountry HIV MENA IHAA","HIV/AIDS","HIV/AIDS","FR528-MCMENAIHAA-H",null,null,"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Y3: Conduct participatory workshops on Global and regional guidance to build knowege of (1) MSM, (2) PWID, (3) Sex Workers to improve national level programming.Lebanoncan host these workshops for the region-wide learning activity.","Y3: Conduct participatory workshops on Global and regional guidance to build knowege of (1) MSM, (2) PWID, (3) Sex Workers to improve national level programming.Lebanoncan host these workshops for the region-wide learning activity.","NA Original Module: RSSH - Community responses and systems","Low","80000",null,"80000","0","0","0","0","1","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFP/view","2021-12-31","HIV/AIDS",0," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713=AN1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713=AO1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713=AP1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713=AN1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713=AO1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713=AP1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFQUA4","PAI-4834","Active","MCMENAIHAA-HIV/AIDS-2","2017-2019","RT Middle East and North Africa","Multicountry HIV MENA IHAA","HIV/AIDS","HIV/AIDS","FR528-MCMENAIHAA-H",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Capacity Development Fund: Additional support for building the institutional capacity of sub recipients for sustainability.","Capacity Development Fund: Additional support for building the institutional capacity of sub recipients for sustainability.","NA Original Module: RSSH - Community responses and systems","High","3e+05",null,"150000","0","0","0","150000","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFQ/view","2021-12-31","HIV/AIDS",150000," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713=AN1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713=AO1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713=AP1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713=AN1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713=AO1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713=AP1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1298)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFWUA4","PAI-4840","Inactive","MCMENAIHAA-HIV/AIDS-6","2017-2019","RT Middle East and North Africa","Multicountry HIV MENA IHAA","HIV/AIDS","HIV/AIDS","FR528-MCMENAIHAA-H",null,null,"RSSH: Community responses and systems","Community led advocacy","Organize national and regional workshops to develop advocacy plans focused on removal of legal barriers to KP access to services.","Organize national and regional workshops to develop advocacy plans focused on removal of legal barriers to KP access to services.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","High","40400",null,"40400","0","0","0","0","1","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFW/view","2021-12-31","HIV/AIDS",0," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713=AN1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713=AO1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713=AP1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713=AN1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713=AO1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713=AP1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1304)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFbUAO","PAI-4845","Active","MCMER-Integrated-10","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Tuberculosis","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"TB care and prevention","Case detection and diagnosis","To procure 7 digital X-ray machines for TB facilities: 4 for Iraq and 3 for Jordan; these machines will cover the needs in TB screening, evaluation and diagnosis for IDPs, refugees and hard-to-reach populations scattered in Iraq and for refugees in Jordan","To procure 7 digital X-ray machines for TB facilities: 4 for Iraq and 3 for Jordan; these machines will cover the needs in TB screening, evaluation and diagnosis for IDPs, refugees and hard-to-reach populations scattered in Iraq and for refugees in Jordan",null,"High","980000",null,"0","560000","0","0","420000","0","0","2020-02-07 10:39:34","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFb/view","2021-12-31","Multi-component",420000," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713=AN1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713=AO1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713=AP1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713=AN1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713=AO1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713=AP1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1309)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFgUAO","PAI-4850","Active","MCMER-Integrated-15","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","RSSH","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"Program management","Other program management intervention(s)","To rehabilitate the TB centers/hospitals damaged in the conflicts in Iraq and Syria (including Ibn Zohr Hospital in Baghdad, Iraq and Al-Hareth Hospital in Homs, Syria), so as to support the provision of admission facilities for patients admitted with TB.","To rehabilitate the TB centers/hospitals damaged in the conflicts in Iraq and Syria (including Ibn Zohr Hospital in Baghdad, Iraq and Al-Hareth Hospital in Homs, Syria), so as to support the provision of admission facilities for patients admitted with TB.",null,"High","1e+05","This activity has been reprioritized as high to support the provision of admission facilities for patients admitted with TB","0","0","0","0","1e+05","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFg/view","2021-12-31","Multi-component",100000," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713=AN1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713=AO1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713=AP1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713=AN1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713=AO1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713=AP1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1314)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFhUAO","PAI-4851","Active","MCMER-Integrated-16","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Tuberculosis","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"TB care and prevention","Case detection and diagnosis","In order to enhance TB microscopy activities in Iraq, yemen and Syria 3 LED microscopes need to be acquired","In order to enhance TB microscopy activities in Iraq, yemen and Syria 3 LED microscopes need to be acquired",null,"Medium","13534",null,"0","0","0","0","13534","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFh/view","2021-12-31","Multi-component",13534," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713=AN1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713=AO1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713=AP1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713=AN1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713=AO1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713=AP1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1315)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFmUAO","PAI-4856","Active","MCMER-Integrated-20","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","RSSH","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To provide support to all the five countries to implement the DHIS2 (TB Tracker) in the settings where it should be implemented","To provide support to all the five countries to implement the DHIS2 (TB Tracker) in the settings where it should be implemented","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Medium","20000",null,"0","0","0","0","20000","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFm/view","2021-12-31","Multi-component",20000," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713=AN1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713=AO1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713=AP1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713=AN1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713=AO1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713=AP1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1320)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFrUAO","PAI-4861","Active","MCMER-Integrated-25","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","RSSH","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"Program management","Other program management intervention(s)","To procure computers for the NTP central units of Iraq, Yemen and Syria","To procure computers for the NTP central units of Iraq, Yemen and Syria",null,"Low","75000",null,"0","0","0","0","75000","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFr/view","2021-12-31","Multi-component",75000," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713=AN1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713=AO1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713=AP1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713=AN1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713=AO1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713=AP1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1325)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFwUAO","PAI-4866","Active","MCMER-Integrated-3","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","RSSH","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"RSSH: Health management information systems and M&E","Other service delivery intervention(s)","PAAR is planned to be used for conducting IBBS and PSE for key populations in both southern part of Yemen and Syria. Results of this exercise will improve the planning capacities of program to delover services to these key populations. Also, results of these surveys will contribute to improving the two countries' estimates and projections. PSE will provide denomirators for monitoring the coverage of implemented services among key populations","PAAR is planned to be used for conducting IBBS and PSE for key populations in both southern part of Yemen and Syria. Results of this exercise will improve the planning capacities of program to delover services to these key populations. Also, results of these surveys will contribute to improving the two countries' estimates and projections. PSE will provide denomirators for monitoring the coverage of implemented services among key populations","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","5e+05","While the TRP recognises that up-to-date data would be very useful, the TRPdoubts the feasibility of conducting IBBS or PSE in Syria and Yemen, given the volatile crisis situation in both countries and therefore considers this low priority.","0","0","0","0","5e+05","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFw/view","2021-12-31","Multi-component",500000," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713=AN1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713=AO1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713=AP1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713=AN1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713=AO1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713=AP1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJFxUAO","PAI-4867","Active","MCMER-Integrated-30","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Tuberculosis","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"TB care and prevention","Prevention","Updating the national guidelines on TB infection prevention and control in Jordan in English , translate to Arabic and printing","Updating the national guidelines on TB infection prevention and control in Jordan in English , translate to Arabic and printing",null,"High","22444",null,"0","0","0","0","22444","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJFx/view",null,"Multi-component",22444," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713=AN1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713=AO1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713=AP1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713=AN1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713=AO1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713=AP1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1331)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJG2UAO","PAI-4872","Active","MCMER-Integrated-35","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Tuberculosis","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"TB care and prevention","Case detection and diagnosis","Laboratory Xpert Cartridges, accessories and spare parts, LPA, MGIT reagents and other laboratory kits, consumable kits","Laboratory Xpert Cartridges, accessories and spare parts, LPA, MGIT reagents and other laboratory kits, consumable kits",null,"High","112221",null,"0","0","0","0","112221","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJG2/view",null,"Multi-component",112221," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713=AN1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713=AO1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713=AP1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713=AN1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713=AO1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713=AP1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1336)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJG7UAO","PAI-4877","Active","MCMER-Integrated-4","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Malaria","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The PAAR amount includes procurement and supply of LLIN for mass campaign and LLIN for refugees and IDPs to cover target populations at risk in 2019, 20 and 21, with a prioritization in high transmission areas and where people are at greatest risk for malaria.","The PAAR amount includes procurement and supply of LLIN for mass campaign and LLIN for refugees and IDPs to cover target populations at risk in 2019, 20 and 21, with a prioritization in high transmission areas and where people are at greatest risk for malaria.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","8761404","Given Yemen's current epidemiological profile, with 80%+ cases reported from the Tehama region and the country --generally speaking-- being of low/very low endemicity, the TRP believes that the LLINs mass distribution campaign as currently proposed does not represent value for money and, hence, does not represent strategic investment for impact. The TRP recommends that LLINs distribution be prioritized to high transmission areas and/or where people are at greatest risk for malaria (e.g. Tehama).","61341","4380702","0","0","4319361","0","0","2020-02-07 10:39:34","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJG7/view","2021-12-31","Multi-component",4319361," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713=AN1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713=AO1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713=AP1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713=AN1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713=AO1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713=AP1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1341)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJGDUA4","PAI-4883","Active","MCMER-Integrated-45","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Tuberculosis","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"TB care and prevention","Treatment","Translate and print the national guidelines on TB treatment in Jordan to Arabic","Translate and print the national guidelines on TB treatment in Jordan to Arabic",null,"High","6733",null,"0","0","0","0","6733","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGD/view",null,{"$f":"IF(OR(I1347=\"HIV/AIDS\",I1347=\"Tuberculosis\",I1347=\"Malaria\",I1347=\"RSSH\"),I1347, IF(I1347=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"Multi-component"},{"$f":"VALUE(Y1347)","v":6733},{"$f":"RIGHT(F1347,LEN(F1347)-2)","v":" Middle East and North Africa"},"HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,{"$f":"TRIM(AK1347)","v":"Tuberculosis"},{"$f":"TRIM(AL1347)","v":"RSSH"},{"$f":"TRIM(AM1347)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713=AN1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713=AO1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713=AP1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IF(AE1347<>\"\",AE1347,IF(MAX(AQ1347,AR1347,AS1347,AT1347)<>0,MAX(AQ1347,AR1347,AS1347,AT1347),AU1347))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713=AN1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713=AO1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713=AP1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1347)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IF(AE1347<>\"\",AE1347,IF(MAX(AW1347,AX1347,AY1347,AZ1347)<>0,MAX(AW1347,AX1347,AY1347,AZ1347),BA1347))","v":"2018-01-01"}]
["a6Q1R000000AJGEUA4","PAI-4884","Active","MCMER-Integrated-46","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Tuberculosis","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"TB care and prevention","Treatment","FLD for Jordan (Pharmaceutical Products)","FLD for Jordan (Pharmaceutical Products)",null,"High","14589",null,"0","0","0","0","14589","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGE/view",null,"Multi-component",14589," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713=AN1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713=AO1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713=AP1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713=AN1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713=AO1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713=AP1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1348)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJGJUA4","PAI-4889","Active","MCMER-Integrated-50","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Tuberculosis","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"MDR-TB","Treatment: MDR-TB","Procurement of Second Line Drugs SLD","Procurement of Second Line Drugs SLD","NA Original Module: Multidrugresistant TB","High","31422",null,"0","0","0","0","31422","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGJ/view",null,"Multi-component",31422," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713=AN1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713=AO1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713=AP1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713=AN1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713=AO1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713=AP1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1353)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJGOUA4","PAI-4894","Active","MCMER-Integrated-55","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","RSSH","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"RSSH: Human resources for health (HRH), including community health workers","Other health and community workforce intervention(s)","NTP staff participation in international trainings, conferences, workshops etc.","NTP staff participation in international trainings, conferences, workshops etc.","NA Original Module: RSSH: Human resources for health, including community health workers. Original Intervention: In-service training (excluding community health workers)","High","44888",null,"0","0","0","0","44888","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGO/view",null,"Multi-component",44888," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713=AN1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713=AO1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713=AP1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713=AN1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713=AO1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713=AP1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1358)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJGTUA4","PAI-4899","Active","MCMER-Integrated-6","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Malaria","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"Vector control","Entomological monitoring","This includes the cost for entomological survey and BCC/Tracking system in 2019, 20 and 21.","This includes the cost for entomological survey and BCC/Tracking system in 2019, 20 and 21.",null,"Medium","220800",null,"0","0","0","0","220800","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGT/view","2021-12-31","Multi-component",220800," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713=AN1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713=AO1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713=AP1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713=AN1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713=AO1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713=AP1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1363)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJGUUA4","PAI-4900","Active","MCMER-Integrated-60","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","RSSH","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"Program management","Other program management intervention(s)","NTP offices supplies (12 centers)","NTP offices supplies (12 centers)","NA Original Intervention: Coordination and management of national disease control programs","High","39277",null,"0","0","0","0","39277","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGU/view",null,"Multi-component",39277," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713=AN1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713=AO1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713=AP1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713=AN1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713=AO1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713=AP1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1364)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJGZUA4","PAI-4905","Active","MCMER-Integrated-65","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","HIV/AIDS","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Procurement of OI medications","Procurement of OI medications","NA Original Intervention: Prevention programs for other vulnerable populations","High","11222",null,"0","0","0","0","11222","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGZ/view",null,"Multi-component",11222," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713=AN1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713=AO1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713=AP1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713=AN1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713=AO1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713=AP1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1369)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJGeUAO","PAI-4910","Active","MCMER-Integrated-7","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","RSSH","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"RSSH: Health management information systems and M&E","Policy, planning, coordination and management of national disease control programs","This intervention is of great importance to build the capacity of eDEWS sentinel sites to determine the alert and outbreak thresholds and develop a preparedness and prompt response plan to contain malaria outbreak. It fosters the collaboration and coordination with the surveillance department and eDEWS programme and ensure the flow of malaria case management data on weekly basis from 2000 HFs in the country","This intervention is of great importance to build the capacity of eDEWS sentinel sites to determine the alert and outbreak thresholds and develop a preparedness and prompt response plan to contain malaria outbreak. It fosters the collaboration and coordination with the surveillance department and eDEWS programme and ensure the flow of malaria case management data on weekly basis from 2000 HFs in the country","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","462000",null,"0","0","0","0","462000","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGe/view","2021-12-31","Multi-component",462000," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713=AN1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713=AO1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713=AP1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713=AN1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713=AO1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713=AP1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1374)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJGjUAO","PAI-4915","Active","MCMER-Integrated-74","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","HIV/AIDS","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"Treatment, care and support","Other intervention(s) for treatment","Design and develop a comprehensive treatment retention and adherence strategy","Design and develop a comprehensive treatment retention and adherence strategy","NA Original Module: Treatment, care, and support. Original Intervention: Treatment, care, and support","High","16833",null,"0","0","0","0","16833","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGj/view",null,"Multi-component",16833," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713=AN1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713=AO1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713=AP1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713=AN1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713=AO1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713=AP1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJGkUAO","PAI-4916","Active","MCMER-Integrated-75","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","HIV/AIDS","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"Treatment, care and support","Other intervention(s) for treatment","Procure ARV (1st line and second line) for PLHIV","Procure ARV (1st line and second line) for PLHIV","NA Original Module: Treatment, care, and support. Original Intervention: Treatment, care, and support","High","56110",null,"0","0","0","0","56110","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGk/view",null,"Multi-component",56110," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713=AN1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713=AO1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713=AP1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713=AN1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713=AO1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713=AP1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1380)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJGpUAO","PAI-4921","Active","MCMER-Integrated-8","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","Malaria","HIV/AIDS, Tuberculosis, Malaria","FR461-MCMER-Z",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","This includes procurement and supply of LLIN for mass campaign and LLIN for refugees and IDPs to cover target populations at risk in 2019, 20 and 21, in areas of lower risk of transmission","This includes procurement and supply of LLIN for mass campaign and LLIN for refugees and IDPs to cover target populations at risk in 2019, 20 and 21, in areas of lower risk of transmission","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","Low","8299572","Given Yemen's current epidemiological profile, with 80%+ cases reported from the Tehama region and the country --generally speaking-- being of low/very low endemicity, the TRP believes that the LLINs mass distribution campaign as currently proposed does not represent value for money and, hence, does not represent strategic investment for impact. The TRP recommends that LLINs distruibution be prioritized to high transmission areas and/or where people are at greatest risk for malaria (e.g. Tehama).","0","0","0","0","8299572","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGp/view","2021-12-31","Multi-component",8299572," Middle East and North Africa","HIV/AIDS, Tuberculosis, Malaria","HIV/AIDS"," Tuberculosis"," Malaria",null,"Tuberculosis","Malaria","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713=AN1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713=AO1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713=AP1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713=AN1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713=AO1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713=AP1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1385)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJGvUAO","PAI-4927","Active","MCMER-Integrated-85","2017-2019","RT Middle East and North Africa","Multicountry Middle East MER","RSSH","HIV/AIDS, Tuberculosis, RSSH","FR601-MCMER-Z",null,null,"Other module","Other module","\"Contribute to the Jordan Health Fund for Refugees (JHFR); \"\"In exchange for a GoJ commitment to provide quality primary and secondary health care services for Syrian refugees in MOH facilities at the same rate as for uninsured Jordanians, contributions to the JHFR will off-set the following component costs of the MOH's annual budget related to providing subsidized primary and secondary health care services in MOH facilities to Syrian refugees: ( I) primary health care; (2) secondary health care; and (3) medicines, medical solutions, consumables, and supplies. \"","\"Contribute to the Jordan Health Fund for Refugees (JHFR); \"\"In exchange for a GoJ commitment to provide quality primary and secondary health care services for Syrian refugees in MOH facilities at the same rate as for uninsured Jordanians, contributions to the JHFR will off-set the following component costs of the MOH's annual budget related to providing subsidized primary and secondary health care services in MOH facilities to Syrian refugees: ( I) primary health care; (2) secondary health care; and (3) medicines, medical solutions, consumables, and supplies. \"","NA Original Module: RSSH. Original Intervention: RSSH","High","5611043","Very high priority intervention to sum up current efforts to avoid catastrophic health costs for Syrian refugees, improve health access, harmonize with other key donors and contribute to national efforts.","0","0","0","0","5611043","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJGv/view",null,"Multi-component",5611043," Middle East and North Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713=AN1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713=AO1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713=AP1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713=AN1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713=AO1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713=AP1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1391)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2018-01-01"]
["a6Q1R000000AJH4UAO","PAI-4936","Inactive","MCMOSASWA-Malaria-8","2017-2019","RT High Impact Africa 2","Multicountry Southern Africa MOSASWA","Malaria","Malaria","FR515-MCMOSASWA-M",null,null,"Other module","Other module",null,null,"To align with the FR data Original Module: Other modules. Original Intervention: Other",null,"21226512",null,"0","0","21226512","0","0","1","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJH4/view","2022-12-31","Malaria",0," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713=AN1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713=AO1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713=AP1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713=AN1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713=AO1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713=AP1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1396)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2022-12-31"]
["a6Q1R000000AJH5UAO","PAI-4937","Active","MCPAS-Tuberculosis-1","2017-2019","RT Eastern Europe and Central Asia","Multicountry EECA PAS","Tuberculosis","Tuberculosis","FR524-MCPAS-T",null,null,"MDR-TB","Other MDR-TB intervention(s)","Regional work to improve quality of TB care and clinical practice. The activity will focus on supporting countries in developing a planning approach to rapid and modern diagnostics at subregional level.","Regional work to improve quality of TB care and clinical practice. The activity will focus on supporting countries in developing a planning approach to rapid and modern diagnostics at subregional level.","NA Original Module: Multidrug-resistant TB","High","75000","The patient centered approach is essential to efficient implementation of the project and constitutes one of the core activities.","38460","0","0","0","36540","0","0","2019-10-30 15:33:43","2019-10-30 15:33:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJH5/view","2021-12-31","Tuberculosis",36540," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713=AN1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713=AO1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713=AP1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713=AN1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713=AO1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713=AP1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1397)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJHAUA4","PAI-4942","Active","MCPAS-Tuberculosis-14","2017-2019","RT Eastern Europe and Central Asia","Multicountry EECA PAS","Tuberculosis","Tuberculosis","FR524-MCPAS-T",null,null,"MDR-TB","Other MDR-TB intervention(s)","Oversight committee meetings to ensure effective project implementation.","Oversight committee meetings to ensure effective project implementation.","NA Original Module: Multidrug-resistant TB","Medium","45000",null,"0","0","0","0","45000","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHA/view","2021-12-31","Tuberculosis",45000," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713=AN1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713=AO1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713=AP1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713=AN1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713=AO1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713=AP1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1402)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJHFUA4","PAI-4947","Active","MCPAS-Tuberculosis-5","2017-2019","RT Eastern Europe and Central Asia","Multicountry EECA PAS","Tuberculosis","Tuberculosis","FR524-MCPAS-T",null,null,"MDR-TB","Other MDR-TB intervention(s)","Support development and implementation of evaluation of health services delivery transformations to ensure sustainable changes of TB care model. Existing tools on evaluation of health services delivery will be applied to TB care to monitor development and implementation of people-centered TB care model.","Support development and implementation of evaluation of health services delivery transformations to ensure sustainable changes of TB care model. Existing tools on evaluation of health services delivery will be applied to TB care to monitor development and implementation of people-centered TB care model.","NA Original Module: Multidrug-resistant TB","High","30000","This item is considered as the highest priority and proposed activities should be included into the core grant through efficiencies  identified.","0","0","0","0","30000","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHF/view","2021-12-31","Tuberculosis",30000," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713=AN1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713=AO1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713=AP1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713=AN1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713=AO1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713=AP1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1407)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJHKUA4","PAI-4952","Inactive","MCPIH-Tuberculosis-1","2017-2019","RT Latin America and Caribbean","Multicountry TB LAC PIH","Tuberculosis","Tuberculosis","FR560-MCPIH-T",null,null,"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Adaptation of the module for TB stigma measurement from the KNCV Tuberculosis Foundation in the Netherlands.","Adaptation of the module for TB stigma measurement from the KNCV Tuberculosis Foundation in the Netherlands.","NA Original Module: RSSH - Community responses and systems","High","14000","The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","14000","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHK/view","2022-06-30","Tuberculosis",0," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713=AN1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713=AO1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713=AP1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713=AN1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713=AO1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713=AP1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1412)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2022-06-30"]
["a6Q1R000000AJHLUA4","PAI-4953","Inactive","MCPIH-Tuberculosis-10","2017-2019","RT Latin America and Caribbean","Multicountry TB LAC PIH","Tuberculosis","Tuberculosis","FR560-MCPIH-T",null,null,"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","National workshops on Social Protection in TB. This event will bring together government and civil society representatives from each country to exchange experiences and learn from opportunities in other countries.","National workshops on Social Protection in TB. This event will bring together government and civil society representatives from each country to exchange experiences and learn from opportunities in other countries.","NA Original Module: RSSH - Community responses and systems","Medium","150800",null,"150800","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHL/view","2022-06-30","Tuberculosis",0," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713=AN1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713=AO1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713=AP1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713=AN1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713=AO1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713=AP1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1413)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2022-06-30"]
["a6Q1R000000AJHQUA4","PAI-4958","Inactive","MCPIH-Tuberculosis-4","2017-2019","RT Latin America and Caribbean","Multicountry TB LAC PIH","Tuberculosis","Tuberculosis","FR560-MCPIH-T",null,null,"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Technical assistance on the analysis of the legal environment that limits the rights of people with TB. With the support of technical members of the National Social TB Observatories, a standardized protocol will be developed and the survey will be carried out in each of the 8 countries participating in the grant.","Technical assistance on the analysis of the legal environment that limits the rights of people with TB. With the support of technical members of the National Social TB Observatories, a standardized protocol will be developed and the survey will be carried out in each of the 8 countries participating in the grant.","NA Original Module: RSSH - Community responses and systems","High","86000","The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","86000","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHQ/view","2022-06-30","Tuberculosis",0," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713=AN1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713=AO1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713=AP1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713=AN1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713=AO1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713=AP1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1418)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2022-06-30"]
["a6Q1R000000AJHVUA4","PAI-4963","Inactive","MCPIH-Tuberculosis-9","2017-2019","RT Latin America and Caribbean","Multicountry TB LAC PIH","Tuberculosis","Tuberculosis","FR560-MCPIH-T",null,null,"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Regional workshop on Social Protection in TB. This event will bring together representatives of government, cooperating and multilateral organizations and civil society from the 8 LAC countries to exchange experiences and new agreements.","Regional workshop on Social Protection in TB. This event will bring together representatives of government, cooperating and multilateral organizations and civil society from the 8 LAC countries to exchange experiences and new agreements.","NA Original Module: RSSH - Community responses and systems","High","40550","The TRP considers that this intervention should have high priority as it would inform the Social Observatories for TB. The TRP requests the applicant to work with the Secretariat to include this intervention in the main allocation through efficiencies identified by optimizing its implementation arrangements.","40550","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHV/view","2022-06-30","Tuberculosis",0," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713=AN1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713=AO1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713=AP1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713=AN1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713=AO1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713=AP1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1423)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2022-06-30"]
["a6Q1R000000AJHaUAO","PAI-4968","Inactive","MCRAI-Malaria-13","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria","FR196-MCRAI-M",null,null,"Vector control","Other vector control measure(s)","To conduct a study on the efficacy of IEC/BCC materials in order to improve the efficacy and targeting.","To conduct a study on the efficacy of IEC/BCC materials in order to improve the efficacy and targeting.","NA Original Intervention: Evaluation of IEC/BCC (Lao PDR )","Low","26000","Low priority.","26000","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHa/view","2020-12-31","Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713=AN1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713=AO1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713=AP1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713=AN1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713=AO1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713=AP1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJHbUAO","PAI-4969","Active","MCRAI-Malaria-14","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria","FR196-MCRAI-M",null,null,"Program management","Other program management intervention(s)","1. The semi-annual meetings are to review 6 months activities and adjust annual workplan based on results 2. WHO TA fees in 2018 and 2019 are included in within allocation budget. In 2020, even though it is expected that the program's capacity has been strengthened, TA from WHO will still be necessary to develop elimination strategies for 2021 - 2025 period.","1. The semi-annual meetings are to review 6 months activities and adjust annual workplan based on results 2. WHO TA fees in 2018 and 2019 are included in within allocation budget. In 2020, even though it is expected that the program's capacity has been strengthened, TA from WHO will still be necessary to develop elimination strategies for 2021 - 2025 period.","NA Original Intervention: Conduct semi - annual meetings. Maintain technical assistance from WHO in 2020 (Viet Nam)","Low","464727","Low priority.","155727","0","0","0","309000","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJHb/view","2020-12-31","Malaria",309000," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713=AN1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713=AO1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713=AP1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713=AN1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713=AO1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713=AP1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1429)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJI0UAO","PAI-4994","Inactive","MCRAI-Malaria-5","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria","FR196-MCRAI-M",null,null,"Vector control","Other vector control measure(s)","Adding value to malaria outreach program.","Adding value to malaria outreach program.","NA Original Intervention: Promote LLIN among malaria risk population entering transmission areas (Thailand )","High","1500000","These are key activities that should be incorporated as part of regular allocation, if efficiencies are found during grant making.","1500000","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJI0/view","2020-12-31","Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713=AN1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713=AO1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713=AP1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713=AN1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713=AO1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713=AP1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1436)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJI4UAO","PAI-4998","Active","MCRAI-Malaria-9","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria","FR196-MCRAI-M",null,null,"Case management","Other case management intervention(s)","Communities mobilization and sensitization during Malaria day.","Communities mobilization and sensitization during Malaria day.","Listed intervention does not match the one in UQD updated form. Original Intervention: World Malaria Day (Cambodia )","Medium","3e+05","Community mobilization","0","0","103584","0","196416","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJI4/view","2020-12-31","Malaria",196416," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713=AN1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713=AO1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713=AP1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713=AN1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713=AO1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713=AP1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1440)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJI9UAO","PAI-5003","Active","MCSEAAFAO-HIV/AIDS-5","2017-2019","RT High Impact Asia","Multicountry South-Eastern Asia AFAO","HIV/AIDS","HIV/AIDS","FR543-MCSEAAFAO-H",null,null,"RSSH: National health strategies","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 187 for Philippines for year 2 second round grants","Additional amount to add to Within Allocation Budget Line 187 for Philippines for year 2 second round grants","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","High","119652.38",null,"0","0","0","0","119652.38","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJI9/view","2021-12-31","HIV/AIDS",119652.38," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713=AN1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713=AO1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713=AP1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713=AN1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713=AO1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713=AP1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1445)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJIAUA4","PAI-5004","Active","MCSEAAFAO-HIV/AIDS-6","2017-2019","RT High Impact Asia","Multicountry South-Eastern Asia AFAO","HIV/AIDS","HIV/AIDS","FR543-MCSEAAFAO-H",null,null,"RSSH: National health strategies","Other policy and governance intervention(s)","Additional amount to add to Within Allocation Budget Line 188 for Papua New Guinea for year 2 second round grants","Additional amount to add to Within Allocation Budget Line 188 for Papua New Guinea for year 2 second round grants","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with diseasespecific plans, health sector governance and financing","High","119652.38",null,"0","0","0","0","119652.38","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIA/view","2021-12-31","HIV/AIDS",119652.38," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713=AN1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713=AO1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713=AP1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713=AN1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713=AO1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713=AP1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1446)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJIFUA4","PAI-5009","Active","MDA-HIV/AIDS-1","2017-2019","RT Eastern Europe and Central Asia","Moldova","HIV/AIDS","HIV/AIDS","FR437-MDA-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Taking  into  consideration  the  need  to  cover  more PWID  with  prevention  programs  (according  to  new estimations)  and  the  flow  of  employed  persons,  it  is crucial   to   have   an   opportunity   to   train   the   new employed  persons  (most  of  them  outreach)onbasic harm   reduction issuesto   ensure   quality   service provision and minimal standards of services.","Taking  into  consideration  the  need  to  cover  more PWID  with  prevention  programs  (according  to  new estimations)  and  the  flow  of  employed  persons,  it  is crucial   to   have   an   opportunity   to   train   the   new employed  persons  (most  of  them  outreach)onbasic harm   reduction issuesto   ensure   quality   service provision and minimal standards of services.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Train service providers in basic harm reduction interventions","High","20981.93","The TRP considers harm reduction interventions and other inventions for people who inject drugs and their partners as high priority given the epidemiology of HIV in Moldova. In order to start expanded services, it will be necessary to train service providers in order to safeguard the quality of the services to be provided. Additionally, to the requested amount of EUR 11,197 for this activity, the TRP recommends 50% of the requested amount for the participation of members of the civil society in International events (EUR 7,500) to be allocated to extra training in harm reduction services or service provision","0","0","0","0","20981.93","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIF/view","2020-12-31","HIV/AIDS",20981.93," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713=AN1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713=AO1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713=AP1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713=AN1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713=AO1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713=AP1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1451)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJIKUA4","PAI-5014","Active","MDA-HIV/AIDS-14","2017-2019","RT Eastern Europe and Central Asia","Moldova","HIV/AIDS","HIV/AIDS","FR437-MDA-H",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","The established Harm Reduction Resource Centeris the only one consolidated center for providing technical support and trainings in harmreduction. It is important to maintain the specialist of the center, the website with developed resources in order to continue the  advocacy activities at local and national level (workshops / roundtables at central and local (rayon) level) to increase commitment for Harm Reduction of public authorities, improve coordination between LPAs, health and social services, civil society and other relevantactors.","The established Harm Reduction Resource Centeris the only one consolidated center for providing technical support and trainings in harmreduction. It is important to maintain the specialist of the center, the website with developed resources in order to continue the  advocacy activities at local and national level (workshops / roundtables at central and local (rayon) level) to increase commitment for Harm Reduction of public authorities, improve coordination between LPAs, health and social services, civil society and other relevantactors.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: RSSH - Community responses and systems. Original Intervention: Guidance and technical support to HIV service providers through Harm Reduction Resource Center.","High","61126.7","Low-threshold expertise, training and coordination in the field of harm reduction are some of the functions of the resource centre. This expertise is linked to one of the main key populations in Moldova. Knowledge and skills need to be kept up-to-date and therefore the proposed activity is considered high priority.","0","0","0","0","61126.7","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIK/view","2020-12-31","HIV/AIDS",61126.7," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713=AN1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713=AO1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713=AP1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713=AN1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713=AO1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713=AP1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1456)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJIPUA4","PAI-5019","Active","MDA-HIV/AIDS-3","2017-2019","RT Eastern Europe and Central Asia","Moldova","HIV/AIDS","HIV/AIDS","FR437-MDA-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","Providing   harm   reduction   services   through   mobile services has been launchedin 2017 and this modality of   preventive   services   provision   for   PWID   is   an important  opportunity  to  cover  the  PWID  in  territories with   luck   of   outreaches   and   due   to   diversity   of provided services: testing, medical counseling, etc.","Providing   harm   reduction   services   through   mobile services has been launchedin 2017 and this modality of   preventive   services   provision   for   PWID   is   an important  opportunity  to  cover  the  PWID  in  territories with   luck   of   outreaches   and   due   to   diversity   of provided services: testing, medical counseling, etc.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Provide harm reduction services through mobile services","High","273304.9","Harm reduction services through mobile outreach allows for extended linkage of people who inject drugs to services. This is a high priority in this hard -to -reach group.","0","0","0","0","273304.9","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIP/view","2020-12-31","HIV/AIDS",273304.90000000002," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713=AN1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713=AO1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713=AP1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713=AN1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713=AO1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713=AP1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJIQUA4","PAI-5020","Active","MDA-HIV/AIDS-4","2017-2019","RT Eastern Europe and Central Asia","Moldova","HIV/AIDS","HIV/AIDS","FR437-MDA-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","This intervention is very important to recruit additional new  clients,  by  providing  peer-to-peer  educational session  and  referring  them  to  NSP  sites  to  access services.   Estimated   750   additional   clients   to   be reached each year. Taking into consideration the new estimations    and    the established    targets,    this intervention  will  contribute  to  cover  more  PWID  with prevention services.","This intervention is very important to recruit additional new  clients,  by  providing  peer-to-peer  educational session  and  referring  them  to  NSP  sites  to  access services.   Estimated   750   additional   clients   to   be reached each year. Taking into consideration the new estimations    and    the established    targets,    this intervention  will  contribute  to  cover  more  PWID  with prevention services.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Develop and provide peer driven interventions for people who inject drugs","High","40399.51","The TRP considers this intervention high priority, as peer driven interventions are an essential part of the package for services that targetpeople who inject drugs.","0","0","0","0","40399.51","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIQ/view","2020-12-31","HIV/AIDS",40399.51," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713=AN1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713=AO1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713=AP1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713=AN1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713=AO1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713=AP1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1462)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJIVUA4","PAI-5025","Active","MDA-HIV/AIDS-9","2017-2019","RT Eastern Europe and Central Asia","Moldova","HIV/AIDS","HIV/AIDS","FR437-MDA-H",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","The sessions will be organized for MSM beneficiaries, III generation and young MSM from Chisinau and from Balti in order to provide information about MSM practices, services providers, education, stigma and discrimination, etc.","The sessions will be organized for MSM beneficiaries, III generation and young MSM from Chisinau and from Balti in order to provide information about MSM practices, services providers, education, stigma and discrimination, etc.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Information and communication sessions for men who have sex with men","High","4174.62","The TRP considers this intervention high priority as the information education and communication (IEC) proposed in this request is part of the package of prevention services aimed at behaviour change, empowerment and access to services for men who have sex with men. This intervention is therefore an important intervention for this key population in Moldova","0","0","0","0","4174.62","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIV/view","2020-12-31","HIV/AIDS",4174.62," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713=AN1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713=AO1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713=AP1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713=AN1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713=AO1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713=AP1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1467)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJIaUAO","PAI-5030","Active","MDA-Tuberculosis-5","2017-2019","RT Eastern Europe and Central Asia","Moldova","Tuberculosis","Tuberculosis","FR438-MDA-T",null,null,"Program management","Other program management intervention(s)","To support realization of the three operation researches realized by PI Institute of Phthysio-pneumology Chiril Draganiuc in 2019-2020. It will look into the issues of TB control activities in country and aim to: \"Evaluate resistance to new anti-TB drugs in Moldova\", \"MDR-TB at children in Moldova\" and \"Minimal inhibitory concentration of the anti-TB drugs\". The results should help to update treatment guidelines and national protocols using evidence-based data.","To support realization of the three operation researches realized by PI Institute of Phthysio-pneumology Chiril Draganiuc in 2019-2020. It will look into the issues of TB control activities in country and aim to: \"Evaluate resistance to new anti-TB drugs in Moldova\", \"MDR-TB at children in Moldova\" and \"Minimal inhibitory concentration of the anti-TB drugs\". The results should help to update treatment guidelines and national protocols using evidence-based data.","Grant went to 17/18 Oct 2017 GAC. The PAAR was approved on 24/10/17 and thus the grant sign off form did not have the UQD table. Lindsay said that if the PAAR goes is TRP approved after grant making, then any efficiences found would have already been included in PAAR, so technically there wont be more efficiences & thus the TRP amount can be the final amount. For simplifcation of reporting, the GAC date of the grant is recorded as the GAC date for UQD as well. Original Intervention: Operational researches in priority issues of TB and DRTB","Medium","89451.24","The TRP considers this intervention of medium priority. Additional sources under PAAR are requested for 3 operational research projects during 2019-2020: Evaluation of resistance to new anti-TB drugs in Moldova, MDR-TB in children, and Minimal inhibitory concentration of the anti-TB drugs\". The mentioned research projects are of course important, as they will help the NTP to up-date the treatment guidelines and national protocols using evidence-based data. However, TRP considers that strategic interventions towards strengthening MDR-TB control in the country at this stage (as high MDR-TB burden country) have highest priority compare to research activities.","0","0","0","0","89451.24","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIa/view","2020-12-31","Tuberculosis",89451.24," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713=AN1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713=AO1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713=AP1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713=AN1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713=AO1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713=AP1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1472)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJIfUAO","PAI-5035","Active","MDG-HIV/AIDS-11","2017-2019","RT Southern and Eastern Africa","Madagascar","HIV/AIDS","HIV/AIDS","FR547-MDG-H",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Given the poor quality and inconsistency of data, and the stock-outs of supplies, it is essential that managers receive training in monitoring and evaluation. This training should also improve the completeness of reports.","Given the poor quality and inconsistency of data, and the stock-outs of supplies, it is essential that managers receive training in monitoring and evaluation. This training should also improve the completeness of reports.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","7345",null,"0","0","0","0","7345","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIf/view","2020-12-31","HIV/AIDS",7345," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713=AN1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713=AO1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713=AP1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713=AN1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713=AO1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713=AP1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJIiUAO","PAI-5038","Active","MDG-HIV/AIDS-14","2017-2019","RT Southern and Eastern Africa","Madagascar","HIV/AIDS","HIV/AIDS","FR547-MDG-H",null,null,"RSSH: Health management information systems and M&E","Surveys","This refers to a contribution from the Global Fund grant toward the Madagascar HIV/AIDS seroprevalence study. Discussions about practical methodology for running and financing the study are ongoing with the various technical and financial partners (TFPs). Total estimated cost of the survey is US$ 1 million.","This refers to a contribution from the Global Fund grant toward the Madagascar HIV/AIDS seroprevalence study. Discussions about practical methodology for running and financing the study are ongoing with the various technical and financial partners (TFPs). Total estimated cost of the survey is US$ 1 million.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","5e+05",null,"0","0","0","0","5e+05","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIi/view","2020-12-31","HIV/AIDS",500000," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713=AN1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713=AO1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713=AP1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713=AN1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713=AO1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713=AP1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1480)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJImUAO","PAI-5042","Active","MDG-HIV/AIDS-18","2017-2019","RT Southern and Eastern Africa","Madagascar","HIV/AIDS","HIV/AIDS","FR547-MDG-H",null,null,"Prevention programs for other vulnerable populations","Diagnosis and treatment of STIs and other sexual health services for other vulnerable populations","It is essential that STI tests and drugs are available given the current prevalence of STIs, especially among the key populations. Madagascar is also aiming to eliminate congenital syphilis. This goal is dependent on the availability of STI drugs.  There is a high prevalence of syphilis among pregnant women.","It is essential that STI tests and drugs are available given the current prevalence of STIs, especially among the key populations. Madagascar is also aiming to eliminate congenital syphilis. This goal is dependent on the availability of STI drugs.  There is a high prevalence of syphilis among pregnant women.","NA Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for other vulnerable populations","Medium","2304096",null,"0","0","0","0","2304096","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIm/view","2020-12-31","HIV/AIDS",2304096," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713=AN1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713=AO1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713=AP1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713=AN1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713=AO1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713=AP1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1484)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJIrUAO","PAI-5047","Active","MDG-HIV/AIDS-22","2017-2019","RT Southern and Eastern Africa","Madagascar","HIV/AIDS","HIV/AIDS","FR547-MDG-H",null,null,"Program management","Grant management","This will cover a proportion of the running costs and human resources of the PR and the SRs implementing the grant. The allocation amount is not sufficient to cover the direct costs of managing the grant over the three years. This would also cover supervision of the SRs by the PR (Finance team), to support the SRs and implementation teams on the ground and ensure good mastery and understanding of the finance component down to the community level.","This will cover a proportion of the running costs and human resources of the PR and the SRs implementing the grant. The allocation amount is not sufficient to cover the direct costs of managing the grant over the three years. This would also cover supervision of the SRs by the PR (Finance team), to support the SRs and implementation teams on the ground and ensure good mastery and understanding of the finance component down to the community level.",null,"Low","378071","Under the within allocation grant, the two PRs were already allocated cumulatively $3.2 million for human resources and program administration (roughly 23%). PSIs proportion for these was already 30.3% of its grant amount. A repeat request is therefore not justified.The cost of the SR peer educator supervisors (US$ 363,316) may be included here as quality demand as well as costs for Supervision by the PR: US$ 13,194 and Procurement of computer equipment: US$ 1,561","0","0","0","0","378071","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIr/view","2020-12-31","HIV/AIDS",378071," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713=AN1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713=AO1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713=AP1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713=AN1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713=AO1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713=AP1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1489)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJIwUAO","PAI-5052","Active","MDG-HIV/AIDS-27","2017-2019","RT Southern and Eastern Africa","Madagascar","HIV/AIDS","HIV/AIDS","FR547-MDG-H",null,null,"Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Due to budget limitations, activities related to the practical use of new information communication technology (ICT) to provide free advice for young people (Facebook, website, internet connection) will be covered under the above allocation amount.","Due to budget limitations, activities related to the practical use of new information communication technology (ICT) to provide free advice for young people (Facebook, website, internet connection) will be covered under the above allocation amount.",null,"Low","23148","The TRP does not consider new information communication technology (ICT) tools to  provide free advice for young people to be a high impact program in this epidemic context.","0","0","0","0","23148","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIw/view","2020-12-31","HIV/AIDS",23148," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713=AN1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713=AO1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713=AP1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713=AN1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713=AO1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713=AP1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1494)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJIxUAO","PAI-5053","Active","MDG-HIV/AIDS-28","2017-2019","RT Southern and Eastern Africa","Madagascar","HIV/AIDS","HIV/AIDS","FR547-MDG-H",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","This covers attendance by the two technicians in the monitoring and evaluation technical group (GTSE) at the regional training workshop run by UNAIDS, on updating Spectrum software. This is to ensure national capacity to prepare, assess and revise national HIV/AIDS estimates.The activity costs cover airline tickets, registration fees and allowances for attending the regional training workshop in Dakar in 2019.","This covers attendance by the two technicians in the monitoring and evaluation technical group (GTSE) at the regional training workshop run by UNAIDS, on updating Spectrum software. This is to ensure national capacity to prepare, assess and revise national HIV/AIDS estimates.The activity costs cover airline tickets, registration fees and allowances for attending the regional training workshop in Dakar in 2019.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","27140",null,"0","0","0","0","27140","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJIx/view","2020-12-31","HIV/AIDS",27140," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713=AN1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713=AO1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713=AP1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713=AN1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713=AO1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713=AP1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1495)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJJ2UAO","PAI-5058","Active","MDG-HIV/AIDS-32","2017-2019","RT Southern and Eastern Africa","Madagascar","HIV/AIDS","HIV/AIDS","FR547-MDG-H",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","This activity involves holding an annual meeting to draft the DLIS work plan, to act as a dashboard for all stakeholders in the response. This workshop will be attended by partners and regional teams.The costs of holding the meeting cover transport, allowances, room hire, stationery, coffee breaks and organizational costs.","This activity involves holding an annual meeting to draft the DLIS work plan, to act as a dashboard for all stakeholders in the response. This workshop will be attended by partners and regional teams.The costs of holding the meeting cover transport, allowances, room hire, stationery, coffee breaks and organizational costs.",null,"Low","12268",null,"0","0","0","0","12268","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJ2/view","2020-12-31","HIV/AIDS",12268," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713=AN1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713=AO1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713=AP1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713=AN1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713=AO1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713=AP1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1500)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJJ7UAO","PAI-5063","Active","MDG-HIV/AIDS-5","2017-2019","RT Southern and Eastern Africa","Madagascar","HIV/AIDS","HIV/AIDS","FR547-MDG-H",null,null,"Treatment, care and support","HIV care","This refers to the procurement of laboratory supplies (biochemistry and hematology). This purchasing was originally planned under health systems strengthening (HSS), but had to be omitted following the prioritization of activities and also due to lack of funding.","This refers to the procurement of laboratory supplies (biochemistry and hematology). This purchasing was originally planned under health systems strengthening (HSS), but had to be omitted following the prioritization of activities and also due to lack of funding.",null,"High","869057",null,"0","0","0","0","869057","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJ7/view","2020-12-31","HIV/AIDS",869057," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713=AN1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713=AO1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713=AP1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713=AN1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713=AO1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713=AP1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1505)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJJCUA4","PAI-5068","Active","MDG-Malaria-1","2017-2019","RT Southern and Eastern Africa","Madagascar","Malaria","Malaria","FR75-MDG-M-01",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","To maintain the level of coverage achieved during the mass distribution campaign, continuous distribution will be implemented in 2019 in districts with a high level of endemicity, using the allocation amount. Implementing this intervention using the above allocation amount in 2020 will therefore help to maintain the expected annual progress, to reduce incidence by 40 percent in districts with a high level of endemicity.","To maintain the level of coverage achieved during the mass distribution campaign, continuous distribution will be implemented in 2019 in districts with a high level of endemicity, using the allocation amount. Implementing this intervention using the above allocation amount in 2020 will therefore help to maintain the expected annual progress, to reduce incidence by 40 percent in districts with a high level of endemicity.","NA Original Intervention: Long-lasting insecticidal nets  Continuous distribution","High","2648756","The TRP recommends this request as quality demand, but notes that the funds will not be required until after the mapping planned by applicant is complete. The TRP recommends that, should resources become available to fund this intervention, the Secretariat should ensure the action plan for implementation is aligned with the results of the mapping.","0","0","0","0","2648756","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJC/view","2021-06-30","Malaria",2648756," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713=AN1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713=AO1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713=AP1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713=AN1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713=AO1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713=AP1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJJDUA4","PAI-5069","Inactive","MDG-Malaria-2","2017-2019","RT Southern and Eastern Africa","Madagascar","Malaria","Malaria","FR75-MDG-M-01",null,null,"Case management","Other case management intervention(s)","To provide appropriate treatment for at least 95 percent of diagnosed malaria cases, continuous availability of treatment supplies  including artemisinin-based combination therapy (ACT) and rapid diagnostic tests (RDTs)  in the various health care facilities is essential. This sum from the above allocation amount will cover these requirements for 2021. This intervention will also contribute to achieving the target of zero malaria-related deaths by 2022.","To provide appropriate treatment for at least 95 percent of diagnosed malaria cases, continuous availability of treatment supplies  including artemisinin-based combination therapy (ACT) and rapid diagnostic tests (RDTs)  in the various health care facilities is essential. This sum from the above allocation amount will cover these requirements for 2021. This intervention will also contribute to achieving the target of zero malaria-related deaths by 2022.",null,"High","2148828",null,"2148828","0","0","0","0","1","0","2020-01-14 14:16:10","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJD/view","2021-06-30","Malaria",0," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713=AN1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713=AO1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713=AP1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713=AN1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713=AO1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713=AP1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1511)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJJIUA4","PAI-5074","Inactive","MDG-Malaria-7","2017-2019","RT Southern and Eastern Africa","Madagascar","Malaria","Malaria","FR75-MDG-M-01",null,null,"Vector control","Entomological monitoring","It has been noted that between 2013 and 2016, the amount of endophagic vectors became increasingly lower. This could lead to a major change in the use of indoor residual spraying campaigns (IRSCs) in certain areas. Changes of times at which mosquitoes bite have also been observed, with the insects becoming aggressive increasingly earlier. This amount will be used to continue the surveillance program.","It has been noted that between 2013 and 2016, the amount of endophagic vectors became increasingly lower. This could lead to a major change in the use of indoor residual spraying campaigns (IRSCs) in certain areas. Changes of times at which mosquitoes bite have also been observed, with the insects becoming aggressive increasingly earlier. This amount will be used to continue the surveillance program.",null,"Medium","180529",null,"180529","0","0","0","0","1","0","2020-01-14 14:16:25","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJI/view","2021-06-30","Malaria",0," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713=AN1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713=AO1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713=AP1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713=AN1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713=AO1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713=AP1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1516)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJJMUA4","PAI-5078","Inactive","MLI-HIV/AIDS-4","2017-2019","RT High Impact Africa 1","Mali","HIV/AIDS","RSSH","FR600-MLI-S",null,null,"RSSH: Integrated service delivery and quality improvement","Improving service delivery infrastructure","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.Significant direct impact on 3 diseases:Malaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.Malaria: Increased SP3 coverage among pregnant women from 40% to 60%.HIV: Increased PMTCT testing coverage from 50% to 70%.HIV: Increased PMTCT treatment coverage from 85% to 95%.TB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Significant direct impact on maternal and child health and increased cost-effectiveness of disease-specific investments.Significant direct impact on 3 diseases:Malaria: Increased cases treated from 2.1m to 5.6m (4.8 million additional cases treated with 12% GF contribution). Reaching 71% of WHO estimated cases versus 27% now.Malaria: Increased SP3 coverage among pregnant women from 40% to 60%.HIV: Increased PMTCT testing coverage from 50% to 70%.HIV: Increased PMTCT treatment coverage from 85% to 95%.TB: Increased TB notifications by 10%, pediatric TB notification by 10%, and treatment success above 80% from baseline in districts with the 190 targeted CSCom","Validaed by meeting the PO on 03/06/2019","Medium","1325857","The upgrading of theCSComshas been splitinto several cost categories.Though the completeCSComservice package is seen as quality demand to extend community health services, the total costs for the upgrading, remains high(US$80,400)for a basic health center to serve at the community level. Therefore,mostof these items are considered medium priority; if funding is available, the solar panels could be prioritized as they can be used to keep fridges and lights running and could also generateincome through charging of cell phones and other small equipment.","0","1325857","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJM/view",null,"RSSH",0," High Impact Africa 1","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713=AN1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713=AO1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713=AP1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713=AN1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713=AO1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713=AP1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AJJTUA4","PAI-5085","Active","MMR-TB/HIV-1","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Addressing limited capacity of health and community workforce will help remove bottlenecks for program implementation.","Addressing limited capacity of health and community workforce will help remove bottlenecks for program implementation.","NA Original Module: RSSH - Human resources for health, including community health workers","High","13815383","Limited capacity of health and community workforce is identified as a bottleneck in CN","4747070","0","0","0","9068313","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJT/view",null,"TB/HIV",9068313," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713=AN1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713=AO1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713=AP1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713=AN1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713=AO1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713=AP1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1527)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJJUUA4","PAI-5086","Active","MMR-TB/HIV-10","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"Prevention programs for MSM and TGs","Behavioral change as part of programs for MSM and TGs","The additional investment will support the program to reach more target population.","The additional investment will support the program to reach more target population.","NA Original Module: Prevention programs for men who have sex with men and transgender people","High","9468402","Based on the Optima conclusions that even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up","6796313","0","0","0","2672089","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJU/view",null,"TB/HIV",2672089," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713=AN1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713=AO1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713=AP1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713=AN1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713=AO1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713=AP1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1528)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJJZUA4","PAI-5091","Active","MMR-TB/HIV-15","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","The additional investment will support the program to reach more target population.","The additional investment will support the program to reach more target population.","24/12/17: replaced GAC UQD remaining amount of 3761207 with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","High","3183156","Based on the Optima conclusions that even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up","0","0","0","0","3183156","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJZ/view",null,"TB/HIV",3183156," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713=AN1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713=AO1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713=AP1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713=AN1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713=AO1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713=AP1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1533)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJJeUAO","PAI-5096","Active","MMR-TB/HIV-2","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Addressing high turnover and poor distribution will help remove barriers to access.","Addressing high turnover and poor distribution will help remove barriers to access.","24/12/2017: replaced $14961701 GAC UQD remaining amount with the TRP amount, on email from CT on 22/12/17 bcos the UQD reamining after GAC amount was more than TRP approved which is not right Original Module: RSSH - Human resources for health, including community health workers","High","225000","High turnover and poor distribution are identified as barriers to access in CN","0","0","0","0","225000","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJe/view",null,"TB/HIV",225000," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713=AN1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713=AO1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713=AP1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713=AN1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713=AO1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713=AP1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1538)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJJjUAO","PAI-5101","Active","MMR-TB/HIV-24","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","The additional investment will support the program to reach more target population.","The additional investment will support the program to reach more target population.",null,"High","280500","Based on the Optima conclusions that even, with an extremely tight budget, prevention for key populations has the highest priority, even over ART and With increased budget, programs with testing for both key and other populations should be scaled up","145066","0","0","0","135434","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJj/view",null,"TB/HIV",135434," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713=AN1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713=AO1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713=AP1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713=AN1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713=AO1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713=AP1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJJkUAO","PAI-5102","Active","MMR-TB/HIV-25","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","This intervention will fund critical activities to ensure the program is implemented and designed with quality.","This intervention will fund critical activities to ensure the program is implemented and designed with quality.",null,"High","25628432","Program management is critical to ensuring that program is implemented as designed with quality. It is necessary to ensure that program management costs are appropriate, however.","21634536","0","0","0","3993896","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJk/view",null,"TB/HIV",3993896," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713=AN1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713=AO1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713=AP1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713=AN1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713=AO1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713=AP1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1544)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJJpUAO","PAI-5107","Inactive","MMR-TB/HIV-3","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","836304","HMIS was identified as a major constrain in the NSP II review in 2015 with high impact in the three programs and beyond","836304","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJp/view",null,"TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713=AN1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713=AO1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713=AP1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713=AN1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713=AO1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713=AP1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJJuUAO","PAI-5112","Inactive","MMR-TB/HIV-34","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately.","NA Original Intervention: Pre-ART care","High","2743598","HIV prevention efforts and TB HIV efforts are identifying people living with HIV who, based on national policy, should be started on treatment immediately. For both decreased mortality and decreased HIV transmission HIV treatment is a high priority.","2743598","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJu/view",null,"TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713=AN1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713=AO1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713=AP1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713=AN1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713=AO1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713=AP1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJJzUAO","PAI-5117","Inactive","MMR-TB/HIV-4","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","1087576","HMIS was identified as a major constrain in the NSP II review in 2015 with high impact in the three programs and beyond","1087576","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJJz/view",null,"TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713=AN1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713=AO1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713=AP1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713=AN1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713=AO1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713=AP1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJK0UAO","PAI-5118","Inactive","MMR-TB/HIV-5","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","This intervention will allow improvement of HMIS, which was identified as a major constraint in the NSP II review in 2015 with high impact on the three programs and beyond.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","341440","HMIS was identified as a major constrain in the NSP II review in 2015 with high impact in the three programs and beyond","341440","0","0","0","0","1","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJK0/view",null,"TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713=AN1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713=AO1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713=AP1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713=AN1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713=AO1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713=AP1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJK4UAO","PAI-5122","Active","MMR-TB/HIV-9","2017-2019","RT High Impact Asia","Myanmar","HIV/TB","HIV/AIDS, Tuberculosis","FR301-MMR-C",null,null,"MDR-TB","Treatment: MDR-TB","The funds are requested for diagnosis and treatment for MDRTB.","The funds are requested for diagnosis and treatment for MDRTB.","NA Original Module: Multidrug-resistant TB","High","28302082","The funds are requested for diagnosis and treatment for MDR-TB. Interruption of transmission of drug resistant TB has a high priority.","25278756","0","0","0","3023326","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJK4/view",null,"TB/HIV",3023326," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713=AN1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713=AO1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713=AP1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713=AN1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713=AO1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713=AP1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJKBUA4","PAI-5129","Active","MNE-HIV/AIDS-5","2017-2019","RT Eastern Europe and Central Asia","Montenegro","HIV/AIDS","HIV/AIDS","FR392-MNE-H",null,null,"Prevention programs for other vulnerable populations","HIV testing services for other vulnerable populations","Montenegro needs two field-testing vehicles to conduct outreach work, in order to reach a higher number of KAPs and enable greater service delivery.","Montenegro needs two field-testing vehicles to conduct outreach work, in order to reach a higher number of KAPs and enable greater service delivery.",null,"High","56110.43","Testing coverage is currently low and self-testing has the potential to increase HIV testing coverage. It is also among the current World Health Organization (WHO) guidance. For these two reasons, the TRP considers this intervention as of high priority.","0","0","0","0","56110.43","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKB/view","2021-12-31","HIV/AIDS",56110.43," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713=AN1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713=AO1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713=AP1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713=AN1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713=AO1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713=AP1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJKGUA4","PAI-5134","Inactive","MNG-Tuberculosis-1","2017-2019","RT South East Asia","Mongolia","Tuberculosis","Tuberculosis","FR183-MNG-T",null,null,"TB care and prevention","Case detection and diagnosis","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.",null,"High","367802","TB diagnostic, GeneXpert and TB lamp proposed to support active case finding interventions. Improved diagnosis to TB is a high impact intervention. TB-LAMP investments from the proposed amount needs to be deprioritized.","0","367802","0","0","0","1","0","2020-01-14 14:28:43","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKG/view","2020-12-31","Tuberculosis",0," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713=AN1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713=AO1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713=AP1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713=AN1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713=AO1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713=AP1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJKHUA4","PAI-5135","Active","MNG-Tuberculosis-2","2017-2019","RT South East Asia","Mongolia","Tuberculosis","Tuberculosis","FR183-MNG-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","With introduction of new diagnostic technologies, lab staff require capacity building to work and provide update to other lab network units through on-the-job- training.  Diagnostic and treatment equipment at the National Centre of Infectious Disease has not been fully updated since 90s. TB hospital provides care for 2000 patients each year. Of these, 34.5% are surgical and 15% are pediatric cases. Increasiing trend of EPTB cases (41%) require modern equipment (3D ultrasound and CRAM) for accurate diagnosis and treatment of these cases.","With introduction of new diagnostic technologies, lab staff require capacity building to work and provide update to other lab network units through on-the-job- training.  Diagnostic and treatment equipment at the National Centre of Infectious Disease has not been fully updated since 90s. TB hospital provides care for 2000 patients each year. Of these, 34.5% are surgical and 15% are pediatric cases. Increasiing trend of EPTB cases (41%) require modern equipment (3D ultrasound and CRAM) for accurate diagnosis and treatment of these cases.","NA Original Intervention: Capacity building of 2 lab staff at National Reference TB Laboratory 3D ultrasound","High","10000","Lack of existing capacity and lab capacity building necessary to improve diagnosis is noted. Proposed capacity building of laboratory staff at the National reference laboratory is essential for high impact.","0","0","0","0","10000","0","0","2019-10-30 15:33:50","2019-10-30 15:33:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKH/view","2020-12-31","Tuberculosis",10000," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713=AN1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713=AO1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713=AP1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713=AN1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713=AO1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713=AP1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJKMUA4","PAI-5140","Active","MNG-Tuberculosis-7","2017-2019","RT South East Asia","Mongolia","Tuberculosis","Tuberculosis","FR183-MNG-T",null,null,"MDR-TB","Other MDR-TB intervention(s)","As the introduction of the shortened MDR-TB regimen, will require testing for risk factors, especially those related to hormonal changes, thyroid hormone testing equipment would be needed. Currently, this test is done privately, which not many patients can afford.","As the introduction of the shortened MDR-TB regimen, will require testing for risk factors, especially those related to hormonal changes, thyroid hormone testing equipment would be needed. Currently, this test is done privately, which not many patients can afford.","NA Original Module: Multidrug-resistant TB. Original Intervention: Diagnostic lab equipment for thyroid hormones testing","Low","23878","Proposed equipment is required to monitor MDR-TB treatment","0","0","0","0","23878","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKM/view","2020-12-31","Tuberculosis",23878," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713=AN1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713=AO1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713=AP1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713=AN1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713=AO1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713=AP1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJKRUA4","PAI-5145","Inactive","MOZ-Malaria-3","2017-2019","RT High Impact Africa 2","Mozambique","Malaria","Malaria","FR408-MOZ-M",null,null,"Vector control","Indoor residual spraying (IRS)","Insecticide cost (including procurement costs) to expand the spraying campaign of 2019 and 2020 from focalized to full coverage of 8 districts of Maputo province, 10 districts of Zambezia province and 8 districts of Nampula province.","Insecticide cost (including procurement costs) to expand the spraying campaign of 2019 and 2020 from focalized to full coverage of 8 districts of Maputo province, 10 districts of Zambezia province and 8 districts of Nampula province.","NA Original Intervention: Indoor residual spraying","High","15097428","IRS will be helpful in reducing the high burden of malaria in districts. IRS funding should only be targeting the high burden districts of northern and central Mozambique. This is where real impact, with such an expensive intervention, will be achieved. Since the mass campaign has just taken place, it is also important that the addition of another vector based intervention is done following WHO guidance.","11419523.84","3677904.16","0","0","0","1","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKR/view","2020-12-31","Malaria",0," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713=AN1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713=AO1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713=AP1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713=AN1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713=AO1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713=AP1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJKWUA4","PAI-5150","Active","MOZ-TB/HIV-1","2017-2019","RT High Impact Africa 2","Mozambique","HIV/TB","HIV/AIDS, Tuberculosis","FR217-MOZ-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","PAAR investment is requested to support reaching the following outcomes and impact: Increase in the proportion of PLHIV receiving ART from 54% in 2014 to 80% in 2020, and increased ART retention rates from 70% at 12 months in 2016 to 80% in 2020. This will lead to reduction in AIDS related mortality by 40% by 2020 and reduction in incidence by 40% by 2020.","PAAR investment is requested to support reaching the following outcomes and impact: Increase in the proportion of PLHIV receiving ART from 54% in 2014 to 80% in 2020, and increased ART retention rates from 70% at 12 months in 2016 to 80% in 2020. This will lead to reduction in AIDS related mortality by 40% by 2020 and reduction in incidence by 40% by 2020.","NA Original Intervention: Differenditated ART for people living with HIV/AIDS","High","70795813","The interventions are considered high priority as they address critical interventions which plan to increase the proportion of people living with HIV/AIDS receiving ART from 54% in 2014 to 80% in 2020, increase ART retention rates from 70% at 12 months in 2016 to 80% in 2020 and reduce AIDS-related mortality by 40% by 2020 and incidence by 40% by 2020.","3118755","37794658","0","0","29882400","0","0","2020-01-17 14:05:40","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKW/view","2020-12-31","TB/HIV",29882400," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713=AN1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713=AO1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713=AP1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713=AN1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713=AO1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713=AP1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJKXUA4","PAI-5151","Active","MOZ-TB/HIV-2","2017-2019","RT High Impact Africa 2","Mozambique","HIV/TB","HIV/AIDS, Tuberculosis","FR217-MOZ-C",null,null,"Other module","Other module","The PAAR for RSSH addresses critical gaps in management of health system risks to program implementation by providing adequate storage and distribution conditions for the supply chain, training of health workers and human resource managers, development of community based monitoring of disease management data, expansion of financial management systems and health information systems and supportive policy and programmatic environment for integrated service delivery of TB and HIV.","The PAAR for RSSH addresses critical gaps in management of health system risks to program implementation by providing adequate storage and distribution conditions for the supply chain, training of health workers and human resource managers, development of community based monitoring of disease management data, expansion of financial management systems and health information systems and supportive policy and programmatic environment for integrated service delivery of TB and HIV.","NA Original Module: RSSH. Original Intervention: PSM; QA HMIS M&E; Community: HRH","High","67016662","The interventions are considered high priority as they address critically important areas in view of bringing improvements to the supply chain infrastructure, staffing, staff capacity,HMIS and community systems capacity, which have been identified as critical risks for the Program.","3500000","0","0","0","63516662","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKX/view","2020-12-31","TB/HIV",63516662," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713=AN1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713=AO1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713=AP1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713=AN1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713=AO1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713=AP1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJKcUAO","PAI-5156","Active","MRT-HIV/AIDS-2","2017-2019","RT Middle East and North Africa","Mauritania","HIV/AIDS","HIV/AIDS","FR346-MRT-H",null,null,"Comprehensive prevention programs for MSM","Interventions for young men who have sex with men","Contracting 1 NGO for managing and monitoring the activities carried out by CSOs and MSM outreach workers The PAAR amount will allow for the extension to 3 other regions from year 2 for greater geographical coverage of the interventions and requiring the recruitment of an additional NGO to guarantee the quality of the interventions by the community outreach workers.","Contracting 1 NGO for managing and monitoring the activities carried out by CSOs and MSM outreach workers The PAAR amount will allow for the extension to 3 other regions from year 2 for greater geographical coverage of the interventions and requiring the recruitment of an additional NGO to guarantee the quality of the interventions by the community outreach workers.","NA Original Module: Comprehensive prevention programs for men who have sex with men","High","35657",null,"0","0","0","0","35657","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKc/view","2021-12-31","HIV/AIDS",35657," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713=AN1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713=AO1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713=AP1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713=AN1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713=AO1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713=AP1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJKhUAO","PAI-5161","Active","MRT-HIV/AIDS-7","2017-2019","RT Middle East and North Africa","Mauritania","HIV/AIDS","HIV/AIDS","FR346-MRT-H",null,null,"Treatment, care and support","Treatment adherence","IGA feasibility study for PLHIV: Ensuring the independence of PLHIV requires the creation of conditions that enable them to provide for their health needs and to cover a certain cost linked to ARV treatment. Experiments have been carried out through IGAs, but they have not been documented. This request in the above allocation amount will make it possible to conduct a feasibility study and provide the country with clarity regarding the effectiveness of this strategy.","IGA feasibility study for PLHIV: Ensuring the independence of PLHIV requires the creation of conditions that enable them to provide for their health needs and to cover a certain cost linked to ARV treatment. Experiments have been carried out through IGAs, but they have not been documented. This request in the above allocation amount will make it possible to conduct a feasibility study and provide the country with clarity regarding the effectiveness of this strategy.",null,"Medium","7540",null,"0","0","0","0","7540","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKh/view","2021-12-31",{"$f":"IF(OR(I1603=\"HIV/AIDS\",I1603=\"Tuberculosis\",I1603=\"Malaria\",I1603=\"RSSH\"),I1603, IF(I1603=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"HIV/AIDS"},{"$f":"VALUE(Y1603)","v":7540},{"$f":"RIGHT(F1603,LEN(F1603)-2)","v":" Middle East and North Africa"},"HIV/AIDS","HIV/AIDS",null,null,null,{"$f":"TRIM(AK1603)","v":""},{"$f":"TRIM(AL1603)","v":""},{"$f":"TRIM(AM1603)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713=AN1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713=AO1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713=AP1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IF(AE1603<>\"\",AE1603,IF(MAX(AQ1603,AR1603,AS1603,AT1603)<>0,MAX(AQ1603,AR1603,AS1603,AT1603),AU1603))","v":"2021-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713=AN1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713=AO1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713=AP1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IF(AE1603<>\"\",AE1603,IF(MAX(AW1603,AX1603,AY1603,AZ1603)<>0,MAX(AW1603,AX1603,AY1603,AZ1603),BA1603))","v":"2021-12-31"}]
["a6Q1R000000AJKmUAO","PAI-5166","Active","MRT-Tuberculosis-1","2017-2019","RT Middle East and North Africa","Mauritania","Tuberculosis","Tuberculosis","FR350-MRT-T",null,null,"TB care and prevention","Case detection and diagnosis","Screening activities for the key populations will make it possible/will continue to achieve the objectives of the End TB Strategy, in particular the search for subjects having had contact with contagious cases, children under 5 years of age, PLHIV, refugees, nomads, prisoners, diabetics, miners and the populations of the shanty towns in large cities. There are plans to open 5 new TTCs and to renovate 5 other TTCs to broaden access to diagnosis and to improve health care and the training of personnel.","Screening activities for the key populations will make it possible/will continue to achieve the objectives of the End TB Strategy, in particular the search for subjects having had contact with contagious cases, children under 5 years of age, PLHIV, refugees, nomads, prisoners, diabetics, miners and the populations of the shanty towns in large cities. There are plans to open 5 new TTCs and to renovate 5 other TTCs to broaden access to diagnosis and to improve health care and the training of personnel.",null,"High","415730",null,"0","0","0","0","415730","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKm/view","2021-12-31","Tuberculosis",415730," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713=AN1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713=AO1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713=AP1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713=AN1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713=AO1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713=AP1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJKrUAO","PAI-5171","Active","MRT-Tuberculosis-6","2017-2019","RT Middle East and North Africa","Mauritania","Tuberculosis","Tuberculosis","FR350-MRT-T",null,null,"TB care and prevention","Engaging all care providers (TB care and prevention)","Due to a lack of data on the contribution of the private sector to detecting cases and for the need of prioritization, activities aimed at involving the private sector in the referral of suspected cases of TB and in patient follow-up (inventory of private facilities, development of a PPM guide with technical assistance and of memoranda of understanding with the private facilities, discussion meetings and training for private sector personnel) have been selected.","Due to a lack of data on the contribution of the private sector to detecting cases and for the need of prioritization, activities aimed at involving the private sector in the referral of suspected cases of TB and in patient follow-up (inventory of private facilities, development of a PPM guide with technical assistance and of memoranda of understanding with the private facilities, discussion meetings and training for private sector personnel) have been selected.",null,"Low","283384","The TRP considers that TB care and prevention activities such as developing inventory for private facilities, development of public private-mix (PPM) guide with technical assistance are not related to PPM service delivery and given the operational challenges identified and priorities are considered as low priority.","0","0","0","0","283384","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKr/view","2021-12-31","Tuberculosis",283384," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713=AN1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713=AO1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713=AP1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713=AN1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713=AO1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713=AP1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJKtUAO","PAI-5173","Active","MUS-HIV/AIDS-2","2017-2019","RT Southern and Eastern Africa","Mauritius","HIV/AIDS","HIV/AIDS","FR223-MUS-H",null,null,"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","This Key population has a concentrated epidemic and are usually well hidden in the general population because of bisexuality amongst them. They pose a silent bridge to the general population. The request is to increase coverage of prevention activities and increased condom and lubricant distribution.","This Key population has a concentrated epidemic and are usually well hidden in the general population because of bisexuality amongst them. They pose a silent bridge to the general population. The request is to increase coverage of prevention activities and increased condom and lubricant distribution.","NA Original Module: Prevention programs for key populations. Original Intervention: Defined prevention package of services for MSM & TG","High","705585","MSM, with HIV prevalence of 17%, as well as TG people, remain in need of services related to HIV prevention. Interventions that target this key population will equally help the program to reach its targets.","0","0","0","0","705585","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKt/view","2020-12-31","HIV/AIDS",705585," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713=AN1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713=AO1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713=AP1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713=AN1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713=AO1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713=AP1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJKyUAO","PAI-5178","Active","MWI-Malaria-12","2017-2019","RT Southern and Eastern Africa","Malawi","Malaria","Malaria","FR100-MWI-M-01",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Additional funding is being requested for 2020 to ensure that the key SBCC activities are maintained in order to ensure maintained uptake and utilization of the malaria interventions implemented during this period. Specifically, this will include the following activities: Support National Malaria Commemorative Days(SADC Week and World Malaria Day); Identify and orient media team on emerging issues, successes and challenges in malaria programming; Document malaria success stories through Media visits to different communities; Conduct School Based Malaria Awareness Campaign; Conduct training of Primary Teachers as Malaria School Patrons/Matrons; Conduct Community Meetings with Malaria Champions; Conduct malaria information dissemination sessions (malaria open days and community dialogues). Train Community Structures (CLANS) in Care Group Model for dissemination of Malaria messages.","Additional funding is being requested for 2020 to ensure that the key SBCC activities are maintained in order to ensure maintained uptake and utilization of the malaria interventions implemented during this period. Specifically, this will include the following activities: Support National Malaria Commemorative Days(SADC Week and World Malaria Day); Identify and orient media team on emerging issues, successes and challenges in malaria programming; Document malaria success stories through Media visits to different communities; Conduct School Based Malaria Awareness Campaign; Conduct training of Primary Teachers as Malaria School Patrons/Matrons; Conduct Community Meetings with Malaria Champions; Conduct malaria information dissemination sessions (malaria open days and community dialogues). Train Community Structures (CLANS) in Care Group Model for dissemination of Malaria messages.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Communication","Low","445803","Insufficient justification for effectiveness from previous funding and for increase","0","0","0","0","445803","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJKy/view","2020-12-31","Malaria",445803," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713=AN1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713=AO1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713=AP1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713=AN1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713=AO1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713=AP1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJL3UAO","PAI-5183","Active","MWI-Malaria-4","2017-2019","RT Southern and Eastern Africa","Malawi","Malaria","Malaria","FR100-MWI-M-01",null,null,"Case management","Integrated community case management (ICCM)","In order to improve competences of the HSAs manning village clinics, the programme will continue to conduct quarterly supportive supervision and mentorship on case management at Community level (iCCM supervision & mentorship).","In order to improve competences of the HSAs manning village clinics, the programme will continue to conduct quarterly supportive supervision and mentorship on case management at Community level (iCCM supervision & mentorship).","NA Original Intervention: Integrated community case management (iCCM)","High","80000","iCCM in community takes priority for remote areas","0","0","0","0","80000","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJL3/view","2020-12-31","Malaria",80000," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713=AN1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713=AO1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713=AP1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713=AN1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713=AO1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713=AP1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJL4UAO","PAI-5184","Active","MWI-Malaria-5","2017-2019","RT Southern and Eastern Africa","Malawi","Malaria","Malaria","FR100-MWI-M-01",null,null,"Vector control","Indoor residual spraying (IRS)","The current evidence on insecticide resistance in Malawi is sufficient to justify immediate action aimed at preserving the susceptibility of malaria vectors to pyrethroids. As a result and, as per WHO recommendation (reference GRIP) strategic implementation of IRS with non-pyrethroid insecticides in targeted areas with documented resistance and high malaria burden will be prioritized to be implemented with support from above allocation funding. This funding is being requested to support indoor residual spraying in 7 strategically selected districts over the period of 2019-2020 ensuring 79% of Malawis population living in the 7 highest malaria burden districts receives 100% protection by IRS in combination with LLINs. The expected impact will not only be the effective management of the current resistance to pyrethroids but also significant reduction of malaria transmission in these high burden districts.","The current evidence on insecticide resistance in Malawi is sufficient to justify immediate action aimed at preserving the susceptibility of malaria vectors to pyrethroids. As a result and, as per WHO recommendation (reference GRIP) strategic implementation of IRS with non-pyrethroid insecticides in targeted areas with documented resistance and high malaria burden will be prioritized to be implemented with support from above allocation funding. This funding is being requested to support indoor residual spraying in 7 strategically selected districts over the period of 2019-2020 ensuring 79% of Malawis population living in the 7 highest malaria burden districts receives 100% protection by IRS in combination with LLINs. The expected impact will not only be the effective management of the current resistance to pyrethroids but also significant reduction of malaria transmission in these high burden districts.","The TRP split this intervention into two, with different priorities.  The full funding amount still appears but it is split between this and another intervention.  The total requested was $51m and this was split into $29m and $22m interventions Original Intervention: Indoor residual spraying","High","29491636","Out of 7 proposed districts, maximum 4 due to capacity constraints (avoiding the one that will covered through partner investment and vaccine districts)","0","0","0","0","29491636","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJL4/view","2020-12-31","Malaria",29491636," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713=AN1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713=AO1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713=AP1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713=AN1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713=AO1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713=AP1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJL9UAO","PAI-5189","Inactive","MWI-TB/HIV-1","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"Prevention programs for general population","Diagnosis and treatment of STIs and other sexual health services for general population","Training of HCWs in STI syndromic management approach ($0.36M) Important for ongoing capacity building and treatment of STIs and prevention of HIV; already partially funded within allocation; allows full training roll out to HCWs. The STI program has no alternative sources of funding.","Training of HCWs in STI syndromic management approach ($0.36M) Important for ongoing capacity building and treatment of STIs and prevention of HIV; already partially funded within allocation; allows full training roll out to HCWs. The STI program has no alternative sources of funding.","NA Original Intervention: Diagnosis and treatment of sexually transmitted infections and other sexual health services for the general population","High","360000","Training is necessary for effectiveness of STI treatment.","360000","0","0","0","0","1","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJL9/view","2020-12-31","TB/HIV",0," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713=AN1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713=AO1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713=AP1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713=AN1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713=AO1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713=AP1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLEUA4","PAI-5194","Active","MWI-TB/HIV-14","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Double investment for school-based RFHS referral agents ($0.33M) Catalytic funding will allow initial roll out of 400 referral agents. Above allocation funding will provide sufficient funding for an additional 400 (800 total).","Double investment for school-based RFHS referral agents ($0.33M) Catalytic funding will allow initial roll out of 400 referral agents. Above allocation funding will provide sufficient funding for an additional 400 (800 total).","NA Original Intervention: Linkages of HIV, RMNCH, and TB programs for adolescents, girls and young women","High","330000","This will increase the effectiveness and efficiency of catalytic funding that has also been recommended.","0","0","0","0","330000","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLE/view","2020-12-31","TB/HIV",330000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713=AN1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713=AO1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713=AP1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713=AN1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713=AO1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713=AP1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLJUA4","PAI-5199","Active","MWI-TB/HIV-19","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"TB/HIV","TB/HIV collaborative interventions","TB/HIV collaborative interventions (USD 528,233) Above allocation resources will be used to improve screening for TB in ART and PMTCT clinics. In particular, this will be used for hiring and training of a designated cadre placed in 60 high volume district hospitals, and CHAM facilities, which will scale up systematic TB screening. This cadre will also contribute to overall improved case funding in clinical settings. TB/HIV above allocation funds will also be used for the procurement of Omni Xpert machines and cartridges. As small, portable and batterypowered point of care (POC) devices, Omni machines will decentralize Xpert testing capability to nonXpert sites which currently rely on microscopy. This POC technology is expected to provide greater Funding Request: Tailored to Material Change 15 December 2016 34 incentive for HCWs to conduct TB screening among HIV patients as they will be able to deliver results rapidly; the machines contain both HIV and TB testing capacity; and are relatively easy to use. Omni machines will be prioritized for remote, rural settings, piloted as mobile equipment at selected CSCPs, and to integrate EID and VL testing. Funds will also be used for corresponding training of HCWs, and routine monitoring of this activity through regular review meetings.","TB/HIV collaborative interventions (USD 528,233) Above allocation resources will be used to improve screening for TB in ART and PMTCT clinics. In particular, this will be used for hiring and training of a designated cadre placed in 60 high volume district hospitals, and CHAM facilities, which will scale up systematic TB screening. This cadre will also contribute to overall improved case funding in clinical settings. TB/HIV above allocation funds will also be used for the procurement of Omni Xpert machines and cartridges. As small, portable and batterypowered point of care (POC) devices, Omni machines will decentralize Xpert testing capability to nonXpert sites which currently rely on microscopy. This POC technology is expected to provide greater Funding Request: Tailored to Material Change 15 December 2016 34 incentive for HCWs to conduct TB screening among HIV patients as they will be able to deliver results rapidly; the machines contain both HIV and TB testing capacity; and are relatively easy to use. Omni machines will be prioritized for remote, rural settings, piloted as mobile equipment at selected CSCPs, and to integrate EID and VL testing. Funds will also be used for corresponding training of HCWs, and routine monitoring of this activity through regular review meetings.",null,"High","528233","Omni expert machines for TB testing among PLHIV cases","0","0","0","0","528233","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLJ/view","2020-12-31","TB/HIV",528233," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713=AN1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713=AO1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713=AP1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713=AN1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713=AO1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713=AP1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLKUA4","PAI-5200","Active","MWI-TB/HIV-2","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"HIV Testing Services","Differentiated HIV testing services","HTS trainings ($6.20M) Covers half of the need for skills intensive training. Also covers in full: 1) trainings to allow expansion of HDAs to non-PEPFAR-supported facilities. HDAs have proven instrumental in expansion of HTS for reaching 1st 90; 2) orientation in Bioline rapid test kit. This has been endorsed as the first test in the national HIV testing algorithm; 3) district quarterly reviews; and 4) district mentorship.","HTS trainings ($6.20M) Covers half of the need for skills intensive training. Also covers in full: 1) trainings to allow expansion of HDAs to non-PEPFAR-supported facilities. HDAs have proven instrumental in expansion of HTS for reaching 1st 90; 2) orientation in Bioline rapid test kit. This has been endorsed as the first test in the national HIV testing algorithm; 3) district quarterly reviews; and 4) district mentorship.","26/12/2019: Efficiencies (fiels Further efficiencies applied after reprogramming (US$) column AC) due to Portfolio Optimization.","High","6200000","Increased testing through innovative approaches is one of the major changes in approach in this Funding request.","2387275.39","0","0","0","3812724.61","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLK/view","2020-12-31","TB/HIV",3812724.61," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713=AN1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713=AO1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713=AP1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713=AN1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713=AO1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713=AP1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLPUA4","PAI-5205","Active","MWI-TB/HIV-24","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"MDR-TB","Prevention for MDR-TB","MDR TB Prevention (USD 600,000): With the increase in TB diagnosis and treatment that will occur through the emphasis on case detection and diagnosis in this FR, effective infection control measures must be put in place. This line item will be used for the upgrading of MDR-TB wards in three central hospitals to include negative pressure isolation rooms.","MDR TB Prevention (USD 600,000): With the increase in TB diagnosis and treatment that will occur through the emphasis on case detection and diagnosis in this FR, effective infection control measures must be put in place. This line item will be used for the upgrading of MDR-TB wards in three central hospitals to include negative pressure isolation rooms.","NA Original Module: Multidrug-resistant TB","High","6e+05","MDR-TB infection control activities","0","0","0","0","6e+05","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLP/view","2020-12-31","TB/HIV",600000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713=AN1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713=AO1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713=AP1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713=AN1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713=AO1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713=AP1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLUUA4","PAI-5210","Active","MWI-TB/HIV-29","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"Other module","Other module","These funds will be used towards salaries and benefits for two additional data clerks per facility for 600 facilities and builds on M&E capacity development plans within allocation.","These funds will be used towards salaries and benefits for two additional data clerks per facility for 600 facilities and builds on M&E capacity development plans within allocation.","NA Original Module: Other modules. Original Intervention: Other","High","4846588","Critical support for data information staff","1431628.88","0","0","0","3414959.12","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLU/view","2020-12-31","TB/HIV",3414959.12," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713=AN1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713=AO1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713=AP1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713=AN1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713=AO1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713=AP1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLZUA4","PAI-5215","Active","MWI-TB/HIV-33","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","These funds will be used to cover M&E printing costs and CMED activities that build on activities found both within allocation and in the catalytic investment funding.","These funds will be used to cover M&E printing costs and CMED activities that build on activities found both within allocation and in the catalytic investment funding.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","873425","Integral part of project management and monitoring","0","0","0","0","873425","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLZ/view","2020-12-31","TB/HIV",873425," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713=AN1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713=AO1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713=AP1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713=AN1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713=AO1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713=AP1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLbUAO","PAI-5217","Active","MWI-TB/HIV-35","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"Treatment, care and support","Treatment monitoring - Viral load","Point of care for VL/EID ($7.62M) Point of Care is critical for patient monitoring and early provision of lifesaving interventions The Ministry of Health with support from CHAI conducted a POC mapping and identified 99 Health facilities that would benefit from Point of Care for VL/EID. High volume sites will be considered for deployment of POC, because of availability of infrastructure and linkage to care for higher throughput. This will enable providers make timely clinical decisions to switch failing patients to second/third line ART. This request will enable the Ministry of Health to procure an additional 15 platforms and procure 50,000 viral load tests and 15,000 EID tests. This will complement existing POC investments available in country including funding from UNITAID for 2017 to 2019.","Point of care for VL/EID ($7.62M) Point of Care is critical for patient monitoring and early provision of lifesaving interventions The Ministry of Health with support from CHAI conducted a POC mapping and identified 99 Health facilities that would benefit from Point of Care for VL/EID. High volume sites will be considered for deployment of POC, because of availability of infrastructure and linkage to care for higher throughput. This will enable providers make timely clinical decisions to switch failing patients to second/third line ART. This request will enable the Ministry of Health to procure an additional 15 platforms and procure 50,000 viral load tests and 15,000 EID tests. This will complement existing POC investments available in country including funding from UNITAID for 2017 to 2019.","26/12/2019: Efficiencies (fiels Further efficiencies applied after reprogramming (US$) column AC) due to Portfolio Optimization. Original Intervention: Treatment monitoring  Viral load","Medium","7620000","Increasing access to viral load supports maintenance of high national viral suppression rate of 90.8%","3674497.99","0","0","0","3945502.01","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLb/view","2020-12-31","TB/HIV",3945502.01," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713=AN1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713=AO1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713=AP1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713=AN1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713=AO1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713=AP1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLgUAO","PAI-5222","Active","MWI-TB/HIV-4","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Enhanced linkages to care ($0.40M) Additional activities to strengthen FSW programming linkage to care and monitoring in current 11 districts.","Enhanced linkages to care ($0.40M) Additional activities to strengthen FSW programming linkage to care and monitoring in current 11 districts.","NA Original Intervention: Other interventions for sex workers and their clients","High","4e+05","Increased comprehensive programming for key populations will be increasingly needed to control the epidemic as incidence among the general population declines.","0","0","0","0","4e+05","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLg/view","2020-12-31","TB/HIV",400000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713=AN1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713=AO1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713=AP1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713=AN1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713=AO1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713=AP1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLlUAO","PAI-5227","Active","MWI-TB/HIV-5","2017-2019","RT Southern and Eastern Africa","Malawi","HIV/TB","HIV/AIDS, Tuberculosis","FR100-MWI-C",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Drop-in centers for MSM ($1.08M) Establish one drop-in center per district to facilitate provision and linkages of non-biomedical and biomedical services.","Drop-in centers for MSM ($1.08M) Establish one drop-in center per district to facilitate provision and linkages of non-biomedical and biomedical services.","Amount for this component is combined. Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","High","1080000","Increased comprehensive programming for key populations will be increasingly needed to control the epidemic as incidence among the general population declines.","0","0","0","0","1080000","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLl/view","2020-12-31","TB/HIV",1080000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713=AN1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713=AO1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713=AP1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713=AN1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713=AO1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713=AP1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLqUAO","PAI-5232","Active","NAM-Malaria-1","2017-2019","RT Southern and Eastern Africa","Namibia","Malaria","Malaria","FR224-NAM-M-01",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Good surveillance data is the backbone of Namibias elimination programme, allowing robust targeting of all other interventions designed at halting transmission in all foci.This amount includes continued support for implementation of surveillance by 4 surveillance officers in the non-prioritized regions in year 1 and 2 to ensure adequate transmission time to the government structures in line with the ongoing government restructuring.","Good surveillance data is the backbone of Namibias elimination programme, allowing robust targeting of all other interventions designed at halting transmission in all foci.This amount includes continued support for implementation of surveillance by 4 surveillance officers in the non-prioritized regions in year 1 and 2 to ensure adequate transmission time to the government structures in line with the ongoing government restructuring.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","177136","The TRP recommends that this activity is prioritized as surveillance data is important for malaria elimination. Good data would allow for effective targeting of interventions.","0","0","0","0","177136","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLq/view","2020-12-31","Malaria",177136," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713=AN1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713=AO1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713=AP1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713=AN1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713=AO1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713=AP1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1674)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLrUAO","PAI-5233","Active","NAM-Malaria-2","2017-2019","RT Southern and Eastern Africa","Namibia","Malaria","Malaria","FR224-NAM-M-01",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","In order to coordinate the MOHSS strategies on malaria elimination with the community response, the NVDCP proposes the recruitment of a Community-based Interventions Coordinator to ensure increased acceptance of indoor residual spraying and use of long lasting insecticide treated nets. This amount includes the salary of this individual for Years 1 & 2 of the grant.","In order to coordinate the MOHSS strategies on malaria elimination with the community response, the NVDCP proposes the recruitment of a Community-based Interventions Coordinator to ensure increased acceptance of indoor residual spraying and use of long lasting insecticide treated nets. This amount includes the salary of this individual for Years 1 & 2 of the grant.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Recruitment of a community based coordinator","High","48692","The TRP finds that community mobilization will be important for malaria elimination  especially given the remoteness of some of the vulnerable populations. It is expected that this coordinator would work with all stakeholders including the CSOs to mobilize communities in malaria elimination efforts.","0","0","0","0","48692","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLr/view","2020-12-31","Malaria",48692," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713=AN1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713=AO1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713=AP1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713=AN1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713=AO1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713=AP1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1675)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJLwUAO","PAI-5238","Active","NAM-Malaria-7","2017-2019","RT Southern and Eastern Africa","Namibia","Malaria","Malaria","FR224-NAM-M-01",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Surveillance officers at district-level will provide an opportunity to collect, analyse and use data at local level. The amount covers district surveillance officers for Zambezi, Kavango Eeat and West, and Ohangwena regions in Years 1 & 2 to strengthen surveillance as per National Strategic Plan (2017-2022).","Surveillance officers at district-level will provide an opportunity to collect, analyse and use data at local level. The amount covers district surveillance officers for Zambezi, Kavango Eeat and West, and Ohangwena regions in Years 1 & 2 to strengthen surveillance as per National Strategic Plan (2017-2022).","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: District Surveillance Officers implementation and coordination of malaria surveillance","Medium","264498","Surveillance is critical for malaria elimination in Namibia particularly at district level. Surveillance officers at district-level will provide an opportunity to collect, analyse and use data at local level and to allow for timely intervention could be possible","0","0","0","0","264498","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJLw/view","2020-12-31","Malaria",264498," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713=AN1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713=AO1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713=AP1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713=AN1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713=AO1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713=AP1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1680)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJM1UAO","PAI-5243","Active","NAM-TB/HIV-11","2017-2019","RT Southern and Eastern Africa","Namibia","HIV/TB","HIV/AIDS, Tuberculosis","FR229-NAM-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","This is expected to support PLHIV by providing nutritional support to those most in need and unable to meet their daily requirements to access therapeutic food, encouraging them to seek timely treatment and adhere to ART.","This is expected to support PLHIV by providing nutritional support to those most in need and unable to meet their daily requirements to access therapeutic food, encouraging them to seek timely treatment and adhere to ART.","NA Original Intervention: Other interventions for treatment","Low","1360888","Patient monitoring and support are included in the programme supported by the government and other partners","0","0","0","0","1360888","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJM1/view","2020-12-31","TB/HIV",1360888," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713=AN1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713=AO1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713=AP1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713=AN1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713=AO1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713=AP1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1685)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJM6UAO","PAI-5248","Active","NAM-TB/HIV-2","2017-2019","RT Southern and Eastern Africa","Namibia","HIV/TB","HIV/AIDS, Tuberculosis","FR229-NAM-C",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The M&E systems in Namibia are currently very weak. These activities which support improvements in routine monitoring and evaluation at district, regional and national level are expected to result in more timely and accurate information for reporting and decision making.","The M&E systems in Namibia are currently very weak. These activities which support improvements in routine monitoring and evaluation at district, regional and national level are expected to result in more timely and accurate information for reporting and decision making.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","High","3134809","Strengthening of HMIS addresses a clear weakness of the system, and it is instrumental for better impact of disease control programmes.","0","0","0","0","3134809","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJM6/view","2020-12-31","TB/HIV",3134809," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713=AN1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713=AO1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713=AP1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713=AN1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713=AO1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713=AP1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1690)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJM7UAO","PAI-5249","Active","NAM-TB/HIV-3","2017-2019","RT Southern and Eastern Africa","Namibia","HIV/TB","HIV/AIDS, Tuberculosis","FR229-NAM-C",null,null,"Prevention programs for adolescents and youth, in and out of school","HIV testing services for adolescents and youth, in and out of school","This activity is expected to expand the accessibility and quality of PITC and therefore encourage more AGYW to access to HIV testing and know their results. Specific numbers in terms of targets to be reached and the minimum package of interventions are yet to be formulated. This is expected to be completed within the next two months.","This activity is expected to expand the accessibility and quality of PITC and therefore encourage more AGYW to access to HIV testing and know their results. Specific numbers in terms of targets to be reached and the minimum package of interventions are yet to be formulated. This is expected to be completed within the next two months.",null,"High","150000","The TRP supports the increased coverage of adolescent girls and young women, who are one of the identified vulnerable populations.","0","0","0","0","150000","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJM7/view","2020-12-31","TB/HIV",150000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713=AN1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713=AO1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713=AP1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713=AN1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713=AO1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713=AP1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1691)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMCUA4","PAI-5254","Active","NAM-TB/HIV-8","2017-2019","RT Southern and Eastern Africa","Namibia","HIV/TB","HIV/AIDS, Tuberculosis","FR229-NAM-C",null,null,"Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","This activity includes training so that care workers are trained in PrEP and are able to offer care and support to MSM.","This activity includes training so that care workers are trained in PrEP and are able to offer care and support to MSM.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre-exposure prophylaxis (PrEP) for men who have sex with men","Medium","63237","PrEP interventions are important, if not covered by other actors.","0","0","0","0","63237","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMC/view","2020-12-31","TB/HIV",63237," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713=AN1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713=AO1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713=AP1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713=AN1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713=AO1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713=AP1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1696)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMHUA4","PAI-5259","Active","NER-Malaria-4","2017-2019","RT Western Africa","Niger","Malaria","Malaria","FR504-NER-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2020 Niger intends to run a mass LLIN distribution campaign in the hypoendemic districts of Tahoua and Agadez regions (1,246,595 people) to protect the population against vector-borne diseases such as malaria and Rift Valley fever. These zones have not been covered since 2009.","In 2020 Niger intends to run a mass LLIN distribution campaign in the hypoendemic districts of Tahoua and Agadez regions (1,246,595 people) to protect the population against vector-borne diseases such as malaria and Rift Valley fever. These zones have not been covered since 2009.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","2601638.42","LLINs in a COE are value for money and necessary for epidemic-prone areas.","0","0","0","0","2601638.42","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMH/view","2020-12-31","Malaria",2601638.42," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713=AN1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713=AO1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713=AP1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713=AN1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713=AO1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713=AP1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1701)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2020-12-31"]
["a6Q1R000000AJMNUA4","PAI-5265","Active","NGA-HIV/AIDS-5","2017-2019","RT High Impact Africa 1","Nigeria","HIV/AIDS","HIV/AIDS","FR604-NGA-H",null,null,"Treatment, care and support","Other program management intervention(s)","System Strengthening for Pharmacovigilance (PV) & HIV Drug Resistance (HIV-DR) Monitoring Reduce ARVs adverse effects and drug resistance related deaths/morbidity by:- Strengthening capacity of NAFDAC in managing PV monitoring, based on UNAIDS/WHO assessment- Pharmacovigilance active monitoring cohorts for ARVs- Conducting combined PDR/ADR survey - Assessing pediatric ADR - Strengthening stakeholders coordination on HIV-DR","System Strengthening for Pharmacovigilance (PV) & HIV Drug Resistance (HIV-DR) Monitoring Reduce ARVs adverse effects and drug resistance related deaths/morbidity by:- Strengthening capacity of NAFDAC in managing PV monitoring, based on UNAIDS/WHO assessment- Pharmacovigilance active monitoring cohorts for ARVs- Conducting combined PDR/ADR survey - Assessing pediatric ADR - Strengthening stakeholders coordination on HIV-DR",null,"High","6497265",null,"0","0","0","0","6497265","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMN/view","2020-12-31","HIV/AIDS",6497265," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713=AN1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713=AO1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713=AP1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713=AN1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713=AO1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713=AP1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1707)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMOUA4","PAI-5266","Active","NGA-HIV/AIDS-6","2017-2019","RT High Impact Africa 1","Nigeria","HIV/AIDS","HIV/AIDS","FR604-NGA-H",null,null,"TB/HIV","Collaborative activities with other programs and sectors (TB care and prevention)","TB-HIV Collaborative services To respond to:1. Challenges with Xpert optimization activities included in TB grant 2. Low TB preventive therapy coverage because of clinicians reluctance to placing clients on TPT, challenges of adherence to the 6 months INH regimen, and stock out of INH/Cotrimoxazole (yet to be procured by Government)Activities include: o support to staffing of high volume ART siteso additional GeneXpert Cartridges o 16 Modular machines to be installed at 6 high volume ART sites o relocation of existing 4 modular machines to additional priority ART sites that do not have Xpert machineso solar panels and inverters for high volume GeneXpert siteso pilot implementation of shorter TPT regimen o purchase of INH/Cotrimoxazole for half the quantified amount for period of 2019-2020o facilitating patient referral where Xpert is not onsite","TB-HIV Collaborative services To respond to:1. Challenges with Xpert optimization activities included in TB grant 2. Low TB preventive therapy coverage because of clinicians reluctance to placing clients on TPT, challenges of adherence to the 6 months INH regimen, and stock out of INH/Cotrimoxazole (yet to be procured by Government)Activities include: o support to staffing of high volume ART siteso additional GeneXpert Cartridges o 16 Modular machines to be installed at 6 high volume ART sites o relocation of existing 4 modular machines to additional priority ART sites that do not have Xpert machineso solar panels and inverters for high volume GeneXpert siteso pilot implementation of shorter TPT regimen o purchase of INH/Cotrimoxazole for half the quantified amount for period of 2019-2020o facilitating patient referral where Xpert is not onsite",null,"High","1545231",null,"0","0","0","0","1545231","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMO/view","2020-12-31","HIV/AIDS",1545231," High Impact Africa 1","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713=AN1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713=AO1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713=AP1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713=AN1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713=AO1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713=AP1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1708)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMTUA4","PAI-5271","Inactive","NGA-Malaria-2","2017-2019","RT High Impact Africa 1","Nigeria","Malaria","Malaria","FR100-NGA-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","6 States in 2020 will be due for LLINs mass replacement campaigns requiring 16,619,549 LLINs. This is highly prioritized to ensure continued coverage of the population in these States in line with the WHO universal coverage for LLIN, and to ensure that gains made are not lost due to decline in net ownership.","6 States in 2020 will be due for LLINs mass replacement campaigns requiring 16,619,549 LLINs. This is highly prioritized to ensure continued coverage of the population in these States in line with the WHO universal coverage for LLIN, and to ensure that gains made are not lost due to decline in net ownership.","28/06/2018: Changed module from LLINs - continuous distribution to LLINs - mass campaign as per email from Malaria team as part of portfolio optimization process. Also from CT, Bianca email from the 10 July 201 : Back in 2017, the original UQD amount was USD 67,309,174.  Through efficiency analysis, the CT determined the need for the implementation of the 6 mass campaigns to be approximately USD 53,479,314. Grant savings will be used to cover the costs. Second aprt of the email: from Anouk: I have also included the revised UQD template for Nigeria Malaria. However, please note that for entomological monitoring and LLIN mass campaigns, the Excel does not allow me to change the remaining UQD amount to zero as these cells are protected. I leave it to you to make the correct adjustments based on the table included in this email. Counting here the 13M of extra saving as effiency, this is to aligned with SC slide. Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","67309174","LLIN distribution for 6 states on 2020. Considered mission critical to continue to build on the programmatic impact gains made.","67309174","0","0","0","0","1","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMT/view","2020-12-31","Malaria",0," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713=AN1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713=AO1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713=AP1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713=AN1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713=AO1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713=AP1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1713)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMYUA4","PAI-5276","Active","NGA-Tuberculosis-11","2017-2019","RT High Impact Africa 1","Nigeria","Tuberculosis","Tuberculosis","FR491-NGA-T",null,null,"MDR-TB","Case detection and diagnosis","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.","NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","High","8179857",null,"0","0","0","0","8179857","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMY/view","2020-12-31","Tuberculosis",8179857," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713=AN1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713=AO1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713=AP1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713=AN1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713=AO1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713=AP1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1718)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMdUAO","PAI-5281","Active","NGA-Tuberculosis-16","2017-2019","RT High Impact Africa 1","Nigeria","Tuberculosis","Tuberculosis","FR491-NGA-T",null,null,"MDR-TB","Case detection and diagnosis","Procurement of lab reagents and consumables for first and second line LPA:The request is for procurement of Lab reagents and consumables, PPEs, etc. (including consumables for healthcare workers) for additional 2,592 patients (50% of the remaining gap).This will also improve surveillance and diagnosis of XDR TB. This also includes procurement fee, Insurance, Freight, in country distribution, QA charges and in country QA/QC.","Procurement of lab reagents and consumables for first and second line LPA:The request is for procurement of Lab reagents and consumables, PPEs, etc. (including consumables for healthcare workers) for additional 2,592 patients (50% of the remaining gap).This will also improve surveillance and diagnosis of XDR TB. This also includes procurement fee, Insurance, Freight, in country distribution, QA charges and in country QA/QC.","NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","High","3437667",null,"0","0","0","0","3437667","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMd/view","2020-12-31","Tuberculosis",3437667," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713=AN1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713=AO1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713=AP1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713=AN1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713=AO1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713=AP1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1723)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMeUAO","PAI-5282","Active","NGA-Tuberculosis-17","2017-2019","RT High Impact Africa 1","Nigeria","Tuberculosis","Tuberculosis","FR491-NGA-T",null,null,"MDR-TB","Case detection and diagnosis","Optimization of Existing TB Ref Labs:An estimated 29% of the need for these TB Reference Laboratories has been budgeted within allocation. This intervention will provide the remaining 71% optimization need to improve functionality, support monitoring of patients on shorter regimen and new drug, improve communication between laboratories and treatment centres and improve surveillance for XDR TB.","Optimization of Existing TB Ref Labs:An estimated 29% of the need for these TB Reference Laboratories has been budgeted within allocation. This intervention will provide the remaining 71% optimization need to improve functionality, support monitoring of patients on shorter regimen and new drug, improve communication between laboratories and treatment centres and improve surveillance for XDR TB.","NA Original Module: Multidrug-resistant TB. Original Intervention: Case detection","High","202243",null,"0","0","0","0","202243","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMe/view","2020-12-31","Tuberculosis",202243," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713=AN1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713=AO1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713=AP1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713=AN1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713=AO1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713=AP1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1724)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMjUAO","PAI-5287","Active","NGA-Tuberculosis-21","2017-2019","RT High Impact Africa 1","Nigeria","Tuberculosis","Tuberculosis","FR491-NGA-T",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Infrastructural upgrade of selected labs in targets states for lab services integration:Based on the findings and recommendations of the baseline assessment of infrastructural amenities at the labs, the prioritised labs and recommendations of the report will be supported with infrastructural upgrade to raise their standard for effective service provision.","Infrastructural upgrade of selected labs in targets states for lab services integration:Based on the findings and recommendations of the baseline assessment of infrastructural amenities at the labs, the prioritised labs and recommendations of the report will be supported with infrastructural upgrade to raise their standard for effective service provision.","NA Original Module: RSSH - Integrated service delivery and quality improvement","High","1803279",null,"0","0","0","0","1803279","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMj/view","2020-12-31","Tuberculosis",1803279," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713=AN1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713=AO1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713=AP1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713=AN1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713=AO1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713=AP1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1729)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMoUAO","PAI-5292","Active","NGA-Tuberculosis-26","2017-2019","RT High Impact Africa 1","Nigeria","Tuberculosis","Tuberculosis","FR491-NGA-T",null,null,"RSSH: Integrated service delivery and quality improvement","Case detection and diagnosis","Support site level joint lab-clinic patient education program for increased lab services uptake-develop IEC materials, health talk, and awareness creation for uptake of laboratory services.","Support site level joint lab-clinic patient education program for increased lab services uptake-develop IEC materials, health talk, and awareness creation for uptake of laboratory services.","NA Original Module: RSSH - Integrated service delivery and quality improvement","High","209626",null,"0","0","0","0","209626","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMo/view","2020-12-31","Tuberculosis",209626," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713=AN1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713=AO1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713=AP1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713=AN1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713=AO1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713=AP1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1734)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMtUAO","PAI-5297","Active","NGA-Tuberculosis-5","2017-2019","RT High Impact Africa 1","Nigeria","Tuberculosis","Tuberculosis","FR491-NGA-T",null,null,"TB care and prevention","Case detection and diagnosis","Conduct survey to determine TB catastrophic costs:Baseline survey was conducted in 2017 and findings revealed 71% of TB patients and their households experienced catastrophic cost. With the scale up of innovative interventions, most patient related cost might be mitigated and monitoring this is necessary to alleviate burden on TB patients. The follow up catastrophic cost survey is proposed in 2020 using above allocation.","Conduct survey to determine TB catastrophic costs:Baseline survey was conducted in 2017 and findings revealed 71% of TB patients and their households experienced catastrophic cost. With the scale up of innovative interventions, most patient related cost might be mitigated and monitoring this is necessary to alleviate burden on TB patients. The follow up catastrophic cost survey is proposed in 2020 using above allocation.",null,"High","305982",null,"0","0","0","0","305982","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMt/view","2020-12-31","Tuberculosis",305982," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713=AN1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713=AO1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713=AP1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713=AN1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713=AO1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713=AP1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1739)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJMuUAO","PAI-5298","Active","NGA-Tuberculosis-6","2017-2019","RT High Impact Africa 1","Nigeria","Tuberculosis","Tuberculosis","FR491-NGA-T",null,null,"TB care and prevention","Case detection and diagnosis","Conduct end-term evaluation for the TB NSP 2015-2020:The country is implementing TB strategic plan that covers a period of 2015 to 2020. The requested funds under above allocation will facilitate evaluation of the strategic plan to inform implementation achievement and gaps for the new strategic plan.","Conduct end-term evaluation for the TB NSP 2015-2020:The country is implementing TB strategic plan that covers a period of 2015 to 2020. The requested funds under above allocation will facilitate evaluation of the strategic plan to inform implementation achievement and gaps for the new strategic plan.",null,"High","125919",null,"0","0","0","0","125919","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJMu/view","2020-12-31","Tuberculosis",125919," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713=AN1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713=AO1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713=AP1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713=AN1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713=AO1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713=AP1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1740)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJN0UAO","PAI-5304","Active","NPL-HIV/AIDS-3","2017-2019","RT South East Asia","Nepal","HIV/AIDS","HIV/AIDS","FR336-NPL-H",null,null,"Prevention programs for MSM and TGs","Other interventions for MSM and TGs","To date, USAID-FHI360 has supported some MSM/TG interventions in 5 non-GF districts but will not commit funding beyond 2018-19, Since there is still a strong need from the community, and other external resources are not envisaged, support is requested for the continuation of services in 2019-201 and 2020-21.","To date, USAID-FHI360 has supported some MSM/TG interventions in 5 non-GF districts but will not commit funding beyond 2018-19, Since there is still a strong need from the community, and other external resources are not envisaged, support is requested for the continuation of services in 2019-201 and 2020-21.","NA Original Module: Prevention programs for men who have sex with men and transgender people. Original Intervention: Continuation of services for men who have sex with men and transgender people","High","6e+05","Men who have sex with men are also a key population identified in the national strategy; PEPFAR funding is not planned to continue beyond 2018-19. These funds would replace geographic coverage lost when funding from other partners ends (but the Global Fund grant also covers men who have sex with men and transgender people within the allocation amount).","0","0","0","0","6e+05","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJN0/view","2021-03-15","HIV/AIDS",600000," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713=AN1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713=AO1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713=AP1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713=AN1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713=AO1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713=AP1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1746)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJN5UAO","PAI-5309","Active","NPL-HIV/AIDS-8","2017-2019","RT South East Asia","Nepal","HIV/AIDS","HIV/AIDS","FR336-NPL-H",null,null,"Other module","Other module","Migration is recognised as source of infection. However, it is likely that changes in health seeking behaviour and migration patterns over the last decade have implications for HIV transmission and access to HIV services, which assessment will explore. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.","Migration is recognised as source of infection. However, it is likely that changes in health seeking behaviour and migration patterns over the last decade have implications for HIV transmission and access to HIV services, which assessment will explore. The findings of this and the cascade assessment are expected to guide a more strategic targeting of resources and make HIV interventions more efficient and effective.","NA Original Module: Study and assessment. Original Intervention: Cascade assessment","Low","50000","Originally proposed as a single module with two interventions, the TRP recommends to split the interventions; this one is low priority because a cascade assessment has recently been completed and assessment of cascade information should be routine program monitoring.","0","0","0","0","50000","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJN5/view","2021-03-15","HIV/AIDS",50000," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713=AN1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713=AO1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713=AP1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713=AN1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713=AO1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713=AP1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1751)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJNAUA4","PAI-5314","Active","NPL-Malaria-13","2017-2019","RT South East Asia","Nepal","Malaria","Malaria","FR335-NPL-M",null,null,"Case management","Other case management intervention(s)","TA for development of IEC documents for elimination; Production and dissemination of IEC materials.","TA for development of IEC documents for elimination; Production and dissemination of IEC materials.","NA Original Intervention: Information, education, communication/behavior change communication (case management)","Medium","20138","Advocacy activities and IEC documents are a powerful tool to support the long -term political and financial commitment necessary for malaria elimination.","0","0","0","0","20138","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNA/view","2021-03-15","Malaria",20138," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713=AN1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713=AO1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713=AP1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713=AN1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713=AO1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713=AP1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1756)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJNBUA4","PAI-5315","Active","NPL-Malaria-14","2017-2019","RT South East Asia","Nepal","Malaria","Malaria","FR335-NPL-M",null,null,"RSSH: Health management information systems and M&E","Surveys","External program evaluation to review progress and inform programme direction (Y3).","External program evaluation to review progress and inform programme direction (Y3).","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","33428","Training on database management and data analysis is important, as well as mid - term evaluation to guide the program. This is however considered medium priority especially as it is not a country wide epidemics.","0","0","0","0","33428","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNB/view","2021-03-15","Malaria",33428," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713=AN1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713=AO1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713=AP1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713=AN1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713=AO1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713=AP1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1757)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJNGUA4","PAI-5320","Active","NPL-Malaria-19","2017-2019","RT South East Asia","Nepal","Malaria","Malaria","FR335-NPL-M",null,null,"Program management","Other program management intervention(s)","Provide training on leadership and management at Central, Regional and District levels.","Provide training on leadership and management at Central, Regional and District levels.","NA Original Intervention: Policy, planning, coordination and management","Medium","2044","As the burden of disease reduces, strong training on leadership and management at Central, Regional and District levels will be important.","0","0","0","0","2044","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNG/view","2021-03-15","Malaria",2044," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713=AN1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713=AO1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713=AP1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713=AN1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713=AO1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713=AP1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1762)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJNLUA4","PAI-5325","Active","NPL-Malaria-23","2017-2019","RT South East Asia","Nepal","Malaria","Malaria","FR335-NPL-M",null,null,"Vector control","Other vector control measure(s)","Larval source management where vector breeding sites are few, fixed and findable in order to maximize cost effectiveness and sustainability of operations.","Larval source management where vector breeding sites are few, fixed and findable in order to maximize cost effectiveness and sustainability of operations.","NA Original Intervention: Other vector control measures","Low","1373","As larval source management requires a good infrastructure and strong entomological capacity and leadership, the program needs to establish feasibility of this strategy in elimination phase","0","0","0","0","1373","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNL/view","2021-03-15","Malaria",1373," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713=AN1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713=AO1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713=AP1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713=AN1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713=AO1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713=AP1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1767)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJNQUA4","PAI-5330","Active","NPL-Malaria-6","2017-2019","RT South East Asia","Nepal","Malaria","Malaria","FR335-NPL-M",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Procurement of mobile phones/tablets for electronic based malaria reporting. Mapping of all villages in endemic areas based on GIS.  Training workshops to strengthen PSM, M&E, finance and programme management.","Procurement of mobile phones/tablets for electronic based malaria reporting. Mapping of all villages in endemic areas based on GIS.  Training workshops to strengthen PSM, M&E, finance and programme management.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","283538","Considering the geographical impediments for online internet data capturing, use of telephone technologies to transfer data is appropriate and encouraged. The workshops are meant to strengthen program management for Government of Nepal staff.","0","0","0","0","283538","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNQ/view","2021-03-15","Malaria",283538," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713=AN1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713=AO1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713=AP1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713=AN1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713=AO1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713=AP1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1772)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJNRUA4","PAI-5331","Active","NPL-Malaria-7","2017-2019","RT South East Asia","Nepal","Malaria","Malaria","FR335-NPL-M",null,null,"Case management","Private sector case management","Training of other private sector service providers (pharmacies, private companies and selected drug vendors) on National Treatment Protocol.","Training of other private sector service providers (pharmacies, private companies and selected drug vendors) on National Treatment Protocol.",null,"High","35162","Frequent trainings of private providers, or inclusion of private providers in routine public sector training events, is essential for reducing malaria transmission, especially 5 where the PS is a major source of healthcare. Trainings provide the PS with updates to regulations and National Treatment Protocol, and will allow an opportunity to discuss the challenges they face","0","0","0","0","35162","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNR/view","2021-03-15","Malaria",35162," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713=AN1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713=AO1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713=AP1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713=AN1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713=AO1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713=AP1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1773)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJNWUA4","PAI-5336","Active","NPL-Tuberculosis-3","2017-2019","RT South East Asia","Nepal","Tuberculosis","Tuberculosis","FR334-NPL-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","To provide high-end international technical assistance to the NTP.","To provide high-end international technical assistance to the NTP.","NA Original Intervention: TA (1-international)","High","1180000","Access to quality technical assistance is necessary due to high turnover in key NTP personnel. However, the cost should be brought into alignment with international development agency standards.","0","0","0","0","1180000","0","0","2019-10-30 15:34:05","2019-10-30 15:34:04","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNW/view","2021-03-15","Tuberculosis",1180000," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713=AN1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713=AO1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713=AP1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713=AN1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713=AO1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713=AP1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1778)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJNbUAO","PAI-5341","Active","NPL-Tuberculosis-8","2017-2019","RT South East Asia","Nepal","Tuberculosis","Tuberculosis","FR334-NPL-T",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Under the decentralized federal process, investment in institutional capacity building of 744 palikas by training ~10,500 members every 3 years to ensure political commitment, budget allocation and management of community-based health activities.","Under the decentralized federal process, investment in institutional capacity building of 744 palikas by training ~10,500 members every 3 years to ensure political commitment, budget allocation and management of community-based health activities.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Conduct orientation workshops to empower newly elected members of Palikas","Low","297807","Cost efficiencies should be sought through novel networking and training strategies such as Train the Trainer (TTT) methods, Project Echo linkages, telecommunication, etc.","0","0","0","0","297807","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNb/view","2021-03-15","Tuberculosis",297807," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713=AN1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713=AO1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713=AP1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713=AN1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713=AO1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713=AP1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1783)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJNgUAO","PAI-5346","Active","PAK-HIV/AIDS-4","2017-2019","RT High Impact Asia","Pakistan","HIV/AIDS","HIV/AIDS","FR203-PAK-H",null,null,"Comprehensive prevention programs for MSM","Pre-exposure prophylaxis (PrEP) for MSM","Cost of pilot PrEP program for MSM in 2 cities in 2nd and 3rd year of the grant, with 500 MSM on PrEP in 2019 and additional 1000 in 2020. Current MSM program funded under the regional Global Fund grant report an existing demand for PrEP among their clientele. The aim of this pilot is to establish its viability in Pakistan context (page 58 of the revised NSP).","Cost of pilot PrEP program for MSM in 2 cities in 2nd and 3rd year of the grant, with 500 MSM on PrEP in 2019 and additional 1000 in 2020. Current MSM program funded under the regional Global Fund grant report an existing demand for PrEP among their clientele. The aim of this pilot is to establish its viability in Pakistan context (page 58 of the revised NSP).","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Pre-exposure prophylaxis (PrEP) for men who have sex with men","Medium","462000","Proposed pilot should be carefully coordinated with the regional Global Fund grant.","0","0","0","0","462000","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNg/view","2020-12-31","HIV/AIDS",462000," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713=AN1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713=AO1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713=AP1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713=AN1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713=AO1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713=AP1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1788)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJNiUAO","PAI-5348","Active","PAK-HIV/AIDS-6","2017-2019","RT High Impact Asia","Pakistan","HIV/AIDS","HIV/AIDS","FR203-PAK-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","Cost of reaching additional 33,200 FSW with prevention package. It is prioritized because prevalence rate for this population is growing at the fastest rate amongst KP for whom the primary means of transmission is sexual. Unit costs ($71) have been fixed with reference to those used for the AEM modelling. Proposed coverage would amount to 42% of the annual gap for this population through this grant.","Cost of reaching additional 33,200 FSW with prevention package. It is prioritized because prevalence rate for this population is growing at the fastest rate amongst KP for whom the primary means of transmission is sexual. Unit costs ($71) have been fixed with reference to those used for the AEM modelling. Proposed coverage would amount to 42% of the annual gap for this population through this grant.","NA Original Intervention: Condoms and lubricant programming for female sex workers HIV testing services for female sex workers. Diagnosis and treatment of sexually transmitted infections and other sexual health services for female sex workers","Low","2357200","The funding request allocation already provides adequate coverage and resources and priority should go to diagnosis and treatment of sexually transmitted infections and other sexual health services for female sex workers.","250000","131900","0","0","1975300","0","0","2019-11-29 12:41:45","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNi/view","2020-12-31","HIV/AIDS",1975300," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713=AN1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713=AO1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713=AP1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713=AN1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713=AO1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713=AP1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1790)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJNnUAO","PAI-5353","Active","PAK-Malaria-4","2017-2019","RT High Impact Asia","Pakistan","Malaria","Malaria","FR412-PAK-M",null,null,"Program management","Other program management intervention(s)","Current National Malaria Strategic Plan was developed in 2014 for 2015-2020, guided by the MPR led by WHO. National and provincial strategic plans need to be updated to align with GTS 2016  2030. Findings from malaria programmatic review in 2018 and malaria prevalence survey would guide for strategizing interventions (quality case management, prompt and effective treatment, selective vector control, scaling up of treated LLINs use and epidemic preparedness, detection and response) according to disease endemicity.","Current National Malaria Strategic Plan was developed in 2014 for 2015-2020, guided by the MPR led by WHO. National and provincial strategic plans need to be updated to align with GTS 2016  2030. Findings from malaria programmatic review in 2018 and malaria prevalence survey would guide for strategizing interventions (quality case management, prompt and effective treatment, selective vector control, scaling up of treated LLINs use and epidemic preparedness, detection and response) according to disease endemicity.","NA Original Intervention: Updating national and provincial strategic plans for (2021-2025)","Medium","1e+05","This additional support will helpto develop new national andprovincial plans for the 2021-2025 and their alignment withthe Global Technical Strategy 2016-2030.","0","0","0","0","1e+05","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNn/view","2020-12-31",{"$f":"IF(OR(I1795=\"HIV/AIDS\",I1795=\"Tuberculosis\",I1795=\"Malaria\",I1795=\"RSSH\"),I1795, IF(I1795=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"Malaria"},{"$f":"VALUE(Y1795)","v":100000},{"$f":"RIGHT(F1795,LEN(F1795)-2)","v":" High Impact Asia"},"Malaria","Malaria",null,null,null,{"$f":"TRIM(AK1795)","v":""},{"$f":"TRIM(AL1795)","v":""},{"$f":"TRIM(AM1795)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713=AN1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713=AO1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713=AP1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE1795<>\"\",AE1795,IF(MAX(AQ1795,AR1795,AS1795,AT1795)<>0,MAX(AQ1795,AR1795,AS1795,AT1795),AU1795))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713=AN1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713=AO1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713=AP1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1795)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE1795<>\"\",AE1795,IF(MAX(AW1795,AX1795,AY1795,AZ1795)<>0,MAX(AW1795,AX1795,AY1795,AZ1795),BA1795))","v":"2020-12-31"}]
["a6Q1R000000AJNsUAO","PAI-5358","Active","PAK-Tuberculosis-2","2017-2019","RT High Impact Asia","Pakistan","Tuberculosis","Tuberculosis","FR202-PAK-T",null,null,"MDR-TB","Other MDR-TB intervention(s)","Action: Scale-up of Xpert testing of B positive cases Rationale:The expansion of Xpert network across the country has a throughput  to test additional B-positive TB cases to reach up to 90% of B positives cases. This will give a yield of additional 16% of RR-TB cases. The major reason for putting it into  PAAR being requirement of additional resources for Xpert cartridges  and  second line Drugs and social support to reach 55% of all pulmonary MDR cases ( which is  70%.(2019)  90%  (2020) of B positive cases, 1000 + 2150 =3150 additional Cases over three years.Cost implications: SLDs for 3150 MDR cases (4300/case)  US 13,545,000100,000 cartridges:  (US 1 million (diagnostics)Social support  (528 US per patient)  US 1,663,200.","Action: Scale-up of Xpert testing of B positive cases Rationale:The expansion of Xpert network across the country has a throughput  to test additional B-positive TB cases to reach up to 90% of B positives cases. This will give a yield of additional 16% of RR-TB cases. The major reason for putting it into  PAAR being requirement of additional resources for Xpert cartridges  and  second line Drugs and social support to reach 55% of all pulmonary MDR cases ( which is  70%.(2019)  90%  (2020) of B positive cases, 1000 + 2150 =3150 additional Cases over three years.Cost implications: SLDs for 3150 MDR cases (4300/case)  US 13,545,000100,000 cartridges:  (US 1 million (diagnostics)Social support  (528 US per patient)  US 1,663,200.","NA Original Module: Multidrug-resistant TB. Original Intervention: Accelerated MDR detection and treatment to reach 90 percent of bacteriologically positive cases by 2020. (3,150 additional MDR cases)","High","16208000","Allocation funding estimates only 10 percent increase for RR-TB case detection rate. Additional activities boosting the MDR-TB case detection should be prioritized.","0","0","0","0","16208000","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNs/view","2020-12-31","Tuberculosis",16208000," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713=AN1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713=AO1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713=AP1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713=AN1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713=AO1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713=AP1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1800)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJNxUAO","PAI-5363","Active","PAK-Tuberculosis-7","2017-2019","RT High Impact Asia","Pakistan","Tuberculosis","Tuberculosis","FR202-PAK-T",null,null,"MDR-TB","Other MDR-TB intervention(s)","Action: To introduce a comprehensive TB detection, care & prevention package in District Hafizabad (Punjab) and Mirpurkhas (Sindh). The package includes scaling up of PPM interventions, involving GPs in CHTB case detection & management, active case finding through organizing mobile screening chest camps using chest x-rays algorithm, implementing FAST (Finding TB cases Actively, Separating Safely, and Treating effectively) intervention at the District Headquarter Hospitals (DHQ) in 2 districts. Rational: The selected districts have high yield of patients in the current NFM grant and the high influx of patients to these districts from nearby areas. The  proposed  interventions  will  help  to provide  a  rationale  to  scale  up  this  package  of activities in other districts to achieve END TB strategy goals to detect over 90% of cases. Additional 3,000 DS-TB cases and around 385 MDR-TB cases will be detected in three years.","Action: To introduce a comprehensive TB detection, care & prevention package in District Hafizabad (Punjab) and Mirpurkhas (Sindh). The package includes scaling up of PPM interventions, involving GPs in CHTB case detection & management, active case finding through organizing mobile screening chest camps using chest x-rays algorithm, implementing FAST (Finding TB cases Actively, Separating Safely, and Treating effectively) intervention at the District Headquarter Hospitals (DHQ) in 2 districts. Rational: The selected districts have high yield of patients in the current NFM grant and the high influx of patients to these districts from nearby areas. The  proposed  interventions  will  help  to provide  a  rationale  to  scale  up  this  package  of activities in other districts to achieve END TB strategy goals to detect over 90% of cases. Additional 3,000 DS-TB cases and around 385 MDR-TB cases will be detected in three years.","NA Original Module: Multidrug-resistant TB. Original Intervention: Zero TB Initiative in Hafizabad and Mirpurkhas districts","High","1630000","This intervention is a comprehensive TB care package implementing the FAST intervention (Find cases Actively, Separate temporarily and Treat effectively) across 2 districts aimed at promoting early detection of cases in target areas. The TRP considers this a 6 high priority intervention","0","0","0","0","1630000","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNx/view","2020-12-31","Tuberculosis",1630000," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713=AN1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713=AO1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713=AP1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713=AN1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713=AO1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713=AP1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1805)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJNyUAO","PAI-5364","Active","PAK-Tuberculosis-8","2017-2019","RT High Impact Asia","Pakistan","Tuberculosis","Tuberculosis","FR202-PAK-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Action: To engage additional 2,500 GPs, 210 NGOs (from current 240 to 450), 50 private hospitals (from 70 to120) and 50 parastatal hospital (from 70 to 120) with enablers (training, incentives 400 PKR/ case.Rational: Currently 3-5% of private health care providers are engaged with NTP. Engaging private practitioners (PPM-1 model) will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines. Case notification will increase by 30,000/year.","Action: To engage additional 2,500 GPs, 210 NGOs (from current 240 to 450), 50 private hospitals (from 70 to120) and 50 parastatal hospital (from 70 to 120) with enablers (training, incentives 400 PKR/ case.Rational: Currently 3-5% of private health care providers are engaged with NTP. Engaging private practitioners (PPM-1 model) will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines. Case notification will increase by 30,000/year.","NA Original Intervention: Engagement with private practitioners","High","4300000","Private practitioners play a major role in health care in Pakistan. Engaging them will help to ensure that diagnosis and treatment of TB patients is in line with the national TB guidelines.","0","2358315","0","0","1941685","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJNy/view","2020-12-31","Tuberculosis",1941685," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713=AN1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713=AO1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713=AP1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713=AN1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713=AO1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713=AP1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1806)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJO3UAO","PAI-5369","Active","PAN-TB/HIV-4","2017-2019","RT Latin America and Caribbean","Panama","HIV/TB","HIV/AIDS, Tuberculosis","FR376-PAN-C",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","The conceptual proposal would enable the Minsitry of Public Health to create a tool to identify cases of TB and TB/HIV in order to design the range of resources and services in line with actual needs in the future, ensuring a more effective response in the sustainability phase.","The conceptual proposal would enable the Minsitry of Public Health to create a tool to identify cases of TB and TB/HIV in order to design the range of resources and services in line with actual needs in the future, ensuring a more effective response in the sustainability phase.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Technical assistance to create a conceptual proposal for a geo-referencing tool for cases of tuberculosis, cases of TB/HIV (200 cases, approx. 10% of TB/HIV cases nationwide (1900 cases in 2017)","Medium","34000","The TRP considers this intervention to be medium priority as it improves the health information systems ability to trace the tuberculosis cases geographically. The TRP considers this investment could benefit the active case detection but is not critical for its success.","0","0","0","0","34000","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJO3/view","2021-12-31","TB/HIV",34000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713=AN1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713=AO1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713=AP1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713=AN1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713=AO1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713=AP1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1811)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJO8UAO","PAI-5374","Inactive","PER-Tuberculosis-3","2017-2019","RT Latin America and Caribbean","Peru","Tuberculosis","Tuberculosis","FR91-PER-T",null,null,"MDR-TB","Community MDR-TB care delivery","Capacity-building workshops to train CHWs on MDR-TB management and treatment adherence","Capacity-building workshops to train CHWs on MDR-TB management and treatment adherence","NA Original Module: Multidrug-resistant TB","High","142500",null,"142500","0","0","0","0","1","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJO8/view","2022-06-30","Tuberculosis",0," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713=AN1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713=AO1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713=AP1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713=AN1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713=AO1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713=AP1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1816)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJODUA4","PAI-5379","Inactive","PHL-HIV/AIDS-3","2017-2019","RT High Impact Asia","Philippines","HIV/AIDS","HIV/AIDS","FR192-PHL-H",null,null,"HIV Testing Services","Differentiated HIV testing services","This will increased testing uptake, early diagnosis, and linkage to care for those who will test positive.","This will increased testing uptake, early diagnosis, and linkage to care for those who will test positive.",null,"High","86304.49","The estimated numbers of HIV tests overall seem to be modest compared to the people who need testing.","86304.49","0","0","0","0","1","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOD/view","2020-12-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713=AN1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713=AO1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713=AP1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713=AN1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713=AO1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713=AP1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1821)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOEUA4","PAI-5380","Inactive","PHL-HIV/AIDS-4","2017-2019","RT High Impact Asia","Philippines","HIV/AIDS","HIV/AIDS","FR192-PHL-H",null,null,"Prevention programs for adolescents and youth, in and out of school","Other intervention(s) for adolescent and youth","Requirement for parental consent makes it difficult for YKP to address. Through capacity building of YKP and service providers and the issuance of policies, more YKP will be able to access services.","Requirement for parental consent makes it difficult for YKP to address. Through capacity building of YKP and service providers and the issuance of policies, more YKP will be able to access services.","NA Original Intervention: Behavioural interventions counselling and psychosocial support condoms and lubricant programming","High","124944.56","Young MSM and TG are at highest risk to acquire new HIV infections and the ones who face structural barriers in accessing prevention services, condoms and treatment cascade. With parallel efforts to remove disparities in access to prevention and continuum of care, this intervention will help achieve the highly ambitious targets.","124944.56","0","0","0","0","1","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOE/view","2020-12-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713=AN1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713=AO1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713=AP1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713=AN1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713=AO1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713=AP1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1822)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOJUA4","PAI-5385","Active","PHL-Tuberculosis-2","2017-2019","RT High Impact Asia","Philippines","Tuberculosis","Tuberculosis","FR194-PHL-T",null,null,"MDR-TB","Other MDR-TB intervention(s)","Critical to the success of the NTP in finding and treating missing cases is adopting GX as primary diagnostic tool and that making it available in all its 2600 primary health care units. To date, there are existing 336 GX machines and 580 are being request through this funding request ( both from within allocation and matching fund). Through PAAR, an additional 1684 GX machines will help achieve 100% coverage.","Critical to the success of the NTP in finding and treating missing cases is adopting GX as primary diagnostic tool and that making it available in all its 2600 primary health care units. To date, there are existing 336 GX machines and 580 are being request through this funding request ( both from within allocation and matching fund). Through PAAR, an additional 1684 GX machines will help achieve 100% coverage.","NA Original Module: Multidrug-resistant TB. Original Intervention: Procurement of 1684 GeneXpert machines (OMNI)","High","6057028","GeneXpert will help detecting missing susceptible and DR cases","0","0","0","0","6057028","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOJ/view","2020-12-31","Tuberculosis",6057028," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713=AN1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713=AO1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713=AP1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713=AN1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713=AO1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713=AP1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1827)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOOUA4","PAI-5390","Active","PNG-Malaria-1","2017-2019","RT South East Asia","Papua New Guinea","Malaria","Malaria","FR389-PNG-M",null,null,"Vector control","Other vector control measure(s)","This program delivers antenatal nets to about 50% of pregnant women each year. This protects both  pregnant women and newly born children from malaria. Delivery to pregnant women is done through health centers. Nets are also distributed every three years to prisons and boarding pupils in boarding schools.","This program delivers antenatal nets to about 50% of pregnant women each year. This protects both  pregnant women and newly born children from malaria. Delivery to pregnant women is done through health centers. Nets are also distributed every three years to prisons and boarding pupils in boarding schools.","NA Original Intervention: Distribution of Long Lasting Insecticidal Nets (LLINs) to Vulnerable Groups","High","1723192","Use of grant savings to increase coverage of LLIN was recommended by the TRP in its review of the Program Continuation Request","0","0","1720000","0","3192","0","0","2020-01-14 12:43:09","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOO/view","2020-12-31","Malaria",3192," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713=AN1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713=AO1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713=AP1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713=AN1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713=AO1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713=AP1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1832)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOQUA4","PAI-5392","Inactive","PNG-Malaria-11","2017-2019","RT South East Asia","Papua New Guinea","Malaria","Malaria","FR389-PNG-M",null,null,"Other module","Other module","Home Based Management of Malaria (HMM) has been previously supported through three non-governmental organizations in three provinces in the country but will not continue past 2017. Funds are to develop national policies for HMM to be implemented by staff in health centers, supporting National Department of Health to work with provinces (particularly the three provinces) to integrate these programs at the health facility level.","Home Based Management of Malaria (HMM) has been previously supported through three non-governmental organizations in three provinces in the country but will not continue past 2017. Funds are to develop national policies for HMM to be implemented by staff in health centers, supporting National Department of Health to work with provinces (particularly the three provinces) to integrate these programs at the health facility level.","NA Original Module: Community based treatment. Original Intervention: Integration of home based management of malaria into the national health system","Low","6e+05","Home Based Management of Malaria (HMM) extended through national policies for HMM for implementation by health staff in health centers throughout the country where communities live in difficult to reach areas. However, the TRP considers that more work is required before this program can be implemented. In particular, the TRP recommends that the applicant, supported by the Secretariat, considers the implications of the government program of decentralization of health responsibilities and seeks to safeguard arrangements for the extension of HMM accordingly","0","0","6e+05","0","0","1","0","2020-01-14 12:42:48","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOQ/view","2020-12-31","Malaria",0," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713=AN1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713=AO1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713=AP1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713=AN1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713=AO1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713=AP1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1834)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOVUA4","PAI-5397","Active","PNG-Malaria-6","2017-2019","RT South East Asia","Papua New Guinea","Malaria","Malaria","FR389-PNG-M",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Carry out priority entomological and operational work which feeds into malaria program decisions, particularly factor which can reduce man vector contact.","Carry out priority entomological and operational work which feeds into malaria program decisions, particularly factor which can reduce man vector contact.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Entomology research","High","150000","The TRP recommended in its review of the Program Continuation Request that the monitoring of insecticide resistance be sustained.","0","0","0","0","150000","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOV/view","2020-12-31","Malaria",150000," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713=AN1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713=AO1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713=AP1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713=AN1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713=AO1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713=AP1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1839)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOaUAO","PAI-5402","Active","PNG-TB/HIV-10","2017-2019","RT South East Asia","Papua New Guinea","HIV/TB","HIV/AIDS, Tuberculosis","FR100-PNG-C",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","This allocation provides TB/HIV/STI M&E Officers at provincial level in Western Highlands, Enga, Jiwaka, Morobe and Madang. These officers will assist the TB/HIV Coordinators to improve data collecting and reporting, assist in providing up to date information to the TB-HIV Provincial Coordinating Committee and assist in disseminating data and information to services to assist them in service review and planning.","This allocation provides TB/HIV/STI M&E Officers at provincial level in Western Highlands, Enga, Jiwaka, Morobe and Madang. These officers will assist the TB/HIV Coordinators to improve data collecting and reporting, assist in providing up to date information to the TB-HIV Provincial Coordinating Committee and assist in disseminating data and information to services to assist them in service review and planning.","NA Original Module: RSSH - Program management","Medium","388013","The TRP considers strengthening of coordination between TB and HIV staff and non governmental organizations important, but recommends consideration of more emphasis on service delivery, making this a medium priority.","0","0","0","0","388013","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOa/view","2020-12-31","TB/HIV",388013," South East Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713=AN1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713=AO1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713=AP1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713=AN1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713=AO1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713=AP1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1844)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOfUAO","PAI-5407","Active","PNG-TB/HIV-15","2017-2019","RT South East Asia","Papua New Guinea","HIV/TB","HIV/AIDS, Tuberculosis","FR100-PNG-C",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","a) Strategic information: support for 9 positions in Y3 for TB/HIV/STI surveillance and logistics team (shared positions for KP database support; national HIV/STI/TB testing policy and practice support, logistics support and data entry). b) HIV Patient database training: This will provide for an annual HIV patient database training for 10 participants. The HIV patient database will eventually be integrated into the national e-NHIS. c) KPMIS training: Key staff will also be trained in the use of the KPMIS system, collecting data on KP outreach and KP attendance at STI, HIV and TB services.","a) Strategic information: support for 9 positions in Y3 for TB/HIV/STI surveillance and logistics team (shared positions for KP database support; national HIV/STI/TB testing policy and practice support, logistics support and data entry). b) HIV Patient database training: This will provide for an annual HIV patient database training for 10 participants. The HIV patient database will eventually be integrated into the national e-NHIS. c) KPMIS training: Key staff will also be trained in the use of the KPMIS system, collecting data on KP outreach and KP attendance at STI, HIV and TB services.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Other health information systems and monitoring and evaluation intervention(s)","Low","196097","The TRP considers the components of HIV patient database training and key population management information systems (KPMIS) training relevant. The TRP recommends assessment of the quality of the databases before further investment. The TRP considers requested funding for 9 positions at national Department of Health not to be a priority.","0","0","0","0","196097","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOf/view","2020-12-31","TB/HIV",196097," South East Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713=AN1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713=AO1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713=AP1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713=AN1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713=AO1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713=AP1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1849)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOkUAO","PAI-5412","Active","PNG-TB/HIV-5","2017-2019","RT South East Asia","Papua New Guinea","HIV/TB","HIV/AIDS, Tuberculosis","FR100-PNG-C",null,null,"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Outreach: additional 10 MSM peer outreach workers (into existing multi-peer teams)  4 in NCD, 2 in Jiwaka, 2 in Madang, 2 in Western Highland. Peer outreach in Jiwaka and Madang ceased in 2016 and 2017 respectively, so this will re-start these important programs. Increased coverage with a package of prevention programs: Y1-1,467; Y2-2,269; Y3-3,112. HIV testing access targets: Y1-440; Y2-907; Y3-1,559).","Outreach: additional 10 MSM peer outreach workers (into existing multi-peer teams)  4 in NCD, 2 in Jiwaka, 2 in Madang, 2 in Western Highland. Peer outreach in Jiwaka and Madang ceased in 2016 and 2017 respectively, so this will re-start these important programs. Increased coverage with a package of prevention programs: Y1-1,467; Y2-2,269; Y3-3,112. HIV testing access targets: Y1-440; Y2-907; Y3-1,559).","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","High","65002","The TRP considers this highly relevant because of the low coverage with prevention intervention among men who have sex with men (11.1 per cent ) This allocation will increase by 10 the number of peer outreach workers in 4 high burden focus districts.","0","0","0","0","65002","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOk/view","2020-12-31","TB/HIV",65002," South East Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713=AN1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713=AO1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713=AP1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713=AN1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713=AO1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713=AP1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1854)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOlUAO","PAI-5413","Active","PNG-TB/HIV-6","2017-2019","RT South East Asia","Papua New Guinea","HIV/TB","HIV/AIDS, Tuberculosis","FR100-PNG-C",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Create 4 additional model sites, procurement of hardware to replace broken ones or those that may have past their useful life and install in 5 district hospitals; Intl. TA for procurement, Commodities for AMS-Badili and addressing HRH and Laboratory system strengthening (ring fenced).","Create 4 additional model sites, procurement of hardware to replace broken ones or those that may have past their useful life and install in 5 district hospitals; Intl. TA for procurement, Commodities for AMS-Badili and addressing HRH and Laboratory system strengthening (ring fenced).","NA Original Module: RSSH - Procurement and supply chain management systems","High","2700000","The TRP considers it a high priority to continue supporting procurement and suppy chain management (PSM), since investments in PSM so far have shown promising results. This requested allocation is to create additional model PSM sites to cover 5 district hospitals including replacement of obsolete hardware and international technical assistance costs. Also incorporating human resources for health and laboratory systems strengthening.","148264","0","0","0","2551736","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOl/view","2020-12-31","TB/HIV",2551736," South East Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713=AN1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713=AO1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713=AP1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713=AN1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713=AO1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713=AP1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1855)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJOqUAO","PAI-5418","Active","PRK-Malaria-2","2017-2019","RT South East Asia","Korea (Democratic Peoples Republic)","Malaria","Malaria","FR266-PRK-M",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Funding will increase the capabilities of the National Malaria Program  to conduct enhanced parasitological surveillance. This will provide a more nuanced evidence base for decision making from a molecular level analysis. Genotyping of P. vivax strains will help highlight parasite strain diversity and parasite flows between local and imported cases (from other provinces within the country). It will also prove confirm suspicions of asymptomatic parasite carriage or below detection parasite infections in which foci investigation followed by RCD / Reactive focal IRS has not interrupted transmission. Funding will also cover procurement/supply management cost of consumables/equipment to conduct polmerase chain reaaction (PCR) testing, training and external TA. Operational research will also be conducted.","Funding will increase the capabilities of the National Malaria Program  to conduct enhanced parasitological surveillance. This will provide a more nuanced evidence base for decision making from a molecular level analysis. Genotyping of P. vivax strains will help highlight parasite strain diversity and parasite flows between local and imported cases (from other provinces within the country). It will also prove confirm suspicions of asymptomatic parasite carriage or below detection parasite infections in which foci investigation followed by RCD / Reactive focal IRS has not interrupted transmission. Funding will also cover procurement/supply management cost of consumables/equipment to conduct polmerase chain reaaction (PCR) testing, training and external TA. Operational research will also be conducted.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","67000","This component of Resilient and Sustainable Systems for Health (RSSH) is pertinent and a key pillar for malaria elimination as it provides the platform for evidencebased programming using real-time data","0","0","0","0","67000","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOq/view","2021-02-28","Malaria",67000," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-02-28"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713=AN1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713=AO1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713=AP1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2021-02-28",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713=AN1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713=AO1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713=AP1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1860)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2021-02-28"]
["a6Q1R000000AJOvUAO","PAI-5423","Active","PRK-Tuberculosis-2","2017-2019","RT South East Asia","Korea (Democratic Peoples Republic)","Tuberculosis","Tuberculosis","FR297-PRK-T",null,null,"Other module","Other module","Current NRL infrastructure is inadequate to ensure the quality of LPA diagnosis while current C&DST capacity (NRL and 1 RRL (Hamhung RRL)) is too limited to cater for country needs. Under the above allocation the expansion of NRL and establishment of 2 RRLs will be done to strengthen the C&DST capacity and LPA tests.","Current NRL infrastructure is inadequate to ensure the quality of LPA diagnosis while current C&DST capacity (NRL and 1 RRL (Hamhung RRL)) is too limited to cater for country needs. Under the above allocation the expansion of NRL and establishment of 2 RRLs will be done to strengthen the C&DST capacity and LPA tests.","NA Original Module: Strengthen the nation-wide TB diagnosis network and actively find the missing TB cases. Original Intervention: Strengthening capacity of C&DST centres","High","2040304","Laboratory capability is critical to the identification of MDR patients.","0","0","0","0","2040304","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJOv/view","2021-06-30","Tuberculosis",2040304," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713=AN1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713=AO1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713=AP1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-09-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713=AN1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713=AO1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713=AP1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1865)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-10-01"},"2021-06-30"]
["a6Q1R000000AJP0UAO","PAI-5428","Active","PRY-HIV/AIDS-11","2017-2019","RT Latin America and Caribbean","Paraguay","HIV/AIDS","HIV/AIDS","FR432-PRY-H",null,null,"RSSH: Community responses and systems","Community led advocacy","Recruitment of consultancy to study the adequacy of the legal framework, including the tax area for contracting by the state, services and products made by CS. Include the drafting of adjustment proposals. Consulting contract to update the Political Advocacy Plan. Monitoring of the advocacy plan designed in 2017 and its updating, which includes monitoring progress of Law 4313 (Budgetary Assurance of Sexual and Reproductive Health), Law 3940, TB Act, Access to Justice Act, Sexual and Reproductive Health, Law against all forms of discrimination, among others. Recruitment of Consultancy in Political incidence. Recruitment of Consultancy to design and establish a Plan of Institutional Communication of the CSOs and the agreed goals and objectives. Implement the Institutional Communication Plan to inform and sensitize the general population and leaders of different sectors, in particular, about the social work of organizations, especially CSOs of key populations.Develop a training plan on public financing models of civil society and determine their applicability in the national context. Design and implement a fundraising plan for CS. These activities are the gaps identified in the framework of the TA funded by the GF through the CRAT, which sought to identify the key activities required to advance the sustainability of civil society organizations linked to the national response to HIV, and of the interventions implemented by them.","Recruitment of consultancy to study the adequacy of the legal framework, including the tax area for contracting by the state, services and products made by CS. Include the drafting of adjustment proposals. Consulting contract to update the Political Advocacy Plan. Monitoring of the advocacy plan designed in 2017 and its updating, which includes monitoring progress of Law 4313 (Budgetary Assurance of Sexual and Reproductive Health), Law 3940, TB Act, Access to Justice Act, Sexual and Reproductive Health, Law against all forms of discrimination, among others. Recruitment of Consultancy in Political incidence. Recruitment of Consultancy to design and establish a Plan of Institutional Communication of the CSOs and the agreed goals and objectives. Implement the Institutional Communication Plan to inform and sensitize the general population and leaders of different sectors, in particular, about the social work of organizations, especially CSOs of key populations.Develop a training plan on public financing models of civil society and determine their applicability in the national context. Design and implement a fundraising plan for CS. These activities are the gaps identified in the framework of the TA funded by the GF through the CRAT, which sought to identify the key activities required to advance the sustainability of civil society organizations linked to the national response to HIV, and of the interventions implemented by them.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","High","41920","The TRP ranks the activity on public financing of civil society organization (CSO) for sexual and reproductive health activity under this module as of high quality demand and suggests moving its corresponding cost to the high quality ranking under this PAAR","0","0","0","0","41920","0","0","2020-03-11 14:13:54","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJP0/view","2021-02-28","HIV/AIDS",41920," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-02-28"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713=AN1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713=AO1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713=AP1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-02-28",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713=AN1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713=AO1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713=AP1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1870)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-02-28"]
["a6Q1R000000AJP1UAO","PAI-5429","Active","PRY-HIV/AIDS-12","2017-2019","RT Latin America and Caribbean","Paraguay","HIV/AIDS","HIV/AIDS","FR432-PRY-H",null,null,"RSSH: Community responses and systems","Community led advocacy","Recruitment of consultancy to study the adequacy of the legal framework, including the tax area for contracting by the state, services and products made by CS. Include the drafting of adjustment proposals. Consulting contract to update the Political Advocacy Plan. Monitoring of the advocacy plan designed in 2017 and its updating, which includes monitoring progress of Law 4313 (Budgetary Assurance of Sexual and Reproductive Health), Law 3940, TB Act, Access to Justice Act, Sexual and Reproductive Health, Law against all forms of discrimination, among others. Recruitment of Consultancy in Political incidence. Recruitment of Consultancy to design and establish a Plan of Institutional Communication of the CSOs and the agreed goals and objectives. Implement the Institutional Communication Plan to inform and sensitize the general population and leaders of different sectors, in particular, about the social work of organizations, especially CSOs of key populations.Develop a training plan on public financing models of civil society and determine their applicability in the national context. Design and implement a fundraising plan for CS. These activities are the gaps identified in the framework of the TA funded by the GF through the CRAT, which sought to identify the key activities required to advance the sustainability of civil society organizations linked to the national response to HIV, and of the interventions implemented by them.","Recruitment of consultancy to study the adequacy of the legal framework, including the tax area for contracting by the state, services and products made by CS. Include the drafting of adjustment proposals. Consulting contract to update the Political Advocacy Plan. Monitoring of the advocacy plan designed in 2017 and its updating, which includes monitoring progress of Law 4313 (Budgetary Assurance of Sexual and Reproductive Health), Law 3940, TB Act, Access to Justice Act, Sexual and Reproductive Health, Law against all forms of discrimination, among others. Recruitment of Consultancy in Political incidence. Recruitment of Consultancy to design and establish a Plan of Institutional Communication of the CSOs and the agreed goals and objectives. Implement the Institutional Communication Plan to inform and sensitize the general population and leaders of different sectors, in particular, about the social work of organizations, especially CSOs of key populations.Develop a training plan on public financing models of civil society and determine their applicability in the national context. Design and implement a fundraising plan for CS. These activities are the gaps identified in the framework of the TA funded by the GF through the CRAT, which sought to identify the key activities required to advance the sustainability of civil society organizations linked to the national response to HIV, and of the interventions implemented by them.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Community-led advocacy","Medium","1e+05","1. Consultant to study the adequacy of legal framework, tax 2. Draft proposal to update political advocacy plan 3. Monitor 2017 advocacy plan 4. Monitor progress on law 4313, 3940, TB Act, access to justice act, sexual and reproductive health act and law against discrimination, etc. 5. Recruit consultant for tracking political incidence 6. Consultant to design & establish CSO institutional communication plan 7. Implement institutional communication plan regarding social work especially for CSOs dealing with key populations 8. Fund raising plan for CSO","0","0","0","0","1e+05","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJP1/view","2021-02-28","HIV/AIDS",100000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-02-28"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713=AN1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713=AO1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713=AP1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-02-28",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713=AN1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713=AO1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713=AP1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1871)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-02-28"]
["a6Q1R000000AJP9UAO","PAI-5437","Inactive","PRY-HIV/AIDS-2","2017-2019","RT Latin America and Caribbean","Paraguay","HIV/AIDS","HIV/AIDS","FR432-PRY-H",null,null,"Comprehensive prevention programs for TGs","Condoms and lubricant programming for TGs","Acquisition of Lubricants for prevention activities in trans. Acquiring lubricants helps reduce the risk of transmission of HIV and other STIs because of potential condom breaks, and minimizes the possibility of lesions that contribute to transmission. The country does not currently have a regulatory framework that enables the procurement of lubricants for HIV prevention. For this reason, as part of the advocacy actions, we seek to reverse this situation, but it is a medium-term process. Therefore, within the framework of the project, we need to have the financial resources so that this input is part of the prevention package delivered in the different strategies of promotion by pairs, which are directly linked to the goals of the project.","Acquisition of Lubricants for prevention activities in trans. Acquiring lubricants helps reduce the risk of transmission of HIV and other STIs because of potential condom breaks, and minimizes the possibility of lesions that contribute to transmission. The country does not currently have a regulatory framework that enables the procurement of lubricants for HIV prevention. For this reason, as part of the advocacy actions, we seek to reverse this situation, but it is a medium-term process. Therefore, within the framework of the project, we need to have the financial resources so that this input is part of the prevention package delivered in the different strategies of promotion by pairs, which are directly linked to the goals of the project.","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Condoms and lubricant programming for transgender people","High","36400","Due to the necessity of having lubricant to effectively utilize condom, the TRP recommend this as a priority demand. Refer to Issue 3 of section 6.","36400","0","0","0","0","1","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJP9/view","2021-02-28","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-02-28"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713=AN1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713=AO1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713=AP1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-02-28",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713=AN1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713=AO1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713=AP1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1879)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-02-28"]
["a6Q1R000000AJPCUA4","PAI-5440","Inactive","PRY-HIV/AIDS-3","2017-2019","RT Latin America and Caribbean","Paraguay","HIV/AIDS","HIV/AIDS","FR432-PRY-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Acquisition of Lubricants for prevention activities in trans. Acquiring lubricants helps reduce the risk of transmission of HIV and other STIs because of potential condom breaks, and minimizes the possibility of lesions that contribute to transmission. The country does not currently have a regulatory framework that enables the procurement of lubricants for HIV prevention. For this reason, as part of the advocacy actions, we seek to reverse this situation, but it is a medium-term process. Therefore, within the framework of the project, we need to have the financial resources so that this input is part of the prevention package delivered in the different strategies of promotion by pairs, which are directly linked to the goals of the project.","Acquisition of Lubricants for prevention activities in trans. Acquiring lubricants helps reduce the risk of transmission of HIV and other STIs because of potential condom breaks, and minimizes the possibility of lesions that contribute to transmission. The country does not currently have a regulatory framework that enables the procurement of lubricants for HIV prevention. For this reason, as part of the advocacy actions, we seek to reverse this situation, but it is a medium-term process. Therefore, within the framework of the project, we need to have the financial resources so that this input is part of the prevention package delivered in the different strategies of promotion by pairs, which are directly linked to the goals of the project.",null,"High","18598","Due to the necessity of having lubricant to effectively utilize condom, the TRP recommend this as a priority demand. Refer to Issue 3 of section 6.","18598","0","0","0","0","1","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPC/view","2021-02-28","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-02-28"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713=AN1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713=AO1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713=AP1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-02-28",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713=AN1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713=AO1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713=AP1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1882)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-02-28"]
["a6Q1R000000AJPHUA4","PAI-5445","Active","PRY-HIV/AIDS-8","2017-2019","RT Latin America and Caribbean","Paraguay","HIV/AIDS","HIV/AIDS","FR432-PRY-H",null,null,"Treatment, care and support","HIV care","Recruitment of consultancy to carry out the Study of People that continue to 12, 24, 36, 60 months of initiation of therapy, with a new cohort for 2012, and 12 months of initiation of therapy for the cohort of 2014, 2015 and 2016. At the request of UNAIDS, it is necessary to modify the cohorts of people who annually initiate treatment with ARV, in order to adapt them to the annual fiscal cut. Currently, the cohorts begin on August 1 of the year and close on July 31 of the following year. As of 2016, PRONASIDA has decided to report fiscal year cohorts; therefore, with this consultancy we could have information of 24, 36 and 60 months that can be compared with the new cohorts. Having this information will inform the country the state of adherence to ART over time in the different annual cohorts.","Recruitment of consultancy to carry out the Study of People that continue to 12, 24, 36, 60 months of initiation of therapy, with a new cohort for 2012, and 12 months of initiation of therapy for the cohort of 2014, 2015 and 2016. At the request of UNAIDS, it is necessary to modify the cohorts of people who annually initiate treatment with ARV, in order to adapt them to the annual fiscal cut. Currently, the cohorts begin on August 1 of the year and close on July 31 of the following year. As of 2016, PRONASIDA has decided to report fiscal year cohorts; therefore, with this consultancy we could have information of 24, 36 and 60 months that can be compared with the new cohorts. Having this information will inform the country the state of adherence to ART over time in the different annual cohorts.",null,"High","3000","ART adherence monitoring is relevant for HIV treatment effectiveness. Noting the connection between this item and the next one, the TRP suggests the applicant combine the consultancy with shift cohort tracking below to ensure consistency, compatibility of data/ information/ methodology and prioritize M&E for this activity.","0","0","0","0","3000","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPH/view","2021-02-28","HIV/AIDS",3000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-02-28"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713=AN1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713=AO1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713=AP1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-02-28",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713=AN1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713=AO1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713=AP1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1887)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-02-28"]
["a6Q1R000000AJPIUA4","PAI-5446","Active","PRY-HIV/AIDS-9","2017-2019","RT Latin America and Caribbean","Paraguay","HIV/AIDS","HIV/AIDS","FR432-PRY-H",null,null,"HIV Testing Services","Differentiated HIV testing services","Acquisition of portable viral load and CD4 equipment in the community Voluntary Counceling and Testing Center. These teams will facilitate the follow-up of people diagnosed in the community viral loadT as part of the strategy to improve access to comprehensive care. The implementation of the community Voluntary Counceling and Testing Center complements the provision of testing services and the monitoring of reactive persons, since it works in extended hours and facilitates access to people of the target population who do not want or are not able go to the public services of MSPyBS.","Acquisition of portable viral load and CD4 equipment in the community Voluntary Counceling and Testing Center. These teams will facilitate the follow-up of people diagnosed in the community viral loadT as part of the strategy to improve access to comprehensive care. The implementation of the community Voluntary Counceling and Testing Center complements the provision of testing services and the monitoring of reactive persons, since it works in extended hours and facilitates access to people of the target population who do not want or are not able go to the public services of MSPyBS.",null,"High","32624","The requested equipment is necessary to ensure proper treatment monitoring thus it is recommended as high priority. However, the TRP requests the applicant to clarify how many units of the requested equipment; and the allocation be based on the anticipated use rate of the equipment","0","0","0","0","32624","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPI/view","2021-02-28","HIV/AIDS",32624," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-02-28"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713=AN1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713=AO1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713=AP1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-02-28",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713=AN1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713=AO1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713=AP1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1888)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-02-28"]
["a6Q1R000000AJPNUA4","PAI-5451","Active","PRY-Tuberculosis-3","2017-2019","RT Latin America and Caribbean","Paraguay","Tuberculosis","Tuberculosis","FR451-PRY-T",null,null,"Program management","Other program management intervention(s)","National TB Programme (PNCT) - Program Management. Technical-administrative management for optimum implementation of this project, including execution and monitoring of the proposed activities. Production and verification of the funding application for execution of PNCT activities in the context of the project, and provision of the same to the RP. The intention here is to appropriately monitor activities to be implemented and as such to assure effective execution of the same.PNCT monitoring management of data quality, indicator compliance and recording in expert system. Technical-programmatic management relating to monitoring and follow-up on indicators and activities included in the working plan. Data quality management, use of corrective controls, monitoring for optimum implementation of the Expert System, which will serve from this year as the main source of information for reporting indicators.The intention here is to efficiently monitor indicators and activities, promptly identify bottlenecks that could affect execution of the project and offer recommendations.","National TB Programme (PNCT) - Program Management. Technical-administrative management for optimum implementation of this project, including execution and monitoring of the proposed activities. Production and verification of the funding application for execution of PNCT activities in the context of the project, and provision of the same to the RP. The intention here is to appropriately monitor activities to be implemented and as such to assure effective execution of the same.PNCT monitoring management of data quality, indicator compliance and recording in expert system. Technical-programmatic management relating to monitoring and follow-up on indicators and activities included in the working plan. Data quality management, use of corrective controls, monitoring for optimum implementation of the Expert System, which will serve from this year as the main source of information for reporting indicators.The intention here is to efficiently monitor indicators and activities, promptly identify bottlenecks that could affect execution of the project and offer recommendations.","NA Original Module: SRSS: Program management. Original Intervention: National disease monitoring policies, planning, coordination and program management","High","210724.74",null,"0","0","0","0","210724.74","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPN/view","2021-12-31","Tuberculosis",210724.74," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713=AN1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713=AO1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713=AP1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713=AN1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713=AO1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713=AP1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1893)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJPSUA4","PAI-5456","Active","PRY-Tuberculosis-8","2017-2019","RT Latin America and Caribbean","Paraguay","Tuberculosis","Tuberculosis","FR451-PRY-T",null,null,"Program management","Other program management intervention(s)","Hiring staff for PNCT statistics department.Hiring is needed to cover a vacancy in the statistics department as currently there are two professionals actively working (reduced from 3 to 2 due to resignation). These staff will monitor data input in the expert system until hired by the MSPBS.","Hiring staff for PNCT statistics department.Hiring is needed to cover a vacancy in the statistics department as currently there are two professionals actively working (reduced from 3 to 2 due to resignation). These staff will monitor data input in the expert system until hired by the MSPBS.","NA Original Module: SRSS: Program management. Original Intervention: National disease monitoring policies, planning, coordination and program management","Medium","28500",null,"0","0","0","0","28500","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPS/view","2021-12-31","Tuberculosis",28500," Latin America and Caribbean","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713=AN1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713=AO1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713=AP1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713=AN1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713=AO1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713=AP1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1898)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJPXUA4","PAI-5461","Active","ROU-Tuberculosis-4","2017-2019","RT Eastern Europe and Central Asia","Romania","Tuberculosis","Tuberculosis","FR320-ROU-T",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Organisation of trainings, workshops and conferences by National TB Program (Marius Nasta Institute) to improve TB healthcare providers' communication skills with TB patients and sensitize them about patients rights, establish a feedback loop between patients and care providers, and contribute to internal evaluation and re-design of programmatic approaches for the National TB Strategy.","Organisation of trainings, workshops and conferences by National TB Program (Marius Nasta Institute) to improve TB healthcare providers' communication skills with TB patients and sensitize them about patients rights, establish a feedback loop between patients and care providers, and contribute to internal evaluation and re-design of programmatic approaches for the National TB Strategy.","NA Original Module: RSSH - Human resources for health, including community health workers","Medium","336662.55",null,"0","0","0","0","336662.55","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPX/view","2021-03-31","Tuberculosis",336662.55," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713=AN1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713=AO1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713=AP1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713=AN1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713=AO1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713=AP1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1903)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2021-03-31"]
["a6Q1R000000AJPYUA4","PAI-5462","Active","ROU-Tuberculosis-5","2017-2019","RT Eastern Europe and Central Asia","Romania","Tuberculosis","Tuberculosis","FR320-ROU-T",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Capacity building for implementers of the National TB Strategy (Marius Nasta Institute staff, county coordinators, central and local authority representatives) in programmatic, financial management, and procurement, participation at international capacity building events (trainings, conferences), regional and national management meetings for TB stakeholders for improving the capacity of strategic planning based on collected data.","Capacity building for implementers of the National TB Strategy (Marius Nasta Institute staff, county coordinators, central and local authority representatives) in programmatic, financial management, and procurement, participation at international capacity building events (trainings, conferences), regional and national management meetings for TB stakeholders for improving the capacity of strategic planning based on collected data.","NA Original Module: RSSH - Human resources for health, including community health workers","Medium","448883.4",null,"0","0","0","0","448883.4","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPY/view","2021-03-31","Tuberculosis",448883.4," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713=AN1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713=AO1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713=AP1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713=AN1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713=AO1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713=AP1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1904)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2021-03-31"]
["a6Q1R000000AJPdUAO","PAI-5467","Active","RWA-Malaria-5","2017-2019","RT Southern and Eastern Africa","Rwanda","Malaria","Malaria","FR100-RWA-M-01",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Rwanda will undertake the next DHS in 2019-2020. This is a national activity implemented under the leadership of the National Institute of Statistic of Rwanda (NISR). The request will support the NMCP to ensure malaria is included in the DHS such as through the reading of blood smears for malaria prevalence. Part of the TA for this activity will be supported by PMI.","Rwanda will undertake the next DHS in 2019-2020. This is a national activity implemented under the leadership of the National Institute of Statistic of Rwanda (NISR). The request will support the NMCP to ensure malaria is included in the DHS such as through the reading of blood smears for malaria prevalence. Part of the TA for this activity will be supported by PMI.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Support to the DHIS to support the malaria component","Medium","5e+05","The DHIS is an important piece in therunning of the malaria program.","0","0","0","0","5e+05","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPd/view","2021-06-30","Malaria",500000," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713=AN1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713=AO1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713=AP1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713=AN1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713=AO1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713=AP1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1909)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-06-30"]
["a6Q1R000000AJPiUAO","PAI-5472","Active","RWA-TB/HIV-13","2017-2019","RT Southern and Eastern Africa","Rwanda","HIV/TB","HIV/AIDS, Tuberculosis","FR290-RWA-C",null,null,"Prevention programs for general population","Other intervention(s) for general population","Above allocation (USD 3,218,722) will provide educational support to Most Vulnerable Children (particularly vocational training). Economic empowerment and life skills building will reduce the risk of HIV infection for these vulnerable children. The other support covered by above allocation amount in this programmatic area is salary for service providers at decentralized level , which will improve quality of prevention services. (USD 1,396,104)","Above allocation (USD 3,218,722) will provide educational support to Most Vulnerable Children (particularly vocational training). Economic empowerment and life skills building will reduce the risk of HIV infection for these vulnerable children. The other support covered by above allocation amount in this programmatic area is salary for service providers at decentralized level , which will improve quality of prevention services. (USD 1,396,104)","NA Original Intervention: Support for orphans and vulnerable children minimum package","Medium","4614826","OVCs are not driving the epidemic","0","0","0","0","4614826","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPi/view",null,"TB/HIV",4614826," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713=AN1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713=AO1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713=AP1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713=AN1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713=AO1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713=AP1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1914)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJPnUAO","PAI-5477","Inactive","RWA-TB/HIV-2","2017-2019","RT Southern and Eastern Africa","Rwanda","HIV/TB","HIV/AIDS, Tuberculosis","FR290-RWA-C",null,null,"TB care and prevention","Case detection and diagnosis","Above allocation will allow purchasing of 5 digital radiography machines for some district hospitals, thereby increasing access to CXR screening for defined HRGs (new PLHIVs and TB contacts) and improving diagnosis capacities of bacteriologically negative TB. The expected impact is to improve early detection and treatment of TB and TB/HIV and contribute to the reduction of TB mortality.","Above allocation will allow purchasing of 5 digital radiography machines for some district hospitals, thereby increasing access to CXR screening for defined HRGs (new PLHIVs and TB contacts) and improving diagnosis capacities of bacteriologically negative TB. The expected impact is to improve early detection and treatment of TB and TB/HIV and contribute to the reduction of TB mortality.",null,"High","813603",null,"0","813603","0","0","0","1","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPn/view",null,"TB/HIV",0," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713=AN1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713=AO1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713=AP1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713=AN1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713=AO1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713=AP1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1919)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJPrUAO","PAI-5481","Active","RWA-TB/HIV-6","2017-2019","RT Southern and Eastern Africa","Rwanda","HIV/TB","HIV/AIDS, Tuberculosis","FR290-RWA-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Above allocation will: a) cover the purchase of computers to replace those distributed to health facilities in 2012 - to complement interventions on improved access and quality of surveillance data contained in the funding; b) support the NTP for conducting joint sessions with the national Institute of Statistics for analysing causes of TB deaths using available data from the national vital registration system.","Above allocation will: a) cover the purchase of computers to replace those distributed to health facilities in 2012 - to complement interventions on improved access and quality of surveillance data contained in the funding; b) support the NTP for conducting joint sessions with the national Institute of Statistics for analysing causes of TB deaths using available data from the national vital registration system.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","388195",null,"0","0","0","0","388195","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPr/view",null,{"$f":"IF(OR(I1923=\"HIV/AIDS\",I1923=\"Tuberculosis\",I1923=\"Malaria\",I1923=\"RSSH\"),I1923, IF(I1923=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"TB/HIV"},{"$f":"VALUE(Y1923)","v":388195},{"$f":"RIGHT(F1923,LEN(F1923)-2)","v":" Southern and Eastern Africa"},"HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,{"$f":"TRIM(AK1923)","v":"Tuberculosis"},{"$f":"TRIM(AL1923)","v":""},{"$f":"TRIM(AM1923)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713=AN1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713=AO1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713=AP1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IF(AE1923<>\"\",AE1923,IF(MAX(AQ1923,AR1923,AS1923,AT1923)<>0,MAX(AQ1923,AR1923,AS1923,AT1923),AU1923))","v":"2021-06-30"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713=AN1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713=AO1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713=AP1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1923)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE1923<>\"\",AE1923,IF(MAX(AW1923,AX1923,AY1923,AZ1923)<>0,MAX(AW1923,AX1923,AY1923,AZ1923),BA1923))","v":"2018-01-01"}]
["a6Q1R000000AJPuUAO","PAI-5484","Inactive","RWA-TB/HIV-9","2017-2019","RT Southern and Eastern Africa","Rwanda","HIV/TB","HIV/AIDS, Tuberculosis","FR290-RWA-C",null,null,"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","In order to acquire WHO accreditation the following are included in the above allocation: a) 3% out of 9% of MPPD management fees (USD 4,072,691); b) functional costs of the Rwanda Standards Bureaus drug quality control laboratory (USD 1,372,331); c) air conditioning for 25 district pharmacies; d) 2 trucks for supply chain activities; and e) an Enterprise Resource Planning system (ERP) at the central warehouse.","In order to acquire WHO accreditation the following are included in the above allocation: a) 3% out of 9% of MPPD management fees (USD 4,072,691); b) functional costs of the Rwanda Standards Bureaus drug quality control laboratory (USD 1,372,331); c) air conditioning for 25 district pharmacies; d) 2 trucks for supply chain activities; and e) an Enterprise Resource Planning system (ERP) at the central warehouse.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Operationalization of procurement and supply chain management system, PSM infrastructure and development tools","High","5445022",null,"5445022","0","0","0","0","1","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPu/view",null,"TB/HIV",0," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713=AN1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713=AO1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713=AP1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713=AN1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713=AO1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713=AP1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1926)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJPzUAO","PAI-5489","Active","SDN-Integrated-13","2017-2019","RT Middle East and North Africa","Sudan","Malaria","Malaria","FR573-SDN-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Funding to replace 976,130 LLIN with  Quality issues (DawaPlus 2.0 commercialized byTana Nettings Co Ltd REF: quality notice of 01.02.2019)  that were distributed in south Darfur state ( prevelance  9.2 %MIS 2016). Request to replace these bed nets will ensure the needed protection is provided for south Darfur population where the LLINS is the main vector control intervention.","Funding to replace 976,130 LLIN with  Quality issues (DawaPlus 2.0 commercialized byTana Nettings Co Ltd REF: quality notice of 01.02.2019)  that were distributed in south Darfur state ( prevelance  9.2 %MIS 2016). Request to replace these bed nets will ensure the needed protection is provided for south Darfur population where the LLINS is the main vector control intervention.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign (replacement of Dawa 2.0 nets)","Low","2903401","The affected nets still constitute a physical barrier. It remainsto be seen what the actual deltamethrin content of theseaffected nets was at distribution. The issue of belowspecificationinsecticide content is minor compared to moreimportant problems affecting the effectiveness of LLINs,particularly the non-use.","0","0","0","0","2903401","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJPz/view","2020-12-31","Malaria",2903401," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713=AN1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713=AO1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713=AP1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713=AN1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713=AO1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713=AP1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1931)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJQ4UAO","PAI-5494","Active","SDN-Integrated-3","2017-2019","RT Middle East and North Africa","Sudan","Malaria","Malaria","FR467-SDN-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Continuous distribution system in Sudan introduced in 2016 with support NFM1 grant. Currently distribution through ANC in collaboration with UNICEF, IVM and Reproductive Health Department at FMOH. Plan is to expand the routine distribution through EPI in 2018. UQD needed to maintain the coverage among the targeted vulnerable groups, including refugees, miners, and nomads.","Continuous distribution system in Sudan introduced in 2016 with support NFM1 grant. Currently distribution through ANC in collaboration with UNICEF, IVM and Reproductive Health Department at FMOH. Plan is to expand the routine distribution through EPI in 2018. UQD needed to maintain the coverage among the targeted vulnerable groups, including refugees, miners, and nomads.","Sudan has only 1 integrated funding request, and the UQD component is Malaria Original Intervention: Long-lasting insecticidal nets  Continuous distribution","High","1245426","Remaining under-served vulnerable populations identified in the within-allocation funding request should also be addressed by this activity where possible. If the planned Emergency Fund request is successful for this activity, consideration should be given to continuing sufficient funding for the remaining under-served vulnerable populations identified, namely nomads and miners.","0","0","0","0","1245426","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQ4/view","2020-12-31","Malaria",1245426," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713=AN1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713=AO1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713=AP1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713=AN1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713=AO1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713=AP1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1936)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJQ5UAO","PAI-5495","Active","SDN-Integrated-4","2017-2019","RT Middle East and North Africa","Sudan","RSSH","Malaria","FR467-SDN-M",null,null,"Case management","Facility-based treatment","Target population: Refugees. This component is intended to provide malaria case management services mainly ACTs and RDTs to South Sudan Refugees.","Target population: Refugees. This component is intended to provide malaria case management services mainly ACTs and RDTs to South Sudan Refugees.","Sudan has only 1 integrated funding request, and the UQD component is Malaria","High","2100470",null,"0","0","0","0","2100470","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQ5/view","2020-12-31","Malaria",2100470," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713=AN1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713=AO1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713=AP1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713=AN1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713=AO1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713=AP1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1937)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJQAUA4","PAI-5500","Active","SDN-Integrated-9","2017-2019","RT Middle East and North Africa","Sudan","Malaria","Malaria","FR467-SDN-M",null,null,"Case management","Other case management intervention(s)","The national malaria treatment policy was updated in 2017. Approx 30% of the more than 16,000 health care providers in Sudan was trained on the new policy. With domestic resources and others partners another 30% will be trained. UQD to fill 40% gap to ensure adherence of all care providers to the new treatment guidelines and increase the uptake of malaria prevention and treatment services.","The national malaria treatment policy was updated in 2017. Approx 30% of the more than 16,000 health care providers in Sudan was trained on the new policy. With domestic resources and others partners another 30% will be trained. UQD to fill 40% gap to ensure adherence of all care providers to the new treatment guidelines and increase the uptake of malaria prevention and treatment services.","Sudan has only 1 intergrated funding request, and the UQD component is Malaria Original Intervention: Other case management intervention(s)-Health worker training","Medium","1280506",null,"0","0","0","0","1280506","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQA/view","2020-12-31","Malaria",1280506," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713=AN1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713=AO1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713=AP1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713=AN1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713=AO1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713=AP1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1942)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJQFUA4","PAI-5505","Active","SEN-HIV/AIDS-5","2017-2019","RT Western Africa","Senegal","HIV/AIDS","HIV/AIDS","FR556-SEN-H",null,null,"PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","In line with the international community, Senegal has developed a business plan to expedite the elimination of mother-to-child transmission of HIV. To this end, a partnership with midwives has been established. This strategy will be strengthened by the coaching system and support will be provided for finding patients lost to follow-up, as will assistance for transport and checkup costs.","In line with the international community, Senegal has developed a business plan to expedite the elimination of mother-to-child transmission of HIV. To this end, a partnership with midwives has been established. This strategy will be strengthened by the coaching system and support will be provided for finding patients lost to follow-up, as will assistance for transport and checkup costs.","Amount validated by CT Original Module: Prevention of mother-to-child transmission","High","111851.64",null,"0","0","0","0","111851.64","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQF/view","2020-12-31","HIV/AIDS",111851.64," Western Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713=AN1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713=AO1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713=AP1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713=AN1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713=AO1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713=AP1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1947)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJQKUA4","PAI-5510","Active","SEN-Malaria-1","2017-2019","RT Western Africa","Senegal","Malaria","Malaria","FR559-SEN-M",null,null,"Vector control","Indoor residual spraying (IRS)","In the three target districts for this project (Touba, Diourbel and Passy), disease incidence is high.Within each district, criteria for selecting areas are defined based on the intensity of transmission (more than 10 cases per 1,000 population) and the feasibility of the intervention (predominant type of housing and population behavior). The area is demarcated at the health-post level, according to the degree of incidence reported by each health post.One treatment cycle per district (hot spots) is planned per year, to be carried out just before the main malaria transmission period (rainy season). The insecticide used will be chosen based on the susceptibility of the vectors in the intervention areas. IRS activities will be carried out based on the World Health Organization (WHO) IRS operational manual and adapted to the local context, but also based on the countrys ten years of experience with IRS.","In the three target districts for this project (Touba, Diourbel and Passy), disease incidence is high.Within each district, criteria for selecting areas are defined based on the intensity of transmission (more than 10 cases per 1,000 population) and the feasibility of the intervention (predominant type of housing and population behavior). The area is demarcated at the health-post level, according to the degree of incidence reported by each health post.One treatment cycle per district (hot spots) is planned per year, to be carried out just before the main malaria transmission period (rainy season). The insecticide used will be chosen based on the susceptibility of the vectors in the intervention areas. IRS activities will be carried out based on the World Health Organization (WHO) IRS operational manual and adapted to the local context, but also based on the countrys ten years of experience with IRS.","Amount validated by CT Original Intervention: Indoor residual spraying","Medium","11917841.99","The availability of existing funding for IRS in malaria hotspotsis considered of higher priority than in other locations, wheremalaria is of lower endemicity. The TRP graded this item asMedium priority and relies on the Global Fund Secretariat toverify the detailed budget.","0","0","0","0","11917841.99","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQK/view","2020-12-31","Malaria",11917841.99," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713=AN1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713=AO1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713=AP1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713=AN1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713=AO1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713=AP1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1952)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJQLUA4","PAI-5511","Active","SEN-Malaria-2","2017-2019","RT Western Africa","Senegal","Malaria","Malaria","FR559-SEN-M",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Senegal and the Gambia have undertaken cross-border activities to strengthen the malaria response along their shared borders.Identifying gaps has enabled relevant activities in several response areas to be highlighted.Part of the total cost for the identified activities will be funded under the New Funding Model 2 (NFM2); the rest (3,800,678) will be requested under above allocation funding.","Senegal and the Gambia have undertaken cross-border activities to strengthen the malaria response along their shared borders.Identifying gaps has enabled relevant activities in several response areas to be highlighted.Part of the total cost for the identified activities will be funded under the New Funding Model 2 (NFM2); the rest (3,800,678) will be requested under above allocation funding.","SEN-Malaria-2 and SEN-Malaria-3 have the same description because the TRP split the request in 2 differents amounts with different priority rating. Amount validated by CT Original Module: RSSH - Program management","High","1194317.14",null,"0","0","0","0","1194317.14","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQL/view","2020-12-31","Malaria",1194317.1399999999," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713=AN1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713=AO1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713=AP1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713=AN1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713=AO1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713=AP1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1953)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJQQUA4","PAI-5516","Active","SEN-Malaria-7","2017-2019","RT Western Africa","Senegal","Malaria","Malaria","FR559-SEN-M",null,null,"Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","The cost of drugs for the 60120 month target age group for 2019 is 334,251 and operational costs for both target age groups are 1,317,245 euros; for 2020 the cost of drugs for the 60120 month target age group is 343,276 and operational costs for both target age groups are 1,358,520.","The cost of drugs for the 60120 month target age group for 2019 is 334,251 and operational costs for both target age groups are 1,317,245 euros; for 2020 the cost of drugs for the 60120 month target age group is 343,276 and operational costs for both target age groups are 1,358,520.","SEN-Malaria-7 and SEN-Malaria-8 have the same description because the TRP split the request in 2 differents amounts with different priority rating Original Module: Specific prevention interventions","Medium","1909769.95","The TRP has rated the procurement of drugs for 60-120 months as Medium priority, subject to revisions depending on future WHO recommendations on this age group.","0","0","0","0","1909769.95","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQQ/view","2020-12-31","Malaria",1909769.95," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713=AN1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713=AO1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713=AP1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713=AN1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713=AO1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713=AP1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1958)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJQVUA4","PAI-5521","Active","SEN-Tuberculosis-4","2017-2019","RT Western Africa","Senegal","Tuberculosis","Tuberculosis, RSSH","FR288-SEN-Z-01",null,null,"RSSH: Health management information systems and M&E","Surveys","Conducting a national survey  into the prevalence of drug-resistant TB. The conclusions would enable subsequent interventions in the MDR-TB response to be strategically orientated.","Conducting a national survey  into the prevalence of drug-resistant TB. The conclusions would enable subsequent interventions in the MDR-TB response to be strategically orientated.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","100799.01","A drug-resistant survey (DRS) should be conducted every 5 years. This is of high importance in a country with a significant risk for primary drug resistance.","0","0","0","0","100799.01","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQV/view",null,"Multi-component",100799.01," Western Africa","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713=AN1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713=AO1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713=AP1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713=AN1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713=AO1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713=AP1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1963)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJQZUA4","PAI-5525","Active","SEN-Tuberculosis-8","2017-2019","RT Western Africa","Senegal","Tuberculosis","Tuberculosis, RSSH","FR288-SEN-Z-01",null,null,"RSSH: Health management information systems and M&E","Surveys","The country has never undertaken a national TB prevalence survey. Such a survey would enable better knowledge to be gained of the epidemiological context and help orient the response more toward interventions that will have the maximum impact.","The country has never undertaken a national TB prevalence survey. Such a survey would enable better knowledge to be gained of the epidemiological context and help orient the response more toward interventions that will have the maximum impact.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","1122208.51","Senegal is not a high TB burden country and a prevalence survey is not considered of highest priority in this context.","0","0","0","0","1122208.51","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQZ/view",null,"Multi-component",1122208.51," Western Africa","Tuberculosis, RSSH","Tuberculosis"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713=AN1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713=AO1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713=AP1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713=AN1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713=AO1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713=AP1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1967)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJQcUAO","PAI-5528","Active","SLE-HIV/AIDS-2","2017-2019","RT Western Africa","Sierra Leone","HIV/AIDS","HIV/AIDS","FR474-SLE-H",null,null,"PMTCT","Prong 3: Preventing vertical HIV transmission","Sierra Leone has adopted a dual HIV-Syphilis testing protocol for pregnant women during ANC. Within the allocation amount, the country will scale up the dual testing to cover 181,766 pregnant women per year (545,300 total across 3 years) in 691 health facilities (60% of the estimated number of pregnant women).The PAAR will be utilized to procure DUO HIV/syphilis test kits to cover all pregnant women in the country.","Sierra Leone has adopted a dual HIV-Syphilis testing protocol for pregnant women during ANC. Within the allocation amount, the country will scale up the dual testing to cover 181,766 pregnant women per year (545,300 total across 3 years) in 691 health facilities (60% of the estimated number of pregnant women).The PAAR will be utilized to procure DUO HIV/syphilis test kits to cover all pregnant women in the country.","NA Original Module: Prevention of mother-to-child transmission","High","1055356","Sierra Leone has adopted a dual HIV-Syphilis testing protocol for pregnant women during ANC. Within the allocation amount, the country will scale up the dual testing to cover 181,766 pregnant women per year (545,300 total across 3 years) in 691 health facilities. This represents approximately 60% of the estimated number of pregnant women.. The prioritized above allocation request will be utilised to procure DUO HIV/syphilis test kits including PSM costs to cover all pregnant women in the country. Key activities will include the following:  Procurement of HIV/syphilis test kits Scale up to an additional 400 health facilities Build capacity of health staff on the use of the kits and provision of PMTCT services","0","0","0","0","1055356","0","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQc/view","2020-12-31","HIV/AIDS",1055356," Western Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713=AN1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713=AO1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713=AP1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713=AN1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713=AO1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713=AP1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1970)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJQhUAO","PAI-5533","Inactive","SLE-Malaria-1","2017-2019","RT Western Africa","Sierra Leone","Malaria","Tuberculosis, Malaria, RSSH","FR564-SLE-Z",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","According to WHO recommendations, NMCPs and their partners should consider the deployment of pyrethroid-PBO nets in areas where the main malaria vector(s) have pyrethroid resistance that is: a) confirmed, b) of intermediate level (as defined above), and c) conferred (at least in part) by a monooxygenase-based resistance mechanism, as determined by standard. According to WHO recommendations, NMCPs and their partners should consider the deployment of pyrethroid-PBO nets in areas where the main malaria vector(s) have pyrethroid resistance that is: a) confirmed, b) of intermediate level (as defined above), and c) conferred (at least in part) by a monooxygenase-based resistance mechanism, as determined by standard. Based on the WHO recommendations and the review of the insecticide resistance monitoring data the NMCP and partners recommends the deployment of pyrethroid-PBO nets. The available data demonstrates significant high levels of pyrethroid resistance in all four sentinel districts. However, the susceptibility status to pyrethroid increased when mosquitoes were pre-exposed to PBO. Therefore the deployment of PBO nets in Sierra-Leone could help to improve the effectiveness of the LLINs distributed.     NMCP and partners will ensure that the deployment of pyrethroid-PBO nets insecticide nets will not reduce the coverage of the LLIN distributed during mass campaign or routine and NMCP will work with the stakeholders to maintain universal coverage of ITN. PBO LLINs ($2.96 per unit) is higher than standard pyrethroid-only LLINs. ($2.23 per unit). Thus, the decision of going with PBO has created a gap in funding which was not foreseen at the budgeting and approval stage. The anticipated cost of 2,290,769 PBO-LLIN nets is $6,780,676.24 compared to $5,337,647.20 already committed in the GF budget for pyrethroid-only LLINs.","According to WHO recommendations, NMCPs and their partners should consider the deployment of pyrethroid-PBO nets in areas where the main malaria vector(s) have pyrethroid resistance that is: a) confirmed, b) of intermediate level (as defined above), and c) conferred (at least in part) by a monooxygenase-based resistance mechanism, as determined by standard. According to WHO recommendations, NMCPs and their partners should consider the deployment of pyrethroid-PBO nets in areas where the main malaria vector(s) have pyrethroid resistance that is: a) confirmed, b) of intermediate level (as defined above), and c) conferred (at least in part) by a monooxygenase-based resistance mechanism, as determined by standard. Based on the WHO recommendations and the review of the insecticide resistance monitoring data the NMCP and partners recommends the deployment of pyrethroid-PBO nets. The available data demonstrates significant high levels of pyrethroid resistance in all four sentinel districts. However, the susceptibility status to pyrethroid increased when mosquitoes were pre-exposed to PBO. Therefore the deployment of PBO nets in Sierra-Leone could help to improve the effectiveness of the LLINs distributed.     NMCP and partners will ensure that the deployment of pyrethroid-PBO nets insecticide nets will not reduce the coverage of the LLIN distributed during mass campaign or routine and NMCP will work with the stakeholders to maintain universal coverage of ITN. PBO LLINs ($2.96 per unit) is higher than standard pyrethroid-only LLINs. ($2.23 per unit). Thus, the decision of going with PBO has created a gap in funding which was not foreseen at the budgeting and approval stage. The anticipated cost of 2,290,769 PBO-LLIN nets is $6,780,676.24 compared to $5,337,647.20 already committed in the GF budget for pyrethroid-only LLINs.","07/05/2019 : Email from Svetlana Dupriez in CT validation:This item has been fully funded by PMI / TRP June Retreat 2019 / Component multi Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","1443029",null,"0","0","0","1443029","0","1","0","2019-10-30 15:34:20","2019-10-30 15:34:19","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQh/view","2021-06-30","Multi-component",0," Western Africa","Tuberculosis, Malaria, RSSH","Tuberculosis"," Malaria"," RSSH",null,"Malaria","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713=AN1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713=AO1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713=AP1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713=AN1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713=AO1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713=AP1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1975)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJQmUAO","PAI-5538","Active","SLE-TB-4","2017-2019","RT Western Africa","Sierra Leone","Tuberculosis","Tuberculosis, Malaria, RSSH","FR564-SLE-Z",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","NLPT plans to scale-up the TB services in all prison by supporting the health facilities in the prisons to effectively identify and treat all cases of TB, TB-HIV co-infected and DR-TB cases, establishing TB/HIV screening on entry including capacity building, increase access to diagnostic facilities, improve screening among inmates, create awareness and also build a solid infection control model. The TB care in prisons will be also integrated into the national surveillance framework with proper disaggregation and support printing and updating of tools for correctional sites.","NLPT plans to scale-up the TB services in all prison by supporting the health facilities in the prisons to effectively identify and treat all cases of TB, TB-HIV co-infected and DR-TB cases, establishing TB/HIV screening on entry including capacity building, increase access to diagnostic facilities, improve screening among inmates, create awareness and also build a solid infection control model. The TB care in prisons will be also integrated into the national surveillance framework with proper disaggregation and support printing and updating of tools for correctional sites.","TRP June Retreat 2019 Original Intervention: Key populations (TB care and prevention)  Prisoners","High","5e+05",null,"0","0","0","0","5e+05","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQm/view","2021-06-30","Multi-component",500000," Western Africa","Tuberculosis, Malaria, RSSH","Tuberculosis"," Malaria"," RSSH",null,"Malaria","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713=AN1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713=AO1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713=AP1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713=AN1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713=AO1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713=AP1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1980)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJQrUAO","PAI-5543","Active","SLE-TB-9","2017-2019","RT Western Africa","Sierra Leone","RSSH","Tuberculosis, Malaria, RSSH","FR564-SLE-Z",null,null,"Program management","Policy, planning, coordination and management of national disease control programs","Resources are needed to strengthen the TB programme management at district level through supporting monthly DHMT meetings, support DHMT supportive supervisions to PHUs and office supplies (stationary and communication).","Resources are needed to strengthen the TB programme management at district level through supporting monthly DHMT meetings, support DHMT supportive supervisions to PHUs and office supplies (stationary and communication).","TRP June Retreat 2019 / Component multi","High","4e+05",null,"0","0","0","0","4e+05","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQr/view","2021-06-30","Multi-component",400000," Western Africa","Tuberculosis, Malaria, RSSH","Tuberculosis"," Malaria"," RSSH",null,"Malaria","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713=AN1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713=AO1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713=AP1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713=AN1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713=AO1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713=AP1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1985)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJQsUAO","PAI-5544","Inactive","SLV-HIV/AIDS-1","2017-2019","RT Latin America and Caribbean","El Salvador","HIV/AIDS","HIV/AIDS","FR325-SLV-H",null,null,"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Critical infrastructure, due to its characteristics, is of paramount importance when an emergency occurs, since it must remain fully operational for the adequate management of any contingency that affects the population. Therefore, the levels of tolerable risk of these facilities must be particularly strict and conservative according to already established international standards. Most of the infrastructure of the Ministry of Health can be considered critical, as it has a vital role in caring for the affected population in times of disaster. From this point of view, the National Reference Laboratory is considered to be a critical infrastructure. Its role is fundamental in monitoring the health of the population during the period after an earthquake, or other disasters since, in these cases, communicable diseases are considered a major problem that can result in epidemics if they are not controlled over time.","Critical infrastructure, due to its characteristics, is of paramount importance when an emergency occurs, since it must remain fully operational for the adequate management of any contingency that affects the population. Therefore, the levels of tolerable risk of these facilities must be particularly strict and conservative according to already established international standards. Most of the infrastructure of the Ministry of Health can be considered critical, as it has a vital role in caring for the affected population in times of disaster. From this point of view, the National Reference Laboratory is considered to be a critical infrastructure. Its role is fundamental in monitoring the health of the population during the period after an earthquake, or other disasters since, in these cases, communicable diseases are considered a major problem that can result in epidemics if they are not controlled over time.","NA Original Module: SRSS: Provision of integrated services and quality improvement. Original Intervention: Improve the infrastructure of service provision","High","6008214.12",null,"0","0","6008214.12","0","0","1","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQs/view","2021-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713=AN1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713=AO1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713=AP1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713=AN1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713=AO1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713=AP1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1986)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJQxUAO","PAI-5549","Active","SOM-HIV/AIDS-10","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Anonymous free confidential hotlines that are currently supported by the GF funding. Hotlines provide factual information, counselling and referral information and support. This will support the current 3 hotlines which cover all Somalia.","Anonymous free confidential hotlines that are currently supported by the GF funding. Hotlines provide factual information, counselling and referral information and support. This will support the current 3 hotlines which cover all Somalia.","NA Original Intervention: HIV and sexually transmitted infections (STI ) Community Hotlines","High","278822","Anonymous free confidential hotlines that are currently supported by the Global Fund funding. This will support the current 3 hotlines which cover all Somalia","85600","0","0","0","193222","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJQx/view","2020-12-31","HIV/AIDS",193222," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713=AN1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713=AO1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713=AP1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713=AN1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713=AO1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713=AP1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1991)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJR2UAO","PAI-5554","Active","SOM-HIV/AIDS-15","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","WHO technical assistance P3 level  currently funded through the grant. Proposal is 50% from Malaria and 50% from RSSH to support essential medicines oversight for all health areas.","WHO technical assistance P3 level  currently funded through the grant. Proposal is 50% from Malaria and 50% from RSSH to support essential medicines oversight for all health areas.","NA Original Module: RSSH - Community responses and systems. Original Intervention: Essential Medicines TA","Medium","375432","WHO technical assistance P3 level  currently funded through the grant. Proposal is 50% from Malaria and 50% from RSSH to support essential medicines oversight for all health areas.","0","0","0","0","375432","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJR2/view","2020-12-31","HIV/AIDS",375432," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713=AN1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713=AO1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713=AP1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713=AJ1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713=AN1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713=AO1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713=AP1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G1996)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJR7UAO","PAI-5559","Active","SOM-HIV/AIDS-2","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","To address community based stigma and complement the allocation funding in RSSH addressing health worker related stigma. To help improve PLHIV rights knowledge.","To address community based stigma and complement the allocation funding in RSSH addressing health worker related stigma. To help improve PLHIV rights knowledge.","NA Original Intervention: Community based stigma reduction package","High","284811","Supports comprehensive package to address community based stigma and compliment the allocation funding in RSSH addressing health worker related stigma. Will help to improve the rights knowledge of people living with HIV. While it is important to address community based stigma, the TRP felt that the entire amount was not needed to complement the allocation funding in RSSH addressing health worker related stigma.","0","0","0","0","284811","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJR7/view","2020-12-31","HIV/AIDS",284811," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713=AN2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713=AO2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713=AP2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713=AN2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713=AO2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713=AP2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2001)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJR8UAO","PAI-5560","Inactive","SOM-HIV/AIDS-20","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Required to allow the continuation of essential strategic information collection to guide programming and measure outcomes. Current MoT data only recognised sexual transmission and PMTCT. No details available on types of sexual transmission or IDU.","Required to allow the continuation of essential strategic information collection to guide programming and measure outcomes. Current MoT data only recognised sexual transmission and PMTCT. No details available on types of sexual transmission or IDU.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Modes of Transmission Study","High","75000","Required to allow the continuation of essential strategic information collection to guide programming and measure outcomes. Current MoT data only recognized sexual transmission and prevention of mother to child transmission (PMTCT ). No details available on types of sexual transmission or injection drug use (ID U ).","75000","0","0","0","0","1","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJR8/view","2020-12-31","HIV/AIDS",0," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713=AN2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713=AO2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713=AP2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713=AN2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713=AO2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713=AP2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2002)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJRDUA4","PAI-5565","Inactive","SOM-HIV/AIDS-25","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"HIV Testing Services","Other module","To implement quality assurance of HCT counsellors to ensure quality of care and service delivery are of a high standard. To address the issues of availability of services but address key gaps in readiness and capacity. To allow ongoing monitoring and capacity building where most need.","To implement quality assurance of HCT counsellors to ensure quality of care and service delivery are of a high standard. To address the issues of availability of services but address key gaps in readiness and capacity. To allow ongoing monitoring and capacity building where most need.","NA Original Intervention: HCT Quality Assurance Measures  VCT Counsellor Proficiency Testing","High","195000","To implement quality assurance of HCT counsellors to ensure quality of care and service delivery are of a high standard. To address the issues of availability of services but address key gaps in readiness and capacity. To allow ongoing monitoring and capacity building where most need.","195000","0","0","0","0","1","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRD/view","2020-12-31","HIV/AIDS",0," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713=AN2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713=AO2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713=AP2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713=AN2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713=AO2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713=AP2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2007)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJRHUA4","PAI-5569","Active","SOM-HIV/AIDS-29","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"Program management","Other program management intervention(s)","Funding to support important coordination meetings between program partners at the national, sub national and priority regional levels. This will support improved program planning and review.","Funding to support important coordination meetings between program partners at the national, sub national and priority regional levels. This will support improved program planning and review.","NA Original Intervention: Quarterly Coordination Meeting","Medium","401580","Funding to support important coordination meetings between program partners at the national, sub national and priority regional levels. This will support improved program planning and review.","120694.2","0","0","0","280885.8","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRH/view","2020-12-31","HIV/AIDS",280885.8," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713=AN2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713=AO2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713=AP2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713=AN2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713=AO2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713=AP2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2011)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJROUA4","PAI-5576","Active","SOM-HIV/AIDS-35","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"HIV Testing Services","Other module","Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care.","Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care.","NA Original Intervention: HCT Buffer Stock for 2021","Medium","395623","Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care.","0","0","0","0","395623","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRO/view","2020-12-31","HIV/AIDS",395623," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713=AN2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713=AO2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713=AP2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713=AN2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713=AO2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713=AP2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2018)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJRPUA4","PAI-5577","Active","SOM-HIV/AIDS-36","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care.","Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care.","NA Original Intervention: ART Buffer Stock for 2021","Medium","809829","Provide funding to procure 50% of 2021 stock needs as a key buffer to ensure continuity of care","0","0","0","0","809829","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRP/view","2020-12-31","HIV/AIDS",809829," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713=AN2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713=AO2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713=AP2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713=AN2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713=AO2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713=AP2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2019)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJRUUA4","PAI-5582","Active","SOM-HIV/AIDS-40","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.","Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Supply Chain Working Group","Medium","119520","Provide funding to continue the Supply Chain Working Group who oversee the Supply Chain and ensure issues are identified and addressed.","0","0","0","0","119520","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRU/view","2020-12-31","HIV/AIDS",119520," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713=AN2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713=AO2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713=AP2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713=AN2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713=AO2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713=AP2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2024)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJRZUA4","PAI-5587","Active","SOM-HIV/AIDS-6","2017-2019","RT Middle East and North Africa","Somalia","HIV/AIDS","HIV/AIDS","FR100-SOM-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence.","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of PLHIV and their families and affects treatment adherence.",null,"High","270000","Community and health worker related stigma remains a critical barrier to accessing HCT and treatment, contributes to major breaches of the rights of people living with HIV and their families and affects treatment adherence. Proposed to be included in a Community Based Stigma Reduction Package at line 2 above .","193876","0","0","0","76124","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRZ/view","2020-12-31","HIV/AIDS",76124," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713=AN2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713=AO2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713=AP2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713=AN2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713=AO2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713=AP2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2029)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJReUAO","PAI-5592","Active","SOM-Malaria-10","2017-2019","RT Middle East and North Africa","Somalia","Malaria","Malaria","FR405-SOM-M",null,null,"Case management","Other case management intervention(s)","Regional trainings through WHO EMRO. Additional $18,000 to come from WHO. The PAAR amount will support Somali participation in regional IVM training, Surveillance Training and Elimination training.","Regional trainings through WHO EMRO. Additional $18,000 to come from WHO. The PAAR amount will support Somali participation in regional IVM training, Surveillance Training and Elimination training.","NA Original Intervention: Facility-based management","Low","9000","Apart from training in surveillance, the proposed training is not linked with the identified module and intervention","0","0","0","0","9000","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRe/view","2020-12-31","Malaria",9000," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713=AN2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713=AO2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713=AP2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713=AN2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713=AO2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713=AP2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2034)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJRfUAO","PAI-5593","Active","SOM-Malaria-11","2017-2019","RT Middle East and North Africa","Somalia","Malaria","Malaria","FR405-SOM-M",null,null,"Vector control","Indoor residual spraying (IRS)","IRS campaigns are proposed for three new areas that are outbreak prone. Each campaign costs 24,510 USD. The funds will cover IRS campaigns in response to epidemic.","IRS campaigns are proposed for three new areas that are outbreak prone. Each campaign costs 24,510 USD. The funds will cover IRS campaigns in response to epidemic.","NA Original Intervention: Indoor residual spraying","Low","110295","The TRP only approved budget to covercampaign in response to epidemic NOT threerounds as proposed by the applicant (issue 2).","0","0","0","0","110295","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRf/view","2020-12-31","Malaria",110295," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713=AN2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713=AO2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713=AP2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713=AN2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713=AO2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713=AP2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2035)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJRkUAO","PAI-5598","Active","SOM-Malaria-5","2017-2019","RT Middle East and North Africa","Somalia","Malaria","Malaria","FR405-SOM-M",null,null,"RSSH: Health management information systems and M&E","Surveys","There are three operational research planned, specifically for Puntland, to be better able to understand the malaria in Puntland and plan for pre-elimination, as well as outbreaks such as that in Bossaso. The research are: Malaria Vector Identification and geographical distribution of main source of breeding sites including vector behaviour study in Bossaso District; Risk mapping and cases distribution malaria cases density by villages and providing appropriate anti-malaria interventions for both vector control and case management as well as surveillance; and Relation of malaria in pregnancy and Obstetric problems (LPW, Apportions, Stillbirths, Anemia including maternity deaths) among pregnancy mother in Bossaso.","There are three operational research planned, specifically for Puntland, to be better able to understand the malaria in Puntland and plan for pre-elimination, as well as outbreaks such as that in Bossaso. The research are: Malaria Vector Identification and geographical distribution of main source of breeding sites including vector behaviour study in Bossaso District; Risk mapping and cases distribution malaria cases density by villages and providing appropriate anti-malaria interventions for both vector control and case management as well as surveillance; and Relation of malaria in pregnancy and Obstetric problems (LPW, Apportions, Stillbirths, Anemia including maternity deaths) among pregnancy mother in Bossaso.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","128652","Operational research would contribute to abetter understanding on low utilization ofeffective interventions such LLINs, rapiddiagnostic tests (RDTs) and artemisin-basedcombination therapy (ACTs) by women andchildren under 5 years old","0","0","0","0","128652","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRk/view","2020-12-31","Malaria",128652," Middle East and North Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713=AN2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713=AO2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713=AP2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713=AN2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713=AO2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713=AP2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2040)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJRpUAO","PAI-5603","Active","SOM-Tuberculosis-1","2017-2019","RT Middle East and North Africa","Somalia","Tuberculosis","Tuberculosis","FR100-SOM-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","Additional community case finding activities, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. Additional active case finding activities for high-risk groups and cross-border activities.","Additional community case finding activities, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. Additional active case finding activities for high-risk groups and cross-border activities.","NA Original Intervention: Case detection and diagnosis, treatment for key population programs","High","8066920","Additional community case finding activities in areas not covered by the allocation funding request, introduction of the new diagnostic algorithm in additional TBMUs, establishment of additional integrated TBMUs to achieve population coverage of 1/100,000, strengthening of collaborative activities between the NTP and private providers through establishment of a certification/licensing mechanism. ? Additional active case finding activities for high-risk groups and cross-border activities in areas not covered by the allocation funding request.","1462184","1312920","0","0","5291816","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRp/view","2020-12-31","Tuberculosis",5291816," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713=AN2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713=AO2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713=AP2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713=AN2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713=AO2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713=AP2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2045)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJRuUAO","PAI-5608","Inactive","SRB-HIV/AIDS-1","2017-2019","RT Eastern Europe and Central Asia","Serbia","HIV/AIDS","HIV/AIDS","FR390-SRB-H",null,null,"Comprehensive prevention programs for TGs","Other intervention(s) for TGs","Recognizing trans*people as one of  populations at risk  and lacking key information on them  needs assessment survey and size estimation for this population  is necessary for planning preventive  intervention","Recognizing trans*people as one of  populations at risk  and lacking key information on them  needs assessment survey and size estimation for this population  is necessary for planning preventive  intervention","NA Original Module: Comprehensive prevention programs for transgender people. Original Intervention: Other interventions for transgender people","High","16907.15","Transgender people are highlighted as a high needpopulation in the National Strategic Plan. Therefore, thisitem should be moved into the allocation given that thereis no funding requested for transgender people activitieswithin the allocation presently.","16907.15","0","0","0","0","1","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRu/view","2022-06-30","HIV/AIDS",0," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713=AN2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713=AO2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713=AP2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713=AN2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713=AO2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713=AP2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2050)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJRvUAO","PAI-5609","Active","SRB-HIV/AIDS-10","2017-2019","RT Eastern Europe and Central Asia","Serbia","HIV/AIDS","HIV/AIDS","FR390-SRB-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","This amount includes coverage with preventive package of  additional 7% of CSW (from existing gap). 8 people in 2019;19 people in 2020 and 52 people in 2021","This amount includes coverage with preventive package of  additional 7% of CSW (from existing gap). 8 people in 2019;19 people in 2020 and 52 people in 2021",null,"High","11993.04","Expansion of services to reach more sex workers andtheir clients is essential for improving the impact of theinterventions on the epidemic in Serbia.","0","0","0","0","11993.04","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJRv/view","2022-06-30",{"$f":"IF(OR(I2051=\"HIV/AIDS\",I2051=\"Tuberculosis\",I2051=\"Malaria\",I2051=\"RSSH\"),I2051, IF(I2051=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"HIV/AIDS"},{"$f":"VALUE(Y2051)","v":11993.04},{"$f":"RIGHT(F2051,LEN(F2051)-2)","v":" Eastern Europe and Central Asia"},"HIV/AIDS","HIV/AIDS",null,null,null,{"$f":"TRIM(AK2051)","v":""},{"$f":"TRIM(AL2051)","v":""},{"$f":"TRIM(AM2051)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713=AN2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713=AO2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713=AP2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},{"$f":"IF(AE2051<>\"\",AE2051,IF(MAX(AQ2051,AR2051,AS2051,AT2051)<>0,MAX(AQ2051,AR2051,AS2051,AT2051),AU2051))","v":"2022-06-30"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713=AN2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713=AO2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713=AP2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2051)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},{"$f":"IF(AE2051<>\"\",AE2051,IF(MAX(AW2051,AX2051,AY2051,AZ2051)<>0,MAX(AW2051,AX2051,AY2051,AZ2051),BA2051))","v":"2022-06-30"}]
["a6Q1R000000AJS0UAO","PAI-5614","Active","SRB-HIV/AIDS-15","2017-2019","RT Eastern Europe and Central Asia","Serbia","HIV/AIDS","HIV/AIDS","FR390-SRB-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.","International expert/consultant expand knowledge and awareness of outreach workers on VCT and provide new tools and skills on counselling. Expected outcome is an increase number of clients receiving HIV testing.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Other interventions for people who inject drugs and their partners","Medium","5510.04","While training on counselling and testing isimportant, this training is not complex and this can becovered through more innovative local resources ratherthan hiring an international consultant.","0","0","0","0","5510.04","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJS0/view","2022-06-30","HIV/AIDS",5510.04," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713=AN2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713=AO2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713=AP2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713=AN2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713=AO2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713=AP2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2056)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJS6UAO","PAI-5620","Active","SRB-HIV/AIDS-3","2017-2019","RT Eastern Europe and Central Asia","Serbia","HIV/AIDS","HIV/AIDS","FR390-SRB-H",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","MSM Training for outreach workers","MSM Training for outreach workers","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","High","9638.65","Expansion of services for men who have sex with menshould be prioritized given the epidemiologicalbackground in the country as well as the coveragecurrently reported in this population.","0","0","0","0","9638.65","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJS6/view","2022-06-30","HIV/AIDS",9638.65," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713=AN2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713=AO2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713=AP2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713=AN2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713=AO2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713=AP2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2062)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJSBUA4","PAI-5625","Active","SRB-HIV/AIDS-8","2017-2019","RT Eastern Europe and Central Asia","Serbia","HIV/AIDS","HIV/AIDS","FR390-SRB-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","This amount includes coverage with preventive package of  additional 7% of PWID (from existing gap). 63 people in 2019; 95 people in 2020 and 307 people in 2021","This amount includes coverage with preventive package of  additional 7% of PWID (from existing gap). 63 people in 2019; 95 people in 2020 and 307 people in 2021","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Behavioral interventions for people who inject drugs","High","17815.06","Expansion of services to reach people who inject drugsis essential for improving the impact of the interventionson the epidemic in Serbia.","0","0","0","0","17815.06","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSB/view","2022-06-30","HIV/AIDS",17815.060000000001," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713=AN2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713=AO2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713=AP2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713=AN2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713=AO2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713=AP2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2067)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJSCUA4","PAI-5626","Active","SRB-HIV/AIDS-9","2017-2019","RT Eastern Europe and Central Asia","Serbia","HIV/AIDS","HIV/AIDS","FR390-SRB-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Other intervention(s) for sex workers and their clients","CSW Training of outreach workers","CSW Training of outreach workers","NA Original Intervention: Other interventions for sex workers and their clients","High","6425.77","Expansion of services to reach more sex workers andtheir clients is essential for improving the impact of theinterventions on the epidemic in Serbia.","0","0","0","0","6425.77","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSC/view","2022-06-30","HIV/AIDS",6425.77," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713=AN2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713=AO2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713=AP2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2022-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713=AN2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713=AO2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713=AP2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2068)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2022-06-30"]
["a6Q1R000000AJSHUA4","PAI-5631","Active","SSD-HIV/AIDS-5","2017-2019","RT Middle East and North Africa","South Sudan","HIV/AIDS","HIV/AIDS","FR383-SSD-H",null,null,"Treatment, care and support","Treatment adherence","Conduct training of community based organisations, peer counsellors, and civil society coordinators and do outreach to key populations and the general population to ensure treatment adherence. Treatment adherence usually decreases at 24 and 36 months resulting in an increase in AIDS related deaths. With the on-going insecurity and displacement of people, treatment adherence is vitally important.","Conduct training of community based organisations, peer counsellors, and civil society coordinators and do outreach to key populations and the general population to ensure treatment adherence. Treatment adherence usually decreases at 24 and 36 months resulting in an increase in AIDS related deaths. With the on-going insecurity and displacement of people, treatment adherence is vitally important.",null,"High","1059733","This will further support reduction of the very high loss to follow-up (LTFU) among people living with HIV on ART, and improve quality of ART care. This additional funding will enable scale up of viral load testing and help improve effectiveness of the HIV cascade monitoring.","0","0","0","0","1059733","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSH/view","2020-12-31","HIV/AIDS",1059733," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713=AN2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713=AO2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713=AP2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713=AN2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713=AO2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713=AP2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2073)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJSMUA4","PAI-5636","Active","SSD-Tuberculosis-1","2017-2019","RT Middle East and North Africa","South Sudan","Tuberculosis","Tuberculosis","FR367-SSD-T",null,null,"Treatment, care and support","Case detection and diagnosis","Training and outreach activities to remote areas are critical. The outreach activities will target prisons, military, IDP and cattle camps where there are no diagnosis and treatment services for TB. An outreach activity will include a team of 1 lab technician, 1 nurse, 1 counsellor, 1 clinician and 1 driver for a three day visit.","Training and outreach activities to remote areas are critical. The outreach activities will target prisons, military, IDP and cattle camps where there are no diagnosis and treatment services for TB. An outreach activity will include a team of 1 lab technician, 1 nurse, 1 counsellor, 1 clinician and 1 driver for a three day visit.","NA Original Intervention: Case detection","High","1081603","Training and outreach activities to remote areas are critical. The outreach activities will target prisons, military, internally displaced people, and cattle camps, where there are no diagnosis and treatment services for TB.","0","0","0","0","1081603","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSM/view","2020-12-31","Tuberculosis",1081603," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713=AN2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713=AO2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713=AP2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713=AN2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713=AO2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713=AP2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2078)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJSRUA4","PAI-5641","Inactive","STP-Integrated-2","2017-2019","RT Central Africa","Sao Tome and Principe","RSSH","HIV/AIDS, Tuberculosis, Malaria, RSSH","FR100-STP-Z",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","This amount covers recruitment of international consultants and validation workshops.","This amount covers recruitment of international consultants and validation workshops.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Develop the NSP for the HIS and the plan for monitoring and evaluation","High","22444.17","The health information plan and strategy will provide guidance for this development and the basis for monitoring it.","22444.17","0","0","0","0","1","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSR/view",null,"Multi-component",0," Central Africa","HIV/AIDS, Tuberculosis, Malaria, RSSH","HIV/AIDS"," Tuberculosis"," Malaria"," RSSH","Tuberculosis","Malaria","RSSH",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713=AN2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713=AO2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713=AP2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713=AN2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713=AO2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713=AP2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2083)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2018-04-01"]
["a6Q1R000000AJSSUA4","PAI-5642","Active","STP-Integrated-3","2017-2019","RT Central Africa","Sao Tome and Principe","Malaria","HIV/AIDS, Tuberculosis, Malaria, RSSH","FR100-STP-Z",null,null,"Vector control","Indoor residual spraying (IRS)","Focalized spraying planned for 2020, but due to lack of funds, we are requesting this important support in the PAAR. The amount requested in the PAAR for effective implementation of IRS in 2020 will cover procurement of insecticide, transport, storage, payment of sprayers and operating costs.","Focalized spraying planned for 2020, but due to lack of funds, we are requesting this important support in the PAAR. The amount requested in the PAAR for effective implementation of IRS in 2020 will cover procurement of insecticide, transport, storage, payment of sprayers and operating costs.","NA Original Intervention: Indoor residual spraying","High","831143.53","This funding is requested to support IRS gaps (procurement of insecticides and implementation costs). This prioritization is also conditional of TRP approval as stated in issue 7","196360.68","565655","0","0","69127.85","0","0","2020-01-14 12:52:56","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSS/view",null,"Multi-component",69127.850000000006," Central Africa","HIV/AIDS, Tuberculosis, Malaria, RSSH","HIV/AIDS"," Tuberculosis"," Malaria"," RSSH","Tuberculosis","Malaria","RSSH",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713=AN2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713=AO2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713=AP2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713=AN2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713=AO2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713=AP2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2084)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2018-04-01"]
["a6Q1R000000AJSXUA4","PAI-5647","Active","SUR-Malaria-3","2017-2019","RT Latin America and Caribbean","Suriname","Malaria","Malaria","FR568-SUR-M",null,null,"RSSH: Health management information systems and M&E","Administrative and finance data sources","In Suriname interventions for malaria prevention and control, and ultimately elimination, are nowadays focused for a large part on the mobile migrant populations who are considered at high risk of getting infected, especially in high malaria risk areas across the border with French Guiana, and of carrying malaria in Suriname. This is a costly strategy. For a better understanding of and  implementation of the currently ongoing transition process toward sustainable financing of the Malaria response in Suriname, the country is in need of 1) a thorough investigation of the current malaria economics and potential costs of elimination and prevention of reintroduction versus other scenarios, and 2) a financial gap analysis and investment case study.The general objectives of the study proposed here are: 1.  To determine national and international investment in malaria in Suriname since 2015: visualize total economic costs per year per person at risk and per capita, differentiate sources of funding, differentiate uses of funding by type of input (personnel, consumables, etc), and intervention (vector control, prevention, surveillance/diagnosis, curative services, administration etc). 2 To realize cost estimations of the current (elimination-) and alternate scenarios of malaria epidemiology and level of interventions; focusing on the next 5 years which would in the current scenario ideally include elimination and certification of elimination of malaria in Suriname, determine cost estimates for the current and alternate scenarios, taking into account the malaria epidemiology and malaria control/elimination investments in neighboring countries and how it affects the elimination potential in Suriname. Differentiate costs for health system, households (individuals) and society.  3. To determine the funding gap for malaria elimination and maintenance of a malaria free Suriname; focusing on the next 5 years which would int eh current scenario ideally include elimination and certification of elimination of malaria in Suriname, assess the available funding and funding needs and determine the national funding gap.  Include recommendations/potential directions on how to fill this gap. 4. To determination of return of investment/investment case study; specifically determine the cost-benefit ratio and return of investment of malaria elimination in Suriname and prevention of re-introduction versus active resurgence, both in the regional (Guiana Shield, Latin America) and national context.","In Suriname interventions for malaria prevention and control, and ultimately elimination, are nowadays focused for a large part on the mobile migrant populations who are considered at high risk of getting infected, especially in high malaria risk areas across the border with French Guiana, and of carrying malaria in Suriname. This is a costly strategy. For a better understanding of and  implementation of the currently ongoing transition process toward sustainable financing of the Malaria response in Suriname, the country is in need of 1) a thorough investigation of the current malaria economics and potential costs of elimination and prevention of reintroduction versus other scenarios, and 2) a financial gap analysis and investment case study.The general objectives of the study proposed here are: 1.  To determine national and international investment in malaria in Suriname since 2015: visualize total economic costs per year per person at risk and per capita, differentiate sources of funding, differentiate uses of funding by type of input (personnel, consumables, etc), and intervention (vector control, prevention, surveillance/diagnosis, curative services, administration etc). 2 To realize cost estimations of the current (elimination-) and alternate scenarios of malaria epidemiology and level of interventions; focusing on the next 5 years which would in the current scenario ideally include elimination and certification of elimination of malaria in Suriname, determine cost estimates for the current and alternate scenarios, taking into account the malaria epidemiology and malaria control/elimination investments in neighboring countries and how it affects the elimination potential in Suriname. Differentiate costs for health system, households (individuals) and society.  3. To determine the funding gap for malaria elimination and maintenance of a malaria free Suriname; focusing on the next 5 years which would int eh current scenario ideally include elimination and certification of elimination of malaria in Suriname, assess the available funding and funding needs and determine the national funding gap.  Include recommendations/potential directions on how to fill this gap. 4. To determination of return of investment/investment case study; specifically determine the cost-benefit ratio and return of investment of malaria elimination in Suriname and prevention of re-introduction versus active resurgence, both in the regional (Guiana Shield, Latin America) and national context.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Administrative and financial data sources","Medium","267003",null,"0","0","0","0","267003","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSX/view","2021-03-31","Malaria",267003," Latin America and Caribbean","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713=AN2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713=AO2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713=AP2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713=AN2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713=AO2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713=AP2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2089)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-03-31"]
["a6Q1R000000AJScUAO","PAI-5652","Active","SUR-TB/HIV-5","2017-2019","RT Latin America and Caribbean","Suriname","HIV/TB","HIV/AIDS, Tuberculosis","FR415-SUR-C",null,null,"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Refresher training in procurement and supply management icluding revisiting of SOPs and tools that meet specific needs of labs.","Refresher training in procurement and supply management icluding revisiting of SOPs and tools that meet specific needs of labs.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Other procurement and supply chain management intervention(s)","High","6000",null,"0","0","0","0","6000","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSc/view","2021-12-31","TB/HIV",6000," Latin America and Caribbean","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713=AN2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713=AO2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713=AP2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713=AN2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713=AO2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713=AP2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2094)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJShUAO","PAI-5657","Active","SWZ-TB/HIV-10","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"MDR-TB","Community MDR-TB care delivery","Maintain comprehensive patient support of all patients with drug-TB in all regions, inducing a first time package, food, transport, and stipends for community treatment supporters. While 384 patients are prioritized for the allocation, and while this is nearly double the number in the current grant, this still leaves a gap of about 416 patients which MSF was supporting before the transition. This PAAR activity will ensure there is no gap in patient support.","Maintain comprehensive patient support of all patients with drug-TB in all regions, inducing a first time package, food, transport, and stipends for community treatment supporters. While 384 patients are prioritized for the allocation, and while this is nearly double the number in the current grant, this still leaves a gap of about 416 patients which MSF was supporting before the transition. This PAAR activity will ensure there is no gap in patient support.","NA Original Module: Multidrug-resistant TB","High","1774170","Maintain comprehensive patient support of all patients with drug-resistant TB in all regions, inducing a first time package, food, transport, and stipends for community treatment supporters. While 384 patients are prioritized for the allocation, and while this is nearly double the number in the current grant, this still leaves a gap of about 416 patients which MSF was supporting before the transition. This PAAR activity will ensure there is no gap in patient support.","0","0","0","0","1774170","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSh/view","2021-09-30","TB/HIV",1774170," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713=AN2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713=AO2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713=AP2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713=AN2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713=AO2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713=AP2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2099)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJSiUAO","PAI-5658","Active","SWZ-TB/HIV-11","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"TB care and prevention","Case detection and diagnosis","Procurement of additional buffer stock of GeneXpert cartridges (to support government absorbing this in year 2 and 3 of the grant).","Procurement of additional buffer stock of GeneXpert cartridges (to support government absorbing this in year 2 and 3 of the grant).",null,"High","1310137","Since the procurement of buffer stock for GeneXpert for government takes over in year 3 of the funding cycle, it is important to ensure a transition and avoid stock-outs.","694007","0","0","0","616130","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSi/view","2021-09-30","TB/HIV",616130," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713=AN2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713=AO2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713=AP2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713=AN2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713=AO2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713=AP2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2100)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJSoUAO","PAI-5664","Active","SWZ-TB/HIV-17","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"MDR-TB","Treatment: MDR-TB","Procurement of ear tips used for the Kuduwave to monitor for ototoxicity and Procurement of 2 additional pediatric audiology equipment, GSI audiometer and audio booth for Manzini and Lubombo region.","Procurement of ear tips used for the Kuduwave to monitor for ototoxicity and Procurement of 2 additional pediatric audiology equipment, GSI audiometer and audio booth for Manzini and Lubombo region.","NA Original Module: Multidrug-resistant TB","High","80160","Audiometry equipment, including for children, is essential for prevention of disabilities caused by DRTB treatment.","0","0","0","0","80160","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSo/view","2021-09-30","TB/HIV",80160," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713=AN2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713=AO2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713=AP2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713=AN2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713=AO2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713=AP2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2106)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJStUAO","PAI-5669","Active","SWZ-TB/HIV-21","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Procure 2 additional vehicles and drivers for Shiselweni region to support the MSF transitionthere, recalling that this is one of this proposals main strategic modifications. Support Laboratory Personnel for the Lab Commodity Quality Assurance to support Supply Chain System (1 Technologist, 7 Warehouse Assistants). Support Laboratory Personnel to support and strengthen the Quality Assurance Unit.","Procure 2 additional vehicles and drivers for Shiselweni region to support the MSF transitionthere, recalling that this is one of this proposals main strategic modifications. Support Laboratory Personnel for the Lab Commodity Quality Assurance to support Supply Chain System (1 Technologist, 7 Warehouse Assistants). Support Laboratory Personnel to support and strengthen the Quality Assurance Unit.","NA Original Module: Integrated service delivery and quality improvement. Original Intervention: Supportive policy and programmatic environment","High","189306","Integrating CMIS with the Lab Information System (LIS) strengthen service planning and delivery.","0","0","0","0","189306","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSt/view","2021-09-30","TB/HIV",189306," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713=AN2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713=AO2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713=AP2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713=AN2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713=AO2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713=AP2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2111)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJSyUAO","PAI-5674","Active","SWZ-TB/HIV-26","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Additional LIS support and Laboratory Personnel to support and strengthen the Quality Assurance Unit and to support the supply chain system.","Additional LIS support and Laboratory Personnel to support and strengthen the Quality Assurance Unit and to support the supply chain system.","NA Original Module: RSSH - Procurement and supply chain management systems","High","696078","Along with the investments in linking the lab systems and supply chain this fund will allow for Additional LIS support and Laboratory Personnel to support and strengthen the Quality Assurance Unit and to support the supply chain system","0","0","0","0","696078","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSy/view","2021-09-30","TB/HIV",696078," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713=AN2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713=AO2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713=AP2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713=AN2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713=AO2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713=AP2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2116)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJSzUAO","PAI-5675","Active","SWZ-TB/HIV-27","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Interventions to address quality of care issues specific to Adolescent Friendly Health Services (AFHS). These include technical assistance for incorporation of AFHS standards into quality audit forms, quarterly joint technical working group meetings between relevant MOH departments and incorporating the AFHS component into the quality audits conductedby the ministry of health in the 20 priority Tinkundla.","Interventions to address quality of care issues specific to Adolescent Friendly Health Services (AFHS). These include technical assistance for incorporation of AFHS standards into quality audit forms, quarterly joint technical working group meetings between relevant MOH departments and incorporating the AFHS component into the quality audits conductedby the ministry of health in the 20 priority Tinkundla.","NA Original Module: RSSH - Integrated service delivery and quality improvement. Original Intervention: Supportive policy and programmatic environment","High","253000","This funding for technical assistance to integrate adolescent services into routine care through quarterly joint technical working group meetings between relevant MOH departments and incorporating the AFHS component into the quality audits conducted by the ministry of health in the 20 priority Tinkundla is essential for the continued success of the program.","0","0","0","0","253000","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJSz/view","2021-09-30","TB/HIV",253000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713=AN2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713=AO2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713=AP2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713=AN2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713=AO2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713=AP2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2117)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJT4UAO","PAI-5680","Active","SWZ-TB/HIV-31","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Community mobilization and norms change","Conduct a half day orientation for 1300 head teachers and deputies on the LSE curriculum in primary schools.","Conduct a half day orientation for 1300 head teachers and deputies on the LSE curriculum in primary schools.",null,"Medium","32500","While the life skills education is deemed important, an orientation for teachers can be provided without a full-day in service. Options that included innovative approaches such as mobile services or integrated into already existing training should be prioritized.","0","0","0","0","32500","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJT4/view","2021-09-30","TB/HIV",32500," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713=AN2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713=AO2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713=AP2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713=AN2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713=AO2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713=AP2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2122)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJT9UAO","PAI-5685","Active","SWZ-TB/HIV-36","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"TB care and prevention","Treatment","Funding is requested to support Swazilands TB hospital to become a center of excellence. Specifically, funding will support a benchmarking exercise with Kimberly Hospital (Cape Town in South Africa), curriculum development  and workshops for in-country and international trainings, partitioning and extending the mechanical ventilation to operationalize the dialysis machine), and technical assistance to ensure the certification of the hospital as center of excellence.","Funding is requested to support Swazilands TB hospital to become a center of excellence. Specifically, funding will support a benchmarking exercise with Kimberly Hospital (Cape Town in South Africa), curriculum development  and workshops for in-country and international trainings, partitioning and extending the mechanical ventilation to operationalize the dialysis machine), and technical assistance to ensure the certification of the hospital as center of excellence.",null,"Medium","30000","It would be beneficial to establish a Centre of excellence in Swaziland, but this is not considered as a high priority comparing to other interventions.","0","0","0","0","30000","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJT9/view","2021-09-30","TB/HIV",30000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713=AN2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713=AO2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713=AP2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713=AN2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713=AO2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713=AP2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2127)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJTEUA4","PAI-5690","Active","SWZ-TB/HIV-40","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Conduct regular coordination and review meetings at community level by all service providers.","Conduct regular coordination and review meetings at community level by all service providers.","NA Original Module: RSSH - Community responses and systems","Medium","50000","Coordination meetings at local level to strengthen the responsiveness to the needs of the local health environment.","0","0","0","0","50000","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTE/view","2021-09-30","TB/HIV",50000," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713=AN2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713=AO2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713=AP2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713=AN2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713=AO2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713=AP2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2132)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJTFUA4","PAI-5691","Active","SWZ-TB/HIV-41","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Information and communication technology (ICT) system support for the TB program, including licenses, maintenance and upgrades for software and hardware.","Information and communication technology (ICT) system support for the TB program, including licenses, maintenance and upgrades for software and hardware.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","105044","Additional IT support for the TB program.","0","0","0","0","105044","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTF/view","2021-09-30","TB/HIV",105044," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713=AN2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713=AO2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713=AP2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713=AN2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713=AO2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713=AP2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2133)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJTKUA4","PAI-5696","Active","SWZ-TB/HIV-46","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"HIV Testing Services","Differentiated HIV testing services","Additional working tools for HTS providers (lab coats) and further learning and experience sharing(conferences, exchanges) to share results from innovative testing modalities.","Additional working tools for HTS providers (lab coats) and further learning and experience sharing(conferences, exchanges) to share results from innovative testing modalities.",null,"Low","30893","This activity can be covered within the existing testing program.","0","0","0","0","30893","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTK/view","2021-09-30","TB/HIV",30893," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713=AN2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713=AO2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713=AP2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713=AN2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713=AO2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713=AP2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2138)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJTPUA4","PAI-5701","Active","SWZ-TB/HIV-50","2017-2019","RT Southern and Eastern Africa","Eswatini","HIV/TB","HIV/AIDS, Tuberculosis","FR230-SWZ-C",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Support for 3 TB program staff and 3 HIV program staff to attend relevant international conferences.This will enable the program to share the lessons learned from Swazilands response, as well as learn from other countries an contexts to improve innovation.","Support for 3 TB program staff and 3 HIV program staff to attend relevant international conferences.This will enable the program to share the lessons learned from Swazilands response, as well as learn from other countries an contexts to improve innovation.","NA Original Module: RSSH - Human resources for health, including community health workers","Low","26664","This intervention proposes sharing of information on the HIV and TB programs at relevant international conferences. Information exchange is important but the resource constrained setting of the Swaziland program means that the intervention is deemed of low priority.","0","0","0","0","26664","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTP/view","2021-09-30","TB/HIV",26664," Southern and Eastern Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713=AN2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713=AO2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713=AP2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-09-30"},"2021-09-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713=AN2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713=AO2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713=AP2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2143)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-10-01"},"2021-09-30"]
["a6Q1R000000AJTVUA4","PAI-5707","Active","TCD-Integrated-1","2017-2019","RT Central Africa","Chad","Tuberculosis","HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z",null,null,"TB care and prevention","Case detection and diagnosis","In view of the under-reporting, this request includes a plan to carry out active screening for cases of tuberculosis among prisoners, refugees/displaced persons, nomads and children in the malnutrition treatment centers (TNUs) using 2 trucks equipped with screening and diagnostic resources (x-ray and GeneXpert). This active screening will be organized biannually, in accordance with specific focus points (see the supervision focus points). During the screening campaigns, all suspected cases of TB or MDR-TB will initially receive a chest x-ray and those exhibiting symptoms of TB will be given a GeneXpert examination to confirm the diagnosis. In addition, HIV screening will be carried out among these populations. Advocacy sessions will be carried out prior to and during these campaigns. The campaign team will be composed of: 1 x-ray operator, 1 laboratory technician, 1 health-care worker and 1 driver.","In view of the under-reporting, this request includes a plan to carry out active screening for cases of tuberculosis among prisoners, refugees/displaced persons, nomads and children in the malnutrition treatment centers (TNUs) using 2 trucks equipped with screening and diagnostic resources (x-ray and GeneXpert). This active screening will be organized biannually, in accordance with specific focus points (see the supervision focus points). During the screening campaigns, all suspected cases of TB or MDR-TB will initially receive a chest x-ray and those exhibiting symptoms of TB will be given a GeneXpert examination to confirm the diagnosis. In addition, HIV screening will be carried out among these populations. Advocacy sessions will be carried out prior to and during these campaigns. The campaign team will be composed of: 1 x-ray operator, 1 laboratory technician, 1 health-care worker and 1 driver.",null,"High","1292844.25",null,"0","0","0","0","1292844.25","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTV/view",null,"Multi-component",1292844.25," Central Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713=AN2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713=AO2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713=AP2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713=AN2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713=AO2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713=AP2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2149)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AJTWUA4","PAI-5708","Active","TCD-Integrated-10","2017-2019","RT Central Africa","Chad","RSSH","HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z",null,null,"RSSH: Health management information systems and M&E","Surveys","HIV treatment cascade service analysis surveyThe aim is to determine the extent to which the 90-90-90 targets have been achieved, together with the explanatory factors and bottlenecks relating to performance. This will require the following, specifically:- establishing the performance development profile for medical health care and the PMTCT;- determining the current treatment cascade and suggesting its development trend;- determining the current PMTCT cascade and suggesting its development trend;- identifying and analyzing success factors and bottlenecks of the cascade;- proposing modeling scenarios for development trends up to 2022.The costs stated here are historic costs linked to previous grants.","HIV treatment cascade service analysis surveyThe aim is to determine the extent to which the 90-90-90 targets have been achieved, together with the explanatory factors and bottlenecks relating to performance. This will require the following, specifically:- establishing the performance development profile for medical health care and the PMTCT;- determining the current treatment cascade and suggesting its development trend;- determining the current PMTCT cascade and suggesting its development trend;- identifying and analyzing success factors and bottlenecks of the cascade;- proposing modeling scenarios for development trends up to 2022.The costs stated here are historic costs linked to previous grants.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","51324.21",null,"0","0","0","0","51324.21","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTW/view",null,"Multi-component",51324.21," Central Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713=AN2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713=AO2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713=AP2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713=AN2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713=AO2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713=AP2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2150)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AJTbUAO","PAI-5713","Active","TCD-Integrated-3","2017-2019","RT Central Africa","Chad","Tuberculosis","HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z",null,null,"MDR-TB","Treatment: MDR-TB","This request will make it possible to obtain all of the reagents and consumables necessary for carrying out the MDR-TB culture and sensitivity tests.","This request will make it possible to obtain all of the reagents and consumables necessary for carrying out the MDR-TB culture and sensitivity tests.","NA Original Module: Multidrug-resistant TB","High","335434.87",null,"0","0","0","0","335434.87","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTb/view",null,"Multi-component",335434.87," Central Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713=AN2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713=AO2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713=AP2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713=AN2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713=AO2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713=AP2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2155)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AJTgUAO","PAI-5718","Active","TCD-Integrated-8","2017-2019","RT Central Africa","Chad","HIV/AIDS","HIV/AIDS, Tuberculosis, RSSH","FR542-TCD-Z",null,null,"PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Prevention and health care for HIV/early marriage/GBV among adolescents aged 10-19 and young women aged 20-24. This intervention will make it possible to carry out structural activities relating to early marriage and GBV, community screening and counseling, psycho-social health care for cases and the participation of adolescents and young women through the Ureport and Upartner platform. Strengthening the young peoples network, in particular the monitoring of adolescents living with HIV.","Prevention and health care for HIV/early marriage/GBV among adolescents aged 10-19 and young women aged 20-24. This intervention will make it possible to carry out structural activities relating to early marriage and GBV, community screening and counseling, psycho-social health care for cases and the participation of adolescents and young women through the Ureport and Upartner platform. Strengthening the young peoples network, in particular the monitoring of adolescents living with HIV.","NA Original Module: Prevention of mother-to-child transmission","High","953877.23","This activity is considered the highest priority of the HIV related items in the PAAR and if efficiencies are found during grant-making it should be moved into the allocation if possible.","0","0","0","0","953877.23","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTg/view",null,"Multi-component",953877.23," Central Africa","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713=AN2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713=AO2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713=AP2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713=AN2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713=AO2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713=AP2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2160)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2019-01-01"]
["a6Q1R000000AJTlUAO","PAI-5723","Active","TCD-Malaria-4","2017-2019","RT Central Africa","Chad","Malaria","Malaria","FR550-TCD-M",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.In order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.","The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.In order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.","NA Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","6883375.54","The government will mobilize national resources for the 2020 mass distribution campaign in order to distribute 1,155,875 LLINs to 2,080,576 inhabitants in the regions of N'Djamena and Bar El Gazal (12.2% of the population of the endemic areas). This government effort will complement that of the Global Fund described above, bringing the total number of regions covered by the mass distribution campaign in 2020 to 15.In order to ensure a national coverage of all 19 eligible regions, the country requests funding to carry out the mass distribution campaign in the remaining 4 regions (Batha, Kanem, Ouaddai, Wadi Fira) to guarantee LLIN access for an additional 3,173,049 inhabitants (18.7% of the population of malaria-endemic areas). The amount requested will be used to purchase 1,939,089 LLINs and cover logistics and other operating costs.","0","6338971","0","0","544404.54","0","0","2020-01-23 13:08:56","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTl/view","2021-06-30","Malaria",544404.54," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713=AN2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713=AO2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713=AP2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713=AN2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713=AO2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713=AP2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2165)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-06-30"]
["a6Q1R000000AJTmUAO","PAI-5724","Active","TCD-Malaria-5","2017-2019","RT Central Africa","Chad","Malaria","Malaria","FR550-TCD-M",null,null,"RSSH: Health management information systems and M&E","Program and data quality","The Ministry of Public Health has developed their 2018-2022 National Strategic Plan for the development of the Health Information System which was integrated in the 2019-2021 Triennial Operational Plan, to make information available with the purpose of ensuring the effective management of the interventions by health system actors. The Operational Plan for Strengthening the Health Information System will allow Chad to have a well-functioning health information system, producing quality health information in real time at all levels, accessible and used by all stakeholders for evidence-based decision-making on health issues in order to improve the health of populations. The achievement of such an ambition requires the implementation of interventions that revolve around two axes namely:1. Improving the quality of the routine health information system to make readily available information tailored to the needs of the health system's implementing partners;2. Improved coordination of all elements of the health information system. The total cost of the National Strategic Plan for the development of the Health Information System (2018-2022) is 10,580,535 euros (6,940,375,997 FCFA). Of this amount, 8,031,620 euros are being mobilized through other funding sources. The remainder of 2,548,915 euros are requested through the UQD.","The Ministry of Public Health has developed their 2018-2022 National Strategic Plan for the development of the Health Information System which was integrated in the 2019-2021 Triennial Operational Plan, to make information available with the purpose of ensuring the effective management of the interventions by health system actors. The Operational Plan for Strengthening the Health Information System will allow Chad to have a well-functioning health information system, producing quality health information in real time at all levels, accessible and used by all stakeholders for evidence-based decision-making on health issues in order to improve the health of populations. The achievement of such an ambition requires the implementation of interventions that revolve around two axes namely:1. Improving the quality of the routine health information system to make readily available information tailored to the needs of the health system's implementing partners;2. Improved coordination of all elements of the health information system. The total cost of the National Strategic Plan for the development of the Health Information System (2018-2022) is 10,580,535 euros (6,940,375,997 FCFA). Of this amount, 8,031,620 euros are being mobilized through other funding sources. The remainder of 2,548,915 euros are requested through the UQD.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","2860414.02","The Ministry of Public Health has developed their 2018-2022 National Strategic Plan for the development of the Health Information System which was integrated in the 2019-2021 Triennial Operational Plan, to make information available with the purpose of ensuring the effective management of the interventions by health system actors. The Operational Plan for Strengthening the Health Information System will allow Chad to have a well-functioning health information system, producing quality health information in real time at all levels, accessible and used by all stakeholders for evidence-based decision-making on health issues in order to improve the health of populations. The achievement of such an ambition requires the implementation of interventions that revolve around two axes namely:1. Improving the quality of the routine health information system to make readily available information tailored to the needs of the health system's implementing partners;2. Improved coordination of all elements of the health information system. The total cost of the National Strategic Plan for the development of the Health Information System (2018-2022) is 10,580,535 euros (6,940,375,997 FCFA). Of this amount, 8,031,620 euros are being mobilized through other funding sources. The remainder of 2,548,915 euros are requested through the UQD.","0","0","0","0","2860414.02","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTm/view","2021-06-30","Malaria",2860414.02," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713=AN2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713=AO2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713=AP2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713=AN2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713=AO2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713=AP2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2166)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-06-30"]
["a6Q1R000000AJTrUAO","PAI-5729","Active","TGO-Malaria-3","2017-2019","RT Central Africa","Togo","Malaria","Malaria","FR111-TGO-M",null,null,"RSSH: Health management information systems and M&E","Routine reporting","In 2016, the MoH started a national rollout of DHIS 2 in all its 40 health districts. A roadmap for this was drawn up and is currently being implemented with funding from the World Bank and technical assistance from AEDES. In accordance with the national health development plan (2017-2022) the scale-up of DHIS2 will be completed in 2018 and expanded at community level during the NFM2 in partnership with the GF. The funding request will support the reproduction of standardized tools for data collection including at community level.","In 2016, the MoH started a national rollout of DHIS 2 in all its 40 health districts. A roadmap for this was drawn up and is currently being implemented with funding from the World Bank and technical assistance from AEDES. In accordance with the national health development plan (2017-2022) the scale-up of DHIS2 will be completed in 2018 and expanded at community level during the NFM2 in partnership with the GF. The funding request will support the reproduction of standardized tools for data collection including at community level.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","1402760.63","The TRP has ranked this module as a high priority because it will ensure quality of data, enabling timely decision","0","0","0","0","1402760.63","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTr/view","2020-12-31","Malaria",1402760.63," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713=AN2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713=AO2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713=AP2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713=AN2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713=AO2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713=AP2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2171)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJTwUAO","PAI-5734","Active","TGO-TB/HIV-10","2017-2019","RT Central Africa","Togo","HIV/TB","HIV/AIDS, Tuberculosis","FR466-TGO-C",null,null,"PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Elimination of Mother to Child Transmission of HIV:In 2016, with the aim of achieving the objectives of eliminating the mother to child transmission of HIV, the NACP introduced the use of HIV/Syphilis DUO test at the sites for the prevention of mother to  child  transmission  of  HIV  (PMTCT).  This  intervention will contribute to achieving coverage of screening for syphilis, one of the certification criteria for Togo for the elimination of mother to child transmission of HIV.","Elimination of Mother to Child Transmission of HIV:In 2016, with the aim of achieving the objectives of eliminating the mother to child transmission of HIV, the NACP introduced the use of HIV/Syphilis DUO test at the sites for the prevention of mother to  child  transmission  of  HIV  (PMTCT).  This  intervention will contribute to achieving coverage of screening for syphilis, one of the certification criteria for Togo for the elimination of mother to child transmission of HIV.","NA Original Module: Prevention of mother-to-child transmission","High","699585.91","Togo has ambitious targets to reach the HIV epidemic control but national resources are very limited. The funding gaps are substantial. Thus, any available resources should be made available to support HIV testing and counselling services, antiretroviral treatment, and access to viral load monitoring. The PAAR clearly targets key and priority populations to benefit from these resources; men who have sex with men, female sex workers as well as pregnant women with prevention of mother-to-child transmission (PMTCT) of HIV.","0","0","0","0","699585.91","0","0","2019-10-30 15:34:36","2019-10-30 15:34:35","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJTw/view",null,"TB/HIV",699585.91," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713=AN2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713=AO2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713=AP2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713=AN2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713=AO2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713=AP2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2176)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJU1UAO","PAI-5739","Active","TGO-TB/HIV-15","2017-2019","RT Central Africa","Togo","HIV/TB","HIV/AIDS, Tuberculosis","FR466-TGO-C",null,null,"RSSH: Health management information systems and M&E","Surveys","Bio-behavioral monitoring surveys:  Conduct a  bio-behavioral study in 2019 to provide information for the impact indicators (percentage of   key   populations   living   with   HIV)   and   effect   indicators (percentage of key populations whoclaim to have used a condom with their latest client/sexual partner) to better assess the impact of the interventions carried out concerning these key populations.","Bio-behavioral monitoring surveys:  Conduct a  bio-behavioral study in 2019 to provide information for the impact indicators (percentage of   key   populations   living   with   HIV)   and   effect   indicators (percentage of key populations whoclaim to have used a condom with their latest client/sexual partner) to better assess the impact of the interventions carried out concerning these key populations.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","168703.85","Although surveys are needed, the TRP ranked it medium so that resources be primarily dedicated to interventions.","0","0","0","0","168703.85","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU1/view",null,"TB/HIV",168703.85," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713=AN2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713=AO2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713=AP2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713=AN2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713=AO2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713=AP2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2181)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJU2UAO","PAI-5740","Active","TGO-TB/HIV-16","2017-2019","RT Central Africa","Togo","HIV/TB","HIV/AIDS, Tuberculosis","FR466-TGO-C",null,null,"RSSH: Health management information systems and M&E","Surveys","Analysis  of  the  range  of  services  in  the  HIV  treatment cascade:Carry out a study to analyze the range of services in the  HIV  treatment  cascade. The results  of  this  analysis  will  make  it  possible  to  analyze  the progress  made  in  relation  to  the  90-90-90  targets  by  2020, through the identification of the shortcomings of each stage of the HIV   treatment   cascade   concerning   the   different   population groups and sub-national units (health regions and districts).","Analysis  of  the  range  of  services  in  the  HIV  treatment cascade:Carry out a study to analyze the range of services in the  HIV  treatment  cascade. The results  of  this  analysis  will  make  it  possible  to  analyze  the progress  made  in  relation  to  the  90-90-90  targets  by  2020, through the identification of the shortcomings of each stage of the HIV   treatment   cascade   concerning   the   different   population groups and sub-national units (health regions and districts).","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","121499.27","Although surveys are needed, the TRP ranked it medium so that resources be primarily dedicated to interventions.","0","0","0","0","121499.27","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU2/view",null,"TB/HIV",121499.27," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713=AN2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713=AO2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713=AP2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713=AN2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713=AO2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713=AP2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2182)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJU7UAO","PAI-5745","Active","TGO-TB/HIV-6","2017-2019","RT Central Africa","Togo","HIV/TB","HIV/AIDS, Tuberculosis","FR466-TGO-C",null,null,"Treatment, care and support","Treatment monitoring - Viral load","This funding will make  it  possible  to  provide  viral  load  testing  for  the  PLHIV  on ARVs, so as to increase coverage from 20% under the allocation funding  to  50%  by  the  end  of  2020.  The  number  of  PLHIV on ARVs who will receive viral load testing will be 23,126, 30,890 and 39,346 in 2018, 2019 and 2020, respectively.","This funding will make  it  possible  to  provide  viral  load  testing  for  the  PLHIV  on ARVs, so as to increase coverage from 20% under the allocation funding  to  50%  by  the  end  of  2020.  The  number  of  PLHIV on ARVs who will receive viral load testing will be 23,126, 30,890 and 39,346 in 2018, 2019 and 2020, respectively.","NA Original Intervention: Treatment monitoring  Viral load","High","2872542.92","Togo has ambitious targets to reach the HIV epidemic control but national resources are very limited. The funding gaps are substantial. Thus, any available resources should be made available to support HIV testing and counselling services, antiretroviral treatment, and access to viral load monitoring. The PAAR clearly targets key and priority populations to benefit from these resources; men who have sex with men, female sex workers as well as pregnant women with prevention of mother-to-child transmission (PMTCT) of HIV.","769496","796884.75","0","0","1306162.17","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJU7/view",null,"TB/HIV",1306162.17," Central Africa","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713=AN2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713=AO2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713=AP2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713=AN2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713=AO2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713=AP2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2187)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJUDUA4","PAI-5751","Active","THA-TB/HIV-11","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"RSSH: National health strategies","Other policy and governance intervention(s)","DDC BL 360-364Preparing Thailand for effective and sustainable transition from GFATM using domestic funding and efficient implementation system through a partnership between communities, private and public sectors, 1. Setting up management unit of the Thai Fund, a public-private resource mobilization.","DDC BL 360-364Preparing Thailand for effective and sustainable transition from GFATM using domestic funding and efficient implementation system through a partnership between communities, private and public sectors, 1. Setting up management unit of the Thai Fund, a public-private resource mobilization.","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","High","725656","This intervention will prepare Thailand for effective and sustainable transition from the Global Fund funding, using domestic funding and efficient implementation system through a partnership between communities, private and public sectors by setting up the management unit of the Thai Fund, a public-private resource mobilization","0","0","0","0","725656","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUD/view","2020-12-31","TB/HIV",725656," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713=AN2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713=AO2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713=AP2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713=AN2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713=AO2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713=AP2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2193)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUIUA4","PAI-5756","Active","THA-TB/HIV-16","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"Programs to reduce human rights-related barriers to HIV services","Stigma and discrimination reduction","RTF BL 19-211.Training of Trainer (ToT) to document violence and other human rights violation in all KPs2. Training OW and PE in all KPs to document violence and other human rights violation3. Policy advocacy concerning AIDS issues in workplace and educational institution, set up employer alliance to end S&D against HIV and TB.","RTF BL 19-211.Training of Trainer (ToT) to document violence and other human rights violation in all KPs2. Training OW and PE in all KPs to document violence and other human rights violation3. Policy advocacy concerning AIDS issues in workplace and educational institution, set up employer alliance to end S&D against HIV and TB.",null,"High","264886","This intervention will address stigma and discrimination among key populations through training community members to document violence and other human rights violations; empowering and increasing involvement of key population communities at sub -national and regional levels to improve policies; establishing a platform for policy dialogue and funding of a campaign. In addition, the PR will lead the establishment of Human Rights Defenders watch group to support and defend community members from human rights breaches and abuses","0","0","0","0","264886","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUI/view","2020-12-31","TB/HIV",264886," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713=AN2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713=AO2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713=AP2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713=AN2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713=AO2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713=AP2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2198)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUJUA4","PAI-5757","Active","THA-TB/HIV-17","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"Programs to reduce human rights-related barriers to HIV services","HIV and HIV/TB-related legal services","RTF BL 17Meeting on legal services related HIV-TB. Meeting police, MOI, CSO Units/Participants: 37 person per day.","RTF BL 17Meeting on legal services related HIV-TB. Meeting police, MOI, CSO Units/Participants: 37 person per day.",null,"High","30235","Sensitization of law makers and law enforcement agents will complement the stigma and discrimination reduction and human rights awareness efforts. This intervention will support the organization of a meeting on legal services related HIV -TB with police, the Ministry of Interior and CSOs. To ensure the ongoing efforts, meetings on legal services related to HIV/TB will be held regularly","0","0","0","0","30235","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUJ/view","2020-12-31","TB/HIV",30235," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713=AN2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713=AO2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713=AP2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713=AN2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713=AO2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713=AP2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2199)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUOUA4","PAI-5762","Inactive","THA-TB/HIV-21","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"Comprehensive programs for people in prisons and other closed settings","HIV testing services for people in prisons and other closed settings","DDC BL 359HIV testing services for Prisoner by using oral fluidHIV testing  for Prisoner is set 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.","DDC BL 359HIV testing services for Prisoner by using oral fluidHIV testing  for Prisoner is set 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.",null,"High","355100","This intervention will support HIV oral fluid testing services for prisoners in order to reach 100%, 50% and 10% in year 2018, 2019 and 2020 respectively.","355100","0","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUO/view","2020-12-31","TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713=AN2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713=AO2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713=AP2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713=AN2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713=AO2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713=AP2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2204)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUTUA4","PAI-5767","Active","THA-TB/HIV-26","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Interventions for young people who inject drugs","RTF BL 11Pathway to recovery -PWIDs and their families, Event for PWID and family Units/Participants: 32 person (16 families) per day.","RTF BL 11Pathway to recovery -PWIDs and their families, Event for PWID and family Units/Participants: 32 person (16 families) per day.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners","High","64580","This activity supports the Pathway to recovery program for young people who inject drugs and their families,","0","0","0","0","64580","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUT/view","2020-12-31","TB/HIV",64580," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713=AN2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713=AO2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713=AP2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713=AN2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713=AO2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713=AP2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2209)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUYUA4","PAI-5772","Inactive","THA-TB/HIV-30","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","DDC BL 273:Support renovation of isolation TB room and DOT corner for prisoners including UV light in order to prevent TB/MDR transmission in prison in 70 prisons.The prisons are the closed setting areas and crowded, provision of molecular test by GeneXpert will detect more TB patients. Good management for infectious TB control will prevent and cut off transmission in prisons.Emphasizing on infection control and environment management control that is important both for prisoners and prison guards.","DDC BL 273:Support renovation of isolation TB room and DOT corner for prisoners including UV light in order to prevent TB/MDR transmission in prison in 70 prisons.The prisons are the closed setting areas and crowded, provision of molecular test by GeneXpert will detect more TB patients. Good management for infectious TB control will prevent and cut off transmission in prisons.Emphasizing on infection control and environment management control that is important both for prisoners and prison guards.","NA Original Intervention: Key populations (TB care and prevention)  Prisoners","High","397208","This infection control intervention will contribute to decrease the transmission of TB in prisons","0","397208","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUY/view","2020-12-31","TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713=AN2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713=AO2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713=AP2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713=AN2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713=AO2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713=AP2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2214)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUZUA4","PAI-5773","Active","THA-TB/HIV-31","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"TB care and prevention","Community TB care delivery","RTF BL 43: $28,372.01Modeling for community-based sputum transportation ConsultantRTF BL 44: $43,406.34Modeling for community-based sputum transportation -Consultation workshop with LAO, CSO, community, and health facilitiesRationale: To engage the local stakeholder to initiate the community-based sputum transportation.","RTF BL 43: $28,372.01Modeling for community-based sputum transportation ConsultantRTF BL 44: $43,406.34Modeling for community-based sputum transportation -Consultation workshop with LAO, CSO, community, and health facilitiesRationale: To engage the local stakeholder to initiate the community-based sputum transportation.",null,"High","71778","This intervention will contribute to improved treatment outcomes due to patient centred care by engaging CSO in sputum transport systems","0","0","0","0","71778","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUZ/view","2020-12-31","TB/HIV",71778," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713=AN2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713=AO2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713=AP2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713=AN2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713=AO2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713=AP2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2215)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUeUAO","PAI-5778","Active","THA-TB/HIV-36","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"RSSH: National health strategies","Other policy and governance intervention(s)","RTF BL 31-321. Twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii.  Field visit with stakeholders Units/Participants: 27 persons per day, 2 days. Locations: 2 provinces in year 1, year2 2. Fundraising specialist for CRM strategic plan. Contact professional consultant Units/Participants: 4 persons per team  Locations: 1 team in year 1, year 2, year 3.","RTF BL 31-321. Twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii.  Field visit with stakeholders Units/Participants: 27 persons per day, 2 days. Locations: 2 provinces in year 1, year2 2. Fundraising specialist for CRM strategic plan. Contact professional consultant Units/Participants: 4 persons per team  Locations: 1 team in year 1, year 2, year 3.","NA Original Module: RSSH - National health strategies. Original Intervention: National health strategies, alignment with disease specific plans, health sector governance and financing","Medium","43921","This intervention supports twin-cities collaboration for effective cross-border referral and monitoring in Kanchanaburi and Daweii and a fundraising specialist for the community response mobilization (CRM) strategic plan.","0","0","0","0","43921","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUe/view","2020-12-31","TB/HIV",43921," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713=AN2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713=AO2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713=AP2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713=AN2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713=AO2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713=AP2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2220)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUjUAO","PAI-5783","Active","THA-TB/HIV-40","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"RSSH: Health management information systems and M&E","Surveys","DDC BL 284-285Improve surveillance system1 Support devices for collecting data for IBBS, -Tablets 100 sets2 Contract consultant for initiate surveillance survey among prisoners.","DDC BL 284-285Improve surveillance system1 Support devices for collecting data for IBBS, -Tablets 100 sets2 Contract consultant for initiate surveillance survey among prisoners.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Low","31209","The TRP considers improvement in surveillance system by funding devices for collecting data for IBBS, and a contract consultant for initiate surveillance survey among prisoners to be a low priority under this funding request and should be supported through domestic resources","0","0","0","0","31209","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUj/view","2020-12-31","TB/HIV",31209," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713=AN2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713=AO2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713=AP2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713=AN2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713=AO2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713=AP2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2225)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUoUAO","PAI-5788","Inactive","THA-TB/HIV-45","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR588-THA-C",null,null,"MDR-TB","Other MDR-TB intervention(s)","The intervension of $ 1 million will support the transition to the new MDR/RR-TB regimen recommended by the WHO which the country plans to begin implementing from Q4 2019.","The intervension of $ 1 million will support the transition to the new MDR/RR-TB regimen recommended by the WHO which the country plans to begin implementing from Q4 2019.","Amount validated and description updated by CT Original Module: Multidrug-resistant TB. Original Intervention: Treatment: MDR-TB","High","1e+06","The intervension of $ 1 million will support the transition to the new MDR/RR-TB regimen recommended by the WHO which the country plans to begin implementing from Q4 2019.","0","1e+06","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUo/view","2020-12-31","TB/HIV",0," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713=AN2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713=AO2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713=AP2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713=AN2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713=AO2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713=AP2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2230)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUrUAO","PAI-5791","Active","THA-TB/HIV-7","2017-2019","RT High Impact Asia","Thailand","HIV/TB","HIV/AIDS, Tuberculosis","FR200-THA-C-01",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","DDC BL 275, 329-337, 338-3431. Co-invest with PIF for national capacity building forum and scaling up to more sites in Bangkok2. Capacity Building and TA for community Led services in 3 Provinces , BangkokChiang Rai and Naratiwas3.  Capacity Building and TA for Reach and Recruit for Key population, MSM TG and PWID.","DDC BL 275, 329-337, 338-3431. Co-invest with PIF for national capacity building forum and scaling up to more sites in Bangkok2. Capacity Building and TA for community Led services in 3 Provinces , BangkokChiang Rai and Naratiwas3.  Capacity Building and TA for Reach and Recruit for Key population, MSM TG and PWID.","NA Original Module: RSSH - Community responses and systems","High","581432","In order to enhance national commitment on the integration of the Global Fund and PEPFAR aiming to support Thailand's transition, a platform for building capacity will be established. In addition, this activity will provide capacity training and develop tools and guidelines for community based organization (CBO) service provision in order for CBOs to become a viable part of the health system and close the gaps between health facilities and people in the community.","0","0","0","0","581432","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUr/view","2020-12-31","TB/HIV",581432," High Impact Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713=AN2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713=AO2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713=AP2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713=AN2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713=AO2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713=AP2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2233)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJUvUAO","PAI-5795","Active","TJK-HIV/AIDS-2","2017-2019","RT Eastern Europe and Central Asia","Tajikistan","HIV/AIDS","HIV/AIDS","FR100-TJK-H",null,null,"Treatment, care and support","Other intervention(s) for treatment","Aiming to scale up to reach 73.9% (10,800 individuals) of PLWH who aware their status, on ART. The cost also includes VL and CD4 testing. The expected outcome is to achieve viral suppression as per treatment as prevention initiative.","Aiming to scale up to reach 73.9% (10,800 individuals) of PLWH who aware their status, on ART. The cost also includes VL and CD4 testing. The expected outcome is to achieve viral suppression as per treatment as prevention initiative.","NA Original Module: Treatment, care and support for adults, adolescents, and children. Original Intervention: Enroll 2000 people living with HIV to antiretroviral treatment, counselling and support to increase adherence. Viral loas test and CD4 count test.","High","2800000","This intervention will allow the program to reach people who inject drugs who are aware of their status, to scale up antiretroviral therapy, and viral load and CD4 testing, and to achieve viral suppression as per treatment as prevention initiative.","69515","1704235","0","0","1026250","0","0","2020-01-21 09:57:13","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJUv/view","2020-12-31","HIV/AIDS",1026250," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713=AN2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713=AO2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713=AP2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713=AN2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713=AO2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713=AP2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2237)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2020-12-31"]
["a6Q1R000000AJV0UAO","PAI-5800","Active","TJK-HIV/AIDS-7","2017-2019","RT Eastern Europe and Central Asia","Tajikistan","HIV/AIDS","HIV/AIDS","FR100-TJK-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Other intervention(s) for IDUs and their partners","With PAAR, the project will improve the quality and expand the NSEP and OST services for PWID by the end of the project cycle. The expected outcome is to contain the spread of the HIV infection among the key population and eventually general population. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.","With PAAR, the project will improve the quality and expand the NSEP and OST services for PWID by the end of the project cycle. The expected outcome is to contain the spread of the HIV infection among the key population and eventually general population. With this requested amount, the project envisages conducting IBBS among this KP to measure the impact of the project to KP. Additionally, negotiations and resource mobilization will be conducted to cover the cost of IBBS.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Provide needle and syringe exchange program, HIV testing and counselling and opioid substitution treatmentto people who inject drugs","Medium","2e+06","This intervention will allow to improve the quality and expand the needle and syringe exchange program and opioid substitution treatment services for people who inject drugs. It will allow as well to conduct an integrated biobehavioral survey (IBBS) among peope who inject drugs.","154368","961565","0","0","884067","0","0","2020-01-21 09:59:50","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJV0/view","2020-12-31","HIV/AIDS",884067," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713=AN2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713=AO2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713=AP2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713=AN2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713=AO2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713=AP2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2242)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2020-12-31"]
["a6Q1R000000AJV5UAO","PAI-5805","Inactive","TKM-Tuberculosis-1","2017-2019","RT Eastern Europe and Central Asia","Turkmenistan","Tuberculosis","Tuberculosis","FR198-TKM-T",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Community involvement to TB care is weak due to the  lack  of  social  contracting  mechanisms.  Civil society formally   participates in  the Country Coordinating  Mechanism.  Proper  involvement  of CSOs is stipulated in the National Programme for TB Prevention and Control, 2016-2020. However, the only CSO with meaningful engagement to TB care is the National Red Crescent Society through the  Global  Fund  grant,  and its  role is  limited to service provision. The transitional grant includes  technical  support  with  establishing  legal and  financial  mechanisms  for  direct  contracting and building  capacities  of  CSOs  as  to  enhance  their contribution to the national TB response. In order to  increase the number of CSO involved in  providing   TB  prevention  and  treatment adherence support interventions, under Prioritized Above Allocation Budget CCM is asking to fund  a Small grants program for CSOs. The project will support the first grants aiming at involvement of the CSOs in TB control activities, including  work  on  reducing stigma, dissemination of information, advocacy for ambulatory  model,  or support to patients  during ambulatory treatment (focus on women patients or other vulnerable groups).","Community involvement to TB care is weak due to the  lack  of  social  contracting  mechanisms.  Civil society formally   participates in  the Country Coordinating  Mechanism.  Proper  involvement  of CSOs is stipulated in the National Programme for TB Prevention and Control, 2016-2020. However, the only CSO with meaningful engagement to TB care is the National Red Crescent Society through the  Global  Fund  grant,  and its  role is  limited to service provision. The transitional grant includes  technical  support  with  establishing  legal and  financial  mechanisms  for  direct  contracting and building  capacities  of  CSOs  as  to  enhance  their contribution to the national TB response. In order to  increase the number of CSO involved in  providing   TB  prevention  and  treatment adherence support interventions, under Prioritized Above Allocation Budget CCM is asking to fund  a Small grants program for CSOs. The project will support the first grants aiming at involvement of the CSOs in TB control activities, including  work  on  reducing stigma, dissemination of information, advocacy for ambulatory  model,  or support to patients  during ambulatory treatment (focus on women patients or other vulnerable groups).","NA Original Module: RSSH - Community responses and systems","High","1e+05","The TRP considers thisintervention quality demand as itwill to contribute to improvedprogram management andimplementation after transition.Because of its importance, theTRP recommends this module tomove into allocation.","0","1e+05","0","0","0","1","0","2020-01-14 12:57:45","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJV5/view","2021-06-30","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713=AN2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713=AO2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713=AP2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713=AN2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713=AO2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713=AP2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2247)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJV6UAO","PAI-5806","Inactive","TKM-Tuberculosis-2","2017-2019","RT Eastern Europe and Central Asia","Turkmenistan","Tuberculosis","Tuberculosis","FR198-TKM-T",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","Two among five regions of Turkmenistan, Balkan and  Akhal,  do  not  have  laboratory  capacity  to perform   liquid   culture   and   drug   susceptibility testing. In 2012-2017 the Government invested into large renovation works of the Akhal regional TB hospital and   its   laboratory,   including   modernization   of infrastructure   (water,   sewage,   electricity).   The Government also procured general lab equipment (autoclaves,  etc).    However,  procurement  of Bactec  MGIT  and  LPA  equipment  is  still  being delayed.  At  present,  due  to  proximity  of  Akhal regional  TB  lab  to  the  capital  Ashgabat,  DST  is done  by  the  NRL.  However,  this  is  an  interim solution as it adds workload on the NRL staff. Procurement  of  lab  equipment  for  Balkan  and Akhal  regional  TB  labs  was  planned  within  the cost-sharing   agreements   between   UNDP   and MoH  for  2018,  but  due  to  large  investment  into procurement   of   TB   reagents   and   drugs   the Government   decided   to   postpone   funding   the procurement of equipment. The  current Prioritized  Above  Allocation  Requestincludes procurement of some equipment required for  two regional TB labs  in case the Government funding will not be available in 2018.","Two among five regions of Turkmenistan, Balkan and  Akhal,  do  not  have  laboratory  capacity  to perform   liquid   culture   and   drug   susceptibility testing. In 2012-2017 the Government invested into large renovation works of the Akhal regional TB hospital and   its   laboratory,   including   modernization   of infrastructure   (water,   sewage,   electricity).   The Government also procured general lab equipment (autoclaves,  etc).    However,  procurement  of Bactec  MGIT  and  LPA  equipment  is  still  being delayed.  At  present,  due  to  proximity  of  Akhal regional  TB  lab  to  the  capital  Ashgabat,  DST  is done  by  the  NRL.  However,  this  is  an  interim solution as it adds workload on the NRL staff. Procurement  of  lab  equipment  for  Balkan  and Akhal  regional  TB  labs  was  planned  within  the cost-sharing   agreements   between   UNDP   and MoH  for  2018,  but  due  to  large  investment  into procurement   of   TB   reagents   and   drugs   the Government   decided   to   postpone   funding   the procurement of equipment. The  current Prioritized  Above  Allocation  Requestincludes procurement of some equipment required for  two regional TB labs  in case the Government funding will not be available in 2018.","NA Original Module: Multidrug-resistant TB","High","340383","The TRP considers this intervention quality demand as it will to contribute to improved patient management and implementation after transition. Because of its importance, the TRP recommends this module to move into allocation.","176","340207","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJV6/view","2021-06-30","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713=AN2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713=AO2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713=AP2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713=AN2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713=AO2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713=AP2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2248)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJVBUA4","PAI-5811","Inactive","TLS-HIV/AIDS-4","2017-2019","RT South East Asia","Timor-Leste","HIV/AIDS","HIV/AIDS","FR100-TLS-H",null,null,"Treatment, care and support","Treatment adherence","This request includes for TA support for TB/HIV and ART treatment in 2019 and 2020.","This request includes for TA support for TB/HIV and ART treatment in 2019 and 2020.",null,"High","13674","Given the high loss to follow-up rate of 14.7 percent of HIV diagnosed clients, this activity is necessary to improve the prevention and treatment cascade. It is recommended to be transferred to the allocation amount to be financed through cost savings.","13674","0","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVB/view","2020-12-31","HIV/AIDS",0," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713=AN2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713=AO2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713=AP2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713=AN2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713=AO2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713=AP2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2253)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJVGUA4","PAI-5816","Active","TLS-HIV/AIDS-9","2017-2019","RT South East Asia","Timor-Leste","HIV/AIDS","HIV/AIDS","FR100-TLS-H",null,null,"TB/HIV","TB/HIV collaborative interventions","This funding would support a proportion of costs for technical assistance for the TB/HIV and is linked to the support requested in the treatment, care and support above.","This funding would support a proportion of costs for technical assistance for the TB/HIV and is linked to the support requested in the treatment, care and support above.",null,"Low","70500","The TRP requests the applicant to work with technical partners and the Secretariat to develop a plan to ensure that technical capacity is transferred to local staff and that there is an exit strategy by which external Technical Assistance is discontinued by the end of grant implementation. 10 HIV Testing Services Differentiated HIV testing services Low 300,420 The TRP requests the","0","0","0","0","70500","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVG/view","2020-12-31","HIV/AIDS",70500," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713=AN2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713=AO2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713=AP2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713=AN2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713=AO2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713=AP2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2258)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJVLUA4","PAI-5821","Inactive","TLS-Malaria-2","2017-2019","RT South East Asia","Timor-Leste","Malaria","Malaria","FR108-TLS-M",null,null,"RSSH: Integrated service delivery and quality improvement","Other service delivery intervention(s)","Provision of LLIN procurement and routine ANC distribution to maximise coverage in and utilization by pregnant women to prevent the acquisition of malaria with complications. It would complement the above (Priority 1 request) in ensuring complementary coverage would provide the outcome of Universal Access to Coverage (90%) amongst a wider population denominator and would ensure targets are achieved across all 4 Impact Indicators.","Provision of LLIN procurement and routine ANC distribution to maximise coverage in and utilization by pregnant women to prevent the acquisition of malaria with complications. It would complement the above (Priority 1 request) in ensuring complementary coverage would provide the outcome of Universal Access to Coverage (90%) amongst a wider population denominator and would ensure targets are achieved across all 4 Impact Indicators.","NA Original Module: RSSH - Integrated service delivery and quality improvement","High","309536","Pregnant women are one of the most vulnerable groups for malaria with the highest risk of severe complications, and malaria in pregnancy puts unborn children at high risk for premature, underweight or even still birth. Funds aimed at expanding coverage for this group are high priority and should be included in the allocation despite the extremely low risk in most of the country.","309536","0","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVL/view","2020-12-31","Malaria",0," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713=AN2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713=AO2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713=AP2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713=AN2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713=AO2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713=AP2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2263)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJVMUA4","PAI-5822","Inactive","TLS-Malaria-3","2017-2019","RT South East Asia","Timor-Leste","Malaria","Malaria","FR108-TLS-M",null,null,"Case management","Active case detection and investigation (elimination phase)","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Lestes transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Lestes transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector",null,"High","1192","Guidelines for ACD must be available to staff at the central and district levels to ensure case and foci investigation protocols are strictly adhered to (i.e. 2 days for case investigation, 5 days for Mass Blood Survey, and 10 days for response package). These funds will facilitate the printing of the guidelines.","1192","0","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVM/view","2020-12-31","Malaria",0," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713=AN2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713=AO2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713=AP2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713=AN2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713=AO2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713=AP2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2264)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJVRUA4","PAI-5827","Active","TLS-Malaria-8","2017-2019","RT South East Asia","Timor-Leste","Malaria","Malaria","FR108-TLS-M",null,null,"Case management","Facility-based treatment","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Lestes transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector","Provision of additional financial inputs to ensure that Universal Access to effective malaria screening and treatment remains a priority through integrated primary health care services. Despite Timor-Lestes transition towards malaria elimination, in which only 31 active-foci were recorded in 2015; the country needs to remain vigilant for newly acquired cases (both imported and indigenous) as local vector receptivity and a more immunesusceptible population could lead to an upsurge in active-foci or outbreaks. Country vigilance from a case-management perspective, given that malaria is a notifiable disease, would contribute to all Impact Indicator targets being met and would ensure the ABER of 10% could be achieved. To ensure that vigilance and best practice for case management is maintained additional funding is sought for; 1) TOT for municipality based health personnel on Management of uncomplicated malaria, Case notification reporting, Case / Foci Investigation and Response Implementation and Antimalaria Drug Efficacy Guidelines Adherence (Year 3), 2) Training of malaria microscopists and doctors / nurses conducting the Antimalaria Drug Efficacy Evaluation and costs to cover procurement of supplies and implementation in Year 3, 3) Costs to support International Technical Assistance to a) Update guidelines and SOPs for the elimination setting and assist with case management refresher trainings, b) Provide municipality based coordination, c) Enhance Malaria Microscopy QC / QA, 4) Supporting maintenance costs of existing microscopes (Year 3), and 5) Production and dissemination of national treatment guidelines, regulatory documents and case-reporting SOP to the Private Sector",null,"Low","71100","Malaria elimination activities commenced in Timor-Leste over a year ago and the country has a fairly strong laboratory system that is equipped and manned by skilled personnel. Recruitment of specialised external technical assistance (TA) for quality assurance and control as well is not indicated in relation to the activities prioritized above.","0","0","0","0","71100","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVR/view","2020-12-31","Malaria",71100," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713=AN2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713=AO2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713=AP2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713=AN2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713=AO2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713=AP2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2269)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJVWUA4","PAI-5832","Active","TUN-HIV/AIDS-12","2017-2019","RT Middle East and North Africa","Tunisia","HIV/AIDS","HIV/AIDS","FR391-TUN-H",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Reproducing and making available copies of harmonized data collection tools to Centers for Anonymous and Free Testing and Counseling (CCDAGs), laboratories, treatment centers and nongovernmental organizations (NGOs), and printing service provider and PE data collection registers will make it possible to report and save reliable information relating to services aimed at consolidating HIV control outcomes.","Reproducing and making available copies of harmonized data collection tools to Centers for Anonymous and Free Testing and Counseling (CCDAGs), laboratories, treatment centers and nongovernmental organizations (NGOs), and printing service provider and PE data collection registers will make it possible to report and save reliable information relating to services aimed at consolidating HIV control outcomes.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","93439","While reproducing and making available copies of harmonized data collection tools to Centres for Anonymous and Free Testing and Counselling (CCDAGs), laboratories, treatment centres and non-governmental organizations (NGOs), and printing service provider and PE data collection registers is important for reporting and saving reliable information, the TRP considers this intervention not to be a high priority.","15117","0","0","0","78322","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVW/view","2021-12-31","HIV/AIDS",78322," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713=AN2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713=AO2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713=AP2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713=AN2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713=AO2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713=AP2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2274)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJVZUA4","PAI-5835","Active","TUN-HIV/AIDS-15","2017-2019","RT Middle East and North Africa","Tunisia","HIV/AIDS","HIV/AIDS","FR391-TUN-H",null,null,"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","The development of a regulatory manual on sexual health among young people (girls and boys) and risk reduction associated with STIs/HIV, HIV awareness-raising campaigns aimed at young people, training of peer educators (PEs) and awareness-raising activities targeting migrants will strengthen HIV control outcomes among young people and migrants, a vulnerable population.","The development of a regulatory manual on sexual health among young people (girls and boys) and risk reduction associated with STIs/HIV, HIV awareness-raising campaigns aimed at young people, training of peer educators (PEs) and awareness-raising activities targeting migrants will strengthen HIV control outcomes among young people and migrants, a vulnerable population.","NA Original Intervention: Other interventions for other vulnerable populations","Low","314138","The development of a regulatory manual on sexual health among young people (girls and boys) and risk reduction associated with STIs/HIV, HIV awareness-raising campaigns aimed at young people, training of peer educators (PEs) and awareness-raising activities targeting migrants is a low priority given the key population focus of the epidemic and the lack of information on the migrant population which would be needed for appropriate messaging.","0","0","0","0","314138","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVZ/view","2021-12-31","HIV/AIDS",314138," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713=AN2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713=AO2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713=AP2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713=AN2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713=AO2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713=AP2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2277)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJVdUAO","PAI-5839","Active","TUN-HIV/AIDS-5","2017-2019","RT Middle East and North Africa","Tunisia","HIV/AIDS","HIV/AIDS","FR391-TUN-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Strengthening the conditions for addressing stigma, discrimination and violence against people in prisons and other closed settings through the establishment of an accreditation mechanism for HIV screening by community actors and by raising awareness of the rights of key populations will, in the long term, have a positive and sustainable impact on HIV control.","Strengthening the conditions for addressing stigma, discrimination and violence against people in prisons and other closed settings through the establishment of an accreditation mechanism for HIV screening by community actors and by raising awareness of the rights of key populations will, in the long term, have a positive and sustainable impact on HIV control.",null,"High","130065",null,"122904","0","0","0","7161","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVd/view","2021-12-31","HIV/AIDS",7161," Middle East and North Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713=AN2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713=AO2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713=AP2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713=AN2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713=AO2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713=AP2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2281)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJViUAO","PAI-5844","Active","TZA-Malaria-1","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","Malaria","Malaria, RSSH","FR220-TZA-Z",null,null,"Case management","Therapeutic efficacy surveillance","These funds are critical for covering therapeutic efficacy studies (TES), and detection of any other evidence of treatment failures or emerging drug resistance.","These funds are critical for covering therapeutic efficacy studies (TES), and detection of any other evidence of treatment failures or emerging drug resistance.",null,"High","6e+05","This funds are critical for covering therapeutic efficacy studies (TES), and detection of any other evidence of treatment failures or emerging drug resistance.","360000","0","0","0","240000","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVi/view",null,"Multi-component",240000," High Impact Africa 2","Malaria, RSSH","Malaria"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713=AN2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713=AO2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713=AP2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713=AN2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713=AO2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713=AP2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2286)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJVnUAO","PAI-5849","Active","TZA-Malaria-6","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","Malaria","Malaria, RSSH","FR220-TZA-Z",null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","This fund supports ongoing monitoring of population coverage with utilization of LLINs.","This fund supports ongoing monitoring of population coverage with utilization of LLINs.","NA Original Intervention: Long-lasting insecticidal nets  Continuous distribution","High","3e+05","This fund supports ongoing monitoring of population coverage with utilization of LLINs","248111","0","0","0","51889","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVn/view",null,"Multi-component",51889," High Impact Africa 2","Malaria, RSSH","Malaria"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713=AN2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713=AO2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713=AP2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713=AN2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713=AO2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713=AP2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2291)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJVsUAO","PAI-5854","Active","TZA-RSSH-4","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","RSSH","RSSH","FR341-TZA-S-01",null,null,"RSSH: Procurement and supply chain management systems","National product selection, registration and quality monitoring","This intervention will complement the Global Fund investment but is an upstream investment.","This intervention will complement the Global Fund investment but is an upstream investment.","NA Original Module: RSSH - Procurement and supply chain management systems","Medium","2341931","This intervention will complement the Global Fund investment but is an upstream investment","0","0","0","0","2341931","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVs/view","2020-12-31","RSSH",2341931," High Impact Africa 2","RSSH","RSSH",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713=AN2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713=AO2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713=AP2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713=AN2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713=AO2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713=AP2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2296)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJVtUAO","PAI-5855","Active","TZA-TB/HIV-1","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR219-TZA-C",null,null,"Prevention programs for general population","Other intervention(s) for general population","During 2018-2020 Global fund grant application only 7201996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44% of the blood recipients to be at risk of infections through blood transfusion.","During 2018-2020 Global fund grant application only 7201996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44% of the blood recipients to be at risk of infections through blood transfusion.","NA Original Intervention: Scale up availability and accessibility of safe blood to patients in need of blood transfusion therapy","High","5769918","Under the current application only 7,201,996.20 USD were allocated for procurement of reagents and supplies for blood safety activities for the period of 2018-2020 leaving a deficit of 5,769,918 USD meaning about 44 percent of the blood recipients are at risk of infections through blood transfusion","0","0","0","0","5769918","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVt/view","2020-12-31","TB/HIV",5769918," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713=AN2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713=AO2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713=AP2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713=AN2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713=AO2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713=AP2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2297)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJVyUAO","PAI-5860","Active","TZA-TB/HIV-14","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR219-TZA-C",null,null,"TB/HIV","Other TB/HIV intervention(s)","It is hypothesized that Low TB case notification among PLHIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among PLHIV disaggregated by age, gender and pregnancy status.","It is hypothesized that Low TB case notification among PLHIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among PLHIV disaggregated by age, gender and pregnancy status.","NA Original Intervention: Operational research to improve TB case notification among people living with HIV in HIV care and treatment services","Low","356600","It is hypothesized that Low TB case notification among People Living with HIV may be because of the limited sensitivity of the TB screening process in use. This requested amount is for an evaluation that compares the performance of TB screening tool at case notification compared to the use of GeneXpert. The study will also determine the burden of TB among People Living with HIV disaggregated by age, gender and pregnancy status.","0","0","0","0","356600","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJVy/view","2020-12-31","TB/HIV",356600," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713=AN2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713=AO2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713=AP2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713=AN2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713=AO2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713=AP2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2302)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJW3UAO","PAI-5865","Active","TZA-TB/HIV-19","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR219-TZA-C",null,null,"TB care and prevention","Engaging all care providers (TB care and prevention)","High level priority: it is in line with FR of the main objective  to intensify TB case notification  and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.","High level priority: it is in line with FR of the main objective  to intensify TB case notification  and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.",null,"High","45694","High level priority: it is in line with FR of the main objective  to intensify TB case notification  and module 1 TB care and prevention: Additional mentorships and follow up supervision to Accredited Drug Dispensing Outlets (ADDOs) in the nine regions.","0","0","0","0","45694","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJW3/view","2020-12-31",{"$f":"IF(OR(I2307=\"HIV/AIDS\",I2307=\"Tuberculosis\",I2307=\"Malaria\",I2307=\"RSSH\"),I2307, IF(I2307=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"TB/HIV"},{"$f":"VALUE(Y2307)","v":45694},{"$f":"RIGHT(F2307,LEN(F2307)-2)","v":" High Impact Africa 2"},"HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,{"$f":"TRIM(AK2307)","v":"Tuberculosis"},{"$f":"TRIM(AL2307)","v":""},{"$f":"TRIM(AM2307)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713=AN2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713=AO2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713=AP2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE2307<>\"\",AE2307,IF(MAX(AQ2307,AR2307,AS2307,AT2307)<>0,MAX(AQ2307,AR2307,AS2307,AT2307),AU2307))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713=AN2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713=AO2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713=AP2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2307)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE2307<>\"\",AE2307,IF(MAX(AW2307,AX2307,AY2307,AZ2307)<>0,MAX(AW2307,AX2307,AY2307,AZ2307),BA2307))","v":"2020-12-31"}]
["a6Q1R000000AJW8UAO","PAI-5870","Active","TZA-TB/HIV-23","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR219-TZA-C",null,null,"MDR-TB","Prevention for MDR-TB","High level priority: it is in line with FR one of the main objective  to increase MDR-TB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services.","High level priority: it is in line with FR one of the main objective  to increase MDR-TB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services.","NA Original Module: Multidrug-resistant TB","High","1071389","High level priority: it is in line with FR one of the main objective  to increase MDRTB case detection and treatment and module 3 MDR-TB: To reach the remaining 10 percent of NSP targets by 2020. Furthermore, additional funding is requested to strengthen one zonal culture laboratory and one satellite MDR TB center for supporting provision of decentralized MDR TB services","0","0","0","0","1071389","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJW8/view","2020-12-31","TB/HIV",1071389," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713=AN2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713=AO2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713=AP2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713=AN2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713=AO2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713=AP2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2312)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJW9UAO","PAI-5871","Active","TZA-TB/HIV-24","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR219-TZA-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","High level priority: it is in line with FR one of the main objective  to improve health information system and module 4: Estimation of regional TB burden.Assessment of notification levels among the elderly: Digitalization of the supportive supervision tool.Revision of the program management Manual and Strategic plan.","High level priority: it is in line with FR one of the main objective  to improve health information system and module 4: Estimation of regional TB burden.Assessment of notification levels among the elderly: Digitalization of the supportive supervision tool.Revision of the program management Manual and Strategic plan.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","431858","High level priority: it is in line with FR one of the main objective  to improve health information system and module 4: Estimation of regional TB burden Assessment of notification levels among the elderly: Digitalization of the supportive supervision tool Revision of the program management Manual and Strategic plan","0","0","0","0","431858","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJW9/view","2020-12-31","TB/HIV",431858," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713=AN2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713=AO2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713=AP2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713=AN2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713=AO2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713=AP2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2313)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJWEUA4","PAI-5876","Active","TZA-TB/HIV-5","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR219-TZA-C",null,null,"Treatment, care and support","Other intervention(s) for treatment","A scale up plan for HVL testing is being implemented in Tanzania. The funding request has set ambitious target to enrol 95% of PLHIV on ART by 2020. To achieve the third ninety of the 90-90-90 strategy, scale up of HVL testing to district level will be crucial. The PAAR will be used to procure HVL reagents and build capacity of health care workers including laboratory personnel to conduct Viral Load tests and EID testing. This will also involve strengthening lab systems and providing technical assistance for accreditation of new sites. The aim is to increase coverage and reduce the turnaround time.","A scale up plan for HVL testing is being implemented in Tanzania. The funding request has set ambitious target to enrol 95% of PLHIV on ART by 2020. To achieve the third ninety of the 90-90-90 strategy, scale up of HVL testing to district level will be crucial. The PAAR will be used to procure HVL reagents and build capacity of health care workers including laboratory personnel to conduct Viral Load tests and EID testing. This will also involve strengthening lab systems and providing technical assistance for accreditation of new sites. The aim is to increase coverage and reduce the turnaround time.","NA Original Intervention: Scale up HIV viral load and early infant diagnosis testing","Medium","1612000","A scale up plan for HIV viral load testing is being implemented in Tanzania. The funding request has set ambitious target to enrol 95 percent of People Living with HIV on ART by 2020. To achieve the third ninety of the 90-90-90 strategy, scale up of viral load testing to district level will be crucial. The PAAR will be used to procure viral load reagents and build capacity of health care workers including laboratory personnel to conduct viral load tests and Early Infant Diagnosis (EID) testing. This will also involve strengthening lab systems and providing technical assistance for accreditation of new sites. The aim is to increase coverage and reduce the turnaround time.","0","0","0","0","1612000","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWE/view","2020-12-31","TB/HIV",1612000," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713=AN2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713=AO2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713=AP2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713=AN2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713=AO2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713=AP2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2318)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJWHUA4","PAI-5879","Active","TZA-TB/HIV-8","2017-2019","RT High Impact Africa 2","Tanzania (United Republic)","HIV/TB","HIV/AIDS, Tuberculosis","FR219-TZA-C",null,null,"TB/HIV","Other TB/HIV intervention(s)","Testing of TB patients partners for HIV is also an important component of HIV prevention services for TB patients. Partner/ Couple testing and partner notification remain low in our settings. Few TB clinics have systems in place to adequately document partner testing. This requested funding is to provide minimal additional training in line with the Couple Counselling refresher training package and HTC tools for documentation. It is expected that through this, existing cadres of skilled medical staff will be able to extend HIV testing Tanzania Funding Request: Full review 22 May 2017 | 43 and counselling to the partners of their TB patients.","Testing of TB patients partners for HIV is also an important component of HIV prevention services for TB patients. Partner/ Couple testing and partner notification remain low in our settings. Few TB clinics have systems in place to adequately document partner testing. This requested funding is to provide minimal additional training in line with the Couple Counselling refresher training package and HTC tools for documentation. It is expected that through this, existing cadres of skilled medical staff will be able to extend HIV testing Tanzania Funding Request: Full review 22 May 2017 | 43 and counselling to the partners of their TB patients.","NA Original Intervention: Strengthening Couple HIV Testing for TB/HIV patients partners","Medium","350000","Testing of TB patients partners for HIV is also an important component of HIV prevention services for TB patients. Partner/ Couple testing and partner notification remain low in our settings. Few TB clinics have systems in place to adequately document partner testing. This requested funding is to provide minimal additional training in line with the Couple Counselling refresher training package and HTC tools for documentation. It is expected that through this, existing cadres of skilled medical staff will be able to extend HIV testing and counselling to the partners of their TB patients.","0","0","0","0","350000","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWH/view","2020-12-31","TB/HIV",350000," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713=AN2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713=AO2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713=AP2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713=AN2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713=AO2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713=AP2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2321)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJWPUA4","PAI-5887","Active","UGA-TB/HIV-3","2017-2019","RT High Impact Africa 2","Uganda","HIV/TB","HIV/AIDS, Tuberculosis","FR188-UGA-C",null,null,"PMTCT","Other intervention(s) for PMTCT","Additional funding will support capacity enhancement for PLHIV community groups to deliver interventions that are intended to further increase uptake of PMTCT services, increase male partner testing, reduce loss to follow up for mother-baby pairs, and improve treatment adherence.","Additional funding will support capacity enhancement for PLHIV community groups to deliver interventions that are intended to further increase uptake of PMTCT services, increase male partner testing, reduce loss to follow up for mother-baby pairs, and improve treatment adherence.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: PMTCT quality improvement --capacity enhancement for community groups","Medium","913488","Additional funding will support capacity enhancement for people living with HIV community groups to deliver interventions that are intended to further increase uptake of PMTCT services, increase male partner testing, reduce loss to follow up for motherbaby pairs, and improve treatment adherence.","0","0","0","0","913488","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWP/view",null,"TB/HIV",913488," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713=AN2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713=AO2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713=AP2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713=AN2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713=AO2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713=AP2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2329)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJWQUA4","PAI-5888","Active","UGA-TB/HIV-4","2017-2019","RT High Impact Africa 2","Uganda","HIV/TB","HIV/AIDS, Tuberculosis","FR188-UGA-C",null,null,"HIV Testing Services","Other module","The HTS test kits have a gap of $21.2 million (after the allocation request). Additional funding is sought to support HTS services including review and update of HTS training materials; printing of revised HTS tools to complement PEPFAR support; support for quarterly performance review meetings at national level; finalize the HTS certification framework; Conduct routine QC; Quarterly support supervision visits to HTS points; and HTS outreaches in safe places and hard-to-reach settings such as fishing communities.  This request includes $21.2 million for test kits and 1,991,800 for the support activities.","The HTS test kits have a gap of $21.2 million (after the allocation request). Additional funding is sought to support HTS services including review and update of HTS training materials; printing of revised HTS tools to complement PEPFAR support; support for quarterly performance review meetings at national level; finalize the HTS certification framework; Conduct routine QC; Quarterly support supervision visits to HTS points; and HTS outreaches in safe places and hard-to-reach settings such as fishing communities.  This request includes $21.2 million for test kits and 1,991,800 for the support activities.","NA Original Intervention: HTS quality improvement","Medium","23240688","The HTS test kits have a gap of US$21.2 million for 1.99 million people (after the allocation request). Additional funding is sought to support HTS services including review and update of HTS training materials; printing of revised HTS tools to complement PEPFAR support; support for quarterly performance review meetings at national level; finalize the HTS certification framework; conduct routine quality control; support quarterly supervision visits to HTS points; and HTS outreaches in safe places and hard-to-reach settings such as fishing communities. These interventions will extend the reach of HTS to the most vulnerable groups and enhance the quality of HTS.","0","11620344","0","0","11620344","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWQ/view",null,"TB/HIV",11620344," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713=AN2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713=AO2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713=AP2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713=AN2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713=AO2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713=AP2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2330)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJWVUA4","PAI-5893","Inactive","UKR-TB/HIV-1","2017-2019","RT Eastern Europe and Central Asia","Ukraine","HIV/TB","HIV/AIDS, Tuberculosis","FR100-UKR-C",null,null,"MDR-TB","Case detection and diagnosis: MDR-TB","TB case detection and diagnosis among general population in Non-Government Controlled Areas (NGCA) Donetsk and Luhansk. It is planned to cover about 3,800 additional MDR-TB cases implementing rapid testing. In addition, a total of 3,100 Xpert cartridges will be procured (1,800 for Donetsk and 1,300 for Luhansk).","TB case detection and diagnosis among general population in Non-Government Controlled Areas (NGCA) Donetsk and Luhansk. It is planned to cover about 3,800 additional MDR-TB cases implementing rapid testing. In addition, a total of 3,100 Xpert cartridges will be procured (1,800 for Donetsk and 1,300 for Luhansk).","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear Original Module: Multidrug-resistant TB","High","220643","This is considered a high priority and if possible should be moved to within allocation.","220643","0","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWV/view","2020-12-31","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713=AN2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713=AO2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713=AP2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713=AN2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713=AO2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713=AP2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2335)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJWaUAO","PAI-5898","Active","UKR-TB/HIV-14","2017-2019","RT Eastern Europe and Central Asia","Ukraine","HIV/TB","HIV/AIDS, Tuberculosis","FR100-UKR-C",null,null,"RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","1. Improving technical capacity of the laboratories2. Developing  technical compliance and biological safety and security.3. Building of 4 regional reference centers (This was considered as low priority by TRP).4. Capacity building and support to the national surveillance system.","1. Improving technical capacity of the laboratories2. Developing  technical compliance and biological safety and security.3. Building of 4 regional reference centers (This was considered as low priority by TRP).4. Capacity building and support to the national surveillance system.","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear Original Module: RSSH - Integrated service delivery and quality improvement","High","11317522","1. Improving technical capacity of the laboratories. 2. Development of technical compliance and biological safety and security. 3. Buildings of 4 regional reference centres. (* This is considered as low priority) 4. Capacity building and support to the national surveillance system.","0","0","0","0","11317522","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWa/view","2020-12-31","TB/HIV",11317522," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713=AN2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713=AO2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713=AP2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713=AN2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713=AO2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713=AP2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2340)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJWfUAO","PAI-5903","Inactive","UKR-TB/HIV-6","2017-2019","RT Eastern Europe and Central Asia","Ukraine","HIV/TB","HIV/AIDS, Tuberculosis","FR100-UKR-C",null,null,"Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","The PAAR funds are requested for creation of integrated centers providing services based on community and safe places (centers of social and medical care). Extended package for specific subgroups and needs, including HBV testing, vaccination, STI testing procurement. Also, the Project includes essential package on prevention and case-finding for NGCA Donetsk and Luhansk as well as communication materials. The PAAR request also includes 50% of SW outreach package funding in 2019 and 80% in 2020 for piloting Social Impact Bond as described under Module 2.2. above.","The PAAR funds are requested for creation of integrated centers providing services based on community and safe places (centers of social and medical care). Extended package for specific subgroups and needs, including HBV testing, vaccination, STI testing procurement. Also, the Project includes essential package on prevention and case-finding for NGCA Donetsk and Luhansk as well as communication materials. The PAAR request also includes 50% of SW outreach package funding in 2019 and 80% in 2020 for piloting Social Impact Bond as described under Module 2.2. above.","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear","High","1637084","The essential package of services component for NGCA Donetsk and Luhansk is considered a high priority and if possible should be moved to within allocation .","1637084","0","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWf/view","2020-12-31","TB/HIV",0," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713=AN2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713=AO2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713=AP2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713=AN2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713=AO2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713=AP2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2345)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJWgUAO","PAI-5904","Active","UKR-TB/HIV-7","2017-2019","RT Eastern Europe and Central Asia","Ukraine","HIV/TB","HIV/AIDS, Tuberculosis","FR100-UKR-C",null,null,"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","The intervention covers HIV rapid test kits as well as procurement of condoms and lubricants for NGCA in Donetsk and Luhansk. The intervention will improve HIV prevention and detection in NGCA.","The intervention covers HIV rapid test kits as well as procurement of condoms and lubricants for NGCA in Donetsk and Luhansk. The intervention will improve HIV prevention and detection in NGCA.","on 29/01/2018, the intervention was resent to the CT for valadition, because the grant is not clear","High","5154","The support for HIV rapid test kits for NGCA Donetsk and Luhansk is considered a high priority and if possible should be moved to within allocation","0","0","0","0","5154","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWg/view","2020-12-31","TB/HIV",5154," Eastern Europe and Central Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713=AN2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713=AO2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713=AP2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713=AN2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713=AO2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713=AP2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2346)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJWlUAO","PAI-5909","Inactive","UZB-HIV/AIDS-11","2017-2019","RT Eastern Europe and Central Asia","Uzbekistan","HIV/AIDS","HIV/AIDS","FR490-UZB-H",null,null,"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Encouraging packages to attract vulnerable groups to HIV testing (for testing 800 MSM).","Encouraging packages to attract vulnerable groups to HIV testing (for testing 800 MSM).","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Medium","16800",null,"16800","0","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWl/view","2021-06-30","HIV/AIDS",0," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713=AN2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713=AO2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713=AP2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713=AN2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713=AO2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713=AP2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2351)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJWqUAO","PAI-5914","Inactive","UZB-HIV/AIDS-6","2017-2019","RT Eastern Europe and Central Asia","Uzbekistan","HIV/AIDS","HIV/AIDS","FR490-UZB-H",null,null,"RSSH: Health management information systems and M&E","Surveys","Conduction of IBSS will allow in the dynamics to monitor the HIV epidemic process trends and their relationship to risky behavior among key populations, and will provide necessary information to take informed decisions when formulating strategies for combating HIV infection.","Conduction of IBSS will allow in the dynamics to monitor the HIV epidemic process trends and their relationship to risky behavior among key populations, and will provide necessary information to take informed decisions when formulating strategies for combating HIV infection.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","188864",null,"188864","0","0","0","0","1","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWq/view","2021-06-30","HIV/AIDS",0," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713=AN2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713=AO2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713=AP2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713=AN2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713=AO2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713=AP2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2356)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJWvUAO","PAI-5919","Active","VNM-HIV/AIDS-10","2017-2019","RT High Impact Asia","Viet Nam","HIV/AIDS","HIV/AIDS","FR100-VNM-H",null,null,"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Currently, there are more than 100,000 prisoners detained in more than 100 prisons managed by the Ministry of Public Security. Female offenders account for about 11% of the total number of detainees. Approximately 30% of prisoners have a history of drug abuse and other infectious diseases such as hepatitis, tuberculosis and HIV and services for HIV infected people in closed settings remain limited. Delivering HIV services including prevention, counselling, and care and treatment in closed settings face challenges including limited funding and a lack of facilities. Health staffs are few in number, with low capacity to deliver HIV services and little chance to exchange or update new knowledge. The Ministry of Public Security currently manages HIV prevention, care and treatment activities at 54 prisons in 63 provinces and cities, of which 32 are supported by the Global Fund. In the near future, prisons will implement MMT. The police force plays an important role in supporting HIV prevention interventions in the community. In the 2018-2020 allocation period, VAAC requests Global Fund support for the following activities: i. Training for medical staff working in detention centres, prisons, medical facilities in the police force on HIV prevention and harm reduction, counselling, testing, and treatment and care (2018). ii. Training for police officers belonging to the criminal police, drug and crime prevention police, social order police in HIV harm reduction interventions (2019- 2020) These interventions will provide capacity building for health workers in custody and health facilities in HIV prevention, counselling, and care and treatment activities; as well as assist the medical staff in the implementation of HIV prevention interventions in prisons and in the community.","Currently, there are more than 100,000 prisoners detained in more than 100 prisons managed by the Ministry of Public Security. Female offenders account for about 11% of the total number of detainees. Approximately 30% of prisoners have a history of drug abuse and other infectious diseases such as hepatitis, tuberculosis and HIV and services for HIV infected people in closed settings remain limited. Delivering HIV services including prevention, counselling, and care and treatment in closed settings face challenges including limited funding and a lack of facilities. Health staffs are few in number, with low capacity to deliver HIV services and little chance to exchange or update new knowledge. The Ministry of Public Security currently manages HIV prevention, care and treatment activities at 54 prisons in 63 provinces and cities, of which 32 are supported by the Global Fund. In the near future, prisons will implement MMT. The police force plays an important role in supporting HIV prevention interventions in the community. In the 2018-2020 allocation period, VAAC requests Global Fund support for the following activities: i. Training for medical staff working in detention centres, prisons, medical facilities in the police force on HIV prevention and harm reduction, counselling, testing, and treatment and care (2018). ii. Training for police officers belonging to the criminal police, drug and crime prevention police, social order police in HIV harm reduction interventions (2019- 2020) These interventions will provide capacity building for health workers in custody and health facilities in HIV prevention, counselling, and care and treatment activities; as well as assist the medical staff in the implementation of HIV prevention interventions in prisons and in the community.","NA Original Intervention: Training for health staff in prisons","High","363080","Prison populations are at high risk of HIV and therefore prevention programs are vital in this area. Training of staff and police to facilitate prevention and harm reduction strategies is very appropriate.","279153","0","0","0","83927","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWv/view","2020-12-31","HIV/AIDS",83927," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713=AN2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713=AO2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713=AP2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713=AN2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713=AO2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713=AP2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2361)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJWwUAO","PAI-5920","Active","VNM-HIV/AIDS-11","2017-2019","RT High Impact Asia","Viet Nam","HIV/AIDS","HIV/AIDS","FR100-VNM-H",null,null,"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","With above allocation funding, VUSTA proposes to extend the coverage of PWID reached with the defined package of prevention and harm reduction services. Activities will still focus on Hanoi, Thai Nguyen, Hai Duong, Vinh Phuc, Nam Dinh, and Ho Chi Minh City. With above allocation funding VUSTA will reach the following number of additional PWID: 2018: 7,247 2019: 7,747 2020: 8,147 Of those reached with prevention services, 75% will also be referred for HTS by 2020.","With above allocation funding, VUSTA proposes to extend the coverage of PWID reached with the defined package of prevention and harm reduction services. Activities will still focus on Hanoi, Thai Nguyen, Hai Duong, Vinh Phuc, Nam Dinh, and Ho Chi Minh City. With above allocation funding VUSTA will reach the following number of additional PWID: 2018: 7,247 2019: 7,747 2020: 8,147 Of those reached with prevention services, 75% will also be referred for HTS by 2020.","NA Original Module: Comprehensive prevention programs for key populations. Original Intervention: People who inject drugs activities","High","576523","Extended coverage of prevention for people who inject drugs is of high priority if funding allows.","0","0","0","0","576523","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJWw/view","2020-12-31","HIV/AIDS",576523," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713=AN2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713=AO2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713=AP2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713=AN2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713=AO2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713=AP2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2362)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJX0UAO","PAI-5924","Active","VNM-HIV/AIDS-15","2017-2019","RT High Impact Asia","Viet Nam","HIV/AIDS","HIV/AIDS","FR100-VNM-H",null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Targets for sub-national coverage of HIV services are currently set at the central level. Sometime, the provincial agencies feel that these targets are not realistic. There is a need for province and district level agencies to be involved in the development of ambitious but realistic targets for HIV service delivery. These targets will then be shared with district-level authorities for their consensus. Once consensus has been reached, the province and district level agencies can develop a plan to achieve their targets, which will then be submitted to the CPMU for approval. In above allocation, support is requested in each of the 32 Global Fund-focus provinces for the following: i. Technical assistance for PPAC to develop relevant and realistic target; ii. 1 x workshop between province and district level agencies to finalise the targets; and iii. Technical assistance to develop a plan to reach the targets.","Targets for sub-national coverage of HIV services are currently set at the central level. Sometime, the provincial agencies feel that these targets are not realistic. There is a need for province and district level agencies to be involved in the development of ambitious but realistic targets for HIV service delivery. These targets will then be shared with district-level authorities for their consensus. Once consensus has been reached, the province and district level agencies can develop a plan to achieve their targets, which will then be submitted to the CPMU for approval. In above allocation, support is requested in each of the 32 Global Fund-focus provinces for the following: i. Technical assistance for PPAC to develop relevant and realistic target; ii. 1 x workshop between province and district level agencies to finalise the targets; and iii. Technical assistance to develop a plan to reach the targets.","NA Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Sub-national target setting","Medium","610976","The TRP considers this to be a medium priority as decentralization occurs so that provinces and districts can take ownership for their data and targets. Half of the amount is proposed, to make sure there is a match and national ownership.","0","0","0","0","610976","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJX0/view","2020-12-31","HIV/AIDS",610976," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713=AN2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713=AO2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713=AP2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713=AN2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713=AO2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713=AP2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2366)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJX7UAO","PAI-5931","Active","VNM-HIV/AIDS-21","2017-2019","RT High Impact Asia","Viet Nam","HIV/AIDS","HIV/AIDS","FR100-VNM-H",null,null,"PMTCT","Other intervention(s) for PMTCT","Following WHO recommendation for triple elimination, VAAC proposes to pilot triple HIVsyphilis-HBV testing among pregnant women in three provinces that indicate high prevalence of at least two of the three diseases. Triple test will be offer free of charge at ANC as early as possible. Women who are identified to be infected with any of the three infection and their infants will receive treatment as indicated, including ARV, penicillin and/or HBV vaccination. Certain health care workers will be trained on service implementation and data collection and reporting. VAAC propose to demonstrate the integration of syphilis and HBV to MNCH care package at all ANC levels reaching 85% of pregnant women in six districts in three provinces in 2018. In 2019 and 2020, 95% of pregnant women in 9 districts (the same six districts form 2018 + three new districts) will be offered the triple test. Results from this pilot will inform the National Triple Elimination Policy with a view to nation-wide rollout.","Following WHO recommendation for triple elimination, VAAC proposes to pilot triple HIVsyphilis-HBV testing among pregnant women in three provinces that indicate high prevalence of at least two of the three diseases. Triple test will be offer free of charge at ANC as early as possible. Women who are identified to be infected with any of the three infection and their infants will receive treatment as indicated, including ARV, penicillin and/or HBV vaccination. Certain health care workers will be trained on service implementation and data collection and reporting. VAAC propose to demonstrate the integration of syphilis and HBV to MNCH care package at all ANC levels reaching 85% of pregnant women in six districts in three provinces in 2018. In 2019 and 2020, 95% of pregnant women in 9 districts (the same six districts form 2018 + three new districts) will be offered the triple test. Results from this pilot will inform the National Triple Elimination Policy with a view to nation-wide rollout.","NA Original Module: Prevention of mother-to-child transmission. Original Intervention: Pilot HIV-syphilis-Hepatitis B testing among pregnant women","Low","711944","The TRP does not believe this to be a high priority. Testing for HIV and syphilis is already being done.","0","0","0","0","711944","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJX7/view","2020-12-31","HIV/AIDS",711944," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713=AN2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713=AO2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713=AP2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713=AN2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713=AO2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713=AP2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2373)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXCUA4","PAI-5936","Active","VNM-HIV/AIDS-26","2017-2019","RT High Impact Asia","Viet Nam","HIV/AIDS","HIV/AIDS","FR100-VNM-H",null,null,"Programs to reduce human rights-related barriers to HIV services","Other intervention(s) to reduce human rights-related barriers to HIV services","Information and sensitization programs for legal aid providers on critical health and human rights aspects of HIV response, with emphasis on those that pertain to key populations.","Information and sensitization programs for legal aid providers on critical health and human rights aspects of HIV response, with emphasis on those that pertain to key populations.","NA Original Intervention: Sensitization of lawmakers and law enforcement agents","Low","12488","Low priority which could be covered from existing funds.","0","0","0","0","12488","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXC/view","2020-12-31","HIV/AIDS",12488," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713=AN2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713=AO2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713=AP2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713=AN2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713=AO2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713=AP2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2378)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXDUA4","PAI-5937","Active","VNM-HIV/AIDS-27","2017-2019","RT High Impact Asia","Viet Nam","HIV/AIDS","HIV/AIDS","FR100-VNM-H",null,null,"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Facilitate meetings among key CBOs, VNGOs and local stakeholders to review progress of CBO's outreach activities, and discuss about challenges/barriers, needs for further support and improvement. Organize community events through small grants to CBOs to mobilize and encourage active lifestyles for KP.","Facilitate meetings among key CBOs, VNGOs and local stakeholders to review progress of CBO's outreach activities, and discuss about challenges/barriers, needs for further support and improvement. Organize community events through small grants to CBOs to mobilize and encourage active lifestyles for KP.","NA Original Module: RSSH - Community responses and systems","Low","44131","There should be room to fund this within other activities.","0","0","0","0","44131","0","0","2019-10-30 15:35:00","2019-10-30 15:34:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXD/view","2020-12-31","HIV/AIDS",44131," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713=AN2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713=AO2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713=AP2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713=AN2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713=AO2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713=AP2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2379)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXIUA4","PAI-5942","Active","VNM-HIV/AIDS-31","2017-2019","RT High Impact Asia","Viet Nam","HIV/AIDS","HIV/AIDS","FR589-VNM-H",null,null,"Comprehensive prevention programs for MSM","Behavioral interventions for MSM","Due to the preference for anonymity when it comes to accessing healthcare, communication through social media and technology is essential to provide HIV prevention information to MSM. The Global Fund is requested to support communication on HIV prevention for MSM, HIV/HCV (Hep-C Virus) co-infection and Sexually Transmitted Infection (STI).","Due to the preference for anonymity when it comes to accessing healthcare, communication through social media and technology is essential to provide HIV prevention information to MSM. The Global Fund is requested to support communication on HIV prevention for MSM, HIV/HCV (Hep-C Virus) co-infection and Sexually Transmitted Infection (STI).","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Behavioral interventions for men who have sex with men","Medium","1e+05",null,"0","0","0","0","1e+05","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXI/view","2020-12-31","HIV/AIDS",100000," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713=AN2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713=AO2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713=AP2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713=AN2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713=AO2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713=AP2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2384)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXNUA4","PAI-5947","Active","VNM-HIV/AIDS-8","2017-2019","RT High Impact Asia","Viet Nam","HIV/AIDS","HIV/AIDS","FR100-VNM-H",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Buprenorphine results in fewer adverse effects than methadone, especially among ART patients, and enables less frequent clinic visits and allows take-home doses (weekly, then once every few weeks or every month). This offers a considerable advantage in promoting adherence, particularly in remote areas, where an estimated 50% of PWID live (REF). Two pharmaceutical companies have imported buprenorphine raw material but it will take two to three years for the domestic supply to reach the market. In 2016, adherence among MMT clients was lower in remote and mountainous areas (50-80%) compared with urban areas (97%)(REF). In remote areas, villages may be located up to 150km away from the commune where the MMT clinic is located, making it very challenging to maintain treatment. As such, many clients stop treatment after only one or two months. The introduction of buprenorphine is likely to promote better adherence among PWID living in these areas. In order to assess the suitability of buprenorphine in the Vietnam context and with Global Fund support, VAAC proposes to introduce buprenorphine as a drug treatment option of heroin-addicted PWID in three to five remote areas where daily access to health clinicsis challenging (12 months to end 2018). The Ministry of Health has asked pharmaceutical companies to produce buprenorphine domestically. Two pharmaceutical companies have imported buprenorphine raw material but it will take two to three years for the domestic supply to reach the market. As such, Global Fund support is still required for the introductory phase. From 2020, Vietnam can allocate national budget to procure buprenorphine, using funds that have already been earmarked for OST for the 2016-2020 period. Procurement of buprenorphine for 2,000patients per year for three years is requested to support this transition period.","Buprenorphine results in fewer adverse effects than methadone, especially among ART patients, and enables less frequent clinic visits and allows take-home doses (weekly, then once every few weeks or every month). This offers a considerable advantage in promoting adherence, particularly in remote areas, where an estimated 50% of PWID live (REF). Two pharmaceutical companies have imported buprenorphine raw material but it will take two to three years for the domestic supply to reach the market. In 2016, adherence among MMT clients was lower in remote and mountainous areas (50-80%) compared with urban areas (97%)(REF). In remote areas, villages may be located up to 150km away from the commune where the MMT clinic is located, making it very challenging to maintain treatment. As such, many clients stop treatment after only one or two months. The introduction of buprenorphine is likely to promote better adherence among PWID living in these areas. In order to assess the suitability of buprenorphine in the Vietnam context and with Global Fund support, VAAC proposes to introduce buprenorphine as a drug treatment option of heroin-addicted PWID in three to five remote areas where daily access to health clinicsis challenging (12 months to end 2018). The Ministry of Health has asked pharmaceutical companies to produce buprenorphine domestically. Two pharmaceutical companies have imported buprenorphine raw material but it will take two to three years for the domestic supply to reach the market. As such, Global Fund support is still required for the introductory phase. From 2020, Vietnam can allocate national budget to procure buprenorphine, using funds that have already been earmarked for OST for the 2016-2020 period. Procurement of buprenorphine for 2,000patients per year for three years is requested to support this transition period.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","High","4514000","While this is expensive, the TRP believes that providing buprenorphine would be catalytic funding to diversify options of OST as the country transitions to domestic provision of OST programs and with local production of generic versions of buprenorphine in the pipeline.","3913037","0","0","0","600963","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXN/view","2020-12-31","HIV/AIDS",600963," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713=AN2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713=AO2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713=AP2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713=AN2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713=AO2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713=AP2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2389)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXSUA4","PAI-5952","Active","VNM-Tuberculosis-12","2017-2019","RT High Impact Asia","Viet Nam","Tuberculosis","Tuberculosis","FR100-VNM-T",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","The elderly in Vietnam have a high prevalence of TB. According to the TIME model, about 10,000 elderly cases can be detected with large scale ACF. The PAAR will provide screening for 6000 elderly in community, 2000 in mental health institutions, and 2000 in in some social protection centers in 0seven provinces per year using CXR and Xpert . PAAR will also support workshops to improve awareness of TB among the elderly.","The elderly in Vietnam have a high prevalence of TB. According to the TIME model, about 10,000 elderly cases can be detected with large scale ACF. The PAAR will provide screening for 6000 elderly in community, 2000 in mental health institutions, and 2000 in in some social protection centers in 0seven provinces per year using CXR and Xpert . PAAR will also support workshops to improve awareness of TB among the elderly.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Intervention: Key populations - Elderly","High","316820","To support screening for 10,000 elderly people.","0","0","0","0","316820","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXS/view","2020-12-31","Tuberculosis",316820," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713=AN2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713=AO2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713=AP2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713=AN2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713=AO2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713=AP2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2394)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXTUA4","PAI-5953","Active","VNM-Tuberculosis-13","2017-2019","RT High Impact Asia","Viet Nam","Tuberculosis","Tuberculosis","FR100-VNM-T",null,null,"TB/HIV","TB/HIV collaborative interventions","The current allocation amount covers 30,000 Xpert tests in 2018, 35,000 tests in 2019, and 50,000 tests in 2020. The PAAR will provide 20,000 additional tests in 2018, 25,000 tests in 2019, and 40,000 tests in 2020. PAAR scale-up of TB screening 5000 newly detected HIV patients per year. (Current allocation for the 2018-2020 period is 37,000 patients)\\ - Additional PAAR-supported costs are:  TB/HIV training for TB and HIV staff  Conference and training on ARV and CPT, including monitoring for HIV positive TB patients  Reagents, consumables, and test kit supplies to maintain LF-LAM in 2020.","The current allocation amount covers 30,000 Xpert tests in 2018, 35,000 tests in 2019, and 50,000 tests in 2020. The PAAR will provide 20,000 additional tests in 2018, 25,000 tests in 2019, and 40,000 tests in 2020. PAAR scale-up of TB screening 5000 newly detected HIV patients per year. (Current allocation for the 2018-2020 period is 37,000 patients)\\ - Additional PAAR-supported costs are:  TB/HIV training for TB and HIV staff  Conference and training on ARV and CPT, including monitoring for HIV positive TB patients  Reagents, consumables, and test kit supplies to maintain LF-LAM in 2020.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used.","High","688328","Adds screening for 5 ,000 newly diagnosed HIV cases per year.","0","0","0","0","688328","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXT/view","2020-12-31","Tuberculosis",688328," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713=AN2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713=AO2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713=AP2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713=AN2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713=AO2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713=AP2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2395)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXYUA4","PAI-5958","Active","VNM-Tuberculosis-18","2017-2019","RT High Impact Asia","Viet Nam","Tuberculosis","Tuberculosis","FR100-VNM-T",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Procurement of 400 computers and printers for VITIMES/ ETB Manager implementation and two training courses per year for PPM facilities delivering TB services.","Procurement of 400 computers and printers for VITIMES/ ETB Manager implementation and two training courses per year for PPM facilities delivering TB services.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Module: RSSH - Health management information system and monitoring and evaluation","Medium","283264","Procurement of 400 computers and printers for VITIMES/E -TB managers and two training courses per year for PPM facilities","0","0","0","0","283264","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXY/view","2020-12-31","Tuberculosis",283264," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713=AN2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713=AO2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713=AP2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713=AN2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713=AO2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713=AP2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2400)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXdUAO","PAI-5963","Active","VNM-Tuberculosis-22","2017-2019","RT High Impact Asia","Viet Nam","Tuberculosis","Tuberculosis","FR100-VNM-T",null,null,"TB care and prevention","Treatment","Scaling up mHEalthin four provinces and piloting mHealth for MDR-TB - Renovating to improve TBIC for five TB/HIV patient care facilities per year and training in TBIC for general hospital and prison staff.","Scaling up mHEalthin four provinces and piloting mHealth for MDR-TB - Renovating to improve TBIC for five TB/HIV patient care facilities per year and training in TBIC for general hospital and prison staff.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used.","Low","424820","Scaling up eHealth and mHealth interventions for MDR TB along with renovation and training for TB infection control. Given competing priorities this is given a lower priority.","0","0","0","0","424820","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXd/view","2020-12-31","Tuberculosis",424820," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713=AN2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713=AO2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713=AP2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713=AN2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713=AO2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713=AP2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2405)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXiUAO","PAI-5968","Active","VNM-Tuberculosis-5","2017-2019","RT High Impact Asia","Viet Nam","Tuberculosis","Tuberculosis","FR100-VNM-T",null,null,"RSSH: Health management information systems and M&E","Analysis, review and transparency","The goals of the NSP is to apply/use innovative approach for TB detection and management. For effective implementation of innovative methods, studies, reviews and assessment are needed including: - Survey of TB prevalence among diabetes patients - Evaluation of backto-back service provision for TB/HIV, diagnosis of TB using induced sputum in patents who do not have productive cough or who are smear negative through a randomized controlled clinical trial.","The goals of the NSP is to apply/use innovative approach for TB detection and management. For effective implementation of innovative methods, studies, reviews and assessment are needed including: - Survey of TB prevalence among diabetes patients - Evaluation of backto-back service provision for TB/HIV, diagnosis of TB using induced sputum in patents who do not have productive cough or who are smear negative through a randomized controlled clinical trial.","Grant sign off form indicates that they refer to the TRP review and recommendation form for PAAR activities so the same amounts and descriptions have been used. Original Module: RSSH - Health management information system and monitoring and evaluation","High","298591","This includes additional research for example determining TB prevalence amongst diabetics. This can be included in research activities already incorporated in the allocation.","0","0","0","0","298591","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXi/view","2020-12-31","Tuberculosis",298591," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713=AN2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713=AO2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713=AP2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713=AN2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713=AO2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713=AP2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2410)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJXnUAO","PAI-5973","Active","XKX-HIV/AIDS-1","2017-2019","RT Eastern Europe and Central Asia","Kosovo","HIV/AIDS","HIV/AIDS","FR265-QNA-H",null,null,"Comprehensive prevention programs for MSM","HIV testing services for MSM","Given limited amount allocated to HIV prevention services among MSM in the grant, additional funds will be used to expand VCT delivered by NGOs. It will help to attain targets set.","Given limited amount allocated to HIV prevention services among MSM in the grant, additional funds will be used to expand VCT delivered by NGOs. It will help to attain targets set.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: HIV testing services for men who have sex with men","High","24522.5","Any additional resources for men who have sex with (MSM) programs will be primarily used for increasing HIV counselling and testing by nongovernment organizations (NGO), medical staff, as well as through outreach workers. This will contribute to attaining the targets, as it will be difficult to do so with the limited number of staff and volunteers financed through the within-allocation amount.","0","0","0","0","24522.5","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXn/view","2020-12-31","HIV/AIDS",24522.5," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713=AN2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713=AO2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713=AP2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713=AN2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713=AO2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713=AP2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2415)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2020-12-31"]
["a6Q1R000000AJXpUAO","PAI-5975","Inactive","XKX-HIV/AIDS-11","2017-2019","RT Eastern Europe and Central Asia","Kosovo","HIV/AIDS","HIV/AIDS","FR265-QNA-H",null,null,"RSSH: Community responses and systems","Social mobilization, building community linkages, collaboration and coordination","Additional funds will be used to conduct additional advocacy activities at local level in support of enabling environments for service delivery among KAPs.","Additional funds will be used to conduct additional advocacy activities at local level in support of enabling environments for service delivery among KAPs.","NA Original Module: RSSH - Community responses and systems","High","33666.26","In addition to already supported advocacy activities within the allocation, additional funds will be used to conduct additional advocacy activities at local level in support of enabling environments for key population (KP) service delivery","0","33666.26","0","0","0","1","0","2020-02-06 10:56:28","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXp/view","2020-12-31","HIV/AIDS",0," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713=AN2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713=AO2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713=AP2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713=AN2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713=AO2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713=AP2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2417)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2020-12-31"]
["a6Q1R000000AJXuUAO","PAI-5980","Inactive","XKX-HIV/AIDS-16","2017-2019","RT Eastern Europe and Central Asia","Kosovo","HIV/AIDS","HIV/AIDS","FR265-QNA-H",null,null,"RSSH: Human resources for health (HRH), including community health workers","Capacity building for health workers, including those at community level","Additional funds will be used to support HIV related trainings for outreach and medical workers who work with PWIDs, MSM, SW: this will strengthen the continuum of care and collaboration between civil society and government healthcare providers.","Additional funds will be used to support HIV related trainings for outreach and medical workers who work with PWIDs, MSM, SW: this will strengthen the continuum of care and collaboration between civil society and government healthcare providers.","NA Original Module: RSSH - Human resources for health, including community health workers","High","20603.75","Additional funds will be used to support HIV related trainings for outreach and medical workers who work with people who inject drugs (PWIDs), men who have sex with men (MSM), sex workers (SW): this will strengthen the continuum of care and collaboration between civil society and government health-care providers","0","20603.75","0","0","0","1","0","2020-02-06 10:56:28","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXu/view","2020-12-31","HIV/AIDS",0," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713=AN2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713=AO2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713=AP2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713=AN2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713=AO2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713=AP2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2422)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2020-12-31"]
["a6Q1R000000AJXzUAO","PAI-5985","Active","XKX-HIV/AIDS-4","2017-2019","RT Eastern Europe and Central Asia","Kosovo","HIV/AIDS","HIV/AIDS","FR265-QNA-H",null,null,"Comprehensive prevention programs for sex workers and their clients","Behavioral interventions for sex workers","Given limited amount allocated to HIV prevention services among sex workers in the grant, these additional resources will be used for additional outreach workers and peer educators. It will help to attain targets set.","Given limited amount allocated to HIV prevention services among sex workers in the grant, these additional resources will be used for additional outreach workers and peer educators. It will help to attain targets set.",null,"High","10099.88","These additional resources for Sex Worker programs will be used for additional outreach workers and Peer educators beyond the withinallocation amount: this will contribute to attaining the targets, as it will be difficult to do so with the limited number of staff and volunteers financed through the within-allocation amount.","0","0","0","0","10099.88","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJXz/view","2020-12-31","HIV/AIDS",10099.879999999999," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713=AN2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713=AO2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713=AP2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713=AN2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713=AO2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713=AP2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2427)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2020-12-31"]
["a6Q1R000000AJY0UAO","PAI-5986","Active","XKX-HIV/AIDS-5","2017-2019","RT Eastern Europe and Central Asia","Kosovo","HIV/AIDS","HIV/AIDS","FR265-QNA-H",null,null,"Comprehensive prevention programs for sex workers and their clients","HIV testing services for sex workers","Additional funds for sex workers programmes will be used for increasing HIV counselling and testing in medical facilities includes, by providing incentives for sex workers to get tested.","Additional funds for sex workers programmes will be used for increasing HIV counselling and testing in medical facilities includes, by providing incentives for sex workers to get tested.",null,"High","11429.69","HIV testing in medical facilities: These additional resources for sex worker programs will be used for increasing HIV counselling and testing beyond the within-allocation amount. Costs for HIV testing in medical facilities includes the cost of incentives for sex workers to get tested.","0","0","0","0","11429.69","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJY0/view","2020-12-31","HIV/AIDS",11429.69," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713=AN2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713=AO2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713=AP2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713=AN2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713=AO2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713=AP2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2428)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2020-12-31"]
["a6Q1R000000AJY5UAO","PAI-5991","Active","ZAF-TB/HIV-1","2017-2019","RT High Impact Africa 2","South Africa","HIV/TB","HIV/AIDS, Tuberculosis","FR427-ZAF-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Funding will allow to increase coverage of the AGYW program by 50% in the additional 6 sub-districts within the districts covered with the allocation amount. With above allocation funding, the program will reach an additional 82,967 AGYW with the comprehensive package, for total program coverage of 248,870 AGYW. This will increase district saturation from 12% with the allocation amount, to 18% with the PAAR added.","Funding will allow to increase coverage of the AGYW program by 50% in the additional 6 sub-districts within the districts covered with the allocation amount. With above allocation funding, the program will reach an additional 82,967 AGYW with the comprehensive package, for total program coverage of 248,870 AGYW. This will increase district saturation from 12% with the allocation amount, to 18% with the PAAR added.",null,"High","58491735",null,"0","0","0","0","58491735","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJY5/view","2022-03-31","TB/HIV",58491735," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713=AN2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713=AO2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713=AP2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713=AN2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713=AO2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713=AP2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2433)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJYAUA4","PAI-5996","Active","ZAF-TB/HIV-14","2017-2019","RT High Impact Africa 2","South Africa","HIV/TB","HIV/AIDS, Tuberculosis","FR427-ZAF-C",null,null,"Comprehensive prevention programs for people who inject drugs (PWID) and their partners","OST and other drug dependence treatment for PWID","Funding will support in placing an additional 500 drug users on OST. With the allocation amount, 300 people will be placed on OST by year three of the grant. If PAAR is granted, OST coverage will increase from 4% of PWID reached, to 10%. Note: This PAAR request is only for the OST procurement, since human resources for OST and site costs are provided for in the allocation request.","Funding will support in placing an additional 500 drug users on OST. With the allocation amount, 300 people will be placed on OST by year three of the grant. If PAAR is granted, OST coverage will increase from 4% of PWID reached, to 10%. Note: This PAAR request is only for the OST procurement, since human resources for OST and site costs are provided for in the allocation request.","NA Original Module: Comprehensive prevention programs for people who inject drugs and their partners. Original Intervention: Opioid substitution therapy and other drug dependence treatment for people who inject drugs","High","2602628",null,"0","0","0","0","2602628","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYA/view","2022-03-31","TB/HIV",2602628," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713=AN2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713=AO2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713=AP2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713=AN2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713=AO2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713=AP2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2438)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJYFUA4","PAI-6001","Active","ZAF-TB/HIV-19","2017-2019","RT High Impact Africa 2","South Africa","HIV/TB","HIV/AIDS, Tuberculosis","FR427-ZAF-C",null,null,"Comprehensive prevention programs for sex workers and their clients","Prevention and management of coinfections and co-morbidities for sex workers","PAAR investment will support in reaching 3,385 sex workers with in-patient alcohol and drug treatment programs (3% of sex workers reached through the allocation amount) in districts and sub-districts where referrals to these services are not possible since they are not available. A 2009 study among sex workers in Pretoria found that 3% of SW tried but were unable to enter alcohol and drug treatment programs in the past year (Wechsberg et al., 2009).","PAAR investment will support in reaching 3,385 sex workers with in-patient alcohol and drug treatment programs (3% of sex workers reached through the allocation amount) in districts and sub-districts where referrals to these services are not possible since they are not available. A 2009 study among sex workers in Pretoria found that 3% of SW tried but were unable to enter alcohol and drug treatment programs in the past year (Wechsberg et al., 2009).","NA Original Intervention: Prevention and management of co-infections and co-morbidities for sex workers","Low","3934721",null,"0","0","0","0","3934721","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYF/view","2022-03-31","TB/HIV",3934721," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713=AN2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713=AO2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713=AP2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713=AN2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713=AO2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713=AP2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2443)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJYGUA4","PAI-6002","Inactive","ZAF-TB/HIV-2","2017-2019","RT High Impact Africa 2","South Africa","HIV/TB","HIV/AIDS, Tuberculosis","FR427-ZAF-C",null,null,"TB/HIV","TB/HIV collaborative interventions","This additional funding will support the roll out of 3HP for people living with HIV and household contacts of TB patients. 6% of the total country need is covered by the allocation request, with the PAAR filling the rest of the national request (20% of total national projected need). This total investment (main allocation and PAAR) will avert 9,159 TB cases.","This additional funding will support the roll out of 3HP for people living with HIV and household contacts of TB patients. 6% of the total country need is covered by the allocation request, with the PAAR filling the rest of the national request (20% of total national projected need). This total investment (main allocation and PAAR) will avert 9,159 TB cases.",null,"High","12486210",null,"12486210","0","0","0","0","1","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYG/view","2022-03-31","TB/HIV",0," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713=AN2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713=AO2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713=AP2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713=AN2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713=AO2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713=AP2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2444)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJYLUA4","PAI-6007","Active","ZAF-TB/HIV-24","2017-2019","RT High Impact Africa 2","South Africa","HIV/TB","HIV/AIDS, Tuberculosis","FR427-ZAF-C",null,null,"Programs to reduce human rights-related barriers to HIV services","Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity","This PAAR request is for technical and operational support to the Department of Women to complete the development of the National Strategic Plan for Gender Based Violence. A process to develop this plan has been started, but the human rights baseline assessment notes that a stalemate has been reached between civil society and the relevant governmental department. As such, implementing this activity is dependent on successful advocacy within the program to enable the process of developing the plan to continue.","This PAAR request is for technical and operational support to the Department of Women to complete the development of the National Strategic Plan for Gender Based Violence. A process to develop this plan has been started, but the human rights baseline assessment notes that a stalemate has been reached between civil society and the relevant governmental department. As such, implementing this activity is dependent on successful advocacy within the program to enable the process of developing the plan to continue.",null,"Low","4e+05",null,"0","0","0","0","4e+05","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYL/view","2022-03-31","TB/HIV",400000," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713=AN2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713=AO2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713=AP2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713=AN2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713=AO2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713=AP2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2449)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJYQUA4","PAI-6012","Active","ZAF-TB/HIV-7","2017-2019","RT High Impact Africa 2","South Africa","HIV/TB","HIV/AIDS, Tuberculosis","FR427-ZAF-C",null,null,"TB care and prevention","Community TB care delivery","Funding will support expansion of the TB screening and testing services in facilities and community hot spots by supporting fee-for-service agreements for 264,000 digital chest x-rays and 66,000 Xpert tests. This will catalyze the impact of both the allocation (in facilities) and the matching funds request (in community hot spots), to find an estimated additional 5,280 missing TB patients.","Funding will support expansion of the TB screening and testing services in facilities and community hot spots by supporting fee-for-service agreements for 264,000 digital chest x-rays and 66,000 Xpert tests. This will catalyze the impact of both the allocation (in facilities) and the matching funds request (in community hot spots), to find an estimated additional 5,280 missing TB patients.",null,"High","5834695",null,"0","0","0","0","5834695","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYQ/view","2022-03-31","TB/HIV",5834695," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713=AN2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713=AO2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713=AP2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-03-31"},"2022-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713=AN2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713=AO2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713=AP2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2454)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-04-01"},"2022-03-31"]
["a6Q1R000000AJYVUA4","PAI-6017","Active","ZAN-Malaria-3","2017-2019","RT High Impact Africa 2","Zanzibar","Malaria","Malaria","FR377-QNB-M",null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","The installation of network infrastructure will support and strengthen procurement and supply chain activities.","The installation of network infrastructure will support and strengthen procurement and supply chain activities.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Procurement and supply chain management systems","High","1548","The installation of network infrastructure is considered a high priority by the TRP because it will support and strengthen procurement and supply chain activities which TRP considers are critical","0","0","0","0","1548","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYV/view","2020-12-31","Malaria",1548," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713=AN2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713=AO2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713=AP2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713=AN2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713=AO2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713=AP2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2459)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJYXUA4","PAI-6019","Active","ZAN-Malaria-5","2017-2019","RT High Impact Africa 2","Zanzibar","Malaria","Malaria","FR377-QNB-M",null,null,"RSSH: Health management information systems and M&E","Surveys","Data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","Data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: RSSH - Health management information system and monitoring and evaluation","High","51510","This activity is deemed quality demand as the data obtained through these surveys will serve to strengthen the program and provide a basis for evidence-based decision making.","0","0","0","0","51510","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYX/view","2020-12-31","Malaria",51510," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713=AN2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713=AO2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713=AP2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713=AN2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713=AO2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713=AP2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2461)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJYcUAO","PAI-6024","Active","ZAN-TB/HIV-1","2017-2019","RT High Impact Africa 2","Zanzibar","HIV/TB","HIV/AIDS, Tuberculosis","FR378-QNB-C",null,null,"Treatment, care and support","Treatment adherence","The intervention will fund treatment of opportunistic infections, toxicity monitoring and home-based care interventions in view of maintaining safety and efficacy of ART and improve survival and overall impact of ART scale up.","The intervention will fund treatment of opportunistic infections, toxicity monitoring and home-based care interventions in view of maintaining safety and efficacy of ART and improve survival and overall impact of ART scale up.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form","High","1029107","Treatment of opportunistic infections, toxicity monitoring and home-based care interventions are highly valuable interventions for maintaining safety and efficacy of ART and will improve survival and overall impact of ART scale up.","0","0","0","0","1029107","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYc/view","2020-12-31","TB/HIV",1029107," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713=AN2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713=AO2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713=AP2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713=AN2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713=AO2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713=AP2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2466)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJYhUAO","PAI-6029","Active","ZAN-TB/HIV-6","2017-2019","RT High Impact Africa 2","Zanzibar","HIV/TB","HIV/AIDS, Tuberculosis","FR378-QNB-C",null,null,"PMTCT","Prong 3: Preventing vertical HIV transmission","This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women.","This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women.","Form emailed by Will to me as its not on the site. UQD not included in Grant sign off form Original Module: Prevention of mother-to-child transmission","High","544241","This activity will enhance the overall impact of prevention of vertical transmission of HIV by including screening for two prevalent transmissible co-infections among pregnant women","0","0","0","0","544241","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYh/view","2020-12-31","TB/HIV",544241," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713=AN2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713=AO2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713=AP2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713=AN2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713=AO2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713=AP2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2471)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJYmUAO","PAI-6034","Active","ZMB-Malaria-2","2017-2019","RT High Impact Africa 2","Zambia","Malaria","Malaria, RSSH","FR254-ZMB-Z",null,null,"Vector control","Other vector control measure(s)","This will complement the support for entomological surveillance to ensure quality and effectiveness of the vector control operations, particularly IRS.","This will complement the support for entomological surveillance to ensure quality and effectiveness of the vector control operations, particularly IRS.","NA Original Intervention: Entomological surveillance","High","1e+06","This will complement the support for entomological surveillance to ensure quality and effectiveness of the vector control operations, particularly IRS","1e+05","0","0","0","9e+05","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYm/view",null,"Multi-component",900000," High Impact Africa 2","Malaria, RSSH","Malaria"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713=AN2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713=AO2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713=AP2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713=AN2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713=AO2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713=AP2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2476)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJYnUAO","PAI-6035","Inactive","ZMB-Malaria-3","2017-2019","RT High Impact Africa 2","Zambia","Malaria","Malaria","FR575-ZMB-M",null,null,"Vector control","Indoor residual spraying (IRS)","The target number of structures in 2019 is 3,376,196 translating in estimated 14,585,167 people protected at an average of 4.32 persons per structure. For 2020 the target is 3,474,106 structures translating in 15,008,138 people protected.","The target number of structures in 2019 is 3,376,196 translating in estimated 14,585,167 people protected at an average of 4.32 persons per structure. For 2020 the target is 3,474,106 structures translating in 15,008,138 people protected.","NA Original Intervention: Indoor residual spraying","High","12437067","The proposed action is in line with the national strategic plan and vector control interventions for significant reduction in malaria by 2020.","0","12437067","0","0","0","1","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYn/view","2020-12-31","Malaria",0," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713=AN2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713=AO2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713=AP2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713=AN2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713=AO2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713=AP2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2477)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJYsUAO","PAI-6040","Active","ZMB-TB/HIV-11","2017-2019","RT High Impact Africa 2","Zambia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR257-ZMB-Z",null,null,"TB/HIV","TB/HIV collaborative interventions","Additional 100 Xpert machines, with related cartridges, printers and UPS, and 4 digital X-Ray machines. The TRP considers this low priority as there are 200 machines within allocation funding that need to be phased in while ensuring optimum utilisation.","Additional 100 Xpert machines, with related cartridges, printers and UPS, and 4 digital X-Ray machines. The TRP considers this low priority as there are 200 machines within allocation funding that need to be phased in while ensuring optimum utilisation.",null,"Low","8137710","Additional 100 Xpert machines, with related cartridges, printers and UPS, and 4 digital X -Ray machines. The TRP considers this low priority as there are 200 machines within allocation funding that need to be phased in while ensuring optimum utilisation.","0","0","0","0","8137710","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYs/view",null,"Multi-component",8137710," High Impact Africa 2","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713=AN2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713=AO2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713=AP2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713=AN2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713=AO2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713=AP2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2482)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJYxUAO","PAI-6045","Inactive","ZMB-TB/HIV-16","2017-2019","RT High Impact Africa 2","Zambia","HIV/TB","HIV/AIDS","FR595-ZMB-H",null,null,"MDR-TB","Treatment: MDR-TB","Due to the changes that have been made to the Drug Resistant-TB guidelines, the gap has increased as the drugs being introduced are more expensive. Most of the patients will be on Bedaquiline which will no longer be a donation and a few on Delamanide which is more costly. Note that the Bedaquiline gap is in 2020.","Due to the changes that have been made to the Drug Resistant-TB guidelines, the gap has increased as the drugs being introduced are more expensive. Most of the patients will be on Bedaquiline which will no longer be a donation and a few on Delamanide which is more costly. Note that the Bedaquiline gap is in 2020.","TRP June Retreat 2019 Original Module: Multidrug-resistant TB","High","1033887.39",null,"33887.39","1e+06","0","0","0","1","0","2020-02-06 16:25:28","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJYx/view","2020-12-31","HIV/AIDS",0," High Impact Africa 2","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713=AN2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713=AO2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713=AP2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713=AN2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713=AO2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713=AP2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2487)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJZ2UAO","PAI-6050","Active","ZMB-TB/HIV-3","2017-2019","RT High Impact Africa 2","Zambia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR257-ZMB-Z",null,null,"TB care and prevention","Treatment","Second line drugs for additional MDR-TB patients and improvement of Treatment Success Rate.","Second line drugs for additional MDR-TB patients and improvement of Treatment Success Rate.",null,"High","3887235","Second line drugs (SLD ) for additional MDR -TB patients and improvement of Treatment Success Rate.","2287484","0","0","0","1599751","0","0","2020-02-06 16:24:12","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZ2/view",null,"Multi-component",1599751," High Impact Africa 2","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713=AN2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713=AO2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713=AP2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713=AN2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713=AO2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713=AP2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2492)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZ3UAO","PAI-6051","Active","ZMB-TB/HIV-4","2017-2019","RT High Impact Africa 2","Zambia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR257-ZMB-Z",null,null,"Treatment, care and support","Treatment monitoring - Viral load","These are RSSH PSM strengthening activities although labelled as viral load and monitoring. The request will further strengthen PSM quality of health products, and improve rational use of medicines.","These are RSSH PSM strengthening activities although labelled as viral load and monitoring. The request will further strengthen PSM quality of health products, and improve rational use of medicines.","25/02/2019: According to the email form Paul McCarrick on the 17 October 2018 :The full gap in viral load commodities and a portion of the gap in male condoms have been incorporated into a grant. The IL will be available in November.\" According to an email from Paul McCarrick sent to Bianca only 7M were used as in Country Optimization. Original Intervention: Treatment monitoring  Viral load","High","14942654","These are RSSH PSM strengthening activities although labelled as viral load (VL ) and monitoring. The request will further strengthen PSM quality of health products, and improve rational use of medicines.","7082734","0","0","0","7859920","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZ3/view",null,"Multi-component",7859920," High Impact Africa 2","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713=AN2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713=AO2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713=AP2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713=AN2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713=AO2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713=AP2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2493)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZ8UAO","PAI-6056","Active","ZMB-TB/HIV-9","2017-2019","RT High Impact Africa 2","Zambia","HIV/TB","HIV/AIDS, Tuberculosis, RSSH","FR257-ZMB-Z",null,null,"Prevention programs for general population","Male circumcision","Voluntary medical male circumcision reusable and consumables kits, early infant male circumcision training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly.","Voluntary medical male circumcision reusable and consumables kits, early infant male circumcision training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly.",null,"Medium","10862539","Voluntary medical male circumcision (VMMC) reusable and consumables kits, early infant male circumcision (EIMC) training, a land cruiser, and autoclaves. There are adequate awareness raising activities within allocation budget. Incremental activities should be phased in slowly","119180","0","0","0","10743359","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZ8/view",null,"Multi-component",10743359," High Impact Africa 2","HIV/AIDS, Tuberculosis, RSSH","HIV/AIDS"," Tuberculosis"," RSSH",null,"Tuberculosis","RSSH","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713=AN2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713=AO2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713=AP2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713=AN2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713=AO2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713=AP2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2498)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZDUA4","PAI-6061","Active","ZWE-TB/HIV-11","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Prevention programs for general population","Other intervention(s) for general population","Procure and provide targeted PrEP for populations at elevated risk, prioritizing PrEP for serodiscordant couples ($3,413,954.14) and scaling up through a phased approach.","Procure and provide targeted PrEP for populations at elevated risk, prioritizing PrEP for serodiscordant couples ($3,413,954.14) and scaling up through a phased approach.","NA Original Intervention: Other interventions for the general population","Medium","1495731","Prioritise Pre-exposure prophylaxis (PrEP) for SDC for difficult cases while investing in treatment for prevention for the others","0","0","0","0","1495731","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZD/view",null,"TB/HIV",1495731," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713=AN2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713=AO2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713=AP2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713=AN2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713=AO2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713=AP2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2503)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZJUA4","PAI-6067","Active","ZWE-TB/HIV-17","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.",null,"High","142164","People with disabilities are identified as an important KP","0","0","0","0","142164","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZJ/view",null,"TB/HIV",142164," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713=AN2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713=AO2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713=AP2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713=AN2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713=AO2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713=AP2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2509)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZKUA4","PAI-6068","Active","ZWE-TB/HIV-18","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","Funding is requested for prevention of HIV among people with disabilities will focus on information dissemination, addressing stigma, and strengthening involvement in designing and leading programming.","NA Original Intervention: Other interventions for other vulnerable populations","High","276588","People with disabilities are identified as an important KP","0","0","0","0","276588","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZK/view",null,"TB/HIV",276588," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713=AN2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713=AO2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713=AP2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713=AN2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713=AO2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713=AP2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2510)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZPUA4","PAI-6073","Active","ZWE-TB/HIV-22","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Prevention programs for general population","Other intervention(s) for general population","Positive health dignity and prevention (PHDP) activities.","Positive health dignity and prevention (PHDP) activities.","NA Original Intervention: Other interventions for the general population","Low","10185","Interventions already exist elsewhere","0","0","0","0","10185","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZP/view",null,"TB/HIV",10185," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713=AN2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713=AO2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713=AP2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713=AN2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713=AO2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713=AP2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2515)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZUUA4","PAI-6078","Active","ZWE-TB/HIV-27","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Prevention programs for adolescents and youth, in and out of school","Behavioral change as part of programs for adolescent and youth","Community adolescent treatment supporters in 6 additional districts.","Community adolescent treatment supporters in 6 additional districts.",null,"Low","1300000","Interventions already exist elsewhere","0","0","0","0","1300000","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZU/view",null,"TB/HIV",1300000," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713=AN2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713=AO2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713=AP2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713=AN2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713=AO2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713=AP2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2520)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZZUA4","PAI-6083","Active","ZWE-TB/HIV-31","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"PMTCT","Prong 3: Preventing vertical HIV transmission","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","NA Original Module: Prevention of mother-to-child transmission","High","568000","PMTCT is a high priority given the country is close to meeting elimination targets","0","0","0","0","568000","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZZ/view",null,"TB/HIV",568000," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713=AN2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713=AO2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713=AP2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713=AN2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713=AO2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713=AP2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2525)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZaUAO","PAI-6084","Active","ZWE-TB/HIV-32","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","Funding is requested for additional PMTCT activities, supporting the countrys eMTCT validation.","NA Original Module: Prevention of mother-to-child transmission","High","375900","PMTCT is a high priority given the country is close to meeting elimination targets","0","0","0","0","375900","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZa/view",null,"TB/HIV",375900," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713=AN2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713=AO2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713=AP2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713=AN2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713=AO2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713=AP2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2526)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZfUAO","PAI-6089","Active","ZWE-TB/HIV-37","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Comprehensive prevention programs for MSM","Other intervention(s) for MSM","Additional scale up through extended outreach from fixed and mobile sites.","Additional scale up through extended outreach from fixed and mobile sites.","NA Original Module: Comprehensive prevention programs for men who have sex with men. Original Intervention: Other interventions for men who have sex with men","High","402785","Recommend to utilise 50% of this amount to augment provision of condoms and lubricants","0","0","0","0","402785","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZf/view",null,"TB/HIV",402785," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713=AN2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713=AO2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713=AP2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713=AN2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713=AO2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713=AP2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2531)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZkUAO","PAI-6094","Active","ZWE-TB/HIV-41","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Program management","Grant management","PR (7%) and SR (3%) costs for implementation of the total PAAR request.","PR (7%) and SR (3%) costs for implementation of the total PAAR request.",null,"High","8953015","Program costs seem too high","8925327","0","0","0","27688","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZk/view",null,"TB/HIV",27688," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713=AN2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713=AO2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713=AP2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713=AN2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713=AO2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713=AP2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2536)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZpUAO","PAI-6099","Active","ZWE-TB/HIV-46","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"TB care and prevention","Other TB care and prevention intervention(s)","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","PAAR TB care and prevention funding will aim to deepen and expand the impact form the within allocation focus on targeted screening among high risk TB key populations. This funding will prioritize targeted screening of TB at community level, with mobile outreach. The program will train provincial teams for targeted TB screening campaigns, mobilize communities for targeted TB screening campaigns. Funding will also support the mobile trucks, x-rays, and other tool on the mobile unites for community-level targeted screening. This PAAR still has a strong focus on improving case detection among TB key populations. This funding will support the printing of algorithms for bidirectional screening of TB and Diabetes patients, as well as print the revised Childhood TB diagnosis algorithm to include stool specimen.","NA Original Intervention: Key populations (TB care and prevention)  Prisoners","High","9450","Prisoners are important key populations. High impact intervention","0","0","0","0","9450","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZp/view",null,"TB/HIV",9450," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713=AN2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713=AO2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713=AP2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713=AN2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713=AO2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713=AP2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2541)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZrUAO","PAI-6101","Active","ZWE-TB/HIV-48","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"MDR-TB","Other MDR-TB intervention(s)","The final proposed investment will support prevention for MDR-TB and will include activities to strengthen and support TB infection control (IC) at community levels. Specifically the investment will support IC assessments for homes of diagnosed DR-TB patients and provide education on transmission risk reduction to family members, as well as initiate investigation of contacts. Engaging community leaders will place DR-TB on the agenda and facilitate a cascade of information within communities as part of the broader community TB care intervention. Decentralization of DR-TB treatment has meant that the majority of diagnosed patients are managed from their homes, justifying the rationale for these interventions, aimed at empowering community members to protect themselves and other vulnerable groups such as children, the elderly and PLHIV from acquiring TB.","The final proposed investment will support prevention for MDR-TB and will include activities to strengthen and support TB infection control (IC) at community levels. Specifically the investment will support IC assessments for homes of diagnosed DR-TB patients and provide education on transmission risk reduction to family members, as well as initiate investigation of contacts. Engaging community leaders will place DR-TB on the agenda and facilitate a cascade of information within communities as part of the broader community TB care intervention. Decentralization of DR-TB treatment has meant that the majority of diagnosed patients are managed from their homes, justifying the rationale for these interventions, aimed at empowering community members to protect themselves and other vulnerable groups such as children, the elderly and PLHIV from acquiring TB.","NA Original Module: Multidrug-resistant TB","High","493087","The interventions described do not warrant full budget requested.","0","0","0","0","493087","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZr/view",null,"TB/HIV",493087," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713=AN2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713=AO2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713=AP2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713=AN2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713=AO2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713=AP2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2543)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZvUAO","PAI-6105","Active","ZWE-TB/HIV-51","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"RSSH: Health management information systems and M&E","Routine reporting","Support and maintenance for the ePMS, DHIS2 and plans for greater integration with HIV, TB and RMNCAH indicators, including improving patient-level tracking","Support and maintenance for the ePMS, DHIS2 and plans for greater integration with HIV, TB and RMNCAH indicators, including improving patient-level tracking","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","9e+06","Greater integration of at least HIV,TB, RMNCAH indicators--and probably malaria indicators, will be critical in enhancing system efficiencies","7671150","0","0","0","1328850","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZv/view",null,"TB/HIV",1328850," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713=AN2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713=AO2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713=AP2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713=AN2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713=AO2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713=AP2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2547)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZwUAO","PAI-6106","Active","ZWE-TB/HIV-52","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"RSSH: Health management information systems and M&E","Program and data quality","Funding is requested to support an additional 267 data entry clerks for the ePMS and DHIS2 systems.","Funding is requested to support an additional 267 data entry clerks for the ePMS and DHIS2 systems.","NA Original Module: RSSH - Health management information system and monitoring and evaluation","High","2883600","Human resources support for an improved integrated data system is essential","961200","0","0","0","1922400","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZw/view",null,"TB/HIV",1922400," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713=AN2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713=AO2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713=AP2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713=AN2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713=AO2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713=AP2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2548)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZxUAO","PAI-6107","Active","ZWE-TB/HIV-53","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"RSSH: Community responses and systems","Institutional capacity building, planning and leadership development","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations and womens networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations and womens networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","NA Original Module: RSSH - Community responses and systems","High","850295","Integration of mobile outreach and development of a CSO portal will contribute to integrated efforts","0","0","0","0","850295","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZx/view",null,"TB/HIV",850295," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713=AN2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713=AO2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713=AP2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713=AN2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713=AO2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713=AP2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2549)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZyUAO","PAI-6108","Active","ZWE-TB/HIV-54","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"RSSH: Community responses and systems","Other community responses and systems intervention(s)","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations and womens networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","Funding is requested for institutional capacity building, planning and leadership development to support organizational and systems development, M&E, financial management, human resources and leadership of sectoral coordinating bodies, networks of people living with HIV, structures for work place based interventions and community based organizations. In particular, support will be prioritized for key populations and womens networks, bolstering the investments in prevention programs for these groups. Funding is requested for capacity building for community-based organization, centering on programme delivery on community engagement tools on the three diseases (i.e. prevention and treatment literacy). A mapping of community-led organizations working with and addressing adolescent girls and young women, gender based violence, key populations, and SRHR/HIV/TB services will be conducted as a basis for improved planning, coordination and involvement in delivery. Integrated mobile outreach clinics and services will prioritize the provision of SRHR/HIV/TB/Cervical Cancer services at community and work place levels including those used by informal traders. This will include integrated services for growth monitoring, expanded programme on immunization, HPV vaccination, cancer screening, TB screening, HTS , STI screening and providing treatment for all screened services, including awareness. Above allocation funding is requested for community health information systems, M&E and advocacy to support the development of a portal for all CSO M&E data and reference hub to enable consolidation of different efforts. Above allocation funding is requested to support planning, coordination and management investments will support the functions of CSOs, PLHIV structures and communitylevel structures (HCC, Advocacy committees, DAAC, VAAC, WAAC, support groups, Community ART Groups and Community Health Cadres) as well as capacity strengthening of the CSO sectoral coordination framework at all levels of coordination on rights based approaches, gender analysis and planning, monitoring and evaluation skills and to mainstream cross-cutting groups (e.g. MSM, sex workers, etc.).","NA Original Module: RSSH - Community responses and systems","High","8410509","Better collaboration with CSO and other community structures will allow for more effective consolidation of effort and valuefor-money","0","0","0","0","8410509","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZy/view",null,"TB/HIV",8410509," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713=AN2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713=AO2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713=AP2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713=AN2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713=AO2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713=AP2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2550)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJZzUAO","PAI-6109","Active","ZWE-TB/HIV-55","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"RSSH: Procurement and supply chain management systems","Other procurement supply chain management intervention(s)","Additional PSM strengthening to scale up viral load monitoring, optimize the use of GeneXpert, strengthen LMIS and links it to patient monitoring, and ensure quality medicines and diagnostics.","Additional PSM strengthening to scale up viral load monitoring, optimize the use of GeneXpert, strengthen LMIS and links it to patient monitoring, and ensure quality medicines and diagnostics.","NA Original Module: RSSH - Procurement and supply chain management systems. Original Intervention: Other procurement and supply chain management intervention(s)","High","7312508","Supply chain systemic allocations are investments, not recurrent costs and are crucial for achieving disease objectives","0","0","0","0","7312508","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJZz/view",null,"TB/HIV",7312508," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713=AN2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713=AO2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713=AP2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713=AN2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713=AO2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713=AP2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2551)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJa0UAG","PAI-6110","Active","ZWE-TB/HIV-56","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"RSSH: Human resources for health (HRH), including community health workers","Retention and scale-up of health workers, including for community health workers","Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).","Funding is also requested to support 5800 additional community health workers, contributing to the new targets of the CSS Framework (Annex 10), which recommends 23,700 community health workers (1 for every 100 households).","NA Original Module: RSSH - Human resources for health, including community health workers","High","3132000","Support for the expanded CCS framework is needed to broaden access and CHW workload","0","0","0","0","3132000","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa0/view",null,"TB/HIV",3132000," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713=AN2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713=AO2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713=AP2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713=AN2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713=AO2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713=AP2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2552)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJa1UAG","PAI-6111","Active","ZWE-TB/HIV-57","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"RSSH: Financial management systems","Public financial management (PFM) strengthening","Additional scale up through extended outreach from fixed and mobile sites.","Additional scale up through extended outreach from fixed and mobile sites.","NA Original Module: RSSH - Financial management systems. Original Intervention: Public financial management strengthening","High","254910","Global Fund Additional Safeguards regarding financial accountability applies in Zimbabwe","0","0","0","0","254910","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa1/view",null,"TB/HIV",254910," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713=AN2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713=AO2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713=AP2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713=AN2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713=AO2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713=AP2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2553)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJa2UAG","PAI-6112","Active","ZWE-TB/HIV-58","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"RSSH: Financial management systems","Routine financial management improvement (non-PFM)","Additional scale up through extended outreach from fixed and mobile sites.","Additional scale up through extended outreach from fixed and mobile sites.","NA Original Module: RSSH - Financial management systems. Original Intervention: Routine financial management improvement (non-public financial management)","High","929559","Global Fund Additional Safeguards regarding financial accountability applies in Zimbabwe","0","0","0","0","929559","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa2/view",null,"TB/HIV",929559," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713=AN2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713=AO2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713=AP2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713=AN2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713=AO2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713=AP2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2554)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJa3UAG","PAI-6113","Active","ZWE-TB/HIV-59","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"RSSH: Financial management systems","Other financial management intervention(s)","Additional scale up through extended outreach from fixed and mobile sites.","Additional scale up through extended outreach from fixed and mobile sites.","NA Original Module: RSSH - Financial management systems","High","3446640","Global Fund Additional Safeguards regarding financial accountability applies in Zimbabwe","0","0","0","0","3446640","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa3/view",null,"TB/HIV",3446640," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713=AN2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713=AO2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713=AP2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713=AN2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713=AO2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713=AP2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2555)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJa4UAG","PAI-6114","Active","ZWE-TB/HIV-6","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Comprehensive programs for people in prisons and other closed settings","Community empowerment for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",null,"High","184701","Prisoners are identified as an important Key Population (KP) group and a comprehensive program exists targeting this KPs","0","0","0","0","184701","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa4/view",null,"TB/HIV",184701," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713=AN2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713=AO2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713=AP2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713=AN2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713=AO2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713=AP2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2556)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJa6UAG","PAI-6116","Active","ZWE-TB/HIV-7","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Comprehensive programs for people in prisons and other closed settings","Addressing stigma, discrimination and violence against people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",null,"High","76500","Prisoners are identified as an important KP group and a comprehensive program exists targeting this KPs","0","0","0","0","76500","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa6/view",null,"TB/HIV",76500," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713=AN2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713=AO2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713=AP2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713=AN2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713=AO2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713=AP2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2557)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJa7UAG","PAI-6117","Active","ZWE-TB/HIV-8","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Comprehensive programs for people in prisons and other closed settings","Behavioral interventions for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.",null,"High","11700","Prisoners are identified as an important KP group and a comprehensive program exists targeting this KPs","0","0","0","0","11700","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa7/view",null,"TB/HIV",11700," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713=AN2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713=AO2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713=AP2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713=AN2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713=AO2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713=AP2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2558)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJa8UAG","PAI-6118","Active","ZWE-TB/HIV-9","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis","FR100-ZWE-C",null,null,"Comprehensive programs for people in prisons and other closed settings","Other intervention(s) for people in prisons and other closed settings","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","Informed by the country context suggesting that prison populations in Zimbabwe are at least twice more likely to have HIV than the general population (28% compared to 14%), funding is requested to strengthen the comprehensive HIV, TB, STI and violence reduction programs currently being implemented in Zimbabwes 72 prisons. The rationale for prioritizing this module is based on a recent assessment of HIV prevalence and risk behaviours among prisoners in Zimbabwe which suggests significant service provision gaps. Closing theses gaps is especially critical among female inmates, given that HIV prevalence among this group is 39%.","NA Original Intervention: Other interventions for people in prisons and other closed settings","High","251100","Some of the budget in this budget line should be reserved for condom programming in prisons, because it is not included, whereas the funding request mentions negotiated sex in prisons.","0","0","0","0","251100","0","0","2019-10-30 15:35:07","2019-10-30 15:35:06","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJa8/view",null,"TB/HIV",251100," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713=AN2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713=AO2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713=AP2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713=AN2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713=AO2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713=AP2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2559)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJaYUAW","PAI-6119","Inactive",null,"2017-2019","RT High Impact Asia","Pakistan",null,"HIV/AIDS","FR623-PAK-H","High","1e+05","RSSH: Health management information systems and M&E","Routine reporting","Surveillance system through sentinel sites in Sindh Province after the HIV outbreak (as recommended by WHO led investigation): a. HIV screening in all TB centresb. Screening in all registered blood banks (public and private)c. Screening of all Ante Natal clinics attendee in all BHUs in Sindh (Done by PPHI).d. Screening in all PPTCT centres in Larkana and Ratodero, e.HIV screening in sentinel sites in Larkana (Urban setting) and Ratodero (Rural settings)f. support for routine reporting, improving reporting.","Surveillance system through sentinel sites in Sindh Province after the HIV outbreak (as recommended by WHO led investigation): a. HIV screening in all TB centresb. Screening in all registered blood banks (public and private)c. Screening of all Ante Natal clinics attendee in all BHUs in Sindh (Done by PPHI).d. Screening in all PPTCT centres in Larkana and Ratodero, e.HIV screening in sentinel sites in Larkana (Urban setting) and Ratodero (Rural settings)f. support for routine reporting, improving reporting.",null,"High","1e+05",null,null,"1e+05",null,null,"0","1","0","2019-11-29 12:37:00","2019-10-31 12:16:18","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJaY/view","2020-12-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713=AN2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713=AO2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713=AP2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713=AN2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713=AO2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713=AP2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2560)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJaZUAW","PAI-6120","Inactive",null,"2017-2019","RT High Impact Asia","Pakistan",null,"HIV/AIDS","FR623-PAK-H","High","2e+05","HIV Testing Services","Differentiated HIV testing services","Outreach and Community Based testing in Sindh Province. Outreach workers, Counsellors and Test kits and consummables.","Outreach and Community Based testing in Sindh Province. Outreach workers, Counsellors and Test kits and consummables.",null,"High","2e+05",null,null,"2e+05",null,null,"0","1","0","2019-11-29 12:37:12","2019-10-31 12:16:18","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJaZ/view","2020-12-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713=AN2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713=AO2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713=AP2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713=AN2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713=AO2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713=AP2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2561)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJaaUAG","PAI-6121","Inactive",null,"2017-2019","RT High Impact Asia","Pakistan",null,"HIV/AIDS","FR623-PAK-H","High","6e+05","Treatment, care and support","HIV care","Treatment services for general population in Sindh: Funding for ARVs, Management of Opportunistic infections, Provision of psychosocial  and nutritional support. Improving retention on ART through outreach support. Training of counsellors and health workers and case managers.","Treatment services for general population in Sindh: Funding for ARVs, Management of Opportunistic infections, Provision of psychosocial  and nutritional support. Improving retention on ART through outreach support. Training of counsellors and health workers and case managers.",null,"High","6e+05",null,null,"6e+05",null,null,"0","1","0","2019-11-29 12:37:23","2019-10-31 12:16:18","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJaa/view","2020-12-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713=AN2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713=AO2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713=AP2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713=AN2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713=AO2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713=AP2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2562)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJc5UAG","PAI-6122","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Belarus",null,"Tuberculosis","FR605-BLR-T","High","1150000","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","1150000",null,"0","1149999.92","0","0","0.08","1","0","2019-11-27 13:38:31","2019-11-06 13:50:08","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJc5/view","2021-12-31",{"$f":"IF(OR(I2563=\"HIV/AIDS\",I2563=\"Tuberculosis\",I2563=\"Malaria\",I2563=\"RSSH\"),I2563, IF(I2563=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"Tuberculosis"},{"$f":"VALUE(Y2563)","v":0.08},{"$f":"RIGHT(F2563,LEN(F2563)-2)","v":" Eastern Europe and Central Asia"},"Tuberculosis","Tuberculosis",null,null,null,{"$f":"TRIM(AK2563)","v":""},{"$f":"TRIM(AL2563)","v":""},{"$f":"TRIM(AM2563)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713=AN2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713=AO2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713=AP2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},{"$f":"IF(AE2563<>\"\",AE2563,IF(MAX(AQ2563,AR2563,AS2563,AT2563)<>0,MAX(AQ2563,AR2563,AS2563,AT2563),AU2563))","v":"2021-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713=AN2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713=AO2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713=AP2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2563)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},{"$f":"IF(AE2563<>\"\",AE2563,IF(MAX(AW2563,AX2563,AY2563,AZ2563)<>0,MAX(AW2563,AX2563,AY2563,AZ2563),BA2563))","v":"2021-12-31"}]
["a6Q1R000000AJcAUAW","PAI-6123","Inactive",null,"2017-2019","RT Central Africa","Congo",null,"Tuberculosis","FR606-COG-T","High","391999.78","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","391999.78",null,null,"391999.78",null,null,"0","1","0","2020-01-30 10:54:28","2019-11-06 14:01:30","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcA/view","2020-12-31","Tuberculosis",0," Central Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713=AN2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713=AO2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713=AP2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713=AN2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713=AO2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713=AP2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2564)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJcFUAW","PAI-6124","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Moldova",null,"Tuberculosis","FR607-MDA-T","High","1074153.67","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","1074153.67",null,"392670.86","1074153.67",null,null,"0","1","0","2020-01-30 11:04:44","2019-11-06 14:11:01","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcF/view","2020-12-31","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713=AN2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713=AO2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713=AP2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713=AN2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713=AO2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713=AP2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2565)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJcKUAW","PAI-6125","Inactive",null,"2017-2019","RT High Impact Asia","Philippines",null,"Tuberculosis","FR608-PHL-T","High","2e+07","MDR-TB","Treatment: MDR-TB","This amount is needed in order to allow the roll-out of the new MDR-TB treatment regimen from Q2 2019 for a target of 10,000 patients (42% of new enrollment taking long oral regimen, 45% taking on the modified shorter regimen (replacing KM with AM), and the remaining 13% of patients to be enrolled in an OR with a modified shorter regimen with BDQ, which is already registered in country). The transition has been carefully planned in consultation with national stakeholders and with the support from partners.Regimen Change: introduction of new treatment regimen approved by WHO","This amount is needed in order to allow the roll-out of the new MDR-TB treatment regimen from Q2 2019 for a target of 10,000 patients (42% of new enrollment taking long oral regimen, 45% taking on the modified shorter regimen (replacing KM with AM), and the remaining 13% of patients to be enrolled in an OR with a modified shorter regimen with BDQ, which is already registered in country). The transition has been carefully planned in consultation with national stakeholders and with the support from partners.Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","2e+07",null,null,"2e+07",null,null,"0","1","0","2019-11-27 14:15:50","2019-11-06 14:13:17","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcK/view","2020-12-31","Tuberculosis",0," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713=AN2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713=AO2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713=AP2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713=AN2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713=AO2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713=AP2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2566)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJcPUAW","PAI-6126","Active",null,"2017-2019","RT Eastern Europe and Central Asia","Tajikistan",null,"Tuberculosis","FR609-TJK-T","High","1419703","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","1419703",null,null,"1419701.93",null,null,"1.07","0","0","2019-11-27 14:16:52","2019-11-06 14:16:28","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcP/view","2021-03-31","Tuberculosis",1.07," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713=AN2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713=AO2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713=AP2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713=AN2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713=AO2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713=AP2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2567)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2021-03-31"]
["a6Q1R000000AJcUUAW","PAI-6127","Inactive",null,"2017-2019","RT High Impact Africa 2","Uganda",null,"Tuberculosis","FR610-UGA-T","High","2e+06","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","2e+06",null,null,"2e+06",null,null,"0","1","0","2019-11-27 14:17:35","2019-11-06 14:22:03","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcU/view","2020-12-31","Tuberculosis",0," High Impact Africa 2","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713=AN2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713=AO2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713=AP2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713=AN2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713=AO2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713=AP2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2568)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJcZUAW","PAI-6128","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Ukraine",null,"Tuberculosis","FR611-UKR-T","High","1600000","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","1600000",null,null,"1600000",null,null,"0","1","0","2019-11-27 14:18:09","2019-11-06 14:26:45","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcZ/view","2020-12-31","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713=AN2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713=AO2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713=AP2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713=AN2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713=AO2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713=AP2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2569)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJceUAG","PAI-6129","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Azerbaijan",null,"Tuberculosis","FR612-AZE-T","High","2227664","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","2227664",null,null,"2227664",null,null,"0","1","0","2019-11-27 14:19:03","2019-11-06 14:28:57","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJce/view","2020-12-31","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713=AN2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713=AO2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713=AP2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713=AN2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713=AO2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713=AP2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2570)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2020-12-31"]
["a6Q1R000000AJcjUAG","PAI-6130","Active",null,"2017-2019","RT High Impact Africa 2","Ethiopia",null,"Tuberculosis","FR613-ETH-T","High","3e+06","MDR-TB","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",null,"High","3e+06",{"$nulls":5},"3e+06","0","0","2019-11-06 14:30:53","2019-11-06 14:30:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcj/view","2021-06-30","Tuberculosis",3000000," High Impact Africa 2","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713=AN2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713=AO2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713=AP2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713=AN2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713=AO2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713=AP2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2571)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-06-30"]
["a6Q1R000000AJcoUAG","PAI-6131","Active",null,"2017-2019","RT High Impact Africa 2","Kenya",null,"Tuberculosis","FR614-KEN-T","High","1578834","MDR-TB","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",null,"High","1578834",{"$nulls":5},"1578834","0","0","2019-11-06 14:33:24","2019-11-06 14:33:24","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJco/view","2021-06-30","Tuberculosis",1578834," High Impact Africa 2","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713=AN2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713=AO2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713=AP2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713=AN2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713=AO2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713=AP2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2572)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2021-06-30"]
["a6Q1R000000AJctUAG","PAI-6132","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Kyrgyzstan",null,"Tuberculosis","FR615-KGZ-T","High","1197668","MDR-TB","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",null,"High","1197668",null,null,"1197668",null,null,"0","1","0","2019-12-10 10:18:20","2019-11-06 14:37:17","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJct/view","2020-12-31","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713=AN2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713=AO2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713=AP2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713=AN2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713=AO2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713=AP2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2573)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJcyUAG","PAI-6133","Inactive",null,"2017-2019","RT Southern and Eastern Africa","Namibia",null,"Tuberculosis","FR616-NAM-T","High","1059911","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","1059911",null,null,"1059911",null,null,"0","1","0","2019-11-27 14:22:18","2019-11-06 14:42:36","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJcy/view","2020-12-31","Tuberculosis",0," Southern and Eastern Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713=AN2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713=AO2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713=AP2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713=AN2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713=AO2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713=AP2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2574)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJd3UAG","PAI-6134","Active",null,"2017-2019","RT Eastern Europe and Central Asia","Romania",null,"Tuberculosis","FR617-ROU-T","High","862153.52","MDR-TB","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",null,"High","862153.52",{"$nulls":5},"862153.52","0","0","2020-01-30 11:05:15","2019-11-06 14:52:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJd3/view","2021-03-31","Tuberculosis",862153.52," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713=AN2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713=AO2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713=AP2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2021-03-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-04-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713=AN2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713=AO2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713=AP2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2575)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2021-03-31"]
["a6Q1R000000AJd8UAG","PAI-6135","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Turkmenistan",null,"Tuberculosis","FR618-TKM-T","High","786793","MDR-TB","Treatment: MDR-TB","Turkmenistan plans to make the transition to the new WHO guidelines from July 2019 and would require additional funding for 2019 and 2020. Over 1000 RR/MDR TB patients are expected to transition to the new RR/MDR TB treatment regimens in next 1.5 years, leading to an estimated gap to be funded through portfolio optimization.","Turkmenistan plans to make the transition to the new WHO guidelines from July 2019 and would require additional funding for 2019 and 2020. Over 1000 RR/MDR TB patients are expected to transition to the new RR/MDR TB treatment regimens in next 1.5 years, leading to an estimated gap to be funded through portfolio optimization.",null,"High","786793",null,null,"786793",null,null,"0","1","0","2019-11-28 09:26:41","2019-11-06 14:54:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJd8/view","2021-06-30","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713=AN2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713=AO2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713=AP2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713=AN2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713=AO2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713=AP2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2576)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJdDUAW","PAI-6136","Active",null,"2017-2019","RT Eastern Europe and Central Asia","Uzbekistan",null,"Tuberculosis","FR619-UZB-T","High","2958638","MDR-TB","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",null,"High","2958638",null,null,"0",null,null,"2958638","0","0","2019-11-28 09:28:44","2019-11-06 14:57:20","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJdD/view","2021-06-30","Tuberculosis",2958638," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713=AN2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713=AO2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713=AP2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713=AN2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713=AO2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713=AP2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2577)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJdIUAW","PAI-6137","Inactive",null,"2017-2019","RT High Impact Asia","Viet Nam",null,"Tuberculosis","FR620-VNM-T","High","1500000","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","1500000",null,null,"1500000",null,null,"0","1","0","2019-11-28 09:27:39","2019-11-06 15:00:31","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJdI/view","2020-12-31","Tuberculosis",0," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713=AN2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713=AO2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713=AP2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713=AN2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713=AO2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713=AP2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2578)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJe1UAG","PAI-6138","Inactive",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","142697","PMTCT","Prong 3: Preventing vertical HIV transmission","Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women, adapted to needs. This plan must be specific for clearly identified target groups and with translation into the local language, including people's rights approaches .The same TA will be used to conduct end user surveys to evaluate the impact of messages devliered by the campaignIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 119290","Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women, adapted to needs. This plan must be specific for clearly identified target groups and with translation into the local language, including people's rights approaches .The same TA will be used to conduct end user surveys to evaluate the impact of messages devliered by the campaignIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 119290",null,"High","142697",null,null,null,"142697",null,"0","1","0","2019-11-28 13:17:53","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe1/view","2020-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713=AN2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713=AO2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713=AP2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713=AN2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713=AO2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713=AP2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2579)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJe2UAG","PAI-6139","Active",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","349001","PMTCT","Prong 3: Preventing vertical HIV transmission","Involve key community actors (organized networks of women and departmental networks of responsible paternity and HIV and HIV), leaders, promoters, auxiliary mayors and midwives to search and recruit of pregnant women and in the promotion of screening in pregnant women.Includes consultancy fees to do a mapping exercice of actors, and costs for meetings and training sessions for community leaders and midwives, as well as training kits for midwives (to facilitate the implementation of renewed EMTCT scope of work)Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","Involve key community actors (organized networks of women and departmental networks of responsible paternity and HIV and HIV), leaders, promoters, auxiliary mayors and midwives to search and recruit of pregnant women and in the promotion of screening in pregnant women.Includes consultancy fees to do a mapping exercice of actors, and costs for meetings and training sessions for community leaders and midwives, as well as training kits for midwives (to facilitate the implementation of renewed EMTCT scope of work)Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",null,"High","349001",null,null,null,"236745",null,"112256","0","0","2019-11-28 13:23:18","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe2/view","2020-12-31","HIV/AIDS",112256," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713=AN2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713=AO2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713=AP2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713=AN2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713=AO2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713=AP2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2580)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJe3UAG","PAI-6140","Inactive",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","119938","PMTCT","Prong 3: Preventing vertical HIV transmission","Pilot to articulate and integrate test screening into midwives and other community actors EMTCT activities.Includes; consultancy fees for the design of the pilot program (tools, pedagogic materials, monitoring and evaluation system, includes syphilis, Hep B and HIV tests, as well as costs to evaluate the program and a final consultancy to analyze the sustainability of this strategy and potential absorption by MSPAS.Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 70211","Pilot to articulate and integrate test screening into midwives and other community actors EMTCT activities.Includes; consultancy fees for the design of the pilot program (tools, pedagogic materials, monitoring and evaluation system, includes syphilis, Hep B and HIV tests, as well as costs to evaluate the program and a final consultancy to analyze the sustainability of this strategy and potential absorption by MSPAS.Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 70211",null,"High","119938",null,null,null,"119938",null,"0","1","0","2019-11-28 13:31:12","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe3/view","2020-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713=AN2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713=AO2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713=AP2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713=AN2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713=AO2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713=AP2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2581)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJe4UAG","PAI-6141","Active",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","10395","PMTCT","Prong 3: Preventing vertical HIV transmission","Special TA for the expansion of ETMI interventions progressively to establishments of all levels of care, prioritizing the first and second levels to increase the coverage of prenatal, delivery and puerperium care with qualified personnel within the framework of the primary health care strategy.Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","Special TA for the expansion of ETMI interventions progressively to establishments of all levels of care, prioritizing the first and second levels to increase the coverage of prenatal, delivery and puerperium care with qualified personnel within the framework of the primary health care strategy.Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",null,"High","10395",{"$nulls":5},"10395","0","0","2019-11-08 12:43:53","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe4/view","2020-12-31","HIV/AIDS",10395," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713=AN2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713=AO2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713=AP2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713=AN2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713=AO2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713=AP2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2582)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJe5UAG","PAI-6142","Active",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","75000","PMTCT","Prong 3: Preventing vertical HIV transmission","Update and implement protocols, care guides and standards for prenatal monitoring and follow-up of pregnant women with HIV, syphilis and hepatitis B and feeding children exposed to HIV with breast milk substitutes, to children exposed to HIV.Includes funds to print all the updated materials for all services accross the EMTCT care continuumIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","Update and implement protocols, care guides and standards for prenatal monitoring and follow-up of pregnant women with HIV, syphilis and hepatitis B and feeding children exposed to HIV with breast milk substitutes, to children exposed to HIV.Includes funds to print all the updated materials for all services accross the EMTCT care continuumIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",null,"High","75000",null,null,null,"62216",null,"12784","0","0","2019-11-28 13:34:14","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe5/view","2020-12-31","HIV/AIDS",12784," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713=AN2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713=AO2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713=AP2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713=AN2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713=AO2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713=AP2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2583)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJe6UAG","PAI-6143","Active",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","1129912","PMTCT",null,"Expand the resolution capacity of the health service network of the second and third level of care, for the diagnosis of HIV, syphilis and hepatitis B in pregnant women, as well as ensuring the link of newborns exposed to HIV to the UAI that corresponds to them .Includes: TA to conduct the needs assessment and 2 other sums to cover; (i) design of a costed strengthening plan based on the assessment and (ii) fund to implement actions of the stenghtening planIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","Expand the resolution capacity of the health service network of the second and third level of care, for the diagnosis of HIV, syphilis and hepatitis B in pregnant women, as well as ensuring the link of newborns exposed to HIV to the UAI that corresponds to them .Includes: TA to conduct the needs assessment and 2 other sums to cover; (i) design of a costed strengthening plan based on the assessment and (ii) fund to implement actions of the stenghtening planIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",null,"High","1129912",null,null,null,"486642",null,"643270","0","0","2019-11-28 13:24:09","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe6/view","2020-12-31","HIV/AIDS",643270," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713=AN2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713=AO2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713=AP2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713=AN2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713=AO2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713=AP2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2584)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJe7UAG","PAI-6144","Active",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","517363","PMTCT","Prong 3: Preventing vertical HIV transmission","Strengthening of capacities, improvement of sensitivity and quality care to all health providers in topics related to orientation, screening and the approach of pregnant women with HIV, Sifilis and Hepatitis B, integrating these topics into the routine work of health services. HealthIncludes: pedagogical material for trainings, training costs (accomodation, food and transportation),  consultancy fees to provide support conducting the trainings that are scheduled and reduce the work volumen for the National HIV program (a total of 87 trainings) and development of an online training module through a consultancyIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)","Strengthening of capacities, improvement of sensitivity and quality care to all health providers in topics related to orientation, screening and the approach of pregnant women with HIV, Sifilis and Hepatitis B, integrating these topics into the routine work of health services. HealthIncludes: pedagogical material for trainings, training costs (accomodation, food and transportation),  consultancy fees to provide support conducting the trainings that are scheduled and reduce the work volumen for the National HIV program (a total of 87 trainings) and development of an online training module through a consultancyIndicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)",null,"High","517363",null,null,null,"399798",null,"117565","0","0","2019-11-28 13:38:31","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe7/view","2020-12-31","HIV/AIDS",117565," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713=AN2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713=AO2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713=AP2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713=AN2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713=AO2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713=AP2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2585)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJe8UAG","PAI-6145","Inactive",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","913060","PMTCT","Prong 3: Preventing vertical HIV transmission","Assurance of availability and access to screening tests for HIV, syphilis and hepatitis B for women in pregnancy, delivery and puerperiumIncludes HIV and Syphilis tests to cover the gap of pregnant women not receiving an HIV or syphilis test (PSM costs included)Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 808989","Assurance of availability and access to screening tests for HIV, syphilis and hepatitis B for women in pregnancy, delivery and puerperiumIncludes HIV and Syphilis tests to cover the gap of pregnant women not receiving an HIV or syphilis test (PSM costs included)Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 808989",null,"High","913060",null,null,null,"913060",null,"0","1","0","2019-11-28 13:39:35","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe8/view","2020-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713=AN2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713=AO2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713=AP2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713=AN2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713=AO2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713=AP2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2586)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJe9UAG","PAI-6146","Active",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","15000","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","onsultancy fees to develop a strategy to strengthen the system for monitoring compliance and achieving results through a non-economic recognition system.Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","onsultancy fees to develop a strategy to strengthen the system for monitoring compliance and achieving results through a non-economic recognition system.Indicators:Reduce the 2016 gap on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",null,"High","15000",null,null,null,"10000",null,"5000","0","0","2019-11-28 13:40:52","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJe9/view","2020-12-31","HIV/AIDS",5000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713=AN2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713=AO2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713=AP2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713=AN2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713=AO2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713=AP2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2587)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJeAUAW","PAI-6147","Active",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","25000","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Establishment of a routine system for measuring the quality of care in NC services through measurement of user satisfaction and provision of services (mystery clients) (consultancy fees)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","Establishment of a routine system for measuring the quality of care in NC services through measurement of user satisfaction and provision of services (mystery clients) (consultancy fees)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)",null,"Low","25000","The TRP recommends this activity to be embedded in the scope of work for the \"Special TA to develop a National communication plan that promotes prenatal screening and screening for HIV, syphilis and hepatitis B for pregnant women as detailed in the second item recommended in this Review Form.",null,null,"10000",null,"15000","0","0","2019-11-28 13:41:44","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeA/view","2020-12-31","HIV/AIDS",15000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713=AN2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713=AO2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713=AP2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713=AN2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713=AO2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713=AP2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2588)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJeBUAW","PAI-6148","Inactive",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","30000","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Strategy for tracking positive cases lost and improving the link (mobilization vouchers, health promoters, mobile phones) (will investigate possible synergies with existing strategies such as multisectoral networks. (consultancy fees)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017). This item was updated in October 2019 to increment the original approaved amount of 20000","Strategy for tracking positive cases lost and improving the link (mobilization vouchers, health promoters, mobile phones) (will investigate possible synergies with existing strategies such as multisectoral networks. (consultancy fees)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017). This item was updated in October 2019 to increment the original approaved amount of 20000",null,"High","30000","The TRP recommends this activity to be included in the ongoing program submitted under the Program Continuation modality, to be funded with the savings / efficiencies found from within allocation funds.",null,null,"30000",null,"0","1","0","2019-11-28 13:43:30","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeB/view","2020-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713=AN2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713=AO2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713=AP2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713=AN2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713=AO2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713=AP2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2589)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJeCUAW","PAI-6149","Inactive",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","20000","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Based on official guidelines, design a training protocol to ensure readiness of health services to attend pregnant women arriving to health facilities at the moment of delivery without having attended previously ANC. (consultancy fees)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","Based on official guidelines, design a training protocol to ensure readiness of health services to attend pregnant women arriving to health facilities at the moment of delivery without having attended previously ANC. (consultancy fees)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)",null,"High","20000","The TRP recommends this activity to be included in the proposed activities to \"Strengthening of capacities, improvement of sensitivity and quality care to all health providers in topics related to orientation, screening and the approach of pregnant women with HIV, Syphilis and Hepatitis B as detailed in the eighth item recommended in this Review Form.",null,null,"20000",null,"0","1","0","2019-11-28 13:55:09","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeC/view","2020-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713=AN2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713=AO2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713=AP2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713=AN2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713=AO2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713=AP2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2590)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJeDUAW","PAI-6150","Active",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","20000","PMTCT","Prong 4: Treatment, care and support to mothers living with HIV, their children and families","Consultancy to develop a follow-up strategy for new-born babies to HIV-positive mothers and ensure adequate care (resources for mobilization, promoters, linkage to strategies already in progress)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)","Consultancy to develop a follow-up strategy for new-born babies to HIV-positive mothers and ensure adequate care (resources for mobilization, promoters, linkage to strategies already in progress)Indicators:Reduction in the rate of HIV transmission in pregnant women (24% according to data from MSPAS and UNAIDS)Reduction of the positivity rate in pregnant women (of 0.24% according to programmatic data of 2017)",null,"High","20000",{"$nulls":5},"20000","0","0","2019-11-08 12:43:53","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeD/view","2020-12-31","HIV/AIDS",20000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713=AN2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713=AO2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713=AP2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713=AN2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713=AO2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713=AP2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2591)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJeEUAW","PAI-6151","Active",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","20000","PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","IEC actions (information, education and communication) to develop a strategy to promote safe and responsible sexual practices (consultancy fees)Indicators:Reduce the gap of 2016 on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)","IEC actions (information, education and communication) to develop a strategy to promote safe and responsible sexual practices (consultancy fees)Indicators:Reduce the gap of 2016 on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap)",null,"High","20000",{"$nulls":5},"20000","0","0","2019-11-08 12:43:53","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeE/view","2020-12-31","HIV/AIDS",20000," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713=AN2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713=AO2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713=AP2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713=AN2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713=AO2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713=AP2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2592)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJeFUAW","PAI-6152","Inactive",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","2069","PMTCT","Prong 1: Primary prevention of HIV infection among women of childbearing age","Interinstitutional Articulation National Program of STIs, HIV and AIDS - Comprehensive Health System - National Reproductive Health Plan - Health Areas Directorate - National Health Laboratory - Hospitals; IGSS, APROFAM, Military Health, Association of private hospitals among others and non-governmental organizations that work on the subject, to support the sustainability of interventions.Covers the cost of consultancy to facilitate thisIndicators:Reduce the gap of 2016 on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 2000","Interinstitutional Articulation National Program of STIs, HIV and AIDS - Comprehensive Health System - National Reproductive Health Plan - Health Areas Directorate - National Health Laboratory - Hospitals; IGSS, APROFAM, Military Health, Association of private hospitals among others and non-governmental organizations that work on the subject, to support the sustainability of interventions.Covers the cost of consultancy to facilitate thisIndicators:Reduce the gap of 2016 on the access of pregnant women to ANC (32% gap)Reduce the 2016 gap on access of pregnant women to HIV testing (58% gap). This item was updated in October 2019 to increment the original approaved amount of 2000",null,"High","2069",null,null,null,"2069",null,"0","1","0","2019-11-28 13:56:30","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeF/view","2020-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713=AN2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713=AO2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713=AP2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713=AN2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713=AO2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713=AP2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2593)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJeGUAW","PAI-6153","Inactive",null,"2017-2019","RT Latin America and Caribbean","Guatemala",null,"HIV/AIDS","FR640-GTM-H","High","261834","Program management","Grant management","Operational support of personnel for the MSPAS and INCAP consisting of:1- A facilitator for the ETMI hired for the PNS.2- Officer dedicated to the Monitoring and Evaluation of the ETMI component in the PNS3- Responsible for ETMI4- Secretarial supportTo this is added the percentage of operational expenses of INCAP (1% for the acquisition of tests and 5% for the rest of the items)Transversal contribution to the indicators related to prevention and treatment. This item was updated in October 2019 to increment the original approaved amount of 211260","Operational support of personnel for the MSPAS and INCAP consisting of:1- A facilitator for the ETMI hired for the PNS.2- Officer dedicated to the Monitoring and Evaluation of the ETMI component in the PNS3- Responsible for ETMI4- Secretarial supportTo this is added the percentage of operational expenses of INCAP (1% for the acquisition of tests and 5% for the rest of the items)Transversal contribution to the indicators related to prevention and treatment. This item was updated in October 2019 to increment the original approaved amount of 211260",null,"High","261834",null,null,null,"261834",null,"0","1","0","2019-11-28 13:57:39","2019-11-08 12:43:53","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJeG/view","2020-12-31","HIV/AIDS",0," Latin America and Caribbean","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713=AN2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713=AO2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713=AP2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713=AN2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713=AO2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713=AP2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2594)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJgmUAG","PAI-6154","Inactive",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","Low","1049562","TB care and prevention","Treatment","The updated forecasting and quantification of First Line Anti-TB drugs (FLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnerships Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the budget required the FLD is USD1,049,562 to cover the treatment needs up to the end of 2020.  By the end of 2018, a total of 14,362 cases were notified against a set target of 12,678. Similarly, an increasing trend was reported as at June 2019 - 8,566 cases notified which is above the set target of 6,973 by 23%. It is projected that by the end of 2020, the number of notified cases will increase to 20,832.","The updated forecasting and quantification of First Line Anti-TB drugs (FLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnerships Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the budget required the FLD is USD1,049,562 to cover the treatment needs up to the end of 2020.  By the end of 2018, a total of 14,362 cases were notified against a set target of 12,678. Similarly, an increasing trend was reported as at June 2019 - 8,566 cases notified which is above the set target of 6,973 by 23%. It is projected that by the end of 2020, the number of notified cases will increase to 20,832.",null,"High","1049562",null,null,"1049562",null,null,"0","1","0","2020-02-05 09:15:37","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgm/view","2020-12-31","Tuberculosis",0," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713=AN2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713=AO2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713=AP2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713=AN2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713=AO2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713=AP2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2595)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgnUAG","PAI-6155","Inactive",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","122794","MDR-TB","Treatment: MDR-TB","The updated forecasting and quantification of Second Line Anti-TB drugs (SLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments of 220 for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnerships Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the requires resources for SLD up to the end of the grant with 6 months buffer is USD122,794.  The National TB Program at central level now has on board the Inspector for Management of Multi-Drug Resistant TB who is mandated to provide oversight, monitoring and support to the implementation of the PMDT program. With this newly created position, it is expected that the proposed critical intensive case detection and treatment activities being proposed for support under this application will improve case notification and linkage to treatment.","The updated forecasting and quantification of Second Line Anti-TB drugs (SLD) for the period 30 September 2019 - December 2020 considered the current patient enrollments of by end of June 2019, projected enrolments of 220 for 2020, stock on hand at central level and stock on order.  This exercise was undertaken with in-country technical support from the Stop TB Partnerships Global Drug Facility (GDF) in October 2019.  The updated quantification has indicated that the requires resources for SLD up to the end of the grant with 6 months buffer is USD122,794.  The National TB Program at central level now has on board the Inspector for Management of Multi-Drug Resistant TB who is mandated to provide oversight, monitoring and support to the implementation of the PMDT program. With this newly created position, it is expected that the proposed critical intensive case detection and treatment activities being proposed for support under this application will improve case notification and linkage to treatment.",null,"High","122794",null,null,"122794",null,null,"0","1","0","2020-02-05 09:15:37","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgn/view","2020-12-31","Tuberculosis",0," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713=AN2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713=AO2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713=AP2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713=AN2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713=AO2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713=AP2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2596)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgoUAG","PAI-6156","Inactive",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","531171","MDR-TB","Case detection and diagnosis: MDR-TB","The number of MDR-TB cases being diagnosed is currently below the set target.  Currently, there are 17 GeneXpert MTB/RIF machines deployed at 16 sites across the country - 10 of these machines were procured using Global Fund resources.  The rollout of this GeneXpert MTB/RIF test highlights the existing need for strong testing site networks, good infrastructure, robust quality assurance systems and uninterrupted supplies. With the projected number of 220 MDR cases to be notified in 2020, there is need to procure adequate cartridges ($252,160), LPA and liquid culture reagents, and other laboratory supplies and consumables valued at ($194,688).  To ensure optimal functionality of these machines, it is necessary that a maintenance and technical support contract with the Cephied is in place to cover the year 2020.  This contract is valued at $38,776. In additional $6,679 will be used to cover the travel, lodging and facilitation feed of the Cepheid certified trainer and in-country training expenses for participants.  An additional 7 super users will be trained to support the roll-out and in-country trouble shooting of the GeneXpert platforms across the country for accurate and timely diagnosis.  This covers the cost of the trainer, A total of 10 super users were trained in May 2019.   A separate maintenance contract for the maintenance of other equipment such as the BD BACTEC MGIT 960 System, LPA machine, medical refrigerators is being also being finalized at a cost of $37,930.","The number of MDR-TB cases being diagnosed is currently below the set target.  Currently, there are 17 GeneXpert MTB/RIF machines deployed at 16 sites across the country - 10 of these machines were procured using Global Fund resources.  The rollout of this GeneXpert MTB/RIF test highlights the existing need for strong testing site networks, good infrastructure, robust quality assurance systems and uninterrupted supplies. With the projected number of 220 MDR cases to be notified in 2020, there is need to procure adequate cartridges ($252,160), LPA and liquid culture reagents, and other laboratory supplies and consumables valued at ($194,688).  To ensure optimal functionality of these machines, it is necessary that a maintenance and technical support contract with the Cephied is in place to cover the year 2020.  This contract is valued at $38,776. In additional $6,679 will be used to cover the travel, lodging and facilitation feed of the Cepheid certified trainer and in-country training expenses for participants.  An additional 7 super users will be trained to support the roll-out and in-country trouble shooting of the GeneXpert platforms across the country for accurate and timely diagnosis.  This covers the cost of the trainer, A total of 10 super users were trained in May 2019.   A separate maintenance contract for the maintenance of other equipment such as the BD BACTEC MGIT 960 System, LPA machine, medical refrigerators is being also being finalized at a cost of $37,930.",null,"High","531171",null,null,"531171",null,null,"0","1","0","2020-02-05 09:15:37","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgo/view","2020-12-31","Tuberculosis",0," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713=AN2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713=AO2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713=AP2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713=AN2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713=AO2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713=AP2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2597)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgpUAG","PAI-6157","Active",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","30464","MDR-TB","Engaging all care providers (MDR-TB)","In order to optimize the utilization of GeneXpert platforms, improve diagnostic access for TB and undertake patient monitoring; quarterly focused supervisory and mentorship site level visits will be undertaken by team composed of 1 clinician, 1 laboratory staff and 1 State TB/HIV Coordinator.  These field visits will also include the orientation of staff in the recently developed PMDT guidelines and DR Recording and Reporting tools and strengthening prompt linkage to treatment for all detected cases. PMDT job aids have also been developed.","In order to optimize the utilization of GeneXpert platforms, improve diagnostic access for TB and undertake patient monitoring; quarterly focused supervisory and mentorship site level visits will be undertaken by team composed of 1 clinician, 1 laboratory staff and 1 State TB/HIV Coordinator.  These field visits will also include the orientation of staff in the recently developed PMDT guidelines and DR Recording and Reporting tools and strengthening prompt linkage to treatment for all detected cases. PMDT job aids have also been developed.",null,"High","30464",{"$nulls":5},"30464","0","0","2019-11-18 14:38:56","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgp/view","2020-12-31","Tuberculosis",30464," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713=AN2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713=AO2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713=AP2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713=AN2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713=AO2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713=AP2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2598)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgqUAG","PAI-6158","Active",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","22820","Program management","Policy, planning, coordination and management of national disease control programs","In order to strengthen the capacity of the National TB Program in PMDT, it is important that central-level staff who are charged with the responsibility of providing oversight, supervision and mentorship are adequately trained.  As the country is currently scaling up the implementation and coverage of MDR TB services, this training is critical. 3 staff will be undergo international training in PMDT at a cost of USD22,820.00.  As this intervention is already approved, the country has updated the intervention highlighting the training in PMDT as a priority.","In order to strengthen the capacity of the National TB Program in PMDT, it is important that central-level staff who are charged with the responsibility of providing oversight, supervision and mentorship are adequately trained.  As the country is currently scaling up the implementation and coverage of MDR TB services, this training is critical. 3 staff will be undergo international training in PMDT at a cost of USD22,820.00.  As this intervention is already approved, the country has updated the intervention highlighting the training in PMDT as a priority.",null,"High","22820",{"$nulls":5},"22820","0","0","2019-11-18 14:38:56","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgq/view","2020-12-31","Tuberculosis",22820," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713=AN2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713=AO2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713=AP2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713=AN2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713=AO2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713=AP2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2599)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgrUAG","PAI-6159","Active",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","422163","TB care and prevention","Treatment","With the operationalisation of the Wau Warehouse  starting January 2020, health commodities for the selected states will be prepositioned in this location thereby greatly reducing the delivery timeliness of health commodities to facilities and overall enhancing the supply chain management support to this region.  In addition, procured commodities meant for this region will in due course be delivered directly to the Wau Regional Warehouse thereby reducing the distribution costs currently being incurred from Juba.  Following the integration of the malaria commodities HIV and TB grant health commodities under the Juba Riverside Warehouse, this integration will also be decentralized to the Wau Regional Warehouse.  Going forward, it is expected that there will be a gradual integration of other health commodities by being procured by other partners.","With the operationalisation of the Wau Warehouse  starting January 2020, health commodities for the selected states will be prepositioned in this location thereby greatly reducing the delivery timeliness of health commodities to facilities and overall enhancing the supply chain management support to this region.  In addition, procured commodities meant for this region will in due course be delivered directly to the Wau Regional Warehouse thereby reducing the distribution costs currently being incurred from Juba.  Following the integration of the malaria commodities HIV and TB grant health commodities under the Juba Riverside Warehouse, this integration will also be decentralized to the Wau Regional Warehouse.  Going forward, it is expected that there will be a gradual integration of other health commodities by being procured by other partners.",null,"High","422163",{"$nulls":5},"422163","0","0","2019-11-18 14:38:56","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgr/view","2020-12-31","Tuberculosis",422163," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713=AN2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713=AO2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713=AP2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713=AN2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713=AO2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713=AP2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2600)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgsUAG","PAI-6160","Inactive",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","438674","TB care and prevention","Treatment","This is to cater for the PSM-related costs for the drugs, laboratory reagents and other supplies for FY2020.   These costs include:   Procurement agent and handling fees Freight and insurance costs  Warehouse Storage Costs, i.e. insurance for commodities In-country distribution costs Quality assurance and quality control costs (QA/QC) PSM Customs clearance, i.e. clearance agent fees; Drug and Food Control Authority Fees","This is to cater for the PSM-related costs for the drugs, laboratory reagents and other supplies for FY2020.   These costs include:   Procurement agent and handling fees Freight and insurance costs  Warehouse Storage Costs, i.e. insurance for commodities In-country distribution costs Quality assurance and quality control costs (QA/QC) PSM Customs clearance, i.e. clearance agent fees; Drug and Food Control Authority Fees",null,"High","438674",null,null,"438674",null,null,"0","1","0","2020-02-05 09:15:37","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgs/view","2020-12-31","Tuberculosis",0," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713=AN2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713=AO2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713=AP2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713=AN2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713=AO2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713=AP2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2601)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgtUAG","PAI-6161","Active",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","212469","Program management","Grant management","General Management Service (GMS) Fee for UNDP","General Management Service (GMS) Fee for UNDP",null,"High","212469",{"$nulls":5},"212469","0","0","2019-11-18 14:38:56","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgt/view","2020-12-31","Tuberculosis",212469," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713=AN2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713=AO2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713=AP2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713=AN2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713=AO2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713=AP2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2602)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJguUAG","PAI-6162","Active",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","21812","TB care and prevention","Community TB care delivery","Community TB care delivery continues to be an important intervention.  Cordaid works closely with the Home Health Promoters (HHPs) to conduct outreach activities, including contact tracing, treatment support and community sensitisation.  These resources will go towards continuing support for incentives for HHPs. This budget line is increased to support the intergration of TB services to more health facilities.","Community TB care delivery continues to be an important intervention.  Cordaid works closely with the Home Health Promoters (HHPs) to conduct outreach activities, including contact tracing, treatment support and community sensitisation.  These resources will go towards continuing support for incentives for HHPs. This budget line is increased to support the intergration of TB services to more health facilities.",null,"High","21812",{"$nulls":5},"21812","0","0","2019-11-18 14:38:56","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgu/view","2020-12-31","Tuberculosis",21812," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713=AN2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713=AO2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713=AP2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713=AN2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713=AO2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713=AP2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2603)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgvUAG","PAI-6163","Inactive",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","209003","TB care and prevention","Case detection and diagnosis","Given the challenges of limited government support to the health sector, there is a risk of service interruption if additional funding is not provided. There is a need to maintain essential clinical and laboratory staff at selected facilties.  With additional funding, Cordaid will continue to support direct service delivery for key TB diagnostic and treatment services and its presence is critical especially is high volume facilities such as these facilities such Munuki PHCC, Torit State Hospital, Nyong PHCC, Hiyala PHCC, Hileu PHCC, Lowoi PHCC, Chukudum Hospital, Nimule Hospital , Bentiu state Hospital, Kapoeta Mission Hospital, Kapoeta State Hospital, Mary Help Hospital, Tharkueng PHCC, Achong Chong PHCC and Marial Bai PHCC.  These facilities are mostly in localities where Cordaid has presence with other health projects ongoing.  This is so because it will help cut down on running costs by cost-sharing with other projects. Under this budget line, Cordaid shall also support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, and intergrate TB services at new health facilities.","Given the challenges of limited government support to the health sector, there is a risk of service interruption if additional funding is not provided. There is a need to maintain essential clinical and laboratory staff at selected facilties.  With additional funding, Cordaid will continue to support direct service delivery for key TB diagnostic and treatment services and its presence is critical especially is high volume facilities such as these facilities such Munuki PHCC, Torit State Hospital, Nyong PHCC, Hiyala PHCC, Hileu PHCC, Lowoi PHCC, Chukudum Hospital, Nimule Hospital , Bentiu state Hospital, Kapoeta Mission Hospital, Kapoeta State Hospital, Mary Help Hospital, Tharkueng PHCC, Achong Chong PHCC and Marial Bai PHCC.  These facilities are mostly in localities where Cordaid has presence with other health projects ongoing.  This is so because it will help cut down on running costs by cost-sharing with other projects. Under this budget line, Cordaid shall also support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, and intergrate TB services at new health facilities.",null,"High","209003",null,null,"209003",null,null,"0","1","0","2020-02-05 09:15:37","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgv/view","2020-12-31","Tuberculosis",0," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713=AN2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713=AO2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713=AP2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713=AN2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713=AO2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713=AP2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2604)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgwUAG","PAI-6164","Active",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","109822","Program management","Grant management","This is to cover the costs of key technical project personnel under Cordaid who are required to continue providing technical backup to the project in 2020.  The two key staff will continue to provide supervision, oversight and mentoring to the local staff and to ensure smooth handing over to local authorities at project termination. These staff also undertake grant management functions related to the Sub-Recipient Agreement.","This is to cover the costs of key technical project personnel under Cordaid who are required to continue providing technical backup to the project in 2020.  The two key staff will continue to provide supervision, oversight and mentoring to the local staff and to ensure smooth handing over to local authorities at project termination. These staff also undertake grant management functions related to the Sub-Recipient Agreement.",null,"High","109822",{"$nulls":5},"109822","0","0","2019-11-18 14:38:56","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgw/view","2020-12-31","Tuberculosis",109822," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713=AN2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713=AO2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713=AP2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713=AN2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713=AO2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713=AP2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2605)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgxUAG","PAI-6165","Active",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","56993","RSSH: Health management information systems and M&E","Program and data quality","Cordaid shall support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, intergrate TB services at new health facilities.","Cordaid shall support the Ministry of Health to improve the MDR-TB and childhood TB service delivery, intergrate TB services at new health facilities.",null,"High","56993",{"$nulls":5},"56993","0","0","2019-11-18 14:38:56","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgx/view","2020-12-31","Tuberculosis",56993," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713=AN2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713=AO2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713=AP2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713=AN2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713=AO2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713=AP2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2606)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJgyUAG","PAI-6166","Active",null,"2017-2019","RT Middle East and North Africa","South Sudan",null,"Tuberculosis","FR625-SSD-T","High","20000","RSSH: Health management information systems and M&E","Routine reporting","Cordaid shall support the Ministry of Health to improve MDR-TB and TB data management (eTBr, customize and install GenEX software)","Cordaid shall support the Ministry of Health to improve MDR-TB and TB data management (eTBr, customize and install GenEX software)",null,"High","20000",{"$nulls":5},"20000","0","0","2019-11-18 14:38:56","2019-11-18 14:38:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJgy/view","2020-12-31","Tuberculosis",20000," Middle East and North Africa","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713=AN2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713=AO2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713=AP2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713=AN2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713=AO2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713=AP2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2607)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJiqUAG","PAI-6167","Active",null,"2017-2019","RT Eastern Europe and Central Asia","Belarus",null,"HIV/AIDS","FR650-BLR-H","High","331819.28","HIV Testing Services","Differentiated HIV testing services","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. From 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the clients desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant Sustainability of Services for Key Populations in the EECA Region, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.","Since 2010 till 2019, the VCT in vulnerable groups (PWID, CSW, MSM) has been performed with the use of saliva rapid tests. This was less stressfull and more safe way both for clients and for social workers to perform testing; in addition, in line with the national legisloation, performing blood tests by the social workers require compliance to the sanitary-epidemiological rules and regulations, and is subject to the licensing. From 2020 onwards, HIV self-testing using rapid blood tests was included in the budget of the BLR-C-RSPCMT project due to a budget deficit. Preliminary surveys of implementing organizations have shown that switching to blood-based self-testing among vulnerable groups (PWID, CSW, MSM) will negatively affect the clients desire to undergo testing. This is primarily due to the inconvenience and unsafety in the use of blood tests in \"field\" conditions. For this reason, we consider it appropriate to provide for the possibility of purchasing saliva HIV tests, as it was done before. At the same time, Belarus, in the framework of the regional grant Sustainability of Services for Key Populations in the EECA Region, will work to lower the price of saliva tests in order to bring them closer to the level of prices for blood tests. Lowering the cost would also allow government co-financing of saliva-tests procurement and widespread use in the future.",null,"High","331819.28","The TRP agrees that some oral fluid based tests may be needed, especially for self-screening or CSO based screening programmes. The TRP notes that it is important to ensure that adequate information is available emphasising the need for  confirmation of any positive oral fluid tests with blood-based rapid tests.",{"$nulls":4},"331819.28","0","0","2019-12-03 13:35:20","2019-11-25 08:50:48","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJiq/view","2021-12-31","HIV/AIDS",331819.28000000003," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713=AN2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713=AO2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713=AP2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713=AN2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713=AO2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713=AP2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2608)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJirUAG","PAI-6168","Active",null,"2017-2019","RT Eastern Europe and Central Asia","Belarus",null,"HIV/AIDS","FR650-BLR-H","High","185040.65","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Needle and Syringe programs for PWID and their partners","When planning the BLR-C-RSPCMT grant for 2019-2021, it was assumed that, starting in 2020, Belarus will purchase supplies (syringes, condoms, etc.) for HIV prevention cabinets for PWID at the expense of the state budget. An analysis of the existing legislative framework showed that legislative amendments are required to conduct such purchases. Changes can be made to the rulemaking plan only for 2021, adopted - not earlier than 2022. Thus, we consider it necessary to include the provision of supplies for HIV prevention cabinets for PWID at the expense of the grant BLR-C-RSPCMT.","When planning the BLR-C-RSPCMT grant for 2019-2021, it was assumed that, starting in 2020, Belarus will purchase supplies (syringes, condoms, etc.) for HIV prevention cabinets for PWID at the expense of the state budget. An analysis of the existing legislative framework showed that legislative amendments are required to conduct such purchases. Changes can be made to the rulemaking plan only for 2021, adopted - not earlier than 2022. Thus, we consider it necessary to include the provision of supplies for HIV prevention cabinets for PWID at the expense of the grant BLR-C-RSPCMT.",null,"High","185040.65","This activity is in line with the main allocation and provides additional prevention programming which is technically sound and strategically focussed",{"$nulls":4},"185040.65","0","0","2019-12-03 13:38:36","2019-11-25 08:50:48","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJir/view","2021-12-31","HIV/AIDS",185040.65," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713=AN2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713=AO2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713=AP2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713=AN2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713=AO2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713=AP2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2609)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJisUAG","PAI-6169","Active",null,"2017-2019","RT Eastern Europe and Central Asia","Belarus",null,"HIV/AIDS","FR650-BLR-H","High","98759.99","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Interventions for young people who inject drugs","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.In Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".","Preliminary data from a UNAIDS study, reporting data from national agencies for controlling and countering the spread of illicit substances, indicate a significant change in the drug scene in Belarus. Significant proportion of illicit drugs used (50.6%) are psychostimulants. Psychostimulants are most oftenly used by people aged 18 to 24 years (67.9%), while opiates in this age group were used only by 35.1% of respondents (several answers were possible). The existing services provided at the sites now do not fully meet the demands of users of new drugs either in composition or in the place of their provision.In Belarus, it is planned to adapt the existing package of services so that it takes into account the needs of this group of PWID. When forming a package of services, the community will be actively involved. The basis will be the Technical Guide \"HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs\".",null,"High","98759.99","This activity is in line with the main allocation and provides additional prevention programming which is technically sound and strategically focussed",{"$nulls":4},"98759.99","0","0","2019-11-25 08:50:49","2019-11-25 08:50:48","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJis/view","2021-12-31","HIV/AIDS",98759.99," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713=AN2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713=AO2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713=AP2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713=AN2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713=AO2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713=AP2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2610)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJitUAG","PAI-6170","Active",null,"2017-2019","RT Eastern Europe and Central Asia","Belarus",null,"HIV/AIDS","FR650-BLR-H","High","556161.96","Comprehensive prevention programs for people who inject drugs (PWID) and their partners","Behavioral interventions for PWID","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.","Despite of multiple efforts on increasing linkage-to-care for PWID HIV-positive clients, those numbers still remain very low. During last 9 months, out of 126 PWID clients, who received a positive rapid test result, only 8 were involved in ART. An analysis of the pilot initiatives shows that PWID clients need comprehensive psychosocial councelling and support, and only if such support is available for a long period, the client can form motivation to maintain their own health, including by taking ART. In the scope of the BLR-C-RSPCMT project, psychosocial support for PWID is carried out only in 2 cities (Minsk, Vitebsk); service coverage needs to be significantly expanded.",null,"High","556161.96","Linkage-to care is a critical gap in the treatment cascade and therefore this activity is especially welcome. The TRP requests that active linkage to care and retention should be included int eh psychosocial support and the impact monitored. The TRP would also encourage the expansion of OST within this framework as this has been shown to assist with linkage and retention.",{"$nulls":4},"556161.96","0","0","2019-11-25 08:50:49","2019-11-25 08:50:48","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJit/view","2021-12-31","HIV/AIDS",556161.96," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713=AN2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713=AO2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713=AP2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713=AN2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713=AO2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713=AP2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2611)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJiuUAG","PAI-6171","Active",null,"2017-2019","RT Eastern Europe and Central Asia","Belarus",null,"HIV/AIDS","FR650-BLR-H","High","986668","Treatment, care and support","Differentiated ART service delivery","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. As a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. In line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD). MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.","MoH for 2 years has been negotiating the inclusion of Belarus into the  license  agreement  for  DTG.  The price level currently confirmed by ViiV, is 109 USD per pack (decrease from 170 USD, or 36%), or 1308 USD per year, which is still to high. High DTG price is the main barrier to fully introduce recent WHO guidelines on HIV treatment in the country - switching all the eligible patients to the DTG  will require  13 475 016 USD per year for DTG only. As a matter of priority, the patients with SUPPRESSED  VIRAL  LOAD  (current  level  -  74%  of  all  who receive treatment), who are currently on NVP-based regimens, will be switched to DTG (932 people). As of 30/06/2019, 286 patients already receive DTG, so the total number of \"priority\" patients will be 1218. In line with the Transition and Sustainability Plan, the Government will take over the procurement of DTG in 2020, and plans to purchase 6400 packs of DTG. Additionally, the buffer procurement of DTG to create 1-quarter buffer was conducted from  the GF grant. So, the total available quantity of DTG \"in the pipeline\" is 8 000 packs. On the other hand, the yearly need and 2-months buffer stock for the \"priority patients\" is equal to 17 052 packs; so, the existing gap is 9 052 packs (or 986 668 USD). MoH will continue working on price decrease in order to fully introduce updated WHO guidelines and ensure proper up-to-date treatment for all patients in need.",null,"High","986668","The TRP applauds the recipients efforts to reduce the costs of DTG and the cost-savings that this has resulted in, and urges the country to continue to work with GF and others to achieve the best price. Gaps in the treatment cascade, especially in the second 90 are still marked and the TRP requests that these additional resources be prioritized to closing that gap and enabling more PLWH to access ART.",{"$nulls":4},"986668","0","0","2019-11-25 08:50:49","2019-11-25 08:50:48","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJiu/view","2021-12-31","HIV/AIDS",986668," Eastern Europe and Central Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713=AN2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713=AO2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713=AP2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713=AN2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713=AO2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713=AP2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2612)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJjFUAW","PAI-6177","Inactive",null,"2017-2019","RT High Impact Asia","Philippines",null,"HIV/AIDS","FR654-PHL-H",null,"2500000","Treatment, care and support","Differentiated ART service delivery","The current allocation is mostly focused on prevention but the GF investment to the treatment is minimal due to limited allocation. The grant has a high absorption as 92% and has limited savings for reprogramming to support treatment related activities. The Philippines is prepared to fast track the  transition to TLD regimen from 2020, under the strong encouragement from the partners and request from the communities. The Government funding covers ARV and VL but faces gaps for 2020 for transition to new TLD regimen. The CCM would like to request the Global Fund to fund this fast-tracked transition. This additional funding will support the transition of 13,000 patients to TLD regimen in Philippines and cover up to 40,000 VL tests. This will bridge the gap in 2020 so the  Government could plan the budget for procurement for TLD from 2021 onwards. This investment will also be supported by the TA provided by PEPFAR project to start from 2020, to assist the national program in developing the new treatment guideline, fast tracking the FDA registration and training of facilities to adopt the new treatment guidelines.","This additional investment will help transitioning 13,000 patients to TLD regimen",null,"High","2500000","The PAAR request is aligned with and complements the within-allocation program, and increases the overall contribution of funding support to maximize impact in the fight against HIV in Philippines. The request is strategically focused and technically sound, aiming to scale up an optimized antiretroviral treatment regimen in accordance with WHO recommendations. The TRP recommends the country continue working on strengthening the HIV cascade specially focusing on linkage to care as recommended in the TRP form dated 2 May 2017.",null,"2500000",null,null,"0","1","0","2020-01-14 12:45:48","2019-11-26 11:18:59","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJjF/view","2020-12-31","HIV/AIDS",0," High Impact Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713=AN2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713=AO2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713=AP2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713=AN2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713=AO2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713=AP2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2613)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJjUUAW","PAI-6178","Active",null,"2017-2019","RT High Impact Africa 1","Ghana",null,"Malaria","FR636-GHA-M","High","2.3e+07","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","The funds are required to ensure continued VC coverage by procuring LLIN for the 2021 Q1 mass distribution campaign. The funds for the 2021 campaign were not included in the current grant. The bed nets used for the 2018 mass distribution campaign where procured in 2017 with NFM1 grant budget.","The funds are required to ensure continued VC coverage by procuring LLIN for the 2021 Q1 mass distribution campaign. The funds for the 2021 campaign were not included in the current grant. The bed nets used for the 2018 mass distribution campaign where procured in 2017 with NFM1 grant budget.",null,"High","2.3e+07","The TRP recommends that only pre-qualified nets be considered, and that the optimization exercise is informed by entomological information on the type, intensity and geographic spread of pyrethroid resistance, durability as well as unit costs. In addition, the TRP recommends that the Secretariat ensures that, by the time the intervention is incorporated into the grant, data on entomological stratification support the use of PBOs and new nets in appropriate locations.",{"$nulls":4},"2.3e+07","0","0","2019-11-26 12:24:25","2019-11-26 12:24:25","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJjU/view","2020-12-31","Malaria",23000000," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713=AN2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713=AO2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713=AP2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713=AN2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713=AO2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713=AP2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2614)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJkmUAG","PAI-6180","Active",null,"2017-2019","RT Southern and Eastern Africa","Namibia",null,"Malaria","FR655-NAM-M","High","1384600","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Procure essential   350 000 LLIN's to cover cover the gap currently experieneced with populations living in Zinc Structures.   The Zinc structures were earmarked for IRS as well but it was found that IRS is not best suited for Zinc Structures.  The programme is currently testing the residual efficacy of insecticides (Actelic) on Zinc structures, while collecting this data, people residing in these structure should be protected by mosquito nets. The 300,000  Nets constitute the gap since these population were not targeted  for nets before. Price includes PSM costs","Procure essential   350 000 LLIN's to cover cover the gap currently experieneced with populations living in Zinc Structures.   The Zinc structures were earmarked for IRS as well but it was found that IRS is not best suited for Zinc Structures.  The programme is currently testing the residual efficacy of insecticides (Actelic) on Zinc structures, while collecting this data, people residing in these structure should be protected by mosquito nets. The 300,000  Nets constitute the gap since these population were not targeted  for nets before. Price includes PSM costs",null,"High","1384600","Population at risk to malaria  should always be protected. As zinc structure is not sprayable and as the change from zink structure to sprayable surfaces is not possible now and as research is going on to find  a solution for this problem; it isjustified to shift to LLINs to protect at risk population",null,"699999",null,null,"684601","0","0","2020-02-11 11:08:29","2019-11-29 13:56:54","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJkm/view","2020-12-31","Malaria",684601," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713=AN2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713=AO2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713=AP2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713=AN2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713=AO2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713=AP2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2615)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJmnUAG","PAI-6181","Active",null,"2017-2019","RT Southern and Eastern Africa","Comoros",null,"Malaria","FR663-COM-M","High","419652","Vector control","Indoor residual spraying (IRS)","IRS for indigenous cases in elimination areas (5 km radius): In the elimination areas, malaria cases should undergo both epidemiological and entomological investigations to determine the origin of the case. Once the case is declared indigenous, case management (treatment) and interruption of parasite transmission by the vector (IRS) are the two main response interventions used to prevent epidemics. This activity will take place following the results of the prior entomological investigations. A total of nine IRS interventions are planned based on an expected 5 percent of imported cases over the three years in elimination areas. Thus, nine cases are expected in total  two cases in 2019, four cases in 2020 and three cases in 2021. Expected outcome: interruption of transmission. Expected impact: prevention of re-introduction of the disease.","IRS for indigenous cases in elimination areas (5 km radius): In the elimination areas, malaria cases should undergo both epidemiological and entomological investigations to determine the origin of the case. Once the case is declared indigenous, case management (treatment) and interruption of parasite transmission by the vector (IRS) are the two main response interventions used to prevent epidemics. This activity will take place following the results of the prior entomological investigations. A total of nine IRS interventions are planned based on an expected 5 percent of imported cases over the three years in elimination areas. Thus, nine cases are expected in total  two cases in 2019, four cases in 2020 and three cases in 2021. Expected outcome: interruption of transmission. Expected impact: prevention of re-introduction of the disease.",null,"High","419652",{"$nulls":5},"419652","0","0","2020-01-30 11:05:41","2019-12-04 08:43:40","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJmn/view","2021-12-31","Malaria",419652," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713=AN2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713=AO2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713=AP2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713=AN2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713=AO2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713=AP2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2616)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2021-12-31"]
["a6Q1R000000AJmsUAG","PAI-6182","Inactive",null,"2017-2019","RT Southern and Eastern Africa","Madagascar",null,"Malaria","FR664-MDG-M","High","16758100","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.","Universal distribution will take place in 2018 and 2021. To ensure the continuity of this intervention, in the 56 districts in the control phase not targeted by the continuous distribution, preparatory activities for the 2021 campaign are be included in this PAAR request. This will help to maintain the expected annual progress of a 40-percent annual reduction in incidence in these districts.",null,"High","16758100",null,null,"16758100",null,null,"0","1","0","2020-01-14 12:31:37","2019-12-04 08:44:42","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJms/view","2021-06-30","Malaria",0," Southern and Eastern Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713=AN2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713=AO2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713=AP2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713=AN2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713=AO2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713=AP2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2617)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJmxUAG","PAI-6183","Active",null,"2017-2019","RT High Impact Africa 1","Nigeria",null,"Tuberculosis","FR665-NGA-T","High","9515528","MDR-TB","Case detection and diagnosis: MDR-TB","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.","Procurement of additional cartridges and PSM costs:The country plans to procure additional 280, 4 modular machines to address the diagnostic gap. A total of 645,120 cartridges would be required for the machines to run optimally at 3 runs per day. The cartridge would be procured by GON (30%), USG (20%) and GF (50%). Above allocation will be used to procure, 322, 560 cartridges including PSM costs.",null,"High","9515528",{"$nulls":5},"9515528","0","0","2019-12-04 08:45:43","2019-12-04 08:45:43","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJmx/view","2020-12-31","Tuberculosis",9515528," High Impact Africa 1","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713=AN2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713=AO2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713=AP2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713=AN2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713=AO2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713=AP2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2618)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJn2UAG","PAI-6184","Active",null,"2017-2019","RT High Impact Asia","Pakistan",null,"Malaria","FR667-PAK-M","High","206900","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.","In 2016-2017, DOMC has covered targeted 25 Stratum-IA districts (API >10) for mass distribution of LLINs to pregnant women. Yet, for 2018-2020, 7 / 25 districts (N.Waziristan, Kurram, Tharpakar, Khairpur, Kech, Sibi and Noushki) have not been targeted for replacement of LLINs to sustain the universal coverage amongst this at risk population. Therefore, mass distribution of around 2,212,151 LLINs in 2019 is targeted for PAAR.",null,"High","206900",{"$nulls":5},"206900","0","0","2019-12-04 08:48:49","2019-12-04 08:48:49","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJn2/view","2020-12-31","Malaria",206900," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713=AN2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713=AO2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713=AP2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713=AN2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713=AO2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713=AP2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2619)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJnCUAW","PAI-6190","Active",null,"2017-2019","RT Southern and Eastern Africa","Rwanda",null,"HIV/AIDS, Malaria","FR668-RWA-Z","High","10958103","Vector control","Indoor residual spraying (IRS)","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.","This is to support immediate action  aimed  at preserving the susceptibility of malaria vectors to pyrethroids and will support IRS  in  4 districts  (Nyanza, Huye,Bugeseraand  Ngoma) in 2018 and 5 districts  (Nyanza,  Huye,Bugesera,Gatsibo  and Ngoma) in  2019 and 2020 in line  with the  WHO  guidelines.",null,"High","10958103",{"$nulls":5},"10958103","0","0","2019-12-04 09:01:43","2019-12-04 09:01:43","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnC/view",null,"Multi-component",10958103," Southern and Eastern Africa","HIV/AIDS, Malaria","HIV/AIDS"," Malaria",null,null,"Malaria","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713=AN2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713=AO2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713=AP2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713=AN2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713=AO2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713=AP2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2620)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJnDUAW","PAI-6191","Active",null,"2017-2019","RT Southern and Eastern Africa","Rwanda",null,"HIV/AIDS, Malaria","FR668-RWA-Z","High","11617393","Treatment, care and support","Other intervention(s) for treatment","This request is for alignment of grant.","This request is for alignment of grant.",null,"High","11617393",{"$nulls":5},"11617393","0","0","2019-12-04 09:01:43","2019-12-04 09:01:43","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnD/view",null,"Multi-component",11617393," Southern and Eastern Africa","HIV/AIDS, Malaria","HIV/AIDS"," Malaria",null,null,"Malaria","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713=AN2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713=AO2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713=AP2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713=AN2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713=AO2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713=AP2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2621)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJnEUAW","PAI-6192","Active",null,"2017-2019","RT Southern and Eastern Africa","Rwanda",null,"HIV/AIDS, Malaria","FR668-RWA-Z","High","5166187","HIV Testing Services","Differentiated HIV testing services","This request is for alignment of grant.","This request is for alignment of grant.",null,"High","5166187",{"$nulls":5},"5166187","0","0","2019-12-04 09:01:43","2019-12-04 09:01:43","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnE/view",null,"Multi-component",5166187," Southern and Eastern Africa","HIV/AIDS, Malaria","HIV/AIDS"," Malaria",null,null,"Malaria","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713=AN2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713=AO2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713=AP2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713=AN2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713=AO2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713=AP2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2622)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJnFUAW","PAI-6193","Active",null,"2017-2019","RT Southern and Eastern Africa","Rwanda",null,"HIV/AIDS, Malaria","FR668-RWA-Z","High","1003118","PMTCT","Other intervention(s) for PMTCT","This request is for alignment of grant.","This request is for alignment of grant.",null,"High","1003118",{"$nulls":5},"1003118","0","0","2019-12-04 09:01:43","2019-12-04 09:01:43","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnF/view",null,"Multi-component",1003118," Southern and Eastern Africa","HIV/AIDS, Malaria","HIV/AIDS"," Malaria",null,null,"Malaria","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713=AN2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713=AO2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713=AP2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713=AN2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713=AO2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713=AP2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2623)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJnGUAW","PAI-6194","Active",null,"2017-2019","RT Southern and Eastern Africa","Rwanda",null,"HIV/AIDS, Malaria","FR668-RWA-Z","High","2100000","HIV Testing Services","Differentiated HIV testing services","This request is for alignment of grant.","This request is for alignment of grant.",null,"High","2100000",{"$nulls":5},"2100000","0","0","2019-12-04 09:01:43","2019-12-04 09:01:43","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnG/view",null,"Multi-component",2100000," Southern and Eastern Africa","HIV/AIDS, Malaria","HIV/AIDS"," Malaria",null,null,"Malaria","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713=AN2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713=AO2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713=AP2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713=AN2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713=AO2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713=AP2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2624)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AJnHUAW","PAI-6195","Inactive",null,"2017-2019","RT Central Africa","Central African Republic",null,"Malaria","FR630-CAF-M","High","6410432","Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Il tait prvu la distribution des MILD dans les rgions 1, 2 et 3 en 2019 pour protger les populations contre le paludisme, car la dernire campagne dans ces 3 rgions remonte  2014. Le rapport de la micro planification dans ces rgions rvle que la population a augment de 49% par rapport aux chiffres de macro planification. Etant donn que les MILDs disponibles pour la campagne au niveau du pays ne sont que 1,800,700, alors que le besoin avec l'augmentation exige d'avoir 2,552,998 MILD afin de pouvoir couvrir ces rgions, entrainant ainsi un gap de 752,300 MILDs qui couteront 1,847,798 euros.Le budget initialement prvue pour la campagne tait seulement 3,325,097euros (cot oprationnel). Laugmentation de la population a engendr non seulement le gap en moustiquaires mais aussi un gap financier exorbitant relatif au cout oprationnel s'levant  3,864,538 euros. Il se trouve que pour couvrir les trois rgions, le pays aura besoin de 7,189,635 euros incluant les couts lis aux ONG de mise en uvre; ce qui dgage ainsi un gap de 5,712,336 Euros incluant les moustiquaires additionnelles, leur distribution et les couts oprationnels. Si ce gap n'est pas combl, le pays ne pourra pas faire la campagne dans ces trois rgions et par consquent il ne pourra pas atteindre l'objectif de la distribution de masse pour l'anne 2019-2020.","The distribution of LLINs in Regions 1, 2 and 3 in 2019 was planned to protect populations against malaria, as the last campaign in these 3 regions was in 2014.The report of micro planning in these areas reveals that the population has increased by 49% compared to macro planning figures. Given that the LLINs available in country for the campaign are only 1,800,700, while the need resulting from population increase requires 2,552,998 LLINs to cover these areas, there is a resulting gap of 752,300 LLINs that will cost EUR 1,847,798.The initial budget for the campaign was only EUR 3,325,097(operational cost). The increase of the population has generated not only a gap in nets but also an exorbitant financial gap related to operational costs amounting to EUR 3,864,538. In order to keep covering the three regions within the mass campaing, the new budget would reach EUR 7,189,635 (including costs related to implementing NGOs). With the current level of funding, this results in a gap of EUR 5,712,336 including additional nets and respective distribution and operational costs.If this gap is not filled, the country will not be able to implement the campaign in the 3 regions and will not be able to achieve coverage targets of mass distribution for the year 2019-2020.",null,"High","6410432",null,null,"6410432",null,null,"0","1","0","2020-01-30 10:56:17","2019-12-04 10:24:38","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnH/view","2020-12-31","Malaria",0," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713=AN2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713=AO2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713=AP2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713=AN2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713=AO2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713=AP2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2625)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJnIUAW","PAI-6196","Inactive",null,"2017-2019","RT Central Africa","Central African Republic",null,"Malaria","FR630-CAF-M","High","1878183","Case management","Facility-based treatment","Dans le cadre d'une bonne gestion de stocks des intrants de sant et de rendre disponible les intrants financs par le Fonds Mondial en RCA, il a t opt de chercher un partenaire ayant une expertise et une capacit logistique qui est le Programme Alimentaire Mondial (PAM). Les couts y relatifs couvrent le transport des intrants  l'intrieur du pays, l'assurance des intrants, les frais de manutention, la scurit et les cots doprations de support. Le budget qui tait initialement prvu pour les trois annes de la subvention tait estim  2,100,000 Euros seulement et ne prenait en compte les frais de gestion pays au PAM. Cependant, il s'avre que ce budget soit insuffisant vu les factures du PAM jusquen Dcembre 2019 estim  2,326,922 Euros d'o un dpassement de 226,922 euros, soit 10% du budget initialement prvu  cet effet. Ce budget est seulement pour la logistique des produits de sant excluant les moustiquaires. Notons que pour l'anne 2019 le Fonds Mondial avait recommand que ces frais ne devraient pas dpasse 1,260,000 euros. Pour l'anne 2020, il y aura une augmentation des Formations Sanitaires qui passeront de 736  838, ce qui va occasionner une augmentation des besoins en intrants (antipaludens et TDR; mais leur achat sera couvert par les conomies des autres lignes), des frais de transport (surtout qu'ils sont estims en terme de volume transport), de manutention et assurance. Ainsi, les prvisions budgtaires pour le PAM pour l'anne 2020, estimes sur la base des dpenses actuelles, s'lvent  1,653, 302 Euros. Considrant le dficit actuel de 226,922 euros sur cette ligne budgtaire, il se dgage un gap financier cumulatif de 1,880,224 euros. Toutefois, sur base des conomies dgages sur les autres lignes budgtaires, le gap  combler s'lve  1,673,649.68 euros.","To ensure sound management of commodities procured with Global Fund grant funds and their availability in CAR, the World Food Program (WFP) was selected as SCM partner, given their known expertise and logistical capacity. WFPs budget and costs cover transportation of inputs in country, insurance, warehousing, handling, security and support costs. The original budget that was estimated to cover their services during three years of implementation reached EUR 2,100,000 and did not include management fees paid to WFP. Given WFPs budget rate consumption so far and projected level of expenses at the end of 2019, EUR 2,326,922, it results in a EUR 226,922 over expenditure (10% above original budget planned for this purpose). This budget only covers logistics of health products excluding mosquito nets. Note that for the year 2019 the Global Fund had recommended that these costs should not exceed EUR 1,260,000.During year 2020, there will be an increase of number of functional health facilities (going from 736 to 838) in the country that will result in an increase demand of commodities (ACTs and RDTs, partly covered with grant savings), transportation costs (especially considering that their estimation is based on volume), warehousing and insurance. Adding this, the projected budget needs for WFP in 2020 (which are estimated on current budget absorption) raise up to EUR 1,653,302. If we consider the above mentioned 10% over expense, the funding gap is EUR 1,880,224. However, some efficiencies in country (identified in other budget lines) will contribute to cover part of the gap. Which results in a final gap of EUR 1,673,649.68.",null,"High","1878183",null,null,"1878183",null,null,"0","1","0","2020-01-30 11:02:56","2019-12-04 10:24:38","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnI/view","2020-12-31","Malaria",0," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713=AN2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713=AO2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713=AP2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713=AN2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713=AO2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713=AP2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2626)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJnJUAW","PAI-6197","Inactive",null,"2017-2019","RT Central Africa","Central African Republic",null,"Malaria","FR630-CAF-M","High","514827","Case management","Integrated community case management (ICCM)","Une des stratgies de la prise en charge du paludisme en temps rel est la cration des Points Paludisme avec le soutien technique de MSF dans leurs zones d'intervention.  Cette stratgie va faire augmenter la demande de service au niveau communautaire et par consquent la demande accrue des ACTs. Le nombre des points palu grs par le groupe MSF est 78 avec une consommation mensuelle moyenne de 420 doses. La dose totale estime est de 589,680 incluant un stock de scurit de 6 mois. Pour l'acquisition de ces intrants, 272,974.67 euros sont ncessaires. Le cot de transport et d'assurance depuis chez le fournisseur/fabriquant jusqu'  Bangui est de 185,788 euros.   Ce qui donne un budget global d'achat de 458,762.67 Euros faisant objet de demande additionnelle.","One of the strategies that will strengthen real-time malaria case management is the creation of Malaria Points (palu points) with MSF's technical support within their areas of intervention. This strategy will increase the demand for services at the community level and consequently the demand of commodities. The number of palu points managed by MSF is 78 with an average monthly consumption of 420 doses of ACTs. The total estimated dose is therefore 589,680 (including a 6-month buffer stock). The procurement of these inputs (EUR 272,974.67) also requires the estimation of transport and insurance costs from the supplier / manufacturer to Bangui, which were estimated to raise EUR 185,788.This gives an overall budget of EUR 458,762.67 for this intervention.",null,"High","514827",null,null,"514827",null,null,"0","1","0","2020-01-30 10:53:37","2019-12-04 10:24:38","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJnJ/view","2020-12-31",{"$f":"IF(OR(I2627=\"HIV/AIDS\",I2627=\"Tuberculosis\",I2627=\"Malaria\",I2627=\"RSSH\"),I2627, IF(I2627=\"HIV/AIDS, Tuberculosis\",\"TB/HIV\",\"Multi-component\"))","v":"Malaria"},{"$f":"VALUE(Y2627)","v":0},{"$f":"RIGHT(F2627,LEN(F2627)-2)","v":" Central Africa"},"Malaria","Malaria",null,null,null,{"$f":"TRIM(AK2627)","v":""},{"$f":"TRIM(AL2627)","v":""},{"$f":"TRIM(AM2627)","v":""},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713=AN2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713=AO2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713=AP2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IF(AE2627<>\"\",AE2627,IF(MAX(AQ2627,AR2627,AS2627,AT2627)<>0,MAX(AQ2627,AR2627,AS2627,AT2627),AU2627))","v":"2020-12-31"},{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713=AN2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713=AO2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713=AP2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2627)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IF(AE2627<>\"\",AE2627,IF(MAX(AW2627,AX2627,AY2627,AZ2627)<>0,MAX(AW2627,AX2627,AY2627,AZ2627),BA2627))","v":"2020-12-31"}]
["a6Q1R000000AJpSUAW","PAI-6198","Inactive",null,"2017-2019","RT South East Asia","Mongolia",null,"Tuberculosis","FR672-MNG-T","High","832198","TB care and prevention","Case detection and diagnosis","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.","ACF strategy requires reaching more vulnerable and remote populations by mobile active case finding teams equipped with proper equipment. Three TB high burden provinces (Khetii, Uvurkhangai and Orkhon) along the Trans-Siberian Railways require Xperts and 4 inter-soum hospitals need TB-LAMPs. These inter-soums hospitals are located in provinces with higher population density, mining activities and close to borders. Contact tracing during ACF will reveal more TB cases. Due to current limitation in access and inadequate services by the soum health centres, household contact tracing lags behind at 3.2%. With these equipment, this can go up to 5%.",null,"High","832198",null,null,"832198",null,null,"0","1","0","2020-01-14 14:28:32","2019-12-10 09:24:21","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJpS/view","2020-12-31","Tuberculosis",0," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713=AN2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713=AO2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713=AP2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713=AN2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713=AO2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713=AP2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2628)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJpXUAW","PAI-6199","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Belarus",null,"Tuberculosis","FR675-BLR-T","High","3400000","MDR-TB","Treatment: MDR-TB","Regimen Change: introduction of new treatment regimen approved by WHO","Regimen Change: introduction of new treatment regimen approved by WHO",null,"High","3400000",null,null,"3400000",null,null,"0","1","0","2020-01-14 12:18:11","2019-12-10 10:10:41","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJpX/view","2021-12-31","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713=AN2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713=AO2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713=AP2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2019-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713=AN2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713=AO2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713=AP2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2629)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-12-31"]
["a6Q1R000000AJpcUAG","PAI-6200","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Kyrgyzstan",null,"Tuberculosis","FR629-KGZ-T","High","3020000","MDR-TB","Treatment: MDR-TB","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization","Reflecting TRP in-principle approval of MDR-TB regimen change UQD interventions in November 2018. This allowed the interventions to be prioritized and awarded through Portfolio Optimization",null,"High","3020000",null,"1012","3018988",null,null,"0","1","0","2020-03-03 09:48:43","2019-12-10 10:34:48","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJpc/view","2020-12-31","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713=AN2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713=AO2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713=AP2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713=AN2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713=AO2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713=AP2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2630)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJphUAG","PAI-6201","Inactive",null,"2017-2019","RT South East Asia","Mongolia",null,"Tuberculosis","FR631-MNG-T","High","350000","MDR-TB","Treatment: MDR-TB","MDR-TB Regimen change","MDR-TB Regimen change",null,"High","350000",null,null,"350000",null,null,"0","1","0","2020-01-14 12:33:53","2019-12-10 12:28:52","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJph/view","2020-12-31","Tuberculosis",0," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713=AN2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713=AO2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713=AP2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713=AN2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713=AO2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713=AP2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2631)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJpmUAG","PAI-6202","Inactive",null,"2017-2019","RT High Impact Asia","Thailand",null,"Tuberculosis","FR676-THA-T","High","5e+05","MDR-TB","Treatment: MDR-TB","MDR-TB regimen change","MDR-TB regimen change",null,"High","5e+05",null,null,"5e+05",null,null,"0","1","0","2020-01-14 12:55:08","2019-12-10 12:37:07","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJpm/view","2020-12-31","Tuberculosis",0," High Impact Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713=AN2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713=AO2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713=AP2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713=AN2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713=AO2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713=AP2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2632)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJprUAG","PAI-6203","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Turkmenistan",null,"Tuberculosis","FR632-TKM-T","High","1460500","MDR-TB","Treatment: MDR-TB","Increase of funding needs for XDR-TB due to WHO recommendation to increase treatment with Bedaquilin/Delamanit to 12-18m instead of 6m, this amount is expected to cover 2020-2021 needs. This comes in addition to previously approved Portfolio Optimization Amount. Module: MDR-TB; Intervention: Treatment","Increase of funding needs for XDR-TB due to WHO recommendation to increase treatment with Bedaquilin/Delamanit to 12-18m instead of 6m, this amount is expected to cover 2020-2021 needs. This comes in addition to previously approved Portfolio Optimization Amount. Module: MDR-TB; Intervention: Treatment",null,"High","1460500",null,null,"1460500",null,null,"0","1","0","2020-01-14 12:57:45","2019-12-10 12:40:18","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJpr/view","2021-06-30","Tuberculosis",0," Eastern Europe and Central Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713=AN2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713=AO2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713=AP2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713=AN2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713=AO2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713=AP2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2633)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJs2UAG","PAI-6204","Active",null,"2017-2019","RT Southern and Eastern Africa","Lesotho",null,"HIV/AIDS","FR651-LSO-H","High","9212649","Treatment, care and support","Differentiated ART service delivery",null,"The Ministry of Health conducted quantifications for health products in order to inform the government 2019/2020 finacial year budget for health products. From the quantification, it was determined that the national need for ARVs would need LSL 444,172,844.54 (approximately US$ 32 million). It was already known that the Global Fund contribution for ARVs for the 2019/2020 financial year is LSL 68,536,085.87. Due to fiscus challenges, the Ministry of Health was only allocated LSL 236,775,819 for the ARVs and this led to a funding gap of LSL 138,860,939.67. Efforts were made by both the Ministry of Health and Ministry of Finance to mobilise the funds but the resource mobilisation did not yield positive results. It is against this background that the country is requesting support from the Global Fund towards procurement of ARVs in order to close the eminent funding gap. The funds that are being sought will go a long way in ensuring that there is availability of commodities (ARVs) so tht there is continuity of treatment for People Living with HIV. The ARVs to be procured with the funds being sought will take ARV stock holding to December 2020 and this will give the Government of Lesotho ample time to mobilise adequate resources to ensure there will not be any shortages going forward.",null,"High","9212649","The TRP supports the additional request for ARVs, given that the programmes shift in strategic approaches with an increased focus on test and start towards the targets of 95/95/95 have led to an increased in expected need for ARVs.",null,"8544633",null,null,"668016","0","0","2020-01-17 14:03:56","2019-12-16 14:15:34","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJs2/view","2021-06-30","HIV/AIDS",668016," Southern and Eastern Africa","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713=AN2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713=AO2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713=AP2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-06-30"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713=AN2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713=AO2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713=AP2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2634)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-07-01"},"2021-06-30"]
["a6Q1R000000AJsRUAW","PAI-6205","Inactive",null,"2017-2019","RT South East Asia","Nepal",null,"HIV/AIDS","FR658-NPL-H","High","860000","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Differentiated service package for migrants with linkages to testing & treatment. This key population is the driver of new HIV infections, however, currently not covered with HIV prevention services. As mentioned above, in order to ensure meaning scale-up of coverage with comprehensive HIV prevention services for this population  and roll-out of the differentiated service package from 2020, additional funding is requested by the country. Expected outcome: coverage of 100,000 migrants with HIV prevention services and linkages of HIV+ migrants to treatment and care. MigrantsKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 100,000KP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 80,000","Differentiated service package for migrants with linkages to testing & treatment. This key population is the driver of new HIV infections, however, currently not covered with HIV prevention services. As mentioned above, in order to ensure meaning scale-up of coverage with comprehensive HIV prevention services for this population  and roll-out of the differentiated service package from 2020, additional funding is requested by the country. Expected outcome: coverage of 100,000 migrants with HIV prevention services and linkages of HIV+ migrants to treatment and care. MigrantsKP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 100,000KP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 80,000",null,"High","860000","The TRP considers prevention services for Migrants as high priority as migration is a key driver of new HIV infections in Nepal. However, few HIV services have been tailored to migrants. Therefore, it's  important to ensure coverage for this population.",null,"860000",null,null,"0","1","0","2020-01-14 12:38:27","2019-12-17 12:42:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJsR/view","2021-03-15","HIV/AIDS",0," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713=AN2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713=AO2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713=AP2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713=AN2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713=AO2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713=AP2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2635)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJsSUAW","PAI-6206","Inactive",null,"2017-2019","RT South East Asia","Nepal",null,"HIV/AIDS","FR658-NPL-H","High","1e+05","Prevention programs for other vulnerable populations","Behavioral interventions for other vulnerable populations","Prevention services for prisoners with linkages to testing & treatment. This is a high risk group and no prevention services are currently provided to them. As mentioned above, in order to ensure meaningful scale-up of coverage with comprehensive HIV prevention services for this population, additional funding is requested by the country. Expected outcome: coverage of 14,000 with HIV prevention services and linkages of HIV+ prisoners to treatment and care.KP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 14,000KP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 11,200","Prevention services for prisoners with linkages to testing & treatment. This is a high risk group and no prevention services are currently provided to them. As mentioned above, in order to ensure meaningful scale-up of coverage with comprehensive HIV prevention services for this population, additional funding is requested by the country. Expected outcome: coverage of 14,000 with HIV prevention services and linkages of HIV+ prisoners to treatment and care.KP-1e: Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services.  Target by the end of the grant: 14,000KP-3e: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results. Target by the end of the grant: 11,200",null,"High","1e+05","While approving this intervention, the TRP considers that prevention services for prisoners are very high priority. According to the funding request, out of 14,000 prisoners, 11,200 will be tested, indicating one-time testing rather than ongoing access (taking into account prisoner turnover). The TRP suggests that, should any efficiencies be identified in the the migrants' intervention (row above), funds should be re-programmed to expand the prisoners intervention, to increase number of tests and improve ongoing access to testing and services to ensure linkage to treatment.",null,"1e+05",null,null,"0","1","0","2020-01-14 12:38:49","2019-12-17 12:42:23","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJsS/view","2021-03-15","HIV/AIDS",0," South East Asia","HIV/AIDS","HIV/AIDS",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713=AN2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713=AO2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713=AP2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713=AN2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713=AO2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713=AP2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2636)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJsWUAW","PAI-6207","Inactive",null,"2017-2019","RT South East Asia","Nepal",null,"Malaria","FR659-NPL-M","High","88000","Case management","Integrated community case management (ICCM)","National Malaria Program needs to strengthen activities to eliminate malaria including rolling out a community-based response. Additional funding is therefore needed to support  a critical gap in RDTs for the roll-out of community-based testing of in-risk and vulnerable populations. Outcome: strengthened case management at the community level; approximately 88,000 persons will be tested for malaria at the community level.No increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.","National Malaria Program needs to strengthen activities to eliminate malaria including rolling out a community-based response. Additional funding is therefore needed to support  a critical gap in RDTs for the roll-out of community-based testing of in-risk and vulnerable populations. Outcome: strengthened case management at the community level; approximately 88,000 persons will be tested for malaria at the community level.No increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.",null,"High","88000","A community intervention to control malaria is very important in a country such as Nepal where health centers are remote and difficult to access. Rolling out a community based response is a productive way to control malaria in hard to reach communities where malaria risk is still present; therefore the TRP approves this intervention.",null,"88000",null,null,"0","1","0","2020-01-27 11:12:57","2019-12-17 12:45:17","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJsW/view","2021-03-15","Malaria",0," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713=AN2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713=AO2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713=AP2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713=AN2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713=AO2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713=AP2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2637)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJsXUAW","PAI-6208","Inactive",null,"2017-2019","RT South East Asia","Nepal",null,"Malaria","FR659-NPL-M","High","320000","Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","National Malaria Program needs to strengthen activities to eliminate malaria and address malaria outbreaks in 2018-2019 in areas originally classified malaria-free. Additional funding is therefore needed to support LLINs where due to decentralization, Government funding for LLINs for continuous distribution for 2020 has not been realized.Outcome: coverage with LLINs of vulnerable and in-risk populations, approximately 180,000 persons will be covered with LLINs.No increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.","National Malaria Program needs to strengthen activities to eliminate malaria and address malaria outbreaks in 2018-2019 in areas originally classified malaria-free. Additional funding is therefore needed to support LLINs where due to decentralization, Government funding for LLINs for continuous distribution for 2020 has not been realized.Outcome: coverage with LLINs of vulnerable and in-risk populations, approximately 180,000 persons will be covered with LLINs.No increase in PF targets is planned as grant funding will cover gaps in procurement of LLINs and RDTs.",null,"High","320000","This intervention is appropriate for the endemic situation in country and for control of the epidemic through a dual net distribution scheme. The vulnerable groups are identified and the distribution method are adequate. The TRP approves this intervention and recommends on-going monitoring of factors  which could influence the epidemic such as climate or seasonal migration to ensure that the continuous distribution to target groups is conducted at appropriate times.",null,"320000",null,null,"0","1","0","2020-01-14 12:37:17","2019-12-17 12:45:17","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJsX/view","2021-03-15","Malaria",0," South East Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713=AN2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713=AO2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713=AP2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713=AN2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713=AO2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713=AP2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2638)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJsbUAG","PAI-6209","Inactive",null,"2017-2019","RT South East Asia","Nepal",null,"Tuberculosis","FR660-NPL-T","High","2150000","TB care and prevention","Case detection and diagnosis","As described above, the following prioritized interventions of US$ 2,150,000 are requested to strenghten TB case detection and diagnosis and address existing gaps:  i) the expansion of GenXperts and sputum transportation to expand access to rapid diagnosis (US$950,000); ii) strengthening two regional laboratories to make them fully operational and efficient to strengthen case detection and expand TB diagnosis also at the regional level (US$800,000); iii) strengthening drug susceptibility testing (DST) at the regional level to scale-up MDR-TB diagnosis (US$200,000), and; iv) supporting the development of a structured quality improvement program based on SLMTA model designed for resource limited settings (US$200,000).  Sustainability of activities: these activities represent a 12-month investment of predominantly products to be procured to strengthen the existing laboratory system.Expected outcomes: increased case notification by 25% as compared to current achievement resulting in 8,000 additional TB cases notified and linked to treatment by the end of the grant; expanded access to early TB diagnosis; improved treatment monitoring and outcomes for DR-TB; strengthened laboratory system at the regional level to deliver timely TB diagnostic services, and; a SLMTA program design and costed implementation plan in place as well as the training of a core quality management team.  PF Indicator: TCP-1 (M): Number of notified cases of all forms of TB-(i.e. bacteriologically confirmed + clinically diagnosed), includes new and relapse casesTargets will be revised upwards for 2020. Revised target for 2020: 40,451.","As described above, the following prioritized interventions of US$ 2,150,000 are requested to strenghten TB case detection and diagnosis and address existing gaps:  i) the expansion of GenXperts and sputum transportation to expand access to rapid diagnosis (US$950,000); ii) strengthening two regional laboratories to make them fully operational and efficient to strengthen case detection and expand TB diagnosis also at the regional level (US$800,000); iii) strengthening drug susceptibility testing (DST) at the regional level to scale-up MDR-TB diagnosis (US$200,000), and; iv) supporting the development of a structured quality improvement program based on SLMTA model designed for resource limited settings (US$200,000).  Sustainability of activities: these activities represent a 12-month investment of predominantly products to be procured to strengthen the existing laboratory system.Expected outcomes: increased case notification by 25% as compared to current achievement resulting in 8,000 additional TB cases notified and linked to treatment by the end of the grant; expanded access to early TB diagnosis; improved treatment monitoring and outcomes for DR-TB; strengthened laboratory system at the regional level to deliver timely TB diagnostic services, and; a SLMTA program design and costed implementation plan in place as well as the training of a core quality management team.  PF Indicator: TCP-1 (M): Number of notified cases of all forms of TB-(i.e. bacteriologically confirmed + clinically diagnosed), includes new and relapse casesTargets will be revised upwards for 2020. Revised target for 2020: 40,451.",null,"High","2150000","The PAAR is strategically sound and scientifically based to support increased access to diagnostic testing, based on the recent surveillance survey identifying a larger gap in undiagnosed cases than previously predicted.",null,"2150000",null,null,"0","1","0","2020-01-14 12:36:20","2019-12-17 12:46:07","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJsb/view","2021-03-15","Tuberculosis",0," South East Asia","Tuberculosis","Tuberculosis",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-03-15"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713=AN2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713=AO2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713=AP2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-15"},"2021-03-15",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-03-16"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713=AN2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713=AO2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713=AP2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2639)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-03-16"},"2021-03-15"]
["a6Q1R000000AJsgUAG","PAI-6210","Active",null,"2017-2019","RT South East Asia","Papua New Guinea",null,"HIV/AIDS, Tuberculosis","FR657-PNG-C","High","2975000","Treatment, care and support","Differentiated ART service delivery","Switch the cohort of 29,420 PHIV on ART to DTG based regiment to respond to very high ART drug resistance and replenish the ART buffer stock back to the required minimum of 12 months to ensure the linkage between the currently supported prevention activities and treatment and care. No change in the targets for the treatment indicator.","Switch the cohort of 29,420 PHIV on ART to DTG based regiment to respond to very high ART drug resistance and replenish the ART buffer stock back to the required minimum of 12 months to ensure the linkage between the currently supported prevention activities and treatment and care. No change in the targets for the treatment indicator.",null,"High","2975000","This funding request is critical to procure needed drugs and buffer stocks to prevent ART resistance and to align the PNG to the current ART recommendations. The rationale and description indicate that this is a much needed expenditure within the context of on-going technical and programmatic support provided by the Global Fund, WHO and other partners, and it is therefore approved by the TRP",null,"2919868",null,null,"55132","0","0","2020-01-14 12:41:19","2019-12-17 12:47:27","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJsg/view","2020-12-31","TB/HIV",55132," South East Asia","HIV/AIDS, Tuberculosis","HIV/AIDS"," Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713=AN2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713=AO2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713=AP2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713=AN2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713=AO2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713=AP2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2640)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJtPUAW","PAI-6211","Active",null,"2017-2019","RT Central Africa","Benin",null,"Malaria","FR692-BEN-M","High","750000","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",null,"High","750000","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. The TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",{"$nulls":4},"750000","0","0","2020-01-30 11:03:20","2019-12-19 14:22:55","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJtP/view","2020-12-31","Malaria",750000," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713=AN2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713=AO2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713=AP2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-06-30"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713=AN2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713=AO2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713=AP2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2641)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-07-01"},"2020-12-31"]
["a6Q1R000000AJtUUAW","PAI-6212","Active",null,"2017-2019","RT Central Africa","Chad",null,"Malaria","FR693-TCD-M","High","5400000","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",null,"High","5400000","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. The TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"4e+06",null,null,"1400000","0","0","2020-01-30 11:04:08","2019-12-19 14:26:36","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJtU/view","2021-06-30","Malaria",1400000," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2021-06-30"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713=AN2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713=AO2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713=AP2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-12-31"},"2021-06-30",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-07-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713=AN2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713=AO2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713=AP2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2642)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2019-01-01"},"2021-06-30"]
["a6Q1R000000AJtZUAW","PAI-6213","Inactive",null,"2017-2019","RT High Impact Africa 1","Nigeria",null,"Malaria","FR694-NGA-M","High","1e+07","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",null,"High","1e+07","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. The TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"1e+07",null,null,"0","1","0","2020-01-29 11:47:21","2019-12-19 14:29:37","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJtZ/view","2020-12-31","Malaria",0," High Impact Africa 1","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713=AN2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713=AO2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713=AP2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713=AN2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713=AO2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713=AP2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2643)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJteUAG","PAI-6214","Inactive",null,"2017-2019","RT Central Africa","Togo",null,"Malaria","FR695-TGO-M","High","309000","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019","Seasonal malaria chemoprevention as part of portfolio optimization wave 4 Nov 2019",null,"High","309000","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. The TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",null,"309000",null,null,"0","1","0","2020-01-30 10:55:26","2019-12-19 14:32:11","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJte/view","2020-12-31","Malaria",0," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713=AN2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713=AO2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713=AP2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713=AN2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713=AO2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713=AP2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2644)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AJtjUAG","PAI-6215","Active",null,"2017-2019","RT Western Africa","Guinea-Bissau",null,"Malaria","FR696-GNB-M","High","312318","Specific prevention interventions (SPI)","Seasonal malaria chemoprevention","SMC was initiated in Guinea Bissau in 2016 by the MOH in partnership with MSF, UNDP and AIFO covering 50% of the Bafata Region (7 of 14 ADS = Area de Saud = Health Districts) and 74% of the Gabu region (14 of 19 ADS). Over 85% (37,379 / 43,715) children aged 3-59 months in the 21 ADS received at least 1 dose of SMC. In 2017, SMC was expanded to geographically cover 100% of the 2 high malaria prevalence regions. Over 99% of 83,667 children received at least 1 dose, 82% received 3 doses and 61% of children received 4 doses, with a high level of acceptability and tolerance by the community. WHO recommends an SMC coverage with 3 to 4 doses for an effective impact. It is essential to maintain SMC in these regions to ensure a sustainable impact of the intervention.The operational costs for SMC have been significantly reduced by changing the strategy from Fixed Point to Door to Door. In 2019 and 2020 the MOH has planned the SMC campaigns to be implemented without International NGOs only by regional health departments, further reducing costs. Despite these efforts the country has a gap of 523,683 EUR for SMC operational costs, including UNDP GMS.","SMC was initiated in Guinea Bissau in 2016 by the MOH in partnership with MSF, UNDP and AIFO covering 50% of the Bafata Region (7 of 14 ADS = Area de Saud = Health Districts) and 74% of the Gabu region (14 of 19 ADS). Over 85% (37,379 / 43,715) children aged 3-59 months in the 21 ADS received at least 1 dose of SMC. In 2017, SMC was expanded to geographically cover 100% of the 2 high malaria prevalence regions. Over 99% of 83,667 children received at least 1 dose, 82% received 3 doses and 61% of children received 4 doses, with a high level of acceptability and tolerance by the community. WHO recommends an SMC coverage with 3 to 4 doses for an effective impact. It is essential to maintain SMC in these regions to ensure a sustainable impact of the intervention.The operational costs for SMC have been significantly reduced by changing the strategy from Fixed Point to Door to Door. In 2019 and 2020 the MOH has planned the SMC campaigns to be implemented without International NGOs only by regional health departments, further reducing costs. Despite these efforts the country has a gap of 523,683 EUR for SMC operational costs, including UNDP GMS.",null,"High","312318","In principle, the TRP considers the request of the current Portfolio Optimization Wave 4 prioritized interventions for scaling up Seasonal Malaria Chemoprevention (SMC) for children aged 3 to 59 months during the high-transmission season in 2020, to be technically sound and strategically focused given that the provision of this preventive therapy at monthly intervals has been shown to have a significant protective effect against uncomplicated and severe malaria in the Sahel sub-region. The TRP recommends the GF Secretariat to proceed with the plan to provide additional resources for the requested SMC intervention and move forward the procurement of drugs. However, The TRP recommends that i) only pre-qualified drugs be considered, and ii) that the optimization exercise is informed by epidemiological and meteorological data to support the justification of SMC among children less than 5 years of age in areas with highly seasonal malaria transmission in the identified countries as per WHO guidance, drug resistance data, country malaria treatment guidelines, as well as unit cost per treatment.",{"$nulls":4},"312318","0","0","2020-01-30 11:06:09","2019-12-19 14:37:34","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AJtj/view","2020-12-31","Malaria",312318," Western Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713=AN2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713=AO2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713=AP2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713=AN2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713=AO2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713=AP2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2645)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AK01UAG","PAI-6217","Inactive",null,"2017-2019","RT Central Africa","Burundi",null,"Malaria","FR634-BDI-M","High","5328486","Case management","Facility-based treatment","Les bases de quantification nationale des intrants antipaludiques pour la priode 2020-2021 au Burundi tiennent compte de l'volution des cas sur 5 ans (2017-2021). La demande soumise pour le financement au-del prend en compte la priode 2020 et 6 mois de stock de scurit correspondant  la priode de transition entre 2 subventions. En plus, l'Arthemether-Lumfantrine tant une nouvelle molcule, la reconstitution des stocks  tous les niveaux de la pyramide sanitaire est indispensable. Les donnes pidmiologiques de la priode en cours corroborent les besoins exprims (voir Fichier de quantification snario moyen). Les engagements dj reus des partenaires restent ceux inventoris : Allocation du FM pour l'anne 2020, la contribution de PMI et celle du gouvernement. L'analyse des gaps en intrants nous conduit  la demande de financement au-del . Une fois que la demande soumise est approuve, les intrants de prise en charge seront disponibles dans toutes les formations sanitaires  la satisfaction des malades. Nous anticipons en disant que les pisodes de paludisme seront rduits au sein de la communaut, par consquent rduction de la morbidit lie au paludisme.","National quantification of antimalarial drugs for the period 2020-2021 takes into account the evolution of cases over 5 years (2017-2021). The request submitted for this above allocation funds takes into account the 2020 period and 6 months of security stock corresponding to the transition period between two allocations. In addition, since Arthemether-Lumefantrine is a new molecule, stocks rebuilding at all levels of the health pyramid is essential. Epidemiological data for the current period corroborate the expressed needs (see Quantification File - average scenario). The commitments already received from partners remain those inventoried: Global Fund, PMI and government contributions. The gap analysis related to antimalarians drugs leads us to this demand for funds above allocation. Once the submitted application is approved, the treatment inputs will be available in all facilities to the benefit of patients. We anticipate that new cases of malaria will be reduced within the community, thus reducing the morbidity associated with malaria.",null,"High","5328486","o The request is justified as a bridge between two allocation periods, to build appropriate stock of the newly introduced drug in all facilities, and (by the CT) as a critical measure to cope with current upsurge of malaria in the country. o The quantification provided appears technically sound. It takes into account epidemiological data, projected according to the expected evolution, choosing a medium scenario. o The request for funding takes into account the resources allocated by other funding parties including the government (mostly zero for this need).   o The absorption rate of external resources  as communicated by the CT  is acceptable, at 69%, and for expected to reach 98%.  o Assets and capacities for drug storage, management, distribution and data are provided through the already approved PAAR, implementation currently ongoing: upgrade of drug stores, LMIS, vehicles for drug transport. The allocation and approved PAAR also cover vector control activities, presumably appropriate to cope with current malaria upsurge.","28486","5300000",null,null,"0","1","0","2020-01-14 12:27:29","2020-01-08 15:18:55","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AK01/view","2020-12-31","Malaria",0," Central Africa","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713=AN2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713=AO2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713=AP2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713=AN2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713=AO2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713=AP2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2646)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2020-12-31"]
["a6Q1R000000AK06UAG","PAI-6218","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Tajikistan",null,"HIV/AIDS, RSSH","FR628-TJK-Z","High","1626520","RSSH: Integrated service delivery and quality improvement","Laboratory systems for disease prevention, control, treatment and disease surveillance","Intervention planned to strengthen control of nosocomial infection, strengthening lab capacity, and human resources, assess and improve infection control measures, assess and improve QA and QC of the center of blood safety, health facilities providing blood transfusions, waste management. Establishing greater integration and improve linkage to HIV services, Integrate and offer HIV tests in all levels of the national health care system. Different modalities including Facility based HIV testing, Community based testing.",null,null,"Medium","1626520","The TRP notes that some elements included in the request are considered as high priority ( trainings for CHW, development of ME tools, evaluation of QA and QC of center for blood safety and health facilities). The TRP rates this request overall as medium priority based on the limited information available with regards to numberous items such as justification on the proposed location of EIA lab facilities and , justification for creation and use of software (ie development of an EMR software vs exploring opportunities to use a commercialised version), overall IT support, etc. Additionally, the TRP considers that some elements (purchase of cars and renovation of warehouse) should be of a low priority and can potentially be funded from domestic sources. In addition, the TRP considers the request for funds to establish and further enhance systems for medical waste disposal & management a priority, ensuring (future) compliance with international environmental health standards.The TRP would like to note the following recommendations, should the funding become available:1) The TRP recommends that the applicant review the practice of pediatric blood transfusions to ensure practices are conforming to the WHO guidelines and standards as well as revise practices that deviate from the WHO guidelines. 2) The implementation of the proposed system strengthening through expansion of access to testing and enhanced blood safety to the existing district and city health polyclinics would require close monitoring. The TRP recommends build-in regular monitoring with plans for system improvement. 3) The request for funds to improve medical waste disposal & management is a priority.",null,"1626520",null,null,"0","1","0","2020-01-21 10:00:00","2020-01-08 15:18:56","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AK06/view",null,"Multi-component",0," Eastern Europe and Central Asia","HIV/AIDS, RSSH","HIV/AIDS"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713=AN2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713=AO2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713=AP2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713=AN2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713=AO2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713=AP2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2647)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2018-01-01"]
["a6Q1R000000AK0BUAW","PAI-6219","Inactive",null,"2017-2019","RT Eastern Europe and Central Asia","Tajikistan",null,"HIV/AIDS, RSSH","FR628-TJK-Z","High","73561","Prevention programs for other vulnerable populations","Other intervention(s) for other vulnerable populations","Request for additional funding for PreP. Rationale: PEPFAR is in the process of initiating a work with in country stakeholders in understanding programing of innovative prevention strategies, namely Pre Exposure Prophylaxes (PrEP) among MSM and developing an engagement strategy for the design and roll-out of the pilot programme. According to the new estimates, in order to offer the pre-exposure prophylaxis to key population, there is a need of USD 173K as opposed to the originally planned USD 100K.",null,null,"High","73561",null,null,"73561",null,null,"0","1","0","2020-01-29 15:09:35","2020-01-08 15:18:57","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AK0B/view",null,"Multi-component",0," Eastern Europe and Central Asia","HIV/AIDS, RSSH","HIV/AIDS"," RSSH",null,null,"RSSH","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713=AN2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713=AO2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713=AP2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2021-03-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713=AN2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713=AO2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713=AP2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2648)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-04-01"},"2018-01-01"]
["a6Q1R000000AKHvUAO","PAI-6220","Inactive","MCRAI-Malaria-35","2017-2019","RT High Impact Africa 2","Zimbabwe","Malaria","Malaria",null,null,null,"Program management","Other program management intervention(s)","Cost reductions should be obtainable through efficiencies and synergies with RSSH.","Cost reductions should be obtainable through efficiencies and synergies with RSSH.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Policy, planning, coordination and management of national disease control programs (Myanmar)","High","6560172","Cost reductions should be obtainable through efficiencies and synergies with RSSH.","6560172","0","0","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKHv/view",null,"Malaria",0," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713=AN2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713=AO2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713=AP2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713=AN2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713=AO2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713=AP2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2649)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKHwUAO","PAI-6221","Active","MCRAI-Malaria-34","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Program management","Other program management intervention(s)","Essential to continue trajectory of malaria reduction and avert outbreaks.","Essential to continue trajectory of malaria reduction and avert outbreaks.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Grant management (Myanmar)","High","10716712","Proportional to rest of above allocation amount","9300308","0","0","0","1416404","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKHw/view",null,"Malaria",1416404," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713=AN2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713=AO2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713=AP2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713=AN2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713=AO2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713=AP2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2650)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKHxUAO","PAI-6222","Active","MCRAI-Malaria-27","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Case management","Other case management intervention(s)","Essential to monitor known delayed parasite clearance times.","Essential to monitor known delayed parasite clearance times.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Therapeutic efficacy surveillance (Myanmar)","High","720000","Essential to monitor known delayed parasite clearance times","0","0","0","0","720000","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKHx/view",null,"Malaria",720000," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713=AN2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713=AO2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713=AP2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713=AN2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713=AO2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713=AP2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2651)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKHyUAO","PAI-6223","Active","MCRAI-Malaria-29","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Case management","Other case management intervention(s)","IEC/BCC also covered under iCCM. However, the mass media campaign is not fully optimized.","IEC/BCC also covered under iCCM. However, the mass media campaign is not fully optimized.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Information, education, communication/behavior change communication (case management) (Myanmar)","High","2689000","IEC/BCC also covered under iCCM. It should be determined whether this additional funding will provide proportional benefit.","959187","0","0","0","1729813","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKHy/view",null,"Malaria",1729813," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713=AN2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713=AO2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713=AP2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713=AN2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713=AO2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713=AP2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2652)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKHzUAO","PAI-6224","Inactive","MCMOSASWA-Malaria-6","2017-2019","RT High Impact Africa 2","Multicountry Southern Africa MOSASWA","Malaria","Malaria",null,null,null,"Vector control","Other vector control measure(s)","The PAAR request entails expansion of IEC/BCC programs into Gaza and Inhambane Provinces in Southern Mozambique in order to strengthen uptake of IRS within the districts.","The PAAR request entails expansion of IEC/BCC programs into Gaza and Inhambane Provinces in Southern Mozambique in order to strengthen uptake of IRS within the districts.","This is from the 2014-2016 allocation cycle which has been added to the 2017-2019 Register, as suggested by Silvio. This is part of the standalone PAAR request that came for Window 607/12/2018: As per email from CT, the entire UQD activities totalling 2,773,492 are funded by Gates funding (even though the Grant-making sign off form says 2,773,488). The $4 difference is due to adjustments during grant negotiations Original Intervention: Information, education, communication/Behavior change communications (vector control)","Low","31894","The need for additional funds is not well substantiated given existing allocation for this multi country grant and other resources","0","0","31894","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKHz/view",null,"Malaria",0," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713=AN2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713=AO2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713=AP2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713=AN2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713=AO2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713=AP2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2653)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2020-01-01"]
["a6Q1R000000AKI0UAO","PAI-6225","Active","MCRAI-Malaria-24","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","A lot of investment is budgeted to improve the malaria surveillance system and the overall HMIS in the country. There are efforts to adopt DHIS2 all over the country. Under PR1, NMCP requires USD 1 million to expand case based surveillance with DHIS2 to all over the country (specifically in parts that are not covered under allocation).","A lot of investment is budgeted to improve the malaria surveillance system and the overall HMIS in the country. There are efforts to adopt DHIS2 all over the country. Under PR1, NMCP requires USD 1 million to expand case based surveillance with DHIS2 to all over the country (specifically in parts that are not covered under allocation).","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Routine reporting (Myanmar)","High","15895181","Routine reporting (M&E) budget within allocation is low, need is high","14895181","0","0","0","1e+06","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI0/view",null,"Malaria",1000000," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713=AN2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713=AO2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713=AP2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713=AN2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713=AO2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713=AP2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2654)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKI1UAO","PAI-6226","Active","MCRAI-Malaria-21","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Case management","Other case management intervention(s)","With allocation amount, the program is likely to reach 20,000 villages through ICMVs. However, in order to ensure 100% universal coverage for all the villages which are 5 km or more away from the nearest health facility, there is a need to establish another 20,000 ICMVs.","With allocation amount, the program is likely to reach 20,000 villages through ICMVs. However, in order to ensure 100% universal coverage for all the villages which are 5 km or more away from the nearest health facility, there is a need to establish another 20,000 ICMVs.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Integrated community case management (iCCM) (Myanmar)","High","22358810","iCCM is vital to reach vulnerable groups, though this level of community empowerment meetings may not be necessary","9519639","0","1485572","0","11353599","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI1/view",null,"Malaria",11353599," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713=AN2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713=AO2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713=AP2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713=AN2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713=AO2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713=AP2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2655)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKI2UAO","PAI-6227","Inactive","MCMOSASWA-Malaria-5","2017-2019","RT High Impact Africa 2","Multicountry Southern Africa MOSASWA","Malaria","Malaria",null,null,null,"Vector control","Indoor residual spraying (IRS)","The PAAR request entails expansion of IRS operations into 4 new districts in Gaza and Inhambane Provinces in Southern Mozambique. Regional epidemiological analyses clearly demonstrate the urgency by which activities must be expanded to Gaza and Inhambane provinces if the MOSASWA sub-region hopes to accelerate its pathway to elimination.","The PAAR request entails expansion of IRS operations into 4 new districts in Gaza and Inhambane Provinces in Southern Mozambique. Regional epidemiological analyses clearly demonstrate the urgency by which activities must be expanded to Gaza and Inhambane provinces if the MOSASWA sub-region hopes to accelerate its pathway to elimination.","This is from the 2014-2016 allocation cycle which has been added to the 2017-2019 Register, as suggested by Silvio. This is part of the standalone PAAR request that came for Window 607/12/2018: As per email from CT, the entire UQD activities totalling 2,773,492 are funded by Gates funding (even though the Grant-making sign off form says 2,773,488). The $4 difference is due to adjustments during grant negotiations Original Intervention: Indoor residual spraying","Low","2278106","The need for additional funds is not well substantiated given existing allocation for this multi country grant and other resources","0","0","2278106","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI2/view",null,"Malaria",0," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713=AN2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713=AO2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713=AP2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713=AN2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713=AO2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713=AP2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2656)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2020-01-01"]
["a6Q1R000000AKI3UAO","PAI-6228","Inactive","MCRAI-Malaria-30","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Case management","Other case management intervention(s)","Ensuring drug and other health product quality.","Ensuring drug and other health product quality.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Ensuring drug and other health product quality (Myanmar)","High","1758000","Large private sector with limited governance, and known falsified products in surrounding countries.","1758000","0","0","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI3/view",null,"Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713=AN2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713=AO2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713=AP2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713=AN2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713=AO2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713=AP2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2657)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKI4UAO","PAI-6229","Inactive","MCRAI-Malaria-18","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Mass campaign","Essential to continue trajectory of malaria reduction and avert outbreaks.","Essential to continue trajectory of malaria reduction and avert outbreaks.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Long-lasting insecticidal nets  Mass campaign","High","28475555","Essential to continue trajectory of malaria reduction and avert outbreaks","28475555","0","0","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI4/view",null,"Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713=AN2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713=AO2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713=AP2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713=AN2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713=AO2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713=AP2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2658)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKI5UAO","PAI-6230","Active","MCRAI-Malaria-20","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Case management","Other case management intervention(s)","There will be no more oAMT replacement project funded for 2018 - 2020 under RAI2E. If funds are available, this project should continue until there is zero oAMT in the country.","There will be no more oAMT replacement project funded for 2018 - 2020 under RAI2E. If funds are available, this project should continue until there is zero oAMT in the country.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Private sector case management (Myanmar)","High","3804000","Important area of health delivery, with relatively little allocation.","1041963","0","0","0","2762037","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI5/view",null,"Malaria",2762037," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713=AN2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713=AO2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713=AP2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713=AN2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713=AO2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713=AP2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2659)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKI6UAO","PAI-6231","Active","MCRAI-Malaria-23","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Case management","Other case management intervention(s)","Microscopy, G6PD mapping, private hospitals, pharmacies and border screening are important, but of lesser priority than above interventions at this stage in the control program.","Microscopy, G6PD mapping, private hospitals, pharmacies and border screening are important, but of lesser priority than above interventions at this stage in the control program.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Facility-based treatment (Myanmar)","High","12528048","Microscopy, G6PD mapping and border screening are important, but of lesser priority than above interventions at this stage in the control program.","6407722","0","0","0","6120326","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI6/view",null,"Malaria",6120326," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713=AN2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713=AO2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713=AP2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713=AN2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713=AO2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713=AP2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2660)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKI7UAO","PAI-6232","Active","MCRAI-Malaria-26","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","To carry out Malaria Indicator Survey.","To carry out Malaria Indicator Survey.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Analysis, review and transparency (Myanmar)","High","13545382","Includes large number of WHO national staff to support implementation","11545382","0","0","0","2e+06","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI7/view",null,"Malaria",2000000," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713=AN2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713=AO2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713=AP2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713=AN2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713=AO2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713=AP2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2661)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKI8UAO","PAI-6233","Active","MCRAI-Malaria-25","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Program management","Other program management intervention(s)","Strengthening national procurement and supply chain systems.","Strengthening national procurement and supply chain systems.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Remaining UQD is more than TRP recommended amount.24/12/17; replaced remaining UQD after GAC of 1M with TRP approved amount as per email from CT on 22/12/17 bcos remaining UQD cannot be more than TRP approved Original Intervention: Supporting procurement and supply management (Myanmar)","High","250000","This area appears underaddressed.","0","0","0","0","250000","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI8/view",null,"Malaria",250000," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713=AN2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713=AO2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713=AP2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713=AN2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713=AO2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713=AP2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2662)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKI9UAO","PAI-6234","Inactive","MCMOSASWA-Malaria-4","2017-2019","RT High Impact Africa 2","Multicountry Southern Africa MOSASWA","Malaria","Malaria",null,null,null,"Case management","Integrated community case management (ICCM)","This PAAR request is to expand APEs into 4 key districts in Gaza and Inhambane provinces of Southern Mozambique in order serve new geographies receiving IRS.","This PAAR request is to expand APEs into 4 key districts in Gaza and Inhambane provinces of Southern Mozambique in order serve new geographies receiving IRS.","This is from the 2014-2016 allocation cycle which has been added to the 2017-2019 Register, as suggested by Silvio. This is part of the standalone PAAR request that came for Window 607/12/2018: As per email from CT, the entire UQD activities totalling 2,773,492 are funded by Gates funding (even though the Grant-making sign off form says 2,773,488). The $4 difference is due to adjustments during grant negotiations Original Intervention: Integrated community case management (iCCM)","Low","313492","The need for additional funds is not well substantiated given existing allocation for this multi country grant and other resources","0","0","313492","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKI9/view",null,"Malaria",0," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713=AN2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713=AO2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713=AP2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713=AN2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713=AO2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713=AP2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2663)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2020-01-01"]
["a6Q1R000000AKIAUA4","PAI-6235","Inactive","MCRAI-Malaria-32","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Vector control","Other vector control measure(s)","Essential to continue trajectory of malaria reduction and avert outbreaks.","Essential to continue trajectory of malaria reduction and avert outbreaks.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Indoor residual spraying (Myanmar)","High","2494919","For epidemic containment, but no evidence of local effectiveness or experience in use.","2494919","0","0","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKIA/view",null,"Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713=AN2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713=AO2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713=AP2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713=AN2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713=AO2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713=AP2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2664)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKIBUA4","PAI-6236","Inactive","MCRAI-Malaria-33","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"RSSH: Health management information systems and M&E","Other health information systems and M&E intervention(s)","Secondary importance to intensified routine M&E.","Secondary importance to intensified routine M&E.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Module: RSSH - Health management information system and monitoring and evaluation. Original Intervention: Surveys (Myanmar)","High","1531789","Secondary importance to intensified routine M&E","1531789","0","0","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKIB/view",null,"Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713=AN2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713=AO2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713=AP2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713=AN2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713=AO2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713=AP2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2665)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKICUA4","PAI-6237","Inactive","MCMOSASWA-Malaria-7","2017-2019","RT High Impact Africa 2","Multicountry Southern Africa MOSASWA","Malaria","Malaria",null,null,null,"Program management","Grant management","This request is to cover for grant management costs in order for the program to expand to 4 new districts in Gaza and Inhambane Provinces in Southern Mozambique.","This request is to cover for grant management costs in order for the program to expand to 4 new districts in Gaza and Inhambane Provinces in Southern Mozambique.","This is from the 2014-2016 allocation cycle which has been added to the 2017-2019 Register, as suggested by Silvio. This is part of the standalone PAAR request that came for Window 607/12/2018: As per email from CT, the entire UQD activities totalling 2,773,492 are funded by Gates funding (even though the Grant-making sign off form says 2,773,488). The $4 difference is due to adjustments during grant negotiations","Low","150000","The need for additional funds is not well substantiated given existing allocation for this multi country grant and other resources","0","0","150000","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKIC/view",null,"Malaria",0," High Impact Africa 2","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2022-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713=AN2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713=AO2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713=AP2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2022-12-31"},"2022-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2020-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713=AN2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713=AO2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713=AP2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2666)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2020-01-01"},"2020-01-01"]
["a6Q1R000000AKIDUA4","PAI-6238","Inactive","MCRAI-Malaria-19","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Vector control","Long-lasting insecticidal nets (LLIN) - Continuous distribution","Essential to continue trajectory of malaria reduction and avert outbreaks.","Essential to continue trajectory of malaria reduction and avert outbreaks.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Long-lasting insecticidal nets  Continuous distribution","High","32921545","Essential to continue trajectory of malaria reduction and avert outbreaks","32921545","0","0","0","0","1","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKID/view",null,"Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713=AN2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713=AO2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713=AP2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713=AN2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713=AO2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713=AP2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2667)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKIEUA4","PAI-6239","Active","ZWE-TB/HIV-60","2017-2019","RT High Impact Africa 2","Zimbabwe","HIV/TB","HIV/AIDS, Tuberculosis",null,null,null,"RSSH: Procurement and supply chain management systems","Supply chain infrastructure and development of tools","Phase II: Construction of Harare NatPharm Central warehouse and purchase of equipment. Previously TRP cleared in 2013, transferred from NFM grant (2014-2017) due to transition policy.","Phase II: Construction of Harare NatPharm Central warehouse and purchase of equipment. Previously TRP cleared in 2013, transferred from NFM grant (2014-2017) due to transition policy.","8/3/2018: recvd email from Jacqueline conveying the message of CT that this intervention that was approved in 2014-16 has been approved by Mark Eddington & Adda Faye to be included in the 2017-19 register. 9/3/2018: Jacqueline confirmed to Bianca that no further TRP approvals are required, and as an exception this intervention must be recorded in the register with TRP priorty rating =\"Undefined\", The TRP approved date as TRP review date of the other Zimbabwe interventions. Also, to see this intervention with other ZMB interventions and to get the expiry date, the GAC approval date is made same as others. The remaining UQD in BUD is also updated. As the CT asked us to include the amount, it is assumed to be validated by them and no further validation is required Original Module: RSSH - Procurement and supply chain management systems",null,"22737584",null,"0","0","0","0","22737584","0","0","2020-03-05 12:19:15","2020-03-05 12:19:15","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKIE/view",null,"TB/HIV",22737584," High Impact Africa 2","HIV/AIDS, Tuberculosis","HIV/AIDS","Tuberculosis",null,null,"Tuberculosis","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713=AN2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713=AO2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713=AP2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713=AN2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713=AO2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713=AP2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2668)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKIFUA4","PAI-6240","Inactive","MCRAI-Malaria-28","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Vector control","Other vector control measure(s)","Essential to continue trajectory of malaria reduction and avert outbreaks.","Essential to continue trajectory of malaria reduction and avert outbreaks.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Entomological monitoring (Myanmar)","High","1617680","Assessment of LLIN effectiveness","1617680","0","0","0","0","1","0","2020-03-05 12:19:16","2020-03-05 12:19:16","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKIF/view",null,"Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713=AN2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713=AO2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713=AP2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713=AN2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713=AO2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713=AP2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2669)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKIGUA4","PAI-6241","Active","MCRAI-Malaria-22","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Case management","Other case management intervention(s)","As moving towards elimination, 3 types of ACD will be required; 1) RACD (Reactive Case Detection), 2) Proactive Case Detection and 3) routine active case detection. Additional requirement could cover either of the three in both elimination and transmission reduction areas.","As moving towards elimination, 3 types of ACD will be required; 1) RACD (Reactive Case Detection), 2) Proactive Case Detection and 3) routine active case detection. Additional requirement could cover either of the three in both elimination and transmission reduction areas.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Active case detection and investigation (elimination phase) (Myanmar)","High","340000","Needs to start in eliminated areas.","183274","0","0","0","156726","0","0","2020-03-05 12:19:16","2020-03-05 12:19:16","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKIG/view",null,"Malaria",156726," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713=AN2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713=AO2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713=AP2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713=AN2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713=AO2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713=AP2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2670)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]
["a6Q1R000000AKIHUA4","PAI-6242","Inactive","MCRAI-Malaria-31","2017-2019","RT High Impact Asia","Multicountry East Asia and Pacific RAI","Malaria","Malaria",null,null,null,"Case management","Other case management intervention(s)","Essential to continue trajectory of malaria reduction and avert outbreaks.","Essential to continue trajectory of malaria reduction and avert outbreaks.","Myanmar malaria is a part of RAI but they submitted their PAAR in 2014-2016 cycle (early applicant). Their PAAR was later consolidated into RAI's grant sign off form. Original Intervention: Epidemic preparedness (Myanmar)","High","4505000","Lacking in detail to determine priority.","4505000","0","0","0","0","1","0","2020-03-05 12:19:16","2020-03-05 12:19:16","https://globalfund.lightning.force.com/lightning/r/L1FR_PAAR_UQD_Intervention__c/a6Q1R000000AKIH/view",null,"Malaria",0," High Impact Asia","Malaria","Malaria",null,null,null,"","","",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AJ2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0)),\"\")","v":"2020-12-31"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713=AN2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713=AO2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713=AP2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$G$2:$G$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$G$2:$G$713<>\"\"),0))),\"\")","v":"2020-12-31"},"2020-12-31",{"$f":"IFERROR(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713=AJ2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0)),\"\")","v":"2018-01-01"},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713=AN2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AN2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713=AO2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AO2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713=AP2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$E$2:$E$713='PAAR_UQD report'!AP2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":""},{"$f":"IFERROR(IF(INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))=0,\"\",INDEX('AUP dates 2017-2019'!$F$2:$F$713,MATCH(1,('AUP dates 2017-2019'!$R$2:$R$713='PAAR_UQD report'!G2671)*('AUP dates 2017-2019'!$P$2:$P$713=\"Approved\")*('AUP dates 2017-2019'!$F$2:$F$713<>\"\"),0))),\"\")","v":"2018-01-01"},"2018-01-01"]

{"sheet":"Country Comp missing end date","index":8,"n_rows":29,"n_cols":4,"rows_kept":29,"cut":false,"hidden":true,"merged":[]}
["End Date","(blank)"]
[]
["Row Labels","FR Component","Min of Final AUP start date to use","Min of Final AUP end date to use"]
["Afghanistan","Tuberculosis, RSSH","2018-01-01","2020-12-31"]
["Angola","HIV/AIDS, Tuberculosis","2019-01-01","2021-12-31"]
["Cabo Verde","HIV/AIDS, Tuberculosis, Malaria, RSSH","2018-01-01","2020-12-31"]
["Cameroon","HIV/AIDS, Tuberculosis","2018-01-01","2020-12-31"]
["Chad","HIV/AIDS, Tuberculosis, RSSH","2019-01-01","2021-12-31"]
["Ethiopia","HIV/AIDS, Tuberculosis","2018-01-01","2021-06-30"]
["Indonesia","HIV/AIDS, Tuberculosis, RSSH","2018-01-01","2020-12-31"]
["Kenya","HIV/AIDS, Tuberculosis","2018-01-01","2021-06-30"]
["Kyrgyzstan","HIV/AIDS, Tuberculosis, RSSH","2018-01-01","2020-12-31"]
["Mali","RSSH","2019-01-01","2021-12-31"]
["Multicountry East Asia and Pacific RAI","Malaria","2018-01-01","2020-12-31"]
["Multicountry Middle East MER","HIV/AIDS, Tuberculosis, RSSH","2018-01-01","2020-12-31"]
["Multicountry Southern Africa MOSASWA","Malaria","2020-01-01","2022-12-31"]
["Myanmar","HIV/AIDS, Tuberculosis","2018-01-01","2020-12-31"]
["Rwanda","HIV/AIDS, Malaria","2018-01-01","2021-06-30"]
["Rwanda","HIV/AIDS, Tuberculosis","2018-01-01","2021-06-30"]
["Sao Tome and Principe","HIV/AIDS, Tuberculosis, Malaria, RSSH","2018-04-01","2021-03-31"]
["Senegal","Tuberculosis, RSSH","2018-01-01","2020-12-31"]
["Tajikistan","HIV/AIDS, RSSH","2018-01-01","2020-12-31"]
["Tanzania (United Republic)","Malaria, RSSH","2018-01-01","2020-12-31"]
["Togo","HIV/AIDS, Tuberculosis","2018-01-01","2020-12-31"]
["Uganda","HIV/AIDS, Tuberculosis","2018-01-01","2020-12-31"]
["Zambia","HIV/AIDS, Tuberculosis, RSSH","2018-01-01","2020-12-31"]
["Zambia","Malaria, RSSH","2018-01-01","2020-12-31"]
["Zimbabwe","HIV/AIDS, Tuberculosis","2018-01-01","2020-12-31"]
["Zimbabwe","Malaria","2018-01-01","2020-12-31"]

{"sheet":"AUP dates 2017-2019","index":9,"n_rows":713,"n_cols":18,"rows_kept":713,"cut":false,"hidden":true,"merged":[]}
["Allocation Cycle: Allocation Cycle ID","Single country: Name","Group of Countries: Country Group Name","AUP Component Name","AIM selectedComponents","AUP Start Date (Current)","AUP End Date (Current)","AUP Start Date (Current)","AUP End Date (Current)","AUP Start Date (Original)","AUP End Date (Original)","AUP Start Date (Old)","AUP End Date (Old)","AUP Start Date FO","AUP End Date FO","Status","AUP Name","Country"]
["2017-2019",null,"Multicountry Americas EMMIE","AUP-Comp-000726","Malaria","2018-01-01","2023-12-31","2018-01-01","2023-12-31",null,null,"2018-01-01","2022-12-31","2018-01-01","2023-12-31","Approved","AUP-00629",{"$f":"IF(B2=\"\",C2,B2)","v":"Multicountry Americas EMMIE"}]
["2017-2019","Albania",null,"AUP-Comp-000281","HIV/AIDS","2020-01-01","2022-12-31","2020-01-01","2022-12-31","2020-01-01","2022-12-31",null,null,"2020-01-01","2022-12-31","Approved","AUP-00011",{"$f":"IF(B3=\"\",C3,B3)","v":"Albania"}]
["2017-2019","Albania",null,"AUP-Comp-000282","Tuberculosis","2020-01-01","2022-12-31","2020-01-01","2022-12-31","2020-01-01","2022-12-31",null,null,"2020-01-01","2022-12-31","Approved","AUP-00012","Albania"]
["2017-2019","Algeria",null,"AUP-Comp-000283","HIV/AIDS","2020-01-01","2022-12-31","2020-01-01","2022-12-31","2020-01-01","2022-12-31",null,null,"2020-01-01","2022-12-31","Approved","AUP-00013","Algeria"]
["2017-2019","Bolivia (Plurinational State)",null,"AUP-Comp-000306","Tuberculosis","2020-01-01","2022-12-31","2020-01-01","2022-12-31","2020-01-01","2022-12-31",null,null,"2020-01-01","2022-12-31","Approved","AUP-00036","Bolivia (Plurinational State)"]
["2017-2019","Ecuador",null,"AUP-Comp-000350","HIV/AIDS","2020-01-01","2022-12-31","2020-01-01","2022-12-31","2020-01-01","2022-12-31",null,null,"2020-01-01","2022-12-31","Approved","AUP-00080","Ecuador"]
["2017-2019","Georgia",null,"AUP-Comp-000364","Tuberculosis","2020-01-01","2022-12-31","2020-01-01","2022-12-31","2020-01-01","2022-12-31",null,null,"2020-01-01","2022-12-31","Approved","AUP-00094","Georgia"]
["2017-2019","Guyana",null,"AUP-Comp-000378","Malaria","2020-01-01","2022-12-31","2020-01-01","2022-12-31","2020-01-01","2022-12-31",null,null,"2020-01-01","2022-12-31","Approved","AUP-00403","Guyana"]
["2017-2019","Kazakhstan",null,"AUP-Comp-000395","Tuberculosis","2020-01-01","2022-12-31","2020-01-01","2022-12-31","2020-01-01","2022-12-31",null,null,"2020-01-01","2022-12-31","Approved","AUP-00420","Kazakhstan"]
["2017-2019","Albania",null,"AUP-Comp-000805","HIV/AIDS,Tuberculosis","2020-01-01","2022-12-31","2020-01-01","2022-12-31",{"$nulls":4},"2020-01-01","2022-12-31","Approved","AUP-00666","Albania"]
["2017-2019","Albania",null,"AUP-Comp-000806","HIV/AIDS,Tuberculosis","2020-01-01","2022-12-31","2020-01-01","2022-12-31",{"$nulls":4},"2020-01-01","2022-12-31","Approved","AUP-00666","Albania"]
["2017-2019",null,"Multicountry Southern Africa MOSASWA","AUP-Comp-000939","Malaria","2020-01-01","2022-12-31","2020-01-01","2022-12-31",{"$nulls":4},"2020-01-01","2022-12-31","Approved","AUP-00736","Multicountry Southern Africa MOSASWA"]
["2017-2019","Colombia",null,"AUP-Comp-000331","HIV/AIDS","2019-11-01","2022-10-31","2019-11-01","2022-10-31","2019-11-01","2022-10-31",null,null,"2019-11-01","2022-10-31","Approved","AUP-00061","Colombia"]
["2017-2019",null,"Multicountry HIV Caribbean PCC Consortium","AUP-Comp-001049","HIV/AIDS","2019-10-01","2022-09-30","2019-10-01","2022-09-30",null,null,"2019-10-01","2022-09-30","2019-10-01","2022-09-30","Approved","AUP-00828","Multicountry HIV Caribbean PCC Consortium"]
["2017-2019",null,"Multicountry HIV Latin America ALEP","AUP-Comp-001091","HIV/AIDS","2019-10-01","2022-09-30","2019-10-01","2022-09-30",{"$nulls":4},"2019-10-01","2022-09-30","Approved","AUP-00853","Multicountry HIV Latin America ALEP"]
["2017-2019",null,"Multicountry TB LAC PIH","AUP-Comp-001093","HIV/AIDS","2019-10-01","2022-09-30","2019-10-01","2022-09-30",{"$nulls":4},"2019-10-01","2022-09-30","Approved","AUP-00855","Multicountry TB LAC PIH"]
["2017-2019","Korea (Democratic Peoples Republic)",null,"AUP-Comp-001128","Malaria,Tuberculosis","2019-10-01","2022-09-30","2019-10-01","2022-09-30",{"$nulls":4},"2019-10-01","2022-09-30","Approved","AUP-00869","Korea (Democratic Peoples Republic)"]
["2017-2019","Korea (Democratic Peoples Republic)",null,"AUP-Comp-001129","Malaria,Tuberculosis","2019-10-01","2022-09-30","2019-10-01","2022-09-30",{"$nulls":4},"2019-10-01","2022-09-30","Approved","AUP-00869","Korea (Democratic Peoples Republic)"]
["2017-2019","Honduras",null,"AUP-Comp-000383","HIV/AIDS","2019-08-01","2022-07-31","2019-08-01","2022-07-31","2019-08-01","2022-07-31",null,null,"2019-08-01","2022-07-31","Approved","AUP-00408","Honduras"]
["2017-2019","Honduras",null,"AUP-Comp-000385","Tuberculosis","2019-08-01","2022-07-31","2019-08-01","2022-07-31","2020-01-01","2022-12-31","2020-01-01","2022-12-31","2019-08-01","2022-07-31","Approved","AUP-00410","Honduras"]
["2017-2019","Honduras",null,"AUP-Comp-001117","HIV/AIDS,Tuberculosis","2019-08-01","2022-07-31","2019-08-01","2022-07-31",{"$nulls":4},"2019-08-01","2022-07-31","Approved","AUP-00864","Honduras"]
["2017-2019","Honduras",null,"AUP-Comp-001118","HIV/AIDS,Tuberculosis","2019-08-01","2022-07-31","2019-08-01","2022-07-31",{"$nulls":4},"2019-08-01","2022-07-31","Approved","AUP-00864","Honduras"]
["2017-2019","Comoros",null,"AUP-Comp-000332","HIV/AIDS","2019-07-01","2022-06-30","2019-07-01","2022-06-30","2019-07-01","2022-06-30",null,null,"2019-07-01","2022-06-30","Approved","AUP-00062","Comoros"]
["2017-2019","Georgia",null,"AUP-Comp-000363","HIV/AIDS","2019-07-01","2022-06-30","2019-07-01","2022-06-30","2019-07-01","2022-06-30",null,null,"2019-07-01","2022-06-30","Approved","AUP-00093","Georgia"]
["2017-2019","Guatemala",null,"AUP-Comp-000370","Tuberculosis","2019-07-01","2022-06-30","2019-07-01","2022-06-30","2019-07-01","2022-06-30",null,null,"2019-07-01","2022-06-30","Approved","AUP-00100","Guatemala"]
["2017-2019","Malaysia",null,"AUP-Comp-000418","HIV/AIDS","2019-01-01","2022-06-30","2019-01-01","2022-06-30","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2022-06-30","Approved","AUP-00443","Malaysia"]
["2017-2019","Peru",null,"AUP-Comp-000463","HIV/AIDS","2019-07-01","2022-06-30","2019-07-01","2022-06-30","2019-07-01","2022-06-30",null,null,"2019-07-01","2022-06-30","Approved","AUP-00488","Peru"]
["2017-2019","Peru",null,"AUP-Comp-000464","Tuberculosis","2019-07-01","2022-06-30","2019-07-01","2022-06-30","2019-07-01","2022-06-30",null,null,"2019-07-01","2022-06-30","Approved","AUP-00489","Peru"]
["2017-2019","Benin",null,"AUP-Comp-000848","RSSH","2019-07-01","2022-06-30","2019-07-01","2022-06-30",null,null,"2019-01-01","2021-12-31","2019-07-01","2022-06-30","Approved","AUP-00690","Benin"]
["2017-2019","Serbia",null,"AUP-Comp-000849","HIV/AIDS","2019-07-01","2022-06-30","2019-07-01","2022-06-30",null,null,"2019-04-01","2022-03-31","2019-07-01","2022-06-30","Approved","AUP-00691","Serbia"]
["2017-2019",null,"Multicountry Africa ECSA-HC","AUP-Comp-000894","Tuberculosis","2019-07-01","2022-06-30","2019-07-01","2022-06-30",null,null,"2019-11-01","2022-10-31","2019-07-01","2022-06-30","Approved","AUP-00711","Multicountry Africa ECSA-HC"]
["2017-2019",null,"Multicountry TB LAC PIH","AUP-Comp-001050","Tuberculosis","2019-07-01","2022-06-30","2019-07-01","2022-06-30",null,null,"2019-01-01","2021-12-31","2019-07-01","2022-06-30","Approved","AUP-00829","Multicountry TB LAC PIH"]
["2017-2019",null,"Multicountry Caribbean MCC","AUP-Comp-000273","HIV/AIDS","2019-04-01","2022-03-31","2019-04-01","2022-03-31","2019-04-01","2022-03-31",null,null,"2019-04-01","2022-03-31","Approved","AUP-00003","Multicountry Caribbean MCC"]
["2017-2019",null,"Multicountry Caribbean MCC","AUP-Comp-000274","Tuberculosis","2019-04-01","2022-03-31","2019-04-01","2022-03-31","2019-04-01","2022-03-31",null,null,"2019-04-01","2022-03-31","Approved","AUP-00004","Multicountry Caribbean MCC"]
["2017-2019","South Africa",null,"AUP-Comp-000487","HIV/AIDS","2019-04-01","2022-03-31","2019-04-01","2022-03-31","2019-04-01","2022-03-31",null,null,"2019-04-01","2022-03-31","Approved","AUP-00512","South Africa"]
["2017-2019","South Africa",null,"AUP-Comp-000488","Tuberculosis","2019-04-01","2022-03-31","2019-04-01","2022-03-31","2019-04-01","2022-03-31",null,null,"2019-04-01","2022-03-31","Approved","AUP-00513","South Africa"]
["2017-2019",null,"Multicountry Eastern Africa IGAD","AUP-Comp-000945","Tuberculosis","2019-04-01","2022-03-31","2019-04-01","2022-03-31",null,null,"2019-01-01","2021-12-31","2019-04-01","2022-03-31","Approved","AUP-00742","Multicountry Eastern Africa IGAD"]
["2017-2019",null,"Multicountry Caribbean MCC","AUP-Comp-000953","HIV/AIDS,Tuberculosis","2019-04-01","2022-03-31","2019-04-01","2022-03-31",{"$nulls":4},"2019-04-01","2022-03-31","Approved","AUP-00747","Multicountry Caribbean MCC"]
["2017-2019",null,"Multicountry Caribbean MCC","AUP-Comp-000954","HIV/AIDS,Tuberculosis","2019-04-01","2022-03-31","2019-04-01","2022-03-31",{"$nulls":4},"2019-04-01","2022-03-31","Approved","AUP-00747","Multicountry Caribbean MCC"]
["2017-2019","South Africa",null,"AUP-Comp-001040","HIV/AIDS,Tuberculosis","2019-04-01","2022-03-31","2019-04-01","2022-03-31",{"$nulls":4},"2019-04-01","2022-03-31","Approved","AUP-00822","South Africa"]
["2017-2019","South Africa",null,"AUP-Comp-001039","HIV/AIDS,Tuberculosis","2019-04-01","2022-03-31","2019-04-01","2022-03-31",{"$nulls":4},"2019-04-01","2022-03-31","Approved","AUP-00822","South Africa"]
["2017-2019","Egypt",null,"AUP-Comp-001089","HIV/AIDS,Tuberculosis","2019-04-01","2022-03-31","2019-04-01","2022-03-31",{"$nulls":4},"2019-04-01","2022-03-31","Approved","AUP-00852","Egypt"]
["2017-2019","Egypt",null,"AUP-Comp-001090","HIV/AIDS,Tuberculosis","2019-04-01","2022-03-31","2019-04-01","2022-03-31",{"$nulls":4},"2019-04-01","2022-03-31","Approved","AUP-00852","Egypt"]
["2017-2019","Angola",null,"AUP-Comp-000286","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00016","Angola"]
["2017-2019","Belarus",null,"AUP-Comp-000294","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00024","Belarus"]
["2017-2019","Belarus",null,"AUP-Comp-000295","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00025","Belarus"]
["2017-2019","Belize",null,"AUP-Comp-000296","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00026","Belize"]
["2017-2019","Belize",null,"AUP-Comp-000297","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00027","Belize"]
["2017-2019","Bolivia (Plurinational State)",null,"AUP-Comp-000304","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00034","Bolivia (Plurinational State)"]
["2017-2019","Bolivia (Plurinational State)",null,"AUP-Comp-000305","Malaria","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00035","Bolivia (Plurinational State)"]
["2017-2019","Botswana",null,"AUP-Comp-000307","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00037","Botswana"]
["2017-2019","Botswana",null,"AUP-Comp-000309","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31","Rejected","AUP-00039","Botswana"]
["2017-2019","Chad",null,"AUP-Comp-000328","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00058","Chad"]
["2017-2019","Chad",null,"AUP-Comp-000330","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00060","Chad"]
["2017-2019","Comoros",null,"AUP-Comp-000333","Malaria","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00063","Comoros"]
["2017-2019","Dominican Republic",null,"AUP-Comp-000348","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00078","Dominican Republic"]
["2017-2019","Dominican Republic",null,"AUP-Comp-000349","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00079","Dominican Republic"]
["2017-2019","El Salvador",null,"AUP-Comp-000351","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00081","El Salvador"]
["2017-2019","El Salvador",null,"AUP-Comp-000352","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00082","El Salvador"]
["2017-2019","Gabon",null,"AUP-Comp-000359","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00089","Gabon"]
["2017-2019","Guyana",null,"AUP-Comp-000379","Tuberculosis","2019-04-01","2021-12-31","2019-04-01","2021-12-31","2019-04-01","2022-03-31","2019-04-01","2022-03-31","2019-04-01","2021-12-31","Approved","AUP-00404","Guyana"]
["2017-2019","Jamaica",null,"AUP-Comp-000393","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00418","Jamaica"]
["2017-2019","Kosovo",null,"AUP-Comp-000402","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00427","Kosovo"]
["2017-2019","Mali",null,"AUP-Comp-000420","Malaria","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00445","Mali"]
["2017-2019","Mauritania",null,"AUP-Comp-000422","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00447","Mauritania"]
["2017-2019","Mauritania",null,"AUP-Comp-000423","Malaria","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00448",{"$f":"IF(B67=\"\",C67,B67)","v":"Mauritania"}]
["2017-2019","Mauritania",null,"AUP-Comp-000424","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00449","Mauritania"]
["2017-2019","Nicaragua",null,"AUP-Comp-000444","Malaria","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00469","Nicaragua"]
["2017-2019","Nicaragua",null,"AUP-Comp-000445","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00470","Nicaragua"]
["2017-2019","Niger",null,"AUP-Comp-000448","RSSH","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00473","Niger"]
["2017-2019","Niger",null,"AUP-Comp-000449","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00474","Niger"]
["2017-2019","Panama",null,"AUP-Comp-000456","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00481","Panama"]
["2017-2019","Panama",null,"AUP-Comp-000457","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00482","Panama"]
["2017-2019","Paraguay",null,"AUP-Comp-000462","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00487","Paraguay"]
["2017-2019","Sri Lanka",null,"AUP-Comp-000492","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00517","Sri Lanka"]
["2017-2019","Sri Lanka",null,"AUP-Comp-000493","Malaria","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00518","Sri Lanka"]
["2017-2019","Sri Lanka",null,"AUP-Comp-000494","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00519","Sri Lanka"]
["2017-2019","Suriname",null,"AUP-Comp-000498","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00523","Suriname"]
["2017-2019","Suriname",null,"AUP-Comp-000500","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00525","Suriname"]
["2017-2019","Tunisia",null,"AUP-Comp-000517","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2019-01-01","2021-12-31","Approved","AUP-00542","Tunisia"]
["2017-2019","Montenegro",null,"AUP-Comp-000711","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31",null,null,"2018-10-01","2021-09-30","2019-01-01","2021-12-31","Approved","AUP-00621","Montenegro"]
["2017-2019","Angola",null,"AUP-Comp-000725","RSSH","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00628","Angola"]
["2017-2019",null,"Multicountry EECA PAS","AUP-Comp-000809","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00668","Multicountry EECA PAS"]
["2017-2019",null,"Multicountry Middle East MER","AUP-Comp-000851","HIV/AIDS,Malaria,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00693","Multicountry Middle East MER"]
["2017-2019",null,"Multicountry Middle East MER","AUP-Comp-000852","HIV/AIDS,Malaria,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00693","Multicountry Middle East MER"]
["2017-2019",null,"Multicountry Middle East MER","AUP-Comp-000853","HIV/AIDS,Malaria,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00693","Multicountry Middle East MER"]
["2017-2019","Suriname",null,"AUP-Comp-000876","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00702","Suriname"]
["2017-2019","Suriname",null,"AUP-Comp-000877","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00702","Suriname"]
["2017-2019","Botswana",null,"AUP-Comp-000892","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00710","Botswana"]
["2017-2019","Botswana",null,"AUP-Comp-000893","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00710","Botswana"]
["2017-2019","Belize",null,"AUP-Comp-000899","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00715","Belize"]
["2017-2019","Belize",null,"AUP-Comp-000900","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00715","Belize"]
["2017-2019","Panama",null,"AUP-Comp-000901","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00716","Panama"]
["2017-2019","Panama",null,"AUP-Comp-000902","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00716","Panama"]
["2017-2019","Belarus",null,"AUP-Comp-000937","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00735","Belarus"]
["2017-2019","Belarus",null,"AUP-Comp-000938","HIV/AIDS,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00735","Belarus"]
["2017-2019",null,"Multicountry TB Asia UNDP","AUP-Comp-000941","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00738","Multicountry TB Asia UNDP"]
["2017-2019",null,"Multicountry HIV MENA IHAA","AUP-Comp-000942","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00739","Multicountry HIV MENA IHAA"]
["2017-2019",null,"Multicountry HIV EECA APH","AUP-Comp-000943","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00740","Multicountry HIV EECA APH"]
["2017-2019",null,"Multicountry TB Asia UNOPS","AUP-Comp-000944","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00741","Multicountry TB Asia UNOPS"]
["2017-2019",null,"Multicountry TB WC Africa NTP/SRL","AUP-Comp-000946","Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00743","Multicountry TB WC Africa NTP/SRL"]
["2017-2019",null,"Multicountry South-Eastern Asia AFAO","AUP-Comp-001019","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00812","Multicountry South-Eastern Asia AFAO"]
["2017-2019",null,"Multicountry","AUP-Comp-001048","HIV/AIDS","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00827","Multicountry"]
["2017-2019","Mauritania",null,"AUP-Comp-001121","HIV/AIDS,Malaria,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00866","Mauritania"]
["2017-2019","Mauritania",null,"AUP-Comp-001122","HIV/AIDS,Malaria,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00866","Mauritania"]
["2017-2019","Mauritania",null,"AUP-Comp-001123","HIV/AIDS,Malaria,Tuberculosis","2019-01-01","2021-12-31","2019-01-01","2021-12-31",{"$nulls":4},"2019-01-01","2021-12-31","Approved","AUP-00866","Mauritania"]
["2017-2019","Armenia",null,"AUP-Comp-000287","HIV/AIDS","2018-10-01","2021-09-30","2018-10-01","2021-09-30","2018-10-01","2021-09-30",null,null,"2018-10-01","2021-09-30","Approved","AUP-00017","Armenia"]
["2017-2019","Armenia",null,"AUP-Comp-000288","Tuberculosis","2018-10-01","2021-09-30","2018-10-01","2021-09-30","2018-10-01","2021-09-30",null,null,"2018-10-01","2021-09-30","Approved","AUP-00018","Armenia"]
["2017-2019","Botswana",null,"AUP-Comp-000308","Malaria","2018-10-01","2021-09-30","2018-10-01","2021-09-30","2018-10-01","2021-09-30",null,null,"2018-10-01","2021-09-30","Approved","AUP-00038","Botswana"]
["2017-2019","Comoros",null,"AUP-Comp-000334","Tuberculosis","2018-10-01","2021-09-30","2018-10-01","2021-09-30","2018-10-01","2021-09-30",null,null,"2018-10-01","2021-09-30","Approved","AUP-00064","Comoros"]
["2017-2019","Eswatini",null,"AUP-Comp-000501","HIV/AIDS","2018-10-01","2021-09-30","2018-10-01","2021-09-30","2018-10-01","2021-09-30",null,null,"2018-10-01","2021-09-30","Approved","AUP-00526","Eswatini"]
["2017-2019","Eswatini",null,"AUP-Comp-000503","Tuberculosis","2018-10-01","2021-09-30","2018-10-01","2021-09-30","2018-07-01","2021-06-30","2018-07-01","2021-09-30","2018-10-01","2021-09-30","Approved","AUP-00528","Eswatini"]
["2017-2019","Eswatini",null,"AUP-Comp-000760","HIV/AIDS,Tuberculosis","2018-10-01","2021-09-30","2018-10-01","2021-09-30",{"$nulls":4},"2018-10-01","2021-09-30","Approved","AUP-00643","Eswatini"]
["2017-2019","Eswatini",null,"AUP-Comp-000761","HIV/AIDS,Tuberculosis","2018-10-01","2021-09-30","2018-10-01","2021-09-30",{"$nulls":4},"2018-10-01","2021-09-30","Approved","AUP-00643","Eswatini"]
["2017-2019",null,"Multicountry Southern Africa E8","AUP-Comp-000896","Malaria","2018-10-01","2021-09-30","2018-10-01","2021-09-30",null,null,"2019-04-01","2022-03-31","2018-10-01","2021-09-30","Approved","AUP-00713","Multicountry Southern Africa E8"]
["2017-2019","Armenia",null,"AUP-Comp-000928","HIV/AIDS,Tuberculosis","2018-10-01","2021-09-30","2018-10-01","2021-09-30",{"$nulls":4},"2018-10-01","2021-09-30","Approved","AUP-00730","Armenia"]
["2017-2019","Armenia",null,"AUP-Comp-000929","HIV/AIDS,Tuberculosis","2018-10-01","2021-09-30","2018-10-01","2021-09-30",{"$nulls":4},"2018-10-01","2021-09-30","Approved","AUP-00730","Armenia"]
["2017-2019","Angola",null,"AUP-Comp-000284","HIV/AIDS","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00014","Angola"]
["2017-2019","Angola",null,"AUP-Comp-000285","Malaria","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00015","Angola"]
["2017-2019","Azerbaijan",null,"AUP-Comp-000289","HIV/AIDS","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00019","Azerbaijan"]
["2017-2019","Bhutan",null,"AUP-Comp-000301","HIV/AIDS","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00031","Bhutan"]
["2017-2019","Bhutan",null,"AUP-Comp-000302","Malaria","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00032","Bhutan"]
["2017-2019","Bhutan",null,"AUP-Comp-000303","Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00033","Bhutan"]
["2017-2019","Chad",null,"AUP-Comp-000329","Malaria","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00059","Chad"]
["2017-2019","Costa Rica",null,"AUP-Comp-000340","HIV/AIDS","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00070","Costa Rica"]
["2017-2019","Ethiopia",null,"AUP-Comp-000356","HIV/AIDS","2018-01-01","2021-06-30","2018-01-01","2021-06-30","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-06-30","Approved","AUP-00086","Ethiopia"]
["2017-2019","Ethiopia",null,"AUP-Comp-000357","Malaria","2018-01-01","2021-06-30","2018-01-01","2021-06-30","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-06-30","Approved","AUP-00087","Ethiopia"]
["2017-2019","Ethiopia",null,"AUP-Comp-000358","Tuberculosis","2018-01-01","2021-06-30","2018-01-01","2021-06-30","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-06-30","Approved","AUP-00088","Ethiopia"]
["2017-2019","Gambia",null,"AUP-Comp-000361","Malaria","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00091","Gambia"]
["2017-2019","Guatemala",null,"AUP-Comp-000369","Malaria","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00099",{"$f":"IF(B131=\"\",C131,B131)","v":"Guatemala"}]
["2017-2019","Kenya",null,"AUP-Comp-000396","HIV/AIDS","2018-01-01","2021-06-30","2018-01-01","2021-06-30","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-06-30","Approved","AUP-00421","Kenya"]
["2017-2019","Kenya",null,"AUP-Comp-000397","Malaria","2018-01-01","2021-06-30","2018-01-01","2021-06-30","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-06-30","Approved","AUP-00422","Kenya"]
["2017-2019","Kenya",null,"AUP-Comp-000398","Tuberculosis","2018-01-01","2021-06-30","2018-01-01","2021-06-30","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-06-30","Approved","AUP-00423","Kenya"]
["2017-2019","Korea (Democratic Peoples Republic)",null,"AUP-Comp-000400","Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00425","Korea (Democratic Peoples Republic)"]
["2017-2019","Lesotho",null,"AUP-Comp-000407","HIV/AIDS","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00432","Lesotho"]
["2017-2019","Lesotho",null,"AUP-Comp-000408","Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00433","Lesotho"]
["2017-2019","Liberia",null,"AUP-Comp-000410","Malaria","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00435","Liberia"]
["2017-2019","Madagascar",null,"AUP-Comp-000413","Malaria","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00438","Madagascar"]
["2017-2019","Rwanda",null,"AUP-Comp-000469","HIV/AIDS","2018-01-01","2021-06-30","2018-01-01","2021-06-30","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-06-30","Approved","AUP-00494","Rwanda"]
["2017-2019","Rwanda",null,"AUP-Comp-000470","Malaria","2018-01-01","2021-06-30","2018-01-01","2021-06-30","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-06-30","Approved","AUP-00495","Rwanda"]
["2017-2019","Rwanda",null,"AUP-Comp-000471","Tuberculosis","2018-01-01","2021-06-30","2018-01-01","2021-06-30","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-06-30","Approved","AUP-00496","Rwanda"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000479","Malaria","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00504","Sierra Leone"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000480","RSSH","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00505","Sierra Leone"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000481","Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00506","Sierra Leone"]
["2017-2019","Turkmenistan",null,"AUP-Comp-000518","Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00543","Turkmenistan"]
["2017-2019","Uzbekistan",null,"AUP-Comp-000525","HIV/AIDS","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00550","Uzbekistan"]
["2017-2019","Uzbekistan",null,"AUP-Comp-000526","Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","Approved","AUP-00551","Uzbekistan"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000599","Malaria,RSSH,Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","2018-07-01","2021-06-30","Approved","AUP-00570","Sierra Leone"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000600","Malaria,RSSH,Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","2018-07-01","2021-06-30","Approved","AUP-00570","Sierra Leone"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000601","Malaria,RSSH,Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30",null,null,"2018-07-01","2021-06-30","2018-07-01","2021-06-30","Approved","AUP-00570","Sierra Leone"]
["2017-2019","Ethiopia",null,"AUP-Comp-000691","RSSH","2018-01-01","2021-06-30","2018-01-01","2021-06-30",{"$nulls":4},"2018-01-01","2021-06-30","Approved","AUP-00610","Ethiopia"]
["2017-2019","Lesotho",null,"AUP-Comp-000815","HIV/AIDS,Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30",{"$nulls":4},"2018-07-01","2021-06-30","Approved","AUP-00672","Lesotho"]
["2017-2019","Lesotho",null,"AUP-Comp-000816","HIV/AIDS,Tuberculosis","2018-07-01","2021-06-30","2018-07-01","2021-06-30",{"$nulls":4},"2018-07-01","2021-06-30","Approved","AUP-00672","Lesotho"]
["2017-2019","Rwanda",null,"AUP-Comp-000834","HIV/AIDS,Malaria,Tuberculosis","2018-01-01","2021-06-30","2018-01-01","2021-06-30",{"$nulls":4},"2018-01-01","2021-06-30","Approved","AUP-00685","Rwanda"]
["2017-2019","Rwanda",null,"AUP-Comp-000835","HIV/AIDS,Malaria,Tuberculosis","2018-01-01","2021-06-30","2018-01-01","2021-06-30",{"$nulls":4},"2018-01-01","2021-06-30","Approved","AUP-00685","Rwanda"]
["2017-2019","Rwanda",null,"AUP-Comp-000836","HIV/AIDS,Malaria,Tuberculosis","2018-01-01","2021-06-30","2018-01-01","2021-06-30",{"$nulls":4},"2018-01-01","2021-06-30","Approved","AUP-00685","Rwanda"]
["2017-2019","India",null,"AUP-Comp-000386","HIV/AIDS","2018-01-01","2021-03-31","2018-01-01","2021-03-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-03-31","Approved","AUP-00411","India"]
["2017-2019","India",null,"AUP-Comp-000387","Malaria","2018-01-01","2021-03-31","2018-01-01","2021-03-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-03-31","Approved","AUP-00412","India"]
["2017-2019","India",null,"AUP-Comp-000388","Tuberculosis","2018-01-01","2021-03-31","2018-01-01","2021-03-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2021-03-31","Approved","AUP-00413","India"]
["2017-2019","Iran (Islamic Republic)",null,"AUP-Comp-000392","HIV/AIDS","2018-04-01","2021-03-31","2018-04-01","2021-03-31","2018-04-01","2021-03-31",null,null,"2018-04-01","2021-03-31","Approved","AUP-00417","Iran (Islamic Republic)"]
["2017-2019","Romania",null,"AUP-Comp-000468","Tuberculosis","2018-04-01","2021-03-31","2018-04-01","2021-03-31","2018-04-01","2021-03-31",null,null,"2018-04-01","2021-03-31","Approved","AUP-00493","Romania"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000472","HIV/AIDS","2018-04-01","2021-03-31","2018-04-01","2021-03-31","2018-04-01","2021-03-31",null,null,"2018-04-01","2021-03-31","Approved","AUP-00497","Sao Tome and Principe"]
["2017-2019","Suriname",null,"AUP-Comp-000499","Malaria","2018-04-01","2021-03-31","2018-04-01","2021-03-31","2018-04-01","2021-03-31",null,null,"2018-04-01","2021-03-31","Approved","AUP-00524","Suriname"]
["2017-2019","Tajikistan",null,"AUP-Comp-000505","Tuberculosis","2018-04-01","2021-03-31","2018-04-01","2021-03-31","2018-04-01","2021-03-31",null,null,"2018-04-01","2021-03-31","Approved","AUP-00530","Tajikistan"]
["2017-2019","India",null,"AUP-Comp-000605","HIV/AIDS,Tuberculosis","2018-01-01","2021-03-31","2018-01-01","2021-03-31",{"$nulls":4},"2018-01-01","2021-03-31","Approved","AUP-00572","India"]
["2017-2019","India",null,"AUP-Comp-000606","HIV/AIDS,Tuberculosis","2018-01-01","2021-03-31","2018-01-01","2021-03-31",{"$nulls":4},"2018-01-01","2021-03-31","Approved","AUP-00572","India"]
["2017-2019","Nepal",null,"AUP-Comp-000440","HIV/AIDS","2018-03-16","2021-03-15","2018-03-16","2021-03-15","2018-03-16","2021-03-15",null,null,"2018-03-16","2021-03-15","Approved","AUP-00465","Nepal"]
["2017-2019","Nepal",null,"AUP-Comp-000441","Malaria","2018-03-16","2021-03-15","2018-03-16","2021-03-15","2018-03-16","2021-03-15",null,null,"2018-03-16","2021-03-15","Approved","AUP-00466","Nepal"]
["2017-2019","Nepal",null,"AUP-Comp-000442","Tuberculosis","2018-03-16","2021-03-15","2018-03-16","2021-03-15","2018-03-16","2021-03-15",null,null,"2018-03-16","2021-03-15","Approved","AUP-00467","Nepal"]
["2017-2019","Korea (Democratic Peoples Republic)",null,"AUP-Comp-000399","Malaria","2018-03-01","2021-02-28","2018-03-01","2021-02-28","2018-03-01","2021-02-28",null,null,"2018-03-01","2021-02-28","Approved","AUP-00424","Korea (Democratic Peoples Republic)"]
["2017-2019","Paraguay",null,"AUP-Comp-000461","HIV/AIDS","2018-03-01","2021-02-28","2018-03-01","2021-02-28","2018-03-01","2021-02-28",null,null,"2018-03-01","2021-02-28","Approved","AUP-00486","Paraguay"]
["2017-2019",null,"Multicountry Middle East MER","AUP-Comp-000270","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00000","Multicountry Middle East MER"]
["2017-2019",null,"Multicountry Middle East MER","AUP-Comp-000271","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00001","Multicountry Middle East MER"]
["2017-2019",null,"Multicountry Middle East MER","AUP-Comp-000272","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00002","Multicountry Middle East MER"]
["2017-2019",null,"Multicountry Western Pacific","AUP-Comp-000275","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00005","Multicountry Western Pacific"]
["2017-2019",null,"Multicountry Western Pacific","AUP-Comp-000276","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00006","Multicountry Western Pacific"]
["2017-2019",null,"Multicountry Western Pacific","AUP-Comp-000277","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00007","Multicountry Western Pacific"]
["2017-2019","Afghanistan",null,"AUP-Comp-000278","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00008","Afghanistan"]
["2017-2019","Afghanistan",null,"AUP-Comp-000279","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00009","Afghanistan"]
["2017-2019","Afghanistan",null,"AUP-Comp-000280","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00010","Afghanistan"]
["2017-2019","Azerbaijan",null,"AUP-Comp-000290","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00020","Azerbaijan"]
["2017-2019","Bangladesh",null,"AUP-Comp-000292","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00022","Bangladesh"]
["2017-2019","Bangladesh",null,"AUP-Comp-000293","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00023","Bangladesh"]
["2017-2019","Benin",null,"AUP-Comp-000298","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00028","Benin"]
["2017-2019","Benin",null,"AUP-Comp-000299","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00029","Benin"]
["2017-2019","Benin",null,"AUP-Comp-000300","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00030","Benin"]
["2017-2019","Burkina Faso",null,"AUP-Comp-000310","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00040","Burkina Faso"]
["2017-2019","Burkina Faso",null,"AUP-Comp-000311","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00041","Burkina Faso"]
["2017-2019","Burkina Faso",null,"AUP-Comp-000312","RSSH","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00042","Burkina Faso"]
["2017-2019","Burkina Faso",null,"AUP-Comp-000313","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00043","Burkina Faso"]
["2017-2019","Burundi",null,"AUP-Comp-000314","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00044","Burundi"]
["2017-2019","Burundi",null,"AUP-Comp-000315","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00045","Burundi"]
["2017-2019","Burundi",null,"AUP-Comp-000316","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00046","Burundi"]
["2017-2019","Cambodia",null,"AUP-Comp-000317","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00047",{"$f":"IF(B195=\"\",C195,B195)","v":"Cambodia"}]
["2017-2019","Cambodia",null,"AUP-Comp-000318","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00048","Cambodia"]
["2017-2019","Cameroon",null,"AUP-Comp-000319","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00049","Cameroon"]
["2017-2019","Cameroon",null,"AUP-Comp-000320","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00050","Cameroon"]
["2017-2019","Cameroon",null,"AUP-Comp-000321","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00051","Cameroon"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000322","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00052","Cabo Verde"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000323","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00053","Cabo Verde"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000324","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00054","Cabo Verde"]
["2017-2019","Central African Republic",null,"AUP-Comp-000325","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00055","Central African Republic"]
["2017-2019","Central African Republic",null,"AUP-Comp-000326","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00056","Central African Republic"]
["2017-2019","Central African Republic",null,"AUP-Comp-000327","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00057","Central African Republic"]
["2017-2019","Congo",null,"AUP-Comp-000335","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00065","Congo"]
["2017-2019","Congo",null,"AUP-Comp-000336","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00066","Congo"]
["2017-2019","Congo (Democratic Republic)",null,"AUP-Comp-000337","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00067","Congo (Democratic Republic)"]
["2017-2019","Congo (Democratic Republic)",null,"AUP-Comp-000338","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00068","Congo (Democratic Republic)"]
["2017-2019","Congo (Democratic Republic)",null,"AUP-Comp-000339","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00069","Congo (Democratic Republic)"]
["2017-2019","Côte d'Ivoire",null,"AUP-Comp-000341","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00071","Côte d'Ivoire"]
["2017-2019","Côte d'Ivoire",null,"AUP-Comp-000342","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00072","Côte d'Ivoire"]
["2017-2019","Côte d'Ivoire",null,"AUP-Comp-000343","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00073","Côte d'Ivoire"]
["2017-2019","Cuba",null,"AUP-Comp-000344","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00074","Cuba"]
["2017-2019","Djibouti",null,"AUP-Comp-000345","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00075","Djibouti"]
["2017-2019","Djibouti",null,"AUP-Comp-000346","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00076","Djibouti"]
["2017-2019","Djibouti",null,"AUP-Comp-000347","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00077","Djibouti"]
["2017-2019","Eritrea",null,"AUP-Comp-000353","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00083","Eritrea"]
["2017-2019","Eritrea",null,"AUP-Comp-000354","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00084","Eritrea"]
["2017-2019","Eritrea",null,"AUP-Comp-000355","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00085","Eritrea"]
["2017-2019","Gambia",null,"AUP-Comp-000360","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00090","Gambia"]
["2017-2019","Gambia",null,"AUP-Comp-000362","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00092","Gambia"]
["2017-2019","Ghana",null,"AUP-Comp-000365","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00095","Ghana"]
["2017-2019","Ghana",null,"AUP-Comp-000366","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00096","Ghana"]
["2017-2019","Ghana",null,"AUP-Comp-000367","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00097","Ghana"]
["2017-2019","Guatemala",null,"AUP-Comp-000368","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00098","Guatemala"]
["2017-2019","Guinea",null,"AUP-Comp-000371","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00101","Guinea"]
["2017-2019","Guinea",null,"AUP-Comp-000372","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00102","Guinea"]
["2017-2019","Guinea",null,"AUP-Comp-000373","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00103","Guinea"]
["2017-2019","Guinea-Bissau",null,"AUP-Comp-000374","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00104","Guinea-Bissau"]
["2017-2019","Guinea-Bissau",null,"AUP-Comp-000375","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00400","Guinea-Bissau"]
["2017-2019","Guinea-Bissau",null,"AUP-Comp-000376","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00401","Guinea-Bissau"]
["2017-2019","Guyana",null,"AUP-Comp-000377","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00402","Guyana"]
["2017-2019","Haiti",null,"AUP-Comp-000380","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00405","Haiti"]
["2017-2019","Haiti",null,"AUP-Comp-000381","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00406","Haiti"]
["2017-2019","Haiti",null,"AUP-Comp-000382","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00407","Haiti"]
["2017-2019","Honduras",null,"AUP-Comp-000384","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00409","Honduras"]
["2017-2019","Indonesia",null,"AUP-Comp-000389","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00414","Indonesia"]
["2017-2019","Indonesia",null,"AUP-Comp-000390","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00415","Indonesia"]
["2017-2019","Indonesia",null,"AUP-Comp-000391","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00416","Indonesia"]
["2017-2019","Kazakhstan",null,"AUP-Comp-000394","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00419","Kazakhstan"]
["2017-2019","Kosovo",null,"AUP-Comp-000401","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00426","Kosovo"]
["2017-2019","Kyrgyzstan",null,"AUP-Comp-000403","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00428","Kyrgyzstan"]
["2017-2019","Kyrgyzstan",null,"AUP-Comp-000404","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00429","Kyrgyzstan"]
["2017-2019","Lao (Peoples Democratic Republic)",null,"AUP-Comp-000405","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00430","Lao (Peoples Democratic Republic)"]
["2017-2019","Lao (Peoples Democratic Republic)",null,"AUP-Comp-000406","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00431","Lao (Peoples Democratic Republic)"]
["2017-2019","Liberia",null,"AUP-Comp-000409","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00434","Liberia"]
["2017-2019","Liberia",null,"AUP-Comp-000411","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00436","Liberia"]
["2017-2019","Madagascar",null,"AUP-Comp-000412","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00437","Madagascar"]
["2017-2019","Madagascar",null,"AUP-Comp-000414","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00439","Madagascar"]
["2017-2019","Malawi",null,"AUP-Comp-000415","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00440","Malawi"]
["2017-2019","Malawi",null,"AUP-Comp-000416","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00441","Malawi"]
["2017-2019","Malawi",null,"AUP-Comp-000417","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00442","Malawi"]
["2017-2019","Mali",null,"AUP-Comp-000419","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00444","Mali"]
["2017-2019","Mali",null,"AUP-Comp-000421","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00446","Mali"]
["2017-2019","Mauritius",null,"AUP-Comp-000425","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00450","Mauritius"]
["2017-2019","Moldova",null,"AUP-Comp-000426","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00451","Moldova"]
["2017-2019","Moldova",null,"AUP-Comp-000427","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00452","Moldova"]
["2017-2019","Mongolia",null,"AUP-Comp-000428","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00453",{"$f":"IF(B259=\"\",C259,B259)","v":"Mongolia"}]
["2017-2019","Mongolia",null,"AUP-Comp-000429","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00454","Mongolia"]
["2017-2019","Morocco",null,"AUP-Comp-000430","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00455","Morocco"]
["2017-2019","Morocco",null,"AUP-Comp-000431","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00456","Morocco"]
["2017-2019","Mozambique",null,"AUP-Comp-000432","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00457","Mozambique"]
["2017-2019","Mozambique",null,"AUP-Comp-000433","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00458","Mozambique"]
["2017-2019","Mozambique",null,"AUP-Comp-000434","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00459","Mozambique"]
["2017-2019","Myanmar",null,"AUP-Comp-000435","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00460","Myanmar"]
["2017-2019","Myanmar",null,"AUP-Comp-000436","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00461","Myanmar"]
["2017-2019","Namibia",null,"AUP-Comp-000437","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00462","Namibia"]
["2017-2019","Namibia",null,"AUP-Comp-000438","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00463","Namibia"]
["2017-2019","Namibia",null,"AUP-Comp-000439","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00464","Namibia"]
["2017-2019","Nicaragua",null,"AUP-Comp-000443","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00468","Nicaragua"]
["2017-2019","Niger",null,"AUP-Comp-000446","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00471","Niger"]
["2017-2019","Niger",null,"AUP-Comp-000447","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00472","Niger"]
["2017-2019","Nigeria",null,"AUP-Comp-000450","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00475","Nigeria"]
["2017-2019","Nigeria",null,"AUP-Comp-000451","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00476","Nigeria"]
["2017-2019","Nigeria",null,"AUP-Comp-000452","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00477","Nigeria"]
["2017-2019","Pakistan",null,"AUP-Comp-000453","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00478","Pakistan"]
["2017-2019","Pakistan",null,"AUP-Comp-000454","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00479","Pakistan"]
["2017-2019","Pakistan",null,"AUP-Comp-000455","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00480","Pakistan"]
["2017-2019","Papua New Guinea",null,"AUP-Comp-000458","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00483","Papua New Guinea"]
["2017-2019","Papua New Guinea",null,"AUP-Comp-000459","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00484","Papua New Guinea"]
["2017-2019","Papua New Guinea",null,"AUP-Comp-000460","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00485","Papua New Guinea"]
["2017-2019","Philippines",null,"AUP-Comp-000465","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00490","Philippines"]
["2017-2019","Philippines",null,"AUP-Comp-000466","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00491","Philippines"]
["2017-2019","Philippines",null,"AUP-Comp-000467","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00492","Philippines"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000473","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00498","Sao Tome and Principe"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000474","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00499","Sao Tome and Principe"]
["2017-2019","Senegal",null,"AUP-Comp-000475","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00500","Senegal"]
["2017-2019","Senegal",null,"AUP-Comp-000476","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00501","Senegal"]
["2017-2019","Senegal",null,"AUP-Comp-000477","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00502","Senegal"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000478","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00503","Sierra Leone"]
["2017-2019","Solomon Islands",null,"AUP-Comp-000482","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00507","Solomon Islands"]
["2017-2019","Solomon Islands",null,"AUP-Comp-000483","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00508","Solomon Islands"]
["2017-2019","Somalia",null,"AUP-Comp-000484","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00509","Somalia"]
["2017-2019","Somalia",null,"AUP-Comp-000485","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00510","Somalia"]
["2017-2019","Somalia",null,"AUP-Comp-000486","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00511","Somalia"]
["2017-2019","South Sudan",null,"AUP-Comp-000489","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00514","South Sudan"]
["2017-2019","South Sudan",null,"AUP-Comp-000490","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00515","South Sudan"]
["2017-2019","South Sudan",null,"AUP-Comp-000491","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00516","South Sudan"]
["2017-2019","Sudan",null,"AUP-Comp-000495","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00520","Sudan"]
["2017-2019","Sudan",null,"AUP-Comp-000496","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00521","Sudan"]
["2017-2019","Sudan",null,"AUP-Comp-000497","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00522","Sudan"]
["2017-2019","Eswatini",null,"AUP-Comp-000502","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00527","Eswatini"]
["2017-2019","Tajikistan",null,"AUP-Comp-000504","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00529","Tajikistan"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000506","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00531","Tanzania (United Republic)"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000507","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00532","Tanzania (United Republic)"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000508","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00533","Tanzania (United Republic)"]
["2017-2019","Thailand",null,"AUP-Comp-000509","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00534","Thailand"]
["2017-2019","Thailand",null,"AUP-Comp-000510","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00535","Thailand"]
["2017-2019","Timor-Leste",null,"AUP-Comp-000511","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00536","Timor-Leste"]
["2017-2019","Timor-Leste",null,"AUP-Comp-000512","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00537","Timor-Leste"]
["2017-2019","Timor-Leste",null,"AUP-Comp-000513","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00538","Timor-Leste"]
["2017-2019","Togo",null,"AUP-Comp-000514","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00539","Togo"]
["2017-2019","Togo",null,"AUP-Comp-000515","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00540","Togo"]
["2017-2019","Togo",null,"AUP-Comp-000516","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00541","Togo"]
["2017-2019","Uganda",null,"AUP-Comp-000519","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00544","Uganda"]
["2017-2019","Uganda",null,"AUP-Comp-000520","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00545","Uganda"]
["2017-2019","Uganda",null,"AUP-Comp-000521","RSSH","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00546","Uganda"]
["2017-2019","Uganda",null,"AUP-Comp-000522","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00547","Uganda"]
["2017-2019","Ukraine",null,"AUP-Comp-000523","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00548","Ukraine"]
["2017-2019","Ukraine",null,"AUP-Comp-000524","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00549","Ukraine"]
["2017-2019","Viet Nam",null,"AUP-Comp-000527","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00552","Viet Nam"]
["2017-2019","Viet Nam",null,"AUP-Comp-000528","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00553",{"$f":"IF(B323=\"\",C323,B323)","v":"Viet Nam"}]
["2017-2019","Zambia",null,"AUP-Comp-000529","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00554","Zambia"]
["2017-2019","Zambia",null,"AUP-Comp-000530","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00555","Zambia"]
["2017-2019","Zambia",null,"AUP-Comp-000531","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00556","Zambia"]
["2017-2019","Zanzibar",null,"AUP-Comp-000532","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00557","Zanzibar"]
["2017-2019","Zanzibar",null,"AUP-Comp-000533","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00558","Zanzibar"]
["2017-2019","Zanzibar",null,"AUP-Comp-000534","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00559","Zanzibar"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000535","HIV/AIDS","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00560","Zimbabwe"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000536","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00561","Zimbabwe"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000537","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","Approved","AUP-00562","Zimbabwe"]
["2017-2019",null,"Multicountry Southern Africa WHC","AUP-Comp-000591","Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","2018-01-01","2020-12-31","Approved","AUP-00566","Multicountry Southern Africa WHC"]
["2017-2019","Liberia",null,"AUP-Comp-000592","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","2018-01-01","2020-12-31","Approved","AUP-00567","Liberia"]
["2017-2019","Liberia",null,"AUP-Comp-000593","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",null,null,"2018-01-01","2020-12-31","2018-01-01","2020-12-31","Approved","AUP-00567","Liberia"]
["2017-2019","Ghana",null,"AUP-Comp-000612","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00575","Ghana"]
["2017-2019","Ghana",null,"AUP-Comp-000613","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00575","Ghana"]
["2017-2019","Congo",null,"AUP-Comp-000617","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00578","Congo"]
["2017-2019","Congo",null,"AUP-Comp-000618","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00578","Congo"]
["2017-2019","Central African Republic",null,"AUP-Comp-000623","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00580","Central African Republic"]
["2017-2019","Central African Republic",null,"AUP-Comp-000624","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00580","Central African Republic"]
["2017-2019","Cambodia",null,"AUP-Comp-000631","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00584","Cambodia"]
["2017-2019","Cambodia",null,"AUP-Comp-000632","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00584","Cambodia"]
["2017-2019","Malawi",null,"AUP-Comp-000645","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00593","Malawi"]
["2017-2019","Malawi",null,"AUP-Comp-000646","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00593","Malawi"]
["2017-2019","Papua New Guinea",null,"AUP-Comp-000655","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00596","Papua New Guinea"]
["2017-2019","Papua New Guinea",null,"AUP-Comp-000656","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00596","Papua New Guinea"]
["2017-2019","Haiti",null,"AUP-Comp-000664","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00599","Haiti"]
["2017-2019","Haiti",null,"AUP-Comp-000665","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00599","Haiti"]
["2017-2019","Namibia",null,"AUP-Comp-000666","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00600","Namibia"]
["2017-2019","Namibia",null,"AUP-Comp-000667","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00600","Namibia"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000688","HIV/AIDS,Malaria,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00609","Sao Tome and Principe"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000689","HIV/AIDS,Malaria,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00609","Sao Tome and Principe"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000690","HIV/AIDS,Malaria,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00609","Sao Tome and Principe"]
["2017-2019","Mozambique",null,"AUP-Comp-000699","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00613","Mozambique"]
["2017-2019","Mozambique",null,"AUP-Comp-000700","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00613","Mozambique"]
["2017-2019",null,"Multicountry East Asia and Pacific RAI","AUP-Comp-000729","Malaria","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00631","Multicountry East Asia and Pacific RAI"]
["2017-2019",null,"Multicountry Western Pacific","AUP-Comp-000730","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00632","Multicountry Western Pacific"]
["2017-2019",null,"Multicountry Western Pacific","AUP-Comp-000731","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00632","Multicountry Western Pacific"]
["2017-2019","Solomon Islands",null,"AUP-Comp-000745","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00638","Solomon Islands"]
["2017-2019","Solomon Islands",null,"AUP-Comp-000746","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00638","Solomon Islands"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000753","HIV/AIDS,Malaria,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00641","Cabo Verde"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000754","HIV/AIDS,Malaria,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00641","Cabo Verde"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000755","HIV/AIDS,Malaria,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00641","Cabo Verde"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000762","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00644","Tanzania (United Republic)"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000763","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00644","Tanzania (United Republic)"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000768","RSSH","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00646","Tanzania (United Republic)"]
["2017-2019","Kyrgyzstan",null,"AUP-Comp-000774","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00649","Kyrgyzstan"]
["2017-2019","Kyrgyzstan",null,"AUP-Comp-000775","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00649","Kyrgyzstan"]
["2017-2019","Burundi",null,"AUP-Comp-000776","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00650","Burundi"]
["2017-2019","Burundi",null,"AUP-Comp-000777","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00650","Burundi"]
["2017-2019","Congo (Democratic Republic)",null,"AUP-Comp-000790","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00657","Congo (Democratic Republic)"]
["2017-2019","Congo (Democratic Republic)",null,"AUP-Comp-000791","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00657","Congo (Democratic Republic)"]
["2017-2019","Gambia",null,"AUP-Comp-000794","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00659","Gambia"]
["2017-2019","Gambia",null,"AUP-Comp-000795","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00659","Gambia"]
["2017-2019","Zanzibar",null,"AUP-Comp-000796","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00660","Zanzibar"]
["2017-2019","Zanzibar",null,"AUP-Comp-000797","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00660","Zanzibar"]
["2017-2019","Zambia",null,"AUP-Comp-000800","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00662","Zambia"]
["2017-2019","Zambia",null,"AUP-Comp-000801","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00662","Zambia"]
["2017-2019","Burkina Faso",null,"AUP-Comp-000807","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00667","Burkina Faso"]
["2017-2019","Burkina Faso",null,"AUP-Comp-000808","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00667","Burkina Faso"]
["2017-2019","Thailand",null,"AUP-Comp-000811","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00670","Thailand"]
["2017-2019","Thailand",null,"AUP-Comp-000812","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00670","Thailand"]
["2017-2019","Ukraine",null,"AUP-Comp-000813","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00671","Ukraine"]
["2017-2019","Ukraine",null,"AUP-Comp-000814","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00671","Ukraine"]
["2017-2019","Senegal",null,"AUP-Comp-000817","RSSH","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00673","Senegal"]
["2017-2019","Djibouti",null,"AUP-Comp-000821","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00676",{"$f":"IF(B387=\"\",C387,B387)","v":"Djibouti"}]
["2017-2019","Djibouti",null,"AUP-Comp-000822","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00676","Djibouti"]
["2017-2019","Congo",null,"AUP-Comp-000829","Malaria","2018-05-01","2020-12-31","2018-05-01","2020-12-31",null,null,"2018-05-01","2021-04-30","2018-05-01","2020-12-31","Approved","AUP-00681","Congo"]
["2017-2019","Guinea-Bissau",null,"AUP-Comp-000854","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00694","Guinea-Bissau"]
["2017-2019","Guinea-Bissau",null,"AUP-Comp-000855","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00694","Guinea-Bissau"]
["2017-2019","Nigeria",null,"AUP-Comp-000888","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00707","Nigeria"]
["2017-2019","Nigeria",null,"AUP-Comp-000889","HIV/AIDS,Tuberculosis","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00707","Nigeria"]
["2017-2019","Nigeria",null,"AUP-Comp-001071","RSSH","2018-01-01","2020-12-31","2018-01-01","2020-12-31",{"$nulls":4},"2018-01-01","2020-12-31","Approved","AUP-00840","Nigeria"]
["2017-2019",null,"Multicountry Asia IHAA","AUP-Comp-001130","HIV/AIDS","2017-01-01","2020-12-31","2017-01-01","2020-12-31",{"$nulls":4},"2017-01-01","2020-12-31","Approved","AUP-00870","Multicountry Asia IHAA"]
["2017-2019","Bangladesh",null,"AUP-Comp-000291","HIV/AIDS","2017-12-01","2020-11-30","2017-12-01","2020-11-30","2017-12-01","2020-11-30",null,null,"2017-12-01","2020-11-30","Approved","AUP-00021","Bangladesh"]
["2017-2019",null,"Multicountry HIV EECA APH","AUP-Comp-001057","HIV/AIDS,Tuberculosis","2017-01-01","2019-12-31","2017-01-01","2019-12-31",{"$nulls":4},"2017-01-01","2019-12-31","Approved","AUP-00833","Multicountry HIV EECA APH"]
["2017-2019",null,"Multicountry HIV EECA APH","AUP-Comp-001058","HIV/AIDS,Tuberculosis","2017-01-01","2019-12-31","2017-01-01","2019-12-31",{"$nulls":4},"2017-01-01","2019-12-31","Approved","AUP-00833","Multicountry HIV EECA APH"]
["2017-2019",null,"Multicountry EECA IHAU","AUP-Comp-001059","HIV/AIDS,Tuberculosis","2017-01-01","2019-12-31","2017-01-01","2019-12-31",{"$nulls":4},"2017-01-01","2019-12-31","Approved","AUP-00834","Multicountry EECA IHAU"]
["2017-2019",null,"Multicountry EECA IHAU","AUP-Comp-001060","HIV/AIDS,Tuberculosis","2017-01-01","2019-12-31","2017-01-01","2019-12-31",{"$nulls":4},"2017-01-01","2019-12-31","Approved","AUP-00834","Multicountry EECA IHAU"]
["2017-2019",null,"Multicountry Western Africa ANCS","AUP-Comp-001126","HIV/AIDS,Tuberculosis","2017-01-01","2019-12-31","2017-01-01","2019-12-31",{"$nulls":4},"2017-01-01","2019-12-31","Approved","AUP-00868","Multicountry Western Africa ANCS"]
["2017-2019",null,"Multicountry Western Africa ANCS","AUP-Comp-001127","HIV/AIDS,Tuberculosis","2017-01-01","2019-12-31","2017-01-01","2019-12-31",{"$nulls":4},"2017-01-01","2019-12-31","Approved","AUP-00868","Multicountry Western Africa ANCS"]
["2017-2019",null,"Multicountry Southern Africa HIVOS","AUP-Comp-001079","HIV/AIDS","2016-01-01","2019-06-30","2016-01-01","2019-06-30",{"$nulls":4},"2016-01-01","2019-06-30","Approved","AUP-00848","Multicountry Southern Africa HIVOS"]
["2017-2019","Austria",null,"AUP-Comp-000588","Malaria",{"$nulls":11},"AUP-00563","Austria"]
["2017-2019","Azerbaijan",null,"AUP-Comp-000589","Malaria",{"$nulls":11},"AUP-00564","Azerbaijan"]
["2017-2019","Yemen",null,"AUP-Comp-000590","Malaria",{"$nulls":11},"AUP-00565","Yemen"]
["2017-2019","India",null,"AUP-Comp-000607","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00573","India"]
["2017-2019","India",null,"AUP-Comp-000608","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00573","India"]
["2017-2019","India",null,"AUP-Comp-000609","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00573","India"]
["2017-2019","India",null,"AUP-Comp-000610","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00573","India"]
["2017-2019","Eritrea",null,"AUP-Comp-000614","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00576","Eritrea"]
["2017-2019","Eritrea",null,"AUP-Comp-000615","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00576","Eritrea"]
["2017-2019","Ghana",null,"AUP-Comp-000616","RSSH",{"$nulls":11},"AUP-00577","Ghana"]
["2017-2019","Central African Republic",null,"AUP-Comp-000619","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00579","Central African Republic"]
["2017-2019","Central African Republic",null,"AUP-Comp-000620","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00579","Central African Republic"]
["2017-2019","Central African Republic",null,"AUP-Comp-000621","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00579","Central African Republic"]
["2017-2019","Central African Republic",null,"AUP-Comp-000622","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00579","Central African Republic"]
["2017-2019","Ethiopia",null,"AUP-Comp-000627","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00582","Ethiopia"]
["2017-2019","Ethiopia",null,"AUP-Comp-000628","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00582","Ethiopia"]
["2017-2019","Cambodia",null,"AUP-Comp-000635","Malaria",{"$nulls":11},"AUP-00586","Cambodia"]
["2017-2019","Cambodia",null,"AUP-Comp-000636","RSSH",{"$nulls":11},"AUP-00587","Cambodia"]
["2017-2019",null,"Multicountry Southern Africa WHC","AUP-Comp-000638","HIV/AIDS",{"$nulls":11},"AUP-00589","Multicountry Southern Africa WHC"]
["2017-2019",null,"Multicountry Southern Africa WHC","AUP-Comp-000639","Malaria",{"$nulls":11},"AUP-00590","Multicountry Southern Africa WHC"]
["2017-2019",null,"Multicountry Southern Africa WHC","AUP-Comp-000640","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00591","Multicountry Southern Africa WHC"]
["2017-2019",null,"Multicountry Southern Africa WHC","AUP-Comp-000641","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00591","Multicountry Southern Africa WHC"]
["2017-2019","Malawi",null,"AUP-Comp-000642","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00592","Malawi"]
["2017-2019","Malawi",null,"AUP-Comp-000643","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00592","Malawi"]
["2017-2019","Malawi",null,"AUP-Comp-000644","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00592","Malawi"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000647","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00594","Sierra Leone"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000648","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00594","Sierra Leone"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000649","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00594","Sierra Leone"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000650","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00594","Sierra Leone"]
["2017-2019","Haiti",null,"AUP-Comp-000657","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00597","Haiti"]
["2017-2019","Haiti",null,"AUP-Comp-000658","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00597","Haiti"]
["2017-2019","Haiti",null,"AUP-Comp-000659","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00597","Haiti"]
["2017-2019","Haiti",null,"AUP-Comp-000660","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00598","Haiti"]
["2017-2019","Haiti",null,"AUP-Comp-000661","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00598","Haiti"]
["2017-2019","Haiti",null,"AUP-Comp-000662","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00598","Haiti"]
["2017-2019","Haiti",null,"AUP-Comp-000663","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00598","Haiti"]
["2017-2019","France",null,"AUP-Comp-000668","HIV/AIDS",{"$nulls":11},"AUP-00601","France"]
["2017-2019","Nigeria",null,"AUP-Comp-000670","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00603","Nigeria"]
["2017-2019","Nigeria",null,"AUP-Comp-000671","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00603","Nigeria"]
["2017-2019","Nigeria",null,"AUP-Comp-000672","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00603","Nigeria"]
["2017-2019","Nigeria",null,"AUP-Comp-000673","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00603","Nigeria"]
["2017-2019","Ethiopia",null,"AUP-Comp-000678","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00605","Ethiopia"]
["2017-2019","Ethiopia",null,"AUP-Comp-000679","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00605","Ethiopia"]
["2017-2019","Ethiopia",null,"AUP-Comp-000680","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00605","Ethiopia"]
["2017-2019","Ethiopia",null,"AUP-Comp-000681","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00605","Ethiopia"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000682","RSSH",{"$nulls":11},"AUP-00606","Cabo Verde"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000683","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":6},"2018-01-01","2020-12-31",null,null,"Approved","AUP-00607","Sao Tome and Principe"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000684","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":6},"2018-01-01","2020-12-31",null,null,"Approved","AUP-00607",{"$f":"IF(B451=\"\",C451,B451)","v":"Sao Tome and Principe"}]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000685","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":6},"2018-01-01","2020-12-31",null,null,"Approved","AUP-00607","Sao Tome and Principe"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000686","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":6},"2018-01-01","2020-12-31",null,null,"Approved","AUP-00607","Sao Tome and Principe"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000687","RSSH",{"$nulls":11},"AUP-00608","Sao Tome and Principe"]
["2017-2019","Papua New Guinea",null,"AUP-Comp-000695","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00612","Papua New Guinea"]
["2017-2019","Papua New Guinea",null,"AUP-Comp-000696","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00612","Papua New Guinea"]
["2017-2019","Papua New Guinea",null,"AUP-Comp-000697","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00612","Papua New Guinea"]
["2017-2019","Papua New Guinea",null,"AUP-Comp-000698","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00612","Papua New Guinea"]
["2017-2019",null,"Multicountry Middle East MER","AUP-Comp-000701","RSSH",{"$nulls":11},"AUP-00614","Multicountry Middle East MER"]
["2017-2019","Iraq",null,"AUP-Comp-000705","Tuberculosis",{"$nulls":11},"AUP-00618","Iraq"]
["2017-2019",null,"Multicountry Eastern Africa IGAD","AUP-Comp-000719","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00626","Multicountry Eastern Africa IGAD"]
["2017-2019",null,"Multicountry Eastern Africa IGAD","AUP-Comp-000720","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00626","Multicountry Eastern Africa IGAD"]
["2017-2019","Angola",null,"AUP-Comp-000721","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00627","Angola"]
["2017-2019","Angola",null,"AUP-Comp-000722","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00627","Angola"]
["2017-2019","Angola",null,"AUP-Comp-000723","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00627","Angola"]
["2017-2019","Angola",null,"AUP-Comp-000724","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00627","Angola"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000735","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00634","Sierra Leone"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000736","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00634","Sierra Leone"]
["2017-2019","Sierra Leone",null,"AUP-Comp-000737","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00634","Sierra Leone"]
["2017-2019","Moldova",null,"AUP-Comp-000738","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00635","Moldova"]
["2017-2019","Moldova",null,"AUP-Comp-000739","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00635","Moldova"]
["2017-2019","Moldova",null,"AUP-Comp-000740","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00635","Moldova"]
["2017-2019","Moldova",null,"AUP-Comp-000741","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00635","Moldova"]
["2017-2019","Moldova",null,"AUP-Comp-000742","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00636","Moldova"]
["2017-2019","Moldova",null,"AUP-Comp-000743","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00636","Moldova"]
["2017-2019",null,"Multicountry Americas ICW","AUP-Comp-000744","HIV/AIDS",{"$nulls":11},"AUP-00637","Multicountry Americas ICW"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000751","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00640","Sao Tome and Principe"]
["2017-2019","Sao Tome and Principe",null,"AUP-Comp-000752","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00640","Sao Tome and Principe"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000756","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00642","Cabo Verde"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000757","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00642","Cabo Verde"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000758","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00642","Cabo Verde"]
["2017-2019","Cabo Verde",null,"AUP-Comp-000759","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00642","Cabo Verde"]
["2017-2019","Namibia",null,"AUP-Comp-000767","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00645","Namibia"]
["2017-2019","Namibia",null,"AUP-Comp-000764","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00645","Namibia"]
["2017-2019","Namibia",null,"AUP-Comp-000765","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00645","Namibia"]
["2017-2019","Namibia",null,"AUP-Comp-000766","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00645","Namibia"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000770","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00648","Tanzania (United Republic)"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000771","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00648","Tanzania (United Republic)"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000772","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00648","Tanzania (United Republic)"]
["2017-2019","Tanzania (United Republic)",null,"AUP-Comp-000773","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00648","Tanzania (United Republic)"]
["2017-2019","Namibia",null,"AUP-Comp-000778","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00651","Namibia"]
["2017-2019","Namibia",null,"AUP-Comp-000779","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00651","Namibia"]
["2017-2019","Namibia",null,"AUP-Comp-000780","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00651","Namibia"]
["2017-2019","South Sudan",null,"AUP-Comp-000781","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00652","South Sudan"]
["2017-2019","South Sudan",null,"AUP-Comp-000782","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00652","South Sudan"]
["2017-2019",null,"Multicountry South Asia","AUP-Comp-000784","HIV/AIDS",{"$nulls":6},"2017-01-01","2018-09-30",null,null,"Approved","AUP-00654","Multicountry South Asia"]
["2017-2019","India",null,"AUP-Comp-000785","RSSH",{"$nulls":11},"AUP-00655","India"]
["2017-2019","Sudan",null,"AUP-Comp-000786","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00656","Sudan"]
["2017-2019","Sudan",null,"AUP-Comp-000787","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00656","Sudan"]
["2017-2019","Sudan",null,"AUP-Comp-000788","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00656","Sudan"]
["2017-2019","Sudan",null,"AUP-Comp-000789","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00656","Sudan"]
["2017-2019","Chad",null,"AUP-Comp-000792","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00658","Chad"]
["2017-2019","Chad",null,"AUP-Comp-000793","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00658","Chad"]
["2017-2019","Afghanistan",null,"AUP-Comp-000798","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00661","Afghanistan"]
["2017-2019","Afghanistan",null,"AUP-Comp-000799","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00661","Afghanistan"]
["2017-2019","Kenya",null,"AUP-Comp-000818","RSSH",{"$nulls":11},"AUP-00674","Kenya"]
["2017-2019","Kenya",null,"AUP-Comp-000819","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00675","Kenya"]
["2017-2019","Kenya",null,"AUP-Comp-000820","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00675","Kenya"]
["2017-2019","Thailand",null,"AUP-Comp-000823","Malaria",{"$nulls":11},"AUP-00677","Thailand"]
["2017-2019",null,"Multicountry Americas REDTRASEX","AUP-Comp-000824","HIV/AIDS",{"$nulls":11},"AUP-00678","Multicountry Americas REDTRASEX"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000825","HIV/AIDS,Malaria,RSSH",{"$nulls":11},"AUP-00679","Zimbabwe"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000826","HIV/AIDS,Malaria,RSSH",{"$nulls":11},"AUP-00679","Zimbabwe"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000827","HIV/AIDS,Malaria,RSSH",{"$nulls":11},"AUP-00679","Zimbabwe"]
["2017-2019",null,"Multicountry EECA EHRN","AUP-Comp-000828","HIV/AIDS",{"$nulls":11},"AUP-00680","Multicountry EECA EHRN"]
["2017-2019","Uganda",null,"AUP-Comp-000832","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00684",{"$f":"IF(B515=\"\",C515,B515)","v":"Uganda"}]
["2017-2019","Uganda",null,"AUP-Comp-000833","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00684","Uganda"]
["2017-2019","Rwanda",null,"AUP-Comp-000837","RSSH",{"$nulls":11},"AUP-00686","Rwanda"]
["2017-2019","Uganda",null,"AUP-Comp-000838","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00687","Uganda"]
["2017-2019","Uganda",null,"AUP-Comp-000839","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00687","Uganda"]
["2017-2019","Uganda",null,"AUP-Comp-000840","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00687","Uganda"]
["2017-2019","Uganda",null,"AUP-Comp-000841","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00687","Uganda"]
["2017-2019",null,"Multicountry Americas EMMIE","AUP-Comp-000844","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00689","Multicountry Americas EMMIE"]
["2017-2019",null,"Multicountry Americas EMMIE","AUP-Comp-000845","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00689","Multicountry Americas EMMIE"]
["2017-2019",null,"Multicountry Americas EMMIE","AUP-Comp-000846","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00689","Multicountry Americas EMMIE"]
["2017-2019",null,"Multicountry Americas EMMIE","AUP-Comp-000847","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00689","Multicountry Americas EMMIE"]
["2017-2019","Kazakhstan",null,"AUP-Comp-000856","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00695","Kazakhstan"]
["2017-2019","Kazakhstan",null,"AUP-Comp-000857","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00695","Kazakhstan"]
["2017-2019","Kazakhstan",null,"AUP-Comp-000858","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00695","Kazakhstan"]
["2017-2019","Kazakhstan",null,"AUP-Comp-000859","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00695","Kazakhstan"]
["2017-2019","Kyrgyzstan",null,"AUP-Comp-000860","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00696","Kyrgyzstan"]
["2017-2019","Kyrgyzstan",null,"AUP-Comp-000861","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00696","Kyrgyzstan"]
["2017-2019","Kyrgyzstan",null,"AUP-Comp-000862","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00696","Kyrgyzstan"]
["2017-2019","Kyrgyzstan",null,"AUP-Comp-000863","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00696","Kyrgyzstan"]
["2017-2019","Djibouti",null,"AUP-Comp-000868","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00698","Djibouti"]
["2017-2019","Djibouti",null,"AUP-Comp-000869","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00698","Djibouti"]
["2017-2019","Djibouti",null,"AUP-Comp-000870","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00698","Djibouti"]
["2017-2019","Djibouti",null,"AUP-Comp-000871","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00698","Djibouti"]
["2017-2019",null,"Multicountry EECA ECUO","AUP-Comp-000875","HIV/AIDS",{"$nulls":6},"2015-11-01","2018-10-31",null,null,"Approved","AUP-00701","Multicountry EECA ECUO"]
["2017-2019","Switzerland",null,"AUP-Comp-000878","Tuberculosis",{"$nulls":11},"AUP-00703","Switzerland"]
["2017-2019",null,"Multicountry South-Eastern Asia AFAO","AUP-Comp-000879","HIV/AIDS",{"$nulls":6},"2017-01-01","2018-12-31",null,null,"Approved","AUP-00704","Multicountry South-Eastern Asia AFAO"]
["2017-2019",null,"Multicountry Eastern Africa IGAD","AUP-Comp-000880","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00705","Multicountry Eastern Africa IGAD"]
["2017-2019",null,"Multicountry Eastern Africa IGAD","AUP-Comp-000881","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00705","Multicountry Eastern Africa IGAD"]
["2017-2019",null,"Multicountry Eastern Africa IGAD","AUP-Comp-000882","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00705","Multicountry Eastern Africa IGAD"]
["2017-2019",null,"Multicountry Eastern Africa IGAD","AUP-Comp-000883","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00705","Multicountry Eastern Africa IGAD"]
["2017-2019","Romania",null,"AUP-Comp-000890","HIV/AIDS",{"$nulls":11},"AUP-00708","Romania"]
["2017-2019",null,"Multicountry Southern Africa E8","AUP-Comp-000895","Tuberculosis",{"$nulls":11},"AUP-00712","Multicountry Southern Africa E8"]
["2017-2019","Eswatini",null,"AUP-Comp-000897","Malaria,Tuberculosis",{"$nulls":11},"AUP-00714","Eswatini"]
["2017-2019","Eswatini",null,"AUP-Comp-000898","Malaria,Tuberculosis",{"$nulls":11},"AUP-00714","Eswatini"]
["2017-2019",null,"Multicountry Americas CVC-COIN","AUP-Comp-000904","HIV/AIDS",{"$nulls":11},"AUP-00718","Multicountry Americas CVC-COIN"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000908","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00722","Zimbabwe"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000909","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00722","Zimbabwe"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000910","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00722","Zimbabwe"]
["2017-2019",null,"Multicountry Southern Africa ARASA","AUP-Comp-000914","HIV/AIDS",{"$nulls":11},"AUP-00724","Multicountry Southern Africa ARASA"]
["2017-2019",null,"Multicountry Eastern Africa ANECCA","AUP-Comp-000915","HIV/AIDS",{"$nulls":11},"AUP-00725","Multicountry Eastern Africa ANECCA"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000917","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00727","Zimbabwe"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000918","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00727","Zimbabwe"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000919","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00727","Zimbabwe"]
["2017-2019","Zimbabwe",null,"AUP-Comp-000920","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00727","Zimbabwe"]
["2017-2019",null,"Multicountry Africa ECSA-HC","AUP-Comp-000925","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00729","Multicountry Africa ECSA-HC"]
["2017-2019",null,"Multicountry Africa ECSA-HC","AUP-Comp-000926","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00729","Multicountry Africa ECSA-HC"]
["2017-2019",null,"Multicountry Africa ECSA-HC","AUP-Comp-000927","HIV/AIDS,Malaria,Tuberculosis",{"$nulls":11},"AUP-00729","Multicountry Africa ECSA-HC"]
["2017-2019",null,"Multicountry West Africa ALCO","AUP-Comp-000930","HIV/AIDS",{"$nulls":10},"Rejected","AUP-00731","Multicountry West Africa ALCO"]
["2017-2019","Armenia",null,"AUP-Comp-000935","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00733","Armenia"]
["2017-2019","Armenia",null,"AUP-Comp-000932","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00733","Armenia"]
["2017-2019","Armenia",null,"AUP-Comp-000933","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00733","Armenia"]
["2017-2019","Armenia",null,"AUP-Comp-000934","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00733","Armenia"]
["2017-2019",null,"Multicountry Caribbean MCC","AUP-Comp-000947","Malaria",{"$nulls":11},"AUP-00744","Multicountry Caribbean MCC"]
["2017-2019",null,"Multicountry Caribbean MCC","AUP-Comp-000948","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00745","Multicountry Caribbean MCC"]
["2017-2019",null,"Multicountry Caribbean MCC","AUP-Comp-000949","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00745","Multicountry Caribbean MCC"]
["2017-2019",null,"Multicountry Caribbean MCC","AUP-Comp-000950","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00745","Multicountry Caribbean MCC"]
["2017-2019",null,"Multicountry Caribbean MCC","AUP-Comp-000951","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00745","Multicountry Caribbean MCC"]
["2017-2019",null,"Multicountry Americas EMMIE","AUP-Comp-000952","Tuberculosis",{"$nulls":11},"AUP-00746","Multicountry Americas EMMIE"]
["2017-2019","Afghanistan",null,"AUP-Comp-000956","RSSH",{"$nulls":11},"AUP-00749","Afghanistan"]
["2017-2019","Albania",null,"AUP-Comp-000957","Malaria",{"$nulls":11},"AUP-00750","Albania"]
["2017-2019","Albania",null,"AUP-Comp-000958","RSSH",{"$nulls":11},"AUP-00751","Albania"]
["2017-2019","Algeria",null,"AUP-Comp-000959","Malaria",{"$nulls":11},"AUP-00752","Algeria"]
["2017-2019","Algeria",null,"AUP-Comp-000960","Tuberculosis",{"$nulls":11},"AUP-00753","Algeria"]
["2017-2019","Armenia",null,"AUP-Comp-000961","Malaria",{"$nulls":11},"AUP-00754","Armenia"]
["2017-2019","Chad",null,"AUP-Comp-000962","RSSH",{"$nulls":11},"AUP-00755",{"$f":"IF(B579=\"\",C579,B579)","v":"Chad"}]
["2017-2019","Colombia",null,"AUP-Comp-000963","Malaria",{"$nulls":11},"AUP-00756","Colombia"]
["2017-2019","Colombia",null,"AUP-Comp-000964","RSSH",{"$nulls":11},"AUP-00757","Colombia"]
["2017-2019","Colombia",null,"AUP-Comp-000965","Tuberculosis",{"$nulls":11},"AUP-00758","Colombia"]
["2017-2019","Congo (Democratic Republic)",null,"AUP-Comp-000966","RSSH",{"$nulls":11},"AUP-00759","Congo (Democratic Republic)"]
["2017-2019","Costa Rica",null,"AUP-Comp-000967","Malaria",{"$nulls":11},"AUP-00760","Costa Rica"]
["2017-2019","Cuba",null,"AUP-Comp-000968","Malaria",{"$nulls":11},"AUP-00761","Cuba"]
["2017-2019","Cuba",null,"AUP-Comp-000969","Tuberculosis",{"$nulls":11},"AUP-00762","Cuba"]
["2017-2019","Dominican Republic",null,"AUP-Comp-000970","Malaria",{"$nulls":11},"AUP-00763","Dominican Republic"]
["2017-2019","Ecuador",null,"AUP-Comp-000971","Malaria",{"$nulls":11},"AUP-00764","Ecuador"]
["2017-2019","Ecuador",null,"AUP-Comp-000972","Tuberculosis",{"$nulls":11},"AUP-00765","Ecuador"]
["2017-2019","Egypt",null,"AUP-Comp-000973","HIV/AIDS",{"$nulls":11},"AUP-00766","Egypt"]
["2017-2019","Egypt",null,"AUP-Comp-000974","Tuberculosis",{"$nulls":11},"AUP-00767","Egypt"]
["2017-2019","Egypt",null,"AUP-Comp-000975","Malaria",{"$nulls":11},"AUP-00768","Egypt"]
["2017-2019","El Salvador",null,"AUP-Comp-000976","Malaria",{"$nulls":11},"AUP-00769","El Salvador"]
["2017-2019","Gabon",null,"AUP-Comp-000977","HIV/AIDS",{"$nulls":11},"AUP-00770","Gabon"]
["2017-2019","Gabon",null,"AUP-Comp-000978","Malaria",{"$nulls":11},"AUP-00771","Gabon"]
["2017-2019","Georgia",null,"AUP-Comp-000979","Malaria",{"$nulls":11},"AUP-00772","Georgia"]
["2017-2019","Iran (Islamic Republic)",null,"AUP-Comp-000980","Malaria",{"$nulls":11},"AUP-00773","Iran (Islamic Republic)"]
["2017-2019","Iran (Islamic Republic)",null,"AUP-Comp-000981","Tuberculosis",{"$nulls":11},"AUP-00774","Iran (Islamic Republic)"]
["2017-2019","Jamaica",null,"AUP-Comp-000982","Tuberculosis",{"$nulls":11},"AUP-00775","Jamaica"]
["2017-2019","Jamaica",null,"AUP-Comp-000983","Malaria",{"$nulls":11},"AUP-00776","Jamaica"]
["2017-2019","Korea (Democratic Peoples Republic)",null,"AUP-Comp-000984","HIV/AIDS",{"$nulls":11},"AUP-00777","Korea (Democratic Peoples Republic)"]
["2017-2019","Kyrgyzstan",null,"AUP-Comp-000985","Malaria",{"$nulls":11},"AUP-00778","Kyrgyzstan"]
["2017-2019","Lao (Peoples Democratic Republic)",null,"AUP-Comp-000986","Malaria",{"$nulls":11},"AUP-00779","Lao (Peoples Democratic Republic)"]
["2017-2019","Lesotho",null,"AUP-Comp-000987","Malaria",{"$nulls":11},"AUP-00780","Lesotho"]
["2017-2019","Malaysia",null,"AUP-Comp-000988","Tuberculosis",{"$nulls":11},"AUP-00781","Malaysia"]
["2017-2019","Mauritius",null,"AUP-Comp-000989","Tuberculosis",{"$nulls":11},"AUP-00782","Mauritius"]
["2017-2019","Mauritius",null,"AUP-Comp-000990","Malaria",{"$nulls":11},"AUP-00783","Mauritius"]
["2017-2019","Moldova",null,"AUP-Comp-000991","Malaria",{"$nulls":11},"AUP-00784","Moldova"]
["2017-2019","Mongolia",null,"AUP-Comp-000992","Malaria",{"$nulls":11},"AUP-00785","Mongolia"]
["2017-2019","Montenegro",null,"AUP-Comp-000993","Malaria",{"$nulls":11},"AUP-00786","Montenegro"]
["2017-2019","Morocco",null,"AUP-Comp-000994","Malaria",{"$nulls":11},"AUP-00787","Morocco"]
["2017-2019","Myanmar",null,"AUP-Comp-000995","Malaria",{"$nulls":11},"AUP-00788","Myanmar"]
["2017-2019","Panama",null,"AUP-Comp-000996","Malaria",{"$nulls":11},"AUP-00789","Panama"]
["2017-2019","Paraguay",null,"AUP-Comp-000997","Malaria",{"$nulls":11},"AUP-00790","Paraguay"]
["2017-2019","Peru",null,"AUP-Comp-000998","Malaria",{"$nulls":11},"AUP-00791","Peru"]
["2017-2019","Romania",null,"AUP-Comp-000999","Malaria",{"$nulls":11},"AUP-00792","Romania"]
["2017-2019","Serbia",null,"AUP-Comp-001000","Malaria",{"$nulls":11},"AUP-00793","Serbia"]
["2017-2019","Serbia",null,"AUP-Comp-001001","Tuberculosis",{"$nulls":11},"AUP-00794","Serbia"]
["2017-2019","Solomon Islands",null,"AUP-Comp-001002","HIV/AIDS",{"$nulls":11},"AUP-00795","Solomon Islands"]
["2017-2019","Tunisia",null,"AUP-Comp-001003","Malaria",{"$nulls":11},"AUP-00796","Tunisia"]
["2017-2019","Turkmenistan",null,"AUP-Comp-001004","HIV/AIDS",{"$nulls":11},"AUP-00797","Turkmenistan"]
["2017-2019","Turkmenistan",null,"AUP-Comp-001005","Malaria",{"$nulls":11},"AUP-00798","Turkmenistan"]
["2017-2019","Ukraine",null,"AUP-Comp-001006","Malaria",{"$nulls":11},"AUP-00799","Ukraine"]
["2017-2019","Uzbekistan",null,"AUP-Comp-001007","Malaria",{"$nulls":11},"AUP-00800","Uzbekistan"]
["2017-2019",null,"Multicountry Americas EMMIE","AUP-Comp-001008","HIV/AIDS",{"$nulls":11},"AUP-00801","Multicountry Americas EMMIE"]
["2017-2019",null,"Multicountry East Asia and Pacific RAI","AUP-Comp-001009","HIV/AIDS",{"$nulls":11},"AUP-00802","Multicountry East Asia and Pacific RAI"]
["2017-2019",null,"Multicountry East Asia and Pacific RAI","AUP-Comp-001010","Tuberculosis",{"$nulls":11},"AUP-00803","Multicountry East Asia and Pacific RAI"]
["2017-2019",null,"Multicountry Southern Africa E8","AUP-Comp-001011","HIV/AIDS",{"$nulls":11},"AUP-00804","Multicountry Southern Africa E8"]
["2017-2019",null,"Multicountry Southern Africa MOSASWA","AUP-Comp-001012","HIV/AIDS",{"$nulls":11},"AUP-00805","Multicountry Southern Africa MOSASWA"]
["2017-2019",null,"Multicountry Southern Africa MOSASWA","AUP-Comp-001013","RSSH",{"$nulls":11},"AUP-00806","Multicountry Southern Africa MOSASWA"]
["2017-2019",null,"Multicountry Africa ECSA-HC","AUP-Comp-001014","HIV/AIDS",{"$nulls":11},"AUP-00807","Multicountry Africa ECSA-HC"]
["2017-2019",null,"Multicountry South-Eastern Asia AFAO","AUP-Comp-001015","Malaria",{"$nulls":11},"AUP-00808","Multicountry South-Eastern Asia AFAO"]
["2017-2019",null,"Multicountry South-Eastern Asia AFAO","AUP-Comp-001016","RSSH",{"$nulls":11},"AUP-00809","Multicountry South-Eastern Asia AFAO"]
["2017-2019",null,"Multicountry South-Eastern Asia AFAO","AUP-Comp-001017","Tuberculosis",{"$nulls":11},"AUP-00810","Multicountry South-Eastern Asia AFAO"]
["2017-2019",null,"Multicountry TB Asia UNDP","AUP-Comp-001018","HIV/AIDS",{"$nulls":11},"AUP-00811","Multicountry TB Asia UNDP"]
["2017-2019","Nigeria",null,"AUP-Comp-001020","HIV/AIDS,RSSH,Tuberculosis",{"$nulls":11},"AUP-00813","Nigeria"]
["2017-2019","Nigeria",null,"AUP-Comp-001021","HIV/AIDS,RSSH,Tuberculosis",{"$nulls":11},"AUP-00813","Nigeria"]
["2017-2019","Nigeria",null,"AUP-Comp-001022","HIV/AIDS,RSSH,Tuberculosis",{"$nulls":11},"AUP-00813","Nigeria"]
["2017-2019","South Africa",null,"AUP-Comp-001025","HIV/AIDS,Malaria,RSSH",{"$nulls":11},"AUP-00814","South Africa"]
["2017-2019","South Africa",null,"AUP-Comp-001023","HIV/AIDS,Malaria,RSSH",{"$nulls":11},"AUP-00814","South Africa"]
["2017-2019","South Africa",null,"AUP-Comp-001024","HIV/AIDS,Malaria,RSSH",{"$nulls":11},"AUP-00814","South Africa"]
["2017-2019","South Africa",null,"AUP-Comp-001026","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00815","South Africa"]
["2017-2019","South Africa",null,"AUP-Comp-001027","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00815",{"$f":"IF(B643=\"\",C643,B643)","v":"South Africa"}]
["2017-2019","South Africa",null,"AUP-Comp-001028","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00815","South Africa"]
["2017-2019","South Africa",null,"AUP-Comp-001029","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00815","South Africa"]
["2017-2019",null,"Multicountry Africa ECSA-HC","AUP-Comp-001031","Malaria",{"$nulls":11},"AUP-00817","Multicountry Africa ECSA-HC"]
["2017-2019",null,"Multicountry Africa ECSA-HC","AUP-Comp-001032","RSSH",{"$nulls":11},"AUP-00818","Multicountry Africa ECSA-HC"]
["2017-2019",null,"Multicountry Southern Africa MOSASWA","AUP-Comp-001033","Tuberculosis",{"$nulls":11},"AUP-00819","Multicountry Southern Africa MOSASWA"]
["2017-2019",null,"Multicountry Southern Africa MOSASWA","AUP-Comp-001034","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00820","Multicountry Southern Africa MOSASWA"]
["2017-2019",null,"Multicountry Southern Africa MOSASWA","AUP-Comp-001035","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00820","Multicountry Southern Africa MOSASWA"]
["2017-2019",null,"Multicountry Southern Africa MOSASWA","AUP-Comp-001036","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00820","Multicountry Southern Africa MOSASWA"]
["2017-2019",null,"Multicountry Southern Africa MOSASWA","AUP-Comp-001037","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00820","Multicountry Southern Africa MOSASWA"]
["2017-2019","Afghanistan",null,"AUP-Comp-001041","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00823","Afghanistan"]
["2017-2019","Afghanistan",null,"AUP-Comp-001042","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00823","Afghanistan"]
["2017-2019","Afghanistan",null,"AUP-Comp-001043","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00823","Afghanistan"]
["2017-2019","Afghanistan",null,"AUP-Comp-001044","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00823","Afghanistan"]
["2017-2019",null,"Multicountry South-Eastern Asia AFAO","AUP-Comp-001047","Malaria",{"$nulls":11},"AUP-00826","Multicountry South-Eastern Asia AFAO"]
["2017-2019","Angola",null,"AUP-Comp-001055","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00832","Angola"]
["2017-2019","Angola",null,"AUP-Comp-001056","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00832","Angola"]
["2017-2019",null,"Multicountry EECA EHRN","AUP-Comp-001061","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00835","Multicountry EECA EHRN"]
["2017-2019",null,"Multicountry EECA EHRN","AUP-Comp-001062","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00835","Multicountry EECA EHRN"]
["2017-2019",null,"Multicountry EECA ECOM","AUP-Comp-001063","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00836","Multicountry EECA ECOM"]
["2017-2019",null,"Multicountry EECA ECOM","AUP-Comp-001064","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00836","Multicountry EECA ECOM"]
["2017-2019",null,"Multicountry EECA ECUO","AUP-Comp-001065","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00837","Multicountry EECA ECUO"]
["2017-2019",null,"Multicountry EECA ECUO","AUP-Comp-001066","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00837","Multicountry EECA ECUO"]
["2017-2019",null,"Multicountry EECA PAS","AUP-Comp-001067","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00838","Multicountry EECA PAS"]
["2017-2019",null,"Multicountry EECA PAS","AUP-Comp-001068","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00838","Multicountry EECA PAS"]
["2017-2019",null,"Multicountry East Asia and Pacific HIVOS","AUP-Comp-001072","HIV/AIDS",{"$nulls":11},"AUP-00841","Multicountry East Asia and Pacific HIVOS"]
["2017-2019","Mauritania",null,"AUP-Comp-001080","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00849","Mauritania"]
["2017-2019","Mauritania",null,"AUP-Comp-001081","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00849","Mauritania"]
["2017-2019","Mauritania",null,"AUP-Comp-001082","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00849","Mauritania"]
["2017-2019","Mauritania",null,"AUP-Comp-001083","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00849","Mauritania"]
["2017-2019","Egypt",null,"AUP-Comp-001088","RSSH",{"$nulls":11},"AUP-00851","Egypt"]
["2017-2019",null,"Multicountry Caribbean CARICOM-PANCAP","AUP-Comp-001092","HIV/AIDS",{"$nulls":10},"Rejected","AUP-00854","Multicountry Caribbean CARICOM-PANCAP"]
["2017-2019",null,"Multicountry Central Americas REDCA","AUP-Comp-001095","HIV/AIDS",{"$nulls":6},"2016-07-01","2019-12-31",null,null,"Approved","AUP-00857","Multicountry Central Americas REDCA"]
["2017-2019","Bolivia (Plurinational State)",null,"AUP-Comp-001097","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00859","Bolivia (Plurinational State)"]
["2017-2019","Bolivia (Plurinational State)",null,"AUP-Comp-001098","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00859","Bolivia (Plurinational State)"]
["2017-2019","Bolivia (Plurinational State)",null,"AUP-Comp-001099","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00859","Bolivia (Plurinational State)"]
["2017-2019","Bolivia (Plurinational State)",null,"AUP-Comp-001100","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00859","Bolivia (Plurinational State)"]
["2017-2019","Burkina Faso",null,"AUP-Comp-001101","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00860","Burkina Faso"]
["2017-2019","Burkina Faso",null,"AUP-Comp-001102","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00860","Burkina Faso"]
["2017-2019","Burkina Faso",null,"AUP-Comp-001103","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00860","Burkina Faso"]
["2017-2019","Burkina Faso",null,"AUP-Comp-001104","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00860","Burkina Faso"]
["2017-2019","Bhutan",null,"AUP-Comp-001105","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00861","Bhutan"]
["2017-2019","Bhutan",null,"AUP-Comp-001106","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00861","Bhutan"]
["2017-2019","Bhutan",null,"AUP-Comp-001107","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00861","Bhutan"]
["2017-2019","Bhutan",null,"AUP-Comp-001108","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00861","Bhutan"]
["2017-2019","Benin",null,"AUP-Comp-001109","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00862","Benin"]
["2017-2019","Benin",null,"AUP-Comp-001110","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00862","Benin"]
["2017-2019","Benin",null,"AUP-Comp-001111","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00862","Benin"]
["2017-2019","Benin",null,"AUP-Comp-001112","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00862","Benin"]
["2017-2019","Bangladesh",null,"AUP-Comp-001113","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00863","Bangladesh"]
["2017-2019","Bangladesh",null,"AUP-Comp-001114","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00863","Bangladesh"]
["2017-2019","Bangladesh",null,"AUP-Comp-001115","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00863","Bangladesh"]
["2017-2019","Bangladesh",null,"AUP-Comp-001116","HIV/AIDS,Malaria,RSSH,Tuberculosis",{"$nulls":11},"AUP-00863","Bangladesh"]
["2017-2019","Afghanistan",null,"AUP-Comp-001119","HIV/AIDS,Malaria",{"$nulls":11},"AUP-00865","Afghanistan"]
["2017-2019","Afghanistan",null,"AUP-Comp-001120","HIV/AIDS,Malaria",{"$nulls":11},"AUP-00865","Afghanistan"]
["2017-2019","Mauritania",null,"AUP-Comp-001124","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00867","Mauritania"]
["2017-2019","Mauritania",null,"AUP-Comp-001125","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00867","Mauritania"]
["2017-2019","Kazakhstan",null,"AUP-Comp-001131","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00871","Kazakhstan"]
["2017-2019","Kazakhstan",null,"AUP-Comp-001132","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00871","Kazakhstan"]
["2017-2019",null,"Multicountry Americas (Andean)","AUP-Comp-001133","HIV/AIDS,Malaria",{"$nulls":11},"AUP-00872","Multicountry Americas (Andean)"]
["2017-2019",null,"Multicountry Americas (Andean)","AUP-Comp-001134","HIV/AIDS,Malaria",{"$nulls":11},"AUP-00872","Multicountry Americas (Andean)"]
["2017-2019",null,"Multicountry Americas EMMIE","AUP-Comp-001135","HIV/AIDS,Malaria",{"$nulls":11},"AUP-00873","Multicountry Americas EMMIE"]
["2017-2019",null,"Multicountry Americas EMMIE","AUP-Comp-001136","HIV/AIDS,Malaria",{"$nulls":11},"AUP-00873","Multicountry Americas EMMIE"]
["2017-2019","Sudan",null,"AUP-Comp-001137","RSSH",{"$nulls":11},"AUP-00874","Sudan"]
["2017-2019","Sudan",null,"AUP-Comp-001138","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00875",{"$f":"IF(B707=\"\",C707,B707)","v":"Sudan"}]
["2017-2019","Sudan",null,"AUP-Comp-001139","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-00875","Sudan"]
["2017-2019","Turkmenistan",null,"AUP-Comp-002459","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-01566","Turkmenistan"]
["2017-2019","Turkmenistan",null,"AUP-Comp-002460","HIV/AIDS,Tuberculosis",{"$nulls":11},"AUP-01566","Turkmenistan"]
["2017-2019","Sri Lanka",null,"AUP-Comp-003374","RSSH",{"$nulls":11},"AUP-02070","Sri Lanka"]
["2017-2019","Liberia",null,"AUP-Comp-003394","RSSH",{"$nulls":11},"AUP-02081","Liberia"]
["2017-2019","Guyana",null,"AUP-Comp-003398","RSSH",{"$nulls":11},"AUP-02084","Guyana"]